Gene	gene_variant	Bio_Batch	U2OS_cc_t_stat	U2OS_cc_t_pval	U2OS_cc_t_pval_fdr_bh_adj	U2OS_prot_abun_t_stat	U2OS_prot_abun_t_pval	U2OS_prot_abun_t_pval_fdr_bh_adj	Metadata_Bio_Batch	Altered_95th_perc_both_batches_GFP_ADJ	Altered_95th_perc_both_batches_GFP	Altered_95th_perc_both_batches_DNA	Altered_95th_perc_both_batches_Mito	Altered_95th_perc_both_batches_AGP	Altered_95th_perc_both_batches_Morph	Altered_99th_perc_both_batches_GFP_ADJ	Altered_99th_perc_both_batches_GFP	Altered_99th_perc_both_batches_DNA	Altered_99th_perc_both_batches_Mito	Altered_99th_perc_both_batches_AGP	Altered_99th_perc_both_batches_Morph	AUROC_Mean_GFP_ADJ	AUROC_Mean_GFP	AUROC_Mean_DNA	AUROC_Mean_Mito	AUROC_Mean_AGP	AUROC_Mean_Morph	AUROC_BioRep1_Morph	AUROC_BioRep1_AGP	AUROC_BioRep1_Mito	AUROC_BioRep1_DNA	AUROC_BioRep1_GFP	AUROC_BioRep1_GFP_ADJ	AUROC_BioRep2_Morph	AUROC_BioRep2_AGP	AUROC_BioRep2_Mito	AUROC_BioRep2_DNA	AUROC_BioRep2_GFP	AUROC_BioRep2_GFP_ADJ	symbol	aa_change	spdi	nt_change	chr_num	nuc_loc	ref_allele	alt_allele	Chrom	ensembl_gene_id	orf_id	mut_id	ccsb_mutation_id	ccsb_allele_id	ensembl_protein_id	collection	entry_plate_orig	entry_well_orig	entry_plate_conso	entry_well_conso	entry_seq_pool	db_plate	db_well	n2h_plate	n2h_well	dualip_plate	dualip_well	mislocalization_plate	mislocalization_well	entry_sequenced	entry_sequence_confirmation_class	db_sequenced	db_sequence_confirmation_class	n2h_sequenced	n2h_sequence_confirmation_class	n2h_ref_sequence_confirmation_class	dualip_sequenced	dualip_sequence_confirmation_class	dualip_ref_sequence_confirmation_class	mislocalization_sequenced	mislocalization_sequence_confirmation_class	mislocalization_ref_sequence_confirmation_class	entry_seq_final	db_seq_final	n2h_seq_final	dualip_seq_final	mislocalization_seq_final	#AlleleID	Type	Name	GeneID	GeneSymbol	HGNC_ID	ClinicalSignificance	ClinSigSimple	LastEvaluated	RS# (dbSNP)	nsv/esv (dbVar)	RCVaccession	PhenotypeIDS	PhenotypeList	Origin	OriginSimple	Assembly	ChromosomeAccession	Chromosome	Start	Stop	Cytogenetic	ReviewStatus	NumberSubmitters	Guidelines	TestedInGTR	OtherIDs	SubmitterCategories	VariationID	PositionVCF	ReferenceAlleleVCF	AlternateAlleleVCF	SomaticClinicalImpact	SomaticClinicalImpactLastEvaluated	ReviewStatusClinicalImpact	Oncogenicity	OncogenicityLastEvaluated	ReviewStatusOncogenicity	clinvar_nt_change	clinvar_aa_change	RefSeq_mRNA	StarStatus	clinvar_clnsig_clean	clinvar_clnsig_clean_pp_strict	clinvar_id	#chr	pos(1-based)	ref	alt	aaref	aaalt	rs_dbSNP	hg19_chr	hg19_pos(1-based)	hg18_chr	hg18_pos(1-based)	aapos	genename	Ensembl_geneid	Ensembl_transcriptid	Ensembl_proteinid	Uniprot_acc	Uniprot_entry	HGVSc_snpEff	HGVSp_snpEff	HGVSc_VEP	HGVSp_VEP	APPRIS	GENCODE_basic	TSL	VEP_canonical	MANE	cds_strand	refcodon	codonpos	codon_degeneracy	Ancestral_allele	AltaiNeandertal	Denisova	VindijiaNeandertal	ChagyrskayaNeandertal	SIFT_score	SIFT_converted_rankscore	SIFT_pred	SIFT4G_score	SIFT4G_converted_rankscore	SIFT4G_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationTaster_model	MutationTaster_trees_benign	MutationTaster_trees_deleterious	MutationAssessor_score	MutationAssessor_rankscore	MutationAssessor_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST4_score	VEST4_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	Reliability_index	MetaRNN_score	MetaRNN_rankscore	MetaRNN_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	REVEL_score	REVEL_rankscore	MutPred_score	MutPred_rankscore	MutPred_protID	MutPred_AAchange	MutPred_Top5features	MVP_score	MVP_rankscore	gMVP_score	gMVP_rankscore	MPC_score	MPC_rankscore	PrimateAI_score	PrimateAI_rankscore	PrimateAI_pred	DEOGEN2_score	DEOGEN2_rankscore	DEOGEN2_pred	BayesDel_addAF_score	BayesDel_addAF_rankscore	BayesDel_addAF_pred	BayesDel_noAF_score	BayesDel_noAF_rankscore	BayesDel_noAF_pred	ClinPred_score	ClinPred_rankscore	ClinPred_pred	LIST-S2_score	LIST-S2_rankscore	LIST-S2_pred	VARITY_R_score	VARITY_R_rankscore	VARITY_ER_score	VARITY_ER_rankscore	VARITY_R_LOO_score	VARITY_R_LOO_rankscore	VARITY_ER_LOO_score	VARITY_ER_LOO_rankscore	ESM1b_score	ESM1b_rankscore	ESM1b_pred	AlphaMissense_score	AlphaMissense_rankscore	AlphaMissense_pred	PHACTboost_score	PHACTboost_rankscore	MutFormer_score	MutFormer_rankscore	MutScore_score	MutScore_rankscore	Aloft_Fraction_transcripts_affected	Aloft_prob_Tolerant	Aloft_prob_Recessive	Aloft_prob_Dominant	Aloft_pred	Aloft_Confidence	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-XF_coding_score	fathmm-XF_coding_rankscore	fathmm-XF_coding_pred	Eigen-raw_coding	Eigen-raw_coding_rankscore	Eigen-phred_coding	Eigen-PC-raw_coding	Eigen-PC-raw_coding_rankscore	Eigen-PC-phred_coding	GERP++_NR	GERP++_RS	GERP++_RS_rankscore	GERP_91_mammals	GERP_91_mammals_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP470way_mammalian	phyloP470way_mammalian_rankscore	phyloP17way_primate	phyloP17way_primate_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons470way_mammalian	phastCons470way_mammalian_rankscore	phastCons17way_primate	phastCons17way_primate_rankscore	bStatistic	bStatistic_converted_rankscore	1000Gp3_AC	1000Gp3_AF	1000Gp3_AFR_AC	1000Gp3_AFR_AF	1000Gp3_EUR_AC	1000Gp3_EUR_AF	1000Gp3_AMR_AC	1000Gp3_AMR_AF	1000Gp3_EAS_AC	1000Gp3_EAS_AF	1000Gp3_SAS_AC	1000Gp3_SAS_AF	TOPMed_frz8_AC	TOPMed_frz8_AN	TOPMed_frz8_AF	gnomAD2.1.1_exomes_flag	gnomAD2.1.1_exomes_controls_AC	gnomAD2.1.1_exomes_controls_AN	gnomAD2.1.1_exomes_controls_AF	gnomAD2.1.1_exomes_controls_nhomalt	gnomAD2.1.1_exomes_non_neuro_AC	gnomAD2.1.1_exomes_non_neuro_AN	gnomAD2.1.1_exomes_non_neuro_AF	gnomAD2.1.1_exomes_non_neuro_nhomalt	gnomAD2.1.1_exomes_non_cancer_AC	gnomAD2.1.1_exomes_non_cancer_AN	gnomAD2.1.1_exomes_non_cancer_AF	gnomAD2.1.1_exomes_non_cancer_nhomalt	gnomAD2.1.1_exomes_controls_AFR_AC	gnomAD2.1.1_exomes_controls_AFR_AN	gnomAD2.1.1_exomes_controls_AFR_AF	gnomAD2.1.1_exomes_controls_AFR_nhomalt	gnomAD2.1.1_exomes_controls_AMR_AC	gnomAD2.1.1_exomes_controls_AMR_AN	gnomAD2.1.1_exomes_controls_AMR_AF	gnomAD2.1.1_exomes_controls_AMR_nhomalt	gnomAD2.1.1_exomes_controls_ASJ_AC	gnomAD2.1.1_exomes_controls_ASJ_AN	gnomAD2.1.1_exomes_controls_ASJ_AF	gnomAD2.1.1_exomes_controls_ASJ_nhomalt	gnomAD2.1.1_exomes_controls_EAS_AC	gnomAD2.1.1_exomes_controls_EAS_AN	gnomAD2.1.1_exomes_controls_EAS_AF	gnomAD2.1.1_exomes_controls_EAS_nhomalt	gnomAD2.1.1_exomes_controls_FIN_AC	gnomAD2.1.1_exomes_controls_FIN_AN	gnomAD2.1.1_exomes_controls_FIN_AF	gnomAD2.1.1_exomes_controls_FIN_nhomalt	gnomAD2.1.1_exomes_controls_NFE_AC	gnomAD2.1.1_exomes_controls_NFE_AN	gnomAD2.1.1_exomes_controls_NFE_AF	gnomAD2.1.1_exomes_controls_NFE_nhomalt	gnomAD2.1.1_exomes_controls_SAS_AC	gnomAD2.1.1_exomes_controls_SAS_AN	gnomAD2.1.1_exomes_controls_SAS_AF	gnomAD2.1.1_exomes_controls_SAS_nhomalt	gnomAD2.1.1_exomes_controls_POPMAX_AC	gnomAD2.1.1_exomes_controls_POPMAX_AN	gnomAD2.1.1_exomes_controls_POPMAX_AF	gnomAD2.1.1_exomes_controls_POPMAX_nhomalt	gnomAD2.1.1_exomes_non_neuro_AFR_AC	gnomAD2.1.1_exomes_non_neuro_AFR_AN	gnomAD2.1.1_exomes_non_neuro_AFR_AF	gnomAD2.1.1_exomes_non_neuro_AFR_nhomalt	gnomAD2.1.1_exomes_non_neuro_AMR_AC	gnomAD2.1.1_exomes_non_neuro_AMR_AN	gnomAD2.1.1_exomes_non_neuro_AMR_AF	gnomAD2.1.1_exomes_non_neuro_AMR_nhomalt	gnomAD2.1.1_exomes_non_neuro_ASJ_AC	gnomAD2.1.1_exomes_non_neuro_ASJ_AN	gnomAD2.1.1_exomes_non_neuro_ASJ_AF	gnomAD2.1.1_exomes_non_neuro_ASJ_nhomalt	gnomAD2.1.1_exomes_non_neuro_EAS_AC	gnomAD2.1.1_exomes_non_neuro_EAS_AN	gnomAD2.1.1_exomes_non_neuro_EAS_AF	gnomAD2.1.1_exomes_non_neuro_EAS_nhomalt	gnomAD2.1.1_exomes_non_neuro_FIN_AC	gnomAD2.1.1_exomes_non_neuro_FIN_AN	gnomAD2.1.1_exomes_non_neuro_FIN_AF	gnomAD2.1.1_exomes_non_neuro_FIN_nhomalt	gnomAD2.1.1_exomes_non_neuro_NFE_AC	gnomAD2.1.1_exomes_non_neuro_NFE_AN	gnomAD2.1.1_exomes_non_neuro_NFE_AF	gnomAD2.1.1_exomes_non_neuro_NFE_nhomalt	gnomAD2.1.1_exomes_non_neuro_SAS_AC	gnomAD2.1.1_exomes_non_neuro_SAS_AN	gnomAD2.1.1_exomes_non_neuro_SAS_AF	gnomAD2.1.1_exomes_non_neuro_SAS_nhomalt	gnomAD2.1.1_exomes_non_neuro_POPMAX_AC	gnomAD2.1.1_exomes_non_neuro_POPMAX_AN	gnomAD2.1.1_exomes_non_neuro_POPMAX_AF	gnomAD2.1.1_exomes_non_neuro_POPMAX_nhomalt	gnomAD2.1.1_exomes_non_cancer_AFR_AC	gnomAD2.1.1_exomes_non_cancer_AFR_AN	gnomAD2.1.1_exomes_non_cancer_AFR_AF	gnomAD2.1.1_exomes_non_cancer_AFR_nhomalt	gnomAD2.1.1_exomes_non_cancer_AMR_AC	gnomAD2.1.1_exomes_non_cancer_AMR_AN	gnomAD2.1.1_exomes_non_cancer_AMR_AF	gnomAD2.1.1_exomes_non_cancer_AMR_nhomalt	gnomAD2.1.1_exomes_non_cancer_ASJ_AC	gnomAD2.1.1_exomes_non_cancer_ASJ_AN	gnomAD2.1.1_exomes_non_cancer_ASJ_AF	gnomAD2.1.1_exomes_non_cancer_ASJ_nhomalt	gnomAD2.1.1_exomes_non_cancer_EAS_AC	gnomAD2.1.1_exomes_non_cancer_EAS_AN	gnomAD2.1.1_exomes_non_cancer_EAS_AF	gnomAD2.1.1_exomes_non_cancer_EAS_nhomalt	gnomAD2.1.1_exomes_non_cancer_FIN_AC	gnomAD2.1.1_exomes_non_cancer_FIN_AN	gnomAD2.1.1_exomes_non_cancer_FIN_AF	gnomAD2.1.1_exomes_non_cancer_FIN_nhomalt	gnomAD2.1.1_exomes_non_cancer_NFE_AC	gnomAD2.1.1_exomes_non_cancer_NFE_AN	gnomAD2.1.1_exomes_non_cancer_NFE_AF	gnomAD2.1.1_exomes_non_cancer_NFE_nhomalt	gnomAD2.1.1_exomes_non_cancer_SAS_AC	gnomAD2.1.1_exomes_non_cancer_SAS_AN	gnomAD2.1.1_exomes_non_cancer_SAS_AF	gnomAD2.1.1_exomes_non_cancer_SAS_nhomalt	gnomAD2.1.1_exomes_non_cancer_POPMAX_AC	gnomAD2.1.1_exomes_non_cancer_POPMAX_AN	gnomAD2.1.1_exomes_non_cancer_POPMAX_AF	gnomAD2.1.1_exomes_non_cancer_POPMAX_nhomalt	gnomAD4.1_joint_flag	gnomAD4.1_joint_AC	gnomAD4.1_joint_AN	gnomAD4.1_joint_AF	gnomAD4.1_joint_nhomalt	gnomAD4.1_joint_POPMAX_AC	gnomAD4.1_joint_POPMAX_AN	gnomAD4.1_joint_POPMAX_AF	gnomAD4.1_joint_POPMAX_nhomalt	gnomAD4.1_joint_AFR_AC	gnomAD4.1_joint_AFR_AN	gnomAD4.1_joint_AFR_AF	gnomAD4.1_joint_AFR_nhomalt	gnomAD4.1_joint_AMI_AC	gnomAD4.1_joint_AMI_AN	gnomAD4.1_joint_AMI_AF	gnomAD4.1_joint_AMI_nhomalt	gnomAD4.1_joint_AMR_AC	gnomAD4.1_joint_AMR_AN	gnomAD4.1_joint_AMR_AF	gnomAD4.1_joint_AMR_nhomalt	gnomAD4.1_joint_ASJ_AC	gnomAD4.1_joint_ASJ_AN	gnomAD4.1_joint_ASJ_AF	gnomAD4.1_joint_ASJ_nhomalt	gnomAD4.1_joint_EAS_AC	gnomAD4.1_joint_EAS_AN	gnomAD4.1_joint_EAS_AF	gnomAD4.1_joint_EAS_nhomalt	gnomAD4.1_joint_FIN_AC	gnomAD4.1_joint_FIN_AN	gnomAD4.1_joint_FIN_AF	gnomAD4.1_joint_FIN_nhomalt	gnomAD4.1_joint_MID_AC	gnomAD4.1_joint_MID_AN	gnomAD4.1_joint_MID_AF	gnomAD4.1_joint_MID_nhomalt	gnomAD4.1_joint_NFE_AC	gnomAD4.1_joint_NFE_AN	gnomAD4.1_joint_NFE_AF	gnomAD4.1_joint_NFE_nhomalt	gnomAD4.1_joint_SAS_AC	gnomAD4.1_joint_SAS_AN	gnomAD4.1_joint_SAS_AF	gnomAD4.1_joint_SAS_nhomalt	ALFA_European_AC	ALFA_European_AN	ALFA_European_AF	ALFA_African_Others_AC	ALFA_African_Others_AN	ALFA_African_Others_AF	ALFA_East_Asian_AC	ALFA_East_Asian_AN	ALFA_East_Asian_AF	ALFA_African_American_AC	ALFA_African_American_AN	ALFA_African_American_AF	ALFA_Latin_American_1_AC	ALFA_Latin_American_1_AN	ALFA_Latin_American_1_AF	ALFA_Latin_American_2_AC	ALFA_Latin_American_2_AN	ALFA_Latin_American_2_AF	ALFA_Other_Asian_AC	ALFA_Other_Asian_AN	ALFA_Other_Asian_AF	ALFA_South_Asian_AC	ALFA_South_Asian_AN	ALFA_South_Asian_AF	ALFA_Other_AC	ALFA_Other_AN	ALFA_Other_AF	ALFA_African_AC	ALFA_African_AN	ALFA_African_AF	ALFA_Asian_AC	ALFA_Asian_AN	ALFA_Asian_AF	ALFA_Total_AC	ALFA_Total_AN	ALFA_Total_AF	clinvar_trait	clinvar_review	clinvar_hgvs	clinvar_var_source	clinvar_MedGen_id	clinvar_OMIM_id	clinvar_Orphanet_id	Interpro_domain	aaref_3	aaalt_3	plddt	rsa	g2p_00000001-d-2 avg	g2p_00000001-d-2 outliers⁺⁺	g2p_00000003-a-2 avg	g2p_00000003-a-2 outliers⁺⁺	g2p_00000003-b-2 avg	g2p_00000003-b-2 outliers⁺⁺	g2p_00000005-a-1 avg	g2p_00000005-a-1 outliers⁺⁺	g2p_00000005-a-2 avg	g2p_00000005-a-2 outliers⁺⁺	g2p_00000005-a-3 avg	g2p_00000005-a-3 outliers⁺⁺	g2p_00000005-a-4 avg	g2p_00000005-a-4 outliers⁺⁺	g2p_00000013-a-1 avg	g2p_00000013-a-1 outliers⁺⁺	g2p_00000013-b-1 avg	g2p_00000013-b-1 outliers⁺⁺	g2p_00000036-a-1 avg	g2p_00000036-a-1 outliers⁺⁺	g2p_00000036-a-2 avg	g2p_00000036-a-2 outliers⁺⁺	g2p_00000045-a-1 avg	g2p_00000045-a-1 outliers⁺⁺	g2p_00000045-b-1 avg	g2p_00000045-b-1 outliers⁺⁺	g2p_00000045-c-1 avg	g2p_00000045-c-1 outliers⁺⁺	g2p_00000045-d-1 avg	g2p_00000045-d-1 outliers⁺⁺	g2p_00000045-e-1 avg	g2p_00000045-e-1 outliers⁺⁺	g2p_00000045-f-1 avg	g2p_00000045-f-1 outliers⁺⁺	g2p_00000045-g-1 avg	g2p_00000045-g-1 outliers⁺⁺	g2p_00000045-h-1 avg	g2p_00000045-h-1 outliers⁺⁺	g2p_00000045-i-1 avg	g2p_00000045-i-1 outliers⁺⁺	g2p_00000045-j-1 avg	g2p_00000045-j-1 outliers⁺⁺	g2p_00000045-k-1 avg	g2p_00000045-k-1 outliers⁺⁺	g2p_00000045-l-1 avg	g2p_00000045-l-1 outliers⁺⁺	g2p_00000050-a-1 avg	g2p_00000050-a-1 outliers⁺⁺	g2p_00000051-c-1 avg	g2p_00000051-c-1 outliers⁺⁺	g2p_00000057-a-1 avg	g2p_00000057-a-1 outliers⁺⁺	g2p_00000057-b-1 avg	g2p_00000057-b-1 outliers⁺⁺	g2p_00000057-c-1 avg	g2p_00000057-c-1 outliers⁺⁺	g2p_00000057-d-1 avg	g2p_00000057-d-1 outliers⁺⁺	g2p_00000059-a-1 avg	g2p_00000059-a-1 outliers⁺⁺	g2p_00000060-a-1 avg	g2p_00000060-a-1 outliers⁺⁺	g2p_00000060-a-2 avg	g2p_00000060-a-2 outliers⁺⁺	g2p_00000061-a-1 avg	g2p_00000061-a-1 outliers⁺⁺	g2p_00000061-b-1 avg	g2p_00000061-b-1 outliers⁺⁺	g2p_00000061-c-1 avg	g2p_00000061-c-1 outliers⁺⁺	g2p_00000061-d-1 avg	g2p_00000061-d-1 outliers⁺⁺	g2p_00000061-e-1 avg	g2p_00000061-e-1 outliers⁺⁺	g2p_00000061-f-1 avg	g2p_00000061-f-1 outliers⁺⁺	g2p_00000061-g-1 avg	g2p_00000061-g-1 outliers⁺⁺	g2p_00000061-h-1 avg	g2p_00000061-h-1 outliers⁺⁺	g2p_00000061-i-1 avg	g2p_00000061-i-1 outliers⁺⁺	g2p_00000066-a-1 avg	g2p_00000066-a-1 outliers⁺⁺	g2p_00000067-a-1 avg	g2p_00000067-a-1 outliers⁺⁺	g2p_00000068-a-1 avg	g2p_00000068-a-1 outliers⁺⁺	g2p_00000068-b-1 avg	g2p_00000068-b-1 outliers⁺⁺	g2p_00000068-c-1 avg	g2p_00000068-c-1 outliers⁺⁺	g2p_00000081-a-1 avg	g2p_00000081-a-1 outliers⁺⁺	g2p_00000081-a-2 avg	g2p_00000081-a-2 outliers⁺⁺	g2p_00000091-a-1 avg	g2p_00000091-a-1 outliers⁺⁺	g2p_00000094-a-14 avg	g2p_00000094-a-14 outliers⁺⁺	g2p_00000094-a-15 avg	g2p_00000094-a-15 outliers⁺⁺	g2p_00000095-a-1 avg	g2p_00000095-a-1 outliers⁺⁺	g2p_00000095-b-1 avg	g2p_00000095-b-1 outliers⁺⁺	g2p_00000096-a-1 avg	g2p_00000096-a-1 outliers⁺⁺	g2p_00000096-b-1 avg	g2p_00000096-b-1 outliers⁺⁺	g2p_00000097-a-1 avg	g2p_00000097-a-1 outliers⁺⁺	g2p_00000097-b-1 avg	g2p_00000097-b-1 outliers⁺⁺	g2p_00000097-c-1 avg	g2p_00000097-c-1 outliers⁺⁺	g2p_00000097-d-1 avg	g2p_00000097-d-1 outliers⁺⁺	g2p_00000097-e-1 avg	g2p_00000097-e-1 outliers⁺⁺	g2p_00000097-f-1 avg	g2p_00000097-f-1 outliers⁺⁺	g2p_00000097-g-1 avg	g2p_00000097-g-1 outliers⁺⁺	g2p_00000097-h-1 avg	g2p_00000097-h-1 outliers⁺⁺	g2p_00000097-i-1 avg	g2p_00000097-i-1 outliers⁺⁺	g2p_00000097-j-1 avg	g2p_00000097-j-1 outliers⁺⁺	g2p_00000097-k-1 avg	g2p_00000097-k-1 outliers⁺⁺	g2p_00000097-l-1 avg	g2p_00000097-l-1 outliers⁺⁺	g2p_00000097-m-1 avg	g2p_00000097-m-1 outliers⁺⁺	g2p_00000097-n-1 avg	g2p_00000097-n-1 outliers⁺⁺	g2p_00000097-o-1 avg	g2p_00000097-o-1 outliers⁺⁺	g2p_00000097-p-1 avg	g2p_00000097-p-1 outliers⁺⁺	g2p_00000097-q-1 avg	g2p_00000097-q-1 outliers⁺⁺	g2p_00000097-r-1 avg	g2p_00000097-r-1 outliers⁺⁺	g2p_00000097-s-1 avg	g2p_00000097-s-1 outliers⁺⁺	g2p_00000097-t-1 avg	g2p_00000097-t-1 outliers⁺⁺	g2p_00000097-u-1 avg	g2p_00000097-u-1 outliers⁺⁺	g2p_00000097-v-1 avg	g2p_00000097-v-1 outliers⁺⁺	g2p_00000097-w-1 avg	g2p_00000097-w-1 outliers⁺⁺	g2p_00000097-x-1 avg	g2p_00000097-x-1 outliers⁺⁺	g2p_00000097-y-1 avg	g2p_00000097-y-1 outliers⁺⁺	g2p_00000097-z-1 avg	g2p_00000097-z-1 outliers⁺⁺	g2p_00000101-a-1 avg	g2p_00000101-a-1 outliers⁺⁺	g2p_00000102-0-1 avg	g2p_00000102-0-1 outliers⁺⁺	g2p_00000107-a-1 avg	g2p_00000107-a-1 outliers⁺⁺	g2p_00000107-b-1 avg	g2p_00000107-b-1 outliers⁺⁺	g2p_00000108-a-1 avg	g2p_00000108-a-1 outliers⁺⁺	g2p_00000108-a-2 avg	g2p_00000108-a-2 outliers⁺⁺	g2p_00000108-a-3 avg	g2p_00000108-a-3 outliers⁺⁺	g2p_00000112-a-1 avg	g2p_00000112-a-1 outliers⁺⁺	g2p_00000114-a-1 avg	g2p_00000114-a-1 outliers⁺⁺	g2p_00000115-a-1 avg	g2p_00000115-a-1 outliers⁺⁺	g2p_00000115-a-10 avg	g2p_00000115-a-10 outliers⁺⁺	g2p_00000115-a-11 avg	g2p_00000115-a-11 outliers⁺⁺	g2p_00000115-a-12 avg	g2p_00000115-a-12 outliers⁺⁺	g2p_00000115-a-13 avg	g2p_00000115-a-13 outliers⁺⁺	g2p_00000115-a-14 avg	g2p_00000115-a-14 outliers⁺⁺	g2p_00000115-a-15 avg	g2p_00000115-a-15 outliers⁺⁺	g2p_00000115-a-16 avg	g2p_00000115-a-16 outliers⁺⁺	g2p_00000115-a-17 avg	g2p_00000115-a-17 outliers⁺⁺	g2p_00000115-a-18 avg	g2p_00000115-a-18 outliers⁺⁺	g2p_00000115-a-19 avg	g2p_00000115-a-19 outliers⁺⁺	g2p_00000115-a-2 avg	g2p_00000115-a-2 outliers⁺⁺	g2p_00000115-a-20 avg	g2p_00000115-a-20 outliers⁺⁺	g2p_00000115-a-21 avg	g2p_00000115-a-21 outliers⁺⁺	g2p_00000115-a-22 avg	g2p_00000115-a-22 outliers⁺⁺	g2p_00000115-a-23 avg	g2p_00000115-a-23 outliers⁺⁺	g2p_00000115-a-24 avg	g2p_00000115-a-24 outliers⁺⁺	g2p_00000115-a-25 avg	g2p_00000115-a-25 outliers⁺⁺	g2p_00000115-a-26 avg	g2p_00000115-a-26 outliers⁺⁺	g2p_00000115-a-27 avg	g2p_00000115-a-27 outliers⁺⁺	g2p_00000115-a-28 avg	g2p_00000115-a-28 outliers⁺⁺	g2p_00000115-a-3 avg	g2p_00000115-a-3 outliers⁺⁺	g2p_00000115-a-4 avg	g2p_00000115-a-4 outliers⁺⁺	g2p_00000115-a-5 avg	g2p_00000115-a-5 outliers⁺⁺	g2p_00000115-a-6 avg	g2p_00000115-a-6 outliers⁺⁺	g2p_00000115-a-7 avg	g2p_00000115-a-7 outliers⁺⁺	g2p_00000115-a-8 avg	g2p_00000115-a-8 outliers⁺⁺	g2p_00000115-a-9 avg	g2p_00000115-a-9 outliers⁺⁺	g2p_00000657-a-1 avg	g2p_00000657-a-1 outliers⁺⁺	g2p_00000657-a-2 avg	g2p_00000657-a-2 outliers⁺⁺	g2p_00000659-a-1 avg	g2p_00000659-a-1 outliers⁺⁺	g2p_00000664-a-1 avg	g2p_00000664-a-1 outliers⁺⁺	g2p_00000664-a-2 avg	g2p_00000664-a-2 outliers⁺⁺	g2p_00000664-a-3 avg	g2p_00000664-a-3 outliers⁺⁺	g2p_00000664-a-4 avg	g2p_00000664-a-4 outliers⁺⁺	g2p_00000664-a-6 avg	g2p_00000664-a-6 outliers⁺⁺	g2p_00000674-a-1 avg	g2p_00000674-a-1 outliers⁺⁺	g2p_00000674-a-2 avg	g2p_00000674-a-2 outliers⁺⁺	g2p_00000674-a-3 avg	g2p_00000674-a-3 outliers⁺⁺	g2p_00000674-a-4 avg	g2p_00000674-a-4 outliers⁺⁺	g2p_00000685-a-1 avg	g2p_00000685-a-1 outliers⁺⁺	g2p_00000686-a-1 avg	g2p_00000686-a-1 outliers⁺⁺	g2p_00000691-a-1 avg	g2p_00000691-a-1 outliers⁺⁺	g2p_00000697-a-1 avg	g2p_00000697-a-1 outliers⁺⁺	g2p_00000703-a-1 avg	g2p_00000703-a-1 outliers⁺⁺	g2p_00000706-a-1 avg	g2p_00000706-a-1 outliers⁺⁺	g2p_00000708-a-1 avg	g2p_00000708-a-1 outliers⁺⁺	g2p_00000710-a-1 avg	g2p_00000710-a-1 outliers⁺⁺	g2p_00000715-a-1 avg	g2p_00000715-a-1 outliers⁺⁺	g2p_00000736-a-1 avg	g2p_00000736-a-1 outliers⁺⁺	g2p_00000738-a-1 avg	g2p_00000738-a-1 outliers⁺⁺	g2p_00000739-a-1 avg	g2p_00000739-a-1 outliers⁺⁺	g2p_00000745-a-1 avg	g2p_00000745-a-1 outliers⁺⁺	g2p_00000746-a-1 avg	g2p_00000746-a-1 outliers⁺⁺	g2p_00000747-a-1 avg	g2p_00000747-a-1 outliers⁺⁺	g2p_00000748-a-1 avg	g2p_00000748-a-1 outliers⁺⁺	g2p_00000764-a-1 avg	g2p_00000764-a-1 outliers⁺⁺	g2p_00000780-a-1 avg	g2p_00000780-a-1 outliers⁺⁺	g2p_00000787-a-1 avg	g2p_00000787-a-1 outliers⁺⁺	g2p_00000803-a-1 avg	g2p_00000803-a-1 outliers⁺⁺	g2p_00000809-a-1 avg	g2p_00000809-a-1 outliers⁺⁺	g2p_00000810-a-1 avg	g2p_00000810-a-1 outliers⁺⁺	g2p_00000847-a-1 avg	g2p_00000847-a-1 outliers⁺⁺	g2p_00000858-a-1 avg	g2p_00000858-a-1 outliers⁺⁺	g2p_00000875-a-1 avg	g2p_00000875-a-1 outliers⁺⁺	g2p_00000878-a-1 avg	g2p_00000878-a-1 outliers⁺⁺	g2p_00000895-a-1 avg	g2p_00000895-a-1 outliers⁺⁺	g2p_00000899-a-1 avg	g2p_00000899-a-1 outliers⁺⁺	g2p_00000910-a-1 avg	g2p_00000910-a-1 outliers⁺⁺	g2p_00000911-a-1 avg	g2p_00000911-a-1 outliers⁺⁺	g2p_00000925-a-1 avg	g2p_00000925-a-1 outliers⁺⁺	g2p_00000926-a-1 avg	g2p_00000926-a-1 outliers⁺⁺	g2p_00000927-a-1 avg	g2p_00000927-a-1 outliers⁺⁺	g2p_00000928-a-1 avg	g2p_00000928-a-1 outliers⁺⁺	g2p_00000939-a-1 avg	g2p_00000939-a-1 outliers⁺⁺	g2p_00000940-a-1 avg	g2p_00000940-a-1 outliers⁺⁺	g2p_00000942-a-1 avg	g2p_00000942-a-1 outliers⁺⁺	g2p_00000959-a-1 avg	g2p_00000959-a-1 outliers⁺⁺	g2p_00000963-a-1 avg	g2p_00000963-a-1 outliers⁺⁺	g2p_00000966-a-1 avg	g2p_00000966-a-1 outliers⁺⁺	g2p_00000978-a-1 avg	g2p_00000978-a-1 outliers⁺⁺	g2p_00000990-a-1 avg	g2p_00000990-a-1 outliers⁺⁺	g2p_00000998-a-1 avg	g2p_00000998-a-1 outliers⁺⁺	g2p_00001002-a-1 avg	g2p_00001002-a-1 outliers⁺⁺	g2p_00001003-a-1 avg	g2p_00001003-a-1 outliers⁺⁺	g2p_00001007-a-1 avg	g2p_00001007-a-1 outliers⁺⁺	g2p_00001032-a-1 avg	g2p_00001032-a-1 outliers⁺⁺	g2p_00001033-a-1 avg	g2p_00001033-a-1 outliers⁺⁺	g2p_00001034-a-1 avg	g2p_00001034-a-1 outliers⁺⁺	g2p_00001050-a-1 avg	g2p_00001050-a-1 outliers⁺⁺	g2p_00001051-a-1 avg	g2p_00001051-a-1 outliers⁺⁺	g2p_00001053-a-1 avg	g2p_00001053-a-1 outliers⁺⁺	g2p_00001056-a-1 avg	g2p_00001056-a-1 outliers⁺⁺	g2p_00001062-a-1 avg	g2p_00001062-a-1 outliers⁺⁺	g2p_00001065-a-1 avg	g2p_00001065-a-1 outliers⁺⁺	g2p_00001077-a-1 avg	g2p_00001077-a-1 outliers⁺⁺	g2p_00001078-a-1 avg	g2p_00001078-a-1 outliers⁺⁺	g2p_00001082-a-1 avg	g2p_00001082-a-1 outliers⁺⁺	g2p_00001084-a-1 avg	g2p_00001084-a-1 outliers⁺⁺	g2p_00001087-a-1 avg	g2p_00001087-a-1 outliers⁺⁺	g2p_00001090-a-1 avg	g2p_00001090-a-1 outliers⁺⁺	g2p_00001102-a-1 avg	g2p_00001102-a-1 outliers⁺⁺	g2p_00001112-a-1 avg	g2p_00001112-a-1 outliers⁺⁺	g2p_00001125-a-1 avg	g2p_00001125-a-1 outliers⁺⁺	g2p_00001131-a-1 avg	g2p_00001131-a-1 outliers⁺⁺	g2p_00001135-a-1 avg	g2p_00001135-a-1 outliers⁺⁺	g2p_00001161-a-1 avg	g2p_00001161-a-1 outliers⁺⁺	g2p_00001173-a-1 avg	g2p_00001173-a-1 outliers⁺⁺	g2p_00001177-a-1 avg	g2p_00001177-a-1 outliers⁺⁺	g2p_00001200-a-1 avg	g2p_00001200-a-1 outliers⁺⁺	g2p_00001200-b-1 avg	g2p_00001200-b-1 outliers⁺⁺	g2p_00001200-c-1 avg	g2p_00001200-c-1 outliers⁺⁺	g2p_00001200-d-1 avg	g2p_00001200-d-1 outliers⁺⁺	g2p_00001200-e-1 avg	g2p_00001200-e-1 outliers⁺⁺	g2p_00001204-a-1 avg	g2p_00001204-a-1 outliers⁺⁺	g2p_00001204-a-2 avg	g2p_00001204-a-2 outliers⁺⁺	g2p_00001204-a-3 avg	g2p_00001204-a-3 outliers⁺⁺	g2p_00001204-a-4 avg	g2p_00001204-a-4 outliers⁺⁺	g2p_00001204-a-5 avg	g2p_00001204-a-5 outliers⁺⁺	g2p_00001204-a-6 avg	g2p_00001204-a-6 outliers⁺⁺	g2p_00001205-a-1 avg	g2p_00001205-a-1 outliers⁺⁺	g2p_00001206-a-1 avg	g2p_00001206-a-1 outliers⁺⁺	g2p_00001206-a-2 avg	g2p_00001206-a-2 outliers⁺⁺	g2p_00001207-a-1 avg	g2p_00001207-a-1 outliers⁺⁺	g2p_00001207-a-2 avg	g2p_00001207-a-2 outliers⁺⁺	g2p_00001207-a-3 avg	g2p_00001207-a-3 outliers⁺⁺	g2p_00001211-0-2 avg	g2p_00001211-0-2 outliers⁺⁺	g2p_00001211-a-10 avg	g2p_00001211-a-10 outliers⁺⁺	g2p_00001211-a-11 avg	g2p_00001211-a-11 outliers⁺⁺	g2p_00001211-a-12 avg	g2p_00001211-a-12 outliers⁺⁺	g2p_00001211-a-13 avg	g2p_00001211-a-13 outliers⁺⁺	g2p_00001211-a-14 avg	g2p_00001211-a-14 outliers⁺⁺	g2p_00001211-a-15 avg	g2p_00001211-a-15 outliers⁺⁺	g2p_00001211-a-16 avg	g2p_00001211-a-16 outliers⁺⁺	g2p_00001211-a-9 avg	g2p_00001211-a-9 outliers⁺⁺	g2p_00001216-a-1 avg	g2p_00001216-a-1 outliers⁺⁺	g2p_00001222-a-1 avg	g2p_00001222-a-1 outliers⁺⁺	g2p_00001229-a-1 avg	g2p_00001229-a-1 outliers⁺⁺	g2p_00001230-a-1 avg	g2p_00001230-a-1 outliers⁺⁺	g2p_00001231-a-1 avg	g2p_00001231-a-1 outliers⁺⁺	g2p_Accessible surface area (Å²)*	g2p_Acetylation	g2p_Active site (UniProt)	g2p_AlphaFold confidence (pLDDT)	g2p_Amino acid properties	g2p_Amino acid residues	g2p_Binding site (UniProt)	g2p_Chain (UniProt)	g2p_Coiled coil (UniProt)	g2p_Compositional bias (UniProt)	g2p_Cross-link (UniProt)	g2p_DNA binding (UniProt)	g2p_Disease-associated PTMs	g2p_Disulfide bond (UniProt)	g2p_Domain (UniProt)	g2p_Druggability score (fpocket)*	g2p_Glycosylation (UniProt)	g2p_Hydropathy	g2p_Initiator methionine (UniProt)	g2p_Inter-chain Disulfide bond (PDB)	g2p_Inter-chain Hydrogen bond (PDB)	g2p_Inter-chain Non-bonded interaction (PDB)	g2p_Inter-chain Salt bridge (PDB)	g2p_Intra-chain Disulfide bond (AlphaFold2)	g2p_Intra-chain Disulfide bond (PDB)	g2p_Intra-chain Hydrogen bond (AlphaFold2)	g2p_Intra-chain Hydrogen bond (PDB)	g2p_Intra-chain Non-bonded interaction (AlphaFold2)	g2p_Intra-chain Non-bonded interaction (PDB)	g2p_Intra-chain Salt bridge (AlphaFold2)	g2p_Intra-chain Salt bridge (PDB)	g2p_Intramembrane (UniProt)	g2p_Lipidation (UniProt)	g2p_Methylation	g2p_Modified residue (UniProt)	g2p_Molar mass (g/mol)	g2p_Motif (UniProt)	g2p_Mutagenesis (UniProt)	g2p_Non-adjacent residues (UniProt)	g2p_Non-standard residue (UniProt)	g2p_Non-terminal residue (UniProt)	g2p_O-GalNAc	g2p_O-GlcNAc	g2p_Peptide (UniProt)	g2p_Phi angle (degrees)*	g2p_Phosphorylation	g2p_Pocket number (fpocket)*	g2p_Propeptide (UniProt)	g2p_Psi angle (degrees)*	g2p_Region (UniProt)	g2p_Regulatory sites	g2p_Repeat (UniProt)	g2p_SNP-associated PTMs	g2p_SUMOylation	g2p_Secondary structure (DSSP 3-state)*	g2p_Secondary structure (DSSP 9-state)*	g2p_Secondary structure (PDBe/SIFTS)	g2p_Sequence conflict (UniProt)	g2p_Sequence uncertainty (UniProt)	g2p_Signal (UniProt)	g2p_Site (UniProt)	g2p_Substrate genes	g2p_Topological domain (UniProt)	g2p_Transit peptide (UniProt)	g2p_Transmembrane (UniProt)	g2p_Ubiquitination	g2p_Zinc finger (UniProt)	plddt_f32	rsa_f32	pLDDT_Category	RSA_Category	OMIM_IDs	inheritance_pattern	inheritance_source	disease_modules	disease_module_count	OMIM_disease_names	splicing_variant	img_pheno_score	img_misloc_score	img_pheno_hit	img_misloc_hit	img_pheno_hit_strict
DES	DES_Ala337Pro	B_7-8	-0.6922247706543194	1.0	1.0	-6.716310981480478	0.0008947258402494482	0.002093128556617442	2024_01_Batch_7-8		false	false	false	false	false		false	false	false	false	false		0.9487397015480964	0.6621760220812437	0.7156276409959634	0.6065621018702774	0.6745886693199062	0.8482952190724526	0.7196789958150416	0.7825892818800642	0.8135196558306893	0.9802788415532617		0.5008821195673598	0.4934452079255132	0.6486660001118627	0.5108323883317981	0.9172005615429311		DES	Ala337Pro	NC_000002.12:219420939:G:C	1009G>C	2	219420939	G	C	2	ENSG00000175084	12573	2293	CCSBVarC006506	ALE00006505	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	C09	GDEhDisVCh_40003	E09	1	VUSMutGDDh003	C09	VUSN2Hmut_GDN2h_01	C04	NULL	NULL	VUSmut_GDEh01	C04	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	31859.0	single nucleotide variant	NM_001927.4(DES):c.1009G>C (p.Ala337Pro)	1674.0	DES	HGNC:2770	Pathogenic	1.0	Mar 01, 2024	59962885.0	-	RCV000056762|RCV002265557|RCV000856836	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154	not provided|Desmin-related myofibrillar myopathy|Dilated cardiomyopathy 1I	germline;unknown	germline	GRCh38	NC_000002.12	2	219420939.0	219420939.0	2q35	criteria provided, multiple submitters, no conflicts	4.0	ACMG2022	N	ClinGen:CA216997,UniProtKB:P17661#VAR_007900,OMIM:125660.0001	3.0	16820.0	219420939.0	G	C	-	-	-	-	-	-	1009G>C 	Ala337Pro	NM_001927.4	2.0	Pathogenic	Pathogenic	16820	2	219420939.0	G	C	A	P	rs59962885	2	220285661	2	219993905	337	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1009G>C	p.Ala337Pro	c.1009G>C	p.Ala337Pro	principal1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.009	0.67073	D	0.991	0.64084	D	0.947	0.68403	D	0.86	0.90354	A	simple_aae	14.0	86.0	3.755	0.94977	H	-3.29	0.65771	D	0.853	0.84884	1.0934	0.99376	D	0.9415	0.98078	D	9	0.97619796	0.97369	D	0.28287	0.90271	D	0.896	0.97054	0.873	0.96457	P17661	A337P	Gain of catalytic residue at A337 (P = 0.0242)| Loss of stability (P = 0.0733)| Gain of disorder (P = 0.1153)| Loss of MoRF binding (P = 0.1162)| Loss of ubiquitination at K339 (P = 0.1403)	0.992559475871	0.99238	0.9291538252917882	0.92849	1.65461298271	0.89553	0.752128839493	0.74716	T	0.869126	0.97134	D	0.483583	0.93771	D	0.456857	0.93692	D	0.994471073150635	0.85670	D	0.959604	0.84795	D	0.9244607	0.93590	0.8944268	0.94506	0.9518627	0.96399	0.8745567	0.93090	-13.516	0.91394	D	0.9994	0.98903	P	0.99968693276012	0.97477	0.99842894	0.98780	0.898	0.94604	.	.	.	.	.	.	5.838568	0.93777	33.0	0.99800532418854859	0.88559	0.963906	0.98587	D	0.799552432387004	0.86001	8.771361	0.702634919095136	0.82482	7.802001	4.84	4.84	0.62077	3.79	0.69847	6.199	0.72107	9.973000	0.82902	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.845	0.39945	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Desmin-related_myofibrillar_myopathy|Dilated_cardiomyopathy_1I|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219420939G>C	ClinGen:CA216997|OMIM:125660.0001|UniProtKB:P17661#VAR_007900	C1832370|C1858154|C3661900	601419|604765	363543|98909|154	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ala	Pro	90.74	0.5566037735849056																																																																																																																																																																																																																																																																																																																																																																																																																																																																													59			90.74	Aliphatic	Alanine		Desmin							IF rod			1.8								 A337-T341 (PAE:  1.0), A337-C333 (PAE: 1.0)		 A337-T341 (PAE:  1.0), A337-C333 (PAE: 1.0)								89									-62.7				-48.0	Interaction with NEB; Coil 2B			dbSNP: rs59962885; Variant type: LP/P; AA change: Ala337Pro; PTM type: Acetylation; PTM morphology: EIDA*LkGTNDS; Var class: II&rs59962885		H (helix)	H (α-helix)												90.74	55.660378	>90	10-90	601419;604765	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1; CARDIOMYOPATHY, DILATED, 1I	false	0.9487397015480964		false		false
AGXT	AGXT_Ile202Asn	B_7-8	-2.991273621486499	0.020189910078362325	0.04568469952912741	-7.265048247357121	0.0001677355078754896	0.0005965012731618671	2024_01_Batch_7-8	true	false	false	false	false	false	false	false	false	false	false	false	0.9387900640248266	0.952060731261242	0.629039712569629	0.7334551044451563	0.6341118098882799	0.6711942694558258	0.7599880375610282	0.6766766830809783	0.8674896702066259	0.6563071350570082	0.9783884597680044	0.9714510726885057	0.5824005013506235	0.5915469366955816	0.5994205386836865	0.6017722900822498	0.9257330027544797	0.9061290553611474	AGXT	Ile202Asn	NC_000002.12:240873987:T:A	605T>A	2	240873987	T	A	2	ENSG00000172482	70497	3845	CCSBVarC008205	ALE00008191	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	C06	GDEhDisVCh_40002	B08	2	VUSMutGDDh004	C06	VUSN2Hmut_GDN2h_01	B08	VUSMutpDEST2_14	E07	VUSmut_GDEh01	B08	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	200521.0	single nucleotide variant	NM_000030.3(AGXT):c.605T>A (p.Ile202Asn)	189.0	AGXT	HGNC:341	Pathogenic	1.0	Aug 26, 2024	536352238.0	-	RCV000186322	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598	Primary hyperoxaluria, type I	germline;maternal	germline	GRCh38	NC_000002.12	2	240873987.0	240873987.0	2q37.3	no assertion criteria provided	2.0	-	N	ClinGen:CA275716,UniProtKB:P21549#VAR_074589	2.0	204116.0	240873987.0	T	A	-	-	-	-	-	-	605T>A 	Ile202Asn	NM_000030.3		Pathogenic	Pathogenic	204116	2	240873987.0	T	A	I	N	rs536352238	2	241813404	2	241462077	202	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.605T>A	p.Ile202Asn	c.605T>A	p.Ile202Asn	principal1	Y	1	YES	Select	+	ATC	2	0	T	T/T	T/T	T/T	T/T	0.003	0.68399	D	0.003	0.76775	D	0.968	0.56597	D	0.939	0.67445	D	0.61	0.77437	A	simple_aae	39.0	61.0	.	.	.	-5.07	0.82854	D	0.695	0.69856	0.5180	0.90762	D	0.7573	0.91708	D	10	0.99037945	0.99533	D	0.556414	0.95925	D	0.840	0.94975	0.831	0.94010	P21549	I202N	Gain of disorder (P = 0.0191)| Gain of sheet (P = 0.039)| Loss of stability (P = 0.0621)| Gain of glycosylation at S207 (P = 0.0902)| Gain of loop (P = 0.1069)	0.928704643095	0.92743	0.9475343968078962	0.94703	0.273132865442	0.29522	0.436109930277	0.30009	T	0.915603	0.98429	D	0.180518	0.71884	D	0.0215249	0.71520	D	0.983766078948975	0.75134	D	0.940306	0.77428	D	0.95781916	0.97013	0.8461887	0.91134	0.95781916	0.97013	0.8461887	0.91134	-14.836	0.95465	D	0.9339	0.85318	P	0.995501366463658	0.91382	0.31235924	0.77212	0.825	0.90346	.	.	.	.	.	.	3.62885	0.51479	23.1	0.98672654387604042	0.44611	0.925459	0.90470	D	0.214049927434982	0.51641	3.365922	-0.00127491600645044	0.39364	2.354782	4.1	2.94	0.33105	2.16	0.41537	3.487	0.53079	4.819000	0.45180	0.593	0.32293	0.681	0.28539	0.897000	0.27994	0.019	0.11385	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Primary_hyperoxaluria,_type_I	no_assertion_criteria_provided	NC_000002.12:g.240873987T>A	ClinGen:CA275716|UniProtKB:P21549#VAR_074589	C0268164	259900	416|93598	Aminotransferase class V domain|Aminotransferase class-V, pyridoxal-phosphate binding site	Ile	Asn	98.98	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.98	Aliphatic	Isoleucine		Alanine--glyoxylate aminotransferase										4.5								 I202-V182 (PAE:  1.0), I202-L180 (PAE: 1.0)	I202-L180 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), I202-V182 (PDBs: 6RV1, 3R9A)	 I202-L180 (PAE:  1.0)	I202-L180 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)							131									-132.7				127.7						B (undefined)	E (parallel sheets)	Beta strand											98.98	0.0	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.952060731261242	0.9387900640248266	false	true	false
AGXT	AGXT_Ala85Asp	B_7-8	-0.32092395182730593	0.7693249601732763	0.8172473158681633	-0.9230595163599699	0.42405550203262266	0.4776806913627149	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8513491502192931	0.8236313421875195	0.739949083199097	0.7030303003213287	0.6796059538777257	0.7972445966996807	0.7972445966996807	0.6796059538777257	0.7030303003213287	0.739949083199097	0.8236313421875195	0.8513491502192931							AGXT	Ala85Asp	NC_000002.12:240869258:C:A	254C>A	2	240869258	C	A	2	ENSG00000172482	70497	3805	CCSBVarC008176	ALE00008162	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	B02	GDEhDisVCh_40002	B04	2	VUSMutGDDh004	B02	VUSN2Hmut_GDN2h_01	E06	VUSMutpDEST2_14	D03	VUSmut_GDEh01	E06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200459.0	single nucleotide variant	NM_000030.3(AGXT):c.254C>A (p.Ala85Asp)	189.0	AGXT	HGNC:341	Pathogenic	1.0	Nov 27, 2014	796052059.0	-	RCV000186292	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598	Primary hyperoxaluria, type I	germline	germline	GRCh38	NC_000002.12	2	240869258.0	240869258.0	2q37.3	no assertion criteria provided	1.0	-	N	ClinGen:CA275657	2.0	204086.0	240869258.0	C	A	-	-	-	-	-	-	254C>A 	Ala85Asp	NM_000030.3		Pathogenic	Pathogenic	204086	2	240869258.0	C	A	A	D	rs796052059	2	241808675	2	241457348	85	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.254C>A	p.Ala85Asp	c.254C>A	p.Ala85Asp	principal1	Y	1	YES	Select	+	GCC	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.004	0.74454	D	0.999	0.77914	D	0.983	0.75798	D	0.61	0.77437	A	simple_aae	39.0	61.0	.	.	.	-3.74	0.71080	D	0.931	0.93613	1.0733	0.98678	D	0.9390	0.97992	D	10	0.9904994	0.99549	D	0.859407	0.98917	D	0.873	0.96198	0.859	0.95694	P21549	A85D	Loss of helix (P = 0.1706)| Loss of glycosylation at S81 (P = 0.272)| Gain of catalytic residue at A85 (P = 0.2807)| Loss of loop (P = 0.4412)| Gain of disorder (P = 0.4819)	0.976463472848	0.97598	0.9939985005546835	0.99395	0.280812327754	0.30258	0.60423374176	0.53435	T	0.93629	0.98950	D	0.489333	0.93929	D	0.465116	0.93851	D	0.994016885757446	0.84950	D	0.910709	0.68259	D	0.9935056	0.99917	0.97312385	0.99587	0.9884094	0.99672	0.95866024	0.98882	-15.009	0.95882	D	0.9521	0.87107	P	0.999454489169714	0.96641	0.55175200	0.82992	0.986	0.99524	.	.	.	.	.	.	4.242166	0.64398	24.7	0.99521806906168486	0.69323	0.928148	0.91161	D	0.375376563838213	0.59884	4.194326	0.199414155559678	0.49556	3.180318	4.27	3.37	0.37618	2.42	0.44885	5.579	0.6723	1.625000	0.27793	0.545	0.25635	1.0	0.71675	0.898000	0.28009	0.832	0.39259	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Primary_hyperoxaluria,_type_I	no_assertion_criteria_provided	NC_000002.12:g.240869258C>A	ClinGen:CA275657	C0268164	259900	416|93598	Aminotransferase class V domain	Ala	Asp	98.82	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.82	Aliphatic	Alanine		Alanine--glyoxylate aminotransferase										1.8								 A85-S81 (PAE:  1.0), A85-A89 (PAE: 1.0)	A85-A89 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), A85-S81 (PDBs: 6RV1)	 A85-S81 (PAE:  1.0), A85-S218 (PAE: 1.0), A85-A89 (PAE: 1.0)	A85-A89 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 3R9A), A85-S81 (PDBs: 6RV1, 3R9A), A85-S218 (PDBs: 6RV1, 3R9A), A85-I78 (PDBs: 6RV1, 7NS7)							89									-67.7				-38.9						H (helix)	H (α-helix)	Helix											98.82	0.0	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.8236313421875195	0.8513491502192931	false	false	false
NMNAT1	NMNAT1_Leu153Val	B_7-8	-0.06228343873617609	0.952360103879343	0.9624855285899029	-1.0605266600066088	0.3297178881173107	0.38293185107295263	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5322332981378589	0.5509207493661814	0.5381217613127212	0.6489887020163314	0.6923322105913431	0.6391857902805698	0.6433090960771128	0.6652993003515333	0.6579133512784265	0.6411473067736531	0.6074669087429342	0.5923431799004621	0.6350624844840268	0.7193651208311529	0.6400640527542364	0.4350962158517893	0.4943745899894285	0.4721234163752556	NMNAT1	Leu153Val	NC_000001.11:9982318:C:G	457C>G	1	9982318	C	G	1	ENSG00000173614	7675	202590	CCSBVarC005695	ALE00005695	ENSP00000366410.1	CEGS2	CegsMutGDEh1035	F04	GDEhDisVCh_40020	A02	2	CegsMutGDDh1035	F04	VUSN2Hmut_GDN2h_06	H11	VUSMutpDEST2_06	E12	VUSmut_GDEh06	H11	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	45800.0	single nucleotide variant	NM_022787.4(NMNAT1):c.457C>G (p.Leu153Val)	64802.0	NMNAT1	HGNC:17877	Pathogenic	1.0	Sep 01, 2012	387907293.0	-	RCV000030770	MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65	Leber congenital amaurosis 9	germline	germline	GRCh38	NC_000001.11	1	9982318.0	9982318.0	1p36.22	no assertion criteria provided	1.0	-	N	ClinGen:CA260598,UniProtKB:Q9HAN9#VAR_068870,OMIM:608700.0008	1.0	37139.0	9982318.0	C	G	-	-	-	-	-	-	457C>G 	Leu153Val	NM_022787.4		Pathogenic	Pathogenic	37139	1	9982318.0	C	G	L	V	rs387907293	1	10042376	1	9964963	153	NMNAT1	ENSG00000173614	ENST00000377205	ENSP00000366410	Q9HAN9	NMNA1_HUMAN	c.457C>G	p.Leu153Val	c.457C>G	p.Leu153Val	principal1	Y	1	YES	Select	+	CTG	1	2	C	./.	./.	./.	./.	0.003	0.68399	D	0.005	0.72530	D	0.987	0.61929	D	0.86	0.61226	P	0.68	0.81345	A	simple_aae	32.0	68.0	3.52	0.92870	H	-2.76	0.58599	D	0.542	0.56699	0.9167	0.95898	D	0.9081	0.96947	D	10	0.88519263	0.87711	D	0.211255	0.87263	D	0.755	0.91594	0.831	0.94010	Q9HAN9	L153V	Gain of ubiquitination at K152 (P = 0.1215)| Loss of stability (P = 0.1953)| Gain of MoRF binding (P = 0.2247)| Loss of disorder (P = 0.2398)| Loss of glycosylation at P149 (P = 0.3445)	0.909999032364	0.90842	0.8164372609709907	0.81491	0.308008756825	0.32805	0.501667559147	0.39007	T	0.863269	0.96959	D	0.367396	0.87742	D	0.289962	0.87585	D	0.948785781860352	0.62743	D	.	.	.	0.91344166	0.92508	0.82451046	0.89697	0.91979986	0.93129	0.8001508	0.88131	-10.286	0.75682	D	0.4028	0.59689	A	0.945817362863101	0.79971	0.76621747	0.87534	0.924	0.96172	.	.	.	.	.	.	2.215531	0.28321	17.74	0.98858990981321526	0.47542	0.200498	0.32511	N	-0.348385643796362	0.27053	1.498697	-0.615916527640303	0.18786	1.022375	5.12	-6.28	0.01848	-5.43	0.03846	-0.164	0.10003	-1.059000	0.06487	-0.313	0.06027	0.546	0.27405	0.003000	0.18726	0.876	0.41839	649	0.63066	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	segdup	0	108920	0.000000e+00	0	1	207216	4.825880e-06	0	1	235546	4.245460e-06	0	0	7164	0.000000e+00	0	0	17028	0.000000e+00	0	0	2288	0.000000e+00	0	0	9046	0.000000e+00	0	0	13364	0.000000e+00	0	0	42508	0.000000e+00	0	0	15614	0.000000e+00	0	.	.	.	.	0	16214	0.000000e+00	0	0	30354	0.000000e+00	0	0	6132	0.000000e+00	0	0	13414	0.000000e+00	0	0	16694	0.000000e+00	0	1	89124	1.122030e-05	0	0	30446	0.000000e+00	0	1	89124	1.122030e-05	0	0	14898	0.000000e+00	0	0	34072	0.000000e+00	0	0	9454	0.000000e+00	0	0	17690	0.000000e+00	0	0	21532	0.000000e+00	0	1	101952	9.808540e-06	0	0	30364	0.000000e+00	0	1	101952	9.808540e-06	0	.	2	1612490	1.240320e-06	0	2	1179064	1.696260e-06	0	0	74890	0.000000e+00	0	0	912	0.000000e+00	0	0	59834	0.000000e+00	0	0	29494	0.000000e+00	0	0	44874	0.000000e+00	0	0	63994	0.000000e+00	0	0	6068	0.000000e+00	0	2	1179064	1.696260e-06	0	0	90938	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Leber_congenital_amaurosis_9	no_assertion_criteria_provided	NC_000001.11:g.9982318C>G	ClinGen:CA260598|OMIM:608700.0008|UniProtKB:Q9HAN9#VAR_068870	C1837873	608553	65	.	Leu	Val	98.83	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.83	Aliphatic	Leucine		Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1										3.8								 L153-I184 (PAE:  1.0), L153-G182 (PAE: 1.0)	L153-I184 (PDBs: 1KKU, 8QE8), L153-G182 (PDBs: 1KKU, 1GZU, 1KQN, 1KQO, 1KR2, 8QE8)	 L153-I184 (PAE:  1.0)	L153-I184 (PDBs: 1KKU, 1GZU, 1KQN, 1KR2, 8QE8), L153-L99 (PDBs: 1KQO), L153-L183 (PDBs: 8QE8), L153-G182 (PDBs: 8QE8), L153-L12 (PDBs: 8QE8)							131									-77.4				124.0						B (undefined)	E (parallel sheets)	Beta strand											98.83	0.0	>90	<10	608553	autosomal recessive	OMIM	Rare genetic eye disease; Ciliopathy	2	LEBER CONGENITAL AMAUROSIS 9	false	0.5509207493661814	0.5322332981378589	false	false	false
SFTPC	SFTPC_Leu188Gln	B_7-8	-3.2688936557097956	0.017057825342994496	0.04057340772742153	7.219705569897845	0.0003579376653308508	0.0010610914634605999	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.9697079929537993	0.963824736663176	0.73309420977555	0.7079014584414857	0.7124870028424655	0.7473243936318029	0.9189139064284267	0.861084697297374	0.9131910005865004	0.8964783261927767	0.9788693784978045	0.966044052285665	0.5757348808351791	0.563889308387557	0.502611916296471	0.5697100933583231	0.9487800948285474	0.9733719336219336	SFTPC	Leu188Gln	NC_000008.11:22164010:T:A	563T>A	8	22164010	T	A	8	ENSG00000168484	5723	201965	CCSBVarC006062	ALE00006062	ENSP00000316152.3	CEGS2	CegsMutGDEh1036	G03	GDEhDisVCh_40072	H07	2	CegsMutGDDh1036	G03	VUSN2Hmut_GDN2h_07	H03	VUSMutpDEST2_05	A07	VUSmut_GDEh07	H03	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	28249.0	single nucleotide variant	NM_001317778.2(SFTPC):c.545T>A (p.Leu182Gln)	6440.0	SFTPC	HGNC:10802	Pathogenic	1.0	May 01, 2002	121917835.0	-	RCV000014097	MONDO:MONDO:0024465,MedGen:C1970470,OMIM:610913	Surfactant metabolism dysfunction, pulmonary, 2	germline	germline	GRCh38	NC_000008.11	8	22164010.0	22164010.0	8p21.3	no assertion criteria provided	1.0	-	N	ClinGen:CA210540,OMIM:178620.0004	1.0	13210.0	22164010.0	T	A	-	-	-	-	-	-	545T>A 	Leu182Gln	NM_001317778.2		Pathogenic	Pathogenic	13210	8	22164010.0	T	A	L	Q	rs121917835	8	22021523	8	22077468	188	SFTPC	ENSG00000168484	ENST00000318561	ENSP00000316152	P11686	PSPC_HUMAN	c.563T>A	p.Leu188Gln	c.563T>A	p.Leu188Gln	principal4	Y	1	.	.	+	CTG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.96253	A	simple_aae	7.0	93.0	1.585	0.39718	L	-3.89	0.77502	D	0.906	0.98852	0.6050	0.91936	D	0.6794	0.88874	D	9	0.97859347	0.97719	D	0.57723	0.96192	D	0.849	0.95310	0.892	0.97398	P11686	L188Q	Loss of helix (P = 0.0093)| Gain of sheet (P = 0.0125)| Gain of solvent accessibility (P = 0.0137)| Gain of relative solvent accessibility (P = 0.0215)| Loss of stability (P = 0.0662)	0.987075158978	0.98679	0.9430555744142222	0.94252	1.33848163075	0.83718	0.591202139854	0.51597	T	0.587672	0.86470	D	0.375225	0.88319	D	0.301208	0.88171	D	0.995912730693817	0.88211	D	0.80432	0.45013	T	.	.	.	.	.	.	.	.	-4.098	0.25285	T	0.6968	0.73868	P	.	.	0.99947268	0.99411	0.493	0.70993	.	.	.	.	.	.	4.881697	0.801	27.2	0.99623398071417235	0.75622	0.821837	0.74136	D	0.697520818230033	0.79358	7.084348	0.670745179339753	0.80054	7.238325	5.5	5.5	0.81360	2.99	0.54692	2.94	0.48792	7.845000	0.70743	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.962	0.52152	555	0.71761	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Surfactant_metabolism_dysfunction,_pulmonary,_2	no_assertion_criteria_provided	NC_000008.11:g.22164010T>A	ClinGen:CA210540|OMIM:178620.0004	C1970470	610913	.	BRICHOS domain|BRICHOS domain|BRICHOS domain	Leu	Gln	90.06	0.12195121951219512																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	Aliphatic	Leucine									BRICHOS			3.8																		131												Propeptide					dbSNP: rs121917835; Variant type: LP/P; AA change: Leu188Gln; PTM type: Phosphorylation; PTM morphology: GMAVStL*CGEV; Var class: II				Helix											90.06	12.195122	>90	10-90	610913	autosomal dominant	OMIM	Rare genetic respiratory disease	1	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	false	0.963824736663176	0.9697079929537993	true	true	false
SFTPC	SFTPC_Leu194Pro	B_7-8	-1.2557078627493705	0.2559066302307894	0.34037720316212244	4.069423646456388	0.006580104037989381	0.011954941494762885	2024_01_Batch_7-8	true	false	false	false	false	false	false	false	false	false	false	false	0.9388557932296713	0.9457838418165694	0.7286514999386506	0.7045730684258296	0.7271636314507062	0.7661452810310003	0.8814526651592236	0.8318894428966546	0.8876282872809349	0.8115491458740904	0.9630983442407157	0.9606971574006458	0.650837896902777	0.6224378200047577	0.5215178495707241	0.6457538540032108	0.9284693393924229	0.9170144290586969	SFTPC	Leu194Pro	NC_000008.11:22164028:T:C	581T>C	8	22164028	T	C	8	ENSG00000168484	5723	201967	CCSBVarC006063	ALE00006063	ENSP00000316152.3	CEGS2	CegsMutGDEh1036	F07	GDEhDisVCh_40072	A08	2	CegsMutGDDh1036	F07	VUSN2Hmut_GDN2h_07	F05	VUSMutpDEST2_05	C07	VUSmut_GDEh07	F05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	28253.0	single nucleotide variant	NM_001317778.2(SFTPC):c.563T>C (p.Leu188Pro)	6440.0	SFTPC	HGNC:10802	Pathogenic	1.0	Jul 01, 2009	121918560.0	-	RCV000014101	MONDO:MONDO:0024465,MedGen:C1970470,OMIM:610913	Surfactant metabolism dysfunction, pulmonary, 2	germline	germline	GRCh38	NC_000008.11	8	22164028.0	22164028.0	8p21.3	no assertion criteria provided	1.0	-	N	ClinGen:CA210546,OMIM:178620.0008	1.0	13214.0	22164028.0	T	C	-	-	-	-	-	-	563T>C 	Leu188Pro	NM_001317778.2		Pathogenic	Pathogenic	13214	8	22164028.0	T	C	L	P	rs121918560	8	22021541	8	22077486	194	SFTPC	ENSG00000168484	ENST00000318561	ENSP00000316152	P11686	PSPC_HUMAN	c.581T>C	p.Leu194Pro	c.581T>C	p.Leu194Pro	principal4	Y	1	.	.	+	CTC	2	0	T	T/T	T/T	T/T	T/T	0.003	0.68399	D	0.012	0.64242	D	0.997	0.70687	D	0.93	0.66460	D	0.59	0.90354	A	simple_aae	41.0	59.0	1.585	0.39718	L	-3.28	0.81300	D	0.83	0.92907	0.2617	0.86883	D	0.5834	0.84980	D	9	0.7226228	0.73518	D	0.392094	0.93197	D	0.679	0.88152	0.854	0.95408	P11686	L194P	Loss of sheet (P = 0.0037)| Gain of disorder (P = 0.007)| Gain of relative solvent accessibility (P = 0.0082)| Gain of catalytic residue at P193 (P = 0.0116)| Gain of solvent accessibility (P = 0.0256)	0.946821583234	0.94583	0.9069675870886417	0.90610	1.64042593093	0.89318	0.616652011871	0.55190	T	0.470927	0.80235	T	0.32403	0.84644	D	0.22767	0.84444	D	0.907126903533936	0.55884	D	0.725127	0.33675	T	.	.	.	.	.	.	.	.	-3.944	0.24020	T	0.4392	0.65229	A	.	.	0.99922440	0.99225	0.452	0.68270	.	.	.	.	.	.	4.7936	0.77861	26.8	0.99853447029639664	0.93284	0.459033	0.50811	N	0.364389279797487	0.59294	4.130295	0.284545304492581	0.54398	3.628094	5.5	4.14	0.47761	.	.	1.405	0.34349	5.029000	0.46887	0.66	0.55068	0.007	0.17722	0.927000	0.28534	0.994	0.71086	555	0.71761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Surfactant_metabolism_dysfunction,_pulmonary,_2	no_assertion_criteria_provided	NC_000008.11:g.22164028T>C	ClinGen:CA210546|OMIM:178620.0008	C1970470	610913	.	BRICHOS domain|BRICHOS domain|BRICHOS domain	Leu	Pro	90.97	0.2682926829268293																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	Aliphatic	Leucine									BRICHOS			3.8																		131												Propeptide									Beta strand											90.97	26.82927	>90	10-90	610913	autosomal dominant	OMIM	Rare genetic respiratory disease	1	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	false	0.9457838418165694	0.9388557932296713	false	true	false
AGXT	AGXT_Gly82Arg	B_7-8	-1.5877940230097234	0.1563554350776465	0.2318081231029061	0.6542599078478976	0.5338417547388525	0.5883481200875642	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8247580294588952	0.8085869178665719	0.5399874174549137	0.5012532987574294	0.4810506941219278	0.5868366761685546	0.5749904849165968	0.4652124468678745	0.4667299363497457	0.5240853742306234	0.839339282831773	0.8764944443732735	0.5986828674205124	0.49688894137598105	0.5357766611651132	0.5558894606792041	0.7778345529013707	0.7730216145445168	AGXT	Gly82Arg	NC_000002.12:240869248:G:C	244G>C	2	240869248	G	C	2	ENSG00000172482	70497	3802	CCSBVarC008175	ALE00008161	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	H01	GDEhDisVCh_40002	H03	2	VUSMutGDDh004	H01	VUSN2Hmut_GDN2h_01	D06	VUSMutpDEST2_14	B03	VUSmut_GDEh01	D06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200457.0	single nucleotide variant	NM_000030.3(AGXT):c.244G>C (p.Gly82Arg)	189.0	AGXT	HGNC:341	Pathogenic	1.0	Jul 06, 2023	180177185.0	-	RCV000186290|RCV001852424	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900	Primary hyperoxaluria, type I|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	240869248.0	240869248.0	2q37.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA275654,UniProtKB:P21549#VAR_060548	2.0	204084.0	240869248.0	G	C	-	-	-	-	-	-	244G>C 	Gly82Arg	NM_000030.3	2.0	Pathogenic	Pathogenic	204084	2	240869248.0	G	C	G	R	rs180177185	2	241808665	2	241457338	82	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.244G>C	p.Gly82Arg	c.244G>C	p.Gly82Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	.	.	.	-7.38	0.94718	D	0.985	0.99419	1.0179	0.97490	D	0.8637	0.95456	D	9	0.99632454	0.99998	D	0.787397	0.98325	D	0.833	0.94713	0.976	0.99775	P21549	G82R	Loss of glycosylation at S81 (P = 0.0359)| Loss of sheet (P = 0.1501)| Gain of loop (P = 0.2045)| Gain of methylation at G82 (P = 0.2915)| Loss of catalytic residue at S79 (P = 0.3357)	0.984387714843	0.98405	0.9936774288861715	0.99363	0.266775748541	0.28922	0.651084423065	0.60076	T	0.960056	0.99476	D	0.459783	0.92863	D	0.42267	0.92775	D	0.999637484550476	0.98238	D	0.938006	0.76700	D	0.97743773	0.98890	0.9653023	0.99234	0.9849392	0.99453	0.9628061	0.99107	-14.308	0.94027	D	0.8813	0.81507	P	0.999187527424777	0.95902	0.57788324	0.83537	1	0.99985	.	.	.	.	.	.	4.438844	0.68965	25.3	0.99883918271233718	0.95973	0.975438	0.99617	D	0.668198564832954	0.77427	6.696509	0.441652591954678	0.63989	4.667647	4.27	4.27	0.49950	2.42	0.44885	9.12	0.93698	9.360000	0.80398	0.614	0.49322	1.0	0.71675	1.000000	0.68239	0.644	0.32572	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109394	0.000000e+00	0	1	207982	4.808110e-06	0	1	236812	4.222760e-06	0	0	7162	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16204	0.000000e+00	0	0	30514	0.000000e+00	0	0	6206	0.000000e+00	0	1	13412	7.456010e-05	0	0	16730	0.000000e+00	0	0	89448	0.000000e+00	0	0	30608	0.000000e+00	0	1	13412	7.456010e-05	0	0	14898	0.000000e+00	0	0	34248	0.000000e+00	0	0	9566	0.000000e+00	0	1	17692	5.652270e-05	0	0	21628	0.000000e+00	0	0	102640	0.000000e+00	0	0	30526	0.000000e+00	0	1	17692	5.652270e-05	0	.	1	1613894	6.196190e-07	0	1	44876	2.228360e-05	0	0	75052	0.000000e+00	0	0	912	0.000000e+00	0	0	60022	0.000000e+00	0	0	29608	0.000000e+00	0	1	44876	2.228360e-05	0	0	63760	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180018	0.000000e+00	0	0	91082	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Primary_hyperoxaluria,_type_I	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240869248G>C	ClinGen:CA275654|UniProtKB:P21549#VAR_060548	C3661900|C0268164	259900	416|93598	Aminotransferase class V domain	Gly	Arg	94.1	0.08333333333333333																																																																																																																																																																																																																																																																																																																																																																																																																																																																													7			94.1	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Alanine--glyoxylate aminotransferase								0.1782		-0.4								 G82-L86 (PAE:  1.0)	G82-L86 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7)	 G82-L86 (PAE:  1.0)	G82-L86 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)							75									-52.3		Pocket 2: Mean pLDDT: 96.54, Volume: 238.78 Å³, Druggability score: 0.18		-35.3				dbSNP: rs121908522; Variant type: LP/P; AA change: Gly82Glu; PTM type: Phosphorylation; PTM morphology: LVISGsG*HCAL; Var class: II&rs180177185		H (helix)	H (α-helix)	Helix											94.1	8.333334	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.8085869178665719	0.8247580294588952	false	false	false
CCBE1	CCBE1_Gly136Arg	B_15-16	6.440563496065129	0.0003534099533398642	0.002126651566841424	-5.918919940770552	0.000588154517646305	0.0015664202320478514	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8765062860993478	0.9055046923900043	0.5246696425523982	0.7912580103550431	0.7474451254792565	0.5526208843174805	0.5289442531681969	0.7844418485987256	0.846512962166841	0.4756812214655509	0.8413218584200831	0.8102377129440939	0.5762975154667641	0.7104484023597872	0.7360030585432452	0.5736580636392455	0.9696875263599254	0.9427748592546018	CCBE1	Gly136Arg	NC_000018.10:59438119:C:G	406G>C	18	59438119	C	G	18	ENSG00000183287	11443	217252	CCSBVarC005988	ALE00005988	ENSP00000404464.2	CEGS2	CegsMutGDEh1030	H03	GDEhDisVCh_40034	H10	2	CegsMutGDDh1030	H03	VUSN2Hmut_GDN2h_05	C03	VUSMutpDEST2_08	F11	VUSmut_GDEh05	C03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	15486.0	single nucleotide variant	NM_133459.4(CCBE1):c.979G>C (p.Gly327Arg)	147372.0	CCBE1	HGNC:29426	Pathogenic	1.0	Dec 01, 2009	121908252.0	-	RCV000000476	MONDO:MONDO:0009337,MedGen:C4012050,OMIM:235510,Orphanet:2136	Hennekam lymphangiectasia-lymphedema syndrome 1	germline	germline	GRCh38	NC_000018.10	18	59438119.0	59438119.0	18q21.32	no assertion criteria provided	2.0	-	N	ClinGen:CA278005,UniProtKB:Q6UXH8#VAR_063750,UniProtKB/Swiss-Prot:VAR_063750,OMIM:612753.0003	1.0	447.0	59438119.0	C	G	-	-	-	-	-	-	979G>C 	Gly327Arg	NM_133459.4		Pathogenic	Pathogenic	447	18	59438119.0	C	G	G	R	rs121908252	18	57105351	18	55256331	327	CCBE1	ENSG00000183287	ENST00000439986	ENSP00000404464	Q6UXH8	CCBE1_HUMAN	c.979G>C	p.Gly327Arg	c.979G>C	p.Gly327Arg	principal1	Y	1	YES	Select	-	GGG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.93829	A	simple_aae	7.0	93.0	3.955	0.96415	H	-6.0	0.89554	D	0.926	0.93024	0.9249	0.96017	D	0.9935	0.99849	D	10	0.9878793	0.99170	D	0.626035	0.96770	D	0.976	0.99783	0.952	0.99445	Q6UXH8	G327R	Gain of methylation at G327 (P = 0.0456)| Gain of glycosylation at P325 (P = 0.0647)| Loss of catalytic residue at P323 (P = 0.0761)| Gain of MoRF binding (P = 0.2764)| Gain of relative solvent accessibility (P = 0.281)	0.99595485415	0.99585	.	0.74130	0.423261060789	0.42510	0.881892442703	0.94206	D	0.448279	0.78864	T	0.556505	0.95991	D	0.561605	0.95930	D	0.999431192874908	0.97367	D	.	0.95295	.	0.7856177	0.82788	0.7453755	0.84767	0.7699227	0.81823	0.72828317	0.83756	-15.201	0.96315	D	0.9325	0.85434	LP	0.987137401757368	0.87335	0.87941250	0.90519	0.869	0.92884	.	.	.	.	.	.	4.916483	0.80973	27.4	0.99933958547494328	0.99535	0.820121	0.74003	D	1.07112583244622	0.97547	16.34447	0.945975689156119	0.97267	15.872	5.58	5.58	0.84339	3.93	0.74723	6.652	0.74291	7.544000	0.60205	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.902	0.43838	964	0.07711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hennekam_lymphangiectasia-lymphedema_syndrome_1	no_assertion_criteria_provided	NC_000018.10:g.59438119C>G	ClinGen:CA278005|OMIM:612753.0003|UniProtKB/Swiss-Prot:VAR_063750|UniProtKB:Q6UXH8#VAR_063750	C4012050	235510	2136	.	Gly	Arg	80.01	0.7261904761904762																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																80.01	72.61904	70-90	10-90	235510	autosomal recessive	OMIM	Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare genetic skin disease	4	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1	false	0.9055046923900043	0.8765062860993478	false	false	false
GFAP	GFAP_Asn77Ser	B_15-16	0.602115775755446	0.566081412549674	0.6443477341894382	11.461787264380765	8.646311108565493e-6	0.00006958763545709508	2025_03_Batch_15-16	true	true	false	false	false	false	true	false	false	false	false	false	0.9792333958766841	0.968504917875106	0.5895234779592509	0.8142417812444667	0.8688593852144029	0.7111899997364293	0.6126482142400905	0.8699743885397723	0.7344535026959074	0.5826575589813191	0.9602694331241177	0.9718400714578612	0.8097317852327679	0.8677443818890336	0.8940300597930259	0.5963893969371826	0.9767404026260942	0.986626720295507	GFAP	Asn77Ser	NC_000017.11:44915257:T:C	230A>G	17	44915257	T	C	17	ENSG00000131095	2920	214397	CCSBVarC004659	ALE00004659	ENSP00000466598.2	CEGS2	CegsMutGDEh1038	D12	GDEhDisVCh_40051	C06	1	CegsMutGDDh1038	D12	VUSN2Hmut_GDN2h_08	C01	VUSMutpDEST2_02	C12	VUSmut_GDEh08	C01	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77365.0	single nucleotide variant	NM_002055.5(GFAP):c.230A>G (p.Asn77Ser)	2670.0	GFAP	HGNC:4235	Pathogenic	1.0	Mar 20, 2023	57590980.0	-	RCV000192107|RCV000056865	MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MedGen:C3661900	Alexander disease|not provided	germline	germline	GRCh38	NC_000017.11	17	44915257.0	44915257.0	17q21.31	criteria provided, single submitter	4.0	-	N	ClinGen:CA217162,UniProtKB:P14136#VAR_071528	3.0	66468.0	44915257.0	T	C	-	-	-	-	-	-	230A>G 	Asn77Ser	NM_002055.5	1.0	Pathogenic	Pathogenic	66468	17	44915257.0	T	C	N	S	rs57590980	17	42992625	17	40348151	77	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.230A>G	p.Asn77Ser	c.230A>G	p.Asn77Ser	principal1	Y	1	YES	Select	-	AAT	2	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	0.8	0.99291	A	without_aae	20.0	80.0	4.36	0.98474	H	.	0.77092	.	.	0.89904	1.0945	0.99425	D	0.9590	0.98674	D	10	0.9879266	0.99176	D	0.580437	0.96232	D	.	0.98743	0.974	0.99756	P14136	N77S	Gain of phosphorylation at N77 (P = 0.0191)| Gain of disorder (P = 0.0783)| Gain of MoRF binding (P = 0.1435)| Gain of catalytic residue at R79 (P = 0.2057)| Loss of stability (P = 0.2482)	.	0.99996	.	0.96663	.	0.76728	0.773889541626	0.77968	T	0.969895	0.99664	D	0.283474	0.81477	D	0.169414	0.81238	D	0.998970508575439	0.95724	D	0.996942	0.98836	D	0.9373734	0.94903	0.8951142	0.94556	0.91911066	0.93060	0.8964455	0.94652	-10.478	0.77293	D	0.9648	0.90713	P	0.979583955055945	0.85215	0.99882050	0.98981	0.992	0.99727	.	.	.	.	.	.	5.06255	0.84416	28.3	0.9987608235740667	0.95331	.	.	.	0.946459976734609	0.93808	12.3159	0.834077319021701	0.92008	11.21044	4.82	4.82	0.61594	.	.	7.947	0.87271	7.898000	0.73439	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.992	0.67791	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Alexander_disease	criteria_provided,_single_submitter	NC_000017.11:g.44915257T>C	ClinGen:CA217162|UniProtKB:P14136#VAR_071528	C3661900|C0270726	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Asn	Ser	90.75	0.6242038216560509																																																																																																																																																																																																																																																																																																																																																																																																																																																																													98			90.75	Polar/Neutral	Asparagine		Glial fibrillary acidic protein							IF rod	0.0152		-3.5								 N77-A81 (PAE:  2.5), N77-M73 (PAE: 3.0)		 N77-A81 (PAE:  2.5), N77-M73 (PAE: 3.0)								132									-64.5		Pocket 5: Mean pLDDT: 80.91, Volume: 329.67 Å³, Druggability score: 0.02		-39.8	Coil 1A			dbSNP: rs58732244; Variant type: LP/P; AA change: Asn77Tyr; PTM type: Phosphorylation; PTM morphology: N*DRFAsYIEKV; Var class: II&-		H (helix)	H (α-helix)												90.75	62.42038	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.968504917875106	0.9792333958766841	true	true	false
KLHL3	KLHL3_Glu85Ala	B_7-8	3.434851336992985	0.010913131968237651	0.0289501139712971	-0.7748310107345587	0.46380373280503007	0.5173737688129059	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7719329834090553	0.7871584113437358	0.8025098036151725	0.8660553066757568	0.776113065494367	0.8392870439922597	0.9001858975606626	0.7478375493890752	0.932618853233271	0.8864703705914629	0.7693925295165492	0.7493642380107475	0.7783881904238568	0.8043885815996588	0.7994917601182425	0.7185492366388821	0.8049242931709222	0.794501728807363	KLHL3	Glu85Ala	NC_000005.10:137698396:T:G	254A>C	5	137698396	T	G	5	ENSG00000146021	1256	214009	CCSBVarC005558	ALE00005558	ENSP00000312397.4	CEGS2	CegsMutGDEh1034	C06	GDEhDisVCh_40013	D01	1	CegsMutGDDh1034	C06	VUSN2Hmut_GDN2h_06	F08	VUSMutpDEST2_01	G08	VUSmut_GDEh06	F08	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	106411.0	single nucleotide variant	NM_017415.3(KLHL3):c.254A>C (p.Glu85Ala)	26249.0	KLHL3	HGNC:6354	Pathogenic	1.0	-	199469625.0	-	RCV000128506	MONDO:MONDO:0007772,MedGen:C1840389,OMIM:145260,Orphanet:757,Orphanet:88938	Pseudohypoaldosteronism type 2A	germline	germline	GRCh38	NC_000005.10	5	137698396.0	137698396.0	5q31.2	no assertion criteria provided	1.0	-	N	ClinGen:CA269975,UniProtKB:Q9UH77#VAR_067503	2.0	100534.0	137698396.0	T	G	-	-	-	-	-	-	254A>C 	Glu85Ala	NM_017415.3		Pathogenic	Pathogenic	100534	5	137698396.0	T	G	E	A	rs199469625	5	137034085	5	137061984	85	KLHL3	ENSG00000146021	ENST00000309755	ENSP00000312397	Q9UH77	KLHL3_HUMAN	c.254A>C	p.Glu85Ala	c.254A>C	p.Glu85Ala	principal1	Y	1	YES	Select	-	GAG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.848	0.46859	P	0.651	0.52493	P	0.93	0.97926	A	simple_aae	7.0	93.0	3.245	0.89619	M	-5.12	0.83383	D	0.965	0.97550	0.2289	0.86338	D	0.5386	0.82900	D	9	0.948389	0.94102	D	0.258185	0.89373	D	0.801	0.93482	0.82	0.93292	Q9UH77	E85A	Loss of ubiquitination at K90 (P = 0.0634)| Loss of disorder (P = 0.0777)| Gain of relative solvent accessibility (P = 0.1571)| Gain of phosphorylation at T80 (P = 0.2771)| Loss of solvent accessibility (P = 0.2882)	0.863928787066	0.86155	0.8348478258001598	0.83344	1.33067464203	0.83560	0.79447644949	0.81089	T	0.685525	0.90716	D	0.420586	0.90988	D	0.366366	0.90876	D	0.995448052883148	0.87333	D	0.958304	0.84290	D	0.952677	0.96483	0.9106484	0.95674	0.9570951	0.96938	0.92506224	0.96706	-15.134	0.96183	D	0.9757	0.90318	P	0.990582547024871	0.88646	0.99034120	0.96784	0.975	0.99076	.	.	.	.	.	.	5.202004	0.87293	29.2	0.99622290507098843	0.75501	0.871751	0.79253	D	0.569414961355553	0.71119	5.625721	0.645737199201448	0.78173	6.847295	6.1	6.1	0.99107	.	.	8.004	0.88091	7.863000	0.71589	0.644	0.52462	1.0	0.71675	1.000000	0.68239	1.0	0.97202	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pseudohypoaldosteronism_type_2A	no_assertion_criteria_provided	NC_000005.10:g.137698396T>G	ClinGen:CA269975|UniProtKB:Q9UH77#VAR_067503	C1840389	145260	757|88938	BTB/POZ domain|BTB/POZ domain|BTB/POZ domain	Glu	Ala	77.43	0.3865979381443299																																																																																																																																																																																																																																																																																																																																																																																																																																																																													75			77.43	Negatively-charged	Glutamic Acid		Kelch-like protein 3							BTB	0.6299		-3.5								 E85-R65 (PAE:  5.5)										146									-63.4		Pocket 1: Mean pLDDT: 82.48, Volume: 446.44 Å³, Druggability score: 0.63		-29.4						H (helix)	G (3₁₀-helix)												77.43	38.659794	70-90	10-90	145260	autosomal dominant	OMIM	Rare genetic renal disease	1	PSEUDOHYPOALDOSTERONISM, TYPE IIA	false	0.7871584113437358	0.7719329834090553	false	false	false
PLP1	PLP1_Gly186Cys	B_7-8	-0.27908609396766687	0.7913542438090195	0.8350754727487444	1.969815314807577	0.09637489014383441	0.12805787357996823	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.9745262928347168	0.9777190131926232	0.7058585030188171	0.7099638150046805	0.6555473451478285	0.8519821355109868	0.8519821355109868	0.6260479533223584	0.8278434306731471	0.8030251290669782	0.9820014397233678	0.9703110069278548		0.6850467369732987	0.5920841993362138	0.608691876970656	0.9734365866618787	0.9787415787415789	PLP1	Gly186Cys	NC_000023.11:103788475:G:T	556G>T	23	103788475	G	T	X	ENSG00000123560	4062	201434	CCSBVarC005864	ALE00005864	ENSP00000477619.1	CEGS2	CegsMutGDEh1042	B03	GDEhDisVCh_40062	C09	2	CegsMutGDDh1042	B03	VUSN2Hmut_GDN2h_08	C11	VUSMutpDEST2_04	A04	VUSmut_GDEh08	C11	1.0	1.0	1.0	2.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	26122.0	single nucleotide variant	NM_000533.5(PLP1):c.661G>T (p.Gly221Cys)	5354.0	PLP1	HGNC:9086	Pathogenic	1.0	Jan 01, 1993	132630286.0	-	RCV000011832	MedGen:C4016483	Pelizaeus-Merzbacher disease, connatal	germline	germline	GRCh38	NC_000023.11	X	103788475.0	103788475.0	Xq22.2	no assertion criteria provided	1.0	-	N	ClinGen:CA121349,UniProtKB:P60201#VAR_004561,OMIM:300401.0011	1.0	11083.0	103788475.0	G	T	-	-	-	-	-	-	661G>T 	Gly221Cys	NM_000533.5		Pathogenic	Pathogenic	11083	X	103788475.0	G	T	G	C	rs132630286	X	103043404	X	102930060	221	PLP1	ENSG00000123560	ENST00000621218	ENSP00000484450	P60201	MYPR_HUMAN	c.661G>T	p.Gly221Cys	c.661G>T	p.Gly221Cys	principal1	Y	1	YES	Select	+	GGC	1	0	G	G/G	G/G	G/G	G/G	.	.	.	0.084	0.45880	T	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	2.275	0.64456	M	.	.	.	0.966	0.97658	1.0703	0.98596	D	0.9798	0.99376	D	10	0.99496657	0.99969	D	0.935329	0.99534	D	.	.	0.988	0.99876	P60201	G221C	Loss of ubiquitination at K218 (P = 0.1673)| Loss of helix (P = 0.1706)| Gain of methylation at K218 (P = 0.2028)| Loss of loop (P = 0.2897)| Gain of catalytic residue at G221 (P = 0.299)	0.999611515404	0.99959	.	0.99350	.	.	0.797753930092	0.81588	T	0.98487	0.99902	D	0.571407	0.96600	D	0.58301	0.96544	D	0.99495028592054	0.86472	D	0.948505	0.80163	D	0.9236427	0.93508	0.8518223	0.91515	0.9281257	0.93960	0.86888576	0.92692	-16.207	0.98058	D	0.9955	0.96717	P	0.998663867370318	0.94835	0.99815200	0.98654	0.987	0.99559	.	.	.	.	.	.	5.412651	0.90608	31.0	0.99681626380798227	0.79329	.	.	.	.	.	.	.	.	.	5.36	5.36	0.76590	2.67	0.48823	9.552	0.9722	11.825000	0.97355	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pelizaeus-Merzbacher_disease,_connatal	no_assertion_criteria_provided	NC_000023.11:g.103788475G>T	ClinGen:CA121349|OMIM:300401.0011|UniProtKB:P60201#VAR_004561	C4016483	.	.	.	Gly	Cys	87.14	0.05952380952380952																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																87.14	5.952381	70-90	<10		unknown		Rare genetic eye disease; Rare genetic neurological disorder	2		false	0.9777190131926232	0.9745262928347168	true	true	false
SH3BP2	SH3BP2_Arg415Gln	B_7-8	0.21958364327465738	0.836945917624612	0.8692586746400266	1.55609005143493	0.1636404082921498	0.2051195530428483	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5688855706403773	0.5861174216250413	0.6977521677399752	0.5309268918112758	0.5629573249666395	0.6780974351267834	0.6780974351267834	0.6480190167243488	0.5645040773213943	0.6977521677399752	0.6686021111472766	0.5688855706403773		0.4778956332089302	0.4973497063011574		0.5036327321028059		SH3BP2	Arg415Gln	NC_000004.12:2831573:G:A	1244G>A	4	2831573	G	A	4	ENSG00000087266	8143	202836	CCSBVarC003709	ALE00003709	ENSP00000422168.3	CEGS2	CegsMutGDEh1036	B12	GDEhDisVCh_40022	A06	2	CegsMutGDDh1036	B12	VUSN2Hmut_GDN2h_07	B07	VUSMutpDEST2_07	E08	VUSmut_GDEh07	B07	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	22590.0	single nucleotide variant	NM_001122681.2(SH3BP2):c.1244G>A (p.Arg415Gln)	6452.0	SH3BP2	HGNC:10825	Pathogenic	1.0	Dec 01, 2023	121909149.0	-	RCV000007987|RCV003886359	MONDO:MONDO:0007315,MedGen:C0008029,OMIM:118400,Orphanet:184|MedGen:C3661900	Fibrous dysplasia of jaw|not provided	germline	germline	GRCh38	NC_000004.12	4	2831573.0	2831573.0	4p16.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA254210,UniProtKB:P78314#VAR_013258,OMIM:602104.0005	3.0	7551.0	2831573.0	G	A	-	-	-	-	-	-	1244G>A 	Arg415Gln	NM_001122681.2	2.0	Pathogenic	Pathogenic	7551	4	2831573.0	G	A	R	Q	rs121909149	4	2833300	4	2803098	415	SH3BP2	ENSG00000087266	ENST00000513095	ENSP00000423823	P78314	3BP2_HUMAN	.	.	c.1244G>A	p.Arg415Gln	principal2	Y	4	.	.	+	CGA	2	0	G	./.	./.	./.	./.	.	.	.	.	.	.	0.995	0.67505	D	0.691	0.53827	P	.	0.96253	.	.	.	.	.	.	.	.	.	.	.	.	1.0254	0.97626	D	0.9464	0.98246	D	10	.	.	.	0.33934	0.91954	D	.	0.91208	.	.	.	.	.	.	0.95638	.	0.56659	.	0.45142	0.588646650314	0.51236	T	0.517166	0.82896	D	0.441984	0.92058	D	0.397103	0.91960	D	0.945050358772278	0.61953	D	.	0.67135	.	0.89006615	0.90378	0.79090077	0.87546	0.88670117	0.90090	0.73978055	0.84434	-4.042	0.26108	T	.	0.73314	.	0.512967200086698	0.61178	0.99223703	0.97105	0.762	0.86821	.	.	.	.	.	.	4.594401	0.72754	25.9	0.99935336647766615	0.99579	0.932634	0.92300	D	0.537688379889815	0.69171	5.342422	0.517826379064615	0.69021	5.325171	5.69	5.69	0.88329	3.72	0.68345	7.784	0.84365	11.411000	0.92701	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.118	0.19127	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1579824	1.265960e-06	0	2	1161982	1.721200e-06	0	0	74116	0.000000e+00	0	0	912	0.000000e+00	0	0	55870	0.000000e+00	0	0	29016	0.000000e+00	0	0	42862	0.000000e+00	0	0	61168	0.000000e+00	0	0	6016	0.000000e+00	0	2	1161982	1.721200e-06	0	0	86736	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	430	0	0	0	0	0	0	0	0	0	0	0	6	0	1	108	0.009259259259259259	0	430	0	0	34	0	1	656	0.001524390243902439	not_provided|Fibrous_dysplasia_of_jaw	criteria_provided,_multiple_submitters,_no_conflicts	NC_000004.12:g.2831573G>A	ClinGen:CA254210|OMIM:602104.0005|UniProtKB:P78314#VAR_013258	C3661900|C0008029	118400	184	.	Arg	Gln	45.59	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													248			45.59	Positively-charged	Arginine		SH3 domain-binding protein 2										-4.5			G:R415-C:E1007 (PDBs: 3TWR), F:R415-B:D998 (PDBs: 3TWR), F:R415-B:E1007 (PDBs: 3TWR), E:R415-A:E1007 (PDBs: 3TWR), H:R415-D:E1007 (PDBs: 3TWR), G:R415-C:D998 (PDBs: 3TWR), E:R415-A:D998 (PDBs: 3TWR), H:R415-D:D998 (PDBs: 3TWR)	H:R415-D:W1000 (PDBs: 3TWR), G:R415-C:W1000 (PDBs: 3TWR), E:R415-A:W1000 (PDBs: 3TWR)	G:R415-C:E1007 (PDBs: 3TWR), F:R415-B:D998 (PDBs: 3TWR), F:R415-B:E1007 (PDBs: 3TWR), E:R415-A:E1007 (PDBs: 3TWR), H:R415-D:E1007 (PDBs: 3TWR), G:R415-C:D998 (PDBs: 3TWR), E:R415-A:D998 (PDBs: 3TWR), H:R415-D:D998 (PDBs: 3TWR)													175									-157.9				138.1	Disordered			dbSNP: rs121909149; Variant type: LP/P; AA change: Arg415Pro; PTM type: Phosphorylation; PTM morphology: PHLQR*sPPDGQ; Var class: II&rs121909149		C (loop/coil)	C (loop/coil)												45.59	100.0	$\leqslant$50	$\geqslant$90	118400	autosomal dominant	OMIM	Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	3	CHERUBISM	false	0.5861174216250413	0.5688855706403773	false	false	false
PYGL	PYGL_Val456Met	B_7-8	-1.4497648712181508	0.20681050967619768	0.28769706735727424	-3.424908113355973	0.014058752581308188	0.023074965104383297	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.637081070486101	0.6346445194399497	0.5431001084731628	0.6465942769432815	0.6158166187867826	0.6239395428915637	0.884501232972065	0.8174118225280542	0.8959504705068426	0.7312281957351809	0.7768851667349216	0.7503228841300349	0.3633778528110626	0.414221415045511	0.3972380833797205	0.35497202121114463	0.4924038721449779	0.5238392568421671	PYGL	Val456Met	NC_000014.9:50915373:C:T	1366G>A	14	50915373	C	T	14	ENSG00000100504	55246	3221	CCSBVarC008112	ALE00008098	ENSP00000216392.7	Edgotyping3	VUSMutGDEh009	H01	GDEhDisVCh_40063	D12	1	VUSMutGDDh009	H01	VUSN2Hmut_GDN2h_03	B01	VUSMutpDEST2_13	E04	VUSmut_GDEh03	B01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	34180.0	single nucleotide variant	NM_002863.5(PYGL):c.1366G>A (p.Val456Met)	5836.0	PYGL	HGNC:9725	Pathogenic	1.0	May 22, 2022	113993979.0	-	RCV000020493	MONDO:MONDO:0009294,MedGen:C0017925,OMIM:232700,Orphanet:369	Glycogen storage disease, type VI	germline;unknown	germline	GRCh38	NC_000014.9	14	50915373.0	50915373.0	14q22.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA341906	3.0	21328.0	50915373.0	C	T	-	-	-	-	-	-	1366G>A 	Val456Met	NM_002863.5	1.0	Pathogenic	Pathogenic	21328	14	50915373.0	C	T	V	M	rs113993979	14	51382091	14	50451841	456	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.1366G>A	p.Val456Met	c.1366G>A	p.Val456Met	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	0.81	0.91795	A	simple_aae	19.0	81.0	4.395	0.98605	H	-2.62	0.56328	D	0.958	0.97110	1.0410	0.97926	D	0.9817	0.99438	D	10	0.9148871	0.90748	D	0.40988	0.93563	D	0.935	0.98525	.	.	.	.	.	0.975741027169	0.97523	0.9339705613291229	0.93335	0.527504655777	0.50065	0.776646733284	0.78385	T	0.855756	0.96730	D	0.412151	0.90533	D	0.590918	0.96869	D	0.977745294570923	0.71798	D	0.9952	0.98381	D	0.9199244	0.93140	0.8412327	0.90800	0.9401725	0.95193	0.8439481	0.90983	-14.279	0.93940	D	0.9599	0.89363	P	0.998704084879215	0.94906	0.91780950	0.91880	0.841	0.91258	.	.	.	.	.	.	5.547174	0.92027	32.0	0.99915210377578356	0.98380	0.937380	0.93484	D	1.10462763040872	0.98208	17.70826	1.00601789474683	0.98733	19.21298	5.66	5.66	0.87274	5.13	0.91238	7.905	0.86513	7.592000	0.61341	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.983	0.59808	364	0.84712	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	1	9.92063492063492E-4	0	0.0	7	264690	2.644603E-5	.	4	109408	3.656040e-05	0	9	208132	4.324180e-05	1	9	236944	3.798370e-05	1	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	1	15690	6.373490e-05	0	1	9046	1.105460e-04	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	1	13416	7.453790e-05	0	0	16734	0.000000e+00	0	4	89554	4.466580e-05	0	4	30608	1.306850e-04	1	4	30608	1.306850e-04	1	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	0	21632	0.000000e+00	0	4	102740	3.893320e-05	0	4	30526	1.310360e-04	1	4	30526	1.310360e-04	1	.	39	1614130	2.416160e-05	1	9	91084	9.880990e-05	1	2	75018	2.666030e-05	0	0	912	0.000000e+00	0	2	60012	3.332670e-05	0	0	29608	0.000000e+00	0	2	44882	4.456130e-05	0	0	64010	0.000000e+00	0	0	6062	0.000000e+00	0	23	1180040	1.949090e-05	0	9	91084	9.880990e-05	1	2	155648	1.2849506578947368E-5	0	162	0	0	4474	0	0	4082	0	0	796	0	0	968	0	0	1816	0	0	276	0	0	13256	0	0	4244	0	0	6290	0	2	181478	1.1020619579232745E-5	Glycogen_storage_disease,_type_VI	criteria_provided,_single_submitter	NC_000014.9:g.50915373C>T	ClinGen:CA341906	C0017925	232700	369	.	Val	Met	93.78	0.007042253521126761																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			93.78	Aliphatic	Valine		Glycogen phosphorylase, liver form										4.2								 V456-S675 (PAE:  2.0), V456-H460 (PAE: 1.5), V456-N485 (PAE: 1.0)	V456-N485 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 8EMS, 2QLL)	 V456-S675 (PAE:  2.0), V456-H460 (PAE: 1.5), V456-N485 (PAE: 1.0)	V456-T484 (PDBs: 1FA9), V456-S461 (PDBs: 1FA9, 2QLL), V456-H460 (PDBs: 1FA9), V456-N485 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 2QLL), V456-A674 (PDBs: 8EMS), V456-S675 (PDBs: 2QLL), V456-N482 (PDBs: 2QLL)							117									-111.3				1.1						C (loop/coil)	S (bend)	Beta strand											93.78	0.70422536	>90	<10	232700	autosomal recessive	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE VI	false	0.6346445194399497	0.637081070486101	false	false	false
THAP1	THAP1_Gly9Cys	B_7-8	2.4727257200927877	0.05634147004196475	0.10209886886162492	-4.17347556032121	0.005855839263764478	0.010799462360811876	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7044099832721786	0.7229482561366227	0.5237775022137524	0.5930476700047185	0.5843226714363303	0.5613063491338228	0.6035235195714046	0.6135737901259796	0.6761265809855551	0.5472155344376973	0.8184395081206141	0.8074184254466606	0.5190891786962412	0.5550715527466812	0.5099687590238817	0.5003394699898075	0.6274570041526314	0.6014015410976965	THAP1	Gly9Cys	NC_000008.11:42843070:C:A	25G>T	8	42843070	C	A	8	ENSG00000131931	1668	214082	CCSBVarC005990	ALE00005990	ENSP00000254250.3	CEGS2	CegsMutGDEh1032	F09	GDEhDisVCh_40085	C04	1	CegsMutGDDh1032	F09	VUSN2Hmut_GDN2h_06	D01	VUSMutpDEST2_01	C09	VUSmut_GDEh06	D01	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	16690.0	single nucleotide variant	NM_018105.3(THAP1):c.25G>T (p.Gly9Cys)	55145.0	THAP1	HGNC:20856	Pathogenic	1.0	Jan 19, 2010	267607112.0	-	RCV000001718	MONDO:MONDO:0011264,MedGen:C1414216,OMIM:602629,Orphanet:98806	Torsion dystonia 6	germline	germline	GRCh38	NC_000008.11	8	42843070.0	42843070.0	8p11.21	no assertion criteria provided	1.0	-	N	ClinGen:CA115123,UniProtKB:Q9NVV9#VAR_066680,OMIM:609520.0007	1.0	1651.0	42843070.0	C	A	-	-	-	-	-	-	25G>T 	Gly9Cys	NM_018105.3		Pathogenic	Pathogenic	1651	8	42843070.0	C	A	G	C	rs267607112	8	42698213	8	42817370	9	THAP1	ENSG00000131931	ENST00000254250	ENSP00000254250	Q9NVV9	THAP1_HUMAN	c.25G>T	p.Gly9Cys	c.25G>T	p.Gly9Cys	principal1	Y	1	YES	Select	-	GGC	1	0	C	C/C	C/C	C/C	C/C	0.005	0.91343	D	0.014	0.62681	D	0.999	0.90580	D	0.975	0.74106	D	0.66	0.81880	A	simple_aae	34.0	66.0	3.24	0.89550	M	-4.25	0.97409	D	0.846	0.84151	1.1411	0.99938	D	0.9361	0.97892	D	10	0.979369	0.97833	D	0.448999	0.94296	D	0.837	0.94863	0.894	0.97491	Q9NVV9	G9C	Loss of disorder (P = 0.1512)| Loss of loop (P = 0.2237)| Loss of ubiquitination at K11 (P = 0.2335)| Loss of relative solvent accessibility (P = 0.3219)| Loss of catalytic residue at Y8 (P = 0.3509)	0.841760828283	0.83900	0.7881797868040054	0.78648	1.57158735611	0.88145	0.817083179951	0.84554	D	0.836311	0.96110	D	0.508439	0.94493	D	0.492561	0.94413	D	0.998078346252441	0.93103	D	0.856014	0.61678	D	0.87154216	0.88832	0.7674627	0.86096	0.819795	0.85015	0.76642716	0.86034	-8.673	0.65646	D	0.8901	0.82057	P	0.925002457650324	0.77962	0.13653542	0.69534	0.979	0.99252	.	.	.	.	.	.	5.554693	0.92093	32.0	0.96388691749584154	0.29849	0.646760	0.62082	D	0.635621212649323	0.75310	6.30643	0.604060075556654	0.75098	6.2747	5.55	4.68	0.58268	4.77	0.87531	5.033	0.64015	4.742000	0.44689	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.984	0.60417	298	0.88077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Torsion_dystonia_6	no_assertion_criteria_provided	NC_000008.11:g.42843070C>A	ClinGen:CA115123|OMIM:609520.0007|UniProtKB:Q9NVV9#VAR_066680	C1414216	602629	98806	THAP-type zinc finger|THAP-type zinc finger|THAP-type zinc finger	Gly	Cys	80.91	0.8214285714285714																																																																																																																																																																																																																																																																																																																																																																																																																																																																													69			80.91	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		THAP domain-containing protein 1								0.1822		-0.4																		75									76.6		Pocket 3: Mean pLDDT: 53.63, Volume: 487.44 Å³, Druggability score: 0.18		-7.7				dbSNP: rs267607112; Variant type: LP/P; AA change: Gly9Cys; PTM type: Phosphorylation; PTM morphology: G*CKNRyDKDkP; Var class: II		C (loop/coil)	T (turn)	Beta strand										THAP-type	80.91	82.14286	70-90	10-90	602629	autosomal dominant	OMIM	Rare genetic neurological disorder	1	DYSTONIA 6, TORSION	false	0.7229482561366227	0.7044099832721786	false	false	false
KRT6A	KRT6A_Asn171Ser	B_7-8	-0.6157439037929581	0.5606795230260277	0.6389605542838384	-1.5667946733462197	0.16114633825957142	0.20246432946457327	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.845013815008818	0.7666761074260197	0.7147792814369995	0.5496851321062929	0.5762013642360946	0.7201222693019778	0.7209595987887938	0.6209446931705036	0.5753824155447566	0.6804660498745847	0.8082197405656093	0.845013815008818	0.7192849398151618	0.5314580353016857	0.5239878486678292	0.7490925129994143	0.72513247428643		KRT6A	Asn171Ser	NC_000012.12:52492677:T:C	512A>G	12	52492677	T	C	12	ENSG00000205420	4870	215270	CCSBVarC003669	ALE00003669	ENSP00000369317.3	CEGS2	CegsMutGDEh1035	C06	GDEhDisVCh_40048	G08	2	CegsMutGDDh1035	C06	VUSN2Hmut_GDN2h_07	A01	VUSMutpDEST2_04	B09	VUSmut_GDEh07	A01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	Y	Y	N	Y	77485.0	single nucleotide variant	NM_005554.4(KRT6A):c.512A>G (p.Asn171Ser)	3853.0	KRT6A	HGNC:6443	Pathogenic	1.0	Aug 23, 2021	58556099.0	-	RCV000128820|RCV000057010	MONDO:MONDO:0014324,MedGen:C3714948,OMIM:615726,Orphanet:2309|MedGen:C3661900	Pachyonychia congenita 3|not provided	germline;unknown	germline	GRCh38	NC_000012.12	12	52492677.0	52492677.0	12q13.13	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA217355,UniProtKB:P02538#VAR_072452,OMIM:148041.0006	3.0	66588.0	52492677.0	T	C	-	-	-	-	-	-	512A>G 	Asn171Ser	NM_005554.4	2.0	Pathogenic	Pathogenic	66588	12	52492677.0	T	C	N	S	rs58556099	12	52886461	12	51172728	171	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.512A>G	p.Asn171Ser	c.512A>G	p.Asn171Ser	principal1	Y	1	YES	Select	-	AAC	2	0	.	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.83643	D	0.997	0.70687	D	0.951	0.68937	D	0.92	0.93300	A	simple_aae	8.0	92.0	4.11	0.97321	H	-4.4	0.77340	D	0.996	0.99956	1.0774	0.98798	D	0.9673	0.98959	D	10	0.9705024	0.96599	D	0.117486	0.79666	D	0.913	0.97697	0.847	0.94998	P02538	N171S	Gain of catalytic residue at A175 (P = 0.0803)| Gain of disorder (P = 0.1043)| Gain of MoRF binding (P = 0.1178)| Gain of ubiquitination at K168 (P = 0.1204)| Loss of methylation at K173 (P = 0.1766)	0.954649245539	0.95379	0.8316850460860062	0.83026	0.865105964612	0.68976	0.683935284615	0.64776	T	0.923355	0.98629	D	0.271394	0.80423	D	0.152062	0.80168	D	0.998836696147919	0.95270	D	0.89721	0.63951	D	0.72389907	0.79136	0.7744728	0.86525	0.72389907	0.79137	0.7744728	0.86526	-13.415	0.91019	D	0.9675	0.89027	P	0.993025267865252	0.89819	0.89761126	0.91126	0.997	0.99892	.	.	.	.	.	.	4.064533	0.60417	24.2	0.99879595490815087	0.95576	0.872294	0.79332	D	1.04608520221539	0.96979	15.437	0.926690015599904	0.96614	14.94272	5.31	5.31	0.75027	.	.	7.811	0.84671	.	.	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.998	0.85369	764	0.49916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pachyonychia_congenita_3|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.52492677T>C	ClinGen:CA217355|OMIM:148041.0006|UniProtKB:P02538#VAR_072452	C3714948|C3661900	615726	2309	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Asn	Ser	83.26	0.5732484076433121																																																																																																																																																																																																																																																																																																																																																																																																																																																																													90			83.26	Polar/Neutral	Asparagine		Keratin, type II cytoskeletal 6A							IF rod			-3.5								 N171-I167 (PAE:  3.0), N171-A175 (PAE: 2.5)		 N171-I167 (PAE:  3.0), N171-A175 (PAE: 2.5)								132									-66.5				-35.6	Coil 1A			dbSNP: rs62635294; Variant type: LP/P; AA change: Asn171Asp; PTM type: Phosphorylation; PTM morphology: REQIktLN*NkF; Var class: II&rs59685571		H (helix)	H (α-helix)												83.26	57.324837	70-90	10-90	615726	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2	PACHYONYCHIA CONGENITA 3	false	0.7666761074260197	0.845013815008818	false	false	false
GMPPB	GMPPB_Pro22Ser	B_7-8	-5.135325157367588	0.014303563475901643	0.03580577488725051	-5.0500732160911985	0.0023334639278288273	0.004854769056197163	2024_01_Batch_7-8	false	false	true	false	false	false	false	false	false	false	false	false	0.92313782098922	0.7785166032620249	0.9398355611761452	0.9279370914328241	0.8794196957276939	0.9753858092478808	0.9753858092478808	0.9293975109256749	0.9789776999055069	0.9398355611761452	0.9420068348296684	0.92313782098922		0.8294418805297129	0.8768964829601413		0.6150263716943813		GMPPB	Pro22Ser	NC_000003.12:49723663:G:A	64C>T	3	49723663	G	A	3	ENSG00000173540	3449	214607	CCSBVarC005209	ALE00005209	ENSP00000311130.6	CEGS2	CegsMutGDEh1033	E12	GDEhDisVCh_40031	D12	1	CegsMutGDDh1033	E12	VUSN2Hmut_GDN2h_06	F06	VUSMutpDEST2_03	H06	VUSmut_GDEh06	F06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	75123.0	single nucleotide variant	NM_021971.4(GMPPB):c.64C>T (p.Pro22Ser)	29925.0	GMPPB	HGNC:22932	Pathogenic	1.0	Jul 11, 2013	397509424.0	-	RCV000054435	MONDO:MONDO:0014142,MedGen:C4518000,OMIM:615352,Orphanet:363623	Autosomal recessive limb-girdle muscular dystrophy type 2T	germline	germline	GRCh38	NC_000003.12	3	49723663.0	49723663.0	3p21.31	no assertion criteria provided	1.0	-	N	ClinGen:CA144557,UniProtKB:Q9Y5P6#VAR_070142,OMIM:615320.0003	1.0	60542.0	49723663.0	G	A	-	-	-	-	-	-	64C>T 	Pro22Ser	NM_021971.4		Pathogenic	Pathogenic	60542	3	49723663.0	G	A	P	S	rs397509424	3	49761096	3	49736100	22	GMPPB	ENSG00000173540	ENST00000480687	ENSP00000418565	Q9Y5P6	GMPPB_HUMAN	c.64C>T	p.Pro22Ser	c.64C>T	p.Pro22Ser	principal1	Y	2	.	.	-	CCG	1	0	G	G/G	G/G	G/G	G/G	0.031	0.47069	D	0.026	0.56104	D	1.0	0.90580	D	0.992	0.80453	D	0.88	0.92786	A	simple_aae	12.0	88.0	3.785	0.95215	H	-7.23	0.94316	D	0.743	0.74166	1.0608	0.98355	D	0.9347	0.97845	D	10	0.96664953	0.96118	D	0.941494	0.99585	D	0.909	0.97545	0.819	0.93225	Q9Y5P6	P22S	Loss of stability (P = 0.0747)| Loss of phosphorylation at T21 (P = 0.0943)| Gain of disorder (P = 0.1259)| Loss of glycosylation at T21 (P = 0.129)| Loss of catalytic residue at L19 (P = 0.2089)	0.98868559826	0.98843	.	0.90216	.	0.87171	0.583902478218	0.50569	T	0.875623	0.97327	D	0.323921	0.84637	D	0.227514	0.84436	D	0.970469906726072	0.68753	D	.	0.97656	.	0.81009513	0.84361	0.8195733	0.89376	0.791999	0.83191	0.82602286	0.89796	-10.614	0.78306	D	0.9493	0.88346	LP	0.998986529166207	0.95450	0.99957758	0.99505	0.934	0.96777	.	.	.	.	.	.	5.027645	0.83625	28.1	0.99863437496255947	0.94188	0.899148	0.84264	D	0.795836310596804	0.85767	8.699304	0.690568438994202	0.81560	7.579458	4.84	3.97	0.45177	5.51	0.94414	6.133	0.71495	11.711000	0.94660	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	2	0.99503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1582460	6.319280e-07	0	1	86330	1.158350e-05	0	0	73990	0.000000e+00	0	0	912	0.000000e+00	0	0	55164	0.000000e+00	0	0	27138	0.000000e+00	0	0	44704	0.000000e+00	0	0	61162	0.000000e+00	0	0	5900	0.000000e+00	0	0	1166096	0.000000e+00	0	1	86330	1.158350e-05	0	0	6962	0	0	84	0	0	84	0	0	2632	0	0	146	0	0	610	0	0	24	0	0	94	0	1	518	0.0019305019305019305	0	2716	0	0	108	0	1	11154	8.965393580778196E-5	Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2T	no_assertion_criteria_provided	NC_000003.12:g.49723663G>A	ClinGen:CA144557|OMIM:615320.0003|UniProtKB:Q9Y5P6#VAR_070142	C4518000	615352	363623	Nucleotidyl transferase domain|Mannose-1-phosphate guanyltransferase, N-terminal domain	Pro	Ser	92.07	0.07352941176470588																																																																																																																																																																																																																																																																																																																																																																																																																																																																													10			92.07	Special, No backbone hydrogen	Proline		Mannose-1-phosphate guanylyltransferase catalytic subunit beta										1.6										 P22-V26 (PAE:  1.0)	P22-V26 (PDBs: 7D72, 7D73, 7D74), P22-S57 (PDBs: 7D74)							115									-52.6				139.4	Substrate-binding domain					C (loop/coil)	C (loop/coil)												92.07	7.3529415	>90	<10	615352	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14	false	0.7785166032620249	0.92313782098922	false	false	false
DCX	DCX_Ser129Leu	B_7-8	-7.538492007847747	0.004839134801910486	0.015481989064738742	-15.307343476573067	1.2237462104730772e-6	0.00001846580032824103	2024_01_Batch_7-8		true	false	false	false	false		true	false	false	false	false		0.9931698630065948	0.7865615270310715	0.813677488651382	0.7186675160169123	0.8555587922603225	0.8555587922603225	0.777154358258087	0.8619709107552916	0.7865615270310715	0.9966987154607652			0.6601806737757376	0.7653840665474723		0.9896410105524245		DCX	Ser129Leu	NC_000023.11:111401309:G:A	386C>T	23	111401309	G	A	X	ENSG00000077279	8416	216641	CCSBVarC005192	ALE00005192	ENSP00000419861.1	CEGS2	CegsMutGDEh1035	F12	GDEhDisVCh_40049	D05	1	CegsMutGDDh1035	F12	VUSN2Hmut_GDN2h_07	B03	VUSMutpDEST2_08	D01	VUSmut_GDEh07	B03	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	169899.0	single nucleotide variant	NM_001195553.2(DCX):c.386C>T (p.Ser129Leu)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	Aug 07, 2013	587783548.0	-	RCV000145842	MedGen:C0008519	Ectopic tissue	germline	germline	GRCh38	NC_000023.11	X	111401309.0	111401309.0	Xq23	criteria provided, single submitter	1.0	-	N	ClinGen:CA171948	2.0	158460.0	111401309.0	G	A	-	-	-	-	-	-	386C>T 	Ser129Leu	NM_001195553.2	1.0	Pathogenic	Pathogenic	158460	X	111401309.0	G	A	S	L	rs587783548	X	110644537	X	110531193	129	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.386C>T	p.Ser129Leu	c.386C>T	p.Ser129Leu	alternative1	Y	1	.	.	-	TCA	2	0	G	G/G	G/G	G/G	G/G	.	0.61594	.	.	0.67073	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.82367	.	.	0.95151	1.0170	0.97474	D	0.8982	0.96616	D	10	0.9153397	0.90794	D	0.843935	0.98792	D	.	0.95607	.	.	.	.	.	.	0.99961	.	0.98788	.	.	0.807170391083	0.83028	D	.	0.96053	.	0.643034	0.99878	D	0.685898	0.99878	D	0.997630476951599	0.91970	D	0.997769	0.99085	D	0.9635655	0.97599	0.95959073	0.98933	0.9598571	0.97221	0.96024364	0.98969	-15.275	0.96472	D	0.9955	0.96039	LP	0.999572257638633	0.97044	0.99975747	0.99689	0.975	0.99076	.	.	.	.	.	.	4.886616	0.80235	27.3	0.99913374943356326	0.98239	.	.	.	.	.	.	.	.	.	4.74	4.74	0.59667	.	.	10.003	0.9969	11.875000	0.98680	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Ectopic_tissue	criteria_provided,_single_submitter	NC_000023.11:g.111401309G>A	ClinGen:CA171948	C0008519	.	.	.	Ser	Leu	89.55	0.038461538461538464																																																																																																																																																																																																																																																																																																																																																																																																																																																																													5			89.55	Polar/Neutral	Serine		Neuronal migration protein doublecortin							Doublecortin 1			-0.8								 S129-G100 (PAE:  3.0), S129-R102 (PAE: 2.0), S129-Q99 (PAE: 3.5)	S129-G100 (PDBs: 5IKC), S129-R102 (PDBs: 5IKC), S129-Q99 (PDBs: 5IKC)	 S129-L97 (PAE:  4.0), S129-G100 (PAE: 3.0), S129-P98 (PAE: 4.0), S129-Q99 (PAE: 3.5)	S129-P98 (PDBs: 2XRP), S129-R102 (PDBs: 4ATU, 6RFD), S129-Q99 (PDBs: 5IKC, 6RFD), S129-V101 (PDBs: 6REV, 6RF8), S129-G100 (PDBs: 6RFD)							105									-76.4				-29.5						C (loop/coil)	S (bend)	Beta strand											89.55	3.846154	70-90	<10		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.9931698630065948		true		true
ALAS2	ALAS2_Cys358Tyr	B_7-8	-0.06950480468569159	0.9489614283126149	0.9605279958013219	2.495967977180686	0.06705494321953431	0.09216915416318013	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7493082848315751	0.8011665210628278	0.7935262842796662	0.7758618766193397	0.743196289397625	0.79762259800236	0.79762259800236	0.743196289397625	0.7758618766193397	0.7935262842796662	0.8011665210628278	0.7493082848315751							ALAS2	Cys358Tyr	NC_000023.11:55015000:C:T	1073G>A	23	55015000	C	T	X	ENSG00000158578	8420	216662	CCSBVarC003768	ALE00003768	ENSP00000337131.4	CEGS2	CegsMutGDEh1041	F03	GDEhDisVCh_40062	C08	2	CegsMutGDDh1041	F03	VUSN2Hmut_GDN2h_08	B08	VUSMutpDEST2_08	B04	VUSmut_GDEh08	B08	1.0	1.0	1.0	1.0	1.0	5.0	6.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	Y	N	N	Y	25516.0	single nucleotide variant	NM_000032.5(ALAS2):c.1184G>A (p.Cys395Tyr)	212.0	ALAS2	HGNC:397	Pathogenic	1.0	Sep 21, 2005	137852307.0	-	RCV000011223	MONDO:MONDO:0020721,MedGen:C4551511,OMIM:300751,Orphanet:75563	X-linked sideroblastic anemia 1	germline	germline	GRCh38	NC_000023.11	X	55015000.0	55015000.0	Xp11.21	no assertion criteria provided	1.0	-	N	ClinGen:CA121090,OMIM:301300.0010	1.0	10477.0	55015000.0	C	T	-	-	-	-	-	-	1184G>A 	Cys395Tyr	NM_000032.5		Pathogenic	Pathogenic	10477	X	55015000.0	C	T	C	Y	rs137852307	X	55041433	X	55058158	395	ALAS2	ENSG00000158578	ENST00000650242	ENSP00000497236	P22557	HEM0_HUMAN	c.1184G>A	p.Cys395Tyr	c.1184G>A	p.Cys395Tyr	principal1	Y	.	YES	Select	-	TGT	2	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.50015	.	0.621	0.39950	P	0.566	0.49754	P	.	0.94378	.	.	.	.	1.46	0.36676	L	.	0.74848	.	.	0.81598	0.9992	0.97167	D	0.8951	0.96512	D	9	0.9131528	0.90575	D	0.875282	0.99045	D	.	0.96606	0.677	0.81414	P22557	C395Y	Loss of ubiquitination at K391 (P = 0.1322)| Gain of loop (P = 0.2045)| Loss of helix (P = 0.2662)| Loss of catalytic residue at G397 (P = 0.2764)| Loss of sheet (P = 0.3635)	.	0.99421	.	.	.	.	0.78536093235	0.79703	T	0.896382	0.97913	D	0.595333	0.97609	D	0.617378	0.97572	D	0.989533483982086	0.79611	D	0.985201	0.95531	D	0.95339596	0.96558	0.9691659	0.99419	0.9490402	0.96108	0.9628817	0.99110	-12.955	0.90814	D	0.887	0.85177	P	0.999692841480872	0.97521	0.99981529	0.99765	0.957	0.98136	.	.	.	.	.	.	4.699022	0.75415	26.3	0.99643225028677007	0.76845	.	.	.	.	.	.	.	.	.	5.64	5.64	0.86461	.	.	6.151	0.71658	7.658000	0.64127	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.983	0.59808	104	0.95693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	X-linked_sideroblastic_anemia_1	no_assertion_criteria_provided	NC_000023.11:g.55015000C>T	ClinGen:CA121090|OMIM:301300.0010	C4551511	300751	75563	Aminotransferase, class I/classII, large domain|Aminotransferase, class-II, pyridoxal-phosphate binding site|Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase	Cys	Tyr	97.56	0.23703703703703705																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.56	23.703703	>90	10-90	300751	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare inborn errors of metabolism; Rare genetic skin disease	4	ANEMIA, SIDEROBLASTIC, 1	false	0.8011665210628278	0.7493082848315751	false	false	false
NT5C3A	NT5C3A_Gly275Arg	B_15-16	-1.9697388740313049	0.08952564242399018	0.14999471669282566	-7.97420302829472	0.00009304798101615799	0.0003845564080284908	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9612668905859493	0.9776641103264845	0.626268755799094	0.7197277371382875	0.7490458394367492	0.6754757188652205	0.49909184833652503	0.5993488487130038	0.5045917803962823	0.5330681187503354	0.9761966660536838	0.949713337291508	0.851859589393916	0.8987428301604946	0.9348636938802928	0.7194693928478526	0.9791315545992851	0.9728204438803906	NT5C3A	Gly275Arg	NC_000007.14:33015741:C:G	823G>C	7	33015741	C	G	7	ENSG00000122643	14396	23463	CCSBVarC002093	ALE00002093	ENSP00000476480.2	RC4	RC4_Mut_GDEh1016	G10	GDEhDisVCh_40039	B09	1	RC4_Mut_GDDh1016	G10	NULL	NULL	VUSMutpDEST2_11	G08	VUSmut_GDEh12	F12	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	19527.0	single nucleotide variant	NM_001002010.5(NT5C3A):c.823G>C (p.Gly275Arg)	51251.0	NT5C3A	HGNC:17820	Pathogenic	1.0	Jul 01, 2004	104894029.0	-	RCV000004745	MONDO:MONDO:0009946,MedGen:C1849507,OMIM:266120,Orphanet:35120	Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency	germline	germline	GRCh38	NC_000007.14	7	33015741.0	33015741.0	7p14.3	no assertion criteria provided	1.0	-	N	ClinGen:CA116896,UniProtKB:Q9H0P0#VAR_023514,OMIM:606224.0010	1.0	4488.0	33015741.0	C	G	-	-	-	-	-	-	823G>C 	Gly275Arg	NM_001002010.5		Pathogenic	Pathogenic	4488	7	33015741.0	C	G	G	R	rs104894029	7	33055353	7	33021878	275	NT5C3A	ENSG00000122643	ENST00000610140	ENSP00000476480	X6RM59	X6RM59_HUMAN	c.823G>C	p.Gly275Arg	c.823G>C	p.Gly275Arg	principal3	Y	1	YES	Select	-	GGA	1	0	C	./.	./.	./.	./.	.	0.78662	.	0.001	0.83643	D	.	0.90580	.	.	0.77493	.	0.97	0.99291	A	simple_aae	3.0	97.0	.	.	.	.	0.92712	.	0.991	0.99781	0.9788	0.96831	D	0.9060	0.96876	D	9	0.9831016	0.98412	D	0.330391	0.91715	D	.	0.98227	.	.	.	.	.	0.975816274401	0.97531	.	.	.	.	0.80720436573	0.83034	D	0.813493	0.95327	D	0.493269	0.94040	D	0.47077	0.93963	D	0.996986925601959	0.90432	D	0.89841	0.64381	D	.	.	.	.	.	.	.	.	.	0.96271	.	0.9829	0.92334	LP	.	.	0.95079390	0.93418	0.836	0.90972	.	.	.	.	.	.	5.222504	0.87674	29.3	0.99937429700363511	0.99661	0.925127	0.90386	D	0.975945086748178	0.94929	13.18337	0.929908793326736	0.96732	15.09441	5.8	5.8	0.92070	4.12	0.78551	7.727	0.83838	7.654000	0.63915	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	814	0.42043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hemolytic_anemia_due_to_pyrimidine_5'_nucleotidase_deficiency	no_assertion_criteria_provided	NC_000007.14:g.33015741C>G	ClinGen:CA116896|OMIM:606224.0010|UniProtKB:Q9H0P0#VAR_023514	C1849507	266120	35120	.	Gly	Arg																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				NaN	NaN	266120	autosomal recessive	OMIM	Rare genetic hematologic disease; Rare inborn errors of metabolism	2	ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 8	false	0.9776641103264845	0.9612668905859493	true	true	false
FA2H	FA2H_Phe144Ser	B_7-8	-2.0041084028443055	0.11557321737737615	0.18376144481619042	-2.1769070691643875	0.06594113613463612	0.09084233093622919	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7426282354288848	0.8031046906944974	0.7856574871002919	0.8316137519877931	0.7942421184618144	0.9159209348766757	0.9159209348766757	0.8488656749749698	0.8639116267567963	0.7856574871002919	0.8546352863003368	0.7840155486034572		0.7396185619486589	0.7993158772187897		0.7515740950886581	0.7012409222543123	FA2H	Phe144Ser	NC_000016.10:74719067:A:G	431T>C	16	74719067	A	G	16	ENSG00000103089	513	213754	CCSBVarC005693	ALE00005693	ENSP00000219368.3	CEGS2	CegsMutGDEh1033	B02	GDEhDisVCh_40032	B12	2	CegsMutGDDh1033	B02	VUSN2Hmut_GDN2h_06	H02	VUSMutpDEST2_01	C08	VUSmut_GDEh06	H02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	99.0	Y	Y	Y	N	Y	40302.0	single nucleotide variant	NM_024306.5(FA2H):c.707T>C (p.Phe236Ser)	79152.0	FA2H	HGNC:21197	Pathogenic	1.0	Apr 01, 2012	387907172.0	-	RCV000024321	MONDO:MONDO:0012866,MedGen:C3496228,OMIM:612319,Orphanet:171629	Hereditary spastic paraplegia 35	germline	germline	GRCh38	NC_000016.10	16	74719067.0	74719067.0	16q23.1	no assertion criteria provided	1.0	-	N	ClinGen:CA260036,OMIM:611026.0007	1.0	31624.0	74719067.0	A	G	-	-	-	-	-	-	707T>C 	Phe236Ser	NM_024306.5		Pathogenic	Pathogenic	31624	16	74719067.0	A	G	F	S	rs387907172	16	74752965	16	73310466	236	FA2H	ENSG00000103089	ENST00000219368	ENSP00000219368	Q7L5A8	FA2H_HUMAN	c.707T>C	p.Phe236Ser	c.707T>C	p.Phe236Ser	principal1	Y	1	YES	Select	-	TTC	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.054	0.47448	T	0.954	0.54410	P	0.778	0.57206	P	0.92	0.93300	A	simple_aae	8.0	92.0	4.055	0.97021	H	-4.11	0.75007	D	0.989	0.99676	0.9531	0.96430	D	0.8491	0.94957	D	10	0.9208679	0.91345	D	0.644131	0.96968	D	0.892	0.96904	.	.	.	.	.	0.959336753721	0.95855	0.8898052425942613	0.88880	1.07880436334	0.76940	0.738910317421	0.72764	T	0.910454	0.98291	D	0.470042	0.93282	D	0.437407	0.93197	D	0.999327778816223	0.96939	D	0.871813	0.75543	D	0.9180991	0.92960	0.9112249	0.95717	0.9028687	0.91522	0.92326415	0.96579	-8.714	0.65914	D	0.6079	0.73289	P	0.997903166394995	0.93699	0.96931840	0.94604	0.899	0.94663	.	.	.	.	.	.	5.346145	0.89703	31.0	0.99854729403928388	0.93373	0.974840	0.99582	D	0.906324849818961	0.92021	11.21473	0.840921436020259	0.92433	11.44754	5.36	5.36	0.76590	.	.	9.269	0.94905	11.082000	0.85789	0.74	0.86203	1.0	0.71675	1.000000	0.68239	0.994	0.71086	657	0.62204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	1613990	2.478330e-06	0	4	1180020	3.389770e-06	0	0	75034	0.000000e+00	0	0	910	0.000000e+00	0	0	60028	0.000000e+00	0	0	29604	0.000000e+00	0	0	44878	0.000000e+00	0	0	63870	0.000000e+00	0	0	6062	0.000000e+00	0	4	1180020	3.389770e-06	0	0	91078	0.000000e+00	0	0	0	0	0	0	0	0	0	0	1	424	0.0023584905660377358	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	1	424	0.0023584905660377358	0	0	0	1	476	0.0021008403361344537	Hereditary_spastic_paraplegia_35	no_assertion_criteria_provided	NC_000016.10:g.74719067A>G	ClinGen:CA260036|OMIM:611026.0007	C3496228	612319	171629	Fatty acid hydroxylase	Phe	Ser	97.58	0.6142131979695431																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.58	61.421318	>90	10-90	612319	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION	false	0.8031046906944974	0.7426282354288848	false	false	false
KRT2	KRT2_Asn186Tyr	B_7-8	0.7145126769847091	0.4980389283434763	0.5813355573031962	-4.275209021281974	0.003677004258638867	0.007147566540892289	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6383489927066528	0.6438936983516979	0.523651199796477	0.4865480538188545	0.4529040171019798	0.5309209701513976	0.44785845700241445	0.3931449887867139	0.40107814477906534	0.4308174498276444	0.6410818265795218	0.671792167165896	0.6139834833003808	0.5126630454172457	0.5720179628586437	0.6164849497653095	0.6467055701238738	0.6049058182474096	KRT2	Asn186Tyr	NC_000012.12:52651587:T:A	556A>T	12	52651587	T	A	12	ENSG00000172867	55855	219414	CCSBVarC003451	ALE00003451	ENSP00000310861.3	CEGS2	CegsMutGDEh1033	B10	GDEhDisVCh_40073	B06	1	CegsMutGDDh1033	B10	VUSN2Hmut_GDN2h_06	E05	VUSMutpDEST2_13	F06	VUSmut_GDEh06	E05	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	2.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	24352.0	single nucleotide variant	NM_000423.3(KRT2):c.556A>T (p.Asn186Tyr)	3849.0	KRT2	HGNC:6439	Pathogenic	1.0	Nov 01, 1998	137852631.0	-	RCV000009898|RCV000056538	MONDO:MONDO:0007813,MedGen:C0432306,OMIM:146800,Orphanet:455|MedGen:CN517202	Ichthyosis bullosa of Siemens|not provided	germline	germline	GRCh38	NC_000012.12	12	52651587.0	52651587.0	12q13.13	no assertion criteria provided	2.0	-	N	ClinGen:CA120294,UniProtKB:P35908#VAR_009185,OMIM:600194.0005	3.0	9313.0	52651587.0	T	A	-	-	-	-	-	-	556A>T 	Asn186Tyr	NM_000423.3		Pathogenic	Pathogenic	9313	12	52651587.0	T	A	N	Y	rs137852631	12	53045371	12	51331638	186	KRT2	ENSG00000172867	ENST00000309680	ENSP00000310861	P35908	K22E_HUMAN	c.556A>T	p.Asn186Tyr	c.556A>T	p.Asn186Tyr	principal1	Y	1	YES	Select	-	AAC	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.105	0.97294	H	-7.46	0.94944	D	0.992	0.99826	1.1006	0.99685	D	0.9599	0.98704	D	9	0.97184014	0.96773	D	0.199485	0.86621	D	0.953	0.99157	0.835	0.94263	P35908	N186Y	Loss of disorder (P = 0.0233)| Gain of catalytic residue at A190 (P = 0.0787)| Loss of ubiquitination at K183 (P = 0.0982)| Loss of MoRF binding (P = 0.1104)| Loss of methylation at K188 (P = 0.1285)	0.985510803357	0.98519	0.9751409830309733	0.97491	0.518840836325	0.49434	0.687863945961	0.65342	T	0.93888	0.99013	D	0.558243	0.96024	D	0.564101	0.95961	D	0.999772131443024	0.98923	D	0.968303	0.88512	D	0.9331881	0.94474	0.96361315	0.99148	0.9331881	0.94475	0.96361315	0.99148	-14.612	0.94887	D	0.9854	0.92309	P	0.996091299143102	0.91847	0.59194905	0.83831	0.739	0.85541	.	.	.	.	.	.	4.998045	0.82936	27.9	0.99503892264804805	0.68246	0.818923	0.73911	D	0.95904230470167	0.94307	12.68068	0.869031164512486	0.94045	12.48791	5.54	5.54	0.82883	4.52	0.84500	6.271	0.72633	.	.	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.999	0.91597	764	0.49916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Ichthyosis_bullosa_of_Siemens	no_assertion_criteria_provided	NC_000012.12:g.52651587T>A	ClinGen:CA120294|OMIM:600194.0005|UniProtKB:P35908#VAR_009185	CN517202|C0432306	146800	455	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Asn	Tyr	84.92	0.5732484076433121																																																																																																																																																																																																																																																																																																																																																																																																																																																																													90			84.92	Polar/Neutral	Asparagine		Keratin, type II cytoskeletal 2 epidermal							IF rod			-3.5								 N186-A190 (PAE:  2.5), N186-I182 (PAE: 3.5)		 N186-A190 (PAE:  2.5), N186-I182 (PAE: 3.5)								132									-66.5				-35.4	Coil 1A			dbSNP: rs137852631; Variant type: LP/P; AA change: Asn186Tyr; PTM type: Acetylation; PTM morphology: ktLN*NkFAsFI; Var class: II&rs137852631		H (helix)	H (α-helix)												84.92	57.324837	70-90	10-90	146800	autosomal dominant	OMIM	Rare genetic skin disease	1	ICHTHYOSIS BULLOSA OF SIEMENS	false	0.6438936983516979	0.6383489927066528	false	false	false
GFAP	GFAP_Arg376Trp	B_15-16	1.1193986023820854	0.29990456020762424	0.38730068289152286	6.230691201851499	0.00043216528438700893	0.0012352387801404382	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.9005801182913176	0.885658024507102	0.6586952369271384	0.8357076911782985	0.783779750612936	0.7766603264003075	0.7014098290014121	0.7360169707805007	0.7981153413089315	0.635718504803178	0.8440974866272095	0.8700812546690933	0.8519108237992028	0.8315425304453714	0.8733000410476655	0.6816719690510988	0.9272185623869943	0.9310789819135418	GFAP	Arg376Trp	NC_000017.11:44911237:G:A	1126C>T	17	44911237	G	A	17	ENSG00000131095	2920	214442	CCSBVarC004679	ALE00004679	ENSP00000466598.2	CEGS2	CegsMutGDEh1042	C07	GDEhDisVCh_40051	A09	1	CegsMutGDDh1042	C07	VUSN2Hmut_GDN2h_08	D12	NULL	NULL	VUSmut_GDEh08	D12	1.0	1.0	1.0	1.0	1.0	1.0	6.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	77340.0	single nucleotide variant	NM_002055.5(GFAP):c.1126C>T (p.Arg376Trp)	2670.0	GFAP	HGNC:4235	Pathogenic	1.0	Dec 06, 2021	267607512.0	-	RCV000192177|RCV000056837	MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MedGen:C3661900	Alexander disease|not provided	germline	germline	GRCh38	NC_000017.11	17	44911237.0	44911237.0	17q21.31	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA217122	3.0	66443.0	44911237.0	G	A	-	-	-	-	-	-	1126C>T 	Arg376Trp	NM_002055.5	2.0	Pathogenic	Pathogenic	66443	17	44911237.0	G	A	R	W	rs267607512	17	42988605	17	40344131	376	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.1126C>T	p.Arg376Trp	c.1126C>T	p.Arg376Trp	principal1	Y	1	YES	Select	-	CGG	1	2	G	./.	./.	./.	./.	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	0.02	0.90832	A	without_aae	98.0	2.0	3.6	0.93646	H	.	0.93941	.	.	0.95970	0.8242	0.94693	D	0.8465	0.94867	D	10	0.9830048	0.98396	D	0.457886	0.94450	D	.	0.96979	0.941	0.99203	P14136	R376W	Loss of disorder (P = 0.0421)| Loss of glycosylation at T378 (P = 0.1594)| Loss of solvent accessibility (P = 0.1651)| Gain of catalytic residue at R376 (P = 0.214)| Loss of phosphorylation at T378 (P = 0.3056)	.	0.99330	.	0.87900	.	0.81293	0.823112726212	0.85480	D	0.967392	0.99618	D	0.458167	0.92789	D	0.420349	0.92700	D	0.99928492307663	0.96791	D	0.911709	0.87121	D	0.93462664	0.94622	0.94733226	0.98209	0.93433696	0.94592	0.9514644	0.98465	-13.114	0.89848	D	0.9297	0.85912	P	0.990860007087314	0.88768	0.99923337	0.99231	0.989	0.99628	.	.	.	.	.	.	6.26544	0.94915	34.0	0.99882420538535743	0.95815	0.944476	0.95144	D	0.374572501634177	0.59840	4.189573	0.247698782621779	0.52272	3.426199	4.25	2.04	0.25718	2.46	0.45475	1.847	0.39044	9.918000	0.82509	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.994	0.71086	754	0.51253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Alexander_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.44911237G>A	ClinGen:CA217122	C3661900|C0270726	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Trp	66.13	0.6532258064516129																																																																																																																																																																																																																																																																																																																																																																																																																																																																													162			66.13	Positively-charged	Arginine		Glial fibrillary acidic protein							IF rod			-4.5								 R376-G372 (PAE:  5.5)		 R376-G372 (PAE:  5.5)		 R376-E373 (PAE:  4.5)						175									-72.7				-35.8	Coil 2B					H (helix)	H (α-helix)												66.13	65.32258	50-70	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.885658024507102	0.9005801182913176	false	false	false
ALAS2	ALAS2_Lys262Gln	B_7-8	-5.574782102353581	0.011392929488026381	0.02989079027765163	0.6420177601502908	0.5665502831009553	0.616985026403711	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.642575577525656	0.7559699121962301	0.8017645619754137	0.7930320866073521	0.7896824845552054	0.8068886112424711	0.8068886112424711	0.7896824845552054	0.7930320866073521	0.8017645619754137	0.7559699121962301	0.642575577525656							ALAS2	Lys262Gln	NC_000023.11:55017594:T:G	784A>C	23	55017594	T	G	X	ENSG00000158578	8420	216660	CCSBVarC003766	ALE00003766	ENSP00000337131.4	CEGS2	CegsMutGDEh1033	C04	GDEhDisVCh_40062	E05	2	CegsMutGDDh1033	C04	VUSN2Hmut_GDN2h_06	G03	VUSMutpDEST2_08	H03	VUSmut_GDEh06	G03	1.0	1.0	1.0	2.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25511.0	single nucleotide variant	NM_000032.5(ALAS2):c.895A>C (p.Lys299Gln)	212.0	ALAS2	HGNC:397	Pathogenic	1.0	Sep 21, 2005	137852303.0	-	RCV000011218	MedGen:C4225593	Sideroblastic anemia 1, late-onset	germline	germline	GRCh38	NC_000023.11	X	55017594.0	55017594.0	Xp11.21	no assertion criteria provided	1.0	-	N	ClinGen:CA121081,OMIM:301300.0005	1.0	10472.0	55017594.0	T	G	-	-	-	-	-	-	895A>C 	Lys299Gln	NM_000032.5		Pathogenic	Pathogenic	10472	X	55017594.0	T	G	K	Q	rs137852303	X	55044027	X	55060752	299	ALAS2	ENSG00000158578	ENST00000650242	ENSP00000497236	P22557	HEM0_HUMAN	c.895A>C	p.Lys299Gln	c.895A>C	p.Lys299Gln	principal1	Y	.	YES	Select	-	AAG	1	0	T	T/T	T/T	T/T	T/T	.	0.78662	.	.	0.79703	.	0.994	0.66535	D	0.944	0.68055	D	.	0.90832	.	.	.	.	2.27	0.64340	M	.	0.71314	.	.	0.51076	0.9218	0.95971	D	0.8568	0.95221	D	10	0.9751628	0.97225	D	0.638682	0.96909	D	.	0.96979	0.85	0.95175	P22557	K299Q	Loss of ubiquitination at K299 (P = 0.0297)| Loss of MoRF binding (P = 0.0932)| Loss of methylation at K299 (P = 0.1121)| Loss of loop (P = 0.2237)| Loss of sheet (P = 0.302)	.	0.97634	.	.	.	.	0.519374370575	0.41478	T	0.910178	0.98284	D	0.31638	0.84098	D	0.216681	0.83891	D	0.991044878959656	0.81150	D	0.988951	0.96297	D	0.9862698	0.99540	0.97056717	0.99481	0.98083466	0.99159	0.9619075	0.99059	-8.912	0.69566	D	0.4561	0.63580	A	0.996865759526678	0.92538	0.99965727	0.99581	0.695	0.83079	.	.	.	.	.	.	4.474394	0.69817	25.4	0.99533462382866567	0.70063	.	.	.	.	.	.	.	.	.	5.24	5.24	0.72825	4.01	0.76498	4.274	0.58803	7.850000	0.70966	0.665	0.62996	1.0	0.71675	1.000000	0.68239	1.0	0.97202	103	0.95731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Sideroblastic_anemia_1,_late-onset	no_assertion_criteria_provided	NC_000023.11:g.55017594T>G	ClinGen:CA121081|OMIM:301300.0005	C4225593	.	.	Aminotransferase, class I/classII, large domain|Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase	Lys	Gln	97.66	0.526829268292683																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.66	52.682922	>90	10-90		unknown		Rare genetic renal disease; Rare genetic hematologic disease; Rare inborn errors of metabolism; Rare genetic skin disease	4		false	0.7559699121962301	0.642575577525656	false	false	false
NR0B1	NR0B1_Tyr380Asp	B_15-16	1.166968310258347	0.28143413041548543	0.3684298760065642	-2.0262838251400828	0.0823631660891541	0.11072264452278226	2025_03_Batch_15-16	true	true	false	false	false	false	true	false	false	false	false	false	0.993868930333526	0.9807262852395322	0.5740912297297407	0.6226680169600732	0.6182214492322426	0.6327284770149446	0.7048436817813887	0.801910514604913	0.8225238333506194	0.5826011683784711	0.9813416062446458	0.9946747341272251	0.5606132722485004	0.43453238385957227	0.42281220056952706	0.5655812910810104	0.9801109642344185	0.9930631265398269	NR0B1	Tyr380Asp	NC_000023.11:30308226:A:C	1138T>G	23	30308226	A	C	X	ENSG00000169297	7215	216195	CCSBVarC006816	ALE00006814	ENSP00000368253.4	CEGS2	CegsMutGDEh1046	F05	GDEhDisVCh_40038	B05	2	CegsMutGDDh1046	F05	VUSN2Hmut_GDN2h_10	H01	VUSMutpDEST2_06	C02	VUSmut_GDEh10	H01	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	26012.0	single nucleotide variant	NM_000475.5(NR0B1):c.1138T>G (p.Tyr380Asp)	190.0	NR0B1	HGNC:7960	Pathogenic	1.0	Jan 01, 2002	104894900.0	-	RCV000011720	MONDO:MONDO:0010264,MedGen:C0342482,OMIM:300200,Orphanet:95702	Congenital adrenal hypoplasia, X-linked	germline	germline	GRCh38	NC_000023.11	X	30308226.0	30308226.0	Xp21.2	no assertion criteria provided	1.0	-	N	ClinGen:CA255639,UniProtKB:P51843#VAR_018300,OMIM:300473.0025	1.0	10973.0	30308226.0	A	C	-	-	-	-	-	-	1138T>G 	Tyr380Asp	NM_000475.5		Pathogenic	Pathogenic	10973	X	30308226.0	A	C	Y	D	rs104894900	X	30326343	X	30236264	380	NR0B1	ENSG00000169297	ENST00000378970	ENSP00000368253	P51843	NR0B1_HUMAN	c.1138T>G	p.Tyr380Asp	c.1138T>G	p.Tyr380Asp	principal1	Y	1	YES	Select	-	TAC	1	0	A	A/A	A/A	A/A	A/A	0.001	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.135	0.88015	M	-9.19	0.98243	D	0.886	0.95034	1.0950	0.99447	D	0.9473	0.98276	D	9	0.99122465	0.99642	D	0.97165	0.99830	D	0.963	0.99463	0.925	0.98733	P51843	Y380D	Loss of stability (P = 0.0355)| Gain of ubiquitination at K376 (P = 0.0509)| Gain of phosphorylation at Y378 (P = 0.0851)| Loss of sheet (P = 0.1158)| Gain of relative solvent accessibility (P = 0.1259)	0.996620274428	0.99654	0.9770719987965217	0.97686	2.05838413245	0.94369	0.69314956665	0.66101	T	0.980268	0.99837	D	0.724394	0.99951	D	0.802766	0.99950	D	0.999882102012634	0.99520	D	0.907009	0.67082	D	0.98634374	0.99545	0.98946357	0.99974	0.98534346	0.99480	0.9862895	0.99942	-11.227	0.80949	D	0.9882	0.93046	P	0.997061853121893	0.92738	0.97447056	0.95015	0.997	0.99892	.	.	.	.	.	.	5.25336	0.88221	29.5	0.99346702472567716	0.60469	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	4.06	0.77529	8.818	0.91638	11.050000	0.85310	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	832	0.38867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Congenital_adrenal_hypoplasia,_X-linked	no_assertion_criteria_provided	NC_000023.11:g.30308226A>C	ClinGen:CA255639|OMIM:300473.0025|UniProtKB:P51843#VAR_018300	C0342482	300200	95702	Nuclear hormone receptor, ligand-binding domain|Nuclear hormone receptor, ligand-binding domain|Nuclear hormone receptor, ligand-binding domain	Tyr	Asp	89.53	0.07657657657657657																																																																																																																																																																																																																																																																																																																																																																																																																																																																													17			89.53	Aromatic	Tyrosine		Nuclear receptor subfamily 0 group B member 1							NR LBD			-1.3								 Y380-T384 (PAE:  1.0), Y380-K376 (PAE: 1.0)		 Y380-T384 (PAE:  1.0), Y380-K376 (PAE: 1.0)								181									-69.5				-32.3						H (helix)	H (α-helix)												89.53	7.6576576	70-90	<10	300200	x-linked recessive	OMIM	Rare genetic gynecological and obstetrical diseases; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic urogenital disease; Rare genetic endocrine disease; Genetic infertility; Rare genetic skin disease	7	ADRENAL HYPOPLASIA, CONGENITAL	false	0.9807262852395322	0.993868930333526	true	true	false
DCX	DCX_Ala71Ser	B_7-8	2.9576168842851	0.021176573127721702	0.04714132246380938	0.7895619201312758	0.4556914072779289	0.50956351758379	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8200393061734506	0.8056619522838497	0.7559027218376582	0.5733467345386267	0.4824178272258778	0.7408393763922395	0.8500038696385084	0.6098885917290315	0.6512643379536827	0.8298969597734579	0.8366620489564445	0.8494541295056132	0.6316748831459706	0.354947062722724	0.4954291311235707	0.6819084839018584	0.7746618556112549	0.7906244828412881	DCX	Ala71Ser	NC_000023.11:111410188:C:A	211G>T	23	111410188	C	A	X	ENSG00000077279	8416	216621	CCSBVarC005184	ALE00005184	ENSP00000419861.1	CEGS2	CegsMutGDEh1039	A07	GDEhDisVCh_40049	F06	1	CegsMutGDDh1039	A07	VUSN2Hmut_GDN2h_08	H02	VUSMutpDEST2_07	A11	VUSmut_GDEh08	H02	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26649.0	single nucleotide variant	NM_001195553.2(DCX):c.211G>T (p.Ala71Ser)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	Jan 28, 2003	104894786.0	-	RCV000012376|RCV000012375	MedGen:C1848070|MONDO:MONDO:0010239,MedGen:C4551968,OMIM:300067,Orphanet:2148	Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation	germline	germline	GRCh38	NC_000023.11	X	111410188.0	111410188.0	Xq23	no assertion criteria provided	1.0	-	N	ClinGen:CA121609,UniProtKB:O43602#VAR_026026,OMIM:300121.0014	1.0	11610.0	111410188.0	C	A	-	-	-	-	-	-	211G>T 	Ala71Ser	NM_001195553.2		Pathogenic	Pathogenic	11610	X	111410188.0	C	A	A	S	rs104894786	X	110653416	X	110540072	71	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.211G>T	p.Ala71Ser	c.211G>T	p.Ala71Ser	alternative1	Y	1	.	.	-	GCT	1	0	C	C/C	C/C	C/C	C/C	.	0.41520	.	.	0.65108	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.60380	.	.	0.88119	0.9790	0.96835	D	0.9014	0.96722	D	9	0.85247195	0.84264	D	0.515602	0.95360	D	.	0.95310	.	.	.	.	.	.	0.99710	.	0.87924	.	.	0.860826432705	0.91219	D	.	0.74713	.	0.568225	0.96543	D	0.578439	0.96486	D	0.995288133621216	0.87046	D	0.991701	0.97387	D	0.89041835	0.90409	0.87748957	0.93297	0.8921756	0.90563	0.8866917	0.93951	-9.466	0.70727	D	0.9087	0.83532	LP	0.997044697119206	0.92717	0.99949040	0.99428	0.872	0.93060	.	.	.	.	.	.	5.489894	0.91483	32.0	0.99806649250505108	0.89094	.	.	.	.	.	.	.	.	.	5.37	5.37	0.76916	4.4	0.82834	6.109	0.71273	7.658000	0.64127	0.599	0.40292	1.0	0.71675	1.000000	0.68239	1.0	0.97202	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Subcortical_laminar_heterotopia,_X-linked|Lissencephaly_type_1_due_to_doublecortin_gene_mutation	no_assertion_criteria_provided	NC_000023.11:g.111410188C>A	ClinGen:CA121609|OMIM:300121.0014|UniProtKB:O43602#VAR_026026	C1848070|C4551968	300067	2148	.	Ala	Ser	91.95	0.4716981132075472																																																																																																																																																																																																																																																																																																																																																																																																																																																																													50			91.95	Aliphatic	Alanine		Neuronal migration protein doublecortin							Doublecortin 1	0.0714		1.8											A71-K54 (PDBs: 2XRP, 4ATU)							89									-98.4		Pocket 5: Mean pLDDT: 79.41, Volume: 331.77 Å³, Druggability score: 0.07		119.8				dbSNP: rs104894786; Variant type: LP/P; AA change: Ala71Ser; PTM type: Phosphorylation; PTM morphology: VYA*VSsDRFRS; Var class: II&rs104894786		B (undefined)	E (parallel sheets)	Beta strand											91.95	47.16981	>90	10-90	300067	x-linked	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	LISSENCEPHALY, X-LINKED, 1	true	0.8056619522838497	0.8200393061734506	false	false	false
PLP1	PLP1_Pro181Ser	B_7-8	0.8082387533135127	0.44980262275572147	0.5379605569589405	0.9214604958779741	0.392354042577255	0.44580165209242284	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8956264239781407	0.9182667101842696	0.6791364744008442	0.5871308627499787	0.49996190962700326	0.6860658376811276	0.7185742532091718	0.4479947498091633	0.5999229221524233	0.7093493699965512	0.931242980675687	0.8794369942144574	0.6535574221530834	0.5519290694448432	0.5743388033475341	0.6489235788051373	0.9052904396928523	0.9118158537418241	PLP1	Pro181Ser	NC_000023.11:103788460:C:T	541C>T	23	103788460	C	T	X	ENSG00000123560	4062	201431	CCSBVarC005862	ALE00005862	ENSP00000477619.1	CEGS2	CegsMutGDEh1041	G08	GDEhDisVCh_40062	G08	2	CegsMutGDDh1041	G08	VUSN2Hmut_GDN2h_08	G09	VUSMutpDEST2_04	F03	VUSmut_GDEh08	G09	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26112.0	single nucleotide variant	NM_000533.5(PLP1):c.646C>T (p.Pro216Ser)	5354.0	PLP1	HGNC:9086	Pathogenic	1.0	Sep 28, 2012	132630278.0	-	RCV000011822|RCV000079100	Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702|MedGen:C3661900	Pelizaeus-Merzbacher disease|not provided	germline	germline	GRCh38	NC_000023.11	X	103788460.0	103788460.0	Xq22.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA221109,UniProtKB:P60201#VAR_004558,OMIM:300401.0001	3.0	11073.0	103788460.0	C	T	-	-	-	-	-	-	646C>T 	Pro216Ser	NM_000533.5	1.0	Pathogenic	Pathogenic	11073	X	103788460.0	C	T	P	S	rs132630278	X	103043389	X	102930045	216	PLP1	ENSG00000123560	ENST00000612423	ENSP00000481006	P60201	MYPR_HUMAN	c.646C>T	p.Pro216Ser	c.646C>T	p.Pro216Ser	principal1	Y	2	.	.	+	CCT	1	0	C	C/C	C/C	C/C	C/C	.	.	.	0.004	0.74454	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	2.65	0.77408	M	.	.	.	0.928	0.93259	1.0963	0.99502	D	0.9748	0.99211	D	10	0.9911996	0.99638	D	0.965221	0.99779	D	.	.	0.941	0.99203	P60201	P216S	Gain of glycosylation at P216 (P = 0.0582)| Loss of ubiquitination at K218 (P = 0.1537)| Loss of methylation at K218 (P = 0.1634)| Loss of helix (P = 0.1706)| Loss of loop (P = 0.2237)	0.996400904199	0.99631	0.9524939384726154	0.95204	.	.	0.789383411407	0.80314	T	0.9692	0.99652	D	0.563535	0.96271	D	0.571702	0.96211	D	0.990846636014503	0.80932	D	.	0.99713	.	0.7364847	0.79853	0.7727896	0.86422	0.7244523	0.79168	0.71615654	0.83050	-4.008	0.23945	T	0.9295	0.92665	LP	0.999898856490561	0.98645	0.99758106	0.98429	0.964	0.98523	.	.	.	.	.	.	4.713407	0.75789	26.4	0.99907643446975869	0.97802	.	.	.	.	.	.	.	.	.	5.36	5.36	0.76590	.	.	7.53	0.80904	7.668000	0.64675	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.999	0.91597	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pelizaeus-Merzbacher_disease|not_provided	criteria_provided,_single_submitter	NC_000023.11:g.103788460C>T	ClinGen:CA221109|OMIM:300401.0001|UniProtKB:P60201#VAR_004558	C0205711|C3661900	312080	702	.	Pro	Ser	81.33	0.41911764705882354																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																81.33	41.911766	70-90	10-90	312080	x-linked recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	PELIZAEUS-MERZBACHER DISEASE	false	0.9182667101842696	0.8956264239781407	false	false	false
ALAS2	ALAS2_Phe128Leu	B_7-8	0.05195892634569444	0.9618276197052229	0.9704652686935952	0.5009651419053094	0.6508436163926948	0.6984199041406989	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7321863877300081	0.7313782522096046	0.8506181742072518	0.6820171441763807	0.6993950261246706	0.8350299586557529	0.8350299586557529	0.6422485932797616	0.8106300799695907	0.8506181742072518	0.7313782522096046	0.7321863877300081		0.7565414589695796	0.5534042083831706				ALAS2	Phe128Leu	NC_000023.11:55021195:G:T	384C>A	23	55021195	G	T	X	ENSG00000158578	8420	216655	CCSBVarC003762	ALE00003762	ENSP00000337131.4	CEGS2	CegsMutGDEh1039	F04	GDEhDisVCh_40062	C06	2	CegsMutGDDh1039	F04	VUSN2Hmut_GDN2h_08	C02	VUSMutpDEST2_08	D03	VUSmut_GDEh08	C02	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25509.0	single nucleotide variant	NM_000032.5(ALAS2):c.495C>A (p.Phe165Leu)	212.0	ALAS2	HGNC:397	Pathogenic	1.0	Apr 08, 2021	137852301.0	-	RCV000011216|RCV001857329	MONDO:MONDO:0020721,MedGen:C4551511,OMIM:300751,Orphanet:75563|MedGen:C3661900	X-linked sideroblastic anemia 1|not provided	germline	germline	GRCh38	NC_000023.11	X	55021195.0	55021195.0	Xp11.21	criteria provided, single submitter	2.0	-	N	ClinGen:CA121078,UniProtKB:P22557#VAR_072328,OMIM:301300.0003	3.0	10470.0	55021195.0	G	T	-	-	-	-	-	-	495C>A 	Phe165Leu	NM_000032.5	1.0	Pathogenic	Pathogenic	10470	X	55021195.0	G	T	F	L	rs137852301	X	55047628	X	55064353	165	ALAS2	ENSG00000158578	ENST00000650242	ENSP00000497236	P22557	HEM0_HUMAN	c.495C>A	p.Phe165Leu	c.495C>A	p.Phe165Leu	principal1	Y	.	YES	Select	-	TTC	3	2	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.83643	.	0.995	0.67505	D	0.85	0.60650	P	.	0.91795	.	.	.	.	3.115	0.87696	M	.	0.88866	.	.	0.71364	-0.1786	0.78117	T	0.3473	0.71073	T	9	0.9720086	0.96795	D	0.308672	0.91095	D	.	0.98562	0.872	0.96404	P22557	F165L	Loss of methylation at K166 (P = 0.0384)| Gain of MoRF binding (P = 0.1319)| Gain of helix (P = 0.132)| Gain of ubiquitination at K166 (P = 0.1725)| Gain of phosphorylation at Y162 (P = 0.1794)	.	0.99561	.	.	.	.	0.812987029552	0.83923	D	0.750533	0.93097	D	0.601913	0.97649	D	0.62683	0.97612	D	0.996291756629944	0.88961	D	0.981452	0.97304	D	0.96783733	0.98024	0.90851194	0.95521	0.9738777	0.98586	0.90851194	0.95522	-11.811	0.88346	D	0.9991	0.98500	P	0.999950031360047	0.99183	0.99928790	0.99274	0.912	0.95445	.	.	.	.	.	.	3.882905	0.56525	23.7	0.99759935648021569	0.85024	.	.	.	.	.	.	.	.	.	4.92	3.15	0.35223	1.04	0.29558	4.267	0.58762	4.514000	0.43738	-0.633	0.04495	1.0	0.71675	1.000000	0.68239	0.992	0.67791	103	0.95731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	not_provided|X-linked_sideroblastic_anemia_1	criteria_provided,_single_submitter	NC_000023.11:g.55021195G>T	ClinGen:CA121078|OMIM:301300.0003|UniProtKB:P22557#VAR_072328	C3661900|C4551511	300751	75563	Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase	Phe	Leu	88.67	0.8375634517766497																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																88.67	83.75635	70-90	10-90	300751	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare inborn errors of metabolism; Rare genetic skin disease	4	ANEMIA, SIDEROBLASTIC, 1	false	0.7313782522096046	0.7321863877300081	false	false	false
AP2S1	AP2S1_Arg15Cys	B_15-16	0.4571864702465914	0.661387505899413	0.7310475325624298	8.642636702231393	0.00005547619653114772	0.00026236809441921666	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.9398067891109425	0.9373526528811408	0.6037963428872154	0.6118834544008998	0.6566224081132626	0.6132187925562864	0.7158318763479194	0.6917590163576259	0.6766945938407702	0.6983306637864986	0.933170743201279	0.9413405821186793	0.5106057087646533	0.6214857998688993	0.5470723149610293	0.5092620219879322	0.9415345625610025	0.9382729961032057	AP2S1	Arg15Cys	NC_000019.10:46846103:G:A	43C>T	19	46846103	G	A	19	ENSG00000042753	4983	215314	CCSBVarC006273	ALE00006273	ENSP00000263270.6	CEGS2	CegsMutGDEh1033	E05	GDEhDisVCh_40033	A12	1	CegsMutGDDh1033	E05	VUSN2Hmut_GDN2h_06	B04	NULL	NULL	VUSmut_GDEh06	B04	1.0	1.0	1.0	1.0	1.0	3.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	48023.0	single nucleotide variant	NM_004069.6(AP2S1):c.43C>T (p.Arg15Cys)	1175.0	AP2S1	HGNC:565	Pathogenic	1.0	Oct 23, 2024	397514498.0	-	RCV000032619|RCV001228882|RCV004748539	MONDO:MONDO:0010926,MedGen:C1833372,OMIM:600740,Orphanet:101050,Orphanet:405|MedGen:C3661900|	Familial hypocalciuric hypercalcemia 3|not provided|AP2S1-related disorder	germline;maternal;unknown	germline	GRCh38	NC_000019.10	19	46846103.0	46846103.0	19q13.32	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA130281,UniProtKB:P53680#VAR_069570,OMIM:602242.0001	3.0	39424.0	46846103.0	G	A	-	-	-	-	-	-	43C>T 	Arg15Cys	NM_004069.6	2.0	Pathogenic	Pathogenic	39424	19	46846103.0	G	A	R	C	rs397514498	19	47349360	19	52041200	15	AP2S1	ENSG00000042753	ENST00000263270	ENSP00000263270	P53680	AP2S1_HUMAN	c.43C>T	p.Arg15Cys	c.43C>T	p.Arg15Cys	principal4	Y	1	YES	Select	-	CGC	1	0	g	G/G	G/G	G/G	G/G	0.02	0.91343	D	0.018	0.62681	D	0.745	0.48758	P	0.132	0.44276	B	1.0	0.99291	A	simple_aae	0.0	100.0	4.055	0.97021	H	-7.82	0.95993	D	0.759	0.81397	0.3676	0.88561	D	0.4844	0.80257	T	9	0.95849967	0.95180	D	0.841435	0.98772	D	0.763	0.91933	0.858	0.95637	P53680	R15C	Loss of MoRF binding (P = 0.0089)| Gain of catalytic residue at L16 (P = 0.0623)| Gain of methylation at K18 (P = 0.0786)| Loss of ubiquitination at K18 (P = 0.0997)| Loss of sheet (P = 0.1398)	0.700584501296	0.69562	.	0.98527	2.22324046253	0.95842	0.91032987833	0.97500	D	0.750868	0.93109	D	0.461913	0.92957	D	0.425729	0.92870	D	0.999167203903198	0.96363	D	0.996	0.98636	D	0.91459006	0.92620	0.73560613	0.84185	0.92549723	0.93695	0.7795332	0.86839	-12.027	0.85024	D	0.9977	0.99393	P	0.999992767855987	0.99831	0.77865350	0.87823	0.786	0.88157	.	.	.	.	.	.	5.647531	0.92797	33.0	0.9986493517999494	0.94280	0.917722	0.88533	D	0.63981609455521	0.75580	6.354565	0.576902418909917	0.73141	5.945968	4.87	4.87	0.62830	3.48	0.63010	6.965	0.75916	9.451000	0.80879	0.594	0.32546	1.0	0.71675	1.000000	0.68239	0.992	0.67791	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Familial_hypocalciuric_hypercalcemia_3|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.46846103G>A	ClinGen:CA130281|OMIM:602242.0001|UniProtKB:P53680#VAR_069570	C1833372|C3661900	600740	101050|405	AP complex, mu/sigma subunit	Arg	Cys	98.23	0.2620967741935484																																																																																																																																																																																																																																																																																																																																																																																																																																																																													65			98.23	Positively-charged	Arginine		AP-2 complex subunit sigma										-4.5								 R15-I7 (PAE:  1.0), R15-E100 (PAE: 1.0)	R15-I7 (PDBs: 6URI), R15-E100 (PDBs: 6URI)	 R15-I7 (PAE:  1.0), R15-N9 (PAE: 1.5)	R15-I7 (PDBs: 6URI), R15-N9 (PDBs: 6URI)		R15-E100 (PDBs: 6URI)					175									-104.1				-28.2				dbSNP: rs397514498; Variant type: LP/P; AA change: Arg15Cys; PTM type: Ubiquitylation; PTM morphology: KTR*LAkWYMQF; Var class: II&rs397514499		B (undefined)	E (parallel sheets)	Beta strand											98.23	26.209677	>90	10-90	600740	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic endocrine disease	3	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	false	0.9373526528811408	0.9398067891109425	false	false	false
DCX	DCX_Arg89Gly	B_7-8	5.261463943179778	0.0011714711892482587	0.005302156330483825	0.26472924740360393	0.7988437138310891	0.8364305341001493	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7843494764519914	0.7764143294860628	0.8294568170438714	0.5985215734946739	0.579968014343995	0.8275830849586534	0.8765198598013428	0.6222530615438497	0.5922992616742069	0.858936779174885	0.8080700816728221	0.808209137978908	0.7786463101159639	0.5376829671441403	0.604743885315141	0.7999768549128577	0.7447585772993034	0.7604898149250747	DCX	Arg89Gly	NC_000023.11:111410134:G:C	265C>G	23	111410134	G	C	X	ENSG00000077279	8416	216633	CCSBVarC005188	ALE00005188	ENSP00000419861.1	CEGS2	CegsMutGDEh1045	E02	GDEhDisVCh_40049	H09	1	CegsMutGDDh1045	E02	VUSN2Hmut_GDN2h_09	G08	VUSMutpDEST2_07	C12	VUSmut_GDEh09	G08	1.0	1.0	1.0	1.0	1.0	5.0	6.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	Y	N	N	Y	26647.0	single nucleotide variant	NM_001195553.2(DCX):c.265C>G (p.Arg89Gly)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	Sep 01, 1999	104894785.0	-	RCV000012372	MedGen:C1848070	Subcortical laminar heterotopia, X-linked	germline	germline	GRCh38	NC_000023.11	X	111410134.0	111410134.0	Xq23	no assertion criteria provided	1.0	-	N	ClinGen:CA121604,UniProtKB:O43602#VAR_010536,OMIM:300121.0012	1.0	11608.0	111410134.0	G	C	-	-	-	-	-	-	265C>G 	Arg89Gly	NM_001195553.2		Pathogenic	Pathogenic	11608	X	111410134.0	G	C	R	G	rs104894785	X	110653362	X	110540018	89	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.265C>G	p.Arg89Gly	c.265C>G	p.Arg89Gly	alternative1	Y	1	.	.	-	CGA	1	2	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.76775	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.91932	.	.	0.94916	0.8413	0.94905	D	0.8572	0.95234	D	10	0.8796673	0.87133	D	0.670786	0.97248	D	.	0.97659	.	.	.	.	.	.	0.99967	.	0.96656	.	.	0.846717000008	0.89100	D	.	0.93104	.	0.550085	0.95762	D	0.552382	0.95699	D	0.992138922214508	0.82404	D	0.994251	0.98117	D	0.98530847	0.99477	0.9446103	0.98036	0.9736268	0.98564	0.9492353	0.98328	-12.001	0.84899	D	0.9696	0.89577	LP	0.999746722827363	0.97751	0.99973255	0.99655	0.979	0.99252	.	.	.	.	.	.	3.993375	0.58866	24.0	0.99841461727937697	0.92149	.	.	.	.	.	.	.	.	.	5.5	3.72	0.41790	2.64	0.48287	3.389	0.52349	3.393000	0.38161	-0.154	0.11924	1.0	0.71675	1.000000	0.68239	0.98	0.58201	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Subcortical_laminar_heterotopia,_X-linked	no_assertion_criteria_provided	NC_000023.11:g.111410134G>C	ClinGen:CA121604|OMIM:300121.0012|UniProtKB:O43602#VAR_010536	C1848070	.	.	.	Arg	Gly	88.43	0.625																																																																																																																																																																																																																																																																																																																																																																																																																																																																													155			88.43	Positively-charged	Arginine		Neuronal migration protein doublecortin							Doublecortin 1			-4.5								 R89-A85 (PAE:  1.0)	R89-A85 (PDBs: 2XRP, 4ATU, 5IKC)	 R89-A85 (PAE:  1.0)	R89-A85 (PDBs: 2XRP, 4ATU, 5IKC)		R89-D86 (PDBs: 5IKC)					175									-68.0				-39.2				dbSNP: rs104894785; Variant type: LP/P; AA change: Arg89Gly; PTM type: Phosphorylation; PTM morphology: ADLTR*sLSDNI; Var class: II&rs104894785		H (helix)	H (α-helix)	Helix											88.43	62.5	70-90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.7764143294860628	0.7843494764519914	false	false	false
APOA1	APOA1_Trp74Arg	B_15-16	9.694201310270596	0.00002624527534123719	0.00038266012138750405	6.804760353385878	0.0002521138511072123	0.0008130560927622751	2025_03_Batch_15-16	false	true	true	true	true	true	false	false	true	true	false	true	0.8119276187714348	0.8890601176182109	0.838804239795446	0.9551369026111728	0.8962723423745508	0.923866163211071						0.8133295962877648	0.923866163211071	0.8962723423745508	0.9551369026111728	0.838804239795446	0.8890601176182109	0.8105256412551048	APOA1	Trp74Arg	NC_000011.10:116836392:A:G	220T>C	11	116836392	A	G	11	ENSG00000118137	5613	215451	CCSBVarC006762	ALE00006760	ENSP00000236850.3	CEGS2	CegsMutGDEh1046	C12	GDEhDisVCh_40037	D08	1	CegsMutGDDh1046	C12	VUSN2Hmut_GDN2h_10	G03	VUSMutpDEST2_05	E04	VUSmut_GDEh10	G03	1.0	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	32967.0	single nucleotide variant	NM_000039.3(APOA1):c.220T>C (p.Trp74Arg)	335.0	APOA1	HGNC:600	Pathogenic	1.0	Apr 25, 2023	121912726.0	-	RCV003556051|RCV004555842	MedGen:C3661900|MONDO:MONDO:0971008,MedGen:C4551500,OMIM:620657	not provided|Familial amyloid polyneuropathy, Iowa type	germline	germline	GRCh38	NC_000011.10	11	116836392.0	116836392.0	11q23.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA127577,OMIM:107680.0021	3.0	17928.0	116836392.0	A	G	-	-	-	-	-	-	220T>C 	Trp74Arg	NM_000039.3	1.0	Pathogenic	Pathogenic	17928	11	116836392.0	A	G	W	R	rs121912726	11	116707108	11	116212318	74	APOA1	ENSG00000118137	ENST00000236850	ENSP00000236850	P02647	APOA1_HUMAN	c.220T>C	p.Trp74Arg	c.220T>C	p.Trp74Arg	principal1	Y	1	YES	Select	-	TGG	1	0	A	A/A	A/A	A/A	A/A	0.016	0.63383	D	0.009	0.74454	D	0.967	0.56423	D	0.894	0.63411	P	1.0	0.99291	A	simple_aae	0.0	100.0	2.655	0.77560	M	-4.09	0.74848	D	0.783	0.77890	-0.4815	0.69176	T	0.4809	0.80080	T	10	0.95606947	0.94913	D	0.163711	0.84256	D	0.547	0.81097	0.777	0.90183	P02647	W74R	Gain of disorder (P = 0.0019)| Gain of methylation at W74 (P = 0.0294)| Loss of stability (P = 0.0353)| Gain of phosphorylation at S76 (P = 0.0583)| Gain of ubiquitination at K69 (P = 0.0898)	0.876001915683	0.87383	0.6561654863008091	0.65387	2.10314439069	0.94843	0.414488434792	0.27045	T	0.33854	0.70604	T	0.225462	0.76116	D	0.0860839	0.75805	D	0.972565948963165	0.69546	D	0.686731	0.29309	T	0.9335678	0.94512	0.8836355	0.93733	0.8692325	0.88648	0.8959671	0.94617	-4.296	0.28150	T	0.9737	0.90352	P	0.997827862407269	0.93597	0.99910933	0.99153	0.726	0.84817	.	.	.	.	.	.	4.286564	0.65405	24.8	0.98878368226279811	0.47870	0.705581	0.65969	D	0.490044376937075	0.66332	4.959073	0.407459517358237	0.61823	4.411718	5.38	2.62	0.30256	4.65	0.86143	3.223	0.51027	5.881000	0.50718	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.897	0.43414	490	0.76745	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Familial_amyloid_polyneuropathy,_Iowa_type	criteria_provided,_single_submitter	NC_000011.10:g.116836392A>G	ClinGen:CA127577|OMIM:107680.0021	C3661900|C4551500	620657	.	.	Trp	Arg	57.23	0.8105726872246696																																																																																																																																																																																																																																																																																																																																																																																																																																																																													184			57.23	Aromatic	Tryptophan		Proapolipoprotein A-I; Apolipoprotein A-I; Truncated apolipoprotein A-I										-0.9								 W74-T78 (PAE:  2.5)	W74-T78 (PDBs: 1AV1, 2MSC, 6W4F), W74-L70 (PDBs: 2MSD, 2MSE, 6CC9, 6CCH, 6CCX, 6PTS, 6PTW, 6W4E, 6W4F)	 W74-T78 (PAE:  2.5), W74-L70 (PAE: 2.5)	W74-R51 (PDBs: 3R2P), W74-T78 (PDBs: 1AV1, 6W4F), W74-L70 (PDBs: 2MSC, 2MSD, 2MSE, 6CC9, 6CCH, 6CCX, 6PTS, 6PTW, 6W4E, 6W4F)							204									-77.3				-38.5	10 X approximate tandem repeats		1			H (helix)	H (α-helix)												57.23	81.05727	50-70	10-90	620657	unknown		Rare genetic systemic or rheumatologic disease; Rare genetic renal disease; Rare genetic endocrine disease; Rare inborn errors of metabolism	4	AMYLOIDOSIS, HEREDITARY SYSTEMIC 3	false	0.8890601176182109	0.8119276187714348	true	false	false
KLHL3	KLHL3_Cys164Phe	B_7-8	-0.19407783784323293	0.8516269310911996	0.8821081553059605	-3.553228221863068	0.009303418191058418	0.01610544564206811	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8653678321604173	0.8535430272346876	0.8154116096207362	0.8715176283828068	0.8133323223714479	0.8562157871640672	0.9831930983833181	0.8720665688274691	0.9789787362707544	0.9588348085854388	0.890815115449697	0.8791679312875845	0.7292384759448164	0.7545980759154267	0.7640565204948593	0.6719884106560338	0.8162709390196781	0.8515677330332502	KLHL3	Cys164Phe	NC_000005.10:137692320:C:A	491G>T	5	137692320	C	A	5	ENSG00000146021	1256	214010	CCSBVarC005559	ALE00005559	ENSP00000312397.4	CEGS2	CegsMutGDEh1034	H08	GDEhDisVCh_40013	E01	1	CegsMutGDDh1034	H08	VUSN2Hmut_GDN2h_06	F09	VUSMutpDEST2_01	H08	VUSmut_GDEh06	F09	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	106410.0	single nucleotide variant	NM_017415.3(KLHL3):c.491G>T (p.Cys164Phe)	26249.0	KLHL3	HGNC:6354	Pathogenic	1.0	-	199469626.0	-	RCV000128505	MONDO:MONDO:0007772,MedGen:C1840389,OMIM:145260,Orphanet:757,Orphanet:88938	Pseudohypoaldosteronism type 2A	germline	germline	GRCh38	NC_000005.10	5	137692320.0	137692320.0	5q31.2	no assertion criteria provided	1.0	-	N	ClinGen:CA269974,UniProtKB:Q9UH77#VAR_067504	2.0	100533.0	137692320.0	C	A	-	-	-	-	-	-	491G>T 	Cys164Phe	NM_017415.3		Pathogenic	Pathogenic	100533	5	137692320.0	C	A	C	F	rs199469626	5	137028009	5	137055908	164	KLHL3	ENSG00000146021	ENST00000309755	ENSP00000312397	Q9UH77	KLHL3_HUMAN	c.491G>T	p.Cys164Phe	c.491G>T	p.Cys164Phe	principal1	Y	1	YES	Select	-	TGC	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.95	0.95575	A	simple_aae	5.0	95.0	3.235	0.89481	M	-10.4	0.99013	D	0.891	0.89007	0.5315	0.90949	D	0.6385	0.87312	D	9	0.98696345	0.99026	D	0.244344	0.88813	D	0.834	0.94750	0.899	0.97715	Q9UH77	C164F	Gain of loop (P = 0.2754)| Gain of catalytic residue at C164 (P = 0.3406)| Loss of helix (P = 0.3949)| Gain of disorder (P = 0.5646)| Gain of phosphorylation at T165 (P = 0.7315)	0.763008196867	0.75897	0.8295775958269138	0.82813	2.0454015372	0.94284	0.856776356697	0.90618	D	0.510568	0.82539	D	0.406422	0.90212	D	0.346021	0.90090	D	0.999653458595276	0.98331	D	0.9962	0.98664	D	0.980254	0.99114	0.9501777	0.98385	0.9774286	0.98889	0.9639817	0.99168	-15.292	0.96508	D	0.9776	0.90676	P	0.998365130314644	0.94344	0.99358750	0.97365	0.937	0.96958	.	.	.	.	.	.	5.466972	0.91239	32.0	0.99213183953796935	0.55725	0.943082	0.94828	D	0.922668343026902	0.92786	11.65179	0.827539033325623	0.91593	10.99	4.6	4.6	0.56461	.	.	7.837	0.85053	7.633000	0.62883	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.996	0.76032	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pseudohypoaldosteronism_type_2A	no_assertion_criteria_provided	NC_000005.10:g.137692320C>A	ClinGen:CA269974|UniProtKB:Q9UH77#VAR_067504	C1840389	145260	757|88938	BTB/Kelch-associated|BTB/Kelch-associated|Kelch-like protein 3, BACK domain	Cys	Phe	90.95	0.022222222222222223																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3			90.95	Special, a very reactive sulfhydryl group	Cysteine		Kelch-like protein 3							BACK			2.5								 C164-L168 (PAE:  2.5), C164-A159 (PAE: 3.0), C164-C140 (PAE: 3.5)		 C164-L168 (PAE:  2.5), C164-A159 (PAE: 3.0), C164-C140 (PAE: 3.5)								121									-85.2				79.8						C (loop/coil)	C (loop/coil)												90.95	2.2222223	>90	<10	145260	autosomal dominant	OMIM	Rare genetic renal disease	1	PSEUDOHYPOALDOSTERONISM, TYPE IIA	false	0.8535430272346876	0.8653678321604173	false	false	false
POMT1	POMT1_Asn144Asp	B_7-8	-4.6723683653684205	0.009501537610850881	0.026225342249602865	-6.572233931336663	0.001223562532419919	0.002829627842819084	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6901880669465414	0.676924231271217	0.6588880426674558	0.7397168159936661	0.6519484073306642	0.7398467348686392	0.7398467348686392	0.6519484073306642	0.7397168159936661	0.6588880426674558	0.676924231271217	0.6901880669465414							POMT1	Asn144Asp	NC_000009.12:131508913:A:G	430A>G	9	131508913	A	G	9	ENSG00000130714	71206	205717	CCSBVarC003245	ALE00003245	ENSP00000385797.4	CEGS2	CegsMutGDEh1037	A06	GDEhDisVCh_40022	B07	2	CegsMutGDDh1037	A06	VUSN2Hmut_GDN2h_07	D08	VUSMutpDEST2_15	C03	VUSmut_GDEh07	D08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	48033.0	single nucleotide variant	NM_001077365.2(POMT1):c.430A>G (p.Asn144Asp)	10585.0	POMT1	HGNC:9202	Pathogenic	1.0	Dec 01, 2012	397514501.0	-	RCV000032629	MONDO:MONDO:0012248,MedGen:C1836373,OMIM:609308,Orphanet:86812	Autosomal recessive limb-girdle muscular dystrophy type 2K	germline	germline	GRCh38	NC_000009.12	9	131508913.0	131508913.0	9q34.13	no assertion criteria provided	1.0	-	N	ClinGen:CA211169,OMIM:607423.0019	1.0	39434.0	131508913.0	A	G	-	-	-	-	-	-	430A>G 	Asn144Asp	NM_001077365.2		Pathogenic	Pathogenic	39434	9	131508913.0	A	G	N	D	rs397514501	9	134384300	9	133374121	144	POMT1	ENSG00000130714	ENST00000372228	ENSP00000361302	Q9Y6A1	POMT1_HUMAN	c.430A>G	p.Asn144Asp	c.430A>G	p.Asn144Asp	.	Y	1	.	.	+	AAT	1	0	A	A/A	A/A	A/A	A/A	0.016	0.54059	D	0.0	0.92967	D	0.709	0.49259	P	0.302	0.56670	B	0.9	0.94956	A	simple_aae	10.0	90.0	3.425	0.91850	M	-4.48	0.79349	D	0.986	0.99488	0.8958	0.95601	D	0.8282	0.94222	D	10	0.94725204	0.93986	D	0.168276	0.84601	D	0.802	0.93522	0.812	0.92749	Q9Y6A1	N144D	Gain of relative solvent accessibility (P = 0.09)| Gain of solvent accessibility (P = 0.1376)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2754)| Loss of sheet (P = 0.3635)	0.947108923689	0.94612	0.9171153659874123	0.91634	0.955548422641	0.72637	0.614741384983	0.54920	T	0.964079	0.99555	D	0.198728	0.73575	D	0.0476825	0.73232	D	0.992724895477295	0.83147	D	0.960304	0.85894	D	0.93807256	0.94975	0.8768049	0.93249	0.934768	0.94636	0.90994704	0.95624	-15.87	0.97565	D	0.8846	0.81710	P	0.994353081470155	0.90595	0.91521720	0.91778	0.755	0.86432	.	.	.	.	.	.	4.342061	0.66685	25.0	0.99798776651209264	0.88381	0.928894	0.91350	D	0.723577784957512	0.81077	7.461738	0.714314456388248	0.83375	8.028728	5.57	5.57	0.83999	.	.	8.05	0.89252	11.127000	0.86716	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.994	0.71086	397	0.82899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	432	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	432	0	0	34	0	0	658	0	Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2K	no_assertion_criteria_provided	NC_000009.12:g.131508913A>G	ClinGen:CA211169|OMIM:607423.0019	C1836373	609308	86812	Glycosyl transferase family 39/83	Asn	Asp	96.85	0.012738853503184714																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			96.44	Polar/Neutral	Asparagine		Protein O-mannosyl-transferase 1										-3.5								 N144-S713 (PAE:  2.0), N144-T148 (PAE: 1.0), N144-T720 (PAE: 2.0)		 N144-S713 (PAE:  2.0), N144-N596 (PAE: 1.5), N144-T148 (PAE: 1.0), N144-L716 (PAE: 2.0), N144-L594 (PAE: 2.0), N144-T720 (PAE: 2.0)								132									-58.8				-41.4						H (helix)	H (α-helix)												96.85	1.2738854	>90	<10	609308	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1	false	0.676924231271217	0.6901880669465414	false	false	false
KLHL3	KLHL3_Ala77Glu	B_7-8	4.549140117826014	0.0026387982917211975	0.009692509109975937	-1.1890684299801793	0.27317952764097153	0.32382715324365813	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6797060189090494	0.741988249314224	0.7270562814798411	0.7930983432077282	0.7787196714761337	0.7935010246792072	0.8571691435899926	0.7587359522716709	0.8299786449095917	0.8015198463394064	0.7598663405617453	0.7123339233465084	0.7298329057684219	0.7987033906805965	0.7562180415058647	0.6525927166202758	0.7241101580667029	0.6470781144715902	KLHL3	Ala77Glu	NC_000005.10:137709761:G:T	230C>A	5	137709761	G	T	5	ENSG00000146021	1256	214008	CCSBVarC005556	ALE00005556	ENSP00000312397.4	CEGS2	CegsMutGDEh1033	A12	GDEhDisVCh_40013	B01	1	CegsMutGDDh1033	A12	VUSN2Hmut_GDN2h_06	E06	VUSMutpDEST2_01	F08	VUSmut_GDEh06	E06	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	106409.0	single nucleotide variant	NM_017415.3(KLHL3):c.230C>A (p.Ala77Glu)	26249.0	KLHL3	HGNC:6354	Pathogenic	1.0	-	199469623.0	-	RCV000128504	MONDO:MONDO:0007772,MedGen:C1840389,OMIM:145260,Orphanet:757,Orphanet:88938	Pseudohypoaldosteronism type 2A	germline	germline	GRCh38	NC_000005.10	5	137709761.0	137709761.0	5q31.2	no assertion criteria provided	1.0	-	N	ClinGen:CA269973,UniProtKB:Q9UH77#VAR_067501	2.0	100532.0	137709761.0	G	T	-	-	-	-	-	-	230C>A 	Ala77Glu	NM_017415.3		Pathogenic	Pathogenic	100532	5	137709761.0	G	T	A	E	rs199469623	5	137045450	5	137073349	77	KLHL3	ENSG00000146021	ENST00000309755	ENSP00000312397	Q9UH77	KLHL3_HUMAN	c.230C>A	p.Ala77Glu	c.230C>A	p.Ala77Glu	principal1	Y	1	YES	Select	-	GCG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.89	0.92286	A	simple_aae	11.0	89.0	2.985	0.85444	M	-4.1	0.75325	D	0.967	0.97765	0.2749	0.87096	D	0.5652	0.84157	D	9	0.91359437	0.90620	D	0.249411	0.89023	D	0.822	0.94297	0.766	0.89317	Q9UH77	A77E	Gain of disorder (P = 0.0859)| Loss of catalytic residue at C76 (P = 0.1656)| Loss of helix (P = 0.3949)| Gain of phosphorylation at T80 (P = 0.4013)| Loss of stability (P = 0.5528)	0.884040248843	0.88200	0.9224230807164673	0.92170	1.78935454329	0.91438	0.87643122673	0.93465	D	0.58111	0.86156	D	0.385029	0.88952	D	0.315291	0.88813	D	0.998457193374634	0.94146	D	0.975402	0.92325	D	0.9820479	0.99249	0.97502726	0.99659	0.97811586	0.98945	0.9688412	0.99405	-16.503	0.98425	D	0.994	0.95096	P	0.999629178877996	0.97231	0.99293510	0.97235	0.995	0.99826	.	.	.	.	.	.	5.581437	0.92315	32.0	0.99348595327557654	0.60550	0.887812	0.81970	D	0.954913735954365	0.94147	12.55983	0.897692587390425	0.95445	13.65356	5.35	5.35	0.76261	.	.	9.602	0.97629	11.641000	0.93799	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.994	0.71086	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pseudohypoaldosteronism_type_2A	no_assertion_criteria_provided	NC_000005.10:g.137709761G>T	ClinGen:CA269973|UniProtKB:Q9UH77#VAR_067501	C1840389	145260	757|88938	BTB/POZ domain|BTB/POZ domain|BTB/POZ domain	Ala	Glu	92.22	0.6037735849056604																																																																																																																																																																																																																																																																																																																																																																																																																																																																													64			92.22	Aliphatic	Alanine		Kelch-like protein 3							BTB	0.6299		1.8								 A77-G81 (PAE:  3.0), A77-P73 (PAE: 1.0)		 A77-G81 (PAE:  3.0), A77-P73 (PAE: 1.0)								89									-61.5		Pocket 1: Mean pLDDT: 82.48, Volume: 446.44 Å³, Druggability score: 0.63		-42.8						H (helix)	H (α-helix)												92.22	60.377357	>90	10-90	145260	autosomal dominant	OMIM	Rare genetic renal disease	1	PSEUDOHYPOALDOSTERONISM, TYPE IIA	false	0.741988249314224	0.6797060189090494	false	false	false
PRKAR1A	PRKAR1A_Arg335Pro	B_7-8	-2.7537652378320385	0.033126193623972365	0.067597254083106	-7.671607454235887	0.000599638637291113	0.0015900822246086594	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8119901335344603	0.8197751698566073	0.5922644763427242	0.5477155420072749	0.45654310904565837	0.5983151393961993							0.5983151393961993	0.45654310904565837	0.5477155420072749	0.5922644763427242	0.8197751698566073	0.8119901335344603	PRKAR1A	Arg335Pro	NC_000017.11:68530307:G:C	1004G>C	17	68530307	G	C	17	ENSG00000108946	2455	200621	CCSBVarC004971	ALE00004971	ENSP00000464977.2	CEGS2	CegsMutGDEh1032	B03	GDEhDisVCh_40076	C05	2	CegsMutGDDh1032	B03	VUSN2Hmut_GDN2h_05	F11	VUSMutpDEST2_01	F11	VUSmut_GDEh05	F11	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	38864.0	single nucleotide variant	NM_002734.5(PRKAR1A):c.1004G>C (p.Arg335Pro)	5573.0	PRKAR1A	HGNC:9388	Pathogenic	1.0	Apr 06, 2012	387906694.0	-	RCV000022793	MONDO:MONDO:0007044,MedGen:C3276228,OMIM:101800,Orphanet:280651	Acrodysostosis 1 with or without hormone resistance	germline	germline	GRCh38	NC_000017.11	17	68530307.0	68530307.0	17q24.2	no assertion criteria provided	1.0	-	N	ClinGen:CA128749,UniProtKB:P10644#VAR_069463,OMIM:188830.0017	1.0	29909.0	68530307.0	G	C	-	-	-	-	-	-	1004G>C 	Arg335Pro	NM_002734.5		Pathogenic	Pathogenic	29909	17	68530307.0	G	C	R	P	rs387906694	17	66526448	17	64038043	335	PRKAR1A	ENSG00000108946	ENST00000586397	ENSP00000466459	P10644	KAP0_HUMAN	c.1004G>C	p.Arg335Pro	c.1004G>C	p.Arg335Pro	principal1	Y	1	.	.	+	CGT	2	0	G	G/G	G/G	G/G	G/G	.	0.78662	.	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.51	0.92765	H	.	0.79093	.	0.993	0.99866	0.9972	0.97134	D	0.9022	0.96749	D	10	0.9518384	0.94462	D	0.463977	0.94553	D	.	0.98114	0.76	0.88835	P10644	R335P	Loss of MoRF binding (P = 0.001)| Gain of catalytic residue at P334 (P = 0.014)| Gain of glycosylation at R335 (P = 0.0314)| Loss of methylation at R335 (P = 0.0446)| Gain of sheet (P = 0.0827)	0.969697485704	0.96909	.	0.99934	.	0.99291	0.892079532146	0.95511	D	0.972783	0.99714	D	0.503596	0.94338	D	0.485605	0.94258	D	0.999158263206482	0.96329	D	0.880212	0.59672	D	0.9871013	0.99593	0.9741392	0.99626	0.9885777	0.99681	0.9640449	0.99171	-18.937	0.99798	D	0.9962	0.96154	P	0.999527540066867	0.96869	0.91647875	0.91828	0.889	0.94066	.	.	.	.	.	.	5.777962	0.93519	33.0	0.99730777919628233	0.82777	0.983161	0.99918	D	1.08038457076344	0.97740	16.69987	1.02264199384411	0.99013	20.3012	5.9	5.9	0.94944	4.61	0.85657	10.003	0.9969	8.648000	0.77955	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.982	0.59239	968	0.07020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Acrodysostosis_1_with_or_without_hormone_resistance	no_assertion_criteria_provided	NC_000017.11:g.68530307G>C	ClinGen:CA128749|OMIM:188830.0017|UniProtKB:P10644#VAR_069463	C3276228	101800	280651	.	Arg	Pro	93.38	0.06451612903225806																																																																																																																																																																																																																																																																																																																																																																																																																																																																													16			93.38	Positively-charged	Arginine	3',5'-cyclic AMP; 3',5'-cyclic AMP	cAMP-dependent protein kinase type I-alpha regulatory subunit								0.8682		-4.5								 R335-E291 (PAE:  2.0), R335-G286 (PAE: 1.0), R335-G325 (PAE: 2.0), R335-E287 (PAE: 1.0)	R335-E291 (PDBs: 5KJX), R335-G286 (PDBs: 5KJX), R335-G325 (PDBs: 5KJX), R335-E287 (PDBs: 5KJX)	 R335-V283 (PAE:  1.0), R335-G289 (PAE: 1.5), R335-G325 (PAE: 2.0), R335-E287 (PAE: 1.0)	R335-G289 (PDBs: 5KJX), R335-V283 (PDBs: 5KJX), R335-E287 (PDBs: 5KJX), R335-A328 (PDBs: 5KJX), R335-G325 (PDBs: 5KJX)							175									-55.3		Pocket 1: Mean pLDDT: 73.37, Volume: 588.38 Å³, Druggability score: 0.87		128.7				dbSNP: rs387906694; Variant type: LP/P; AA change: Arg335Pro; PTM type: Phosphorylation; PTM morphology: RPR*AAtVVArG; Var class: II&-		C (loop/coil)	C (loop/coil)												93.38	6.4516125	>90	<10	101800	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic endocrine disease; Rare genetic skin disease; Rare genetic tumor	5	ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE	false	0.8197751698566073	0.8119901335344603	false	false	false
AGXT	AGXT_Gly161Arg	B_7-8	-2.748265176299886	0.03336830143381568	0.0680109577580126	-6.970134129568279	0.0002172539315059796	0.0007248381169335865	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9443980079932759	0.9270464503026122	0.7939438578420528	0.7319077416154917	0.5923704502804787	0.8127260832597196	0.7917785166570751	0.5956149304038016	0.7975938987578096	0.7823388397888428	0.9770213309877276	0.9443980079932759	0.833673649862364	0.5891259701571557	0.6662215844731737	0.8055488758952629	0.8770715696174969		AGXT	Gly161Arg	NC_000002.12:240871406:G:C	481G>C	2	240871406	G	C	2	ENSG00000172482	70497	3826	CCSBVarC008191	ALE00008177	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	C04	GDEhDisVCh_40002	C06	2	VUSMutGDDh004	C04	VUSN2Hmut_GDN2h_01	D07	VUSMutpDEST2_14	E05	VUSmut_GDEh01	D07	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	Y	Y	Y	N	Y	200502.0	single nucleotide variant	NM_000030.3(AGXT):c.481G>C (p.Gly161Arg)	189.0	AGXT	HGNC:341	Pathogenic	1.0	Nov 27, 2014	180177227.0	-	RCV000186312	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598	Primary hyperoxaluria, type I	germline	germline	GRCh38	NC_000002.12	2	240871406.0	240871406.0	2q37.3	no assertion criteria provided	1.0	-	N	ClinGen:CA275700,UniProtKB:P21549#VAR_060554	2.0	204106.0	240871406.0	G	C	-	-	-	-	-	-	481G>C 	Gly161Arg	NM_000030.3		Pathogenic	Pathogenic	204106	2	240871406.0	G	C	G	R	rs180177227	2	241810823	2	241459496	161	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.481G>C	p.Gly161Arg	c.481G>C	p.Gly161Arg	principal1	Y	1	YES	Select	+	GGC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	.	.	.	-7.11	0.94014	D	0.992	0.99826	1.0823	0.98955	D	0.9705	0.99068	D	10	0.99676895	0.99999	D	0.929931	0.99490	D	0.930	0.98339	0.992	0.99914	P21549	G161R	Loss of catalytic residue at V162 (P = 0.0463)| Loss of disorder (P = 0.168)| Gain of phosphorylation at T160 (P = 0.1776)| Loss of glycosylation at S159 (P = 0.2391)| Gain of helix (P = 0.2684)	0.975938006718	0.97544	0.9782759727975798	0.97807	0.266775748541	0.28922	0.659375667572	0.61257	T	0.966982	0.99610	D	0.562301	0.96245	D	0.56993	0.96185	D	0.999451696872711	0.97447	D	0.958604	0.84360	D	0.9668932	0.97931	0.9621559	0.99072	0.9668932	0.97931	0.9621559	0.99072	-15.36	0.96647	D	0.9363	0.85532	P	0.996707887763808	0.92386	0.63538000	0.84730	0.997	0.99892	.	.	.	.	.	.	5.229651	0.87801	29.4	0.99910675409484617	0.98024	0.937302	0.93464	D	0.609017724088912	0.73604	6.016462	0.414078074573927	0.62238	4.459519	4.1	4.1	0.47135	.	.	8.515	0.90398	6.298000	0.55477	0.601	0.45913	1.0	0.71675	1.000000	0.68239	0.641	0.32491	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Primary_hyperoxaluria,_type_I	no_assertion_criteria_provided	NC_000002.12:g.240871406G>C	ClinGen:CA275700|UniProtKB:P21549#VAR_060554	C0268164	259900	416|93598	Aminotransferase class V domain	Gly	Arg	98.71	0.011904761904761904																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			98.71	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Alanine--glyoxylate aminotransferase										-0.4								 G161-L318 (PAE:  1.0), G161-E157 (PAE: 1.0)	G161-E157 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), G161-L318 (PDBs: 6RV1, 3R9A)	 G161-T323 (PAE:  1.0), G161-L318 (PAE: 1.0), G161-E157 (PAE: 1.0)	G161-E157 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), G161-T323 (PDBs: 6RV1, 3R9A), G161-L318 (PDBs: 6RV1, 3R9A)							75									76.8				20.2						C (loop/coil)	T (turn)												98.71	1.1904762	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.9270464503026122	0.9443980079932759	false	false	false
SFTPC	SFTPC_Glu66Lys	B_7-8	-1.5037338958480757	0.18334533802811867	0.2625109412546527	2.87163739475446	0.028366255155034836	0.04298272354210481	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7705675979065894	0.8044737232271642	0.7427221867802615	0.9008415123779004	0.9243366871615625	0.8567694601308478	0.9686656451915856	0.9728794783618404	0.9641604465538299	0.896991151103213	0.8996797622525039	0.9081967810765185	0.7448732750701098	0.8757938959612845	0.837522578201971	0.5884532224573099	0.7092676842018243	0.6329384147366603	SFTPC	Glu66Lys	NC_000008.11:22162727:G:A	196G>A	8	22162727	G	A	8	ENSG00000168484	5723	201962	CCSBVarC006058	ALE00006058	ENSP00000316152.3	CEGS2	CegsMutGDEh1035	H02	GDEhDisVCh_40072	D07	2	CegsMutGDDh1035	H02	VUSN2Hmut_GDN2h_06	E11	VUSMutpDEST2_05	F06	VUSmut_GDEh06	E11	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	28252.0	single nucleotide variant	NM_001317778.2(SFTPC):c.196G>A (p.Glu66Lys)	6440.0	SFTPC	HGNC:10802	Pathogenic	1.0	Jan 01, 2005	121917836.0	-	RCV000014100	MONDO:MONDO:0024465,MedGen:C1970470,OMIM:610913	Surfactant metabolism dysfunction, pulmonary, 2	germline	germline	GRCh38	NC_000008.11	8	22162727.0	22162727.0	8p21.3	no assertion criteria provided	1.0	-	N	ClinGen:CA210544,OMIM:178620.0007	1.0	13213.0	22162727.0	G	A	-	-	-	-	-	-	196G>A 	Glu66Lys	NM_001317778.2		Pathogenic	Pathogenic	13213	8	22162727.0	G	A	E	K	rs121917836	8	22020240	8	22076185	66	SFTPC	ENSG00000168484	ENST00000318561	ENSP00000316152	P11686	PSPC_HUMAN	c.196G>A	p.Glu66Lys	c.196G>A	p.Glu66Lys	principal4	Y	1	.	.	+	GAG	1	0	G	G/G	G/G	G/G	G/G	0.004	0.65576	D	0.007	0.69466	D	0.999	0.90580	D	0.996	0.86259	D	0.58	0.78586	A	simple_aae	42.0	58.0	1.1	0.27864	L	-2.54	0.59090	D	0.8	0.90358	0.9249	0.96017	D	0.8779	0.95937	D	9	0.9773322	0.97532	D	0.535234	0.95640	D	0.806	0.93679	0.901	0.97803	P11686	E66K	Gain of ubiquitination at E66 (P = 0.0192)| Gain of methylation at K63 (P = 0.1395)| Gain of MoRF binding (P = 0.1648)| Gain of helix (P = 0.1736)| Loss of disorder (P = 0.2322)	0.983079488835	0.98272	0.8686572439924068	0.86749	1.38724322197	0.84837	0.756899178028	0.75424	T	0.706549	0.91515	D	0.449083	0.92384	D	0.4073	0.92290	D	0.945745766162872	0.62097	D	0.921108	0.73360	D	.	.	.	.	.	.	.	.	-3.863	0.21768	T	0.6094	0.69212	P	.	.	0.99958712	0.99514	0.269	0.53957	.	.	.	.	.	.	5.173948	0.86756	29.0	0.99920968034914737	0.98722	0.801315	0.72605	D	0.608754699419885	0.73586	6.013761	0.557387932839962	0.71758	5.727776	4.56	4.56	0.55591	.	.	5.357	0.659	11.777000	0.96014	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.678	0.33524	555	0.71761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Surfactant_metabolism_dysfunction,_pulmonary,_2	no_assertion_criteria_provided	NC_000008.11:g.22162727G>A	ClinGen:CA210544|OMIM:178620.0007	C1970470	610913	.	Surfactant protein C, N-terminal propeptide	Glu	Lys	50.16	0.8814432989690721																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	Negatively-charged	Glutamic Acid												-3.5																		146												Propeptide										in Ref. 4; AAB60332										50.16	88.14433	50-70	10-90	610913	autosomal dominant	OMIM	Rare genetic respiratory disease	1	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	false	0.8044737232271642	0.7705675979065894	false	false	false
KRT4	KRT4_Glu449Lys	B_7-8	0.5335428764098861	0.6101726993951206	0.6848406332397136	-7.985385834396815	0.00009221944626036218	0.00038285675087729545	2024_01_Batch_7-8	true	false	false	false	false	false	false	false	false	false	false	false	0.9547846875598822	0.9362059248107681	0.6484463511499388	0.6115984932573144	0.4701911008455172	0.6183551531892012	0.718662516911691	0.6257599903952529	0.6006411462555735	0.8945594748990977	0.9377313246934093	0.9575786115512422	0.5180477894667114	0.31462221129578155	0.6225558402590552	0.4023332274007797	0.934680524928127	0.9519907635685222	KRT4	Glu449Lys	NC_000012.12:52807687:C:T	1345G>A	12	52807687	C	T	12	ENSG00000170477	13592	218110	CCSBVarC003893	ALE00003893	ENSP00000448220.1	CEGS2	CegsMutGDEh1031	A05	GDEhDisVCh_40089	H05	1	CegsMutGDDh1031	A05	VUSN2Hmut_GDN2h_05	B08	VUSMutpDEST2_11	A05	VUSmut_GDEh05	B08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	31959.0	single nucleotide variant	NM_002272.4(KRT4):c.1303G>A (p.Glu435Lys)	3851.0	KRT4	HGNC:6441	Pathogenic	1.0	Jun 01, 2003	62642055.0	-	RCV000018422	MONDO:MONDO:0008676,MedGen:C4011926,OMIM:193900	White sponge nevus 1	germline	germline	GRCh38	NC_000012.12	12	52807687.0	52807687.0	12q13.13	no assertion criteria provided	1.0	-	N	ClinGen:CA126972,OMIM:123940.0003	1.0	16920.0	52807687.0	C	T	-	-	-	-	-	-	1303G>A 	Glu435Lys	NM_002272.4		Pathogenic	Pathogenic	16920	12	52807687.0	C	T	E	K	rs62642055	12	53201471	12	51487738	435	KRT4	ENSG00000170477	ENST00000551956	ENSP00000448220	P19013	K2C4_HUMAN	c.1303G>A	p.Glu435Lys	c.1303G>A	p.Glu435Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	./.	./.	./.	./.	0.0	0.91343	D	0.022	0.57928	D	.	.	.	.	.	.	0.9	0.92286	A	simple_aae	10.0	90.0	.	.	.	-3.87	0.72631	D	0.996	0.99956	1.0898	0.99228	D	0.9631	0.98814	D	10	0.9651408	0.95938	D	0.303241	0.90930	D	0.968	0.99597	.	.	.	.	.	0.934121199345	0.93293	0.9583494787236554	0.95795	0.714330807097	0.61626	0.759853005409	0.75865	T	0.930162	0.98799	D	0.563041	0.96261	D	0.570993	0.96202	D	0.999750673770905	0.98821	D	.	.	.	.	.	.	.	.	.	.	.	-11.625	0.83028	D	0.8355	0.78963	P	0.978219275140724	0.84899	0.93898390	0.92807	0.581	0.76482	.	.	.	.	.	.	5.526388	0.91841	32.0	0.99919968887543598	0.98655	0.953210	0.96919	D	0.896264226865771	0.91529	10.95359	0.767491704201199	0.87388	9.228836	5.47	5.47	0.80318	3.89	0.73480	7.905	0.86513	.	.	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.717	0.34713	644	0.63698	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	White_sponge_nevus_1	no_assertion_criteria_provided	NC_000012.12:g.52807687C>T	ClinGen:CA126972|OMIM:123940.0003	C4011926	193900	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Glu	Lys	93.93	0.4793814432989691																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																93.93	47.938145	>90	10-90	193900	autosomal dominant	OMIM	Rare genetic tumor	1	WHITE SPONGE NEVUS 1	false	0.9362059248107681	0.9547846875598822	false	true	false
APOA1	APOA1_Val180Glu	B_15-16	8.434661744647073	0.001082035961142358	0.005016705040412351	6.276486539683042	0.0032896096388560364	0.006511794700432391	2025_03_Batch_15-16	false	true	false	true	false	false	false	false	false	false	false	false	0.8460460872670958	0.8950631442809841	0.6388582466321321	0.8489588179367711	0.7940800987732277	0.7617656475382717							0.7617656475382717	0.7940800987732277	0.8489588179367711	0.6388582466321321	0.8950631442809841	0.8460460872670958	APOA1	Val180Glu	NC_000011.10:116836073:A:T	539T>A	11	116836073	A	T	11	ENSG00000118137	5613	215452	CCSBVarC006763	ALE00006761	ENSP00000236850.3	CEGS2	CegsMutGDEh1047	H02	GDEhDisVCh_40037	F08	1	CegsMutGDDh1047	H02	VUSN2Hmut_GDN2h_10	D04	VUSMutpDEST2_05	F04	VUSmut_GDEh10	D04	1.0	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	32968.0	single nucleotide variant	NM_000039.3(APOA1):c.539T>A (p.Val180Glu)	335.0	APOA1	HGNC:600	Pathogenic	1.0	Mar 01, 1998	121912727.0	-	RCV004555843	MONDO:MONDO:0032766,MedGen:C5551172,OMIM:618463	Hypoalphalipoproteinemia, primary, 2	germline	germline	GRCh38	NC_000011.10	11	116836073.0	116836073.0	11q23.3	no assertion criteria provided	1.0	-	N	ClinGen:CA127580,UniProtKB:P02647#VAR_021362,OMIM:107680.0022	1.0	17929.0	116836073.0	A	T	-	-	-	-	-	-	539T>A 	Val180Glu	NM_000039.3		Pathogenic	Pathogenic	17929	11	116836073.0	A	T	V	E	rs121912727	11	116706789	11	116211999	180	APOA1	ENSG00000118137	ENST00000236850	ENSP00000236850	P02647	APOA1_HUMAN	c.539T>A	p.Val180Glu	c.539T>A	p.Val180Glu	principal1	Y	1	YES	Select	-	GTG	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.002	0.79703	D	0.991	0.64084	D	0.977	0.73823	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.76	0.80456	M	-4.88	0.83182	D	0.927	0.93141	0.4526	0.89835	D	0.6509	0.87797	D	10	0.9875046	0.99111	D	0.472756	0.94698	D	0.843	0.95087	0.874	0.96509	P02647	V180E	Loss of MoRF binding (P = 0.0315)| Gain of loop (P = 0.1081)| Loss of methylation at R177 (P = 0.1444)| Gain of phosphorylation at T185 (P = 0.2037)| Gain of disorder (P = 0.2406)	0.954859689604	0.95400	0.8550393158902617	0.85377	2.0161753597	0.93914	0.487260848284	0.37010	T	0.494911	0.81640	T	0.380997	0.88695	D	0.3095	0.88553	D	0.997772634029388	0.92324	D	0.744825	0.36291	T	0.9508301	0.96292	0.96651924	0.99294	0.9727572	0.98486	0.92654616	0.96810	-8.921	0.67264	D	0.9365	0.85734	P	0.99663407485506	0.92321	0.99967015	0.99591	0.728	0.84929	.	.	.	.	.	.	3.819185	0.55218	23.6	0.98752461328636199	0.45786	0.849018	0.76498	D	0.530358254420187	0.68731	5.280438	0.435313934745956	0.63582	4.618634	5.17	5.17	0.70808	.	.	2.579	0.45825	4.199000	0.42534	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.591	0.31208	489	0.76818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hypoalphalipoproteinemia,_primary,_2	no_assertion_criteria_provided	NC_000011.10:g.116836073A>T	ClinGen:CA127580|OMIM:107680.0022|UniProtKB:P02647#VAR_021362	C5551172	618463	.	.	Val	Glu	89.07	0.6549295774647887																																																																																																																																																																																																																																																																																																																																																																																																																																																																													93			89.07	Aliphatic	Valine		Proapolipoprotein A-I; Apolipoprotein A-I; Truncated apolipoprotein A-I										4.2								 V180-R184 (PAE:  2.0), V180-A176 (PAE: 1.5)	V180-R184 (PDBs: 1GW3, 1GW4, 3R2P, 6W4F), V180-A176 (PDBs: 3R2P, 1AV1, 2N5E, 2MSC, 2MSD, 2MSE, 6CC9, 6CCH, 6CCX, 6PTS, 6PTW, 6W4E, 6W4F)	 V180-R184 (PAE:  2.0), V180-A176 (PAE: 1.5)	V180-A176 (PDBs: 1GW3, 1GW4, 3R2P, 1AV1, 2N5E, 2MSC, 2MSD, 2MSE, 6CC9, 6CCH, 6CCX, 6PTS, 6PTW, 6W4E, 6W4F), V180-R184 (PDBs: 3R2P, 6W4F)							117									-64.3				-41.3	10 X approximate tandem repeats		6	dbSNP: rs121912727; Variant type: LB/B; AA change: Val180Glu; PTM type: Phosphorylation; PTM morphology: V*DALRtHLAPy; Var class: II		H (helix)	H (α-helix)	Helix											89.07	65.49296	70-90	10-90	618463	autosomal recessive	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic renal disease; Rare genetic endocrine disease; Rare inborn errors of metabolism	4	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2	false	0.8950631442809841	0.8460460872670958	true	false	false
KCTD1	KCTD1_His74Pro	B_7-8	2.38113342512119	0.048800722244499474	0.09129224239666404	1.8052853871683008	0.11399905898070803	0.14857410393338225	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7841042559009229	0.7747633274310902	0.7626856696176414	0.7219183703535808	0.7103228601076024	0.7752159613627823	0.9548538672588895	0.8739331957316985	0.9612171539355032	0.9418669957584592	0.9607121570258308	0.9698345421739687	0.5955780554666751	0.5467125244835063	0.4826195867716584	0.5835043434768235	0.5888144978363496	0.5983739696278771	KCTD1	His74Pro	NC_000018.10:26476603:T:G	221A>C	18	26476603	T	G	18	ENSG00000134504	14221	218282	CCSBVarC005807	ALE00005807	ENSP00000464170.1	CEGS2	CegsMutGDEh1038	A07	GDEhDisVCh_40022	E09	2	CegsMutGDDh1038	A07	VUSN2Hmut_GDN2h_07	D11	VUSMutpDEST2_11	B08	VUSmut_GDEh07	D11	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	70535.0	single nucleotide variant	NM_001142730.3(KCTD1):c.2045A>C (p.His682Pro)	284252.0	KCTD1	HGNC:18249	Pathogenic	1.0	Jan 29, 2014	587777002.0	-	RCV000049298	MONDO:MONDO:0008404,MedGen:C1867020,OMIM:181270,Orphanet:2036	Scalp-ear-nipple syndrome	germline;unknown	germline	GRCh38	NC_000018.10	18	26476603.0	26476603.0	18q11.2	no assertion criteria provided	2.0	-	N	ClinGen:CA143999,UniProtKB:Q719H9#VAR_069978,OMIM:613420.0007	3.0	55887.0	26476603.0	T	G	-	-	-	-	-	-	2045A>C 	His682Pro	NM_001142730.3		Pathogenic	Pathogenic	55887	18	26476603.0	T	G	H	P	rs587777002	18	24056567	18	22310565	74	KCTD1	ENSG00000134504	ENST00000579973	ENSP00000464170	Q719H9	KCTD1_HUMAN	c.221A>C	p.His74Pro	c.221A>C	p.His74Pro	.	Y	1	.	.	-	CAC	2	0	T	./.	./.	./.	./.	.	0.63383	.	0.012	0.64242	D	0.999	0.77914	D	0.992	0.80453	D	0.99	0.97926	A	simple_aae	1.0	99.0	2.625	0.76666	M	.	0.98309	.	0.962	0.97221	0.0465	0.83100	D	0.5283	0.82401	D	10	0.89633274	0.88865	D	0.177724	0.85270	D	.	0.93403	0.66	0.79705	Q719H9	H74P	Gain of ubiquitination at K72 (P = 0.1162)| Loss of catalytic residue at D78 (P = 0.2141)| Loss of loop (P = 0.2237)| Loss of MoRF binding (P = 0.2578)| Gain of relative solvent accessibility (P = 0.2629)	0.851642057556	0.84905	.	0.96479	.	0.93651	0.926447331905	0.98774	D	0.562037	0.85222	D	0.378232	0.88514	D	0.305528	0.88369	D	0.999057114124298	0.95987	D	.	0.82435	.	0.980293	0.99117	0.9774624	0.99741	0.98941225	0.99728	0.9814362	0.99852	-17.669	0.99368	D	.	0.99393	.	0.999853739515327	0.98365	0.89544135	0.91050	0.887	0.93946	.	.	.	.	.	.	5.444078	0.90984	32.0	0.98881403267520052	0.47922	0.963691	0.98560	D	0.699653507474129	0.79499	7.114009	0.723938001920363	0.84111	8.225258	5.78	5.78	0.91407	.	.	7.626	0.82389	7.829000	0.70086	0.665	0.62996	1.0	0.71675	1.000000	0.68239	1.0	0.97202	876	0.30319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Scalp-ear-nipple_syndrome	no_assertion_criteria_provided	NC_000018.10:g.26476603T>G	ClinGen:CA143999|OMIM:613420.0007|UniProtKB:Q719H9#VAR_069978	C1867020	181270	2036	Potassium channel tetramerisation-type BTB domain|BTB/POZ domain|BTB/POZ domain-containing protein KCTD1, BTB/POZ domain	His	Pro	94.04	0.09782608695652174																																																																																																																																																																																																																																																																																																																																																																																																																																																																													18			94.04	Positively-charged	Histidine		BTB/POZ domain-containing protein KCTD1							BTB			-3.2								 H74-D69 (PAE:  1.5)	H74-D69 (PDBs: 5BXB, 5BXD, 6S4L)	 H74-D69 (PAE:  1.5), H74-D35 (PAE: 1.5)	H74-D35 (PDBs: 5BXB, 5BXD), H74-L68 (PDBs: 6S4L), H74-D69 (PDBs: 6S4L), H74-H33 (PDBs: 6S4L)							155									-135.6				159.8						B (undefined)	E (parallel sheets)	Beta strand											94.04	9.782609	>90	<10	181270	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	3	SCALP-EAR-NIPPLE SYNDROME	false	0.7747633274310902	0.7841042559009229	false	false	false
SFTPC	SFTPC_Ala116Asp	B_7-8	-1.2955341593171297	0.2427431894998113	0.32627691199482023	10.211827629913616	0.00005138811166334424	0.00024620674909200176	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9020773881953816	0.8982941957470599	0.7585135279374052	0.7171910528274412	0.6573076762436822	0.7906900234807822	0.9322351744821581	0.7922854945394511	0.9100649376646464	0.8462568347535667	0.9277512514409254	0.9262488153522721	0.6491448724794063	0.5223298579479135	0.5243171679902362	0.6707702211212437	0.8688371400531945	0.8779059610384911	SFTPC	Ala116Asp	NC_000008.11:22163458:C:A	347C>A	8	22163458	C	A	8	ENSG00000168484	5723	201964	CCSBVarC006060	ALE00006060	ENSP00000316152.3	CEGS2	CegsMutGDEh1035	G07	GDEhDisVCh_40072	F07	2	CegsMutGDDh1035	G07	VUSN2Hmut_GDN2h_07	B01	VUSMutpDEST2_05	H06	VUSmut_GDEh07	B01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	28251.0	single nucleotide variant	NM_001317778.2(SFTPC):c.347C>A (p.Ala116Asp)	6440.0	SFTPC	HGNC:10802	Pathogenic	1.0	Jan 13, 2005	121918559.0	-	RCV000014099	MONDO:MONDO:0024465,MedGen:C1970470,OMIM:610913	Surfactant metabolism dysfunction, pulmonary, 2	germline	germline	GRCh38	NC_000008.11	8	22163458.0	22163458.0	8p21.3	no assertion criteria provided	1.0	-	N	ClinGen:CA210542,OMIM:178620.0006	1.0	13212.0	22163458.0	C	A	-	-	-	-	-	-	347C>A 	Ala116Asp	NM_001317778.2		Pathogenic	Pathogenic	13212	8	22163458.0	C	A	A	D	rs121918559	8	22020971	8	22076916	116	SFTPC	ENSG00000168484	ENST00000318561	ENSP00000316152	P11686	PSPC_HUMAN	c.347C>A	p.Ala116Asp	c.347C>A	p.Ala116Asp	principal4	Y	1	.	.	+	GCC	2	0	C	C/C	C/C	C/C	C/C	0.032	0.68399	D	0.069	0.92967	T	0.185	0.29250	B	0.104	0.31023	B	0.98	0.97926	A	simple_aae	2.0	98.0	1.585	0.39718	L	-3.81	0.78586	D	0.76	0.85840	0.0571	0.83304	D	0.4776	0.79912	T	9	0.7765638	0.77286	D	0.186488	0.85842	D	0.622	0.85283	0.698	0.83422	P11686	A116D	Gain of relative solvent accessibility (P = 0.005)| Gain of solvent accessibility (P = 0.0059)| Gain of sheet (P = 0.039)| Loss of ubiquitination at K114 (P = 0.069)| Loss of loop (P = 0.2237)	0.919661246558	0.91824	0.9299648290534014	0.92931	0.951689256858	0.72495	0.505978226662	0.39605	T	0.526452	0.83386	D	0.301219	0.82944	D	0.194904	0.82724	D	0.986076295375824	0.76720	D	0.892211	0.66836	D	.	.	.	.	.	.	.	.	-3.661	0.19172	T	0.3035	0.63096	B	.	.	0.99840313	0.98766	0.328	0.59189	.	.	.	.	.	.	3.54799	0.49949	22.8	0.99490984532939397	0.67502	0.514401	0.54019	D	0.12757033584103	0.47500	2.996555	0.256433800019636	0.52770	3.472791	5.49	5.49	0.80997	3.25	0.58902	1.501	0.35407	4.859000	0.45528	0.594	0.32546	0.998	0.41403	1.000000	0.68239	0.995	0.73271	555	0.71761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	432	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	432	0	0	34	0	0	658	0	Surfactant_metabolism_dysfunction,_pulmonary,_2	no_assertion_criteria_provided	NC_000008.11:g.22163458C>A	ClinGen:CA210542|OMIM:178620.0006	C1970470	610913	.	BRICHOS domain|BRICHOS domain|BRICHOS domain	Ala	Asp	90.57	0.2358490566037736																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	Aliphatic	Alanine									BRICHOS			1.8																		89												Propeptide									Beta strand											90.57	23.584906	>90	10-90	610913	autosomal dominant	OMIM	Rare genetic respiratory disease	1	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	false	0.8982941957470599	0.9020773881953816	false	false	false
GFAP	GFAP_Arg79Cys	B_15-16	1.4060838453425686	0.2025025619103891	0.2841880185516849	10.958063896829024	0.000011669175882477893	0.00008299588273002688	2025_03_Batch_15-16	true	true	false	false	false	false	true	false	false	false	false	false	0.9729842221524838	0.9557873089766051	0.6566614826844365	0.7624604924778576	0.8265257944509228	0.6990294269475041	0.6629492221589852	0.8211770389302315	0.6831037950173908	0.6506331200148434	0.9491901129973688	0.9737596586265932	0.735109631736023	0.831874549971614	0.8418171899383244	0.6626898453540295	0.9623845049558415	0.9722087856783743	GFAP	Arg79Cys	NC_000017.11:44915252:G:A	235C>T	17	44915252	G	A	17	ENSG00000131095	2920	214382	CCSBVarC004660	ALE00004660	ENSP00000466598.2	CEGS2	CegsMutGDEh1039	C04	GDEhDisVCh_40051	E06	1	CegsMutGDDh1039	C04	VUSN2Hmut_GDN2h_08	B02	VUSMutpDEST2_02	G11	VUSmut_GDEh08	B02	1.0	1.0	1.0	4.0	1.0	1.0	6.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	N	Y	N	Y	31210.0	single nucleotide variant	NM_002055.5(GFAP):c.235C>T (p.Arg79Cys)	2670.0	GFAP	HGNC:4235	Pathogenic	1.0	Aug 05, 2022	59793293.0	-	RCV000056868|RCV000017554	MedGen:C3661900|MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58	not provided|Alexander disease	germline;unknown	germline	GRCh38	NC_000017.11	17	44915252.0	44915252.0	17q21.31	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA217166,UniProtKB:P14136#VAR_017467,OMIM:137780.0005	3.0	16171.0	44915252.0	G	A	-	-	-	-	-	-	235C>T 	Arg79Cys	NM_002055.5	2.0	Pathogenic	Pathogenic	16171	17	44915252.0	G	A	R	C	rs59793293	17	42992620	17	40348146	79	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.235C>T	p.Arg79Cys	c.235C>T	p.Arg79Cys	principal1	Y	1	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.60671	.	0.466	0.36483	P	0.504	0.47759	P	0.02	0.99291	A	without_aae	98.0	2.0	3.72	0.94692	H	.	0.93639	.	.	0.99866	1.0529	0.98176	D	0.8898	0.96335	D	9	0.9911275	0.99629	D	0.557999	0.95946	D	.	0.97621	0.985	0.99851	P14136	R79C	Loss of MoRF binding (P = 0.0103)| Loss of disorder (P = 0.0242)| Loss of phosphorylation at S82 (P = 0.0504)| Loss of methylation at R79 (P = 0.0851)| Loss of stability (P = 0.1391)	.	0.99780	.	0.95499	.	0.84909	0.883898973465	0.94472	D	0.905624	0.98163	D	0.525586	0.94995	D	0.517192	0.94921	D	0.997942388057709	0.92761	D	0.993726	0.98584	D	0.90264446	0.91500	0.8378805	0.90577	0.88538235	0.89977	0.7729704	0.86434	-9.562	0.71324	D	0.9097	0.87749	P	0.99887233527181	0.95226	0.99922370	0.99225	0.989	0.99628	.	.	.	.	.	.	5.9295	0.94102	33.0	0.99906857098051705	0.97728	.	.	.	0.641875716456581	0.75714	6.378318	0.589811726723542	0.74064	6.098099	4.82	3.85	0.43489	3.93	0.74723	7.996	0.88001	9.916000	0.82494	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614210	6.194980e-07	0	1	1180046	8.474250e-07	0	0	75070	0.000000e+00	0	0	912	0.000000e+00	0	0	60034	0.000000e+00	0	0	29606	0.000000e+00	0	0	44878	0.000000e+00	0	0	64010	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180046	8.474250e-07	0	0	91082	0.000000e+00	0	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50	0	0	424	0	0	0	0	0	474	0	Alexander_disease|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.44915252G>A	ClinGen:CA217166|OMIM:137780.0005|UniProtKB:P14136#VAR_017467	C0270726|C3661900	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Cys	92.32	0.5443548387096774																																																																																																																																																																																																																																																																																																																																																																																																																																																																													135			92.32	Positively-charged	Arginine		Glial fibrillary acidic protein							IF rod			-4.5								 R79-Y83 (PAE:  2.0), R79-E75 (PAE: 2.0)		 R79-Y83 (PAE:  2.0), R79-E75 (PAE: 2.0)								175									-63.1				-44.2	Coil 1A			dbSNP: rs59793293; Variant type: LP/P; AA change: Arg79Cys; PTM type: Phosphorylation; PTM morphology: NDR*FAsYIEKV; Var class: II&rs59285727		H (helix)	H (α-helix)												92.32	54.435486	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.9557873089766051	0.9729842221524838	true	true	false
GFAP	GFAP_Leu352Pro	B_15-16	-0.34846343008897124	0.7377372901285819	0.7909421701731469	3.7781062429308787	0.006909345660392582	0.01248860421093343	2025_03_Batch_15-16	true	true	false	false	false	false	true	false	false	false	false	false	0.9783244645901026	0.9672158472381454	0.7157327902067763	0.8665928991519419	0.8355318367381253	0.8374881395274738	0.7140149899485466	0.7780772501261018	0.8152304480726535	0.6709958123336053	0.9684427990448103	0.9812136451422576	0.960961289106401	0.8929864233501488	0.9179553502312303	0.7604697680799473	0.9659888954314805	0.9754352840379477	GFAP	Leu352Pro	NC_000017.11:44911308:A:G	1055T>C	17	44911308	A	G	17	ENSG00000131095	2920	214430	CCSBVarC004673	ALE00004673	ENSP00000466598.2	CEGS2	CegsMutGDEh1047	D05	GDEhDisVCh_40051	A11	1	CegsMutGDDh1047	D05	VUSN2Hmut_GDN2h_10	A05	VUSMutpDEST2_03	A02	VUSmut_GDEh10	A05	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	31217.0	single nucleotide variant	NM_002055.5(GFAP):c.1055T>C (p.Leu352Pro)	2670.0	GFAP	HGNC:4235	Pathogenic	1.0	Oct 14, 2003	28932769.0	-	RCV000056820|RCV000017561	MedGen:C3661900|MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58	not provided|Alexander disease	germline	germline	GRCh38	NC_000017.11	17	44911308.0	44911308.0	17q21.31	no assertion criteria provided	3.0	-	N	ClinGen:CA217100,UniProtKB:P14136#VAR_071555,OMIM:137780.0012	3.0	16178.0	44911308.0	A	G	-	-	-	-	-	-	1055T>C 	Leu352Pro	NM_002055.5		Pathogenic	Pathogenic	16178	17	44911308.0	A	G	L	P	rs28932769	17	42988676	17	40344202	352	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.1055T>C	p.Leu352Pro	c.1055T>C	p.Leu352Pro	principal1	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.999	0.92348	D	0.23	0.99291	A	without_aae	77.0	23.0	4.86	0.99726	H	.	0.91203	.	.	0.98575	1.0815	0.98928	D	0.9627	0.98801	D	9	0.9921749	0.99751	D	0.795468	0.98393	D	.	0.99858	0.979	0.99802	P14136	L352P	Loss of stability (P = 0.0071)| Gain of methylation at K356 (P = 0.0596)| Gain of disorder (P = 0.0611)| Gain of phosphorylation at Y349 (P = 0.0876)| Loss of ubiquitination at K356 (P = 0.1231)	.	0.99707	.	0.99586	.	0.87987	0.804413199425	0.82605	D	0.97173	0.99697	D	0.585449	0.97298	D	0.60318	0.97255	D	0.999377310276031	0.97130	D	0.966003	0.88372	D	0.98714983	0.99596	0.9864304	0.99943	0.9860276	0.99525	0.9839017	0.99904	-16.519	0.98443	D	0.9992	0.98627	P	0.998772930877601	0.95035	0.99964261	0.99561	1	0.99985	.	.	.	.	.	.	6.118747	0.9461	34.0	0.9988558488566287	0.96051	0.985297	0.99958	D	0.933903668259224	0.93282	11.96125	0.768780081522695	0.87484	9.261749	4.25	4.25	0.49600	.	.	9.325	0.96016	11.208000	0.89310	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.998	0.85369	754	0.51253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	not_provided|Alexander_disease	no_assertion_criteria_provided	NC_000017.11:g.44911308A>G	ClinGen:CA217100|OMIM:137780.0012|UniProtKB:P14136#VAR_071555	C3661900|C0270726	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Pro	97.8	0.7073170731707317																																																																																																																																																																																																																																																																																																																																																																																																																																																																													116			97.8	Aliphatic	Leucine		Glial fibrillary acidic protein							IF rod			3.8								 L352-K356 (PAE:  1.0), L352-E348 (PAE: 1.0)		 L352-K356 (PAE:  1.0), L352-E348 (PAE: 1.0)								131									-63.1				-41.5	Coil 2B			dbSNP: rs28932769; Variant type: LP/P; AA change: Leu352Pro; PTM type: Phosphorylation; PTM morphology: RHLQEyQDL*LN; Var class: II		H (helix)	H (α-helix)												97.8	70.731705	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.9672158472381454	0.9783244645901026	true	true	false
CFP	CFP_Tyr414Asp	B_15-16	2.987198395573705	0.02030674142104034	0.04570573061885448	-4.3419165075898825	0.003388129322543458	0.006670834020243826	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7231255196934429	0.7384382466471451	0.5264059589942589	0.6781471272405093	0.6452242883302597	0.5455624418150571	0.5434273350405541	0.7237790324188669	0.7734713355679779	0.5239909115505468	0.7817023323315919	0.7830832448476766	0.5476975485895602	0.5666695442416524	0.5828229189130406	0.5288210064379711	0.6951741609626982	0.6631677945392092	CFP	Tyr414Asp	NC_000023.11:47626062:A:C	1240T>G	23	47626062	A	C	X	ENSG00000126759	7637	216439	CCSBVarC004314	ALE00004314	ENSP00000380189.3	CEGS2	CegsMutGDEh1031	C02	GDEhDisVCh_40086	B04	2	CegsMutGDDh1031	C02	VUSN2Hmut_GDN2h_05	H06	VUSMutpDEST2_06	G05	VUSmut_GDEh05	H06	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26224.0	single nucleotide variant	NM_001145252.3(CFP):c.1240T>G (p.Tyr414Asp)	5199.0	CFP	HGNC:8864	Pathogenic	1.0	Oct 15, 1996	132630261.0	-	RCV000011935	MedGen:C1839456	Properdin deficiency, type III	germline	germline	GRCh38	NC_000023.11	X	47626062.0	47626062.0	Xp11.23	no assertion criteria provided	1.0	-	N	OMIM:300383.0005,ClinGen:CA121405,UniProtKB:P27918#VAR_002004	1.0	11185.0	47626062.0	A	C	-	-	-	-	-	-	1240T>G 	Tyr414Asp	NM_001145252.3		Pathogenic	Pathogenic	11185	X	47626062.0	A	C	Y	D	rs132630261	X	47485461	X	47370405	414	CFP	ENSG00000126759	ENST00000247153	ENSP00000247153	P27918	PROP_HUMAN	c.1240T>G	p.Tyr414Asp	c.1240T>G	p.Tyr414Asp	principal1	Y	5	.	.	-	TAC	1	0	A	A/A	A/A	A/A	A/A	0.005	0.63383	D	0.0	0.92967	D	0.934	0.52216	P	0.862	0.61331	P	0.65	0.79708	A	simple_aae	35.0	65.0	2.225	0.62836	M	-3.42	0.74531	D	0.389	0.71811	-0.0498	0.81126	T	0.3598	0.72053	T	10	0.83164036	0.82142	D	0.285094	0.90346	D	0.361	0.67972	0.786	0.90870	P27918	Y414D	Gain of ubiquitination at K413 (P = 0.0261)| Loss of catalytic residue at Y414 (P = 0.0291)| Gain of disorder (P = 0.0559)| Loss of stability (P = 0.125)| Gain of phosphorylation at T417 (P = 0.1257)	0.426488350529	0.41877	0.9275514139506033	0.92687	2.16898582345	0.95461	0.508712410927	0.39986	T	0.574673	0.85844	D	0.115877	0.65712	D	-0.0713278	0.65285	T	0.951183259487152	0.63278	D	0.483352	0.14411	T	0.69755745	0.77669	0.67866445	0.80909	0.6927762	0.77408	0.5833056	0.75594	-0.467	0.00564	T	0.6685	0.71642	P	0.924461307556851	0.77917	0.76185970	0.87435	0.617	0.78611	.	.	.	.	.	.	3.650768	0.51892	23.1	0.99247385875120719	0.56827	.	.	.	.	.	.	.	.	.	5.53	5.53	0.82506	3.84	0.71805	6.287	0.72758	11.126000	0.86691	0.756	0.943	0.945	0.32938	1.000000	0.68239	0.938	0.47792	628	0.65178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Properdin_deficiency,_type_III	no_assertion_criteria_provided	NC_000023.11:g.47626062A>C	ClinGen:CA121405|OMIM:300383.0005|UniProtKB:P27918#VAR_002004	C1839456	.	.	.	Tyr	Asp	92.99	0.22072072072072071																																																																																																																																																																																																																																																																																																																																																																																																																																																																													49			92.99	Aromatic	Tyrosine		Properdin							TSP type-1 6			-1.3										 Y414-E339 (PAE:  1.5)	Y414-E339 (PDBs: 6S08, 6S0A, 6S0B)							181									-79.1				154.5						C (loop/coil)	C (loop/coil)												92.99	22.072073	>90	10-90		unknown		Rare genetic immune disease	1		false	0.7384382466471451	0.7231255196934429	false	false	false
DCX	DCX_Arg102Cys	B_7-8	5.275853520244242	0.0011532460877933894	0.005257834667514899	-5.944689386567014	0.0005731123982931919	0.0015375164486374374	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.9569652997759791	0.9484874004127322	0.8169798790742677	0.7326517344153367	0.7017349151383778	0.8407282620951595	0.8681740038584925	0.7188826494841714	0.7889522800795654	0.8363945485570644	0.9586910795441652	0.958335768185068	0.8132825203318265	0.6845871807925843	0.676351188751108	0.7975652095914711	0.9382837212812992	0.9555948313668902	DCX	Arg102Cys	NC_000023.11:111410095:G:A	304C>T	23	111410095	G	A	X	ENSG00000077279	8416	216627	CCSBVarC005190	ALE00005190	ENSP00000419861.1	CEGS2	CegsMutGDEh1040	G06	GDEhDisVCh_40049	D07	1	CegsMutGDDh1040	G06	VUSN2Hmut_GDN2h_08	G05	VUSMutpDEST2_07	G11	VUSmut_GDEh08	G05	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	169907.0	single nucleotide variant	NM_001195553.2(DCX):c.304C>T (p.Arg102Cys)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	Feb 08, 2013	587783541.0	-	RCV000145833	MedGen:C0008519	Ectopic tissue	germline	germline	GRCh38	NC_000023.11	X	111410095.0	111410095.0	Xq23	criteria provided, single submitter	1.0	-	N	ClinGen:CA171923	2.0	158452.0	111410095.0	G	A	-	-	-	-	-	-	304C>T 	Arg102Cys	NM_001195553.2	1.0	Pathogenic	Pathogenic	158452	X	111410095.0	G	A	R	C	rs587783541	X	110653323	X	110539979	102	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.304C>T	p.Arg102Cys	c.304C>T	p.Arg102Cys	alternative1	Y	1	.	.	-	CGT	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.96508	.	.	0.99191	1.0916	0.99302	D	0.9411	0.98064	D	10	0.9436394	0.93618	D	0.9427	0.99595	D	.	0.99918	.	.	.	.	.	.	0.99926	.	0.98626	.	.	0.904978275299	0.96970	D	.	0.98378	.	0.676439	0.99906	D	0.733881	0.99906	D	0.999849677085876	0.99303	D	0.999706	0.99911	D	0.98820484	0.99660	0.96952003	0.99435	0.9856312	0.99499	0.97218406	0.99550	-10.403	0.76363	D	0.9971	0.96786	LP	0.999821824268145	0.98179	0.99973124	0.99655	1	0.99985	.	.	.	.	.	.	5.191363	0.87089	29.1	0.99944841318784416	0.99886	.	.	.	.	.	.	.	.	.	5.5	5.5	0.81360	3.56	0.64876	6.7	0.74504	9.957000	0.82797	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Ectopic_tissue	criteria_provided,_single_submitter	NC_000023.11:g.111410095G>A	ClinGen:CA171923	C0008519	.	.	.	Arg	Cys	91.02	0.4112903225806452																																																																																																																																																																																																																																																																																																																																																																																																																																																																													102			91.02	Positively-charged	Arginine		Neuronal migration protein doublecortin							Doublecortin 1			-4.5			N:R102-a:K338 (PDBs: 6REV, 6RF8, 6RFD), N:R102-a:I341 (PDBs: 6RFD)	N:R102-a:R339 (PDBs: 6RFD)				 R102-S129 (PAE:  2.0), R102-S128 (PAE: 2.0)	R102-S128 (PDBs: 2XRP, 4ATU, 5IKC, 6REV)		R102-L84 (PDBs: 2XRP, 4ATU), R102-S129 (PDBs: 6REV, 6RF8, 6RFD)							175									-105.4				-25.9				dbSNP: rs587783541; Variant type: LP/P; AA change: Arg102Ser; PTM type: Phosphorylation; PTM morphology: GVR*yIyTIDGS; Var class: II&rs587783541		C (loop/coil)	C (loop/coil)												91.02	41.129032	>90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.9484874004127322	0.9569652997759791	true	true	false
AGXT	AGXT_Met195Leu	B_7-8	-2.927621801454708	0.02636850143509696	0.05595981971226133	-2.3185038907926847	0.05351224290869481	0.07530288783547161	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.598472797241383	0.7292967762468561	0.7383937275191902	0.6424940814261162	0.5589323012223275	0.7493736784325986	0.6132959989544496	0.5902780524311543	0.6298452905679318	0.6005223053333334	0.5979463747319854	0.598472797241383	0.8854513579107475	0.5275865500135009	0.6551428722843006	0.876265149705047	0.8606471777617267		AGXT	Met195Leu	NC_000002.12:240873037:A:C	583A>C	2	240873037	A	C	2	ENSG00000172482	70497	3839	CCSBVarC008200	ALE00008186	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	F05	GDEhDisVCh_40002	E07	2	VUSMutGDDh004	F05	VUSN2Hmut_GDN2h_01	H07	VUSMutpDEST2_14	H06	VUSmut_GDEh01	H07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200516.0	single nucleotide variant	NM_000030.3(AGXT):c.583A>C (p.Met195Leu)	189.0	AGXT	HGNC:341	Pathogenic	1.0	Nov 27, 2014	180177243.0	-	RCV000186318	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598	Primary hyperoxaluria, type I	germline	germline	GRCh38	NC_000002.12	2	240873037.0	240873037.0	2q37.3	no assertion criteria provided	1.0	-	N	ClinGen:CA275710	2.0	204112.0	240873037.0	A	C	-	-	-	-	-	-	583A>C 	Met195Leu	NM_000030.3		Pathogenic	Pathogenic	204112	2	240873037.0	A	C	M	L	rs180177243	2	241812454	2	241461127	195	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.583A>C	p.Met195Leu	c.583A>C	p.Met195Leu	principal1	Y	1	YES	Select	+	ATG	1	0	A	A/A	A/A	A/A	A/A	0.312	0.14005	T	0.139	0.33996	T	0.552	0.38176	P	0.393	0.44247	B	0.57	0.75048	A	simple_aae	43.0	57.0	.	.	.	-2.1	0.47863	N	0.688	0.69238	0.1370	0.84765	D	0.6319	0.87049	D	10	0.8920504	0.88423	D	0.223851	0.87892	D	0.751	0.91423	0.836	0.94325	P21549	M195L	Gain of catalytic residue at M195 (P = 0.0541)| Loss of phosphorylation at Y194 (P = 0.1002)| Gain of loop (P = 0.1069)| Loss of sheet (P = 0.1907)| Loss of disorder (P = 0.3788)	0.928364655671	0.92708	0.857485877873013	0.85624	0.0533161000258	0.05732	0.536957740784	0.43953	T	0.559319	0.85085	D	0.352551	0.86578	D	0.268638	0.86402	D	0.390656858281204	0.28283	T	0.884811	0.60801	D	0.7022535	0.77927	0.5369399	0.72985	0.7022535	0.77929	0.5369399	0.72986	-7.446	0.57300	T	0.3132	0.53978	B	0.944025782860013	0.79777	0.15984120	0.71009	0.542	0.74109	.	.	.	.	.	.	3.175282	0.43161	21.7	0.91237277686386276	0.20747	0.971040	0.99317	D	0.199217886254609	0.50919	3.299653	0.225825019987124	0.51033	3.312364	4.14	4.14	0.47761	.	.	4.253	0.58668	10.723000	0.83653	0.677	0.82346	1.0	0.71675	1.000000	0.68239	0.521	0.29544	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109252	0.000000e+00	0	1	206266	4.848110e-06	0	1	234938	4.256440e-06	0	0	7160	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9038	0.000000e+00	0	0	13282	0.000000e+00	0	0	42754	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16206	0.000000e+00	0	0	30508	0.000000e+00	0	0	6204	0.000000e+00	0	0	13406	0.000000e+00	0	0	16622	0.000000e+00	0	1	87856	1.138230e-05	0	0	30608	0.000000e+00	0	1	87856	1.138230e-05	0	0	14896	0.000000e+00	0	0	34232	0.000000e+00	0	0	9550	0.000000e+00	0	0	17684	0.000000e+00	0	0	21520	0.000000e+00	0	1	100926	9.908250e-06	0	0	30526	0.000000e+00	0	1	100926	9.908250e-06	0	.	1	1613446	6.197910e-07	0	1	1179726	8.476540e-07	0	0	74960	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29588	0.000000e+00	0	0	44842	0.000000e+00	0	0	63804	0.000000e+00	0	0	6058	0.000000e+00	0	1	1179726	8.476540e-07	0	0	91062	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Primary_hyperoxaluria,_type_I	no_assertion_criteria_provided	NC_000002.12:g.240873037A>C	ClinGen:CA275710	C0268164	259900	416|93598	Aminotransferase class V domain	Met	Leu	98.92	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.92	Aliphatic	Methionine		Alanine--glyoxylate aminotransferase										1.9								 M195-I200 (PAE:  1.0), M195-F68 (PAE: 1.0)	M195-F68 (PDBs: 1H0C, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), M195-Q69 (PDBs: 5OG0, 6RV0), M195-I200 (PDBs: 6RV1, 3R9A)	 M195-G199 (PAE:  1.0), M195-L203 (PAE: 1.0), M195-Q69 (PAE: 1.0), M195-I200 (PAE: 1.0), M195-F68 (PAE: 1.0)	M195-F68 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), M195-G199 (PDBs: 6RV1, 3R9A), M195-L203 (PDBs: 6RV1, 3R9A), M195-Q69 (PDBs: 6RV1, 3R9A), M195-I200 (PDBs: 6RV1, 3R9A)							149									-50.3				-54.3				dbSNP: rs180177244; Variant type: LP/P; AA change: Met195Arg; PTM type: Phosphorylation; PTM morphology: GGTPLyM*DRQG; Var class: II		C (loop/coil)	T (turn)	Turn											98.92	0.0	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.7292967762468561	0.598472797241383	false	false	false
DCX	DCX_Lys50Asn	B_7-8	1.1745341621197936	0.2930690293703971	0.38130915946693356	-4.541088599811218	0.0026642353018439084	0.0054424412554179595	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8799920601735607	0.8235062136861973	0.6958643197187812	0.5137237026036068	0.4928476617557138	0.7015051228717581	0.6518227424403082	0.5954755290577514	0.5542250004146975	0.6124625462078177	0.8636493303872008	0.8734772986336344	0.751187503303208	0.3902197944536763	0.4732224047925162	0.7792660932297446	0.7833630969851937	0.8865068217134869	DCX	Lys50Asn	NC_000023.11:111410249:C:A	150G>T	23	111410249	C	A	X	ENSG00000077279	8416	216624	CCSBVarC005181	ALE00005181	ENSP00000419861.1	CEGS2	CegsMutGDEh1038	G11	GDEhDisVCh_40049	A06	1	CegsMutGDDh1038	G11	VUSN2Hmut_GDN2h_08	A01	VUSMutpDEST2_07	D11	VUSmut_GDEh08	A01	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	169929.0	single nucleotide variant	NM_001195553.2(DCX):c.150G>T (p.Lys50Asn)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	Feb 08, 2013	587783523.0	-	RCV000145810	MedGen:C0008519	Ectopic tissue	germline	germline	GRCh38	NC_000023.11	X	111410249.0	111410249.0	Xq23	criteria provided, single submitter	1.0	-	N	ClinGen:CA171856,UniProtKB:O43602#VAR_026023	2.0	158429.0	111410249.0	C	A	-	-	-	-	-	-	150G>T 	Lys50Asn	NM_001195553.2	1.0	Pathogenic	Pathogenic	158429	X	111410249.0	C	A	K	N	rs587783523	X	110653477	X	110540133	50	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.150G>T	p.Lys50Asn	c.150G>T	p.Lys50Asn	alternative1	Y	1	.	.	-	AAG	3	2	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.76775	.	.	.	.	.	.	.	.	0.96253	.	.	.	.	.	.	.	.	0.74769	.	.	0.69856	-0.9754	0.35897	T	0.1744	0.51594	T	10	0.66762614	0.70256	D	0.084626	0.74280	D	.	0.72710	.	.	.	.	.	.	0.92586	.	0.93142	.	.	0.891975462437	0.95498	D	.	0.69016	.	0.110228	0.65129	D	-0.079442	0.64694	T	0.964173376560211	0.66664	D	0.982268	0.94027	D	0.9567887	0.96906	0.7746437	0.86536	0.921936	0.93339	0.7936477	0.87719	-13.212	0.90237	D	0.9884	0.93102	LP	0.995358335523163	0.91272	0.99572986	0.97860	0.949	0.97673	.	.	.	.	.	.	3.232186	0.44161	21.9	0.99718373110444392	0.81861	.	.	.	.	.	.	.	.	.	5.37	2.57	0.29847	-0.326	0.19437	1.809	0.38665	0.825000	0.21973	-0.182	0.10118	1.0	0.71675	0.999000	0.35501	0.994	0.71086	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Ectopic_tissue	criteria_provided,_single_submitter	NC_000023.11:g.111410249C>A	ClinGen:CA171856|UniProtKB:O43602#VAR_026023	C0008519	.	.	.	Lys	Asn	65.75	0.8146341463414634																																																																																																																																																																																																																																																																																																																																																																																																																																																																													167	Morphology: LQALsNEkkAKKVRF		65.75	Positively-charged	Lysine		Neuronal migration protein doublecortin										-3.9				N:K50-B:G400 (PDBs: 6RF8)				 K50-L46 (PAE:  8.0)		 K50-L46 (PAE:  8.0)								147									-89.6				-7.9				dbSNP: rs587783523; Variant type: LP/P; AA change: Lys50Asn; PTM type: Acetylation; PTM morphology: ALsNEkkAKKV; Var class: I&rs587783523		H (helix)	H (α-helix)												65.75	81.46342	50-70	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.8235062136861973	0.8799920601735607	false	false	false
FXN	FXN_Met1Ile	B_7-8	3.283046695660289	0.016758670346644175	0.040068081213603536	-3.475178502576244	0.010333329039319657	0.017605997016853826	2024_01_Batch_7-8	true	true	false	false	false	false	true	true	false	false	false	false	0.9900326443708796	0.9959417171051579	0.7681909899381383	0.8681541028988009	0.7530293039293718	0.7911189111869636	0.7703076404659184	0.6966929150567296	0.8704919965388828	0.7466707791299916	0.9970739275701815	0.9900326443708796	0.811930181908009	0.8093656928020141	0.865816209258719	0.7897112007462849	0.9948095066401343		FXN	Met1Ile	NC_000009.12:69035785:G:T	3G>T	9	69035785	G	T	9	ENSG00000165060	10735	203289	CCSBVarC006448	ALE00006448	ENSP00000419243.2	CEGS2	CegsMutGDEh1044	B03	GDEhDisVCh_40038	C03	2	CegsMutGDDh1044	B03	VUSN2Hmut_GDN2h_09	B05	VUSMutpDEST2_08	D10	VUSmut_GDEh09	B05	1.0	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	7.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	19022.0	single nucleotide variant	NM_000144.5(FXN):c.3G>T (p.Met1Ile)	2395.0	FXN	HGNC:3951	Pathogenic	1.0	Apr 12, 2022	104894108.0	-	RCV000004190|RCV001579769|RCV004017228	MONDO:MONDO:0100339,MedGen:C0016719,Orphanet:95|MedGen:C3661900|MONDO:MONDO:0100340,MedGen:C1856689,OMIM:229300,Orphanet:95	Friedreich ataxia|not provided|Friedreich ataxia 1	germline;unknown	germline	GRCh38	NC_000009.12	9	69035785.0	69035785.0	9q21.11	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA252968,OMIM:606829.0006	3.0	3983.0	69035785.0	G	T	-	-	-	-	-	-	3G>T 	Met1Ile	NM_000144.5	2.0	Pathogenic	Pathogenic	3983	9	69035785.0	G	T	M	I	rs104894108	9	71650701	9	70840521	1	FXN	ENSG00000165060	ENST00000484259	ENSP00000419243	Q16595	FRDA_HUMAN	c.3G>T	p.Met1?	c.3G>T	p.Met1?	principal1	Y	3	YES	Select	+	ATG	3	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.924	0.51298	P	0.827	0.59421	P	.	0.98441	.	.	.	.	.	.	.	.	0.32359	.	.	0.90017	0.9630	0.96581	D	0.9088	0.96970	D	9	0.86733586	0.85832	D	0.987396	0.99946	D	.	0.89789	0.592	0.72019	Q16595	M1I	Loss of disorder (P = 0.0292)| Loss of methylation at R6 (P = 0.0778)| Loss of phosphorylation at T3 (P = 0.2434)| Loss of MoRF binding (P = 0.3837)| Gain of loop (P = 0.4661)	.	0.99191	.	.	.	.	.	.	.	0.373462	0.73571	T	0.625005	0.99405	D	0.66	0.99395	D	0.99003005027771	0.80089	D	0.9	0.64967	D	0.9659772	0.97841	0.91199577	0.95772	0.9659772	0.97841	0.91199577	0.95773	-7.454	0.61266	T	.	.	.	0.999999393416945	0.99831	0.99300270	0.97248	.	.	.	.	.	.	.	.	3.993167	0.58866	24.0	0.9947140324842183	0.66409	0.015204	0.00283	N	0.104984549409664	0.46442	2.905976	0.018404829091657	0.40279	2.423305	2.75	2.75	0.31357	.	.	2.798	0.47677	8.153000	0.76751	0.526	0.24477	1.0	0.71675	1.000000	0.68239	0.09	0.17829	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	0	44688	0.000000e+00	0	1	93618	1.068170e-05	0	1	109436	9.137760e-06	0	0	876	0.000000e+00	0	0	10798	0.000000e+00	0	0	1332	0.000000e+00	0	0	2816	0.000000e+00	0	0	1446	0.000000e+00	0	0	16600	0.000000e+00	0	0	9794	0.000000e+00	0	.	.	.	.	0	2798	0.000000e+00	0	0	17982	0.000000e+00	0	0	4158	0.000000e+00	0	0	5526	0.000000e+00	0	0	3366	0.000000e+00	0	1	37204	2.687880e-05	0	0	19844	0.000000e+00	0	1	37204	2.687880e-05	0	0	2818	0.000000e+00	0	0	21748	0.000000e+00	0	0	7370	0.000000e+00	0	0	8020	0.000000e+00	0	0	5204	0.000000e+00	0	1	41050	2.436050e-05	0	0	19846	0.000000e+00	0	1	41050	2.436050e-05	0	.	7	1509896	4.636080e-06	0	7	1135850	6.162790e-06	0	0	70004	0.000000e+00	0	0	910	0.000000e+00	0	0	49036	0.000000e+00	0	0	27824	0.000000e+00	0	0	38468	0.000000e+00	0	0	43528	0.000000e+00	0	0	4326	0.000000e+00	0	7	1135850	6.162790e-06	0	0	81134	0.000000e+00	0	1	15728	6.358087487283825E-5	0	122	0	0	110	0	0	3368	0	0	146	0	0	610	0	0	56	0	0	98	0	0	2768	0	0	3490	0	0	166	0	1	23006	4.3466921672607145E-5	Friedreich_ataxia|not_provided|Friedreich_ataxia_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.69035785G>T	ClinGen:CA252968|OMIM:606829.0006	C0016719|C3661900|C1856689	229300	95|95	.	Met	Ile	45.27	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													233			45.27	Aliphatic	Methionine												1.9																		149									360.0				80.4						C (loop/coil)	C (loop/coil)								Mitochondrion				45.27	100.0	$\leqslant$50	$\geqslant$90	229300	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic neurological disorder	3	FRIEDREICH ATAXIA	false	0.9959417171051579	0.9900326443708796	true	true	true
SH3BP2	SH3BP2_Pro418Arg	B_7-8	0.7750117182411813	0.4677668958664164	0.5537287410120795	3.4866551511798476	0.010174461743327002	0.017399941564776374	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6736758093479029	0.6892729340648155	0.652979818349416	0.6477862881478448	0.6479665054583634	0.7064888895876813	0.8694271604454913	0.8646677616105907	0.8285040175715012	0.7759806933210307	0.7659818959926303	0.6736758093479029	0.5435506187298713	0.4312652493061363	0.46706855872418845	0.5299789433778014	0.6125639721370006		SH3BP2	Pro418Arg	NC_000004.12:2831582:C:G	1253C>G	4	2831582	C	G	4	ENSG00000087266	8143	202838	CCSBVarC003711	ALE00003711	ENSP00000422168.3	CEGS2	CegsMutGDEh1037	A09	GDEhDisVCh_40022	F07	2	CegsMutGDDh1037	A09	VUSN2Hmut_GDN2h_07	G08	VUSMutpDEST2_07	F08	VUSmut_GDEh07	G08	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	Y	N	N	Y	22587.0	single nucleotide variant	NM_001122681.2(SH3BP2):c.1253C>G (p.Pro418Arg)	6452.0	SH3BP2	HGNC:10825	Pathogenic	1.0	Aug 25, 2023	121909146.0	-	RCV000007984|RCV000486508	MONDO:MONDO:0007315,MedGen:C0008029,OMIM:118400,Orphanet:184|MedGen:C3661900	Fibrous dysplasia of jaw|not provided	germline	germline	GRCh38	NC_000004.12	4	2831582.0	2831582.0	4p16.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA254207,UniProtKB:P78314#VAR_013261,OMIM:602104.0002	3.0	7548.0	2831582.0	C	G	-	-	-	-	-	-	1253C>G 	Pro418Arg	NM_001122681.2	2.0	Pathogenic	Pathogenic	7548	4	2831582.0	C	G	P	R	rs121909146	4	2833309	4	2803107	418	SH3BP2	ENSG00000087266	ENST00000513095	ENSP00000423823	P78314	3BP2_HUMAN	.	.	c.1253C>G	p.Pro418Arg	principal2	Y	4	.	.	+	CCC	2	0	C	./.	./.	./.	./.	.	.	.	.	.	.	1.0	0.90580	D	0.999	0.92348	D	.	0.99291	.	.	.	.	.	.	.	.	.	.	.	.	1.0682	0.98540	D	0.9384	0.97971	D	10	.	.	.	0.348156	0.92180	D	.	0.89698	0.467	0.53754	P78314	P418R	Gain of MoRF binding (P = 0.0053)| Loss of catalytic residue at P417 (P = 0.0191)| Gain of solvent accessibility (P = 0.0216)| Loss of glycosylation at P418 (P = 0.0707)| Gain of sheet (P = 0.1208)	.	0.97110	.	0.60494	.	0.61099	0.636878252029	0.58056	T	0.772375	0.93864	D	0.520224	0.94858	D	0.50949	0.94783	D	0.977605283260345	0.71731	D	.	0.75048	.	0.8034089	0.83922	0.31203118	0.56985	0.61213076	0.73061	0.43910044	0.67017	-4.368	0.29534	T	.	0.79607	.	0.987762709411516	0.87554	0.99208504	0.97076	0.959	0.98248	.	.	.	.	.	.	3.48937	0.48851	22.7	0.99736916881083126	0.83207	0.750290	0.69033	D	0.599357392060539	0.72989	5.91686	0.53333979053209	0.70083	5.47721	5.69	5.69	0.88329	3.72	0.68345	4.676	0.61402	7.409000	0.58695	0.599	0.40292	0.999	0.42732	1.000000	0.68239	0.019	0.11385	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1588300	1.259210e-06	0	1	87560	1.142070e-05	0	0	74370	0.000000e+00	0	0	912	0.000000e+00	0	0	57066	0.000000e+00	0	0	29150	0.000000e+00	0	0	43424	0.000000e+00	0	0	61772	0.000000e+00	0	0	6032	0.000000e+00	0	1	1166540	8.572360e-07	0	1	87560	1.142070e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Fibrous_dysplasia_of_jaw	criteria_provided,_multiple_submitters,_no_conflicts	NC_000004.12:g.2831582C>G	ClinGen:CA254207|OMIM:602104.0002|UniProtKB:P78314#VAR_013261	C3661900|C0008029	118400	184	.	Pro	Arg	61.53	0.8970588235294118																																																																																																																																																																																																																																																																																																																																																																																																																																																																													122			61.53	Special, No backbone hydrogen	Proline		SH3 domain-binding protein 2										1.6			H:P418-D:Y978 (PDBs: 3TWR), F:P418-B:Y978 (PDBs: 3TWR), E:P418-A:Y978 (PDBs: 3TWR), G:P418-C:Y978 (PDBs: 3TWR)															115									-105.7				147.8	Disordered			dbSNP: rs121909146; Variant type: LP/P; AA change: Pro418His; PTM type: Phosphorylation; PTM morphology: PHLQRsPP*DGQ; Var class: II&rs121909146		C (loop/coil)	C (loop/coil)												61.53	89.70589	50-70	10-90	118400	autosomal dominant	OMIM	Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	3	CHERUBISM	false	0.6892729340648155	0.6736758093479029	false	false	false
APOA1	APOA1_Leu84Arg	B_15-16	7.339511430677596	0.00015733680781251263	0.0012469431656510336	6.806139646520246	0.00025179823445634146	0.0008130560927622751	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8117295425159097	0.8883243494097697	0.7656783979522069	0.884969069487131	0.8599423541803117	0.8239687174246508	0.6879574048230787	0.7936414204921329	0.7979901776771796	0.6381685428931114	0.8620289348816098	0.7622500164844407	0.9599800300262231	0.9262432878684906	0.9719479612970824	0.8931882530113024	0.9146197639379295	0.8612090685473788	APOA1	Leu84Arg	NC_000011.10:116836361:A:C	251T>G	11	116836361	A	C	11	ENSG00000118137	5613	215450	CCSBVarC006761	ALE00006759	ENSP00000236850.3	CEGS2	CegsMutGDEh1046	E10	GDEhDisVCh_40037	H07	1	CegsMutGDDh1046	E10	VUSN2Hmut_GDN2h_10	B03	VUSMutpDEST2_05	D04	VUSmut_GDEh10	B03	1.0	1.0	1.0	1.0	1.0	2.0	7.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	32962.0	single nucleotide variant	NM_000039.3(APOA1):c.251T>G (p.Leu84Arg)	335.0	APOA1	HGNC:600	Pathogenic	1.0	Aug 15, 1992	121912724.0	-	RCV004555838	MONDO:MONDO:0971008,MedGen:C4551500,OMIM:620657	Familial amyloid polyneuropathy, Iowa type	germline	germline	GRCh38	NC_000011.10	11	116836361.0	116836361.0	11q23.3	no assertion criteria provided	1.0	-	N	ClinGen:CA127569,UniProtKB:P02647#VAR_000610,OMIM:107680.0016	1.0	17923.0	116836361.0	A	C	-	-	-	-	-	-	251T>G 	Leu84Arg	NM_000039.3		Pathogenic	Pathogenic	17923	11	116836361.0	A	C	L	R	rs121912724	11	116707077	11	116212287	84	APOA1	ENSG00000118137	ENST00000375320	ENSP00000364469	P02647	APOA1_HUMAN	c.251T>G	p.Leu84Arg	c.251T>G	p.Leu84Arg	principal1	Y	3	.	.	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.007	0.78662	D	0.003	0.76775	D	0.999	0.77914	D	0.97	0.72228	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.545	0.74100	M	-4.45	0.77749	D	0.918	0.92086	-0.1327	0.79245	T	0.6884	0.89208	D	10	0.9929051	0.99825	D	0.236619	0.88479	D	0.648	0.86624	0.851	0.95234	P02647	L84R	Gain of disorder (P = 0.0348)| Gain of ubiquitination at K83 (P = 0.0716)| Loss of stability (P = 0.1137)| Gain of methylation at K83 (P = 0.1519)| Gain of phosphorylation at T80 (P = 0.1623)	0.959484012332	0.95870	.	0.84412	.	0.92957	0.395892500877	0.24469	T	0.539789	0.84078	D	0.384248	0.88904	D	0.314169	0.88765	D	0.966342091560364	0.67342	D	.	0.45157	.	0.9367415	0.94839	0.8486564	0.91301	0.9416238	0.95342	0.81879234	0.89325	-11.413	0.81930	D	.	0.86085	.	0.992655484037873	0.89624	0.99970690	0.99632	0.857	0.92182	.	.	.	.	.	.	3.327942	0.45881	22.2	0.99493392563950522	0.67614	0.920757	0.89283	D	0.307244176589699	0.56298	3.816818	0.144999991330121	0.46608	2.926679	5.38	4.26	0.49774	3.54	0.64349	4.64	0.61149	7.907000	0.73875	0.756	0.943	0.991	0.37341	0.994000	0.32271	0.143	0.20099	490	0.76745	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614124	6.195310e-07	0	1	1180042	8.474270e-07	0	0	75054	0.000000e+00	0	0	912	0.000000e+00	0	0	60026	0.000000e+00	0	0	29608	0.000000e+00	0	0	44878	0.000000e+00	0	0	63946	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180042	8.474270e-07	0	0	91088	0.000000e+00	0	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	424	0	0	0	0	0	476	0	Familial_amyloid_polyneuropathy,_Iowa_type	no_assertion_criteria_provided	NC_000011.10:g.116836361A>C	ClinGen:CA127569|OMIM:107680.0016|UniProtKB:P02647#VAR_000610	C4551500	620657	.	.	Leu	Arg	66.57	0.5426829268292683																																																																																																																																																																																																																																																																																																																																																																																																																																																																													89			66.57	Aliphatic	Leucine		Proapolipoprotein A-I; Apolipoprotein A-I; Truncated apolipoprotein A-I										3.8				A:L84-C:H421 (PDBs: 2MSC)				 L84-L88 (PAE:  3.0), L84-T80 (PAE: 2.5)	L84-L88 (PDBs: 3R2P, 2N5E, 7KJR, 8EQS), L84-T80 (PDBs: 3R2P, 2MSC, 2MSD, 2MSE, 6CC9, 6CCH, 6CCX, 6PTS, 6PTW, 6W4E, 6W4F)	 L84-L88 (PAE:  3.0), L84-T80 (PAE: 2.5)	L84-L88 (PDBs: 3R2P, 2N5E, 7KJR, 8EQS), L84-T80 (PDBs: 3R2P, 1AV1, 2MSC, 2MSD, 2MSE, 6CC9, 6CCH, 6CCX, 6PTS, 6PTW, 6W4E, 6W4F)							131									-62.3				-43.6	10 X approximate tandem repeats		1			H (helix)	H (α-helix)	Helix											66.57	54.268295	50-70	10-90	620657	unknown		Rare genetic systemic or rheumatologic disease; Rare genetic renal disease; Rare genetic endocrine disease; Rare inborn errors of metabolism	4	AMYLOIDOSIS, HEREDITARY SYSTEMIC 3	false	0.8883243494097697	0.8117295425159097	false	false	false
HPRT1	HPRT1_Pro176Leu	B_7-8	0.2940071672531553	0.7772789755757039	0.8243214010825066	-4.267023393792782	0.0037142779767921296	0.007212381044882071	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7046805989882321	0.7225980733409544	0.6730454170617761	0.5968500394793165	0.5330529172550593	0.7147018284576686	0.5904195689861665	0.4926142992224999	0.5266857246274124	0.577854804080785	0.7758716536779644	0.7531151117368993	0.8389840879291707	0.5734915352876189	0.6670143543312206	0.7682360300427671	0.6693244930039444	0.656246086239565	HPRT1	Pro176Leu	NC_000023.11:134498431:C:T	527C>T	23	134498431	C	T	X	ENSG00000165704	7982	202805	CCSBVarC005940	ALE00005940	ENSP00000298556.7	CEGS2	CegsMutGDEh1041	H05	GDEhDisVCh_40052	G09	2	CegsMutGDDh1041	H05	VUSN2Hmut_GDN2h_08	G08	VUSMutpDEST2_07	G07	VUSmut_GDEh08	G08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25097.0	single nucleotide variant	NM_000194.3(HPRT1):c.527C>T (p.Pro176Leu)	3251.0	HPRT1	HGNC:5157	Pathogenic	1.0	Jul 01, 1989	137852493.0	-	RCV000010758	MONDO:MONDO:0010298,MedGen:C0023374,OMIM:300322,Orphanet:510	Lesch-Nyhan syndrome	germline	germline	GRCh38	NC_000023.11	X	134498431.0	134498431.0	Xq26.2	no assertion criteria provided	1.0	-	N	ClinGen:CA255003,UniProtKB:P00492#VAR_006790,OMIM:308000.0033	1.0	10058.0	134498431.0	C	T	-	-	-	-	-	-	527C>T 	Pro176Leu	NM_000194.3		Pathogenic	Pathogenic	10058	X	134498431.0	C	T	P	L	rs137852493	X	133632461	X	133460127	176	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.527C>T	p.Pro176Leu	c.527C>T	p.Pro176Leu	principal1	Y	1	YES	Select	+	CCA	2	0	C	./.	./.	./.	./.	0.001	0.78662	D	0.005	0.72530	D	0.994	0.66535	D	0.845	0.60425	P	0.88	0.91311	A	simple_aae	12.0	88.0	2.415	0.69565	M	-8.41	0.97166	D	0.874	0.87133	1.0665	0.98496	D	0.9325	0.97770	D	9	0.93561876	0.92813	D	0.919075	0.99401	D	0.904	0.97356	0.597	0.72636	P00492	P176L	Loss of catalytic residue at P176 (P = 0.0357)| Gain of MoRF binding (P = 0.0644)| Loss of methylation at K175 (P = 0.0673)| Loss of disorder (P = 0.0692)| Loss of sheet (P = 0.0817)	0.999501397049	0.99948	0.9838948853634367	0.98375	2.31666214769	0.96592	0.779787302017	0.78858	T	0.983937	0.99890	D	0.656274	0.99892	D	0.704915	0.99892	D	0.997392654418945	0.91382	D	0.942906	0.78449	D	0.9293605	0.94085	0.9688278	0.99404	0.9293605	0.94085	0.9688278	0.99404	-14.285	0.93958	D	0.9627	0.88372	P	0.996548940937451	0.92238	0.99976546	0.99701	0.96	0.98304	.	.	.	.	.	.	4.851411	0.79337	27.1	0.99854513184647886	0.93373	.	.	.	.	.	.	.	.	.	5.79	5.79	0.91740	3.64	0.66725	5.717	0.6817	7.669000	0.64727	0.598	0.34656	1.0	0.71675	1.000000	0.68239	0.98	0.58201	242	0.90535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Lesch-Nyhan_syndrome	no_assertion_criteria_provided	NC_000023.11:g.134498431C>T	ClinGen:CA255003|OMIM:308000.0033|UniProtKB:P00492#VAR_006790	C0023374	300322	510	Phosphoribosyltransferase domain|Phosphoribosyltransferase domain	Pro	Leu	97.37	0.058823529411764705																																																																																																																																																																																																																																																																																																																																																																																																																																																																													8			97.37	Special, No backbone hydrogen	Proline		Hypoxanthine-guanine phosphoribosyltransferase								0.209		1.6																		115									-69.4		Pocket 1: Mean pLDDT: 91.78, Volume: 289.82 Å³, Druggability score: 0.21		161.8				dbSNP: rs137852493; Variant type: LP/P; AA change: Pro176Leu; PTM type: Ubiquitylation; PTM morphology: RSVGYkP*DFVG; Var class: II		C (loop/coil)	C (loop/coil)												97.37	5.882353	>90	<10	300322	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	LESCH-NYHAN SYNDROME	false	0.7225980733409544	0.7046805989882321	false	false	false
KLHL3	KLHL3_Met78Val	B_7-8	3.9423463135361607	0.0055865171988150894	0.017349996503637107	-2.690213022270074	0.031076155866581846	0.04643708958890691	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7179226017665402	0.7477482233187174	0.7411379760144523	0.8019873638014503	0.74805899242763	0.7753201906549407	0.8652301003230423	0.719981462351529	0.918944852393262	0.7839925281366069	0.7143213245206901	0.6835777982631597	0.6854102809868393	0.7761365225037309	0.6850298752096388	0.6982834238922978	0.7811751221167447	0.7522674052699208	KLHL3	Met78Val	NC_000005.10:137709759:T:C	232A>G	5	137709759	T	C	5	ENSG00000146021	1256	214007	CCSBVarC005557	ALE00005557	ENSP00000312397.4	CEGS2	CegsMutGDEh1034	A03	GDEhDisVCh_40013	C01	1	CegsMutGDDh1034	A03	VUSN2Hmut_GDN2h_06	E07	VUSMutpDEST2_01	E08	VUSmut_GDEh06	E07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	106415.0	single nucleotide variant	NM_017415.3(KLHL3):c.232A>G (p.Met78Val)	26249.0	KLHL3	HGNC:6354	Pathogenic	1.0	-	199469624.0	-	RCV000128510	MONDO:MONDO:0007772,MedGen:C1840389,OMIM:145260,Orphanet:757,Orphanet:88938	Pseudohypoaldosteronism type 2A	germline	germline	GRCh38	NC_000005.10	5	137709759.0	137709759.0	5q31.2	no assertion criteria provided	1.0	-	N	ClinGen:CA269978,UniProtKB:Q9UH77#VAR_067502	2.0	100538.0	137709759.0	T	C	-	-	-	-	-	-	232A>G 	Met78Val	NM_017415.3		Pathogenic	Pathogenic	100538	5	137709759.0	T	C	M	V	rs199469624	5	137045448	5	137073347	78	KLHL3	ENSG00000146021	ENST00000309755	ENSP00000312397	Q9UH77	KLHL3_HUMAN	c.232A>G	p.Met78Val	c.232A>G	p.Met78Val	principal1	Y	1	YES	Select	-	ATG	1	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.009	0.67073	D	0.151	0.28044	B	0.232	0.38315	B	0.85	0.91311	A	simple_aae	15.0	85.0	3.5	0.92661	M	-3.28	0.66466	D	0.952	0.96086	-0.1520	0.78772	T	0.4223	0.76607	T	10	0.8937037	0.88594	D	0.180702	0.85470	D	0.763	0.91933	0.748	0.87844	Q9UH77	M78V	Gain of catalytic residue at M78 (P = 0.0409)| Loss of stability (P = 0.0794)| Gain of phosphorylation at T80 (P = 0.0975)| Loss of disorder (P = 0.1092)| Loss of helix (P = 0.3949)	0.866319331098	0.86397	0.8955185280592952	0.89456	1.15223493278	0.79126	0.724454283714	0.70645	T	0.612671	0.87632	D	0.381508	0.88725	D	0.310234	0.88584	D	0.977121770381927	0.71503	D	0.956404	0.83452	D	0.96747	0.97988	0.9187496	0.96257	0.959496	0.97185	0.9007289	0.94960	-13.846	0.92561	D	0.947	0.86564	P	0.972751652990238	0.83778	0.98423344	0.95971	0.977	0.99166	.	.	.	.	.	.	4.3253	0.66297	24.9	0.98973945528174345	0.49691	0.846310	0.76232	D	0.388078004074055	0.60573	4.270276	0.457725166125939	0.65025	4.795643	5.35	5.35	0.76261	5.15	0.91432	7.674	0.83188	7.764000	0.68398	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pseudohypoaldosteronism_type_2A	no_assertion_criteria_provided	NC_000005.10:g.137709759T>C	ClinGen:CA269978|UniProtKB:Q9UH77#VAR_067502	C1840389	145260	757|88938	BTB/POZ domain|BTB/POZ domain|BTB/POZ domain	Met	Val	91.78	0.14361702127659576																																																																																																																																																																																																																																																																																																																																																																																																																																																																													27			91.78	Aliphatic	Methionine		Kelch-like protein 3							BTB	0.6299		1.9								 M78-Y74 (PAE:  1.5)		 M78-S86 (PAE:  5.0), M78-Y74 (PAE: 1.5)								149									-63.6		Pocket 1: Mean pLDDT: 82.48, Volume: 446.44 Å³, Druggability score: 0.63		-40.2						H (helix)	H (α-helix)												91.78	14.361702	>90	10-90	145260	autosomal dominant	OMIM	Rare genetic renal disease	1	PSEUDOHYPOALDOSTERONISM, TYPE IIA	false	0.7477482233187174	0.7179226017665402	false	false	false
PHYH	PHYH_Gln176Lys	B_15-16	1.0895334882131429	0.31199913092641357	0.3994090751135724	-5.8169784652310215	0.0006521443956598382	0.001695021198350996	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6396569866636579	0.6303093220537048	0.4912753691702634	0.5142822716375126	0.5564688441503887	0.4900855552975679	0.47779717815960876	0.5582567912852576	0.5061068729570636	0.4797699555398485	0.5895575316732226	0.6009410726223298	0.5023739324355271	0.5546808970155198	0.5224576703179615	0.5027807828006783	0.6710611124341871	0.6783729007049861	PHYH	Gln176Lys	NC_000010.11:13288512:G:T	526C>A	10	13288512	G	T	10	ENSG00000107537	2156	214168	CCSBVarC005360	ALE00005360	ENSP00000263038.4	CEGS2	CegsMutGDEh1030	G08	GDEhDisVCh_40076	H04	2	CegsMutGDDh1030	G08	VUSN2Hmut_GDN2h_05	B05	VUSMutpDEST2_01	C10	VUSmut_GDEh05	B05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	22625.0	single nucleotide variant	NM_006214.4(PHYH):c.526C>A (p.Gln176Lys)	5264.0	PHYH	HGNC:8940	Pathogenic	1.0	May 01, 2000	28939672.0	-	RCV000008024	MedGen:C2749345	Refsum disease, adult, 1	germline	germline	GRCh38	NC_000010.11	10	13288512.0	13288512.0	10p13	no assertion criteria provided	1.0	-	N	ClinGen:CA118906,UniProtKB:O14832#VAR_017484,OMIM:602026.0007	1.0	7586.0	13288512.0	G	T	-	-	-	-	-	-	526C>A 	Gln176Lys	NM_006214.4		Pathogenic	Pathogenic	7586	10	13288512.0	G	T	Q	K	rs28939672	10	13330512	10	13370518	176	PHYH	ENSG00000107537	ENST00000263038	ENSP00000263038	O14832	PAHX_HUMAN	c.526C>A	p.Gln176Lys	c.526C>A	p.Gln176Lys	principal1	Y	1	YES	Select	-	CAG	1	0	g	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.88	0.96253	A	simple_aae	12.0	88.0	3.435	0.91961	M	-3.72	0.72390	D	0.981	0.99110	1.0533	0.98185	D	0.9097	0.97001	D	9	0.9866784	0.98981	D	0.042649	0.60421	D	0.926	0.98190	0.977	0.99784	O14832	Q176K	Gain of methylation at Q176 (P = 0.0047)| Gain of disorder (P = 0.0993)| Gain of ubiquitination at Q176 (P = 0.1008)| Gain of glycosylation at Q176 (P = 0.1357)| Gain of relative solvent accessibility (P = 0.1571)	0.946107888634	0.94510	0.9567511711507404	0.95634	0.637711510295	0.57225	0.591122031212	0.51585	T	0.957843	0.99430	D	0.50449	0.94384	D	0.486889	0.94304	D	0.998625516891479	0.94631	D	0.918608	0.81170	D	0.9854344	0.99486	0.92785615	0.96903	0.9834726	0.99352	0.9331255	0.97270	-12.443	0.87653	D	0.8911	0.84054	P	0.970377096420201	0.83345	0.71101123	0.86313	0.986	0.99524	.	.	.	.	.	.	5.262613	0.88378	29.6	0.99643273052766979	0.76845	0.948673	0.96041	D	0.961714789344751	0.94409	12.75881	0.881775802962302	0.94699	12.99339	5.8	4.89	0.63341	2.39	0.44462	9.859	0.98419	11.726000	0.94911	0.569	0.28905	1.0	0.71675	1.000000	0.68239	0.995	0.73271	934	0.15398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	1614162	3.717100e-06	0	6	1180036	5.084590e-06	0	0	75050	0.000000e+00	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	0	29606	0.000000e+00	0	0	44874	0.000000e+00	0	0	64034	0.000000e+00	0	0	6034	0.000000e+00	0	6	1180036	5.084590e-06	0	0	91078	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Refsum_disease,_adult,_1	no_assertion_criteria_provided	NC_000010.11:g.13288512G>T	ClinGen:CA118906|OMIM:602026.0007|UniProtKB:O14832#VAR_017484	C2749345	.	.	.	Gln	Lys	96.77	0.005050505050505051																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			96.77	Polar/Neutral	Glutamine	2-oxoglutarate	Phytanoyl-CoA dioxygenase, peroxisomal										-3.5								 Q176-S216 (PAE:  1.0), Q176-H220 (PAE: 1.0), Q176-L261 (PAE: 1.0), Q176-K218 (PAE: 1.0)	Q176-S216 (PDBs: 2A1X), Q176-H220 (PDBs: 2A1X), Q176-L261 (PDBs: 2A1X), Q176-K218 (PDBs: 2A1X)	 Q176-K218 (PAE:  1.0)	Q176-K218 (PDBs: 2A1X)							146									-125.2				128.7						C (loop/coil)	C (loop/coil)												96.77	0.5050505	>90	<10		unknown		Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease	4		false	0.6303093220537048	0.6396569866636579	false	false	false
DCX	DCX_Ala251Ser	B_7-8	4.221390694049208	0.003929824305219644	0.013308447558456594	-3.155495832320868	0.016028679063430078	0.026005858604238898	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8630276287088527	0.7888367688611166	0.778734677252103	0.5665184307632032	0.5390569042482363	0.7739805524858201	0.8425015019243267	0.591106538506825	0.6416486230251917	0.8344168125181783	0.8517394316991596	0.8931348952068143	0.7054596030473135	0.4870072699896475	0.4913882385012146	0.7230525419860276	0.7259341060230736	0.8329203622108912	DCX	Ala251Ser	NC_000023.11:111333108:C:A	751G>T	23	111333108	C	A	X	ENSG00000077279	8416	216652	CCSBVarC005207	ALE00005207	ENSP00000419861.1	CEGS2	CegsMutGDEh1044	E09	GDEhDisVCh_40049	E09	1	CegsMutGDDh1044	E09	VUSN2Hmut_GDN2h_09	A07	VUSMutpDEST2_08	F02	VUSmut_GDEh09	A07	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	169856.0	single nucleotide variant	NM_001195553.2(DCX):c.751G>T (p.Ala251Ser)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	Jul 02, 2021	587783585.0	-	RCV000145888|RCV001857505	MedGen:C0008519|MedGen:C3661900	Ectopic tissue|not provided	germline	germline	GRCh38	NC_000023.11	X	111333108.0	111333108.0	Xq23	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA172066,UniProtKB:O43602#VAR_026037	2.0	158504.0	111333108.0	C	A	-	-	-	-	-	-	751G>T 	Ala251Ser	NM_001195553.2	2.0	Pathogenic	Pathogenic	158504	X	111333108.0	C	A	A	S	rs587783585	X	110576336	X	110462992	251	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.751G>T	p.Ala251Ser	c.751G>T	p.Ala251Ser	alternative1	Y	1	.	.	-	GCC	1	0	C	C/C	C/C	C/C	C/C	.	0.72322	.	.	0.66047	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.53599	.	.	0.96086	0.2697	0.87012	D	0.5575	0.83798	D	10	0.91795254	0.91055	D	0.778257	0.98248	D	.	0.99253	.	.	.	.	.	.	0.99925	.	0.93884	.	.	0.882662832737	0.94310	D	.	0.96235	.	0.682188	0.99917	D	0.74214	0.99917	D	0.989148318767548	0.79244	D	0.989876	0.96802	D	0.96966	0.98198	0.9553173	0.98692	0.9718078	0.98400	0.9587121	0.98885	-12.033	0.85144	D	0.9673	0.91219	LP	0.972134460652213	0.83662	0.99945265	0.99395	0.97	0.98836	.	.	.	.	.	.	4.344463	0.66734	25.0	0.99757015709220054	0.84785	.	.	.	.	.	.	.	.	.	5.44	5.44	0.79319	4.38	0.82553	7.903	0.86169	7.660000	0.64235	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.989	0.64309	832	0.38867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Ectopic_tissue	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.111333108C>A	ClinGen:CA172066|UniProtKB:O43602#VAR_026037	C3661900|C0008519	.	.	.	Ala	Ser	87.81	0.009433962264150943																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			87.81	Aliphatic	Alanine		Neuronal migration protein doublecortin							Doublecortin 2	0.4847		1.8			C:A251-A:I185 (PDBs: 6FNZ), C:A251-A:S187 (PDBs: 6FNZ), B:A251-D:S187 (PDBs: 6FNZ), A:A251-C:I185 (PDBs: 6FNZ), D:A251-B:S187 (PDBs: 6FNZ), A:A251-C:S187 (PDBs: 6FNZ), B:A251-D:I185 (PDBs: 6FNZ), D:A251-B:I185 (PDBs: 6FNZ)	D:A251-B:I185 (PDBs: 6FNZ), C:A251-A:I185 (PDBs: 6FNZ), A:A251-C:S187 (PDBs: 6FNZ), B:A251-D:S187 (PDBs: 6FNZ)				 A251-I185 (PAE:  2.0), A251-S187 (PAE: 3.5)	A251-I185 (PDBs: 6RF2)	 A251-L228 (PAE:  1.5), A251-I185 (PAE: 2.0)	A251-I184 (PDBs: 6RF2), A251-I185 (PDBs: 6RF2)							89									-89.1		Pocket 3: Mean pLDDT: 53.44, Volume: 667.23 Å³, Druggability score: 0.48		117.0						B (undefined)	E (parallel sheets)	Beta strand											87.81	0.9433962	70-90	<10		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.7888367688611166	0.8630276287088527	false	false	false
LITAF	LITAF_Pro135Thr	B_15-16	-4.524171485538316	0.0027185671950240467	0.009928228188328735	-6.396441058095169	0.0003685278255092563	0.0010854712035465253	2025_03_Batch_15-16	false	true	false	false	false	false	false	false	false	false	false	false	0.9546986949608489	0.9606993000231892	0.5553962853233576	0.7756590986218648	0.7348722396455352	0.6099953186277234	0.675248415355361	0.7560278054638094	0.8216151754386986	0.581975752832036	0.9489659073247838	0.942903316116362	0.5447422219000858	0.7137166738272609	0.7297030218050309	0.5288168178146794	0.9724326927215945	0.9664940738053358	LITAF	Pro135Thr	NC_000016.10:11549720:G:T	403C>A	16	11549720	G	T	16	ENSG00000189067	52920	2669	CCSBVarC007934	ALE00007920	ENSP00000483114.1	Edgotyping3	VUSMutGDEh006	G11	GDEhDisVCh_40036	H05	2	VUSMutGDDh006	G11	VUSN2Hmut_GDN2h_02	C05	VUSMutpDEST2_11	A12	VUSmut_GDEh02	C05	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	49654.0	single nucleotide variant	NM_001136472.2(LITAF):c.403C>A (p.Pro135Thr)	9516.0	LITAF	HGNC:16841	Pathogenic	1.0	Dec 25, 2020	281865135.0	-	RCV000789996|RCV000034129	MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 1C	germline;unknown	germline	GRCh38	NC_000016.10	16	11549720.0	11549720.0	16p13.13	criteria provided, single submitter	3.0	-	N	ClinGen:CA344234	3.0	41230.0	11549720.0	G	T	-	-	-	-	-	-	403C>A 	Pro135Thr	NM_001136472.2	1.0	Pathogenic	Pathogenic	41230	16	11549720.0	G	T	P	T	rs281865135	16	11643576	16	11551077	135	LITAF	ENSG00000189067	ENST00000574763	ENSP00000461813	Q99732	LITAF_HUMAN	c.403C>A	p.Pro135Thr	c.403C>A	p.Pro135Thr	principal1	Y	3	.	.	-	CCC	1	0	.	G/G	G/G	G/G	G/G	.	0.72322	.	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.725	0.94735	H	.	0.95782	.	0.985	0.99419	1.0634	0.98419	D	0.9140	0.97145	D	10	0.95713687	0.95029	D	0.373716	0.92793	D	.	0.98815	0.829	0.93882	Q99732	P135T	Gain of sheet (P = 0.1208)| Loss of helix (P = 0.1706)| Loss of stability (P = 0.182)| Gain of loop (P = 0.2045)| Gain of catalytic residue at P135 (P = 0.2868)	0.999432143325	0.99941	.	0.82565	.	0.60252	0.683367729187	0.64694	T	0.975855	0.99766	D	0.175526	0.71420	D	0.0143546	0.71052	D	0.998420238494873	0.94061	D	0.944805	0.94381	D	0.94496185	0.95686	0.90886486	0.95547	0.92091954	0.93238	0.8924557	0.94365	-14.346	0.94139	D	0.99	0.93906	P	0.991323361056813	0.88976	0.99738413	0.98358	0.823	0.90233	.	.	.	.	.	.	5.158253	0.86447	28.9	0.9979485507584317	0.88027	0.922585	0.89742	D	0.979700870126169	0.95059	13.2969	0.881479093443982	0.94683	12.98158	5.01	5.01	0.66433	.	.	7.61	0.82198	11.543000	0.93152	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.997	0.79771	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Charcot-Marie-Tooth_disease|Charcot-Marie-Tooth_disease_type_1C	criteria_provided,_single_submitter	NC_000016.10:g.11549720G>T	ClinGen:CA344234	C0007959|C0270913	PS118220|601098	166|101083	LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor	Pro	Thr	75.73	0.029411764705882353																																																																																																																																																																																																																																																																																																																																																																																																																																																																													4			75.73	Special, No backbone hydrogen	Proline		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF	0.003		1.6																		115		Mutation: P -> T. Decreases protein stability and association with early endosome membranes. Impaired function in targeting endocytosed proteins for lysosomal degradation.							-62.1		Pocket 3: Mean pLDDT: 79.3, Volume: 304.37 Å³, Druggability score: 0		-27.1						H (helix)	H (α-helix)												75.73	2.9411764	70-90	<10	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.9606993000231892	0.9546986949608489	true	false	false
DCX	DCX_Lys174Glu	B_7-8	2.371954723362576	0.04946381711661194	0.092171600675833	4.556534678236334	0.002615672708355189	0.005374870570920237	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7874080682553958	0.8504926993913258	0.85950072576307	0.6555771313021777	0.6347158412671405	0.8619472337043865	0.9638146872298738	0.85145783274778	0.9254728394841543	0.9550107353934163	0.9279560399012834	0.9219691430918144	0.7600797801788993	0.4179738497865012	0.38568142312020115	0.7639907161327236	0.7730293588813681	0.6528469934189771	DCX	Lys174Glu	NC_000023.11:111401175:T:C	520A>G	23	111401175	T	C	X	ENSG00000077279	8416	216643	CCSBVarC005194	ALE00005194	ENSP00000419861.1	CEGS2	CegsMutGDEh1040	D10	GDEhDisVCh_40049	E07	1	CegsMutGDDh1040	D10	VUSN2Hmut_GDN2h_08	F06	VUSMutpDEST2_08	F01	VUSmut_GDEh08	F06	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	169889.0	single nucleotide variant	NM_001195553.2(DCX):c.520A>G (p.Lys174Glu)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	Feb 08, 2013	587783557.0	-	RCV000145852	MedGen:C0008519	Ectopic tissue	germline	germline	GRCh38	NC_000023.11	X	111401175.0	111401175.0	Xq23	criteria provided, single submitter	1.0	-	N	ClinGen:CA171974	2.0	158470.0	111401175.0	T	C	-	-	-	-	-	-	520A>G 	Lys174Glu	NM_001195553.2	1.0	Pathogenic	Pathogenic	158470	X	111401175.0	T	C	K	E	rs587783557	X	110644403	X	110531059	174	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.520A>G	p.Lys174Glu	c.520A>G	p.Lys174Glu	alternative1	Y	1	.	.	-	AAG	1	0	T	T/T	T/T	T/T	T/T	.	0.27322	.	.	0.55281	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.56493	.	.	0.90700	0.7568	0.93857	D	0.8297	0.94275	D	10	0.8564184	0.84678	D	0.431126	0.93972	D	.	0.95570	.	.	.	.	.	.	0.99457	.	0.97904	.	.	0.729735255241	0.71418	T	.	0.28564	.	0.561489	0.96229	D	0.568763	0.96169	D	0.960695564746857	0.65658	D	0.963604	0.87185	D	0.91720206	0.92873	0.7499395	0.85039	0.87965	0.89495	0.7764371	0.86647	-11.761	0.83715	D	0.9697	0.90078	LP	0.993053120495067	0.89836	0.99947304	0.99411	0.898	0.94604	.	.	.	.	.	.	4.20629	0.63581	24.6	0.99805515531708233	0.89004	.	.	.	.	.	.	.	.	.	4.74	4.74	0.59667	4.4	0.82834	7.674	0.83188	7.885000	0.72767	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.991	0.66489	889	0.27289	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Ectopic_tissue	criteria_provided,_single_submitter	NC_000023.11:g.111401175T>C	ClinGen:CA171974	C0008519	.	.	.	Lys	Glu	48.49	0.8390243902439024																																																																																																																																																																																																																																																																																																																																																																																																																																																																													172			48.49	Positively-charged	Lysine		Neuronal migration protein doublecortin										-3.9																		147									-102.3				45.0						C (loop/coil)	C (loop/coil)												48.49	83.902435	$\leqslant$50	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.8504926993913258	0.7874080682553958	false	false	false
KCTD7	KCTD7_Asp115Tyr	B_7-8	-1.338949681766492	0.2224323899825018	0.3037330971845687	-6.971950204987777	0.00021690249178283968	0.0007248381169335865	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.90026061234128	0.8806016555838452	0.6138653247294859	0.6242914714716016	0.5885429700988767	0.6489029027731211	0.7365015185846728	0.6629933201440574	0.7831595763558511	0.6387589139200589	0.9014778317268171	0.9236330237561143	0.5613042869615694	0.5140926200536958	0.46542336658735206	0.5889717355389127	0.8597254794408733	0.8768882009264456	KCTD7	Asp115Tyr	NC_000007.14:66638281:G:T	343G>T	7	66638281	G	T	7	ENSG00000243335	70368	205543	CCSBVarC005606	ALE00005606	ENSP00000411624.1	CEGS2	CegsMutGDEh1034	A06	GDEhDisVCh_40029	E12	1	CegsMutGDDh1034	A06	VUSN2Hmut_GDN2h_06	E08	VUSMutpDEST2_13	G11	VUSmut_GDEh06	E08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	45678.0	single nucleotide variant	NM_153033.5(KCTD7):c.343G>T (p.Asp115Tyr)	154881.0	KCTD7	HGNC:21957	Pathogenic	1.0	Jun 01, 2012	387907262.0	-	RCV000030689	MONDO:MONDO:0012721,MedGen:C2673257,OMIM:611726,Orphanet:263516	Progressive myoclonic epilepsy type 3	germline	germline	GRCh38	NC_000007.14	7	66638281.0	66638281.0	7q11.21	no assertion criteria provided	1.0	-	N	ClinGen:CA130030,UniProtKB:Q96MP8#VAR_068778,OMIM:611725.0006	1.0	37012.0	66638281.0	G	T	-	-	-	-	-	-	343G>T 	Asp115Tyr	NM_153033.5		Pathogenic	Pathogenic	37012	7	66638281.0	G	T	D	Y	rs387907262	7	66103268	7	65740703	115	KCTD7	ENSG00000243335	ENST00000639828	ENSP00000492240	Q96MP8	KCTD7_HUMAN	c.343G>T	p.Asp115Tyr	c.343G>T	p.Asp115Tyr	principal4	Y	2	YES	Select	+	GAC	1	0	G	G/G	G/G	G/G	G/G	.	0.53331	.	.	0.60067	.	0.142	0.27637	B	0.216	0.37573	B	.	0.89397	.	.	.	.	2.025	0.55249	M	.	0.60697	.	.	0.63783	-0.6841	0.61016	T	0.2973	0.66727	T	9	0.724114	0.73613	D	0.011099	0.28105	T	.	0.82314	0.489	0.57283	Q96MP8	D115Y	Gain of catalytic residue at D115 (P = 0.0148)| Loss of disorder (P = 0.0324)| Gain of phosphorylation at D115 (P = 0.0939)| Gain of MoRF binding (P = 0.0955)| Gain of glycosylation at P117 (P = 0.0977)	.	0.89546	0.6807418803295453	0.67854	.	.	0.572769641876	0.49002	T	0.64248	0.88943	D	0.175549	0.71424	D	0.0143879	0.71053	D	0.956324071024029	0.64507	D	0.937806	0.77989	D	0.4519172	0.63845	0.37578157	0.62470	0.33698997	0.55709	0.35063347	0.60432	-11.922	0.84767	D	0.2192	0.61415	B	0.970831146065179	0.83427	0.98849220	0.96510	0.93	0.96535	.	.	.	.	.	.	4.734969	0.76345	26.5	0.99618469507458052	0.75321	0.858786	0.77553	D	0.39978521653869	0.61212	4.341805	0.497944478181771	0.67679	5.14	5.61	5.61	0.85327	.	.	9.236	0.94487	11.790000	0.96350	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.792	0.37428	851	0.35263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Progressive_myoclonic_epilepsy_type_3	no_assertion_criteria_provided	NC_000007.14:g.66638281G>T	ClinGen:CA130030|OMIM:611725.0006|UniProtKB:Q96MP8#VAR_068778	C2673257	611726	263516	Potassium channel tetramerisation-type BTB domain|BTB/POZ domain	Asp	Tyr	96.84	0.4785276073619632																																																																																																																																																																																																																																																																																																																																																																																																																																																																													78			96.84	Negatively-charged	Aspartic Acid		BTB/POZ domain-containing protein KCTD7							BTB			-3.5										 D115-N109 (PAE:  1.5), D115-F110 (PAE: 1.0)								132									-62.2				133.8						H (helix)	P (polyproline helix)												96.84	47.85276	>90	10-90	611726	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	false	0.8806016555838452	0.90026061234128	false	false	false
NMNAT1	NMNAT1_Asn273Asp	B_7-8	-1.232910914456366	0.26372049522368	0.34955318936657104	3.00615431410231	0.023818331313883147	0.03675915724219981	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5249413824809644	0.6027325636459974	0.6526081347893857	0.5699555230105862	0.714009225618963	0.6715896796638313	0.6110003007330664	0.701317305873203	0.501956899674805	0.6026239372227833	0.5826045789516576	0.5583126238083951	0.7321790585945962	0.7267011453647229	0.6379541463463675	0.7025923323559882	0.6228605483403371	0.4915701411535338	NMNAT1	Asn273Asp	NC_000001.11:9982678:A:G	817A>G	1	9982678	A	G	1	ENSG00000173614	7675	202587	CCSBVarC005699	ALE00005699	ENSP00000366410.1	CEGS2	CegsMutGDEh1036	B08	GDEhDisVCh_40020	E02	2	CegsMutGDDh1036	B08	VUSN2Hmut_GDN2h_07	H05	VUSMutpDEST2_06	C12	VUSmut_GDEh07	H05	1.0	7.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	45796.0	single nucleotide variant	NM_022787.4(NMNAT1):c.817A>G (p.Asn273Asp)	64802.0	NMNAT1	HGNC:17877	Pathogenic	1.0	Sep 01, 2012	387907291.0	-	RCV000030766	MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65	Leber congenital amaurosis 9	germline	germline	GRCh38	NC_000001.11	1	9982678.0	9982678.0	1p36.22	no assertion criteria provided	1.0	-	N	ClinGen:CA260592,UniProtKB:Q9HAN9#VAR_068883,OMIM:608700.0003	1.0	37135.0	9982678.0	A	G	-	-	-	-	-	-	817A>G 	Asn273Asp	NM_022787.4		Pathogenic	Pathogenic	37135	1	9982678.0	A	G	N	D	rs387907291	1	10042736	1	9965323	273	NMNAT1	ENSG00000173614	ENST00000377205	ENSP00000366410	Q9HAN9	NMNA1_HUMAN	c.817A>G	p.Asn273Asp	c.817A>G	p.Asn273Asp	principal1	Y	1	YES	Select	+	AAC	1	0	A	./.	./.	./.	./.	0.024	0.47905	D	0.179	0.29853	T	0.915	0.50611	P	0.477	0.46993	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.635	0.76933	M	-1.75	0.41427	N	0.71	0.71185	0.9578	0.96502	D	0.8714	0.95716	D	10	0.6738789	0.70610	D	0.212387	0.87322	D	0.396	0.70929	0.242	0.17431	Q9HAN9	N273D	Gain of relative solvent accessibility (P = 0.0479)| Gain of solvent accessibility (P = 0.0704)| Gain of phosphorylation at T274 (P = 0.1048)| Gain of disorder (P = 0.1651)| Loss of helix (P = 0.1706)	0.983514493703	0.98316	0.5603940972609054	0.55779	0.0740834531561	0.08128	0.396113812923	0.24499	T	0.024096	0.18123	T	0.0516325	0.58263	T	-0.16361	0.57733	T	0.478741884231567	0.31540	T	.	.	.	0.37525475	0.58643	0.19867784	0.43558	0.41649777	0.61536	0.23085344	0.48019	-3.432	0.15503	T	0.2281	0.46059	B	0.923041755460316	0.77797	0.24832545	0.75086	0.369	0.62388	.	.	.	.	.	.	2.354359	0.30247	18.36	0.99545640300123273	0.70810	0.319265	0.42079	N	0.244189076015059	0.53119	3.504462	0.242406611380394	0.51971	3.39817	5.01	3.79	0.42689	4.23	0.80332	1.003	0.29507	2.423000	0.32779	0.756	0.943	0.849	0.30519	0.009000	0.19951	0.688	0.33818	643	0.63791	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	segdup	0	108394	0.000000e+00	0	1	204512	4.889690e-06	0	1	232784	4.295830e-06	0	0	7160	0.000000e+00	0	0	16786	0.000000e+00	0	0	2260	0.000000e+00	0	0	9046	0.000000e+00	0	0	13358	0.000000e+00	0	0	42396	0.000000e+00	0	0	15486	0.000000e+00	0	.	.	.	.	0	15420	0.000000e+00	0	0	29882	0.000000e+00	0	0	6044	0.000000e+00	0	0	13410	0.000000e+00	0	0	16682	0.000000e+00	0	1	88168	1.134200e-05	0	0	30178	0.000000e+00	0	1	88168	1.134200e-05	0	0	14108	0.000000e+00	0	0	33592	0.000000e+00	0	0	9314	0.000000e+00	0	0	17660	0.000000e+00	0	0	21514	0.000000e+00	0	1	101042	9.896870e-06	0	0	30096	0.000000e+00	0	1	101042	9.896870e-06	0	.	2	1611726	1.240910e-06	0	2	1178868	1.696540e-06	0	0	74866	0.000000e+00	0	0	912	0.000000e+00	0	0	59572	0.000000e+00	0	0	29432	0.000000e+00	0	0	44878	0.000000e+00	0	0	63998	0.000000e+00	0	0	6074	0.000000e+00	0	2	1178868	1.696540e-06	0	0	90772	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	1	3216	3.109452736318408E-4	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	1	3330	3.003003003003003E-4	0	146	0	1	14708	6.799020940984498E-5	Leber_congenital_amaurosis_9	no_assertion_criteria_provided	NC_000001.11:g.9982678A>G	ClinGen:CA260592|OMIM:608700.0003|UniProtKB:Q9HAN9#VAR_068883	C1837873	608553	65	.	Asn	Asp	92.56	0.08917197452229299																																																																																																																																																																																																																																																																																																																																																																																																																																																																													14			92.56	Polar/Neutral	Asparagine		Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1								0.7997		-3.5								 N273-A277 (PAE:  3.0), N273-N167 (PAE: 2.0), N273-P269 (PAE: 1.5)	N273-P269 (PDBs: 1KQN, 1KQO, 1KR2, 8QE8)	 N273-L168 (PAE:  2.0), N273-A277 (PAE: 3.0), N273-N167 (PAE: 2.0), N273-P269 (PAE: 1.5)	N273-P269 (PDBs: 1KQN, 1KQO, 1KR2, 8QE8)							132									-69.9		Pocket 1: Mean pLDDT: 97.09, Volume: 1190.82 Å³, Druggability score: 0.8		-32.9						H (helix)	H (α-helix)	Helix											92.56	8.917197	>90	<10	608553	autosomal recessive	OMIM	Rare genetic eye disease; Ciliopathy	2	LEBER CONGENITAL AMAUROSIS 9	false	0.6027325636459974	0.5249413824809644	false	false	false
ALAS2	ALAS2_Gly254Ser	B_7-8	-0.5608277588560456	0.6140754769279635	0.6879085987873373	2.1789293238438487	0.1174669800969227	0.15254912135729168	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8017110272933192	0.7930290510305544	0.7958537834266243	0.7498285386196947	0.6685580314057805	0.7403507535746086	0.7403507535746086	0.6685580314057805	0.7498285386196947	0.7958537834266243	0.7930290510305544	0.8017110272933192							ALAS2	Gly254Ser	NC_000023.11:55017618:C:T	760G>A	23	55017618	C	T	X	ENSG00000158578	8420	216659	CCSBVarC003765	ALE00003765	ENSP00000337131.4	CEGS2	CegsMutGDEh1040	A08	GDEhDisVCh_40062	E07	2	CegsMutGDDh1040	A08	VUSN2Hmut_GDN2h_08	A06	VUSMutpDEST2_08	G03	VUSmut_GDEh08	A06	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25510.0	single nucleotide variant	NM_000032.5(ALAS2):c.871G>A (p.Gly291Ser)	212.0	ALAS2	HGNC:397	Pathogenic	1.0	Sep 21, 2005	137852302.0	-	RCV000011217	MONDO:MONDO:0020721,MedGen:C4551511,OMIM:300751,Orphanet:75563	X-linked sideroblastic anemia 1	germline	germline	GRCh38	NC_000023.11	X	55017618.0	55017618.0	Xp11.21	no assertion criteria provided	1.0	-	N	ClinGen:CA121079,OMIM:301300.0004	1.0	10471.0	55017618.0	C	T	-	-	-	-	-	-	871G>A 	Gly291Ser	NM_000032.5		Pathogenic	Pathogenic	10471	X	55017618.0	C	T	G	S	rs137852302	X	55044051	X	55060776	291	ALAS2	ENSG00000158578	ENST00000650242	ENSP00000497236	P22557	HEM0_HUMAN	c.871G>A	p.Gly291Ser	c.871G>A	p.Gly291Ser	principal1	Y	.	YES	Select	-	GGT	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.999	0.92348	D	.	0.97016	.	.	.	.	4.535	0.99063	H	.	0.89056	.	.	0.88561	1.0909	0.99274	D	0.9632	0.98818	D	9	0.99269235	0.99804	D	0.846395	0.98812	D	.	0.99874	0.968	0.99690	P22557	G291S	Gain of disorder (P = 0.0857)| Gain of phosphorylation at G291 (P = 0.0921)| Loss of methylation at R293 (P = 0.1519)| Loss of helix (P = 0.2022)| Gain of MoRF binding (P = 0.2219)	.	0.99919	.	.	.	.	0.839760422707	0.88038	D	0.983768	0.99888	D	0.707449	0.99933	D	0.778425	0.99933	D	0.999737322330475	0.98718	D	0.997552	0.99026	D	0.99357176	0.99919	0.98994774	0.99978	0.99359834	0.99920	0.9897704	0.99977	-11.862	0.84996	D	0.9756	0.90300	P	0.999846442051538	0.98301	0.99985075	0.99806	0.96	0.98304	.	.	.	.	.	.	4.997402	0.82924	27.9	0.99889807605531378	0.96438	.	.	.	.	.	.	.	.	.	5.43	5.43	0.78977	.	.	7.905	0.86513	7.646000	0.63501	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.999	0.91597	103	0.95731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	X-linked_sideroblastic_anemia_1	no_assertion_criteria_provided	NC_000023.11:g.55017618C>T	ClinGen:CA121079|OMIM:301300.0004	C4551511	300751	75563	Aminotransferase, class I/classII, large domain|Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase	Gly	Ser	97.3	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.3	0.0	>90	<10	300751	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare inborn errors of metabolism; Rare genetic skin disease	4	ANEMIA, SIDEROBLASTIC, 1	false	0.7930290510305544	0.8017110272933192	false	false	false
GMPPB	GMPPB_Pro32Leu	B_7-8	-0.7507795636889057	0.4811818724631499	0.5659220298057982	-1.6842023751331532	0.13601492233455295	0.1738073694177609	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8221599631723142	0.8220605727905383	0.8940235786758327	0.9166833745084992	0.8952413251560476	0.9205216737640383	0.9813032718167047	0.9650907424783589	0.9828337324147197	0.9681959696369252	0.92931843418457	0.9495168632111624	0.8597400757113717	0.8253919078337362	0.8505330166022789	0.8198511877147402	0.7148027113965065	0.694803063133466	GMPPB	Pro32Leu	NC_000003.12:49723632:G:A	95C>T	3	49723632	G	A	3	ENSG00000173540	3449	214608	CCSBVarC005211	ALE00005211	ENSP00000311130.6	CEGS2	CegsMutGDEh1034	F03	GDEhDisVCh_40031	E12	1	CegsMutGDDh1034	F03	VUSN2Hmut_GDN2h_06	F07	VUSMutpDEST2_03	A07	VUSmut_GDEh06	F07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	75125.0	single nucleotide variant	NM_021971.4(GMPPB):c.95C>T (p.Pro32Leu)	29925.0	GMPPB	HGNC:22932	Pathogenic	1.0	Jan 12, 2024	397509426.0	-	RCV000054438|RCV000209926|RCV000493576|RCV000684892	MONDO:MONDO:0014141,MedGen:C3809221,OMIM:615351|MONDO:MONDO:0014142,MedGen:C4518000,OMIM:615352,Orphanet:363623|MedGen:C3661900|MONDO:MONDO:0014141,MedGen:C3809221,OMIM:615351;MONDO:MONDO:0014142,MedGen:C4518000,OMIM:615352,Orphanet:363623;MONDO:MONDO:0014140,MedGen:C3809216,OMIM:615350,Orphanet:588	Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14|Autosomal recessive limb-girdle muscular dystrophy type 2T|not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14;Autosomal recessive limb-girdle muscular dystrophy type 2T;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14	germline;paternal	germline	GRCh38	NC_000003.12	3	49723632.0	49723632.0	3p21.31	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA090934,UniProtKB:Q9Y5P6#VAR_070144,OMIM:615320.0005	3.0	60544.0	49723632.0	G	A	-	-	-	-	-	-	95C>T 	Pro32Leu	NM_021971.4	2.0	Pathogenic	Pathogenic	60544	3	49723632.0	G	A	P	L	rs397509426	3	49761065	3	49736069	32	GMPPB	ENSG00000173540	ENST00000308388	ENSP00000311130	Q9Y5P6	GMPPB_HUMAN	c.95C>T	p.Pro32Leu	c.95C>T	p.Pro32Leu	principal1	Y	1	YES	Select	-	CCC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.994	0.82066	D	0.99	0.97926	A	simple_aae	1.0	99.0	5.11	0.99925	H	-8.2	0.96835	D	0.769	0.84569	1.0513	0.98141	D	0.9714	0.99099	D	10	0.9837215	0.98510	D	0.954602	0.99693	D	0.933	0.98451	0.884	0.97015	Q9Y5P6	P32L	Gain of ubiquitination at K31 (P = 0.0747)| Loss of catalytic residue at N30 (P = 0.1515)| Gain of helix (P = 0.2059)| Loss of loop (P = 0.2897)| Loss of methylation at K31 (P = 0.3011)	0.935686578602	0.93452	.	0.90143	.	0.86721	0.762626647949	0.76279	T	0.926256	0.98702	D	0.385782	0.88998	D	0.580801	0.96516	D	0.992536783218384	0.82903	D	0.994121	0.98068	D	0.9827808	0.99303	0.95158404	0.98471	0.97442853	0.98635	0.97411287	0.99625	-11.296	0.81315	D	0.9128	0.86143	P	0.990193903199805	0.88481	0.99981016	0.99752	0.988	0.99594	.	.	.	.	.	.	5.432053	0.90845	32.0	0.99847489818665991	0.92756	0.884622	0.81376	D	0.93315361089803	0.93249	11.94031	0.776625283953952	0.88060	9.466464	4.84	3.95	0.44887	.	.	7.3	0.78221	11.711000	0.94660	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	2	0.99503	.	.	.	.	.	.	.	.	.	.	.	.	11	264690	4.155805E-5	.	6	96902	6.191820e-05	0	18	184720	9.744480e-05	0	16	210554	7.599000e-05	0	0	7150	0.000000e+00	0	1	15258	6.553940e-05	0	0	1698	0.000000e+00	0	0	9036	0.000000e+00	0	0	11728	0.000000e+00	0	2	37246	5.369700e-05	0	0	13126	0.000000e+00	0	1	15258	6.553940e-05	0	0	15956	0.000000e+00	0	2	26988	7.410700e-05	0	0	4454	0.000000e+00	0	0	13390	0.000000e+00	0	0	14616	0.000000e+00	0	9	79414	1.133300e-04	0	0	25706	0.000000e+00	0	9	79414	1.133300e-04	0	0	14648	0.000000e+00	0	2	30330	6.594130e-05	0	0	6904	0.000000e+00	0	0	17082	0.000000e+00	0	0	18996	0.000000e+00	0	8	92138	8.682630e-05	0	0	25624	0.000000e+00	0	8	92138	8.682630e-05	0	.	110	1584344	6.942940e-05	0	7	56358	1.242060e-04	0	0	74148	0.000000e+00	0	0	912	0.000000e+00	0	7	56358	1.242060e-04	0	0	27320	0.000000e+00	0	0	44660	0.000000e+00	0	0	61664	0.000000e+00	0	0	5932	0.000000e+00	0	95	1165366	8.151950e-05	0	0	86854	0.000000e+00	0	2	15824	1.263902932254803E-4	0	122	0	0	146	0	0	3804	0	0	146	0	0	610	0	0	56	0	0	104	0	0	2878	0	0	3926	0	0	202	0	2	23690	8.442380751371887E-5	Muscular_dystrophy-dystroglycanopathy_(congenital_with_intellectual_disability),_type_B14|Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),_type_A14|Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2T|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.49723632G>A	ClinGen:CA090934|OMIM:615320.0005|UniProtKB:Q9Y5P6#VAR_070144	C3809221|C3809216|C4518000|C3661900	615351|615350|615352	588|363623	Nucleotidyl transferase domain|Mannose-1-phosphate guanyltransferase, N-terminal domain	Pro	Leu	96.03	0.16911764705882354																																																																																																																																																																																																																																																																																																																																																																																																																																																																													23			96.03	Special, No backbone hydrogen	Proline		Mannose-1-phosphate guanylyltransferase catalytic subunit beta										1.6									P32-H36 (PDBs: 7D72, 7D73, 7D74)	 P32-H36 (PAE:  1.0)	P32-H36 (PDBs: 7D72, 7D73, 7D74)							115									-51.4				138.0	Substrate-binding domain					B (undefined)	E (parallel sheets)	Beta strand											96.03	16.911764	>90	10-90	615351;615352;615351;615352;615350	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14	false	0.8220605727905383	0.8221599631723142	false	false	false
FBP1	FBP1_Phe194Ser	B_7-8	-4.374858083000476	0.004694261050594037	0.015096486097988653	-5.549843049324048	0.0008600566765277423	0.0021098983976315603	2024_01_Batch_7-8		true	false	false	false	false		true	false	false	false	false		0.9847667942580087	0.7474608430800227	0.6992328621158367	0.6514682108861946	0.7492248271944555	0.774155068176932	0.6858328878761019	0.759867522575072	0.8200250254000138	0.9877173588304309		0.7242945862119788	0.6171035338962872	0.6385982016566014	0.6748966607600316	0.9818162296855865		FBP1	Phe194Ser	NC_000009.12:94606939:A:G	581T>C	9	94606939	A	G	9	ENSG00000165140	2654	4169	CCSBVarC000306	ALE00000306	ENSP00000364475.5	RC4	RC4_Mut_GDEh1017	G01	GDEhDisVCh_40075	F07	1	RC4_Mut_GDDh1017	G01	NULL	NULL	VUSMutpDEST2_02	G01	VUSmut_GDEh13	E01	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	15910.0	single nucleotide variant	NM_000507.4(FBP1):c.581T>C (p.Phe194Ser)	2203.0	FBP1	HGNC:3606	Pathogenic	1.0	Jul 01, 2002	121918191.0	-	RCV000000919	MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348	Fructose-biphosphatase deficiency	germline	germline	GRCh38	NC_000009.12	9	94606939.0	94606939.0	9q22.32	no assertion criteria provided	1.0	-	N	ClinGen:CA114590,UniProtKB:P09467#VAR_038812,OMIM:611570.0005	1.0	871.0	94606939.0	A	G	-	-	-	-	-	-	581T>C 	Phe194Ser	NM_000507.4		Pathogenic	Pathogenic	871	9	94606939.0	A	G	F	S	rs121918191	9	97369221	9	96409042	194	FBP1	ENSG00000165140	ENST00000375326	ENSP00000364475	P09467	F16P1_HUMAN	c.581T>C	p.Phe194Ser	c.581T>C	p.Phe194Ser	principal1	Y	1	YES	Select	-	TTC	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.445	0.98779	H	-7.88	0.96158	D	0.94	0.94679	0.9504	0.96389	D	0.8156	0.93772	D	9	0.9832521	0.98435	D	0.349613	0.92216	D	0.962	0.99434	0.909	0.98139	P09467	F194S	Loss of stability (P = 0.0386)| Loss of catalytic residue at F194 (P = 0.0423)| Gain of disorder (P = 0.054)| Gain of loop (P = 0.1069)| Loss of methylation at K199 (P = 0.1079)	0.983704287733	0.98335	.	0.98161	.	0.84108	0.729681253433	0.71409	T	0.905548	0.98160	D	0.453472	0.92579	D	0.413604	0.92487	D	0.999880075454712	0.99520	D	.	0.98468	.	0.99225336	0.99868	0.9801531	0.99819	0.9930441	0.99900	0.9751153	0.99663	-12.121	0.85475	D	0.9972	0.96786	LP	0.993765556179993	0.90236	0.60030705	0.84003	0.989	0.99628	.	.	.	.	.	.	5.304309	0.89069	29.8	0.9987614909715834	0.95331	0.975339	0.99611	D	1.06429390741259	0.97400	16.08829	0.94658397002594	0.97285	15.90173	5.39	5.39	0.77583	.	.	9.325	0.96016	11.101000	0.86142	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	834	0.38591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614144	6.195230e-07	0	1	44880	2.228160e-05	0	0	75050	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29602	0.000000e+00	0	1	44880	2.228160e-05	0	0	64038	0.000000e+00	0	0	6062	0.000000e+00	0	0	1179998	0.000000e+00	0	0	91082	0.000000e+00	0	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50	0	0	426	0	0	0	0	0	476	0	Fructose-biphosphatase_deficiency	no_assertion_criteria_provided	NC_000009.12:g.94606939A>G	ClinGen:CA114590|OMIM:611570.0005|UniProtKB:P09467#VAR_038812	C0016756	229700	348	.	Phe	Ser	97.78	0.02030456852791878																																																																																																																																																																																																																																																																																																																																																																																																																																																																													4			97.78	Aromatic	Phenylalanine		Fructose-1,6-bisphosphatase 1										2.8								 F194-L14 (PAE:  1.0)	F194-L14 (PDBs: 2JJK, 2VT5, 2WBB, 2WBD, 2Y5K, 2Y5L, 3A29, 3KBZ, 3KC0, 3KC1, 4MJO, 5LDZ, 6LW2, 7C9Q, 7CVH, 7CVN, 7CWE, 7EZF, 7EZP, 7EZR)		F194-L187 (PDBs: 7CVH)							165									-89.3				113.7						B (undefined)	E (parallel sheets)	Beta strand											97.78	2.0304568	>90	<10	229700	autosomal recessive	OMIM	Rare inborn errors of metabolism	1	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	false	0.9847667942580087		true		true
SMAD3	SMAD3_Arg279Lys	B_15-16	-3.2062341702157955	0.29355315691956263	0.33327612663773726	0.18364390332568642	0.8594991609237606	0.8860567192669104	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8049337322386252	0.7940861240737512	0.6942202659588732	0.7123195511682215	0.7331350629355939	0.7314922660431984	0.7798657997095039	0.7673547478463162	0.6983172825124726	0.764624212899957	0.7446960098561946	0.7652990494276096	0.683118732376893	0.6989153780248716	0.7263218198239705	0.6238163190177896	0.8434762382913079	0.8445684150496406	SMAD3	Arg279Lys	NC_000015.10:67181418:G:A	836G>A	15	67181418	G	A	15	ENSG00000166949	11805	2156	CCSBVarC004696	ALE00004696	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	G02	GDEhDisVCh_40014	D09	2	VUSMutGDDh005	G02	VUSN2Hmut_GDN2h_01	A12	VUSMutpDEST2_09	C05	VUSmut_GDEh01	A12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	39266.0	single nucleotide variant	NM_005902.4(SMAD3):c.836G>A (p.Arg279Lys)	4088.0	SMAD3	HGNC:6769	Pathogenic	1.0	Sep 02, 2011	387906852.0	-	RCV000023245	MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984	Aneurysm-osteoarthritis syndrome	germline	germline	GRCh38	NC_000015.10	15	67181418.0	67181418.0	15q22.33	no assertion criteria provided	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020124,UniProtKB:P84022#VAR_067048,OMIM:603109.0005	1.0	30310.0	67181418.0	G	A	-	-	-	-	-	-	836G>A 	Arg279Lys	NM_005902.4		Pathogenic	Pathogenic	30310	15	67181418.0	G	A	R	K	rs387906852	15	67473756	15	65260810	279	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.836G>A	p.Arg279Lys	c.836G>A	p.Arg279Lys	principal1	Y	1	YES	Select	+	AGG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.93	0.95575	A	simple_aae	7.0	93.0	3.3	0.90350	M	-2.89	0.61467	D	0.97	0.98079	1.0912	0.99286	D	0.9719	0.99116	D	10	0.9830497	0.98700	D	0.639075	0.96914	D	0.949	0.99024	0.914	0.98337	P84022	R279K	Gain of ubiquitination at R279 (P = 0.0138)| Gain of methylation at R279 (P = 0.0321)| Loss of MoRF binding (P = 0.0828)| Loss of stability (P = 0.2212)| Gain of disorder (P = 0.2378)	0.989748482218	0.98952	0.9393822060552726	0.93881	2.35524105362	0.96825	0.936728715897	0.99323	D	0.985167	0.99905	D	0.578706	0.96947	D	0.593494	0.96897	D	0.99406898021698	0.85027	D	0.973003	0.90270	D	0.9544752	0.96668	0.8679038	0.92624	0.9565279	0.96879	0.88299984	0.93688	-10.401	0.78424	D	0.9934	0.96584	P	0.999639519312274	0.97271	0.99522310	0.97730	0.984	0.99450	.	.	.	.	.	.	5.637023	0.92725	32.0	0.99772724841805271	0.86100	0.898062	0.84034	D	0.971208277116616	0.94760	13.04119	0.900147121987621	0.95555	13.75796	5.1	5.1	0.68875	3.79	0.69847	9.87	0.98471	11.739000	0.95160	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.657	0.32926	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Aneurysm-osteoarthritis_syndrome	no_assertion_criteria_provided	NC_000015.10:g.67181418G>A	ClinGen:CA020124|OMIM:603109.0005|UniProtKB:P84022#VAR_067048	C3151087	613795	284984	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Arg	Lys	97.96	0.2217741935483871																																																																																																																																																																																																																																																																																																																																																																																																																																																																													55			97.96	Positively-charged	Arginine		Mothers against decapentaplegic homolog 3							MH2			-4.5								 R279-L274 (PAE:  1.5), R279-E239 (PAE: 1.5)	R279-L274 (PDBs: 1MJS, 1MK2, 5XOC), R279-E239 (PDBs: 1MJS, 5XOC)	 R279-E239 (PAE:  1.5)	R279-E239 (PDBs: 1MJS, 5XOC), R279-E284 (PDBs: 1MK2)	 R279-E239 (PAE:  1.5)						175									-68.2				122.7	Sufficient for interaction with XPO4			dbSNP: rs387906852; Variant type: LP/P; AA change: Arg279Lys; PTM type: Phosphorylation; PTM morphology: CLGLLsNVNR*N; Var class: II		C (loop/coil)	C (loop/coil)												97.96	22.17742	>90	10-90	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	false	0.7940861240737512	0.8049337322386252	false	false	false
PNKP	PNKP_Glu326Lys	B_15-16	-4.147863331311847	0.004306586193532413	0.014305355877646796	-5.963346045033627	0.0005624907560412809	0.0015156689241347292	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8158967703791502	0.8237217410085003	0.6860579398549145	0.7005926207464332	0.7125867452780418	0.7119525817391554	0.5940833485009019	0.5869070760066437	0.5402264379423332	0.6104150198702533	0.7279132378450542	0.7325299775809397	0.8298218149774089	0.8382664145494398	0.8609588035505333	0.7617008598395756	0.9195302441719463	0.8992635631773608	PNKP	Glu326Lys	NC_000019.10:49862424:C:T	976G>A	19	49862424	C	T	19	ENSG00000039650	9905	216952	CCSBVarC004010	ALE00004010	ENSP00000323511.2	CEGS2	CegsMutGDEh1033	A11	GDEhDisVCh_40018	E01	2	CegsMutGDDh1033	A11	VUSN2Hmut_GDN2h_06	C06	VUSMutpDEST2_08	E09	VUSmut_GDEh06	C06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	6.0	Y	Y	Y	N	Y	19885.0	single nucleotide variant	NM_007254.4(PNKP):c.976G>A (p.Glu326Lys)	11284.0	PNKP	HGNC:9154	Pathogenic	1.0	Nov 20, 2022	267606956.0	-	RCV000005119|RCV000188441|RCV001813953|RCV002512794	MONDO:MONDO:0013254,MedGen:C3150667,OMIM:613402,Orphanet:1934|MedGen:C3661900|Human Phenotype Ontology:HP:0000707,Human Phenotype Ontology:HP:0001333,Human Phenotype Ontology:HP:0006987,MONDO:MONDO:0002320,MedGen:C0497552|MONDO:MONDO:0013389,MedGen:C3150988,OMIM:613722	Microcephaly, seizures, and developmental delay|not provided|Abnormality of the nervous system|Developmental and epileptic encephalopathy, 12	germline	germline	GRCh38	NC_000019.10	19	49862424.0	49862424.0	19q13.33	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA250516,UniProtKB:Q96T60#VAR_063836,OMIM:605610.0001	3.0	4846.0	49862424.0	C	T	-	-	-	-	-	-	976G>A 	Glu326Lys	NM_007254.4	2.0	Pathogenic	Pathogenic	4846	19	49862424.0	C	T	E	K	rs267606956	19	50365681	19	55057493	326	PNKP	ENSG00000039650	ENST00000596014	ENSP00000472300	Q96T60	PNKP_HUMAN	c.976G>A	p.Glu326Lys	c.976G>A	p.Glu326Lys	principal1	Y	1	.	.	-	GAG	1	0	C	C/C	C/C	C/C	C/C	.	0.56615	.	0.03	0.67073	D	1.0	0.90580	D	0.987	0.77493	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.975	0.96541	H	.	0.62369	.	0.941	0.94798	0.3182	0.87796	D	0.5860	0.85095	D	10	0.98058724	0.98017	D	0.895115	0.99205	D	.	0.88582	0.889	0.97257	Q96T60	E326K	Gain of methylation at E326 (P = 0.0061)| Gain of sheet (P = 0.0149)| Gain of ubiquitination at E326 (P = 0.0258)| Loss of loop (P = 0.0374)| Loss of helix (P = 0.079)	0.847155551282	0.84448	.	0.91507	.	0.48656	0.876164495945	0.93428	D	0.603971	0.87231	D	0.347454	0.86238	D	0.261317	0.86057	D	0.994795739650726	0.86198	D	0.98999	0.96908	D	0.7257512	0.79240	0.5859781	0.75743	0.7476898	0.80503	0.59809154	0.76416	-12.236	0.86018	D	0.5966	0.75870	P	0.972175097940766	0.83670	0.44017547	0.80549	0.459	0.68744	.	.	.	.	.	.	4.156228	0.62452	24.5	0.99919958047750035	0.98655	0.837762	0.75446	D	0.737357779696476	0.81981	7.674985	0.634799345421949	0.77359	6.688079	5.11	5.11	0.69146	5.11	0.91052	3.567	0.53649	5.580000	0.49042	0.597	0.3436	1.0	0.71675	1.000000	0.68239	0.191	0.21676	590	0.68875	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1577052	6.340950e-07	0	1	1161202	8.611770e-07	0	0	74236	0.000000e+00	0	0	912	0.000000e+00	0	0	54540	0.000000e+00	0	0	28886	0.000000e+00	0	0	42968	0.000000e+00	0	0	60910	0.000000e+00	0	0	5966	0.000000e+00	0	1	1161202	8.611770e-07	0	0	86372	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	3134	0	0	146	0	0	610	0	0	24	0	0	94	0	0	522	0	0	3242	0	0	108	0	0	12340	0	not_provided|Developmental_and_epileptic_encephalopathy,_12|Microcephaly,_seizures,_and_developmental_delay|Abnormality_of_the_nervous_system	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.49862424C>T	ClinGen:CA250516|OMIM:605610.0001|UniProtKB:Q96T60#VAR_063836	C3661900|C3150988|C3150667|C0497552	613722|613402	1934	Polynucleotide 3'-phosphatase	Glu	Lys	98.1	0.16494845360824742																																																																																																																																																																																																																																																																																																																																																																																																																																																																													32			98.1	Negatively-charged	Glutamic Acid		Bifunctional polynucleotide phosphatase/kinase										-3.5								 E326-A334 (PAE:  2.0)		 E326-K330 (PAE:  1.0)								146									-61.4				-44.9	Phosphatase					H (helix)	H (α-helix)												98.1	16.494844	>90	10-90	613402;613722	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12	false	0.8237217410085003	0.8158967703791502	false	false	false
STAR	STAR_Arg182Leu	B_7-8	11.886087235395921	0.001280550825604212	0.005622648452652978	4.115429407348154	0.004485222901084754	0.008537742762956975	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6594207117425712	0.6648468020429843	0.7473711817507893	0.6722694459722789	0.7070000130466405	0.8372174313346923	0.8372174313346923	0.8764893555212001	0.7875129284724163	0.7473711817507893	0.8021287933586821	0.7788650651702123		0.5375106705720809	0.5570259634721414		0.5275648107272863	0.5399763583149302	STAR	Arg182Leu	NC_000008.11:38146068:C:A	545G>T	8	38146068	C	A	8	ENSG00000147465	386	213661	CCSBVarC005622	ALE00005622	ENSP00000276449.3	CEGS2	CegsMutGDEh1032	A10	GDEhDisVCh_40077	E04	1	CegsMutGDDh1032	A10	VUSN2Hmut_GDN2h_06	F01	VUSMutpDEST2_01	F07	VUSmut_GDEh06	F01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	24027.0	single nucleotide variant	NM_000349.3(STAR):c.545G>T (p.Arg182Leu)	6770.0	STAR	HGNC:11359	Pathogenic	1.0	Oct 17, 2024	104894086.0	-	RCV000009551|RCV004700211	MONDO:MONDO:0008725,MedGen:C0342474,OMIM:201710,Orphanet:418,Orphanet:90790|MedGen:C3661900	Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided	germline	germline	GRCh38	NC_000008.11	8	38146068.0	38146068.0	8p11.23	criteria provided, single submitter	2.0	-	N	ClinGen:CA120036,UniProtKB:P49675#VAR_005627,OMIM:600617.0003	3.0	8988.0	38146068.0	C	A	-	-	-	-	-	-	545G>T 	Arg182Leu	NM_000349.3	1.0	Pathogenic	Pathogenic	8988	8	38146068.0	C	A	R	L	rs104894086	8	38003586	8	38122743	182	STAR	ENSG00000147465	ENST00000276449	ENSP00000276449	P49675	STAR_HUMAN	c.545G>T	p.Arg182Leu	c.545G>T	p.Arg182Leu	principal1	Y	1	YES	Select	-	CGT	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.003	0.76775	D	1.0	0.90580	D	1.0	0.97365	D	0.92	0.93300	A	simple_aae	8.0	92.0	3.035	0.86364	M	-6.15	0.90195	D	0.993	0.99866	0.3947	0.88973	D	0.6181	0.86478	D	10	0.9938531	0.99904	D	0.346542	0.92139	D	0.921	0.98001	0.997	0.99969	P49675	R182L	Loss of MoRF binding (P = 0.0377)| Gain of catalytic residue at R182 (P = 0.2929)| Loss of disorder (P = 0.3212)| Loss of sheet (P = 0.3635)| Loss of loop (P = 0.4412)	0.961282077946	0.96052	0.9609466958234353	0.96057	0.933879907611	0.71780	0.801340579987	0.82135	T	0.916352	0.98448	D	0.489881	0.93942	D	0.465903	0.93865	D	0.999663472175598	0.98376	D	0.965403	0.87234	D	0.9673835	0.97979	0.9338453	0.97319	0.96038914	0.97277	0.93256027	0.97231	-13.818	0.92465	D	0.9729	0.89848	P	0.997293984920465	0.92980	0.96282730	0.94145	0.983	0.99413	.	.	.	.	.	.	5.454172	0.91101	32.0	0.99867453915666116	0.94551	0.895218	0.83440	D	0.660176746414883	0.76904	6.596691	0.678612417129408	0.80654	7.370631	5.84	5.84	0.93363	4.84	0.88298	7.316	0.78371	7.678000	0.65201	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.891	0.42933	121	0.95159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Congenital_lipoid_adrenal_hyperplasia_due_to_STAR_deficency	no_assertion_criteria_provided	NC_000008.11:g.38146068C>A	ClinGen:CA120036|OMIM:600617.0003|UniProtKB:P49675#VAR_005627	C0342474	201710	418|90790	START domain|START domain|START domain	Arg	Leu	94.76	0.05241935483870968																																																																																																																																																																																																																																																																																																																																																																																																																																																																													13			94.76	Positively-charged	Arginine		Steroidogenic acute regulatory protein, mitochondrial							START	0.9709		-4.5								 R182-A171 (PAE:  1.0), R182-K248 (PAE: 1.5), R182-L247 (PAE: 1.0)	R182-A171 (PDBs: 3P0L), R182-L247 (PDBs: 3P0L)		R182-A171 (PDBs: 3P0L)							175									-122.5		Pocket 1: Mean pLDDT: 96.54, Volume: 773.88 Å³, Druggability score: 0.97		142.9						B (undefined)	E (parallel sheets)	Beta strand											94.76	5.2419353	>90	<10	201710	autosomal recessive	OMIM	Rare genetic gynecological and obstetrical diseases; Rare genetic developmental defect during embryogenesis; Rare genetic urogenital disease; Rare genetic endocrine disease; Genetic infertility	5	LIPOID CONGENITAL ADRENAL HYPERPLASIA	false	0.6648468020429843	0.6594207117425712	false	false	false
THAP1	THAP1_His23Pro	B_7-8	1.5510308051558104	0.18159101452039927	0.2607810810029794	-8.257393674280701	0.0004247733424477858	0.0012198107721309657	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8835506230992112	0.8787443918603204	0.5887690450994716	0.5392458554583395	0.5862210572612652	0.6122522102827885	0.6461030053376972	0.5726983538371367	0.5865508444462871	0.6384330483529531	0.9176617944764569	0.9251703457409978	0.57840141522788	0.5997437606853935	0.4919408664703919	0.5391050418459901	0.839826989244184	0.8419309004574247	THAP1	His23Pro	NC_000008.11:42843027:T:G	68A>C	8	42843027	T	G	8	ENSG00000131931	1668	214083	CCSBVarC005991	ALE00005991	ENSP00000254250.3	CEGS2	CegsMutGDEh1031	B10	GDEhDisVCh_40085	E03	1	CegsMutGDDh1031	B10	VUSN2Hmut_GDN2h_05	H09	VUSMutpDEST2_01	D09	VUSmut_GDEh05	H09	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	40311.0	single nucleotide variant	NM_018105.3(THAP1):c.68A>C (p.His23Pro)	55145.0	THAP1	HGNC:20856	Pathogenic	1.0	Feb 01, 2012	387907177.0	-	RCV000024330	MONDO:MONDO:0011264,MedGen:C1414216,OMIM:602629,Orphanet:98806	Torsion dystonia 6	germline	germline	GRCh38	NC_000008.11	8	42843027.0	42843027.0	8p11.21	no assertion criteria provided	1.0	-	N	ClinGen:CA129856,UniProtKB:Q9NVV9#VAR_066684,OMIM:609520.0009	1.0	31632.0	42843027.0	T	G	-	-	-	-	-	-	68A>C 	His23Pro	NM_018105.3		Pathogenic	Pathogenic	31632	8	42843027.0	T	G	H	P	rs387907177	8	42698170	8	42817327	23	THAP1	ENSG00000131931	ENST00000254250	ENSP00000254250	Q9NVV9	THAP1_HUMAN	c.68A>C	p.His23Pro	c.68A>C	p.His23Pro	principal1	Y	1	YES	Select	-	CAC	2	0	T	T/T	T/T	T/T	T/T	0.003	0.91343	D	0.013	0.92967	D	0.978	0.62341	D	0.878	0.62305	P	0.81	0.92786	A	simple_aae	19.0	81.0	3.72	0.94692	H	-8.86	0.98724	D	0.983	0.99270	1.0839	0.99009	D	0.9748	0.99211	D	10	0.9738282	0.97649	D	0.838326	0.98746	D	0.957	0.99285	0.816	0.93022	Q9NVV9	H23P	Gain of disorder (P = 0.0191)| Gain of phosphorylation at S21 (P = 0.1042)| Loss of sheet (P = 0.1158)| Loss of ubiquitination at K18 (P = 0.1268)| Loss of stability (P = 0.1608)	0.967000810385	0.96634	0.951724743571633	0.95126	1.76827272956	0.91220	0.774694263935	0.78089	T	0.898968	0.97983	D	0.571442	0.96601	D	0.583061	0.96544	D	0.98958694934845	0.79659	D	0.865913	0.56473	D	0.9873935	0.99611	0.9891234	0.99972	0.98960227	0.99739	0.99155855	0.99988	-14.727	0.95190	D	0.9982	0.97565	P	0.977405338039553	0.84720	0.22903877	0.74338	0.994	0.99793	.	.	.	.	.	.	5.620125	0.92608	32.0	0.92010759884951521	0.21598	0.871078	0.79153	D	0.866874791851532	0.89992	10.22968	0.790521758645971	0.89068	9.84892	5.24	5.24	0.72825	.	.	6.658	0.74317	6.049000	0.53148	0.605	0.46302	1.0	0.71675	1.000000	0.68239	0.964	0.52647	298	0.88077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Torsion_dystonia_6	no_assertion_criteria_provided	NC_000008.11:g.42843027T>G	ClinGen:CA129856|OMIM:609520.0009|UniProtKB:Q9NVV9#VAR_066684	C1414216	602629	98806	THAP-type zinc finger|THAP-type zinc finger|THAP-type zinc finger|THAP-type zinc finger	His	Pro	86.11	0.059782608695652176																																																																																																																																																																																																																																																																																																																																																																																																																																																																													11			86.11	Positively-charged	Histidine		THAP domain-containing protein 1								0.5361		-3.2								 H23-I53 (PAE:  1.0)	H23-I53 (PDBs: 2JTG)	 H23-I53 (PAE:  1.0)	H23-I53 (PDBs: 2JTG), H23-L71 (PDBs: 2JTG)							155									-103.4		Pocket 2: Mean pLDDT: 70.11, Volume: 491.24 Å³, Druggability score: 0.54		125.8				dbSNP: rs387907177; Variant type: LP/P; AA change: His23Pro; PTM type: Phosphorylation; PTM morphology: KDkPVsFH*KFP; Var class: II&rs387907177		B (undefined)	E (parallel sheets)	Beta strand										THAP-type	86.11	5.978261	70-90	<10	602629	autosomal dominant	OMIM	Rare genetic neurological disorder	1	DYSTONIA 6, TORSION	false	0.8787443918603204	0.8835506230992112	false	false	false
DCX	DCX_Met1Thr	B_7-8	-1.445924077559005	0.19144128746898986	0.27125583016748567	3.3301546771649275	0.012588403281716431	0.020866955756052078	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.569224004363551	0.6799187525395987	0.8345846671541385	0.53879453084915	0.5034439728717359	0.83007652225488	0.8930436951673848	0.5296323084663039	0.5801949183343063	0.8900717223993109	0.683489014589043	0.6388416224663039	0.7671093493423752	0.47725563727716797	0.4973941433639938	0.7790976119089661	0.6763484904901542	0.499606386260798	DCX	Met1Thr	NC_000023.11:111410397:A:G	2T>C	23	111410397	A	G	X	ENSG00000077279	8416	216625	CCSBVarC005180	ALE00005180	ENSP00000419861.1	CEGS2	CegsMutGDEh1044	B12	GDEhDisVCh_40049	F09	1	CegsMutGDDh1044	B12	VUSN2Hmut_GDN2h_09	H07	VUSMutpDEST2_07	E11	VUSmut_GDEh09	H07	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	169936.0	single nucleotide variant	NM_001195553.2(DCX):c.2T>C (p.Met1Thr)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	Feb 08, 2013	587783539.0	-	RCV000145831	MedGen:C0008519	Ectopic tissue	germline	germline	GRCh38	NC_000023.11	X	111410397.0	111410397.0	Xq23	criteria provided, single submitter	1.0	-	N	ClinGen:CA171917	2.0	158450.0	111410397.0	A	G	-	-	-	-	-	-	2T>C 	Met1Thr	NM_001195553.2	1.0	Pathogenic	Pathogenic	158450	X	111410397.0	A	G	M	T	rs587783539	X	110653625	X	110540281	1	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.2T>C	p.Met1?	c.2T>C	p.Met1?	alternative1	Y	1	.	.	-	ATG	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	.	.	.	.	.	.	.	0.97016	.	.	.	.	.	.	.	.	0.23537	.	.	0.95970	-0.9945	0.31324	T	0.1034	0.37834	T	10	0.7664217	0.76513	D	0.106532	0.78151	D	.	0.76955	.	.	.	.	.	.	0.97780	.	0.76597	.	.	0.782644867897	0.79290	T	.	0.38478	.	0.279151	0.81106	D	0.163204	0.80863	D	0.880308747291565	0.52772	D	0.9	0.64967	D	0.91608554	0.92764	0.8737769	0.93035	0.9051757	0.91732	0.86458665	0.92393	-13.209	0.90225	D	.	.	.	0.999999270648967	0.99831	.	.	0.935	0.96837	.	.	.	.	.	.	3.402158	0.47238	22.4	0.98237696620378012	0.39588	.	.	.	.	.	.	.	.	.	5.25	5.25	0.73133	.	.	8.718	0.9117	11.133000	0.86872	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.999	0.91597	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Ectopic_tissue	criteria_provided,_single_submitter	NC_000023.11:g.111410397A>G	ClinGen:CA171917	C0008519	.	.	.	Met	Thr	48.99	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													239			48.99	Aliphatic	Methionine		Neuronal migration protein doublecortin										1.9																		149									360.0				130.4						C (loop/coil)	C (loop/coil)												48.99	100.0	$\leqslant$50	$\geqslant$90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.6799187525395987	0.569224004363551	false	false	false
ALAS2	ALAS2_Ser531Gly	B_7-8	-2.1726529262997714	0.11816118482549298	0.18709605481791203	-0.24476474180343047	0.8186821993085688	0.8511511817174072	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5792226560225685	0.6496665222934112	0.8402613182800451	0.5941009873736255	0.6358056117654574	0.8486485862162673	0.8486485862162673	0.6941017910701426	0.6656923706453398	0.8402613182800451	0.6496665222934112	0.5792226560225685		0.5775094324607722	0.5225096041019112				ALAS2	Ser531Gly	NC_000023.11:55009242:T:C	1591A>G	23	55009242	T	C	X	ENSG00000158578	8420	216668	CCSBVarC003771	ALE00003771	ENSP00000337131.4	CEGS2	CegsMutGDEh1042	F05	GDEhDisVCh_40062	E09	2	CegsMutGDDh1042	F05	VUSN2Hmut_GDN2h_08	G11	VUSMutpDEST2_08	F04	VUSmut_GDEh08	G11	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25515.0	single nucleotide variant	NM_000032.5(ALAS2):c.1702A>G (p.Ser568Gly)	212.0	ALAS2	HGNC:397	Pathogenic	1.0	Jul 01, 1999	137852306.0	-	RCV000011222	MONDO:MONDO:0020721,MedGen:C4551511,OMIM:300751,Orphanet:75563	X-linked sideroblastic anemia 1	germline	germline	GRCh38	NC_000023.11	X	55009242.0	55009242.0	Xp11.21	no assertion criteria provided	1.0	-	N	ClinGen:CA121088,OMIM:301300.0009	1.0	10476.0	55009242.0	T	C	-	-	-	-	-	-	1702A>G 	Ser568Gly	NM_000032.5		Pathogenic	Pathogenic	10476	X	55009242.0	T	C	S	G	rs137852306	X	55035675	X	55052400	568	ALAS2	ENSG00000158578	ENST00000650242	ENSP00000497236	P22557	HEM0_HUMAN	c.1702A>G	p.Ser568Gly	c.1702A>G	p.Ser568Gly	principal1	Y	.	YES	Select	-	AGT	1	0	T	T/T	T/T	T/T	T/T	.	0.72322	.	.	0.76775	.	0.997	0.70687	D	0.928	0.66273	D	.	0.97016	.	.	.	.	2.265	0.64249	M	.	0.53921	.	.	0.77416	1.1139	0.99886	D	0.9348	0.97849	D	9	0.8959279	0.88823	D	0.903066	0.99270	D	.	0.98376	0.625	0.75933	P22557	S568G	Loss of helix (P = 0.028)| Gain of loop (P = 0.0435)| Loss of disorder (P = 0.1786)| Gain of catalytic residue at M567 (P = 0.3333)| Loss of stability (P = 0.3582)	.	0.99880	.	.	.	.	0.669497728348	0.62706	T	0.705098	0.91461	D	0.605946	0.97687	D	0.632623	0.97651	D	0.954530835151672	0.64065	D	0.926607	0.72925	D	0.81362695	0.84597	0.7426648	0.84605	0.7895504	0.83036	0.6845266	0.81241	-4.654	0.33839	T	0.1915	0.41113	B	0.9617140156423	0.81964	0.99972290	0.99643	0.938	0.97019	.	.	.	.	.	.	4.25215	0.64619	24.7	0.99858772428936671	0.93734	.	.	.	.	.	.	.	.	.	5.39	5.39	0.77583	.	.	8.017	0.8876	7.852000	0.71055	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.997	0.79771	106	0.95645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	1	426	0.002347417840375587	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	1	426	0.002347417840375587	0	0	0	1	478	0.0020920502092050207	X-linked_sideroblastic_anemia_1	no_assertion_criteria_provided	NC_000023.11:g.55009242T>C	ClinGen:CA121088|OMIM:301300.0009	C4551511	300751	75563	.	Ser	Gly	65.8	0.43846153846153846																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																65.8	43.846153	50-70	10-90	300751	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare inborn errors of metabolism; Rare genetic skin disease	4	ANEMIA, SIDEROBLASTIC, 1	false	0.6496665222934112	0.5792226560225685	false	false	false
AGXT	AGXT_Pro319Leu	B_7-8	-2.470719277441793	0.09000698519077265	0.15066901114318645	-3.1228366298739574	0.035429397046837875	0.0523032530820173	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6927096024799801	0.7363891770239229	0.6136722629873116	0.6098678528557362	0.6024591195682194	0.5909071779554053	0.5909071779554053	0.6024591195682194	0.6098678528557362	0.6136722629873116	0.7363891770239229	0.6927096024799801							AGXT	Pro319Leu	NC_000002.12:240878035:C:T	956C>T	2	240878035	C	T	2	ENSG00000172482	70497	3878	CCSBVarC008228	ALE00008214	ENSP00000302620.3	Edgotyping3	VUSMutGDEh005	F06	GDEhDisVCh_40002	E11	2	VUSMutGDDh005	F06	VUSN2Hmut_GDN2h_02	F02	VUSMutpDEST2_14	A11	VUSmut_GDEh02	F02	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	200588.0	single nucleotide variant	NM_000030.3(AGXT):c.956C>T (p.Pro319Leu)	189.0	AGXT	HGNC:341	Pathogenic	1.0	Nov 27, 2014	180177299.0	-	RCV000186347	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598	Primary hyperoxaluria, type I	germline	germline	GRCh38	NC_000002.12	2	240878035.0	240878035.0	2q37.3	no assertion criteria provided	1.0	-	N	ClinGen:CA275767	2.0	204140.0	240878035.0	C	T	-	-	-	-	-	-	956C>T 	Pro319Leu	NM_000030.3		Pathogenic	Pathogenic	204140	2	240878035.0	C	T	P	L	rs180177299	2	241817452	2	241466125	319	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.956C>T	p.Pro319Leu	c.956C>T	p.Pro319Leu	principal1	Y	1	YES	Select	+	CCC	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.008	0.68204	D	0.998	0.73231	D	0.964	0.71005	D	0.81	0.87956	A	simple_aae	19.0	81.0	.	.	.	-8.11	0.96705	D	0.869	0.86590	1.0858	0.99076	D	0.9106	0.97031	D	9	0.9943377	0.99937	D	0.754975	0.98046	D	0.857	0.95607	0.905	0.97974	P21549	P319L	Gain of sheet (P = 0.0477)| Loss of glycosylation at T322 (P = 0.133)| Loss of loop (P = 0.2897)| Loss of catalytic residue at L316 (P = 0.3841)| Loss of phosphorylation at T320 (P = 0.4024)	0.974790511527	0.97427	0.9678643271074578	0.96756	0.246014848544	0.26838	0.609181404114	0.54133	T	0.857179	0.96774	D	0.482241	0.93722	D	0.454929	0.93642	D	0.998080849647522	0.93130	D	0.944506	0.78943	D	0.93461895	0.94621	0.82848805	0.89958	0.93461895	0.94621	0.82848805	0.89958	-11.21	0.80858	D	0.2856	0.51781	B	0.971831662125352	0.83607	0.59514290	0.83897	0.967	0.98682	.	.	.	.	.	.	4.363637	0.67187	25.1	0.99820368646051572	0.90334	0.906974	0.85992	D	0.539271352578224	0.69267	5.355934	0.355114291814955	0.58596	4.054658	4.36	3.45	0.38530	1.24	0.31442	5.3	0.65593	5.584000	0.49053	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.28	0.24065	976	0.04721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Primary_hyperoxaluria,_type_I	no_assertion_criteria_provided	NC_000002.12:g.240878035C>T	ClinGen:CA275767	C0268164	259900	416|93598	Aminotransferase class V domain	Pro	Leu	98.89	0.125																																																																																																																																																																																																																																																																																																																																																																																																																																																																													17			98.89	Special, No backbone hydrogen	Proline		Alanine--glyoxylate aminotransferase										1.6																		115									-61.4				-31.4						C (loop/coil)	T (turn)												98.89	12.5	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.7363891770239229	0.6927096024799801	false	false	false
MLH1	MLH1_Ser44Phe	B_11-12	7.229935281561982	0.00040258609835087933	0.0023094907934366306	19.785050171891815	0.000013186275714743875	0.00008971009901117585	2024_12_Batch_11-12	true	true	true	true	true	true	true	true	false	false	false	false	0.9977436621131175	0.9976030529334996	0.9606376380084043	0.879146223036598	0.9267253116613516	0.9537326220268435		0.9595642123869702		0.98280583430531	0.9988644216904652	0.9980620627660517	0.9537326220268435	0.8938864109357332	0.879146223036598	0.9384694417114985	0.996341684176534	0.9974252614601833	MLH1	Ser44Phe	NC_000003.12:36996633:C:T	131C>T	3	36996633	C	T	3	ENSG00000076242	2713	4400	CCSBVarC000316	ALE00000316	ENSP00000231790.3	RC4	RC4_Mut_GDEh1029	C12	GDEhDisVCh_40019	E04	1	RC4_Mut_GDDh1029	C12	VUSN2Hmut_GDN2h_10	D10	VUSMutpDEST2_02	H06	VUSmut_GDEh13	A06	1.0	1.0	1.0	6.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	N	Y	Y	Y	32118.0	single nucleotide variant	NM_000249.4(MLH1):c.131C>T (p.Ser44Phe)	4292.0	MLH1	HGNC:7127	Pathogenic	1.0	Sep 05, 2013	63751109.0	-	RCV000018608|RCV000075169|RCV001269530|RCV002381257	MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Colorectal cancer, hereditary nonpolyposis, type 2|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000003.12	3	36996633.0	36996633.0	3p22.2	reviewed by expert panel	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA004973,UniProtKB:P40692#VAR_004436,OMIM:120436.0002	3.0	17079.0	36996633.0	C	T	-	-	-	-	-	-	131C>T 	Ser44Phe	NM_000249.4	3.0	Pathogenic	Pathogenic	17079	3	36996633.0	C	T	S	F	rs63751109	3	37038124	3	37013128	44	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.131C>T	p.Ser44Phe	c.131C>T	p.Ser44Phe	principal1	Y	1	YES	Select	+	TCC	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	0.995	0.67505	D	0.953	0.69273	D	0.85	0.89875	A	simple_aae	15.0	85.0	3.865	0.95808	H	-4.61	0.79093	D	0.887	0.88561	1.0421	0.97948	D	0.8970	0.96576	D	9	0.98675984	0.98994	D	0.282462	0.90257	D	0.837	0.94863	0.936	0.99070	P40692	S44F	Gain of ubiquitination at K43 (P = 0.1378)| Gain of catalytic residue at S44 (P = 0.1623)| Gain of methylation at K43 (P = 0.1742)| Loss of helix (P = 0.2022)| Loss of disorder (P = 0.2886)	0.964211572358	0.96350	0.9184817693399651	0.91772	0.39785884657	0.40582	0.635271906853	0.57828	T	0.956891	0.99411	D	0.449255	0.92390	D	0.407547	0.92296	D	0.998545289039612	0.94400	D	0.989351	0.96493	D	0.9556187	0.96785	0.907205	0.95427	0.9558532	0.96810	0.91385424	0.95907	-15.705	0.97291	D	0.9874	0.92825	P	0.999241744657876	0.96052	0.99986291	0.99820	0.995	0.99826	.	.	.	.	.	.	5.056729	0.84284	28.3	0.99775403145246733	0.86271	0.722205	0.67102	D	0.868204209815214	0.90063	10.26111	0.774741645419911	0.87920	9.416519	5.85	4.97	0.65374	4.21	0.80015	4.736	0.61838	5.997000	0.52497	0.589	0.31595	1.0	0.71675	1.000000	0.68239	1.0	0.97202	307	0.87658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613190	6.198900e-07	0	1	91050	1.098300e-05	0	0	74996	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29596	0.000000e+00	0	0	44872	0.000000e+00	0	0	64006	0.000000e+00	0	0	6062	0.000000e+00	0	0	1179194	0.000000e+00	0	1	91050	1.098300e-05	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	not_provided|Hereditary_cancer-predisposing_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Lynch_syndrome	reviewed_by_expert_panel	NC_000003.12:g.36996633C>T	ClinGen:CA004973|OMIM:120436.0002|UniProtKB:P40692#VAR_004436	C3661900|C0027672|C1333991|C4552100	609310	140162|144|144	.	Ser	Phe	95.22	0.015384615384615385																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			95.22	Polar/Neutral	Serine		DNA mismatch repair protein Mlh1										-0.8								 S44-C39 (PAE:  1.5)	S44-C39 (PDBs: 4P7A)	 S44-C39 (PAE:  1.5), S44-G65 (PAE: 2.0)	S44-C39 (PDBs: 4P7A), S44-G65 (PDBs: 4P7A)							105									-72.2				139.8						C (loop/coil)	C (loop/coil)												95.22	1.5384616	>90	<10	609310	autosomal dominant	GenCC	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 2	false	0.9976030529334996	0.9977436621131175	true	true	true
NR0B1	NR0B1_Asn440Ile	B_15-16	-3.2576129554658255	0.013910176635705743	0.035032371242416975	-10.693789403598533	0.000013725630784151467	0.00009158739086879252	2025_03_Batch_15-16	true	true	false	false	false	false	true	true	false	false	false	false	0.9981688169932929	0.9915143882979344	0.4866618680059151	0.7784240895396379	0.691976690761304	0.6253349729767649	0.7907285386880571	0.7663745563005702	0.8311383547817265	0.5728374174363179	0.9885669116945268	0.9970788861449414	0.4599414072654726	0.6175788252220378	0.7257098242975493	0.4004863185755123	0.9944618649013419	0.9992587478416443	NR0B1	Asn440Ile	NC_000023.11:30304673:T:A	1319A>T	23	30304673	T	A	X	ENSG00000169297	7215	216202	CCSBVarC006819	ALE00006817	ENSP00000368253.4	CEGS2	CegsMutGDEh1042	G09	GDEhDisVCh_40038	B01	2	CegsMutGDDh1042	G09	VUSN2Hmut_GDN2h_09	B01	VUSMutpDEST2_06	F02	VUSmut_GDEh09	B01	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	N	Y	Y	Y	25996.0	single nucleotide variant	NM_000475.5(NR0B1):c.1319A>T (p.Asn440Ile)	190.0	NR0B1	HGNC:7960	Pathogenic	1.0	Jul 01, 2000	28935481.0	-	RCV000011704	MONDO:MONDO:0010264,MedGen:C0342482,OMIM:300200,Orphanet:95702	Congenital adrenal hypoplasia, X-linked	germline	germline	GRCh38	NC_000023.11	X	30304673.0	30304673.0	Xp21.2	no assertion criteria provided	1.0	-	N	ClinGen:CA255628,UniProtKB:P51843#VAR_004746,OMIM:300473.0008	1.0	10957.0	30304673.0	T	A	-	-	-	-	-	-	1319A>T 	Asn440Ile	NM_000475.5		Pathogenic	Pathogenic	10957	X	30304673.0	T	A	N	I	rs28935481	X	30322790	X	30232711	440	NR0B1	ENSG00000169297	ENST00000378970	ENSP00000368253	P51843	NR0B1_HUMAN	c.1319A>T	p.Asn440Ile	c.1319A>T	p.Asn440Ile	principal1	Y	1	YES	Select	-	AAT	2	0	T	T/T	T/T	T/T	T/T	0.004	0.65576	D	0.02	0.58950	D	0.966	0.56216	D	0.837	0.59978	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.395	0.69015	M	-3.96	0.73614	D	0.831	0.82607	0.9345	0.96156	D	0.9329	0.97784	D	9	0.9869633	0.99026	D	0.5927	0.96382	D	0.656	0.87025	0.876	0.96613	P51843	N440I	Loss of catalytic residue at N440 (P = 0.1579)| Gain of MoRF binding (P = 0.3445)| Loss of methylation at R437 (P = 0.4118)| Gain of helix (P = 0.5668)| Loss of stability (P = 0.7932)	0.983490836235	0.98313	0.823505313264456	0.82202	1.65461298271	0.89553	0.283096343279	0.07925	T	0.944918	0.99152	D	0.216854	0.75295	D	0.0737196	0.74973	D	0.980911254882812	0.73434	D	0.842916	0.51797	T	0.65963537	0.75612	0.5698029	0.74841	0.6873023	0.77108	0.56454915	0.74548	-10.152	0.74894	D	0.7858	0.76582	P	0.939184095923421	0.79273	0.87859320	0.90493	0.751	0.86209	.	.	.	.	.	.	3.012643	0.40372	21.1	0.98992387373482527	0.50053	.	.	.	.	.	.	.	.	.	5.58	-1.59	0.07985	-0.167	0.20445	0.629	0.24316	0.642000	0.20407	0.665	0.62996	0.779	0.29553	0.372000	0.24651	0.998	0.85369	832	0.38867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Congenital_adrenal_hypoplasia,_X-linked	no_assertion_criteria_provided	NC_000023.11:g.30304673T>A	ClinGen:CA255628|OMIM:300473.0008|UniProtKB:P51843#VAR_004746	C0342482	300200	95702	Nuclear hormone receptor, ligand-binding domain|Nuclear hormone receptor, ligand-binding domain|Nuclear hormone receptor, ligand-binding domain	Asn	Ile	91.15	0.5222929936305732																																																																																																																																																																																																																																																																																																																																																																																																																																																																													82			91.15	Polar/Neutral	Asparagine		Nuclear receptor subfamily 0 group B member 1							NR LBD			-3.5								 N440-I444 (PAE:  1.5)		 N440-I444 (PAE:  1.5)								132									-84.0				131.3						C (loop/coil)	C (loop/coil)												91.15	52.229298	>90	10-90	300200	x-linked recessive	OMIM	Rare genetic gynecological and obstetrical diseases; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic urogenital disease; Rare genetic endocrine disease; Genetic infertility; Rare genetic skin disease	7	ADRENAL HYPOPLASIA, CONGENITAL	false	0.9915143882979344	0.9981688169932929	true	true	true
PYGL	PYGL_Asn339Ser	B_7-8	1.6794603639239638	0.14406559166621677	0.21925520325296732	3.6541675113743652	0.010653246801938515	0.018083911083771668	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5628620243244571	0.5753117229357086	0.4100571735138043	0.5888076972476739	0.46894628840547414	0.42841018005567166	0.3996565574036496	0.5166134931017213	0.5872287240027234	0.4002129866876777	0.6059785212245326	0.6099379924561904	0.4571638027076938	0.421279083709227	0.5903866704926243	0.41990136033993086	0.5446449246468847	0.5157860561927237	PYGL	Asn339Ser	NC_000014.9:50916718:T:C	1016A>G	14	50916718	T	C	14	ENSG00000100504	55246	30086	CCSBVarC002419	ALE00002419	ENSP00000216392.7	RC4	RC4_Mut_GDEh1007	C06	GDEhDisVCh_40063	D09	1	RC4_Mut_GDDh1007	C06	VUSN2Hmut_GDN2h_10	B06	VUSMutpDEST2_13	H04	VUSmut_GDEh12	E08	1.0	1.0	1.0	1.0	1.0	3.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	38457.0	single nucleotide variant	NM_002863.5(PYGL):c.1016A>G (p.Asn339Ser)	5836.0	PYGL	HGNC:9725	Pathogenic	1.0	Apr 01, 1998	113993976.0	-	RCV000031853	MONDO:MONDO:0009294,MedGen:C0017925,OMIM:232700,Orphanet:369	Glycogen storage disease, type VI	germline;unknown	germline	GRCh38	NC_000014.9	14	50916718.0	50916718.0	14q22.1	no assertion criteria provided	2.0	-	N	ClinGen:CA342908,UniProtKB:P06737#VAR_007908,OMIM:613741.0003	1.0	38367.0	50916718.0	T	C	-	-	-	-	-	-	1016A>G 	Asn339Ser	NM_002863.5		Pathogenic	Pathogenic	38367	14	50916718.0	T	C	N	S	rs113993976	14	51383436	14	50453186	339	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.1016A>G	p.Asn339Ser	c.1016A>G	p.Asn339Ser	principal1	Y	1	YES	Select	-	AAT	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.999	0.77914	D	0.971	0.72446	D	0.82	0.94378	A	simple_aae	18.0	82.0	4.545	0.99092	H	-4.31	0.77749	D	0.897	0.90472	1.0902	0.99245	D	0.9639	0.98842	D	9	0.9913672	0.99659	D	0.348957	0.92200	D	0.951	0.99091	0.974	0.99756	P06737	N339S	Loss of stability (P = 0.0684)| Gain of glycosylation at N339 (P = 0.1055)| Loss of sheet (P = 0.302)| Gain of disorder (P = 0.3152)| Gain of loop (P = 0.4661)	0.986629134977	0.98634	0.9016478227044312	0.90074	0.483244084845	0.46989	0.787042617798	0.79956	T	0.85273	0.96636	D	0.277834	0.80990	D	0.161313	0.80745	D	0.999093055725098	0.96125	D	0.998313	0.99203	D	0.96742845	0.97984	0.90637654	0.95367	0.96295905	0.97538	0.8961974	0.94633	-13.207	0.90217	D	0.7988	0.82871	P	0.999240422494286	0.96052	0.42844670	0.80273	0.968	0.98734	.	.	.	.	.	.	4.639414	0.73898	26.1	0.99891792735750673	0.96592	0.942324	0.94656	D	1.03538426943843	0.96714	15.07045	0.936011274950159	0.96942	15.38441	5.57	5.57	0.83999	.	.	8.017	0.8876	7.810000	0.69451	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.99	0.65338	364	0.84712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614086	6.195460e-07	0	1	1179940	8.475010e-07	0	0	75048	0.000000e+00	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29608	0.000000e+00	0	0	44892	0.000000e+00	0	0	64042	0.000000e+00	0	0	6042	0.000000e+00	0	1	1179940	8.475010e-07	0	0	91078	0.000000e+00	0	0	0	0	0	0	0	0	0	0	1	426	0.002347417840375587	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	1	426	0.002347417840375587	0	0	0	1	478	0.0020920502092050207	Glycogen_storage_disease,_type_VI	no_assertion_criteria_provided	NC_000014.9:g.50916718T>C	ClinGen:CA342908|OMIM:613741.0003|UniProtKB:P06737#VAR_007908	C0017925	232700	369	.	Asn	Ser	95.96	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			95.96	Polar/Neutral	Asparagine		Glycogen phosphorylase, liver form										-3.5								 N339-H378 (PAE:  1.0), N339-S87 (PAE: 1.5), N339-L86 (PAE: 1.0)	N339-H378 (PDBs: 1FA9, 2QLL), N339-S87 (PDBs: 1FA9, 1L5S, 1L7X), N339-L86 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 8EMS, 2QLL)	 N339-Y85 (PAE:  1.0), N339-S87 (PAE: 1.5), N339-L86 (PAE: 1.0)	N339-L137 (PDBs: 1FA9), N339-Y85 (PDBs: 1FA9, 2QLL), N339-S87 (PDBs: 1FA9, 1L5S, 1L7X, 3CEH, 3CEJ, 8EMS), N339-L86 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 2ZB2, 3CEM, 3DD1, 3DDS, 3DDW, 2QLL), N339-H378 (PDBs: 2QLL)							132									-91.2				101.8						B (undefined)	E (parallel sheets)	Beta strand											95.96	0.0	>90	<10	232700	autosomal recessive	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE VI	false	0.5753117229357086	0.5628620243244571	false	false	false
GALE	GALE_Leu313Met	B_7-8	3.095523350619567	0.01743138323778645	0.04125664728007291	5.753066552667851	0.000696218078527209	0.0017768569876181204	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8092988012261412	0.8480288885231834	0.8476372075871224	0.8990409121130915	0.7976882819048048	0.8651995642486177	0.9852773211575974	0.8993055245339017	0.9908876258720498	0.9654425405639271	0.9516767174804375	0.9387806637806638	0.745121807339638	0.696071039275708	0.8071941983541331	0.7298318746103176	0.7443810595659293	0.6798169386716185	GALE	Leu313Met	NC_000001.11:23796202:G:T	937C>A	1	23796202	G	T	1	ENSG00000117308	2767	214363	CCSBVarC005292	ALE00005292	ENSP00000483375.1	CEGS2	CegsMutGDEh1036	E08	GDEhDisVCh_40068	C07	2	CegsMutGDDh1036	E08	VUSN2Hmut_GDN2h_07	B06	VUSMutpDEST2_02	B11	VUSmut_GDEh07	B06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	18719.0	single nucleotide variant	NM_001008216.2(GALE):c.937C>A (p.Leu313Met)	2582.0	GALE	HGNC:4116	Pathogenic	1.0	Jan 01, 1998	3180383.0	-	RCV000003865	MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238	UDPglucose-4-epimerase deficiency	germline	germline	GRCh38	NC_000001.11	1	23796202.0	23796202.0	1p36.11	no assertion criteria provided	1.0	-	N	ClinGen:CA252858,UniProtKB:Q14376#VAR_002545,OMIM:606953.0006	1.0	3680.0	23796202.0	G	T	-	-	-	-	-	-	937C>A 	Leu313Met	NM_001008216.2		Pathogenic	Pathogenic	3680	1	23796202.0	G	T	L	M	rs3180383	1	24122692	1	23995279	313	GALE	ENSG00000117308	ENST00000374497	ENSP00000363621	Q14376	GALE_HUMAN	c.937C>A	p.Leu313Met	c.937C>A	p.Leu313Met	principal1	Y	1	.	.	-	CTG	1	2	G	G/G	G/G	G/G	G/G	0.166	0.23299	T	0.217	0.27895	T	0.999	0.77914	D	0.979	0.74458	D	0.47	0.69040	A	simple_aae	53.0	47.0	.	.	.	-0.91	0.24409	N	0.806	0.80109	0.9655	0.96621	D	0.8710	0.95703	D	10	0.83168304	0.82146	D	0.12515	0.80606	D	0.748	0.91294	0.779	0.90338	Q14376	L313M	Gain of catalytic residue at L313 (P = 0.0101)| Loss of glycosylation at S312 (P = 0.0887)| Loss of sheet (P = 0.1158)| Loss of helix (P = 0.2022)| Gain of disorder (P = 0.2109)	0.87065958303	0.86839	.	0.59875	0.550956348002	0.51660	0.522289872169	0.41888	T	0.736055	0.92583	D	0.37375	0.88222	D	0.299089	0.88073	D	0.981164038181305	0.73573	D	0.976502	0.93728	D	0.75401795	0.80872	0.44115916	0.67153	0.6625247	0.75768	0.40201417	0.64445	-9.272	0.69510	D	0.1473	0.36670	B	0.892579658234464	0.75555	0.99952304	0.99453	0.157	0.39664	.	.	.	.	.	.	3.80787	0.54989	23.5	0.99539997745978348	0.70497	0.752981	0.69219	D	0.725298055812207	0.81188	7.487799	0.611947478708904	0.75673	6.376213	5.52	4.61	0.56673	3.5	0.63398	4.275	0.58809	4.565000	0.43935	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.901	0.43752	507	0.75491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614134	6.195270e-07	0	0	75044	0.000000e+00	0	0	75044	0.000000e+00	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29604	0.000000e+00	0	0	44886	0.000000e+00	0	0	64010	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180000	0.000000e+00	0	0	91086	0.000000e+00	0	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	UDPglucose-4-epimerase_deficiency	no_assertion_criteria_provided	NC_000001.11:g.23796202G>T	ClinGen:CA252858|OMIM:606953.0006|UniProtKB:Q14376#VAR_002545	C0751161	230350	352|79238	NAD(P)-binding domain	Leu	Met	98.84	0.3048780487804878																																																																																																																																																																																																																																																																																																																																																																																																																																																																													50			98.84	Aliphatic	Leucine		UDP-glucose 4-epimerase										3.8								 L313-E317 (PAE:  1.0)	L313-E317 (PDBs: 1EK5, 1EK6, 1HZJ)	 L313-E317 (PAE:  1.0)	L313-E317 (PDBs: 1EK5, 1EK6, 1HZJ)							131									-66.8				-38.5						H (helix)	H (α-helix)	Helix											98.84	30.487806	>90	10-90	230350	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic hepatic disease; Rare inborn errors of metabolism	4	GALACTOSEMIA III	false	0.8480288885231834	0.8092988012261412	false	false	false
HPRT1	HPRT1_Asp194Asn	B_7-8	-2.2102064193912323	0.06277811252292047	0.11113272925545303	-3.5937037901770292	0.008813487161322613	0.015358735936397905	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6385504257176313	0.6513307288347042	0.7395767148636093	0.7476325064475988	0.6917956222785595	0.8012362518814042	0.776883930709368	0.7916498876295754	0.7723177293090243	0.7349144065760652	0.7528210253225922	0.766456610915422	0.8255885730534405	0.5919413569275437	0.7229472835861734	0.7442390231511534	0.5498404323468162	0.5106442405198406	HPRT1	Asp194Asn	NC_000023.11:134498655:G:A	580G>A	23	134498655	G	A	X	ENSG00000165704	7982	202808	CCSBVarC005942	ALE00005942	ENSP00000298556.7	CEGS2	CegsMutGDEh1041	D12	GDEhDisVCh_40052	A10	2	CegsMutGDDh1041	D12	VUSN2Hmut_GDN2h_08	G10	VUSMutpDEST2_07	B08	VUSmut_GDEh08	G10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25076.0	single nucleotide variant	NM_000194.2(HPRT1):c.580G>A (p.Asp194Asn)	3251.0	HPRT1	HGNC:5157	Pathogenic	1.0	Jun 01, 1990	267606863.0	-	RCV000010728	MONDO:MONDO:0010298,MedGen:C0023374,OMIM:300322,Orphanet:510	Lesch-Nyhan syndrome	germline	germline	GRCh38	NC_000023.11	X	134498655.0	134498655.0	Xq26.2	no assertion criteria provided	1.0	-	N	ClinGen:CA120893,UniProtKB:P00492#VAR_006798,OMIM:308000.0009	1.0	10037.0	134498655.0	G	A	-	-	-	-	-	-	580G>A 	Asp194Asn	NM_000194.2		Pathogenic	Pathogenic	10037	X	134498655.0	G	A	D	N	rs267606863	X	133632685	X	133460351	194	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.580G>A	p.Asp194Asn	c.580G>A	p.Asp194Asn	principal1	Y	1	YES	Select	+	GAC	1	0	G	G/G	G/G	G/G	G/G	0.004	0.65576	D	0.008	0.68204	D	0.973	0.57613	D	0.92	0.65544	D	0.56	0.74433	A	simple_aae	44.0	56.0	3.645	0.94054	H	-4.04	0.74454	D	0.986	0.99488	0.8940	0.95576	D	0.9982	0.99953	D	10	0.9950098	0.99971	D	0.953235	0.99682	D	0.922	0.98039	0.974	0.99756	P00492	D194N	Loss of catalytic residue at D194 (P = 0.1186)| Loss of stability (P = 0.1846)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.2045)| Loss of helix (P = 0.2662)	0.996677612825	0.99660	0.9970801413337792	0.99706	2.49711821215	0.97592	0.825120568275	0.85790	D	0.990834	0.99962	D	0.270396	0.80333	D	0.150628	0.80080	D	0.997291147708893	0.91144	D	0.991001	0.97241	D	0.93153554	0.94305	0.93092585	0.97117	0.93153554	0.94306	0.93092585	0.97118	-13.539	0.91479	D	0.9977	0.97151	P	0.999279755859242	0.96129	0.99930394	0.99281	0.992	0.99727	.	.	.	.	.	.	5.352807	0.89805	31.0	0.99915568074387806	0.98380	.	.	.	.	.	.	.	.	.	5.76	5.76	0.90713	.	.	9.4	0.96645	11.851000	0.98079	0.653	0.53474	1.0	0.71675	1.000000	0.68239	0.997	0.79771	245	0.90406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Lesch-Nyhan_syndrome	no_assertion_criteria_provided	NC_000023.11:g.134498655G>A	ClinGen:CA120893|OMIM:308000.0009|UniProtKB:P00492#VAR_006798	C0023374	300322	510	Phosphoribosyltransferase domain	Asp	Asn	96.89	0.2822085889570552																																																																																																																																																																																																																																																																																																																																																																																																																																																																													46			96.89	Negatively-charged	Aspartic Acid	GMP; Mg(2+)	Hypoxanthine-guanine phosphoribosyltransferase										-3.5								 D194-R200 (PAE:  1.0)	D194-R200 (PDBs: 4RAN)	 D194-R200 (PAE:  1.0)	D194-R200 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)	 D194-R200 (PAE:  1.0)	D194-R200 (PDBs: 4KN6, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)					132									-128.8				164.8				dbSNP: rs137852504; Variant type: LP/P; AA change: Asp194Glu; PTM type: Phosphorylation; PTM morphology: LD*YNEyFRDLN; Var class: II&rs267606863		C (loop/coil)	C (loop/coil)												96.89	28.22086	>90	10-90	300322	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	LESCH-NYHAN SYNDROME	false	0.6513307288347042	0.6385504257176313	false	false	false
TPM1	TPM1_Asp230Asn	B_15-16	-0.2477303470947588	1.0	1.0	0.6719322347957137	1.0	1.0	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.626072517261451	0.6106120362907335	0.6226462409997715	0.669706034703667	0.6792129952449255	0.7706414254337605	0.7225077354771215	0.6128398290588511	0.567732512052929	0.6838336377323957	0.5652434604476737	0.5944493748987981	0.8187751153903994	0.7455861614309998	0.7716795573544051	0.5614588442671472	0.6559806121337932	0.6576956596241039	TPM1	Asp230Asn	NC_000015.10:63062263:G:A	688G>A	15	63062263	G	A	15	ENSG00000140416	4723	201744	CCSBVarC005645	ALE00005645	ENSP00000288398.6	CEGS2	CegsMutGDEh1036	B04	GDEhDisVCh_40050	D05	2	CegsMutGDDh1036	B04	VUSN2Hmut_GDN2h_07	C04	VUSMutpDEST2_04	H07	VUSmut_GDEh07	C04	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	40544.0	single nucleotide variant	NM_001018005.2(TPM1):c.688G>A (p.Asp230Asn)	7168.0	TPM1	HGNC:12010	Pathogenic	1.0	Dec 23, 2023	199476317.0	-	RCV000024580|RCV000036354|RCV000695968|RCV000850515	MedGen:C3661900|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569|MONDO:MONDO:0007267,MedGen:C1861863,OMIM:115196;MONDO:MONDO:0012744,MedGen:C2678476,OMIM:611878,Orphanet:154,Orphanet:54260	not provided|Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 3;Dilated cardiomyopathy 1Y	germline	germline	GRCh38	NC_000015.10	15	63062263.0	63062263.0	15q22.2	criteria provided, multiple submitters, no conflicts	8.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018280,Leiden Muscular Dystrophy (TPM1):TPM1_00015	2.0	31884.0	63062263.0	G	A	-	-	-	-	-	-	688G>A 	Asp230Asn	NM_001018005.2	2.0	Pathogenic	Pathogenic	31884	15	63062263.0	G	A	D	N	rs199476317	15	63354462	15	61141515	230	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.688G>A	p.Asp230Asn	c.688G>A	p.Asp230Asn	alternative1	Y	1	YES	Select	+	GAC	1	0	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.103	0.53076	T	0.906	0.62341	P	0.542	0.68403	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.13	0.87936	M	-2.75	0.66236	D	0.806	0.87788	0.1756	0.85433	D	0.6571	0.88036	D	10	0.6830356	0.71135	D	0.088535	0.75071	D	0.489	0.77537	.	0.73485	.	.	.	0.918927047136	0.91749	.	0.87479	.	0.97372	0.795938014984	0.81312	T	0.907056	0.98201	D	0.0863324	0.62511	D	-0.113766	0.62042	T	0.979095578193665	0.72466	D	0.926207	0.73664	D	0.7836067	0.82662	0.63644254	0.78541	0.79726624	0.83527	0.65704525	0.79693	-8.642	0.67096	D	0.2157	0.51525	B	0.984395262997464	0.86475	0.99810284	0.98633	0.942	0.97259	.	.	.	.	.	.	5.694203	0.93084	33.0	0.99769899618394198	0.85846	0.948302	0.95963	D	0.65560263837557	0.76605	6.541038	0.720765517832106	0.83866	8.159661	5.84	5.84	0.93363	.	.	9.883	0.98532	11.794000	0.96462	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.99	0.65338	791	0.46035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	not_provided|Dilated_cardiomyopathy_1Y|Hypertrophic_cardiomyopathy_3|Primary_dilated_cardiomyopathy|Hypertrophic_cardiomyopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.63062263G>A	ClinGen:CA018280|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00015	C3661900|C2678476|C1861863|C0007193|C0007194	611878|115196	154|54260|217604|217569	.	Asp	Asn	96.38	0.5828220858895705																																																																																																																																																																																																																																																																																																																																																																																																																																																																													95			96.38	Negatively-charged	Aspartic Acid		Tropomyosin alpha-1 chain	Coiled coil									-3.5								 D230-K226 (PAE:  1.0), D230-E234 (PAE: 1.0)		 D230-K226 (PAE:  1.0), D230-E234 (PAE: 1.0)								132									-65.0				-43.1						H (helix)	H (α-helix)												96.38	58.282207	>90	10-90	115196;611878	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CARDIOMYOPATHY, DILATED, 1Y	false	0.6106120362907335	0.626072517261451	false	false	false
GFAP	GFAP_Arg239Leu	B_15-16	0.10779392361630347	0.9171837636851483	0.9393142030233959	10.109483547485839	0.000019911383556219327	0.00011710701546686687	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9666698852825522	0.953343595920209	0.7037351793914957	0.8372768889574874	0.8541733537465211	0.7553172489402444	0.715006884956157	0.8485061555035059	0.8125205460364749	0.663635507689154	0.944282782987864	0.964358180717341	0.7956276129243318	0.8598405519895364	0.8620332318784999	0.7438348510938374	0.962404408852554	0.9689815898477632	GFAP	Arg239Leu	NC_000017.11:44913333:C:A	716G>T	17	44913333	C	A	17	ENSG00000131095	2920	214422	CCSBVarC004669	ALE00004669	ENSP00000466598.2	CEGS2	CegsMutGDEh1040	A11	GDEhDisVCh_40051	F07	1	CegsMutGDDh1040	A11	VUSN2Hmut_GDN2h_08	H06	VUSMutpDEST2_03	E01	VUSmut_GDEh08	H06	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77395.0	single nucleotide variant	NM_002055.5(GFAP):c.716G>T (p.Arg239Leu)	2670.0	GFAP	HGNC:4235	Pathogenic	1.0	Feb 18, 2022	59565950.0	-	RCV000192137|RCV000056901	MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MedGen:C3661900	Alexander disease|not provided	de novo;germline	germline	GRCh38	NC_000017.11	17	44913333.0	44913333.0	17q21.31	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA217211,UniProtKB:P14136#VAR_071545	3.0	66498.0	44913333.0	C	A	-	-	-	-	-	-	716G>T 	Arg239Leu	NM_002055.5	2.0	Pathogenic	Pathogenic	66498	17	44913333.0	C	A	R	L	rs59565950	17	42990701	17	40346227	239	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.716G>T	p.Arg239Leu	c.716G>T	p.Arg239Leu	principal1	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	0.42	0.97926	A	without_aae	58.0	42.0	4.765	0.99584	H	.	0.91415	.	.	0.99191	1.0735	0.98684	D	0.9326	0.97773	D	10	0.9925636	0.99791	D	0.588098	0.96326	D	.	0.98039	0.972	0.99735	P14136	R239L	Loss of disorder (P = 0.068)| Gain of ubiquitination at K236 (P = 0.07)| Loss of solvent accessibility (P = 0.1077)| Loss of MoRF binding (P = 0.1115)| Loss of phosphorylation at T240 (P = 0.1128)	.	0.99168	.	0.97490	.	0.84147	0.601212918758	0.53008	T	0.973682	0.99730	D	0.517207	0.94762	D	0.505156	0.94685	D	0.999402642250061	0.97246	D	0.987501	0.96469	D	0.9712506	0.98349	0.9658545	0.99261	0.9650323	0.97745	0.96250075	0.99090	-14.207	0.93880	D	0.9505	0.86932	P	0.99427444733168	0.90545	0.99948186	0.99419	1	0.99985	.	.	.	.	.	.	5.657556	0.9286	33.0	0.99773369675019341	0.86100	0.968793	0.99121	D	0.640997006466392	0.75657	6.368131	0.465836667375305	0.65552	4.862144	4.93	3.97	0.45177	.	.	7.905	0.86513	7.694000	0.65990	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	749	0.51874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Alexander_disease|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.44913333C>A	ClinGen:CA217211|UniProtKB:P14136#VAR_071545	C0270726|C3661900	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Leu	91.82	0.6854838709677419																																																																																																																																																																																																																																																																																																																																																																																																																																																																													170			91.82	Positively-charged	Arginine		Glial fibrillary acidic protein							IF rod			-4.5								 R239-L235 (PAE:  1.5), R239-E243 (PAE: 2.0)		 R239-L235 (PAE:  1.5), R239-E243 (PAE: 2.0)								175									-61.5				-45.8	Coil 2A			dbSNP: rs58064122; Variant type: LP/P; AA change: Arg239Cys; PTM type: Phosphorylation; PTM morphology: LKEIR*tQyEAM; Var class: II&rs59565950		H (helix)	H (α-helix)												91.82	68.548386	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.953343595920209	0.9666698852825522	true	true	false
DCX	DCX_Arg78His	B_7-8	3.6348888527255823	0.008343501091592523	0.023714415304972796	1.4329085569095	0.19499384842030876	0.23934027548579703	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8134757398591203	0.7971124358319378	0.5481582381722729	0.5566015683080432	0.5269279184092575	0.5456207304940612	0.6101213648102517	0.6133348990916261	0.5870403627846026	0.5746551479751016	0.8157455243098357	0.8464713356605102	0.48112009617787077	0.44052093772688883	0.5261627738314839	0.5216613283694442	0.7784793473540399	0.7804801440577303	DCX	Arg78His	NC_000023.11:111410166:C:T	233G>A	23	111410166	C	T	X	ENSG00000077279	8416	216632	CCSBVarC005186	ALE00005186	ENSP00000419861.1	CEGS2	CegsMutGDEh1039	A11	GDEhDisVCh_40049	H06	1	CegsMutGDDh1039	A11	VUSN2Hmut_GDN2h_08	A04	VUSMutpDEST2_07	B12	VUSmut_GDEh08	A04	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26646.0	single nucleotide variant	NM_001195553.2(DCX):c.233G>A (p.Arg78His)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	Sep 01, 1999	104894784.0	-	RCV000012371	MedGen:C1848070	Subcortical laminar heterotopia, X-linked	germline	germline	GRCh38	NC_000023.11	X	111410166.0	111410166.0	Xq23	no assertion criteria provided	1.0	-	N	ClinGen:CA121602,UniProtKB:O43602#VAR_010202,OMIM:300121.0011	1.0	11607.0	111410166.0	C	T	-	-	-	-	-	-	233G>A 	Arg78His	NM_001195553.2		Pathogenic	Pathogenic	11607	X	111410166.0	C	T	R	H	rs104894784	X	110653394	X	110540050	78	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.233G>A	p.Arg78His	c.233G>A	p.Arg78His	alternative1	Y	1	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	.	0.72322	.	.	0.74454	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.80975	.	.	0.91853	1.0284	0.97681	D	0.9052	0.96850	D	10	0.9253213	0.91790	D	0.890439	0.99167	D	.	0.99253	.	.	.	.	.	.	0.99728	.	0.86134	.	.	0.843877911568	0.88667	D	.	0.97468	.	0.630276	0.99866	D	0.667572	0.99865	D	0.996542870998383	0.89478	D	0.99695	0.98836	D	0.97227085	0.98442	0.95689386	0.98783	0.9502985	0.96238	0.9552171	0.98686	-10.027	0.74152	D	0.9567	0.87630	LP	0.99763976369707	0.93365	0.99970210	0.99622	0.99	0.99661	.	.	.	.	.	.	5.388386	0.90296	31.0	0.99952697010603286	0.99957	.	.	.	.	.	.	.	.	.	5.5	5.5	0.81360	.	.	7.905	0.86513	7.693000	0.65941	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.994	0.71086	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Subcortical_laminar_heterotopia,_X-linked	no_assertion_criteria_provided	NC_000023.11:g.111410166C>T	ClinGen:CA121602|OMIM:300121.0011|UniProtKB:O43602#VAR_010202	C1848070	.	.	.	Arg	His	85.24	0.9596774193548387																																																																																																																																																																																																																																																																																																																																																																																																																																																																													238			85.24	Positively-charged	Arginine		Neuronal migration protein doublecortin							Doublecortin 1			-4.5				I:R78-B:V159 (PDBs: 2XRP, 4ATU), N:R78-A:S158 (PDBs: 6REV, 6RF8, 6RFD)					R78-S74 (PDBs: 6REV)		R78-S74 (PDBs: 6REV, 6RF8, 6RFD)							175									-65.7				-18.6				dbSNP: rs104894784; Variant type: LP/P; AA change: Arg78Leu; PTM type: Phosphorylation; PTM morphology: VYAVSsDRFR*S; Var class: II&rs104894784		C (loop/coil)	S (bend)	Beta strand											85.24	95.96774	70-90	$\geqslant$90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.7971124358319378	0.8134757398591203	false	false	false
COMP	COMP_Cys348Arg	B_7-8	-3.532829751438318	0.03856100316353881	0.07515460820648891	1.5372603553881448	0.16811398514928969	0.20957144208488218	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9443116552603958	0.877427375796416	0.8661589367792902	0.7875354472883116	0.7583673782246876	0.9118396887589368	0.9118396887589368	0.822673829072281	0.8928813254452099	0.8661589367792902	0.9227573716630881	0.9443116552603958		0.694060927377094	0.6821895691314133		0.832097379929744		COMP	Cys348Arg	NC_000019.10:18787584:A:G	1042T>C	19	18787584	A	G	19	ENSG00000105664	56661	3360	CCSBVarC006426	ALE00006426	ENSP00000222271.2	Edgotyping3	VUSMutGDEh015	E08	GDEhDisVCh_40037	A12	1	VUSMutGDDh015	E08	VUSN2Hmut_GDN2h_04	G09	VUSMutpDEST2_13	B09	VUSmut_GDEh04	G09	1.0	1.0	1.0	2.0	1.0	6.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	24234.0	single nucleotide variant	NM_000095.3(COMP):c.1042T>C (p.Cys348Arg)	1311.0	COMP	HGNC:2227	Pathogenic	1.0	Mar 03, 2023	137852656.0	-	RCV000009773|RCV003555993	MONDO:MONDO:0008322,MedGen:C0410538,OMIM:177170,Orphanet:750|MedGen:C3661900	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided	germline	germline	GRCh38	NC_000019.10	19	18787584.0	18787584.0	19p13.11	criteria provided, single submitter	2.0	-	N	ClinGen:CA254703,UniProtKB:P49747#VAR_017102,OMIM:600310.0014	3.0	9195.0	18787584.0	A	G	-	-	-	-	-	-	1042T>C 	Cys348Arg	NM_000095.3	1.0	Pathogenic	Pathogenic	9195	19	18787584.0	A	G	C	R	rs137852656	19	18898393	19	18759393	348	COMP	ENSG00000105664	ENST00000222271	ENSP00000222271	P49747	COMP_HUMAN	c.1042T>C	p.Cys348Arg	c.1042T>C	p.Cys348Arg	principal1	Y	1	YES	Select	-	TGC	1	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.83643	D	0.994	0.66535	D	0.892	0.63270	P	0.97	0.97016	A	simple_aae	3.0	97.0	3.805	0.95368	H	-11.04	0.99328	D	0.992	0.99826	1.1348	0.99931	D	0.9633	0.98821	D	9	0.9751345	0.97221	D	0.850486	0.98845	D	0.916	0.97811	0.758	0.88672	P49747	C348R	Loss of stability (P = 0.1293)| Loss of helix (P = 0.1299)| Loss of methylation at K343 (P = 0.1527)| Gain of loop (P = 0.2045)| Gain of solvent accessibility (P = 0.2192)	0.960320181888	0.95955	0.9810309095550681	0.98086	.	.	0.741464316845	0.73142	T	0.89888	0.97981	D	0.569983	0.96575	D	0.580964	0.96518	D	0.999836921691895	0.99248	D	0.978502	0.92421	D	0.961489	0.97389	0.9404233	0.97763	0.9750361	0.98688	0.9421325	0.97876	-10.445	0.77844	D	0.9885	0.94220	P	0.999662404369004	0.97392	0.98999390	0.96730	0.917	0.95747	.	.	.	.	.	.	5.124043	0.85743	28.7	0.97971321180907067	0.37405	0.973315	0.99484	D	0.728680444920481	0.81413	7.539761	0.569462575089558	0.72611	5.861179	3.33	3.33	0.37171	4.3	0.81401	9.136	0.93774	11.046000	0.85259	0.587	0.31004	1.0	0.71675	1.000000	0.68239	0.562	0.30505	867	0.32049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	not_provided|Pseudoachondroplastic_spondyloepiphyseal_dysplasia_syndrome	criteria_provided,_single_submitter	NC_000019.10:g.18787584A>G	ClinGen:CA254703|OMIM:600310.0014|UniProtKB:P49747#VAR_017102	C3661900|C0410538	177170	750	.	Cys	Arg	96.48	0.2740740740740741																																																																																																																																																																																																																																																																																																																																																																																																																																																																													37			96.48	Special, a very reactive sulfhydryl group	Cysteine		Cartilage oligomeric matrix protein						Disulfide bond 328-348				2.5						 C348-C328 (PAE:  1.5)	C348-C328 (PDBs: 3FBY)			 C348-C328 (PAE:  1.5)	C348-C328 (PDBs: 3FBY)							121									-119.1				-2.7	Disordered		TSP type-3 3			C (loop/coil)	T (turn)	Helix											96.48	27.407408	>90	10-90	177170	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	2	PSEUDOACHONDROPLASIA	false	0.877427375796416	0.9443116552603958	false	false	false
UBQLN2	UBQLN2_Pro497Ser	B_7-8	1.5477904479144684	0.16559856417172467	0.2419994319571493	-2.101618012725241	0.07369491933564948	0.10002232025215739	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6935014228702143	0.6932224461654846	0.6859879539125583	0.715520801794117	0.6145062911316104	0.7233082382477206	0.7350974011393709	0.6185551306379421	0.8238683771874853	0.6953990143004677	0.6755477894176528	0.6943829255784837	0.7115190753560703	0.6104574516252785	0.6071732264007489	0.6765768935246489	0.7108971029133163	0.692619920161945	UBQLN2	Pro497Ser	NC_000023.11:56565362:C:T	1489C>T	23	56565362	C	T	X	ENSG00000188021	71001	205674	CCSBVarC003502	ALE00003502	ENSP00000345195.5	CEGS2	CegsMutGDEh1034	A02	GDEhDisVCh_40022	D02	2	CegsMutGDDh1034	A02	VUSN2Hmut_GDN2h_06	B07	NULL	NULL	VUSmut_GDEh06	B07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	38906.0	single nucleotide variant	NM_013444.4(UBQLN2):c.1489C>T (p.Pro497Ser)	29978.0	UBQLN2	HGNC:12509	Pathogenic	1.0	Aug 27, 2023	387906710.0	-	RCV000022843	MONDO:MONDO:0010459,MedGen:C3275459,OMIM:300857,Orphanet:803	Amyotrophic lateral sclerosis type 15	germline	germline	GRCh38	NC_000023.11	X	56565362.0	56565362.0	Xp11.21	criteria provided, single submitter	2.0	-	N	UniProtKB:Q9UHD9#VAR_066563,OMIM:300264.0002,ClinGen:CA259705	3.0	29951.0	56565362.0	C	T	-	-	-	-	-	-	1489C>T 	Pro497Ser	NM_013444.4	1.0	Pathogenic	Pathogenic	29951	X	56565362.0	C	T	P	S	rs387906710	X	56591795	X	56608520	497	UBQLN2	ENSG00000188021	ENST00000338222	ENSP00000345195	Q9UHD9	UBQL2_HUMAN	c.1489C>T	p.Pro497Ser	c.1489C>T	p.Pro497Ser	principal1	Y	NA	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.722	0.03925	T	0.641	0.07060	T	0.588	0.39002	P	0.026	0.20792	B	0.89	0.91795	A	simple_aae	11.0	89.0	0	0.06502	N	0.14	0.05378	N	0.628	0.64040	-0.1142	0.79678	T	0.4553	0.78686	T	10	0.5963855	0.66377	D	0.368943	0.92683	D	0.473	0.76495	0.233	0.16068	Q9UHD9	P497S	Gain of glycosylation at P497 (P = 0.0075)| Gain of phosphorylation at P497 (P = 0.0786)| Loss of disorder (P = 0.2112)| Loss of loop (P = 0.3664)| Loss of catalytic residue at P494 (P = 0.4188)	0.996022440636	0.99592	0.8042890327509076	0.80268	0.47578793126	0.46448	0.714166879654	0.69145	T	0.045394	0.26848	T	0.269839	0.80282	D	0.149828	0.80028	D	0.41353166103363	0.29141	T	0.955404	0.82996	D	0.10381045	0.24318	0.1378983	0.32855	0.10381045	0.24318	0.1378983	0.32854	-6.41	0.49650	T	0.1992	0.42273	B	0.979956905649634	0.85303	0.99950504	0.99436	0.115	0.31465	.	.	.	.	.	.	2.910939	0.38685	20.8	0.91370366437748596	0.20888	.	.	.	.	.	.	.	.	.	4.18	4.18	0.48414	.	.	3.787	0.55235	.	.	0.599	0.40292	1.0	0.71675	.	.	0.976	0.56441	101	0.95825	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Amyotrophic_lateral_sclerosis_type_15	criteria_provided,_single_submitter	NC_000023.11:g.56565362C>T	ClinGen:CA259705|OMIM:300264.0002|UniProtKB:Q9UHD9#VAR_066563	C3275459	300857	803	.	Pro	Ser	44.45	0.8602941176470589																																																																																																																																																																																																																																																																																																																																																																																																																																																																													117			44.45	Special, No backbone hydrogen	Proline		Ubiquilin-2										1.6																		115									-130.2				137.8	12 X 3 AA tandem repeats of P-X-X		3.0			C (loop/coil)	C (loop/coil)												44.45	86.02941	$\leqslant$50	10-90	300857	x-linked dominant	OMIM		0	AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	false	0.6932224461654846	0.6935014228702143	false	false	false
TPM1	TPM1_Asp175Asn	B_15-16	-3.2399761769906257	0.0444670083135223	0.0775905716469595	3.9169447505566426	0.007082402149551709	0.012452644789038703	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7668218880943232	0.8078627452577885	0.6789944172127198	0.6156199929905832	0.6338980557031699	0.6759710095656966	0.640453926693776	0.6275091902646546	0.6364131249297904	0.64933179010465	0.8401334951335845	0.7821961975685957	0.7114880924376171	0.6402869211416853	0.5948268610513762	0.7086570443207897	0.7755919953819924	0.7514475786200507	TPM1	Asp175Asn	NC_000015.10:63060899:G:A	523G>A	15	63060899	G	A	15	ENSG00000140416	4723	8952	CCSBVarC000699	ALE00000699	ENSP00000288398.6	RC4	RC4_Mut_GDEh1014	H09	GDEhDisVCh_40050	E11	2	RC4_Mut_GDDh1014	H09	VUSN2Hmut_GDN2h_10	A08	VUSMutpDEST2_04	E05	VUSmut_GDEh12	A12	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	N	Y	Y	27495.0	single nucleotide variant	NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn)	7168.0	TPM1	HGNC:12010	Pathogenic	1.0	Oct 07, 2024	104894503.0	-	RCV000036340|RCV000159366|RCV000013272|RCV001197088|RCV000474684|RCV000622165|RCV001170568	MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MedGen:C3661900|MONDO:MONDO:0007267,MedGen:C1861863,OMIM:115196|MONDO:MONDO:0012744,MedGen:C2678476,OMIM:611878,Orphanet:154,Orphanet:54260|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569|MedGen:CN230736|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy 3|Dilated cardiomyopathy 1Y|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Cardiomyopathy	germline;unknown	germline	GRCh38	NC_000015.10	15	63060899.0	63060899.0	15q22.2	criteria provided, multiple submitters, no conflicts	20.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018106,UniProtKB:P09493#VAR_007601,Leiden Muscular Dystrophy (TPM1):TPM1_00009,OMIM:191010.0002	3.0	12456.0	63060899.0	G	A	-	-	-	-	-	-	523G>A 	Asp175Asn	NM_001018005.2	2.0	Pathogenic	Pathogenic	12456	15	63060899.0	G	A	D	N	rs104894503	15	63353098	15	61140151	175	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.523G>A	p.Asp175Asn	c.523G>A	p.Asp175Asn	alternative1	Y	1	YES	Select	+	GAC	1	0	G	G/G	G/G	G/G	G/G	0.042	0.78662	D	0.046	0.50577	D	0.241	0.49197	B	0.319	0.56117	B	1.0	0.99291	A	simple_aae	0.0	100.0	3.325	0.90661	M	-3.47	0.69272	D	0.838	0.89904	1.0953	0.99459	D	0.9702	0.99058	D	10	0.90321386	0.89570	D	0.732213	0.97842	D	0.785	0.92843	.	0.92541	.	.	.	0.959468760123	0.95868	.	0.95444	.	0.96512	0.833561182022	0.87087	D	0.973719	0.99730	D	0.273205	0.80583	D	0.154663	0.80334	D	0.913489401340485	0.56731	D	0.791921	0.43678	T	0.5612141	0.70283	0.4835364	0.69841	0.5259945	0.68301	0.4445741	0.67378	-11.418	0.81957	D	0.5117	0.70216	A	0.988187110545618	0.87703	0.99896990	0.99067	0.94	0.97139	.	.	.	.	.	.	5.216548	0.87566	29.3	0.99833930115273317	0.91548	0.915688	0.88038	D	0.740737975930308	0.82204	7.728829	0.778522816956595	0.88198	9.517074	5.8	5.8	0.92070	.	.	10.003	0.9969	11.864000	0.98400	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.991	0.66489	792	0.45931	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	3	109360	2.743230e-05	0	3	208076	1.441780e-05	0	4	236870	1.688690e-05	0	0	7162	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	2	13350	1.498130e-04	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16216	0.000000e+00	0	0	30522	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	2	16688	1.198470e-04	0	1	89552	1.116670e-05	0	0	30608	0.000000e+00	0	1	89552	1.116670e-05	0	0	14900	0.000000e+00	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	3	21586	1.389790e-04	0	1	102722	9.735010e-06	0	0	30526	0.000000e+00	0	1	102722	9.735010e-06	0	.	14	1614042	8.673880e-06	0	8	64018	1.249650e-04	0	0	74914	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	1	29608	3.377470e-05	0	0	44900	0.000000e+00	0	8	64018	1.249650e-04	0	0	6084	0.000000e+00	0	4	1180052	3.389680e-06	0	1	91062	1.098150e-05	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Cardiovascular_phenotype|Cardiomyopathy|Hypertrophic_cardiomyopathy|Primary_familial_hypertrophic_cardiomyopathy|Hypertrophic_cardiomyopathy_3|Dilated_cardiomyopathy_1Y|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.63060899G>A	ClinGen:CA018106|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00009|OMIM:191010.0002|UniProtKB:P09493#VAR_007601	CN230736|C0878544|C0007194|C0949658|C1861863|C2678476|C3661900	PS192600|115196|611878	167848|217569|155|154|54260	.	Asp	Asn	98.37	0.5153374233128835																																																																																																																																																																																																																																																																																																																																																																																																																																																																													84			98.37	Negatively-charged	Aspartic Acid		Tropomyosin alpha-1 chain	Coiled coil									-3.5					P:D175-J:R369 (PDBs: 6X5Z)			 D175-A179 (PAE:  1.0), D175-I171 (PAE: 1.0)	D175-I171 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), D175-A179 (PDBs: 8ENC)	 D175-A179 (PAE:  1.0), D175-I171 (PAE: 1.0)	D175-I171 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), D175-A179 (PDBs: 8ENC)		D175-R178 (PDBs: 8EFH)					132									-71.3				-33.8				dbSNP: rs104894503; Variant type: LP/P; AA change: Asp175Asn; PTM type: Phosphorylation; PTM morphology: LVIIEsD*LERA; Var class: II		H (helix)	H (α-helix)	Helix											98.37	51.53374	>90	10-90	115196;611878	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CARDIOMYOPATHY, DILATED, 1Y	false	0.8078627452577885	0.7668218880943232	false	false	false
DES	DES_Ala357Pro	B_7-8	1.032047524545696	0.3493618639104882	0.44074052844718126	-3.001160044949236	0.0199094304546956	0.03133259424045148	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.842354544841776	0.8276562844518864	0.7520258280519136	0.7929760233717676	0.8312558130856083	0.7938977991338958	0.927877022287396	0.9386669097564388	0.9538141296185283	0.8946827799230691	0.8673937487872824	0.842354544841776	0.6599185759803956	0.7238447164147775	0.632137917125007	0.6093688761807583	0.7879188201164905		DES	Ala357Pro	NC_000002.12:219421385:G:C	1069G>C	2	219421385	G	C	2	ENSG00000175084	12573	2306	CCSBVarC007863	ALE00007849	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	H10	GDEhDisVCh_40003	B11	1	VUSMutGDDh003	H10	VUSN2Hmut_GDN2h_01	C05	NULL	NULL	VUSmut_GDEh01	C05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	77287.0	single nucleotide variant	NM_001927.4(DES):c.1069G>C (p.Ala357Pro)	1674.0	DES	HGNC:2770	Pathogenic	1.0	Jul 27, 2017	58898021.0	-	RCV000056769|RCV000239682	MedGen:C3661900|Human Phenotype Ontology:HP:0003715,MONDO:MONDO:0018943,MedGen:C2678065,OMIM:PS601419,Orphanet:593	not provided|Myofibrillar myopathy	germline;unknown	germline	GRCh38	NC_000002.12	2	219421385.0	219421385.0	2q35	criteria provided, single submitter	3.0	ACMG2022	N	ClinGen:CA217007,UniProtKB:P17661#VAR_042456	2.0	66390.0	219421385.0	G	C	-	-	-	-	-	-	1069G>C 	Ala357Pro	NM_001927.4	1.0	Pathogenic	Pathogenic	66390	2	219421385.0	G	C	A	P	rs58898021	2	220286107	2	219994351	357	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1069G>C	p.Ala357Pro	c.1069G>C	p.Ala357Pro	principal1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.033	0.44516	D	0.156	0.32156	T	0.979	0.59057	D	0.906	0.64345	P	0.77	0.85999	A	simple_aae	23.0	77.0	3.285	0.90150	M	-2.9	0.60859	D	0.862	0.85840	1.0028	0.97228	D	0.9130	0.97111	D	10	0.9711082	0.96678	D	0.334213	0.91818	D	0.726	0.90329	0.785	0.90795	P17661	A357P	Gain of glycosylation at A357 (P = 0.2042)| Gain of phosphorylation at S361 (P = 0.2067)| Loss of helix (P = 0.2271)| Gain of relative solvent accessibility (P = 0.2363)| Gain of solvent accessibility (P = 0.28)	0.990206318917	0.98998	0.8878966185307502	0.88688	1.46616907579	0.86389	0.456700503826	0.32816	T	0.84517	0.96396	D	0.443547	0.92130	D	0.399348	0.92033	D	0.96927410364151	0.68326	D	0.751225	0.37071	T	0.8032397	0.83911	0.815194	0.89092	0.7719805	0.81948	0.7071234	0.82530	-13.768	0.92294	D	0.9632	0.88438	P	0.998327518194517	0.94284	0.99793420	0.98563	0.852	0.91893	.	.	.	.	.	.	4.750828	0.76761	26.6	0.9975120834211838	0.84319	0.960176	0.98079	D	0.65095558482258	0.76305	6.485179	0.570868787779099	0.72711	5.876984	5.12	4.25	0.49600	1.92	0.38734	3.952	0.56489	6.443000	0.55725	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Myofibrillar_myopathy|not_provided	criteria_provided,_single_submitter	NC_000002.12:g.219421385G>C	ClinGen:CA217007|UniProtKB:P17661#VAR_042456	C2678065|C3661900	PS601419	593	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ala	Pro	95.24	0.5660377358490566																																																																																																																																																																																																																																																																																																																																																																																																																																																																													60			95.24	Aliphatic	Alanine		Desmin							IF rod			1.8								 A357-E353 (PAE:  1.0), A357-S361 (PAE: 1.0)		 A357-E353 (PAE:  1.0), A357-S361 (PAE: 1.0)								89									-62.0				-41.9	Interaction with NEB; Coil 2B			dbSNP: rs58898021; Variant type: LP/P; AA change: Ala357Pro; PTM type: Phosphorylation; PTM morphology: FA*sEAsGyQDN; Var class: II&rs58898021		H (helix)	H (α-helix)												95.24	56.60377	>90	10-90		unknown		Rare genetic cardiac disease; Rare genetic neurological disorder	2		false	0.8276562844518864	0.842354544841776	false	false	false
COMP	COMP_Thr585Met	B_7-8	-4.2207151232608355	0.02431306532767415	0.052591115261446914	0.14489946107641677	0.8888740859261406	0.9107113052342088	2024_01_Batch_7-8	false	false	true	false	false	false	false	false	false	false	false	false	0.8513335240558684	0.7744174241421486	0.965084588301228	0.9398478309614695	0.8774438569042948	0.9801179485316365	0.9801179485316365	0.8744095867169345	0.9429164722924023	0.965084588301228	0.8754773540183393	0.8513335240558684		0.8804781270916552	0.9367791896305369		0.6733574942659581		COMP	Thr585Met	NC_000019.10:18785056:G:A	1754C>T	19	18785056	G	A	19	ENSG00000105664	56661	219644	CCSBVarC006431	ALE00006431	ENSP00000222271.2	CEGS2	CegsMutGDEh1045	D08	GDEhDisVCh_40037	D05	1	CegsMutGDDh1045	D08	VUSN2Hmut_GDN2h_09	F10	VUSMutpDEST2_13	E10	VUSmut_GDEh09	F10	1.0	1.0	1.0	5.0	1.0	6.0	7.0	1.0	2.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	49417.0	single nucleotide variant	NM_000095.3(COMP):c.1754C>T (p.Thr585Met)	1311.0	COMP	HGNC:2227	Pathogenic	1.0	Apr 29, 2024	312262900.0	-	RCV000033887|RCV001388112|RCV002054553|RCV004754281	MONDO:MONDO:0008322,MedGen:C0410538,OMIM:177170,Orphanet:750|MedGen:C3661900|Human Phenotype Ontology:HP:0002654,MONDO:MONDO:0016648,MedGen:C0026760,OMIM:PS132400,Orphanet:251|	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided|Multiple epiphyseal dysplasia|COMP-related disorder	germline	germline	GRCh38	NC_000019.10	19	18785056.0	18785056.0	19p13.11	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA343861,UniProtKB:P49747#VAR_007641	3.0	40995.0	18785056.0	G	A	-	-	-	-	-	-	1754C>T 	Thr585Met	NM_000095.3	2.0	Pathogenic	Pathogenic	40995	19	18785056.0	G	A	T	M	rs312262900	19	18895866	19	18756866	585	COMP	ENSG00000105664	ENST00000222271	ENSP00000222271	P49747	COMP_HUMAN	c.1754C>T	p.Thr585Met	c.1754C>T	p.Thr585Met	principal1	Y	1	YES	Select	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.215	0.89201	M	-5.73	0.87641	D	0.795	0.96431	1.0443	0.97993	D	0.9084	0.96957	D	10	0.9817045	0.98190	D	0.732327	0.97843	D	0.928	0.98265	0.913	0.98298	P49747	T585M	Loss of glycosylation at T585 (P = 0.0302)| Gain of sheet (P = 0.0827)| Loss of phosphorylation at T585 (P = 0.1169)| Loss of catalytic residue at T585 (P = 0.439)| Loss of disorder (P = 0.4558)	0.9461764722	0.94517	0.7737584152381675	0.77198	.	.	0.76771235466	0.77042	T	0.944158	0.99135	D	0.388885	0.89183	D	0.32083	0.89047	D	0.998580694198608	0.94516	D	0.995723	0.98506	D	0.8818567	0.89678	0.7051136	0.82414	0.87115085	0.88802	0.7300146	0.83857	-8.631	0.65370	D	0.8517	0.79811	P	0.997865785193649	0.93647	0.99722470	0.98303	0.997	0.99892	.	.	.	.	.	.	5.50018	0.91587	32.0	0.99914394362973702	0.98310	0.967518	0.98995	D	0.846776583827159	0.88863	9.765092	0.735579960890882	0.84995	8.473926	4.19	4.19	0.48586	4.3	0.81401	9.824	0.98309	11.795000	0.96488	0.614	0.49322	1.0	0.71675	1.000000	0.68239	0.947	0.4917	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	not_provided|Pseudoachondroplastic_spondyloepiphyseal_dysplasia_syndrome|Multiple_epiphyseal_dysplasia	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.18785056G>A	ClinGen:CA343861|UniProtKB:P49747#VAR_007641	C3661900|C0410538|C0026760	177170|PS132400	750|251	Thrombospondin, C-terminal|Thrombospondin, C-terminal	Thr	Met	98.34	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.34	Polar/Neutral	Threonine		Cartilage oligomeric matrix protein							TSP C-terminal			-0.7								 T585-A735 (PAE:  1.0), T585-L272 (PAE: 1.0)	T585-A735 (PDBs: 3FBY), T585-R683 (PDBs: 3FBY), T585-L272 (PDBs: 3FBY)	 T585-A735 (PAE:  1.0), T585-L272 (PAE: 1.0)	T585-A735 (PDBs: 3FBY), T585-R683 (PDBs: 3FBY), T585-L272 (PDBs: 3FBY), T585-S681 (PDBs: 3FBY)							119									-112.2				122.7	Mediates cell survival and induction of the IAP family of survival proteins					B (undefined)	E (parallel sheets)	Beta strand											98.34	0.0	>90	<10	177170	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	2	PSEUDOACHONDROPLASIA	false	0.7744174241421486	0.8513335240558684	false	false	false
CTNNA3	CTNNA3_Val94Asp	B_15-16	0.8286182388535513	0.4346601957037892	0.5271117293931666	-1.4385266186268382	0.19345320820333362	0.23776733895051386	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.9121737025441353	0.9038665772722724	0.5196626029245528	0.6999041480337252	0.7533438450279526	0.5676759064708177	0.7717973928206978	0.8952176473751895	0.8466737435367881	0.6800261511549602	0.9078439307368057	0.9059941880001205	0.3635544201209374	0.6114700426807156	0.5531345525306623	0.3592990546941453	0.8998892238077391	0.9183532170881501	CTNNA3	Val94Asp	NC_000010.11:67606868:A:T	281T>A	10	67606868	A	T	10	ENSG00000183230	71258	220347	CCSBVarC004024	ALE00004024	ENSP00000389714.1	CEGS2	CegsMutGDEh1031	E04	GDEhDisVCh_40088	A05	2	CegsMutGDDh1031	E04	VUSN2Hmut_GDN2h_05	H07	NULL	NULL	VUSmut_GDEh05	H07	1.0	1.0	1.0	1.0	1.0	5.0	1.0	0.0			1.0	1.0	99.0	Y	Y	N	N	Y	106528.0	single nucleotide variant	NM_013266.4(CTNNA3):c.281T>A (p.Val94Asp)	29119.0	CTNNA3	HGNC:2511	Pathogenic	1.0	Jan 01, 2013	587777134.0	-	RCV000087056	MONDO:MONDO:0000908,MedGen:C3810138,OMIM:615616	Arrhythmogenic right ventricular dysplasia 13	germline	germline	GRCh38	NC_000010.11	10	67606868.0	67606868.0	10q21.3	no assertion criteria provided	2.0	-	N	ClinGen:CA150594,UniProtKB:Q9UI47#VAR_070998,OMIM:607667.0001	1.0	100656.0	67606868.0	A	T	-	-	-	-	-	-	281T>A 	Val94Asp	NM_013266.4		Pathogenic	Pathogenic	100656	10	67606868.0	A	T	V	D	rs587777134	10	69366626	10	69036632	94	CTNNA3	ENSG00000183230	ENST00000433211	ENSP00000389714	Q9UI47	CTNA3_HUMAN	c.281T>A	p.Val94Asp	c.281T>A	p.Val94Asp	principal1	Y	1	YES	Select	-	GTT	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.83643	D	0.999	0.77914	D	0.998	0.88579	D	0.95	0.94956	A	simple_aae	5.0	95.0	1.79	0.46598	L	-5.05	0.86180	D	0.982	0.99191	-0.3553	0.73282	T	0.3404	0.70517	T	10	0.78779876	0.78182	D	0.125299	0.80623	D	0.740	0.90947	0.576	0.69978	Q9UI47	V94D	Loss of stability (P = 0.0507)| Gain of disorder (P = 0.2681)| Gain of ubiquitination at K96 (P = 0.2891)| Gain of glycosylation at K96 (P = 0.4318)| Loss of methylation at R95 (P = 0.4911)	0.908432749899	0.90682	0.8637418247221081	0.86255	0.0976149281938	0.10802	0.478553026915	0.35809	T	0.475079	0.80480	T	0.323036	0.84578	D	0.226243	0.84377	D	0.998002827167511	0.92920	D	0.829717	0.49373	T	0.910881	0.92265	0.94251776	0.97901	0.93309313	0.94464	0.92542046	0.96731	-16.39	0.98292	D	0.9757	0.90318	P	0.958237665873227	0.81479	0.97909707	0.95432	0.954	0.97964	.	.	.	.	.	.	5.293646	0.88897	29.8	0.98809900343512647	0.46710	0.934800	0.92846	D	0.777781904930076	0.84613	8.361063	0.780662048091782	0.88352	9.574563	5.66	5.66	0.87274	3.87	0.72853	9.049	0.93308	11.238000	0.90348	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.999	0.91597	925	0.17908	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Arrhythmogenic_right_ventricular_dysplasia_13	no_assertion_criteria_provided	NC_000010.11:g.67606868A>T	ClinGen:CA150594|OMIM:607667.0001|UniProtKB:Q9UI47#VAR_070998	C3810138	615616	.	.	Val	Asp	93.57	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			93.57	Aliphatic	Valine		Catenin alpha-3	Coiled coil									4.2								 V94-S90 (PAE:  1.0), V94-S98 (PAE: 1.0)		 V94-S90 (PAE:  1.0), V94-S98 (PAE: 1.0), V94-V132 (PAE: 1.0)								117									-58.6				-43.5						H (helix)	H (α-helix)												93.57	0.0	>90	<10	615616	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy	2	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13	false	0.9038665772722724	0.9121737025441353	false	false	false
POLR1C	POLR1C_Arg279Trp	B_7-8	-1.7837498431526742	0.12472751099995734	0.19543030845768541	-2.4628726121780793	0.04892840380358449	0.0694382219486292	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8618309004806279	0.8631562732049975	0.7435391873060564	0.7797537128681076	0.7947734998330676	0.7882708391382139	0.6583432526611225	0.6570264288554656	0.6973529460260176	0.6181031692466993	0.8530699423855133	0.8192301545449671	0.9181984256153054	0.9325205708106695	0.8621544797101977	0.8689752053654135	0.873242604024482	0.9044316464162888	POLR1C	Arg279Trp	NC_000006.12:43520961:C:T	835C>T	6	43520961	C	T	6	ENSG00000171453	5431	201911	CCSBVarC005348	ALE00005348	ENSP00000496044.1	CEGS2	CegsMutGDEh1031	G10	GDEhDisVCh_40034	E11	2	CegsMutGDDh1031	G10	VUSN2Hmut_GDN2h_05	C10	VUSMutpDEST2_05	G01	VUSmut_GDEh05	C10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	39772.0	single nucleotide variant	NM_203290.4(POLR1C):c.835C>T (p.Arg279Trp)	9533.0	POLR1C	HGNC:20194	Pathogenic	1.0	Dec 27, 2016	141156009.0	-	RCV000023800|RCV000382254|RCV000788033	MONDO:MONDO:0009558,MedGen:C1855433,OMIM:248390,Orphanet:861|MedGen:C3661900|MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637	Treacher Collins syndrome 3|not provided|Hypomyelinating leukodystrophy 11	germline;inherited	germline	GRCh38	NC_000006.12	6	43520961.0	43520961.0	6p21.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA259912,UniProtKB:O15160#VAR_064900,OMIM:610060.0005	3.0	30815.0	43520961.0	C	T	-	-	-	-	-	-	835C>T 	Arg279Trp	NM_203290.4	2.0	Pathogenic	Pathogenic	30815	6	43520961.0	C	T	R	W	rs141156009	6	43488699	6	43596677	279	POLR1C	ENSG00000171453	ENST00000642195	ENSP00000496044	O15160	RPAC1_HUMAN	c.835C>T	p.Arg279Trp	c.835C>T	p.Arg279Trp	principal1	Y	.	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.79703	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97016	.	.	.	.	3.53	0.92972	H	.	0.94135	.	.	0.94916	0.6397	0.92385	D	0.7212	0.90415	D	10	0.92820454	0.92076	D	0.206366	0.87002	D	.	0.96013	.	.	.	.	.	.	0.94175	.	.	.	.	0.654308378696	0.60535	T	0.899527	0.97998	D	0.212634	0.74892	D	0.373634	0.91140	D	0.84374862909317	0.49363	D	0.989101	0.96607	D	0.84441894	0.86752	0.82565457	0.89771	0.8590053	0.87848	0.84162885	0.90827	-12.055	0.85159	D	0.7861	0.76595	P	0.998882218684093	0.95246	0.99203520	0.97067	0.951	0.97790	.	.	.	.	.	.	5.431989	0.90845	31.0	0.99915164177573457	0.98380	0.814715	0.73590	D	0.642976803776804	0.75785	6.391082	0.522894417433362	0.69366	5.374038	4.89	2.92	0.32915	1.95	0.39072	4.018	0.56975	5.030000	0.46895	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.988	0.63383	216	0.91604	.	.	.	.	.	.	.	.	.	.	.	.	18	264690	6.800408E-5	.	6	109398	5.484560e-05	0	10	208078	4.805890e-05	0	10	236896	4.221260e-05	0	5	7164	6.979340e-04	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13384	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	5	7164	6.979340e-04	0	6	16182	3.707820e-04	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	2	13416	1.490760e-04	0	0	16724	0.000000e+00	0	2	89550	2.233390e-05	0	0	30608	0.000000e+00	0	6	16182	3.707820e-04	0	6	14868	4.035510e-04	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	2	17692	1.130450e-04	0	1	21622	4.624920e-05	0	1	102744	9.732930e-06	0	0	30526	0.000000e+00	0	6	14868	4.035510e-04	0	.	68	1614048	4.213010e-05	0	3	6084	4.930970e-04	0	11	74910	1.468430e-04	0	0	910	0.000000e+00	0	0	60004	0.000000e+00	0	0	29604	0.000000e+00	0	3	44890	6.683000e-05	0	3	64040	4.684570e-05	0	3	6084	4.930970e-04	0	47	1180028	3.982960e-05	0	0	91090	0.000000e+00	0	1	107370	9.313588525658936E-6	0	352	0	0	2682	0	1	8248	1.2124151309408342E-4	0	436	0	0	926	0	0	626	0	0	280	0	0	3448	0	1	8600	1.1627906976744187E-4	0	3308	0	2	124368	1.6081307088640165E-5	Treacher_Collins_syndrome_3|not_provided|Hypomyelinating_leukodystrophy_11	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.43520961C>T	ClinGen:CA259912|OMIM:610060.0005|UniProtKB:O15160#VAR_064900	C1855433|C3661900|C4225305	248390|616494	861|88637	DNA-directed RNA polymerase, RpoA/D/Rpb3-type|DNA-directed RNA polymerase, RpoA/D/Rpb3-type	Arg	Trp	94.39	0.10887096774193548																																																																																																																																																																																																																																																																																																																																																																																																																																																																													27			94.39	Positively-charged	Arginine		DNA-directed RNA polymerases I and III subunit RPAC1										-4.5			C:R279-N:G153 (PDBs: 7OB9, 7OBA, 7OBB)					 R279-D64 (PAE:  2.0), R279-R234 (PAE: 2.0), R279-E62 (PAE: 2.5)	R279-R234 (PDBs: 7A6H, 7AE1, 7AE3, 7AST, 7D58, 7D59, 7FJI, 7FJJ, 7OB9, 7OBA, 7OBB, 8A43, 8IUE, 8IUH), R279-E62 (PDBs: 7DN3, 7DU2), R279-D64 (PDBs: 8ITY, 8IUH)		R279-L236 (PDBs: 7A6H, 7AE3, 7AEA, 7FJI, 7FJJ, 7OB9, 7OBA, 7OBB)		R279-D64 (PDBs: 7A6H, 7AE1, 7AE3, 7AEA, 7DN3, 7DU2, 7FJI, 7FJJ, 7OB9, 7OBA, 7OBB, 8A43, 8ITY, 8IUE, 8IUH)					175									-56.9				-32.3				dbSNP: rs191582628; Variant type: LP/P; AA change: Arg279Gln; PTM type: Phosphorylation; PTM morphology: R*LDtFsREIFR; Var class: II&rs141156009		H (helix)	G (3₁₀-helix)	Helix											94.39	10.887096	>90	10-90	248390;616494	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic gynecological and obstetrical diseases; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility	8	TREACHER COLLINS SYNDROME 3; LEUKODYSTROPHY, HYPOMYELINATING, 11	false	0.8631562732049975	0.8618309004806279	false	false	false
MLH1	MLH1_Gln701His	B_11-12	9.412687406396024	0.00010146012199285268	0.000927541709085358	-0.047117075332861455	0.9649217826874207	0.9728744347425368	2024_12_Batch_11-12	true	true	true	true	true	true	true	true	false	false	false	false	0.9924188703925887	0.9929599308994734	0.8971264750267418	0.8897864757460319	0.8775922831122487	0.9284228568887991		0.8918231245703903		0.8999757825715797	0.9922741192465491	0.9919674189491982	0.9284228568887991	0.8633614416541071	0.8897864757460319	0.8942771674819039	0.9936457425523978	0.9928703218359793	MLH1	Gln701His	NC_000003.12:37049017:G:C	2103G>C	3	37049017	G	C	3	ENSG00000076242	2713	1005	CCSBVarC007400	ALE00007388	ENSP00000231790.3	Edgotyping3	VUSMutGDEh011	E11	GDEhDisVCh_40019	H08	1	VUSMutGDDh011	E11	VUSN2Hmut_GDN2h_04	H02	VUSMutpDEST2_02	E06	VUSmut_GDEh04	H02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	95523.0	single nucleotide variant	NM_000249.4(MLH1):c.2103G>C (p.Gln701His)	4292.0	MLH1	HGNC:7127	Pathogenic	1.0	Sep 05, 2013	63750603.0	-	RCV000075534|RCV000694604|RCV001014446|RCV001093697|RCV001549279|RCV003477468|RCV002288570	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MONDO:MONDO:0018630,MedGen:C1333990,OMIM:PS120435,Orphanet:443909|MedGen:C3661900|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144	Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|Lynch syndrome 1|Hereditary nonpolyposis colon cancer|not provided|Colorectal cancer, hereditary nonpolyposis, type 2	germline;unknown	germline	GRCh38	NC_000003.12	3	37049017.0	37049017.0	3p22.2	reviewed by expert panel	8.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008661	2.0	90049.0	37049017.0	G	C	-	-	-	-	-	-	2103G>C 	Gln701His	NM_000249.4	3.0	Pathogenic	Pathogenic	90049	3	37049017.0	G	C	Q	H	rs63750603	3	37090508	3	37065512	701	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.2103G>C	p.Gln701His	c.2103G>C	p.Gln701His	principal1	Y	1	YES	Select	+	CAG	3	2	G	G/G	G/G	G/G	G/G	0.11	0.91343	T	0.133	0.36968	T	0.902	0.49757	P	0.466	0.46636	P	0.96	0.97926	A	simple_aae	4.0	96.0	1.915	0.51044	L	-1.0	0.30311	N	0.594	0.67402	0.8129	0.94552	D	0.8480	0.94919	D	10	0.41147354	0.55906	D	0.063574	0.68898	D	0.492	0.77729	0.096	0.01278	P40692	Q701H	Loss of glycosylation at S702 (P = 0.1765)| Gain of disorder (P = 0.2146)| Loss of phosphorylation at S702 (P = 0.2195)| Gain of catalytic residue at E703 (P = 0.3245)| Loss of helix (P = 0.4763)	0.976338982497	0.97585	0.66452019388625	0.66226	0.0735682647296	0.08072	0.428551614285	0.28976	T	0.668586	0.90037	D	0.51196	0.94592	D	0.497618	0.94512	D	0.789552616904688	0.45373	D	0.770723	0.39888	T	0.10875404	0.25484	0.093194366	0.21964	0.11729815	0.27410	0.11494373	0.27683	-4.167	0.26298	T	0.1008	0.22822	B	0.933002679558366	0.78675	0.99932300	0.99296	0.87	0.92942	.	.	.	.	.	.	5.476244	0.91343	32.0	0.99638993176632018	0.76536	0.919793	0.89043	D	0.58835296692992	0.72302	5.80723	0.613177027338524	0.75765	6.392364	4.94	4.94	0.64600	.	.	8.049	0.89249	11.831000	0.97527	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.864	0.41056	154	0.93969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Lynch_syndrome|Lynch_syndrome_1|Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_nonpolyposis_colon_cancer|Hereditary_nonpolyposis_colorectal_neoplasms	reviewed_by_expert_panel	NC_000003.12:g.37049017G>C	ClinGen:CA008661	C4552100|C2936783|C1333991|C0027672|C3661900|C1333990|C0009405	120435|609310|PS120435	144|144|144|140162|443909	DNA mismatch repair protein Mlh1, C-terminal	Gln	His	36.5	0.9545454545454546																																																																																																																																																																																																																																																																																																																																																																																																																																																																													189			36.5	Polar/Neutral	Glutamine		DNA mismatch repair protein Mlh1										-3.5																		146									-66.6				85.6						C (loop/coil)	C (loop/coil)												36.5	95.454544	$\leqslant$50	$\geqslant$90	120435;609310	autosomal dominant	OMIM	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 1; LYNCH SYNDROME 2	true	0.9929599308994734	0.9924188703925887	true	true	true
AGXT	AGXT_Gly41Arg	B_7-8	0.8028800598994426	0.44844179251003846	0.537610538546545	2.7470039059918094	0.028627417262907413	0.043224429128595684	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.845945957343852	0.8110782969630279	0.519338728586523	0.4631572334300949	0.5159280491103293	0.49591192085888397	0.4829500371058447	0.5219563986853072	0.3982302581533804	0.5068553966859511	0.8207290247060643	0.8639042625448795	0.5088738046119232	0.5098996995353513	0.5280842087068094	0.5318220604870948	0.8014275692199914	0.8279876521428245	AGXT	Gly41Arg	NC_000002.12:240868986:G:A	121G>A	2	240868986	G	A	2	ENSG00000172482	70497	3791	CCSBVarC004880	ALE00004880	ENSP00000302620.3	Edgotyping3	VUSMutGDEh003	C12	GDEhDisVCh_40002	D02	2	VUSMutGDDh003	C12	VUSN2Hmut_GDN2h_01	A06	VUSMutpDEST2_14	G01	VUSmut_GDEh01	A06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	20683.0	single nucleotide variant	NM_000030.3(AGXT):c.121G>A (p.Gly41Arg)	189.0	AGXT	HGNC:341	Pathogenic	1.0	Feb 20, 2024	121908523.0	-	RCV000005998|RCV001221086|RCV000662315|RCV002509145	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900|Human Phenotype Ontology:HP:0000121,MONDO:MONDO:0001567,MedGen:C0027709;Human Phenotype Ontology:HP:0000102,Human Phenotype Ontology:HP:0000787,MONDO:MONDO:0008171,MedGen:C0392525|MONDO:MONDO:0002474,MedGen:C0020501,OMIM:PS259900,Orphanet:416	Primary hyperoxaluria, type I|not provided|Nephrocalcinosis;Nephrolithiasis|Primary hyperoxaluria	biparental;germline;unknown	germline	GRCh38	NC_000002.12	2	240868986.0	240868986.0	2q37.3	criteria provided, multiple submitters, no conflicts	13.0	-	N	ClinGen:CA340443,UniProtKB:P21549#VAR_000588,OMIM:604285.0005	3.0	5644.0	240868986.0	G	A	-	-	-	-	-	-	121G>A 	Gly41Arg	NM_000030.3	2.0	Pathogenic	Pathogenic	5644	2	240868986.0	G	A	G	R	rs121908523	2	241808403	2	241457076	41	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.121G>A	p.Gly41Arg	c.121G>A	p.Gly41Arg	principal1	Y	1	YES	Select	+	GGG	1	0	G	./.	./.	./.	./.	0.053	0.39016	T	0.09	0.40612	T	1.0	0.90580	D	0.99	0.78943	D	0.97	0.96253	A	simple_aae	3.0	97.0	.	.	.	-3.53	0.68566	D	0.975	0.98575	0.9509	0.96397	D	0.8757	0.95863	D	9	0.9950976	0.99974	D	0.674089	0.97282	D	0.748	0.91294	0.937	0.99098	P21549	G41R	Gain of MoRF binding (P = 0.0162)| Gain of methylation at G41 (P = 0.0631)| Loss of catalytic residue at G42 (P = 0.1221)| Loss of helix (P = 0.2022)| Gain of disorder (P = 0.2133)	0.920425721499	0.91901	0.9475539654478686	0.94705	0.258188672319	0.28082	0.452999591827	0.32312	T	0.706514	0.91513	D	0.34281	0.85926	D	0.355276	0.90455	D	0.963820278644562	0.66555	D	0.907009	0.67082	D	0.8027166	0.83876	0.6118891	0.77180	0.71003443	0.78362	0.46361843	0.68605	-8.516	0.64610	D	0.3789	0.58323	A	0.989034553527794	0.88019	0.34832240	0.78243	0.856	0.92124	.	.	.	.	.	.	3.371763	0.46675	22.3	0.99774955493904649	0.86271	0.824729	0.74363	D	0.292568740874358	0.55547	3.741239	0.126760966968527	0.45650	2.846944	4.42	4.42	0.52717	1.2	0.31051	3.805	0.55371	4.638000	0.44221	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.003	0.0525	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	13	264690	4.9114056E-5	.	1	109262	9.152310e-06	0	3	204274	1.468620e-05	0	3	233546	1.284540e-05	0	0	7158	0.000000e+00	0	0	17088	0.000000e+00	0	0	2320	0.000000e+00	0	0	9028	0.000000e+00	0	0	13310	0.000000e+00	0	0	42760	0.000000e+00	0	1	15684	6.375920e-05	0	1	15684	6.375920e-05	0	0	15726	0.000000e+00	0	0	30492	0.000000e+00	0	0	6142	0.000000e+00	0	0	13372	0.000000e+00	0	0	16648	0.000000e+00	0	2	86474	2.312830e-05	0	1	30592	3.268830e-05	0	1	30592	3.268830e-05	0	0	14456	0.000000e+00	0	0	34222	0.000000e+00	0	0	9522	0.000000e+00	0	0	17674	0.000000e+00	0	0	21546	0.000000e+00	0	2	100030	1.999400e-05	0	1	30510	3.277610e-05	0	1	30510	3.277610e-05	0	.	142	1612724	8.804980e-05	0	2	6084	3.287310e-04	0	1	74898	1.335150e-05	0	0	912	0.000000e+00	0	0	59998	0.000000e+00	0	0	29604	0.000000e+00	0	2	44880	4.456330e-05	0	1	62818	1.591900e-05	0	2	6084	3.287310e-04	0	129	1179996	1.093220e-04	0	2	91070	2.196110e-05	0	0	32728	0	0	122	0	0	146	0	0	3824	0	0	500	0	0	628	0	0	56	0	0	104	0	3	6972	4.302925989672978E-4	0	3946	0	0	202	0	3	45080	6.654835847382431E-5	Primary_hyperoxaluria|Nephrocalcinosis|Nephrolithiasis|not_provided|Primary_hyperoxaluria,_type_I	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240868986G>A	ClinGen:CA340443|OMIM:604285.0005|UniProtKB:P21549#VAR_000588	C0020501|C0027709|C0392525|C3661900|C0268164	PS259900|259900	416|416|93598	.	Gly	Arg	98.26	0.5119047619047619																																																																																																																																																																																																																																																																																																																																																																																																																																																																													43			98.26	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Alanine--glyoxylate aminotransferase										-0.4								 G41-I37 (PAE:  1.0)	G41-I37 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)	 G41-S271 (PAE:  1.0), G41-I37 (PAE: 1.0)	G41-S271 (PDBs: 1H0C, 6RV0, 3R9A), G41-I37 (PDBs: 5OG0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)							75									-66.1				-18.0						C (loop/coil)	T (turn)	Helix											98.26	51.19048	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.8110782969630279	0.845945957343852	false	false	false
LITAF	LITAF_Leu122Val	B_15-16	3.5171225798426944	0.013803433131317905	0.032499041523825746	-7.625143393551578	0.000134687293053999	0.0004993224532654523	2025_03_Batch_15-16	false	true	false	false	false	false	false	false	false	false	false	false	0.9601402970955333	0.9750583519701682	0.7364468650791973	0.6084043311722476	0.7712209623882255	0.7675275157641709	0.7037372736332301	0.7527495322393226	0.6174997791044036	0.680343972899228	0.9650828697745152	0.9477941596156056	0.8313177578951116	0.7896923925371283	0.5993088832400917	0.7925497572591667	0.9850338341658212	0.972486434575461	LITAF	Leu122Val	NC_000016.10:11553546:G:C	364C>G	16	11553546	G	C	16	ENSG00000189067	52920	2673	CCSBVarC006149	ALE00006149	ENSP00000483114.1	Edgotyping3	VUSMutGDEh006	B12	GDEhDisVCh_40036	C06	2	VUSMutGDDh006	B12	VUSN2Hmut_GDN2h_02	F05	VUSMutpDEST2_11	D12	VUSmut_GDEh02	F05	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	21099.0	single nucleotide variant	NM_001136472.2(LITAF):c.364C>G (p.Leu122Val)	9516.0	LITAF	HGNC:16841	Pathogenic	1.0	Apr 01, 2005	104894522.0	-	RCV000006432	MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083	Charcot-Marie-Tooth disease type 1C	germline	germline	GRCh38	NC_000016.10	16	11553546.0	11553546.0	16p13.13	no assertion criteria provided	1.0	-	N	OMIM:603795.0004,ClinGen:CA253743,UniProtKB:Q99732#VAR_024020	1.0	6060.0	11553546.0	G	C	-	-	-	-	-	-	364C>G 	Leu122Val	NM_001136472.2		Pathogenic	Pathogenic	6060	16	11553546.0	G	C	L	V	rs104894522	16	11647402	16	11554903	122	LITAF	ENSG00000189067	ENST00000576036	ENSP00000461667	Q99732	LITAF_HUMAN	c.364C>G	p.Leu122Val	c.364C>G	p.Leu122Val	principal1	Y	4	.	.	-	CTG	1	2	.	G/G	G/G	G/G	G/G	.	0.91343	.	0.013	0.92967	D	0.996	0.68795	D	0.939	0.67445	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.43	0.70264	M	.	0.43153	.	0.788	0.87898	0.8233	0.94681	D	0.8061	0.93430	D	9	0.7333299	0.74207	D	0.203118	0.86825	D	.	0.93204	0.562	0.68116	Q99732	L122V	Gain of loop (P = 0.069)| Gain of sheet (P = 0.0827)| Gain of catalytic residue at L122 (P = 0.1535)| Loss of helix (P = 0.2662)| Loss of glycosylation at S121 (P = 0.6659)	0.995537813079	0.99542	.	0.67166	.	0.58216	0.476400256157	0.35515	T	0.654846	0.89465	D	0.440814	0.92002	D	0.395422	0.91904	D	0.968088269233704	0.67915	D	.	0.68733	.	0.4819427	0.65706	0.34393427	0.59863	0.39775687	0.60252	0.3227181	0.57982	-8.127	0.62006	D	0.3709	0.58883	A	0.846993113440777	0.72955	0.98677510	0.96280	0.474	0.69744	.	.	.	.	.	.	4.555991	0.71803	25.7	0.99856663685707314	0.93553	0.790871	0.71860	D	0.620499508201471	0.74337	6.138602	0.584501064922534	0.73686	6.034835	5.48	4.53	0.54956	.	.	5.477	0.66601	5.650000	0.49255	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Charcot-Marie-Tooth_disease_type_1C	no_assertion_criteria_provided	NC_000016.10:g.11553546G>C	ClinGen:CA253743|OMIM:603795.0004|UniProtKB:Q99732#VAR_024020	C0270913	601098	101083	LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor	Leu	Val	87.9	0.25																																																																																																																																																																																																																																																																																																																																																																																																																																																																													41			87.9	Aliphatic	Leucine		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF	0.003		3.8								 L122-S118 (PAE:  2.0)		 L122-G126 (PAE:  4.5), L122-C132 (PAE: 7.5), L122-C127 (PAE: 7.0), L122-C131 (PAE: 9.0), L122-S118 (PAE: 2.0)								131									-71.8		Pocket 3: Mean pLDDT: 79.3, Volume: 304.37 Å³, Druggability score: 0		-34.8	Membrane-binding amphipathic helix					H (helix)	H (α-helix)												87.9	25.0	70-90	10-90	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.9750583519701682	0.9601402970955333	true	false	false
HPRT1	HPRT1_Met143Lys	B_7-8	-0.7966174433731525	0.45184075913120036	0.5400599811893572	-4.963148929391778	0.0016317713409293244	0.0036032495915828042	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.855601510875623	0.863635902441344	0.5095373833749103	0.6507445124279054	0.5943024110662979	0.5835204812603345	0.5296850299125674	0.5469655125849171	0.5905524742220041	0.5137722353683427	0.9108682543233395	0.9335768338123807	0.6373559326081017	0.6416393095476787	0.7109365506338068	0.5053025313814778	0.8164035505593485	0.7776261879388652	HPRT1	Met143Lys	NC_000023.11:134493533:T:A	428T>A	23	134493533	T	A	X	ENSG00000165704	7982	202800	CCSBVarC005937	ALE00005937	ENSP00000298556.7	CEGS2	CegsMutGDEh1041	G01	GDEhDisVCh_40052	F09	2	CegsMutGDDh1041	G01	VUSN2Hmut_GDN2h_08	D07	VUSMutpDEST2_07	B07	VUSmut_GDEh08	D07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25101.0	single nucleotide variant	NM_000194.3(HPRT1):c.428T>A (p.Met143Lys)	3251.0	HPRT1	HGNC:5157	Pathogenic	1.0	Mar 01, 1989	137852496.0	-	RCV000010765	MONDO:MONDO:0010298,MedGen:C0023374,OMIM:300322,Orphanet:510	Lesch-Nyhan syndrome	germline	germline	GRCh38	NC_000023.11	X	134493533.0	134493533.0	Xq26.2	no assertion criteria provided	1.0	-	N	ClinGen:CA255004,UniProtKB:P00492#VAR_006785,OMIM:308000.0037	1.0	10062.0	134493533.0	T	A	-	-	-	-	-	-	428T>A 	Met143Lys	NM_000194.3		Pathogenic	Pathogenic	10062	X	134493533.0	T	A	M	K	rs137852496	X	133627563	X	133455229	143	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.428T>A	p.Met143Lys	c.428T>A	p.Met143Lys	principal1	Y	1	YES	Select	+	ATG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.93	0.93829	A	simple_aae	7.0	93.0	4.015	0.96789	H	-5.49	0.85795	D	0.895	0.89455	1.0221	0.97566	D	0.9863	0.99590	D	9	0.9944078	0.99941	D	0.980661	0.99898	D	0.968	0.99597	0.942	0.99227	P00492	M143K	Gain of disorder (P = 0.0345)| Gain of ubiquitination at M143 (P = 0.0388)| Gain of MoRF binding (P = 0.1005)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2754)	0.999006825115	0.99898	0.9990878617612883	0.99908	3.59650284428	0.99815	0.785502672195	0.79724	T	0.994052	0.99984	D	0.727004	0.99952	D	0.806514	0.99952	D	0.99972265958786	0.98666	D	0.875712	0.58666	D	0.99620783	0.99984	0.99582493	0.99999	0.99620783	0.99984	0.99582493	0.99999	-15.96	0.97705	D	0.9922	0.94329	P	0.997813487996252	0.93584	0.99977118	0.99701	0.982	0.99374	.	.	.	.	.	.	4.578265	0.72349	25.8	0.98639162585599949	0.44144	.	.	.	.	.	.	.	.	.	5.56	5.56	0.83655	.	.	7.438	0.79637	7.810000	0.69451	0.664	0.57	1.0	0.71675	1.000000	0.68239	0.97	0.54336	218	0.91521	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Lesch-Nyhan_syndrome	no_assertion_criteria_provided	NC_000023.11:g.134493533T>A	ClinGen:CA255004|OMIM:308000.0037|UniProtKB:P00492#VAR_006785	C0023374	300322	510	Phosphoribosyltransferase domain|Phosphoribosyltransferase domain	Met	Lys	93.43	0.010638297872340425																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			93.43	Aliphatic	Methionine		Hypoxanthine-guanine phosphoribosyltransferase										1.9								 M143-L147 (PAE:  1.0)	M143-L147 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)	 M143-L147 (PAE:  1.0)	M143-L147 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4RAB, 4RAC, 4RAD, 4RAN, 5W8V, 6BNJ), M143-Y174 (PDBs: 4IJQ, 4RAO, 4RAQ, 6BNJ)							149									-68.2				-39.2				dbSNP: rs137852496; Variant type: LP/P; AA change: Met143Lys; PTM type: Phosphorylation; PTM morphology: EDIIDtGKtM*Q; Var class: II&rs137852496		H (helix)	H (α-helix)	Helix											93.43	1.0638298	>90	<10	300322	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	LESCH-NYHAN SYNDROME	false	0.863635902441344	0.855601510875623	false	false	false
THAP1	THAP1_Lys24Glu	B_7-8	1.7276117909877928	0.14463597822566143	0.21994802421259024	-1.1714155492429392	0.2858401777049257	0.3375268507648254	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7558047087261546	0.7830109407838932	0.554353895539943	0.7153582143743642	0.6131852874279569	0.598815922352627	0.5786801924555655	0.6676366561800169	0.7004220366133197	0.5427602583148713	0.7581217354437614	0.7462776151344871	0.6189516522496885	0.5587339186758967	0.7302943921354087	0.5659475327650145	0.8079001461240249	0.765331802317822	THAP1	Lys24Glu	NC_000008.11:42843025:T:C	70A>G	8	42843025	T	C	8	ENSG00000131931	1668	214084	CCSBVarC005992	ALE00005992	ENSP00000254250.3	CEGS2	CegsMutGDEh1030	F03	GDEhDisVCh_40085	H02	1	CegsMutGDDh1030	F03	VUSN2Hmut_GDN2h_05	B03	VUSMutpDEST2_01	E09	VUSmut_GDEh05	B03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	40310.0	single nucleotide variant	NM_018105.3(THAP1):c.70A>G (p.Lys24Glu)	55145.0	THAP1	HGNC:20856	Pathogenic	1.0	Feb 01, 2012	387907176.0	-	RCV000024329	MONDO:MONDO:0011264,MedGen:C1414216,OMIM:602629,Orphanet:98806	Torsion dystonia 6	germline	germline	GRCh38	NC_000008.11	8	42843025.0	42843025.0	8p11.21	no assertion criteria provided	1.0	-	N	ClinGen:CA129855,UniProtKB:Q9NVV9#VAR_066685,OMIM:609520.0008	1.0	31631.0	42843025.0	T	C	-	-	-	-	-	-	70A>G 	Lys24Glu	NM_018105.3		Pathogenic	Pathogenic	31631	8	42843025.0	T	C	K	E	rs387907176	8	42698168	8	42817325	24	THAP1	ENSG00000131931	ENST00000254250	ENSP00000254250	Q9NVV9	THAP1_HUMAN	c.70A>G	p.Lys24Glu	c.70A>G	p.Lys24Glu	principal1	Y	1	YES	Select	-	AAG	1	0	T	T/T	T/T	T/T	T/T	0.006	0.91343	D	0.077	0.92967	T	0.117	0.43501	B	0.078	0.42306	B	0.86	0.94956	A	simple_aae	14.0	86.0	.	.	.	-2.5	0.74082	D	0.845	0.84047	0.9967	0.97125	D	0.8623	0.95408	D	10	0.85201555	0.84217	D	0.432467	0.93997	D	0.789	0.93005	0.634	0.76939	Q9NVV9	K24E	Loss of methylation at K24 (P = 2e-04)| Loss of sheet (P = 0.1398)| Loss of disorder (P = 0.1567)| Gain of phosphorylation at S21 (P = 0.2312)| Loss of glycosylation at K24 (P = 0.364)	0.961618008205	0.96086	0.7819431469452279	0.78022	1.10467441802	0.77721	0.667407274246	0.62408	T	0.761746	0.93493	D	0.540626	0.95429	D	0.538795	0.95361	D	0.991933524608612	0.82167	D	0.736326	0.35066	T	0.9241139	0.93555	0.8417347	0.90834	0.87372404	0.89010	0.8537782	0.91649	-13.72	0.92127	D	0.9952	0.95614	P	0.705252779736053	0.67207	0.10470266	0.67000	0.874	0.93177	.	.	.	.	.	.	5.370076	0.90047	31.0	0.96763592305847901	0.31204	0.608334	0.59652	D	0.194944892903533	0.50713	3.280862	0.313586483365627	0.56107	3.79693	5.24	5.24	0.72825	3.64	0.66725	5.007	0.6382	7.746000	0.68123	-0.183	0.09969	1.0	0.71675	1.000000	0.68239	0.92	0.4558	298	0.88077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Torsion_dystonia_6	no_assertion_criteria_provided	NC_000008.11:g.42843025T>C	ClinGen:CA129855|OMIM:609520.0008|UniProtKB:Q9NVV9#VAR_066685	C1414216	602629	98806	THAP-type zinc finger|THAP-type zinc finger|THAP-type zinc finger|THAP-type zinc finger	Lys	Glu	86.31	0.6682926829268293																																																																																																																																																																																																																																																																																																																																																																																																																																																																													137			86.31	Positively-charged	Lysine		THAP domain-containing protein 1								0.5361		-3.9																		147		Mutation: K -> A. Strongly affects DNA-binding.							-75.1		Pocket 2: Mean pLDDT: 70.11, Volume: 491.24 Å³, Druggability score: 0.54		151.1				dbSNP: rs387907176; Variant type: LP/P; AA change: Lys24Glu; PTM type: Phosphorylation; PTM morphology: KDkPVsFHK*FP; Var class: II		B (undefined)	E (parallel sheets)	Beta strand										THAP-type	86.31	66.82927	70-90	10-90	602629	autosomal dominant	OMIM	Rare genetic neurological disorder	1	DYSTONIA 6, TORSION	false	0.7830109407838932	0.7558047087261546	false	false	false
ALAS2	ALAS2_Arg374Cys	B_7-8	0.2810913475705226	0.7969124956548266	0.8395492921680744	2.7267965181555045	0.052616500177801645	0.07421312669198003	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7539874213091344	0.7738200127567929	0.7495656881134767	0.7428000354262247	0.7668602546432678	0.7273180379301358	0.7273180379301358	0.6774952709356935	0.6821775897729635	0.7495656881134767	0.7738200127567929	0.7539874213091344		0.8562252383508421	0.8034224810794859				ALAS2	Arg374Cys	NC_000023.11:55014953:G:A	1120C>T	23	55014953	G	A	X	ENSG00000158578	8420	216664	CCSBVarC003769	ALE00003769	ENSP00000337131.4	CEGS2	CegsMutGDEh1041	B07	GDEhDisVCh_40062	E08	2	CegsMutGDDh1041	B07	VUSN2Hmut_GDN2h_08	B09	VUSMutpDEST2_08	C04	VUSmut_GDEh08	B09	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25514.0	single nucleotide variant	NM_000032.5(ALAS2):c.1231C>T (p.Arg411Cys)	212.0	ALAS2	HGNC:397	Pathogenic	1.0	May 08, 2023	137852305.0	-	RCV000011221|RCV003555997	MONDO:MONDO:0020721,MedGen:C4551511,OMIM:300751,Orphanet:75563|MedGen:C3661900	X-linked sideroblastic anemia 1|not provided	germline	germline	GRCh38	NC_000023.11	X	55014953.0	55014953.0	Xp11.21	criteria provided, single submitter	2.0	-	N	ClinGen:CA121087,UniProtKB:P22557#VAR_000563,OMIM:301300.0008	3.0	10475.0	55014953.0	G	A	-	-	-	-	-	-	1231C>T 	Arg411Cys	NM_000032.5	1.0	Pathogenic	Pathogenic	10475	X	55014953.0	G	A	R	C	rs137852305	X	55041386	X	55058111	411	ALAS2	ENSG00000158578	ENST00000650242	ENSP00000497236	P22557	HEM0_HUMAN	c.1231C>T	p.Arg411Cys	c.1231C>T	p.Arg411Cys	principal1	Y	.	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.93829	.	.	.	.	4.27	0.98099	H	.	0.96048	.	.	0.89904	1.0904	0.99253	D	0.9270	0.97583	D	9	0.99024296	0.99515	D	0.793306	0.98375	D	.	0.99434	0.926	0.98766	P22557	R411C	Gain of catalytic residue at M409 (P = 0.0031)| Loss of methylation at R411 (P = 0.1177)| Loss of solvent accessibility (P = 0.1434)| Loss of helix (P = 0.2022)| Loss of phosphorylation at S412 (P = 0.2495)	.	0.98860	.	.	.	.	0.738745808601	0.72740	T	0.97753	0.99794	D	0.637398	0.99873	D	0.677802	0.99872	D	0.999896049499512	0.99573	D	0.994213	0.98101	D	0.9892398	0.99719	0.96914613	0.99418	0.98637426	0.99547	0.96662426	0.99300	-10.888	0.80644	D	0.8033	0.78614	P	0.999861573656503	0.98431	0.99983668	0.99792	0.98	0.99294	.	.	.	.	.	.	5.40725	0.9054	31.0	0.99944253610214906	0.99869	.	.	.	.	.	.	.	.	.	5.55	5.55	0.83275	4.01	0.76498	9.923	0.98789	9.860000	0.82079	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.998	0.85369	104	0.95693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	not_provided|X-linked_sideroblastic_anemia_1	criteria_provided,_single_submitter	NC_000023.11:g.55014953G>A	ClinGen:CA121087|OMIM:301300.0008|UniProtKB:P22557#VAR_000563	C3661900|C4551511	300751	75563	Aminotransferase, class I/classII, large domain|Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase	Arg	Cys	97.19	0.43951612903225806																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.19	43.951614	>90	10-90	300751	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare inborn errors of metabolism; Rare genetic skin disease	4	ANEMIA, SIDEROBLASTIC, 1	false	0.7738200127567929	0.7539874213091344	false	false	false
DES	DES_Arg350Pro	B_7-8	-3.517811819867572	0.012551824486918245	0.032309952520234296	-7.661201895868445	0.00012002972908237871	0.0004646720524602636	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8765214567812678	0.9463350981944277	0.5522003843428667	0.6058363587624979	0.48202787975029404	0.5196895322084857	0.7217690383164193	0.6198664834085044	0.7605464254186183	0.6630484100905648	0.9392192666876849	0.8765214567812678	0.31761002610055217	0.3441892760920837	0.45112629210637745	0.4413523585951686	0.9534509297011706		DES	Arg350Pro	NC_000002.12:219421365:G:C	1049G>C	2	219421365	G	C	2	ENSG00000175084	12573	2303	CCSBVarC007860	ALE00007846	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	E10	GDEhDisVCh_40003	G10	1	VUSMutGDDh003	E10	VUSN2Hmut_GDN2h_01	A05	NULL	NULL	VUSmut_GDEh01	A05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	31874.0	single nucleotide variant	NM_001927.4(DES):c.1049G>C (p.Arg350Pro)	1674.0	DES	HGNC:2770	Pathogenic	1.0	Sep 26, 2023	57965306.0	-	RCV000056767|RCV000018329|RCV000651542	MedGen:C3661900|MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Neurogenic scapuloperoneal syndrome, Kaeser type|Desmin-related myofibrillar myopathy	germline;unknown	germline	GRCh38	NC_000002.12	2	219421365.0	219421365.0	2q35	criteria provided, multiple submitters, no conflicts	7.0	ACMG2022	N	OMIM:125660.0016,ClinGen:CA126906,UniProtKB:P17661#VAR_042454	3.0	16835.0	219421365.0	G	C	-	-	-	-	-	-	1049G>C 	Arg350Pro	NM_001927.4	2.0	Pathogenic	Pathogenic	16835	2	219421365.0	G	C	R	P	rs57965306	2	220286087	2	219994331	350	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1049G>C	p.Arg350Pro	c.1049G>C	p.Arg350Pro	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.015	0.61973	D	0.999	0.77914	D	0.979	0.74458	D	0.88	0.91311	A	simple_aae	12.0	88.0	3.33	0.90723	M	-5.62	0.86790	D	0.976	0.98669	1.0780	0.98817	D	0.9425	0.98112	D	9	0.9823242	0.98288	D	0.28935	0.90487	D	0.940	0.98707	0.883	0.96965	P17661	R350P	Loss of MoRF binding (P = 0.0506)| Loss of disorder (P = 0.2078)| Gain of glycosylation at R350 (P = 0.2156)| Loss of solvent accessibility (P = 0.2668)| Loss of stability (P = 0.3462)	0.996789237362	0.99671	0.9200262734812319	0.91928	1.73374694832	0.90732	0.744822919369	0.73636	T	0.914299	0.98393	D	0.54498	0.95581	D	0.54505	0.95516	D	0.997417449951172	0.91429	D	0.959804	0.84843	D	0.9621954	0.97460	0.9665217	0.99294	0.9685674	0.98094	0.967226	0.99329	-18.065	0.99551	D	0.985	0.92211	P	0.999228307506272	0.96001	0.99869890	0.98916	1	0.99985	.	.	.	.	.	.	5.989076	0.94281	34.0	0.99762094998897388	0.85185	0.993513	0.99999	D	1.018794210736	0.96274	14.52392	0.952482693911525	0.97464	16.19705	5.24	5.24	0.72825	4.05	0.77340	9.864	0.98446	11.713000	0.94693	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Desmin-related_myofibrillar_myopathy|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219421365G>C	ClinGen:CA126906|OMIM:125660.0016|UniProtKB:P17661#VAR_042454	C3661900|C1832370|C1867005	601419|181400	363543|98909|85146	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Pro	96.3	0.5685483870967742																																																																																																																																																																																																																																																																																																																																																																																																																																																																													141			96.3	Positively-charged	Arginine		Desmin							IF rod			-4.5								 R350-M346 (PAE:  1.0), R350-D354 (PAE: 1.0)		 R350-M346 (PAE:  1.0), R350-D354 (PAE: 1.0)								175									-61.0				-43.1	Interaction with NEB; Coil 2B					H (helix)	H (α-helix)												96.3	56.85484	>90	10-90	181400;601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; MYOPATHY, MYOFIBRILLAR, 1	false	0.9463350981944277	0.8765214567812678	false	false	false
KRT6A	KRT6A_Asn171Asp	B_7-8	-1.5051158873817092	0.18300025453549157	0.2622134179765858	-0.6023262850365011	0.5659489774487575	0.616696183858949	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9168628782425411	0.8724250898501824	0.7336347184914999	0.663914134412357	0.6423994676170423	0.772543257209767	0.7745399975613174	0.7999455064594925	0.8026260894030507	0.7060583784432358	0.876650122977493	0.9168628782425411	0.7705465168582166	0.48485342877459203	0.5252021794216634	0.7612110585397639	0.8682000567228719		KRT6A	Asn171Asp	NC_000012.12:52492678:T:C	511A>G	12	52492678	T	C	12	ENSG00000205420	4870	215274	CCSBVarC003668	ALE00003668	ENSP00000369317.3	CEGS2	CegsMutGDEh1045	A04	GDEhDisVCh_40048	D10	2	CegsMutGDDh1045	A04	VUSN2Hmut_GDN2h_09	C09	VUSMutpDEST2_04	E09	VUSmut_GDEh09	C09	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77482.0	single nucleotide variant	NM_005554.4(KRT6A):c.511A>G (p.Asn171Asp)	3853.0	KRT6A	HGNC:6443	Pathogenic	1.0	Feb 15, 2016	62635294.0	-	RCV000057007|RCV000128818	MedGen:C3661900|MONDO:MONDO:0014324,MedGen:C3714948,OMIM:615726,Orphanet:2309	not provided|Pachyonychia congenita 3	germline	germline	GRCh38	NC_000012.12	12	52492678.0	52492678.0	12q13.13	criteria provided, single submitter	3.0	-	N	ClinGen:CA217351,UniProtKB:P02538#VAR_072450	3.0	66585.0	52492678.0	T	C	-	-	-	-	-	-	511A>G 	Asn171Asp	NM_005554.4	1.0	Pathogenic	Pathogenic	66585	12	52492678.0	T	C	N	D	rs62635294	12	52886462	12	51172729	171	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.511A>G	p.Asn171Asp	c.511A>G	p.Asn171Asp	principal1	Y	1	YES	Select	-	AAC	1	0	.	./.	./.	./.	./.	0.006	0.61594	D	0.005	0.72530	D	0.969	0.56783	D	0.859	0.61177	P	0.87	0.90832	A	simple_aae	13.0	87.0	4.66	0.99381	H	-4.33	0.76771	D	0.991	0.99781	1.0988	0.99610	D	0.9541	0.98508	D	10	0.9730857	0.96939	D	0.141986	0.82388	D	0.921	0.98001	0.866	0.96082	P02538	N171D	Gain of ubiquitination at K173 (P = 0.0393)| Loss of MoRF binding (P = 0.0446)| Gain of catalytic residue at A175 (P = 0.0718)| Loss of methylation at K173 (P = 0.0941)| Gain of phosphorylation at T169 (P = 0.2044)	0.946748225326	0.94575	0.8819534256453513	0.88089	1.04261981764	0.75707	0.756456792355	0.75358	T	0.907135	0.98203	D	0.276722	0.80894	D	0.159716	0.80647	D	0.998521149158478	0.94345	D	0.89931	0.64637	D	0.86057913	0.87968	0.8748143	0.93108	0.86057913	0.87969	0.8748143	0.93108	-14.058	0.93257	D	0.9959	0.95983	P	0.995747100686538	0.91565	0.92550886	0.92197	0.997	0.99892	.	.	.	.	.	.	4.315679	0.66073	24.9	0.99737464493099037	0.83280	0.872294	0.79332	D	0.936205862997089	0.93381	12.02577	0.854173595064239	0.93222	11.92517	5.31	5.31	0.75027	3.9	0.73887	7.811	0.84671	.	.	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.997	0.79771	764	0.49916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Pachyonychia_congenita_3	criteria_provided,_single_submitter	NC_000012.12:g.52492678T>C	ClinGen:CA217351|UniProtKB:P02538#VAR_072450	C3661900|C3714948	615726	2309	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Asn	Asp	83.26	0.5732484076433121																																																																																																																																																																																																																																																																																																																																																																																																																																																																													90			83.26	Polar/Neutral	Asparagine		Keratin, type II cytoskeletal 6A							IF rod			-3.5								 N171-I167 (PAE:  3.0), N171-A175 (PAE: 2.5)		 N171-I167 (PAE:  3.0), N171-A175 (PAE: 2.5)								132									-66.5				-35.6	Coil 1A			dbSNP: rs62635294; Variant type: LP/P; AA change: Asn171Asp; PTM type: Phosphorylation; PTM morphology: REQIktLN*NkF; Var class: II&rs59685571		H (helix)	H (α-helix)												83.26	57.324837	70-90	10-90	615726	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2	PACHYONYCHIA CONGENITA 3	false	0.8724250898501824	0.9168628782425411	false	false	false
LITAF	LITAF_Gly112Ser	B_15-16	2.3008168845221455	0.054924940485426565	0.10010175222057704	-6.7868796717345	0.000256245915976968	0.000819183372504767	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.9051307928381711	0.8984537523613932	0.513117775543031	0.7567558101614815	0.7643597395791766	0.6592662226067938	0.5889356496254476	0.7861873167346163	0.7370626218015685	0.4994040841042968	0.8902459592763186	0.9101275948682892	0.72959679558814	0.742532162423737	0.7764489985213945	0.5268314669817651	0.9066615454464679	0.900133990808053	LITAF	Gly112Ser	NC_000016.10:11553576:C:T	334G>A	16	11553576	C	T	16	ENSG00000189067	52920	2677	CCSBVarC002195	ALE00002195	ENSP00000483114.1	Edgotyping3	VUSMutGDEh006	F12	NULL	NULL	NULL	VUSMutGDDh006	F12	VUSN2Hmut_GDN2h_02	B06	VUSMutpDEST2_12	B01	VUSmut_GDEh02	B06	0.0		1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	21096.0	single nucleotide variant	NM_001136472.2(LITAF):c.334G>A (p.Gly112Ser)	9516.0	LITAF	HGNC:16841	Pathogenic	1.0	Jan 31, 2024	104894519.0	-	RCV000006429|RCV000235719|RCV001173620|RCV002321474	MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083|MedGen:C3661900|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MeSH:D030342,MedGen:C0950123	Charcot-Marie-Tooth disease type 1C|not provided|Charcot-Marie-Tooth disease|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000016.10	16	11553576.0	11553576.0	16p13.13	criteria provided, multiple submitters, no conflicts	13.0	-	N	ClinGen:CA340507,UniProtKB:Q99732#VAR_024017,OMIM:603795.0001	3.0	6057.0	11553576.0	C	T	-	-	-	-	-	-	334G>A 	Gly112Ser	NM_001136472.2	2.0	Pathogenic	Pathogenic	6057	16	11553576.0	C	T	G	S	rs104894519	16	11647432	16	11554933	112	LITAF	ENSG00000189067	ENST00000622633	ENSP00000483114	Q99732	LITAF_HUMAN	c.334G>A	p.Gly112Ser	c.334G>A	p.Gly112Ser	principal1	Y	1	YES	Select	-	GGT	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	0.0	0.92967	D	0.998	0.73231	D	0.918	0.65388	D	.	0.99291	.	.	.	.	1.745	0.45066	L	.	0.89237	.	0.923	0.97765	0.8356	0.94834	D	0.8738	0.95798	D	9	0.9203533	0.91294	D	0.287085	0.90412	D	.	0.94221	.	.	.	.	.	0.999170694822	0.99914	.	0.82501	.	0.57972	0.606606245041	0.53769	T	0.886184	0.97630	D	0.471762	0.93347	D	0.439877	0.93264	D	0.998103499412537	0.93183	D	.	0.79408	.	0.849695	0.87142	0.7774505	0.86709	0.847996	0.87018	0.7873241	0.87323	-10.652	0.77788	D	.	0.81648	.	0.989098267452275	0.88042	0.99533650	0.97760	0.651	0.80578	.	.	.	.	.	.	4.87386	0.7991	27.2	0.99800729739055716	0.88559	0.841107	0.75744	D	0.497950794585184	0.66796	5.019632	0.402186994918846	0.61493	4.373965	5.39	5.39	0.77583	.	.	5.693	0.68	5.773000	0.49829	0.599	0.40292	0.997	0.40243	1.000000	0.68239	0.721	0.34842	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614082	6.195470e-07	0	1	1180018	8.474450e-07	0	0	75004	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29606	0.000000e+00	0	0	44878	0.000000e+00	0	0	64004	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180018	8.474450e-07	0	0	91072	0.000000e+00	0	1	100080	9.992006394884094E-6	0	322	0	0	2680	0	0	8098	0	0	436	0	0	928	0	0	620	0	0	276	0	0	3464	0	0	8420	0	0	3300	0	1	116904	8.554027236022719E-6	Charcot-Marie-Tooth_disease_type_1C|Charcot-Marie-Tooth_disease|Inborn_genetic_diseases|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.11553576C>T	ClinGen:CA340507|OMIM:603795.0001|UniProtKB:Q99732#VAR_024017	C0270913|C0007959|C0950123|C3661900	601098|PS118220	101083|166	LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor	Gly	Ser	87.33	0.08333333333333333																																																																																																																																																																																																																																																																																																																																																																																																																																																																													7			87.33	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF			-0.4								 G112-W116 (PAE:  2.5)		 G112-W116 (PAE:  2.5)								75									-81.7				-177.1	Membrane-binding amphipathic helix					C (loop/coil)	C (loop/coil)												87.33	8.333334	70-90	<10	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.8984537523613932	0.9051307928381711	false	false	false
TPM1	TPM1_Lys248Glu	B_15-16	0.1784995283299159	1.0	1.0	-1.121493453840772	1.0	1.0	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6965262277148445	0.7012684174077543	0.6540934995722205	0.6271100792672561	0.6846463305405286	0.6759902422772982	0.6983026205996903	0.6491538446500953	0.6159565280765409	0.6954402208063213	0.628800273274657	0.6585100850542824	0.6536778639549061	0.7201388164309619	0.6382636304579715	0.6127467783381196	0.7737365615408515	0.7345423703754065	TPM1	Lys248Glu	NC_000015.10:63062615:A:G	742A>G	15	63062615	A	G	15	ENSG00000140416	4723	201747	CCSBVarC005648	ALE00005648	ENSP00000288398.6	CEGS2	CegsMutGDEh1042	F12	GDEhDisVCh_40050	F09	2	CegsMutGDDh1042	F12	VUSN2Hmut_GDN2h_09	B02	VUSMutpDEST2_04	C08	VUSmut_GDEh09	B02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	40561.0	single nucleotide variant	NM_001018005.2(TPM1):c.742A>G (p.Lys248Glu)	7168.0	TPM1	HGNC:12010	Pathogenic	1.0	Aug 01, 2011	199476319.0	-	RCV000024597|RCV000054794	MedGen:CN517202|MONDO:MONDO:0800346,MedGen:C3808145	not provided|Left ventricular noncompaction 9	germline	germline	GRCh38	NC_000015.10	15	63062615.0	63062615.0	15q22.2	no assertion criteria provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018317,UniProtKB:P09493#VAR_070122,Leiden Muscular Dystrophy (TPM1):TPM1_00032,OMIM:191010.0006	3.0	31901.0	63062615.0	A	G	-	-	-	-	-	-	742A>G 	Lys248Glu	NM_001018005.2		Pathogenic	Pathogenic	31901	15	63062615.0	A	G	K	E	rs199476319	15	63354814	15	61141867	248	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.742A>G	p.Lys248Glu	c.742A>G	p.Lys248Glu	alternative1	Y	1	YES	Select	+	AAA	1	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.118	0.53775	T	0.632	0.50486	P	0.642	0.65825	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.79	0.95254	H	-2.94	0.65771	D	0.906	0.94561	1.0855	0.99065	D	0.9609	0.98739	D	10	0.8251754	0.81512	D	0.586486	0.96306	D	0.867	0.95976	.	0.53429	.	.	.	0.993821467443	0.99367	.	0.92724	.	0.98729	0.876287102699	0.93445	D	0.975177	0.99754	D	0.580042	0.96967	D	0.595413	0.96917	D	0.997629523277283	0.91945	D	0.883312	0.61383	D	0.8941155	0.90733	0.86133474	0.92167	0.89568263	0.90872	0.8159123	0.89140	-14.331	0.98091	D	0.9555	0.88984	P	0.999696174728361	0.97521	0.99974173	0.99666	0.92	0.95929	.	.	.	.	.	.	5.153747	0.8635	28.9	0.99797422286373971	0.88293	0.954629	0.97178	D	0.620156449320536	0.74313	6.134904	0.631870925579193	0.77140	6.646458	6.06	4.94	0.64600	3.39	0.61436	9.325	0.96016	11.267000	0.91286	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	786	0.46777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Left_ventricular_noncompaction_9|not_provided	no_assertion_criteria_provided	NC_000015.10:g.63062615A>G	ClinGen:CA018317|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00032|OMIM:191010.0006|UniProtKB:P09493#VAR_070122	C3808145|CN517202	.	.	.	Lys	Glu	92.63	0.7658536585365854																																																																																																																																																																																																																																																																																																																																																																																																																																																																													157	Morphology: FAERSVtkLEKsIDD; Domain: Tropomyosin		92.63	Positively-charged	Lysine		Tropomyosin alpha-1 chain	Coiled coil							0.1619		-3.9								 K248-R244 (PAE:  2.0), K248-S252 (PAE: 2.5)		 K248-R244 (PAE:  2.0), K248-S252 (PAE: 2.5)								147									-67.6		Pocket 2: Mean pLDDT: 88.25, Volume: 398.5 Å³, Druggability score: 0.16		-43.6				dbSNP: rs199476319; Variant type: LP/P; AA change: Lys248Glu; PTM type: Phosphorylation; PTM morphology: AERSVtk*LEKs; Var class: II&rs199476319		H (helix)	H (α-helix)										Morphology: FAERSVtkLEKsIDD; Domain: Tropomyosin		92.63	76.585365	>90	10-90		unknown		Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3		false	0.7012684174077543	0.6965262277148445	false	false	false
SMAD3	SMAD3_Pro263Ala	B_15-16	1.9642518756355836	0.09025248344437437	0.15094767371169443	4.408238972823329	0.0031254784632835744	0.00624075405889593	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7389557854272707	0.7484070376348918	0.5894564943406584	0.6289482478710384	0.5603081511301683	0.586752067354557	0.5096450971078037	0.4499782897573276	0.525739754555711	0.5249103477799739	0.5736251862475135	0.5566955103357535	0.6638590376013104	0.6706380125030089	0.7321567411863659	0.654002640901343	0.9231888890222701	0.9212160605187879	SMAD3	Pro263Ala	NC_000015.10:67181369:C:G	787C>G	15	67181369	C	G	15	ENSG00000166949	11805	2148	CCSBVarC007729	ALE00007715	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	H01	GDEhDisVCh_40014	E08	2	VUSMutGDDh005	H01	VUSN2Hmut_GDN2h_01	C11	VUSMutpDEST2_09	D04	VUSmut_GDEh01	C11	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	3.0	1.0	1.0	1.0	2.0	Y	Y	Y	N	Y	210281.0	single nucleotide variant	NM_005902.4(SMAD3):c.787C>G (p.Pro263Ala)	4088.0	SMAD3	HGNC:6769	Pathogenic	1.0	Jun 16, 2023	863223739.0	-	RCV000471572	MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000015.10	15	67181369.0	67181369.0	15q22.33	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA321192	2.0	213764.0	67181369.0	C	G	-	-	-	-	-	-	787C>G 	Pro263Ala	NM_005902.4	1.0	Pathogenic	Pathogenic	213764	15	67181369.0	C	G	P	A	rs863223739	15	67473707	15	65260761	263	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.787C>G	p.Pro263Ala	c.787C>G	p.Pro263Ala	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.003	0.92967	D	0.999	0.77914	D	0.999	0.92348	D	0.48	0.85999	N	simple_aae	52.0	48.0	3.665	0.94230	H	-7.68	0.96441	D	0.837	0.83220	1.0987	0.99606	D	0.9627	0.98801	D	10	0.9730288	0.96932	D	0.565736	0.96047	D	0.941	0.98743	0.852	0.95292	P84022	P263A	Loss of disorder (P = 0.0839)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T261 (P = 0.2342)| Gain of catalytic residue at P263 (P = 0.3506)| Loss of stability (P = 0.4429)	0.929500782601	0.92823	0.7315438461612401	0.72957	2.40152624107	0.97187	0.893437027931	0.95675	D	0.991787	0.99970	D	0.434868	0.91714	D	0.386881	0.91612	D	0.999440014362335	0.97407	D	0.981402	0.93728	D	0.960082	0.97245	0.8714862	0.92874	0.960082	0.97245	0.8714862	0.92875	-11.8	0.85039	D	0.9877	0.95515	P	0.999389393789621	0.96432	0.99357180	0.97361	0.948	0.97614	.	.	.	.	.	.	5.13942	0.86066	28.8	0.99654784598235202	0.77530	0.916968	0.88350	D	0.944060794945803	0.93710	12.24773	0.862710509526015	0.93700	12.24452	5.1	5.1	0.68875	.	.	7.803	0.84582	7.629000	0.62706	0.594	0.32546	1.0	0.71675	1.000000	0.68239	0.978	0.57275	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_single_submitter	NC_000015.10:g.67181369C>G	ClinGen:CA321192	C4707243	PS607086	91387	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Pro	Ala	92.14	0.8014705882352942																																																																																																																																																																																																																																																																																																																																																																																																																																																																													109			92.14	Special, No backbone hydrogen	Proline		Mothers against decapentaplegic homolog 3							MH2			1.6									P263-R268 (PDBs: 1MJS, 1MK2)									115									-86.7				-9.0						C (loop/coil)	S (bend)												92.14	80.14706	>90	10-90		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.7484070376348918	0.7389557854272707	false	false	false
DCX	DCX_Thr203Arg	B_7-8	2.452306279246002	0.04395835426175361	0.0838765800598895	-6.767458701896348	0.0002608204174409019	0.000830912267368151	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8525528179654978	0.8377470722253553	0.8111844751779491	0.8795269089982646	0.7265031088880005	0.8176098526503734	0.9739619277271241	0.9558487242311557	0.969765543411201	0.9419647876636108	0.9237955383769884	0.9138286633267623	0.6612577775736229	0.4971574935448453	0.7892882745853281	0.6804041626922875	0.7516986060737221	0.7912769726042334	DCX	Thr203Arg	NC_000023.11:111401087:G:C	608C>G	23	111401087	G	C	X	ENSG00000077279	8416	216650	CCSBVarC005204	ALE00005204	ENSP00000419861.1	CEGS2	CegsMutGDEh1036	F08	GDEhDisVCh_40049	H05	1	CegsMutGDDh1036	F08	VUSN2Hmut_GDN2h_07	C06	VUSMutpDEST2_08	D02	VUSmut_GDEh07	C06	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26641.0	single nucleotide variant	NM_001195553.2(DCX):c.608C>G (p.Thr203Arg)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	Jun 28, 2021	104894782.0	-	RCV000012365|RCV000012364|RCV001778649	MedGen:C1848070|MONDO:MONDO:0010239,MedGen:C4551968,OMIM:300067,Orphanet:2148|MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	Subcortical laminar heterotopia, X-linked|Lissencephaly type 1 due to doublecortin gene mutation|Neurodevelopmental disorder	germline	germline	GRCh38	NC_000023.11	X	111401087.0	111401087.0	Xq23	criteria provided, single submitter	2.0	-	N	ClinGen:CA121598,UniProtKB:O43602#VAR_007835,OMIM:300121.0006	3.0	11602.0	111401087.0	G	C	-	-	-	-	-	-	608C>G 	Thr203Arg	NM_001195553.2	1.0	Pathogenic	Pathogenic	11602	X	111401087.0	G	C	T	R	rs104894782	X	110644315	X	110530971	203	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.608C>G	p.Thr203Arg	c.608C>G	p.Thr203Arg	alternative1	Y	1	.	.	-	ACA	2	0	G	G/G	G/G	G/G	G/G	.	0.43243	.	.	0.79703	.	.	.	.	.	.	.	.	0.97926	.	.	.	.	.	.	.	.	0.82662	.	.	0.99617	0.6918	0.93048	D	0.7943	0.93011	D	9	0.91953695	0.91212	D	0.857019	0.98898	D	.	0.95495	.	.	.	.	.	.	0.99864	.	0.97800	.	.	0.837765097618	0.87732	D	.	0.90416	.	0.560801	0.96216	D	0.567775	0.96156	D	0.993919014930725	0.84800	D	0.993001	0.97738	D	0.9682064	0.98060	0.92548215	0.96735	0.9647794	0.97721	0.9359697	0.97464	-13.443	0.91123	D	0.999	0.98378	LP	0.999913803802632	0.98806	0.99959310	0.99514	0.962	0.98414	.	.	.	.	.	.	4.780111	0.77513	26.7	0.99397209522653751	0.62662	.	.	.	.	.	.	.	.	.	4.74	4.74	0.59667	.	.	10.003	0.9969	11.880000	0.98809	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	889	0.27289	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Neurodevelopmental_disorder|Subcortical_laminar_heterotopia,_X-linked|Lissencephaly_type_1_due_to_doublecortin_gene_mutation	criteria_provided,_single_submitter	NC_000023.11:g.111401087G>C	ClinGen:CA121598|OMIM:300121.0006|UniProtKB:O43602#VAR_007835	C1535926|C1848070|C4551968	300067	2148	.	Thr	Arg	79.91	0.5563380281690141																																																																																																																																																																																																																																																																																																																																																																																																																																																																													79			79.91	Polar/Neutral	Threonine		Neuronal migration protein doublecortin							Doublecortin 2			-0.7				C:T203-A:K163 (PDBs: 6RF2)					T203-L198 (PDBs: 6FNZ), T203-Q209 (PDBs: 6FNZ)		T203-L199 (PDBs: 6FNZ), T203-L198 (PDBs: 6FNZ)							119									-113.6	Morphology: RVLLNKKtAHsFEQV; Domain: DCX			-26.5				dbSNP: rs104894782; Variant type: LP/P; AA change: Thr203Arg; PTM type: Phosphorylation; PTM morphology: LLNKKtAHsFE; Var class: I&rs587783570		C (loop/coil)	T (turn)	Turn											79.91	55.6338	70-90	10-90	300067	x-linked	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	LISSENCEPHALY, X-LINKED, 1	false	0.8377470722253553	0.8525528179654978	false	false	false
COMP	COMP_Thr585Arg	B_7-8	-2.9086459133911786	0.06206479525216109	0.11037593941492335	0.7626284330977129	0.47059797031235207	0.5239971332058047	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.838378620534075	0.8913593085393736	0.9028804196792148	0.7895746613997598	0.6966801804326865	0.9260954943916958	0.9260954943916958	0.7237598531530781	0.8317469691172854	0.9028804196792148	0.8569962437441725	0.838378620534075		0.669600507712295	0.7474023536822343		0.9257223733345747		COMP	Thr585Arg	NC_000019.10:18785056:G:C	1754C>G	19	18785056	G	C	19	ENSG00000105664	56661	219643	CCSBVarC006430	ALE00006430	ENSP00000222271.2	CEGS2	CegsMutGDEh1045	D06	GDEhDisVCh_40037	H04	1	CegsMutGDDh1045	D06	VUSN2Hmut_GDN2h_09	H09	VUSMutpDEST2_13	D10	VUSmut_GDEh09	H09	1.0	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	49416.0	single nucleotide variant	NM_000095.3(COMP):c.1754C>G (p.Thr585Arg)	1311.0	COMP	HGNC:2227	Pathogenic	1.0	Oct 22, 2021	312262900.0	-	RCV000033886|RCV002496507|RCV002054552	MONDO:MONDO:0008322,MedGen:C0410538,OMIM:177170,Orphanet:750|MONDO:MONDO:0007561,MedGen:C1838280,OMIM:132400,Orphanet:93308;MONDO:MONDO:0008322,MedGen:C0410538,OMIM:177170,Orphanet:750;MONDO:MONDO:0030883,MedGen:C5436916,OMIM:619161|Human Phenotype Ontology:HP:0002654,MONDO:MONDO:0016648,MedGen:C0026760,OMIM:PS132400,Orphanet:251	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|Multiple epiphyseal dysplasia type 1;Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome;Carpal tunnel syndrome 2|Multiple epiphyseal dysplasia	germline;unknown	germline	GRCh38	NC_000019.10	19	18785056.0	18785056.0	19p13.11	criteria provided, single submitter	2.0	-	N	ClinGen:CA343860,UniProtKB:P49747#VAR_007642	3.0	40994.0	18785056.0	G	C	-	-	-	-	-	-	1754C>G 	Thr585Arg	NM_000095.3	1.0	Pathogenic	Pathogenic	40994	19	18785056.0	G	C	T	R	rs312262900	19	18895866	19	18756866	585	COMP	ENSG00000105664	ENST00000222271	ENSP00000222271	P49747	COMP_HUMAN	c.1754C>G	p.Thr585Arg	c.1754C>G	p.Thr585Arg	principal1	Y	1	YES	Select	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.215	0.89201	M	-5.73	0.87641	D	0.885	0.97658	1.0443	0.97993	D	0.9084	0.96957	D	10	0.98425806	0.98595	D	0.735445	0.97871	D	0.962	0.99434	0.91	0.98179	P49747	T585R	Gain of methylation at T585 (P = 0.0177)| Loss of glycosylation at T585 (P = 0.0302)| Gain of catalytic residue at T585 (P = 0.0387)| Gain of sheet (P = 0.0827)| Loss of phosphorylation at T585 (P = 0.1169)	0.945709433568	0.94470	0.9269030736480707	0.92622	.	.	0.787881731987	0.80085	T	0.945272	0.99160	D	0.517029	0.94759	D	0.5049	0.94682	D	0.998580694198608	0.94516	D	0.991718	0.97398	D	0.97155344	0.98377	0.92121005	0.96433	0.97308856	0.98516	0.9201887	0.96361	-16.297	0.98176	D	0.9827	0.91682	P	0.999485093924508	0.96737	0.99835086	0.98743	1	0.99985	.	.	.	.	.	.	5.443299	0.90978	32.0	0.99501119829462292	0.68072	0.970153	0.99244	D	0.846925500721307	0.88872	9.768426	0.735685123220331	0.85003	8.476242	4.19	4.19	0.48586	4.3	0.81401	9.824	0.98309	11.795000	0.96488	0.614	0.49322	1.0	0.71675	1.000000	0.68239	0.947	0.4917	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pseudoachondroplastic_spondyloepiphyseal_dysplasia_syndrome|Multiple_epiphyseal_dysplasia_type_1|Carpal_tunnel_syndrome_2|Multiple_epiphyseal_dysplasia	criteria_provided,_single_submitter	NC_000019.10:g.18785056G>C	ClinGen:CA343860|UniProtKB:P49747#VAR_007642	C0410538|C1838280|C5436916|C0026760	177170|132400|619161|PS132400	750|93308|251	Thrombospondin, C-terminal|Thrombospondin, C-terminal	Thr	Arg	98.34	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.34	Polar/Neutral	Threonine		Cartilage oligomeric matrix protein							TSP C-terminal			-0.7								 T585-A735 (PAE:  1.0), T585-L272 (PAE: 1.0)	T585-A735 (PDBs: 3FBY), T585-R683 (PDBs: 3FBY), T585-L272 (PDBs: 3FBY)	 T585-A735 (PAE:  1.0), T585-L272 (PAE: 1.0)	T585-A735 (PDBs: 3FBY), T585-R683 (PDBs: 3FBY), T585-L272 (PDBs: 3FBY), T585-S681 (PDBs: 3FBY)							119									-112.2				122.7	Mediates cell survival and induction of the IAP family of survival proteins					B (undefined)	E (parallel sheets)	Beta strand											98.34	0.0	>90	<10	177170;132400;177170;619161	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	2	PSEUDOACHONDROPLASIA; EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; PSEUDOACHONDROPLASIA; CARPAL TUNNEL SYNDROME 2	false	0.8913593085393736	0.838378620534075	false	false	false
NR0B1	NR0B1_Arg425Ile	B_15-16	0.25188761123065967	0.8083633030903852	0.8474060970925553	3.1629270189281216	0.015863437286709865	0.02578335466883313	2025_03_Batch_15-16	true	true	false	false	false	false	true	true	false	false	false	false	0.9991926059569445	0.9939530863208957	0.5494836578461997	0.6758146235226627	0.6237535968792458	0.5720411173106175	0.5975970193594474	0.7374709973345721	0.7685254092574183	0.5436797348027844	0.9929515893636227	0.9993427680498109	0.5464852152617876	0.5100361964239195	0.5831038377879072	0.5552875808896149	0.9949545832781688	0.9990424438640779	NR0B1	Arg425Ile	NC_000023.11:30304718:C:A	1274G>T	23	30304718	C	A	X	ENSG00000169297	7215	216201	CCSBVarC006818	ALE00006816	ENSP00000368253.4	CEGS2	CegsMutGDEh1047	D06	GDEhDisVCh_40038	E06	2	CegsMutGDDh1047	D06	VUSN2Hmut_GDN2h_10	D05	VUSMutpDEST2_06	E02	VUSmut_GDEh10	D05	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	70525.0	single nucleotide variant	NM_000475.5(NR0B1):c.1274G>T (p.Arg425Ile)	190.0	NR0B1	HGNC:7960	Pathogenic	1.0	-	387907373.0	-	RCV000049288	MONDO:MONDO:0010264,MedGen:C0342482,OMIM:300200,Orphanet:95702	Congenital adrenal hypoplasia, X-linked	maternal	germline	GRCh38	NC_000023.11	X	30304718.0	30304718.0	Xp21.2	no assertion criteria provided	1.0	-	N	ClinGen:CA263240	2.0	55874.0	30304718.0	C	A	-	-	-	-	-	-	1274G>T 	Arg425Ile	NM_000475.5		Pathogenic	Pathogenic	55874	X	30304718.0	C	A	R	I	rs387907373	X	30322835	X	30232756	425	NR0B1	ENSG00000169297	ENST00000378970	ENSP00000368253	P51843	NR0B1_HUMAN	c.1274G>T	p.Arg425Ile	c.1274G>T	p.Arg425Ile	principal1	Y	1	YES	Select	-	AGA	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.26	0.89820	M	-6.89	0.93276	D	0.977	0.98762	1.0883	0.99170	D	0.9741	0.99188	D	10	0.99515057	0.99976	D	0.756477	0.98059	D	0.893	0.96941	0.917	0.98450	P51843	R425I	Loss of disorder (P = 0.0238)| Loss of catalytic residue at R425 (P = 0.1718)| Gain of helix (P = 0.1736)| Loss of methylation at R425 (P = 0.3331)| Loss of solvent accessibility (P = 0.4436)	0.989841346312	0.98961	0.9746714182978434	0.97444	2.05838413245	0.94369	0.368289679289	0.20564	T	0.985517	0.99909	D	0.713474	0.99939	D	0.787079	0.99939	D	0.998166024684906	0.93345	D	0.654835	0.26255	T	0.96761626	0.98003	0.9456724	0.98104	0.96510017	0.97752	0.94292563	0.97928	-8.683	0.65712	D	0.5823	0.68093	P	0.997764722383369	0.93521	0.97498110	0.95058	0.89	0.94126	.	.	.	.	.	.	4.046583	0.60026	24.2	0.97446586701898585	0.34180	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	.	.	7.568	0.81592	7.644000	0.63402	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.232	0.22834	832	0.38867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Congenital_adrenal_hypoplasia,_X-linked	no_assertion_criteria_provided	NC_000023.11:g.30304718C>A	ClinGen:CA263240	C0342482	300200	95702	Nuclear hormone receptor, ligand-binding domain|Nuclear hormone receptor, ligand-binding domain|Nuclear hormone receptor, ligand-binding domain	Arg	Ile	92.04	0.09274193548387097																																																																																																																																																																																																																																																																																																																																																																																																																																																																													23			92.04	Positively-charged	Arginine		Nuclear receptor subfamily 0 group B member 1							NR LBD			-4.5								 R425-L371 (PAE:  2.0), R425-E377 (PAE: 1.0), R425-L429 (PAE: 1.0)		 R425-H419 (PAE:  4.0), R425-L429 (PAE: 1.0)								175									-49.6				-36.6						H (helix)	H (α-helix)												92.04	9.274194	>90	<10	300200	x-linked recessive	OMIM	Rare genetic gynecological and obstetrical diseases; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic urogenital disease; Rare genetic endocrine disease; Genetic infertility; Rare genetic skin disease	7	ADRENAL HYPOPLASIA, CONGENITAL	false	0.9939530863208957	0.9991926059569445	true	true	true
MVK	MVK_His20Pro	B_7-8	0.9732293792511769	0.3751372851395143	0.46617580651689805	0.25545103088374344	0.806906220154144	0.842248529000486	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6647790922556676	0.6616198145788116	0.681975511234725	0.7585590204354276	0.7578277556037567	0.7847706596163475	0.7801761934410352	0.709667604841052	0.7440747155746551	0.6701049880770373	0.6608808225818689	0.6355511768333034	0.7893651257916597	0.8059879063664616	0.7730433252962001	0.6938460343924128	0.6623588065757543	0.6940070076780316	MVK	His20Pro	NC_000012.12:109574881:A:C	59A>C	12	109574881	A	C	12	ENSG00000110921	281	3	CCSBVarC007114	ALE00007112	ENSP00000228510.3	Edgotyping3	VUSMutGDEh009	B11	GDEhDisVCh_40020	G05	2	VUSMutGDDh009	B11	VUSN2Hmut_GDN2h_03	G03	VUSMutpDEST2_01	B01	VUSmut_GDEh03	G03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26970.0	single nucleotide variant	NM_000431.4(MVK):c.59A>C (p.His20Pro)	4598.0	MVK	HGNC:7530	Pathogenic	1.0	Apr 01, 2024	104895295.0	-	RCV000012707|RCV000012708|RCV001093432|RCV001240497	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29|MedGen:C3661900|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29	Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria|not provided|Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria	germline;unknown	germline	GRCh38	NC_000012.12	12	109574881.0	109574881.0	12q24.11	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA121780,UniProtKB:Q03426#VAR_004022,OMIM:251170.0003	3.0	11931.0	109574881.0	A	C	-	-	-	-	-	-	59A>C 	His20Pro	NM_000431.4	2.0	Pathogenic	Pathogenic	11931	12	109574881.0	A	C	H	P	rs104895295	12	110012686	12	108497069	20	MVK	ENSG00000110921	ENST00000546277	ENSP00000438153	Q03426	KIME_HUMAN	c.59A>C	p.His20Pro	c.59A>C	p.His20Pro	principal1	Y	5	.	.	+	CAT	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.004	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	0.94956	.	.	.	.	4.055	0.97021	H	-9.07	0.98480	D	.	0.97870	0.9708	0.96704	D	0.9431	0.98132	D	10	0.99369663	0.99893	D	0.728938	0.97812	D	0.894	0.96979	0.989	0.99885	Q03426	H20P	Loss of catalytic residue at H20 (P = 0.2553)| Gain of loop (P = 0.2754)| Loss of sheet (P = 0.302)| Loss of MoRF binding (P = 0.3664)| Gain of disorder (P = 0.4474)	0.989270736308	0.98902	.	0.98298	.	0.85802	0.771171450615	0.77560	T	0.79027	0.94497	D	0.544579	0.95575	D	0.544473	0.95510	D	0.99993884563446	0.99780	D	.	0.78345	.	0.9608756	0.97326	0.8369178	0.90513	0.9601588	0.97253	0.85667115	0.91847	-14.191	0.93673	D	0.906	0.85569	LP	0.999173234362819	0.95877	0.99959511	0.99514	0.992	0.99727	.	.	.	.	.	.	4.954425	0.81895	27.6	0.97698565216772837	0.35581	0.901793	0.84836	D	0.695420642702339	0.79218	7.05547	0.537306284435045	0.70357	5.517179	4.36	3.2	0.35749	3.38	0.61261	6.145	0.71602	9.201000	0.79214	0.75	0.87077	1.0	0.71675	1.000000	0.68239	0.998	0.85369	735	0.53648	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	1	106010	9.433070e-06	0	1	201874	4.953580e-06	0	1	230450	4.339340e-06	0	0	6706	0.000000e+00	0	0	16800	0.000000e+00	0	0	2164	0.000000e+00	0	0	8866	0.000000e+00	0	0	13254	0.000000e+00	0	1	41396	2.415690e-05	0	0	14968	0.000000e+00	0	1	41396	2.415690e-05	0	0	15512	0.000000e+00	0	0	29866	0.000000e+00	0	0	5954	0.000000e+00	0	0	13296	0.000000e+00	0	0	16496	0.000000e+00	0	1	86770	1.152470e-05	0	0	29232	0.000000e+00	0	1	86770	1.152470e-05	0	0	14284	0.000000e+00	0	0	33624	0.000000e+00	0	0	9356	0.000000e+00	0	0	17496	0.000000e+00	0	0	21010	0.000000e+00	0	1	100024	9.997600e-06	0	0	29162	0.000000e+00	0	1	100024	9.997600e-06	0	.	16	1609898	9.938520e-06	0	16	1178214	1.357990e-05	0	0	74864	0.000000e+00	0	0	910	0.000000e+00	0	0	59518	0.000000e+00	0	0	29430	0.000000e+00	0	0	44854	0.000000e+00	0	0	63756	0.000000e+00	0	0	6074	0.000000e+00	0	16	1178214	1.357990e-05	0	0	89924	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2642	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2726	0	0	142	0	0	11338	0	not_provided|Hyperimmunoglobulin_D_with_periodic_fever|Mevalonic_aciduria|Porokeratosis_3,_disseminated_superficial_actinic_type	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.109574881A>C	ClinGen:CA121780|OMIM:251170.0003|UniProtKB:Q03426#VAR_004022	C3661900|C0398691|C1959626|C1867981	260920|610377|175900	343|29	.	His	Pro	94.91	0.043478260869565216																																																																																																																																																																																																																																																																																																																																																																																																																																																																													8			94.91	Positively-charged	Histidine		Mevalonate kinase								0.384		-3.2								 H20-A334 (PAE:  1.5)	H20-A334 (PDBs: 2R3V)		H20-V247 (PDBs: 2R3V)							155									-92.8		Pocket 2: Mean pLDDT: 90.7, Volume: 500.25 Å³, Druggability score: 0.38		-21.4						C (loop/coil)	T (turn)	Turn											94.91	4.347826	>90	<10	260920;610377;260920;175900;610377	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; MEVALONIC ACIDURIA; HYPER-IgD SYNDROME; POROKERATOSIS 3, MULTIPLE TYPES; MEVALONIC ACIDURIA	false	0.6616198145788116	0.6647790922556676	false	false	false
KCTD1	KCTD1_His33Gln	B_7-8	1.5400885256381909	0.17446753860404976	0.2528023952821363	-1.7039060687303773	0.13217612776458543	0.16972931731841448	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8201448425491729	0.8342693495089631	0.6762731219501861	0.6324317278908305	0.6127235263193975	0.6125536140019643	0.6990843529199672	0.6369035812761099	0.69374187161474	0.7169691570832434	0.789411622069019	0.7560968259400693	0.5260228750839615	0.5885434713626851	0.5711215841669209	0.6355770868171287	0.8791270769489072	0.8841928591582763	KCTD1	His33Gln	NC_000018.10:26501137:G:T	99C>A	18	26501137	G	T	18	ENSG00000134504	14221	218278	CCSBVarC005805	ALE00005805	ENSP00000464170.1	CEGS2	CegsMutGDEh1037	C11	GDEhDisVCh_40022	C08	2	CegsMutGDDh1037	C11	VUSN2Hmut_GDN2h_07	F09	VUSMutpDEST2_11	G07	VUSmut_GDEh07	F09	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	70533.0	single nucleotide variant	NM_001142730.3(KCTD1):c.1923C>A (p.His641Gln)	284252.0	KCTD1	HGNC:18249	Pathogenic	1.0	Jan 29, 2014	587777000.0	-	RCV000049296	MONDO:MONDO:0008404,MedGen:C1867020,OMIM:181270,Orphanet:2036	Scalp-ear-nipple syndrome	de novo;germline	germline	GRCh38	NC_000018.10	18	26501137.0	26501137.0	18q11.2	no assertion criteria provided	2.0	-	N	ClinGen:CA143995,UniProtKB:Q719H9#VAR_069976,OMIM:613420.0005	3.0	55885.0	26501137.0	G	T	-	-	-	-	-	-	1923C>A 	His641Gln	NM_001142730.3		Pathogenic	Pathogenic	55885	18	26501137.0	G	T	H	Q	rs587777000	18	24081101	18	22335099	33	KCTD1	ENSG00000134504	ENST00000417602	ENSP00000408405	Q719H9	KCTD1_HUMAN	c.99C>A	p.His33Gln	c.99C>A	p.His33Gln	.	Y	5	.	.	-	CAC	3	2	G	./.	./.	./.	./.	.	0.55689	.	0.109	0.37788	T	1.0	0.90580	D	0.999	0.92348	D	0.91	0.99291	A	simple_aae	9.0	91.0	1.965	0.53028	M	.	0.93527	.	0.766	0.76289	-0.2696	0.75713	T	0.4817	0.80121	T	10	0.8125739	0.80328	D	0.243584	0.88781	D	0.516	0.79231	0.326	0.30737	Q719H9	H33Q	Gain of disorder (P = 0.1308)| Loss of glycosylation at S28 (P = 0.1816)| Loss of catalytic residue at H33 (P = 0.2865)| Loss of sheet (P = 0.302)| Loss of loop (P = 0.4412)	0.926088469832	0.92476	.	0.70300	.	0.88583	0.898521780968	0.96270	D	0.537307	0.83950	D	0.456008	0.92692	D	0.417247	0.92602	D	0.9977747797966	0.92324	D	.	0.99293	.	0.9259911	0.93744	0.93818146	0.97613	0.95530176	0.96754	0.93818146	0.97613	-13.906	0.92762	D	.	0.99584	.	0.99972375983341	0.97656	0.85544970	0.89796	0.903	0.94903	.	.	.	.	.	.	4.251035	0.64594	24.7	0.9944179126020436	0.64867	0.856726	0.77317	D	0.669864948369012	0.77538	6.717477	0.689105025491305	0.81448	7.55334	5.68	5.68	0.88004	.	.	6.172	0.71909	7.652000	0.63812	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Scalp-ear-nipple_syndrome	no_assertion_criteria_provided	NC_000018.10:g.26501137G>T	ClinGen:CA143995|OMIM:613420.0005|UniProtKB:Q719H9#VAR_069976	C1867020	181270	2036	Potassium channel tetramerisation-type BTB domain|BTB/POZ domain|BTB/POZ domain-containing protein KCTD1, BTB/POZ domain	His	Gln	97.95	0.45108695652173914																																																																																																																																																																																																																																																																																																																																																																																																																																																																													83			97.95	Positively-charged	Histidine		BTB/POZ domain-containing protein KCTD1							BTB			-3.2			D:H33-E:K72 (PDBs: 5BXB), D:H33-E:D69 (PDBs: 5BXD), E:H33-A:D69 (PDBs: 6S4L), C:H33-D:D69 (PDBs: 6S4L)					 H33-T42 (PAE:  1.0), H33-Y75 (PAE: 1.0)	H33-Y75 (PDBs: 5BXB, 6S4L), H33-T42 (PDBs: 5BXD, 6S4L)	 H33-T42 (PAE:  1.0), H33-Y75 (PAE: 1.0)	H33-H74 (PDBs: 5BXB, 6S4L), H33-Q73 (PDBs: 5BXD), H33-T42 (PDBs: 6S4L), H33-Y75 (PDBs: 6S4L)							155									-91.5				132.8						B (undefined)	E (parallel sheets)	Beta strand											97.95	45.108696	>90	10-90	181270	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	3	SCALP-EAR-NIPPLE SYNDROME	false	0.8342693495089631	0.8201448425491729	false	false	false
ALAS2	ALAS2_Asp122Asn	B_7-8	-6.966892750017265	0.006067987426519381	0.018603300135878038	0.024583352305470325	0.9819310765439566	0.9862307200099399	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7357811861273883	0.779483057112152	0.8160639265624863	0.8042376243204359	0.784708515084537	0.8158813969203517	0.8158813969203517	0.784708515084537	0.8042376243204359	0.8160639265624863	0.779483057112152	0.7357811861273883							ALAS2	Asp122Asn	NC_000023.11:55021215:C:T	364G>A	23	55021215	C	T	X	ENSG00000158578	8420	216654	CCSBVarC003761	ALE00003761	ENSP00000337131.4	CEGS2	CegsMutGDEh1032	B12	GDEhDisVCh_40062	C05	2	CegsMutGDDh1032	B12	VUSN2Hmut_GDN2h_06	D02	VUSMutpDEST2_08	C03	VUSmut_GDEh06	D02	1.0	1.0	1.0	1.0	1.0	5.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	25518.0	single nucleotide variant	NM_000032.5(ALAS2):c.475G>A (p.Asp159Asn)	212.0	ALAS2	HGNC:397	Pathogenic	1.0	Jun 01, 2003	137852308.0	-	RCV000011225	MONDO:MONDO:0020721,MedGen:C4551511,OMIM:300751,Orphanet:75563	X-linked sideroblastic anemia 1	germline	germline	GRCh38	NC_000023.11	X	55021215.0	55021215.0	Xp11.21	no assertion criteria provided	1.0	-	N	ClinGen:CA121093,OMIM:301300.0012	1.0	10479.0	55021215.0	C	T	-	-	-	-	-	-	475G>A 	Asp159Asn	NM_000032.5		Pathogenic	Pathogenic	10479	X	55021215.0	C	T	D	N	rs137852308	X	55047648	X	55064373	159	ALAS2	ENSG00000158578	ENST00000650242	ENSP00000497236	P22557	HEM0_HUMAN	c.475G>A	p.Asp159Asn	c.475G>A	p.Asp159Asn	principal1	Y	.	YES	Select	-	GAT	1	0	C	C/C	C/C	C/C	C/C	.	0.51407	.	.	0.52410	.	0.967	0.56423	D	0.558	0.49492	P	.	0.93300	.	.	.	.	2.745	0.80081	M	.	0.79516	.	.	0.82302	0.8661	0.95214	D	0.8422	0.94717	D	10	0.8101722	0.80109	D	0.249302	0.89019	D	.	0.87075	0.572	0.69454	P22557	D159N	Gain of MoRF binding (P = 0.0362)| Gain of helix (P = 0.062)| Loss of phosphorylation at T161 (P = 0.1123)| Loss of ubiquitination at K156 (P = 0.1392)| Loss of disorder (P = 0.1598)	.	0.96871	.	.	.	.	0.653790593147	0.60461	T	0.745061	0.92905	D	0.0699383	0.60565	D	-0.137315	0.60070	T	0.993876755237579	0.84741	D	0.987201	0.95872	D	0.78510606	0.82756	0.53370476	0.72800	0.7502448	0.80652	0.5649979	0.74573	-6.364	0.52065	T	0.2865	0.55435	B	0.991250833004821	0.88943	0.99744880	0.98383	0.979	0.99252	.	.	.	.	.	.	4.559171	0.71882	25.7	0.99880243529516344	0.95656	.	.	.	.	.	.	.	.	.	4.81	4.81	0.61353	4.01	0.76498	7.905	0.86513	7.621000	0.62369	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.997	0.79771	103	0.95731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X-linked_sideroblastic_anemia_1	no_assertion_criteria_provided	NC_000023.11:g.55021215C>T	ClinGen:CA121093|OMIM:301300.0012	C4551511	300751	75563	Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase	Asp	Asn	84.52	0.3312883435582822																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																84.52	33.128834	70-90	10-90	300751	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare inborn errors of metabolism; Rare genetic skin disease	4	ANEMIA, SIDEROBLASTIC, 1	false	0.779483057112152	0.7357811861273883	false	false	false
PLP1	PLP1_Thr147Pro	B_7-8	-0.7058461467835201	0.5067509741234404	0.5891018627971827	-1.455669660660065	0.1957311140366079	0.24008462182966275	2024_01_Batch_7-8	true	true	false	false	false	false	true	true	false	false	false	false	0.9935115418382505	0.9938863333624692	0.5585987478100729	0.6611987220860547	0.6116630416521684	0.5972987154106446	0.6150412527124542	0.5128947779387334	0.6406378980057835	0.571895706555264	0.9898851602676357	0.9918904967196687	0.5795561781088349	0.7104313053656036	0.681759546166326	0.5453017890648818	0.9978875064573027	0.9951325869568325	PLP1	Thr147Pro	NC_000023.11:103787888:A:C	439A>C	23	103787888	A	C	X	ENSG00000123560	4062	201426	CCSBVarC005859	ALE00005859	ENSP00000477619.1	CEGS2	CegsMutGDEh1040	D06	GDEhDisVCh_40062	D07	2	CegsMutGDDh1040	D06	VUSN2Hmut_GDN2h_08	E05	VUSMutpDEST2_04	A03	VUSmut_GDEh08	E05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26118.0	single nucleotide variant	NM_000533.5(PLP1):c.544A>C (p.Thr182Pro)	5354.0	PLP1	HGNC:9086	Pathogenic	1.0	Oct 01, 1992	132630282.0	-	RCV000011828	Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702	Pelizaeus-Merzbacher disease	germline	germline	GRCh38	NC_000023.11	X	103787888.0	103787888.0	Xq22.2	no assertion criteria provided	1.0	-	N	ClinGen:CA255687,UniProtKB:P60201#VAR_004555,OMIM:300401.0007	1.0	11079.0	103787888.0	A	C	-	-	-	-	-	-	544A>C 	Thr182Pro	NM_000533.5		Pathogenic	Pathogenic	11079	X	103787888.0	A	C	T	P	rs132630282	X	103042817	X	102929473	182	PLP1	ENSG00000123560	ENST00000612423	ENSP00000481006	P60201	MYPR_HUMAN	c.544A>C	p.Thr182Pro	c.544A>C	p.Thr182Pro	principal1	Y	2	.	.	+	ACC	1	0	A	A/A	A/A	A/A	A/A	.	.	.	0.011	0.65108	D	0.966	0.56216	D	0.69	0.53776	P	.	.	.	.	.	.	1.7	0.43657	L	.	.	.	0.877	0.87459	1.1157	0.99893	D	0.9422	0.98101	D	10	0.9861916	0.98903	D	0.960916	0.99744	D	.	.	0.895	0.97537	P60201	T182P	Gain of loop (P = 0.0851)| Gain of helix (P = 0.1736)| Gain of relative solvent accessibility (P = 0.1894)| Loss of sheet (P = 0.1907)| Gain of glycosylation at T183 (P = 0.1957)	0.999812538853	0.99980	0.9763192878237917	0.97609	.	.	0.565854609013	0.48026	T	0.948922	0.99241	D	0.43579	0.91762	D	0.388206	0.91661	D	0.636630399980993	0.37586	D	.	0.36636	.	0.744199	0.80299	0.81851125	0.89307	0.7635117	0.81438	0.69764143	0.81987	-8.006	0.71280	D	0.9015	0.86222	LP	0.993852230896557	0.90289	0.99821150	0.98680	0.361	0.61784	.	.	.	.	.	.	4.432442	0.68811	25.3	0.99194697098187146	0.55155	.	.	.	.	.	.	.	.	.	5.58	5.58	0.84339	2.19	0.41903	2.535	0.45444	6.122000	0.53870	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.999	0.91597	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pelizaeus-Merzbacher_disease	no_assertion_criteria_provided	NC_000023.11:g.103787888A>C	ClinGen:CA255687|OMIM:300401.0007|UniProtKB:P60201#VAR_004555	C0205711	312080	702	.	Thr	Pro	90.83	0.3380281690140845																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																90.83	33.802814	>90	10-90	312080	x-linked recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	PELIZAEUS-MERZBACHER DISEASE	false	0.9938863333624692	0.9935115418382505	true	true	true
GCK	GCK_Gly299Arg	B_7-8	3.701133173422515	0.03425107917849796	0.06892784805979092	3.911387062255804	0.029694893910502985	0.04455448105132705	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8110029799294158	0.8275540848347532	0.4653420606478782	0.5753739705408706	0.4923519414664873	0.5066819414778703	0.5066819414778703	0.4923519414664873	0.5753739705408706	0.4653420606478782	0.8275540848347532	0.8110029799294158							GCK	Gly299Arg	NC_000007.14:44146587:C:G	895G>C	7	44146587	C	G	7	ENSG00000106633	3689	214851	CCSBVarC006694	ALE00006692	ENSP00000384247.3	CEGS2	CegsMutGDEh1045	E10	GDEhDisVCh_40037	G05	1	CegsMutGDDh1045	E10	VUSN2Hmut_GDN2h_09	B11	VUSMutpDEST2_03	E09	VUSmut_GDEh09	B11	1.0	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	7.0	1.0	Y	Y	Y	Y	Y	31175.0	single nucleotide variant	NM_000162.5(GCK):c.895G>C (p.Gly299Arg)	2645.0	GCK	HGNC:4195	Pathogenic	1.0	Nov 27, 2019	104894009.0	-	RCV000017516|RCV001288185	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900	Maturity-onset diabetes of the young type 2|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	44146587.0	44146587.0	7p13	criteria provided, single submitter	2.0	-	N	ClinGen:CA126212,UniProtKB:P35557#VAR_003710,OMIM:138079.0005	3.0	16136.0	44146587.0	C	G	-	-	-	-	-	-	895G>C 	Gly299Arg	NM_000162.5	1.0	Pathogenic	Pathogenic	16136	7	44146587.0	C	G	G	R	rs104894009	7	44186186	7	44152711	299	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.895G>C	p.Gly299Arg	c.895G>C	p.Gly299Arg	principal1	Y	1	YES	Select	-	GGC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	0.999	0.77914	D	0.967	0.80453	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.615	0.93786	H	-7.4	0.95559	D	0.991	0.99781	0.9545	0.96452	D	0.9917	0.99792	D	9	0.9954407	0.99985	D	0.958393	0.99723	D	0.985	0.99930	0.997	0.99969	P35557	G299R	Gain of MoRF binding (P = 0.0095)| Gain of methylation at K296 (P = 0.1057)| Loss of ubiquitination at K296 (P = 0.152)| Gain of glycosylation at K296 (P = 0.1608)| Gain of helix (P = 0.1736)	0.992121500454	0.99194	.	0.99891	.	0.97104	0.775753200054	0.78249	T	0.968658	0.99642	D	0.564186	0.96283	D	0.572637	0.96224	D	0.999379277229309	0.97130	D	0.999394	0.99805	D	0.9890143	0.99706	0.96495694	0.99216	0.9860968	0.99530	0.960452	0.98980	-13.277	0.90754	D	0.9967	0.96856	P	0.999827466907589	0.98179	0.99984097	0.99792	0.997	0.99892	.	.	.	.	.	.	5.624991	0.92642	32.0	0.9993193236961907	0.99439	0.967442	0.98988	D	0.926695616404469	0.92965	11.76197	0.826377040188961	0.91519	10.9513	4.77	4.77	0.60376	.	.	7.766	0.84189	7.538000	0.60097	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.995	0.73271	712	0.56407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Maturity-onset_diabetes_of_the_young_type_2	criteria_provided,_single_submitter	NC_000007.14:g.44146587C>G	ClinGen:CA126212|OMIM:138079.0005|UniProtKB:P35557#VAR_003710	C3661900|C0342277	125851	552	Hexokinase, C-terminal	Gly	Arg	98.36	0.011904761904761904																																																																																																											0.238		0.224																																																																																																																																																																																																																																																																																																																																																																1			98.36	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Hexokinase-4							Hexokinase			-0.4								 G299-R303 (PAE:  1.0), G299-T332 (PAE: 1.0)	G299-T332 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9), G299-R303 (PDBs: 6E0I, 4LC9)	 G299-R303 (PAE:  1.0), G299-T332 (PAE: 1.0)	G299-T332 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9), G299-R303 (PDBs: 6E0I, 4LC9)							75									-63.2				-39.2	Hexokinase large subdomain			dbSNP: rs104894009; Variant type: LP/P; AA change: Gly299Arg; PTM type: Acetylation; PTM morphology: KLIGGkYMG*EL; Var class: II		H (helix)	H (α-helix)	Helix											98.36	1.1904762	>90	<10	125851	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism	3	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2	false	0.8275540848347532	0.8110029799294158	false	false	false
MVK	MVK_Leu255Pro	B_7-8	0.3806518822719304	0.7190973452002799	0.7768529012061848	-5.704597310623486	0.0012549639600398944	0.002885788053475196	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.9507933064451387	0.9650009080014299	0.6074565749183716	0.5768594778994034	0.5079275486870322	0.5883785882897116	0.548560772433665	0.558936885293029	0.6028765149224419	0.5602293573207666	0.9862399299186587	0.968889469292695	0.6281964041457582	0.4569182120810353	0.550842440876365	0.6546837925159765	0.9437618860842011	0.9326971435975824	MVK	Leu255Pro	NC_000012.12:109590857:T:C	764T>C	12	109590857	T	C	12	ENSG00000110921	281	18	CCSBVarC007125	ALE00007123	ENSP00000228510.3	Edgotyping3	VUSMutGDEh010	A01	GDEhDisVCh_40020	C07	2	VUSMutGDDh010	A01	VUSN2Hmut_GDN2h_03	B05	VUSMutpDEST2_01	G02	VUSmut_GDEh03	B05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	48323.0	single nucleotide variant	NM_000431.4(MVK):c.764T>C (p.Leu255Pro)	4598.0	MVK	HGNC:7530	Pathogenic	1.0	Oct 01, 2012	397514570.0	-	RCV000032936	MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900	Porokeratosis 3, disseminated superficial actinic type	germline	germline	GRCh38	NC_000012.12	12	109590857.0	109590857.0	12q24.11	no assertion criteria provided	1.0	-	N	ClinGen:CA130485,UniProtKB:Q03426#VAR_075038,OMIM:251170.0009	1.0	39724.0	109590857.0	T	C	-	-	-	-	-	-	764T>C 	Leu255Pro	NM_000431.4		Pathogenic	Pathogenic	39724	12	109590857.0	T	C	L	P	rs397514570	12	110028662	12	108513045	255	MVK	ENSG00000110921	ENST00000546277	ENSP00000438153	Q03426	KIME_HUMAN	c.*4761T>C	.	c.764T>C	p.Leu255Pro	principal1	Y	5	.	.	+	CTC	2	0	T	T/T	T/T	T/T	T/T	.	0.14337	.	.	0.18421	.	0.884	0.48632	P	0.389	0.44119	B	.	0.82936	.	.	.	.	2.81	0.81703	M	.	0.59257	.	.	0.84884	0.2207	0.86203	D	0.7407	0.91119	D	10	.	0.74271	.	0.320234	0.91432	D	.	0.90947	0.491	0.57600	Q03426	L255P	Loss of stability (P = 0.0198)| Gain of helix (P = 0.0425)| Loss of loop (P = 0.0512)| Loss of MoRF binding (P = 0.0753)| Loss of ubiquitination at K256 (P = 0.0919)	.	0.98208	.	0.91273	.	0.68173	0.321103721857	0.13577	T	0.274146	0.64464	T	0.274174	0.80669	D	0.156055	0.80420	D	0.666496336460114	0.38876	D	.	0.39467	.	0.65678555	0.75458	0.4278088	0.66259	0.6075704	0.72816	0.40843213	0.64909	-10.926	0.79318	D	.	0.62755	.	0.99329750429738	0.89968	0.99439245	0.97536	0.595	0.77317	.	.	.	.	.	.	2.938314	0.39135	20.9	0.98317657350502075	0.40346	0.430527	0.49145	N	0.0351367672646776	0.43197	2.638443	0.0062749246860979	0.39712	2.380721	5.47	1.82	0.24143	2.75	0.50313	2.491	0.45063	2.265000	0.31873	0.665	0.62996	0.962	0.33812	0.075000	0.22356	0.802	0.37852	734	0.53826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	76	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	1	108	0.009259259259259259	0	434	0	0	34	0	1	658	0.001519756838905775	Porokeratosis_3,_disseminated_superficial_actinic_type	no_assertion_criteria_provided	NC_000012.12:g.109590857T>C	ClinGen:CA130485|OMIM:251170.0009|UniProtKB:Q03426#VAR_075038	C1867981	175900	.	.	Leu	Pro	98.07	0.75																																																																																																																																																																																																																																																																																																																																																																																																																																																																													123			98.07	Aliphatic	Leucine		Mevalonate kinase										3.8								 L255-R251 (PAE:  1.0)	L255-R251 (PDBs: 2R3V)	 L255-R251 (PAE:  1.0)	L255-R251 (PDBs: 2R3V)							131									-65.6				-35.7				dbSNP: rs397514570; Variant type: LP/P; AA change: Leu255Pro; PTM type: Sumoylation; PTM morphology: RNRLL*kFPEIV; Var class: II		H (helix)	H (α-helix)	Helix											98.07	75.0	>90	10-90	175900	autosomal dominant	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	POROKERATOSIS 3, MULTIPLE TYPES	false	0.9650009080014299	0.9507933064451387	true	true	false
DOLK	DOLK_Tyr441Ser	B_7-8	0.8219918257022747	0.47132382160174097	0.5565614154031046	-0.3346250430482549	0.7477109011275265	0.7889876386250783	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5269016180079831	0.5497839606558581	0.520967751104489	0.5403574878585509	0.45971758130563456	0.5451808022885302	0.5451808022885302	0.45466042622343983	0.3902388486040814	0.520967751104489	0.5205060144764035	0.4522316192269582		0.4647747363878293	0.6904761271130202		0.5790619068353127	0.6015716167890081	DOLK	Tyr441Ser	NC_000009.12:128945982:T:G	1322A>C	9	128945982	T	G	9	ENSG00000175283	9726	216902	CCSBVarC006898	ALE00006896	ENSP00000361667.3	CEGS2	CegsMutGDEh1044	F05	GDEhDisVCh_40088	B07	2	CegsMutGDDh1044	F05	VUSN2Hmut_GDN2h_09	H05	NULL	NULL	VUSmut_GDEh09	H05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	16171.0	single nucleotide variant	NM_014908.4(DOLK):c.1322A>C (p.Tyr441Ser)	22845.0	DOLK	HGNC:23406	Pathogenic	1.0	Mar 01, 2007	137853110.0	-	RCV000001191	MONDO:MONDO:0012556,MedGen:C1835849,OMIM:610768,Orphanet:91131	DK1-congenital disorder of glycosylation	germline	germline	GRCh38	NC_000009.12	9	128945982.0	128945982.0	9q34.11	no assertion criteria provided	1.0	-	N	ClinGen:CA251704,UniProtKB:Q9UPQ8#VAR_032852,OMIM:610746.0002	1.0	1132.0	128945982.0	T	G	-	-	-	-	-	-	1322A>C 	Tyr441Ser	NM_014908.4		Pathogenic	Pathogenic	1132	9	128945982.0	T	G	Y	S	rs137853110	9	131708261	9	130748082	441	DOLK	ENSG00000175283	ENST00000372586	ENSP00000361667	Q9UPQ8	DOLK_HUMAN	c.1322A>C	p.Tyr441Ser	c.1322A>C	p.Tyr441Ser	principal1	Y	NA	YES	Select	-	TAT	2	0	T	T/T	T/T	T/T	T/T	0.067	0.36067	T	0.0	0.92967	D	0.999	0.77914	D	0.973	0.72925	D	0.74	0.84487	A	simple_aae	26.0	74.0	2.87	0.83121	M	-4.22	0.75883	D	0.865	0.86161	-0.4936	0.68741	T	0.2330	0.59774	T	9	0.9398179	0.93233	D	0.189599	0.86036	D	0.684	0.88392	0.831	0.94010	Q9UPQ8	Y441S	Gain of disorder (P = 0.0321)| Gain of glycosylation at Y441 (P = 0.0451)| Gain of loop (P = 0.1069)| Gain of methylation at R436 (P = 0.1794)| Loss of helix (P = 0.2022)	0.759708072053	0.75561	0.8840311304700029	0.88299	1.37926964747	0.84668	0.793942332268	0.81009	T	0.414299	0.76624	T	0.278752	0.81071	D	0.162632	0.80827	D	0.989417731761932	0.79497	D	0.920508	0.71188	D	0.44697553	0.63532	0.39052942	0.63598	0.4987117	0.66713	0.34746787	0.60164	-7.151	0.55198	T	0.7293	0.74124	P	0.990532691575259	0.88625	0.77512060	0.87741	0.66	0.81095	.	.	.	.	.	.	4.727386	0.7615	26.5	0.99020790782532564	0.50657	0.916731	0.88292	D	0.605598515796492	0.73385	5.980899	0.575577225695069	0.73048	5.930689	5.09	5.09	0.68605	.	.	7.934	0.87139	7.951000	0.75869	0.644	0.52462	1.0	0.71675	1.000000	0.68239	0.957	0.51031	897	0.25363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	DK1-congenital_disorder_of_glycosylation	no_assertion_criteria_provided	NC_000009.12:g.128945982T>G	ClinGen:CA251704|OMIM:610746.0002|UniProtKB:Q9UPQ8#VAR_032852	C1835849	610768	91131	.	Tyr	Ser	96.71	0.0045045045045045045																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			96.71	Aromatic	Tyrosine		Dolichol kinase										-1.3								 Y441-D494 (PAE:  1.5), Y441-L445 (PAE: 1.0)		 Y441-I352 (PAE:  1.0), Y441-L445 (PAE: 1.0)								181									-89.1				-1.6						H (helix)	G (3₁₀-helix)									Helical; Name=13			96.71	0.45045045	>90	<10	610768	autosomal recessive	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease	4	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im	false	0.5497839606558581	0.5269016180079831	false	false	false
GCM2	GCM2_Arg47Leu	B_7-8	4.012789110229252	0.015959597826731908	0.03863476786952844	-4.0712976509080825	0.004741453182892145	0.008960418733889891	2024_01_Batch_7-8	false	false	true	true	false	true	false	false	false	false	false	false	0.7294093094408101	0.9201239142305412	0.9723359531475776	0.9915462729871608	0.8682052257856518	0.9866328233667673	0.9866328233667673	0.8682052257856518	0.9915462729871608	0.9723359531475776	0.9201239142305412	0.9073782515313195						0.5514403673503007	GCM2	Arg47Leu	NC_000006.12:10877343:C:A	140G>T	6	10877343	C	A	6	ENSG00000124827	13943	23001	CCSBVarC002034	ALE00002034	ENSP00000368805.4	RC4	RC4_Mut_GDEh1006	A11	GDEhDisVCh_40044	H03	2	RC4_Mut_GDDh1006	A11	NULL	NULL	NULL	NULL	VUSmut_GDEh12	C08	1.0	1.0	1.0	1.0	0.0			0.0			1.0	1.0	1.0	Y	Y	N	N	Y	21130.0	single nucleotide variant	NM_004752.4(GCM2):c.140G>T (p.Arg47Leu)	9247.0	GCM2	HGNC:4198	Pathogenic	1.0	May 15, 2010	104893959.0	-	RCV000006464	MONDO:MONDO:0020798,MedGen:C5394383,OMIM:618883	Hypoparathyroidism, familial isolated, 2	germline	germline	GRCh38	NC_000006.12	6	10877343.0	10877343.0	6p24.2	no assertion criteria provided	1.0	-	N	ClinGen:CA117936,UniProtKB:O75603#VAR_058044,OMIM:603716.0002	1.0	6091.0	10877343.0	C	A	-	-	-	-	-	-	140G>T 	Arg47Leu	NM_004752.4		Pathogenic	Pathogenic	6091	6	10877343.0	C	A	R	L	rs104893959	6	10877576	6	10985562	47	GCM2	ENSG00000124827	ENST00000379491	ENSP00000368805	O75603	GCM2_HUMAN	c.140G>T	p.Arg47Leu	c.140G>T	p.Arg47Leu	principal1	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.006	0.70891	D	1.0	0.90580	D	0.995	0.83178	D	0.89	0.91795	A	simple_aae	11.0	89.0	2.65	0.77408	M	-5.63	0.86867	D	0.927	0.93141	0.1699	0.85335	D	0.5693	0.84346	D	9	0.98930067	0.99382	D	0.164738	0.84335	D	0.758	0.91722	0.934	0.99013	O75603	R47L	Loss of MoRF binding (P = 0.0582)| Loss of disorder (P = 0.1076)| Gain of sheet (P = 0.1451)| Loss of loop (P = 0.2237)| Gain of catalytic residue at D43 (P = 0.3042)	0.929772676086	0.92851	0.8179082553302923	0.81639	0.877447913962	0.69449	0.619254887104	0.55558	T	0.735869	0.92576	D	0.164153	0.70369	D	0.257697	0.85887	D	0.910496056079865	0.56328	D	0.962204	0.85727	D	0.72707975	0.79317	0.72711384	0.83687	0.72707975	0.79318	0.72711384	0.83688	-12.272	0.86186	D	0.8712	0.80904	P	0.995187506862101	0.91150	0.97526120	0.95083	0.544	0.74233	.	.	.	.	.	.	4.667709	0.74613	26.2	0.99856838986333973	0.93553	0.533579	0.55140	D	0.720816545156314	0.80892	7.420084	0.676376036648317	0.80480	7.332487	5.69	5.69	0.88329	2.98	0.54511	3.752	0.5498	4.817000	0.45165	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.166	0.20893	786	0.46777	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	5	109404	4.570220e-05	0	5	208106	2.402620e-05	0	5	236916	2.110450e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	0	42768	0.000000e+00	0	5	15690	3.186740e-04	0	5	15690	3.186740e-04	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16730	0.000000e+00	0	0	89540	0.000000e+00	0	5	30608	1.633560e-04	0	5	30608	1.633560e-04	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	0	102720	0.000000e+00	0	5	30526	1.637950e-04	0	5	30526	1.637950e-04	0	.	19	1614120	1.177110e-05	0	19	91086	2.085940e-04	0	0	75046	0.000000e+00	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	0	29602	0.000000e+00	0	0	44876	0.000000e+00	0	0	64032	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179966	0.000000e+00	0	19	91086	2.085940e-04	0	0	32780	0	0	122	0	0	112	0	0	3864	0	0	500	0	0	628	0	0	56	0	0	98	0	1	7102	1.40805406927626E-4	0	3986	0	0	168	0	1	45262	2.2093588440634527E-5	Hypoparathyroidism,_familial_isolated,_2	no_assertion_criteria_provided	NC_000006.12:g.10877343C>A	ClinGen:CA117936|OMIM:603716.0002|UniProtKB:O75603#VAR_058044	C5394383	618883	.	Transcription regulator GCM domain|Transcription regulator GCM domain	Arg	Leu	96.64	0.2217741935483871																																																																																																																																																																																																																																																																																																																																																																																																																																																																													55			96.64	Positively-charged	Arginine		Chorion-specific transcription factor GCMb				GCM						-4.5								 R47-S14 (PAE:  3.0), R47-D22 (PAE: 2.0)		 R47-Q152 (PAE:  1.0), R47-M17 (PAE: 1.5)								175									-118.3				141.5						B (undefined)	E (parallel sheets)												96.64	22.17742	>90	10-90	618883	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic endocrine disease	2	HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2	false	0.9201239142305412	0.7294093094408101	false	false	false
AGXT	AGXT_Gly161Ser	B_7-8	-1.4002285246957424	0.20417549306737212	0.28486135263599766	1.6892368963290263	0.1350241698818834	0.1726615691520948	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6384607592997791	0.5983763611824254	0.5868198897416836	0.5805610450289684	0.5398748351464915	0.6083234247166385	0.47233073076517346	0.48094094458053194	0.47858472103308236	0.4772200412902004	0.5302607772858692	0.5422494120415468	0.7443161186681035	0.5988087257124511	0.6825373690248544	0.6964197381931668	0.6664919450789817	0.7346721065580113	AGXT	Gly161Ser	NC_000002.12:240871406:G:A	481G>A	2	240871406	G	A	2	ENSG00000172482	70497	3825	CCSBVarC008190	ALE00008176	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	B04	GDEhDisVCh_40002	B06	2	VUSMutGDDh004	B04	VUSN2Hmut_GDN2h_01	C07	VUSMutpDEST2_14	D05	VUSmut_GDEh01	C07	1.0	1.0	1.0	6.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	200501.0	single nucleotide variant	NM_000030.3(AGXT):c.481G>A (p.Gly161Ser)	189.0	AGXT	HGNC:341	Pathogenic	1.0	Oct 12, 2023	180177227.0	-	RCV000186311|RCV000662317|RCV001069631|RCV003226241	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|Human Phenotype Ontology:HP:0000121,MONDO:MONDO:0001567,MedGen:C0027709;Human Phenotype Ontology:HP:0000102,Human Phenotype Ontology:HP:0000787,MONDO:MONDO:0008171,MedGen:C0392525|MedGen:C3661900|MONDO:MONDO:0002474,MedGen:C0020501,OMIM:PS259900,Orphanet:416	Primary hyperoxaluria, type I|Nephrocalcinosis;Nephrolithiasis|not provided|Primary hyperoxaluria	germline;paternal;unknown	germline	GRCh38	NC_000002.12	2	240871406.0	240871406.0	2q37.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA275698,UniProtKB:P21549#VAR_074587	2.0	204105.0	240871406.0	G	A	-	-	-	-	-	-	481G>A 	Gly161Ser	NM_000030.3	2.0	Pathogenic	Pathogenic	204105	2	240871406.0	G	A	G	S	rs180177227	2	241810823	2	241459496	161	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.481G>A	p.Gly161Ser	c.481G>A	p.Gly161Ser	principal1	Y	1	YES	Select	+	GGC	1	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.007	0.69466	D	0.999	0.77914	D	0.994	0.82066	D	0.96	0.95575	A	simple_aae	4.0	96.0	.	.	.	-5.09	0.82986	D	0.987	0.99555	1.1038	0.99791	D	0.9575	0.98623	D	10	0.99611104	0.99996	D	0.933076	0.99516	D	0.907	0.97469	0.986	0.99859	P21549	G161S	Gain of disorder (P = 0.0919)| Loss of catalytic residue at V162 (P = 0.1002)| Loss of phosphorylation at T160 (P = 0.2492)| Gain of glycosylation at T160 (P = 0.252)| Gain of helix (P = 0.2684)	0.945035359676	0.94402	0.944155893838875	0.94362	0.243824273026	0.26597	0.583588182926	0.50524	T	0.951596	0.99299	D	0.54632	0.95604	D	0.546974	0.95539	D	0.97897070646286	0.72405	D	0.943606	0.78641	D	0.82819957	0.85592	0.8023042	0.88267	0.82819957	0.85593	0.8023042	0.88268	-9.997	0.73973	D	0.4881	0.63981	A	0.992238799487952	0.89410	0.56408630	0.83250	0.982	0.99374	.	.	.	.	.	.	5.258536	0.88314	29.5	0.9987407969210329	0.95164	0.893109	0.83009	D	0.503186798179489	0.67107	5.06033	0.346391988712941	0.58069	3.998782	4.1	4.1	0.47135	.	.	8.515	0.90398	6.298000	0.55477	0.601	0.45913	1.0	0.71675	1.000000	0.68239	0.641	0.32491	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	1	98516	1.015060e-05	0	1	188238	5.312420e-06	0	4	215850	1.853140e-05	0	0	5776	0.000000e+00	0	0	16008	0.000000e+00	0	0	2034	0.000000e+00	0	0	8200	0.000000e+00	0	0	12780	0.000000e+00	0	1	37942	2.635600e-05	0	0	14036	0.000000e+00	0	1	37942	2.635600e-05	0	0	13998	0.000000e+00	0	0	28390	0.000000e+00	0	0	5686	0.000000e+00	0	0	12484	0.000000e+00	0	0	15678	0.000000e+00	0	1	80098	1.248470e-05	0	0	27496	0.000000e+00	0	1	80098	1.248470e-05	0	0	12976	0.000000e+00	0	0	32204	0.000000e+00	0	0	9154	0.000000e+00	0	0	16506	0.000000e+00	0	0	18998	0.000000e+00	0	4	93334	4.285680e-05	0	0	27456	0.000000e+00	0	4	93334	4.285680e-05	0	.	18	1600490	1.124660e-05	0	2	44270	4.517730e-05	0	0	74710	0.000000e+00	0	0	912	0.000000e+00	0	0	58410	0.000000e+00	0	1	29304	3.412500e-05	0	2	44270	4.517730e-05	0	2	62196	3.215640e-05	0	0	6036	0.000000e+00	0	12	1174276	1.021910e-05	0	0	88390	0.000000e+00	0	0	15750	0	0	122	0	0	112	0	0	3794	0	0	146	0	0	610	0	0	56	0	0	98	0	0	2824	0	0	3916	0	0	168	0	0	23512	0	Primary_hyperoxaluria,_type_I|Primary_hyperoxaluria|not_provided|Nephrolithiasis|Nephrocalcinosis	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240871406G>A	ClinGen:CA275698|UniProtKB:P21549#VAR_074587	C0268164|C0020501|C3661900|C0392525|C0027709	259900|PS259900	416|93598|416	Aminotransferase class V domain	Gly	Ser	98.71	0.011904761904761904																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			98.71	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Alanine--glyoxylate aminotransferase										-0.4								 G161-L318 (PAE:  1.0), G161-E157 (PAE: 1.0)	G161-E157 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), G161-L318 (PDBs: 6RV1, 3R9A)	 G161-T323 (PAE:  1.0), G161-L318 (PAE: 1.0), G161-E157 (PAE: 1.0)	G161-E157 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), G161-T323 (PDBs: 6RV1, 3R9A), G161-L318 (PDBs: 6RV1, 3R9A)							75									76.8				20.2						C (loop/coil)	T (turn)												98.71	1.1904762	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.5983763611824254	0.6384607592997791	false	false	false
AGXT	AGXT_Phe152Ile	B_7-8	-2.8513354377107007	1.0	1.0	-0.5593443588657525	1.0	1.0	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7129584594952737	0.7037129718961491	0.41756060239169523	0.5603858019385473	0.5177944819009801	0.4489208255504916	0.5717332477611934	0.5672344843445779	0.6217883923022545	0.5342585238562537	0.727771096676237	0.7285371124853681	0.32610840333978985	0.4683544794573822	0.49898321157484016	0.30086268092713675	0.6796548471160613	0.6973798065051793	AGXT	Phe152Ile	NC_000002.12:240871379:T:A	454T>A	2	240871379	T	A	2	ENSG00000172482	70497	3821	CCSBVarC004882	ALE00004882	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	F03	GDEhDisVCh_40002	F05	2	VUSMutGDDh004	F03	VUSN2Hmut_GDN2h_01	B07	VUSMutpDEST2_14	H04	VUSmut_GDEh01	B07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	20684.0	single nucleotide variant	NM_000030.3(AGXT):c.454T>A (p.Phe152Ile)	189.0	AGXT	HGNC:341	Pathogenic	1.0	Mar 28, 2024	121908524.0	-	RCV000005999|RCV000779687|RCV000727639	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MONDO:MONDO:0002474,MedGen:C0020501,OMIM:PS259900,Orphanet:416|MedGen:C3661900	Primary hyperoxaluria, type I|Primary hyperoxaluria|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	240871379.0	240871379.0	2q37.3	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA340444,UniProtKB:P21549#VAR_000589,OMIM:604285.0006	3.0	5645.0	240871379.0	T	A	-	-	-	-	-	-	454T>A 	Phe152Ile	NM_000030.3	2.0	Pathogenic	Pathogenic	5645	2	240871379.0	T	A	F	I	rs121908524	2	241810796	2	241459469	152	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.454T>A	p.Phe152Ile	c.454T>A	p.Phe152Ile	principal1	Y	1	YES	Select	+	TTC	1	0	T	T/T	T/T	T/T	T/T	0.01	0.56615	D	0.029	0.54888	D	0.995	0.67505	D	0.963	0.70837	D	0.96	0.95575	A	simple_aae	4.0	96.0	.	.	.	-5.43	0.85353	D	0.788	0.78366	0.8686	0.95245	D	0.8529	0.95087	D	9	0.9449767	0.93753	D	0.83995	0.98760	D	0.869	0.96050	.	.	.	.	.	0.94613008747	0.94513	0.925202226952542	0.92450	0.273358827671	0.29536	0.616872429848	0.55221	T	0.765788	0.93635	D	0.251653	0.78599	D	0.388134	0.91658	D	0.767224311828613	0.43981	D	0.929607	0.73936	D	0.9209267	0.93238	0.756282	0.85420	0.9209267	0.93239	0.756282	0.85421	-9.291	0.69629	D	0.7767	0.76172	P	0.986751258808726	0.87208	0.45884368	0.80978	0.971	0.98885	.	.	.	.	.	.	4.591323	0.72687	25.9	0.99149893546298706	0.53869	0.921649	0.89508	D	0.454033679212343	0.64246	4.697678	0.377389845792201	0.59961	4.202117	4.05	4.05	0.46353	.	.	6.818	0.75108	4.814000	0.45141	0.595	0.32887	1.0	0.71675	1.000000	0.68239	0.936	0.47515	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	31	264690	1.17118136E-4	.	6	96644	6.208350e-05	0	19	185198	1.025930e-04	0	19	212264	8.951120e-05	0	1	5586	1.790190e-04	0	0	15804	0.000000e+00	0	0	2010	0.000000e+00	0	0	8036	0.000000e+00	0	0	12658	0.000000e+00	0	5	37020	1.350620e-04	0	0	13794	0.000000e+00	0	1	5586	1.790190e-04	0	1	13700	7.299270e-05	0	0	28018	0.000000e+00	0	0	5650	0.000000e+00	0	0	12294	0.000000e+00	0	0	15422	0.000000e+00	0	18	78710	2.286880e-04	0	0	27020	0.000000e+00	0	18	78710	2.286880e-04	0	1	12702	7.872780e-05	0	0	31838	0.000000e+00	0	0	9108	0.000000e+00	0	0	16234	0.000000e+00	0	0	18642	0.000000e+00	0	18	91570	1.965710e-04	0	0	26984	0.000000e+00	0	18	91570	1.965710e-04	0	.	171	1597214	1.070610e-04	0	163	1172600	1.390070e-04	0	4	74628	5.359920e-05	0	0	912	0.000000e+00	0	1	57958	1.725390e-05	0	0	29252	0.000000e+00	0	0	44026	0.000000e+00	0	0	62048	0.000000e+00	0	0	6022	0.000000e+00	0	163	1172600	1.390070e-04	0	0	87918	0.000000e+00	0	2	32784	6.1005368472425575E-5	0	122	0	0	112	0	0	3438	0	0	500	0	0	628	0	0	56	0	0	98	0	2	7052	2.836074872376631E-4	0	3560	0	0	168	0	4	44790	8.930564858227282E-5	Primary_hyperoxaluria|not_provided|Primary_hyperoxaluria,_type_I	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240871379T>A	ClinGen:CA340444|OMIM:604285.0006|UniProtKB:P21549#VAR_000589	C0020501|C3661900|C0268164	PS259900|259900	416|416|93598	Aminotransferase class V domain	Phe	Ile	98.97	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.97	Aromatic	Phenylalanine		Alanine--glyoxylate aminotransferase										2.8								 F152-L101 (PAE:  1.0), F152-G103 (PAE: 1.0)	F152-G103 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), F152-L101 (PDBs: 6RV1, 3R9A)	 F152-L101 (PAE:  1.0), F152-F100 (PAE: 1.0)	F152-L101 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5HHY, 3R9A), F152-F100 (PDBs: 5F9S, 3R9A)							165									-102.2				128.4						B (undefined)	E (parallel sheets)	Beta strand											98.97	0.0	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.7037129718961491	0.7129584594952737	false	false	false
AMPD2	AMPD2_Glu697Asp	B_7-8	4.567802685219396	0.019681901216605714	0.045109366894457464	-5.4245591603014525	0.0016257990589155498	0.0035943870760361853	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7710268727411139	0.7444088536101743	0.4836553643497836	0.5054418877860029	0.4270115702605529	0.4827876803515625	0.4827876803515625	0.44419263221849214	0.4962906745811332	0.4836553643497836	0.8178808589807727	0.7710268727411139		0.4098305083026137	0.5145931009908725		0.670936848239576		AMPD2	Glu697Asp	NC_000001.11:109630697:G:C	2091G>C	1	109630697	G	C	1	ENSG00000116337	4910	201776	CCSBVarC003133	ALE00003133	ENSP00000345498.4	CEGS2	CegsMutGDEh1033	C10	GDEhDisVCh_40034	F12	2	CegsMutGDDh1033	C10	VUSN2Hmut_GDN2h_06	F05	VUSMutpDEST2_04	H11	VUSmut_GDEh06	F05	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	Y	Y	N	Y	Y	136559.0	single nucleotide variant	NM_001368809.2(AMPD2):c.2172G>C (p.Glu724Asp)	271.0	AMPD2	HGNC:469	Pathogenic	1.0	Aug 01, 2013	587777392.0	-	RCV000119279	MONDO:MONDO:0014351,MedGen:C4014354,OMIM:615809,Orphanet:369920	Pontocerebellar hypoplasia type 9	germline	germline	GRCh38	NC_000001.11	1	109630697.0	109630697.0	1p13.3	no assertion criteria provided	1.0	-	N	ClinGen:CA156214,UniProtKB:Q01433#VAR_071193,OMIM:102771.0003	1.0	132810.0	109630697.0	G	C	-	-	-	-	-	-	2172G>C 	Glu724Asp	NM_001368809.2		Pathogenic	Pathogenic	132810	1	109630697.0	G	C	E	D	rs587777392	1	110173319	1	109974842	724	AMPD2	ENSG00000116337	ENST00000528667	ENSP00000436541	Q01433	AMPD2_HUMAN	c.2172G>C	p.Glu724Asp	c.2172G>C	p.Glu724Asp	principal1	Y	1	YES	Select	+	GAG	3	2	G	G/G	G/G	G/G	G/G	.	0.72322	.	.	0.92967	.	.	0.90580	.	.	0.82066	.	1.0	0.99291	A	simple_aae	0.0	100.0	.	.	.	.	0.53599	.	.	0.97765	-0.5335	0.67265	T	0.2669	0.63681	T	10	.	0.78963	.	0.17569	0.85130	D	0.750	0.91380	.	.	.	.	.	0.770271105398	0.76634	.	.	.	0.88743	0.883723258972	0.94449	D	.	.	.	0.235666	0.77084	D	0.100741	0.76786	D	0.996113300323486	0.88602	D	.	0.99007	.	.	.	.	.	.	.	.	.	.	0.93054	.	.	0.99217	.	.	.	0.94958840	0.93352	0.701	0.83417	.	.	.	.	.	.	3.994468	0.58889	24.0	0.99794222120436304	0.87938	0.681409	0.64349	D	0.200917995249701	0.51002	3.307216	0.205707443562222	0.49907	3.211339	4.9	3.97	0.45177	1.39	0.32974	0.8	0.26795	0.805000	0.21778	0.618	0.50684	1.0	0.71675	0.999000	0.35501	0.999	0.91597	840	0.37322	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pontocerebellar_hypoplasia_type_9	no_assertion_criteria_provided	NC_000001.11:g.109630697G>C	ClinGen:CA156214|OMIM:102771.0003|UniProtKB:Q01433#VAR_071193	C4014354	615809	369920	.	Glu	Asp																																																																																																																																																																																																																																																																																																																																																																																																																																																																																			Negatively-charged	Glutamic Acid		AMP deaminase 2										-3.5																		146																					Helix													NaN	NaN	615809	autosomal recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	PONTOCEREBELLAR HYPOPLASIA, TYPE 9	false	0.7444088536101743	0.7710268727411139	false	false	false
KCTD1	KCTD1_His33Pro	B_7-8	1.976958404049458	0.08857805836182597	0.14866791869164114	2.592677493460505	0.03580488536937917	0.052730308710121	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7570153009158693	0.7829743060610406	0.7077442860324434	0.7883487514992724	0.7093967032114867	0.749966823323328	0.9533377781435874	0.888010311747184	0.9620778597976914	0.8844470768426678	0.9781895017716009	0.9689513346845109	0.5465958685030685	0.5307830946757893	0.6146196432008535	0.5310414952222191	0.5877591103504802	0.5450792671472278	KCTD1	His33Pro	NC_000018.10:26501138:T:G	98A>C	18	26501138	T	G	18	ENSG00000134504	14221	218279	CCSBVarC005804	ALE00005804	ENSP00000464170.1	CEGS2	CegsMutGDEh1037	D07	GDEhDisVCh_40022	D07	2	CegsMutGDDh1037	D07	VUSN2Hmut_GDN2h_07	E08	VUSMutpDEST2_11	H07	VUSmut_GDEh07	E08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	70534.0	single nucleotide variant	NM_001142730.3(KCTD1):c.1922A>C (p.His641Pro)	284252.0	KCTD1	HGNC:18249	Pathogenic	1.0	Jan 29, 2014	587777001.0	-	RCV000049297	MONDO:MONDO:0008404,MedGen:C1867020,OMIM:181270,Orphanet:2036	Scalp-ear-nipple syndrome	germline;inherited	germline	GRCh38	NC_000018.10	18	26501138.0	26501138.0	18q11.2	no assertion criteria provided	2.0	-	N	ClinGen:CA143997,UniProtKB:Q719H9#VAR_069975,OMIM:613420.0006	3.0	55886.0	26501138.0	T	G	-	-	-	-	-	-	1922A>C 	His641Pro	NM_001142730.3		Pathogenic	Pathogenic	55886	18	26501138.0	T	G	H	P	rs587777001	18	24081102	18	22335100	33	KCTD1	ENSG00000134504	ENST00000579973	ENSP00000464170	Q719H9	KCTD1_HUMAN	c.98A>C	p.His33Pro	c.98A>C	p.His33Pro	.	Y	1	.	.	-	CAC	2	0	T	./.	./.	./.	./.	.	0.63383	.	0.127	0.35415	T	1.0	0.90580	D	0.999	0.92348	D	0.99	0.97926	A	simple_aae	1.0	99.0	2.235	0.62971	M	.	0.97628	.	0.853	0.85308	0.0899	0.83919	D	0.5761	0.84655	D	10	0.89655244	0.88888	D	0.259692	0.89431	D	.	0.91849	0.539	0.64898	Q719H9	H33P	Gain of disorder (P = 0.0558)| Gain of glycosylation at S28 (P = 0.14)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at D35 (P = 0.2613)| Loss of solvent accessibility (P = 0.3646)	0.936929985409	0.93578	.	0.96179	.	0.93728	0.878531098366	0.93753	D	0.65112	0.89308	D	0.485261	0.93813	D	0.459267	0.93734	D	0.997937321662903	0.92736	D	.	0.99293	.	0.9799661	0.99091	0.97616416	0.99699	0.9681966	0.98059	0.9840036	0.99906	-11.184	0.80720	D	.	0.98378	.	0.999852638850817	0.98365	0.91787815	0.91883	0.993	0.99760	.	.	.	.	.	.	4.857522	0.79501	27.1	0.98848174460688476	0.47355	0.972125	0.99400	D	0.720276018591319	0.80856	7.412012	0.723266044665883	0.84057	8.211294	5.68	5.68	0.88004	.	.	7.597	0.82034	7.918000	0.74412	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.997	0.79771	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Scalp-ear-nipple_syndrome	no_assertion_criteria_provided	NC_000018.10:g.26501138T>G	ClinGen:CA143997|OMIM:613420.0006|UniProtKB:Q719H9#VAR_069975	C1867020	181270	2036	Potassium channel tetramerisation-type BTB domain|BTB/POZ domain|BTB/POZ domain-containing protein KCTD1, BTB/POZ domain	His	Pro	97.95	0.45108695652173914																																																																																																																																																																																																																																																																																																																																																																																																																																																																													83			97.95	Positively-charged	Histidine		BTB/POZ domain-containing protein KCTD1							BTB			-3.2			D:H33-E:K72 (PDBs: 5BXB), D:H33-E:D69 (PDBs: 5BXD), E:H33-A:D69 (PDBs: 6S4L), C:H33-D:D69 (PDBs: 6S4L)					 H33-T42 (PAE:  1.0), H33-Y75 (PAE: 1.0)	H33-Y75 (PDBs: 5BXB, 6S4L), H33-T42 (PDBs: 5BXD, 6S4L)	 H33-T42 (PAE:  1.0), H33-Y75 (PAE: 1.0)	H33-H74 (PDBs: 5BXB, 6S4L), H33-Q73 (PDBs: 5BXD), H33-T42 (PDBs: 6S4L), H33-Y75 (PDBs: 6S4L)							155									-91.5				132.8						B (undefined)	E (parallel sheets)	Beta strand											97.95	45.108696	>90	10-90	181270	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	3	SCALP-EAR-NIPPLE SYNDROME	false	0.7829743060610406	0.7570153009158693	false	false	false
PLP1	PLP1_Asp168His	B_7-8	1.3441001800719468	0.22750767123095447	0.3084028758347218	-0.7708183995565996	0.4700694428786044	0.5237264284652332	2024_01_Batch_7-8	false	true	false	false	false	false	false	false	false	false	false	false	0.9422496044452725	0.9448758087181757	0.4418144197916771	0.5145370702170764	0.5155606734856151	0.44012841393493807	0.45870438434253813	0.417282170555377	0.480674753383488	0.4794271045878423	0.9454352839066784	0.930730600942524	0.42155244352733806	0.6138391764158532	0.5483993870506648	0.4042017349955119	0.9443163335296728	0.953768607948021	PLP1	Asp168His	NC_000023.11:103787951:G:C	502G>C	23	103787951	G	C	X	ENSG00000123560	4062	201427	CCSBVarC005861	ALE00005861	ENSP00000477619.1	CEGS2	CegsMutGDEh1041	A02	GDEhDisVCh_40062	B08	2	CegsMutGDDh1041	A02	VUSN2Hmut_GDN2h_08	E07	VUSMutpDEST2_04	B03	VUSmut_GDEh08	E07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26120.0	single nucleotide variant	NM_000533.5(PLP1):c.607G>C (p.Asp203His)	5354.0	PLP1	HGNC:9086	Pathogenic	1.0	Jul 01, 1992	132630284.0	-	RCV000011830	Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702	Pelizaeus-Merzbacher disease	germline	germline	GRCh38	NC_000023.11	X	103787951.0	103787951.0	Xq22.2	no assertion criteria provided	1.0	-	N	ClinGen:CA255693,UniProtKB:P60201#VAR_004557,OMIM:300401.0009	1.0	11081.0	103787951.0	G	C	-	-	-	-	-	-	607G>C 	Asp203His	NM_000533.5		Pathogenic	Pathogenic	11081	X	103787951.0	G	C	D	H	rs132630284	X	103042880	X	102929536	203	PLP1	ENSG00000123560	ENST00000612423	ENSP00000481006	P60201	MYPR_HUMAN	c.607G>C	p.Asp203His	c.607G>C	p.Asp203His	principal1	Y	2	.	.	+	GAT	1	0	G	G/G	G/G	G/G	G/G	.	.	.	0.003	0.79703	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	2.78	0.80945	M	.	.	.	0.987	0.99555	1.0461	0.98030	D	0.9841	0.99516	D	10	0.99412644	0.99924	D	0.94444	0.99610	D	.	.	0.977	0.99784	P60201	D203H	Gain of methylation at R205 (P = 0.0641)| Gain of disorder (P = 0.1264)| Loss of helix (P = 0.2022)| Loss of stability (P = 0.2231)| Loss of loop (P = 0.2237)	0.99988649107	0.99988	0.9901140222374114	0.99003	.	.	0.757399082184	0.75499	T	0.990684	0.99961	D	0.576138	0.96900	D	0.589806	0.96849	D	0.994146993188539	0.85150	D	.	0.82826	.	0.9377415	0.94940	0.9228003	0.96546	0.9339009	0.94548	0.9087969	0.95542	-9.053	0.68116	D	0.997	0.97748	LP	0.999930342928322	0.98982	0.99850106	0.98815	0.978	0.99209	.	.	.	.	.	.	4.980572	0.8253	27.8	0.99466762507628703	0.66146	.	.	.	.	.	.	.	.	.	5.58	5.58	0.84339	.	.	9.602	0.97629	11.769000	0.95819	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pelizaeus-Merzbacher_disease	no_assertion_criteria_provided	NC_000023.11:g.103787951G>C	ClinGen:CA255693|OMIM:300401.0009|UniProtKB:P60201#VAR_004557	C0205711	312080	702	.	Asp	His	89.16	0.1411042944785276																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																89.16	14.11043	70-90	10-90	312080	x-linked recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	PELIZAEUS-MERZBACHER DISEASE	false	0.9448758087181757	0.9422496044452725	true	false	false
ALAS2	ALAS2_Asp153Val	B_7-8	-1.7070343018992538	0.18635459961215084	0.26582321527946834	-0.030324011843360685	0.9772613469902052	0.9830354876265335	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5851129113618212	0.5921103276992707	0.6593309079901427	0.5199921038751462	0.45110675306415826	0.5457539151474506	0.5457539151474506	0.45110675306415826	0.5199921038751462	0.6593309079901427	0.5921103276992707	0.5851129113618212							ALAS2	Asp153Val	NC_000023.11:55021121:T:A	458A>T	23	55021121	T	A	X	ENSG00000158578	8420	216657	CCSBVarC003764	ALE00003764	ENSP00000337131.4	CEGS2	CegsMutGDEh1039	C12	GDEhDisVCh_40062	H06	2	CegsMutGDDh1039	C12	VUSN2Hmut_GDN2h_08	D04	VUSMutpDEST2_08	F03	VUSmut_GDEh08	D04	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25513.0	single nucleotide variant	NM_000032.5(ALAS2):c.569A>T (p.Asp190Val)	212.0	ALAS2	HGNC:397	Pathogenic	1.0	Jul 15, 1997	28935484.0	-	RCV003322588	MONDO:MONDO:0020721,MedGen:C4551511,OMIM:300751,Orphanet:75563	X-linked sideroblastic anemia 1	germline	germline	GRCh38	NC_000023.11	X	55021121.0	55021121.0	Xp11.21	no assertion criteria provided	1.0	-	N	ClinGen:CA121085,OMIM:301300.0007	1.0	10474.0	55021121.0	T	A	-	-	-	-	-	-	569A>T 	Asp190Val	NM_000032.5		Pathogenic	Pathogenic	10474	X	55021121.0	T	A	D	V	rs28935484	X	55047554	X	55064279	190	ALAS2	ENSG00000158578	ENST00000650242	ENSP00000497236	P22557	HEM0_HUMAN	c.569A>T	p.Asp190Val	c.569A>T	p.Asp190Val	principal1	Y	.	YES	Select	-	GAT	2	0	T	T/T	T/T	T/T	T/T	.	0.45552	.	.	0.47214	.	0.036	0.20746	B	0.15	0.34163	B	.	0.93829	.	.	.	.	2.105	0.58252	M	.	0.72035	.	.	0.64810	-0.5253	0.67575	T	0.3113	0.68022	T	10	0.9429184	0.93545	D	0.246226	0.88892	D	.	0.95902	0.815	0.92954	P22557	D190V	Loss of sheet (P = 0.0181)| Gain of methylation at K189 (P = 0.0263)| Loss of loop (P = 0.0512)| Loss of disorder (P = 0.0561)| Gain of MoRF binding (P = 0.1163)	.	0.99057	.	.	.	.	0.408845514059	0.26266	T	0.736405	0.92595	D	0.565466	0.96308	D	0.574477	0.96248	D	0.985243439674377	0.76124	D	0.950605	0.82530	D	0.90529	0.91741	0.74633425	0.84823	0.8853304	0.89973	0.78656596	0.87276	-5.288	0.39871	T	0.1424	0.43876	B	0.968884858712283	0.83086	0.99798030	0.98583	0.685	0.82515	.	.	.	.	.	.	4.292962	0.65552	24.8	0.98831792694875842	0.47071	.	.	.	.	.	.	.	.	.	4.92	4.92	0.64102	4.01	0.76498	8.017	0.8876	6.122000	0.53870	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	103	0.95731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	X-linked_sideroblastic_anemia_1	no_assertion_criteria_provided	NC_000023.11:g.55021121T>A	ClinGen:CA121085|OMIM:301300.0007	C4551511	300751	75563	Aminotransferase, class I/classII, large domain|Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase	Asp	Val	94.61	0.6748466257668712																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																94.61	67.484665	>90	10-90	300751	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare inborn errors of metabolism; Rare genetic skin disease	4	ANEMIA, SIDEROBLASTIC, 1	true	0.5921103276992707	0.5851129113618212	false	false	false
MLH1	MLH1_Ala681Thr	B_11-12	1.5957993985892436	0.16500665216108837	0.24150398898672704	5.4784146452798765	0.010099576882570621	0.017304130326346492	2024_12_Batch_11-12	true	true	false	false	false	false	false	false	false	false	false	false	0.9273440572521223	0.9261053624986593	0.6976098990811673	0.585626424946484	0.6718053821195065	0.7469690959699635		0.6881010526617846		0.6383325532114166	0.9330909732325601	0.9436309089834956	0.7469690959699635	0.6555097115772283	0.585626424946484	0.7568872449509181	0.9191197517647586	0.9110572055207491	MLH1	Ala681Thr	NC_000003.12:37048955:G:A	2041G>A	3	37048955	G	A	3	ENSG00000076242	2713	983	CCSBVarC007397	ALE00007385	ENSP00000231790.3	Edgotyping3	VUSMutGDEh011	B11	GDEhDisVCh_40019	E08	1	VUSMutGDDh011	B11	VUSN2Hmut_GDN2h_04	F02	VUSMutpDEST2_02	B06	VUSmut_GDEh04	F02	1.0	3.0	1.0	5.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	N	N	N	Y	Y	32138.0	single nucleotide variant	NM_000249.4(MLH1):c.2041G>A (p.Ala681Thr)	4292.0	MLH1	HGNC:7127	Pathogenic	1.0	Sep 05, 2013	63750217.0	-	RCV000018632|RCV000075495|RCV000213700|RCV000202172|RCV000524270|RCV000519240|RCV000763105|RCV001328323|RCV002288511	MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MeSH:D003123,MedGen:C0009405|MedGen:C3661900|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144;MONDO:MONDO:0010159,MedGen:C5399763,OMIM:276300,Orphanet:252202;MONDO:MONDO:0008018,MedGen:C1321489,OMIM:158320,Orphanet:587|MONDO:MONDO:0018630,MedGen:C1333990,OMIM:PS120435,Orphanet:443909|MONDO:MONDO:0008018,MedGen:C1321489,OMIM:158320,Orphanet:587	Colorectal cancer, hereditary nonpolyposis, type 2|Lynch syndrome|Hereditary cancer-predisposing syndrome|not specified|Hereditary nonpolyposis colorectal neoplasms|not provided|Colorectal cancer, hereditary nonpolyposis, type 2;Mismatch repair cancer syndrome 1;Muir-Torré syndrome|Hereditary nonpolyposis colon cancer|Muir-Torré syndrome	germline;unknown	germline	GRCh38	NC_000003.12	3	37048955.0	37048955.0	3p22.2	reviewed by expert panel	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008304,UniProtKB:P40692#VAR_004466,OMIM:120436.0022	3.0	17099.0	37048955.0	G	A	-	-	-	-	-	-	2041G>A 	Ala681Thr	NM_000249.4	3.0	Pathogenic	Pathogenic	17099	3	37048955.0	G	A	A	T	rs63750217	3	37090446	3	37065450	681	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.2041G>A	p.Ala681Thr	c.2041G>A	p.Ala681Thr	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.007	0.69466	D	0.995	0.67505	D	0.748	0.55966	P	0.89	0.97926	A	simple_aae	11.0	89.0	3.305	0.90410	M	-2.23	0.50028	N	0.868	0.86483	1.0370	0.97846	D	0.8951	0.96512	D	9	0.9601218	0.95360	D	0.423904	0.93836	D	0.831	0.94638	0.82	0.93292	P40692	A681T	Gain of phosphorylation at A681 (P = 0.0412)| Gain of helix (P = 0.132)| Gain of disorder (P = 0.1417)| Loss of ubiquitination at K678 (P = 0.1459)| Loss of stability (P = 0.2845)	0.980891545777	0.98049	0.7722985616457466	0.77051	0.289883819029	0.31096	0.485512852669	0.36767	T	0.917558	0.98480	D	0.492908	0.94032	D	0.470252	0.93954	D	0.910370469093323	0.56311	D	0.839216	0.53310	T	0.7239079	0.79136	0.70640314	0.82487	0.71722686	0.78763	0.67211837	0.80540	-8.834	0.66699	D	0.7352	0.74374	P	0.989514692554341	0.88205	0.99975425	0.99678	0.923	0.96111	.	.	.	.	.	.	4.941002	0.81569	27.6	0.99902637930543181	0.97428	0.388864	0.46650	N	0.771358581792363	0.84201	8.245907	0.766790634613585	0.87335	9.210925	5.93	5.93	0.95881	.	.	4.676	0.61402	11.857000	0.98228	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.983	0.59808	154	0.93969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1614098	1.858620e-06	0	1	60008	1.666440e-05	0	0	75032	0.000000e+00	0	0	912	0.000000e+00	0	1	60008	1.666440e-05	0	0	29608	0.000000e+00	0	0	44886	0.000000e+00	0	0	64032	0.000000e+00	0	0	6060	0.000000e+00	0	2	1179974	1.694950e-06	0	0	91078	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Hereditary_nonpolyposis_colon_cancer|Muir-Torré_syndrome|Mismatch_repair_cancer_syndrome_1|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome|not_provided|not_specified	reviewed_by_expert_panel	NC_000003.12:g.37048955G>A	ClinGen:CA008304|OMIM:120436.0022|UniProtKB:P40692#VAR_004466	C1333991|C1333990|C1321489|C5399763|C0027672|C0009405|C4552100|C3661900|CN169374	609310|PS120435|158320|276300	144|443909|587|252202|140162|144	DNA mismatch repair protein Mlh1, C-terminal	Ala	Thr	94.7	0.009433962264150943																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			94.7	Aliphatic	Alanine		DNA mismatch repair protein Mlh1										1.8								 A681-S685 (PAE:  1.5), A681-S677 (PAE: 1.0)	A681-S685 (PDBs: 3RBN), A681-S677 (PDBs: 3RBN)	 A681-S677 (PAE:  1.0), A681-L564 (PAE: 2.0), A681-S685 (PAE: 1.5)	A681-S677 (PDBs: 3RBN), A681-L564 (PDBs: 3RBN), A681-S685 (PDBs: 3RBN)							89									-61.4				-39.3						H (helix)	H (α-helix)	Helix											94.7	0.9433962	>90	<10	609310;609310;276300;158320;158320	multiple	OMIM	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 2; LYNCH SYNDROME 2; MISMATCH REPAIR CANCER SYNDROME 1; MUIR-TORRE SYNDROME; MUIR-TORRE SYNDROME	false	0.9261053624986593	0.9273440572521223	true	true	false
KRT6A	KRT6A_Leu170Phe	B_7-8	-0.7339332409121162	0.4906630138857567	0.5754515490842763	-0.2001864952055851	0.8470263922298896	0.8746727235463407	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8808759428909387	0.8336118722760746	0.5958162280806623	0.5348925300070544	0.4582579163753402	0.6593006089530431	0.6000992651951365	0.6152366517143937	0.5934421637764796	0.43055387489559793	0.848073853391546	0.9280940945080322	0.7185019527109496	0.30127918103628665	0.47634289623762927	0.7610785812657266	0.8191498911606033	0.8336577912738454	KRT6A	Leu170Phe	NC_000012.12:52492681:G:A	508C>T	12	52492681	G	A	12	ENSG00000205420	4870	215272	CCSBVarC003666	ALE00003666	ENSP00000369317.3	CEGS2	CegsMutGDEh1039	G09	GDEhDisVCh_40048	F09	2	CegsMutGDDh1039	G09	VUSN2Hmut_GDN2h_08	E03	VUSMutpDEST2_04	C09	VUSmut_GDEh08	E03	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77481.0	single nucleotide variant	NM_005554.4(KRT6A):c.508C>T (p.Leu170Phe)	3853.0	KRT6A	HGNC:6443	Pathogenic	1.0	Feb 03, 2016	57448541.0	-	RCV000057006	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000012.12	12	52492681.0	52492681.0	12q13.13	criteria provided, single submitter	2.0	-	N	ClinGen:CA217350,UniProtKB:P02538#VAR_072449	2.0	66584.0	52492681.0	G	A	-	-	-	-	-	-	508C>T 	Leu170Phe	NM_005554.4	1.0	Pathogenic	Pathogenic	66584	12	52492681.0	G	A	L	F	rs57448541	12	52886465	12	51172732	170	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.508C>T	p.Leu170Phe	c.508C>T	p.Leu170Phe	principal1	Y	1	YES	Select	-	CTC	1	0	.	./.	./.	./.	./.	0.0	0.91343	D	0.009	0.67073	D	1.0	0.90580	D	0.998	0.88579	D	0.81	0.87956	A	simple_aae	19.0	81.0	4.315	0.98290	H	-3.56	0.68915	D	0.986	0.99488	1.0881	0.99163	D	0.9656	0.98900	D	10	0.97198796	0.96793	D	0.096227	0.76491	D	0.974	0.99740	0.879	0.96766	P02538	L170F	Gain of catalytic residue at A175 (P = 0.0495)| Loss of ubiquitination at K168 (P = 0.1062)| Loss of MoRF binding (P = 0.1136)| Gain of methylation at K173 (P = 0.16)| Loss of disorder (P = 0.2356)	0.989570740721	0.98933	0.6869343151676955	0.68476	1.01835501036	0.74866	0.789270401001	0.80296	T	0.943389	0.99118	D	0.557488	0.96009	D	0.563016	0.95948	D	0.999496936798096	0.97611	D	0.848415	0.52826	T	0.8289188	0.85641	0.8645251	0.92389	0.8289188	0.85643	0.8645251	0.92389	-10.75	0.78340	D	0.9921	0.94292	P	0.988318276537006	0.87750	0.96986747	0.94646	0.94	0.97139	.	.	.	.	.	.	4.171493	0.62802	24.5	0.99897304260027553	0.96973	0.875038	0.79750	D	1.06739059063059	0.97467	16.20344	0.966849188925643	0.97865	16.94502	5.31	5.31	0.75027	3.9	0.73887	7.879	0.8573	.	.	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.987	0.62545	764	0.49916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000012.12:g.52492681G>A	ClinGen:CA217350|UniProtKB:P02538#VAR_072449	CN517202	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Phe	80.95	0.5548780487804879																																																																																																																																																																																																																																																																																																																																																																																																																																																																													91			80.95	Aliphatic	Leucine		Keratin, type II cytoskeletal 6A							IF rod			3.8								 L170-Q166 (PAE:  3.5), L170-F174 (PAE: 2.5)		 L170-Q166 (PAE:  3.5), L170-F174 (PAE: 2.5)								131									-71.2				-41.8	Coil 1A			dbSNP: rs57448541; Variant type: LP/P; AA change: Leu170Phe; PTM type: Phosphorylation; PTM morphology: REQIktL*NNkF; Var class: II&rs57448541		H (helix)	H (α-helix)												80.95	55.487804	70-90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2		false	0.8336118722760746	0.8808759428909387	false	false	false
DES	DES_Asn342Asp	B_7-8	-1.5161290322580645	0.189926989671972	0.26991112371537684	-7.149053438955154	0.0001855135037749004	0.0006410871552296464	2024_01_Batch_7-8		false	false	false	false	false		false	false	false	false	false		0.9404284729045365	0.7609442006568778	0.8308929366559556	0.7446026691796251	0.840237939157092	0.8821817221048478	0.8982587406744946	0.9014325186945191	0.8128035296728766	0.9567450417317325		0.7982941562093363	0.5909465976847557	0.7603533546173922	0.709084871640879	0.9241119040773405		DES	Asn342Asp	NC_000002.12:219421340:A:G	1024A>G	2	219421340	A	G	2	ENSG00000175084	12573	2296	CCSBVarC007853	ALE00007839	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	F09	GDEhDisVCh_40003	H09	1	VUSMutGDDh003	F09	VUSN2Hmut_GDN2h_01	E04	NULL	NULL	VUSmut_GDEh01	E04	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	77285.0	single nucleotide variant	NM_001927.4(DES):c.1024A>G (p.Asn342Asp)	1674.0	DES	HGNC:2770	Pathogenic	1.0	Dec 27, 2016	267607482.0	-	RCV000056764|RCV001380949	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219421340.0	219421340.0	2q35	criteria provided, single submitter	5.0	ACMG2022	N	ClinGen:CA217001,UniProtKB:P17661#VAR_042453,OMIM:125660.0020	3.0	66388.0	219421340.0	A	G	-	-	-	-	-	-	1024A>G 	Asn342Asp	NM_001927.4	1.0	Pathogenic	Pathogenic	66388	2	219421340.0	A	G	N	D	rs267607482	2	220286062	2	219994306	342	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1024A>G	p.Asn342Asp	c.1024A>G	p.Asn342Asp	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.002	0.72322	D	0.006	0.70891	D	0.999	0.77914	D	0.986	0.76920	D	0.79	0.86984	A	simple_aae	21.0	79.0	4.22	0.97873	H	-4.48	0.77997	D	0.931	0.93613	1.1009	0.99697	D	0.9517	0.98426	D	9	0.98640203	0.98937	D	0.404968	0.93464	D	0.909	0.97545	0.893	0.97445	P17661	N342D	Loss of MoRF binding (P = 0.0781)| Gain of ubiquitination at K339 (P = 0.0853)| Gain of phosphorylation at S344 (P = 0.0893)| Gain of disorder (P = 0.107)| Gain of relative solvent accessibility (P = 0.1259)	0.992147753689	0.99196	0.9221110290755287	0.92138	1.54913524828	0.87818	0.732968270779	0.71891	T	0.889684	0.97728	D	0.235826	0.77098	D	0.100971	0.76801	D	0.999002277851105	0.95821	D	0.956004	0.83241	D	0.9468314	0.95880	0.9117542	0.95755	0.9387867	0.95049	0.88136065	0.93572	-14.294	0.93985	D	0.9429	0.86153	P	0.999093393372798	0.95689	0.99665016	0.98120	0.945	0.97437	.	.	.	.	.	.	5.327589	0.89429	30.0	0.99791788727525077	0.87760	0.976415	0.99671	D	0.918384011269186	0.92591	11.53549	0.807669557449632	0.90269	10.35463	5.24	5.24	0.72825	.	.	7.153	0.77073	11.100000	0.86123	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.472	0.28435	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Desmin-related_myofibrillar_myopathy|not_provided	criteria_provided,_single_submitter	NC_000002.12:g.219421340A>G	ClinGen:CA217001|OMIM:125660.0020|UniProtKB:P17661#VAR_042453	C1832370|C3661900	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Asn	Asp	85.75	0.5796178343949044																																																																																																																																																																																																																																																																																																																																																																																																																																																																													91			85.75	Polar/Neutral	Asparagine		Desmin							IF rod			-3.5								 N342-L338 (PAE:  1.0), N342-M346 (PAE: 1.0)		 N342-L338 (PAE:  1.0), N342-M346 (PAE: 1.0)								132									-61.7				-46.1	Interaction with NEB; Coil 2B			dbSNP: rs267607482; Variant type: LP/P; AA change: Asn342Asp; PTM type: Acetylation; PTM morphology: EIDALkGTN*DS; Var class: II&rs267607482		H (helix)	H (α-helix)												85.75	57.961784	70-90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.9404284729045365		false		false
LITAF	LITAF_Ala111Gly	B_15-16	1.5777753572891533	0.1586244598779815	0.234499008023951	-2.8680508077048694	0.024058962159627006	0.03706817427616755	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8223060488539817	0.8242993455927257	0.6247021650987391	0.46283234433136367	0.5158531444714418	0.5966456629711117	0.6960486560603566	0.5708557131189778	0.45306760756857684	0.7355027748157332	0.8552913986586294	0.8392521859508979	0.49724266988186683	0.46085057582390576	0.47259708109415044	0.513901555381745	0.7933072925268221	0.8053599117570656	LITAF	Ala111Gly	NC_000016.10:11553578:G:C	332C>G	16	11553578	G	C	16	ENSG00000189067	52920	2678	CCSBVarC002194	ALE00002194	ENSP00000483114.1	Edgotyping3	VUSMutGDEh007	A01	NULL	NULL	NULL	VUSMutGDDh007	A01	VUSN2Hmut_GDN2h_02	C06	VUSMutpDEST2_12	C01	VUSmut_GDEh02	C06	0.0		1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	49653.0	single nucleotide variant	NM_001136472.2(LITAF):c.332C>G (p.Ala111Gly)	9516.0	LITAF	HGNC:16841	Pathogenic	1.0	Jul 12, 2024	281865134.0	-	RCV000789997|RCV000034128	MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 1C	germline;unknown	germline	GRCh38	NC_000016.10	16	11553578.0	11553578.0	16p13.13	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA344230	3.0	41229.0	11553578.0	G	C	-	-	-	-	-	-	332C>G 	Ala111Gly	NM_001136472.2	2.0	Pathogenic	Pathogenic	41229	16	11553578.0	G	C	A	G	rs281865134	16	11647434	16	11554935	111	LITAF	ENSG00000189067	ENST00000570904	ENSP00000459138	Q99732	LITAF_HUMAN	c.332C>G	p.Ala111Gly	c.332C>G	p.Ala111Gly	principal1	Y	1	.	.	-	GCC	2	0	G	G/G	G/G	G/G	G/G	.	0.47480	.	0.035	0.52739	D	0.826	0.45934	P	0.294	0.40805	B	1.0	0.99291	A	simple_aae	0.0	100.0	2.485	0.72164	M	.	0.43912	.	0.555	0.62845	0.7179	0.93374	D	0.7126	0.90099	D	10	0.7264603	0.73762	D	0.11559	0.79419	D	.	0.81390	0.413	0.44908	Q99732	A111G	Gain of sheet (P = 0.1208)| Loss of stability (P = 0.1258)| Loss of helix (P = 0.2662)| Gain of catalytic residue at S108 (P = 0.4613)| Gain of disorder (P = 0.6039)	0.99604168251	0.99594	.	0.46694	.	0.36542	0.523463606834	0.42053	T	0.636686	0.88694	D	0.281149	0.81279	D	0.166075	0.81038	D	0.955770909786224	0.64369	D	.	0.66978	.	0.34404737	0.56269	0.32932168	0.58583	0.41598582	0.61501	0.30730587	0.56532	-8.919	0.67252	D	.	0.58558	.	0.893462440768685	0.75614	0.97675800	0.95214	0.275	0.54537	.	.	.	.	.	.	3.830914	0.55459	23.6	0.99541552709857184	0.70560	0.858468	0.77516	D	0.387912268322694	0.60564	4.269257	0.327050733938517	0.56906	3.878252	5.39	5.39	0.77583	.	.	7.179	0.77263	11.491000	0.92936	0.676	0.76753	0.984	0.35906	1.000000	0.68239	0.74	0.35475	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Charcot-Marie-Tooth_disease|Charcot-Marie-Tooth_disease_type_1C	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.11553578G>C	ClinGen:CA344230	C0007959|C0270913	PS118220|601098	166|101083	LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor	Ala	Gly	87.64	0.39622641509433965																																																																																																																																																																																																																																																																																																																																																																																																																																																																													42			87.64	Aliphatic	Alanine		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF			1.8										 A111-T115 (PAE:  5.5), A111-W116 (PAE: 5.0)								89									-67.0				97.6	Membrane-binding amphipathic helix					C (loop/coil)	C (loop/coil)												87.64	39.622643	70-90	10-90	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.8242993455927257	0.8223060488539817	false	false	false
LITAF	LITAF_Trp116Gly	B_15-16	0.9282762239775726	0.38415609302232573	0.47491141596934766	-7.309819340440901	0.00016139363579788091	0.0005795642303113727	2025_03_Batch_15-16	true	true	false	false	false	false	true	false	false	false	false	false	0.9799099879973705	0.9774856017474156	0.7094858631509533	0.6336160342328747	0.6808004064169093	0.7307783999596196	0.6457465518909231	0.6570328661824154	0.6668563463897076	0.6668491139523443	0.9754201589263862	0.9761281030279582	0.815810248028316	0.7045679466514032	0.6003757220760417	0.7521226123495622	0.979551044568445	0.983691872966783	LITAF	Trp116Gly	NC_000016.10:11553564:A:C	346T>G	16	11553564	A	C	16	ENSG00000189067	52920	2675	CCSBVarC007938	ALE00007924	ENSP00000483114.1	Edgotyping3	VUSMutGDEh006	D12	GDEhDisVCh_40036	E06	2	VUSMutGDDh006	D12	VUSN2Hmut_GDN2h_02	H05	VUSMutpDEST2_11	F12	VUSmut_GDEh02	H05	1.0	2.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	21098.0	single nucleotide variant	NM_001136472.2(LITAF):c.346T>G (p.Trp116Gly)	9516.0	LITAF	HGNC:16841	Pathogenic	1.0	Jan 27, 2022	104894521.0	-	RCV000006431	MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083	Charcot-Marie-Tooth disease type 1C	germline;unknown	germline	GRCh38	NC_000016.10	16	11553564.0	11553564.0	16p13.13	criteria provided, single submitter	3.0	-	N	ClinGen:CA340515,UniProtKB:Q99732#VAR_024019,OMIM:603795.0003	3.0	6059.0	11553564.0	A	C	-	-	-	-	-	-	346T>G 	Trp116Gly	NM_001136472.2	1.0	Pathogenic	Pathogenic	6059	16	11553564.0	A	C	W	G	rs104894521	16	11647420	16	11554921	116	LITAF	ENSG00000189067	ENST00000570904	ENSP00000459138	Q99732	LITAF_HUMAN	c.346T>G	p.Trp116Gly	c.346T>G	p.Trp116Gly	principal1	Y	1	.	.	-	TGG	1	0	.	A/A	A/A	A/A	A/A	.	0.91343	.	0.001	0.83643	D	1.0	0.90580	D	0.99	0.78943	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.945	0.84662	M	.	0.99550	.	0.927	0.94087	0.9110	0.95816	D	0.8372	0.94541	D	9	0.93852586	0.93103	D	0.252221	0.89138	D	.	0.94938	0.774	0.89950	Q99732	W116G	Loss of catalytic residue at L114 (P = 0.0543)| Gain of sheet (P = 0.0827)| Gain of disorder (P = 0.1826)| Loss of stability (P = 0.2189)| Loss of helix (P = 0.2662)	0.990653667622	0.99044	.	0.79127	.	0.69662	0.701548576355	0.67313	T	0.964998	0.99573	D	0.44938	0.92396	D	0.407727	0.92302	D	0.999321222305298	0.96939	D	.	0.66836	.	0.9823376	0.99270	0.96223015	0.99076	0.9858436	0.99513	0.970768	0.99490	-16.228	0.98086	D	.	0.86311	.	0.995853177016867	0.91652	0.99722350	0.98303	0.839	0.91143	.	.	.	.	.	.	5.506198	0.91646	32.0	0.98214861249042618	0.39386	0.868635	0.78806	D	0.828323411842117	0.87774	9.360059	0.772105426005064	0.87729	9.347591	5.48	5.48	0.80649	.	.	6.703	0.74518	10.894000	0.84131	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.989	0.64309	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	1	426	0.002347417840375587	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	1	426	0.002347417840375587	0	0	0	1	478	0.0020920502092050207	Charcot-Marie-Tooth_disease_type_1C	criteria_provided,_single_submitter	NC_000016.10:g.11553564A>C	ClinGen:CA340515|OMIM:603795.0003|UniProtKB:Q99732#VAR_024019	C0270913	601098	101083	LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor	Trp	Gly	88.76	0.7048458149779736																																																																																																																																																																																																																																																																																																																																																																																																																																																																													160			88.76	Aromatic	Tryptophan		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF			-0.9								 W116-G112 (PAE:  2.5), W116-G120 (PAE: 2.0)		 W116-A111 (PAE:  5.0), W116-G112 (PAE: 2.5), W116-G120 (PAE: 2.0)								204									-69.7				-40.6	Membrane-binding amphipathic helix					H (helix)	H (α-helix)												88.76	70.48458	70-90	10-90	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.9774856017474156	0.9799099879973705	true	true	false
CTH	CTH_Gln240Glu	B_15-16	-1.9083035021861599	0.09800183987977297	0.16164379462035092	-5.411304532529716	0.0009963418079378095	0.0023836860724457372	2025_03_Batch_15-16	false	false	true	false	false	true	false	false	false	false	false	true	0.8881055232347926	0.8909445046662243	0.7946610362426649	0.9073442110654242	0.892796910432807	0.8845942304783768	0.8987916533688856	0.8912251714618751	0.877811262132555	0.8208581966983535	0.852853041403583	0.8563075507069801	0.8703968075878681	0.8943686494037388	0.9368771599982932	0.7684638757869763	0.9290359679288658	0.9199034957626052	CTH	Gln240Glu	NC_000001.11:70430388:C:G	718C>G	1	70430388	C	G	1	ENSG00000116761	268	714	CCSBVarC000020	ALE00000020	ENSP00000359976.3	RC4	RC4_Mut_GDEh1008	F11	GDEhDisVCh_40012	B12	2	RC4_Mut_GDDh1008	F11	NULL	NULL	NULL	NULL	VUSmut_GDEh12	B09	1.0	1.0	1.0	1.0	0.0			0.0			1.0	1.0	99.0	Y	Y	N	N	Y	17979.0	single nucleotide variant	NM_001902.6(CTH):c.718C>G (p.Gln240Glu)	1491.0	CTH	HGNC:2501	Pathogenic	1.0	Apr 01, 2003	28941786.0	-	RCV000003074	Human Phenotype Ontology:HP:0003153,MONDO:MONDO:0009058,MedGen:C0220993,OMIM:219500,Orphanet:212	Cystathioninuria	germline	germline	GRCh38	NC_000001.11	1	70430388.0	70430388.0	1p31.1	no assertion criteria provided	1.0	-	N	ClinGen:CA115890,UniProtKB:P32929#VAR_015451,OMIM:607657.0004	1.0	2940.0	70430388.0	C	G	-	-	-	-	-	-	718C>G 	Gln240Glu	NM_001902.6		Pathogenic	Pathogenic	2940	1	70430388.0	C	G	Q	E	rs28941786	1	70896071	1	70668659	240	CTH	ENSG00000116761	ENST00000370938	ENSP00000359976	P32929	CGL_HUMAN	c.718C>G	p.Gln240Glu	c.718C>G	p.Gln240Glu	principal1	Y	1	YES	Select	+	CAA	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.425	0.70064	M	-2.88	0.60539	D	0.962	0.97221	0.4013	0.89073	D	0.6747	0.88699	D	9	0.9745281	0.97136	D	0.097687	0.76741	D	0.793	0.93165	0.872	0.96404	P32929	Q240E	Gain of methylation at R237 (P = 0.0747)| Gain of helix (P = 0.2294)| Gain of relative solvent accessibility (P = 0.2363)| Gain of solvent accessibility (P = 0.3089)| Gain of loop (P = 0.3485)	0.951996521406	0.95109	0.8690099339560466	0.86785	0.490635962763	0.47484	0.708794236183	0.68366	T	0.735289	0.92556	D	0.416079	0.90748	D	0.375378	0.91205	D	0.974295914173126	0.70249	D	0.992892	0.98156	D	0.9638068	0.97623	0.91655356	0.96100	0.9676712	0.98007	0.9239881	0.96631	-12.0	0.84894	D	0.5095	0.64957	A	0.986590279770328	0.87155	0.13069156	0.69122	0.693	0.82967	.	.	.	.	.	.	3.659443	0.52057	23.2	0.9917266986157115	0.54515	0.934267	0.92712	D	0.701563403170665	0.79625	7.140814	0.637586654366726	0.77565	6.727987	5.45	5.45	0.79660	.	.	7.569	0.8176	7.523000	0.59857	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.191	0.21676	609	0.67070	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	0	109348	0.000000e+00	0	0	208006	0.000000e+00	0	2	236830	8.444880e-06	0	0	7162	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9040	0.000000e+00	0	0	13354	0.000000e+00	0	0	42760	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16216	0.000000e+00	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13410	0.000000e+00	0	0	16690	0.000000e+00	0	0	89496	0.000000e+00	0	0	30604	0.000000e+00	0	.	.	.	.	0	14900	0.000000e+00	0	0	34256	0.000000e+00	0	0	9572	0.000000e+00	0	0	17686	0.000000e+00	0	0	21586	0.000000e+00	0	2	102694	1.947530e-05	0	0	30522	0.000000e+00	0	2	102694	1.947530e-05	0	.	4	1545396	2.588330e-06	0	4	1117570	3.579190e-06	0	0	73690	0.000000e+00	0	0	912	0.000000e+00	0	0	59884	0.000000e+00	0	0	29158	0.000000e+00	0	0	44508	0.000000e+00	0	0	63888	0.000000e+00	0	0	5918	0.000000e+00	0	4	1117570	3.579190e-06	0	0	89720	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Cystathioninuria	no_assertion_criteria_provided	NC_000001.11:g.70430388C>G	ClinGen:CA115890|OMIM:607657.0004|UniProtKB:P32929#VAR_015451	C0220993	219500	212	.	Gln	Glu	98.83	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.83	Polar/Neutral	Glutamine		Cystathionine gamma-lyase										-3.5								 Q240-G244 (PAE:  1.0), Q240-E72 (PAE: 1.0), Q240-A86 (PAE: 1.0), Q240-L236 (PAE: 1.0)	Q240-A86 (PDBs: 2NMP, 3COG, 5TT2, 6NBA, 6OVG), Q240-L236 (PDBs: 3ELP, 6OVG), Q240-E72 (PDBs: 6OVG), Q240-G244 (PDBs: 6OVG)	 Q240-L85 (PAE:  1.0), Q240-G244 (PAE: 1.0), Q240-L236 (PAE: 1.0)	Q240-L236 (PDBs: 2NMP, 3COG, 3ELP, 5TT2, 6NBA, 6OVG), Q240-L85 (PDBs: 6OVG), Q240-G244 (PDBs: 6OVG)							146									-54.7				-44.7						H (helix)	H (α-helix)	Helix											98.83	0.0	>90	<10	219500	autosomal recessive	OMIM	Rare inborn errors of metabolism	1	CYSTATHIONINURIA	false	0.8909445046662243	0.8881055232347926	false	false	false
PMP22	PMP22_Leu16Pro	B_7-8	2.8798992072908893	0.02806143449889629	0.058833523482867085	-8.219643706094692	0.00017501941468366756	0.0006148889814751898	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.9717679975653859	0.9784471868408433	0.534291693893039	0.6857102102741994	0.7178060014249212	0.5919497522071832	0.6844177173542756	0.7301923674364105	0.7432556020167695	0.6348212379586198	0.9900594505868128	0.9858411809843447	0.49948178706009067	0.7054196354134321	0.6281648185316292	0.4337621498274582	0.9668349230948738	0.9576948141464271	PMP22	Leu16Pro	NC_000017.11:15260681:A:G	47T>C	17	15260681	A	G	17	ENSG00000109099	7323	13235	CCSBVarC001160	ALE00001160	ENSP00000308937.3	RC4	RC4_Mut_GDEh1011	C05	GDEhDisVCh_40078	B08	2	RC4_Mut_GDDh1011	C05	VUSN2Hmut_GDN2h_10	C06	VUSMutpDEST2_06	A03	VUSmut_GDEh12	D09	1.0	1.0	1.0	99.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	23467.0	single nucleotide variant	NM_000304.4(PMP22):c.47T>C (p.Leu16Pro)	5376.0	PMP22	HGNC:9118	Pathogenic	1.0	Jul 11, 2019	104894617.0	-	RCV000008940|RCV000685070	MONDO:MONDO:0007309,MedGen:C0270911,OMIM:118220,Orphanet:101081|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753	Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type I	germline;unknown	germline	GRCh38	NC_000017.11	17	15260681.0	15260681.0	17p12	criteria provided, single submitter	3.0	-	N	ClinGen:CA340784,UniProtKB:Q01453#VAR_006360,OMIM:601097.0002	3.0	8428.0	15260681.0	A	G	-	-	-	-	-	-	47T>C 	Leu16Pro	NM_000304.4	1.0	Pathogenic	Pathogenic	8428	17	15260681.0	A	G	L	P	rs104894617	17	15163998	17	15104723	16	PMP22	ENSG00000109099	ENST00000675950	ENSP00000501546	Q01453	PMP22_HUMAN	.	.	c.47T>C	p.Leu16Pro	principal1	Y	.	.	.	-	CTG	2	0	A	A/A	A/A	A/A	A/A	.	0.40988	.	.	0.52739	.	0.928	0.51624	P	0.802	0.58260	P	.	0.95575	.	.	.	.	2.945	0.84662	M	.	0.74928	.	.	0.97658	0.5680	0.91444	D	0.7265	0.90608	D	9	.	0.87944	.	0.450088	0.94315	D	.	0.93561	0.727	0.86044	Q01453	L16P	Loss of stability (P = 0.0826)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.5184)| Gain of catalytic residue at L18 (P = 0.5828)| Loss of MoRF binding (P = 0.5981)	.	0.98312	.	0.98152	.	0.79272	0.825031161308	0.85776	D	0.941366	0.99072	D	0.420699	0.90993	D	0.366529	0.90881	D	0.981060147285461	0.73511	D	.	0.31281	.	0.7719636	0.81946	0.7713206	0.86332	0.79495513	0.83379	0.78849626	0.87396	-11.539	0.82586	D	.	0.86847	.	0.995800579143409	0.91612	0.99965692	0.99581	0.808	0.89388	.	.	.	.	.	.	5.352282	0.89797	31.0	0.92450176795446548	0.22125	0.919227	0.88904	D	0.492323835426425	0.66464	4.976398	0.432445566164429	0.63402	4.596711	4.45	3.36	0.37505	1.56	0.34791	5.44	0.66389	11.130000	0.86794	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.999	0.91597	876	0.30319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	1	422	0.002369668246445498	0	0	0	0	0	0	0	0	0	0	0	0	0	50	0	1	422	0.002369668246445498	0	0	0	1	472	0.00211864406779661	Charcot-Marie-Tooth_disease,_type_I|Charcot-Marie-Tooth_disease,_type_IA	criteria_provided,_single_submitter	NC_000017.11:g.15260681A>G	ClinGen:CA340784|OMIM:601097.0002|UniProtKB:Q01453#VAR_006360	C0751036|C0270911	118220	65753|101081	.	Leu	Pro	98.0	0.14634146341463414																																																																																																																																																																																																																																																																																																																																																																																																																																																																													24			98.0	Aliphatic	Leucine		Peripheral myelin protein 22										3.8								 L16-F20 (PAE:  1.0), L16-H12 (PAE: 1.0)		 L16-F20 (PAE:  1.0), L16-S76 (PAE: 1.0), L16-H12 (PAE: 1.0)								131									-59.6				-42.5						H (helix)	H (α-helix)									Helical			98.0	14.634146	>90	10-90	118220	autosomal dominant	OMIM	Genetic otorhinolaryngologic disease; Rare genetic neurological disorder; Rare chromosomal anomaly	3	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	false	0.9784471868408433	0.9717679975653859	true	true	false
STAR	STAR_Arg188Cys	B_7-8	2.1308382052545545	0.12291360586098159	0.1930353713847962	2.5226538233711837	0.03965640468071427	0.05770777366305367	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7620166462889824	0.764909407109513	0.8652149123083834	0.743825332669053	0.7799890238440816	0.9332797233245558	0.9332797233245558	0.9410994252425804	0.9325359133976499	0.8652149123083834	0.9088877491934612	0.8921998325960087		0.6188786224455829	0.5551147519404562		0.620931065025565	0.6318334599819562	STAR	Arg188Cys	NC_000008.11:38146051:G:A	562C>T	8	38146051	G	A	8	ENSG00000147465	386	213660	CCSBVarC005624	ALE00005624	ENSP00000276449.3	CEGS2	CegsMutGDEh1032	H08	GDEhDisVCh_40077	D04	1	CegsMutGDDh1032	H08	VUSN2Hmut_GDN2h_06	C01	VUSMutpDEST2_01	E07	VUSmut_GDEh06	C01	1.0	1.0	1.0	2.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	24036.0	single nucleotide variant	NM_000349.3(STAR):c.562C>T (p.Arg188Cys)	6770.0	STAR	HGNC:11359	Pathogenic	1.0	Jan 24, 2024	104894090.0	-	RCV000009560|RCV000812202	MONDO:MONDO:0008725,MedGen:C0342474,OMIM:201710,Orphanet:418,Orphanet:90790|MedGen:C3661900	Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided	germline;unknown	germline	GRCh38	NC_000008.11	8	38146051.0	38146051.0	8p11.23	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA120045,OMIM:600617.0012	3.0	8997.0	38146051.0	G	A	-	-	-	-	-	-	562C>T 	Arg188Cys	NM_000349.3	2.0	Pathogenic	Pathogenic	8997	8	38146051.0	G	A	R	C	rs104894090	8	38003569	8	38122726	188	STAR	ENSG00000147465	ENST00000276449	ENSP00000276449	P49675	STAR_HUMAN	c.562C>T	p.Arg188Cys	c.562C>T	p.Arg188Cys	principal1	Y	1	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.987	0.61929	D	0.813	0.58742	P	0.73	0.83975	A	simple_aae	27.0	73.0	2.93	0.84361	M	-6.61	0.92107	D	0.98	0.99026	0.8982	0.95634	D	0.8446	0.94801	D	9	0.955539	0.94856	D	0.296247	0.90711	D	0.873	0.96198	.	.	.	.	.	0.960371443939	0.95960	0.8896741010330672	0.88867	0.970798519185	0.73191	0.834276676178	0.87196	D	0.862971	0.96950	D	0.229863	0.76534	D	0.388598	0.91672	D	0.894335806369781	0.54317	D	0.913209	0.68976	D	0.85720253	0.87709	0.67940843	0.80951	0.851711	0.87295	0.64527535	0.79034	-8.686	0.65731	D	0.609	0.69196	P	0.986672631930277	0.87182	0.97058254	0.94700	0.986	0.99524	.	.	.	.	.	.	5.908103	0.94031	33.0	0.99939653748222113	0.99734	0.725688	0.67341	D	0.862970926126142	0.89778	10.13737	0.819607104336197	0.91072	10.72951	5.84	5.84	0.93363	4.87	0.88614	4.196	0.5829	11.842000	0.97838	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.997	0.79771	121	0.95159	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	segdup	7	109400	6.398540e-05	0	10	208018	4.807280e-05	0	11	236880	4.643700e-05	0	1	7164	1.395870e-04	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	0	42764	0.000000e+00	0	6	15690	3.824090e-04	0	6	15690	3.824090e-04	0	1	16206	6.170550e-05	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16730	0.000000e+00	0	1	89470	1.117690e-05	0	8	30608	2.613700e-04	0	8	30608	2.613700e-04	0	1	14894	6.714110e-05	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21622	0.000000e+00	0	2	102698	1.947460e-05	0	8	30526	2.620720e-04	0	8	30526	2.620720e-04	0	.	76	1614102	4.708500e-05	0	21	91090	2.305410e-04	0	1	74946	1.334290e-05	0	0	910	0.000000e+00	0	2	60006	3.333000e-05	0	0	29606	0.000000e+00	0	0	44894	0.000000e+00	0	0	64034	0.000000e+00	0	0	6084	0.000000e+00	0	49	1180048	4.152370e-05	0	21	91090	2.305410e-04	0	1	25922	3.857727027235553E-5	0	298	0	0	86	0	0	7864	0	0	146	0	0	610	0	0	26	0	0	98	0	0	2232	0	0	8162	0	0	112	0	1	37282	2.6822595354326485E-5	not_provided|Congenital_lipoid_adrenal_hyperplasia_due_to_STAR_deficency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000008.11:g.38146051G>A	ClinGen:CA120045|OMIM:600617.0012	C3661900|C0342474	201710	418|90790	START domain|START domain|START domain	Arg	Cys	98.65	0.13709677419354838																																																																																																																																																																																																																																																																																																																																																																																																																																																																													34			98.65	Positively-charged	Arginine		Steroidogenic acute regulatory protein, mitochondrial							START	0.9709		-4.5								 R188-F165 (PAE:  1.0)	R188-T167 (PDBs: 3P0L), R188-F165 (PDBs: 3P0L)	 R188-T167 (PAE:  1.0), R188-F165 (PAE: 1.0)	R188-T167 (PDBs: 3P0L), R188-F165 (PDBs: 3P0L)							175									-125.9		Pocket 1: Mean pLDDT: 96.54, Volume: 773.88 Å³, Druggability score: 0.97		143.8						B (undefined)	E (parallel sheets)	Beta strand											98.65	13.709678	>90	10-90	201710	autosomal recessive	OMIM	Rare genetic gynecological and obstetrical diseases; Rare genetic developmental defect during embryogenesis; Rare genetic urogenital disease; Rare genetic endocrine disease; Genetic infertility	5	LIPOID CONGENITAL ADRENAL HYPERPLASIA	false	0.764909407109513	0.7620166462889824	false	false	false
DES	DES_Gln389Pro	B_7-8	-0.9958804519329355	0.36503116043001516	0.4571865681451337	0.8024017540864584	0.4487007588780191	0.50327988541636	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8368285155251945	0.7910333248415573	0.7850205133232149	0.7099620079987301	0.5806052741638199	0.8072464480768669	0.9534751699453896	0.8391333133541339	0.8750896611497965	0.8955247134357043	0.8637047957432675	0.8751636600833429	0.661017726208344	0.3220772349735058	0.5448343548476637	0.6745163132107256	0.7183618539398471	0.7984933709670462	DES	Gln389Pro	NC_000002.12:219421482:A:C	1166A>C	2	219421482	A	C	2	ENSG00000175084	12573	2312	CCSBVarC007868	ALE00007854	ENSP00000363071.3	Edgotyping3	VUSMutGDEh005	G09	GDEhDisVCh_40003	G11	1	VUSMutGDDh005	G09	VUSN2Hmut_GDN2h_02	D03	NULL	NULL	VUSmut_GDEh02	D03	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	31869.0	single nucleotide variant	NM_001927.4(DES):c.1166A>C (p.Gln389Pro)	1674.0	DES	HGNC:2770	Pathogenic	1.0	Nov 01, 2001	121913004.0	-	RCV000056776|RCV002265563	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219421482.0	219421482.0	2q35	no assertion criteria provided	2.0	ACMG2022	N	ClinGen:CA217025,UniProtKB:P17661#VAR_018772,OMIM:125660.0011	3.0	16830.0	219421482.0	A	C	-	-	-	-	-	-	1166A>C 	Gln389Pro	NM_001927.4		Pathogenic	Pathogenic	16830	2	219421482.0	A	C	Q	P	rs121913004	2	220286204	2	219994448	389	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1166A>C	p.Gln389Pro	c.1166A>C	p.Gln389Pro	principal1	Y	1	YES	Select	+	CAG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.83643	D	0.999	0.77914	D	0.99	0.78943	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.065	0.97077	H	-5.26	0.84133	D	0.983	0.99270	1.0313	0.97737	D	0.8817	0.96065	D	9	0.98043513	0.97994	D	0.304406	0.90966	D	0.892	0.96904	0.892	0.97398	P17661	Q389P	Loss of phosphorylation at Y388 (P = 0.1139)| Loss of MoRF binding (P = 0.1243)| Gain of disorder (P = 0.2292)| Loss of stability (P = 0.2486)| Loss of solvent accessibility (P = 0.4995)	0.988238771408	0.98798	0.9890946351822995	0.98900	1.6131558255	0.88896	0.859997034073	0.91096	D	0.9549	0.99369	D	0.490851	0.93983	D	0.467297	0.93905	D	0.995804369449615	0.88004	D	0.968903	0.88769	D	0.9504909	0.96257	0.958434	0.98869	0.96635747	0.97878	0.9573142	0.98807	-16.156	0.97989	D	0.9992	0.98627	P	0.999949396721542	0.99079	0.99791664	0.98559	0.992	0.99727	.	.	.	.	.	.	5.727373	0.93269	33.0	0.99450014829404576	0.65269	0.991929	0.99997	D	0.863670003581851	0.89817	10.15379	0.75048785530971	0.86118	8.811733	5.12	3.98	0.45320	4.05	0.77340	9.197	0.94136	11.103000	0.86182	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.994	0.71086	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Desmin-related_myofibrillar_myopathy|not_provided	no_assertion_criteria_provided	NC_000002.12:g.219421482A>C	ClinGen:CA217025|OMIM:125660.0011|UniProtKB:P17661#VAR_018772	C1832370|C3661900	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Gln	Pro	97.08	0.46464646464646464																																																																																																																																																																																																																																																																																																																																																																																																																																																																													92			97.08	Polar/Neutral	Glutamine		Desmin							IF rod			-3.5								 Q389-L385 (PAE:  1.0), Q389-N393 (PAE: 1.0)		 Q389-L385 (PAE:  1.0), Q389-N393 (PAE: 1.0)								146									-63.6				-42.4	Interaction with NEB; Coil 2B			dbSNP: rs121913004; Variant type: LP/P; AA change: Gln389Pro; PTM type: Phosphorylation; PTM morphology: RHLrEyQ*DLLN; Var class: II		H (helix)	H (α-helix)												97.08	46.464645	>90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.7910333248415573	0.8368285155251945	false	false	false
CUL3	CUL3_Lys459Arg	B_15-16	-0.3910350377611268	0.7074004543445305	0.7676902657943484	0.9403119034062781	0.37836442031980455	0.43124143558188904	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6731036196509963	0.6661152610459022	0.5317641128860436	0.6729941076657042	0.6558372935288652	0.552057703219978	0.48722018587699145	0.6671832509010076	0.6600078470904293	0.4455222882122798	0.6790095020016762	0.713061907304473	0.6168952205629648	0.6444913361567229	0.6859803682409793	0.6180059375598075	0.6532210200901283	0.6331453319975197	CUL3	Lys459Arg	NC_000002.12:224503653:T:C	1376A>G	2	224503653	T	C	2	ENSG00000036257	11305	217226	CCSBVarC003147	ALE00003147	ENSP00000264414.4	CEGS2	CegsMutGDEh1031	F09	GDEhDisVCh_40088	H05	2	CegsMutGDDh1031	F09	VUSN2Hmut_GDN2h_05	G09	VUSMutpDEST2_08	H10	VUSmut_GDEh05	G09	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	106399.0	single nucleotide variant	NM_003590.5(CUL3):c.1376A>G (p.Lys459Arg)	8452.0	CUL3	HGNC:2553	Pathogenic	1.0	-	199469658.0	-	RCV000128494	MONDO:MONDO:0007772,MedGen:C1840389,OMIM:145260,Orphanet:757,Orphanet:88938	Pseudohypoaldosteronism type 2A	germline	germline	GRCh38	NC_000002.12	2	224503653.0	224503653.0	2q36.2	no assertion criteria provided	1.0	-	N	ClinGen:CA269962,UniProtKB:Q13618#VAR_067533	2.0	100522.0	224503653.0	T	C	-	-	-	-	-	-	1376A>G 	Lys459Arg	NM_003590.5		Pathogenic	Pathogenic	100522	2	224503653.0	T	C	K	R	rs199469658	2	225368370	2	225076614	459	CUL3	ENSG00000036257	ENST00000264414	ENSP00000264414	Q13618	CUL3_HUMAN	c.1376A>G	p.Lys459Arg	c.1376A>G	p.Lys459Arg	principal1	Y	1	YES	Select	-	AAG	2	0	T	./.	./.	./.	./.	0.053	0.39488	T	0.049	0.49207	D	0.709	0.45628	P	0.392	0.46266	B	0.97	0.97926	A	simple_aae	3.0	97.0	1.975	0.53326	M	-2.35	0.51987	N	0.876	0.92320	0.2161	0.86123	D	0.5027	0.81159	D	9	0.9137808	0.90637	D	0.073736	0.71766	D	0.799	0.93403	0.808	0.92471	Q13618	K459R	Loss of ubiquitination at K459 (P = 0.0118)| Loss of methylation at K459 (P = 0.0416)| Gain of phosphorylation at S456 (P = 0.1213)| Gain of helix (P = 0.1736)| Loss of disorder (P = 0.1778)	0.97451319531	0.97399	0.7480393007696658	0.74613	1.85840211033	0.92338	0.90842705965	0.97317	D	0.769192	0.93754	D	0.377816	0.88486	D	0.30493	0.88340	D	0.912725687026978	0.56627	D	0.974802	0.91057	D	0.58181155	0.71418	0.5353865	0.72896	0.52009004	0.67961	0.4879798	0.70113	-8.075	0.61654	D	0.4708	0.67706	A	0.991787438290121	0.89191	0.88674960	0.90756	0.634	0.79598	.	.	.	.	.	.	4.713629	0.75802	26.4	0.99746861681891497	0.83941	0.902291	0.84945	D	0.53042506735216	0.68734	5.281006	0.589281771584985	0.74029	6.091668	5.67	5.67	0.87655	.	.	7.674	0.83188	7.906000	0.73829	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.971	0.54653	912	0.21478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1579984	6.329180e-07	0	1	1166486	8.572760e-07	0	0	73678	0.000000e+00	0	0	912	0.000000e+00	0	0	53512	0.000000e+00	0	0	27506	0.000000e+00	0	0	44584	0.000000e+00	0	0	62734	0.000000e+00	0	0	5884	0.000000e+00	0	1	1166486	8.572760e-07	0	0	83546	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pseudohypoaldosteronism_type_2A	no_assertion_criteria_provided	NC_000002.12:g.224503653T>C	ClinGen:CA269962|UniProtKB:Q13618#VAR_067533	C1840389	145260	757|88938	Cullin, N-terminal|Cullin homology domain|Cullin homology domain	Lys	Arg	94.17	0.3463414634146341																																																																																																																																																																																																																																																																																																																																																																																																																																																																													71	Morphology: KNMIsKLkTECGCQF; Domain: Cullin		94.17	Positively-charged	Lysine		Cullin-3										-3.9				L:K459-B:A227 (PDBs: 8H38, 8H3A, 8H3F), L:K459-B:S226 (PDBs: 8H3F)				 K459-G463 (PAE:  1.5), K459-I455 (PAE: 1.0), K459-E471 (PAE: 2.0)	K459-I455 (PDBs: 8GQ6, 8H33, 8H34, 8H36, 8H37, 8H38, 8H3A, 8H3F, 8H3Q, 8K8T, 8K9I, 8KHP), K459-C464 (PDBs: 8H35, 8H3R), K459-G463 (PDBs: 8KHP)	 K459-T467 (PAE:  1.0), K459-G463 (PAE: 1.5), K459-I455 (PAE: 1.0), K459-C464 (PAE: 1.0)	K459-I455 (PDBs: 8GQ6, 8H36, 8H37, 8H38, 8H3A, 8H3F, 8K8T, 8KHP), K459-S468 (PDBs: 8H33), K459-C464 (PDBs: 8H34, 8H35, 8H3Q, 8H3R, 8K9I), K459-T467 (PDBs: 8KHP), K459-G463 (PDBs: 8KHP)	 K459-E471 (PAE:  2.0)	K459-E471 (PDBs: 8H33)					147									-66.0				-40.5				dbSNP: rs199469658; Variant type: LP/P; AA change: Lys459Arg; PTM type: Phosphorylation; PTM morphology: EKNMIsKLk*TE; Var class: II&rs199469658		H (helix)	H (α-helix)										Morphology: KNMIsKLkTECGCQF; Domain: Cullin		94.17	34.634148	>90	10-90	145260	autosomal dominant	OMIM	Rare genetic renal disease	1	PSEUDOHYPOALDOSTERONISM, TYPE IIA	true	0.6661152610459022	0.6731036196509963	false	false	false
GCK	GCK_Gly175Arg	B_7-8	5.1203726837517305	0.014418835884813175	0.03604708971203294	5.920720235374396	0.009626144116813624	0.016585891506434743	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8006480805412917	0.8805942309449305	0.6741305688450852	0.7490071134377845	0.5908701005331651	0.7230014295283926	0.7230014295283926	0.5908701005331651	0.7490071134377845	0.6741305688450852	0.8805942309449305	0.8006480805412917							GCK	Gly175Arg	NC_000007.14:44150025:C:G	523G>C	7	44150025	C	G	7	ENSG00000106633	3689	214825	CCSBVarC006688	ALE00006686	ENSP00000384247.3	CEGS2	CegsMutGDEh1046	E05	GDEhDisVCh_40037	A07	1	CegsMutGDDh1046	E05	VUSN2Hmut_GDN2h_10	G01	VUSMutpDEST2_03	G08	VUSmut_GDEh10	G01	1.0	1.0	1.0	1.0	1.0	1.0	7.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	Y	Y	N	Y	3184695.0	single nucleotide variant	NM_000162.5(GCK):c.523G>C (p.Gly175Arg)	2645.0	GCK	HGNC:4195	Pathogenic	1.0	Feb 23, 2024	-1.0	-	RCV003883459	MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44150025.0	44150025.0	7p13	reviewed by expert panel	1.0	-	N	-	2.0	3024423.0	44150025.0	C	G	-	-	-	-	-	-	523G>C 	Gly175Arg	NM_000162.5	3.0	Pathogenic	Pathogenic	3024423	7	44150025.0	C	G	G	R	.	7	44189624	7	44156149	175	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.523G>C	p.Gly175Arg	c.523G>C	p.Gly175Arg	principal1	Y	1	YES	Select	-	GGA	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.002	0.79703	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	D	simple_aae	0.0	100.0	3.12	0.87775	M	-4.9	0.82724	D	0.986	0.99555	1.0855	0.99065	D	0.9786	0.99336	D	10	0.9885726	0.99275	D	0.644074	0.96968	D	0.965	0.99518	0.931	0.98924	P35557	G175R	Gain of solvent accessibility (P = 0.0042)| Gain of MoRF binding (P = 0.0243)| Loss of ubiquitination at K172 (P = 0.0303)| Loss of catalytic residue at G175 (P = 0.0658)| Gain of relative solvent accessibility (P = 0.09)	0.980989907939	0.98059	.	0.97734	.	0.97218	0.894961953163	0.95857	D	0.965681	0.99586	D	0.537165	0.95302	D	0.533824	0.95233	D	0.998664021492004	0.94753	D	0.976102	0.91686	D	0.8858796	0.90018	0.8613234	0.92165	0.89920586	0.91188	0.87691617	0.93257	-11.47	0.82228	D	0.8182	0.84062	P	0.996650295463753	0.92339	0.99983668	0.99792	0.977	0.99166	.	.	.	.	.	.	5.143258	0.86143	28.8	0.99941511458053944	0.99797	0.960488	0.98125	D	0.923742279552392	0.92833	11.68111	0.882600563202776	0.94739	13.02673	5.69	5.69	0.88329	3.87	0.72853	6.164	0.71785	7.609000	0.61899	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.994	0.71086	667	0.61202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Monogenic_diabetes	reviewed_by_expert_panel	NC_000007.14:g.44150025C>G	.	C3888631	.	183625	Hexokinase, N-terminal	Gly	Arg	95.88	0.6190476190476191																																																																																																											-0.031	1 mutation(s) (Gly175Trp: -0.565)	0.805																																																																																																																																																																																																																																																																																																																																																																52			95.88	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Hexokinase-4							Hexokinase			-0.4									G175-N179 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DHY, 4MLE, 4NO7, 4RCH, 6E0I)	 G175-N179 (PAE:  1.0)	G175-N179 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DHY, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I)							75									82.3				0.3	Hexokinase small subdomain			dbSNP: rs587780344; Variant type: LP/P; AA change: Gly175Arg; PTM type: Ubiquitylation; PTM morphology: WTkGFkASG*AE; Var class: II		C (loop/coil)	T (turn)												95.88	61.904762	>90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism	3		false	0.8805942309449305	0.8006480805412917	false	false	false
DCX	DCX_Pro191Arg	B_7-8	-0.6689361318589961	0.5284198482620597	0.6083676372396226	-15.091784992401545	1.347963284062644e-6	0.000019572510719154533	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.9625284162488147	0.9580262018695235	0.5971867738722023	0.6835351917095809	0.5745220537571829	0.6398910021237845	0.7239481441981697	0.7275091103945959	0.7401314825348144	0.6528612608180602	0.974278557210466	0.968642821843058	0.5558338600493993	0.4215349971197698	0.6269389008843473	0.5415122869263446	0.941773846528581	0.9564140106545713	DCX	Pro191Arg	NC_000023.11:111401123:G:C	572C>G	23	111401123	G	C	X	ENSG00000077279	8416	216635	CCSBVarC005198	ALE00005198	ENSP00000419861.1	CEGS2	CegsMutGDEh1041	C06	GDEhDisVCh_40049	B08	1	CegsMutGDDh1041	C06	VUSN2Hmut_GDN2h_08	A09	VUSMutpDEST2_07	E12	VUSmut_GDEh08	A09	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	169879.0	single nucleotide variant	NM_001195553.2(DCX):c.572C>G (p.Pro191Arg)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	May 30, 2017	587783566.0	-	RCV000145863|RCV000498232	MedGen:C0008519|MedGen:CN517202	Ectopic tissue|not provided	germline	germline	GRCh38	NC_000023.11	X	111401123.0	111401123.0	Xq23	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA172007,UniProtKB:O43602#VAR_007832	2.0	158481.0	111401123.0	G	C	-	-	-	-	-	-	572C>G 	Pro191Arg	NM_001195553.2	2.0	Pathogenic	Pathogenic	158481	X	111401123.0	G	C	P	R	rs587783566	X	110644351	X	110531007	191	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.572C>G	p.Pro191Arg	c.572C>G	p.Pro191Arg	alternative1	Y	1	.	.	-	CCT	2	0	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.79703	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.95712	.	.	0.89342	1.0310	0.97731	D	0.9064	0.96890	D	10	0.9443019	0.93684	D	0.923263	0.99436	D	.	0.97205	.	.	.	.	.	.	0.99760	.	0.98514	.	.	0.912398517132	0.97690	D	.	0.62022	.	0.653249	0.99891	D	0.70057	0.99890	D	0.998768866062164	0.95055	D	0.99904	0.99536	D	0.93695605	0.94860	0.88625073	0.93920	0.8977796	0.91060	0.8762037	0.93207	-12.75	0.88333	D	0.9992	0.98761	LP	0.999211114884786	0.95976	0.99971193	0.99632	0.937	0.96958	.	.	.	.	.	.	4.887501	0.80249	27.3	0.99861822291616986	0.94006	.	.	.	.	.	.	.	.	.	4.74	4.74	0.59667	.	.	10.003	0.9969	11.833000	0.97587	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	889	0.27289	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Ectopic_tissue	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.111401123G>C	ClinGen:CA172007|UniProtKB:O43602#VAR_007832	CN517202|C0008519	.	.	.	Pro	Arg	66.11	0.9632352941176471																																																																																																																																																																																																																																																																																																																																																																																																																																																																													131			66.11	Special, No backbone hydrogen	Proline		Neuronal migration protein doublecortin							Doublecortin 2			1.6																		115									-82.1				121.2						C (loop/coil)	S (bend)	Beta strand											66.11	96.32353	50-70	$\geqslant$90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.9580262018695235	0.9625284162488147	true	true	false
PLP1	PLP1_Thr121Ile	B_7-8	-1.0897756785605663	0.3176331388485335	0.4054964565090187	-1.0207517834509552	0.3467523797846414	0.39942913804445507	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7418173208913235	0.8061119682278702	0.6497538864887147	0.6867656431863524	0.6726085567761844	0.654078018579062	0.9274252319861496	0.818784541602725	0.932464533588929	0.9111667636587734	0.8879518112993117	0.8212007457454126	0.38073080517197444	0.5264325719496439	0.44106675278377566	0.3883410093186561	0.7242721251564288	0.6624338960372342	PLP1	Thr121Ile	NC_000023.11:103787811:C:T	362C>T	23	103787811	C	T	X	ENSG00000123560	4062	201425	CCSBVarC005856	ALE00005856	ENSP00000477619.1	CEGS2	CegsMutGDEh1039	A09	GDEhDisVCh_40062	E06	2	CegsMutGDDh1039	A09	VUSN2Hmut_GDN2h_08	C03	VUSMutpDEST2_04	H02	VUSmut_GDEh08	C03	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	N	Y	Y	Y	Y	26115.0	single nucleotide variant	NM_000533.5(PLP1):c.467C>T (p.Thr156Ile)	5354.0	PLP1	HGNC:9086	Pathogenic	1.0	Jan 01, 1991	132630280.0	-	RCV000011825	Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702	Pelizaeus-Merzbacher disease	germline	germline	GRCh38	NC_000023.11	X	103787811.0	103787811.0	Xq22.2	no assertion criteria provided	1.0	-	N	ClinGen:CA255681,UniProtKB:P60201#VAR_004552,OMIM:300401.0004	1.0	11076.0	103787811.0	C	T	-	-	-	-	-	-	467C>T 	Thr156Ile	NM_000533.5		Pathogenic	Pathogenic	11076	X	103787811.0	C	T	T	I	rs132630280	X	103042740	X	102929396	156	PLP1	ENSG00000123560	ENST00000612423	ENSP00000481006	P60201	MYPR_HUMAN	c.467C>T	p.Thr156Ile	c.467C>T	p.Thr156Ile	principal1	Y	2	.	.	+	ACC	2	0	C	C/C	C/C	C/C	C/C	.	.	.	0.002	0.79703	D	1.0	0.90580	D	0.998	0.88579	D	.	.	.	.	.	.	2.75	0.80203	M	.	.	.	0.981	0.99110	1.0776	0.98804	D	0.9786	0.99336	D	10	0.98396766	0.98549	D	0.929475	0.99486	D	.	.	0.882	0.96916	P60201	T156I	Gain of catalytic residue at T156 (P = 0.071)| Gain of sheet (P = 0.1208)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K151 (P = 0.1317)| Loss of glycosylation at T156 (P = 0.1513)	0.999979392836	0.99997	0.9928839005672923	0.99283	.	.	0.814007878304	0.84079	D	0.983972	0.99890	D	0.558421	0.96027	D	0.564357	0.95964	D	0.991090303665459	0.81204	D	.	0.67135	.	0.64584726	0.74870	0.49039772	0.70259	0.6012033	0.72472	0.48975614	0.70220	-7.8	0.79861	D	0.934	0.94184	LP	0.999892772923374	0.98645	0.99782490	0.98519	0.883	0.93708	.	.	.	.	.	.	4.422451	0.68568	25.2	0.99825986890837193	0.90858	.	.	.	.	.	.	.	.	.	5.73	4.85	0.62327	2.39	0.44462	7.568	0.81592	7.680000	0.65297	0.599	0.40292	1.0	0.71675	1.000000	0.68239	1.0	0.97202	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pelizaeus-Merzbacher_disease	no_assertion_criteria_provided	NC_000023.11:g.103787811C>T	ClinGen:CA255681|OMIM:300401.0004|UniProtKB:P60201#VAR_004552	C0205711	312080	702	.	Thr	Ile	87.3	0.007042253521126761																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																87.3	0.70422536	70-90	<10	312080	x-linked recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	PELIZAEUS-MERZBACHER DISEASE	false	0.8061119682278702	0.7418173208913235	false	false	false
MLH1	MLH1_Val185Gly	B_11-12	9.817384920440686	0.001483029463646828	0.006280679103249316	7.123712931573369	0.004979604365633598	0.009371870780448875	2024_12_Batch_11-12	true	true	true	false	true	true	true	true	true	false	false	true	0.993432077051951	0.9939776230009552	0.9801114573110561	0.8442623427021774	0.8968813237774627	0.9772591661345728		0.9203712147793247		0.9861469181182604	0.9958185661360925	0.9931271778893117	0.9772591661345728	0.8733914327756005	0.8442623427021774	0.9740759965038519	0.9921366798658178	0.9937369762145903	MLH1	Val185Gly	NC_000003.12:37011828:T:G	554T>G	3	37011828	T	G	3	ENSG00000076242	2713	200837	CCSBVarC003200	ALE00003200	ENSP00000231790.3	CEGS2	CegsMutGDEh1041	A08	GDEhDisVCh_40019	E02	1	CegsMutGDDh1041	A08	VUSN2Hmut_GDN2h_08	E09	VUSMutpDEST2_02	F08	VUSmut_GDEh08	E09	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	95746.0	single nucleotide variant	NM_000249.4(MLH1):c.554T>G (p.Val185Gly)	4292.0	MLH1	HGNC:7127	Pathogenic	1.0	Sep 05, 2013	63750515.0	-	RCV000075761|RCV000218149|RCV003452749|RCV001385098|RCV002345382	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MedGen:C3661900|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Lynch syndrome|not provided|Colorectal cancer, hereditary nonpolyposis, type 2|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000003.12	3	37011828.0	37011828.0	3p22.2	reviewed by expert panel	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA011003,UniProtKB:P40692#VAR_004447	2.0	90272.0	37011828.0	T	G	-	-	-	-	-	-	554T>G 	Val185Gly	NM_000249.4	3.0	Pathogenic	Pathogenic	90272	3	37011828.0	T	G	V	G	rs63750515	3	37053319	3	37028323	185	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.554T>G	p.Val185Gly	c.554T>G	p.Val185Gly	principal1	Y	1	YES	Select	+	GTA	2	0	T	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.83643	D	0.41	0.35080	B	0.375	0.43709	B	0.83	0.88920	A	simple_aae	17.0	83.0	3.355	0.91029	M	-6.69	0.92453	D	0.48	0.51256	-0.2490	0.76280	T	0.4098	0.75752	T	10	0.8398533	0.82962	D	0.204945	0.86925	D	0.821	0.94259	0.922	0.98631	P40692	V185G	Loss of stability (P = 0.0045)| Gain of disorder (P = 0.0376)| Loss of MoRF binding (P = 0.1128)| Gain of methylation at R182 (P = 0.1558)| Gain of phosphorylation at S184 (P = 0.2877)	0.954253640734	0.95338	0.8737723432624236	0.87265	0.256710802097	0.27944	0.530144631863	0.42993	T	0.850244	0.96558	D	0.478509	0.93596	D	0.449569	0.93516	D	0.995804905891418	0.88004	D	0.763824	0.59346	T	0.9252546	0.93670	0.8524182	0.91556	0.90395486	0.91620	0.869246	0.92717	-10.685	0.82030	D	0.8901	0.83349	P	0.989397024514185	0.88158	0.99940560	0.99364	1	0.99985	.	.	.	.	.	.	4.26851	0.64999	24.8	0.99558630182477192	0.71680	0.864748	0.78284	D	0.535769229242169	0.69056	5.326197	0.604045758998829	0.75098	6.274515	6.08	6.08	0.98980	.	.	7.126	0.7687	7.766000	0.68432	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.978	0.57275	253	0.90071	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613582	1.239480e-06	0	1	91070	1.098060e-05	0	0	75040	0.000000e+00	0	0	912	0.000000e+00	0	0	60022	0.000000e+00	0	0	29596	0.000000e+00	0	0	44866	0.000000e+00	0	0	64026	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179500	8.478170e-07	0	1	91070	1.098060e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Lynch_syndrome|not_provided|Hereditary_cancer-predisposing_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Hereditary_nonpolyposis_colorectal_neoplasms	reviewed_by_expert_panel	NC_000003.12:g.37011828T>G	ClinGen:CA011003|UniProtKB:P40692#VAR_004447	C4552100|C3661900|C0027672|C1333991|C0009405	609310	144|140162|144	.	Val	Gly	95.47	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			95.47	Aliphatic	Valine		DNA mismatch repair protein Mlh1										4.2								 V185-G181 (PAE:  1.0)	V185-G181 (PDBs: 4P7A)	 V185-G181 (PAE:  1.0)	V185-G181 (PDBs: 4P7A)							117									-70.2				-46.5				dbSNP: rs63750515; Variant type: LP/P; AA change: Val185Gly; PTM type: Phosphorylation; PTM morphology: VVGRysV*HNAG; Var class: II&rs63750515		H (helix)	H (α-helix)	Helix											95.47	0.0	>90	<10	609310	autosomal dominant	GenCC	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 2	false	0.9939776230009552	0.993432077051951	true	true	true
SH3BP2	SH3BP2_Pro418His	B_7-8	1.0825061496894879	0.3284478687765013	0.4173888418916284	3.325943580185582	0.01588655530110976	0.025798078741182662	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6321227020460737	0.6728814365402778	0.6295683031372228	0.6481870420477578	0.6364268959730677	0.6511505294573257	0.8482182590173794	0.8293237376878139	0.7945620349313544	0.8247920885592364	0.7348565647940816	0.6321227020460737	0.4540827998972719	0.4435300542583215	0.5018120491641613	0.43434451771520927	0.6109063082864739		SH3BP2	Pro418His	NC_000004.12:2831582:C:A	1253C>A	4	2831582	C	A	4	ENSG00000087266	8143	202839	CCSBVarC003712	ALE00003712	ENSP00000422168.3	CEGS2	CegsMutGDEh1038	A01	GDEhDisVCh_40022	D08	2	CegsMutGDDh1038	A01	VUSN2Hmut_GDN2h_07	H09	VUSMutpDEST2_07	G08	VUSmut_GDEh07	H09	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	22588.0	single nucleotide variant	NM_001122681.2(SH3BP2):c.1253C>A (p.Pro418His)	6452.0	SH3BP2	HGNC:10825	Pathogenic	1.0	May 05, 2022	121909146.0	-	RCV000007985	MONDO:MONDO:0007315,MedGen:C0008029,OMIM:118400,Orphanet:184	Fibrous dysplasia of jaw	germline	germline	GRCh38	NC_000004.12	4	2831582.0	2831582.0	4p16.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA254208,UniProtKB:P78314#VAR_013259,OMIM:602104.0003	3.0	7549.0	2831582.0	C	A	-	-	-	-	-	-	1253C>A 	Pro418His	NM_001122681.2	1.0	Pathogenic	Pathogenic	7549	4	2831582.0	C	A	P	H	rs121909146	4	2833309	4	2803107	418	SH3BP2	ENSG00000087266	ENST00000503393	ENSP00000422168	P78314	3BP2_HUMAN	c.1253C>A	p.Pro418His	c.1253C>A	p.Pro418His	principal2	Y	1	YES	Select	+	CCC	2	0	C	./.	./.	./.	./.	.	.	.	.	.	.	1.0	0.90580	D	0.999	0.92348	D	0.98	0.99291	A	simple_aae	2.0	98.0	.	.	.	.	.	.	.	.	1.0700	0.98588	D	0.9476	0.98287	D	10	.	.	.	0.347294	0.92158	D	0.690	0.88677	0.509	0.60412	P78314	P418H	Loss of catalytic residue at P417 (P = 0.016)| Loss of glycosylation at P418 (P = 0.0707)| Gain of solvent accessibility (P = 0.1583)| Loss of loop (P = 0.2237)| Gain of MoRF binding (P = 0.2335)	0.972087712862	0.97152	.	0.52596	0.73894062318	0.62886	0.628487706184	0.56865	T	0.771659	0.93839	D	0.476261	0.93513	D	0.44634	0.93431	D	0.965456824728407	0.67060	D	.	0.68570	.	0.8260269	0.85440	0.5799924	0.75409	0.7726435	0.81988	0.6493925	0.79265	-6.025	0.46671	T	0.8816	0.84514	LP	0.977720914563771	0.84790	0.99251790	0.97157	0.96	0.98304	.	.	.	.	.	.	3.54981	0.49979	22.9	0.99556703905834631	0.71556	0.736103	0.68055	D	0.584164663161874	0.72037	5.766222	0.520323352665731	0.69191	5.349092	5.69	5.69	0.88329	3.72	0.68345	4.676	0.61402	7.409000	0.58695	0.599	0.40292	0.999	0.42732	1.000000	0.68239	0.019	0.11385	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1588300	6.296040e-07	0	1	74370	1.344630e-05	0	1	74370	1.344630e-05	0	0	912	0.000000e+00	0	0	57066	0.000000e+00	0	0	29150	0.000000e+00	0	0	43424	0.000000e+00	0	0	61772	0.000000e+00	0	0	6032	0.000000e+00	0	0	1166540	0.000000e+00	0	0	87560	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Fibrous_dysplasia_of_jaw	criteria_provided,_single_submitter	NC_000004.12:g.2831582C>A	ClinGen:CA254208|OMIM:602104.0003|UniProtKB:P78314#VAR_013259	C0008029	118400	184	.	Pro	His	61.53	0.8970588235294118																																																																																																																																																																																																																																																																																																																																																																																																																																																																													122			61.53	Special, No backbone hydrogen	Proline		SH3 domain-binding protein 2										1.6			H:P418-D:Y978 (PDBs: 3TWR), F:P418-B:Y978 (PDBs: 3TWR), E:P418-A:Y978 (PDBs: 3TWR), G:P418-C:Y978 (PDBs: 3TWR)															115									-105.7				147.8	Disordered			dbSNP: rs121909146; Variant type: LP/P; AA change: Pro418His; PTM type: Phosphorylation; PTM morphology: PHLQRsPP*DGQ; Var class: II&rs121909146		C (loop/coil)	C (loop/coil)												61.53	89.70589	50-70	10-90	118400	autosomal dominant	OMIM	Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	3	CHERUBISM	false	0.6728814365402778	0.6321227020460737	false	false	false
TPK1	TPK1_Asn50His	B_7-8	2.973710934217195	0.020698545446724354	0.046456194833423635	5.588379140049916	0.0008259404119098465	0.002037097655718506	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6106901405389177	0.6878081345767095	0.6271448530768609	0.5948268228341245	0.5836072735324258	0.6281776159361057	0.7401873839638026	0.6549442401519654	0.6998010431480598	0.7431987328481553	0.8187283630246671	0.7792355671729078	0.5161678479084088	0.5122703069128863	0.48985260252018925	0.5110909733055664	0.556887906128752	0.44214471390492754	TPK1	Asn50His	NC_000007.14:144682946:T:G	148A>C	7	144682946	T	G	7	ENSG00000196511	14468	218332	CCSBVarC005853	ALE00005853	ENSP00000353165.3	CEGS2	CegsMutGDEh1033	C08	GDEhDisVCh_40090	D06	2	CegsMutGDDh1033	C08	VUSN2Hmut_GDN2h_06	B05	VUSMutpDEST2_11	A09	VUSmut_GDEh06	B05	1.0	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	39525.0	single nucleotide variant	NM_022445.4(TPK1):c.148A>C (p.Asn50His)	27010.0	TPK1	HGNC:17358	Pathogenic	1.0	Dec 09, 2011	387906935.0	-	RCV000023531	MONDO:MONDO:0013761,MedGen:C3280866,OMIM:614458,Orphanet:293955	Childhood encephalopathy due to thiamine pyrophosphokinase deficiency	germline	germline	GRCh38	NC_000007.14	7	144682946.0	144682946.0	7q35	no assertion criteria provided	1.0	-	N	ClinGen:CA129339,UniProtKB:Q9H3S4#VAR_067392,OMIM:606370.0001	1.0	30568.0	144682946.0	T	G	-	-	-	-	-	-	148A>C 	Asn50His	NM_022445.4		Pathogenic	Pathogenic	30568	7	144682946.0	T	G	N	H	rs387906935	7	144380039	7	144010972	50	TPK1	ENSG00000196511	ENST00000360057	ENSP00000353165	Q9H3S4	TPK1_HUMAN	c.148A>C	p.Asn50His	c.148A>C	p.Asn50His	principal1	Y	1	YES	Select	-	AAC	1	0	T	T/T	T/T	T/T	T/T	0.002	0.72322	D	0.028	0.55281	D	1.0	0.90580	D	0.998	0.88579	D	0.82	0.89397	A	simple_aae	18.0	82.0	3.165	0.88471	M	-3.15	0.72390	D	0.803	0.87459	0.6356	0.92333	D	0.7563	0.91673	D	10	0.9722638	0.96830	D	0.129243	0.81072	D	0.706	0.89423	0.927	0.98799	Q9H3S4	N50H	Gain of disorder (P = 0.0849)| Gain of loop (P = 0.1069)| Loss of helix (P = 0.2022)| Gain of catalytic residue at L52 (P = 0.2669)| Gain of phosphorylation at Y53 (P = 0.2887)	0.844119709855	0.84140	0.8469067075486448	0.84558	0.670258421466	0.59130	0.471933841705	0.34900	T	0.832489	0.95983	D	0.121089	0.66240	D	-0.063841	0.65820	T	0.985888185988907	0.76580	D	0.963804	0.86602	D	0.92997354	0.94147	0.8282496	0.89942	0.9366974	0.94834	0.8183861	0.89299	-12.885	0.88908	D	0.8159	0.77989	P	0.983044329435162	0.86093	0.67232020	0.85496	0.473	0.69678	.	.	.	.	.	.	4.68795	0.75138	26.3	0.99675581558913762	0.78934	0.469733	0.51431	N	0.776684384396305	0.84543	8.341359	0.75073761053793	0.86135	8.817646	6.02	6.02	0.97555	.	.	4.036	0.57104	7.831000	0.70162	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	936	0.14735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Childhood_encephalopathy_due_to_thiamine_pyrophosphokinase_deficiency	no_assertion_criteria_provided	NC_000007.14:g.144682946T>G	ClinGen:CA129339|OMIM:606370.0001|UniProtKB:Q9H3S4#VAR_067392	C3280866	614458	293955	Thiamin pyrophosphokinase, catalytic domain	Asn	His	98.87	0.07006369426751592	0.729																																																																																																																																																																																																																																																																																																																																																																																																																																																																												11			98.87	Polar/Neutral	Asparagine		Thiamine pyrophosphokinase 1										-3.5								 N50-D54 (PAE:  1.0), N50-R76 (PAE: 1.0), N50-S74 (PAE: 1.0)	N50-D54 (PDBs: 3S4Y), N50-R76 (PDBs: 3S4Y), N50-S74 (PDBs: 3S4Y)	 N50-D54 (PAE:  1.0), N50-R76 (PAE: 1.0)	N50-D54 (PDBs: 3S4Y), N50-R76 (PDBs: 3S4Y)							132									-62.0				-43.2						H (helix)	H (α-helix)	Helix											98.87	7.0063696	>90	<10	614458	autosomal recessive	OMIM	Rare inborn errors of metabolism	1	THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	false	0.6878081345767095	0.6106901405389177	false	false	false
SFTPA2	SFTPA2_Phe198Ser	B_15-16	-2.599657400436074	0.0354428365372903	0.07077789447496038	8.76745172804591	0.00005055912123537037	0.0002432118981251832	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9661843070956152	0.9570387878480949	0.5046601882230671	0.5399119075392274	0.54445922742659	0.5571015612948806	0.5193823247751639	0.6256931932241636	0.6763075858732093	0.5388199379147203	0.9673798946297955	0.977634990474801	0.5948207978145975	0.46322526162901645	0.40351622920524544	0.470500438531414	0.9466976810663944	0.9547336237164294	SFTPA2	Phe198Ser	NC_000010.11:79557363:A:G	593T>C	10	79557363	A	G	10	ENSG00000185303	56023	31342	CCSBVarC002521	ALE00002521	ENSP00000361400.2	RC4	RC4_Mut_GDEh1013	E06	GDEhDisVCh_40043	E05	1	RC4_Mut_GDDh1013	E06	NULL	NULL	VUSMutpDEST2_13	D07	VUSmut_GDEh12	H10	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	99.0	Y	Y	N	Y	Y	28239.0	single nucleotide variant	NM_001098668.4(SFTPA2):c.593T>C (p.Phe198Ser)	729238.0	SFTPA2	HGNC:10799	Pathogenic	1.0	Jan 01, 2009	121917738.0	-	RCV000014087	MONDO:MONDO:0800029,MedGen:C5561926,OMIM:178500,Orphanet:2032,Orphanet:79126	Interstitial lung disease 2	germline	germline	GRCh38	NC_000010.11	10	79557363.0	79557363.0	10q22.3	no assertion criteria provided	1.0	-	N	OMIM:178642.0002,ClinGen:CA256738	1.0	13200.0	79557363.0	A	G	-	-	-	-	-	-	593T>C 	Phe198Ser	NM_001098668.4		Pathogenic	Pathogenic	13200	10	79557363.0	A	G	F	S	rs121917738	10	81317119	10	80987125	198	SFTPA2	ENSG00000185303	ENST00000372327	ENSP00000361402	Q8IWL1	SFPA2_HUMAN	c.593T>C	p.Phe198Ser	c.593T>C	p.Phe198Ser	principal1	Y	1	.	.	-	TTC	2	0	A	./.	./.	./.	./.	0.004	0.65576	D	0.001	0.83643	D	.	.	.	.	.	.	0.92	0.93300	A	simple_aae	8.0	92.0	4.33	0.98352	H	-7.62	0.95411	D	0.948	0.95621	0.2825	0.87223	D	0.5091	0.81470	D	9	0.99324846	0.99856	D	0.008787	0.22922	T	0.452	0.75078	0.914	0.98337	ENST00000372325	F198S	Gain of glycosylation at F198 (P = 0.0055)| Gain of disorder (P = 0.0078)| Gain of phosphorylation at F198 (P = 0.0373)| Gain of sheet (P = 0.0827)| Loss of methylation at R199 (P = 0.0976)	0.646904784714	0.64122	.	0.86892	.	0.99005	0.51423484087	0.40758	T	0.136734	0.46633	T	0.293041	0.82275	D	0.183156	0.82047	D	0.976777136325836	0.71339	D	.	.	.	.	.	.	.	.	.	.	.	-10.502	0.76933	D	0.9288	0.85300	P	.	.	0.97259170	0.94859	0.733	0.85206	.	.	.	.	.	.	4.128713	0.61838	24.4	0.99570208778771696	0.72352	0.187251	0.31242	N	0.325705665178762	0.57253	3.914573	0.0157310190449653	0.40153	2.413804	2.81	2.81	0.31889	.	.	4.624	0.6104	8.950000	0.78471	0.554	0.28258	0.852	0.30569	1.000000	0.68239	0.031	0.13278	649	0.63066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Interstitial_lung_disease_2	no_assertion_criteria_provided	NC_000010.11:g.79557363A>G	ClinGen:CA256738|OMIM:178642.0002	C5561926	178500	2032|79126	C-type lectin-like|C-type lectin-like|C-type lectin-like|Collectin, C-type lectin-like domain	Phe	Ser	97.09	0.05583756345177665																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	Aromatic	Phenylalanine		Pulmonary surfactant-associated protein A2							C-type lectin			2.8																		165																																97.09	5.5837564	>90	<10	178500	autosomal dominant	OMIM		0	INTERSTITIAL LUNG DISEASE 2	false	0.9570387878480949	0.9661843070956152	true	true	false
GFAP	GFAP_Arg88Cys	B_15-16	-0.09420888305581449	0.9275831682326516	0.9463974323572685	15.063546432315947	1.365275952071815e-6	0.000019572510719154533	2025_03_Batch_15-16	true	true	true	false	true	true	true	false	false	false	false	false	0.9797287025948648	0.9769282847084899	0.7740654121224846	0.8453586608146741	0.9148269990319527	0.8380082071562609	0.8143748287273278	0.9459962463691983	0.7858896566895958	0.7422654585503748	0.9723173280927353	0.9713131843620848	0.8616415855851941	0.8836577516947072	0.9048276649397526	0.8058653656945942	0.9815392413242444	0.9881442208276447	GFAP	Arg88Cys	NC_000017.11:44915225:G:A	262C>T	17	44915225	G	A	17	ENSG00000131095	2920	214386	CCSBVarC004662	ALE00004662	ENSP00000466598.2	CEGS2	CegsMutGDEh1035	B09	GDEhDisVCh_40051	B05	1	CegsMutGDDh1035	B09	VUSN2Hmut_GDN2h_07	A02	VUSMutpDEST2_02	H11	VUSmut_GDEh07	A02	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	31211.0	single nucleotide variant	NM_002055.5(GFAP):c.262C>T (p.Arg88Cys)	2670.0	GFAP	HGNC:4235	Pathogenic	1.0	Feb 20, 2024	61622935.0	-	RCV000017555|RCV000056879	MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MedGen:C3661900	Alexander disease|not provided	de novo;germline;unknown	germline	GRCh38	NC_000017.11	17	44915225.0	44915225.0	17q21.31	criteria provided, multiple submitters, no conflicts	10.0	-	N	ClinGen:CA217183,UniProtKB:P14136#VAR_017469,OMIM:137780.0006	3.0	16172.0	44915225.0	G	A	-	-	-	-	-	-	262C>T 	Arg88Cys	NM_002055.5	2.0	Pathogenic	Pathogenic	16172	17	44915225.0	G	A	R	C	rs61622935	17	42992593	17	40348119	88	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.262C>T	p.Arg88Cys	c.262C>T	p.Arg88Cys	principal1	Y	1	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.83643	.	0.999	0.77914	D	0.983	0.75798	D	0.91	0.97926	A	without_aae	9.0	91.0	3.98	0.96573	H	.	0.92846	.	.	0.97110	1.0454	0.98016	D	0.9074	0.96924	D	9	0.99090445	0.99602	D	0.519186	0.95412	D	.	0.98779	0.946	0.99321	P14136	R88C	Loss of MoRF binding (P = 0.0054)| Loss of disorder (P = 0.0359)| Gain of methylation at K86 (P = 0.0656)| Loss of ubiquitination at K86 (P = 0.0992)| Loss of solvent accessibility (P = 0.1434)	.	0.99691	.	0.94713	.	0.84909	0.76029843092	0.75930	T	0.968449	0.99638	D	0.507567	0.94478	D	0.491308	0.94397	D	0.998142838478088	0.93292	D	0.966803	0.93621	D	0.8313547	0.85812	0.732476	0.84001	0.7764692	0.82221	0.69186676	0.81657	-11.069	0.80099	D	0.7338	0.78805	P	0.993277837335008	0.89957	0.99920017	0.99211	1	0.99985	.	.	.	.	.	.	6.256289	0.94897	34.0	0.9994095311662472	0.99797	.	.	.	0.975814581732804	0.94923	13.17933	0.884704256627659	0.94842	13.11252	4.69	4.69	0.58495	3.93	0.74723	9.775	0.9818	11.841000	0.97813	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614224	6.194930e-07	0	1	1180044	8.474260e-07	0	0	75064	0.000000e+00	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	0	29606	0.000000e+00	0	0	44878	0.000000e+00	0	0	64024	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180044	8.474260e-07	0	0	91092	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Alexander_disease|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.44915225G>A	ClinGen:CA217183|OMIM:137780.0006|UniProtKB:P14136#VAR_017469	C0270726|C3661900	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Cys	95.35	0.6532258064516129																																																																																																																																																																																																																																																																																																																																																																																																																																																																													162			95.35	Positively-charged	Arginine		Glial fibrillary acidic protein							IF rod	0.0528		-4.5								 R88-I84 (PAE:  1.0), R88-Q92 (PAE: 1.0)		 R88-I84 (PAE:  1.0), R88-Q92 (PAE: 1.0)								175									-59.0		Pocket 3: Mean pLDDT: 95.29, Volume: 249.11 Å³, Druggability score: 0.05		-43.3	Coil 1A			dbSNP: rs61622935; Variant type: LP/P; AA change: Arg88Cys; PTM type: Acetylation; PTM morphology: ASYIEkVR*FLE; Var class: II&rs61622935		H (helix)	H (α-helix)												95.35	65.32258	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.9769282847084899	0.9797287025948648	true	true	false
COMP	COMP_His441Arg	B_7-8	-4.437536402476972	0.021273757266615095	0.047247530673528874	-2.5886725769864634	0.036014352163047866	0.05299625999935271	2024_01_Batch_7-8		false	false	false	false	false		false	false	false	false	false		0.8588640206761572	0.8711154258835186	0.8463546231339114	0.9048594665723471	0.8921795928093409	0.8921795928093409	0.8290141182584205	0.8463546231339114	0.8711154258835186	0.7932960485839334			0.9807048148862735			0.924431992768381		COMP	His441Arg	NC_000019.10:18786132:T:C	1322A>G	19	18786132	T	C	19	ENSG00000105664	56661	3355	CCSBVarC008147	ALE00008133	ENSP00000222271.2	Edgotyping3	VUSMutGDEh015	B08	GDEhDisVCh_40037	F11	1	VUSMutGDDh015	B08	VUSN2Hmut_GDN2h_04	D09	VUSMutpDEST2_13	G08	VUSmut_GDEh04	D09	1.0	1.0	1.0	6.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	422254.0	single nucleotide variant	NM_000095.3(COMP):c.1322A>G (p.His441Arg)	1311.0	COMP	HGNC:2227	Pathogenic	1.0	Jun 26, 2024	1131691682.0	-	RCV000493700	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000019.10	19	18786132.0	18786132.0	19p13.11	criteria provided, single submitter	1.0	-	N	ClinGen:CA404885232	2.0	429931.0	18786132.0	T	C	-	-	-	-	-	-	1322A>G 	His441Arg	NM_000095.3	1.0	Pathogenic	Pathogenic	429931	19	18786132.0	T	C	H	R	rs1131691682	19	18896942	19	18757942	441	COMP	ENSG00000105664	ENST00000222271	ENSP00000222271	P49747	COMP_HUMAN	c.1322A>G	p.His441Arg	c.1322A>G	p.His441Arg	principal1	Y	1	YES	Select	-	CAT	2	0	T	T/T	T/T	T/T	T/T	0.178	0.22861	T	0.349	0.17823	T	0.994	0.66535	D	0.929	0.66362	D	.	.	.	.	.	.	1.7	0.43657	L	-5.77	0.89178	D	0.643	0.68886	0.6379	0.92363	D	0.8907	0.96365	D	10	0.645176	0.69012	D	0.115898	0.79460	D	0.691	0.88724	0.57	0.69189	P49747	H441R	Loss of glycosylation at S444 (P = 0.196)| Gain of phosphorylation at S444 (P = 0.2036)| Gain of solvent accessibility (P = 0.2689)| Gain of relative solvent accessibility (P = 0.2751)| Loss of catalytic residue at H441 (P = 0.3067)	0.812070229973	0.80881	0.8313074994051601	0.82987	.	.	0.678918898106	0.64054	T	0.958199	0.99438	D	0.184887	0.72288	D	0.0278003	0.71928	D	0.946474492549896	0.62248	D	0.950105	0.80860	D	0.6632697	0.75807	0.5256166	0.72336	0.64836013	0.75007	0.44754773	0.67574	-8.24	0.62768	D	0.15	0.46944	B	0.963552117580653	0.82236	0.98497266	0.96057	0.788	0.88269	.	.	.	.	.	.	3.927173	0.57451	23.8	0.93078200622282103	0.22946	0.904415	0.85415	D	-0.0364093024663331	0.39945	2.384218	-0.0709138152405337	0.36295	2.131938	3.95	2.9	0.32725	3.35	0.60746	6.138	0.71543	6.112000	0.53748	0.519	0.23729	1.0	0.71675	1.000000	0.68239	0.229	0.22753	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000019.10:g.18786132T>C	ClinGen:CA404885232	CN517202	.	.	.	His	Arg	96.73	0.31521739130434784																																																																																																																																																																																																																																																																																																																																																																																																																																																																													58			96.73	Positively-charged	Histidine		Cartilage oligomeric matrix protein										-3.2								 H441-S454 (PAE:  1.0)	H441-S454 (PDBs: 3FBY)		H441-D435 (PDBs: 3FBY)							155									-104.3				135.8	Disordered		TSP type-3 6			C (loop/coil)	S (bend)												96.73	31.52174	>90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	2		false	0.8588640206761572		false		false
MVK	MVK_Leu41Pro	B_7-8	-0.580769126709319	0.5825368693588792	0.6599320406141513	-6.293970224018622	0.000749358034108339	0.0018862441599297698	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.9819031167245453	0.9818402662023813	0.7346217986282035	0.8859119864813539	0.8112794173607851	0.8808192140569242	0.9297134196380453	0.8577749516464541	0.9134785176714352	0.7797334636663564	0.9903985962702617	0.9819031167245453	0.8319250084758031	0.7647838830751162	0.8583454552912727	0.6895101335900508	0.973281936134501		MVK	Leu41Pro	NC_000012.12:109576041:T:C	122T>C	12	109576041	T	C	12	ENSG00000110921	281	4	CCSBVarC007115	ALE00007113	ENSP00000228510.3	Edgotyping3	VUSMutGDEh009	C11	GDEhDisVCh_40020	H05	2	VUSMutGDDh009	C11	VUSN2Hmut_GDN2h_03	H03	VUSMutpDEST2_01	C01	VUSmut_GDEh03	H03	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	48327.0	single nucleotide variant	NM_000431.4(MVK):c.122T>C (p.Leu41Pro)	4598.0	MVK	HGNC:7530	Pathogenic	1.0	Oct 01, 2012	397514571.0	-	RCV000032943	MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900	Porokeratosis 3, disseminated superficial actinic type	germline	germline	GRCh38	NC_000012.12	12	109576041.0	109576041.0	12q24.11	no assertion criteria provided	1.0	-	N	ClinGen:CA130493,UniProtKB:Q03426#VAR_075037,OMIM:251170.0013	1.0	39728.0	109576041.0	T	C	-	-	-	-	-	-	122T>C 	Leu41Pro	NM_000431.4		Pathogenic	Pathogenic	39728	12	109576041.0	T	C	L	P	rs397514571	12	110013846	12	108498229	41	MVK	ENSG00000110921	ENST00000228510	ENSP00000228510	Q03426	KIME_HUMAN	c.122T>C	p.Leu41Pro	c.122T>C	p.Leu41Pro	principal1	Y	1	YES	Select	+	CTT	2	0	T	T/T	T/T	T/T	T/T	0.023	0.72322	D	0.004	0.76775	D	1.0	0.90580	D	0.994	0.82066	D	0.98	0.97926	A	simple_aae	2.0	98.0	3.455	0.92175	M	-4.62	0.84629	D	0.915	0.92320	0.9622	0.96569	D	0.8796	0.95994	D	10	0.9861126	0.98891	D	0.574173	0.96154	D	0.895	0.97016	0.898	0.97671	Q03426	L41P	Gain of disorder (P = 0.0116)| Loss of stability (P = 0.0273)| Loss of MoRF binding (P = 0.0891)| Loss of sheet (P = 0.1501)| Loss of catalytic residue at L41 (P = 0.2433)	0.994617063146	0.99449	0.9765760212192912	0.97635	1.46281189863	0.86323	0.518629133701	0.41374	T	0.663496	0.89828	D	0.476807	0.93538	D	0.447124	0.93457	D	0.977108776569366	0.71494	D	0.854215	0.54058	D	0.95243865	0.96458	0.7842117	0.87127	0.9384795	0.95018	0.7513982	0.85127	-14.074	0.93307	D	0.9189	0.84077	LP	0.99896675612323	0.95408	0.99851960	0.98824	0.878	0.93412	.	.	.	.	.	.	5.045159	0.8403	28.2	0.99914028530316301	0.98239	0.846448	0.76245	D	0.754019517141737	0.83073	7.946743	0.690266386512931	0.81539	7.574055	5.25	5.25	0.73133	4.9	0.88943	6.659	0.74321	7.823000	0.69868	0.665	0.62996	0.931	0.32399	1.000000	0.68239	0.938	0.47792	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Porokeratosis_3,_disseminated_superficial_actinic_type	no_assertion_criteria_provided	NC_000012.12:g.109576041T>C	ClinGen:CA130493|OMIM:251170.0013|UniProtKB:Q03426#VAR_075037	C1867981	175900	.	.	Leu	Pro	96.87	0.006097560975609756																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			96.87	Aliphatic	Leucine		Mevalonate kinase										3.8								 L41-L6 (PAE:  1.0)	L41-L6 (PDBs: 2R3V)	 L41-L6 (PAE:  1.0)	L41-L157 (PDBs: 2R3V), L41-L6 (PDBs: 2R3V)							131									-121.8				124.3				dbSNP: rs397514571; Variant type: LP/P; AA change: Leu41Pro; PTM type: Phosphorylation; PTM morphology: SLNLRtFLRL*Q; Var class: II&rs397514571		B (undefined)	E (parallel sheets)	Beta strand											96.87	0.60975605	>90	<10	175900	autosomal dominant	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	POROKERATOSIS 3, MULTIPLE TYPES	false	0.9818402662023813	0.9819031167245453	true	true	false
DCX	DCX_Thr203Ala	B_7-8	2.424475713960376	0.051548275893801676	0.095219735935359	-4.947162295759614	0.0016615869963824434	0.003650212692303261	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9248439158907121	0.9075917886893847	0.8415129060676028	0.7961616767603252	0.8632159148694927	0.8804254652754298	0.8678758480893547	0.8194928910230562	0.8761809480678588	0.8302841575711597	0.9007066504050845	0.9248439158907121	0.8929750824615047	0.9069389387159291	0.7161424054527915	0.8527416545640459	0.9144769269736851		DCX	Thr203Ala	NC_000023.11:111401088:T:C	607A>G	23	111401088	T	C	X	ENSG00000077279	8416	216636	CCSBVarC005203	ALE00005203	ENSP00000419861.1	CEGS2	CegsMutGDEh1036	F04	GDEhDisVCh_40049	E05	1	CegsMutGDDh1036	F04	VUSN2Hmut_GDN2h_07	F04	VUSMutpDEST2_07	F12	VUSmut_GDEh07	F04	1.0	3.0	1.0	6.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	N	N	Y	Y	Y	169872.0	single nucleotide variant	NM_001195553.2(DCX):c.607A>G (p.Thr203Ala)	1641.0	DCX	HGNC:2714	Pathogenic	1.0	Feb 08, 2013	587783570.0	-	RCV000145872	MedGen:C0008519	Ectopic tissue	germline	germline	GRCh38	NC_000023.11	X	111401088.0	111401088.0	Xq23	criteria provided, single submitter	1.0	-	N	ClinGen:CA172026,UniProtKB:O43602#VAR_026034	2.0	158488.0	111401088.0	T	C	-	-	-	-	-	-	607A>G 	Thr203Ala	NM_001195553.2	1.0	Pathogenic	Pathogenic	158488	X	111401088.0	T	C	T	A	rs587783570	X	110644316	X	110530972	203	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.607A>G	p.Thr203Ala	c.607A>G	p.Thr203Ala	alternative1	Y	1	.	.	-	ACA	1	0	T	T/T	T/T	T/T	T/T	.	0.65576	.	.	0.70891	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.75724	.	.	0.96202	0.7288	0.93509	D	0.8197	0.93920	D	10	0.9120263	0.90462	D	0.578244	0.96205	D	.	0.98076	.	.	.	.	.	.	0.99971	.	0.91993	.	.	0.779707312584	0.78846	T	.	0.89379	.	0.570173	0.96578	D	0.581237	0.96521	D	0.99140852689743	0.81553	D	0.969003	0.88827	D	0.82257617	0.85204	0.7888019	0.87415	0.85790634	0.87764	0.7874026	0.87328	-9.681	0.72059	D	0.9985	0.98152	LP	0.999784610304029	0.97955	0.99954033	0.99470	0.984	0.99450	.	.	.	.	.	.	4.329005	0.66385	24.9	0.99856963240770147	0.93553	.	.	.	.	.	.	.	.	.	4.74	4.74	0.59667	4.4	0.82834	8.017	0.8876	7.921000	0.74563	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	889	0.27289	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Ectopic_tissue	criteria_provided,_single_submitter	NC_000023.11:g.111401088T>C	ClinGen:CA172026|UniProtKB:O43602#VAR_026034	C0008519	.	.	.	Thr	Ala	79.91	0.5563380281690141																																																																																																																																																																																																																																																																																																																																																																																																																																																																													79			79.91	Polar/Neutral	Threonine		Neuronal migration protein doublecortin							Doublecortin 2			-0.7				C:T203-A:K163 (PDBs: 6RF2)					T203-L198 (PDBs: 6FNZ), T203-Q209 (PDBs: 6FNZ)		T203-L199 (PDBs: 6FNZ), T203-L198 (PDBs: 6FNZ)							119									-113.6	Morphology: RVLLNKKtAHsFEQV; Domain: DCX			-26.5				dbSNP: rs104894782; Variant type: LP/P; AA change: Thr203Arg; PTM type: Phosphorylation; PTM morphology: LLNKKtAHsFE; Var class: I&rs587783570		C (loop/coil)	T (turn)	Turn											79.91	55.6338	70-90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.9075917886893847	0.9248439158907121	false	false	false
SFTPC	SFTPC_Ile73Thr	B_7-8	-1.5761000789888402	0.16607383206952775	0.24250842450519725	12.523974752629526	0.000015850191297841316	0.00010241232757584089	2024_01_Batch_7-8	true	true	false	false	false	false	true	true	false	false	false	false	0.9949268295051675	0.9943134585180533	0.8262416755651378	0.8234936535167958	0.8086883763229755	0.8472584181951002	0.9676535505545734	0.8206604708497327	0.9521195413562537	0.9360411642539821	0.9939715537639459	0.9949268295051675	0.7268632858356269	0.7967162817962185	0.694867765677338	0.7164421868762937	0.9946553632721608		SFTPC	Ile73Thr	NC_000008.11:22163096:T:C	218T>C	8	22163096	T	C	8	ENSG00000168484	5723	201963	CCSBVarC006059	ALE00006059	ENSP00000316152.3	CEGS2	CegsMutGDEh1035	B04	GDEhDisVCh_40072	E07	2	CegsMutGDDh1035	B04	VUSN2Hmut_GDN2h_06	G11	VUSMutpDEST2_05	G06	VUSmut_GDEh06	G11	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	28247.0	single nucleotide variant	NM_001317778.2(SFTPC):c.218T>C (p.Ile73Thr)	6440.0	SFTPC	HGNC:10802	Pathogenic	1.0	Jan 17, 2024	121917834.0	-	RCV000014095|RCV000731190|RCV002415413|RCV002509156	MONDO:MONDO:0024465,MedGen:C1970470,OMIM:610913|MedGen:C3661900|MONDO:MONDO:0012580,MedGen:C3711368,OMIM:PS265120,Orphanet:264675|Human Phenotype Ontology:HP:0002206,Human Phenotype Ontology:HP:0006523,MONDO:MONDO:0002771,MedGen:C0034069	Surfactant metabolism dysfunction, pulmonary, 2|not provided|Hereditary pulmonary alveolar proteinosis|Pulmonary fibrosis	germline;unknown	germline	GRCh38	NC_000008.11	8	22163096.0	22163096.0	8p21.3	criteria provided, multiple submitters, no conflicts	14.0	-	N	ClinGen:CA210536,OMIM:178620.0002	3.0	13208.0	22163096.0	T	C	-	-	-	-	-	-	218T>C 	Ile73Thr	NM_001317778.2	2.0	Pathogenic	Pathogenic	13208	8	22163096.0	T	C	I	T	rs121917834	8	22020609	8	22076554	73	SFTPC	ENSG00000168484	ENST00000318561	ENSP00000316152	P11686	PSPC_HUMAN	c.218T>C	p.Ile73Thr	c.218T>C	p.Ile73Thr	principal4	Y	1	.	.	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.003	0.72322	D	0.006	0.70891	D	0.855	0.47137	P	0.587	0.50366	P	1.0	0.99291	A	simple_aae	0.0	100.0	0.895	0.22286	L	-2.59	0.67858	D	0.592	0.85308	0.9091	0.95789	D	0.7938	0.92993	D	9	0.65962654	0.69808	D	0.815569	0.98561	D	0.731	0.90551	.	.	.	.	.	0.995530386705	0.99541	0.8260470193243142	0.82458	1.24940525845	0.81671	0.563839197159	0.47743	T	0.553072	0.88239	D	0.288022	0.81860	D	0.175947	0.81626	D	0.820129990577698	0.47502	D	0.89941	0.64684	D	.	.	.	.	.	.	.	.	-2.429	0.05896	T	0.1816	0.42360	B	.	.	0.99920040	0.99211	0.191	0.44905	.	.	.	.	.	.	4.172276	0.62815	24.5	0.99631908053637286	0.76108	0.336795	0.43290	N	0.217715355064163	0.51820	3.382474	0.221190580086118	0.50772	3.288696	4.68	4.68	0.58268	3.26	0.59083	2.223	0.42681	7.843000	0.70657	0.66	0.55068	0.977	0.35015	1.000000	0.68239	0.82	0.3867	555	0.71761	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	1614090	2.478180e-06	0	4	1179980	3.389890e-06	0	0	75026	0.000000e+00	0	0	912	0.000000e+00	0	0	60028	0.000000e+00	0	0	29606	0.000000e+00	0	0	44880	0.000000e+00	0	0	64012	0.000000e+00	0	0	6060	0.000000e+00	0	4	1179980	3.389890e-06	0	0	91084	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	not_provided|Pulmonary_fibrosis|Hereditary_pulmonary_alveolar_proteinosis|Surfactant_metabolism_dysfunction,_pulmonary,_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000008.11:g.22163096T>C	ClinGen:CA210536|OMIM:178620.0002	C3661900|C0034069|C3711368|C1970470	PS265120|610913	264675	Surfactant protein C, N-terminal propeptide	Ile	Thr	50.61	0.8284023668639053																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	Aliphatic	Isoleucine												4.5																		131												Propeptide																				50.61	82.84023	50-70	10-90	610913	autosomal dominant	OMIM	Rare genetic respiratory disease	1	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	false	0.9943134585180533	0.9949268295051675	true	true	true
APOA1	APOA1_Ala199Pro	B_15-16	7.946525538492515	0.00009513500072303456	0.0008951125683792907	8.397628448387708	0.00006678582670555073	0.0002960193043591439	2025_03_Batch_15-16	false	false	false	false	false	true	false	false	false	false	false	false	0.8766144360269137	0.9149980354734805	0.7363716305866591	0.8120779886216822	0.7696416620751583	0.8220730407701556	0.8220730407701556	0.7696416620751583	0.8120779886216822	0.7363716305866591	0.9149980354734805	0.8546679687576599						0.8985609032961673	APOA1	Ala199Pro	NC_000011.10:116836017:C:G	595G>C	11	116836017	C	G	11	ENSG00000118137	5613	215447	CCSBVarC006759	ALE00006757	ENSP00000236850.3	CEGS2	CegsMutGDEh1046	F04	GDEhDisVCh_40037	G06	1	CegsMutGDDh1046	F04	VUSN2Hmut_GDN2h_10	D01	VUSMutpDEST2_05	B04	VUSmut_GDEh10	D01	1.0	1.0	1.0	6.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	N	Y	Y	Y	32973.0	single nucleotide variant	NM_000039.3(APOA1):c.595G>C (p.Ala199Pro)	335.0	APOA1	HGNC:600	Pathogenic	1.0	Jun 06, 2002	121912730.0	-	RCV004555847	MONDO:MONDO:0971008,MedGen:C4551500,OMIM:620657	Familial amyloid polyneuropathy, Iowa type	germline	germline	GRCh38	NC_000011.10	11	116836017.0	116836017.0	11q23.3	no assertion criteria provided	1.0	-	N	ClinGen:CA127592,OMIM:107680.0027	1.0	17934.0	116836017.0	C	G	-	-	-	-	-	-	595G>C 	Ala199Pro	NM_000039.3		Pathogenic	Pathogenic	17934	11	116836017.0	C	G	A	P	rs121912730	11	116706733	11	116211943	199	APOA1	ENSG00000118137	ENST00000359492	ENSP00000352471	P02647	APOA1_HUMAN	c.595G>C	p.Ala199Pro	c.595G>C	p.Ala199Pro	principal1	Y	2	.	.	-	GCC	1	0	C	C/C	C/C	C/C	C/C	0.037	0.43243	D	0.151	0.32679	T	0.706	0.42020	P	0.641	0.52113	P	0.98	0.97016	A	simple_aae	2.0	98.0	2.505	0.72748	M	-1.71	0.44100	N	0.339	0.37784	-0.6498	0.62561	T	0.3924	0.74506	T	10	0.8104583	0.80135	D	0.178433	0.85318	D	0.524	0.79720	0.667	0.80417	P02647	A199P	Loss of MoRF binding (P = 0.0591)| Gain of glycosylation at A199 (P = 0.1214)| Loss of stability (P = 0.2118)| Gain of disorder (P = 0.2647)| Loss of methylation at R197 (P = 0.3558)	0.87429726181	0.87209	.	0.59742	.	0.90564	0.440502285957	0.30607	T	0.302948	0.67351	T	0.146096	0.68675	D	-0.0279198	0.68278	D	0.795153617858887	0.45742	D	.	0.17879	.	0.9113513	0.92309	0.7991036	0.88064	0.8919612	0.90544	0.72110003	0.83337	-7.064	0.54569	T	.	0.80095	.	0.970299444710981	0.83331	0.99886630	0.99009	0.421	0.66141	.	.	.	.	.	.	3.062993	0.41226	21.3	0.99375346443257362	0.61682	0.673422	0.63818	D	-0.3500193316256	0.26993	1.494918	-0.521272898737383	0.21265	1.167832	5.05	-1.3	0.08756	-1.47	0.13634	0.535	0.22904	0.983000	0.23222	0.599	0.40292	0.189	0.24259	0.996000	0.32869	0.802	0.37852	489	0.76818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1607202	6.221990e-07	0	1	1179668	8.476960e-07	0	0	75054	0.000000e+00	0	0	908	0.000000e+00	0	0	59982	0.000000e+00	0	0	29558	0.000000e+00	0	0	44842	0.000000e+00	0	0	57786	0.000000e+00	0	0	5976	0.000000e+00	0	1	1179668	8.476960e-07	0	0	91016	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Familial_amyloid_polyneuropathy,_Iowa_type	no_assertion_criteria_provided	NC_000011.10:g.116836017C>G	ClinGen:CA127592|OMIM:107680.0027	C4551500	620657	.	.	Ala	Pro	89.15	0.5																																																																																																																																																																																																																																																																																																																																																																																																																																																																													53			89.15	Aliphatic	Alanine		Proapolipoprotein A-I; Apolipoprotein A-I; Truncated apolipoprotein A-I										1.8								 A199-E203 (PAE:  1.5), A199-R195 (PAE: 1.5)	A199-R195 (PDBs: 1GW3, 1GW4, 1ODP, 1ODQ, 1ODR, 3R2P, 2N5E, 2MSC, 2MSD, 2MSE, 6CC9, 6CCH, 6CCX, 6PTS, 6PTW, 6W4E, 6W4F), A199-E203 (PDBs: 3R2P, 1AV1, 6W4F)	 A199-E203 (PAE:  1.5), A199-R195 (PAE: 1.5)	A199-R195 (PDBs: 1GW3, 1GW4, 1ODP, 1ODQ, 1ODR, 3R2P, 1AV1, 2MSD, 6CC9, 6PTS, 6PTW, 6W4E, 6W4F), A199-E203 (PDBs: 3R2P, 2N5E, 2MSC, 2MSE, 6CCH, 6CCX, 6W4F)							89									-59.9				-49.6	10 X approximate tandem repeats		7			H (helix)	H (α-helix)	Helix											89.15	50.0	70-90	10-90	620657	unknown		Rare genetic systemic or rheumatologic disease; Rare genetic renal disease; Rare genetic endocrine disease; Rare inborn errors of metabolism	4	AMYLOIDOSIS, HEREDITARY SYSTEMIC 3	false	0.9149980354734805	0.8766144360269137	false	false	false
NMNAT1	NMNAT1_Arg207Trp	B_7-8	-1.6730032682427427	0.14535419807248953	0.22075210317615562	-0.8426321838983876	0.43173482059979323	0.48543712977979203	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5813536224648366	0.5972839255849351	0.7581775868322793	0.7402301705071648	0.7061884611884424	0.7812139266386905	0.8790767719966781	0.8207987678591898	0.8584137496741485	0.8192884723229653	0.6186401666498218	0.5885252140479301	0.6833510812807029	0.5915781545176949	0.6220465913401809	0.6970667013415933	0.5759276845200484	0.5741820308817431	NMNAT1	Arg207Trp	NC_000001.11:9982480:C:T	619C>T	1	9982480	C	T	1	ENSG00000173614	7675	202586	CCSBVarC005696	ALE00005696	ENSP00000366410.1	CEGS2	CegsMutGDEh1035	A08	GDEhDisVCh_40020	B02	2	CegsMutGDDh1035	A08	VUSN2Hmut_GDN2h_07	C01	VUSMutpDEST2_06	B12	VUSmut_GDEh07	C01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	45794.0	single nucleotide variant	NM_022787.4(NMNAT1):c.619C>T (p.Arg207Trp)	64802.0	NMNAT1	HGNC:17877	Pathogenic	1.0	May 27, 2024	142968179.0	-	RCV000030764|RCV001090803|RCV004794346	MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65|MedGen:C3661900|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	Leber congenital amaurosis 9|not provided|Retinal dystrophy	germline;inherited	germline	GRCh38	NC_000001.11	1	9982480.0	9982480.0	1p36.22	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA260590,UniProtKB:Q9HAN9#VAR_068876,OMIM:608700.0005	3.0	37133.0	9982480.0	C	T	-	-	-	-	-	-	619C>T 	Arg207Trp	NM_022787.4	2.0	Pathogenic	Pathogenic	37133	1	9982480.0	C	T	R	W	rs142968179	1	10042538	1	9965125	207	NMNAT1	ENSG00000173614	ENST00000377205	ENSP00000366410	Q9HAN9	NMNA1_HUMAN	c.619C>T	p.Arg207Trp	c.619C>T	p.Arg207Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.003	0.68399	D	0.003	0.76775	D	0.21	0.29985	B	0.08	0.28875	B	0.37	0.61445	A	simple_aae	63.0	37.0	2.41	0.69445	M	-4.8	0.80714	D	0.175	0.18668	0.9447	0.96305	D	0.8665	0.95551	D	10	0.47042376	0.59499	D	0.107163	0.78244	D	0.715	0.89834	.	.	.	.	.	0.984411659881	0.98408	0.7958402001449099	0.79419	0.0471258549327	0.04993	0.226586788893	0.01727	T	0.829198	0.95872	D	0.16884	0.70802	D	0.185047	0.82157	D	0.367898106575012	0.27413	T	.	.	.	0.3990104	0.60338	0.49177146	0.70342	0.4620159	0.64481	0.37008047	0.62022	-9.24	0.69307	D	0.1165	0.23673	B	0.807989383609549	0.71128	0.43261570	0.80372	0.852	0.91893	.	.	.	.	.	.	3.40526	0.47297	22.4	0.99740707041295951	0.83497	0.622437	0.60535	D	0.0133749492960289	0.42200	2.558952	0.0289828928134325	0.40778	2.461074	5.16	2.95	0.33202	1.41	0.33185	4.057	0.57258	1.792000	0.28893	-0.915	0.02241	0.998	0.41403	0.152000	0.23259	0.1	0.18324	647	0.63312	.	.	.	.	.	.	.	.	.	.	.	.	9	264690	3.400204E-5	segdup	1	109404	9.140430e-06	0	7	208124	3.363380e-05	0	8	236878	3.377270e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2318	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	6	89552	6.700020e-05	0	0	30608	0.000000e+00	0	6	89552	6.700020e-05	0	0	14902	0.000000e+00	0	1	34260	2.918860e-05	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	6	102684	5.843170e-05	0	0	30526	0.000000e+00	0	6	102684	5.843170e-05	0	.	39	1613964	2.416410e-05	0	37	1180046	3.135470e-05	0	0	74898	0.000000e+00	0	0	910	0.000000e+00	0	0	59954	0.000000e+00	0	0	29606	0.000000e+00	0	0	44894	0.000000e+00	0	0	64016	0.000000e+00	0	0	6084	0.000000e+00	0	37	1180046	3.135470e-05	0	0	91072	0.000000e+00	0	2	25920	7.716049382716049E-5	0	306	0	0	146	0	1	8458	1.1823126034523528E-4	0	146	0	0	610	0	0	56	0	0	104	0	0	4314	0	1	8764	1.1410314924691921E-4	0	202	0	3	40060	7.488766849725412E-5	not_provided|Leber_congenital_amaurosis_9	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.9982480C>T	ClinGen:CA260590|OMIM:608700.0005|UniProtKB:Q9HAN9#VAR_068876	C3661900|C1837873	608553	65	.	Arg	Trp	97.55	0.5																																																																																																																																																																																																																																																																																																																																																																																																																																																																													124			97.55	Positively-charged	Arginine		Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1										-4.5			A:R207-C:G37 (PDBs: 1KQO), 3:R207-1:G37 (PDBs: 8QE8), 4:R207-6:G37 (PDBs: 8QE8)							 R207-L203 (PAE:  1.0)	R207-L203 (PDBs: 1KKU, 1GZU, 1KQN, 1KQO, 1KR2, 8QE8)							175									-57.7				-25.5						H (helix)	G (3₁₀-helix)	Helix											97.55	50.0	>90	10-90	608553	autosomal recessive	OMIM	Rare genetic eye disease; Ciliopathy	2	LEBER CONGENITAL AMAUROSIS 9	false	0.5972839255849351	0.5813536224648366	false	false	false
AGXT	AGXT_Gly41Glu	B_7-8	-0.3308704281239826	0.7504259886412553	0.8007338761479316	-1.4699663293899243	0.18503193648319313	0.22864215720313766	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8604788092605524	0.8497130778907145	0.6236167344893191	0.8469489507034723	0.740696876326443	0.7394441507678978	0.7771693211887769	0.7815483433306232	0.9029433967810204	0.5695653304861392	0.8694237421159463	0.8923419629985766	0.7017189803470187	0.6998454093222628	0.7909545046259242	0.677668138492499	0.8300024136654827	0.8286156555225282	AGXT	Gly41Glu	NC_000002.12:240868987:G:A	122G>A	2	240868987	G	A	2	ENSG00000172482	70497	3792	CCSBVarC008165	ALE00008151	ENSP00000302620.3	Edgotyping3	VUSMutGDEh003	D12	GDEhDisVCh_40002	E02	2	VUSMutGDDh003	D12	VUSN2Hmut_GDN2h_01	B06	VUSMutpDEST2_14	H01	VUSmut_GDEh01	B06	1.0	3.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	N	Y	Y	Y	Y	200433.0	single nucleotide variant	NM_000030.3(AGXT):c.122G>A (p.Gly41Glu)	189.0	AGXT	HGNC:341	Pathogenic	1.0	Nov 27, 2014	180177168.0	-	RCV000186279	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598	Primary hyperoxaluria, type I	germline	germline	GRCh38	NC_000002.12	2	240868987.0	240868987.0	2q37.3	no assertion criteria provided	1.0	-	N	ClinGen:CA275629,UniProtKB:P21549#VAR_074583	2.0	204073.0	240868987.0	G	A	-	-	-	-	-	-	122G>A 	Gly41Glu	NM_000030.3		Pathogenic	Pathogenic	204073	2	240868987.0	G	A	G	E	rs180177168	2	241808404	2	241457077	41	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.122G>A	p.Gly41Glu	c.122G>A	p.Gly41Glu	principal1	Y	1	YES	Select	+	GGG	2	0	G	./.	./.	./.	./.	0.051	0.39488	T	0.087	0.41092	T	0.996	0.68795	D	0.983	0.75798	D	0.87	0.90832	A	simple_aae	13.0	87.0	.	.	.	-3.56	0.68915	D	0.927	0.93141	0.9807	0.96862	D	0.8848	0.96168	D	10	0.995095	0.99974	D	0.666476	0.97204	D	0.785	0.92843	0.932	0.98955	P21549	G41E	Loss of catalytic residue at A40 (P = 0.0853)| Gain of disorder (P = 0.1272)| Loss of MoRF binding (P = 0.2008)| Loss of helix (P = 0.2271)| Loss of loop (P = 0.2897)	0.954310459078	0.95344	0.9397204364327258	0.93916	0.26035772333	0.28308	0.441536396742	0.30748	T	0.734576	0.92530	D	0.377241	0.88449	D	0.38697	0.91614	D	0.831396281719208	0.48362	D	0.873813	0.58200	D	0.8500806	0.87171	0.6921288	0.81671	0.7315211	0.79570	0.6026673	0.76669	-9.254	0.69396	D	0.3041	0.53285	B	0.992257199241615	0.89420	0.49581957	0.81799	0.927	0.96353	.	.	.	.	.	.	3.730402	0.5344	23.4	0.98988172126808727	0.49972	0.937705	0.93562	D	0.397631943803568	0.61092	4.328485	0.227883202154653	0.51149	3.322889	4.42	4.42	0.52717	2.42	0.44885	6.764	0.74816	9.389000	0.80597	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.004	0.06081	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	1	109302	9.148960e-06	0	1	204452	4.891120e-06	0	1	233628	4.280310e-06	0	0	7160	0.000000e+00	0	1	17090	5.851380e-05	0	0	2320	0.000000e+00	0	0	9034	0.000000e+00	0	0	13338	0.000000e+00	0	0	42764	0.000000e+00	0	0	15686	0.000000e+00	0	1	17090	5.851380e-05	0	0	15776	0.000000e+00	0	1	30492	3.279550e-05	0	0	6136	0.000000e+00	0	0	13378	0.000000e+00	0	0	16676	0.000000e+00	0	0	86570	0.000000e+00	0	0	30596	0.000000e+00	0	1	30492	3.279550e-05	0	0	14496	0.000000e+00	0	1	34226	2.921760e-05	0	0	9516	0.000000e+00	0	0	17678	0.000000e+00	0	0	21572	0.000000e+00	0	0	100040	0.000000e+00	0	0	30514	0.000000e+00	0	1	34226	2.921760e-05	0	.	3	1612874	1.860030e-06	0	2	60000	3.333330e-05	0	0	74926	0.000000e+00	0	0	912	0.000000e+00	0	2	60000	3.333330e-05	0	0	29608	0.000000e+00	0	1	44884	2.227970e-05	0	0	62872	0.000000e+00	0	0	6084	0.000000e+00	0	0	1180032	0.000000e+00	0	0	91082	0.000000e+00	0	0	9688	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14048	0	Primary_hyperoxaluria,_type_I	no_assertion_criteria_provided	NC_000002.12:g.240868987G>A	ClinGen:CA275629|UniProtKB:P21549#VAR_074583	C0268164	259900	416|93598	.	Gly	Glu	98.26	0.5119047619047619																																																																																																																																																																																																																																																																																																																																																																																																																																																																													43			98.26	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Alanine--glyoxylate aminotransferase										-0.4								 G41-I37 (PAE:  1.0)	G41-I37 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)	 G41-S271 (PAE:  1.0), G41-I37 (PAE: 1.0)	G41-S271 (PDBs: 1H0C, 6RV0, 3R9A), G41-I37 (PDBs: 5OG0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)							75									-66.1				-18.0						C (loop/coil)	T (turn)	Helix											98.26	51.19048	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.8497130778907145	0.8604788092605524	false	false	false
KRT2	KRT2_Thr479Pro	B_7-8	-1.727460311572558	0.1348273212361642	0.20776127353152	-5.776354069781155	0.0006797846162667201	0.0017397556078792627	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7546480798728222	0.7985901446008372	0.48864044614194585	0.5375664232786462	0.4925848432188008	0.4855966008854149	0.45331782985395586	0.5181926100487095	0.550547346109767	0.46743284611173486	0.8309906920896943	0.7578472750389984	0.5178753719168739	0.4669770763888921	0.5245855004475255	0.5098480461721568	0.76618959711198	0.7514488847066461	KRT2	Thr479Pro	NC_000012.12:52646774:T:G	1435A>C	12	52646774	T	G	12	ENSG00000172867	55855	219419	CCSBVarC003453	ALE00003453	ENSP00000310861.3	CEGS2	CegsMutGDEh1038	G02	GDEhDisVCh_40073	A08	1	CegsMutGDDh1038	G02	VUSN2Hmut_GDN2h_07	D10	VUSMutpDEST2_13	G06	VUSmut_GDEh07	D10	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	2.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	24351.0	single nucleotide variant	NM_000423.3(KRT2):c.1435A>C (p.Thr479Pro)	3849.0	KRT2	HGNC:6439	Pathogenic	1.0	Jul 01, 1997	137852630.0	-	RCV000009897|RCV000056529	MONDO:MONDO:0007813,MedGen:C0432306,OMIM:146800,Orphanet:455|MedGen:CN517202	Ichthyosis bullosa of Siemens|not provided	germline	germline	GRCh38	NC_000012.12	12	52646774.0	52646774.0	12q13.13	no assertion criteria provided	2.0	-	N	ClinGen:CA120293,UniProtKB:P35908#VAR_009187,OMIM:600194.0004	3.0	9312.0	52646774.0	T	G	-	-	-	-	-	-	1435A>C 	Thr479Pro	NM_000423.3		Pathogenic	Pathogenic	9312	12	52646774.0	T	G	T	P	rs137852630	12	53040558	12	51326825	479	KRT2	ENSG00000172867	ENST00000309680	ENSP00000310861	P35908	K22E_HUMAN	c.1435A>C	p.Thr479Pro	c.1435A>C	p.Thr479Pro	principal1	Y	1	YES	Select	-	ACC	1	0	T	./.	./.	./.	./.	0.001	0.78662	D	0.019	0.59495	D	1.0	0.90580	D	1.0	0.97365	D	0.94	0.94378	A	simple_aae	6.0	94.0	3.635	0.93965	H	-5.75	0.87790	D	0.942	0.94916	1.0381	0.97868	D	0.9019	0.96739	D	9	0.973204	0.96955	D	0.045049	0.61643	D	0.921	0.98001	0.815	0.92954	P35908	T479P	Gain of catalytic residue at T479 (P = 0.0077)| Loss of phosphorylation at T479 (P = 0.0654)| Loss of stability (P = 0.0965)| Gain of ubiquitination at K482 (P = 0.0975)| Gain of methylation at K482 (P = 0.1856)	0.977494915894	0.97702	0.9675997855354177	0.96729	0.53341979916	0.50486	0.444084525108	0.31097	T	0.935353	0.98927	D	0.481492	0.93702	D	0.453854	0.93622	D	0.997315108776093	0.91190	D	0.483852	0.14458	T	0.97034454	0.98263	0.957994	0.98845	0.97034454	0.98263	0.957994	0.98846	-14.681	0.95070	D	0.9665	0.88886	P	0.994226672468106	0.90514	0.96588856	0.94355	0.77	0.87266	.	.	.	.	.	.	5.13399	0.85956	28.7	0.99688953437753303	0.79796	0.927549	0.91007	D	0.827137897516934	0.87702	9.334837	0.718854319661016	0.83721	8.120694	4.48	4.48	0.53919	3.85	0.72111	8.011	0.88214	.	.	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.999	0.91597	814	0.42043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	not_provided|Ichthyosis_bullosa_of_Siemens	no_assertion_criteria_provided	NC_000012.12:g.52646774T>G	ClinGen:CA120293|OMIM:600194.0004|UniProtKB:P35908#VAR_009187	CN517202|C0432306	146800	455	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	Thr	Pro	89.02	0.5140845070422535																																																																																																																																																																																																																																																																																																																																																																																																																																																																													73			89.02	Polar/Neutral	Threonine		Keratin, type II cytoskeletal 2 epidermal							IF rod			-0.7								 T479-L483 (PAE:  2.5), T479-V475 (PAE: 1.0)		 T479-L483 (PAE:  2.5), T479-V475 (PAE: 1.0)								119									-73.6				-39.8	Coil 2			dbSNP: rs137852630; Variant type: LP/P; AA change: Thr479Pro; PTM type: Ubiquitylation; PTM morphology: IAT*YRkLLEGE; Var class: II		H (helix)	H (α-helix)												89.02	51.40845	70-90	10-90	146800	autosomal dominant	OMIM	Rare genetic skin disease	1	ICHTHYOSIS BULLOSA OF SIEMENS	false	0.7985901446008372	0.7546480798728222	false	false	false
IL2RG	IL2RG_Arg285Gln	B_7-8	0.2692733669982634	0.7954838003478025	0.8385066548919994	2.2998795869445097	0.055000853600274006	0.07710203694156058	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5896637818180472	0.6344948961794368	0.5392106293543781	0.6652158207027958	0.6574598522448181	0.6063985768996074	0.4957307783446591	0.6166812777360746	0.5837951867983003	0.4457602920470233	0.6052386554307629	0.5661449325016356	0.7170663754545556	0.6982384267535614	0.7466364546072912	0.6326609666617331	0.6637511369281107	0.613182631134459	IL2RG	Arg285Gln	NC_000023.11:71108599:C:T	854G>A	23	71108599	C	T	X	ENSG00000147168	7651	13909	CCSBVarC001218	ALE00001218	ENSP00000363318.3	RC4	RC4_Mut_GDEh1018	H08	GDEhDisVCh_40084	B09	2	RC4_Mut_GDDh1018	H08	NULL	NULL	NULL	NULL	VUSmut_GDEh13	G02	1.0	1.0	1.0	7.0	0.0			0.0			1.0	1.0	1.0	Y	Y	N	N	Y	25065.0	single nucleotide variant	NM_000206.3(IL2RG):c.854G>A (p.Arg285Gln)	3561.0	IL2RG	HGNC:6010	Pathogenic	1.0	Oct 13, 2023	111033617.0	-	RCV000010709|RCV003231098	MONDO:MONDO:0010315,MedGen:C1279481,OMIM:300400,Orphanet:276|MedGen:C3661900	X-linked severe combined immunodeficiency|not provided	germline	germline	GRCh38	NC_000023.11	X	71108599.0	71108599.0	Xq13.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA254992,UniProtKB:P31785#VAR_002701,OMIM:308380.0011	3.0	10026.0	71108599.0	C	T	-	-	-	-	-	-	854G>A 	Arg285Gln	NM_000206.3	2.0	Pathogenic	Pathogenic	10026	X	71108599.0	C	T	R	Q	rs111033617	X	70328449	X	70245174	285	IL2RG	ENSG00000147168	ENST00000374202	ENSP00000363318	P31785	IL2RG_HUMAN	c.854G>A	p.Arg285Gln	c.854G>A	p.Arg285Gln	principal1	Y	1	YES	Select	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.016	0.61305	D	0.995	0.67505	D	0.588	0.50399	P	0.55	0.73810	A	simple_aae	45.0	55.0	2.835	0.82327	M	-2.12	0.48196	N	0.477	0.50987	1.1160	0.99894	D	0.9170	0.97245	D	9	0.965065	0.95928	D	0.874422	0.99038	D	0.772	0.92308	0.89	0.97304	P31785	R285Q	Loss of sheet (P = 0.0817)| Loss of catalytic residue at R285 (P = 0.136)| Loss of MoRF binding (P = 0.4531)| Gain of loop (P = 0.4661)| Loss of glycosylation at P288 (P = 0.5131)	0.998079992489	0.99803	0.8752502093679224	0.87414	1.56847412068	0.88097	0.42424684763	0.28387	T	0.723123	0.92117	D	0.542744	0.95465	D	0.541837	0.95397	D	0.996261179447174	0.88900	D	0.867113	0.56662	D	0.54310656	0.69271	0.4667278	0.68801	0.5049688	0.67080	0.44379267	0.67327	-5.604	0.42881	T	0.123	0.25851	B	0.998884356648956	0.95246	0.99962795	0.99551	0.826	0.90403	.	.	.	.	.	.	5.995323	0.94299	34.0	0.99916731654158175	0.98450	.	.	.	.	.	.	.	.	.	4.87	4.87	0.62830	3.6	0.65802	3.53	0.53386	7.326000	0.58250	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.997	0.79771	519	0.74474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|X-linked_severe_combined_immunodeficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.71108599C>T	ClinGen:CA254992|OMIM:308380.0011|UniProtKB:P31785#VAR_002701	C3661900|C1279481	300400	276	.	Arg	Gln	74.55	0.9274193548387096																																																																																																																																																																																																																																																																																																																																																																																																																																																																													230			74.55	Positively-charged	Arginine		Cytokine receptor common subunit gamma								0.0304		-4.5								 R285-F281 (PAE:  2.5)		 R285-F281 (PAE:  2.5)								175									-78.7		Pocket 4: Mean pLDDT: 78.56, Volume: 188.33 Å³, Druggability score: 0.03		-26.4						H (helix)	H (α-helix)							Cytoplasmic					74.55	92.741936	70-90	$\geqslant$90	300400	x-linked recessive	OMIM	Rare genetic immune disease	1	SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	true	0.6344948961794368	0.5896637818180472	false	false	false
HPRT1	HPRT1_Gly70Glu	B_7-8	-0.4212350357346021	0.6862161423356621	0.7502420331202716	-3.4037765521177183	0.011383810873671815	0.019199717787856417	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9140502763623476	0.8930507220762384	0.6603797940911261	0.6413770862903331	0.5585775044778127	0.6655534377924532	0.7032166783164101	0.5897964022912247	0.72161536481131	0.6825007534206675	0.9169021336091179	0.9185727750707926	0.6278901972684963	0.5273586066644007	0.5611388077693562	0.6382588347615847	0.8691993105433589	0.9095277776539026	HPRT1	Gly70Glu	NC_000023.11:134475255:G:A	209G>A	23	134475255	G	A	X	ENSG00000165704	7982	202788	CCSBVarC005928	ALE00005928	ENSP00000298556.7	CEGS2	CegsMutGDEh1039	H08	GDEhDisVCh_40052	A09	2	CegsMutGDDh1039	H08	VUSN2Hmut_GDN2h_08	B03	VUSMutpDEST2_07	H05	VUSmut_GDEh08	B03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25083.0	single nucleotide variant	NM_000194.2(HPRT1):c.209G>A (p.Gly70Glu)	3251.0	HPRT1	HGNC:5157	Pathogenic	1.0	Nov 25, 2020	137852487.0	-	RCV000010742|RCV000010743|RCV001851784	MONDO:MONDO:0010298,MedGen:C0023374,OMIM:300322,Orphanet:510||MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233;MONDO:MONDO:0010298,MedGen:C0023374,OMIM:300322,Orphanet:510	Lesch-Nyhan syndrome|HPRT NEW HAVEN|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency;Lesch-Nyhan syndrome	germline	germline	GRCh38	NC_000023.11	X	134475255.0	134475255.0	Xq26.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA120899,UniProtKB:P00492#VAR_006773,OMIM:308000.0016	3.0	10044.0	134475255.0	G	A	-	-	-	-	-	-	209G>A 	Gly70Glu	NM_000194.2	1.0	Pathogenic	Pathogenic	10044	X	134475255.0	G	A	G	E	rs137852487	X	133609285	X	133436951	70	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.209G>A	p.Gly70Glu	c.209G>A	p.Gly70Glu	principal1	Y	1	YES	Select	+	GGG	2	0	G	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.997	0.86259	D	0.89	0.91795	A	simple_aae	11.0	89.0	4.83	0.99685	H	-7.3	0.94499	D	0.985	0.99419	0.8764	0.95344	D	0.9974	0.99936	D	9	0.99444556	0.99944	D	0.945734	0.99620	D	0.977	0.99803	0.936	0.99070	P00492	G70E	Gain of solvent accessibility (P = 0.0026)| Gain of relative solvent accessibility (P = 0.0166)| Gain of ubiquitination at K69 (P = 0.1165)| Loss of helix (P = 0.1299)| Gain of sheet (P = 0.1451)	0.999989451543	0.99998	0.9987891542527447	0.99877	2.16132611022	0.95357	0.889028668404	0.95133	D	0.997522	0.99997	D	0.733796	0.99959	D	0.816271	0.99959	D	0.999631524085999	0.98238	D	0.915608	0.69816	D	0.99471045	0.99954	0.9937098	0.99995	0.99471045	0.99954	0.9937098	0.99996	-12.536	0.87394	D	0.9988	0.98152	P	0.993864494921241	0.90295	0.99978977	0.99726	0.994	0.99793	.	.	.	.	.	.	5.251826	0.88193	29.5	0.99820715232531565	0.90334	.	.	.	.	.	.	.	.	.	4.68	4.68	0.58268	3.92	0.74494	9.503	0.96982	9.668000	0.81241	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	280	0.88958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Partial_hypoxanthine-guanine_phosphoribosyltransferase_deficiency|Lesch-Nyhan_syndrome|HPRT_NEW_HAVEN	criteria_provided,_single_submitter	NC_000023.11:g.134475255G>A	ClinGen:CA120899|OMIM:308000.0016|UniProtKB:P00492#VAR_006773	C0268117|C0023374	300323|300322	79233|510	Phosphoribosyltransferase domain|Phosphoribosyltransferase domain	Gly	Glu	95.08	0.08333333333333333																																																																																																																																																																																																																																																																																																																																																																																																																																																																													7			95.08	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Hypoxanthine-guanine phosphoribosyltransferase										-0.4									G70-R200 (PDBs: 4KN6), G70-F74 (PDBs: 1BZY), G70-V66 (PDBs: 1BZY)	 G70-R200 (PAE:  1.0)	G70-D134 (PDBs: 1BZY), G70-R200 (PDBs: 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)							75									-55.6				-33.1				dbSNP: rs137852487; Variant type: LP/P; AA change: Gly70Glu; PTM type: Ubiquitylation; PTM morphology: LKG*GYkFFADL; Var class: II		C (loop/coil)	T (turn)	Turn											95.08	8.333334	>90	<10	300322;300323;300322	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	LESCH-NYHAN SYNDROME; HYPERURICEMIA, HPRT-RELATED; LESCH-NYHAN SYNDROME	false	0.8930507220762384	0.9140502763623476	false	false	false
NFU1	NFU1_Gly208Cys	B_7-8	1.8818630817711928	0.10887343826708253	0.17548376969631024	-2.288174254452979	0.062099364875767914	0.08613177214439464	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.549090111069011	0.5462370361507694	0.4701490898761105	0.45765036555669236	0.3941317431272907	0.4769637456362486	0.6238046544518634	0.5334740243762948	0.575397233372579	0.5886184416994384	0.6306108048293433	0.6343072518323251	0.3301228368206338	0.2547894618782867	0.3399034977408057	0.35167973805278246	0.46186326747219536	0.4638729703056968	NFU1	Gly208Cys	NC_000002.12:69400462:C:A	622G>T	2	69400462	C	A	2	ENSG00000169599	53798	218765	CCSBVarC005816	ALE00005816	ENSP00000387219.3	CEGS2	CegsMutGDEh1030	D05	GDEhDisVCh_40035	G11	1	CegsMutGDDh1030	D05	VUSN2Hmut_GDN2h_05	A04	NULL	NULL	VUSmut_GDEh05	A04	1.0	1.0	1.0	2.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	39657.0	single nucleotide variant	NM_001002755.4(NFU1):c.622G>T (p.Gly208Cys)	27247.0	NFU1	HGNC:16287	Pathogenic	1.0	Dec 11, 2023	374514431.0	-	RCV000023678|RCV000385109|RCV003415735	MONDO:MONDO:0011582,MedGen:C3276432,OMIM:605711,Orphanet:401869|MedGen:C3661900|	Multiple mitochondrial dysfunctions syndrome 1|not provided|NFU1-related disorder	germline;unknown	germline	GRCh38	NC_000002.12	2	69400462.0	69400462.0	2p13.3	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA129406,UniProtKB:Q9UMS0#VAR_066639,OMIM:608100.0002	3.0	30700.0	69400462.0	C	A	-	-	-	-	-	-	622G>T 	Gly208Cys	NM_001002755.4	2.0	Pathogenic	Pathogenic	30700	2	69400462.0	C	A	G	C	rs374514431	2	69627594	2	69481098	208	NFU1	ENSG00000169599	ENST00000410022	ENSP00000387219	Q9UMS0	NFU1_HUMAN	c.622G>T	p.Gly208Cys	c.622G>T	p.Gly208Cys	alternative1	Y	1	YES	Select	-	GGT	1	0	C	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.94	0.96253	A	simple_aae	6.0	94.0	5.215	0.99959	H	-8.85	0.97911	D	0.963	0.98479	1.0819	0.98942	D	0.9612	0.98749	D	10	0.9425671	0.93508	D	0.52803	0.95539	D	0.972	0.99695	.	.	.	.	.	0.982215801553	0.98184	0.9634757600736563	0.96313	0.637461451962	0.57206	0.842590630054	0.88470	D	0.83947	0.96529	D	0.282221	0.81369	D	0.553353	0.95710	D	0.986955463886261	0.77385	D	0.994516	0.98188	D	0.98039114	0.99124	0.9504615	0.98403	0.9815704	0.99214	0.945104	0.98069	-13.146	0.90868	D	0.9983	0.98627	P	0.998056323475301	0.93898	0.92064154	0.91995	0.973	0.98982	.	.	.	.	.	.	5.737106	0.93319	33.0	0.99658486215293796	0.77781	0.907498	0.86109	D	1.09480508330067	0.98026	17.28641	0.95794243513913	0.97621	16.47645	5.19	5.19	0.71389	3.51	0.63605	7.378	0.79008	7.571000	0.60774	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.997	0.79771	769	0.49251	.	.	.	.	.	.	.	.	.	.	.	.	46	264690	1.7378821E-4	segdup	22	109406	2.010860e-04	0	32	208124	1.537540e-04	0	36	236920	1.519500e-04	0	0	7164	0.000000e+00	0	18	17110	1.052020e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	4	42768	9.352790e-05	0	0	15690	0.000000e+00	0	18	17110	1.052020e-03	0	0	16218	0.000000e+00	0	26	30522	8.518450e-04	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	6	89550	6.700170e-05	0	0	30608	0.000000e+00	0	26	30522	8.518450e-04	0	0	14902	0.000000e+00	0	29	34258	8.465180e-04	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	7	102724	6.814380e-05	0	0	30526	0.000000e+00	0	29	34258	8.465180e-04	0	.	109	1613872	6.753940e-05	0	41	59976	6.836070e-04	0	0	74888	0.000000e+00	0	0	912	0.000000e+00	0	41	59976	6.836070e-04	0	0	29606	0.000000e+00	0	1	44888	2.227770e-05	0	0	64008	0.000000e+00	0	0	6084	0.000000e+00	0	63	1179942	5.339250e-05	0	0	91082	0.000000e+00	0	4	42898	9.32444403002471E-5	0	298	0	0	120	0	0	7888	0	0	500	0	0	628	0	0	26	0	0	104	0	0	6378	0	0	8186	0	0	146	0	4	58840	6.798096532970769E-5	not_provided|NFU1-related_disorder|Multiple_mitochondrial_dysfunctions_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.69400462C>A	ClinGen:CA129406|OMIM:608100.0002|UniProtKB:Q9UMS0#VAR_066639	C3661900|C3276432	605711	401869	NIF system FeS cluster assembly, NifU, C-terminal	Gly	Cys	94.67	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			94.67	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		NFU1 iron-sulfur cluster scaffold homolog, mitochondrial										-0.4								 G208-D87 (PAE:  2.0)		 G208-D87 (PAE:  2.0), G208-F113 (PAE: 1.5)								75									63.2				-137.6	NifU					B (undefined)	E (parallel sheets)	Turn											94.67	0.0	>90	<10	605711	autosomal recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1	false	0.5462370361507694	0.549090111069011	false	false	false
AGXT	AGXT_Ser221Pro	B_7-8	-1.3757279735161365	0.21130958531284005	0.29267680054207723	-5.992026528377945	0.0005465892766391231	0.0014793382339716677	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8715688544873853	0.8999207051828633	0.5608110468978726	0.6281881331513675	0.5616510090025876	0.6102029928683966	0.6829558592780398	0.548009073126194	0.7028654199857696	0.61064610116684	0.9409483401778908	0.9326120348896496	0.5374501264587535	0.5752929448789812	0.5535108463169655	0.5109759926289054	0.8588930701878357	0.810525674085121	AGXT	Ser221Pro	NC_000002.12:240874043:T:C	661T>C	2	240874043	T	C	2	ENSG00000172482	70497	3851	CCSBVarC008210	ALE00008196	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	A07	GDEhDisVCh_40002	H08	2	VUSMutGDDh004	A07	VUSN2Hmut_GDN2h_01	E08	VUSMutpDEST2_14	C08	VUSmut_GDEh01	E08	1.0	3.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	N	Y	Y	N	Y	200528.0	single nucleotide variant	NM_000030.3(AGXT):c.661T>C (p.Ser221Pro)	189.0	AGXT	HGNC:341	Pathogenic	1.0	Nov 27, 2014	180177254.0	-	RCV000186328	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598	Primary hyperoxaluria, type I	germline	germline	GRCh38	NC_000002.12	2	240874043.0	240874043.0	2q37.3	no assertion criteria provided	1.0	-	N	ClinGen:CA275730	2.0	204122.0	240874043.0	T	C	-	-	-	-	-	-	661T>C 	Ser221Pro	NM_000030.3		Pathogenic	Pathogenic	204122	2	240874043.0	T	C	S	P	rs180177254	2	241813460	2	241462133	221	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.661T>C	p.Ser221Pro	c.661T>C	p.Ser221Pro	principal1	Y	1	YES	Select	+	TCC	1	0	T	T/T	T/T	T/T	T/T	0.002	0.72322	D	0.004	0.74454	D	1.0	0.90580	D	0.999	0.92348	D	0.91	0.92786	A	simple_aae	9.0	91.0	.	.	.	-4.66	0.79516	D	0.964	0.97441	0.8261	0.94716	D	0.8110	0.93606	D	9	0.9929408	0.99828	D	0.671422	0.97255	D	0.795	0.93244	0.928	0.98831	P21549	S221P	Loss of stability (P = 0.0496)| Loss of phosphorylation at S221 (P = 0.0547)| Loss of MoRF binding (P = 0.064)| Gain of glycosylation at S223 (P = 0.085)| Gain of sheet (P = 0.1208)	0.945636655104	0.94463	0.9799765853855227	0.97979	0.271045825776	0.29331	0.579091012478	0.49891	T	0.954276	0.99356	D	0.422236	0.91075	D	0.368736	0.90963	D	0.995808005332947	0.88004	D	0.906209	0.66886	D	0.99313474	0.99903	0.96612597	0.99275	0.99313474	0.99903	0.96612597	0.99276	-12.065	0.85207	D	0.9788	0.90884	P	0.997784588629996	0.93546	0.56540316	0.83277	0.989	0.99628	.	.	.	.	.	.	4.683814	0.75027	26.3	0.99386835947924401	0.62210	0.958214	0.97778	D	0.305315842262392	0.56200	3.806766	0.116372567183182	0.45111	2.802648	4.1	2.94	0.33105	.	.	5.427	0.66296	7.606000	0.61793	0.593	0.32293	1.0	0.71675	1.000000	0.68239	0.623	0.32017	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Primary_hyperoxaluria,_type_I	no_assertion_criteria_provided	NC_000002.12:g.240874043T>C	ClinGen:CA275730	C0268164	259900	416|93598	Aminotransferase class V domain	Ser	Pro	98.97	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.97	Polar/Neutral	Serine		Alanine--glyoxylate aminotransferase										-0.8								 S221-L203 (PAE:  1.0), S221-T75 (PAE: 1.0)	S221-T75 (PDBs: 1H0C, 5OG0, 5F9S, 5HHY, 3R9A), S221-L203 (PDBs: 6RV0, 6RV1, 7NS7, 3R9A), S221-L74 (PDBs: 6RV1)	 S221-L74 (PAE:  1.0), S221-N72 (PAE: 1.0), S221-L203 (PAE: 1.0), S221-T75 (PAE: 1.0)	S221-T75 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 3R9A), S221-L74 (PDBs: 6RV1, 3R9A), S221-N72 (PDBs: 6RV1, 3R9A), S221-L203 (PDBs: 6RV1, 3R9A), S221-F68 (PDBs: 7NS7)							105									-141.0				147.7						B (undefined)	E (parallel sheets)	Beta strand											98.97	0.0	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.8999207051828633	0.8715688544873853	false	false	false
KCTD1	KCTD1_Ala30Glu	B_7-8	2.3156238386015326	0.05373973471982695	0.09850565577242752	0.3229864578627531	0.7561394681475732	0.7965074190877134	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7947830785969924	0.7783017750610801	0.728449296989568	0.7979265222358314	0.6249128240169977	0.7447098451787288	0.9627007357959482	0.9480791781564797	0.9496459813891291	0.9203544837561151	0.9887667686908861	0.9765292053798609	0.5267189545615094	0.30174646987751574	0.6462070630825335	0.536544110223021	0.567836781431274	0.6130369518141239	KCTD1	Ala30Glu	NC_000018.10:26501147:G:T	89C>A	18	26501147	G	T	18	ENSG00000134504	14221	218276	CCSBVarC005802	ALE00005802	ENSP00000464170.1	CEGS2	CegsMutGDEh1036	F10	GDEhDisVCh_40022	G05	2	CegsMutGDDh1036	F10	VUSN2Hmut_GDN2h_07	H06	VUSMutpDEST2_11	F07	VUSmut_GDEh07	H06	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	70529.0	single nucleotide variant	NM_001142730.3(KCTD1):c.1913C>A (p.Ala638Glu)	284252.0	KCTD1	HGNC:18249	Pathogenic	1.0	Jan 29, 2014	587776998.0	-	RCV000049292	MONDO:MONDO:0008404,MedGen:C1867020,OMIM:181270,Orphanet:2036	Scalp-ear-nipple syndrome	germline;inherited	germline	GRCh38	NC_000018.10	18	26501147.0	26501147.0	18q11.2	no assertion criteria provided	2.0	-	N	ClinGen:CA143987,UniProtKB:Q719H9#VAR_069971,OMIM:613420.0001	3.0	55881.0	26501147.0	G	T	-	-	-	-	-	-	1913C>A 	Ala638Glu	NM_001142730.3		Pathogenic	Pathogenic	55881	18	26501147.0	G	T	A	E	rs587776998	18	24081111	18	22335109	30	KCTD1	ENSG00000134504	ENST00000579973	ENSP00000464170	Q719H9	KCTD1_HUMAN	c.89C>A	p.Ala30Glu	c.89C>A	p.Ala30Glu	.	Y	1	.	.	-	GCG	2	0	G	./.	./.	./.	./.	.	0.91343	.	0.11	0.37649	T	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.745	0.80081	M	.	0.76365	.	0.903	0.90472	-0.3804	0.72517	T	0.4946	0.80764	T	10	0.7088544	0.72662	D	0.586165	0.96302	D	.	0.81097	0.368	0.37543	Q719H9	A30E	Gain of disorder (P = 0.0642)| Loss of glycosylation at S28 (P = 0.0932)| Gain of ubiquitination at K27 (P = 0.1117)| Gain of methylation at K27 (P = 0.1148)| Gain of solvent accessibility (P = 0.1185)	0.683162217899	0.67796	.	0.78561	.	0.90471	0.85899990797	0.90948	D	0.182836	0.53268	T	0.335147	0.85405	D	0.243639	0.85215	D	0.996293485164642	0.88961	D	.	0.94885	.	0.8558993	0.87609	0.83546644	0.90417	0.76729834	0.81664	0.85172576	0.91509	-9.76	0.72541	D	.	0.99584	.	0.999613187552117	0.97193	0.75925010	0.87375	0.719	0.84426	.	.	.	.	.	.	4.809161	0.78262	26.9	0.99478609789869721	0.66785	0.937736	0.93570	D	0.583638314761718	0.72004	5.761204	0.642104722817139	0.77901	6.793685	5.68	5.68	0.88004	.	.	9.503	0.96982	8.712000	0.78172	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Scalp-ear-nipple_syndrome	no_assertion_criteria_provided	NC_000018.10:g.26501147G>T	ClinGen:CA143987|OMIM:613420.0001|UniProtKB:Q719H9#VAR_069971	C1867020	181270	2036	BTB/POZ domain|BTB/POZ domain-containing protein KCTD1, BTB/POZ domain	Ala	Glu	92.16	0.22641509433962265																																																																																																																																																																																																																																																																																																																																																																																																																																																																													24			92.16	Aliphatic	Alanine		BTB/POZ domain-containing protein KCTD1							BTB			1.8								 A30-T26 (PAE:  2.0)	A30-S26 (PDBs: 5BXB)	 A30-T26 (PAE:  2.0)	A30-S26 (PDBs: 5BXB, 6S4L)							89									-63.2				124.7				dbSNP: rs587776998; Variant type: LP/P; AA change: Ala30Glu; PTM type: Phosphorylation; PTM morphology: tPAQLtKSNA*P; Var class: II		C (loop/coil)	S (bend)												92.16	22.64151	>90	10-90	181270	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	3	SCALP-EAR-NIPPLE SYNDROME	false	0.7783017750610801	0.7947830785969924	false	false	false
POMT1	POMT1_Thr392Met	B_7-8	1.384695758221824	0.21543845687128904	0.29753250370510637	-1.9689353160073562	0.09649252282058357	0.12812140331097746	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5131079806399165	0.5598408465608922	0.4411737710159674	0.3997214059917512	0.42493976327076977	0.4454352535922833	0.519290322469367	0.34801567532556815	0.41772599730733656	0.5239739690212956	0.4446449818712891	0.4387314696197141	0.3715801847151996	0.5018638512159713	0.3817168146761658	0.3583735730106392	0.6750367112504952	0.5874844916601188	POMT1	Thr392Met	NC_000009.12:131513331:C:T	1175C>T	9	131513331	C	T	9	ENSG00000130714	71206	205719	CCSBVarC003247	ALE00003247	ENSP00000385797.4	CEGS2	CegsMutGDEh1031	F08	GDEhDisVCh_40022	F01	2	CegsMutGDDh1031	F08	VUSN2Hmut_GDN2h_05	D09	VUSMutpDEST2_15	E03	VUSmut_GDEh05	D09	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	48034.0	single nucleotide variant	NM_001077365.2(POMT1):c.1175C>T (p.Thr392Met)	10585.0	POMT1	HGNC:9202	Pathogenic	1.0	Dec 01, 2012	397515400.0	-	RCV000032630	MONDO:MONDO:0012248,MedGen:C1836373,OMIM:609308,Orphanet:86812	Autosomal recessive limb-girdle muscular dystrophy type 2K	germline	germline	GRCh38	NC_000009.12	9	131513331.0	131513331.0	9q34.13	no assertion criteria provided	1.0	-	N	ClinGen:CA211172,OMIM:607423.0020	1.0	39435.0	131513331.0	C	T	-	-	-	-	-	-	1175C>T 	Thr392Met	NM_001077365.2		Pathogenic	Pathogenic	39435	9	131513331.0	C	T	T	M	rs397515400	9	134388718	9	133378539	414	POMT1	ENSG00000130714	ENST00000372228	ENSP00000361302	Q9Y6A1	POMT1_HUMAN	c.1241C>T	p.Thr414Met	c.1241C>T	p.Thr414Met	.	Y	1	.	.	+	ACG	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.987	0.77493	D	0.99	0.97926	A	simple_aae	1.0	99.0	2.915	0.84068	M	-3.05	0.63000	D	0.823	0.82403	0.8322	0.94791	D	0.8157	0.93776	D	10	0.9563864	0.94948	D	0.432192	0.93992	D	0.852	0.95421	0.808	0.92471	Q9Y6A1	T414M	Loss of glycosylation at T414 (P = 0.0434)| Loss of phosphorylation at T414 (P = 0.0959)| Loss of disorder (P = 0.1356)| Loss of catalytic residue at T414 (P = 0.1374)| Gain of helix (P = 0.1736)	0.951015637916	0.95009	0.6940996047355062	0.69195	0.9077017835	0.70736	0.645573616028	0.59293	T	0.888989	0.97709	D	0.372331	0.88127	D	0.379917	0.91367	D	0.971478402614594	0.69127	D	0.975302	0.94955	D	0.83096933	0.85785	0.61147666	0.77157	0.7937297	0.83301	0.6184088	0.77542	-9.428	0.76003	D	0.5036	0.65318	A	0.993821024425665	0.90271	0.98785190	0.96422	0.62	0.78786	.	.	.	.	.	.	5.521946	0.91801	32.0	0.99854588366072916	0.93373	0.660392	0.62965	D	0.644655255571948	0.75895	6.410604	0.554191685541166	0.71536	5.69337	5.08	5.08	0.68332	.	.	5.422	0.66268	7.531000	0.59982	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.669	0.33263	400	0.82728	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	1	107112	9.336020e-06	0	2	203656	9.820480e-06	0	2	230868	8.662960e-06	0	0	6998	0.000000e+00	0	1	16964	5.894840e-05	0	0	2284	0.000000e+00	0	0	8976	0.000000e+00	0	0	12208	0.000000e+00	0	0	42282	0.000000e+00	0	0	15514	0.000000e+00	0	1	16964	5.894840e-05	0	0	15768	0.000000e+00	0	1	30262	3.304470e-05	0	0	6104	0.000000e+00	0	0	13268	0.000000e+00	0	0	15516	0.000000e+00	0	1	87648	1.140930e-05	0	0	30318	0.000000e+00	0	1	30262	3.304470e-05	0	0	14644	0.000000e+00	0	1	34004	2.940830e-05	0	0	9458	0.000000e+00	0	0	17590	0.000000e+00	0	0	19802	0.000000e+00	0	1	99602	1.004000e-05	0	0	30240	0.000000e+00	0	1	34004	2.940830e-05	0	.	6	1610922	3.724580e-06	0	1	59946	1.668170e-05	0	0	75010	0.000000e+00	0	0	912	0.000000e+00	0	1	59946	1.668170e-05	0	0	29576	0.000000e+00	0	0	44828	0.000000e+00	0	1	61728	1.620010e-05	0	0	6050	0.000000e+00	0	4	1179566	3.391080e-06	0	0	90870	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2642	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2726	0	0	142	0	0	11338	0	Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2K	no_assertion_criteria_provided	NC_000009.12:g.131513331C>T	ClinGen:CA211172|OMIM:607423.0020	C1836373	609308	86812	MIR motif	Thr	Met	93.98	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																93.98	0.0	>90	<10	609308	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1	false	0.5598408465608922	0.5131079806399165	false	false	false
BAP1	BAP1_Pro12Thr	B_13-14	1.2327266947006599	0.2574688649083334	0.34197881222177795	-4.225969335815301	0.003907589099015427	0.007547816838624536	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6942051787357705	0.7099334972091577	0.6080084626712445	0.4976663822024905	0.5517428090074206	0.6133211012555586	0.5515039441180573	0.6143850495184825	0.5057950708759242	0.558131743986529	0.7181121830948589	0.7037076716238088	0.6751382583930599	0.4891005684963585	0.48953769352905674	0.6578851813559601	0.7017548113234564	0.6847026858477322	BAP1	Pro12Thr	NC_000003.12:52409845:G:T	34C>A	3	52409845	G	T	3	ENSG00000163930	3760	0	CCSBVarC009495	ALE00015205	ENSP00000417132.1																																	1053076.0	single nucleotide variant	NM_004656.4(BAP1):c.34C>A (p.Pro12Thr)	8314.0	BAP1	HGNC:950	Pathogenic	1.0	Feb 24, 2022	2153228682.0	-	RCV001374940|RCV001839042	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0859230,MedGen:C5676925,OMIM:619762	Neurodevelopmental disorder|Kury-Isidor syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52409845.0	52409845.0	3p21.1	no assertion criteria provided	2.0	-	N	OMIM:603089.0011	3.0	1064792.0	52409845.0	G	T	-	-	-	-	-	-	34C>A 	Pro12Thr	NM_004656.4		Pathogenic	Pathogenic	1064792	3	52409845.0	G	T	P	T	rs2153228682	3	52443861	3	52418901	12	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.34C>A	p.Pro12Thr	c.34C>A	p.Pro12Thr	principal1	Y	1	YES	Select	-	CCA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	0.994	0.66535	D	0.943	0.67917	D	.	.	.	.	.	.	3.34	0.90844	M	-7.52	0.95806	D	0.717	0.76196	0.5791	0.91592	D	0.6438	0.87520	D	10	0.9533975	0.94626	D	0.613498	0.96627	D	0.834	0.94750	0.826	0.93687	Q92560	P12T	Gain of catalytic residue at F15 (P = 0.1611)| Loss of stability (P = 0.1989)| Loss of disorder (P = 0.2123)| Loss of glycosylation at P12 (P = 0.257)| Gain of phosphorylation at S10 (P = 0.4485)	0.910963055978	0.90939	0.932184403075094	0.93154	2.47156410767	0.97481	0.78230202198	0.79237	T	0.587622	0.86468	D	0.322782	0.84559	D	0.225878	0.84358	D	0.99904853105545	0.95954	D	0.89941	0.64684	D	0.9520596	0.96419	0.9296314	0.97027	0.9520596	0.96420	0.9296314	0.97028	-13.412	0.91007	D	0.9986	0.97942	P	0.938734357228053	0.79228	0.99978024	0.99714	0.862	0.92474	.	.	.	.	.	.	5.259026	0.88323	29.5	0.99758718307023109	0.84864	0.875323	0.79793	D	0.957361183823445	0.94241	12.63146	0.862850773711547	0.93709	12.2498	4.93	4.93	0.64349	2.88	0.52655	6.576	0.73975	11.420000	0.92722	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Kury-Isidor_syndrome|Neurodevelopmental_disorder	no_assertion_criteria_provided	NC_000003.12:g.52409845G>T	OMIM:603089.0011	C5676925|C1535926	619762	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Pro	Thr	95.22	0.11029411764705882																																																																																																																																																																																																																																																																																																																																																																																																																																																																													15			95.22	Special, No backbone hydrogen	Proline		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			1.6								 P12-T16 (PAE:  1.0)	P12-T16 (PDBs: 8SVF)	 P12-T16 (PAE:  1.0)	P12-M231 (PDBs: 8SVF), P12-T16 (PDBs: 8SVF), P12-V29 (PDBs: 8SVF), P12-E31 (PDBs: 8SVF)							115									-61.1				-25.5						H (helix)	H (α-helix)	Helix											95.22	11.029412	>90	10-90	619762	autosomal dominant	GenCC	Rare genetic tumor	1	KURY-ISIDOR SYNDROME	false	0.7099334972091577	0.6942051787357705	false	false	false
BRCA1	BRCA1_Val632Ala	B_13-14	2.1490587662768768	0.06870905490576534	0.12017792570513902	6.115289664824691	0.0004837443157969204	0.0013531567370233977	2025_01_Batch_13-14	false	false	false	false	false	true	false	false	false	false	false	false	0.8928532467594096	0.8980824348190553	0.8572283585035794	0.9400371392319107	0.9013281177846075	0.9293236077271974	0.8796530559913893	0.8781657510997292	0.9055069116428573	0.763886384553141	0.8646658491222726	0.8594874374916739	0.9789941594630055	0.924490484469486	0.974567366820964	0.9505703324540177	0.9314990205158378	0.9262190560271453	BRCA1	Val632Ala	NC_000017.11:43057122:A:G	1895T>C	17	43057122	A	G	17	ENSG00000012048	14613	0	CCSBVarC011853	ALE00012376	ENSP00000417148.1																																	46204.0	single nucleotide variant	NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 25, 2019	45553935.0	-	RCV000031229|RCV000048857|RCV000131291|RCV000195366|RCV000585878	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43057122.0	43057122.0	17q21.31	reviewed by expert panel	23.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003357,UniProtKB:P38398#VAR_070506,OMIM:113705.0038	3.0	37648.0	43057122.0	A	G	-	-	-	-	-	-	5207T>C 	Val1736Ala	NM_007294.4	3.0	Pathogenic	Pathogenic	37648	17	43057122.0	A	G	V	A	rs45553935	17	41209139	17	38462665	1736	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.5207T>C	p.Val1736Ala	principal2	Y	.	.	.	-	GTC	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	0.802	0.90580	P	0.38	0.92348	B	.	0.99291	.	.	.	.	3.265	0.89891	M	.	0.66695	.	.	0.89680	0.8523	0.95041	D	0.8418	0.94704	D	10	.	0.91075	.	0.753957	0.98037	D	.	0.94487	.	.	.	.	.	.	0.89179	.	0.79043	.	0.13518	0.580183625221	0.50045	T	0.137814	0.46804	T	0.456703	0.92720	D	0.418246	0.92630	D	0.982382714748383	0.74278	D	.	0.83839	.	0.64500636	0.74826	0.18117532	0.40826	0.56882757	0.70704	0.19759434	0.43395	-8.463	0.64259	D	.	0.87654	.	0.989452318288449	0.88181	0.99978083	0.99714	0.81	0.89500	.	.	.	.	.	.	4.681403	0.74972	26.2	0.99880114867489878	0.95656	0.684452	0.64551	D	0.735250864207851	0.81845	7.641852	0.688539164513861	0.81406	7.543151	5.07	5.07	0.68064	.	.	5.554	0.67074	10.840000	0.83929	0.748	0.86774	1.0	0.71675	1.000000	0.68239	1.0	0.97202	518	0.74567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13	1613984	8.054600e-06	0	12	1179920	1.017020e-05	0	0	75034	0.000000e+00	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29600	0.000000e+00	0	0	44870	0.000000e+00	0	0	64010	0.000000e+00	0	0	6056	0.000000e+00	0	12	1179920	1.017020e-05	0	0	91084	0.000000e+00	0	1	24506	4.080633314290378E-5	0	84	0	0	84	0	0	2656	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4632	0	0	2740	0	0	108	0	1	33208	3.0113225728740063E-5	not_provided|Fanconi_anemia,_complementation_group_S|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43057122A>G	ClinGen:CA003357|OMIM:113705.0038|UniProtKB:P38398#VAR_070506	C3661900|C4554406|C0027672|C2676676|C0677776	617883|604370	140162|145|145	BRCT domain	Val	Ala	97.64	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.64	0.0	>90	<10	604370;617883	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; FANCONI ANEMIA, COMPLEMENTATION GROUP S	false	0.8980824348190553	0.8928532467594096	false	false	false
ZC4H2	ZC4H2_Arg198Gln	B_13-14	-4.669579694535985	0.0022886216209041625	0.008777645172544079	6.833150230736553	0.0002457062062229511	0.0007965916756521471	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9037525752786608	0.9130319655591184	0.5736425624520354	0.7415036992974238	0.7339859893845713	0.7064504017139552	0.6148301356082663	0.7558119587484177	0.6943695371275554	0.5232721988247433	0.8885718240913488	0.8770730676620033	0.7980706678196443	0.712160020020725	0.7886378614672922	0.6240129260793275	0.9374921070268878	0.9304320828953183	ZC4H2	Arg198Gln	NC_000023.11:64917865:C:T	593G>A	23	64917865	C	T	X	ENSG00000126970	4320	0	CCSBVarC009191	ALE00014249	ENSP00000363972.3																																	65652.0	single nucleotide variant	NM_018684.4(ZC4H2):c.593G>A (p.Arg198Gln)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	May 27, 2023	879255235.0	-	RCV000043677|RCV000498696|RCV001770066	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MedGen:CN517202|MONDO:MONDO:0026762,MedGen:C5393303,OMIM:301041	Wieacker-Wolff syndrome|not provided|Wieacker-Wolff syndrome, female-restricted	germline;unknown	germline	GRCh38	NC_000023.11	X	64917865.0	64917865.0	Xq11.2	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA10575580,UniProtKB:Q9NQZ6#VAR_069622,OMIM:300897.0002	3.0	50981.0	64917865.0	C	T	-	-	-	-	-	-	593G>A 	Arg198Gln	NM_018684.4	2.0	Pathogenic	Pathogenic	50981	X	64917865.0	C	T	R	Q	rs879255235	X	64137745	X	64054470	198	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.593G>A	p.Arg198Gln	c.593G>A	p.Arg198Gln	principal1	Y	1	YES	Select	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.009	0.67073	D	0.998	0.73231	D	0.988	0.77983	D	0.93	0.94378	A	simple_aae	7.0	93.0	.	.	.	-3.56	0.68915	D	0.865	0.89118	-0.0594	0.80920	T	0.4448	0.78059	T	8	0.91766816	0.91026	D	0.931883	0.99506	D	0.540	0.80683	0.558	0.67570	Q9NQZ6	R198Q	Loss of MoRF binding (P = 0.0352)| Loss of helix (P = 0.1299)| Gain of relative solvent accessibility (P = 0.1684)| Gain of catalytic residue at R198 (P = 0.2542)| Gain of loop (P = 0.3485)	0.896646558922	0.89483	0.6985962743898447	0.69647	3.04366087562	0.99279	0.863531589508	0.91618	D	0.861236	0.96898	D	0.619807	0.98328	D	0.652534	0.98300	D	0.998395621776581	0.93976	D	0.974003	0.91550	D	0.8665144	0.88431	0.84589994	0.91114	0.8701332	0.88719	0.84851253	0.91292	-14.555	0.95182	D	0.9999	0.99795	P	0.999345122363188	0.96318	0.99758303	0.98429	0.99	0.99661	.	.	.	.	.	.	5.374841	0.90114	31.0	0.99954933178758143	0.99969	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	7.301	0.78228	7.539000	0.60115	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.995	0.73271	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Wieacker-Wolff_syndrome,_female-restricted|Wieacker-Wolff_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64917865C>T	ClinGen:CA10575580|OMIM:300897.0002|UniProtKB:Q9NQZ6#VAR_069622	CN517202|C5393303|C0796200	301041|314580	3454|85283	Zinc finger C4H2-type	Arg	Gln	88.17	0.4435483870967742																																																																																																																																																																																																																																																																																																																																																																																																																																																																													110			88.17	Positively-charged	Arginine		Zinc finger C4H2 domain-containing protein										-4.5								 R198-K187 (PAE:  2.0), R198-P185 (PAE: 3.5)		 R198-P185 (PAE:  3.5)								175									-53.7				-30.5						C (loop/coil)	T (turn)											C4H2-type	88.17	44.35484	70-90	10-90	314580;301041	x-linked recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME; WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED	false	0.9130319655591184	0.9037525752786608	false	false	false
F9	F9_Ala233Thr	B_13-14	-0.7705435338155132	0.46618328932048236	0.5530413656235885	2.7825226153659015	0.027199331986286768	0.04135109709597035	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7730713135455434	0.7671321491158922	0.6225946189534203	0.7966155556881216	0.8218759307790156	0.7745573698219822	0.6965819889408906	0.7609870632901867	0.6994307162862603	0.6310562977723285	0.7069653256314208	0.7243064230090177	0.8525327507030738	0.8827647982678444	0.8938003950899828	0.614132940134512	0.8272989726003636	0.8218362040820689	F9	Ala233Thr	NC_000023.11:139551238:G:A	697G>A	23	139551238	G	A	X	ENSG00000101981	52861	0	CCSBVarC030569	ALE00024417	ENSP00000218099.2																																	25640.0	single nucleotide variant	NM_000133.4(F9):c.697G>A (p.Ala233Thr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	387906478.0	-	RCV000011347	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551238.0	139551238.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255365,OMIM:300746.0042	1.0	10601.0	139551238.0	G	A	-	-	-	-	-	-	697G>A 	Ala233Thr	NM_000133.4		Pathogenic	Pathogenic	10601	X	139551238.0	G	A	A	T	rs387906478	X	138633397	X	138461063	233	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.697G>A	p.Ala233Thr	c.697G>A	p.Ala233Thr	principal1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.009	0.57638	D	0.02	0.58950	D	0.835	0.46269	P	0.508	0.47888	P	0.81	0.89397	A	simple_aae	19.0	81.0	1.585	0.39718	L	-1.68	0.40077	N	0.205	0.25325	0.2747	0.87093	D	0.8126	0.93664	D	10	0.7169125	0.73158	D	0.551716	0.95863	D	0.601	0.84159	0.837	0.94387	P00740	A233T	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.996876262872	0.99680	0.9744568104967672	0.97421	0.692767066121	0.60419	0.402713298798	0.25417	T	0.679272	0.90470	D	0.294947	0.82433	D	0.185895	0.82207	D	0.590011954307556	0.35695	D	0.912709	0.71602	D	0.42786407	0.62291	0.38942766	0.63514	0.37815922	0.58855	0.36422572	0.61553	-7.14	0.59571	T	0.2233	0.46513	B	0.990832113786758	0.88755	0.99996746	0.99978	0.798	0.88827	.	.	.	.	.	.	3.182106	0.43284	21.7	0.99893111899062204	0.96668	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	3.93	0.74723	2.501	0.4515	6.519000	0.55895	0.676	0.76753	0.906	0.31665	1.000000	0.68239	0.98	0.58201	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139551238G>A	ClinGen:CA255365|OMIM:300746.0042	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Thr	91.81	0.03773584905660377																																																																																																																																																																																																																																																																																																																																																																																																															0.943		0.832		0.825		0.79		0.821																																																						4			91.81	Aliphatic	Alanine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			1.8								 A233-L369 (PAE:  1.0)	A233-H282 (PDBs: 6X5J, 6X5L, 8OL9), A233-L369 (PDBs: 8OL9)		A233-H282 (PDBs: 6X5J, 6X5L, 8OL9), A233-L369 (PDBs: 8OL9), A233-Q237 (PDBs: 8OL9)							89									-68.6				153.5						H (helix)	P (polyproline helix)												91.81	3.7735848	>90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.7671321491158922	0.7730713135455434	false	false	false
F9	F9_Arg294Gln	B_13-14	-2.7915177487330602	0.03837601004671841	0.07487045882454767	3.529775888263387	0.00960071092369769	0.016557617053557575	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	false	false	0.9595936425212283	0.9651010367523498	0.6231415404300601	0.8310615109064865	0.735796513566711	0.6966864775147393		0.7894302972243974	0.8717370389557493		0.9636526423546399	0.9496592406413835	0.6966864775147393	0.6821627299090247	0.7903859828572237	0.6231415404300601	0.9665494311500596	0.969528044401073	F9	Arg294Gln	NC_000023.11:139561566:G:A	881G>A	23	139561566	G	A	X	ENSG00000101981	52861	0	CCSBVarC004382	ALE00004382	ENSP00000218099.2	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25641.0	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Nov 01, 2024	137852249.0	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566.0	139561566.0	Xq27.1	reviewed by expert panel	11.0	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3.0	10602.0	139561566.0	G	A	-	-	-	-	-	-	881G>A 	Arg294Gln	NM_000133.4	3.0	Pathogenic	Pathogenic	10602	X	139561566.0	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	97.66	0.12903225806451613																																																																																																																																																																																																																																																																																																																																																																																																															0.178		0.112		0.14		0.114		0.106																																																						32			97.66	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-4.5								 R294-P324 (PAE:  1.0), R294-V277 (PAE: 1.0)	R294-E323 (PDBs: 6X5J, 6X5L, 8OL9), R294-V277 (PDBs: 8OL9), R294-T276 (PDBs: 8OL9)	 R294-V277 (PAE:  1.0)	R294-V277 (PDBs: 6X5J, 6X5L, 8OL9), R294-L321 (PDBs: 8OL9), R294-E323 (PDBs: 8OL9), R294-T276 (PDBs: 8OL9), R294-D322 (PDBs: 8OL9)							175									-139.5				136.9						B (undefined)	E (parallel sheets)	Beta strand											97.66	12.903225	>90	10-90	306900;306900;300807;306700	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA A	false	0.9651010367523498	0.9595936425212283	true	false	false
RAF1	RAF1_Thr491Ile	B_13-14	-3.8359287255680843	0.2755942932717806	0.28987067066660194	2.8254810197240707	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7295554159653809	0.6794858335170757	0.753558524043971	0.7108906957448161	0.6492328854527207	0.7767013872187863	0.812626112212113	0.6905186848764154	0.7017666056985714	0.7871577089284197	0.7549800459559515	0.7443492183711635	0.7407766622254597	0.6079470860290259	0.7200147857910608	0.7199593391595221	0.6039916210781999	0.7147616135595982	RAF1	Thr491Ile	NC_000003.12:12585745:G:A	1472C>T	3	12585745	G	A	3	ENSG00000132155	732	0	CCSBVarC008868	ALE00012317	ENSP00000251849.4																																	34194.0	single nucleotide variant	NM_002880.4(RAF1):c.1472C>T (p.Thr491Ile)	5894.0	RAF1	HGNC:9829	Pathogenic	1.0	Apr 03, 2017	80338799.0	-	RCV000037676|RCV000020507|RCV000523483|RCV000621393|RCV000159086	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736|MedGen:C3661900	Noonan syndrome|Noonan syndrome with multiple lentigines|RASopathy|Cardiovascular phenotype|not provided	germline;unknown	germline	GRCh38	NC_000003.12	3	12585745.0	12585745.0	3p25.2	reviewed by expert panel	6.0	-	N	ClinGen:CA261612,UniProtKB:P04049#VAR_037818	3.0	21342.0	12585745.0	G	A	-	-	-	-	-	-	1472C>T 	Thr491Ile	NM_002880.4	3.0	Pathogenic	Pathogenic	21342	3	12585745.0	G	A	T	I	rs80338799	3	12627244	3	12602244	491	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.1472C>T	p.Thr491Ile	principal3	Y	.	.	.	-	ACA	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.72530	.	0.992	0.64752	D	0.993	0.81117	D	.	0.97926	.	.	.	.	1.1	0.27864	L	.	0.84984	.	.	0.99270	0.2967	0.87455	D	0.6071	0.86014	D	10	.	0.91723	.	0.181388	0.85514	D	.	0.95680	0.801	0.91975	P04049	T491I	Gain of methylation at K493 (P = 0.0498)| Loss of disorder (P = 0.0648)| Gain of glycosylation at T491 (P = 0.07)| Loss of ubiquitination at K493 (P = 0.0727)| Gain of sheet (P = 0.0827)	.	0.98248	.	0.77918	.	0.97725	0.866992950439	0.92123	D	0.916059	0.98441	D	0.422262	0.91075	D	0.368773	0.90965	D	0.996801376342773	0.90034	D	.	0.88869	.	0.950552	0.96263	0.88725847	0.93992	0.92476356	0.93621	0.9026804	0.95101	-13.234	0.90339	D	.	0.96039	.	0.999943145463238	0.99079	0.99845386	0.98790	0.989	0.99628	.	.	.	.	.	.	5.630439	0.9268	32.0	0.99892157575248453	0.96592	0.901642	0.84802	D	0.769741033321538	0.84095	8.217369	0.796443984461197	0.89485	10.01913	5.26	5.26	0.73443	.	.	9.996	0.99292	11.849000	0.98025	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.994	0.71086	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Noonan_syndrome_with_multiple_lentigines|RASopathy|not_provided|Cardiovascular_phenotype|Noonan_syndrome	reviewed_by_expert_panel	NC_000003.12:g.12585745G>A	ClinGen:CA261612|UniProtKB:P04049#VAR_037818	C0175704|C5555857|C3661900|CN230736|C0028326	PS151100|PS163950	500|536391|648	Protein kinase domain|Protein kinase domain|Protein kinase domain	Thr	Ile	53.92	0.2746478873239437																																																																																																																																																																																																																																																																																																																																																																																																																																																																													39			53.92	Polar/Neutral	Threonine		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase			-0.7								 T491-R495 (PAE:  5.0)	T491-I465 (PDBs: 3OMV, 8CHF, 8CPD), T491-R467 (PDBs: 8CPD)	 T491-R495 (PAE:  5.0)	T491-I465 (PDBs: 3OMV, 8CHF, 8CPD), T491-R467 (PDBs: 8CPD)						Phosphothreonine	119		Mutation: T -> D. Increased kinase activity but can still be inhibited by PPP5C; when associated with D-494.							-65.0	Morphology: IGDFGLAtVksRWsG; Domain: PK_Tyr_Ser-Thr			-32.9		Regulatory site: T491-p; Morphology: IGDFGLAtVKSRWSG; Domain: PK_Tyr_Ser-Thr; On-Function: enzymatic activity, induced		dbSNP: rs80338799; Variant type: LP/P; AA change: Thr491Ile; PTM type: Ubiquitylation; PTM morphology: GLAt*VksRWsG; Var class: II&rs80338799		H (helix)	H (α-helix)												53.92	27.464788	50-70	10-90		autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.6794858335170757	0.7295554159653809	false	false	false
ABCD1	ABCD1_Arg389Gly	B_13-14	7.214936905963234	0.00017516911910830517	0.0013224229940587465	2.0015698058408478	0.10173533425681955	0.13430527939659273	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.573402852651401	0.6933777748394039	0.6345619884834257	0.7599358797153402	0.7158266453529856	0.7181391242071676	0.5624020740151221	0.6741127101294353	0.6411234528916463	0.5357649140141871	0.6589113085759324	0.5250591410653331	0.8738761743992132	0.757540580576536	0.878748306539034	0.7333590629526643	0.7278442411028755	0.6217465642374689	ABCD1	Arg389Gly	NC_000023.11:153736195:C:G	1165C>G	23	153736195	C	G	X	ENSG00000101986	100008637	0	CCSBVarC007023	ALE00007021	ENSP00000218104.3	CEGS2	CegsMutGDEh1023	H04	GDEhDisVCh_40030	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	5.0	0.0		0.0			0.0			0.0			N	N	N	N	N	26335.0	single nucleotide variant	NM_000033.4(ABCD1):c.1165C>G (p.Arg389Gly)	215.0	ABCD1	HGNC:61	Pathogenic	1.0	May 29, 2023	128624215.0	-	RCV000012048|RCV003488335	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900	Adrenoleukodystrophy|not provided	germline	germline	GRCh38	NC_000023.11	X	153736195.0	153736195.0	Xq28	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA278102,UniProtKB:P33897#VAR_000062,OMIM:300371.0005	3.0	11296.0	153736195.0	C	G	-	-	-	-	-	-	1165C>G 	Arg389Gly	NM_000033.4	2.0	Pathogenic	Pathogenic	11296	X	153736195.0	C	G	R	G	rs128624215	X	153001649	X	152654843	389	ABCD1	ENSG00000101986	ENST00000218104	ENSP00000218104	P33897	ABCD1_HUMAN	c.1165C>G	p.Arg389Gly	c.1165C>G	p.Arg389Gly	principal1	Y	1	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	0.999	0.77914	D	0.975	0.73364	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.46	0.71273	M	-5.91	0.88932	D	0.854	0.84989	0.7399	0.93647	D	0.8189	0.93891	D	9	0.97479206	0.97172	D	0.361811	0.92514	D	0.876	0.96308	0.848	0.95057	P33897	R389G	Loss of helix (P = 3e-04)| Gain of loop (P = 0.002)| Gain of sheet (P = 0.0036)| Loss of MoRF binding (P = 0.0526)| Loss of stability (P = 0.0594)	0.999475327291	0.99945	0.9960308022787095	0.99601	1.06563260916	0.76482	0.685714960098	0.65032	T	0.896327	0.97912	D	0.570331	0.96581	D	0.581464	0.96524	D	0.994085788726807	0.85058	D	0.963104	0.86253	D	0.7260219	0.79256	0.6468293	0.79120	0.7260219	0.79257	0.6468293	0.79121	-8.866	0.66907	D	0.8374	0.79060	P	0.999806454133949	0.98063	0.99975282	0.99678	0.926	0.96292	.	.	.	.	.	.	4.162932	0.62608	24.5	0.99748446393215284	0.84091	.	.	.	.	.	.	.	.	.	4.85	4.85	0.62327	.	.	2.238	0.42822	.	.	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Adrenoleukodystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.153736195C>G	ClinGen:CA278102|OMIM:300371.0005|UniProtKB:P33897#VAR_000062	C3661900|C0162309	300100	43	.	Arg	Gly	83.03	0.45564516129032256																																																																																																																																																																																																																																																																																																																																																																																																																																																																													113			83.03	Positively-charged	Arginine		ATP-binding cassette sub-family D member 1										-4.5			A:R389-B:D115 (PDBs: 7X07), B:R389-A:D115 (PDBs: 7X07)		A:R389-B:D115 (PDBs: 7X07), B:R389-A:D115 (PDBs: 7X07)			 R389-F385 (PAE:  1.0), R389-T393 (PAE: 1.0)	R389-T393 (PDBs: 7RR9, 7RRA, 7VR1, 7VWC, 7VZB, 7X07, 7YRQ), R389-F385 (PDBs: 7YRQ)	 R389-F385 (PAE:  1.0), R389-T393 (PAE: 1.0)	R389-L344 (PDBs: 7RR9, 7X07), R389-T393 (PDBs: 7RRA, 7VR1, 7VWC, 7VZB, 7YRQ), R389-F385 (PDBs: 7YRQ)							175									-61.7				-54.0						H (helix)	H (α-helix)	Turn											83.03	45.564518	70-90	10-90	300100	x-linked recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic hepatic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Genetic infertility	6	ADRENOLEUKODYSTROPHY	false	0.6933777748394039	0.573402852651401	false	false	false
KRAS	KRAS_Gly13Asp	B_13-14	-1.6558698671862377	0.1417194965294439	0.21602892128590412	3.0207259226056062	0.019366453268833718	0.03055669969760092	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.73600340336279	0.7502432872059421	0.5637112991700186	0.8130908345806064	0.8628176968729389	0.7586629619303791	0.6211067004857899	0.8536881843495427	0.6994361330407938	0.4499154246543373	0.6725713289851581	0.6731208760120221	0.8962192233749682	0.871947209396335	0.926745536120419	0.6775071736856999	0.827915245426726	0.7988859307135578	KRAS	Gly13Asp	NC_000012.12:25245347:C:T	38G>A	12	25245347	C	T	12	ENSG00000133703	3084	0	CCSBVarC006091	ALE00006091	ENSP00000308495.3	CEGS2	CegsMutGDEh1039	E06	GDEhDisVCh_40061	E09	1	CegsMutGDDh1039	E06	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	27619.0	single nucleotide variant	NM_004985.5(KRAS):c.38G>A (p.Gly13Asp)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Dec 18, 2024	112445441.0	-	RCV000013409|RCV000038269|RCV000144967|RCV000144968|RCV001092389|RCV001266168|RCV001813183|RCV001839444|RCV001526657|RCV000791297|RCV001857340|RCV004668723|RCV004549358|RCV004813034	MONDO:MONDO:0004988,MedGen:C0858252|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114|MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396|Human Phenotype Ontology:HP:0010815,MedGen:C3854181||MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651||MONDO:MONDO:0015278,MedGen:C2931038,OMIM:260350,Orphanet:1333	Breast adenocarcinoma|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|not provided|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome|Encephalocraniocutaneous lipomatosis|Nevus sebaceous|OCULOECTODERMAL SYNDROME, SOMATIC|RASopathy|Neoplasm|KRAS-related disorder|Familial pancreatic carcinoma	germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245347.0	25245347.0	12p12.1	criteria provided, multiple submitters, no conflicts	15.0	-	N	ClinGen:CA122534,UniProtKB:P01116#VAR_016029,OMIM:190070.0003	3.0	12580.0	25245347.0	C	T	-	-	-	Oncogenic	Jul 31, 2024	criteria provided, single submitter	38G>A 	Gly13Asp	NM_004985.5	2.0	Pathogenic	Pathogenic	12580	12	25245347.0	C	T	G	D	rs112445441	12	25398281	12	25289548	13	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.38G>A	p.Gly13Asp	c.38G>A	p.Gly13Asp	alternative1	Y	1	.	Plus_Clinical	-	GGC	2	0	C	./.	./.	./.	./.	0.032	0.54841	D	0.023	0.60671	D	0.803	0.45147	P	0.506	0.47822	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.025	0.86187	M	-5.4	0.92581	D	0.977	0.98762	0.5692	0.91461	D	0.6901	0.89270	D	10	0.9007832	0.89322	D	0.225927	0.87991	D	0.832	0.94675	0.722	0.85604	P01116	G13D	Gain of catalytic residue at A11 (P = 0)| Gain of solvent accessibility (P = 0.0648)| Loss of ubiquitination at K16 (P = 0.1191)| Loss of methylation at K16 (P = 0.1236)| Gain of relative solvent accessibility (P = 0.1684)	0.974405323578	0.97388	0.9548591274127232	0.95442	2.43727951051	0.97301	0.92631560564	0.98765	D	0.897336	0.97939	D	0.43077	0.91511	D	0.380995	0.91406	D	0.993683218955994	0.84461	D	0.853715	0.56129	D	0.91416115	0.92578	0.8911059	0.94268	0.90101796	0.91352	0.8511729	0.91471	-9.831	0.73003	D	0.998	0.98262	P	0.999983137957112	0.99579	0.99862206	0.98875	0.995	0.99826	.	.	.	.	.	.	4.988767	0.82721	27.9	0.99835685265907259	0.91720	0.894850	0.83365	D	0.645709001054705	0.75963	6.423009	0.687742056596172	0.81343	7.528909	5.68	5.68	0.88004	.	.	7.892	0.85894	5.998000	0.52513	0.58	0.29757	1.0	0.71675	1.000000	0.68239	0.999	0.91597	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5	1612796	3.100210e-06	0	5	1179366	4.239570e-06	0	0	74896	0.000000e+00	0	0	912	0.000000e+00	0	0	59938	0.000000e+00	0	0	29526	0.000000e+00	0	0	44868	0.000000e+00	0	0	63986	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179366	4.239570e-06	0	0	90796	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Juvenile_myelomonocytic_leukemia|OCULOECTODERMAL_SYNDROME,_SOMATIC|Noonan_syndrome_and_Noonan-related_syndrome|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Inborn_genetic_diseases|Acute_myeloid_leukemia|not_provided|RASopathy|Breast_adenocarcinoma|Ovarian_neoplasm|Non-small_cell_lung_carcinoma|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|KRAS-related_disorder	criteria_provided,_conflicting_classifications	NC_000012.12:g.25245347C>T	ClinGen:CA122534|OMIM:190070.0003|UniProtKB:P01116#VAR_016029	C0349639|C5681679|C0406612|C0009404|C0040136|C0950123|C0023467|C3661900|C5555857|C0858252|C0919267|C0007131|C2674723|C3854181	607785|613001|601626|614470	86834|98733|2396|100087|519|536391|268114	Small GTP-binding domain	Gly	Asp	94.74	0.2857142857142857																																																																																																																																																																																					-0.085						-0.346	1 mutation(s) (Gly13Ter: -1.068)					0.006						-0.065				0.302				-0.19		-0.047		-0.224						-0.039						0.043		-0.13		-0.13		-0.054		0.429																																																																																																																																																																																																																																						24			94.74	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine	GTP	GTPase KRas; GTPase KRas, N-terminally processed								0.7716		-0.4								 G13-K117 (PAE:  1.5)	G13-K117 (PDBs: 4L8G, 4LDJ, 4LYJ, 5OCG, 5V9O, 6GJ6, 6GJ7, 6GJ8, 6GOD, 6M9W, 6MBQ, 6MQG, 6T5B, 6T5V, 6V5L, 6ZL5, 7LGI, 7MQU, 7R0N, 8AFB, 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B78, 8JHL, 8QUG, 3GFT, 4LPK, 4LRW, 4LUC, 4LV6, 4LYF, 4LYH, 4M1O, 4M1S, 4M1T, 4M1W, 4M1Y, 4M21, 4M22, 4OBE, 5KYK, 5UK9, 5V9L, 5VQ2, 6BOF, 6MBT, 6MBU, 6MNX, 6MQN, 6MS9, 6MTA, 6O36, 6O46, 6P0Z, 6QUU, 6QUV, 6QUW, 6QUX, 6VC8, 6ZLI, 7ACA, 7ACF, 7ACH, 7ACQ, 7O70, 7R0M, 7R0Q, 8AFC, 8AFD, 8AQ7, 8B6I, 8ECR, 8T71, 8T72, 2MSC, 2MSD, 2MSE, 5MLA, 5MLB, 5O2S, 5O2T, 5TAR, 5TB5, 5UFE, 5WLB, 5WPM, 6H46, 6H47, 6OB2, 6PTS, 6PTW, 6V65, 6VJJ, 6W4E, 6W4F, 6XHB, 6YXW, 7NY8, 7SCW, 7VVB, 8QU8, 8T74, 8T75, 8TBF), G13-Y32 (PDBs: 7KYZ)	 G13-Y32 (PAE:  9.5)	G13-Y32 (PDBs: 5OCG, 6GJ6, 6GJ7, 6GJ8, 6GOD, 3GFT, 6MNX, 6MTA, 6QUU, 6QUV, 6QUW, 6QUX, 6VC8, 6ZLI, 7ACA, 7ACF, 8T72, 6OB2, 6PTS, 6PTW, 6V65, 6VJJ, 6W4E, 6XHB, 7VVB, 8T75)							75									68.8		Pocket 1: Mean pLDDT: 82.52, Volume: 1126.64 Å³, Druggability score: 0.77		3.2						C (loop/coil)	T (turn)	Beta strand											94.74	28.57143	>90	10-90	607785;614470;613001;260350	multiple	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	JUVENILE MYELOMONOCYTIC LEUKEMIA; RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; PANCREATIC CANCER	false	0.7502432872059421	0.73600340336279	false	false	false
BRCA1	BRCA1_Cys44Tyr	B_13-14	-0.8137193508629426	0.4426010528135844	0.535043044856928	6.484348876448501	0.00033909230654164806	0.0010234118133288226	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8291212992445647	0.8691548078027695	0.8003056204326958	0.8922985657344886	0.8865844128343285	0.8867189006577947	0.829842730435466	0.9052019358784729	0.8194936131840005	0.742269625955619	0.822797368465504	0.78098040748631	0.9435950708801233	0.8679668897901843	0.9651035182849766	0.8583416149097727	0.9155122471400351	0.8772621910028194	BRCA1	Cys44Tyr	NC_000017.11:43115729:C:T	131G>A	17	43115729	C	T	17	ENSG00000012048	14613	0	CCSBVarC003296	ALE00003296	ENSP00000417148.1	CEGS2	CegsMutGDEh1010	C05	GDEhDisVCh_40059	D03	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	7.0	0.0		0.0			0.0			0.0			N	N	N	N	N	68866.0	single nucleotide variant	NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357446.0	-	RCV000077486|RCV000235119|RCV000509871|RCV001386839	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115729.0	43115729.0	17q21.31	reviewed by expert panel	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00114,ClinGen:CA000861	2.0	54199.0	43115729.0	C	T	-	-	-	-	-	-	131G>A 	Cys44Tyr	NM_007294.4	3.0	Pathogenic	Pathogenic	54199	17	43115729.0	C	T	C	Y	rs80357446	17	41267746	17	38521272	44	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.131G>A	p.Cys44Tyr	c.131G>A	p.Cys44Tyr	principal2	Y	1	.	.	-	TGC	2	0	C	C/C	C/C	C/C	C/C	0.016	0.91343	D	0.0	0.92967	D	0.994	0.66535	D	0.84	0.60164	P	.	0.99291	.	.	.	.	4.005	0.96727	H	-2.52	0.98949	D	.	0.95504	1.0538	0.98195	D	0.9802	0.99389	D	10	0.99267334	0.99802	D	0.72305	0.97758	D	0.853	0.95458	0.99	0.99894	E9PFC7	C44Y	Loss of disorder (P = 0.0407)| Loss of helix (P = 0.1299)| Loss of catalytic residue at I42 (P = 0.1404)| Loss of stability (P = 0.2362)| Loss of ubiquitination at K45 (P = 0.2592)	0.998941922364	0.99891	.	0.91966	.	0.18552	0.729841411114	0.71433	T	0.47499	0.93038	T	0.562886	0.96259	D	0.57077	0.96199	D	0.987259089946747	0.77622	D	.	0.90786	.	0.92106634	0.93252	0.6351263	0.78468	0.91385037	0.92549	0.69650024	0.81922	-13.581	0.94506	D	0.9966	0.97393	LP	0.999496437666765	0.96769	0.99973255	0.99655	0.94	0.97139	.	.	.	.	.	.	5.096311	0.85159	28.5	0.99228087188246783	0.56189	0.829447	0.74743	D	0.895383086000917	0.91485	10.93124	0.837834818254792	0.92242	11.33957	5.97	5.97	0.96929	.	.	3.475	0.52993	7.600000	0.61593	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.996	0.76032	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43115729C>T	BRCA1-HCI:BRCA1_00114|ClinGen:CA000861	C3661900|C0027672|C0677776|C2676676	604370	140162|145|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Tyr	92.79	0.02962962962962963			-3.161	3 mutation(s) (Cys44Phe: -4.612, Cys44Val: -4.385, Cys44Asn: -4.066)	-2.621	5 mutation(s) (Cys44Phe: -5.060, Cys44Ter: -4.611, Cys44Tyr: -4.428, Cys44Ala: -3.794, Cys44Arg: -3.759)																																																																																							2.8		-0.683	1 mutation(s) (Cys44Tyr: 0.835)																			-2.223		-2.155																																																																																																																																																																																																																																																																																																																																																								3			93.31	Special, a very reactive sulfhydryl group	Cysteine		Breast cancer type 1 susceptibility protein										2.5								 C44-C24 (PAE:  1.5), C44-K32 (PAE: 2.0), C44-M48 (PAE: 1.0), C44-C27 (PAE: 2.0)	C44-E29 (PDBs: 8GRQ)	 C44-E33 (PAE:  1.5), C44-C24 (PAE: 1.5), C44-K32 (PAE: 2.0), C44-I31 (PAE: 1.5), C44-M48 (PAE: 1.0)	C44-I31 (PDBs: 1JM7, 7LYB, 8GRQ), C44-E33 (PDBs: 1JM7, 7LYB), C44-C24 (PDBs: 7LYB, 8GRQ), C44-K32 (PDBs: 7LYB), C44-C27 (PDBs: 8GRQ), C44-E29 (PDBs: 8GRQ)							121									-61.0				137.6						B (undefined)	E (parallel sheets)											RING-type	92.79	2.9629629	>90	<10	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.8691548078027695	0.8291212992445647	false	false	false
F9	F9_Glu79Asp	B_13-14	-2.573421637299557	0.03682372229763606	0.07250856658606687	-0.09341300931805499	0.9281929053186053	0.9410132493147186	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5980394553956037	0.5959584746364119	0.6819472257853532	0.7017271310142561	0.6362594373988569	0.7544706726811412	0.7719802647068146	0.6279614882190551	0.7415034485337275	0.6212138840435375	0.5733383591697054	0.594972295969391	0.7369610806554678	0.6445573865786588	0.6619508134947846	0.7426805675271689	0.6185785901031184	0.6011066148218164	F9	Glu79Asp	NC_000023.11:139537158:A:C	237A>C	23	139537158	A	C	X	ENSG00000101981	52861	0	CCSBVarC004375	ALE00004375	ENSP00000218099.2	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25613.0	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	137852229.0	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158.0	139537158.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1.0	10574.0	139537158.0	A	C	-	-	-	-	-	-	237A>C 	Glu79Asp	NM_000133.4		Pathogenic	Pathogenic	10574	X	139537158.0	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	86.43	0.9072164948453608																																																																																																																																																																																																																																																																																																																																																																																																															1.049		1.01	2 mutation(s) (Glu79Gln: 1.209, Glu79Lys: 1.253)	0.965	1 mutation(s) (Glu79Thr: 1.137)	0.759	1 mutation(s) (Glu79Gln: 1.103)	0.99	2 mutation(s) (Glu79Asn: 1.294, Glu79Pro: 1.295)																																																					176			86.43	Negatively-charged	Glutamic Acid		Coagulation factor IX; Coagulation factor IXa light chain							Gla			-3.5								 E79-R75 (PAE:  3.5)		 E79-R75 (PAE:  3.5)							4-carboxyglutamate	146									49.6				22.1						C (loop/coil)	C (loop/coil)	Beta strand											86.43	90.72165	70-90	$\geqslant$90	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.5959584746364119	0.5980394553956037	false	false	false
F9	F9_Pro333Leu	B_13-14	-4.0195915697666935	0.010124880784179249	0.027468798763494402	2.5484361537213944	0.03819069027630669	0.05588510100241051	2025_01_Batch_13-14	false	true	false	false	false	false	false	true	false	false	false	false	0.9735559982135145	0.980555392385528	0.6926656276833538	0.8863011072048483	0.8002522481895761	0.8169093842538253						0.9593743374878655	0.8169093842538253	0.8002522481895761	0.8863011072048483	0.6926656276833538	0.980555392385528	0.9877376589391633	F9	Pro333Leu	NC_000023.11:139561683:C:T	998C>T	23	139561683	C	T	X	ENSG00000101981	52861	0	CCSBVarC004385	ALE00004385	ENSP00000218099.2	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25644.0	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852252.0	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683.0	139561683.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255375,OMIM:300746.0048	1.0	10605.0	139561683.0	C	T	-	-	-	-	-	-	998C>T 	Pro333Leu	NM_000133.4		Pathogenic	Pathogenic	10605	X	139561683.0	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	97.66	0.09558823529411764																																																																																																																																																																																																																																																																																																																																																																																																															0.386		0.287		0.258		0.243		0.258																																																						13			97.66	Special, No backbone hydrogen	Proline		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1	0.2107		1.6			A:P333-B:G344 (PDBs: 6X5J, 6X5L), H:P333-L:G222 (PDBs: 8OL9)	A:P333-B:G344 (PDBs: 6X5J, 6X5L), H:P333-L:G222 (PDBs: 8OL9), H:P333-L:C221 (PDBs: 8OL9)				 P333-G179 (PAE:  1.0)			P333-I256 (PDBs: 8OL9), P333-V257 (PDBs: 8OL9)							115									-65.3		Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21		154.6						H (helix)	P (polyproline helix)												97.66	9.558824	>90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.980555392385528	0.9735559982135145	true	false	true
CTCF	CTCF_Tyr226Cys	B_13-14	-2.0081090165748017	0.08460141469372065	0.14300791928075274	7.012101443406622	0.00020929367632655448	0.0007046860478150963	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7770067903995492	0.7982105674620472	0.687289967705276	0.667792842192819	0.7211281635388158	0.7544742003700537	0.7528144524726907	0.7467126333607229	0.7078396773204285	0.6669402241529324	0.7913141650965285	0.769509084351315	0.7561339482674166	0.6955436937169087	0.6277460070652096	0.7076397112576194	0.8051069698275658	0.7845044964477834	CTCF	Tyr226Cys	NC_000016.10:67611509:A:G	677A>G	16	67611509	A	G	16	ENSG00000102974	6173	0	CCSBVarC010845	ALE00015425	ENSP00000264010.4																																	1244743.0	single nucleotide variant	NM_006565.4(CTCF):c.677A>G (p.Tyr226Cys)	10664.0	CTCF	HGNC:13723	Pathogenic	1.0	Sep 17, 2024	2142826609.0	-	RCV002471133|RCV001658992	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MedGen:C3661900	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|not provided	germline	germline	GRCh38	NC_000016.10	16	67611509.0	67611509.0	16q22.1	criteria provided, multiple submitters, no conflicts	2.0	-	N	-	2.0	1254810.0	67611509.0	A	G	-	-	-	-	-	-	677A>G 	Tyr226Cys	NM_006565.4	2.0	Pathogenic	Pathogenic	1254810	16	67611509.0	A	G	Y	C	rs2142826609	16	67645412	16	66202913	226	CTCF	ENSG00000102974	ENST00000644753	ENSP00000493495	P49711	CTCF_HUMAN	c.677A>G	p.Tyr226Cys	c.677A>G	p.Tyr226Cys	principal4	Y	.	.	.	+	TAC	2	0	A	A/A	A/A	A/A	A/A	.	0.41793	.	.	0.57928	.	0.999	0.77914	D	0.994	0.82066	D	.	0.93300	.	.	.	.	0	0.06502	N	.	0.63348	.	.	0.82100	-1.1031	0.03749	T	0.0480	0.20364	T	10	0.539923	0.63354	D	0.02103	0.43507	T	.	0.68503	0.299	0.26397	P49711	Y226C	Loss of helix (P = 0.0123)| Loss of phosphorylation at Y226 (P = 0.0176)| Gain of loop (P = 0.0195)| Gain of sheet (P = 0.0507)| Loss of solvent accessibility (P = 0.1322)	.	0.57041	.	0.57532	.	0.84168	0.925917685032	0.98740	D	0.788068	0.94419	D	0.0396152	0.56698	T	-0.180872	0.56141	T	0.918294548988342	0.57406	D	.	0.94986	.	0.5466574	0.69471	0.56271493	0.74444	0.5466574	0.69472	0.56271493	0.74445	-4.564	0.31751	T	.	0.82640	.	0.983475363820255	0.86213	0.91155195	0.91636	0.692	0.82910	.	.	.	.	.	.	4.655767	0.74309	26.1	0.99793481628287251	0.87938	0.923554	0.89985	D	0.63659219199805	0.75371	6.317652	0.680657746933852	0.80807	7.405549	5.5	5.5	0.81360	6.5	0.99641	8.886	0.92093	11.212000	0.89448	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.991	0.66489	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614212	6.194970e-07	0	0	75060	0.000000e+00	0	0	75060	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29604	0.000000e+00	0	0	44890	0.000000e+00	0	0	64044	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180026	0.000000e+00	0	0	91084	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.67611509A>G	.	C3809686|C3661900	615502	363611	.	Tyr	Cys	38.83	0.6261261261261262																																																																																																																																																																																																																																																																																																																																																																																																																																																																													139			38.83	Aromatic	Tyrosine		Transcriptional repressor CTCF										-1.3			C:Y226-A:W334 (PDBs: 6QNX), C:Y226-A:D326 (PDBs: 6QNX)	C:Y226-A:D326 (PDBs: 6QNX), H:Y226-D:K333 (PDBs: 7W1M)														181									-58.6	Morphology: KDVDVsVyDFEEEQQ			111.4						C (loop/coil)	C (loop/coil)	Helix											38.83	62.61261	$\leqslant$50	10-90	615502	autosomal dominant	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21	false	0.7982105674620472	0.7770067903995492	false	false	false
RPS19	RPS19_Arg62Trp	B_13-14	2.4791241841752996	0.042264292882514945	0.08113045166392316	-2.714487908231321	0.03000369106244107	0.044925020949342746	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8372454360953123	0.7611851939690722	0.7319177110026287	0.47939183406502656	0.5496642658530178	0.7340936507731264	0.7340936507731264	0.5496642658530178	0.47939183406502656	0.7319177110026287	0.7611851939690722	0.693973016650804						0.9805178555398207	RPS19	Arg62Trp	NC_000019.10:41869042:C:T	184C>T	19	41869042	C	T	19	ENSG00000105372	3441	0	CCSBVarC000467	ALE00000467	ENSP00000470972.1	RC4	RC4_Mut_GDEh1010	F11	GDEhDisVCh_40042	C02	2	RC4_Mut_GDDh1010	F11	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	21353.0	single nucleotide variant	NM_001022.4(RPS19):c.184C>T (p.Arg62Trp)	6223.0	RPS19	HGNC:10402	Pathogenic	1.0	Mar 09, 2023	104894711.0	-	RCV000033183|RCV000497714|RCV001065746|RCV003415668	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|MedGen:C3661900|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124|	Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia|RPS19-related disorder	germline	germline	GRCh38	NC_000019.10	19	41869042.0	41869042.0	19q13.2	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA130763,UniProtKB:P39019#VAR_006924,OMIM:603474.0002	3.0	6314.0	41869042.0	C	T	-	-	-	-	-	-	184C>T 	Arg62Trp	NM_001022.4	2.0	Pathogenic	Pathogenic	6314	19	41869042.0	C	T	R	W	rs104894711	19	42373112	19	47064952	62	RPS19	ENSG00000105372	ENST00000598742	ENSP00000470972	P39019	RS19_HUMAN	c.184C>T	p.Arg62Trp	c.184C>T	p.Arg62Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	./.	./.	./.	./.	.	.	.	0.019	0.60067	D	0.987	0.61929	D	0.679	0.53438	P	0.97	0.96253	A	simple_aae	3.0	97.0	3.89	0.95985	H	.	.	.	0.96	0.96999	0.2823	0.87220	D	0.4950	0.80784	T	9	0.98888874	0.99322	D	0.794641	0.98386	D	.	.	0.982	0.99827	P39019	R62W	Gain of catalytic residue at A61 (P = 0.0262)| Loss of methylation at R67 (P = 0.0445)| Loss of disorder (P = 0.0768)| Loss of phosphorylation at T60 (P = 0.1237)| Loss of MoRF binding (P = 0.1355)	0.969246388482	0.96863	0.9363405839023272	0.93574	1.09019113237	0.77275	0.841621756554	0.88322	D	0.99269	0.99976	D	0.423948	0.91161	D	0.371195	0.91051	D	0.997496426105499	0.91622	D	.	0.75590	.	0.96338874	0.97581	0.87987745	0.93466	0.93570024	0.94732	0.88595665	0.93899	-12.316	0.86392	D	0.9544	0.90441	LP	0.999645938344676	0.97310	0.99993860	0.99939	0.169	0.41634	.	.	.	.	.	.	5.900132	0.94003	33.0	0.99907463222353998	0.97802	0.886495	0.81725	D	0.68503384224157	0.78536	6.914856	0.596564645006298	0.74551	6.180586	4.3	4.3	0.50482	.	.	3.204	0.5088	2.200000	0.31363	0.596	0.33565	0.995	0.38864	0.976000	0.30138	0.996	0.76032	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RPS19-related_disorder|Diamond-Blackfan_anemia|not_provided|Diamond-Blackfan_anemia_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.41869042C>T	ClinGen:CA130763|OMIM:603474.0002|UniProtKB:P39019#VAR_006924	C1260899|C3661900|C2676137	PS105650|105650	124|124	.	Arg	Trp	95.33	0.1814516129032258																																																																																																																																																																																																																																																																																																																																																																																																																																																																													45			95.33	Positively-charged	Arginine		Small ribosomal subunit protein eS19								0.032		-4.5								 R62-A58 (PAE:  1.0), R62-L66 (PAE: 1.0)	R62-L66 (PDBs: 5A2Q, 5FLX, 5OA3, 6G18, 6G4S, 6G4W, 6ZMT, 6ZN5, 7K5I, 7TQL, 7WTX, 7WTZ, 7WU0, 8T4S), R62-Q11 (PDBs: 6G5H, 6G5I, 6YBS, 6ZLW, 6ZOJ, 6ZOL, 6ZUO, 6ZVH, 6ZXD, 6ZXF, 6ZXG, 6ZXH, 7R4X, 7WTT, 7WTU, 7WTV, 7WTW, 8PPK, 8T4S), R62-A58 (PDBs: 6ZV6, 6ZXE, 8T4S)	 R62-A58 (PAE:  1.0), R62-L66 (PAE: 1.0)	R62-L66 (PDBs: 5A2Q, 5FLX, 6G4S, 6G4W, 6G51, 6G53, 6G5H, 6G5I, 6ZMT, 6ZUO, 6ZXE, 6ZXF, 6ZXG, 6ZXH, 7TQL, 7WTV, 7WTX, 8T4S), R62-V15 (PDBs: 5OA3, 6G18, 6YBS, 6ZLW, 6ZN5, 6ZOJ, 6ZOL, 6ZV6, 6ZVH, 6ZXD, 7K5I, 7R4X, 7WTT, 7WTU, 7WTW, 7WTZ, 7WU0, 8PPK, 8T4S), R62-A58 (PDBs: 8T4S)							175									-60.1		Pocket 4: Mean pLDDT: 95.63, Volume: 462.36 Å³, Druggability score: 0.03		-41.6				dbSNP: rs104894711; Variant type: LP/P; AA change: Arg62Trp; PTM type: Phosphorylation; PTM morphology: ytrAAsTAR*HL; Var class: II&rs1555841301		H (helix)	H (α-helix)	Helix											95.33	18.145163	>90	10-90	105650	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare inborn errors of metabolism; Inherited cancer-predisposing syndrome	4	DIAMOND-BLACKFAN ANEMIA 1	false	0.7611851939690722	0.8372454360953123	false	false	false
BRCA1	BRCA1_Gly666Val	B_13-14	0.8111849338867764	0.4439619283781052	0.5360096606840588	5.301094274612864	0.0011220347033239419	0.0026329075199481244	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8503560016053033	0.8588837134992221	0.7395021414858918	0.9278493154353157	0.8629987168740807	0.8835768777682322	0.8436866311488849	0.9063040766810607	0.9145988231171143	0.7090823521488306	0.8684480423015456	0.8489232660401007	0.9234671243875797	0.8196933570671006	0.9410998077535171	0.769921930822953	0.8493193846968986	0.851788737170506	BRCA1	Gly666Val	NC_000017.11:43051086:C:A	1997G>T	17	43051086	C	A	17	ENSG00000012048	14613	0	CCSBVarC011818	ALE00013499	ENSP00000417148.1																																	404710.0	single nucleotide variant	NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jul 18, 2018	863224765.0	-	RCV000477771|RCV001023895|RCV000502156|RCV001865421|RCV001572739	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051086.0	43051086.0	17q21.31	reviewed by expert panel	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10590929	2.0	417832.0	43051086.0	C	A	-	-	-	-	-	-	5309G>T 	Gly1770Val	NM_007294.4	3.0	Pathogenic	Pathogenic	417832	17	43051086.0	C	A	G	V	rs863224765	17	41203103	17	38456629	1770	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	.	.	c.5309G>T	p.Gly1770Val	principal2	Y	1	.	.	-	GGG	2	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.83643	.	0.583	0.77914	P	0.055	0.73565	B	.	0.99291	.	.	.	.	2.215	0.62356	M	.	0.90790	.	.	0.94206	0.6824	0.92930	D	0.7985	0.93160	D	10	.	0.91415	.	0.786529	0.98318	D	.	0.94788	.	.	.	.	.	.	0.93785	.	0.83211	.	0.40658	0.485455960035	0.36760	T	0.327304	0.69606	T	0.420504	0.90984	D	0.366249	0.90872	D	0.977009236812592	0.71446	D	.	0.91429	.	0.58132803	0.71391	0.22660044	0.47467	0.58380777	0.71528	0.32384387	0.58085	-9.173	0.85385	D	.	0.77473	.	0.994521859597463	0.90703	0.99981505	0.99752	0.916	0.95687	.	.	.	.	.	.	3.272588	0.44882	22.0	0.99741871120433134	0.83570	0.471283	0.51522	N	0.484917239323781	0.66032	4.920639	0.444495820101055	0.64170	4.689884	5.06	4.09	0.46976	4.36	0.82260	2.72	0.47021	4.864000	0.45576	0.599	0.40292	0.981	0.35482	1.000000	0.68239	0.98	0.58201	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613796	1.239310e-06	0	1	91068	1.098080e-05	0	0	74882	0.000000e+00	0	0	912	0.000000e+00	0	0	59982	0.000000e+00	0	0	29600	0.000000e+00	0	0	44870	0.000000e+00	0	0	63966	0.000000e+00	0	0	6056	0.000000e+00	0	0	1179952	0.000000e+00	0	1	91068	1.098080e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Malignant_tumor_of_breast|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43051086C>A	ClinGen:CA10590929	C0006142|C0027672|C0677776|C3661900|C2676676	604370	140162|145|145	.	Gly	Val	84.89	0.3333333333333333																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																84.89	33.333336	70-90	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.8588837134992221	0.8503560016053033	false	false	false
ZC4H2	ZC4H2_Val63Leu	B_13-14	-3.772508957351957	0.009520442136421024	0.024888074606554397	-3.575493464130579	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8056412802606155	0.9211600478261888	0.6129770472577996	0.6112535300418251	0.6230905069219581	0.6150421036922161	0.6180901787972732	0.5817346449125665	0.520673116986776	0.6256732206843896	0.8780189617774373	0.7007216358034372	0.611994028587159	0.6644463689313497	0.7018339430968742	0.6002808738312095	0.9643011338749403	0.9105609247177939	ZC4H2	Val63Leu	NC_000023.11:64921855:C:G	187G>C	23	64921855	C	G	X	ENSG00000126970	4320	0	CCSBVarC005916	ALE00005916	ENSP00000363972.3	CEGS2	CegsMutGDEh1032	H01	GDEhDisVCh_40034	G11	2	CegsMutGDDh1032	H01	NULL	NULL	NULL	NULL	NULL	NULL	1.0	3.0	1.0	4.0	0.0			0.0			0.0			N	N	N	N	N	65651.0	single nucleotide variant	NM_018684.4(ZC4H2):c.187G>C (p.Val63Leu)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	May 02, 2013	398122938.0	-	RCV000043676	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64921855.0	64921855.0	Xq11.2	no assertion criteria provided	1.0	-	N	ClinGen:CA143907,UniProtKB:Q9NQZ6#VAR_069621,OMIM:300897.0001	1.0	50980.0	64921855.0	C	G	-	-	-	-	-	-	187G>C 	Val63Leu	NM_018684.4		Pathogenic	Pathogenic	50980	X	64921855.0	C	G	V	L	rs398122938	X	64141735	X	64058460	63	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.187G>C	p.Val63Leu	c.187G>C	p.Val63Leu	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.052	0.92967	T	0.992	0.64752	D	0.983	0.75798	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.465	0.71362	M	-2.24	0.50191	N	0.845	0.84047	-0.1655	0.78440	T	0.4181	0.76324	T	9	0.84414655	0.83403	D	0.205808	0.86973	D	0.743	0.91077	0.716	0.85070	Q9NQZ6	V63L	Gain of disorder (P = 0.0736)| Loss of ubiquitination at K59 (P = 0.0816)| Gain of stability (P = 0.1765)| Gain of glycosylation at K59 (P = 0.3702)| Gain of methylation at R67 (P = 0.5403)	0.884996165071	0.88298	0.8373184595511529	0.83593	1.97721070638	0.93584	0.891219079494	0.95406	D	0.512428	0.82640	D	0.470646	0.93309	D	0.438274	0.93226	D	0.97698700428009	0.71437	D	0.969003	0.92268	D	0.85009694	0.87173	0.87122726	0.92856	0.8581468	0.87783	0.87122726	0.92856	-7.039	0.54387	T	0.9994	0.99054	P	0.996518372777224	0.92210	0.99788480	0.98543	0.933	0.96717	.	.	.	.	.	.	4.346719	0.66797	25.0	0.99821887779931795	0.90510	.	.	.	.	.	.	.	.	.	5.56	5.56	0.83655	4.31	0.81542	7.641	0.82558	5.916000	0.51166	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64921855C>G	ClinGen:CA143907|OMIM:300897.0001|UniProtKB:Q9NQZ6#VAR_069621	C0796200	314580	3454|85283	.	Val	Leu	91.94	0.3380281690140845																																																																																																																																																																																																																																																																																																																																																																																																																																																																													48			91.94	Aliphatic	Valine		Zinc finger C4H2 domain-containing protein	Coiled coil							0.0136		4.2								 V63-K59 (PAE:  1.0), V63-R67 (PAE: 1.0)		 V63-K59 (PAE:  1.0), V63-R67 (PAE: 1.0)								117									-62.0		Pocket 3: Mean pLDDT: 80.71, Volume: 332.58 Å³, Druggability score: 0.01		-40.4				dbSNP: rs398122938; Variant type: LP/P; AA change: Val63Leu; PTM type: Ubiquitylation; PTM morphology: LLLQEkMAHV*E; Var class: II		H (helix)	H (α-helix)												91.94	33.802814	>90	10-90	314580	x-linked recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	false	0.9211600478261888	0.8056412802606155	false	false	false
FARS2	FARS2_Asp142Tyr	B_13-14	-2.483576660753394	1.0	1.0	-0.12544325386242416	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6843409001257872	0.6642306296020684	0.5322111442037858	0.6858267843422259	0.6662720344208183	0.5784112484446433	0.581770099185536	0.6466568110378409	0.6620624154111983	0.5270831443648476	0.6711374057076634	0.6880864861268798	0.5750523977037505	0.6858872578037957	0.7095911532732536	0.5373391440427239	0.6573238534964733	0.6805953141246945	FARS2	Asp142Tyr	NC_000006.12:5368994:G:T	424G>T	6	5368994	G	T	6	ENSG00000145982	12653	0	CCSBVarC011914	ALE00013136	ENSP00000274680.4																																	247571.0	single nucleotide variant	NM_006567.5(FARS2):c.424G>T (p.Asp142Tyr)	10667.0	FARS2	HGNC:21062	Pathogenic	1.0	Jun 13, 2018	145555213.0	-	RCV000239526	MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722	Hereditary spastic paraplegia 77	germline	germline	GRCh38	NC_000006.12	6	5368994.0	5368994.0	6p25.1	criteria provided, single submitter	3.0	-	N	ClinGen:CA10586223,UniProtKB:O95363#VAR_077044,OMIM:611592.0005	3.0	253159.0	5368994.0	G	T	-	-	-	-	-	-	424G>T 	Asp142Tyr	NM_006567.5	1.0	Pathogenic	Pathogenic	253159	6	5368994.0	G	T	D	Y	rs145555213	6	5369227	6	5314226	142	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.424G>T	p.Asp142Tyr	c.424G>T	p.Asp142Tyr	principal1	Y	1	YES	Select	+	GAC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.425	0.98710	H	-8.05	0.96618	D	0.974	0.98479	0.6034	0.91916	D	0.6504	0.87777	D	10	0.93858135	0.93109	D	0.279745	0.90164	D	0.809	0.93796	0.791	0.91245	O95363	D142Y	Loss of solvent accessibility (P = 0.0152)| Loss of relative solvent accessibility (P = 0.0186)| Loss of ubiquitination at K139 (P = 0.0246)| Loss of disorder (P = 0.0373)| Loss of phosphorylation at Y144 (P = 0.0593)	0.952766475807	0.95187	.	0.93477	.	0.62839	0.784124493599	0.79514	T	0.511236	0.82575	D	0.286301	0.81716	D	0.342604	0.89952	D	0.999397754669189	0.97208	D	0.961304	0.85467	D	0.9639511	0.97638	0.8991653	0.94847	0.95198554	0.96412	0.9112432	0.95718	-13.759	0.92263	D	0.6133	0.69372	P	0.998275433556404	0.94209	0.97490570	0.95052	0.995	0.99826	.	.	.	.	.	.	5.212362	0.87485	29.2	0.99564433392369855	0.72048	0.890111	0.82419	D	0.948429081889747	0.93888	12.37248	0.847583306341376	0.92834	11.68468	5.38	4.49	0.54123	2.52	0.46380	9.553	0.97226	9.744000	0.81475	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109406	0.000000e+00	0	0	208056	0.000000e+00	0	1	236838	4.222300e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16212	0.000000e+00	0	0	30522	0.000000e+00	0	0	6210	0.000000e+00	0	0	13406	0.000000e+00	0	0	16734	0.000000e+00	0	0	89506	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	1	17688	5.653550e-05	0	0	21632	0.000000e+00	0	0	102650	0.000000e+00	0	0	30526	0.000000e+00	0	1	17688	5.653550e-05	0	.	1	1614168	6.195140e-07	0	1	44882	2.228060e-05	0	0	75044	0.000000e+00	0	0	910	0.000000e+00	0	0	60024	0.000000e+00	0	0	29604	0.000000e+00	0	1	44882	2.228060e-05	0	0	64038	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180018	0.000000e+00	0	0	91082	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_spastic_paraplegia_77	criteria_provided,_single_submitter	NC_000006.12:g.5368994G>T	ClinGen:CA10586223|OMIM:611592.0005|UniProtKB:O95363#VAR_077044	C5569007	617046	466722	Phenylalanyl-tRNA synthetase	Asp	Tyr	96.08	0.3496932515337423																																																																																																																																																																																																																																																																																																																																																																																																																																																																													57			96.08	Negatively-charged	Aspartic Acid												-3.5								 D142-R180 (PAE:  1.0)	D142-R180 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP)	 D142-R180 (PAE:  1.0)	D142-N379 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X), D142-R180 (PDBs: 8P8X, 3TUP), D142-R179 (PDBs: 8P8X)							132									-115.7				-12.1						C (loop/coil)	T (turn)	Turn											96.08	34.969322	>90	10-90	617046	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE	false	0.6642306296020684	0.6843409001257872	false	false	false
FANCC	FANCC_Leu496Arg	B_13-14	-1.549280011711085	0.1652455454136042	0.24166844696782852	-6.025745376237592	0.0005285343966927559	0.0014432449671595343	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9024150512233631	0.9315673705639625	0.6726761288349599	0.7478994911892716	0.7406141029445161	0.6978147771298621	0.6469733607134508	0.6219740715848738	0.7620244379133317	0.6387714611286607	0.896075315915866	0.8682815489366478	0.7486561935462733	0.8592541343041584	0.7337745444652113	0.7065807965412592	0.9670594252120591	0.9365485535100783	FANCC	Leu496Arg	NC_000009.12:95107112:A:C	1487T>G	9	95107112	A	C	9	ENSG00000158169	7699	0	CCSBVarC001230	ALE00001230	ENSP00000289081.3	RC4	RC4_Mut_GDEh1009	C09	GDEhDisVCh_40044	F07	2	RC4_Mut_GDDh1009	C09	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	27089.0	single nucleotide variant	NM_000136.3(FANCC):c.1487T>G (p.Leu496Arg)	2176.0	FANCC	HGNC:3584	Pathogenic	1.0	Aug 01, 1999	121917785.0	-	RCV000012830	MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84	Fanconi anemia complementation group C	germline	germline	GRCh38	NC_000009.12	9	95107112.0	95107112.0	9q22.32	no assertion criteria provided	1.0	-	N	ClinGen:CA256207,UniProtKB:Q00597#VAR_005232,OMIM:613899.0008	1.0	12050.0	95107112.0	A	C	-	-	-	-	-	-	1487T>G 	Leu496Arg	NM_000136.3		Pathogenic	Pathogenic	12050	9	95107112.0	A	C	L	R	rs121917785	9	97869394	9	96909215	496	FANCC	ENSG00000158169	ENST00000289081	ENSP00000289081	Q00597	FANCC_HUMAN	c.1487T>G	p.Leu496Arg	c.1487T>G	p.Leu496Arg	principal1	Y	1	YES	Select	-	CTC	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.99	0.78943	D	0.74	0.84487	A	simple_aae	26.0	74.0	2.395	0.69015	M	-5.08	0.82920	D	0.944	0.95151	-0.0954	0.80115	T	0.3623	0.72245	T	9	0.9910704	0.99622	D	0.041256	0.59673	D	0.522	0.79598	0.932	0.98955	Q00597	L496R	Gain of MoRF binding (P = 0.0166)| Gain of methylation at L496 (P = 0.0294)| Gain of solvent accessibility (P = 0.0584)| Gain of relative solvent accessibility (P = 0.09)| Loss of stability (P = 0.101)	0.91854953846	0.91711	0.7235648123959582	0.72155	0.400379318551	0.40752	0.527930855751	0.42681	T	0.502392	0.82079	D	0.30647	0.83356	D	0.202447	0.83141	D	0.990214049816132	0.80281	D	.	0.39699	.	0.87331074	0.88974	0.7835274	0.87085	0.8566318	0.87667	0.77439195	0.86521	-6.134	0.47446	T	0.5133	0.65167	A	0.939888730715306	0.79344	0.95983505	0.93950	0.809	0.89444	.	.	.	.	.	.	3.643055	0.51746	23.1	0.99737588940490851	0.83280	0.455600	0.50611	N	0.551271328372298	0.70000	5.460852	0.462495863549082	0.65336	4.834584	4.94	4.94	0.64600	5.03	0.90264	5.392	0.66097	11.055000	0.85376	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.023	0.12113	167	0.93511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Fanconi_anemia_complementation_group_C	no_assertion_criteria_provided	NC_000009.12:g.95107112A>C	ClinGen:CA256207|OMIM:613899.0008|UniProtKB:Q00597#VAR_005232	C3468041	227645	84	.	Leu	Arg	88.47	0.012195121951219513																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			88.47	Aliphatic	Leucine		Fanconi anemia group C protein										3.8								 L496-H502 (PAE:  2.0), L496-S543 (PAE: 3.0), L496-L492 (PAE: 1.0)		 L496-H502 (PAE:  2.0), L496-S543 (PAE: 3.0), L496-L492 (PAE: 1.0)								131									-84.2				-26.7						H (helix)	H (α-helix)												88.47	1.2195121	70-90	<10	227645	autosomal recessive	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Inherited cancer-predisposing syndrome	6	FANCONI ANEMIA, COMPLEMENTATION GROUP C	false	0.9315673705639625	0.9024150512233631	false	false	false
BRIP1	BRIP1_Gln255His	B_13-14	0.732346824162546	0.5112396507139866	0.5855280117229745	1.2439471189610838	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7556619957966667	0.7950899992365581	0.7207586564930537	0.8165906941026754	0.791984948784165	0.786405595021153	0.7523613157507364	0.7771692499379353	0.778831290554496	0.6957758876982344	0.8081766088396467	0.7467159670066402	0.8204498742915698	0.8068006476303946	0.8543500976508548	0.7457414252878731	0.7820033896334696	0.7646080245866932	BRIP1	Gln255His	NC_000017.11:61808620:C:A	765G>T	17	61808620	C	A	17	ENSG00000136492	55128	0	CCSBVarC031354	ALE00028333	ENSP00000259008.2																																	917865.0	single nucleotide variant	NM_032043.3(BRIP1):c.765G>T (p.Gln255His)	83990.0	BRIP1	HGNC:20473	Pathogenic	1.0	Feb 07, 2011	2078111971.0	-	RCV001194716	MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84	Fanconi anemia complementation group J	germline	germline	GRCh38	NC_000017.11	17	61808620.0	61808620.0	17q23.2	no assertion criteria provided	1.0	-	N	-	2.0	929523.0	61808620.0	C	A	-	-	-	-	-	-	765G>T 	Gln255His	NM_032043.3		Pathogenic	Pathogenic	929523	17	61808620.0	C	A	Q	H	rs2078111971	17	59885981	17	57240763	255	BRIP1	ENSG00000136492	ENST00000682453	ENSP00000506943	Q9BX63	FANCJ_HUMAN	.	.	c.765G>T	p.Gln255His	principal2	Y	.	.	.	-	CAG	3	2	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.76775	.	1.0	0.90580	D	0.999	0.92348	D	.	0.90832	.	.	.	.	4.365	0.98493	H	.	0.79862	.	.	0.99419	0.5765	0.91558	D	0.6879	0.89189	D	9	.	0.98250	.	0.227769	0.88077	D	.	0.93600	0.913	0.98298	Q9BX63	Q255H	Gain of phosphorylation at T252 (P = 0.1383)| Gain of catalytic residue at K254 (P = 0.178)| Loss of methylation at K254 (P = 0.1938)| Loss of disorder (P = 0.2059)| Gain of helix (P = 0.2294)	.	0.97798	.	0.96706	.	0.58020	0.720037281513	0.70000	T	0.799612	0.94832	D	0.393787	0.89480	D	0.327871	0.89348	D	0.999322414398193	0.96939	D	0.918508	0.70644	D	0.92846745	0.93994	0.8937532	0.94458	0.9292196	0.94071	0.88003564	0.93477	-14.306	0.94021	D	.	0.97151	.	0.999870395781411	0.98499	0.98894000	0.96574	0.738	0.85485	.	.	.	.	.	.	4.62463	0.73515	26.0	0.99764672733639892	0.85348	0.713631	0.66516	D	0.878838601052151	0.90632	10.51746	0.789515383178468	0.88995	9.820491	5.29	5.29	0.74394	.	.	4.371	0.5938	5.995000	0.52465	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.999	0.91597	46	0.97740	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Fanconi_anemia_complementation_group_J	no_assertion_criteria_provided	NC_000017.11:g.61808620C>A	.	C1836860	609054	84	.	Gln	His	87.04	0.14646464646464646																																																																																																																																																																																																																																																																																																																																																																																																																																																																													29			87.04	Polar/Neutral	Glutamine		Fanconi anemia group J protein							Helicase ATP-binding	0.0242		-3.5								 Q255-I259 (PAE:  1.0)		 Q255-I259 (PAE:  1.0)								146									-73.7		Pocket 5: Mean pLDDT: 71.11, Volume: 1880.97 Å³, Druggability score: 0.02		-37.1				dbSNP: -; Variant type: LP/P; AA change: Gln255His; PTM type: Ubiquitylation; PTM morphology: GTRTHkQ*IAQI; Var class: II		H (helix)	H (α-helix)												87.04	14.646464	70-90	10-90	609054	autosomal recessive	GenCC	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	FANCONI ANEMIA, COMPLEMENTATION GROUP J	false	0.7950899992365581	0.7556619957966667	false	false	false
KRAS	KRAS_Tyr71His	B_13-14	-4.892479479558333	0.001768232186353	0.007170538165465457	6.889330606006399	0.00023355876445148906	0.0007655583100346809	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9387332048903478	0.9417030621149093	0.4373434701279459	0.7087829258766676	0.8367611505722018	0.6044343228274591	0.6044343228274591	0.8367611505722018	0.7087829258766676	0.4373434701279459	0.9417030621149093	0.9387332048903478							KRAS	Tyr71His	NC_000012.12:25227313:A:G	211T>C	12	25227313	A	G	12	ENSG00000133703	3084	0	CCSBVarC006099	ALE00006099	ENSP00000308495.3	CEGS2	CegsMutGDEh1036	F03	GDEhDisVCh_40061	B09	1	CegsMutGDDh1036	F03	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	40605.0	single nucleotide variant	NM_033360.4(KRAS):c.211T>C (p.Tyr71His)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Jan 15, 2013	387907205.0	-	RCV000024617	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	Cardiofaciocutaneous syndrome 2	germline	germline	GRCh38	NC_000012.12	12	25227313.0	25227313.0	12p12.1	no assertion criteria provided	1.0	-	N	ClinGen:CA279983,UniProtKB:P01116#VAR_069784,OMIM:190070.0021	1.0	31940.0	25227313.0	A	G	-	-	-	-	-	-	211T>C 	Tyr71His	NM_033360.4		Pathogenic	Pathogenic	31940	12	25227313.0	A	G	Y	H	rs387907205	12	25380247	12	25271514	71	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.211T>C	p.Tyr71His	c.211T>C	p.Tyr71His	alternative1	Y	1	.	Plus_Clinical	-	TAC	1	0	A	A/A	A/A	A/A	A/A	0.025	0.48345	D	0.061	0.45880	T	0.919	0.50939	P	0.913	0.64880	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.48	0.71880	M	-4.45	0.77749	D	0.968	0.97870	0.6011	0.91886	D	0.7268	0.90619	D	10	0.88397557	0.87583	D	0.096778	0.76586	D	0.895	0.97016	0.693	0.82954	P01116	Y71H	Gain of catalytic residue at T74 (P = 0.0026)| Gain of disorder (P = 0.029)| Loss of phosphorylation at Y71 (P = 0.0387)| Loss of stability (P = 0.1315)| Loss of helix (P = 0.1706)	0.967032760806	0.96637	0.9119234105740558	0.91111	3.04366087562	0.99279	0.940733075142	0.99483	D	0.901474	0.98050	D	0.41344	0.90604	D	0.356102	0.90487	D	0.988144636154175	0.78358	D	0.884911	0.60851	D	0.93090373	0.94241	0.9041667	0.95206	0.927135	0.93859	0.8970921	0.94698	-12.052	0.85144	D	0.9986	0.98903	P	0.999975559545648	0.99427	0.99871314	0.98921	0.987	0.99559	.	.	.	.	.	.	5.005977	0.83126	28.0	0.99860396733546142	0.93915	0.873516	0.79516	D	0.756487767865435	0.83238	7.988538	0.776357426611185	0.88040	9.459321	5.77	5.77	0.91065	3.95	0.75212	9.309	0.95324	11.259000	0.91022	0.731	0.85655	1.0	0.71675	1.000000	0.68239	0.998	0.85369	856	0.34333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Cardiofaciocutaneous_syndrome_2	no_assertion_criteria_provided	NC_000012.12:g.25227313A>G	ClinGen:CA279983|OMIM:190070.0021|UniProtKB:P01116#VAR_069784	C3809005	615278	1340	Small GTP-binding domain	Tyr	His	91.78	0.04054054054054054																																																																																																																																																																																					1.134				0.208						0.106	1 mutation(s) (Tyr71His: 0.484)					-0.048						0.058		0.001										-0.046				0.01				-0.757	3 mutation(s) (Tyr71Cys: -1.237, Tyr71Asp: -1.158, Tyr71Trp: -1.119)	0.093		-0.123	1 mutation(s) (Tyr71Gly: -0.527)	0.045		0.158				-1.0																																																																																																																																																																																																																																		9			91.78	Aromatic	Tyrosine		GTPase KRas; GTPase KRas, N-terminally processed								0.0156		-1.3			B:Y71-A:D119 (PDBs: 6MS9), B:Y71-A:D92 (PDBs: 8AQ7), E:Y71-F:K132 (PDBs: 5MLB, 5O2S), A:Y71-C:H18 (PDBs: 5WLB, 5WPM), A:Y71-B:Q45 (PDBs: 6YR8)	D:Y71-E:W25 (PDBs: 5WLB), A:Y71-B:Y29 (PDBs: 5WPM), A:Y71-B:W25 (PDBs: 5WPM)				 Y71-G75 (PAE:  2.0)	Y71-M67 (PDBs: 4LDJ, 4LYJ, 5OCG, 5V9O, 6E6G, 6GJ6, 6GJ8, 6GOD, 6M9W, 6MBQ, 6MQG, 6T5V, 6ZL5, 7KYZ, 7LGI, 7MQU, 7R0N, 8AFB, 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8B78, 8CPR, 8JHL, 8ONV, 8QUG, 3GFT, 4LPK, 4LUC, 4LV6, 4LYF, 4LYH, 4M1S, 4M1W, 4M1Y, 4M21, 4OBE, 4TQA, 5UK9, 5V9L, 6BOF, 6MBT, 6MBU, 6MNX, 6MQN, 6MS9, 6O36, 6O46, 6P0Z, 7ACA, 7ACF, 7ACQ, 7O70, 7R0M, 7R0Q, 8AFC, 8AFD, 8AQ7, 8B6I, 8ECR, 8T71, 8UN5, 2MSC, 2MSD, 2MSE, 5MLB, 5O2S, 5TAR, 5TB5, 5UFE, 5WLB, 5WPM, 6H46, 6H47, 6PTW, 6VJJ, 6W4F, 6YR8, 6YXW, 7NY8, 8QU8, 8QVU, 8T75), Y71-G75 (PDBs: 6GJ7, 4M22, 5VQ2, 6MTA, 6QUU, 6QUV, 6QUW, 6QUX, 6VC8, 6ZLI, 7ACH, 8T72, 5MLA, 5O2T, 6OB2, 6V65, 6W4E, 7SCW, 7VVB, 8T74, 8TBF), Y71-E37 (PDBs: 6V5L), Y71-Q61 (PDBs: 4M1O, 4M1T)	 Y71-G75 (PAE:  2.0), Y71-M67 (PAE: 5.0)	Y71-G75 (PDBs: 4L8G, 6T5B, 6V5L, 8B78, 8CPR, 4LRW, 4M22, 5VQ2, 6MTA, 6QUW, 6VC8, 8ECR, 8T71, 6XHB, 8TBF), Y71-M67 (PDBs: 4LDJ, 4LYJ, 5OCG, 5V9O, 6E6G, 6GJ6, 6GJ7, 6GJ8, 6GOD, 6M9W, 6MBQ, 6MQG, 6T5V, 6ZL5, 7KYZ, 7LGI, 7MQU, 7R0N, 8AFB, 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8JHL, 8ONV, 8QUG, 3GFT, 4LPK, 4LUC, 4LV6, 4LYF, 4LYH, 4M1O, 4M1S, 4M1T, 4M1W, 4M1Y, 4M21, 4OBE, 4TQA, 5UK9, 5V9L, 6BOF, 6MBT, 6MBU, 6MNX, 6MQN, 6MS9, 6O36, 6O46, 6P0Z, 6QUU, 6QUV, 6QUX, 6ZLI, 7ACA, 7ACF, 7ACH, 7ACQ, 7O70, 7R0M, 7R0Q, 8AFC, 8AFD, 8AQ7, 8B6I, 8UN5, 2MSC, 2MSD, 2MSE, 5MLA, 5MLB, 5O2S, 5O2T, 5TAR, 5TB5, 5UFE, 5WLB, 5WPM, 6H46, 6H47, 6OB2, 6PTS, 6PTW, 6V65, 6VJJ, 6W4E, 6W4F, 6YR8, 6YXW, 7NY8, 7SCW, 7VVB, 8QU8, 8QVU, 8T74, 8T75), Y71-L56 (PDBs: 8T72), Y71-V7 (PDBs: 8TBF)							181									-68.9		Pocket 2: Mean pLDDT: 74.91, Volume: 215.87 Å³, Druggability score: 0.02		-32.1						H (helix)	H (α-helix)	Helix											91.78	4.054054	>90	<10	615278	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	CARDIOFACIOCUTANEOUS SYNDROME 2	false	0.9417030621149093	0.9387332048903478	false	false	false
BRAF	BRAF_Gly469Glu	B_13-14	1.200036246927843	0.2691587309971123	0.35503672389812463	-3.0243624593274268	0.0192672781731555	0.030426381624561395	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8957798896210175	0.899876787830967	0.6356028996867316	0.864104649785485	0.8420518349981052	0.7548843293495833	0.741632242770709	0.7555785443432006	0.8589066846378637	0.6164860586192897	0.8660477409209804	0.8618564317870924	0.7681364159284574	0.9285251256530098	0.8693026149331061	0.6547197407541734	0.9337058347409537	0.9297033474549427	BRAF	Gly469Glu	NC_000007.14:140781602:C:T	1406G>A	7	140781602	C	T	7	ENSG00000157764	71969	0	CCSBVarC003160	ALE00003160	ENSP00000493543.1	CEGS2	CegsMutGDEh1028	A09	GDEhDisVCh_40058	F10	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	5.0	0.0		0.0			0.0			0.0			N	N	N	N	N	29013.0	single nucleotide variant	NM_004333.6(BRAF):c.1406G>A (p.Gly469Glu)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Sep 17, 2024	121913355.0	-	RCV000015008|RCV000033307|RCV000211748|RCV000212152|RCV000506575|RCV002287336|RCV001813209|RCV003450641	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	Cardiofaciocutaneous syndrome 1|RASopathy|Cardio-facio-cutaneous syndrome|not provided|not specified|Noonan syndrome 7|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140781602.0	140781602.0	7q34	reviewed by expert panel	18.0	-	N	ClinGen:CA279970,UniProtKB:P15056#VAR_018621,OMIM:164757.0014	3.0	13974.0	140781602.0	C	T	-	-	-	-	-	-	1406G>A 	Gly469Glu	NM_004333.6	3.0	Pathogenic	Pathogenic	13974	7	140781602.0	C	T	G	E	rs121913355	7	140481402	7	140127871	469	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1406G>A	p.Gly469Glu	c.1406G>A	p.Gly469Glu	principal4	Y	.	YES	Select	-	GGA	2	0	C	./.	./.	./.	./.	.	.	.	.	.	.	0.999	0.77914	D	0.999	0.92348	D	.	0.95575	.	.	.	.	3.445	0.92067	M	.	.	.	.	.	1.0760	0.98756	D	0.9172	0.97252	D	10	0.992007	0.99733	D	0.612203	0.96612	D	.	0.98001	0.992	0.99914	P15056	G469E	Loss of MoRF binding (P = 0.0591)| Gain of catalytic residue at G469 (P = 0.1084)| Gain of methylation at K473 (P = 0.1128)| Gain of phosphorylation at Y472 (P = 0.1612)| Gain of ubiquitination at K473 (P = 0.1827)	.	0.97730	.	0.97263	.	0.96811	0.941216766834	0.99500	D	0.964899	0.99571	D	0.481639	0.93706	D	0.454064	0.93626	D	0.999017953872681	0.95854	D	0.990601	0.97084	D	0.99422306	0.99940	0.9877916	0.99959	0.9873307	0.99607	0.98307276	0.99888	-13.528	0.91438	D	1.0	0.99952	P	0.999985580220805	0.99579	0.99919707	0.99211	1	0.99985	.	.	.	.	.	.	5.508136	0.91667	32.0	0.99796911589266579	0.88204	0.905235	0.85598	D	1.07569399882665	0.97644	16.51806	0.981768342919213	0.98233	17.76874	5.62	5.62	0.85695	.	.	7.886	0.85829	7.656000	0.64019	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.998	0.85369	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	13024	0	0	92	0	0	110	0	0	3222	0	0	146	0	0	610	0	0	54	0	0	94	0	0	2794	0	0	3314	0	0	164	0	0	20146	0	not_specified|Squamous_cell_carcinoma_of_the_skin|Transitional_cell_carcinoma_of_the_bladder|Melanoma|Prostate_adenocarcinoma|Neoplasm_of_the_large_intestine|not_provided|Cardio-facio-cutaneous_syndrome|Malignant_melanoma_of_skin|Noonan_syndrome_1|Noonan_syndrome_and_Noonan-related_syndrome|Lung_adenocarcinoma|Cardiofaciocutaneous_syndrome_1|RASopathy|Noonan_syndrome_7|Multiple_myeloma|Squamous_cell_lung_carcinoma	reviewed_by_expert_panel	NC_000007.14:g.140781602C>T	ClinGen:CA279970|OMIM:164757.0014|UniProtKB:P15056#VAR_018621	CN169374|C0553723|C0279680|C0025202|C0007112|C0009404|C3661900|C1275081|C0151779|C4551602|C5681679|C0152013|CN029449|C5555857|C3150970|C0026764|C0149782	PS115150|163950|115150|613706|254500	1340|648|98733|1340|536391|648|29073|85443	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Gly	Glu	75.46	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			75.46	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine	ATP	Serine/threonine-protein kinase B-raf							Protein kinase			-0.4									G469-N486 (PDBs: 3SKC, 4MBJ), G469-S465 (PDBs: 4H58, 5HIE, 7MFF), G469-L597 (PDBs: 5VAM), G469-R462 (PDBs: 4MNE)	 G469-N486 (PAE:  3.0)	G469-N486 (PDBs: 5CSX, 3II5, 3SKC, 3TV4, 3TV6, 4E4X, 4EHE, 4G9C, 4MBJ, 5VAM, 6N0P, 6NYB, 6PP9, 6U2G, 6V2W, 7M0W, 7M0X, 7M0Y, 7M0Z, 7MFE, 8DGT), G469-M484 (PDBs: 8C7X, 8C7Y, 8F7O, 8QQG, 8DGS, 8DGT), G469-L597 (PDBs: 8F7P), G469-R462 (PDBs: 4MNE), G469-S465 (PDBs: 8DGT)							75									168.4				175.0				dbSNP: rs121913355; Variant type: LP/P; AA change: Gly469Ala; PTM type: Ubiquitylation; PTM morphology: FG*tVYkGkWHG; Var class: II&rs121913355		B (undefined)	E (parallel sheets)	Beta strand											75.46	0.0	70-90	<10	115150;613706;163950	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1; NOONAN SYNDROME 7; NOONAN SYNDROME 1	false	0.899876787830967	0.8957798896210175	false	false	false
BRAF	BRAF_Gly596Val	B_13-14	2.2257131093137597	0.06135777408658752	0.10944132679803537	-4.18296054546987	0.004122021750159124	0.007903772112374077	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	false	false	false	true	0.9515377420761907	0.9640163514966194	0.8629025322942941	0.9606643840556036	0.9582242152782587	0.9532439336079833	0.9381989293347653	0.9498807705529784	0.9480535719287884	0.8573532299016946	0.9439814715342749	0.9235389801541711	0.9682889378812013	0.9665676600035391	0.9732751961824189	0.8684518346868937	0.9840512314589639	0.9795365039982102	BRAF	Gly596Val	NC_000007.14:140753348:C:A	1787G>T	7	140753348	C	A	7	ENSG00000157764	71969	0	CCSBVarC003171	ALE00003171	ENSP00000493543.1	CEGS2	CegsMutGDEh1020	G07	GDEhDisVCh_40058	F08	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	48857.0	single nucleotide variant	NM_004333.6(BRAF):c.1787G>T (p.Gly596Val)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Apr 03, 2017	397507483.0	-	RCV000033332|RCV000208758|RCV000077865|RCV000844615|RCV000856749|RCV001265809	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MeSH:D030342,MedGen:C0950123	RASopathy|Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000007.14	7	140753348.0	140753348.0	7q34	reviewed by expert panel	12.0	-	N	ClinGen:CA220161,UniProtKB:P15056#VAR_035098	3.0	40387.0	140753348.0	C	A	-	-	-	-	-	-	1787G>T 	Gly596Val	NM_004333.6	3.0	Pathogenic	Pathogenic	40387	7	140753348.0	C	A	G	V	rs397507483	7	140453148	7	140099617	596	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1787G>T	p.Gly596Val	c.1787G>T	p.Gly596Val	principal4	Y	.	YES	Select	-	GGT	2	0	C	./.	./.	./.	./.	.	.	.	.	.	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97926	.	.	.	.	3.295	0.90281	M	.	.	.	.	.	0.6405	0.92395	D	0.6951	0.89454	D	10	0.99041414	0.99538	D	0.395627	0.93272	D	.	0.99969	0.986	0.99859	P15056	G596V	Loss of sheet (P = 0.0817)| Loss of ubiquitination at K601 (P = 0.0992)| Loss of disorder (P = 0.1248)| Gain of methylation at K591 (P = 0.1331)| Loss of catalytic residue at G596 (P = 0.1549)	.	0.98509	.	0.98578	.	0.96552	0.919968366623	0.98320	D	0.963797	0.99550	D	0.575047	0.96883	D	0.588239	0.96832	D	0.999177873134613	0.96398	D	0.99514	0.98365	D	0.99520737	0.99966	0.98436314	0.99912	0.9940386	0.99934	0.98400426	0.99906	-12.721	0.88207	D	0.9996	0.99584	P	0.999992243767439	0.99831	0.99971479	0.99632	1	0.99985	.	.	.	.	.	.	5.562398	0.92161	32.0	0.99798908246520857	0.88381	0.917943	0.88587	D	0.742007177940642	0.82286	7.749107	0.747081129508623	0.85861	8.732487	5.65	5.65	0.86862	.	.	7.831	0.84961	7.673000	0.64945	0.595	0.32887	1.0	0.71675	1.000000	0.68239	0.999	0.91597	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Transitional_cell_carcinoma_of_the_bladder|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|Inborn_genetic_diseases|Glioblastoma|not_provided|RASopathy|Multiple_myeloma|Lung_adenocarcinoma|Cardiofaciocutaneous_syndrome_1	reviewed_by_expert_panel	NC_000007.14:g.140753348C>A	ClinGen:CA220161|UniProtKB:P15056#VAR_035098	C0279680|C1275081|C0028326|C0950123|C0017636|C3661900|C5555857|C0026764|C0152013|CN029449	PS115150|PS163950|254500|115150	1340|648|360|536391|29073|85443|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Gly	Val	56.55	0.10714285714285714																																																																																																																																																																																																																																																																																																																																																																																																																																																																													9			56.55	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Serine/threonine-protein kinase B-raf							Protein kinase			-0.4									G596-S467 (PDBs: 6P3D), G596-R575 (PDBs: 3PRF), G596-N581 (PDBs: 4G9C), G596-H574 (PDBs: 5CSW, 5HIE, 6V2U, 7P3V, 7MFD, 7MFE, 8DGT), G596-K601 (PDBs: 5FD2, 6NYB, 6PP9, 6U2G, 6V2W, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 8DGS, 8DGT)		G596-F468 (PDBs: 6P3D), G596-E501 (PDBs: 2FB8, 3Q4C, 4E26, 4H58, 4MNE, 6UAN, 7MFF), G596-S467 (PDBs: 3D4Q, 3PPJ, 3PPK, 3PSB, 3PSD, 7SHV, 6U2H, 6XAG), G596-N581 (PDBs: 3Q96, 4DBN, 4G9C, 4KSP, 4KSQ, 5CT7, 8C7Y, 8F7O, 8F7P), G596-H574 (PDBs: 3SKC, 5CSW, 5HIE, 6V2U, 7MFE, 8DGS, 8DGT), G596-L505 (PDBs: 5FD2), G596-D576 (PDBs: 7P3V, 7MFD), G596-I573 (PDBs: 6NYB, 6PP9, 6U2G, 6V2W, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 8DGT)							75									79.2				-45.2				dbSNP: rs121913361; Variant type: US; AA change: Gly596Arg; PTM type: Ubiquitylation; PTM morphology: G*LAtVksRWsG; Var class: II&rs397507483		C (loop/coil)	S (bend)												56.55	10.714286	50-70	10-90	115150	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1	false	0.9640163514966194	0.9515377420761907	false	false	false
LMNA	LMNA_Arg41His	B_13-14	4.266345707886469	0.0037173824125443845	0.012724373490967337	-7.925259481334789	0.0000967745026011612	0.0003963866345382384	2025_01_Batch_13-14	false	false	true	false	true	true	false	false	false	false	false	false	0.9524538811352774	0.9597628989385087	0.8757126360259004	0.9142701907323308	0.9289543995664764	0.9519761588783208	0.9684007094670471	0.939509699674886	0.8725852427460785	0.9180130577398969	0.953205361499835	0.9443883084547613	0.9355516082895944	0.9183990994580667	0.9559551387185832	0.833412214311904	0.9663204363771826	0.9605194538157935	LMNA	Arg41His	NC_000001.11:156115040:G:A	122G>A	1	156115040	G	A	1	ENSG00000160789	3903	0	CCSBVarC021100	ALE00025725	ENSP00000357284.2																																	390827.0	single nucleotide variant	NM_170707.4(LMNA):c.122G>A (p.Arg41His)	4000.0	LMNA	HGNC:6636	Pathogenic	1.0	Mar 14, 2023	1060502215.0	-	RCV000457713|RCV000994129	MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:C3661900	Charcot-Marie-Tooth disease type 2|not provided	germline	germline	GRCh38	NC_000001.11	1	156115040.0	156115040.0	1q22	criteria provided, multiple submitters, no conflicts	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA16609885	2.0	408994.0	156115040.0	G	A	-	-	-	-	-	-	122G>A 	Arg41His	NM_170707.4	2.0	Pathogenic	Pathogenic	408994	1	156115040.0	G	A	R	H	rs1060502215	1	156084831	1	154351455	41	LMNA	ENSG00000160789	ENST00000675939	ENSP00000502256	P02545	LMNA_HUMAN	.	.	c.122G>A	p.Arg41His	principal1	Y	.	.	.	+	CGC	2	0	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.79703	.	1.0	0.90580	D	0.997	0.86259	D	.	0.99291	.	.	.	.	3.65	0.94095	H	.	0.76931	.	.	0.94442	1.0096	0.97344	D	0.8998	0.96669	D	10	.	0.95527	.	0.697456	0.97514	D	.	0.98921	0.839	0.94511	P02545	R41H	Loss of disorder (P = 0.0408)| Loss of MoRF binding (P = 0.0657)| Loss of stability (P = 0.0853)| Gain of catalytic residue at Y45 (P = 0.2364)| Gain of phosphorylation at Y45 (P = 0.3525)	.	0.98195	.	0.99019	.	0.96618	0.826536655426	0.86008	D	0.981432	0.99855	D	0.543151	0.95472	D	0.542423	0.95404	D	0.998799562454224	0.95146	D	.	0.60605	.	0.8277698	0.85561	0.67164475	0.80513	0.7031715	0.77980	0.6304929	0.78213	-11.691	0.83363	D	.	0.93873	.	0.999670505958946	0.97434	0.99995460	0.99953	0.989	0.99628	.	.	.	.	.	.	5.697397	0.93103	33.0	0.99939450855587175	0.99734	0.969077	0.99147	D	0.920677880494411	0.92694	11.59756	0.8501245464411	0.92984	11.77651	4.77	4.77	0.60376	5.21	0.92006	9.725	0.9802	11.667000	0.94064	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.996	0.76032	420	0.81453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Charcot-Marie-Tooth_disease_type_2|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.156115040G>A	ClinGen:CA16609885	C0270914|C3661900	.	64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	His	87.29	0.6895161290322581																																																																																																																																																																																																																																																																																																																																																																																																																																																																													171			87.29	Positively-charged	Arginine		Prelamin-A/C; Lamin-A/C							IF rod			-4.5								 R41-Y45 (PAE:  3.5), R41-E37 (PAE: 5.5)	R41-Y45 (PDBs: 6JLB), R41-E37 (PDBs: 6JLB)	 R41-Y45 (PAE:  3.5), R41-E37 (PAE: 5.5)	R41-Y45 (PDBs: 6JLB), R41-E37 (PDBs: 6JLB)		R41-E37 (PDBs: 6JLB)			Morphology: DLQELNDrLAVyIDr; Domain: Filament		175		Mutation: R -> H. Impaired lamin assembly.							-62.3				-40.5	Interaction with MLIP; Coil 1A					H (helix)	H (α-helix)	Helix											87.29	68.951614	70-90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9		false	0.9597628989385087	0.9524538811352774	false	false	false
F9	F9_Arg384Pro	B_13-14	-3.6845709938138382	0.007812380013432871	0.022608554281298158	2.747600798952158	0.02860277980339594	0.043224429128595684	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6148761792845984	0.642666969871202	0.4535161596010009	0.6310761927308304	0.5387331538240554	0.5037457889102298	0.5371303452692945	0.5660145284578785	0.6331885502816951	0.45539580712663824	0.6475459863575939	0.592071800164499	0.47036123255116513	0.5114517791902324	0.6289638351799658	0.4516365120753635	0.63778795338481	0.6376805584046977	F9	Arg384Pro	NC_000023.11:139561836:G:C	1151G>C	23	139561836	G	C	X	ENSG00000101981	52861	0	CCSBVarC004389	ALE00004389	ENSP00000218099.2	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25699.0	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Aug 04, 2016	137852283.0	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836.0	139561836.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255463,OMIM:300746.0111	1.0	10660.0	139561836.0	G	C	-	-	-	-	-	-	1151G>C 	Arg384Pro	NM_000133.4		Pathogenic	Pathogenic	10660	X	139561836.0	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	94.23	0.7620967741935484																																																																																																																																																																																																																																																																																																																																																																																																															1.099		0.946		0.91	1 mutation(s) (Arg384Asn: 1.152)	0.889	1 mutation(s) (Arg384Asn: 1.142)	0.889																																																						189			94.23	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-4.5			H:R384-B:S274 (PDBs: 8OL9), H:R384-A:N264 (PDBs: 8OL9), H:R384-A:Y263 (PDBs: 8OL9)	H:R384-B:S274 (PDBs: 8OL9), H:R384-B:Y278 (PDBs: 8OL9), H:R384-B:N279 (PDBs: 8OL9), H:R384-B:S276 (PDBs: 8OL9)				 R384-A380 (PAE:  1.0)	R384-A380 (PDBs: 6X5J, 6X5L, 8OL9)	 R384-A380 (PAE:  1.0)	R384-A380 (PDBs: 6X5J, 6X5L, 8OL9)							175									-78.1				-25.4				dbSNP: rs137852283; Variant type: LP/P; AA change: Arg384Leu; PTM type: Phosphorylation; PTM morphology: LVDRAtCLR*ST; Var class: II		H (helix)	H (α-helix)	Helix											94.23	76.20968	>90	10-90	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.642666969871202	0.6148761792845984	false	false	false
FARS2	FARS2_His84Pro	B_13-14	-0.6685215350519559	1.0	1.0	-1.7797378199391343	0.14564882882800625	0.18129745368141986	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8648898687849833	0.8978055480913999	0.5898623721783351	0.662163484940578	0.6176848079726439	0.612173997096173	0.6114822640257489	0.6160316477036053	0.6147122715458336	0.6770695820768142	0.9121793296083599	0.8864517937833528	0.6128657301665972	0.6193379682416825	0.7096146983353222	0.5026551622798561	0.8834317665744399	0.8433279437866137	FARS2	His84Pro	NC_000006.12:5368821:A:C	251A>C	6	5368821	A	C	6	ENSG00000145982	12653	0	CCSBVarC011910	ALE00015564	ENSP00000274680.4																																	962036.0	single nucleotide variant	NM_006567.5(FARS2):c.251A>C (p.His84Pro)	10667.0	FARS2	HGNC:21062	Pathogenic	1.0	Dec 12, 2019	1758844499.0	-	RCV001250396	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5368821.0	5368821.0	6p25.1	no assertion criteria provided	1.0	-	N	-	2.0	973746.0	5368821.0	A	C	-	-	-	-	-	-	251A>C 	His84Pro	NM_006567.5		Pathogenic	Pathogenic	973746	6	5368821.0	A	C	H	P	rs1758844499	6	5369054	6	5314053	84	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.251A>C	p.His84Pro	c.251A>C	p.His84Pro	principal1	Y	1	YES	Select	+	CAC	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.002	0.79703	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.98	0.99849	H	-9.18	0.98237	D	0.929	0.93495	0.5682	0.91447	D	0.6119	0.86217	D	10	0.97114253	0.96682	D	0.337595	0.91908	D	0.841	0.95012	0.815	0.92954	O95363	H84P	Gain of catalytic residue at H84 (P = 0.0281)| Gain of glycosylation at H84 (P = 0.0433)| Loss of MoRF binding (P = 0.0679)| Loss of helix (P = 0.079)| Loss of disorder (P = 0.1597)	0.958043335942	0.95723	.	0.96295	.	0.68072	0.523846149445	0.42108	T	0.640816	0.88872	D	0.362787	0.87376	D	0.283342	0.87214	D	0.999933004379272	0.99780	D	0.922108	0.71602	D	0.9622549	0.97466	0.9041385	0.95204	0.9622549	0.97466	0.9041385	0.95205	-13.227	0.90296	D	0.7894	0.77044	P	0.999515333251888	0.96835	0.96594020	0.94359	0.95	0.97732	.	.	.	.	.	.	4.99072	0.82771	27.9	0.98859005853011162	0.47542	0.956935	0.97572	D	1.04327041522056	0.96912	15.34014	0.934733790292807	0.96898	15.32305	5.33	5.33	0.75646	3.49	0.63201	8.916	0.92352	11.098000	0.86082	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Combined_oxidative_phosphorylation_defect_type_14	no_assertion_criteria_provided	NC_000006.12:g.5368821A>C	.	C4755312	614946	319519	Phenylalanyl-tRNA synthetase	His	Pro	98.41	0.005434782608695652																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			98.41	Positively-charged	Histidine												-3.2								 H84-L88 (PAE:  1.0), H84-F332 (PAE: 1.0)	H84-F332 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP), H84-L88 (PDBs: 8P8X, 3TUP)	 H84-L78 (PAE:  1.0), H84-L88 (PAE: 1.0)	H84-L88 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP), H84-L78 (PDBs: 8P8X, 3TUP)							155									-72.5				141.5						C (loop/coil)	C (loop/coil)	Beta strand											98.41	0.54347825	>90	<10	614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.8978055480913999	0.8648898687849833	false	false	false
F9	F9_Ala397Pro	B_13-14	-2.551530951626418	0.038018558926100524	0.07440107330825	1.8115033514430214	0.11296584138457301	0.14753901703963807	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8892371356386053	0.8860694027788933	0.4941019946508107	0.7219215540589328	0.6400317147023187	0.5315144840434948	0.556442168095446	0.6775576163635836	0.7463850940568916	0.5047801817057196	0.834688851865815	0.8393204930832165	0.5065867999915435	0.6025058130410539	0.697458014060974	0.4834238075959019	0.9374499536919716	0.939153778193994	F9	Ala397Pro	NC_000023.11:139561874:G:C	1189G>C	23	139561874	G	C	X	ENSG00000101981	52861	0	CCSBVarC004392	ALE00004392	ENSP00000218099.2	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25701.0	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158.0	F9	HGNC:3551	Pathogenic	1.0	May 01, 1998	137852281.0	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874.0	139561874.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1.0	10662.0	139561874.0	G	C	-	-	-	-	-	-	1189G>C 	Ala397Pro	NM_000133.4		Pathogenic	Pathogenic	10662	X	139561874.0	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	92.51	0.0																																																																																																																																																																																																																																																																																																																																																																																																															0.487		0.307		0.251		0.239		0.247																																																						0			92.51	Aliphatic	Alanine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			1.8								 A397-G442 (PAE:  1.0)	A397-G442 (PDBs: 6X5J, 6X5L, 8OL9)	 A397-G442 (PAE:  1.0)	A397-G442 (PDBs: 6X5J, 6X5L, 8OL9), A397-P375 (PDBs: 8OL9), A397-Y444 (PDBs: 8OL9), A397-Y441 (PDBs: 8OL9)							89									-142.1				146.8						B (undefined)	E (parallel sheets)	Beta strand											92.51	0.0	>90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.8860694027788933	0.8892371356386053	false	false	false
F9	F9_Phe395Ile	B_13-14	-2.751249441409619	0.028452659811841512	0.05958835552699264	3.1809845132947037	0.015469437981578186	0.025165264801592174	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8685614475571856	0.8751686067981687	0.49578458818608895	0.7605783517976057	0.6111635126995072	0.6471483189420264	0.7835703710612687	0.5896051144105002	0.7330673755402575	0.5375531898524	0.8199812271857942	0.8098458065957443	0.5107262668227842	0.6327219109885143	0.7880893280549539	0.454015986519778	0.9303559864105431	0.9272770885186268	F9	Phe395Ile	NC_000023.11:139561868:T:A	1183T>A	23	139561868	T	A	X	ENSG00000101981	52861	0	CCSBVarC030626	ALE00032916	ENSP00000218099.2																																	1386208.0	single nucleotide variant	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Apr 18, 2021	1175050951.0	-	RCV001905309	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561868.0	139561868.0	Xq27.1	criteria provided, single submitter	1.0	-	N	-	2.0	1364269.0	139561868.0	T	A	-	-	-	-	-	-	1183T>A 	Phe395Ile	NM_000133.4	1.0	Pathogenic	Pathogenic	1364269	X	139561868.0	T	A	F	I	rs1175050951	X	138644027	X	138471693	395	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1183T>A	p.Phe395Ile	c.1183T>A	p.Phe395Ile	principal1	Y	1	YES	Select	+	TTC	1	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.98	0.74847	D	1.0	0.99291	D	simple_aae	0.0	100.0	0.935	0.23470	L	-5.97	0.89297	D	0.694	0.95387	0.3983	0.89027	D	0.6139	0.86302	D	10	0.98510087	0.98730	D	0.874725	0.99041	D	0.891	0.96866	0.903	0.97889	P00740	F395I	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.999082510293	0.99905	0.9980519219227515	0.99804	1.94421044628	0.93244	0.69013696909	0.65668	T	0.860248	0.96868	D	0.52535	0.94991	D	0.516853	0.94917	D	0.99892920255661	0.95561	D	0.906209	0.66886	D	0.9748932	0.98675	0.9731375	0.99587	0.9870631	0.99591	0.9672711	0.99332	-7.756	0.63197	D	0.6552	0.73049	P	0.999904283247364	0.98723	0.99998820	0.99996	0.995	0.99826	.	.	.	.	.	.	4.455722	0.69364	25.4	0.99205605394600549	0.55483	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.991	0.87929	7.926000	0.74810	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139561868T>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Phe	Ile	95.32	0.07614213197969544																																																																																																																																																																																																																																																																																																																																																																																																															0.275		0.118		0.102		0.097		0.092																																																						15			95.32	Aromatic	Phenylalanine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			2.8								 F395-Y444 (PAE:  1.0)	F395-Y444 (PDBs: 6X5J, 6X5L, 8OL9)	 F395-Y444 (PAE:  1.0)	F395-Y444 (PDBs: 6X5J, 6X5L, 8OL9), F395-T445 (PDBs: 8OL9), F395-I443 (PDBs: 8OL9), F395-K446 (PDBs: 8OL9)							165									-141.1				160.4						B (undefined)	E (parallel sheets)	Beta strand											95.32	7.614213	>90	<10	300807;306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	false	0.8751686067981687	0.8685614475571856	false	false	false
F9	F9_Asn166Tyr	B_13-14	-2.143030102118312	0.06932343798974207	0.12103086522889153	4.976788660107431	0.0016068015194850096	0.0035695893320278364	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9497475197491587	0.9416054095771403	0.5693018457313801	0.7111251474573962	0.6149325660019493	0.677100302794065	0.8634170843029272	0.6758610736709711	0.7773646616971812	0.6681639140888771	0.9218837237604487	0.9278482066072455	0.49078352128520286	0.5540040583329274	0.6448856332176112	0.4704397773738831	0.961327095393832	0.971646832891072	F9	Asn166Tyr	NC_000023.11:139548467:A:T	496A>T	23	139548467	A	T	X	ENSG00000101981	52861	0	CCSBVarC004378	ALE00004378	ENSP00000218099.2	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25621.0	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Apr 01, 1989	137852236.0	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467.0	139548467.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255337,OMIM:300746.0025	1.0	10582.0	139548467.0	A	T	-	-	-	-	-	-	496A>T 	Asn166Tyr	NM_000133.4		Pathogenic	Pathogenic	10582	X	139548467.0	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	90.75	0.535031847133758																																																																																																																																																																																																																																																																																																																																																																																																															0.476		0.292		0.286		0.261		0.224																																																						84			90.75	Polar/Neutral	Asparagine		Coagulation factor IX; Coagulation factor IXa light chain							EGF-like 2			-3.5																		132									-68.3				-3.7						C (loop/coil)	T (turn)	Beta strand											90.75	53.503185	>90	10-90	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.9416054095771403	0.9497475197491587	false	false	false
KRAS	KRAS_Lys5Asn	B_13-14	0.08584326223585399	0.9339947865923037	0.950415579324081	4.319478100134986	0.003482413960523058	0.006819882195901613	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7861208842914427	0.8111116633511135	0.7153393809372561	0.8146808903625637	0.861911133258753	0.850399729391765	0.7884393726669987	0.8261825087969352	0.7087457260133179	0.7233707359217132	0.6882356042102458	0.6605986970134637	0.9123600861165313	0.8976397577205708	0.9206160547118095	0.7073080259527991	0.9339877224919814	0.9116430715694217	KRAS	Lys5Asn	NC_000012.12:25245370:T:A	15A>T	12	25245370	T	A	12	ENSG00000133703	3084	0	CCSBVarC006087	ALE00006087	ENSP00000308495.3	CEGS2	CegsMutGDEh1038	C11	GDEhDisVCh_40061	C09	1	CegsMutGDDh1038	C11	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	27633.0	single nucleotide variant	NM_033360.4(KRAS):c.15A>T (p.Lys5Asn)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Apr 03, 2017	104894361.0	-	RCV000013425|RCV000623267|RCV000153427|RCV000520745	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MeSH:D030342,MedGen:C0950123|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	Cardiofaciocutaneous syndrome 2|Inborn genetic diseases|not provided|Noonan syndrome	germline	germline	GRCh38	NC_000012.12	12	25245370.0	25245370.0	12p12.1	reviewed by expert panel	4.0	-	N	ClinGen:CA234191,UniProtKB:P01116#VAR_064849,OMIM:190070.0017	3.0	12594.0	25245370.0	T	A	-	-	-	-	-	-	15A>T 	Lys5Asn	NM_033360.4	3.0	Pathogenic	Pathogenic	12594	12	25245370.0	T	A	K	N	rs104894361	12	25398304	12	25289571	5	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.15A>T	p.Lys5Asn	c.15A>T	p.Lys5Asn	alternative1	Y	1	.	Plus_Clinical	-	AAA	3	2	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.992	0.80453	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.925	0.84244	M	-3.84	0.80714	D	0.972	0.99419	0.7231	0.93439	D	0.7261	0.90593	D	9	0.89535224	0.88765	D	0.199646	0.86630	D	0.764	0.91975	0.746	0.87676	P01116	K5N	Gain of catalytic residue at E3 (P = 8e-04)| Loss of methylation at T5 (P = 0.0037)| Loss of ubiquitination at K5 (P = 0.021)| Gain of glycosylation at K2 (P = 0.1048)| Loss of disorder (P = 0.1189)	0.988022322716	0.98776	0.9939208319203104	0.99388	2.91440076523	0.99109	0.898385763168	0.96255	D	0.815684	0.95403	D	0.180387	0.71872	D	0.0213364	0.71506	D	0.998155415058136	0.93318	D	0.913609	0.69172	D	0.95635056	0.96861	0.89014167	0.94198	0.96346295	0.97588	0.8948088	0.94534	-11.193	0.83720	D	0.992	0.96154	P	0.999992346462973	0.99831	0.99815910	0.98658	0.995	0.99826	.	.	.	.	.	.	4.203335	0.6352	24.6	0.99859761066323194	0.93824	0.371023	0.45534	N	0.614844979912789	0.73972	6.077792	0.563747131663172	0.72208	5.797508	5.68	4.55	0.55376	2.79	0.51050	0.726	0.25745	1.824000	0.29148	-0.137	0.12603	1.0	0.71675	1.000000	0.68239	0.997	0.79771	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Cardiofaciocutaneous_syndrome_2|not_provided|Noonan_syndrome|Inborn_genetic_diseases	reviewed_by_expert_panel	NC_000012.12:g.25245370T>A	ClinGen:CA234191|OMIM:190070.0017|UniProtKB:P01116#VAR_064849	C3809005|C3661900|C0028326|C0950123	615278|PS163950	1340|648	Small GTP-binding domain	Lys	Asn	98.33	0.43902439024390244																																																																																																																																																																																					-0.056						-0.443						-0.457						-0.472				0.33				-0.68		-0.292		-0.582						-0.23						0.318		0.283		0.125		0.529		0.871																																																																																																																																																																																																																																						90			98.33	Positively-charged	Lysine		GTPase KRas; GTPase KRas, N-terminally processed								0.0011		-3.9					A:K5-C:E3 (PDBs: 7ACA), B:K5-C:E3 (PDBs: 7ACF), A:K5-B:E3 (PDBs: 7ACQ), B:K5-A:E3 (PDBs: 7ACQ)			 K5-G77 (PAE:  1.0), K5-E76 (PAE: 1.0)	K5-E76 (PDBs: 4L8G, 4LDJ, 4LYJ, 5OCG, 5V9O, 6E6G, 6GJ6, 6GJ7, 6GJ8, 6GOD, 6M9W, 6MBQ, 6MQG, 6T5B, 6T5V, 6V5L, 6ZL5, 7KYZ, 7LGI, 7MQU, 7R0N, 8AFB, 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8B78, 8CPR, 8JHL, 8ONV, 8QUG, 3GFT, 4LPK, 4LRW, 4LUC, 4LV6, 4LYF, 4LYH, 4M1O, 4M1S, 4M1T, 4M1W, 4M1Y, 4M21, 4M22, 4OBE, 4TQA, 5KYK, 5UK9, 5V9L, 5VQ2, 6BOF, 6MBT, 6MBU, 6MNX, 6MQN, 6MS9, 6MTA, 6O36, 6O46, 6P0Z, 6QUU, 6QUV, 6QUW, 6QUX, 6VC8, 6ZLI, 7ACA, 7ACF, 7ACH, 7ACQ, 7O70, 7R0M, 7R0Q, 8AFC, 8AFD, 8AQ7, 8B6I, 8T71, 8T72, 8UN5, 2MSC, 2MSD, 2MSE, 5MLA, 5MLB, 5O2S, 5O2T, 5TAR, 5TB5, 5UFE, 5WLB, 5WPM, 6H46, 6H47, 6OB2, 6PTS, 6PTW, 6V65, 6VJJ, 6W4E, 6W4F, 6XHB, 6YR8, 6YXW, 7NY8, 7SCW, 7VVB, 8QVU, 8T74, 8T75, 8TBF), K5-D54 (PDBs: 8QUG), K5-G77 (PDBs: 8QUG, 8TBF), K5-S39 (PDBs: 8QUG, 8ECR, 8QU8)	 K5-G77 (PAE:  1.0), K5-E76 (PAE: 1.0)	K5-E76 (PDBs: 4L8G, 4LDJ, 4LYJ, 5OCG, 5V9O, 6E6G, 6GJ6, 6GJ7, 6GJ8, 6GOD, 6M9W, 6MBQ, 6MQG, 6T5B, 6T5V, 6V5L, 6ZL5, 7KYZ, 7LGI, 7MQU, 7R0N, 8AFB, 8JHL, 8QUG, 3GFT, 4LPK, 4LRW, 4LUC, 4LV6, 4LYF, 4LYH, 4M1O, 4M1S, 4M1T, 4M1W, 4M1Y, 4M21, 4M22, 4OBE, 4TQA, 5KYK, 5UK9, 5V9L, 5VQ2, 6BOF, 6MBT, 6MBU, 6MNX, 6MQN, 6MS9, 6MTA, 6O36, 6O46, 6P0Z, 6QUU, 6QUV, 6QUW, 6QUX, 6VC8, 6ZLI, 7ACA, 7ACF, 7ACH, 7ACQ, 7O70, 7R0M, 7R0Q, 8AFC, 8AFD, 2MSC, 2MSD, 2MSE, 5MLA, 5MLB, 5O2S, 5O2T, 5TAR, 5TB5, 5UFE, 5WLB, 5WPM, 6H46, 6H47, 6OB2, 6PTS, 6PTW, 6V65, 6VJJ, 6W4E, 6W4F, 6XHB, 6YR8, 6YXW, 7NY8, 7SCW, 7VVB, 8QVU, 8T74, 8T75, 8TBF), K5-T74 (PDBs: 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8B78, 8CPR, 8ONV, 8QUG, 8AQ7, 8B6I, 8ECR, 8T71, 8T72, 8UN5, 8QU8, 8TBF), K5-G77 (PDBs: 8QUG, 8TBF), K5-D54 (PDBs: 8QUG, 8TBF), K5-G75 (PDBs: 8QUG, 8TBF)		K5-E3 (PDBs: 6V5L, 7LGI, 7MQU, 6MBU, 6MS9, 6MTA, 2MSC, 6PTS, 6PTW, 8T75), K5-D54 (PDBs: 4OBE, 4TQA, 5V9L, 5VQ2, 6MBT, 6MQN, 6P0Z, 7ACA, 8T71, 5WLB, 8QU8), K5-E76 (PDBs: 2MSD, 2MSE, 6W4E, 6W4F)			Morphology: ___MtEykLVVVGAG		147									-88.1		Pocket 5: Mean pLDDT: 96.98, Volume: 218.96 Å³, Druggability score: 0		104.5				dbSNP: rs104894361; Variant type: LP/P; AA change: Lys5Asn; PTM type: Phosphorylation; PTM morphology: __MtEyk*LVVV; Var class: II&rs104894361		B (undefined)	E (parallel sheets)	Beta strand											98.33	43.90244	>90	10-90	615278	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	CARDIOFACIOCUTANEOUS SYNDROME 2	false	0.8111116633511135	0.7861208842914427	false	false	false
BRCA1	BRCA1_Arg595Gln	B_13-14	-1.2480440075438437	0.25214139106590744	0.33630590568148266	5.806878409546107	0.000658897044143643	0.0017077345706265326	2025_01_Batch_13-14	false	false	false	false	true	true	false	false	false	false	false	false	0.8420611368929223	0.862795892310036	0.8247579032659833	0.9228311095088264	0.9082138232615518	0.9174024760910724	0.874645668973899	0.9154634697391362	0.8902371531856264	0.7611713067676766	0.8509528008019327	0.8445432150857709	0.960159283208246	0.9009641767839673	0.9554250658320266	0.88834449976429	0.8746389838181392	0.8395790587000735	BRCA1	Arg595Gln	NC_000017.11:43063930:C:T	1784G>A	17	43063930	C	T	17	ENSG00000012048	14613	0	CCSBVarC003306	ALE00003306	ENSP00000417148.1	CEGS2	CegsMutGDEh1012	D06	GDEhDisVCh_40059	B04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	46192.0	single nucleotide variant	NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	May 10, 2017	41293459.0	-	RCV000031217|RCV000048790|RCV000131564|RCV000195350|RCV000735446|RCV000785422|RCV004554634|RCV002250479|RCV002496477|RCV003162265|RCV004802991	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267||MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0700268,MedGen:CN377757	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Ovarian neoplasm|BRCA1-related disorder|Familial cancer of breast|Fanconi anemia, complementation group S;Familial cancer of breast;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|Gastric cancer|BRCA1-related cancer predisposition	germline;maternal;unknown	germline	GRCh38	NC_000017.11	17	43063930.0	43063930.0	17q21.31	reviewed by expert panel	49.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003235,UniProtKB:P38398#VAR_070501,OMIM:113705.0037	3.0	37636.0	43063930.0	C	T	-	-	-	-	-	-	5096G>A 	Arg1699Gln	NM_007294.4	3.0	Pathogenic	Pathogenic	37636	17	43063930.0	C	T	R	Q	rs41293459	17	41215947	17	38469473	1699	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5096G>A	p.Arg1699Gln	principal2	Y	1	.	.	-	CGG	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.995	0.90580	D	0.454	0.97365	P	.	0.97926	.	.	.	.	3.23	0.89408	M	.	0.63232	.	.	0.96659	0.9361	0.96178	D	0.8732	0.95778	D	10	.	0.83114	.	0.74691	0.97975	D	.	0.92843	.	.	.	.	.	.	0.96647	.	0.87449	.	0.39535	0.661911010742	0.61621	T	0.392783	0.80349	T	0.34877	0.86324	D	0.419574	0.92678	D	0.950455367565155	0.63113	D	.	0.97283	.	0.96523166	0.97765	0.7972393	0.87946	0.9692461	0.98160	0.77520096	0.86571	-11.318	0.81678	D	.	0.82063	.	0.987067707466189	0.87311	0.99990070	0.99879	0.902	0.94843	.	.	.	.	.	.	5.19884	0.87233	29.2	0.99957871779371688	0.99986	0.805899	0.72937	D	0.871042515796463	0.90217	10.32869	0.832238134394619	0.91891	11.14783	5.83	5.83	0.93049	.	.	4.855	0.62708	7.634000	0.62929	0.53	0.24764	1.0	0.71675	1.000000	0.68239	0.998	0.85369	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	2	109352	1.828960e-05	0	4	207994	1.923130e-05	0	6	236774	2.534060e-05	0	0	7152	0.000000e+00	0	0	17106	0.000000e+00	0	0	2310	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	2	42748	4.678580e-05	0	0	15686	0.000000e+00	0	2	42748	4.678580e-05	0	0	16198	0.000000e+00	0	0	30512	0.000000e+00	0	0	6206	0.000000e+00	0	0	13408	0.000000e+00	0	0	16734	0.000000e+00	0	4	89478	4.470370e-05	0	0	30598	0.000000e+00	0	4	89478	4.470370e-05	0	0	14886	0.000000e+00	0	0	34248	0.000000e+00	0	0	9556	0.000000e+00	0	0	17686	0.000000e+00	0	0	21630	0.000000e+00	0	6	102642	5.845560e-05	0	0	30516	0.000000e+00	0	6	102642	5.845560e-05	0	.	30	1613816	1.858950e-05	0	3	44856	6.688070e-05	0	0	74854	0.000000e+00	0	0	912	0.000000e+00	0	0	59980	0.000000e+00	0	0	29598	0.000000e+00	0	3	44856	6.688070e-05	0	0	64006	0.000000e+00	0	0	6084	0.000000e+00	0	25	1179960	2.118720e-05	0	1	91080	1.097940e-05	0	0	49660	0	0	364	0	0	398	0	0	9488	0	0	498	0	0	802	0	0	62	0	0	146	0	0	2420	0	0	9852	0	0	460	0	0	63838	0	BRCA1-related_disorder|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Ovarian_neoplasm|Gastric_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	reviewed_by_expert_panel	NC_000017.11:g.43063930C>T	ClinGen:CA003235|OMIM:113705.0037|UniProtKB:P38398#VAR_070501	C0346153|C3280442|C2676676|C4554406|C0677776|CN221562|C0919267|C0024623|C0027672|C3661900	114480|614320|604370|617883|613659	227535|1333|145|145|140162	BRCT domain|BRCT domain|BRCT domain	Arg	Gln	96.0	0.2862903225806452																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																96.0	28.629032	>90	10-90	604370;114480;617883;114480;604370;614320;613659	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; GASTRIC CANCER	false	0.862795892310036	0.8420611368929223	false	false	false
RAF1	RAF1_Leu603Pro	B_13-14	-1.790881684197182	1.0	1.0	-6.4739177359242595	0.020788784472461172	0.028945740909541964	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9518524149606299	0.9507429984006455	0.7238448407626084	0.7344957654227868	0.7625614436297714	0.7772416855210806	0.8102218623084947	0.7656539210236774	0.7120847284454354	0.7755765371971134	0.9629181474645159	0.9647239296668854	0.7442615087336665	0.7594689662358655	0.7569068024001382	0.6721131443281033	0.9385678493367752	0.9389809002543744	RAF1	Leu603Pro	NC_000003.12:12584653:A:G	1808T>C	3	12584653	A	G	3	ENSG00000132155	732	0	CCSBVarC008861	ALE00012511	ENSP00000251849.4																																	152010.0	single nucleotide variant	NM_002880.4(RAF1):c.1808T>C (p.Leu603Pro)	5894.0	RAF1	HGNC:9829	Pathogenic	1.0	Jun 01, 2014	587777586.0	-	RCV000131334	MONDO:MONDO:0014396,MedGen:C4014656,OMIM:615916,Orphanet:154	Dilated cardiomyopathy 1NN	germline	germline	GRCh38	NC_000003.12	3	12584653.0	12584653.0	3p25.2	no assertion criteria provided	1.0	-	N	ClinGen:CA167980,UniProtKB:P04049#VAR_071847,OMIM:164760.0005	1.0	142296.0	12584653.0	A	G	-	-	-	-	-	-	1808T>C 	Leu603Pro	NM_002880.4		Pathogenic	Pathogenic	142296	3	12584653.0	A	G	L	P	rs587777586	3	12626152	3	12601152	603	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1808T>C	p.Leu603Pro	c.1808T>C	p.Leu603Pro	principal3	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.006	0.72530	D	1.0	0.90580	D	0.999	0.92348	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.055	0.86694	M	-5.94	0.89120	D	0.954	0.97221	1.0563	0.98251	D	0.9820	0.99448	D	10	0.9554792	0.94850	D	0.905219	0.99287	D	0.986	0.99942	0.791	0.91245	P04049	L603P	Gain of disorder (P = 0.017)| Gain of helix (P = 0.0325)| Gain of glycosylation at S604 (P = 0.0488)| Loss of loop (P = 0.0804)| Loss of stability (P = 0.1069)	0.973766025508	0.97323	.	0.95923	1.08258798955	0.77046	0.886617004871	0.94825	D	0.932912	0.98867	D	0.575938	0.96897	D	0.589519	0.96846	D	0.999162554740906	0.96363	D	.	0.93270	.	0.99187005	0.99851	0.9862118	0.99940	0.9903099	0.99776	0.98532397	0.99928	-13.29	0.90541	D	0.9993	0.98761	P	0.999902317115662	0.98723	0.99897957	0.99072	0.987	0.99559	.	.	.	.	.	.	5.064217	0.84452	28.3	0.99912388320110823	0.98168	0.956235	0.97455	D	0.915325109665532	0.92448	11.45292	0.863677081222081	0.93754	12.28152	5.51	5.51	0.81744	.	.	8.809	0.91585	11.190000	0.88645	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Dilated_cardiomyopathy_1NN	no_assertion_criteria_provided	NC_000003.12:g.12584653A>G	ClinGen:CA167980|OMIM:164760.0005|UniProtKB:P04049#VAR_071847	C4014656	615916	154	Protein kinase domain|Protein kinase domain|Protein kinase domain	Leu	Pro	95.67	0.12195121951219512																																																																																																																																																																																																																																																																																																																																																																																																																																																																													20			95.67	Aliphatic	Leucine		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase			3.8								 L603-E607 (PAE:  1.0), L603-F599 (PAE: 1.0)	L603-F599 (PDBs: 3OMV, 7Z38, 8CHF, 8CPD, 8GAE, 8GFT, 8U1L), L603-E607 (PDBs: 8U1L)	 L603-E607 (PAE:  1.0), L603-F599 (PAE: 1.0)	L603-F599 (PDBs: 3OMV, 7Z38, 8CHF, 8GAE, 8GFT, 8U1L), L603-E607 (PDBs: 8CPD, 8U1L)							131									-59.9				-48.2						H (helix)	H (α-helix)	Helix											95.67	12.195122	>90	10-90	615916	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOMYOPATHY, DILATED, 1NN	false	0.9507429984006455	0.9518524149606299	false	false	false
F9	F9_Gly442Arg	B_13-14	1.7405705383053478	0.1253045662462782	0.19610242379124587	-1.8000237000578818	0.11488046831135514	0.14961366880861368	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.597150738603515	0.5810859123957921	0.6092147526687453	0.6271763445400491	0.6192391490851533	0.6489502338587674	0.7323074696778342	0.7573064376731917	0.765709407654548	0.6432833279432084	0.6366923730535496	0.6764777102513662	0.5655929980397005	0.48117186049711497	0.4886432814255503	0.5751461773942821	0.5254794517380346	0.5178237669556638	F9	Gly442Arg	NC_000023.11:139562009:G:A	1324G>A	23	139562009	G	A	X	ENSG00000101981	52861	0	CCSBVarC004397	ALE00004397	ENSP00000218099.2	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25663.0	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 11, 2013	137852267.0	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009.0	139562009.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1.0	10624.0	139562009.0	G	A	-	-	-	-	-	-	1324G>A 	Gly442Arg	NM_000133.4		Pathogenic	Pathogenic	10624	X	139562009.0	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	90.12	0.0																																																																																																																																																																																																																																																																																																																																																																																																															1.05		0.861		0.844	1 mutation(s) (Gly442Ter: -0.015)	0.823		0.845																																																						0			90.12	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-0.4								 G442-A397 (PAE:  1.0)	G442-A397 (PDBs: 6X5J, 6X5L, 8OL9)	 G442-A397 (PAE:  1.0), G442-D405 (PAE: 6.5)	G442-D405 (PDBs: 6X5J, 6X5L, 8OL9), G442-C396 (PDBs: 8OL9), G442-A397 (PDBs: 8OL9), G442-W431 (PDBs: 8OL9)							75									-67.9				141.7						B (undefined)	E (parallel sheets)	Beta strand											90.12	0.0	>90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.5810859123957921	0.597150738603515	false	false	false
F9	F9_Trp453Arg	B_13-14	-4.222977072156634	0.0055429861400118005	0.017246641574135933	4.415149146023866	0.003099428650434033	0.006202237266680971	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9596832700670044	0.9620809727927975	0.5721610316665857	0.8267101915314761	0.7397403614298181	0.6808026268360181	0.6808026268360181	0.6317423640136428	0.7874009820310356	0.5721610316665857	0.9461511664421499	0.9311219723308604		0.8477383588459934	0.8660194010319167		0.9780107791434449	0.9882445678031483	F9	Trp453Arg	NC_000023.11:139562042:T:C	1357T>C	23	139562042	T	C	X	ENSG00000101981	52861	0	CCSBVarC004398	ALE00004398	ENSP00000218099.2	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25667.0	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	137852269.0	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042.0	139562042.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1.0	10628.0	139562042.0	T	C	-	-	-	-	-	-	1357T>C 	Trp453Arg	NM_000133.4		Pathogenic	Pathogenic	10628	X	139562042.0	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	97.31	0.09691629955947137																																																																																																																																																																																																																																																																																																																																																																																																															0.112	1 mutation(s) (Trp453Arg: 0.005)	0.073	1 mutation(s) (Trp453Lys: -0.000)	0.035	4 mutation(s) (Trp453Pro: -0.021, Trp453His: -0.008, Trp453Val: -0.007, Trp453Lys: -0.005)	0.041	1 mutation(s) (Trp453Pro: -0.004)	0.041	6 mutation(s) (Trp453Pro: -0.049, Trp453Lys: -0.008, Trp453Glu: -0.007, Trp453Ile: -0.005, Trp453Cys: -0.002, Trp453Gln: -0.002)																																																					22			97.31	Aromatic	Tryptophan		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-0.9								 W453-K457 (PAE:  1.0)	W453-K457 (PDBs: 6X5J, 6X5L)	 W453-K457 (PAE:  1.0)	W453-K457 (PDBs: 6X5J, 6X5L, 8OL9)							204									-66.9				-41.7						H (helix)	H (α-helix)	Helix											97.31	9.69163	>90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.9620809727927975	0.9596832700670044	false	false	false
SDHD	SDHD_His102Leu	B_13-14	10.438326676694441	0.000021211171344780724	0.0003302927392368711	10.675261658839622	0.00033573179036110016	0.0008712965627157731	2025_01_Batch_13-14	false	true	false	false	true	false	false	false	false	false	false	false	0.9577384309626356	0.9645863304668809	0.778995606127943	0.8780320935728738	0.8917712719921207	0.8888613147151811	0.8296618179170914	0.8935095438803589	0.8495550999557546	0.7431072848679399	0.9660175919493953	0.9688257039991928	0.9480608115132708	0.8900330001038826	0.906509087189993	0.8148839273879461	0.9631550689843665	0.9466511579260785	SDHD	His102Leu	NC_000011.10:112089002:A:T	305A>T	11	112089002	A	T	11	ENSG00000204370	5678	201957	CCSBVarC006160	ALE00006160	ENSP00000364699.3	CEGS2	CegsMutGDEh1014	D09	GDEhDisVCh_40066	F02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	21937.0	single nucleotide variant	NM_003002.4(SDHD):c.305A>T (p.His102Leu)	6392.0	SDHD	HGNC:10683	Pathogenic	1.0	Jul 01, 2021	104894302.0	-	RCV000007307|RCV000566289|RCV002228003	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	germline	germline	GRCh38	NC_000011.10	11	112089002.0	112089002.0	11q23.1	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016665,UniProtKB:O14521#VAR_010040,OMIM:602690.0005	3.0	6898.0	112089002.0	A	T	-	-	-	-	-	-	305A>T 	His102Leu	NM_003002.4	2.0	Pathogenic	Pathogenic	6898	11	112089002.0	A	T	H	L	rs104894302	11	111959726	11	111464936	102	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.305A>T	p.His102Leu	c.305A>T	p.His102Leu	principal1	Y	1	YES	Select	+	CAT	2	0	A	./.	./.	./.	./.	0.001	0.91343	D	0.002	0.92967	D	0.999	0.77914	D	0.928	0.66273	D	0.99	0.99291	A	simple_aae	1.0	99.0	3.925	0.96220	H	-10.94	0.99269	D	0.946	0.98282	0.8082	0.94493	D	0.9985	0.99959	D	9	0.99472225	0.99961	D	0.795712	0.98395	D	0.909	0.97545	0.988	0.99876	O14521	H102L	Loss of catalytic residue at G103 (P = 0.0541)| Gain of helix (P = 0.2294)| Loss of disorder (P = 0.6187)| Gain of stability (P = 0.6318)| Gain of loop (P = 0.6993)	0.994554434502	0.99442	0.9890505541009824	0.98896	0.822681584721	0.67039	0.580342292786	0.50068	T	0.976715	0.99780	D	0.566984	0.96335	D	0.576657	0.96276	D	0.999900341033936	0.99626	D	0.716128	0.45817	T	0.8378367	0.86274	0.7502163	0.85055	0.8351151	0.86080	0.7859342	0.87236	-9.818	0.80483	D	0.8306	0.78714	P	0.996540517566282	0.92238	0.99904233	0.99109	0.983	0.99413	.	.	.	.	.	.	4.855792	0.79446	27.1	0.96663677478836951	0.30834	0.948642	0.96033	D	0.654068949213661	0.76505	6.522557	0.496041743816457	0.67552	5.122925	5.04	3.86	0.43622	.	.	8.712	0.9112	9.318000	0.80050	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.699	0.34149	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112089002A>T	ClinGen:CA016665|OMIM:602690.0005|UniProtKB:O14521#VAR_010040	C0027672|CN166604|C1868633|C0031511|C1847319|C3494181	171300|606864|168000	140162|201|29072|97286|29072	.	His	Leu	98.8	0.3858695652173913																																																																																																																																																																																																																																																																																																																																																																																																																																																																													71			98.8	Positively-charged	Histidine	heme b	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-3.2								 H102-G106 (PAE:  1.0), H102-A98 (PAE: 1.0)	H102-G106 (PDBs: 8GS8), H102-A98 (PDBs: 8GS8)	 H102-S73 (PAE:  1.0), H102-G106 (PAE: 1.0), H102-A98 (PAE: 1.0)	H102-V72 (PDBs: 8GS8), H102-G106 (PDBs: 8GS8), H102-A98 (PDBs: 8GS8), H102-S73 (PDBs: 8GS8)							155									-59.3		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-46.5						H (helix)	H (α-helix)	Helix								Helical			98.8	38.586956	>90	10-90	168000;171300;606864	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	false	0.9645863304668809	0.9577384309626356	true	false	false
BRAF	BRAF_Leu245Phe	B_13-14	-6.838409603080999	0.00024453937326696584	0.0016504247453706883	2.8902583829788178	0.02330765356847928	0.036062010369443065	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7638380410887531	0.7839102225381593	0.6793787601514603	0.7833403559472186	0.7414422053484204	0.7366099627720781	0.8369673366827362	0.7920711989368122	0.800163821962671	0.7628317833812533	0.795060627402024	0.7546858534858414	0.6362525888614201	0.6908132117600287	0.7665168899317663	0.5959257369216673	0.7727598176742948	0.7729902286916648	BRAF	Leu245Phe	NC_000007.14:140801537:T:A	735A>T	7	140801537	T	A	7	ENSG00000157764	71969	0	CCSBVarC003155	ALE00003155	ENSP00000493543.1	CEGS2	CegsMutGDEh1028	A06	GDEhDisVCh_40058	E10	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	48818.0	single nucleotide variant	NM_004333.6(BRAF):c.735A>T (p.Leu245Phe)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	May 10, 2019	397507466.0	-	RCV000788012|RCV000688777|RCV002273939|RCV000033284|RCV000055897|RCV000037957	MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MedGen:C3661900|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	Noonan syndrome and Noonan-related syndrome|RASopathy|Neurodevelopmental delay|not provided|Noonan syndrome with multiple lentigines|Cardio-facio-cutaneous syndrome	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140801537.0	140801537.0	7q34	reviewed by expert panel	6.0	-	N	ClinGen:CA280029,UniProtKB:P15056#VAR_058623	3.0	40348.0	140801537.0	T	A	-	-	-	-	-	-	735A>T 	Leu245Phe	NM_004333.6	3.0	Pathogenic	Pathogenic	40348	7	140801537.0	T	A	L	F	rs397507466	7	140501337	7	140147806	245	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.735A>T	p.Leu245Phe	c.735A>T	p.Leu245Phe	principal4	Y	.	YES	Select	-	TTA	3	2	T	./.	./.	./.	./.	.	0.72322	.	.	0.74454	.	0.817	0.45628	P	0.556	0.49409	P	.	0.93829	.	.	.	.	1.93	0.51259	L	.	0.59576	.	.	0.89792	0.5278	0.90900	D	0.7689	0.92118	D	10	0.9152295	0.90783	D	0.407429	0.93514	D	.	0.94750	0.828	0.93817	P15056	L245F	Loss of ubiquitination at K240 (P = 0.1231)| Gain of MoRF binding (P = 0.2184)| Gain of methylation at K240 (P = 0.3546)| Loss of loop (P = 0.3664)| Loss of helix (P = 0.3949)	.	0.99312	.	0.87638	.	0.95469	0.921125054359	0.98407	D	0.901578	0.98053	D	0.430121	0.91476	D	0.380062	0.91371	D	0.966380715370178	0.67355	D	0.982152	0.93952	D	0.8534249	0.87422	0.7093109	0.82655	0.84129506	0.86525	0.7422232	0.84579	-9.514	0.71025	D	0.9939	0.96927	P	0.997428543660156	0.93122	0.98961290	0.96672	0.984	0.99450	.	.	.	.	.	.	4.42959	0.68734	25.3	0.99892765569899233	0.96668	0.414992	0.48227	N	0.326061389643417	0.57270	3.916485	0.339330026637409	0.57643	3.954269	5.43	4.28	0.50124	4.59	0.85410	3.384	0.5231	5.043000	0.47004	0.661	0.55789	1.0	0.71675	1.000000	0.68239	1.0	0.97202	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Neurodevelopmental_delay|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_with_multiple_lentigines|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140801537T>A	ClinGen:CA280029|UniProtKB:P15056#VAR_058623	C4022738|C1275081|C0175704|C5681679|C5555857|C3661900	PS115150|PS151100	1340|500|98733|536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Leu	Phe	84.36	0.8841463414634146																																																																																																																																																																																																																																																																																																																																																																																																																																																																													145			84.36	Aliphatic	Leucine		Serine/threonine-protein kinase B-raf										3.8											L245-L254 (PDBs: 8DGT)							131									-55.0				109.9				dbSNP: rs397507466; Variant type: LP/P; AA change: Leu245Phe; PTM type: Phosphorylation; PTM morphology: RKTFFtL*AFCD; Var class: II		C (loop/coil)	C (loop/coil)											Phorbol-ester/DAG-type	84.36	88.414635	70-90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.7839102225381593	0.7638380410887531	false	false	false
F9	F9_Arg379Gln	B_13-14	-2.6628463076730364	0.03233336193180533	0.06626257649114613	1.0691261677479627	0.32048795721115075	0.3738686595565554	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7126981089979687	0.7425125345685835	0.6952755522757028	0.7869701191852989	0.7096493822184742	0.7594412785535007	0.6234251115378505	0.6022310917324372	0.681231401681047	0.5854245114609621	0.6463998058945514	0.6322889619899366	0.8954574455691509	0.8170676727045113	0.8927088366895507	0.8051265930904435	0.8386252632426154	0.793107256006001	F9	Arg379Gln	NC_000023.11:139561821:G:A	1136G>A	23	139561821	G	A	X	ENSG00000101981	52861	0	CCSBVarC004388	ALE00004388	ENSP00000218099.2	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25652.0	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 05, 2024	137852259.0	-	RCV000011359|RCV001851792|RCV001000156|RCV000851995|RCV004799740	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821.0	139561821.0	Xq27.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3.0	10613.0	139561821.0	G	A	-	-	-	-	-	-	1136G>A 	Arg379Gln	NM_000133.4	2.0	Pathogenic	Pathogenic	10613	X	139561821.0	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	92.81	0.4112903225806452																																																																																																																																																																																																																																																																																																																																																																																																															1.205	1 mutation(s) (Arg379Glu: 1.342)	0.981		0.956		0.972		0.977																																																						102			92.81	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-4.5								 R379-Y391 (PAE:  2.0), R379-I390 (PAE: 2.0), R379-L383 (PAE: 1.0)	R379-L383 (PDBs: 6X5J, 6X5L, 8OL9), R379-Y391 (PDBs: 8OL9), R379-I390 (PDBs: 8OL9)	 R379-L383 (PAE:  1.0)	R379-L383 (PDBs: 6X5J, 6X5L, 8OL9)							175									-62.8				-34.1				dbSNP: rs137852258; Variant type: LP/P; AA change: Arg379Gly; PTM type: Phosphorylation; PTM morphology: LVDR*AtCLRST; Var class: II&rs137852259		H (helix)	H (α-helix)	Helix											92.81	41.129032	>90	10-90	306900;306900;300807;306700	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA A	false	0.7425125345685835	0.7126981089979687	false	false	false
BRAF	BRAF_Leu485Phe	B_13-14	-3.8216848768826113	0.006527941362460827	0.019678315994699477	3.0948589616255147	0.017447636321062537	0.027937532852661217	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6237026385756181	0.6543464956772951	0.494893713105586	0.6303768653687527	0.5660045242668977	0.5542527174288377	0.5104940211471254	0.5534417343243074	0.5979084281940278	0.47743280688673695	0.6878831048235545	0.6756443491835655	0.5980114137105501	0.578567314209488	0.6628453025434777	0.512354619324435	0.6208098865310356	0.5717609279676706	BRAF	Leu485Phe	NC_000007.14:140778053:C:G	1455G>C	7	140778053	C	G	7	ENSG00000157764	71969	0	CCSBVarC003163	ALE00003163	ENSP00000493543.1	CEGS2	CegsMutGDEh1018	H07	GDEhDisVCh_40058	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	29014.0	single nucleotide variant	NM_004333.6(BRAF):c.1455G>C (p.Leu485Phe)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Feb 28, 2020	180177036.0	-	RCV000015009|RCV000211749|RCV000680805|RCV001849264|RCV000208764|RCV001172276|RCV003415705|RCV004018629	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||MedGen:CN230736	Cardiofaciocutaneous syndrome 1|Noonan syndrome;Cardio-facio-cutaneous syndrome|not provided|Ataxia-telangiectasia syndrome|Cardio-facio-cutaneous syndrome|RASopathy|BRAF-related disorder|Cardiovascular phenotype	germline	germline	GRCh38	NC_000007.14	7	140778053.0	140778053.0	7q34	reviewed by expert panel	13.0	-	N	ClinGen:CA273414,UniProtKB:P15056#VAR_026115,OMIM:164757.0015	3.0	13975.0	140778053.0	C	G	-	-	-	-	-	-	1455G>C 	Leu485Phe	NM_004333.6	3.0	Pathogenic	Pathogenic	13975	7	140778053.0	C	G	L	F	rs180177036	7	140477853	7	140124322	485	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1455G>C	p.Leu485Phe	c.1455G>C	p.Leu485Phe	principal4	Y	.	YES	Select	-	TTG	3	2	C	./.	./.	./.	./.	.	0.20412	.	.	.	.	0.264	0.31620	B	0.309	0.41361	B	.	0.97926	.	.	.	.	1.13	0.28751	L	.	0.43153	.	.	.	-0.7046	0.60048	T	0.1770	0.52004	T	9	0.94275165	0.93527	D	0.08652	0.74669	D	.	0.91679	0.859	0.95694	P15056	L485F	Gain of catalytic residue at L485 (P = 0.046)| Loss of ubiquitination at K483 (P = 0.1322)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.1405)| Loss of glycosylation at P490 (P = 0.2882)	.	0.99026	.	0.81127	.	0.95017	0.899181604385	0.96345	D	0.854571	0.96693	D	0.40148	0.89929	D	0.338922	0.89804	D	0.993222117424011	0.83810	D	0.993067	0.97789	D	0.9472474	0.95923	0.87014675	0.92780	0.94315636	0.95501	0.88148624	0.93580	-10.017	0.74092	D	0.9978	0.97942	P	0.999864334331402	0.98431	0.99597543	0.97927	0.953	0.97907	.	.	.	.	.	.	4.137508	0.6203	24.4	0.99892768971460666	0.96668	0.649139	0.62235	D	0.19994089429288	0.50957	3.302872	0.260588829807926	0.53010	3.495244	5.03	4.14	0.47761	4.1	0.78208	5.0	0.63767	4.860000	0.45538	0.545	0.25635	1.0	0.71675	1.000000	0.68239	0.999	0.91597	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BRAF-related_disorder|Ataxia-telangiectasia_syndrome|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|Cardiofaciocutaneous_syndrome_1|Cardiovascular_phenotype|not_provided|RASopathy	reviewed_by_expert_panel	NC_000007.14:g.140778053C>G	ClinGen:CA273414|OMIM:164757.0015|UniProtKB:P15056#VAR_026115	C0004135|C0028326|C1275081|CN029449|CN230736|C3661900|C5555857	208900|PS163950|PS115150|115150	100|648|1340|1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Leu	Phe	82.49	0.03048780487804878																																																																																																	6.959																																																																																																																																																																																																																																																																																																																																																																												5			82.49	Aliphatic	Leucine		Serine/threonine-protein kinase B-raf							Protein kinase			3.8								 L485-L525 (PAE:  1.5)	L485-L525 (PDBs: 5CSX, 6P3D, 2FB8, 3D4Q, 3II5, 3PPJ, 3PPK, 3PRF, 3PSB, 3PSD, 3Q96, 3SKC, 3TV4, 3TV6, 4DBN, 4E4X, 4EHE, 4FC0, 4H58, 4KSP, 4KSQ, 4MBJ, 4PP7, 5CSW, 5CT7, 5FD2, 5HID, 5HIE, 5VAL, 5VAM, 6B8U, 6CAD, 6N0P, 6N0Q, 6V2U, 7P3V, 7SHV, 8C7X, 8C7Y, 8F7O, 8F7P, 8QQG, 4MNE, 6PP9, 6Q0K, 6U2G, 6U2H, 6UAN, 6V2W, 6XAG, 7M0U, 7M0V, 7M0X, 7M0Y, 7M0Z, 8DGT)		L485-Q524 (PDBs: 5CSX, 4KSP, 5CT7, 5FD2, 5VAL, 5VAM, 6B8U, 6N0P, 6N0Q, 4MNE, 6UAN, 6XAG, 7MFD), L485-Q494 (PDBs: 3D4Q, 3PPJ, 3PPK, 8C7X, 8C7Y, 8QQG), L485-F498 (PDBs: 3PRI), L485-A526 (PDBs: 3SKC, 3TV4, 3TV6, 4E4X, 4EHE, 4MBJ), L485-F468 (PDBs: 4H58, 8F7O, 8F7P, 8DGS, 8DGT), L485-T491 (PDBs: 5HID), L485-L495 (PDBs: 5HIE), L485-L525 (PDBs: 7P3V, 7MFF, 8DGT), L485-I527 (PDBs: 8DGT), L485-V600 (PDBs: 8DGT)							131									-81.5				147.6						B (undefined)	E (parallel sheets)												82.49	3.0487804	70-90	<10	115150;208900	multiple	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1; ATAXIA-TELANGIECTASIA	false	0.6543464956772951	0.6237026385756181	false	false	false
F9	F9_Asp110Gly	B_13-14	-4.032269083219418	0.00498144213801118	0.015857590806002256	2.9476460677186003	0.021478578999262612	0.033600334581114145	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8529336918497796	0.8534943806277739	0.599326819348096	0.9137294466722162	0.8089803061282973	0.8633669615722563	0.8511059299838629	0.8446920431553131	0.9067667306148158	0.5222596029556514	0.8741215950212369	0.8655919673594739	0.8756279931606497	0.7732685691012815	0.9206921627296166	0.6763940357405405	0.832867166234311	0.8402754163400854	F9	Asp110Gly	NC_000023.11:139541127:A:G	329A>G	23	139541127	A	G	X	ENSG00000101981	52861	0	CCSBVarC004377	ALE00004377	ENSP00000218099.2	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25619.0	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Apr 01, 1989	137852234.0	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127.0	139541127.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255331,OMIM:300746.0023	1.0	10580.0	139541127.0	A	G	-	-	-	-	-	-	329A>G 	Asp110Gly	NM_000133.4		Pathogenic	Pathogenic	10580	X	139541127.0	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	87.17	0.18404907975460122																																																																																																																																																																																																																																																																																																																																																																																																															1.153	2 mutation(s) (Asp110Gly: 1.356, Asp110Lys: 1.359)	1.078	7 mutation(s) (Asp110Thr: 1.169, Asp110Ala: 1.172, Asp110Pro: 1.179, Asp110His: 1.180, Asp110Gln: 1.192, Asp110Gly: 1.196, Asp110Lys: 1.206)	0.924	1 mutation(s) (Asp110Ser: 1.135)	0.967		0.706																																																						30			87.17	Negatively-charged	Aspartic Acid	Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain							EGF-like 1; calcium-binding			-3.5			B:D110-C:N104 (PDBs: 1EDM, 5VYG), B:D110-C:G105 (PDBs: 5VYG), A:D110-B:N104 (PDBs: 5VYG), A:D110-B:G105 (PDBs: 5VYG)	B:D110-C:N104 (PDBs: 1EDM, 5VYG), B:D110-C:G105 (PDBs: 5VYG)				 D110-Q96 (PAE:  2.0)	D110-Q96 (PDBs: 1EDM, 5VYG, 5F84), D110-C97 (PDBs: 5F85, 5F86)	 D110-C97 (PAE:  1.5)	D110-C97 (PDBs: 1EDM, 5VYG, 5F84, 5F85, 5F86)						(3R)-3-hydroxyaspartate	132									-72.1				143.4				dbSNP: rs137852274; Variant type: LP/P; AA change: Asp110Asn; PTM type: Phosphorylation; PTM morphology: KD*DINsYECWC; Var class: II		B (undefined)	E (parallel sheets)	Beta strand											87.17	18.40491	70-90	10-90	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.8534943806277739	0.8529336918497796	false	false	false
ZC4H2	ZC4H2_Leu66His	B_13-14	-6.503081082564646	0.0003331667654269905	0.0020619410354956727	4.396655815279685	0.003169686792505649	0.0063015983361298655	2025_01_Batch_13-14	true	true	true	false	false	false	false	false	false	false	false	false	0.9820733711413498	0.9826473080152025	0.8589602504105225	0.756551711664641	0.8442965905619534	0.8828894118670891	0.8151927120142868	0.8459591165415604	0.6189805765892167	0.8507465572389834	0.9808720300434555	0.9822442403892754	0.9505861117198915	0.8426340645823464	0.8941228467400651	0.8671739435820615	0.9844225859869495	0.9819025018934242	ZC4H2	Leu66His	NC_000023.11:64921845:A:T	197T>A	23	64921845	A	T	X	ENSG00000126970	4320	0	CCSBVarC009188	ALE00013415	ENSP00000363972.3																																	380135.0	single nucleotide variant	NM_018684.4(ZC4H2):c.197T>A (p.Leu66His)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Mar 02, 2017	1057520297.0	-	RCV000425925	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64921845.0	64921845.0	Xq11.2	no assertion criteria provided	1.0	-	N	ClinGen:CA16609220,OMIM:300897.0005	1.0	378042.0	64921845.0	A	T	-	-	-	-	-	-	197T>A 	Leu66His	NM_018684.4		Pathogenic	Pathogenic	378042	X	64921845.0	A	T	L	H	rs1057520297	X	64141725	X	64058450	66	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.197T>A	p.Leu66His	c.197T>A	p.Leu66His	principal1	Y	1	YES	Select	-	CTC	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	0.94	0.94378	A	simple_aae	6.0	94.0	2.58	0.75182	M	-6.17	0.90790	D	0.966	0.97658	-0.4130	0.71488	T	0.3407	0.70541	T	9	0.91775376	0.91035	D	0.110217	0.78686	D	0.673	0.87862	0.827	0.93752	Q9NQZ6	L66H	Loss of stability (P = 0.0086)| Gain of disorder (P = 0.0553)| Loss of helix (P = 0.079)| Gain of catalytic residue at L68 (P = 0.0857)| Loss of MoRF binding (P = 0.5018)	0.958049427582	0.95723	0.9684491553990456	0.96815	2.23748090164	0.95976	0.934989273548	0.99245	D	0.857357	0.96779	D	0.55841	0.96027	D	0.564341	0.95964	D	0.997178673744202	0.90862	D	0.950605	0.87028	D	0.9276844	0.93915	0.8559096	0.91794	0.9275634	0.93903	0.858151	0.91947	-11.957	0.85475	D	1.0	0.99952	P	0.99974676713688	0.97751	0.99785450	0.98531	0.994	0.99793	.	.	.	.	.	.	4.36859	0.67299	25.1	0.98348546103222834	0.40650	.	.	.	.	.	.	.	.	.	5.7	4.54	0.55168	.	.	9.008	0.9315	11.114000	0.86409	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.995	0.73271	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64921845A>T	ClinGen:CA16609220|OMIM:300897.0005	C0796200	314580	3454|85283	.	Leu	His	93.3	0.5																																																																																																																																																																																																																																																																																																																																																																																																																																																																													82			93.3	Aliphatic	Leucine		Zinc finger C4H2 domain-containing protein	Coiled coil							0.0136		3.8								 L66-H62 (PAE:  1.0), L66-H70 (PAE: 1.0)		 L66-H62 (PAE:  1.0), L66-H70 (PAE: 1.0)								131									-61.8		Pocket 3: Mean pLDDT: 80.71, Volume: 332.58 Å³, Druggability score: 0.01		-37.9						H (helix)	H (α-helix)												93.3	50.0	>90	10-90	314580	x-linked recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	false	0.9826473080152025	0.9820733711413498	true	true	false
RPS19	RPS19_Val15Phe	B_13-14	-2.3726616409620696	0.0765985741724703	0.13168611761423787	-7.26643432023655	0.00016753500704300546	0.0005965012731618671	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9536368685492654	0.9458653747369388	0.6171291162584134	0.6989558853996078	0.5624076686333882	0.6618350611055541	0.6862668954536221	0.5694986352490707	0.6420952221178998	0.6462592826539488	0.9467640595194289	0.957838682225629	0.6374032267574861	0.5553167020177057	0.7558165486813158	0.5879989498628779	0.9449666899544487	0.9494350548729019	RPS19	Val15Phe	NC_000019.10:41860817:G:T	43G>T	19	41860817	G	T	19	ENSG00000105372	3441	0	CCSBVarC000466	ALE00000466	ENSP00000470972.1	RC4	RC4_Mut_GDEh1010	E11	GDEhDisVCh_40042	B02	2	RC4_Mut_GDDh1010	E11	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	21358.0	single nucleotide variant	NM_001022.4(RPS19):c.43G>T (p.Val15Phe)	6223.0	RPS19	HGNC:10402	Pathogenic	1.0	Aug 03, 2015	104894717.0	-	RCV000482973	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000019.10	19	41860817.0	41860817.0	19q13.2	criteria provided, single submitter	1.0	-	N	ClinVar:6319,ClinGen:CA045535,UniProtKB:P39019#VAR_018438,OMIM:603474.0007	2.0	242804.0	41860817.0	G	T	-	-	-	-	-	-	43G>T 	Val15Phe	NM_001022.4	1.0	Pathogenic	Pathogenic	242804	19	41860817.0	G	T	V	F	rs104894717	19	42364887	19	47056727	15	RPS19	ENSG00000105372	ENST00000598742	ENSP00000470972	P39019	RS19_HUMAN	c.43G>T	p.Val15Phe	c.43G>T	p.Val15Phe	principal1	Y	1	YES	Select	+	GTC	1	0	G	./.	./.	./.	./.	.	.	.	0.002	0.83643	D	0.997	0.70687	D	0.961	0.70481	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.395	0.91508	M	.	.	.	0.966	0.97658	-0.2458	0.76366	T	0.3830	0.73812	T	9	0.9739928	0.97062	D	0.40126	0.93389	D	.	.	0.909	0.98139	P39019	V15F	Loss of MoRF binding (P = 0.0787)| Loss of stability (P = 0.3828)| Loss of disorder (P = 0.4358)| Gain of methylation at R16 (P = 0.5521)| Loss of catalytic residue at F14 (P = 0.6366)	0.991857985221	0.99167	0.9614224850641426	0.96106	1.80914359211	0.91745	0.8935765028	0.95692	D	0.984477	0.99897	D	0.554303	0.95835	D	0.558441	0.95771	D	0.983127236366272	0.74730	D	.	0.56568	.	0.9801354	0.99104	0.91802967	0.96206	0.97457075	0.98647	0.9133168	0.95867	-13.184	0.90127	D	0.9629	0.91158	LP	0.997229277562924	0.92904	0.99992170	0.99909	0.795	0.88659	.	.	.	.	.	.	5.206373	0.87374	29.2	0.99412599951109681	0.63408	0.939381	0.93969	D	0.630628753833532	0.74985	6.250244	0.550537727116612	0.71277	5.654391	4.53	3.49	0.38994	.	.	6.938	0.75774	11.663000	0.94018	0.662	0.56385	1.0	0.71675	1.000000	0.68239	0.998	0.85369	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000019.10:g.41860817G>T	ClinGen:CA045535|OMIM:603474.0007|UniProtKB:P39019#VAR_018438	C3661900	.	.	.	Val	Phe	96.18	0.15492957746478872																																																																																																																																																																																																																																																																																																																																																																																																																																																																													22			96.18	Aliphatic	Valine		Small ribosomal subunit protein eS19								0.032		4.2								 V15-Q11 (PAE:  1.0), V15-A19 (PAE: 1.0)	V15-A19 (PDBs: 5A2Q, 5FLX, 5OA3, 6G18, 6G4S, 6G4W, 6YBS, 6ZLW, 6ZMT, 6ZN5, 6ZOJ, 6ZOL, 6ZUO, 6ZV6, 6ZVH, 6ZXD, 6ZXF, 6ZXG, 6ZXH, 7K5I, 7R4X, 7TQL, 7WTT, 7WTU, 7WTV, 7WTW, 7WTX, 7WTZ, 7WU0, 8PPK, 8T4S), V15-Q11 (PDBs: 6ZXE, 8T4S)	 V15-Q11 (PAE:  1.0), V15-A19 (PAE: 1.0)	V15-A19 (PDBs: 5A2Q, 5FLX, 5OA3, 6G18, 6G4S, 6G4W, 6YBS, 6ZLW, 6ZMT, 6ZN5, 6ZOJ, 6ZOL, 6ZUO, 6ZV6, 6ZVH, 6ZXD, 6ZXE, 6ZXF, 6ZXG, 6ZXH, 7K5I, 7R4X, 7TQL, 7WTT, 7WTU, 7WTV, 7WTW, 7WTX, 7WTZ, 7WU0, 8PPK, 8T4S), V15-S59 (PDBs: 6G5H), V15-Q11 (PDBs: 8T4S), V15-R62 (PDBs: 8T4S), V15-A58 (PDBs: 8T4S)							117									-63.3		Pocket 4: Mean pLDDT: 95.63, Volume: 462.36 Å³, Druggability score: 0.03		-41.1						H (helix)	H (α-helix)	Helix											96.18	15.492958	>90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare inborn errors of metabolism; Inherited cancer-predisposing syndrome	4		false	0.9458653747369388	0.9536368685492654	false	false	false
KRAS	KRAS_Pro34Leu	B_13-14	-1.422648105997645	0.1978359955775831	0.27866279613066647	5.607048332369264	0.0008099575857921664	0.0020084759053089533	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7892972196609729	0.8161540707216288	0.62149591315242	0.7495582859942083	0.7226184410245213	0.7118013981429762	0.4717155431463823	0.5845697520010791	0.5392100614012636	0.46629580881074106	0.7465770947034855	0.7217608848327199	0.95188725313957	0.8606671300479636	0.9599065105871528	0.7766960174940989	0.8857310467397722	0.8568335544892259	KRAS	Pro34Leu	NC_000012.12:25245284:G:A	101C>T	12	25245284	G	A	12	ENSG00000133703	3084	0	CCSBVarC006093	ALE00006093	ENSP00000308495.3	CEGS2	CegsMutGDEh1035	F07	GDEhDisVCh_40061	H08	1	CegsMutGDDh1035	F07	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	48924.0	single nucleotide variant	NM_004985.5(KRAS):c.101C>T (p.Pro34Leu)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Sep 17, 2024	104894366.0	-	RCV000150892|RCV000232330|RCV000157668|RCV003152670|RCV003450654	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	Noonan syndrome|RASopathy|not provided|Noonan syndrome 3|Noonan syndrome 1	de novo;germline;unknown	germline	GRCh38	NC_000012.12	12	25245284.0	25245284.0	12p12.1	reviewed by expert panel	7.0	-	N	ClinGen:CA235301,UniProtKB:P01116#VAR_064852	2.0	40454.0	25245284.0	G	A	-	-	-	-	-	-	101C>T 	Pro34Leu	NM_004985.5	3.0	Pathogenic	Pathogenic	40454	12	25245284.0	G	A	P	L	rs104894366	12	25398218	12	25289485	34	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.101C>T	p.Pro34Leu	c.101C>T	p.Pro34Leu	alternative1	Y	1	.	Plus_Clinical	-	CCA	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	3.155	0.88323	M	-8.45	0.98724	D	0.966	0.97658	0.8491	0.95002	D	0.8110	0.93606	D	10	0.9343852	0.92690	D	0.2884	0.90456	D	0.867	0.95976	0.768	0.89476	P01116	P34L	Gain of catalytic residue at I36 (P = 0.0054)| Loss of disorder (P = 0.0163)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.1364)| Loss of relative solvent accessibility (P = 0.1807)	0.993019268771	0.99286	0.9624586865523342	0.96210	2.72839044085	0.98645	0.913879752159	0.97821	D	0.916481	0.98452	D	0.461598	0.92940	D	0.425277	0.92852	D	0.999580919742584	0.98005	D	0.906909	0.69125	D	0.9735194	0.98554	0.9422203	0.97882	0.96042603	0.97281	0.9655402	0.99246	-15.775	0.98455	D	0.9976	0.97942	P	0.999893295116841	0.98645	0.99935130	0.99318	0.997	0.99892	.	.	.	.	.	.	5.430283	0.90819	31.0	0.99866189682566164	0.94461	0.907536	0.86118	D	1.07681546054986	0.97667	16.56095	1.0082682822431	0.98773	19.35518	5.68	5.68	0.88004	.	.	9.985	0.99185	11.891000	0.99094	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Noonan_syndrome|RASopathy|Noonan_syndrome_1|not_provided|Noonan_syndrome_3	reviewed_by_expert_panel	NC_000012.12:g.25245284G>A	ClinGen:CA235301|UniProtKB:P01116#VAR_064852	C0028326|C5555857|C4551602|C3661900|C1860991	PS163950|163950|609942	648|536391|648|648	Small GTP-binding domain	Pro	Leu	86.47	0.45588235294117646																																																																																																																																																																																					0.627						-0.051						-0.799						-0.99				-0.302				-0.504		-0.244		-0.318						-0.318						1.379		1.061	1 mutation(s) (Pro34Asn: 2.134)	0.507		0.398		0.429																																																																																																																																																																																																																																						62			86.47	Special, No backbone hydrogen	Proline	GTP	GTPase KRas; GTPase KRas, N-terminally processed								0.7716		1.6			A:P34-B:K66 (PDBs: 5MLA, 5O2T), B:P34-D:N371 (PDBs: 6PTS)	A:P34-B:R1276 (PDBs: 6OB2), B:P34-D:N371 (PDBs: 6PTS), A:P34-C:K128 (PDBs: 8T75)					P34-G60 (PDBs: 6T5V, 7R0N, 8AQ5, 8B78, 5V9L, 7R0M, 8AQ7, 8UN5)		P34-Q61 (PDBs: 6GJ8, 6QUU, 6QUV, 6QUW, 6QUX, 6ZLI, 7ACA, 7ACH, 5MLA, 5O2T, 6VJJ, 7SCW, 7VVB, 8T74), P34-G60 (PDBs: 6MBQ, 6T5V, 7R0N, 5V9L, 7R0M), P34-A59 (PDBs: 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8B78, 8JHL, 8ONV, 8QUG, 8AQ7, 8B6I, 8ECR, 8UN5, 8QU8, 8QVU), P34-S39 (PDBs: 8CPR), P34-S17 (PDBs: 8T71)							115	Effector region								-60.2		Pocket 1: Mean pLDDT: 82.52, Volume: 1126.64 Å³, Druggability score: 0.77		113.3				dbSNP: rs104894366; Variant type: LP/P; AA change: Pro34Arg; PTM type: Phosphorylation; PTM morphology: P*TIEDsyRkQV; Var class: II&rs104894366		C (loop/coil)	C (loop/coil)	Turn											86.47	45.588234	70-90	10-90	609942;163950	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	NOONAN SYNDROME 3; NOONAN SYNDROME 1	false	0.8161540707216288	0.7892972196609729	false	false	false
RHO	RHO_Pro267Thr	B_13-14	-6.437157064447852	0.0003545519851312502	0.002126651566841424	-14.907619954138292	1.465555727552797e-6	0.000020017998095403237	2025_01_Batch_13-14	true	true	false	false	false	false	false	true	false	false	false	false	0.987100173111567	0.9965851391198347	0.7511307561447335	0.8911219016779397	0.9050116920058741	0.9013049374372891	0.8471299929095787	0.8645084992343854	0.847764070960149	0.7039542103475596	0.9947871877626462	0.9837786295070642	0.9554798819649996	0.9455148847773627	0.9344797323957303	0.7983073019419074	0.9983830904770232	0.9904217167160698	RHO	Pro267Thr	NC_000003.12:129532635:C:A	799C>A	3	129532635	C	A	3	ENSG00000163914	40080645	0	CCSBVarC013575	ALE00014740	ENSP00000296271.3																																	827539.0	single nucleotide variant	NM_000539.3(RHO):c.799C>A (p.Pro267Thr)	6010.0	RHO	HGNC:10012	Pathogenic	1.0	May 22, 2023	2084789550.0	-	RCV001058214	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000003.12	3	129532635.0	129532635.0	3q22.1	criteria provided, single submitter	1.0	-	N	-	2.0	853413.0	129532635.0	C	A	-	-	-	-	-	-	799C>A 	Pro267Thr	NM_000539.3	1.0	Pathogenic	Pathogenic	853413	3	129532635.0	C	A	P	T	rs2084789550	3	129251478	3	130734168	267	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.799C>A	p.Pro267Thr	c.799C>A	p.Pro267Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	4.65	0.99359	H	-7.12	0.94038	D	0.965	0.97550	0.9999	0.97178	D	0.8404	0.94654	D	10	0.99142945	0.99666	D	0.443179	0.94193	D	0.946	0.98921	0.926	0.98766	P08100	P267T	Loss of glycosylation at S270 (P = 0.1504)| Gain of helix (P = 0.1736)| Gain of catalytic residue at P267 (P = 0.1854)| Loss of loop (P = 0.2897)| Loss of sheet (P = 0.302)	0.990985566321	0.99077	0.9222913745428601	0.92157	0.915089302012	0.71030	0.700365960598	0.67140	T	0.905498	0.98159	D	0.464614	0.93069	D	0.429609	0.92983	D	0.999821364879608	0.99193	D	0.989501	0.96561	D	0.9601639	0.97253	0.9319166	0.97186	0.9601639	0.97253	0.9319166	0.97186	-13.396	0.90947	D	0.9653	0.88720	P	0.999611079235613	0.97193	0.99991560	0.99909	0.995	0.99826	.	.	.	.	.	.	4.83405	0.78897	27.0	0.99803833658587948	0.88826	0.897847	0.83988	D	1.09702721159454	0.98067	17.37958	0.975528194122127	0.98084	17.41673	5.51	5.51	0.81744	.	.	7.9	0.86061	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.798	0.37682	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	not_provided	criteria_provided,_single_submitter	NC_000003.12:g.129532635C>A	.	C3661900	.	.	GPCR, rhodopsin-like, 7TM	Pro	Thr	97.49	0.3602941176470588																																																																																																																																																																																																																																																																																																																																																																																																																																																																													49			97.49	Special, No backbone hydrogen	Proline		Rhodopsin										1.6								 P267-V271 (PAE:  1.0)	P267-V271 (PDBs: 6CMO)	 P267-V271 (PAE:  1.0)	P267-V271 (PDBs: 6CMO)							115									-57.7				-43.4						H (helix)	H (α-helix)	Helix								Helical; Name=6			97.49	36.02941	>90	10-90		unknown		Rare genetic eye disease; Ciliopathy	2		false	0.9965851391198347	0.987100173111567	true	true	true
SDHD	SDHD_Tyr114Cys	B_13-14	4.506251060822262	0.004604751431917464	0.014131743593142029	-5.682189281819903	0.4870599876081264	0.4902976868942017	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7864093171075607	0.8107149875236194	0.7415888329820166	0.7455019068512023	0.8431806051990718	0.823816509927535	0.866673359526523	0.8676807651031828	0.7662832283426625	0.7723548111660947	0.8437299003911696	0.8532181531250859	0.780959660328547	0.8186804452949608	0.7247205853597423	0.7108228547979384	0.7777000746560692	0.7196004810900355	SDHD	Tyr114Cys	NC_000011.10:112094831:A:G	341A>G	11	112094831	A	G	11	ENSG00000204370	5678	201959	CCSBVarC006161	ALE00006161	ENSP00000364699.3	CEGS2	CegsMutGDEh1008	F02	GDEhDisVCh_40066	D01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	21939.0	single nucleotide variant	NM_003002.4(SDHD):c.341A>G (p.Tyr114Cys)	6392.0	SDHD	HGNC:10683	Pathogenic	1.0	Nov 02, 2023	104894304.0	-	RCV000007309|RCV000155750|RCV000221353|RCV001810833|RCV002228004	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Paragangliomas 1|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	germline	germline	GRCh38	NC_000011.10	11	112094831.0	112094831.0	11q23.1	criteria provided, multiple submitters, no conflicts	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016797,UniProtKB:O14521#VAR_017872,OMIM:602690.0007	3.0	6900.0	112094831.0	A	G	-	-	-	-	-	-	341A>G 	Tyr114Cys	NM_003002.4	2.0	Pathogenic	Pathogenic	6900	11	112094831.0	A	G	Y	C	rs104894304	11	111965555	11	111470765	114	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.341A>G	p.Tyr114Cys	c.341A>G	p.Tyr114Cys	principal1	Y	1	YES	Select	+	TAT	2	0	A	./.	./.	./.	./.	0.018	0.50835	D	0.065	0.45051	T	0.964	0.55869	D	0.844	0.60367	P	0.87	0.93829	A	simple_aae	13.0	87.0	.	.	.	-7.31	0.94609	D	0.976	0.98669	1.0006	0.97190	D	0.9867	0.99604	D	9	0.9957507	0.99992	D	0.633257	0.96850	D	0.943	0.98815	0.983	0.99835	O14521	Y114C	Loss of phosphorylation at Y114 (P = 0.1741)| Loss of disorder (P = 0.1918)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2363)| Loss of helix (P = 0.2662)	0.936232506373	0.93507	0.976168329744005	0.97594	0.746907957965	0.63330	0.698327541351	0.66847	T	0.978102	0.99803	D	0.331545	0.85161	D	0.238465	0.84966	D	0.993272423744202	0.83880	D	0.867413	0.57053	D	0.6309356	0.74072	0.5530032	0.73898	0.56750697	0.70631	0.64086455	0.78789	-10.9	0.82441	D	0.6697	0.73951	P	0.99848854137229	0.94531	0.99825233	0.98698	0.801	0.88995	.	.	.	.	.	.	4.453053	0.69299	25.3	0.95053500918197487	0.26304	0.957666	0.97690	D	0.756609150763795	0.83245	7.990596	0.715173977717976	0.83441	8.04602	4.85	4.85	0.62327	.	.	8.931	0.92428	9.292000	0.79831	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.992	0.67791	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|not_provided|Hereditary_pheochromocytoma-paraganglioma	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112094831A>G	ClinGen:CA016797|OMIM:602690.0007|UniProtKB:O14521#VAR_017872	CN166604|C1868633|C0031511|C1847319|C0027672|C3494181|C3661900|C1708353	171300|606864|168000	201|29072|97286|140162|29072|29072	.	Tyr	Cys	98.58	0.7522522522522522																																																																																																																																																																																																																																																																																																																																																																																																																																																																													167			98.58	Aromatic	Tyrosine	a ubiquinone	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										-1.3				D:Y114-B:W201 (PDBs: 8GS8)				 Y114-V110 (PAE:  1.0)	Y114-V110 (PDBs: 8GS8)	 Y114-V110 (PAE:  1.0)	Y114-V110 (PDBs: 8GS8)							181									-120.4				-20.6						H (helix)	H (α-helix)	Helix						Mitochondrial matrix					98.58	75.22523	>90	10-90	168000;171300;606864	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	false	0.8107149875236194	0.7864093171075607	false	false	false
BRCA1	BRCA1_Arg71Lys	B_13-14	0.07187573777971566	0.9447113095236084	0.9582573559161401	4.455663203778334	0.0029514293962042914	0.005938457173283854	2025_01_Batch_13-14	false	false	false	false	true	true	false	false	false	false	false	true	0.8836705988149532	0.8934069339044575	0.8152705010284185	0.9390839249526275	0.9385263812824427	0.956574682796767	0.933613678360622	0.9456713978989084	0.9029836123534726	0.726418941921323	0.849376487985481	0.827366488162333	0.9795356872329121	0.931381364665977	0.9751842375517823	0.9041220601355141	0.9374373798234339	0.9399747094675734	BRCA1	Arg71Lys	NC_000017.11:43106456:C:T	212G>A	17	43106456	C	T	17	ENSG00000012048	14613	0	CCSBVarC003297	ALE00003297	ENSP00000417148.1	CEGS2	CegsMutGDEh1010	A12	GDEhDisVCh_40059	E03	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	7.0	0.0		0.0			0.0			0.0			N	N	N	N	N	69138.0	single nucleotide variant	NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 28, 2023	80356913.0	-	RCV000112023|RCV000503702|RCV001180531|RCV001384425|RCV004795985	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43106456.0	43106456.0	17q21.31	criteria provided, multiple submitters, no conflicts	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001420,UniProtKB:P38398#VAR_020681	2.0	54471.0	43106456.0	C	T	-	-	-	-	-	-	212G>A 	Arg71Lys	NM_007294.4	2.0	Pathogenic	Pathogenic	54471	17	43106456.0	C	T	R	K	rs80356913	17	41258473	17	38511999	71	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.212G>A	p.Arg71Lys	c.212G>A	p.Arg71Lys	principal2	Y	1	.	.	-	AGG	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.016	0.68204	D	0.9	0.59057	P	0.275	0.68273	B	.	0.99291	.	.	.	.	2.455	0.71058	M	-0.66	0.59576	N	.	0.78462	0.7801	0.94146	D	0.8430	0.94745	D	9	0.82008123	0.81025	D	0.514985	0.95351	D	0.737	0.90816	0.727	0.86044	E9PFC7	R71K	Gain of methylation at R71 (P = 0.0062)| Gain of relative solvent accessibility (P = 0.0522)| Gain of ubiquitination at R71 (P = 0.068)| Gain of disorder (P = 0.0771)| Gain of solvent accessibility (P = 0.1456)	0.968767862813	0.96814	.	0.47432	.	0.17790	0.610298812389	0.54292	T	0.29865	0.66937	T	0.411382	0.90492	D	0.353145	0.90373	D	0.960748553276062	0.65672	D	.	0.27626	.	0.80958927	0.84328	0.4717919	0.69118	0.759881	0.81221	0.3838624	0.63093	-8.907	0.67174	D	0.7791	0.80812	LP	0.996372846491178	0.92086	0.99942493	0.99371	0.917	0.95747	.	.	.	.	.	.	5.467383	0.91245	32.0	0.99505402231752338	0.68305	0.849361	0.76532	D	0.589132871463434	0.72350	5.814887	0.56907193894025	0.72585	5.856808	4.64	4.64	0.57348	.	.	4.108	0.57643	7.641000	0.63257	0.531	0.24877	1.0	0.71675	1.000000	0.68239	0.995	0.73271	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	424	0	0	0	0	0	476	0	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43106456C>T	ClinGen:CA001420|UniProtKB:P38398#VAR_020681	C0677776|C0027672|C3661900|C2676676	604370	145|140162|145	.	Arg	Lys	82.37	0.9758064516129032			0.023		-0.229																																																																																								0.0		0.19	1 mutation(s) (Arg71Leu: 0.904)																							-2.11		-1.89		-2.954		-1.507																																																																																																																																																																																																																																																																																																																																																246			83.06	Positively-charged	Arginine		Breast cancer type 1 susceptibility protein										-4.5			M:R71-G:E61 (PDBs: 7LYB), M:R71-G:E92 (PDBs: 7LYB), M:R71-G:D90 (PDBs: 7LYB), K:R71-C:Y57 (PDBs: 8GRQ), K:R71-C:E61 (PDBs: 8GRQ)		M:R71-G:E61 (PDBs: 7LYB), M:R71-G:E92 (PDBs: 7LYB), M:R71-G:D90 (PDBs: 7LYB), K:R71-C:E61 (PDBs: 8GRQ)													175		Mutation: R -> G. No effect on interaction with BAP1.							-99.0				-2.3						C (loop/coil)	T (turn)	Turn											82.37	97.58065	70-90	$\geqslant$90	604370;604370;614320;617883	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; FANCONI ANEMIA, COMPLEMENTATION GROUP S	true	0.8934069339044575	0.8836705988149532	false	false	false
F9	F9_Val374Phe	B_13-14	-5.504701111376828	0.0009020360212474599	0.004383940968403686	2.1832000557729714	0.06533133145041142	0.09020541249925128	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8960236161219718	0.8780370798962258	0.6152554393326406	0.7167517496058076	0.6056534701148432	0.6544565678531676	0.6619305912429196	0.6068931495358636	0.6976868213099502	0.6225153642395406	0.8329828402113308	0.8701963752856082	0.6469825444634156	0.6044137906938227	0.7358166779016649	0.6079955144257407	0.9230913195811208	0.9218508569583354	F9	Val374Phe	NC_000023.11:139561805:G:T	1120G>T	23	139561805	G	T	X	ENSG00000101981	52861	0	CCSBVarC004387	ALE00004387	ENSP00000218099.2	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25678.0	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Dec 18, 2018	137852271.0	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805.0	139561805.0	Xq27.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA255427,OMIM:300746.0083	3.0	10639.0	139561805.0	G	T	-	-	-	-	-	-	1120G>T 	Val374Phe	NM_000133.4	1.0	Pathogenic	Pathogenic	10639	X	139561805.0	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	91.21	0.0																																																																																																																																																																																																																																																																																																																																																																																																															0.739		0.491		0.426		0.397		0.401																																																						0			91.21	Aliphatic	Valine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			4.2								 V374-G351 (PAE:  1.5)	V374-G351 (PDBs: 6X5J, 6X5L, 8OL9)	 V374-G351 (PAE:  1.5)	V374-G351 (PDBs: 6X5J, 6X5L, 8OL9)							117									-115.9				133.2						B (undefined)	E (parallel sheets)	Beta strand											91.21	0.0	>90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.8780370798962258	0.8960236161219718	false	false	false
F9	F9_Cys28Arg	B_13-14	2.152584623455668	0.06835226540196286	0.11966345272020995	-14.72395644713804	1.5946040956690216e-6	0.000021203612431540977	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	false	false	0.9665905898981202	0.9826925969627043	0.5608069657973367	0.7798443229468143	0.7186430439486022	0.675475497490061	0.6112449667731137	0.6466991330465833	0.7212613440717216	0.5556641009609116	0.9796185201191754	0.9628235272644785	0.7397060282070083	0.7905869548506211	0.838427301821907	0.5659498306337618	0.9857666738062333	0.9703576525317618	F9	Cys28Arg	NC_000023.11:139530846:T:C	82T>C	23	139530846	T	C	X	ENSG00000101981	52861	0	CCSBVarC004373	ALE00004373	ENSP00000218099.2	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25696.0	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 02, 2021	387906481.0	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139530846.0	139530846.0	Xq27.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3.0	10657.0	139530846.0	T	C	-	-	-	-	-	-	82T>C 	Cys28Arg	NM_000133.4	1.0	Pathogenic	Pathogenic	10657	X	139530846.0	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	60.23	0.8296296296296296																																																																																																																																																																																																																																																																																																																																																																																																															0.323	2 mutation(s) (Cys28Trp: -0.011, Cys28Leu: 0.006)	0.379		0.499		0.512		0.41																																																						112			60.23	Special, a very reactive sulfhydryl group	Cysteine												2.5																		121									-67.7				84.2						C (loop/coil)	C (loop/coil)				Signal								60.23	82.96296	50-70	10-90	306900;306900;300807	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.9826925969627043	0.9665905898981202	true	false	false
BRCA1	BRCA1_Cys61Gly	B_13-14	0.9686368160707995	0.36499496144588084	0.4571865681451337	5.221066099016583	0.0012243730284459688	0.002829627842819084	2025_01_Batch_13-14	false	false	true	true	false	true	false	false	true	false	false	false	0.8982851556157698	0.9155231473258633	0.890545323065725	0.9543747801785496	0.8869050454361632	0.9649386300710765	0.9808013280229353	0.9367765174017317	0.9650071328251765	0.8789992518293115	0.9387004921399611	0.9305916496967616	0.9490759321192176	0.8370335734705947	0.9437424275319227	0.9020913943021385	0.8923458025117654	0.8659786615347781	BRCA1	Cys61Gly	NC_000017.11:43106487:A:C	181T>G	17	43106487	A	C	17	ENSG00000012048	14613	0	CCSBVarC011874	ALE00012158	ENSP00000417148.1																																	32700.0	single nucleotide variant	NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	28897672.0	-	RCV000047597|RCV000131902|RCV000412714|RCV000019229|RCV000159935|RCV000763010|RCV000415051|RCV000785199|RCV000239114|RCV001270967|RCV004802937	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|Human Phenotype Ontology:HP:0003002,MONDO:MONDO:0004989,MedGen:C0678222|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN221562|MONDO:MONDO:0700268,MedGen:CN377757	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|Breast carcinoma|Ovarian neoplasm|Familial cancer of breast|Breast and/or ovarian cancer|BRCA1-related cancer predisposition	germline;not applicable;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	43106487.0	43106487.0	17q21.31	reviewed by expert panel	59.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00099,ClinGen:CA001182,UniProtKB:P38398#VAR_007757,OMIM:113705.0002	3.0	17661.0	43106487.0	A	C	-	-	-	-	-	-	181T>G 	Cys61Gly	NM_007294.4	3.0	Pathogenic	Pathogenic	17661	17	43106487.0	A	C	C	G	rs28897672	17	41258504	17	38512030	61	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.181T>G	p.Cys61Gly	c.181T>G	p.Cys61Gly	principal2	Y	1	.	.	-	TGT	1	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	0.116	0.77914	B	0.026	0.82066	B	.	0.99291	.	.	.	.	4.355	0.98454	H	-2.81	0.99397	D	.	0.99781	0.9506	0.96392	D	0.9929	0.99832	D	10	0.99176705	0.99706	D	0.963103	0.99761	D	0.948	0.98989	0.995	0.99946	E9PFC7	C61G	Gain of disorder (P = 0.0488)| Loss of stability (P = 0.105)| Gain of phosphorylation at S59 (P = 0.1362)| Loss of methylation at K56 (P = 0.1519)| Gain of glycosylation at P62 (P = 0.1609)	0.998499671764	0.99845	.	0.90513	.	0.44456	0.648884236813	0.59765	T	0.479885	0.92979	T	0.433365	0.91638	D	0.565018	0.95972	D	0.983885645866394	0.75212	D	.	0.85963	.	0.9937476	0.99925	0.9444327	0.98025	0.98292416	0.99313	0.9264142	0.96801	-14.65	0.98194	D	0.9865	0.94756	LP	0.998778029465221	0.95035	0.99978560	0.99726	0.984	0.99450	.	.	.	.	.	.	4.174515	0.62863	24.5	0.98518170788822967	0.42557	0.869181	0.78883	D	0.838128507262834	0.88357	9.572342	0.742507123425794	0.85517	8.62807	5.17	5.17	0.70808	5.61	0.95042	5.098	0.64462	11.169000	0.87924	0.667	0.69024	1.0	0.71675	1.000000	0.68239	0.995	0.73271	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	4	109170	3.664010e-05	0	7	207470	3.373980e-05	0	6	236276	2.539400e-05	0	0	7152	0.000000e+00	0	0	17022	0.000000e+00	0	0	2310	0.000000e+00	0	0	9042	0.000000e+00	0	1	13390	7.468260e-05	0	3	42724	7.021810e-05	0	0	15618	0.000000e+00	0	3	42724	7.021810e-05	0	0	16132	0.000000e+00	0	0	30412	0.000000e+00	0	0	6194	0.000000e+00	0	0	13404	0.000000e+00	0	1	16718	5.981580e-05	0	6	89312	6.718020e-05	0	0	30448	0.000000e+00	0	6	89312	6.718020e-05	0	0	14822	0.000000e+00	0	0	34140	0.000000e+00	0	0	9556	0.000000e+00	0	0	17674	0.000000e+00	0	1	21614	4.626630e-05	0	5	102510	4.877570e-05	0	0	30366	0.000000e+00	0	5	102510	4.877570e-05	0	.	30	1604818	1.869370e-05	0	28	1172588	2.387880e-05	0	0	74730	0.000000e+00	0	0	912	0.000000e+00	0	0	59940	0.000000e+00	0	0	29524	0.000000e+00	0	0	44766	0.000000e+00	0	1	63978	1.563040e-05	0	0	5856	0.000000e+00	0	28	1172588	2.387880e-05	0	0	90418	0.000000e+00	0	0	10344	0	0	144	0	0	88	0	0	4314	0	0	154	0	0	616	0	0	28	0	0	98	0	0	860	0	0	4458	0	0	116	0	0	16646	0	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided|Pancreatic_cancer,_susceptibility_to,_4|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_carcinoma|Breast_neoplasm|Ovarian_neoplasm	reviewed_by_expert_panel	NC_000017.11:g.43106487A>C	BRCA1-HCI:BRCA1_00099|ClinGen:CA001182|OMIM:113705.0002|UniProtKB:P38398#VAR_007757	C2676676|C0346153|C0027672|CN221562|C3661900|C3280442|C4554406|C0677776|C0678222|C1458155|C0919267	604370|114480|614320|617883	145|227535|140162|1333|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Gly	86.97	0.014814814814814815			-2.481		-1.864																																																																																								4.0		-1.268																								-1.627		-1.767																																																																																																																																																																																																																																																																																																																																																				3			87.56	Special, a very reactive sulfhydryl group	Cysteine		Breast cancer type 1 susceptibility protein										2.5								 C61-K65 (PAE:  1.5), C61-C39 (PAE: 2.0), C61-N66 (PAE: 2.0)	C61-K65 (PDBs: 1JM7, 7LYB)	 C61-K65 (PAE:  1.5), C61-N66 (PAE: 2.0), C61-I68 (PAE: 3.0), C61-H41 (PAE: 2.0)	C61-K65 (PDBs: 1JM7, 7LYB, 8GRQ), C61-C39 (PDBs: 1JM7), C61-N66 (PDBs: 1JM7, 8GRQ), C61-I68 (PDBs: 1JM7, 7LYB, 8GRQ), C61-D67 (PDBs: 8GRQ)							121									-58.7				132.5				dbSNP: rs28897672; Variant type: LP/P; AA change: Cys61Gly; PTM type: Ubiquitylation; PTM morphology: LLNQKkGPSQC*; Var class: II&rs28897672		C (loop/coil)	C (loop/coil)											RING-type	86.97	1.4814814	70-90	<10	604370;617883;604370;614320;114480;114480	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; BREAST CANCER; BREAST CANCER	false	0.9155231473258633	0.8982851556157698	false	false	false
SHOC2	SHOC2_Ser2Gly	B_13-14	-3.1962184734631762	0.015145173112769224	0.037277423512099506	9.184718991012415	0.000037369764022047716	0.00019154613681692057	2025_01_Batch_13-14	true	true	false	false	true	true	false	false	false	false	false	false	0.9733124439858674	0.9773965719506201	0.7571842131453211	0.8376162310263288	0.9196882488335887	0.8801953828637147	0.8801953828637147	0.9196882488335887	0.8376162310263288	0.7571842131453211	0.9773965719506201	0.9733124439858674							SHOC2	Ser2Gly	NC_000010.11:110964362:A:G	4A>G	10	110964362	A	G	10	ENSG00000108061	11602	203498	CCSBVarC003572	ALE00003572	ENSP00000358464.5	CEGS2	CegsMutGDEh1003	E02	GDEhDisVCh_40089	E02	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	21860.0	single nucleotide variant	NM_007373.4(SHOC2):c.4A>G (p.Ser2Gly)	8036.0	SHOC2	HGNC:15454	Pathogenic	1.0	Apr 03, 2017	267607048.0	-	RCV000007223|RCV000149834|RCV000208379|RCV000853278|RCV000213000|RCV000624656|RCV002221469|RCV001813181|RCV003330311|RCV004752691	MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0011899,MedGen:C1843181,OMIM:PS607721,Orphanet:2701|MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0033004,MedGen:C4540575,OMIM:263200|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701;Human Phenotype Ontology:HP:0000767,Human Phenotype Ontology:HP:0006613,Human Phenotype Ontology:HP:0006617,MONDO:MONDO:0008213,MedGen:C2051831,OMIM:169300|	Noonan syndrome-like disorder with loose anagen hair 1|RASopathy|Noonan syndrome|Noonan syndrome-like disorder with loose anagen hair|not provided|Inborn genetic diseases|Polycystic kidney disease 4|Noonan syndrome and Noonan-related syndrome|Noonan syndrome-like disorder with loose anagen hair 1;Pectus excavatum|SHOC2-related disorder	de novo;germline;unknown	germline	GRCh38	NC_000010.11	10	110964362.0	110964362.0	10q25.2	reviewed by expert panel	43.0	-	N	ClinGen:CA118524,UniProtKB:Q9UQ13#VAR_060199,OMIM:602775.0001	3.0	6821.0	110964362.0	A	G	-	-	-	-	-	-	4A>G 	Ser2Gly	NM_007373.4	3.0	Pathogenic	Pathogenic	6821	10	110964362.0	A	G	S	G	rs267607048	10	112724120	10	112714110	2	SHOC2	ENSG00000108061	ENST00000689118	ENSP00000510554	Q9UQ13	SHOC2_HUMAN	.	.	c.4A>G	p.Ser2Gly	principal1	Y	.	.	.	+	AGT	1	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.08048	.	0.924	0.54410	P	0.827	0.65195	P	.	0.90832	.	.	.	.	1.95	0.52299	M	.	0.18812	.	.	0.79136	-0.8710	0.50259	T	0.1062	0.38523	T	10	.	0.84179	.	0.02323	0.45962	T	.	0.70445	0.737	0.86913	Q9UQ13	S2G	Loss of phosphorylation at S2 (P = 0.0013)| Gain of sheet (P = 0.0028)| Loss of loop (P = 0.0112)| Gain of ubiquitination at K7 (P = 0.0913)| Loss of methylation at K7 (P = 0.0917)	.	0.50012	.	0.01588	.	0.81400	0.709850311279	0.68519	T	0.168512	0.51307	T	0.158547	0.69846	D	-0.0100348	0.69461	D	0.952564656734467	0.63597	D	0.756024	0.37697	T	0.43829516	0.62973	0.3389099	0.59430	0.3963055	0.60151	0.3356854	0.59147	-3.508	0.17366	T	.	0.20926	.	0.949115075084258	0.80343	0.03609608	0.55985	0.27	0.54055	.	.	.	.	.	.	4.350761	0.66885	25.0	0.99693813541009024	0.80133	0.926990	0.90862	D	0.506295370116211	0.67289	5.084776	0.576779642148786	0.73134	5.944563	5.22	5.22	0.72246	.	.	8.492	0.90332	10.555000	0.83455	0.751	0.87726	1.0	0.71675	1.000000	0.68239	1.0	0.97202	914	0.21043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	1613004	3.719770e-06	0	1	29596	3.378830e-05	0	0	74876	0.000000e+00	0	0	912	0.000000e+00	0	0	59750	0.000000e+00	0	1	29596	3.378830e-05	0	0	44884	0.000000e+00	0	0	63960	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179528	4.238980e-06	0	0	90972	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Noonan_syndrome_and_Noonan-related_syndrome|Noonan_syndrome|Noonan_syndrome-like_disorder_with_loose_anagen_hair|RASopathy|Polycystic_kidney_disease_4|Inborn_genetic_diseases|not_provided|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|Pectus_excavatum	reviewed_by_expert_panel	NC_000010.11:g.110964362A>G	ClinGen:CA118524|OMIM:602775.0001|UniProtKB:Q9UQ13#VAR_060199	C5681679|C0028326|C1843181|C5555857|C4540575|C0950123|C3661900|C4478716|C2051831	PS163950|PS607721|263200|607721|169300	98733|648|2701|536391|2701	.	Ser	Gly	36.92	0.8692307692307693																																																																																																																																																																																																																																																																																																																																																																																																																																																																													113			36.92	Polar/Neutral	Serine		Leucine-rich repeat protein SHOC-2		Basic and acidic residues								-0.8																		105									29.4				117.1	Disordered					C (loop/coil)	C (loop/coil)												36.92	86.92307	$\leqslant$50	10-90	607721;263200;607721;169300	multiple	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; PECTUS EXCAVATUM	false	0.9773965719506201	0.9733124439858674	true	true	false
F9	F9_Ser411Ile	B_13-14	1.2452466356035585	0.2531072668651517	0.3373586041259175	0.6306296539522278	0.5483102320593058	0.6014042294254789	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5968324344603052	0.5833334067485807	0.6143267536168264	0.5297408808342834	0.5934345253036267	0.6233184210617659	0.5693138425802752	0.5469851205848535	0.47308283773526205	0.5708302511193557	0.5073822281821239	0.5777273851285618	0.6773229995432566	0.6398839300224	0.5863989239333048	0.6578232561142972	0.6592845853150374	0.6159374837920486	F9	Ser411Ile	NC_000023.11:139561917:G:T	1232G>T	23	139561917	G	T	X	ENSG00000101981	52861	0	CCSBVarC004395	ALE00004395	ENSP00000218099.2	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25688.0	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Mar 01, 1992	137852276.0	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917.0	139561917.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1.0	10649.0	139561917.0	G	T	-	-	-	-	-	-	1232G>T 	Ser411Ile	NM_000133.4		Pathogenic	Pathogenic	10649	X	139561917.0	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	85.31	0.05384615384615385																																																																																																																																																																																																																																																																																																																																																																																																															1.116		1.032		1.055		1.054	4 mutation(s) (Ser411Val: 1.109, Ser411Asp: 1.109, Ser411Ile: 1.110, Ser411Trp: 1.113)	1.055																																																						7		Charge relay system	85.31	Polar/Neutral	Serine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-0.8								 S411-S430 (PAE:  2.5), S411-G253 (PAE: 2.0)	S411-G253 (PDBs: 6X5J, 6X5L, 8OL9), S411-S430 (PDBs: 8OL9), S411-I429 (PDBs: 8OL9)		S411-S430 (PDBs: 8OL9), S411-C268 (PDBs: 8OL9), S411-G253 (PDBs: 8OL9), S411-I429 (PDBs: 8OL9), S411-C252 (PDBs: 8OL9)							105									-48.8				132.6						C (loop/coil)	T (turn)	Turn											85.31	5.3846154	70-90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.5833334067485807	0.5968324344603052	false	false	false
KRAS	KRAS_Asp153Val	B_13-14	-0.3822084358919264	0.7136459741761332	0.7731502045810632	4.458581826426934	0.002941072175065041	0.005924113546920252	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8144861850353421	0.8052879512830047	0.6613951575723463	0.8282168912227078	0.7862958153456058	0.7434789688692942	0.9472535428192275	0.9588365270754962	0.9469492849119447	0.8460263554043131	0.9091588649553752	0.8951143560711118	0.539704394919361	0.6137551036157154	0.7094844975334709	0.47676395974037955	0.7014170376106341	0.7338580139995724	KRAS	Asp153Val	NC_000012.12:25209904:T:A	458A>T	12	25209904	T	A	12	ENSG00000133703	3084	0	CCSBVarC006101	ALE00006101	ENSP00000308495.3	CEGS2	CegsMutGDEh1042	B12	GDEhDisVCh_40061	E10	1	CegsMutGDDh1042	B12	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	27626.0	single nucleotide variant	NM_004985.5(KRAS):c.458A>T (p.Asp153Val)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Nov 15, 2018	104894360.0	-	RCV000013418|RCV000013417|RCV000523200|RCV000507330|RCV000157940|RCV000763307|RCV003450634|RCV004018621|RCV000212501|RCV000844634	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|11 conditions|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MedGen:CN230736|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|Noonan syndrome|not specified|RASopathy|11 conditions|Noonan syndrome 1|Cardiovascular phenotype|not provided|Cardio-facio-cutaneous syndrome;Noonan syndrome	de novo;germline;unknown	germline	GRCh38	NC_000012.12	12	25209904.0	25209904.0	12p12.1	reviewed by expert panel	16.0	-	N	ClinGen:CA256478,OMIM:190070.0010,OMIM:190070.0015	3.0	12587.0	25209904.0	T	A	-	-	-	-	-	-	458A>T 	Asp153Val	NM_004985.5	3.0	Pathogenic	Pathogenic	12587	12	25209904.0	T	A	D	V	rs104894360	12	25362838	12	25254105	128	KRAS	ENSG00000133703	ENST00000693229	ENSP00000509223	A0A8I5KQ21	A0A8I5KQ21_HUMAN	.	.	c.383A>T	p.Asp128Val	.	Y	.	.	.	-	GAT	2	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.83643	.	.	0.50195	.	.	0.47676	.	.	0.94378	.	.	.	.	.	.	.	.	0.82015	.	.	0.93732	0.2042	0.85920	D	0.4729	0.79666	T	7	.	0.91672	.	0.435687	0.94056	D	.	0.93084	.	0.87760	.	.	.	.	0.92600	.	.	.	.	.	.	.	.	.	.	0.432327	0.91589	D	0.383231	0.91485	D	0.955039322376251	0.64186	D	.	0.90939	.	.	.	.	.	.	.	.	.	.	0.77191	.	.	0.91639	.	.	.	0.96898425	0.94579	0.991	0.99694	.	.	.	.	.	.	4.964316	0.82142	27.7	0.99233185239291311	0.56347	0.867497	0.78650	D	0.565827697853449	0.70896	5.592508	0.631385021559758	0.77104	6.639681	5.87	5.87	0.94257	.	.	7.628	0.82424	7.901000	0.73593	0.583	0.30331	1.0	0.71675	1.000000	0.68239	0.997	0.79771	874	0.30573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Acute_myeloid_leukemia|Autoimmune_lymphoproliferative_syndrome_type_4|Malignant_tumor_of_urinary_bladder|Lung_carcinoma|Cardiofaciocutaneous_syndrome_2|Carcinoma_of_pancreas|Hereditary_diffuse_gastric_adenocarcinoma|Linear_nevus_sebaceous_syndrome|Cerebral_arteriovenous_malformation|Noonan_syndrome_3|Familial_cancer_of_breast|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|not_provided|Cardiovascular_phenotype|RASopathy|Noonan_syndrome_1|not_specified	reviewed_by_expert_panel	NC_000012.12:g.25209904T>A	ClinGen:CA256478|OMIM:190070.0010|OMIM:190070.0015	C0023467|C2674723|C0005684|C0684249|C3809005|C0235974|C1708349|C4552097|C0917804|C1860991|C0346153|C1275081|C0028326|C3661900|CN230736|C5555857|C4551602|CN169374	601626|614470|109800|615278|137215|163200|108010|609942|114480|PS115150|PS163950|163950	519|268114|157980|1340|1333|217074|26106|2612|46724|648|227535|1340|648|536391|648	.	Asp	Val																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				NaN	NaN	609942;615278;163950	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	NOONAN SYNDROME 3; CARDIOFACIOCUTANEOUS SYNDROME 2; NOONAN SYNDROME 1	false	0.8052879512830047	0.8144861850353421	false	false	false
ZC4H2	ZC4H2_Arg213Trp	B_13-14	-6.429607337566906	0.00035709788012483603	0.002126651566841424	5.341864212921037	0.0010735873843517084	0.002538702126656424	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8282282679497175	0.8605760692957631	0.6453521201490611	0.674029126983839	0.6649041415200279	0.7383762505900112	0.722771635785026	0.6667005552751268	0.6825698063786672	0.6193182869277376	0.7911678529767817	0.7396266335920045	0.7539808653949964	0.663107727764929	0.6654884475890108	0.6713859533703846	0.9299842856147447	0.9168299023074303	ZC4H2	Arg213Trp	NC_000023.11:64917821:G:A	637C>T	23	64917821	G	A	X	ENSG00000126970	4320	0	CCSBVarC009197	ALE00014253	ENSP00000363972.3																																	65654.0	single nucleotide variant	NM_018684.4(ZC4H2):c.637C>T (p.Arg213Trp)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Feb 14, 2022	879255236.0	-	RCV000043679|RCV001384432|RCV002354226	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	Wieacker-Wolff syndrome|not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000023.11	X	64917821.0	64917821.0	Xq11.2	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA10575581,UniProtKB:Q9NQZ6#VAR_069624,OMIM:300897.0004	3.0	50983.0	64917821.0	G	A	-	-	-	-	-	-	637C>T 	Arg213Trp	NM_018684.4	2.0	Pathogenic	Pathogenic	50983	X	64917821.0	G	A	R	W	rs879255236	X	64137701	X	64054426	213	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.637C>T	p.Arg213Trp	c.637C>T	p.Arg213Trp	principal1	Y	1	YES	Select	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	0.999	0.77914	D	0.993	0.81117	D	0.92	0.93300	A	simple_aae	8.0	92.0	.	.	.	-6.81	0.92962	D	0.63	0.64382	-0.2160	0.77155	T	0.4185	0.76351	T	8	0.838971	0.82873	D	0.886685	0.99137	D	0.374	0.69109	0.495	0.58232	Q9NQZ6	R213W	Loss of solvent accessibility (P = 0.0036)| Loss of methylation at K209 (P = 0.0666)| Loss of relative solvent accessibility (P = 0.0676)| Gain of glycosylation at S210 (P = 0.1548)| Loss of helix (P = 0.2662)	0.964658073467	0.96396	0.7886100765468459	0.78692	3.13339230401	0.99404	0.893401861191	0.95671	D	0.814106	0.95348	D	0.49627	0.94129	D	0.475081	0.94052	D	0.998362839221954	0.93893	D	0.984002	0.95472	D	0.8943117	0.90750	0.79658544	0.87905	0.8859753	0.90028	0.83650655	0.90487	-12.468	0.87537	D	0.9996	0.99217	P	0.999161681495248	0.95853	0.99830365	0.98720	0.973	0.98982	.	.	.	.	.	.	4.527004	0.71085	25.6	0.99915480374987564	0.98380	.	.	.	.	.	.	.	.	.	5.42	3.58	0.40064	2.53	0.46530	3.404	0.52465	4.548000	0.43870	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Wieacker-Wolff_syndrome|not_provided|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64917821G>A	ClinGen:CA10575581|OMIM:300897.0004|UniProtKB:Q9NQZ6#VAR_069624	C0796200|C3661900|C0950123	314580	3454|85283	Zinc finger C4H2-type	Arg	Trp	70.32	0.8387096774193549																																																																																																																																																																																																																																																																																																																																																																																																																																																																													208			70.32	Positively-charged	Arginine		Zinc finger C4H2 domain-containing protein										-4.5																		175									-66.7				-27.0				dbSNP: rs879255236; Variant type: LP/P; AA change: Arg213Trp; PTM type: Phosphorylation; PTM morphology: LCKAKsRSR*NP; Var class: II		C (loop/coil)	S (bend)												70.32	83.870964	70-90	10-90	314580	x-linked recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	false	0.8605760692957631	0.8282282679497175	false	false	false
BRCA1	BRCA1_Thr581Ile	B_13-14	2.1265294642858166	0.07103329880869202	0.12344198028788403	0.19497894827829038	0.8509478942030293	0.8782280010475584	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	false	true	false	true	0.923882981695384	0.9204106286039557	0.8599871142760895	0.9694001042305166	0.9321000016471083	0.9551639293358644	0.9305548324052624	0.9080783100724923	0.9575363555493963	0.8058618910847669	0.9331976319589934	0.9206494645948209	0.9797730262664663	0.9561216932217242	0.9812638529116369	0.9141123374674122	0.907623625248918	0.927116498795947	BRCA1	Thr581Ile	NC_000017.11:43067628:G:A	1742C>T	17	43067628	G	A	17	ENSG00000012048	14613	0	CCSBVarC003303	ALE00003303	ENSP00000417148.1	CEGS2	CegsMutGDEh1018	D09	GDEhDisVCh_40059	C06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	70032.0	single nucleotide variant	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357043.0	-	RCV000112476|RCV001853017|RCV002336188	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067628.0	43067628.0	17q21.31	reviewed by expert panel	8.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	2.0	55365.0	43067628.0	G	A	-	-	-	-	-	-	5054C>T 	Thr1685Ile	NM_007294.4	3.0	Pathogenic	Pathogenic	55365	17	43067628.0	G	A	T	I	rs80357043	17	41219645	17	38473171	1685	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5054C>T	p.Thr1685Ile	principal2	Y	1	.	.	-	ACT	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.89	0.90580	P	0.329	0.92348	B	.	0.99291	.	.	.	.	3.31	0.90471	M	.	0.82367	.	.	0.95034	0.7600	0.93898	D	0.7898	0.92853	D	10	.	0.85827	.	0.72506	0.97777	D	.	0.96457	.	.	.	.	.	.	0.96144	.	0.90972	.	0.19319	0.753464519978	0.74914	T	0.409904	0.82120	T	0.438305	0.91883	D	0.391819	0.91782	D	0.983474791049957	0.74950	D	0.958004	0.85541	D	0.88979423	0.90355	0.6439081	0.78957	0.9066492	0.91869	0.62467957	0.77890	-14.562	0.94802	D	.	0.91617	.	0.991231594940223	0.88934	0.99987290	0.99835	0.987	0.99559	.	.	.	.	.	.	4.1672	0.62705	24.5	0.99904362282002479	0.97578	0.771366	0.70495	D	0.813238141695724	0.86857	9.04512	0.757877512501455	0.86669	8.988454	5.24	5.24	0.72825	.	.	6.008	0.70468	11.804000	0.96740	0.569	0.28905	1.0	0.71675	1.000000	0.68239	0.976	0.56441	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1612146	1.860870e-06	0	1	44884	2.227970e-05	0	0	74826	0.000000e+00	0	0	912	0.000000e+00	0	0	59984	0.000000e+00	0	0	29592	0.000000e+00	0	1	44884	2.227970e-05	0	0	64008	0.000000e+00	0	0	6078	0.000000e+00	0	2	1178384	1.697240e-06	0	0	91058	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43067628G>A	BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903	C0677776|C2676676|C0027672	604370	145|145|140162	BRCT domain|BRCT domain|BRCT domain	Thr	Ile	94.85	0.352112676056338																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																94.85	35.21127	>90	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.9204106286039557	0.923882981695384	false	false	false
F9	F9_Cys170Tyr	B_13-14	-5.196104915678863	0.0012583859585505689	0.005551612458491068	4.3939222449916775	0.003180219860308009	0.006315696367603027	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9378044830221823	0.9423648239814648	0.6951239691077873	0.7927416562320414	0.6563345825309519	0.7955759613126814	0.8913776242071569	0.6122963319401173	0.775827482476472	0.7714926864150998	0.9080124826407046	0.8914169753265803	0.6997742984182057	0.7003728331217863	0.8096558299876108	0.6187552518004747	0.9767171653222252	0.9841919907177845	F9	Cys170Tyr	NC_000023.11:139548480:G:A	509G>A	23	139548480	G	A	X	ENSG00000101981	52861	0	CCSBVarC002181	ALE00002181	ENSP00000218099.2	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	800231.0	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 28, 2019	1603265500.0	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480.0	139548480.0	Xq27.1	criteria provided, single submitter	1.0	-	N	-	2.0	811517.0	139548480.0	G	A	-	-	-	-	-	-	509G>A 	Cys170Tyr	NM_000133.4	1.0	Pathogenic	Pathogenic	811517	X	139548480.0	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	95.58	0.044444444444444446																																																																																																																																																																																																																																																																																																																																																																																																															0.134	1 mutation(s) (Cys170Thr: 0.006)	0.085	1 mutation(s) (Cys170Tyr: -0.003)	0.084		0.076		0.085	2 mutation(s) (Cys170Met: -0.007, Cys170Tyr: -0.002)																																																					6			95.58	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa light chain						Disulfide bond 157-170	EGF-like 2			2.5								 C170-E142 (PAE:  1.5)	C170-E142 (PDBs: 2WPH, 2WPJ, 2WPK, 2WPL, 2WPM, 5JB8, 5JB9, 5JBA, 5JBB, 5JBC, 6RFK)	 C170-E142 (PAE:  1.5)	C170-E142 (PDBs: 2WPH, 2WPI, 2WPJ, 2WPK, 2WPL, 2WPM, 5JB8, 5JB9, 5JBA, 5JBB, 5JBC, 6RFK)							121									-115.1				105.3						B (undefined)	E (parallel sheets)	Beta strand											95.58	4.4444447	>90	<10		unknown		Rare genetic hematologic disease	1		false	0.9423648239814648	0.9378044830221823	false	false	false
BRCA1	BRCA1_Leu660Pro	B_13-14	0.7722291595565172	0.4652467741162628	0.552625210548546	-0.08365655654394928	0.9356716193611984	0.9470256048140093	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6527400898853779	0.6801741825112791	0.4997618681283364	0.6760405549351461	0.6550849493503593	0.6343444242042298	0.7177233185414482	0.7703088085272976	0.8213487908079209	0.4969675120124242	0.8312742562105837	0.8328374172620021	0.5509655298670112	0.5398610901734211	0.5307323190623714	0.5025562242442486	0.5290741088119746	0.47264276250875376	BRCA1	Leu660Pro	NC_000017.11:43051104:A:G	1979T>C	17	43051104	A	G	17	ENSG00000012048	14613	0	CCSBVarC003309	ALE00003309	ENSP00000417148.1	CEGS2	CegsMutGDEh1027	B03	GDEhDisVCh_40059	B09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	70177.0	single nucleotide variant	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357281.0	-	RCV000112604|RCV000509995|RCV000588744|RCV001528204	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051104.0	43051104.0	17q21.31	reviewed by expert panel	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	2.0	55510.0	43051104.0	A	G	-	-	-	-	-	-	5291T>C 	Leu1764Pro	NM_007294.4	3.0	Pathogenic	Pathogenic	55510	17	43051104.0	A	G	L	P	rs80357281	17	41203121	17	38456647	1764	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5291T>C	p.Leu1764Pro	principal2	Y	1	.	.	-	CTA	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.79703	.	0.999	0.90580	D	0.937	0.77493	D	.	0.99291	.	.	.	.	2.255	0.63995	M	.	0.80457	.	.	0.93732	0.6256	0.92204	D	0.7595	0.91786	D	10	.	0.90949	.	0.852334	0.98860	D	.	0.88008	.	.	.	.	.	.	0.98778	.	0.82492	.	0.52805	0.554721057415	0.46456	T	0.394982	0.75228	T	0.436743	0.91807	D	0.389575	0.91707	D	0.994264304637909	0.85335	D	0.89611	0.63951	D	0.8910151	0.90460	0.6202942	0.77645	0.89131314	0.90488	0.55023813	0.73742	-11.462	0.82186	D	.	0.84401	.	0.997750985165462	0.93509	0.99987125	0.99835	0.96	0.98304	.	.	.	.	.	.	4.871541	0.79856	27.2	0.99898762507631778	0.97125	0.796452	0.72256	D	0.591172089691292	0.72477	5.834971	0.566318150584601	0.72388	5.826055	5.06	5.06	0.67796	5.33	0.93090	5.026	0.63961	11.097000	0.86063	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.96	0.51684	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43051104A>G	BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908	C3661900|C0677776|C0027672|C2676676	604370	145|140162|145	.	Leu	Pro	93.27	0.16463414634146342																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																93.27	16.463415	>90	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.6801741825112791	0.6527400898853779	false	false	false
F9	F9_Cys396Ser	B_13-14	5.334346676148364	0.0010823425346290789	0.005016705040412351	1.3156979738998422	0.22972639498056355	0.2773341676245619	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8970160820346753	0.901917579173913	0.42481629273053956	0.633523714798231	0.6061095392753273	0.4412945808306715	0.45725100951979797	0.6250665001820297	0.6693276046535308	0.4363000323689882	0.8584414109183627	0.8472361542460476	0.425338152141545	0.5871525783686248	0.5977198249429312	0.41333255309209094	0.9453937474294634	0.9467960098233029	F9	Cys396Ser	NC_000023.11:139561872:G:C	1187G>C	23	139561872	G	C	X	ENSG00000101981	52861	0	CCSBVarC004391	ALE00004391	ENSP00000218099.2	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25681.0	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jan 01, 1991	137852273.0	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872.0	139561872.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1.0	10642.0	139561872.0	G	C	-	-	-	-	-	-	1187G>C 	Cys396Ser	NM_000133.4		Pathogenic	Pathogenic	10642	X	139561872.0	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	93.62	0.007407407407407408																																																																																																																																																																																																																																																																																																																																																																																																															0.294		0.137		0.104		0.101		0.079	1 mutation(s) (Cys396Gln: -0.016)																																																					1			93.62	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa heavy chain						Disulfide bond 382-396	Peptidase S1			2.5						 C396-C382 (PAE:  1.5)		 C396-V377 (PAE:  1.0)	C396-V377 (PDBs: 6X5J, 6X5L, 8OL9)	 C396-C382 (PAE:  1.5)	C396-G442 (PDBs: 8OL9), C396-C382 (PDBs: 8OL9), C396-L376 (PDBs: 8OL9), C396-V377 (PDBs: 8OL9)							121									-103.5				143.8						B (undefined)	E (parallel sheets)	Beta strand											93.62	0.7407407	>90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.901917579173913	0.8970160820346753	false	false	false
KRAS	KRAS_Gly60Ser	B_13-14	-0.09720436679761342	0.9252887309563864	0.944705087835014	0.9504758263710318	0.37352495835952293	0.4270518994328502	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7053840949642542	0.7329304704628499	0.6374103243488365	0.7548505575720423	0.6867994898709582	0.6978149190737282	0.9171766989176443	0.9304853528045832	0.952253544317528	0.8050624953118449	0.8895227120156611	0.8952267036175477	0.4784531392298119	0.44311362693733314	0.5574475708265566	0.46975815338582805	0.5763382289100385	0.5155414863109608	KRAS	Gly60Ser	NC_000012.12:25227346:C:T	178G>A	12	25227346	C	T	12	ENSG00000133703	3084	0	CCSBVarC006098	ALE00006098	ENSP00000308495.3	CEGS2	CegsMutGDEh1036	F02	GDEhDisVCh_40061	A09	1	CegsMutGDDh1036	F02	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	3.0	0.0			0.0			0.0			Y	N	N	N	N	27636.0	single nucleotide variant	NM_033360.4(KRAS):c.178G>A (p.Gly60Ser)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Nov 25, 2022	104894359.0	-	RCV000013428|RCV000157934|RCV000689097|RCV002470709	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	Noonan syndrome 3|not provided|RASopathy|Cardiofaciocutaneous syndrome 2	de novo;germline	germline	GRCh38	NC_000012.12	12	25227346.0	25227346.0	12p12.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA256484,UniProtKB:P01116#VAR_065146,OMIM:190070.0020	3.0	12597.0	25227346.0	C	T	-	-	-	-	-	-	178G>A 	Gly60Ser	NM_033360.4	2.0	Pathogenic	Pathogenic	12597	12	25227346.0	C	T	G	S	rs104894359	12	25380280	12	25271547	60	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.178G>A	p.Gly60Ser	c.178G>A	p.Gly60Ser	alternative1	Y	1	.	Plus_Clinical	-	GGT	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.195	0.88911	M	-5.82	0.88318	D	0.958	0.96773	1.0665	0.98496	D	0.9342	0.97828	D	10	0.9487096	0.94136	D	0.407238	0.93510	D	0.943	0.98815	0.776	0.90105	P01116	G60S	Gain of catalytic residue at L56 (P = 0.0034)| Gain of disorder (P = 0.0769)| Gain of phosphorylation at G60 (P = 0.0926)| Loss of sheet (P = 0.1398)| Loss of helix (P = 0.2022)	0.996255802933	0.99616	0.9459025843081321	0.94539	2.69341285729	0.98552	0.926605463028	0.98783	D	0.929646	0.98786	D	0.524795	0.94982	D	0.516055	0.94909	D	0.999157786369324	0.96329	D	0.966103	0.87543	D	0.98016226	0.99107	0.96225566	0.99077	0.9698139	0.98214	0.94146484	0.97832	-12.139	0.87851	D	0.9985	0.98500	P	0.999680939266056	0.97477	0.99929273	0.99274	0.997	0.99892	.	.	.	.	.	.	5.28558	0.88766	29.7	0.9989031345780135	0.96438	0.908603	0.86363	D	1.06893418515311	0.97500	16.26098	0.997770489382923	0.98575	18.70474	5.77	5.77	0.91065	3.95	0.75212	7.892	0.85894	7.701000	0.66341	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	not_provided|RASopathy|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25227346C>T	ClinGen:CA256484|OMIM:190070.0020|UniProtKB:P01116#VAR_065146	C3661900|C5555857|C1860991|C3809005	609942|615278	536391|648|1340	Small GTP-binding domain	Gly	Ser	82.99	0.10714285714285714																																																																																																																																																																																					2.33	4 mutation(s) (Gly60Ala: 2.365, Gly60Arg: 2.384, Gly60His: 2.601, Gly60Glu: 2.710)					0.296						-0.355						-0.843				-0.652				-0.97		-0.459		-0.518						-1.207						0.18		1.421		1.601		0.68		0.58																																																																																																																																																																																																																																						9			82.99	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine	GTP	GTPase KRas; GTPase KRas, N-terminally processed								0.7716		-0.4									G60-R68 (PDBs: 5V9O, 6YXW, 7NY8), G60-Y96 (PDBs: 6GJ6, 6ZL5, 3GFT, 5UK9, 6MNX, 6O46, 7ACA), G60-T35 (PDBs: 6T5B, 7R0M), G60-P34 (PDBs: 6T5V, 7R0N, 8AQ5, 8B78, 8AQ7, 8UN5), G60-E37 (PDBs: 5V9L, 2MSC), G60-D12 (PDBs: 6W4F)		G60-E37 (PDBs: 5V9O, 8AFB, 4LUC, 5V9L, 8ECR, 2MSC), G60-P34 (PDBs: 6MBQ, 6T5V, 8B78, 8AQ7, 8B6I, 8QVU), G60-T35 (PDBs: 6T5B, 7R0N, 8AQ5, 8JHL, 7R0M, 8UN5), G60-D12 (PDBs: 6ZL5, 6W4F), G60-R68 (PDBs: 4LYH), G60-G10 (PDBs: 6VC8, 8T71, 8TBF), G60-A11 (PDBs: 8T72, 8T74, 8T75, 8TBF), G60-G12 (PDBs: 8TBF)							75									-95.8		Pocket 1: Mean pLDDT: 82.52, Volume: 1126.64 Å³, Druggability score: 0.77		-10.0				dbSNP: rs104894359; Variant type: LP/P; AA change: Gly60Arg; PTM type: Phosphorylation; PTM morphology: AG*QEEySAMRD; Var class: II&rs104894359		C (loop/coil)	C (loop/coil)	Helix											82.99	10.714286	70-90	10-90	609942;615278	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	NOONAN SYNDROME 3; CARDIOFACIOCUTANEOUS SYNDROME 2	true	0.7329304704628499	0.7053840949642542	false	false	false
RHO	RHO_Cys110Tyr	B_13-14	-5.373754793745742	0.001037313511567956	0.0049531720177369894	-15.001906186263495	1.4039537956208934e-6	0.000019970970658638292	2025_01_Batch_13-14	true	true	false	false	true	true	true	true	false	false	false	false	0.9990208462996393	0.9995678588724056	0.7622294096572068	0.867951631935544	0.9101795685123496	0.8774546795907359	0.8770573296430564	0.8966513890997317	0.9141538593490118	0.7629133898378586	0.9993772652781144	0.9991936171382999	0.8778520295384153	0.9237077479249675	0.8217494045220763	0.7615454294765549	0.9997584524666968	0.9988480754609786	RHO	Cys110Tyr	NC_000003.12:129529062:G:A	329G>A	3	129529062	G	A	3	ENSG00000163914	40080645	0	CCSBVarC013625	ALE00012053	ENSP00000296271.3																																	28074.0	single nucleotide variant	NM_000539.3(RHO):c.329G>A (p.Cys110Tyr)	6010.0	RHO	HGNC:10012	Pathogenic	1.0	Dec 19, 2020	104893787.0	-	RCV000013910|RCV001234924|RCV001073635	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	Retinitis pigmentosa 4|not provided|Retinal dystrophy	germline	germline	GRCh38	NC_000003.12	3	129529062.0	129529062.0	3q22.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA256681,UniProtKB:P08100#VAR_004790,OMIM:180380.0035	3.0	13035.0	129529062.0	G	A	-	-	-	-	-	-	329G>A 	Cys110Tyr	NM_000539.3	2.0	Pathogenic	Pathogenic	13035	3	129529062.0	G	A	C	Y	rs104893787	3	129247905	3	130730595	110	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.329G>A	p.Cys110Tyr	c.329G>A	p.Cys110Tyr	principal1	Y	1	YES	Select	+	TGC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.65	0.99359	H	-10.25	0.98944	D	0.973	0.98381	0.7379	0.93623	D	0.6727	0.88624	D	9	0.99468315	0.99956	D	0.356575	0.92389	D	0.790	0.93044	0.936	0.99070	P08100	C110Y	Loss of glycosylation at T108 (P = 0.1174)| Loss of catalytic residue at C110 (P = 0.1303)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.437)| Loss of stability (P = 0.5943)	0.98071754066	0.98031	0.9872522222524879	0.98714	1.14035379566	0.78786	0.632616996765	0.57451	T	0.872212	0.97226	D	0.401147	0.89909	D	0.338444	0.89782	D	0.999984264373779	0.99981	D	0.989657	0.96643	D	0.9926738	0.99885	0.9854278	0.99929	0.99123245	0.99822	0.9922701	0.99991	-9.757	0.72523	D	0.9978	0.97230	P	0.999956226333039	0.99183	0.99990320	0.99879	0.997	0.99892	.	.	.	.	.	.	5.01551	0.83352	28.0	0.9977197502818197	0.86015	0.938668	0.93795	D	1.15131989520089	0.98970	20.11403	1.01875670206705	0.98952	20.03965	5.31	5.31	0.75027	4.99	0.89858	9.996	0.99292	11.806000	0.96796	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.566	0.306	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	not_provided|Retinitis_pigmentosa_4|Retinal_dystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.129529062G>A	ClinGen:CA256681|OMIM:180380.0035|UniProtKB:P08100#VAR_004790	C3661900|C3151001|C0854723	613731	791|71862	GPCR, rhodopsin-like, 7TM	Cys	Tyr	98.33	0.007407407407407408																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			98.33	Special, a very reactive sulfhydryl group	Cysteine		Rhodopsin						Disulfide bond 110-187				2.5								 C110-G106 (PAE:  1.0), C110-G114 (PAE: 1.0)	C110-G114 (PDBs: 6CMO)	 C110-G106 (PAE:  1.0), C110-G114 (PAE: 1.0), C110-F103 (PAE: 1.0)	C110-G106 (PDBs: 6CMO), C110-G114 (PDBs: 6CMO)							121									-68.1				-42.6						H (helix)	H (α-helix)	Helix						Extracellular					98.33	0.7407407	>90	<10	613731	autosomal recessive	GenCC	Rare genetic eye disease; Ciliopathy	2	RETINITIS PIGMENTOSA 4	false	0.9995678588724056	0.9990208462996393	true	true	true
FARS2	FARS2_Leu371Phe	B_13-14	0.24590492354475124	1.0	1.0	-2.39654084312888	0.07203020474370399	0.0957825480032792	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.705594332070518	0.7876425920738873	0.5536876899621155	0.759683446491944	0.7436615893614424	0.7029227577907677	0.6812209118541005	0.7183431555463075	0.7241092512044052	0.5432013615140434	0.7726068406223164	0.6887729095384492	0.7246246037274351	0.7689800231765775	0.7952576417794829	0.5641740184101875	0.8026783435254582	0.7224157546025868	FARS2	Leu371Phe	NC_000006.12:5613216:G:T	1113G>T	6	5613216	G	T	6	ENSG00000145982	12653	0	CCSBVarC011882	ALE00015565	ENSP00000274680.4																																	962037.0	single nucleotide variant	NM_006567.5(FARS2):c.1113G>T (p.Leu371Phe)	10667.0	FARS2	HGNC:21062	Pathogenic	1.0	Dec 12, 2019	1204079767.0	-	RCV001250395	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5613216.0	5613216.0	6p25.1	no assertion criteria provided	1.0	-	N	-	2.0	973745.0	5613216.0	G	T	-	-	-	-	-	-	1113G>T 	Leu371Phe	NM_006567.5		Pathogenic	Pathogenic	973745	6	5613216.0	G	T	L	F	rs1204079767	6	5613449	6	5558448	371	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.1113G>T	p.Leu371Phe	c.1113G>T	p.Leu371Phe	principal1	Y	1	YES	Select	+	TTG	3	2	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.005	0.72530	D	0.984	0.60748	D	0.905	0.64254	P	0.98	0.97016	A	simple_aae	2.0	98.0	3.49	0.92559	M	-3.3	0.65888	D	0.828	0.82302	0.0185	0.82548	D	0.5146	0.81736	D	10	0.87487864	0.86629	D	0.114229	0.79238	D	0.721	0.90105	0.653	0.78980	O95363	L371F	Loss of catalytic residue at L371 (P = 0.134)| Gain of sheet (P = 0.1451)| Loss of stability (P = 0.1495)| Gain of loop (P = 0.3485)| Gain of disorder (P = 0.4546)	0.934491293691	0.93330	.	0.75719	.	0.59072	0.566125333309	0.48064	T	0.632922	0.88531	D	0.282506	0.81394	D	0.168024	0.81155	D	0.98774379491806	0.78021	D	0.949505	0.80529	D	0.6913538	0.77328	0.57329565	0.75036	0.6913538	0.77329	0.57329565	0.75036	-9.639	0.71800	D	0.4567	0.62580	A	0.937195805839724	0.79075	0.94634580	0.93179	0.82	0.90063	.	.	.	.	.	.	2.807945	0.37026	20.4	0.99854701034997717	0.93373	0.344351	0.43798	N	0.383302004000591	0.60314	4.241475	0.254276606892227	0.52647	3.461171	5.53	0.378	0.15396	0.251	0.23301	0.161	0.16353	0.741000	0.21243	0.676	0.76753	0.99	0.37076	0.997000	0.33331	0.996	0.76032	976	0.04721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Combined_oxidative_phosphorylation_defect_type_14	no_assertion_criteria_provided	NC_000006.12:g.5613216G>T	.	C4755312	614946	319519	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	Leu	Phe	96.82	0.17682926829268292																																																																																																																																																																																																																																																																																																																																																																																																																																																																													29			96.82	Aliphatic	Leucine									FDX-ACB			3.8								 L371-T410 (PAE:  1.0)	L371-T410 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP)	 L371-H412 (PAE:  1.0)	L371-H412 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP), L371-T410 (PDBs: 8P8X), L371-Y376 (PDBs: 8P8X)							131									-72.3				150.5						H (helix)	P (polyproline helix)												96.82	17.682926	>90	10-90	614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.7876425920738873	0.705594332070518	false	false	false
BRCA1	BRCA1_Met671Lys	B_13-14	2.267013845164269	0.05773114204962296	0.10422162695158776	1.7073574675266083	0.1315143412709758	0.16899777047075673	2025_01_Batch_13-14	false	false	true	true	false	true	false	false	false	false	false	false	0.9210093284127369	0.9222555081071995	0.8508175385192771	0.9365346291073813	0.8876946431518128	0.9594343597238888	0.9703792965953607	0.9118607399437889	0.9345970041682733	0.901186567217964	0.9464393513562595	0.945589051496553	0.948489422852417	0.8635285463598367	0.9384722540464893	0.8004485098205902	0.8980716648581396	0.8964296053289207	BRCA1	Met671Lys	NC_000017.11:43051071:A:T	2012T>A	17	43051071	A	T	17	ENSG00000012048	14613	0	CCSBVarC011871	ALE00012163	ENSP00000417148.1																																	32734.0	single nucleotide variant	NM_007294.4(BRCA1):c.5324T>A (p.Met1775Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	41293463.0	-	RCV000019265|RCV000496817|RCV001526335	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43051071.0	43051071.0	17q21.31	reviewed by expert panel	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00110,ClinGen:CA003476,UniProtKB:P38398#VAR_063212,OMIM:113705.0036	3.0	17695.0	43051071.0	A	T	-	-	-	-	-	-	5324T>A 	Met1775Lys	NM_007294.4	3.0	Pathogenic	Pathogenic	17695	17	43051071.0	A	T	M	K	rs41293463	17	41203088	17	38456614	1775	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.5324T>A	p.Met1775Lys	c.5324T>A	p.Met1775Lys	principal2	Y	1	YES	Select	-	ATG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	0.99	0.90580	D	0.798	0.86259	P	0.95	0.99291	A	simple_aae	5.0	95.0	2.33	0.66629	M	-1.1	0.77340	N	0.878	0.98669	0.6922	0.93053	D	0.7837	0.92637	D	10	0.8988125	0.89121	D	0.804846	0.98472	D	0.734	0.90683	.	.	.	.	.	0.963482532597	0.96276	.	0.86847	.	0.52277	0.562978863716	0.47621	T	0.234774	0.59973	T	0.436191	0.91778	D	0.388781	0.91677	D	0.990923941135406	0.81018	D	.	0.83947	.	0.9531011	0.96527	0.80974793	0.88742	0.9654434	0.97787	0.735878	0.84203	-12.423	0.89812	D	0.8787	0.86232	P	0.996656271029341	0.92339	0.99989700	0.99879	0.957	0.98136	.	.	.	.	.	.	3.769401	0.54208	23.4	0.98558459070339721	0.43068	0.719653	0.66927	D	0.693440170392724	0.79088	7.028289	0.666244745644706	0.79713	7.165023	5.21	5.21	0.71966	.	.	5.026	0.63961	11.142000	0.87118	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.997	0.79771	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43051071A>T	BRCA1-HCI:BRCA1_00110|ClinGen:CA003476|OMIM:113705.0036|UniProtKB:P38398#VAR_063212	C2676676|C0027672|C0677776	604370	145|140162|145	.	Met	Lys	90.88	0.0797872340425532																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																90.88	7.978723	>90	<10	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.9222555081071995	0.9210093284127369	false	false	false
F9	F9_Glu73Val	B_13-14	-2.6225172420292235	0.03428348463706878	0.06892784805979092	5.236829928039937	0.001203420081771499	0.0027974960036718766	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7019095479259863	0.7107821027184371	0.6998007211275363	0.6727172737858442	0.5772958325588297	0.7703845548279611	0.8411980552126845	0.6057412143525323	0.7251767095514514	0.7334195874170185	0.743245237948424	0.7749001740046422	0.6995710544432377	0.5488504507651271	0.6202578380202369	0.666181854838054	0.6783189674884502	0.6289189218473302	F9	Glu73Val	NC_000023.11:139537139:A:T	218A>T	23	139537139	A	T	X	ENSG00000101981	52861	0	CCSBVarC004374	ALE00004374	ENSP00000218099.2	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25610.0	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 19, 1990	137852226.0	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139.0	139537139.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255316,UniProtKB:P00740#VAR_006542,OMIM:300746.0014	1.0	10571.0	139537139.0	A	T	-	-	-	-	-	-	218A>T 	Glu73Val	NM_000133.4		Pathogenic	Pathogenic	10571	X	139537139.0	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	86.94	0.4072164948453608																																																																																																																																																																																																																																																																																																																																																																																																															1.004		0.808		0.84		0.061	5 mutation(s) (Glu73Lys: -0.019, Glu73Trp: -0.013, Glu73Ala: -0.005, Glu73Tyr: -0.005, Glu73Cys: -0.004)	0.964	4 mutation(s) (Glu73Thr: 1.256, Glu73Asn: 1.284, Glu73Gly: 1.293, Glu73Ser: 1.308)																																																					79			86.94	Negatively-charged	Glutamic Acid	Ca(2+); Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain							Gla			-3.5										 E73-V77 (PAE:  1.5)							4-carboxyglutamate	146									-62.5				-41.0						H (helix)	H (α-helix)	Helix											86.94	40.72165	70-90	10-90	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.7107821027184371	0.7019095479259863	false	false	false
BRCA1	BRCA1_Thr581Ala	B_13-14	0.0497091547769512	0.9617428060924307	0.9704652686935952	5.853936604185313	0.0006280865188124798	0.0016441351811995726	2025_01_Batch_13-14	false	false	false	true	false	true	false	false	false	false	false	false	0.858750642985153	0.8793942846000966	0.7765240073890152	0.9366260363027827	0.8718305264190214	0.8972148121697264	0.9146496608875625	0.902598321885189	0.9238503528767139	0.7901756184826245	0.903251059546849	0.8833246979570615	0.8797799634518904	0.8410627309528537	0.9494017197288516	0.7628723962954059	0.8555375096533442	0.8341765880132445	BRCA1	Thr581Ala	NC_000017.11:43067629:T:C	1741A>G	17	43067629	T	C	17	ENSG00000012048	14613	0	CCSBVarC011843	ALE00014341	ENSP00000417148.1																																	70031.0	single nucleotide variant	NM_007294.4(BRCA1):c.5053A>G (p.Thr1685Ala)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80356890.0	-	RCV000048749|RCV000112475|RCV000163024|RCV000212192	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067629.0	43067629.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00042,ClinGen:CA003174,UniProtKB:P38398#VAR_063902	2.0	55364.0	43067629.0	T	C	-	-	-	-	-	-	5053A>G 	Thr1685Ala	NM_007294.4	3.0	Pathogenic	Pathogenic	55364	17	43067629.0	T	C	T	A	rs80356890	17	41219646	17	38473172	1685	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.5053A>G	p.Thr1685Ala	c.5053A>G	p.Thr1685Ala	principal2	Y	1	YES	Select	-	ACT	1	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.53	0.77914	P	0.183	0.88579	B	0.91	0.99291	A	simple_aae	9.0	91.0	3.31	0.90471	M	-0.82	0.74769	N	0.875	0.91505	0.7304	0.93530	D	0.7785	0.92454	D	10	0.8680128	0.85903	D	0.754689	0.98044	D	0.882	0.96531	.	.	.	.	.	0.952919659821	0.95202	.	0.86482	.	0.09116	0.670587182045	0.62862	T	0.403358	0.81781	T	0.418536	0.90878	D	0.363421	0.90764	D	0.970580279827118	0.68797	D	.	0.76208	.	0.96085334	0.97324	0.6886691	0.81474	0.9444927	0.95639	0.6872717	0.81396	-14.503	0.94593	D	0.523	0.76577	A	0.979632873704045	0.85227	0.99986613	0.99835	0.966	0.98629	.	.	.	.	.	.	3.78294	0.54478	23.5	0.99777731049735807	0.86531	0.717269	0.66764	D	0.641941303045784	0.75718	6.379083	0.607013709110586	0.75311	6.31232	5.24	5.24	0.72825	3.42	0.61925	4.786	0.62201	7.873000	0.72109	0.56	0.28431	1.0	0.71675	1.000000	0.68239	0.983	0.59808	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43067629T>C	BRCA1-HCI:BRCA1_00042|ClinGen:CA003174|UniProtKB:P38398#VAR_063902	C3661900|C0677776|C2676676|C0027672	604370	145|145|140162	BRCT domain|BRCT domain|BRCT domain	Thr	Ala	94.85	0.352112676056338																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																94.85	35.21127	>90	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.8793942846000966	0.858750642985153	false	false	false
F9	F9_Arg384Leu	B_13-14	-3.007334038146191	0.019736371292147295	0.045128295885949514	2.069988729844694	0.07721803720039067	0.10449491022324253	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6880188414348481	0.6663812411658481	0.6204405713410267	0.5897676076251279	0.5706282499159075	0.6008951656046571	0.6395044622143259	0.5631818361688306	0.5676009558328297	0.6515293658143739	0.6386324318746129	0.6619977391754881	0.5622858689949882	0.5780746636629845	0.6119342594174262	0.5893517768676795	0.6941300504570832	0.7140399436942082	F9	Arg384Leu	NC_000023.11:139561836:G:T	1151G>T	23	139561836	G	T	X	ENSG00000101981	52861	0	CCSBVarC004390	ALE00004390	ENSP00000218099.2	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25707.0	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 22, 2009	137852283.0	-	RCV000011414|RCV000119810	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836.0	139561836.0	Xq27.1	no assertion criteria provided	2.0	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1.0	10668.0	139561836.0	G	T	-	-	-	-	-	-	1151G>T 	Arg384Leu	NM_000133.4		Pathogenic	Pathogenic	10668	X	139561836.0	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	94.23	0.7620967741935484																																																																																																																																																																																																																																																																																																																																																																																																															1.099		0.946		0.91	1 mutation(s) (Arg384Asn: 1.152)	0.889	1 mutation(s) (Arg384Asn: 1.142)	0.889																																																						189			94.23	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-4.5			H:R384-B:S274 (PDBs: 8OL9), H:R384-A:N264 (PDBs: 8OL9), H:R384-A:Y263 (PDBs: 8OL9)	H:R384-B:S274 (PDBs: 8OL9), H:R384-B:Y278 (PDBs: 8OL9), H:R384-B:N279 (PDBs: 8OL9), H:R384-B:S276 (PDBs: 8OL9)				 R384-A380 (PAE:  1.0)	R384-A380 (PDBs: 6X5J, 6X5L, 8OL9)	 R384-A380 (PAE:  1.0)	R384-A380 (PDBs: 6X5J, 6X5L, 8OL9)							175									-78.1				-25.4				dbSNP: rs137852283; Variant type: LP/P; AA change: Arg384Leu; PTM type: Phosphorylation; PTM morphology: LVDRAtCLR*ST; Var class: II		H (helix)	H (α-helix)	Helix											94.23	76.20968	>90	10-90	300807;306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	false	0.6663812411658481	0.6880188414348481	false	false	false
KRAS	KRAS_Thr58Ile	B_13-14	-0.39527774123572407	0.7044069422700285	0.7657468752053241	1.8618547153095657	0.10492537310114099	0.13821827684177582	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7187640749770632	0.7170500013649644	0.7063242395841233	0.8382414644371837	0.8431100780996936	0.8430785369561657	0.7990051316887743	0.8503627363250661	0.7560377881075696	0.670477074891386	0.6436088368839719	0.6258530037899723	0.8871519422235573	0.835857419874321	0.9204451407667978	0.7421714042768606	0.790491165845957	0.8116751461641541	KRAS	Thr58Ile	NC_000012.12:25227351:G:A	173C>T	12	25227351	G	A	12	ENSG00000133703	3084	0	CCSBVarC006096	ALE00006096	ENSP00000308495.3	CEGS2	CegsMutGDEh1040	G09	GDEhDisVCh_40061	H09	1	CegsMutGDDh1040	G09	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	2.0	0.0			0.0			0.0			Y	Y	N	N	N	27627.0	single nucleotide variant	NM_004985.5(KRAS):c.173C>T (p.Thr58Ile)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Apr 03, 2017	104894364.0	-	RCV000013419|RCV000211785|RCV000157933|RCV000704828	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 3|Noonan syndrome|not provided|RASopathy	germline	germline	GRCh38	NC_000012.12	12	25227351.0	25227351.0	12p12.1	reviewed by expert panel	7.0	-	N	ClinGen:CA256480,UniProtKB:P01116#VAR_026111,OMIM:190070.0011	3.0	12588.0	25227351.0	G	A	-	-	-	-	-	-	173C>T 	Thr58Ile	NM_004985.5	3.0	Pathogenic	Pathogenic	12588	12	25227351.0	G	A	T	I	rs104894364	12	25380285	12	25271552	58	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.173C>T	p.Thr58Ile	c.173C>T	p.Thr58Ile	alternative1	Y	1	.	Plus_Clinical	-	ACA	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.87	0.90832	A	simple_aae	13.0	87.0	2.76	0.80456	M	-5.82	0.88318	D	0.985	0.99419	0.9591	0.96522	D	0.8519	0.95052	D	9	0.95001256	0.94271	D	0.262968	0.89556	D	0.921	0.98001	0.826	0.93687	P01116	T58I	Gain of catalytic residue at A59 (P = 0)| Loss of glycosylation at T58 (P = 0.0493)| Loss of disorder (P = 0.0697)| Loss of sheet (P = 0.1398)| Loss of phosphorylation at T58 (P = 0.1979)	0.993069005404	0.99291	0.9692766844020148	0.96898	2.79487049805	0.98863	0.928796410561	0.98917	D	0.892475	0.97806	D	0.461113	0.92920	D	0.42458	0.92832	D	0.997460722923279	0.91549	D	0.931307	0.74400	D	0.98686	0.99577	0.96777624	0.99355	0.98655695	0.99559	0.97297084	0.99581	-12.877	0.90103	D	0.9994	0.99054	P	0.999977356359875	0.99427	0.99922788	0.99231	0.997	0.99892	.	.	.	.	.	.	5.459501	0.91162	32.0	0.99889978765528353	0.96438	0.874898	0.79727	D	0.989759110368124	0.95396	13.60356	0.904634796992952	0.95748	13.95184	5.77	4.87	0.62830	3.17	0.57548	9.985	0.99185	9.977000	0.82927	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613990	6.195830e-07	0	1	64002	1.562450e-05	0	0	75010	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29598	0.000000e+00	0	0	44872	0.000000e+00	0	1	64002	1.562450e-05	0	0	6060	0.000000e+00	0	0	1179936	0.000000e+00	0	0	91080	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Noonan_syndrome|RASopathy|Noonan_syndrome_3|not_provided	reviewed_by_expert_panel	NC_000012.12:g.25227351G>A	ClinGen:CA256480|OMIM:190070.0011|UniProtKB:P01116#VAR_026111	C0028326|C5555857|C1860991|C3661900	PS163950|609942	648|536391|648	Small GTP-binding domain	Thr	Ile	94.05	0.007042253521126761																																																																																																																																																																																					1.861						-0.061						-0.51						-0.904				0.155				-0.68		-0.365		-0.132						-0.961						0.865		0.778		1.538		0.626		0.285																																																																																																																																																																																																																																						1			94.05	Polar/Neutral	Threonine		GTPase KRas; GTPase KRas, N-terminally processed								0.7716		-0.7			D:T58-E:R30 (PDBs: 5WLB)	A:T58-B:Y29 (PDBs: 5WLB, 5WPM), A:T58-B:R30 (PDBs: 5WPM)				 T58-V8 (PAE:  3.0)	T58-V8 (PDBs: 4L8G, 4LDJ, 5OCG, 5V9O, 6E6G, 6GJ6, 6GJ7, 6GJ8, 6GOD, 6MBQ, 6T5B, 6T5V, 6V5L, 6ZL5, 7R0N, 8AFB, 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8B78, 8JHL, 8ONV, 8QUG, 3GFT, 4LPK, 4LRW, 4LUC, 4LV6, 4LYF, 4LYH, 4M1O, 4M1S, 4M1T, 4M1W, 4M1Y, 4M21, 4M22, 4OBE, 4TQA, 5KYK, 5UK9, 5V9L, 5VQ2, 6MBT, 6MBU, 6MNX, 6MS9, 6MTA, 6O36, 6O46, 6P0Z, 6QUU, 6QUV, 6QUW, 6QUX, 6VC8, 6ZLI, 7ACA, 7ACF, 7ACH, 7ACQ, 7O70, 7R0M, 7R0Q, 8AFC, 8AFD, 8AQ7, 8B6I, 8ECR, 8T71, 8T72, 8UN5, 2MSC, 2MSD, 5MLA, 5MLB, 5O2S, 5O2T, 5TAR, 5TB5, 5UFE, 5WLB, 5WPM, 6H46, 6H47, 6OB2, 6PTS, 6PTW, 6V65, 6VJJ, 6W4E, 6W4F, 6XHB, 6YR8, 6YXW, 7NY8, 7VVB, 8QU8, 8QVU, 8T74, 8T75, 8TBF), T58-E62 (PDBs: 4LYJ), T58-Y96 (PDBs: 6M9W, 6MQG, 8CPR, 6BOF), T58-K16 (PDBs: 7LGI, 7MQU, 2MSE)	 T58-V8 (PAE:  3.0)	T58-V9 (PDBs: 4L8G, 6GJ7, 6GJ8, 6GOD, 6T5B, 6T5V, 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8JHL, 8ONV, 8QUG, 4LYF, 4LYH, 4M1S, 4M21, 4OBE, 6MBU, 6MTA, 6O46, 6P0Z, 7R0Q, 8AQ7, 8B6I, 8ECR, 8T71, 8UN5, 2MSC, 5MLA, 5MLB, 5O2S, 5O2T, 5TAR, 5UFE, 5WLB, 5WPM, 6H47, 6PTW, 6VJJ, 6W4E, 6XHB, 7NY8, 7VVB, 8QU8, 8QVU, 8T74, 8T75, 8TBF), T58-V8 (PDBs: 4LDJ, 5OCG, 5V9O, 6E6G, 6GJ6, 6MBQ, 6V5L, 6ZL5, 7LGI, 7MQU, 7R0N, 8AFB, 8B78, 8QUG, 3GFT, 4LPK, 4LRW, 4LUC, 4LV6, 4M1O, 4M1T, 4M1W, 4M1Y, 4M22, 4TQA, 5KYK, 5UK9, 5V9L, 5VQ2, 6MBT, 6MNX, 6MQN, 6MS9, 6O36, 6QUU, 6QUV, 6QUW, 6QUX, 6VC8, 6ZLI, 7ACA, 7ACF, 7ACH, 7ACQ, 7O70, 7R0M, 8AFC, 8AFD, 8T72, 2MSD, 5TB5, 6H46, 6OB2, 6PTS, 6V65, 6W4F, 6YR8, 6YXW, 7SCW, 8TBF), T58-E62 (PDBs: 4LYJ, 8CPR), T58-E63 (PDBs: 6M9W, 6MQG, 6BOF), T58-V7 (PDBs: 8QUG, 8TBF), T58-K16 (PDBs: 8QUG, 8TBF), T58-E37 (PDBs: 8QUG)							119									-114.0		Pocket 1: Mean pLDDT: 82.52, Volume: 1126.64 Å³, Druggability score: 0.77		157.1						B (undefined)	E (parallel sheets)												94.05	0.70422536	>90	<10	609942	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	NOONAN SYNDROME 3	false	0.7170500013649644	0.7187640749770632	false	false	false
BRAF	BRAF_Thr241Arg	B_13-14	-8.877044476380464	0.0000466454663945854	0.0005465818454825651	4.342228023678122	0.003386840271271843	0.006670834020243826	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7528216227636998	0.8073223395925827	0.7277534213672423	0.7214659338940304	0.7407622038441499	0.8224089609134391	0.8224089609134391	0.7407622038441499	0.7214659338940304	0.7277534213672423	0.8073223395925827	0.7786277089319072						0.7270155365954923	BRAF	Thr241Arg	NC_000007.14:140801550:G:C	722C>G	7	140801550	G	C	7	ENSG00000157764	71969	0	CCSBVarC003154	ALE00003154	ENSP00000493543.1	CEGS2	CegsMutGDEh1016	G06	GDEhDisVCh_40058	D05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	38761.0	single nucleotide variant	NM_004333.6(BRAF):c.722C>G (p.Thr241Arg)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Feb 01, 2023	387906660.0	-	RCV000022679|RCV000208548|RCV000624512|RCV001703420|RCV002513171	MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MeSH:D030342,MedGen:C0950123|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 7|Noonan syndrome 1|Inborn genetic diseases|not provided|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140801550.0	140801550.0	7q34	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA259663,UniProtKB:P15056#VAR_058622,OMIM:164757.0023	3.0	29806.0	140801550.0	G	C	-	-	-	-	-	-	722C>G 	Thr241Arg	NM_004333.6	2.0	Pathogenic	Pathogenic	29806	7	140801550.0	G	C	T	R	rs387906660	7	140501350	7	140147819	241	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.722C>G	p.Thr241Arg	c.722C>G	p.Thr241Arg	principal4	Y	.	YES	Select	-	ACG	2	0	G	./.	./.	./.	./.	.	0.91343	.	.	0.53421	.	1.0	0.90580	D	0.998	0.88579	D	.	0.86984	.	.	.	.	3.175	0.88626	M	.	0.77586	.	.	0.96886	0.9426	0.96274	D	0.8732	0.95778	D	10	0.9803134	0.97976	D	0.440713	0.94148	D	.	0.99124	0.93	0.98894	P15056	T241R	Gain of solvent accessibility (P = 0.008)| Gain of relative solvent accessibility (P = 0.0289)| Gain of MoRF binding (P = 0.033)| Gain of methylation at T241 (P = 0.0391)| Loss of ubiquitination at K240 (P = 0.0594)	.	0.98932	.	0.97131	.	0.95664	0.916709661484	0.98061	D	0.89813	0.97961	D	0.503099	0.94327	D	0.484891	0.94248	D	0.998121440410614	0.93238	D	0.983902	0.95725	D	0.94158983	0.95338	0.8970028	0.94691	0.92752135	0.93899	0.90271693	0.95103	-14.509	0.94604	D	0.9977	0.98500	P	0.999963000543786	0.99297	0.99600226	0.97933	0.973	0.98982	.	.	.	.	.	.	5.408322	0.90554	31.0	0.99652661569364764	0.77405	0.880398	0.80631	D	0.884148484170867	0.90911	10.64868	0.845660358607975	0.92720	11.61548	5.17	5.17	0.70808	.	.	9.943	0.9894	11.755000	0.95501	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.94	0.48078	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Inborn_genetic_diseases|RASopathy|not_provided|Noonan_syndrome_7|Noonan_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140801550G>C	ClinGen:CA259663|OMIM:164757.0023|UniProtKB:P15056#VAR_058622	C0950123|C5555857|C3661900|C3150970|C4551602	613706|163950	536391|648|648	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Thr	Arg	89.33	0.3380281690140845																																																																																																																																																																																																																																																																																																																																																																																																																																																																													48			89.33	Polar/Neutral	Threonine		Serine/threonine-protein kinase B-raf										-0.7			A:T241-D:E17 (PDBs: 7MFD), A:T241-B:E17 (PDBs: 7MFE), A:T241-C:S57 (PDBs: 8DGT)	A:T241-C:S57 (PDBs: 7MFD, 7MFE, 8DGT)					T241-F256 (PDBs: 8DGS)		T241-Q257 (PDBs: 8DGS, 8DGT), T241-F256 (PDBs: 8DGT)							119									-92.2				132.5				dbSNP: rs387906660; Variant type: LP/P; AA change: Thr241Met; PTM type: Phosphorylation; PTM morphology: RKT*FFtLAFCD; Var class: II&rs387906661		B (undefined)	E (parallel sheets)											Phorbol-ester/DAG-type	89.33	33.802814	70-90	10-90	613706;163950	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	NOONAN SYNDROME 7; NOONAN SYNDROME 1	false	0.8073223395925827	0.7528216227636998	false	false	false
BRAF	BRAF_Val600Gly	B_13-14	3.466058469875043	0.010461482848769289	0.02806380932745694	-2.6271460056936986	0.03405357216252174	0.050556881001802105	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8067596839126709	0.8388076700192832	0.7339701035201884	0.8181569584551509	0.8749066852446434	0.7774399167450907	0.75106693320048	0.8196915713211466	0.7230048915455809	0.6814024021348768	0.7590138358596461	0.7106270656043203	0.8038129002897014	0.9301217991681404	0.9133090253647208	0.7865378049055001	0.9186015041789203	0.9028923022210215	BRAF	Val600Gly	NC_000007.14:140753336:A:C	1799T>G	7	140753336	A	C	7	ENSG00000157764	71969	0	CCSBVarC003172	ALE00003172	ENSP00000493543.1	CEGS2	CegsMutGDEh1021	A01	GDEhDisVCh_40058	A09	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	48859.0	single nucleotide variant	NM_004333.6(BRAF):c.1799T>G (p.Val600Gly)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Jun 25, 2020	113488022.0	-	RCV000208774|RCV001354831|RCV000798913	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Cardio-facio-cutaneous syndrome|not provided|RASopathy	germline;unknown	germline	GRCh38	NC_000007.14	7	140753336.0	140753336.0	7q34	reviewed by expert panel	4.0	-	Y	ClinGen:CA281998	3.0	40389.0	140753336.0	A	C	-	-	-	-	-	-	1799T>G 	Val600Gly	NM_004333.6	3.0	Pathogenic	Pathogenic	40389	7	140753336.0	A	C	V	G	rs113488022	7	140453136	7	140099605	600	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1799T>G	p.Val600Gly	c.1799T>G	p.Val600Gly	principal4	Y	.	YES	Select	-	GTG	2	0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.822	0.45782	P	0.963	0.70837	D	.	0.99291	.	.	.	.	1.53	0.38641	L	.	.	.	.	.	-0.3730	0.72748	T	0.3689	0.72751	T	10	0.9087879	0.90136	D	0.179839	0.85412	D	.	0.98152	0.749	0.87927	P15056	V600G	Loss of stability (P = 0.0081)| Gain of disorder (P = 0.0094)| Gain of ubiquitination at K601 (P = 0.0582)| Gain of phosphorylation at S605 (P = 0.152)| Loss of sheet (P = 0.1907)	.	0.98536	.	0.95955	.	0.91438	0.836802065372	0.87585	D	0.854038	0.96676	D	0.414274	0.90651	D	0.357299	0.90535	D	0.995703637599945	0.87816	D	0.874613	0.58418	D	0.9755868	0.98734	0.95782745	0.98836	0.9773177	0.98880	0.9476951	0.98232	-15.5	0.96920	D	0.9773	0.94797	P	0.999897984516839	0.98645	0.99933314	0.99303	1	0.99985	.	.	.	.	.	.	5.376319	0.90129	31.0	0.99637999643544239	0.76475	0.917884	0.88572	D	0.535279311356242	0.69026	5.322119	0.606101544715016	0.75248	6.300693	5.65	5.65	0.86862	.	.	9.236	0.94487	11.216000	0.89597	0.75	0.87077	1.0	0.71675	1.000000	0.68239	0.999	0.91597	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Cardio-facio-cutaneous_syndrome|RASopathy|Melanoma|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140753336A>C	ClinGen:CA281998|Genetic_Testing_Registry_(GTR):GTR000522729|Genetic_Testing_Registry_(GTR):GTR000569880	C1275081|C5555857|C0025202|C3661900	PS115150	1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Val	Gly	49.51	0.035211267605633804																																																																																																																																																																																																																																																																																																																																																																																																																																																																													5			49.51	Aliphatic	Valine		Serine/threonine-protein kinase B-raf							Protein kinase			4.2								 V600-W604 (PAE:  5.0)	V600-S571 (PDBs: 3PRF), V600-N580 (PDBs: 3Q96, 4DBN, 4H58), V600-W604 (PDBs: 3TV6, 4PP7, 5FD2), V600-E501 (PDBs: 4EHE), V600-S467 (PDBs: 8F7P)	 V600-E501 (PAE:  7.5), V600-W604 (PAE: 5.0)	V600-F468 (PDBs: 5CSX, 8F7P, 8QQG, 8DGS), V600-Q612 (PDBs: 3II5, 5HID), V600-S571 (PDBs: 3PRF), V600-W604 (PDBs: 3TV6, 4EHE, 4PP7, 5FD2), V600-N580 (PDBs: 8C7X), V600-L485 (PDBs: 8DGT), V600-F498 (PDBs: 8DGT), V600-V487 (PDBs: 8DGT)							117									-61.3				-57.9				dbSNP: rs121913377; Variant type: US; AA change: Val600Asp; PTM type: Ubiquitylation; PTM morphology: GLAtV*ksRWsG; Var class: II&rs113488022		H (helix)	H (α-helix)	Turn											49.51	3.521127	$\leqslant$50	<10		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.8388076700192832	0.8067596839126709	false	false	false
BAP1	BAP1_Cys91Ser	B_13-14	0.5371858858067884	0.607783622798212	0.683264696612469	-2.5252776118798073	0.03950462125013418	0.0575325238047589	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6185692259964383	0.6550190803159444	0.7698389313388747	0.7149945482805888	0.6832712958630998	0.7921182862239253	0.933585077456487	0.7600620257385963	0.7911946280935688	0.8852075217167055	0.6622087335036446	0.6279657589060483	0.6506514949913637	0.6064805659876031	0.6387944684676089	0.6544703409610438	0.6478294271282441	0.6091726930868282	BAP1	Cys91Ser	NC_000003.12:52408061:C:G	272G>C	3	52408061	C	G	3	ENSG00000163930	3760	0	CCSBVarC009484	ALE00015196	ENSP00000417132.1																																	1162263.0	single nucleotide variant	NM_004656.4(BAP1):c.272G>C (p.Cys91Ser)	8314.0	BAP1	HGNC:950	Pathogenic	1.0	Apr 06, 2024	1559591264.0	-	RCV001797187|RCV004762154	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900	Neurodevelopmental disorder|not provided	de novo;germline	germline	GRCh38	NC_000003.12	3	52408061.0	52408061.0	3p21.1	criteria provided, single submitter	2.0	-	N	-	2.0	1173081.0	52408061.0	C	G	-	-	-	-	-	-	272G>C 	Cys91Ser	NM_004656.4	1.0	Pathogenic	Pathogenic	1173081	3	52408061.0	C	G	C	S	rs1559591264	3	52442077	3	52417117	91	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.272G>C	p.Cys91Ser	c.272G>C	p.Cys91Ser	principal1	Y	1	YES	Select	-	TGT	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.145	0.97505	H	-9.46	0.98771	D	0.955	0.96431	1.0958	0.99480	D	0.9489	0.98331	D	10	0.9872064	0.99064	D	0.596811	0.96431	D	0.962	0.99434	0.905	0.97974	Q92560	C91S	Gain of disorder (P = 0.0084)| Loss of stability (P = 0.0799)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2045)| Loss of catalytic residue at T93 (P = 0.2182)	0.955221855794	0.95437	0.9595328650281908	0.95915	2.72839044085	0.98645	0.864477872849	0.91757	D	0.614019	0.87693	D	0.541235	0.95439	D	0.53967	0.95371	D	0.999951362609863	0.99873	D	0.998731	0.99346	D	0.94517225	0.95709	0.93077695	0.97107	0.94517225	0.95709	0.93077695	0.97108	-12.137	0.85551	D	0.9993	0.98761	P	0.999965302743864	0.99297	0.99989426	0.99864	0.869	0.92884	.	.	.	.	.	.	5.171826	0.86714	29.0	0.99414808621726736	0.63503	0.954506	0.97155	D	1.0231602614017	0.96393	14.66464	0.934896275402238	0.96904	15.33076	5.49	5.49	0.80997	.	.	7.657	0.82777	7.613000	0.62049	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Neurodevelopmental_disorder	no_assertion_criteria_provided	NC_000003.12:g.52408061C>G	.	C1535926	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Cys	Ser	93.1	0.14814814814814814																																																																																																																																																																																																																																																																																																																																																																																																																																																																													20		Nucleophile	93.1	Special, a very reactive sulfhydryl group	Cysteine		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			2.5								 C91-A95 (PAE:  1.0)	C91-A95 (PDBs: 8SVF)	 C91-Q85 (PAE:  1.5), C91-A95 (PAE: 1.0)	C91-Q85 (PDBs: 8SVF), C91-A95 (PDBs: 8SVF), C91-F170 (PDBs: 8SVF), C91-H169 (PDBs: 8SVF)							121		Mutation: C -> A. Abolishes deubiquitinase activity. Has no effect on interaction with HCFC1.							-59.3				-46.3						H (helix)	H (α-helix)	Helix											93.1	14.814815	>90	10-90		unknown		Rare genetic tumor	1		false	0.6550190803159444	0.6185692259964383	false	false	false
BRCA1	BRCA1_Thr37Lys	B_13-14	-0.25728289233865603	0.80435939653231	0.8450640524624379	5.811053388630985	0.0006560963239190668	0.001702880840723462	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.883288517593551	0.8915923382229266	0.7978434696592147	0.9170210877088494	0.8891545363208155	0.8793074536901229	0.8225579510825002	0.9079391658630301	0.8805053138870207	0.6613854296988618	0.870772588229326	0.8535433290673781	0.9360569562977454	0.8703699067786009	0.9535368615306782	0.9343015096195675	0.9124120882165272	0.9130337061197239	BRCA1	Thr37Lys	NC_000017.11:43115750:G:T	110C>A	17	43115750	G	T	17	ENSG00000012048	14613	0	CCSBVarC011837	ALE00014318	ENSP00000417148.1																																	68798.0	single nucleotide variant	NM_007294.4(BRCA1):c.110C>A (p.Thr37Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80356880.0	-	RCV000111781|RCV000763401|RCV001378528|RCV002433536	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast;Fanconi anemia, complementation group S|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115750.0	43115750.0	17q21.31	reviewed by expert panel	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00112,ClinGen:CA000742	2.0	54131.0	43115750.0	G	T	-	-	-	-	-	-	110C>A 	Thr37Lys	NM_007294.4	3.0	Pathogenic	Pathogenic	54131	17	43115750.0	G	T	T	K	rs80356880	17	41267767	17	38521293	37	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.110C>A	p.Thr37Lys	c.110C>A	p.Thr37Lys	principal2	Y	1	YES	Select	-	ACA	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.979	0.90580	D	0.777	0.92348	P	0.99	0.99291	A	simple_aae	1.0	99.0	2.54	0.73893	M	-0.91	0.87019	N	0.909	0.91390	1.0434	0.97975	D	0.9155	0.97195	D	10	0.9803947	0.97988	D	0.597518	0.96439	D	0.823	0.94336	0.94	0.99178	E9PFC7	T37K	Gain of methylation at T37 (P = 0.0325)| Gain of disorder (P = 0.0355)| Gain of ubiquitination at T37 (P = 0.0369)| Loss of catalytic residue at T37 (P = 0.1105)| Loss of sheet (P = 0.1158)	0.980248173759	0.97984	.	0.87940	.	0.46547	0.74592012167	0.73798	T	0.4401	0.88719	T	0.478281	0.93590	D	0.449241	0.93510	D	0.992633044719696	0.83032	D	.	0.77715	.	0.9560325	0.96828	0.8919265	0.94327	0.96704304	0.97946	0.84243727	0.90882	-15.301	0.98159	D	0.9729	0.92484	P	0.992970792932514	0.89793	0.99969053	0.99611	0.962	0.98414	.	.	.	.	.	.	4.997611	0.82936	27.9	0.99301403670490562	0.58711	0.726971	0.67428	D	0.984277674482382	0.95215	13.43596	0.917667809072401	0.96277	14.52852	5.97	5.97	0.96929	.	.	4.401	0.59561	11.711000	0.94660	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43115750G>T	BRCA1-HCI:BRCA1_00112|ClinGen:CA000742	C0677776|C0346153|C4554406|C2676676|C3280442|C0027672	114480|617883|604370|614320	145|227535|145|1333|140162	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Thr	Lys	88.99	0.028169014084507043			-2.349	1 mutation(s) (Thr37Tyr: -4.258)	0.081																																																																																								1.0		-0.479																				-0.633		-0.557																																																																																																																																																																																																																																																																																																																																																								5			89.44	Polar/Neutral	Threonine		Breast cancer type 1 susceptibility protein										-0.7								 T37-H41 (PAE:  2.0)	T37-H41 (PDBs: 1JM7, 7LYB)	 T37-I68 (PAE:  3.0), T37-H41 (PAE: 2.0), T37-S72 (PAE: 2.5)	T37-H41 (PDBs: 1JM7, 7LYB, 8GRQ), T37-L73 (PDBs: 1JM7), T37-F43 (PDBs: 1JM7), T37-D67 (PDBs: 8GRQ)							119									-107.1				168.4						B (undefined)	E (parallel sheets)											RING-type	88.99	2.8169014	70-90	<10	604370;604370;614320;114480;617883	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S	false	0.8915923382229266	0.883288517593551	false	false	false
BRCA1	BRCA1_Arg71Gly	B_13-14	-1.183279693007538	0.275321882540562	0.3619165833809177	6.8385726493883485	0.00024450329988398285	0.0007955027576012563	2025_01_Batch_13-14	false	false	true	false	true	true	false	false	false	false	false	true	0.8473109429181775	0.8927028275142521	0.8920411294522398	0.945984305732075	0.9373872699661406	0.955310429941837	0.9258218070098707	0.9394927557677359	0.9107193238210888	0.8465916280233126	0.8571828984434086	0.8049880069927952	0.9847990528738033	0.9352817841645453	0.9812492876430613	0.937490630881167	0.9282227565850958	0.88963387884356	BRCA1	Arg71Gly	NC_000017.11:43106457:T:C	211A>G	17	43106457	T	C	17	ENSG00000012048	14613	0	CCSBVarC011856	ALE00012160	ENSP00000417148.1																																	32732.0	single nucleotide variant	NM_007294.4(BRCA1):c.211A>G (p.Arg71Gly)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 18, 2019	80357382.0	-	RCV000131899|RCV000019263|RCV000047713|RCV004758595|RCV000195359|RCV000469732|RCV000508177|RCV000763009|RCV004802945	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900||MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN169374|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0700268,MedGen:CN377757	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|BRCA1-related disorder|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|not specified|Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1;Familial cancer of breast|BRCA1-related cancer predisposition	germline;not applicable;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	43106457.0	43106457.0	17q21.31	reviewed by expert panel	33.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001398,OMIM:113705.0034	3.0	17693.0	43106457.0	T	C	-	-	-	-	-	-	211A>G 	Arg71Gly	NM_007294.4	3.0	Pathogenic	Pathogenic	17693	17	43106457.0	T	C	R	G	rs80357382	17	41258474	17	38512000	71	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.211A>G	p.Arg71Gly	principal2	Y	.	.	.	-	AGG	1	2	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.83643	.	0.956	0.59057	P	0.444	0.68273	B	.	0.99291	.	.	.	.	2.455	0.71058	M	.	0.92366	.	.	0.86054	0.8364	0.94843	D	0.8394	0.94619	D	10	.	0.92374	.	0.80066	0.98437	D	.	0.95939	0.809	0.92541	E9PFC7	R71G	Gain of ubiquitination at K70 (P = 0.0519)| Loss of solvent accessibility (P = 0.0807)| Loss of phosphorylation at T69 (P = 0.1027)| Gain of relative solvent accessibility (P = 0.1684)| Loss of disorder (P = 0.1823)	.	0.93459	.	0.57140	.	0.24793	0.550648927689	0.45883	T	0.325403	0.69435	T	0.464929	0.93082	D	0.430062	0.92996	D	0.867488086223602	0.51486	D	.	0.86835	.	0.7237265	0.79126	0.32902288	0.58556	0.63329226	0.74199	0.31909144	0.57647	-13.862	0.93673	D	.	0.89378	.	0.999229197308064	0.96001	0.99944407	0.99387	0.931	0.96596	.	.	.	.	.	.	5.274462	0.88579	29.6	0.99887384451911465	0.96206	0.840976	0.75732	D	0.586117233560111	0.72160	5.78522	0.5471513750929	0.71040	5.618586	4.64	4.64	0.57348	5.61	0.95042	4.16	0.58035	7.857000	0.71293	0.588	0.31377	1.0	0.71675	1.000000	0.68239	0.994	0.71086	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	108704	0.000000e+00	0	1	206546	4.841540e-06	0	1	235294	4.250000e-06	0	0	7112	0.000000e+00	0	0	16894	0.000000e+00	0	0	2294	0.000000e+00	0	0	9040	0.000000e+00	0	0	13388	0.000000e+00	0	0	42620	0.000000e+00	0	0	15456	0.000000e+00	0	.	.	.	.	0	16078	0.000000e+00	0	0	30222	0.000000e+00	0	0	6166	0.000000e+00	0	0	13382	0.000000e+00	0	0	16704	0.000000e+00	0	1	89038	1.123120e-05	0	0	30132	0.000000e+00	0	1	89038	1.123120e-05	0	0	14770	0.000000e+00	0	0	33946	0.000000e+00	0	0	9522	0.000000e+00	0	0	17632	0.000000e+00	0	0	21592	0.000000e+00	0	1	102222	9.782630e-06	0	0	30050	0.000000e+00	0	1	102222	9.782630e-06	0	.	2	1580162	1.265690e-06	0	2	1150962	1.737680e-06	0	0	74308	0.000000e+00	0	0	912	0.000000e+00	0	0	59768	0.000000e+00	0	0	29370	0.000000e+00	0	0	44596	0.000000e+00	0	0	63918	0.000000e+00	0	0	5674	0.000000e+00	0	2	1150962	1.737680e-06	0	0	89324	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome|not_specified|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Fanconi_anemia,_complementation_group_S|not_provided|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43106457T>C	ClinGen:CA001398|OMIM:113705.0034	C2676676|C0027672|CN169374|C0346153|C3280442|C4554406|C3661900|C0677776	604370|114480|614320|617883	145|140162|227535|1333|145	.	Arg	Gly	82.37	0.9758064516129032			0.023		-0.229																																																																																								0.0		0.19	1 mutation(s) (Arg71Leu: 0.904)																							-2.11		-1.89		-2.954		-1.507																																																																																																																																																																																																																																																																																																																																																246			83.06	Positively-charged	Arginine		Breast cancer type 1 susceptibility protein										-4.5			M:R71-G:E61 (PDBs: 7LYB), M:R71-G:E92 (PDBs: 7LYB), M:R71-G:D90 (PDBs: 7LYB), K:R71-C:Y57 (PDBs: 8GRQ), K:R71-C:E61 (PDBs: 8GRQ)		M:R71-G:E61 (PDBs: 7LYB), M:R71-G:E92 (PDBs: 7LYB), M:R71-G:D90 (PDBs: 7LYB), K:R71-C:E61 (PDBs: 8GRQ)													175		Mutation: R -> G. No effect on interaction with BAP1.							-99.0				-2.3						C (loop/coil)	T (turn)	Turn											82.37	97.58065	70-90	$\geqslant$90	604370;114480;617883;614320;604370;114480	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER	true	0.8927028275142521	0.8473109429181775	false	false	false
F9	F9_Ser406Leu	B_13-14	-4.062357799312671	0.006632809747877582	0.01985684422953947	4.644571769800711	0.0023568789121224307	0.004897930695067565	2025_01_Batch_13-14	false	false	false	false	false	true	false	false	false	false	false	false	0.8913424641868325	0.8874905036661624	0.8096718416838562	0.9022503798670198	0.8507705194306857	0.9130556602180688	0.8914348357197026	0.8322065973537484	0.8927077936555832	0.693229143191282	0.8678200410202317	0.8988615932604362	0.934676484716435	0.8693344415076231	0.9117929660784565	0.9261145401764304	0.9071609663120932	0.8838233351132287	F9	Ser406Leu	NC_000023.11:139561902:C:T	1217C>T	23	139561902	C	T	X	ENSG00000101981	52861	0	CCSBVarC004393	ALE00004393	ENSP00000218099.2	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25656.0	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852263.0	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902.0	139561902.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255405,OMIM:300746.0061	1.0	10617.0	139561902.0	C	T	-	-	-	-	-	-	1217C>T 	Ser406Leu	NM_000133.4		Pathogenic	Pathogenic	10617	X	139561902.0	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	60.89	0.11538461538461539																																																																																																																																																																																																																																																																																																																																																																																																															1.075		1.038		1.037		1.022	1 mutation(s) (Ser406Glu: 1.118)	1.047																																																						15			60.89	Polar/Neutral	Serine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-0.8								 S406-Y444 (PAE:  7.5)	S406-Y444 (PDBs: 6X5L, 8OL9)		S406-D410 (PDBs: 8OL9), S406-I429 (PDBs: 8OL9), S406-C435 (PDBs: 8OL9)							105									-67.6				141.3						C (loop/coil)	C (loop/coil)												60.89	11.538462	50-70	10-90	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.8874905036661624	0.8913424641868325	false	false	false
SDHD	SDHD_Asp92Gly	B_13-14	8.432612836805006	0.00007012093234778765	0.0007165997502811489	-2.4981390885644545	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.838945305985499	0.8610377556803341	0.7567566589414079	0.8103609636111353	0.8474624861010864	0.8201721263350145	0.8362093155709843	0.8918108179700466	0.8808983417541077	0.7441864694280789	0.894466127986647	0.8654118775614423	0.8041349370990446	0.8031141542321263	0.739823585468163	0.769326848454737	0.8276093833740213	0.8124787344095556	SDHD	Asp92Gly	NC_000011.10:112088972:A:G	275A>G	11	112088972	A	G	11	ENSG00000204370	6363	0	CCSBVarC023312	ALE00024715	ENSP00000364699.3																																	178768.0	single nucleotide variant	NM_003002.4(SDHD):c.275A>G (p.Asp92Gly)	6392.0	SDHD	HGNC:10683	Pathogenic	1.0	May 26, 2015	786205436.0	-	RCV000171136|RCV000186596	MedGen:C3532243|MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167	Fatal infantile mitochondrial cardiomyopathy|Mitochondrial complex 2 deficiency, nuclear type 3	germline	germline	GRCh38	NC_000011.10	11	112088972.0	112088972.0	11q23.1	no assertion criteria provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016709,UniProtKB:O14521#VAR_074106,OMIM:602690.0031	3.0	180590.0	112088972.0	A	G	-	-	-	-	-	-	275A>G 	Asp92Gly	NM_003002.4		Pathogenic	Pathogenic	180590	11	112088972.0	A	G	D	G	rs786205436	11	111959696	11	111464906	92	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.275A>G	p.Asp92Gly	c.275A>G	p.Asp92Gly	principal1	Y	1	YES	Select	+	GAC	2	0	A	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97926	A	simple_aae	2.0	98.0	3.9	0.96054	H	-6.8	0.92923	D	0.998	0.99987	1.0131	0.97405	D	0.9872	0.99622	D	10	0.99263144	0.99798	D	0.822633	0.98618	D	0.976	0.99783	0.96	0.99581	O14521	D92G	Loss of stability (P = 0.0632)| Gain of glycosylation at S89 (P = 0.0743)| Gain of catalytic residue at D92 (P = 0.078)| Gain of helix (P = 0.2294)| Gain of disorder (P = 0.6219)	0.981310432533	0.98091	0.9625151340225994	0.96216	0.852731849783	0.68423	0.656035840511	0.60780	T	0.980289	0.99837	D	0.583575	0.97037	D	0.600488	0.96988	D	0.999705016613007	0.98567	D	0.842116	0.51695	T	0.9904235	0.99782	0.970635	0.99484	0.99101526	0.99812	0.97202027	0.99543	-12.11	0.85423	D	0.8975	0.82539	P	0.993190100922059	0.89912	0.99926764	0.99259	0.997	0.99892	.	.	.	.	.	.	5.193893	0.8714	29.1	0.99866692114947953	0.94461	0.957097	0.97598	D	0.854382185558375	0.89298	9.938285	0.777690480254967	0.88139	9.494944	5.04	5.04	0.67250	.	.	8.791	0.91503	9.300000	0.79897	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.964	0.52647	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Fatal_infantile_mitochondrial_cardiomyopathy|Mitochondrial_complex_2_deficiency,_nuclear_type_3	no_assertion_criteria_provided	NC_000011.10:g.112088972A>G	ClinGen:CA016709|OMIM:602690.0031|UniProtKB:O14521#VAR_074106	C3532243|C5436934	619167	.	.	Asp	Gly	98.68	0.07975460122699386																																																																																																																																																																																																																																																																																																																																																																																																																																																																													13			98.68	Negatively-charged	Aspartic Acid		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										-3.5								 D92-C88 (PAE:  1.0), D92-C150 (PAE: 1.0), D92-A96 (PAE: 1.0)	D92-C88 (PDBs: 8GS8), D92-C150 (PDBs: 8GS8), D92-A96 (PDBs: 8GS8)	 D92-N143 (PAE:  1.0), D92-C88 (PAE: 1.0), D92-I149 (PAE: 1.0), D92-C150 (PAE: 1.0), D92-A96 (PAE: 1.0)	D92-C88 (PDBs: 8GS8), D92-C150 (PDBs: 8GS8), D92-N143 (PDBs: 8GS8), D92-A96 (PDBs: 8GS8)							132									-58.8				-46.1						H (helix)	H (α-helix)	Helix								Helical			98.68	7.97546	>90	<10	619167	autosomal recessive	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3	true	0.8610377556803341	0.838945305985499	false	false	false
F9	F9_Arg191His	B_13-14	-2.575191626456613	0.03672882890207274	0.07247113967247824	3.5057024225478575	0.009916585141305978	0.017054295908431553	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7304579706028462	0.7337607663972145	0.5683653561467112	0.7441679620157362	0.7535514107260076	0.6461381374444859	0.6695847476601356	0.7263654931792622	0.7096596547107672	0.5509013249900649	0.7208092490039585	0.7335046389142571	0.6226915272288363	0.780737328272753	0.7786762693207052	0.5858293873033574	0.7467122837904705	0.7274113022914355	F9	Arg191His	NC_000023.11:139551113:G:A	572G>A	23	139551113	G	A	X	ENSG00000101981	52861	0	CCSBVarC004379	ALE00004379	ENSP00000218099.2	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25624.0	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 09, 2024	137852238.0	-	RCV000011331|RCV000851602|RCV001390296|RCV002284168|RCV002247326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided|Thrombophilia, X-linked, due to factor 9 defect	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113.0	139551113.0	Xq27.1	reviewed by expert panel	8.0	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3.0	10585.0	139551113.0	G	A	-	-	-	-	-	-	572G>A 	Arg191His	NM_000133.4	3.0	Pathogenic	Pathogenic	10585	X	139551113.0	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	42.03	1.0																																																																																																																																																																																																																																																																																																																																																																																																															1.012		1.008		1.004		0.988	1 mutation(s) (Arg191Pro: 1.100)	0.978																																																						259			42.03	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa light chain										-4.5											R191-Q185 (PDBs: 2WPJ)							175									-68.1				40.0						C (loop/coil)	S (bend)					Cleavage; by factor XIa							42.03	100.0	$\leqslant$50	$\geqslant$90	306900;306700;306900;300807;300807	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA A; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.7337607663972145	0.7304579706028462	false	false	false
BRCA1	BRCA1_Glu455Lys	B_13-14	-0.7002018322598149	0.5063990015883388	0.5890512137842431	-21.198611384232994	1.308385214335618e-7	6.488883427853673e-6	2025_01_Batch_13-14	true	true	false	false	false	false	false	true	false	false	false	false	0.985578243455862	0.9896363091621161	0.6548373705565851	0.687344416128185	0.6691379840876892	0.7388522361117137	0.8260135772983548	0.7079892418517046	0.7198696370345821	0.7053474346965134	0.9885859148440279	0.9851380204226392	0.6516908949250726	0.6302867263236739	0.6548191952217878	0.6043273064166567	0.9906867034802044	0.9860184664890849	BRCA1	Glu455Lys	NC_000017.11:43074331:C:T	1363G>A	17	43074331	C	T	17	ENSG00000012048	14613	0	CCSBVarC011868	ALE00012373	ENSP00000417148.1																																	46160.0	single nucleotide variant	NM_007294.4(BRCA1):c.4675G>A (p.Glu1559Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 18, 2019	80356988.0	-	RCV000031185|RCV000131823|RCV000482921|RCV000496604	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	43074331.0	43074331.0	17q21.31	reviewed by expert panel	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002963	2.0	37604.0	43074331.0	C	T	-	-	-	-	-	-	4675G>A 	Glu1559Lys	NM_007294.4	3.0	Pathogenic	Pathogenic	37604	17	43074331.0	C	T	E	K	rs80356988	17	41226348	17	38479874	1559	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.4675G>A	p.Glu1559Lys	principal2	Y	1	.	.	-	GAG	1	0	c	C/C	C/C	C/C	C/C	.	0.68399	.	.	0.74454	.	0.011	0.43580	B	0.006	0.35928	B	.	0.99291	.	.	.	.	1.75	0.45271	L	.	0.37944	.	.	0.78942	-0.0701	0.80692	T	0.5963	0.85548	D	9	.	0.70725	.	0.851739	0.98855	D	.	0.92017	.	.	.	.	.	.	0.80535	.	0.33367	.	0.11248	0.348278313875	0.17650	T	0.166952	0.51091	T	0.26768	0.80087	D	0.146727	0.79829	D	0.861642837524414	0.50935	D	.	0.48225	.	0.16502066	0.36448	0.16464907	0.38009	0.15768379	0.35225	0.16500245	0.38072	-3.995	0.26211	T	.	0.39417	.	0.95000846091201	0.80446	0.99910450	0.99146	0.831	0.90686	.	.	.	.	.	.	6.609515	0.95486	35.0	0.9984248885113004	0.92321	0.733049	0.67845	D	0.189406980124867	0.50447	3.256703	0.339873231586349	0.57676	3.957668	5.54	5.54	0.82883	3.53	0.64053	3.38	0.52274	5.613000	0.49136	0.591	0.32125	0.985	0.36067	1.000000	0.68239	0.995	0.73271	534	0.73376	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613716	1.239380e-06	0	1	64026	1.561870e-05	0	0	74882	0.000000e+00	0	0	912	0.000000e+00	0	0	59978	0.000000e+00	0	0	29604	0.000000e+00	0	0	44886	0.000000e+00	0	1	64026	1.561870e-05	0	0	6080	0.000000e+00	0	1	1179808	8.475960e-07	0	0	91074	0.000000e+00	0	2	20546	9.734254842791784E-5	0	0	0	0	44	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	288	0	0	426	0	0	44	0	2	21304	9.38790837401427E-5	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43074331C>T	ClinGen:CA002963	C3661900|C0027672|C2676676|C0677776	604370	140162|145|145	.	Glu	Lys	29.18	0.8092783505154639																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																29.18	80.92783	$\leqslant$50	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	true	0.9896363091621161	0.985578243455862	true	true	true
F9	F9_Arg75Gln	B_13-14	-0.6220852274614853	0.5535999388326938	0.6327803011193567	1.6363295976951715	0.14578393634569953	0.18474691167885726	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5514160398220805	0.5599252555515212	0.6367263814027861	0.5781310841962342	0.5156273166872911	0.6973627599414015	0.7808015355193345	0.5645245384390769	0.6450341347474591	0.6610081852745983	0.5762039344401314	0.5700083274848868	0.6139239843634685	0.4667300949355053	0.5112280336450093	0.6124445775309741	0.5436465766629109	0.5328237521592742	F9	Arg75Gln	NC_000023.11:139537145:G:A	224G>A	23	139537145	G	A	X	ENSG00000101981	52861	0	CCSBVarC030501	ALE00024410	ENSP00000218099.2																																	25612.0	single nucleotide variant	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 11, 2024	137852228.0	-	RCV000011319|RCV000757260|RCV000852079|RCV002490353|RCV001851790	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|not provided|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease;Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline;unknown	germline	GRCh38	NC_000023.11	X	139537145.0	139537145.0	Xq27.1	reviewed by expert panel	9.0	-	N	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	3.0	10573.0	139537145.0	G	A	-	-	-	-	-	-	224G>A 	Arg75Gln	NM_000133.4	3.0	Pathogenic	Pathogenic	10573	X	139537145.0	G	A	R	Q	rs137852228	X	138619304	X	138446970	75	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.224G>A	p.Arg75Gln	c.224G>A	p.Arg75Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.004	0.74454	D	1.0	0.90580	D	0.997	0.86259	D	0.87	0.91311	A	simple_aae	13.0	87.0	2.865	0.82980	M	-3.08	0.64159	D	0.619	0.83632	1.0936	0.99385	D	0.9754	0.99231	D	10	0.9611795	0.95480	D	0.450308	0.94319	D	0.904	0.97356	0.922	0.98631	P00740	R75Q	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.998839519055	0.99881	0.9873855396371272	0.98728	0.164289705123	0.18266	0.501060843468	0.38922	T	0.964669	0.99567	D	0.400284	0.89858	D	0.449695	0.93519	D	0.917611181735992	0.57309	D	0.667233	0.27380	T	0.83249354	0.85893	0.6057016	0.76837	0.7617112	0.81330	0.6656928	0.80179	-8.736	0.66059	D	0.1299	0.32639	B	0.994754450870779	0.90854	0.99998808	0.99996	0.941	0.97199	.	.	.	.	.	.	4.359394	0.67086	25.0	0.99953252965582506	0.99957	.	.	.	.	.	.	.	.	.	5.19	4.33	0.51026	4.22	0.80172	7.322	0.78419	9.750000	0.81498	-0.113	0.14846	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80303	1.245280e-05	0	1	151610	6.595870e-06	0	1	171789	5.821090e-06	0	0	5701	0.000000e+00	0	1	13652	7.324930e-05	0	0	1767	0.000000e+00	0	0	6911	0.000000e+00	0	0	9932	0.000000e+00	0	0	30951	0.000000e+00	0	0	9939	0.000000e+00	0	1	13652	7.324930e-05	0	0	13067	0.000000e+00	0	1	24361	4.104920e-05	0	0	4642	0.000000e+00	0	0	10118	0.000000e+00	0	0	12188	0.000000e+00	0	0	64582	0.000000e+00	0	0	19047	0.000000e+00	0	1	24361	4.104920e-05	0	0	11996	0.000000e+00	0	1	27139	3.684730e-05	0	0	7069	0.000000e+00	0	0	13313	0.000000e+00	0	0	15991	0.000000e+00	0	0	73179	0.000000e+00	0	0	18982	0.000000e+00	0	1	27139	3.684730e-05	0	.	4	1211104	3.302770e-06	0	1	45990	2.174390e-05	0	0	57788	0.000000e+00	0	0	689	0.000000e+00	0	1	45990	2.174390e-05	0	0	22029	0.000000e+00	0	0	33765	0.000000e+00	0	0	46861	0.000000e+00	0	0	4343	0.000000e+00	0	3	895062	3.351720e-06	0	0	56959	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139537145G>A	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	C0008533|C2749016|C0019069|C5393318|C3661900	306900|300807|134500|306700|301052	98879|98878	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Arg	Gln	87.64	0.375																																																																																																																																																																																																																																																																																																																																																																																																															1.061	1 mutation(s) (Arg75Asp: 1.392)	0.92	1 mutation(s) (Arg75Asp: 1.186)	0.944	2 mutation(s) (Arg75Gly: 1.143, Arg75Asp: 1.171)	0.83	1 mutation(s) (Arg75Asp: 1.099)	1.053	5 mutation(s) (Arg75Lys: 1.270, Arg75Asn: 1.277, Arg75His: 1.287, Arg75Asp: 1.310, Arg75Gly: 1.315)																																																					93			87.64	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa light chain							Gla			-4.5								 R75-E79 (PAE:  3.5), R75-F71 (PAE: 1.0)	R75-F71 (PDBs: 1CFI, 1MGX, 1NL0)	 R75-E79 (PAE:  3.5), R75-F71 (PAE: 1.0), R75-T84 (PAE: 2.0)	R75-T81 (PDBs: 1CFI, 1NL0), R75-F71 (PDBs: 1MGX, 1NL0), R75-N80 (PDBs: 1MGX), R75-T84 (PDBs: 1NL0)							175									-64.7				-39.7						H (helix)	H (α-helix)	Helix											87.64	37.5	70-90	10-90	306900;306700;306900;301052;300807;306900;300807	x-linked	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA A; HEMOPHILIA B; WARFARIN SENSITIVITY, X-LINKED; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.5599252555515212	0.5514160398220805	false	false	false
F9	F9_Arg226Gln	B_13-14	-1.7008128767404025	0.1327719074838614	0.2056726222986012	0.12028807631780493	0.9076347128020703	0.9262157497199396	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7372733032480838	0.7492458652423949	0.6165141849034779	0.8243768293887777	0.7360557654577643	0.7537323042006923	0.6629882333556205	0.7628025489375103	0.784995069961713	0.5046403544335851	0.7755716746055519	0.7851050224678682	0.8444763750457641	0.7093089819780183	0.8637585888158422	0.7283880153733707	0.7229200558792379	0.6894415840282995	F9	Arg226Gln	NC_000023.11:139551218:G:A	677G>A	23	139551218	G	A	X	ENSG00000101981	52861	0	CCSBVarC004380	ALE00004380	ENSP00000218099.2	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25630.0	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 21, 2024	137852241.0	-	RCV000011337|RCV004814880|RCV004752695|RCV001727513	MedGen:CN043453|MedGen:C3661900||MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hemophilia b(m)|not provided|F9-related disorder|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551218.0	139551218.0	Xq27.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3.0	10591.0	139551218.0	G	A	-	-	-	-	-	-	677G>A 	Arg226Gln	NM_000133.4	2.0	Pathogenic	Pathogenic	10591	X	139551218.0	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	43.81	0.3024193548387097																																																																																																																																																																																																																																																																																																																																																																																																															0.972		0.967		0.961		0.958		0.955																																																						75			43.81	Positively-charged	Arginine		Coagulation factor IX										-4.5								 R226-D232 (PAE:  12.5)		 R226-Q370 (PAE:  12.0)								175									-94.8			Activation peptide	-2.3						C (loop/coil)	S (bend)					Cleavage; by factor XIa							43.81	30.241936	$\leqslant$50	10-90	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.7492458652423949	0.7372733032480838	false	false	false
ZC4H2	ZC4H2_Ala200Thr	B_13-14	-5.682062973976312	0.0007491281331314925	0.0037852770748178595	5.9783752544958135	0.000554094398136057	0.0014952400302642127	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8873532700252496	0.9205078599868894	0.6984024351217583	0.7742583500498457	0.666114934421594	0.7465963116705422	0.7022013600306634	0.6239530231582602	0.7358610932198171	0.6470108420877356	0.8659213251658228	0.8369317649999017	0.790991263310421	0.7082768456849279	0.8126556068798741	0.7497940281557809	0.975094394807956	0.9377747750505973	ZC4H2	Ala200Thr	NC_000023.11:64917860:C:T	598G>A	23	64917860	C	T	X	ENSG00000126970	4320	0	CCSBVarC009163	ALE00014763	ENSP00000363972.3																																	920050.0	single nucleotide variant	NM_018684.4(ZC4H2):c.598G>A (p.Ala200Thr)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Mar 23, 2020	1929006117.0	-	RCV001197017	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	unknown	unknown	GRCh38	NC_000023.11	X	64917860.0	64917860.0	Xq11.2	criteria provided, single submitter	1.0	-	N	-	2.0	930963.0	64917860.0	C	T	-	-	-	-	-	-	598G>A 	Ala200Thr	NM_018684.4	1.0	Pathogenic	Pathogenic	930963	X	64917860.0	C	T	A	T	rs1929006117	X	64137740	X	64054465	200	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.598G>A	p.Ala200Thr	c.598G>A	p.Ala200Thr	principal1	Y	1	YES	Select	-	GCA	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	0.997	0.70687	D	0.994	0.82066	D	0.97	0.96253	A	simple_aae	3.0	97.0	.	.	.	-3.52	0.68446	D	0.866	0.87678	-0.8962	0.48170	T	0.1833	0.52977	T	8	0.8993199	0.89172	D	0.645518	0.96983	D	0.493	0.77793	0.541	0.65184	Q9NQZ6	A200T	Gain of phosphorylation at A200 (P = 0.0325)| Loss of MoRF binding (P = 0.1211)| Loss of helix (P = 0.1299)| Loss of catalytic residue at A200 (P = 0.3072)| Loss of stability (P = 0.3362)	0.883420790715	0.88137	0.8527665168203684	0.85148	3.0674637903	0.99314	0.833977639675	0.87150	D	0.861348	0.96901	D	0.478681	0.93601	D	0.449816	0.93521	D	0.997183978557587	0.90886	D	0.958704	0.85578	D	0.8956946	0.90872	0.8811168	0.93554	0.8956946	0.90873	0.8811168	0.93554	-11.278	0.81389	D	0.9998	0.99584	P	0.992700566218043	0.89650	0.99633140	0.98026	0.997	0.99892	.	.	.	.	.	.	5.023812	0.83539	28.1	0.9994258080004339	0.99824	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	7.301	0.78228	7.539000	0.60115	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.997	0.79771	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Wieacker-Wolff_syndrome	criteria_provided,_single_submitter	NC_000023.11:g.64917860C>T	.	C0796200	314580	3454|85283	Zinc finger C4H2-type	Ala	Thr	86.6	0.1792452830188679																																																																																																																																																																																																																																																																																																																																																																																																																																																																													19			86.6	Aliphatic	Alanine		Zinc finger C4H2 domain-containing protein								0.1134		1.8								 A200-K187 (PAE:  2.0)		 A200-S210 (PAE:  4.5)								89									-60.6		Pocket 1: Mean pLDDT: 78.68, Volume: 1167.67 Å³, Druggability score: 0.11		125.7						C (loop/coil)	C (loop/coil)											C4H2-type	86.6	17.924528	70-90	10-90	314580	x-linked recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	false	0.9205078599868894	0.8873532700252496	false	false	false
BRCA1	BRCA1_His41Arg	B_13-14	-0.7905479031010616	0.45515193572773704	0.5423207718278089	3.3659379453642804	0.011986645329539395	0.0200323262110244	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	false	false	0.7987498910443687	0.8173318024149027	0.7566958922953536	0.8113256274937424	0.9292064638847006	0.8752994312926008	0.7674447105208672	0.9165703713662232	0.6427559665174591	0.5712250998895864	0.6940214974343273	0.6664403819850325	0.9831541520643343	0.9418425564031782	0.9798952884700257	0.9421666847011209	0.940642107395478	0.9310594001037047	BRCA1	His41Arg	NC_000017.11:43115738:T:C	122A>G	17	43115738	T	C	17	ENSG00000012048	14613	0	CCSBVarC011865	ALE00014326	ENSP00000417148.1																																	68833.0	single nucleotide variant	NM_007294.4(BRCA1):c.122A>G (p.His41Arg)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357276.0	-	RCV000047383|RCV000111820|RCV000569789|RCV000484980	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115738.0	43115738.0	17q21.31	reviewed by expert panel	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00130,ClinGen:CA000805	2.0	54166.0	43115738.0	T	C	-	-	-	-	-	-	122A>G 	His41Arg	NM_007294.4	3.0	Pathogenic	Pathogenic	54166	17	43115738.0	T	C	H	R	rs80357276	17	41267755	17	38521281	41	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.122A>G	p.His41Arg	principal2	Y	1	.	.	-	CAC	2	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.92967	.	0.959	0.90580	D	0.542	0.92348	P	.	0.99291	.	.	.	.	3.995	0.96666	H	.	0.95148	.	.	0.88119	0.9682	0.96663	D	0.9917	0.99792	D	10	.	0.99449	.	0.885446	0.99127	D	.	0.99491	0.966	0.99665	E9PFC7	H41R	Gain of MoRF binding (P = 0.0172)| Loss of catalytic residue at D40 (P = 0.0761)| Gain of disorder (P = 0.0885)| Gain of helix (P = 0.132)| Gain of phosphorylation at T37 (P = 0.2265)	.	0.99628	.	0.94303	.	0.46401	0.697537183762	0.66732	T	0.460215	0.93020	T	0.562828	0.96258	D	0.570687	0.96198	D	0.998141407966614	0.93292	D	0.955504	0.83052	D	0.9505324	0.96261	0.6308536	0.78232	0.9015565	0.91402	0.6761325	0.80766	-13.38	0.93979	D	.	0.95417	.	0.999422575166627	0.96550	0.99957854	0.99505	0.964	0.98523	.	.	.	.	.	.	4.490848	0.70206	25.5	0.99650553719529922	0.77280	0.750685	0.69060	D	0.939969350591933	0.93540	12.13134	0.850731219321243	0.93019	11.79838	5.97	5.97	0.96929	.	.	3.518	0.533	7.815000	0.69605	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43115738T>C	BRCA1-HCI:BRCA1_00130|ClinGen:CA000805	C0677776|C0027672|C3661900|C2676676	604370	145|140162|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	His	Arg	90.04	0.33695652173913043			-3.26	1 mutation(s) (His41Ter: -5.088)	-0.376																																																																																								2.778		-0.895	1 mutation(s) (His41Ile: -2.125)																			-1.723		-1.833	1 mutation(s) (His41Gln: -2.625)																																																																																																																																																																																																																																																																																																																																																							50			90.5	Positively-charged	Histidine		Breast cancer type 1 susceptibility protein										-3.2								 H41-T37 (PAE:  2.0)	H41-T37 (PDBs: 1JM7, 7LYB), H41-S36 (PDBs: 8GRQ)	 H41-C61 (PAE:  2.0), H41-C64 (PAE: 2.5), H41-T37 (PAE: 2.0), H41-S36 (PAE: 1.5), H41-L63 (PAE: 2.5)	H41-T37 (PDBs: 1JM7, 7LYB, 8GRQ), H41-S36 (PDBs: 1JM7, 7LYB, 8GRQ), H41-L63 (PDBs: 1JM7, 7LYB), H41-V35 (PDBs: 1JM7, 7LYB)							155									-79.9				141.6						C (loop/coil)	C (loop/coil)											RING-type	90.04	33.695652	>90	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.8173318024149027	0.7987498910443687	false	false	false
F9	F9_Asp410His	B_13-14	0.3037471613702286	0.7715783044374144	0.8191854149391115	1.8236880182496336	0.11096723890084839	0.14534252918133964	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6567110498875814	0.688839979501741	0.6249223709142536	0.716193818490027	0.6236673702637148	0.6550012853741822	0.6299633159238356	0.5594720637698691	0.6645241336402034	0.6470708686586384	0.6925218184267763	0.6897735555742248	0.6800392548245288	0.6878626767575604	0.7678635033398504	0.6027738731698689	0.6851581405767059	0.623648544200938	F9	Asp410His	NC_000023.11:139561913:G:C	1228G>C	23	139561913	G	C	X	ENSG00000101981	52861	0	CCSBVarC004394	ALE00004394	ENSP00000218099.2	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25690.0	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Mar 01, 1992	137852278.0	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913.0	139561913.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1.0	10651.0	139561913.0	G	C	-	-	-	-	-	-	1228G>C 	Asp410His	NM_000133.4		Pathogenic	Pathogenic	10651	X	139561913.0	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	76.62	0.0736196319018405																																																																																																																																																																																																																																																																																																																																																																																																															1.03		0.954		0.974		0.971		0.984																																																						12			76.62	Negatively-charged	Aspartic Acid		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-3.5								 D410-G357 (PAE:  3.0)	D410-G357 (PDBs: 6X5J, 6X5L, 8OL9), D410-V227 (PDBs: 8OL9)	 D410-G357 (PAE:  3.0)	D410-G357 (PDBs: 6X5L, 8OL9), D410-S406 (PDBs: 8OL9), D410-G355 (PDBs: 8OL9), D410-W356 (PDBs: 8OL9), D410-V227 (PDBs: 8OL9), D410-I429 (PDBs: 8OL9)							132									-81.4				-10.3						C (loop/coil)	C (loop/coil)	Turn											76.62	7.3619633	70-90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.688839979501741	0.6567110498875814	false	false	false
BAP1	BAP1_Arg59Pro	B_13-14	-2.590423379221777	0.037552604621238606	0.07364639674395394	-6.337624151527198	0.0014440220120268232	0.003018166711515043	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.856647208506079	0.8957127792118925	0.538887179958603	0.6715526759297521	0.6482931063101288	0.6451511545072537	0.5156497805387629	0.5941769063806458	0.5572498472334986	0.4723219653723221	0.8833217747451192	0.8720224382111075	0.7746525284757444	0.7024093062396118	0.7858555046260056	0.6054523945448839	0.9081037836786658	0.8412719788010505	BAP1	Arg59Pro	NC_000003.12:52408553:C:G	176G>C	3	52408553	C	G	3	ENSG00000163930	3760	0	CCSBVarC009502	ALE00015200	ENSP00000417132.1																																	1162265.0	single nucleotide variant	NM_004656.4(BAP1):c.176G>C (p.Arg59Pro)	8314.0	BAP1	HGNC:950	Pathogenic	1.0	Jun 22, 2021	1298276806.0	-	RCV001797186	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	Neurodevelopmental disorder	de novo	germline	GRCh38	NC_000003.12	3	52408553.0	52408553.0	3p21.1	no assertion criteria provided	1.0	-	N	-	2.0	1173080.0	52408553.0	C	G	-	-	-	-	-	-	176G>C 	Arg59Pro	NM_004656.4		Pathogenic	Pathogenic	1173080	3	52408553.0	C	G	R	P	rs1298276806	3	52442569	3	52417609	59	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.176G>C	p.Arg59Pro	c.176G>C	p.Arg59Pro	principal1	Y	1	YES	Select	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.033	0.44516	D	0.019	0.69466	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	2.33	0.66629	M	-6.28	0.91119	D	0.734	0.73344	-0.4620	0.69867	T	0.3193	0.68734	T	10	0.73717695	0.74462	D	0.080609	0.73409	D	0.516	0.79231	0.438	0.49015	Q92560	R59P	Gain of glycosylation at S58 (P = 0.0035)| Loss of MoRF binding (P = 0.0099)| Gain of relative solvent accessibility (P = 0.0166)| Gain of loop (P = 0.0435)| Gain of ubiquitination at K61 (P = 0.0519)	0.836624110132	0.83377	0.8990698988239344	0.89814	3.06138964259	0.99302	0.848732292652	0.89405	D	0.266761	0.63670	T	0.213371	0.74962	D	0.0687164	0.74637	D	0.978495126974096	0.72163	D	0.983202	0.94307	D	0.9713552	0.98358	0.9540301	0.98616	0.9713552	0.98358	0.9540301	0.98617	-16.228	0.98086	D	0.9967	0.96455	P	0.99866373685461	0.94835	0.99953306	0.99461	0.706	0.83697	.	.	.	.	.	.	5.519378	0.91776	32.0	0.99817551053923181	0.90069	0.969708	0.99205	D	0.78803106441148	0.85268	8.550095	0.78537237783733	0.88696	9.704019	5.43	5.43	0.78977	.	.	7.867	0.85526	7.674000	0.64997	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.98	0.58201	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Neurodevelopmental_disorder	no_assertion_criteria_provided	NC_000003.12:g.52408553C>G	.	C1535926	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Arg	Pro	48.83	0.782258064516129																																																																																																																																																																																																																																																																																																																																																																																																																																																																													194			48.83	Positively-charged	Arginine		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			-4.5			K:R59-C:E64 (PDBs: 8SVF)		K:R59-C:E64 (PDBs: 8SVF)			 R59-E55 (PAE:  5.5)		 R59-E55 (PAE:  5.5)		 R59-E55 (PAE:  5.5)						175	Arg-finger motif	Mutation: RRSRR -> AASAA. Probably disrupts interaction with the histone H2A-H2B acidic patch. Severely attenuates deubiquitination of histone H2AK119ub1 substrates in the context of the nucleosome but does not disrupt nucleosome interaction.; Mutation: R -> W. Reduces deubiquitination activity towards H2AK119ub1 substrates in the context of the nucleosome.							-77.2				-35.5						H (helix)	H (α-helix)	Helix											48.83	78.22581	$\leqslant$50	10-90		unknown		Rare genetic tumor	1		false	0.8957127792118925	0.856647208506079	false	false	false
KRAS	KRAS_Phe156Ile	B_13-14	-1.3743464521347168	0.2117183578603233	0.2928182936373769	6.450900416899214	0.0003499696180274488	0.001047625202414957	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7614483037128247	0.7573048662742364	0.4591124647528732	0.4733799398095713	0.5173304610580491	0.4998208923398906	0.5244992029669224	0.5035380031950834	0.4584577820474023	0.4622509253589107	0.8156146961430495	0.8019001988308717	0.4751425817128587	0.5311229189210149	0.48830209757174037	0.4559740041468357	0.6989950364054234	0.7209964085947776	KRAS	Phe156Ile	NC_000012.12:25209896:A:T	466T>A	12	25209896	A	T	12	ENSG00000133703	3084	0	CCSBVarC006102	ALE00006102	ENSP00000308495.3	CEGS2	CegsMutGDEh1042	D03	GDEhDisVCh_40061	C10	1	CegsMutGDDh1042	D03	NULL	NULL	NULL	NULL	NULL	NULL	1.0	6.0	1.0	1.0	0.0			0.0			0.0			N	Y	N	N	N	175711.0	single nucleotide variant	NM_004985.5(KRAS):c.466T>A (p.Phe156Ile)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Jan 05, 2022	397517042.0	-	RCV000150884|RCV000493013|RCV001813760	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:CN517202|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	Noonan syndrome;Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome 3	germline	germline	GRCh38	NC_000012.12	12	25209896.0	25209896.0	12p12.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA273160	2.0	163758.0	25209896.0	A	T	-	-	-	-	-	-	466T>A 	Phe156Ile	NM_004985.5	2.0	Pathogenic	Pathogenic	163758	12	25209896.0	A	T	F	I	rs397517042	12	25362830	12	25254097	131	KRAS	ENSG00000133703	ENST00000693229	ENSP00000509223	A0A8I5KQ21	A0A8I5KQ21_HUMAN	.	.	c.391T>A	p.Phe131Ile	.	Y	.	.	.	-	TTC	1	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	.	0.90580	.	.	0.73823	.	.	0.95575	.	.	.	.	.	.	.	.	0.84554	.	.	0.86483	0.5739	0.91524	D	0.7138	0.90143	D	8	.	0.88974	.	0.39769	0.93315	D	.	0.97054	.	0.92541	.	.	.	.	0.98060	.	.	.	.	.	.	.	.	.	.	0.456603	0.92716	D	0.418102	0.92627	D	0.984689116477966	0.75739	D	.	0.88326	.	.	.	.	.	.	.	.	.	.	0.98607	.	.	0.95820	.	.	.	0.98468506	0.96023	0.937	0.96958	.	.	.	.	.	.	4.958659	0.82	27.7	0.98951824215402029	0.49243	0.871179	0.79169	D	0.741140742699006	0.82229	7.73527	0.744583996035912	0.85673	8.675262	5.43	5.43	0.78977	.	.	8.891	0.9215	11.233000	0.90185	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.999	0.91597	874	0.30573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Noonan_syndrome|Cardio-facio-cutaneous_syndrome|not_provided|Noonan_syndrome_3	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25209896A>T	ClinGen:CA273160	C0028326|C1275081|CN517202|C1860991	PS163950|PS115150|609942	648|1340|648	.	Phe	Ile																																																																																																																																																																																							0.212		-0.027	1 mutation(s) (Phe156Leu: 0.421)					-0.558						-0.474						-0.498		-0.259										-0.103								-0.583		0.025		0.325		0.001		0.212		0.908		-0.416																																																																																																																																																																																																																																				0			98.7	Aromatic	Phenylalanine		GTPase KRas; GTPase KRas, N-terminally processed										2.8								 F156-V160 (PAE:  1.0)	F156-V152 (PDBs: 4L8G, 4LDJ, 4LYJ, 5OCG, 5V9O, 6E6G, 6GJ6, 6GJ7, 6GJ8, 6GOD, 6T5V, 6V5L, 6ZL5, 7KYZ, 7LGI, 7MQU, 7R0N, 8AFB, 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8B78, 8JHL, 8ONV, 8QUG, 3GFT, 4LPK, 4LRW, 4LUC, 4LYF, 4LYH, 4M1O, 4M1S, 4M1T, 4M1W, 4M1Y, 4M21, 4M22, 4OBE, 4TQA, 5KYK, 5UK9, 5V9L, 5VQ2, 6MBT, 6MBU, 6MNX, 6MQN, 6MS9, 6MTA, 6O36, 6O46, 6P0Z, 6QUU, 6QUV, 6QUW, 6QUX, 6VC8, 6ZLI, 7ACA, 7ACF, 7ACH, 7ACQ, 7O70, 7R0M, 8AFC, 8AFD, 8AQ7, 8B6I, 8ECR, 8T72, 8UN5, 5MLA, 5MLB, 5O2S, 5O2T, 5TAR, 5TB5, 5UFE, 5WLB, 5WPM, 6H46, 6H47, 6OB2, 6PTW, 6V65, 6VJJ, 6W4E, 6W4F, 6XHB, 6YR8, 6YXW, 7NY8, 7VVB, 8QU8, 8T74, 8T75, 8TBF), F156-V160 (PDBs: 6M9W, 6MBQ, 6MQG, 8CPR, 8QUG, 4LV6, 6BOF, 7R0Q, 8T71, 2MSC, 2MSD, 2MSE, 6PTS, 7SCW, 8QVU, 8TBF), F156-I160 (PDBs: 6T5B)	 F156-V160 (PAE:  1.0), F156-V152 (PAE: 1.0)	F156-V152 (PDBs: 4L8G, 4LDJ, 4LYJ, 5OCG, 5V9O, 6E6G, 6GJ6, 6GJ7, 6GJ8, 6GOD, 6M9W, 6MBQ, 6MQG, 6T5V, 6V5L, 6ZL5, 7KYZ, 7LGI, 7MQU, 7R0N, 8AFB, 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8B78, 8CPR, 8JHL, 8ONV, 8QUG, 3GFT, 4LPK, 4LRW, 4LUC, 4LV6, 4LYF, 4LYH, 4M1O, 4M1S, 4M1T, 4M1W, 4M1Y, 4M21, 4M22, 4OBE, 4TQA, 5KYK, 5UK9, 5V9L, 5VQ2, 6BOF, 6MBT, 6MBU, 6MNX, 6MQN, 6MS9, 6MTA, 6O36, 6O46, 6P0Z, 6QUU, 6QUV, 6QUW, 6QUX, 6VC8, 6ZLI, 7ACA, 7ACF, 7ACH, 7ACQ, 7O70, 7R0M, 7R0Q, 8AFC, 8AFD, 8AQ7, 8B6I, 8ECR, 8T71, 8T72, 8UN5, 2MSC, 2MSD, 2MSE, 5MLA, 5MLB, 5O2S, 5O2T, 5TAR, 5TB5, 5UFE, 5WLB, 5WPM, 6H46, 6H47, 6OB2, 6PTS, 6PTW, 6V65, 6VJJ, 6W4E, 6W4F, 6XHB, 6YR8, 6YXW, 7NY8, 7SCW, 7VVB, 8QU8, 8QVU, 8T74, 8T75, 8TBF), F156-I160 (PDBs: 6T5B), F156-L79 (PDBs: 8QUG, 8TBF), F156-V160 (PDBs: 8QUG, 8TBF)							165									-69.2				-38.5						H (helix)	H (α-helix)	Helix													NaN	NaN	609942	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	NOONAN SYNDROME 3	false	0.7573048662742364	0.7614483037128247	false	false	false
ZC4H2	ZC4H2_Lys217Arg	B_13-14	-4.109348315318837	0.004519611248172494	0.014731156116057104	-0.028994446789252497	0.9776783460045906	0.9830354876265335	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9516010436300548	0.9413267764179074	0.4679250002176709	0.5553989056603269	0.6031149042157056	0.4906600585592725	0.5463305312439766	0.64174664077154	0.5985218499419681	0.5194253197758313	0.9501228229522486	0.957930815008952	0.43498958587456854	0.5644831676598712	0.5122759613786857	0.41642468065951055	0.9325307298835663	0.9452712722511576	ZC4H2	Lys217Arg	NC_000023.11:64917808:T:C	650A>G	23	64917808	T	C	X	ENSG00000126970	4320	0	CCSBVarC009181	ALE00014706	ENSP00000363972.3																																	822347.0	single nucleotide variant	NM_018684.4(ZC4H2):c.650A>G (p.Lys217Arg)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Apr 09, 2020	1929002470.0	-	RCV001034718	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64917808.0	64917808.0	Xq11.2	no assertion criteria provided	1.0	-	N	OMIM:300897.0011	1.0	834097.0	64917808.0	T	C	-	-	-	-	-	-	650A>G 	Lys217Arg	NM_018684.4		Pathogenic	Pathogenic	834097	X	64917808.0	T	C	K	R	rs1929002470	X	64137688	X	64054413	217	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.650A>G	p.Lys217Arg	c.650A>G	p.Lys217Arg	principal1	Y	1	YES	Select	-	AAG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.941	0.52895	P	0.973	0.72925	D	0.97	0.96253	A	simple_aae	3.0	97.0	.	.	.	-2.44	0.53442	N	0.465	0.51703	-0.9665	0.37756	T	0.1423	0.46144	T	8	0.3894233	0.54427	D	0.189364	0.86022	D	0.333	0.65341	0.44	0.49343	Q9NQZ6	K217R	Loss of methylation at K217 (P = 0.007)| Loss of glycosylation at K217 (P = 0.0664)| Gain of helix (P = 0.1736)| Loss of ubiquitination at K217 (P = 0.2936)| Loss of solvent accessibility (P = 0.322)	0.814197371498	0.81098	0.5036670474541309	0.50093	2.6112261011	0.98235	0.826741635799	0.86039	D	0.521062	0.83103	D	0.142269	0.68312	D	-0.033417	0.67911	D	0.994114935398102	0.85104	D	0.967303	0.88633	D	0.75298744	0.80812	0.7599174	0.85640	0.75298744	0.80813	0.7599174	0.85641	-6.96	0.53810	T	0.2619	0.49675	B	0.965892135885726	0.82597	0.99151430	0.96976	0.921	0.95990	.	.	.	.	.	.	4.467578	0.69648	25.4	0.9988496640312855	0.96051	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	7.404	0.79277	7.742000	0.68069	0.665	0.62996	1.0	0.71675	1.000000	0.68239	1.0	0.97202	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64917808T>C	OMIM:300897.0011	C0796200	314580	3454|85283	Zinc finger C4H2-type	Lys	Arg	67.1	0.9463414634146341																																																																																																																																																																																																																																																																																																																																																																																																																																																																													194			67.1	Positively-charged	Lysine		Zinc finger C4H2 domain-containing protein										-3.9																		147									-55.1				128.3						H (helix)	P (polyproline helix)												67.1	94.63415	50-70	$\geqslant$90	314580	x-linked recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	false	0.9413267764179074	0.9516010436300548	false	false	false
BRCA1	BRCA1_Cys64Tyr	B_13-14	-0.2411116846042154	0.8163785956912686	0.8539337994361024	-3.086713019102096	0.017648228915318507	0.02820949482544378	2025_01_Batch_13-14	false	false	false	false	true	true	false	false	false	false	false	false	0.9242911171586767	0.9216057756517617	0.8096753286848771	0.8611150248438314	0.9597243826833379	0.9300773123176018	0.876309438095252	0.9726323555907477	0.7372544186603099	0.6598999879834793	0.8760539683588572	0.8774679025869975	0.9838451865399518	0.9468164097759282	0.9849756310273529	0.959450669386275	0.9671575829446661	0.971114331730356	BRCA1	Cys64Tyr	NC_000017.11:43106477:C:T	191G>A	17	43106477	C	T	17	ENSG00000012048	14613	0	CCSBVarC011839	ALE00014334	ENSP00000417148.1																																	69067.0	single nucleotide variant	NM_007294.4(BRCA1):c.191G>A (p.Cys64Tyr)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 11, 2024	55851803.0	-	RCV000047641|RCV000077501|RCV000131896|RCV000236464|RCV003334380|RCV004566890	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition	germline;not applicable;paternal;unknown	germline	GRCh38	NC_000017.11	17	43106477.0	43106477.0	17q21.31	reviewed by expert panel	27.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001262,UniProtKB:P38398#VAR_007759	2.0	54400.0	43106477.0	C	T	-	-	-	-	-	-	191G>A 	Cys64Tyr	NM_007294.4	3.0	Pathogenic	Pathogenic	54400	17	43106477.0	C	T	C	Y	rs55851803	17	41258494	17	38512020	64	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.191G>A	p.Cys64Tyr	c.191G>A	p.Cys64Tyr	principal2	Y	1	.	.	-	TGT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.91343	D	0.0	0.92967	D	0.999	0.77914	D	0.972	0.84488	D	.	0.99291	.	.	.	.	4.34	0.98393	H	-2.59	0.99046	D	.	0.97441	0.9543	0.96449	D	0.9922	0.99809	D	10	0.9909615	0.99609	D	0.946477	0.99626	D	0.954	0.99189	0.991	0.99904	E9PFC7	C64Y	Loss of stability (P = 0.0601)| Loss of disorder (P = 0.0647)| Loss of methylation at K65 (P = 0.0701)| Gain of phosphorylation at T69 (P = 0.1857)| Loss of catalytic residue at L63 (P = 0.238)	0.999548998322	0.99953	.	0.88610	.	0.52543	0.801703929901	0.82191	T	0.476203	0.92995	T	0.553373	0.95819	D	0.557106	0.95755	D	0.998311161994934	0.93754	D	.	0.87587	.	0.98057026	0.99138	0.92475754	0.96684	0.9736041	0.98562	0.9065188	0.95378	-12.677	0.94701	D	0.9941	0.96039	LP	0.999711406740052	0.97610	0.99977249	0.99701	0.97	0.98836	.	.	.	.	.	.	5.19196	0.87099	29.1	0.99179197590808121	0.54687	0.851286	0.76729	D	0.880338828138272	0.90713	10.55451	0.762986794469818	0.87052	9.115097	4.64	4.64	0.57348	.	.	4.108	0.57643	7.641000	0.63257	0.531	0.24877	1.0	0.71675	1.000000	0.68239	0.997	0.79771	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1601934	1.248490e-06	0	1	1170064	8.546540e-07	0	0	74760	0.000000e+00	0	0	912	0.000000e+00	0	0	59914	0.000000e+00	0	0	29512	0.000000e+00	0	0	44730	0.000000e+00	0	0	63954	0.000000e+00	0	0	5808	0.000000e+00	0	1	1170064	8.546540e-07	0	0	90238	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|BRCA1-related_cancer_predisposition	reviewed_by_expert_panel	NC_000017.11:g.43106477C>T	ClinGen:CA001262|UniProtKB:P38398#VAR_007759	C3661900|C0677776|C3280442|C0027672|C2676676|CN377757	614320|604370	145|1333|140162|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Tyr	88.77	0.3333333333333333			-3.087	1 mutation(s) (Cys64Ter: -4.185)	-1.686																																																																																										-1.143	1 mutation(s) (Cys64Gly: -2.190)																							-2.131	1 mutation(s) (Cys64Ser: -3.694)	-1.679																																																																																																																																																																																																																																																																																																																																																				35			88.56	Special, a very reactive sulfhydryl group	Cysteine		Breast cancer type 1 susceptibility protein										2.5						 C64-C39 (PAE:  2.0)				 C64-C39 (PAE:  2.0), C64-H41 (PAE: 2.5)	C64-C39 (PDBs: 7LYB, 8GRQ)							121									-76.7				-9.5				dbSNP: rs80357064; Variant type: LP/P; AA change: Cys64Gly; PTM type: Ubiquitylation; PTM morphology: QCPLC*kNDITK; Var class: II&rs55851803		C (loop/coil)	T (turn)	Beta strand										RING-type	88.77	33.333336	70-90	10-90	604370;614320	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4	true	0.9216057756517617	0.9242911171586767	false	false	false
ABCD1	ABCD1_Arg518Gln	B_13-14	6.2907017796871	0.00040780087036125073	0.0023250736190745937	-0.5642973313423817	0.5969244898414112	0.645086241966425	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6918674621514003	0.7849929711895267	0.6756238140210004	0.7750839700079717	0.7466458763561425	0.7532301352417266	0.7210828350204783	0.7102696511359662	0.7086533033455688	0.7005767138021322	0.772404880164864	0.6049677938808374	0.7853774354629747	0.783022101576319	0.8415146366703745	0.6506709142398686	0.7975810622141893	0.778767130421963	ABCD1	Arg518Gln	NC_000023.11:153740156:G:A	1553G>A	23	153740156	G	A	X	ENSG00000101986	100008637	0	CCSBVarC007021	ALE00007019	ENSP00000218104.3	CEGS2	CegsMutGDEh1023	H06	GDEhDisVCh_40030	H07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	98228.0	single nucleotide variant	NM_000033.4(ABCD1):c.1553G>A (p.Arg518Gln)	215.0	ABCD1	HGNC:61	Pathogenic	1.0	May 22, 2024	398123102.0	-	RCV000077955|RCV000723540|RCV004752737	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900|	Adrenoleukodystrophy|not provided|ABCD1-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	153740156.0	153740156.0	Xq28	criteria provided, multiple submitters, no conflicts	13.0	-	N	ClinGen:CA278403,UniProtKB:P33897#VAR_000070	2.0	92317.0	153740156.0	G	A	-	-	-	-	-	-	1553G>A 	Arg518Gln	NM_000033.4	2.0	Pathogenic	Pathogenic	92317	X	153740156.0	G	A	R	Q	rs398123102	X	153005610	X	152658804	518	ABCD1	ENSG00000101986	ENST00000218104	ENSP00000218104	P33897	ABCD1_HUMAN	c.1553G>A	p.Arg518Gln	c.1553G>A	p.Arg518Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	0.999	0.77914	D	0.984	0.76117	D	0.8	0.87470	A	simple_aae	20.0	80.0	2.185	0.61163	M	-3.6	0.69394	D	0.814	0.80898	0.9308	0.96101	D	0.9934	0.99846	D	10	0.9942995	0.99935	D	0.874464	0.99039	D	0.942	0.98779	0.971	0.99725	P33897	R518Q	Gain of methylation at K513 (P = 0.0396)| Loss of MoRF binding (P = 0.0759)| Gain of ubiquitination at K513 (P = 0.1295)| Loss of catalytic residue at R518 (P = 0.1494)| Loss of loop (P = 0.2237)	0.999847574799	0.99984	0.9166754227494129	0.91590	1.62602313597	0.89103	0.596089541912	0.52286	T	0.956453	0.99402	D	0.679029	0.99908	D	0.737601	0.99907	D	0.954029619693756	0.63942	D	0.994593	0.98244	D	0.8978354	0.91064	0.8459693	0.91118	0.8978354	0.91065	0.8459693	0.91119	-13.047	0.89579	D	0.9361	0.85514	P	0.999942948768151	0.99079	0.99904543	0.99115	0.977	0.99166	.	.	.	.	.	.	5.329675	0.89461	30.0	0.99951095395162337	0.99945	.	.	.	.	.	.	.	.	.	4.93	4.93	0.64349	.	.	9.996	0.99292	.	.	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.904	0.44015	56	0.97530	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	79946	1.250840e-05	0	1	151049	6.620370e-06	0	1	171265	5.838900e-06	0	0	5702	0.000000e+00	0	0	13607	0.000000e+00	0	0	1752	0.000000e+00	0	0	6916	0.000000e+00	0	0	9842	0.000000e+00	0	1	30802	3.246540e-05	0	0	9880	0.000000e+00	0	1	30802	3.246540e-05	0	0	13127	0.000000e+00	0	0	24304	0.000000e+00	0	0	4606	0.000000e+00	0	0	10125	0.000000e+00	0	0	12095	0.000000e+00	0	1	64282	1.555650e-05	0	0	18901	0.000000e+00	0	1	64282	1.555650e-05	0	0	12059	0.000000e+00	0	0	27059	0.000000e+00	0	0	6992	0.000000e+00	0	0	13307	0.000000e+00	0	0	15893	0.000000e+00	0	1	72992	1.370010e-05	0	0	18836	0.000000e+00	0	1	72992	1.370010e-05	0	.	1	1210866	8.258550e-07	0	1	894577	1.117850e-06	0	0	57962	0.000000e+00	0	0	687	0.000000e+00	0	0	46080	0.000000e+00	0	0	22002	0.000000e+00	0	0	33820	0.000000e+00	0	0	46886	0.000000e+00	0	0	4348	0.000000e+00	0	1	894577	1.117850e-06	0	0	56926	0.000000e+00	0	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	424	0	0	0	0	0	476	0	Adrenoleukodystrophy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.153740156G>A	ClinGen:CA278403|UniProtKB:P33897#VAR_000070	C0162309|C3661900	300100	43	ABC transporter-like, ATP-binding domain|ABC transporter-like, ATP-binding domain|AAA+ ATPase domain	Arg	Gln	92.92	0.33064516129032256																																																																																																																																																																																																																																																																																																																																																																																																																																																																													82			92.92	Positively-charged	Arginine		ATP-binding cassette sub-family D member 1							ABC transporter			-4.5			A:R518-B:E291 (PDBs: 7RR9, 7VR1, 7VWC, 7YRQ), B:R518-A:E291 (PDBs: 7X07, 7YRQ)	A:R518-B:F295 (PDBs: 7X07)	A:R518-B:E291 (PDBs: 7VR1, 7VWC, 7YRQ), B:R518-A:E291 (PDBs: 7X07, 7YRQ)			 R518-S514 (PAE:  1.0), R518-L523 (PAE: 1.0), R518-W524 (PAE: 1.0)	R518-L523 (PDBs: 7RR9, 7RRA), R518-S514 (PDBs: 7VR1, 7VZB, 7YRQ), R518-G522 (PDBs: 7VWC, 7X07), R518-W524 (PDBs: 7YRQ)	 R518-S514 (PAE:  1.0), R518-L523 (PAE: 1.0), R518-W524 (PAE: 1.0), R518-G522 (PAE: 1.5)	R518-G522 (PDBs: 7RR9, 7RRA, 7VWC, 7X07, 7YRQ), R518-W524 (PDBs: 7VR1, 7VZB, 7YRQ), R518-S514 (PDBs: 7YRQ), R518-L523 (PDBs: 7YRQ)							175									-63.7				-36.0						H (helix)	H (α-helix)	Helix											92.92	33.064518	>90	10-90	300100	x-linked recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic hepatic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Genetic infertility	6	ADRENOLEUKODYSTROPHY	false	0.7849929711895267	0.6918674621514003	false	false	false
ZC4H2	ZC4H2_Arg18Lys	B_13-14	-6.340999360000492	0.00038856290197054536	0.0022695875925496686	6.383370379835618	0.0003731446272996475	0.0010955526257517651	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	false	false	0.9643042498880852	0.9715631601664603	0.6667998097444325	0.7748045351872227	0.8045480249541568	0.6951207216547234	0.7412261029375958	0.7783640113681833	0.7936881066772628	0.7536633071180068	0.9642420450430147	0.9537814556473786	0.6490153403718509	0.8307320385401303	0.7559209636971826	0.5799363123708584	0.9788842752899057	0.9748270441287918	ZC4H2	Arg18Lys	NC_000023.11:64976325:C:T	53G>A	23	64976325	C	T	X	ENSG00000126970	4320	0	CCSBVarC009194	ALE00013418	ENSP00000363972.3																																	380137.0	single nucleotide variant	NM_018684.4(ZC4H2):c.53G>A (p.Arg18Lys)	55906.0	ZC4H2	HGNC:24931	Pathogenic	1.0	Mar 02, 2017	1057520299.0	-	RCV000426615	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	Wieacker-Wolff syndrome	germline	germline	GRCh38	NC_000023.11	X	64976325.0	64976325.0	Xq11.2	no assertion criteria provided	1.0	-	N	ClinGen:CA16609222,OMIM:300897.0007	1.0	378045.0	64976325.0	C	T	-	-	-	-	-	-	53G>A 	Arg18Lys	NM_018684.4		Pathogenic	Pathogenic	378045	X	64976325.0	C	T	R	K	rs1057520299	X	64196205	X	64112930	18	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.53G>A	p.Arg18Lys	c.53G>A	p.Arg18Lys	principal1	Y	1	YES	Select	-	AGG	2	0	C	C/C	C/C	C/C	C/C	0.162	0.24024	T	0.428	0.54507	T	0.979	0.59057	D	0.973	0.72925	D	0.39	0.63057	A	simple_aae	61.0	39.0	1.61	0.40979	L	-1.74	0.52471	N	0.866	0.86268	-0.6422	0.62892	T	0.2792	0.64962	T	8	0.76925564	0.76724	D	0.017247	0.38628	T	0.231	0.52992	0.607	0.73845	Q9NQZ6	R18K	Gain of methylation at R18 (P = 0.0377)| Gain of ubiquitination at K15 (P = 0.0632)| Loss of MoRF binding (P = 0.0922)| Loss of phosphorylation at T21 (P = 0.1157)| Loss of glycosylation at K15 (P = 0.2)	0.622178612725	0.61618	0.901597971559674	0.90069	1.62403551474	0.89065	0.773836612701	0.77960	T	0.486907	0.81174	T	0.0608247	0.59433	T	-0.150406	0.58921	T	0.973198473453522	0.69797	D	0.89491	0.63411	D	0.6772347	0.76559	0.5044407	0.71097	0.6783023	0.76618	0.41600963	0.65445	-4.683	0.36534	T	0.7363	0.75522	P	0.99398228578285	0.90367	0.99041635	0.96797	0.321	0.58615	.	.	.	.	.	.	5.580871	0.92311	32.0	0.99599773954017523	0.74191	.	.	.	.	.	.	.	.	.	4.73	4.73	0.59435	4.0	0.76287	5.226	0.65208	7.412000	0.58717	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.967	0.53449	45	0.97779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1209679	8.266660e-07	0	1	45815	2.182690e-05	0	0	57101	0.000000e+00	0	0	687	0.000000e+00	0	1	45815	2.182690e-05	0	0	22031	0.000000e+00	0	0	33732	0.000000e+00	0	0	46659	0.000000e+00	0	0	4372	0.000000e+00	0	0	894933	0.000000e+00	0	0	56759	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Wieacker-Wolff_syndrome	no_assertion_criteria_provided	NC_000023.11:g.64976325C>T	ClinGen:CA16609222|OMIM:300897.0007	C0796200	314580	3454|85283	.	Arg	Lys	97.95	0.7056451612903226																																																																																																																																																																																																																																																																																																																																																																																																																																																																													175			97.95	Positively-charged	Arginine		Zinc finger C4H2 domain-containing protein	Coiled coil									-4.5								 R18-L22 (PAE:  1.0), R18-I14 (PAE: 1.0)		 R18-L22 (PAE:  1.0), R18-I14 (PAE: 1.0)								175									-56.7				-46.0				dbSNP: rs1057520299; Variant type: LP/P; AA change: Arg18Lys; PTM type: Acetylation; PTM morphology: KLESIkEIR*Nk; Var class: II		H (helix)	H (α-helix)												97.95	70.564514	>90	10-90	314580	x-linked recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	false	0.9715631601664603	0.9643042498880852	true	false	false
RAF1	RAF1_Leu613Val	B_13-14	-5.363339586207128	0.09863537623739276	0.1289176816043391	5.024623972695487	0.01089392382330008	0.016641250708266293	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7672774801254654	0.7976087957615273	0.683042570266921	0.7794633325001543	0.722381959650658	0.7613242559350756	0.7613242559350756	0.722381959650658	0.7794633325001543	0.683042570266921	0.7976087957615273	0.7672774801254654							RAF1	Leu613Val	NC_000003.12:12584624:G:C	1837C>G	3	12584624	G	C	3	ENSG00000132155	732	0	CCSBVarC008860	ALE00011641	ENSP00000251849.4																																	28999.0	single nucleotide variant	NM_002880.4(RAF1):c.1837C>G (p.Leu613Val)	5894.0	RAF1	HGNC:9829	Pathogenic	1.0	Apr 03, 2017	80338797.0	-	RCV000014990|RCV000020508|RCV000014989|RCV000159089|RCV000254689|RCV000440827|RCV004532353|RCV000824753|RCV001256891	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648||MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|MONDO:MONDO:0008647,MedGen:C3495498,OMIM:192600	Noonan syndrome 5|Noonan syndrome with multiple lentigines|LEOPARD syndrome 2|RASopathy|not provided|Noonan syndrome|RAF1-related disorder|Noonan syndrome;Noonan syndrome with multiple lentigines|Hypertrophic cardiomyopathy 1	germline;unknown	germline	GRCh38	NC_000003.12	3	12584624.0	12584624.0	3p25.2	reviewed by expert panel	11.0	-	N	ClinGen:CA257066,UniProtKB:P04049#VAR_037821,OMIM:164760.0004	3.0	13960.0	12584624.0	G	C	-	-	-	-	-	-	1837C>G 	Leu613Val	NM_002880.4	3.0	Pathogenic	Pathogenic	13960	3	12584624.0	G	C	L	V	rs80338797	3	12626123	3	12601123	613	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1837C>G	p.Leu613Val	c.1837C>G	p.Leu613Val	principal3	Y	1	YES	Select	-	CTA	1	2	G	G/G	G/G	G/G	G/G	0.019	0.60085	D	0.022	0.57928	D	0.135	0.27320	B	0.252	0.39069	B	0.79	0.86984	A	simple_aae	21.0	79.0	2.485	0.72164	M	-2.57	0.56009	D	0.568	0.59354	-0.0874	0.80297	T	0.4146	0.76085	T	9	0.8424604	0.83230	D	0.082094	0.73737	D	0.579	0.82939	0.809	0.92541	P04049	L613V	Loss of catalytic residue at L613 (P = 0.0273)| Loss of glycosylation at K615 (P = 0.0453)| Gain of methylation at K615 (P = 0.0691)| Gain of ubiquitination at K615 (P = 0.1132)| Loss of stability (P = 0.1352)	0.91975856692	0.91833	.	0.69748	0.394351984474	0.40309	0.81423997879	0.84115	D	0.760318	0.93442	D	0.221088	0.75698	D	0.0798012	0.75382	D	0.969073593616486	0.68255	D	.	0.83110	.	0.5087415	0.67300	0.225398	0.47307	0.5052323	0.67095	0.22544135	0.47312	-9.343	0.70025	D	0.5072	0.64853	A	0.993864972354477	0.90295	0.98658720	0.96257	0.839	0.91143	.	.	.	.	.	.	4.008235	0.59191	24.1	0.99627613236244716	0.75865	0.504613	0.53448	D	0.1905950925256	0.50505	3.261897	0.307022034721395	0.55718	3.75805	5.41	4.46	0.53511	4.17	0.79380	3.761	0.55045	5.815000	0.50112	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.995	0.73271	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Hypertrophic_cardiomyopathy_1|Noonan_syndrome|RAF1-related_disorder|Noonan_syndrome_with_multiple_lentigines|RASopathy|Noonan_syndrome_5|LEOPARD_syndrome_2	reviewed_by_expert_panel	NC_000003.12:g.12584624G>C	ClinGen:CA257066|OMIM:164760.0004|UniProtKB:P04049#VAR_037821	C3661900|C3495498|C0028326|C0175704|C5555857|C1969057|C1969056	192600|PS163950|PS151100|611553|611554	648|500|536391|648|500	.	Leu	Val	71.21	0.23780487804878048																																																																																																																																																																																																																																																																																																																																																																																																																																																																													39			71.21	Aliphatic	Leucine		RAF proto-oncogene serine/threonine-protein kinase								0.0748		3.8				B:L613-D:T232 (PDBs: 8CPD), A:L613-C:T232 (PDBs: 8CPD)				 L613-L609 (PAE:  2.5)		 L613-L609 (PAE:  2.5)	L613-L609 (PDBs: 3OMV, 7Z38, 8CHF, 8CPD, 8U1L)							131									-68.2		Pocket 4: Mean pLDDT: 63.95, Volume: 1859.51 Å³, Druggability score: 0.07		142.2				dbSNP: rs80338797; Variant type: LP/P; AA change: Leu613Val; PTM type: Phosphorylation; PTM morphology: ELLQHsL*PKIN; Var class: II		C (loop/coil)	S (bend)	Turn											71.21	23.780487	70-90	10-90	611553;611554;192600	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	NOONAN SYNDROME 5; LEOPARD SYNDROME 2; CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	false	0.7976087957615273	0.7672774801254654	false	false	false
KRAS	KRAS_Gly12Val	B_13-14	-5.955690773263131	0.0005668221876575696	0.0030410965686122416	7.61190074927341	0.00012503779786052498	0.0004800091194018061	2025_01_Batch_13-14	false	false	false	false	true	true	false	false	false	false	false	false	0.925006765440386	0.9286603455569333	0.7822269660692889	0.8975039328055767	0.9489654859469556	0.9492381000300864	0.9233947028979574	0.9532769466158217	0.8175001737466994	0.6262501737112349	0.9019807504124815	0.9037776955903766	0.9750814971622153	0.9446540252780894	0.9775076918644542	0.9382037584273428	0.9553399407013852	0.9462358352903955	KRAS	Gly12Val	NC_000012.12:25245350:C:A	35G>T	12	25245350	C	A	12	ENSG00000133703	3084	0	CCSBVarC006089	ALE00006089	ENSP00000308495.3	CEGS2	CegsMutGDEh1035	A04	GDEhDisVCh_40061	G08	1	CegsMutGDDh1035	A04	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	27622.0	single nucleotide variant	NM_004985.5(KRAS):c.35G>T (p.Gly12Val)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Oct 13, 2023	121913529.0	-	RCV000029216|RCV000150895|RCV000154262|RCV000013413|RCV000157944|RCV000585801|RCV002291496|RCV003455987|RCV004668725|RCV003322589|RCV003539760	Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C3661900|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724|Human Phenotype Ontology:HP:0005506,Human Phenotype Ontology:HP:0005544,MONDO:MONDO:0011996,MeSH:D015464,MedGen:C0279543,OMIM:608232,Orphanet:521|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0006279,MedGen:C1708781|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Nevus sebaceous|Juvenile myelomonocytic leukemia|Non-small cell lung carcinoma|Carcinoma of pancreas|not provided|Cerebral arteriovenous malformation|Chronic myelogenous leukemia, BCR-ABL1 positive|Linear nevus sebaceous syndrome|Neoplasm|Lung sarcomatoid carcinoma|RASopathy	germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245350.0	25245350.0	12p12.1	criteria provided, multiple submitters, no conflicts	12.0	-	N	COSMIC:520,ClinGen:CA122540,UniProtKB:P01116#VAR_006840,OMIM:190070.0006,OMIM:190070.0026	3.0	12583.0	25245350.0	C	A	-	-	-	Oncogenic	Jul 31, 2024	criteria provided, single submitter	35G>T 	Gly12Val	NM_004985.5	2.0	Pathogenic	Pathogenic	12583	12	25245350.0	C	A	G	V	rs121913529	12	25398284	12	25289551	12	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.35G>T	p.Gly12Val	c.35G>T	p.Gly12Val	alternative1	Y	1	.	Plus_Clinical	-	GGT	2	0	C	./.	./.	./.	./.	0.008	0.60085	D	0.001	0.83643	D	0.999	0.77914	D	0.978	0.74106	D	1.0	0.99291	A	simple_aae	0.0	100.0	1.84	0.48108	L	-7.11	0.97229	D	0.939	0.94561	0.5429	0.91106	D	0.6987	0.89587	D	10	0.9236257	0.91620	D	0.181073	0.85494	D	0.910	0.97583	0.767	0.89397	P01116	G12V	Gain of catalytic residue at V14 (P = 0)| Loss of ubiquitination at K16 (P = 0.1037)| Loss of methylation at K16 (P = 0.1785)| Loss of disorder (P = 0.1841)| Loss of sheet (P = 0.302)	0.988619423247	0.98836	0.9781072363123009	0.97790	2.35052041495	0.96801	0.898488461971	0.96267	D	0.843047	0.96328	D	0.385769	0.88997	D	0.316354	0.88859	D	0.990357935428619	0.80423	D	0.366763	0.56662	T	0.96866757	0.98104	0.9503655	0.98397	0.9776439	0.98906	0.9436424	0.97974	-15.17	0.98083	D	0.9949	0.96393	P	0.999985518475673	0.99579	0.99924910	0.99245	0.997	0.99892	.	.	.	.	.	.	4.859019	0.79528	27.1	0.99792542458718392	0.87849	0.919073	0.88866	D	0.947784823501693	0.93861	12.35383	0.901530992395951	0.95614	13.81752	5.68	5.68	0.88004	.	.	7.892	0.85894	7.698000	0.66189	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612866	6.200140e-07	0	1	1179302	8.479590e-07	0	0	75026	0.000000e+00	0	0	912	0.000000e+00	0	0	59958	0.000000e+00	0	0	29524	0.000000e+00	0	0	44856	0.000000e+00	0	0	63988	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179302	8.479590e-07	0	0	90794	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Linear_nevus_sebaceous_syndrome|Nevus_sebaceous|not_provided|Non-small_cell_lung_carcinoma|Chronic_myelogenous_leukemia,_BCR-ABL1_positive|Carcinoma_of_pancreas|Lung_sarcomatoid_carcinoma|Acute_myeloid_leukemia|Juvenile_myelomonocytic_leukemia|Cerebral_arteriovenous_malformation|Thyroid_tumor|Ovarian_neoplasm|RASopathy|Neoplasm_of_the_large_intestine	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245350C>A	COSMIC:520|ClinGen:CA122540|OMIM:190070.0006|OMIM:190070.0026|UniProtKB:P01116#VAR_006840	C4552097|C3854181|C3661900|C0007131|C0279543|C0235974|C1708781|C0023467|C0349639|C0917804|C0040136|C0919267|C5555857|C0009404	163200|608232|601626|607785|108010	2612|521|1333|217074|519|86834|46724|100087|536391	Small GTP-binding domain	Gly	Val	94.86	0.2261904761904762																																																																																																																																																																																					-0.112						-0.383						-0.394						-0.086				0.206				-0.126		-0.119		-0.492						-0.25						0.417		-0.158		0.011		0.043		0.376																																																																																																																																																																																																																																						19			94.86	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine	GTP	GTPase KRas; GTPase KRas, N-terminally processed										-0.4									G12-E62 (PDBs: 6O36, 6O46, 8T71)		G12-K16 (PDBs: 6MQG, 6MQN, 6YXW, 8T75), G12-A59 (PDBs: 8CPR), G12-E62 (PDBs: 8T71), G12-G60 (PDBs: 8T72, 8T74, 8TBF), G12-Q61 (PDBs: 2MSD)							75									-55.3				143.2						C (loop/coil)	T (turn)	Beta strand											94.86	22.619047	>90	10-90	607785;108010;608232;163200	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	JUVENILE MYELOMONOCYTIC LEUKEMIA; ARTERIOVENOUS MALFORMATIONS OF THE BRAIN; LEUKEMIA, CHRONIC MYELOID; SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME	false	0.9286603455569333	0.925006765440386	false	false	false
F9	F9_Cys134Ser	B_13-14	-3.3797959324717373	0.014861540864500467	0.03671832610606634	2.02518199256615	0.0824971752926137	0.1108216080980572	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7764941829822163	0.8151376223245079	0.6055804612780811	0.7790922537413174	0.669969828099577	0.7580996047496837	0.7916798781659558	0.7053068099153815	0.7907971819914114	0.6459485413026576	0.807847829791276	0.7598327745907333	0.7245193313334117	0.6346328462837724	0.7673873254912233	0.5652123812535047	0.8224274148577397	0.7931555913736993	F9	Cys134Ser	NC_000023.11:139548372:G:C	401G>C	23	139548372	G	C	X	ENSG00000101981	52861	0	CCSBVarC030525	ALE00028411	ENSP00000218099.2																																	962086.0	single nucleotide variant	NM_000133.4(F9):c.401G>C (p.Cys134Ser)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 01, 2019	1927764839.0	-	RCV001265104	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548372.0	139548372.0	Xq27.1	no assertion criteria provided	1.0	-	N	-	2.0	973818.0	139548372.0	G	C	-	-	-	-	-	-	401G>C 	Cys134Ser	NM_000133.4		Pathogenic	Pathogenic	973818	X	139548372.0	G	C	C	S	rs1927764839	X	138630531	X	138458197	134	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.401G>C	p.Cys134Ser	c.401G>C	p.Cys134Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.72	0.99504	H	-6.94	0.94803	D	0.899	0.94679	0.9872	0.96968	D	0.9993	0.99975	D	10	0.9919677	0.99728	D	0.454898	0.94399	D	0.936	0.98562	0.983	0.99835	P00740	C134S	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.999909622329	0.99990	0.9998499921215912	0.99985	3.32765753199	0.99614	0.624931335449	0.56360	T	0.872264	0.97227	D	0.720984	0.99946	D	0.797867	0.99946	D	0.999232292175293	0.96610	D	0.773323	0.40263	T	0.988561	0.99681	0.9841814	0.99909	0.9918276	0.99850	0.98336446	0.99894	-7.378	0.65331	T	0.979	0.95276	P	0.99951099997631	0.96835	0.99999320	0.99996	0.995	0.99826	.	.	.	.	.	.	4.089855	0.60976	24.3	0.98390809585124928	0.41088	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	7.472	0.80047	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.685	0.33728	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548372G>C	.	C0008533	306900	98879	.	Cys	Ser	85.56	0.14074074074074075																																																																																																																																																																																																																																																																																																																																																																																																															0.419		0.337		0.349		0.301		0.117																																																						19			85.56	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa light chain						Disulfide bond 134-145	EGF-like 2			2.5								 C134-N147 (PAE:  3.5)	C134-N147 (PDBs: 2WPH, 2WPK, 2WPL, 6RFK)	 C134-N147 (PAE:  3.5), C134-N138 (PAE: 2.0), C134-G139 (PAE: 2.0), C134-K146 (PAE: 2.5)	C134-K146 (PDBs: 2WPH, 2WPI, 2WPJ, 2WPK, 2WPL, 2WPM, 5JB8, 5JB9, 5JBA, 5JBB, 5JBC, 6RFK), C134-N147 (PDBs: 6RFK), C134-N138 (PDBs: 6RFK), C134-G139 (PDBs: 6RFK)							121									-59.0				-21.4						C (loop/coil)	T (turn)	Turn											85.56	14.074074	70-90	10-90	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.8151376223245079	0.7764941829822163	false	false	false
BRAF	BRAF_Gln257Arg	B_13-14	-4.0967768173781565	0.004591621866850185	0.014889639670091432	0.12688298867875483	0.9026008312567233	0.9223307243170084	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7755103206585325	0.7900705322536581	0.6438071251349171	0.7049048010568358	0.5984984117182952	0.6977444689042289	0.7126273261551193	0.5922234905801343	0.7032536331866199	0.6153052123929819	0.8040086130109787	0.8171838987534361	0.6828616116533385	0.6047733328564562	0.7065559689270517	0.6723090378768525	0.7761324514963375	0.7338367425636291	BRAF	Gln257Arg	NC_000007.14:140801502:T:C	770A>G	7	140801502	T	C	7	ENSG00000157764	71969	0	CCSBVarC003156	ALE00003156	ENSP00000493543.1	CEGS2	CegsMutGDEh1027	G07	GDEhDisVCh_40058	D10	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	2.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	29012.0	single nucleotide variant	NM_004333.6(BRAF):c.770A>G (p.Gln257Arg)	673.0	BRAF	HGNC:1097	Pathogenic	1.0	Apr 03, 2017	180177035.0	-	RCV000015007|RCV001813208|RCV001813744|RCV000033289|RCV000080904|RCV000208766|RCV003224098|RCV004018628|RCV001027771|RCV001261967|RCV001329219|RCV004752707	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|6 conditions|MedGen:CN230736|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340;MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648;MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500|	Cardiofaciocutaneous syndrome 1|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1|RASopathy|not provided|Cardio-facio-cutaneous syndrome|6 conditions|Cardiovascular phenotype|Cardiofaciocutaneous syndrome 1;Noonan syndrome 7;LEOPARD syndrome 3|Noonan syndrome 7|LEOPARD syndrome 3|BRAF-related disorder	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140801502.0	140801502.0	7q34	reviewed by expert panel	33.0	-	N	ClinGen:CA222583,UniProtKB:P15056#VAR_026114,OMIM:164757.0013	3.0	13973.0	140801502.0	T	C	-	-	-	-	-	-	770A>G 	Gln257Arg	NM_004333.6	3.0	Pathogenic	Pathogenic	13973	7	140801502.0	T	C	Q	R	rs180177035	7	140501302	7	140147771	257	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.770A>G	p.Gln257Arg	c.770A>G	p.Gln257Arg	principal4	Y	.	YES	Select	-	CAG	2	0	T	./.	./.	./.	./.	.	0.48802	.	.	0.24199	.	0.959	0.55150	D	0.626	0.51596	P	.	0.94956	.	.	.	.	3.07	0.86962	M	.	0.25939	.	.	0.91737	1.0162	0.97459	D	0.8814	0.96054	D	9	0.962993	0.95685	D	0.23991	0.88624	D	.	0.94900	0.914	0.98337	P15056	Q257R	Gain of MoRF binding (P = 0.0136)| Loss of helix (P = 0.0376)| Loss of sheet (P = 0.0457)| Gain of loop (P = 0.0502)| Loss of ubiquitination at K253 (P = 0.0525)	.	0.99132	.	0.99541	.	0.81887	0.876263439655	0.93441	D	0.758931	0.93394	D	0.497157	0.94149	D	0.476355	0.94072	D	0.946888327598572	0.62335	D	0.937906	0.77715	D	0.8394073	0.86387	0.6523551	0.79429	0.8253214	0.85393	0.65886503	0.79796	-13.31	0.90620	D	0.9831	0.93940	P	0.984355110891765	0.86463	0.99508744	0.97698	0.646	0.80291	.	.	.	.	.	.	4.989844	0.82746	27.9	0.99828950546521744	0.91119	0.858490	0.77519	D	0.801626318931521	0.86133	8.812097	0.761899469924724	0.86971	9.087886	5.43	5.43	0.78977	.	.	7.971	0.87647	7.808000	0.69392	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.997	0.79771	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Cardiofaciocutaneous_syndrome_1|Noonan_syndrome_7|LEOPARD_syndrome_3|Cardio-facio-cutaneous_syndrome|Lung_cancer|Colorectal_cancer|Melanoma,_cutaneous_malignant,_susceptibility_to,_1|Noonan_syndrome_1|Noonan_syndrome_and_Noonan-related_syndrome|Cardiovascular_phenotype|RASopathy|not_provided	reviewed_by_expert_panel	NC_000007.14:g.140801502T>C	ClinGen:CA222583|OMIM:164757.0013|UniProtKB:P15056#VAR_026114	CN029449|C3150970|C3150971|C1275081|C0242379|C0346629|C1835047|C4551602|C5681679|CN230736|C5555857|C3661900	115150|613706|613707|PS115150|211980|114500|155600|163950	1340|648|500|1340|618|648|98733|536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Gln	Arg	88.5	0.5858585858585859																																																																																																																																																																																																																																																																																																																																																																																																																																																																													116			88.5	Polar/Neutral	Glutamine		Serine/threonine-protein kinase B-raf										-3.5			A:Q257-C:S57 (PDBs: 6NYB, 8DGT)	A:Q257-C:S57 (PDBs: 6NYB, 8DGT)							Q257-H269 (PDBs: 7MFD), Q257-T241 (PDBs: 8DGS, 8DGT), Q257-K240 (PDBs: 8DGT)							146									-138.4				139.5				dbSNP: rs180177035; Variant type: LP/P; AA change: Gln257Arg; PTM type: Acetylation; PTM morphology: CDFCRkLLFQ*G; Var class: II		B (undefined)	E (parallel sheets)											Phorbol-ester/DAG-type	88.5	58.585857	70-90	10-90	115150;163950;115150;613706;613707;613706;613707	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1; NOONAN SYNDROME 1; CARDIOFACIOCUTANEOUS SYNDROME 1; NOONAN SYNDROME 7; LEOPARD SYNDROME 3; NOONAN SYNDROME 7; LEOPARD SYNDROME 3	true	0.7900705322536581	0.7755103206585325	false	false	false
BRCA1	BRCA1_Met1Ile	B_13-14	6.765004300970164	0.0002614050448425321	0.0017489405759784974	-18.83358370213424	2.956885464415597e-7	8.390976792275268e-6	2025_01_Batch_13-14	false	true	true	true	false	true	false	true	false	false	false	false	0.9830606866049652	0.988032287437633	0.9088312569085095	0.9532048382105265	0.8962728187361115	0.956455594289188	0.9699984720424418	0.927279773984532	0.9580416230302209	0.9434490520166344	0.9917734350989148	0.993264513404557	0.9429127165359342	0.8652658634876911	0.9483680533908321	0.8742134618003845	0.9842911397763512	0.9728568598053734	BRCA1	Met1Ile	NC_000017.11:43124094:C:A	3G>T	17	43124094	C	A	17	ENSG00000012048	14613	0	CCSBVarC003295	ALE00003295	ENSP00000417148.1	CEGS2	CegsMutGDEh1009	D10	GDEhDisVCh_40059	B03	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	4.0	0.0		0.0			0.0			0.0			N	N	N	N	N	69739.0	single nucleotide variant	NM_007294.4(BRCA1):c.3G>T (p.Met1Ile)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 18, 2019	80357475.0	-	RCV000048405|RCV000111552|RCV000131890|RCV000763402|RCV001357041	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124094.0	43124094.0	17q21.31	reviewed by expert panel	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002562	2.0	55072.0	43124094.0	C	A	-	-	-	-	-	-	3G>T 	Met1Ile	NM_007294.4	3.0	Pathogenic	Pathogenic	55072	17	43124094.0	C	A	M	I	rs80357475	17	41276111	17	38529637	1	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	c.3G>T	p.Met1?	c.3G>T	p.Met1?	principal2	Y	1	.	.	-	ATG	3	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.009	0.92967	D	0.924	0.51298	P	0.878	0.62305	P	.	0.99291	.	.	.	.	.	.	.	-0.56	0.54406	N	.	0.93850	0.5223	0.90822	D	0.7099	0.90000	D	9	0.9873682	0.99089	D	0.932498	0.99511	D	0.696	0.88959	0.996	0.99957	E9PFC7	M1I	Gain of catalytic residue at M1 (P = 0.0314)| Loss of disorder (P = 0.1193)| Loss of loop (P = 0.1242)| Gain of helix (P = 0.2684)| Loss of phosphorylation at S4 (P = 0.3332)	0.887736870969	0.88576	.	0.24402	.	.	.	.	.	0.280176	0.65093	T	0.398321	0.89744	D	0.334384	0.89616	D	0.996361911296844	0.89105	D	.	0.64967	.	0.90739095	0.91937	0.707353	0.82542	0.9052275	0.91737	0.64797	0.79185	-12.231	0.90483	D	.	.	.	0.999999926062728	0.99831	0.99954283	0.99470	.	.	.	.	.	.	.	.	4.144486	0.62186	24.4	0.99635003892177543	0.76291	0.062568	0.11864	N	0.34664899273018	0.58348	4.029269	0.312639291828477	0.56049	3.791295	3.83	3.83	0.43219	.	.	3.426	0.52638	3.191000	0.36784	-0.284	0.0639	1.0	0.71675	1.000000	0.68239	0.255	0.23438	469	0.78193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612162	6.202850e-07	0	1	1178330	8.486590e-07	0	0	74994	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29594	0.000000e+00	0	0	44826	0.000000e+00	0	0	64006	0.000000e+00	0	0	6024	0.000000e+00	0	1	1178330	8.486590e-07	0	0	91032	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43124094C>A	ClinGen:CA002562	C0027672|C3661900|C0346153|C4554406|C2676676|C3280442|C0677776	114480|617883|604370|614320	140162|227535|145|1333|145	.	Met	Ile	41.59	1.0																																																																																																															-1.657		-2.936																																																																																																																																																																																																																																																																																																																																																												184			41.44	Aliphatic	Methionine		Breast cancer type 1 susceptibility protein										1.9											M1-T97 (PDBs: 1JM7), M1-D96 (PDBs: 1JM7)						N-acetylmethionine	149									360.0				130.4						C (loop/coil)	C (loop/coil)												41.59	100.0	$\leqslant$50	$\geqslant$90	604370;114480;617883;614320;604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.988032287437633	0.9830606866049652	true	false	true
F9	F9_Asp110Asn	B_13-14	1.7930019133298674	0.11606692398250139	0.18412610033768906	0.4587166468892154	0.6603405189429533	0.706957323372415	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7161207454671888	0.7063471047757568	0.653702892157268	0.8068150821954356	0.70721025391578	0.7699950381192149	0.886892168449369	0.73221431228053	0.8712950467374695	0.726428336242992	0.7496425303940333	0.7873713832593123	0.6530979077890608	0.6822061955510299	0.7423351176534019	0.580977448071544	0.6630516791574802	0.6448701076750654	F9	Asp110Asn	NC_000023.11:139541126:G:A	328G>A	23	139541126	G	A	X	ENSG00000101981	52861	0	CCSBVarC004376	ALE00004376	ENSP00000218099.2	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25682.0	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852274.0	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126.0	139541126.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1.0	10643.0	139541126.0	G	A	-	-	-	-	-	-	328G>A 	Asp110Asn	NM_000133.4		Pathogenic	Pathogenic	10643	X	139541126.0	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	87.17	0.18404907975460122																																																																																																																																																																																																																																																																																																																																																																																																															1.153	2 mutation(s) (Asp110Gly: 1.356, Asp110Lys: 1.359)	1.078	7 mutation(s) (Asp110Thr: 1.169, Asp110Ala: 1.172, Asp110Pro: 1.179, Asp110His: 1.180, Asp110Gln: 1.192, Asp110Gly: 1.196, Asp110Lys: 1.206)	0.924	1 mutation(s) (Asp110Ser: 1.135)	0.967		0.706																																																						30			87.17	Negatively-charged	Aspartic Acid	Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain							EGF-like 1; calcium-binding			-3.5			B:D110-C:N104 (PDBs: 1EDM, 5VYG), B:D110-C:G105 (PDBs: 5VYG), A:D110-B:N104 (PDBs: 5VYG), A:D110-B:G105 (PDBs: 5VYG)	B:D110-C:N104 (PDBs: 1EDM, 5VYG), B:D110-C:G105 (PDBs: 5VYG)				 D110-Q96 (PAE:  2.0)	D110-Q96 (PDBs: 1EDM, 5VYG, 5F84), D110-C97 (PDBs: 5F85, 5F86)	 D110-C97 (PAE:  1.5)	D110-C97 (PDBs: 1EDM, 5VYG, 5F84, 5F85, 5F86)						(3R)-3-hydroxyaspartate	132									-72.1				143.4				dbSNP: rs137852274; Variant type: LP/P; AA change: Asp110Asn; PTM type: Phosphorylation; PTM morphology: KD*DINsYECWC; Var class: II		B (undefined)	E (parallel sheets)	Beta strand											87.17	18.40491	70-90	10-90	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.7063471047757568	0.7161207454671888	false	false	false
BRCA1	BRCA1_Cys39Arg	B_13-14	0.8472010433103342	0.4248979667525149	0.5172435414259423	6.176662907203266	0.00045550350607088887	0.0012856882203950563	2025_01_Batch_13-14	false	false	false	true	true	true	false	false	false	false	false	false	0.8972118642247596	0.9158358702816362	0.854005289435658	0.9489581709505943	0.9141981838878953	0.9379635548164111	0.9109422147679234	0.9127898133115244	0.9362263544604061	0.7696876651072171	0.9062317718469863	0.889650749551502	0.9649848948648989	0.9156065544642662	0.9616899874407825	0.9383229137640989	0.925439968716286	0.9047729788980172	BRCA1	Cys39Arg	NC_000017.11:43115745:A:G	115T>C	17	43115745	A	G	17	ENSG00000012048	14613	0	CCSBVarC011862	ALE00014322	ENSP00000417148.1																																	68819.0	single nucleotide variant	NM_007294.4(BRCA1):c.115T>C (p.Cys39Arg)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357164.0	-	RCV000077483|RCV000496824|RCV000570028|RCV000985365|RCV001270963	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115745.0	43115745.0	17q21.31	reviewed by expert panel	18.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000766,BRCA1-HCI:BRCA1_00113	2.0	54152.0	43115745.0	A	G	-	-	-	-	-	-	115T>C 	Cys39Arg	NM_007294.4	3.0	Pathogenic	Pathogenic	54152	17	43115745.0	A	G	C	R	rs80357164	17	41267762	17	38521288	39	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.115T>C	p.Cys39Arg	principal2	Y	.	.	.	-	TGT	1	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	0.987	0.90580	D	0.879	0.92348	P	.	0.99291	.	.	.	.	4.355	0.98454	H	.	0.99400	.	.	0.97441	0.9518	0.96410	D	0.9931	0.99838	D	10	.	0.99503	.	0.908305	0.99312	D	.	0.98488	0.996	0.99957	E9PFC7	C39R	Gain of catalytic residue at C39 (P = 0.0465)| Gain of phosphorylation at T37 (P = 0.077)| Gain of helix (P = 0.132)| Gain of MoRF binding (P = 0.136)| Gain of glycosylation at T37 (P = 0.1377)	.	0.99932	.	0.93989	.	0.50598	0.773955702782	0.77978	T	0.409909	0.93004	T	0.564887	0.96297	D	0.573645	0.96237	D	0.998840510845184	0.95303	D	.	0.97903	.	0.98947704	0.99732	0.93276787	0.97245	0.97528833	0.98709	0.93651694	0.97501	-13.367	0.98539	D	.	0.97565	.	0.999949474096148	0.99079	0.99980813	0.99752	0.992	0.99727	.	.	.	.	.	.	4.933548	0.81398	27.5	0.99705377574859155	0.80955	0.797421	0.72325	D	0.971278320987367	0.94761	13.04323	0.87581144299615	0.94398	12.75438	5.97	5.97	0.96929	3.64	0.66725	4.109	0.57651	11.102000	0.86162	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613730	6.196820e-07	0	1	1179810	8.475940e-07	0	0	75044	0.000000e+00	0	0	910	0.000000e+00	0	0	59942	0.000000e+00	0	0	29584	0.000000e+00	0	0	44862	0.000000e+00	0	0	64014	0.000000e+00	0	0	6060	0.000000e+00	0	1	1179810	8.475940e-07	0	0	91016	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43115745A>G	BRCA1-HCI:BRCA1_00113|ClinGen:CA000766	C0677776|CN221562|C3661900|C2676676|C0027672	604370	145|145|140162	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Arg	88.54	0.15555555555555556			-3.153	1 mutation(s) (Cys39Tyr: -4.333)	-1.941																																																																																								4.0	1 mutation(s) (Cys39Phe: 4.000)	-1.156	1 mutation(s) (Cys39Met: -3.223)																			-1.943		-1.791																																																																																																																																																																																																																																																																																																																																																								21			88.69	Special, a very reactive sulfhydryl group	Cysteine		Breast cancer type 1 susceptibility protein										2.5						 C39-C64 (PAE:  2.0)		 C39-C61 (PAE:  2.0)	C39-K65 (PDBs: 7LYB), C39-D67 (PDBs: 8GRQ)	 C39-C64 (PAE:  2.0), C39-N66 (PAE: 3.5)	C39-C61 (PDBs: 1JM7), C39-C64 (PDBs: 7LYB, 8GRQ), C39-K65 (PDBs: 7LYB), C39-D67 (PDBs: 8GRQ)							121									-129.2				28.0						C (loop/coil)	T (turn)											RING-type	88.54	15.555556	70-90	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.9158358702816362	0.8972118642247596	false	false	false
F9	F9_Pro414Thr	B_13-14	-1.1216143046907852	0.29902269163657036	0.38642309947621745	0.8811362108566082	0.4074784577436449	0.46127265265859857	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5115446741973937	0.5266209622545852	0.5845693391842368	0.5971371471482897	0.5529384397490151	0.6755575772835152	0.7276925866019291	0.573103089495385	0.6970177559372247	0.578008967417404	0.5110188414298178	0.4948601393576495	0.6234225679651012	0.5327737900026452	0.4972565383593547	0.5911297109510696	0.5422230830793526	0.5282292090371378	F9	Pro414Thr	NC_000023.11:139561925:C:A	1240C>A	23	139561925	C	A	X	ENSG00000101981	52861	0	CCSBVarC004396	ALE00004396	ENSP00000218099.2	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25659.0	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852265.0	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925.0	139561925.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1.0	10620.0	139561925.0	C	A	-	-	-	-	-	-	1240C>A 	Pro414Thr	NM_000133.4		Pathogenic	Pathogenic	10620	X	139561925.0	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	96.53	0.0																																																																																																																																																																																																																																																																																																																																																																																																															1.0		0.825		0.798		0.808	3 mutation(s) (Pro414Gln: 1.104, Pro414Leu: 1.109, Pro414Ile: 1.118)	0.765																																																						0			96.53	Special, No backbone hydrogen	Proline		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			1.6											P414-Q241 (PDBs: 8OL9), P414-S255 (PDBs: 8OL9), P414-S354 (PDBs: 8OL9), P414-V353 (PDBs: 8OL9), P414-G427 (PDBs: 8OL9), P414-L425 (PDBs: 8OL9), P414-I429 (PDBs: 8OL9)							115									-77.7				147.6						B (undefined)	E (parallel sheets)	Beta strand											96.53	0.0	>90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.5266209622545852	0.5115446741973937	false	false	false
BRCA1	BRCA1_Cys64Ser	B_13-14	-0.5198160846601582	0.619220375890755	0.6924536990347435	-4.922164968922964	0.0017094264265996762	0.003729842440916059	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7270269903962541	0.7446255954098674	0.5710826330786485	0.6974173625228902	0.6212428972854931	0.6142383331296806	0.5026662514711002	0.6532909435711116	0.6927607260551674	0.4353344381986304	0.7657924160751834	0.7623072495494313	0.7258104147882609	0.5891948509998746	0.7020739989906131	0.7068308279586666	0.7234587747445513	0.6917467312430767	BRCA1	Cys64Ser	NC_000017.11:43106477:C:G	191G>C	17	43106477	C	G	17	ENSG00000012048	14613	0	CCSBVarC011841	ALE00013967	ENSP00000417148.1																																	468251.0	single nucleotide variant	NM_007294.4(BRCA1):c.191G>C (p.Cys64Ser)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Nov 09, 2022	55851803.0	-	RCV000559047|RCV001076723	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43106477.0	43106477.0	17q21.31	criteria provided, single submitter	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10601786	2.0	462571.0	43106477.0	C	G	-	-	-	-	-	-	191G>C 	Cys64Ser	NM_007294.4	1.0	Pathogenic	Pathogenic	462571	17	43106477.0	C	G	C	S	rs55851803	17	41258494	17	38512020	64	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.191G>C	p.Cys64Ser	c.191G>C	p.Cys64Ser	principal2	Y	1	YES	Select	-	TGT	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	0.99	0.68795	D	0.903	0.78943	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.99	0.96635	H	-1.45	0.98450	N	0.982	0.99346	0.9381	0.96208	D	0.9931	0.99838	D	10	0.9888865	0.99322	D	0.959083	0.99729	D	0.922	0.98039	0.968	0.99690	E9PFC7	C64S	Gain of disorder (P = 0.0079)| Loss of stability (P = 0.0171)| Gain of phosphorylation at C64 (P = 0.0837)| Gain of glycosylation at P62 (P = 0.1363)| Loss of methylation at K65 (P = 0.1443)	0.999450167335	0.99943	.	0.86148	.	0.40765	0.717033147812	0.69562	T	0.46945	0.92995	T	0.553376	0.95819	D	0.55711	0.95755	D	0.997346639633179	0.91262	D	.	0.80441	.	0.9870781	0.99591	0.88999635	0.94188	0.97642994	0.98806	0.88973695	0.94170	-12.832	0.92342	D	0.9961	0.97310	P	0.999399190328388	0.96461	0.99976617	0.99701	0.964	0.98523	.	.	.	.	.	.	5.090651	0.85032	28.5	0.99110843159672235	0.52805	0.851286	0.76729	D	0.91310061370465	0.92344	11.39386	0.783598264701654	0.88566	9.654935	4.64	4.64	0.57348	.	.	4.108	0.57643	7.641000	0.63257	0.531	0.24877	1.0	0.71675	1.000000	0.68239	0.997	0.79771	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	criteria_provided,_single_submitter	NC_000017.11:g.43106477C>G	ClinGen:CA10601786	C2676676|C0677776	604370	145|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Ser	88.77	0.3333333333333333			-3.087	1 mutation(s) (Cys64Ter: -4.185)	-1.686																																																																																										-1.143	1 mutation(s) (Cys64Gly: -2.190)																							-2.131	1 mutation(s) (Cys64Ser: -3.694)	-1.679																																																																																																																																																																																																																																																																																																																																																				35			88.56	Special, a very reactive sulfhydryl group	Cysteine		Breast cancer type 1 susceptibility protein										2.5						 C64-C39 (PAE:  2.0)				 C64-C39 (PAE:  2.0), C64-H41 (PAE: 2.5)	C64-C39 (PDBs: 7LYB, 8GRQ)							121									-76.7				-9.5				dbSNP: rs80357064; Variant type: LP/P; AA change: Cys64Gly; PTM type: Ubiquitylation; PTM morphology: QCPLC*kNDITK; Var class: II&rs55851803		C (loop/coil)	T (turn)	Beta strand										RING-type	88.77	33.333336	70-90	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	true	0.7446255954098674	0.7270269903962541	false	false	false
KRAS	KRAS_Gly60Arg	B_13-14	-2.525125755633534	0.03951338958819366	0.07669773792017265	7.470146501094296	0.0001408016453172378	0.0005251443478803482	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9055479401566127	0.9013310838275048	0.45886891827080534	0.5998129184262677	0.5821270491957642	0.5163115865340359	0.42542408295110157	0.50866111829547	0.43112167846751537	0.4630692259821988	0.896869980094066	0.9028718223165776	0.6071990901169702	0.6555929800960585	0.7685041583850201	0.4546686105594118	0.9057921875609435	0.9082240579966478	KRAS	Gly60Arg	NC_000012.12:25227346:C:G	178G>C	12	25227346	C	G	12	ENSG00000133703	3084	0	CCSBVarC006097	ALE00006097	ENSP00000308495.3	CEGS2	CegsMutGDEh1041	E01	GDEhDisVCh_40061	A10	1	CegsMutGDDh1041	E01	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	27625.0	single nucleotide variant	NM_004985.5(KRAS):c.178G>C (p.Gly60Arg)	3845.0	KRAS	HGNC:6407	Pathogenic	1.0	Apr 03, 2017	104894359.0	-	RCV000013416|RCV000254661|RCV000157935|RCV001267316|RCV000844635|RCV000521390|RCV003313917	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	Cardiofaciocutaneous syndrome 2|not provided|RASopathy|Inborn genetic diseases|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardio-facio-cutaneous syndrome|Noonan syndrome 3	germline;unknown	germline	GRCh38	NC_000012.12	12	25227346.0	25227346.0	12p12.1	reviewed by expert panel	9.0	-	N	ClinGen:CA273416,UniProtKB:P01116#VAR_026112,OMIM:190070.0009	3.0	12586.0	25227346.0	C	G	-	-	-	-	-	-	178G>C 	Gly60Arg	NM_004985.5	3.0	Pathogenic	Pathogenic	12586	12	25227346.0	C	G	G	R	rs104894359	12	25380280	12	25271547	60	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.178G>C	p.Gly60Arg	c.178G>C	p.Gly60Arg	alternative1	Y	1	.	Plus_Clinical	-	GGT	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.17	0.97633	H	-7.76	0.95831	D	0.956	0.96546	1.0884	0.99174	D	0.9502	0.98375	D	9	0.96227115	0.95603	D	0.451783	0.94345	D	0.938	0.98634	0.802	0.92046	P01116	G60R	Gain of catalytic residue at L56 (P = 0.1064)| Gain of phosphorylation at T58 (P = 0.1068)| Loss of glycosylation at T58 (P = 0.123)| Gain of solvent accessibility (P = 0.1319)| Gain of loop (P = 0.2045)	0.995530386705	0.99541	0.9776364459571039	0.97742	2.98422368777	0.99182	0.947138845921	0.99682	D	0.960754	0.99490	D	0.541091	0.95437	D	0.539464	0.95369	D	0.999921560287476	0.99730	D	0.89791	0.64215	D	0.9893387	0.99724	0.98382205	0.99902	0.98968154	0.99743	0.9740602	0.99623	-12.016	0.88337	D	0.9998	0.99795	P	0.999979503899075	0.99427	0.99919980	0.99211	1	0.99985	.	.	.	.	.	.	5.208984	0.87425	29.2	0.99936203639780719	0.99621	0.908603	0.86363	D	1.15990254133055	0.99090	20.65427	1.0558655561841	0.99443	22.78603	5.77	5.77	0.91065	3.95	0.75212	7.892	0.85894	7.701000	0.66341	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	855	0.34655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Cardiofaciocutaneous_syndrome_2|Inborn_genetic_diseases|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_3|not_provided|RASopathy|Noonan_syndrome	reviewed_by_expert_panel	NC_000012.12:g.25227346C>G	ClinGen:CA273416|OMIM:190070.0009|UniProtKB:P01116#VAR_026112	C3809005|C0950123|C1275081|C1860991|C3661900|C5555857|C0028326	615278|PS115150|609942|PS163950	1340|1340|648|536391|648	Small GTP-binding domain	Gly	Arg	82.99	0.10714285714285714																																																																																																																																																																																					2.33	4 mutation(s) (Gly60Ala: 2.365, Gly60Arg: 2.384, Gly60His: 2.601, Gly60Glu: 2.710)					0.296						-0.355						-0.843				-0.652				-0.97		-0.459		-0.518						-1.207						0.18		1.421		1.601		0.68		0.58																																																																																																																																																																																																																																						9			82.99	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine	GTP	GTPase KRas; GTPase KRas, N-terminally processed								0.7716		-0.4									G60-R68 (PDBs: 5V9O, 6YXW, 7NY8), G60-Y96 (PDBs: 6GJ6, 6ZL5, 3GFT, 5UK9, 6MNX, 6O46, 7ACA), G60-T35 (PDBs: 6T5B, 7R0M), G60-P34 (PDBs: 6T5V, 7R0N, 8AQ5, 8B78, 8AQ7, 8UN5), G60-E37 (PDBs: 5V9L, 2MSC), G60-D12 (PDBs: 6W4F)		G60-E37 (PDBs: 5V9O, 8AFB, 4LUC, 5V9L, 8ECR, 2MSC), G60-P34 (PDBs: 6MBQ, 6T5V, 8B78, 8AQ7, 8B6I, 8QVU), G60-T35 (PDBs: 6T5B, 7R0N, 8AQ5, 8JHL, 7R0M, 8UN5), G60-D12 (PDBs: 6ZL5, 6W4F), G60-R68 (PDBs: 4LYH), G60-G10 (PDBs: 6VC8, 8T71, 8TBF), G60-A11 (PDBs: 8T72, 8T74, 8T75, 8TBF), G60-G12 (PDBs: 8TBF)							75									-95.8		Pocket 1: Mean pLDDT: 82.52, Volume: 1126.64 Å³, Druggability score: 0.77		-10.0				dbSNP: rs104894359; Variant type: LP/P; AA change: Gly60Arg; PTM type: Phosphorylation; PTM morphology: AG*QEEySAMRD; Var class: II&rs104894359		C (loop/coil)	C (loop/coil)	Helix											82.99	10.714286	70-90	10-90	615278;609942	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	CARDIOFACIOCUTANEOUS SYNDROME 2; NOONAN SYNDROME 3	true	0.9013310838275048	0.9055479401566127	false	false	false
FH	FH_Arg233Cys	B_13-14	0.840040754452072	0.4330774414127768	0.526194601207636	-0.6823690990205227	0.5169422876274314	0.5714392155399618	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8052616050458954	0.7702711306823569	0.5132628095000618	0.7061210945417449	0.5071434025824599	0.5851118146919484	0.5762573893543866	0.4271769594045485	0.6702964963090456	0.4618133702872831	0.746723922268297	0.7947013642865562	0.5939662400295102	0.5871098457603713	0.741945692774444	0.5647122487128404	0.7938183390964167	0.8158218458052345	FH	Arg233Cys	NC_000001.11:241508644:G:A	697C>T	1	241508644	G	A	1	ENSG00000091483	3408	0	CCSBVarC004049	ALE00004049	ENSP00000355518.4	CEGS2	CegsMutGDEh1039	B12	GDEhDisVCh_40065	D08	1	CegsMutGDDh1039	B12	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	151069.0	single nucleotide variant	NM_000143.4(FH):c.697C>T (p.Arg233Cys)	2271.0	FH	HGNC:3700	Pathogenic	1.0	Nov 17, 2023	587781682.0	-	RCV000129845|RCV000153237|RCV000549060	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Hereditary cancer-predisposing syndrome|not provided|Fumarase deficiency	germline;unknown	germline	GRCh38	NC_000001.11	1	241508644.0	241508644.0	1q43	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA165194	2.0	141355.0	241508644.0	G	A	-	-	-	-	-	-	697C>T 	Arg233Cys	NM_000143.4	2.0	Pathogenic	Pathogenic	141355	1	241508644.0	G	A	R	C	rs587781682	1	241671944	1	239738567	233	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.697C>T	p.Arg233Cys	c.697C>T	p.Arg233Cys	principal1	Y	1	YES	Select	-	CGT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	5.07	0.99905	H	-7.81	0.95967	D	0.962	0.97221	0.9273	0.96051	D	0.9945	0.99874	D	10	0.9892357	0.99374	D	0.699957	0.97538	D	0.949	0.99024	0.89	0.97304	P07954	R233C	Loss of catalytic residue at R233 (P = 0.0152)| Loss of phosphorylation at T236 (P = 0.0683)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of MoRF binding (P = 0.0767)| Loss of methylation at K230 (P = 0.1519)	0.967472502496	0.96682	0.9655328358886819	0.96521	1.15023203385	0.79062	0.858424127102	0.90864	D	0.994652	0.99988	D	0.592007	0.97345	D	0.612601	0.97303	D	0.999971151351929	0.99958	D	0.994141	0.98073	D	0.97714406	0.98865	0.9070807	0.95418	0.97714406	0.98865	0.9070807	0.95418	-13.351	0.90777	D	0.9741	0.90045	P	0.999896646635663	0.98645	0.93132580	0.92451	1	0.99985	.	.	.	.	.	.	5.655055	0.92846	33.0	0.99925707796903818	0.99043	0.944500	0.95149	D	1.1397818748542	0.98799	19.44741	1.00471014856407	0.98709	19.13286	5.65	5.65	0.86862	5.55	0.94672	9.516	0.97049	8.562000	0.77604	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.947	0.4917	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	1613696	3.718170e-06	0	1	29598	3.378610e-05	0	1	74894	1.335220e-05	0	0	912	0.000000e+00	0	0	59986	0.000000e+00	0	1	29598	3.378610e-05	0	0	44874	0.000000e+00	0	0	64016	0.000000e+00	0	0	6080	0.000000e+00	0	3	1179784	2.542840e-06	0	0	91076	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241508644G>A	ClinGen:CA165194	C0342770|C0027672|C3661900	606812	24|140162	Fumarate lyase, N-terminal	Arg	Cys	98.76	0.29838709677419356																																																																																																																																																																																																																																																																																																																																																																																																																																																																													74			98.76	Positively-charged	Arginine		Fumarate hydratase, mitochondrial								0.0745		-4.5			C:R233-B:E404 (PDBs: 3E04), B:R233-A:E404 (PDBs: 5UPP, 7LUB), A:R233-B:E404 (PDBs: 7LUB)	C:R233-B:E404 (PDBs: 3E04), B:R233-A:E404 (PDBs: 5UPP, 7LUB), A:R233-B:E404 (PDBs: 7LUB)				 R233-E355 (PAE:  1.0)	R233-E355 (PDBs: 5D6B, 3E04, 5UPP, 7LUB)			 R233-E355 (PAE:  1.0)	R233-E355 (PDBs: 5D6B, 3E04, 5UPP, 7LUB)					175									-131.5		Pocket 2: Mean pLDDT: 99.39, Volume: 605.37 Å³, Druggability score: 0.07		124.2				dbSNP: rs121913123; Variant type: LP/P; AA change: Arg233His; PTM type: Ubiquitylation; PTM morphology: FAQIIkIGR*TH; Var class: II&rs121913123		B (undefined)	E (parallel sheets)	Beta strand											98.76	29.83871	>90	10-90	606812	autosomal recessive	OMIM	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	FUMARASE DEFICIENCY	false	0.7702711306823569	0.8052616050458954	false	false	false
SMAD3	SMAD3_Arg287Trp	B_15-16	-7.486942662719075	0.003293249393341989	0.0100736126684802	-4.405254917341486	0.004974070196163054	0.009030232298509362	2025_03_Batch_15-16	false	false	false	true	false	false	false	false	false	false	false	false	0.8295452834173038	0.8447009358764193	0.6282867584329564	0.8807629138289761	0.8093092922772203	0.7070196870082677	0.8020085666109761	0.8960185940128566	0.9400271126311175	0.7405521826104996	0.9553201676058756	0.933377221035724	0.6120308074055594	0.722599990541584	0.8214987150268348	0.5160213342554133	0.7340817041469628	0.7257133457988836	SMAD3	Arg287Trp	NC_000015.10:67181441:C:T	859C>T	15	67181441	C	T	15	ENSG00000166949	11805	2158	CCSBVarC004697	ALE00004697	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	A03	GDEhDisVCh_40014	F09	2	VUSMutGDDh005	A03	VUSN2Hmut_GDN2h_01	C12	VUSMutpDEST2_09	E05	VUSmut_GDEh01	C12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	39262.0	single nucleotide variant	NM_005902.4(SMAD3):c.859C>T (p.Arg287Trp)	4088.0	SMAD3	HGNC:6769	Pathogenic/Likely pathogenic	1.0	May 30, 2024	387906850.0	-	RCV000023241|RCV000195645|RCV002276569|RCV000699559	MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984|MedGen:C3661900|MONDO:MONDO:0020066,MedGen:C0013720,OMIM:PS130000,Orphanet:98249|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Aneurysm-osteoarthritis syndrome|not provided|Ehlers-Danlos syndrome|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000015.10	15	67181441.0	67181441.0	15q22.33	criteria provided, multiple submitters, no conflicts	8.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020130,UniProtKB:P84022#VAR_065579,OMIM:603109.0001	3.0	30306.0	67181441.0	C	T	-	-	-	-	-	-	859C>T 	Arg287Trp	NM_005902.4	2.0	Pathogenic	Likely pathogenic	30306	15	67181441.0	C	T	R	W	rs387906850	15	67473779	15	65260833	287	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.859C>T	p.Arg287Trp	c.859C>T	p.Arg287Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.96253	A	simple_aae	7.0	93.0	4.135	0.97453	H	-7.7	0.95993	D	0.984	0.99346	1.0015	0.97205	D	0.9916	0.99788	D	10	0.99082774	0.99592	D	0.808163	0.98499	D	0.871	0.96123	0.918	0.98488	P84022	R287W	Gain of catalytic residue at L285 (P = 0.037)| Loss of methylation at R292 (P = 0.0532)| Loss of disorder (P = 0.0834)| Loss of phosphorylation at T286 (P = 0.1256)| Loss of MoRF binding (P = 0.1272)	0.987331868429	0.98705	0.9507416294212974	0.95027	2.49711821215	0.97592	0.935320854187	0.99261	D	0.994394	0.99986	D	0.511355	0.94581	D	0.49675	0.94501	D	0.99613744020462	0.88642	D	0.994978	0.98316	D	0.9603582	0.97273	0.83641857	0.90480	0.9070717	0.91908	0.84299254	0.90919	-12.77	0.88419	D	0.9994	0.99584	P	0.999260505500382	0.96103	0.99548775	0.97798	0.946	0.97496	.	.	.	.	.	.	3.050297	0.41006	21.3	0.99520808342563494	0.69261	0.341228	0.43589	N	-0.141986997461491	0.35301	2.045245	-0.461702466839317	0.22902	1.26501	5.1	-1.19	0.09068	0.1	0.22238	0.667	0.24883	0.361000	0.17646	-0.195	0.09113	0.091	0.22678	0.010000	0.20072	0.018	0.11182	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613160	6.199010e-07	0	1	1179892	8.475350e-07	0	0	75032	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29608	0.000000e+00	0	0	44872	0.000000e+00	0	0	63372	0.000000e+00	0	0	5924	0.000000e+00	0	1	1179892	8.475350e-07	0	0	91048	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Ehlers-Danlos_syndrome|not_provided|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Aneurysm-osteoarthritis_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.67181441C>T	ClinGen:CA020130|OMIM:603109.0001|UniProtKB:P84022#VAR_065579	C0013720|C3661900|C4707243|C3151087	PS130000|PS607086|613795	98249|91387|284984	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Arg	Trp	98.55	0.10887096774193548																																																																																																																																																																																																																																																																																																																																																																																																																																																																													27			98.55	Positively-charged	Arginine		Mothers against decapentaplegic homolog 3							MH2			-4.5								 R287-G272 (PAE:  1.0), R287-L271 (PAE: 1.0), R287-V283 (PAE: 1.0), R287-Y237 (PAE: 1.0), R287-E239 (PAE: 1.0)	R287-L271 (PDBs: 1MJS, 5XOC), R287-V283 (PDBs: 1MJS, 5XOC), R287-Y237 (PDBs: 1MJS, 1MK2, 5XOC)	 R287-C394 (PAE:  1.0), R287-V283 (PAE: 1.0), R287-G272 (PAE: 1.0)	R287-C394 (PDBs: 1MJS, 5XOC), R287-V283 (PDBs: 1MJS, 5XOC), R287-G272 (PDBs: 1MJS, 1MK2, 5XOC)	 R287-E239 (PAE:  1.0)						175									-55.6				-41.1	Sufficient for interaction with XPO4					H (helix)	H (α-helix)	Helix											98.55	10.887096	>90	10-90	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	false	0.8447009358764193	0.8295452834173038	false	false	false
GCK	GCK_Arg377His	B_7-8	4.463238968736741	0.020946807553891982	0.046903168145291545	3.039786887948162	0.055876722988605396	0.07827006617106176	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6927539453820138	0.7559413553368997	0.543565728472742	0.647242119151319	0.6140021285473942	0.5931577637991521	0.5931577637991521	0.6140021285473942	0.647242119151319	0.543565728472742	0.7559413553368997	0.6927539453820138							GCK	Arg377His	NC_000007.14:44145620:C:T	1130G>A	7	44145620	C	T	7	ENSG00000106633	3689	214856	CCSBVarC006696	ALE00006694	ENSP00000384247.3	CEGS2	CegsMutGDEh1044	C05	GDEhDisVCh_40037	G02	1	CegsMutGDDh1044	C05	VUSN2Hmut_GDN2h_09	G05	VUSMutpDEST2_03	G09	VUSmut_GDEh09	G05	1.0	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	44840.0	single nucleotide variant	NM_000162.5(GCK):c.1130G>A (p.Arg377His)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Aug 08, 2023	193922264.0	-	RCV000029839|RCV000518143|RCV001818186|RCV002321490|RCV003325945	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:CN169374|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Maturity-onset diabetes of the young type 2|not specified|not provided|Maturity onset diabetes mellitus in young|Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44145620.0	44145620.0	7p13	reviewed by expert panel	6.0	-	N	ClinGen:CA213715	2.0	36176.0	44145620.0	C	T	-	-	-	-	-	-	1130G>A 	Arg377His	NM_000162.5	3.0	Pathogenic	Likely pathogenic	36176	7	44145620.0	C	T	R	H	rs193922264	7	44185219	7	44151744	377	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.1130G>A	p.Arg377His	c.1130G>A	p.Arg377His	principal1	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.012	0.91343	D	0.016	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.665	0.94230	H	-4.58	0.80373	D	0.987	0.99555	0.9513	0.96403	D	0.9919	0.99799	D	10	0.9927044	0.99805	D	0.92279	0.99432	D	0.981	0.99874	0.998	0.99980	P35557	R377H	Loss of MoRF binding (P = 0.0301)| Loss of methylation at R377 (P = 0.1359)| Loss of disorder (P = 0.1407)| Loss of phosphorylation at S375 (P = 0.166)| Gain of glycosylation at T376 (P = 0.2133)	0.991665179887	0.99147	.	0.99511	.	0.97457	0.870703577995	0.92657	D	0.968607	0.99641	D	0.563151	0.96263	D	0.571151	0.96204	D	0.999769032001495	0.98872	D	0.861414	0.55397	D	0.96201694	0.97442	0.6692838	0.80380	0.94607353	0.95801	0.783297	0.87071	-14.066	0.93311	D	0.9367	0.85569	P	0.993254127371425	0.89946	0.99981445	0.99752	0.981	0.99334	.	.	.	.	.	.	5.982029	0.94261	34.0	0.9994390743564775	0.99869	0.938367	0.93723	D	0.933056278161452	0.93244	11.93765	0.826275423044149	0.91512	10.94791	5.2	5.2	0.71681	.	.	6.104	0.71225	7.529000	0.59950	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.957	0.51031	716	0.55914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50	0	0	424	0	0	0	0	0	474	0	not_provided|Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young|Monogenic_diabetes|not_specified	reviewed_by_expert_panel	NC_000007.14:g.44145620C>T	ClinGen:CA213715	C3661900|C0342277|C0342276|C3888631|CN169374	125851|606391	552|552|183625	Hexokinase, C-terminal	Arg	His	98.72	0.020161290322580645																																																																																																											-0.011	1 mutation(s) (Arg377Met: -0.647)	-0.094	4 mutation(s) (Arg377Glu: -0.752, Arg377Ala: -0.485, Arg377Ile: -0.458, Arg377Cys: -0.416)																																																																																																																																																																																																																																																																																																																																																															5			98.72	Positively-charged	Arginine		Hexokinase-4							Hexokinase			-4.5								 R377-D274 (PAE:  1.5), R377-M381 (PAE: 1.0), R377-S373 (PAE: 1.0)	R377-S373 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I), R377-D274 (PDBs: 6E0I, 4LC9), R377-M381 (PDBs: 6E0I, 4LC9)	 R377-F23 (PAE:  1.0), R377-M381 (PAE: 1.0), R377-S373 (PAE: 1.0)	R377-M381 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9), R377-S373 (PDBs: 4ISG, 6E0I, 4LC9), R377-F23 (PDBs: 6E0I), R377-L292 (PDBs: 6E0I, 4LC9)	 R377-D274 (PAE:  1.5)	R377-D274 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9)					175									-59.5				-44.5	Hexokinase large subdomain			dbSNP: rs193922264; Variant type: LP/P; AA change: Arg377His; PTM type: Phosphorylation; PTM morphology: CEsVstR*AAHM; Var class: II&rs193922264		H (helix)	H (α-helix)	Helix											98.72	2.016129	>90	<10	125851;606391	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism	3	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MATURITY-ONSET DIABETES OF THE YOUNG	false	0.7559413553368997	0.6927539453820138	false	false	false
DES	DES_Leu274Pro	B_7-8	-1.8696759085644523	0.13488166449166744	0.20776127353152	2.81079787704624	0.02611598624414971	0.03980301890200558	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9302383628069442	0.853878293468105	0.867920351763554	0.6503211386835221	0.6313195645841728	0.916886204191393	0.916886204191393	0.6797498131937263	0.742750703431803	0.867920351763554	0.8779435513755699	0.9302383628069442		0.5828893159746193	0.5578915739352412		0.82981303556064		DES	Leu274Pro	NC_000002.12:219420580:T:C	821T>C	2	219420580	T	C	2	ENSG00000175084	12573	203769	CCSBVarC006504	ALE00006503	ENSP00000363071.3	CEGS2	CegsMutGDEh1046	C10	GDEhDisVCh_40092	C01	1	CegsMutGDDh1046	C10	VUSN2Hmut_GDN2h_10	A03	NULL	NULL	VUSmut_GDEh10	A03	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	77318.0	single nucleotide variant	NM_001927.4(DES):c.821T>C (p.Leu274Pro)	1674.0	DES	HGNC:2770	Likely pathogenic	1.0	Nov 05, 2024	267607494.0	-	RCV000056812|RCV004776428	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219420580.0	219420580.0	2q35	criteria provided, single submitter	2.0	ACMG2022	N	ClinGen:CA217087	2.0	66421.0	219420580.0	T	C	-	-	-	-	-	-	821T>C 	Leu274Pro	NM_001927.4	1.0	Pathogenic	Likely pathogenic	66421	2	219420580.0	T	C	L	P	rs267607494	2	220285302	2	219993546	274	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.821T>C	p.Leu274Pro	c.821T>C	p.Leu274Pro	principal1	Y	1	YES	Select	+	CTC	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	D	simple_aae	0.0	100.0	4.655	0.99370	H	-6.44	0.91373	D	0.986	0.99488	1.0881	0.99163	D	0.9371	0.97926	D	10	0.9871803	0.99059	D	0.537999	0.95677	D	0.973	0.99718	0.908	0.98098	P17661	L274P	Loss of stability (P = 0.0067)| Gain of disorder (P = 0.0148)| Gain of glycosylation at T271 (P = 0.0401)| Loss of MoRF binding (P = 0.0795)| Gain of phosphorylation at T271 (P = 0.1296)	0.997827063075	0.99777	0.9816966289030933	0.98153	1.86334380764	0.92395	0.866387724876	0.92034	D	0.939485	0.99028	D	0.533942	0.95249	D	0.529194	0.95179	D	0.999724090099335	0.98666	D	0.987835	0.95891	D	0.98919255	0.99716	0.96906954	0.99415	0.98919255	0.99716	0.96906954	0.99415	-16.823	0.98757	D	0.9997	0.99393	P	0.999976731969185	0.99427	0.99877520	0.98953	0.995	0.99826	.	.	.	.	.	.	6.033221	0.94401	34.0	0.99924962160840591	0.98981	0.990494	0.99995	D	0.975752015604632	0.94921	13.17739	0.845445444208996	0.92707	11.6078	4.67	4.67	0.58039	4.05	0.77340	8.017	0.8876	7.938000	0.75400	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.987	0.62545	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	no_classification_provided	NC_000002.12:g.219420580T>C	ClinGen:CA217087	CN517202	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Pro	83.15	0.6097560975609756																																																																																																																																																																																																																																																																																																																																																																																																																																																																													100			83.15	Aliphatic	Leucine		Desmin							IF rod			3.8								 L274-L270 (PAE:  3.0), L274-R278 (PAE: 1.5)		 L274-L270 (PAE:  3.0), L274-R278 (PAE: 1.5)								131									-65.2				-39.7	Interaction with NEB; Coil 2A					H (helix)	H (α-helix)												83.15	60.975613	70-90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.853878293468105	0.9302383628069442	false	false	false
DES	DES_Leu136Pro	B_7-8	-0.18547341085754296	0.8601469817836266	0.8899678955616072	1.3976239000425987	0.20492360964554424	0.2500231540555676	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9141093313543259	0.8690156101696132	0.7342846579726275	0.7128797331896561	0.6729328932291336	0.7575792665191453	0.9501700610859635	0.9202866014489753	0.9565796832758121	0.8918903468485766	0.8862511668045537	0.9263505439951123	0.5649884719523272	0.42557918500929204	0.4691797831035003	0.5766789690966785	0.8517800535346725	0.9018681187135396	DES	Leu136Pro	NC_000002.12:219418869:T:C	407T>C	2	219418869	T	C	2	ENSG00000175084	12573	2251	CCSBVarC007813	ALE00007799	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	C04	GDEhDisVCh_40003	E04	1	VUSMutGDDh003	C04	VUSN2Hmut_GDN2h_01	F02	NULL	NULL	VUSmut_GDEh01	F02	1.0	6.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	N	Y	Y	N	Y	260526.0	single nucleotide variant	NM_001927.4(DES):c.407T>C (p.Leu136Pro)	1674.0	DES	HGNC:2770	Likely pathogenic	1.0	May 01, 2016	397516695.0	-	RCV000491641|RCV001701986	MONDO:MONDO:0013262,MedGen:C1834481,OMIM:613426,Orphanet:154,Orphanet:54260|MedGen:C3661900	Dilated cardiomyopathy 1S|not provided	germline;inherited	germline	GRCh38	NC_000002.12	2	219418869.0	219418869.0	2q35	no assertion criteria provided	3.0	ACMG2022	N	ClinGen:CA350685955	2.0	265811.0	219418869.0	T	C	-	-	-	-	-	-	407T>C 	Leu136Pro	NM_001927.4		Pathogenic	Likely pathogenic	265811	2	219418869.0	T	C	L	P	rs397516695	2	220283591	2	219991835	136	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.407T>C	p.Leu136Pro	c.407T>C	p.Leu136Pro	principal1	Y	1	YES	Select	+	CTC	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.996	0.84488	D	0.96	0.95575	A	simple_aae	4.0	96.0	4.955	0.99828	H	-6.22	0.90468	D	0.981	0.99110	1.0961	0.99494	D	0.9548	0.98532	D	10	0.9932954	0.99861	D	0.64302	0.96956	D	0.980	0.99858	0.912	0.98259	P17661	L136P	Gain of glycosylation at L136 (P = 0.0279)| Loss of stability (P = 0.0332)| Gain of disorder (P = 0.0353)| Loss of MoRF binding (P = 0.0594)| Loss of helix (P = 0.5596)	0.980559037756	0.98015	0.9980046597324734	0.99799	2.54581013605	0.97829	0.800633728504	0.82027	T	0.954603	0.99363	D	0.549466	0.95658	D	0.551493	0.95593	D	0.999285519123077	0.96791	D	0.989451	0.96545	D	0.9805685	0.99138	0.9728855	0.99577	0.9805685	0.99138	0.9728855	0.99578	-11.446	0.82103	D	0.9973	0.96856	P	0.999708552119574	0.97565	0.99813384	0.98645	0.971	0.98885	.	.	.	.	.	.	5.840479	0.93786	33.0	0.99873788122613993	0.95079	0.988678	0.99988	D	0.957807567655431	0.94258	12.64446	0.825578028626543	0.91466	10.92486	4.69	4.69	0.58495	4.05	0.77340	7.836	0.85042	7.711000	0.66857	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.954	0.50428	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1574354	6.351810e-07	0	1	1160570	8.616460e-07	0	0	74182	0.000000e+00	0	0	912	0.000000e+00	0	0	53536	0.000000e+00	0	0	28954	0.000000e+00	0	0	42746	0.000000e+00	0	0	60400	0.000000e+00	0	0	5968	0.000000e+00	0	1	1160570	8.616460e-07	0	0	86018	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Dilated_cardiomyopathy_1S|not_provided	no_assertion_criteria_provided	NC_000002.12:g.219418869T>C	ClinGen:CA350685955	C1834481|C3661900	613426	154|54260	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Pro	94.54	0.5975609756097561																																																																																																																																																																																																																																																																																																																																																																																																																																																																													98			94.54	Aliphatic	Leucine		Desmin							IF rod			3.8								 L136-V140 (PAE:  1.0), L136-Q132 (PAE: 1.5)		 L136-V140 (PAE:  1.0), L136-Q132 (PAE: 1.5)								131									-63.1				-40.8	Coil 1A					H (helix)	H (α-helix)												94.54	59.7561	>90	10-90	613426	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	CARDIOMYOPATHY, DILATED, 1S	false	0.8690156101696132	0.9141093313543259	false	false	false
POMT1	POMT1_Ala200Pro	B_7-8	-2.824313046750751	0.036920787952894434	0.0726248249124906	-8.946471667899907	0.00010887044834087447	0.00043301741348265155	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7548613123052665	0.8430081001420595	0.4610025945727932	0.5166827122341195	0.539281540798259	0.47559857063409816	0.5318052554672396	0.48123589022315577	0.5054572008730399	0.5325942259313915	0.8112735025157928	0.6928604744150495	0.41939188580095677	0.5973271913733621	0.5279082235951992	0.3894109632141949	0.8747426977683261	0.8168621501954835	POMT1	Ala200Pro	NC_000009.12:131509801:G:C	598G>C	9	131509801	G	C	9	ENSG00000130714	71206	205718	CCSBVarC003246	ALE00003246	ENSP00000385797.4	CEGS2	CegsMutGDEh1037	G09	GDEhDisVCh_40022	H07	2	CegsMutGDDh1037	G09	VUSN2Hmut_GDN2h_07	C09	NULL	NULL	VUSmut_GDEh07	C09	1.0	1.0	1.0	7.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	18282.0	single nucleotide variant	NM_001077365.2(POMT1):c.598G>C (p.Ala200Pro)	10585.0	POMT1	HGNC:9202	Pathogenic/Likely pathogenic	1.0	Nov 01, 2024	119462982.0	-	RCV000003399|RCV001385876|RCV000179928|RCV001264826|RCV003234890|RCV003472966|RCV001813942	MONDO:MONDO:0012248,MedGen:C1836373,OMIM:609308,Orphanet:86812|MONDO:MONDO:0013159,MedGen:C5436962,OMIM:613155;MONDO:MONDO:0012248,MedGen:C1836373,OMIM:609308,Orphanet:86812;MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899|MedGen:C3661900|MONDO:MONDO:0013159,MedGen:C5436962,OMIM:613155|MONDO:MONDO:0015152,MedGen:C2931907,OMIM:PS253600,Orphanet:102015|MONDO:MONDO:0009364,MedGen:C4284790,OMIM:236670,Orphanet:588,Orphanet:899|Human Phenotype Ontology:HP:0000707,Human Phenotype Ontology:HP:0001333,Human Phenotype Ontology:HP:0006987,MONDO:MONDO:0002320,MedGen:C0497552	Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy|not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1|Autosomal recessive limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Abnormality of the nervous system	biparental;germline;unknown	germline	GRCh38	NC_000009.12	9	131509801.0	131509801.0	9q34.13	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA203493,UniProtKB:Q9Y6A1#VAR_022661,OMIM:607423.0005	3.0	3243.0	131509801.0	G	C	-	-	-	-	-	-	598G>C 	Ala200Pro	NM_001077365.2	2.0	Pathogenic	Likely pathogenic	3243	9	131509801.0	G	C	A	P	rs119462982	9	134385188	9	133375009	200	POMT1	ENSG00000130714	ENST00000372228	ENSP00000361302	Q9Y6A1	POMT1_HUMAN	c.598G>C	p.Ala200Pro	c.598G>C	p.Ala200Pro	.	Y	1	.	.	+	GCA	1	0	G	G/G	G/G	G/G	G/G	0.004	0.65576	D	0.007	0.70891	D	1.0	0.90580	D	0.992	0.82066	D	0.94	0.95575	A	simple_aae	6.0	94.0	3.7	0.94529	H	-3.92	0.73186	D	0.951	0.95970	0.9625	0.96574	D	0.8643	0.95477	D	9	0.9842629	0.98596	D	0.248059	0.88968	D	0.831	0.94638	0.933	0.98984	Q9Y6A1	A200P	Loss of stability (P = 0.0656)| Loss of ubiquitination at K204 (P = 0.0834)| Loss of helix (P = 0.1299)| Gain of methylation at K204 (P = 0.1626)| Loss of catalytic residue at A200 (P = 0.1738)	0.969713300421	0.96910	0.8250960605394505	0.82362	0.998285732466	0.74171	0.418078869581	0.27540	T	0.94372	0.99126	D	0.42462	0.91196	D	0.387647	0.91637	D	0.982199788093567	0.74167	D	0.913509	0.69696	D	0.95897686	0.97132	0.88475686	0.93813	0.93275356	0.94430	0.90887636	0.95548	-13.378	0.90879	D	0.9142	0.83718	P	0.992384925668815	0.89485	0.95561610	0.93694	0.3	0.56822	.	.	.	.	.	.	2.976385	0.39768	21.0	0.99716169404523058	0.81721	0.594921	0.58821	D	0.360177384703055	0.59068	4.106014	0.165196934421636	0.47686	3.017929	5.63	3.78	0.42561	1.21	0.31149	2.568	0.45729	3.059000	0.36234	0.676	0.76753	0.994	0.38383	0.999000	0.35501	0.044	0.14692	397	0.82899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109408	9.140100e-06	0	2	208136	9.609100e-06	0	1	236958	4.220160e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	2	89558	2.233190e-05	0	0	30608	0.000000e+00	0	2	89558	2.233190e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102754	9.731980e-06	0	0	30526	0.000000e+00	0	1	102754	9.731980e-06	0	.	8	1614224	4.955940e-06	0	5	1180046	4.237120e-06	0	0	75052	0.000000e+00	0	0	912	0.000000e+00	0	0	60026	0.000000e+00	0	0	29606	0.000000e+00	0	0	44890	0.000000e+00	0	0	64040	0.000000e+00	0	0	6062	0.000000e+00	0	5	1180046	4.237120e-06	0	0	91078	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2K|Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),_type_A1|not_provided|Abnormality_of_the_nervous_system|Muscular_dystrophy-dystroglycanopathy_(congenital_with_intellectual_disability),_type_B1|Walker-Warburg_congenital_muscular_dystrophy|Autosomal_recessive_limb-girdle_muscular_dystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.131509801G>C	ClinGen:CA203493|OMIM:607423.0005|UniProtKB:Q9Y6A1#VAR_022661	C1836373|C4284790|C3661900|C0497552|C5436962|C0265221|C2931907	609308|236670|613155|PS236670|PS253600	86812|588|899|899|102015	Glycosyl transferase family 39/83	Ala	Pro	97.84	0.009433962264150943																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			97.62	Aliphatic	Alanine		Protein O-mannosyl-transferase 1										1.8								 A200-K204 (PAE:  1.0), A200-A196 (PAE: 1.0)		 A200-A196 (PAE:  1.0), A200-L159 (PAE: 1.0), A200-K204 (PAE: 1.0), A200-G207 (PAE: 1.5), A200-N163 (PAE: 1.0)								89									-60.6				-49.6						H (helix)	H (α-helix)									Helical			97.84	0.9433962	>90	<10	609308;613155;609308;613155;236670	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1	false	0.8430081001420595	0.7548613123052665	false	false	false
GCK	GCK_Arg303Trp	B_7-8	7.216216216216216	0.005486614190920422	0.017151281677018012	17.450083207724287	0.00041017341683726013	0.001189049320531394	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7387103692229546	0.7544354689666777	0.6842419564782738	0.7034279868323933	0.6203135593974423	0.71658428777882	0.71658428777882	0.6203135593974423	0.7034279868323933	0.6842419564782738	0.7544354689666777	0.7387103692229546							GCK	Arg303Trp	NC_000007.14:44146575:G:A	907C>T	7	44146575	G	A	7	ENSG00000106633	3689	214847	CCSBVarC006693	ALE00006691	ENSP00000384247.3	CEGS2	CegsMutGDEh1045	B08	GDEhDisVCh_40037	C05	1	CegsMutGDDh1045	B08	VUSN2Hmut_GDN2h_09	E10	VUSMutpDEST2_03	D09	VUSmut_GDEh09	E10	1.0	1.0	1.0	1.0	1.0	1.0	7.0	1.0	6.0	1.0	1.0	1.0	1.0	Y	Y	Y	N	Y	44928.0	single nucleotide variant	NM_000162.5(GCK):c.907C>T (p.Arg303Trp)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Oct 20, 2023	193922336.0	-	RCV000029927|RCV002371788|RCV000711788	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552|MedGen:C3661900	Maturity-onset diabetes of the young type 2|Maturity onset diabetes mellitus in young|not provided	germline	germline	GRCh38	NC_000007.14	7	44146575.0	44146575.0	7p13	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA213862	2.0	36264.0	44146575.0	G	A	-	-	-	-	-	-	907C>T 	Arg303Trp	NM_000162.5	2.0	Pathogenic	Likely pathogenic	36264	7	44146575.0	G	A	R	W	rs193922336	7	44186174	7	44152699	303	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.907C>T	p.Arg303Trp	c.907C>T	p.Arg303Trp	principal1	Y	1	YES	Select	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.996	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.91	0.96121	H	-7.43	0.95620	D	0.984	0.99346	1.0240	0.97601	D	0.9827	0.99470	D	10	0.9946202	0.99953	D	0.874274	0.99037	D	0.971	0.99671	0.983	0.99835	P35557	R303W	Gain of catalytic residue at L301 (P = 0.0054)| Loss of MoRF binding (P = 0.2334)| Loss of methylation at R303 (P = 0.529)| Loss of helix (P = 0.5596)| Loss of disorder (P = 0.704)	0.990771566325	0.99056	.	0.99530	.	0.96238	0.825230181217	0.85806	D	0.963923	0.99552	D	0.535654	0.95277	D	0.531653	0.95208	D	0.999597728252411	0.98050	D	0.99598	0.98629	D	0.9196614	0.93114	0.86529386	0.92441	0.9396137	0.95135	0.86898375	0.92699	-14.04	0.93199	D	0.9475	0.89484	P	0.999429393664456	0.96550	0.99983537	0.99792	0.981	0.99334	.	.	.	.	.	.	5.83412	0.9376	33.0	0.999174190492922	0.98519	0.892615	0.82911	D	0.801043153705935	0.86095	8.800712	0.663109094355815	0.79479	7.114674	4.77	3.78	0.42561	1.37	0.32764	3.129	0.5029	3.042000	0.36167	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.956	0.50825	712	0.56407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612312	6.202270e-07	0	1	62198	1.607770e-05	0	0	75046	0.000000e+00	0	0	912	0.000000e+00	0	0	60032	0.000000e+00	0	0	29602	0.000000e+00	0	0	44862	0.000000e+00	0	1	62198	1.607770e-05	0	0	6062	0.000000e+00	0	0	1180014	0.000000e+00	0	0	91086	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2642	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2726	0	0	142	0	0	11338	0	not_provided|Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.44146575G>A	ClinGen:CA213862	C3661900|C0342277|C0342276	125851|606391	552|552	Hexokinase, C-terminal	Arg	Trp	98.7	0.056451612903225805																																																																																																											0.151		0.152																																																																																																																																																																																																																																																																																																																																																																14			98.7	Positively-charged	Arginine		Hexokinase-4							Hexokinase			-4.5								 R303-L324 (PAE:  1.0), R303-L307 (PAE: 1.0), R303-G299 (PAE: 1.0)	R303-G299 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9), R303-L324 (PDBs: 6E0I, 4LC9), R303-L307 (PDBs: 6E0I, 4LC9)	 R303-L307 (PAE:  1.0), R303-G328 (PAE: 1.0), R303-G299 (PAE: 1.0)	R303-G299 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4NO7, 4RCH, 6E0I, 4LC9), R303-F330 (PDBs: 4MLH), R303-L307 (PDBs: 6E0I, 4LC9)	 R303-E300 (PAE:  1.0)	R303-E300 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9)					175									-54.0				-46.0	Hexokinase large subdomain					H (helix)	H (α-helix)	Helix											98.7	5.645161	>90	<10	125851;606391	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism	3	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MATURITY-ONSET DIABETES OF THE YOUNG	false	0.7544354689666777	0.7387103692229546	false	false	false
STAR	STAR_Arg182His	B_7-8	0.41576092031014994	0.717948717948718	0.7760509628081784	1.0236908321022704	0.3454697772868937	0.39870254171160374	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6095382061030685	0.6477688721824479	0.6766590126714753	0.6312205121184935	0.6775197989934281	0.7654358446032922	0.7654358446032922	0.7853340469368394	0.7595826826078887	0.6766590126714753	0.66840830747315	0.6322090885150417		0.5697055510500166	0.5028583416290981		0.6271294368917459	0.5868673236910955	STAR	Arg182His	NC_000008.11:38146068:C:T	545G>A	8	38146068	C	T	8	ENSG00000147465	386	213658	CCSBVarC005621	ALE00005621	ENSP00000276449.3	CEGS2	CegsMutGDEh1032	D02	GDEhDisVCh_40077	C04	1	CegsMutGDDh1032	D02	VUSN2Hmut_GDN2h_05	D11	VUSMutpDEST2_01	C07	VUSmut_GDEh05	D11	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	24034.0	single nucleotide variant	NM_000349.3(STAR):c.545G>A (p.Arg182His)	6770.0	STAR	HGNC:11359	Pathogenic/Likely pathogenic	1.0	Jan 04, 2024	104894086.0	-	RCV000009558|RCV000518086	MONDO:MONDO:0008725,MedGen:C0342474,OMIM:201710,Orphanet:418,Orphanet:90790|MedGen:C3661900	Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided	germline;unknown	germline	GRCh38	NC_000008.11	8	38146068.0	38146068.0	8p11.23	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA120041,OMIM:600617.0010	3.0	8995.0	38146068.0	C	T	-	-	-	-	-	-	545G>A 	Arg182His	NM_000349.3	2.0	Pathogenic	Likely pathogenic	8995	8	38146068.0	C	T	R	H	rs104894086	8	38003586	8	38122743	182	STAR	ENSG00000147465	ENST00000276449	ENSP00000276449	P49675	STAR_HUMAN	c.545G>A	p.Arg182His	c.545G>A	p.Arg182His	principal1	Y	1	YES	Select	-	CGT	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.002	0.79703	D	1.0	0.90580	D	1.0	0.97365	D	0.89	0.91795	A	simple_aae	11.0	89.0	3.035	0.86364	M	-4.4	0.77340	D	0.986	0.99488	0.3947	0.88973	D	0.6181	0.86478	D	10	0.99289614	0.99825	D	0.26756	0.89728	D	0.876	0.96308	0.996	0.99957	P49675	R182H	Loss of MoRF binding (P = 0.0279)| Gain of catalytic residue at D183 (P = 0.1516)| Gain of disorder (P = 0.2352)| Loss of sheet (P = 0.3635)| Loss of loop (P = 0.4412)	0.965946583377	0.96527	0.9413932866151907	0.94084	0.933116055964	0.71746	0.799603939056	0.81870	T	0.912201	0.98337	D	0.482363	0.93738	D	0.455105	0.93660	D	0.999460160732269	0.97487	D	0.973953	0.90678	D	0.93790007	0.94957	0.87087375	0.92831	0.92619395	0.93765	0.86071813	0.92124	-11.903	0.84419	D	0.9237	0.84457	P	0.997022334113976	0.92697	0.95337650	0.93564	0.995	0.99826	.	.	.	.	.	.	5.666266	0.92915	33.0	0.99955466147677707	0.99975	0.895218	0.83440	D	0.660176746414883	0.76904	6.596691	0.678612417129408	0.80654	7.370631	5.84	5.84	0.93363	4.84	0.88298	7.316	0.78371	7.678000	0.65201	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.891	0.42933	121	0.95159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9	1614242	5.575370e-06	0	1	44884	2.227970e-05	0	0	75070	0.000000e+00	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	0	29602	0.000000e+00	0	1	44884	2.227970e-05	0	0	64034	0.000000e+00	0	0	6062	0.000000e+00	0	7	1180048	5.931960e-06	0	0	91090	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Congenital_lipoid_adrenal_hyperplasia_due_to_STAR_deficency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000008.11:g.38146068C>T	ClinGen:CA120041|OMIM:600617.0010	C3661900|C0342474	201710	418|90790	START domain|START domain|START domain	Arg	His	94.76	0.05241935483870968																																																																																																																																																																																																																																																																																																																																																																																																																																																																													13			94.76	Positively-charged	Arginine		Steroidogenic acute regulatory protein, mitochondrial							START	0.9709		-4.5								 R182-A171 (PAE:  1.0), R182-K248 (PAE: 1.5), R182-L247 (PAE: 1.0)	R182-A171 (PDBs: 3P0L), R182-L247 (PDBs: 3P0L)		R182-A171 (PDBs: 3P0L)							175									-122.5		Pocket 1: Mean pLDDT: 96.54, Volume: 773.88 Å³, Druggability score: 0.97		142.9						B (undefined)	E (parallel sheets)	Beta strand											94.76	5.2419353	>90	<10	201710	autosomal recessive	OMIM	Rare genetic gynecological and obstetrical diseases; Rare genetic developmental defect during embryogenesis; Rare genetic urogenital disease; Rare genetic endocrine disease; Genetic infertility	5	LIPOID CONGENITAL ADRENAL HYPERPLASIA	false	0.6477688721824479	0.6095382061030685	false	false	false
PHYH	PHYH_Arg275Trp	B_15-16	4.133085492605546	0.004386992330540224	0.014471770900400393	6.706096590875462	0.0002758883236198962	0.0008698540787671984	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8631944193975156	0.8701317756195313	0.46594425073206114	0.5765238304990723	0.5853168531306112	0.47097487050107356	0.47178344418194307	0.5267410622140605	0.5654110933779977	0.4673105322661488	0.795158610360543	0.7783861201997577	0.4701662968202041	0.6438926440471621	0.587636567620147	0.4645779691979734	0.9451049408785195	0.9480027185952734	PHYH	Arg275Trp	NC_000010.11:13283695:G:A	823C>T	10	13283695	G	A	10	ENSG00000107537	2156	214172	CCSBVarC005362	ALE00005362	ENSP00000263038.4	CEGS2	CegsMutGDEh1031	F10	GDEhDisVCh_40076	A05	2	CegsMutGDDh1031	F10	VUSN2Hmut_GDN2h_05	B10	VUSMutpDEST2_01	F10	VUSmut_GDEh05	B10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	22619.0	single nucleotide variant	NM_006214.4(PHYH):c.823C>T (p.Arg275Trp)	5264.0	PHYH	HGNC:8940	Pathogenic/Likely pathogenic	1.0	Apr 04, 2024	104894178.0	-	RCV000008018|RCV000255609|RCV000505105|RCV000665657|RCV002426496	MedGen:C2749345|MedGen:C3661900|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0009958,MedGen:C0034960,OMIM:266500,Orphanet:773|MeSH:D030342,MedGen:C0950123	Refsum disease, adult, 1|not provided|Retinitis pigmentosa|Phytanic acid storage disease|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000010.11	10	13283695.0	13283695.0	10p13	criteria provided, multiple submitters, no conflicts	14.0	-	N	OMIM:602026.0001,ClinGen:CA118904,UniProtKB:O14832#VAR_005526	3.0	7580.0	13283695.0	G	A	-	-	-	-	-	-	823C>T 	Arg275Trp	NM_006214.4	2.0	Pathogenic	Likely pathogenic	7580	10	13283695.0	G	A	R	W	rs104894178	10	13325695	10	13365701	275	PHYH	ENSG00000107537	ENST00000263038	ENSP00000263038	O14832	PAHX_HUMAN	c.823C>T	p.Arg275Trp	c.823C>T	p.Arg275Trp	principal1	Y	1	YES	Select	-	CGG	1	2	g	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.8	0.87956	A	simple_aae	20.0	80.0	3.395	0.91508	M	-7.78	0.95967	D	0.975	0.98940	1.0925	0.99339	D	0.9737	0.99175	D	9	0.72966444	0.73968	D	0.202138	0.86770	D	0.848	0.95273	.	.	.	.	.	0.975868439659	0.97536	0.9437759234559634	0.94324	0.654731206335	0.58265	0.551488161087	0.46002	T	0.969858	0.99664	D	0.40728	0.90262	D	0.538936	0.95363	D	0.978210389614105	0.72026	D	0.971103	0.90270	D	0.9822864	0.99267	0.93219984	0.97206	0.99054164	0.99788	0.9283445	0.96937	-14.452	0.94444	D	0.7989	0.81531	P	0.985477449457715	0.86798	0.69610727	0.85996	0.982	0.99374	.	.	.	.	.	.	4.472022	0.69751	25.4	0.99887926430649798	0.96284	0.826947	0.74540	D	0.410614999593176	0.61807	4.409624	0.230424867659138	0.51291	3.335991	5.86	0.573	0.16508	-0.571	0.17977	2.28	0.43206	1.446000	0.26652	0.608	0.46638	1.0	0.71675	1.000000	0.68239	0.54	0.29984	934	0.15398	.	.	.	.	.	.	.	.	.	.	.	.	36	264690	1.3600817E-4	.	9	109406	8.226240e-05	0	27	208128	1.297280e-04	0	46	236946	1.941370e-04	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	6	2320	2.586210e-03	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	3	42768	7.014590e-05	0	0	15690	0.000000e+00	0	3	42768	7.014590e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	22	6212	3.541530e-03	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	5	89552	5.583350e-05	0	0	30608	0.000000e+00	0	5	89552	5.583350e-05	0	0	14902	0.000000e+00	0	1	34260	2.918860e-05	0	35	9570	3.657260e-03	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	9	102746	8.759470e-05	0	0	30526	0.000000e+00	0	9	102746	8.759470e-05	0	.	130	1613918	8.054930e-05	0	78	29608	2.634420e-03	0	3	74858	4.007590e-05	0	0	912	0.000000e+00	0	1	59972	1.667440e-05	0	78	29608	2.634420e-03	0	0	44878	0.000000e+00	0	0	64032	0.000000e+00	0	0	6084	0.000000e+00	0	36	1180010	3.050820e-05	0	1	91078	1.097960e-05	0	29	125884	2.3037081757808776E-4	0	360	0	0	2708	0	0	9280	0	0	790	0	0	946	0	0	656	0	0	280	0	5	9862	5.069965524234435E-4	0	9640	0	0	3364	0	34	150766	2.255150365467015E-4	Inborn_genetic_diseases|Phytanic_acid_storage_disease|not_provided|Refsum_disease,_adult,_1|Retinitis_pigmentosa	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.13283695G>A	ClinGen:CA118904|OMIM:602026.0001|UniProtKB:O14832#VAR_005526	C0950123|C0034960|C3661900|C2749345|C0035334	266500|268000|PS268000	773|791	.	Arg	Trp	95.72	0.008064516129032258																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			95.72	Positively-charged	Arginine	2-oxoglutarate	Phytanoyl-CoA dioxygenase, peroxisomal								0.9918		-4.5								 R275-K161 (PAE:  1.0), R275-G204 (PAE: 1.0)	R275-K161 (PDBs: 2A1X), R275-G204 (PDBs: 2A1X)	 R275-N203 (PAE:  1.0), R275-K161 (PAE: 1.0), R275-G204 (PAE: 1.0), R275-N269 (PAE: 1.0)	R275-N203 (PDBs: 2A1X), R275-K161 (PDBs: 2A1X), R275-G204 (PDBs: 2A1X)							175									-103.3		Pocket 1: Mean pLDDT: 74.94, Volume: 2163.98 Å³, Druggability score: 0.99		115.2						B (undefined)	E (parallel sheets)	Beta strand											95.72	0.80645156	>90	<10	268000;266500	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease	4	RETINITIS PIGMENTOSA; REFSUM DISEASE, CLASSIC	false	0.8701317756195313	0.8631944193975156	false	false	false
DCX	DCX_Arg196Cys	B_7-8	4.621657951668667	0.0024213993702781457	0.009104080309510352	-1.5235480311574754	0.17144214195447027	0.21285272698677465	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8826221469302831	0.8601594030584793	0.7825004245839551	0.6600069633770274	0.7217548539554729	0.8110112006451067	0.903523161502187	0.739069994153138	0.7503994781307533	0.8939161047523021	0.8903748627660726	0.9167659710328261	0.7184992397880264	0.7044397137578078	0.5696144486233014	0.6710847444156081	0.829943943350886	0.8484783228277399	DCX	Arg196Cys	NC_000023.11:111401109:G:A	586C>T	23	111401109	G	A	X	ENSG00000077279	8416	216644	CCSBVarC005200	ALE00005200	ENSP00000419861.1	CEGS2	CegsMutGDEh1045	E07	GDEhDisVCh_40049	D10	1	CegsMutGDDh1045	E07	VUSN2Hmut_GDN2h_09	D10	VUSMutpDEST2_08	G01	VUSmut_GDEh09	D10	1.0	6.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	N	Y	Y	Y	Y	169875.0	single nucleotide variant	NM_001195553.2(DCX):c.586C>T (p.Arg196Cys)	1641.0	DCX	HGNC:2714	Pathogenic/Likely pathogenic	1.0	Dec 06, 2024	587783568.0	-	RCV000145868|RCV000440789|RCV001781484	MedGen:C0008519|MedGen:C3661900|MONDO:MONDO:0010239,MedGen:C4551968,OMIM:300067,Orphanet:2148	Ectopic tissue|not provided|Lissencephaly type 1 due to doublecortin gene mutation	germline;unknown	germline	GRCh38	NC_000023.11	X	111401109.0	111401109.0	Xq23	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA172017	2.0	158485.0	111401109.0	G	A	-	-	-	-	-	-	586C>T 	Arg196Cys	NM_001195553.2	2.0	Pathogenic	Likely pathogenic	158485	X	111401109.0	G	A	R	C	rs587783568	X	110644337	X	110530993	196	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.586C>T	p.Arg196Cys	c.586C>T	p.Arg196Cys	alternative1	Y	1	.	.	-	CGT	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.48180	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.91287	.	.	0.94561	1.0590	0.98313	D	0.9175	0.97262	D	10	0.9341066	0.92663	D	0.917823	0.99391	D	.	0.98376	.	.	.	.	.	.	0.99904	.	0.98802	.	.	0.936447679996	0.99311	D	.	0.73021	.	0.644468	0.99879	D	0.687957	0.99879	D	0.997901558876038	0.92658	D	0.994989	0.98320	D	0.9544206	0.96663	0.86865145	0.92675	0.9470504	0.95903	0.87625706	0.93210	-12.91	0.89013	D	0.9975	0.97655	LP	0.998943615908951	0.95367	0.99971026	0.99632	0.984	0.99450	.	.	.	.	.	.	5.138621	0.86044	28.8	0.99929641680308556	0.99279	.	.	.	.	.	.	.	.	.	4.74	4.74	0.59667	2.62	0.47948	5.628	0.67542	9.918000	0.82509	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	889	0.27289	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Ectopic_tissue|not_provided|Lissencephaly_type_1_due_to_doublecortin_gene_mutation	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.111401109G>A	ClinGen:CA172017	C0008519|C3661900|C4551968	300067	2148	.	Arg	Cys	89.33	0.5403225806451613																																																																																																																																																																																																																																																																																																																																																																																																																																																																													134			89.33	Positively-charged	Arginine		Neuronal migration protein doublecortin							Doublecortin 2			-4.5			C:R196-B:K202 (PDBs: 6FNZ)							 R196-L181 (PAE:  2.0)								175									-93.0				111.7						B (undefined)	E (parallel sheets)	Beta strand											89.33	54.03226	70-90	10-90	300067	x-linked	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	LISSENCEPHALY, X-LINKED, 1	false	0.8601594030584793	0.8826221469302831	false	false	false
ALAS2	ALAS2_Ala135Thr	B_7-8	0.46275313735817614	0.6750416417101974	0.7418466833524033	2.2511970929085647	0.1098163404231214	0.14414376586296693	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6846922569732403	0.7000731216134084	0.628979327852465	0.6372600664650045	0.6538526907748283	0.6020016710182534	0.6020016710182534	0.5185100872215123	0.6455279160754732	0.628979327852465	0.7000731216134084	0.6846922569732403		0.7891952943281445	0.6289922168545358				ALAS2	Ala135Thr	NC_000023.11:55021176:C:T	403G>A	23	55021176	C	T	X	ENSG00000158578	8420	216656	CCSBVarC003763	ALE00003763	ENSP00000337131.4	CEGS2	CegsMutGDEh1039	F09	GDEhDisVCh_40062	F06	2	CegsMutGDDh1039	F09	VUSN2Hmut_GDN2h_08	D03	VUSMutpDEST2_08	E03	VUSmut_GDEh08	D03	1.0	1.0	1.0	2.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25512.0	single nucleotide variant	NM_000032.5(ALAS2):c.514G>A (p.Ala172Thr)	212.0	ALAS2	HGNC:397	Likely pathogenic	1.0	Oct 05, 2021	137852304.0	-	RCV000011219|RCV001729346	MedGen:C4225593|MONDO:MONDO:0020721,MedGen:C4551511,OMIM:300751,Orphanet:75563	Sideroblastic anemia 1, late-onset|X-linked sideroblastic anemia 1	germline;unknown	germline	GRCh38	NC_000023.11	X	55021176.0	55021176.0	Xp11.21	criteria provided, single submitter	2.0	-	N	ClinGen:CA121083,OMIM:301300.0006	3.0	10473.0	55021176.0	C	T	-	-	-	-	-	-	514G>A 	Ala172Thr	NM_000032.5	1.0	Pathogenic	Likely pathogenic	10473	X	55021176.0	C	T	A	T	rs137852304	X	55047609	X	55064334	172	ALAS2	ENSG00000158578	ENST00000650242	ENSP00000497236	P22557	HEM0_HUMAN	c.514G>A	p.Ala172Thr	c.514G>A	p.Ala172Thr	principal1	Y	.	YES	Select	-	GCT	1	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.70891	.	0.989	0.62839	D	0.893	0.63333	P	.	0.81880	.	.	.	.	2.765	0.80595	M	.	0.71800	.	.	0.69502	1.0357	0.97821	D	0.9065	0.96893	D	10	0.9623673	0.95615	D	0.552665	0.95876	D	.	0.99253	0.767	0.89397	P22557	A172T	Loss of MoRF binding (P = 0.1289)| Loss of stability (P = 0.1694)| Loss of phosphorylation at T167 (P = 0.2846)| Loss of helix (P = 0.3949)| Gain of loop (P = 0.4248)	.	0.98184	.	.	.	.	0.587045609951	0.51010	T	0.724211	0.92157	D	0.570327	0.96581	D	0.633295	0.97652	D	0.978339934674511	0.72084	D	0.89491	0.65876	D	0.93466	0.94625	0.90622896	0.95357	0.9183721	0.92988	0.89074653	0.94242	-9.909	0.73810	D	0.3045	0.69204	B	0.992194749924599	0.89390	0.99961036	0.99532	0.984	0.99450	.	.	.	.	.	.	4.72892	0.76192	26.5	0.99910062935890176	0.97950	.	.	.	.	.	.	.	.	.	4.92	4.92	0.64102	4.01	0.76498	7.905	0.86513	7.606000	0.61793	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.999	0.91597	103	0.95731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	80333	2.489640e-05	0	1	151856	6.585190e-06	0	2	172109	1.162050e-05	0	0	5701	0.000000e+00	0	0	13664	0.000000e+00	0	0	1767	0.000000e+00	0	0	6913	0.000000e+00	0	0	9934	0.000000e+00	0	2	30954	6.461200e-05	0	0	9950	0.000000e+00	0	2	30954	6.461200e-05	0	0	13133	0.000000e+00	0	0	24386	0.000000e+00	0	0	4647	0.000000e+00	0	0	10125	0.000000e+00	0	0	12192	0.000000e+00	0	1	64676	1.546170e-05	0	0	19072	0.000000e+00	0	1	64676	1.546170e-05	0	0	12063	0.000000e+00	0	0	27162	0.000000e+00	0	0	7078	0.000000e+00	0	0	13316	0.000000e+00	0	0	15995	0.000000e+00	0	2	73345	2.726840e-05	0	0	19007	0.000000e+00	0	2	73345	2.726840e-05	0	.	12	1211483	9.905220e-06	0	12	895239	1.340420e-05	0	0	57783	0.000000e+00	0	0	689	0.000000e+00	0	0	46064	0.000000e+00	0	0	22044	0.000000e+00	0	0	33829	0.000000e+00	0	0	46887	0.000000e+00	0	0	4336	0.000000e+00	0	12	895239	1.340420e-05	0	0	56972	0.000000e+00	0	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Sideroblastic_anemia_1,_late-onset|X-linked_sideroblastic_anemia_1	criteria_provided,_single_submitter	NC_000023.11:g.55021176C>T	ClinGen:CA121083|OMIM:301300.0006	C4225593|C4551511	300751	75563	Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase	Ala	Thr	95.16	0.42452830188679247																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																95.16	42.45283	>90	10-90	300751	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare inborn errors of metabolism; Rare genetic skin disease	4	ANEMIA, SIDEROBLASTIC, 1	false	0.7000731216134084	0.6846922569732403	false	false	false
HPRT1	HPRT1_Asp80Val	B_7-8	0.4086460531925218	0.6950115864198108	0.7572573474397253	-4.0171589838747215	0.005077896687477088	0.009517814526578608	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8851637622312307	0.8902910231916956	0.7133077096176785	0.7219018662622096	0.6927287527706945	0.7687407472464336	0.7625872787593247	0.7552079470468139	0.8080339592543035	0.6797509208737889	0.9375300498177552	0.9451197929493113	0.7748942157335424	0.6302495584945749	0.6357697732701156	0.7468644983615683	0.843051996565636	0.8252077315131501	HPRT1	Asp80Val	NC_000023.11:134475285:A:T	239A>T	23	134475285	A	T	X	ENSG00000165704	7982	202790	CCSBVarC005932	ALE00005932	ENSP00000298556.7	CEGS2	CegsMutGDEh1045	A02	GDEhDisVCh_40052	G10	2	CegsMutGDDh1045	A02	VUSN2Hmut_GDN2h_09	F08	VUSMutpDEST2_07	B06	VUSmut_GDEh09	F08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25069.0	single nucleotide variant	NM_000194.2(HPRT1):c.239A>T (p.Asp80Val)	3251.0	HPRT1	HGNC:5157	Likely pathogenic	1.0	Jan 11, 2021	137852478.0	-	RCV000010714|RCV000010715|RCV001851783	MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233||MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233;MONDO:MONDO:0010298,MedGen:C0023374,OMIM:300322,Orphanet:510	Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT ARLINGTON|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency;Lesch-Nyhan syndrome	germline	germline	GRCh38	NC_000023.11	X	134475285.0	134475285.0	Xq26.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA120888,UniProtKB:P00492#VAR_006777,OMIM:308000.0002	3.0	10030.0	134475285.0	A	T	-	-	-	-	-	-	239A>T 	Asp80Val	NM_000194.2	1.0	Pathogenic	Likely pathogenic	10030	X	134475285.0	A	T	D	V	rs137852478	X	133609315	X	133436981	80	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.239A>T	p.Asp80Val	c.239A>T	p.Asp80Val	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.01	0.56615	D	0.056	0.46983	T	0.732	0.42730	P	0.657	0.52721	P	0.98	0.97016	A	simple_aae	2.0	98.0	2.405	0.69373	M	-5.76	0.87865	D	0.938	0.94442	0.9874	0.96971	D	0.9886	0.99673	D	9	0.98752904	0.99114	D	0.964304	0.99771	D	0.927	0.98227	0.85	0.95175	P00492	D80V	Loss of ubiquitination at K83 (P = 0.0734)| Gain of MoRF binding (P = 0.0911)| Loss of disorder (P = 0.1955)| Gain of loop (P = 0.2754)| Gain of catalytic residue at Y81 (P = 0.3065)	0.999768875776	0.99976	0.9834274551406487	0.98327	3.40020819914	0.99696	0.824857115746	0.85749	D	0.98676	0.99923	D	0.667141	0.99900	D	0.720526	0.99899	D	0.995382010936737	0.87223	D	0.989623	0.96607	D	0.94839567	0.96042	0.9456045	0.98100	0.94839567	0.96042	0.9456045	0.98100	-14.303	0.94012	D	0.9541	0.87330	P	0.992310685268137	0.89450	0.99975770	0.99689	0.956	0.98079	.	.	.	.	.	.	4.495215	0.70311	25.5	0.99252165260998682	0.56990	.	.	.	.	.	.	.	.	.	4.68	4.68	0.58268	3.92	0.74494	8.855	0.91861	9.096000	0.78792	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	280	0.88958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Partial_hypoxanthine-guanine_phosphoribosyltransferase_deficiency|Lesch-Nyhan_syndrome|HPRT_ARLINGTON	criteria_provided,_single_submitter	NC_000023.11:g.134475285A>T	ClinGen:CA120888|OMIM:308000.0002|UniProtKB:P00492#VAR_006777	C0268117|C0023374	300323|300322	79233|510	Phosphoribosyltransferase domain|Phosphoribosyltransferase domain	Asp	Val	98.54	0.48466257668711654																																																																																																																																																																																																																																																																																																																																																																																																																																																																													79			98.54	Negatively-charged	Aspartic Acid		Hypoxanthine-guanine phosphoribosyltransferase										-3.5			C:D80-A:K73 (PDBs: 4IJQ, 4RAB, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ), A:D80-C:K73 (PDBs: 4RAC), D:D80-B:K73 (PDBs: 6BNJ), B:D80-D:K73 (PDBs: 6BNJ)		C:D80-A:K73 (PDBs: 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ), A:D80-C:K73 (PDBs: 6BNJ), B:D80-D:K73 (PDBs: 6BNJ), D:D80-B:K73 (PDBs: 6BNJ)			 D80-A84 (PAE:  1.0), D80-A76 (PAE: 1.0)	D80-A84 (PDBs: 4KN6, 6BNJ), D80-A76 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)	 D80-A84 (PAE:  1.0), D80-A76 (PAE: 1.0)	D80-A84 (PDBs: 4KN6, 6BNJ), D80-A76 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)	 D80-K83 (PAE:  1.0)	D80-K83 (PDBs: 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)					132									-61.4				-43.2				dbSNP: rs137852478; Variant type: LP/P; AA change: Asp80Val; PTM type: Phosphorylation; PTM morphology: ADLLD*yIKALN; Var class: II&rs137852478		H (helix)	H (α-helix)	Helix											98.54	48.466255	>90	10-90	300323;300323;300322	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	HYPERURICEMIA, HPRT-RELATED; HYPERURICEMIA, HPRT-RELATED; LESCH-NYHAN SYNDROME	false	0.8902910231916956	0.8851637622312307	false	false	false
PNPO	PNPO_Arg95His	B_7-8	-3.300656364392516	0.01639445745392115	0.03928910130111593	-14.763872076384178	6.069248419451141e-6	0.00005432717487655045	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.96522655899588	0.9810371103440406	0.5125033669872329	0.5774831204696963	0.5193014104643603	0.5056614304926761	0.5593192475208246	0.517766998928097	0.6349458119495087	0.5507943725664637	0.9857182965828367	0.9832262891728912	0.4520036134645276	0.5208358220006236	0.5200204289898839	0.474212361408002	0.9763559241052445	0.9472268288188687	PNPO	Arg95His	NC_000017.11:47944636:G:A	284G>A	17	47944636	G	A	17	ENSG00000108439	4515	8610	CCSBVarC000660	ALE00000660	ENSP00000493302.2	RC4	RC4_Mut_GDEh1008	G03	GDEhDisVCh_40042	D01	2	RC4_Mut_GDDh1008	G03	NULL	NULL	VUSMutpDEST2_04	C04	VUSmut_GDEh12	G08	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	845554.0	single nucleotide variant	NM_018129.4(PNPO):c.284G>A (p.Arg95His)	55163.0	PNPO	HGNC:30260	Pathogenic/Likely pathogenic	1.0	Mar 10, 2023	552833222.0	-	RCV001053333	MONDO:MONDO:0012407,MedGen:C1864723,OMIM:610090,Orphanet:79096	Pyridoxal phosphate-responsive seizures	germline	germline	GRCh38	NC_000017.11	17	47944636.0	47944636.0	17q21.32	criteria provided, multiple submitters, no conflicts	2.0	-	N	-	2.0	849386.0	47944636.0	G	A	-	-	-	-	-	-	284G>A 	Arg95His	NM_018129.4	2.0	Pathogenic	Likely pathogenic	849386	17	47944636.0	G	A	R	H	rs552833222	17	46022002	17	43377001	95	PNPO	ENSG00000108439	ENST00000642017	ENSP00000493302	Q9NVS9	PNPO_HUMAN	c.284G>A	p.Arg95His	c.284G>A	p.Arg95His	principal1	Y	.	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.79703	.	1.0	0.90580	D	0.991	0.79680	D	.	0.99291	.	.	.	.	4.705	0.99476	H	.	0.80883	.	.	0.99781	1.0075	0.97307	D	0.8480	0.94919	D	10	0.98841	0.99251	D	0.290506	0.90525	D	.	0.97925	0.968	0.99690	Q9NVS9	R95H	Loss of MoRF binding (P = 0.0236)| Gain of ubiquitination at K91 (P = 0.0292)| Gain of methylation at K100 (P = 0.0627)| Gain of catalytic residue at L97 (P = 0.0713)| Loss of phosphorylation at S93 (P = 0.1162)	.	0.97782	0.8965008021765285	0.89556	.	0.87147	0.596009135246	0.52275	T	0.548302	0.84519	D	0.326706	0.84832	D	0.400643	0.92076	D	0.999110877513885	0.96192	D	0.998567	0.99872	D	0.96392196	0.97635	0.88571376	0.93881	0.96768785	0.98009	0.8846283	0.93804	-11.254	0.87047	D	0.9122	0.84210	P	0.979386839827419	0.85168	0.18863596	0.72545	0.901	0.94783	.	.	.	.	.	.	5.859382	0.93858	33.0	0.99954590997910397	0.99969	0.925261	0.90419	D	1.02256711155847	0.96376	14.64527	0.88781038263827	0.94991	13.23985	5.22	5.22	0.72246	4.57	0.85150	7.761	0.84145	9.716000	0.81379	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.654	0.32844	523	0.74166	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109404	1.828090e-05	0	2	208132	9.609290e-06	0	3	236954	1.266070e-05	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13392	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	9046	1.105460e-04	0	0	16218	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	1	89558	1.116590e-05	0	0	30608	0.000000e+00	0	1	89558	1.116590e-05	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	0	21630	0.000000e+00	0	1	102754	9.731980e-06	0	0	30526	0.000000e+00	0	1	17692	5.652270e-05	0	.	8	1613886	4.956980e-06	0	7	1179916	5.932630e-06	0	0	74920	0.000000e+00	0	0	912	0.000000e+00	0	0	59998	0.000000e+00	0	0	29604	0.000000e+00	0	0	44898	0.000000e+00	0	0	64034	0.000000e+00	0	0	6052	0.000000e+00	0	7	1179916	5.932630e-06	0	0	91082	0.000000e+00	0	0	6062	0	0	8	0	0	26	0	1	1012	9.881422924901185E-4	0	0	0	0	0	0	0	30	0	0	0	0	0	2328	0	1	1020	9.80392156862745E-4	0	56	0	1	9466	1.0564124234100993E-4	Pyridoxal_phosphate-responsive_seizures	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.47944636G>A	.	C1864723	610090	79096	Pyridoxamine 5'-phosphate oxidase, putative	Arg	His	97.78	0.24193548387096775																																																																																																																																																																																																																																																																																																																																																																																																																																																																													60			97.78	Positively-charged	Arginine	FMN	Pyridoxine-5'-phosphate oxidase										-4.5								 R95-T111 (PAE:  1.0), R95-L83 (PAE: 1.0), R95-Q174 (PAE: 2.5)	R95-L83 (PDBs: 1NRG, 8QYT, 8QYW), R95-T85 (PDBs: 8QYW)	 R95-L83 (PAE:  1.0)	R95-L83 (PDBs: 1NRG, 8QYT, 8QYW), R95-C82 (PDBs: 8QYW)							175									-157.3				158.4						B (undefined)	E (parallel sheets)	Beta strand											97.78	24.193548	>90	10-90	610090	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	false	0.9810371103440406	0.96522655899588	true	true	false
AGXT	AGXT_Gly116Arg	B_7-8	-3.209929374320814	0.014859535225655689	0.03671832610606634	-6.0837301086832865	0.0004990263517957661	0.001389549856669546	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.9442984428430479	0.942550530818997	0.5544406295532948	0.7134843046947772	0.6283352737897333	0.5648138581367873	0.6348371267169454	0.6689611538713048	0.7761475803673228	0.6178775553292142	0.9503446165801452	0.9568728943459672	0.4947905895566293	0.5877093937081618	0.6508210290222316	0.49100370377737534	0.9347564450578487	0.9317239913401285	AGXT	Gly116Arg	NC_000002.12:240869350:G:A	346G>A	2	240869350	G	A	2	ENSG00000172482	70497	3814	CCSBVarC008183	ALE00008169	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	A03	GDEhDisVCh_40002	A05	2	VUSMutGDDh004	A03	VUSN2Hmut_GDN2h_01	G06	VUSMutpDEST2_14	C04	VUSmut_GDEh01	G06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	186655.0	single nucleotide variant	NM_000030.3(AGXT):c.346G>A (p.Gly116Arg)	189.0	AGXT	HGNC:341	Pathogenic/Likely pathogenic	1.0	Feb 24, 2024	180177207.0	-	RCV000169408|RCV001814082|RCV001236818	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|Human Phenotype Ontology:HP:0001939,Human Phenotype Ontology:HP:0002146,MedGen:C4021768|MedGen:C3661900	Primary hyperoxaluria, type I|Abnormality of metabolism/homeostasis|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	240869350.0	240869350.0	2q37.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA274270,UniProtKB:P21549#VAR_010971	2.0	189021.0	240869350.0	G	A	-	-	-	-	-	-	346G>A 	Gly116Arg	NM_000030.3	2.0	Pathogenic	Likely pathogenic	189021	2	240869350.0	G	A	G	R	rs180177207	2	241808767	2	241457440	116	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.346G>A	p.Gly116Arg	c.346G>A	p.Gly116Arg	principal1	Y	1	YES	Select	+	GGG	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.003	0.76775	D	0.999	0.77914	D	0.93	0.66460	D	0.79	0.86984	A	simple_aae	21.0	79.0	.	.	.	-1.97	0.45596	N	0.86	0.85626	0.9343	0.96152	D	0.8558	0.95187	D	9	0.9372549	0.92976	D	0.652498	0.97057	D	0.802	0.93522	0.946	0.99321	P21549	G116R	Gain of methylation at G116 (P = 0.0405)| Gain of MoRF binding (P = 0.0428)| Loss of catalytic residue at I115 (P = 0.219)| Loss of stability (P = 0.287)| Loss of helix (P = 0.3949)	0.94852298556	0.94755	0.984429256584751	0.98428	0.242540841782	0.26470	0.451283574104	0.32079	T	0.546878	0.84446	D	0.444375	0.92170	D	0.400537	0.92074	D	0.928973436355591	0.59037	D	0.962104	0.85677	D	0.98566043	0.99501	0.91211873	0.95781	0.98566043	0.99501	0.91211873	0.95781	-12.04	0.85087	D	0.956	0.87547	P	0.970860764469489	0.83432	0.45240155	0.80831	0.909	0.95264	.	.	.	.	.	.	5.442681	0.90965	32.0	0.99899706875365446	0.97201	0.964982	0.98717	D	0.500127930895002	0.66926	5.036571	0.394984194754631	0.61046	4.323092	4.12	4.12	0.47444	2.42	0.44885	8.864	0.91918	11.322000	0.92538	0.614	0.49322	1.0	0.71675	1.000000	0.68239	0.314	0.24879	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	0	101396	0.000000e+00	0	1	194370	5.144830e-06	0	1	221010	4.524680e-06	0	0	7156	0.000000e+00	0	0	16784	0.000000e+00	0	0	1866	0.000000e+00	0	0	9014	0.000000e+00	0	0	12512	0.000000e+00	0	0	38666	0.000000e+00	0	0	13618	0.000000e+00	0	.	.	.	.	0	16078	0.000000e+00	0	0	30052	0.000000e+00	0	0	5048	0.000000e+00	0	0	13390	0.000000e+00	0	0	15726	0.000000e+00	0	1	82714	1.208990e-05	0	0	26800	0.000000e+00	0	1	82714	1.208990e-05	0	0	14836	0.000000e+00	0	0	33556	0.000000e+00	0	0	7888	0.000000e+00	0	0	17638	0.000000e+00	0	0	20226	0.000000e+00	0	1	94910	1.053630e-05	0	0	26716	0.000000e+00	0	1	94910	1.053630e-05	0	.	15	1597378	9.390390e-06	0	2	62450	3.202560e-05	0	0	74794	0.000000e+00	0	0	912	0.000000e+00	0	0	59408	0.000000e+00	0	0	28260	0.000000e+00	0	0	44768	0.000000e+00	0	2	62450	3.202560e-05	0	0	5988	0.000000e+00	0	12	1170848	1.024900e-05	0	1	88072	1.135430e-05	0	4	24228	1.650982334489021E-4	0	298	0	0	86	0	1	7436	1.3448090371167293E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	1936	0	1	7734	1.2929919834497026E-4	0	112	0	5	34864	1.4341441027994494E-4	Primary_hyperoxaluria,_type_I|not_provided|Abnormality_of_metabolism/homeostasis	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240869350G>A	ClinGen:CA274270|UniProtKB:P21549#VAR_010971	C0268164|C3661900|C4021768	259900	416|93598	Aminotransferase class V domain	Gly	Arg	98.89	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.89	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Alanine--glyoxylate aminotransferase										-0.4								 G116-A121 (PAE:  1.0), G116-A112 (PAE: 1.0)	G116-A112 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), G116-A121 (PDBs: 6RV1, 3R9A)	 G116-A121 (PAE:  1.0), G116-G120 (PAE: 1.0), G116-A112 (PAE: 1.0)	G116-A112 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), G116-A121 (PDBs: 6RV1, 3R9A), G116-G120 (PDBs: 6RV1, 3R9A)							75									-59.2				-42.9						H (helix)	H (α-helix)	Helix											98.89	0.0	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.942550530818997	0.9442984428430479	true	true	false
GCK	GCK_Ala387Glu	B_7-8	2.3384730497773156	0.10136246406783898	0.16640769437582933	0.23434965917153114	0.8297967723033309	0.8597837815791147	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.684629076403584	0.7331359866540604	0.5255885060339054	0.5442827150239941	0.5245943660386911	0.5151231938772384	0.5151231938772384	0.5245943660386911	0.5442827150239941	0.5255885060339054	0.7331359866540604	0.684629076403584							GCK	Ala387Glu	NC_000007.14:44145590:G:T	1160C>A	7	44145590	G	T	7	ENSG00000106633	3689	214861	CCSBVarC006699	ALE00006697	ENSP00000384247.3	CEGS2	CegsMutGDEh1043	B11	GDEhDisVCh_40037	F01	1	CegsMutGDDh1043	B11	VUSN2Hmut_GDN2h_09	H03	VUSMutpDEST2_03	B10	VUSmut_GDEh09	H03	1.0	1.0	1.0	1.0	1.0	5.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	44845.0	single nucleotide variant	NM_000162.5(GCK):c.1160C>A (p.Ala387Glu)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Feb 28, 2024	193921338.0	-	RCV000029844|RCV003883122	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Maturity-onset diabetes of the young type 2|Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44145590.0	44145590.0	7p13	reviewed by expert panel	2.0	-	N	ClinGen:CA213725	2.0	36181.0	44145590.0	G	T	-	-	-	-	-	-	1160C>A 	Ala387Glu	NM_000162.5	3.0	Pathogenic	Likely pathogenic	36181	7	44145590.0	G	T	A	E	rs193921338	7	44185189	7	44151714	387	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.1160C>A	p.Ala387Glu	c.1160C>A	p.Ala387Glu	principal1	Y	1	YES	Select	-	GCG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.002	0.79703	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.375	0.91274	M	-4.12	0.76771	D	0.844	0.83943	1.0862	0.99092	D	0.9717	0.99109	D	10	0.99201083	0.99734	D	0.870064	0.99003	D	0.958	0.99315	0.935	0.99041	P35557	A387E	Gain of disorder (P = 0.0374)| Loss of MoRF binding (P = 0.059)| Loss of catalytic residue at A387 (P = 0.1806)| Gain of helix (P = 0.2294)| Loss of methylation at R392 (P = 0.4738)	0.987331409019	0.98705	.	0.99984	.	0.96565	0.811778783798	0.83736	D	0.947901	0.99219	D	0.560597	0.96212	D	0.567482	0.96152	D	0.997854888439178	0.92528	D	0.964304	0.88661	D	0.98488784	0.99450	0.9533024	0.98573	0.9799398	0.99090	0.97126704	0.99511	-13.645	0.91965	D	0.9824	0.93458	P	0.999603109944392	0.97154	0.99983466	0.99778	0.978	0.99209	.	.	.	.	.	.	5.614955	0.9257	32.0	0.99531726386056985	0.69939	0.974355	0.99552	D	1.03310609236388	0.96655	14.9943	0.958102556661233	0.97626	16.48479	5.46	5.46	0.79994	3.81	0.70705	9.901	0.98627	11.604000	0.93507	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.969	0.5403	716	0.55914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	99980	0.000000e+00	0	1	191874	5.211750e-06	0	1	218022	4.586690e-06	0	0	6062	0.000000e+00	0	0	16398	0.000000e+00	0	0	2158	0.000000e+00	0	0	8222	0.000000e+00	0	0	10776	0.000000e+00	0	0	39570	0.000000e+00	0	0	15040	0.000000e+00	0	.	.	.	.	0	14210	0.000000e+00	0	1	29300	3.412970e-05	0	0	5846	0.000000e+00	0	0	12418	0.000000e+00	0	0	13834	0.000000e+00	0	0	82322	0.000000e+00	0	0	29408	0.000000e+00	0	1	29300	3.412970e-05	0	0	13174	0.000000e+00	0	1	33064	3.024440e-05	0	0	9234	0.000000e+00	0	0	16688	0.000000e+00	0	0	17606	0.000000e+00	0	0	93648	0.000000e+00	0	0	29338	0.000000e+00	0	1	33064	3.024440e-05	0	.	1	1604628	6.231970e-07	0	1	59324	1.685660e-05	0	0	74932	0.000000e+00	0	0	912	0.000000e+00	0	1	59324	1.685660e-05	0	0	29448	0.000000e+00	0	0	44558	0.000000e+00	0	0	59780	0.000000e+00	0	0	6032	0.000000e+00	0	0	1177334	0.000000e+00	0	0	90186	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Monogenic_diabetes|Maturity-onset_diabetes_of_the_young_type_2	reviewed_by_expert_panel	NC_000007.14:g.44145590G>T	ClinGen:CA213725	C3888631|C0342277	125851	183625|552	Hexokinase, C-terminal	Ala	Glu	98.76	0.0																																																																																																											0.171		0.088	4 mutation(s) (Ala387Tyr: -0.950, Ala387Pro: -0.600, Ala387His: -0.482, Ala387Trp: -0.435)																																																																																																																																																																																																																																																																																																																																																															0			98.76	Aliphatic	Alanine		Hexokinase-4							Hexokinase			1.8								 A387-N391 (PAE:  1.0), A387-S383 (PAE: 1.0)	A387-S383 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9), A387-N391 (PDBs: 6E0I, 4LC9)	 A387-N391 (PAE:  1.0), A387-S383 (PAE: 1.0)	A387-S383 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9), A387-N391 (PDBs: 6E0I, 4LC9)							89									-60.0				-35.7	Hexokinase large subdomain					H (helix)	H (α-helix)	Helix											98.76	0.0	>90	<10	125851	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism	3	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2	false	0.7331359866540604	0.684629076403584	false	false	false
PLP1	PLP1_Trp128Arg	B_7-8	2.1757385656383215	0.07248599802252874	0.12551972459023564	-4.0572391695458965	0.006671285730271443	0.012108614554943716	2024_01_Batch_7-8	true	true	false	false	false	false	false	true	false	false	false	false	0.9497316466749043	0.9873355817381881	0.8241806745914213	0.87798543531281	0.670563551541995	0.8561883679609885	0.9567464627238427	0.770696458247409	0.9812845073668904	0.9380821723745969	0.980157647856521	0.9497316466749043	0.7556302731981344	0.5704306448365809	0.7746863632587297	0.7102791768082457	0.9945135156198551		PLP1	Trp128Arg	NC_000023.11:103787831:T:C	382T>C	23	103787831	T	C	X	ENSG00000123560	4062	201424	CCSBVarC005857	ALE00005857	ENSP00000477619.1	CEGS2	CegsMutGDEh1039	F10	GDEhDisVCh_40062	G06	2	CegsMutGDDh1039	F10	VUSN2Hmut_GDN2h_08	G03	VUSMutpDEST2_04	G02	VUSmut_GDEh08	G03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26113.0	single nucleotide variant	NM_000533.5(PLP1):c.487T>C (p.Trp163Arg)	5354.0	PLP1	HGNC:9086	Likely pathogenic	1.0	May 01, 2024	132630279.0	-	RCV000011823|RCV000079097	Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702|MedGen:C3661900	Pelizaeus-Merzbacher disease|not provided	germline;maternal;unknown	germline	GRCh38	NC_000023.11	X	103787831.0	103787831.0	Xq22.2	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA221105,UniProtKB:P60201#VAR_004553,OMIM:300401.0002	3.0	11074.0	103787831.0	T	C	-	-	-	-	-	-	487T>C 	Trp163Arg	NM_000533.5	2.0	Pathogenic	Likely pathogenic	11074	X	103787831.0	T	C	W	R	rs132630279	X	103042760	X	102929416	163	PLP1	ENSG00000123560	ENST00000621218	ENSP00000484450	P60201	MYPR_HUMAN	c.487T>C	p.Trp163Arg	c.487T>C	p.Trp163Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	T/T	T/T	T/T	T/T	.	.	.	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	2.74	0.79912	M	.	.	.	0.935	0.94087	1.0501	0.98115	D	0.9830	0.99480	D	10	0.9931667	0.99849	D	0.964562	0.99773	D	.	.	0.953	0.99464	P60201	W163R	Gain of methylation at W163 (P = 0.0155)| Loss of glycosylation at T160 (P = 0.1446)| Loss of catalytic residue at V162 (P = 0.1863)| Loss of stability (P = 0.199)| Loss of helix (P = 0.2271)	0.999984667065	0.99998	.	0.99871	.	.	0.84253436327	0.88461	D	0.991861	0.99970	D	0.560736	0.96215	D	0.567682	0.96155	D	0.986588954925537	0.77099	D	0.907009	0.67082	D	0.9734272	0.98546	0.94947577	0.98343	0.9758744	0.98759	0.94947577	0.98343	-13.56	0.95852	D	0.9996	0.99217	P	0.999942909939163	0.99079	0.99852294	0.98824	0.915	0.95626	.	.	.	.	.	.	4.927297	0.81239	27.5	0.99539229281110475	0.70435	.	.	.	.	.	.	.	.	.	5.73	5.73	0.89714	.	.	7.674	0.83188	7.906000	0.73829	0.665	0.62996	1.0	0.71675	1.000000	0.68239	1.0	0.97202	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pelizaeus-Merzbacher_disease|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.103787831T>C	ClinGen:CA221105|OMIM:300401.0002|UniProtKB:P60201#VAR_004553	C0205711|C3661900	312080	702	.	Trp	Arg	95.13	0.01762114537444934																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																95.13	1.7621145	>90	<10	312080	x-linked recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	PELIZAEUS-MERZBACHER DISEASE	false	0.9873355817381881	0.9497316466749043	true	true	true
KCTD1	KCTD1_Gly62Asp	B_7-8	1.1885934163489962	0.27335479857460127	0.3598260959872422	2.598056759771155	0.03552552478178866	0.0524030048027188	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5386810679636134	0.7831524289856738	0.6489564178846854	0.6995590251833301	0.664009500675256	0.7180059048332531	0.8743398684600869	0.8286915167552757	0.8822430391276905	0.7746999559616554	0.9892886320969244		0.5616719412064193	0.49932748459523624	0.5168750112389697	0.5232128798077154	0.5770162258744232	0.5386810679636134	KCTD1	Gly62Asp	NC_000018.10:26476639:C:T	185G>A	18	26476639	C	T	18	ENSG00000134504	14221	218283	CCSBVarC005806	ALE00005806	ENSP00000464170.1	CEGS2	CegsMutGDEh1038	E03	GDEhDisVCh_40022	H08	2	CegsMutGDDh1038	E03	VUSN2Hmut_GDN2h_07	F10	VUSMutpDEST2_11	C08	VUSmut_GDEh07	F10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	70536.0	single nucleotide variant	NM_001142730.3(KCTD1):c.2009G>A (p.Gly670Asp)	284252.0	KCTD1	HGNC:18249	Likely pathogenic	1.0	May 06, 2019	587777003.0	-	RCV000049299	MONDO:MONDO:0008404,MedGen:C1867020,OMIM:181270,Orphanet:2036	Scalp-ear-nipple syndrome	germline;unknown	germline	GRCh38	NC_000018.10	18	26476639.0	26476639.0	18q11.2	criteria provided, single submitter	3.0	-	N	ClinGen:CA144001,UniProtKB:Q719H9#VAR_069977,OMIM:613420.0008	3.0	55888.0	26476639.0	C	T	-	-	-	-	-	-	2009G>A 	Gly670Asp	NM_001142730.3	1.0	Pathogenic	Likely pathogenic	55888	18	26476639.0	C	T	G	D	rs587777003	18	24056603	18	22310601	62	KCTD1	ENSG00000134504	ENST00000579973	ENSP00000464170	Q719H9	KCTD1_HUMAN	c.185G>A	p.Gly62Asp	c.185G>A	p.Gly62Asp	.	Y	1	.	.	-	GGT	2	0	C	./.	./.	./.	./.	.	0.78662	.	0.013	0.63436	D	0.998	0.73231	D	0.995	0.83178	D	0.99	0.97926	A	simple_aae	1.0	99.0	2.475	0.71705	M	.	0.91456	.	0.806	0.80404	-0.6674	0.61782	T	0.2517	0.61996	T	10	0.7778436	0.77385	D	0.033514	0.54859	D	.	0.71795	0.524	0.62694	Q719H9	G62D	Gain of helix (P = 0.132)| Gain of solvent accessibility (P = 0.2192)| Gain of loop (P = 0.2754)| Gain of catalytic residue at G62 (P = 0.3895)| Gain of disorder (P = 0.4071)	0.554032115606	0.54729	.	0.86231	.	0.91716	0.940782546997	0.99485	D	0.59095	0.86625	D	0.116977	0.65824	D	-0.0697469	0.65398	T	0.994011342525482	0.84950	D	.	0.57645	.	0.9722792	0.98443	0.956426	0.98756	0.95167565	0.96380	0.95169574	0.98478	-12.047	0.85120	D	.	0.99393	.	0.999409921951799	0.96490	0.68011594	0.85658	0.894	0.94364	.	.	.	.	.	.	4.480546	0.6996	25.4	0.99873250510503386	0.95079	0.920713	0.89271	D	0.812300042010482	0.86799	9.026028	0.811307664792745	0.90518	10.467	5.63	5.63	0.86088	.	.	5.809	0.68916	7.617000	0.62206	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.994	0.71086	876	0.30319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Scalp-ear-nipple_syndrome	criteria_provided,_single_submitter	NC_000018.10:g.26476639C>T	ClinGen:CA144001|OMIM:613420.0008|UniProtKB:Q719H9#VAR_069977	C1867020	181270	2036	Potassium channel tetramerisation-type BTB domain|BTB/POZ domain|BTB/POZ domain-containing protein KCTD1, BTB/POZ domain	Gly	Asp	95.54	0.8095238095238095																																																																																																																																																																																																																																																																																																																																																																																																																																																																													68			95.54	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		BTB/POZ domain-containing protein KCTD1							BTB			-0.4									G62-R58 (PDBs: 5BXB)	 G62-R58 (PAE:  1.0)	G62-R58 (PDBs: 5BXB, 5BXD, 6S4L)							75									98.0				1.9						C (loop/coil)	T (turn)	Beta strand											95.54	80.952385	>90	10-90	181270	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	3	SCALP-EAR-NIPPLE SYNDROME	false	0.7831524289856738	0.5386810679636134	false	false	false
PHYH	PHYH_Gly204Ser	B_15-16	-0.31640049777752755	0.760924876772656	0.8096749385157509	6.686332986617741	0.0002809478687246795	0.000882772840941416	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8781417048857505	0.8785190835141055	0.5860990696502736	0.716854949643644	0.7486712167412028	0.6079737077495477	0.4633903859298319	0.6674603852299992	0.6732638342460895	0.4672319854870595	0.8058454150707705	0.8037766581137199	0.7525570295692636	0.8298820482524064	0.7604460650411986	0.7049661538134877	0.9511927519574406	0.952506751657781	PHYH	Gly204Ser	NC_000010.11:13288428:C:T	610G>A	10	13288428	C	T	10	ENSG00000107537	2156	214169	CCSBVarC005361	ALE00005361	ENSP00000263038.4	CEGS2	CegsMutGDEh1032	C10	GDEhDisVCh_40076	F05	2	CegsMutGDDh1032	C10	VUSN2Hmut_GDN2h_06	H01	VUSMutpDEST2_01	D10	VUSmut_GDEh06	H01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	22626.0	single nucleotide variant	NM_006214.4(PHYH):c.610G>A (p.Gly204Ser)	5264.0	PHYH	HGNC:8940	Likely pathogenic	1.0	Sep 09, 2023	104894173.0	-	RCV000008025|RCV003473055	MedGen:C2749345|MONDO:MONDO:0009958,MedGen:C0034960,OMIM:266500,Orphanet:773	Refsum disease, adult, 1|Phytanic acid storage disease	germline;unknown	germline	GRCh38	NC_000010.11	10	13288428.0	13288428.0	10p13	criteria provided, single submitter	2.0	-	N	ClinGen:CA118907,UniProtKB:O14832#VAR_017489,OMIM:602026.0008	3.0	7587.0	13288428.0	C	T	-	-	-	-	-	-	610G>A 	Gly204Ser	NM_006214.4	1.0	Pathogenic	Likely pathogenic	7587	10	13288428.0	C	T	G	S	rs104894173	10	13330428	10	13370434	204	PHYH	ENSG00000107537	ENST00000263038	ENSP00000263038	O14832	PAHX_HUMAN	c.610G>A	p.Gly204Ser	c.610G>A	p.Gly204Ser	principal1	Y	1	YES	Select	-	GGC	1	0	c	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.97926	A	simple_aae	7.0	93.0	3.485	0.92505	M	-5.65	0.88727	D	0.857	0.85308	0.9992	0.97167	D	0.9905	0.99746	D	9	0.9938359	0.99904	D	0.184172	0.85696	D	0.948	0.98989	0.977	0.99784	O14832	G204S	Gain of catalytic residue at G204 (P = 0.0178)| Loss of stability (P = 0.2357)| Loss of sheet (P = 0.3635)| Gain of disorder (P = 0.5284)| Loss of helix (P = 0.5596)	0.988046287826	0.98778	0.9081461397600805	0.90730	0.629891857601	0.56719	0.571324110031	0.48799	T	0.944577	0.99145	D	0.487518	0.93884	D	0.559363	0.95900	D	0.985695540904999	0.76443	D	0.978136	0.95122	D	0.9436932	0.95556	0.85443294	0.91693	0.928189	0.93966	0.91921216	0.96291	-7.761	0.59502	D	0.7722	0.79996	P	0.98860728682098	0.87857	0.39468142	0.79456	0.903	0.94903	.	.	.	.	.	.	3.95021	0.57942	23.9	0.99839245903979357	0.91978	0.858889	0.77564	D	0.771428782353622	0.84204	8.247149	0.630423452305182	0.77035	6.626174	5.69	5.69	0.88329	3.32	0.60205	6.074	0.70956	5.965000	0.51966	0.506	0.23112	1.0	0.71675	1.000000	0.68239	0.009	0.08693	934	0.15398	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	0	109404	0.000000e+00	0	1	208016	4.807320e-06	0	2	236930	8.441310e-06	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16212	0.000000e+00	0	0	30518	0.000000e+00	0	0	6210	0.000000e+00	0	0	13404	0.000000e+00	0	0	16732	0.000000e+00	0	0	89476	0.000000e+00	0	1	30608	3.267120e-05	0	1	30608	3.267120e-05	0	0	14902	0.000000e+00	0	0	34256	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	1	102732	9.734070e-06	0	1	30526	3.275900e-05	0	1	30526	3.275900e-05	0	.	26	1614054	1.610850e-05	0	1	6070	1.647450e-04	0	0	74930	0.000000e+00	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29608	0.000000e+00	0	0	44886	0.000000e+00	0	0	64038	0.000000e+00	0	1	6070	1.647450e-04	0	23	1180038	1.949090e-05	0	1	91090	1.097820e-05	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Phytanic_acid_storage_disease|Refsum_disease,_adult,_1	criteria_provided,_single_submitter	NC_000010.11:g.13288428C>T	ClinGen:CA118907|OMIM:602026.0008|UniProtKB:O14832#VAR_017489	C0034960|C2749345	266500	773	.	Gly	Ser	93.6	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			93.6	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Phytanoyl-CoA dioxygenase, peroxisomal										-0.4								 G204-R275 (PAE:  1.0)	G204-R275 (PDBs: 2A1X)	 G204-S200 (PAE:  1.0), G204-R275 (PAE: 1.0)	G204-S200 (PDBs: 2A1X), G204-R275 (PDBs: 2A1X)							75									77.7				54.9						C (loop/coil)	T (turn)												93.6	0.0	>90	<10	266500	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease	4	REFSUM DISEASE, CLASSIC	false	0.8785190835141055	0.8781417048857505	false	false	false
MVK	MVK_Pro167Leu	B_7-8	-0.12362091919024873	0.9056526703202008	0.9299981722105287	-1.70881137001799	0.1383461667859513	0.17641780128715817	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6576380706574665	0.673252533984592	0.5699067177558774	0.7653860836514994	0.7448580385433844	0.7875529564556568	0.7452680883505394	0.7540542794257841	0.7210375824537405	0.543770014382789	0.6439353184680427	0.6698929199260188	0.8298378245607743	0.7356617976609847	0.8097345848492584	0.5960434211289659	0.7025697495011411	0.645383221388914	MVK	Pro167Leu	NC_000012.12:109581523:C:T	500C>T	12	109581523	C	T	12	ENSG00000110921	281	13	CCSBVarC000027	ALE00000027	ENSP00000228510.3	Edgotyping3	VUSMutGDEh009	C12	NULL	NULL	NULL	VUSMutGDDh009	C12	VUSN2Hmut_GDN2h_03	H04	VUSMutpDEST2_01	C02	VUSmut_GDEh03	H04	0.0		1.0	1.0	1.0	5.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	Y	N	N	Y	48324.0	single nucleotide variant	NM_000431.4(MVK):c.500C>T (p.Pro167Leu)	4598.0	MVK	HGNC:7530	Pathogenic/Likely pathogenic	1.0	Jun 20, 2024	104895300.0	-	RCV000032937|RCV000445120|RCV003764651	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:C3661900|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900	Hyperimmunoglobulin D with periodic fever|not provided|Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type	germline;unknown	germline	GRCh38	NC_000012.12	12	109581523.0	109581523.0	12q24.11	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA130488,UniProtKB:Q03426#VAR_004023,OMIM:251170.0011	3.0	39725.0	109581523.0	C	T	-	-	-	-	-	-	500C>T 	Pro167Leu	NM_000431.4	2.0	Pathogenic	Likely pathogenic	39725	12	109581523.0	C	T	P	L	rs104895300	12	110019328	12	108503711	167	MVK	ENSG00000110921	ENST00000228510	ENSP00000228510	Q03426	KIME_HUMAN	c.500C>T	p.Pro167Leu	c.500C>T	p.Pro167Leu	principal1	Y	1	YES	Select	+	CCG	2	0	C	C/C	C/C	C/C	C/C	0.559	0.68399	T	0.154	0.68204	T	0.99	0.63438	D	0.781	0.57331	P	0.67	0.80805	A	simple_aae	33.0	67.0	2.31	0.65934	M	-4.53	0.87641	D	0.732	0.73163	0.8355	0.94832	D	0.8990	0.96643	D	10	0.90341914	0.89591	D	0.272149	0.89896	D	0.726	0.90329	.	.	.	.	.	0.949714778069	0.94877	0.7911910438259592	0.78951	0.990223870893	0.73877	0.393547087908	0.24141	T	0.746399	0.92951	D	0.159478	0.69932	D	0.217004	0.83908	D	0.930825531482697	0.59340	D	0.827017	0.58713	T	0.3626759	0.57710	0.11851994	0.28541	0.20926586	0.42867	0.088632494	0.20650	-5.542	0.42311	T	0.2005	0.42461	LB	0.923271751683764	0.77816	0.99954945	0.99479	0.737	0.85429	.	.	.	.	.	.	3.647661	0.51829	23.1	0.99717505580110666	0.81791	0.186161	0.31135	N	0.351857955760191	0.58624	4.058552	0.296269814040618	0.55087	3.695301	5.14	4.19	0.48586	4.62	0.85779	3.431	0.52675	3.319000	0.37610	0.599	0.40292	0.996	0.3946	0.998000	0.34068	0.075	0.16993	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	1	109408	9.140100e-06	0	1	208032	4.806950e-06	0	2	236884	8.442950e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	9046	1.105460e-04	0	1	16214	6.167510e-05	0	0	30522	0.000000e+00	0	0	6208	0.000000e+00	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	0	89472	0.000000e+00	0	0	30608	0.000000e+00	0	1	16214	6.167510e-05	0	1	14902	6.710510e-05	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	1	17692	5.652270e-05	0	0	21632	0.000000e+00	0	0	102686	0.000000e+00	0	0	30526	0.000000e+00	0	1	14902	6.710510e-05	0	.	13	1614202	8.053510e-06	0	2	60032	3.331560e-05	0	0	75044	0.000000e+00	0	0	912	0.000000e+00	0	2	60032	3.331560e-05	0	0	29608	0.000000e+00	0	1	44880	2.228160e-05	0	0	64038	0.000000e+00	0	0	6062	0.000000e+00	0	10	1180032	8.474350e-06	0	0	91086	0.000000e+00	0	0	13176	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	824	0	0	2728	0	0	142	0	0	17726	0	not_provided|Hyperimmunoglobulin_D_with_periodic_fever|Mevalonic_aciduria|Porokeratosis_3,_disseminated_superficial_actinic_type	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.109581523C>T	ClinGen:CA130488|OMIM:251170.0011|UniProtKB:Q03426#VAR_004023	C3661900|C0398691|C1959626|C1867981	260920|610377|175900	343|29	GHMP kinase N-terminal domain	Pro	Leu	93.32	0.1323529411764706																																																																																																																																																																																																																																																																																																																																																																																																																																																																													18			93.32	Special, No backbone hydrogen	Proline		Mevalonate kinase										1.6										 P167-W177 (PAE:  1.0), P167-N175 (PAE: 2.5)	P167-W177 (PDBs: 2R3V), P167-N175 (PDBs: 2R3V)							115									-82.3				-10.4						C (loop/coil)	C (loop/coil)	Turn											93.32	13.235294	>90	10-90	260920;260920;610377;175900	autosomal recessive	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; HYPER-IgD SYNDROME; MEVALONIC ACIDURIA; POROKERATOSIS 3, MULTIPLE TYPES	false	0.673252533984592	0.6576380706574665	false	false	false
SMAD3	SMAD3_Arg268Cys	B_15-16	1.9622759137633665	0.09051564826149161	0.15112315400301485	2.22789750761941	0.061160316008011924	0.08502210596568324	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6772475308014323	0.6961188318844009	0.47857712442147604	0.572081675189315	0.5297139995362096	0.44191300693997226	0.4211388844786522	0.45908442172225983	0.49100870823102316	0.4585213982744801	0.541831408248765	0.4997493017216619	0.4626871294012923	0.6003435773501593	0.6531546421476068	0.49863285056847206	0.850406255520037	0.8547457598812028	SMAD3	Arg268Cys	NC_000015.10:67181384:C:T	802C>T	15	67181384	C	T	15	ENSG00000166949	11805	2151	CCSBVarC007731	ALE00007717	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	C02	GDEhDisVCh_40014	H08	2	VUSMutGDDh005	C02	VUSN2Hmut_GDN2h_01	E11	VUSMutpDEST2_09	G04	VUSmut_GDEh01	E11	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	195348.0	single nucleotide variant	NM_005902.4(SMAD3):c.802C>T (p.Arg268Cys)	4088.0	SMAD3	HGNC:6769	Pathogenic/Likely pathogenic	1.0	Jul 31, 2024	794727798.0	-	RCV000179456|RCV001852232	MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000015.10	15	67181384.0	67181384.0	15q22.33	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020119	2.0	198187.0	67181384.0	C	T	-	-	-	-	-	-	802C>T 	Arg268Cys	NM_005902.4	2.0	Pathogenic	Likely pathogenic	198187	15	67181384.0	C	T	R	C	rs794727798	15	67473722	15	65260776	268	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.802C>T	p.Arg268Cys	c.802C>T	p.Arg268Cys	principal1	Y	1	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	0.014	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.91795	A	simple_aae	18.0	82.0	4.025	0.96847	H	-7.67	0.96411	D	0.979	0.99419	1.0677	0.98527	D	0.9771	0.99288	D	10	0.9896215	0.99428	D	0.768124	0.98161	D	0.970	0.99647	0.947	0.99343	P84022	R268C	Loss of disorder (P = 0.0557)| Loss of catalytic residue at R268 (P = 0.1231)| Loss of solvent accessibility (P = 0.239)| Loss of sheet (P = 0.302)| Loss of MoRF binding (P = 0.3657)	0.991673311881	0.99148	0.9000356752418807	0.89912	2.78200157186	0.98837	0.941024780273	0.99493	D	0.996462	0.99995	D	0.557354	0.96007	D	0.562824	0.95945	D	0.999905824661255	0.99626	D	0.962504	0.85963	D	0.9502042	0.96227	0.8534361	0.91625	0.9502042	0.96228	0.8534361	0.91625	-10.736	0.78261	D	0.9978	0.97655	P	0.998426854083322	0.94436	0.99542870	0.97782	0.883	0.93708	.	.	.	.	.	.	6.190521	0.94767	34.0	0.9993696437237517	0.99661	0.799695	0.72488	D	0.901979921570662	0.91811	11.10103	0.80475495327301	0.90067	10.26581	5.1	5.1	0.68875	.	.	3.948	0.56459	7.628000	0.62662	0.594	0.32546	1.0	0.71675	1.000000	0.68239	0.995	0.73271	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.67181384C>T	ClinGen:CA020119	C3661900|C4707243	PS607086	91387	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Arg	Cys	96.71	0.2540322580645161																																																																																																																																																																																																																																																																																																																																																																																																																																																																													63			96.71	Positively-charged	Arginine		Mothers against decapentaplegic homolog 3							MH2			-4.5								 R268-D262 (PAE:  2.0), R268-D258 (PAE: 1.0)	R268-P263 (PDBs: 1MJS, 1MK2), R268-D258 (PDBs: 5XOC)	 R268-D262 (PAE:  2.0), R268-D258 (PAE: 1.0)	R268-D262 (PDBs: 5XOC), R268-D258 (PDBs: 5XOC)	 R268-D262 (PAE:  2.0), R268-D258 (PAE: 1.0)						175									-135.5				114.8						B (undefined)	E (parallel sheets)	Beta strand											96.71	25.403225	>90	10-90		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.6961188318844009	0.6772475308014323	false	false	false
KRT2	KRT2_Glu488Lys	B_7-8	-2.9083570327905788	0.027038244789788994	0.057001156234544124	-2.136732683835079	0.0699710862038243	0.09546241128923241	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.640596672309979	0.6358074259208121	0.5205083162761808	0.5186095570369813	0.49727724500264325	0.4929365093497749	0.47283465816064585	0.5188978974233702	0.5275432865088336	0.502191199540882	0.6454375340086758	0.6519015906919323	0.513038360538904	0.4756565925819162	0.509675827565129	0.5388254330114796	0.6261773178329484	0.6292917539280255	KRT2	Glu488Lys	NC_000012.12:52646747:C:T	1462G>A	12	52646747	C	T	12	ENSG00000172867	55855	219420	CCSBVarC003454	ALE00003454	ENSP00000310861.3	CEGS2	CegsMutGDEh1038	A10	GDEhDisVCh_40073	D08	1	CegsMutGDDh1038	A10	VUSN2Hmut_GDN2h_07	C12	VUSMutpDEST2_13	H06	VUSmut_GDEh07	C12	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	2.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	77089.0	single nucleotide variant	NM_000423.3(KRT2):c.1462G>A (p.Glu488Lys)	3849.0	KRT2	HGNC:6439	Likely pathogenic	1.0	Mar 20, 2024	61726452.0	-	RCV000056534	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000012.12	12	52646747.0	52646747.0	12q13.13	criteria provided, single submitter	2.0	-	N	ClinGen:CA216632,UniProtKB:P35908#VAR_031086	2.0	66192.0	52646747.0	C	T	-	-	-	-	-	-	1462G>A 	Glu488Lys	NM_000423.3	1.0	Pathogenic	Likely pathogenic	66192	12	52646747.0	C	T	E	K	rs61726452	12	53040531	12	51326798	488	KRT2	ENSG00000172867	ENST00000309680	ENSP00000310861	P35908	K22E_HUMAN	c.1462G>A	p.Glu488Lys	c.1462G>A	p.Glu488Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.93829	D	simple_aae	7.0	93.0	3.86	0.95772	H	-3.78	0.71557	D	0.976	0.98669	1.0297	0.97706	D	0.8911	0.96379	D	9	0.9732355	0.96959	D	0.196461	0.86447	D	0.955	0.99221	0.844	0.94817	P35908	E488K	Gain of methylation at E488 (P = 0.0026)| Gain of catalytic residue at G493 (P = 0.0029)| Gain of ubiquitination at E488 (P = 0.0082)| Loss of disorder (P = 0.2209)| Gain of relative solvent accessibility (P = 0.2363)	0.972023083338	0.97145	0.9321805884985477	0.93154	0.497612009223	0.47968	0.613218903542	0.54705	T	0.919542	0.98532	D	0.481394	0.93699	D	0.453712	0.93619	D	0.999384164810181	0.97169	D	0.945705	0.79299	D	0.9142555	0.92587	0.86532974	0.92444	0.9142555	0.92588	0.86532974	0.92445	-12.295	0.86293	D	0.9504	0.86921	P	0.989313345177371	0.88127	0.96441954	0.94253	0.832	0.90743	.	.	.	.	.	.	5.352929	0.89805	31.0	0.99916942528994723	0.98450	0.932733	0.92326	D	0.90087106797924	0.91757	11.07233	0.789759083205515	0.89014	9.827429	4.33	4.33	0.51026	.	.	7.878	0.85696	.	.	0.594	0.32546	1.0	0.71675	1.000000	0.68239	0.975	0.56052	814	0.42043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	no_classification_provided	NC_000012.12:g.52646747C>T	ClinGen:CA216632|UniProtKB:P35908#VAR_031086	CN517202	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Glu	Lys	66.43	0.6237113402061856																																																																																																																																																																																																																																																																																																																																																																																																																																																																													121			66.43	Negatively-charged	Glutamic Acid		Keratin, type II cytoskeletal 2 epidermal							IF rod			-3.5								 E488-S492 (PAE:  6.0), E488-L484 (PAE: 3.0)		 E488-S492 (PAE:  6.0), E488-L484 (PAE: 3.0)								146									-59.5				-37.3	Tail					H (helix)	H (α-helix)												66.43	62.371136	50-70	10-90		autosomal dominant	OMIM	Rare genetic skin disease	1		false	0.6358074259208121	0.640596672309979	false	false	false
PMP22	PMP22_Arg157Trp	B_7-8	0.810462282254141	0.448618304110326	0.537610538546545	-3.0310918007633383	0.02306550393533265	0.03571746811927039	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6895820889911548	0.7559618518443167	0.6293049113751137	0.7620512238056478	0.6495063758004255	0.7433835561669848	0.8148247182592225	0.6802555212184959	0.7677796437149624	0.7231054899029233	0.790082324137882	0.7861729234423727	0.6719423940747471	0.6187572303823551	0.7563228038963332	0.5355043328473039	0.7218413795507513	0.5929912545399368	PMP22	Arg157Trp	NC_000017.11:15230931:G:A	469C>T	17	15230931	G	A	17	ENSG00000109099	7323	216371	CCSBVarC006153	ALE00006153	ENSP00000308937.3	CEGS2	CegsMutGDEh1033	E10	GDEhDisVCh_40078	E06	2	CegsMutGDDh1033	E10	VUSN2Hmut_GDN2h_06	H05	VUSMutpDEST2_06	G03	VUSmut_GDEh06	H05	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	23483.0	single nucleotide variant	NM_000304.4(PMP22):c.469C>T (p.Arg157Trp)	5376.0	PMP22	HGNC:9118	Pathogenic/Likely pathogenic	1.0	Nov 22, 2024	28936682.0	-	RCV000008957|RCV000778488|RCV001173916|RCV001332355|RCV000193053|RCV001229968	MedGen:CN069172||MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MONDO:MONDO:0008087,MedGen:C0393814,OMIM:162500,Orphanet:640|MONDO:MONDO:0007311,MedGen:C3495591,OMIM:118300,Orphanet:90658|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753	Autosomal recessive Dejerine-Sottas syndrome|PMP22-related disorder|Charcot-Marie-Tooth disease|Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease, type I	de novo;germline;unknown	germline	GRCh38	NC_000017.11	17	15230931.0	15230931.0	17p12	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA119628,UniProtKB:Q01453#VAR_009664,OMIM:601097.0018	3.0	8444.0	15230931.0	G	A	-	-	-	-	-	-	469C>T 	Arg157Trp	NM_000304.4	2.0	Pathogenic	Likely pathogenic	8444	17	15230931.0	G	A	R	W	rs28936682	17	15134248	17	15074973	157	PMP22	ENSG00000109099	ENST00000675808	ENSP00000502310	Q01453	PMP22_HUMAN	.	.	c.469C>T	p.Arg157Trp	principal1	Y	.	.	.	-	CGG	1	2	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.999	0.92348	D	.	0.92286	.	.	.	.	3.265	0.89891	M	.	0.95091	.	.	0.85414	1.0764	0.98768	D	0.9382	0.97964	D	9	.	0.83535	.	0.579661	0.96223	D	.	0.97659	0.688	0.82479	Q01453	R157W	Loss of disorder (P = 0.0022)| Gain of ubiquitination at K158 (P = 0.0601)| Loss of loop (P = 0.1242)| Gain of helix (P = 0.2059)| Gain of catalytic residue at V154 (P = 0.2142)	.	0.97046	.	0.88390	.	.	0.733134388924	0.71915	T	0.879723	0.97447	D	-0.27299	0.11183	T	-0.629907	0.10180	T	0.998637020587921	0.94660	D	.	0.88197	.	0.8325736	0.85899	0.73183346	0.83963	0.82044894	0.85059	0.69802636	0.82009	-12.238	0.86028	D	.	0.84678	.	0.9967217138572	0.92405	0.99945563	0.99403	0.928	0.96414	.	.	.	.	.	.	5.292609	0.8888	29.8	0.99910933241173117	0.98024	0.775167	0.70759	D	0.757113336789463	0.83277	7.999077	0.694518219664841	0.81862	7.650878	5.05	5.05	0.67523	2.91	0.53205	3.165	0.50573	5.772000	0.49823	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.995	0.73271	806	0.43519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109234	0.000000e+00	0	0	207894	0.000000e+00	0	1	236636	4.225900e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13228	0.000000e+00	0	0	42762	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16212	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13412	0.000000e+00	0	0	16568	0.000000e+00	0	0	89496	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9564	0.000000e+00	0	0	17690	0.000000e+00	0	0	21466	0.000000e+00	0	1	102616	9.745070e-06	0	0	30526	0.000000e+00	0	1	102616	9.745070e-06	0	.	6	1614020	3.717430e-06	0	1	44870	2.228660e-05	0	0	75042	0.000000e+00	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	0	29608	0.000000e+00	0	1	44870	2.228660e-05	0	0	63888	0.000000e+00	0	0	6058	0.000000e+00	0	5	1180030	4.237180e-06	0	0	91074	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	PMP22-related_disorder|Charcot-Marie-Tooth_disease,_type_I|Charcot-Marie-Tooth_disease|Hereditary_liability_to_pressure_palsies|Autosomal_recessive_Dejerine-Sottas_syndrome|Charcot-Marie-Tooth_disease_type_1E	criteria_provided,_conflicting_classifications	NC_000017.11:g.15230931G>A	ClinGen:CA119628|OMIM:601097.0018|UniProtKB:Q01453#VAR_009664	C0751036|C0007959|C0393814|CN069172|C3495591	PS118220|162500|118300	65753|166|640|90658	.	Arg	Trp	86.92	0.6008064516129032																																																																																																																																																																																																																																																																																																																																																																																																																																																																													149			86.92	Positively-charged	Arginine		Peripheral myelin protein 22								0.6561		-4.5								 R157-G93 (PAE:  3.5)		 R157-G93 (PAE:  3.5)								175									-116.0		Pocket 1: Mean pLDDT: 62.92, Volume: 685.82 Å³, Druggability score: 0.66		130.3				dbSNP: rs28936682; Variant type: LB/B; AA change: Arg157Gly; PTM type: Phosphorylation; PTM morphology: LSGVIyVILR*K; Var class: II&rs28936682		B (undefined)	B (beta bridge)							Cytoplasmic					86.92	60.080647	70-90	10-90	162500;118300	autosomal dominant	OMIM	Genetic otorhinolaryngologic disease; Rare genetic neurological disorder; Rare chromosomal anomaly	3	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS	false	0.7559618518443167	0.6895820889911548	false	false	false
TH	TH_Leu205Pro	B_7-8	0.9747428380896954	0.3673322419030473	0.45910554548349564	0.3407041005263361	0.7433230773599635	0.7848088877764862	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6409515064327699	0.7262804944141981	0.6304308154324367	0.6988535288749883	0.5637448190366381	0.696852783302431	0.7282819190125984	0.553018937184641	0.7544420143254043	0.6350562403484625	0.7356033011278675	0.6919814599063523	0.6654236475922635	0.5744707008886353	0.6432650434245724	0.6258053905164109	0.7169576877005286	0.5899215529591875	TH	Leu205Pro	NC_000011.10:2167896:A:G	614T>C	11	2167896	A	G	11	ENSG00000180176	71892	4015	CCSBVarC008294	ALE00008280	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	C11	GDEhDisVCh_40019	A11	1	VUSMutGDDh015	C11	VUSN2Hmut_GDN2h_04	E12	VUSMutpDEST2_15	A09	VUSmut_GDEh04	E12	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	27364.0	single nucleotide variant	NM_000360.4(TH):c.614T>C (p.Leu205Pro)	7054.0	TH	HGNC:11782	Pathogenic/Likely pathogenic	1.0	Jul 01, 2024	121917763.0	-	RCV000013118|RCV002274896	MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150|MedGen:C3661900	Autosomal recessive DOPA responsive dystonia|not provided	germline;paternal;unknown	germline	GRCh38	NC_000011.10	11	2167896.0	2167896.0	11p15.5	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA341191,UniProtKB:P07101#VAR_014027,OMIM:191290.0002	3.0	12325.0	2167896.0	A	G	-	-	-	-	-	-	614T>C 	Leu205Pro	NM_000360.4	2.0	Pathogenic	Likely pathogenic	12325	11	2167896.0	A	G	L	P	rs121917763	11	2189126	11	2145702	236	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.707T>C	p.Leu236Pro	c.707T>C	p.Leu236Pro	.	Y	1	.	.	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.132	0.28526	T	0.194	0.30054	T	0.708	0.42053	P	0.472	0.46816	P	0.99	0.99291	A	simple_aae	1.0	99.0	0.345	0.11102	N	-1.53	0.37165	N	0.737	0.85626	0.9927	0.97058	D	0.9149	0.97175	D	9	0.96955276	0.96478	D	0.873007	0.99027	D	0.618	0.85072	0.847	0.94998	P07101	L236P	Loss of stability (P = 0.0158)| Gain of disorder (P = 0.0361)| Loss of MoRF binding (P = 0.0596)| Gain of methylation at K235 (P = 0.1098)| Gain of catalytic residue at K235 (P = 0.1791)	0.85125097569	0.84865	0.847768209693635	0.84645	0.251773821176	0.27463	0.434190928936	0.29746	T	0.81705	0.95451	D	0.335942	0.85458	D	0.314619	0.88782	D	0.35216623544693	0.26804	T	0.926107	0.75227	D	0.54888535	0.69596	0.27055734	0.52744	0.4616021	0.64456	0.32584116	0.58267	-14.167	0.94481	D	0.8539	0.79931	P	0.930615764940879	0.78456	0.99364185	0.97375	0.39	0.63936	.	.	.	.	.	.	1.739695	0.22175	15.5	0.95761362461486255	0.27970	0.297249	0.40492	N	-0.781772458249798	0.13619	0.6816538	-0.786662010039434	0.14570	0.7764884	3.06	0.701	0.17220	-1.69	0.12741	-0.4	0.07319	0.174000	0.15620	-0.933	0.02142	0.0	0.06393	0.000000	0.08389	0.852	0.40339	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	2	107150	1.866540e-05	0	1	203042	4.925090e-06	0	3	231600	1.295340e-05	0	0	6728	0.000000e+00	0	0	16884	0.000000e+00	0	0	2252	0.000000e+00	0	0	8984	0.000000e+00	0	0	13280	0.000000e+00	0	2	41802	4.784460e-05	0	0	15358	0.000000e+00	0	2	41802	4.784460e-05	0	0	15464	0.000000e+00	0	0	30128	0.000000e+00	0	0	6024	0.000000e+00	0	0	13292	0.000000e+00	0	0	16566	0.000000e+00	0	1	86864	1.151220e-05	0	0	29960	0.000000e+00	0	1	86864	1.151220e-05	0	0	14254	0.000000e+00	0	0	33878	0.000000e+00	0	0	9460	0.000000e+00	0	0	17588	0.000000e+00	0	0	20448	0.000000e+00	0	3	100566	2.983120e-05	0	0	29890	0.000000e+00	0	3	100566	2.983120e-05	0	.	7	1610598	4.346210e-06	0	1	74880	1.335470e-05	0	1	74880	1.335470e-05	0	0	912	0.000000e+00	0	0	59806	0.000000e+00	0	0	29540	0.000000e+00	0	0	44804	0.000000e+00	0	0	62618	0.000000e+00	0	0	6078	0.000000e+00	0	6	1179054	5.088830e-06	0	0	90568	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Autosomal_recessive_DOPA_responsive_dystonia|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.2167896A>G	ClinGen:CA341191|OMIM:191290.0002|UniProtKB:P07101#VAR_014027	C2673535|C3661900	605407	101150	Aromatic amino acid hydroxylase, C-terminal|Aromatic amino acid hydroxylase, C-terminal|Aromatic amino acid hydroxylase, C-terminal|Tyrosine 3-monooxygenase, catalytic domain	Leu	Pro	95.75	0.5975609756097561																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																95.75	59.7561	>90	10-90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.7262804944141981	0.6409515064327699	false	false	false
DES	DES_Ser46Tyr	B_7-8	0.6794433572054654	0.5221908864727175	0.6022853823447406	1.449004201662139	0.1906091372642262	0.23442879817684656	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7488440469276856	0.6460823104025326	0.6596978502632754	0.709498499530434	0.7682393937239551	0.6730175109354541	0.943479842532281	0.9280468763974284	0.9455934805821833	0.8974635355807882	0.727123538352361	0.7488440469276856	0.40255517933862733	0.6084319110504819	0.47340351847868467	0.42193216494576274	0.5650410824527041		DES	Ser46Tyr	NC_000002.12:219418599:C:A	137C>A	2	219418599	C	A	2	ENSG00000175084	12573	2226	CCSBVarC006502	ALE00006501	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	F01	GDEhDisVCh_40003	G01	1	VUSMutGDDh003	F01	VUSN2Hmut_GDN2h_01	E01	NULL	NULL	VUSmut_GDEh01	E01	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	77302.0	single nucleotide variant	NM_001927.4(DES):c.137C>A (p.Ser46Tyr)	1674.0	DES	HGNC:2770	Likely pathogenic	1.0	Oct 04, 2021	60794845.0	-	RCV000056793	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000002.12	2	219418599.0	219418599.0	2q35	criteria provided, single submitter	2.0	ACMG2022	N	ClinGen:CA217053,UniProtKB:P17661#VAR_042450	2.0	66405.0	219418599.0	C	A	-	-	-	-	-	-	137C>A 	Ser46Tyr	NM_001927.4	1.0	Pathogenic	Likely pathogenic	66405	2	219418599.0	C	A	S	Y	rs60794845	2	220283321	2	219991565	46	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.137C>A	p.Ser46Tyr	c.137C>A	p.Ser46Tyr	principal1	Y	1	YES	Select	+	TCC	2	0	C	C/C	C/C	C/C	C/C	0.039	0.42645	D	0.074	0.43323	T	0.911	0.50348	P	0.601	0.50805	P	0.87	0.90832	A	simple_aae	13.0	87.0	1.7	0.43657	L	-0.85	0.23101	N	0.797	0.79233	-0.1071	0.79845	T	0.4904	0.80557	T	10	0.9714304	0.96720	D	0.438643	0.94110	D	0.548	0.81155	0.909	0.98139	P17661	S46Y	Loss of relative solvent accessibility (P = 0.0306)| Loss of sheet (P = 0.0357)| Loss of solvent accessibility (P = 0.0468)| Gain of catalytic residue at S46 (P = 0.0685)| Loss of phosphorylation at S48 (P = 0.1145)	0.92984043673	0.92858	0.8043300842046428	0.80273	1.13862094755	0.78733	0.732769906521	0.71863	T	0.359175	0.72390	T	0.220851	0.75676	D	0.0794609	0.75359	D	0.868884146213531	0.51620	D	0.70113	0.30848	T	0.42450768	0.62068	0.41549513	0.65409	0.42450768	0.62069	0.41549513	0.65409	-6.529	0.50574	T	0.2276	0.46000	B	0.978669530082009	0.85001	0.99068380	0.96838	0.646	0.80291	.	.	.	.	.	.	3.559863	0.50172	22.9	0.96828735034294078	0.31449	0.793048	0.72014	D	0.146221632668104	0.48385	3.0732	0.193932307737566	0.49252	3.153661	5.13	5.13	0.69688	2.56	0.46987	5.753	0.68465	7.378000	0.58502	0.524	0.24207	0.964	0.33941	1.000000	0.68239	0.755	0.36	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000002.12:g.219418599C>A	ClinGen:CA217053|UniProtKB:P17661#VAR_042450	CN517202	.	.	Intermediate filament head, DNA-binding domain	Ser	Tyr	38.61	0.9538461538461539																																																																																																																																																																																																																																																																																																																																																																																																																																																																													124			38.61	Polar/Neutral	Serine		Desmin										-0.8																		105									-79.1				102.5	Head			dbSNP: rs60794845; Variant type: LP/P; AA change: Ser46Phe; PTM type: Phosphorylation; PTM morphology: GskGssSSVTS; Var class: I&rs60794845		C (loop/coil)	C (loop/coil)												38.61	95.38461	$\leqslant$50	$\geqslant$90		unknown		Rare genetic cardiac disease; Rare genetic neurological disorder	2		false	0.6460823104025326	0.7488440469276856	false	false	false
TPM1	TPM1_Ser215Leu	B_15-16	0.8458426010747999	0.543882278678881	0.5892955458232992	-3.2756106800344176	0.3200457830484313	0.34447433612936984	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6596941943207517	0.6577731698959581	0.6056381049267943	0.6283935377484104	0.6432419723422396	0.6492627410347798	0.6391222628013328	0.5516413758874001	0.5598946223535739	0.6452745653379711	0.5898000629223379	0.6003892366211991	0.6594032192682269	0.7348425687970789	0.6968924531432469	0.5660016445156175	0.7257462768695784	0.7189991520203042	TPM1	Ser215Leu	NC_000015.10:63062219:C:T	644C>T	15	63062219	C	T	15	ENSG00000140416	4723	201743	CCSBVarC005644	ALE00005644	ENSP00000288398.6	CEGS2	CegsMutGDEh1041	A12	GDEhDisVCh_40050	G08	2	CegsMutGDDh1041	A12	VUSN2Hmut_GDN2h_08	F10	VUSMutpDEST2_04	G07	VUSmut_GDEh08	F10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	40543.0	single nucleotide variant	NM_001018005.2(TPM1):c.644C>T (p.Ser215Leu)	7168.0	TPM1	HGNC:12010	Pathogenic/Likely pathogenic	1.0	Aug 12, 2024	199476316.0	-	RCV000024579|RCV000144848|RCV000143959|RCV000168063|RCV000617620|RCV001594373	MedGen:C3661900|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569|MedGen:CN230736|MONDO:MONDO:0012744,MedGen:C2678476,OMIM:611878,Orphanet:154,Orphanet:54260	not provided|Cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy 1Y	germline	germline	GRCh38	NC_000015.10	15	63062219.0	63062219.0	15q22.2	criteria provided, multiple submitters, no conflicts	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018243,Leiden Muscular Dystrophy (TPM1):TPM1_00014	2.0	31883.0	63062219.0	C	T	-	-	-	-	-	-	644C>T 	Ser215Leu	NM_001018005.2	2.0	Pathogenic	Likely pathogenic	31883	15	63062219.0	C	T	S	L	rs199476316	15	63354418	15	61141471	215	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.644C>T	p.Ser215Leu	c.644C>T	p.Ser215Leu	alternative1	Y	1	YES	Select	+	TCG	2	0	C	C/C	C/C	C/C	C/C	0.05	0.91343	D	0.129	0.37649	T	0.911	0.90580	P	0.759	0.86259	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.24	0.89550	M	-4.26	0.82171	D	0.878	0.93024	1.0555	0.98232	D	0.9541	0.98508	D	10	0.8846915	0.87659	D	0.241713	0.88702	D	0.867	0.95976	.	0.81117	.	.	.	0.971049458813	0.97046	.	0.90184	.	0.95825	0.701864242554	0.67358	T	0.970897	0.99682	D	0.569138	0.96559	D	0.579751	0.96501	D	0.985477784015943	0.76286	D	0.974903	0.91082	D	0.4892984	0.66151	0.35662696	0.60932	0.42342064	0.61998	0.46626267	0.68772	-12.182	0.85764	D	0.4144	0.65870	A	0.998076167346462	0.93925	0.99948376	0.99419	0.924	0.96172	.	.	.	.	.	.	5.619741	0.92604	32.0	0.99900924864264717	0.97276	0.951063	0.96515	D	0.810764631490801	0.86705	8.994989	0.812055793974829	0.90566	10.49034	5.95	5.95	0.96408	4.46	0.83695	7.813	0.847	7.647000	0.63553	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.992	0.67791	791	0.46035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109402	0.000000e+00	0	1	208112	4.805100e-06	0	0	236732	0.000000e+00	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	0	42766	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	1	89540	1.116820e-05	0	0	30608	0.000000e+00	0	1	89540	1.116820e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9564	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	0	102548	0.000000e+00	0	0	30526	0.000000e+00	0	.	.	.	.	.	2	1613842	1.239280e-06	0	1	59986	1.667060e-05	0	0	74888	0.000000e+00	0	0	912	0.000000e+00	0	1	59986	1.667060e-05	0	0	29604	0.000000e+00	0	0	44876	0.000000e+00	0	0	64014	0.000000e+00	0	0	6084	0.000000e+00	0	1	1179924	8.475120e-07	0	0	91072	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Hypertrophic_cardiomyopathy|Cardiomyopathy|Primary_familial_hypertrophic_cardiomyopathy|Cardiovascular_phenotype|not_provided|Dilated_cardiomyopathy_1Y	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.63062219C>T	ClinGen:CA018243|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00014	C0007194|C0878544|C0949658|CN230736|C3661900|C2678476	PS192600|611878	217569|167848|155|154|54260	.	Ser	Leu	96.12	0.38461538461538464																																																																																																																																																																																																																																																																																																																																																																																																																																																																													50			96.12	Polar/Neutral	Serine		Tropomyosin alpha-1 chain	Coiled coil									-0.8								 S215-D219 (PAE:  1.0), S215-A211 (PAE: 1.0)		 S215-D219 (PAE:  1.0), S215-A211 (PAE: 1.0)								105									-57.0	Morphology: EAQAEkysQKEDRyE; Domain: Tropomyosin			-48.7						H (helix)	H (α-helix)												96.12	38.46154	>90	10-90	611878	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	CARDIOMYOPATHY, DILATED, 1Y	false	0.6577731698959581	0.6596941943207517	false	false	false
STAR	STAR_Val187Met	B_7-8	5.003447087620763	0.01536338488453455	0.037765849587465886	8.765543350432546	0.00005063048778409808	0.0002432118981251832	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8219119772728962	0.8506776965236216	0.7140917307051853	0.6597179090832465	0.6813050847055522	0.7518173167381275	0.7518173167381275	0.8240525136230288	0.7708036638991385	0.7140917307051853	0.920460204223986	0.9049995316860435		0.5385576557880757	0.5486321542673545		0.7808951888232573	0.7388244228597489	STAR	Val187Met	NC_000008.11:38146054:C:T	559G>A	8	38146054	C	T	8	ENSG00000147465	386	213659	CCSBVarC005623	ALE00005623	ENSP00000276449.3	CEGS2	CegsMutGDEh1033	C02	GDEhDisVCh_40077	G04	1	CegsMutGDDh1033	C02	VUSN2Hmut_GDN2h_06	A03	VUSMutpDEST2_01	D07	VUSmut_GDEh06	A03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	24035.0	single nucleotide variant	NM_000349.3(STAR):c.559G>A (p.Val187Met)	6770.0	STAR	HGNC:11359	Pathogenic/Likely pathogenic	1.0	Feb 01, 2024	104894089.0	-	RCV000009559|RCV000811531|RCV004566708	MONDO:MONDO:0008725,MedGen:C0342474,OMIM:201710,Orphanet:418,Orphanet:90790|MedGen:C3661900|MONDO:MONDO:0010408,MedGen:C2678045,OMIM:300707,Orphanet:140952	Congenital lipoid adrenal hyperplasia due to STAR deficency|not provided|Syndactyly-telecanthus-anogenital and renal malformations syndrome	germline;unknown	germline	GRCh38	NC_000008.11	8	38146054.0	38146054.0	8p11.23	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA120043,OMIM:600617.0011	3.0	8996.0	38146054.0	C	T	-	-	-	-	-	-	559G>A 	Val187Met	NM_000349.3	2.0	Pathogenic	Likely pathogenic	8996	8	38146054.0	C	T	V	M	rs104894089	8	38003572	8	38122729	187	STAR	ENSG00000147465	ENST00000276449	ENSP00000276449	P49675	STAR_HUMAN	c.559G>A	p.Val187Met	c.559G>A	p.Val187Met	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.002	0.79703	D	0.998	0.73231	D	0.937	0.67258	D	0.73	0.83975	A	simple_aae	27.0	73.0	2.93	0.84361	M	-1.96	0.45412	N	0.949	0.95739	0.7159	0.93349	D	0.7815	0.92559	D	9	0.98322296	0.98431	D	0.240662	0.88656	D	0.825	0.94411	0.944	0.99276	P49675	V187M	Gain of MoRF binding (P = 0.1048)| Loss of sheet (P = 0.1501)| Gain of loop (P = 0.2045)| Gain of disorder (P = 0.2386)| Gain of methylation at K191 (P = 0.2575)	0.876665853579	0.87450	0.7390887480650664	0.73714	0.784353754413	0.65212	0.797731280327	0.81586	T	0.502557	0.82090	D	0.415977	0.90744	D	0.359745	0.90628	D	0.966121852397919	0.67272	D	0.888311	0.61678	D	0.74101067	0.80114	0.7209574	0.83328	0.76545244	0.81554	0.74293864	0.84622	-8.292	0.63116	D	0.6642	0.71441	P	0.948254686856137	0.80244	0.95063230	0.93409	0.766	0.87043	.	.	.	.	.	.	5.117829	0.85618	28.6	0.99900820893186948	0.97276	0.864095	0.78200	D	0.968662034197404	0.94667	12.96437	0.922786931693963	0.96471	14.76154	5.84	5.84	0.93363	4.87	0.88614	7.316	0.78371	4.830000	0.45268	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.99	0.65338	121	0.95159	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	segdup	0	109394	0.000000e+00	0	1	208036	4.806860e-06	0	2	236900	8.442380e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13388	0.000000e+00	0	0	42760	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16212	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13412	0.000000e+00	0	0	16728	0.000000e+00	0	1	89484	1.117520e-05	0	0	30608	0.000000e+00	0	1	89484	1.117520e-05	0	0	14898	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21622	0.000000e+00	0	2	102712	1.947190e-05	0	0	30526	0.000000e+00	0	2	102712	1.947190e-05	0	.	20	1614128	1.239060e-05	0	1	6084	1.643660e-04	0	1	74938	1.334440e-05	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29608	0.000000e+00	0	1	44896	2.227370e-05	0	0	64040	0.000000e+00	0	1	6084	1.643660e-04	0	16	1180048	1.355880e-05	0	0	91096	0.000000e+00	0	1	12080	8.278145695364238E-5	0	108	0	0	84	0	0	3134	0	0	146	0	0	610	0	0	24	0	0	94	0	0	530	0	0	3242	0	0	108	0	1	16810	5.94883997620464E-5	Congenital_lipoid_adrenal_hyperplasia_due_to_STAR_deficency|not_provided|Syndactyly-telecanthus-anogenital_and_renal_malformations_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000008.11:g.38146054C>T	ClinGen:CA120043|OMIM:600617.0011	C0342474|C3661900|C2678045	201710|300707	418|90790|140952	START domain|START domain|START domain	Val	Met	98.81	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.81	Aliphatic	Valine		Steroidogenic acute regulatory protein, mitochondrial							START			4.2								 V187-M202 (PAE:  1.0)	V187-M202 (PDBs: 3P0L)	 V187-M202 (PAE:  1.0)	V187-M202 (PDBs: 3P0L)							117									-80.6				134.8						B (undefined)	E (parallel sheets)	Beta strand											98.81	0.0	>90	<10	201710;300707	multiple	OMIM	Rare genetic gynecological and obstetrical diseases; Rare genetic developmental defect during embryogenesis; Rare genetic urogenital disease; Rare genetic endocrine disease; Genetic infertility	5	LIPOID CONGENITAL ADRENAL HYPERPLASIA; TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS	false	0.8506776965236216	0.8219119772728962	false	false	false
SH3BP2	SH3BP2_Pro418Leu	B_7-8	-4.743349821948639	0.017772580125270953	0.041753540023699284	1.5679301748113172	0.16088384611722178	0.20234534449972721	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5768037784269154	0.6030104761712097	0.6050150404046256	0.733191198199693	0.7164130581838792	0.6779591859769015	0.6779591859769015	0.7188556959373898	0.6500560272952393	0.6050150404046256	0.6260199216953941	0.5768037784269154		0.7139704204303687	0.8163263691041469		0.5800010306470254		SH3BP2	Pro418Leu	NC_000004.12:2831582:C:T	1253C>T	4	2831582	C	T	4	ENSG00000087266	8143	202840	CCSBVarC003710	ALE00003710	ENSP00000422168.3	CEGS2	CegsMutGDEh1037	E05	GDEhDisVCh_40022	H06	2	CegsMutGDDh1037	E05	VUSN2Hmut_GDN2h_07	A08	VUSMutpDEST2_07	H08	VUSmut_GDEh07	A08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	22586.0	single nucleotide variant	NM_001122681.2(SH3BP2):c.1253C>T (p.Pro418Leu)	6452.0	SH3BP2	HGNC:10825	Pathogenic/Likely pathogenic	1.0	Jan 28, 2022	121909146.0	-	RCV000007983	MONDO:MONDO:0007315,MedGen:C0008029,OMIM:118400,Orphanet:184	Fibrous dysplasia of jaw	germline;maternal	germline	GRCh38	NC_000004.12	4	2831582.0	2831582.0	4p16.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA254206,UniProtKB:P78314#VAR_013260,OMIM:602104.0001	3.0	7547.0	2831582.0	C	T	-	-	-	-	-	-	1253C>T 	Pro418Leu	NM_001122681.2	2.0	Pathogenic	Likely pathogenic	7547	4	2831582.0	C	T	P	L	rs121909146	4	2833309	4	2803107	418	SH3BP2	ENSG00000087266	ENST00000508385	ENSP00000424917	P78314	3BP2_HUMAN	c.*3930C>T	.	c.1253C>T	p.Pro418Leu	principal2	Y	3	.	.	+	CCC	2	0	C	./.	./.	./.	./.	.	.	.	.	.	.	1.0	0.90580	D	0.998	0.88579	D	.	0.99291	.	.	.	.	.	.	.	.	.	.	.	.	1.0757	0.98747	D	0.9387	0.97981	D	10	.	.	.	0.39349	0.93227	D	.	0.94975	0.745	0.87592	P78314	P418L	Loss of catalytic residue at P417 (P = 0.016)| Loss of relative solvent accessibility (P = 0.0186)| Loss of solvent accessibility (P = 0.0329)| Loss of glycosylation at P418 (P = 0.0707)| Gain of MoRF binding (P = 0.2432)	.	0.98346	.	0.49633	.	0.60376	0.649144768715	0.59801	T	0.775102	0.93960	D	0.473949	0.93434	D	0.443018	0.93352	D	0.981902837753296	0.73997	D	.	0.85418	.	0.5979539	0.72296	0.26983854	0.52665	0.4901722	0.66204	0.3363786	0.59208	-3.639	0.19719	T	.	0.74598	.	0.982712914110028	0.86004	0.98991287	0.96718	0.917	0.95747	.	.	.	.	.	.	3.574499	0.50447	22.9	0.99855464880531064	0.93463	0.750290	0.69033	D	0.603230147221406	0.73235	5.956477	0.536728262601352	0.70320	5.511388	5.69	5.69	0.88329	3.72	0.68345	4.676	0.61402	7.409000	0.58695	0.599	0.40292	0.999	0.42732	1.000000	0.68239	0.019	0.11385	726	0.54730	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1588300	6.296040e-07	0	1	1166540	8.572360e-07	0	0	74370	0.000000e+00	0	0	912	0.000000e+00	0	0	57066	0.000000e+00	0	0	29150	0.000000e+00	0	0	43424	0.000000e+00	0	0	61772	0.000000e+00	0	0	6032	0.000000e+00	0	1	1166540	8.572360e-07	0	0	87560	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Fibrous_dysplasia_of_jaw	criteria_provided,_multiple_submitters,_no_conflicts	NC_000004.12:g.2831582C>T	ClinGen:CA254206|OMIM:602104.0001|UniProtKB:P78314#VAR_013260	C0008029	118400	184	.	Pro	Leu	61.53	0.8970588235294118																																																																																																																																																																																																																																																																																																																																																																																																																																																																													122			61.53	Special, No backbone hydrogen	Proline		SH3 domain-binding protein 2										1.6			H:P418-D:Y978 (PDBs: 3TWR), F:P418-B:Y978 (PDBs: 3TWR), E:P418-A:Y978 (PDBs: 3TWR), G:P418-C:Y978 (PDBs: 3TWR)															115									-105.7				147.8	Disordered			dbSNP: rs121909146; Variant type: LP/P; AA change: Pro418His; PTM type: Phosphorylation; PTM morphology: PHLQRsPP*DGQ; Var class: II&rs121909146		C (loop/coil)	C (loop/coil)												61.53	89.70589	50-70	10-90	118400	autosomal dominant	OMIM	Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	3	CHERUBISM	false	0.6030104761712097	0.5768037784269154	false	false	false
AGXT	AGXT_Ser187Phe	B_7-8	-2.1091882379095477	0.07946191920651298	0.13563205154999086	-9.54864392896777	0.000028984439589213753	0.00015735635102428176	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8907653507800123	0.9109791118271255	0.6923999975754362	0.6863687163183598	0.6650266569321187	0.7190235993387015	0.7756486464237433	0.7456350152459459	0.7888810291346993	0.740154225955185	0.9357322929683927	0.9355318824012675	0.6623985522536596	0.5844182986182915	0.5838564035020203	0.6446457691956874	0.8862259306858585	0.8459988191587571	AGXT	Ser187Phe	NC_000002.12:240873014:C:T	560C>T	2	240873014	C	T	2	ENSG00000172482	70497	3837	CCSBVarC002677	ALE00002677	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	D05	NULL	NULL	NULL	VUSMutGDDh004	D05	VUSN2Hmut_GDN2h_01	G07	VUSMutpDEST2_14	F06	VUSmut_GDEh01	G07	0.0		1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	150265.0	single nucleotide variant	NM_000030.3(AGXT):c.560C>T (p.Ser187Phe)	189.0	AGXT	HGNC:341	Pathogenic/Likely pathogenic	1.0	Feb 05, 2024	180177238.0	-	RCV000128801|RCV003317095	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MONDO:MONDO:0002474,MedGen:C0020501,OMIM:PS259900,Orphanet:416	Primary hyperoxaluria, type I|Primary hyperoxaluria	germline;unknown	germline	GRCh38	NC_000002.12	2	240873014.0	240873014.0	2q37.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA345702,UniProtKB:P21549#VAR_000591	3.0	140584.0	240873014.0	C	T	-	-	-	-	-	-	560C>T 	Ser187Phe	NM_000030.3	2.0	Pathogenic	Likely pathogenic	140584	2	240873014.0	C	T	S	F	rs180177238	2	241812431	2	241461104	187	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.560C>T	p.Ser187Phe	c.560C>T	p.Ser187Phe	principal1	Y	1	YES	Select	+	TCC	2	0	C	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	.	.	.	-5.61	0.86717	D	0.977	0.98762	1.0798	0.98872	D	0.9123	0.97088	D	9	0.9967766	0.99999	D	0.752156	0.98021	D	0.928	0.98265	.	.	.	.	.	0.993435045351	0.99328	0.9767121892080645	0.97649	0.257923042972	0.28056	0.498416483402	0.38554	T	0.942629	0.99100	D	0.447513	0.92313	D	0.405045	0.92218	D	0.998096287250519	0.93157	D	0.967803	0.88326	D	0.9841405	0.99399	0.9367787	0.97518	0.9841405	0.99399	0.9367787	0.97519	-13.099	0.89788	D	0.8329	0.78831	P	0.996330628772937	0.92051	0.61166930	0.84239	0.968	0.98734	.	.	.	.	.	.	4.197926	0.63399	24.6	0.99779477821699625	0.86617	0.946485	0.95583	D	0.720775539154618	0.80888	7.419447	0.547561069085765	0.71071	5.622893	4.14	4.14	0.47761	1.9	0.38508	3.351	0.52041	7.345000	0.58333	0.539	0.25183	0.993	0.37982	1.000000	0.68239	0.039	0.14199	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	0	109342	0.000000e+00	0	1	206520	4.842150e-06	0	0	235222	0.000000e+00	0	0	7162	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13354	0.000000e+00	0	0	42760	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16214	0.000000e+00	0	0	30508	0.000000e+00	0	0	6204	0.000000e+00	0	0	13412	0.000000e+00	0	0	16694	0.000000e+00	0	1	88016	1.136160e-05	0	0	30608	0.000000e+00	0	1	88016	1.136160e-05	0	0	14900	0.000000e+00	0	0	34232	0.000000e+00	0	0	9558	0.000000e+00	0	0	17690	0.000000e+00	0	0	21592	0.000000e+00	0	0	101112	0.000000e+00	0	0	30526	0.000000e+00	0	.	.	.	.	.	3	1613866	1.858890e-06	0	3	1179954	2.542470e-06	0	0	74924	0.000000e+00	0	0	912	0.000000e+00	0	0	60000	0.000000e+00	0	0	29592	0.000000e+00	0	0	44880	0.000000e+00	0	0	63950	0.000000e+00	0	0	6082	0.000000e+00	0	3	1179954	2.542470e-06	0	0	91090	0.000000e+00	0	2	36614	5.46239143497023E-5	0	298	0	0	86	0	0	7450	0	0	498	0	0	628	0	0	26	0	0	98	0	1	6008	1.6644474034620507E-4	0	7748	0	0	112	0	3	51706	5.8020345801260975E-5	Primary_hyperoxaluria,_type_I|Primary_hyperoxaluria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240873014C>T	ClinGen:CA345702|UniProtKB:P21549#VAR_000591	C0268164|C0020501	259900|PS259900	416|93598|416	Aminotransferase class V domain	Ser	Phe	98.91	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.91	Polar/Neutral	Serine		Alanine--glyoxylate aminotransferase										-0.8								 S187-T191 (PAE:  1.0), S187-H155 (PAE: 1.0)	S187-T191 (PDBs: 1H0C), S187-H155 (PDBs: 6RV0, 5F9S, 5HHY, 7NS7, 3R9A)	 S187-T191 (PAE:  1.0), S187-G156 (PAE: 1.0), S187-H155 (PAE: 1.0)	S187-H155 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), S187-T191 (PDBs: 6RV1, 3R9A), S187-G156 (PDBs: 3R9A)							105									-101.9				-33.4						C (loop/coil)	T (turn)	Turn											98.91	0.0	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.9109791118271255	0.8907653507800123	false	false	false
DCX	DCX_Arg59His	B_7-8	-0.218109727706306	0.83596589209559	0.8687131958120657	-18.36944898075802	3.510382373530704e-7	8.946599521428946e-6	2024_01_Batch_7-8	false	true	false	false	false	false	false	false	false	false	false	false	0.9237602604266266	0.9477848995506538	0.45950406968799007	0.6949927101794676	0.5762284559546946	0.5395210845964986	0.7428682630108061	0.718017826849127	0.7842819616911259	0.6619019935633931	0.9619191799346911	0.9237602604266266	0.3361739061821912	0.4344390850602623	0.6057034586678094	0.2571061458125871	0.9336506191666165		DCX	Arg59His	NC_000023.11:111410223:C:T	176G>A	23	111410223	C	T	X	ENSG00000077279	8416	216622	CCSBVarC005182	ALE00005182	ENSP00000419861.1	CEGS2	CegsMutGDEh1039	G03	GDEhDisVCh_40049	D06	1	CegsMutGDDh1039	G03	VUSN2Hmut_GDN2h_08	A02	VUSMutpDEST2_07	B11	VUSmut_GDEh08	A02	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	169925.0	single nucleotide variant	NM_001195553.2(DCX):c.176G>A (p.Arg59His)	1641.0	DCX	HGNC:2714	Pathogenic/Likely pathogenic	1.0	Apr 08, 2024	122457137.0	-	RCV000145814|RCV001857504|RCV003991506	MedGen:C0008519|MedGen:C3661900|MONDO:MONDO:0010239,MedGen:C4551968,OMIM:300067,Orphanet:2148	Ectopic tissue|not provided|Lissencephaly type 1 due to doublecortin gene mutation	germline	germline	GRCh38	NC_000023.11	X	111410223.0	111410223.0	Xq23	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA171866,UniProtKB:O43602#VAR_007822	2.0	158433.0	111410223.0	C	T	-	-	-	-	-	-	176G>A 	Arg59His	NM_001195553.2	2.0	Pathogenic	Likely pathogenic	158433	X	111410223.0	C	T	R	H	rs122457137	X	110653451	X	110540107	59	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.176G>A	p.Arg59His	c.176G>A	p.Arg59His	alternative1	Y	1	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	.	0.52012	.	.	0.79703	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.80373	.	.	0.96202	1.0808	0.98904	D	0.9348	0.97849	D	10	0.9191353	0.91172	D	0.66936	0.97234	D	.	0.98598	.	.	.	.	.	.	0.99847	.	0.94755	.	.	0.898819386959	0.96304	D	.	0.83707	.	0.659014	0.99894	D	0.708852	0.99893	D	0.998123228549957	0.93238	D	0.993009	0.97738	D	0.89718366	0.91005	0.7603826	0.85668	0.88321006	0.89793	0.7783353	0.86764	-13.646	0.91866	D	0.9969	0.96584	LP	0.997991984704351	0.93817	0.99966884	0.99591	0.992	0.99727	.	.	.	.	.	.	5.03102	0.83712	28.1	0.99953409722205933	0.99957	.	.	.	.	.	.	.	.	.	5.37	5.37	0.76916	.	.	7.905	0.86513	7.658000	0.64127	0.599	0.40292	1.0	0.71675	1.000000	0.68239	1.0	0.97202	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Lissencephaly_type_1_due_to_doublecortin_gene_mutation|not_provided|Ectopic_tissue	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.111410223C>T	ClinGen:CA171866|UniProtKB:O43602#VAR_007822	C4551968|C3661900|C0008519	300067	2148	.	Arg	His	91.82	0.1935483870967742																																																																																																																																																																																																																																																																																																																																																																																																																																																																													48			91.82	Positively-charged	Arginine		Neuronal migration protein doublecortin							Doublecortin 1			-4.5									R59-D93 (PDBs: 2XRP, 4ATU), R59-L91 (PDBs: 5IKC, 6REV, 6RF8, 6RFD)				R59-D93 (PDBs: 2XRP, 4ATU), R59-D62 (PDBs: 5IKC)					175									-95.3				127.5				dbSNP: rs122457137; Variant type: LP/P; AA change: Arg59Leu; PTM type: Phosphorylation; PTM morphology: R*NGDRyFKGIV; Var class: II&rs122457137		B (undefined)	E (parallel sheets)	Beta strand											91.82	19.354837	>90	10-90	300067	x-linked	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	LISSENCEPHALY, X-LINKED, 1	false	0.9477848995506538	0.9237602604266266	true	false	false
TPM1	TPM1_Val95Ala	B_15-16	-2.656946185578102	0.03904741294077495	0.07488970039087037	-1.5736596322058367	1.0	1.0	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6246001350649837	0.6339828355217088	0.7385263096737366	0.6080506408706048	0.7107105156555235	0.7714053965009874	0.7376750713127684	0.674312639181146	0.6474535008566304	0.692738713908762	0.5843423031819894	0.5909152635812661	0.8051357216892063	0.7471083921299009	0.5686477808845792	0.7843139054387112	0.683623367861428	0.6582850065487014	TPM1	Val95Ala	NC_000015.10:63057028:T:C	284T>C	15	63057028	T	C	15	ENSG00000140416	4723	8950	CCSBVarC000698	ALE00000698	ENSP00000288398.6	RC4	RC4_Mut_GDEh1014	G09	GDEhDisVCh_40050	D11	2	RC4_Mut_GDDh1014	G09	VUSN2Hmut_GDN2h_10	H07	VUSMutpDEST2_04	D05	VUSmut_GDEh12	H11	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	N	Y	Y	27496.0	single nucleotide variant	NM_001018005.2(TPM1):c.284T>C (p.Val95Ala)	7168.0	TPM1	HGNC:12010	Pathogenic/Likely pathogenic	1.0	Jul 30, 2024	104894504.0	-	RCV000013273|RCV000211870|RCV000159356|RCV000619092	MONDO:MONDO:0007267,MedGen:C1861863,OMIM:115196|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569|MedGen:C3661900|MedGen:CN230736	Hypertrophic cardiomyopathy 3|Hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	germline	germline	GRCh38	NC_000015.10	15	63057028.0	63057028.0	15q22.2	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017934,Leiden Muscular Dystrophy (TPM1):TPM1_00007,OMIM:191010.0003	3.0	12457.0	63057028.0	T	C	-	-	-	-	-	-	284T>C 	Val95Ala	NM_001018005.2	2.0	Pathogenic	Likely pathogenic	12457	15	63057028.0	T	C	V	A	rs104894504	15	63349227	15	61136280	95	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.284T>C	p.Val95Ala	c.284T>C	p.Val95Ala	alternative1	Y	1	YES	Select	+	GTT	2	0	T	T/T	T/T	T/T	T/T	0.001	0.91343	D	0.356	0.23784	T	0.03	0.54410	B	0.161	0.72228	B	0.99	0.99291	A	simple_aae	1.0	99.0	3.705	0.94571	H	-3.13	0.63927	D	0.892	0.93613	1.0963	0.99502	D	0.9627	0.98801	D	10	0.9385519	0.93106	D	0.520017	0.95424	D	0.946	0.98921	.	0.92118	.	.	.	0.982355181837	0.98198	.	0.99383	.	0.98188	0.757299423218	0.75484	T	0.978754	0.99813	D	0.577631	0.96930	D	0.59195	0.96880	D	0.989287853240967	0.79375	D	0.685431	0.59150	T	0.85150266	0.87278	0.7470281	0.84866	0.7840119	0.82689	0.75488967	0.85337	-14.61	0.94881	D	0.8487	0.85133	P	0.999434254456298	0.96580	0.99969542	0.99622	0.937	0.96958	.	.	.	.	.	.	4.596145	0.72809	25.9	0.96700716295355471	0.30971	0.961728	0.98302	D	0.620568539310083	0.74341	6.139368	0.653101025113396	0.78727	6.958297	5.72	5.72	0.89363	4.46	0.83695	8.017	0.8876	7.949000	0.75828	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.998	0.85369	797	0.45178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	not_provided|Hypertrophic_cardiomyopathy|Cardiovascular_phenotype|Hypertrophic_cardiomyopathy_3	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.63057028T>C	ClinGen:CA017934|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00007|OMIM:191010.0003	C3661900|C0007194|CN230736|C1861863	115196	217569	.	Val	Ala	98.27	0.5492957746478874																																																																																																																																																																																																																																																																																																																																																																																																																																																																													78			98.27	Aliphatic	Valine		Tropomyosin alpha-1 chain	Coiled coil							0.1229		4.2				O:V95-P:L99 (PDBs: 8EFH)				 V95-L99 (PAE:  1.0), V95-R91 (PAE: 1.0)	V95-R91 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), V95-L99 (PDBs: 8ENC)	 V95-L99 (PAE:  1.0), V95-R91 (PAE: 1.0)	V95-R91 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), V95-L99 (PDBs: 8ENC)							117									-69.7		Pocket 3: Mean pLDDT: 99.38, Volume: 213.68 Å³, Druggability score: 0.12		-37.9						H (helix)	H (α-helix)	Helix											98.27	54.929577	>90	10-90	115196	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3	false	0.6339828355217088	0.6246001350649837	false	false	false
GATA2	GATA2_Cys373Arg	B_7-8	4.078973170651033	0.004695761202146587	0.015096486097988653	3.993122006063162	0.005235569971182767	0.009753574514843022	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8619817613846388	0.9250427603201198	0.7941973460767502	0.827812467730991	0.7188581651549557	0.8412060026611551	0.908906293748623	0.7852223359590724	0.9404671095540971	0.8741961707925026	0.9574365383906236	0.9280102476493358	0.7735057115736872	0.652493994350839	0.7151578259078849	0.7141985213609978	0.892648982249616	0.7959532751199417	GATA2	Cys373Arg	NC_000003.12:128481845:A:G	1117T>C	3	128481845	A	G	3	ENSG00000179348	7465	216383	CCSBVarC004272	ALE00004272	ENSP00000345681.2	CEGS2	CegsMutGDEh1033	H08	GDEhDisVCh_40035	F12	1	CegsMutGDDh1033	H08	VUSN2Hmut_GDN2h_06	C05	VUSMutpDEST2_06	B05	VUSmut_GDEh06	C05	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	38675.0	single nucleotide variant	NM_032638.5(GATA2):c.1117T>C (p.Cys373Arg)	2624.0	GATA2	HGNC:4171	Pathogenic/Likely pathogenic	1.0	Jun 04, 2024	387906633.0	-	RCV000022572|RCV001542161|RCV001543679	MONDO:MONDO:0013540,MedGen:C3279664,OMIM:614038,Orphanet:3226|MONDO:MONDO:0013540,MedGen:C3279664,OMIM:614038,Orphanet:3226;MONDO:MONDO:0042982,MedGen:CN300066|MedGen:C3661900	Deafness-lymphedema-leukemia syndrome|Deafness-lymphedema-leukemia syndrome;GATA2 deficiency with susceptibility to MDS/AML|not provided	germline;unknown	germline	GRCh38	NC_000003.12	3	128481845.0	128481845.0	3q21.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA128589,UniProtKB:P23769#VAR_066645,OMIM:137295.0012	3.0	29720.0	128481845.0	A	G	-	-	-	-	-	-	1117T>C 	Cys373Arg	NM_032638.5	2.0	Pathogenic	Likely pathogenic	29720	3	128481845.0	A	G	C	R	rs387906633	3	128200688	3	129683378	373	GATA2	ENSG00000179348	ENST00000341105	ENSP00000345681	P23769	GATA2_HUMAN	c.1117T>C	p.Cys373Arg	c.1117T>C	p.Cys373Arg	principal1	Y	1	YES	Select	-	TGT	1	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	5.07	0.99905	H	-11.37	0.99420	D	0.992	0.99866	1.4752	0.99993	D	0.9999	0.99993	D	10	0.9904617	0.99544	D	0.98879	0.99955	D	0.955	0.99221	0.886	0.97113	P23769	C373R	Gain of MoRF binding (P = 0.0068)| Loss of stability (P = 0.0658)| Gain of methylation at C373 (P = 0.0955)| Loss of catalytic residue at C373 (P = 0.096)| Gain of disorder (P = 0.1023)	0.994331033255	0.99420	0.9982638306010729	0.99825	4.61769214335	0.99970	0.950294017792	0.99757	D	0.988364	0.99940	D	0.588561	0.97322	D	0.60765	0.97279	D	0.999967217445374	0.99918	D	0.98969	0.96681	D	0.9937099	0.99923	0.98666036	0.99946	0.99270827	0.99887	0.98514557	0.99925	-13.562	0.91563	D	1.0	0.99952	LP	0.999992904727174	0.99831	0.99960226	0.99523	0.995	0.99826	.	.	.	.	.	.	5.902285	0.94011	33.0	0.99731830020687984	0.82849	0.973978	0.99528	D	1.07114294581369	0.97549	16.34507	0.92877206765996	0.96691	15.04081	4.95	4.95	0.64849	5.83	0.96354	9.241	0.94539	11.053000	0.85349	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.999	0.91597	648	0.63207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Deafness-lymphedema-leukemia_syndrome|GATA2_deficiency_with_susceptibility_to_MDS/AML|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.128481845A>G	ClinGen:CA128589|OMIM:137295.0012|UniProtKB:P23769#VAR_066645	C3279664|CN300066|CN517202	614038	3226	.	Cys	Arg	97.86	0.037037037037037035																																																																																																																																																																																																																																																																																																																																																																																																																																																																													5			97.86	Special, a very reactive sulfhydryl group	Cysteine		Endothelial transcription factor GATA-2										2.5								 C373-N351 (PAE:  1.5), C373-Y377 (PAE: 1.0), C373-C352 (PAE: 1.0)	C373-Y377 (PDBs: 5O9B), C373-N351 (PDBs: 5O9B)	 C373-N351 (PAE:  1.5), C373-Y377 (PAE: 1.0), C373-C352 (PAE: 1.0)	C373-Y377 (PDBs: 5O9B)							121									-68.0				-45.9				dbSNP: rs387906633; Variant type: LP/P; AA change: Cys373Arg; PTM type: Phosphorylation; PTM morphology: NAC*GLyYKLHN; Var class: II		H (helix)	H (α-helix)	Helix										GATA-type 2	97.86	3.7037036	>90	<10	614038;614038	autosomal dominant	OMIM	Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic skin disease; Rare genetic tumor	5	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA; LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	false	0.9250427603201198	0.8619817613846388	false	false	false
FBP1	FBP1_Gly164Ser	B_7-8	-4.526315789473684	0.006246562516494053	0.018949049230109028	-4.77485206303472	0.0020243081738357534	0.004279499422797935	2024_01_Batch_7-8		true	false	false	false	false		false	false	false	false	false		0.9434509975577228	0.6851267112125163	0.7188436673587136	0.63768414346037	0.6879573904203142							0.6879573904203142	0.63768414346037	0.7188436673587136	0.6851267112125163	0.9434509975577228		FBP1	Gly164Ser	NC_000009.12:94609998:C:T	490G>A	9	94609998	C	T	9	ENSG00000165140	2654	4167	CCSBVarC000305	ALE00000305	ENSP00000364475.5	RC4	RC4_Mut_GDEh1017	F01	GDEhDisVCh_40075	E07	1	RC4_Mut_GDDh1017	F01	NULL	NULL	VUSMutpDEST2_02	F01	VUSmut_GDEh13	D01	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	15907.0	single nucleotide variant	NM_000507.4(FBP1):c.490G>A (p.Gly164Ser)	2203.0	FBP1	HGNC:3606	Pathogenic/Likely pathogenic	1.0	Jul 10, 2024	121918188.0	-	RCV000000916	MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348	Fructose-biphosphatase deficiency	biparental;germline	germline	GRCh38	NC_000009.12	9	94609998.0	94609998.0	9q22.32	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA114584,UniProtKB:P09467#VAR_002380,OMIM:611570.0002	3.0	868.0	94609998.0	C	T	-	-	-	-	-	-	490G>A 	Gly164Ser	NM_000507.4	2.0	Pathogenic	Likely pathogenic	868	9	94609998.0	C	T	G	S	rs121918188	9	97372280	9	96412101	164	FBP1	ENSG00000165140	ENST00000415431	ENSP00000408025	P09467	F16P1_HUMAN	c.490G>A	p.Gly164Ser	c.490G>A	p.Gly164Ser	principal1	Y	2	.	.	-	GGC	1	0	C	C/C	C/C	C/C	C/C	0.001	0.91343	D	0.002	0.79703	D	0.999	0.77914	D	0.954	0.69444	D	0.91	0.92786	A	simple_aae	9.0	91.0	3.77	0.95096	H	-5.94	0.89120	D	0.965	0.97550	0.9193	0.95936	D	0.8004	0.93228	D	9	0.95934427	0.95273	D	0.183692	0.85665	D	0.822	0.94297	.	.	.	.	.	0.948251963057	0.94728	0.9654894709011569	0.96516	0.966947630935	0.73056	0.769214749336	0.77267	T	0.89775	0.97950	D	0.256213	0.79025	D	0.355958	0.90482	D	0.986097812652588	0.76735	D	0.998078	0.99134	D	0.9748632	0.98672	0.9378469	0.97590	0.95995677	0.97232	0.9185547	0.96244	-12.904	0.88987	D	0.8159	0.80513	P	0.992291312960244	0.89440	0.52785265	0.82487	0.992	0.99727	.	.	.	.	.	.	4.703519	0.7554	26.3	0.99823216474519794	0.90597	0.968805	0.99122	D	0.959605726052741	0.94328	12.69738	0.805054445180614	0.90089	10.27486	5.65	5.65	0.86862	3.81	0.70705	7.905	0.86513	7.700000	0.66290	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.161	0.20726	836	0.37999	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	4	109384	3.656840e-05	0	6	207066	2.897630e-05	0	6	235822	2.544290e-05	0	0	7164	0.000000e+00	0	0	17104	0.000000e+00	0	0	2318	0.000000e+00	0	2	9046	2.210920e-04	0	0	13392	0.000000e+00	0	2	42758	4.677490e-05	0	0	15688	0.000000e+00	0	2	9046	2.210920e-04	0	0	16214	0.000000e+00	0	0	30508	0.000000e+00	0	0	6202	0.000000e+00	0	2	13414	1.490980e-04	0	0	16732	0.000000e+00	0	4	88532	4.518140e-05	0	0	30606	0.000000e+00	0	2	13414	1.490980e-04	0	0	14900	0.000000e+00	0	0	34244	0.000000e+00	0	0	9564	0.000000e+00	0	2	17692	1.130450e-04	0	0	21628	0.000000e+00	0	4	101654	3.934920e-05	0	0	30524	0.000000e+00	0	2	17692	1.130450e-04	0	.	31	1614008	1.920680e-05	0	7	44904	1.558880e-04	0	0	74918	0.000000e+00	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29604	0.000000e+00	0	7	44904	1.558880e-04	0	0	64048	0.000000e+00	0	0	6084	0.000000e+00	0	22	1179972	1.864450e-05	0	0	91076	0.000000e+00	0	1	19780	5.0556117290192114E-5	0	298	0	0	86	0	0	7864	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1980	0	0	8162	0	0	112	0	1	30888	3.237503237503238E-5	Fructose-biphosphatase_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.94609998C>T	ClinGen:CA114584|OMIM:611570.0002|UniProtKB:P09467#VAR_002380	C0016756	229700	348	.	Gly	Ser	98.63	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.63	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Fructose-1,6-bisphosphatase 1										-0.4								 G164-F137 (PAE:  1.0)	G164-F137 (PDBs: 2JJK, 2VT5, 2WBB, 2WBD, 2Y5K, 2Y5L, 3A29, 3KBZ, 3KC0, 3KC1, 4MJO, 5LDZ, 6LW2, 7C9Q, 7CVH, 7CVN, 7CWE, 7EZF, 7EZP, 7EZR)	 G164-F137 (PAE:  1.0)	G164-F137 (PDBs: 2JJK, 2VT5, 2WBB, 2WBD, 2Y5K, 2Y5L, 3A29, 3KBZ, 3KC0, 3KC1, 4MJO, 5LDZ, 6LW2, 7C9Q, 7CVH, 7CVN, 7CWE, 7EZF, 7EZP, 7EZR)							75									175.8				-170.5						B (undefined)	E (parallel sheets)	Beta strand											98.63	0.0	>90	<10	229700	autosomal recessive	OMIM	Rare inborn errors of metabolism	1	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	false	0.9434509975577228		true		false
IER3IP1	IER3IP1_Leu78Pro	B_7-8	0.6544613452323619	0.5337194391508093	0.6129910575935332	-9.48304368443014	0.00003032380674072707	0.00016365936873304169	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.849245265356851	0.9132060139098761	0.6595128017818321	0.8978219791901456	0.8792077304965908	0.8314811297849004	0.9386283623825264	0.9218368261266684	0.9651140911622975	0.772516830482855	0.9412504485011376	0.859268056022477	0.7243338971872744	0.8365786348665132	0.8305298672179937	0.5465087730808091	0.8851615793186147	0.8392224746912248	IER3IP1	Leu78Pro	NC_000018.10:47156193:A:G	233T>C	18	47156193	A	G	18	ENSG00000134049	6408	215946	CCSBVarC006355	ALE00006355	ENSP00000256433.3	CEGS2	CegsMutGDEh1032	F05	GDEhDisVCh_40033	E10	1	CegsMutGDDh1032	F05	VUSN2Hmut_GDN2h_05	C12	VUSMutpDEST2_05	B09	VUSmut_GDEh05	C12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	39743.0	single nucleotide variant	NM_016097.5(IER3IP1):c.233T>C (p.Leu78Pro)	51124.0	IER3IP1	HGNC:18550	Pathogenic/Likely pathogenic	1.0	May 07, 2022	387907012.0	-	RCV000023768|RCV001799508	MONDO:MONDO:0100328,MedGen:C3280240,OMIM:PS614231,Orphanet:306558|MONDO:MONDO:0031481,MedGen:CN305347,OMIM:614231	Microcephaly, epilepsy, and diabetes syndrome|Microcephaly, epilepsy, and diabetes syndrome 1	germline	germline	GRCh38	NC_000018.10	18	47156193.0	47156193.0	18q21.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA129466,UniProtKB:Q9Y5U9#VAR_066570,OMIM:609382.0002	3.0	30786.0	47156193.0	A	G	-	-	-	-	-	-	233T>C 	Leu78Pro	NM_016097.5	2.0	Pathogenic	Likely pathogenic	30786	18	47156193.0	A	G	L	P	rs387907012	18	44682564	18	42936562	78	IER3IP1	ENSG00000134049	ENST00000256433	ENSP00000256433	Q9Y5U9	IR3IP_HUMAN	c.233T>C	p.Leu78Pro	c.233T>C	p.Leu78Pro	principal1	Y	1	YES	Select	-	CTT	2	0	A	./.	./.	./.	./.	0.108	0.29555	T	0.198	0.28071	T	0.96	0.55293	D	0.827	0.59421	P	0.78	0.86494	A	simple_aae	22.0	78.0	.	.	.	-1.89	0.44100	N	0.908	0.90930	0.1802	0.85513	D	0.6189	0.86511	D	9	0.8438831	0.83375	D	0.301782	0.90885	D	0.745	0.91164	0.569	0.69057	Q9Y5U9	L78P	Loss of stability (P = 0.002)| Gain of disorder (P = 0.0134)| Gain of loop (P = 0.1069)| Gain of catalytic residue at L77 (P = 0.1782)| Loss of helix (P = 0.2022)	0.761821658201	0.75776	0.9609233263779511	0.96055	0.424303151291	0.42579	0.817304909229	0.84587	D	0.487855	0.81229	T	0.407569	0.90278	D	0.347668	0.90158	D	0.986083924770355	0.76727	D	0.835117	0.50302	T	0.8934871	0.90677	0.789894	0.87483	0.892656	0.90605	0.75893474	0.85581	-7.617	0.58501	D	0.9568	0.87642	P	0.978777090642648	0.85026	0.99082650	0.96862	0.555	0.74911	.	.	.	.	.	.	4.297471	0.65651	24.9	0.99907017118405961	0.97728	0.854662	0.77086	D	0.629836495787572	0.74936	6.241425	0.668668494039964	0.79898	7.204336	5.91	5.91	0.95233	5.2	0.91904	7.227	0.77601	11.132000	0.86846	0.754	0.88385	1.0	0.71675	1.000000	0.68239	0.997	0.79771	873	0.30767	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1563768	1.918440e-06	0	1	1134564	8.813960e-07	0	0	73932	0.000000e+00	0	0	912	0.000000e+00	0	0	59908	0.000000e+00	0	0	29292	0.000000e+00	0	0	44560	0.000000e+00	0	0	63976	0.000000e+00	0	0	5982	0.000000e+00	0	1	1134564	8.813960e-07	0	0	89844	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Microcephaly,_epilepsy,_and_diabetes_syndrome_1|Microcephaly,_epilepsy,_and_diabetes_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000018.10:g.47156193A>G	ClinGen:CA129466|OMIM:609382.0002|UniProtKB:Q9Y5U9#VAR_066570	CN305347|C3280240	614231|PS614231	306558	.	Leu	Pro	57.4	0.2682926829268293																																																																																																																																																																																																																																																																																																																																																																																																																																																																													44			57.4	Aliphatic	Leucine		Immediate early response 3-interacting protein 1								0.0022		3.8								 L78-A74 (PAE:  2.0), L78-G82 (PAE: 6.0)		 L78-A74 (PAE:  2.0), L78-G82 (PAE: 6.0)								131									-65.7		Pocket 4: Mean pLDDT: 59.64, Volume: 156.14 Å³, Druggability score: 0		-45.3						H (helix)	H (α-helix)									Helical			57.4	26.82927	50-70	10-90	614231	autosomal recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder	3	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1	false	0.9132060139098761	0.849245265356851	false	false	false
FBP1	FBP1_Gly260Arg	B_7-8	-4.254259447448213	0.008058930801087726	0.023111948693810145	-5.381203119850089	0.0010290394310497409	0.002449140539528242	2024_01_Batch_7-8		true	false	false	false	false		false	false	false	false	false		0.9626792320908715	0.4671168862876683	0.676334585814415	0.5938535241268093	0.5644550752832739							0.5644550752832739	0.5938535241268093	0.676334585814415	0.4671168862876683	0.9626792320908715		FBP1	Gly260Arg	NC_000009.12:94605504:C:T	778G>A	9	94605504	C	T	9	ENSG00000165140	2654	4172	CCSBVarC000308	ALE00000308	ENSP00000364475.5	RC4	RC4_Mut_GDEh1017	A02	GDEhDisVCh_40075	H07	1	RC4_Mut_GDDh1017	A02	NULL	NULL	VUSMutpDEST2_02	A02	VUSmut_GDEh13	G01	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	553126.0	single nucleotide variant	NM_000507.4(FBP1):c.778G>A (p.Gly260Arg)	2203.0	FBP1	HGNC:3606	Pathogenic/Likely pathogenic	1.0	Oct 09, 2024	780803192.0	-	RCV000681451|RCV003918122	MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348|	Fructose-biphosphatase deficiency|FBP1-related disorder	germline;inherited;maternal	germline	GRCh38	NC_000009.12	9	94605504.0	94605504.0	9q22.32	criteria provided, multiple submitters, no conflicts	7.0	-	N	-	2.0	561989.0	94605504.0	C	T	-	-	-	-	-	-	778G>A 	Gly260Arg	NM_000507.4	2.0	Pathogenic	Likely pathogenic	561989	9	94605504.0	C	T	G	R	rs780803192	9	97367786	9	96407607	260	FBP1	ENSG00000165140	ENST00000375326	ENSP00000364475	P09467	F16P1_HUMAN	c.778G>A	p.Gly260Arg	c.778G>A	p.Gly260Arg	principal1	Y	1	YES	Select	-	GGA	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.51	0.98988	H	-7.06	0.93893	D	0.996	0.99956	0.9275	0.96054	D	0.8116	0.93628	D	10	0.9868262	0.99005	D	0.132495	0.81428	D	0.858	0.95643	0.97	0.99713	P09467	G260R	Gain of MoRF binding (P = 0.0268)| Loss of phosphorylation at Y259 (P = 0.1637)| Loss of catalytic residue at I262 (P = 0.2601)| Loss of stability (P = 0.3201)| Loss of helix (P = 0.3949)	0.969574346944	0.96896	.	0.85360	.	0.77414	0.836426973343	0.87527	D	0.768313	0.93723	D	0.30771	0.83454	D	0.373356	0.91129	D	0.999235272407532	0.96610	D	.	0.92455	.	0.9404153	0.95217	0.830823	0.90111	0.94672376	0.95869	0.83744496	0.90549	-13.172	0.90080	D	0.9778	0.90695	LP	0.993224017693034	0.89929	0.57297590	0.83435	0.953	0.97907	.	.	.	.	.	.	5.552672	0.92079	32.0	0.99922702734891644	0.98853	0.976876	0.99694	D	0.996126757947258	0.95599	13.80033	0.846637347282806	0.92778	11.65034	5.75	5.75	0.90377	3.81	0.70705	7.905	0.86513	7.627000	0.62620	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.915	0.45059	833	0.38756	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	2	109370	1.828660e-05	0	2	208020	9.614460e-06	0	2	236852	8.444090e-06	0	0	7158	0.000000e+00	0	0	17100	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13390	0.000000e+00	0	1	42754	2.338960e-05	0	0	15688	0.000000e+00	0	1	9046	1.105460e-04	0	0	16204	0.000000e+00	0	0	30506	0.000000e+00	0	0	6212	0.000000e+00	0	1	13414	7.454900e-05	0	0	16730	0.000000e+00	0	1	89492	1.117420e-05	0	0	30598	0.000000e+00	0	1	13414	7.454900e-05	0	0	14888	0.000000e+00	0	0	34242	0.000000e+00	0	0	9572	0.000000e+00	0	1	17690	5.652910e-05	0	0	21620	0.000000e+00	0	1	102704	9.736720e-06	0	0	30516	0.000000e+00	0	1	17690	5.652910e-05	0	.	7	1614008	4.337030e-06	0	1	29608	3.377470e-05	0	0	75018	0.000000e+00	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	1	29608	3.377470e-05	0	1	44882	2.228060e-05	0	0	64010	0.000000e+00	0	0	6050	0.000000e+00	0	2	1179962	1.694970e-06	0	2	91062	2.196310e-05	0	1	23858	4.191466174867969E-5	0	84	0	0	84	0	0	2230	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4558	0	0	2314	0	0	108	0	1	32060	3.1191515907673116E-5	FBP1-related_disorder|Fructose-biphosphatase_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.94605504C>T	.	C0016756	229700	348	.	Gly	Arg	98.56	0.023809523809523808																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			98.56	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Fructose-1,6-bisphosphatase 1										-0.4								 G260-T256 (PAE:  1.0)	G260-S320 (PDBs: 1FTA), G260-T256 (PDBs: 2JJK, 2VT5, 2WBB, 2WBD, 2Y5K, 2Y5L, 3A29, 3KBZ, 3KC0, 3KC1, 4MJO, 5LDZ, 6LW2, 7C9Q, 7CVH, 7CVN, 7CWE, 7EZF, 7EZP, 7EZR)	 G260-T256 (PAE:  1.0), G260-S321 (PAE: 1.0)	G260-S320 (PDBs: 1FTA), G260-S321 (PDBs: 2JJK, 2VT5, 2WBB, 2Y5L, 3A29, 3KBZ, 3KC0, 3KC1, 4MJO, 7C9Q, 7CVN, 7CWE, 7EZF, 7EZR), G260-R255 (PDBs: 2WBD, 2Y5K, 5LDZ, 6LW2, 7CVH, 7EZP, 7EZR), G260-T256 (PDBs: 7EZR)							75									75.2				175.3						C (loop/coil)	C (loop/coil)												98.56	2.3809524	>90	<10	229700	autosomal recessive	OMIM	Rare inborn errors of metabolism	1	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	false	0.9626792320908715		true		false
MVK	MVK_Val250Ile	B_7-8	3.200225287914478	0.018594773667486436	0.04294560786565791	2.8642045111822894	0.028643545406197467	0.043224429128595684	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6686726049131109	0.6835199514881045	0.748438125654478	0.7316735190947528	0.6945172600192782	0.8783827857455182	0.8619118808721453	0.7326365338848893	0.7313416969132001	0.7369430449607004	0.7028599631880497	0.7130403501376176	0.894853690618891	0.6563979861536672	0.7320053412763055	0.7599332063482556	0.6641799397881595	0.6243048596886042	MVK	Val250Ile	NC_000012.12:109590841:G:A	748G>A	12	109590841	G	A	12	ENSG00000110921	281	200093	CCSBVarC004841	ALE00004841	ENSP00000228510.3	CEGS2	CegsMutGDEh1040	G10	GDEhDisVCh_40020	G03	2	CegsMutGDDh1040	G10	VUSN2Hmut_GDN2h_08	G06	VUSMutpDEST2_01	C05	VUSmut_GDEh08	G06	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	103508.0	single nucleotide variant	NM_000431.4(MVK):c.748G>A (p.Val250Ile)	4598.0	MVK	HGNC:7530	Likely pathogenic	1.0	Jan 19, 2024	104895339.0	-	RCV000083868|RCV002513866	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343	Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever	germline;unknown	germline	GRCh38	NC_000012.12	12	109590841.0	109590841.0	12q24.11	criteria provided, single submitter	2.0	-	N	ClinGen:CA149887,UniProtKB:Q03426#VAR_029523	2.0	97616.0	109590841.0	G	A	-	-	-	-	-	-	748G>A 	Val250Ile	NM_000431.4	1.0	Pathogenic	Likely pathogenic	97616	12	109590841.0	G	A	V	I	rs104895339	12	110028646	12	108513029	250	MVK	ENSG00000110921	ENST00000228510	ENSP00000228510	Q03426	KIME_HUMAN	c.748G>A	p.Val250Ile	c.748G>A	p.Val250Ile	principal1	Y	1	YES	Select	+	GTC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.012	0.65108	D	0.999	0.90580	D	0.963	0.88579	D	0.82	0.92786	D	simple_aae	18.0	82.0	3.835	0.95592	H	-0.93	0.25503	N	0.728	0.72801	0.9984	0.97154	D	0.9176	0.97266	D	10	0.62145257	0.67720	D	0.357516	0.92412	D	0.731	0.90551	.	.	.	.	.	0.944448756425	0.94342	0.8586161906107269	0.85738	0.611632773968	0.55506	0.434344053268	0.29766	T	0.349668	0.71576	T	0.244565	0.77928	D	0.339226	0.89816	D	0.983241081237793	0.74805	D	0.893711	0.63072	D	0.43191135	0.62557	0.18890676	0.42061	0.3109127	0.53533	0.1906727	0.42335	-9.704	0.72200	D	0.1659	0.36630	LB	0.901147395661541	0.76132	0.99647660	0.98069	0.837	0.91029	.	.	.	.	.	.	3.96228	0.58195	23.9	0.99863648466991106	0.94188	0.683982	0.64520	D	0.688543245683745	0.78767	6.961841	0.571642672160872	0.72765	5.885724	5.47	4.58	0.56024	3.68	0.67565	6.427	0.7337	5.012000	0.46754	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.529	0.2973	734	0.53826	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	3	109398	2.742280e-05	0	3	208100	1.441610e-05	0	6	236922	2.532480e-05	0	0	7164	0.000000e+00	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13394	0.000000e+00	0	1	42764	2.338420e-05	0	1	15688	6.374300e-05	0	1	9046	1.105460e-04	0	0	16218	0.000000e+00	0	0	30514	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	2	89540	2.233640e-05	0	1	30604	3.267550e-05	0	1	30604	3.267550e-05	0	0	14902	0.000000e+00	0	0	34250	0.000000e+00	0	0	9572	0.000000e+00	0	2	17692	1.130450e-04	0	0	21632	0.000000e+00	0	3	102734	2.920160e-05	0	1	30522	3.276330e-05	0	2	17692	1.130450e-04	0	.	21	1614046	1.301080e-05	0	2	44896	4.454740e-05	0	0	74910	0.000000e+00	0	0	910	0.000000e+00	0	0	59994	0.000000e+00	0	0	29608	0.000000e+00	0	2	44896	4.454740e-05	0	0	64036	0.000000e+00	0	0	6084	0.000000e+00	0	14	1180036	1.186400e-05	0	3	91086	3.293590e-05	0	1	92826	1.0772843815310366E-5	0	168	0	0	2682	0	0	4018	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	0	4186	0	0	3308	0	1	104026	9.612981370042105E-6	Hyperimmunoglobulin_D_with_periodic_fever|Mevalonic_aciduria|Porokeratosis_3,_disseminated_superficial_actinic_type	criteria_provided,_single_submitter	NC_000012.12:g.109590841G>A	ClinGen:CA149887|UniProtKB:Q03426#VAR_029523	C0398691|C1959626|C1867981	260920|610377|175900	343|29	.	Val	Ile	97.23	0.014084507042253521																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			97.23	Aliphatic	Valine		Mevalonate kinase										4.2								 V250-L246 (PAE:  1.0), V250-L254 (PAE: 1.0)	V250-L246 (PDBs: 2R3V), V250-L254 (PDBs: 2R3V)	 V250-L246 (PAE:  1.0), V250-L254 (PAE: 1.0)	V250-L246 (PDBs: 2R3V), V250-L254 (PDBs: 2R3V)							117									-62.0				-46.8						H (helix)	H (α-helix)	Helix											97.23	1.4084507	>90	<10	260920;175900;610377;260920	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; POROKERATOSIS 3, MULTIPLE TYPES; MEVALONIC ACIDURIA; HYPER-IgD SYNDROME	false	0.6835199514881045	0.6686726049131109	false	false	false
KRT6A	KRT6A_Glu472Lys	B_7-8	-1.4112348825711147	0.21726286336781103	0.2993905465962713	-0.612017531468894	0.5598718489381391	0.6115266921437412	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8806847575906813	0.8385021711593666	0.5922355279056034	0.6085181227763786	0.6059732710307963	0.5965344542818938	0.5713467450383454	0.6879637367851393	0.6560485924913478	0.5547863900609673	0.8604203917138107	0.9347109173947563	0.6217221635254422	0.5239828052764532	0.5609876530614094	0.6296846657502395	0.8165839506049226	0.8266585977866063	KRT6A	Glu472Lys	NC_000012.12:52488338:C:T	1414G>A	12	52488338	C	T	12	ENSG00000205420	4870	215286	CCSBVarC003678	ALE00003678	ENSP00000369317.3	CEGS2	CegsMutGDEh1036	F09	GDEhDisVCh_40048	C09	2	CegsMutGDDh1036	F09	VUSN2Hmut_GDN2h_07	F06	VUSMutpDEST2_04	E10	VUSmut_GDEh07	F06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	29675.0	single nucleotide variant	NM_005554.4(KRT6A):c.1414G>A (p.Glu472Lys)	3853.0	KRT6A	HGNC:6443	Pathogenic/Likely pathogenic	1.0	Jan 17, 2022	60554162.0	-	RCV000015742|RCV000056998	MONDO:MONDO:0014324,MedGen:C3714948,OMIM:615726,Orphanet:2309|MedGen:CN517202	Pachyonychia congenita 3|not provided	germline;unknown	germline	GRCh38	NC_000012.12	12	52488338.0	52488338.0	12q13.13	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA124169,UniProtKB:P02538#VAR_017077,OMIM:148041.0003	3.0	14636.0	52488338.0	C	T	-	-	-	-	-	-	1414G>A 	Glu472Lys	NM_005554.4	2.0	Pathogenic	Likely pathogenic	14636	12	52488338.0	C	T	E	K	rs60554162	12	52882122	12	51168389	472	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.1414G>A	p.Glu472Lys	c.1414G>A	p.Glu472Lys	principal1	Y	1	YES	Select	-	GAG	1	0	.	./.	./.	./.	./.	0.0	0.91343	D	0.042	0.50577	D	0.993	0.65587	D	0.951	0.68937	D	0.98	0.97016	A	simple_aae	2.0	98.0	3.42	0.91792	M	-3.67	0.70228	D	0.938	0.94442	1.0716	0.98630	D	0.9225	0.97431	D	9	0.96319926	0.95710	D	0.080036	0.73280	D	0.926	0.98190	0.86	0.95750	P02538	E472K	Gain of catalytic residue at L476 (P = 0.0072)| Gain of ubiquitination at E472 (P = 0.0082)| Gain of glycosylation at E472 (P = 0.0795)| Loss of disorder (P = 0.167)| Gain of MoRF binding (P = 0.2885)	0.975386155459	0.97487	0.9290620826601937	0.92840	0.895140481352	0.70244	0.752627789974	0.74790	T	0.814566	0.95364	D	0.486826	0.93867	D	0.461515	0.93790	D	0.997814893722534	0.92425	D	0.89811	0.64313	D	0.866905	0.88462	0.84146607	0.90816	0.866905	0.88463	0.84146607	0.90817	-15.472	0.96867	D	0.9574	0.87713	P	0.993129060199364	0.89874	0.95638070	0.93739	0.898	0.94604	.	.	.	.	.	.	5.939721	0.94134	33.0	0.99924043139537488	0.98981	0.722850	0.67146	D	0.889322299849989	0.91179	10.77787	0.805609275974086	0.90127	10.2917	5.02	5.02	0.66699	3.9	0.73887	5.904	0.69696	.	.	0.541	0.25267	1.0	0.71675	1.000000	0.68239	0.973	0.55324	734	0.53826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pachyonychia_congenita_3|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.52488338C>T	ClinGen:CA124169|OMIM:148041.0003|UniProtKB:P02538#VAR_017077	C3714948|CN517202	615726	2309	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Glu	Lys	66.46	0.520618556701031																																																																																																																																																																																																																																																																																																																																																																																																																																																																													101			66.46	Negatively-charged	Glutamic Acid		Keratin, type II cytoskeletal 6A							IF rod	0.1155		-3.5								 E472-L468 (PAE:  5.0), E472-L476 (PAE: 4.5)		 E472-L468 (PAE:  5.0), E472-L476 (PAE: 4.5)								146									-82.5		Pocket 2: Mean pLDDT: 70.76, Volume: 452.79 Å³, Druggability score: 0.12		-36.7	Coil 2			dbSNP: rs60554162; Variant type: LP/P; AA change: Glu472Lys; PTM type: Ubiquitylation; PTM morphology: IATYRkLLEGE*; Var class: II		H (helix)	H (α-helix)												66.46	52.061855	50-70	10-90	615726	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2	PACHYONYCHIA CONGENITA 3	true	0.8385021711593666	0.8806847575906813	false	false	false
GALE	GALE_Arg239Trp	B_7-8	1.6366027362742306	0.1457263777809613	0.22090268377907626	3.372195824677216	0.011884621916907664	0.019898494897074202	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7486157751482425	0.7891560362062506	0.6459485826990732	0.6273672824356538	0.60431979141225	0.6615452261255526	0.6784946238988343	0.5898758769675404	0.7371743559429621	0.6681235264790627	0.8233429309266878	0.8141801083803203	0.6445958283522708	0.6187637058569595	0.5175602089283455	0.6237736389190838	0.7549691414858134	0.6830514419161647	GALE	Arg239Trp	NC_000001.11:23796777:G:A	715C>T	1	23796777	G	A	1	ENSG00000117308	2767	214360	CCSBVarC005289	ALE00005289	ENSP00000483375.1	CEGS2	CegsMutGDEh1035	E08	GDEhDisVCh_40068	H06	2	CegsMutGDDh1035	E08	VUSN2Hmut_GDN2h_07	F01	VUSMutpDEST2_02	G10	VUSmut_GDEh07	F01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	34024.0	single nucleotide variant	NM_001008216.2(GALE):c.715C>T (p.Arg239Trp)	2582.0	GALE	HGNC:4116	Pathogenic/Likely pathogenic	1.0	May 05, 2023	137853860.0	-	RCV000020294	MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238	UDPglucose-4-epimerase deficiency	germline	germline	GRCh38	NC_000001.11	1	23796777.0	23796777.0	1p36.11	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA341699,UniProtKB:Q14376#VAR_037738	3.0	21172.0	23796777.0	G	A	-	-	-	-	-	-	715C>T 	Arg239Trp	NM_001008216.2	2.0	Pathogenic	Likely pathogenic	21172	1	23796777.0	G	A	R	W	rs137853860	1	24123267	1	23995854	239	GALE	ENSG00000117308	ENST00000374497	ENSP00000363621	Q14376	GALE_HUMAN	c.715C>T	p.Arg239Trp	c.715C>T	p.Arg239Trp	principal1	Y	1	.	.	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.89	0.91795	A	simple_aae	11.0	89.0	5.185	0.99951	H	-7.89	0.96508	D	0.992	0.99826	1.0181	0.97493	D	0.9795	0.99366	D	9	0.98584664	0.98849	D	0.472947	0.94701	D	0.918	0.97887	0.968	0.99690	Q14376	R239W	Loss of disorder (P = 0.0283)| Loss of phosphorylation at T236 (P = 0.1145)| Loss of helix (P = 0.2022)| Gain of loop (P = 0.3485)| Gain of catalytic residue at V238 (P = 0.3612)	0.988000926731	0.98774	.	0.93349	0.630741355494	0.56767	0.861201524734	0.91275	D	0.922132	0.98598	D	0.530041	0.95124	D	0.523591	0.95051	D	0.998983800411224	0.95757	D	0.996634	0.98875	D	0.98303545	0.99320	0.9325439	0.97229	0.9765661	0.98817	0.8990035	0.94835	-13.749	0.92228	D	0.8417	0.79282	P	0.999095802897717	0.95689	0.99985266	0.99806	0.903	0.94903	.	.	.	.	.	.	5.418809	0.90681	31.0	0.99919932770253828	0.98655	0.831483	0.74909	D	0.858806876943848	0.89547	10.04024	0.707063853432941	0.82819	7.886867	5.65	4.72	0.59198	3.49	0.63201	1.744	0.37999	5.582000	0.49048	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.896	0.43332	507	0.75491	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	1	264690	3.7780044E-6	.	3	105568	2.841770e-05	0	4	202100	1.979220e-05	0	4	229972	1.739340e-05	0	1	6522	1.533270e-04	0	1	16680	5.995200e-05	0	0	2128	0.000000e+00	0	1	8888	1.125110e-04	0	0	13266	0.000000e+00	0	0	41020	0.000000e+00	0	0	15206	0.000000e+00	0	1	6522	1.533270e-04	0	1	15360	6.510420e-05	0	1	29714	3.365420e-05	0	0	5938	0.000000e+00	0	1	13334	7.499630e-05	0	0	16522	0.000000e+00	0	1	86790	1.152210e-05	0	0	29676	0.000000e+00	0	1	13334	7.499630e-05	0	1	14072	7.106310e-05	0	1	33456	2.989000e-05	0	0	9294	0.000000e+00	0	1	17508	5.711670e-05	0	0	21014	0.000000e+00	0	1	99526	1.004760e-05	0	0	29598	0.000000e+00	0	1	14072	7.106310e-05	0	.	14	1610332	8.693860e-06	0	4	44840	8.920610e-05	0	3	74968	4.001710e-05	0	0	912	0.000000e+00	0	1	59494	1.680840e-05	0	0	29438	0.000000e+00	0	4	44840	8.920610e-05	0	0	63820	0.000000e+00	0	0	6058	0.000000e+00	0	6	1178054	5.093150e-06	0	0	90364	0.000000e+00	0	0	13084	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	766	0	0	2720	0	0	108	0	0	17528	0	UDPglucose-4-epimerase_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.23796777G>A	ClinGen:CA341699|UniProtKB:Q14376#VAR_037738	C0751161	230350	352|79238	NAD(P)-binding domain	Arg	Trp	98.64	0.11290322580645161																																																																																																																																																																																																																																																																																																																																																																																																																																																																													28			98.64	Positively-charged	Arginine	substrate	UDP-glucose 4-epimerase								0.849		-4.5								 R239-V304 (PAE:  1.5), R239-A305 (PAE: 1.0), R239-Y275 (PAE: 1.0)	R239-V304 (PDBs: 1EK5, 1HZJ), R239-Y275 (PDBs: 1EK5, 1EK6, 1HZJ)	 R239-Y275 (PAE:  1.0)	R239-Y275 (PDBs: 1EK5, 1HZJ), R239-A306 (PDBs: 1EK6, 1HZJ)							175									-137.1		Pocket 1: Mean pLDDT: 92.66, Volume: 1091.39 Å³, Druggability score: 0.85		148.7				dbSNP: rs137853860; Variant type: LP/P; AA change: Arg239Trp; PTM type: Phosphorylation; PTM morphology: TGVR*DyIHVVD; Var class: II		B (undefined)	E (parallel sheets)												98.64	11.290322	>90	10-90	230350	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic hepatic disease; Rare inborn errors of metabolism	4	GALACTOSEMIA III	false	0.7891560362062506	0.7486157751482425	false	false	false
RP2	RP2_Arg118His	B_7-8	-1.3589795170973735	0.22301479022073398	0.3038218611423694	1.3826405101236114	0.21603525844908672	0.26270689148712667	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5364373841993315	0.5756206495460088	0.7003793629766515	0.5916905987500269	0.7051663538742949	0.7295206746785126	0.6248508330599573	0.5585599061389093	0.6146728814398599	0.6087294443240878	0.5980733592502734	0.5640563844379537	0.8341905162970679	0.8517728016096807	0.5687083160601939	0.792029281629215	0.5531679398417443	0.5088183839607093	RP2	Arg118His	NC_000023.11:46853726:G:A	353G>A	23	46853726	G	A	X	ENSG00000102218	11374	19281	CCSBVarC001707	ALE00001707	ENSP00000218340.3	RC4	RC4_Mut_GDEh1017	D08	GDEhDisVCh_40085	E09	1	RC4_Mut_GDDh1017	D08	NULL	NULL	VUSMutpDEST2_08	B11	VUSmut_GDEh13	B02	1.0	1.0	1.0	1.0	0.0			1.0	3.0	1.0	1.0	1.0	1.0	Y	Y	N	N	Y	25585.0	single nucleotide variant	NM_006915.3(RP2):c.353G>A (p.Arg118His)	6102.0	RP2	HGNC:10274	Pathogenic/Likely pathogenic	1.0	Oct 01, 2023	28933687.0	-	RCV000011292|RCV001075110|RCV001215347	MONDO:MONDO:0010723,MedGen:C2681923,OMIM:312600,Orphanet:791|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862|MedGen:C3661900	Retinitis pigmentosa 2|Retinal dystrophy|not provided	germline;inherited	germline	GRCh38	NC_000023.11	X	46853726.0	46853726.0	Xp11.3	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA255301,UniProtKB:O75695#VAR_008499,OMIM:300757.0003	3.0	10546.0	46853726.0	G	A	-	-	-	-	-	-	353G>A 	Arg118His	NM_006915.3	2.0	Pathogenic	Likely pathogenic	10546	X	46853726.0	G	A	R	H	rs28933687	X	46713161	X	46598105	118	RP2	ENSG00000102218	ENST00000218340	ENSP00000218340	O75695	XRP2_HUMAN	c.353G>A	p.Arg118His	c.353G>A	p.Arg118His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.43	0.91906	M	-5.0	0.82367	D	0.983	0.99270	1.0307	0.97726	D	0.9016	0.96729	D	9	0.9951422	0.99976	D	0.712952	0.97663	D	0.942	0.98779	0.981	0.99819	O75695	R118H	Loss of MoRF binding (P = 0.0696)| Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1473)| Loss of catalytic residue at R118 (P = 0.182)| Gain of loop (P = 0.2754)	0.993971895972	0.99382	0.8867041295724345	0.88568	1.12773366393	0.78382	0.746192395687	0.73838	T	0.905893	0.98170	D	0.619942	0.98562	D	0.652727	0.98538	D	0.999521732330322	0.97739	D	0.986301	0.95367	D	0.9692732	0.98162	0.97191113	0.99538	0.97766143	0.98908	0.97383344	0.99615	-12.594	0.87653	D	0.9581	0.87797	P	0.998065857687715	0.93912	0.99954718	0.99479	0.963	0.98469	.	.	.	.	.	.	5.119232	0.85641	28.7	0.99952234549354402	0.99951	.	.	.	.	.	.	.	.	.	5.62	5.62	0.85695	3.72	0.68345	9.45	0.96778	11.844000	0.97888	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.996	0.76032	135	0.94621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211951	8.251160e-07	0	1	895633	1.116530e-06	0	0	57813	0.000000e+00	0	0	688	0.000000e+00	0	0	45998	0.000000e+00	0	0	22046	0.000000e+00	0	0	33857	0.000000e+00	0	0	46898	0.000000e+00	0	0	4355	0.000000e+00	0	1	895633	1.116530e-06	0	0	57007	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Retinal_dystrophy|Retinitis_pigmentosa_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.46853726G>A	ClinGen:CA255301|OMIM:300757.0003|UniProtKB:O75695#VAR_008499	C3661900|C0854723|C2681923	312600	71862|791	Tubulin binding cofactor C-like domain|Tubulin binding cofactor C-like domain|C-CAP/cofactor C-like domain	Arg	His	98.71	0.4153225806451613																																																																																																																																																																																																																																																																																																																																																																																																																																																																													103			98.71	Positively-charged	Arginine	GTP	Protein XRP2							C-CAP/cofactor C-like			-4.5								 R118-V100 (PAE:  1.0), R118-F102 (PAE: 1.0)	R118-V100 (PDBs: 2BX6, 3BH7), R118-F102 (PDBs: 2BX6, 3BH6, 3BH7)	 R118-V100 (PAE:  1.0)	R118-V100 (PDBs: 2BX6, 3BH6, 3BH7)							175		Mutation: R -> A. Reduces affinity and GTP-hydrolysis rate for mouse ARL3.							-132.2				137.2						B (undefined)	E (parallel sheets)	Beta strand											98.71	41.532257	>90	10-90	312600	x-linked	OMIM	Rare genetic eye disease; Ciliopathy	2	RETINITIS PIGMENTOSA 2	false	0.5756206495460088	0.5364373841993315	false	false	false
NT5C3A	NT5C3A_Asp132Val	B_15-16	2.0523656175236207	0.07925318527722482	0.1353967655451694	-8.681104210182873	0.00005390532712478761	0.0002569253903220397	2025_03_Batch_15-16	true	true	false	false	false	false	true	true	false	false	false	false	0.9818603331495988	0.988205574291002	0.6727655624646531	0.5871941069063862	0.5950295597959419	0.6657441044327473	0.6140948247999942	0.6678632440047196	0.660044686322311	0.6153953912903104	0.9829509048129423	0.9801765568526576	0.7173933840655005	0.522195875587164	0.5143435274904613	0.7301357336389958	0.9934602437690616	0.9835441094465399	NT5C3A	Asp132Val	NC_000007.14:33021317:T:A	395A>T	7	33021317	T	A	7	ENSG00000122643	14396	23457	CCSBVarC002091	ALE00002091	ENSP00000476480.2	RC4	RC4_Mut_GDEh1016	E10	GDEhDisVCh_40039	H08	1	RC4_Mut_GDDh1016	E10	NULL	NULL	VUSMutpDEST2_11	E08	VUSmut_GDEh12	D12	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	19518.0	single nucleotide variant	NM_001002010.5(NT5C3A):c.395A>T (p.Asp132Val)	51251.0	NT5C3A	HGNC:17820	Pathogenic/Likely pathogenic	1.0	May 29, 2023	104894025.0	-	RCV000004736|RCV003555917	MONDO:MONDO:0009946,MedGen:C1849507,OMIM:266120,Orphanet:35120|MedGen:C3661900	Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency|not provided	germline	germline	GRCh38	NC_000007.14	7	33021317.0	33021317.0	7p14.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	OMIM:606224.0001,ClinGen:CA116881,UniProtKB:Q9H0P0#VAR_023511	3.0	4479.0	33021317.0	T	A	-	-	-	-	-	-	395A>T 	Asp132Val	NM_001002010.5	2.0	Pathogenic	Likely pathogenic	4479	7	33021317.0	T	A	D	V	rs104894025	7	33060929	7	33027454	98	NT5C3A	ENSG00000122643	ENST00000409787	ENSP00000387205	B9A035	B9A035_HUMAN	c.293A>T	p.Asp98Val	c.293A>T	p.Asp98Val	.	Y	2	.	.	-	GAT	2	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	.	0.90580	.	.	0.88579	.	0.9	0.97926	A	simple_aae	10.0	90.0	.	.	.	-7.75	0.95886	D	0.953	0.97221	0.8262	0.94718	D	0.8054	0.93405	D	9	0.9693078	0.96447	D	0.214649	0.87437	D	0.947	0.98955	.	.	.	.	.	0.954156692996	0.95328	.	.	.	.	0.524302363396	0.42173	T	.	0.95778	.	0.324476	0.84675	D	0.409839	0.92370	D	0.997593343257904	0.91871	D	0.982002	0.94657	D	.	.	.	.	.	.	.	.	.	0.93844	.	0.6885	0.77511	LP	.	.	0.94142520	0.92926	0.881	0.93590	.	.	.	.	.	.	4.870441	0.79828	27.2	0.99407883903331906	0.63173	0.727265	0.67448	D	0.879998956438763	0.90696	10.54607	0.818261671477128	0.90982	10.68589	5.68	5.68	0.88004	4.12	0.78551	6.252	0.72468	6.173000	0.54588	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	819	0.41138	.	.	.	.	.	.	.	.	.	.	.	.	7	264690	2.644603E-5	segdup	2	109320	1.829490e-05	0	2	207806	9.624360e-06	0	3	236388	1.269100e-05	0	1	7150	1.398600e-04	0	0	17074	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	0	42748	0.000000e+00	0	1	15676	6.379180e-05	0	1	7150	1.398600e-04	0	1	16180	6.180470e-05	0	0	30464	0.000000e+00	0	0	6208	0.000000e+00	0	0	13412	0.000000e+00	0	0	16732	0.000000e+00	0	0	89388	0.000000e+00	0	1	30568	3.271390e-05	0	1	16180	6.180470e-05	0	1	14872	6.724050e-05	0	0	34196	0.000000e+00	0	0	9566	0.000000e+00	0	0	17692	0.000000e+00	0	0	21622	0.000000e+00	0	1	102356	9.769820e-06	0	1	30486	3.280190e-05	0	1	14872	6.724050e-05	0	.	22	1612244	1.364560e-05	0	2	74870	2.671300e-05	0	2	74870	2.671300e-05	0	0	912	0.000000e+00	0	0	59968	0.000000e+00	0	0	29538	0.000000e+00	0	0	44708	0.000000e+00	0	0	63972	0.000000e+00	0	0	6074	0.000000e+00	0	17	1178758	1.442200e-05	0	2	91042	2.196790e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	not_provided|Hemolytic_anemia_due_to_pyrimidine_5'_nucleotidase_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.33021317T>A	ClinGen:CA116881|OMIM:606224.0001|UniProtKB:Q9H0P0#VAR_023511	C3661900|C1849507	266120	35120	.	Asp	Val																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																				NaN	NaN	266120	autosomal recessive	OMIM	Rare genetic hematologic disease; Rare inborn errors of metabolism	2	ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 8	false	0.988205574291002	0.9818603331495988	true	true	true
SMAD3	SMAD3_Glu239Lys	B_15-16	-5.120224588181966	0.0013684061501671107	0.00589990010568664	-6.188281315128267	0.00045036795457963297	0.0012773186965280162	2025_03_Batch_15-16	true	true	false	false	false	false	true	false	false	false	false	false	0.9765500383031416	0.9725882534468295	0.536552863392107	0.7361724298532318	0.7449679162391216	0.564985254723817	0.7009505596861859	0.8532629164908179	0.8927930066485805	0.636537537063007	0.9865040346007408	0.9859527878946958	0.42901994976144797	0.6366729159874254	0.5795518530578831	0.4365681897212069	0.9586724722929183	0.9671472887115874	SMAD3	Glu239Lys	NC_000015.10:67181297:G:A	715G>A	15	67181297	G	A	15	ENSG00000166949	11805	2140	CCSBVarC004693	ALE00004693	ENSP00000332973.4	Edgotyping3	VUSMutGDEh004	F12	GDEhDisVCh_40014	E07	2	VUSMutGDDh004	F12	VUSN2Hmut_GDN2h_01	G10	VUSMutpDEST2_09	D03	VUSmut_GDEh01	G10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	2.0	Y	Y	Y	N	Y	39267.0	single nucleotide variant	NM_005902.4(SMAD3):c.715G>A (p.Glu239Lys)	4088.0	SMAD3	HGNC:6769	Likely pathogenic	1.0	Aug 06, 2024	387906853.0	-	RCV000023246|RCV001703421|RCV003528136	MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Aneurysm-osteoarthritis syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000015.10	15	67181297.0	67181297.0	15q22.33	criteria provided, multiple submitters, no conflicts	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020100,UniProtKB:P84022#VAR_067047,OMIM:603109.0006	3.0	30311.0	67181297.0	G	A	-	-	-	-	-	-	715G>A 	Glu239Lys	NM_005902.4	2.0	Pathogenic	Likely pathogenic	30311	15	67181297.0	G	A	E	K	rs387906853	15	67473635	15	65260689	239	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.715G>A	p.Glu239Lys	c.715G>A	p.Glu239Lys	principal1	Y	1	YES	Select	+	GAG	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.017	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.92	0.94378	A	simple_aae	8.0	92.0	4.14	0.97479	H	-3.86	0.74082	D	0.999	0.99995	1.0184	0.97499	D	0.9854	0.99559	D	10	0.98444915	0.98627	D	0.831163	0.98688	D	0.987	0.99952	0.911	0.98220	P84022	E239K	Gain of methylation at E239 (P = 0.0202)| Gain of ubiquitination at E239 (P = 0.0388)| Gain of relative solvent accessibility (P = 0.1259)| Gain of solvent accessibility (P = 0.1708)| Gain of catalytic residue at E239 (P = 0.1715)	0.995933984291	0.99583	0.9857670712697579	0.98564	2.57629945819	0.98019	0.912695884705	0.97717	D	0.99356	0.99982	D	0.587694	0.97315	D	0.606405	0.97272	D	0.999899625778198	0.99573	D	0.985835	0.95233	D	0.9932776	0.99908	0.962082	0.99068	0.99190885	0.99853	0.96221924	0.99076	-15.967	0.97716	D	0.9996	0.99584	P	0.999770794868352	0.97903	0.99653673	0.98087	0.939	0.97079	.	.	.	.	.	.	6.227742	0.94841	34.0	0.99932186540007328	0.99439	0.909871	0.86657	D	1.06607634856089	0.97438	16.15491	0.966271369467495	0.97849	16.91408	5.1	5.1	0.68875	.	.	9.87	0.98471	11.749000	0.95369	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.998	0.85369	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	not_provided|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Aneurysm-osteoarthritis_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.67181297G>A	ClinGen:CA020100|OMIM:603109.0006|UniProtKB:P84022#VAR_067047	C3661900|C4707243|C3151087	PS607086|613795	91387|284984	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Glu	Lys	98.62	0.020618556701030927																																																																																																																																																																																																																																																																																																																																																																																																																																																																													4			98.62	Negatively-charged	Glutamic Acid		Mothers against decapentaplegic homolog 3							MH2			-3.5								 E239-R279 (PAE:  1.5), E239-N276 (PAE: 1.0), E239-R287 (PAE: 1.0)	E239-R279 (PDBs: 1MJS, 5XOC), E239-N276 (PDBs: 5XOC)	 E239-R279 (PAE:  1.5)	E239-R279 (PDBs: 1MJS, 1MK2, 5XOC)	 E239-R279 (PAE:  1.5), E239-R287 (PAE: 1.0)						146									-118.2				112.2						B (undefined)	E (parallel sheets)	Beta strand											98.62	2.0618556	>90	<10	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	false	0.9725882534468295	0.9765500383031416	true	true	false
GALE	GALE_Val94Met	B_7-8	1.201423328330532	0.31578480856030877	0.4037141796186009	4.998083086504592	0.015408625426391027	0.02508857822309453	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7587573258007934	0.6935441255916184	0.5845950998930284	0.6089411715635819	0.5503102180896522	0.5487293792464447	0.5487293792464447	0.5503102180896522	0.6089411715635819	0.5845950998930284	0.6935441255916184	0.7587573258007934							GALE	Val94Met	NC_000001.11:23798188:C:T	280G>A	1	23798188	C	T	1	ENSG00000117308	2767	214357	CCSBVarC005286	ALE00005286	ENSP00000483375.1	CEGS2	CegsMutGDEh1034	F12	GDEhDisVCh_40068	F06	2	CegsMutGDDh1034	F12	VUSN2Hmut_GDN2h_06	H10	VUSMutpDEST2_02	E10	VUSmut_GDEh06	H10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	18721.0	single nucleotide variant	NM_001008216.2(GALE):c.280G>A (p.Val94Met)	2582.0	GALE	HGNC:4116	Pathogenic/Likely pathogenic	1.0	Jan 13, 2024	121908047.0	-	RCV000003867|RCV000020292|RCV000727367|RCV002512728	MedGen:C4017048|MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	Galactosemia III, severe|UDPglucose-4-epimerase deficiency|not provided|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000001.11	1	23798188.0	23798188.0	1p36.11	criteria provided, multiple submitters, no conflicts	10.0	-	N	ClinGen:CA116434,UniProtKB:Q14376#VAR_010058,OMIM:606953.0008	3.0	3682.0	23798188.0	C	T	-	-	-	-	-	-	280G>A 	Val94Met	NM_001008216.2	2.0	Pathogenic	Likely pathogenic	3682	1	23798188.0	C	T	V	M	rs121908047	1	24124678	1	23997265	94	GALE	ENSG00000117308	ENST00000617979	ENSP00000483375	Q14376	GALE_HUMAN	c.280G>A	p.Val94Met	c.280G>A	p.Val94Met	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	.	0.50291	.	0.015	0.62681	D	1.0	0.90580	D	0.909	0.64559	D	.	0.92786	.	.	.	.	4.6	0.99241	H	.	0.60380	.	0.927	0.94206	1.0824	0.98958	D	0.9090	0.96977	D	9	0.8916069	0.88377	D	0.326228	0.91602	D	.	0.95902	.	.	.	.	.	0.896168233943	0.89434	0.722372103101091	0.72036	.	0.48212	0.729596376419	0.71397	T	0.910129	0.98283	D	0.385791	0.88999	D	0.413239	0.92477	D	0.990747690200806	0.80828	D	.	0.98907	.	0.8254288	0.85400	0.63791233	0.78623	0.74582124	0.80394	0.6767532	0.80801	-12.156	0.85642	D	0.9232	0.84417	LP	0.996434365700928	0.92139	0.99967730	0.99601	0.921	0.95990	.	.	.	.	.	.	5.398111	0.90423	31.0	0.99896530361846603	0.96973	0.909826	0.86648	D	0.954686705678597	0.94136	12.55326	0.843628533248784	0.92599	11.54321	4.79	4.79	0.60860	4.3	0.81401	7.135	0.76934	7.693000	0.65941	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.98	0.58201	510	0.75232	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	1	109398	9.140930e-06	0	1	207918	4.809590e-06	0	2	236902	8.442310e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13390	0.000000e+00	0	0	42768	0.000000e+00	0	1	15688	6.374300e-05	0	1	15688	6.374300e-05	0	0	16188	0.000000e+00	0	0	30520	0.000000e+00	0	0	6206	0.000000e+00	0	0	13398	0.000000e+00	0	0	16730	0.000000e+00	0	0	89410	0.000000e+00	0	1	30606	3.267330e-05	0	1	30606	3.267330e-05	0	0	14888	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17688	0.000000e+00	0	0	21628	0.000000e+00	0	1	102722	9.735010e-06	0	1	30524	3.276110e-05	0	1	30524	3.276110e-05	0	.	89	1613938	5.514460e-05	0	81	1180016	6.864310e-05	0	2	74930	2.669160e-05	0	0	910	0.000000e+00	0	1	60006	1.666500e-05	0	0	29608	0.000000e+00	0	0	44894	0.000000e+00	0	0	63916	0.000000e+00	0	0	6084	0.000000e+00	0	81	1180016	6.864310e-05	0	4	91088	4.391360e-05	0	2	19780	1.0111223458038423E-4	0	298	0	0	86	0	0	7864	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1982	0	0	8162	0	0	112	0	2	30890	6.474587245063128E-5	Inborn_genetic_diseases|Galactosemia_III,_severe|UDPglucose-4-epimerase_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.23798188C>T	ClinGen:CA116434|OMIM:606953.0008|UniProtKB:Q14376#VAR_010058	C0950123|C4017048|C0751161|C3661900	230350	352|79238	NAD(P)-binding domain	Val	Met	86.62	0.4225352112676056																																																																																																																																																																																																																																																																																																																																																																																																																																																																													60			86.62	Aliphatic	Valine		UDP-glucose 4-epimerase								0.849		4.2									V94-N206 (PDBs: 1EK5), V94-V98 (PDBs: 1EK6, 1HZJ)	 V94-N155 (PAE:  2.0), V94-V98 (PAE: 1.5)	V94-V98 (PDBs: 1EK5, 1EK6, 1HZJ), V94-N155 (PDBs: 1HZJ)							117									-51.1		Pocket 1: Mean pLDDT: 92.66, Volume: 1091.39 Å³, Druggability score: 0.85		-51.2				dbSNP: rs121908047; Variant type: LP/P; AA change: Val94Met; PTM type: Phosphorylation; PTM morphology: KAV*GEsVQkPL; Var class: II		H (helix)	H (α-helix)	Helix											86.62	42.25352	70-90	10-90	230350	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic hepatic disease; Rare inborn errors of metabolism	4	GALACTOSEMIA III	false	0.6935441255916184	0.7587573258007934	false	false	false
TPM1	TPM1_Met8Arg	B_15-16	-0.5032124142869533	0.6669170012115716	0.7165697441789145	-0.6865966876277402	1.0	1.0	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6138563619752166	0.594221467087558	0.5437083188734746	0.6369115926530156	0.6114000704161079	0.6270662592012933	0.5722372326502828	0.573406486810066	0.6533374721026162	0.5028429247257299	0.5722496459115791	0.6063020985091885	0.6818952857523038	0.6493936540221498	0.620485713203415	0.5845737130212194	0.6161932882635368	0.6214106254412449	TPM1	Met8Arg	NC_000015.10:63042852:T:G	23T>G	15	63042852	T	G	15	ENSG00000140416	4723	201728	CCSBVarC005628	ALE00005628	ENSP00000288398.6	CEGS2	CegsMutGDEh1038	E11	GDEhDisVCh_40050	D06	2	CegsMutGDDh1038	E11	VUSN2Hmut_GDN2h_07	F12	VUSMutpDEST2_04	C06	VUSmut_GDEh07	F12	1.0	1.0	1.0	1.0	1.0	4.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	N	Y	Y	52576.0	single nucleotide variant	NM_001018005.2(TPM1):c.23T>G (p.Met8Arg)	7168.0	TPM1	HGNC:12010	Likely pathogenic	1.0	Mar 01, 2008	397516364.0	-	RCV000036318	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604	Primary dilated cardiomyopathy	germline	germline	GRCh38	NC_000015.10	15	63042852.0	63042852.0	15q22.2	no assertion criteria provided	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017898	2.0	43406.0	63042852.0	T	G	-	-	-	-	-	-	23T>G 	Met8Arg	NM_001018005.2		Pathogenic	Likely pathogenic	43406	15	63042852.0	T	G	M	R	rs397516364	15	63335051	15	61122104	8	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.23T>G	p.Met8Arg	c.23T>G	p.Met8Arg	alternative1	Y	1	YES	Select	+	ATG	2	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.002	0.92967	D	0.998	0.77914	D	0.984	0.81117	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.865	0.95808	H	-3.33	0.72035	D	0.953	0.98852	1.0548	0.98217	D	0.9807	0.99405	D	10	0.87105346	0.86223	D	0.956788	0.99710	D	0.922	0.98039	0.327	0.30898	Q6ZN40	M8R	Loss of ubiquitination at K12 (P = 0.0286)| Gain of methylation at K7 (P = 0.0486)| Gain of glycosylation at K5 (P = 0.07)| Gain of MoRF binding (P = 0.0939)| Gain of relative solvent accessibility (P = 0.1259)	0.965157505225	0.96446	.	0.99650	.	0.99262	0.911636948586	0.97621	D	0.947879	0.99218	D	0.557593	0.96013	D	0.563167	0.95950	D	0.998527765274048	0.94345	D	0.982152	0.95531	D	0.97475696	0.98663	0.9602252	0.98967	0.9720705	0.98424	0.94344807	0.97961	-20.528	0.99960	D	0.9903	0.95515	P	0.999179368804142	0.95877	0.99972910	0.99655	0.828	0.90516	.	.	.	.	.	.	5.862979	0.9387	33.0	0.98594019697997193	0.43532	0.941716	0.94517	D	0.858366351738997	0.89523	10.03007	0.750632916516733	0.86126	8.815132	4.5	4.5	0.54328	.	.	7.725	0.8381	7.721000	0.67359	0.659	0.54735	1.0	0.71675	1.000000	0.68239	0.998	0.85369	786	0.46777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Primary_dilated_cardiomyopathy	no_assertion_criteria_provided	NC_000015.10:g.63042852T>G	ClinGen:CA017898	C0007193	.	217604	.	Met	Arg	73.98	0.7180851063829787																																																																																																																																																																																																																																																																																																																																																																																																																																																																													135			73.98	Aliphatic	Methionine		Tropomyosin alpha-1 chain	Coiled coil									1.9								 M8-I4 (PAE:  9.5), M8-K12 (PAE: 7.5)		 M8-I4 (PAE:  9.5), M8-K12 (PAE: 7.5)								149									-71.2				-35.4	Disordered					H (helix)	H (α-helix)	Helix											73.98	71.80851	70-90	10-90		unknown		Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3		false	0.594221467087558	0.6138563619752166	false	false	false
POMT1	POMT1_Ala647Thr	B_7-8	-1.243076568452781	0.26021072351623276	0.3451406124416698	-3.057197784000787	0.022305001668457662	0.03474505777726639	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5945951652981489	0.6407099855475032	0.686272106840508	0.4819976195423371	0.6264776163995617	0.7076605812523789	0.7195907465781219	0.46208589642747216	0.40695561336442637	0.7056724113259256	0.636434238618128	0.597519301031715	0.6957304159266359	0.7908693363716512	0.5570396257202479	0.6668718023550905	0.6449857324768785	0.5916710295645827	POMT1	Ala647Thr	NC_000009.12:131522160:G:A	1939G>A	9	131522160	G	A	9	ENSG00000130714	71206	205723	CCSBVarC003251	ALE00003251	ENSP00000385797.4	CEGS2	CegsMutGDEh1038	C10	GDEhDisVCh_40022	B10	2	CegsMutGDDh1038	C10	VUSN2Hmut_GDN2h_07	D12	VUSMutpDEST2_15	A04	VUSmut_GDEh07	D12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	18289.0	single nucleotide variant	NM_001077365.2(POMT1):c.1939G>A (p.Ala647Thr)	10585.0	POMT1	HGNC:9202	Pathogenic/Likely pathogenic	1.0	May 30, 2024	119462987.0	-	RCV000414180|RCV000694423|RCV003460409|RCV002286394	MedGen:C3661900|MONDO:MONDO:0013159,MedGen:C5436962,OMIM:613155;MONDO:MONDO:0012248,MedGen:C1836373,OMIM:609308,Orphanet:86812;MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899|MONDO:MONDO:0009364,MedGen:C4284790,OMIM:236670,Orphanet:588,Orphanet:899|MONDO:MONDO:0013159,MedGen:C5436962,OMIM:613155	not provided|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1;Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1	germline;unknown	germline	GRCh38	NC_000009.12	9	131522160.0	131522160.0	9q34.13	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA116114,UniProtKB:Q9Y6A1#VAR_065036,OMIM:607423.0013	3.0	3250.0	131522160.0	G	A	-	-	-	-	-	-	1939G>A 	Ala647Thr	NM_001077365.2	2.0	Pathogenic	Likely pathogenic	3250	9	131522160.0	G	A	A	T	rs119462987	9	134397547	9	133387368	669	POMT1	ENSG00000130714	ENST00000372228	ENSP00000361302	Q9Y6A1	POMT1_HUMAN	c.2005G>A	p.Ala669Thr	c.2005G>A	p.Ala669Thr	.	Y	1	.	.	+	GCA	1	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.004	0.74454	D	1.0	0.90580	D	0.998	0.88579	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.4	0.69265	M	-3.44	0.67509	D	0.92	0.92320	1.0978	0.99568	D	0.9536	0.98491	D	9	0.91080403	0.90339	D	0.518337	0.95400	D	0.926	0.98190	.	.	.	.	.	0.97052147054	0.96992	0.7746449255817429	0.77288	0.590526079068	0.54224	0.583067953587	0.50450	T	0.958275	0.99440	D	0.527346	0.95023	D	0.519719	0.94950	D	0.96971769214918	0.68482	D	0.944805	0.79363	D	0.8212805	0.85115	0.8150724	0.89084	0.7702158	0.81841	0.7719306	0.86370	-8.823	0.67426	D	0.6817	0.74293	P	0.969279836122689	0.83153	0.96638900	0.94391	0.963	0.98469	.	.	.	.	.	.	5.366546	0.89995	31.0	0.99909479789106714	0.97950	0.925586	0.90504	D	0.833743661996467	0.88098	9.476632	0.717920748451537	0.83650	8.101675	5.55	5.55	0.83275	.	.	9.53	0.9712	11.584000	0.93371	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.898	0.43497	414	0.81871	.	.	.	.	.	.	.	.	.	.	.	.	7	264690	2.644603E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	1613972	3.717540e-06	0	2	74902	2.670160e-05	0	2	74902	2.670160e-05	0	0	910	0.000000e+00	0	0	60002	0.000000e+00	0	0	29604	0.000000e+00	0	0	44902	0.000000e+00	0	0	63954	0.000000e+00	0	0	6084	0.000000e+00	0	3	1180046	2.542270e-06	0	1	91090	1.097820e-05	0	1	32774	3.051199121254653E-5	0	114	0	0	120	0	0	3238	0	0	498	0	0	628	0	0	26	0	0	104	0	0	4936	0	0	3352	0	0	146	0	1	42438	2.3563787171874265E-5	Muscular_dystrophy-dystroglycanopathy_(congenital_with_intellectual_disability),_type_B1|not_provided|Walker-Warburg_congenital_muscular_dystrophy|Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2K|Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),_type_A1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.131522160G>A	ClinGen:CA116114|OMIM:607423.0013|UniProtKB:Q9Y6A1#VAR_065036	C5436962|C3661900|C0265221|C1836373|C4284790	613155|PS236670|609308|236670	899|86812|588|899	Protein O-mannosyl-transferase, C-terminal four TM domain	Ala	Thr	97.37	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.37	0.0	>90	<10	613155;609308;236670;613155	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1	false	0.6407099855475032	0.5945951652981489	false	false	false
GCK	GCK_Met251Thr	B_7-8	5.080191792436492	0.014734661649919168	0.03664479655123126	6.530983006291094	0.0072952990493274136	0.013047635239294154	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7755574398584801	0.8387915154310729	0.5282088459592875	0.7667995870610421	0.6416659684523105	0.5894207775865237	0.5894207775865237	0.6416659684523105	0.7667995870610421	0.5282088459592875	0.8387915154310729	0.7755574398584801							GCK	Met251Thr	NC_000007.14:44147761:A:G	752T>C	7	44147761	A	G	7	ENSG00000106633	3689	214842	CCSBVarC006691	ALE00006689	ENSP00000384247.3	CEGS2	CegsMutGDEh1044	E12	GDEhDisVCh_40037	H03	1	CegsMutGDDh1044	E12	VUSN2Hmut_GDN2h_09	A08	VUSMutpDEST2_03	B09	VUSmut_GDEh09	A08	1.0	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	44915.0	single nucleotide variant	NM_000162.5(GCK):c.752T>C (p.Met251Thr)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Aug 18, 2011	193922326.0	-	RCV000029914	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552	Maturity-onset diabetes of the young type 2	germline	germline	GRCh38	NC_000007.14	7	44147761.0	44147761.0	7p13	criteria provided, single submitter	1.0	-	N	ClinGen:CA213840	2.0	36251.0	44147761.0	A	G	-	-	-	-	-	-	752T>C 	Met251Thr	NM_000162.5	1.0	Pathogenic	Likely pathogenic	36251	7	44147761.0	A	G	M	T	rs193922326	7	44187360	7	44153885	251	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.752T>C	p.Met251Thr	c.752T>C	p.Met251Thr	principal1	Y	1	YES	Select	-	ATG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.017	0.60671	D	0.995	0.67505	D	0.986	0.76920	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.875	0.83215	M	-5.42	0.85499	D	0.984	0.99346	1.0939	0.99398	D	0.9434	0.98142	D	10	0.9929316	0.99827	D	0.810136	0.98516	D	0.958	0.99315	0.964	0.99639	P35557	M251T	Gain of phosphorylation at M251 (P = 0.0354)| Loss of stability (P = 0.0855)| Gain of glycosylation at M251 (P = 0.1029)| Gain of disorder (P = 0.1361)| Gain of catalytic residue at M251 (P = 0.2063)	0.968788596446	0.96816	.	0.99555	.	0.95313	0.82486641407	0.85751	D	0.914621	0.98402	D	0.549203	0.95653	D	0.551115	0.95589	D	0.997693359851837	0.92120	D	0.929807	0.73982	D	0.9549938	0.96722	0.9617509	0.99050	0.96466744	0.97710	0.96202224	0.99065	-11.075	0.80132	D	0.97	0.90769	P	0.999031307169696	0.95557	0.99983132	0.99778	0.985	0.99487	.	.	.	.	.	.	5.062186	0.84404	28.3	0.99328249489691056	0.59720	0.946730	0.95635	D	0.810235373814387	0.86670	8.984149	0.778746685223209	0.88214	9.523028	5.33	5.33	0.75646	.	.	9.269	0.94905	11.133000	0.86872	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.99	0.65338	698	0.58020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613630	6.197210e-07	0	0	75068	0.000000e+00	0	0	75068	0.000000e+00	0	0	910	0.000000e+00	0	0	60034	0.000000e+00	0	0	29608	0.000000e+00	0	0	44888	0.000000e+00	0	0	63438	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180030	0.000000e+00	0	0	91086	0.000000e+00	0	0	74	0	0	0	0	0	30	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	30	0	0	652	0	Maturity-onset_diabetes_of_the_young_type_2	criteria_provided,_single_submitter	NC_000007.14:g.44147761A>G	ClinGen:CA213840	C0342277	125851	552	Hexokinase, C-terminal	Met	Thr	94.49	0.0																																																																																																											0.803	2 mutation(s) (Met251His: 3.856, Met251Thr: -0.556)	0.448	1 mutation(s) (Met251Ile: 1.294)																																																																																																																																																																																																																																																																																																																																																															0			94.49	Aliphatic	Methionine		Hexokinase-4							Hexokinase			1.9								 M251-E236 (PAE:  1.0)	M251-E236 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9)	 M251-E236 (PAE:  1.0), M251-M235 (PAE: 1.0)	M251-E236 (PDBs: 3F9M, 3H1V, 3ID8, 3IDH, 3S41, 3VEY, 4DCH, 4DHY, 4ISE, 4ISF, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9), M251-M235 (PDBs: 3FGU, 3VEV, 3VF6, 4ISG), M251-M238 (PDBs: 4L3Q)							149									-135.9				140.8	Hexokinase large subdomain					B (undefined)	E (parallel sheets)	Beta strand											94.49	0.0	>90	<10	125851	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism	3	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2	false	0.8387915154310729	0.7755574398584801	false	false	false
MVK	MVK_His20Gln	B_7-8	0.9650655955250064	0.3717815498182178	0.46312466521949014	-0.649452834609613	0.5400961121946324	0.5945269141434616	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5630777268041469	0.5953977410252813	0.6180797028560239	0.5747639214690281	0.570736036380324	0.6603268441500401	0.6106456103936027	0.6171650952763771	0.5717403194866225	0.5773635781838664	0.6380084288545782	0.6022986364213976	0.7100080779064775	0.5243069774842708	0.5777875234514337	0.6587958275281814	0.5527870531959845	0.5238568171868964	MVK	His20Gln	NC_000012.12:109574882:T:A	60T>A	12	109574882	T	A	12	ENSG00000110921	281	727	CCSBVarC000026	ALE00000026	ENSP00000228510.3	RC4	RC4_Mut_GDEh1020	B03	GDEhDisVCh_40020	F04	2	RC4_Mut_GDDh1020	B03	VUSN2Hmut_GDN2h_10	D08	VUSMutpDEST2_01	B04	VUSmut_GDEh13	E03	1.0	2.0	1.0	1.0	1.0	99.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	Y	Y	N	Y	103494.0	single nucleotide variant	NM_000431.4(MVK):c.60T>A (p.His20Gln)	4598.0	MVK	HGNC:7530	Pathogenic/Likely pathogenic	1.0	Oct 22, 2023	104895335.0	-	RCV000083854|RCV001509433|RCV003764776	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:C3661900|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343	Hyperimmunoglobulin D with periodic fever|not provided|Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever	germline;unknown	germline	GRCh38	NC_000012.12	12	109574882.0	109574882.0	12q24.11	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA149856,UniProtKB:Q03426#VAR_029519	2.0	97602.0	109574882.0	T	A	-	-	-	-	-	-	60T>A 	His20Gln	NM_000431.4	2.0	Pathogenic	Likely pathogenic	97602	12	109574882.0	T	A	H	Q	rs104895335	12	110012687	12	108497070	20	MVK	ENSG00000110921	ENST00000228510	ENSP00000228510	Q03426	KIME_HUMAN	c.60T>A	p.His20Gln	c.60T>A	p.His20Gln	principal1	Y	1	YES	Select	+	CAT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	D	simple_aae	1.0	99.0	3.71	0.94612	H	-7.2	0.95529	D	0.972	0.98282	0.8959	0.95603	D	0.9288	0.97644	D	10	0.98995876	0.99476	D	0.644881	0.96976	D	0.861	0.95754	0.987	0.99867	Q03426	H20Q	Loss of sheet (P = 0.0228)| Gain of loop (P = 0.069)| Gain of catalytic residue at H20 (P = 0.1413)| Gain of relative solvent accessibility (P = 0.2363)| Gain of solvent accessibility (P = 0.2987)	0.977978894687	0.97752	0.9536377605951378	0.95319	1.13761330329	0.78701	0.797176718712	0.81501	T	0.814674	0.95368	D	0.488104	0.93899	D	0.463351	0.93821	D	0.998581051826477	0.94516	D	0.940673	0.78345	D	0.92884755	0.94033	0.70882726	0.82626	0.94058895	0.95235	0.76449174	0.85917	-12.308	0.86355	D	0.9499	0.90300	LP	0.990485783011409	0.88603	0.99955195	0.99479	0.977	0.99166	.	.	.	.	.	.	3.459009	0.48281	22.6	0.9891017875410828	0.48459	0.266778	0.38161	N	0.350992715592573	0.58581	4.05371	0.157515795463121	0.47274	2.982835	4.36	0.00221	0.13335	-1.11	0.15234	-0.196	0.09562	-2.312000	0.03935	0.66	0.55068	0.848	0.30503	0.000000	0.08389	0.997	0.79771	735	0.53648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hyperimmunoglobulin_D_with_periodic_fever|not_provided|Mevalonic_aciduria|Porokeratosis_3,_disseminated_superficial_actinic_type	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.109574882T>A	ClinGen:CA149856|UniProtKB:Q03426#VAR_029519	C0398691|C3661900|C1959626|C1867981	260920|610377|175900	343|29	.	His	Gln	94.91	0.043478260869565216																																																																																																																																																																																																																																																																																																																																																																																																																																																																													8			94.91	Positively-charged	Histidine		Mevalonate kinase								0.384		-3.2								 H20-A334 (PAE:  1.5)	H20-A334 (PDBs: 2R3V)		H20-V247 (PDBs: 2R3V)							155									-92.8		Pocket 2: Mean pLDDT: 90.7, Volume: 500.25 Å³, Druggability score: 0.38		-21.4						C (loop/coil)	T (turn)	Turn											94.91	4.347826	>90	<10	260920;175900;610377;260920	autosomal recessive	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; POROKERATOSIS 3, MULTIPLE TYPES; MEVALONIC ACIDURIA; HYPER-IgD SYNDROME	false	0.5953977410252813	0.5630777268041469	false	false	false
COMP	COMP_Asp271His	B_7-8	-2.459477382708509	0.06973060433470316	0.12151957507233853	4.540422643243186	0.0026663513289486352	0.0054424412554179595	2024_01_Batch_7-8	false	false	true	false	false	false	false	false	false	false	false	false	0.9202885935249753	0.9287501703185392	0.9457987175384456	0.8005832321142533	0.8401504418438434	0.9451880798183895	0.9451880798183895	0.8577382985899826	0.8565591179173893	0.9457987175384456	0.9316494043552039	0.9202885935249753		0.8225625850977041	0.7446073463111174		0.9258509362818744		COMP	Asp271His	NC_000019.10:18788466:C:G	811G>C	19	18788466	C	G	19	ENSG00000105664	56661	3366	CCSBVarC008151	ALE00008137	ENSP00000222271.2	Edgotyping3	VUSMutGDEh015	G08	GDEhDisVCh_40037	C12	1	VUSMutGDDh015	G08	VUSN2Hmut_GDN2h_04	A10	VUSMutpDEST2_13	D09	VUSmut_GDEh04	A10	1.0	1.0	1.0	5.0	1.0	6.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	422255.0	single nucleotide variant	NM_000095.3(COMP):c.811G>C (p.Asp271His)	1311.0	COMP	HGNC:2227	Likely pathogenic	1.0	Jan 22, 2016	1131691835.0	-	RCV000493984	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000019.10	19	18788466.0	18788466.0	19p13.11	criteria provided, single submitter	1.0	-	N	ClinGen:CA404892739	2.0	430218.0	18788466.0	C	G	-	-	-	-	-	-	811G>C 	Asp271His	NM_000095.3	1.0	Pathogenic	Likely pathogenic	430218	19	18788466.0	C	G	D	H	rs1131691835	19	18899275	19	18760275	271	COMP	ENSG00000105664	ENST00000222271	ENSP00000222271	P49747	COMP_HUMAN	c.811G>C	p.Asp271His	c.811G>C	p.Asp271His	principal1	Y	1	YES	Select	-	GAC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.91311	A	simple_aae	18.0	82.0	2.89	0.83536	M	-6.17	0.90272	D	0.962	0.99555	1.0357	0.97821	D	0.9833	0.99490	D	10	0.9902823	0.99520	D	0.938107	0.99557	D	0.948	0.98989	0.833	0.94137	P49747	D271H	Loss of sheet (P = 0.0457)| Loss of loop (P = 0.0603)| Loss of disorder (P = 0.0651)| Loss of stability (P = 0.0726)| Gain of catalytic residue at D271 (P = 0.1247)	0.949835306109	0.94889	0.9740120060836024	0.97377	.	.	0.845226764679	0.88874	D	0.892587	0.97809	D	0.415523	0.90719	D	0.359094	0.90604	D	0.996518969535828	0.89415	D	0.989979	0.96898	D	0.9571752	0.96946	0.845465	0.91084	0.9613313	0.97373	0.8587393	0.91988	-18.52	0.99702	D	0.994	0.95820	P	0.998246956019068	0.94165	0.92699885	0.92261	0.995	0.99826	.	.	.	.	.	.	5.225167	0.87723	29.3	0.99379884481885328	0.61901	0.942230	0.94636	D	0.717685219787803	0.80686	7.373364	0.569825131391914	0.72638	5.865205	4.2	4.2	0.48755	4.28	0.81107	7.763	0.84161	5.857000	0.50468	0.541	0.25267	1.0	0.71675	1.000000	0.68239	0.003	0.0525	867	0.32049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000019.10:g.18788466C>G	ClinGen:CA404892739	CN517202	.	.	.	Asp	His	97.43	0.006134969325153374																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			97.43	Negatively-charged	Aspartic Acid		Cartilage oligomeric matrix protein										-3.5								 D271-S681 (PAE:  1.0)	D271-S681 (PDBs: 3FBY)	 D271-S681 (PAE:  1.0), D271-V295 (PAE: 1.0), D271-T294 (PAE: 1.0)	D271-S681 (PDBs: 3FBY), D271-V295 (PDBs: 3FBY)							132									-109.2				0.6			TSP type-3 1			C (loop/coil)	S (bend)												97.43	0.6134969	>90	<10		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	2		false	0.9287501703185392	0.9202885935249753	false	false	false
COMP	COMP_Asp511Glu	B_7-8	-5.511470029564931	0.011761211861812806	0.030688408000085328	1.0900514822743799	0.3117860417246504	0.36534315872588347	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8698498151031855	0.8643294387176137	0.7107010632898791	0.7946190621877736	0.7546213210724204	0.7465801033130753	0.7465801033130753	0.7550968685303051	0.773539987909183	0.7107010632898791	0.8783839058566226	0.8698498151031855		0.7541457736145358	0.815698136466364		0.8502749715786049		COMP	Asp511Glu	NC_000019.10:18785808:G:C	1533C>G	19	18785808	G	C	19	ENSG00000105664	56661	3350	CCSBVarC008146	ALE00008132	ENSP00000222271.2	Edgotyping3	VUSMutGDEh015	A08	GDEhDisVCh_40037	E11	1	VUSMutGDDh015	A08	VUSN2Hmut_GDN2h_04	C09	VUSMutpDEST2_13	F08	VUSmut_GDEh04	C09	1.0	3.0	1.0	5.0	1.0	5.0	7.0	1.0	2.0	1.0	1.0	1.0	1.0	N	N	N	Y	Y	410556.0	single nucleotide variant	NM_000095.3(COMP):c.1533C>G (p.Asp511Glu)	1311.0	COMP	HGNC:2227	Pathogenic/Likely pathogenic	1.0	Jul 26, 2022	1064794293.0	-	RCV000483120	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000019.10	19	18785808.0	18785808.0	19p13.11	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA16620813	2.0	420111.0	18785808.0	G	C	-	-	-	-	-	-	1533C>G 	Asp511Glu	NM_000095.3	2.0	Pathogenic	Likely pathogenic	420111	19	18785808.0	G	C	D	E	rs1064794293	19	18896618	19	18757618	511	COMP	ENSG00000105664	ENST00000222271	ENSP00000222271	P49747	COMP_HUMAN	c.1533C>G	p.Asp511Glu	c.1533C>G	p.Asp511Glu	principal1	Y	1	YES	Select	-	GAC	3	2	G	G/G	G/G	G/G	G/G	0.011	0.57638	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.96	0.95575	A	simple_aae	4.0	96.0	4.17	0.97633	H	-3.69	0.70469	D	0.894	0.93732	1.0061	0.97284	D	0.9964	0.99916	D	10	0.97436506	0.97114	D	0.902755	0.99267	D	0.928	0.98265	0.763	0.89077	P49747	D511E	Loss of stability (P = 0.0402)| Loss of ubiquitination at K516 (P = 0.1191)| Gain of methylation at K512 (P = 0.1199)| Loss of disorder (P = 0.2197)| Loss of helix (P = 0.2662)	0.8976869274	0.89589	0.966540903153465	0.96623	.	.	0.626184523106	0.56538	T	0.993645	0.99982	D	0.337806	0.85585	D	0.247458	0.85396	D	0.998655438423157	0.94722	D	0.890111	0.62265	D	0.8450811	0.86801	0.74714935	0.84873	0.8298859	0.85710	0.66931146	0.80382	-14.334	0.94104	D	0.9691	0.90732	P	0.994784794575911	0.90874	0.99673235	0.98144	0.688	0.82685	.	.	.	.	.	.	4.270266	0.65036	24.8	0.99658665829948245	0.77781	0.737886	0.68179	D	0.361403483745029	0.59136	4.113057	0.209345334757255	0.50110	3.229354	4.61	1.29	0.20667	-3.15	0.08180	3.365	0.52154	2.109000	0.30732	-0.373	0.05445	1.0	0.71675	0.994000	0.32271	0.969	0.5403	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.18785808G>C	ClinGen:CA16620813	C3661900	.	.	.	Asp	Glu	95.69	0.15337423312883436																																																																																																																																																																																																																																																																																																																																																																																																																																																																													25			95.69	Negatively-charged	Aspartic Acid		Cartilage oligomeric matrix protein										-3.5										 D511-D507 (PAE:  1.0)	D511-T527 (PDBs: 3FBY), D511-D507 (PDBs: 3FBY)							132									-77.4				-6.9			TSP type-3 8			C (loop/coil)	S (bend)	Beta strand											95.69	15.337424	>90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	2		false	0.8643294387176137	0.8698498151031855	false	false	false
DES	DES_Leu345Pro	B_7-8	0.18357321576630903	0.8615605595531775	0.8909478444756735	-7.1432762138037	0.000186452914537226	0.0006431223649921234	2024_01_Batch_7-8		false	false	false	false	false		false	false	false	false	false		0.9414900258569912	0.7634274206067205	0.8028694554923699	0.8282463892359677	0.8171718715085942	0.9515311731367884	0.9037300342348766	0.9160002334667592	0.9415608845292851	0.9707109726989182		0.6828125698804	0.7527627442370588	0.6897386775179806	0.585293956684156	0.9122690790150643		DES	Leu345Pro	NC_000002.12:219421350:T:C	1034T>C	2	219421350	T	C	2	ENSG00000175084	12573	2299	CCSBVarC007856	ALE00007842	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	A10	GDEhDisVCh_40003	C10	1	VUSMutGDDh003	A10	VUSN2Hmut_GDN2h_01	G04	NULL	NULL	VUSmut_GDEh01	G04	1.0	3.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	N	Y	Y	N	Y	31864.0	single nucleotide variant	NM_001927.4(DES):c.1034T>C (p.Leu345Pro)	1674.0	DES	HGNC:2770	Pathogenic/Likely pathogenic	1.0	Jan 01, 2024	57639980.0	-	RCV000056765|RCV001044194	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline;unknown	germline	GRCh38	NC_000002.12	2	219421350.0	219421350.0	2q35	criteria provided, multiple submitters, no conflicts	7.0	ACMG2022	N	ClinGen:CA217003,UniProtKB:P17661#VAR_009189,OMIM:125660.0006	3.0	16825.0	219421350.0	T	C	-	-	-	-	-	-	1034T>C 	Leu345Pro	NM_001927.4	2.0	Pathogenic	Likely pathogenic	16825	2	219421350.0	T	C	L	P	rs57639980	2	220286072	2	219994316	345	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1034T>C	p.Leu345Pro	c.1034T>C	p.Leu345Pro	principal1	Y	1	YES	Select	+	CTG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.999	0.77914	D	0.995	0.83178	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.16	0.97582	H	-6.2	0.90390	D	0.993	0.99866	1.1009	0.99697	D	0.9517	0.98426	D	9	0.9942647	0.99933	D	0.487823	0.94940	D	0.982	0.99890	0.983	0.99835	P17661	L345P	Loss of stability (P = 0.0113)| Gain of disorder (P = 0.0828)| Loss of MoRF binding (P = 0.0845)| Gain of phosphorylation at S344 (P = 0.1197)| Loss of catalytic residue at L345 (P = 0.4641)	0.996503101183	0.99641	0.9878325474158062	0.98773	1.85576430493	0.92306	0.867776036263	0.92237	D	0.958209	0.99438	D	0.555968	0.95982	D	0.560833	0.95921	D	0.999246001243591	0.96645	D	0.976552	0.91871	D	0.97282976	0.98493	0.9584676	0.98871	0.9703254	0.98261	0.95384747	0.98606	-16.301	0.98181	D	0.9997	0.99393	P	0.999820554096733	0.98179	0.99883586	0.98992	1	0.99985	.	.	.	.	.	.	5.642767	0.92765	33.0	0.99914004994343486	0.98239	0.992088	0.99998	D	0.980840733436087	0.95098	13.33129	0.881257678758345	0.94672	12.97264	5.24	5.24	0.72825	4.05	0.77340	7.798	0.84529	7.809000	0.69422	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.978	0.57275	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Desmin-related_myofibrillar_myopathy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219421350T>C	ClinGen:CA217003|OMIM:125660.0006|UniProtKB:P17661#VAR_009189	C1832370|C3661900	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Pro	90.57	0.5853658536585366																																																																																																																																																																																																																																																																																																																																																																																																																																																																													96			90.57	Aliphatic	Leucine		Desmin							IF rod			3.8								 L345-T341 (PAE:  1.0), L345-M349 (PAE: 1.0)		 L345-T341 (PAE:  1.0), L345-M349 (PAE: 1.0)								131									-67.7				-41.7	Interaction with NEB; Coil 2B			dbSNP: rs57639980; Variant type: LP/P; AA change: Leu345Pro; PTM type: Phosphorylation; PTM morphology: kGTNDsL*MRQM; Var class: II		H (helix)	H (α-helix)												90.57	58.536583	>90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.9414900258569912		false		false
KCTD7	KCTD7_Arg184Cys	B_7-8	-3.7998864874691014	0.008968990770634318	0.025044988847823902	-3.8829643742702884	0.006029871899395085	0.01109810926317952	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7343871786968023	0.7703047960933072	0.6702746519143297	0.6880305519485499	0.6988530030697743	0.7452180086625232	0.8775877137242778	0.79401514482484	0.9043254203206745	0.7998681107175427	0.9019657119339508	0.8913511591611876	0.6128483036007686	0.6036908613147085	0.4717356835764253	0.5406811931111167	0.6386438802526636	0.577423198232417	KCTD7	Arg184Cys	NC_000007.14:66638912:C:T	550C>T	7	66638912	C	T	7	ENSG00000243335	70368	205546	CCSBVarC005607	ALE00005607	ENSP00000411624.1	CEGS2	CegsMutGDEh1034	F08	GDEhDisVCh_40029	F12	1	CegsMutGDDh1034	F08	VUSN2Hmut_GDN2h_06	E09	VUSMutpDEST2_13	B12	VUSmut_GDEh06	E09	1.0	1.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	45589.0	single nucleotide variant	NM_153033.5(KCTD7):c.550C>T (p.Arg184Cys)	154881.0	KCTD7	HGNC:21957	Pathogenic/Likely pathogenic	1.0	Feb 28, 2024	387907246.0	-	RCV000030608|RCV000519234|RCV000548914|RCV001582502|RCV002513270	MedGen:C4017260|MedGen:C3661900|MONDO:MONDO:0012721,MedGen:C2673257,OMIM:611726,Orphanet:263516|MONDO:MONDO:0016295,MedGen:C0027877,OMIM:PS256730,Orphanet:216,Orphanet:79263|MeSH:D030342,MedGen:C0950123	Epilepsy, progressive myoclonic, 3, with intracellular inclusions|not provided|Progressive myoclonic epilepsy type 3|Neuronal ceroid lipofuscinosis|Inborn genetic diseases	germline	germline	GRCh38	NC_000007.14	7	66638912.0	66638912.0	7q11.21	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA129977,UniProtKB:Q96MP8#VAR_068779,OMIM:611725.0002	3.0	36926.0	66638912.0	C	T	-	-	-	-	-	-	550C>T 	Arg184Cys	NM_153033.5	2.0	Pathogenic	Likely pathogenic	36926	7	66638912.0	C	T	R	C	rs387907246	7	66103899	7	65741334	184	KCTD7	ENSG00000243335	ENST00000639828	ENSP00000492240	Q96MP8	KCTD7_HUMAN	c.550C>T	p.Arg184Cys	c.550C>T	p.Arg184Cys	principal4	Y	2	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.83643	.	1.0	0.90580	D	0.985	0.76461	D	.	.	.	.	.	.	1.445	0.36203	L	.	0.77830	.	.	0.80998	0.2624	0.86894	D	0.6019	0.85792	D	9	0.8118233	0.80259	D	0.139845	0.82181	D	.	0.90816	0.551	0.66599	Q96MP8	R184C	Loss of sheet (P = 0.0181)| Loss of solvent accessibility (P = 0.0199)| Loss of MoRF binding (P = 0.0222)| Gain of loop (P = 0.0435)| Loss of helix (P = 0.1299)	.	0.91642	0.7597855662647994	0.75794	.	.	0.921057164669	0.98402	D	0.348797	0.71501	T	0.409595	0.90393	D	0.57628	0.96272	D	0.760653432661191	0.43595	D	0.989668	0.96652	D	0.49201456	0.66313	0.2734087	0.53055	0.47030863	0.64996	0.23597409	0.48672	-8.348	0.63593	D	0.99	0.93582	P	0.996870706458158	0.92548	0.99234210	0.97124	0.94	0.97139	.	.	.	.	.	.	5.670286	0.92942	33.0	0.98189269036498539	0.39160	0.546852	0.55924	D	0.714138224960399	0.80452	7.321113	0.680797573998539	0.80819	7.407965	5.26	5.26	0.73443	.	.	3.53	0.53386	7.656000	0.64019	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.985	0.61072	851	0.35263	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	4	109360	3.657640e-05	0	5	208040	2.403380e-05	0	5	236766	2.111790e-05	0	0	7164	0.000000e+00	0	3	17102	1.754180e-04	0	0	2320	0.000000e+00	0	1	9044	1.105710e-04	0	0	13364	0.000000e+00	0	0	42764	0.000000e+00	0	0	15688	0.000000e+00	0	3	17102	1.754180e-04	0	0	16216	0.000000e+00	0	4	30504	1.311300e-04	0	0	6212	0.000000e+00	0	1	13414	7.454900e-05	0	0	16704	0.000000e+00	0	0	89522	0.000000e+00	0	0	30606	0.000000e+00	0	4	30504	1.311300e-04	0	0	14900	0.000000e+00	0	4	34238	1.168290e-04	0	0	9564	0.000000e+00	0	1	17690	5.652910e-05	0	0	21598	0.000000e+00	0	0	102638	0.000000e+00	0	0	30524	0.000000e+00	0	4	34238	1.168290e-04	0	.	9	1614036	5.576080e-06	0	4	59998	6.666890e-05	0	0	74920	0.000000e+00	0	0	912	0.000000e+00	0	4	59998	6.666890e-05	0	0	29606	0.000000e+00	0	2	44892	4.455140e-05	0	0	64014	0.000000e+00	0	0	6082	0.000000e+00	0	3	1180040	2.542290e-06	0	0	91090	0.000000e+00	0	1	9690	1.0319917440660474E-4	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	1	14528	6.883259911894274E-5	Progressive_myoclonic_epilepsy_type_3|Neuronal_ceroid_lipofuscinosis|Inborn_genetic_diseases|not_provided|Epilepsy,_progressive_myoclonic,_3,_with_intracellular_inclusions	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.66638912C>T	ClinGen:CA129977|OMIM:611725.0002|UniProtKB:Q96MP8#VAR_068779	C2673257|C0027877|C0950123|C3661900|C4017260	611726|PS256730	263516|216|79263	.	Arg	Cys	91.99	0.6733870967741935																																																																																																																																																																																																																																																																																																																																																																																																																																																																													167			91.99	Positively-charged	Arginine		BTB/POZ domain-containing protein KCTD7								0.0205		-4.5								 R184-W289 (PAE:  5.0), R184-W288 (PAE: 2.5)		 R184-W288 (PAE:  2.5)								175									-74.6		Pocket 1: Mean pLDDT: 89.88, Volume: 400.33 Å³, Druggability score: 0.02		6.5						C (loop/coil)	S (bend)												91.99	67.338715	>90	10-90	611726	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	false	0.7703047960933072	0.7343871786968023	false	false	false
HPRT1	HPRT1_Gly71Arg	B_7-8	0.0	1.0	1.0	-2.0506242261227485	0.07945715203511454	0.10712995884234768	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5258327258983085	0.573384898711227	0.6380310500399532	0.6679443638791769	0.6246651707006587	0.7106815729801985	0.7055703733882029	0.667992516948923	0.7060806174098111	0.6862024117603984	0.6021495052779174	0.6129417385601192	0.7157927725721942	0.5813378244523945	0.6298081103485426	0.589859688319508	0.5446202921445366	0.43872371323649784	HPRT1	Gly71Arg	NC_000023.11:134475257:G:C	211G>C	23	134475257	G	C	X	ENSG00000165704	7982	202789	CCSBVarC005929	ALE00005929	ENSP00000298556.7	CEGS2	CegsMutGDEh1039	D10	GDEhDisVCh_40052	B09	2	CegsMutGDDh1039	D10	VUSN2Hmut_GDN2h_08	F03	VUSMutpDEST2_07	A06	VUSmut_GDEh08	F03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25084.0	single nucleotide variant	NM_000194.2(HPRT1):c.211G>C (p.Gly71Arg)	3251.0	HPRT1	HGNC:5157	Likely pathogenic	1.0	Jun 13, 2017	137852488.0	-	RCV000010745|RCV000010744|RCV000790697	|MONDO:MONDO:0010298,MedGen:C0023374,OMIM:300322,Orphanet:510|MedGen:CN517202	HPRT YALE|Lesch-Nyhan syndrome|not provided	germline	germline	GRCh38	NC_000023.11	X	134475257.0	134475257.0	Xq26.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA120900,UniProtKB:P00492#VAR_006774,OMIM:308000.0017	3.0	10045.0	134475257.0	G	C	-	-	-	-	-	-	211G>C 	Gly71Arg	NM_000194.2	1.0	Pathogenic	Likely pathogenic	10045	X	134475257.0	G	C	G	R	rs137852488	X	133609287	X	133436953	71	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.211G>C	p.Gly71Arg	c.211G>C	p.Gly71Arg	principal1	Y	1	YES	Select	+	GGC	1	0	G	./.	./.	./.	./.	0.001	0.78662	D	0.026	0.56104	D	0.971	0.57200	D	0.89	0.63151	P	0.9	0.92286	A	simple_aae	10.0	90.0	3.885	0.95950	H	-6.83	0.93040	D	0.989	0.99676	0.9194	0.95937	D	0.9932	0.99841	D	9	0.99468803	0.99956	D	0.959603	0.99733	D	0.964	0.99491	0.937	0.99098	P00492	G71R	Gain of methylation at G71 (P = 0.013)| Gain of MoRF binding (P = 0.0697)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K69 (P = 0.2244)| Loss of catalytic residue at F74 (P = 0.2523)	0.99979502088	0.99979	0.9983041246479125	0.99829	2.25033622233	0.96079	0.910011768341	0.97469	D	0.994521	0.99987	D	0.728331	0.99953	D	0.80842	0.99953	D	0.998252093791962	0.93590	D	0.933407	0.74982	D	0.99460655	0.99951	0.9890805	0.99971	0.99460655	0.99951	0.9890805	0.99972	-13.244	0.90363	D	0.9975	0.97000	P	0.999461026236376	0.96673	0.99977416	0.99701	0.989	0.99628	.	.	.	.	.	.	5.345183	0.89687	31.0	0.999276982086441	0.99164	.	.	.	.	.	.	.	.	.	4.68	4.68	0.58268	3.92	0.74494	9.503	0.96982	11.552000	0.93195	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	280	0.88958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Lesch-Nyhan_syndrome|HPRT_YALE	criteria_provided,_single_submitter	NC_000023.11:g.134475257G>C	ClinGen:CA120900|OMIM:308000.0017|UniProtKB:P00492#VAR_006774	CN517202|C0023374	300322	510	Phosphoribosyltransferase domain|Phosphoribosyltransferase domain	Gly	Arg	96.35	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			96.35	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Hypoxanthine-guanine phosphoribosyltransferase										-0.4								 G71-V67 (PAE:  1.0), G71-F75 (PAE: 1.0)	G71-F75 (PDBs: 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ), G71-V67 (PDBs: 6BNJ)	 G71-V67 (PAE:  1.0), G71-F75 (PAE: 1.0), G71-D135 (PAE: 1.0)	G71-F75 (PDBs: 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 5W8V, 6BNJ), G71-D135 (PDBs: 4RAQ, 6BNJ), G71-V67 (PDBs: 6BNJ)							75									-67.6				-12.4				dbSNP: rs137852488; Variant type: LP/P; AA change: Gly71Arg; PTM type: Ubiquitylation; PTM morphology: LKGG*YkFFADL; Var class: II		C (loop/coil)	T (turn)	Turn											96.35	0.0	>90	<10	300322	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	LESCH-NYHAN SYNDROME	false	0.573384898711227	0.5258327258983085	false	false	false
TPM1	TPM1_Glu180Val	B_15-16	1.0899046126781857	0.4264390807405246	0.48555730854050605	-6.182467001059623	0.084650085127264	0.10534606445229934	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7553975556533663	0.7667205345968642	0.7139904133326509	0.8245554630846732	0.8169304197529066	0.7890181429731348	0.9384212310621695	0.856502240052046	0.9054799892867577	0.8856412840996434	0.8008892051560266	0.7801173494594649	0.6396150548841001	0.7773585994537673	0.7436309368825886	0.5423395425656583	0.7325518640377018	0.7306777618472676	TPM1	Glu180Val	NC_000015.10:63060915:A:T	539A>T	15	63060915	A	T	15	ENSG00000140416	4723	201738	CCSBVarC005641	ALE00005641	ENSP00000288398.6	CEGS2	CegsMutGDEh1041	B02	GDEhDisVCh_40050	B08	2	CegsMutGDDh1041	B02	VUSN2Hmut_GDN2h_08	F07	VUSMutpDEST2_04	C07	VUSmut_GDEh08	F07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	6.0	Y	Y	Y	N	Y	40540.0	single nucleotide variant	NM_001018005.2(TPM1):c.539A>T (p.Glu180Val)	7168.0	TPM1	HGNC:12010	Likely pathogenic	1.0	Jan 28, 2022	104894502.0	-	RCV000024576|RCV002513229	MedGen:C3661900|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569	not provided|Hypertrophic cardiomyopathy	germline	germline	GRCh38	NC_000015.10	15	63060915.0	63060915.0	15q22.2	criteria provided, single submitter	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA019024,UniProtKB:P09493#VAR_029452,Leiden Muscular Dystrophy (TPM1):TPM1_00011	2.0	31880.0	63060915.0	A	T	-	-	-	-	-	-	539A>T 	Glu180Val	NM_001018005.2	1.0	Pathogenic	Likely pathogenic	31880	15	63060915.0	A	T	E	V	rs104894502	15	63353114	15	61140167	180	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.539A>T	p.Glu180Val	c.539A>T	p.Glu180Val	alternative1	Y	1	YES	Select	+	GAG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.92967	D	0.998	0.73231	D	0.995	0.83178	D	1.0	0.99291	D	simple_aae	0.0	100.0	4.315	0.98290	H	-6.12	0.91847	D	0.912	0.92907	0.9305	0.96097	D	0.8240	0.94072	D	10	0.93486655	0.92738	D	0.495751	0.95063	D	0.925	0.98152	.	0.89317	.	.	.	0.948400302032	0.94743	.	0.96194	.	0.98188	0.734310984612	0.72089	T	0.991323	0.99966	D	0.466681	0.93153	D	0.432578	0.93068	D	0.999251544475555	0.96681	D	0.974802	0.92325	D	0.8442924	0.86742	0.878134	0.93342	0.822768	0.85218	0.8428009	0.90906	-13.353	0.92708	D	0.8007	0.81391	P	0.997010149847592	0.92687	0.99968636	0.99611	0.993	0.99760	.	.	.	.	.	.	5.405745	0.9052	31.0	0.99413998452192387	0.63455	0.960581	0.98140	D	1.03539840347159	0.96714	15.07098	0.955585609710696	0.97555	16.35589	5.8	5.8	0.92070	4.46	0.83695	9.325	0.96016	11.246000	0.90597	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.999	0.91597	792	0.45931	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Hypertrophic_cardiomyopathy	criteria_provided,_single_submitter	NC_000015.10:g.63060915A>T	ClinGen:CA019024|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00011|UniProtKB:P09493#VAR_029452	C3661900|C0007194	.	217569	.	Glu	Val	98.44	0.5463917525773195																																																																																																																																																																																																																																																																																																																																																																																																																																																																													106			98.44	Negatively-charged	Glutamic Acid		Tropomyosin alpha-1 chain	Coiled coil									-3.5								 E180-E184 (PAE:  1.0), E180-L176 (PAE: 1.0)	E180-L176 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), E180-E184 (PDBs: 8ENC)	 E180-E184 (PAE:  1.0), E180-L176 (PAE: 1.0)	E180-L176 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), E180-E184 (PDBs: 8ENC)							146									-64.6				-49.0						H (helix)	H (α-helix)	Helix											98.44	54.63917	>90	10-90		unknown		Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3		false	0.7667205345968642	0.7553975556533663	false	false	false
MLH1	MLH1_Leu653Pro	B_11-12	2.117539864937324	0.07973392937962612	0.13585352820257438	-4.323628369220576	0.14383305430371493	0.18277953922944384	2024_12_Batch_11-12	true	true	true	false	true	true	true	true	false	false	false	false	0.9647270910190278	0.9820945207991691	0.8850748410208106	0.8371845416827053	0.8396133307218143	0.9034719937338992		0.8616127196754844		0.882044965663318			0.9034719937338992	0.8176139417681443	0.8371845416827053	0.8881047163783031	0.9820945207991691	0.9647270910190278	MLH1	Leu653Pro	NC_000003.12:37048578:T:C	1958T>C	3	37048578	T	C	3	ENSG00000076242	2713	953	CCSBVarC007390	ALE00007378	ENSP00000231790.3	Edgotyping3	VUSMutGDEh011	C10	GDEhDisVCh_40019	F07	1	VUSMutGDDh011	C10	VUSN2Hmut_GDN2h_04	A02	VUSMutpDEST2_02	C05	VUSmut_GDEh04	A02	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	N	Y	Y	Y	212330.0	single nucleotide variant	NM_000249.4(MLH1):c.1958T>C (p.Leu653Pro)	4292.0	MLH1	HGNC:7127	Likely pathogenic	1.0	Apr 26, 2024	63751202.0	-	RCV000200648|RCV004639173	MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000003.12	3	37048578.0	37048578.0	3p22.2	criteria provided, multiple submitters, no conflicts	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA339456	2.0	216336.0	37048578.0	T	C	-	-	-	-	-	-	1958T>C 	Leu653Pro	NM_000249.4	2.0	Pathogenic	Likely pathogenic	216336	3	37048578.0	T	C	L	P	rs63751202	3	37090069	3	37065073	653	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.1958T>C	p.Leu653Pro	c.1958T>C	p.Leu653Pro	principal1	Y	1	YES	Select	+	CTG	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	3.765	0.95058	H	-6.62	0.92149	D	0.94	0.96999	1.0984	0.99594	D	0.9466	0.98253	D	10	0.95682746	0.94996	D	0.705897	0.97596	D	0.980	0.99858	0.761	0.88916	P40692	L653P	Gain of glycosylation at L653 (P = 0.0309)| Loss of stability (P = 0.0315)| Loss of helix (P = 0.0444)| Gain of loop (P = 0.0851)| Gain of relative solvent accessibility (P = 0.284)	0.968642903731	0.96801	0.9770387968324307	0.97682	0.506429629694	0.48553	0.740718722343	0.73031	T	0.942827	0.99105	D	0.549228	0.95654	D	0.551151	0.95589	D	0.997326374053955	0.91213	D	0.927907	0.81627	D	0.9888777	0.99699	0.9712489	0.99510	0.9888777	0.99699	0.9712489	0.99510	-12.377	0.86673	D	0.9934	0.95370	P	0.999886987996496	0.98571	0.99987197	0.99835	1	0.99985	.	.	.	.	.	.	4.779874	0.77499	26.7	0.99923050207487663	0.98918	0.961605	0.98284	D	0.969221672544961	0.94687	12.98117	0.903636717806827	0.95706	13.90806	5.81	5.81	0.92402	5.18	0.91720	7.695	0.83532	7.829000	0.70086	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	154	0.93969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_nonpolyposis_colorectal_neoplasms|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.37048578T>C	ClinGen:CA339456	C0009405|C0027672	.	140162	DNA mismatch repair protein Mlh1, C-terminal	Leu	Pro	91.94	0.06707317073170732																																																																																																																																																																																																																																																																																																																																																																																																																																																																													11			91.94	Aliphatic	Leucine		DNA mismatch repair protein Mlh1										3.8								 L653-I657 (PAE:  1.0)	L653-I657 (PDBs: 3RBN)	 L653-I657 (PAE:  1.0)	L653-I657 (PDBs: 3RBN)							131									-60.6				-41.8						H (helix)	H (α-helix)	Helix											91.94	6.7073174	>90	<10		unknown		Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3		false	0.9820945207991691	0.9647270910190278	true	true	true
SMAD3	SMAD3_Arg385Thr	B_15-16	-0.12216542465932571	0.9062012625213021	0.9300614784608743	0.370017034177931	0.7223111273261256	0.7648245347048127	2025_03_Batch_15-16	false	false	false	false	false	true	false	false	false	false	false	false	0.7714972346064122	0.780478552447758	0.7311168683020446	0.8463798107326013	0.8397142880306866	0.8937535177029916	0.828509345570516	0.852041070866949	0.882058006378279	0.6841784000898384	0.7990887392709476	0.8087030887513578	0.9589976898354673	0.8273875051944242	0.8107016150869235	0.7780553365142506	0.7618683656245685	0.7342913804614665	SMAD3	Arg385Thr	NC_000015.10:67187509:G:C	1154G>C	15	67187509	G	C	15	ENSG00000166949	11805	2177	CCSBVarC007753	ALE00007739	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	C05	GDEhDisVCh_40014	H11	2	VUSMutGDDh005	C05	VUSN2Hmut_GDN2h_02	G01	VUSMutpDEST2_09	G07	VUSmut_GDEh02	G01	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	N	Y	Y	Y	258951.0	single nucleotide variant	NM_005902.4(SMAD3):c.1154G>C (p.Arg385Thr)	4088.0	SMAD3	HGNC:6769	Likely pathogenic	1.0	Sep 16, 2015	886038770.0	-	RCV000247435	MedGen:CN230736	Cardiovascular phenotype	germline	germline	GRCh38	NC_000015.10	15	67187509.0	67187509.0	15q22.33	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10587882	2.0	263338.0	67187509.0	G	C	-	-	-	-	-	-	1154G>C 	Arg385Thr	NM_005902.4	1.0	Pathogenic	Likely pathogenic	263338	15	67187509.0	G	C	R	T	rs886038770	15	67479847	15	65266901	385	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.1154G>C	p.Arg385Thr	c.1154G>C	p.Arg385Thr	principal1	Y	1	YES	Select	+	AGG	2	0	G	G/G	G/G	G/G	G/G	0.008	0.58783	D	0.133	0.34690	T	0.935	0.52291	P	0.934	0.66900	D	0.98	0.97016	A	simple_aae	2.0	98.0	1.61	0.40979	L	-4.13	0.83448	D	0.834	0.82912	1.0438	0.97983	D	0.9348	0.97849	D	10	0.8969276	0.88927	D	0.283739	0.90300	D	0.798	0.93363	0.596	0.72514	P84022	R385T	Loss of MoRF binding (P = 0.0306)| Gain of phosphorylation at R385 (P = 0.099)| Loss of catalytic residue at R385 (P = 0.1924)| Gain of sheet (P = 0.1945)| Gain of relative solvent accessibility (P = 0.2363)	0.957379035477	0.95655	0.9355614600854967	0.93496	2.78200157186	0.98837	0.884838342667	0.94595	D	0.961312	0.99502	D	0.410103	0.90420	D	0.351308	0.90300	D	0.97110915184021	0.68988	D	0.937606	0.77428	D	0.83252835	0.85895	0.67813516	0.80879	0.7908491	0.83118	0.65790343	0.79741	-11.217	0.83389	D	0.9955	0.96927	P	0.995803669840681	0.91612	0.99076504	0.96851	0.747	0.85986	.	.	.	.	.	.	8.417064	0.97545	37.0	0.98147516284923864	0.38799	0.925240	0.90414	D	0.719725157947061	0.80820	7.403825	0.700846910090249	0.82344	7.768158	5.71	5.71	0.89013	.	.	9.724	0.98015	11.826000	0.97384	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.309	0.24762	923	0.18499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Cardiovascular_phenotype	criteria_provided,_single_submitter	NC_000015.10:g.67187509G>C	ClinGen:CA10587882	CN230736	.	.	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Arg	Thr	95.6	0.6693548387096774																																																																																																																																																																																																																																																																																																																																																																																																																																																																													166			95.6	Positively-charged	Arginine		Mothers against decapentaplegic homolog 3							MH2			-4.5								 R385-E178 (PAE:  29.5)										175									-56.5				-22.1						C (loop/coil)	S (bend)	Beta strand											95.6	66.935486	>90	10-90		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		true	0.780478552447758	0.7714972346064122	false	false	false
BAG3	BAG3_Leu462Pro	B_15-16	12.862152736149255	3.9862282440461315e-6	0.00013357361308996685	0.54606513937819	0.6019821455845258	0.6501690624765184	2025_03_Batch_15-16	false	true	true	true	true	true	false	false	true	true	false	true	0.8141648884784496	0.8801231711944577	0.7924756746580022	0.9780046825400606	0.910029121539128	0.8967033097016242						0.7815438986672635	0.8967033097016242	0.910029121539128	0.9780046825400606	0.7924756746580022	0.8801231711944577	0.8467858782896358	BAG3	Leu462Pro	NC_000010.11:119676939:T:C	1385T>C	10	119676939	T	C	10	ENSG00000151929	5066	201831	CCSBVarC003586	ALE00003586	ENSP00000358081.4	CEGS2	CegsMutGDEh1038	G09	GDEhDisVCh_40022	A10	2	CegsMutGDDh1038	G09	VUSN2Hmut_GDN2h_07	A12	VUSMutpDEST2_04	C12	VUSmut_GDEh07	A12	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	48064.0	single nucleotide variant	NM_004281.4(BAG3):c.1385T>C (p.Leu462Pro)	9531.0	BAG3	HGNC:939	Likely pathogenic	1.0	Nov 18, 2020	397514507.0	-	RCV000032661|RCV000437344	MONDO:MONDO:0013479,MedGen:C3151293,OMIM:613881,Orphanet:154|MedGen:CN517202	Dilated cardiomyopathy 1HH|not provided	germline	germline	GRCh38	NC_000010.11	10	119676939.0	119676939.0	10q26.11	criteria provided, single submitter	2.0	ACMG2022	N	ClinGen:CA261131,UniProtKB:O95817#VAR_066786,OMIM:603883.0008	3.0	39465.0	119676939.0	T	C	-	-	-	-	-	-	1385T>C 	Leu462Pro	NM_004281.4	1.0	Pathogenic	Likely pathogenic	39465	10	119676939.0	T	C	L	P	rs397514507	10	121436451	10	121426441	462	BAG3	ENSG00000151929	ENST00000369085	ENSP00000358081	O95817	BAG3_HUMAN	c.1385T>C	p.Leu462Pro	c.1385T>C	p.Leu462Pro	principal1	Y	1	YES	Select	+	CTG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.88	0.91311	A	simple_aae	12.0	88.0	2.945	0.84662	M	-6.52	0.91716	D	0.993	0.99866	0.5682	0.91447	D	0.7057	0.89846	D	10	0.9516065	0.94438	D	0.273761	0.89954	D	0.933	0.98451	0.793	0.91393	O95817	L462P	Gain of disorder (P = 0.0173)| Loss of helix (P = 0.0376)| Loss of stability (P = 0.0459)| Gain of methylation at K460 (P = 0.0528)| Gain of phosphorylation at Y457 (P = 0.0851)	0.964337212013	0.96363	0.9254962109962647	0.92479	0.110571958066	0.12249	0.892663300037	0.95583	D	0.911796	0.98326	D	0.431512	0.91547	D	0.382061	0.91443	D	0.994939923286438	0.86436	D	0.957504	0.83981	D	0.98556805	0.99495	0.9782688	0.99767	0.9847067	0.99438	0.9732092	0.99591	-15.985	0.97743	D	1.0	0.99952	P	0.99908831972322	0.95667	0.95089950	0.93424	0.927	0.96353	.	.	.	.	.	.	5.087924	0.84973	28.5	0.99917048568639644	0.98450	.	.	.	0.855559876810558	0.89363	9.965386	0.815810630984631	0.90819	10.60806	5.59	5.59	0.84656	6.03	0.97566	7.578	0.81836	7.879000	0.72438	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.997	0.79771	912	0.21478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	not_provided|Dilated_cardiomyopathy_1HH	criteria_provided,_single_submitter	NC_000010.11:g.119676939T>C	ClinGen:CA261131|OMIM:603883.0008|UniProtKB:O95817#VAR_066786	CN517202|C3151293	613881	154	BAG domain|BAG domain|BAG domain	Leu	Pro	98.17	0.21951219512195122																																																																																																																																																																																																																																																																																																																																																																																																																																																																													36			98.17	Aliphatic	Leucine		BAG family molecular chaperone regulator 3							BAG			3.8								 L462-D466 (PAE:  1.0), L462-L458 (PAE: 1.0)		 L462-D466 (PAE:  1.0), L462-L458 (PAE: 1.0)								131									-64.4				-47.6				dbSNP: rs397514507; Variant type: LP/P; AA change: Leu462Pro; PTM type: Phosphorylation; PTM morphology: IEEyLtKEL*LA; Var class: II&rs397514507		H (helix)	H (α-helix)												98.17	21.95122	>90	10-90	613881	autosomal dominant	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	CARDIOMYOPATHY, DILATED, 1HH	false	0.8801231711944577	0.8141648884784496	true	false	false
GCK	GCK_Gly44Asp	B_7-8	4.1723512498170585	0.02506634014909403	0.05381276581982528	0.6044723228886159	0.5881845212175851	0.637142028591658	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6990256619161914	0.7745775120718894	0.7384203618751908	0.8285354447145822	0.6513066250197956	0.7617208379893122	0.7617208379893122	0.6513066250197956	0.8285354447145822	0.7384203618751908	0.7745775120718894	0.6990256619161914							GCK	Gly44Asp	NC_000007.14:44153378:C:T	131G>A	7	44153378	C	T	7	ENSG00000106633	3689	214816	CCSBVarC006686	ALE00006684	ENSP00000384247.3	CEGS2	CegsMutGDEh1046	C02	GDEhDisVCh_40037	C06	1	CegsMutGDDh1046	C02	VUSN2Hmut_GDN2h_09	D12	VUSMutpDEST2_03	E08	VUSmut_GDEh09	D12	1.0	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	44860.0	single nucleotide variant	NM_000162.5(GCK):c.131G>A (p.Gly44Asp)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Dec 22, 2020	193922279.0	-	RCV000029859|RCV001659731	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900	Maturity-onset diabetes of the young type 2|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	44153378.0	44153378.0	7p13	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA213753	2.0	36196.0	44153378.0	C	T	-	-	-	-	-	-	131G>A 	Gly44Asp	NM_000162.5	2.0	Pathogenic	Likely pathogenic	36196	7	44153378.0	C	T	G	D	rs193922279	7	44192977	7	44159502	44	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.131G>A	p.Gly44Asp	c.131G>A	p.Gly44Asp	principal1	Y	1	YES	Select	-	GGC	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.43	0.91906	M	-6.61	0.92107	D	0.987	0.99555	1.0420	0.97946	D	0.9843	0.99522	D	10	0.9938576	0.99905	D	0.730092	0.97823	D	0.995	0.99995	0.975	0.99765	P35557	G44D	Gain of ubiquitination at K39 (P = 0.0338)| Gain of relative solvent accessibility (P = 0.0479)| Loss of MoRF binding (P = 0.0547)| Gain of solvent accessibility (P = 0.0704)| Gain of methylation at K39 (P = 0.1946)	0.994501673353	0.99437	.	0.99561	.	0.97725	0.765996813774	0.76783	T	0.983493	0.99884	D	0.558376	0.96027	D	0.564292	0.95963	D	0.99753725528717	0.91722	D	0.852415	0.53609	D	0.98802197	0.99649	0.96305007	0.99119	0.9821352	0.99256	0.96254826	0.99093	-13.79	0.92369	D	0.9952	0.96856	P	0.999849354954065	0.98301	0.99985075	0.99806	0.989	0.99628	.	.	.	.	.	.	5.049595	0.84127	28.2	0.99871518253421354	0.94906	0.960824	0.98174	D	0.938107438145651	0.93462	12.07909	0.85351650784371	0.93181	11.90075	5.08	5.08	0.68332	.	.	7.879	0.8573	7.617000	0.62206	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.96	0.51684	649	0.63066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614180	6.195100e-07	0	1	1180034	8.474330e-07	0	0	75044	0.000000e+00	0	0	912	0.000000e+00	0	0	60026	0.000000e+00	0	0	29608	0.000000e+00	0	0	44888	0.000000e+00	0	0	64014	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180034	8.474330e-07	0	0	91086	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Maturity-onset_diabetes_of_the_young_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.44153378C>T	ClinGen:CA213753	C3661900|C0342277	125851	552	Hexokinase, N-terminal	Gly	Asp	97.95	0.0																																																																																																											0.132	1 mutation(s) (Gly44Pro: -0.667)	0.111	1 mutation(s) (Gly44Ter: -0.664)																																																																																																																																																																																																																																																																																																																																																															0			97.95	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Hexokinase-4							Hexokinase			-0.4								 G44-H50 (PAE:  1.0), G44-E40 (PAE: 1.0)	G44-E40 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I), G44-H50 (PDBs: 6E0I, 4LC9)	 G44-H50 (PAE:  1.0), G44-E40 (PAE: 1.0)	G44-E40 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9), G44-H50 (PDBs: 6E0I, 4LC9)							75									-65.5				-31.7						H (helix)	H (α-helix)	Helix											97.95	0.0	>90	<10	125851	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism	3	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2	false	0.7745775120718894	0.6990256619161914	false	false	false
DES	DES_Leu338Arg	B_7-8	0.2271406227016986	0.8278558947992416	0.8631030344249735	-4.971681983598727	0.0016161001627832457	0.0035815746361198744	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7444220515840252	0.8358655473219656	0.7171089096156913	0.8069558580646412	0.8444325247022757	0.813319723708948	0.9313125964813845	0.9206113401917426	0.936525428932837	0.8840107209984122	0.8541241320193182	0.7283175996596367	0.6953268509365116	0.7682537092128089	0.6773862871964454	0.5502070982329705	0.817606962624613	0.7605265035084137	DES	Leu338Arg	NC_000002.12:219420943:T:G	1013T>G	2	219420943	T	G	2	ENSG00000175084	12573	2295	CCSBVarC007852	ALE00007838	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	E09	GDEhDisVCh_40003	G09	1	VUSMutGDDh003	E09	VUSN2Hmut_GDN2h_01	D04	NULL	NULL	VUSmut_GDEh01	D04	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	77284.0	single nucleotide variant	NM_001927.4(DES):c.1013T>G (p.Leu338Arg)	1674.0	DES	HGNC:2770	Pathogenic/Likely pathogenic	1.0	Jan 29, 2022	57496341.0	-	RCV000056763|RCV000796175	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219420943.0	219420943.0	2q35	criteria provided, multiple submitters, no conflicts	3.0	ACMG2022	N	ClinGen:CA216999,UniProtKB:P17661#VAR_067209	2.0	66387.0	219420943.0	T	G	-	-	-	-	-	-	1013T>G 	Leu338Arg	NM_001927.4	2.0	Pathogenic	Likely pathogenic	66387	2	219420943.0	T	G	L	R	rs57496341	2	220285665	2	219993909	338	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1013T>G	p.Leu338Arg	c.1013T>G	p.Leu338Arg	principal1	Y	1	YES	Select	+	CTG	2	0	T	T/T	T/T	T/T	T/T	0.015	0.52650	D	0.018	0.60067	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.125	0.97400	H	-5.12	0.83182	D	0.982	0.99191	1.0578	0.98285	D	0.9522	0.98443	D	10	0.99009883	0.99495	D	0.51869	0.95405	D	0.969	0.99622	0.936	0.99070	P17661	L338R	Loss of stability (P = 0.0074)| Gain of MoRF binding (P = 0.0207)| Gain of disorder (P = 0.0216)| Gain of phosphorylation at T341 (P = 0.06)| Gain of methylation at K339 (P = 0.0856)	0.99491096691	0.99478	0.97453589754769	0.97429	1.67518803718	0.89869	0.8638048172	0.91658	D	0.932933	0.98867	D	0.538037	0.95317	D	0.535076	0.95247	D	0.999293684959412	0.96829	D	0.671533	0.27769	T	0.89465123	0.90780	0.87522995	0.93138	0.9094521	0.92131	0.8725003	0.92946	-13.594	0.91680	D	0.9452	0.86381	P	0.999846333179297	0.98301	0.99859875	0.98864	0.905	0.95023	.	.	.	.	.	.	5.685692	0.93034	33.0	0.99759872579043674	0.84944	0.982943	0.99913	D	0.801780404178857	0.86139	8.81513	0.672350723505994	0.80174	7.26503	5.01	3.86	0.43622	3.79	0.69847	7.835	0.85025	7.938000	0.75400	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.936	0.47515	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Desmin-related_myofibrillar_myopathy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219420943T>G	ClinGen:CA216999|UniProtKB:P17661#VAR_067209	C1832370|C3661900	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Arg	88.83	0.6097560975609756																																																																																																																																																																																																																																																																																																																																																																																																																																																																													100			88.83	Aliphatic	Leucine		Desmin							IF rod			3.8								 L338-E334 (PAE:  1.0), L338-N342 (PAE: 1.0)		 L338-E334 (PAE:  1.0), L338-N342 (PAE: 1.0)								131									-62.2				-42.8	Interaction with NEB; Coil 2B			dbSNP: rs57496341; Variant type: LP/P; AA change: Leu338Arg; PTM type: Acetylation; PTM morphology: EIDAL*kGTNDS; Var class: II		H (helix)	H (α-helix)												88.83	60.975613	70-90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.8358655473219656	0.7444220515840252	false	false	false
PLP1	PLP1_Cys193Tyr	B_7-8	-2.550585641673705	0.06326611186766325	0.11168047473866617	-1.4428470328581076	0.19916410206747118	0.2434817636867486	2024_01_Batch_7-8	true	true	false	false	false	false	true	true	false	false	false	false	0.9936765544141402	0.9938140234682006	0.6999664523187475	0.7700968399942694	0.6758972217812892	0.6911635631992444	0.6911635631992444	0.6758972217812892	0.7700968399942694	0.6999664523187475	0.9938140234682006	0.9932476499008758						0.9941054589274044	PLP1	Cys193Tyr	NC_000023.11:103788497:G:A	578G>A	23	103788497	G	A	X	ENSG00000123560	4062	201430	CCSBVarC005866	ALE00005866	ENSP00000477619.1	CEGS2	CegsMutGDEh1033	E09	GDEhDisVCh_40062	G05	2	CegsMutGDDh1033	E09	VUSN2Hmut_GDN2h_06	D05	VUSMutpDEST2_04	E03	VUSmut_GDEh06	D05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	99141.0	single nucleotide variant	NM_000533.5(PLP1):c.683G>A (p.Cys228Tyr)	5354.0	PLP1	HGNC:9086	Likely pathogenic	1.0	Nov 20, 2012	398123466.0	-	RCV000079101	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000023.11	X	103788497.0	103788497.0	Xq22.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA221112,UniProtKB:P60201#VAR_015047	2.0	93234.0	103788497.0	G	A	-	-	-	-	-	-	683G>A 	Cys228Tyr	NM_000533.5	1.0	Pathogenic	Likely pathogenic	93234	X	103788497.0	G	A	C	Y	rs398123466	X	103043426	X	102930082	228	PLP1	ENSG00000123560	ENST00000612423	ENSP00000481006	P60201	MYPR_HUMAN	c.683G>A	p.Cys228Tyr	c.683G>A	p.Cys228Tyr	principal1	Y	2	.	.	+	TGC	2	0	G	G/G	G/G	G/G	G/G	.	.	.	0.0	0.92967	D	0.999	0.77914	D	0.998	0.88579	D	.	.	.	.	.	.	2.74	0.79912	M	.	.	.	0.989	0.99676	1.0444	0.97995	D	0.9839	0.99509	D	10	0.9937352	0.99896	D	0.905537	0.99290	D	.	.	0.978	0.99793	P60201	C228Y	Loss of methylation at K229 (P = 0.013)| Loss of stability (P = 0.029)| Gain of catalytic residue at I227 (P = 0.0424)| Gain of ubiquitination at K229 (P = 0.1181)| Loss of helix (P = 0.1299)	0.999967751861	0.99996	0.999573827796464	0.99957	.	.	0.888310194016	0.95041	D	0.994405	0.99986	D	0.558608	0.96031	D	0.564625	0.95967	D	0.993428888450139	0.84091	D	.	0.84414	.	0.96834207	0.98073	0.9754077	0.99672	0.9688256	0.98119	0.9822484	0.99870	-12.377	0.86673	D	0.9994	0.99217	LP	0.999948663235179	0.99079	0.99876430	0.98948	0.965	0.98576	.	.	.	.	.	.	5.281567	0.88695	29.7	0.9968814660952473	0.79729	.	.	.	.	.	.	.	.	.	5.36	5.36	0.76590	3.61	0.66044	9.552	0.9722	11.825000	0.97355	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000023.11:g.103788497G>A	ClinGen:CA221112|UniProtKB:P60201#VAR_015047	C3661900	.	.	Myelin proteolipid protein PLP, conserved site	Cys	Tyr	92.79	0.022222222222222223																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																92.79	2.2222223	>90	<10		unknown		Rare genetic eye disease; Rare genetic neurological disorder	2		false	0.9938140234682006	0.9936765544141402	true	true	true
GCM2	GCM2_Gly63Ser	B_7-8	3.5761521272508947	0.023247479030366617	0.050629863331745496	0.38535347478915155	0.7132668012694844	0.7565849017758338	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6735527529967678	0.739684700172069	0.7090931353040384	0.6748485087642939	0.5696169037528103	0.7278248459197652	0.7278248459197652	0.6391206480794832	0.8212682308303818	0.7090931353040384	0.7759364793951745	0.7532122362337701		0.5001131594261373	0.5284287866982059		0.7034329209489636	0.5938932697597653	GCM2	Gly63Ser	NC_000006.12:10877296:C:T	187G>A	6	10877296	C	T	6	ENSG00000124827	13943	23002	CCSBVarC002035	ALE00002035	ENSP00000368805.4	RC4	RC4_Mut_GDEh1006	H10	GDEhDisVCh_40044	G03	2	RC4_Mut_GDDh1006	H10	NULL	NULL	NULL	NULL	VUSmut_GDEh12	B08	1.0	1.0	1.0	1.0	0.0			0.0			1.0	1.0	1.0	Y	Y	N	N	Y	21131.0	single nucleotide variant	NM_004752.4(GCM2):c.187G>A (p.Gly63Ser)	9247.0	GCM2	HGNC:4198	Likely pathogenic	1.0	Jul 09, 2021	104893960.0	-	RCV000006465|RCV002496283	MONDO:MONDO:0020798,MedGen:C5394383,OMIM:618883|MONDO:MONDO:0020798,MedGen:C5394383,OMIM:618883;MONDO:MONDO:0024570,MedGen:C4479229,OMIM:617343	Hypoparathyroidism, familial isolated, 2|Hypoparathyroidism, familial isolated, 2;Hyperparathyroidism 4	germline;unknown	germline	GRCh38	NC_000006.12	6	10877296.0	10877296.0	6p24.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA117937,UniProtKB:O75603#VAR_058045,OMIM:603716.0003	3.0	6092.0	10877296.0	C	T	-	-	-	-	-	-	187G>A 	Gly63Ser	NM_004752.4	1.0	Pathogenic	Likely pathogenic	6092	6	10877296.0	C	T	G	S	rs104893960	6	10877529	6	10985515	63	GCM2	ENSG00000124827	ENST00000379491	ENSP00000368805	O75603	GCM2_HUMAN	c.187G>A	p.Gly63Ser	c.187G>A	p.Gly63Ser	principal1	Y	1	YES	Select	-	GGC	1	0	C	C/C	C/C	C/C	C/C	0.067	0.36067	T	0.441	0.13488	T	1.0	0.90580	D	1.0	0.97365	D	0.95	0.94956	A	simple_aae	5.0	95.0	1.885	0.49870	L	-3.4	0.67045	D	0.673	0.67924	-0.1057	0.79878	T	0.5488	0.83388	D	9	0.8528994	0.84309	D	0.152748	0.83366	D	0.648	0.86624	.	.	.	.	.	0.954337495093	0.95347	0.7642731194943232	0.76245	0.757983570904	0.63864	0.774181246758	0.78012	T	0.501062	0.81995	D	0.336686	0.85510	D	0.24585	0.85319	D	0.971302032470703	0.69063	D	0.754824	0.37564	T	0.47081998	0.65027	0.47586396	0.69370	0.47081998	0.65027	0.47586396	0.69370	-11.278	0.81220	D	0.578	0.67914	P	0.996697170454304	0.92377	0.95999270	0.93960	0.339	0.60074	.	.	.	.	.	.	5.119709	0.85652	28.7	0.9987865389520183	0.95495	0.758648	0.69612	D	0.65267307956273	0.76416	6.505763	0.673527432271537	0.80265	7.284586	5.69	5.69	0.88329	2.98	0.54511	4.814	0.62402	5.884000	0.50753	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.997	0.79771	786	0.46777	.	.	.	.	.	.	.	.	.	.	.	.	10	264690	3.7780046E-5	.	0	109408	0.000000e+00	0	1	208126	4.804780e-06	0	1	236936	4.220550e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	1	89552	1.116670e-05	0	0	30608	0.000000e+00	0	1	89552	1.116670e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102734	9.733880e-06	0	0	30526	0.000000e+00	0	1	102734	9.733880e-06	0	.	9	1614066	5.575980e-06	0	4	74920	5.339030e-05	0	4	74920	5.339030e-05	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29606	0.000000e+00	0	0	44882	0.000000e+00	0	0	64030	0.000000e+00	0	0	6084	0.000000e+00	0	5	1180048	4.237120e-06	0	0	91088	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	546	0	0	3324	0	0	112	0	0	14526	0	Hypoparathyroidism,_familial_isolated,_2|Hyperparathyroidism_4	criteria_provided,_single_submitter	NC_000006.12:g.10877296C>T	ClinGen:CA117937|OMIM:603716.0003|UniProtKB:O75603#VAR_058045	C5394383|C4479229	618883|617343	.	Transcription regulator GCM domain|Transcription regulator GCM domain	Gly	Ser	96.03	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			96.03	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Chorion-specific transcription factor GCMb				GCM						-0.4								 G63-R102 (PAE:  1.5), G63-E40 (PAE: 1.0)		 G63-E40 (PAE:  1.0)								75									-62.6				-30.3						C (loop/coil)	S (bend)												96.03	0.0	>90	<10	618883;618883;617343	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic endocrine disease	2	HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2; HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2; HYPERPARATHYROIDISM 4	false	0.739684700172069	0.6735527529967678	false	false	false
GSS	GSS_Arg283Cys	B_7-8	-2.5001690812128836	0.04651759032427951	0.08796890843502364	-4.740306406463392	0.002107123639017292	0.004415327599619065	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8307034409956967	0.8590879061994252	0.4364661398641198	0.6945852872792295	0.6461963797520922	0.610998365313564	0.5343417922315877	0.6214371094110329	0.6113443981322402	0.4209920283570402	0.9256456538501656	0.9164208690185651	0.6876549383955403	0.6709556500931514	0.7778261764262188	0.4519402513711994	0.7925301585486847	0.7449860129728283	GSS	Arg283Cys	NC_000020.11:34932121:G:A	847C>T	20	34932121	G	A	20	ENSG00000100983	5132	9487	CCSBVarC000773	ALE00000773	ENSP00000498303.1	CEGS2	CegsMutGDEh1044	B11	NULL	NULL	NULL	CegsMutGDDh1044	B11	VUSN2Hmut_GDN2h_09	F07	VUSMutpDEST2_05	A01	VUSmut_GDEh09	F07	0.0		1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	Y	Y	Y	N	Y	23567.0	single nucleotide variant	NM_000178.4(GSS):c.847C>T (p.Arg283Cys)	2937.0	GSS	HGNC:4624	Pathogenic/Likely pathogenic	1.0	Mar 27, 2023	121909309.0	-	RCV000009054|RCV003488331|RCV004566700	MONDO:MONDO:0017909,MedGen:CN030166,Orphanet:32|MedGen:C3661900|Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0009947,MedGen:C0398746,OMIM:266130,Orphanet:289846	Inherited glutathione synthetase deficiency|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria	germline	germline	GRCh38	NC_000020.11	20	34932121.0	34932121.0	20q11.22	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA119693,UniProtKB:P48637#VAR_003610,OMIM:601002.0004	3.0	8528.0	34932121.0	G	A	-	-	-	-	-	-	847C>T 	Arg283Cys	NM_000178.4	2.0	Pathogenic	Likely pathogenic	8528	20	34932121.0	G	A	R	C	rs121909309	20	33519924	20	32983585	283	GSS	ENSG00000100983	ENST00000651619	ENSP00000498303	P48637	GSHB_HUMAN	c.847C>T	p.Arg283Cys	c.847C>T	p.Arg283Cys	principal1	Y	.	YES	Select	-	CGT	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.999	0.92348	D	.	0.93300	.	.	.	.	3.665	0.94230	H	.	0.95712	.	.	0.99617	1.0980	0.99576	D	0.9572	0.98612	D	9	.	0.94915	.	0.298614	0.90785	D	.	0.99858	.	.	.	.	.	.	0.99435	.	0.93599	.	.	0.602791786194	0.53233	T	0.975835	0.99765	D	0.576681	0.96916	D	0.590586	0.96866	D	0.999866008758545	0.99413	D	.	0.94804	.	0.9675638	0.97997	0.8420446	0.90855	0.9603764	0.97276	0.8482112	0.91271	-9.819	0.72899	D	.	0.72897	.	0.998705017022186	0.94906	0.98307710	0.95841	0.932	0.96656	.	.	.	.	.	.	6.141451	0.94661	34.0	0.99948711497407805	0.99931	0.940493	0.94229	D	1.00849548747627	0.95978	14.19144	0.921961850084455	0.96441	14.72388	5.34	5.34	0.75945	.	.	7.875	0.85636	11.837000	0.97710	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109406	9.140270e-06	0	1	208072	4.806030e-06	0	1	236908	4.221050e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15688	0.000000e+00	0	1	42768	2.338200e-05	0	0	16208	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	1	89514	1.117140e-05	0	0	30606	0.000000e+00	0	1	89514	1.117140e-05	0	0	14898	0.000000e+00	0	0	34260	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102712	9.735960e-06	0	0	30524	0.000000e+00	0	1	102712	9.735960e-06	0	.	20	1613428	1.239600e-05	0	17	1179422	1.441380e-05	0	0	74940	0.000000e+00	0	0	910	0.000000e+00	0	0	60006	0.000000e+00	0	0	29600	0.000000e+00	0	0	44886	0.000000e+00	0	0	64034	0.000000e+00	0	0	6082	0.000000e+00	0	17	1179422	1.441380e-05	0	0	91088	0.000000e+00	0	0	17708	0	0	292	0	0	84	0	1	7788	1.2840267077555214E-4	0	146	0	0	610	0	0	24	0	0	94	0	0	1956	0	1	8080	1.2376237623762376E-4	0	108	0	1	28702	3.484077764615706E-5	Glutathione_synthetase_deficiency_with_5-oxoprolinuria|Inherited_glutathione_synthetase_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000020.11:g.34932121G>A	ClinGen:CA119693|OMIM:601002.0004|UniProtKB:P48637#VAR_003610	C0398746|CN030166|C3661900	266130	289846|32	Glutathione synthase, substrate-binding domain	Arg	Cys	98.61	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.61	Positively-charged	Arginine		Glutathione synthetase										-4.5								 R283-N279 (PAE:  1.0), R283-E287 (PAE: 1.0), R283-Q300 (PAE: 1.0), R283-Y275 (PAE: 1.0)	R283-N279 (PDBs: 2HGS), R283-E287 (PDBs: 2HGS), R283-Q300 (PDBs: 2HGS), R283-Y275 (PDBs: 2HGS)	 R283-N279 (PAE:  1.0), R283-E287 (PAE: 1.0)	R283-N279 (PDBs: 2HGS), R283-E287 (PDBs: 2HGS)	 R283-E287 (PAE:  1.0)	R283-E287 (PDBs: 2HGS)					175									-61.1				-43.2						H (helix)	H (α-helix)	Helix											98.61	0.0	>90	<10	266130	autosomal recessive	OMIM	Rare genetic hematologic disease; Rare inborn errors of metabolism	2	GLUTATHIONE SYNTHETASE DEFICIENCY	false	0.8590879061994252	0.8307034409956967	false	false	false
DES	DES_Glu413Lys	B_7-8	0.5630462919917797	0.5977140168166843	0.6731331203536952	3.2667266675309303	0.013736234364726149	0.02258601259791441	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9384909578336864	0.8991719678797677	0.7747207461632708	0.7232002756800358	0.7143554377064236	0.7816974829928767	0.9132038754267797	0.7655346805113816	0.8396544463642086	0.8815353138368393	0.9062884583463111	0.9384909578336864	0.6501910905589736	0.6631761949014657	0.6067461049958629	0.6679061784897025	0.8920554774132243		DES	Glu413Lys	NC_000002.12:219421553:G:A	1237G>A	2	219421553	G	A	2	ENSG00000175084	12573	2323	CCSBVarC007877	ALE00007863	ENSP00000363071.3	Edgotyping3	VUSMutGDEh005	A11	GDEhDisVCh_40092	G05	1	VUSMutGDDh005	A11	VUSN2Hmut_GDN2h_02	G03	NULL	NULL	VUSmut_GDEh02	G03	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	77295.0	single nucleotide variant	NM_001927.4(DES):c.1237G>A (p.Glu413Lys)	1674.0	DES	HGNC:2770	Pathogenic/Likely pathogenic	1.0	Dec 17, 2021	61726467.0	-	RCV000056782|RCV000685786	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219421553.0	219421553.0	2q35	criteria provided, multiple submitters, no conflicts	3.0	ACMG2022	N	ClinGen:CA284673	2.0	66398.0	219421553.0	G	A	-	-	-	-	-	-	1237G>A 	Glu413Lys	NM_001927.4	2.0	Pathogenic	Likely pathogenic	66398	2	219421553.0	G	A	E	K	rs61726467	2	220286275	2	219994519	413	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1237G>A	p.Glu413Lys	c.1237G>A	p.Glu413Lys	principal1	Y	1	YES	Select	+	GAG	1	0	G	./.	./.	./.	./.	0.001	0.78662	D	0.002	0.79703	D	0.972	0.57419	D	0.909	0.64559	D	0.96	0.95575	A	simple_aae	4.0	96.0	3.765	0.95058	H	-3.4	0.67045	D	0.97	0.98079	0.9948	0.97093	D	0.8800	0.96008	D	10	0.9897052	0.99441	D	0.359535	0.92460	D	0.923	0.98076	0.928	0.98831	P17661	E413K	Gain of ubiquitination at E413 (P = 0.0162)| Gain of MoRF binding (P = 0.0646)| Gain of methylation at E413 (P = 0.1301)| Loss of phosphorylation at S414 (P = 0.1787)| Loss of glycosylation at S414 (P = 0.216)	0.991859911452	0.99167	0.9737101174660977	0.97347	1.5168048885	0.87288	0.764061331749	0.76493	T	0.936658	0.98959	D	0.487403	0.93881	D	0.462344	0.93804	D	0.997020423412323	0.90519	D	0.883612	0.60512	D	0.89601856	0.90901	0.8373137	0.90539	0.90192044	0.91435	0.82325923	0.89616	-15.592	0.97091	D	0.9946	0.95323	P	0.999540187081235	0.96938	0.99837357	0.98752	0.997	0.99892	.	.	.	.	.	.	6.038934	0.94417	34.0	0.99927777394815243	0.99164	0.981431	0.99873	D	0.981641598582488	0.95126	13.35564	0.906792418089142	0.95840	14.0457	4.94	4.94	0.64600	.	.	9.864	0.98446	11.695000	0.94421	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Desmin-related_myofibrillar_myopathy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219421553G>A	ClinGen:CA284673	C1832370|C3661900	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Glu	Lys	69.33	0.6134020618556701																																																																																																																																																																																																																																																																																																																																																																																																																																																																													119			69.33	Negatively-charged	Glutamic Acid		Desmin							IF rod			-3.5								 E413-N417 (PAE:  7.0), E413-L409 (PAE: 3.5)		 E413-N417 (PAE:  7.0), E413-L409 (PAE: 3.5)								146									-60.4				-37.8	Interaction with NEB; Tail					H (helix)	H (α-helix)												69.33	61.340206	50-70	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.8991719678797677	0.9384909578336864	false	false	false
KRT6A	KRT6A_Ile462Asn	B_7-8	-1.8055642350673042	0.13081717881904592	0.20297385178259766	-2.48349646533157	0.04199453901577646	0.060677148892873865	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8767200678969334	0.8192864001467475	0.6987064220265328	0.6699264866378346	0.6566777310009547	0.7201869494163111	0.7353399916860391	0.8043553527377156	0.7837466092321533	0.665461879003509	0.8528555041508279	0.8767200678969334	0.7050339071465832	0.5090001092641938	0.5561063640435159	0.7319509650495566	0.785717296142667		KRT6A	Ile462Asn	NC_000012.12:52488367:A:T	1385T>A	12	52488367	A	T	12	ENSG00000205420	4870	215289	CCSBVarC003674	ALE00003674	ENSP00000369317.3	CEGS2	CegsMutGDEh1041	D07	GDEhDisVCh_40048	B10	2	CegsMutGDDh1041	D07	VUSN2Hmut_GDN2h_08	C09	VUSMutpDEST2_04	F10	VUSmut_GDEh08	C09	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77465.0	single nucleotide variant	NM_005554.4(KRT6A):c.1385T>A (p.Ile462Asn)	3853.0	KRT6A	HGNC:6443	Pathogenic/Likely pathogenic	1.0	Oct 23, 2020	57629991.0	-	RCV000056988	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000012.12	12	52488367.0	52488367.0	12q13.13	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA217331,UniProtKB:P02538#VAR_072459	2.0	66568.0	52488367.0	A	T	-	-	-	-	-	-	1385T>A 	Ile462Asn	NM_005554.4	2.0	Pathogenic	Likely pathogenic	66568	12	52488367.0	A	T	I	N	rs57629991	12	52882151	12	51168418	462	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.1385T>A	p.Ile462Asn	c.1385T>A	p.Ile462Asn	principal1	Y	1	YES	Select	-	ATC	2	0	.	./.	./.	./.	./.	0.0	0.91343	D	0.009	0.67073	D	1.0	0.90580	D	0.998	0.88579	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.32	0.98311	H	-6.5	0.91629	D	0.998	0.99987	1.0928	0.99352	D	0.9593	0.98684	D	10	0.981022	0.98084	D	0.219638	0.87687	D	0.966	0.99545	0.887	0.97162	P02538	I462N	Gain of ubiquitination at K467 (P = 0.0725)| Loss of stability (P = 0.0929)| Gain of disorder (P = 0.1017)| Gain of relative solvent accessibility (P = 0.1259)| Gain of catalytic residue at Y465 (P = 0.1392)	0.985190644709	0.98487	0.9338958534671595	0.93327	1.31169626058	0.83153	0.812497496605	0.83846	D	0.951894	0.99305	D	0.51006	0.94523	D	0.49489	0.94443	D	0.999163746833801	0.96363	D	0.872513	0.57839	D	0.9106485	0.92243	0.8775108	0.93299	0.9106485	0.92244	0.8775108	0.93299	-14.512	0.94613	D	0.9947	0.95370	P	0.995674140623459	0.91511	0.95732370	0.93795	0.989	0.99628	.	.	.	.	.	.	4.785116	0.77638	26.7	0.99412147123064754	0.63408	0.899219	0.84279	D	1.03279943925503	0.96648	14.98391	0.910531643195214	0.95992	14.20973	5.02	5.02	0.66699	.	.	8.983	0.93056	.	.	0.679	0.82395	1.0	0.71675	1.000000	0.68239	0.832	0.39259	734	0.53826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.52488367A>T	ClinGen:CA217331|UniProtKB:P02538#VAR_072459	C3661900	.	.	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	Ile	Asn	92.64	0.47928994082840237																																																																																																																																																																																																																																																																																																																																																																																																																																																																													81			92.64	Aliphatic	Isoleucine		Keratin, type II cytoskeletal 6A							IF rod			4.5								 I462-R466 (PAE:  1.0), I462-L458 (PAE: 1.5)		 I462-R466 (PAE:  1.0), I462-L458 (PAE: 1.5)								131									-60.3				-38.8	Coil 2			dbSNP: rs57629991; Variant type: LP/P; AA change: Ile462Asn; PTM type: Ubiquitylation; PTM morphology: I*ATYRkLLEGE; Var class: II&rs57629991		H (helix)	H (α-helix)												92.64	47.928993	>90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2		false	0.8192864001467475	0.8767200678969334	false	false	false
AGXT	AGXT_Ser218Leu	B_7-8	0.561600194878897	0.5919060822164763	0.6685633453775693	1.2610657070115185	0.24768659274185748	0.2966742151966765	2024_01_Batch_7-8	true	false	false	false	false	false	false	false	false	false	false	false	0.9352118995503031	0.9188704309378142	0.7619713482118474	0.5165177006178387	0.5251242457338479	0.7653327642630339	0.8174689733583343	0.49688373531341345	0.4980685638766005	0.8453557808656527	0.932859718874554	0.9512783237279432	0.7131965551677334	0.5533647561542822	0.534966837359077	0.6785869155580422	0.9048811430010744	0.9191454753726631	AGXT	Ser218Leu	NC_000002.12:240874035:C:T	653C>T	2	240874035	C	T	2	ENSG00000172482	70497	3850	CCSBVarC008209	ALE00008195	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	H06	GDEhDisVCh_40002	G08	2	VUSMutGDDh004	H06	VUSN2Hmut_GDN2h_01	D08	VUSMutpDEST2_14	B08	VUSmut_GDEh01	D08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	186658.0	single nucleotide variant	NM_000030.3(AGXT):c.653C>T (p.Ser218Leu)	189.0	AGXT	HGNC:341	Pathogenic/Likely pathogenic	1.0	Jan 29, 2023	180177253.0	-	RCV000169358|RCV001386996	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900	Primary hyperoxaluria, type I|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	240874035.0	240874035.0	2q37.3	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA274210,UniProtKB:P21549#VAR_060559	2.0	188979.0	240874035.0	C	T	-	-	-	-	-	-	653C>T 	Ser218Leu	NM_000030.3	2.0	Pathogenic	Likely pathogenic	188979	2	240874035.0	C	T	S	L	rs180177253	2	241813452	2	241462125	218	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.653C>T	p.Ser218Leu	c.653C>T	p.Ser218Leu	principal1	Y	1	YES	Select	+	TCG	2	0	C	C/C	C/C	C/C	C/C	0.007	0.60085	D	0.008	0.68204	D	0.985	0.61134	D	0.663	0.52889	P	0.78	0.86494	A	simple_aae	22.0	78.0	.	.	.	-3.12	0.63808	D	0.853	0.84884	0.9160	0.95888	D	0.7602	0.91811	D	9	0.9957668	0.99992	D	0.390135	0.93155	D	0.603	0.84268	0.912	0.98259	P21549	S218L	Loss of disorder (P = 0.011)| Loss of sheet (P = 0.0357)| Loss of phosphorylation at S218 (P = 0.0469)| Loss of loop (P = 0.0804)| Loss of catalytic residue at S218 (P = 0.0869)	0.933561090184	0.93236	0.9374218442152829	0.93683	0.137469544768	0.15241	0.44676977396	0.31463	T	0.918292	0.98499	D	0.219967	0.75591	D	0.259719	0.85979	D	0.946510434150696	0.62257	D	0.965803	0.87365	D	0.73934644	0.80018	0.57384187	0.75066	0.73934644	0.80019	0.57384187	0.75067	-11.772	0.83770	D	0.6736	0.71825	P	0.991451223578871	0.89035	0.42886436	0.80283	0.78	0.87822	.	.	.	.	.	.	3.72533	0.53344	23.3	0.9973877410387052	0.83352	0.891960	0.82779	D	0.211490786075384	0.51515	3.354357	-0.0146340577438968	0.38758	2.309804	4.1	4.1	0.47135	2.16	0.41537	3.396	0.52403	5.720000	0.49542	0.535	0.24985	0.388	0.26159	0.742000	0.26570	0.004	0.06081	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	0	109332	0.000000e+00	0	1	207880	4.810470e-06	0	1	236724	4.224330e-06	0	0	7160	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13348	0.000000e+00	0	0	42752	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	1	16196	6.174360e-05	0	0	30510	0.000000e+00	0	0	6206	0.000000e+00	0	0	13404	0.000000e+00	0	0	16688	0.000000e+00	0	0	89416	0.000000e+00	0	0	30608	0.000000e+00	0	1	16196	6.174360e-05	0	1	14890	6.715920e-05	0	0	34240	0.000000e+00	0	0	9566	0.000000e+00	0	0	17692	0.000000e+00	0	0	21584	0.000000e+00	0	0	102612	0.000000e+00	0	0	30526	0.000000e+00	0	1	14890	6.715920e-05	0	.	5	1613612	3.098640e-06	0	3	74932	4.003630e-05	0	3	74932	4.003630e-05	0	0	912	0.000000e+00	0	0	60012	0.000000e+00	0	0	29608	0.000000e+00	0	0	44884	0.000000e+00	0	0	63578	0.000000e+00	0	0	6084	0.000000e+00	0	2	1180030	1.694870e-06	0	0	91088	0.000000e+00	0	1	19770	5.058168942842691E-5	0	298	0	0	86	0	0	7438	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1930	0	0	7736	0	0	112	0	1	30402	3.2892572857048876E-5	Primary_hyperoxaluria,_type_I|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240874035C>T	ClinGen:CA274210|UniProtKB:P21549#VAR_060559	C0268164|C3661900	259900	416|93598	Aminotransferase class V domain|Aminotransferase class-V, pyridoxal-phosphate binding site	Ser	Leu	98.91	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.91	Polar/Neutral	Serine		Alanine--glyoxylate aminotransferase										-0.8								 S218-S81 (PAE:  1.0), S218-I78 (PAE: 1.0), S218-G80 (PAE: 1.0)	S218-G80 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), S218-S81 (PDBs: 6RV1, 3R9A), S218-I78 (PDBs: 6RV1, 3R9A)	 S218-S81 (PAE:  1.0), S218-I78 (PAE: 1.0), S218-G80 (PAE: 1.0), S218-A85 (PAE: 1.0)	S218-A85 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 3R9A), S218-S81 (PDBs: 6RV1, 3R9A), S218-I78 (PDBs: 6RV1, 3R9A), S218-G80 (PDBs: 6RV1, 7NS7, 3R9A)							105									-140.5				149.6						B (undefined)	E (parallel sheets)	Beta strand											98.91	0.0	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.9188704309378142	0.9352118995503031	false	true	false
TPM1	TPM1_Ala166Thr	B_15-16	-0.41350258055286304	1.0	1.0	-2.7362534053167247	0.29647524847407686	0.32191352036345006	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.684261766017474	0.682023085459633	0.6224466341277061	0.6786388170449017	0.719976891039698	0.6866654186010226	0.6566739578610234	0.642224571259809	0.6164494620210962	0.6435513872728514	0.6594028685527403	0.6542442128867676	0.7166568793410217	0.7977292108195868	0.7408281720687072	0.6013418809825607	0.7046433023665257	0.7142793191481804	TPM1	Ala166Thr	NC_000015.10:63060872:G:A	496G>A	15	63060872	G	A	15	ENSG00000140416	4723	1438	CCSBVarC007531	ALE00007517	ENSP00000288398.6	Edgotyping3	VUSMutGDEh013	C04	GDEhDisVCh_40050	F12	2	VUSMutGDDh013	C04	VUSN2Hmut_GDN2h_04	C03	VUSMutpDEST2_04	B05	VUSmut_GDEh04	C03	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	N	Y	Y	Y	230595.0	single nucleotide variant	NM_001018005.2(TPM1):c.496G>A (p.Ala166Thr)	7168.0	TPM1	HGNC:12010	Likely pathogenic	1.0	Mar 16, 2016	876657662.0	-	RCV000221536	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604	Primary dilated cardiomyopathy	germline	germline	GRCh38	NC_000015.10	15	63060872.0	63060872.0	15q22.2	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10576996	2.0	228297.0	63060872.0	G	A	-	-	-	-	-	-	496G>A 	Ala166Thr	NM_001018005.2	1.0	Pathogenic	Likely pathogenic	228297	15	63060872.0	G	A	A	T	rs876657662	15	63353071	15	61140124	166	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.496G>A	p.Ala166Thr	c.496G>A	p.Ala166Thr	alternative1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.012	0.91343	D	0.096	0.58429	T	0.966	0.77914	D	0.937	0.92348	D	0.82	0.88440	A	simple_aae	18.0	82.0	2.85	0.82639	M	-3.38	0.68798	D	0.855	0.85095	1.0985	0.99598	D	0.9569	0.98603	D	10	0.8963872	0.88871	D	0.551976	0.95867	D	0.846	0.95199	.	0.82954	.	.	.	0.969593545731	0.96898	.	0.87051	.	0.97285	0.90568870306	0.97044	D	0.976771	0.99781	D	0.550949	0.95777	D	0.553624	0.95714	D	0.982911705970764	0.74601	D	0.832017	0.50203	T	0.6754878	0.76465	0.5134915	0.71630	0.6916959	0.77348	0.5735067	0.75049	-10.879	0.79058	D	0.7556	0.83801	P	0.997680202990465	0.93424	0.99955469	0.99479	0.862	0.92474	.	.	.	.	.	.	5.520369	0.91786	32.0	0.99405093223834196	0.63032	0.979085	0.99793	D	0.774347745206736	0.84394	8.299037	0.791815187343808	0.89158	9.885865	5.58	5.58	0.84339	.	.	10.003	0.9969	11.864000	0.98400	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.976	0.56441	792	0.45931	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Primary_dilated_cardiomyopathy	criteria_provided,_single_submitter	NC_000015.10:g.63060872G>A	ClinGen:CA10576996	C0007193	.	217604	.	Ala	Thr	98.23	0.49056603773584906																																																																																																																																																																																																																																																																																																																																																																																																																																																																													52			98.23	Aliphatic	Alanine		Tropomyosin alpha-1 chain	Coiled coil									1.8								 A166-V170 (PAE:  1.0), A166-Y162 (PAE: 1.0)	A166-Y162 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), A166-V170 (PDBs: 8ENC)	 A166-V170 (PAE:  1.0), A166-Y162 (PAE: 1.0)	A166-Y162 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), A166-V170 (PDBs: 8ENC)							89									-60.6				-42.5						H (helix)	H (α-helix)	Helix											98.23	49.056606	>90	10-90		unknown		Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3		false	0.682023085459633	0.684261766017474	false	false	false
TH	TH_Ile219Thr	B_7-8	0.8116157962686673	0.44800479097139956	0.537610538546545	0.20632166292568577	0.8424123183405422	0.8713791455213613	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7478381605879646	0.7669218927241874	0.6243360719148724	0.7502320490732342	0.6932407313536522	0.6892195721072993	0.521980490834884	0.5489013661308655	0.6223158763941415	0.5225656186185138	0.7239818831680864	0.7419347766849604	0.8564586533797146	0.8375800965764388	0.8781482217523269	0.726106525211231	0.8098619022802885	0.7537415444909688	TH	Ile219Thr	NC_000011.10:2167474:A:G	656T>C	11	2167474	A	G	11	ENSG00000180176	71892	4012	CCSBVarC008291	ALE00008277	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	H10	GDEhDisVCh_40019	F10	1	VUSMutGDDh015	H10	VUSN2Hmut_GDN2h_04	B12	VUSMutpDEST2_15	F08	VUSmut_GDEh04	B12	1.0	1.0	1.0	5.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	408318.0	single nucleotide variant	NM_000360.4(TH):c.656T>C (p.Ile219Thr)	7054.0	TH	HGNC:11782	Likely pathogenic	1.0	Sep 16, 2016	1064795631.0	-	RCV000478105	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000011.10	11	2167474.0	2167474.0	11p15.5	criteria provided, single submitter	1.0	-	N	ClinGen:CA16619300	2.0	422210.0	2167474.0	A	G	-	-	-	-	-	-	656T>C 	Ile219Thr	NM_000360.4	1.0	Pathogenic	Likely pathogenic	422210	11	2167474.0	A	G	I	T	rs1064795631	11	2188704	11	2145280	250	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.749T>C	p.Ile250Thr	c.749T>C	p.Ile250Thr	.	Y	1	.	.	-	ATT	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	0.864	0.47529	P	0.987	0.77493	D	.	.	.	.	.	.	3.395	0.91508	M	-4.34	0.76853	D	0.846	0.87350	1.0658	0.98478	D	0.9854	0.99559	D	10	0.9666922	0.96123	D	0.963438	0.99764	D	0.800	0.93443	0.741	0.87254	P07101	I250T	Gain of disorder (P = 0.0109)| Gain of phosphorylation at I250 (P = 0.012)| Gain of glycosylation at I250 (P = 0.0406)| Gain of relative solvent accessibility (P = 0.09)| Gain of methylation at R252 (P = 0.0936)	0.994055629281	0.99391	0.8465401914664039	0.84522	0.342150454951	0.35857	0.651578962803	0.60146	T	0.981604	0.99857	D	0.327846	0.84911	D	0.233151	0.84713	D	0.994907438755035	0.86386	D	0.979402	0.96996	D	0.81804234	0.84895	0.73197067	0.83971	0.782155	0.82573	0.7770108	0.86682	-11.469	0.87706	D	0.9579	0.89170	P	0.982731111812094	0.86009	0.99694530	0.98214	0.943	0.97319	.	.	.	.	.	.	4.485153	0.70077	25.5	0.9944352661180843	0.64917	0.732565	0.67811	D	0.39632106869725	0.61020	4.320453	0.228127325913747	0.51162	3.324132	3.4	2.12	0.26302	.	.	4.359	0.59309	10.560000	0.83460	0.674	0.70877	1.0	0.71675	1.000000	0.68239	0.424	0.27366	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000011.10:g.2167474A>G	ClinGen:CA16619300	CN517202	.	.	Aromatic amino acid hydroxylase, C-terminal|Aromatic amino acid hydroxylase, C-terminal|Tyrosine 3-monooxygenase, catalytic domain	Ile	Thr	97.91	0.03550295857988166																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.91	3.5502958	>90	<10		unknown		Rare genetic neurological disorder; Rare inborn errors of metabolism	2		false	0.7669218927241874	0.7478381605879646	false	false	false
TPM1	TPM1_Met281Thr	B_15-16	-0.18037368450093255	1.0	1.0	2.0572646230972196	0.19051130225677423	0.2219434685596303	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.673841688698655	0.6781927254341462	0.6991855818020614	0.7144371146716268	0.6989748742215636	0.768048328609467	0.703547031534307	0.5694062464709448	0.5490952133754597	0.6516234156519187	0.5881131561939184	0.5664180715429634	0.832549625684627	0.8285435019721823	0.8797790159677941	0.746747747952204	0.768272294674374	0.7812653058543466	TPM1	Met281Thr	NC_000015.10:63064133:T:C	842T>C	15	63064133	T	C	15	ENSG00000140416	4723	8956	CCSBVarC000700	ALE00000700	ENSP00000288398.6	RC4	RC4_Mut_GDEh1014	A10	GDEhDisVCh_40050	F11	2	RC4_Mut_GDDh1014	A10	VUSN2Hmut_GDN2h_10	B08	VUSMutpDEST2_04	F05	VUSmut_GDEh12	B12	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	N	Y	Y	40545.0	single nucleotide variant	NM_001018005.2(TPM1):c.842T>C (p.Met281Thr)	7168.0	TPM1	HGNC:12010	Pathogenic/Likely pathogenic	1.0	Aug 12, 2024	199476321.0	-	RCV000024581|RCV000618291|RCV000232738|RCV001594374|RCV000622737|RCV003149577	MedGen:C3661900|MedGen:CN230736|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569|MONDO:MONDO:0012744,MedGen:C2678476,OMIM:611878,Orphanet:154,Orphanet:54260|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848	not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Dilated cardiomyopathy 1Y|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy	germline	germline	GRCh38	NC_000015.10	15	63064133.0	63064133.0	15q22.2	criteria provided, multiple submitters, no conflicts	13.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018416,Leiden Muscular Dystrophy (TPM1):TPM1_00016	2.0	31885.0	63064133.0	T	C	-	-	-	-	-	-	842T>C 	Met281Thr	NM_001018005.2	2.0	Pathogenic	Likely pathogenic	31885	15	63064133.0	T	C	M	T	rs199476321	15	63356332	15	61143385	281	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.842T>C	p.Met281Thr	c.842T>C	p.Met281Thr	alternative1	Y	1	YES	Select	+	ATG	2	0	T	T/T	T/T	T/T	T/T	0.015	0.54059	D	0.001	0.83643	D	0.014	0.21130	B	0.146	0.33947	B	0.97	0.96253	A	simple_aae	3.0	97.0	2.925	0.84244	M	-2.54	0.56009	D	0.963	0.97332	0.8798	0.95387	D	0.8886	0.96295	D	9	0.96276057	0.95659	D	0.471251	0.94674	D	0.846	0.95199	0.865	0.96028	P09493	M281T	Loss of stability (P = 0.0104)| Gain of glycosylation at M281 (P = 0.0357)| Gain of disorder (P = 0.1134)| Gain of phosphorylation at S283 (P = 0.3549)| Loss of helix (P = 0.3949)	0.996106677599	0.99601	.	.	.	.	.	.	.	0.975001	0.99751	D	0.541222	0.95439	D	0.539651	0.95371	D	0.62959204126251	0.37292	D	0.881012	0.60062	D	0.6650948	0.75905	0.5971904	0.76366	0.56185806	0.70319	0.69196934	0.81663	-8.572	0.64980	D	0.8808	0.81476	P	0.958675316730291	0.81539	0.99965417	0.99571	0.209	0.47298	.	.	.	.	.	.	4.591703	0.72687	25.9	0.98139461547893214	0.38732	0.927427	0.90973	D	0.253236694143315	0.53568	3.547374	0.411315973110819	0.62064	4.439484	5.79	5.79	0.91740	.	.	8.017	0.8876	7.913000	0.74164	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.997	0.79771	786	0.46777	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	0	109138	0.000000e+00	0	0	207548	0.000000e+00	0	1	236364	4.230760e-06	0	0	7134	0.000000e+00	0	0	17082	0.000000e+00	0	0	2306	0.000000e+00	0	0	9042	0.000000e+00	0	0	13382	0.000000e+00	0	0	42678	0.000000e+00	0	0	15606	0.000000e+00	0	.	.	.	.	0	16162	0.000000e+00	0	0	30448	0.000000e+00	0	0	6190	0.000000e+00	0	0	13408	0.000000e+00	0	0	16720	0.000000e+00	0	0	89344	0.000000e+00	0	0	30434	0.000000e+00	0	.	.	.	.	0	14854	0.000000e+00	0	0	34188	0.000000e+00	0	0	9554	0.000000e+00	0	0	17688	0.000000e+00	0	0	21574	0.000000e+00	0	1	102548	9.751530e-06	0	0	30354	0.000000e+00	0	1	102548	9.751530e-06	0	.	3	1613870	1.858890e-06	0	2	74942	2.668730e-05	0	2	74942	2.668730e-05	0	0	912	0.000000e+00	0	0	59982	0.000000e+00	0	0	29594	0.000000e+00	0	0	44894	0.000000e+00	0	0	64030	0.000000e+00	0	0	6084	0.000000e+00	0	1	1179974	8.474760e-07	0	0	90972	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	not_provided|Cardiovascular_phenotype|Dilated_cardiomyopathy_1Y|Cardiomyopathy|Hypertrophic_cardiomyopathy|Primary_familial_hypertrophic_cardiomyopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.63064133T>C	ClinGen:CA018416|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00016	C3661900|CN230736|C2678476|C0878544|C0007194|C0949658	611878|PS192600	154|54260|167848|217569|155	.	Met	Thr	56.12	0.7659574468085106																																																																																																																																																																																																																																																																																																																																																																																																																																																																													144			56.12	Aliphatic	Methionine		Tropomyosin alpha-1 chain	Coiled coil									1.9								 M281-A277 (PAE:  9.0)		 M281-A277 (PAE:  9.0)								149									-80.7				-20.1						H (helix)	H (α-helix)												56.12	76.59575	50-70	10-90	611878	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	CARDIOMYOPATHY, DILATED, 1Y	false	0.6781927254341462	0.673841688698655	false	false	false
PLP1	PLP1_Ile152Thr	B_7-8	-0.457445290904105	0.6710948294052727	0.7385184114533495	1.6542102412235942	0.1491681989199998	0.18877492759875836	2024_01_Batch_7-8	true	true	false	false	false	false	false	true	false	false	false	false	0.9660411056545194	0.9813099170509103	0.5994659822616335	0.5968243448909782	0.5565837857664275	0.5954306060230715	0.5954306060230715	0.511462183720363	0.6365067693151173	0.5994659822616335	0.981875226103336	0.9528077175478166		0.601705387812492	0.5571419204668393		0.9807446079984846	0.9792744937612222	PLP1	Ile152Thr	NC_000023.11:103787904:T:C	455T>C	23	103787904	T	C	X	ENSG00000123560	4062	201428	CCSBVarC005860	ALE00005860	ENSP00000477619.1	CEGS2	CegsMutGDEh1040	A10	GDEhDisVCh_40062	G07	2	CegsMutGDDh1040	A10	VUSN2Hmut_GDN2h_08	D06	VUSMutpDEST2_04	C03	VUSmut_GDEh08	D06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26124.0	single nucleotide variant	NM_000533.5(PLP1):c.560T>C (p.Ile187Thr)	5354.0	PLP1	HGNC:9086	Pathogenic/Likely pathogenic	1.0	Sep 13, 2022	132630288.0	-	RCV000011834|RCV004595482	MONDO:MONDO:0010733,MedGen:C1839264,OMIM:312920,Orphanet:99015|Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702	Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease	germline;maternal;unknown	germline	GRCh38	NC_000023.11	X	103787904.0	103787904.0	Xq22.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA255701,UniProtKB:P60201#VAR_004556,OMIM:300401.0013	3.0	11085.0	103787904.0	T	C	-	-	-	-	-	-	560T>C 	Ile187Thr	NM_000533.5	2.0	Pathogenic	Likely pathogenic	11085	X	103787904.0	T	C	I	T	rs132630288	X	103042833	X	102929489	187	PLP1	ENSG00000123560	ENST00000612423	ENSP00000481006	P60201	MYPR_HUMAN	c.560T>C	p.Ile187Thr	c.560T>C	p.Ile187Thr	principal1	Y	2	.	.	+	ATT	2	0	T	T/T	T/T	T/T	T/T	.	.	.	0.264	0.23039	T	0.98	0.59367	D	0.721	0.54895	P	.	.	.	.	.	.	1.2	0.30152	L	.	.	.	0.867	0.86375	1.0566	0.98257	D	0.9553	0.98549	D	10	0.9856414	0.98816	D	0.925028	0.99450	D	.	.	0.928	0.98831	P60201	I187T	Gain of disorder (P = 0.007)| Gain of glycosylation at I187 (P = 0.014)| Loss of stability (P = 0.0819)| Gain of ubiquitination at K192 (P = 0.0822)| Loss of sheet (P = 0.1158)	0.999567136539	0.99955	0.9487172460420876	0.94822	.	.	0.691649317741	0.65886	T	0.886786	0.97647	D	0.512645	0.94603	D	0.498603	0.94524	D	0.872730314731598	0.51997	D	.	0.86684	.	0.42677936	0.62219	0.42521912	0.66083	0.3787962	0.58902	0.34684417	0.60111	-3.159	0.11998	T	0.9696	0.89333	LP	0.956165811351463	0.81205	0.99598290	0.97927	0.872	0.93060	.	.	.	.	.	.	4.175774	0.62888	24.5	0.97667387116372861	0.35400	.	.	.	.	.	.	.	.	.	5.58	5.58	0.84339	3.13	0.56939	7.674	0.83188	7.848000	0.70876	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Hereditary_spastic_paraplegia_2|Pelizaeus-Merzbacher_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.103787904T>C	ClinGen:CA255701|OMIM:300401.0013|UniProtKB:P60201#VAR_004556	C1839264|C0205711	312920|312080	99015|702	.	Ile	Thr	86.83	0.05325443786982249																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																86.83	5.3254437	70-90	<10	312920;312080	x-linked recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	SPASTIC PARAPLEGIA 2, X-LINKED; PELIZAEUS-MERZBACHER DISEASE	false	0.9813099170509103	0.9660411056545194	true	true	true
MLH1	MLH1_Pro640Ser	B_11-12	10.106371125897395	0.00007033901331586594	0.0007184359114080425	9.205004393896298	0.00017558682631771088	0.0006148889814751898	2024_12_Batch_11-12	true	true	true	true	true	true	false	false	false	false	false	false	0.9394271392568485	0.9408114882873246	0.9461313477040278	0.9255581082224583	0.9068778391218619	0.9556158014351757		0.921157587168268		0.9515760581167096	0.955611715848786	0.9472523129025849	0.9556158014351757	0.8925980910754557	0.9255581082224583	0.940686637291346	0.9260112607258634	0.931601965611112	MLH1	Pro640Ser	NC_000003.12:37048538:C:T	1918C>T	3	37048538	C	T	3	ENSG00000076242	2713	200887	CCSBVarC003208	ALE00003208	ENSP00000231790.3	CEGS2	CegsMutGDEh1036	D06	GDEhDisVCh_40019	E01	1	CegsMutGDDh1036	D06	VUSN2Hmut_GDN2h_07	A05	VUSMutpDEST2_02	F09	VUSmut_GDEh07	A05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	95419.0	single nucleotide variant	NM_000249.4(MLH1):c.1918C>T (p.Pro640Ser)	4292.0	MLH1	HGNC:7127	Likely pathogenic	1.0	Oct 18, 2018	63749792.0	-	RCV000075424|RCV000569430|RCV000791363|RCV001193959|RCV001354000|RCV002223786|RCV002291271	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0018630,MedGen:C1333990,OMIM:PS120435,Orphanet:443909|MONDO:MONDO:0002032,MedGen:C0699790|MedGen:C3661900|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary nonpolyposis colon cancer|Carcinoma of colon|not provided|Colorectal cancer, hereditary nonpolyposis, type 2	germline;unknown	germline	GRCh38	NC_000003.12	3	37048538.0	37048538.0	3p22.2	reviewed by expert panel	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007602,UniProtKB:P40692#VAR_043429	2.0	89945.0	37048538.0	C	T	-	-	-	-	-	-	1918C>T 	Pro640Ser	NM_000249.4	3.0	Pathogenic	Likely pathogenic	89945	3	37048538.0	C	T	P	S	rs63749792	3	37090029	3	37065033	640	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.1918C>T	p.Pro640Ser	c.1918C>T	p.Pro640Ser	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.745	0.94897	H	-7.75	0.95806	D	0.966	0.97658	1.0847	0.99037	D	0.9531	0.98474	D	10	0.9820831	0.98249	D	0.467101	0.94605	D	0.974	0.99740	0.889	0.97257	P40692	P640S	Gain of sheet (P = 0.0073)| Loss of helix (P = 0.0444)| Loss of relative solvent accessibility (P = 0.0793)| Loss of solvent accessibility (P = 0.089)| Loss of loop (P = 0.1242)	0.973330939336	0.97278	0.911865338121724	0.91105	0.406905597714	0.41278	0.618619441986	0.55468	T	0.948986	0.99242	D	0.549912	0.95759	D	0.552134	0.95696	D	0.998158395290375	0.93318	D	0.957904	0.84136	D	0.96864724	0.98102	0.9792173	0.99794	0.9757278	0.98746	0.9660773	0.99273	-12.707	0.88693	D	0.9421	0.86472	P	0.999826796575882	0.98179	0.99987054	0.99835	0.773	0.87433	.	.	.	.	.	.	4.522608	0.7098	25.6	0.99910091656674049	0.97950	0.880749	0.80690	D	1.02834271595602	0.96531	14.83514	0.962139499570304	0.97738	16.69629	5.81	5.81	0.92402	.	.	7.394	0.79186	7.614000	0.62087	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.996	0.76032	154	0.93969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Carcinoma_of_colon|Hereditary_cancer-predisposing_syndrome|not_provided|Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Hereditary_nonpolyposis_colon_cancer|Lynch_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms	reviewed_by_expert_panel	NC_000003.12:g.37048538C>T	ClinGen:CA007602|UniProtKB:P40692#VAR_043429	C0699790|C0027672|C3661900|C1333991|C1333990|C4552100|C0009405	609310|PS120435	140162|144|443909|144	DNA mismatch repair protein Mlh1, C-terminal	Pro	Ser	92.87	0.007352941176470588																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			92.87	Special, No backbone hydrogen	Proline		DNA mismatch repair protein Mlh1										1.6								 P640-Y684 (PAE:  3.0)	P640-Y684 (PDBs: 3RBN)									115									-62.6				124.1	Interaction with EXO1					B (undefined)	E (parallel sheets)	Beta strand											92.87	0.7352941	>90	<10	609310	autosomal dominant	GenCC	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 2	false	0.9408114882873246	0.9394271392568485	true	true	false
DES	DES_Pro419Ser	B_7-8	-0.21301204265961451	1.0	1.0	1.8612383416556193	0.11114158887698511	0.14404527459835792	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7883735391296086	0.753044935289387	0.8509989774648646	0.7306951458541052	0.7469975302130846	0.8508045616898506	0.9785548343541025	0.9159322598299191	0.932947327330361	0.9560492178624691	0.8126167458942467	0.7883735391296086	0.7230542890255988	0.57806280059625	0.5284429643778494	0.7459487370672602	0.6934731246845273		DES	Pro419Ser	NC_000002.12:219423787:C:T	1255C>T	2	219423787	C	T	2	ENSG00000175084	12573	2325	CCSBVarC006508	ALE00006507	ENSP00000363071.3	Edgotyping3	VUSMutGDEh005	C11	GDEhDisVCh_40003	A12	1	VUSMutGDDh005	C11	VUSN2Hmut_GDN2h_02	H03	NULL	NULL	VUSmut_GDEh02	H03	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	48317.0	single nucleotide variant	NM_001927.4(DES):c.1255C>T (p.Pro419Ser)	1674.0	DES	HGNC:2770	Pathogenic/Likely pathogenic	1.0	Dec 12, 2019	62635763.0	-	RCV000056783|RCV000817811	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline;unknown	germline	GRCh38	NC_000002.12	2	219423787.0	219423787.0	2q35	criteria provided, multiple submitters, no conflicts	6.0	ACMG2022	N	ClinGen:CA217034,UniProtKB:P17661#VAR_069074,OMIM:125660.0017	3.0	39718.0	219423787.0	C	T	-	-	-	-	-	-	1255C>T 	Pro419Ser	NM_001927.4	2.0	Pathogenic	Likely pathogenic	39718	2	219423787.0	C	T	P	S	rs62635763	2	220288509	2	219996753	419	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1255C>T	p.Pro419Ser	c.1255C>T	p.Pro419Ser	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.074	0.34767	T	0.069	0.44261	T	0.773	0.44030	P	0.607	0.50996	P	0.92	0.93300	A	simple_aae	8.0	92.0	3.4	0.91562	M	-6.43	0.91330	D	0.917	0.91970	0.0730	0.83604	D	0.6112	0.86188	D	10	0.9548317	0.94780	D	0.078201	0.72857	D	0.720	0.90060	0.816	0.93022	P17661	P419S	Loss of catalytic residue at N417 (P = 0.1002)| Gain of disorder (P = 0.1113)| Loss of phosphorylation at T422 (P = 0.16)| Loss of stability (P = 0.1976)| Loss of glycosylation at S414 (P = 0.208)	0.95024763043	0.94931	0.8235052030961802	0.82202	0.880419966817	0.69566	0.759251773357	0.75774	T	0.590605	0.86609	D	0.396358	0.89631	D	0.331565	0.89502	D	0.976723432540894	0.71317	D	0.872413	0.57791	D	0.3162979	0.53993	0.4123511	0.65187	0.23510994	0.46013	0.3802132	0.62812	-6.593	0.51065	T	0.6001	0.68828	P	0.986597477004604	0.87155	0.99286145	0.97221	0.874	0.93177	.	.	.	.	.	.	4.611816	0.73202	25.9	0.99864634338978175	0.94280	0.953452	0.96965	D	0.537677150012848	0.69171	5.342329	0.5731135069292	0.72870	5.90244	5.97	5.97	0.96929	.	.	6.651	0.74287	7.707000	0.66650	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.755	0.36	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Desmin-related_myofibrillar_myopathy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219423787C>T	ClinGen:CA217034|OMIM:125660.0017|UniProtKB:P17661#VAR_069074	C1832370|C3661900	601419	363543|98909	.	Pro	Ser	49.14	0.7794117647058824																																																																																																																																																																																																																																																																																																																																																																																																																																																																													106			49.14	Special, No backbone hydrogen	Proline		Desmin										1.6																		115									-49.3				133.9	Tail			dbSNP: rs62635763; Variant type: LP/P; AA change: Pro419Ser; PTM type: Phosphorylation; PTM morphology: NLP*IQtysALN; Var class: II&rs62635763		C (loop/coil)	C (loop/coil)												49.14	77.94118	$\leqslant$50	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.753044935289387	0.7883735391296086	false	false	false
MLH1	MLH1_Cys680Arg	B_11-12	2.960290486332099	0.03615945488222715	0.07171812962103205	24.629489101747186	3.0838409264530843e-7	8.390976792275268e-6	2024_12_Batch_11-12	true	true	true	true	true	true	false	false	false	false	false	false	0.8776213847710699	0.8986663086342168	0.8177950086758683	0.8992840597306059	0.7996866963006672	0.9260244653138878		0.769949163084674		0.769997664584292	0.9069837585839686	0.8786497080597515	0.9260244653138878	0.8294242295166606	0.8992840597306059	0.8655923527674447	0.890348858684465	0.8765930614823884	MLH1	Cys680Arg	NC_000003.12:37048952:T:C	2038T>C	3	37048952	T	C	3	ENSG00000076242	2713	981	CCSBVarC007395	ALE00007383	ENSP00000231790.3	Edgotyping3	VUSMutGDEh011	H10	GDEhDisVCh_40019	C08	1	VUSMutGDDh011	H10	VUSN2Hmut_GDN2h_04	E02	VUSMutpDEST2_02	H05	VUSmut_GDEh04	E02	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	N	Y	Y	Y	95480.0	single nucleotide variant	NM_000249.4(MLH1):c.2038T>C (p.Cys680Arg)	4292.0	MLH1	HGNC:7127	Likely pathogenic	1.0	Jun 21, 2019	63750809.0	-	RCV000075490|RCV000215088|RCV000791351|RCV001353998|RCV003451096	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0002032,MedGen:C0699790|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|Carcinoma of colon|Colorectal cancer, hereditary nonpolyposis, type 2	germline;unknown	germline	GRCh38	NC_000003.12	3	37048952.0	37048952.0	3p22.2	reviewed by expert panel	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008266	2.0	90006.0	37048952.0	T	C	-	-	-	-	-	-	2038T>C 	Cys680Arg	NM_000249.4	3.0	Pathogenic	Likely pathogenic	90006	3	37048952.0	T	C	C	R	rs63750809	3	37090443	3	37065447	680	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.2038T>C	p.Cys680Arg	c.2038T>C	p.Cys680Arg	principal1	Y	1	YES	Select	+	TGC	1	0	T	T/T	T/T	T/T	T/T	0.009	0.63383	D	0.039	0.54888	D	0.97	0.56988	D	0.742	0.55758	P	.	.	.	.	.	.	2.455	0.71058	M	-5.32	0.86481	D	0.933	0.93850	0.7467	0.93730	D	0.8388	0.94598	D	10	0.93895763	0.93147	D	0.458515	0.94460	D	0.879	0.96419	0.78	0.90415	P40692	C680R	Gain of disorder (P = 0.0144)| Gain of MoRF binding (P = 0.0474)| Gain of ubiquitination at K678 (P = 0.062)| Gain of phosphorylation at S677 (P = 0.0669)| Gain of methylation at C680 (P = 0.2652)	0.955339868077	0.95449	0.9407219762271734	0.94016	0.39073154982	0.39998	0.720441937447	0.70060	T	0.856595	0.96756	D	0.407904	0.90294	D	0.348149	0.90174	D	0.98318350315094	0.74767	D	0.875412	0.60512	D	0.9830282	0.99320	0.9571543	0.98798	0.9781899	0.98950	0.92178047	0.96474	-9.777	0.77567	D	0.9665	0.89244	P	0.992197572121448	0.89390	0.99980217	0.99739	0.914	0.95566	.	.	.	.	.	.	4.630957	0.73679	26.0	0.99676903697859209	0.79000	0.507566	0.53620	D	0.542927745487876	0.69491	5.387588	0.522474014064239	0.69336	5.369992	5.93	4.76	0.60139	.	.	3.08	0.49907	7.907000	0.73875	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.988	0.63383	154	0.93969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Lynch_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|Carcinoma_of_colon	reviewed_by_expert_panel	NC_000003.12:g.37048952T>C	ClinGen:CA008266	C0027672|C1333991|C4552100|C0009405|C0699790	609310	140162|144|144	DNA mismatch repair protein Mlh1, C-terminal	Cys	Arg	94.15	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			94.15	Special, a very reactive sulfhydryl group	Cysteine		DNA mismatch repair protein Mlh1										2.5								 C680-Y684 (PAE:  1.0), C680-L676 (PAE: 1.0)	C680-Y684 (PDBs: 3RBN), C680-L676 (PDBs: 3RBN)	 C680-Y684 (PAE:  1.0), C680-L676 (PAE: 1.0), C680-F656 (PAE: 1.5)	C680-Y684 (PDBs: 3RBN), C680-L676 (PDBs: 3RBN), C680-F656 (PDBs: 3RBN)							121									-58.5				-47.0						H (helix)	H (α-helix)	Helix											94.15	0.0	>90	<10	609310	autosomal dominant	GenCC	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 2	false	0.8986663086342168	0.8776213847710699	true	true	false
TPM1	TPM1_Arg160His	B_15-16	0.7871371081405313	1.0	1.0	0.337786708898425	1.0	1.0	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6360536071310898	0.6422730509123867	0.6264166847430439	0.6421851272333416	0.6713921427311098	0.6890225817085363	0.6694874849446719	0.6130589935299641	0.5664447367403298	0.6606305719686589	0.5955575387587375	0.5907240055020097	0.7085576784724005	0.7297252919322554	0.7179255177263535	0.592202797517429	0.688988563066036	0.6813832087601701	TPM1	Arg160His	NC_000015.10:63059667:G:A	479G>A	15	63059667	G	A	15	ENSG00000140416	4723	201737	CCSBVarC005639	ALE00005639	ENSP00000288398.6	CEGS2	CegsMutGDEh1035	B08	GDEhDisVCh_40050	B05	2	CegsMutGDDh1035	B08	VUSN2Hmut_GDN2h_07	D01	VUSMutpDEST2_04	B07	VUSmut_GDEh07	D01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	40559.0	single nucleotide variant	NM_001018005.2(TPM1):c.479G>A (p.Arg160His)	7168.0	TPM1	HGNC:12010	Pathogenic/Likely pathogenic	1.0	Nov 27, 2023	199476311.0	-	RCV000024595|RCV000036336|RCV001331475|RCV003586127	MedGen:C3661900|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0012744,MedGen:C2678476,OMIM:611878,Orphanet:154,Orphanet:54260|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569	not provided|Primary dilated cardiomyopathy|Dilated cardiomyopathy 1Y|Hypertrophic cardiomyopathy	de novo;germline;unknown	germline	GRCh38	NC_000015.10	15	63059667.0	63059667.0	15q22.2	criteria provided, multiple submitters, no conflicts	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018077,Leiden Muscular Dystrophy (TPM1):TPM1_00030	2.0	31899.0	63059667.0	G	A	-	-	-	-	-	-	479G>A 	Arg160His	NM_001018005.2	2.0	Pathogenic	Likely pathogenic	31899	15	63059667.0	G	A	R	H	rs199476311	15	63351866	15	61138919	160	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.479G>A	p.Arg160His	c.479G>A	p.Arg160His	alternative1	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.057	0.62681	T	0.866	0.90580	P	0.562	0.81117	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.915	0.96154	H	-4.36	0.79349	D	0.782	0.87569	1.0919	0.99314	D	0.9692	0.99024	D	10	0.8905184	0.88264	D	0.439091	0.94118	D	0.834	0.94750	.	0.75933	.	.	.	0.979155608839	0.97872	.	0.86933	.	0.98425	0.870841145515	0.92677	D	0.983978	0.99890	D	0.567866	0.96537	D	0.577924	0.96479	D	0.999027013778687	0.95887	D	0.948605	0.81380	D	0.8276683	0.85554	0.66816616	0.80317	0.75411475	0.80879	0.6743059	0.80663	-12.31	0.86442	D	0.2868	0.58080	B	0.999524212350301	0.96869	0.99961752	0.99542	0.992	0.99727	.	.	.	.	.	.	5.921515	0.94076	33.0	0.99934780092192466	0.99535	0.960942	0.98191	D	0.926450016983913	0.92956	11.75523	0.912703104889556	0.96080	14.30569	5.82	5.82	0.92730	4.46	0.83695	10.003	0.9969	11.849000	0.98025	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	792	0.45931	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Dilated_cardiomyopathy_1Y|Hypertrophic_cardiomyopathy|Primary_dilated_cardiomyopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.63059667G>A	ClinGen:CA018077|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00030	C3661900|C2678476|C0007194|C0007193	611878	154|54260|217569|217604	.	Arg	His	98.27	0.6330645161290323																																																																																																																																																																																																																																																																																																																																																																																																																																																																													157			98.27	Positively-charged	Arginine		Tropomyosin alpha-1 chain	Coiled coil									-4.5								 R160-E164 (PAE:  1.0), R160-E156 (PAE: 1.0)	R160-E156 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), R160-E164 (PDBs: 8ENC)	 R160-E164 (PAE:  1.0), R160-E156 (PAE: 1.0)	R160-E156 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), R160-E164 (PDBs: 8ENC)		R160-D157 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC)			Morphology: HIAEDADrkyEEVAR; Domain: Tropomyosin		175									-58.2				-42.4						H (helix)	H (α-helix)	Helix											98.27	63.30645	>90	10-90	611878	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	CARDIOMYOPATHY, DILATED, 1Y	false	0.6422730509123867	0.6360536071310898	false	false	false
PLP1	PLP1_Ser135Phe	B_7-8	0.45440766386553494	0.6655113315706339	0.733906837932974	1.7913498829560215	0.12342198291860738	0.1598301613660159	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8914212299961377	0.917608776362383	0.6981903544130896	0.7054690923101236	0.6849600100489193	0.8086068677170399	0.7187322841631218	0.49479989170962924	0.738647945176342	0.662392642650417	0.9310440356510605	0.8947782684272927	0.8984814512709581	0.8751201283882092	0.6722902394439051	0.7339880661757624	0.9041735170737054	0.8880641915649826	PLP1	Ser135Phe	NC_000023.11:103787853:C:T	404C>T	23	103787853	C	T	X	ENSG00000123560	4062	201429	CCSBVarC005858	ALE00005858	ENSP00000477619.1	CEGS2	CegsMutGDEh1040	G02	GDEhDisVCh_40062	B07	2	CegsMutGDDh1040	G02	VUSN2Hmut_GDN2h_08	G04	VUSMutpDEST2_04	D03	VUSmut_GDEh08	G04	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26131.0	single nucleotide variant	NM_000533.5(PLP1):c.509C>T (p.Ser170Phe)	5354.0	PLP1	HGNC:9086	Likely pathogenic	1.0	May 28, 2021	132630294.0	-	RCV000011841|RCV001786328	MONDO:MONDO:0010733,MedGen:C1839264,OMIM:312920,Orphanet:99015|MedGen:CN517202	Hereditary spastic paraplegia 2|not provided	germline	germline	GRCh38	NC_000023.11	X	103787853.0	103787853.0	Xq22.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA255710,UniProtKB:P60201#VAR_015029,OMIM:300401.0020	3.0	11092.0	103787853.0	C	T	-	-	-	-	-	-	509C>T 	Ser170Phe	NM_000533.5	1.0	Pathogenic	Likely pathogenic	11092	X	103787853.0	C	T	S	F	rs132630294	X	103042782	X	102929438	170	PLP1	ENSG00000123560	ENST00000612423	ENSP00000481006	P60201	MYPR_HUMAN	c.509C>T	p.Ser170Phe	c.509C>T	p.Ser170Phe	principal1	Y	2	.	.	+	TCT	2	0	C	C/C	C/C	C/C	C/C	.	.	.	0.001	0.83643	D	0.995	0.67505	D	0.899	0.63796	P	.	.	.	.	.	.	2.47	0.71525	M	.	.	.	0.93	0.93495	1.0952	0.99455	D	0.9730	0.99152	D	10	0.99016833	0.99505	D	0.965048	0.99777	D	.	.	0.919	0.98524	P60201	S170F	Loss of glycosylation at S170 (P = 0.0168)| Gain of helix (P = 0.2059)| Loss of sheet (P = 0.3635)| Gain of loop (P = 0.4248)| Loss of relative solvent accessibility (P = 0.4508)	0.997219050046	0.99714	0.9896592613663295	0.98957	.	.	0.739655137062	0.72874	T	0.988536	0.99941	D	0.529054	0.95108	D	0.522173	0.95035	D	0.980002410976509	0.72940	D	.	0.96418	.	0.70710415	0.78197	0.7753799	0.86581	0.63797516	0.74450	0.7295805	0.83832	-11.075	0.80132	D	0.9264	0.85487	LP	0.999286770940358	0.96155	0.99813735	0.98650	0.874	0.93177	.	.	.	.	.	.	4.869166	0.79788	27.2	0.99812904042785966	0.89628	.	.	.	.	.	.	.	.	.	5.73	5.73	0.89714	3.34	0.60572	7.568	0.81592	7.688000	0.65699	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Hereditary_spastic_paraplegia_2	criteria_provided,_single_submitter	NC_000023.11:g.103787853C>T	ClinGen:CA255710|OMIM:300401.0020|UniProtKB:P60201#VAR_015029	CN517202|C1839264	312920	99015	.	Ser	Phe	95.06	0.13076923076923078																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																95.06	13.076923	>90	10-90	312920	x-linked recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	SPASTIC PARAPLEGIA 2, X-LINKED	false	0.917608776362383	0.8914212299961377	false	false	false
TH	TH_Gln381Lys	B_7-8	-0.8118485755489554	0.4537780607691476	0.5413592105365845	0.7947036594574547	0.45288299940008425	0.5073147905387336	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6930707190184522	0.747794443199108	0.8431945964717922	0.7203561074954786	0.7293140585967544	0.867189746092653	0.8782476382181221	0.7246373357699013	0.7230596230116175	0.8209743852898044	0.7095289680549084	0.6347236854499805	0.8561318539671838	0.7339907814236074	0.7176525919793397	0.86541480765378	0.7860599183433077	0.7514177525869238	TH	Gln381Lys	NC_000011.10:2165727:G:T	1141C>A	11	2165727	G	T	11	ENSG00000180176	71892	36345	CCSBVarC002844	ALE00002844	ENSP00000325951.4	RC4	RC4_Mut_GDEh1024	E04	GDEhDisVCh_40019	B04	1	RC4_Mut_GDDh1024	E04	VUSN2Hmut_GDN2h_10	E09	VUSMutpDEST2_15	B11	VUSmut_GDEh13	B05	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	27363.0	single nucleotide variant	NM_000360.4(TH):c.1141C>A (p.Gln381Lys)	7054.0	TH	HGNC:11782	Pathogenic/Likely pathogenic	1.0	Mar 02, 2024	121917762.0	-	RCV000013117	MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150	Autosomal recessive DOPA responsive dystonia	germline;unknown	germline	GRCh38	NC_000011.10	11	2165727.0	2165727.0	11p15.5	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA278129,UniProtKB:P07101#VAR_014031,OMIM:191290.0001	3.0	12324.0	2165727.0	G	T	-	-	-	-	-	-	1141C>A 	Gln381Lys	NM_000360.4	2.0	Pathogenic	Likely pathogenic	12324	11	2165727.0	G	T	Q	K	rs121917762	11	2186957	11	2143533	412	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.1234C>A	p.Gln412Lys	c.1234C>A	p.Gln412Lys	.	Y	1	.	.	-	CAG	1	0	G	G/G	G/G	G/G	G/G	0.011	0.55689	D	0.002	0.79703	D	0.993	0.77914	D	0.961	0.78402	D	0.88	0.93300	A	simple_aae	12.0	88.0	2.925	0.84244	M	-3.01	0.62541	D	0.837	0.91737	1.0263	0.97642	D	0.9862	0.99587	D	10	0.9240036	0.91658	D	0.772166	0.98196	D	0.807	0.93718	.	.	.	.	.	0.956599909788	0.95576	0.7572553727897524	0.75539	1.65484946215	0.89559	0.739582300186	0.72864	T	0.957958	0.99433	D	0.549853	0.95758	D	0.552049	0.95695	D	0.982650220394135	0.74442	D	0.980469	0.93358	D	0.8994047	0.91205	0.78482157	0.87165	0.91298497	0.92466	0.8381349	0.90594	-10.762	0.80773	D	0.2671	0.62419	B	0.993202510804612	0.89918	0.99782610	0.98523	0.921	0.95990	.	.	.	.	.	.	4.317531	0.66123	24.9	0.99310899669382147	0.59041	0.959018	0.97905	D	0.602655635085301	0.73200	5.950533	0.473029765089811	0.66026	4.922319	4.03	4.03	0.46052	3.82	0.71118	7.899	0.86031	9.527000	0.80972	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.372	0.26205	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	0	109278	0.000000e+00	0	1	206282	4.847730e-06	0	1	236422	4.229720e-06	0	0	7148	0.000000e+00	0	0	17084	0.000000e+00	0	0	2318	0.000000e+00	0	0	9038	0.000000e+00	0	0	13392	0.000000e+00	0	0	42704	0.000000e+00	0	0	15682	0.000000e+00	0	.	.	.	.	0	16022	0.000000e+00	0	0	30470	0.000000e+00	0	0	6122	0.000000e+00	0	0	13386	0.000000e+00	0	0	16728	0.000000e+00	0	1	88144	1.134510e-05	0	0	30584	0.000000e+00	0	1	88144	1.134510e-05	0	0	14796	0.000000e+00	0	0	34218	0.000000e+00	0	0	9562	0.000000e+00	0	0	17680	0.000000e+00	0	0	21592	0.000000e+00	0	1	102448	9.761050e-06	0	0	30512	0.000000e+00	0	1	102448	9.761050e-06	0	.	8	1612614	4.960890e-06	0	8	1179962	6.779880e-06	0	0	74900	0.000000e+00	0	0	910	0.000000e+00	0	0	60002	0.000000e+00	0	0	29602	0.000000e+00	0	0	44874	0.000000e+00	0	0	62754	0.000000e+00	0	0	6084	0.000000e+00	0	8	1179962	6.779880e-06	0	0	91056	0.000000e+00	0	1	17052	5.864414731409805E-5	0	268	0	0	84	0	0	7290	0	0	146	0	0	610	0	0	24	0	0	94	0	0	1952	0	0	7558	0	0	108	0	1	27520	3.633720930232558E-5	Autosomal_recessive_DOPA_responsive_dystonia	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.2165727G>T	ClinGen:CA278129|OMIM:191290.0001|UniProtKB:P07101#VAR_014031	C2673535	605407	101150	Aromatic amino acid hydroxylase, C-terminal|Aromatic amino acid hydroxylase, C-terminal|Tyrosine 3-monooxygenase, catalytic domain	Gln	Lys	97.19	0.21212121212121213																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.19	21.212122	>90	10-90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.747794443199108	0.6930707190184522	false	false	false
MYOZ2	MYOZ2_Ser48Pro	B_7-8	0.6367117527321438	0.5478196120204102	0.6269235823600859	-4.136098582122605	0.006105195955065726	0.011214248826371979	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6027607026497541	0.6786669825430844	0.5847664512222024	0.5781034739172204	0.5758270140082029	0.6137542234275117	0.6556378681731299	0.49289847885821636	0.4527490117544248	0.6460174175618869	0.6852358965600924	0.636148350442479	0.5718705786818935	0.6587555491581893	0.703457936080016	0.5235154848825178	0.6720980685260765	0.5693730548570294	MYOZ2	Ser48Pro	NC_000004.12:119150937:T:C	142T>C	4	119150937	T	C	4	ENSG00000172399	5651	10277	CCSBVarC000866	ALE00000866	ENSP00000306997.6	RC4	RC4_Mut_GDEh1005	D07	GDEhDisVCh_40044	E03	2	RC4_Mut_GDDh1005	D07	NULL	NULL	NULL	NULL	VUSmut_GDEh12	D07	1.0	1.0	1.0	1.0	0.0			0.0			1.0	1.0	99.0	Y	Y	N	N	Y	39465.0	single nucleotide variant	NM_016599.5(MYOZ2):c.142T>C (p.Ser48Pro)	51778.0	MYOZ2	HGNC:1330	Likely pathogenic	1.0	Aug 23, 2021	199476398.0	-	RCV000023465|RCV000024476	MONDO:MONDO:0013455,MedGen:C3151204,OMIM:613838|MedGen:CN517202	Hypertrophic cardiomyopathy 16|not provided	germline;unknown	germline	GRCh38	NC_000004.12	4	119150937.0	119150937.0	4q26	criteria provided, single submitter	3.0	-	N	ClinGen:CA129291,Leiden Muscular Dystrophy (MYOZ2):MYOZ2_00001,UniProtKB:Q9NPC6#VAR_065469,OMIM:605602.0001	3.0	30508.0	119150937.0	T	C	-	-	-	-	-	-	142T>C 	Ser48Pro	NM_016599.5	1.0	Pathogenic	Likely pathogenic	30508	4	119150937.0	T	C	S	P	rs199476398	4	120072092	4	120291540	48	MYOZ2	ENSG00000172399	ENST00000307128	ENSP00000306997	Q9NPC6	MYOZ2_HUMAN	c.142T>C	p.Ser48Pro	c.142T>C	p.Ser48Pro	principal1	Y	1	YES	Select	+	TCC	1	0	T	T/T	T/T	T/T	T/T	0.028	0.46288	D	0.005	0.72530	D	0.982	0.60051	D	0.822	0.59143	P	0.89	0.91795	A	simple_aae	11.0	89.0	3.05	0.86613	M	-4.31	0.76607	D	0.905	0.90585	0.3368	0.88086	D	0.5626	0.84037	D	9	0.98989743	0.99467	D	0.143163	0.82501	D	0.816	0.94067	0.946	0.99321	Q9NPC6	S48P	Loss of phosphorylation at S48 (P = 0.044)| Loss of helix (P = 0.0626)| Loss of stability (P = 0.064)| Loss of MoRF binding (P = 0.0681)| Gain of loop (P = 0.0851)	0.969282671092	0.96867	0.6568364799550337	0.65454	0.68615799813	0.60049	0.684967756271	0.64924	T	0.834111	0.96037	D	0.354821	0.86756	D	0.2719	0.86583	D	0.995611011981964	0.87648	D	0.90421	0.66305	D	0.8739204	0.89024	0.863076	0.92288	0.8803782	0.89555	0.8586182	0.91980	-10.176	0.75036	D	0.953	0.87206	P	0.988704777473551	0.87895	0.06176982	0.61704	0.769	0.87211	.	.	.	.	.	.	4.597644	0.72836	25.9	0.99896673128778102	0.96973	0.980009	0.99827	D	0.795065926224901	0.85718	8.684283	0.77630686995636	0.88036	9.457947	5.75	5.75	0.90377	.	.	7.479	0.80164	6.198000	0.54925	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.997	0.79771	432	0.80699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	not_provided|Hypertrophic_cardiomyopathy_16	criteria_provided,_single_submitter	NC_000004.12:g.119150937T>C	ClinGen:CA129291|Leiden_Muscular_Dystrophy_(MYOZ2):MYOZ2_00001|OMIM:605602.0001|UniProtKB:Q9NPC6#VAR_065469	CN517202|C3151204	613838	.	.	Ser	Pro	84.97	0.5923076923076923																																																																																																																																																																																																																																																																																																																																																																																																																																																																													77			84.97	Polar/Neutral	Serine		Myozenin-2										-0.8								 S48-L44 (PAE:  3.0)		 S48-L44 (PAE:  3.0)								105									-81.1				-26.5				dbSNP: rs199476398; Variant type: LP/P; AA change: Ser48Pro; PTM type: Phosphorylation; PTM morphology: ELS*HLsNRGAR; Var class: II		H (helix)	H (α-helix)												84.97	59.23077	70-90	10-90	613838	autosomal dominant	OMIM		0	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16	false	0.6786669825430844	0.6027607026497541	false	false	false
AGXT	AGXT_Arg111Gln	B_7-8	0.600532412516807	0.5670781186416904	0.6447138134557314	3.386576932947367	0.011653685857125546	0.0195876757179665	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7263069248700902	0.7045252085303473	0.6783656695452818	0.6024647020537757	0.5605439756602756	0.7002235570104042	0.7762185128491451	0.6435677786716896	0.6939679886503103	0.7574467563242242	0.6676603210181464	0.6998883312996669	0.6242286011716632	0.4775201726488616	0.5109614154572409	0.5992845827663393	0.7413900960425481	0.7527255184405135	AGXT	Arg111Gln	NC_000002.12:240869336:G:A	332G>A	2	240869336	G	A	2	ENSG00000172482	70497	3812	CCSBVarC008181	ALE00008167	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	G02	GDEhDisVCh_40002	G04	2	VUSMutGDDh004	G02	VUSN2Hmut_GDN2h_01	F06	VUSMutpDEST2_14	A04	VUSmut_GDEh01	F06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200472.0	single nucleotide variant	NM_000030.3(AGXT):c.332G>A (p.Arg111Gln)	189.0	AGXT	HGNC:341	Pathogenic/Likely pathogenic	1.0	Oct 09, 2024	180177203.0	-	RCV000186298|RCV002305454	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900	Primary hyperoxaluria, type I|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	240869336.0	240869336.0	2q37.3	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA275671	2.0	204092.0	240869336.0	G	A	-	-	-	-	-	-	332G>A 	Arg111Gln	NM_000030.3	2.0	Pathogenic	Likely pathogenic	204092	2	240869336.0	G	A	R	Q	rs180177203	2	241808753	2	241457426	111	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.332G>A	p.Arg111Gln	c.332G>A	p.Arg111Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.007	0.69466	D	1.0	0.90580	D	0.999	0.92348	D	0.93	0.93829	A	simple_aae	7.0	93.0	.	.	.	-3.81	0.71919	D	0.984	0.99346	1.1083	0.99851	D	0.9413	0.98071	D	10	0.98729414	0.99078	D	0.903927	0.99277	D	0.954	0.99189	.	.	.	.	.	0.964948117445	0.96425	0.9680569701085651	0.96775	0.263199542763	0.28579	0.497315853834	0.38401	T	0.891317	0.97774	D	0.385047	0.88953	D	0.520823	0.94963	D	0.992587268352509	0.82968	D	0.956971	0.83650	D	0.92776644	0.93923	0.82952845	0.90026	0.92776644	0.93924	0.82952845	0.90026	-11.323	0.81457	D	0.4424	0.61777	A	0.994737243598133	0.90841	0.52729500	0.82476	0.995	0.99826	.	.	.	.	.	.	5.261481	0.8836	29.6	0.99955185936666069	0.99969	0.958616	0.97841	D	0.848130492506997	0.88942	9.795716	0.684633239185617	0.81107	7.474165	4.12	4.12	0.47444	2.42	0.44885	9.213	0.94254	9.438000	0.80851	0.614	0.49322	1.0	0.71675	1.000000	0.68239	0.73	0.35136	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	3	106406	2.819390e-05	0	7	202706	3.453280e-05	0	7	230448	3.037560e-05	0	0	7158	0.000000e+00	0	0	16978	0.000000e+00	0	0	2094	0.000000e+00	0	0	9042	0.000000e+00	0	1	12974	7.707720e-05	0	1	41232	2.425300e-05	0	1	15052	6.643640e-05	0	1	15052	6.643640e-05	0	0	16148	0.000000e+00	0	0	30308	0.000000e+00	0	0	5708	0.000000e+00	0	0	13394	0.000000e+00	0	1	16262	6.149310e-05	0	2	86762	2.305160e-05	0	3	29366	1.021590e-04	0	3	29366	1.021590e-04	0	0	14876	0.000000e+00	0	0	33990	0.000000e+00	0	0	8836	0.000000e+00	0	0	17676	0.000000e+00	0	1	20968	4.769170e-05	0	2	99334	2.013410e-05	0	3	29282	1.024520e-04	0	3	29282	1.024520e-04	0	.	34	1606274	2.116700e-05	0	2	6040	3.311260e-04	0	0	74868	0.000000e+00	0	0	912	0.000000e+00	0	0	59802	0.000000e+00	0	0	29056	0.000000e+00	0	0	44798	0.000000e+00	0	1	63052	1.585990e-05	0	2	6040	3.311260e-04	0	21	1175300	1.786780e-05	0	10	90252	1.108010e-04	0	0	9688	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14048	0	Primary_hyperoxaluria,_type_I|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240869336G>A	ClinGen:CA275671	C0268164|C3661900	259900	416|93598	Aminotransferase class V domain	Arg	Gln	98.75	0.4153225806451613																																																																																																																																																																																																																																																																																																																																																																																																																																																																													103			98.75	Positively-charged	Arginine		Alanine--glyoxylate aminotransferase										-4.5			B:R111-A:H261 (PDBs: 5F9S, 5HHY), A:R111-B:H261 (PDBs: 7NS7), A:R111-C:H261 (PDBs: 3R9A), C:R111-A:H261 (PDBs: 3R9A), A:R111-C:Y260 (PDBs: 3R9A)					 R111-I107 (PAE:  1.0), R111-I115 (PAE: 1.0), R111-H83 (PAE: 1.0)	R111-H83 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7), R111-I107 (PDBs: 6RV1, 3R9A), R111-I115 (PDBs: 6RV1, 3R9A)	 R111-I107 (PAE:  1.0), R111-I115 (PAE: 1.0)	R111-I115 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), R111-I107 (PDBs: 6RV1, 3R9A)							175									-68.0				-39.2						H (helix)	H (α-helix)	Helix											98.75	41.532257	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.7045252085303473	0.7263069248700902	false	false	false
POLR1C	POLR1C_Arg279Gln	B_7-8	0.024626383942261253	0.9811515742167104	0.9857966895075838	-4.141632675291973	0.006067536501808435	0.011156241964747973	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.79354459565391	0.8275732105643157	0.47293100053051934	0.692812717039408	0.679525137890737	0.6487493785836272	0.5862941754209011	0.6373406052814323	0.7148812883879754	0.5237332025234677	0.8374181589759238	0.8083225952210533	0.7112045817463534	0.7217096705000415	0.6707441456908407	0.422128798537571	0.8177282621527077	0.7787665960867667	POLR1C	Arg279Gln	NC_000006.12:43520962:G:A	836G>A	6	43520962	G	A	6	ENSG00000171453	5431	201910	CCSBVarC005349	ALE00005349	ENSP00000496044.1	CEGS2	CegsMutGDEh1030	C09	GDEhDisVCh_40034	B11	2	CegsMutGDDh1030	C09	VUSN2Hmut_GDN2h_05	D05	VUSMutpDEST2_05	F01	VUSmut_GDEh05	D05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	39768.0	single nucleotide variant	NM_203290.4(POLR1C):c.836G>A (p.Arg279Gln)	9533.0	POLR1C	HGNC:20194	Pathogenic/Likely pathogenic	1.0	Jan 18, 2024	191582628.0	-	RCV000023796|RCV000788034|RCV000513700|RCV002281718|RCV002513205|RCV002504821	MONDO:MONDO:0009558,MedGen:C1855433,OMIM:248390,Orphanet:861|MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637|MedGen:C3661900|MONDO:MONDO:0700278,MedGen:CN239394|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0014666,MedGen:C4225305,OMIM:616494,Orphanet:88637;MONDO:MONDO:0009558,MedGen:C1855433,OMIM:248390,Orphanet:861	Treacher Collins syndrome 3|Hypomyelinating leukodystrophy 11|not provided|POLR1C-related disorder|Inborn genetic diseases|Hypomyelinating leukodystrophy 11;Treacher Collins syndrome 3	germline;inherited;unknown	germline	GRCh38	NC_000006.12	6	43520962.0	43520962.0	6p21.1	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA259909,UniProtKB:O15160#VAR_064899,OMIM:610060.0001	3.0	30811.0	43520962.0	G	A	-	-	-	-	-	-	836G>A 	Arg279Gln	NM_203290.4	2.0	Pathogenic	Likely pathogenic	30811	6	43520962.0	G	A	R	Q	rs191582628	6	43488700	6	43596678	279	POLR1C	ENSG00000171453	ENST00000642195	ENSP00000496044	O15160	RPAC1_HUMAN	c.836G>A	p.Arg279Gln	c.836G>A	p.Arg279Gln	principal1	Y	.	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	.	0.68399	.	.	0.58950	.	1.0	0.90580	D	0.998	0.88579	D	.	0.97926	.	.	.	.	2.9	0.83739	M	.	0.69154	.	.	0.97765	0.3602	0.88449	D	0.6763	0.88759	D	10	0.56610686	0.64761	D	0.104786	0.77886	D	.	0.90463	.	.	.	.	.	.	0.95957	.	.	.	.	0.510794103146	0.40278	T	0.868055	0.97102	D	0.17342	0.71226	D	0.385973	0.91579	D	0.719808757305145	0.41389	D	0.963904	0.86835	D	0.8401624	0.86442	0.5669306	0.74681	0.8463973	0.86899	0.6392705	0.78700	-10.163	0.74959	D	0.7854	0.76564	P	0.996567235472969	0.92256	0.98619030	0.96206	0.905	0.95023	.	.	.	.	.	.	5.825625	0.93725	33.0	0.9995391994979016	0.99963	0.925663	0.90522	D	0.820918338977849	0.87326	9.203484	0.779050524902382	0.88238	9.531113	4.89	4.89	0.63341	2.96	0.54135	10.003	0.9969	11.906000	0.99485	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.99	0.65338	216	0.91604	1	1.9968051118210862E-4	0	0.0	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	80	264690	3.0224037E-4	.	19	109402	1.736710e-04	0	43	208080	2.066510e-04	0	49	236896	2.068420e-04	0	0	7164	0.000000e+00	0	10	17112	5.843850e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13388	0.000000e+00	0	9	42768	2.104380e-04	0	0	15690	0.000000e+00	0	10	17112	5.843850e-04	0	0	16182	0.000000e+00	0	20	30524	6.552220e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16728	0.000000e+00	0	23	89548	2.568450e-04	0	0	30608	0.000000e+00	0	20	30524	6.552220e-04	0	0	14868	0.000000e+00	0	24	34260	7.005250e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21624	0.000000e+00	0	24	102742	2.335950e-04	0	0	30526	0.000000e+00	0	24	34260	7.005250e-04	0	.	291	1614158	1.802800e-04	0	56	60024	9.329600e-04	0	8	75026	1.066300e-04	0	0	912	0.000000e+00	0	56	60024	9.329600e-04	0	1	29602	3.378150e-05	0	0	44888	0.000000e+00	0	1	64038	1.561570e-05	0	0	6062	0.000000e+00	0	216	1180018	1.830480e-04	0	0	91082	0.000000e+00	0	21	125994	1.6667460355255013E-4	0	360	0	0	2708	0	0	8902	0	1	790	0.0012658227848101266	0	944	0	0	656	0	0	280	0	1	9996	1.0004001600640257E-4	0	9262	0	0	3364	0	23	150630	1.5269202682068644E-4	Treacher_Collins_syndrome_3|not_provided|Hypomyelinating_leukodystrophy_11|POLR1C-related_disorder|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.43520962G>A	ClinGen:CA259909|OMIM:610060.0001|UniProtKB:O15160#VAR_064899	C1855433|C3661900|C4225305|CN239394|C0950123	248390|616494	861|88637	DNA-directed RNA polymerase, RpoA/D/Rpb3-type|DNA-directed RNA polymerase, RpoA/D/Rpb3-type	Arg	Gln	94.39	0.10887096774193548																																																																																																																																																																																																																																																																																																																																																																																																																																																																													27			94.39	Positively-charged	Arginine		DNA-directed RNA polymerases I and III subunit RPAC1										-4.5			C:R279-N:G153 (PDBs: 7OB9, 7OBA, 7OBB)					 R279-D64 (PAE:  2.0), R279-R234 (PAE: 2.0), R279-E62 (PAE: 2.5)	R279-R234 (PDBs: 7A6H, 7AE1, 7AE3, 7AST, 7D58, 7D59, 7FJI, 7FJJ, 7OB9, 7OBA, 7OBB, 8A43, 8IUE, 8IUH), R279-E62 (PDBs: 7DN3, 7DU2), R279-D64 (PDBs: 8ITY, 8IUH)		R279-L236 (PDBs: 7A6H, 7AE3, 7AEA, 7FJI, 7FJJ, 7OB9, 7OBA, 7OBB)		R279-D64 (PDBs: 7A6H, 7AE1, 7AE3, 7AEA, 7DN3, 7DU2, 7FJI, 7FJJ, 7OB9, 7OBA, 7OBB, 8A43, 8ITY, 8IUE, 8IUH)					175									-56.9				-32.3				dbSNP: rs191582628; Variant type: LP/P; AA change: Arg279Gln; PTM type: Phosphorylation; PTM morphology: R*LDtFsREIFR; Var class: II&rs141156009		H (helix)	G (3₁₀-helix)	Helix											94.39	10.887096	>90	10-90	248390;616494;616494;248390	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic gynecological and obstetrical diseases; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility	8	TREACHER COLLINS SYNDROME 3; LEUKODYSTROPHY, HYPOMYELINATING, 11; LEUKODYSTROPHY, HYPOMYELINATING, 11; TREACHER COLLINS SYNDROME 3	false	0.8275732105643157	0.79354459565391	false	false	false
HPRT1	HPRT1_Ala161Ser	B_7-8	-1.1145244819573936	0.30185197605685443	0.389026500856	-4.828041133751851	0.001903753567400627	0.004043272912245544	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7182884651895547	0.7688353989519787	0.5627677802672588	0.6252299087081402	0.5315705564676003	0.6046927371316768	0.6723638393967432	0.5271675437593911	0.5844608904849988	0.677322957913765	0.8669079068505527	0.8648095454242981	0.5370216348666105	0.5359735691758094	0.6659989269312816	0.44821260262075274	0.6707628910534048	0.5717673849548113	HPRT1	Ala161Ser	NC_000023.11:134493586:G:T	481G>T	23	134493586	G	T	X	ENSG00000165704	7982	202801	CCSBVarC005938	ALE00005938	ENSP00000298556.7	CEGS2	CegsMutGDEh1035	G11	GDEhDisVCh_40052	D08	2	CegsMutGDDh1035	G11	VUSN2Hmut_GDN2h_07	E02	VUSMutpDEST2_07	C07	VUSmut_GDEh07	E02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25080.0	single nucleotide variant	NM_000194.2(HPRT1):c.481G>T (p.Ala161Ser)	3251.0	HPRT1	HGNC:5157	Likely pathogenic	1.0	Feb 14, 2023	137852484.0	-	RCV000010737|RCV000010736|RCV003764547	|MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233;MONDO:MONDO:0010298,MedGen:C0023374,OMIM:300322,Orphanet:510	HPRT MILWAUKEE|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency;Lesch-Nyhan syndrome	germline	germline	GRCh38	NC_000023.11	X	134493586.0	134493586.0	Xq26.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA120896,UniProtKB:P00492#VAR_006787,OMIM:308000.0013	3.0	10041.0	134493586.0	G	T	-	-	-	-	-	-	481G>T 	Ala161Ser	NM_000194.2	1.0	Pathogenic	Likely pathogenic	10041	X	134493586.0	G	T	A	S	rs137852484	X	133627616	X	133455282	161	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.481G>T	p.Ala161Ser	c.481G>T	p.Ala161Ser	principal1	Y	1	YES	Select	+	GCA	1	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.04	0.51160	D	0.905	0.49931	P	0.884	0.62752	P	0.85	0.89875	A	simple_aae	15.0	85.0	2.97	0.85148	M	-2.44	0.53442	N	0.767	0.76382	1.0940	0.99402	D	0.9581	0.98643	D	9	0.9704771	0.96596	D	0.568234	0.96079	D	0.855	0.95533	0.822	0.93425	P00492	A161S	Gain of disorder (P = 0.0453)| Gain of phosphorylation at A161 (P = 0.0841)| Loss of methylation at K159 (P = 0.1294)| Loss of MoRF binding (P = 0.1632)| Loss of ubiquitination at K159 (P = 0.3498)	0.991232537077	0.99103	0.9042082573711596	0.90332	2.44743042796	0.97323	0.653111577034	0.60365	T	0.989504	0.99950	D	0.53164	0.95150	D	0.525888	0.95078	D	0.990142822265625	0.80209	D	0.969203	0.88897	D	0.82045954	0.85059	0.80540586	0.88464	0.82045954	0.85060	0.80540586	0.88465	-9.246	0.69345	D	0.2662	0.50053	B	0.871336632335705	0.74264	0.99964094	0.99561	0.827	0.90459	.	.	.	.	.	.	3.752969	0.53887	23.4	0.99758598447364133	0.84864	.	.	.	.	.	.	.	.	.	5.4	5.4	0.77927	3.68	0.67565	7.28	0.7803	6.634000	0.56229	-0.105	0.15707	1.0	0.71675	1.000000	0.68239	0.963	0.52396	215	0.91648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Partial_hypoxanthine-guanine_phosphoribosyltransferase_deficiency|Lesch-Nyhan_syndrome|HPRT_MILWAUKEE	criteria_provided,_single_submitter	NC_000023.11:g.134493586G>T	ClinGen:CA120896|OMIM:308000.0013|UniProtKB:P00492#VAR_006787	C0268117|C0023374	300323|300322	79233|510	Phosphoribosyltransferase domain|Phosphoribosyltransferase domain	Ala	Ser	98.69	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.69	Aliphatic	Alanine		Hypoxanthine-guanine phosphoribosyltransferase										1.8								 A161-I132 (PAE:  1.0), A161-E134 (PAE: 1.0)	A161-I132 (PDBs: 4KN6, 6BNJ), A161-E134 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)	 A161-I132 (PAE:  1.0)	A161-I132 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4RAO, 5W8V, 6BNJ), A161-L131 (PDBs: 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAQ)							89									-104.7				129.5				dbSNP: rs137852484; Variant type: LP/P; AA change: Ala161Ser; PTM type: Ubiquitylation; PTM morphology: RQYNPkMVkVA*; Var class: II&rs137852484		B (undefined)	E (parallel sheets)	Beta strand											98.69	0.0	>90	<10	300323;300323;300322	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	HYPERURICEMIA, HPRT-RELATED; HYPERURICEMIA, HPRT-RELATED; LESCH-NYHAN SYNDROME	false	0.7688353989519787	0.7182884651895547	false	false	false
GCK	GCK_Met381Arg	B_7-8	3.872517955272523	0.030475796657166845	0.06313315793404412	0.7076224796320532	0.5301993119540843	0.5853885303464168	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7238987228304485	0.7661574931332897	0.6603298549418005	0.6649231390564195	0.6214521619543528	0.640610062043427	0.640610062043427	0.6214521619543528	0.6649231390564195	0.6603298549418005	0.7661574931332897	0.7238987228304485							GCK	Met381Arg	NC_000007.14:44145608:A:C	1142T>G	7	44145608	A	C	7	ENSG00000106633	3689	214860	CCSBVarC006698	ALE00006696	ENSP00000384247.3	CEGS2	CegsMutGDEh1044	B10	GDEhDisVCh_40037	D03	1	CegsMutGDDh1044	B10	VUSN2Hmut_GDN2h_09	C07	VUSMutpDEST2_03	A10	VUSmut_GDEh09	C07	1.0	2.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	44842.0	single nucleotide variant	NM_000162.5(GCK):c.1142T>G (p.Met381Arg)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Jul 17, 2023	193922266.0	-	RCV002281721	MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44145608.0	44145608.0	7p13	reviewed by expert panel	2.0	-	N	ClinGen:CA213719	2.0	36178.0	44145608.0	A	C	-	-	-	-	-	-	1142T>G 	Met381Arg	NM_000162.5	3.0	Pathogenic	Likely pathogenic	36178	7	44145608.0	A	C	M	R	rs193922266	7	44185207	7	44151732	381	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.1142T>G	p.Met381Arg	c.1142T>G	p.Met381Arg	principal1	Y	1	YES	Select	-	ATG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	0.997	0.70687	D	0.937	0.67258	D	0.99	0.97926	A	simple_aae	1.0	99.0	2.175	0.60790	M	-3.83	0.73614	D	0.922	0.92554	1.0491	0.98094	D	0.9188	0.97306	D	10	0.9870709	0.99042	D	0.795514	0.98394	D	0.963	0.99463	0.902	0.97846	P35557	M381R	Gain of MoRF binding (P = 0.0144)| Gain of methylation at M381 (P = 0.0225)| Gain of disorder (P = 0.0368)| Gain of phosphorylation at S383 (P = 0.1717)| Gain of glycosylation at T376 (P = 0.2722)	0.986712009296	0.98642	.	0.99995	.	0.98380	0.814544439316	0.84162	D	0.936668	0.98959	D	0.527074	0.95019	D	0.519329	0.94945	D	0.995235490642908	0.86959	D	0.955004	0.82826	D	0.98682237	0.99576	0.95436186	0.98636	0.9881108	0.99654	0.9653637	0.99237	-9.737	0.72444	D	0.9599	0.88016	P	0.997770718554719	0.93534	0.99981171	0.99752	0.997	0.99892	.	.	.	.	.	.	5.191984	0.87099	29.1	0.98589210283069695	0.43467	0.972335	0.99416	D	0.681140257682479	0.78280	6.863321	0.659791826520524	0.79230	7.062115	5.2	5.2	0.71681	3.45	0.62472	7.396	0.79204	10.997000	0.84758	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.992	0.67791	716	0.55914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Monogenic_diabetes	reviewed_by_expert_panel	NC_000007.14:g.44145608A>C	ClinGen:CA213719	C3888631	.	183625	Hexokinase, C-terminal	Met	Arg	98.71	0.010638297872340425																																																																																																											0.433		0.384	1 mutation(s) (Met381Glu: -0.493)																																																																																																																																																																																																																																																																																																																																																															2			98.71	Aliphatic	Methionine		Hexokinase-4							Hexokinase			1.9								 M381-G385 (PAE:  1.0), M381-R377 (PAE: 1.0), M381-Y289 (PAE: 1.0)	M381-Y289 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9), M381-R377 (PDBs: 6E0I, 4LC9)	 M381-G385 (PAE:  1.0), M381-R377 (PAE: 1.0)	M381-R377 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9), M381-G385 (PDBs: 6E0I, 4LC9)							149									-57.5				-54.5	Hexokinase large subdomain					H (helix)	H (α-helix)	Helix											98.71	1.0638298	>90	<10		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism	3		false	0.7661574931332897	0.7238987228304485	false	false	false
PLP1	PLP1_Val184Phe	B_7-8	1.9299520189768038	0.10185098230952257	0.166830638390259	0.931023785457904	0.38776852784371857	0.441137785860647	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9227554644464061	0.9257019788043435	0.49106748051068494	0.6172578963813821	0.5482591132607659	0.5567776641606635	0.7640401241899241	0.619007572684508	0.8749460077828243	0.6460785404858077	0.9244470120502501	0.8962511024751015	0.34951520413140297	0.47751065383702374	0.3595697849799398	0.3360564205355621	0.9269569455584369	0.9492598264177107	PLP1	Val184Phe	NC_000023.11:103788469:G:T	550G>T	23	103788469	G	T	X	ENSG00000123560	4062	201432	CCSBVarC005863	ALE00005863	ENSP00000477619.1	CEGS2	CegsMutGDEh1041	A10	GDEhDisVCh_40062	H08	2	CegsMutGDDh1041	A10	VUSN2Hmut_GDN2h_08	A10	VUSMutpDEST2_04	G03	VUSmut_GDEh08	A10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26116.0	single nucleotide variant	NM_000533.5(PLP1):c.655G>T (p.Val219Phe)	5354.0	PLP1	HGNC:9086	Likely pathogenic	1.0	Oct 09, 2024	132630281.0	-	RCV000011826	Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702	Pelizaeus-Merzbacher disease	germline;maternal;unknown	germline	GRCh38	NC_000023.11	X	103788469.0	103788469.0	Xq22.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA255684,UniProtKB:P60201#VAR_004560,OMIM:300401.0005	3.0	11077.0	103788469.0	G	T	-	-	-	-	-	-	655G>T 	Val219Phe	NM_000533.5	2.0	Pathogenic	Likely pathogenic	11077	X	103788469.0	G	T	V	F	rs132630281	X	103043398	X	102930054	219	PLP1	ENSG00000123560	ENST00000612423	ENSP00000481006	P60201	MYPR_HUMAN	c.655G>T	p.Val219Phe	c.655G>T	p.Val219Phe	principal1	Y	2	.	.	+	GTT	1	0	G	G/G	G/G	G/G	G/G	.	.	.	0.116	0.36834	T	0.966	0.56216	D	0.876	0.62166	P	.	.	.	.	.	.	2.085	0.57546	M	.	.	.	0.922	0.92554	1.0913	0.99290	D	0.9720	0.99119	D	10	0.9819912	0.98235	D	0.958486	0.99724	D	.	.	0.873	0.96457	P60201	V219F	Gain of helix (P = 0.132)| Gain of methylation at K218 (P = 0.1341)| Gain of ubiquitination at K218 (P = 0.1621)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2363)	0.999220695078	0.99919	0.9851560229285521	0.98502	.	.	0.68555533886	0.65008	T	0.943159	0.99113	D	0.534394	0.95257	D	0.529844	0.95186	D	0.981429722469747	0.73720	D	.	0.84645	.	0.6782026	0.76611	0.5382704	0.73061	0.54873526	0.69589	0.45352304	0.67961	-8.082	0.61702	D	0.7435	0.76034	LP	0.991980177335865	0.89287	0.99670260	0.98135	0.948	0.97614	.	.	.	.	.	.	4.923084	0.81134	27.5	0.99687892608799444	0.79729	.	.	.	.	.	.	.	.	.	5.36	5.36	0.76590	1.66	0.35877	9.552	0.9722	7.609000	0.61899	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pelizaeus-Merzbacher_disease	criteria_provided,_single_submitter	NC_000023.11:g.103788469G>T	ClinGen:CA255684|OMIM:300401.0005|UniProtKB:P60201#VAR_004560	C0205711	312080	702	.	Val	Phe	89.15	0.1056338028169014																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																89.15	10.56338	70-90	10-90	312080	x-linked recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	PELIZAEUS-MERZBACHER DISEASE	false	0.9257019788043435	0.9227554644464061	false	false	false
DES	DES_Tyr122Asp	B_7-8	-2.8642422200550066	0.0352311026071162	0.07052858645682429	0.7019500756561476	0.5090101194846053	0.5633495592607061	2024_01_Batch_7-8	true	false	false	false	false	false	false	false	false	false	false	false	0.939831256144215	0.8952347010735449	0.6688788367769696	0.7511304544477435	0.5203020121290908	0.7117224164515483	0.7117224164515483	0.6008635183323501	0.739152927076533	0.6688788367769696	0.9361751654961403	0.9566210609861092		0.4397405059258315	0.7631079818189541		0.8542942366509494	0.9230414513023208	DES	Tyr122Asp	NC_000002.12:219418826:T:G	364T>G	2	219418826	T	G	2	ENSG00000175084	12573	2245	CCSBVarC007808	ALE00007794	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	F03	GDEhDisVCh_40003	H03	1	VUSMutGDDh003	F03	VUSN2Hmut_GDN2h_01	A02	NULL	NULL	VUSmut_GDEh01	A02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	198118.0	single nucleotide variant	NM_001927.4(DES):c.364T>G (p.Tyr122Asp)	1674.0	DES	HGNC:2770	Likely pathogenic	1.0	May 08, 2014	794728994.0	-	RCV000183370	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000002.12	2	219418826.0	219418826.0	2q35	criteria provided, single submitter	1.0	ACMG2022	N	ClinGen:CA308313	2.0	201721.0	219418826.0	T	G	-	-	-	-	-	-	364T>G 	Tyr122Asp	NM_001927.4	1.0	Pathogenic	Likely pathogenic	201721	2	219418826.0	T	G	Y	D	rs794728994	2	220283548	2	219991792	122	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.364T>G	p.Tyr122Asp	c.364T>G	p.Tyr122Asp	principal1	Y	1	YES	Select	+	TAC	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	0.999	0.77914	D	0.99	0.78943	D	.	.	.	.	.	.	4.06	0.97048	H	-7.78	0.95886	D	0.941	0.94798	1.0919	0.99314	D	0.9421	0.98098	D	10	0.9886651	0.99288	D	0.478726	0.94795	D	0.977	0.99803	0.911	0.98220	P17661	Y122D	Gain of disorder (P = 0.0036)| Loss of methylation at K125 (P = 0.1236)| Gain of relative solvent accessibility (P = 0.1259)| Loss of ubiquitination at K125 (P = 0.1372)| Loss of MoRF binding (P = 0.1468)	0.978623845151	0.97818	0.9980939786620024	0.99808	2.62646606766	0.98303	0.857509732246	0.90728	D	0.946495	0.99188	D	0.542554	0.95462	D	0.541565	0.95394	D	0.999705731868744	0.98567	D	0.919208	0.70822	D	0.9641225	0.97655	0.96277857	0.99105	0.9641225	0.97655	0.96277857	0.99105	-15.406	0.96739	D	0.9954	0.95716	P	0.999976051969175	0.99427	0.99888283	0.99015	1	0.99985	.	.	.	.	.	.	5.972214	0.94232	34.0	0.99309237995775435	0.59004	0.974915	0.99586	D	0.923467502597274	0.92821	11.67366	0.796470948362517	0.89489	10.01991	4.55	4.55	0.55376	4.05	0.77340	7.836	0.85042	7.710000	0.66806	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000002.12:g.219418826T>G	ClinGen:CA308313	CN517202	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Tyr	Asp	95.8	0.7162162162162162																																																																																																																																																																																																																																																																																																																																																																																																																																																																													159			95.8	Aromatic	Tyrosine		Desmin							IF rod	0.4453		-1.3								 Y122-V126 (PAE:  1.0), Y122-R118 (PAE: 2.0)		 Y122-V126 (PAE:  1.0), Y122-R118 (PAE: 2.0)								181									-66.6	Morphology: LNDRFANyIEKVRFL; Domain: Filament	Pocket 1: Mean pLDDT: 95.03, Volume: 185.15 Å³, Druggability score: 0.45		-41.8	Coil 1A					H (helix)	H (α-helix)		in Ref. 1 and 2; AAA99221										95.8	71.62162	>90	10-90		unknown		Rare genetic cardiac disease; Rare genetic neurological disorder	2		false	0.8952347010735449	0.939831256144215	false	true	false
PLP1	PLP1_Thr43Ile	B_7-8	-0.8244372480433396	0.44722186327933716	0.537610538546545	0.8266172612165424	0.44008103740721044	0.49451849580050894	2024_01_Batch_7-8	true	true	false	false	false	false	true	true	false	false	false	false	0.9938942683532312	0.9933166285275125	0.6241364621551425	0.5248322070977041	0.47098055781910564	0.6118541865012288	0.6620195036900645	0.5262801541993947	0.6044572779648866	0.6331038660458046	0.9902523618738136	0.993781687391394	0.5616888693123933	0.4156809614388166	0.44520713623052144	0.6151690582644804	0.9963808951812113	0.9940068493150686	PLP1	Thr43Ile	NC_000023.11:103785705:C:T	128C>T	23	103785705	C	T	X	ENSG00000123560	4062	201422	CCSBVarC005854	ALE00005854	ENSP00000477619.1	CEGS2	CegsMutGDEh1039	D02	GDEhDisVCh_40062	A06	2	CegsMutGDDh1039	D02	VUSN2Hmut_GDN2h_08	E01	VUSMutpDEST2_04	E02	VUSmut_GDEh08	E01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26125.0	single nucleotide variant	NM_000533.5(PLP1):c.128C>T (p.Thr43Ile)	5354.0	PLP1	HGNC:9086	Likely pathogenic	1.0	Feb 18, 2021	132630289.0	-	RCV000011835	Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702	Pelizaeus-Merzbacher disease	germline;maternal;unknown	germline	GRCh38	NC_000023.11	X	103785705.0	103785705.0	Xq22.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA255704,UniProtKB:P60201#VAR_004547,OMIM:300401.0014	3.0	11086.0	103785705.0	C	T	-	-	-	-	-	-	128C>T 	Thr43Ile	NM_000533.5	1.0	Pathogenic	Likely pathogenic	11086	X	103785705.0	C	T	T	I	rs132630289	X	103040634	X	102927290	43	PLP1	ENSG00000123560	ENST00000612423	ENSP00000481006	P60201	MYPR_HUMAN	c.128C>T	p.Thr43Ile	c.128C>T	p.Thr43Ile	principal1	Y	2	.	.	+	ACA	2	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	.	.	.	.	.	.	2.74	0.79912	M	.	0.83117	.	0.961	0.97110	1.0997	0.99648	D	0.9730	0.99152	D	10	0.9878774	0.99168	D	0.887214	0.99141	D	.	0.98779	0.922	0.98631	P60201	T43I	Loss of disorder (P = 0.0278)| Loss of glycosylation at T43 (P = 0.0522)| Loss of ubiquitination at K45 (P = 0.0801)| Gain of methylation at K45 (P = 0.1028)| Loss of catalytic residue at T43 (P = 0.3035)	0.999576404112	0.99956	0.9879253917301578	0.98782	.	.	0.837573647499	0.87703	D	0.990277	0.99957	D	0.671611	0.99902	D	0.726946	0.99902	D	0.995309054851532	0.87081	D	.	0.87758	.	0.8381465	0.86297	0.8300132	0.90058	0.83726305	0.86234	0.8437366	0.90968	-10.267	0.75571	D	0.9858	0.92484	LP	0.998854752139086	0.95187	0.99433280	0.97523	0.961	0.98360	.	.	.	.	.	.	4.744593	0.76595	26.5	0.99900231735773837	0.97201	.	.	.	.	.	.	.	.	.	5.58	5.58	0.84339	3.87	0.72853	5.773	0.68626	7.666000	0.64570	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	432	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	432	0	0	34	0	0	658	0	Pelizaeus-Merzbacher_disease	criteria_provided,_single_submitter	NC_000023.11:g.103785705C>T	ClinGen:CA255704|OMIM:300401.0014|UniProtKB:P60201#VAR_004547	C0205711	312080	702	.	Thr	Ile	90.94	0.13380281690140844																																																																																																																																																																																																																																																																																																																																																																																																																																																																													22			90.44	Polar/Neutral	Threonine		Myelin proteolipid protein								0.9999		-0.7								 T43-A39 (PAE:  1.0), T43-I47 (PAE: 1.0), T43-Y177 (PAE: 2.0)		 T43-A39 (PAE:  1.0), T43-T236 (PAE: 2.0), T43-I47 (PAE: 1.0)								119									-67.5		Pocket 1: Mean pLDDT: 91.36, Volume: 1487.75 Å³, Druggability score: 1		-41.4						H (helix)	H (α-helix)							Extracellular					90.94	13.380281	>90	10-90	312080	x-linked recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	PELIZAEUS-MERZBACHER DISEASE	false	0.9933166285275125	0.9938942683532312	true	true	true
MVK	MVK_Pro165Leu	B_7-8	1.4859588141755817	0.18783828409349979	0.2674700201811037	2.0058060796898998	0.09168572844787744	0.12218105424971322	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6320454576827839	0.665922701142287	0.6821031000364688	0.7971717379999177	0.6991002037795786	0.8018147255749949	0.8925686637166513	0.7579466398086854	0.847319897970766	0.7677934757856341	0.7298667063003246	0.7081962125231906	0.7110607874333384	0.6402537677504719	0.7470235780290694	0.5964127242873034	0.6019786959842494	0.5558947028423772	MVK	Pro165Leu	NC_000012.12:109581517:C:T	494C>T	12	109581517	C	T	12	ENSG00000110921	281	12	CCSBVarC007121	ALE00007119	ENSP00000228510.3	Edgotyping3	VUSMutGDEh009	B12	GDEhDisVCh_40020	G06	2	VUSMutGDDh009	B12	VUSN2Hmut_GDN2h_03	G04	VUSMutpDEST2_01	B02	VUSmut_GDEh03	G04	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	3.0	1.0	1.0	1.0	1.0	Y	N	Y	N	Y	26972.0	single nucleotide variant	NM_000431.4(MVK):c.494C>T (p.Pro165Leu)	4598.0	MVK	HGNC:7530	Likely pathogenic	1.0	Apr 19, 2019	121917790.0	-	RCV000012711|RCV001219913	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29	Hyperimmunoglobulin D with periodic fever|Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria	germline	germline	GRCh38	NC_000012.12	12	109581517.0	109581517.0	12q24.11	criteria provided, single submitter	2.0	-	N	ClinGen:CA121784,OMIM:251170.0005	3.0	11933.0	109581517.0	C	T	-	-	-	-	-	-	494C>T 	Pro165Leu	NM_000431.4	1.0	Pathogenic	Likely pathogenic	11933	12	109581517.0	C	T	P	L	rs121917790	12	110019322	12	108503705	165	MVK	ENSG00000110921	ENST00000546277	ENSP00000438153	Q03426	KIME_HUMAN	c.494C>T	p.Pro165Leu	c.494C>T	p.Pro165Leu	principal1	Y	5	.	.	+	CCA	2	0	C	C/C	C/C	C/C	C/C	0.04	0.55689	D	0.296	0.38070	T	0.259	0.31489	B	0.167	0.35120	B	.	0.85499	.	.	.	.	1.645	0.41851	L	-3.3	0.65888	D	.	0.72170	0.3266	0.87927	D	0.7141	0.90154	D	9	0.8705837	0.86174	D	0.299471	0.90812	D	0.606	0.84430	0.852	0.95292	Q03426	P165L	Loss of helix (P = 0.0626)| Gain of ubiquitination at K169 (P = 0.0872)| Loss of disorder (P = 0.0929)| Gain of catalytic residue at P165 (P = 0.0997)| Gain of loop (P = 0.1069)	0.881574606426	0.87949	.	0.54387	.	0.42037	0.275766849518	0.06908	T	0.469032	0.80123	T	0.258499	0.79238	D	0.133539	0.78970	D	0.408153414726257	0.28941	T	.	0.51028	.	0.16394228	0.36271	0.070779786	0.15074	0.11572553	0.27063	0.06417513	0.12824	-6.43	0.49807	T	0.1053	0.24498	LB	0.810976546696974	0.71259	0.99856526	0.98849	0.608	0.78084	.	.	.	.	.	.	1.876971	0.23886	16.17	0.98826409572861795	0.46971	0.197886	0.32266	N	-0.597525185981531	0.18788	0.9921674	-0.548136131669695	0.20548	1.125554	5.14	3.27	0.36504	2.57	0.47140	2.186	0.42328	1.409000	0.26349	-0.217	0.0818	0.016	0.19295	0.001000	0.17376	0.048	0.15055	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	16976	5.89066918001885E-5	0	0	0	0	34	0	0	454	0	0	354	0	0	18	0	0	0	0	0	6	0	0	4200	0	0	454	0	0	34	0	1	22042	4.536793394428818E-5	Hyperimmunoglobulin_D_with_periodic_fever|Mevalonic_aciduria|Porokeratosis_3,_disseminated_superficial_actinic_type	criteria_provided,_single_submitter	NC_000012.12:g.109581517C>T	ClinGen:CA121784|OMIM:251170.0005	C0398691|C1959626|C1867981	260920|610377|175900	343|29	GHMP kinase N-terminal domain	Pro	Leu	94.66	0.5588235294117647																																																																																																																																																																																																																																																																																																																																																																																																																																																																													76			94.66	Special, No backbone hydrogen	Proline		Mevalonate kinase										1.6										 P165-W177 (PAE:  2.0)	P165-W177 (PDBs: 2R3V)							115									-68.7				154.0						C (loop/coil)	C (loop/coil)												94.66	55.88235	>90	10-90	260920;260920;175900;610377	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; HYPER-IgD SYNDROME; POROKERATOSIS 3, MULTIPLE TYPES; MEVALONIC ACIDURIA	false	0.665922701142287	0.6320454576827839	false	false	false
MVK	MVK_Asn205Asp	B_7-8	-1.9236731947899144	0.10274153428479774	0.1675801285089357	-2.9533228782515595	0.025502785940234633	0.03903053561328653	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6372389211954266	0.6340408680131157	0.7243586204240466	0.5511657961369699	0.5743743525207554	0.8545347597135056	0.8630222224192882	0.6061188112815203	0.5385724182525322	0.7643942337323586	0.7207348087754843	0.6946774344654454	0.8460472970077229	0.5426298937599905	0.5637591740214076	0.6843230071157346	0.547346927250747	0.5798004079254079	MVK	Asn205Asp	NC_000012.12:109586107:A:G	613A>G	12	109586107	A	G	12	ENSG00000110921	281	744	CCSBVarC000028	ALE00000028	ENSP00000228510.3	RC4	RC4_Mut_GDEh1020	D03	GDEhDisVCh_40020	H04	2	RC4_Mut_GDDh1020	D03	VUSN2Hmut_GDN2h_10	E08	VUSMutpDEST2_01	D04	VUSmut_GDEh13	F03	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	103495.0	single nucleotide variant	NM_000431.4(MVK):c.613A>G (p.Asn205Asp)	4598.0	MVK	HGNC:7530	Pathogenic/Likely pathogenic	1.0	Aug 08, 2024	104895364.0	-	RCV000083855|RCV001594835|RCV002262662|RCV001857407|RCV004767066	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:C3661900|MONDO:MONDO:0019751,MedGen:C3890737,Orphanet:93665|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900|MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29	Hyperimmunoglobulin D with periodic fever|not provided|Autoinflammatory syndrome|Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type|Mevalonic aciduria	germline;unknown	germline	GRCh38	NC_000012.12	12	109586107.0	109586107.0	12q24.11	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA149858	2.0	97603.0	109586107.0	A	G	-	-	-	-	-	-	613A>G 	Asn205Asp	NM_000431.4	2.0	Pathogenic	Likely pathogenic	97603	12	109586107.0	A	G	N	D	rs104895364	12	110023912	12	108508295	205	MVK	ENSG00000110921	ENST00000546277	ENSP00000438153	Q03426	KIME_HUMAN	c.*11A>G	.	c.613A>G	p.Asn205Asp	principal1	Y	5	.	.	+	AAT	1	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.997	0.86259	D	.	0.93829	.	.	.	.	4.425	0.98710	H	.	0.80975	.	.	0.99730	1.0979	0.99572	D	0.9646	0.98866	D	9	.	0.99730	.	0.550614	0.95848	D	.	0.97811	0.941	0.99203	Q03426	N205D	Loss of MoRF binding (P = 0.0672)| Gain of loop (P = 0.069)| Loss of sheet (P = 0.0817)| Gain of helix (P = 0.0854)| Gain of disorder (P = 0.1321)	.	0.98574	.	0.99162	.	0.80825	0.599839687347	0.52814	T	0.791928	0.96294	D	0.0756888	0.61261	D	0.145245	0.79734	D	0.997616648674011	0.91920	D	.	0.85963	.	0.9849889	0.99456	0.9397452	0.97717	0.97647107	0.98809	0.93277794	0.97246	-13.845	0.92557	D	.	0.79354	.	0.99796099851043	0.93777	0.99846650	0.98800	0.995	0.99826	.	.	.	.	.	.	5.05361	0.84211	28.2	0.99767003141929822	0.85596	0.895188	0.83434	D	0.870302003017101	0.90178	10.31086	0.792008036614692	0.89173	9.8914	5.27	5.27	0.73761	.	.	8.368	0.90037	11.171000	0.87986	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.964	0.52647	735	0.53648	.	.	.	.	.	.	.	.	.	.	.	.	7	264690	2.644603E-5	.	2	109394	1.828250e-05	0	8	208036	3.845490e-05	0	8	236858	3.377550e-05	0	0	7162	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	0	42764	0.000000e+00	0	2	15690	1.274700e-04	0	2	15690	1.274700e-04	0	0	16214	0.000000e+00	0	1	30512	3.277400e-05	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	0	89488	0.000000e+00	0	6	30604	1.960530e-04	0	6	30604	1.960530e-04	0	0	14900	0.000000e+00	0	1	34248	2.919880e-05	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	0	102678	0.000000e+00	0	6	30522	1.965800e-04	0	6	30522	1.965800e-04	0	.	41	1613930	2.540380e-05	0	18	91086	1.976150e-04	0	1	74940	1.334400e-05	0	0	912	0.000000e+00	0	2	60006	3.333000e-05	0	0	29604	0.000000e+00	0	0	44902	0.000000e+00	0	0	64042	0.000000e+00	0	1	6084	1.643660e-04	0	15	1179868	1.271330e-05	0	18	91086	1.976150e-04	0	0	15752	0	0	122	0	0	112	0	0	3796	0	0	146	0	0	610	0	0	56	0	0	98	0	1	2824	3.541076487252125E-4	0	3918	0	0	168	0	1	23516	4.252423881612519E-5	not_provided|Autoinflammatory_syndrome|Mevalonic_aciduria|Hyperimmunoglobulin_D_with_periodic_fever|Porokeratosis_3,_disseminated_superficial_actinic_type	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.109586107A>G	ClinGen:CA149858	C3661900|C3890737|C1959626|C0398691|C1867981	610377|260920|175900	93665|29|343	GHMP kinase N-terminal domain	Asn	Asp	95.45	0.012738853503184714																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			95.45	Polar/Neutral	Asparagine		Mevalonate kinase								0.0172		-3.5								 N205-T209 (PAE:  1.0)	N205-N186 (PDBs: 2R3V), N205-T209 (PDBs: 2R3V)	 N205-F190 (PAE:  1.0), N205-E193 (PAE: 1.5), N205-A147 (PAE: 1.0), N205-T209 (PAE: 1.0)	N205-F190 (PDBs: 2R3V), N205-E193 (PDBs: 2R3V), N205-A147 (PDBs: 2R3V), N205-T209 (PDBs: 2R3V)							132									-70.2		Pocket 5: Mean pLDDT: 91.52, Volume: 453.4 Å³, Druggability score: 0.02		-35.3						H (helix)	H (α-helix)	Helix											95.45	1.2738854	>90	<10	260920;260920;610377;175900;610377	autosomal recessive	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; HYPER-IgD SYNDROME; MEVALONIC ACIDURIA; POROKERATOSIS 3, MULTIPLE TYPES; MEVALONIC ACIDURIA	false	0.6340408680131157	0.6372389211954266	false	false	false
NR0B1	NR0B1_Arg267Pro	B_15-16	-1.3377922934499746	0.2227906121233407	0.3037330971845687	-4.242161158410579	0.003830057837514706	0.0074214953873701014	2025_03_Batch_15-16	true	true	false	false	false	false	true	true	false	false	false	false	0.999201488756112	0.9922741080847921	0.7357669307493819	0.7050765119481139	0.6758517309979946	0.7729815717000186	0.6681091744373228	0.5664144426777855	0.6294735779822324	0.6161366053226385	0.9899064811659312	0.9993530890818155	0.8778539689627145	0.7852890193182035	0.7806794459139956	0.8553972561761253	0.9946417350036529	0.9990498884304085	NR0B1	Arg267Pro	NC_000023.11:30308564:C:G	800G>C	23	30308564	C	G	X	ENSG00000169297	7215	12825	CCSBVarC001146	ALE00001146	ENSP00000368253.4	RC4	RC4_Mut_GDEh1023	B03	GDEhDisVCh_40038	G11	2	RC4_Mut_GDDh1023	B03	VUSN2Hmut_GDN2h_10	C09	VUSMutpDEST2_06	B02	VUSmut_GDEh13	A05	1.0	1.0	1.0	6.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	N	Y	Y	Y	25991.0	single nucleotide variant	NM_000475.5(NR0B1):c.800G>C (p.Arg267Pro)	190.0	NR0B1	HGNC:7960	Pathogenic/Likely pathogenic	1.0	Sep 02, 2021	104894888.0	-	RCV000011699|RCV001851797	MONDO:MONDO:0010264,MedGen:C0342482,OMIM:300200,Orphanet:95702|MONDO:MONDO:0010226,MedGen:C1848296,OMIM:300018;MONDO:MONDO:0010264,MedGen:C0342482,OMIM:300200,Orphanet:95702	Congenital adrenal hypoplasia, X-linked|46,XY sex reversal 2;Congenital adrenal hypoplasia, X-linked	germline;maternal	germline	GRCh38	NC_000023.11	X	30308564.0	30308564.0	Xp21.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA255621,UniProtKB:P51843#VAR_004738,OMIM:300473.0004	3.0	10952.0	30308564.0	C	G	-	-	-	-	-	-	800G>C 	Arg267Pro	NM_000475.5	2.0	Pathogenic	Likely pathogenic	10952	X	30308564.0	C	G	R	P	rs104894888	X	30326681	X	30236602	267	NR0B1	ENSG00000169297	ENST00000378970	ENSP00000368253	P51843	NR0B1_HUMAN	c.800G>C	p.Arg267Pro	c.800G>C	p.Arg267Pro	principal1	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.004	0.65576	D	0.015	0.61973	D	1.0	0.90580	D	0.995	0.83178	D	0.75	0.84994	A	simple_aae	25.0	75.0	2.67	0.77975	M	-3.54	0.68685	D	0.853	0.84884	1.0876	0.99144	D	0.9263	0.97560	D	9	0.98024595	0.97965	D	0.764075	0.98126	D	0.941	0.98743	0.832	0.94073	P51843	R267P	Gain of methylation at K270 (P = 0.0395)| Loss of ubiquitination at K270 (P = 0.0957)| Loss of stability (P = 0.1389)| Gain of catalytic residue at F268 (P = 0.1442)| Loss of MoRF binding (P = 0.1457)	0.998478724158	0.99843	0.8506813067819342	0.84939	1.84979452733	0.92234	0.45600771904	0.32723	T	0.967756	0.99625	D	0.608926	0.97989	D	0.636903	0.97958	D	0.985702037811279	0.76450	D	0.907509	0.67186	D	0.9779302	0.98929	0.96671325	0.99303	0.9771513	0.98866	0.9656007	0.99249	-12.281	0.86228	D	0.9539	0.87307	P	0.994135998416948	0.90458	0.97008574	0.94663	0.893	0.94305	.	.	.	.	.	.	4.400158	0.68045	25.2	0.99761562952681793	0.85104	.	.	.	.	.	.	.	.	.	5.47	4.61	0.56673	1.13	0.30383	1.11	0.30862	2.067000	0.30508	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.999	0.91597	832	0.38867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Congenital_adrenal_hypoplasia,_X-linked|46,XY_sex_reversal_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.30308564C>G	ClinGen:CA255621|OMIM:300473.0004|UniProtKB:P51843#VAR_004738	C0342482|C1848296	300200|300018	95702	Nuclear hormone receptor, ligand-binding domain|Nuclear hormone receptor, ligand-binding domain|Nuclear hormone receptor, ligand-binding domain	Arg	Pro	87.54	0.3629032258064516																																																																																																																																																																																																																																																																																																																																																																																																																																																																													90			87.54	Positively-charged	Arginine		Nuclear receptor subfamily 0 group B member 1							NR LBD	0.886		-4.5								 R267-Y271 (PAE:  1.0), R267-L263 (PAE: 1.0), R267-I470 (PAE: 8.5)		 R267-Y271 (PAE:  1.0), R267-L263 (PAE: 1.0)								175									-59.9		Pocket 1: Mean pLDDT: 61.47, Volume: 721.82 Å³, Druggability score: 0.89		-47.9				dbSNP: rs104894888; Variant type: LP/P; AA change: Arg267Pro; PTM type: Ubiquitylation; PTM morphology: TLR*FVkYLPCF; Var class: II		H (helix)	H (α-helix)												87.54	36.290325	70-90	10-90	300200;300018;300200	x-linked recessive	OMIM	Rare genetic gynecological and obstetrical diseases; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic urogenital disease; Rare genetic endocrine disease; Genetic infertility; Rare genetic skin disease	7	ADRENAL HYPOPLASIA, CONGENITAL; 46,XY SEX REVERSAL 2; ADRENAL HYPOPLASIA, CONGENITAL	false	0.9922741080847921	0.999201488756112	true	true	true
PNPO	PNPO_Arg95Cys	B_7-8	-2.761608163935253	0.03278420719430722	0.06711450776112196	-6.679205235596191	0.0005455950172471065	0.0014788284440892768	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.9488426414595527	0.964093416326257	0.5479023769879006	0.5287718733481219	0.5100772656247793	0.5313627921815003	0.5617401124868495	0.5492148494795085	0.5673379813703471	0.5747799595589687	0.978279277702851	0.966146598099959	0.500985471876151	0.47093968177005013	0.49020576532589666	0.5210247944168326	0.9499075549496631	0.9315386848191464	PNPO	Arg95Cys	NC_000017.11:47944635:C:T	283C>T	17	47944635	C	T	17	ENSG00000108439	4515	8609	CCSBVarC000659	ALE00000659	ENSP00000493302.2	RC4	RC4_Mut_GDEh1008	F03	GDEhDisVCh_40042	B01	2	RC4_Mut_GDDh1008	F03	NULL	NULL	VUSMutpDEST2_04	B04	VUSmut_GDEh12	F08	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	1286809.0	single nucleotide variant	NM_018129.4(PNPO):c.283C>T (p.Arg95Cys)	55163.0	PNPO	HGNC:30260	Pathogenic/Likely pathogenic	1.0	May 16, 2023	1483600034.0	-	RCV001724755	MONDO:MONDO:0012407,MedGen:C1864723,OMIM:610090,Orphanet:79096	Pyridoxal phosphate-responsive seizures	germline;unknown	germline	GRCh38	NC_000017.11	17	47944635.0	47944635.0	17q21.32	criteria provided, multiple submitters, no conflicts	2.0	-	N	-	2.0	1297019.0	47944635.0	C	T	-	-	-	-	-	-	283C>T 	Arg95Cys	NM_018129.4	2.0	Pathogenic	Likely pathogenic	1297019	17	47944635.0	C	T	R	C	rs1483600034	17	46022001	17	43377000	95	PNPO	ENSG00000108439	ENST00000642017	ENSP00000493302	Q9NVS9	PNPO_HUMAN	c.283C>T	p.Arg95Cys	c.283C>T	p.Arg95Cys	principal1	Y	.	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.83643	.	1.0	0.90580	D	0.996	0.84488	D	.	0.99291	.	.	.	.	4.705	0.99476	H	.	0.95681	.	.	0.99617	1.0075	0.97307	D	0.8480	0.94919	D	10	0.9906213	0.99565	D	0.257628	0.89351	D	.	0.98414	0.965	0.99652	Q9NVS9	R95C	Loss of MoRF binding (P = 0.0191)| Gain of ubiquitination at K91 (P = 0.0342)| Loss of disorder (P = 0.0486)| Gain of methylation at K100 (P = 0.1009)| Loss of phosphorylation at S93 (P = 0.1076)	.	0.98489	0.9170728134909206	0.91630	.	0.88466	0.66065621376	0.61442	T	0.552725	0.84746	D	0.331539	0.85160	D	0.407584	0.92297	D	0.999881505966187	0.99520	D	0.998715	0.99911	D	0.95602536	0.96827	0.81983	0.89392	0.9542811	0.96649	0.82065666	0.89446	-14.746	0.95239	D	0.8758	0.81175	P	0.982169844806744	0.85857	0.23796444	0.74691	0.935	0.96837	.	.	.	.	.	.	5.958888	0.94192	33.0	0.99942670463356931	0.99848	0.942646	0.94730	D	1.01964323972613	0.96297	14.55138	0.884086798395945	0.94811	13.08731	5.22	5.22	0.72246	.	.	7.6	0.82063	7.538000	0.60097	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.63	0.322	523	0.74166	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109406	9.140270e-06	0	1	208134	4.804600e-06	0	1	236956	4.220190e-06	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	9046	1.105460e-04	0	0	16218	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	1	13416	7.453790e-05	0	0	16734	0.000000e+00	0	0	89558	0.000000e+00	0	0	30608	0.000000e+00	0	1	13416	7.453790e-05	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	0	21632	0.000000e+00	0	0	102754	0.000000e+00	0	0	30526	0.000000e+00	0	1	17692	5.652270e-05	0	.	4	1614012	2.478300e-06	0	1	44892	2.227570e-05	0	0	75034	0.000000e+00	0	0	912	0.000000e+00	0	0	60014	0.000000e+00	0	0	29604	0.000000e+00	0	1	44892	2.227570e-05	0	0	64038	0.000000e+00	0	0	6036	0.000000e+00	0	1	1179908	8.475240e-07	0	2	91070	2.196110e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pyridoxal_phosphate-responsive_seizures	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.47944635C>T	.	C1864723	610090	79096	Pyridoxamine 5'-phosphate oxidase, putative	Arg	Cys	97.78	0.24193548387096775																																																																																																																																																																																																																																																																																																																																																																																																																																																																													60			97.78	Positively-charged	Arginine	FMN	Pyridoxine-5'-phosphate oxidase										-4.5								 R95-T111 (PAE:  1.0), R95-L83 (PAE: 1.0), R95-Q174 (PAE: 2.5)	R95-L83 (PDBs: 1NRG, 8QYT, 8QYW), R95-T85 (PDBs: 8QYW)	 R95-L83 (PAE:  1.0)	R95-L83 (PDBs: 1NRG, 8QYT, 8QYW), R95-C82 (PDBs: 8QYW)							175									-157.3				158.4						B (undefined)	E (parallel sheets)	Beta strand											97.78	24.193548	>90	10-90	610090	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	false	0.964093416326257	0.9488426414595527	true	true	false
BRAF	BRAF_Glu501Lys	B_13-14	0.6633972900818994	0.528310912774345	0.6083676372396226	-1.1836032662476619	0.2752017617119537	0.3260137073863364	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7667076606637826	0.8039993338619538	0.47441156467612755	0.7196727647696026	0.7391232448833494	0.5728659656123132	0.5813336917040152	0.6891264661166843	0.6929356476321527	0.4654791976283564	0.7891425378074841	0.7622019150260474	0.5643982395206113	0.7891200236500145	0.7464098819070525	0.4833439317238988	0.8188561299164234	0.7712134063015177	BRAF	Glu501Lys	NC_000007.14:140778007:C:T	1501G>A	7	140778007	C	T	7	ENSG00000157764	71969	0	CCSBVarC003167	ALE00003167	ENSP00000493543.1	CEGS2	CegsMutGDEh1019	E10	GDEhDisVCh_40058	A08	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	5.0	0.0		0.0			0.0			0.0			N	N	N	N	N	29016.0	single nucleotide variant	NM_004333.6(BRAF):c.1501G>A (p.Glu501Lys)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Oct 22, 2023	180177038.0	-	RCV000015011|RCV000033315|RCV000207513|RCV000844616|RCV004018630	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:CN230736	Cardiofaciocutaneous syndrome 1|RASopathy|not provided|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000007.14	7	140778007.0	140778007.0	7q34	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA273130,UniProtKB:P15056#VAR_026118,OMIM:164757.0017	3.0	13977.0	140778007.0	C	T	-	-	-	-	-	-	1501G>A 	Glu501Lys	NM_004333.6	2.0	Pathogenic	Likely pathogenic	13977	7	140778007.0	C	T	E	K	rs180177038	7	140477807	7	140124276	501	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1501G>A	p.Glu501Lys	c.1501G>A	p.Glu501Lys	principal4	Y	.	YES	Select	-	GAA	1	0	C	C/C	C/C	C/C	C/C	.	.	.	.	.	.	1.0	0.90580	D	1.0	0.97365	D	.	0.96253	.	.	.	.	2.92	0.84163	M	.	.	.	.	.	0.5272	0.90891	D	0.6189	0.86511	D	9	0.98748183	0.99108	D	0.412682	0.93618	D	.	0.99740	0.984	0.99843	P15056	E501K	Gain of MoRF binding (P = 0.0045)| Gain of methylation at E501 (P = 0.0827)| Loss of ubiquitination at K499 (P = 0.1356)| Loss of stability (P = 0.2896)| Gain of catalytic residue at K499 (P = 0.3037)	.	0.99090	.	0.99420	.	0.95797	0.938608407974	0.99402	D	0.958012	0.99434	D	0.554969	0.95963	D	0.559398	0.95900	D	0.99942809343338	0.97327	D	0.959604	0.84795	D	0.9500797	0.96215	0.8697107	0.92749	0.96031433	0.97269	0.83118904	0.90135	-12.836	0.88701	D	0.9999	0.99795	P	0.999976740337915	0.99427	0.99923956	0.99238	0.995	0.99826	.	.	.	.	.	.	5.637157	0.92725	32.0	0.99903041562417938	0.97428	0.904129	0.85351	D	0.639137191857678	0.75537	6.346777	0.630565185681596	0.77043	6.628201	4.96	4.96	0.65108	6.58	0.99812	7.869	0.85551	7.641000	0.63257	0.545	0.25635	1.0	0.71675	1.000000	0.68239	0.999	0.91597	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Noonan_syndrome|Cardio-facio-cutaneous_syndrome|Cardiovascular_phenotype|not_provided|Cardiofaciocutaneous_syndrome_1|RASopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778007C>T	ClinGen:CA273130|OMIM:164757.0017|UniProtKB:P15056#VAR_026118	C0028326|C1275081|CN230736|C3661900|CN029449|C5555857	PS163950|PS115150|115150	648|1340|1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Glu	Lys	70.99	0.04639175257731959																																																																																																	2.038																																																																																																																																																																																																																																																																																																																																																																												9			70.99	Negatively-charged	Glutamic Acid		Serine/threonine-protein kinase B-raf							Protein kinase			-3.5								 E501-T599 (PAE:  7.0), E501-L505 (PAE: 1.5), E501-A497 (PAE: 1.0)	E501-K601 (PDBs: 5CSX), E501-K483 (PDBs: 6P3D, 5VAL, 6B8U, 6N0Q), E501-L505 (PDBs: 6P3D, 3SKC, 4E4X, 4MBJ, 8DGT), E501-A497 (PDBs: 6P3D, 3II5, 3PSB, 3Q4C, 3Q96, 4DBN, 4E26, 4FC0, 4G9C, 4H58, 4KSP, 4KSQ, 4PP7, 5CSW, 5CT7, 5HID, 5VAM, 6CAD, 6N0P, 6V2U, 8C7X, 8C7Y, 8F7O, 8F7P, 8QQG, 4MNE, 6Q0K, 6U2H, 6UAN, 6XAG, 7MFD, 7MFE, 7MFF, 8DGT), E501-F595 (PDBs: 2FB8, 3D4Q, 3PPJ, 3PPK, 3PRF, 3PRI, 3PSD, 7SHV), E501-A598 (PDBs: 3TV4, 3TV6, 6PP9, 6U2G, 6V2W, 7M0V, 7M0X, 7M0Y, 7M0Z), E501-V600 (PDBs: 4EHE), E501-L597 (PDBs: 5FD2, 6NYB, 7M0T, 7M0U, 7M0W, 8DGS), E501-R575 (PDBs: 5HIE), E501-R603 (PDBs: 7P3V)	 E501-T599 (PAE:  7.0), E501-A497 (PAE: 1.0), E501-L597 (PAE: 7.0), E501-L505 (PAE: 1.5), E501-V600 (PAE: 7.5)	E501-A497 (PDBs: 5CSX, 6P3D, 3II5, 3Q96, 4DBN, 4FC0, 4G9C, 4KSP, 4KSQ, 5CSW, 5CT7, 5HID, 5HIE, 5VAL, 5VAM, 6B8U, 6CAD, 6N0P, 6N0Q, 6V2U, 8C7X, 8C7Y, 8F7O, 8F7P, 8QQG, 6Q0K, 7MFE, 8DGT), E501-L505 (PDBs: 6P3D, 8DGT), E501-G596 (PDBs: 2FB8, 3D4Q, 3PPJ, 3PPK, 3PSB, 3PSD, 3Q4C, 4E26, 4H58, 7SHV, 4MNE, 6U2H, 6UAN, 6XAG, 7MFF), E501-F595 (PDBs: 3PRF, 3PRI), E501-L597 (PDBs: 3SKC, 4E4X, 4MBJ, 6NYB, 6PP9, 6V2W, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 8DGS, 8DGT), E501-A598 (PDBs: 3TV4, 3TV6, 4EHE, 5FD2, 6U2G, 7MFD), E501-V600 (PDBs: 4PP7), E501-R603 (PDBs: 7P3V)		E501-K483 (PDBs: 8C7X, 8C7Y, 8F7P, 8QQG, 4MNE, 6U2H, 6XAG)					146									-74.9				-38.7						H (helix)	H (α-helix)	Helix											70.99	4.639175	70-90	<10	115150	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1	false	0.8039993338619538	0.7667076606637826	false	false	false
SDHD	SDHD_Leu107Pro	B_13-14	0.2849529271708783	1.0	1.0	1.6003300038664925	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7972952411860934	0.835159195132962	0.7837812721839763	0.8451719520231871	0.8096108200097609	0.8309201648031649	0.8307299060760582	0.8174161551634186	0.8806504527246316	0.7850250364322242	0.8479001889288709	0.7943977330291935	0.8311104235302715	0.8018054848561033	0.8096934513217426	0.7825375079357285	0.822418201337053	0.8001927493429932	SDHD	Leu107Pro	NC_000011.10:112094810:T:C	320T>C	11	112094810	T	C	11	ENSG00000204370	6363	0	CCSBVarC023335	ALE00035393	ENSP00000364699.3																																	1785214.0	single nucleotide variant	NM_003002.4(SDHD):c.320T>C (p.Leu107Pro)	6392.0	SDHD	HGNC:10683	Likely pathogenic	1.0	May 30, 2024	-1.0	-	RCV002324587	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000011.10	11	112094810.0	112094810.0	11q23.1	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	-	2.0	1728924.0	112094810.0	T	C	-	-	-	-	-	-	320T>C 	Leu107Pro	NM_003002.4	1.0	Pathogenic	Likely pathogenic	1728924	11	112094810.0	T	C	L	P	.	11	111965534	11	111470744	107	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.320T>C	p.Leu107Pro	c.320T>C	p.Leu107Pro	principal1	Y	1	YES	Select	+	CTT	2	0	T	./.	./.	./.	./.	0.002	0.72322	D	0.006	0.74454	D	0.989	0.62839	D	0.926	0.66089	D	0.96	0.95575	D	simple_aae	4.0	96.0	.	.	.	-5.05	0.82724	D	0.769	0.81497	1.0953	0.99459	D	0.9673	0.98959	D	10	0.91400754	0.90660	D	0.636512	0.96886	D	0.920	0.97963	0.667	0.80417	O14521	L107P	Loss of stability (P = 0.0278)| Gain of sheet (P = 0.039)| Loss of helix (P = 0.079)| Loss of catalytic residue at L107 (P = 0.0817)| Gain of loop (P = 0.0851)	0.93826696464	0.93714	0.9866521081126458	0.98654	0.939674812069	0.72002	0.464732289314	0.33914	T	0.966942	0.99610	D	0.510562	0.94567	D	0.49561	0.94487	D	0.983124061519632	0.74730	D	0.839116	0.51220	T	0.9550924	0.96731	0.9385074	0.97635	0.9550924	0.96731	0.9385074	0.97635	-14.207	0.94089	D	0.8325	0.78811	P	0.995669802072404	0.91503	0.99935895	0.99325	0.994	0.99793	.	.	.	.	.	.	4.675112	0.74806	26.2	0.99891369030107691	0.96515	0.966134	0.98849	D	0.781789244315126	0.84870	8.434356	0.709516226177353	0.83010	7.934285	4.53	4.53	0.54956	.	.	7.682	0.8343	7.854000	0.71149	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.999	0.91597	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome	criteria_provided,_single_submitter	NC_000011.10:g.112094810T>C	.	C0027672	.	140162	.	Leu	Pro	98.67	0.5182926829268293																																																																																																																																																																																																																																																																																																																																																																																																																																																																													85			98.67	Aliphatic	Leucine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0134		3.8				D:L107-C:S79 (PDBs: 8GS8)				 L107-G103 (PAE:  1.0), L107-V111 (PAE: 1.0)	L107-G103 (PDBs: 8GS8), L107-V111 (PDBs: 8GS8)	 L107-G103 (PAE:  1.0), L107-V111 (PAE: 1.0)	L107-G103 (PDBs: 8GS8), L107-L128 (PDBs: 8GS8), L107-V111 (PDBs: 8GS8)							131									-64.2		Pocket 3: Mean pLDDT: 99.91, Volume: 203.66 Å³, Druggability score: 0.01		-30.7						H (helix)	H (α-helix)	Helix								Helical			98.67	51.829266	>90	10-90		unknown		Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7		false	0.835159195132962	0.7972952411860934	false	false	false
FANCC	FANCC_Leu554Pro	B_13-14	-0.3335628604146983	0.7484786135159357	0.7991023766436206	-6.197087675148789	0.00044651860288579437	0.0012703281182874925	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9523410138327031	0.9565693594900087	0.7159880341700251	0.9101660374191081	0.8722109316942788	0.8254629790352918	0.6919117045090372	0.832300504586082	0.8585212078971154	0.5291285716109787	0.9442301408873844	0.9439886982745775	0.9590142535615463	0.9121213588024757	0.9618108669411007	0.9028474967290715	0.9689085780926328	0.9606933293908287	FANCC	Leu554Pro	NC_000009.12:95101723:A:G	1661T>C	9	95101723	A	G	9	ENSG00000158169	7699	0	CCSBVarC001231	ALE00001231	ENSP00000289081.3	RC4	RC4_Mut_GDEh1009	D09	GDEhDisVCh_40044	G07	2	RC4_Mut_GDDh1009	D09	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	27082.0	single nucleotide variant	NM_000136.3(FANCC):c.1661T>C (p.Leu554Pro)	2176.0	FANCC	HGNC:3584	Pathogenic/Likely pathogenic	1.0	Dec 17, 2023	104886458.0	-	RCV000012823|RCV001221431|RCV000058925|RCV002399319|RCV003421917	MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	Fanconi anemia complementation group C|Fanconi anemia|not provided|Hereditary cancer-predisposing syndrome|FANCC-related disorder	germline;unknown	germline	GRCh38	NC_000009.12	9	95101723.0	95101723.0	9q22.32	criteria provided, multiple submitters, no conflicts	14.0	-	N	ClinGen:CA284829,UniProtKB:Q00597#VAR_005233,OMIM:613899.0001	3.0	12043.0	95101723.0	A	G	-	-	-	-	-	-	1661T>C 	Leu554Pro	NM_000136.3	2.0	Pathogenic	Likely pathogenic	12043	9	95101723.0	A	G	L	P	rs104886458	9	97864005	9	96903826	554	FANCC	ENSG00000158169	ENST00000289081	ENSP00000289081	Q00597	FANCC_HUMAN	c.1661T>C	p.Leu554Pro	c.1661T>C	p.Leu554Pro	principal1	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.3	0.55288	A	simple_aae	70.0	30.0	2.215	0.62356	M	-3.85	0.72390	D	0.896	0.89567	-0.0283	0.81584	T	0.3880	0.74183	T	9	0.9469856	0.93958	D	0.055743	0.66224	D	0.617	0.85019	.	.	.	.	.	0.900282806353	0.89853	0.8253407305087601	0.82387	0.413463600646	0.41766	0.590069651604	0.51437	T	0.473774	0.80403	T	0.271784	0.80457	D	0.216268	0.83872	D	0.949487268924713	0.62897	D	.	0.12239	.	0.90733176	0.91931	0.87151235	0.92876	0.87194806	0.88866	0.8482753	0.91276	-7.71	0.59149	D	0.6917	0.72637	LP	0.921516655278869	0.77669	0.95718740	0.93787	0.731	0.85095	.	.	.	.	.	.	4.178114	0.62948	24.5	0.99839825199499255	0.92063	0.586505	0.58304	D	0.440542923641051	0.63480	4.605117	0.331677567903355	0.57182	3.906634	4.76	4.76	0.60139	.	.	4.529	0.60386	10.861000	0.84000	0.756	0.943	0.99	0.37076	1.000000	0.68239	0.016	0.10745	167	0.93511	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	2	109336	1.829220e-05	0	2	207912	9.619450e-06	0	3	236760	1.267110e-05	0	0	7156	0.000000e+00	0	0	17096	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13380	0.000000e+00	0	2	42740	4.679460e-05	0	0	15684	0.000000e+00	0	2	42740	4.679460e-05	0	0	16190	0.000000e+00	0	0	30492	0.000000e+00	0	0	6200	0.000000e+00	0	0	13412	0.000000e+00	0	0	16720	0.000000e+00	0	2	89440	2.236140e-05	0	0	30596	0.000000e+00	0	2	89440	2.236140e-05	0	0	14880	0.000000e+00	0	0	34228	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21610	0.000000e+00	0	3	102652	2.922500e-05	0	0	30514	0.000000e+00	0	3	102652	2.922500e-05	0	.	24	1613908	1.487070e-05	0	24	1180000	2.033900e-05	0	0	74904	0.000000e+00	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29608	0.000000e+00	0	0	44874	0.000000e+00	0	0	63982	0.000000e+00	0	0	6074	0.000000e+00	0	24	1180000	2.033900e-05	0	0	91068	0.000000e+00	0	4	92818	4.3095089314572604E-5	0	168	0	0	2680	0	0	4020	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	0	4188	0	0	3306	0	4	104018	3.845488280874464E-5	Fanconi_anemia_complementation_group_C|not_provided|Hereditary_cancer-predisposing_syndrome|Fanconi_anemia|FANCC-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.95101723A>G	ClinGen:CA284829|Genetic_Testing_Registry_(GTR):GTR000603994|OMIM:613899.0001|UniProtKB:Q00597#VAR_005233	C3468041|C3661900|C0027672|C0015625	227645|PS227650	84|140162|84	.	Leu	Pro	88.01	0.018292682926829267																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3			88.01	Aliphatic	Leucine		Fanconi anemia group C protein										3.8								 L554-L550 (PAE:  1.0)		 L554-L550 (PAE:  1.0), L554-V558 (PAE: 2.5)								131									-67.3				-34.1						H (helix)	H (α-helix)												88.01	1.8292682	70-90	<10	227645	autosomal recessive	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Inherited cancer-predisposing syndrome	6	FANCONI ANEMIA, COMPLEMENTATION GROUP C	false	0.9565693594900087	0.9523410138327031	false	false	false
BRAF	BRAF_Glu501Val	B_13-14	0.06923700484882474	0.9467373185822208	0.9593486007786629	0.613589922225558	0.5588895104969295	0.6108173030148097	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6315362409966154	0.6668271454254869	0.5403108380817687	0.5468442268583362	0.4982887320330648	0.5422792151222735	0.6719453519442279	0.46131420647265337	0.5522409284582703	0.6727179698326173	0.6792922334518262	0.6583188940650601	0.41261307830031907	0.5352632575934761	0.5414475252584021	0.4079037063309201	0.6543620573991477	0.6047535879281709	BRAF	Glu501Val	NC_000007.14:140778006:T:A	1502A>T	7	140778006	T	A	7	ENSG00000157764	71969	0	CCSBVarC003169	ALE00003169	ENSP00000493543.1	CEGS2	CegsMutGDEh1028	A12	GDEhDisVCh_40058	G10	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	48844.0	single nucleotide variant	NM_004333.6(BRAF):c.1502A>T (p.Glu501Val)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	May 18, 2022	180177039.0	-	RCV000037924|RCV001852671|RCV001775071|RCV000033318	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900	Cardio-facio-cutaneous syndrome|RASopathy|Cardiofaciocutaneous syndrome 1|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	140778006.0	140778006.0	7q34	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA280013	2.0	40374.0	140778006.0	T	A	-	-	-	-	-	-	1502A>T 	Glu501Val	NM_004333.6	2.0	Pathogenic	Likely pathogenic	40374	7	140778006.0	T	A	E	V	rs180177039	7	140477806	7	140124275	501	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1502A>T	p.Glu501Val	c.1502A>T	p.Glu501Val	principal4	Y	.	YES	Select	-	GAA	2	0	T	T/T	T/T	T/T	T/T	.	.	.	.	.	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97016	.	.	.	.	3.175	0.88626	M	.	.	.	.	.	0.4949	0.90439	D	0.6087	0.86082	D	10	0.9891212	0.99356	D	0.575626	0.96172	D	.	0.99995	0.984	0.99843	P15056	E501V	Gain of MoRF binding (P = 0.016)| Gain of methylation at K499 (P = 0.0368)| Gain of catalytic residue at Q496 (P = 0.0688)| Loss of disorder (P = 0.1462)| Loss of ubiquitination at K499 (P = 0.255)	.	0.99555	.	0.97864	.	0.96099	0.905288159847	0.97002	D	0.959346	0.99462	D	0.583525	0.97036	D	0.600417	0.96988	D	0.999093770980835	0.96125	D	0.984901	0.94804	D	0.970521	0.98280	0.8958858	0.94611	0.9600396	0.97241	0.9024512	0.95083	-13.783	0.92345	D	0.9998	0.99795	P	0.999948727464199	0.99079	0.99934202	0.99310	1	0.99985	.	.	.	.	.	.	5.908522	0.94033	33.0	0.99046473600024798	0.51225	0.901308	0.84728	D	0.603356423307565	0.73242	5.957777	0.588108124975153	0.73943	6.077588	4.96	4.96	0.65108	.	.	7.981	0.87756	7.857000	0.71293	0.605	0.46302	1.0	0.71675	1.000000	0.68239	0.999	0.91597	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Cardio-facio-cutaneous_syndrome|not_provided|RASopathy|Cardiofaciocutaneous_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778006T>A	ClinGen:CA280013	C1275081|C3661900|C5555857|CN029449	PS115150|115150	1340|536391|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Glu	Val	70.99	0.04639175257731959																																																																																																	2.038																																																																																																																																																																																																																																																																																																																																																																												9			70.99	Negatively-charged	Glutamic Acid		Serine/threonine-protein kinase B-raf							Protein kinase			-3.5								 E501-T599 (PAE:  7.0), E501-L505 (PAE: 1.5), E501-A497 (PAE: 1.0)	E501-K601 (PDBs: 5CSX), E501-K483 (PDBs: 6P3D, 5VAL, 6B8U, 6N0Q), E501-L505 (PDBs: 6P3D, 3SKC, 4E4X, 4MBJ, 8DGT), E501-A497 (PDBs: 6P3D, 3II5, 3PSB, 3Q4C, 3Q96, 4DBN, 4E26, 4FC0, 4G9C, 4H58, 4KSP, 4KSQ, 4PP7, 5CSW, 5CT7, 5HID, 5VAM, 6CAD, 6N0P, 6V2U, 8C7X, 8C7Y, 8F7O, 8F7P, 8QQG, 4MNE, 6Q0K, 6U2H, 6UAN, 6XAG, 7MFD, 7MFE, 7MFF, 8DGT), E501-F595 (PDBs: 2FB8, 3D4Q, 3PPJ, 3PPK, 3PRF, 3PRI, 3PSD, 7SHV), E501-A598 (PDBs: 3TV4, 3TV6, 6PP9, 6U2G, 6V2W, 7M0V, 7M0X, 7M0Y, 7M0Z), E501-V600 (PDBs: 4EHE), E501-L597 (PDBs: 5FD2, 6NYB, 7M0T, 7M0U, 7M0W, 8DGS), E501-R575 (PDBs: 5HIE), E501-R603 (PDBs: 7P3V)	 E501-T599 (PAE:  7.0), E501-A497 (PAE: 1.0), E501-L597 (PAE: 7.0), E501-L505 (PAE: 1.5), E501-V600 (PAE: 7.5)	E501-A497 (PDBs: 5CSX, 6P3D, 3II5, 3Q96, 4DBN, 4FC0, 4G9C, 4KSP, 4KSQ, 5CSW, 5CT7, 5HID, 5HIE, 5VAL, 5VAM, 6B8U, 6CAD, 6N0P, 6N0Q, 6V2U, 8C7X, 8C7Y, 8F7O, 8F7P, 8QQG, 6Q0K, 7MFE, 8DGT), E501-L505 (PDBs: 6P3D, 8DGT), E501-G596 (PDBs: 2FB8, 3D4Q, 3PPJ, 3PPK, 3PSB, 3PSD, 3Q4C, 4E26, 4H58, 7SHV, 4MNE, 6U2H, 6UAN, 6XAG, 7MFF), E501-F595 (PDBs: 3PRF, 3PRI), E501-L597 (PDBs: 3SKC, 4E4X, 4MBJ, 6NYB, 6PP9, 6V2W, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 8DGS, 8DGT), E501-A598 (PDBs: 3TV4, 3TV6, 4EHE, 5FD2, 6U2G, 7MFD), E501-V600 (PDBs: 4PP7), E501-R603 (PDBs: 7P3V)		E501-K483 (PDBs: 8C7X, 8C7Y, 8F7P, 8QQG, 4MNE, 6U2H, 6XAG)					146									-74.9				-38.7						H (helix)	H (α-helix)	Helix											70.99	4.639175	70-90	<10	115150	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1	false	0.6668271454254869	0.6315362409966154	false	false	false
BRCA1	BRCA1_Thr587Arg	B_13-14	-0.4548873787721197	0.6629621326061451	0.7319408516056284	11.188454921727086	0.000010158429901823806	0.00007639638881084706	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	false	false	false	false	0.8614063216406985	0.8931597973787204	0.8234136488599757	0.9269428259228654	0.898206343096644	0.9196812433587133	0.9129942293783451	0.9124516587061154	0.9207549524938204	0.8147951652720694	0.8850453553488353	0.8423253697318717	0.9263682573390815	0.8839610274871725	0.9331306993519102	0.8320321324478821	0.9012742394086055	0.8804872735495254	BRCA1	Thr587Arg	NC_000017.11:43067610:G:C	1760C>G	17	43067610	G	C	17	ENSG00000012048	14613	0	CCSBVarC003304	ALE00003304	ENSP00000417148.1	CEGS2	CegsMutGDEh1003	H05	GDEhDisVCh_40059	C01	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	70040.0	single nucleotide variant	NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg)	672.0	BRCA1	HGNC:1100	Likely pathogenic	1.0	Oct 04, 2021	80357034.0	-	RCV000577017|RCV001077998|RCV002257395	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067610.0	43067610.0	17q21.31	criteria provided, multiple submitters, no conflicts	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003189	3.0	55373.0	43067610.0	G	C	-	-	-	-	-	-	5072C>G 	Thr1691Arg	NM_007294.4	2.0	Pathogenic	Likely pathogenic	55373	17	43067610.0	G	C	T	R	rs80357034	17	41219627	17	38473153	1691	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5072C>G	p.Thr1691Arg	principal2	Y	1	.	.	-	ACA	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.585	0.90580	P	0.218	0.92348	B	.	.	.	.	.	.	3.175	0.88626	M	.	0.81626	.	.	0.90585	0.5201	0.90791	D	0.6944	0.89429	D	10	.	0.86953	.	0.786117	0.98314	D	.	0.94900	.	.	.	.	.	.	0.94962	.	0.79901	.	0.15475	0.765162229538	0.76658	T	0.292953	0.76109	T	0.409641	0.90394	D	0.350645	0.90276	D	0.983474791049957	0.74950	D	0.952305	0.85727	D	0.955418	0.96765	0.8308187	0.90111	0.950228	0.96231	0.7571084	0.85471	-6.573	0.63425	T	.	0.88256	.	0.991494696303718	0.89054	0.99986839	0.99835	0.994	0.99793	.	.	.	.	.	.	4.249871	0.64569	24.7	0.99500239805060597	0.68015	0.838290	0.75493	D	0.775208299271413	0.84447	8.314456	0.736429675756228	0.85057	8.492664	5.24	5.24	0.72825	.	.	6.008	0.70468	11.808000	0.96854	0.569	0.28905	1.0	0.71675	1.000000	0.68239	0.985	0.61072	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43067610G>C	ClinGen:CA003189	C0346153|C0027672|C2676676	114480|604370	227535|140162|145	BRCT domain|BRCT domain|BRCT domain	Thr	Arg	96.65	0.11267605633802817																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																96.65	11.267606	>90	10-90	114480;604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	true	0.8931597973787204	0.8614063216406985	false	false	false
ZC4H2	ZC4H2_Arg211Trp	B_13-14	-11.187153169578217	0.00001016631686776567	0.00022672355626272045	7.874721243068885	0.00010080029656043797	0.00040741970085551475	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9279293985128321	0.9592300837402044	0.7151235405282712	0.8143038211599488	0.7480729862498017	0.7829274401613942	0.7259522228333525	0.74978525892379	0.7948693587378004	0.6732022755249023	0.944337082275326	0.926509646490073	0.8399026574894359	0.7463607135758132	0.8337382835820972	0.75704480553164	0.9741230852050828	0.9293491505355912	ZC4H2	Arg211Trp	NC_000023.11:64917827:G:A	631C>T	23	64917827	G	A	X	ENSG00000126970	4320	0	CCSBVarC009207	ALE00013887	ENSP00000363972.3																																	446729.0	single nucleotide variant	NM_018684.4(ZC4H2):c.631C>T (p.Arg211Trp)	55906.0	ZC4H2	HGNC:24931	Likely pathogenic	1.0	Aug 05, 2022	1555933616.0	-	RCV000521213|RCV001375995|RCV004758699	MedGen:C3661900|Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|	not provided|Wieacker-Wolff syndrome|ZC4H2-related disorder	germline;maternal	germline	GRCh38	NC_000023.11	X	64917827.0	64917827.0	Xq11.2	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA413411099	2.0	451159.0	64917827.0	G	A	-	-	-	-	-	-	631C>T 	Arg211Trp	NM_018684.4	2.0	Pathogenic	Likely pathogenic	451159	X	64917827.0	G	A	R	W	rs1555933616	X	64137707	X	64054432	211	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.631C>T	p.Arg211Trp	c.631C>T	p.Arg211Trp	principal1	Y	1	YES	Select	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.999	0.77914	D	0.993	0.81117	D	0.86	0.90832	A	simple_aae	14.0	86.0	.	.	.	-7.09	0.93964	D	0.739	0.76009	-0.0594	0.80920	T	0.4448	0.78059	T	8	0.9010761	0.89353	D	0.951091	0.99664	D	0.659	0.87175	0.543	0.65470	Q9NQZ6	R211W	Gain of glycosylation at K207 (P = 0.1309)| Gain of methylation at K209 (P = 0.1951)| Loss of MoRF binding (P = 0.2024)| Loss of helix (P = 0.2662)| Loss of solvent accessibility (P = 0.2668)	0.962268395915	0.96153	0.7471255375488876	0.74521	3.13339230401	0.99404	0.906362950802	0.97112	D	0.864508	0.96996	D	0.550822	0.95775	D	0.553441	0.95711	D	0.99964702129364	0.98285	D	0.950905	0.82300	D	0.9233236	0.93476	0.92333007	0.96584	0.92091435	0.93238	0.9177878	0.96190	-14.699	0.95317	D	0.9995	0.99217	P	0.998500480413866	0.94564	0.99873880	0.98937	0.997	0.99892	.	.	.	.	.	.	5.163537	0.86543	28.9	0.99920383742745356	0.98722	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.42	0.61925	7.402	0.79258	6.482000	0.55808	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Wieacker-Wolff_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64917827G>A	ClinGen:CA413411099	C3661900|C0796200	314580	3454|85283	Zinc finger C4H2-type	Arg	Trp	78.85	0.8064516129032258																																																																																																																																																																																																																																																																																																																																																																																																																																																																													200			78.85	Positively-charged	Arginine		Zinc finger C4H2 domain-containing protein										-4.5																		175									-115.1				133.9						C (loop/coil)	C (loop/coil)												78.85	80.645164	70-90	10-90	314580	x-linked recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	false	0.9592300837402044	0.9279293985128321	false	false	false
BRAF	BRAF_Val471Phe	B_13-14	2.3797904528016036	0.04889717181123469	0.09138316845348166	-3.34655660145611	0.012308641923586394	0.020495787595082606	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	false	true	false	true	0.9132163281643575	0.9376961788259118	0.8860265573151976	0.9692854395593462	0.9628083820264459	0.9728941462392977	0.9616371433361914	0.9651230277460313	0.9534207076653647	0.8410004471114012	0.903439762878814	0.8653793512567347	0.9841511491424041	0.9604937363068605	0.9851501714533276	0.9310526675189941	0.9719525947730097	0.9610533050719803	BRAF	Val471Phe	NC_000007.14:140781597:C:A	1411G>T	7	140781597	C	A	7	ENSG00000157764	71969	0	CCSBVarC003161	ALE00003161	ENSP00000493543.1	CEGS2	CegsMutGDEh1018	F01	GDEhDisVCh_40058	C06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	48837.0	single nucleotide variant	NM_004333.6(BRAF):c.1411G>T (p.Val471Phe)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	May 17, 2024	121913376.0	-	RCV000033308|RCV000654957|RCV002051798	MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100	not provided|RASopathy|Ataxia-telangiectasia syndrome	germline	germline	GRCh38	NC_000007.14	7	140781597.0	140781597.0	7q34	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA281968	2.0	40367.0	140781597.0	C	A	-	-	-	-	-	-	1411G>T 	Val471Phe	NM_004333.6	2.0	Pathogenic	Likely pathogenic	40367	7	140781597.0	C	A	V	F	rs121913376	7	140481397	7	140127866	471	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1411G>T	p.Val471Phe	c.1411G>T	p.Val471Phe	principal4	Y	.	YES	Select	-	GTC	1	0	C	./.	./.	./.	./.	.	0.78662	.	.	.	.	0.999	0.77914	D	0.978	0.74106	D	.	0.93300	.	.	.	.	3.085	0.87210	M	.	0.75724	.	.	.	0.9449	0.96308	D	0.9940	0.99862	D	10	0.98959863	0.99425	D	0.776752	0.98235	D	.	0.99762	0.928	0.98831	P15056	V471F	Loss of MoRF binding (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of methylation at K473 (P = 0.132)| Gain of ubiquitination at K473 (P = 0.2122)| Gain of phosphorylation at T470 (P = 0.2345)	.	0.99319	.	0.97785	.	0.94779	0.875435829163	0.93326	D	0.969342	0.99654	D	0.565576	0.96310	D	0.574634	0.96250	D	0.997305870056152	0.91167	D	0.994967	0.98313	D	0.97874874	0.98996	0.9485988	0.98289	0.98134124	0.99197	0.94787174	0.98244	-16.156	0.97989	D	0.9991	0.99217	P	0.999981316373626	0.99579	0.99920601	0.99218	0.997	0.99892	.	.	.	.	.	.	5.405591	0.9052	31.0	0.99709975588964905	0.81301	0.888659	0.82134	D	1.04820146480743	0.97030	15.51097	0.96315625170976	0.97767	16.74944	5.62	5.62	0.85695	.	.	7.886	0.85829	7.654000	0.63915	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.994	0.71086	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RASopathy|Ataxia-telangiectasia_syndrome|Melanoma|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781597C>A	ClinGen:CA281968	C5555857|C0004135|C0025202|C3661900	208900	536391|100	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Val	Phe	89.55	0.1056338028169014																																																																																																																																																																																																																																																																																																																																																																																																																																																																													15			89.55	Aliphatic	Valine	ATP	Serine/threonine-protein kinase B-raf							Protein kinase	0.5186		4.2								 V471-G464 (PAE:  1.0), V471-I463 (PAE: 1.0)	V471-I463 (PDBs: 5CSX, 6P3D, 2FB8, 3D4Q, 3II5, 3PPJ, 3PPK, 3PRF, 3PRI, 3PSB, 3PSD, 3Q4C, 3Q96, 3SKC, 3TV4, 3TV6, 4DBN, 4E26, 4E4X, 4EHE, 4FC0, 4G9C, 4H58, 4KSP, 4KSQ, 4MBJ, 4PP7, 5CSW, 5CT7, 5FD2, 5HID, 5HIE, 5VAL, 5VAM, 6B8U, 6CAD, 6N0P, 6N0Q, 6V2U, 7P3V, 7SHV, 8C7X, 8C7Y, 8F7O, 8F7P, 8QQG, 4MNE, 6NYB, 6PP9, 6Q0K, 6U2G, 6U2H, 6UAN, 6V2W, 6XAG, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 7MFE, 7MFF, 8DGS, 8DGT), V471-G464 (PDBs: 6P3D, 8DGT)	 V471-G464 (PAE:  1.0)	V471-G464 (PDBs: 5CSX, 6P3D, 2FB8, 3D4Q, 3II5, 3PPJ, 3PPK, 3PRF, 3PRI, 3PSB, 3PSD, 3Q4C, 3Q96, 3SKC, 3TV4, 3TV6, 4DBN, 4E26, 4E4X, 4EHE, 4FC0, 4G9C, 4H58, 4KSP, 4KSQ, 4MBJ, 4PP7, 5CSW, 5CT7, 5HID, 5HIE, 5VAL, 5VAM, 6B8U, 6CAD, 6N0P, 6N0Q, 6V2U, 7P3V, 7SHV, 4MNE, 6NYB, 6PP9, 6Q0K, 6U2G, 6U2H, 6V2W, 6XAG, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 7MFE, 7MFF, 8DGT), V471-V482 (PDBs: 5FD2, 8F7O, 8F7P, 8DGS, 8DGT), V471-R462 (PDBs: 8C7X, 8C7Y, 8QQG), V471-I463 (PDBs: 6UAN, 8DGT), V471-K483 (PDBs: 8DGT)							117									-97.8		Pocket 1: Mean pLDDT: 73.28, Volume: 405.11 Å³, Druggability score: 0.52		140.9						B (undefined)	E (parallel sheets)	Beta strand											89.55	10.56338	70-90	10-90	208900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	ATAXIA-TELANGIECTASIA	false	0.9376961788259118	0.9132163281643575	false	false	false
FARS2	FARS2_Tyr144Cys	B_13-14	-0.31983357585618055	1.0	1.0	-1.0293494520089046	0.5030591106066327	0.5267971630218737	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6378704660928751	0.653099941641924	0.5613511684254565	0.7348263369055625	0.6742465300906032	0.6711716906763401	0.5925847629755118	0.7046478793649928	0.69055344827816	0.49759662378343034	0.6679718658739272	0.7086913671384695	0.7497586183771685	0.6438451808162136	0.779099225532965	0.6251057130674826	0.6382280174099207	0.5670495650472807	FARS2	Tyr144Cys	NC_000006.12:5369001:A:G	431A>G	6	5369001	A	G	6	ENSG00000145982	12653	0	CCSBVarC011920	ALE00012100	ENSP00000274680.4																																	48423.0	single nucleotide variant	NM_006567.5(FARS2):c.431A>G (p.Tyr144Cys)	10667.0	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1.0	Mar 14, 2024	397514610.0	-	RCV000033044|RCV000162158|RCV000497519	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|Human Phenotype Ontology:HP:0000754,Human Phenotype Ontology:HP:0001255,Human Phenotype Ontology:HP:0001263,Human Phenotype Ontology:HP:0001277,Human Phenotype Ontology:HP:0001292,Human Phenotype Ontology:HP:0002433,Human Phenotype Ontology:HP:0002473,Human Phenotype Ontology:HP:0002532,Human Phenotype Ontology:HP:0006793,Human Phenotype Ontology:HP:0006867,Human Phenotype Ontology:HP:0006885,Human Phenotype Ontology:HP:0006935,Human Phenotype Ontology:HP:0007005,Human Phenotype Ontology:HP:0007094,Human Phenotype Ontology:HP:0007106,Human Phenotype Ontology:HP:0007174,Human Phenotype Ontology:HP:0007224,Human Phenotype Ontology:HP:0007228,Human Phenotype Ontology:HP:0007342,Human Phenotype Ontology:HP:0025356,MedGen:C0557874;MONDO:MONDO:0004675,MedGen:C0162666|MedGen:C3661900	Combined oxidative phosphorylation defect type 14|Global developmental delay;Mitochondrial encephalomyopathy|not provided	germline;inherited	germline	GRCh38	NC_000006.12	6	5369001.0	5369001.0	6p25.1	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA130596,UniProtKB:O95363#VAR_069487,OMIM:611592.0001	3.0	39824.0	5369001.0	A	G	-	-	-	-	-	-	431A>G 	Tyr144Cys	NM_006567.5	2.0	Pathogenic	Likely pathogenic	39824	6	5369001.0	A	G	Y	C	rs397514610	6	5369234	6	5314233	144	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.431A>G	p.Tyr144Cys	c.431A>G	p.Tyr144Cys	principal1	Y	1	.	.	+	TAT	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.145	0.97505	H	-8.24	0.96895	D	0.886	0.88450	0.1109	0.84306	D	0.4650	0.79239	T	10	0.94212466	0.93464	D	0.137269	0.81925	D	0.703	0.89285	0.815	0.92954	O95363	Y144C	Loss of phosphorylation at Y144 (P = 0.0287)| Loss of methylation at K140 (P = 0.0513)| Loss of disorder (P = 0.0822)| Loss of ubiquitination at K140 (P = 0.0949)| Loss of stability (P = 0.1997)	0.912760158171	0.91122	0.8535715990371623	0.85230	0.75116851782	0.63550	0.795505642891	0.81246	T	0.548925	0.84551	D	0.377045	0.88436	D	0.303823	0.88290	D	0.999801814556122	0.99082	D	.	0.88094	.	0.9363221	0.94794	0.7782626	0.86759	0.9463944	0.95835	0.72315854	0.83457	-11.22	0.80911	D	0.5541	0.66907	A	0.999742363997179	0.97751	0.96441020	0.94252	1	0.99985	.	.	.	.	.	.	4.621909	0.73447	26.0	0.99840462098120319	0.92063	0.879351	0.80452	D	0.824854143750858	0.87566	9.286241	0.715026058591333	0.83429	8.04306	5.38	4.2	0.48755	2.35	0.43917	7.079	0.76566	7.903000	0.73696	0.756	0.943	1.0	0.71675	0.999000	0.35501	0.995	0.73271	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7	1614150	4.336650e-06	0	1	6062	1.649620e-04	0	0	75038	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29606	0.000000e+00	0	2	44878	4.456530e-05	0	0	64024	0.000000e+00	0	1	6062	1.649620e-04	0	1	1180020	8.474430e-07	0	2	91080	2.195870e-05	0	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Global_developmental_delay|Mitochondrial_encephalomyopathy|not_provided|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5369001A>G	ClinGen:CA130596|OMIM:611592.0001|UniProtKB:O95363#VAR_069487	C0557874|C0162666|C3661900|C4755312	614946	319519	Phenylalanyl-tRNA synthetase	Tyr	Cys	98.45	0.013513513513513514																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3			98.45	Aromatic	Tyrosine												-1.3								 Y144-D383 (PAE:  1.5), Y144-L152 (PAE: 1.0)	Y144-L152 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP), Y144-D383 (PDBs: 8P8X)	 Y144-L152 (PAE:  1.0), Y144-R179 (PAE: 1.0), Y144-R180 (PAE: 1.0)	Y144-L152 (PDBs: 3CMQ, 5MGH, 5MGU, 5MGV, 8P8X, 3TUP), Y144-R180 (PDBs: 3HFV, 3TEG, 5MGW, 8P8X, 3TUP), Y144-M151 (PDBs: 8P8X), Y144-N65 (PDBs: 8P8X), Y144-L66 (PDBs: 8P8X), Y144-R179 (PDBs: 8P8X)							181									-92.9				94.7						C (loop/coil)	C (loop/coil)												98.45	1.3513514	>90	<10	614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.653099941641924	0.6378704660928751	false	false	false
BRCA1	BRCA1_Met1Thr	B_13-14	2.6505609192138624	0.03291488248938516	0.06730987746758635	-13.289186733906769	3.1970151056312993e-6	0.00003445963826976376	2025_01_Batch_13-14	false	true	false	false	false	true	false	false	false	false	false	false	0.9693189467676223	0.9745951821586886	0.7783428083375836	0.8981070919685874	0.8290636767280688	0.8829429502453919	0.9150788025698997	0.9071470019185239	0.9319295136313278	0.7787648007815516	0.9840466657677104	0.9879733323749116	0.8508070979208842	0.7509803515376137	0.8642846703058471	0.7779208158936156	0.9651436985496668	0.950664561160333	BRCA1	Met1Thr	NC_000017.11:43124095:A:G	2T>C	17	43124095	A	G	17	ENSG00000012048	14613	0	CCSBVarC003294	ALE00003294	ENSP00000417148.1	CEGS2	CegsMutGDEh1015	F12	GDEhDisVCh_40059	F04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	69412.0	single nucleotide variant	NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	672.0	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1.0	Feb 09, 2022	80357111.0	-	RCV000111545|RCV001017950|RCV001387017	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124095.0	43124095.0	17q21.31	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001954	2.0	54745.0	43124095.0	A	G	-	-	-	-	-	-	2T>C 	Met1Thr	NM_007294.4	2.0	Pathogenic	Likely pathogenic	54745	17	43124095.0	A	G	M	T	rs80357111	17	41276112	17	38529638	1	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	c.2T>C	p.Met1?	c.2T>C	p.Met1?	principal2	Y	1	.	.	-	ATG	2	0	A	./.	./.	./.	./.	.	0.91343	.	.	0.92967	.	0.967	0.56423	D	0.916	0.65195	D	.	0.99291	.	.	.	.	.	.	.	.	0.71435	.	.	0.96886	0.4652	0.90013	D	0.7036	0.89769	D	9	0.98665875	0.98978	D	0.950787	0.99662	D	.	0.89789	0.987	0.99867	E9PFC7	M1T	Loss of stability (P = 2e-04)| Gain of catalytic residue at M1 (P = 0.0208)| Gain of glycosylation at M1 (P = 0.121)| Gain of disorder (P = 0.1374)| Gain of helix (P = 0.2684)	0.883389812914	0.88134	.	0.29790	.	.	.	.	.	0.298644	0.66936	T	0.3844	0.88912	D	0.314388	0.88772	D	0.991858303546906	0.82073	D	0.9	0.64967	D	0.9435044	0.95537	0.71842754	0.83181	0.9426614	0.95450	0.7257	0.83606	-9.871	0.82067	D	.	.	.	0.999999935724936	0.99831	0.99948680	0.99428	.	.	.	.	.	.	.	.	3.997208	0.58947	24.0	0.97714747887968068	0.35682	0.056815	0.10376	N	0.358832926107613	0.58998	4.098281	0.311400030491244	0.55978	3.783919	3.83	3.83	0.43219	2.37	0.44186	4.168	0.58094	11.022000	0.84990	0.634	0.51995	1.0	0.71675	1.000000	0.68239	0.255	0.23438	469	0.78193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43124095A>G	ClinGen:CA001954	C0677776|C0027672|C2676676	604370	145|140162|145	.	Met	Thr	41.59	1.0																																																																																																															-1.657		-2.936																																																																																																																																																																																																																																																																																																																																																												184			41.44	Aliphatic	Methionine		Breast cancer type 1 susceptibility protein										1.9											M1-T97 (PDBs: 1JM7), M1-D96 (PDBs: 1JM7)						N-acetylmethionine	149									360.0				130.4						C (loop/coil)	C (loop/coil)												41.59	100.0	$\leqslant$50	$\geqslant$90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.9745951821586886	0.9693189467676223	true	false	false
BRAF	BRAF_Gly464Val	B_13-14	-4.383115862384623	0.003222238147491784	0.011292768923021654	-0.5425173687147155	0.6042964959090807	0.6522847470548019	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7695755355551538	0.8336522846550607	0.6013615904840666	0.7695160444363331	0.7931831667658567	0.7338071857913064	0.7529961199945461	0.7805934760700239	0.8474881735951852	0.6003948410082152	0.8595111112321868	0.7668434648986223	0.7146182515880669	0.8057728574616893	0.6915439152774809	0.6023283399599179	0.8077934580779347	0.7723076062116853	BRAF	Gly464Val	NC_000007.14:140781617:C:A	1391G>T	7	140781617	C	A	7	ENSG00000157764	71969	0	CCSBVarC003158	ALE00003158	ENSP00000493543.1	CEGS2	CegsMutGDEh1009	F10	GDEhDisVCh_40058	G01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	48834.0	single nucleotide variant	NM_004333.6(BRAF):c.1391G>T (p.Gly464Val)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Jul 16, 2023	121913348.0	-	RCV000037914|RCV000033302|RCV001813221|RCV002250499|RCV001811232	Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900	Non-small cell lung carcinoma|RASopathy|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1|not provided	germline;somatic	germline/somatic	GRCh38	NC_000007.14	7	140781617.0	140781617.0	7q34	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA135076,UniProtKB:P15056#VAR_018616	2.0	40364.0	140781617.0	C	A	-	-	-	-	-	-	1391G>T 	Gly464Val	NM_004333.6	2.0	Pathogenic	Likely pathogenic	40364	7	140781617.0	C	A	G	V	rs121913348	7	140481417	7	140127886	464	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1391G>T	p.Gly464Val	c.1391G>T	p.Gly464Val	principal4	Y	.	YES	Select	-	GGA	2	0	C	./.	./.	./.	./.	.	.	.	.	.	.	0.999	0.77914	D	0.989	0.78402	D	.	0.99291	.	.	.	.	3.33	0.90723	M	.	.	.	.	.	1.0580	0.98290	D	0.9095	0.96994	D	10	0.9907639	0.99584	D	0.535553	0.95644	D	.	0.98743	0.987	0.99867	P15056	G464V	Loss of disorder (P = 0.0738)| Gain of MoRF binding (P = 0.081)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S465 (P = 0.1405)| Loss of loop (P = 0.2237)	.	0.98525	.	0.87595	.	0.96493	0.860752463341	0.91208	D	0.964298	0.99559	D	0.488804	0.93915	D	0.464356	0.93838	D	0.997959613800049	0.92787	D	0.835416	0.50397	T	0.99103737	0.99812	0.9789484	0.99787	0.98836577	0.99669	0.97783434	0.99754	-16.405	0.98310	D	0.9999	0.99795	P	0.999967477835789	0.99297	0.99925166	0.99245	1	0.99985	.	.	.	.	.	.	5.543189	0.91993	32.0	0.99831981023057448	0.91377	0.896613	0.83728	D	1.05336862643538	0.97152	15.69308	0.967625534540837	0.97885	16.98583	5.62	5.62	0.85695	.	.	7.886	0.85829	7.656000	0.64019	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.998	0.85369	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	RASopathy|Neoplasm|Noonan_syndrome_and_Noonan-related_syndrome|not_provided|Non-small_cell_lung_carcinoma|Breast_neoplasm|Cardiofaciocutaneous_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781617C>A	ClinGen:CA135076|UniProtKB:P15056#VAR_018616	C5555857|C0027651|C5681679|C3661900|C0007131|C1458155|CN029449	115150	536391|98733|1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Gly	Val	76.48	0.21428571428571427																																																																																																																																																																																																																																																																																																																																																																																																																																																																													18			76.48	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine	ATP	Serine/threonine-protein kinase B-raf							Protein kinase			-0.4								 G464-V471 (PAE:  1.0)	G464-V471 (PDBs: 5CSX, 6P3D, 2FB8, 3D4Q, 3II5, 3PPJ, 3PPK, 3PRF, 3PRI, 3PSB, 3PSD, 3Q4C, 3Q96, 3SKC, 3TV4, 3TV6, 4DBN, 4E26, 4E4X, 4EHE, 4FC0, 4G9C, 4H58, 4KSP, 4KSQ, 4MBJ, 4PP7, 5CSW, 5CT7, 5FD2, 5HID, 5HIE, 5VAL, 5VAM, 6B8U, 6CAD, 6N0P, 6N0Q, 6V2U, 7P3V, 7SHV, 8C7X, 8C7Y, 8F7P, 8QQG, 4MNE, 6NYB, 6PP9, 6Q0K, 6U2G, 6U2H, 6UAN, 6V2W, 6XAG, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 7MFF, 8DGS, 8DGT), G464-T470 (PDBs: 8F7O, 7MFD)	 G464-V471 (PAE:  1.0)	G464-V471 (PDBs: 5CSX, 6P3D, 2FB8, 3D4Q, 3II5, 3PPJ, 3PPK, 3PRF, 3PRI, 3PSB, 3PSD, 3Q4C, 3Q96, 4DBN, 4E4X, 4EHE, 4FC0, 4G9C, 4H58, 4KSP, 4KSQ, 4MBJ, 4PP7, 5CSW, 5CT7, 5FD2, 5HID, 5HIE, 5VAL, 5VAM, 6B8U, 6CAD, 6N0P, 6N0Q, 6V2U, 7P3V, 7SHV, 4MNE, 6NYB, 6PP9, 6Q0K, 6U2G, 6U2H, 6UAN, 6V2W, 6XAG, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 7MFE, 7MFF, 8DGT), G464-T470 (PDBs: 3SKC, 3TV4, 3TV6, 4E26, 8C7X, 8C7Y, 8F7O, 8F7P, 8QQG, 7MFD, 8DGS, 8DGT)							75									152.8				178.1				dbSNP: rs121913348; Variant type: LP/P; AA change: Gly464Glu; PTM type: Phosphorylation; PTM morphology: RIG*sGsFGtVY; Var class: II&rs121913348		B (undefined)	E (parallel sheets)	Beta strand											76.48	21.428572	70-90	10-90	115150	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1	false	0.8336522846550607	0.7695755355551538	false	false	false
G6PD	G6PD_Glu398Lys	B_13-14	-2.2270130039444096	0.061240193067420415	0.1094188669399186	-0.3612802146651411	0.7285479908969512	0.7709836005166698	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6496765842292671	0.659169957764898	0.5961238482258475	0.6794233438394051	0.6547458762659921	0.6504632436067146	0.6518083158897536	0.6645771795378788	0.7350021814584188	0.5704749491354242	0.6935196906349717	0.674494921524654	0.6491181713236754	0.6449145729941055	0.6238445062203912	0.6217727473162709	0.6248202248948242	0.6248582469338804	G6PD	Glu398Lys	NC_000023.11:154532662:C:T	1192G>A	23	154532662	C	T	X	ENSG00000160211	4006	0	CCSBVarC004025	ALE00004025	ENSP00000377192.3	CEGS2	CegsMutGDEh1002	A11	GDEhDisVCh_40035	E04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	7.0	0.0		0.0			0.0			0.0			N	N	N	N	N	792173.0	single nucleotide variant	NM_001360016.2(G6PD):c.1192G>A (p.Glu398Lys)	2539.0	G6PD	HGNC:4057	Pathogenic/Likely pathogenic	1.0	May 20, 2023	137852325.0	-	RCV000991012	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	germline;maternal;unknown	germline	GRCh38	NC_000023.11	X	154532662.0	154532662.0	Xq28	criteria provided, multiple submitters, no conflicts	3.0	-	N	-	2.0	804134.0	154532662.0	C	T	-	-	-	-	-	-	1192G>A 	Glu398Lys	NM_001360016.2	2.0	Pathogenic	Likely pathogenic	804134	X	154532662.0	C	T	E	K	rs137852325	X	153760877	X	153414071	398	G6PD	ENSG00000160211	ENST00000696430	ENSP00000512625	P11413	G6PD_HUMAN	.	.	c.1192G>A	p.Glu398Lys	principal4	Y	.	.	.	-	GAG	1	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.83643	.	1.0	0.90580	D	1.0	0.97365	D	.	0.94956	.	.	.	.	4.61	0.99266	H	.	0.69872	.	.	0.73617	0.9214	0.95965	D	0.9960	0.99908	D	10	.	0.98957	.	0.848963	0.98832	D	.	0.97849	0.949	0.99385	P11413	E398K	Gain of MoRF binding (P = 0.0029)| Gain of methylation at E398 (P = 0.0073)| Loss of stability (P = 0.1334)| Gain of phosphorylation at T402 (P = 0.1773)| Loss of loop (P = 0.2237)	.	0.99692	.	.	.	0.95480	0.819497585297	0.84925	D	0.972763	0.99714	D	0.667932	0.99900	D	0.721661	0.99899	D	0.999545991420746	0.97827	D	0.99725	0.98926	D	0.95874125	0.97108	0.9285496	0.96951	0.9683203	0.98071	0.90745586	0.95445	-11.128	0.80418	D	.	0.90566	.	0.999990459212003	0.99831	0.99881110	0.98976	0.989	0.99628	.	.	.	.	.	.	4.526718	0.71085	25.6	0.99914936147112188	0.98310	.	.	.	.	.	.	.	.	.	5.82	4.96	0.65108	3.01	0.55043	5.668	0.67818	5.880000	0.50706	0.585	0.3052	1.0	0.71675	1.000000	0.68239	0.977	0.56847	80	0.96675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.154532662C>T	.	C2720289	300908	466026	Glucose-6-phosphate dehydrogenase, C-terminal	Glu	Lys	97.56	0.29896907216494845																																																																																																																																																																																																																																																																																																																																																																																																																																																																													58			97.56	Negatively-charged	Glutamic Acid		Glucose-6-phosphate 1-dehydrogenase										-3.5								 E398-Y424 (PAE:  1.0)	E398-Y424 (PDBs: 6E08, 6JYU, 7ZVD, 7SNI)	 E398-Y424 (PAE:  1.0)	E398-Y424 (PDBs: 6E08, 6JYU, 7ZVD, 7SNI), E398-R393 (PDBs: 7ZVD, 7UAG), E398-M207 (PDBs: 7ZVD, 7UAG), E398-V394 (PDBs: 7ZVD, 7SNG, 7UAG), E398-T423 (PDBs: 7ZVD)							146									-46.2				121.4				dbSNP: rs137852325; Variant type: LP/P; AA change: Glu398Lys; PTM type: Phosphorylation; PTM morphology: NE*AVytkMMTK; Var class: II&rs137852325		C (loop/coil)	C (loop/coil)												97.56	29.896906	>90	10-90	300908	x-linked	OMIM	Rare genetic hematologic disease	1	ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1	false	0.659169957764898	0.6496765842292671	false	false	false
FH	FH_His318Tyr	B_13-14	3.1703971636548824	0.019309050557584827	0.04438060958482192	-7.510482840405078	0.00013609892431414565	0.0005117654223697895	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9428173061496643	0.9505433289402831	0.721302111965505	0.8021434154688807	0.7046739425501001	0.7162975863147726	0.7217102858499993	0.715474116221102	0.7850238198058045	0.6430333863893858	0.9424522457162465	0.9376599642472292	0.7108848867795459	0.693873768879098	0.8192630111319568	0.7995708375416241	0.9586344121643198	0.9479746480520995	FH	His318Tyr	NC_000001.11:241504198:G:A	952C>T	1	241504198	G	A	1	ENSG00000091483	3408	0	CCSBVarC004052	ALE00004052	ENSP00000355518.4	CEGS2	CegsMutGDEh1041	E03	GDEhDisVCh_40065	G08	1	CegsMutGDDh1041	E03	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	98367.0	single nucleotide variant	NM_000143.4(FH):c.952C>T (p.His318Tyr)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Sep 26, 2024	398123168.0	-	RCV000078152|RCV000762893|RCV000445608|RCV002371923|RCV003460742	MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	not provided|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer|Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|Fumarase deficiency	germline;unknown	germline	GRCh38	NC_000001.11	1	241504198.0	241504198.0	1q43	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA285329	2.0	92458.0	241504198.0	G	A	-	-	-	-	-	-	952C>T 	His318Tyr	NM_000143.4	2.0	Pathogenic	Likely pathogenic	92458	1	241504198.0	G	A	H	Y	rs398123168	1	241667498	1	239734121	318	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.952C>T	p.His318Tyr	c.952C>T	p.His318Tyr	principal1	Y	1	YES	Select	-	CAT	1	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.002	0.79703	D	0.998	0.73231	D	0.967	0.71532	D	0.51	0.71237	A	simple_aae	49.0	51.0	4.24	0.97965	H	-5.19	0.83652	D	0.855	0.85095	1.0075	0.97307	D	0.9896	0.99711	D	10	0.96449435	0.95861	D	0.783796	0.98295	D	0.981	0.99874	0.748	0.87844	P07954	H318Y	Gain of phosphorylation at H318 (P = 0.111)| Loss of catalytic residue at D319 (P = 0.1709)| Loss of disorder (P = 0.2552)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.5184)	0.970197299285	0.96959	0.9644412197578099	0.96411	1.04814267846	0.75889	0.870154500008	0.92578	D	0.96242	0.99523	D	0.580039	0.96967	D	0.595409	0.96917	D	0.998691618442535	0.94843	D	0.990021	0.96938	D	0.95636344	0.96862	0.92381674	0.96618	0.95636344	0.96862	0.92381674	0.96619	-11.478	0.82269	D	0.8651	0.80553	P	0.999672043470544	0.97434	0.96164210	0.94067	0.997	0.99892	.	.	.	.	.	.	4.864406	0.79665	27.1	0.99843370951524324	0.92321	0.934609	0.92797	D	1.05284626535223	0.97140	15.67457	0.99436337600402	0.98507	18.50119	5.73	5.73	0.89714	6.28	0.98834	9.346	0.96466	9.909000	0.82440	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.976	0.56441	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614178	6.195100e-07	0	1	1180018	8.474450e-07	0	0	75048	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64038	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180018	8.474450e-07	0	0	91080	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_leiomyomatosis_and_renal_cell_cancer|Fumarase_deficiency|not_provided|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241504198G>A	ClinGen:CA285329	C1708350|C0342770|C3661900|C0027672	150800|606812	523|24|140162	Fumarate lyase, N-terminal	His	Tyr	98.8	0.02717391304347826																																																																																																																																																																																																																																																																																																																																																																																																																																																																													5			98.8	Positively-charged	Histidine		Fumarate hydratase, mitochondrial										-3.2								 H318-K409 (PAE:  1.0), H318-V322 (PAE: 1.0)	H318-K409 (PDBs: 5D6B, 7LUB), H318-V322 (PDBs: 5D6B, 3E04, 5UPP, 7LUB)	 H318-K409 (PAE:  1.0), H318-V322 (PAE: 1.0)	H318-K409 (PDBs: 5D6B, 7LUB), H318-V322 (PDBs: 5D6B, 3E04, 5UPP, 7LUB), H318-A314 (PDBs: 7LUB)							155									-137.4				45.9						C (loop/coil)	C (loop/coil)												98.8	2.7173913	>90	<10	606812;150800;150800;606812	multiple	OMIM	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	FUMARASE DEFICIENCY; HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; FUMARASE DEFICIENCY	false	0.9505433289402831	0.9428173061496643	false	false	false
CTCF	CTCF_Tyr407Cys	B_13-14	2.2604531941423103	0.058292407096491645	0.10503631844745193	4.8815308469715015	0.0017904841907079834	0.00385626583327365	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.650149877427783	0.6503624358166451	0.5822214238191235	0.6963704097529512	0.7121367792294702	0.6399859765206312	0.5890271314100037	0.8000531812495679	0.6519913840617222	0.5655820936217307	0.6867364376551036	0.6453561518055733	0.6909448216312586	0.6242203772093723	0.7407494354441801	0.5988607540165163	0.6139884339781867	0.6549436030499927	CTCF	Tyr407Cys	NC_000016.10:67621454:A:G	1220A>G	16	67621454	A	G	16	ENSG00000102974	6173	0	CCSBVarC010870	ALE00013232	ENSP00000264010.4																																	260121.0	single nucleotide variant	NM_006565.4(CTCF):c.1220A>G (p.Tyr407Cys)	10664.0	CTCF	HGNC:13723	Likely pathogenic	1.0	Jan 12, 2016	886039600.0	-	RCV000255519	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000016.10	16	67621454.0	67621454.0	16q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA10588621	2.0	265526.0	67621454.0	A	G	-	-	-	-	-	-	1220A>G 	Tyr407Cys	NM_006565.4	1.0	Pathogenic	Likely pathogenic	265526	16	67621454.0	A	G	Y	C	rs886039600	16	67655357	16	66212858	407	CTCF	ENSG00000102974	ENST00000644753	ENSP00000493495	P49711	CTCF_HUMAN	c.1220A>G	p.Tyr407Cys	c.1220A>G	p.Tyr407Cys	principal4	Y	.	.	.	+	TAT	2	0	A	A/A	A/A	A/A	A/A	.	0.78662	.	.	0.92967	.	0.914	0.50540	P	0.665	0.52957	P	.	0.86984	.	.	.	.	3.095	0.87372	M	.	0.96158	.	.	0.77038	-0.7497	0.57774	T	0.1518	0.47848	T	10	0.84561706	0.83554	D	0.084978	0.74353	D	.	0.78861	0.615	0.74786	P49711	Y407C	Loss of phosphorylation at Y407 (P = 0.0811)| Gain of ubiquitination at K405 (P = 0.1079)| Gain of disorder (P = 0.1124)| Gain of glycosylation at K405 (P = 0.1594)| Loss of MoRF binding (P = 0.1621)	.	0.78538	.	0.94871	.	0.99706	0.954362869263	0.99834	D	0.875329	0.97318	D	0.258403	0.79229	D	0.133401	0.78960	D	0.997824430465698	0.92450	D	.	0.93500	.	0.8909639	0.90456	0.6975476	0.81981	0.8259339	0.85435	0.7453358	0.84765	-16.773	0.98709	D	.	0.96717	.	0.999749203930458	0.97751	0.97100700	0.94734	0.889	0.94066	.	.	.	.	.	.	5.434312	0.90871	32.0	0.99770787246477033	0.85930	0.932506	0.92271	D	0.717981494107391	0.80704	7.377784	0.688130749716732	0.81373	7.535864	5.83	4.72	0.59198	4.73	0.87084	9.325	0.96016	11.234000	0.90219	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	54	0.97580	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000016.10:g.67621454A>G	ClinGen:CA10588621	CN517202	.	.	.	Tyr	Cys	85.11	0.3333333333333333																																																																																																																																																																																																																																																																																																																																																																																																																																																																													74			85.11	Aromatic	Tyrosine		Transcriptional repressor CTCF								0.2481		-1.3								 Y407-F416 (PAE:  2.0)	Y407-F416 (PDBs: 2CT1, 5K5H, 5K5I, 5K5J, 5KKQ, 5T00, 5T0U, 5UND, 5YEF, 5YEG, 5YEH, 8SSQ, 8SSS), Y407-R415 (PDBs: 7W1M), Y407-R399 (PDBs: 8SSR)	 Y407-Q418 (PAE:  2.0), Y407-S419 (PAE: 2.5), Y407-F416 (PAE: 2.0)	Y407-S419 (PDBs: 2CT1, 8SSS), Y407-F416 (PDBs: 2CT1, 5K5H, 5K5I, 5K5J, 5KKQ, 5T00, 5T0U, 5UND, 5YEF, 5YEG, 5YEH, 8SSQ, 8SSR, 8SSS), Y407-T417 (PDBs: 8SSS), Y407-Q418 (PDBs: 8SSS), Y407-R415 (PDBs: 8SSS)							181									-113.7	Morphology: tHsGEKPyECyICHA	Pocket 2: Mean pLDDT: 83.64, Volume: 523.05 Å³, Druggability score: 0.25		108.8						B (undefined)	E (parallel sheets)	Beta strand										C2H2-type 6	85.11	33.333336	70-90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.6503624358166451	0.650149877427783	false	false	false
FH	FH_Asn340Lys	B_13-14	10.63377390618422	0.00004075682484155514	0.0004976811834366609	-8.634081439849895	0.0000558325612656041	0.00026259929932931245	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	false	false	0.9560164879623596	0.9732595992994735	0.7740106783751048	0.8790929470567067	0.773701396270164	0.7885997034893018	0.7885997034893018	0.773701396270164	0.8790929470567067	0.7740106783751048	0.9732595992994735	0.947389824007471						0.9646431519172484	FH	Asn340Lys	NC_000001.11:241504130:A:T	1020T>A	1	241504130	A	T	1	ENSG00000091483	3408	0	CCSBVarC004054	ALE00004054	ENSP00000355518.4	CEGS2	CegsMutGDEh1041	D11	GDEhDisVCh_40065	A09	1	CegsMutGDDh1041	D11	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	6.0	0.0			0.0			0.0			Y	N	N	N	N	98356.0	single nucleotide variant	NM_000143.4(FH):c.1020T>A (p.Asn340Lys)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Mar 02, 2024	398123159.0	-	RCV000220396|RCV000078140|RCV000445596|RCV003460741|RCV004555535	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|	Hereditary cancer-predisposing syndrome|not provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|FH-related disorder	germline;unknown	germline	GRCh38	NC_000001.11	1	241504130.0	241504130.0	1q43	criteria provided, multiple submitters, no conflicts	10.0	-	N	ClinGen:CA285319	2.0	92447.0	241504130.0	A	T	-	-	-	-	-	-	1020T>A 	Asn340Lys	NM_000143.4	2.0	Pathogenic	Likely pathogenic	92447	1	241504130.0	A	T	N	K	rs398123159	1	241667430	1	239734053	340	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1020T>A	p.Asn340Lys	c.1020T>A	p.Asn340Lys	principal1	Y	1	YES	Select	-	AAT	3	2	A	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.43	0.98728	H	-5.97	0.89297	D	0.997	0.99974	1.0745	0.98713	D	0.9852	0.99552	D	10	0.98295367	0.98388	D	0.933702	0.99521	D	0.885	0.96643	0.826	0.93687	P07954	N340K	Gain of MoRF binding (P = 0.0281)| Loss of stability (P = 0.0682)| Gain of ubiquitination at N340 (P = 0.0797)| Loss of catalytic residue at D341 (P = 0.1005)| Gain of loop (P = 0.1069)	0.976600358983	0.97612	0.992874591347995	0.99282	1.05267121501	0.76067	0.819319963455	0.84898	D	0.976563	0.99778	D	0.195964	0.73318	D	0.107358	0.77230	D	0.996594965457916	0.89586	D	0.989601	0.96580	D	0.9459451	0.95788	0.9137381	0.95897	0.9459451	0.95788	0.9137381	0.95898	-10.892	0.79130	D	0.994	0.95051	P	0.99958943095219	0.97080	0.90775520	0.91492	0.975	0.99076	.	.	.	.	.	.	3.413967	0.47456	22.4	0.99842744111750026	0.92321	0.475086	0.51740	N	0.628093012181	0.74823	6.222027	0.508360094466945	0.68379	5.235775	5.73	3.43	0.38299	-0.0628	0.21136	0.55	0.23134	-0.065000	0.12424	0.751	0.87726	0.996	0.3946	0.009000	0.19951	0.994	0.71086	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	segdup	1	109394	9.141270e-06	0	3	208100	1.441610e-05	0	3	236778	1.267010e-05	0	0	7164	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30502	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	2	89552	2.233340e-05	0	0	30606	0.000000e+00	0	2	89552	2.233340e-05	0	0	14902	0.000000e+00	0	0	34236	0.000000e+00	0	0	9566	0.000000e+00	0	0	17688	0.000000e+00	0	0	21632	0.000000e+00	0	2	102612	1.949090e-05	0	0	30524	0.000000e+00	0	2	102612	1.949090e-05	0	.	10	1614142	6.195240e-06	0	10	1179978	8.474730e-06	0	0	75056	0.000000e+00	0	0	910	0.000000e+00	0	0	60018	0.000000e+00	0	0	29608	0.000000e+00	0	0	44888	0.000000e+00	0	0	64034	0.000000e+00	0	0	6062	0.000000e+00	0	10	1179978	8.474730e-06	0	0	91078	0.000000e+00	0	1	15752	6.348400203148806E-5	0	122	0	0	112	0	0	3370	0	0	146	0	0	610	0	0	56	0	0	98	0	1	2772	3.6075036075036075E-4	0	3492	0	0	168	0	2	23038	8.681309141418526E-5	FH-related_disorder|Fumarase_deficiency|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241504130A>T	ClinGen:CA285319	C0342770|C3661900|C1708350|C0027672	606812|150800	24|523|140162	Fumarate lyase, N-terminal	Asn	Lys	98.84	0.39490445859872614																																																																																																																																																																																																																																																																																																																																																																																																																																																																													62			98.84	Polar/Neutral	Asparagine		Fumarate hydratase, mitochondrial								0.0745		-3.5								 N340-F344 (PAE:  1.0), N340-M336 (PAE: 1.0)	N340-F344 (PDBs: 5D6B, 7LUB), N340-M336 (PDBs: 5D6B, 3E04, 5UPP, 7LUB)	 N340-F344 (PAE:  1.0), N340-M336 (PAE: 1.0)	N340-F344 (PDBs: 5D6B, 7LUB), N340-M336 (PDBs: 5D6B, 3E04, 5UPP, 7LUB)							132									-71.2		Pocket 2: Mean pLDDT: 99.39, Volume: 605.37 Å³, Druggability score: 0.07		-39.8						H (helix)	H (α-helix)	Helix											98.84	39.490448	>90	10-90	150800;606812	multiple	OMIM	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; FUMARASE DEFICIENCY	false	0.9732595992994735	0.9560164879623596	true	false	false
FH	FH_Arg233Leu	B_13-14	1.6531294030768622	0.14939045875507265	0.22469011098288946	-3.205913968580473	0.014942586608623023	0.02439470322671107	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7313657625285395	0.7208168381989959	0.5882890659115768	0.6745378112519467	0.5851660414576296	0.6614889813300504	0.6566071837445612	0.5582608226396315	0.6866581395184059	0.5520550340000472	0.7047538084698176	0.7202601058869765	0.6663707789155396	0.6120712602756279	0.6624174829854873	0.6245230978231064	0.7368798679281741	0.7424714191701025	FH	Arg233Leu	NC_000001.11:241508643:C:A	698G>T	1	241508643	C	A	1	ENSG00000091483	3408	0	CCSBVarC004050	ALE00004050	ENSP00000355518.4	CEGS2	CegsMutGDEh1040	H07	GDEhDisVCh_40065	E08	1	CegsMutGDDh1040	H07	NULL	NULL	NULL	NULL	NULL	NULL	1.0	2.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	31276.0	single nucleotide variant	NM_000143.4(FH):c.698G>T (p.Arg233Leu)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Sep 25, 2023	121913123.0	-	RCV000017624|RCV001781272|RCV002362588	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary leiomyomatosis and renal cell cancer|not provided|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000001.11	1	241508643.0	241508643.0	1q43	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA257461,OMIM:136850.0008	3.0	16237.0	241508643.0	C	A	-	-	-	-	-	-	698G>T 	Arg233Leu	NM_000143.4	2.0	Pathogenic	Likely pathogenic	16237	1	241508643.0	C	A	R	L	rs121913123	1	241671943	1	239738566	233	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.698G>T	p.Arg233Leu	c.698G>T	p.Arg233Leu	principal1	Y	1	YES	Select	-	CGT	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	5.07	0.99905	H	-6.84	0.93080	D	0.963	0.97332	0.9273	0.96051	D	0.9945	0.99874	D	10	0.989849	0.99460	D	0.745296	0.97960	D	0.945	0.98886	0.889	0.97257	P07954	R233L	Loss of phosphorylation at T236 (P = 0.0525)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of methylation at K230 (P = 0.0761)| Loss of MoRF binding (P = 0.0923)| Loss of glycosylation at K230 (P = 0.1752)	0.972808251769	0.97225	0.9751746669812705	0.97494	1.09694667183	0.77481	0.830429792404	0.86606	D	0.995902	0.99993	D	0.51557	0.94692	D	0.599658	0.96962	D	0.999926209449768	0.99730	D	0.988918	0.96274	D	0.99120563	0.99821	0.9549934	0.98673	0.99120563	0.99821	0.9549934	0.98673	-15.96	0.97705	D	0.9946	0.95323	P	0.999900398311514	0.98723	0.93478185	0.92608	1	0.99985	.	.	.	.	.	.	5.201626	0.87283	29.2	0.99866098052584062	0.94461	0.927182	0.90912	D	1.08057729138192	0.97745	16.70746	0.942227821079248	0.97147	15.68653	5.65	5.65	0.86862	6.32	0.99010	7.503	0.80522	7.704000	0.66498	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.948	0.49339	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109390	9.141600e-06	0	1	208074	4.805980e-06	0	1	236740	4.224040e-06	0	0	7164	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13392	0.000000e+00	0	0	42766	0.000000e+00	0	1	15688	6.374300e-05	0	1	15688	6.374300e-05	0	0	16216	0.000000e+00	0	0	30494	0.000000e+00	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	0	89538	0.000000e+00	0	1	30604	3.267550e-05	0	1	30604	3.267550e-05	0	0	14900	0.000000e+00	0	0	34228	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	0	21628	0.000000e+00	0	0	102598	0.000000e+00	0	1	30522	3.276330e-05	0	1	30522	3.276330e-05	0	.	5	1613808	3.098260e-06	0	5	91072	5.490160e-05	0	0	74994	0.000000e+00	0	0	912	0.000000e+00	0	0	60012	0.000000e+00	0	0	29598	0.000000e+00	0	0	44856	0.000000e+00	0	0	64020	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179792	0.000000e+00	0	5	91072	5.490160e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241508643C>A	ClinGen:CA257461|OMIM:136850.0008	C3661900|C1708350|C0027672	150800	523|140162	Fumarate lyase, N-terminal	Arg	Leu	98.76	0.29838709677419356																																																																																																																																																																																																																																																																																																																																																																																																																																																																													74			98.76	Positively-charged	Arginine		Fumarate hydratase, mitochondrial								0.0745		-4.5			C:R233-B:E404 (PDBs: 3E04), B:R233-A:E404 (PDBs: 5UPP, 7LUB), A:R233-B:E404 (PDBs: 7LUB)	C:R233-B:E404 (PDBs: 3E04), B:R233-A:E404 (PDBs: 5UPP, 7LUB), A:R233-B:E404 (PDBs: 7LUB)				 R233-E355 (PAE:  1.0)	R233-E355 (PDBs: 5D6B, 3E04, 5UPP, 7LUB)			 R233-E355 (PAE:  1.0)	R233-E355 (PDBs: 5D6B, 3E04, 5UPP, 7LUB)					175									-131.5		Pocket 2: Mean pLDDT: 99.39, Volume: 605.37 Å³, Druggability score: 0.07		124.2				dbSNP: rs121913123; Variant type: LP/P; AA change: Arg233His; PTM type: Ubiquitylation; PTM morphology: FAQIIkIGR*TH; Var class: II&rs121913123		B (undefined)	E (parallel sheets)	Beta strand											98.76	29.83871	>90	10-90	150800	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	false	0.7208168381989959	0.7313657625285395	false	false	false
ZC4H2	ZC4H2_Pro201Ser	B_13-14	-5.809680916000794	0.002975023338819346	0.009527265617471005	3.412556331098637	0.05848320816223985	0.07682711757918612	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7761842379269881	0.8021429661944859	0.6655543272494318	0.6751520062746205	0.6790771002543967	0.7071371147136283	0.6313554425380045	0.6695842961194767	0.6544281238331573	0.6400448839216449	0.7076275360458802	0.6895217096077518	0.7829187868892521	0.6885699043893166	0.6958758887160836	0.6910637705772186	0.8966583963430914	0.8628467662462243	ZC4H2	Pro201Ser	NC_000023.11:64917857:G:A	601C>T	23	64917857	G	A	X	ENSG00000126970	4320	0	CCSBVarC005917	ALE00005917	ENSP00000363972.3	CEGS2	CegsMutGDEh1032	E08	GDEhDisVCh_40034	A12	2	CegsMutGDDh1032	E08	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	65653.0	single nucleotide variant	NM_018684.4(ZC4H2):c.601C>T (p.Pro201Ser)	55906.0	ZC4H2	HGNC:24931	Likely pathogenic	1.0	Jun 24, 2020	398122939.0	-	RCV000043678|RCV001374903	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	Wieacker-Wolff syndrome|Neurodevelopmental disorder	germline	germline	GRCh38	NC_000023.11	X	64917857.0	64917857.0	Xq11.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA143908,UniProtKB:Q9NQZ6#VAR_069623,OMIM:300897.0003	3.0	50982.0	64917857.0	G	A	-	-	-	-	-	-	601C>T 	Pro201Ser	NM_018684.4	1.0	Pathogenic	Likely pathogenic	50982	X	64917857.0	G	A	P	S	rs398122939	X	64137737	X	64054462	201	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.601C>T	p.Pro201Ser	c.601C>T	p.Pro201Ser	principal1	Y	1	YES	Select	-	CCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	0.96	0.95575	A	simple_aae	4.0	96.0	.	.	.	-6.88	0.93237	D	0.933	0.93850	-0.0166	0.81829	T	0.4584	0.78867	T	8	0.9272647	0.91983	D	0.879436	0.99079	D	0.949	0.99024	0.568	0.68924	Q9NQZ6	P201S	Gain of MoRF binding (P = 0.0359)| Gain of phosphorylation at P201 (P = 0.0595)| Loss of loop (P = 0.0603)| Loss of stability (P = 0.0799)| Gain of helix (P = 0.132)	0.924160061229	0.92281	0.717222727726295	0.71518	3.14057088863	0.99417	0.90233540535	0.96691	D	0.841119	0.96267	D	0.579811	0.96963	D	0.595082	0.96914	D	0.99885880947113	0.95336	D	0.959004	0.85727	D	0.9243852	0.93582	0.9158107	0.96047	0.90647143	0.91852	0.90109336	0.94986	-12.964	0.90166	D	1.0	0.99952	P	0.999295186201027	0.96182	0.99900264	0.99084	0.997	0.99892	.	.	.	.	.	.	4.866916	0.79733	27.2	0.99923738092883418	0.98918	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	.	.	9.224	0.94382	11.614000	0.93576	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Wieacker-Wolff_syndrome|Neurodevelopmental_disorder	criteria_provided,_single_submitter	NC_000023.11:g.64917857G>A	ClinGen:CA143908|OMIM:300897.0003|UniProtKB:Q9NQZ6#VAR_069623	C0796200|C1535926	314580	3454|85283	Zinc finger C4H2-type	Pro	Ser	87.12	0.7720588235294118																																																																																																																																																																																																																																																																																																																																																																																																																																																																													105			87.12	Special, No backbone hydrogen	Proline		Zinc finger C4H2 domain-containing protein										1.6								 P201-S210 (PAE:  3.0)		 P201-S210 (PAE:  3.0)								115									-75.8				-27.6						C (loop/coil)	S (bend)											C4H2-type	87.12	77.20589	70-90	10-90	314580	x-linked recessive	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	WIEACKER-WOLFF SYNDROME	false	0.8021429661944859	0.7761842379269881	false	false	false
SDHD	SDHD_His102Pro	B_13-14	4.677318243891225	0.0025703667270182804	0.009401756583357328	1.843204876330938	1.0	1.0	2025_01_Batch_13-14	false	false	true	false	true	true	false	false	false	false	false	false	0.8405673413539836	0.8791005004986361	0.8082757432568133	0.8973375345225314	0.8949879301410973	0.9092818256784829	0.9118915439970252	0.9096271708063013	0.926085518861056	0.8144729589799293	0.8796521570181974	0.839215238797434	0.9066721073599406	0.8803486894758934	0.8685895501840067	0.8020785275336973	0.8785488439790746	0.8419194439105332	SDHD	His102Pro	NC_000011.10:112089002:A:C	305A>C	11	112089002	A	C	11	ENSG00000204370	6363	0	CCSBVarC023321	ALE00022517	ENSP00000364699.3																																	926123.0	single nucleotide variant	NM_003002.4(SDHD):c.305A>C (p.His102Pro)	6392.0	SDHD	HGNC:10683	Likely pathogenic	1.0	May 06, 2021	104894302.0	-	RCV002241296	MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072	Cowden syndrome 3;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Pheochromocytoma	germline	germline	GRCh38	NC_000011.10	11	112089002.0	112089002.0	11q23.1	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	-	2.0	950869.0	112089002.0	A	C	-	-	-	-	-	-	305A>C 	His102Pro	NM_003002.4	1.0	Pathogenic	Likely pathogenic	950869	11	112089002.0	A	C	H	P	rs104894302	11	111959726	11	111464936	102	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.305A>C	p.His102Pro	c.305A>C	p.His102Pro	principal1	Y	1	YES	Select	+	CAT	2	0	A	./.	./.	./.	./.	0.003	0.91343	D	0.006	0.92967	D	0.999	0.77914	D	0.986	0.76920	D	1.0	0.99291	D	simple_aae	0.0	100.0	3.925	0.96220	H	-9.9	0.98744	D	0.974	0.99419	0.8482	0.94990	D	0.9986	0.99961	D	10	0.99432874	0.99941	D	0.720051	0.97730	D	0.929	0.98302	0.983	0.99835	O14521	H102P	Loss of loop (P = 0.2237)| Loss of helix (P = 0.2271)| Loss of catalytic residue at L101 (P = 0.3531)| Loss of stability (P = 0.4934)| Gain of glycosylation at H102 (P = 0.6204)	0.994429284596	0.99430	0.994954265430575	0.99492	0.94536333913	0.72230	0.556130588055	0.46655	T	0.976804	0.99782	D	0.567998	0.96540	D	0.578113	0.96482	D	0.99975723028183	0.98821	D	0.911209	0.68451	D	0.9729964	0.98507	0.93879443	0.97654	0.9567221	0.96900	0.9501346	0.98384	-12.078	0.92404	D	0.7574	0.75321	P	0.999806621831839	0.98063	0.99926025	0.99252	0.984	0.99450	.	.	.	.	.	.	4.880315	0.80073	27.2	0.95460008024022269	0.27217	0.982646	0.99906	D	0.671343308934847	0.77635	6.736192	0.508240574032574	0.68372	5.234679	5.04	3.86	0.43622	.	.	8.712	0.9112	9.318000	0.80050	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.699	0.34149	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Carney-Stratakis_syndrome|Cowden_syndrome_3|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss	criteria_provided,_single_submitter	NC_000011.10:g.112089002A>C	.	C1847319|CN166604|C0031511|C1868633	606864|171300	97286|201|29072	.	His	Pro	98.8	0.3858695652173913																																																																																																																																																																																																																																																																																																																																																																																																																																																																													71			98.8	Positively-charged	Histidine	heme b	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-3.2								 H102-G106 (PAE:  1.0), H102-A98 (PAE: 1.0)	H102-G106 (PDBs: 8GS8), H102-A98 (PDBs: 8GS8)	 H102-S73 (PAE:  1.0), H102-G106 (PAE: 1.0), H102-A98 (PAE: 1.0)	H102-V72 (PDBs: 8GS8), H102-G106 (PDBs: 8GS8), H102-A98 (PDBs: 8GS8), H102-S73 (PDBs: 8GS8)							155									-59.3		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-46.5						H (helix)	H (α-helix)	Helix								Helical			98.8	38.586956	>90	10-90	606864;171300	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA	false	0.8791005004986361	0.8405673413539836	false	false	false
RHO	RHO_Asp190Gly	B_13-14	-2.929431263260496	0.022042111608632748	0.048649942945025455	-20.557452822978444	1.6172969394705232e-7	7.061886158006236e-6	2025_01_Batch_13-14	true	true	false	false	false	false	true	true	false	false	false	false	0.9990895718837411	0.9994664453824342	0.5840940454258825	0.831839884575397	0.8459124555991275	0.7772944965434185	0.7846435989560069	0.8424769442735629	0.812776115235741	0.5654655254540454	0.9993493372455271	0.9986715389828486	0.7699453941308301	0.8493479669246923	0.8509036539150531	0.6027225653977195	0.9995835535193414	0.9995076047846337	RHO	Asp190Gly	NC_000003.12:129532289:A:G	569A>G	3	129532289	A	G	3	ENSG00000163914	40080645	0	CCSBVarC013544	ALE00012047	ENSP00000296271.3																																	28065.0	single nucleotide variant	NM_000539.3(RHO):c.569A>G (p.Asp190Gly)	6010.0	RHO	HGNC:10012	Pathogenic/Likely pathogenic	1.0	Oct 01, 2023	104893777.0	-	RCV000013900|RCV001386998|RCV003887863	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	Retinitis pigmentosa 4|not provided|Retinal dystrophy	germline	germline	GRCh38	NC_000003.12	3	129532289.0	129532289.0	3q22.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA256673,UniProtKB:P08100#VAR_004814,OMIM:180380.0014	3.0	13026.0	129532289.0	A	G	-	-	-	-	-	-	569A>G 	Asp190Gly	NM_000539.3	2.0	Pathogenic	Likely pathogenic	13026	3	129532289.0	A	G	D	G	rs104893777	3	129251132	3	130733822	190	RHO	ENSG00000163914	ENST00000296271	ENSP00000296271	P08100	OPSD_HUMAN	c.569A>G	p.Asp190Gly	c.569A>G	p.Asp190Gly	principal1	Y	1	YES	Select	+	GAC	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.018	0.60067	D	0.754	0.43372	P	0.826	0.59366	P	0.93	0.93829	A	simple_aae	7.0	93.0	3.785	0.95215	H	-5.64	0.86945	D	0.993	0.99866	-0.0993	0.80024	T	0.3223	0.68995	T	9	0.9891775	0.99365	D	0.192539	0.86214	D	0.664	0.87421	0.937	0.99098	P08100	D190G	Loss of ubiquitination at K195 (P = 0.0596)| Gain of catalytic residue at G188 (P = 0.097)| Loss of stability (P = 0.1082)| Gain of sheet (P = 0.1208)| Gain of methylation at K195 (P = 0.1246)	0.775995073384	0.77216	0.9390784996612188	0.93850	0.888851575013	0.69945	0.75512355566	0.75160	T	0.836933	0.96131	D	0.326972	0.84848	D	0.231896	0.84650	D	0.995872437953949	0.88134	D	0.983802	0.94524	D	0.9865587	0.99559	0.97526824	0.99667	0.9865587	0.99559	0.97526824	0.99668	-13.655	0.91898	D	0.9863	0.92535	P	0.999678264541609	0.97434	0.99981183	0.99752	0.961	0.98360	.	.	.	.	.	.	4.848578	0.79269	27.1	0.99740077491250712	0.83425	0.915171	0.87913	D	0.415179912855261	0.62061	4.438596	0.317870176801044	0.56361	3.822499	5.19	4.02	0.45905	.	.	9.32	0.95493	11.251000	0.90759	-0.083	0.16243	1.0	0.71675	1.000000	0.68239	0.259	0.23539	511	0.75154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	106	0	0	434	0	0	34	0	0	658	0	not_provided|Retinitis_pigmentosa_4|Retinal_dystrophy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.129532289A>G	ClinGen:CA256673|OMIM:180380.0014|UniProtKB:P08100#VAR_004814	C3661900|C3151001|C0854723	613731	791|71862	GPCR, rhodopsin-like, 7TM	Asp	Gly	96.4	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			96.4	Negatively-charged	Aspartic Acid		Rhodopsin										-3.5								 D190-N200 (PAE:  1.0), D190-R177 (PAE: 1.0)		 D190-N200 (PAE:  1.0), D190-R177 (PAE: 1.0)	D190-E181 (PDBs: 6CMO)							132									-68.6				98.1						C (loop/coil)	C (loop/coil)							Extracellular					96.4	0.0	>90	<10	613731	autosomal recessive	GenCC	Rare genetic eye disease; Ciliopathy	2	RETINITIS PIGMENTOSA 4	false	0.9994664453824342	0.9990895718837411	true	true	true
KRAS	KRAS_Ile36Met	B_13-14	-3.4018910795778345	0.011413064402871407	0.029902541851144566	7.234220244875865	0.0001722655236133858	0.0006067317386383166	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9692505835175627	0.9671496544810259	0.7682996094891552	0.83992782856366	0.8978341128796739	0.8310244910848036	0.6732857654395183	0.8122315743748246	0.6895174289135609	0.5806942559012689	0.9466328965397489	0.9533829894414467	0.9887632167300888	0.9834366513845232	0.9903382282137592	0.9559049630770416	0.9876664124223029	0.9851181775936785	KRAS	Ile36Met	NC_000012.12:25245277:T:C	108A>G	12	25245277	T	C	12	ENSG00000133703	3084	0	CCSBVarC006095	ALE00006095	ENSP00000308495.3	CEGS2	CegsMutGDEh1040	D09	GDEhDisVCh_40061	G09	1	CegsMutGDDh1040	D09	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	175716.0	single nucleotide variant	NM_004985.5(KRAS):c.108A>G (p.Ile36Met)	3845.0	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1.0	Oct 23, 2024	727503109.0	-	RCV000150891|RCV000260877|RCV000844636|RCV000856729|RCV002444616|RCV004551310	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:CN230736|	RASopathy|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|Cardiovascular phenotype|KRAS-related disorder	germline;unknown	germline	GRCh38	NC_000012.12	12	25245277.0	25245277.0	12p12.1	criteria provided, multiple submitters, no conflicts	11.0	-	N	UniProtKB:P01116#VAR_064854,ClinGen:CA273162	2.0	163768.0	25245277.0	T	C	-	-	-	-	-	-	108A>G 	Ile36Met	NM_004985.5	2.0	Pathogenic	Likely pathogenic	163768	12	25245277.0	T	C	I	M	rs727503109	12	25398211	12	25289478	36	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.108A>G	p.Ile36Met	c.108A>G	p.Ile36Met	alternative1	Y	1	.	Plus_Clinical	-	ATA	3	3	T	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.92967	D	0.999	0.77914	D	0.982	0.75481	D	0.83	0.88920	A	simple_aae	17.0	83.0	3.16	0.88393	M	-2.35	0.60859	N	0.866	0.95970	0.6818	0.92922	D	0.7745	0.92315	D	10	0.90810716	0.90066	D	0.260605	0.89466	D	0.864	0.95865	0.768	0.89476	P01116	I36M	Gain of catalytic residue at E31 (P = 0.0146)| Gain of disorder (P = 0.0401)| Gain of phosphorylation at Y40 (P = 0.0722)| Gain of glycosylation at T35 (P = 0.271)| Loss of sheet (P = 0.302)	0.957860125292	0.95704	0.8805200537522034	0.87945	2.38980543874	0.97077	0.802328705788	0.82287	T	0.899405	0.97995	D	0.388059	0.89138	D	0.319644	0.89001	D	0.964436054229736	0.66744	D	0.819518	0.90586	T	0.9472728	0.95925	0.8332933	0.90274	0.9514009	0.96352	0.7634177	0.85851	-13.662	0.93015	D	0.9755	0.92907	P	0.999853564238121	0.98365	0.99868040	0.98905	0.979	0.99252	.	.	.	.	.	.	3.518299	0.49383	22.8	0.99539106627103746	0.70435	0.242004	0.36148	N	0.613285447805062	0.73875	6.061257	0.51615875806198	0.68905	5.309093	5.68	4.51	0.54535	1.47	0.33823	0.81	0.26933	2.363000	0.32466	0.644	0.52462	1.0	0.71675	1.000000	0.68239	0.998	0.85369	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Cardiovascular_phenotype|Cardiofaciocutaneous_syndrome_1|RASopathy|not_provided|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|KRAS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245277T>C	ClinGen:CA273162|UniProtKB:P01116#VAR_064854	CN230736|CN029449|C5555857|C3661900|C0028326|C1275081	115150|PS163950|PS115150	1340|536391|648|1340	Small GTP-binding domain	Ile	Met	83.3	0.621301775147929																																																																																																																																																																																					0.592						-0.683						-1.056						-1.007				0.59				-0.783		-0.339		-0.026						-0.724						1.26	1 mutation(s) (Ile36Asn: 2.008)	1.396	1 mutation(s) (Ile36Thr: 2.144)	1.896	2 mutation(s) (Ile36Asn: 2.304, Ile36Pro: 2.349)	1.197		0.202																																																																																																																																																																																																																																						105			83.3	Aliphatic	Isoleucine		GTPase KRas; GTPase KRas, N-terminally processed								0.7716		4.5			B:I36-D:V369 (PDBs: 6PTS, 6PTW)	B:I36-A:T148 (PDBs: 8ECR), A:I36-B:T148 (PDBs: 8UN5), B:I36-D:N371 (PDBs: 6PTW), A:I36-B:V69 (PDBs: 8T74), C:I36-D:V69 (PDBs: 8T75), B:I36-C:N149 (PDBs: 8TBF), A:I36-D:N149 (PDBs: 8TBF)				 I36-A59 (PAE:  9.5)	I36-Y71 (PDBs: 6E6G), I36-A59 (PDBs: 2MSE)	 I36-Y64 (PAE:  13.5), I36-A59 (PAE: 9.5)	I36-A59 (PDBs: 5OCG, 6GJ6, 6GJ7, 6GJ8, 6GOD, 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8B78, 8JHL, 8ONV, 8QUG, 3GFT, 6MNX, 6MTA, 6QUU, 6QUV, 6QUW, 6QUX, 6VC8, 6ZLI, 7ACA, 7ACF, 7ACH, 8AQ7, 8B6I, 8ECR, 8T72, 8UN5, 2MSD, 2MSE, 5MLA, 5O2T, 6OB2, 6PTW, 6V65, 6W4E, 7SCW, 7VVB, 8QU8, 8QVU, 8T74, 8T75, 8TBF), I36-Y40 (PDBs: 6M9W), I36-R41 (PDBs: 6MQG, 6BOF), I36-Y64 (PDBs: 6VJJ)							131	Effector region								-91.9		Pocket 1: Mean pLDDT: 82.52, Volume: 1126.64 Å³, Druggability score: 0.77		-64.4				dbSNP: rs727503109; Variant type: LP/P; AA change: Ile36Met; PTM type: Phosphorylation; PTM morphology: TI*EDsyRkQVV; Var class: II&rs727503109		C (loop/coil)	S (bend)	Turn											83.3	62.130177	70-90	10-90	115150	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	CARDIOFACIOCUTANEOUS SYNDROME 1	false	0.9671496544810259	0.9692505835175627	false	false	false
RPS19	RPS19_Arg101His	B_13-14	-2.407724429948076	0.04693058430635163	0.08848708393398975	-2.241162505890439	0.05997493541979265	0.08358112955460112	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9120956293177086	0.8644795807162473	0.5524002362854905	0.5668524844204659	0.5286602159678184	0.5825204752945186	0.6376340657837142	0.5555154518605389	0.572946824142595	0.5931496481335674	0.880574748638074	0.9100934700079326	0.5274068848053228	0.501804980075098	0.5607581446983366	0.5116508244374137	0.8483844127944208	0.9140977886274846	RPS19	Arg101His	NC_000019.10:41869160:G:A	302G>A	19	41869160	G	A	19	ENSG00000105372	3441	0	CCSBVarC000468	ALE00000468	ENSP00000470972.1	RC4	RC4_Mut_GDEh1010	G11	GDEhDisVCh_40042	D02	2	RC4_Mut_GDDh1010	G11	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	1329648.0	single nucleotide variant	NM_001022.4(RPS19):c.302G>A (p.Arg101His)	6223.0	RPS19	HGNC:10402	Pathogenic/Likely pathogenic	1.0	Sep 20, 2024	2123284131.0	-	RCV001818012|RCV004594595	MedGen:C3661900|MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124	not provided|Diamond-Blackfan anemia 1	germline	germline	GRCh38	NC_000019.10	19	41869160.0	41869160.0	19q13.2	criteria provided, multiple submitters, no conflicts	2.0	-	N	-	2.0	1338641.0	41869160.0	G	A	-	-	-	-	-	-	302G>A 	Arg101His	NM_001022.4	2.0	Pathogenic	Likely pathogenic	1338641	19	41869160.0	G	A	R	H	rs2123284131	19	42373230	19	47065070	101	RPS19	ENSG00000105372	ENST00000593863	ENSP00000470004	P39019	RS19_HUMAN	c.302G>A	p.Arg101His	c.302G>A	p.Arg101His	principal1	Y	3	.	.	+	CGC	2	0	G	./.	./.	./.	./.	.	.	.	0.043	0.50294	D	0.576	0.38738	P	0.098	0.30481	B	0.98	0.97016	D	simple_aae	2.0	98.0	2.455	0.71058	M	.	.	.	0.85	0.84569	-0.6497	0.62566	T	0.1836	0.53023	T	9	0.9784213	0.97692	D	0.232972	0.88316	D	.	0.78612	0.944	0.99276	P39019	R101H	Loss of stability (P = 0.0435)| Loss of MoRF binding (P = 0.0519)| Loss of phosphorylation at S98 (P = 0.0846)| Loss of disorder (P = 0.1018)| Loss of methylation at K97 (P = 0.1559)	0.990308341565	0.99009	.	0.88980	.	0.79939	0.621480226517	0.55873	T	0.973089	0.99719	D	0.540061	0.95419	D	0.537984	0.95351	D	0.973375916481018	0.69870	D	0.919808	0.70916	D	0.7501296	0.80644	0.5398206	0.73150	0.59962654	0.72387	0.4817109	0.69730	-12.948	0.89171	D	0.9394	0.85818	P	0.998556217770197	0.94646	0.99979788	0.99739	0.552	0.74727	.	.	.	.	.	.	4.811919	0.78331	26.9	0.99767382566551488	0.85596	0.938159	0.93672	D	0.169104588964979	0.49474	3.169182	0.184437639525419	0.48733	3.108112	4.3	4.3	0.50482	.	.	6.962	0.75901	9.866000	0.82120	0.658	0.54518	1.0	0.71675	1.000000	0.68239	0.789	0.37304	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Diamond-Blackfan_anemia_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.41869160G>A	.	C3661900|C2676137	105650	124	Small ribosomal subunit protein eS19, conserved site	Arg	His	95.0	0.49193548387096775																																																																																																																																																																																																																																																																																																																																																																																																																																																																													122			95.0	Positively-charged	Arginine		Small ribosomal subunit protein eS19										-4.5								 R101-Q105 (PAE:  1.0), R101-K97 (PAE: 1.5)	R101-K97 (PDBs: 5A2Q, 5FLX, 5OA3, 6G18, 6G4S, 6G4W, 6YBS, 6ZLW, 6ZN5, 6ZOJ, 6ZOL, 6ZUO, 6ZV6, 6ZVH, 6ZXF, 6ZXG, 6ZXH, 7K5I, 7R4X, 7TQL, 7WTT, 7WTU, 7WTV, 7WTW, 7WTX, 7WTZ, 7WU0, 8PPK, 8T4S), R101-Q105 (PDBs: 6ZXD, 6ZXE, 8T4S)	 R101-Q105 (PAE:  1.0), R101-K97 (PAE: 1.5)	R101-K97 (PDBs: 5A2Q, 5FLX, 5OA3, 6G18, 6G4S, 6G4W, 6G51, 6G53, 6G5H, 6YBS, 6ZLW, 6ZMT, 6ZN5, 6ZOJ, 6ZOL, 6ZUO, 6ZV6, 6ZVH, 6ZXD, 6ZXE, 6ZXF, 6ZXG, 6ZXH, 7K5I, 7R4X, 7TQL, 7WTT, 7WTU, 7WTV, 7WTW, 7WTX, 7WTZ, 7WU0, 8PPK, 8T4S), R101-V72 (PDBs: 8T4S), R101-Q105 (PDBs: 8T4S)							175									-65.2				-48.4						H (helix)	H (α-helix)	Helix											95.0	49.19355	>90	10-90	105650	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare inborn errors of metabolism; Inherited cancer-predisposing syndrome	4	DIAMOND-BLACKFAN ANEMIA 1	false	0.8644795807162473	0.9120956293177086	false	false	false
RAF1	RAF1_Ser427Gly	B_13-14	-5.8571434739081925	0.08915991405016992	0.11832907078068074	4.521553491880699	0.022318231418365555	0.0313587391205787	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7425131866415617	0.7705423303352286	0.7287310241993448	0.8339175083480657	0.8270919505780758	0.8135238273655534	0.7933505379119956	0.8120882969315054	0.833336433282573	0.7274918546646718	0.8213037013237577	0.824116653871454	0.8336971168191112	0.8420956042246462	0.8344985834135584	0.7299701937340178	0.7197809593466995	0.6609097194116693	RAF1	Ser427Gly	NC_000003.12:12590889:T:C	1279A>G	3	12590889	T	C	3	ENSG00000132155	732	0	CCSBVarC008873	ALE00012146	ENSP00000251849.4																																	49086.0	single nucleotide variant	NM_002880.4(RAF1):c.1279A>G (p.Ser427Gly)	5894.0	RAF1	HGNC:9829	Pathogenic/Likely pathogenic	1.0	Mar 26, 2024	730881002.0	-	RCV000159084|RCV001852678|RCV001813271|RCV004668748	MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MedGen:CN230736	not provided|RASopathy|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype	germline	germline	GRCh38	NC_000003.12	3	12590889.0	12590889.0	3p25.2	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA297127	2.0	40616.0	12590889.0	T	C	-	-	-	-	-	-	1279A>G 	Ser427Gly	NM_002880.4	2.0	Pathogenic	Likely pathogenic	40616	3	12590889.0	T	C	S	G	rs730881002	3	12632388	3	12607388	427	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.1279A>G	p.Ser427Gly	principal3	Y	.	.	.	-	AGC	1	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.39532	.	1.0	0.90580	D	0.999	0.92348	D	.	0.93300	.	.	.	.	-1.72	0.00342	N	.	0.71557	.	.	0.91505	-0.2179	0.77104	T	0.2268	0.59002	T	10	.	0.70236	.	0.179624	0.85398	D	.	0.89880	0.82	0.93292	P04049	S427G	Loss of ubiquitination at K431 (P = 0.0801)| Loss of stability (P = 0.2308)| Gain of catalytic residue at S427 (P = 0.2489)| Gain of methylation at K431 (P = 0.262)| Loss of disorder (P = 0.2717)	.	0.96743	.	0.97149	.	0.96921	0.699861168861	0.67068	T	0.897908	0.97955	D	0.30741	0.83430	D	0.203797	0.83214	D	0.995037019252777	0.86609	D	.	0.92775	.	0.93729275	0.94895	0.8914141	0.94290	0.9370056	0.94866	0.8904818	0.94223	-13.689	0.92018	D	.	0.65901	.	0.999960555285628	0.99297	0.99608827	0.97958	0.619	0.78728	.	.	.	.	.	.	5.003768	0.83076	27.9	0.99859374417457669	0.93824	0.534511	0.55195	D	0.247654629085886	0.53289	3.520768	0.331680700016892	0.57182	3.906654	4.75	4.75	0.59904	5.35	0.93259	2.072	0.41239	7.869000	0.71902	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	690	0.58843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|RASopathy|Noonan_syndrome_and_Noonan-related_syndrome|Cardiovascular_phenotype	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.12590889T>C	ClinGen:CA297127	C3661900|C5555857|C5681679|CN230736	.	536391|98733	Protein kinase domain|Protein kinase domain|Protein kinase domain	Ser	Gly	90.83	0.13076923076923078																																																																																																																																																																																																																																																																																																																																																																																																																																																																													17			90.83	Polar/Neutral	Serine		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase	0.8539		-0.8				C:S427-B:M619 (PDBs: 8U1L)				 S427-L476 (PAE:  1.0)	S427-L476 (PDBs: 3OMV, 8CPD, 8GAE, 8U1L), S427-Q436 (PDBs: 8GFT)	 S427-H432 (PAE:  1.5), S427-L476 (PAE: 1.0)	S427-K431 (PDBs: 3OMV, 8CHF, 8CPD, 8GFT), S427-L476 (PDBs: 8GAE, 8U1L), S427-H432 (PDBs: 8U1L), S427-F475 (PDBs: 8U1L)							105									-132.8		Pocket 1: Mean pLDDT: 90.5, Volume: 729.78 Å³, Druggability score: 0.85		172.7						B (undefined)	E (parallel sheets)												90.83	13.076923	>90	10-90		autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.7705423303352286	0.7425131866415617	false	false	false
SDHD	SDHD_Gly106Val	B_13-14	3.3461453651413797	0.013103277931052443	0.032958705606770555	0.9865200194047619	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7493022962197753	0.7865985676146412	0.695345620254969	0.7859566557254272	0.8066126369686334	0.7692573176025057	0.781520300119428	0.8160840376021021	0.8063348751152505	0.7223697586544614	0.8023491712145363	0.7704468388953238	0.7569943350855833	0.7971412363351646	0.7655784363356039	0.6683214818554768	0.770847964014746	0.7281577535442268	SDHD	Gly106Val	NC_000011.10:112094807:G:T	317G>T	11	112094807	G	T	11	ENSG00000204370	6363	0	CCSBVarC023331	ALE00031717	ENSP00000364699.3																																	476439.0	single nucleotide variant	NM_003002.4(SDHD):c.317G>T (p.Gly106Val)	6392.0	SDHD	HGNC:10683	Pathogenic/Likely pathogenic	1.0	Sep 01, 2024	1555187574.0	-	RCV000561906|RCV000660262|RCV002232089|RCV003420005|RCV004808786	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201||MedGen:C3661900	Hereditary cancer-predisposing syndrome|Paragangliomas 1|Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3|SDHD-related disorder|not provided	germline	germline	GRCh38	NC_000011.10	11	112094807.0	112094807.0	11q23.1	criteria provided, multiple submitters, no conflicts	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382618730	2.0	480806.0	112094807.0	G	T	-	-	-	-	-	-	317G>T 	Gly106Val	NM_003002.4	2.0	Pathogenic	Likely pathogenic	480806	11	112094807.0	G	T	G	V	rs1555187574	11	111965531	11	111470741	106	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.317G>T	p.Gly106Val	c.317G>T	p.Gly106Val	principal1	Y	1	YES	Select	+	GGC	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.006	0.70891	D	1.0	0.90580	D	0.99	0.78943	D	0.78	0.86494	A	simple_aae	22.0	78.0	.	.	.	-8.4	0.97150	D	0.975	0.98575	0.8648	0.95197	D	0.9966	0.99920	D	10	0.99544626	0.99985	D	0.45813	0.94454	D	0.929	0.98302	0.982	0.99827	O14521	G106V	Loss of sheet (P = 0.0817)| Gain of helix (P = 0.132)| Loss of catalytic residue at L107 (P = 0.1641)| Loss of loop (P = 0.2237)| Loss of relative solvent accessibility (P = 0.3219)	0.957054369045	0.95622	0.98444967902886	0.98430	0.842846843757	0.67951	0.55555254221	0.46573	T	0.980291	0.99837	D	0.324438	0.84673	D	0.228256	0.84473	D	0.993092656135559	0.83635	D	0.79822	0.47259	T	0.94609135	0.95803	0.9640038	0.99168	0.9659864	0.97841	0.9694429	0.99432	-12.833	0.90765	D	0.8109	0.77749	P	0.998577411365903	0.94680	0.99942360	0.99371	0.988	0.99594	.	.	.	.	.	.	4.321877	0.66223	24.9	0.98815045644021704	0.46791	0.966887	0.98931	D	0.927619938196907	0.93007	11.78742	0.847271321840749	0.92817	11.67327	4.53	4.53	0.54956	.	.	9.578	0.97363	9.853000	0.82031	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.998	0.85369	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Paragangliomas_1|SDHD-related_disorder|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112094807G>T	ClinGen:CA382618730	C3494181|C1847319|C0031511|CN166604|C1868633|C0027672	168000|606864|171300	29072|97286|29072|201|140162	.	Gly	Val	98.58	0.4642857142857143																																																																																																																																																																																																																																																																																																																																																																																																																																																																													39			98.58	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-0.4								 G106-V110 (PAE:  1.0), G106-H102 (PAE: 1.0)	G106-V110 (PDBs: 8GS8), G106-H102 (PDBs: 8GS8)	 G106-V110 (PAE:  1.0), G106-H102 (PAE: 1.0)	G106-V110 (PDBs: 8GS8), G106-H102 (PDBs: 8GS8)							75									-59.6		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-51.8						H (helix)	H (α-helix)	Helix								Helical			98.58	46.42857	>90	10-90	168000;606864;171300	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA	false	0.7865985676146412	0.7493022962197753	false	false	false
FH	FH_Pro174Arg	B_13-14	10.162270857596216	0.000052836229120136614	0.0005901590504062043	-7.177547434631301	0.00018095749496161906	0.0006277070004812306	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9050089580829621	0.8641457459010218	0.5569681718750805	0.8832007620560737	0.7801408978154767	0.6808344947270225	0.6808344947270225	0.7801408978154767	0.8832007620560737	0.5569681718750805	0.8641457459010218	0.8513404236504645						0.9586774925154596	FH	Pro174Arg	NC_000001.11:241512001:G:C	521C>G	1	241512001	G	C	1	ENSG00000091483	3408	0	CCSBVarC004048	ALE00004048	ENSP00000355518.4	CEGS2	CegsMutGDEh1039	D09	GDEhDisVCh_40065	C08	1	CegsMutGDDh1039	D09	NULL	NULL	NULL	NULL	NULL	NULL	1.0	3.0	1.0	3.0	0.0			0.0			0.0			N	N	N	N	N	38660.0	single nucleotide variant	NM_000143.4(FH):c.521C>G (p.Pro174Arg)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	May 28, 2024	199822819.0	-	RCV000492836|RCV000022554|RCV000078149|RCV003335052|RCV003483435	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MedGen:C3661900||Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523;MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	Hereditary cancer-predisposing syndrome|Fumarase deficiency|not provided|FH-related disorder|Hereditary leiomyomatosis and renal cell cancer;Fumarase deficiency	germline;unknown	germline	GRCh38	NC_000001.11	1	241512001.0	241512001.0	1q43	criteria provided, multiple submitters, no conflicts	18.0	-	N	ClinGen:CA220381,OMIM:136850.0010	3.0	29705.0	241512001.0	G	C	-	-	-	-	-	-	521C>G 	Pro174Arg	NM_000143.4	2.0	Pathogenic	Likely pathogenic	29705	1	241512001.0	G	C	P	R	rs199822819	1	241675301	1	239741924	174	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.521C>G	p.Pro174Arg	c.521C>G	p.Pro174Arg	principal1	Y	1	YES	Select	-	CCT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.016	0.61305	D	0.999	0.77914	D	0.981	0.75172	D	0.6	0.76851	A	simple_aae	40.0	60.0	2.505	0.72748	M	-7.67	0.95559	D	0.969	0.97975	1.0331	0.97771	D	0.9867	0.99604	D	10	0.9749284	0.97191	D	0.717923	0.97710	D	0.961	0.99405	.	.	.	.	.	0.987495772737	0.98721	0.8682662705529591	0.86710	0.978554424983	0.73484	0.763472080231	0.76405	T	0.951848	0.99304	D	0.469226	0.93253	D	0.566685	0.96142	D	0.918809771537781	0.57480	D	0.976702	0.91928	D	0.8966469	0.90957	0.89710534	0.94698	0.8966469	0.90959	0.89710534	0.94699	-13.629	0.91805	D	0.8317	0.78770	P	0.969616269158006	0.83212	0.92770165	0.92291	0.975	0.99076	.	.	.	.	.	.	5.112622	0.85504	28.6	0.9981003855289049	0.89450	0.904483	0.85431	D	0.949310228068722	0.93923	12.39802	0.89439856430428	0.95298	13.5147	5.24	5.24	0.72825	.	.	9.079	0.9345	11.757000	0.95546	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	968	0.07020	.	.	.	.	.	.	.	.	.	.	.	.	8	264690	3.0224035E-5	.	3	109368	2.743030e-05	0	3	208072	1.441810e-05	0	5	236768	2.111770e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13354	0.000000e+00	0	3	42768	7.014590e-05	0	0	15690	0.000000e+00	0	3	42768	7.014590e-05	0	0	16216	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16694	0.000000e+00	0	3	89538	3.350530e-05	0	0	30608	0.000000e+00	0	3	89538	3.350530e-05	0	0	14900	0.000000e+00	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21592	0.000000e+00	0	5	102618	4.872440e-05	0	0	30526	0.000000e+00	0	5	102618	4.872440e-05	0	.	234	1613826	1.449970e-04	0	230	1179928	1.949270e-04	0	0	74900	0.000000e+00	0	0	912	0.000000e+00	0	0	60000	0.000000e+00	0	0	29598	0.000000e+00	0	0	44872	0.000000e+00	0	0	63972	0.000000e+00	0	0	6082	0.000000e+00	0	230	1179928	1.949270e-04	0	0	91076	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	1	2784	3.5919540229885057E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	1	2898	3.450655624568668E-4	0	112	0	1	14050	7.117437722419929E-5	Fumarase_deficiency|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome|FH-related_disorder|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241512001G>C	ClinGen:CA220381|OMIM:136850.0010	C0342770|C1708350|C0027672|C3661900	606812|150800	24|523|140162	Fumarate lyase, N-terminal	Pro	Arg	98.34	0.35294117647058826																																																																																																																																																																																																																																																																																																																																																																																																																																																																													48			98.34	Special, No backbone hydrogen	Proline		Fumarate hydratase, mitochondrial										1.6																		115									-83.9				-2.6						C (loop/coil)	S (bend)												98.34	35.294117	>90	10-90	606812;150800;606812	multiple	OMIM	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	FUMARASE DEFICIENCY; HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; FUMARASE DEFICIENCY	false	0.8641457459010218	0.9050089580829621	false	false	false
CTCF	CTCF_Arg342Gly	B_13-14	6.0220837101592055	0.0005304623673855454	0.0028620992138598637	-0.01663644363920429	0.9871908981233763	0.9898881410144239	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9000891711073115	0.9277879968247847	0.5989057138426654	0.7726288411575943	0.7999476191762898	0.6448284039260976	0.7222151771123154	0.8270571512905369	0.7946378138100538	0.6527614402009104	0.9336875372392056	0.9121180928056387	0.5674416307398799	0.7728380870620427	0.7506198685051348	0.5450499874844204	0.9218884564103639	0.8880602494089842	CTCF	Arg342Gly	NC_000016.10:67616816:C:G	1024C>G	16	67616816	C	G	16	ENSG00000102974	6173	0	CCSBVarC010867	ALE00015227	ENSP00000264010.4																																	1166187.0	single nucleotide variant	NM_006565.4(CTCF):c.1024C>G (p.Arg342Gly)	10664.0	CTCF	HGNC:13723	Likely pathogenic	1.0	Feb 01, 2021	1131691283.0	-	RCV001532325	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000016.10	16	67616816.0	67616816.0	16q22.1	criteria provided, single submitter	1.0	-	N	-	2.0	1176667.0	67616816.0	C	G	-	-	-	-	-	-	1024C>G 	Arg342Gly	NM_006565.4	1.0	Pathogenic	Likely pathogenic	1176667	16	67616816.0	C	G	R	G	rs1131691283	16	67650719	16	66208220	342	CTCF	ENSG00000102974	ENST00000644753	ENSP00000493495	P49711	CTCF_HUMAN	c.1024C>G	p.Arg342Gly	c.1024C>G	p.Arg342Gly	principal4	Y	.	.	.	+	CGT	1	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.79703	.	0.997	0.70687	D	0.993	0.81117	D	.	0.93829	.	.	.	.	2.485	0.72164	M	.	0.91330	.	.	0.79815	-0.8813	0.49460	T	0.1541	0.48246	T	10	0.8994916	0.89190	D	0.046837	0.62502	D	.	0.85178	0.787	0.90945	P49711	R342G	Loss of stability (P = 0.0064)| Loss of MoRF binding (P = 0.0492)| Gain of methylation at K344 (P = 0.0961)| Gain of phosphorylation at Y343 (P = 0.1164)| Loss of disorder (P = 0.1303)	.	0.90579	.	0.96335	.	0.99365	0.949047386646	0.99729	D	0.857179	0.96774	D	0.260551	0.79429	D	0.136487	0.79163	D	0.986837384407801	0.77291	D	.	0.80202	.	0.9000301	0.91262	0.84071624	0.90766	0.9000301	0.91263	0.84071624	0.90766	-15.136	0.96171	D	.	0.97655	.	0.999648397760086	0.97310	0.96604900	0.94367	0.857	0.92182	.	.	.	.	.	.	4.995947	0.82886	27.9	0.99693360905744033	0.80133	0.947897	0.95882	D	0.75661128044812	0.83245	7.990627	0.730908088587966	0.84641	8.37291	4.89	4.89	0.63341	.	.	7.701	0.83585	7.609000	0.61899	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.995	0.73271	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000016.10:g.67616816C>G	.	C3661900	.	.	.	Arg	Gly	86.65	0.40725806451612906																																																																																																																																																																																																																																																																																																																																																																																																																																																																													101			86.65	Positively-charged	Arginine		Transcriptional repressor CTCF										-4.5								 R342-V338 (PAE:  1.0)	R342-V338 (PDBs: 5KKQ, 5T00, 5T0U, 7W1M, 8SSQ, 8SSR, 8SSS), R342-T346 (PDBs: 5YEF), R342-H347 (PDBs: 8SSS)	 R342-H347 (PAE:  3.0), R342-E348 (PAE: 4.5), R342-V338 (PAE: 1.0), R342-T346 (PAE: 3.0)	R342-T346 (PDBs: 5KKQ, 5T00, 5T0U, 5YEF, 7W1M, 8SSQ, 8SSR, 8SSS), R342-V361 (PDBs: 8SSS), R342-E348 (PDBs: 8SSS), R342-H347 (PDBs: 8SSS), R342-V338 (PDBs: 8SSS)							175									-65.5				-35.5				dbSNP: -; Variant type: US; AA change: Arg342His; PTM type: Phosphorylation; PTM morphology: VRHRR*yKHtHE; Var class: II&-		H (helix)	H (α-helix)	Helix										C2H2-type 3	86.65	40.725807	70-90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.9277879968247847	0.9000891711073115	false	false	false
BRAF	BRAF_Asp565Glu	B_13-14	-2.6309360210738006	0.0338665149617909	0.06834139219533004	2.824515004016611	0.025606847300471365	0.039157137330304126	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6245881080087362	0.6752033045868744	0.4980426192848819	0.6487708480116079	0.6258077654224552	0.5202982761410189	0.5289157411484332	0.6632301135653816	0.6209813806207429	0.5016802177969433	0.7059668890735633	0.6661231738818835	0.5116808111336045	0.5883854172795289	0.6765603154024729	0.49440502077282056	0.6444397201001855	0.583053042135589	BRAF	Asp565Glu	NC_000007.14:140754233:A:C	1695T>G	7	140754233	A	C	7	ENSG00000157764	71969	0	CCSBVarC003170	ALE00003170	ENSP00000493543.1	CEGS2	CegsMutGDEh1012	F06	GDEhDisVCh_40058	F04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	48853.0	single nucleotide variant	NM_004333.6(BRAF):c.1695T>G (p.Asp565Glu)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Dec 29, 2016	397507480.0	-	RCV000037927|RCV000207514|RCV001813224	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733	Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome and Noonan-related syndrome	de novo;germline	germline	GRCh38	NC_000007.14	7	140754233.0	140754233.0	7q34	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA280016	2.0	40383.0	140754233.0	A	C	-	-	-	-	-	-	1695T>G 	Asp565Glu	NM_004333.6	2.0	Pathogenic	Likely pathogenic	40383	7	140754233.0	A	C	D	E	rs397507480	7	140454033	7	140100502	565	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1695T>G	p.Asp565Glu	c.1695T>G	p.Asp565Glu	principal4	Y	.	YES	Select	-	GAT	3	2	A	A/A	A/A	A/A	A/A	.	.	.	.	.	.	0.008	0.14667	B	0.025	0.20509	B	.	0.76851	.	.	.	.	-0.19	0.04221	N	.	.	.	.	.	-1.0620	0.11274	T	0.0795	0.31365	T	10	0.86869705	0.85975	D	.	.	.	.	0.82085	0.809	0.92541	P15056	D565E	Gain of catalytic residue at D565 (P = 0.0544)| Gain of ubiquitination at K570 (P = 0.1162)| Gain of methylation at K570 (P = 0.1449)| Gain of disorder (P = 0.2432)| Loss of helix (P = 0.3949)	.	0.97114	.	0.85572	.	0.71418	0.891400456429	0.95428	D	0.799272	0.94819	D	0.275835	0.80817	D	0.158442	0.80570	D	0.875816404819489	0.52308	D	0.918508	0.70644	D	0.80036193	0.83724	0.73096305	0.83912	0.8693574	0.88657	0.7036775	0.82332	-8.348	0.63492	D	0.9665	0.94256	P	0.983874848762311	0.86325	0.99816126	0.98658	0.689	0.82741	.	.	.	.	.	.	4.448549	0.69197	25.3	0.99305136928065907	0.58857	0.621801	0.60495	D	0.388200223436253	0.60579	4.271038	0.431391921300296	0.63332	4.588634	5.26	4.11	0.47290	5.52	0.94476	3.206	0.50896	9.383000	0.80559	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	789	0.46282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	2	426	0.004694835680751174	0	0	0	0	0	0	0	0	0	0	0	0	1	52	0.019230769230769232	2	426	0.004694835680751174	0	0	0	3	478	0.006276150627615063	Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140754233A>C	ClinGen:CA280016	C1275081|C5681679|C3661900	PS115150	1340|98733	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Asp	Glu	98.17	0.25153374233128833																																																																																																																																																																																																																																																																																																																																																																																																																																																																													41			98.17	Negatively-charged	Aspartic Acid		Serine/threonine-protein kinase B-raf							Protein kinase			-3.5			A:D565-B:H477 (PDBs: 2FB8, 3II5, 3PPJ, 3PSB, 3PSD, 3Q4C, 3Q96, 3SKC, 3TV6, 4DBN, 4E26, 4E4X, 4EHE, 4FC0, 4G9C, 4KSP, 4KSQ, 4MBJ, 4PP7, 5CSW, 5CT7, 5HID, 5VAL, 5VAM, 6CAD, 6N0P, 6N0Q, 8C7X, 8C7Y, 8F7P), B:D565-A:H477 (PDBs: 3D4Q, 6B8U), A:D565-C:H477 (PDBs: 4H58, 8QQG), B:D565-C:H477 (PDBs: 4MNE, 6UAN), D:D565-C:H477 (PDBs: 6U2H), C:D565-D:H477 (PDBs: 6XAG), K:D565-A:R196 (PDBs: 7ZR0)	A:D565-B:H477 (PDBs: 2FB8, 3D4Q, 3II5, 3PPJ, 3PRI, 3PSB, 3PSD, 3Q4C, 3Q96, 3SKC, 3TV4, 3TV6, 4DBN, 4E26, 4E4X, 4EHE, 4FC0, 4G9C, 4KSP, 4KSQ, 4MBJ, 4PP7, 5CSW, 5CT7, 5HID, 5VAL, 5VAM, 6CAD, 6N0P, 6N0Q, 8C7X, 8C7Y, 8F7O, 8F7P), A:D565-C:H477 (PDBs: 4H58, 8QQG), B:D565-C:H477 (PDBs: 4MNE, 6UAN), C:D565-D:H477 (PDBs: 6U2H, 6XAG), A:D565-C:K212 (PDBs: 8DGS)				 D565-A569 (PAE:  1.0), D565-A561 (PAE: 1.0)	D565-A561 (PDBs: 5CSX, 6P3D, 2FB8, 3D4Q, 3II5, 3PPJ, 3PPK, 3PRF, 3PRI, 3PSB, 3PSD, 3Q4C, 3Q96, 3SKC, 3TV4, 3TV6, 4DBN, 4E26, 4E4X, 4EHE, 4FC0, 4G9C, 4H58, 4KSP, 4KSQ, 4MBJ, 4PP7, 5CSW, 5CT7, 5FD2, 5HID, 5HIE, 5VAL, 5VAM, 6B8U, 6CAD, 6N0P, 6N0Q, 6V2U, 7P3V, 7SHV, 8C7X, 8C7Y, 8F7O, 8F7P, 8QQG, 4MNE, 6NYB, 6PP9, 6Q0K, 6U2G, 6U2H, 6V2W, 6XAG, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 7MFF, 7ZR0, 7ZR5, 7ZR6, 8DGS, 8DGT), D565-A569 (PDBs: 6P3D, 6UAN, 7MFD, 7MFE, 8DGT)	 D565-A569 (PAE:  1.0), D565-A561 (PAE: 1.0)	D565-A561 (PDBs: 5CSX, 6P3D, 2FB8, 3D4Q, 3II5, 3PPJ, 3PPK, 3PRF, 3PRI, 3PSB, 3PSD, 3Q4C, 3Q96, 3SKC, 3TV4, 3TV6, 4DBN, 4E26, 4E4X, 4EHE, 4FC0, 4G9C, 4H58, 4KSP, 4KSQ, 4MBJ, 4PP7, 5CSW, 5CT7, 5FD2, 5HID, 5HIE, 5VAL, 5VAM, 6B8U, 6CAD, 6N0P, 6N0Q, 6V2U, 7P3V, 7SHV, 4MNE, 6NYB, 6PP9, 6Q0K, 6U2G, 6U2H, 6UAN, 6V2W, 6XAG, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 7MFD, 7MFE, 7MFF, 7ZR0, 7ZR6, 8DGS, 8DGT), D565-A569 (PDBs: 6P3D, 8DGT), D565-F707 (PDBs: 8C7X, 8C7Y, 8F7O, 8F7P, 8QQG), D565-L711 (PDBs: 7ZR5), D565-P708 (PDBs: 8DGT)							132									-57.1				-46.0						H (helix)	H (α-helix)	Helix											98.17	25.153374	>90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		true	0.6752033045868744	0.6245881080087362	false	false	false
F9	F9_Cys335Tyr	B_13-14	-4.914890869136402	0.001723632887315511	0.007034484646950056	6.1415257607915965	0.00047143849918395233	0.001324792719758886	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9697682723489587	0.9641102578568368	0.6592599008990849	0.7602857660698525	0.761948458865255	0.6962997115900095	0.7174698358884815	0.8081991681689545	0.8002841096725551	0.6967820016081532	0.9536249815012614	0.9600314092882557	0.6751295872915375	0.7156977495615553	0.7202874224671498	0.6217378001900166	0.9745955342124121	0.9795051354096616	F9	Cys335Tyr	NC_000023.11:139561689:G:A	1004G>A	23	139561689	G	A	X	ENSG00000101981	52861	0	CCSBVarC030611	ALE00034321	ENSP00000218099.2																																	2417857.0	single nucleotide variant	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Feb 23, 2023	-1.0	-	RCV003152922	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561689.0	139561689.0	Xq27.1	criteria provided, single submitter	1.0	-	N	-	2.0	2444124.0	139561689.0	G	A	-	-	-	-	-	-	1004G>A 	Cys335Tyr	NM_000133.4	1.0	Pathogenic	Likely pathogenic	2444124	X	139561689.0	G	A	C	Y	.	X	138643848	X	138471514	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1004G>A	p.Cys335Tyr	c.1004G>A	p.Cys335Tyr	principal1	Y	1	YES	Select	+	TGC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	D	simple_aae	2.0	98.0	3.995	0.96666	H	-10.94	0.99269	D	0.878	0.99419	1.0812	0.98918	D	0.9328	0.97780	D	10	0.9946557	0.99955	D	0.929597	0.99487	D	0.959	0.99346	0.961	0.99597	P00740	C335Y	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.997392873545	0.99732	0.9999824557020938	0.99998	2.12843697498	0.95120	0.725244283676	0.70762	T	0.971543	0.99693	D	0.699893	0.99928	D	0.767572	0.99928	D	0.999975562095642	0.99958	D	0.924008	0.72162	D	0.9958085	0.99978	0.9928213	0.99993	0.9953884	0.99970	0.9910561	0.99985	-10.266	0.75565	D	0.986	0.92459	P	0.999974611784801	0.99427	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.989535	0.82746	27.9	0.99785198512514828	0.87142	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.568	0.97322	11.887000	0.98990	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561689G>A	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Tyr	96.87	0.007407407407407408																																																																																																																																																																																																																																																																																																																																																																																																															0.169	1 mutation(s) (Cys335Leu: -0.045)	0.101		0.083	1 mutation(s) (Cys335Ile: -0.004)	0.083	3 mutation(s) (Cys335Phe: -0.014, Cys335Leu: -0.009, Cys335Ala: -0.006)	0.096	1 mutation(s) (Cys335Trp: -0.002)																																																					1			96.87	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa heavy chain						Disulfide bond 178-335	Peptidase S1			2.5				A:C335-B:G344 (PDBs: 6X5J, 6X5L), H:C335-L:C221 (PDBs: 8OL9), H:C335-L:G222 (PDBs: 8OL9)				 C335-L425 (PAE:  1.0), C335-S423 (PAE: 1.0)	C335-L425 (PDBs: 6X5J, 6X5L, 8OL9)	 C335-G179 (PAE:  1.5), C335-L425 (PAE: 1.0), C335-C178 (PAE: 1.5)	C335-L425 (PDBs: 6X5J, 6X5L, 8OL9), C335-F424 (PDBs: 8OL9), C335-T422 (PDBs: 8OL9), C335-S423 (PDBs: 8OL9)							121									-73.1				140.5						B (undefined)	B (beta bridge)												96.87	0.7407407	>90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.9641102578568368	0.9697682723489587	false	false	false
FARS2	FARS2_Ile329Thr	B_13-14	-2.2456562230357777	1.0	1.0	-1.3257036731028407	0.3744974347038238	0.40916475676472064	2025_01_Batch_13-14	false	false	true	false	false	false	false	false	false	false	false	false	0.6924941537644381	0.7360240883814859	0.8887727640180996	0.7985128819751673	0.7773981379948148	0.8914421374508407	0.9534231268933783	0.8294198099636416	0.8407031244262554	0.9426916607422504	0.7909770439963231	0.7734180996767248	0.8294611480083031	0.725376466025988	0.7563226395240793	0.8348538672939488	0.6810711327666488	0.6115702078521514	FARS2	Ile329Thr	NC_000006.12:5545261:T:C	986T>C	6	5545261	T	C	6	ENSG00000145982	12653	0	CCSBVarC011924	ALE00012104	ENSP00000274680.4																																	48424.0	single nucleotide variant	NM_006567.5(FARS2):c.986T>C (p.Ile329Thr)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Jun 13, 2018	397514611.0	-	RCV000033045	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5545261.0	5545261.0	6p25.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA130597,UniProtKB:O95363#VAR_069488,OMIM:611592.0002	3.0	39825.0	5545261.0	T	C	-	-	-	-	-	-	986T>C 	Ile329Thr	NM_006567.5	1.0	Pathogenic	Likely pathogenic	39825	6	5545261.0	T	C	I	T	rs397514611	6	5545494	6	5490493	329	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.986T>C	p.Ile329Thr	c.986T>C	p.Ile329Thr	principal1	Y	1	YES	Select	+	ATC	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	A	simple_aae	3.0	97.0	4.21	0.97827	H	-4.83	0.80975	D	0.969	0.97975	0.7613	0.93913	D	0.7276	0.90648	D	10	0.9569025	0.95004	D	0.551967	0.95867	D	0.926	0.98190	0.769	0.89555	O95363	I329T	Loss of stability (P = 0.0021)| Gain of phosphorylation at I329 (P = 0.0509)| Loss of helix (P = 0.1299)| Gain of sheet (P = 0.1945)| Gain of loop (P = 0.2754)	0.979357470534	0.97892	.	0.96169	.	0.63719	0.75597679615	0.75288	T	0.633828	0.88570	D	0.383	0.88822	D	0.376023	0.91225	D	0.998961210250854	0.95690	D	0.994531	0.98201	D	0.94993186	0.96200	0.90557504	0.95310	0.9474884	0.95948	0.88929117	0.94138	-13.546	0.91505	D	0.899	0.83150	P	0.999640102774092	0.97310	0.97331387	0.94918	0.992	0.99727	.	.	.	.	.	.	5.001397	0.83025	27.9	0.99868570309340743	0.94641	0.907023	0.86001	D	0.963131837071811	0.94462	12.80027	0.855816931618299	0.93315	11.98561	5.27	5.27	0.73761	3.3	0.59857	7.646	0.82647	7.746000	0.68123	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.99	0.65338	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109404	1.828090e-05	0	3	208122	1.441460e-05	0	3	236776	1.267020e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	2	42768	4.676390e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13410	0.000000e+00	0	0	16734	0.000000e+00	0	3	89552	3.350010e-05	0	0	30608	0.000000e+00	0	3	89552	3.350010e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9570	0.000000e+00	0	0	17686	0.000000e+00	0	0	21632	0.000000e+00	0	3	102598	2.924030e-05	0	0	30526	0.000000e+00	0	3	102598	2.924030e-05	0	.	3	1614088	1.858630e-06	0	1	64042	1.561480e-05	0	0	75056	0.000000e+00	0	0	912	0.000000e+00	0	0	60022	0.000000e+00	0	0	29604	0.000000e+00	0	0	44882	0.000000e+00	0	1	64042	1.561480e-05	0	0	6062	0.000000e+00	0	0	1179922	0.000000e+00	0	0	91082	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5545261T>C	ClinGen:CA130597|OMIM:611592.0002|UniProtKB:O95363#VAR_069488	C4755312	614946	319519	Aminoacyl-tRNA synthetase, class II	Ile	Thr	97.54	0.029585798816568046																																																																																																																																																																																																																																																																																																																																																																																																																																																																													5			97.54	Aliphatic	Isoleucine										0.839		4.5								 I329-S185 (PAE:  1.0)	I329-S185 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP)	 I329-S185 (PAE:  1.0)	I329-M321 (PDBs: 3CMQ, 3HFV, 5MGV, 5MGW, 8P8X, 3TUP), I329-S185 (PDBs: 3TEG, 5MGH, 5MGU, 8P8X, 3TUP), I329-W333 (PDBs: 8P8X), I329-E317 (PDBs: 8P8X), I329-H187 (PDBs: 8P8X), I329-Y188 (PDBs: 8P8X)							131									-59.9		Pocket 1: Mean pLDDT: 88.57, Volume: 570.18 Å³, Druggability score: 0.84		-23.1						H (helix)	G (3₁₀-helix)	Helix											97.54	2.95858	>90	<10	614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.7360240883814859	0.6924941537644381	false	false	false
G6PD	G6PD_Ile48Thr	B_13-14	-0.2620179732240577	0.8008506093363101	0.8427684098249875	-6.2877602803466734	0.0004089585762908782	0.0011874034612243062	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.911175000208768	0.8952939636245199	0.6484815144540186	0.7581734767149401	0.7447406276134273	0.7263381065508673	0.4929653099290684	0.5848242259811773	0.5449287049870679	0.4784095260178308	0.8744537111295743	0.88044839354374	0.9597109031726662	0.9046570292456773	0.9714182484428122	0.8185535028902065	0.9161342161194653	0.941901606873796	G6PD	Ile48Thr	NC_000023.11:154536156:A:G	143T>C	23	154536156	A	G	X	ENSG00000160211	4006	0	CCSBVarC021436	ALE00030876	ENSP00000377192.3																																	25441.0	single nucleotide variant	NM_000402.4(G6PD):c.233T>C (p.Ile78Thr)	2539.0	G6PD	HGNC:4057	Pathogenic/Likely pathogenic	1.0	Aug 31, 2024	76645461.0	-	RCV000011145|RCV000224890|RCV000704108|RCV001796957|RCV002482854|RCV003466850|RCV004748514	|MedGen:C3661900|MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026|MONDO:MONDO:0005775,MedGen:C2939465|MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026;MONDO:MONDO:0021024,MedGen:C1970028,OMIM:611162,Orphanet:673|MONDO:MONDO:0021024,MedGen:C1970028,OMIM:611162,Orphanet:673|	G6PD AURES|not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	154536156.0	154536156.0	Xq28	criteria provided, multiple submitters, no conflicts	16.0	-	N	ClinGen:CA121021,OMIM:305900.0043,ClinVar:1722711,ClinVar:1722739	3.0	10402.0	154536156.0	A	G	-	-	-	-	-	-	233T>C 	Ile78Thr	NM_000402.4	2.0	Pathogenic	Likely pathogenic	10402	X	154536156.0	A	G	I	T	rs76645461	X	153764371	X	153417565	48	G6PD	ENSG00000160211	ENST00000393564	ENSP00000377194	P11413	G6PD_HUMAN	c.143T>C	p.Ile48Thr	c.143T>C	p.Ile48Thr	principal4	Y	5	.	.	-	ATC	2	0	A	A/A	A/A	A/A	A/A	1.0	0.06776	T	0.771	0.06347	T	0.985	0.61134	D	0.964	0.71005	D	0.99	0.97926	A	simple_aae	1.0	99.0	1.365	0.34008	L	-3.37	0.66695	D	0.796	0.86268	0.9127	0.95840	D	0.9334	0.97801	D	10	0.9249425	0.91752	D	0.178446	0.85319	D	0.800	0.93443	0.956	0.99517	P11413	I48T	Gain of disorder (P = 0.0198)| Loss of stability (P = 0.024)| Loss of catalytic residue at P50 (P = 0.0321)| Gain of glycosylation at P50 (P = 0.0902)| Loss of methylation at K47 (P = 0.1012)	0.999291972508	0.99927	.	.	.	0.66127	0.810541808605	0.83546	D	0.864655	0.97001	D	0.423939	0.91161	D	0.630861	0.97650	D	0.353604669620596	0.26859	T	.	0.93807	.	0.83749527	0.86250	0.6371406	0.78580	0.7755391	0.82164	0.66341555	0.80049	-5.158	0.46017	T	0.8079	0.82620	P	0.998863967322053	0.95207	0.99580365	0.97879	0.66	0.81095	.	.	.	.	.	.	4.373753	0.67426	25.1	0.87607992308164628	0.17599	.	.	.	.	.	.	.	.	.	5.38	4.19	0.48586	.	.	7.094	0.76658	9.206000	0.79242	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.998	0.85369	80	0.96675	1	2.6490066225165563E-4	0	0.0	0	0.0	0	0.0	1	0.0013089005235602095	0	0.0	4	264690	1.51120175E-5	.	1	80339	1.244730e-05	0	2	151847	1.317120e-05	0	2	172177	1.161600e-05	0	0	5699	0.000000e+00	0	0	13664	0.000000e+00	0	0	1767	0.000000e+00	0	1	6917	1.445710e-04	0	0	9932	0.000000e+00	0	0	30958	0.000000e+00	0	0	9952	0.000000e+00	0	1	6917	1.445710e-04	0	0	13129	0.000000e+00	0	0	24387	0.000000e+00	0	0	4649	0.000000e+00	0	2	10129	1.974530e-04	0	0	12190	0.000000e+00	0	0	64662	0.000000e+00	0	0	19075	0.000000e+00	0	2	10129	1.974530e-04	0	0	12061	0.000000e+00	0	0	27165	0.000000e+00	0	0	7072	0.000000e+00	0	2	13320	1.501500e-04	0	0	15974	0.000000e+00	0	0	73427	0.000000e+00	0	0	19010	0.000000e+00	0	2	13320	1.501500e-04	0	.	17	1209926	1.405040e-05	0	10	4355	2.296210e-03	0	1	57219	1.747670e-05	0	0	678	0.000000e+00	0	0	45816	0.000000e+00	0	0	22029	0.000000e+00	0	2	33749	5.926100e-05	0	0	46637	0.000000e+00	0	10	4355	2.296210e-03	0	0	895021	0.000000e+00	0	0	56799	0.000000e+00	0	0	18236	0	0	122	0	0	342	0	0	3122	0	0	178	0	0	780	0	0	58	0	0	116	0	0	516	0	0	3244	0	0	400	0	0	23470	0	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency|Malaria,_susceptibility_to|G6PD_AURES|G6PD_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.154536156A>G	ClinGen:CA121021|OMIM:305900.0043	C2720289|C1970028|C2939465|C3661900	300908|611162	466026|673	Glucose-6-phosphate dehydrogenase, NAD-binding	Ile	Thr	98.02	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.02	Aliphatic	Isoleucine		Glucose-6-phosphate 1-dehydrogenase										4.5								 I48-I52 (PAE:  1.0), I48-L43 (PAE: 1.0)	I48-L43 (PDBs: 6E08, 6JYU, 7ZVD, 7SNG, 7TOF), I48-I52 (PDBs: 7ZVD, 7UAG), I48-A44 (PDBs: 7SNF, 7SNH, 7SNI, 7TOE, 7UAG)	 I48-I52 (PAE:  1.0), I48-L43 (PAE: 1.0), I48-A44 (PAE: 1.0)	I48-A44 (PDBs: 6E08, 6JYU, 7ZVD, 7SNF, 7SNG, 7SNH, 7SNI, 7TOE, 7TOF, 7UAG), I48-I52 (PDBs: 7ZVD, 7UAG), I48-I36 (PDBs: 7ZVD, 7UAG), I48-L43 (PDBs: 7ZVD, 7UAG)							131									-70.9				-47.5						H (helix)	I (π-helix)	Helix											98.02	0.0	>90	<10	300908;300908;611162;611162	x-linked	OMIM	Rare genetic hematologic disease	1	ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1; ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1; MALARIA, SUSCEPTIBILITY TO; MALARIA, SUSCEPTIBILITY TO	false	0.8952939636245199	0.911175000208768	false	false	false
SDHD	SDHD_Leu139Arg	B_13-14	3.798682331808146	0.014136237819953438	0.03185811419181839	7.753130652821276	0.0019525222746259775	0.003803248905529341	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8007262859409092	0.8317900702341035	0.7622406026235228	0.7691271380030602	0.8067502146506422	0.8456956629071072	0.8217308358580477	0.8147468449675987	0.7297634165774838	0.7259494171397537	0.81811033671968	0.7870809959150668	0.8696604899561666	0.7987535843336858	0.8084908594286367	0.7985317881072919	0.845469803748527	0.8143715759667517	SDHD	Leu139Arg	NC_000011.10:112094906:T:G	416T>G	11	112094906	T	G	11	ENSG00000204370	6363	0	CCSBVarC023371	ALE00022271	ENSP00000364699.3																																	564429.0	single nucleotide variant	NM_003002.4(SDHD):c.416T>G (p.Leu139Arg)	6392.0	SDHD	HGNC:10683	Likely pathogenic	1.0	Jun 09, 2022	80338847.0	-	RCV002532294	MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3	germline	germline	GRCh38	NC_000011.10	11	112094906.0	112094906.0	11q23.1	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	-	2.0	573651.0	112094906.0	T	G	-	-	-	-	-	-	416T>G 	Leu139Arg	NM_003002.4	1.0	Pathogenic	Likely pathogenic	573651	11	112094906.0	T	G	L	R	rs80338847	11	111965630	11	111470840	139	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.416T>G	p.Leu139Arg	c.416T>G	p.Leu139Arg	principal1	Y	1	YES	Select	+	CTT	2	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	3.855	0.95736	H	-5.45	0.85499	D	0.982	0.99346	1.0402	0.97910	D	0.9834	0.99493	D	10	0.9803145	0.97976	D	0.815524	0.98560	D	0.988	0.99961	0.84	0.94573	O14521	L139R	Gain of methylation at L139 (P = 0.0075)| Gain of sheet (P = 0.1208)| Gain of relative solvent accessibility (P = 0.1259)| Loss of helix (P = 0.1299)| Gain of solvent accessibility (P = 0.1319)	0.983425624168	0.98307	0.9940455699504791	0.99400	0.916340064084	0.71077	0.841523647308	0.88307	D	0.976158	0.99771	D	0.5783	0.96940	D	0.592912	0.96890	D	0.99942147731781	0.97327	D	0.929107	0.73846	D	0.9855054	0.99491	0.9717924	0.99533	0.9855054	0.99491	0.9717924	0.99533	-17.005	0.98918	D	0.9277	0.84786	P	0.999298612534229	0.96182	0.99940443	0.99356	0.994	0.99793	.	.	.	.	.	.	4.963449	0.82116	27.7	0.99757144050314794	0.84785	0.951878	0.96672	D	0.890230994464423	0.91223	10.80072	0.800832412790881	0.89794	10.14829	4.85	4.85	0.62327	.	.	7.682	0.8343	7.853000	0.71102	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.999	0.91597	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Cowden_syndrome_3|Carney-Stratakis_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma	criteria_provided,_single_submitter	NC_000011.10:g.112094906T>G	.	CN166604|C1847319|C1868633|C0031511	606864|171300	201|97286|29072	.	Leu	Arg	98.79	0.2804878048780488																																																																																																																																																																																																																																																																																																																																																																																																																																																																													46			98.79	Aliphatic	Leucine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0134		3.8				D:L139-C:F85 (PDBs: 8GS8)				 L139-T135 (PAE:  1.0), L139-N143 (PAE: 1.0)	L139-T135 (PDBs: 8GS8), L139-N143 (PDBs: 8GS8)	 L139-T135 (PAE:  1.0), L139-N143 (PAE: 1.0)	L139-A96 (PDBs: 8GS8), L139-T135 (PDBs: 8GS8), L139-I149 (PDBs: 8GS8), L139-N143 (PDBs: 8GS8)							131									-67.6		Pocket 3: Mean pLDDT: 99.91, Volume: 203.66 Å³, Druggability score: 0.01		-41.5						H (helix)	H (α-helix)	Helix								Helical			98.79	28.04878	>90	10-90	606864;171300	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA	false	0.8317900702341035	0.8007262859409092	false	false	false
F9	F9_Gly357Arg	B_13-14	-2.678554259182531	0.03160539804409802	0.06512007579744036	-0.354012894295189	0.7337527133987192	0.7760439360729969	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5806161436402975	0.6024863437444851	0.6207613086014194	0.6602098080880283	0.6104590058357433	0.6277827115613888	0.5966643303366373	0.5930776566460725	0.565344290755108	0.5865880268610726	0.5406793203870017	0.5467903974532161	0.6589010927861401	0.6278403550254142	0.7550753254209486	0.6549345903417663	0.6642933671019684	0.6144418898273789	F9	Gly357Arg	NC_000023.11:139561754:G:A	1069G>A	23	139561754	G	A	X	ENSG00000101981	52861	0	CCSBVarC004386	ALE00004386	ENSP00000218099.2	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25650.0	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Sep 01, 2022	137852257.0	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754.0	139561754.0	Xq27.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3.0	10611.0	139561754.0	G	A	-	-	-	-	-	-	1069G>A 	Gly357Arg	NM_000133.4	2.0	Pathogenic	Likely pathogenic	10611	X	139561754.0	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	74.08	0.03571428571428571																																																																																																																																																																																																																																																																																																																																																																																																															1.105		1.013		1.001		0.991		1.028																																																						3			74.08	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-0.4								 G357-D410 (PAE:  3.0), G357-A366 (PAE: 4.0)	G357-A366 (PDBs: 6X5J, 6X5L, 8OL9), G357-D410 (PDBs: 8OL9)	 G357-D410 (PAE:  3.0), G357-A366 (PAE: 4.0)	G357-A366 (PDBs: 6X5J, 6X5L, 8OL9), G357-S365 (PDBs: 8OL9), G357-G409 (PDBs: 8OL9), G357-Q408 (PDBs: 8OL9), G357-D410 (PDBs: 8OL9)							75									-61.1				176.2						C (loop/coil)	C (loop/coil)	Beta strand											74.08	3.5714288	70-90	<10	306900;306700	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA A	false	0.6024863437444851	0.5806161436402975	false	false	false
GSS	GSS_Arg125Cys	B_13-14	4.177442907234131	0.004150453370346064	0.013956630171410179	-3.015672145161352	0.0195051797715331	0.030749145086566353	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6294877845312954	0.6525611267777769	0.5215286668278162	0.6642157985465575	0.6238627905192258	0.5716188569779249	0.6067260514007147	0.6229780079805873	0.7192415884110636	0.5552928535869717	0.7621840629455187	0.7530711163401189	0.5365116625551352	0.6247475730578641	0.6091900086820516	0.4877644800686607	0.5429381906100351	0.5059044527224719	GSS	Arg125Cys	NC_000020.11:34942606:G:A	373C>T	20	34942606	G	A	20	ENSG00000100983	5132	215352	CCSBVarC006739	ALE00006737	ENSP00000498303.1	CEGS2	CegsMutGDEh1044	F03	GDEhDisVCh_40044	H01	2	CegsMutGDDh1044	F03	VUSN2Hmut_GDN2h_09	D05	VUSMutpDEST2_04	F12	VUSmut_GDEh09	D05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	23568.0	single nucleotide variant	NM_000178.4(GSS):c.373C>T (p.Arg125Cys)	2937.0	GSS	HGNC:4624	Pathogenic/Likely pathogenic	1.0	Jan 31, 2024	28936396.0	-	RCV000009055|RCV003488332|RCV004566701	MONDO:MONDO:0017909,MedGen:CN030166,Orphanet:32|MedGen:C3661900|Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0009947,MedGen:C0398746,OMIM:266130,Orphanet:289846	Inherited glutathione synthetase deficiency|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria	germline	germline	GRCh38	NC_000020.11	20	34942606.0	34942606.0	20q11.22	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA119694,OMIM:601002.0005	3.0	8529.0	34942606.0	G	A	-	-	-	-	-	-	373C>T 	Arg125Cys	NM_000178.4	2.0	Pathogenic	Likely pathogenic	8529	20	34942606.0	G	A	R	C	rs28936396	20	33530409	20	32994070	125	GSS	ENSG00000100983	ENST00000651619	ENSP00000498303	P48637	GSHB_HUMAN	c.373C>T	p.Arg125Cys	c.373C>T	p.Arg125Cys	principal1	Y	.	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	.	.	.	.	.	.	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	3.785	0.95215	H	.	.	.	.	.	1.0907	0.99266	D	0.9543	0.98514	D	9	.	0.91808	.	0.366447	0.92624	D	.	.	.	.	.	.	.	.	.	.	0.93149	.	.	0.761953830719	0.76178	T	0.979491	0.99825	D	0.272164	0.80492	D	0.567727	0.96156	D	0.988271415233612	0.78469	D	.	0.92613	.	0.96310127	0.97551	0.8506926	0.91438	0.96134293	0.97374	0.837919	0.90580	-12.5	0.87232	D	.	0.85836	.	0.998758874737846	0.94998	0.98256360	0.95785	0.884	0.93768	.	.	.	.	.	.	6.177047	0.94738	34.0	0.99944690997760832	0.99886	0.948579	0.96020	D	1.09872351892217	0.98099	17.45189	1.02848604687915	0.99100	20.69962	5.77	5.77	0.91065	3.8	0.70283	9.908	0.98664	11.765000	0.95724	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.994	0.71086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	67	264690	2.531263E-4	.	6	109394	5.484760e-05	0	13	208114	6.246580e-05	0	13	236900	5.487550e-05	0	5	7162	6.981290e-04	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13384	0.000000e+00	0	0	42768	0.000000e+00	0	1	15690	6.373490e-05	0	5	7162	6.981290e-04	0	10	16216	6.166750e-04	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	2	16724	1.195890e-04	0	0	89554	0.000000e+00	0	1	30606	3.267330e-05	0	10	16216	6.166750e-04	0	10	14900	6.711410e-04	0	0	34256	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	2	21622	9.249840e-05	0	0	102716	0.000000e+00	0	1	30524	3.276110e-05	0	10	14900	6.711410e-04	0	.	67	1613906	4.151420e-05	0	56	74906	7.476040e-04	0	56	74906	7.476040e-04	0	0	910	0.000000e+00	0	0	59982	0.000000e+00	0	0	29600	0.000000e+00	0	0	44882	0.000000e+00	0	2	64012	3.124410e-05	0	0	6084	0.000000e+00	0	4	1179972	3.389910e-06	0	2	91078	2.195920e-05	0	2	30460	6.565988181221274E-5	0	298	0	0	120	0	5	7872	6.351626016260162E-4	0	146	0	0	610	0	0	26	0	0	104	0	0	2294	0	5	8170	6.119951040391676E-4	0	146	0	7	41930	1.669449081803005E-4	Glutathione_synthetase_deficiency_with_5-oxoprolinuria|Inherited_glutathione_synthetase_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000020.11:g.34942606G>A	ClinGen:CA119694|OMIM:601002.0005	C0398746|CN030166|C3661900	266130	289846|32	.	Arg	Cys	98.3	0.04838709677419355																																																																																																																																																																																																																																																																																																																																																																																																																																																																													12			98.3	Positively-charged	Arginine	substrate	Glutathione synthetase								0.1778		-4.5								 R125-N146 (PAE:  1.0), R125-S151 (PAE: 1.0)	R125-N146 (PDBs: 2HGS)	 R125-N146 (PAE:  1.0)	R125-N146 (PDBs: 2HGS), R125-I428 (PDBs: 2HGS)		R125-D127 (PDBs: 2HGS)					175									-132.5		Pocket 2: Mean pLDDT: 79.41, Volume: 936.21 Å³, Druggability score: 0.18		114.9						B (undefined)	E (parallel sheets)	Beta strand											98.3	4.8387094	>90	<10	266130	autosomal recessive	OMIM	Rare genetic hematologic disease; Rare inborn errors of metabolism	2	GLUTATHIONE SYNTHETASE DEFICIENCY	false	0.6525611267777769	0.6294877845312954	false	false	false
FH	FH_Ser334Arg	B_13-14	0.5356287401458311	0.6114778201904933	0.685400608312114	-5.31363743007343	0.0011068751163765785	0.0026006604847004116	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8732394706504816	0.911139176865642	0.6069604974043634	0.8584326086270122	0.7658910855842185	0.7992090866393282	0.8013327519200083	0.7754296956129759	0.859907485652183	0.5418115796003237	0.8958656622713632	0.8703830474349421	0.797085421358648	0.7563524755554609	0.8569577316018413	0.6721094152084031	0.926412691459921	0.876095893866021	FH	Ser334Arg	NC_000001.11:241504148:A:C	1002T>G	1	241504148	A	C	1	ENSG00000091483	3408	0	CCSBVarC004053	ALE00004053	ENSP00000355518.4	CEGS2	CegsMutGDEh1041	C09	GDEhDisVCh_40065	H08	1	CegsMutGDDh1041	C09	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	1314676.0	single nucleotide variant	NM_000143.4(FH):c.1002T>G (p.Ser334Arg)	2271.0	FH	HGNC:3700	Likely pathogenic	1.0	May 22, 2023	2147916185.0	-	RCV003236374	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	Hereditary leiomyomatosis and renal cell cancer	germline	germline	GRCh38	NC_000001.11	1	241504148.0	241504148.0	1q43	criteria provided, single submitter	1.0	-	N	-	2.0	2506143.0	241504148.0	A	C	-	-	-	-	-	-	1002T>G 	Ser334Arg	NM_000143.4	1.0	Pathogenic	Likely pathogenic	2506143	1	241504148.0	A	C	S	R	rs2147916185	1	241667448	1	239734071	334	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1002T>G	p.Ser334Arg	c.1002T>G	p.Ser334Arg	principal1	Y	1	YES	Select	-	AGT	3	2	A	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	D	simple_aae	3.0	97.0	3.55	0.93172	H	-4.9	0.81545	D	0.983	0.99270	1.0955	0.99468	D	0.9817	0.99438	D	10	0.96632713	0.96080	D	0.928795	0.99481	D	0.902	0.97281	0.765	0.89238	P07954	S334R	Gain of MoRF binding (P = 0.012)| Gain of methylation at S334 (P = 0.1999)| Gain of catalytic residue at S334 (P = 0.2478)| Gain of ubiquitination at K337 (P = 0.2694)| Loss of helix (P = 0.3949)	0.986805441107	0.98651	0.991474710610662	0.99141	1.03551510566	0.75429	0.77938503027	0.78796	T	0.968915	0.99646	D	0.540935	0.95434	D	0.539239	0.95366	D	0.996222853660583	0.88820	D	0.991801	0.97448	D	0.988074	0.99652	0.94546735	0.98092	0.988074	0.99652	0.94546735	0.98092	-15.188	0.96286	D	0.9943	0.95185	P	0.999937025252751	0.98982	0.96908960	0.94587	0.973	0.98982	.	.	.	.	.	.	3.81089	0.55043	23.6	0.99825879520171334	0.90858	0.530379	0.54952	D	0.60202261948517	0.73159	5.94406	0.506605376223128	0.68262	5.219445	5.73	3.45	0.38530	2.53	0.46530	1.348	0.33697	1.133000	0.24427	0.756	0.943	1.0	0.71675	0.994000	0.32271	0.999	0.91597	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_single_submitter	NC_000001.11:g.241504148A>C	.	C1708350	150800	523	Fumarate lyase, N-terminal	Ser	Arg	98.88	0.08461538461538462																																																																																																																																																																																																																																																																																																																																																																																																																																																																													11			98.88	Polar/Neutral	Serine		Fumarate hydratase, mitochondrial										-0.8			C:S334-B:D319 (PDBs: 3E04), B:S334-A:D319 (PDBs: 5UPP, 7LUB), A:S334-B:D319 (PDBs: 7LUB)	C:S334-B:D319 (PDBs: 3E04), B:S334-A:D319 (PDBs: 5UPP, 7LUB)				 S334-I338 (PAE:  1.0), S334-T330 (PAE: 1.0)	S334-I338 (PDBs: 5D6B, 7LUB), S334-T330 (PDBs: 5D6B, 3E04, 5UPP, 7LUB)	 S334-I338 (PAE:  1.0), S334-T330 (PAE: 1.0), S334-Q254 (PAE: 1.0)	S334-I338 (PDBs: 5D6B, 7LUB), S334-T330 (PDBs: 5D6B, 5UPP, 7LUB), S334-Q254 (PDBs: 3E04)							105									-66.5				-48.8						H (helix)	H (α-helix)	Helix											98.88	8.461538	>90	<10	150800	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	false	0.911139176865642	0.8732394706504816	false	false	false
SHOC2	SHOC2_Leu174Phe	B_13-14	1.1759562196714102	0.2780523239715201	0.36450236018229465	-1.2179065510729294	0.26271411919537624	0.3126332092889205	2025_01_Batch_13-14	false	false	true	false	false	true	false	false	false	false	false	false	0.8307723406449503	0.8355733039928572	0.8817633335908399	0.9076186950310666	0.9053598130385867	0.935730673083492	0.931677486999182	0.9547114441161965	0.9287731199448263	0.8228215268106989	0.8030605208925298	0.8151939019306136	0.9397838591678019	0.8560081819609768	0.886464270117307	0.9407051403709811	0.8680860870931846	0.846350779359287	SHOC2	Leu174Phe	NC_000010.11:110964878:C:T	520C>T	10	110964878	C	T	10	ENSG00000108061	11602	0	CCSBVarC028033	ALE00035175	ENSP00000358464.5																																	1330562.0	single nucleotide variant	NM_007373.4(SHOC2):c.520C>T (p.Leu174Phe)	8036.0	SHOC2	HGNC:15454	Likely pathogenic	1.0	May 22, 2020	2134121762.0	-	RCV002274220	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	Noonan syndrome	de novo	germline	GRCh38	NC_000010.11	10	110964878.0	110964878.0	10q25.2	no assertion criteria provided	1.0	-	N	-	2.0	1339463.0	110964878.0	C	T	-	-	-	-	-	-	520C>T 	Leu174Phe	NM_007373.4		Pathogenic	Likely pathogenic	1339463	10	110964878.0	C	T	L	F	rs2134121762	10	112724636	10	112714626	174	SHOC2	ENSG00000108061	ENST00000369452	ENSP00000358464	Q9UQ13	SHOC2_HUMAN	c.520C>T	p.Leu174Phe	c.520C>T	p.Leu174Phe	principal1	Y	1	YES	Select	+	CTT	1	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.74454	D	0.987	0.61929	D	0.977	0.73823	D	0.47	0.75656	N	simple_aae	53.0	47.0	2.65	0.77408	M	-3.65	0.71677	D	0.773	0.77132	0.3095	0.87657	D	0.6308	0.87004	D	10	0.7698511	0.76770	D	0.104362	0.77821	D	0.645	0.86473	0.72	0.85426	Q9UQ13	L174F	Loss of disorder (P = 0.0798)| Gain of MoRF binding (P = 0.0873)| Gain of ubiquitination at K169 (P = 0.0985)| Loss of stability (P = 0.1641)| Gain of helix (P = 0.1736)	0.81671705878	0.81353	0.7925932518681166	0.79092	1.30329818613	0.82987	0.874531209469	0.93201	D	0.512822	0.82662	D	0.253024	0.78727	D	0.125675	0.78452	D	0.962094068527222	0.66052	D	.	0.78725	.	0.6081138	0.72844	0.4974863	0.70684	0.6081138	0.72845	0.4974863	0.70685	-10.486	0.78126	D	0.9728	0.89831	P	0.999654661901879	0.97351	0.21834308	0.73896	0.609	0.78143	.	.	.	.	.	.	4.9293	0.81292	27.5	0.9960600581215977	0.74545	0.458380	0.50773	N	0.356511443656887	0.58872	4.085063	0.352619838281492	0.58443	4.03845	5.79	4.89	0.63341	2.69	0.49185	4.126	0.57779	5.925000	0.51299	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.999	0.91597	916	0.20739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Noonan_syndrome	no_assertion_criteria_provided	NC_000010.11:g.110964878C>T	.	C0028326	PS163950	648	.	Leu	Phe	98.65	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.65	Aliphatic	Leucine		Leucine-rich repeat protein SHOC-2										3.8								 L174-T196 (PAE:  1.0), L174-Y198 (PAE: 1.0)	L174-T196 (PDBs: 7TVG, 7UPI), L174-Y198 (PDBs: 7TVG, 7SD1, 7T7A, 7TYG, 7SD0, 7TVF, 7UPI)	 L174-Y198 (PAE:  1.0)	L174-Y198 (PDBs: 7TVG, 7SD1, 7T7A, 7TYG, 7SD0, 7TVF, 7UPI)							131									-124.0				116.9			LRR 4			B (undefined)	E (parallel sheets)	Beta strand											98.65	0.0	>90	<10		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5		false	0.8355733039928572	0.8307723406449503	false	false	false
KRAS	KRAS_Met72Leu	B_13-14	-2.4492678134739627	0.04415464746417742	0.084167042571436	6.061396204703247	0.0005101677844292108	0.0014077562171843634	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7970241494907587	0.8002889741665583	0.6578816550273114	0.7250261994144416	0.736619501611546	0.7184411265282719	0.4815045054080578	0.6097389809920771	0.5206529887663283	0.44987796698461086	0.7305567736070158	0.6927057207086076	0.9553777476484859	0.8635000222310147	0.929399410062555	0.865885343070012	0.8700211747261009	0.9013425782729099	KRAS	Met72Leu	NC_000012.12:25227310:T:G	214A>C	12	25227310	T	G	12	ENSG00000133703	3084	0	CCSBVarC006100	ALE00006100	ENSP00000308495.3	CEGS2	CegsMutGDEh1041	F08	GDEhDisVCh_40061	B10	1	CegsMutGDDh1041	F08	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	1010371.0	single nucleotide variant	NM_004985.5(KRAS):c.214A>C (p.Met72Leu)	3845.0	KRAS	HGNC:6407	Likely pathogenic	1.0	Jun 19, 2022	727504662.0	-	RCV001315183	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	RASopathy	germline	germline	GRCh38	NC_000012.12	12	25227310.0	25227310.0	12p12.1	criteria provided, single submitter	1.0	-	N	-	2.0	1016209.0	25227310.0	T	G	-	-	-	-	-	-	214A>C 	Met72Leu	NM_004985.5	1.0	Pathogenic	Likely pathogenic	1016209	12	25227310.0	T	G	M	L	rs727504662	12	25380244	12	25271511	72	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.214A>C	p.Met72Leu	c.214A>C	p.Met72Leu	alternative1	Y	1	.	Plus_Clinical	-	ATG	1	0	T	T/T	T/T	T/T	T/T	0.029	0.46288	D	0.083	0.41751	T	0.236	0.30787	B	0.256	0.39260	B	0.97	0.96253	D	simple_aae	3.0	97.0	0.855	0.21196	L	-2.55	0.55206	D	0.755	0.75268	-0.4018	0.71845	T	0.3464	0.71002	T	10	0.6263549	0.67986	D	0.0458	0.62008	D	0.658	0.87125	0.665	0.80215	P01116	M72L	Gain of catalytic residue at T74 (P = 0.0197)| Loss of phosphorylation at Y71 (P = 0.0909)| Loss of disorder (P = 0.0926)| Loss of helix (P = 0.2271)| Loss of sheet (P = 0.302)	0.869051532231	0.86675	0.8560956093177353	0.85484	1.59547003884	0.88549	0.892316937447	0.95540	D	0.810422	0.95217	D	0.353299	0.86638	D	0.269713	0.86464	D	0.740672528743744	0.42477	D	0.939506	0.77609	D	0.9555017	0.96774	0.87500864	0.93122	0.9538084	0.96601	0.89415234	0.94486	-8.664	0.66608	D	0.8556	0.80172	P	0.999925671145259	0.98892	0.99469410	0.97604	0.986	0.99524	.	.	.	.	.	.	4.690966	0.75207	26.3	0.97578417483957014	0.34888	0.885317	0.81506	D	0.259874108519936	0.53898	3.579291	0.425460968171894	0.62956	4.543828	5.77	5.77	0.91065	3.95	0.75212	8.004	0.88091	7.919000	0.74463	0.644	0.52462	1.0	0.71675	1.000000	0.68239	0.999	0.91597	856	0.34333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RASopathy	criteria_provided,_single_submitter	NC_000012.12:g.25227310T>G	.	C5555857	.	536391	Small GTP-binding domain	Met	Leu	93.98	0.0																																																																																																																																																																																					0.359				-0.03						-0.179						-0.172						0.274		-0.089										-0.083				-0.294				0.095		0.289		0.066		0.055		0.277				-0.593																																																																																																																																																																																																																																		0			93.98	Aliphatic	Methionine		GTPase KRas; GTPase KRas, N-terminally processed										1.9				A:M72-B:I43 (PDBs: 6YXW)				 M72-K104 (PAE:  2.0), M72-R68 (PAE: 2.0)	M72-R68 (PDBs: 4LDJ, 4LYJ, 5OCG, 5V9O, 6E6G, 6GJ6, 6GJ7, 6GJ8, 6GOD, 6M9W, 6MBQ, 6MQG, 6T5B, 6T5V, 6ZL5, 7KYZ, 7R0N, 8AFB, 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8B78, 8CPR, 8JHL, 8ONV, 8QUG, 3GFT, 4LPK, 4LUC, 4LV6, 4LYF, 4LYH, 4M1O, 4M1S, 4M1T, 4M1W, 4M1Y, 4M21, 4M22, 4OBE, 4TQA, 5KYK, 5UK9, 5V9L, 6BOF, 6MBT, 6MBU, 6MNX, 6MQN, 6MS9, 6MTA, 6O36, 6O46, 6P0Z, 6QUU, 6QUV, 6QUW, 6QUX, 6ZLI, 7ACA, 7ACF, 7ACH, 7ACQ, 7O70, 7R0M, 7R0Q, 8AFC, 8AFD, 8AQ7, 8B6I, 8ECR, 8T71, 8UN5, 2MSC, 2MSD, 2MSE, 5MLA, 5MLB, 5O2S, 5O2T, 5TAR, 5TB5, 5UFE, 5WLB, 5WPM, 6H46, 6H47, 6OB2, 6PTS, 6PTW, 6V65, 6VJJ, 6W4E, 6W4F, 6XHB, 6YR8, 6YXW, 7NY8, 7SCW, 7VVB, 8QU8, 8QVU, 8T74, 8T75, 8TBF), M72-K104 (PDBs: 6VC8, 8T72, 8TBF)	 M72-I100 (PAE:  1.5), M72-K104 (PAE: 2.0), M72-R68 (PAE: 2.0)	M72-R68 (PDBs: 4LDJ, 4LYJ, 5OCG, 5V9O, 6E6G, 6GJ6, 6GJ7, 6GJ8, 6GOD, 6M9W, 6MBQ, 6MQG, 6T5B, 6T5V, 6V5L, 6ZL5, 7KYZ, 7LGI, 7MQU, 7R0N, 8AFB, 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8B78, 8CPR, 8JHL, 8ONV, 8QUG, 3GFT, 4LPK, 4LUC, 4LV6, 4LYF, 4LYH, 4M1O, 4M1S, 4M1T, 4M1W, 4M1Y, 4M21, 4M22, 4OBE, 4TQA, 5KYK, 5UK9, 5V9L, 6BOF, 6MBT, 6MBU, 6MNX, 6MQN, 6MS9, 6MTA, 6O36, 6O46, 6P0Z, 6QUU, 6QUV, 6QUW, 6QUX, 6ZLI, 7ACA, 7ACF, 7ACH, 7ACQ, 7O70, 7R0M, 7R0Q, 8AFC, 8AFD, 8AQ7, 8B6I, 8ECR, 8T71, 8UN5, 2MSC, 2MSD, 2MSE, 5MLA, 5MLB, 5O2S, 5O2T, 5TAR, 5TB5, 5UFE, 5WLB, 5WPM, 6H46, 6H47, 6OB2, 6PTS, 6PTW, 6V65, 6VJJ, 6W4E, 6W4F, 6XHB, 6YR8, 6YXW, 7NY8, 7SCW, 7VVB, 8QU8, 8QVU, 8T74, 8T75, 8TBF), M72-K104 (PDBs: 6VC8, 8T72, 8TBF), M72-I100 (PDBs: 8TBF), M72-V103 (PDBs: 8TBF)							149									-66.6				-32.4						H (helix)	H (α-helix)	Helix											93.98	0.0	>90	<10		unknown		Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13		false	0.8002889741665583	0.7970241494907587	false	false	false
KRAS	KRAS_Pro34Arg	B_13-14	-1.8765842108443014	0.10267990481406933	0.1675801285089357	8.780959234340912	0.0000500572303660495	0.00024236152433166445	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.856767308976135	0.8787711009277404	0.5509208582646477	0.7639061978752231	0.7756714927022463	0.7031737777599926	0.6598311014620402	0.7376871809540524	0.6534427153881266	0.5545258531360271	0.8554571719869749	0.8187940318608687	0.746516454057945	0.8136558044504403	0.8743696803623197	0.5473158633932681	0.9020850298685058	0.8947405860914012	KRAS	Pro34Arg	NC_000012.12:25245284:G:C	101C>G	12	25245284	G	C	12	ENSG00000133703	3084	0	CCSBVarC006094	ALE00006094	ENSP00000308495.3	CEGS2	CegsMutGDEh1040	C02	GDEhDisVCh_40061	F09	1	CegsMutGDDh1040	C02	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	27629.0	single nucleotide variant	NM_004985.5(KRAS):c.101C>G (p.Pro34Arg)	3845.0	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1.0	Jun 14, 2022	104894366.0	-	RCV000043674|RCV000211723|RCV000207495|RCV000850569|RCV001851825	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:C3661900|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519;MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114;MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340;MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Cardiofaciocutaneous syndrome 2|Cardio-facio-cutaneous syndrome;Noonan syndrome|not provided|Acute myeloid leukemia;Autoimmune lymphoproliferative syndrome type 4;Cardiofaciocutaneous syndrome 2;Noonan syndrome 3|RASopathy	germline;unknown	germline	GRCh38	NC_000012.12	12	25245284.0	25245284.0	12p12.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA280040,UniProtKB:P01116#VAR_026110,OMIM:190070.0013	3.0	12590.0	25245284.0	G	C	-	-	-	-	-	-	101C>G 	Pro34Arg	NM_004985.5	2.0	Pathogenic	Likely pathogenic	12590	12	25245284.0	G	C	P	R	rs104894366	12	25398218	12	25289485	34	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.101C>G	p.Pro34Arg	c.101C>G	p.Pro34Arg	alternative1	Y	1	.	Plus_Clinical	-	CCA	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.445	0.92067	M	-7.6	0.97924	D	0.961	0.98079	0.8728	0.95298	D	0.8174	0.93837	D	9	0.94139737	0.93391	D	0.322268	0.91490	D	0.905	0.97394	0.79	0.91170	P01116	P34R	Gain of catalytic residue at I36 (P = 0.0042)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.0874)| Gain of solvent accessibility (P = 0.1708)| Loss of disorder (P = 0.1763)	0.993217693452	0.99306	0.9765456698593341	0.97632	2.76950302636	0.98787	0.913441181183	0.97783	D	0.919051	0.98519	D	0.468623	0.93232	D	0.435368	0.93147	D	0.999483346939087	0.97568	D	0.976402	0.92683	D	0.9888393	0.99697	0.96837485	0.99382	0.9863729	0.99547	0.978969	0.99788	-17.558	0.99602	D	0.9972	0.97478	P	0.999953297071636	0.99183	0.99935538	0.99325	0.97	0.98836	.	.	.	.	.	.	5.331179	0.89486	30.0	0.99851702522609986	0.93107	0.907375	0.86082	D	1.08644740414511	0.97862	16.94078	1.01441952461028	0.98880	19.75079	5.68	5.68	0.88004	.	.	9.985	0.99185	11.891000	0.99094	0.654	0.53775	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Cardio-facio-cutaneous_syndrome|Noonan_syndrome|RASopathy|not_provided|Acute_myeloid_leukemia|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2|Autoimmune_lymphoproliferative_syndrome_type_4	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245284G>C	ClinGen:CA280040|OMIM:190070.0013|UniProtKB:P01116#VAR_026110	C1275081|C0028326|C5555857|C3661900|C0023467|C1860991|C3809005|C2674723	PS115150|PS163950|601626|609942|615278|614470	1340|648|536391|519|648|1340|268114	Small GTP-binding domain	Pro	Arg	86.47	0.45588235294117646																																																																																																																																																																																					0.627						-0.051						-0.799						-0.99				-0.302				-0.504		-0.244		-0.318						-0.318						1.379		1.061	1 mutation(s) (Pro34Asn: 2.134)	0.507		0.398		0.429																																																																																																																																																																																																																																						62			86.47	Special, No backbone hydrogen	Proline	GTP	GTPase KRas; GTPase KRas, N-terminally processed								0.7716		1.6			A:P34-B:K66 (PDBs: 5MLA, 5O2T), B:P34-D:N371 (PDBs: 6PTS)	A:P34-B:R1276 (PDBs: 6OB2), B:P34-D:N371 (PDBs: 6PTS), A:P34-C:K128 (PDBs: 8T75)					P34-G60 (PDBs: 6T5V, 7R0N, 8AQ5, 8B78, 5V9L, 7R0M, 8AQ7, 8UN5)		P34-Q61 (PDBs: 6GJ8, 6QUU, 6QUV, 6QUW, 6QUX, 6ZLI, 7ACA, 7ACH, 5MLA, 5O2T, 6VJJ, 7SCW, 7VVB, 8T74), P34-G60 (PDBs: 6MBQ, 6T5V, 7R0N, 5V9L, 7R0M), P34-A59 (PDBs: 8AQ5, 8AZR, 8AZV, 8AZX, 8AZY, 8AZZ, 8B00, 8B78, 8JHL, 8ONV, 8QUG, 8AQ7, 8B6I, 8ECR, 8UN5, 8QU8, 8QVU), P34-S39 (PDBs: 8CPR), P34-S17 (PDBs: 8T71)							115	Effector region								-60.2		Pocket 1: Mean pLDDT: 82.52, Volume: 1126.64 Å³, Druggability score: 0.77		113.3				dbSNP: rs104894366; Variant type: LP/P; AA change: Pro34Arg; PTM type: Phosphorylation; PTM morphology: P*TIEDsyRkQV; Var class: II&rs104894366		C (loop/coil)	C (loop/coil)	Turn											86.47	45.588234	70-90	10-90	615278;601626;614470;615278;609942	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	CARDIOFACIOCUTANEOUS SYNDROME 2; LEUKEMIA, ACUTE MYELOID; RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; CARDIOFACIOCUTANEOUS SYNDROME 2; NOONAN SYNDROME 3	false	0.8787711009277404	0.856767308976135	false	false	false
BRAF	BRAF_Val487Gly	B_13-14	-6.116199946608242	0.00048331137760885195	0.0026603018191150066	3.97397278194632	0.005365012238222538	0.009964369895889025	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6961855608613019	0.7375191882224249	0.5792923177653093	0.6619473539643548	0.7270339184281387	0.6479785209766052	0.5323509149201255	0.6648013738905071	0.6465281041638615	0.5118389228075595	0.7555155724169524	0.6991816396841284	0.763606127033085	0.7892664629657702	0.6773666037648481	0.646745712723059	0.7195228040278974	0.6931894820384754	BRAF	Val487Gly	NC_000007.14:140778048:A:C	1460T>G	7	140778048	A	C	7	ENSG00000157764	71969	0	CCSBVarC003164	ALE00003164	ENSP00000493543.1	CEGS2	CegsMutGDEh1011	H06	GDEhDisVCh_40058	E03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	53973.0	single nucleotide variant	NM_004333.6(BRAF):c.1460T>G (p.Val487Gly)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Jul 21, 2021	397516893.0	-	RCV000037922|RCV000622585|RCV000788814|RCV001852794	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MeSH:D030342,MedGen:C0950123|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Cardio-facio-cutaneous syndrome|Inborn genetic diseases|not provided|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140778048.0	140778048.0	7q34	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA280007	2.0	44806.0	140778048.0	A	C	-	-	-	-	-	-	1460T>G 	Val487Gly	NM_004333.6	2.0	Pathogenic	Likely pathogenic	44806	7	140778048.0	A	C	V	G	rs397516893	7	140477848	7	140124317	487	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1460T>G	p.Val487Gly	c.1460T>G	p.Val487Gly	principal4	Y	.	YES	Select	-	GTG	2	0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.478	0.36724	P	0.148	0.34068	B	.	0.99291	.	.	.	.	0.895	0.22286	L	.	.	.	.	.	-0.8552	0.51413	T	0.1922	0.54309	T	10	0.9420905	0.93461	D	0.174902	0.85076	D	.	0.96086	0.828	0.93817	P15056	V487G	Gain of disorder (P = 0.0281)| Loss of stability (P = 0.0406)| Gain of ubiquitination at K483 (P = 0.0985)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.2005)	.	0.98130	.	0.92090	.	0.93269	0.828899681568	0.86370	D	0.848438	0.96500	D	0.417248	0.90811	D	0.361572	0.90697	D	0.99738210439682	0.91358	D	0.946505	0.79494	D	0.9640127	0.97644	0.93370944	0.97310	0.948537	0.96056	0.9274714	0.96876	-13.971	0.92975	D	0.9903	0.95874	P	0.999977702097208	0.99427	0.99449290	0.97559	0.997	0.99892	.	.	.	.	.	.	5.288129	0.8881	29.7	0.99591389096133687	0.73662	0.903643	0.85245	D	0.341902369550804	0.58100	4.002832	0.436077121338009	0.63630	4.624474	4.96	4.96	0.65108	.	.	9.289	0.95099	11.177000	0.88188	0.686	0.82694	1.0	0.71675	1.000000	0.68239	0.997	0.79771	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Cardio-facio-cutaneous_syndrome|not_provided|Inborn_genetic_diseases|RASopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778048A>C	ClinGen:CA280007	C1275081|C3661900|C0950123|C5555857	PS115150	1340|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Val	Gly	72.04	0.16901408450704225																																																																																																																																																																																																																																																																																																																																																																																																																																																																													24			72.04	Aliphatic	Valine		Serine/threonine-protein kinase B-raf							Protein kinase			4.2									V487-Q524 (PDBs: 8C7X, 6UAN, 7MFD)		V487-Q524 (PDBs: 2FB8, 4FC0, 4KSP, 5CT7, 8C7X, 8C7Y, 4MNE, 6U2H), V487-L525 (PDBs: 8F7O), V487-R603 (PDBs: 7MFD, 7MFE), V487-V600 (PDBs: 8DGT)							117									-137.8				105.0						C (loop/coil)	C (loop/coil)	Beta strand											72.04	16.901407	70-90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.7375191882224249	0.6961855608613019	false	false	false
RPS19	RPS19_Gly127Glu	B_13-14	-7.707857851852217	0.0001154978914415701	0.0010213007993212912	-10.451724769792817	0.000015976681032977155	0.0001025077262080877	2025_01_Batch_13-14		false	false	false	false	false		false	false	false	false	false		0.9523329778587529	0.7032884769202062	0.7188878435191466	0.6243720072462051	0.7635189638742281	0.7965045267847746	0.7272896928780691	0.782728557354866	0.7034013937559885	0.9554581766859456		0.7305334009636817	0.521454321614341	0.6550471296834273	0.703175560084424	0.9492077790315603		RPS19	Gly127Glu	NC_000019.10:41869722:G:A	380G>A	19	41869722	G	A	19	ENSG00000105372	3441	0	CCSBVarC000469	ALE00000469	ENSP00000470972.1	RC4	RC4_Mut_GDEh1010	H11	GDEhDisVCh_40042	E02	2	RC4_Mut_GDDh1010	H11	NULL	NULL	NULL	NULL	NULL	NULL	1.0	2.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	21359.0	single nucleotide variant	NM_001022.4(RPS19):c.380G>A (p.Gly127Glu)	6223.0	RPS19	HGNC:10402	Likely pathogenic	1.0	Jan 12, 2022	786200936.0	-	RCV000033189|RCV002512845	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124	Diamond-Blackfan anemia 1|Diamond-Blackfan anemia	germline	germline	GRCh38	NC_000019.10	19	41869722.0	41869722.0	19q13.2	criteria provided, single submitter	2.0	-	N	UniProtKB:P39019#VAR_055444,OMIM:603474.0008,ClinGen:CA130769	3.0	6320.0	41869722.0	G	A	-	-	-	-	-	-	380G>A 	Gly127Glu	NM_001022.4	1.0	Pathogenic	Likely pathogenic	6320	19	41869722.0	G	A	G	E	rs786200936	19	42373792	19	47065632	127	RPS19	ENSG00000105372	ENST00000593863	ENSP00000470004	P39019	RS19_HUMAN	c.380G>A	p.Gly127Glu	c.380G>A	p.Gly127Glu	principal1	Y	3	.	.	+	GGA	2	0	G	./.	./.	./.	./.	.	.	.	0.034	0.53076	D	0.988	0.62341	D	0.996	0.84488	D	0.99	0.97926	A	simple_aae	1.0	99.0	2.73	0.79671	M	.	.	.	0.985	0.99419	0.2563	0.86794	D	0.5614	0.83981	D	9	0.9862165	0.98908	D	0.407513	0.93515	D	.	0.91208	0.984	0.99843	P39019	G127E	Loss of MoRF binding (P = 0.0171)| Gain of relative solvent accessibility (P = 0.09)| Gain of solvent accessibility (P = 0.0971)| Gain of methylation at K122 (P = 0.1056)| Gain of sheet (P = 0.1451)	0.972294440432	0.97173	.	0.99657	.	0.96144	0.76795142889	0.77078	T	0.98826	0.99938	D	0.558625	0.96031	D	0.56465	0.95968	D	0.991606083214429	0.81780	D	0.847515	0.52781	T	0.97176737	0.98397	0.93296444	0.97258	0.9559469	0.96820	0.9024854	0.95086	-13.608	0.91730	D	0.9981	0.97478	P	0.999816468006815	0.98120	0.99993120	0.99924	0.683	0.82402	.	.	.	.	.	.	4.995052	0.82873	27.9	0.99809882945303208	0.89361	0.952808	0.96846	D	0.931537152194926	0.93180	11.89543	0.874714639492237	0.94342	12.711	5.24	5.24	0.72825	.	.	8.506	0.90371	11.829000	0.97469	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	747	0.52199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Diamond-Blackfan_anemia|Diamond-Blackfan_anemia_1	criteria_provided,_single_submitter	NC_000019.10:g.41869722G>A	ClinGen:CA130769|OMIM:603474.0008|UniProtKB:P39019#VAR_055444	C1260899|C2676137	PS105650|105650	124|124	.	Gly	Glu	93.5	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			93.5	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Small ribosomal subunit protein eS19										-0.4								 G127-L131 (PAE:  1.0)	G127-L131 (PDBs: 5A2Q, 5FLX, 5OA3, 6G18, 6G4S, 6G4W, 6YBS, 6ZMT, 6ZOJ, 6ZOL, 6ZUO, 6ZV6, 6ZVH, 6ZXD, 6ZXE, 6ZXF, 6ZXG, 6ZXH, 7K5I, 7R4X, 7TQL, 7WTT, 7WTU, 7WTV, 7WTW, 7WTX, 7WTZ, 7WU0, 8PPK, 8T4S)	 G127-L131 (PAE:  1.0)	G127-L131 (PDBs: 5A2Q, 5OA3, 6G18, 6G4S, 6G4W, 6YBS, 6ZLW, 6ZOJ, 6ZOL, 6ZUO, 6ZVH, 6ZXD, 6ZXE, 6ZXF, 6ZXG, 6ZXH, 7K5I, 7TQL, 7WTT, 7WTU, 7WTV, 7WTW, 7WTX, 7WTZ, 7WU0, 8PPK, 8T4S), G127-K111 (PDBs: 5FLX, 6G5I, 6ZMT), G127-M112 (PDBs: 6G51, 6G53, 6G5H, 6ZV6, 7R4X, 8T4S)							75									-61.0				-38.3				dbSNP: rs786200936; Variant type: LP/P; AA change: Gly127Glu; PTM type: Ubiquitylation; PTM morphology: QDGGRkLTPQG*; Var class: II		H (helix)	H (α-helix)	Helix											93.5	0.0	>90	<10	105650	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare inborn errors of metabolism; Inherited cancer-predisposing syndrome	4	DIAMOND-BLACKFAN ANEMIA 1	false	0.9523329778587529		false		false
SDHD	SDHD_His102Arg	B_13-14	4.23284378127999	0.003902401439764406	0.013176996890768802	-1.4404529547031009	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.745212918954951	0.7709887797139708	0.6988189489330139	0.7178928378359339	0.78226463469211	0.7234584316017454	0.7596198032951937	0.8089284091814832	0.7936584026583867	0.714857687219315	0.7907222359174506	0.7620084051372282	0.6872970599082971	0.7556008602027369	0.6421272730134812	0.6827802106467128	0.7512553235104911	0.7284174327726738	SDHD	His102Arg	NC_000011.10:112089002:A:G	305A>G	11	112089002	A	G	11	ENSG00000204370	6363	0	CCSBVarC023323	ALE00032062	ENSP00000364699.3																																	639710.0	single nucleotide variant	NM_003002.4(SDHD):c.305A>G (p.His102Arg)	6392.0	SDHD	HGNC:10683	Pathogenic/Likely pathogenic	1.0	Feb 09, 2024	104894302.0	-	RCV001018360|RCV002538159|RCV004028788	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072	Hereditary cancer-predisposing syndrome|Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3|Paragangliomas 1	germline;unknown	germline	GRCh38	NC_000011.10	11	112089002.0	112089002.0	11q23.1	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	-	2.0	656860.0	112089002.0	A	G	-	-	-	-	-	-	305A>G 	His102Arg	NM_003002.4	2.0	Pathogenic	Likely pathogenic	656860	11	112089002.0	A	G	H	R	rs104894302	11	111959726	11	111464936	102	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.305A>G	p.His102Arg	c.305A>G	p.His102Arg	principal1	Y	1	YES	Select	+	CAT	2	0	A	./.	./.	./.	./.	0.002	0.91343	D	0.005	0.92967	D	0.999	0.77914	D	0.96	0.70309	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.58	0.93458	H	-7.95	0.96333	D	0.981	0.99987	0.8464	0.94968	D	0.9986	0.99961	D	10	0.9932964	0.99869	D	0.668847	0.97228	D	0.925	0.98152	0.96	0.99581	O14521	H102R	Gain of relative solvent accessibility (P = 0.1259)| Gain of solvent accessibility (P = 0.1319)| Loss of catalytic residue at L101 (P = 0.168)| Gain of loop (P = 0.2045)| Gain of MoRF binding (P = 0.3566)	0.99569366784	0.99559	0.9941230044772663	0.99408	0.822716399301	0.67041	0.615795195103	0.55067	T	0.978249	0.99805	D	0.565929	0.96317	D	0.575142	0.96257	D	0.995160043239594	0.86836	D	0.931507	0.74447	D	0.95057625	0.96266	0.9087782	0.95540	0.93406326	0.94564	0.9051902	0.95282	-9.682	0.83515	D	0.8694	0.80800	P	0.9963025324275	0.92025	0.99930870	0.99288	0.993	0.99760	.	.	.	.	.	.	4.730387	0.76234	26.5	0.99595436499868495	0.73897	0.960222	0.98087	D	0.663599630439143	0.77127	6.639008	0.502772132901211	0.68002	5.184201	5.04	3.86	0.43622	.	.	8.712	0.9112	9.318000	0.80050	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.699	0.34149	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	0	109408	0.000000e+00	0	1	208128	4.804740e-06	0	1	236948	4.220340e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89552	1.116670e-05	0	0	30608	0.000000e+00	0	1	89552	1.116670e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102746	9.732740e-06	0	0	30526	0.000000e+00	0	1	102746	9.732740e-06	0	.	5	1614116	3.097670e-06	0	5	1180006	4.237270e-06	0	0	75020	0.000000e+00	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29608	0.000000e+00	0	0	44878	0.000000e+00	0	0	64020	0.000000e+00	0	0	6060	0.000000e+00	0	5	1180006	4.237270e-06	0	0	91086	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|Carney-Stratakis_syndrome|Cowden_syndrome_3|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112089002A>G	.	C0027672|C3494181|C1847319|CN166604|C0031511|C1868633	168000|606864|171300	140162|29072|97286|201|29072	.	His	Arg	98.8	0.3858695652173913																																																																																																																																																																																																																																																																																																																																																																																																																																																																													71			98.8	Positively-charged	Histidine	heme b	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-3.2								 H102-G106 (PAE:  1.0), H102-A98 (PAE: 1.0)	H102-G106 (PDBs: 8GS8), H102-A98 (PDBs: 8GS8)	 H102-S73 (PAE:  1.0), H102-G106 (PAE: 1.0), H102-A98 (PAE: 1.0)	H102-V72 (PDBs: 8GS8), H102-G106 (PDBs: 8GS8), H102-A98 (PDBs: 8GS8), H102-S73 (PDBs: 8GS8)							155									-59.3		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-46.5						H (helix)	H (α-helix)	Helix								Helical			98.8	38.586956	>90	10-90	606864;171300;168000	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA; PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1	false	0.7709887797139708	0.745212918954951	false	false	false
BRAF	BRAF_Lys499Asn	B_13-14	-4.944762682826767	0.0016661142958100037	0.006858358415942041	3.1187357524993065	0.016873536307570804	0.02716047291613371	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6653892795753322	0.7551298654362383	0.5568092212808835	0.695105208658455	0.6862128310902955	0.6730824988218392	0.6817654272906335	0.6831658050783542	0.7473710021721504	0.5252828618297487	0.7774994219522121	0.6737276125420153	0.664399570353045	0.6892598571022367	0.6428394151447596	0.5883355807320184	0.7327603089202644	0.6570509466086492	BRAF	Lys499Asn	NC_000007.14:140778011:T:G	1497A>C	7	140778011	T	G	7	ENSG00000157764	71969	0	CCSBVarC003166	ALE00003166	ENSP00000493543.1	CEGS2	CegsMutGDEh1012	C01	GDEhDisVCh_40058	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	5.0	0.0		0.0			0.0			0.0			N	N	N	N	N	48841.0	single nucleotide variant	NM_004333.6(BRAF):c.1497A>C (p.Lys499Asn)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Jul 23, 2015	397507476.0	-	RCV000207509|RCV001814021	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	not provided|Cardio-facio-cutaneous syndrome	de novo;germline;unknown	germline	GRCh38	NC_000007.14	7	140778011.0	140778011.0	7q34	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA281974,UniProtKB:P15056#VAR_058625	2.0	40371.0	140778011.0	T	G	-	-	-	-	-	-	1497A>C 	Lys499Asn	NM_004333.6	2.0	Pathogenic	Likely pathogenic	40371	7	140778011.0	T	G	K	N	rs397507476	7	140477811	7	140124280	499	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1497A>C	p.Lys499Asn	c.1497A>C	p.Lys499Asn	principal4	Y	.	YES	Select	-	AAA	3	2	T	T/T	T/T	T/T	T/T	.	.	.	.	.	.	0.947	0.53490	P	0.688	0.53696	P	.	0.97926	.	.	.	.	0.965	0.23851	L	.	.	.	.	.	0.1071	0.84236	D	0.5198	0.81988	D	10	0.9434156	0.93596	D	0.1256	0.80658	D	.	0.88818	0.889	0.97257	P15056	K499N	Loss of methylation at K499 (P = 0.0305)| Loss of MoRF binding (P = 0.0517)| Loss of ubiquitination at K499 (P = 0.0546)| Gain of helix (P = 0.2059)| Gain of disorder (P = 0.292)	.	0.81448	.	0.87500	.	0.95599	0.913059830666	0.97749	D	0.824469	0.95710	D	0.110668	0.65175	D	-0.078809	0.64743	T	0.9956134557724	0.87648	D	0.958804	0.84469	D	0.97060555	0.98288	0.9186677	0.96252	0.9693646	0.98171	0.9186677	0.96252	-12.924	0.89071	D	0.9993	0.99393	P	0.999246574469187	0.96052	0.99575126	0.97865	0.98	0.99294	.	.	.	.	.	.	4.441576	0.69029	25.3	0.99865938726691972	0.94371	0.620121	0.60389	D	0.22632943565752	0.52240	3.421713	0.30192289424299	0.55416	3.728117	4.96	4.96	0.65108	4.21	0.80015	3.119	0.50212	4.195000	0.42508	0.605	0.46302	1.0	0.71675	1.000000	0.68239	1.0	0.97202	776	0.48248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Cardio-facio-cutaneous_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140778011T>G	ClinGen:CA281974|UniProtKB:P15056#VAR_058625	C1275081|C3661900	PS115150	1340	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	Lys	Asn	78.83	0.2048780487804878																																																																																																																																																																																																																																																																																																																																																																																																																																																																													42			78.83	Positively-charged	Lysine		Serine/threonine-protein kinase B-raf							Protein kinase			-3.9								 K499-G503 (PAE:  1.0), K499-D448 (PAE: 8.0), K499-L495 (PAE: 1.0), K499-S447 (PAE: 10.0)	K499-L495 (PDBs: 5CSX, 6P3D, 2FB8, 3D4Q, 3II5, 3PPJ, 3PPK, 3PRF, 3PRI, 3PSB, 3PSD, 3Q4C, 3Q96, 3TV4, 3TV6, 4DBN, 4E26, 4E4X, 4EHE, 4FC0, 4G9C, 4H58, 4KSP, 4KSQ, 4MBJ, 4PP7, 5CSW, 5CT7, 5FD2, 5HID, 5HIE, 5VAL, 5VAM, 6B8U, 6CAD, 6N0P, 6N0Q, 6V2U, 7P3V, 7SHV, 8C7X, 8C7Y, 8F7O, 8F7P, 8QQG, 4MNE, 6NYB, 6PP9, 6Q0K, 6U2G, 6U2H, 6UAN, 6V2W, 6XAG, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 7MFD, 7MFE, 7MFF, 8DGS, 8DGT), K499-G503 (PDBs: 6P3D, 8DGT), K499-Y519 (PDBs: 3SKC)	 K499-G503 (PAE:  1.0), K499-L495 (PAE: 1.0), K499-S447 (PAE: 10.0)	K499-L495 (PDBs: 5CSX, 6P3D, 2FB8, 3D4Q, 3II5, 3PPJ, 3PPK, 3PRF, 3PRI, 3PSB, 3PSD, 3Q4C, 3Q96, 3SKC, 3TV4, 3TV6, 4DBN, 4E26, 4E4X, 4EHE, 4FC0, 4G9C, 4H58, 4KSP, 4KSQ, 4MBJ, 4PP7, 5CSW, 5CT7, 5FD2, 5HID, 5HIE, 5VAL, 5VAM, 6B8U, 6CAD, 6N0P, 6N0Q, 6V2U, 7P3V, 7SHV, 8C7X, 8C7Y, 8F7O, 8F7P, 8QQG, 4MNE, 6NYB, 6PP9, 6Q0K, 6U2G, 6U2H, 6UAN, 6V2W, 6XAG, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 7MFD, 7MFE, 7MFF, 8DGS, 8DGT), K499-G503 (PDBs: 6P3D, 8DGT)	 K499-D448 (PAE:  8.0)						147									-59.1				-39.0						H (helix)	H (α-helix)	Helix											78.83	20.487804	70-90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.7551298654362383	0.6653892795753322	false	false	false
SHOC2	SHOC2_Gly53Arg	B_13-14	-1.3521828512316285	0.21837236832015264	0.3002816583812034	7.059159648859733	0.00020075568205577907	0.0006796802150781451	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7181443580124467	0.7133308092007742	0.685074129595368	0.787490038586897	0.8641732225061163	0.7825374406248048	0.8245506805963665	0.8819803143207742	0.758256311129256	0.6672513485585667	0.7588381378910265	0.7671027727562545	0.7405242006532431	0.8463661306914583	0.8167237660445382	0.7028969106321692	0.667823480510522	0.6691859432686389	SHOC2	Gly53Arg	NC_000010.11:110964515:G:A	157G>A	10	110964515	G	A	10	ENSG00000108061	11602	0	CCSBVarC028008	ALE00034532	ENSP00000358464.5																																	1330365.0	single nucleotide variant	NM_007373.4(SHOC2):c.157G>A (p.Gly53Arg)	8036.0	SHOC2	HGNC:15454	Likely pathogenic	1.0	Jan 05, 2022	2134121169.0	-	RCV002272501	MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701	Noonan syndrome-like disorder with loose anagen hair 1	de novo	germline	GRCh38	NC_000010.11	10	110964515.0	110964515.0	10q25.2	criteria provided, single submitter	1.0	-	N	-	2.0	1339314.0	110964515.0	G	A	-	-	-	-	-	-	157G>A 	Gly53Arg	NM_007373.4	1.0	Pathogenic	Likely pathogenic	1339314	10	110964515.0	G	A	G	R	rs2134121169	10	112724273	10	112714263	53	SHOC2	ENSG00000108061	ENST00000691369	ENSP00000509754	Q9UQ13	SHOC2_HUMAN	.	.	c.157G>A	p.Gly53Arg	principal1	Y	.	.	.	+	GGA	1	0	G	G/G	G/G	G/G	G/G	.	0.41793	.	.	0.24765	.	0.982	0.62839	D	0.785	0.63333	P	.	0.88440	.	.	.	.	1.445	0.36203	L	.	0.20730	.	.	0.69502	0.5925	0.91770	D	0.8012	0.93256	D	10	.	0.60049	.	0.084434	0.74238	D	.	0.79415	0.2	0.11319	Q9UQ13	G53R	Gain of MoRF binding (P = 0.0334)| Loss of ubiquitination at K55 (P = 0.0365)| Gain of methylation at K54 (P = 0.0787)| Gain of loop (P = 0.1069)| Loss of glycosylation at K54 (P = 0.1528)	.	0.65811	.	0.19691	.	0.67780	0.874739408493	0.93229	D	0.259483	0.62867	T	0.335781	0.85447	D	0.24455	0.85257	D	0.902562320232391	0.55306	D	.	0.60013	.	0.30022958	0.52593	0.27641422	0.53380	0.30022958	0.52593	0.27641422	0.53379	-5.121	0.38173	T	.	0.64318	.	0.970648187277183	0.83393	0.15046370	0.70447	0.389	0.63863	.	.	.	.	.	.	4.506791	0.70599	25.5	0.99772429166242937	0.86015	0.909199	0.86504	D	0.713091895322115	0.80383	7.305809	0.767502526075403	0.87388	9.229115	5.99	5.99	0.97294	.	.	8.002	0.8806	9.913000	0.82471	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.998	0.85369	915	0.20912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Noonan_syndrome-like_disorder_with_loose_anagen_hair_1	criteria_provided,_single_submitter	NC_000010.11:g.110964515G>A	.	C4478716	607721	2701	.	Gly	Arg	29.72	0.8333333333333334																																																																																																																																																																																																																																																																																																																																																																																																																																																																													70			29.72	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Leucine-rich repeat protein SHOC-2		Basic and acidic residues								-0.4																		75									-87.4				170.3	Disordered					C (loop/coil)	C (loop/coil)												29.72	83.33333	$\leqslant$50	10-90	607721	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	false	0.7133308092007742	0.7181443580124467	false	false	false
LMNA	LMNA_Leu162Pro	B_13-14	-3.3189154883621836	0.012784044679513561	0.03277520179579987	-3.767405046492536	0.007006667102666885	0.012629896005298364	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9196386176449182	0.934761140191612	0.7154039405225165	0.8724716334503166	0.8403487442024928	0.8423968625822018	0.8727074769030542	0.8644456080199936	0.8524330441123773	0.7540635983996711	0.9305172577976744	0.9232503868681651	0.8120862482613493	0.8162518803849922	0.8925102227882559	0.6767442826453621	0.9390050225855497	0.9160268484216713	LMNA	Leu162Pro	NC_000001.11:156130745:T:C	485T>C	1	156130745	T	C	1	ENSG00000160789	3903	0	CCSBVarC000579	ALE00000579	ENSP00000357284.2	RC4	RC4_Mut_GDEh1027	A01	GDEhDisVCh_40057	E12	1	RC4_Mut_GDDh1027	A01	NULL	NULL	NULL	NULL	NULL	NULL	1.0	2.0	1.0	7.0	0.0			0.0			0.0			Y	Y	N	N	N	57232.0	single nucleotide variant	NM_170707.4(LMNA):c.485T>C (p.Leu162Pro)	4000.0	LMNA	HGNC:6636	Likely pathogenic	1.0	Apr 02, 2009	267607594.0	-	RCV000041352|RCV000057410	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900	Primary dilated cardiomyopathy|not provided	germline	germline	GRCh38	NC_000001.11	1	156130745.0	156130745.0	1q22	no assertion criteria provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018144	2.0	48068.0	156130745.0	T	C	-	-	-	-	-	-	485T>C 	Leu162Pro	NM_170707.4		Pathogenic	Likely pathogenic	48068	1	156130745.0	T	C	L	P	rs267607594	1	156100536	1	154367160	162	LMNA	ENSG00000160789	ENST00000368300	ENSP00000357283	P02545	LMNA_HUMAN	c.485T>C	p.Leu162Pro	c.485T>C	p.Leu162Pro	principal1	Y	1	YES	Select	+	CTG	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.033	0.70891	D	0.899	0.66535	P	0.701	0.71005	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.525	0.92921	H	-4.21	0.78753	D	0.649	0.88009	0.9396	0.96230	D	0.8568	0.95221	D	10	0.98645115	0.98945	D	0.700292	0.97542	D	0.855	0.95533	0.872	0.96404	P02545	L162P	Loss of stability (P = 0.0302)| Loss of catalytic residue at L162 (P = 0.1798)| Loss of MoRF binding (P = 0.2541)| Gain of methylation at R166 (P = 0.2594)| Gain of glycosylation at L162 (P = 0.618)	0.97668052646	0.97620	0.9799140373469903	0.97973	2.28727837	0.96349	0.738907754421	0.72764	T	0.97322	0.99722	D	0.467231	0.93175	D	0.433368	0.93090	D	0.994527041912079	0.85750	D	0.922208	0.75543	D	0.91780204	0.92932	0.88798314	0.94044	0.89284736	0.90622	0.90807116	0.95490	-16.821	0.98755	D	0.9901	0.93613	P	0.996923279603381	0.92597	0.99995673	0.99965	0.965	0.98576	.	.	.	.	.	.	4.84313	0.79131	27.0	0.99902297693059472	0.97352	0.974602	0.99567	D	0.755506102375548	0.83173	7.971851	0.697166544701107	0.82066	7.699593	5.59	5.59	0.84656	5.37	0.93424	6.268	0.72593	7.897000	0.73388	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.286	0.24211	447	0.79601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Primary_dilated_cardiomyopathy	no_assertion_criteria_provided	NC_000001.11:g.156130745T>C	ClinGen:CA018144	C3661900|C0007193	.	217604	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Pro	96.21	0.5792682926829268																																																																																																																																																																																																																																																																																																																																																																																																																																																																													95			96.21	Aliphatic	Leucine		Prelamin-A/C; Lamin-A/C							IF rod			3.8								 L162-L158 (PAE:  1.0), L162-R166 (PAE: 1.0)	L162-R166 (PDBs: 6JLB, 6SNZ), L162-L158 (PDBs: 6SNZ)	 L162-L158 (PAE:  1.0), L162-R166 (PAE: 1.0)	L162-R166 (PDBs: 6JLB, 6SNZ), L162-L158 (PDBs: 6SNZ)							131									-63.2				-38.1	Coil 1B					H (helix)	H (α-helix)	Helix											96.21	57.926826	>90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9		false	0.934761140191612	0.9196386176449182	false	false	false
FARS2	FARS2_Arg419Cys	B_13-14	1.6552138932581775	1.0	1.0	-1.4698956071499465	0.3684416130040028	0.39949472134780356	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6872761153542735	0.7385209749745318	0.5569668136937826	0.6992764151391551	0.6661208266058705	0.6990852215170825	0.7586722303302732	0.6565802716201137	0.6663146170049855	0.6515966633542633	0.696594649800956	0.6248408920758775	0.6394982127038918	0.6756613815916274	0.7322382132733247	0.46233696403330204	0.7804473001481077	0.7497113386326694	FARS2	Arg419Cys	NC_000006.12:5771328:C:T	1255C>T	6	5771328	C	T	6	ENSG00000145982	12653	0	CCSBVarC011932	ALE00012868	ENSP00000274680.4																																	211261.0	single nucleotide variant	NM_006567.5(FARS2):c.1255C>T (p.Arg419Cys)	10667.0	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1.0	Jan 06, 2024	775690041.0	-	RCV000197201|RCV000578139|RCV001378476	MedGen:C3661900|MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not provided|Hereditary spastic paraplegia 77|Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5771328.0	5771328.0	6p25.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA321645,OMIM:611592.0006	3.0	214336.0	5771328.0	C	T	-	-	-	-	-	-	1255C>T 	Arg419Cys	NM_006567.5	2.0	Pathogenic	Likely pathogenic	214336	6	5771328.0	C	T	R	C	rs775690041	6	5771561	6	5716560	419	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.1255C>T	p.Arg419Cys	c.1255C>T	p.Arg419Cys	principal1	Y	1	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.995	0.83178	D	0.94	0.94378	A	simple_aae	6.0	94.0	3.715	0.94651	H	-7.26	0.94393	D	0.932	0.99026	0.6632	0.92683	D	0.7452	0.91281	D	10	0.928861	0.92141	D	0.349699	0.92219	D	0.945	0.98886	0.723	0.85693	O95363	R419C	Loss of MoRF binding (P = 5e-04)| Loss of disorder (P = 0.0261)| Gain of catalytic residue at E422 (P = 0.0714)| Gain of sheet (P = 0.0827)| Loss of phosphorylation at T417 (P = 0.1046)	0.955839850528	0.95499	.	0.77993	.	0.65239	0.68183016777	0.64473	T	0.810547	0.95222	D	0.348511	0.86306	D	0.35969	0.90625	D	0.998910188674927	0.95528	D	0.995867	0.98584	D	0.9438368	0.95571	0.897082	0.94697	0.92678815	0.93825	0.8879299	0.94041	-10.535	0.77122	D	0.2542	0.50506	B	0.98820251721525	0.87710	0.97777240	0.95306	0.994	0.99793	.	.	.	.	.	.	5.901953	0.94011	33.0	0.99937551864799379	0.99661	0.856660	0.77309	D	0.97565369231617	0.94917	13.17435	0.915579723915553	0.96194	14.4338	5.81	5.81	0.92402	.	.	6.805	0.75041	7.527000	0.59919	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	964	0.07711	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	2	109402	1.828120e-05	0	2	207842	9.622690e-06	0	3	236614	1.267890e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13390	0.000000e+00	0	1	42768	2.338200e-05	0	1	15690	6.373490e-05	0	1	15690	6.373490e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6208	0.000000e+00	0	0	13414	0.000000e+00	0	0	16730	0.000000e+00	0	1	89280	1.120070e-05	0	1	30606	3.267330e-05	0	1	30606	3.267330e-05	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	0	21628	0.000000e+00	0	2	102430	1.952550e-05	0	1	30524	3.276110e-05	0	1	30524	3.276110e-05	0	.	33	1614088	2.044500e-05	0	28	1180044	2.372790e-05	0	1	74938	1.334440e-05	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29604	0.000000e+00	0	0	44888	0.000000e+00	0	0	64038	0.000000e+00	0	0	6084	0.000000e+00	0	28	1180044	2.372790e-05	0	2	91084	2.195780e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Hereditary_spastic_paraplegia_77|not_provided|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5771328C>T	ClinGen:CA321645|OMIM:611592.0006	C5569007|C3661900|C4755312	617046|614946	466722|319519	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	Arg	Cys	96.95	0.16129032258064516																																																																																																																																																																																																																																																																																																																																																																																																																																																																													40			96.95	Positively-charged	Arginine									FDX-ACB	0.1701		-4.5								 R419-R330 (PAE:  1.5), R419-L392 (PAE: 1.0), R419-Y360 (PAE: 1.5), R419-E394 (PAE: 1.0)	R419-E394 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGU, 8P8X, 3TUP), R419-Y360 (PDBs: 5MGH, 5MGV, 8P8X, 3TUP), R419-R330 (PDBs: 8P8X), R419-L392 (PDBs: 8P8X, 3TUP)	 R419-A362 (PAE:  1.0), R419-Y360 (PAE: 1.5), R419-L392 (PAE: 1.0), R419-E394 (PAE: 1.0)	R419-E394 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 8P8X, 3TUP), R419-P361 (PDBs: 8P8X), R419-A362 (PDBs: 8P8X, 3TUP), R419-L425 (PDBs: 8P8X), R419-Y360 (PDBs: 8P8X, 3TUP), R419-L392 (PDBs: 8P8X, 3TUP), R419-S358 (PDBs: 3TUP)	 R419-E394 (PAE:  1.0)	R419-E394 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 8P8X, 3TUP)					175									-150.5		Pocket 4: Mean pLDDT: 91.52, Volume: 344.54 Å³, Druggability score: 0.17		119.6						C (loop/coil)	C (loop/coil)												96.95	16.129032	>90	10-90	617046;614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE; COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.7385209749745318	0.6872761153542735	false	false	false
F9	F9_Ile136Thr	B_13-14	1.8596057282386111	0.10527238859817044	0.17068782871180435	-4.410901602851765	0.0031154124998878634	0.006227431304242081	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6579184560322806	0.6784017755767313	0.648341418099128	0.6859158717179649	0.7546156643103321	0.7125571821412958	0.6821111035410414	0.7433023744932171	0.6815767830427426	0.6011582277503629	0.6640392414497926	0.6558377143154812	0.7430032607415502	0.765928954127447	0.6902549603931871	0.6955246084478933	0.6927643097036701	0.6599991977490801	F9	Ile136Thr	NC_000023.11:139548378:T:C	407T>C	23	139548378	T	C	X	ENSG00000101981	52861	0	CCSBVarC030528	ALE00027364	ENSP00000218099.2																																	615665.0	single nucleotide variant	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Nov 01, 2024	1603265481.0	-	RCV000851938|RCV004812364	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139548378.0	139548378.0	Xq27.1	reviewed by expert panel	2.0	-	N	-	2.0	627177.0	139548378.0	T	C	-	-	-	-	-	-	407T>C 	Ile136Thr	NM_000133.4	3.0	Pathogenic	Likely pathogenic	627177	X	139548378.0	T	C	I	T	rs1603265481	X	138630537	X	138458203	136	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.407T>C	p.Ile136Thr	c.407T>C	p.Ile136Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.184	0.22252	T	0.145	0.33327	T	0.007	0.14196	B	0.018	0.18486	B	0.82	0.88440	A	simple_aae	18.0	82.0	0.92	0.23286	L	-1.59	0.42193	N	0.323	0.68623	0.0233	0.82642	D	0.6609	0.88180	D	10	0.61334246	0.67284	D	0.215404	0.87475	D	0.634	0.85909	0.864	0.95972	P00740	I136T	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.999803421972	0.99980	0.9571971461018347	0.95679	1.94467123622	0.93269	0.526858687401	0.42531	T	0.638754	0.88783	D	0.47971	0.93640	D	0.451294	0.93561	D	0.265829622745514	0.23290	T	0.725127	0.33926	T	0.45117912	0.63798	0.22186896	0.46839	0.54474115	0.69365	0.33303738	0.58914	-5.866	0.45201	T	0.1348	0.38457	B	0.982214726841226	0.85871	0.99995446	0.99953	0.745	0.85875	.	.	.	.	.	.	1.886718	0.24009	16.22	0.91815137977279504	0.21374	.	.	.	.	.	.	.	.	.	4.94	3.75	0.42169	3.53	0.64053	1.274	0.32841	6.148000	0.54222	0.609	0.47831	0.759	0.29323	1.000000	0.68239	0.912	0.44761	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_factor_VIII_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139548378T>C	.	C0019069	134500|306700	98878	.	Ile	Thr	78.46	0.3727810650887574																																																																																																																																																																																																																																																																																																																																																																																																															1.023		0.991		0.953		0.967		0.888																																																						63			78.46	Aliphatic	Isoleucine		Coagulation factor IX; Coagulation factor IXa light chain							EGF-like 2			4.5									I136-R140 (PDBs: 2WPH)		I136-R140 (PDBs: 2WPH, 2WPI, 2WPK, 2WPM)							131									-109.4				114.7						C (loop/coil)	T (turn)	Turn											78.46	37.278107	70-90	10-90	306700;306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA A; HEMOPHILIA B	false	0.6784017755767313	0.6579184560322806	false	false	false
F9	F9_Cys335Trp	B_13-14	3.001490748607782	0.019900120042260484	0.04532071164916202	1.8125204117721025	0.11279769975292003	0.14742434405029078	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9617720506292956	0.959307979131164	0.5045530384515615	0.60996063330457	0.5634739159791774	0.5214280745031973	0.549322901385515	0.594964031037813	0.6650843359610784	0.5037407651425292	0.9401360749092125	0.9420433743966325	0.4935332476208796	0.5319838009205418	0.5548369306480616	0.505365311760594	0.9784798833531154	0.9815007268619587	F9	Cys335Trp	NC_000023.11:139561690:C:G	1005C>G	23	139561690	C	G	X	ENSG00000101981	52861	0	CCSBVarC030614	ALE00028418	ENSP00000218099.2																																	962089.0	single nucleotide variant	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Jun 01, 2019	1928110579.0	-	RCV001265097	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561690.0	139561690.0	Xq27.1	no assertion criteria provided	1.0	-	N	-	2.0	973811.0	139561690.0	C	G	-	-	-	-	-	-	1005C>G 	Cys335Trp	NM_000133.4		Pathogenic	Likely pathogenic	973811	X	139561690.0	C	G	C	W	rs1928110579	X	138643849	X	138471515	335	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1005C>G	p.Cys335Trp	c.1005C>G	p.Cys335Trp	principal1	Y	1	YES	Select	+	TGC	3	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.93	0.93829	A	simple_aae	7.0	93.0	4.345	0.98414	H	-10.94	0.99269	D	0.867	0.94798	0.9106	0.95810	D	0.9301	0.97688	D	10	0.99144864	0.99668	D	0.785421	0.98309	D	0.874	0.96234	0.927	0.98799	P00740	C335W	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.998771782893	0.99874	0.9999734769876236	0.99997	1.9161241583	0.92915	0.691920042038	0.65925	T	0.970652	0.99678	D	0.619316	0.98093	D	0.651828	0.98062	D	0.99990177154541	0.99626	D	0.90321	0.66020	D	0.99243474	0.99876	0.9700131	0.99457	0.99243474	0.99876	0.9700131	0.99457	-13.176	0.90095	D	0.9894	0.93397	P	0.999969305192545	0.99297	0.99999310	0.99996	0.978	0.99209	.	.	.	.	.	.	3.435492	0.47852	22.5	0.99364900823550439	0.61211	.	.	.	.	.	.	.	.	.	5.66	1.89	0.24633	1.11	0.30197	1.625	0.36745	-0.017000	0.13030	-0.202	0.08747	0.857	0.30652	0.001000	0.17376	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561690C>G	.	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	96.87	0.007407407407407408																																																																																																																																																																																																																																																																																																																																																																																																															0.169	1 mutation(s) (Cys335Leu: -0.045)	0.101		0.083	1 mutation(s) (Cys335Ile: -0.004)	0.083	3 mutation(s) (Cys335Phe: -0.014, Cys335Leu: -0.009, Cys335Ala: -0.006)	0.096	1 mutation(s) (Cys335Trp: -0.002)																																																					1			96.87	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa heavy chain						Disulfide bond 178-335	Peptidase S1			2.5				A:C335-B:G344 (PDBs: 6X5J, 6X5L), H:C335-L:C221 (PDBs: 8OL9), H:C335-L:G222 (PDBs: 8OL9)				 C335-L425 (PAE:  1.0), C335-S423 (PAE: 1.0)	C335-L425 (PDBs: 6X5J, 6X5L, 8OL9)	 C335-G179 (PAE:  1.5), C335-L425 (PAE: 1.0), C335-C178 (PAE: 1.5)	C335-L425 (PDBs: 6X5J, 6X5L, 8OL9), C335-F424 (PDBs: 8OL9), C335-T422 (PDBs: 8OL9), C335-S423 (PDBs: 8OL9)							121									-73.1				140.5						B (undefined)	B (beta bridge)												96.87	0.7407407	>90	<10	306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B	false	0.959307979131164	0.9617720506292956	false	false	false
F9	F9_Ile316Thr	B_13-14	-4.807759772349099	0.002977039338873639	0.010668189750935553	6.047281654620102	0.0005173524805746467	0.0014190460416359891	2025_01_Batch_13-14	false	true	false	false	false	true	false	false	false	false	false	false	0.9706199948843885	0.9755046492227055	0.7608823750467423	0.8609629714663518	0.8114636401542592	0.837889018433513						0.9581041187481292	0.837889018433513	0.8114636401542592	0.8609629714663518	0.7608823750467423	0.9755046492227055	0.9831358710206479	F9	Ile316Thr	NC_000023.11:139561632:T:C	947T>C	23	139561632	T	C	X	ENSG00000101981	52861	0	CCSBVarC030590	ALE00027517	ENSP00000218099.2																																	800240.0	single nucleotide variant	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Nov 13, 2023	1603267344.0	-	RCV001001414|RCV004792605|RCV003769385	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	not specified|not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561632.0	139561632.0	Xq27.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	-	2.0	811502.0	139561632.0	T	C	-	-	-	-	-	-	947T>C 	Ile316Thr	NM_000133.4	2.0	Pathogenic	Likely pathogenic	811502	X	139561632.0	T	C	I	T	rs1603267344	X	138643791	X	138471457	316	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.947T>C	p.Ile316Thr	c.947T>C	p.Ile316Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	0.9	0.92786	A	simple_aae	10.0	90.0	3.94	0.96320	H	-4.77	0.80975	D	0.884	0.98575	1.0921	0.99323	D	0.9553	0.98549	D	10	0.99409103	0.99921	D	0.969256	0.99811	D	0.976	0.99783	0.964	0.99639	P00740	I316T	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.999203327797	0.99918	0.9996498989908393	0.99964	1.84500378867	0.92182	0.573964655399	0.49171	T	0.972778	0.99714	D	0.694692	0.99926	D	0.7601	0.99925	D	0.998964428901672	0.95690	D	0.935206	0.78054	D	0.9802627	0.99114	0.9668009	0.99308	0.98325217	0.99336	0.9520444	0.98499	-12.147	0.85599	D	0.5673	0.75544	P	0.999656738398078	0.97351	0.99999190	0.99996	0.981	0.99334	.	.	.	.	.	.	4.529531	0.71151	25.6	0.99859680176771604	0.93824	.	.	.	.	.	.	.	.	.	5.57	5.57	0.83999	4.99	0.89858	7.647	0.82668	7.922000	0.74613	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561632T>C	.	CN169374|C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	97.7	0.0																																																																																																																																																																																																																																																																																																																																																																																																															0.228		0.195		0.174		0.165	1 mutation(s) (Ile316Glu: -0.007)	0.176																																																						0			97.7	Aliphatic	Isoleucine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			4.5								 I316-H302 (PAE:  1.0)	I316-H302 (PDBs: 6X5J, 6X5L)	 I316-A266 (PAE:  1.0)	I316-A266 (PDBs: 6X5J, 6X5L, 8OL9), I316-H302 (PDBs: 8OL9), I316-I428 (PDBs: 8OL9), I316-T264 (PDBs: 8OL9)							131									-149.7				136.6						C (loop/coil)	C (loop/coil)												97.7	0.0	>90	<10	306900;300807	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.9755046492227055	0.9706199948843885	true	false	false
RAF1	RAF1_Thr145Pro	B_13-14	-6.387994716345845	0.1333777500132942	0.16433015971869222	3.4740690180528837	0.1387095016292574	0.15815415767121452	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.786804089668166	0.6853214201323568	0.6685493355542973	0.7441743763730804	0.7278512505369719	0.73687053636646	0.6927275690368087	0.764200224077608	0.6993414725826874	0.6702867418613431	0.8279406164878871	0.786804089668166	0.7810135036961114	0.6915022769963358	0.7890072801634733	0.6668119292472515	0.5427022237768263		RAF1	Thr145Pro	NC_000003.12:12608914:T:G	433A>C	3	12608914	T	G	3	ENSG00000132155	732	0	CCSBVarC008929	ALE00013049	ENSP00000251849.4																																	359447.0	single nucleotide variant	NM_002880.4(RAF1):c.433A>C (p.Thr145Pro)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Nov 03, 2016	1057518155.0	-	RCV000414587	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000003.12	3	12608914.0	12608914.0	3p25.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA16042457	2.0	373032.0	12608914.0	T	G	-	-	-	-	-	-	433A>C 	Thr145Pro	NM_002880.4	1.0	Pathogenic	Likely pathogenic	373032	3	12608914.0	T	G	T	P	rs1057518155	3	12650413	3	12625413	145	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.433A>C	p.Thr145Pro	principal3	Y	.	.	.	-	ACG	1	0	T	T/T	T/T	T/T	T/T	.	0.78662	.	.	0.79703	.	0.884	0.48632	P	0.651	0.52493	P	.	0.94378	.	.	.	.	3.94	0.96320	H	.	0.76607	.	.	0.66620	1.0870	0.99121	D	0.9288	0.97644	D	10	.	0.92727	.	0.77786	0.98245	D	.	0.99189	0.737	0.86913	P04049	T145P	Gain of glycosylation at T145 (P = 0.0599)| Gain of methylation at K144 (P = 0.1056)| Loss of MoRF binding (P = 0.1062)| Loss of ubiquitination at K144 (P = 0.1287)| Loss of stability (P = 0.1872)	.	0.96289	.	0.91688	.	0.82338	0.8487200737	0.89403	D	0.964761	0.99568	D	0.532258	0.95160	D	0.526776	0.95088	D	0.999636769294739	0.98238	D	.	0.87265	.	0.9750533	0.98689	0.9437567	0.97981	0.97559345	0.98735	0.95809036	0.98851	-11.037	0.80472	D	.	0.93458	.	0.999952511305676	0.99183	0.98135380	0.95656	0.995	0.99826	.	.	.	.	.	.	5.106479	0.85379	28.6	0.99400133114841904	0.62800	0.965951	0.98828	D	0.899566054000196	0.91692	11.03838	0.836522703996796	0.92161	11.29401	5.62	5.62	0.85695	5.35	0.93259	8.012	0.88241	7.910000	0.74019	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	646	0.63408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000003.12:g.12608914T>G	ClinGen:CA16042457	CN517202	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Thr	Pro	90.82	0.5563380281690141																																																																																																																																																																																																																																																																																																																																																																																																																																																																													79			90.82	Polar/Neutral	Threonine		RAF proto-oncogene serine/threonine-protein kinase										-0.7								 T145-N161 (PAE:  1.5)	T145-R164 (PDBs: 6PTW), T145-N161 (PDBs: 6XGU, 6XGV, 6XHA, 6XHB, 8T75)		T145-N161 (PDBs: 7JHP, 8T75), T145-L160 (PDBs: 8T75)							119									-93.8				125.8						B (undefined)	E (parallel sheets)	Beta strand										Phorbol-ester/DAG-type	90.82	55.6338	>90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.6853214201323568	0.786804089668166	false	false	false
CTCF	CTCF_Arg342Cys	B_13-14	4.0251147636350355	0.005026859283026853	0.015953941931620717	1.8584910793419462	0.10544478926604771	0.13880286104963957	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7182093380914636	0.7108352080464307	0.6115656901944587	0.7066928486054467	0.7325294307511753	0.6866893342421714	0.7297822854804187	0.798254733956309	0.7003089387009662	0.7068398708639556	0.7335939739647963	0.7248843108463705	0.6435963830039241	0.6668041275460416	0.7130767585099271	0.5162915095249618	0.6880764421280652	0.7115343653365567	CTCF	Arg342Cys	NC_000016.10:67616816:C:T	1024C>T	16	67616816	C	T	16	ENSG00000102974	6173	0	CCSBVarC010851	ALE00013946	ENSP00000264010.4																																	422102.0	single nucleotide variant	NM_006565.4(CTCF):c.1024C>T (p.Arg342Cys)	10664.0	CTCF	HGNC:13723	Pathogenic/Likely pathogenic	1.0	Aug 31, 2022	1131691283.0	-	RCV000494182|RCV001253429|RCV004535549	MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|	not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|CTCF-related disorder	de novo;germline	germline	GRCh38	NC_000016.10	16	67616816.0	67616816.0	16q22.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA396312251	2.0	429261.0	67616816.0	C	T	-	-	-	-	-	-	1024C>T 	Arg342Cys	NM_006565.4	2.0	Pathogenic	Likely pathogenic	429261	16	67616816.0	C	T	R	C	rs1131691283	16	67650719	16	66208220	342	CTCF	ENSG00000102974	ENST00000642819	ENSP00000494408	P49711	CTCF_HUMAN	c.1024C>T	p.Arg342Cys	c.1024C>T	p.Arg342Cys	principal4	Y	.	.	.	+	CGT	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.996	0.84488	D	.	0.91795	.	.	.	.	2.925	0.84244	M	.	0.94690	.	.	0.66102	-0.5414	0.66965	T	0.2195	0.58068	T	10	0.90816814	0.90073	D	0.072612	0.71478	D	.	0.81796	0.799	0.91830	P49711	R342C	Loss of MoRF binding (P = 0.0286)| Loss of disorder (P = 0.0417)| Gain of methylation at K344 (P = 0.0462)| Loss of loop (P = 0.0804)| Loss of solvent accessibility (P = 0.1077)	.	0.78989	.	0.92611	.	0.99749	0.963747024536	0.99943	D	0.874794	0.97303	D	0.243152	0.77795	D	0.111494	0.77506	D	0.998596012592316	0.94546	D	.	0.91755	.	0.8758145	0.89177	0.75798017	0.85523	0.79036707	0.83088	0.75543875	0.85370	-13.341	0.91976	D	0.9958	0.95928	LP	0.999472519562105	0.96705	0.95648080	0.93745	0.846	0.91546	.	.	.	.	.	.	5.456603	0.91125	32.0	0.99912080062961595	0.98096	0.927208	0.90917	D	0.872885598481848	0.90318	10.37319	0.805277495105465	0.90104	10.28159	4.89	4.89	0.63341	.	.	7.701	0.83585	7.609000	0.61899	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.995	0.73271	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614136	6.195260e-07	0	1	1180010	8.474500e-07	0	0	75034	0.000000e+00	0	0	912	0.000000e+00	0	0	60000	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64030	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180010	8.474500e-07	0	0	91086	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	not_provided|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|CTCF-related_disorder	criteria_provided,_conflicting_classifications	NC_000016.10:g.67616816C>T	ClinGen:CA396312251	C3661900|C3809686	615502	363611	.	Arg	Cys	86.65	0.40725806451612906																																																																																																																																																																																																																																																																																																																																																																																																																																																																													101			86.65	Positively-charged	Arginine		Transcriptional repressor CTCF										-4.5								 R342-V338 (PAE:  1.0)	R342-V338 (PDBs: 5KKQ, 5T00, 5T0U, 7W1M, 8SSQ, 8SSR, 8SSS), R342-T346 (PDBs: 5YEF), R342-H347 (PDBs: 8SSS)	 R342-H347 (PAE:  3.0), R342-E348 (PAE: 4.5), R342-V338 (PAE: 1.0), R342-T346 (PAE: 3.0)	R342-T346 (PDBs: 5KKQ, 5T00, 5T0U, 5YEF, 7W1M, 8SSQ, 8SSR, 8SSS), R342-V361 (PDBs: 8SSS), R342-E348 (PDBs: 8SSS), R342-H347 (PDBs: 8SSS), R342-V338 (PDBs: 8SSS)							175									-65.5				-35.5				dbSNP: -; Variant type: US; AA change: Arg342His; PTM type: Phosphorylation; PTM morphology: VRHRR*yKHtHE; Var class: II&-		H (helix)	H (α-helix)	Helix										C2H2-type 3	86.65	40.725807	70-90	10-90	615502	autosomal dominant	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21	false	0.7108352080464307	0.7182093380914636	false	false	false
BRCA1	BRCA1_Ser611Arg	B_13-14	0.9435653387772786	1.0	1.0	4.562711114888771	0.012450121366398254	0.01942939199680961	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	true	false	false	true	0.9123224996979213	0.9149496741107959	0.8866432081448484	0.964146262442205	0.9445725039373087	0.9679047844788691	0.9556749997892622	0.9508232350943917	0.9489520431675258	0.8877991628476729	0.9068718700217675	0.9154607371390774	0.980134569168476	0.9383217727802257	0.9793404817168843	0.885487253442024	0.9230274781998243	0.9091842622567653	BRCA1	Ser611Arg	NC_000017.11:43063881:G:C	1833C>G	17	43063881	G	C	17	ENSG00000012048	14613	0	CCSBVarC011835	ALE00014354	ENSP00000417148.1																																	70085.0	single nucleotide variant	NM_007294.4(BRCA1):c.5145C>G (p.Ser1715Arg)	672.0	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1.0	Mar 06, 2024	80357094.0	-	RCV000112509|RCV002336193	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43063881.0	43063881.0	17q21.31	criteria provided, multiple submitters, no conflicts	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003268,UniProtKB:P38398#VAR_063906	2.0	55418.0	43063881.0	G	C	-	-	-	-	-	-	5145C>G 	Ser1715Arg	NM_007294.4	2.0	Pathogenic	Likely pathogenic	55418	17	43063881.0	G	C	S	R	rs80357094	17	41215898	17	38469424	1715	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5145C>G	p.Ser1715Arg	principal2	Y	1	.	.	-	AGC	3	2	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.064	0.90580	B	0.031	0.92348	B	.	0.99291	.	.	.	.	3.09	0.87301	M	.	0.74220	.	.	0.93850	0.3749	0.88675	D	0.6610	0.88183	D	10	.	0.79960	.	0.483874	0.94878	D	.	0.88582	.	.	.	.	.	.	0.91515	.	0.92636	.	0.45682	0.678713917732	0.64025	T	0.249441	0.61729	T	0.397653	0.89708	D	0.333424	0.89578	D	0.98091846704483	0.73434	D	.	0.85294	.	0.9707088	0.98298	0.7604528	0.85672	0.97296304	0.98504	0.7653877	0.85971	-15.775	0.97410	D	.	0.96584	.	0.998593400129946	0.94714	0.99986792	0.99835	0.992	0.99727	.	.	.	.	.	.	3.655532	0.51985	23.2	0.99838730133180587	0.91978	0.429032	0.49057	N	0.670045961903725	0.77549	6.719747	0.654600882003088	0.78837	6.981316	6.04	4.89	0.63341	4.33	0.81833	2.013	0.40665	4.969000	0.46465	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.998	0.85369	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43063881G>C	ClinGen:CA003268|UniProtKB:P38398#VAR_063906	C0027672|C2676676	604370	140162|145	BRCT domain|BRCT domain|BRCT domain	Ser	Arg	97.51	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.51	0.0	>90	<10	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.9149496741107959	0.9123224996979213	false	false	false
FARS2	FARS2_Asp325Tyr	B_13-14	-0.023869672948344745	1.0	1.0	-3.0326764915490694	0.023298109859245034	0.03546515118639845	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6867739065233056	0.7276767259178316	0.6805070147451602	0.6400968740148937	0.6791286003317617	0.7093729177879136	0.7659318343754765	0.6979352766528598	0.6095452095505229	0.7592689433379963	0.7457826413605942	0.7107153796319059	0.6528140012003507	0.6603219240106636	0.6706485384792644	0.6017450861523241	0.7095708104750689	0.6628324334147053	FARS2	Asp325Tyr	NC_000006.12:5545248:G:T	973G>T	6	5545248	G	T	6	ENSG00000145982	12653	0	CCSBVarC011942	ALE00013134	ENSP00000274680.4																																	247570.0	single nucleotide variant	NM_006567.5(FARS2):c.973G>T (p.Asp325Tyr)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Jun 13, 2018	764427452.0	-	RCV000239485	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5545248.0	5545248.0	6p25.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA10586222,OMIM:611592.0004	3.0	253158.0	5545248.0	G	T	-	-	-	-	-	-	973G>T 	Asp325Tyr	NM_006567.5	1.0	Pathogenic	Likely pathogenic	253158	6	5545248.0	G	T	D	Y	rs764427452	6	5545481	6	5490480	325	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.973G>T	p.Asp325Tyr	c.973G>T	p.Asp325Tyr	principal1	Y	1	.	.	+	GAC	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.019	0.59495	D	0.997	0.70687	D	0.856	0.60995	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.89	0.83536	M	-3.91	0.73078	D	0.892	0.89118	-0.4312	0.70898	T	0.2879	0.65824	T	10	0.8789767	0.87061	D	0.327437	0.91634	D	0.365	0.68327	0.549	0.66319	O95363	D325Y	Loss of sheet (P = 0.0457)| Gain of helix (P = 0.1736)| Loss of relative solvent accessibility (P = 0.1903)| Loss of solvent accessibility (P = 0.2668)| Gain of loop (P = 0.2754)	0.863127915216	0.86073	0.818542452780431	0.81703	0.666257477821	0.58909	0.481479197741	0.36213	T	0.386013	0.74554	T	0.0497619	0.58021	T	-0.166297	0.57486	T	0.969270646572113	0.68326	D	.	0.94767	.	0.7669591	0.81643	0.55408955	0.73958	0.7752676	0.82147	0.51400286	0.71661	-13.746	0.92217	D	0.2762	0.51168	LB	0.927914649263957	0.78214	0.86435160	0.90056	0.613	0.78377	.	.	.	.	.	.	4.293796	0.65565	24.8	0.99486466779059812	0.67222	0.403449	0.47535	N	0.582178761681802	0.71915	5.747102	0.542820554954507	0.70738	5.573649	5.27	4.28	0.50124	2.38	0.44324	2.399	0.4425	2.441000	0.32855	0.676	0.76753	1.0	0.71675	0.995000	0.32549	0.978	0.57275	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5545248G>T	ClinGen:CA10586222|OMIM:611592.0004	C4755312	614946	319519	Aminoacyl-tRNA synthetase, class II	Asp	Tyr	94.72	0.2822085889570552																																																																																																																																																																																																																																																																																																																																																																																																																																																																													46			94.72	Negatively-charged	Aspartic Acid										0.1923		-3.5								 D325-K353 (PAE:  2.0)	D325-H282 (PDBs: 3CMQ, 5MGU), D325-M321 (PDBs: 3TEG, 5MGU, 3TUP)	 D325-M321 (PAE:  1.0), D325-K353 (PAE: 2.0)	D325-M321 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGW, 8P8X, 3TUP), D325-F354 (PDBs: 8P8X)	 D325-K353 (PAE:  2.0)						132									62.0		Pocket 3: Mean pLDDT: 74.2, Volume: 1231.61 Å³, Druggability score: 0.19		38.0						C (loop/coil)	T (turn)												94.72	28.22086	>90	10-90	614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.7276767259178316	0.6867739065233056	false	false	false
KRAS	KRAS_Gly12Asp	B_13-14	-1.282954401654033	0.24035037393394657	0.32374415670933565	6.567134953108474	0.0003137660893001123	0.0009580046154171483	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	false	false	0.8995125043139606	0.9022625223211441	0.7844270484928562	0.837466334415198	0.9090966235592102	0.8784998767021812	0.8028791237079094	0.8991757197424731	0.729037312304978	0.6846238604679095	0.860411456294941	0.8488979701187157	0.9541206296964531	0.9190175273759473	0.9458953565254181	0.8842302365178027	0.9441135883473473	0.9501270385092054	KRAS	Gly12Asp	NC_000012.12:25245350:C:T	35G>A	12	25245350	C	T	12	ENSG00000133703	3084	0	CCSBVarC006090	ALE00006090	ENSP00000308495.3	CEGS2	CegsMutGDEh1034	G11	GDEhDisVCh_40061	F08	1	CegsMutGDDh1034	G11	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	27621.0	single nucleotide variant	NM_004985.5(KRAS):c.35G>A (p.Gly12Asp)	3845.0	KRAS	HGNC:6407	Pathogenic/Likely pathogenic	1.0	Nov 03, 2023	121913529.0	-	RCV000013411|RCV000022799|RCV000029214|RCV000029215|RCV000144969|RCV000144970|RCV000150896|RCV000150897|RCV000548006|RCV000585796|RCV000662266|RCV001839445|RCV000272938|RCV000433573|RCV004554600|RCV004668724|RCV000856666|RCV001799604|RCV002508117|RCV003327361|RCV004018620	MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|Human Phenotype Ontology:HP:0010816,MONDO:MONDO:0008093,MedGen:C0334082,OMIM:162900,Orphanet:79414|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724||MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396|MedGen:C3661900|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519||Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MedGen:C4302356|MONDO:MONDO:0020783,MedGen:C4747394,OMIM:608354,Orphanet:137667,Orphanet:90307|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0006096,MedGen:C0349579;MONDO:MONDO:0006193,MedGen:C1516855|MedGen:CN230736	Carcinoma of pancreas|Epidermal nevus|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|Non-small cell lung carcinoma|Ovarian neoplasm|RASopathy|Cerebral arteriovenous malformation|Vascular Tumors Including Pyogenic Granuloma|Encephalocraniocutaneous lipomatosis|not provided|Acute myeloid leukemia|Congenital Pulmonary Airway Malformations|Neoplasm|Primary low grade serous adenocarcinoma of ovary|Capillary malformation-arteriovenous malformation 1|Gastric cancer|Atypical endometrial hyperplasia;Endometrial hyperplasia without atypia|Cardiovascular phenotype	de novo;germline;somatic;unknown	germline/somatic	GRCh38	NC_000012.12	12	25245350.0	25245350.0	12p12.1	criteria provided, multiple submitters, no conflicts	23.0	-	N	ClinGen:CA122538,UniProtKB:P01116#VAR_016026,OMIM:190070.0005,OMIM:190070.0025	3.0	12582.0	25245350.0	C	T	-	-	-	Oncogenic	Jul 31, 2024	criteria provided, single submitter	35G>A 	Gly12Asp	NM_004985.5	2.0	Pathogenic	Likely pathogenic	12582	12	25245350.0	C	T	G	D	rs121913529	12	25398284	12	25289551	12	KRAS	ENSG00000133703	ENST00000256078	ENSP00000256078	P01116	RASK_HUMAN	c.35G>A	p.Gly12Asp	c.35G>A	p.Gly12Asp	alternative1	Y	1	.	Plus_Clinical	-	GGT	2	0	C	./.	./.	./.	./.	0.01	0.56615	D	0.0	0.92967	D	0.517	0.37470	P	0.361	0.43233	B	1.0	0.99291	A	simple_aae	0.0	100.0	2.685	0.78379	M	-5.37	0.90914	D	0.915	0.91737	0.2670	0.86969	D	0.5809	0.84869	D	10	0.897719	0.89008	D	0.164646	0.84329	D	0.875	0.96271	0.772	0.89792	P01116	G12D	Gain of catalytic residue at G13 (P = 0.001)| Gain of ubiquitination at K16 (P = 0.1181)| Loss of methylation at K16 (P = 0.1388)| Gain of solvent accessibility (P = 0.2192)| Loss of sheet (P = 0.302)	0.957447700615	0.95662	0.9871709593781199	0.98706	2.25690945348	0.96132	0.929049253464	0.98932	D	0.839213	0.96205	D	0.397866	0.89719	D	0.33373	0.89591	D	0.965350031852722	0.67026	D	0.331367	0.19106	T	0.92127717	0.93272	0.924745	0.96683	0.9358444	0.94746	0.9112568	0.95720	-14.566	0.96931	D	0.9984	0.98378	P	0.999983137957112	0.99579	0.99778840	0.98508	0.995	0.99826	.	.	.	.	.	.	4.925041	0.81187	27.5	0.99776655469088438	0.86444	0.891815	0.82751	D	0.605638712679719	0.73388	5.981318	0.66049645547495	0.79283	7.073244	5.68	5.68	0.88004	.	.	7.892	0.85894	7.698000	0.66189	0.58	0.29757	1.0	0.71675	1.000000	0.68239	1.0	0.97202	707	0.56997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	108342	9.230030e-06	0	1	206404	4.844870e-06	0	1	234992	4.255460e-06	0	0	7046	0.000000e+00	0	0	17030	0.000000e+00	0	0	2232	0.000000e+00	0	0	9026	0.000000e+00	0	0	13384	0.000000e+00	0	1	42218	2.368660e-05	0	0	15506	0.000000e+00	0	1	42218	2.368660e-05	0	0	16014	0.000000e+00	0	0	30376	0.000000e+00	0	0	6112	0.000000e+00	0	0	13384	0.000000e+00	0	0	16720	0.000000e+00	0	1	88728	1.127040e-05	0	0	30232	0.000000e+00	0	1	88728	1.127040e-05	0	0	14710	0.000000e+00	0	0	34116	0.000000e+00	0	0	9462	0.000000e+00	0	0	17666	0.000000e+00	0	0	21592	0.000000e+00	0	1	101710	9.831870e-06	0	0	30152	0.000000e+00	0	1	101710	9.831870e-06	0	.	6	1612744	3.720370e-06	0	5	1179306	4.239780e-06	0	0	74904	0.000000e+00	0	0	912	0.000000e+00	0	0	59938	0.000000e+00	0	0	29524	0.000000e+00	0	0	44868	0.000000e+00	0	0	63988	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179306	4.239780e-06	0	0	90798	0.000000e+00	0	0	90742	0	0	162	0	0	2680	0	0	3944	0	0	436	0	0	928	0	0	624	0	0	276	0	1	2036	4.911591355599214E-4	0	4106	0	0	3304	0	1	101828	9.820481596417489E-6	Juvenile_myelomonocytic_leukemia|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Acute_myeloid_leukemia|Gastric_cancer|Congenital_Pulmonary_Airway_Malformations|not_provided|Carcinoma_of_pancreas|Cardiovascular_phenotype|Ovarian_neoplasm|RASopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|Non-small_cell_lung_carcinoma|Capillary_malformation-arteriovenous_malformation_1|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|Linear_nevus_sebaceous_syndrome|Vascular_Tumors_Including_Pyogenic_Granuloma|Atypical_endometrial_hyperplasia|Endometrial_hyperplasia_without_atypia|Cerebral_arteriovenous_malformation|Lung_carcinoma|Epidermal_nevus	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.25245350C>T	ClinGen:CA122538|OMIM:190070.0005|OMIM:190070.0025|UniProtKB:P01116#VAR_016026	C0349639|C0406612|C0009404|C0040136|C0023467|C0024623|C3661900|C0235974|CN230736|C0919267|C5555857|C4302356|C0007131|C4747394|C2674723|C3854181|C4552097|C0349579|C1516855|C0917804|C0684249|C0334082	607785|613001|601626|613659|608354|614470|163200|108010|162900	86834|2396|100087|519|1333|217074|536391|137667|90307|268114|2612|46724|79414	Small GTP-binding domain	Gly	Asp	94.86	0.2261904761904762																																																																																																																																																																																					-0.112						-0.383						-0.394						-0.086				0.206				-0.126		-0.119		-0.492						-0.25						0.417		-0.158		0.011		0.043		0.376																																																																																																																																																																																																																																						19			94.86	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine	GTP	GTPase KRas; GTPase KRas, N-terminally processed										-0.4									G12-E62 (PDBs: 6O36, 6O46, 8T71)		G12-K16 (PDBs: 6MQG, 6MQN, 6YXW, 8T75), G12-A59 (PDBs: 8CPR), G12-E62 (PDBs: 8T71), G12-G60 (PDBs: 8T72, 8T74, 8TBF), G12-Q61 (PDBs: 2MSD)							75									-55.3				143.2						C (loop/coil)	T (turn)	Beta strand											94.86	22.619047	>90	10-90	162900;163200;607785;614470;108010;613001;601626;608354;613659	somatic	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Rare genetic gastroenterological disease; Genetic infertility; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	13	NEVUS, EPIDERMAL; SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; JUVENILE MYELOMONOCYTIC LEUKEMIA; RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; ARTERIOVENOUS MALFORMATIONS OF THE BRAIN; ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; LEUKEMIA, ACUTE MYELOID; CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1; GASTRIC CANCER	false	0.9022625223211441	0.8995125043139606	false	false	false
BAP1	BAP1_Leu49Pro	B_13-14	1.5336173628501408	0.16899235826402517	0.24620549525880095	-3.8167942109575983	0.006569580903600427	0.011947652089303056	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7083600737137509	0.7238733038430509	0.5746282897761967	0.6384417618749961	0.6622432246191852	0.603354894251291	0.6301315865051607	0.6994309716373834	0.623126004929676	0.6108565349355898	0.7218304636860048	0.7046803056251445	0.5765782019974213	0.6250554776009869	0.6537575188203163	0.5384000446168037	0.725916144000097	0.7120398418023572	BAP1	Leu49Pro	NC_000003.12:52408583:A:G	146T>C	3	52408583	A	G	3	ENSG00000163930	3760	0	CCSBVarC009492	ALE00015202	ENSP00000417132.1																																	1162266.0	single nucleotide variant	NM_004656.4(BAP1):c.146T>C (p.Leu49Pro)	8314.0	BAP1	HGNC:950	Likely pathogenic	1.0	Sep 28, 2022	2153228340.0	-	RCV001797185|RCV003161062	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900	Neurodevelopmental disorder|not provided	de novo;germline	germline	GRCh38	NC_000003.12	3	52408583.0	52408583.0	3p21.1	criteria provided, single submitter	2.0	-	N	-	2.0	1173079.0	52408583.0	A	G	-	-	-	-	-	-	146T>C 	Leu49Pro	NM_004656.4	1.0	Pathogenic	Likely pathogenic	1173079	3	52408583.0	A	G	L	P	rs2153228340	3	52442599	3	52417639	49	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.146T>C	p.Leu49Pro	c.146T>C	p.Leu49Pro	principal1	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.14	0.97479	H	-6.34	0.91806	D	0.964	0.97441	0.4731	0.90127	D	0.5835	0.84984	D	10	0.9803013	0.97974	D	0.465198	0.94573	D	0.830	0.94600	0.911	0.98220	Q92560	L49P	Loss of stability (P = 0.0111)| Gain of sheet (P = 0.0477)| Loss of MoRF binding (P = 0.0633)| Gain of disorder (P = 0.1336)| Gain of glycosylation at Y44 (P = 0.1882)	0.919171306595	0.91774	0.9942708640742988	0.99423	3.28525368344	0.99563	0.917951464653	0.98162	D	0.61312	0.87653	D	0.399268	0.89798	D	0.335745	0.89671	D	0.999857425689697	0.99358	D	0.998712	0.99310	D	0.98750603	0.99618	0.97671837	0.99717	0.98750603	0.99618	0.97671837	0.99718	-17.779	0.99425	D	0.9998	0.99584	P	0.999944798679913	0.99079	0.99983054	0.99778	0.979	0.99252	.	.	.	.	.	.	5.605936	0.92502	32.0	0.99900871002661273	0.97276	0.961659	0.98292	D	1.02132438138349	0.96342	14.6051	0.93110546969636	0.96774	15.15042	5.43	5.43	0.78977	3.34	0.60572	9.279	0.94993	9.358000	0.80383	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.995	0.73271	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Neurodevelopmental_disorder|not_provided	criteria_provided,_single_submitter	NC_000003.12:g.52408583A>G	.	C1535926|C3661900	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Leu	Pro	92.13	0.07317073170731707																																																																																																																																																																																																																																																																																																																																																																																																																																																																													12			92.13	Aliphatic	Leucine		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			3.8								 L49-N229 (PAE:  1.5)	L49-N229 (PDBs: 8SVF)	 L49-H169 (PAE:  1.0), L49-N229 (PAE: 1.5)	L49-H169 (PDBs: 8SVF), L49-F228 (PDBs: 8SVF), L49-F170 (PDBs: 8SVF), L49-N229 (PDBs: 8SVF), L49-R227 (PDBs: 8SVF), L49-F168 (PDBs: 8SVF)							131									-103.1				135.5						B (undefined)	E (parallel sheets)	Beta strand											92.13	7.317073	>90	<10		unknown		Rare genetic tumor	1		false	0.7238733038430509	0.7083600737137509	false	false	false
RAF1	RAF1_Thr491Arg	B_13-14	-5.242335541861087	0.17352561940663744	0.2010522392018278	2.2142650562662	0.20819766860665642	0.23216562487529244	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7102642038775082	0.7770489092581461	0.7406413227893183	0.6958134918831577	0.6747710054948919	0.7522015856684436	0.7978055020436187	0.7062549937186899	0.6676469146733599	0.7660629179134818	0.8454598377371397	0.7685513085885857	0.7065976692932685	0.6432870172710937	0.7239800690929554	0.7152197276651548	0.7086379807791525	0.6519770991664307	RAF1	Thr491Arg	NC_000003.12:12585745:G:C	1472C>G	3	12585745	G	C	3	ENSG00000132155	732	0	CCSBVarC003427	ALE00003427	ENSP00000251849.4	CEGS2	CegsMutGDEh1015	G06	GDEhDisVCh_40029	F08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	28998.0	single nucleotide variant	NM_002880.4(RAF1):c.1472C>G (p.Thr491Arg)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Nov 29, 2022	80338799.0	-	RCV000014988|RCV000680803|RCV001229313	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	Noonan syndrome 5|not provided|RASopathy	germline	germline	GRCh38	NC_000003.12	3	12585745.0	12585745.0	3p25.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA257064,UniProtKB:P04049#VAR_037819,OMIM:164760.0003	3.0	13959.0	12585745.0	G	C	-	-	-	-	-	-	1472C>G 	Thr491Arg	NM_002880.4	2.0	Pathogenic	Likely pathogenic	13959	3	12585745.0	G	C	T	R	rs80338799	3	12627244	3	12602244	491	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1472C>G	p.Thr491Arg	c.1472C>G	p.Thr491Arg	principal3	Y	1	YES	Select	-	ACA	2	0	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.122	0.40143	T	1.0	0.90580	D	0.999	0.92348	D	0.98	0.99291	A	simple_aae	2.0	98.0	0.02	0.07909	N	-5.37	0.84911	D	0.961	0.99191	0.1373	0.84771	D	0.4388	0.77686	T	10	0.899554	0.89196	D	0.235705	0.88439	D	0.786	0.92884	0.752	0.88177	P04049	T491R	Gain of MoRF binding (P = 0.0086)| Loss of ubiquitination at K493 (P = 0.0532)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K493 (P = 0.0976)| Gain of solvent accessibility (P = 0.1456)	0.974052792841	0.97352	.	0.85535	2.53490677304	0.97794	0.845280706882	0.88882	D	0.900422	0.98022	D	0.39866	0.89767	D	0.334871	0.89639	D	0.996480882167816	0.89353	D	.	0.92373	.	0.9571182	0.96940	0.9388268	0.97656	0.9463269	0.95828	0.90921533	0.95572	-12.126	0.85499	D	0.9852	0.92260	P	0.999988562000968	0.99579	0.99762386	0.98444	0.978	0.99209	.	.	.	.	.	.	5.424006	0.90747	31.0	0.99437118353782505	0.64619	0.916990	0.88355	D	0.626065396186754	0.74692	6.199454	0.704879681503555	0.82653	7.84486	5.26	5.26	0.73443	.	.	9.996	0.99292	11.849000	0.98025	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.994	0.71086	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RASopathy|not_provided|Noonan_syndrome_5	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.12585745G>C	ClinGen:CA257064|OMIM:164760.0003|UniProtKB:P04049#VAR_037819	C5555857|C3661900|C1969057	611553	536391|648	Protein kinase domain|Protein kinase domain|Protein kinase domain	Thr	Arg	53.92	0.2746478873239437																																																																																																																																																																																																																																																																																																																																																																																																																																																																													39			53.92	Polar/Neutral	Threonine		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase			-0.7								 T491-R495 (PAE:  5.0)	T491-I465 (PDBs: 3OMV, 8CHF, 8CPD), T491-R467 (PDBs: 8CPD)	 T491-R495 (PAE:  5.0)	T491-I465 (PDBs: 3OMV, 8CHF, 8CPD), T491-R467 (PDBs: 8CPD)						Phosphothreonine	119		Mutation: T -> D. Increased kinase activity but can still be inhibited by PPP5C; when associated with D-494.							-65.0	Morphology: IGDFGLAtVksRWsG; Domain: PK_Tyr_Ser-Thr			-32.9		Regulatory site: T491-p; Morphology: IGDFGLAtVKSRWSG; Domain: PK_Tyr_Ser-Thr; On-Function: enzymatic activity, induced		dbSNP: rs80338799; Variant type: LP/P; AA change: Thr491Ile; PTM type: Ubiquitylation; PTM morphology: GLAt*VksRWsG; Var class: II&rs80338799		H (helix)	H (α-helix)												53.92	27.464788	50-70	10-90	611553	unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	NOONAN SYNDROME 5	false	0.7770489092581461	0.7102642038775082	false	false	false
F9	F9_Ile443Thr	B_13-14	-2.603126825347658	0.035264293228412145	0.07052858645682429	1.0768268601982265	0.31726317412988003	0.3703421911757824	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7812743994653423	0.747328334403939	0.5762965078610238	0.740013274085426	0.6276591250560064	0.6367541927510756	0.7003884337741859	0.6261868393870788	0.7456242733079486	0.5888443584344446	0.7444138746536962	0.7813941378430216	0.5731199517279653	0.6291314107249342	0.7344022748629035	0.5637486572876029	0.7502427941541817	0.781154661087663	F9	Ile443Thr	NC_000023.11:139562013:T:C	1328T>C	23	139562013	T	C	X	ENSG00000101981	52861	0	CCSBVarC030634	ALE00024424	ENSP00000218099.2																																	25666.0	single nucleotide variant	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Feb 27, 2024	137852268.0	-	RCV000011371|RCV001382695|RCV001810850	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|not provided	germline	germline	GRCh38	NC_000023.11	X	139562013.0	139562013.0	Xq27.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	3.0	10627.0	139562013.0	T	C	-	-	-	-	-	-	1328T>C 	Ile443Thr	NM_000133.4	2.0	Pathogenic	Likely pathogenic	10627	X	139562013.0	T	C	I	T	rs137852268	X	138644172	X	138471838	443	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1328T>C	p.Ile443Thr	c.1328T>C	p.Ile443Thr	principal1	Y	1	YES	Select	+	ATA	2	0	T	T/T	T/T	T/T	T/T	0.003	0.68399	D	0.003	0.76775	D	0.973	0.57613	D	0.951	0.68937	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.195	0.61650	M	-4.11	0.75007	D	0.704	0.93024	0.7153	0.93342	D	0.7847	0.92672	D	10	0.9883479	0.99241	D	0.919322	0.99403	D	0.905	0.97394	0.953	0.99464	P00740	I443T	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.999526675672	0.99951	0.9967505453949344	0.99673	1.8200784132	0.91900	0.708432018757	0.68313	T	0.894511	0.97862	D	0.538835	0.95331	D	0.536223	0.95261	D	0.993006281329265	0.83514	D	0.931207	0.78302	D	0.9132074	0.92487	0.92443126	0.96661	0.92416036	0.93561	0.8973755	0.94718	-10.184	0.79899	D	0.7773	0.84877	P	0.99926867450489	0.96103	0.99998903	0.99996	0.986	0.99524	.	.	.	.	.	.	4.4192	0.68492	25.2	0.9985035315891414	0.93018	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	5.23	0.92191	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1210935	8.258080e-07	0	1	895048	1.117260e-06	0	0	57682	0.000000e+00	0	0	688	0.000000e+00	0	0	45970	0.000000e+00	0	0	22027	0.000000e+00	0	0	33829	0.000000e+00	0	0	46791	0.000000e+00	0	0	4350	0.000000e+00	0	1	895048	1.117260e-06	0	0	56919	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139562013T>C	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	C0008533|C2749016|C3661900	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ile	Thr	93.18	0.03550295857988166																																																																																																																																																																																																																																																																																																																																																																																																															0.844		0.611		0.553		0.519		0.523																																																						6			93.18	Aliphatic	Isoleucine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			4.5								 I443-S430 (PAE:  1.0), I443-W431 (PAE: 1.0)	I443-W431 (PDBs: 6X5J, 6X5L, 8OL9), I443-S430 (PDBs: 8OL9)	 I443-W431 (PAE:  1.0)	I443-W431 (PDBs: 6X5J, 6X5L, 8OL9), I443-M394 (PDBs: 8OL9), I443-G432 (PDBs: 8OL9), I443-S430 (PDBs: 8OL9), I443-F395 (PDBs: 8OL9)							131									-110.3				129.7						B (undefined)	E (parallel sheets)	Beta strand											93.18	3.5502958	>90	<10	306900;300807;306900	x-linked	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	false	0.747328334403939	0.7812743994653423	false	false	false
RAF1	RAF1_Cys95Trp	B_13-14	2.1174108905084634	0.25563446626635816	0.298832409899961	-0.7341478353766485	0.6086007600525194	0.6374278814956559	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7557434336371445	0.7634285288454937	0.713788402856929	0.804730610522456	0.8228071036524931	0.7921962064652646	0.6753082431293986	0.8043962937301815	0.7078418443569905	0.6206592333541907	0.708503490004847	0.7067614172508424	0.9090841698011306	0.8412179135748047	0.9016193766879215	0.8069175723596674	0.8183535676861404	0.8047254500234466	RAF1	Cys95Trp	NC_000003.12:12611985:G:C	285C>G	3	12611985	G	C	3	ENSG00000132155	732	0	CCSBVarC008910	ALE00012708	ENSP00000251849.4																																	173887.0	single nucleotide variant	NM_002880.4(RAF1):c.285C>G (p.Cys95Trp)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Aug 11, 2014	727503384.0	-	RCV000151719	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	Noonan syndrome	germline	germline	GRCh38	NC_000003.12	3	12611985.0	12611985.0	3p25.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA273221	2.0	165011.0	12611985.0	G	C	-	-	-	-	-	-	285C>G 	Cys95Trp	NM_002880.4	1.0	Pathogenic	Likely pathogenic	165011	3	12611985.0	G	C	C	W	rs727503384	3	12653484	3	12628484	95	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.285C>G	p.Cys95Trp	principal3	Y	.	.	.	-	TGC	3	2	G	G/G	G/G	G/G	G/G	.	0.68399	.	.	0.38356	.	1.0	0.90580	D	0.996	0.84488	D	.	0.94956	.	.	.	.	2.485	0.72164	M	.	0.79947	.	.	0.79136	0.1432	0.84874	D	0.5496	0.83427	D	10	.	0.89682	.	0.141331	0.82326	D	.	0.91849	0.754	0.88343	P04049	C95W	Gain of MoRF binding (P = 0.0301)| Gain of sheet (P = 0.0827)| Gain of catalytic residue at C96 (P = 0.2212)| Loss of loop (P = 0.2897)| Loss of stability (P = 0.5099)	.	0.87322	.	0.85122	.	0.87009	0.869541406631	0.92491	D	0.903854	0.98115	D	0.365418	0.87570	D	0.287121	0.87410	D	0.994695365428925	0.86028	D	.	0.92203	.	0.87996113	0.89519	0.8072368	0.88581	0.8894862	0.90329	0.8686348	0.92675	-10.122	0.74995	D	.	0.94636	.	0.999741413090409	0.97751	0.95872940	0.93882	0.627	0.79193	.	.	.	.	.	.	4.838956	0.79021	27.0	0.99282249625692609	0.58002	0.756013	0.69429	D	0.698857312374925	0.79444	7.102922	0.676399396255758	0.80484	7.33289	5.77	4.71	0.58959	3.37	0.61085	3.451	0.52821	6.510000	0.55873	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Noonan_syndrome	criteria_provided,_single_submitter	NC_000003.12:g.12611985G>C	ClinGen:CA273221	C0028326	PS163950	648	Raf-like Ras-binding|Raf-like Ras-binding|Raf-like Ras-binding	Cys	Trp	71.64	0.037037037037037035																																																																																																																																																																																																																																																																																																																																																											-0.11	1 mutation(s) (Cys95Glu: 0.374)																																																																																																																	5			71.64	Special, a very reactive sulfhydryl group	Cysteine		RAF proto-oncogene serine/threonine-protein kinase							RBD			2.5								 C95-L131 (PAE:  2.5)	C95-L131 (PDBs: 1C1Y, 1GUA, 6VJJ, 6XI7, 8EPW, 8T74), C95-D132 (PDBs: 6PTS)	 C95-L131 (PAE:  2.5)	C95-L131 (PDBs: 1RFA, 8JOF, 8JOG, 1C1Y, 1GUA, 4G0N, 4G3X, 6VJJ, 6XI7, 7JHP, 8T74), C95-D129 (PDBs: 8JOG), C95-F130 (PDBs: 8JOG, 8EPW), C95-D132 (PDBs: 6PTS, 6PTW)							121									-87.1				-4.0						H (helix)	G (3₁₀-helix)	Helix											71.64	3.7037036	70-90	<10		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.7634285288454937	0.7557434336371445	false	false	false
FARS2	FARS2_His135Asp	B_13-14	2.635252319289227	1.0	1.0	-1.2067628026462482	0.5211399928800905	0.531213479418906	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6333609056194979	0.6339430921597573	0.5643593811659025	0.7248127115261165	0.6436831368930767	0.6990440247067728	0.7581170315688891	0.67902738908432	0.7915736447220024	0.5735323142148167	0.6573093754536978	0.6632962282944755	0.6399710178446565	0.6083388847018333	0.6580517783302305	0.5551864481169881	0.6105768088658169	0.6034255829445202	FARS2	His135Asp	NC_000006.12:5368973:C:G	403C>G	6	5368973	C	G	6	ENSG00000145982	12653	0	CCSBVarC011938	ALE00012867	ENSP00000274680.4																																	211250.0	single nucleotide variant	NM_006567.5(FARS2):c.403C>G (p.His135Asp)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Jun 13, 2018	1554169353.0	-	RCV000714939	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5368973.0	5368973.0	6p25.1	criteria provided, single submitter	1.0	-	N	-	2.0	214339.0	5368973.0	C	G	-	-	-	-	-	-	403C>G 	His135Asp	NM_006567.5	1.0	Pathogenic	Likely pathogenic	214339	6	5368973.0	C	G	H	D	rs1554169353	6	5369206	6	5314205	135	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.403C>G	p.His135Asp	c.403C>G	p.His135Asp	principal1	Y	1	.	.	+	CAC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.485	0.98910	H	-8.41	0.97166	D	0.959	0.96886	0.5303	0.90933	D	0.6251	0.86770	D	10	0.9888847	0.99321	D	0.373027	0.92777	D	0.882	0.96531	0.912	0.98259	O95363	H135D	Gain of ubiquitination at K140 (P = 0.0395)| Gain of methylation at K140 (P = 0.0835)| Gain of phosphorylation at S137 (P = 0.1076)| Gain of disorder (P = 0.1088)| Gain of relative solvent accessibility (P = 0.1571)	0.967068046118	0.96641	0.9676189548153906	0.96731	0.789096686981	0.65457	0.638907074928	0.58343	T	0.608311	0.87433	D	0.392218	0.89385	D	0.325617	0.89250	D	0.999627828598022	0.98192	D	.	0.69489	.	0.9517225	0.96384	0.93154466	0.97160	0.93853235	0.95023	0.92687786	0.96834	-9.08	0.68288	D	0.9357	0.85478	LP	0.999854978671078	0.98365	0.97500426	0.95060	0.978	0.99209	.	.	.	.	.	.	4.904405	0.80679	27.4	0.99386437466063282	0.62166	0.882442	0.80986	D	1.00590361464167	0.95901	14.10817	0.89920352941961	0.95512	13.71825	5.38	5.38	0.77246	.	.	7.564	0.81354	7.594000	0.61402	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.67	0.33292	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5368973C>G	.	C4755312	614946	319519	Phenylalanyl-tRNA synthetase	His	Asp	96.5	0.1358695652173913																																																																																																																																																																																																																																																																																																																																																																																																																																																																													25			96.5	Positively-charged	Histidine												-3.2											H135-I131 (PDBs: 8P8X)							155									-63.0				132.7						C (loop/coil)	C (loop/coil)												96.5	13.586956	>90	10-90	614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.6339430921597573	0.6333609056194979	false	false	false
BRAF	BRAF_Gln262Lys	B_13-14	-3.3290490377403623	0.012607505897050326	0.03236604336473941	2.1481671213234943	0.06879957779760018	0.09435517582854733	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6561647356794218	0.6951592113324325	0.5634805526272437	0.6998200188403163	0.6418411044052714	0.615218432058315	0.7687300292606131	0.726087678035597	0.8085347550516406	0.6460673298732134	0.7873719771119402	0.7332546252352657	0.46170683485601677	0.5575945307749457	0.591105282628992	0.480893775381274	0.6029464455529249	0.5790748461235777	BRAF	Gln262Lys	NC_000007.14:140801488:G:T	784C>A	7	140801488	G	T	7	ENSG00000157764	71969	0	CCSBVarC003157	ALE00003157	ENSP00000493543.1	CEGS2	CegsMutGDEh1017	C07	GDEhDisVCh_40058	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	2.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	48822.0	single nucleotide variant	NM_004333.6(BRAF):c.784C>A (p.Gln262Lys)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Nov 22, 2024	397507470.0	-	RCV000033290|RCV001193980	MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|RASopathy	germline	germline	GRCh38	NC_000007.14	7	140801488.0	140801488.0	7q34	criteria provided, multiple submitters, no conflicts	2.0	-	N	UniProtKB:P15056#VAR_065172,ClinGen:CA281957	2.0	40352.0	140801488.0	G	T	-	-	-	-	-	-	784C>A 	Gln262Lys	NM_004333.6	2.0	Pathogenic	Likely pathogenic	40352	7	140801488.0	G	T	Q	K	rs397507470	7	140501288	7	140147757	262	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.784C>A	p.Gln262Lys	c.784C>A	p.Gln262Lys	principal4	Y	.	YES	Select	-	CAA	1	0	G	./.	./.	./.	./.	.	0.31974	.	.	0.25963	.	0.476	0.36683	P	0.145	0.33873	B	.	0.92786	.	.	.	.	0.335	0.10354	N	.	0.39882	.	.	0.92789	0.1437	0.84883	D	0.5754	0.84624	D	10	0.9098774	0.90245	D	0.119437	0.79914	D	.	0.88724	0.854	0.95408	P15056	Q262K	Gain of methylation at Q262 (P = 0.0013)| Gain of MoRF binding (P = 0.034)| Loss of sheet (P = 0.0457)| Gain of catalytic residue at Q262 (P = 0.0492)| Gain of helix (P = 0.0854)	.	0.99108	.	0.89159	.	0.83165	0.890452325344	0.95311	D	0.767013	0.93678	D	0.433189	0.91632	D	0.384469	0.91529	D	0.877448976039886	0.52474	D	0.972478	0.90100	D	0.7150027	0.78637	0.36088184	0.61282	0.69711965	0.77646	0.29162404	0.54973	-8.711	0.65895	D	0.9841	0.91998	P	0.999639817524742	0.97271	0.98278390	0.95809	0.783	0.87990	.	.	.	.	.	.	4.792683	0.77833	26.8	0.99520084160858091	0.69200	0.875019	0.79748	D	0.229428578319334	0.52393	3.435949	0.399610595300935	0.61333	4.355617	5.21	5.21	0.71966	5.79	0.96129	9.943	0.9894	11.707000	0.94599	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.996	0.76032	794	0.45529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|RASopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140801488G>T	ClinGen:CA281957|UniProtKB:P15056#VAR_065172	CN517202|C5555857	.	536391	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Gln	Lys	87.3	0.5707070707070707																																																																																																																																																																																																																																																																																																																																																																																																																																																																													113			87.3	Polar/Neutral	Glutamine		Serine/threonine-protein kinase B-raf										-3.5								 Q262-N236 (PAE:  2.0)	Q262-N236 (PDBs: 6NYB, 7MFE, 8DGS, 8DGT)	 Q262-V238 (PAE:  3.0), Q262-N236 (PAE: 2.0)	Q262-N236 (PDBs: 6NYB, 7MFD, 8DGS, 8DGT), Q262-V238 (PDBs: 7MFE, 8DGT)							146									-64.0				-45.1						C (loop/coil)	T (turn)											Phorbol-ester/DAG-type	87.3	57.07071	70-90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.6951592113324325	0.6561647356794218	false	false	false
CTCF	CTCF_His455Gln	B_13-14	3.8257806455949326	0.006493290691325369	0.019623710791821923	-8.101336513189299	0.00008410249567572472	0.0003578068785132897	2025_01_Batch_13-14	false	false	true	false	false	true	false	false	false	false	false	false	0.8015291938065967	0.814743204008775	0.8116124259315944	0.836816893849585	0.9137696631872538	0.9013880164858137	0.9098504425796392	0.9710337040025431	0.8522843581689472	0.8044520700361244	0.8482986938324115	0.8234878455479896	0.8929255903919882	0.8565056223719645	0.8213494295302227	0.8187727818270645	0.7811877141851385	0.7795705420652037	CTCF	His455Gln	NC_000016.10:67626562:C:G	1365C>G	16	67626562	C	G	16	ENSG00000102974	6173	0	CCSBVarC010858	ALE00014571	ENSP00000264010.4																																	799962.0	single nucleotide variant	NM_006565.4(CTCF):c.1365C>G (p.His455Gln)	10664.0	CTCF	HGNC:13723	Likely pathogenic	1.0	Jun 10, 2019	1597725291.0	-	RCV001002552	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome	germline	germline	GRCh38	NC_000016.10	16	67626562.0	67626562.0	16q22.1	criteria provided, single submitter	1.0	-	N	-	2.0	812003.0	67626562.0	C	G	-	-	-	-	-	-	1365C>G 	His455Gln	NM_006565.4	1.0	Pathogenic	Likely pathogenic	812003	16	67626562.0	C	G	H	Q	rs1597725291	16	67660465	16	66217966	455	CTCF	ENSG00000102974	ENST00000264010	ENSP00000264010	P49711	CTCF_HUMAN	c.1365C>G	p.His455Gln	c.1365C>G	p.His455Gln	principal4	Y	1	YES	Select	+	CAC	3	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	0.997	0.70687	D	0.992	0.80453	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.485	0.98910	H	-7.51	0.95091	D	0.92	0.92320	-0.2605	0.75966	T	0.3925	0.74513	T	10	0.8887602	0.88083	D	0.149609	0.83093	D	0.579	0.82939	0.748	0.87844	P49711	H455Q	Gain of MoRF binding (P = 0.0878)| Loss of helix (P = 0.1706)| Gain of disorder (P = 0.19)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2629)	0.949006423897	0.94804	.	0.97634	3.03790854674	0.99266	0.889497578144	0.95192	D	0.917886	0.98488	D	0.309664	0.83603	D	0.207035	0.83391	D	0.989961684048839	0.80030	D	.	0.80399	.	0.969477	0.98182	0.83204865	0.90192	0.969477	0.98182	0.83204865	0.90192	-13.14	0.89952	D	.	0.99795	.	0.99981684735099	0.98120	0.98982334	0.96704	0.864	0.92591	.	.	.	.	.	.	3.86468	0.56146	23.7	0.99143631297156454	0.53677	0.530946	0.54986	D	0.449511622968474	0.63986	4.666273	0.33042528030055	0.57107	3.898847	5.48	1.99	0.25354	2.62	0.47948	2.183	0.42298	0.800000	0.21732	-0.182	0.10118	1.0	0.71675	0.999000	0.35501	0.99	0.65338	53	0.97599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome	criteria_provided,_single_submitter	NC_000016.10:g.67626562C>G	.	C3809686	615502	363611	.	His	Gln	85.99	0.16847826086956522																																																																																																																																																																																																																																																																																																																																																																																																																																																																													31			85.99	Positively-charged	Histidine		Transcriptional repressor CTCF										-3.2								 H455-Q459 (PAE:  1.0), H455-H460 (PAE: 2.0), H455-D451 (PAE: 1.0), H455-C442 (PAE: 2.5), H455-C439 (PAE: 2.0)	H455-H460 (PDBs: 2CT1), H455-D451 (PDBs: 2CT1, 8SSS), H455-Q459 (PDBs: 2CT1, 5K5H, 5K5I, 5K5J, 5K5L, 5KKQ, 5T00, 5T0U, 5UND, 5YEF, 5YEG, 5YEH, 7W1M, 8SSQ, 8SSR, 8SSS)	 H455-H460 (PAE:  2.0), H455-D451 (PAE: 1.0), H455-Q459 (PAE: 1.0)	H455-H460 (PDBs: 2CT1, 8SSS), H455-D451 (PDBs: 2CT1, 8SSS), H455-Q459 (PDBs: 2CT1, 5K5H, 5K5I, 5K5J, 5K5L, 5KKQ, 5T00, 5T0U, 5UND, 5YEF, 5YEG, 5YEH, 7W1M, 8SSQ, 8SSR, 8SSS)							155									-63.8				-53.6						H (helix)	H (α-helix)	Helix										C2H2-type 7	85.99	16.847826	70-90	10-90	615502	autosomal dominant	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21	false	0.814743204008775	0.8015291938065967	false	false	false
F9	F9_Tyr161Cys	B_13-14	-3.7117760436139156	0.009948666026274195	0.027145645871691017	6.150156084158924	0.0004674674896665031	0.0013156485330337933	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9352210081980068	0.9259042018714112	0.7215144017099484	0.806751826056596	0.6978498352844493	0.807576709793711	0.8659392901911367	0.6839666608458864	0.8132705410962973	0.7090082804144099	0.9015381028345079	0.9304439115888259	0.7492141293962854	0.7117330097230122	0.8002331110168949	0.7340205230054869	0.9502703009083145	0.9399981048071877	F9	Tyr161Cys	NC_000023.11:139548453:A:G	482A>G	23	139548453	A	G	X	ENSG00000101981	52861	0	CCSBVarC030535	ALE00028267	ENSP00000218099.2																																	951629.0	single nucleotide variant	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Sep 09, 2019	1927768329.0	-	RCV001238122	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139548453.0	139548453.0	Xq27.1	criteria provided, single submitter	1.0	-	N	-	2.0	963994.0	139548453.0	A	G	-	-	-	-	-	-	482A>G 	Tyr161Cys	NM_000133.4	1.0	Pathogenic	Likely pathogenic	963994	X	139548453.0	A	G	Y	C	rs1927768329	X	138630612	X	138458278	161	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.482A>G	p.Tyr161Cys	c.482A>G	p.Tyr161Cys	principal1	Y	1	YES	Select	+	TAT	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.002	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	4.505	0.98972	H	-7.54	0.95177	D	0.86	0.94798	1.0827	0.98968	D	0.9698	0.99044	D	9	0.9925639	0.99791	D	0.727081	0.97795	D	0.969	0.99622	0.948	0.99364	P00740	Y161C	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.999628882684	0.99961	0.9993750153719172	0.99937	3.35052041495	0.99644	0.548684835434	0.45607	T	0.947563	0.99211	D	0.709682	0.99937	D	0.781633	0.99937	D	0.999352633953094	0.97053	D	0.907809	0.67286	D	0.98005635	0.99098	0.9677569	0.99354	0.9801722	0.99107	0.95718026	0.98799	-13.466	0.91210	D	0.817	0.87118	P	0.999984402408099	0.99579	0.99999213	0.99996	0.989	0.99628	.	.	.	.	.	.	4.195203	0.63338	24.6	0.99787297672792052	0.87318	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.69	0.86632	6.975	0.7597	9.248000	0.79501	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.954	0.50428	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139548453A>G	.	C0008533|C2749016	306900|300807	98879	.	Tyr	Cys	95.8	0.10810810810810811																																																																																																																																																																																																																																																																																																																																																																																																															0.327		0.249	1 mutation(s) (Tyr161Cys: -0.005)	0.25		0.256		0.232	1 mutation(s) (Tyr161Asn: -0.004)																																																					24			95.8	Aromatic	Tyrosine		Coagulation factor IX; Coagulation factor IXa light chain							EGF-like 2			-1.3								 Y161-C178 (PAE:  1.5)	Y161-C178 (PDBs: 2WPH, 2WPI, 2WPJ, 2WPK, 2WPL, 2WPM, 5JB8, 5JB9, 5JBA, 5JBB, 5JBC, 6RFK)									181									-121.4				150.1						B (undefined)	E (parallel sheets)	Beta strand											95.8	10.810811	>90	10-90	306900;300807	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.9259042018714112	0.9352210081980068	false	false	false
FARS2	FARS2_Ile388Ser	B_13-14	1.0162955675066876	1.0	1.0	-4.262653512272488	0.008708706837718317	0.014472031252986732	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8000033105422473	0.8445623957547012	0.4957900540426965	0.6328756547435601	0.6218703889869812	0.5203687890205999	0.5982401241578904	0.6311220625677345	0.6406051241454641	0.5802498528087766	0.8269146954920341	0.7704674906915737	0.44249745388330947	0.6126187154062279	0.6251461853416561	0.4113302552766163	0.8622100960173682	0.8295391303929209	FARS2	Ile388Ser	NC_000006.12:5613266:T:G	1163T>G	6	5613266	T	G	6	ENSG00000145982	12653	0	CCSBVarC011922	ALE00013649	ENSP00000274680.4																																	481384.0	single nucleotide variant	NM_006567.5(FARS2):c.1163T>G (p.Ile388Ser)	10667.0	FARS2	HGNC:21062	Likely pathogenic	1.0	Nov 15, 2017	1407198979.0	-	RCV000578458	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5613266.0	5613266.0	6p25.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA362736964	2.0	488516.0	5613266.0	T	G	-	-	-	-	-	-	1163T>G 	Ile388Ser	NM_006567.5	1.0	Pathogenic	Likely pathogenic	488516	6	5613266.0	T	G	I	S	rs1407198979	6	5613499	6	5558498	388	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.1163T>G	p.Ile388Ser	c.1163T>G	p.Ile388Ser	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.002	0.72322	D	0.002	0.79703	D	0.714	0.42184	P	0.367	0.43429	B	.	.	.	.	.	.	2.125	0.58867	M	-4.96	0.82015	D	0.84	0.83632	-0.4338	0.70810	T	0.2675	0.63745	T	10	0.8248781	0.81483	D	0.051707	0.64640	D	0.511	0.78922	0.559	0.67707	O95363	I388S	Loss of stability (P = 0.0161)| Gain of disorder (P = 0.0363)| Gain of glycosylation at I388 (P = 0.0591)| Gain of helix (P = 0.0854)| Gain of relative solvent accessibility (P = 0.09)	0.935486347505	0.93431	.	0.78077	.	0.44430	0.315835446119	0.12779	T	0.571252	0.85676	D	0.0869603	0.62581	D	-0.112864	0.62116	T	0.979173302650452	0.72507	D	0.978802	0.92613	D	0.7625783	0.81381	0.80076313	0.88169	0.80483794	0.84016	0.7604622	0.85673	-13.402	0.90970	D	0.2564	0.49112	B	0.980686339579557	0.85480	0.83609140	0.89259	0.977	0.99166	.	.	.	.	.	.	4.872277	0.79869	27.2	0.99235441243343336	0.56442	0.866864	0.78564	D	0.407863502934099	0.61656	4.392269	0.462304649405172	0.65325	4.833016	5.53	5.53	0.82506	3.23	0.58548	7.299	0.78213	6.134000	0.54028	0.665	0.62996	0.997	0.40243	0.978000	0.30284	0.903	0.43926	976	0.04721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_single_submitter	NC_000006.12:g.5613266T>G	ClinGen:CA362736964	C4755312	614946	319519	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	Ile	Ser	97.64	0.31952662721893493																																																																																																																																																																																																																																																																																																																																																																																																																																																																													54			97.64	Aliphatic	Isoleucine									FDX-ACB			4.5								 I388-L384 (PAE:  1.0)	I388-L384 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP)	 I388-L384 (PAE:  1.0), I388-L437 (PAE: 1.0)	I388-L384 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 8P8X, 3TUP), I388-L437 (PDBs: 5MGV, 5MGW)							131									-87.8				-49.4						H (helix)	H (α-helix)	Helix											97.64	31.952662	>90	10-90	614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.8445623957547012	0.8000033105422473	false	false	false
LMNA	LMNA_Arg335Trp	B_13-14	4.583862108039076	0.0025321301333144763	0.00942761901487456	-0.2556608087336149	0.8055625098137831	0.8413245335846852	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7490896073682203	0.7701953815790505	0.6320490762864128	0.6565382378258586	0.6810891331705271	0.666385200230775	0.7247977449599785	0.8157777312700383	0.6431495788699527	0.6552764215098696	0.7657055241824613	0.7617859589044529	0.6079726555015714	0.5464005350710159	0.6699268967817644	0.6088217310629561	0.7746852389756398	0.7363932558319877	LMNA	Arg335Trp	NC_000001.11:156135967:C:T	1003C>T	1	156135967	C	T	1	ENSG00000160789	3903	0	CCSBVarC003620	ALE00003620	ENSP00000357284.2	CEGS2	CegsMutGDEh1047	B06	GDEhDisVCh_40057	G10	1	CegsMutGDDh1047	B06	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	45135.0	single nucleotide variant	NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	4000.0	LMNA	HGNC:6636	Pathogenic/Likely pathogenic	1.0	Mar 24, 2024	386134243.0	-	RCV000030145|RCV000182368|RCV000620788|RCV000546102|RCV000721960|RCV000845456|RCV000852407|RCV000844672|RCV001196390|RCV003149579|RCV003492303|RCV002477025|RCV004532421	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MONDO:MONDO:0012417,MedGen:C1857829,OMIM:610140,Orphanet:168796|Human Phenotype Ontology:HP:0030682,MONDO:MONDO:0018901,MedGen:C1960469,OMIM:PS604169,Orphanet:54260|MONDO:MONDO:0016587,MeSH:D019571,MedGen:C0349788,Orphanet:247|MONDO:MONDO:0021106,MedGen:C5392094,Orphanet:98301;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0007269,MedGen:C1449563,OMIM:115200,Orphanet:300751|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0016333,MedGen:C0340427,OMIM:PS115200,Orphanet:217607|11 conditions|	Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype|Charcot-Marie-Tooth disease type 2|Heart-hand syndrome, Slovenian type|Left ventricular noncompaction|Arrhythmogenic right ventricular cardiomyopathy|Laminopathy;Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|Cardiomyopathy|Primary familial dilated cardiomyopathy|11 conditions|LMNA-related disorder	germline;unknown	germline	GRCh38	NC_000001.11	1	156135967.0	156135967.0	1q22	criteria provided, multiple submitters, no conflicts	18.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016426,OMIM:150330.0058	3.0	36473.0	156135967.0	C	T	-	-	-	-	-	-	1003C>T 	Arg335Trp	NM_170707.4	2.0	Pathogenic	Likely pathogenic	36473	1	156135967.0	C	T	R	W	rs386134243	1	156105758	1	154372382	335	LMNA	ENSG00000160789	ENST00000368300	ENSP00000357283	P02545	LMNA_HUMAN	c.1003C>T	p.Arg335Trp	c.1003C>T	p.Arg335Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.001	0.91343	D	0.003	0.92967	D	1.0	0.90580	D	0.964	0.76461	D	0.98	0.99291	A	simple_aae	2.0	98.0	3.775	0.95135	H	-6.78	0.93600	D	0.96	0.97765	0.9382	0.96209	D	0.8766	0.95894	D	10	0.9271074	0.91967	D	0.816539	0.98568	D	0.819	0.94182	0.588	0.71518	P02545	R335W	Loss of solvent accessibility (P = 0.1077)| Gain of MoRF binding (P = 0.1637)| Loss of relative solvent accessibility (P = 0.3219)| Loss of methylation at R331 (P = 0.4354)| Loss of glycosylation at S334 (P = 0.5435)	0.964334009803	0.96363	0.9541123517558469	0.95368	2.09983672442	0.94792	0.747377514839	0.74014	T	0.978141	0.99804	D	0.458005	0.92783	D	0.420116	0.92694	D	0.997435510158539	0.91475	D	0.962604	0.86719	D	0.8800445	0.89526	0.80577844	0.88487	0.8201633	0.85040	0.8051204	0.88446	-12.785	0.89664	D	0.5886	0.68353	P	0.99922285455029	0.96001	0.99997473	0.99978	0.78	0.87822	.	.	.	.	.	.	5.395437	0.90388	31.0	0.99922039172766042	0.98853	0.948098	0.95922	D	0.829224154962615	0.87830	9.3793	0.777752911999856	0.88143	9.496604	5.87	5.87	0.94257	.	.	2.013	0.40665	4.774000	0.44870	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.992	0.67791	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613920	6.196090e-07	0	1	1180030	8.474360e-07	0	0	74930	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29604	0.000000e+00	0	0	44890	0.000000e+00	0	0	63884	0.000000e+00	0	0	6082	0.000000e+00	0	1	1180030	8.474360e-07	0	0	91088	0.000000e+00	0	1	26588	3.761095230931247E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4588	2.1795989537925023E-4	0	2918	0	0	112	0	2	35432	5.644615037254459E-5	LMNA-related_disorder|Cardiovascular_phenotype|Left_ventricular_noncompaction|Cardiomyopathy|Primary_familial_dilated_cardiomyopathy|not_provided|Arrhythmogenic_right_ventricular_cardiomyopathy|Charcot-Marie-Tooth_disease_type_2B1|Emery-Dreifuss_muscular_dystrophy_2,_autosomal_dominant|Mandibuloacral_dysplasia_with_type_A_lipodystrophy|Dilated_cardiomyopathy-hypergonadotropic_hypogonadism_syndrome|Dilated_cardiomyopathy_1A|Heart-hand_syndrome,_Slovenian_type|Hutchinson-Gilford_syndrome|Emery-Dreifuss_muscular_dystrophy_3,_autosomal_recessive|Congenital_muscular_dystrophy_due_to_LMNA_mutation|Familial_partial_lipodystrophy,_Dunnigan_type|Restrictive_dermopathy_2|Primary_dilated_cardiomyopathy|Laminopathy|Charcot-Marie-Tooth_disease_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.156135967C>T	ClinGen:CA016426|OMIM:150330.0058	CN230736|C1960469|C0878544|C0340427|C3661900|C0349788|C1854154|C0410190|C5399785|C0796031|C1449563|C1857829|C0033300|C2750035|C2750785|C1720860|C5676942|C0007193|C5392094|C0270914	PS604169|PS115200|605588|181350|248370|212112|115200|610140|176670|616516|613205|151660|619793	54260|167848|217607|247|98856|261|264|2457|90153|2229|300751|168796|740|261|98855|157973|2348|217604|98301|64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Trp	95.78	0.6048387096774194																																																																																																																																																																																																																																																																																																																																																																																																																																																																													150			95.78	Positively-charged	Arginine		Prelamin-A/C; Lamin-A/C							IF rod			-4.5								 R335-R331 (PAE:  3.5), R335-A339 (PAE: 3.0)	R335-A339 (PDBs: 1X8Y, 3V5B, 2XV5), R335-R331 (PDBs: 3V5B, 2XV5)	 R335-R331 (PAE:  3.5), R335-A339 (PAE: 3.0)	R335-A339 (PDBs: 1X8Y, 3V5B, 2XV5), R335-R331 (PDBs: 3V5B, 2XV5)	 R335-D332 (PAE:  3.0)						175									-61.6				-44.0	Coil 2					H (helix)	H (α-helix)	Helix											95.78	60.48387	>90	10-90	610140;115200	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9	HEART-HAND SYNDROME, SLOVENIAN TYPE; CARDIOMYOPATHY, DILATED, 1A	false	0.7701953815790505	0.7490896073682203	false	false	false
FARS2	FARS2_Gly309Ser	B_13-14	0.9477119419492293	1.0	1.0	-5.259931737910365	0.006835929204146723	0.011421439412778428	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8415940116888152	0.9110012215264507	0.6245539384417711	0.7730529056671679	0.800248677020849	0.7327553179253004	0.8919337690959713	0.8842580322784815	0.8995447401822345	0.6946792347768707	0.9346868300566868	0.8564737214039982	0.5735768667546295	0.7162393217632165	0.6465610711521013	0.5544286421066714	0.8873156129962146	0.8267143019736322	FARS2	Gly309Ser	NC_000006.12:5545200:G:A	925G>A	6	5545200	G	A	6	ENSG00000145982	12653	0	CCSBVarC011917	ALE00014428	ENSP00000274680.4																																	578624.0	single nucleotide variant	NM_006567.5(FARS2):c.925G>A (p.Gly309Ser)	10667.0	FARS2	HGNC:21062	Pathogenic/Likely pathogenic	1.0	Feb 23, 2023	746746116.0	-	RCV000714943|RCV001092144	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	Combined oxidative phosphorylation defect type 14|not provided	germline;unknown	germline	GRCh38	NC_000006.12	6	5545200.0	5545200.0	6p25.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	-	2.0	587672.0	5545200.0	G	A	-	-	-	-	-	-	925G>A 	Gly309Ser	NM_006567.5	2.0	Pathogenic	Likely pathogenic	587672	6	5545200.0	G	A	G	S	rs746746116	6	5545433	6	5490432	309	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.925G>A	p.Gly309Ser	c.925G>A	p.Gly309Ser	principal1	Y	1	YES	Select	+	GGC	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.009	0.67073	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.685	0.94401	H	-5.03	0.82599	D	0.947	0.95504	0.3946	0.88971	D	0.5964	0.85552	D	10	0.9779998	0.97630	D	0.369966	0.92707	D	0.885	0.96643	0.858	0.95637	O95363	G309S	Loss of sheet (P = 0.0817)| Gain of disorder (P = 0.1887)| Gain of loop (P = 0.2045)| Loss of catalytic residue at L314 (P = 0.2562)| Gain of MoRF binding (P = 0.4653)	0.888883061527	0.88693	.	0.92879	.	0.58884	0.59725445509	0.52451	T	0.449003	0.78909	T	0.390908	0.89307	D	0.323736	0.89172	D	0.998481690883636	0.94233	D	0.986551	0.95437	D	0.8830356	0.89777	0.78077585	0.86915	0.86086655	0.87992	0.7646657	0.85927	-10.138	0.74812	D	0.436	0.63025	A	0.990712134343876	0.88703	0.96428716	0.94244	0.855	0.92066	.	.	.	.	.	.	5.233765	0.87878	29.4	0.99892301299548369	0.96592	0.940941	0.94336	D	0.851669104685455	0.89143	9.876117	0.738735397986046	0.85233	8.543429	5.27	5.27	0.73761	.	.	9.507	0.96998	11.605000	0.93514	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.947	0.4917	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613742	1.239360e-06	0	1	75024	1.332910e-05	0	1	75024	1.332910e-05	0	0	912	0.000000e+00	0	0	59968	0.000000e+00	0	0	29600	0.000000e+00	0	0	44878	0.000000e+00	0	0	64020	0.000000e+00	0	0	6058	0.000000e+00	0	1	1179784	8.476130e-07	0	0	91016	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Combined_oxidative_phosphorylation_defect_type_14|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5545200G>A	.	C4755312|C3661900	614946	319519	Aminoacyl-tRNA synthetase, class II	Gly	Ser	98.62	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.62	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine												-0.4								 G309-M294 (PAE:  1.0)	G309-M294 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP)		G309-V293 (PDBs: 8P8X), G309-M294 (PDBs: 8P8X), G309-L199 (PDBs: 8P8X), G309-V239 (PDBs: 8P8X), G309-L198 (PDBs: 8P8X)							75									-150.8				167.2						B (undefined)	E (parallel sheets)	Beta strand											98.62	0.0	>90	<10	614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.9110012215264507	0.8415940116888152	false	false	false
BRAF	BRAF_Phe468Ser	B_13-14	-5.287701209677223	0.0011384771237647243	0.005214607449377994	2.3697823462370775	0.049622098981574284	0.07025968490060865	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6547520448551551	0.6720621272587066	0.5375882588559269	0.6904388153993586	0.6768143390148533	0.589019593611767	0.5757315197924627	0.6760966000795803	0.6929546970407459	0.5305084122345434	0.6646948713694983	0.6409561581356934	0.6023076674310713	0.6775320779501264	0.6879229337579713	0.5446681054773104	0.6794293831479149	0.6685479315746169	BRAF	Phe468Ser	NC_000007.14:140781605:A:G	1403T>C	7	140781605	A	G	7	ENSG00000157764	71969	0	CCSBVarC003159	ALE00003159	ENSP00000493543.1	CEGS2	CegsMutGDEh1010	E05	GDEhDisVCh_40058	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	48836.0	single nucleotide variant	NM_004333.6(BRAF):c.1403T>C (p.Phe468Ser)	673.0	BRAF	HGNC:1097	Pathogenic/Likely pathogenic	1.0	Feb 24, 2023	397507473.0	-	RCV000033305|RCV000037917|RCV000797502|RCV001813222|RCV001293860|RCV002251944|RCV003407389	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340||	not provided|Cardio-facio-cutaneous syndrome|RASopathy|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1|See cases|BRAF-related disorder	de novo;germline	germline	GRCh38	NC_000007.14	7	140781605.0	140781605.0	7q34	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA280002,UniProtKB:P15056#VAR_035097	2.0	40366.0	140781605.0	A	G	-	-	-	-	-	-	1403T>C 	Phe468Ser	NM_004333.6	2.0	Pathogenic	Likely pathogenic	40366	7	140781605.0	A	G	F	S	rs397507473	7	140481405	7	140127874	468	BRAF	ENSG00000157764	ENST00000646891	ENSP00000493543	P15056	BRAF_HUMAN	c.1403T>C	p.Phe468Ser	c.1403T>C	p.Phe468Ser	principal4	Y	.	YES	Select	-	TTT	2	0	A	./.	./.	./.	./.	.	.	.	.	.	.	0.474	0.36638	P	0.333	0.42166	B	.	0.99291	.	.	.	.	1.375	0.34130	L	.	.	.	.	.	0.2775	0.87139	D	0.6181	0.86478	D	10	0.9654888	0.95979	D	0.370597	0.92721	D	.	0.96308	0.907	0.98057	P15056	F468S	Gain of disorder (P = 0.003)| Gain of catalytic residue at F468 (P = 0.0093)| Gain of glycosylation at F468 (P = 0.0356)| Gain of methylation at K473 (P = 0.0485)| Gain of ubiquitination at K473 (P = 0.0682)	.	0.99561	.	0.93588	.	0.97063	0.896780073643	0.96070	D	0.8689	0.97127	D	0.433457	0.91644	D	0.384855	0.91542	D	0.996321439743042	0.89024	D	0.981002	0.93472	D	0.9767253	0.98831	0.96972746	0.99444	0.9715668	0.98378	0.95852166	0.98875	-13.116	0.89856	D	0.9997	0.99795	P	0.99997234991302	0.99427	0.99889910	0.99026	0.997	0.99892	.	.	.	.	.	.	5.459799	0.91162	32.0	0.99801327173541676	0.88648	0.883596	0.81195	D	0.395979229302215	0.61003	4.318368	0.517485622092491	0.68999	5.32187	5.62	5.62	0.85695	.	.	9.302	0.95273	11.190000	0.88645	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.998	0.85369	809	0.42973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	1	109386	9.141940e-06	0	1	208098	4.805430e-06	0	1	236886	4.221440e-06	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13378	0.000000e+00	0	1	42766	2.338310e-05	0	0	15688	0.000000e+00	0	1	42766	2.338310e-05	0	0	16218	0.000000e+00	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16718	0.000000e+00	0	1	89544	1.116770e-05	0	0	30604	0.000000e+00	0	1	89544	1.116770e-05	0	0	14902	0.000000e+00	0	0	34254	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21616	0.000000e+00	0	1	102710	9.736150e-06	0	0	30522	0.000000e+00	0	1	102710	9.736150e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	83130	0	0	54	0	0	2596	0	0	1234	0	0	290	0	0	318	0	0	600	0	0	182	0	0	1566	0	0	1288	0	0	3196	0	0	89970	0	Cardiofaciocutaneous_syndrome_1|not_provided|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|See_cases|RASopathy|BRAF-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.140781605A>G	ClinGen:CA280002|UniProtKB:P15056#VAR_035097	CN029449|C3661900|C1275081|C5681679|C5555857	115150|PS115150	1340|1340|98733|536391	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	Phe	Ser	64.72	0.08629441624365482																																																																																																																																																																																																																																																																																																																																																																																																																																																																													17			64.72	Aromatic	Phenylalanine	ATP	Serine/threonine-protein kinase B-raf							Protein kinase	0.1384		2.8								 F468-N486 (PAE:  4.0)	F468-L597 (PDBs: 5CSX, 3II5, 3Q96, 5VAM, 6B8U, 6N0P, 8QQG), F468-K483 (PDBs: 6P3D, 5HIE), F468-N486 (PDBs: 4PP7, 7P3V, 8F7O, 8F7P, 6NYB, 6PP9, 6U2G, 6V2W, 7M0T, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 8DGS, 8DGT), F468-T491 (PDBs: 5HID)	 F468-N486 (PAE:  4.0)	F468-V600 (PDBs: 5CSX), F468-G596 (PDBs: 6P3D), F468-K483 (PDBs: 6P3D), F468-N486 (PDBs: 3Q96, 4PP7, 5FD2, 6CAD, 7P3V, 6NYB, 6PP9, 6U2G, 6V2W, 7M0T, 7M0U, 7M0V, 7M0W, 7M0X, 7M0Y, 7M0Z, 8DGT), F468-K601 (PDBs: 3TV4, 4EHE, 8DGT), F468-H608 (PDBs: 3TV6), F468-A598 (PDBs: 4G9C, 8QQG), F468-L485 (PDBs: 4H58, 8F7P, 8DGS, 8DGT), F468-T599 (PDBs: 5HID, 5VAM), F468-Q494 (PDBs: 5HIE), F468-L597 (PDBs: 8C7X, 8C7Y, 8F7O)							165									-95.0		Pocket 3: Mean pLDDT: 56.91, Volume: 905.32 Å³, Druggability score: 0.14		-24.3				dbSNP: rs397507473; Variant type: LP/P; AA change: Phe468Ser; PTM type: Ubiquitylation; PTM morphology: F*GtVYkGkWHG; Var class: II&rs397507473		C (loop/coil)	T (turn)												64.72	8.629441	50-70	<10	115150	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11	CARDIOFACIOCUTANEOUS SYNDROME 1	false	0.6720621272587066	0.6547520448551551	false	false	false
RAF1	RAF1_Asn140His	B_13-14	-0.04961800914186343	1.0	1.0	0.323741652913962	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7247113368135931	0.7546769916623612	0.714651852732971	0.7888016779628755	0.7849627891298514	0.8184427683868909	0.878758392176358	0.7936004378914406	0.8468758599571382	0.7505142774785717	0.7538004958782158	0.7421489221616167	0.7581271445974237	0.7763251403682621	0.7307274959686129	0.6787894279873705	0.7555534874465066	0.7072737514655696	RAF1	Asn140His	NC_000003.12:12609238:T:G	418A>C	3	12609238	T	G	3	ENSG00000132155	732	0	CCSBVarC008912	ALE00012127	ENSP00000251849.4																																	49060.0	single nucleotide variant	NM_002880.4(RAF1):c.418A>C (p.Asn140His)	5894.0	RAF1	HGNC:9829	Likely pathogenic	1.0	Oct 03, 2012	730881009.0	-	RCV000159094	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000003.12	3	12609238.0	12609238.0	3p25.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA297148	2.0	40590.0	12609238.0	T	G	-	-	-	-	-	-	418A>C 	Asn140His	NM_002880.4	1.0	Pathogenic	Likely pathogenic	40590	3	12609238.0	T	G	N	H	rs730881009	3	12650737	3	12625737	140	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.418A>C	p.Asn140His	principal3	Y	.	.	.	-	AAC	1	0	T	T/T	T/T	T/T	T/T	.	0.72322	.	.	0.50294	.	1.0	0.90580	D	0.994	0.82066	D	.	0.76851	.	.	.	.	1.78	0.46014	L	.	0.72035	.	.	0.89342	0.8725	0.95294	D	0.8467	0.94874	D	10	.	0.81918	.	0.486445	0.94918	D	.	0.92184	0.507	0.60104	P04049	N140H	Loss of loop (P = 0.0374)| Loss of glycosylation at T138 (P = 0.0472)| Loss of catalytic residue at N140 (P = 0.0473)| Gain of sheet (P = 0.1208)| Gain of methylation at K144 (P = 0.1389)	.	0.93906	.	0.78656	.	0.84295	0.864215731621	0.91719	D	0.90447	0.98131	D	0.19048	0.72806	D	0.0358342	0.72452	D	0.969879031181335	0.68540	D	.	0.92893	.	0.7594829	0.81195	0.8015472	0.88218	0.8018196	0.83820	0.7257919	0.83611	-10.417	0.76444	D	.	0.80100	.	0.999536362008549	0.96903	0.94453880	0.93084	0.975	0.99076	.	.	.	.	.	.	4.983822	0.82606	27.8	0.99556719294456497	0.71556	0.925488	0.90478	D	0.743491548643859	0.82383	7.773029	0.718547825165139	0.83700	8.114436	5.84	5.84	0.93363	5.35	0.93259	8.012	0.88241	7.876000	0.72273	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	646	0.63408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000003.12:g.12609238T>G	ClinGen:CA297148	CN517202	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	Asn	His	79.03	0.535031847133758																																																																																																																																																																																																																																																																																																																																																																																																																																																																													84			79.03	Polar/Neutral	Asparagine		RAF proto-oncogene serine/threonine-protein kinase										-3.5								 N140-Q166 (PAE:  2.0)	N140-T167 (PDBs: 6PTS), N140-C165 (PDBs: 6XGU, 6XGV, 6XHA, 6XHB, 6XI7, 7JHP, 8T75), N140-Q166 (PDBs: 8T75)	 N140-Q166 (PAE:  2.0), N140-C165 (PAE: 1.5)	N140-T167 (PDBs: 1FAQ, 1FAR, 6PTS, 6XI7), N140-C165 (PDBs: 1FAR, 6PTW, 8T75), N140-Q166 (PDBs: 6XGU, 6XGV, 6XHA, 6XHB, 7JHP, 8T75), N140-R164 (PDBs: 8T75)							132									-91.2				86.9						C (loop/coil)	C (loop/coil)											Phorbol-ester/DAG-type	79.03	53.503185	70-90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.7546769916623612	0.7247113368135931	false	false	false
F9	F9_Arg191Cys	B_13-14	-2.6399707567644133	0.04597780860921224	0.08719576921881295	4.535885058625422	0.0026808186171023663	0.005459824819514809	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8671070578719104	0.8890417386687974	0.5379746505421346	0.809678622696315	0.7038297128964186	0.5832919549600709		0.7668998785600044	0.851045607604698		0.8999422136220527	0.876703349904718	0.5832919549600709	0.6407595472328329	0.7683116377879319	0.5379746505421346	0.8781412637155421	0.8575107658391028	F9	Arg191Cys	NC_000023.11:139551112:C:T	571C>T	23	139551112	C	T	X	ENSG00000101981	52861	0	CCSBVarC030555	ALE00024416	ENSP00000218099.2																																	25623.0	single nucleotide variant	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Feb 23, 2024	137852237.0	-	RCV000011330|RCV001390295|RCV004700216	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;maternal	germline	GRCh38	NC_000023.11	X	139551112.0	139551112.0	Xq27.1	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	3.0	10584.0	139551112.0	C	T	-	-	-	-	-	-	571C>T 	Arg191Cys	NM_000133.4	2.0	Pathogenic	Likely pathogenic	10584	X	139551112.0	C	T	R	C	rs137852237	X	138633271	X	138460937	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.571C>T	p.Arg191Cys	c.571C>T	p.Arg191Cys	principal1	Y	1	YES	Select	+	CGT	1	0	C	C/C	C/C	C/C	C/C	0.007	0.60085	D	0.012	0.67073	D	1.0	0.90580	D	0.889	0.63094	P	0.78	0.90354	A	simple_aae	22.0	78.0	2.175	0.60790	M	-3.45	0.68090	D	0.607	0.78558	0.8340	0.94814	D	0.8689	0.95632	D	10	0.9160565	0.90865	D	0.425573	0.93868	D	0.808	0.93758	.	.	.	.	.	0.999785564942	0.99978	0.9946210614807007	0.99458	1.92440498635	0.92993	0.471319615841	0.34817	T	0.800814	0.94875	D	0.535847	0.95281	D	0.53193	0.95211	D	0.855446166052384	0.50373	D	0.90041	0.67589	D	0.42700288	0.62235	0.24540712	0.49838	0.4647663	0.64653	0.22915632	0.47799	-7.779	0.59626	D	0.46	0.67153	A	0.999002392944659	0.95492	0.99998224	0.99989	0.779	0.87767	.	.	.	.	.	.	3.352229	0.46322	22.3	0.99835540160048397	0.91634	.	.	.	.	.	.	.	.	.	4.94	4.04	0.46200	.	.	2.17	0.42174	4.855000	0.45490	0.599	0.40292	0.996	0.3946	1.000000	0.68239	0.058	0.15862	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	1	80341	1.244690e-05	0	1	151843	6.585750e-06	0	1	172245	5.805680e-06	0	0	5701	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	1	30954	3.230600e-05	0	0	9951	0.000000e+00	0	1	30954	3.230600e-05	0	0	13133	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	1	64659	1.546580e-05	0	0	19069	0.000000e+00	0	1	64659	1.546580e-05	0	0	12063	0.000000e+00	0	0	27168	0.000000e+00	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15993	0.000000e+00	0	1	73470	1.361100e-05	0	0	19004	0.000000e+00	0	1	73470	1.361100e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	92836	0	0	168	0	0	2682	0	0	3594	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2010	0	0	3762	0	0	3308	0	0	103560	0	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551112C>T	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	C2749016|C0008533	300807|306900	98879	.	Arg	Cys	42.03	1.0																																																																																																																																																																																																																																																																																																																																																																																																															1.012		1.008		1.004		0.988	1 mutation(s) (Arg191Pro: 1.100)	0.978																																																						259			42.03	Positively-charged	Arginine		Coagulation factor IX; Coagulation factor IXa light chain										-4.5											R191-Q185 (PDBs: 2WPJ)							175									-68.1				40.0						C (loop/coil)	S (bend)					Cleavage; by factor XIa							42.03	100.0	$\leqslant$50	$\geqslant$90	306900;306900;300807	x-linked	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.8890417386687974	0.8671070578719104	false	false	false
FH	FH_Ser419Pro	B_13-14	1.6917016548170403	0.14165291060128632	0.21602892128590412	-5.928129248913769	0.000582728723620866	0.0015587568627467771	2025_01_Batch_13-14	false	false	false	false	false	true	false	false	false	false	false	false	0.8816578174151981	0.9121596744871314	0.8312315003533307	0.895836714993121	0.8192640275864911	0.8960834510212536	0.9216702309656462	0.822757436797082	0.8869762760385925	0.8966613618747227	0.9025864026787669	0.9015524511757746	0.8704966710768612	0.8157706183759001	0.9046971539476494	0.7658016388319387	0.921732946295496	0.8617631836546216	FH	Ser419Pro	NC_000001.11:241500572:A:G	1255T>C	1	241500572	A	G	1	ENSG00000091483	3408	0	CCSBVarC004056	ALE00004056	ENSP00000355518.4	CEGS2	CegsMutGDEh1042	E07	GDEhDisVCh_40065	C09	1	CegsMutGDDh1042	E07	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	98360.0	single nucleotide variant	NM_000143.4(FH):c.1255T>C (p.Ser419Pro)	2271.0	FH	HGNC:3700	Pathogenic/Likely pathogenic	1.0	Jan 16, 2024	200004220.0	-	RCV000078144|RCV000445624|RCV000492881|RCV004555536	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	not provided|Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|FH-related disorder	germline;unknown	germline	GRCh38	NC_000001.11	1	241500572.0	241500572.0	1q43	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA285322	2.0	92451.0	241500572.0	A	G	-	-	-	-	-	-	1255T>C 	Ser419Pro	NM_000143.4	2.0	Pathogenic	Likely pathogenic	92451	1	241500572.0	A	G	S	P	rs200004220	1	241663872	1	239730495	419	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1255T>C	p.Ser419Pro	c.1255T>C	p.Ser419Pro	principal1	Y	1	YES	Select	-	TCA	1	0	A	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.865	0.99733	H	-4.94	0.81865	D	0.942	0.94916	1.0873	0.99132	D	0.9643	0.98856	D	10	0.9089949	0.90156	D	0.541982	0.95732	D	0.822	0.94297	0.474	0.54885	P07954	S419P	Loss of MoRF binding (P = 0.0866)| Gain of ubiquitination at K414 (P = 0.2044)| Loss of methylation at R421 (P = 0.225)| Loss of catalytic residue at S419 (P = 0.2816)| Loss of disorder (P = 0.2882)	0.988284473714	0.98802	0.9942181623254077	0.99417	1.10507444367	0.77742	0.735592842102	0.72276	T	0.924582	0.98660	D	0.567543	0.96347	D	0.57746	0.96286	D	0.999648451805115	0.98285	D	0.987601	0.95789	D	0.94234765	0.95416	0.89128804	0.94281	0.94234765	0.95417	0.89128804	0.94282	-14.165	0.93593	D	0.9921	0.94292	P	0.999992778285156	0.99831	0.96268230	0.94135	0.992	0.99727	.	.	.	.	.	.	5.38469	0.90245	31.0	0.99890297198214184	0.96438	0.950240	0.96356	D	1.0315813013022	0.96616	14.9433	0.929047610943649	0.96701	15.05383	5.71	5.71	0.89013	5.93	0.96971	7.0	0.76103	11.015000	0.84918	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1598452	1.876820e-06	0	1	72718	1.375180e-05	0	1	72718	1.375180e-05	0	0	886	0.000000e+00	0	0	58902	0.000000e+00	0	0	29280	0.000000e+00	0	0	44352	0.000000e+00	0	0	61956	0.000000e+00	0	0	5882	0.000000e+00	0	1	1171916	8.533030e-07	0	0	90710	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	FH-related_disorder|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.241500572A>G	ClinGen:CA285322	C1708350|C0027672|C3661900	150800	523|140162	.	Ser	Pro	98.92	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.92	Polar/Neutral	Serine		Fumarate hydratase, mitochondrial										-0.8								 S419-N390 (PAE:  1.0), S419-L423 (PAE: 1.0), S419-N415 (PAE: 1.0)	S419-N390 (PDBs: 5D6B, 7LUB), S419-L423 (PDBs: 5D6B, 5UPP, 7LUB), S419-N415 (PDBs: 5D6B, 3E04, 7LUB)	 S419-N390 (PAE:  1.0), S419-L423 (PAE: 1.0), S419-V387 (PAE: 1.0), S419-N415 (PAE: 1.0)	S419-N390 (PDBs: 5D6B, 7LUB), S419-L423 (PDBs: 5D6B, 5UPP, 7LUB), S419-V387 (PDBs: 5D6B, 7LUB), S419-N415 (PDBs: 5D6B, 3E04, 7LUB)							105									-64.6				-46.6						H (helix)	H (α-helix)	Helix											98.92	0.0	>90	<10	150800	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	false	0.9121596744871314	0.8816578174151981	false	false	false
G6PD	G6PD_Arg365His	B_13-14	-0.12537883577312148	0.9037485339254261	0.9285420655177858	-0.47068237958158676	0.6521815080236295	0.6994465617903917	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5771350897571561	0.5916952644345537	0.5058800124782509	0.5761968538774203	0.5945068063908528	0.5350069798210375	0.5571077789403447	0.7127144858020559	0.6482878066473777	0.5097183248513559	0.6168495211050593	0.608510279259174	0.5129061807017302	0.4762991269796498	0.5041059011074627	0.5020417001051458	0.5665410077640481	0.5457599002551382	G6PD	Arg365His	NC_000023.11:154532760:C:T	1094G>A	23	154532760	C	T	X	ENSG00000160211	4006	0	CCSBVarC021512	ALE00036705	ENSP00000377192.3																																	1780128.0	single nucleotide variant	NM_001360016.2(G6PD):c.1094G>A (p.Arg365His)	2539.0	G6PD	HGNC:4057	Likely pathogenic	1.0	Aug 12, 2022	-1.0	-	RCV002305722	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	unknown	unknown	GRCh38	NC_000023.11	X	154532760.0	154532760.0	Xq28	criteria provided, single submitter	1.0	-	N	-	2.0	1722612.0	154532760.0	C	T	-	-	-	-	-	-	1094G>A 	Arg365His	NM_001360016.2	1.0	Pathogenic	Likely pathogenic	1722612	X	154532760.0	C	T	R	H	rs781967767	X	153760975	X	153414169	365	G6PD	ENSG00000160211	ENST00000393562	ENSP00000377192	P11413	G6PD_HUMAN	c.1094G>A	p.Arg365His	c.1094G>A	p.Arg365His	principal4	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	.	0.48345	.	.	0.52739	.	0.535	0.37823	P	0.12	0.32232	B	0.87	0.91311	D	simple_aae	13.0	87.0	3.26	0.89820	M	.	0.75883	.	.	0.68273	1.0246	0.97612	D	0.9807	0.99405	D	10	0.8802651	0.87196	D	0.613028	0.96622	D	0.798	0.93363	0.603	0.73365	P11413	R365H	Loss of solvent accessibility (P = 0.0364)| Loss of stability (P = 0.0369)| Gain of ubiquitination at K360 (P = 0.0542)| Loss of MoRF binding (P = 0.0803)| Loss of methylation at K360 (P = 0.1029)	0.998371958706	0.99832	.	.	1.20514760124	0.80587	0.833622932434	0.87096	D	0.967016	0.99611	D	0.594247	0.97356	D	0.615818	0.97313	D	0.961354553699493	0.65842	D	.	0.95367	.	0.8231586	0.85244	0.6705637	0.80452	0.8231586	0.85245	0.6705637	0.80453	-9.6	0.75018	D	0.5174	0.69466	A	0.997402931741911	0.93099	0.99792010	0.98559	0.947	0.97555	.	.	.	.	.	.	3.345784	0.46204	22.2	0.99806085228496089	0.89004	.	.	.	.	.	.	.	.	.	5.73	4.87	0.62830	.	.	5.68	0.67905	3.272000	0.37248	0.535	0.24985	1.0	0.71675	1.000000	0.68239	0.906	0.44196	80	0.96675	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1210393	8.261780e-07	0	1	45926	2.177420e-05	0	0	57896	0.000000e+00	0	0	686	0.000000e+00	0	1	45926	2.177420e-05	0	0	22013	0.000000e+00	0	0	33766	0.000000e+00	0	0	46693	0.000000e+00	0	0	4352	0.000000e+00	0	0	894734	0.000000e+00	0	0	56740	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	criteria_provided,_single_submitter	NC_000023.11:g.154532760C>T	.	C2720289	300908	466026	Glucose-6-phosphate dehydrogenase, C-terminal	Arg	His	98.02	0.42338709677419356																																																																																																																																																																																																																																																																																																																																																																																																																																																																													105			98.02	Positively-charged	Arginine	D-glucose 6-phosphate	Glucose-6-phosphate 1-dehydrogenase										-4.5								 R365-Q395 (PAE:  1.5)	R365-Q395 (PDBs: 6E08, 7SNF, 7SNI, 7TOE, 7UAG)	 R365-Q395 (PAE:  1.5), R365-P240 (PAE: 1.0)	R365-P240 (PDBs: 6E08, 6JYU, 7ZVD, 7SNF, 7SNG, 7SNH, 7SNI, 7TOE, 7UAG), R365-Q395 (PDBs: 7ZVD, 7UAG), R365-K238 (PDBs: 7ZVD, 7UAG), R365-P396 (PDBs: 7ZVD, 7UAG), R365-E239 (PDBs: 7TOF, 7UAG)							175									-85.1				117.7						C (loop/coil)	C (loop/coil)												98.02	42.33871	>90	10-90	300908	x-linked	OMIM	Rare genetic hematologic disease	1	ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1	false	0.5916952644345537	0.5771350897571561	false	false	false
IRAK4	IRAK4_Ala428Thr	B_7-8	5.01962896640939	0.0015310912217215088	0.006441374963630136	3.128942570207846	0.025988432315368945	0.03964430969185402	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6017911505958669	0.6459561981471955	0.5094234035438219	0.6754991652209963	0.6550432582338102	0.5662704532156821	0.5049131569958821	0.6855919932273831	0.7224578643550048	0.3966148324835717	0.6737239963827151	0.6436673962392239	0.6276277494354823	0.6244945232402372	0.6285404660869877	0.6222319746040721	0.618188399911676	0.5599149049525098	IRAK4	Ala428Thr	NC_000012.12:43786492:G:A	1282G>A	12	43786492	G	A	12	ENSG00000198001	6395	312	CCSBVarC008460	ALE00008448	ENSP00000479889.3	Edgotyping3	VUSmut_GDEh11	H03	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh11	H03	0.0		0.0		0.0			0.0			1.0	1.0	1.0	Y	N	N	N	Y	317132.0	single nucleotide variant	NM_016123.4(IRAK4):c.1282G>A (p.Ala428Thr)	51135.0	IRAK4	HGNC:17967	Benign	0.0	Feb 01, 2024	4251545.0	-	RCV000325464|RCV000455521|RCV001653515	MONDO:MONDO:0011888,MedGen:C1843256,OMIM:607676,Orphanet:70592|MedGen:CN169374|MedGen:C3661900	Immunodeficiency 67|not specified|not provided	germline	germline	GRCh38	NC_000012.12	12	43786492.0	43786492.0	12q12	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA6522626,UniProtKB:Q9NWZ3#VAR_019356	2.0	308732.0	43786492.0	G	A	-	-	-	-	-	-	1282G>A 	Ala428Thr	NM_016123.4	2.0	Benign	Benign	308732	12	43786492.0	G	A	A	T	rs4251545	12	44180295	12	42466562	428	IRAK4	ENSG00000198001	ENST00000551736	ENSP00000446490	Q9NWZ3	IRAK4_HUMAN	c.1282G>A	p.Ala428Thr	c.1282G>A	p.Ala428Thr	principal1	Y	1	.	.	+	GCT	1	0	A	A/A	A/A	A/A	A/A	0.61	0.05502	T	0.567	0.09291	T	0.0	0.02950	B	0.001	0.04348	B	0.0	0.05039	P	simple_aae	100.0	0.0	1.165	0.29574	L	-0.33	0.15106	N	0.022	0.00609	-1.0163	0.24854	T	0.0000	0.00011	T	9	0.0038244724	0.00071	T	.	.	.	0.056	0.15858	.	.	.	.	.	.	.	.	0.08771	.	.	0.259773641825	0.04865	T	0.166493	0.51025	T	-0.69311	0.00039	T	-0.624561	0.10585	T	0.00258845232290206	0.00027	T	0.624238	0.23818	T	0.060123887	0.12188	0.057342928	0.10415	0.06330766	0.13193	0.053697735	0.09106	-4.354	0.28957	T	0.063	0.01513	B	0.00382265881691163	0.17028	0.00331491	0.28477	0.011	0.00835	.	.	.	.	.	.	0.786767	0.11593	8.163	0.61635794347031891	0.06857	0.033114	0.03798	N	-0.741591974438414	0.14682	0.7440378	-0.662574747928396	0.17612	0.953846	6.02	-0.286	0.12197	-0.728	0.17110	0.863	0.2766	1.630000	0.27819	-0.673	0.04293	0.99	0.37076	0.444000	0.24998	0.988	0.63383	595	0.68467	854	0.17052715654952078	419	0.31694402420574885	87	0.08648111332007952	101	0.14553314121037464	128	0.12698412698412698	119	0.12167689161554192	41738	264690	0.15768635	.	12399	109202	1.135420e-01	862	24037	207570	1.158020e-01	1664	26814	236348	1.134510e-01	1797	2015	7158	2.815030e-01	299	2217	17008	1.303500e-01	146	356	2318	1.535810e-01	24	1050	9044	1.160990e-01	68	835	13392	6.235070e-02	28	4019	42752	9.400730e-02	187	1710	15616	1.095030e-01	99	2015	7158	2.815030e-01	299	4384	16148	2.714890e-01	591	3902	30400	1.283550e-01	238	965	6202	1.555950e-01	67	1506	13414	1.122710e-01	101	1038	16728	6.205160e-02	34	8397	89364	9.396400e-02	407	3323	30470	1.090580e-01	191	4384	16148	2.714890e-01	591	4038	14834	2.722120e-01	551	4462	34132	1.307280e-01	287	1490	9558	1.558900e-01	114	1967	17684	1.112300e-01	119	1364	21624	6.307810e-02	44	9557	102530	9.321170e-02	448	3313	30388	1.090230e-01	190	4038	14834	2.722120e-01	551	.	167824	1612510	1.040760e-01	10368	20602	74846	2.752590e-01	2893	20602	74846	2.752590e-01	2893	37	912	4.057020e-02	0	8097	59894	1.351890e-01	561	4688	29566	1.585610e-01	381	4098	44768	9.153860e-02	210	4215	63920	6.594180e-02	158	1019	6052	1.683740e-01	116	108024	1179254	9.160370e-02	4999	9691	90858	1.066610e-01	557	30375	314658	0.09653337909730565	210	594	0.35353535353535354	413	4968	0.08313204508856682	4422	15954	0.2771718691237307	227	1488	0.15255376344086022	1022	7196	0.14202334630350194	196	1968	0.09959349593495935	533	5226	0.10199004975124377	2755	23600	0.11673728813559323	4632	16548	0.27991298042059465	609	6936	0.08780276816608996	40153	375652	0.10688882263371419	Immunodeficiency_67|not_provided|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.43786492G>A	ClinGen:CA6522626|UniProtKB:Q9NWZ3#VAR_019356	C1843256|C3661900|CN169374	607676	70592	.	Ala	Thr	97.65	0.33962264150943394																																																																																																																																																																																																																																																																																																																																																																																																																																																																													36			97.65	Aliphatic	Alanine		Interleukin-1 receptor-associated kinase 4							Protein kinase			1.8								 A428-T424 (PAE:  1.0), A428-V432 (PAE: 1.0)	A428-V432 (PDBs: 6EGF, 8WTF, 2NRU, 2NRY, 2O8Y, 2OIB, 2OIC, 2OID, 4RMZ, 4Y73, 4YO6, 4YP8, 4ZTL, 4ZTM, 4ZTN, 5K72, 5K75, 5K76, 5K7G, 5K7I, 5KX7, 5KX8, 5T1S, 5T1T, 5UIQ, 5UIR, 5UIS, 5UIT, 5UIU, 6EG9, 6EGA, 6EGD, 6EGE, 6F3E, 6F3G, 6LXY, 6MOM, 6O8U, 6O94, 6O95, 6RFI, 6RFJ, 7C2V, 7C2W, 7QG1, 8DKS), A428-T424 (PDBs: 8WTF, 4XS2, 7QG3, 8DKS)	 A428-T424 (PAE:  1.0), A428-V432 (PAE: 1.0)	A428-V432 (PDBs: 6EGF, 8WTF, 2NRU, 2NRY, 2O8Y, 2OIB, 2OIC, 2OID, 4RMZ, 4XS2, 4Y73, 4YO6, 4YP8, 4ZTL, 4ZTM, 4ZTN, 5K72, 5K75, 5K76, 5K7G, 5K7I, 5KX7, 5KX8, 5T1S, 5T1T, 5UIQ, 5UIR, 5UIS, 5UIT, 5UIU, 6EG9, 6EGA, 6EGD, 6EGE, 6F3E, 6F3G, 6LXY, 6MOM, 6O8U, 6O94, 6O95, 6RFI, 6RFJ, 7C2V, 7C2W, 7QG1, 7QG3, 8DKS), A428-M457 (PDBs: 8WTF), A428-T424 (PDBs: 8WTF, 8DKS)							89									-63.0				-46.8						H (helix)	H (α-helix)	Helix											97.65	33.962265	>90	10-90	607676	autosomal recessive	OMIM	Rare genetic immune disease	1	IMMUNODEFICIENCY 67	false	0.6459561981471955	0.6017911505958669	false	false	false
WRAP53	WRAP53_Arg68Gly	B_7-8	-1.6358470484842618	0.16279875937054772	0.23900509638566192	-1.5343794435958067	0.1688082630737354	0.2102940683912454	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.682367900279615	0.5976520257248265	0.6102691449317024	0.7451418254512115	0.6101870141147681	0.6898009600711651						0.682367900279615	0.6898009600711651	0.6101870141147681	0.7451418254512115	0.6102691449317024	0.5976520257248265		WRAP53	Arg68Gly	NC_000017.11:7688850:C:G	202C>G	17	7688850	C	G	17	ENSG00000141499	5385	9894	CCSBVarC000802	ALE00000802	ENSP00000379727.3	RC4	RC4_Mut_GDEh1003	E10	GDEhDisVCh_40088	B09	2	RC4_Mut_GDDh1003	E10	NULL	NULL	VUSMutpDEST2_05	C01	VUSmut_GDEh12	E06	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	256465.0	single nucleotide variant	NM_001143992.2(WRAP53):c.202C>G (p.Arg68Gly)	-1.0	TP53;WRAP53	-	Benign	0.0	Feb 01, 2024	2287499.0	-	RCV000253368|RCV000354405|RCV000989732|RCV001516489|RCV002418084	MedGen:CN169374|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MONDO:MONDO:0013520,MedGen:C3151442,OMIM:613988,Orphanet:1775|MedGen:C3661900|MONDO:MONDO:0015780,MedGen:C0265965,OMIM:PS127550,Orphanet:1775	not specified|Li-Fraumeni syndrome|Dyskeratosis congenita, autosomal recessive 3|not provided|Dyskeratosis congenita	germline;unknown	germline	GRCh38	NC_000017.11	17	7688850.0	7688850.0	17p13.1	criteria provided, multiple submitters, no conflicts	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA8354906,UniProtKB:Q9BUR4#VAR_026866	2.0	261001.0	7688850.0	C	G	-	-	-	-	-	-	202C>G 	Arg68Gly	NM_001143992.2	2.0	Benign	Benign	261001	17	7688850.0	C	G	R	G	rs2287499	17	7592168	17	7532893	68	WRAP53	ENSG00000141499	ENST00000316024	ENSP00000324203	Q9BUR4	TCAB1_HUMAN	c.202C>G	p.Arg68Gly	c.202C>G	p.Arg68Gly	principal1	Y	1	.	.	+	CGG	1	2	G	G/G	G/G	G/G	G/G	0.803	0.03109	T	0.458	0.15675	T	0.0	0.02950	B	0.0	0.01384	B	0.0	0.05039	P	simple_aae	100.0	0.0	.	.	.	0.36	0.03678	N	0.01	0.03063	-1.0023	0.29162	T	0.0000	0.00011	T	9	9.1231465e-07	0.00003	T	.	.	.	0.041	0.10768	.	.	.	.	.	.	.	0.10658473580532032	0.10442	0.309330519025	0.32946	0.231321245432	0.02070	T	0.005737	0.05209	T	-0.755978	0.00015	T	-0.714867	0.04866	T	0.00181573899385578	0.00018	T	.	0.00941	.	0.04007013	0.05597	0.026338767	0.00724	0.03612915	0.04343	0.026902797	0.00813	-2.617	0.06640	T	.	0.00111	.	5.42599465040623e-06	0.00398	0.00679519	0.36792	0.005	0.00124	.	.	.	.	.	.	0.963231	0.13417	9.905	0.61214006816114774	0.06749	0.028093	0.02372	N	-1.54459546494822	0.01552	0.06843831	-1.45960468066301	0.02647	0.1239179	5.41	1.08	0.19414	-0.0372	0.21309	0.419	0.21042	1.425000	0.26483	-0.777	0.03383	0.003	0.16092	0.015000	0.20513	0.18	0.21341	422	0.81336	2037	0.4067492012779553	1172	0.886535552193646	143	0.14214711729622267	168	0.2420749279538905	302	0.2996031746031746	252	0.25766871165644173	90379	264690	0.34145227	.	22231	109348	2.033050e-01	3927	43819	207630	2.110440e-01	8042	47202	236464	1.996160e-01	8110	5605	7150	7.839160e-01	2230	3448	17110	2.015200e-01	363	263	2320	1.133620e-01	19	2757	9034	3.051800e-01	435	770	13390	5.750560e-02	29	4994	42748	1.168240e-01	295	4093	15682	2.610000e-01	530	5605	7150	7.839160e-01	2230	12421	16062	7.733160e-01	4867	6148	30522	2.014280e-01	640	702	6192	1.133720e-01	52	4140	13404	3.088630e-01	667	998	16730	5.965330e-02	32	10542	89258	1.181070e-01	628	8031	30600	2.624510e-01	1074	12421	16062	7.733160e-01	4867	11437	14746	7.756000e-01	4503	6937	34256	2.025050e-01	733	1088	9554	1.138790e-01	72	5450	17680	3.082580e-01	876	1317	21628	6.089330e-02	49	12070	102466	1.177950e-01	724	8005	30518	2.623040e-01	1071	11437	14746	7.756000e-01	4503	.	258540	1614002	1.601860e-01	38182	57638	74958	7.689370e-01	22425	57638	74958	7.689370e-01	22425	76	912	8.333330e-02	0	12652	60002	2.108600e-01	1383	3292	29608	1.111860e-01	206	12895	44868	2.873990e-01	1865	4093	64012	6.394110e-02	154	1093	6062	1.803040e-01	108	131797	1179994	1.116930e-01	7431	23688	91082	2.600730e-01	3242	10785	98590	0.10939243330966629	56	66	0.8484848484848485	604	2624	0.2301829268292683	870	1662	0.5234657039711191	234	738	0.3170731707317073	49	726	0.0674931129476584	173	642	0.26947040498442365	48	240	0.2	1256	7854	0.15991851285968933	926	1728	0.5358796296296297	777	3266	0.23790569503980405	14075	113142	0.12440119495854766	not_provided|Li-Fraumeni_syndrome|not_specified|Dyskeratosis_congenita|Dyskeratosis_congenita,_autosomal_recessive_3	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7688850C>G	ClinGen:CA8354906|UniProtKB:Q9BUR4#VAR_026866	C3661900|C0085390|CN169374|C0265965|C3151442	PS151623|PS127550|613988	524|1775|1775	.	Arg	Gly	34.12	0.7701612903225806																																																																																																																																																																																																																																																																																																																																																																																																																																																																													191			34.12	Positively-charged	Arginine		Telomerase Cajal body protein 1										-4.5																		175									65.3				149.2	Disordered			dbSNP: rs2287499; Variant type: LB/B; AA change: Arg68Gly; PTM type: Phosphorylation; PTM morphology: AGSAVsQELR*E; Var class: II		C (loop/coil)	C (loop/coil)												34.12	77.01613	$\leqslant$50	10-90	613988	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare genetic skin disease	6	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3	false	0.5976520257248265	0.682367900279615	false	false	false
SERPINF1	SERPINF1_Thr72Met	B_7-8	-2.3089389597035366	0.06899851696115172	0.12057380365580951	0.05173452459157133	0.9604196008224674	0.9688674917587837	2024_01_Batch_7-8		false	false	false	false	false		false	false	false	false	false		0.6982323191028549	0.6724258814102564	0.5823552150561079	0.5430224413483341	0.6716603708791209							0.6716603708791209	0.5430224413483341	0.5823552150561079	0.6724258814102564	0.6982323191028549		SERPINF1	Thr72Met	NC_000017.11:1769982:C:T	215C>T	17	1769982	C	T	17	ENSG00000132386	4676	8807	CCSBVarC000679	ALE00000679	ENSP00000254722.4	RC4	RC4_Mut_GDEh1003	G02	GDEhDisVCh_40009	G03	1	RC4_Mut_GDDh1003	G02	NULL	NULL	NULL	NULL	VUSmut_GDEh12	A06	1.0	1.0	1.0	1.0	0.0			0.0			1.0	1.0	1.0	Y	Y	N	N	Y	337339.0	single nucleotide variant	NM_002615.7(SERPINF1):c.215C>T (p.Thr72Met)	5176.0	SERPINF1	HGNC:8824	Benign	0.0	Jan 31, 2024	1136287.0	-	RCV002061217|RCV000593863|RCV002278488|RCV000611660	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0019019,MeSH:D010013,MedGen:C0029434,OMIM:PS166200,Orphanet:666|MONDO:MONDO:0013515,MedGen:C3279564,OMIM:613982,Orphanet:666	not provided|not specified|Osteogenesis imperfecta|Osteogenesis imperfecta type 6	germline;unknown	germline	GRCh38	NC_000017.11	17	1769982.0	1769982.0	17p13.3	criteria provided, multiple submitters, no conflicts	10.0	-	N	ClinGen:CA8274571,UniProtKB:P36955#VAR_009126	2.0	322000.0	1769982.0	C	T	-	-	-	-	-	-	215C>T 	Thr72Met	NM_002615.7	2.0	Benign	Benign	322000	17	1769982.0	C	T	T	M	rs1136287	17	1673276	17	1620026	72	SERPINF1	ENSG00000132386	ENST00000254722	ENSP00000254722	P36955	PEDF_HUMAN	c.215C>T	p.Thr72Met	c.215C>T	p.Thr72Met	principal1	Y	1	YES	Select	+	ACG	2	0	T	T/T	T/T	T/T	T/T	0.271	0.16074	T	0.194	0.35170	T	0.005	0.13006	B	0.006	0.12129	B	0.0	0.01751	P	simple_aae	100.0	0.0	0.975	0.24371	L	-0.5	0.15712	N	0.08	0.05530	-0.9554	0.39850	T	0.0000	0.00011	T	9	1.7483504e-06	0.00003	T	.	.	.	0.281	0.59659	.	.	.	.	.	.	.	0.29604713747979	0.29318	0.0717297491931	0.07864	0.245125055313	0.03274	T	0.138989	0.46988	T	-0.498753	0.00554	T	-0.345381	0.39382	T	0.0287384150289317	0.01788	T	0.0844916	0.00639	T	0.012640775	0.00038	0.022093572	0.00244	0.016333638	0.00191	0.024122749	0.00432	-5.047	0.37390	T	0.0742	0.05209	B	8.48788466062812e-06	0.00398	0.00005217	0.00492	0.024	0.04173	.	.	.	.	.	.	0.02263	0.04454	1.168	0.92414718718587052	0.22081	0.418738	0.48449	N	-1.59213410309891	0.01293	0.05679136	-1.72244247552863	0.01030	0.04673711	5.67	-11.3	0.00084	-8.34	0.00691	-0.725	0.05052	-2.415000	0.03803	-0.115	0.14609	0.0	0.06393	0.000000	0.08389	0.273	0.23891	636	0.64449	3136	0.6261980830670927	1158	0.875945537065053	658	0.6540755467196819	409	0.5893371757925072	491	0.4871031746031746	420	0.4294478527607362	183648	264690	0.693823	.	65470	109398	5.984570e-01	20262	126225	208080	6.066180e-01	39649	143768	236926	6.068060e-01	45029	5998	7164	8.372420e-01	2515	8916	17110	5.210990e-01	2391	1676	2320	7.224140e-01	608	4923	9046	5.442180e-01	1344	7254	13386	5.419090e-01	2014	27783	42768	6.496210e-01	9044	7734	15690	4.929250e-01	1989	5998	7164	8.372420e-01	2515	13578	16214	8.374240e-01	5686	15614	30520	5.115990e-01	4127	4493	6212	7.232780e-01	1629	7186	13410	5.358690e-01	1948	9121	16726	5.453190e-01	2554	58176	89526	6.498220e-01	18909	14977	30608	4.893170e-01	3808	13578	16214	8.374240e-01	5686	12471	14900	8.369800e-01	5223	17681	34256	5.161430e-01	4704	6933	9572	7.243000e-01	2500	9624	17692	5.439750e-01	2629	11841	21622	5.476370e-01	3324	66722	102740	6.494260e-01	21717	14938	30526	4.893530e-01	3798	12471	14900	8.369800e-01	5223	.	1023654	1613816	6.343070e-01	329446	63038	74990	8.406190e-01	26496	63038	74990	8.406190e-01	26496	647	912	7.094300e-01	234	32851	59996	5.475530e-01	9244	21450	29606	7.245150e-01	7764	22361	44860	4.984620e-01	5687	35730	63984	5.584210e-01	10002	4105	6060	6.773930e-01	1416	758319	1179840	6.427300e-01	244096	44769	91066	4.916100e-01	11326	215755	331398	0.6510449670788598	516	606	0.8514851485148515	2681	5002	0.5359856057576969	13804	16618	0.8306655433866892	1090	1568	0.6951530612244898	2877	5336	0.539167916041979	1133	1998	0.5670670670670671	2634	5236	0.5030557677616501	15845	24566	0.6449971505332573	14320	17224	0.8313980492336275	3814	7000	0.5448571428571428	256335	392328	0.6533691197161559	Osteogenesis_imperfecta_type_6|not_specified|not_provided|Osteogenesis_imperfecta	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.1769982C>T	ClinGen:CA8274571|UniProtKB:P36955#VAR_009126	C3279564|CN169374|C3661900|C0029434	613982|PS166200	666|666	Serpin domain|Serpin domain|Pigment epithelium derived factor, serpin domain	Thr	Met	93.57	0.4788732394366197																																																																																																																																																																																																																																																																																																																																																																																																																																																																													68			93.57	Polar/Neutral	Threonine		Pigment epithelium-derived factor										-0.7								 T72-V68 (PAE:  1.0)		 T72-V68 (PAE:  1.0)								119									-80.3				-10.7						H (helix)	H (α-helix)	Helix											93.57	47.887325	>90	10-90	613982	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic odontologic disease	4	OSTEOGENESIS IMPERFECTA, TYPE VI	false	0.6982323191028549		false		false
KRT6A	KRT6A_Thr552Ser	B_7-8	-2.5012391739573627	0.05453524115290785	0.09956151652765327	0.05808130768816435	0.9553323399578759	0.9636558853670614	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5717481997685321	0.5599499020026342	0.8297047996660796	0.5626014143916542	0.5928999319812405	0.8524992779481757	0.8387028123095999	0.6842398351012899	0.6597385812578918	0.7726876612613522	0.5998264159665087	0.571874192720892	0.8662957435867517	0.5015600288611911	0.46546424752541676	0.8867219380708069	0.5200733880387597	0.5716222068161723	KRT6A	Thr552Ser	NC_000012.12:52487760:G:C	1655C>G	12	52487760	G	C	12	ENSG00000205420	4870	900196	CCSBVarC002916	ALE00002916	ENSP00000369317.3	RC4	NatVar_GDE_001	E05	GDEhDisVCh_40048	A11	2	NULL	NULL	NULL	NULL	VUSMutpDEST2_04	F11	VUSmut_GDEh12	D02	1.0	1.0	0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	1554818.0	single nucleotide variant	NM_005554.4(KRT6A):c.1655C>G (p.Thr552Ser)	3853.0	KRT6A	HGNC:6443	Benign	0.0	Jan 22, 2024	11540301.0	-	RCV002198209	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000012.12	12	52487760.0	52487760.0	12q13.13	criteria provided, multiple submitters, no conflicts	2.0	-	N	-	2.0	1561393.0	52487760.0	G	C	-	-	-	-	-	-	1655C>G 	Thr552Ser	NM_005554.4	2.0	Benign	Benign	1561393	12	52487760.0	G	C	T	S	rs11540301	12	52881544	12	51167811	552	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.1655C>G	p.Thr552Ser	c.1655C>G	p.Thr552Ser	principal1	Y	1	YES	Select	-	ACC	2	0	.	./.	./.	./.	./.	0.116	0.28526	T	0.58	0.08643	T	0.003	0.11208	B	0.005	0.11213	B	0.07	0.21442	P	simple_aae	93.0	7.0	0.935	0.23470	L	-0.82	0.22452	N	0.04	0.01339	-1.0785	0.07656	T	0.0000	0.00011	T	9	0.0021026134	0.00029	T	.	.	.	0.145	0.38375	0.31	0.28159	P02538	T552S	Gain of catalytic residue at S555 (P = 9e-04)| Gain of phosphorylation at T552 (P = 0.0357)| Gain of glycosylation at T552 (P = 0.038)| Loss of sheet (P = 0.0817)| Gain of MoRF binding (P = 0.1072)	.	.	0.24327183749364087	0.24050	0.252241599255	0.27500	0.423592925072	0.28297	T	0.145037	0.47915	T	-0.57743	0.00194	T	-0.458394	0.26423	T	0.00444316755789109	0.00047	T	0.39556	0.09735	T	0.061335888	0.12574	0.07373827	0.16046	0.061335888	0.12574	0.07373827	0.16046	-3.468	0.16000	T	0.1037	0.18813	B	0.00490496643234456	0.18709	0.00478653	0.32702	0.048	0.12436	.	.	.	.	.	.	1.736059	0.22129	15.48	0.94770856695405004	0.25727	0.053227	0.09423	N	-0.554508858479115	0.20097	1.071675	-0.462122809133644	0.22889	1.264307	4.75	2.72	0.31097	1.54	0.34573	-0.014	0.12633	.	.	0.586	0.30628	0.285	0.25273	0.000000	0.08389	0.996	0.76032	734	0.53826	553	0.11042332268370607	394	0.2980332829046899	13	0.012922465208747515	55	0.0792507204610951	56	0.05555555555555555	35	0.03578732106339468	24861	264690	0.09392497	segdup	4484	109404	4.098570e-02	317	9065	208126	4.355530e-02	666	9374	236922	3.956580e-02	637	1806	7162	2.521640e-01	230	1345	17112	7.859980e-02	59	28	2320	1.206900e-02	1	430	9046	4.753480e-02	12	10	13394	7.466030e-04	0	292	42768	6.827530e-03	1	522	15688	3.327380e-02	11	1806	7162	2.521640e-01	230	4006	16216	2.470400e-01	507	2438	30522	7.987680e-02	108	59	6212	9.497750e-03	1	668	13416	4.979130e-02	19	10	16734	5.975860e-04	0	705	89556	7.872170e-03	4	1030	30606	3.365350e-02	20	4006	16216	2.470400e-01	507	3712	14900	2.491280e-01	467	2705	34258	7.895970e-02	117	98	9568	1.024250e-02	1	866	17692	4.894870e-02	21	13	21630	6.010170e-04	0	796	102732	7.748320e-03	4	1028	30524	3.367840e-02	20	3712	14900	2.491280e-01	467	.	38822	1613996	2.405330e-02	2793	18526	74930	2.472440e-01	2328	18526	74930	2.472440e-01	2328	67	912	7.346490e-02	2	4791	60002	7.984730e-02	211	284	29606	9.592650e-03	1	1771	44864	3.947490e-02	49	46	64046	7.182340e-04	0	260	6062	4.289010e-02	7	8086	1180002	6.852530e-03	34	3034	91074	3.331360e-02	73	269	37288	0.007214117142244154	29	122	0.23770491803278687	3	112	0.026785714285714284	718	3452	0.20799536500579374	57	500	0.114	37	628	0.0589171974522293	2	56	0.03571428571428571	1	98	0.01020408163265306	169	7064	0.023924122310305777	747	3574	0.20900951315053162	5	168	0.02976190476190476	1285	49320	0.026054339010543392	not_provided	criteria_provided,_single_submitter	NC_000012.12:g.52487760G>C	.	C3661900	.	.	.	Thr	Ser	34.69	0.823943661971831																																																																																																																																																																																																																																																																																																																																																																																																																																																																													117			34.69	Polar/Neutral	Threonine		Keratin, type II cytoskeletal 6A										-0.7																		119									-102.1	Morphology: GsSTIkytTTSSssR			103.7	Tail					C (loop/coil)	C (loop/coil)												34.69	82.39437	$\leqslant$50	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2		false	0.5599499020026342	0.5717481997685321	false	false	false
TMEM43	TMEM43_Ala366Thr	B_15-16	-6.260588903027929	0.00041982861542374524	0.0023865257602956945	-1.7910636830787663	0.11639648869725612	0.151265975042114	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6167866321601898	0.629285941669497	0.5322313488210111	0.7344009272084923	0.7366835870144394	0.5696254466821657	0.4293828856849542	0.6717274693119843	0.6777638990133439	0.42450972646152246	0.585500728666373	0.5487435374211926	0.7098680076793772	0.8016397047168944	0.7910379554036406	0.6399529711804997	0.673071154672621	0.6848297268991869	TMEM43	Ala366Thr	NC_000003.12:14141688:G:A	1096G>A	3	14141688	G	A	3	ENSG00000170876	3438	287	CCSBVarC008440	ALE00008459	ENSP00000303992.5	Edgotyping3	VUSmut_GDEh11	F02	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_03	E05	VUSmut_GDEh11	F02	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	2.0	Y	N	N	Y	Y	55303.0	single nucleotide variant	NM_024334.3(TMEM43):c.1096G>A (p.Ala366Thr)	79188.0	TMEM43	HGNC:28472	Benign	0.0	Jan 31, 2024	36083134.0	-	RCV000039376|RCV000233079|RCV000246312|RCV000769160|RCV001682735	MedGen:CN169374|MONDO:MONDO:0011459,MedGen:C1858379,OMIM:604400|MedGen:CN230736|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MedGen:C3661900	not specified|Arrhythmogenic right ventricular dysplasia 5|Cardiovascular phenotype|Cardiomyopathy|not provided	germline	germline	GRCh38	NC_000003.12	3	14141688.0	14141688.0	3p25.1	criteria provided, multiple submitters, no conflicts	13.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA024577	2.0	46138.0	14141688.0	G	A	-	-	-	-	-	-	1096G>A 	Ala366Thr	NM_024334.3	2.0	Benign	Benign	46138	3	14141688.0	G	A	A	T	rs36083134	3	14183188	3	14158189	366	TMEM43	ENSG00000170876	ENST00000306077	ENSP00000303992	Q9BTV4	TMM43_HUMAN	c.1096G>A	p.Ala366Thr	c.1096G>A	p.Ala366Thr	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.197	0.20715	T	0.246	0.24269	T	0.684	0.41535	P	0.197	0.36709	B	0.42	0.65374	N	simple_aae	58.0	42.0	1.74	0.44959	L	-0.46	0.14906	N	0.291	0.32697	-1.1262	0.01982	T	0.0223	0.09387	T	10	0.008789092	0.00196	T	.	.	.	0.116	0.32262	.	.	.	.	.	0.309530620856	0.30151	0.41647198325728646	0.41361	0.166796694662	0.18545	0.446556985378	0.31434	T	0.008724	0.07985	T	-0.47116	0.00787	T	-0.433309	0.29201	T	0.012343121455428	0.00200	T	0.890111	0.62265	D	0.08843719	0.20443	0.11912199	0.28685	0.09701862	0.22656	0.1183183	0.28491	-4.504	0.30975	T	0.0846	0.10109	B	0.108698647127539	0.44087	0.85268500	0.89716	0.111	0.30556	.	.	.	.	.	.	2.942467	0.39206	20.9	0.9966206600317391	0.78035	0.493146	0.52785	N	0.148217738307284	0.48479	3.08151	0.278694044138677	0.54059	3.595141	5.71	5.71	0.89013	.	.	4.225	0.58485	7.580000	0.60999	0.614	0.49322	0.784	0.29612	1.000000	0.68239	0.987	0.62545	830	0.39194	28	0.005591054313099041	23	0.01739788199697428	0	0.0	5	0.007204610951008645	0	0.0	0	0.0	1665	264690	0.0062903776	.	152	109382	1.389630e-03	1	344	208054	1.653420e-03	5	320	236852	1.351050e-03	5	120	7164	1.675040e-02	1	24	17112	1.402520e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13372	0.000000e+00	0	4	42766	9.353220e-05	0	2	15690	1.274700e-04	0	120	7164	1.675040e-02	1	296	16218	1.825130e-02	5	33	30520	1.081260e-03	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16712	0.000000e+00	0	7	89506	7.820700e-05	0	2	30608	6.534240e-05	0	296	16218	1.825130e-02	5	271	14902	1.818550e-02	5	33	34256	9.633350e-04	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21608	0.000000e+00	0	9	102680	8.765100e-05	0	2	30526	6.551790e-05	0	271	14902	1.818550e-02	5	.	1678	1614190	1.039530e-03	19	1431	75048	1.906780e-02	19	1431	75048	1.906780e-02	19	0	912	0.000000e+00	0	95	60028	1.582590e-03	0	0	29608	0.000000e+00	0	0	44882	0.000000e+00	0	0	64012	0.000000e+00	0	7	6062	1.154730e-03	0	31	1180044	2.627020e-05	0	10	91082	1.097910e-04	0	5	190548	2.6240107479480237E-5	7	370	0.01891891891891892	0	4532	0	161	9946	0.016187412024934646	9	832	0.010817307692307692	0	1092	0	0	1854	0	0	312	0	17	20256	8.392575039494471E-4	168	10316	0.016285381930981	0	6386	0	199	229742	8.661890294330162E-4	Cardiomyopathy|not_provided|Cardiovascular_phenotype|Arrhythmogenic_right_ventricular_dysplasia_5|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.14141688G>A	ClinGen:CA024577	C0878544|C3661900|CN230736|C1858379|CN169374	604400	167848	.	Ala	Thr	92.07	0.44339622641509435																																																																																																																																																																																																																																																																																																																																																																																																																																																																													47			92.07	Aliphatic	Alanine		Transmembrane protein 43										1.8								 A366-L362 (PAE:  1.0)		 A366-L362 (PAE:  1.0)								89									-59.7				-39.7						H (helix)	H (α-helix)									Helical			92.07	44.339622	>90	10-90	604400	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5	false	0.629285941669497	0.6167866321601898	false	false	false
FBP1	FBP1_Arg218Lys	B_7-8	-2.225607225288514	0.061367361780469046	0.10944132679803537	-3.9253248419664115	0.005709849747772325	0.010572728846783267	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6655997780946777	0.7963832814928037	0.7330253245163618	0.7581287923344622	0.7443826981620911	0.7549289293124734	0.915881032424222	0.9210101647940669	0.8980340623910651	0.8847877702298038	0.8855057719312069		0.5939768262007247	0.5677552315301153	0.6182235222778591	0.5812628788029197	0.7072607910544004	0.6655997780946777	FBP1	Arg218Lys	NC_000009.12:94606867:C:T	653G>A	9	94606867	C	T	9	ENSG00000165140	2654	900206	CCSBVarC002925	ALE00002925	ENSP00000364475.5	RC4	NatVar_GDE_001	F06	GDEhDisVCh_40075	D06	1	NULL	NULL	NULL	NULL	VUSMutpDEST2_02	D02	VUSmut_GDEh12	D03	1.0	2.0	0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	253590.0	single nucleotide variant	NM_000507.4(FBP1):c.653G>A (p.Arg218Lys)	2203.0	FBP1	HGNC:3606	Benign	0.0	Feb 01, 2024	1769259.0	-	RCV000250848|RCV000336163|RCV001651130	MedGen:CN169374|MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348|MedGen:C3661900	not specified|Fructose-biphosphatase deficiency|not provided	germline	germline	GRCh38	NC_000009.12	9	94606867.0	94606867.0	9q22.32	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA5136172,UniProtKB:P09467#VAR_022212	2.0	256323.0	94606867.0	C	T	-	-	-	-	-	-	653G>A 	Arg218Lys	NM_000507.4	2.0	Benign	Benign	256323	9	94606867.0	C	T	R	K	rs1769259	9	97369149	9	96408970	218	FBP1	ENSG00000165140	ENST00000375326	ENSP00000364475	P09467	F16P1_HUMAN	c.653G>A	p.Arg218Lys	c.653G>A	p.Arg218Lys	principal1	Y	1	YES	Select	-	AGG	2	0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	1.0	0.02944	T	0.0	0.02950	B	0.001	0.04348	B	0.01	0.05039	P	simple_aae	99.0	1.0	-0.16	0.04344	N	0.81	0.02052	N	0.026	0.00518	-0.9434	0.41890	T	0.0000	0.00011	T	9	5.689069e-07	0.00003	T	.	.	.	0.083	0.24023	.	.	.	.	.	.	.	.	0.49472	.	0.31619	0.31260985136	0.12291	T	0.100037	0.40256	T	-0.629968	0.00093	T	-0.625834	0.10488	T	0.00518849848405968	0.00056	T	.	0.06283	.	0.28738895	0.51417	0.16726068	0.38472	0.24188724	0.46781	0.12563594	0.30191	-0.586	0.00640	T	0.0756	0.05824	LB	0.000167660715352055	0.03820	0.00022172	0.03614	0.02	0.02966	.	.	.	.	.	.	1.385568	0.18003	13.48	0.79008328200750977	0.12753	0.259177	0.37555	N	-0.877275818063655	0.11248	0.5491114	-0.650144404301843	0.17922	0.9719528	5.49	1.55	0.22298	2.73	0.49939	0.154	0.16215	1.381000	0.26120	-0.108	0.15302	0.989	0.36837	1.000000	0.68239	0.993	0.69292	834	0.38591	4890	0.9764376996805112	1310	0.9909228441754917	961	0.9552683896620279	684	0.9855907780979827	1008	1.0	927	0.9478527607361963	254672	264690	0.96215194	.	104845	109400	9.583640e-01	50256	199180	208120	9.570440e-01	95370	226571	236822	9.567140e-01	108457	7070	7164	9.868790e-01	3489	16771	17110	9.801870e-01	8222	2231	2320	9.616380e-01	1072	9043	9046	9.996680e-01	4520	12685	13394	9.470660e-01	6001	40308	42762	9.426130e-01	18998	14928	15690	9.514340e-01	7101	9043	9046	9.996680e-01	4520	15992	16218	9.860650e-01	7884	29936	30520	9.808650e-01	14686	5965	6212	9.602380e-01	2862	13414	13416	9.998510e-01	6706	15850	16734	9.471730e-01	7503	84197	89546	9.402650e-01	39592	29188	30608	9.536070e-01	13925	13414	13416	9.998510e-01	6706	14705	14902	9.867800e-01	7255	33570	34256	9.799740e-01	16455	9207	9572	9.618680e-01	4426	17689	17692	9.998300e-01	8843	20438	21630	9.448910e-01	9657	96508	102626	9.403850e-01	45389	29109	30526	9.535810e-01	13887	17689	17692	9.998300e-01	8843	.	1517590	1613876	9.403390e-01	713898	44858	44872	9.996880e-01	22422	74088	75064	9.869980e-01	36558	872	912	9.561400e-01	417	58643	60024	9.769930e-01	28649	28413	29600	9.598990e-01	13635	44858	44872	9.996880e-01	22422	60461	64022	9.443780e-01	28556	5767	6050	9.532230e-01	2747	1098562	1179772	9.311650e-01	511531	86811	91068	9.532550e-01	41420	294974	314302	0.9385050047406635	590	592	0.9966216216216216	4968	4968	1.0	15707	15958	0.9842712119313197	1438	1488	0.9663978494623656	7043	7236	0.9733278054173576	1968	1968	1.0	4991	5222	0.9557640750670241	22586	23720	0.9521922428330523	16297	16550	0.9847129909365558	6936	6936	1.0	354265	375454	0.9435643247907867	not_specified|not_provided|Fructose-biphosphatase_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.94606867C>T	ClinGen:CA5136172|UniProtKB:P09467#VAR_022212	CN169374|C3661900|C0016756	229700	348	.	Arg	Lys	96.14	0.7540322580645161																																																																																																																																																																																																																																																																																																																																																																																																																																																																													187			96.14	Positively-charged	Arginine		Fructose-1,6-bisphosphatase 1										-4.5			D:R218-C:S238 (PDBs: 7EZR)	D:R218-C:F233 (PDBs: 7CVN, 7EZR), B:R218-A:F233 (PDBs: 7EZF, 7EZP, 7EZR)														175									-69.2				-26.9				dbSNP: rs1769259; Variant type: LB/B; AA change: Arg218Lys; PTM type: Phosphorylation; PTM morphology: SLNEGyAR*DFD; Var class: II		C (loop/coil)	T (turn)	Helix											96.14	75.40323	>90	10-90	229700	autosomal recessive	OMIM	Rare inborn errors of metabolism	1	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	false	0.7963832814928037	0.6655997780946777	false	false	false
CDKN1A	CDKN1A_Ser31Arg	B_15-16	-1.951863741646784	0.09191486441456846	0.15319144069094745	2.9543022014995444	0.021276469789578062	0.03331256148794859	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8232941258370075	0.8125683855426573	0.5223005115207557	0.6728407795978396	0.6968084663249834	0.5421466599155451	0.5811869286547093	0.6995938469552494	0.6917773254246434	0.5583026368106505	0.7770022631464996	0.8196027217720429	0.5031063911763808	0.6940230856947175	0.6539042337710358	0.48629838623086097	0.848134507938815	0.8269855299019722	CDKN1A	Ser31Arg	NC_000006.12:36684194:C:A	93C>A	6	36684194	C	A	6	ENSG00000124762	3192	5563	CCSBVarC000413	ALE00000413	ENSP00000244741.6	RC4	RC4_Mut_GDEh1011	G07	GDEhDisVCh_40040	A01	2	RC4_Mut_GDDh1011	G07	NULL	NULL	VUSMutpDEST2_03	A05	VUSmut_GDEh12	H09	1.0	1.0	1.0	99.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	32604.0	single nucleotide variant	NM_000389.5(CDKN1A):c.93C>A (p.Ser31Arg)	1026.0	CDKN1A	HGNC:1784	Benign	0.0	Jul 01, 1996	1801270.0	-	RCV000019125	-	CIP1/WAF1 TUMOR-ASSOCIATED POLYMORPHISM 1	unknown	unknown	GRCh38	NC_000006.12	6	36684194.0	36684194.0	6p21.2	no assertion criteria provided	1.0	-	N	ClinGen:CA127261,UniProtKB:P38936#VAR_011870,OMIM:116899.0001	1.0	17565.0	36684194.0	C	A	-	-	-	-	-	-	93C>A 	Ser31Arg	NM_000389.5		Benign	Benign	17565	6	36684194.0	C	A	S	R	rs1801270	6	36651971	6	36759949	31	CDKN1A	ENSG00000124762	ENST00000448526	ENSP00000409259	P38936	CDN1A_HUMAN	c.93C>A	p.Ser31Arg	c.93C>A	p.Ser31Arg	principal1	Y	3	.	.	+	AGC	3	2	C	C/C	A/A	A/A	C/C	.	0.00968	.	1.0	0.01173	T	0.0	0.02950	B	0.001	0.04348	B	0.02	0.08015	P	simple_aae	98.0	2.0	-1.02	0.01140	N	.	0.01878	.	0.219	0.24343	-1.0753	0.08301	T	0.0775	0.30761	T	9	0.0002681613	0.00010	T	.	.	.	0.244	0.54847	0.117	0.02491	P38936	S31R	Gain of solvent accessibility (P = 0.0766)| Loss of phosphorylation at S31 (P = 0.1721)| Gain of helix (P = 0.1736)| Loss of disorder (P = 0.2313)| Gain of relative solvent accessibility (P = 0.2363)	.	.	.	0.48644	.	0.20633	0.327420920134	0.14532	T	0.04917	0.27974	T	-0.572442	0.00208	T	-0.45123	0.27206	T	0.00709448639025024	0.00080	T	.	0.04912	.	0.19516234	0.40979	0.073066466	0.15826	0.19516234	0.40979	0.073066466	0.15826	-1.335	0.01460	T	.	0.10206	.	0.000454307761092796	0.06484	0.00079351	0.13242	0.025	0.04491	.	.	.	.	.	.	0.210148	0.05961	2.378	0.85452171148624834	0.16142	0.200289	0.32492	N	-1.532948199988	0.01622	0.07157242	-1.45238643684247	0.02710	0.1269908	5.06	-3.6	0.04278	-5.08	0.04365	0.899	0.28143	-0.978000	0.06753	-0.96	0.01991	0.965	0.34008	0.000000	0.08389	0.033	0.13527	808	0.43257	1283	0.25619009584664537	409	0.3093797276853253	67	0.06660039761431412	173	0.24927953890489912	492	0.4880952380952381	142	0.14519427402862986	46359	264690	0.17514451	.	17660	107686	1.639950e-01	2653	32679	206066	1.585850e-01	4768	36781	235058	1.564760e-01	5419	1899	7130	2.663390e-01	240	5913	17064	3.465190e-01	1075	215	2310	9.307360e-02	13	4487	9016	4.976710e-01	1130	671	11922	5.628250e-02	16	2711	42686	6.351030e-02	81	1551	15668	9.899160e-02	91	4487	9016	4.976710e-01	1130	4191	16146	2.595690e-01	523	10998	30440	3.613010e-01	2121	548	6198	8.841560e-02	31	6541	13380	4.888640e-01	1633	855	15258	5.603620e-02	23	5872	89232	6.580600e-02	228	3108	30582	1.016280e-01	171	6541	13380	4.888640e-01	1633	3843	14846	2.588580e-01	478	11929	34182	3.489850e-01	2251	852	9560	8.912130e-02	38	8675	17660	4.912230e-01	2172	1142	20124	5.674820e-02	35	6633	102590	6.465540e-02	237	3096	30502	1.015020e-01	170	8675	17660	4.912230e-01	2172	.	159422	1611622	9.892020e-02	14561	21576	44844	4.811350e-01	5205	18903	75008	2.520130e-01	2337	124	910	1.362640e-01	12	18292	60000	3.048670e-01	3153	2654	29588	8.969850e-02	116	21576	44844	4.811350e-01	5205	3486	61706	5.649370e-02	102	756	6062	1.247110e-01	58	77031	1179930	6.528440e-02	2501	9521	91078	1.045370e-01	552	17070	250862	0.06804537953137582	51	276	0.18478260869565216	2066	4528	0.45627208480565373	1639	8338	0.19656992084432717	170	1026	0.16569200779727095	1094	4172	0.2622243528283797	831	1914	0.4341692789968652	31	286	0.10839160839160839	2846	19340	0.14715615305067217	1690	8614	0.19619224518226144	2897	6442	0.4497050605402049	25798	290742	0.08873159020712522	CIP1/WAF1_TUMOR-ASSOCIATED_POLYMORPHISM_1	no_assertion_criteria_provided	NC_000006.12:g.36684194C>A	ClinGen:CA127261|OMIM:116899.0001|UniProtKB:P38936#VAR_011870	.	.	.	Cyclin-dependent kinase inhibitor domain	Ser	Arg	96.78	0.4307692307692308																																																																																																																																																																																																																																																																																																																																																																																																																																																																													56			96.78	Polar/Neutral	Serine		Cyclin-dependent kinase inhibitor 1										-0.8								 S31-D35 (PAE:  1.0), S31-S27 (PAE: 1.0)	S31-S27 (PDBs: 6P8H)	 S31-D35 (PAE:  1.0), S31-S27 (PAE: 1.0)	S31-D35 (PDBs: 6P8H), S31-S27 (PDBs: 6P8H)							105									-64.0	Morphology: PVDSEQLsRDCDALM; Domain: CDI			-45.5				dbSNP: rs1801270; Variant type: LB/B; AA change: Ser31Arg; PTM type: Phosphorylation; PTM morphology: DSEQLsRDCDA; Var class: I		H (helix)	H (α-helix)	Helix										C4-type	96.78	43.076923	>90	10-90		unknown		Rare genetic endocrine disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3		false	0.8125683855426573	0.8232941258370075	false	false	false
EIF2B4	EIF2B4_Arg306Gly	B_7-8	-0.7878660290915689	0.4664657801149744	0.5530413656235885	-2.675678117519193	0.03173739936588348	0.047386597100403736	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5817448415797049	0.589217700616294	0.48738716920478736	0.521470363785161	0.5477782621889016	0.4842726894313464	0.46904987117752994	0.5799907404963898	0.565227496800483	0.4572577713240421	0.510367083068855	0.5379072389005569	0.4994955076851629	0.5155657838814133	0.47771323076983907	0.5175165670855326	0.6680683181637329	0.6255824442588529	EIF2B4	Arg306Gly	NC_000002.12:27367171:G:C	916C>G	2	27367171	G	C	2	ENSG00000115211	3643	900170	CCSBVarC002896	ALE00002896	ENSP00000233552.6	RC4	NatVar_GDE_001	A03	GDEhDisVCh_40044	C02	2	NULL	NULL	NULL	NULL	VUSMutpDEST2_03	D08	VUSmut_GDEh12	E01	1.0	1.0	0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	134437.0	single nucleotide variant	NM_001034116.2(EIF2B4):c.916C>G (p.Arg306Gly)	8890.0	EIF2B4	HGNC:3260	Benign	0.0	Jan 31, 2024	78599355.0	-	RCV000116972|RCV000288347|RCV000711604	MedGen:CN169374|MONDO:MONDO:0800448,MedGen:C1858991,OMIM:PS603896,Orphanet:135,Orphanet:99853|MedGen:C3661900	not specified|Vanishing white matter disease|not provided	germline	germline	GRCh38	NC_000002.12	2	27367171.0	27367171.0	2p23.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA152722	2.0	128990.0	27367171.0	G	C	-	-	-	-	-	-	916C>G 	Arg306Gly	NM_001034116.2	2.0	Benign	Benign	128990	2	27367171.0	G	C	R	G	rs78599355	2	27590038	2	27443542	306	EIF2B4	ENSG00000115211	ENST00000347454	ENSP00000233552	Q9UI10	EI2BD_HUMAN	c.916C>G	p.Arg306Gly	c.916C>G	p.Arg306Gly	principal4	Y	1	YES	Select	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.109	0.30095	T	0.342	0.18151	T	0.009	0.27666	B	0.049	0.31372	B	0.05	0.16373	P	simple_aae	95.0	5.0	1.04	0.26055	L	-1.92	0.44664	N	0.186	0.20131	-0.4867	0.68988	T	0.3843	0.73908	T	10	0.006406039	0.00142	T	.	.	.	0.264	0.57533	.	.	.	.	.	.	.	.	0.40539	.	0.44189	0.309570521116	0.11833	T	0.682081	0.90581	D	-0.265006	0.12067	T	-0.132489	0.60486	T	0.00420616035412261	0.00044	T	0.684832	0.29080	T	0.23651697	0.46175	0.19392823	0.42839	0.2659075	0.49329	0.20280847	0.44168	-6.0	0.47192	T	0.0797	0.09768	B	0.067244613389917	0.39771	0.12252675	0.68510	0.021	0.03256	.	.	.	.	.	.	1.514602	0.19481	14.27	0.92718444247533782	0.22465	0.264071	0.37946	N	-0.588034751454882	0.19072	1.009445	-0.592809166801589	0.19378	1.05694	5.97	3.18	0.35537	3.0	0.54868	0.641	0.24498	1.754000	0.28583	0.676	0.76753	0.035	0.20792	0.051000	0.21899	0.801	0.3781	321	0.86960	37	0.007388178913738019	3	0.0022692889561270802	28	0.027833001988071572	4	0.005763688760806916	0	0.0	2	0.002044989775051125	3636	264690	0.0137368245	.	1704	109392	1.557700e-02	23	3158	208118	1.517410e-02	36	3643	236938	1.537530e-02	46	36	7164	5.025130e-03	0	87	17112	5.084150e-03	1	31	2320	1.336210e-02	0	3	9034	3.320790e-04	0	462	13390	3.450340e-02	10	1018	42768	2.380280e-02	9	30	15690	1.912050e-03	1	1018	42768	2.380280e-02	9	73	16218	4.501170e-03	0	163	30524	5.340060e-03	2	61	6212	9.819700e-03	0	2	13402	1.492310e-04	0	570	16730	3.407050e-02	10	2141	89558	2.390630e-02	18	66	30608	2.156300e-03	3	2141	89558	2.390630e-02	18	64	14902	4.294730e-03	0	189	34260	5.516640e-03	2	88	9572	9.193480e-03	0	3	17678	1.697020e-04	0	732	21628	3.384500e-02	14	2401	102752	2.336690e-02	24	66	30526	2.162090e-03	3	2401	102752	2.336690e-02	24	.	37110	1614070	2.299160e-02	539	2255	64020	3.522340e-02	47	302	75018	4.025700e-03	0	0	912	0.000000e+00	0	401	60002	6.683110e-03	5	285	29608	9.625780e-03	0	3	44878	6.684790e-05	0	2255	64020	3.522340e-02	47	12	6062	1.979540e-03	0	32374	1180008	2.743540e-02	462	208	91056	2.284310e-03	8	2137	96788	0.022079183369839238	0	174	0	0	2674	0	19	4198	0.004525964745116722	2	794	0.0025188916876574307	3	956	0.0031380753138075313	0	654	0	0	274	0	146	8066	0.018100669476816267	19	4372	0.00434583714547118	0	3328	0	2307	114578	0.020134755363158723	Vanishing_white_matter_disease|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.27367171G>C	ClinGen:CA152722	C1858991|CN169374|C3661900	PS603896	135|99853	.	Arg	Gly	97.1	0.4637096774193548																																																																																																																																																																																																																																																																																																																																																																																																																																																																													115			97.1	Positively-charged	Arginine		Translation initiation factor eIF2B subunit delta										-4.5								 R306-A302 (PAE:  1.0), R306-E310 (PAE: 1.0)	R306-E310 (PDBs: 6CAJ, 6EZO, 6K71, 6K72, 6O81, 6O85, 6O9Z, 7D43, 7D44, 7D45, 7D46, 7F64, 7F66, 7F67, 7KMF, 7L70, 7L7G, 7RLO, 7TRJ, 7VLK, 8TQO), R306-A302 (PDBs: 8TQO)	 R306-A302 (PAE:  1.0), R306-E310 (PAE: 1.0)	R306-E310 (PDBs: 6CAJ, 6EZO, 6K71, 6K72, 6O81, 6O85, 6O9Z, 7D43, 7D44, 7D45, 7D46, 7F64, 7F66, 7F67, 7KMF, 7L70, 7L7G, 7RLO, 7TRJ, 7VLK, 8TQO), R306-A302 (PDBs: 8TQO)		R306-E299 (PDBs: 7D44)					175									-57.5				-45.8						H (helix)	H (α-helix)	Helix											97.1	46.370968	>90	10-90		unknown		Rare genetic neurological disorder	1		false	0.589217700616294	0.5817448415797049	false	false	false
KRT8	KRT8_Tyr54His	B_7-8	-12.630864580203795	0.0010701815564362407	0.005011433491727018	-4.006232852977928	0.005148914896614037	0.00963125263535857	2024_01_Batch_7-8	true	true	false	false	false	false	true	false	false	false	false	false	0.9898335495163788	0.9682829129139544	0.7263107240241014	0.7297669536865752	0.6471007467835408	0.7505249602095232	0.7505249602095232	0.6830183530609305	0.8077745231487149	0.7263107240241014	0.9921383396709584	0.9898335495163788		0.611183140506151	0.6517593842244356		0.9444274861569504		KRT8	Tyr54His	NC_000012.12:52904822:A:G	160T>C	12	52904822	A	G	12	ENSG00000170421	14966	218511	CCSBVarC004264	ALE00004264	ENSP00000509398.1	CEGS2	CegsMutGDEh1037	C05	GDEhDisVCh_40069	B07	1	CegsMutGDDh1037	C05	VUSN2Hmut_GDN2h_07	H07	VUSMutpDEST2_11	E10	VUSmut_GDEh07	H07	1.0	1.0	1.0	1.0	1.0	7.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	29670.0	single nucleotide variant	NM_002273.4(KRT8):c.160T>C (p.Tyr54His)	3856.0	KRT8	HGNC:6446	Benign	0.0	Aug 22, 2023	57749775.0	-	RCV000015737|RCV000056936|RCV000988859|RCV001777139	MedGen:C0267809|MedGen:C3661900|MONDO:MONDO:0012292,MedGen:C1835407,OMIM:609532|MedGen:CN169374	Cirrhosis, cryptogenic|not provided|Hepatitis C virus, susceptibility to|not specified	germline	germline	GRCh38	NC_000012.12	12	52904822.0	52904822.0	12q13.13	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA124165,OMIM:148060.0002	3.0	14631.0	52904822.0	A	G	-	-	-	-	-	-	160T>C 	Tyr54His	NM_002273.4	2.0	Benign	Benign	14631	12	52904822.0	A	G	Y	H	rs57749775	12	53298606	12	51584873	54	KRT8	ENSG00000170421	ENST00000552551	ENSP00000447566	P05787	K2C8_HUMAN	c.160T>C	p.Tyr54His	c.160T>C	p.Tyr54His	principal2	Y	2	.	.	-	TAT	1	0	A	./.	./.	./.	./.	0.045	0.46288	D	0.063	0.55281	T	0.007	0.14196	B	0.027	0.21085	B	0.06	0.18971	N	simple_aae	94.0	6.0	2.88	0.83286	M	-3.22	0.65311	D	0.738	0.73708	-0.5035	0.68383	T	0.4669	0.79344	T	10	0.06538835	0.08782	T	.	.	.	0.337	0.65734	.	.	.	.	.	0.870451544205	0.86818	.	0.56133	.	0.62352	0.438689947128	0.30360	T	0.657778	0.89588	D	-0.290225	0.09389	T	-0.171411	0.57018	T	0.0427036682072286	0.04147	T	.	0.00338	.	0.1692296	0.37125	0.1920497	0.42549	0.15894334	0.35438	0.2848964	0.54279	-9.452	0.70640	D	.	0.66383	.	0.00741825461063942	0.21673	0.97431666	0.95002	0.127	0.34041	.	.	.	.	.	.	1.793196	0.22833	15.76	0.79957597843107564	0.13188	0.766413	0.70151	D	-0.752156761913448	0.14397	0.7271627	-0.846119051030525	0.13150	0.6938359	4.59	2.12	0.26302	3.3	0.59857	0.392	0.20602	.	.	-0.064	0.1661	0.002	0.15293	0.370000	0.24642	0.001	0.02614	623	0.65761	34	0.006789137380191693	33	0.024962178517397883	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	1899	264690	0.0071744304	segdup	217	109248	1.986310e-03	8	412	205252	2.007290e-03	9	391	234400	1.668090e-03	9	188	7140	2.633050e-02	8	22	17096	1.286850e-03	0	0	2308	0.000000e+00	0	0	9016	0.000000e+00	0	0	13386	0.000000e+00	0	5	42712	1.170630e-04	0	0	15676	0.000000e+00	0	188	7140	2.633050e-02	8	351	15316	2.291720e-02	9	48	30482	1.574700e-03	0	0	6098	0.000000e+00	0	0	13356	0.000000e+00	0	0	16720	0.000000e+00	0	8	87868	9.104570e-05	0	1	30588	3.269260e-05	0	351	15316	2.291720e-02	9	325	14026	2.317130e-02	9	53	34236	1.548080e-03	0	0	9478	0.000000e+00	0	0	17662	0.000000e+00	0	0	21618	0.000000e+00	0	7	101288	6.910990e-05	0	1	30506	3.278040e-05	0	325	14026	2.317130e-02	9	.	1957	1612398	1.213720e-03	19	1686	74988	2.248360e-02	19	1686	74988	2.248360e-02	19	0	912	0.000000e+00	0	119	60012	1.982940e-03	0	0	29590	0.000000e+00	0	0	44858	0.000000e+00	0	0	63336	0.000000e+00	0	7	5324	1.314800e-03	0	43	1179954	3.644210e-05	0	6	91012	6.592540e-05	0	2	48766	4.101218061764344E-5	8	306	0.026143790849673203	0	112	0	149	8470	0.017591499409681226	1	500	0.002	0	628	0	0	56	0	0	98	0	17	8748	0.0019433013260173753	157	8776	0.017889699179580675	0	168	0	177	67684	0.002615093670586845	not_specified|not_provided|Hepatitis_C_virus,_susceptibility_to|Cirrhosis,_cryptogenic	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.52904822A>G	ClinGen:CA124165|OMIM:148060.0002	CN169374|C3661900|C1835407|C0267809	609532	.	Keratin type II head	Tyr	His	28.51	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													228			31.42	Aromatic	Tyrosine		Keratin, type II cytoskeletal 8										-1.3																		181									78.1	Morphology: rGGLGGGyGGAsGMG; Domain: Keratin_2_head			81.5	Head			dbSNP: -; Variant type: LP/P; AA change: Tyr54Cys; PTM type: Phosphorylation; PTM morphology: GLGGGyGGAsG; Var class: I&-		C (loop/coil)	C (loop/coil)	Beta strand											28.51	100.0	$\leqslant$50	$\geqslant$90	609532	unknown			0	HEPATITIS C VIRUS, SUSCEPTIBILITY TO	false	0.9682829129139544	0.9898335495163788	true	true	false
GLYCTK	GLYCTK_His490Tyr	B_7-8	-1.7341152311950354	0.22503443126421827	0.30570111217258666	-3.3084757134363687	0.08048259120125527	0.10827386719523711	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.691932629155731	0.7305171924254753	0.41417956167397313	0.6332426081018588	0.5155232840788523	0.49773347192827694	0.49773347192827694	0.5155232840788523	0.6332426081018588	0.41417956167397313	0.7305171924254753	0.691932629155731							GLYCTK	His490Tyr	NC_000003.12:52293022:C:T	1468C>T	3	52293022	C	T	3	ENSG00000168237	13554	2231	CCSBVarC008486	ALE00008443	ENSP00000389175.2	Edgotyping3	VUSmut_GDEh11	H02	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh11	H02	0.0		0.0		0.0			0.0			1.0	1.0	1.0	Y	N	N	N	Y	708959.0	single nucleotide variant	NM_145262.4(GLYCTK):c.1468C>T (p.His490Tyr)	132158.0	GLYCTK	HGNC:24247	Benign	0.0	Jan 02, 2024	78388149.0	-	RCV000974981	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000003.12	3	52293022.0	52293022.0	3p21.2	criteria provided, multiple submitters, no conflicts	2.0	-	N	-	2.0	791925.0	52293022.0	C	T	-	-	-	-	-	-	1468C>T 	His490Tyr	NM_145262.4	2.0	Benign	Benign	791925	3	52293022.0	C	T	H	Y	rs78388149	3	52327038	3	52302078	490	GLYCTK	ENSG00000168237	ENST00000436784	ENSP00000389175	Q8IVS8	GLCTK_HUMAN	c.1468C>T	p.His490Tyr	c.1468C>T	p.His490Tyr	principal1	Y	1	YES	Select	+	CAT	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.001	0.04348	B	0.02	0.08015	N	simple_aae	98.0	2.0	-0.55	0.02423	N	3.11	0.00124	N	0.136	0.13276	-1.0519	0.13875	T	0.0176	0.07218	T	9	0.003324926	0.00056	T	.	.	.	0.051	0.14197	.	.	.	.	.	0.307966526162	0.30003	0.672555757748004	0.67032	0.120016260902	0.13270	0.438631564379	0.30353	T	0.152253	0.48987	T	-0.635463	0.00086	T	-0.670639	0.07357	T	0.000739990495429504	0.00007	T	0.882912	0.60360	D	0.06555971	0.13895	0.044208884	0.05691	0.053370655	0.09997	0.046687	0.06577	-1.099	0.01117	T	0.0547	0.00373	B	0.00679795671406606	0.21031	0.00256377	0.25581	0.016	0.01897	.	.	.	.	.	.	0.593335	0.09646	6.391	0.47509894889950383	0.03931	0.295890	0.40392	N	-1.04483682427297	0.07597	0.3580546	-0.912151203717144	0.11603	0.603767	5.22	-0.473	0.11477	-1.29	0.14417	1.217	0.32162	0.368000	0.17716	-0.202	0.08747	0.751	0.29235	0.026000	0.21129	0.906	0.44196	85	0.96453	25	0.0049920127795527154	22	0.01664145234493192	0	0.0	3	0.004322766570605188	0	0.0	0	0.0	1630	264690	0.0061581475	.	150	109372	1.371470e-03	0	315	208028	1.514220e-03	1	302	236806	1.275310e-03	1	135	7164	1.884420e-02	0	13	17102	7.601450e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13368	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	135	7164	1.884420e-02	0	288	16206	1.777120e-02	1	21	30510	6.882990e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16708	0.000000e+00	0	2	89506	2.234490e-05	0	0	30608	0.000000e+00	0	288	16206	1.777120e-02	1	274	14902	1.838680e-02	1	23	34244	6.716510e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21598	0.000000e+00	0	2	102654	1.948290e-05	0	0	30524	0.000000e+00	0	274	14902	1.838680e-02	1	.	1625	1614212	1.006680e-03	11	1444	75068	1.923590e-02	9	1444	75068	1.923590e-02	9	0	912	0.000000e+00	0	72	60026	1.199480e-03	0	0	29604	0.000000e+00	0	0	44888	0.000000e+00	0	0	64016	0.000000e+00	0	3	6062	4.948860e-04	0	16	1180042	1.355880e-05	0	3	91084	3.293660e-05	0	7	190424	3.6760072259799185E-5	11	370	0.02972972972972973	0	4532	0	194	9930	0.019536757301107755	4	822	0.004866180048661801	0	1076	0	0	1854	0	0	312	0	17	20228	8.404192208819458E-4	205	10300	0.019902912621359223	0	6386	0	233	229548	0.0010150382490808022	not_provided	criteria_provided,_single_submitter	NC_000003.12:g.52293022C>T	.	C3661900	.	.	MOFRL domain	His	Tyr	98.56	0.11956521739130435																																																																																																																																																																																																																																																																																																																																																																																																																																																																													22			98.56	Positively-charged	Histidine		Glycerate kinase										-3.2								 H490-C494 (PAE:  1.0), H490-Q424 (PAE: 1.0), H490-R419 (PAE: 1.0)		 H490-T458 (PAE:  1.0), H490-Q424 (PAE: 1.0), H490-C494 (PAE: 1.0), H490-R419 (PAE: 1.0)								155									-66.7				-48.8						H (helix)	H (α-helix)												98.56	11.956522	>90	10-90		unknown		Rare inborn errors of metabolism	1		false	0.7305171924254753	0.691932629155731	false	false	false
CTH	CTH_Ser403Ile	B_15-16	2.4805173069271156	0.04217814902743756	0.08104654390584078	-1.0324355038214075	0.3362136471243005	0.3894899258037194	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6278378759565356	0.6378563116683154	0.6668242124242192	0.7105515011099106	0.7915265786691361	0.6849687323581269	0.741425027729018	0.7687356486668272	0.6907966859223726	0.7148744242629899	0.6134827056992218	0.6180481211420994	0.6285124369872359	0.8143175086714451	0.7303063162974487	0.6187740005854485	0.6622299176374088	0.6376276307709718	CTH	Ser403Ile	NC_000001.11:70439117:G:T	1208G>T	1	70439117	G	T	1	ENSG00000116761	268	715	CCSBVarC000021	ALE00000021	ENSP00000359976.3	RC4	RC4_Mut_GDEh1008	G11	GDEhDisVCh_40012	C12	2	RC4_Mut_GDDh1008	G11	NULL	NULL	NULL	NULL	VUSmut_GDEh12	C09	1.0	1.0	1.0	1.0	0.0			0.0			1.0	1.0	99.0	Y	Y	N	N	Y	17980.0	single nucleotide variant	NM_001902.6(CTH):c.1208G>T (p.Ser403Ile)	1491.0	CTH	HGNC:2501	Benign	0.0	Apr 11, 2023	1021737.0	-	RCV000003075|RCV000331590|RCV003974791|RCV004713165	MedGen:C4551332|Human Phenotype Ontology:HP:0003153,MONDO:MONDO:0009058,MedGen:C0220993,OMIM:219500,Orphanet:212||MedGen:C3661900	Homocysteine level elevated|Cystathioninuria|CTH-related disorder|not provided	germline	germline	GRCh38	NC_000001.11	1	70439117.0	70439117.0	1p31.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA115891,UniProtKB:P32929#VAR_015452,OMIM:607657.0005	3.0	2941.0	70439117.0	G	T	-	-	-	-	-	-	1208G>T 	Ser403Ile	NM_001902.6	2.0	Benign	Benign	2941	1	70439117.0	G	T	S	I	rs1021737	1	70904800	1	70677388	403	CTH	ENSG00000116761	ENST00000370938	ENSP00000359976	P32929	CGL_HUMAN	c.1208G>T	p.Ser403Ile	c.1208G>T	p.Ser403Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.098	0.37477	T	0.103	0.38646	T	0.232	0.33530	B	0.102	0.37139	B	0.01	0.05039	P	simple_aae	99.0	1.0	0.695	0.17891	N	-0.2	0.10073	N	0.084	0.24219	-1.0949	0.04780	T	0.0730	0.29360	T	9	0.0007174313	0.00011	T	.	.	.	0.120	0.33155	.	.	.	.	.	.	.	0.4677656025613904	0.46497	0.181871657853	0.20176	0.330711066723	0.15029	T	0.026006	0.19163	T	-0.526906	0.00386	T	-0.38582	0.34680	T	0.00264129625450673	0.00027	T	0.564644	0.19642	T	0.049042515	0.08566	0.063107714	0.12454	0.048627906	0.08426	0.05772718	0.10552	-5.047	0.39372	T	0.0947	0.14905	B	0.0289965585835928	0.32532	0.00011977	0.01318	0.122	0.32993	.	.	.	.	.	.	1.838142	0.23397	15.98	0.87943144389930894	0.17847	0.234468	0.35515	N	-1.04079871627377	0.07676	0.3620399	-1.06275517033058	0.08303	0.4151601	4.79	0.838	0.17993	-0.345	0.19320	0.084	0.14782	0.233000	0.16282	-0.135	0.12819	0.001	0.13799	0.000000	0.08389	0.121	0.19252	602	0.67811	1028	0.20527156549520767	83	0.06278366111951589	260	0.2584493041749503	257	0.3703170028818444	219	0.21726190476190477	209	0.21370143149284254	63793	264690	0.24101023	.	31169	109370	2.849870e-01	4871	59325	208010	2.852030e-01	9397	67596	236562	2.857430e-01	10668	674	7160	9.413410e-02	32	7469	17100	4.367840e-01	1662	648	2320	2.793100e-01	96	1921	9046	2.123590e-01	207	3702	13392	2.764340e-01	510	12458	42752	2.914020e-01	1818	3764	15686	2.399590e-01	469	7469	17100	4.367840e-01	1662	1592	16210	9.821100e-02	84	13632	30504	4.468920e-01	3114	1734	6210	2.792270e-01	245	2912	13410	2.171510e-01	318	4681	16730	2.797970e-01	654	26014	89492	2.906850e-01	3838	7407	30596	2.420900e-01	941	13632	30504	4.468920e-01	3114	1447	14896	9.714020e-02	74	15037	34240	4.391650e-01	3393	2602	9562	2.721190e-01	372	3702	17692	2.092470e-01	397	6080	21628	2.811170e-01	858	29741	102428	2.903600e-01	4390	7386	30514	2.420530e-01	938	15037	34240	4.391650e-01	3393	.	450391	1608522	2.800030e-01	66116	24008	59966	4.003600e-01	5031	7352	74918	9.813400e-02	369	291	912	3.190790e-01	59	24008	59966	4.003600e-01	5031	7890	29560	2.669150e-01	1070	10513	44822	2.345500e-01	1269	18239	63940	2.852520e-01	2613	1275	6054	2.106050e-01	145	342321	1175082	2.913170e-01	50446	21708	90966	2.386390e-01	2801	86503	302622	0.28584504761715934	25	396	0.06313131313131314	1087	4922	0.2208451848841934	1004	10898	0.09212699577904203	294	1366	0.21522693997071743	968	2758	0.3509789702683104	418	1948	0.21457905544147843	1254	5182	0.2419915090698572	5923	22140	0.2675248419150858	1029	11294	0.09111032406587569	1505	6870	0.2190684133915575	97476	352232	0.27673805900656384	Cystathioninuria|Homocysteine_level_elevated|CTH-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.70439117G>T	ClinGen:CA115891|OMIM:607657.0005|UniProtKB:P32929#VAR_015452	C0220993|C4551332	219500	212	.	Ser	Ile	52.26	0.47692307692307695																																																																																																																																																																																																																																																																																																																																																																																																																																																																													62			52.26	Polar/Neutral	Serine		Cystathionine gamma-lyase										-0.8										 S403-P399 (PAE:  10.0)								105									-92.1				3.8						C (loop/coil)	C (loop/coil)												52.26	47.692307	50-70	10-90	219500	autosomal recessive	OMIM	Rare inborn errors of metabolism	1	CYSTATHIONINURIA	false	0.6378563116683154	0.6278378759565356	false	false	false
SFTPA2	SFTPA2_Gln223Lys	B_15-16	1.2604983565750476	0.24787927364655718	0.33154720774854635	-9.1375794430513	0.00003864480139332366	0.00019752983441991343	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.9065889079050332	0.9143101822234698	0.6277004773101398	0.6566434961770282	0.7963288216393819	0.560581185853662	0.7101261929899393	0.8503939234138833	0.7109480473475012	0.6806765512367215	0.8601367993337637	0.8570455833016659	0.4110361787173846	0.7422637198648805	0.6023389450065554	0.5747244033835581	0.9684835651131758	0.9561322325084005	SFTPA2	Gln223Lys	NC_000010.11:79557289:G:T	667C>A	10	79557289	G	T	10	ENSG00000185303	56023	31343	CCSBVarC002522	ALE00002522	ENSP00000361400.2	RC4	RC4_Mut_GDEh1013	F06	GDEhDisVCh_40043	F05	1	RC4_Mut_GDDh1013	F06	NULL	NULL	VUSMutpDEST2_13	E07	VUSmut_GDEh12	A11	1.0	2.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	99.0	99.0	Y	Y	N	Y	Y	229920.0	single nucleotide variant	NM_001098668.4(SFTPA2):c.667C>A (p.Gln223Lys)	729238.0	SFTPA2	HGNC:10799	Benign	0.0	Jul 15, 2021	1965708.0	-	RCV000219264|RCV001610530|RCV001807144	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0800029,MedGen:C5561926,OMIM:178500,Orphanet:2032,Orphanet:79126	not specified|not provided|Interstitial lung disease 2	germline	germline	GRCh38	NC_000010.11	10	79557289.0	79557289.0	10q22.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA5573983	2.0	227071.0	79557289.0	G	T	-	-	-	-	-	-	667C>A 	Gln223Lys	NM_001098668.4	2.0	Benign	Benign	227071	10	79557289.0	G	T	Q	K	rs1965708	10	81317045	10	80987051	223	SFTPA2	ENSG00000185303	ENST00000372327	ENSP00000361402	Q8IWL1	SFPA2_HUMAN	c.667C>A	p.Gln223Lys	c.667C>A	p.Gln223Lys	principal1	Y	1	.	.	-	CAG	1	0	G	./.	./.	./.	./.	1.0	0.00968	T	1.0	0.01173	T	.	.	.	.	.	.	0.05	0.16373	P	simple_aae	95.0	5.0	-0.99	0.01188	N	0.13	0.05476	N	0.034	0.01905	-0.9033	0.47439	T	0.0000	0.00011	T	9	0.0025300682	0.00037	T	.	.	.	0.014	0.01935	.	.	.	.	.	.	.	.	0.49356	.	0.82556	0.373376876116	0.21293	T	0.011807	0.10427	T	-0.883762	0.00001	T	-0.898419	0.00456	T	0.00306212132245863	0.00032	T	.	.	.	.	.	.	.	.	.	.	.	-4.523	0.31223	T	0.0595	0.01091	B	.	.	0.05875130	0.61184	0	0.00000	.	.	.	.	.	.	-0.426344	0.02121	0.2	0.3046960941358518	0.01667	0.023448	0.01291	N	-1.57569216816385	0.01378	0.06060803	-1.55187554012821	0.01938	0.08963443	2.81	-3.22	0.04807	.	.	-0.945	0.04023	0.284000	0.16868	-0.606	0.04604	0.002	0.15293	0.000000	0.08389	0.018	0.11182	649	0.63066	1276	0.2547923322683706	524	0.39636913767019666	203	0.20178926441351888	96	0.138328530259366	204	0.20238095238095238	249	0.254601226993865	65721	264690	0.24829423	segdup	23665	109392	2.163320e-01	2823	45691	208070	2.195940e-01	5604	51356	236876	2.168050e-01	6130	2692	7164	3.757680e-01	507	2229	17100	1.303510e-01	170	716	2320	3.086210e-01	97	1786	9046	1.974350e-01	155	2836	13394	2.117370e-01	351	8522	42766	1.992700e-01	862	4526	15690	2.884640e-01	639	2692	7164	3.757680e-01	507	6041	16216	3.725330e-01	1119	3902	30498	1.279430e-01	285	1912	6212	3.077910e-01	270	2555	13416	1.904440e-01	223	3566	16734	2.130990e-01	424	17997	89534	2.010070e-01	1884	8745	30600	2.857840e-01	1277	6041	16216	3.725330e-01	1119	5560	14900	3.731540e-01	1023	4477	34232	1.307840e-01	328	2938	9568	3.070650e-01	428	3414	17692	1.929690e-01	310	4584	21632	2.119080e-01	541	20546	102718	2.000230e-01	2100	8724	30520	2.858450e-01	1274	5560	14900	3.731540e-01	1023	.	339954	1613734	2.106630e-01	38163	28195	74836	3.767570e-01	5245	28195	74836	3.767570e-01	5245	123	910	1.351650e-01	5	8649	59986	1.441840e-01	664	9134	29608	3.084980e-01	1416	8738	44878	1.947060e-01	859	13654	63954	2.134970e-01	1553	1931	6062	3.185420e-01	324	229773	1179926	1.947350e-01	22605	26185	91068	2.875320e-01	3972	9470	43500	0.21770114942528734	53	122	0.4344262295081967	24	112	0.21428571428571427	1187	3450	0.34405797101449276	125	500	0.25	94	628	0.14968152866242038	7	56	0.125	23	98	0.23469387755102042	1755	7332	0.2393617021276596	1240	3572	0.3471444568868981	31	168	0.18452380952380953	12738	55798	0.22828775224918457	not_provided|Interstitial_lung_disease_2|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.79557289G>T	ClinGen:CA5573983	C3661900|C5561926|CN169374	178500	2032|79126	C-type lectin-like|C-type lectin-like|C-type lectin-like|Collectin, C-type lectin-like domain	Gln	Lys	96.01	0.5808080808080808																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	Polar/Neutral	Glutamine		Pulmonary surfactant-associated protein A2							C-type lectin			-3.5																		146																																96.01	58.08081	>90	10-90	178500	autosomal dominant	OMIM		0	INTERSTITIAL LUNG DISEASE 2	false	0.9143101822234698	0.9065889079050332	false	false	false
KRT6A	KRT6A_Val523Phe	B_7-8	-2.3698270611154175	0.07683540953419025	0.13197448939775486	2.1215449402634508	0.07155806402336347	0.097482589074144	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6329730679119366	0.6304673289619089	0.8839680467407419	0.6829956996533125	0.745690251063132	0.9168383514572737	0.9168383514572737	0.8888784316224331	0.9134505846153935	0.8839680467407419	0.6965923172312058	0.6544068614612575		0.6025020705038311	0.4525408146912316		0.5643423406926119	0.6115392743626158	KRT6A	Val523Phe	NC_000012.12:52487848:C:A	1567G>T	12	52487848	C	A	12	ENSG00000205420	4870	900200	CCSBVarC002920	ALE00002920	ENSP00000369317.3	RC4	NatVar_GDE_001	A06	GDEhDisVCh_40048	B11	2	NULL	NULL	NULL	NULL	VUSMutpDEST2_04	G11	VUSmut_GDEh12	H02	1.0	1.0	0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	1610223.0	single nucleotide variant	NM_005554.4(KRT6A):c.1567G>T (p.Val523Phe)	3853.0	KRT6A	HGNC:6443	Benign	0.0	Jan 22, 2024	62617088.0	-	RCV002136740	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000012.12	12	52487848.0	52487848.0	12q13.13	criteria provided, multiple submitters, no conflicts	2.0	-	N	-	2.0	1601017.0	52487848.0	C	A	-	-	-	-	-	-	1567G>T 	Val523Phe	NM_005554.4	2.0	Benign	Benign	1601017	12	52487848.0	C	A	V	F	rs62617088	12	52881632	12	51167899	523	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.1567G>T	p.Val523Phe	c.1567G>T	p.Val523Phe	principal1	Y	1	YES	Select	-	GTT	1	0	.	./.	./.	./.	./.	0.694	0.04276	T	0.703	0.05756	T	0.0	0.02950	B	0.001	0.04348	B	0.0	0.01751	P	simple_aae	100.0	0.0	0.75	0.18917	N	-0.83	0.22672	N	0.088	0.06571	-1.1086	0.03205	T	0.0003	0.00112	T	9	0.0022658408	0.00032	T	.	.	.	0.129	0.35107	.	.	.	.	.	.	.	0.3767624892885451	0.37388	0.369988861418	0.38244	0.54864525795	0.45601	T	0.136606	0.46613	T	-0.632333	0.00090	T	-0.537259	0.18256	T	0.000667951612823512	0.00006	T	0.150285	0.01299	T	0.04688494	0.07847	0.045893483	0.06293	0.04688494	0.07846	0.045893483	0.06293	-4.293	0.28107	T	0.0773	0.06600	B	0.017268210286986	0.28251	0.00496005	0.33108	0.034	0.07526	.	.	.	.	.	.	0.801324	0.11742	8.298	0.18927699362560269	0.00612	0.055631	0.10062	N	-1.33894299117966	0.03206	0.1444433	-1.36469947585274	0.03582	0.1699927	5.07	-1.01	0.09622	-2.33	0.10489	-2.315	0.01204	.	.	-0.379	0.05411	0.0	0.06393	0.000000	0.08389	0.04	0.14302	734	0.53826	485	0.09684504792332269	350	0.264750378214826	10	0.009940357852882704	54	0.07780979827089338	56	0.05555555555555555	15	0.015337423312883436	22082	264690	0.083425894	segdup	3910	109378	3.574760e-02	252	7870	208058	3.782600e-02	527	8193	236714	3.461140e-02	509	1572	7156	2.196760e-01	181	1294	17110	7.562830e-02	53	28	2320	1.206900e-02	1	427	9038	4.724500e-02	11	9	13394	6.719430e-04	0	245	42766	5.728850e-03	0	287	15680	1.830360e-02	3	1572	7156	2.196760e-01	181	3508	16176	2.168640e-01	395	2334	30514	7.648950e-02	97	59	6212	9.497750e-03	1	665	13408	4.959730e-02	18	9	16734	5.378270e-04	0	606	89550	6.767170e-03	2	556	30598	1.817110e-02	8	3508	16176	2.168640e-01	395	3245	14858	2.184010e-01	367	2592	34250	7.567880e-02	105	98	9572	1.023820e-02	1	863	17684	4.880120e-02	20	12	21632	5.547340e-04	0	689	102586	6.716320e-03	3	556	30516	1.822000e-02	8	3245	14858	2.184010e-01	367	.	32953	1613990	2.041710e-02	2129	16246	75016	2.165670e-01	1775	16246	75016	2.165670e-01	1775	2	912	2.192980e-03	0	4576	60024	7.623620e-02	194	283	29604	9.559520e-03	1	1769	44876	3.941970e-02	49	44	64048	6.869850e-04	0	211	6058	3.483000e-02	5	6426	1179886	5.446290e-03	23	1695	91074	1.861120e-02	28	80	20154	0.003969435347821773	3	78	0.038461538461538464	0	106	0	56	2342	0.02391118701964133	0	124	0	0	540	0	1	54	0.018518518518518517	0	98	0	41	2720	0.015073529411764706	59	2420	0.024380165289256198	1	160	0.00625	181	26216	0.006904180653036314	not_provided	criteria_provided,_single_submitter	NC_000012.12:g.52487848C>A	.	C3661900	.	.	.	Val	Phe	30.21	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													149			30.21	Aliphatic	Valine		Keratin, type II cytoskeletal 6A										4.2																		117									44.0				120.6	Tail					C (loop/coil)	C (loop/coil)												30.21	100.0	$\leqslant$50	$\geqslant$90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2		false	0.6304673289619089	0.6329730679119366	false	false	false
AGXT	AGXT_Asn22Ser	B_7-8	-0.11440360668710005	0.9121301690423005	0.934639819136692	2.2853521575539615	0.05619117103683032	0.07865049492950697	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7035846901626063	0.7452353355741234	0.682582874703447	0.8424825590752274	0.6392142702101007	0.761784028011721	0.8588435186064844	0.7647370826680692	0.8937926569612701	0.7552690369570395	0.8714672488183861	0.8631518827025204	0.6647245374169574	0.5136914577521322	0.7911724611891847	0.6098967124498546	0.6190034223298606	0.5440174976226921	AGXT	Asn22Ser	NC_000002.12:240868930:A:G	65A>G	2	240868930	A	G	2	ENSG00000172482	70497	3786	CCSBVarC008160	ALE00008146	ENSP00000302620.3	Edgotyping3	VUSMutGDEh003	F11	GDEhDisVCh_40002	G01	2	VUSMutGDDh003	F11	VUSN2Hmut_GDN2h_01	G05	VUSMutpDEST2_14	B01	VUSmut_GDEh01	G05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200427.0	single nucleotide variant	NM_000030.3(AGXT):c.65A>G (p.Asn22Ser)	189.0	AGXT	HGNC:341	Benign	0.0	Jan 31, 2024	34885252.0	-	RCV000186222|RCV000280164|RCV001513320	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN169374|MedGen:C3661900	Primary hyperoxaluria, type I|not specified|not provided	germline	germline	GRCh38	NC_000002.12	2	240868930.0	240868930.0	2q37.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA275548,UniProtKB:P21549#VAR_048236	2.0	204020.0	240868930.0	A	G	-	-	-	-	-	-	65A>G 	Asn22Ser	NM_000030.3	2.0	Benign	Benign	204020	2	240868930.0	A	G	N	S	rs34885252	2	241808347	2	241457020	22	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.65A>G	p.Asn22Ser	c.65A>G	p.Asn22Ser	principal1	Y	1	YES	Select	+	AAC	2	0	A	G/G	G/G	G/G	G/G	0.906	0.02400	T	0.855	0.03512	T	0.0	0.02950	B	0.0	0.01384	B	0.0	0.01751	P	simple_aae	100.0	0.0	.	.	.	-0.01	0.07116	N	0.026	0.00518	-0.6346	0.63216	T	0.0343	0.14655	T	9	0.0016427934	0.00019	T	.	.	.	0.223	0.51805	.	.	.	.	.	.	.	0.6394699523326659	0.63711	0.0286701757673	0.02857	0.210069715977	0.00816	T	0.077094	0.35312	T	-0.570789	0.00213	T	-0.525868	0.19385	T	0.000963207370913098	0.00009	T	0.221078	0.02855	T	0.043207407	0.06629	0.041283403	0.04672	0.062370792	0.12900	0.041283403	0.04671	-3.212	0.12639	T	0.0607	0.01058	B	0.00806228166875076	0.22297	0.00026306	0.04524	0.017	0.02149	.	.	.	.	.	.	-1.652556	0.00215	0.003	0.25523718732341394	0.01176	0.531711	0.55030	D	-1.98991633201899	0.00221	0.009530977	-2.06227032265424	0.00224	0.009918363	4.42	-8.85	0.00690	-4.75	0.04895	-0.24	0.08997	-2.420000	0.03797	-0.792	0.03243	0.0	0.06393	0.000000	0.08389	0.007	0.07843	982	0.03399	261	0.05211661341853035	128	0.09682299546142209	1	9.940357852882703E-4	2	0.002881844380403458	85	0.08432539682539683	45	0.046012269938650305	7383	264690	0.027893007	.	2004	109372	1.832280e-02	67	3628	205078	1.769080e-02	110	3976	234590	1.694870e-02	119	522	7158	7.292540e-02	18	139	17098	8.129610e-03	3	4	2320	1.724140e-03	0	814	9042	9.002430e-02	34	4	13390	2.987300e-04	0	45	42762	1.052340e-03	0	460	15688	2.932180e-02	12	814	9042	9.002430e-02	34	1154	16024	7.201700e-02	35	264	30502	8.655170e-03	4	15	6148	2.439820e-03	0	1160	13392	8.661890e-02	51	7	16728	4.184600e-04	0	84	86854	9.671400e-04	0	899	30596	2.938290e-02	20	1160	13392	8.661890e-02	51	1065	14754	7.218380e-02	29	281	34236	8.207730e-03	4	26	9560	2.719670e-03	0	1549	17688	8.757350e-02	66	8	21624	3.699590e-04	0	103	100604	1.023820e-03	0	895	30520	2.932500e-02	20	1549	17688	8.757350e-02	66	.	13580	1613066	8.418750e-03	415	3433	44858	7.653040e-02	139	5389	74986	7.186670e-02	198	0	912	0.000000e+00	0	514	60014	8.564670e-03	8	90	29602	3.040340e-03	0	3433	44858	7.653040e-02	139	47	63144	7.443300e-04	0	39	6062	6.433520e-03	0	808	1179912	6.847970e-04	0	2595	91080	2.849140e-02	61	104	105314	9.875230263782593E-4	37	312	0.11858974358974358	148	1908	0.07756813417190776	567	8300	0.06831325301204819	15	502	0.029880478087649404	3	660	0.004545454545454545	89	1244	0.07154340836012862	0	98	0	229	15922	0.014382615249340536	604	8612	0.07013469577333953	237	3152	0.07519035532994923	1192	134260	0.008878295843885	not_specified|Primary_hyperoxaluria,_type_I|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240868930A>G	ClinGen:CA275548|UniProtKB:P21549#VAR_048236	CN169374|C0268164|C3661900	259900	416|93598	.	Asn	Ser	98.33	0.9299363057324841																																																																																																																																																																																																																																																																																																																																																																																																																																																																													146			98.33	Polar/Neutral	Asparagine		Alanine--glyoxylate aminotransferase								0.0041		-3.5																		132									-85.5		Pocket 4: Mean pLDDT: 98.86, Volume: 500.16 Å³, Druggability score: 0		111.4						C (loop/coil)	C (loop/coil)												98.33	92.99363	>90	$\geqslant$90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.7452353355741234	0.7035846901626063	false	false	false
KRT2	KRT2_Gly219Asp	B_7-8	-4.7552102051304015	0.0031418269039534415	0.011112758123242727	-0.2646588677863389	0.7988957885603613	0.8364305341001493	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5272159726898511	0.5064070202886686	0.6071114014996011	0.4647246857816252	0.44262346767826605	0.5671569741916542	0.5329066050173833	0.32073693956710814	0.4312265630486911	0.5881864450203251	0.4774319748970619	0.5219821719935561	0.601407343365925	0.564509995789424	0.4982228085145592	0.6260363579788771	0.5353820656802752	0.5324497733861462	KRT2	Gly219Asp	NC_000012.12:52650483:C:T	656G>A	12	52650483	C	T	12	ENSG00000172867	55855	900198	CCSBVarC002918	ALE00002918	ENSP00000310861.3	RC4	NatVar_GDE_001	G05	GDEhDisVCh_40073	E08	1	NULL	NULL	NULL	NULL	VUSMutpDEST2_13	B07	VUSmut_GDEh12	F02	1.0	2.0	0.0		0.0			1.0	1.0	2.0	1.0	1.0	99.0	Y	N	N	Y	Y	331979.0	single nucleotide variant	NM_000423.3(KRT2):c.656G>A (p.Gly219Asp)	3849.0	KRT2	HGNC:6439	Benign	0.0	Jan 29, 2024	638043.0	-	RCV000274857|RCV001653519	MONDO:MONDO:0007813,MedGen:C0432306,OMIM:146800,Orphanet:455|MedGen:C3661900	Ichthyosis bullosa of Siemens|not provided	germline	germline	GRCh38	NC_000012.12	12	52650483.0	52650483.0	12q13.13	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA6585768,UniProtKB:P35908#VAR_058294	2.0	309616.0	52650483.0	C	T	-	-	-	-	-	-	656G>A 	Gly219Asp	NM_000423.3	2.0	Benign	Benign	309616	12	52650483.0	C	T	G	D	rs638043	12	53044267	12	51330534	219	KRT2	ENSG00000172867	ENST00000309680	ENSP00000310861	P35908	K22E_HUMAN	c.656G>A	p.Gly219Asp	c.656G>A	p.Gly219Asp	principal1	Y	1	YES	Select	-	GGC	2	0	C	C/C	C/C	C/C	C/C	0.12	0.28034	T	0.236	0.24982	T	0.115	0.26446	B	0.066	0.27434	B	0.07	0.21442	P	simple_aae	93.0	7.0	1.28	0.32068	L	-0.63	0.18393	N	0.072	0.04539	-0.9525	0.40361	T	0.0026	0.00825	T	8	0.0016930401	0.00020	T	.	.	.	0.189	0.46391	.	.	.	.	.	.	.	0.5067389658828956	0.50401	0.144869896826	0.16102	0.295037746429	0.09658	T	0.303484	0.67401	T	-0.605454	0.00131	T	-0.524338	0.19538	T	0.00309516298976704	0.00032	T	0.0853915	0.00645	T	0.048528235	0.08394	0.060007617	0.11363	0.048528235	0.08393	0.060007617	0.11363	-3.26	0.13238	T	0.1872	0.40431	B	0.00672218585171032	0.20956	0.00031499	0.05620	0.09	0.25353	.	.	.	.	.	.	1.556658	0.19973	14.51	0.95038960698839248	0.26275	0.137209	0.25597	N	-0.603088495464897	0.18620	0.9820203	-0.692295513363541	0.16872	0.9107957	5.19	2.15	0.26520	3.85	0.72111	-0.131	0.10495	.	.	0.594	0.32546	0.0	0.06393	0.000000	0.08389	0.274	0.23916	771	0.49004	361	0.07208466453674121	31	0.023449319213313162	158	0.15705765407554673	70	0.10086455331412104	26	0.025793650793650792	76	0.07770961145194274	26792	264690	0.101220295	.	11834	109406	1.081660e-01	858	23260	208084	1.117820e-01	1646	26816	236878	1.132060e-01	1930	304	7164	4.243440e-02	2	1304	17112	7.620380e-02	67	533	2320	2.297410e-01	60	158	9046	1.746630e-02	3	1617	13392	1.207440e-01	96	6144	42768	1.436590e-01	501	1491	15690	9.502870e-02	100	6144	42768	1.436590e-01	501	692	16218	4.266860e-02	7	2297	30524	7.525230e-02	124	1434	6212	2.308440e-01	166	236	13416	1.759090e-02	3	2028	16732	1.212050e-01	120	12966	89508	1.448590e-01	985	2871	30608	9.379900e-02	171	12966	89508	1.448590e-01	985	633	14902	4.247750e-02	7	2669	34260	7.790430e-02	142	2184	9572	2.281650e-01	252	303	17692	1.712640e-02	4	2580	21628	1.192900e-01	147	14736	102678	1.435170e-01	1122	2863	30526	9.378890e-02	171	14736	102678	1.435170e-01	1122	.	213891	1613492	1.325640e-01	15687	1304	5682	2.294970e-01	178	3277	74996	4.369570e-02	83	9	912	9.868420e-03	0	5199	60020	8.662110e-02	287	6705	29606	2.264740e-01	804	695	44888	1.548300e-02	6	7511	64020	1.173230e-01	468	1304	5682	2.294970e-01	178	171720	1179842	1.455450e-01	12671	8665	91060	9.515700e-02	525	49393	332038	0.14875706997391866	20	594	0.03367003367003367	116	5006	0.02317219336795845	796	15776	0.050456389452332655	182	1488	0.12231182795698925	598	7246	0.0825282914711565	62	1968	0.031504065040650404	484	5224	0.09264931087289434	3325	23974	0.13869191624259614	816	16370	0.04984728161270617	178	6974	0.025523372526527102	54976	393314	0.13977636188897422	not_provided|Ichthyosis_bullosa_of_Siemens	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.52650483C>T	ClinGen:CA6585768|UniProtKB:P35908#VAR_058294	C3661900|C0432306	146800	455	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Gly	Asp	54.82	0.5833333333333334																																																																																																																																																																																																																																																																																																																																																																																																																																																																													49			54.82	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Keratin, type II cytoskeletal 2 epidermal							IF rod			-0.4																		75									-61.6				92.3	Linker 1					C (loop/coil)	S (bend)												54.82	58.333332	50-70	10-90	146800	autosomal dominant	OMIM	Rare genetic skin disease	1	ICHTHYOSIS BULLOSA OF SIEMENS	false	0.5064070202886686	0.5272159726898511	false	false	false
NCF2	NCF2_Asn448Asp	B_7-8	1.9360336338767798	0.11063159667344669	0.17771882455486787	5.285422954518238	0.001855547396491803	0.003963829420910895	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5945670411076754	0.5820912227469313	0.5314428066864225	0.5162355564751993	0.4786564827640808	0.5516777023904917	0.5750850938682089	0.6000792621504791	0.6688283439968584	0.48727852725620935	0.7100729266763537	0.6975270051331687	0.5282703109127747	0.3572337033776825	0.36364276895354014	0.5756070861166358	0.45410951881750883	0.49160707708218226	NCF2	Asn448Asp	NC_000001.11:183560222:T:C	1342A>G	1	183560222	T	C	1	ENSG00000116701	3727	1704	CCSBVarC008447	ALE00008477	ENSP00000356505.4	Edgotyping3	VUSmut_GDEh11	B08	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_03	G10	VUSmut_GDEh11	B08	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	1153381.0	single nucleotide variant	NM_000433.4(NCF2):c.1342A>G (p.Asn448Asp)	4688.0	NCF2	HGNC:7661	Benign	0.0	Jan 17, 2024	141569987.0	-	RCV002222714|RCV001514536|RCV004715443|RCV004756263	MedGen:CN169374|MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379|MedGen:C3661900|	not specified|Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided|NCF2-related disorder	germline	germline	GRCh38	NC_000001.11	1	183560222.0	183560222.0	1q25.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	-	2.0	1166381.0	183560222.0	T	C	-	-	-	-	-	-	1342A>G 	Asn448Asp	NM_000433.4	2.0	Benign	Benign	1166381	1	183560222.0	T	C	N	D	rs141569987	1	183529357	1	181795980	448	NCF2	ENSG00000116701	ENST00000367535	ENSP00000356505	P19878	NCF2_HUMAN	c.1342A>G	p.Asn448Asp	c.1342A>G	p.Asn448Asp	principal1	Y	1	YES	Select	-	AAT	1	0	T	T/T	T/T	T/T	T/T	0.572	0.07641	T	0.723	0.09260	T	0.001	0.07480	B	0.001	0.04348	B	0.01	0.05039	N	simple_aae	99.0	1.0	1.67	0.42718	L	-0.57	0.24626	N	0.045	0.05786	-1.0462	0.15472	T	0.1904	0.54044	T	10	0.006901711	0.00154	T	0.019605	0.41783	T	0.034	0.08325	.	.	.	.	.	0.665323958199	0.65988	0.2878602299492843	0.28501	0.351142958433	0.36672	0.320630550385	0.13506	T	0.042876	0.26060	T	-0.596228	0.00150	T	-0.633832	0.09886	T	0.00969891824350102	0.00126	T	.	0.19778	.	0.044200443	0.06957	0.04574806	0.06240	0.06277556	0.13028	0.03476043	0.02613	-3.088	0.11574	T	0.0624	0.03453	B	0.0178620119581999	0.28528	0.00935490	0.40545	0.021	0.03256	.	.	.	.	.	.	-0.091491	0.03703	0.75	0.75203315493765988	0.11163	0.045522	0.07329	N	-1.07573713594562	0.07008	0.3284624	-1.13260217532042	0.06968	0.3432896	5.18	-1.45	0.08346	-2.04	0.11452	-0.692	0.05236	-0.757000	0.07586	-0.121	0.13924	0.0	0.06393	0.000000	0.08389	0.014	0.10256	730	0.54265	2	3.9936102236421724E-4	0	0.0	0	0.0	0	0.0	0	0.0	2	0.002044989775051125	17	264690	6.422608E-5	.	52	109400	4.753200e-04	1	95	208116	4.564760e-04	1	94	236918	3.967620e-04	1	0	7164	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	5	42768	1.169100e-04	0	47	15690	2.995540e-03	1	47	15690	2.995540e-03	1	0	16218	0.000000e+00	0	0	30514	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	10	89550	1.116690e-04	0	83	30608	2.711710e-03	1	83	30608	2.711710e-03	1	0	14902	0.000000e+00	0	0	34250	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	10	102728	9.734440e-05	0	83	30526	2.718990e-03	1	83	30526	2.718990e-03	1	.	316	1614230	1.957590e-04	3	245	91084	2.689820e-03	3	4	75056	5.329350e-05	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29608	0.000000e+00	0	0	44884	0.000000e+00	0	0	64046	0.000000e+00	0	7	6062	1.154730e-03	0	52	1180048	4.406600e-05	0	245	91084	2.689820e-03	3	3	47280	6.34517766497462E-5	0	306	0	0	146	0	1	8478	1.1795234725171031E-4	0	500	0	0	628	0	0	56	0	1	104	0.009615384615384616	3	8414	3.565486094604231E-4	1	8784	1.1384335154826958E-4	0	202	0	8	65912	1.2137395314965408E-4	not_specified|Granulomatous_disease,_chronic,_autosomal_recessive,_cytochrome_b-positive,_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.183560222T>C	.	CN169374|C1856245	233710	379	.	Asn	Asp	34.18	0.9490445859872612																																																																																																																																																																																																																																																																																																																																																																																																																																																																													149			34.18	Polar/Neutral	Asparagine		Neutrophil cytosol factor 2										-3.5																		132									-167.6				110.0	Disordered					C (loop/coil)	C (loop/coil)												34.18	94.90446	$\leqslant$50	$\geqslant$90	233710	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic skin disease	3	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2	false	0.5820912227469313	0.5945670411076754	false	false	false
MIP	MIP_Val67Ile	B_7-8	3.225589550567309	0.01801008888036776	0.04205289701895161	0.1529580466224763	0.8834457412570038	0.9056552710651408	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5712532765665187	0.5741175610201831	0.6040080921129165	0.44697479419407293	0.502909330632855	0.5870093256930726	0.7191774930851561	0.6237665581727834	0.6531413349390233	0.7102489292976206	0.6605464210300283	0.6453036938145458	0.45484115830098926	0.38205210309292664	0.24080825344912257	0.49776725492821244	0.48768870101033795	0.4972028593184916	MIP	Val67Ile	NC_000012.12:56454415:C:T	199G>A	12	56454415	C	T	12	ENSG00000135517	54230	2463	CCSBVarC008490	ALE00008446	ENSP00000498622.1	Edgotyping3	VUSmut_GDEh11	G05	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh11	G05	0.0		0.0		0.0			0.0			1.0	1.0	1.0	Y	N	N	N	Y	693248.0	single nucleotide variant	NM_012064.4(MIP):c.199G>A (p.Val67Ile)	4284.0	MIP	HGNC:7103	Benign	0.0	Dec 26, 2022	77163805.0	-	RCV000871663|RCV001692306	MONDO:MONDO:0014110,MedGen:C3809001,OMIM:615274,Orphanet:91492|MedGen:C3661900	Cataract 15 multiple types|not provided	germline	germline	GRCh38	NC_000012.12	12	56454415.0	56454415.0	12q13.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	-	2.0	702547.0	56454415.0	C	T	-	-	-	-	-	-	199G>A 	Val67Ile	NM_012064.4	2.0	Benign	Benign	702547	12	56454415.0	C	T	V	I	rs77163805	12	56848199	12	55134466	67	MIP	ENSG00000135517	ENST00000652304	ENSP00000498622	P30301	MIP_HUMAN	c.199G>A	p.Val67Ile	c.199G>A	p.Val67Ile	principal1	Y	.	YES	Select	-	GTC	1	0	C	C/C	C/C	C/C	C/C	.	.	.	.	.	.	0.0	0.02950	B	0.002	0.06938	B	.	.	.	.	.	.	-1.385	0.00625	N	.	.	.	.	.	-0.8410	0.52390	T	0.1569	0.48726	T	10	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.298207633763635	0.29534	.	.	0.385029017925	0.22942	T	0.168085	0.51248	T	-0.4982	0.00558	T	-0.485517	0.23521	T	0.00226114482200732	0.00023	T	0.668933	0.27518	T	0.033437464	0.03529	0.03581138	0.02916	0.033437464	0.03529	0.03581138	0.02916	-3.252	0.13137	T	0.0976	0.16208	B	0.000172887522981852	0.03941	0.29814150	0.76778	0.021	0.03256	.	.	.	.	.	.	1.795629	0.22866	15.78	0.23423461022821754	0.00984	0.102970	0.20432	N	-0.869494955437316	0.11434	0.5592429	-0.669399593435754	0.17441	0.9439143	5.18	3.35	0.37394	0.706	0.26741	-0.046	0.11975	1.351000	0.25893	-0.804	0.0314	0.127	0.23376	0.752000	0.26639	0.934	0.47248	154	0.93969	27	0.005391373801916933	19	0.014372163388804841	0	0.0	3	0.004322766570605188	5	0.00496031746031746	0	0.0	647	264690	0.0024443688	.	82	109372	7.497350e-04	0	162	207888	7.792660e-04	0	169	236654	7.141230e-04	0	50	7158	6.985190e-03	0	7	17106	4.092130e-04	0	0	2320	0.000000e+00	0	24	9046	2.653110e-03	0	0	13392	0.000000e+00	0	1	42754	2.338960e-05	0	0	15682	0.000000e+00	0	50	7158	6.985190e-03	0	106	16190	6.547250e-03	0	13	30516	4.260060e-04	0	0	6210	0.000000e+00	0	38	13410	2.833710e-03	0	0	16732	0.000000e+00	0	3	89382	3.356380e-05	0	2	30600	6.535950e-05	0	106	16190	6.547250e-03	0	101	14890	6.783080e-03	0	14	34252	4.087350e-04	0	0	9556	0.000000e+00	0	48	17692	2.713090e-03	0	0	21624	0.000000e+00	0	4	102510	3.902060e-05	0	2	30518	6.553510e-05	0	101	14890	6.783080e-03	0	.	805	1614146	4.987160e-04	1	488	75050	6.502330e-03	1	488	75050	6.502330e-03	1	0	912	0.000000e+00	0	34	60022	5.664590e-04	0	1	29608	3.377470e-05	0	195	44882	4.344730e-03	0	0	63994	0.000000e+00	0	4	6062	6.598480e-04	0	21	1180022	1.779630e-05	0	11	91088	1.207620e-04	0	8	193312	4.138387684158252E-5	5	370	0.013513513513513514	15	4514	0.003322995126273815	57	9612	0.005930087390761548	4	814	0.004914004914004914	1	1042	9.596928982725527E-4	4	1850	0.002162162162162162	0	296	0	17	17884	9.505703422053232E-4	62	9982	0.006211180124223602	19	6364	0.0029855436832181017	111	229694	4.832516304300504E-4	not_provided|Cataract_15_multiple_types	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.56454415C>T	.	C3661900|C3809001	615274	91492	Major intrinsic protein, conserved site	Val	Ile	98.69	0.007042253521126761																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			98.69	Aliphatic	Valine		Lens fiber major intrinsic protein										4.2								 V67-E16 (PAE:  1.0), V67-N184 (PAE: 1.0)		 V67-E16 (PAE:  1.0), V67-Q93 (PAE: 1.0)				Discontinuously helical				117									55.9				14.0						C (loop/coil)	C (loop/coil)												98.69	0.70422536	>90	<10	615274	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis	2	CATARACT 15, MULTIPLE TYPES	false	0.5741175610201831	0.5712532765665187	false	false	false
KRT8	KRT8_Gly434Ser	B_7-8	-2.8285061284738284	0.03001662905240647	0.06238494177377188	-3.7786968133392946	0.006904017723928942	0.01248860421093343	2024_01_Batch_7-8	true	true	false	false	false	false	true	false	false	false	false	false	0.9783670348066982	0.984474808237969	0.6914368708096474	0.7499932569204539	0.714834978464223	0.729319545996586	0.7542854467159649	0.6968679146379999	0.780746790460954	0.7456093501524577	0.9913309516972133	0.9897184765108468	0.7043536452772071	0.7328020422904459	0.719239723379954	0.6372643914668373	0.9776186647787246	0.9670155931025496	KRT8	Gly434Ser	NC_000012.12:52897580:C:T	1300G>A	12	52897580	C	T	12	ENSG00000170421	14966	218521	CCSBVarC004268	ALE00004268	ENSP00000509398.1	CEGS2	CegsMutGDEh1038	D06	GDEhDisVCh_40069	A08	1	CegsMutGDDh1038	D06	VUSN2Hmut_GDN2h_07	A11	VUSMutpDEST2_11	C11	VUSmut_GDEh07	A11	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	99.0	1.0	Y	Y	Y	Y	Y	77425.0	single nucleotide variant	NM_002273.4(KRT8):c.1300G>A (p.Gly434Ser)	3856.0	KRT8	HGNC:6446	Benign	0.0	Dec 31, 2019	58573614.0	-	RCV000056932|RCV003935000	MedGen:C3661900|	not provided|KRT8-related disorder	germline	germline	GRCh38	NC_000012.12	12	52897580.0	52897580.0	12q13.13	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA217254	2.0	66528.0	52897580.0	C	T	-	-	-	-	-	-	1300G>A 	Gly434Ser	NM_002273.4	2.0	Benign	Benign	66528	12	52897580.0	C	T	G	S	rs58573614	12	53291364	12	51577631	434	KRT8	ENSG00000170421	ENST00000692008	ENSP00000509398	P05787	K2C8_HUMAN	.	.	c.1300G>A	p.Gly434Ser	principal2	Y	.	YES	Select	-	GGC	1	0	C	./.	./.	./.	./.	.	0.30794	.	.	0.36701	.	0.07	0.23882	B	0.055	0.25997	B	.	0.10877	.	.	.	.	1.26	0.31717	L	.	0.59576	.	.	0.19867	-0.7137	0.59600	T	0.0660	0.27046	T	10	.	0.00044	.	.	.	.	.	0.65341	.	.	.	.	.	.	0.89293	.	0.51042	.	0.50966	0.436664402485	0.30084	T	0.549476	0.84579	D	-0.307375	0.07774	T	-0.170277	0.57121	T	0.0223565430785245	0.00945	T	.	0.01141	.	0.2909674	0.51750	0.21411994	0.45782	0.27991033	0.50708	0.20290023	0.44183	-4.461	0.30408	T	.	0.10206	.	0.00114231946472168	0.10166	0.96685640	0.94424	0.353	0.61170	.	.	.	.	.	.	1.999168	0.25442	16.75	0.99189089876701775	0.55008	0.625870	0.60750	D	-0.0351332602619982	0.40001	2.388568	0.0678935411876005	0.42663	2.606644	4.65	4.65	0.57575	3.4	0.61598	0.681	0.2509	.	.	0.597	0.3436	0.053	0.21596	0.001000	0.17376	0.836	0.39465	623	0.65761	77	0.015375399361022364	75	0.056732223903177004	0	0.0	2	0.002881844380403458	0	0.0	0	0.0	4983	264690	0.018825796	segdup	503	98708	5.095840e-03	19	979	190880	5.128880e-03	34	933	220984	4.222030e-03	35	446	6994	6.376890e-02	18	40	17016	2.350730e-03	0	0	2318	0.000000e+00	0	0	8858	0.000000e+00	0	0	3570	0.000000e+00	0	12	42458	2.826320e-04	1	3	15650	1.916930e-04	0	446	6994	6.376890e-02	18	869	14538	5.977440e-02	33	68	30384	2.238020e-03	0	0	6044	0.000000e+00	0	0	13126	0.000000e+00	0	0	6906	0.000000e+00	0	24	84652	2.835140e-04	1	6	30564	1.963090e-04	0	869	14538	5.977440e-02	33	810	13378	6.054720e-02	33	83	34150	2.430450e-03	1	0	9482	0.000000e+00	0	0	17504	0.000000e+00	0	0	11804	0.000000e+00	0	22	98714	2.228660e-04	1	6	30486	1.968120e-04	0	810	13378	6.054720e-02	33	.	5235	1598104	3.275760e-03	156	4530	74936	6.045160e-02	145	4530	74936	6.045160e-02	145	0	910	0.000000e+00	0	196	60014	3.265900e-03	2	0	29606	0.000000e+00	0	0	44882	0.000000e+00	0	0	49822	0.000000e+00	0	37	4784	7.734110e-03	0	146	1179864	1.237430e-04	0	16	91010	1.758050e-04	0	4	15886	2.517940324814302E-4	9	122	0.07377049180327869	0	112	0	162	3418	0.047396138092451724	5	146	0.03424657534246575	0	610	0	0	56	0	0	98	0	17	2960	0.0057432432432432436	171	3540	0.048305084745762714	0	168	0	197	23408	0.008415926179084075	KRT8-related_disorder|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.52897580C>T	ClinGen:CA217254	C3661900	.	.	.	Gly	Ser	27.55	0.8571428571428571																																																																																																																																																																																																																																																																																																																																																																																																																																																																													71			27.33	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Keratin, type II cytoskeletal 8										-0.4																		75									-57.1				144.6	Tail					C (loop/coil)	C (loop/coil)												27.55	85.71429	$\leqslant$50	10-90		unknown			0		false	0.984474808237969	0.9783670348066982	true	true	false
FKBP6	FKBP6_Arg202His	B_15-16	21.198800947290326	1.3083044348742234e-7	0.000017849010504355474	6.353129122875109	0.0003840772340537908	0.0011222638924979398	2025_03_Batch_15-16	false	false	true	false	false	true	false	false	false	false	false	false	0.8862639073507114	0.9230236151067731	0.8836427937398256	0.9012044437716509	0.9077482541032803	0.9240550982458404	0.8638664031620501	0.8367416731719576	0.8836286028193383	0.7969742411923628	0.9051394577209755	0.8616100203259854	0.9842437933296309	0.978754835034603	0.9187802847239636	0.9703113462872883	0.9409077724925707	0.9109177943754373	FKBP6	Arg202His	NC_000007.14:73340654:G:A	605G>A	7	73340654	G	A	7	ENSG00000077800	10177	900211	CCSBVarC002929	ALE00002929	ENSP00000252037.4	RC4	NatVar_GDE_001	B07	GDEhDisVCh_40046	F03	2	NULL	NULL	NULL	NULL	VUSMutpDEST2_08	A10	VUSmut_GDEh12	F03	1.0	7.0	0.0		0.0			1.0	1.0	99.0	1.0	1.0	99.0	Y	N	N	Y	Y	3196226.0	single nucleotide variant	NM_003602.5(FKBP6):c.605G>A (p.Arg202His)	8468.0	FKBP6	HGNC:3722	Benign	0.0	May 01, 2019	-1.0	-	RCV003974098	-	FKBP6-related disorder	germline	germline	GRCh38	NC_000007.14	7	73340654.0	73340654.0	7q11.23	no assertion criteria provided	1.0	-	N	-	2.0	3057196.0	73340654.0	G	A	-	-	-	-	-	-	605G>A 	Arg202His	NM_003602.5		Benign	Benign	3057196	7	73340654.0	G	A	R	H	rs142831087	7	72754656	7	72392592	202	FKBP6	ENSG00000077800	ENST00000252037	ENSP00000252037	O75344	FKBP6_HUMAN	c.605G>A	p.Arg202His	c.605G>A	p.Arg202His	principal4	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.206	0.22427	T	0.36	0.17878	T	0.0	0.02950	B	0.0	0.04348	B	0.01	0.08015	N	simple_aae	99.0	1.0	-1.61	0.00417	N	0.54	0.04510	N	0.102	0.12001	-1.0283	0.20970	T	0.0416	0.17774	T	10	0.0029876232	0.00048	T	.	.	.	0.097	0.27724	.	.	.	.	.	0.74031885357	0.73593	0.0744850741678997	0.07261	0.36578637288	0.37883	0.199410527945	0.00441	T	0.051597	0.28675	T	-0.517982	0.00435	T	-0.494509	0.22584	T	0.00513537246450921	0.00055	T	0.335566	0.07961	T	0.026217991	0.01639	0.024403192	0.00464	0.026217991	0.01639	0.024403192	0.00464	-3.141	0.19659	T	0.072	0.07685	B	1.9533159675281e-05	0.00991	0.00465074	0.32383	0.048	0.12436	.	.	.	.	.	.	-0.412628	0.02172	0.211	0.8545064728728391	0.16141	0.031855	0.03425	N	-1.19671646467086	0.04991	0.2293021	-1.19375191661858	0.05917	0.2882049	4.91	0.267	0.14835	.	.	-0.377	0.07531	-0.425000	0.09300	-0.688	0.0416	0.0	0.06393	0.000000	0.08389	0.001	0.02614	929	0.16852	53	0.010583067092651758	50	0.037821482602118005	0	0.0	3	0.004322766570605188	0	0.0	0	0.0	2729	264690	0.010310174	.	273	108608	2.513630e-03	3	540	206216	2.618610e-03	7	528	234976	2.247040e-03	6	214	7136	2.998880e-02	3	35	17054	2.052300e-03	0	0	2320	0.000000e+00	0	20	8638	2.315350e-03	0	0	13280	0.000000e+00	0	2	42608	4.693950e-05	0	2	15676	1.275840e-04	0	214	7136	2.998880e-02	3	449	15450	2.906150e-02	7	54	30462	1.772700e-03	0	0	6200	0.000000e+00	0	20	13000	1.538460e-03	0	0	16620	0.000000e+00	0	6	89096	6.734310e-05	0	2	30594	6.537230e-05	0	449	15450	2.906150e-02	7	411	14134	2.907880e-02	6	62	34196	1.813080e-03	0	0	9560	0.000000e+00	0	41	17284	2.372140e-03	0	0	21518	0.000000e+00	0	7	102228	6.847440e-05	0	2	30512	6.554800e-05	0	411	14134	2.907880e-02	6	.	2659	1613438	1.648030e-03	49	2277	74906	3.039810e-02	48	2277	74906	3.039810e-02	48	0	912	0.000000e+00	0	146	59966	2.434710e-03	0	0	29606	0.000000e+00	0	28	44862	6.241360e-04	0	0	63962	0.000000e+00	0	6	5758	1.042030e-03	0	54	1179974	4.576370e-05	0	9	91034	9.886420e-05	0	12	175884	6.822678583611926E-5	13	360	0.03611111111111111	0	4470	0	283	8962	0.03157777281856729	10	804	0.012437810945273632	1	974	0.001026694045174538	2	1824	0.0010964912280701754	0	274	0	28	15816	0.0017703591299949419	296	9322	0.031752842737609956	2	6294	3.1776294884016526E-4	349	209368	0.0016669214015513354	FKBP6-related_disorder	criteria_provided,_single_submitter	NC_000007.14:g.73340654G>A	.	.	.	.	.	Arg	His	92.65	0.5201612903225806																																																																																																																																																																																																																																																																																																																																																																																																																																																																													129			92.65	Positively-charged	Arginine		Inactive peptidyl-prolyl cis-trans isomerase FKBP6										-4.5								 R202-L198 (PAE:  1.0), R202-Q244 (PAE: 2.5)		 R202-L198 (PAE:  1.0)								175									-79.9				-36.6			TPR 1			H (helix)	H (α-helix)												92.65	52.01613	>90	10-90		unknown			0		false	0.9230236151067731	0.8862639073507114	false	false	false
CLDN19	CLDN19_Arg200Gln	B_15-16	-2.8767116411631983	0.023762962425675483	0.05162911863705134	7.410044051863126	0.00014815263555466226	0.0005481050125863009	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7729226396362869	0.8027339467286169	0.5426610101329878	0.7845990857136049	0.712958003056358	0.6358292856589234	0.7933800170319016	0.886445380521728	0.9600541448800032	0.638363369021446	0.835529898572958	0.8038337559429913	0.478278554285945	0.539470625590988	0.6091440265472066	0.44695865124452977	0.7699379948842757	0.7420115233295825	CLDN19	Arg200Gln	NC_000001.11:42735905:C:T	599G>A	1	42735905	C	T	1	ENSG00000164007	9634	900213	CCSBVarC002931	ALE00002931	ENSP00000361617.3	RC4	NatVar_GDE_001	D07	GDEhDisVCh_40086	F04	2	NULL	NULL	NULL	NULL	VUSMutpDEST2_08	A09	VUSmut_GDEh12	H03	1.0	1.0	0.0		0.0			1.0	1.0	1.0	1.0	1.0	99.0	Y	N	N	Y	Y	282288.0	single nucleotide variant	NM_148960.3(CLDN19):c.599G>A (p.Arg200Gln)	149461.0	CLDN19	HGNC:2040	Benign	0.0	Aug 01, 2024	116804195.0	-	RCV000295255|RCV001516776	MONDO:MONDO:0009548,MedGen:C4721891,OMIM:248190,Orphanet:2196|MedGen:C3661900	Renal hypomagnesemia 5 with ocular involvement|not provided	germline	germline	GRCh38	NC_000001.11	1	42735905.0	42735905.0	1p34.2	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA801335	2.0	297340.0	42735905.0	C	T	-	-	-	-	-	-	599G>A 	Arg200Gln	NM_148960.3	2.0	Benign	Benign	297340	1	42735905.0	C	T	R	Q	rs116804195	1	43201576	1	42974163	200	CLDN19	ENSG00000164007	ENST00000296387	ENSP00000296387	Q8N6F1	CLD19_HUMAN	c.599G>A	p.Arg200Gln	c.599G>A	p.Arg200Gln	.	Y	2	YES	Select	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.171	0.22861	T	0.297	0.20813	T	0.328	0.33214	B	0.018	0.26932	B	0.02	0.10877	N	simple_aae	98.0	2.0	.	.	.	-0.3	0.11844	N	0.632	0.64382	-0.5667	0.65997	T	0.1336	0.44491	T	10	0.0029183626	0.00046	T	.	.	.	0.317	0.63716	.	.	.	.	.	.	.	0.47111397450700593	0.46833	0.338299000605	0.35514	0.523969352245	0.42125	T	0.095515	0.39353	T	-0.365488	0.03670	T	-0.270615	0.47424	T	0.00703394281372223	0.00079	T	0.809319	0.45770	T	0.06599338	0.14029	0.050660808	0.08011	0.07158169	0.15712	0.04689134	0.06652	-4.223	0.36523	T	0.0995	0.17039	B	0.0506528483546372	0.37294	0.00077099	0.12999	0.108	0.29858	.	.	.	.	.	.	3.832589	0.55492	23.6	0.99768957213322562	0.85762	0.799681	0.72487	D	-0.264727516517986	0.30239	1.702527	-0.0851547889302658	0.35699	2.089801	4.31	4.31	0.50660	.	.	4.4	0.59555	7.647000	0.63553	0.585	0.3052	1.0	0.71675	1.000000	0.68239	0.909	0.44474	507	0.75491	54	0.010782747603833865	2	0.0015128593040847202	13	0.012922465208747515	22	0.03170028818443804	0	0.0	17	0.017382413087934562	3612	264690	0.013646152	.	1335	83026	1.607930e-02	13	2512	162178	1.548920e-02	28	2875	185994	1.545750e-02	30	14	4458	3.140420e-03	0	471	14180	3.321580e-02	6	18	1704	1.056340e-02	0	0	6544	0.000000e+00	0	224	12058	1.857690e-02	1	455	29878	1.522860e-02	4	129	12624	1.021860e-02	2	471	14180	3.321580e-02	6	30	11590	2.588440e-03	0	811	24366	3.328410e-02	12	56	5166	1.084010e-02	1	1	11302	8.847990e-05	0	265	14450	1.833910e-02	1	1027	66204	1.551270e-02	10	260	25104	1.035690e-02	4	811	24366	3.328410e-02	12	28	10802	2.592110e-03	0	934	28260	3.305020e-02	13	84	8694	9.661840e-03	0	1	14284	7.000840e-05	0	309	17086	1.808500e-02	1	1174	77006	1.524560e-02	11	258	25066	1.029280e-02	4	934	28260	3.305020e-02	13	.	23651	1580342	1.496570e-02	229	1862	54726	3.402400e-02	36	225	74422	3.023300e-03	1	0	910	0.000000e+00	0	1862	54726	3.402400e-02	36	277	28936	9.572850e-03	0	1	43310	2.308940e-05	0	1166	61716	1.889300e-02	12	48	5878	8.166040e-03	0	18213	1162932	1.566130e-02	155	947	86334	1.096900e-02	18	2874	186048	0.015447626418988648	0	358	0	1	4504	2.2202486678507994E-4	28	9436	0.002967359050445104	12	804	0.014925373134328358	36	974	0.03696098562628337	0	1850	0	2	280	0.007142857142857143	221	17698	0.012487286699062041	28	9794	0.0028588931999183175	1	6354	1.5738117721120554E-4	3174	221952	0.014300389273356402	not_provided|Renal_hypomagnesemia_5_with_ocular_involvement	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.42735905C>T	ClinGen:CA801335	C3661900|C4721891	248190	2196	.	Arg	Gln	51.14	0.9395161290322581																																																																																																																																																																																																																																																																																																																																																																																																																																																																													233			51.14	Positively-charged	Arginine		Claudin-19										-4.5																		175									-83.8				108.5	Disordered					C (loop/coil)	C (loop/coil)							Cytoplasmic					51.14	93.951614	50-70	$\geqslant$90	248190	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT	false	0.8027339467286169	0.7729226396362869	false	false	false
BRCA1	BRCA1_Met548Ile	B_13-14	0.2873204807817469	0.7821863607221871	0.8277977908320524	8.904168709864585	0.00004573055090166232	0.00022497469411407602	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	true	true	false	true	0.9294973541513825	0.9367216311519673	0.9299388134052322	0.9718850355443411	0.9465507603208291	0.9844563890765501	0.9802040981208318	0.9424117626519745	0.9554342865181599	0.8971063524379275	0.9216133471385658	0.910449476913257	0.9887086800322683	0.9506897579896837	0.9883357845705225	0.962771274372537	0.9518299151653689	0.948545231389508	BRCA1	Met548Ile	NC_000017.11:43070958:C:T	1644G>A	17	43070958	C	T	17	ENSG00000012048	14613	0	CCSBVarC013069	ALE00008741	ENSP00000417148.1																																	50269.0	single nucleotide variant	NM_007294.4(BRCA1):c.4956G>A (p.Met1652Ile)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	1799967.0	-	RCV000034756|RCV000048709|RCV000112434|RCV000120261|RCV000128916|RCV000476093|RCV001270155|RCV004803120	MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Malignant tumor of breast|BRCA1-related cancer predisposition	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43070958.0	43070958.0	17q21.31	reviewed by expert panel	46.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00107,ClinGen:CA003103,UniProtKB:P38398#VAR_007795	2.0	41830.0	43070958.0	C	T	-	-	-	-	-	-	4956G>A 	Met1652Ile	NM_007294.4	3.0	Benign	Benign	41830	17	43070958.0	C	T	M	I	rs1799967	17	41222975	17	38476501	1652	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.4956G>A	p.Met1652Ile	principal2	Y	1	.	.	-	ATG	3	0	C	C/C	C/C	C/C	C/C	.	0.33898	.	.	0.36968	.	0.0	0.28566	B	0.004	0.29523	B	.	0.16373	.	.	.	.	0.175	0.08964	N	.	0.38141	.	.	0.33676	-0.8538	0.51511	T	0.1432	0.46308	T	10	.	0.00157	.	.	.	.	.	0.73230	.	.	.	.	.	.	.	.	0.30010	.	0.10046	0.360434174538	0.19429	T	0.099528	0.40156	T	-0.195766	0.21097	T	-0.0261181	0.68398	D	0.0072100418028408	0.00082	T	.	0.64025	.	0.19599688	0.41094	0.13775083	0.32824	0.25679418	0.48390	0.11591255	0.27917	-4.756	0.35788	T	.	0.64691	.	0.164986458329954	0.48018	0.95295440	0.93539	0.216	0.48172	.	.	.	.	.	.	2.32095	0.29778	18.21	0.96644426836776054	0.30766	0.454853	0.50568	N	-0.274289964374125	0.29865	1.678113	-0.0674097859341404	0.36444	2.142461	4.82	3.78	0.42561	3.78	0.69545	1.313	0.33295	2.710000	0.34310	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	544	0.72706	56	0.011182108626198083	0	0.0	16	0.015904572564612324	3	0.004322766570605188	0	0.0	37	0.03783231083844581	2323	264690	0.008776304	.	2157	109398	1.971700e-02	48	3761	207690	1.810870e-02	80	4287	236388	1.813540e-02	88	10	7164	1.395870e-03	0	64	17110	3.740500e-03	0	67	2320	2.887930e-02	0	1	9046	1.105460e-04	0	723	13386	5.401170e-02	25	632	42768	1.477740e-02	3	626	15690	3.989800e-02	20	626	15690	3.989800e-02	20	30	16216	1.850020e-03	0	114	30522	3.735010e-03	0	157	6210	2.528180e-02	1	2	13416	1.490760e-04	0	890	16726	5.321060e-02	31	1317	89130	1.477620e-02	11	1163	30608	3.799660e-02	37	1163	30608	3.799660e-02	37	27	14902	1.811840e-03	0	144	34258	4.203400e-03	0	225	9568	2.351590e-02	2	2	17692	1.130450e-04	0	1113	21624	5.147060e-02	37	1517	102208	1.484230e-02	12	1159	30526	3.796760e-02	37	1159	30526	3.796760e-02	37	.	23606	1614160	1.462430e-02	338	3175	64006	4.960470e-02	99	143	75032	1.905850e-03	0	7	910	7.692310e-03	0	271	60024	4.514860e-03	0	679	29608	2.293300e-02	8	5	44892	1.113780e-04	0	3175	64006	4.960470e-02	99	143	6062	2.358960e-02	3	15052	1180032	1.275560e-02	119	3269	91088	3.588840e-02	99	3242	204736	0.015835026570803375	1	394	0.0025380710659898475	0	4556	0	31	10580	0.0029300567107750472	8	818	0.009779951100244499	9	1028	0.008754863813229572	0	1850	0	6	280	0.02142857142857143	228	18068	0.012618994908124861	32	10974	0.00291598323309641	0	6406	0	3525	242310	0.014547480500185712	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Familial_cancer_of_breast|Malignant_tumor_of_breast	reviewed_by_expert_panel	NC_000017.11:g.43070958C>T	BRCA1-HCI:BRCA1_00107|ClinGen:CA003103|UniProtKB:P38398#VAR_007795	C3661900|C0677776|C0027672|CN169374|C2676676|C0346153|C0006142	604370|114480	145|140162|145|227535	BRCT domain|BRCT domain|BRCT domain	Met	Ile	96.01	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																96.01	0.0	>90	<10	604370;114480	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER	false	0.9367216311519673	0.9294973541513825	false	false	false
BCL10	BCL10_Ala5Ser	B_13-14	-2.0041407511215463	0.11556895061623532	0.18376144481619042	0.2928982794280082	0.778092046015708	0.8177542408011594	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7408552549272631	0.7800456032063268	0.76035312337963	0.7428717001540883	0.7495933635104965	0.8048502474187247	0.8048502474187247	0.7034536704399894	0.6764434043150686	0.76035312337963	0.7874667271514417	0.7408552549272631		0.7957330565810036	0.8092999959931082		0.7726244792612118		BCL10	Ala5Ser	NC_000001.11:85276340:C:A	13G>T	1	85276340	C	A	1	ENSG00000142867	11832	0	CCSBVarC001763	ALE00001763	ENSP00000498104.1	RC4	RC4_Mut_GDEh1005	H03	GDEhDisVCh_40010	D03	2	RC4_Mut_GDDh1005	H03	NULL	NULL	VUSMutpDEST2_09	F09	VUSmut_GDEh12	B07	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	448386.0	single nucleotide variant	NM_003921.5(BCL10):c.13G>T (p.Ala5Ser)	8915.0	BCL10	HGNC:989	Benign	0.0	Jan 31, 2024	12037217.0	-	RCV000532322|RCV003915633|RCV004714073	MONDO:MONDO:0014491,MedGen:C4015195,OMIM:616098||MedGen:C3661900	Immunodeficiency 37|BCL10-related disorder|not provided	germline	germline	GRCh38	NC_000001.11	1	85276340.0	85276340.0	1p22.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA929838	2.0	475271.0	85276340.0	C	A	-	-	-	-	-	-	13G>T 	Ala5Ser	NM_003921.5	2.0	Benign	Benign	475271	1	85276340.0	C	A	A	S	rs12037217	1	85742023	1	85514611	5	BCL10	ENSG00000142867	ENST00000648566	ENSP00000498104	O95999	BCL10_HUMAN	c.13G>T	p.Ala5Ser	c.13G>T	p.Ala5Ser	principal1	Y	.	YES	Select	-	GCA	1	0	C	C/C	C/C	C/C	C/C	.	.	.	.	0.07361	.	0.0	0.02950	B	0.001	0.04348	B	.	.	.	.	.	.	0.69	0.16877	N	.	.	.	.	0.00874	-1.0105	0.26684	T	0.0231	0.09750	T	9	0.0015875101	0.00018	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.494869709015	0.38062	T	0.305241	0.67569	T	-0.689941	0.00041	T	-0.667112	0.07582	T	0.0156444791003721	0.00357	T	0.726327	0.33844	T	0.12828135	0.29734	0.16866185	0.38716	0.11355482	0.26579	0.17036171	0.39010	-2.553	0.06160	T	0.0874	0.11803	B	0.00201335097249276	0.13098	0.00011795	0.01318	0.124	0.33416	.	.	.	.	.	.	2.748674	0.36089	20.1	0.99510976220833802	0.68658	0.140710	0.26053	N	-0.418389870164214	0.24553	1.343174	-0.230976240330979	0.30116	1.713435	5.12	3.19	0.35642	2.73	0.49939	1.77	0.38267	3.253000	0.37120	0.599	0.40292	0.983	0.35756	1.000000	0.68239	0.99	0.65338	839	0.37627	175	0.03494408945686901	0	0.0	27	0.0268389662027833	16	0.023054755043227664	118	0.11706349206349206	14	0.014314928425357873	6745	264690	0.02548264	.	3040	109350	2.780060e-02	98	5798	206954	2.801590e-02	191	7068	235746	2.998140e-02	231	28	7152	3.914990e-03	0	320	17098	1.871560e-02	1	191	2320	8.232760e-02	7	1071	9042	1.184470e-01	70	55	13382	4.110000e-03	0	1026	42754	2.399780e-02	12	294	15690	1.873800e-02	7	1071	9042	1.184470e-01	70	67	16198	4.136310e-03	0	551	30502	1.806440e-02	1	519	6202	8.368270e-02	23	1591	13408	1.186610e-01	114	71	16722	4.245900e-03	1	2251	88452	2.544880e-02	33	572	30608	1.868790e-02	14	1591	13408	1.186610e-01	114	61	14888	4.097260e-03	0	655	34240	1.912970e-02	2	845	9560	8.838910e-02	32	2112	17686	1.194160e-01	139	98	21594	4.538300e-03	1	2528	101642	2.487160e-02	38	572	30526	1.873810e-02	14	2112	17686	1.194160e-01	139	.	39674	1613546	2.458810e-02	780	2701	29582	9.130550e-02	124	369	75002	4.919870e-03	2	55	912	6.030700e-02	2	1324	59992	2.206960e-02	15	2701	29582	9.130550e-02	124	3907	44842	8.712810e-02	225	342	64010	5.342920e-03	1	390	6048	6.448410e-02	19	26788	1179642	2.270860e-02	305	1821	91032	2.000400e-02	41	4527	162754	0.027814984577952	1	360	0.002777777777777778	379	4430	0.0855530474040632	90	9000	0.01	29	786	0.03689567430025445	21	966	0.021739130434782608	261	1826	0.1429353778751369	5	274	0.01824817518248175	725	14392	0.05037520844913841	91	9360	0.009722222222222222	640	6256	0.10230179028132992	6038	194788	0.030997802739388465	BCL10-related_disorder|Immunodeficiency_37	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.85276340C>A	ClinGen:CA929838	C4015195	616098	.	.	Ala	Ser	55.69	0.6981132075471698																																																																																																																																																																																																																																																																																																																																																																																																																																																																													74			55.69	Aliphatic	Alanine		B-cell lymphoma/leukemia 10								0.2502		1.8																		89									-46.4		Pocket 1: Mean pLDDT: 47.42, Volume: 351.14 Å³, Druggability score: 0.25		140.7				dbSNP: rs12037217; Variant type: US; AA change: Ala5Ser; PTM type: Phosphorylation; PTM morphology: __MEPtA*PSLT; Var class: II		C (loop/coil)	C (loop/coil)												55.69	69.81132	50-70	10-90	616098	autosomal recessive	OMIM		0	IMMUNODEFICIENCY 37	false	0.7800456032063268	0.7408552549272631	false	false	false
BRCA1	BRCA1_Pro510Ser	B_13-14	1.2763374668476026	0.24254813146313225	0.32624431767224127	5.335113879487378	0.0010814453934293857	0.002553992660158202	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	true	false	false	true	0.9226685059061588	0.9255389328510607	0.938697934854939	0.9566131972380619	0.922397257526315	0.9739514446412562	0.9637238504695786	0.915972454208585	0.9333420621365476	0.9377317306987328	0.912542811382246	0.911297934707236	0.9841790388129337	0.928822060844045	0.9798843323395763	0.9396641390111452	0.9385350543198754	0.9340390771050816	BRCA1	Pro510Ser	NC_000017.11:43071074:G:A	1528C>T	17	43071074	G	A	17	ENSG00000012048	14613	0	CCSBVarC013098	ALE00008954	ENSP00000417148.1																																	69968.0	single nucleotide variant	NM_007294.4(BRCA1):c.4840C>T (p.Pro1614Ser)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	70953660.0	-	RCV000048676|RCV000112411|RCV000167771|RCV000162988|RCV001811342|RCV003492390	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer	germline	germline	GRCh38	NC_000017.11	17	43071074.0	43071074.0	17q21.31	reviewed by expert panel	13.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00089,ClinGen:CA003048	2.0	55301.0	43071074.0	G	A	-	-	-	-	-	-	4840C>T 	Pro1614Ser	NM_007294.4	3.0	Benign	Benign	55301	17	43071074.0	G	A	P	S	rs70953660	17	41223091	17	38476617	1614	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4840C>T	p.Pro1614Ser	c.4840C>T	p.Pro1614Ser	principal2	Y	1	YES	Select	-	CCA	1	0	G	G/G	G/G	G/G	G/G	0.074	0.34767	T	0.331	0.42259	T	0.001	0.11208	B	0.001	0.11213	B	0.2	0.44282	N	simple_aae	80.0	20.0	1.245	0.31258	L	-1.13	0.49862	N	0.197	0.28185	-0.7260	0.58992	T	0.3747	0.73191	T	10	0.013456136	0.00282	T	0.081866	0.73689	D	0.544	0.80920	.	.	.	.	.	0.445007932271	0.43742	.	0.22008	.	0.10213	0.220991373062	0.01370	T	0.118253	0.43590	T	-0.292457	0.09169	T	-0.197798	0.54546	T	0.00209908424908425	0.00022	T	.	0.52390	.	0.01818675	0.00340	0.03539876	0.02796	0.012395442	0.00033	0.035112027	0.02713	-2.617	0.09611	T	0.0853	0.14859	B	0.209477282755653	0.50387	0.99514270	0.97711	0.086	0.24271	.	.	.	.	.	.	0.15678	0.05499	1.947	0.41163095527126975	0.02973	0.128273	0.24383	N	-1.18046810113445	0.05234	0.241072	-1.24446342853677	0.05132	0.2478793	4.36	-1.9	0.07233	0.973	0.28966	-0.1	0.10995	0.294000	0.16973	-0.106	0.15547	0.0	0.06393	0.000000	0.08389	0.008	0.08289	543	0.72771	2	3.9936102236421724E-4	1	7.564296520423601E-4	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	187	264690	7.064868E-4	.	25	109408	2.285020e-04	0	44	208130	2.114060e-04	0	43	236858	1.815430e-04	0	24	7164	3.350080e-03	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	24	7164	3.350080e-03	0	41	16218	2.528060e-03	0	1	30524	3.276110e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89552	1.116670e-05	0	0	30608	0.000000e+00	0	41	16218	2.528060e-03	0	38	14902	2.549990e-03	0	4	34260	1.167540e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102658	9.741080e-06	0	0	30526	0.000000e+00	0	38	14902	2.549990e-03	0	.	178	1614124	1.102770e-04	0	156	75024	2.079330e-03	0	156	75024	2.079330e-03	0	0	910	0.000000e+00	0	7	60006	1.166550e-04	0	0	29602	0.000000e+00	0	0	44892	0.000000e+00	0	0	64026	0.000000e+00	0	0	6062	0.000000e+00	0	4	1180006	3.389810e-06	0	0	91088	0.000000e+00	0	0	163048	0	0	360	0	0	4502	0	13	9362	0.0013885921811578722	0	442	0	0	950	0	0	1848	0	0	280	0	1	13148	7.6057195010648E-5	13	9722	0.0013371734211067683	0	6350	0	14	193940	7.218727441476746E-5	not_provided|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_and/or_ovarian_cancer	reviewed_by_expert_panel	NC_000017.11:g.43071074G>A	BRCA1-HCI:BRCA1_00089|ClinGen:CA003048	C3661900|CN169374|C0677776|C0027672|C2676676|CN221562	604370	145|140162|145	.	Pro	Ser	39.92	0.8823529411764706																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																39.92	88.2353	$\leqslant$50	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.9255389328510607	0.9226685059061588	false	false	false
F9	F9_Val227Ile	B_13-14	-2.373689508444221	0.049337789284427086	0.09202654055982004	2.758232923056304	0.028167628267768433	0.04271702303417775	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.59581393092969	0.6000613918403892	0.4828779791479117	0.6436245767997991	0.5832166229442226	0.5486589025094726	0.647137340496541	0.6130296502789685	0.6660302436820421	0.5776081561068017	0.5718436303573985	0.5613169396512737	0.4501804645224041	0.5534035956094767	0.6212189099175561	0.3881478021890217	0.62827915332338	0.6303109222081064	F9	Val227Ile	NC_000023.11:139551220:G:A	679G>A	23	139551220	G	A	X	ENSG00000101981	52861	0	CCSBVarC030567	ALE00033982	ENSP00000218099.2																																	1602531.0	single nucleotide variant	NM_000133.4(F9):c.679G>A (p.Val227Ile)	2158.0	F9	HGNC:3551	Benign	0.0	Nov 02, 2020	137852242.0	-	RCV002127085	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139551220.0	139551220.0	Xq27.1	criteria provided, single submitter	1.0	-	N	-	2.0	1596936.0	139551220.0	G	A	-	-	-	-	-	-	679G>A 	Val227Ile	NM_000133.4	1.0	Benign	Benign	1596936	X	139551220.0	G	A	V	I	rs137852242	X	138633379	X	138461045	227	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.679G>A	p.Val227Ile	c.679G>A	p.Val227Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.002	0.06938	B	0.05	0.16373	N	simple_aae	95.0	5.0	-0.745	0.01745	N	0.55	0.02974	N	0.111	0.10159	-0.7209	0.59247	T	0.2776	0.64798	T	10	0.39294234	0.54669	D	0.621022	0.96713	D	0.260	0.57011	0.63	0.76495	P00740	V227I	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.643927873118	0.63820	0.9149323540622197	0.91414	0.556390487147	0.52008	0.328283965588	0.14662	T	0.268576	0.63869	T	-0.334459	0.05599	T	-0.469894	0.25179	T	0.0151561946545469	0.00329	T	0.725427	0.40678	T	0.15264371	0.34352	0.11417206	0.27496	0.15264371	0.34352	0.11417206	0.27495	-1.977	0.03887	T	0.0705	0.07209	B	0.115496154533624	0.44646	0.99916210	0.99185	0.219	0.48537	.	.	.	.	.	.	-0.434396	0.02094	0.194	0.24669674744976147	0.01097	.	.	.	.	.	.	.	.	.	5.31	0.512	0.16159	0.0673	0.22013	-0.416	0.07178	-0.575000	0.08443	0.676	0.76753	0.012	0.18747	0.000000	0.08389	0.969	0.5403	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	5	80344	6.223240e-05	0	9	151854	5.926750e-05	0	12	172253	6.966500e-05	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	5	30956	1.615200e-04	0	0	9951	0.000000e+00	0	5	30956	1.615200e-04	0	0	13134	0.000000e+00	0	0	24393	0.000000e+00	0	0	4649	0.000000e+00	0	0	10127	0.000000e+00	0	0	12192	0.000000e+00	0	9	64659	1.391920e-04	0	0	19074	0.000000e+00	0	9	64659	1.391920e-04	0	0	12064	0.000000e+00	0	0	27171	0.000000e+00	0	0	7083	0.000000e+00	0	0	13318	0.000000e+00	0	0	15997	0.000000e+00	0	12	73464	1.633450e-04	0	0	19009	0.000000e+00	0	12	73464	1.633450e-04	0	.	15	1211372	1.238270e-05	0	14	895405	1.563540e-05	0	0	57663	0.000000e+00	0	0	687	0.000000e+00	0	0	45983	0.000000e+00	0	0	22042	0.000000e+00	0	0	33840	0.000000e+00	0	0	46797	0.000000e+00	0	0	4355	0.000000e+00	0	14	895405	1.563540e-05	0	0	56953	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551220G>A	.	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	47.5	0.08450704225352113																																																																																																																																																																																																																																																																																																																																																																																																															1.008		1.01		1.006		1.006		1.001																																																						12			47.5	Aliphatic	Valine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			4.2									V227-D410 (PDBs: 8OL9), V227-R358 (PDBs: 8OL9)		V227-D410 (PDBs: 8OL9), V227-L372 (PDBs: 8OL9), V227-R358 (PDBs: 8OL9), V227-Q370 (PDBs: 8OL9), V227-D405 (PDBs: 8OL9), V227-V359 (PDBs: 8OL9)							117									-124.5				159.0						B (undefined)	B (beta bridge)					Cleavage; by factor XIa							47.5	8.450704	$\leqslant$50	<10	306900;300807	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.6000613918403892	0.59581393092969	false	false	false
BRCA1	BRCA1_Leu460Pro	B_13-14	1.3818159885120436	0.20951653672145118	0.29103751646397946	1.7383520996516049	0.12571050221887387	0.1623355183473846	2025_01_Batch_13-14	false	false	true	false	false	true	false	false	false	false	false	false	0.9074682168957778	0.8944205542780168	0.8678111428023244	0.9196688229977443	0.9009296159162183	0.9420910939345655	0.9073315473572199	0.8767370911480978	0.863013478450399	0.8845327266906491	0.8374744794936521	0.8563867013155697	0.9768506405119112	0.9251221406843388	0.9763241675450897	0.8510895589139997	0.9513666290623815	0.958549732475986	BRCA1	Leu460Pro	NC_000017.11:43071223:A:G	1379T>C	17	43071223	A	G	17	ENSG00000012048	14613	0	CCSBVarC013122	ALE00008950	ENSP00000417148.1																																	69929.0	single nucleotide variant	NM_007294.4(BRCA1):c.4691T>C (p.Leu1564Pro)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	56119278.0	-	RCV000162687|RCV000120262|RCV000112385|RCV000148377|RCV000587835|RCV001082228|RCV004804006|RCV002483063|RCV004758629	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0700268,MedGen:CN377757|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Breast neoplasm|not provided|Hereditary breast ovarian cancer syndrome|BRCA1-related cancer predisposition|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Familial cancer of breast;Pancreatic cancer, susceptibility to, 4|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43071223.0	43071223.0	17q21.31	reviewed by expert panel	19.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00023,ClinGen:CA002980	2.0	55262.0	43071223.0	A	G	-	-	-	-	-	-	4691T>C 	Leu1564Pro	NM_007294.4	3.0	Benign	Benign	55262	17	43071223.0	A	G	L	P	rs56119278	17	41223240	17	38476766	1564	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4691T>C	p.Leu1564Pro	c.4691T>C	p.Leu1564Pro	principal2	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.167	0.45915	T	0.241	0.38212	T	0.828	0.46036	P	0.221	0.37838	B	0.22	0.57141	N	simple_aae	78.0	22.0	1.935	0.51654	L	-1.07	0.60859	N	0.501	0.60290	-0.1563	0.78666	T	0.6710	0.88560	D	10	0.047209352	0.04012	T	0.323959	0.91538	D	0.554	0.81507	.	.	.	.	.	0.776336265085	0.77250	.	0.35316	.	0.15464	0.41346591711	0.26905	T	0.151297	0.48845	T	0.0819011	0.61994	D	0.339011	0.89807	D	0.0181525713158331	0.00535	T	.	0.39375	.	0.15756732	0.35205	0.12383379	0.29781	0.0936192	0.21792	0.106218696	0.25497	-3.859	0.21903	T	0.1809	0.54067	B	0.77319198328768	0.69688	0.99947375	0.99411	0.651	0.80578	.	.	.	.	.	.	2.053966	0.26159	17.0	0.97050371191633666	0.32337	0.297615	0.40519	N	-0.391511225925735	0.25494	1.401419	-0.372425254023125	0.25504	1.422447	4.78	3.71	0.41665	3.93	0.74723	1.355	0.33777	1.823000	0.29140	0.756	0.943	0.825	0.30151	0.000000	0.08389	0.036	0.13876	543	0.72771	6	0.0011980830670926517	6	0.0045385779122541605	0	0.0	0	0.0	0	0.0	0	0.0	184	264690	6.9515285E-4	.	12	109386	1.097030e-04	0	41	207618	1.974780e-04	0	37	236280	1.565940e-04	0	11	7162	1.535880e-03	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9034	0.000000e+00	0	0	13392	0.000000e+00	0	0	42764	0.000000e+00	0	0	15690	0.000000e+00	0	11	7162	1.535880e-03	0	38	16132	2.355570e-03	0	2	30520	6.553080e-05	0	0	6210	0.000000e+00	0	0	13404	0.000000e+00	0	0	16732	0.000000e+00	0	0	89154	0.000000e+00	0	0	30608	0.000000e+00	0	38	16132	2.355570e-03	0	35	14818	2.361990e-03	0	2	34254	5.838730e-05	0	0	9562	0.000000e+00	0	0	17680	0.000000e+00	0	0	21630	0.000000e+00	0	0	102206	0.000000e+00	0	0	30526	0.000000e+00	0	35	14818	2.361990e-03	0	.	168	1614174	1.040780e-04	1	161	75050	2.145240e-03	1	161	75050	2.145240e-03	1	0	912	0.000000e+00	0	2	60026	3.331890e-05	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	64030	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180006	0.000000e+00	0	0	91088	0.000000e+00	0	0	173958	0	0	352	0	0	2686	0	18	8832	0.0020380434782608695	0	796	0	0	968	0	0	652	0	0	280	0	1	13314	7.51089079164789E-5	18	9184	0.00195993031358885	0	3338	0	19	201838	9.41349002665504E-5	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|Breast_neoplasm|not_specified	reviewed_by_expert_panel	NC_000017.11:g.43071223A>G	BRCA1-HCI:BRCA1_00023|ClinGen:CA002980	C3661900|C0677776|C0346153|C4554406|C2676676|C3280442|C0027672|C1458155|CN169374	114480|617883|604370|614320	145|227535|145|1333|140162	.	Leu	Pro	28.7	0.7560975609756098																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																28.7	75.60976	$\leqslant$50	10-90	604370;604370;617883;114480;614320	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST CANCER; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4	false	0.8944205542780168	0.9074682168957778	false	false	false
F9	F9_Arg3His	B_13-14	-0.6646270003672425	0.5275693100249713	0.6081215341869012	0.7209969603199433	0.49428073364385383	0.5480393632848772	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5644169726665966	0.5786618255702856	0.5230938035945205	0.5981901896278502	0.6499351472552992	0.588091229895444	0.6260695433022359	0.6358428846388819	0.5536880195717349	0.5764622385448674	0.5636078854368404	0.5404463428175581	0.5501129164886522	0.6640274098717166	0.6426923596839655	0.46972536864417364	0.5937157657037307	0.588387602515635	F9	Arg3His	NC_000023.11:139530772:G:A	8G>A	23	139530772	G	A	X	ENSG00000101981	52861	0	CCSBVarC030452	ALE00032243	ENSP00000218099.2																																	684952.0	single nucleotide variant	NM_000133.4(F9):c.8G>A (p.Arg3His)	2158.0	F9	HGNC:3551	Benign	0.0	Feb 09, 2024	148060786.0	-	RCV000861920|RCV001081775|RCV001825712|RCV002265904|RCV002478952|RCV003965649	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease|not specified|Hereditary factor IX deficiency disease;Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530772.0	139530772.0	Xq27.1	reviewed by expert panel	7.0	-	N	-	2.0	695909.0	139530772.0	G	A	-	-	-	-	-	-	8G>A 	Arg3His	NM_000133.4	3.0	Benign	Benign	695909	X	139530772.0	G	A	R	H	rs148060786	X	138612931	X	138440597	3	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.8G>A	p.Arg3His	c.8G>A	p.Arg3His	principal1	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.54	0.06843	T	0.623	0.07487	T	0.001	0.07480	B	0.001	0.04348	B	0.02	0.08015	N	simple_aae	98.0	2.0	0.205	0.09279	N	0.19	0.05100	N	0.091	0.23222	-0.6784	0.61281	T	0.3975	0.74876	T	10	0.012512207	0.00265	T	0.062861	0.68674	D	0.532	0.80205	.	.	.	.	.	0.989276777832	0.98903	0.607146497614182	0.60467	0.0904167817641	0.09995	0.199505895376	0.00444	T	0.285427	0.65629	T	-0.230633	0.16278	T	-0.111328	0.62239	T	0.00217856688188496	0.00022	T	0.586841	0.21248	T	0.04500583	0.07223	0.04018554	0.04300	0.04972076	0.08789	0.0453144	0.06085	-4.362	0.29885	T	0.0795	0.23673	B	0.255918012225158	0.52475	0.99980062	0.99739	0.04	0.09634	.	.	.	.	.	.	0.548254	0.09195	5.951	0.44299318418515177	0.03427	.	.	.	.	.	.	.	.	.	5.08	0.559	0.16423	0.286	0.23548	0.553	0.2318	0.503000	0.19087	0.674	0.70877	0.081	0.22441	0.010000	0.20072	0.697	0.34088	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	144	264690	5.4403266E-4	.	22	80300	2.739730e-04	0	40	151765	2.635650e-04	0	42	171840	2.444130e-04	0	11	5701	1.929490e-03	0	0	13657	0.000000e+00	0	0	1767	0.000000e+00	0	3	6914	4.339020e-04	0	0	9911	0.000000e+00	0	5	30950	1.615510e-04	0	3	9950	3.015080e-04	0	11	5701	1.929490e-03	0	24	13132	1.827600e-03	0	1	24348	4.107110e-05	0	0	4649	0.000000e+00	0	4	10120	3.952570e-04	0	0	12166	0.000000e+00	0	7	64659	1.082600e-04	0	4	19068	2.097760e-04	0	24	13132	1.827600e-03	0	22	12062	1.823910e-03	0	1	27124	3.686770e-05	0	0	7072	0.000000e+00	0	5	13311	3.756290e-04	0	0	15968	0.000000e+00	0	10	73164	1.366790e-04	0	4	19003	2.104930e-04	0	22	12062	1.823910e-03	0	.	185	1208214	1.531190e-04	2	78	57381	1.359330e-03	0	78	57381	1.359330e-03	0	0	687	0.000000e+00	0	11	45755	2.404110e-04	0	0	22010	0.000000e+00	0	18	33770	5.330170e-04	0	0	46663	0.000000e+00	0	1	4346	2.300970e-04	0	49	893284	5.485380e-05	1	21	56779	3.698550e-04	1	5	152892	3.270282290767339E-5	0	176	0	5	4502	0.0011106175033318525	10	4710	0.0021231422505307855	0	442	0	0	950	0	5	1848	0.0027056277056277055	0	280	0	4	11712	3.4153005464480874E-4	10	4886	0.002046663937781416	10	6350	0.0015748031496062992	29	177512	1.6336923700932895E-4	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	reviewed_by_expert_panel	NC_000023.11:g.139530772G>A	.	C0008533|C5393318|C2749016|C3661900|CN169374	306900|301052|300807	98879	.	Arg	His	34.0	0.9717741935483871																																																																																																																																																																																																																																																																																																																																																																																																															0.951		0.953		0.977		1.014		0.968																																																						241			34.0	Positively-charged	Arginine												-4.5																		175									52.1				135.6						C (loop/coil)	C (loop/coil)				Signal								34.0	97.17742	$\leqslant$50	$\geqslant$90	306900;300807;306900;306900;301052;300807	x-linked	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; HEMOPHILIA B; WARFARIN SENSITIVITY, X-LINKED; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.5786618255702856	0.5644169726665966	false	false	false
BRCA1	BRCA1_His239Arg	B_13-14	1.417428348829569	0.1992960548370097	0.2803059386882832	3.364407036958549	0.01201174712743942	0.020056010899773737	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	true	true	false	true	0.9294041484543523	0.9307098777089191	0.9308877954128797	0.9609898624730597	0.9224791525859355	0.9771558307424547	0.9834665172486655	0.9305327142126891	0.9546674146586149	0.9452355643789445	0.9216884971480647	0.9324448433287602	0.9708451442362439	0.9144255909591817	0.9673123102875045	0.9165400264468149	0.9397312582697734	0.9263634535799444	BRCA1	His239Arg	NC_000017.11:43094815:T:C	716A>G	17	43094815	T	C	17	ENSG00000012048	14613	0	CCSBVarC013119	ALE00008997	ENSP00000417148.1																																	70344.0	single nucleotide variant	NM_007294.4(BRCA1):c.716A>G (p.His239Arg)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 18, 2019	80357396.0	-	RCV000112775|RCV000212160|RCV000509604|RCV001284302|RCV001339091|RCV004730865	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43094815.0	43094815.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003832,UniProtKB:P38398#VAR_007760	2.0	55677.0	43094815.0	T	C	-	-	-	-	-	-	716A>G 	His239Arg	NM_007294.4	3.0	Benign	Benign	55677	17	43094815.0	T	C	H	R	rs80357396	17	41246832	17	38500358	239	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.716A>G	p.His239Arg	principal2	Y	.	.	.	-	CAT	2	0	T	T/T	T/T	T/T	T/T	.	0.32128	.	.	0.54888	.	0.246	0.31119	B	0.088	0.29689	B	.	0.37131	.	.	.	.	1.685	0.43087	L	.	0.47184	.	.	0.46309	-0.9591	0.39179	T	0.1025	0.37609	T	10	.	0.21054	.	0.091977	0.75728	D	.	0.84105	0.1	0.01473	E9PFC7	H239R	Gain of helix (P = 0.0496)| Loss of loop (P = 0.0603)| Gain of phosphorylation at S242 (P = 0.0822)| Gain of catalytic residue at H239 (P = 0.1099)| Loss of glycosylation at S242 (P = 0.135)	.	0.84735	.	0.23229	.	0.28222	0.27954185009	0.07426	T	0.185323	0.53598	T	0.239413	0.77438	D	0.12161	0.78181	D	0.148020625114441	0.16733	T	.	0.43633	.	0.035958365	0.04291	0.04630083	0.06439	0.035795223	0.04242	0.04520483	0.06046	-3.317	0.13969	T	.	0.10254	.	0.0751285277574732	0.40751	0.99015945	0.96756	0.062	0.17126	.	.	.	.	.	.	0.040361	0.04582	1.25	0.79293829124576731	0.12881	0.152364	0.27488	N	-0.571032691664479	0.19588	1.040847	-0.739922874726497	0.15702	0.8425785	4.64	-1.76	0.07559	2.57E-4	0.21563	-0.794	0.04696	-0.577000	0.08433	0.609	0.47831	0.004	0.16649	0.001000	0.17376	0.804	0.3794	494	0.76469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109054	9.169770e-06	0	2	206786	9.671830e-06	0	2	235362	8.497550e-06	0	0	7154	0.000000e+00	0	0	16994	0.000000e+00	0	0	2310	0.000000e+00	0	0	9020	0.000000e+00	0	0	13374	0.000000e+00	0	1	42666	2.343790e-05	0	0	15632	0.000000e+00	0	1	42666	2.343790e-05	0	0	15854	0.000000e+00	0	0	30300	0.000000e+00	0	0	6190	0.000000e+00	0	0	13376	0.000000e+00	0	0	16690	0.000000e+00	0	2	89080	2.245170e-05	0	0	30498	0.000000e+00	0	2	89080	2.245170e-05	0	0	14542	0.000000e+00	0	0	34032	0.000000e+00	0	0	9544	0.000000e+00	0	0	17632	0.000000e+00	0	0	21568	0.000000e+00	0	2	102084	1.959170e-05	0	0	30416	0.000000e+00	0	2	102084	1.959170e-05	0	.	5	1613714	3.098440e-06	0	5	1179908	4.237620e-06	0	0	74988	0.000000e+00	0	0	912	0.000000e+00	0	0	59900	0.000000e+00	0	0	29590	0.000000e+00	0	0	44872	0.000000e+00	0	0	63992	0.000000e+00	0	0	6060	0.000000e+00	0	5	1179908	4.237620e-06	0	0	91010	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43094815T>C	ClinGen:CA003832|UniProtKB:P38398#VAR_007760	C3661900|CN169374|C0677776|C2676676|C0027672	604370	145|145|140162	.	His	Arg	32.01	0.8913043478260869			0.357		-0.24																																																																																										-1.264																																																																																																																																																																																																																																																																																																																																																																														152			32.84	Positively-charged	Histidine		Breast cancer type 1 susceptibility protein										-3.2																		155									76.8				147.9	Disordered					C (loop/coil)	C (loop/coil)												32.01	89.13044	$\leqslant$50	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.9307098777089191	0.9294041484543523	false	false	false
BRCA1	BRCA1_Lys502Glu	B_13-14	0.8105603126478718	0.44429777323077857	0.536076277239916	5.61655036149595	0.0008019556151327337	0.0019913241593620653	2025_01_Batch_13-14	false	false	false	false	false	true	false	false	false	false	false	false	0.8424440372445225	0.8502103593442671	0.756725891053692	0.9188430297925092	0.856837491755545	0.8785564468941632	0.8827890628620074	0.8835436093670588	0.9403654538873871	0.7435080850213506	0.8822339998600609	0.8718194235174523	0.874323830926319	0.8301313741440313	0.8973206056976313	0.7699436970860334	0.8181867188284733	0.8130686509715926	BRCA1	Lys502Glu	NC_000017.11:43071098:T:C	1504A>G	17	43071098	T	C	17	ENSG00000012048	14613	0	CCSBVarC003301	ALE00003301	ENSP00000417148.1	CEGS2	CegsMutGDEh1026	D01	GDEhDisVCh_40059	H08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	46168.0	single nucleotide variant	NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 18, 2019	80356943.0	-	RCV000031193|RCV000048668|RCV000130005|RCV000436368|RCV001281714|RCV000735492|RCV004554630	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MedGen:CN221562|	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Breast and/or ovarian cancer|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43071098.0	43071098.0	17q21.31	reviewed by expert panel	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003037,UniProtKB:P38398#VAR_007790	2.0	37612.0	43071098.0	T	C	-	-	-	-	-	-	4816A>G 	Lys1606Glu	NM_007294.4	3.0	Benign	Benign	37612	17	43071098.0	T	C	K	E	rs80356943	17	41223115	17	38476641	1606	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.4816A>G	p.Lys1606Glu	principal2	Y	1	.	.	-	AAA	1	0	T	T/T	T/T	T/T	T/T	.	0.72322	.	.	0.49207	.	0.0	0.02950	B	0.0	0.01384	B	.	0.99291	.	.	.	.	0	0.06502	N	.	0.10767	.	.	0.28302	-0.5432	0.66897	T	0.4017	0.75178	T	10	.	0.37017	.	0.227152	0.88048	D	.	0.75894	.	.	.	.	.	.	0.58443	.	0.16602	.	0.12617	0.260015904903	0.04893	T	0.098826	0.40015	T	0.0938011	0.63355	D	0.0772584	0.75211	D	0.106747360008648	0.12918	T	0.852615	0.53662	D	0.096304744	0.22477	0.09333296	0.22003	0.09800102	0.22901	0.07730816	0.17192	-3.059	0.10842	T	.	0.04993	.	0.00105470856972761	0.09785	0.99718000	0.98290	0.042	0.10339	.	.	.	.	.	.	1.918289	0.24404	16.37	0.91817812478712357	0.21378	0.169829	0.29455	N	-0.929974890242364	0.10024	0.4834715	-0.879878298600479	0.12355	0.6474283	4.92	2.88	0.32534	3.03	0.55386	2.465	0.44835	6.225000	0.55234	-0.114	0.14662	0.492	0.26984	1.000000	0.68239	0.007	0.07843	543	0.72771	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	3	109406	2.742080e-05	0	5	208130	2.402340e-05	0	7	236868	2.955230e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	3	42768	7.014590e-05	0	0	15690	0.000000e+00	0	3	42768	7.014590e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	5	89554	5.583220e-05	0	0	30608	0.000000e+00	0	5	89554	5.583220e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	7	102672	6.817830e-05	0	0	30526	0.000000e+00	0	7	102672	6.817830e-05	0	.	50	1613986	3.097920e-05	0	45	1180018	3.813500e-05	0	1	74914	1.334860e-05	0	0	912	0.000000e+00	0	0	59958	0.000000e+00	0	0	29606	0.000000e+00	0	0	44898	0.000000e+00	0	0	64032	0.000000e+00	0	0	6084	0.000000e+00	0	45	1180018	3.813500e-05	0	0	91082	0.000000e+00	0	1	19780	5.0556117290192114E-5	0	298	0	0	86	0	1	7864	1.271617497456765E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	1982	0	1	8162	1.2251899044351874E-4	0	112	0	2	30890	6.474587245063128E-5	BRCA1-related_disorder|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43071098T>C	ClinGen:CA003037|UniProtKB:P38398#VAR_007790	CN169374|C0677776|CN221562|C0027672|C3661900|C2676676	604370	145|140162|145	.	Lys	Glu	29.69	0.975609756097561																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																29.69	97.560974	$\leqslant$50	$\geqslant$90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.8502103593442671	0.8424440372445225	false	false	false
BRCA1	BRCA1_Val275Ile	B_13-14	-0.4219542876087648	0.6857151825709713	0.7501237106016926	3.575783798699408	0.009026864283015919	0.015685886325127095	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	false	false	0.8378545729380402	0.8464878251590696	0.7678754415372133	0.8830994570509272	0.9364122554132173	0.8951789826859895	0.7967879386323947	0.9161074583757547	0.772338970954175	0.6176903868059498	0.7312784444883468	0.7235572497372625	0.9935700267395842	0.9567170524506798	0.9938599431476792	0.918060496268477	0.9616972058297925	0.9521518961388178	BRCA1	Val275Ile	NC_000017.11:43090997:C:T	823G>A	17	43090997	C	T	17	ENSG00000012048	14613	0	CCSBVarC013078	ALE00008935	ENSP00000417148.1																																	69778.0	single nucleotide variant	NM_007294.4(BRCA1):c.4132G>A (p.Val1378Ile)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 18, 2019	28897690.0	-	RCV000048456|RCV000195345|RCV000130952|RCV000112269|RCV000588834|RCV000735522|RCV001353555|RCV004803994	MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Breast and/or ovarian cancer|Malignant tumor of breast|BRCA1-related cancer predisposition	germline;unknown	germline	GRCh38	NC_000017.11	17	43090997.0	43090997.0	17q21.31	reviewed by expert panel	18.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002653,UniProtKB:P38398#VAR_070487	2.0	55111.0	43090997.0	C	T	-	-	-	-	-	-	4132G>A 	Val1378Ile	NM_007294.4	3.0	Benign	Benign	55111	17	43090997.0	C	T	V	I	rs28897690	17	41243014	17	38496540	1378	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4132G>A	p.Val1378Ile	c.4132G>A	p.Val1378Ile	principal2	Y	1	YES	Select	-	GTC	1	0	C	C/C	C/C	C/C	C/C	0.214	0.26644	T	0.235	0.32573	T	0.001	0.32504	B	0.0	0.18137	B	0.01	0.13669	N	simple_aae	99.0	1.0	-0.69	0.01960	N	-0.03	0.09903	N	0.195	0.22590	-0.7244	0.59072	T	0.3134	0.68210	T	10	0.012888253	0.00272	T	0.079338	0.73121	D	0.497	0.78048	.	.	.	.	.	0.158396225186	0.15034	.	0.03344	.	0.07277	0.214491963387	0.01019	T	0.079098	0.35782	T	-0.262208	0.12388	T	-0.205768	0.53787	T	0.0166096592434054	0.00420	T	.	0.29041	.	0.019548856	0.00487	0.028340364	0.01070	0.016553821	0.00205	0.02649676	0.00748	-3.941	0.23134	T	0.0686	0.07209	B	0.000385430296663524	0.05956	0.96491360	0.94286	0.084	0.23719	.	.	.	.	.	.	-0.113362	0.03572	0.688	0.76991446859715706	0.11882	0.095446	0.19078	N	-1.3898584281667	0.02705	0.1210794	-1.32035774990261	0.04105	0.1960024	4.66	0.167	0.14242	-6.06	0.02993	-0.366	0.07635	0.284000	0.16868	-2.609	0.00233	0.0	0.06393	0.024000	0.21036	0.529	0.2973	519	0.74474	.	.	.	.	.	.	.	.	.	.	.	.	129	264690	4.873626E-4	.	19	108190	1.756170e-04	0	27	206062	1.310290e-04	0	41	234636	1.747390e-04	1	0	6938	0.000000e+00	0	16	16980	9.422850e-04	0	0	2220	0.000000e+00	0	1	9016	1.109140e-04	0	0	13288	0.000000e+00	0	2	42360	4.721440e-05	0	0	15500	0.000000e+00	0	16	16980	9.422850e-04	0	0	15900	0.000000e+00	0	18	30256	5.949230e-04	0	0	6090	0.000000e+00	0	1	13376	7.476080e-05	0	0	16568	0.000000e+00	0	5	88838	5.628220e-05	0	2	30224	6.617260e-05	0	18	30256	5.949230e-04	0	0	14596	0.000000e+00	0	34	33994	1.000180e-03	1	0	9436	0.000000e+00	0	1	17648	5.666360e-05	0	0	21354	0.000000e+00	0	4	101906	3.925190e-05	0	2	30142	6.635260e-05	0	34	33994	1.000180e-03	1	.	164	1612732	1.016910e-04	1	89	59814	1.487950e-03	1	1	74898	1.335150e-05	0	0	912	0.000000e+00	0	89	59814	1.487950e-03	1	1	29506	3.389140e-05	0	1	44890	2.227670e-05	0	0	63834	0.000000e+00	0	4	6084	6.574620e-04	0	61	1179578	5.171340e-05	0	5	90788	5.507340e-05	0	2	26660	7.501875468867217E-5	0	114	0	0	120	0	0	3236	0	0	498	0	0	628	0	0	26	0	0	104	0	0	4696	0	0	3350	0	0	146	0	2	36082	5.542929992794191E-5	Malignant_tumor_of_breast|not_specified|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43090997C>T	ClinGen:CA002653|UniProtKB:P38398#VAR_070487	C0006142|CN169374|C3661900|C0677776|CN221562|C2676676|C0027672	604370	145|145|140162	.	Val	Ile	34.39	0.9436619718309859																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																34.39	94.366196	$\leqslant$50	$\geqslant$90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.8464878251590696	0.8378545729380402	false	false	false
BRCA1	BRCA1_Ala102Gly	B_13-14	-1.4050219512461604	0.20280504742642533	0.2844035540267785	-15.590922854250527	1.0796966552991854e-6	0.000017228203151947872	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	false	false	0.9513094571218874	0.96762211183058	0.7377495524040912	0.7964071696822088	0.71609055506833	0.8000873442297849	0.8782886821151241	0.7991214491883818	0.8321475739095168	0.7999750954304472	0.9803287245006576	0.9786154002326127	0.7218860063444457	0.6330596609482781	0.760666765454901	0.6755240093777353	0.9549154991605024	0.924003514011162	BRCA1	Ala102Gly	NC_000017.11:43104258:G:C	305C>G	17	43104258	G	C	17	ENSG00000012048	14613	0	CCSBVarC013080	ALE00008723	ENSP00000417148.1																																	46061.0	single nucleotide variant	NM_007294.4(BRCA1):c.305C>G (p.Ala102Gly)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 11, 2024	80357190.0	-	RCV000031086|RCV000048062|RCV000166160|RCV000203639|RCV001353922|RCV004566761	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0700268,MedGen:CN377757	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|BRCA1-related cancer predisposition	germline;unknown	germline	GRCh38	NC_000017.11	17	43104258.0	43104258.0	17q21.31	reviewed by expert panel	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002009	2.0	37505.0	43104258.0	G	C	-	-	-	-	-	-	305C>G 	Ala102Gly	NM_007294.4	3.0	Benign	Benign	37505	17	43104258.0	G	C	A	G	rs80357190	17	41256275	17	38509801	102	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	c.305C>G	p.Ala102Gly	c.305C>G	p.Ala102Gly	principal2	Y	1	.	.	-	GCA	2	0	G	G/G	G/G	G/G	G/G	0.006	0.68399	D	0.065	0.48945	T	0.057	0.44237	B	0.023	0.42592	B	.	0.61445	.	.	.	.	2.24	0.63167	M	-0.52	0.48535	N	.	0.53827	-0.8845	0.49200	T	0.1938	0.54543	T	10	0.33566126	0.50348	D	0.118185	0.79755	D	0.606	0.84430	0.48	0.55849	E9PFC7	A102G	Loss of stability (P = 0.0442)| Gain of relative solvent accessibility (P = 0.0999)| Gain of disorder (P = 0.157)| Gain of catalytic residue at S104 (P = 0.1636)| Loss of phosphorylation at Y101 (P = 0.2814)	0.947690629548	0.94671	.	0.33795	.	0.20076	0.312466681004	0.12270	T	0.212967	0.57203	T	0.262764	0.79636	D	0.139666	0.79372	D	0.518966853618622	0.33015	D	.	0.80632	.	0.12579814	0.29224	0.06543072	0.13260	0.12579814	0.29224	0.06543072	0.13260	-4.128	0.40366	T	0.1268	0.35034	LB	0.485608964919914	0.60346	0.99054370	0.96816	0.105	0.29145	.	.	.	.	.	.	2.791559	0.36769	20.3	0.99356524987265227	0.60877	0.328409	0.42717	N	0.0961423372559193	0.46027	2.871031	0.125822333913209	0.45602	2.842934	5.32	3.24	0.36180	4.41	0.82967	1.516	0.35569	6.237000	0.55333	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.968	0.53734	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	1609246	2.485640e-06	0	1	74900	1.335110e-05	0	1	74900	1.335110e-05	0	0	912	0.000000e+00	0	0	59924	0.000000e+00	0	0	29582	0.000000e+00	0	0	44828	0.000000e+00	0	0	63826	0.000000e+00	0	0	6050	0.000000e+00	0	0	1176114	0.000000e+00	0	0	90756	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	1	24	0.041666666666666664	0	94	0	0	466	0	0	2294	0	1	108	0.009259259259259259	1	10680	9.363295880149813E-5	not_specified|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|BRCA1-related_cancer_predisposition|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43104258G>C	ClinGen:CA002009	CN169374|C0677776|C3661900|C2676676|CN377757|C0027672	604370	145|145|140162	.	Ala	Gly	57.52	0.7924528301886793			-0.502		0.104	1 mutation(s) (Ala102Ter: 1.530)																																																																																							0.0		-0.051																																																																																																																																																																																																																																																																																																																																																																														93			56.5	Aliphatic	Alanine		Breast cancer type 1 susceptibility protein										1.8																		89									-63.0				-5.1						C (loop/coil)	T (turn)												57.52	79.245285	50-70	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.96762211183058	0.9513094571218874	true	false	false
BCL10	BCL10_Leu8Leu	B_13-14	-1.1226016048049448	0.3782708234845428	0.4688496254740277	1.8528778935229038	0.1063171348804939	0.13985085484280022	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5148670833122052	0.7192182362507145	0.5153551674668799	0.7243885916983251	0.6997081979540595	0.565193605813816	0.565193605813816	0.6223221909926139	0.6716407458782689	0.5153551674668799	0.6776793525812802	0.5148670833122052		0.7770942049155051	0.7771364375183814		0.7607571199201488		BCL10	Leu8Leu	NC_000001.11:85276329:G:C	24C>G	1	85276329	G	C	1	ENSG00000142867	11832	0	CCSBVarC001764	ALE00001764	ENSP00000498104.1	RC4	RC4_Mut_GDEh1005	A04	GDEhDisVCh_40010	E03	2	RC4_Mut_GDDh1005	A04	NULL	NULL	VUSMutpDEST2_09	G09	VUSmut_GDEh12	C07	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	389441.0	single nucleotide variant	NM_003921.5(BCL10):c.24C>G (p.Leu8=)	8915.0	BCL10	HGNC:989	Benign	0.0	Feb 01, 2024	11576939.0	-	RCV000455048|RCV001510946|RCV004713977	MedGen:CN169374|MONDO:MONDO:0014491,MedGen:C4015195,OMIM:616098|MedGen:C3661900	not specified|Immunodeficiency 37|not provided	germline	germline	GRCh38	NC_000001.11	1	85276329.0	85276329.0	1p22.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA929835	2.0	402411.0	85276329.0	G	C	-	-	-	-	-	-	24C>G 	Leu8=	NM_003921.5	2.0	Benign	Benign																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												29			66.81	Aliphatic	Leucine		B-cell lymphoma/leukemia 10								0.2502		3.8																		131									-55.5		Pocket 1: Mean pLDDT: 47.42, Volume: 351.14 Å³, Druggability score: 0.25		125.3						C (loop/coil)	C (loop/coil)														NaN	NaN	616098	autosomal recessive	OMIM		0	IMMUNODEFICIENCY 37	false	0.7192182362507145	0.5148670833122052	false	false	false
FARS2	FARS2_Asn280Ser	B_13-14	-1.5655811200139778	1.0	1.0	-0.31670226276173263	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.73026572986178	0.7500719602739059	0.6916835167488158	0.7956943646907619	0.786180320262599	0.7992836775505852	0.7608015495377358	0.8126524816748234	0.7504814695342938	0.715320823111051	0.7483761199609679	0.7630993061634195	0.8377658055634346	0.7597081588503745	0.8409072598472299	0.6680462103865804	0.7517678005868438	0.6974321535601404	FARS2	Asn280Ser	NC_000006.12:5431107:A:G	839A>G	6	5431107	A	G	6	ENSG00000145982	12653	0	CCSBVarC011867	ALE00008580	ENSP00000274680.4																																	140995.0	single nucleotide variant	NM_006567.5(FARS2):c.839A>G (p.Asn280Ser)	10667.0	FARS2	HGNC:21062	Benign	0.0	Jul 31, 2024	11243011.0	-	RCV000124983|RCV000714927|RCV000677020|RCV001701760	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900|MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722	not specified|Combined oxidative phosphorylation defect type 14|not provided|Hereditary spastic paraplegia 77	germline;unknown	germline	GRCh38	NC_000006.12	6	5431107.0	5431107.0	6p25.1	criteria provided, multiple submitters, no conflicts	7.0	-	N	UniProtKB:O95363#VAR_052643,ClinGen:CA290845	2.0	137292.0	5431107.0	A	G	-	-	-	-	-	-	839A>G 	Asn280Ser	NM_006567.5	2.0	Benign	Benign	137292	6	5431107.0	A	G	N	S	rs11243011	6	5431340	6	5376339	280	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.839A>G	p.Asn280Ser	c.839A>G	p.Asn280Ser	principal1	Y	1	YES	Select	+	AAC	2	0	A	A/A	A/A	A/A	A/A	0.355	0.12180	T	0.358	0.17298	T	0.001	0.07480	B	0.001	0.04348	B	0.35	0.59775	P	simple_aae	65.0	35.0	-1.405	0.00593	N	-0.85	0.23101	N	0.057	0.02855	-1.0690	0.09648	T	0.0343	0.14655	T	9	0.0024745166	0.00036	T	.	.	.	0.045	0.12154	.	.	.	.	.	.	.	.	0.37527	.	0.13639	0.263113975525	0.05267	T	0.039256	0.24861	T	-0.686866	0.00042	T	-0.615592	0.11282	T	0.00545995115788096	0.00059	T	0.873413	0.59719	D	0.13583922	0.31242	0.081693865	0.18565	0.14538196	0.33047	0.072034046	0.15483	-4.658	0.32930	T	0.071	0.11803	B	0.0760332499692323	0.40859	0.01150617	0.42971	0.104	0.28905	.	.	.	.	.	.	1.830349	0.23297	15.95	0.96326186103365574	0.29640	0.180003	0.30517	N	-0.50634435902713	0.21618	1.164074	-0.278242492394687	0.28498	1.60963	5.5	3.13	0.35013	3.86	0.72457	3.397	0.52411	0.661000	0.20583	0.691	0.84104	1.0	0.71675	0.887000	0.27860	0.997	0.79771	957	0.09723	1178	0.23522364217252395	73	0.05521936459909228	162	0.1610337972166998	163	0.23487031700288186	481	0.4771825396825397	299	0.3057259713701431	45111	264690	0.17042956	.	24540	109368	2.243800e-01	3377	45917	208058	2.206930e-01	6059	52920	236782	2.234970e-01	7082	475	7162	6.632230e-02	25	4417	17098	2.583340e-01	595	655	2320	2.823280e-01	91	4291	9038	4.747730e-01	1044	2111	13394	1.576080e-01	164	7831	42760	1.831380e-01	746	4354	15682	2.776430e-01	667	4291	9038	4.747730e-01	1044	1162	16216	7.165760e-02	53	8147	30502	2.670970e-01	1117	1797	6212	2.892790e-01	257	6295	13402	4.697060e-01	1503	2609	16734	1.559100e-01	200	16375	89532	1.828960e-01	1525	8468	30596	2.767680e-01	1279	6295	13402	4.697060e-01	1503	1054	14900	7.073830e-02	49	8942	34234	2.612020e-01	1211	2718	9568	2.840720e-01	370	8428	17676	4.768050e-01	2039	3422	21632	1.581920e-01	262	18713	102644	1.823100e-01	1743	8452	30514	2.769880e-01	1276	8428	17676	4.768050e-01	2039	.	308230	1613374	1.910470e-01	32055	17868	44846	3.984300e-01	3721	5480	75004	7.306280e-02	224	286	912	3.135960e-01	39	14268	59996	2.378160e-01	1793	8354	29588	2.823440e-01	1158	17868	44846	3.984300e-01	3721	10087	63978	1.576640e-01	749	1150	6058	1.898320e-01	124	213144	1179548	1.807000e-01	19229	24843	90970	2.730900e-01	3623	52614	287826	0.1827979404223385	18	410	0.04390243902439024	2047	4918	0.4162261081740545	734	11560	0.06349480968858132	145	1244	0.11655948553054662	2175	9118	0.23853915332309716	891	1978	0.4504550050556117	1355	5196	0.26077752117013087	4344	18732	0.2319026265214606	752	11970	0.06282372598162071	2938	6896	0.42604408352668216	64323	340982	0.1886404560944566	not_specified|Hereditary_spastic_paraplegia_77|Combined_oxidative_phosphorylation_defect_type_14|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5431107A>G	ClinGen:CA290845|UniProtKB:O95363#VAR_052643	CN169374|C5569007|C4755312|C3661900	617046|614946	466722|319519	Aminoacyl-tRNA synthetase, class II	Asn	Ser	96.15	0.31210191082802546																																																																																																																																																																																																																																																																																																																																																																																																																																																																													49			96.15	Polar/Neutral	Asparagine												-3.5								 N280-E260 (PAE:  1.0)	N280-E260 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP)	 N280-E260 (PAE:  1.0), N280-E284 (PAE: 1.0)	N280-E284 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 8P8X, 3TUP), N280-E260 (PDBs: 5MGW, 8P8X, 3TUP), N280-W285 (PDBs: 8P8X, 3TUP)							132									-76.8				115.8						B (undefined)	E (parallel sheets)	Beta strand											96.15	31.21019	>90	10-90	614946;617046	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE	false	0.7500719602739059	0.73026572986178	false	false	false
SHOC2	SHOC2_Ser4Arg	B_13-14	-2.115892778315492	0.07215780633141851	0.1250648004473769	-1.2779634061574066	0.24200649193138557	0.29062952401445846	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8063542593078008	0.8126780647633207	0.7556558095820509	0.8236454386981857	0.8628676314943933	0.8011723854010754	0.9204682701650834	0.9173606271422792	0.9095657127592726	0.862646112544828	0.883898260562901	0.8713486127959178	0.6818765006370674	0.8083746358465074	0.7377251646370988	0.6486655066192739	0.7414578689637406	0.7413599058196839	SHOC2	Ser4Arg	NC_000010.11:110964368:A:C	10A>C	10	110964368	A	C	10	ENSG00000108061	11602	0	CCSBVarC027999	ALE00017484	ENSP00000358464.5																																	49105.0	single nucleotide variant	NM_007373.4(SHOC2):c.10A>C (p.Ser4Arg)	8036.0	SHOC2	HGNC:15454	Benign	0.0	Sep 17, 2024	397517231.0	-	RCV000038777|RCV000518991|RCV000680308|RCV001286384|RCV003914899	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|	not specified|RASopathy|not provided|Noonan syndrome-like disorder with loose anagen hair 1|SHOC2-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	110964368.0	110964368.0	10q25.2	reviewed by expert panel	8.0	-	N	ClinGen:CA136657	2.0	40635.0	110964368.0	A	C	-	-	-	-	-	-	10A>C 	Ser4Arg	NM_007373.4	3.0	Benign	Benign	40635	10	110964368.0	A	C	S	R	rs397517231	10	112724126	10	112714116	4	SHOC2	ENSG00000108061	ENST00000688928	ENSP00000509273	Q9UQ13	SHOC2_HUMAN	.	.	c.10A>C	p.Ser4Arg	principal1	Y	.	.	.	+	AGT	1	0	A	A/A	A/A	A/A	A/A	.	0.56615	.	.	0.41419	.	0.079	0.24484	B	0.023	0.19965	B	.	0.68318	.	.	.	.	1.39	0.34781	L	.	0.27215	.	.	0.39714	-1.0816	0.07056	T	0.0556	0.23288	T	10	.	0.00200	.	0.006028	0.15489	T	.	0.31580	0.368	0.37543	Q9UQ13	S4R	Loss of phosphorylation at S4 (P = 9e-04)| Gain of MoRF binding (P = 0.0056)| Loss of sheet (P = 0.0315)| Gain of loop (P = 0.069)| Loss of ubiquitination at K7 (P = 0.0702)	.	0.13132	.	0.01051	.	0.52424	0.607206702232	0.53855	T	0.200839	0.55638	T	-0.417862	0.01658	T	-0.376684	0.35750	T	0.0736649466610808	0.09046	T	.	0.74124	.	0.267935	0.49535	0.2938221	0.55197	0.32933065	0.55084	0.33612105	0.59185	-3.61	0.18016	T	.	0.64952	.	0.164860101419667	0.48012	0.00392193	0.30410	0.247	0.51713	.	.	.	.	.	.	3.701145	0.52871	23.3	0.99493880126885215	0.67671	0.875239	0.79781	D	-0.0156583439103937	0.40882	2.456036	0.218876124825274	0.50640	3.276892	5.62	5.62	0.85695	.	.	7.104	0.76723	9.339000	0.80231	0.751	0.87726	1.0	0.71675	1.000000	0.68239	1.0	0.97202	914	0.21043	.	.	.	.	.	.	.	.	.	.	.	.	47	264690	1.7756621E-4	.	56	108758	5.149050e-04	0	101	205586	4.912790e-04	0	104	233670	4.450720e-04	0	0	7132	0.000000e+00	0	54	16920	3.191490e-03	0	0	2310	0.000000e+00	0	0	8928	0.000000e+00	0	0	13386	0.000000e+00	0	0	42570	0.000000e+00	0	0	15610	0.000000e+00	0	54	16920	3.191490e-03	0	0	15362	0.000000e+00	0	99	30182	3.280100e-03	0	0	6158	0.000000e+00	0	0	13368	0.000000e+00	0	0	16712	0.000000e+00	0	0	88600	0.000000e+00	0	0	30440	0.000000e+00	0	99	30182	3.280100e-03	0	0	14110	0.000000e+00	0	102	33912	3.007780e-03	0	0	9530	0.000000e+00	0	0	17430	0.000000e+00	0	0	21590	0.000000e+00	0	0	101240	0.000000e+00	0	0	30358	0.000000e+00	0	102	33912	3.007780e-03	0	.	125	1613066	7.749220e-05	0	124	59742	2.075590e-03	0	0	74862	0.000000e+00	0	0	912	0.000000e+00	0	124	59742	2.075590e-03	0	0	29586	0.000000e+00	0	0	44892	0.000000e+00	0	0	63988	0.000000e+00	0	0	6080	0.000000e+00	0	0	1179630	0.000000e+00	0	0	90932	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	2	610	0.003278688524590164	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	2	14710	1.3596193065941537E-4	SHOC2-related_disorder|not_provided|RASopathy|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|not_specified	reviewed_by_expert_panel	NC_000010.11:g.110964368A>C	ClinGen:CA136657	C3661900|C5555857|C4478716|CN169374	607721	536391|2701	.	Ser	Arg	44.22	0.8692307692307693																																																																																																																																																																																																																																																																																																																																																																																																																																																																													113			44.22	Polar/Neutral	Serine		Leucine-rich repeat protein SHOC-2		Basic and acidic residues								-0.8																		105									-179.0				104.7	Disordered					C (loop/coil)	C (loop/coil)												44.22	86.92307	$\leqslant$50	10-90	607721	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	false	0.8126780647633207	0.8063542593078008	false	false	false
RAF1	RAF1_Pro225Ser	B_13-14	0.045139855443872445	1.0	1.0	5.107601917252922	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8559819638310443	0.8396878542882467	0.5500850854002711	0.6719350245075963	0.6631728120112783	0.6219234927571071	0.6540960662470295	0.6489664102701742	0.6480633539380127	0.618650770990304	0.8471311656546591	0.8647414863068662	0.5897509192671846	0.6773792137523823	0.69580669507718	0.48151939981023834	0.8322445429218344	0.8472224413552224	RAF1	Pro225Ser	NC_000003.12:12606208:G:A	673C>T	3	12606208	G	A	3	ENSG00000132155	732	0	CCSBVarC008834	ALE00011524	ENSP00000251849.4																																	1185992.0	single nucleotide variant	NM_002880.4(RAF1):c.673C>T (p.Pro225Ser)	5894.0	RAF1	HGNC:9829	Benign	0.0	-	1162264411.0	-	RCV001824999	Human Phenotype Ontology:HP:0009733,MONDO:MONDO:0021042,MeSH:D005910,MedGen:C0017638,Orphanet:182067	Glioma	somatic	somatic	GRCh38	NC_000003.12	3	12606208.0	12606208.0	3p25.2	no assertion criteria provided	1.0	-	N	-	2.0	1195988.0	12606208.0	G	A	-	-	-	-	-	-	673C>T 	Pro225Ser	NM_002880.4		Benign	Benign	1195988	3	12606208.0	G	A	P	S	rs1162264411	3	12647707	3	12622707	225	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.673C>T	p.Pro225Ser	c.673C>T	p.Pro225Ser	principal3	Y	1	YES	Select	-	CCT	1	0	G	G/G	G/G	G/G	G/G	0.247	0.17391	T	0.143	0.34455	T	0.001	0.07480	B	0.007	0.12988	B	0.68	0.81345	D	simple_aae	32.0	68.0	1.21	0.30316	L	-2.41	0.52959	N	0.434	0.49995	-0.7128	0.59644	T	0.2594	0.62866	T	10	0.27317715	0.44479	D	0.060663	0.67960	D	0.352	0.67153	0.195	0.10644	P04049	P225S	Gain of glycosylation at S220 (P = 0.0016)| Loss of loop (P = 0.0128)| Gain of helix (P = 0.0164)| Gain of MoRF binding (P = 0.0606)| Gain of phosphorylation at S227 (P = 0.2388)	0.862821236771	0.86042	.	0.66901	0.467073840312	0.45804	0.599457740784	0.52761	T	0.608994	0.87465	D	0.171707	0.71068	D	0.00886876	0.70695	D	0.893479943275452	0.54216	D	.	0.58900	.	0.20557491	0.42383	0.2595798	0.51511	0.20557491	0.42383	0.2595798	0.51510	-3.607	0.17972	T	0.096	0.20027	B	0.983665034452573	0.86265	0.63739080	0.84772	0.667	0.81494	.	.	.	.	.	.	3.640209	0.51695	23.1	0.99510956392309557	0.68658	0.643998	0.61904	D	-0.100171170643471	0.37113	2.174276	0.146625244996397	0.46694	2.933871	5.98	5.98	0.97142	5.35	0.93259	5.539	0.66985	11.868000	0.98500	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	659	0.61944	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Glioma	no_assertion_criteria_provided	NC_000003.12:g.12606208G>A	.	C0017638	.	182067	.	Pro	Ser	30.9	0.7941176470588235																																																																																																																																																																																																																																																																																																																																																																																																																																																																													108			30.9	Special, No backbone hydrogen	Proline		RAF proto-oncogene serine/threonine-protein kinase										1.6																		115									-137.4				173.0	Disordered					C (loop/coil)	C (loop/coil)												30.9	79.411766	$\leqslant$50	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.8396878542882467	0.8559819638310443	false	false	false
BRCA1	BRCA1_Phe558Ser	B_13-14	1.6111167737238428	0.15118946477997378	0.2263102490045062	5.375445540674276	0.0010354288390783917	0.002461155336410426	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	false	true	false	true	0.907177473194849	0.921138759948432	0.8815200849960252	0.9688937571826093	0.929248358819946	0.9668829640916001	0.9481956057491785	0.9304159044117523	0.9561715859467986	0.8050701462518037	0.91585016006786	0.9155622958217323	0.9855703224340218	0.9280808132281398	0.98161592841842	0.9579700237402465	0.926427359829004	0.8987926505679656	BRCA1	Phe558Ser	NC_000017.11:43070929:A:G	1673T>C	17	43070929	A	G	17	ENSG00000012048	14613	0	CCSBVarC013021	ALE00008962	ENSP00000417148.1																																	70006.0	single nucleotide variant	NM_007294.4(BRCA1):c.4985T>C (p.Phe1662Ser)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	28897695.0	-	RCV000112441|RCV000130003|RCV000443012|RCV001421999|RCV001703954	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43070929.0	43070929.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00091,ClinGen:CA003117	2.0	55339.0	43070929.0	A	G	-	-	-	-	-	-	4985T>C 	Phe1662Ser	NM_007294.4	3.0	Benign	Benign	55339	17	43070929.0	A	G	F	S	rs28897695	17	41222946	17	38476472	1662	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.4985T>C	p.Phe1662Ser	c.4985T>C	p.Phe1662Ser	principal2	Y	1	YES	Select	-	TTT	2	0	A	A/A	A/A	A/A	A/A	0.324	0.13470	T	0.483	0.15624	T	0.327	0.33186	B	0.072	0.28044	B	0.26	0.51279	N	simple_aae	74.0	26.0	0	0.06502	N	-0.41	0.54888	N	0.17	0.20657	-0.8141	0.54115	T	0.2316	0.59602	T	10	0.08930129	0.15320	T	0.095936	0.76440	D	0.521	0.79537	.	.	.	.	.	0.346544149963	0.33848	.	0.38144	.	0.17918	0.32687741518	0.14450	T	0.127873	0.45213	T	-0.0538666	0.43515	T	-0.0894503	0.63948	T	0.0101923026540198	0.00137	T	.	0.29269	.	0.15882574	0.35418	0.05462813	0.09445	0.15678944	0.35072	0.06600715	0.13457	-2.062	0.15503	T	0.1159	0.48135	B	0.242492734673284	0.51903	0.99607220	0.97952	0.115	0.31465	.	.	.	.	.	.	1.575156	0.20196	14.62	0.63349936367485471	0.07307	0.176669	0.30175	N	-1.19592149865023	0.05004	0.2298717	-1.20530321707257	0.05732	0.2786036	4.82	-1.61	0.07934	-3.96	0.06349	0.047	0.13983	1.542000	0.27319	-0.681	0.0423	0.006	0.17427	0.000000	0.08389	0.808	0.38116	544	0.72706	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	1	109362	9.143940e-06	0	2	206954	9.663980e-06	0	3	235478	1.274000e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	1	9044	1.105710e-04	0	0	13350	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	9044	1.105710e-04	0	0	16214	0.000000e+00	0	0	30522	0.000000e+00	0	0	6208	0.000000e+00	0	2	13414	1.490980e-04	0	0	16690	0.000000e+00	0	0	88440	0.000000e+00	0	0	30608	0.000000e+00	0	2	13414	1.490980e-04	0	0	14902	0.000000e+00	0	1	34258	2.919030e-05	0	0	9566	0.000000e+00	0	2	17690	1.130580e-04	0	0	21588	0.000000e+00	0	0	101348	0.000000e+00	0	0	30526	0.000000e+00	0	2	17690	1.130580e-04	0	.	21	1614022	1.301100e-05	0	17	44902	3.786020e-04	0	1	74928	1.334610e-05	0	0	912	0.000000e+00	0	1	60004	1.666560e-05	0	0	29608	0.000000e+00	0	17	44902	3.786020e-04	0	0	63964	0.000000e+00	0	0	6084	0.000000e+00	0	2	1180042	1.694850e-06	0	0	91090	0.000000e+00	0	0	85192	0	0	238	0	0	468	0	0	5996	0	0	648	0	0	2154	0	0	126	0	0	168	0	0	2604	0	0	6234	0	0	594	0	0	97594	0	Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43070929A>G	BRCA1-HCI:BRCA1_00091|ClinGen:CA003117	C0027672|CN169374|C0677776|C3661900|C2676676	604370	140162|145|145	BRCT domain|BRCT domain|BRCT domain	Phe	Ser	96.18	0.09644670050761421																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																96.18	9.6446705	>90	<10	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.921138759948432	0.907177473194849	false	false	false
BRCA1	BRCA1_Glu143Lys	B_13-14	1.0715681647773336	0.3194625014850119	0.40705362097156284	-3.763732118828379	0.007040413139430789	0.01267827096256673	2025_01_Batch_13-14	false	false	false	true	false	true	false	false	false	false	false	false	0.9163830637897264	0.9161084958365144	0.8189855688375516	0.921128715704804	0.8698006141944623	0.9254738000936353	0.9492449646846437	0.8921230546348335	0.9259966040168028	0.8950365656044657	0.9505789153166849	0.9481770753541199	0.901702635502627	0.847478173754091	0.9162608273928053	0.7429345720706376	0.8816380763563441	0.884589052225333	BRCA1	Glu143Lys	NC_000017.11:43104136:C:T	427G>A	17	43104136	C	T	17	ENSG00000012048	14613	0	CCSBVarC013134	ALE00008727	ENSP00000417148.1																																	46136.0	single nucleotide variant	NM_007294.4(BRCA1):c.427G>A (p.Glu143Lys)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80356991.0	-	RCV000031161|RCV000162967|RCV000588563|RCV000159939|RCV001798032|RCV001719704|RCV002250474|RCV002504841|RCV004758611	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:CN221562|MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|not provided|Familial cancer of breast|Pancreatic cancer, susceptibility to, 4;Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1|BRCA1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	43104136.0	43104136.0	17q21.31	reviewed by expert panel	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00055,ClinGen:CA002745	2.0	37580.0	43104136.0	C	T	-	-	-	-	-	-	427G>A 	Glu143Lys	NM_007294.4	3.0	Benign	Benign	37580	17	43104136.0	C	T	E	K	rs80356991	17	41256153	17	38509679	143	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.427G>A	p.Glu143Lys	principal2	Y	1	.	.	-	GAA	1	0	C	C/C	C/C	C/C	C/C	.	0.34767	.	.	0.57928	.	0.019	0.68795	B	0.006	0.55829	B	.	0.49097	.	.	.	.	1.5	0.37685	L	.	0.42578	.	.	0.38091	0.5017	0.90534	D	0.8767	0.95897	D	10	.	0.21644	.	0.247707	0.88953	D	.	0.79415	0.303	0.27037	E9PFC7	E143K	Gain of ubiquitination at E143 (P = 0.0025)| Gain of MoRF binding (P = 0.0124)| Gain of methylation at E143 (P = 0.1317)| Gain of relative solvent accessibility (P = 0.1684)| Loss of phosphorylation at S146 (P = 0.184)	.	0.86141	.	0.37990	.	0.10163	0.315168946981	0.12679	T	0.158884	0.49950	T	0.019488	0.54001	T	0.120218	0.78090	D	0.0473425365312362	0.04979	T	0.851115	0.53361	D	0.03369628	0.03605	0.04770675	0.06945	0.034599107	0.03876	0.05370916	0.09113	-4.389	0.42050	T	.	0.13983	.	0.681098547151026	0.66393	0.99696964	0.98220	0.018	0.02411	.	.	.	.	.	.	2.363521	0.30377	18.4	0.99087417036739323	0.52206	0.188915	0.31406	N	-0.366331149050496	0.26398	1.457724	-0.342651888589345	0.26417	1.478785	5.32	3.28	0.36615	2.24	0.42522	1.938	0.39936	1.666000	0.28012	-0.187	0.09644	0.861	0.30721	0.920000	0.28384	0.293	0.24381	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	10	264690	3.7780046E-5	.	11	109208	1.007250e-04	0	16	207718	7.702750e-05	0	19	236486	8.034300e-05	0	0	7152	0.000000e+00	0	1	17062	5.860980e-05	0	0	2320	0.000000e+00	0	5	9040	5.530970e-04	0	0	13370	0.000000e+00	0	2	42726	4.680990e-05	0	3	15626	1.919880e-04	0	5	9040	5.530970e-04	0	0	16186	0.000000e+00	0	1	30464	3.282560e-05	0	0	6212	0.000000e+00	0	5	13390	3.734130e-04	0	0	16710	0.000000e+00	0	6	89418	6.710060e-05	0	4	30484	1.312160e-04	0	5	13390	3.734130e-04	0	0	14870	0.000000e+00	0	1	34186	2.925170e-05	0	0	9572	0.000000e+00	0	8	17664	4.528990e-04	0	1	21600	4.629630e-05	0	5	102588	4.873860e-05	0	4	30402	1.315700e-04	0	8	17664	4.528990e-04	0	.	108	1613230	6.694640e-05	0	11	44878	2.451090e-04	0	0	74812	0.000000e+00	0	0	912	0.000000e+00	0	1	59920	1.668890e-05	0	0	29600	0.000000e+00	0	11	44878	2.451090e-04	0	0	63846	0.000000e+00	0	0	6080	0.000000e+00	0	89	1179784	7.543750e-05	0	6	90930	6.598480e-05	0	3	32728	9.166462967489611E-5	0	122	0	0	146	0	0	3824	0	0	500	0	0	628	0	0	56	0	0	104	0	0	6972	0	0	3946	0	0	202	0	3	45080	6.654835847382431E-5	Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Breast_and/or_ovarian_cancer|Hereditary_breast_ovarian_cancer_syndrome|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided	reviewed_by_expert_panel	NC_000017.11:g.43104136C>T	BRCA1-HCI:BRCA1_00055|ClinGen:CA002745	C0346153|C3280442|C2676676|C4554406|CN221562|C0677776|CN169374|C0027672|C3661900	114480|614320|604370|617883	227535|1333|145|145|140162	.	Glu	Lys	34.79	0.9020618556701031			-0.212		0.051																																																																																								0.143		-0.175																																																																																																																																																																																																																																																																																																																																																																														192			29.47	Negatively-charged	Glutamic Acid		Breast cancer type 1 susceptibility protein										-3.5																		146									179.7				175.4						C (loop/coil)	C (loop/coil)												34.79	90.206184	$\leqslant$50	$\geqslant$90	604370;114480;614320;114480;617883;604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.9161084958365144	0.9163830637897264	false	false	false
RAF1	RAF1_Asp381Asn	B_13-14	0.5714162180205059	1.0	1.0	1.2979507367601886	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6477899455164507	0.6339442097977419	0.5903594483576919	0.6542633369665769	0.6082752270893916	0.6198330463715396	0.5920571285862867	0.5469103205283379	0.5861271662110894	0.5878187606583312	0.6029829853619542	0.6302134679967485	0.6476089641567925	0.6696401336504455	0.7223995077220645	0.5929001360570527	0.6649054342335297	0.665366423036153	RAF1	Asp381Asn	NC_000003.12:12591760:C:T	1141G>A	3	12591760	C	T	3	ENSG00000132155	732	0	CCSBVarC008844	ALE00009037	ENSP00000251849.4																																	179051.0	single nucleotide variant	NM_002880.4(RAF1):c.1141G>A (p.Asp381Asn)	5894.0	RAF1	HGNC:9829	Benign	0.0	Apr 18, 2017	559632360.0	-	RCV000159079|RCV000522135|RCV001261134|RCV001813412|RCV002453552	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MedGen:CN230736	not specified|RASopathy|Noonan syndrome;Noonan syndrome with multiple lentigines|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000003.12	3	12591760.0	12591760.0	3p25.2	reviewed by expert panel	7.0	-	N	ClinGen:CA297118	2.0	181509.0	12591760.0	C	T	-	-	-	-	-	-	1141G>A 	Asp381Asn	NM_002880.4	3.0	Benign	Benign	181509	3	12591760.0	C	T	D	N	rs559632360	3	12633259	3	12608259	381	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.1141G>A	p.Asp381Asn	c.1141G>A	p.Asp381Asn	principal3	Y	1	YES	Select	-	GAC	1	0	c	C/C	C/C	C/C	C/C	0.741	0.05469	T	0.631	0.07289	T	0.0	0.02950	B	0.002	0.06938	B	0.09	0.26006	N	simple_aae	91.0	9.0	0.725	0.18664	N	-1.58	0.42002	N	0.141	0.15800	-0.8085	0.54456	T	0.2621	0.63163	T	10	0.012194514	0.00259	T	.	.	.	0.164	0.41991	0.348	0.34294	P04049	D381N	Gain of glycosylation at T383 (P = 0.0563)| Gain of MoRF binding (P = 0.0665)| Gain of methylation at K378 (P = 0.0678)| Gain of ubiquitination at K378 (P = 0.1989)| Gain of phosphorylation at T383 (P = 0.2411)	0.324009150485	0.31597	.	0.71714	1.20632500761	0.80616	0.628370404243	0.56847	T	0.710307	0.91654	D	-0.470963	0.00789	T	-0.45545	0.26743	T	0.0264849085100513	0.01464	T	.	0.37334	.	0.08191876	0.18674	0.063901514	0.12728	0.058604848	0.11702	0.05158828	0.08346	-4.384	0.37036	T	0.096	0.17894	B	0.00775539406038167	0.22004	0.70292550	0.86141	0.31	0.57690	.	.	.	.	.	.	1.897587	0.24145	16.27	0.69381873695721796	0.09095	0.104954	0.20775	N	-0.798101639362588	0.13197	0.6575577	-0.628625637051928	0.18464	1.003532	5.15	2.44	0.28799	0.329	0.23862	2.247	0.42906	2.200000	0.31363	-3.876	0.00054	0.959	0.33632	0.976000	0.30138	0.034	0.13647	685	0.5936	3	5.990415335463259E-4	0	0.0	0	0.0	0	0.0	0	0.0	3	0.003067484662576687	6	264690	2.2668026E-5	.	31	109408	2.833430e-04	0	70	208130	3.363280e-04	0	70	236836	2.955630e-04	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	30	15690	1.912050e-03	0	30	15690	1.912050e-03	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89556	1.116620e-05	0	69	30608	2.254310e-03	0	69	30608	2.254310e-03	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	1	102644	9.742410e-06	0	69	30526	2.260370e-03	0	69	30526	2.260370e-03	0	.	249	1614126	1.542630e-04	4	230	91082	2.525200e-03	4	0	75020	0.000000e+00	0	0	910	0.000000e+00	0	1	60020	1.666110e-05	0	0	29608	0.000000e+00	0	0	44880	0.000000e+00	0	0	64028	0.000000e+00	0	0	6062	0.000000e+00	0	11	1180012	9.321940e-06	0	230	91082	2.525200e-03	4	0	9902	0	0	114	0	0	120	0	1	3266	3.061849357011635E-4	0	146	0	0	610	0	0	26	0	1	104	0.009615384615384616	0	792	0	1	3380	2.958579881656805E-4	0	146	0	2	15080	1.326259946949602E-4	Cardiovascular_phenotype|RASopathy|not_specified|Noonan_syndrome|Noonan_syndrome_with_multiple_lentigines|Noonan_syndrome_and_Noonan-related_syndrome	reviewed_by_expert_panel	NC_000003.12:g.12591760C>T	ClinGen:CA297118	CN230736|C5555857|CN169374|C0028326|C0175704|C5681679	PS163950|PS151100	536391|648|500|98733	Protein kinase domain|Protein kinase domain|Protein kinase domain	Asp	Asn	81.48	0.8711656441717791																																																																																																																																																																																																																																																																																																																																																																																																																																																																													142			81.48	Negatively-charged	Aspartic Acid		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase			-3.5																		132									-125.2				94.9						C (loop/coil)	S (bend)												81.48	87.11656	70-90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.6339442097977419	0.6477899455164507	false	false	false
BRCA1	BRCA1_His299Tyr	B_13-14	-2.033763125966286	0.08145918034371533	0.13854588998797532	6.2761746546161055	0.00041355439162265147	0.0011937226251941364	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	false	true	false	true	0.9336136557640319	0.94376349053143	0.8744484562084562	0.9805617474116324	0.9405203108036545	0.9798455198681124	0.9754271349328967	0.9355633375381494	0.9744767531371883	0.8192974853701942	0.937131263038477	0.9299677656821802	0.9842639048033283	0.9454772840691597	0.9866467416860766	0.9295994270467183	0.950395718024383	0.9372595458458836	BRCA1	His299Tyr	NC_000017.11:43082557:G:A	895C>T	17	43082557	G	A	17	ENSG00000012048	14613	0	CCSBVarC011806	ALE00008938	ENSP00000417148.1																																	69807.0	single nucleotide variant	NM_007294.4(BRCA1):c.4204C>T (p.His1402Tyr)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357365.0	-	RCV000048486|RCV000083205|RCV000162983|RCV000254639|RCV001087632|RCV004554674|RCV004803996	MedGen:C3661900|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145||MONDO:MONDO:0700268,MedGen:CN377757	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|BRCA1-related disorder|BRCA1-related cancer predisposition	germline;unknown	germline	GRCh38	NC_000017.11	17	43082557.0	43082557.0	17q21.31	reviewed by expert panel	15.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00085,ClinGen:CA002707	2.0	55140.0	43082557.0	G	A	-	-	-	-	-	-	4204C>T 	His1402Tyr	NM_007294.4	3.0	Benign	Benign	55140	17	43082557.0	G	A	H	Y	rs80357365	17	41234574	17	38488100	1402	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	.	.	c.4204C>T	p.His1402Tyr	principal2	Y	1	.	.	-	CAT	1	0	C	G/G	G/G	G/G	G/G	.	0.27673	.	.	0.37649	.	0.019	0.18002	B	0.023	0.19965	B	.	0.21442	.	.	.	.	-0.345	0.03334	N	.	0.40464	.	.	0.37578	-0.7649	0.56959	T	0.3229	0.69047	T	10	.	0.14597	.	0.075011	0.72087	D	.	0.70364	0.173	0.07846	E9PFC7	H1402Y	Loss of catalytic residue at L1404 (P = 0.0693)| Loss of ubiquitination at K1406 (P = 0.071)| Gain of methylation at K1406 (P = 0.1374)| Loss of disorder (P = 0.146)| Loss of phosphorylation at T1399 (P = 0.2256)	.	0.55302	.	0.05014	.	0.12517	0.428560256958	0.28977	T	0.086384	0.37435	T	0.0446199	0.57354	T	-0.173683	0.56807	T	0.169085681438446	0.18287	T	.	0.31359	.	0.035931196	0.04282	0.049696308	0.07661	0.032783277	0.03337	0.04356669	0.05464	-4.172	0.39583	T	.	0.23217	.	0.00428760772610033	0.17785	0.96681190	0.94420	0.22	0.48657	.	.	.	.	.	.	3.245445	0.44401	21.9	0.97578969279789363	0.34893	0.283041	0.39425	N	-0.564913128253644	0.19776	1.052213	-0.336469916680358	0.26612	1.490904	5.35	4.38	0.51962	3.41	0.61757	1.739	0.37947	2.733000	0.34485	-0.805	0.03126	0.996	0.3946	1.000000	0.68239	0.79	0.37345	520	0.74375	.	.	.	.	.	.	.	.	.	.	.	.	7	264690	2.644603E-5	.	1	109398	9.140930e-06	0	1	208096	4.805470e-06	0	1	236816	4.222690e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13388	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13404	0.000000e+00	0	0	16728	0.000000e+00	0	0	89540	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	0	17680	0.000000e+00	0	0	21626	0.000000e+00	0	0	102644	0.000000e+00	0	0	30526	0.000000e+00	0	.	.	.	.	.	45	1614020	2.788070e-05	0	41	1180040	3.474460e-05	0	1	74914	1.334860e-05	0	0	912	0.000000e+00	0	0	59998	0.000000e+00	0	1	29606	3.377690e-05	0	0	44900	0.000000e+00	0	0	63994	0.000000e+00	0	0	6084	0.000000e+00	0	41	1180040	3.474460e-05	0	0	91084	0.000000e+00	0	1	24490	4.083299305839118E-5	0	108	0	0	84	0	0	2728	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4552	0	0	2836	0	0	108	0	1	33208	3.0113225728740063E-5	Hereditary_cancer-predisposing_syndrome|BRCA1-related_disorder|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_specified	reviewed_by_expert_panel	NC_000017.11:g.43082557G>A	BRCA1-HCI:BRCA1_00085|ClinGen:CA002707	C0027672|C0677776|C3661900|C2676676|CN169374	604370	140162|145|145	.	His	Tyr	89.18	0.6521739130434783																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																89.18	65.21739	70-90	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.94376349053143	0.9336136557640319	false	false	false
F9	F9_Ile7Phe	B_13-14	-1.8798922387074215	0.10218205798682319	0.16709565989283587	1.6947772859986143	0.13394174440834675	0.1717561851777193	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6396894946724188	0.6549423020808111	0.45556808697331413	0.6980979662839292	0.5756210155379808	0.6116543165611072	0.6761862436755721	0.5904941046899775	0.7383524326817106	0.4733015349249896	0.6751829732442831	0.7022596907194969	0.5471223894466424	0.560747926385984	0.6578434998861478	0.43783463902163866	0.634701630917339	0.5771192986253406	F9	Ile7Phe	NC_000023.11:139530783:A:T	19A>T	23	139530783	A	T	X	ENSG00000101981	52861	0	CCSBVarC030454	ALE00031028	ENSP00000218099.2																																	348532.0	single nucleotide variant	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	2158.0	F9	HGNC:3551	Benign	0.0	Feb 09, 2024	150190385.0	-	RCV000291239|RCV002282128|RCV001080823|RCV002488831|RCV003389717|RCV003970084	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MedGen:C5393318,OMIM:301052|MedGen:C3661900|	Hereditary factor IX deficiency disease|FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease;Warfarin sensitivity, X-linked|not provided|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139530783.0	139530783.0	Xq27.1	reviewed by expert panel	10.0	-	N	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	3.0	367997.0	139530783.0	A	T	-	-	-	-	-	-	19A>T 	Ile7Phe	NM_000133.4	3.0	Benign	Benign	367997	X	139530783.0	A	T	I	F	rs150190385	X	138612942	X	138440608	7	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.19A>T	p.Ile7Phe	c.19A>T	p.Ile7Phe	principal1	Y	1	YES	Select	+	ATC	1	0	A	A/A	A/A	A/A	A/A	0.006	0.61594	D	0.056	0.49207	T	0.003	0.11208	B	0.002	0.06938	B	0.14	0.35500	P	simple_aae	86.0	14.0	2.08	0.57221	M	-0.35	0.13539	N	0.495	0.79233	-0.2790	0.75458	T	0.5839	0.85002	D	10	0.025558144	0.00744	T	0.100824	0.77263	D	0.582	0.83109	.	.	.	.	.	0.997412915613	0.99734	0.7807951246571943	0.77906	0.154389061079	0.17172	0.449907898903	0.31890	T	0.32948	0.69801	T	-0.0400873	0.45599	T	0.164093	0.80917	D	0.0293591555932887	0.01881	T	0.762524	0.38598	T	0.09779945	0.22850	0.098687075	0.23494	0.115587294	0.27032	0.089293085	0.20840	-4.69	0.33321	T	0.0753	0.14905	B	0.920702462215045	0.77602	0.99992085	0.99909	0.237	0.50624	.	.	.	.	.	.	1.98797	0.25303	16.7	0.9197213938187907	0.21554	.	.	.	.	.	.	.	.	.	4.55	2.05	0.25790	2.76	0.50502	3.489	0.53093	6.602000	0.56127	0.754	0.88385	0.994	0.38383	1.000000	0.68239	0.903	0.43926	937	0.14592	3	7.947019867549669E-4	0	0.0	3	0.0039164490861618795	0	0.0	0	0.0	0	0.0	239	264690	9.029431E-4	.	62	80318	7.719320e-04	0	134	151801	8.827350e-04	0	154	171897	8.958850e-04	0	0	5701	0.000000e+00	0	9	13660	6.588580e-04	0	0	1767	0.000000e+00	0	0	6915	0.000000e+00	0	4	9922	4.031450e-04	0	46	30953	1.486120e-03	0	0	9950	0.000000e+00	0	46	30953	1.486120e-03	0	1	13132	7.614990e-05	0	14	24359	5.747360e-04	0	0	4647	0.000000e+00	0	0	10123	0.000000e+00	0	6	12179	4.926510e-04	0	109	64670	1.685480e-03	0	0	19068	0.000000e+00	0	109	64670	1.685480e-03	0	1	12062	8.290500e-05	0	17	27135	6.264970e-04	0	0	7073	0.000000e+00	0	0	13314	0.000000e+00	0	8	15983	5.005320e-04	0	125	73191	1.707860e-03	0	0	19003	0.000000e+00	0	125	73191	1.707860e-03	0	.	1538	1209789	1.271300e-03	2	1437	894566	1.606370e-03	2	10	57439	1.740980e-04	0	0	685	0.000000e+00	0	20	45789	4.367860e-04	0	0	22018	0.000000e+00	0	0	33784	0.000000e+00	0	21	46726	4.494290e-04	0	4	4352	9.191180e-04	0	1437	894566	1.606370e-03	2	0	56833	0.000000e+00	0	142	79906	0.0017770880784922284	0	174	0	0	2672	0	0	4118	0	0	436	0	2	928	0.0021551724137931034	0	656	0	0	272	0	4	3764	0.0010626992561105207	0	4292	0	0	3328	0	148	92926	0.0015926651313948733	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139530783A>T	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	C0008533|C2749016|C5393318|C3661900	306900|300807|301052	98879	.	Ile	Phe	38.98	0.7810650887573964																																																																																																																																																																																																																																																																																																																																																																																																															0.984		1.013		0.998		1.002		0.999																																																						132			38.98	Aliphatic	Isoleucine												4.5																		131									76.1				123.8						C (loop/coil)	C (loop/coil)				Signal								38.98	78.106514	$\leqslant$50	10-90	306900;300807;306900;300807;306900;301052	x-linked	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; WARFARIN SENSITIVITY, X-LINKED	false	0.6549423020808111	0.6396894946724188	false	false	false
BAP1	BAP1_Ser596Gly	B_13-14	0.351957833731541	0.7352272520962135	0.788923624440319	1.0503718377928355	0.3284513263433175	0.381702459683336	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5354975495673278	0.525436282433906	0.51074389195308	0.5066767854931877	0.5969625738981463	0.49404522393591455	0.531667949245737	0.6829308755635459	0.5497601467630919	0.5325331981687466	0.5776663526636985	0.5907749106425645	0.456422498626092	0.5109942722327468	0.4635934242232834	0.48895458573741335	0.4732062122041135	0.4802201884920909	BAP1	Ser596Gly	NC_000003.12:52403242:T:C	1786A>G	3	52403242	T	C	3	ENSG00000163930	3760	0	CCSBVarC009473	ALE00008910	ENSP00000417132.1																																	137403.0	single nucleotide variant	NM_004656.4(BAP1):c.1786A>G (p.Ser596Gly)	8314.0	BAP1	HGNC:950	Benign	0.0	Jul 17, 2024	79014342.0	-	RCV000120192|RCV000569518|RCV000396271|RCV003654201|RCV003315731	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MedGen:C3661900|MONDO:MONDO:0011696,MedGen:C1847723,OMIM:606661,Orphanet:39044	not specified|Hereditary cancer-predisposing syndrome|BAP1-related tumor predisposition syndrome|not provided|Melanoma, uveal, susceptibility to, 2	germline;unknown	germline	GRCh38	NC_000003.12	3	52403242.0	52403242.0	3p21.1	criteria provided, multiple submitters, no conflicts	14.0	-	N	ClinGen:CA157253	2.0	133664.0	52403242.0	T	C	-	-	-	-	-	-	1786A>G 	Ser596Gly	NM_004656.4	2.0	Benign	Benign	133664	3	52403242.0	T	C	S	G	rs79014342	3	52437258	3	52412298	596	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.1786A>G	p.Ser596Gly	c.1786A>G	p.Ser596Gly	principal1	Y	1	YES	Select	-	AGC	1	0	T	T/T	T/T	T/T	T/T	0.393	0.10794	T	0.485	0.14890	T	0.0	0.02950	B	0.0	0.01384	B	0.02	0.08015	P	simple_aae	98.0	2.0	1.39	0.34781	L	0.01	0.15507	N	0.119	0.10867	-1.0601	0.11740	T	0.0022	0.00700	T	10	0.0015929043	0.00018	T	.	.	.	0.046	0.12499	.	.	.	.	.	0.40146981186	0.39360	0.27734753240827054	0.27451	0.342242573836	0.35868	0.283363044262	0.07963	T	0.019939	0.15680	T	-0.690695	0.00040	T	-0.70984	0.05120	T	0.000335560480817249	0.00003	T	0.556544	0.19051	T	0.023078172	0.01012	0.035254005	0.02755	0.030649683	0.02742	0.042524464	0.05097	-4.038	0.24393	T	0.0674	0.02645	B	0.0411517187189644	0.35503	0.98504820	0.96067	0.024	0.04173	.	.	.	.	.	.	0.911982	0.12883	9.376	0.77187842073536805	0.11964	0.066346	0.12810	N	-1.03807936463251	0.07730	0.3647541	-0.89131888610997	0.12086	0.6318495	5.94	-0.682	0.10740	0.733	0.26955	0.015	0.13291	0.443000	0.18516	-0.12	0.14111	0.001	0.13799	0.545000	0.25517	0.339	0.25458	68	0.97129	135	0.026956869009584664	132	0.09984871406959153	1	9.940357852882703E-4	2	0.002881844380403458	0	0.0	0	0.0	6540	264690	0.02470815	.	683	109386	6.243940e-03	18	1445	208072	6.944710e-03	43	1393	236900	5.880120e-03	40	535	7164	7.467900e-02	18	122	17112	7.129500e-03	0	3	2320	1.293100e-03	0	0	9046	0.000000e+00	0	0	13372	0.000000e+00	0	20	42768	4.676390e-04	0	0	15690	0.000000e+00	0	535	7164	7.467900e-02	18	1203	16216	7.418600e-02	43	175	30514	5.735070e-03	0	7	6210	1.127210e-03	0	0	13416	0.000000e+00	0	0	16712	0.000000e+00	0	42	89532	4.691060e-04	0	2	30608	6.534240e-05	0	1203	16216	7.418600e-02	43	1108	14902	7.435240e-02	40	203	34250	5.927010e-03	0	15	9572	1.567070e-03	0	0	17692	0.000000e+00	0	0	21610	0.000000e+00	0	50	102730	4.867130e-04	0	2	30526	6.551790e-05	0	1108	14902	7.435240e-02	40	.	7156	1614170	4.433240e-03	250	5750	75034	7.663190e-02	242	5750	75034	7.663190e-02	242	0	912	0.000000e+00	0	419	60032	6.979610e-03	1	32	29608	1.080790e-03	0	1	44884	2.227970e-05	0	0	64004	0.000000e+00	0	36	6062	5.938630e-03	0	484	1180040	4.101560e-04	1	15	91084	1.646830e-04	0	75	190482	3.937379909912748E-4	29	370	0.07837837837837838	0	4510	0	681	9628	0.07073120066472788	21	812	0.02586206896551724	9	1042	0.008637236084452975	0	1850	0	0	296	0	79	17940	0.004403567447045708	710	9998	0.07101420284056811	0	6360	0	894	226930	0.0039395408275679725	not_specified|Hereditary_cancer-predisposing_syndrome|BAP1-related_tumor_predisposition_syndrome|Melanoma,_uveal,_susceptibility_to,_2|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52403242T>C	ClinGen:CA157253	CN169374|C0027672|C3280492|C1847723|C3661900	614327|606661	140162|289539|39044	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Ser	Gly	37.93	0.8076923076923077																																																																																																																																																																																																																																																																																																																																																																																																																																																																													105			37.93	Polar/Neutral	Serine		Ubiquitin carboxyl-terminal hydrolase BAP1		Polar residues								-0.8																		105									-162.1	Morphology: IQGsQGsssPVEKEV			173.9	Disordered; Interaction with BRCA1					C (loop/coil)	C (loop/coil)												37.93	80.769226	$\leqslant$50	10-90	614327;606661	autosomal dominant	GenCC	Rare genetic tumor	1	TUMOR PREDISPOSITION SYNDROME 1; MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2	false	0.525436282433906	0.5354975495673278	false	false	false
RAF1	RAF1_Asn71Ser	B_13-14	0.6062636477246898	1.0	1.0	0.8317408591390693	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5907812851370459	0.6285311688947235	0.5667993486494667	0.6518820322560668	0.6518550189226563	0.6302898121886922	0.5453460881744189	0.602837587706816	0.6098583706579526	0.5175520006467739	0.6137214761396921	0.6356232209039445	0.7152335362029656	0.7008724501384966	0.6939056938541811	0.6160466966521596	0.6433408616497549	0.5459393493701472	RAF1	Asn71Ser	NC_000003.12:12612058:T:C	212A>G	3	12612058	T	C	3	ENSG00000132155	732	0	CCSBVarC008840	ALE00008520	ENSP00000251849.4																																	49058.0	single nucleotide variant	NM_002880.4(RAF1):c.212A>G (p.Asn71Ser)	5894.0	RAF1	HGNC:9829	Benign	0.0	Apr 03, 2017	184022679.0	-	RCV000037686|RCV000461248|RCV000586687|RCV000620637|RCV004532499	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MedGen:CN230736|	not specified|RASopathy|not provided|Cardiovascular phenotype|RAF1-related disorder	germline	germline	GRCh38	NC_000003.12	3	12612058.0	12612058.0	3p25.2	reviewed by expert panel	8.0	-	N	ClinGen:CA134721	2.0	40588.0	12612058.0	T	C	-	-	-	-	-	-	212A>G 	Asn71Ser	NM_002880.4	3.0	Benign	Benign	40588	3	12612058.0	T	C	N	S	rs184022679	3	12653557	3	12628557	71	RAF1	ENSG00000132155	ENST00000251849	ENSP00000251849	P04049	RAF1_HUMAN	c.212A>G	p.Asn71Ser	c.212A>G	p.Asn71Ser	principal3	Y	1	YES	Select	-	AAT	2	0	T	T/T	T/T	T/T	T/T	0.466	0.08637	T	0.461	0.12752	T	0.107	0.26097	B	0.199	0.36806	B	0.51	0.71892	D	simple_aae	49.0	51.0	2.075	0.56867	M	-0.85	0.23101	N	0.396	0.46496	-0.7029	0.60130	T	0.2684	0.63840	T	10	0.023561597	0.00618	T	0.047179	0.62660	D	0.194	0.47225	.	.	.	.	.	0.700826663726	0.69587	.	0.38507	0.399458701232	0.40688	0.769439399242	0.77301	T	0.544649	0.84330	D	-0.441197	0.01189	T	-0.441903	0.28238	T	0.0241761773584133	0.01162	T	.	0.55502	.	0.367634	0.58081	0.13760614	0.32795	0.39323702	0.59936	0.16458307	0.37996	-5.34	0.40718	T	0.1357	0.33297	B	0.847923193550861	0.73002	0.26023328	0.75518	0.216	0.48172	.	.	.	.	.	.	2.411032	0.31048	18.61	0.96689436356771608	0.30927	0.643219	0.61854	D	-0.0733448836148503	0.38295	2.260626	0.0541083710929102	0.41984	2.553849	5.81	4.65	0.57575	3.15	0.57234	4.539	0.60453	1.237000	0.25166	-0.188	0.09552	1.0	0.71675	0.965000	0.29555	0.34	0.25482	637	0.64339	3	5.990415335463259E-4	0	0.0	0	0.0	3	0.004322766570605188	0	0.0	0	0.0	48	264690	1.813442E-4	.	31	109408	2.833430e-04	0	57	208132	2.738650e-04	0	60	236954	2.532140e-04	0	0	7164	0.000000e+00	0	27	17112	1.577840e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	3	42768	7.014590e-05	0	1	15690	6.373490e-05	0	27	17112	1.577840e-03	0	1	16218	6.165990e-05	0	48	30524	1.572530e-03	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	6	89556	6.699720e-05	0	2	30608	6.534240e-05	0	48	30524	1.572530e-03	0	1	14902	6.710510e-05	0	49	34260	1.430240e-03	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	0	21632	0.000000e+00	0	7	102752	6.812520e-05	0	2	30526	6.551790e-05	0	49	34260	1.430240e-03	0	.	152	1613932	9.417990e-05	0	63	60008	1.049860e-03	0	8	75034	1.066180e-04	0	0	912	0.000000e+00	0	63	60008	1.049860e-03	0	0	29602	0.000000e+00	0	4	44860	8.916630e-05	0	0	64018	0.000000e+00	0	0	6056	0.000000e+00	0	63	1179858	5.339630e-05	0	11	91088	1.207620e-04	0	28	178468	1.5689087119259476E-4	0	352	0	0	4476	0	0	8846	0	0	796	0	0	968	0	0	1818	0	0	280	0	1	15160	6.596306068601583E-5	0	9198	0	0	6294	0	29	211164	1.3733401526775396E-4	not_specified|Cardiovascular_phenotype|RASopathy|not_provided|RAF1-related_disorder	reviewed_by_expert_panel	NC_000003.12:g.12612058T>C	ClinGen:CA134721	CN169374|CN230736|C5555857|C3661900	.	536391	Raf-like Ras-binding|Raf-like Ras-binding|Raf-like Ras-binding	Asn	Ser	89.2	0.7707006369426752																																																																	-0.015		-0.037		-0.063		-0.055		-0.057		-0.072		-0.075	1 mutation(s) (Asn71Lys: 0.411)	-0.131	1 mutation(s) (Asn71Lys: 0.748)	-0.213	1 mutation(s) (Asn71Lys: 1.232)																																																																																																																																																																																																																																																																									-0.174																																																																																																																		121			89.2	Polar/Neutral	Asparagine		RAF proto-oncogene serine/threonine-protein kinase							RBD			-3.5			D:N71-B:P (PDBs: 6PTS)	D:N71-B:P (PDBs: 6PTS), D:N71-B:I (PDBs: 6PTW), F:N71-E:I36 (PDBs: 8T75)					N71-N56 (PDBs: 6XGU)		N71-C81 (PDBs: 8JOF, 6XI7, 7JHP), N71-N56 (PDBs: 8JOG, 8T74), N71-T57 (PDBs: 1GUA, 4G0N, 6XGU, 8EPW, 8T75)							132									-81.6				134.0						B (undefined)	E (parallel sheets)	Beta strand											89.2	77.07006	70-90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.6285311688947235	0.5907812851370459	false	false	false
F9	F9_Pro175Ser	B_13-14	0.5239758224501593	0.6164710018454577	0.6901873467320189	-1.841541395376454	0.10810028941792629	0.1419928640528953	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7239670666342998	0.7339807364166071	0.5377479930208364	0.7231725645317078	0.6892942419076324	0.613075581247496	0.7145247528518501	0.7209967436647915	0.7819619143620724	0.6019017305232313	0.731518093939602	0.7515190989506942	0.5116264096431418	0.6575917401504734	0.6643832147013431	0.4735942555184416	0.7364433788936123	0.6964150343179053	F9	Pro175Ser	NC_000023.11:139551064:C:T	523C>T	23	139551064	C	T	X	ENSG00000101981	52861	0	CCSBVarC030541	ALE00019038	ENSP00000218099.2																																	689353.0	single nucleotide variant	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	2158.0	F9	HGNC:3551	Benign	0.0	Jan 19, 2024	762986355.0	-	RCV000868038|RCV001825736	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139551064.0	139551064.0	Xq27.1	criteria provided, single submitter	2.0	-	N	-	2.0	700019.0	139551064.0	C	T	-	-	-	-	-	-	523C>T 	Pro175Ser	NM_000133.4	1.0	Benign	Benign	700019	X	139551064.0	C	T	P	S	rs762986355	X	138633223	X	138460889	175	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.523C>T	p.Pro175Ser	c.523C>T	p.Pro175Ser	principal1	Y	1	YES	Select	+	CCA	1	0	C	C/C	C/C	C/C	C/C	0.036	0.44852	D	0.161	0.33883	T	0.354	0.33728	B	0.086	0.29523	B	0.48	0.69764	N	simple_aae	52.0	48.0	2.175	0.60790	M	-2.89	0.60697	D	0.463	0.57301	0.8690	0.95250	D	0.8615	0.95381	D	10	0.250471	0.41984	D	0.228259	0.88100	D	0.756	0.91637	0.388	0.40807	P00740	P175S	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.975270461492	0.97476	0.9703241368253629	0.97004	1.6529612223	0.89525	0.425827980042	0.28604	T	0.697249	0.91165	D	0.0546764	0.58654	T	0.239642	0.85025	D	0.345082526519166	0.26526	T	0.842116	0.51695	T	0.40378746	0.60670	0.38183606	0.62938	0.40378746	0.60670	0.38183606	0.62938	-5.249	0.39483	T	0.1096	0.35518	B	0.970189561557157	0.83311	0.99996960	0.99978	0.852	0.91893	.	.	.	.	.	.	3.416071	0.47496	22.5	0.99894604001216725	0.96821	.	.	.	.	.	.	.	.	.	5.13	5.13	0.69688	.	.	4.715	0.61684	4.861000	0.45547	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	15	264690	5.6670066E-5	.	4	80161	4.989960e-05	0	8	151269	5.288590e-05	0	11	171600	6.410260e-05	0	0	5698	0.000000e+00	0	0	13630	0.000000e+00	0	0	1757	0.000000e+00	0	4	6911	5.787870e-04	0	0	9927	0.000000e+00	0	0	30931	0.000000e+00	0	0	9860	0.000000e+00	0	4	6911	5.787870e-04	0	0	13125	0.000000e+00	0	0	24325	0.000000e+00	0	0	4624	0.000000e+00	0	8	10120	7.905140e-04	0	0	12181	0.000000e+00	0	0	64445	0.000000e+00	0	0	18839	0.000000e+00	0	8	10120	7.905140e-04	0	0	12057	0.000000e+00	0	0	27098	0.000000e+00	0	0	7059	0.000000e+00	0	11	13308	8.265700e-04	0	0	15971	0.000000e+00	0	0	73207	0.000000e+00	0	0	18774	0.000000e+00	0	11	13308	8.265700e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551064C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	94.18	0.8014705882352942																																																																																																																																																																																																																																																																																																																																																																																																															0.866		0.856		0.837		0.802		0.829																																																						109			94.18	Special, No backbone hydrogen	Proline		Coagulation factor IX; Coagulation factor IXa light chain										1.6																		115									-60.0				-37.6						C (loop/coil)	S (bend)	Beta strand											94.18	80.14706	>90	10-90	306900;300807;306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	false	0.7339807364166071	0.7239670666342998	false	false	false
BRCA1	BRCA1_Gly602Ala	B_13-14	3.458879566726189	0.010563565807662701	0.028179344542787373	2.448360476306822	0.044213438463083156	0.0635330145495361	2025_01_Batch_13-14	false	false	false	true	true	true	false	false	false	false	false	false	0.940070530710135	0.9331927418728441	0.8483892224870702	0.955418139898762	0.9297197176257284	0.9418096911821238	0.8928187133129323	0.9222353593583995	0.9259955143721085	0.7714893170698406	0.9164203748573196	0.9288374826809749	0.9908006690513153	0.9372040758930573	0.9848407654254155	0.9252891279042998	0.9499651088883686	0.9513035787392952	BRCA1	Gly602Ala	NC_000017.11:43063909:C:G	1805G>C	17	43063909	C	G	17	ENSG00000012048	14613	0	CCSBVarC013096	ALE00008980	ENSP00000417148.1																																	70073.0	single nucleotide variant	NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80356860.0	-	RCV000048801|RCV000077598|RCV000162991|RCV000586262|RCV001086320|RCV001353853	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43063909.0	43063909.0	17q21.31	reviewed by expert panel	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00109,ClinGen:CA003250,UniProtKB:P38398#VAR_070502	2.0	55406.0	43063909.0	C	G	-	-	-	-	-	-	5117G>C 	Gly1706Ala	NM_007294.4	3.0	Benign	Benign	55406	17	43063909.0	C	G	G	A	rs80356860	17	41215926	17	38469452	1706	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.5117G>C	p.Gly1706Ala	principal2	Y	.	.	.	-	GGA	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.858	0.90580	P	0.415	0.97365	B	.	0.97016	.	.	.	.	1.88	0.49806	L	.	0.77997	.	.	0.83220	-0.0839	0.80378	T	0.4691	0.79463	T	10	.	0.52478	.	0.376865	0.92864	D	.	0.79354	.	.	.	.	.	.	0.85197	.	0.86205	.	0.41014	0.788811266422	0.80226	T	0.144841	0.58712	T	0.220015	0.75596	D	0.234626	0.84783	D	0.174270822478175	0.18632	T	.	0.95417	.	0.7676474	0.81684	0.45108074	0.67803	0.816965	0.84823	0.6340818	0.78412	-8.619	0.65921	D	.	0.77716	.	0.953210802210829	0.80831	0.99961549	0.99542	0.738	0.85485	.	.	.	.	.	.	4.015836	0.59356	24.1	0.99832727521296616	0.91463	0.783255	0.71325	D	0.704029495450117	0.79789	7.175777	0.72533764037511	0.84214	8.254455	5.83	5.83	0.93049	.	.	4.855	0.62708	7.634000	0.62929	0.53	0.24764	1.0	0.71675	1.000000	0.68239	0.995	0.73271	549	0.72286	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	25	264690	9.445011E-5	.	4	109376	3.657110e-05	0	11	208038	5.287500e-05	0	10	236838	4.222300e-05	0	0	7158	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	1	13394	7.466030e-05	0	1	42758	2.338740e-05	0	0	15682	0.000000e+00	0	1	42758	2.338740e-05	0	0	16206	0.000000e+00	0	1	30514	3.277180e-05	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	1	16734	5.975860e-05	0	5	89502	5.586470e-05	0	0	30596	0.000000e+00	0	5	89502	5.586470e-05	0	0	14892	0.000000e+00	0	0	34250	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	1	21628	4.623640e-05	0	5	102688	4.869120e-05	0	0	30514	0.000000e+00	0	5	102688	4.869120e-05	0	.	75	1614060	4.646670e-05	0	4	6062	6.598480e-04	0	0	75038	0.000000e+00	0	0	912	0.000000e+00	0	4	59998	6.666890e-05	0	0	29604	0.000000e+00	0	0	44864	0.000000e+00	0	8	64028	1.249450e-04	0	4	6062	6.598480e-04	0	48	1179976	4.067880e-05	0	0	91072	0.000000e+00	0	2	31050	6.44122383252818E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4596	2.175805047867711E-4	0	2918	0	0	112	0	3	39902	7.518420129316827E-5	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Malignant_tumor_of_breast	reviewed_by_expert_panel	NC_000017.11:g.43063909C>G	BRCA1-HCI:BRCA1_00109|ClinGen:CA003250|UniProtKB:P38398#VAR_070502	C0027672|CN169374|C3661900|C0677776|C2676676|C0006142	604370	140162|145|145	BRCT domain|BRCT domain|BRCT domain	Gly	Ala	95.97	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																95.97	0.0	>90	<10	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.9331927418728441	0.940070530710135	false	false	false
BRCA1	BRCA1_Pro533Leu	B_13-14	-0.7528200911783965	0.47610774311243165	0.560990616498917	5.364005835277965	0.00104825547835976	0.002488420184722069	2025_01_Batch_13-14	false	false	true	false	true	true	false	false	false	false	false	false	0.8953349250665437	0.8863854137895733	0.8544696910911879	0.9340332362256119	0.9089021084212741	0.944197989461495	0.8978125934646467	0.9057839548410447	0.8830280782120254	0.8465892612042061	0.8362594930048287	0.8519497881380609	0.9905833854583433	0.9120202620015034	0.9850383942391984	0.8623501209781697	0.9365113345743177	0.9387200619950264	BRCA1	Pro533Leu	NC_000017.11:43071004:G:A	1598C>T	17	43071004	G	A	17	ENSG00000012048	14613	0	CCSBVarC013043	ALE00008958	ENSP00000417148.1																																	69981.0	single nucleotide variant	NM_007294.4(BRCA1):c.4910C>T (p.Pro1637Leu)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357048.0	-	RCV000048691|RCV000077589|RCV000162989|RCV000586145|RCV001084321|RCV001358461|RCV004554683	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|BRCA1-related disorder	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43071004.0	43071004.0	17q21.31	reviewed by expert panel	15.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00090,ClinGen:CA003076,UniProtKB:P38398#VAR_007794	2.0	55314.0	43071004.0	G	A	-	-	-	-	-	-	4910C>T 	Pro1637Leu	NM_007294.4	3.0	Benign	Benign	55314	17	43071004.0	G	A	P	L	rs80357048	17	41223021	17	38476547	1637	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.4910C>T	p.Pro1637Leu	principal2	Y	.	.	.	-	CCA	2	0	G	G/G	G/G	G/G	G/G	.	0.58783	.	.	0.79703	.	0.364	0.66535	B	0.057	0.65195	B	.	0.53339	.	.	.	.	1.935	0.51654	L	.	0.81462	.	.	0.43554	0.4923	0.90403	D	0.7232	0.90488	D	10	.	0.62760	.	0.458461	0.94460	D	.	0.82485	.	.	.	.	.	.	0.90380	.	0.27141	.	0.09620	0.296533286572	0.09880	T	0.271505	0.64184	T	0.206619	0.74322	D	0.189468	0.82413	D	0.231254577636719	0.21745	T	.	0.48325	.	0.038577784	0.05118	0.050610814	0.07993	0.046824034	0.07827	0.055308446	0.09687	-3.524	0.18016	T	.	0.23603	.	0.544346036701319	0.62126	0.99945563	0.99403	0.431	0.66835	.	.	.	.	.	.	2.130503	0.27171	17.35	0.98451927561516039	0.41758	0.144722	0.26561	N	0.0679651651785688	0.44715	2.761733	-0.0712680779194096	0.36281	2.130881	4.82	4.82	0.61594	2.66	0.48641	0.768	0.26344	6.732000	0.56527	-0.105	0.15707	0.75	0.29224	1.000000	0.68239	0.031	0.13278	543	0.72771	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	1	109402	9.140600e-06	0	7	208052	3.364540e-05	0	5	236818	2.111330e-05	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	7	89482	7.822800e-05	0	0	30608	0.000000e+00	0	7	89482	7.822800e-05	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21626	0.000000e+00	0	5	102628	4.871960e-05	0	0	30526	0.000000e+00	0	5	102628	4.871960e-05	0	.	60	1614068	3.717320e-05	0	57	1180046	4.830320e-05	0	0	74916	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29608	0.000000e+00	0	0	44898	0.000000e+00	0	0	64024	0.000000e+00	0	0	6084	0.000000e+00	0	57	1180046	4.830320e-05	0	0	91086	0.000000e+00	0	1	19780	5.0556117290192114E-5	0	298	0	0	86	0	0	7864	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1982	0	0	8162	0	0	112	0	1	30890	3.237293622531564E-5	Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|BRCA1-related_disorder|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_specified	reviewed_by_expert_panel	NC_000017.11:g.43071004G>A	BRCA1-HCI:BRCA1_00090|ClinGen:CA003076|UniProtKB:P38398#VAR_007794	C0027672|C0006142|C3661900|C0677776|C2676676|CN169374	604370	140162|145|145	.	Pro	Leu	27.9	0.8455882352941176																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																27.9	84.55882	$\leqslant$50	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.8863854137895733	0.8953349250665437	false	false	false
BRCA1	BRCA1_Ser408Ile	B_13-14	0.010557865224829883	0.9918707968983869	0.9934311599768846	9.911212238436196	0.000022689065756006088	0.0001288991816169386	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8533021265123812	0.8655588198555613	0.6849995715242437	0.9043007360070229	0.8085991013747604	0.8253745710154652	0.9189898969615946	0.9055311830215877	0.9502513211758461	0.6960923480729527	0.9066463780462846	0.8766881304011345	0.7317592450693359	0.7116670197279331	0.8583501508381997	0.6739067949755347	0.824471261664838	0.829916122623628	BRCA1	Ser408Ile	NC_000017.11:43074471:C:A	1223G>T	17	43074471	C	A	17	ENSG00000012048	14613	0	CCSBVarC011797	ALE00008735	ENSP00000417148.1																																	50265.0	single nucleotide variant	NM_007294.4(BRCA1):c.4535G>T (p.Ser1512Ile)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	1800744.0	-	RCV000034752|RCV000048591|RCV000120258|RCV000112356|RCV000162492|RCV002490467|RCV004803118	MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0700268,MedGen:CN377757	not provided|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S;Familial cancer of breast;Breast-ovarian cancer, familial, susceptibility to, 1|BRCA1-related cancer predisposition	germline;unknown	germline	GRCh38	NC_000017.11	17	43074471.0	43074471.0	17q21.31	reviewed by expert panel	40.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00016,ClinGen:CA002898,UniProtKB:P38398#VAR_007788	2.0	41826.0	43074471.0	C	A	-	-	-	-	-	-	4535G>T 	Ser1512Ile	NM_007294.4	3.0	Benign	Benign	41826	17	43074471.0	C	A	S	I	rs1800744	17	41226488	17	38480014	1512	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.4535G>T	p.Ser1512Ile	principal2	Y	1	.	.	-	AGT	2	0	c	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.83643	.	0.337	0.48353	B	0.133	0.44046	B	.	0.30097	.	.	.	.	1.895	0.50187	L	.	0.69035	.	.	0.51076	-0.1200	0.79542	T	0.6215	0.86620	D	10	.	0.01326	.	0.681988	0.97361	D	.	0.79231	.	.	.	.	.	.	0.85105	.	0.41210	.	0.11066	0.293080568314	0.09368	T	0.248577	0.61629	T	-0.0795722	0.39433	T	0.113053	0.77610	D	0.0327816211501777	0.02419	T	0.844516	0.52040	T	0.08077421	0.18357	0.10349156	0.24785	0.12831177	0.29740	0.1181652	0.28456	-5.059	0.39100	T	.	0.43431	.	0.215013996355067	0.50654	0.99944790	0.99395	0.237	0.50624	.	.	.	.	.	.	2.346036	0.30125	18.32	0.99298489580117766	0.58603	0.255502	0.37258	N	-0.32701834229789	0.27846	1.548759	-0.413545015947272	0.24281	1.347945	4.95	3.98	0.45320	2.01	0.39759	3.214	0.50958	1.912000	0.29737	0.591	0.32125	0.012	0.18747	0.005000	0.19288	0.122	0.19292	534	0.73376	3	5.990415335463259E-4	1	7.564296520423601E-4	1	9.940357852882703E-4	1	0.001440922190201729	0	0.0	0	0.0	637	264690	0.0024065888	.	244	109396	2.230430e-03	0	497	208108	2.388180e-03	1	554	236830	2.339230e-03	1	4	7164	5.583470e-04	0	37	17112	2.162230e-03	0	14	2320	6.034480e-03	0	0	9040	0.000000e+00	0	23	13390	1.717700e-03	0	154	42766	3.600990e-03	0	11	15690	7.010830e-04	0	154	42766	3.600990e-03	0	12	16218	7.399190e-04	0	58	30524	1.900140e-03	0	29	6210	4.669890e-03	0	0	13410	0.000000e+00	0	27	16730	1.613870e-03	0	348	89544	3.886360e-03	1	15	30608	4.900680e-04	0	348	89544	3.886360e-03	1	12	14902	8.052610e-04	0	59	34260	1.722120e-03	0	42	9568	4.389630e-03	0	0	17686	0.000000e+00	0	31	21628	1.433330e-03	0	387	102648	3.770170e-03	1	15	30526	4.913840e-04	0	387	102648	3.770170e-03	1	.	4969	1614128	3.078440e-03	17	164	29606	5.539420e-03	2	49	75028	6.530900e-04	1	0	912	0.000000e+00	0	87	60012	1.449710e-03	0	164	29606	5.539420e-03	2	0	44892	0.000000e+00	0	86	64022	1.343290e-03	1	12	6060	1.980200e-03	0	4340	1180008	3.677940e-03	10	61	91076	6.697700e-04	2	833	200638	0.004151755898683201	0	360	0	0	2756	0	12	9432	0.001272264631043257	1	796	0.001256281407035176	3	968	0.0030991735537190084	0	682	0	1	280	0.0035714285714285713	57	15836	0.0035993937863096743	12	9792	0.0012254901960784314	0	3438	0	907	231748	0.003913733883356059	Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|not_specified|not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43074471C>A	BRCA1-HCI:BRCA1_00016|ClinGen:CA002898|UniProtKB:P38398#VAR_007788	C0346153|C3280442|C2676676|C4554406|CN169374|C3661900|C0027672|C0677776	114480|614320|604370|617883	227535|1333|145|140162|145	.	Ser	Ile	32.51	0.823076923076923																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																32.51	82.30769	$\leqslant$50	10-90	604370;614320;617883;114480;604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; FANCONI ANEMIA, COMPLEMENTATION GROUP S; BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.8655588198555613	0.8533021265123812	false	false	false
RAD51D	RAD51D_Arg165Gln	B_13-14	2.2867183231461263	1.0	1.0	14.30591068342265	1.0	1.0	2025_01_Batch_13-14	false	false	true	false	false	false	false	false	false	false	false	false	0.9510493756174591	0.941454789770092	0.8373948379087361	0.8556656689273178	0.8065957476222778	0.874369206209436	0.8162999591390852	0.7565449533186301	0.7794345343089092	0.805880606686639	0.9216042828548974	0.9332817981339483	0.9324384532797869	0.8566465419259254	0.9318968035457263	0.8689090691308333	0.9613052966852867	0.9688169531009698	RAD51D	Arg165Gln	NC_000017.11:35106468:C:T	494G>A	17	35106468	C	T	17	ENSG00000185379	7201	0	CCSBVarC002917	ALE00002917	ENSP00000338790.6	RC4	NatVar_GDE_001	F05	GDEhDisVCh_40046	E03	2	NULL	NULL	NULL	NULL	VUSMutpDEST2_06	G01	VUSmut_GDEh12	E02	1.0	1.0	0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	151873.0	single nucleotide variant	NM_002878.4(RAD51D):c.494G>A (p.Arg165Gln)	5892.0	RAD51D	HGNC:9823	Benign	0.0	Feb 01, 2024	4796033.0	-	RCV000131069|RCV000245575|RCV000409134|RCV001705932	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35106468.0	35106468.0	17q12	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA167606,UniProtKB:O75771#VAR_020561	2.0	142159.0	35106468.0	C	T	-	-	-	-	-	-	494G>A 	Arg165Gln	NM_002878.4	2.0	Benign	Benign	142159	17	35106468.0	C	T	R	Q	rs4796033	17	33433487	17	30457600	165	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.494G>A	p.Arg165Gln	c.494G>A	p.Arg165Gln	principal1	Y	5	.	.	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.003	0.68399	D	1.0	0.01173	T	0.0	0.14667	B	0.001	0.04348	B	0.01	0.13669	P	simple_aae	99.0	1.0	-1.43	0.00575	N	-3.12	0.63808	D	0.019	0.15800	-1.0318	0.19845	T	0.0001	0.00038	T	9	0.0022848845	0.00033	T	.	.	.	0.127	0.34681	.	.	.	.	.	.	.	.	0.04975	.	0.41278	.	.	.	0.074496	0.34695	T	-0.647874	0.00072	T	-0.559582	0.16122	T	0.00742585393685776	0.00085	T	0.740726	0.35767	T	0.029415702	0.02411	0.048267353	0.07149	0.029415702	0.02411	0.048267353	0.07148	3.206	0.12431	T	0.057	0.00818	B	2.61638337411342e-05	0.01340	0.02316738	0.51051	0.078	0.22017	.	.	.	.	.	.	1.452401	0.18765	13.9	0.91470505594779028	0.20995	0.077101	0.15335	N	-1.06674822980265	0.07176	0.3368571	-0.830017416971714	0.13532	0.7160679	4.96	0.253	0.14768	1.12	0.30289	1.179	0.31705	0.032000	0.13801	-0.169	0.1135	1.0	0.71675	0.963000	0.29478	0.96	0.51684	917	0.20141	476	0.0950479233226837	18	0.01361573373676248	130	0.12922465208747516	153	0.22046109510086456	41	0.040674603174603176	134	0.13701431492842536	31713	264690	0.119811855	.	17045	107270	1.588980e-01	1699	31945	204674	1.560770e-01	3152	36543	232850	1.569380e-01	3557	180	6652	2.705950e-02	1	5012	16850	2.974480e-01	784	395	2196	1.798720e-01	42	413	9024	4.576680e-02	8	2281	13332	1.710920e-01	204	6003	41956	1.430780e-01	432	2481	15384	1.612710e-01	210	5012	16850	2.974480e-01	784	458	15532	2.948750e-02	12	9035	30024	3.009260e-01	1451	1134	6024	1.882470e-01	111	564	13384	4.213990e-02	6	2827	16654	1.697490e-01	255	12341	88222	1.398860e-01	860	4896	30022	1.630800e-01	411	9035	30024	3.009260e-01	1451	409	14258	2.868570e-02	9	9971	33746	2.954720e-01	1567	1778	9368	1.897950e-01	174	815	17666	4.613380e-02	15	3630	21494	1.688840e-01	330	14237	100834	1.411920e-01	990	4879	29942	1.629480e-01	407	9971	33746	2.954720e-01	1567	.	223574	1611192	1.387630e-01	17336	15964	59646	2.676460e-01	2333	2280	74974	3.041050e-02	55	100	912	1.096490e-01	6	15964	59646	2.676460e-01	2333	5762	29446	1.956800e-01	582	1940	44876	4.323020e-02	36	10732	63890	1.679760e-01	897	779	6052	1.287180e-01	57	162928	1178350	1.382680e-01	11455	14721	90614	1.624580e-01	1305	47230	333254	0.14172373024779897	6	594	0.010101010101010102	215	5014	0.04287993617869964	636	15964	0.03983963918817339	182	1488	0.12231182795698925	1955	7246	0.2698040298095501	99	1968	0.05030487804878049	864	5226	0.1653272101033295	3257	24004	0.13568571904682553	642	16558	0.03877279864717961	314	6982	0.04497278716700086	54444	394758	0.1379174076269512	not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.35106468C>T	ClinGen:CA167606|UniProtKB:O75771#VAR_020561	CN169374|C3661900|C3280345|C0027672	614291	145|140162	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Arg	Gln	95.74	0.7298387096774194																																																																																																																																																																																																																																																																																																																																																																																																																																																																													181			95.74	Positively-charged	Arginine		DNA repair protein RAD51 homolog 4										-4.5				D:R165-C:L88 (PDBs: 8FAZ, 8GBJ), C:R165-B:L88 (PDBs: 8OUY, 8OUZ), C:R165-B:T86 (PDBs: 8OUZ)				 R165-A161 (PAE:  1.0)	R165-A161 (PDBs: 8FAZ, 8GBJ, 8OUZ)	 R165-A161 (PAE:  1.0)	R165-A161 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ)							175									-62.8				-29.4						H (helix)	H (α-helix)	Helix											95.74	72.98387	>90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.941454789770092	0.9510493756174591	false	false	false
F9	F9_Thr194Ala	B_13-14	-4.730674388204422	0.003222282231961676	0.011292768923021654	4.490422328237727	0.002830646151654339	0.005728374893625198	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6650466817764591	0.696386854974979	0.6268938949507408	0.7582773376978944	0.645592938569703	0.7294707819643211	0.7773897341364379	0.6500157981315773	0.7421117001336393	0.6158989121961191	0.7124109507989236	0.7234142689405494	0.6815518297922043	0.6411700790078286	0.7744429752621496	0.6378888777053625	0.6803627591510345	0.6066790946123687	F9	Thr194Ala	NC_000023.11:139551121:A:G	580A>G	23	139551121	A	G	X	ENSG00000101981	52861	0	CCSBVarC030557	ALE00017280	ENSP00000218099.2																																	25627.0	single nucleotide variant	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	2158.0	F9	HGNC:3551	Benign	0.0	Feb 09, 2024	6048.0	-	RCV000011334|RCV000244191|RCV000396693|RCV001810847|RCV001521358|RCV001701639	MedGen:C3275410|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Deep venous thrombosis, protection against|not specified|Hereditary factor IX deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139551121.0	139551121.0	Xq27.1	reviewed by expert panel	10.0	-	N	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	3.0	10588.0	139551121.0	A	G	-	-	-	-	-	-	580A>G 	Thr194Ala	NM_000133.4	3.0	Benign	Benign	10588	X	139551121.0	A	G	T	A	rs6048	X	138633280	X	138460946	194	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.580A>G	p.Thr194Ala	c.580A>G	p.Thr194Ala	principal1	Y	1	YES	Select	+	ACT	1	0	A	A/A	A/A	A/A	A/A	0.648	0.04909	T	0.745	0.09544	T	0.0	0.02950	B	0.003	0.08696	B	0.01	0.30097	P	simple_aae	99.0	1.0	1.52	0.38202	L	-0.92	0.26798	N	0.064	0.03607	-1.0530	0.13578	T	0.0001	0.00038	T	9	0.0049726367	0.00105	T	.	.	.	0.255	0.56351	.	.	.	.	.	.	.	0.9285000041175393	0.92783	0.622737437607	0.56240	0.353132814169	0.18363	T	0.375	0.73694	T	-0.540244	0.00324	T	-0.40498	0.32443	T	0.00193173800424148	0.00020	T	0.315368	0.07400	T	0.058962863	0.11817	0.061581787	0.11917	0.060261868	0.12229	0.08421645	0.19334	-3.651	0.18612	T	0.0698	0.03453	B	0.167231588560137	0.48150	0.97858846	0.95383	0.285	0.55474	.	.	.	.	.	.	-0.17694	0.03219	0.533	0.38829522857183274	0.02657	.	.	.	.	.	.	.	.	.	4.94	1.21	0.20193	2.13	0.41176	0.555	0.23211	1.468000	0.26817	0.756	0.943	0.0	0.06393	0.000000	0.08389	0.058	0.15862	924	0.18019	550	0.1456953642384106	137	0.1365902293120638	225	0.293733681462141	72	0.13740458015267176	1	0.0013089005235602095	115	0.16016713091922005	54902	264690	0.20742	.	16623	80228	2.071970e-01	1323	32071	151686	2.114300e-01	2535	36870	172056	2.142910e-01	2944	770	5700	1.350880e-01	38	1374	13659	1.005930e-01	66	414	1765	2.345610e-01	38	16	6917	2.313140e-03	0	2622	9924	2.642080e-01	201	9294	30871	3.010590e-01	869	1776	9944	1.786000e-01	80	9294	30871	3.010590e-01	869	1728	13131	1.315970e-01	83	2323	24376	9.529870e-02	115	1078	4646	2.320280e-01	82	21	10126	2.073870e-03	0	3254	12177	2.672250e-01	252	19457	64547	3.014390e-01	1795	3334	19061	1.749120e-01	136	19457	64547	3.014390e-01	1795	1589	12061	1.317470e-01	71	2740	27155	1.009020e-01	137	1692	7081	2.389490e-01	131	34	13319	2.552740e-03	0	4254	15975	2.662910e-01	352	22239	73329	3.032770e-01	2037	3328	18996	1.751950e-01	135	22239	73329	3.032770e-01	2037	.	324101	1208948	2.680850e-01	31752	270320	894493	3.022050e-01	27999	7371	57124	1.290350e-01	343	182	680	2.676470e-01	14	5349	45709	1.170230e-01	284	5254	22031	2.384820e-01	418	56	33762	1.658670e-03	0	12521	46443	2.695990e-01	1065	1194	4346	2.747350e-01	111	270320	894493	3.022050e-01	27999	10024	56776	1.765530e-01	425	75761	252184	0.3004195349427402	34	410	0.08292682926829269	8	4970	0.0016096579476861167	1539	11229	0.13705583756345177	252	1072	0.23507462686567165	395	3150	0.1253968253968254	7	1968	0.003556910569105691	946	5224	0.18108728943338437	3661	16561	0.22106153010083932	1573	11639	0.13514906778932897	15	6938	0.0021620063418852694	82603	296768	0.27834200452879015	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	reviewed_by_expert_panel	NC_000023.11:g.139551121A>G	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	C0008533|C2749016|C3661900|CN169374|C3275410	306900|300807	98879	.	Thr	Ala	33.7	0.8309859154929577																																																																																																																																																																																																																																																																																																																																																																																																															0.986		0.983		1.004		0.97		0.985																																																						118			33.7	Polar/Neutral	Threonine		Coagulation factor IX										-0.7																		119									-142.6			Activation peptide	101.6						C (loop/coil)	C (loop/coil)												33.7	83.09859	$\leqslant$50	10-90	306900;300807;306900;300807	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.696386854974979	0.6650466817764591	false	false	false
BRCA1	BRCA1_Asp67Tyr	B_13-14	2.5125896208651195	0.04024421782312692	0.07780005672284658	-1.566566553425073	0.1611991200805131	0.20246432946457327	2025_01_Batch_13-14	false	false	false	true	true	true	false	false	false	false	false	false	0.9459460202866047	0.9466625448097439	0.8563444412090103	0.9630953786466747	0.9248689215294761	0.9514467013955631	0.9912221295997172	0.9584183091911656	0.9836226665277258	0.9641169965660316	0.9749001943297682	0.9834473851373335	0.911671273191409	0.8913195338677867	0.9425680907656238	0.7485718858519891	0.9184248952897197	0.9084446554358758	BRCA1	Asp67Tyr	NC_000017.11:43106469:C:A	199G>T	17	43106469	C	A	17	ENSG00000012048	14613	0	CCSBVarC013083	ALE00008925	ENSP00000417148.1																																	69098.0	single nucleotide variant	NM_007294.4(BRCA1):c.199G>T (p.Asp67Tyr)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357102.0	-	RCV000047675|RCV000083176|RCV000148404|RCV000162582|RCV000195312|RCV000589035|RCV001353503|RCV002490619	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Malignant tumor of breast|Familial cancer of breast;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43106469.0	43106469.0	17q21.31	reviewed by expert panel	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00052,ClinGen:CA001328,UniProtKB:P38398#VAR_070460	2.0	54431.0	43106469.0	C	A	-	-	-	-	-	-	199G>T 	Asp67Tyr	NM_007294.4	3.0	Benign	Benign	54431	17	43106469.0	C	A	D	Y	rs80357102	17	41258486	17	38512012	67	BRCA1	ENSG00000012048	ENST00000713676	ENSP00000518978	P38398	BRCA1_HUMAN	.	.	c.199G>T	p.Asp67Tyr	principal2	Y	.	.	.	-	GAT	1	0	C	C/C	C/C	C/C	C/C	.	0.72322	.	.	0.79703	.	0.868	0.47756	P	0.24	0.38861	B	.	0.51279	.	.	.	.	1.25	0.31597	L	.	0.75325	.	.	0.67836	-0.0620	0.80864	T	0.6621	0.88225	D	10	.	0.34335	.	0.282437	0.90256	D	.	0.87125	.	.	.	.	.	.	0.86240	.	0.43573	.	0.11448	0.42940607667	0.29092	T	0.14757	0.48293	T	0.108459	0.64942	D	0.173063	0.81457	D	0.0394584648311138	0.03564	T	.	0.83345	.	0.28895706	0.51563	0.10798522	0.25949	0.378384	0.58872	0.13106883	0.31396	-6.164	0.51688	T	.	0.56478	.	0.956250935363193	0.81217	0.99734180	0.98344	0.64	0.79945	.	.	.	.	.	.	2.280806	0.29216	18.03	0.99318147251181976	0.59339	0.233566	0.35440	N	-0.260466381601807	0.30407	1.713454	-0.295009425429782	0.27944	1.574398	4.64	-1.4	0.08479	1.19	0.30954	0.033	0.13684	-0.025000	0.12924	0.531	0.24877	0.943	0.32853	0.000000	0.08389	0.993	0.69292	459	0.78836	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	10	264690	3.7780046E-5	.	8	109008	7.338910e-05	0	14	207104	6.759890e-05	0	17	235908	7.206200e-05	0	0	7140	0.000000e+00	0	1	16978	5.889980e-05	0	0	2308	0.000000e+00	0	0	9042	0.000000e+00	0	0	13390	0.000000e+00	0	7	42690	1.639730e-04	0	0	15548	0.000000e+00	0	7	42690	1.639730e-04	0	0	16118	0.000000e+00	0	2	30338	6.592390e-05	0	0	6186	0.000000e+00	0	0	13394	0.000000e+00	0	0	16710	0.000000e+00	0	12	89212	1.345110e-04	0	0	30298	0.000000e+00	0	12	89212	1.345110e-04	0	0	14808	0.000000e+00	0	2	34062	5.871650e-05	0	0	9548	0.000000e+00	0	0	17668	0.000000e+00	0	0	21604	0.000000e+00	0	15	102410	1.464700e-04	0	0	30216	0.000000e+00	0	15	102410	1.464700e-04	0	.	132	1596780	8.266640e-05	0	126	1165696	1.080900e-04	0	1	74666	1.339300e-05	0	0	912	0.000000e+00	0	2	59860	3.341130e-05	0	0	29466	0.000000e+00	0	0	44696	0.000000e+00	0	0	63924	0.000000e+00	0	0	5778	0.000000e+00	0	126	1165696	1.080900e-04	0	0	89912	0.000000e+00	0	12	129722	9.250551178674396E-5	0	352	0	0	2726	0	0	8264	0	0	790	0	0	946	0	0	626	0	0	280	0	0	7514	0	0	8616	0	0	3352	0	12	151220	7.935458272715249E-5	Malignant_tumor_of_breast|not_provided|not_specified|Breast_and/or_ovarian_cancer|Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43106469C>A	BRCA1-HCI:BRCA1_00052|ClinGen:CA001328|UniProtKB:P38398#VAR_070460	C0006142|C3661900|CN169374|CN221562|C0677776|C0346153|C4554406|C2676676|C3280442|C0027672	114480|617883|604370|614320	145|227535|145|1333|140162	.	Asp	Tyr	82.51	0.6073619631901841			-0.338		0.086																																																																																								0.5		-0.096																								0.097		0.028																																																																																																																																																																																																																																																																																																																																																				101			83.38	Negatively-charged	Aspartic Acid		Breast cancer type 1 susceptibility protein										-3.5									D67-S59 (PDBs: 7LYB), D67-C39 (PDBs: 8GRQ)	 D67-Q60 (PAE:  2.5), D67-P58 (PAE: 6.0), D67-S59 (PAE: 3.0)	D67-K38 (PDBs: 1JM7), D67-Q60 (PDBs: 7LYB), D67-P58 (PDBs: 7LYB), D67-S59 (PDBs: 7LYB), D67-T37 (PDBs: 8GRQ), D67-C39 (PDBs: 8GRQ), D67-C61 (PDBs: 8GRQ)							132									-70.7				122.4				dbSNP: rs80357102; Variant type: US; AA change: Asp67Tyr; PTM type: Ubiquitylation; PTM morphology: QCPLCkND*ITK; Var class: II		B (undefined)	E (parallel sheets)	Beta strand											82.51	60.7362	70-90	10-90	604370;114480;617883;614320;604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP S; PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.9466625448097439	0.9459460202866047	false	false	false
BRCA1	BRCA1_Asn132Lys	B_13-14	2.212585170847975	0.06255809591849197	0.11094332702350942	3.691132480091729	0.007745022327135816	0.013744793008021491	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	true	true	false	true	0.9314383937688808	0.9307829053002261	0.9429587547707962	0.9769412010632541	0.9303431353484568	0.9843362940141699	0.9900339880722573	0.9555830010473509	0.9819865411030401	0.9668771142411436	0.951956266350408	0.9537072331298062	0.9786385999560825	0.9051032696495627	0.971895861023468	0.9190403953004487	0.9096095442500444	0.9091695544079554	BRCA1	Asn132Lys	NC_000017.11:43104167:G:T	396C>A	17	43104167	G	T	17	ENSG00000012048	14613	0	CCSBVarC013093	ALE00008931	ENSP00000417148.1																																	69731.0	single nucleotide variant	NM_007294.4(BRCA1):c.396C>A (p.Asn132Lys)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	80357413.0	-	RCV000083203|RCV000162966|RCV000212156|RCV000587325|RCV001083972|RCV001353495	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	43104167.0	43104167.0	17q21.31	reviewed by expert panel	20.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00119,ClinGen:CA002545,UniProtKB:P38398#VAR_070462	2.0	55064.0	43104167.0	G	T	-	-	-	-	-	-	396C>A 	Asn132Lys	NM_007294.4	3.0	Benign	Benign	55064	17	43104167.0	G	T	N	K	rs80357413	17	41256184	17	38509710	132	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.396C>A	p.Asn132Lys	c.396C>A	p.Asn132Lys	principal2	Y	1	YES	Select	-	AAC	3	2	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.014	0.74454	D	0.844	0.70687	P	0.23	0.76920	B	0.48	0.78014	N	simple_aae	52.0	48.0	2.535	0.73728	M	-0.84	0.74082	N	0.728	0.84989	-0.7539	0.57554	T	0.2504	0.61845	T	10	0.49917424	0.61126	D	0.537965	0.95677	D	0.661	0.87273	0.734	0.86654	E9PFC7	N132K	Gain of methylation at N132 (P = 0.0115)| Loss of ubiquitination at K135 (P = 0.027)| Gain of helix (P = 0.0325)| Gain of MoRF binding (P = 0.0503)| Loss of loop (P = 0.0804)	0.91044858891	0.90887	.	0.38932	.	0.14104	0.593114554882	0.51867	T	0.312083	0.68213	T	0.105641	0.64645	D	0.0998727	0.76727	D	0.220903346759768	0.21247	T	.	0.79579	.	0.22508949	0.44837	0.18978201	0.42198	0.24349055	0.46959	0.2039367	0.44334	0.181	0.01204	T	0.5123	0.66770	A	0.633096537117509	0.64846	0.99506503	0.97691	0.111	0.30556	.	.	.	.	.	.	1.435024	0.18568	13.79	0.99611497861979004	0.74843	0.533451	0.55132	D	-0.178148358989986	0.33768	1.938592	-0.156487260348686	0.32848	1.893925	5.32	2.3	0.27660	1.8	0.37395	1.172	0.3162	0.730000	0.21161	-0.727	0.03758	1.0	0.71675	0.998000	0.34068	0.941	0.48226	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	8	264690	3.0224035E-5	.	5	109376	4.571390e-05	0	10	208078	4.805890e-05	0	9	236888	3.799260e-05	0	0	7164	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13386	0.000000e+00	0	5	42766	1.169150e-04	0	0	15682	0.000000e+00	0	5	42766	1.169150e-04	0	0	16218	0.000000e+00	0	0	30508	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16726	0.000000e+00	0	10	89540	1.116820e-04	0	0	30594	0.000000e+00	0	10	89540	1.116820e-04	0	0	14902	0.000000e+00	0	0	34238	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21624	0.000000e+00	0	9	102730	8.760830e-05	0	0	30512	0.000000e+00	0	9	102730	8.760830e-05	0	.	60	1613926	3.717640e-05	0	58	1179978	4.915350e-05	0	1	74908	1.334970e-05	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29606	0.000000e+00	0	0	44890	0.000000e+00	0	0	64002	0.000000e+00	0	0	6082	0.000000e+00	0	58	1179978	4.915350e-05	0	0	91078	0.000000e+00	0	2	31050	6.44122383252818E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4596	0	0	2918	0	0	112	0	2	39902	5.0122800862112174E-5	Hereditary_cancer-predisposing_syndrome|not_specified|Malignant_tumor_of_breast|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43104167G>T	BRCA1-HCI:BRCA1_00119|ClinGen:CA002545|UniProtKB:P38398#VAR_070462	C0027672|CN169374|C0006142|C0677776|C3661900|C2676676	604370	140162|145|145	.	Asn	Lys	36.56	1.0			-0.59		-0.204																																																																																								0.25		-0.181	2 mutation(s) (Asn132Gln: 1.463, Asn132Ter: -2.396)																																																																																																																																																																																																																																																																																																																																																																													124			36.78	Polar/Neutral	Asparagine		Breast cancer type 1 susceptibility protein										-3.5																		132									60.8				124.2						C (loop/coil)	C (loop/coil)												36.56	100.0	$\leqslant$50	$\geqslant$90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.9307829053002261	0.9314383937688808	false	false	false
MYOZ2	MYOZ2_Gln10Pro	B_7-8	-0.1284603452618523	0.9019823856628111	0.9274492625583647	-1.6040503919743705	0.15982447390800925	0.20115082964416803	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.513983341021681	0.6134547757299924	0.4757324777115207	0.6525358192465609	0.6385176408536558	0.5839281341431096	0.4499020298731936	0.5027363378208688	0.4928065671863854	0.46088328695943975	0.5216113360680277	0.47866660292145635	0.7179542384130256	0.7742989438864428	0.8122650713067365	0.49058166846360174	0.7052982153919571	0.5493000791219056	MYOZ2	Gln10Pro	NC_000004.12:119136554:A:C	29A>C	4	119136554	A	C	4	ENSG00000172399	5651	900235	CCSBVarC002949	ALE00002949	ENSP00000306997.6	RC4	NatVar_GDE_001	F09	GDEhDisVCh_40044	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh12	C05	1.0	1.0	0.0		0.0			0.0			1.0	1.0	99.0	Y	N	N	N	Y	54945.0	single nucleotide variant	NM_016599.5(MYOZ2):c.29A>C (p.Gln10Pro)	51778.0	MYOZ2	HGNC:1330	Benign/Likely benign	0.0	Jan 18, 2024	76757102.0	-	RCV000039005|RCV000172571|RCV000242166|RCV000358872|RCV000625132|RCV000852985|RCV001170132	MedGen:CN169374|MedGen:C3661900|MedGen:CN230736|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569|MONDO:MONDO:0013455,MedGen:C3151204,OMIM:613838|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569;Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848	not specified|not provided|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 16|Hypertrophic cardiomyopathy;Cardiomyopathy|Cardiomyopathy	germline;unknown	germline	GRCh38	NC_000004.12	4	119136554.0	119136554.0	4q26	criteria provided, multiple submitters, no conflicts	13.0	-	N	ClinGen:CA238413	2.0	45780.0	119136554.0	A	C	-	-	-	-	-	-	29A>C 	Gln10Pro	NM_016599.5	2.0	Benign	Likely benign	45780	4	119136554.0	A	C	Q	P	rs76757102	4	120057709	4	120277157	10	MYOZ2	ENSG00000172399	ENST00000307128	ENSP00000306997	Q9NPC6	MYOZ2_HUMAN	c.29A>C	p.Gln10Pro	c.29A>C	p.Gln10Pro	principal1	Y	1	YES	Select	+	CAG	2	0	A	A/A	A/A	A/A	A/A	0.011	0.55689	D	0.022	0.57928	D	0.822	0.45782	P	0.494	0.47477	P	0.23	0.47954	N	simple_aae	77.0	23.0	2.005	0.54374	M	-2.01	0.46344	N	0.618	0.63186	-0.8007	0.54920	T	0.0780	0.30912	T	10	0.008525193	0.00190	T	.	.	.	0.228	0.52551	.	.	.	.	.	0.858886171171	0.85641	0.3167212610147275	0.31385	0.529626965662	0.50230	0.363519221544	0.19876	T	0.276797	0.64743	T	-0.303625	0.08111	T	-0.181753	0.56059	T	0.041722688225977	0.03970	T	0.721228	0.33217	T	0.6958758	0.77577	0.7076623	0.82560	0.7140464	0.78585	0.74589473	0.84799	-5.172	0.38702	T	0.2595	0.49415	B	0.0600601683561565	0.38780	0.00678466	0.36775	0.541	0.74046	.	.	.	.	.	.	4.017614	0.59391	24.1	0.99416621670743432	0.63599	0.929791	0.91578	D	0.485644483933927	0.66073	4.926126	0.554495097680813	0.71555	5.69658	5.69	5.69	0.88329	.	.	6.786	0.74937	6.948000	0.57082	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.998	0.85369	463	0.78566	33	0.006589456869009584	0	0.0	0	0.0	0	0.0	33	0.03273809523809524	0	0.0	459	264690	0.001734104	.	317	109294	2.900430e-03	4	472	207864	2.270720e-03	6	643	236392	2.720060e-03	12	0	7158	0.000000e+00	0	0	17094	0.000000e+00	0	0	2320	0.000000e+00	0	287	9030	3.178290e-02	4	0	13390	0.000000e+00	0	2	42708	4.682960e-05	0	28	15684	1.785260e-03	0	287	9030	3.178290e-02	4	1	16200	6.172840e-05	0	0	30462	0.000000e+00	0	0	6204	0.000000e+00	0	418	13388	3.122200e-02	6	1	16726	5.978720e-05	0	4	89442	4.472170e-05	0	42	30590	1.373000e-03	0	418	13388	3.122200e-02	6	1	14888	6.716820e-05	0	0	34202	0.000000e+00	0	0	9564	0.000000e+00	0	586	17666	3.317110e-02	12	1	21620	4.625350e-05	0	6	102350	5.862240e-05	0	42	30508	1.376690e-03	0	586	17666	3.317110e-02	12	.	1730	1613748	1.072040e-03	34	1490	44844	3.322630e-02	34	0	75046	0.000000e+00	0	0	912	0.000000e+00	0	1	60004	1.666560e-05	0	1	29590	3.379520e-05	0	1490	44844	3.322630e-02	34	2	64036	3.123240e-05	0	0	6060	0.000000e+00	0	27	1179698	2.288720e-05	0	145	91074	1.592110e-03	0	14	179330	7.80683655830034E-5	0	360	0	162	4504	0.03596802841918295	0	9734	0	0	812	0	0	1002	0	63	1852	0.03401727861771058	0	294	0	94	19598	0.004796407796713951	0	10094	0	225	6356	0.03539962240402769	333	217486	0.001531133038448452	Hypertrophic_cardiomyopathy_16|not_specified|Cardiovascular_phenotype|Cardiomyopathy|Hypertrophic_cardiomyopathy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000004.12:g.119136554A>C	ClinGen:CA238413	C3151204|CN169374|CN230736|C0878544|C0007194|C3661900	613838	167848|217569	.	Gln	Pro	88.84	0.45454545454545453																																																																																																																																																																																																																																																																																																																																																																																																																																																																													90			88.84	Polar/Neutral	Glutamine		Myozenin-2										-3.5								 Q10-Q14 (PAE:  1.5), Q10-T6 (PAE: 2.0)		 Q10-Q14 (PAE:  1.5), Q10-T6 (PAE: 2.0)								146									-62.7				-45.5						H (helix)	H (α-helix)												88.84	45.454548	70-90	10-90	613838	autosomal dominant	OMIM		0	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16	false	0.6134547757299924	0.513983341021681	false	false	false
KRT8	KRT8_Ile63Val	B_7-8	-3.7478310561932684	0.019984663259338297	0.04538728516686819	-3.7104962252527742	0.007549889914175018	0.01346360349126449	2024_01_Batch_7-8	true	true	false	false	false	false	true	false	false	false	false	false	0.9911337123837125	0.9783998070655313	0.700463140433986	0.7243707125631293	0.6582318630445096	0.7317327644837526	0.7317327644837526	0.7387919479768273	0.7924735337034613	0.700463140433986	0.9951356376962721	0.9911337123837125		0.5776717781121921	0.6562678914227974		0.9616639764347906		KRT8	Ile63Val	NC_000012.12:52904795:T:C	187A>G	12	52904795	T	C	12	ENSG00000170421	14966	218514	CCSBVarC004267	ALE00004267	ENSP00000509398.1	CEGS2	CegsMutGDEh1038	E02	GDEhDisVCh_40069	G07	1	CegsMutGDDh1038	E02	VUSN2Hmut_GDN2h_07	C10	VUSMutpDEST2_11	H10	VUSmut_GDEh07	C10	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77430.0	single nucleotide variant	NM_002273.4(KRT8):c.187A>G (p.Ile63Val)	3856.0	KRT8	HGNC:6446	Benign/Likely benign	0.0	May 28, 2019	59536457.0	-	RCV000056939|RCV000612895|RCV000988858|RCV001258260	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0012292,MedGen:C1835407,OMIM:609532|MONDO:MONDO:0005265,MedGen:C0021390,OMIM:PS266600,Orphanet:104012	not provided|not specified|Hepatitis C virus, susceptibility to|Inflammatory bowel disease	germline;unknown	germline	GRCh38	NC_000012.12	12	52904795.0	52904795.0	12q13.13	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA217264,UniProtKB:P05787#VAR_023061	2.0	66533.0	52904795.0	T	C	-	-	-	-	-	-	187A>G 	Ile63Val	NM_002273.4	2.0	Benign	Likely benign	66533	12	52904795.0	T	C	I	V	rs59536457	12	53298579	12	51584846	63	KRT8	ENSG00000170421	ENST00000552551	ENSP00000447566	P05787	K2C8_HUMAN	c.187A>G	p.Ile63Val	c.187A>G	p.Ile63Val	principal2	Y	2	.	.	-	ATC	1	0	T	./.	./.	./.	./.	0.009	0.78662	D	0.01	0.72530	D	0.494	0.37055	P	0.282	0.40384	B	0.23	0.52324	N	simple_aae	77.0	23.0	3.38	0.91332	M	-0.8	0.25503	N	0.482	0.51434	0.4064	0.89149	D	0.6078	0.86044	D	10	0.013806254	0.00288	T	.	.	.	0.659	0.87175	.	.	.	.	.	0.915724104269	0.91423	.	0.85529	.	0.67130	0.490585416555	0.37469	T	0.414749	0.76655	T	-0.0670859	0.41447	T	0.138821	0.79315	D	0.0585101903485804	0.06857	T	.	0.54658	.	0.32794622	0.54971	0.31198817	0.56981	0.3921806	0.59861	0.37698492	0.62563	-9.514	0.71838	D	.	0.77224	.	0.428973879703565	0.58597	0.99348190	0.97343	0.174	0.42414	.	.	.	.	.	.	3.217321	0.43903	21.8	0.99675783572037613	0.78934	0.909157	0.86492	D	0.35049146353569	0.58552	4.050903	0.318686462401654	0.56410	3.827446	4.78	3.54	0.39580	3.79	0.69847	4.987	0.63666	.	.	0.649	0.52914	1.0	0.71675	1.000000	0.68239	0.166	0.20893	623	0.65761	15	0.0029952076677316293	0	0.0	4	0.003976143141153081	1	0.001440922190201729	0	0.0	10	0.010224948875255624	729	264690	0.0027541653	segdup	472	109346	4.316570e-03	2	892	206096	4.328080e-03	10	963	235224	4.093970e-03	9	2	7158	2.794080e-04	0	14	17098	8.188090e-04	0	6	2318	2.588440e-03	0	0	9042	0.000000e+00	0	73	13390	5.451830e-03	0	210	42748	4.912510e-03	0	160	15678	1.020540e-02	2	160	15678	1.020540e-02	2	8	15652	5.111170e-04	0	23	30492	7.542960e-04	1	10	6136	1.629730e-03	0	0	13388	0.000000e+00	0	95	16728	5.679100e-03	0	410	88278	4.644420e-03	0	326	30590	1.065710e-02	8	326	30590	1.065710e-02	8	6	14364	4.177110e-04	0	26	34244	7.592570e-04	1	14	9508	1.472440e-03	0	0	17688	0.000000e+00	0	111	21620	5.134140e-03	0	461	101702	4.532850e-03	0	326	30508	1.068570e-02	8	326	30508	1.068570e-02	8	.	7257	1612286	4.501060e-03	34	944	91004	1.037320e-02	21	54	75014	7.198660e-04	0	0	912	0.000000e+00	0	85	60008	1.416480e-03	1	51	29596	1.723210e-03	0	1	44878	2.228260e-05	0	338	63404	5.330890e-03	1	13	5132	2.533130e-03	0	5517	1179932	4.675690e-03	10	944	91004	1.037320e-02	21	215	53466	0.004021247147720047	0	306	0	0	112	0	8	8514	9.396288466055908E-4	0	500	0	1	628	0.0015923566878980893	0	56	0	2	98	0.02040816326530612	25	8802	0.0028402635764598954	8	8820	9.070294784580499E-4	0	168	0	251	72482	0.0034629287271322534	Inflammatory_bowel_disease|not_specified|Hepatitis_C_virus,_susceptibility_to|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.52904795T>C	ClinGen:CA217264|UniProtKB:P05787#VAR_023061	C0021390|CN169374|C1835407|C3661900	PS266600|609532	104012	Keratin type II head	Ile	Val	37.25	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													169			34.53	Aliphatic	Isoleucine		Keratin, type II cytoskeletal 8										4.5																		131									-71.4				133.5	Head			dbSNP: rs59536457; Variant type: LB/B; AA change: Ile63Val; PTM type: Phosphorylation; PTM morphology: GyGGAsGMGGI*; Var class: II&rs59536457		C (loop/coil)	C (loop/coil)	Beta strand											37.25	100.0	$\leqslant$50	$\geqslant$90	609532	unknown			0	HEPATITIS C VIRUS, SUSCEPTIBILITY TO	false	0.9783998070655313	0.9911337123837125	true	true	false
AGXT	AGXT_Arg197Gln	B_7-8	-2.783805212147841	0.03183668456684964	0.06552593483047717	-2.539315382412482	0.03870268993461828	0.05649915356406089	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.667469244946437	0.684922532628915	0.626272352836511	0.8070048382295768	0.7374119526409807	0.7276589814541238	0.7103964755392698	0.7101892446121099	0.7785336739736276	0.6520876107140856	0.6235592666717487	0.635592506208655	0.7449214873689778	0.7646346606698515	0.835476002485526	0.6004570949589363	0.7462857985860814	0.699345983684219	AGXT	Arg197Gln	NC_000002.12:240873044:G:A	590G>A	2	240873044	G	A	2	ENSG00000172482	70497	205586	CCSBVarC004885	ALE00004885	ENSP00000302620.3	CEGS2	CegsMutGDEh1037	B02	GDEhDisVCh_40092	A01	1	CegsMutGDDh1037	B02	VUSN2Hmut_GDN2h_07	C07	VUSMutpDEST2_15	H01	VUSmut_GDEh07	C07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	98223.0	single nucleotide variant	NM_000030.3(AGXT):c.590G>A (p.Arg197Gln)	189.0	AGXT	HGNC:341	Benign/Likely benign	0.0	Jan 31, 2024	34664134.0	-	RCV000186224|RCV000594889|RCV001514944	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN169374|MedGen:C3661900	Primary hyperoxaluria, type I|not specified|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	240873044.0	240873044.0	2q37.3	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA275552	2.0	92312.0	240873044.0	G	A	-	-	-	-	-	-	590G>A 	Arg197Gln	NM_000030.3	2.0	Benign	Likely benign	92312	2	240873044.0	G	A	R	Q	rs34664134	2	241812461	2	241461134	197	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.590G>A	p.Arg197Gln	c.590G>A	p.Arg197Gln	principal1	Y	1	YES	Select	+	CGG	2	0	A	A/A	A/A	A/A	A/A	0.985	0.01995	T	0.813	0.03973	T	0.0	0.02950	B	0.0	0.01384	B	0.11	0.30097	P	simple_aae	89.0	11.0	.	.	.	1.45	0.00776	N	0.076	0.05027	-0.9804	0.34779	T	0.0231	0.09750	T	10	0.003585279	0.00064	T	.	.	.	0.364	0.68239	.	.	.	.	.	.	.	0.4446854589691615	0.44186	0.0353105660159	0.03604	0.311518251896	0.12126	T	0.22706	0.59009	T	-0.362019	0.03856	T	-0.226847	0.51756	T	0.0188223425611197	0.00591	T	0.234876	0.03234	T	0.33804733	0.55792	0.11278797	0.27156	0.33804733	0.55792	0.11278797	0.27155	-1.909	0.02858	T	0.071	0.03900	B	0.00662024340205987	0.20847	0.00050823	0.09192	0.284	0.55381	.	.	.	.	.	.	1.210593	0.16057	12.27	0.6345073099972246	0.07334	0.322867	0.42332	N	-0.751250215789141	0.14422	0.7286025	-0.52468884635043	0.21173	1.162415	4.14	4.14	0.47761	1.03	0.29469	1.078	0.30465	2.371000	0.32512	-0.104	0.15767	0.998	0.41403	1.000000	0.68239	0.552	0.30267	982	0.03399	130	0.025958466453674122	0	0.0	1	9.940357852882703E-4	0	0.0	85	0.08432539682539683	44	0.044989775051124746	1101	264690	0.004159583	.	1412	109156	1.293560e-02	48	2320	206024	1.126080e-02	74	2729	234700	1.162760e-02	89	1	7160	1.396650e-04	0	89	17096	5.205900e-03	2	0	2320	0.000000e+00	0	810	9036	8.964140e-02	34	4	13200	3.030300e-04	0	41	42752	9.590190e-04	0	458	15686	2.919800e-02	12	810	9036	8.964140e-02	34	5	16202	3.086040e-04	1	172	30506	5.638240e-03	3	2	6204	3.223730e-04	0	1154	13392	8.617080e-02	51	7	16540	4.232160e-04	0	76	87750	8.660970e-04	0	880	30582	2.877510e-02	19	1154	13392	8.617080e-02	51	4	14894	2.685650e-04	1	179	34230	5.229330e-03	3	2	9548	2.094680e-04	0	1541	17674	8.719020e-02	66	8	21436	3.732040e-04	0	91	100820	9.025990e-04	0	876	30500	2.872130e-02	19	1541	17674	8.719020e-02	66	.	7305	1613450	4.527570e-03	207	3414	44832	7.615100e-02	139	21	75018	2.799330e-04	2	0	912	0.000000e+00	0	245	60022	4.081840e-03	5	1	29594	3.379060e-05	0	3414	44832	7.615100e-02	139	49	63720	7.689890e-04	0	10	6058	1.650710e-03	0	692	1179816	5.865320e-04	0	2542	90994	2.793590e-02	60	106	128356	8.258281654149397E-4	0	364	0	149	1934	0.07704239917269907	5	9812	5.095801059926621E-4	3	834	0.0035971223021582736	3	706	0.00424929178470255	89	1250	0.0712	0	144	0	173	18556	0.009323129984910541	5	10176	4.913522012578616E-4	238	3184	0.07474874371859297	528	161956	0.003260144730667589	Primary_hyperoxaluria,_type_I|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240873044G>A	ClinGen:CA275552	C0268164|CN169374|C3661900	259900	416|93598	Aminotransferase class V domain	Arg	Gln	98.83	0.7943548387096774																																																																																																																																																																																																																																																																																																																																																																																																																																																																													197			98.83	Positively-charged	Arginine		Alanine--glyoxylate aminotransferase										-4.5									R197-D167 (PDBs: 7NS7)									175									-65.4				-36.5						C (loop/coil)	T (turn)	Turn											98.83	79.435486	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.684922532628915	0.667469244946437	false	false	false
PYGL	PYGL_Thr59Met	B_7-8	0.7214731966721494	0.4977568631001066	0.5813355573031962	-0.6526730925547383	0.5381549853026737	0.592745737113089	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5347705843235753	0.5740935498578057	0.570200542024889	0.5254107908364007	0.47820090411093874	0.5841881523007646	0.5536554569737049	0.48538813842913797	0.500624921098234	0.5356272209619616	0.5560282120916076	0.4968221847325147	0.6147208476278244	0.47101366979273956	0.5501966605745675	0.6047738630878166	0.5921588876240039	0.5727189839146359	PYGL	Thr59Met	NC_000014.9:50944228:G:A	176C>T	14	50944228	G	A	14	ENSG00000100504	55246	3236	CCSBVarC008114	ALE00008100	ENSP00000216392.7	Edgotyping3	VUSMutGDEh009	B02	GDEhDisVCh_40063	F12	1	VUSMutGDDh009	B02	VUSN2Hmut_GDN2h_03	D01	VUSMutpDEST2_13	G04	VUSmut_GDEh03	D01	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	190402.0	single nucleotide variant	NM_002863.5(PYGL):c.176C>T (p.Thr59Met)	5836.0	PYGL	HGNC:9725	Benign/Likely benign	0.0	Nov 28, 2023	150483902.0	-	RCV000173285|RCV000969287	MedGen:CN169374|MONDO:MONDO:0009294,MedGen:C0017925,OMIM:232700,Orphanet:369	not specified|Glycogen storage disease, type VI	germline	germline	GRCh38	NC_000014.9	14	50944228.0	50944228.0	14q22.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA200429	2.0	193237.0	50944228.0	G	A	-	-	-	-	-	-	176C>T 	Thr59Met	NM_002863.5	2.0	Benign	Likely benign	193237	14	50944228.0	G	A	T	M	rs150483902	14	51410946	14	50480696	59	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.176C>T	p.Thr59Met	c.176C>T	p.Thr59Met	principal1	Y	1	YES	Select	-	ACG	2	0	G	./.	./.	./.	./.	0.015	0.53331	D	0.011	0.66047	D	0.995	0.67505	D	0.84	0.60164	P	0.03	0.13669	N	simple_aae	97.0	3.0	2.775	0.80827	M	-4.65	0.81300	D	0.413	0.49086	0.4599	0.89937	D	0.6995	0.89616	D	10	0.01179269	0.00253	T	.	.	.	0.669	0.87667	.	.	.	.	.	0.957716214209	0.95690	0.8083915478568373	0.80682	2.39758405531	0.97120	0.694422543049	0.66285	T	0.505984	0.82287	D	-0.253406	0.13419	T	-0.12184	0.61381	T	0.121347023811566	0.14376	T	0.875712	0.60701	D	0.5432816	0.69281	0.5586406	0.74215	0.6646665	0.75884	0.5935438	0.76165	-13.882	0.92681	D	0.3575	0.57016	A	0.730930679042702	0.68105	0.06285722	0.61885	0.839	0.91143	.	.	.	.	.	.	4.894005	0.80411	27.3	0.99873617900589651	0.95079	0.855412	0.77169	D	0.532575636334978	0.68864	5.299201	0.487132142252873	0.66958	5.043834	4.34	3.44	0.38414	4.36	0.82260	7.812	0.84683	11.496000	0.92956	-0.188	0.09552	1.0	0.71675	1.000000	0.68239	0.982	0.59239	385	0.83502	27	0.005391373801916933	25	0.018910741301059002	0	0.0	2	0.002881844380403458	0	0.0	0	0.0	1355	264690	0.005119196	segdup	136	108544	1.252950e-03	3	330	206526	1.597860e-03	4	305	235798	1.293480e-03	3	122	7108	1.716380e-02	3	12	17074	7.028230e-04	0	0	2306	0.000000e+00	0	0	9016	0.000000e+00	0	0	12788	0.000000e+00	0	1	42676	2.343240e-05	0	0	15682	0.000000e+00	0	122	7108	1.716380e-02	3	305	16114	1.892760e-02	4	20	30460	6.565990e-04	0	0	6168	0.000000e+00	0	0	13372	0.000000e+00	0	0	16122	0.000000e+00	0	3	88878	3.375410e-05	0	0	30588	0.000000e+00	0	305	16114	1.892760e-02	4	279	14828	1.881580e-02	3	21	34200	6.140350e-04	0	0	9554	0.000000e+00	0	0	17660	0.000000e+00	0	0	20996	0.000000e+00	0	3	102456	2.928090e-05	0	0	30510	0.000000e+00	0	279	14828	1.881580e-02	3	.	1404	1613148	8.703480e-04	12	1290	75056	1.718720e-02	12	1290	75056	1.718720e-02	12	0	912	0.000000e+00	0	46	60012	7.665130e-04	0	0	29578	0.000000e+00	0	0	44862	0.000000e+00	0	0	63224	0.000000e+00	0	4	6062	6.598480e-04	0	14	1179882	1.186560e-05	0	2	91082	2.195820e-05	0	3	146696	2.045045536347276E-5	1	172	0.005813953488372093	0	4458	0	18	4288	0.004197761194029851	4	796	0.005025125628140704	0	968	0	0	1846	0	0	274	0	4	15372	2.6021337496747333E-4	19	4460	0.004260089686098654	0	6304	0	30	174870	1.7155601303825698E-4	not_specified|Glycogen_storage_disease,_type_VI	criteria_provided,_multiple_submitters,_no_conflicts	NC_000014.9:g.50944228G>A	ClinGen:CA200429	CN169374|C0017925	232700	369	.	Thr	Met	95.18	0.014084507042253521																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			95.18	Polar/Neutral	Threonine		Glycogen phosphorylase, liver form										-0.7								 T59-S31 (PAE:  1.0), T59-A55 (PAE: 1.0)	T59-A55 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 8EMS, 2QLL)	 T59-S31 (PAE:  1.0), T59-F32 (PAE: 1.0), T59-H63 (PAE: 1.0), T59-H35 (PAE: 1.0), T59-A55 (PAE: 1.0)	T59-S31 (PDBs: 1FA9, 2QLL), T59-H63 (PDBs: 1FA9, 2QLL), T59-A55 (PDBs: 1FA9, 1FC0, 1L5S, 3CEJ, 3CEM, 3DD1, 3DDS, 8EMS, 2QLL), T59-H35 (PDBs: 1FA9, 2QLL), T59-F32 (PDBs: 1FA9, 1EM6, 1EXV, 1L5Q, 1L5R, 1L7X, 2ZB2, 3CEH, 3DDW, 2QLL)							119									-57.4				-52.7						H (helix)	H (α-helix)	Helix											95.18	1.4084507	>90	<10	232700	autosomal recessive	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE VI	false	0.5740935498578057	0.5347705843235753	false	false	false
DIABLO	DIABLO_Gly224Arg	B_7-8	-1.7973807282663197	0.17012564654431792	0.24766767141741405	1.652981549875036	0.1494208875387291	0.18896438913409228	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6066237339724334	0.63625818481289	0.6613263940711543	0.665314108233983	0.5190635998102184	0.680920398995121	0.680920398995121	0.5190635998102184	0.665314108233983	0.6613263940711543	0.63625818481289	0.6066237339724334							DIABLO	Gly224Arg	NC_000012.12:122208431:C:T	670G>A	12	122208431	C	T	12	ENSG00000184047	7038	404	CCSBVarC008462	ALE00008433	ENSP00000442360.2	Edgotyping3	VUSmut_GDEh11	E06	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_05	D11	VUSmut_GDEh11	E06	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	272408.0	single nucleotide variant	NM_001371333.1(DIABLO):c.670G>A (p.Gly224Arg)	56616.0	DIABLO	HGNC:21528	Benign/Likely benign	0.0	Jan 07, 2024	150199226.0	-	RCV000295665|RCV000908206|RCV003920139	MedGen:CN169374|MedGen:C3661900|	not specified|not provided|DIABLO-related disorder	germline	germline	GRCh38	NC_000012.12	12	122208431.0	122208431.0	12q24.31	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA6843770	2.0	288171.0	122208431.0	C	T	-	-	-	-	-	-	670G>A 	Gly224Arg	NM_001371333.1	2.0	Benign	Likely benign	288171	12	122208431.0	C	T	G	R	rs150199226	12	122692978	12	121258931	224	DIABLO	ENSG00000184047	ENST00000464942	ENSP00000442360	Q9NR28	DBLOH_HUMAN	c.670G>A	p.Gly224Arg	c.670G>A	p.Gly224Arg	principal1	Y	1	YES	Select	-	GGG	1	0	C	C/C	C/C	C/C	C/C	.	0.27438	.	.	0.14239	.	0.005	0.13006	B	0.009	0.14297	B	0.08	0.23785	N	simple_aae	92.0	8.0	0.205	0.09279	N	.	0.02879	.	.	0.10441	-0.8295	0.53145	T	0.2049	0.56116	T	10	0.0038775206	0.00072	T	0.023384	0.46132	T	0.092	0.26441	0.47	0.54240	Q9NR28	G224R	Gain of helix (P = 0.0496)| Gain of loop (P = 0.1069)| Gain of solvent accessibility (P = 0.1846)| Loss of glycosylation at K219 (P = 0.2694)| Gain of methylation at K219 (P = 0.2712)	0.70978860907	0.70496	.	.	.	.	0.299427568913	0.10309	T	0.248869	0.61662	T	-0.449992	0.01055	T	-0.413891	0.31417	T	0.00672603518081696	0.00075	T	0.782222	0.43086	T	0.06843727	0.14774	0.07715604	0.17146	0.073776044	0.16357	0.05692018	0.10267	-1.392	0.02277	T	0.0978	0.17213	LB	0.0156211375904075	0.27443	0.11833421	0.68179	0.033	0.07179	.	.	.	.	.	.	1.427207	0.18475	13.74	0.82309865265664606	0.14349	0.062942	0.11960	N	-0.79367425244067	0.13311	0.664024	-0.825457896432711	0.13641	0.722346	5.48	0.192	0.14367	2.71	0.49561	0.462	0.21745	-0.540000	0.08625	0.599	0.40292	0.0	0.06393	0.000000	0.08389	0.3	0.24548	725	0.54878	6	0.0011980830670926517	6	0.0045385779122541605	0	0.0	0	0.0	0	0.0	0	0.0	748	264690	0.0028259472	.	67	109348	6.127230e-04	0	147	207874	7.071590e-04	0	144	235772	6.107600e-04	0	57	7154	7.967570e-03	0	7	17108	4.091650e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13362	0.000000e+00	0	3	42768	7.014590e-05	0	0	15676	0.000000e+00	0	57	7154	7.967570e-03	0	124	16152	7.677070e-03	0	16	30506	5.244870e-04	0	0	6200	0.000000e+00	0	0	13410	0.000000e+00	0	0	16702	0.000000e+00	0	7	89450	7.825600e-05	0	0	30594	0.000000e+00	0	124	16152	7.677070e-03	0	117	14892	7.856570e-03	0	20	34240	5.841120e-04	0	0	9540	0.000000e+00	0	0	17686	0.000000e+00	0	0	21598	0.000000e+00	0	7	101704	6.882720e-05	0	0	30510	0.000000e+00	0	117	14892	7.856570e-03	0	.	741	1613946	4.591230e-04	2	623	75056	8.300470e-03	2	623	75056	8.300470e-03	2	0	912	0.000000e+00	0	44	60028	7.329910e-04	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	63886	0.000000e+00	0	3	5956	5.036940e-04	0	38	1180048	3.220210e-05	0	0	91072	0.000000e+00	0	9	180096	4.997334754797441E-5	3	360	0.008333333333333333	0	4502	0	78	9432	0.00826972010178117	2	796	0.002512562814070352	1	968	0.0010330578512396695	0	1848	0	0	280	0	11	17428	6.311682350240991E-4	81	9792	0.008272058823529412	0	6350	0	104	215710	4.821287840155765E-4	not_specified|not_provided|DIABLO-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.122208431C>T	ClinGen:CA6843770	CN169374|C3661900	.	.	.	Gly	Arg	89.99	0.4642857142857143																																																																																																																																																																																																																																																																																																																																																																																																																																																																													39			89.99	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Diablo IAP-binding mitochondrial protein; Diablo IAP-binding mitochondrial protein, cleaved form										-0.4								 G224-A228 (PAE:  1.5), G224-T220 (PAE: 1.0)	G224-A228 (PDBs: 1FEW, 8E2J), G224-T220 (PDBs: 1FEW, 4TX5, 8E2J)	 G224-A228 (PAE:  1.5), G224-T220 (PAE: 1.0)	G224-A228 (PDBs: 1FEW, 8E2J), G224-T220 (PDBs: 1FEW, 4TX5, 6JX6, 8E2J)							75									-71.1				-41.3	Disordered					H (helix)	H (α-helix)	Helix											89.99	46.42857	70-90	10-90		unknown			0		false	0.63625818481289	0.6066237339724334	false	false	false
SMAD3	SMAD3_Ile170Val	B_15-16	-2.6897306429972216	0.03606559946424511	0.07160633573462387	-4.132912709904401	0.004387942117633577	0.00836993117033016	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6766272646368393	0.7157814924127106	0.5518413943293374	0.689980248556632	0.644213458659223	0.6362019889325534	0.6601220089129071	0.7892747996488364	0.8261107237930322	0.4963015631619608	0.8528733154052042	0.8304143721292474	0.6122819689521998	0.49915211766960943	0.5538497733202319	0.607381225496714	0.578689669420217	0.5228401571444312	SMAD3	Ile170Val	NC_000015.10:67165360:A:G	508A>G	15	67165360	A	G	15	ENSG00000166949	11805	2134	CCSBVarC002944	ALE00002944	ENSP00000332973.4	Edgotyping3	VUSMutGDEh004	A12	NULL	NULL	NULL	VUSMutGDDh004	A12	VUSN2Hmut_GDN2h_01	C10	VUSMutpDEST2_09	G02	VUSmut_GDEh01	C10	0.0		1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	142915.0	single nucleotide variant	NM_005902.4(SMAD3):c.508A>G (p.Ile170Val)	4088.0	SMAD3	HGNC:6769	Benign/Likely benign	0.0	Oct 02, 2024	35874463.0	-	RCV000755392|RCV000246765|RCV000128164|RCV000405224|RCV001573465|RCV003148653|RCV002277275	MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374|MONDO:MONDO:0018954,MedGen:C2697932,OMIM:PS609192,Orphanet:60030|MedGen:C3661900|Human Phenotype Ontology:HP:0012727,MONDO:MONDO:0005396,MedGen:C0162872|MONDO:MONDO:0020066,MedGen:C0013720,OMIM:PS130000,Orphanet:98249	Aneurysm-osteoarthritis syndrome|Familial thoracic aortic aneurysm and aortic dissection|not specified|Loeys-Dietz syndrome|not provided|Thoracic aortic aneurysm|Ehlers-Danlos syndrome	germline	germline	GRCh38	NC_000015.10	15	67165360.0	67165360.0	15q22.33	criteria provided, multiple submitters, no conflicts	20.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020092,UniProtKB:P84022#VAR_052021	2.0	139212.0	67165360.0	A	G	-	-	-	-	-	-	508A>G 	Ile170Val	NM_005902.4	2.0	Benign	Likely benign	139212	15	67165360.0	A	G	I	V	rs35874463	15	67457698	15	65244752	170	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.508A>G	p.Ile170Val	c.508A>G	p.Ile170Val	principal1	Y	1	YES	Select	+	ATC	1	0	A	A/A	A/A	A/A	A/A	0.667	0.13037	T	0.771	0.07765	T	0.0	0.02950	B	0.001	0.04348	B	0.04	0.18971	P	simple_aae	96.0	4.0	0.805	0.20110	L	-0.43	0.14318	N	0.12	0.29111	-0.1827	0.78014	T	0.2877	0.65804	T	10	0.00407815	0.00078	T	.	.	.	0.302	0.62096	.	.	.	.	.	.	.	0.17700312709896385	0.17444	1.03534464927	0.75420	0.543536245823	0.44881	T	0.360971	0.72541	T	-0.258078	0.12866	T	-0.101752	0.63002	T	0.0114419629304304	0.00170	T	0.933207	0.75707	D	0.09761598	0.22805	0.07960718	0.17918	0.095535085	0.22281	0.08885679	0.20713	-8.829	0.68071	D	0.0715	0.18813	B	0.0569336184472873	0.38312	0.06103006	0.61579	0.151	0.38624	.	.	.	.	.	.	3.197053	0.43541	21.7	0.98320325678525156	0.40366	0.535750	0.55267	D	-0.265200679919509	0.30222	1.701316	-0.0390114008275826	0.37672	2.230487	4.95	4.95	0.64849	.	.	4.947	0.63365	11.205000	0.89199	0.75	0.87077	1.0	0.71675	1.000000	0.68239	0.992	0.67791	927	0.17628	95	0.01896964856230032	1	7.564296520423601E-4	53	0.05268389662027833	12	0.01729106628242075	0	0.0	29	0.02965235173824131	8438	264690	0.031878803	.	4173	109392	3.814720e-02	131	8132	208058	3.908530e-02	229	9330	236898	3.938400e-02	262	68	7164	9.491900e-03	0	375	17110	2.191700e-02	8	128	2320	5.517240e-02	5	3	9046	3.316380e-04	0	601	13386	4.489770e-02	21	2279	42762	5.329500e-02	72	651	15690	4.149140e-02	25	2279	42762	5.329500e-02	72	153	16218	9.433960e-03	0	634	30518	2.077460e-02	10	349	6208	5.621780e-02	10	4	13412	2.982400e-04	0	757	16726	4.525890e-02	28	4742	89504	5.298090e-02	139	1301	30608	4.250520e-02	42	4742	89504	5.298090e-02	139	145	14902	9.730240e-03	0	728	34254	2.125300e-02	13	536	9564	5.604350e-02	13	6	17692	3.391360e-04	0	970	21624	4.485760e-02	30	5408	102718	5.264900e-02	164	1299	30526	4.255390e-02	42	5408	102718	5.264900e-02	164	.	79206	1614100	4.907130e-02	2257	65443	1179974	5.546140e-02	1909	726	75040	9.674840e-03	8	6	912	6.578950e-03	0	1317	60024	2.194120e-02	18	1639	29602	5.536790e-02	41	9	44878	2.005440e-04	0	2796	64024	4.367110e-02	65	316	6060	5.214520e-02	8	65443	1179974	5.546140e-02	1909	3960	91076	4.348020e-02	137	5230	98988	0.05283468703277165	1	382	0.002617801047120419	0	490	0	136	10672	0.012743628185907047	48	950	0.05052631578947368	107	4970	0.021529175050301812	0	98	0	15	184	0.08152173913043478	612	12816	0.047752808988764044	137	11054	0.0123937036366926	0	588	0	6149	129550	0.04746429949826322	not_specified|Ehlers-Danlos_syndrome|Aneurysm-osteoarthritis_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Thoracic_aortic_aneurysm|Loeys-Dietz_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.67165360A>G	ClinGen:CA020092|UniProtKB:P84022#VAR_052021	CN169374|C0013720|C3151087|C4707243|C0162872|C2697932|C3661900	PS130000|613795|PS607086|PS609192	98249|284984|91387|60030	.	Ile	Val	36.65	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													175			36.65	Aliphatic	Isoleucine		Mothers against decapentaplegic homolog 3		Polar residues								4.5																		131									-173.2				155.0	Linker; Disordered					C (loop/coil)	C (loop/coil)												36.65	100.0	$\leqslant$50	$\geqslant$90	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	false	0.7157814924127106	0.6766272646368393	false	false	false
AIPL1	AIPL1_Thr114Ile	B_7-8	2.974152641424134	0.020685588019864417	0.046456194833423635	0.5610655799362102	0.5922512534077851	0.6404131113749473	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5609297215248098	0.5009353220874107	0.5416692163334637	0.5583240433076335	0.5222738722391893	0.5436758088625001	0.5989641104062677	0.5389854108105616	0.6515447047138645	0.5831589549047227	0.5004094273258879	0.5056611621794638	0.48838750731873254	0.5055623336678169	0.4651033819014026	0.5001794777622046	0.5014612168489335	0.6161982808701558	AIPL1	Thr114Ile	NC_000017.11:6428442:G:A	341C>T	17	6428442	G	A	17	ENSG00000129221	7167	12749	CCSBVarC001134	ALE00001134	ENSP00000370521.3	RC4	RC4_Mut_GDEh1019	F05	GDEhDisVCh_40067	D10	1	RC4_Mut_GDDh1019	F05	NULL	NULL	VUSMutpDEST2_05	A12	VUSmut_GDEh13	A03	1.0	2.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	105690.0	single nucleotide variant	NM_014336.5(AIPL1):c.341C>T (p.Thr114Ile)	23746.0	AIPL1	HGNC:359	Benign/Likely benign	0.0	Jan 31, 2024	8069375.0	-	RCV000086224|RCV000395155|RCV000300344|RCV000393732|RCV001081325|RCV002498465|RCV004815170	MedGen:C3661900|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MedGen:CN239466|MedGen:CN169374|MONDO:MONDO:0011458,MedGen:C1858386,OMIM:604393|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791;MONDO:MONDO:0011458,MedGen:C1858386,OMIM:604393|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	not provided|Retinitis pigmentosa|Retinitis Pigmentosa, Recessive|not specified|Leber congenital amaurosis 4|Retinitis pigmentosa;Leber congenital amaurosis 4|Retinal dystrophy	germline;unknown	germline	GRCh38	NC_000017.11	17	6428442.0	6428442.0	17p13.2	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA227880	2.0	99801.0	6428442.0	G	A	-	-	-	-	-	-	341C>T 	Thr114Ile	NM_014336.5	2.0	Benign	Likely benign	99801	17	6428442.0	G	A	T	I	rs8069375	17	6331762	17	6272486	114	AIPL1	ENSG00000129221	ENST00000381129	ENSP00000370521	Q9NZN9	AIPL1_HUMAN	c.341C>T	p.Thr114Ile	c.341C>T	p.Thr114Ile	principal1	Y	1	YES	Select	-	ACA	2	0	G	G/G	G/G	G/G	G/G	0.188	0.21415	T	0.181	0.29658	T	0.629	0.50611	P	0.316	0.47359	B	0.04	0.13669	P	simple_aae	96.0	4.0	1.85	0.48914	L	0.08	0.05996	N	0.296	0.42877	-0.2841	0.75318	T	0.2279	0.59140	T	10	0.005100429	0.00108	T	.	.	.	0.496	0.77984	.	.	.	.	.	0.956102322667	0.95526	0.3910400361704483	0.38816	0.385713116521	0.39578	0.439004838467	0.30403	T	0.034683	0.23160	T	-0.227443	0.16698	T	-0.0577468	0.66250	T	0.029665195607626	0.01926	T	0.951005	0.83345	D	0.18034132	0.38842	0.16142009	0.37429	0.24771339	0.47423	0.17535856	0.39861	-4.943	0.36257	T	0.2637	0.60342	B	0.0696545861310317	0.40081	0.97045845	0.94691	0.386	0.63644	.	.	.	.	.	.	3.854662	0.55945	23.7	0.99198195307840076	0.55273	0.476235	0.51807	N	0.23719508057493	0.52775	3.471865	0.265474292413198	0.53293	3.52192	4.77	4.77	0.60376	3.15	0.57234	4.828	0.62503	9.848000	0.81998	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.898	0.43497	872	0.31082	67	0.013378594249201278	66	0.049924357034795766	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	4922	264690	0.018595338	.	456	109166	4.177120e-03	14	1015	207786	4.884830e-03	28	969	236632	4.094970e-03	27	400	7162	5.585030e-02	14	44	17112	2.571290e-03	0	0	2320	0.000000e+00	0	0	9040	0.000000e+00	0	0	13168	0.000000e+00	0	6	42764	1.403050e-04	0	3	15690	1.912050e-04	0	400	7162	5.585030e-02	14	910	16210	5.613820e-02	28	72	30520	2.359110e-03	0	0	6208	0.000000e+00	0	0	13408	0.000000e+00	0	0	16508	0.000000e+00	0	13	89468	1.453030e-04	0	9	30608	2.940410e-04	0	910	16210	5.613820e-02	28	856	14900	5.744970e-02	27	81	34258	2.364410e-03	0	0	9572	0.000000e+00	0	0	17686	0.000000e+00	0	0	21404	0.000000e+00	0	12	102674	1.168750e-04	0	9	30526	2.948310e-04	0	856	14900	5.744970e-02	27	.	4941	1613962	3.061410e-03	127	4351	75064	5.796390e-02	123	4351	75064	5.796390e-02	123	0	912	0.000000e+00	0	210	60026	3.498480e-03	1	0	29608	0.000000e+00	0	0	44872	0.000000e+00	0	0	63770	0.000000e+00	0	20	6062	3.299240e-03	0	91	1180052	7.711520e-05	0	22	91092	2.415140e-04	0	26	186984	1.390493304239935E-4	24	364	0.06593406593406594	0	4532	0	550	9868	0.05573571139035265	9	818	0.011002444987775062	3	1036	0.0028957528957528956	0	1854	0	0	296	0	45	20178	0.0022301516503122213	574	10232	0.056098514464425334	0	6386	0	657	225930	0.002907980347895366	Leber_congenital_amaurosis_4|Retinitis_pigmentosa|not_specified|Retinitis_Pigmentosa,_Recessive|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.6428442G>A	ClinGen:CA227880	C1858386|C0035334|CN169374|CN239466|C3661900	604393|268000|PS268000	791	.	Thr	Ile	54.53	0.5492957746478874																																																																																																																																																																																																																																																																																																																																																																																																																																																																													78			54.53	Polar/Neutral	Threonine		Aryl-hydrocarbon-interacting protein-like 1							PPIase FKBP-type	0.1211		-0.7																		119									-98.8		Pocket 1: Mean pLDDT: 63.46, Volume: 2286.87 Å³, Druggability score: 0.12		-10.6						C (loop/coil)	T (turn)												54.53	54.929577	50-70	10-90	268000;604393;268000;604393	autosomal recessive	OMIM	Rare genetic eye disease; Ciliopathy	2	RETINITIS PIGMENTOSA; LEBER CONGENITAL AMAUROSIS 4; RETINITIS PIGMENTOSA; LEBER CONGENITAL AMAUROSIS 4	false	0.5009353220874107	0.5609297215248098	false	false	false
SNIP1	SNIP1_Ala174Val	B_7-8	0.9963025829177942	0.3754912961495076	0.4662849593985026	2.851303879581119	0.029131776521615867	0.04385300239308049	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.47647615868257426	0.5200919650288209	0.5495972287696202	0.44326186507088083	0.45430932879049307	0.49516674064694954	0.49516674064694954	0.4063443266320238	0.43688620576633086	0.5495972287696202	0.5006172191868493	0.5073817044032313		0.5022743309489623	0.44963752437543086		0.5395667108707927	0.44557061296191725	SNIP1	Ala174Val	NC_000001.11:37540562:G:A	521C>T	1	37540562	G	A	1	ENSG00000163877	8177	1932	CCSBVarC008477	ALE00008431	ENSP00000296215.5	Edgotyping3	VUSmut_GDEh11	A03	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_07	H09	VUSmut_GDEh11	A03	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	780678.0	single nucleotide variant	NM_024700.4(SNIP1):c.521C>T (p.Ala174Val)	79753.0	SNIP1	HGNC:30587	Likely benign	0.0	Jan 29, 2024	147613529.0	-	RCV000981741	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000001.11	1	37540562.0	37540562.0	1p34.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	-	2.0	798217.0	37540562.0	G	A	-	-	-	-	-	-	521C>T 	Ala174Val	NM_024700.4	2.0	Benign	Likely benign	798217	1	37540562.0	G	A	A	V	rs147613529	1	38006163	1	37778750	174	SNIP1	ENSG00000163877	ENST00000296215	ENSP00000296215	Q8TAD8	SNIP1_HUMAN	c.521C>T	p.Ala174Val	c.521C>T	p.Ala174Val	principal1	Y	1	YES	Select	-	GCT	2	0	G	G/G	G/G	G/G	G/G	0.124	0.27555	T	0.276	0.22220	T	0.329	0.33246	B	0.023	0.19965	B	0.07	0.21442	N	simple_aae	93.0	7.0	2.015	0.54854	M	-0.93	0.24848	N	0.079	0.05403	-1.0041	0.28635	T	0.0151	0.06035	T	10	0.009179503	0.00204	T	0.005493	0.13872	T	0.022	0.04263	.	.	.	.	.	0.334371577756	0.32629	0.1118918308378245	0.10969	0.57562879392	0.53266	0.431181848049	0.29334	T	0.064636	0.32240	T	-0.556262	0.00260	T	-0.577976	0.14444	T	0.00548965172254646	0.00059	T	0.781422	0.41456	T	0.030039353	0.02576	0.04352365	0.05450	0.030039353	0.02576	0.04352365	0.05450	-4.586	0.32031	T	0.1076	0.20381	B	0.0609494909004412	0.38907	0.04201164	0.57632	0.046	0.11740	.	.	.	.	.	.	2.022329	0.25743	16.86	0.96986741076784078	0.32072	0.101475	0.20171	N	-0.56430966759153	0.19795	1.053331	-0.477086120203942	0.22471	1.239378	4.98	1.91	0.24773	1.4	0.33079	2.197	0.42433	2.652000	0.33904	-0.169	0.1135	1.0	0.71675	1.000000	0.68239	0.191	0.21676	927	0.17628	6	0.0011980830670926517	0	0.0	4	0.003976143141153081	2	0.002881844380403458	0	0.0	0	0.0	314	264690	0.0011862934	.	129	109408	1.179070e-03	0	286	208134	1.374110e-03	2	311	236952	1.312500e-03	2	2	7164	2.791740e-04	0	24	17112	1.402520e-03	0	3	2320	1.293100e-03	0	1	9046	1.105460e-04	0	0	13394	0.000000e+00	0	65	42768	1.519830e-03	0	30	15690	1.912050e-03	0	30	15690	1.912050e-03	0	5	16218	3.082990e-04	0	36	30524	1.179400e-03	0	9	6212	1.448810e-03	0	1	13416	7.453790e-05	0	1	16734	5.975860e-05	0	147	89556	1.641430e-03	1	71	30608	2.319650e-03	1	71	30608	2.319650e-03	1	5	14902	3.355250e-04	0	42	34260	1.225920e-03	0	13	9572	1.358130e-03	0	1	17692	5.652270e-05	0	1	21632	4.622780e-05	0	161	102748	1.566940e-03	1	71	30526	2.325890e-03	1	71	30526	2.325890e-03	1	.	1716	1614042	1.063170e-03	8	182	6062	3.002310e-02	5	30	74986	4.000750e-04	0	0	912	0.000000e+00	0	84	59990	1.400230e-03	0	32	29608	1.080790e-03	0	2	44880	4.456330e-05	0	7	64004	1.093680e-04	0	182	6062	3.002310e-02	5	1058	1180026	8.965900e-04	1	201	91066	2.207190e-03	1	286	180094	0.001588059568891801	0	360	0	0	2712	0	2	9456	2.1150592216582064E-4	3	804	0.0037313432835820895	0	974	0	0	684	0	0	280	0	74	16544	0.004472920696324952	2	9816	2.0374898125509371E-4	0	3396	0	365	211908	0.0017224455895954848	not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.37540562G>A	.	C3661900	.	.	.	Ala	Val	78.57	0.49056603773584906																																																																																																																																																																																																																																																																																																																																																																																																																																																																													52			78.57	Aliphatic	Alanine		Smad nuclear-interacting protein 1	Coiled coil									1.8								 A174-Q170 (PAE:  2.0), A174-E178 (PAE: 2.0)		 A174-Q170 (PAE:  2.0), A174-E178 (PAE: 2.0)								89									-61.7				-39.5	Disordered					H (helix)	H (α-helix)												78.57	49.056606	70-90	10-90		unknown			0		false	0.5200919650288209	0.47647615868257426	false	false	false
SFTPC	SFTPC_Val48Met	B_7-8	-1.5024466497120352	0.18366731063674038	0.26277495379488697	2.3114781465408734	0.06014690586635936	0.08374019139967331	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6428571995590571	0.6435609997416443	0.6274957973859467	0.6816754526528939	0.6662683323420646	0.6510679074412754	0.7397271456159145	0.7664491023881701	0.8069602547071959	0.6692196711265648	0.6426960787336686	0.6341388630363742	0.5624086692666364	0.5660875622959592	0.5563906505985919	0.5857719236453286	0.64442592074962	0.65157553608174	SFTPC	Val48Met	NC_000008.11:22162673:G:A	142G>A	8	22162673	G	A	8	ENSG00000168484	5723	667	CCSBVarC008453	ALE00008424	ENSP00000316152.3	Edgotyping3	VUSmut_GDEh11	B01	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_05	F05	VUSmut_GDEh11	B01	0.0		0.0		0.0			1.0	1.0	6.0	1.0	1.0	1.0	Y	N	N	Y	Y	304874.0	single nucleotide variant	NM_001317778.2(SFTPC):c.142G>A (p.Val48Met)	6440.0	SFTPC	HGNC:10802	Likely benign	0.0	Jan 13, 2018	566914013.0	-	RCV000306866|RCV000407976	MONDO:MONDO:0024465,MedGen:C1970470,OMIM:610913|MONDO:MONDO:0800029,MedGen:C5561926,OMIM:178500,Orphanet:2032,Orphanet:79126	Surfactant metabolism dysfunction, pulmonary, 2|Interstitial lung disease 2	germline	germline	GRCh38	NC_000008.11	8	22162673.0	22162673.0	8p21.3	criteria provided, single submitter	1.0	-	N	ClinGen:CA4663912	2.0	362553.0	22162673.0	G	A	-	-	-	-	-	-	142G>A 	Val48Met	NM_001317778.2	1.0	Benign	Likely benign	362553	8	22162673.0	G	A	V	M	rs566914013	8	22020186	8	22076131	48	SFTPC	ENSG00000168484	ENST00000318561	ENSP00000316152	P11686	PSPC_HUMAN	c.142G>A	p.Val48Met	c.142G>A	p.Val48Met	principal4	Y	1	.	.	+	GTG	1	0	G	G/G	G/G	G/G	G/G	0.005	0.63383	D	0.03	0.54507	D	1.0	0.90580	D	0.999	0.92348	D	0.15	0.41597	N	simple_aae	85.0	15.0	1.1	0.27864	L	-0.9	0.30311	N	0.589	0.60716	0.8910	0.95535	D	0.8667	0.95558	D	10	0.49864182	0.61097	D	0.440446	0.94143	D	0.616	0.84966	0.658	0.79499	P11686	V48M	Loss of sheet (P = 0.0315)| Gain of helix (P = 0.1736)| Gain of MoRF binding (P = 0.288)| Loss of stability (P = 0.3927)| Gain of catalytic residue at V44 (P = 0.6069)	0.977364031073	0.97689	0.8085641126896971	0.80699	1.30891436969	0.83084	0.698670446873	0.66896	T	0.60024	0.87058	D	0.0415407	0.56951	T	-0.00897784	0.69530	D	0.480967432260513	0.31621	T	0.861414	0.60013	D	.	.	.	.	.	.	.	.	-5.916	0.46547	T	0.3102	0.53752	B	.	.	0.99905270	0.99115	0.058	0.15819	.	.	.	.	.	.	4.664957	0.74544	26.2	0.99893504502971575	0.96668	0.415459	0.48254	N	0.469663489140617	0.65144	4.808558	0.416431372356218	0.62385	4.476792	4.41	4.41	0.52530	.	.	1.868	0.39251	8.596000	0.77740	0.671	0.69477	0.99	0.37076	1.000000	0.68239	0.651	0.32761	555	0.71761	2	3.9936102236421724E-4	0	0.0	0	0.0	0	0.0	2	0.001984126984126984	0	0.0	1	264690	3.7780044E-6	.	4	108626	3.682360e-05	0	6	206258	2.908980e-05	0	6	235062	2.552520e-05	0	0	7136	0.000000e+00	0	0	17054	0.000000e+00	0	1	2320	4.310340e-04	0	1	8638	1.157680e-04	0	0	13298	0.000000e+00	0	2	42608	4.693950e-05	0	0	15676	0.000000e+00	0	1	8638	1.157680e-04	0	0	15452	0.000000e+00	0	0	30462	0.000000e+00	0	2	6202	3.224770e-04	0	1	13000	7.692310e-05	0	0	16638	0.000000e+00	0	3	89116	3.366400e-05	0	0	30594	0.000000e+00	0	1	13000	7.692310e-05	0	0	14138	0.000000e+00	0	0	34196	0.000000e+00	0	2	9564	2.091180e-04	0	1	17284	5.785700e-05	0	0	21536	0.000000e+00	0	3	102286	2.932950e-05	0	0	30512	0.000000e+00	0	1	17284	5.785700e-05	0	.	48	1614222	2.973570e-05	0	5	29606	1.688850e-04	0	0	75054	0.000000e+00	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	5	29606	1.688850e-04	0	6	44880	1.336900e-04	0	0	64040	0.000000e+00	0	0	6062	0.000000e+00	0	26	1180040	2.203320e-05	0	0	91088	0.000000e+00	0	1	15752	6.348400203148806E-5	0	122	0	0	112	0	0	3370	0	0	146	0	0	610	0	0	56	0	0	98	0	0	2772	0	0	3492	0	0	168	0	1	23038	4.340654570709263E-5	Interstitial_lung_disease_2|Surfactant_metabolism_dysfunction,_pulmonary,_2	criteria_provided,_single_submitter	NC_000008.11:g.22162673G>A	ClinGen:CA4663912	C5561926|C1970470	178500|610913	2032|79126	Surfactant protein C, N-terminal propeptide	Val	Met	96.23	0.6830985915492958																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	Aliphatic	Valine		Surfactant protein C										4.2																		117																																96.23	68.30986	>90	10-90	610913;178500	autosomal dominant	OMIM	Rare genetic respiratory disease	1	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; INTERSTITIAL LUNG DISEASE 2	false	0.6435609997416443	0.6428571995590571	false	false	false
GLYCTK	GLYCTK_Thr394Ile	B_7-8	-1.622294916474776	0.20319406232014894	0.28453127494976865	-2.9024363866707543	0.04401032540431376	0.06329071090667378	2024_01_Batch_7-8		false	false	false	false	false		false	false	false	false	false		0.6075349116052542	0.43498260662103416	0.46459613204684125	0.46017661563736967	0.40209027656326723	0.40209027656326723	0.49094569462082593	0.5015849993849686	0.43498260662103416	0.6075349116052542			0.42940753665391346	0.42760726470871396				GLYCTK	Thr394Ile	NC_000003.12:52292735:C:T	1181C>T	3	52292735	C	T	3	ENSG00000168237	13554	2230	CCSBVarC008485	ALE00008439	ENSP00000389175.2	Edgotyping3	VUSmut_GDEh11	C07	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh11	C07	0.0		0.0		0.0			0.0			1.0	1.0	1.0	Y	N	N	N	Y	439102.0	single nucleotide variant	NM_145262.4(GLYCTK):c.1181C>T (p.Thr394Ile)	132158.0	GLYCTK	HGNC:24247	Benign/Likely benign	0.0	Jan 24, 2024	9813489.0	-	RCV000514109	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000003.12	3	52292735.0	52292735.0	3p21.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA2432263	2.0	445830.0	52292735.0	C	T	-	-	-	-	-	-	1181C>T 	Thr394Ile	NM_145262.4	2.0	Benign	Likely benign	445830	3	52292735.0	C	T	T	I	rs9813489	3	52326751	3	52301791	394	GLYCTK	ENSG00000168237	ENST00000436784	ENSP00000389175	Q8IVS8	GLCTK_HUMAN	c.1181C>T	p.Thr394Ile	c.1181C>T	p.Thr394Ile	principal1	Y	1	YES	Select	+	ACC	2	0	C	C/C	C/C	C/C	C/C	0.054	0.38786	T	0.204	0.27537	T	0.0	0.02950	B	0.001	0.04348	B	0.03	0.10877	N	simple_aae	97.0	3.0	0.55	0.14367	N	-0.37	0.13154	N	0.054	0.02553	-1.0986	0.04278	T	0.0124	0.04751	T	9	0.002203524	0.00031	T	.	.	.	0.095	0.27216	.	.	.	.	.	0.401753679984	0.39388	0.4945900491110894	0.49185	0.110214083322	0.12204	0.327317118645	0.14515	T	0.049683	0.28123	T	-0.667926	0.00055	T	-0.707831	0.05223	T	0.00116897626624428	0.00011	T	0.340666	0.07229	T	0.04261692	0.06436	0.055315237	0.09691	0.037190814	0.04675	0.055817463	0.09871	-4.57	0.31828	T	0.1092	0.21003	B	0.0193793746481911	0.29189	0.00388983	0.30292	0.011	0.00835	.	.	.	.	.	.	0.666807	0.10376	7.08	0.77121635006794309	0.11936	0.471124	0.51512	N	-1.07124439244912	0.07092	0.3326293	-0.973774502940166	0.10201	0.5222163	5.85	2.13	0.26374	1.8	0.37395	1.058	0.30213	0.847000	0.22181	-0.838	0.02819	0.595	0.27797	0.295000	0.24263	0.011	0.09394	85	0.96453	47	0.009384984025559106	43	0.03252647503782148	3	0.002982107355864811	1	0.001440922190201729	0	0.0	0	0.0	2720	264690	0.010276172	.	275	107656	2.554430e-03	1	607	205438	2.954660e-03	4	564	234112	2.409100e-03	4	238	7158	3.324950e-02	1	24	17014	1.410600e-03	0	0	2272	0.000000e+00	0	0	9038	0.000000e+00	0	0	12420	0.000000e+00	0	13	42352	3.069510e-04	0	0	15516	0.000000e+00	0	238	7158	3.324950e-02	1	534	16164	3.303640e-02	4	36	30374	1.185220e-03	0	0	6070	0.000000e+00	0	0	13400	0.000000e+00	0	0	15740	0.000000e+00	0	31	88648	3.496980e-04	0	1	30234	3.307530e-05	0	534	16164	3.303640e-02	4	487	14866	3.275930e-02	4	43	34032	1.263520e-03	0	0	9366	0.000000e+00	0	0	17674	0.000000e+00	0	0	20606	0.000000e+00	0	29	101864	2.846930e-04	0	1	30152	3.316530e-05	0	487	14866	3.275930e-02	4	.	2892	1608714	1.797710e-03	39	2309	74990	3.079080e-02	38	2309	74990	3.079080e-02	38	0	912	0.000000e+00	0	98	59826	1.638080e-03	0	0	29436	0.000000e+00	0	0	44784	0.000000e+00	0	0	62630	0.000000e+00	0	9	6046	1.488590e-03	0	331	1177116	2.811960e-04	0	8	90744	8.816010e-05	0	51	186128	2.740049858162125E-4	11	400	0.0275	0	4510	0	324	10718	0.030229520432916587	3	794	0.003778337531486146	3	1056	0.002840909090909091	0	1844	0	0	296	0	21	17238	0.0012182387747998607	335	11118	0.030131318582478864	0	6354	0	413	222984	0.0018521508269651633	not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52292735C>T	ClinGen:CA2432263	C3661900	.	.	.	Thr	Ile	93.27	0.19718309859154928																																																																																																																																																																																																																																																																																																																																																																																																																																																																													28			93.27	Polar/Neutral	Threonine		Glycerate kinase										-0.7								 T394-G398 (PAE:  2.5), T394-E390 (PAE: 1.0)		 T394-G398 (PAE:  2.5), T394-V331 (PAE: 1.0), T394-E390 (PAE: 1.0)								119									-57.4				-39.8						H (helix)	H (α-helix)												93.27	19.71831	>90	10-90		unknown		Rare inborn errors of metabolism	1		false	0.6075349116052542		false		false
PMP22	PMP22_Ala135Thr	B_7-8	1.660896936169992	0.14780022856678512	0.22298454704783535	-1.2397273910660442	0.26136252103887125	0.3112266230410959	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5339279627863007	0.5399052019712787	0.45878631464944397	0.5858269074458048	0.5206965595523091	0.4829225511926203	0.6131188522624387	0.5731337211515083	0.6575032396010748	0.5566798598716357	0.5762401295021005	0.5914478590804053	0.35272625012280184	0.46825939795310995	0.5141505752905348	0.3608927694272522	0.503570274440457	0.4764080664921961	PMP22	Ala135Thr	NC_000017.11:15230997:C:T	403G>A	17	15230997	C	T	17	ENSG00000109099	7323	1840	CCSBVarC008467	ALE00008471	ENSP00000308937.3	Edgotyping3	VUSmut_GDEh11	F07	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_06	H02	VUSmut_GDEh11	F07	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	378084.0	single nucleotide variant	NM_000304.4(PMP22):c.403G>A (p.Ala135Thr)	5376.0	PMP22	HGNC:9118	Benign/Likely benign	0.0	Jan 18, 2024	141094419.0	-	RCV000712773|RCV001128284|RCV001082490|RCV002356551|RCV004735512	MedGen:C3661900|MONDO:MONDO:0008087,MedGen:C0393814,OMIM:162500,Orphanet:640|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753|MeSH:D030342,MedGen:C0950123|	not provided|Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease, type I|Inborn genetic diseases|PMP22-related disorder	germline	germline	GRCh38	NC_000017.11	17	15230997.0	15230997.0	17p12	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA8403306	2.0	382636.0	15230997.0	C	T	-	-	-	-	-	-	403G>A 	Ala135Thr	NM_000304.4	2.0	Benign	Likely benign	382636	17	15230997.0	C	T	A	T	rs141094419	17	15134314	17	15075039	135	PMP22	ENSG00000109099	ENST00000675819	ENSP00000502018	Q01453	PMP22_HUMAN	.	.	c.403G>A	p.Ala135Thr	principal1	Y	.	.	.	-	GCC	1	0	C	C/C	C/C	C/C	C/C	.	0.13644	.	.	0.13564	.	0.001	0.07480	B	0.003	0.08696	B	.	0.45549	.	.	.	.	1.815	0.47541	L	.	0.30311	.	.	0.28880	-0.3125	0.74521	T	0.5097	0.81498	D	10	.	0.00263	.	0.041096	0.59585	D	.	0.66120	.	.	.	.	.	.	0.67315	.	0.57738	.	.	0.460412025452	0.33324	T	0.751293	0.93123	D	-0.326371	0.06201	T	-0.234337	0.51026	T	0.0040133966206106	0.00042	T	.	0.40724	.	0.022097621	0.00846	0.04399115	0.05614	0.029713076	0.02489	0.054443978	0.09377	-5.5	0.41919	T	.	0.40544	.	0.0977842219082626	0.43120	0.98794013	0.96434	0.057	0.15488	.	.	.	.	.	.	1.519376	0.19538	14.3	0.94457154927405762	0.25132	0.130336	0.24670	N	-0.856580787394249	0.11746	0.5762949	-0.907461794880603	0.11713	0.6100762	5.05	0.627	0.16805	-0.846	0.16502	0.326	0.19459	0.226000	0.16200	-0.173	0.11029	0.045	0.21277	0.008000	0.19814	0.797	0.37639	806	0.43519	11	0.002196485623003195	11	0.00832072617246596	0	0.0	0	0.0	0	0.0	0	0.0	708	264690	0.0026748271	.	86	109374	7.862930e-04	0	183	208028	8.796890e-04	0	171	236844	7.219940e-04	0	79	7164	1.102740e-02	0	6	17112	3.506310e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13362	0.000000e+00	0	0	42766	0.000000e+00	0	1	15690	6.373490e-05	0	79	7164	1.102740e-02	0	160	16208	9.871670e-03	0	18	30516	5.898550e-04	0	0	6210	0.000000e+00	0	0	13410	0.000000e+00	0	0	16702	0.000000e+00	0	0	89510	0.000000e+00	0	1	30608	3.267120e-05	0	160	16208	9.871670e-03	0	147	14898	9.867100e-03	0	20	34260	5.837710e-04	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21600	0.000000e+00	0	0	102680	0.000000e+00	0	1	30526	3.275900e-05	0	147	14898	9.867100e-03	0	.	759	1614126	4.702240e-04	3	678	75058	9.033010e-03	3	678	75058	9.033010e-03	3	0	912	0.000000e+00	0	36	60026	5.997400e-04	0	0	29608	0.000000e+00	0	0	44872	0.000000e+00	0	0	64006	0.000000e+00	0	1	6058	1.650710e-04	0	7	1180002	5.932190e-06	0	1	91080	1.097940e-05	0	1	173812	5.753342692104112E-6	2	360	0.005555555555555556	0	2712	0	90	9428	0.009546033092914722	1	796	0.001256281407035176	0	968	0	0	682	0	0	280	0	10	15336	6.520605112154408E-4	92	9788	0.00939926440539436	0	3394	0	104	204374	5.08870991417695E-4	Hereditary_liability_to_pressure_palsies|not_provided|Inborn_genetic_diseases|Charcot-Marie-Tooth_disease,_type_I	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.15230997C>T	ClinGen:CA8403306	C0393814|C3661900|C0950123|C0751036	162500	640|65753	.	Ala	Thr	95.92	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			95.92	Aliphatic	Alanine		Peripheral myelin protein 22										1.8								 A135-Q27 (PAE:  2.5), A135-A139 (PAE: 1.0)		 A135-Q27 (PAE:  2.5), A135-A139 (PAE: 1.0)								89									-64.2				-37.4						H (helix)	H (α-helix)									Helical			95.92	0.0	>90	<10	162500	autosomal dominant	OMIM	Genetic otorhinolaryngologic disease; Rare genetic neurological disorder; Rare chromosomal anomaly	3	NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES	false	0.5399052019712787	0.5339279627863007	false	false	false
AGXT	AGXT_Ala280Val	B_7-8	-0.7297943079980777	0.49301177301517873	0.5777009119380315	-1.4273706231011083	0.19652327933319785	0.24073445766116028	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7671774593275812	0.7409846005239553	0.6811798638797288	0.7803990824737063	0.6765712174552638	0.7779793860614876	0.8492667169024302	0.7405203598803896	0.9049022023861567	0.7157462692032732	0.763482790000063	0.7671774593275812	0.7066920552205452	0.612622075030138	0.6558959625612558	0.6466134585561844	0.7184864110478477		AGXT	Ala280Val	NC_000002.12:240875997:C:T	839C>T	2	240875997	C	T	2	ENSG00000172482	70497	3867	CCSBVarC008219	ALE00008205	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	F08	GDEhDisVCh_40002	D10	2	VUSMutGDDh004	F08	VUSN2Hmut_GDN2h_01	C09	VUSMutpDEST2_14	H09	VUSmut_GDEh01	C09	1.0	3.0	1.0	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	N	Y	Y	N	Y	200563.0	single nucleotide variant	NM_000030.3(AGXT):c.839C>T (p.Ala280Val)	189.0	AGXT	HGNC:341	Benign/Likely benign	0.0	Jan 31, 2024	73106685.0	-	RCV000186258|RCV000946704|RCV003917705	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900|	Primary hyperoxaluria, type I|not provided|AGXT-related disorder	germline	germline	GRCh38	NC_000002.12	2	240875997.0	240875997.0	2q37.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA275593,UniProtKB:P21549#VAR_060565	2.0	204052.0	240875997.0	C	T	-	-	-	-	-	-	839C>T 	Ala280Val	NM_000030.3	2.0	Benign	Likely benign	204052	2	240875997.0	C	T	A	V	rs73106685	2	241815414	2	241464087	280	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.839C>T	p.Ala280Val	c.839C>T	p.Ala280Val	principal1	Y	1	YES	Select	+	GCG	2	0	C	C/C	C/C	C/C	C/C	0.143	0.25478	T	0.501	0.11327	T	0.324	0.33125	B	0.051	0.25435	B	0.07	0.21442	N	simple_aae	93.0	7.0	.	.	.	-2.41	0.52959	N	0.273	0.30701	-0.8123	0.54226	T	0.2053	0.56171	T	10	0.007968307	0.00178	T	.	.	.	0.211	0.49965	.	.	.	.	.	0.774614691122	0.77076	0.8038402898218863	0.80224	0.0352708056019	0.03600	0.341960847378	0.16715	T	0.663047	0.89810	D	-0.356084	0.04191	T	-0.256403	0.48853	T	0.0138108365552158	0.00260	T	0.841416	0.51556	T	0.18188076	0.39070	0.0833594	0.19075	0.18188076	0.39070	0.0833594	0.19075	-6.0	0.46337	T	0.139	0.30506	B	0.0906186694133492	0.42433	0.01449318	0.45668	0.325	0.58944	.	.	.	.	.	.	0.557242	0.09286	6.04	0.96426498933613336	0.29983	0.653484	0.62516	D	-0.80934855494016	0.12913	0.641386	-0.889050135096485	0.12139	0.6349178	4.91	1.11	0.19597	-4.26	0.05761	0.074	0.1457	-1.779000	0.04765	0.597	0.3436	0.0	0.06393	0.000000	0.08389	0.003	0.0525	982	0.03399	60	0.011980830670926517	54	0.04084720121028744	0	0.0	6	0.008645533141210375	0	0.0	0	0.0	3185	264690	0.012032944	.	317	109312	2.899960e-03	2	686	207834	3.300710e-03	8	636	236778	2.686060e-03	7	283	7154	3.955830e-02	2	30	17100	1.754390e-03	0	0	2318	0.000000e+00	0	0	9042	0.000000e+00	0	0	13388	0.000000e+00	0	4	42724	9.362420e-05	0	0	15672	0.000000e+00	0	283	7154	3.955830e-02	2	604	16172	3.734850e-02	8	57	30494	1.869220e-03	0	0	6202	0.000000e+00	0	1	13404	7.460460e-05	0	0	16728	0.000000e+00	0	19	89386	2.125610e-04	0	0	30588	0.000000e+00	0	604	16172	3.734850e-02	8	547	14878	3.676570e-02	7	67	34230	1.957350e-03	0	0	9568	0.000000e+00	0	1	17686	5.654190e-05	0	0	21624	0.000000e+00	0	18	102666	1.753260e-04	0	0	30506	0.000000e+00	0	547	14878	3.676570e-02	7	.	3164	1614066	1.960270e-03	42	2735	75042	3.644630e-02	41	2735	75042	3.644630e-02	41	0	912	0.000000e+00	0	185	60022	3.082200e-03	1	0	29608	0.000000e+00	0	1	44874	2.228460e-05	0	0	64014	0.000000e+00	0	5	6060	8.250830e-04	0	87	1179964	7.373110e-05	0	6	91062	6.588920e-05	0	39	181304	2.1510832634690907E-4	8	350	0.022857142857142857	0	4476	0	242	9590	0.025234619395203335	15	820	0.018292682926829267	1	1006	9.940357852882703E-4	1	1850	5.405405405405405E-4	0	296	0	44	20010	0.0021989005497251375	250	9940	0.025150905432595575	1	6326	1.5807777426493836E-4	350	219702	0.0015930669725355254	not_provided|Primary_hyperoxaluria,_type_I|AGXT-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240875997C>T	ClinGen:CA275593|UniProtKB:P21549#VAR_060565	C3661900|C0268164	259900	416|93598	Aminotransferase class V domain	Ala	Val	98.87	0.49056603773584906																																																																																																																																																																																																																																																																																																																																																																																																																																																																													52			98.87	Aliphatic	Alanine		Alanine--glyoxylate aminotransferase										1.8								 A280-L276 (PAE:  1.0)	A280-L276 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)	 A280-L276 (PAE:  1.0)	A280-L276 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)							89									-68.4				-41.4				dbSNP: rs73106685; Variant type: LB/B; AA change: Ala280Val; PTM type: Phosphorylation; PTM morphology: YSLREsLALIA*; Var class: II		H (helix)	H (α-helix)	Helix											98.87	49.056606	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.7409846005239553	0.7671774593275812	false	false	false
MYOZ2	MYOZ2_Ile246Met	B_7-8	0.1659134265232056	0.8736745794044194	0.9015226616220643	-3.1904781851498867	0.018824953838884488	0.029779129564097444	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5833610117058055	0.6079846421985058	0.4678045711276746	0.5787676989255219	0.545412196823898	0.48542786327632714	0.479476228528524	0.4751435627739549	0.42642909370817167	0.5020540201198294	0.5854360350866763	0.5756732960119937	0.4913794980241302	0.615680830873841	0.7311063041428723	0.43355512213551983	0.6305332493103353	0.5910487273996171	MYOZ2	Ile246Met	NC_000004.12:119186143:A:G	738A>G	4	119186143	A	G	4	ENSG00000172399	5651	10278	CCSBVarC000867	ALE00000867	ENSP00000306997.6	RC4	RC4_Mut_GDEh1005	E07	GDEhDisVCh_40044	F03	2	RC4_Mut_GDDh1005	E07	NULL	NULL	NULL	NULL	VUSmut_GDEh12	E07	1.0	6.0	1.0	1.0	0.0			0.0			1.0	1.0	99.0	N	Y	N	N	Y	39466.0	single nucleotide variant	NM_016599.5(MYOZ2):c.738A>G (p.Ile246Met)	51778.0	MYOZ2	HGNC:1330	Benign/Likely benign	1.0	Nov 24, 2023	140126678.0	-	RCV000023466|RCV000024477|RCV000039013|RCV000330572	MONDO:MONDO:0013455,MedGen:C3151204,OMIM:613838|MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569	Hypertrophic cardiomyopathy 16|not provided|not specified|Hypertrophic cardiomyopathy	germline	germline	GRCh38	NC_000004.12	4	119186143.0	119186143.0	4q26	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA129293,Leiden Muscular Dystrophy (MYOZ2):MYOZ2_00002,UniProtKB:Q9NPC6#VAR_065470,OMIM:605602.0002	3.0	30509.0	119186143.0	A	G	-	-	-	-	-	-	738A>G 	Ile246Met	NM_016599.5	2.0	Benign	Likely benign	30509	4	119186143.0	A	G	I	M	rs140126678	4	120107298	4	120326746	246	MYOZ2	ENSG00000172399	ENST00000307128	ENSP00000306997	Q9NPC6	MYOZ2_HUMAN	c.738A>G	p.Ile246Met	c.738A>G	p.Ile246Met	principal1	Y	1	YES	Select	+	ATA	3	3	A	A/A	A/A	A/A	A/A	0.011	0.55689	D	0.294	0.21009	T	0.041	0.21372	B	0.056	0.26150	B	0.05	0.16373	N	simple_aae	95.0	5.0	1.84	0.48108	L	-0.12	0.08754	N	0.644	0.65412	-0.9478	0.41167	T	0.1105	0.39557	T	9	0.028900564	0.01018	T	.	.	.	0.278	0.59294	.	.	.	.	.	0.53832913131	0.53142	0.3409235786633024	0.33804	0.170929810411	0.18990	0.288163453341	0.08651	T	0.142058	0.47460	T	-0.237949	0.15332	T	-0.170922	0.57061	T	0.0271140094545161	0.01552	T	0.807219	0.45534	T	0.09171896	0.21304	0.081842534	0.18611	0.07769057	0.17486	0.069054835	0.14496	-4.177	0.26444	T	0.1031	0.18565	B	0.108387382679684	0.44062	0.00245265	0.25090	0.118	0.32131	.	.	.	.	.	.	1.172767	0.15648	11.99	0.97045443715046009	0.32316	0.343164	0.43719	N	-0.460611115548636	0.23116	1.25522	-0.378033993959275	0.25335	1.412083	5.83	-1.66	0.07807	-3.25	0.07933	-0.008	0.12764	-0.685000	0.07902	0.751	0.87726	0.872	0.30923	0.000000	0.08389	0.988	0.63383	462	0.78630	4	7.987220447284345E-4	0	0.0	4	0.003976143141153081	0	0.0	0	0.0	0	0.0	54	264690	2.0401223E-4	.	312	109376	2.852550e-03	3	410	208060	1.970590e-03	7	534	236708	2.255940e-03	9	0	7162	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	283	13378	2.115410e-02	3	25	42768	5.845490e-04	0	0	15688	0.000000e+00	0	25	42768	5.845490e-04	0	1	16216	6.166750e-05	0	0	30510	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	369	16718	2.207200e-02	7	34	89524	3.797860e-04	0	0	30604	0.000000e+00	0	34	89524	3.797860e-04	0	0	14900	0.000000e+00	0	0	34244	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	466	21606	2.156810e-02	9	55	102572	5.362090e-04	0	0	30522	0.000000e+00	0	55	102572	5.362090e-04	0	.	1750	1614050	1.084230e-03	18	1402	64012	2.190210e-02	18	5	75036	6.663470e-05	0	0	912	0.000000e+00	0	1	60026	1.665940e-05	0	0	29602	0.000000e+00	0	0	44852	0.000000e+00	0	1402	64012	2.190210e-02	18	0	6060	0.000000e+00	0	289	1179968	2.449220e-04	0	0	91080	0.000000e+00	0	188	184558	0.0010186499636970492	0	360	0	0	2710	0	1	9426	1.0608953957139826E-4	0	796	0	0	968	0	0	682	0	0	280	0	13	15620	8.322663252240716E-4	1	9786	1.0218679746576743E-4	0	3392	0	202	215400	9.377901578458682E-4	Hypertrophic_cardiomyopathy_16|not_specified|not_provided|Hypertrophic_cardiomyopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000004.12:g.119186143A>G	ClinGen:CA129293|Leiden_Muscular_Dystrophy_(MYOZ2):MYOZ2_00002|OMIM:605602.0002|UniProtKB:Q9NPC6#VAR_065470	C3151204|CN169374|C3661900|C0007194	613838	217569	.	Ile	Met	53.3	0.8698224852071006																																																																																																																																																																																																																																																																																																																																																																																																																																																																													147			53.3	Aliphatic	Isoleucine		Myozenin-2										4.5																		131									-67.3				97.7						C (loop/coil)	C (loop/coil)												53.3	86.982254	50-70	10-90	613838	autosomal dominant	OMIM		0	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16	false	0.6079846421985058	0.5833610117058055	false	false	false
PNPO	PNPO_Arg116Gln	B_7-8	-2.8153602323412446	0.03731187912395698	0.07331861021271383	-13.325199539630683	0.000011049928463014664	0.00008046277273663456	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.9649563021728966	0.9710034194677796	0.5034298103408663	0.5685375375613868	0.494352286404628	0.5012739116993303	0.6440260390111162	0.5697891273969429	0.6319846780612086	0.6241321063387099	0.9790692003392288	0.9752360024342843	0.35852178438754434	0.41891544541231324	0.505090397061565	0.3827275143430229	0.9629376385963303	0.954676601911509	PNPO	Arg116Gln	NC_000017.11:47944699:G:A	347G>A	17	47944699	G	A	17	ENSG00000108439	4515	900160	CCSBVarC002887	ALE00002887	ENSP00000493302.2	RC4	NatVar_GDE_001	H01	GDEhDisVCh_40042	A01	2	NULL	NULL	NULL	NULL	VUSMutpDEST2_04	E04	VUSmut_GDEh12	B01	1.0	1.0	0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	135427.0	single nucleotide variant	NM_018129.4(PNPO):c.347G>A (p.Arg116Gln)	55163.0	PNPO	HGNC:30260	Benign/Likely benign	0.0	Feb 01, 2024	17679445.0	-	RCV000118002|RCV000357367|RCV001707529|RCV002312225	MedGen:CN169374|MONDO:MONDO:0012407,MedGen:C1864723,OMIM:610090,Orphanet:79096|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	not specified|Pyridoxal phosphate-responsive seizures|not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000017.11	17	47944699.0	47944699.0	17q21.32	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA154714,UniProtKB:Q9NVS9#VAR_029359	2.0	129981.0	47944699.0	G	A	-	-	-	-	-	-	347G>A 	Arg116Gln	NM_018129.4	2.0	Benign	Likely benign	129981	17	47944699.0	G	A	R	Q	rs17679445	17	46022065	17	43377064	116	PNPO	ENSG00000108439	ENST00000642017	ENSP00000493302	Q9NVS9	PNPO_HUMAN	c.347G>A	p.Arg116Gln	c.347G>A	p.Arg116Gln	principal1	Y	.	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	.	0.30233	.	.	0.40143	.	0.974	0.57842	D	0.303	0.41149	B	.	0.13669	.	.	.	.	2.255	0.63995	M	.	0.66466	.	.	0.60205	-0.7765	0.56318	T	0.0460	0.19574	T	10	0.00831601	0.00185	T	.	.	.	.	0.67972	.	.	.	.	.	.	.	0.6245681782295754	0.62215	.	0.76204	0.512418866158	0.40503	T	0.314758	0.68462	T	-0.293726	0.09045	T	-0.137167	0.60084	T	0.0227714221794717	0.00993	T	0.9965	0.98759	D	0.65381503	0.75298	0.52285486	0.72177	0.74423176	0.80302	0.57714987	0.75251	-7.636	0.58634	D	0.2455	0.47997	B	0.267225320610542	0.52941	0.00055477	0.09988	0.614	0.78436	.	.	.	.	.	.	5.567997	0.92206	32.0	0.99937908923414231	0.99699	0.929611	0.91532	D	0.588159513330599	0.72288	5.805309	0.628582659038956	0.76898	6.600475	5.22	5.22	0.72246	4.57	0.85150	7.795	0.84482	11.627000	0.93679	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	523	0.74166	149	0.029752396166134187	1	7.564296520423601E-4	67	0.06660039761431412	36	0.05187319884726225	0	0.0	45	0.046012269938650305	11989	264690	0.045294497	.	5799	109398	5.300830e-02	206	11269	208106	5.415030e-02	388	12818	236942	5.409760e-02	435	79	7164	1.102740e-02	2	669	17110	3.909990e-02	17	109	2320	4.698280e-02	5	3	9046	3.316380e-04	0	877	13388	6.550640e-02	28	2987	42766	6.984520e-02	105	964	15690	6.144040e-02	44	2987	42766	6.984520e-02	105	179	16212	1.104120e-02	3	1114	30522	3.649830e-02	21	335	6212	5.392790e-02	13	3	13416	2.236140e-04	0	1090	16728	6.516020e-02	31	6426	89542	7.176520e-02	225	1829	30608	5.975560e-02	87	6426	89542	7.176520e-02	225	150	14902	1.006580e-02	3	1268	34258	3.701330e-02	26	509	9572	5.317590e-02	19	3	17692	1.695680e-04	0	1409	21626	6.515310e-02	38	7321	102746	7.125340e-02	252	1827	30526	5.985060e-02	87	7321	102746	7.125340e-02	252	.	101691	1612942	6.304690e-02	3593	446	6048	7.374340e-02	14	775	75022	1.033030e-02	8	27	908	2.973570e-02	0	2500	60010	4.165970e-02	64	1606	29598	5.426040e-02	47	11	44888	2.450540e-04	0	4394	64026	6.862840e-02	151	446	6048	7.374340e-02	14	82853	1178920	7.027870e-02	2955	5619	91060	6.170660e-02	264	19382	273410	0.07088987235287664	2	584	0.003424657534246575	2	4928	4.0584415584415587E-4	222	16234	0.013675003079955648	87	1456	0.059752747252747256	256	6746	0.03794841387488882	4	1986	0.002014098690835851	14	380	0.03684210526315789	1270	23762	0.05344667957242656	224	16818	0.013319062908788204	6	6914	8.678044547295343E-4	21239	329486	0.06446100896547957	Inborn_genetic_diseases|not_provided|Pyridoxal_phosphate-responsive_seizures|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.47944699G>A	ClinGen:CA154714|UniProtKB:Q9NVS9#VAR_029359	C0950123|C3661900|C1864723|CN169374	610090	79096	Pyridoxamine 5'-phosphate oxidase, putative	Arg	Gln	95.07	0.5201612903225806																																																																																																																																																																																																																																																																																																																																																																																																																																																																													129			95.07	Positively-charged	Arginine	FMN	Pyridoxine-5'-phosphate oxidase								0.003		-4.5								 R116-E120 (PAE:  1.0)	R116-E120 (PDBs: 1NRG, 8QYT, 8QYW)	 R116-S175 (PAE:  3.0), R116-E120 (PAE: 1.0)	R116-E120 (PDBs: 1NRG, 8QYT, 8QYW), R116-S175 (PDBs: 8QYW)	 R116-E120 (PAE:  1.0)						175									-51.8		Pocket 3: Mean pLDDT: 92.54, Volume: 351.53 Å³, Druggability score: 0		-46.2				dbSNP: rs17679445; Variant type: LB/B; AA change: Arg116Gln; PTM type: Acetylation; PTM morphology: ESR*KGkELDSN; Var class: II		H (helix)	H (α-helix)	Helix											95.07	52.01613	>90	10-90	610090	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	false	0.9710034194677796	0.9649563021728966	true	true	false
MLH1	MLH1_Lys751Arg	B_11-12	-1.4003858928575363	0.2484228025339096	0.3320416744854915	0.3084551093411999	0.7745921294963749	0.8145424399001994	2024_12_Batch_11-12	true	true	true	false	false	true	false	false	false	false	false	false	0.8745797529180814	0.8870597660440533	0.9100745750566099	0.8307800327636377	0.8782518467821079	0.930673732493529		0.9489975255329277		0.9416723217855469	0.9337193661409627	0.9309557542320215	0.930673732493529	0.8075061680312882	0.8307800327636377	0.878476828327673	0.840400165947144	0.8182037516041414	MLH1	Lys751Arg	NC_000003.12:37050634:A:G	2252A>G	3	37050634	A	G	3	ENSG00000076242	2713	200902	CCSBVarC003209	ALE00003209	ENSP00000231790.3	CEGS2	CegsMutGDEh1042	H10	GDEhDisVCh_40019	G02	1	CegsMutGDDh1042	H10	VUSN2Hmut_GDN2h_09	G01	VUSMutpDEST2_02	G09	VUSmut_GDEh09	G01	1.0	1.0	1.0	2.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	N	Y	Y	95574.0	single nucleotide variant	NM_000249.4(MLH1):c.2252A>G (p.Lys751Arg)	4292.0	MLH1	HGNC:7127	Likely benign	0.0	Sep 05, 2013	140195825.0	-	RCV000115476|RCV000148620|RCV000075586|RCV000409128|RCV001082066|RCV000759084|RCV003492414|RCV001355426|RCV003235033|RCV002498364|RCV003925033	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN221576|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144|MeSH:D003123,MedGen:C0009405|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0002032,MedGen:C0699790|MedGen:CN169374|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144;MONDO:MONDO:0010159,MedGen:C5399763,OMIM:276300,Orphanet:252202;MONDO:MONDO:0008018,MedGen:C1321489,OMIM:158320,Orphanet:587|	Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Lynch syndrome|Colorectal cancer, hereditary nonpolyposis, type 2|Hereditary nonpolyposis colorectal neoplasms|not provided|Breast and/or ovarian cancer|Carcinoma of colon|not specified|Colorectal cancer, hereditary nonpolyposis, type 2;Mismatch repair cancer syndrome 1;Muir-Torré syndrome|MLH1-related disorder	germline;unknown	germline	GRCh38	NC_000003.12	3	37050634.0	37050634.0	3p22.2	reviewed by expert panel	18.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009252,UniProtKB:P40692#VAR_012934	2.0	90100.0	37050634.0	A	G	-	-	-	-	-	-	2252A>G 	Lys751Arg	NM_000249.4	3.0	Benign	Likely benign	90100	3	37050634.0	A	G	K	R	rs140195825	3	37092125	3	37067129	751	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.2252A>G	p.Lys751Arg	c.2252A>G	p.Lys751Arg	principal1	Y	1	YES	Select	+	AAA	2	0	A	A/A	A/A	A/A	A/A	0.147	0.42941	T	0.161	0.48432	T	0.007	0.14196	B	0.057	0.26282	B	0.48	0.76257	N	simple_aae	52.0	48.0	1.49	0.37143	L	-1.53	0.50028	N	0.661	0.66880	-0.2203	0.77040	T	0.6459	0.87603	D	10	0.19142485	0.34451	T	0.064965	0.69327	D	0.620	0.85178	.	.	.	.	.	0.993080212312	0.99292	0.7050539118096893	0.70296	0.0612991739917	0.06677	0.376493036747	0.21734	T	0.682321	0.90590	D	0.20633	0.74294	D	0.306912	0.88432	D	0.0639174747127259	0.07682	T	0.829517	0.51556	T	0.25686955	0.48398	0.16356805	0.37817	0.2782309	0.50546	0.18407713	0.41295	-5.763	0.61158	T	0.0726	0.04534	B	0.155367247295405	0.47439	0.99891880	0.99037	0.515	0.72411	.	.	.	.	.	.	1.731603	0.22077	15.46	0.99306253714285331	0.58894	.	.	.	-0.320085401823617	0.28107	1.56523	-0.199435423517501	0.31243	1.787068	5.41	1.72	0.23435	0.681	0.26544	2.153	0.4201	3.030000	0.36119	-0.057	0.167	1.0	0.71675	1.000000	0.68239	0.996	0.76032	154	0.93969	.	.	.	.	.	.	.	.	.	.	.	.	8	264690	3.0224035E-5	.	8	109390	7.313280e-05	0	17	208082	8.169860e-05	0	18	236764	7.602510e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9034	0.000000e+00	0	0	13388	0.000000e+00	0	8	42768	1.870560e-04	0	0	15690	0.000000e+00	0	8	42768	1.870560e-04	0	0	16218	0.000000e+00	0	2	30524	6.552220e-05	0	0	6212	0.000000e+00	0	0	13394	0.000000e+00	0	0	16728	0.000000e+00	0	14	89536	1.563620e-04	0	0	30606	0.000000e+00	0	14	89536	1.563620e-04	0	1	14902	6.710510e-05	0	2	34260	5.837710e-05	0	0	9570	0.000000e+00	0	0	17670	0.000000e+00	0	0	21620	0.000000e+00	0	14	102606	1.364440e-04	0	0	30524	0.000000e+00	0	14	102606	1.364440e-04	0	.	221	1613962	1.369300e-04	0	213	1179960	1.805150e-04	0	1	74904	1.335040e-05	0	0	912	0.000000e+00	0	6	60004	9.999330e-05	0	0	29608	0.000000e+00	0	0	44896	0.000000e+00	0	0	64026	0.000000e+00	0	0	6084	0.000000e+00	0	213	1179960	1.805150e-04	0	0	91084	0.000000e+00	0	21	123042	1.7067342858536109E-4	0	176	0	0	2752	0	0	4622	0	0	790	0	0	946	0	0	656	0	0	280	0	1	8496	1.1770244821092278E-4	0	4798	0	0	3408	0	22	141760	1.551918735891648E-4	Mismatch_repair_cancer_syndrome_1|Muir-Torré_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_2|not_specified|MLH1-related_disorder|Hereditary_nonpolyposis_colorectal_neoplasms|Hereditary_cancer-predisposing_syndrome|not_provided|Lynch_syndrome|Colorectal_cancer,_non-polyposis|Breast_and/or_ovarian_cancer|Carcinoma_of_colon	reviewed_by_expert_panel	NC_000003.12:g.37050634A>G	ClinGen:CA009252|UniProtKB:P40692#VAR_012934	C5399763|C1321489|C1333991|CN169374|C0009405|C0027672|C3661900|C4552100|CN221576|CN221562|C0699790	276300|158320|609310	252202|587|144|140162|144	DNA mismatch repair protein Mlh1, C-terminal	Lys	Arg	72.16	0.5463414634146342																																																																																																																																																																																																																																																																																																																																																																																																																																																																													112			72.16	Positively-charged	Lysine		DNA mismatch repair protein Mlh1								0.0912		-3.9								 K751-P747 (PAE:  3.5)		 K751-P747 (PAE:  3.5), K751-R755 (PAE: 3.0)		 K751-D748 (PAE:  3.0)						147									-65.3		Pocket 3: Mean pLDDT: 61.12, Volume: 518.21 Å³, Druggability score: 0.09		-26.5				dbSNP: rs140195825; Variant type: US; AA change: Lys751Arg; PTM type: Ubiquitylation; PTM morphology: LPDLYkVFERC; Var class: II		H (helix)	H (α-helix)										Morphology: ANLPDLYkVFERC__; Domain: Mlh1_C		72.16	54.634148	70-90	10-90	609310;609310;276300;158320	multiple	OMIM	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 2; LYNCH SYNDROME 2; MISMATCH REPAIR CANCER SYNDROME 1; MUIR-TORRE SYNDROME	false	0.8870597660440533	0.8745797529180814	true	true	false
RP2	RP2_Arg282Trp	B_7-8	-0.6963243956530519	0.512283949750431	0.5938588178554586	2.6520924133030834	0.03792243996483805	0.055625641355298024	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5278743548849815	0.6065105471194544	0.6155799977861418	0.5664567419747973	0.6134695850662913	0.6398098618474934	0.5005150405282734	0.4491066670758614	0.4727338168350053	0.5344072806446847	0.5795027612154867	0.5535288148908013	0.7791046831667136	0.7778325030567212	0.6601796671145893	0.6967527149275988	0.6335183330234221	0.5022198948791616	RP2	Arg282Trp	NC_000023.11:46860063:C:T	844C>T	23	46860063	C	T	X	ENSG00000102218	11374	19295	CCSBVarC001709	ALE00001709	ENSP00000218340.3	RC4	RC4_Mut_GDEh1017	B08	GDEhDisVCh_40085	C09	1	RC4_Mut_GDDh1017	B08	NULL	NULL	VUSMutpDEST2_08	D11	VUSmut_GDEh13	H01	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	193605.0	single nucleotide variant	NM_006915.3(RP2):c.844C>T (p.Arg282Trp)	6102.0	RP2	HGNC:10274	Benign/Likely benign	0.0	Feb 01, 2024	1805147.0	-	RCV000177264|RCV000326876|RCV001000370|RCV001518024	MedGen:CN169374|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0010723,MedGen:C2681923,OMIM:312600,Orphanet:791|MedGen:C3661900	not specified|Retinitis pigmentosa|Retinitis pigmentosa 2|not provided	germline	germline	GRCh38	NC_000023.11	X	46860063.0	46860063.0	Xp11.3	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA202379,UniProtKB:O75695#VAR_014535	2.0	196444.0	46860063.0	C	T	-	-	-	-	-	-	844C>T 	Arg282Trp	NM_006915.3	2.0	Benign	Likely benign	196444	X	46860063.0	C	T	R	W	rs1805147	X	46719498	X	46604442	282	RP2	ENSG00000102218	ENST00000218340	ENSP00000218340	O75695	XRP2_HUMAN	c.844C>T	p.Arg282Trp	c.844C>T	p.Arg282Trp	principal1	Y	1	YES	Select	+	CGG	1	2	c	C/C	C/C	C/C	C/C	0.091	0.31974	T	0.04	0.51160	D	0.925	0.51408	P	0.084	0.29272	B	0.05	0.16373	P	simple_aae	95.0	5.0	1.39	0.34781	L	-1.57	0.37944	N	0.048	0.01993	-0.9730	0.36417	T	0.0785	0.31063	T	10	0.0053629577	0.00115	T	.	.	.	0.215	0.50585	.	.	.	.	.	.	.	0.5258984684213517	0.52321	0.383124245717	0.39363	0.216969117522	0.01144	T	0.174633	0.52153	T	-0.561895	0.00240	T	-0.556902	0.16373	T	0.0169435305836235	0.00443	T	0.887811	0.61552	D	0.23078045	0.45511	0.13033299	0.31235	0.26033896	0.48759	0.18865493	0.42022	-6.676	0.51695	T	0.0917	0.13515	B	0.0174656795328288	0.28344	0.55385540	0.83036	0.156	0.39494	.	.	.	.	.	.	2.567509	0.33325	19.29	0.98859791348651405	0.47542	.	.	.	.	.	.	.	.	.	5.18	3.35	0.37394	1.44	0.33505	3.361	0.52123	2.351000	0.32397	0.599	0.40292	1.0	0.71675	0.986000	0.30920	0.997	0.79771	131	0.94737	25	0.006622516556291391	1	9.970089730807576E-4	16	0.020887728459530026	6	0.011450381679389313	0	0.0	2	0.002785515320334262	4652	264690	0.017575277	.	1345	80071	1.679760e-02	9	2623	151320	1.733410e-02	19	3066	171698	1.785690e-02	26	28	5685	4.925240e-03	0	122	13645	8.941000e-03	0	31	1764	1.757370e-02	0	1	6913	1.446550e-04	0	190	9928	1.913780e-02	1	904	30843	2.930970e-02	7	46	9848	4.671000e-03	1	904	30843	2.930970e-02	7	55	13109	4.195590e-03	0	173	24336	7.108810e-03	0	83	4641	1.788410e-02	0	1	10126	9.875570e-05	0	229	12180	1.880130e-02	1	1930	64461	2.994060e-02	17	82	18853	4.349440e-03	1	1930	64461	2.994060e-02	17	49	12040	4.069770e-03	0	225	27117	8.297380e-03	0	129	7076	1.823060e-02	0	2	13314	1.502180e-04	0	294	15976	1.840260e-02	1	2203	73254	3.007340e-02	24	82	18789	4.364260e-03	1	2203	73254	3.007340e-02	24	.	32063	1206352	2.657850e-02	343	28498	892009	3.194810e-02	318	231	57232	4.036200e-03	2	6	685	8.759120e-03	0	452	45664	9.898390e-03	3	412	21995	1.873150e-02	2	4	33746	1.185330e-04	0	936	46485	2.013550e-02	6	137	4340	3.156680e-02	2	28498	892009	3.194810e-02	318	235	56685	4.145720e-03	1	761	33530	0.022696093050999105	0	122	0	0	156	0	18	3370	0.005341246290801187	5	146	0.03424657534246575	6	610	0.009836065573770493	0	56	0	0	98	0	64	3096	0.020671834625323	18	3492	0.005154639175257732	0	212	0	854	41184	0.020736208236208236	not_specified|not_provided|Retinitis_pigmentosa|Retinitis_pigmentosa_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.46860063C>T	ClinGen:CA202379|UniProtKB:O75695#VAR_014535	CN169374|C3661900|C0035334|C2681923	268000|PS268000|312600	791|791	Tubulin binding cofactor C-like domain	Arg	Trp	92.25	0.5806451612903226																																																																																																																																																																																																																																																																																																																																																																																																																																																																													144			92.25	Positively-charged	Arginine		Protein XRP2										-4.5								 R282-S339 (PAE:  2.0), R282-Q278 (PAE: 1.5)	R282-E328 (PDBs: 2BX6), R282-Q278 (PDBs: 2BX6, 3BH6, 3BH7)	 R282-Q278 (PAE:  1.5)	R282-A277 (PDBs: 2BX6, 3BH7), R282-Q278 (PDBs: 2BX6, 3BH6, 3BH7)		R282-D336 (PDBs: 3BH6, 3BH7)					175									50.7				-124.0				dbSNP: rs1805147; Variant type: LB/B; AA change: Arg282Trp; PTM type: Ubiquitylation; PTM morphology: RVFR*EkAPDFL; Var class: II		H (helix)	G (3₁₀-helix)	Helix											92.25	58.064514	>90	10-90	268000;312600	x-linked	OMIM	Rare genetic eye disease; Ciliopathy	2	RETINITIS PIGMENTOSA; RETINITIS PIGMENTOSA 2	false	0.6065105471194544	0.5278743548849815	false	false	false
TMEM43	TMEM43_Arg299Thr	B_15-16	-1.2014325936773036	0.26865041486634833	0.35465177211637117	-1.010502949160558	0.3459010308137941	0.3989493347223835	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.5208821688353966	0.5354008466413313	0.5155492118535395	0.569438299866731	0.5984769786347581	0.54067862862438	0.4734093393522543	0.6728165156360069	0.587572601915548	0.4564402595366856	0.5452298160823796	0.5040822795078078	0.6079479178965056	0.5241374416335095	0.551303997817914	0.5746581641703934	0.5255718772002829	0.5376820581629853	TMEM43	Arg299Thr	NC_000003.12:14139193:G:C	896G>C	3	14139193	G	C	3	ENSG00000170876	3438	289	CCSBVarC008442	ALE00008462	ENSP00000303992.5	Edgotyping3	VUSmut_GDEh11	A05	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_03	G05	VUSmut_GDEh11	A05	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	2.0	Y	N	N	Y	Y	198157.0	single nucleotide variant	NM_024334.3(TMEM43):c.896G>C (p.Arg299Thr)	79188.0	TMEM43	HGNC:28472	Benign/Likely benign	0.0	May 01, 2024	139590716.0	-	RCV000183927|RCV000771951|RCV000642434|RCV003937652|RCV004567384|RCV000619604|RCV002492830	MedGen:CN169374|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0011459,MedGen:C1858379,OMIM:604400||MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0859235,MedGen:C5676964,OMIM:619832;MONDO:MONDO:0011459,MedGen:C1858379,OMIM:604400;MONDO:MONDO:0013677,MedGen:C3553060,OMIM:614302,Orphanet:261	not specified|Cardiomyopathy|Arrhythmogenic right ventricular dysplasia 5|TMEM43-related disorder|not provided|Cardiovascular phenotype|Auditory neuropathy, autosomal dominant 3;Arrhythmogenic right ventricular dysplasia 5;Emery-Dreifuss muscular dystrophy 7, autosomal dominant	germline;unknown	germline	GRCh38	NC_000003.12	3	14139193.0	14139193.0	3p25.1	criteria provided, multiple submitters, no conflicts	8.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA024791	2.0	202109.0	14139193.0	G	C	-	-	-	-	-	-	896G>C 	Arg299Thr	NM_024334.3	2.0	Benign	Likely benign	202109	3	14139193.0	G	C	R	T	rs139590716	3	14180693	3	14155694	299	TMEM43	ENSG00000170876	ENST00000306077	ENSP00000303992	Q9BTV4	TMM43_HUMAN	c.896G>C	p.Arg299Thr	c.896G>C	p.Arg299Thr	principal1	Y	1	YES	Select	+	AGA	2	0	G	G/G	G/G	G/G	G/G	0.114	0.28778	T	0.218	0.26362	T	0.491	0.36978	P	0.185	0.36049	B	0.71	0.82936	D	simple_aae	29.0	71.0	1.725	0.44368	L	-0.66	0.19020	N	0.819	0.81397	-1.0474	0.15128	T	0.0334	0.14266	T	10	0.016725272	0.00350	T	0.026405	0.49115	D	0.126	0.34465	.	.	.	.	.	0.269558022972	0.26139	0.4355652195779051	0.43273	0.254635136396	0.27741	0.46898779273	0.34496	T	0.003021	0.02435	T	-0.429117	0.01405	T	-0.387393	0.34499	T	0.0452673617739115	0.04607	T	0.906109	0.66836	D	0.083219975	0.19032	0.055740308	0.09844	0.09804995	0.22913	0.059849314	0.11307	-8.595	0.65132	D	0.1411	0.31051	B	0.513240743372539	0.61187	0.89484310	0.91029	0.058	0.15819	.	.	.	.	.	.	3.466466	0.48421	22.6	0.95593929320250537	0.27541	0.598310	0.59031	D	-0.111462775842022	0.36621	2.138756	0.0235615044140346	0.40521	2.441621	5.25	4.37	0.51773	3.54	0.64349	2.101	0.41515	4.567000	0.43943	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.997	0.79771	830	0.39194	6	0.0011980830670926517	0	0.0	0	0.0	0	0.0	6	0.005952380952380952	0	0.0	64	264690	2.4179228E-4	.	64	109394	5.850410e-04	0	88	208100	4.228740e-04	0	119	236916	5.022880e-04	0	0	7160	0.000000e+00	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	56	9046	6.190580e-03	0	2	13388	1.493880e-04	0	4	42768	9.352790e-05	0	0	15690	0.000000e+00	0	56	9046	6.190580e-03	0	0	16214	0.000000e+00	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	71	13416	5.292190e-03	0	4	16728	2.391200e-04	0	9	89538	1.005160e-04	0	1	30608	3.267120e-05	0	71	13416	5.292190e-03	0	0	14898	0.000000e+00	0	0	34254	0.000000e+00	0	0	9572	0.000000e+00	0	96	17692	5.426180e-03	0	4	21626	1.849630e-04	0	15	102728	1.460170e-04	0	1	30526	3.275900e-05	0	96	17692	5.426180e-03	0	.	563	1613974	3.488280e-04	0	273	44882	6.082620e-03	0	2	75044	2.665100e-05	0	0	912	0.000000e+00	0	3	60036	4.997000e-05	0	0	29606	0.000000e+00	0	273	44882	6.082620e-03	0	8	64024	1.249530e-04	0	0	6062	0.000000e+00	0	251	1179834	2.127420e-04	0	4	91076	4.391940e-05	0	16	92468	1.7303283298005797E-4	0	174	0	16	2664	0.006006006006006006	1	4186	2.3889154323936931E-4	0	790	0	0	944	0	1	656	0.001524390243902439	0	274	0	0	8036	0	1	4360	2.2935779816513763E-4	17	3320	0.0051204819277108436	34	110192	3.08552344997822E-4	not_provided|not_specified|TMEM43-related_disorder|Cardiomyopathy|Cardiovascular_phenotype|Emery-Dreifuss_muscular_dystrophy_7,_autosomal_dominant|Auditory_neuropathy,_autosomal_dominant_3|Arrhythmogenic_right_ventricular_dysplasia_5	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.14139193G>C	ClinGen:CA024791	C3661900|CN169374|C0878544|CN230736|C3553060|C5676964|C1858379	614302|619832|604400	167848|261	.	Arg	Thr	98.03	0.4879032258064516																																																																																																																																																																																																																																																																																																																																																																																																																																																																													121			98.03	Positively-charged	Arginine		Transmembrane protein 43										-4.5								 R299-S303 (PAE:  1.0), R299-E295 (PAE: 1.0)		 R299-S303 (PAE:  1.0), R299-E295 (PAE: 1.0)								175									-64.3				-43.0						H (helix)	H (α-helix)							Perinuclear space					98.03	48.790325	>90	10-90	604400;619832;604400;614302	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 3; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT	false	0.5354008466413313	0.5208821688353966	false	false	false
NMNAT1	NMNAT1_Ser255Asn	B_7-8	-2.6807337085061436	0.03650044845309651	0.07215044075876798	-5.579454779530818	0.0014072564973658791	0.003188044040328874	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5168559948480147	0.5861694361644553	0.5689971196759024	0.5659762718721738	0.6810894546671378	0.650408327429112	0.7911979144663502	0.8058505852419315	0.6346904214376012	0.7676063063602173	0.6851590545966906	0.6549124995163726	0.5096187403918738	0.5563283240923439	0.4972621223067463	0.3703879329915874	0.48717981773221997	0.3787994901796568	NMNAT1	Ser255Asn	NC_000001.11:9982625:G:A	764G>A	1	9982625	G	A	1	ENSG00000173614	7675	1769	CCSBVarC008475	ALE00008449	ENSP00000366410.1	Edgotyping3	VUSmut_GDEh11	D06	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_06	H11	VUSmut_GDEh11	D06	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	690681.0	single nucleotide variant	NM_022787.4(NMNAT1):c.764G>A (p.Ser255Asn)	64802.0	NMNAT1	HGNC:17877	Benign/Likely benign	0.0	Jan 22, 2024	138626416.0	-	RCV001002029	MONDO:MONDO:0012056,MedGen:C1837873,OMIM:608553,Orphanet:65	Leber congenital amaurosis 9	germline	germline	GRCh38	NC_000001.11	1	9982625.0	9982625.0	1p36.22	criteria provided, multiple submitters, no conflicts	2.0	-	N	-	2.0	707541.0	9982625.0	G	A	-	-	-	-	-	-	764G>A 	Ser255Asn	NM_022787.4	2.0	Benign	Likely benign	707541	1	9982625.0	G	A	S	N	rs138626416	1	10042683	1	9965270	255	NMNAT1	ENSG00000173614	ENST00000377205	ENSP00000366410	Q9HAN9	NMNA1_HUMAN	c.764G>A	p.Ser255Asn	c.764G>A	p.Ser255Asn	principal1	Y	1	YES	Select	+	AGC	2	0	G	./.	./.	./.	./.	0.817	0.02997	T	0.672	0.06367	T	0.008	0.14667	B	0.007	0.12988	B	0.08	0.23785	N	simple_aae	92.0	8.0	1.295	0.32304	L	-0.92	0.24626	N	0.069	0.04181	-0.2144	0.77196	T	0.5785	0.84762	D	10	0.005019486	0.00106	T	.	.	.	0.210	0.49808	.	.	.	.	.	0.906311155311	0.90467	0.4278195497626383	0.42497	0.0423772627697	0.04430	0.332536578178	0.15304	T	0.011641	0.10304	T	-0.411261	0.01835	T	-0.354129	0.38378	T	0.00576492111319874	0.00062	T	.	.	.	0.041630667	0.06107	0.03861541	0.03783	0.041630667	0.06106	0.03861541	0.03783	-4.94	0.36224	T	0.088	0.11755	B	0.13134209659295	0.45844	0.03120121	0.54383	0.229	0.49717	.	.	.	.	.	.	1.223495	0.16198	12.37	0.69947552576374072	0.09280	0.070906	0.13908	N	-0.895997064468907	0.10805	0.5251934	-0.840981667870441	0.13273	0.7008979	5.01	0.618	0.16757	1.29	0.31943	0.785	0.26583	0.473000	0.18802	-0.106	0.15547	0.511	0.27131	0.013000	0.20359	0.323	0.25089	643	0.63791	17	0.0033945686900958465	0	0.0	0	0.0	0	0.0	16	0.015873015873015872	1	0.0010224948875255625	135	264690	5.100306E-4	segdup	111	109396	1.014660e-03	0	174	207672	8.378600e-04	0	214	236360	9.053990e-04	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	105	9046	1.160730e-02	0	0	13394	0.000000e+00	0	0	42764	0.000000e+00	0	6	15684	3.825550e-04	0	105	9046	1.160730e-02	0	0	15954	0.000000e+00	0	0	30516	0.000000e+00	0	0	6206	0.000000e+00	0	161	13416	1.200060e-02	0	0	16734	0.000000e+00	0	0	89412	0.000000e+00	0	13	30602	4.248090e-04	0	161	13416	1.200060e-02	0	0	14638	0.000000e+00	0	0	34250	0.000000e+00	0	0	9562	0.000000e+00	0	200	17692	1.130450e-02	0	0	21630	0.000000e+00	0	0	102490	0.000000e+00	0	13	30520	4.259500e-04	0	200	17692	1.130450e-02	0	.	882	1614136	5.464220e-04	8	802	44888	1.786670e-02	8	0	75036	0.000000e+00	0	0	910	0.000000e+00	0	1	59990	1.666940e-05	0	0	29606	0.000000e+00	0	802	44888	1.786670e-02	8	0	64022	0.000000e+00	0	0	6062	0.000000e+00	0	12	1180032	1.016920e-05	0	43	91084	4.720920e-04	0	1	102354	9.770013873419701E-6	0	116	0	23	1914	0.012016718913270637	0	3458	0	0	506	0	0	650	0	20	1218	0.016420361247947456	0	104	0	19	12572	0.0015112949411390391	0	3574	0	43	3132	0.013729246487867178	63	122892	5.126452494873548E-4	Leber_congenital_amaurosis_9	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.9982625G>A	.	C1837873	608553	65	.	Ser	Asn	95.44	0.3153846153846154																																																																																																																																																																																																																																																																																																																																																																																																																																																																													41			95.44	Polar/Neutral	Serine		Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1										-0.8								 S255-E259 (PAE:  1.0)	S255-E259 (PDBs: 1KQN, 1KQO, 1KR2, 8QE8)	 S255-E259 (PAE:  1.0)	S255-E259 (PDBs: 1KQN, 1KQO, 1KR2, 8QE8), S255-R231 (PDBs: 8QE8)							105									-65.2				171.3						C (loop/coil)	C (loop/coil)												95.44	31.538464	>90	10-90	608553	autosomal recessive	OMIM	Rare genetic eye disease; Ciliopathy	2	LEBER CONGENITAL AMAUROSIS 9	false	0.5861694361644553	0.5168559948480147	false	false	false
FOXP3	FOXP3_Gly52Val	B_15-16	-0.2859307959501351	0.7832076011433657	0.8279032453594403	-3.3455230078261606	0.012326072874477643	0.02050620464611648	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7326744893927366	0.7457005694323795	0.44699816082436894	0.6182970074343526	0.6577674399682159	0.4714095270560359	0.5915912397245939	0.7646960850363838	0.79940156262735	0.4999977334163943	0.8498066305784142	0.8379188788249798	0.35122781438747785	0.550838794900048	0.4371924522413551	0.3939985882323435	0.6415945082863449	0.6274300999604934	FOXP3	Gly52Val	NC_000023.11:49258351:C:A	155G>T	23	49258351	C	A	X	ENSG00000049768	53657	900167	CCSBVarC002893	ALE00002893	ENSP00000365380.4	RC4	NatVar_GDE_001	F02	GDEhDisVCh_40080	F05	2	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh12	D01	1.0	1.0	0.0		0.0			0.0			1.0	1.0	99.0	Y	N	N	N	Y	729636.0	single nucleotide variant	NM_014009.4(FOXP3):c.155G>T (p.Gly52Val)	50943.0	FOXP3	HGNC:6106	Benign/Likely benign	1.0	Jan 02, 2024	17847095.0	-	RCV000885000|RCV000999510|RCV003910460|RCV001817093	MONDO:MONDO:0010580,MedGen:C0342288,OMIM:304790,Orphanet:37042|Human Phenotype Ontology:HP:0011961,MedGen:C4021107||MedGen:CN169374	Insulin-dependent diabetes mellitus secretory diarrhea syndrome|Non-obstructive azoospermia|FOXP3-related disorder|not specified	germline;maternal;unknown	germline	GRCh38	NC_000023.11	X	49258351.0	49258351.0	Xp11.23	criteria provided, multiple submitters, no conflicts	6.0	-	N	-	2.0	712945.0	49258351.0	C	A	-	-	-	-	-	-	155G>T 	Gly52Val	NM_014009.4	2.0	Benign	Likely benign	712945	X	49258351.0	C	A	G	V	rs17847095	X	49114808	X	49001752	52	FOXP3	ENSG00000049768	ENST00000376207	ENSP00000365380	Q9BZS1	FOXP3_HUMAN	c.155G>T	p.Gly52Val	c.155G>T	p.Gly52Val	principal1	Y	1	YES	Select	-	GGC	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.018	0.74454	D	0.437	0.50939	B	0.157	0.50366	B	0.01	0.08015	P	simple_aae	99.0	1.0	0.805	0.20110	L	-1.1	0.30311	N	0.189	0.47612	0.1813	0.85532	D	0.6565	0.88013	D	10	0.004233569	0.00083	T	.	.	.	0.222	0.51654	.	.	.	.	.	0.80952949098	0.80623	0.18910330817980442	0.18649	0.708992711	0.61327	0.41930603981	0.27708	T	0.358701	0.72350	T	-0.251332	0.13668	T	-0.114201	0.62007	T	0.0221811379320245	0.00926	T	0.871813	0.57694	D	0.16470468	0.36397	0.1584424	0.36886	0.18123333	0.38974	0.17482299	0.39772	-4.218	0.27211	T	0.0932	0.33574	B	0.222867204408117	0.51022	0.68728510	0.85809	0.082	0.23159	.	.	.	.	.	.	1.034516	0.14164	10.72	0.98902395745511451	0.48314	.	.	.	.	.	.	.	.	.	4.47	1.73	0.23502	.	.	0.373	0.20291	0.825000	0.21973	0.599	0.40292	0.049	0.21443	0.297000	0.24275	0.393	0.26674	.	.	30	0.007947019867549669	0	0.0	0	0.0	0	0.0	30	0.03926701570680628	0	0.0	240	264690	9.0672105E-4	.	114	47722	2.388840e-03	2	199	96487	2.062450e-03	2	223	109582	2.035010e-03	2	0	2263	0.000000e+00	0	0	9775	0.000000e+00	0	0	1080	0.000000e+00	0	113	3498	3.230420e-02	2	0	8685	0.000000e+00	0	0	14146	0.000000e+00	0	1	7252	1.378930e-04	0	113	3498	3.230420e-02	2	0	7076	0.000000e+00	0	0	16403	0.000000e+00	0	0	3479	0.000000e+00	0	194	6606	2.936720e-02	2	0	10160	0.000000e+00	0	0	35944	0.000000e+00	0	2	14143	1.414130e-04	0	194	6606	2.936720e-02	2	0	6582	0.000000e+00	0	0	19328	0.000000e+00	0	0	6043	0.000000e+00	0	218	8266	2.637310e-02	2	0	11674	0.000000e+00	0	0	40406	0.000000e+00	0	2	14129	1.415530e-04	0	218	8266	2.637310e-02	2	.	813	1165784	6.973850e-04	9	787	30713	2.562430e-02	9	0	55949	0.000000e+00	0	0	682	0.000000e+00	0	0	38630	0.000000e+00	0	0	21266	0.000000e+00	0	787	30713	2.562430e-02	9	0	43693	0.000000e+00	0	0	4285	0.000000e+00	0	3	872124	3.439880e-06	0	3	52562	5.707550e-05	0	24	52468	4.574216665396051E-4	0	122	0	0	112	0	0	3370	0	0	146	0	0	630	0	2	56	0.03571428571428571	0	98	0	7	6400	0.00109375	0	3492	0	2	168	0.011904761904761904	33	63402	5.204883126715246E-4	Insulin-dependent_diabetes_mellitus_secretory_diarrhea_syndrome|Non-obstructive_azoospermia|FOXP3-related_disorder|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.49258351C>A	.	C0342288|C4021107|CN169374	304790	37042	.	Gly	Val	40.45	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													85			40.45	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Forkhead box protein P3; Forkhead box protein P3, C-terminally processed; Forkhead box protein P3 41 kDa form										-0.4																		75									120.1				133.8	Disordered					C (loop/coil)	C (loop/coil)					Cleavage							40.45	100.0	$\leqslant$50	$\geqslant$90	304790	x-linked recessive	OMIM	Rare genetic immune disease; Rare genetic endocrine disease; Rare genetic gastroenterological disease	3	IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED	false	0.7457005694323795	0.7326744893927366	false	false	false
AGXT	AGXT_Ala186Val	B_7-8	-2.9286126661822185	0.022067801734436412	0.048649942945025455	-4.020407119416259	0.005056991335573859	0.009488322188934592	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6913701861325003	0.7280465864818055	0.8614438864612344	0.8261251513224187	0.7576172423663915	0.8756996788047774	0.8494400339955157	0.7636128798395714	0.8289310656136448	0.8436155011217703	0.7814770501125192	0.7352993454810011	0.9019593236140391	0.7516216048932116	0.8233192370311926	0.8792722718006986	0.6746161228510918	0.6474410267839997	AGXT	Ala186Val	NC_000002.12:240873011:C:T	557C>T	2	240873011	C	T	2	ENSG00000172482	70497	3835	CCSBVarC008198	ALE00008184	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	C05	GDEhDisVCh_40002	C07	2	VUSMutGDDh004	C05	VUSN2Hmut_GDN2h_01	F07	VUSMutpDEST2_14	E06	VUSmut_GDEh01	F07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	98222.0	single nucleotide variant	NM_000030.3(AGXT):c.557C>T (p.Ala186Val)	189.0	AGXT	HGNC:341	Benign/Likely benign	0.0	Jan 31, 2024	117195882.0	-	RCV000186223|RCV001514943|RCV000597486	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900|MedGen:CN169374	Primary hyperoxaluria, type I|not provided|not specified	germline;unknown	germline	GRCh38	NC_000002.12	2	240873011.0	240873011.0	2q37.3	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA275550	2.0	92311.0	240873011.0	C	T	-	-	-	-	-	-	557C>T 	Ala186Val	NM_000030.3	2.0	Benign	Likely benign	92311	2	240873011.0	C	T	A	V	rs117195882	2	241812428	2	241461101	186	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.557C>T	p.Ala186Val	c.557C>T	p.Ala186Val	principal1	Y	1	YES	Select	+	GCA	2	0	T	./.	./.	./.	./.	0.089	0.32282	T	0.04	0.51160	D	0.445	0.35988	B	0.227	0.38085	B	0.51	0.71237	P	simple_aae	49.0	51.0	.	.	.	-3.37	0.66695	D	0.149	0.15105	-0.4512	0.70229	T	0.1512	0.47742	T	10	0.01129064	0.00244	T	.	.	.	0.613	0.84806	.	.	.	.	.	.	.	0.9164592863635113	0.91568	0.0547869391215	0.05916	0.359542876482	0.19299	T	0.884208	0.97575	D	-0.211966	0.18798	T	-0.0113063	0.69377	D	0.0687023323511713	0.08369	T	0.789321	0.42757	T	0.6033275	0.72585	0.49700803	0.70656	0.6033275	0.72587	0.49700803	0.70656	-4.821	0.34876	T	0.2436	0.47795	B	0.0437862705252106	0.36035	0.00307691	0.27620	0.692	0.82910	.	.	.	.	.	.	2.442867	0.31503	18.74	0.98502545878440728	0.42364	0.837640	0.75435	D	-0.341865281685634	0.27294	1.513821	-0.36949435700617	0.25593	1.427942	4.14	3.21	0.35856	-1.91	0.11913	4.091	0.57514	3.086000	0.36341	-2.261	0.00335	0.998	0.41403	0.997000	0.33331	0.019	0.11385	982	0.03399	131	0.02615814696485623	0	0.0	1	9.940357852882703E-4	0	0.0	85	0.08432539682539683	45	0.046012269938650305	1092	264690	0.0041255807	.	1415	109330	1.294250e-02	48	2334	206520	1.130160e-02	75	2746	235214	1.167450e-02	90	1	7162	1.396260e-04	0	89	17098	5.205290e-03	2	0	2320	0.000000e+00	0	813	9044	8.989390e-02	34	4	13352	2.995810e-04	0	39	42756	9.121530e-04	0	460	15684	2.932930e-02	12	813	9044	8.989390e-02	34	4	16214	2.467000e-04	1	172	30508	5.637870e-03	3	2	6206	3.222690e-04	0	1158	13408	8.636630e-02	51	7	16692	4.193630e-04	0	73	88032	8.292440e-04	0	894	30596	2.921950e-02	20	1158	13408	8.636630e-02	51	4	14900	2.684560e-04	1	179	34232	5.229030e-03	3	2	9558	2.092490e-04	0	1546	17686	8.741380e-02	66	8	21590	3.705420e-04	0	89	101122	8.801250e-04	0	890	30514	2.916690e-02	20	1546	17686	8.741380e-02	66	.	7306	1613864	4.527020e-03	207	3417	44838	7.620770e-02	138	21	75052	2.798060e-04	2	0	912	0.000000e+00	0	245	60018	4.082110e-03	5	1	29594	3.379060e-05	0	3417	44838	7.620770e-02	138	50	63960	7.817390e-04	0	10	6060	1.650170e-03	0	667	1179908	5.652980e-04	0	2566	91030	2.818850e-02	61	37	57884	6.392094533895377E-4	0	306	0	9	112	0.08035714285714286	5	8088	6.181998021760633E-4	2	494	0.004048582995951417	3	628	0.004777070063694267	2	56	0.03571428571428571	0	98	0	12	8764	0.0013692377909630307	5	8394	5.956635692161067E-4	11	168	0.06547619047619048	70	76430	9.158707313881983E-4	not_provided|Primary_hyperoxaluria,_type_I|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240873011C>T	ClinGen:CA275550	C3661900|C0268164|CN169374	259900	416|93598	Aminotransferase class V domain	Ala	Val	98.73	0.009433962264150943																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			98.73	Aliphatic	Alanine		Alanine--glyoxylate aminotransferase								0.1782		1.8								 A186-T320 (PAE:  1.0)	A186-T320 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)	 A186-T320 (PAE:  1.0)	A186-T320 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)							89									-94.5		Pocket 2: Mean pLDDT: 96.54, Volume: 238.78 Å³, Druggability score: 0.18		-11.2						C (loop/coil)	T (turn)	Turn											98.73	0.9433962	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.7280465864818055	0.6913701861325003	false	false	false
CDKN1A	CDKN1A_Arg84Gln	B_15-16	-5.664253455952892	0.0013019067116299345	0.005690255879206349	-5.3789659971026715	0.0016973160507045121	0.0037122466663203576	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8967562017912807	0.9143753363345857	0.3913905631071185	0.6827967686575034	0.5758039378503822	0.46707523144949803	0.4912377607695779	0.5742891486946595	0.6347900345193632	0.4546505560170706	0.9047575006752476	0.8775111061111435	0.4429127021294182	0.5773187270061049	0.7308035027956434	0.3281305701971664	0.9239931719939236	0.9160012974714178	CDKN1A	Arg84Gln	NC_000006.12:36684352:G:A	251G>A	6	36684352	G	A	6	ENSG00000124762	3192	5565	CCSBVarC000415	ALE00000415	ENSP00000244741.6	RC4	RC4_Mut_GDEh1011	A08	GDEhDisVCh_40040	D01	2	RC4_Mut_GDDh1011	A08	NULL	NULL	VUSMutpDEST2_03	C05	VUSmut_GDEh12	B10	1.0	1.0	1.0	7.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	710484.0	single nucleotide variant	NM_000389.5(CDKN1A):c.251G>A (p.Arg84Gln)	1026.0	CDKN1A	HGNC:1784	Likely benign	0.0	Sep 01, 2024	34916193.0	-	RCV000973091|RCV001702075	MedGen:C3661900|MedGen:CN169374	not provided|not specified	germline	germline	GRCh38	NC_000006.12	6	36684352.0	36684352.0	6p21.2	criteria provided, multiple submitters, no conflicts	7.0	-	N	-	2.0	790317.0	36684352.0	G	A	-	-	-	-	-	-	251G>A 	Arg84Gln	NM_000389.5	2.0	Benign	Likely benign	790317	6	36684352.0	G	A	R	Q	rs34916193	6	36652129	6	36760107	84	CDKN1A	ENSG00000124762	ENST00000448526	ENSP00000409259	P38936	CDN1A_HUMAN	c.251G>A	p.Arg84Gln	c.251G>A	p.Arg84Gln	principal1	Y	3	.	.	+	CGA	2	0	G	G/G	G/G	G/G	G/G	.	0.11294	.	0.445	0.13337	T	0.244	0.31042	B	0.015	0.17292	B	0.01	0.05039	N	simple_aae	99.0	1.0	0.345	0.11102	N	.	0.09567	.	0.142	0.14123	-1.0972	0.04460	T	0.0318	0.13572	T	10	0.005693376	0.00124	T	0.012895	0.31590	T	0.036	0.09022	.	.	.	.	.	0.615732620514	0.60966	.	0.36305	.	0.22435	0.306365787983	0.11351	T	0.022526	0.17221	T	-0.481118	0.00690	T	-0.461535	0.26080	T	0.0025321024952675	0.00026	T	.	0.24971	.	0.06419129	0.13469	0.04371019	0.05516	0.06419129	0.13469	0.04371019	0.05516	-4.359	0.29026	T	.	0.08649	.	0.0138911991433751	0.26505	0.01634454	0.47059	0.093	0.26143	.	.	.	.	.	.	0.79929	0.1172	8.279	0.85158936865320489	0.15960	0.189546	0.31467	N	-0.997571154014281	0.08551	0.4066668	-1.01294437216849	0.09342	0.472997	3.33	2.45	0.28877	1.08	0.29920	0.663	0.24824	3.858000	0.40202	0.435	0.2105	0.023	0.19988	0.991000	0.31563	0.009	0.08693	807	0.43408	8	0.001597444089456869	0	0.0	4	0.003976143141153081	3	0.004322766570605188	0	0.0	1	0.0010224948875255625	581	264690	0.0021950207	.	233	107974	2.157930e-03	2	476	205760	2.313370e-03	5	570	234340	2.432360e-03	5	7	6996	1.000570e-03	0	20	16988	1.177300e-03	0	0	2296	0.000000e+00	0	2	8986	2.225680e-04	0	21	13008	1.614390e-03	0	151	42164	3.581250e-03	0	30	15652	1.916690e-03	2	151	42164	3.581250e-03	0	14	15840	8.838380e-04	0	36	30326	1.187100e-03	0	1	6172	1.620220e-04	0	1	13354	7.488390e-05	0	31	16328	1.898580e-03	0	322	88392	3.642860e-03	3	62	30544	2.029860e-03	2	322	88392	3.642860e-03	3	14	14550	9.621990e-04	0	42	34070	1.232760e-03	0	2	9526	2.099520e-04	0	3	17612	1.703380e-04	0	40	20980	1.906580e-03	0	394	101580	3.878720e-03	3	62	30462	2.035320e-03	2	394	101580	3.878720e-03	3	.	5613	1613402	3.478980e-03	25	4973	1179888	4.214810e-03	21	63	75036	8.395970e-04	0	1	912	1.096490e-03	0	80	59970	1.334000e-03	0	12	29590	4.055420e-04	0	6	44868	1.337260e-04	0	91	63562	1.431670e-03	1	4	6060	6.600660e-04	0	4973	1179888	4.214810e-03	21	171	91050	1.878090e-03	3	100	37106	0.0026949819436209777	0	122	0	0	112	0	1	3438	2.9086678301337986E-4	0	490	0	2	626	0.003194888178913738	0	56	0	0	98	0	26	7012	0.0037079292641186536	1	3560	2.808988764044944E-4	0	168	0	129	49060	0.002629433346922136	not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.36684352G>A	.	CN169374|C3661900	.	.	.	Arg	Gln	50.85	0.9354838709677419																																																																																																																																																																																																																																																																																																																																																																																																																																																																													232			50.85	Positively-charged	Arginine		Cyclin-dependent kinase inhibitor 1										-4.5																		175									-56.4				109.0	Disordered					C (loop/coil)	C (loop/coil)												50.85	93.548386	50-70	$\geqslant$90		unknown		Rare genetic endocrine disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3		false	0.9143753363345857	0.8967562017912807	false	false	false
SNIP1	SNIP1_Arg116Gln	B_7-8	4.332262105866537	0.02268398916439899	0.049686260669727145	1.7919180911474009	0.12332491813680402	0.15981724913914927	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5744134911920744	0.5919238822695136	0.7790137640294672	0.8346459981821399	0.7700493359780655	0.8899700647926908	0.8899700647926908	0.8744980525127662	0.9176577663412442	0.7790137640294672	0.7126000887136402	0.6760067262305594		0.6656006194433647	0.7516342300230358		0.47124767582538696	0.47282025615358947	SNIP1	Arg116Gln	NC_000001.11:37540736:C:T	347G>A	1	37540736	C	T	1	ENSG00000163877	8177	1933	CCSBVarC008478	ALE00008436	ENSP00000296215.5	Edgotyping3	VUSmut_GDEh11	E04	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_07	A10	VUSmut_GDEh11	E04	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	696713.0	single nucleotide variant	NM_024700.4(SNIP1):c.347G>A (p.Arg116Gln)	79753.0	SNIP1	HGNC:30587	Likely benign	0.0	Jan 22, 2024	80144754.0	-	RCV000946356|RCV003925867	MedGen:C3661900|	not provided|SNIP1-related disorder	germline	germline	GRCh38	NC_000001.11	1	37540736.0	37540736.0	1p34.3	criteria provided, single submitter	2.0	-	N	-	2.0	767581.0	37540736.0	C	T	-	-	-	-	-	-	347G>A 	Arg116Gln	NM_024700.4	1.0	Benign	Likely benign	767581	1	37540736.0	C	T	R	Q	rs80144754	1	38006337	1	37778924	116	SNIP1	ENSG00000163877	ENST00000296215	ENSP00000296215	Q8TAD8	SNIP1_HUMAN	c.347G>A	p.Arg116Gln	c.347G>A	p.Arg116Gln	principal1	Y	1	YES	Select	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.268	0.16235	T	0.249	0.24060	T	0.89	0.48954	P	0.119	0.32165	B	0.07	0.21442	N	simple_aae	93.0	7.0	1.545	0.38945	L	-1.24	0.31344	N	0.185	0.19999	-0.9391	0.42573	T	0.0114	0.04282	T	10	0.005870551	0.00129	T	0.005753	0.14655	T	0.041	0.10768	.	.	.	.	.	0.269682111328	0.26171	0.20781934209543862	0.20513	0.670822488128	0.59159	0.416981995106	0.27390	T	0.070769	0.33790	T	-0.529885	0.00371	T	-0.532	0.18774	T	0.0130565662485011	0.00227	T	0.648535	0.25692	T	0.0760418	0.17013	0.068404704	0.14276	0.0760418	0.17013	0.068404704	0.14276	-5.557	0.42449	T	0.09	0.12711	B	0.0426781158958213	0.35814	0.03690625	0.56228	0.091	0.25618	.	.	.	.	.	.	3.838325	0.55602	23.6	0.99018998522132529	0.50614	0.137462	0.25631	N	0.0324471074487344	0.43074	2.628509	0.140965686452844	0.46396	2.908874	5.14	5.14	0.69967	4.58	0.85278	2.663	0.46539	7.637000	0.63066	0.599	0.40292	0.652	0.28281	1.000000	0.68239	0.862	0.40932	927	0.17628	12	0.0023961661341853034	11	0.00832072617246596	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	450	264690	0.001700102	.	41	106972	3.832780e-04	0	104	202940	5.124670e-04	0	101	231034	4.371650e-04	0	39	7142	5.460660e-03	0	2	16834	1.188070e-04	0	0	2218	0.000000e+00	0	0	9040	0.000000e+00	0	0	12046	0.000000e+00	0	0	42244	0.000000e+00	0	0	15554	0.000000e+00	0	39	7142	5.460660e-03	0	96	16160	5.940590e-03	0	4	29892	1.338150e-04	0	0	5970	0.000000e+00	0	0	13408	0.000000e+00	0	0	15368	0.000000e+00	0	3	87058	3.445980e-05	0	0	30326	0.000000e+00	0	96	16160	5.940590e-03	0	90	14846	6.062240e-03	0	5	33594	1.488360e-04	0	0	9216	0.000000e+00	0	0	17648	0.000000e+00	0	0	20156	0.000000e+00	0	6	99836	6.009860e-05	0	0	30244	0.000000e+00	0	90	14846	6.062240e-03	0	.	531	1602228	3.314140e-04	2	463	74806	6.189340e-03	2	463	74806	6.189340e-03	2	0	912	0.000000e+00	0	12	59392	2.020470e-04	0	0	29316	0.000000e+00	0	1	44622	2.241050e-05	0	0	62042	0.000000e+00	0	2	6022	3.321160e-04	0	24	1172330	2.047210e-05	0	3	90802	3.303890e-05	0	5	173472	2.882309536985796E-5	3	178	0.016853932584269662	2	4490	4.4543429844097997E-4	34	4418	0.007695789950203712	1	808	0.0012376237623762376	0	1056	0	0	1818	0	0	296	0	5	13972	3.5785857429144005E-4	37	4596	0.00805047867711053	2	6308	3.170577045022194E-4	50	200508	2.493666088136134E-4	not_provided|SNIP1-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.37540736C>T	.	C3661900	.	.	.	Arg	Gln	41.94	0.842741935483871																																																																																																																																																																																																																																																																																																																																																																																																																																																																													209			41.94	Positively-charged	Arginine		Smad nuclear-interacting protein 1		Basic and acidic residues								-4.5																		175									-158.6				126.5	Disordered					C (loop/coil)	C (loop/coil)												41.94	84.27419	$\leqslant$50	10-90		unknown			0		false	0.5919238822695136	0.5744134911920744	false	false	false
POMT1	POMT1_Ser515Arg	B_7-8	-1.105332324690641	0.3113564101649565	0.3988536173139282	-1.0301927041804562	0.3426459488810795	0.39632411627121444	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5658539370103783	0.5856610436744493	0.5214499041637026	0.5584617193627864	0.5594448088192197	0.5752933359390928	0.626281877465515	0.5981395671171346	0.6221446491540945	0.5411307164313998	0.5587901384002351	0.5378503437215787	0.5243047944126707	0.5207500505213049	0.4947787895714784	0.5017690918960055	0.6125319489486635	0.5938575302991779	POMT1	Ser515Arg	NC_000009.12:131519447:C:G	1545C>G	9	131519447	C	G	9	ENSG00000130714	71206	205720	CCSBVarC003248	ALE00003248	ENSP00000385797.4	CEGS2	CegsMutGDEh1038	A03	GDEhDisVCh_40022	F08	2	CegsMutGDDh1038	A03	VUSN2Hmut_GDN2h_07	E10	VUSMutpDEST2_15	F03	VUSmut_GDEh07	E10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	172243.0	single nucleotide variant	NM_001077365.2(POMT1):c.1545C>G (p.Ser515Arg)	10585.0	POMT1	HGNC:9202	Benign/Likely benign	0.0	Oct 01, 2024	150367385.0	-	RCV000988264|RCV000680152|RCV000175066|RCV000194020|RCV001086216	MONDO:MONDO:0012248,MedGen:C1836373,OMIM:609308,Orphanet:86812|MONDO:MONDO:0009364,MedGen:C4284790,OMIM:236670,Orphanet:588,Orphanet:899|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0012248,MedGen:C1836373,OMIM:609308,Orphanet:86812;MONDO:MONDO:0000171,MedGen:C0265221,OMIM:PS236670,Orphanet:899;MONDO:MONDO:0013159,MedGen:C5436962,OMIM:613155	Autosomal recessive limb-girdle muscular dystrophy type 2K|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1|not provided|not specified|Autosomal recessive limb-girdle muscular dystrophy type 2K;Walker-Warburg congenital muscular dystrophy;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1	germline;unknown	germline	GRCh38	NC_000009.12	9	131519447.0	131519447.0	9q34.13	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA207903,UniProtKB:Q9Y6A1#VAR_026697	2.0	162591.0	131519447.0	C	G	-	-	-	-	-	-	1545C>G 	Ser515Arg	NM_001077365.2	2.0	Benign	Likely benign	162591	9	131519447.0	C	G	S	R	rs150367385	9	134394834	9	133384655	537	POMT1	ENSG00000130714	ENST00000372228	ENSP00000361302	Q9Y6A1	POMT1_HUMAN	c.1611C>G	p.Ser537Arg	c.1611C>G	p.Ser537Arg	.	Y	1	.	.	+	AGC	3	2	C	C/C	C/C	C/C	C/C	0.134	0.26425	T	0.394	0.15675	T	0.112	0.26307	B	0.051	0.25435	B	0.14	0.35500	N	simple_aae	86.0	14.0	1.575	0.39544	L	-1.14	0.29284	N	0.874	0.87133	-0.5605	0.66237	T	0.5176	0.81882	D	10	0.015325069	0.00318	T	0.158555	0.83849	D	0.508	0.78736	0.655	0.79188	Q9Y6A1	S537R	Gain of MoRF binding (P = 0.0199)| Loss of phosphorylation at S537 (P = 0.0678)| Gain of solvent accessibility (P = 0.0917)| Gain of relative solvent accessibility (P = 0.1571)| Loss of methylation at R538 (P = 0.3068)	0.879825153453	0.87772	0.4723707741962653	0.46959	0.278320214035	0.30023	0.427245855331	0.28798	T	0.297146	0.66791	T	-0.123257	0.32236	T	0.0471233	0.73196	D	0.0129226239014529	0.00221	T	0.855914	0.54259	D	0.03669951	0.04523	0.057629783	0.10517	0.038118996	0.04971	0.046753403	0.06602	-4.726	0.34019	T	0.2467	0.57485	B	0.707621953162391	0.67288	0.50369483	0.81970	0.036	0.08225	.	.	.	.	.	.	2.589032	0.33645	19.38	0.87287446252699985	0.17368	0.432311	0.49250	N	-0.273315332885108	0.29901	1.680578	-0.159350550316487	0.32739	1.886534	5.56	4.63	0.57125	3.37	0.61085	1.254	0.32604	3.925000	0.40576	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.321	0.25043	406	0.82372	3	5.990415335463259E-4	0	0.0	1	9.940357852882703E-4	2	0.002881844380403458	0	0.0	0	0.0	371	264690	0.0014016397	.	91	64814	1.404020e-03	0	207	132556	1.561600e-03	0	245	151120	1.621230e-03	1	2	2896	6.906080e-04	0	39	12394	3.146680e-03	0	7	1458	4.801100e-03	0	0	4654	0.000000e+00	0	5	10990	4.549590e-04	0	22	19608	1.121990e-03	0	12	11444	1.048580e-03	0	39	12394	3.146680e-03	0	3	8756	3.426220e-04	0	62	20694	2.996040e-03	0	18	4758	3.783100e-03	0	0	8894	0.000000e+00	0	6	13030	4.604760e-04	0	85	50030	1.698980e-03	0	21	22796	9.212140e-04	0	62	20694	2.996040e-03	0	3	8230	3.645200e-04	0	80	24652	3.245170e-03	1	27	8318	3.245970e-03	0	0	11144	0.000000e+00	0	8	14912	5.364810e-04	0	93	56772	1.638130e-03	0	21	22784	9.216990e-04	0	80	24652	3.245170e-03	1	.	1803	1551390	1.162180e-03	2	122	5994	2.035370e-02	0	33	73206	4.507830e-04	1	0	912	0.000000e+00	0	160	51006	3.136890e-03	0	99	28652	3.455260e-03	0	0	41042	0.000000e+00	0	42	59254	7.088130e-04	0	122	5994	2.035370e-02	0	1154	1147104	1.006010e-03	1	66	84076	7.850040e-04	0	151	95246	0.001585368414421603	0	174	0	0	2652	0	7	4184	0.0016730401529636712	4	776	0.005154639175257732	5	942	0.005307855626326964	0	650	0	0	274	0	10	7632	0.001310272536687631	7	4358	0.0016062413951353832	0	3302	0	177	112530	0.0015729138896294322	not_specified|Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2K|Muscular_dystrophy-dystroglycanopathy_(congenital_with_intellectual_disability),_type_B1|Walker-Warburg_congenital_muscular_dystrophy|not_provided|Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),_type_A1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.131519447C>G	ClinGen:CA207903|UniProtKB:Q9Y6A1#VAR_026697	CN169374|C1836373|C5436962|C0265221|C3661900|C4284790	609308|613155|PS236670|236670	86812|899|588|899	.	Ser	Arg	48.75	0.7384615384615385																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																48.75	73.84615	$\leqslant$50	10-90	609308;236670;609308;613155	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1	false	0.5856610436744493	0.5658539370103783	false	false	false
BAG3	BAG3_Arg258Trp	B_15-16	2.729378516780091	0.02936503190346213	0.06129749829028708	-6.276410847508257	0.0004134601216731345	0.0011937226251941364	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6461978718378013	0.6536852745376318	0.534798052626462	0.6876353864874654	0.5731188201069972	0.554691499326929	0.6008008051165289	0.6035202034017381	0.7565852228821843	0.5627131769000969	0.6236416964576292	0.6064007985431683	0.5085821935373289	0.5427174368122565	0.6186855500927464	0.506882928352827	0.6837288526176345	0.6859949451324343	BAG3	Arg258Trp	NC_000010.11:119672519:C:T	772C>T	10	119672519	C	T	10	ENSG00000151929	5066	201830	CCSBVarC003584	ALE00003584	ENSP00000358081.4	CEGS2	CegsMutGDEh1037	B09	GDEhDisVCh_40022	G07	2	CegsMutGDDh1037	B09	VUSN2Hmut_GDN2h_07	H08	VUSMutpDEST2_04	B12	VUSmut_GDEh07	H08	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	48065.0	single nucleotide variant	NM_004281.3(BAG3):c.772C>T (p.Arg258Trp)	9531.0	BAG3	HGNC:939	Benign/Likely benign	0.0	Jan 22, 2024	117671123.0	-	RCV000032662|RCV000037897|RCV000490529|RCV000618102|RCV001081302|RCV000590218|RCV001107316|RCV003486548	Human Phenotype Ontology:HP:0003715,MONDO:MONDO:0018943,MedGen:C2678065,OMIM:PS601419,Orphanet:593|MedGen:CN169374|MONDO:MONDO:0013061,MedGen:C2751831,OMIM:612954,Orphanet:199340|MedGen:CN230736|MONDO:MONDO:0013479,MedGen:C3151293,OMIM:613881,Orphanet:154;MONDO:MONDO:0013061,MedGen:C2751831,OMIM:612954,Orphanet:199340|MedGen:C3661900|MONDO:MONDO:0013479,MedGen:C3151293,OMIM:613881,Orphanet:154|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848	Myofibrillar myopathy|not specified|Myofibrillar myopathy 6|Cardiovascular phenotype|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6|not provided|Dilated cardiomyopathy 1HH|Cardiomyopathy	germline;unknown	germline	GRCh38	NC_000010.11	10	119672519.0	119672519.0	10q26.11	criteria provided, multiple submitters, no conflicts	15.0	ACMG2022	N	ClinGen:CA135025,UniProtKB:O95817#VAR_066782,OMIM:603883.0009	3.0	39466.0	119672519.0	C	T	-	-	-	-	-	-	772C>T 	Arg258Trp	NM_004281.3	2.0	Benign	Likely benign	39466	10	119672519.0	C	T	R	W	rs117671123	10	121432031	10	121422021	258	BAG3	ENSG00000151929	ENST00000369085	ENSP00000358081	O95817	BAG3_HUMAN	c.772C>T	p.Arg258Trp	c.772C>T	p.Arg258Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.025	0.61305	D	1.0	0.90580	D	0.936	0.67146	D	0.03	0.10877	N	simple_aae	97.0	3.0	2.52	0.73336	M	-2.18	0.74375	N	0.53	0.55661	-0.2567	0.76070	T	0.2937	0.66385	T	10	0.007297367	0.00163	T	.	.	.	0.441	0.74311	.	.	.	.	.	0.93459561191	0.93341	0.3000833588258133	0.29722	0.415135717693	0.41891	0.400638222694	0.25128	T	0.243802	0.61067	T	-0.0404089	0.45552	T	0.181503	0.81950	D	0.108737966892069	0.13124	T	0.908009	0.69028	D	0.13583577	0.31242	0.19702347	0.43310	0.16535975	0.36504	0.17827278	0.40348	-7.589	0.58305	D	0.1262	0.45458	B	0.340329489269892	0.55679	0.98655814	0.96253	0.356	0.61402	.	.	.	.	.	.	4.058522	0.60286	24.2	0.99919163607355499	0.98655	0.625641	0.60736	D	0.262330175453432	0.54022	3.5912	0.250257838098593	0.52418	3.439763	5.94	2.76	0.31445	2.67	0.48823	1.029	0.29845	0.135000	0.15162	0.599	0.40292	0.969	0.34297	0.003000	0.18726	0.792	0.37428	893	0.26484	21	0.004193290734824281	0	0.0	0	0.0	0	0.0	21	0.020833333333333332	0	0.0	182	264690	6.875968E-4	.	153	109312	1.399660e-03	2	212	207510	1.021640e-03	1	288	236132	1.219660e-03	4	0	7156	0.000000e+00	0	2	17102	1.169450e-04	0	0	2318	0.000000e+00	0	145	9044	1.603270e-02	2	0	13374	0.000000e+00	0	0	42722	0.000000e+00	0	4	15682	2.550700e-04	0	145	9044	1.603270e-02	2	0	16164	0.000000e+00	0	2	30500	6.557380e-05	0	0	6206	0.000000e+00	0	200	13412	1.491200e-02	1	0	16712	0.000000e+00	0	2	89072	2.245370e-05	0	5	30596	1.634200e-04	0	200	13412	1.491200e-02	1	0	14858	0.000000e+00	0	2	34240	5.841120e-05	0	0	9546	0.000000e+00	0	274	17690	1.548900e-02	4	0	21590	0.000000e+00	0	1	102090	9.795280e-06	0	5	30514	1.638590e-04	0	274	17690	1.548900e-02	4	.	736	1614016	4.560050e-04	2	667	44858	1.486910e-02	2	0	75054	0.000000e+00	0	0	912	0.000000e+00	0	2	60022	3.332110e-05	0	0	29594	0.000000e+00	0	667	44858	1.486910e-02	2	0	64018	0.000000e+00	0	0	6062	0.000000e+00	0	15	1179924	1.271270e-05	0	19	91076	2.086170e-04	0	7	171744	4.075833799142911E-5	0	346	0	65	4432	0.014666064981949459	1	8356	1.1967448539971278E-4	0	804	0	0	974	0	12	1812	0.006622516556291391	0	270	0	40	15234	0.0026257056583956937	1	8702	1.1491611123879568E-4	77	6244	0.01233183856502242	125	203972	6.128292118526072E-4	Myofibrillar_myopathy_6|Dilated_cardiomyopathy_1HH|Myofibrillar_myopathy|Cardiomyopathy|not_specified|not_provided|Cardiovascular_phenotype	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.119672519C>T	ClinGen:CA135025|OMIM:603883.0009|UniProtKB:O95817#VAR_066782	C2751831|C3151293|C2678065|C0878544|CN169374|C3661900|CN230736	612954|613881|PS601419	199340|154|593|167848	.	Arg	Trp	39.54	0.8266129032258065																																																																																																																																																																																																																																																																																																																																																																																																																																																																													205			39.54	Positively-charged	Arginine		BAG family molecular chaperone regulator 3		Basic and acidic residues								-4.5																Morphology: QGDDWEPrPLrAAsP		175									-167.8				126.7	Disordered					C (loop/coil)	C (loop/coil)												39.54	82.661285	$\leqslant$50	10-90	612954;613881;612954;613881	autosomal dominant	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 6; CARDIOMYOPATHY, DILATED, 1HH; MYOPATHY, MYOFIBRILLAR, 6; CARDIOMYOPATHY, DILATED, 1HH	false	0.6536852745376318	0.6461978718378013	false	false	false
GRN	GRN_Ser120Tyr	B_7-8	-2.3917350857528663	0.06340280127616768	0.11228459500391756	0.6592971397543317	0.5874364062936731	0.6225698968141063	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6842110246984682	0.6959266518937052	0.7382610821825321	0.7961607535748563	0.717386933285969	0.7224415132921903	0.8682797950738463	0.872348425301005	0.8953710570028135	0.8509414865958141	0.7672001089266134	0.755136847401646	0.5766032315105343	0.5624254412709331	0.6969504501468992	0.62558067776925	0.624653194860797	0.6132852019952904	GRN	Ser120Tyr	NC_000017.11:44350237:C:A	359C>A	17	44350237	C	A	17	ENSG00000030582	3980	201375	CCSBVarC004642	ALE00004642	ENSP00000053867.2	CEGS2	CegsMutGDEh1036	F01	GDEhDisVCh_40075	H05	1	CegsMutGDDh1036	F01	VUSN2Hmut_GDN2h_07	E03	VUSMutpDEST2_03	D12	VUSmut_GDEh07	E03	1.0	1.0	1.0	7.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	104027.0	single nucleotide variant	NM_002087.4(GRN):c.359C>A (p.Ser120Tyr)	2896.0	GRN	HGNC:4601	Benign/Likely benign	0.0	Jan 22, 2024	63750043.0	-	RCV000084437|RCV001125933|RCV001086038|RCV002453414	MedGen:C3661900|MONDO:MONDO:0011842,MedGen:C1843792,OMIM:607485,Orphanet:100070,Orphanet:282|MONDO:MONDO:0013866,MedGen:C3539123,OMIM:614706,Orphanet:314629,Orphanet:79262;MONDO:MONDO:0011842,MedGen:C1843792,OMIM:607485,Orphanet:100070,Orphanet:282|MeSH:D030342,MedGen:C0950123	not provided|GRN-related frontotemporal lobar degeneration with Tdp43 inclusions|Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000017.11	17	44350237.0	44350237.0	17q21.31	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA225234,UniProtKB:P28799#VAR_064629	2.0	98135.0	44350237.0	C	A	-	-	-	-	-	-	359C>A 	Ser120Tyr	NM_002087.4	2.0	Benign	Likely benign	98135	17	44350237.0	C	A	S	Y	rs63750043	17	42427605	17	39783131	120	GRN	ENSG00000030582	ENST00000053867	ENSP00000053867	P28799	GRN_HUMAN	c.359C>A	p.Ser120Tyr	c.359C>A	p.Ser120Tyr	principal1	Y	1	YES	Select	+	TCC	2	0	C	C/C	C/C	C/C	C/C	0.156	0.24210	T	0.113	0.47214	T	0.744	0.43083	P	0.252	0.39069	B	0.03	0.10877	N	simple_aae	97.0	3.0	1.975	0.53326	M	-1.17	0.29897	N	0.293	0.34960	-0.7693	0.56717	T	0.2768	0.64717	T	10	0.0062176883	0.00138	T	0.102502	0.77529	D	0.145	0.38375	.	.	.	.	.	0.857881563427	0.85540	0.2792761382427879	0.27644	0.463953477707	0.45596	0.249592423439	0.03726	T	0.206937	0.56428	T	-0.424986	0.01491	T	-0.385975	0.34663	T	0.00771268445903143	0.00089	T	0.726827	0.33886	T	0.051580228	0.09405	0.05380251	0.09145	0.03801147	0.04936	0.052819293	0.08791	-7.322	0.56422	T	0.1011	0.29036	B	0.0451159371157821	0.36292	0.87218803	0.90293	0.027	0.05141	.	.	.	.	.	.	0.174937	0.05651	2.085	0.83523310676695262	0.15003	0.596953	0.58947	D	-0.652651513790647	0.17169	0.8940387	-0.841620105932744	0.13257	0.7000154	4.07	-1.23	0.08955	-2.76	0.09208	-0.172	0.09889	-0.917000	0.06964	-0.184	0.09934	0.0	0.06393	0.000000	0.08389	0.006	0.0734	501	0.75979	.	.	.	.	.	.	.	.	.	.	.	.	162	264690	6.1203673E-4	.	116	109402	1.060310e-03	2	221	208120	1.061890e-03	3	258	236934	1.088910e-03	3	0	7164	0.000000e+00	0	36	17106	2.104520e-03	1	4	2320	1.724140e-03	0	0	9046	0.000000e+00	0	4	13394	2.986410e-04	0	20	42768	4.676390e-04	0	47	15690	2.995540e-03	1	47	15690	2.995540e-03	1	1	16218	6.165990e-05	0	49	30518	1.605610e-03	1	10	6212	1.609790e-03	0	0	13416	0.000000e+00	0	4	16734	2.390340e-04	0	47	89548	5.248580e-04	0	98	30608	3.201780e-03	2	98	30608	3.201780e-03	2	0	14902	0.000000e+00	0	69	34248	2.014720e-03	1	21	9570	2.194360e-03	0	0	17692	0.000000e+00	0	4	21632	1.849110e-04	0	55	102744	5.353110e-04	0	98	30526	3.210380e-03	2	98	30526	3.210380e-03	2	.	1067	1612426	6.617360e-04	8	87	6058	1.436120e-02	0	18	74974	2.400830e-04	1	0	912	0.000000e+00	0	118	60022	1.965950e-03	1	62	29590	2.095300e-03	0	1	44868	2.228760e-05	0	5	64020	7.810060e-05	0	87	6058	1.436120e-02	0	398	1178490	3.377200e-04	0	290	91054	3.184920e-03	5	128	184556	6.935564273174538E-4	0	360	0	0	4502	0	4	9432	4.2408821034775233E-4	3	796	0.0037688442211055275	0	968	0	0	1848	0	1	280	0.0035714285714285713	28	18118	0.0015454244397836406	4	9792	4.084967320261438E-4	0	6350	0	164	220860	7.425518427963415E-4	not_provided|GRN-related_frontotemporal_lobar_degeneration_with_Tdp43_inclusions|Neuronal_ceroid_lipofuscinosis_11|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.44350237C>A	ClinGen:CA225234|UniProtKB:P28799#VAR_064629	C3661900|C1843792|C3539123|C0950123	607485|614706	100070|282|314629|79262	.	Ser	Tyr	43.53	0.823076923076923																																																																																																																																																																																																																																																																																																																																																																																																																																																																													107			43.53	Polar/Neutral	Serine		Progranulin										-0.8																		105									-72.0				66.4						C (loop/coil)	C (loop/coil)												43.53	82.30769	$\leqslant$50	10-90	607485;614706;607485	multiple	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	FRONTOTEMPORAL DEMENTIA 2; CEROID LIPOFUSCINOSIS, NEURONAL, 11; FRONTOTEMPORAL DEMENTIA 2	false	0.6959266518937052	0.6842110246984682	false	false	false
MIP	MIP_Val107Ile	B_7-8	2.791708791443897	0.03150643900900999	0.064986283485107	1.098980364589119	0.3139066964717457	0.3671247852298619	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6079195299403855	0.5723790265552859	0.6970927186010825	0.6282172577899168	0.6071245452134675	0.7235616232750134	0.7218840117568432	0.6816219185182	0.7373409430396615	0.699100695987035	0.6157632538555708	0.6125109788301009	0.7252392347931835	0.5326271719087351	0.519093572540172	0.6950847412151301	0.528994799255001	0.6033280810506699	MIP	Val107Ile	NC_000012.12:56454295:C:T	319G>A	12	56454295	C	T	12	ENSG00000135517	54230	2462	CCSBVarC008489	ALE00008444	ENSP00000498622.1	Edgotyping3	VUSmut_GDEh11	H01	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh11	H01	0.0		0.0		0.0			0.0			1.0	1.0	1.0	Y	N	N	N	Y	254635.0	single nucleotide variant	NM_012064.4(MIP):c.319G>A (p.Val107Ile)	4284.0	MIP	HGNC:7103	Benign/Likely benign	0.0	Jan 22, 2024	74641138.0	-	RCV000241787|RCV000556222|RCV001723852	MedGen:CN169374|MONDO:MONDO:0014110,MedGen:C3809001,OMIM:615274,Orphanet:91492|MedGen:C3661900	not specified|Cataract 15 multiple types|not provided	germline	germline	GRCh38	NC_000012.12	12	56454295.0	56454295.0	12q13.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA6632632,UniProtKB:P30301#VAR_071602	2.0	260169.0	56454295.0	C	T	-	-	-	-	-	-	319G>A 	Val107Ile	NM_012064.4	2.0	Benign	Likely benign	260169	12	56454295.0	C	T	V	I	rs74641138	12	56848079	12	55134346	107	MIP	ENSG00000135517	ENST00000652304	ENSP00000498622	P30301	MIP_HUMAN	c.319G>A	p.Val107Ile	c.319G>A	p.Val107Ile	principal1	Y	.	YES	Select	-	GTT	1	0	C	C/C	C/C	C/C	C/C	.	.	.	.	.	.	0.008	0.14667	B	0.012	0.16009	B	.	.	.	.	.	.	0.595	0.15390	N	.	.	.	.	.	-0.8487	0.51867	T	0.0877	0.33717	T	10	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.4257961303558411	0.42294	.	.	0.40330529213	0.25499	T	0.163397	0.50590	T	-0.523718	0.00403	T	-0.469174	0.25255	T	0.00170830088576476	0.00017	T	0.879712	0.59491	D	0.08556827	0.19674	0.116972566	0.28170	0.10214651	0.23916	0.12541766	0.30142	-4.61	0.32334	T	0.0997	0.17126	B	0.00878666881930082	0.22940	0.04949807	0.59382	0.038	0.08930	.	.	.	.	.	.	3.521096	0.49443	22.8	0.98385128803694533	0.41025	0.301286	0.40789	N	-0.503425696206928	0.21711	1.169759	-0.345541807856256	0.26328	1.473224	5.18	4.29	0.50301	2.53	0.46530	1.45	0.34852	3.306000	0.37504	0.599	0.40292	0.746	0.29181	0.998000	0.34068	0.996	0.76032	154	0.93969	110	0.02196485623003195	1	7.564296520423601E-4	30	0.02982107355864811	13	0.018731988472622477	46	0.04563492063492063	20	0.02044989775051125	4525	264690	0.01709547	.	2744	109376	2.508780e-02	44	4934	207568	2.377050e-02	82	5750	236502	2.431270e-02	101	31	7162	4.328400e-03	0	152	17104	8.886810e-03	2	46	2320	1.982760e-02	0	331	9042	3.660690e-02	7	596	13384	4.453080e-02	11	1137	42764	2.658780e-02	16	397	15688	2.530600e-02	8	331	9042	3.660690e-02	7	57	15996	3.563390e-03	0	240	30508	7.866790e-03	2	135	6204	2.176020e-02	2	519	13396	3.874290e-02	16	753	16724	4.502510e-02	12	2326	89296	2.604820e-02	30	783	30604	2.558490e-02	20	519	13396	3.874290e-02	16	49	14710	3.331070e-03	0	288	34244	8.410230e-03	2	220	9558	2.301740e-02	3	630	17688	3.561740e-02	15	959	21618	4.436120e-02	20	2676	102556	2.609310e-02	39	782	30524	2.561920e-02	20	630	17688	3.561740e-02	15	.	42952	1614060	2.661120e-02	682	2391	44882	5.327300e-02	80	303	75040	4.037850e-03	0	46	912	5.043860e-02	1	630	60026	1.049550e-02	5	757	29604	2.557090e-02	10	2391	44882	5.327300e-02	80	2784	63936	4.354350e-02	48	161	6062	2.655890e-02	4	31992	1180002	2.711180e-02	458	2307	91084	2.532830e-02	59	4932	196742	0.025068363643756798	1	370	0.002702702702702703	218	4504	0.04840142095914742	47	9644	0.004873496474491912	14	818	0.017114914425427872	13	1058	0.012287334593572778	35	1850	0.01891891891891892	7	296	0.02364864864864865	440	19328	0.022764900662251654	48	10014	0.004793289394847214	253	6354	0.039817437834435004	5707	234610	0.024325476322407398	not_provided|not_specified|Cataract_15_multiple_types	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.56454295C>T	ClinGen:CA6632632|UniProtKB:P30301#VAR_071602	C3661900|CN169374|C3809001	615274	91492	.	Val	Ile	98.31	0.647887323943662																																																																																																																																																																																																																																																																																																																																																																																																																																																																													92			98.31	Aliphatic	Valine		Lens fiber major intrinsic protein										4.2								 V107-V103 (PAE:  1.0)		 V107-V103 (PAE:  1.0)								117									-92.5				-17.2						H (helix)	H (α-helix)							Extracellular					98.31	64.788734	>90	10-90	615274	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic developmental defect during embryogenesis	2	CATARACT 15, MULTIPLE TYPES	false	0.5723790265552859	0.6079195299403855	false	false	false
MLH1	MLH1_Lys618Arg	B_11-12	1.44789232475568	0.22405593644573069	0.3048399339236625	7.911270267630238	0.00031241619885686916	0.0009557208804295567	2024_12_Batch_11-12	true	true	true	false	true	true	false	false	false	false	false	false	0.9124795611647029	0.9107749530736968	0.8656783531947503	0.8538560636191597	0.8323256802669134	0.9174455684569973		0.7871295656240749		0.8339794601185616	0.921599486915694	0.9201013958809205	0.9174455684569973	0.877521794909752	0.8538560636191597	0.8973772462709391	0.8999504192316996	0.9048577264484852	MLH1	Lys618Arg	NC_000003.12:37047640:A:G	1853A>G	3	37047640	A	G	3	ENSG00000076242	2713	919	CCSBVarC007386	ALE00007374	ENSP00000231790.3	Edgotyping3	VUSMutGDEh011	G09	GDEhDisVCh_40019	B07	1	VUSMutGDDh011	G09	VUSN2Hmut_GDN2h_04	G01	VUSMutpDEST2_02	G04	VUSmut_GDEh04	G01	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	N	Y	Y	Y	95381.0	single nucleotide variant	NM_000249.4(MLH1):c.1853A>G (p.Lys618Arg)	4292.0	MLH1	HGNC:7127	Likely benign	0.0	Sep 05, 2013	63750449.0	-	RCV000075385|RCV000131941|RCV000417383|RCV000524255|RCV000663183|RCV001083344|RCV003894920	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144|MeSH:D003123,MedGen:C0009405|	Lynch syndrome|Hereditary cancer-predisposing syndrome|not specified|not provided|Colorectal cancer, hereditary nonpolyposis, type 2|Hereditary nonpolyposis colorectal neoplasms|MLH1-related disorder	germline;unknown	germline	GRCh38	NC_000003.12	3	37047640.0	37047640.0	3p22.2	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007182,UniProtKB:P40692#VAR_043424	2.0	89907.0	37047640.0	A	G	-	-	-	-	-	-	1853A>G 	Lys618Arg	NM_000249.4	3.0	Benign	Likely benign	89907	3	37047640.0	A	G	K	R	rs63750449	3	37089131	3	37064135	618	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.1853A>G	p.Lys618Arg	c.1853A>G	p.Lys618Arg	principal1	Y	1	YES	Select	+	AAG	2	0	A	A/A	A/A	A/A	A/A	0.072	0.37688	T	0.123	0.41254	T	0.454	0.36199	P	0.197	0.36709	B	0.59	0.76851	D	simple_aae	41.0	59.0	1.57	0.39465	L	-1.67	0.49032	N	0.536	0.59864	-0.7597	0.57244	T	0.2344	0.59946	T	10	0.3226472	0.49236	D	0.050896	0.64301	D	0.731	0.90551	0.528	0.63288	P40692	K618R	Loss of ubiquitination at K618 (P = 0.0381)| Loss of methylation at K617 (P = 0.0974)| Gain of helix (P = 0.2294)| Loss of disorder (P = 0.2311)| Loss of solvent accessibility (P = 0.3136)	0.931043268376	0.92980	0.7179342357639108	0.71590	0.0738909618718	0.08106	0.680370867252	0.64262	T	0.678937	0.90456	D	0.0870363	0.62590	D	0.156545	0.80451	D	0.152705887721968	0.17101	T	0.824718	0.48605	T	0.38379946	0.59263	0.29421705	0.55237	0.43259972	0.62602	0.31743172	0.57493	-8.501	0.72754	D	0.1382	0.30294	B	0.884924319522106	0.75071	0.99794453	0.98567	0.398	0.64513	.	.	.	.	.	.	3.453818	0.48192	22.6	0.99818116842926341	0.90158	0.886405	0.81708	D	0.367463235688346	0.59458	4.148102	0.455693015427841	0.64894	4.779105	5.35	5.35	0.76261	4.75	0.87304	7.335	0.78536	11.259000	0.91022	0.686	0.82694	1.0	0.71675	1.000000	0.68239	0.997	0.79771	154	0.93969	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	6	109408	5.484060e-05	0	12	208136	5.765460e-05	0	20	236876	8.443240e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	1	13394	7.466030e-05	0	5	42768	1.169100e-04	0	0	15690	0.000000e+00	0	5	42768	1.169100e-04	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	1	16734	5.975860e-05	0	11	89558	1.228250e-04	0	0	30608	0.000000e+00	0	11	89558	1.228250e-04	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	1	21632	4.622780e-05	0	19	102672	1.850550e-04	0	0	30526	0.000000e+00	0	19	102672	1.850550e-04	0	.	52	1614042	3.221730e-05	0	46	1180016	3.898250e-05	0	0	74928	0.000000e+00	0	0	912	0.000000e+00	0	0	59998	0.000000e+00	0	0	29608	0.000000e+00	0	1	44888	2.227770e-05	0	2	64036	3.123240e-05	0	0	6084	0.000000e+00	0	46	1180016	3.898250e-05	0	0	91088	0.000000e+00	0	0	42352	0	0	122	0	0	156	0	0	3432	0	0	144	0	0	608	0	0	56	0	0	98	0	0	3450	0	0	3554	0	0	212	0	0	50418	0	not_provided|Lynch_syndrome|not_specified|MLH1-related_disorder|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|Colorectal_cancer,_hereditary_nonpolyposis,_type_2	reviewed_by_expert_panel	NC_000003.12:g.37047640A>G	ClinGen:CA007182|UniProtKB:P40692#VAR_043424	C3661900|C4552100|CN169374|C0027672|C0009405|C1333991	609310	144|140162|144	DNA mismatch repair protein Mlh1, C-terminal	Lys	Arg	92.87	0.28292682926829266																																																																																																																																																																																																																																																																																																																																																																																																																																																																													58			92.87	Positively-charged	Lysine		DNA mismatch repair protein Mlh1										-3.9								 K618-L622 (PAE:  1.5)	K618-F614 (PDBs: 3RBN), K618-L622 (PDBs: 3RBN)	 K618-L622 (PAE:  1.5), K618-F614 (PAE: 1.0)	K618-L622 (PDBs: 3RBN), K618-F614 (PDBs: 3RBN)							147									-102.8				-1.3	Interaction with EXO1					H (helix)	H (α-helix)	Helix											92.87	28.292683	>90	10-90	609310	autosomal dominant	GenCC	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 2	false	0.9107749530736968	0.9124795611647029	true	true	false
FBP1	FBP1_Met289Leu	B_7-8	-1.1916330230562582	0.2722348667819067	0.3585990314161668	0.6340679299895743	0.5461903158776702	0.5997960680045031	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6493329726926849	0.6447634835275902	0.8228854077504616	0.7930129149914178	0.8005710699370003	0.8348480533013818	0.8935307753132022	0.8680746667084159	0.9042336337419239	0.8696766486260442	0.6958529277860273	0.6706048793365696	0.7761653312895613	0.7330674731655847	0.6817921962409117	0.776094166874879	0.5936740392691532	0.6280610660488	FBP1	Met289Leu	NC_000009.12:94603533:T:A	865A>T	9	94603533	T	A	9	ENSG00000165140	2654	460	CCSBVarC008438	ALE00008434	ENSP00000364475.5	Edgotyping3	VUSmut_GDEh11	C01	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_02	E01	VUSmut_GDEh11	C01	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	211414.0	single nucleotide variant	NM_000507.4(FBP1):c.865A>T (p.Met289Leu)	2203.0	FBP1	HGNC:3606	Benign/Likely benign	0.0	Jan 31, 2024	145771944.0	-	RCV000195497|RCV000513932|RCV001087746|RCV003947632	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348|	not specified|not provided|Fructose-biphosphatase deficiency|FBP1-related disorder	germline	germline	GRCh38	NC_000009.12	9	94603533.0	94603533.0	9q22.32	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA319841	2.0	214360.0	94603533.0	T	A	-	-	-	-	-	-	865A>T 	Met289Leu	NM_000507.4	2.0	Benign	Likely benign	214360	9	94603533.0	T	A	M	L	rs145771944	9	97365815	9	96405636	289	FBP1	ENSG00000165140	ENST00000375326	ENSP00000364475	P09467	F16P1_HUMAN	c.865A>T	p.Met289Leu	c.865A>T	p.Met289Leu	principal1	Y	1	YES	Select	-	ATG	1	0	T	A/A	A/A	T/T	A/T	0.149	0.24880	T	0.182	0.29561	T	0.001	0.07480	B	0.004	0.10086	B	0.34	0.58915	N	simple_aae	66.0	34.0	1.625	0.41446	L	-0.46	0.14906	N	0.239	0.27127	-0.8244	0.53470	T	0.1737	0.51483	T	10	0.01455909	0.00302	T	.	.	.	0.077	0.22328	0.423	0.46550	P09467	M289L	Loss of ubiquitination at K291 (P = 0.092)| Loss of disorder (P = 0.0926)| Loss of methylation at K291 (P = 0.1043)| Loss of loop (P = 0.1242)| Gain of helix (P = 0.2059)	0.710211490884	0.70538	.	0.45224	.	0.30039	0.396238267422	0.24517	T	0.153202	0.49127	T	-0.453228	0.01010	T	-0.41213	0.31617	T	0.0125642105180162	0.00207	T	.	0.73799	.	0.38834903	0.59588	0.2665995	0.52306	0.47175792	0.65085	0.2674617	0.52402	-5.118	0.38142	T	0.1916	0.46673	LB	0.0237096028264002	0.30849	0.00900598	0.40097	0.295	0.56381	.	.	.	.	.	.	2.358313	0.303	18.38	0.95109162728490637	0.26424	0.873579	0.79526	D	-0.129878297898216	0.35820	2.081846	0.0339991677837825	0.41017	2.479348	5.24	4.09	0.46976	2.69	0.49185	4.955	0.63425	2.258000	0.31823	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.985	0.61072	832	0.38867	16	0.003194888178913738	16	0.012102874432677761	0	0.0	0	0.0	0	0.0	0	0.0	1073	264690	0.004053799	.	107	109408	9.779910e-04	0	226	208126	1.085880e-03	0	210	236956	8.862400e-04	0	101	7164	1.409830e-02	0	5	17112	2.921930e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	101	7164	1.409830e-02	0	213	16218	1.313360e-02	0	10	30524	3.276110e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89552	0.000000e+00	0	0	30608	0.000000e+00	0	213	16218	1.313360e-02	0	192	14902	1.288420e-02	0	13	34260	3.794510e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102752	9.732170e-06	0	0	30526	0.000000e+00	0	192	14902	1.288420e-02	0	.	1018	1614152	6.306720e-04	1	910	75032	1.212820e-02	1	910	75032	1.212820e-02	1	0	912	0.000000e+00	0	36	60014	5.998600e-04	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	64026	0.000000e+00	0	2	6060	3.300330e-04	0	10	1180022	8.474420e-06	0	0	91082	0.000000e+00	0	1	92470	1.0814318157240186E-5	2	174	0.011494252873563218	0	2674	0	52	4186	0.012422360248447204	7	790	0.008860759493670886	0	946	0	0	656	0	0	274	0	2	8036	2.4888003982080636E-4	54	4360	0.012385321100917432	0	3330	0	64	110206	5.807306317260403E-4	FBP1-related_disorder|Fructose-biphosphatase_deficiency|not_provided|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000009.12:g.94603533T>A	ClinGen:CA319841	C0016756|C3661900|CN169374	229700	348	.	Met	Leu	98.77	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.77	Aliphatic	Methionine		Fructose-1,6-bisphosphatase 1										1.9								 M289-G294 (PAE:  1.0), M289-M285 (PAE: 1.0)	M289-M285 (PDBs: 2JJK, 2VT5, 2WBB, 2WBD, 2Y5K, 2Y5L, 3A29, 3KBZ, 3KC0, 3KC1, 4MJO, 5LDZ, 6LW2, 7C9Q, 7CVH, 7CVN, 7CWE, 7EZF, 7EZP, 7EZR), M289-G294 (PDBs: 7EZR)	 M289-M285 (PAE:  1.0), M289-G294 (PAE: 1.0), M289-G293 (PAE: 1.0)	M289-M285 (PDBs: 2JJK, 2WBB, 2WBD, 2Y5K, 3KC1, 7CWE, 7EZF, 7EZP, 7EZR), M289-G293 (PDBs: 2VT5, 2Y5L, 3A29, 3KBZ, 3KC0, 4MJO, 5LDZ, 6LW2, 7C9Q, 7CVH, 7CVN, 7EZR), M289-G294 (PDBs: 7EZR), M289-G320 (PDBs: 7EZR)							149									-61.8				-48.9						H (helix)	H (α-helix)	Helix											98.77	0.0	>90	<10	229700	autosomal recessive	OMIM	Rare inborn errors of metabolism	1	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	false	0.6447634835275902	0.6493329726926849	false	false	false
BAG3	BAG3_Pro380Ser	B_15-16	0.7316697778764504	0.48813555191554203	0.573041735807428	-15.669803911529025	1.043132952088504e-6	0.000017090615777521473	2025_03_Batch_15-16	false	false	false	true	false	false	false	false	false	false	false	false	0.9156988240680276	0.9179418062550895	0.6334608678467976	0.8554451844989179	0.7465166833760846	0.7707377748440227	0.8486898257985548	0.8128245414918206	0.9043667785817578	0.6943226737488963	0.9063335778859126	0.898478856988224	0.6927857238894907	0.6802088252603486	0.806523590416078	0.5725990619446988	0.9295500346242664	0.9329187911478312	BAG3	Pro380Ser	NC_000010.11:119676692:C:T	1138C>T	10	119676692	C	T	10	ENSG00000151929	5066	201832	CCSBVarC003585	ALE00003585	ENSP00000358081.4	CEGS2	CegsMutGDEh1038	B01	GDEhDisVCh_40022	E08	2	CegsMutGDDh1038	B01	VUSN2Hmut_GDN2h_07	A10	VUSMutpDEST2_04	D12	VUSmut_GDEh07	A10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	174893.0	single nucleotide variant	NM_004281.4(BAG3):c.1138C>T (p.Pro380Ser)	9531.0	BAG3	HGNC:939	Benign/Likely benign	0.0	Jan 31, 2024	144692954.0	-	RCV000150183|RCV000621769|RCV000852642|RCV000437120|RCV000988455|RCV001084049|RCV003486666	MedGen:CN169374|MedGen:CN230736|EFO:EFO_0000275,Human Phenotype Ontology:HP:0001715,Human Phenotype Ontology:HP:0005110,Human Phenotype Ontology:HP:0005179,MONDO:MONDO:0004981,MedGen:C0004238|MedGen:C3661900|MONDO:MONDO:0013061,MedGen:C2751831,OMIM:612954,Orphanet:199340|MONDO:MONDO:0013479,MedGen:C3151293,OMIM:613881,Orphanet:154;MONDO:MONDO:0013061,MedGen:C2751831,OMIM:612954,Orphanet:199340|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848	not specified|Cardiovascular phenotype|Atrial fibrillation|not provided|Myofibrillar myopathy 6|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6|Cardiomyopathy	germline;unknown	germline	GRCh38	NC_000010.11	10	119676692.0	119676692.0	10q26.11	criteria provided, multiple submitters, no conflicts	17.0	ACMG2022	N	ClinGen:CA175304,UniProtKB:O95817#VAR_066784	2.0	162782.0	119676692.0	C	T	-	-	-	-	-	-	1138C>T 	Pro380Ser	NM_004281.4	2.0	Benign	Likely benign	162782	10	119676692.0	C	T	P	S	rs144692954	10	121436204	10	121426194	380	BAG3	ENSG00000151929	ENST00000369085	ENSP00000358081	O95817	BAG3_HUMAN	c.1138C>T	p.Pro380Ser	c.1138C>T	p.Pro380Ser	principal1	Y	1	YES	Select	+	CCT	1	0	C	C/C	C/T	C/C	C/C	0.185	0.91343	T	0.4	0.50015	T	0.172	0.28785	B	0.025	0.20509	B	0.09	0.26006	N	simple_aae	91.0	9.0	2.52	0.73336	M	-0.49	0.51010	N	0.697	0.70032	-0.7849	0.55844	T	0.1459	0.46799	T	10	0.004340023	0.00086	T	.	.	.	0.125	0.34250	.	.	.	.	.	0.863083893347	0.86068	0.38075794837255705	0.37787	0.0694255981819	0.07604	0.388317108154	0.23406	T	0.059978	0.31019	T	-0.390924	0.02515	T	-0.324917	0.41685	T	0.00634483206452427	0.00070	T	0.812919	0.46334	T	0.031736292	0.03040	0.03927692	0.03998	0.03096743	0.02828	0.038375434	0.03707	-4.239	0.27340	T	0.0748	0.11803	B	0.0439103172486995	0.36060	0.08687704	0.65169	0.032	0.06833	.	.	.	.	.	.	1.651506	0.21102	15.04	0.98975847563457187	0.49711	0.089319	0.17903	N	-0.2898912248758	0.29258	1.638896	-0.169268928788007	0.32361	1.861266	6.03	4.01	0.45757	.	.	1.019	0.29714	0.955000	0.23033	0.599	0.40292	0.051	0.21521	0.055000	0.21986	0.89	0.42855	912	0.21478	25	0.0049920127795527154	21	0.01588502269288956	0	0.0	0	0.0	1	9.92063492063492E-4	3	0.003067484662576687	902	264690	0.00340776	.	148	109406	1.352760e-03	0	313	208098	1.504100e-03	2	306	236928	1.291530e-03	2	84	7164	1.172530e-02	0	5	17112	2.921930e-04	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	1	13392	7.467140e-05	0	4	42768	9.352790e-05	0	52	15690	3.314210e-03	0	84	7164	1.172530e-02	0	193	16216	1.190180e-02	0	9	30524	2.948500e-04	0	0	6210	0.000000e+00	0	1	13416	7.453790e-05	0	2	16732	1.195310e-04	0	5	89528	5.584840e-05	0	99	30608	3.234450e-03	2	193	16216	1.190180e-02	0	183	14902	1.228020e-02	0	11	34258	3.210930e-04	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	3	21626	1.387220e-04	0	6	102732	5.840440e-05	0	99	30526	3.243140e-03	2	183	14902	1.228020e-02	0	.	1197	1614136	7.415730e-04	9	821	75018	1.094400e-02	4	821	75018	1.094400e-02	4	0	912	0.000000e+00	0	40	60016	6.664890e-04	0	0	29606	0.000000e+00	0	3	44882	6.684190e-05	0	12	64032	1.874060e-04	0	6	6062	9.897720e-04	1	21	1180020	1.779630e-05	0	241	91078	2.646080e-03	3	1	56764	1.761679937988866E-5	5	308	0.016233766233766232	0	112	0	80	8192	0.009765625	0	146	0	0	630	0	0	82	0	1	98	0.01020408163265306	6	6404	9.369144284821987E-4	85	8500	0.01	0	194	0	93	72736	0.0012785965684117906	Cardiovascular_phenotype|not_provided|Myofibrillar_myopathy_6|not_specified|Dilated_cardiomyopathy_1HH|Cardiomyopathy|Atrial_fibrillation	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.119676692C>T	ClinGen:CA175304|UniProtKB:O95817#VAR_066784	CN230736|C3661900|C2751831|CN169374|C3151293|C0878544|C0004238	612954|613881	199340|154|167848	.	Pro	Ser	57.85	0.9411764705882353																																																																																																																																																																																																																																																																																																																																																																																																																																																																													128			57.85	Special, No backbone hydrogen	Proline		BAG family molecular chaperone regulator 3		Pro residues								1.6																		115									-136.6				-177.8	Disordered			dbSNP: rs144692954; Variant type: LB/B; AA change: Pro380Ser; PTM type: Phosphorylation; PTM morphology: PsPGP*sAVPss; Var class: II&rs144692954		C (loop/coil)	C (loop/coil)												57.85	94.117645	50-70	$\geqslant$90	612954;613881;612954	autosomal dominant	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 6; CARDIOMYOPATHY, DILATED, 1HH; MYOPATHY, MYOFIBRILLAR, 6	false	0.9179418062550895	0.9156988240680276	false	false	false
ZMYND10	ZMYND10_Arg243Cys	B_7-8	5.472055941455194	0.011998373084755628	0.03113708232592833	1.676036313980252	0.14474752983609077	0.1838143371966966	2024_01_Batch_7-8	false	false	true	false	false	false	false	false	false	false	false	false	0.8420549989110732	0.9040408090352307	0.9429562787758767	0.97667935611485	0.892036664251676	0.9749564998886144	0.9749564998886144	0.892036664251676	0.97667935611485	0.9429562787758767	0.9040408090352307	0.8420549989110732							ZMYND10	Arg243Cys	NC_000003.12:50342543:G:A	727C>T	3	50342543	G	A	3	ENSG00000004838	9866	298	CCSBVarC008483	ALE00008418	ENSP00000231749.3	Edgotyping3	VUSmut_GDEh11	D02	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh11	D02	0.0		0.0		0.0			0.0			1.0	1.0	1.0	Y	N	N	N	Y	239247.0	single nucleotide variant	NM_015896.4(ZMYND10):c.727C>T (p.Arg243Cys)	51364.0	ZMYND10	HGNC:19412	Benign/Likely benign	0.0	Sep 01, 2024	141055331.0	-	RCV000227698|RCV003430793	Human Phenotype Ontology:HP:0012265,MONDO:MONDO:0016575,MedGen:C0008780,OMIM:PS244400,Orphanet:244|MedGen:C3661900	Primary ciliary dyskinesia|not provided	germline	germline	GRCh38	NC_000003.12	3	50342543.0	50342543.0	3p21.31	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA2417090	2.0	241071.0	50342543.0	G	A	-	-	-	-	-	-	727C>T 	Arg243Cys	NM_015896.4	2.0	Benign	Likely benign	241071	3	50342543.0	G	A	R	C	rs141055331	3	50379974	3	50354978	243	ZMYND10	ENSG00000004838	ENST00000231749	ENSP00000231749	O75800	ZMY10_HUMAN	c.727C>T	p.Arg243Cys	c.727C>T	p.Arg243Cys	principal1	Y	1	YES	Select	-	CGT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.011	0.72530	D	0.992	0.73231	D	0.386	0.54382	B	0.09	0.26006	N	simple_aae	91.0	9.0	2.125	0.58867	M	-3.79	0.76365	D	0.255	0.28650	-0.8253	0.53413	T	0.1475	0.47087	T	9	0.011281699	0.00244	T	.	.	.	0.113	0.31580	.	.	.	.	.	0.0297737177859	0.01290	0.26641414353543713	0.26359	0.220308387695	0.24286	0.275038808584	0.06808	T	0.368436	0.73160	T	-0.364959	0.03697	T	-0.289196	0.45519	T	0.0357683655182107	0.02919	T	0.709529	0.31799	T	0.1843937	0.39441	0.15876746	0.36946	0.23455933	0.45950	0.14893827	0.35081	-4.633	0.44288	T	0.0751	0.08794	B	0.0717044830455769	0.40338	0.22721043	0.74264	0.217	0.48294	.	.	.	.	.	.	2.590189	0.33661	19.39	0.99716806086754772	0.81791	0.542497	0.55666	D	-0.156538224236955	0.34682	2.001907	-0.247624873617131	0.29536	1.675972	5.77	2.93	0.33009	1.47	0.33823	0.345	0.1979	0.411000	0.18182	-0.113	0.14846	0.029	0.20432	0.016000	0.20583	0.005	0.06762	2	0.99503	17	0.0033945686900958465	10	0.007564296520423601	2	0.0019880715705765406	5	0.007204610951008645	0	0.0	0	0.0	998	264690	0.0037704485	.	118	109324	1.079360e-03	0	271	207646	1.305110e-03	0	259	236382	1.095680e-03	0	65	7156	9.083290e-03	0	26	17084	1.521890e-03	0	1	2320	4.310340e-04	0	2	9046	2.210920e-04	0	0	13386	0.000000e+00	0	22	42734	5.148130e-04	0	0	15686	0.000000e+00	0	65	7156	9.083290e-03	0	159	16196	9.817240e-03	0	44	30474	1.443850e-03	0	3	6196	4.841830e-04	0	1	13412	7.456010e-05	0	0	16724	0.000000e+00	0	58	89192	6.502830e-04	0	1	30598	3.268190e-05	0	159	16196	9.817240e-03	0	149	14892	1.000540e-02	0	50	34202	1.461900e-03	0	3	9530	3.147950e-04	0	2	17690	1.130580e-04	0	0	21602	0.000000e+00	0	48	102344	4.690060e-04	0	1	30518	3.276750e-05	0	149	14892	1.000540e-02	0	.	1449	1613592	8.979970e-04	3	655	75030	8.729840e-03	2	655	75030	8.729840e-03	2	0	910	0.000000e+00	0	120	60002	1.999930e-03	1	2	29582	6.760870e-05	0	1	44864	2.228960e-05	0	0	64006	0.000000e+00	0	8	6054	1.321440e-03	0	554	1179586	4.696560e-04	0	1	91074	1.098010e-05	0	98	180008	5.444202479889783E-4	3	360	0.008333333333333333	0	4500	0	85	9430	0.009013785790031814	5	796	0.00628140703517588	0	968	0	0	1848	0	0	280	0	16	17424	9.182736455463728E-4	88	9790	0.008988764044943821	0	6348	0	207	215614	9.600489764115503E-4	Primary_ciliary_dyskinesia|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.50342543G>A	ClinGen:CA2417090	C0008780|C3661900	PS244400	244	.	Arg	Cys	86.3	0.3870967741935484																																																																																																																																																																																																																																																																																																																																																																																																																																																																													96			86.3	Positively-charged	Arginine		Zinc finger MYND domain-containing protein 10								0.0776		-4.5								 R243-E390 (PAE:  12.0)		 R243-F239 (PAE:  1.0)		 R243-E390 (PAE:  12.0)						175									-145.8		Pocket 1: Mean pLDDT: 65.39, Volume: 1681.49 Å³, Druggability score: 0.08		151.2						B (undefined)	E (parallel sheets)												86.3	38.709675	70-90	10-90		autosomal recessive	OMIM	Ciliopathy; Genetic infertility	2		false	0.9040408090352307	0.8420549989110732	false	false	false
DIABLO	DIABLO_Ile59Val	B_7-8	-1.9098382168101278	0.15215021311874846	0.22685941222233377	1.1010442890940932	0.3130761389321146	0.36662074980244436	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.697442188778413	0.6941607160823413	0.820248299501321	0.8951744605935059	0.8588587390044262	0.8903947950593825	0.8903947950593825	0.8588587390044262	0.8951744605935059	0.820248299501321	0.6941607160823413	0.697442188778413							DIABLO	Ile59Val	NC_000012.12:122224520:T:C	175A>G	12	122224520	T	C	12	ENSG00000184047	7038	405	CCSBVarC008463	ALE00008438	ENSP00000442360.2	Edgotyping3	VUSmut_GDEh11	E02	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_05	E11	VUSmut_GDEh11	E02	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	230266.0	single nucleotide variant	NM_001371333.1(DIABLO):c.175A>G (p.Ile59Val)	56616.0	DIABLO	HGNC:21528	Likely benign	0.0	Oct 25, 2023	574777883.0	-	RCV000217433|RCV001551947	MedGen:CN169374|MedGen:C3661900	not specified|not provided	germline	germline	GRCh38	NC_000012.12	12	122224520.0	122224520.0	12q24.31	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA6844013	2.0	227299.0	122224520.0	T	C	-	-	-	-	-	-	175A>G 	Ile59Val	NM_001371333.1	2.0	Benign	Likely benign	227299	12	122224520.0	T	C	I	V	rs574777883	12	122709067	12	121275020	59	DIABLO	ENSG00000184047	ENST00000464942	ENSP00000442360	Q9NR28	DBLOH_HUMAN	c.175A>G	p.Ile59Val	c.175A>G	p.Ile59Val	principal1	Y	1	YES	Select	-	ATT	1	0	T	T/T	T/T	T/T	T/T	.	0.09238	.	.	0.07060	.	0.001	0.07480	B	0.006	0.12129	B	0.0	0.42965	N	without_aae	100.0	0.0	0.945	0.23581	L	.	0.15507	.	.	0.30814	-1.0256	0.21844	T	0.0504	0.21302	T	10	0.023557961	0.00617	T	0.006897	0.17989	T	.	0.34465	0.615	0.74786	Q9NR28	I59V	Gain of disorder (P = 0.1039)| Gain of sheet (P = 0.1945)| Gain of phosphorylation at S63 (P = 0.2765)| Gain of ubiquitination at K62 (P = 0.2793)| Gain of catalytic residue at I59 (P = 0.3101)	.	0.52653	.	.	.	.	0.315899074078	0.12790	T	0.277144	0.64778	T	-0.363843	0.03757	T	-0.345853	0.39328	T	0.009306627522804	0.00117	T	0.711029	0.35944	T	0.11880088	0.27737	0.14478153	0.34261	0.18446438	0.39451	0.12255017	0.29486	-2.932	0.10105	T	0.0675	0.11562	LB	0.0172639644232878	0.28251	0.13329856	0.69308	0.034	0.07526	.	.	.	.	.	.	1.169536	0.15613	11.96	0.94582642171492415	0.25364	0.074561	0.14759	N	-0.279699753476159	0.29653	1.664413	-0.238473471081229	0.29853	1.696444	5.37	4.23	0.49261	1.02	0.29381	0.896	0.28103	0.230000	0.16246	0.66	0.55068	0.429	0.2649	0.047000	0.21808	0.976	0.56441	692	0.58673	2	3.9936102236421724E-4	0	0.0	0	0.0	0	0.0	2	0.001984126984126984	0	0.0	23	264690	8.6894106E-5	.	16	109392	1.462630e-04	0	18	208110	8.649270e-05	0	29	236926	1.224010e-04	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	13	9046	1.437100e-03	0	0	13392	0.000000e+00	0	3	42754	7.016890e-05	0	0	15690	0.000000e+00	0	13	9046	1.437100e-03	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	13	13416	9.689920e-04	0	0	16732	0.000000e+00	0	4	89536	4.467480e-05	0	1	30608	3.267120e-05	0	13	13416	9.689920e-04	0	0	14902	0.000000e+00	0	1	34260	2.918860e-05	0	0	9572	0.000000e+00	0	22	17692	1.243500e-03	0	0	21630	0.000000e+00	0	5	102724	4.867410e-05	0	1	30526	3.275900e-05	0	22	17692	1.243500e-03	0	.	76	1613294	4.710860e-05	0	31	44856	6.911000e-04	0	3	74730	4.014450e-05	0	0	908	0.000000e+00	0	2	59794	3.344820e-05	0	0	29602	0.000000e+00	0	31	44856	6.911000e-04	0	1	63890	1.565190e-05	0	0	6062	0.000000e+00	0	25	1179906	2.118810e-05	0	5	91046	5.491730e-05	0	2	26588	7.522190461862494E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4588	0	0	2918	0	0	112	0	2	35432	5.644615037254459E-5	not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.122224520T>C	ClinGen:CA6844013	CN169374|C3661900	.	.	.	Ile	Val	55.66	0.8165680473372781																																																																																																																																																																																																																																																																																																																																																																																																																																																																													138			55.66	Aliphatic	Isoleucine		Diablo IAP-binding mitochondrial protein; Diablo IAP-binding mitochondrial protein, cleaved form										4.5			B:I59-A:G (PDBs: 1G3F), D:I59-B:G185 (PDBs: 1TW6), K:I59-E:G (PDBs: 1XB0), I:I59-C:G (PDBs: 1XB1), P:I59-A:E118 (PDBs: 3UIH)	B:I59-A:G (PDBs: 1G3F), D:I59-B:G185 (PDBs: 1TW6), K:I59-E:G (PDBs: 1XB0, 1XB1), P:I59-A:E118 (PDBs: 3UIH), Q:I59-B:E118 (PDBs: 3UIH)														131	IAP-binding								-60.0				105.7						C (loop/coil)	C (loop/coil)	Beta strand											55.66	81.65681	50-70	10-90		unknown			0		false	0.6941607160823413	0.697442188778413	false	false	false
AGXT	AGXT_Ile340Met	B_7-8	0.35568646993869724	1.0	1.0	1.9130698760917197	0.11054370966262946	0.14270084626170215	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6849580803010437	0.685173672610613	0.4919930378636574	0.6769085199038267	0.6559712957751301	0.5622694682608712	0.51974194816588	0.6153385854135994	0.6411336856275085	0.4925149421039139	0.7587177999076198	0.7813579516037037	0.6047969883558624	0.6966040061366608	0.712683354180145	0.4914711336234009	0.6116295453136064	0.5885582089983836	AGXT	Ile340Met	NC_000002.12:240878099:A:G	1020A>G	2	240878099	A	G	2	ENSG00000172482	70497	3881	CCSBVarC004890	ALE00004890	ENSP00000302620.3	Edgotyping3	VUSMutGDEh005	A07	GDEhDisVCh_40002	G11	2	VUSMutGDDh005	A07	VUSN2Hmut_GDN2h_02	H02	VUSMutpDEST2_14	D11	VUSmut_GDEh02	H02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	48085.0	single nucleotide variant	NM_000030.3(AGXT):c.1020A>G (p.Ile340Met)	189.0	AGXT	HGNC:341	Benign/Likely benign	0.0	Feb 01, 2024	4426527.0	-	RCV000032682|RCV000247828|RCV001519689	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:CN169374|MedGen:C3661900	Primary hyperoxaluria, type I|not specified|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	240878099.0	240878099.0	2q37.3	criteria provided, multiple submitters, no conflicts	13.0	-	N	UniProtKB:P21549#VAR_000593,OMIM:604285.0014,ClinGen:CA343786	3.0	39486.0	240878099.0	A	G	-	-	-	-	-	-	1020A>G 	Ile340Met	NM_000030.3	2.0	Benign	Likely benign	39486	2	240878099.0	A	G	I	M	rs4426527	2	241817516	2	241466189	340	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.1020A>G	p.Ile340Met	c.1020A>G	p.Ile340Met	principal1	Y	1	YES	Select	+	ATA	3	3	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.001	0.04348	B	0.0	0.01751	P	simple_aae	100.0	0.0	.	.	.	3.24	0.00110	N	0.054	0.02553	-1.0609	0.11543	T	0.0001	0.00038	T	9	0.0022816956	0.00033	T	.	.	.	0.274	0.58802	.	.	.	.	.	.	.	0.7572165660146348	0.75535	0.0328522781127	0.03325	0.399807929993	0.25013	T	0.256404	0.62522	T	-0.537533	0.00336	T	-0.401085	0.32897	T	0.0076275630030724	0.00088	T	0.227177	0.03022	T	0.31599483	0.53967	0.14377931	0.34060	0.31599483	0.53967	0.14377931	0.34059	0.619	0.00190	T	0.053	0.00267	B	0.00223280955298708	0.13691	0.00040831	0.07430	0.146	0.37727	.	.	.	.	.	.	-0.195116	0.03126	0.496	0.091279013105980314	0.00085	0.359834	0.44816	N	-1.6339568996518	0.01095	0.04794774	-1.44632309886687	0.02765	0.1296241	4.02	2.21	0.26970	-4.9	0.04648	2.931	0.48723	-0.069000	0.12372	-2.413	0.00292	1.0	0.71675	0.029000	0.21258	0.0	0.00835	976	0.04721	557	0.1112220447284345	47	0.03555219364599092	205	0.20377733598409542	109	0.15706051873198848	89	0.0882936507936508	107	0.10940695296523517	37736	264690	0.14256677	.	17503	108942	1.606630e-01	1688	32916	207348	1.587480e-01	3057	38531	236378	1.630060e-01	3581	398	7156	5.561770e-02	15	1802	17082	1.054910e-01	101	491	2320	2.116380e-01	47	806	9044	8.911990e-02	34	3303	12994	2.541940e-01	422	8739	42746	2.044400e-01	941	1600	15688	1.019890e-01	99	8739	42746	2.044400e-01	941	1016	16172	6.282460e-02	38	3122	30482	1.024210e-01	169	1247	6206	2.009350e-01	127	1151	13400	8.589550e-02	52	4149	16332	2.540410e-01	532	18240	89298	2.042600e-01	1883	3137	30606	1.024960e-01	181	18240	89298	2.042600e-01	1883	922	14882	6.195400e-02	34	3620	34216	1.057980e-01	190	1870	9564	1.955250e-01	174	1528	17690	8.637650e-02	62	5315	21224	2.504240e-01	679	21130	102660	2.058250e-01	2166	3127	30524	1.024440e-01	180	21130	102660	2.058250e-01	2166	.	304945	1613084	1.890450e-01	30860	226	912	2.478070e-01	26	4637	75032	6.180030e-02	157	226	912	2.478070e-01	26	6887	60014	1.147570e-01	408	5700	29596	1.925940e-01	552	3474	44868	7.742710e-02	141	15412	63184	2.439230e-01	1875	1043	6062	1.720550e-01	101	246801	1179846	2.091810e-01	25935	9641	91078	1.058540e-01	602	53828	266838	0.20172539143600238	17	572	0.02972027972027972	368	4850	0.07587628865979382	1115	15518	0.0718520427890192	182	1298	0.14021571648690292	310	2578	0.12024825446082234	152	1950	0.07794871794871795	34	366	0.09289617486338798	3796	22490	0.16878612716763006	1132	16090	0.07035425730267247	520	6800	0.07647058823529412	59802	316460	0.18897174998420022	not_specified|not_provided|Primary_hyperoxaluria,_type_I	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240878099A>G	ClinGen:CA343786|OMIM:604285.0014|UniProtKB:P21549#VAR_000593	CN169374|C3661900|C0268164	259900	416|93598	Aminotransferase class V domain	Ile	Met	98.74	0.23076923076923078																																																																																																																																																																																																																																																																																																																																																																																																																																																																													39			98.74	Aliphatic	Isoleucine		Alanine--glyoxylate aminotransferase										4.5								 I340-V336 (PAE:  1.0), I340-D344 (PAE: 1.0)	I340-V336 (PDBs: 1H0C, 6RV1, 3R9A), I340-D344 (PDBs: 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 3R9A)	 I340-V336 (PAE:  1.0), I340-E346 (PAE: 1.0), I340-D344 (PAE: 1.0), I340-I345 (PAE: 1.0)	I340-I345 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 3R9A), I340-V336 (PDBs: 6RV1, 3R9A), I340-D344 (PDBs: 6RV1, 3R9A)							131									-73.2				-42.5						H (helix)	H (α-helix)	Helix											98.74	23.076923	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.685173672610613	0.6849580803010437	false	false	false
SUCLA2	SUCLA2_Pro230Ser	B_7-8	0.35050576378974957	0.7379366215960983	0.7909421701731469	2.2032652143138227	0.06342459009569956	0.08777083169352089	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6067413656649729	0.635680109381525	0.5674430212377682	0.5754228528171277	0.5607516201563479	0.5727061838850891	0.5809225544412475	0.5454036730943954	0.5422658126168818	0.5562962694476197	0.6531555541514869	0.6663817191364935	0.5644898133289308	0.5760995672183005	0.6085798930173736	0.5785897730279168	0.618204664611563	0.5471010121934523	SUCLA2	Pro230Ser	NC_000013.11:47968709:G:A	688C>T	13	47968709	G	A	13	ENSG00000136143	1598	532	CCSBVarC008432	ALE00008423	ENSP00000494360.1	Edgotyping3	VUSmut_GDEh11	A02	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh11	A02	0.0		0.0		0.0			0.0			1.0	1.0	1.0	Y	N	N	N	Y	200265.0	single nucleotide variant	NM_003850.3(SUCLA2):c.688C>T (p.Pro230Ser)	8803.0	SUCLA2	HGNC:11448	Likely benign	0.0	Sep 27, 2011	796052047.0	-	RCV000186188	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000013.11	13	47968709.0	47968709.0	13q14.2	criteria provided, single submitter	1.0	-	N	ClinGen:CA313034	2.0	203963.0	47968709.0	G	A	-	-	-	-	-	-	688C>T 	Pro230Ser	NM_003850.3	1.0	Benign	Likely benign	203963	13	47968709.0	G	A	P	S	rs796052047	13	48542844	13	47440845	230	SUCLA2	ENSG00000136143	ENST00000646932	ENSP00000494360	Q9P2R7	SUCB1_HUMAN	c.688C>T	p.Pro230Ser	c.688C>T	p.Pro230Ser	principal1	Y	.	YES	Select	-	CCT	1	0	G	./.	./.	./.	./.	.	0.19743	.	.	0.16603	.	0.0	0.02950	B	0.001	0.04348	B	.	.	.	.	.	.	0.8	0.19557	N	.	0.35381	.	.	.	-1.0272	0.21326	T	0.1166	0.40952	T	10	0.05407685	0.05695	T	0.010639	0.27138	T	.	0.34465	0.472	0.54563	Q9P2R7	P230S	Gain of catalytic residue at V233 (P = 0.0101)| Gain of relative solvent accessibility (P = 0.0479)| Loss of sheet (P = 0.0817)| Gain of solvent accessibility (P = 0.11)| Gain of disorder (P = 0.2006)	.	0.33366	.	.	.	.	0.225297838449	0.01641	T	0.214853	0.57444	T	-0.16675	0.25384	T	-0.477302	0.24388	T	0.0106114236173842	0.00147	T	0.830117	0.49856	T	0.037374415	0.04735	0.03259185	0.02029	0.031154012	0.02877	0.034333717	0.02492	-2.591	0.06441	T	0.0721	0.10206	B	0.228116851188555	0.51263	0.03413935	0.55373	0.044	0.11041	.	.	.	.	.	.	-0.007379	0.04243	1.041	0.59118615759262161	0.06236	0.072270	0.14230	N	-1.34537895430705	0.03140	0.1413084	-1.36929740794184	0.03531	0.1674529	5.98	-7.92	0.01028	-2.35	0.10426	-0.373	0.07568	-1.368000	0.05632	-0.244	0.07322	0.003	0.16092	0.000000	0.08389	0.982	0.59239	945	0.12572	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	segdup	0	109272	0.000000e+00	0	0	207882	0.000000e+00	0	1	236566	4.227150e-06	0	0	7156	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13316	0.000000e+00	0	0	42746	0.000000e+00	0	0	15678	0.000000e+00	0	.	.	.	.	0	16194	0.000000e+00	0	0	30506	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16654	0.000000e+00	0	0	89460	0.000000e+00	0	0	30588	0.000000e+00	0	.	.	.	.	0	14878	0.000000e+00	0	0	34242	0.000000e+00	0	0	9568	0.000000e+00	0	0	17688	0.000000e+00	0	0	21548	0.000000e+00	0	1	102536	9.752670e-06	0	0	30506	0.000000e+00	0	1	102536	9.752670e-06	0	.	8	1612318	4.961800e-06	0	8	1179878	6.780360e-06	0	0	74970	0.000000e+00	0	0	910	0.000000e+00	0	0	60002	0.000000e+00	0	0	29594	0.000000e+00	0	0	44810	0.000000e+00	0	0	63854	0.000000e+00	0	0	4942	0.000000e+00	0	8	1179878	6.780360e-06	0	0	91002	0.000000e+00	0	1	9690	1.0319917440660474E-4	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	1	14050	7.117437722419929E-5	not_provided	criteria_provided,_single_submitter	NC_000013.11:g.47968709G>A	ClinGen:CA313034	CN517202	.	.	ATP-grasp fold, succinyl-CoA synthetase-type|ATP-grasp fold	Pro	Ser	97.16	0.9044117647058824																																																																																																																																																																																																																																																																																																																																																																																																																																																																													123			97.16	Special, No backbone hydrogen	Proline		Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial							ATP-grasp			1.6																		115									-52.5				-32.4						C (loop/coil)	T (turn)	Helix											97.16	90.44118	>90	$\geqslant$90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare inborn errors of metabolism	4		false	0.635680109381525	0.6067413656649729	false	false	false
GRN	GRN_Thr182Met	B_7-8	-2.294443880373474	0.062038468686328146	0.11044217154917849	2.191802163320086	0.1683788180576393	0.19941636192853468	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6758260553056123	0.6893827711758019	0.7092670319703465	0.7982357370170502	0.7251794465851098	0.7549254218266535	0.8057121681320198	0.843025545516368	0.8773332008757	0.7448314946910701	0.7648917560128259	0.7526813492497576	0.704138675521287	0.6073333476538517	0.7191382731584004	0.6737025692496227	0.613873786338778	0.598970761361467	GRN	Thr182Met	NC_000017.11:44350524:C:T	545C>T	17	44350524	C	T	17	ENSG00000030582	3980	201376	CCSBVarC004643	ALE00004643	ENSP00000053867.2	CEGS2	CegsMutGDEh1036	B07	GDEhDisVCh_40075	A06	1	CegsMutGDDh1036	B07	VUSN2Hmut_GDN2h_07	C05	VUSMutpDEST2_03	E12	VUSmut_GDEh07	C05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	104036.0	single nucleotide variant	NM_002087.4(GRN):c.545C>T (p.Thr182Met)	2896.0	GRN	HGNC:4601	Benign/Likely benign	0.0	Jan 24, 2024	63750479.0	-	RCV000084447|RCV000295460|RCV001089192|RCV002316278	MedGen:C3661900|MONDO:MONDO:0011842,MedGen:C1843792,OMIM:607485,Orphanet:100070,Orphanet:282|MONDO:MONDO:0011842,MedGen:C1843792,OMIM:607485,Orphanet:100070,Orphanet:282;MONDO:MONDO:0013866,MedGen:C3539123,OMIM:614706,Orphanet:314629,Orphanet:79262|MeSH:D030342,MedGen:C0950123	not provided|GRN-related frontotemporal lobar degeneration with Tdp43 inclusions|GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;Neuronal ceroid lipofuscinosis 11|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000017.11	17	44350524.0	44350524.0	17q21.31	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA225254,UniProtKB:P28799#VAR_064630	2.0	98144.0	44350524.0	C	T	-	-	-	-	-	-	545C>T 	Thr182Met	NM_002087.4	2.0	Benign	Likely benign	98144	17	44350524.0	C	T	T	M	rs63750479	17	42427892	17	39783418	182	GRN	ENSG00000030582	ENST00000053867	ENSP00000053867	P28799	GRN_HUMAN	c.545C>T	p.Thr182Met	c.545C>T	p.Thr182Met	principal1	Y	1	YES	Select	+	ACG	2	0	C	C/C	C/C	C/C	C/C	0.091	0.31974	T	0.124	0.35789	T	0.386	0.34517	B	0.052	0.25553	B	0.0	0.01751	N	simple_aae	100.0	0.0	0.69	0.16877	N	-1.99	0.45958	N	0.112	0.09877	-0.9539	0.40117	T	0.1323	0.44236	T	10	0.0068762004	0.00153	T	.	.	.	0.139	0.37176	.	.	.	.	.	0.655853083524	0.65028	0.3128465739029588	0.30997	0.272092991101	0.29422	0.211677193642	0.00886	T	0.484955	0.81060	T	-0.461789	0.00897	T	-0.42671	0.29948	T	0.00140190762110267	0.00014	T	0.580842	0.20755	T	0.010939457	0.00012	0.027991194	0.01003	0.017733458	0.00298	0.029063443	0.01212	-4.91	0.35889	T	0.0778	0.16692	B	0.0050876888601833	0.18960	0.77988290	0.87853	0.04	0.09634	.	.	.	.	.	.	0.133312	0.05302	1.781	0.94667359325804012	0.25524	0.331219	0.42910	N	-1.06487462752441	0.07212	0.3386402	-1.14419555538858	0.06760	0.3323171	4.43	-0.209	0.12500	-2.26	0.10713	-2.036	0.01508	-4.771000	0.02005	-0.9	0.02336	0.0	0.06393	0.000000	0.08389	0.019	0.11385	501	0.75979	8	0.001597444089456869	6	0.0045385779122541605	0	0.0	1	0.001440922190201729	0	0.0	1	0.0010224948875255625	894	264690	0.003377536	.	104	109354	9.510400e-04	2	245	207958	1.178120e-03	3	230	236808	9.712510e-04	2	82	7164	1.144610e-02	1	5	17104	2.923290e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13358	0.000000e+00	0	15	42760	3.507950e-04	1	2	15690	1.274700e-04	0	82	7164	1.144610e-02	1	185	16208	1.141410e-02	2	14	30514	4.588060e-04	0	0	6208	0.000000e+00	0	0	13408	0.000000e+00	0	0	16698	0.000000e+00	0	34	89454	3.800840e-04	1	11	30608	3.593830e-04	0	185	16208	1.141410e-02	2	163	14896	1.094250e-02	1	14	34244	4.088310e-04	0	0	9558	0.000000e+00	0	1	17692	5.652270e-05	0	0	21594	0.000000e+00	0	40	102682	3.895520e-04	1	11	30526	3.603490e-04	0	163	14896	1.094250e-02	1	.	1312	1613964	8.129050e-04	7	850	75006	1.133240e-02	6	850	75006	1.133240e-02	6	0	910	0.000000e+00	0	40	60020	6.664450e-04	0	1	29602	3.378150e-05	0	0	44882	0.000000e+00	0	3	63940	4.691900e-05	0	5	6062	8.248100e-04	0	316	1179964	2.678050e-04	1	26	91088	2.854380e-04	0	13	49018	2.652086988453221E-4	6	306	0.0196078431372549	0	148	0	78	8542	0.009131350971669398	1	504	0.001984126984126984	0	634	0	0	58	0	0	104	0	12	9090	0.0013201320132013201	84	8848	0.00949367088607595	0	206	0	110	68404	0.001608093093971113	not_provided|Neuronal_ceroid_lipofuscinosis_11|GRN-related_frontotemporal_lobar_degeneration_with_Tdp43_inclusions|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.44350524C>T	ClinGen:CA225254|UniProtKB:P28799#VAR_064630	C3661900|C3539123|C1843792|C0950123	614706|607485	314629|79262|100070|282	.	Thr	Met	82.57	0.9154929577464789																																																																																																																																																																																																																																																																																																																																																																																																																																																																													130			82.57	Polar/Neutral	Threonine		Progranulin										-0.7																		119						Morphology: HTRCItPtGtHPLAK			-92.0	Morphology: HTRCItPtGtHPLAK			-16.2				dbSNP: rs63750479; Variant type: LB/B; AA change: Thr182Met; PTM type: Phosphorylation; PTM morphology: RCItPtGtHPL; Var class: I&rs63750479		C (loop/coil)	T (turn)												82.57	91.54929	70-90	$\geqslant$90	607485;607485;614706	multiple	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	FRONTOTEMPORAL DEMENTIA 2; FRONTOTEMPORAL DEMENTIA 2; CEROID LIPOFUSCINOSIS, NEURONAL, 11	false	0.6893827711758019	0.6758260553056123	false	false	false
FTH1	FTH1_Lys54Arg	B_7-8	-0.8580348974407832	0.4192794455694183	0.5110553548421116	-0.23915737767913145	0.8178347985509042	0.8511511817174072	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6190824416743137	0.6724438518246911	0.7532798857133298	0.778790074457612	0.7654188328737286	0.7760027260380384	0.979339077946571	0.8871386513222407	0.9666879927362036	0.9358987304892177	0.8315124569936972	0.8131545396620227	0.5726663741295059	0.6436990144252164	0.5908921561790201	0.5706610409374419	0.5133752466556849	0.42501034368660473	FTH1	Lys54Arg	NC_000011.10:61965469:T:C	161A>G	11	61965469	T	C	11	ENSG00000167996	11032	18535	CCSBVarC001665	ALE00001665	ENSP00000273550.7	RC4	RC4_Mut_GDEh1001	E07	GDEhDisVCh_40007	F04	1	RC4_Mut_GDDh1001	E07	NULL	NULL	VUSMutpDEST2_08	G10	VUSmut_GDEh12	E05	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	321070.0	single nucleotide variant	NM_002032.3(FTH1):c.161A>G (p.Lys54Arg)	-1.0	BEST1;FTH1	-	Benign/Likely benign	0.0	Jan 26, 2024	186448909.0	-	RCV000282008|RCV000348713|RCV000385949|RCV001823895|RCV000392462|RCV002056211|RCV003957577	MedGen:CN239466|MONDO:MONDO:0008662,MedGen:C3888099,OMIM:193220,Orphanet:263347,Orphanet:3086|MedGen:C0282193|MONDO:MONDO:0014225,MedGen:C1851316,OMIM:615517,Orphanet:247790|MONDO:MONDO:0007931,MedGen:C2745945,OMIM:153700,Orphanet:1243|MedGen:C3661900|	Retinitis Pigmentosa, Recessive|Autosomal dominant vitreoretinochoroidopathy|Iron Overload|Hemochromatosis type 5|Vitelliform macular dystrophy 2|not provided|FTH1-related disorder	germline	germline	GRCh38	NC_000011.10	11	61965469.0	61965469.0	11q12.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA6041299	2.0	305145.0	61965469.0	T	C	-	-	-	-	-	-	161A>G 	Lys54Arg	NM_002032.3	2.0	Benign	Likely benign	305145	11	61965469.0	T	C	K	R	rs186448909	11	61732941	11	61489517	54	FTH1	ENSG00000167996	ENST00000620041	ENSP00000484477	P02794	FRIH_HUMAN	c.161A>G	p.Lys54Arg	c.161A>G	p.Lys54Arg	principal1	Y	1	.	.	-	AAA	2	0	T	./.	./.	./.	./.	.	0.23568	.	0.314	0.19733	T	0.0	0.02950	B	0.003	0.08696	B	.	0.28107	.	.	.	.	-0.66	0.02075	N	.	0.37554	.	0.615	0.62930	-0.6650	0.61891	T	0.2321	0.59663	T	10	0.01565203	0.00325	T	0.044458	0.61350	D	.	0.69618	.	.	.	.	.	0.929248938194	0.92798	.	0.34348	.	0.82753	0.741810798645	0.73193	T	0.298195	0.66892	T	-0.213169	0.18630	T	-0.0791227	0.64719	T	0.0323155051518829	0.02342	T	0.689931	0.35511	T	0.3138937	0.53788	0.20096953	0.43898	0.42051214	0.61804	0.17429839	0.39683	-7.636	0.58634	D	0.0907	0.19827	B	0.133428559895589	0.45991	0.22396913	0.74132	0.137	0.36038	.	.	.	.	.	.	3.655232	0.51985	23.2	0.99535759079450703	0.70187	0.969301	0.99168	D	0.0493119891701225	0.43850	2.691138	0.181547784924594	0.48574	3.094325	4.56	4.56	0.55591	.	.	7.949	0.8729	3.424000	0.38352	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.998	0.85369	759	0.50583	4	7.987220447284345E-4	0	0.0	3	0.002982107355864811	1	0.001440922190201729	0	0.0	0	0.0	504	264690	0.0019041143	segdup	154	103436	1.488840e-03	0	327	200952	1.627250e-03	0	387	229854	1.683680e-03	1	4	7112	5.624300e-04	0	10	17026	5.873370e-04	0	3	2320	1.293100e-03	0	0	8604	0.000000e+00	0	19	8340	2.278180e-03	0	111	42526	2.610170e-03	0	2	15654	1.277630e-04	0	111	42526	2.610170e-03	0	7	15408	4.543090e-04	0	12	30434	3.942960e-04	0	6	6202	9.674300e-04	0	0	12944	0.000000e+00	0	24	11680	2.054790e-03	0	265	88964	2.978730e-03	0	5	30572	1.635480e-04	0	265	88964	2.978730e-03	0	6	14110	4.252300e-04	0	17	34168	4.975420e-04	0	12	9564	1.254710e-03	0	0	17250	0.000000e+00	0	31	16578	1.869950e-03	0	305	102192	2.984580e-03	1	5	30490	1.639880e-04	0	305	102192	2.984580e-03	1	.	4364	1608172	2.713640e-03	8	3906	1179990	3.310200e-03	7	55	75036	7.329820e-04	0	0	912	0.000000e+00	0	28	60024	4.664800e-04	0	44	29604	1.486290e-03	0	0	44884	0.000000e+00	0	131	58096	2.254890e-03	0	0	6062	0.000000e+00	0	3906	1179990	3.310200e-03	7	18	91078	1.976330e-04	0	67	26568	0.0025218307738632943	0	122	0	0	146	0	4	3852	0.0010384215991692627	0	146	0	1	610	0.001639344262295082	0	56	0	0	104	0	9	3326	0.0027059530968129887	4	3974	0.0010065425264217413	0	202	0	81	34930	0.0023189235614085313	Vitelliform_macular_dystrophy_2|Autosomal_dominant_vitreoretinochoroidopathy|not_provided|Iron_Overload|FTH1-related_disorder|Hemochromatosis_type_5|Retinitis_Pigmentosa,_Recessive	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.61965469T>C	ClinGen:CA6041299	C2745945|C3888099|C3661900|C0282193|C1851316|CN239466	153700|193220|615517	1243|263347|3086|247790	Ferritin/DPS protein domain|Ferritin-like diiron domain	Lys	Arg	98.23	0.33658536585365856																																																																																																																																																																																																																																																																																																																																																																																																																																																																													69			98.23	Positively-charged	Lysine		Ferritin heavy chain; Ferritin heavy chain, N-terminally processed							Ferritin-like diiron			-3.9								 K54-H58 (PAE:  1.0), K54-D180 (PAE: 9.5), K54-S179 (PAE: 7.5), K54-K50 (PAE: 1.0)	K54-K50 (PDBs: 3AJO, 4OYN, 4Y08, 4YKH, 4ZJK, 5N26, 5N27, 5UP7, 5UP8, 5VTD, 6B8F, 6B8G, 6FTV, 7CK9, 7JGK, 7JGO, 7JGP, 7JGQ, 8KFD, 5JKK, 5JKL, 5JKM, 5UP9, 5XB1, 6H6T, 6H6U, 6J4A, 6JOB, 6M52, 6M54, 6Z6U, 6Z9E, 6Z9F, 7A6A, 7A6B, 7K26, 7K3V, 7K3W, 7KE5, 7PF1, 7R5O, 7RRP, 7V66, 7VD8, 7ZG7, 8CPM, 8CPS, 8CPT, 8CPU, 8CPV, 8CPW, 8CPX, 8DNP, 8F49, 8F4L, 8HHS, 8QU9), K54-H58 (PDBs: 8KFD, 5YI5, 8QU9), K54-L176 (PDBs: 8KFD, 8QU9)	 K54-H58 (PAE:  1.0), K54-K50 (PAE: 1.0)	K54-K50 (PDBs: 3AJO, 4OYN, 4Y08, 4YKH, 4ZJK, 5N26, 5N27, 5UP7, 5UP8, 5VTD, 6B8F, 6B8G, 6FTV, 7CK9, 7JGK, 7JGO, 7JGP, 7JGQ, 8KFD, 5JKK, 5JKL, 5JKM, 5UP9, 5XB1, 5YI5, 6H6T, 6H6U, 6J4A, 6JOB, 6M52, 6M54, 6Z6U, 6Z9E, 6Z9F, 7A6A, 7A6B, 7K26, 7K3V, 7K3W, 7KE5, 7PF1, 7R5O, 7RRP, 7V66, 7VD8, 7ZG7, 8CPM, 8CPS, 8CPT, 8CPU, 8CPV, 8CPW, 8CPX, 8DNP, 8F49, 8F4L, 8HHS, 8QU9), K54-H58 (PDBs: 8KFD, 8QU9)							147									-61.2				-45.7						H (helix)	H (α-helix)	Helix									Morphology: VALKNFAkYFLHQSH; Domain: Ferritin		98.23	33.65854	>90	10-90	193220;615517;153700	autosomal dominant	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	VITREORETINOCHOROIDOPATHY; HEMOCHROMATOSIS, TYPE 5; MACULAR DYSTROPHY, VITELLIFORM, 2	false	0.6724438518246911	0.6190824416743137	false	false	false
AGXT	AGXT_Pro11Leu	B_7-8	-1.3049612264903971	0.23316424472782096	0.3149531169944399	-1.1951657312246513	0.270938087543915	0.32161862944345976	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6201545865082614	0.6263490963151674	0.45487496082713974	0.6485320847775151	0.5904482688200567	0.5271604817512068	0.5205288737533711	0.7273541975102034	0.6967690031564261	0.39730655258563935	0.6523293770653998	0.6946913137834194	0.5337920897490425	0.4535423401299101	0.6002951663986041	0.5124433690686401	0.600368815564935	0.5456178592331034	AGXT	Pro11Leu	NC_000002.12:240868897:C:T	32C>T	2	240868897	C	T	2	ENSG00000172482	70497	34545	CCSBVarC002676	ALE00002676	ENSP00000302620.3	RC4	RC4_Mut_GDEh1019	H10	GDEhDisVCh_40092	G01	1	RC4_Mut_GDDh1019	H10	VUSN2Hmut_GDN2h_10	C08	VUSMutpDEST2_14	E12	VUSmut_GDEh13	D03	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	20680.0	single nucleotide variant	NM_000030.3(AGXT):c.32C>T (p.Pro11Leu)	189.0	AGXT	HGNC:341	Benign/Likely benign	0.0	Feb 01, 2024	34116584.0	-	RCV000005995|RCV001513552|RCV000173049	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900|MedGen:CN169374	Primary hyperoxaluria, type I|not provided|not specified	germline;unknown	germline	GRCh38	NC_000002.12	2	240868897.0	240868897.0	2q37.3	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA200272,UniProtKB:P21549#VAR_000587,OMIM:604285.0002,ClinVar:2681193	3.0	5641.0	240868897.0	C	T	-	-	-	-	-	-	32C>T 	Pro11Leu	NM_000030.3	2.0	Benign	Likely benign	5641	2	240868897.0	C	T	P	L	rs34116584	2	241808314	2	241456987	11	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.32C>T	p.Pro11Leu	c.32C>T	p.Pro11Leu	principal1	Y	1	YES	Select	+	CCC	2	0	C	./.	./.	./.	./.	0.015	0.52650	D	0.013	0.63436	D	1.0	0.90580	D	1.0	0.97365	D	0.07	0.21442	P	simple_aae	93.0	7.0	.	.	.	-8.95	0.98003	D	0.203	0.22336	-1.1378	0.01450	T	0.0028	0.00888	T	9	0.0018689036	0.00025	T	.	.	.	0.441	0.74311	.	.	.	.	.	.	.	0.8863890345328795	0.88535	0.253394482153	0.27613	0.457268327475	0.32894	T	0.723703	0.92138	D	-0.310462	0.07504	T	-0.0749134	0.65026	T	0.0635710611455967	0.07631	T	0.684832	0.29080	T	0.6997803	0.77791	0.33792287	0.59344	0.6146047	0.73195	0.34791622	0.60202	-10.938	0.79384	D	0.49	0.64069	A	0.437155622823171	0.58853	0.00477525	0.32678	0.895	0.94425	.	.	.	.	.	.	4.023849	0.59532	24.1	0.99824521148976952	0.90684	0.875332	0.79794	D	0.415411374975923	0.62073	4.44004	0.250270896054513	0.52418	3.439835	4.42	4.42	0.52717	2.42	0.44885	6.621	0.74159	7.334000	0.58284	0.549	0.27038	0.998	0.41403	1.000000	0.68239	0.045	0.14786	982	0.03399	405	0.080870607028754	48	0.036308623298033284	206	0.2047713717693837	91	0.13112391930835735	0	0.0	60	0.06134969325153374	35530	264690	0.13423249	.	15538	108736	1.428970e-01	1517	28814	203856	1.413450e-01	2688	34043	233534	1.457730e-01	3200	381	7090	5.373770e-02	12	1378	17026	8.093500e-02	54	460	2310	1.991340e-01	42	2	9024	2.216310e-04	0	3319	13350	2.486140e-01	412	8536	42382	2.014060e-01	911	1127	15652	7.200360e-02	57	8536	42382	2.014060e-01	911	961	15924	6.034920e-02	34	2313	30378	7.614060e-02	93	1165	6112	1.906090e-01	112	3	13362	2.245170e-04	0	4137	16660	2.483190e-01	514	17249	86092	2.003550e-01	1765	2202	30528	7.213050e-02	103	17249	86092	2.003550e-01	1765	877	14694	5.968420e-02	32	2750	34118	8.060260e-02	113	1752	9546	1.835320e-01	158	5	17664	2.830620e-04	0	5249	21414	2.451200e-01	650	20266	100052	2.025550e-01	2059	2196	30454	7.210880e-02	103	20266	100052	2.025550e-01	2059	.	291944	1612864	1.810100e-01	29291	234	912	2.565790e-01	28	4534	75052	6.041140e-02	151	234	912	2.565790e-01	28	5522	59988	9.205170e-02	283	5321	29600	1.797640e-01	495	24	44862	5.349740e-04	0	15045	63082	2.384990e-01	1795	998	6058	1.647410e-01	87	242864	1179784	2.058550e-01	25132	6914	91044	7.594130e-02	347	5752	35032	0.16419273806805207	4	182	0.02197802197802198	0	434	0	250	5486	0.045570543200874954	62	538	0.11524163568773234	372	4816	0.07724252491694353	1	98	0.01020408163265306	6	150	0.04	893	5706	0.1565019277953032	254	5668	0.04481298517995766	1	532	0.0018796992481203006	7340	52442	0.13996415087143893	not_specified|not_provided|Primary_hyperoxaluria,_type_I	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240868897C>T	ClinGen:CA200272|OMIM:604285.0002|UniProtKB:P21549#VAR_000587	CN169374|C3661900|C0268164	259900	416|93598	.	Pro	Leu	98.04	0.5514705882352942																																																																																																																																																																																																																																																																																																																																																																																																																																																																													75			98.04	Special, No backbone hydrogen	Proline		Alanine--glyoxylate aminotransferase										1.6										 P11-L15 (PAE:  1.0)	P11-L15 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 3R9A)							115									-66.1				121.7				dbSNP: rs34116584; Variant type: LB/B; AA change: Pro11Leu; PTM type: Phosphorylation; PTM morphology: HKLLVtPP*KAL; Var class: II&rs34116584		H (helix)	P (polyproline helix)												98.04	55.147057	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.6263490963151674	0.6201545865082614	false	false	false
NCF2	NCF2_Asn419Ile	B_7-8	2.8455250965381618	0.03601221121809651	0.07157473821702844	1.7106865127928692	0.13798835041496513	0.17608388248363074	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5616618617321298	0.56215561501671	0.6160163617985965	0.5492326073326447	0.4556879357307678	0.5808519522862009	0.5732771038499143	0.5536589922971382	0.5299686518773549	0.5917251994100994	0.5633504375771015	0.5312008831096738	0.5884268007224875	0.3577168791643975	0.5684965627879345	0.6403075241870938	0.5609607924563186	0.5921228403545857	NCF2	Asn419Ile	NC_000001.11:183563229:T:A	1256A>T	1	183563229	T	A	1	ENSG00000116701	3727	6812	CCSBVarC000533	ALE00000533	ENSP00000356505.4	RC4	RC4_Mut_GDEh1025	C10	GDEhDisVCh_40073	C11	1	RC4_Mut_GDDh1025	C10	NULL	NULL	VUSMutpDEST2_03	D11	VUSmut_GDEh13	F05	1.0	2.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	265448.0	single nucleotide variant	NM_000433.4(NCF2):c.1256A>T (p.Asn419Ile)	4688.0	NCF2	HGNC:7661	Benign/Likely benign	0.0	Nov 01, 2024	35012521.0	-	RCV000309636|RCV000539456|RCV001705405|RCV001258235	MedGen:CN169374|MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379|MedGen:C3661900|MONDO:MONDO:0014533,MedGen:C4015519,OMIM:616211,Orphanet:442835	not specified|Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided|Developmental and epileptic encephalopathy, 28	germline;unknown	germline	GRCh38	NC_000001.11	1	183563229.0	183563229.0	1q25.3	criteria provided, multiple submitters, no conflicts	10.0	-	N	ClinGen:CA1284632,UniProtKB:P19878#VAR_052621	2.0	281211.0	183563229.0	T	A	-	-	-	-	-	-	1256A>T 	Asn419Ile	NM_000433.4	2.0	Benign	Likely benign	281211	1	183563229.0	T	A	N	I	rs35012521	1	183532364	1	181798987	419	NCF2	ENSG00000116701	ENST00000367535	ENSP00000356505	P19878	NCF2_HUMAN	c.1256A>T	p.Asn419Ile	c.1256A>T	p.Asn419Ile	principal1	Y	1	YES	Select	-	AAC	2	0	T	T/T	T/T	T/T	T/T	0.004	0.68399	D	0.004	0.76775	D	0.987	0.61929	D	0.942	0.67769	D	0.04	0.41597	N	simple_aae	96.0	4.0	2.725	0.79540	M	-4.31	0.78669	D	0.407	0.50177	-0.7436	0.58092	T	0.1980	0.55149	T	10	0.0100801885	0.00222	T	.	.	.	0.280	0.59538	.	.	.	.	.	0.696356426285	0.69134	0.4952431128784428	0.49250	0.798378576579	0.65908	0.477975904942	0.35730	T	0.244942	0.61203	T	-0.410573	0.01855	T	-0.351505	0.38678	T	0.0335921999053578	0.02552	T	.	0.65638	.	0.8869816	0.90113	0.73654705	0.84242	0.92818314	0.93966	0.76936954	0.86213	-9.315	0.69780	D	0.3641	0.65265	A	0.22141713076937	0.50954	0.12053429	0.68354	0.626	0.79135	.	.	.	.	.	.	4.07981	0.60749	24.2	0.99299000505735635	0.58603	0.325078	0.42485	N	0.489766814090699	0.66312	4.956959	0.450411146364601	0.64552	4.736657	5.58	4.46	0.53511	2.93	0.53584	2.628	0.46243	3.388000	0.38129	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.995	0.73271	730	0.54265	21	0.004193290734824281	0	0.0	6	0.005964214711729622	7	0.010086455331412104	0	0.0	8	0.0081799591002045	1456	264690	0.0055007744	.	559	109400	5.109690e-03	2	1213	208114	5.828540e-03	6	1298	236814	5.481090e-03	6	4	7164	5.583470e-04	0	76	17112	4.441330e-03	0	10	2320	4.310340e-03	0	0	9044	0.000000e+00	0	19	13388	1.419180e-03	0	265	42768	6.196220e-03	1	171	15690	1.089870e-02	1	171	15690	1.089870e-02	1	18	16218	1.109880e-03	0	138	30524	4.521030e-03	0	36	6212	5.795240e-03	0	0	13414	0.000000e+00	0	21	16728	1.255380e-03	0	648	89546	7.236500e-03	2	320	30608	1.045480e-02	3	320	30608	1.045480e-02	3	17	14902	1.140790e-03	0	153	34256	4.466370e-03	0	55	9572	5.745930e-03	0	0	17690	0.000000e+00	0	30	21626	1.387220e-03	0	687	102632	6.693820e-03	2	319	30526	1.045010e-02	3	319	30526	1.045010e-02	3	.	12817	1614052	7.940880e-03	78	964	91086	1.058340e-02	14	105	74976	1.400450e-03	0	0	912	0.000000e+00	0	270	60022	4.498350e-03	1	170	29606	5.742080e-03	0	1	44876	2.228360e-05	0	97	64020	1.515150e-03	0	58	6062	9.567800e-03	0	10561	1179988	8.950090e-03	59	964	91086	1.058340e-02	14	713	96780	0.0073672246331886754	0	174	0	0	2674	0	5	4182	0.0011956001912960307	4	784	0.00510204081632653	1	934	0.0010706638115631692	0	656	0	3	270	0.011111111111111112	49	8036	0.006097560975609756	5	4356	0.001147842056932966	0	3330	0	775	114490	0.006769150144117391	Granulomatous_disease,_chronic,_autosomal_recessive,_cytochrome_b-positive,_type_2|Developmental_and_epileptic_encephalopathy,_28|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.183563229T>A	ClinGen:CA1284632|UniProtKB:P19878#VAR_052621	C1856245|C4015519|CN169374|C3661900	233710|616211	379|442835	PB1 domain|PB1-like domain|PB1 domain|Neutrophil cytosol factor 2, PB1 domain	Asn	Ile	80.42	0.89171974522293																																																																																																																																																																																																																																																																																																																																			-0.52																																																																																																																																										140			80.42	Polar/Neutral	Asparagine		Neutrophil cytosol factor 2							PB1			-3.5																		132									50.9				45.2						C (loop/coil)	T (turn)												80.42	89.171974	70-90	10-90	233710;616211	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic skin disease	3	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2; DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28	false	0.56215561501671	0.5616618617321298	false	false	false
FBP1	FBP1_Asn273Ser	B_7-8	-2.9888560947660427	0.020259131152445507	0.04568469952912741	-3.3022148220278345	0.013080806822834261	0.021624577044955736	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7349106954556046	0.794893739895705	0.7714168734901603	0.7753196179554045	0.7725983163716108	0.7843923492921445	0.8947581946148472	0.9012578280655968	0.8900819030206247	0.9167001872000043	0.8344385397711755	0.8236429973383144	0.674026503969442	0.6439388046776247	0.6605573328901841	0.6261335597803162	0.7553489400202346	0.6461783935728949	FBP1	Asn273Ser	NC_000009.12:94605464:T:C	818A>G	9	94605464	T	C	9	ENSG00000165140	2654	371	CCSBVarC008437	ALE00008476	ENSP00000364475.5	Edgotyping3	VUSmut_GDEh11	F01	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_02	D01	VUSmut_GDEh11	F01	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	1540897.0	single nucleotide variant	NM_000507.4(FBP1):c.818A>G (p.Asn273Ser)	2203.0	FBP1	HGNC:3606	Likely benign	0.0	Jan 30, 2024	143965326.0	-	RCV002190510	MONDO:MONDO:0009251,MedGen:C0016756,OMIM:229700,Orphanet:348	Fructose-biphosphatase deficiency	germline	germline	GRCh38	NC_000009.12	9	94605464.0	94605464.0	9q22.32	criteria provided, single submitter	1.0	-	N	-	2.0	1557878.0	94605464.0	T	C	-	-	-	-	-	-	818A>G 	Asn273Ser	NM_000507.4	1.0	Benign	Likely benign	1557878	9	94605464.0	T	C	N	S	rs143965326	9	97367746	9	96407567	273	FBP1	ENSG00000165140	ENST00000375326	ENSP00000364475	P09467	F16P1_HUMAN	c.818A>G	p.Asn273Ser	c.818A>G	p.Asn273Ser	principal1	Y	1	YES	Select	-	AAT	2	0	T	T/T	T/T	T/T	T/T	0.327	0.13339	T	0.304	0.20359	T	0.0	0.02950	B	0.0	0.01384	B	0.01	0.05039	N	simple_aae	99.0	1.0	0.22	0.09492	N	-1.74	0.41238	N	0.086	0.06571	-0.9960	0.30922	T	0.1779	0.52145	T	10	0.08490437	0.14164	T	0.009766	0.25222	T	0.159	0.41066	.	.	.	.	.	0.520427616228	0.51337	.	0.16756	.	0.25445	0.229560136795	0.01938	T	0.211278	0.56988	T	-0.517675	0.00436	T	-0.60793	0.11895	T	0.01224268398421	0.00196	T	.	0.36336	.	0.23066583	0.45499	0.08938829	0.20870	0.23066583	0.45499	0.08938829	0.20869	-5.804	0.44665	T	0.0574	0.01214	LB	0.00156398744215306	0.11720	0.00517756	0.33612	0.231	0.49947	.	.	.	.	.	.	0.22033	0.06052	2.469	0.33116589908358041	0.01958	0.462968	0.51039	N	-1.22915206370098	0.04530	0.2070945	-1.22834401542918	0.05373	0.260169	5.68	-2.4	0.06194	0.336	0.23916	1.158	0.31449	-3.309000	0.02904	-0.118	0.14421	0.809	0.2993	0.000000	0.08389	0.512	0.29337	833	0.38756	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	46	264690	1.7378821E-4	.	15	109316	1.372170e-04	0	30	207900	1.443000e-04	0	40	236724	1.689730e-04	0	2	7136	2.802690e-04	0	1	17100	5.847950e-05	0	0	2316	0.000000e+00	0	0	9044	0.000000e+00	0	3	13384	2.241480e-04	0	7	42742	1.637730e-04	0	2	15680	1.275510e-04	0	2	7136	2.802690e-04	0	4	16176	2.472800e-04	0	3	30490	9.839290e-05	0	0	6206	0.000000e+00	0	1	13416	7.453790e-05	0	4	16724	2.391770e-04	0	16	89452	1.788670e-04	0	2	30578	6.540650e-05	0	4	16176	2.472800e-04	0	4	14860	2.691790e-04	0	3	34226	8.765270e-05	0	0	9566	0.000000e+00	0	1	17690	5.652910e-05	0	10	21620	4.625350e-04	0	20	102650	1.948370e-04	0	2	30498	6.557810e-05	0	4	14860	2.691790e-04	0	.	206	1613802	1.276490e-04	1	33	64032	5.153670e-04	0	14	75004	1.866570e-04	0	0	912	0.000000e+00	0	6	60004	9.999330e-05	0	0	29600	0.000000e+00	0	3	44888	6.683300e-05	0	33	64032	5.153670e-04	0	1	5860	1.706480e-04	0	134	1179986	1.135610e-04	1	8	91048	8.786570e-05	0	41	178280	2.2997531972178596E-4	0	360	0	1	4500	2.2222222222222223E-4	3	9384	3.1969309462915604E-4	0	796	0	0	968	0	0	1848	0	0	280	0	5	16998	2.9415225320625956E-4	3	9744	3.078817733990148E-4	1	6348	1.575299306868305E-4	50	213414	2.342864104510482E-4	Fructose-biphosphatase_deficiency	criteria_provided,_single_submitter	NC_000009.12:g.94605464T>C	.	C0016756	229700	348	.	Asn	Ser	94.35	0.6878980891719745																																																																																																																																																																																																																																																																																																																																																																																																																																																																													108			94.35	Polar/Neutral	Asparagine		Fructose-1,6-bisphosphatase 1										-3.5										 N273-A315 (PAE:  1.5)	N273-A315 (PDBs: 2JJK, 2VT5, 2WBB, 2WBD, 2Y5K, 2Y5L, 3A29, 3KC1, 4MJO, 5LDZ, 7C9Q, 7CVH, 7CVN, 7CWE, 7EZF, 7EZP, 7EZR), N273-A267 (PDBs: 3KBZ, 3KC0, 6LW2)							132									-102.0				21.2						C (loop/coil)	T (turn)												94.35	68.78981	>90	10-90	229700	autosomal recessive	OMIM	Rare inborn errors of metabolism	1	FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	false	0.794893739895705	0.7349106954556046	false	false	false
NCF2	NCF2_Val297Ala	B_7-8	2.6597867473078605	0.04489540816810074	0.0854937483560044	7.226251539519734	0.00035617184765088564	0.0010609989292846998	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6480773335142331	0.6586019487057891	0.5795951671481337	0.5268823709679377	0.5056788350636556	0.5795670517115326	0.615699295649988	0.5322538849276328	0.5268558182404655	0.622509605021115	0.68594850718763	0.7024868709011932	0.543434807773077	0.47910378519967844	0.5269089236954099	0.5366807292751525	0.6312553902239483	0.5936677961272729	NCF2	Val297Ala	NC_000001.11:183566954:A:G	890T>C	1	183566954	A	G	1	ENSG00000116701	3727	172	CCSBVarC008446	ALE00008456	ENSP00000356505.4	Edgotyping3	VUSmut_GDEh11	D03	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_03	F10	VUSmut_GDEh11	D03	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	265556.0	single nucleotide variant	NM_000433.4(NCF2):c.890T>C (p.Val297Ala)	4688.0	NCF2	HGNC:7661	Benign/Likely benign	0.0	Jan 31, 2024	35937854.0	-	RCV000317093|RCV000545841|RCV004713472	MedGen:CN169374|MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379|MedGen:C3661900	not specified|Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided	germline	germline	GRCh38	NC_000001.11	1	183566954.0	183566954.0	1q25.3	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA1284767,UniProtKB:P19878#VAR_034130	2.0	281319.0	183566954.0	A	G	-	-	-	-	-	-	890T>C 	Val297Ala	NM_000433.4	2.0	Benign	Likely benign	281319	1	183566954.0	A	G	V	A	rs35937854	1	183536089	1	181802712	297	NCF2	ENSG00000116701	ENST00000367535	ENSP00000356505	P19878	NCF2_HUMAN	c.890T>C	p.Val297Ala	c.890T>C	p.Val297Ala	principal1	Y	1	YES	Select	-	GTT	2	0	A	A/A	A/A	A/A	A/A	0.212	0.19959	T	0.051	0.48180	T	0.002	0.09864	B	0.006	0.12129	B	0.01	0.38685	N	simple_aae	99.0	1.0	-0.1	0.04699	N	-1.43	0.38726	N	0.227	0.28880	-1.0571	0.12498	T	0.0122	0.04657	T	10	0.0030933917	0.00050	T	.	.	.	0.046	0.12499	.	.	.	.	.	0.426551566703	0.41885	0.35990084910270553	0.35702	0.378129914211	0.38950	0.491155982018	0.37548	T	0.068949	0.33336	T	-0.552434	0.00274	T	-0.534894	0.18489	T	0.0266387667801755	0.01487	T	.	0.26056	.	0.089661926	0.20766	0.08142933	0.18483	0.07613578	0.17041	0.07434793	0.16245	-3.563	0.17338	T	0.2433	0.49357	B	0.0137963411241221	0.26448	0.00888684	0.39940	0.081	0.22877	.	.	.	.	.	.	3.19394	0.43494	21.7	0.9686749942745585	0.31600	0.552545	0.56263	D	-0.413506280195002	0.24722	1.353637	-0.292729792662682	0.28019	1.579271	4.98	3.83	0.43219	2.04	0.40105	4.323	0.59097	8.012000	0.76229	0.756	0.943	0.892	0.31333	1.000000	0.68239	0.982	0.59239	734	0.53826	68	0.013578274760383386	64	0.048411497730711045	1	9.940357852882703E-4	3	0.004322766570605188	0	0.0	0	0.0	3623	264690	0.01368771	.	345	109408	3.153330e-03	6	763	208124	3.666080e-03	13	715	236942	3.017620e-03	11	298	7164	4.159690e-02	6	37	17112	2.162230e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	6	42768	1.402920e-04	0	0	15690	0.000000e+00	0	298	7164	4.159690e-02	6	674	16216	4.156390e-02	13	65	30524	2.129470e-03	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	15	89552	1.675000e-04	0	0	30608	0.000000e+00	0	674	16216	4.156390e-02	13	618	14900	4.147650e-02	11	78	34260	2.276710e-03	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	12	102744	1.167950e-04	0	0	30526	0.000000e+00	0	618	14900	4.147650e-02	11	.	3619	1614150	2.242050e-03	52	3158	75028	4.209100e-02	48	3158	75028	4.209100e-02	48	0	912	0.000000e+00	0	194	60028	3.231830e-03	2	0	29602	0.000000e+00	0	0	44880	0.000000e+00	0	0	64040	0.000000e+00	0	13	6040	2.152320e-03	0	61	1180040	5.169320e-05	0	5	91080	5.489680e-05	0	18	180022	9.998777927142238E-5	20	360	0.05555555555555555	0	4518	0	359	9736	0.036873459326212	13	812	0.01600985221674877	1	1002	9.98003992015968E-4	0	1852	0	0	296	0	29	19744	0.0014688006482982171	379	10096	0.03753961965134707	0	6370	0	440	218342	0.0020151871834095136	not_specified|Granulomatous_disease,_chronic,_autosomal_recessive,_cytochrome_b-positive,_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000001.11:g.183566954A>G	ClinGen:CA1284767|UniProtKB:P19878#VAR_034130	CN169374|C1856245	233710	379	SH3 domain|SH3 domain|Neutrophil cytosol factor 2, SH3 domain 1	Val	Ala	83.58	0.3028169014084507																																																																																																																																																																																																																																																																																																																																							-0.474																																																																																																																																						43			83.58	Aliphatic	Valine		Neutrophil cytosol factor 2							SH3 1			4.2								 V297-A244 (PAE:  3.0)		 V297-A244 (PAE:  3.0)								117									-119.6				119.2						C (loop/coil)	C (loop/coil)												83.58	30.28169	70-90	10-90	233710	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic skin disease	3	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2	false	0.6586019487057891	0.6480773335142331	false	false	false
GFAP	GFAP_Pro47Leu	B_15-16	1.3385918962767767	0.22254307390633263	0.3037330971845687	9.096074183799578	0.00003980834124984637	0.00020275063963846334	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6246638752194162	0.6880924690413417	0.6698712602218795	0.6739156243244748	0.6906852535003203	0.708082990746776	0.63159315140163	0.6732063351885595	0.6276378043494741	0.6024539068374495	0.6864146919738405	0.6315990810373726	0.784572830091922	0.708164171812081	0.7201934442994755	0.7372886136063095	0.689770246108843	0.6177286694014598	GFAP	Pro47Leu	NC_000017.11:44915347:G:A	140C>T	17	44915347	G	A	17	ENSG00000131095	2920	5153	CCSBVarC000365	ALE00000365	ENSP00000466598.2	RC4	RC4_Mut_GDEh1021	B06	GDEhDisVCh_40051	G11	1	RC4_Mut_GDDh1021	B06	NULL	NULL	VUSMutpDEST2_02	C11	VUSmut_GDEh13	C04	1.0	1.0	1.0	6.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	77354.0	single nucleotide variant	NM_002055.5(GFAP):c.140C>T (p.Pro47Leu)	2670.0	GFAP	HGNC:4235	Benign/Likely benign	0.0	Nov 01, 2024	57474185.0	-	RCV000056852|RCV000263951|RCV000210687	MedGen:C3661900|MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MeSH:D030342,MedGen:C0950123	not provided|Alexander disease|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000017.11	17	44915347.0	44915347.0	17q21.31	criteria provided, multiple submitters, no conflicts	10.0	-	N	ClinGen:CA217146,UniProtKB:P14136#VAR_017464	2.0	66457.0	44915347.0	G	A	-	-	-	-	-	-	140C>T 	Pro47Leu	NM_002055.5	2.0	Benign	Likely benign	66457	17	44915347.0	G	A	P	L	rs57474185	17	42992715	17	40348241	47	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.140C>T	p.Pro47Leu	c.140C>T	p.Pro47Leu	principal1	Y	1	YES	Select	-	CCG	2	0	G	G/G	G/G	G/G	G/G	.	0.13959	.	.	0.32679	.	0.021	0.18486	B	0.018	0.18486	B	0.0	0.05039	N	without_aae	100.0	0.0	1.955	0.52690	M	.	0.17975	.	.	0.44704	-0.5152	0.67953	T	0.3469	0.71041	T	10	0.006749183	0.00150	T	.	.	.	.	0.77602	.	.	.	.	.	.	0.94601	.	0.69784	.	0.55114	0.743649363518	0.73463	T	0.291845	0.66271	T	-0.193332	0.21447	T	-0.0400961	0.67462	D	0.0192209993218184	0.00626	T	0.919108	0.72255	D	0.19096863	0.40390	0.18714233	0.41785	0.20763938	0.42655	0.19905178	0.43612	-7.372	0.56778	T	0.1464	0.40023	B	0.300013686497717	0.54221	0.98844670	0.96505	0.032	0.06833	.	.	.	.	.	.	3.779434	0.54413	23.5	0.80217027156006171	0.13310	0.289900	0.39945	N	-0.293323937752641	0.29125	1.630375	-0.182100719754283	0.31881	1.829219	4.82	4.82	0.61594	3.93	0.74723	2.091	0.4142	8.651000	0.77967	0.676	0.76753	0.321	0.25598	1.000000	0.68239	0.964	0.52647	748	0.52085	10	0.001996805111821086	2	0.0015128593040847202	7	0.006958250497017893	1	0.001440922190201729	0	0.0	0	0.0	1245	264690	0.0047036153	.	456	109138	4.178200e-03	1	975	206712	4.716710e-03	1	1103	235488	4.683890e-03	5	7	7130	9.817670e-04	0	48	17090	2.808660e-03	0	16	2310	6.926410e-03	1	0	9042	0.000000e+00	0	49	13358	3.668210e-03	0	313	42630	7.342250e-03	0	19	15666	1.212820e-03	0	313	42630	7.342250e-03	0	20	15892	1.258490e-03	0	85	30482	2.788530e-03	0	46	6170	7.455430e-03	1	1	13392	7.467140e-05	0	62	16696	3.713460e-03	0	700	88672	7.894260e-03	0	44	30566	1.439510e-03	0	700	88672	7.894260e-03	0	18	14596	1.233210e-03	0	105	34222	3.068200e-03	0	76	9522	7.981520e-03	3	1	17684	5.654830e-05	0	72	21538	3.342930e-03	0	765	101842	7.511640e-03	2	44	30484	1.443380e-03	0	765	101842	7.511640e-03	2	.	10990	1612262	6.816510e-03	47	9764	1178656	8.284010e-03	43	78	75030	1.039580e-03	0	0	912	0.000000e+00	0	172	59998	2.866760e-03	0	234	29592	7.907540e-03	3	1	44854	2.229460e-05	0	187	63720	2.934710e-03	0	16	6030	2.653400e-03	0	9764	1178656	8.284010e-03	43	129	91056	1.416710e-03	0	450	47328	0.009508113590263692	0	306	0	0	112	0	6	8092	7.414730598121602E-4	3	500	0.006	1	628	0.0015923566878980893	0	56	0	0	98	0	67	8494	0.007887920885330822	6	8398	7.144558228149559E-4	0	168	0	527	65614	0.008031822476910415	Inborn_genetic_diseases|Alexander_disease|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.44915347G>A	ClinGen:CA217146|UniProtKB:P14136#VAR_017464	C0950123|C0270726|C3661900	203450	58	Intermediate filament head, DNA-binding domain	Pro	Leu	47.06	0.8602941176470589																																																																																																																																																																																																																																																																																																																																																																																																																																																																													117			47.06	Special, No backbone hydrogen	Proline		Glial fibrillary acidic protein										1.6																		115									-78.9				94.7	Head					C (loop/coil)	C (loop/coil)												47.06	86.02941	$\leqslant$50	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.6880924690413417	0.6246638752194162	false	false	false
HGD	HGD_Ala48Ser	B_15-16	8.728415918821169	0.00005204185797394759	0.0005847055807661171	8.61233097164192	0.000056750284365898976	0.00026485053397642716	2025_03_Batch_15-16	false	false	false	true	false	true	false	false	false	true	false	true	0.8313127695474476	0.9037975938546672	0.6799191202957953	0.9729374697256654	0.898982085142723	0.8943825374282033	0.9046373727321847	0.884293272376484	0.9734424001184787	0.5885020992380768	0.9027842788657956	0.8006731873216832	0.884127702124222	0.913670897908962	0.9724325393328522	0.7713361413535136	0.9048109088435387	0.8619523517732118	HGD	Ala48Ser	NC_000003.12:120674935:C:A	142G>T	3	120674935	C	A	3	ENSG00000113924	14910	990	CCSBVarC008488	ALE00008426	ENSP00000283871.5	Edgotyping3	VUSmut_GDEh11	E05	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_11	C09	VUSmut_GDEh11	E05	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	99.0	Y	N	N	Y	Y	292100.0	single nucleotide variant	NM_000187.4(HGD):c.142G>T (p.Ala48Ser)	3081.0	HGD	HGNC:4892	Benign/Likely benign	0.0	Jan 31, 2024	138846036.0	-	RCV000360783|RCV004710917	MONDO:MONDO:0008753,MedGen:C0002066,OMIM:203500,Orphanet:56|MedGen:C3661900	Alkaptonuria|not provided	germline	germline	GRCh38	NC_000003.12	3	120674935.0	120674935.0	3q13.33	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA2560337	2.0	342753.0	120674935.0	C	A	-	-	-	-	-	-	142G>T 	Ala48Ser	NM_000187.4	2.0	Benign	Likely benign	342753	3	120674935.0	C	A	A	S	rs138846036	3	120393782	3	121876472	48	HGD	ENSG00000113924	ENST00000283871	ENSP00000283871	Q93099	HGD_HUMAN	c.142G>T	p.Ala48Ser	c.142G>T	p.Ala48Ser	principal1	Y	1	YES	Select	-	GCT	1	0	C	C/C	C/C	C/C	C/C	0.07	0.35497	T	0.134	0.34572	T	0.133	0.27252	B	0.428	0.45338	B	0.18	0.41597	N	simple_aae	82.0	18.0	2.37	0.68084	M	-2.49	0.54240	N	0.749	0.74716	0.4886	0.90350	D	0.8765	0.95890	D	10	0.02063483	0.00476	T	.	.	.	0.684	0.88392	.	.	.	.	.	0.945082346544	0.94406	0.7017332609564485	0.69963	0.38333939649	0.39374	0.693797945976	0.66195	T	0.958781	0.99450	D	-0.150015	0.27957	T	0.0354225	0.72426	D	0.0264802345057763	0.01464	T	0.986801	0.95500	D	0.6357875	0.74332	0.6553336	0.79596	0.6915781	0.77342	0.55875766	0.74222	-2.877	0.08925	T	0.1204	0.25001	B	0.0890145432870742	0.42272	0.04594669	0.58590	0.854	0.92008	.	.	.	.	.	.	3.844914	0.55746	23.6	0.9974141181070767	0.83570	0.865568	0.78390	D	0.402015931100345	0.61334	4.355762	0.507077437739874	0.68291	5.223794	5.81	5.81	0.92402	5.97	0.97213	6.877	0.75423	4.849000	0.45434	0.537	0.2507	1.0	0.71675	1.000000	0.68239	0.992	0.67791	317	0.8713	67	0.013378594249201278	65	0.049167927382753406	0	0.0	2	0.002881844380403458	0	0.0	0	0.0	2821	264690	0.010657751	.	277	109392	2.532180e-03	2	612	208080	2.941180e-03	9	579	236732	2.445800e-03	8	238	7162	3.323090e-02	2	27	17102	1.578760e-03	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13392	0.000000e+00	0	9	42768	2.104380e-04	0	0	15690	0.000000e+00	0	238	7162	3.323090e-02	2	532	16212	3.281520e-02	8	53	30488	1.738390e-03	0	0	6212	0.000000e+00	0	0	13412	0.000000e+00	0	0	16732	0.000000e+00	0	16	89552	1.786670e-04	0	3	30608	9.801360e-05	1	532	16212	3.281520e-02	8	492	14896	3.302900e-02	7	59	34224	1.723940e-03	0	0	9566	0.000000e+00	0	0	17688	0.000000e+00	0	0	21630	0.000000e+00	0	16	102590	1.559610e-04	0	3	30526	9.827690e-05	1	492	14896	3.302900e-02	7	.	2896	1611652	1.796910e-03	46	2403	74884	3.208960e-02	41	2403	74884	3.208960e-02	41	0	910	0.000000e+00	0	174	59944	2.902710e-03	2	0	29522	0.000000e+00	0	0	44852	0.000000e+00	0	0	63972	0.000000e+00	0	17	6038	2.815500e-03	1	125	1178112	1.061020e-04	0	5	91050	5.491490e-05	1	20	180050	1.1108025548458761E-4	15	360	0.041666666666666664	0	4504	0	296	9454	0.03130949862492067	20	804	0.024875621890547265	7	974	0.007186858316221766	0	1850	0	0	280	0	39	17684	0.002205383397421398	311	9814	0.03168942327287549	0	6354	0	397	215960	0.001838303389516577	Alkaptonuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.120674935C>A	ClinGen:CA2560337	C0002066	203500	56	Homogentisate 1,2-dioxygenase, N-terminal domain	Ala	Ser	98.49	0.5849056603773585																																																																																																																																																																																																																																																																																																																																																																																																																																																																													62			98.49	Aliphatic	Alanine		Homogentisate 1,2-dioxygenase										1.8										 A48-N56 (PAE:  1.0)	A48-N56 (PDBs: 1EY2, 1EYB)							89									-61.2				146.4						C (loop/coil)	C (loop/coil)												98.49	58.49057	>90	10-90	203500	autosomal recessive	OMIM	Rare genetic eye disease; Rare inborn errors of metabolism; Rare genetic skin disease	3	ALKAPTONURIA	false	0.9037975938546672	0.8313127695474476	false	false	false
GCM2	GCM2_Gly203Ser	B_7-8	3.091972100055773	0.03650435157956673	0.07215044075876798	-1.0294283477898782	0.34297694639710546	0.39632411627121444	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5775507593172167	0.634059339313815	0.4609765062836083	0.515061768361222	0.5680290108248528	0.4656115139211042	0.4656115139211042	0.5167597616854255	0.5314249025715296	0.4609765062836083	0.655352769041393	0.6283517406346552		0.6192982599642801	0.4986986341509143		0.6127659095862369	0.5267497779997781	GCM2	Gly203Ser	NC_000006.12:10874909:C:T	607G>A	6	10874909	C	T	6	ENSG00000124827	13943	900204	CCSBVarC002923	ALE00002923	ENSP00000368805.4	RC4	NatVar_GDE_001	D06	GDEhDisVCh_40044	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh12	C03	1.0	1.0	0.0		0.0			0.0			1.0	1.0	1.0	Y	N	N	N	Y	301181.0	single nucleotide variant	NM_004752.4(GCM2):c.607G>A (p.Gly203Ser)	9247.0	GCM2	HGNC:4198	Benign/Likely benign	0.0	Jan 27, 2024	7744163.0	-	RCV000338761|RCV001712159	MONDO:MONDO:0016390,MedGen:C1832648,OMIM:PS146200,Orphanet:2238|MedGen:C3661900	Familial hypoparathyroidism|not provided	germline	germline	GRCh38	NC_000006.12	6	10874909.0	10874909.0	6p24.2	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA3634018,UniProtKB:O75603#VAR_049132	2.0	355013.0	10874909.0	C	T	-	-	-	-	-	-	607G>A 	Gly203Ser	NM_004752.4	2.0	Benign	Likely benign	355013	6	10874909.0	C	T	G	S	rs7744163	6	10875142	6	10983128	203	GCM2	ENSG00000124827	ENST00000379491	ENSP00000368805	O75603	GCM2_HUMAN	c.607G>A	p.Gly203Ser	c.607G>A	p.Gly203Ser	principal1	Y	1	YES	Select	-	GGT	1	0	C	C/C	C/C	C/C	C/C	0.082	0.33397	T	0.185	0.29268	T	0.802	0.45119	P	0.133	0.33075	B	0.03	0.10877	P	simple_aae	97.0	3.0	2.35	0.67323	M	-1.99	0.45958	N	0.137	0.13417	-0.8915	0.48603	T	0.1359	0.44937	T	10	0.0019478798	0.00026	T	.	.	.	0.173	0.43618	.	.	.	.	.	0.829432510027	0.82647	0.42227856748080933	0.41942	0.256502788538	0.27929	0.274613678455	0.06751	T	0.174784	0.52174	T	-0.483754	0.00667	T	-0.380802	0.35270	T	0.0189050393878567	0.00598	T	0.634537	0.24612	T	0.10751505	0.25196	0.11752139	0.28303	0.10751505	0.25196	0.11752139	0.28302	-2.319	0.04665	T	0.0777	0.06786	B	0.166262835714802	0.48094	0.41835517	0.80033	0.121	0.32779	.	.	.	.	.	.	2.619375	0.34098	19.51	0.99761730314446662	0.85104	0.153094	0.27574	N	-0.1655157144358	0.34301	1.975291	-0.190317408971044	0.31579	1.80913	5.81	4.95	0.64849	2.72	0.49750	2.219	0.42643	2.605000	0.33626	0.599	0.40292	0.964	0.33941	0.027000	0.21174	0.661	0.33037	785	0.46857	156	0.031150159744408944	154	0.11649016641452345	1	9.940357852882703E-4	1	0.001440922190201729	0	0.0	0	0.0	8472	264690	0.032007255	.	913	109378	8.347200e-03	44	1963	208080	9.433870e-03	90	1832	236778	7.737210e-03	80	783	7160	1.093580e-01	44	92	17100	5.380120e-03	0	12	2320	5.172410e-03	0	0	9044	0.000000e+00	0	0	13390	0.000000e+00	0	13	42766	3.039800e-04	0	6	15684	3.825550e-04	0	783	7160	1.093580e-01	44	1697	16212	1.046760e-01	89	171	30510	5.604720e-03	0	20	6210	3.220610e-03	0	0	13414	0.000000e+00	0	0	16730	0.000000e+00	0	41	89540	4.578960e-04	0	17	30600	5.555560e-04	1	1697	16212	1.046760e-01	89	1546	14898	1.037720e-01	79	179	34244	5.227190e-03	0	26	9570	2.716820e-03	0	0	17690	0.000000e+00	0	0	21628	0.000000e+00	0	49	102610	4.775360e-04	0	17	30520	5.570120e-04	1	1546	14898	1.037720e-01	79	.	9071	1613188	5.623030e-03	428	7544	74934	1.006750e-01	415	7544	74934	1.006750e-01	415	0	910	0.000000e+00	0	414	60024	6.897240e-03	3	61	29596	2.061090e-03	0	0	44872	0.000000e+00	0	0	64030	0.000000e+00	0	58	6060	9.570960e-03	0	531	1179214	4.503000e-04	0	40	91070	4.392230e-04	1	192	246582	7.786456432342994E-4	56	478	0.11715481171548117	0	4818	0	1265	13328	0.09491296518607444	41	1252	0.03274760383386582	2	1428	0.0014005602240896359	0	1922	0	0	372	0	127	21244	0.005978158538881567	1321	13806	0.09568303636100246	0	6740	0	1683	291424	0.005775090589656308	Familial_hypoparathyroidism|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.10874909C>T	ClinGen:CA3634018|UniProtKB:O75603#VAR_049132	C1832648|C3661900	PS146200	2238	.	Gly	Ser	41.59	0.9761904761904762																																																																																																																																																																																																																																																																																																																																																																																																																																																																													82			41.59	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Chorion-specific transcription factor GCMb										-0.4																		75									-161.4				142.1	Disordered					C (loop/coil)	C (loop/coil)												41.59	97.61904	$\leqslant$50	$\geqslant$90		unknown		Rare genetic eye disease; Rare genetic endocrine disease	2		false	0.634059339313815	0.5775507593172167	false	false	false
TMEM43	TMEM43_Arg28Trp	B_15-16	-13.068306348978123	0.00001237673864806233	0.00025480056854745544	-24.174773982453274	3.292177702826541e-7	8.755284180705365e-6	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6444877224202119	0.7505677459694207	0.6271351664425094	0.7053592782631593	0.7388825829607177	0.7117410209109476	0.7740834363000357	0.7873103543318454	0.8280308116054935	0.7044587722184734	0.7727320354715245	0.6275133091293618	0.6493986055218594	0.69045481158959	0.5826877449208251	0.5498115606665455	0.7284034564673167	0.6614621357110622	TMEM43	Arg28Trp	NC_000003.12:14129481:C:T	82C>T	3	14129481	C	T	3	ENSG00000170876	3438	201175	CCSBVarC004823	ALE00004823	ENSP00000303992.5	CEGS2	CegsMutGDEh1036	D11	GDEhDisVCh_40077	F05	1	CegsMutGDDh1036	D11	VUSN2Hmut_GDN2h_07	A07	VUSMutpDEST2_03	A06	VUSmut_GDEh07	A07	1.0	2.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	55318.0	single nucleotide variant	NM_024334.3(TMEM43):c.82C>T (p.Arg28Trp)	79188.0	TMEM43	HGNC:28472	Benign/Likely benign	0.0	Nov 01, 2024	35028636.0	-	RCV000039392|RCV000231100|RCV000357662|RCV000245492|RCV000770177|RCV001529993|RCV002490539	MedGen:CN169374|MONDO:MONDO:0011459,MedGen:C1858379,OMIM:604400|MONDO:MONDO:0016587,MeSH:D019571,MedGen:C0349788,Orphanet:247|MedGen:CN230736|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MedGen:C3661900|MONDO:MONDO:0859235,MedGen:C5676964,OMIM:619832;MONDO:MONDO:0011459,MedGen:C1858379,OMIM:604400;MONDO:MONDO:0013677,MedGen:C3553060,OMIM:614302,Orphanet:261	not specified|Arrhythmogenic right ventricular dysplasia 5|Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype|Cardiomyopathy|not provided|Auditory neuropathy, autosomal dominant 3;Arrhythmogenic right ventricular dysplasia 5;Emery-Dreifuss muscular dystrophy 7, autosomal dominant	germline;unknown	germline	GRCh38	NC_000003.12	3	14129481.0	14129481.0	3p25.1	criteria provided, multiple submitters, no conflicts	19.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA024766	2.0	46153.0	14129481.0	C	T	-	-	-	-	-	-	82C>T 	Arg28Trp	NM_024334.3	2.0	Benign	Likely benign	46153	3	14129481.0	C	T	R	W	rs35028636	3	14170981	3	14145982	28	TMEM43	ENSG00000170876	ENST00000306077	ENSP00000303992	Q9BTV4	TMM43_HUMAN	c.82C>T	p.Arg28Trp	c.82C>T	p.Arg28Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.995	0.83178	D	0.28	0.53339	N	simple_aae	72.0	28.0	2.97	0.85148	M	-4.17	0.75485	D	0.867	0.86375	-0.4228	0.71172	T	0.2038	0.55964	T	10	0.011812419	0.00253	T	.	.	.	0.395	0.70849	.	.	.	.	.	0.585624173979	0.57921	0.8509143264560879	0.84962	0.410448358861	0.41547	0.59380787611	0.51964	T	0.273881	0.64437	T	-0.338533	0.05311	T	-0.244776	0.50004	T	0.0585583195871895	0.06865	T	0.959504	0.84730	D	0.49552068	0.66522	0.41299242	0.65232	0.5049861	0.67080	0.48785636	0.70105	-11.969	0.84743	D	0.6949	0.72695	P	0.806286144594271	0.71055	0.98662500	0.96261	0.588	0.76901	.	.	.	.	.	.	5.039401	0.83896	28.2	0.99929177576521133	0.99279	0.550294	0.56129	D	0.678361365327708	0.78096	6.826775	0.618827999199292	0.76179	6.467047	5.04	5.04	0.67250	1.95	0.39072	0.907	0.28248	3.328000	0.37683	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.988	0.63383	830	0.39194	42	0.008386581469648562	39	0.029500756429652043	0	0.0	1	0.001440922190201729	0	0.0	2	0.002044989775051125	1521	264690	0.0057463446	.	276	109404	2.522760e-03	1	578	208088	2.777670e-03	3	605	236872	2.554120e-03	4	133	7164	1.856500e-02	1	32	17112	1.870030e-03	0	21	2320	9.051720e-03	0	1	9042	1.105950e-04	0	4	13394	2.986410e-04	0	23	42768	5.377850e-04	0	56	15690	3.569150e-03	0	133	7164	1.856500e-02	1	280	16218	1.726480e-02	1	47	30524	1.539770e-03	0	75	6212	1.207340e-02	1	3	13412	2.236800e-04	0	4	16734	2.390340e-04	0	58	89514	6.479430e-04	0	96	30608	3.136430e-03	1	280	16218	1.726480e-02	1	253	14902	1.697760e-02	1	53	34260	1.546990e-03	0	120	9570	1.253920e-02	2	3	17688	1.696070e-04	0	5	21630	2.311600e-04	0	61	102676	5.941020e-04	0	96	30526	3.144860e-03	1	253	14902	1.697760e-02	1	.	2705	1614114	1.675840e-03	21	1174	75020	1.564920e-02	7	1174	75020	1.564920e-02	7	0	912	0.000000e+00	0	106	60010	1.766370e-03	0	339	29604	1.145120e-02	5	15	44878	3.342390e-04	0	7	64036	1.093140e-04	0	53	6062	8.742990e-03	0	502	1179996	4.254250e-04	0	321	91086	3.524140e-03	6	232	190004	0.0012210269257489316	6	370	0.016216216216216217	0	4528	0	142	9944	0.014279967819790828	11	834	0.013189448441247002	1	1092	9.157509157509158E-4	0	1854	0	1	312	0.003205128205128205	62	20688	0.002996906419180201	148	10314	0.014349427961993406	0	6382	0	455	229626	0.00198148293311733	Arrhythmogenic_right_ventricular_cardiomyopathy|Cardiomyopathy|Arrhythmogenic_right_ventricular_dysplasia_5|Emery-Dreifuss_muscular_dystrophy_7,_autosomal_dominant|Auditory_neuropathy,_autosomal_dominant_3|not_provided|Cardiovascular_phenotype|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.14129481C>T	ClinGen:CA024766	C0349788|C0878544|C1858379|C3553060|C5676964|C3661900|CN230736|CN169374	604400|614302|619832	247|167848|261	.	Arg	Trp	71.65	0.5604838709677419																																																																																																																																																																																																																																																																																																																																																																																																																																																																													139			71.65	Positively-charged	Arginine		Transmembrane protein 43										-4.5								 R28-T32 (PAE:  4.0), R28-P23 (PAE: 3.5), R28-G24 (PAE: 4.0)		 R28-T32 (PAE:  4.0), R28-P23 (PAE: 3.5), R28-G24 (PAE: 4.0)								175									-59.9				-42.7						H (helix)	H (α-helix)							Nuclear					71.65	56.048386	70-90	10-90	604400;619832;604400;614302	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 3; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT	false	0.7505677459694207	0.6444877224202119	false	false	false
TH	TH_Arg89Arg	B_7-8	0.5888060754880526	0.5774697708088052	0.6557474805260511	0.23617880244248715	0.8200556917884257	0.8516141451226719	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6004365697712155	0.5972636748585115	0.7702618581697434	0.607820118764546	0.4781330275047537	0.7656813108140743	0.732485735314534	0.5597622850091678	0.6300701210703245	0.7274038970656103	0.6047715848717464	0.596346251086971	0.7988768863136145	0.39650377000033965	0.5855701164587674	0.8131198192738763	0.5897557648452766	0.6045268884554599	TH	Arg89Arg	NC_000011.10:2169695:C:T	267G>A	11	2169695	C	T	11	ENSG00000180176	71892	4021	CCSBVarC008300	ALE00008286	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	A12	GDEhDisVCh_40019	G11	1	VUSMutGDDh015	A12	VUSN2Hmut_GDN2h_05	E01	VUSMutpDEST2_15	G09	VUSmut_GDEh05	E01	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	254114.0	single nucleotide variant	NM_000360.4(TH):c.267G>A (p.Arg89=)	7054.0	TH	HGNC:11782	Benign/Likely benign	0.0	Jan 31, 2024	76240471.0	-	RCV000246453|RCV000311361|RCV000829331	MedGen:CN169374|MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150|MedGen:C3661900	not specified|Autosomal recessive DOPA responsive dystonia|not provided	germline	germline	GRCh38	NC_000011.10	11	2169695.0	2169695.0	11p15.5	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA5818744	2.0	263254.0	2169695.0	C	T	-	-	-	-	-	-	267G>A 	Arg89=	NM_000360.4	2.0	Benign	Likely benign																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	NaN	NaN	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.5972636748585115	0.6004365697712155	false	false	false
F9	F9_Lys39Arg	B_13-14	0.5834147239677604	0.5779189782041229	0.6558676460902404	0.0698144139043392	0.9462939494260949	0.95579518879782	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5099701946334381	0.5282851682559128	0.5386854657663265	0.4547976580112212	0.4679844348298267	0.5404969246839697	0.5250778103676356	0.4499457634949616	0.3934249138725266	0.5251522236992102	0.45747861177986315	0.4381092994697555	0.5559160390003037	0.4860231061646918	0.5161704021499157	0.5522187078334428	0.5990917247319624	0.5818310897971206	F9	Lys39Arg	NC_000023.11:139537037:A:G	116A>G	23	139537037	A	G	X	ENSG00000101981	52861	0	CCSBVarC030489	ALE00020739	ENSP00000218099.2																																	1150443.0	single nucleotide variant	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	2158.0	F9	HGNC:3551	Likely benign	0.0	Jan 30, 2024	200505648.0	-	RCV001504446	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537037.0	139537037.0	Xq27.1	criteria provided, single submitter	1.0	-	N	-	2.0	1160362.0	139537037.0	A	G	-	-	-	-	-	-	116A>G 	Lys39Arg	NM_000133.4	1.0	Benign	Likely benign	1160362	X	139537037.0	A	G	K	R	rs200505648	X	138619196	X	138446862	39	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.116A>G	p.Lys39Arg	c.116A>G	p.Lys39Arg	principal1	Y	1	YES	Select	+	AAA	2	0	A	A/A	A/A	A/A	A/A	0.323	0.15597	T	0.417	0.17147	T	0.056	0.22821	B	0.032	0.22132	B	0.01	0.05039	N	simple_aae	99.0	1.0	1.92	0.51123	L	-0.64	0.18812	N	0.312	0.37163	-0.2568	0.76067	T	0.6381	0.87296	D	10	0.014453173	0.00300	T	0.149573	0.83090	D	0.344	0.66405	.	.	.	.	.	0.939239796073	0.93813	0.7314597189117038	0.72948	0.19312899725	0.21378	0.393836945295	0.24181	T	0.357661	0.72262	T	-0.236865	0.15471	T	-0.208103	0.53563	T	0.124255164463254	0.14653	T	0.0863914	0.00987	T	0.113306604	0.26523	0.103917405	0.24897	0.113306604	0.26523	0.103917405	0.24896	-4.174	0.26400	T	0.0743	0.06973	B	0.923986090574331	0.77876	0.99985337	0.99806	0.28	0.55009	.	.	.	.	.	.	3.13775	0.42504	21.5	0.99701738994094546	0.80679	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	1.14	0.30476	1.162	0.31498	9.182000	0.79117	0.756	0.943	0.0	0.06393	1.000000	0.68239	0.997	0.79771	924	0.18019	6	0.0015894039735099338	0	0.0	0	0.0	0	0.0	6	0.007853403141361256	0	0.0	2	264690	7.5560088E-6	.	8	79213	1.009940e-04	0	13	148583	8.749320e-05	0	10	168667	5.928840e-05	0	0	5673	0.000000e+00	0	0	13352	0.000000e+00	0	0	1739	0.000000e+00	0	8	6881	1.162620e-03	0	0	9930	0.000000e+00	0	0	30817	0.000000e+00	0	0	9392	0.000000e+00	0	8	6881	1.162620e-03	0	0	12622	0.000000e+00	0	0	23895	0.000000e+00	0	0	4559	0.000000e+00	0	13	10057	1.292630e-03	0	0	12177	0.000000e+00	0	0	63838	0.000000e+00	0	0	17902	0.000000e+00	0	13	10057	1.292630e-03	0	0	11551	0.000000e+00	0	0	26591	0.000000e+00	0	0	6965	0.000000e+00	0	10	13222	7.563150e-04	0	0	15966	0.000000e+00	0	0	72498	0.000000e+00	0	0	17837	0.000000e+00	0	10	13222	7.563150e-04	0	.	16	1207839	1.324680e-05	0	16	33690	4.749180e-04	0	0	57354	0.000000e+00	0	0	687	0.000000e+00	0	0	45673	0.000000e+00	0	0	21969	0.000000e+00	0	16	33690	4.749180e-04	0	0	46597	0.000000e+00	0	0	4334	0.000000e+00	0	0	894043	0.000000e+00	0	0	55963	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139537037A>G	.	C2749016|C0008533	300807|306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Lys	Arg	74.17	0.6439024390243903																																																																																																																																																																																																																																																																																																																																																																																																															1.01	1 mutation(s) (Lys39Pro: 1.421)	0.974		0.928		0.876		0.972																																																						132			74.17	Positively-charged	Lysine												-3.9										 K39-E35 (PAE:  3.5)								147									-72.1			Propeptide	-30.7						H (helix)	H (α-helix)												74.17	64.39024	70-90	10-90	300807;306900	x-linked recessive	OMIM	Rare genetic hematologic disease	1	THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B	false	0.5282851682559128	0.5099701946334381	false	false	false
SHOC2	SHOC2_Glu13Ala	B_13-14	-3.1184142906339396	0.01688113056320015	0.04030369921964036	-0.49599748744533817	0.6350883549851457	0.6837270468588192	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7407827078961824	0.7529338122345947	0.8185620653005512	0.7810876792764117	0.8025950887739939	0.8559071025817109	0.9756306939946388	0.9678833014286222	0.9657143655361207	0.9046454356894612	0.9190201143010379	0.894407260474491	0.7361835111687829	0.6373068761193657	0.5964609930167025	0.7324786949116412	0.5868475101681514	0.5871581553178737	SHOC2	Glu13Ala	NC_000010.11:110964396:A:C	38A>C	10	110964396	A	C	10	ENSG00000108061	11602	0	CCSBVarC028002	ALE00017629	ENSP00000358464.5																																	179140.0	single nucleotide variant	NM_007373.4(SHOC2):c.38A>C (p.Glu13Ala)	8036.0	SHOC2	HGNC:15454	Likely benign	0.0	Apr 18, 2017	730881018.0	-	RCV000159108|RCV000519096|RCV001286466|RCV003917545	MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|	not provided|RASopathy|Noonan syndrome-like disorder with loose anagen hair 1|SHOC2-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	110964396.0	110964396.0	10q25.2	reviewed by expert panel	7.0	-	N	ClinGen:CA297169	2.0	181526.0	110964396.0	A	C	-	-	-	-	-	-	38A>C 	Glu13Ala	NM_007373.4	3.0	Benign	Likely benign	181526	10	110964396.0	A	C	E	A	rs730881018	10	112724154	10	112714144	13	SHOC2	ENSG00000108061	ENST00000369452	ENSP00000358464	Q9UQ13	SHOC2_HUMAN	c.38A>C	p.Glu13Ala	c.38A>C	p.Glu13Ala	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.064	0.46312	T	0.608	0.42558	P	0.099	0.36883	B	0.59	0.81345	D	simple_aae	41.0	59.0	1.95	0.52299	M	-0.6	0.18812	N	0.423	0.46027	-1.0566	0.12628	T	0.0516	0.21765	T	10	0.08434051	0.14015	T	0.017643	0.39176	T	0.201	0.48371	0.281	0.23526	Q9UQ13	E13A	Gain of MoRF binding (P = 0.0137)| Loss of solvent accessibility (P = 0.0224)| Loss of loop (P = 0.0288)| Gain of helix (P = 0.0349)| Loss of ubiquitination at K12 (P = 0.0513)	0.179529687257	0.17226	0.04928600904487052	0.04770	0.563730636038	0.52505	0.724361896515	0.70633	T	0.180195	0.52911	T	-0.277484	0.10698	T	-0.241522	0.50325	T	0.203609590675606	0.20360	T	.	0.78769	.	0.41888207	0.61694	0.37247154	0.62211	0.40507784	0.60759	0.41437265	0.65330	-4.18	0.26488	T	0.1283	0.44635	B	0.948087201769068	0.80225	0.00728444	0.37610	0.445	0.67796	.	.	.	.	.	.	4.597423	0.72836	25.9	0.99544580227759949	0.70747	0.895634	0.83526	D	0.262818673862206	0.54046	3.593558	0.439003866076337	0.63819	4.647143	5.77	5.77	0.91065	3.37	0.61085	8.947	0.92752	11.188000	0.88575	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.986	0.61779	914	0.21043	.	.	.	.	.	.	.	.	.	.	.	.	17	264690	6.422608E-5	.	14	108822	1.286500e-04	0	27	205876	1.311470e-04	0	30	234158	1.281190e-04	0	0	7146	0.000000e+00	0	14	16894	8.286970e-04	0	0	2304	0.000000e+00	0	0	8976	0.000000e+00	0	0	13390	0.000000e+00	0	0	42660	0.000000e+00	0	0	15548	0.000000e+00	0	14	16894	8.286970e-04	0	0	15604	0.000000e+00	0	27	30178	8.946910e-04	0	0	6148	0.000000e+00	0	0	13386	0.000000e+00	0	0	16710	0.000000e+00	0	0	88826	0.000000e+00	0	0	30260	0.000000e+00	0	27	30178	8.946910e-04	0	0	14306	0.000000e+00	0	30	33898	8.850080e-04	0	0	9508	0.000000e+00	0	0	17430	0.000000e+00	0	0	21604	0.000000e+00	0	0	101728	0.000000e+00	0	0	30178	0.000000e+00	0	30	33898	8.850080e-04	0	.	36	1613068	2.231770e-05	0	36	59758	6.024300e-04	0	0	74780	0.000000e+00	0	0	912	0.000000e+00	0	36	59758	6.024300e-04	0	0	29580	0.000000e+00	0	0	44900	0.000000e+00	0	0	64002	0.000000e+00	0	0	6078	0.000000e+00	0	0	1179780	0.000000e+00	0	0	90854	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	1	610	0.001639344262295082	0	26	0	0	104	0	1	604	0.0016556291390728477	0	3332	0	0	146	0	2	14710	1.3596193065941537E-4	Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|RASopathy|SHOC2-related_disorder|not_provided	reviewed_by_expert_panel	NC_000010.11:g.110964396A>C	ClinGen:CA297169	C4478716|C5555857|C3661900	607721	2701|536391	.	Glu	Ala	36.76	0.9896907216494846																																																																																																																																																																																																																																																																																																																																																																																																																																																																													192			36.76	Negatively-charged	Glutamic Acid		Leucine-rich repeat protein SHOC-2		Basic and acidic residues								-3.5																		146									-129.4				135.4	Disordered					C (loop/coil)	C (loop/coil)												36.76	98.96907	$\leqslant$50	$\geqslant$90	607721	unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	false	0.7529338122345947	0.7407827078961824	false	false	false
F9	F9_Ser220Thr	B_13-14	-1.5813680655719948	0.1578072999155839	0.23347168306643318	-1.0080608886344498	0.3469930359098541	0.39945559654616203	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6861824482306471	0.6718886112372668	0.5099742063702417	0.7336700830007303	0.7106963217118785	0.6596586895836423	0.7829549658978197	0.7747656826245788	0.792200812533792	0.5659984596806475	0.6925143242396778	0.719243779746325	0.536362413269465	0.646626960799178	0.6751393534676685	0.45394995305983593	0.6512628982348557	0.6531211167149691	F9	Ser220Thr	NC_000023.11:139551199:T:A	658T>A	23	139551199	T	A	X	ENSG00000101981	52861	0	CCSBVarC030564	ALE00018711	ENSP00000218099.2																																	352093.0	single nucleotide variant	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2158.0	F9	HGNC:3551	Benign/Likely benign	0.0	Jan 27, 2024	777361659.0	-	RCV000279243|RCV000862176|RCV003950311|RCV002502409	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807||MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder|Hereditary factor IX deficiency disease;Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect	germline;unknown	germline	GRCh38	NC_000023.11	X	139551199.0	139551199.0	Xq27.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA10529817	2.0	368001.0	139551199.0	T	A	-	-	-	-	-	-	658T>A 	Ser220Thr	NM_000133.4	2.0	Benign	Likely benign	368001	X	139551199.0	T	A	S	T	rs777361659	X	138633358	X	138461024	220	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.658T>A	p.Ser220Thr	c.658T>A	p.Ser220Thr	principal1	Y	1	YES	Select	+	TCA	1	0	T	T/T	T/T	T/T	T/T	0.323	0.13513	T	0.558	0.09916	T	0.0	0.02950	B	0.003	0.08696	B	0.02	0.08015	N	simple_aae	98.0	2.0	1.1	0.27864	L	-0.33	0.13346	N	0.092	0.14545	-0.3176	0.74375	T	0.6106	0.86163	D	10	0.011437386	0.00246	T	0.311014	0.91165	D	0.120	0.33155	0.293	0.25438	P00740	S220T	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.68087794957	0.67565	0.8672301792330431	0.86606	0.600742330255	0.54859	0.357546925545	0.19008	T	0.331657	0.69995	T	-0.470828	0.00791	T	-0.455873	0.26695	T	0.0342450906531738	0.02660	T	0.538146	0.20839	T	0.066854715	0.14292	0.059238464	0.11090	0.053613782	0.10077	0.06703769	0.13813	-3.522	0.18335	T	0.0749	0.05513	B	0.483090820042852	0.60269	0.99953437	0.99461	0.214	0.47926	.	.	.	.	.	.	-0.836136	0.0104	0.044	0.53336181712178654	0.04982	.	.	.	.	.	.	.	.	.	5.31	-7.5	0.01209	-4.88	0.04680	-0.667	0.05383	-2.955000	0.03212	0.665	0.62996	0.0	0.06393	0.000000	0.08389	0.021	0.11764	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	75	264690	2.8335032E-4	.	23	80344	2.862690e-04	1	57	151861	3.753430e-04	2	65	172271	3.773120e-04	2	0	5702	0.000000e+00	0	22	13667	1.609720e-03	1	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	22	13667	1.609720e-03	1	0	13134	0.000000e+00	0	48	24393	1.967780e-03	1	0	4649	0.000000e+00	0	0	10125	0.000000e+00	0	0	12192	0.000000e+00	0	0	64670	0.000000e+00	0	0	19072	0.000000e+00	0	48	24393	1.967780e-03	1	0	12064	0.000000e+00	0	56	27171	2.061020e-03	1	0	7083	0.000000e+00	0	0	13316	0.000000e+00	0	0	15997	0.000000e+00	0	0	73484	0.000000e+00	0	0	19007	0.000000e+00	0	56	27171	2.061020e-03	1	.	74	1209534	6.118060e-05	1	71	45655	1.555140e-03	1	0	57031	0.000000e+00	0	0	686	0.000000e+00	0	71	45655	1.555140e-03	1	0	22028	0.000000e+00	0	0	33747	0.000000e+00	0	0	46522	0.000000e+00	0	0	4376	0.000000e+00	0	0	895139	0.000000e+00	0	0	56756	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	1	610	0.001639344262295082	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	1	14050	7.117437722419929E-5	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139551199T>A	ClinGen:CA10529817	C5393318|C0008533|C2749016	301052|306900|300807	98879	.	Ser	Thr	27.51	0.8																																																																																																																																																																																																																																																																																																																																																																																																															0.943		0.922		0.917		0.923		0.918																																																						104			27.51	Polar/Neutral	Serine		Coagulation factor IX										-0.8																		105									-54.2			Activation peptide	92.6						C (loop/coil)	C (loop/coil)												27.51	80.0	$\leqslant$50	10-90	306900;306900;300807;306900;301052;300807	x-linked	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; WARFARIN SENSITIVITY, X-LINKED; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.6718886112372668	0.6861824482306471	false	false	false
SOS2	SOS2_Pro1318Ser	B_13-14	1.0493118206423042	0.328906085228044	0.41769323323508245	12.670492549376737	4.410938552305839e-6	0.00004393628723118101	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8997792101752938	0.9122915098433717	0.5928384550365406	0.6005223585850014	0.5927634751621828	0.6082882801991982	0.572992629237662	0.5468459399952506	0.5757572921378039	0.559859667583572	0.8705819338309168	0.8525478065809637	0.6435839311607343	0.638681010329115	0.6252874250321988	0.6258172424895092	0.9540010858558268	0.9470106137696239	SOS2	Pro1318Ser	NC_000014.9:50118391:G:A	3952C>T	14	50118391	G	A	14	ENSG00000100485	55187	0	CCSBVarC013771	ALE00009955	ENSP00000216373.5																																	463782.0	single nucleotide variant	NM_006939.4(SOS2):c.3952C>T (p.Pro1318Ser)	6655.0	SOS2	HGNC:11188	Benign/Likely benign	0.0	Jan 29, 2024	140995728.0	-	RCV002358610|RCV000555942|RCV001175493|RCV001644664|RCV003962607	MedGen:CN230736|MONDO:MONDO:0014691,MedGen:C4225282,OMIM:616559,Orphanet:648|MedGen:CN169374|MedGen:C3661900|	Cardiovascular phenotype|Noonan syndrome 9|not specified|not provided|SOS2-related disorder	germline	germline	GRCh38	NC_000014.9	14	50118391.0	50118391.0	14q21.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA7176682	2.0	475758.0	50118391.0	G	A	-	-	-	-	-	-	3952C>T 	Pro1318Ser	NM_006939.4	2.0	Benign	Likely benign	475758	14	50118391.0	G	A	P	S	rs140995728	14	50585109	14	49654859	1318	SOS2	ENSG00000100485	ENST00000216373	ENSP00000216373	Q07890	SOS2_HUMAN	c.3952C>T	p.Pro1318Ser	c.3952C>T	p.Pro1318Ser	principal1	Y	1	YES	Select	-	CCA	1	0	G	./.	./.	./.	./.	0.771	0.03390	T	0.183	0.29561	T	0.993	0.65587	D	0.968	0.71743	D	0.38	0.62259	N	simple_aae	62.0	38.0	1.24	0.30804	L	-2.62	0.56328	D	0.107	0.20263	-0.3437	0.73619	T	0.4792	0.79993	T	10	0.014707029	0.00305	T	0.035738	0.56369	D	0.311	0.63079	.	.	.	.	.	0.564192878985	0.55755	0.24931831313751454	0.24653	0.333972655293	0.35131	0.423311650753	0.28258	T	0.459389	0.79546	T	-0.27488	0.10979	T	-0.174886	0.56696	T	0.0457728085513322	0.04699	T	0.754025	0.37784	T	0.1488474	0.33678	0.22177863	0.46827	0.16657373	0.36701	0.19488566	0.42985	-3.805	0.20897	T	0.0792	0.15718	B	0.211387639361191	0.50480	0.92654955	0.92242	0.247	0.51713	.	.	.	.	.	.	1.857218	0.23634	16.08	0.88180507123295981	0.18028	0.426669	0.48918	N	0.376038629970589	0.59920	4.198247	0.407449731798897	0.61823	4.411648	5.37	5.37	0.76916	3.71	0.68166	2.631	0.46269	4.061000	0.41666	0.676	0.76753	0.998	0.41403	1.000000	0.68239	0.996	0.76032	443	0.79891	4	7.987220447284345E-4	0	0.0	3	0.002982107355864811	1	0.001440922190201729	0	0.0	0	0.0	134	264690	5.062526E-4	.	47	109384	4.296790e-04	0	104	208088	4.997890e-04	0	113	236904	4.769860e-04	0	2	7164	2.791740e-04	0	3	17108	1.753570e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	40	42752	9.356290e-04	0	0	15688	0.000000e+00	0	40	42752	9.356290e-04	0	4	16218	2.466400e-04	0	6	30518	1.966050e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	90	89522	1.005340e-03	0	1	30606	3.267330e-05	0	90	89522	1.005340e-03	0	4	14902	2.684200e-04	0	8	34254	2.335490e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21624	0.000000e+00	0	96	102720	9.345790e-04	0	1	30524	3.276110e-05	0	96	102720	9.345790e-04	0	.	1235	1614102	7.651310e-04	1	1160	1180004	9.830480e-04	1	18	75012	2.399620e-04	0	0	912	0.000000e+00	0	17	60006	2.833050e-04	0	1	29606	3.377690e-05	0	0	44886	0.000000e+00	0	0	64020	0.000000e+00	0	0	6060	0.000000e+00	0	1160	1180004	9.830480e-04	1	2	91086	2.195730e-05	0	146	184512	7.912764481442942E-4	0	360	0	0	2712	0	2	9426	2.121790791427965E-4	0	796	0	0	968	0	0	682	0	0	280	0	13	15606	8.330129437395873E-4	2	9786	2.0437359493153485E-4	0	3394	0	161	215342	7.476479274827948E-4	not_specified|not_provided|Cardiovascular_phenotype|SOS2-related_disorder|Noonan_syndrome_9	criteria_provided,_multiple_submitters,_no_conflicts	NC_000014.9:g.50118391G>A	ClinGen:CA7176682	CN169374|C3661900|CN230736|C4225282	616559	648	.	Pro	Ser	44.32	0.7867647058823529																																																																																																																																																																																																																																																																																																																																																																																																																																																																													107			44.32	Special, No backbone hydrogen	Proline		Son of sevenless homolog 2										1.6																		115									-134.6				-158.6	Disordered					C (loop/coil)	C (loop/coil)												44.32	78.67647	$\leqslant$50	10-90	616559	autosomal dominant	GenCC		0	NOONAN SYNDROME 9	false	0.9122915098433717	0.8997792101752938	false	false	false
SDHD	SDHD_His50Arg	B_13-14	3.0284841744564357	0.020352148961914243	0.04581535496076164	5.69672964070171	0.43847762370643184	0.45054010756792956	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7711599139076848	0.7948199453354845	0.7813768295994017	0.8162946618772127	0.8429394757138191	0.8199798855198364	0.8510804431292996	0.8625240646683547	0.8515499481768869	0.8339283554982823	0.8160553424355664	0.7874615387267478	0.788879327910373	0.8233548867592835	0.7810393755775383	0.7288253037005212	0.7735845482354025	0.7548582890886218	SDHD	His50Arg	NC_000011.10:112087953:A:G	149A>G	11	112087953	A	G	11	ENSG00000204370	5678	201953	CCSBVarC006156	ALE00006156	ENSP00000364699.3	CEGS2	CegsMutGDEh1012	G11	GDEhDisVCh_40066	B02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	21948.0	single nucleotide variant	NM_003002.4(SDHD):c.149A>G (p.His50Arg)	6392.0	SDHD	HGNC:10683	Benign/Likely benign	0.0	Nov 01, 2024	11214077.0	-	RCV000007318|RCV000034696|RCV002228009|RCV000023207|RCV003924810|RCV000129149|RCV000122007|RCV000238643|RCV000988743	MONDO:MONDO:0021533,MedGen:C0349535,OMIM:114900|MedGen:C3661900|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072||MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286	Carcinoid tumor of intestine|not provided|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|Pheochromocytoma|SDHD-related disorder|Hereditary cancer-predisposing syndrome|not specified|Paragangliomas 1|Carney-Stratakis syndrome	germline;unknown	germline	GRCh38	NC_000011.10	11	112087953.0	112087953.0	11q23.1	criteria provided, multiple submitters, no conflicts	23.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016777,UniProtKB:O14521#VAR_017871,OMIM:602690.0019	3.0	6909.0	112087953.0	A	G	-	-	-	-	-	-	149A>G 	His50Arg	NM_003002.4	2.0	Benign	Likely benign	6909	11	112087953.0	A	G	H	R	rs11214077	11	111958677	11	111463887	50	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.149A>G	p.His50Arg	c.149A>G	p.His50Arg	principal1	Y	1	YES	Select	+	CAC	2	0	A	./.	./.	./.	./.	0.065	0.91343	T	0.133	0.92967	T	0.985	0.61134	D	0.804	0.58344	P	0.63	0.78586	D	simple_aae	37.0	63.0	2.875	0.83215	M	-1.91	0.84629	N	0.533	0.69591	0.6916	0.93046	D	0.7712	0.92199	D	9	0.00989148	0.00218	T	.	.	.	0.681	0.88248	.	.	.	.	.	0.949941544596	0.94900	0.8321952904549407	0.83077	0.366577337986	0.37946	0.511648774147	0.40396	T	0.604841	0.87272	D	0.00267657	0.51703	T	0.244042	0.85234	D	0.0389905626794946	0.03481	T	0.876112	0.58713	D	0.17611195	0.38200	0.159546	0.37087	0.16287881	0.36096	0.17666198	0.40081	-3.62	0.18161	T	0.134	0.49161	B	0.893627502624236	0.75625	0.99399060	0.97449	0.427	0.66558	.	.	.	.	.	.	3.521592	0.49453	22.8	0.99613682030186279	0.75021	0.739987	0.68322	D	0.49081428387198	0.66377	4.96495	0.424179265049854	0.62877	4.534256	4.9	4.9	0.63598	.	.	2.521	0.45325	7.662000	0.64345	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.796	0.37596	635	0.64545	33	0.006589456869009584	0	0.0	17	0.016898608349900597	14	0.020172910662824207	0	0.0	2	0.002044989775051125	2054	264690	0.0077600214	segdup	699	109374	6.390920e-03	4	1314	208100	6.314270e-03	5	1570	236924	6.626600e-03	5	13	7164	1.814630e-03	0	126	17112	7.363250e-03	0	18	2320	7.758620e-03	0	0	9046	0.000000e+00	0	78	13360	5.838320e-03	0	408	42768	9.539840e-03	4	26	15690	1.657110e-03	0	408	42768	9.539840e-03	4	24	16218	1.479840e-03	0	212	30524	6.945350e-03	0	52	6212	8.370900e-03	0	0	13416	0.000000e+00	0	106	16700	6.347310e-03	0	811	89556	9.055790e-03	5	53	30608	1.731570e-03	0	811	89556	9.055790e-03	5	23	14902	1.543420e-03	0	251	34260	7.326330e-03	1	80	9572	8.357710e-03	0	0	17692	0.000000e+00	0	138	21598	6.389480e-03	0	961	102754	9.352430e-03	4	53	30526	1.736220e-03	0	961	102754	9.352430e-03	4	.	11829	1609602	7.349020e-03	54	15	912	1.644740e-02	1	135	74930	1.801680e-03	0	15	912	1.644740e-02	1	607	60020	1.011330e-02	2	260	29574	8.791510e-03	2	0	44866	0.000000e+00	0	430	63988	6.720010e-03	2	39	6058	6.437770e-03	0	9648	1175866	8.205020e-03	43	164	91004	1.802120e-03	3	1800	206608	0.008712150545961434	1	418	0.0023923444976076554	1	4578	2.1843599825251202E-4	21	11044	0.001901484969214053	9	1138	0.007908611599297012	9	1030	0.008737864077669903	1	1858	5.382131324004305E-4	0	326	0	154	20432	0.007537196554424432	22	11462	0.0019193857965451055	2	6436	3.1075201988812925E-4	1996	247432	0.008066862814833974	Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Paragangliomas_1|not_specified|not_provided|Carcinoid_tumor_of_intestine|SDHD-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112087953A>G	ClinGen:CA016777|OMIM:602690.0019|UniProtKB:O14521#VAR_017871	C0031511|C0027672|CN166604|C1868633|C1847319|C3494181|CN169374|C3661900|C0349535	171300|606864|168000|114900	29072|140162|201|97286|29072	.	His	Arg	76.82	0.9619565217391305																																																																																																																																																																																																																																																																																																																																																																																																																																																																													177			76.82	Positively-charged	Histidine												-3.2																		155									-68.9				106.7						C (loop/coil)	C (loop/coil)								Mitochondrion				76.82	96.19565	70-90	$\geqslant$90	114900;171300;606864;171300;168000;606864	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	CARCINOID TUMORS, INTESTINAL; PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA; PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	false	0.7948199453354845	0.7711599139076848	false	false	false
BAP1	BAP1_Asn290Ser	B_13-14	-0.3729935111171861	0.7201914707181801	0.7774116871608796	-0.4871826502271317	0.641013974880829	0.6886771919826237	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5997608985678954	0.6088212885008897	0.550416229275362	0.6653560886851279	0.5802564524039382	0.5829662683974173	0.5174033495357729	0.5068241364844683	0.5800256405677802	0.5216900002602729	0.5632739984503761	0.5412809521104266	0.6485291872590617	0.653688768323408	0.7506865368024755	0.5791424582904511	0.6543685785514032	0.6582408450253642	BAP1	Asn290Ser	NC_000003.12:52405827:T:C	869A>G	3	52405827	T	C	3	ENSG00000163930	3760	0	CCSBVarC009478	ALE00009839	ENSP00000417132.1																																	453076.0	single nucleotide variant	NM_004656.4(BAP1):c.869A>G (p.Asn290Ser)	8314.0	BAP1	HGNC:950	Benign/Likely benign	0.0	Jan 28, 2024	747079481.0	-	RCV000562577|RCV000843751|RCV001079643|RCV003952834	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|	Hereditary cancer-predisposing syndrome|not provided|BAP1-related tumor predisposition syndrome|BAP1-related disorder	germline;unknown	germline	GRCh38	NC_000003.12	3	52405827.0	52405827.0	3p21.1	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA2436980	2.0	472716.0	52405827.0	T	C	-	-	-	-	-	-	869A>G 	Asn290Ser	NM_004656.4	2.0	Benign	Likely benign	472716	3	52405827.0	T	C	N	S	rs747079481	3	52439843	3	52414883	290	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.869A>G	p.Asn290Ser	c.869A>G	p.Asn290Ser	principal1	Y	1	YES	Select	-	AAC	2	0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	0.697	0.05881	T	0.0	0.02950	B	0.0	0.01384	B	0.02	0.08015	N	simple_aae	98.0	2.0	-1.525	0.00486	N	-0.57	0.17141	N	0.027	0.00817	-1.0098	0.26903	T	0.0329	0.14050	T	10	0.004228443	0.00083	T	0.005388	0.13568	T	0.078	0.22615	0.356	0.35591	Q92560	N290S	Gain of relative solvent accessibility (P = 0.0024)| Gain of glycosylation at S285 (P = 0.0098)| Gain of solvent accessibility (P = 0.012)| Loss of sheet (P = 0.0228)| Gain of loop (P = 0.0502)	0.328222422547	0.32018	0.2007139702985778	0.19805	0.297888856719	0.31871	0.235256686807	0.02381	T	0.021852	0.16819	T	-0.644951	0.00076	T	-0.70131	0.05566	T	0.0150392539939985	0.00323	T	0.616438	0.23328	T	0.020683967	0.00634	0.020063097	0.00119	0.024449877	0.01269	0.018665047	0.00063	-2.044	0.03355	T	0.048	0.00099	B	4.71611775438763e-05	0.01873	0.94490990	0.93104	0.033	0.07179	.	.	.	.	.	.	1.173624	0.15654	11.99	0.76300458640983959	0.11599	0.027530	0.02227	N	-1.10195154957138	0.06531	0.3046936	-0.841934346995282	0.13249	0.6995833	5.38	3.55	0.39700	-0.00352	0.21537	0.83	0.27208	2.762000	0.34693	-1.018	0.01749	0.826	0.30165	0.995000	0.32549	0.841	0.39729	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	72	264690	2.7201633E-4	.	68	109402	6.215610e-04	0	118	208070	5.671170e-04	0	122	236922	5.149370e-04	0	0	7164	0.000000e+00	0	67	17112	3.915380e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	0	42766	0.000000e+00	0	0	15690	0.000000e+00	0	67	17112	3.915380e-03	0	0	16214	0.000000e+00	0	115	30522	3.767770e-03	0	0	6212	0.000000e+00	0	1	13414	7.454900e-05	0	0	16730	0.000000e+00	0	0	89508	0.000000e+00	0	0	30608	0.000000e+00	0	115	30522	3.767770e-03	0	0	14898	0.000000e+00	0	119	34258	3.473640e-03	0	0	9570	0.000000e+00	0	1	17692	5.652270e-05	0	0	21628	0.000000e+00	0	0	102730	0.000000e+00	0	0	30526	0.000000e+00	0	119	34258	3.473640e-03	0	.	147	1613970	9.107980e-05	0	143	60004	2.383170e-03	0	1	74936	1.334470e-05	0	0	912	0.000000e+00	0	143	60004	2.383170e-03	0	0	29608	0.000000e+00	0	0	44904	0.000000e+00	0	0	64032	0.000000e+00	0	0	5986	0.000000e+00	0	0	1180038	0.000000e+00	0	0	91082	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	2	610	0.003278688524590164	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	2	14050	1.4234875444839857E-4	Hereditary_cancer-predisposing_syndrome|not_provided|BAP1-related_disorder|BAP1-related_tumor_predisposition_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52405827T>C	ClinGen:CA2436980	C0027672|C3661900|C3280492	614327	140162|289539	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Asn	Ser	39.41	0.8407643312101911																																																																																																																																																																																																																																																																																																																																																																																																																																																																													132			39.41	Polar/Neutral	Asparagine		Ubiquitin carboxyl-terminal hydrolase BAP1										-3.5																		132									-174.4				153.6						C (loop/coil)	C (loop/coil)												39.41	84.07643	$\leqslant$50	10-90	614327	autosomal dominant	GenCC	Rare genetic tumor	1	TUMOR PREDISPOSITION SYNDROME 1	false	0.6088212885008897	0.5997608985678954	false	false	false
SHOC2	SHOC2_Thr205Ala	B_13-14	-0.7932454090740622	0.45367827402196725	0.5413592105365845	4.52590031283961	0.0027129591164138946	0.005519157404234475	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7075727203285737	0.7063913876133043	0.6875646229451686	0.7714478310124262	0.8133626100900302	0.744958780016568	0.8159820040603378	0.842923168629661	0.7591295924508255	0.8021604767593975	0.6844864090432399	0.7142719568173694	0.6739355559727983	0.7838020515503995	0.7837660695740271	0.5729687691309397	0.7282963661833688	0.7008734838397779	SHOC2	Thr205Ala	NC_000010.11:110964971:A:G	613A>G	10	110964971	A	G	10	ENSG00000108061	11602	0	CCSBVarC028039	ALE00018465	ENSP00000358464.5																																	442530.0	single nucleotide variant	NM_007373.4(SHOC2):c.613A>G (p.Thr205Ala)	8036.0	SHOC2	HGNC:15454	Likely benign	0.0	Apr 18, 2017	768411950.0	-	RCV000521093	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	RASopathy	germline	germline	GRCh38	NC_000010.11	10	110964971.0	110964971.0	10q25.2	reviewed by expert panel	1.0	-	N	ClinGen:CA5689601	2.0	448933.0	110964971.0	A	G	-	-	-	-	-	-	613A>G 	Thr205Ala	NM_007373.4	3.0	Benign	Likely benign	448933	10	110964971.0	A	G	T	A	rs768411950	10	112724729	10	112714719	205	SHOC2	ENSG00000108061	ENST00000691441	ENSP00000509686	Q9UQ13	SHOC2_HUMAN	.	.	c.613A>G	p.Thr205Ala	principal1	Y	.	.	.	+	ACT	1	0	A	A/A	A/A	A/A	A/A	.	0.34240	.	.	0.39834	.	0.485	0.57842	P	0.23	0.72002	B	.	0.60618	.	.	.	.	2.615	0.76302	M	.	0.43722	.	.	0.71096	-0.9193	0.45454	T	0.1724	0.51276	T	10	.	0.48935	.	0.017149	0.38486	T	.	0.57011	0.293	0.25438	Q9UQ13	T205A	Loss of methylation at K209 (P = 0.1135)| Gain of MoRF binding (P = 0.1344)| Loss of disorder (P = 0.1735)| Gain of helix (P = 0.1736)| Gain of ubiquitination at K209 (P = 0.2261)	.	0.40260	.	0.63105	.	0.84207	0.790986120701	0.80559	T	0.271683	0.64203	T	-0.154376	0.27280	T	-0.137561	0.60050	T	0.258627751812722	0.22980	T	.	0.68925	.	0.22402976	0.44711	0.24907	0.50279	0.20188108	0.41895	0.23230855	0.48205	-5.149	0.42680	T	.	0.31635	.	0.875279691495204	0.74491	0.02179968	0.50361	0.554	0.74849	.	.	.	.	.	.	3.467778	0.48451	22.6	0.99717881961411736	0.81861	0.899008	0.84235	D	0.573813009677373	0.71391	5.666972	0.63331388771494	0.77249	6.666899	5.66	5.66	0.87274	.	.	9.325	0.96016	11.226000	0.89948	0.751	0.87726	1.0	0.71675	1.000000	0.68239	1.0	0.97202	916	0.20739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6	109120	5.498530e-05	0	13	207686	6.259450e-05	0	13	236340	5.500550e-05	0	0	7158	0.000000e+00	0	0	17086	0.000000e+00	0	0	2320	0.000000e+00	0	0	9036	0.000000e+00	0	0	13172	0.000000e+00	0	0	42756	0.000000e+00	0	6	15686	3.825070e-04	0	6	15686	3.825070e-04	0	0	16178	0.000000e+00	0	0	30454	0.000000e+00	0	0	6206	0.000000e+00	0	0	13402	0.000000e+00	0	0	16512	0.000000e+00	0	1	89492	1.117420e-05	0	12	30600	3.921570e-04	0	12	30600	3.921570e-04	0	0	14862	0.000000e+00	0	0	34190	0.000000e+00	0	0	9564	0.000000e+00	0	0	17678	0.000000e+00	0	0	21384	0.000000e+00	0	1	102560	9.750390e-06	0	12	30518	3.932110e-04	0	12	30518	3.932110e-04	0	.	31	1613690	1.921060e-05	0	30	91078	3.293880e-04	0	0	75032	0.000000e+00	0	0	912	0.000000e+00	0	0	59980	0.000000e+00	0	0	29602	0.000000e+00	0	0	44880	0.000000e+00	0	0	63774	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179874	8.475480e-07	0	30	91078	3.293880e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RASopathy	reviewed_by_expert_panel	NC_000010.11:g.110964971A>G	ClinGen:CA5689601	C5555857	.	536391	.	Thr	Ala	97.64	0.5070422535211268																																																																																																																																																																																																																																																																																																																																																																																																																																																																													72			97.64	Polar/Neutral	Threonine		Leucine-rich repeat protein SHOC-2								0.0068		-0.7									T205-K228 (PDBs: 7TYG)	 T205-R182 (PAE:  2.0), T205-K228 (PAE: 1.0)	T205-R182 (PDBs: 7TVG, 7UPI), T205-K228 (PDBs: 7TVG, 7SD1, 7T7A, 7TYG, 7SD0, 7TVF, 7UPI)							119									-108.6		Pocket 2: Mean pLDDT: 98.33, Volume: 310.95 Å³, Druggability score: 0.01		-23.8			LRR 5			C (loop/coil)	C (loop/coil)												97.64	50.704224	>90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5		false	0.7063913876133043	0.7075727203285737	false	false	false
BRIP1	BRIP1_Leu195Pro	B_13-14	1.2668702182308096	0.27186458798147173	0.355619354398871	-0.678345949718366	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6706487218038804	0.6845999730545806	0.6619862974393379	0.7010384602071746	0.6907632379094004	0.7039040401396446	0.7390499080056441	0.673038394166782	0.6926728793366373	0.6852525316696855	0.6743093523092599	0.635168935954343	0.6687581722736452	0.7084880816520189	0.709404041077712	0.6387200632089903	0.6948905937999014	0.7061285076534177	BRIP1	Leu195Pro	NC_000017.11:61847144:A:G	584T>C	17	61847144	A	G	17	ENSG00000136492	55128	0	CCSBVarC002407	ALE00002407	ENSP00000259008.2	RC4	RC4_Mut_GDEh1031	G07	GDEhDisVCh_40040	B12	2	RC4_Mut_GDDh1031	G07	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	133650.0	single nucleotide variant	NM_032043.3(BRIP1):c.584T>C (p.Leu195Pro)	83990.0	BRIP1	HGNC:20473	Benign/Likely benign	0.0	Aug 21, 2024	4988347.0	-	RCV000116162|RCV000120407|RCV001082551|RCV000410203|RCV000411259|RCV000589840|RCV001798361|RCV004528812|RCV000990029	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MedGen:C3661900|MedGen:CN221562|MedGen:CN239206|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast;Fanconi anemia complementation group J|Fanconi anemia complementation group J|Ovarian neoplasm|not provided|Breast and/or ovarian cancer|BRIP1-related disorder|Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61847144.0	61847144.0	17q23.2	criteria provided, multiple submitters, no conflicts	25.0	-	N	ClinGen:CA157725	2.0	128193.0	61847144.0	A	G	-	-	-	-	-	-	584T>C 	Leu195Pro	NM_032043.3	2.0	Benign	Likely benign	128193	17	61847144.0	A	G	L	P	rs4988347	17	59924505	17	57279287	195	BRIP1	ENSG00000136492	ENST00000683039	ENSP00000508303	Q9BX63	FANCJ_HUMAN	.	.	c.584T>C	p.Leu195Pro	principal2	Y	.	.	.	-	CTC	2	0	A	A/A	A/A	A/A	A/A	.	0.13823	.	.	0.15573	.	0.0	0.02950	B	0.001	0.04348	B	.	0.37131	.	.	.	.	0.75	0.18917	N	.	0.08443	.	.	0.14123	-0.9191	0.45481	T	0.1553	0.48453	T	9	.	0.00085	.	0.03251	0.54133	D	.	0.29213	.	.	.	.	.	.	0.39799	.	0.47148	.	0.28563	0.3499096632	0.17890	T	0.06698	0.32835	T	-0.505713	0.00508	T	-0.505056	0.21493	T	0.00119638136319552	0.00012	T	.	0.13035	.	0.031770874	0.03049	0.031210301	0.01687	0.029862495	0.02528	0.03966814	0.04125	-4.048	0.24602	T	.	0.00668	.	0.00173275598557616	0.12269	0.23876125	0.74722	0.019	0.02684	.	.	.	.	.	.	0.472332	0.08447	5.175	0.2264141844658854	0.00915	0.039188	0.05557	N	-1.11276007648918	0.06339	0.2952269	-1.00712536356647	0.09467	0.4800915	5.26	-0.0114	0.13280	-1.01	0.15704	0.364	0.20126	3.456000	0.38560	-0.592	0.0465	0.393	0.262	0.999000	0.35501	0.001	0.02614	45	0.97779	4	7.987220447284345E-4	0	0.0	1	9.940357852882703E-4	1	0.001440922190201729	0	0.0	2	0.002044989775051125	318	264690	0.0012014054	.	270	109370	2.468680e-03	1	407	208056	1.956200e-03	2	467	236808	1.972060e-03	2	2	7160	2.793300e-04	0	11	17112	6.428240e-04	0	0	2320	0.000000e+00	0	0	9038	0.000000e+00	0	149	13378	1.113770e-02	1	94	42762	2.198210e-03	0	8	15688	5.099440e-04	0	94	42762	2.198210e-03	0	8	16212	4.934620e-04	0	21	30524	6.879830e-04	1	0	6208	0.000000e+00	0	0	13404	0.000000e+00	0	175	16718	1.046780e-02	1	178	89524	1.988290e-03	0	13	30604	4.247810e-04	0	178	89524	1.988290e-03	0	8	14896	5.370570e-04	0	25	34260	7.297140e-04	1	0	9568	0.000000e+00	0	0	17680	0.000000e+00	0	197	21616	9.113620e-03	1	211	102658	2.055370e-03	0	13	30522	4.259220e-04	0	211	102658	2.055370e-03	0	.	3615	1613712	2.240180e-03	7	525	64018	8.200820e-03	0	32	75020	4.265530e-04	0	0	912	0.000000e+00	0	56	60024	9.329600e-04	1	0	29594	0.000000e+00	0	0	44838	0.000000e+00	0	525	64018	8.200820e-03	0	0	6056	0.000000e+00	0	2836	1179684	2.404030e-03	5	39	91082	4.281860e-04	1	322	198354	0.001623360254897809	0	360	0	0	2728	0	5	9426	5.304476978569913E-4	0	794	0	0	964	0	0	672	0	0	276	0	28	15672	0.0017866258295048494	5	9786	5.109339873288372E-4	0	3400	0	355	229246	0.0015485548275651483	BRIP1-related_disorder|Breast_and/or_ovarian_cancer|Fanconi_anemia_complementation_group_J|not_specified|Ovarian_neoplasm|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.61847144A>G	ClinGen:CA157725	CN239206|CN221562|C1836860|CN169374|C0919267|C0027672|C0346153|C3661900	609054|114480	84|140162|227535	.	Leu	Pro	27.47	0.823170731707317																																																																																																																																																																																																																																																																																																																																																																																																																																																																													135			27.47	Aliphatic	Leucine		Fanconi anemia group J protein							Helicase ATP-binding			3.8																		131									79.8				131.5				dbSNP: rs4988347; Variant type: LB/B; AA change: Leu195Pro; PTM type: Acetylation; PTM morphology: kVDSGkTVKL*N; Var class: II&rs4988347		C (loop/coil)	C (loop/coil)												27.47	82.31707	$\leqslant$50	10-90	114480;609054;609054;114480	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCONI ANEMIA, COMPLEMENTATION GROUP J; BREAST CANCER	false	0.6845999730545806	0.6706487218038804	false	false	false
F9	F9_Val195Gly	B_13-14	1.4590067567152354	0.18792919742567601	0.2674700201811037	0.10231224544958964	0.921378042908125	0.9351375601418193	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6668392062577737	0.6505201464793413	0.5578136410154075	0.6832358949453212	0.6453160366743771	0.6712526467619225	0.6918501874815227	0.6718340405070442	0.707602795131551	0.44853295945411414	0.6441601589305808	0.653868413883244	0.6506551060423224	0.61879803284171	0.6588689947590914	0.667094322576701	0.6568801340281019	0.6798099986323033	F9	Val195Gly	NC_000023.11:139551125:T:G	584T>G	23	139551125	T	G	X	ENSG00000101981	52861	0	CCSBVarC030560	ALE00033565	ENSP00000218099.2																																	1921180.0	single nucleotide variant	NM_000133.4(F9):c.584T>G (p.Val195Gly)	2158.0	F9	HGNC:3551	Likely benign	0.0	Aug 23, 2023	-1.0	-	RCV002632292	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139551125.0	139551125.0	Xq27.1	criteria provided, single submitter	1.0	-	N	-	2.0	2184672.0	139551125.0	T	G	-	-	-	-	-	-	584T>G 	Val195Gly	NM_000133.4	1.0	Benign	Likely benign	2184672	X	139551125.0	T	G	V	G	rs374674030	X	138633284	X	138460950	195	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.584T>G	p.Val195Gly	c.584T>G	p.Val195Gly	principal1	Y	1	YES	Select	+	GTT	2	0	T	T/T	T/T	T/T	T/T	0.349	0.12418	T	0.376	0.16408	T	0.0	0.02950	B	0.002	0.06938	B	0.15	0.45549	N	simple_aae	85.0	15.0	0	0.06502	N	-1.61	0.38726	N	0.132	0.17857	-0.1972	0.77642	T	0.6775	0.88803	D	10	0.1398688	0.26271	T	0.063227	0.68789	D	0.301	0.61985	.	.	.	.	.	0.941715556567	0.94064	0.9536002345262253	0.95316	0.852731849783	0.68423	0.307745546103	0.11558	T	0.471326	0.80258	T	-0.0125828	0.49576	T	-0.14336	0.59542	T	0.0311624814342412	0.02159	T	0.483452	0.15897	T	0.23625271	0.46144	0.14323859	0.33951	0.23625271	0.46144	0.14323859	0.33950	-4.071	0.26473	T	0.0972	0.21572	B	0.962737860313214	0.82113	0.99982518	0.99765	0.329	0.59271	.	.	.	.	.	.	0.903261	0.12793	9.29	0.41800775336298984	0.03062	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	3.33	0.60393	1.842	0.38995	2.316000	0.32189	0.665	0.62996	0.186	0.24222	0.258000	0.24039	0.062	0.16152	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	1	80340	1.244710e-05	0	1	151858	6.585100e-06	0	1	172272	5.804770e-06	0	0	5701	0.000000e+00	0	1	13666	7.317430e-05	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9932	0.000000e+00	0	0	30956	0.000000e+00	0	0	9951	0.000000e+00	0	1	13666	7.317430e-05	0	0	13132	0.000000e+00	0	1	24389	4.100210e-05	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12189	0.000000e+00	0	0	64675	0.000000e+00	0	0	19071	0.000000e+00	0	1	24389	4.100210e-05	0	0	12062	0.000000e+00	0	1	27167	3.680940e-05	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15994	0.000000e+00	0	0	73497	0.000000e+00	0	0	19006	0.000000e+00	0	1	27167	3.680940e-05	0	.	4	1209607	3.306860e-06	0	3	57267	5.238620e-05	0	3	57267	5.238620e-05	0	0	685	0.000000e+00	0	1	45773	2.184690e-05	0	0	22036	0.000000e+00	0	0	33786	0.000000e+00	0	0	46636	0.000000e+00	0	0	4374	0.000000e+00	0	0	894681	0.000000e+00	0	0	56793	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551125T>G	.	C0008533|C2749016	306900|300807	98879	.	Val	Gly	34.93	0.9295774647887324																																																																																																																																																																																																																																																																																																																																																																																																															0.972		0.989		1.025		1.0		0.998																																																						132			34.93	Aliphatic	Valine		Coagulation factor IX										4.2																		117									-66.7			Activation peptide	107.7						C (loop/coil)	C (loop/coil)												34.93	92.95775	$\leqslant$50	$\geqslant$90	306900;300807	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.6505201464793413	0.6668392062577737	false	false	false
F9	F9_Pro197Ser	B_13-14	-3.0775892024267777	0.017875819223215413	0.04189302419182999	2.832744971710679	0.02530639449289021	0.038794681616084827	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6394181852530922	0.6494707504120919	0.613515500493073	0.7315884586080192	0.624395997886716	0.6335469283399147	0.6153481278182761	0.6110483256564949	0.721887642509247	0.5859944693975011	0.7104421750520757	0.6951178844152921	0.6517457288615531	0.6377436701169371	0.7412892747067916	0.6410365315886448	0.5884993257721081	0.5837184860908925	F9	Pro197Ser	NC_000023.11:139551130:C:T	589C>T	23	139551130	C	T	X	ENSG00000101981	52861	0	CCSBVarC030562	ALE00035811	ENSP00000218099.2																																	2009495.0	single nucleotide variant	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	2158.0	F9	HGNC:3551	Likely benign	0.0	Aug 30, 2022	-1.0	-	RCV002710164	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139551130.0	139551130.0	Xq27.1	criteria provided, single submitter	1.0	-	N	-	2.0	1959260.0	139551130.0	C	T	-	-	-	-	-	-	589C>T 	Pro197Ser	NM_000133.4	1.0	Benign	Likely benign	1959260	X	139551130.0	C	T	P	S	rs867548424	X	138633289	X	138460955	197	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.589C>T	p.Pro197Ser	c.589C>T	p.Pro197Ser	principal1	Y	1	YES	Select	+	CCT	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	1.0	0.02435	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.26006	N	simple_aae	93.0	7.0	-1.845	0.00268	N	0.67	0.02246	N	0.041	0.01414	-0.3909	0.72190	T	0.3717	0.72963	T	10	0.036299646	0.01924	T	0.027201	0.49836	D	0.197	0.47720	0.434	0.48357	P00740	P197S	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.445173020498	0.43755	0.9073591802246402	0.90650	0.63775699092	0.57233	0.310453176498	0.11967	T	0.277936	0.64861	T	-0.359869	0.03974	T	-0.562367	0.15863	T	0.0218413153825192	0.00888	T	0.561944	0.19427	T	0.030987347	0.02834	0.06478413	0.13037	0.030987347	0.02833	0.06478413	0.13037	-3.242	0.16375	T	0.0598	0.01911	B	0.0725587346858254	0.40442	0.99871650	0.98926	0.078	0.22017	.	.	.	.	.	.	-0.950913	0.00845	0.029	0.14416938963530473	0.00314	.	.	.	.	.	.	.	.	.	4.94	-2.38	0.06232	-1.7	0.12702	-0.387	0.07437	-0.073000	0.12324	-1.556	0.00956	0.001	0.13799	0.002000	0.18256	0.003	0.0525	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	80343	0.000000e+00	0	1	151864	6.584840e-06	0	1	172276	5.804640e-06	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9934	0.000000e+00	0	0	30955	0.000000e+00	0	0	9952	0.000000e+00	0	.	.	.	.	1	13134	7.613830e-05	0	0	24389	0.000000e+00	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12192	0.000000e+00	0	0	64674	0.000000e+00	0	0	19073	0.000000e+00	0	1	13134	7.613830e-05	0	1	12064	8.289120e-05	0	0	27167	0.000000e+00	0	0	7084	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	0	73493	0.000000e+00	0	0	19008	0.000000e+00	0	1	12064	8.289120e-05	0	.	2	1210973	1.651560e-06	0	1	57790	1.730400e-05	0	1	57790	1.730400e-05	0	0	688	0.000000e+00	0	0	46015	0.000000e+00	0	0	22039	0.000000e+00	0	0	33835	0.000000e+00	0	0	46864	0.000000e+00	0	0	4352	0.000000e+00	0	1	894804	1.117560e-06	0	0	56962	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139551130C>T	.	C0008533|C2749016	306900|300807	98879	.	Pro	Ser	34.65	0.7867647058823529																																																																																																																																																																																																																																																																																																																																																																																																															0.931		0.928		0.921		0.905		0.923																																																						107			34.65	Special, No backbone hydrogen	Proline		Coagulation factor IX										1.6																		115									-69.8			Activation peptide	124.3						C (loop/coil)	C (loop/coil)												34.65	78.67647	$\leqslant$50	10-90	306900;300807	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.6494707504120919	0.6394181852530922	false	false	false
FARS2	FARS2_Ser57Cys	B_13-14	1.8559224483749528	1.0	1.0	-1.0487307151913527	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5950728854168692	0.6319202285646546	0.4692330731465848	0.6479767284946205	0.6328095205960982	0.5813301480972692	0.732822383886189	0.6542069773476665	0.7066524876243013	0.5119526068828096	0.6054178169736549	0.5774204151377879	0.42983791230834956	0.6114120638445297	0.5893009693649396	0.4265135394103599	0.6584226401556542	0.6127253556959505	FARS2	Ser57Cys	NC_000006.12:5368740:C:G	170C>G	6	5368740	C	G	6	ENSG00000145982	12653	0	CCSBVarC011870	ALE00009031	ENSP00000274680.4																																	211248.0	single nucleotide variant	NM_006567.5(FARS2):c.170C>G (p.Ser57Cys)	10667.0	FARS2	HGNC:21062	Benign/Likely benign	0.0	Jan 29, 2024	34382405.0	-	RCV000196113|RCV000539812|RCV004705026	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	not specified|Combined oxidative phosphorylation defect type 14|not provided	germline	germline	GRCh38	NC_000006.12	6	5368740.0	5368740.0	6p25.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA320525,UniProtKB:O95363#VAR_052642	2.0	214327.0	5368740.0	C	G	-	-	-	-	-	-	170C>G 	Ser57Cys	NM_006567.5	2.0	Benign	Likely benign	214327	6	5368740.0	C	G	S	C	rs34382405	6	5368973	6	5313972	57	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.170C>G	p.Ser57Cys	c.170C>G	p.Ser57Cys	principal1	Y	1	.	.	+	TCC	2	0	C	C/C	C/C	C/C	C/C	0.02	0.49772	D	0.028	0.55281	D	0.533	0.37784	P	0.062	0.26932	B	0.04	0.13669	N	simple_aae	96.0	4.0	1.625	0.41446	L	-2.77	0.58763	D	0.439	0.47612	-1.0166	0.24757	T	0.0532	0.22381	T	10	0.0069410205	0.00155	T	.	.	.	0.081	0.23465	.	.	.	.	.	0.650100694605	0.64445	0.6181731990165388	0.61574	0.193570370082	0.21414	0.456006199121	0.32723	T	0.255173	0.62383	T	-0.4711	0.00788	T	-0.429882	0.29590	T	0.0278036979532336	0.01650	T	.	0.50927	.	0.19544396	0.41017	0.09490794	0.22449	0.18928379	0.40151	0.09419375	0.22246	-8.409	0.63900	D	0.0774	0.06880	LB	0.305673527694043	0.54432	0.28674290	0.76416	0.65	0.80521	.	.	.	.	.	.	3.426274	0.47684	22.5	0.98028766321917793	0.37846	0.207729	0.33177	N	-0.0754966821653467	0.38198	2.253606	0.0205336924994149	0.40378	2.430867	5.45	5.45	0.79660	3.61	0.66044	1.388	0.34154	4.823000	0.45211	0.599	0.40292	0.001	0.13799	1.000000	0.68239	0.985	0.61072	944	0.12756	41	0.008186900958466454	37	0.02798789712556732	0	0.0	3	0.004322766570605188	1	9.92063492063492E-4	0	0.0	2308	264690	0.008719634	.	257	109370	2.349820e-03	1	520	207938	2.500750e-03	5	500	236460	2.114520e-03	4	190	7160	2.653630e-02	1	56	17106	3.273710e-03	0	0	2320	0.000000e+00	0	0	9032	0.000000e+00	0	0	13392	0.000000e+00	0	9	42758	2.104870e-04	0	1	15688	6.374300e-05	0	190	7160	2.653630e-02	1	397	16210	2.449110e-02	5	96	30512	3.146300e-03	0	0	6208	0.000000e+00	0	0	13386	0.000000e+00	0	0	16732	0.000000e+00	0	18	89426	2.012840e-04	0	2	30606	6.534670e-05	0	397	16210	2.449110e-02	5	368	14898	2.470130e-02	4	105	34248	3.065870e-03	0	0	9554	0.000000e+00	0	0	17666	0.000000e+00	0	0	21626	0.000000e+00	0	19	102338	1.856590e-04	0	2	30524	6.552220e-05	0	368	14898	2.470130e-02	4	.	2436	1614106	1.509190e-03	25	1902	75000	2.536000e-02	24	1902	75000	2.536000e-02	24	0	912	0.000000e+00	0	213	60010	3.549410e-03	0	0	29604	0.000000e+00	0	0	44870	0.000000e+00	0	0	64040	0.000000e+00	0	6	6062	9.897720e-04	1	181	1180024	1.533870e-04	0	4	91074	4.392030e-05	0	15	92548	1.620780567921511E-4	9	174	0.05172413793103448	0	2676	0	93	4216	0.022058823529411766	6	794	0.007556675062972292	1	958	0.0010438413361169101	0	656	0	0	274	0	16	8052	0.001987083954297069	102	4390	0.023234624145785875	0	3332	0	140	110348	0.001268713524486171	not_specified|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5368740C>G	ClinGen:CA320525|UniProtKB:O95363#VAR_052642	CN169374|C4755312	614946	319519	.	Ser	Cys	96.89	0.47692307692307695																																																																																																																																																																																																																																																																																																																																																																																																																																																																													62			96.89	Polar/Neutral	Serine												-0.8										 S57-V50 (PAE:  2.0)	S57-V50 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 8P8X), S57-V51 (PDBs: 8P8X), S57-E52 (PDBs: 3TUP)							105									-111.0	Morphology: VVELLGksYPQDDHS			123.6				dbSNP: rs34382405; Variant type: LB/B; AA change: Ser57Cys; PTM type: Phosphorylation; PTM morphology: ELLGksYPQDD; Var class: I&rs34382405		B (undefined)	E (parallel sheets)	Beta strand											96.89	47.692307	>90	10-90	614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.6319202285646546	0.5950728854168692	false	false	false
SHOC2	SHOC2_Ser403Gly	B_13-14	-3.861317166307788	0.006200919790985726	0.018919739298374975	6.38788613265301	0.00037154228352073335	0.001092596298494464	2025_01_Batch_13-14	false	false	false	false	true	false	false	false	false	false	false	false	0.7915229085642737	0.8088907166064171	0.7043549567355222	0.8521336583343527	0.9070570140039124	0.8609562362059043	0.8567225962758129	0.9193896580764371	0.819996152375132	0.6658382250976647	0.801478672671309	0.7645914396659218	0.8651898761359957	0.8947243699313876	0.8842711642935734	0.7428716883733797	0.8163027605415252	0.8184543774626254	SHOC2	Ser403Gly	NC_000010.11:111007576:A:G	1207A>G	10	111007576	A	G	10	ENSG00000108061	11602	0	CCSBVarC028051	ALE00020822	ENSP00000358464.5																																	969662.0	single nucleotide variant	NM_007373.4(SHOC2):c.1207A>G (p.Ser403Gly)	8036.0	SHOC2	HGNC:15454	Likely benign	0.0	-	-1.0	-	RCV001261152	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	Noonan syndrome	paternal	germline	GRCh38	NC_000010.11	10	111007576.0	111007576.0	10q25.2	no assertion criteria provided	1.0	-	N	-	2.0	981611.0	111007576.0	A	G	-	-	-	-	-	-	1207A>G 	Ser403Gly	NM_007373.4		Benign	Likely benign	981611	10	111007576.0	A	G	S	G	rs1564730663	10	112767334	10	112757324	403	SHOC2	ENSG00000108061	ENST00000689300	ENSP00000510639	Q9UQ13	SHOC2_HUMAN	.	.	c.1207A>G	p.Ser403Gly	principal1	Y	.	.	.	+	AGT	1	0	A	A/A	A/A	A/A	A/A	.	0.61594	.	.	0.65108	.	0.775	0.47335	P	0.184	0.51811	B	.	.	.	.	.	.	1.495	0.37283	L	.	0.52959	.	.	0.78751	0.3038	0.87567	D	0.6246	0.86749	D	10	.	0.73599	.	0.076346	0.72413	D	.	0.55539	0.484	0.56487	Q9UQ13	S403G	Loss of sheet (P = 0.0817)| Loss of stability (P = 0.1306)| Loss of helix (P = 0.1706)| Gain of catalytic residue at T402 (P = 0.2032)| Loss of solvent accessibility (P = 0.4436)	.	0.74036	.	0.36956	.	0.65897	0.847841501236	0.89271	D	0.621119	0.88010	D	0.15632	0.69638	D	-0.0132338	0.69250	D	0.921698868274689	0.57905	D	.	0.86146	.	0.3641711	0.57823	0.28831485	0.54635	0.3641711	0.57823	0.28831485	0.54634	-5.834	0.44926	T	.	0.24834	.	0.987016332867827	0.87295	0.03628605	0.56043	0.571	0.75882	.	.	.	.	.	.	4.291712	0.65528	24.8	0.99843858264903962	0.92408	0.922270	0.89662	D	0.593668272867563	0.72634	5.859629	0.665622303315765	0.79668	7.154942	5.82	5.82	0.92730	.	.	9.271	0.94934	11.099000	0.86103	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	919	0.19492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Noonan_syndrome	no_assertion_criteria_provided	NC_000010.11:g.111007576A>G	.	C0028326	PS163950	648	.	Ser	Gly	97.54	0.17692307692307693																																																																																																																																																																																																																																																																																																																																																																																																																																																																													23			97.54	Polar/Neutral	Serine		Leucine-rich repeat protein SHOC-2								0.0065		-0.8								 S403-L381 (PAE:  1.0), S403-S382 (PAE: 1.0)	S403-K379 (PDBs: 7TVG, 7T7A, 7TVF, 7UPI), S403-L381 (PDBs: 7SD1, 7TYG)	 S403-L381 (PAE:  1.0), S403-K379 (PAE: 2.0)	S403-K379 (PDBs: 7TVG, 7SD1, 7T7A, 7SD0, 7TVF, 7UPI), S403-S426 (PDBs: 7TYG)							105									-86.9		Pocket 3: Mean pLDDT: 96.3, Volume: 362.12 Å³, Druggability score: 0.01		-7.8			LRR 14			C (loop/coil)	T (turn)												97.54	17.692308	>90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5		false	0.8088907166064171	0.7915229085642737	false	false	false
ZC4H2	ZC4H2_Ile7Val	B_13-14	-1.3973623365001806	0.20499887214456444	0.28559288533633703	6.5155988276416865	0.00032927185651585603	0.0010003540673950261	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8880811565736313	0.9214554678009282	0.6852834850960692	0.7089397231899839	0.8239164654429545	0.7449961222346521	0.7639804924806145	0.8427455311834722	0.7950973545877064	0.6621379325715232	0.8812898056072604	0.8517013155720409	0.7260117519886896	0.8050873997024367	0.6227820917922613	0.7084290376206153	0.961621129994596	0.9244609975752217	ZC4H2	Ile7Val	NC_000023.11:64976359:T:C	19A>G	23	64976359	T	C	X	ENSG00000126970	4320	0	CCSBVarC009155	ALE00011592	ENSP00000363972.3																																	1195793.0	single nucleotide variant	NM_018684.4(ZC4H2):c.19A>G (p.Ile7Val)	55906.0	ZC4H2	HGNC:24931	Benign/Likely benign	0.0	Dec 08, 2023	199516840.0	-	RCV001570468|RCV002570776	MedGen:C3661900|MeSH:D030342,MedGen:C0950123	not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000023.11	X	64976359.0	64976359.0	Xq11.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	-	2.0	1204188.0	64976359.0	T	C	-	-	-	-	-	-	19A>G 	Ile7Val	NM_018684.4	2.0	Benign	Likely benign	1204188	X	64976359.0	T	C	I	V	rs199516840	X	64196239	X	64112964	7	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.19A>G	p.Ile7Val	c.19A>G	p.Ile7Val	principal1	Y	1	YES	Select	-	ATC	1	0	T	T/T	T/T	T/T	T/T	0.351	0.16776	T	0.678	0.12680	T	0.002	0.09864	B	0.001	0.04348	B	0.04	0.13669	N	simple_aae	96.0	4.0	1.32	0.32853	L	-0.26	0.11844	N	0.31	0.34747	-0.9875	0.33106	T	0.1320	0.44177	T	9	0.07205117	0.10648	T	0.006027	0.15489	T	0.095	0.27216	.	.	.	.	.	0.334371577756	0.32629	0.5398168254113483	0.53715	0.722628895279	0.62047	0.768219232559	0.77118	T	0.032331	0.22195	T	-0.305108	0.07976	T	-0.359887	0.37710	T	0.0683943516306379	0.08326	T	0.849515	0.53108	T	0.18977433	0.40220	0.13270241	0.31751	0.18977433	0.40220	0.13270241	0.31750	-3.754	0.20389	T	0.1285	0.50035	B	0.474340545313315	0.60002	0.85911566	0.89902	0.185	0.44051	.	.	.	.	.	.	2.686521	0.35125	19.8	0.96312281054746651	0.29591	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.0	0.76287	5.297	0.65577	7.617000	0.62206	0.609	0.47831	1.0	0.71675	1.000000	0.68239	1.0	0.97202	45	0.97779	.	.	.	.	.	.	.	.	.	.	.	.	46	264690	1.7378821E-4	.	13	80322	1.618490e-04	0	23	151839	1.514760e-04	0	27	172229	1.567680e-04	0	0	5702	0.000000e+00	0	0	13663	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9917	0.000000e+00	0	13	30957	4.199370e-04	0	0	9952	0.000000e+00	0	13	30957	4.199370e-04	0	0	13134	0.000000e+00	0	0	24382	0.000000e+00	0	0	4649	0.000000e+00	0	0	10128	0.000000e+00	0	0	12175	0.000000e+00	0	22	64678	3.401470e-04	0	0	19070	0.000000e+00	0	22	64678	3.401470e-04	0	0	12064	0.000000e+00	0	0	27160	0.000000e+00	0	0	7083	0.000000e+00	0	0	13319	0.000000e+00	0	0	15980	0.000000e+00	0	26	73474	3.538670e-04	0	0	19005	0.000000e+00	0	26	73474	3.538670e-04	0	.	657	1210216	5.428780e-04	1	630	895221	7.037370e-04	1	5	57198	8.741560e-05	0	0	685	0.000000e+00	0	0	45866	0.000000e+00	0	0	22034	0.000000e+00	0	0	33739	0.000000e+00	0	0	46687	0.000000e+00	0	0	4373	0.000000e+00	0	630	895221	7.037370e-04	1	0	56809	0.000000e+00	0	161	146822	0.001096565909741047	0	168	0	0	2686	0	0	4124	0	0	442	0	0	950	0	0	652	0	0	280	0	4	7604	5.260389268805891E-4	0	4292	0	0	3338	0	165	163728	0.0010077689827030197	Inborn_genetic_diseases|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64976359T>C	.	C0950123|C3661900	.	.	.	Ile	Val	94.16	0.4556213017751479																																																																																																																																																																																																																																																																																																																																																																																																																																																																													77			94.16	Aliphatic	Isoleucine		Zinc finger C4H2 domain-containing protein										4.5								 I7-L11 (PAE:  1.0), I7-D3 (PAE: 3.0)		 I7-L11 (PAE:  1.0), I7-D3 (PAE: 3.0)								131									-60.2				-45.0						H (helix)	H (α-helix)												94.16	45.56213	>90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.9214554678009282	0.8880811565736313	false	false	false
CTCF	CTCF_Asp46Asn	B_13-14	-2.5556236375766055	0.04316233733910241	0.08260527486742043	2.8799144243407158	0.023654476066552226	0.0365370063822587	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6234878039273415	0.6242479697058434	0.7597778394428532	0.6866078803232907	0.7715584984819857	0.7960910002411312	0.8452016917440409	0.7756036719576382	0.7097003047030491	0.8429241362875225	0.6639241944099146	0.6511898627334471	0.7469803087382214	0.767513325006333	0.6635154559435323	0.6766315425981838	0.5845717450017723	0.5957857451212358	CTCF	Asp46Asn	NC_000016.10:67610968:G:A	136G>A	16	67610968	G	A	16	ENSG00000102974	6173	0	CCSBVarC010823	ALE00010812	ENSP00000264010.4																																	963811.0	single nucleotide variant	NM_006565.4(CTCF):c.136G>A (p.Asp46Asn)	10664.0	CTCF	HGNC:13723	Likely benign	0.0	Jan 01, 2019	2052054114.0	-	RCV001252212	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	Intellectual disability	inherited	germline	GRCh38	NC_000016.10	16	67610968.0	67610968.0	16q22.1	no assertion criteria provided	1.0	-	N	-	2.0	975529.0	67610968.0	G	A	-	-	-	-	-	-	136G>A 	Asp46Asn	NM_006565.4		Benign	Likely benign	975529	16	67610968.0	G	A	D	N	rs2052054114	16	67644871	16	66202372	46	CTCF	ENSG00000102974	ENST00000642819	ENSP00000494408	P49711	CTCF_HUMAN	c.136G>A	p.Asp46Asn	c.136G>A	p.Asp46Asn	principal4	Y	.	.	.	+	GAT	1	0	G	G/G	G/G	G/G	G/G	.	0.68399	.	.	0.24550	.	0.18	0.29064	B	0.057	0.26282	B	.	0.23785	.	.	.	.	1.1	0.27864	L	.	0.17556	.	.	0.34213	-1.0391	0.17573	T	0.0244	0.10333	T	10	0.26070982	0.43135	D	0.008032	0.21016	T	.	0.29456	0.222	0.14439	P49711	D46N	Gain of loop (P = 0.069)| Loss of helix (P = 0.079)| Loss of catalytic residue at G48 (P = 0.1983)| Loss of sheet (P = 0.302)| Gain of MoRF binding (P = 0.4494)	.	0.54510	.	0.33770	.	0.47360	0.533664166927	0.43488	T	0.37863	0.73981	T	-0.237905	0.15337	T	-0.579511	0.14308	T	0.711651020290767	0.40980	D	.	0.78261	.	0.14355613	0.32709	0.14724985	0.34752	0.14355613	0.32709	0.14724985	0.34751	-4.76	0.34161	T	0.1119	0.24667	LB	0.911406707488065	0.76873	0.35239035	0.78355	0.338	0.59995	.	.	.	.	.	.	4.066878	0.60464	24.2	0.9978644389905249	0.87230	0.903411	0.85191	D	0.173584497680614	0.49687	3.18842	0.363672439989046	0.59120	4.110524	5.19	5.19	0.71389	.	.	8.296	0.89889	11.831000	0.97527	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.946	0.49004	55	0.97558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1595754	6.266630e-07	0	1	1165574	8.579460e-07	0	0	74694	0.000000e+00	0	0	912	0.000000e+00	0	0	59396	0.000000e+00	0	0	29152	0.000000e+00	0	0	44342	0.000000e+00	0	0	63822	0.000000e+00	0	0	5992	0.000000e+00	0	1	1165574	8.579460e-07	0	0	90282	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Intellectual_disability	no_assertion_criteria_provided	NC_000016.10:g.67610968G>A	.	C3714756	.	.	.	Asp	Asn	37.43	0.9570552147239264																																																																																																																																																																																																																																																																																																																																																																																																																																																																													156			37.43	Negatively-charged	Aspartic Acid		Transcriptional repressor CTCF										-3.5																		132									-165.0				170.2						C (loop/coil)	C (loop/coil)												37.43	95.70552	$\leqslant$50	$\geqslant$90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.6242479697058434	0.6234878039273415	false	false	false
SOS2	SOS2_Val869Ile	B_13-14	-1.6906881260572169	0.13473984727334107	0.20776127353152	26.314751185604315	2.9294705203644902e-8	3.162104944040494e-6	2025_01_Batch_13-14	true	true	false	false	false	false	false	true	false	false	false	false	0.9932074049335676	0.9969818817387566	0.6251476030766636	0.7624331080601927	0.7483049569012121	0.7408935597808699	0.673525908553758	0.6722531315538713	0.6752578129120157	0.6507211281985422	0.9965359316458797	0.9898947264696791	0.8082612110079817	0.8243567822485529	0.8496084032083697	0.5995740779547851	0.9974278318316334	0.9965200833974561	SOS2	Val869Ile	NC_000014.9:50145232:C:T	2605G>A	14	50145232	C	T	14	ENSG00000100485	55187	0	CCSBVarC013733	ALE00010389	ENSP00000216373.5																																	572804.0	single nucleotide variant	NM_006939.4(SOS2):c.2605G>A (p.Val869Ile)	6655.0	SOS2	HGNC:11188	Benign/Likely benign	0.0	Dec 12, 2023	373143128.0	-	RCV000701667|RCV002282338|RCV003928173	MONDO:MONDO:0014691,MedGen:C4225282,OMIM:616559,Orphanet:648|MedGen:CN169374|	Noonan syndrome 9|not specified|SOS2-related disorder	germline	germline	GRCh38	NC_000014.9	14	50145232.0	50145232.0	14q21.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	-	2.0	578603.0	50145232.0	C	T	-	-	-	-	-	-	2605G>A 	Val869Ile	NM_006939.4	2.0	Benign	Likely benign	578603	14	50145232.0	C	T	V	I	rs373143128	14	50611950	14	49681700	869	SOS2	ENSG00000100485	ENST00000216373	ENSP00000216373	Q07890	SOS2_HUMAN	c.2605G>A	p.Val869Ile	c.2605G>A	p.Val869Ile	principal1	Y	1	YES	Select	-	GTA	1	0	C	C/C	C/C	C/C	C/C	0.186	0.21830	T	0.193	0.28516	T	0.806	0.45244	P	0.067	0.27544	B	0.03	0.13669	N	simple_aae	97.0	3.0	1.69	0.43161	L	-0.57	0.17141	N	0.62	0.64125	-1.0875	0.05974	T	0.0626	0.25856	T	10	0.033977717	0.01592	T	0.00909	0.23643	T	0.119	0.32934	.	.	.	.	.	0.287411543184	0.27937	0.29752872176459394	0.29466	0.438499540432	0.43595	0.60063201189	0.52926	T	0.261454	0.63086	T	-0.250105	0.13817	T	-0.337356	0.40293	T	0.0685817938580168	0.08353	T	0.980102	0.93270	D	0.13867286	0.31788	0.11979879	0.28843	0.14083904	0.32200	0.11895819	0.28644	-11.018	0.79822	D	0.1295	0.27854	B	0.330054574296633	0.55316	0.93892770	0.92805	0.24	0.50956	.	.	.	.	.	.	4.283071	0.65331	24.8	0.99145193650800156	0.53732	0.819462	0.73952	D	0.283462274563088	0.55083	3.695113	0.376110327940654	0.59881	4.193457	5.64	4.74	0.59667	3.55	0.64634	7.851	0.85271	7.653000	0.63864	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.997	0.79771	467	0.78304	.	.	.	.	.	.	.	.	.	.	.	.	33	264690	1.2467414E-4	.	20	109304	1.829760e-04	0	40	207850	1.924460e-04	1	62	236538	2.621140e-04	1	0	7156	0.000000e+00	0	2	17068	1.171780e-04	0	11	2318	4.745470e-03	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	7	42762	1.636970e-04	0	0	15650	0.000000e+00	0	7	42762	1.636970e-04	0	0	16182	0.000000e+00	0	2	30470	6.563830e-05	0	21	6208	3.382730e-03	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	15	89446	1.676990e-04	0	0	30546	0.000000e+00	0	15	89446	1.676990e-04	0	0	14866	0.000000e+00	0	2	34194	5.848980e-05	0	39	9564	4.077790e-03	0	0	17690	0.000000e+00	0	0	21622	0.000000e+00	0	18	102542	1.755380e-04	0	0	30464	0.000000e+00	0	18	102542	1.755380e-04	0	.	208	1610334	1.291660e-04	1	111	29576	3.753040e-03	0	0	74774	0.000000e+00	0	0	912	0.000000e+00	0	4	59956	6.671560e-05	0	111	29576	3.753040e-03	0	0	44786	0.000000e+00	0	0	63994	0.000000e+00	0	4	6070	6.589790e-04	0	73	1176958	6.202430e-05	0	3	90944	3.298730e-05	1	15	42740	3.5095928872250817E-4	0	306	0	0	112	0	0	8044	0	0	500	0	0	628	0	0	56	0	0	98	0	3	8298	3.6153289949385393E-4	0	8350	0	0	168	0	18	60782	2.9614030469546907E-4	not_specified|SOS2-related_disorder|Noonan_syndrome_9	criteria_provided,_multiple_submitters,_no_conflicts	NC_000014.9:g.50145232C>T	.	CN169374|C4225282	616559	648	Ras guanine-nucleotide exchange factors catalytic domain|Ras guanine-nucleotide exchange factors catalytic domain|Ras guanine-nucleotide exchange factors catalytic domain|Ras guanine-nucleotide exchange factors catalytic domain	Val	Ile	98.28	0.007042253521126761																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			98.28	Aliphatic	Valine		Son of sevenless homolog 2							Ras-GEF			4.2								V869-N865, V869-V873; PAE: 1.0, 1.0	7 interactions	V869-F860, V869-N865, V869-V873; PAE: 1.0, 1.0, 1.0	10 interactions							117									-58.6				-48.6						H (helix)	H (α-helix)	Helix											98.28	0.70422536	>90	<10	616559	autosomal dominant	GenCC		0	NOONAN SYNDROME 9	false	0.9969818817387566	0.9932074049335676	true	true	true
FARS2	FARS2_Thr246Met	B_13-14	-0.10148333665327636	1.0	1.0	-2.2892724416038037	0.0572911553710658	0.07975381986312452	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7699327126919627	0.7653180927828084	0.5208441273698659	0.7504311174337518	0.6620930791223796	0.6484315091107389	0.6228314552590996	0.6482845289997101	0.6963357370720057	0.5937314836670955	0.7484544569862158	0.7816439030124396	0.6740315629623782	0.675901629245049	0.8045264977954979	0.4479567710726363	0.7821817285794009	0.7582215223714859	FARS2	Thr246Met	NC_000006.12:5404666:C:T	737C>T	6	5404666	C	T	6	ENSG00000145982	12653	0	CCSBVarC011873	ALE00008576	ENSP00000274680.4																																	140994.0	single nucleotide variant	NM_006567.5(FARS2):c.737C>T (p.Thr246Met)	10667.0	FARS2	HGNC:21062	Benign/Likely benign	0.0	Nov 01, 2024	116567033.0	-	RCV000124982|RCV000527403|RCV000677019	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	not specified|Combined oxidative phosphorylation defect type 14|not provided	germline;unknown	germline	GRCh38	NC_000006.12	6	5404666.0	5404666.0	6p25.1	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA290843	2.0	137291.0	5404666.0	C	T	-	-	-	-	-	-	737C>T 	Thr246Met	NM_006567.5	2.0	Benign	Likely benign	137291	6	5404666.0	C	T	T	M	rs116567033	6	5404899	6	5349898	246	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.737C>T	p.Thr246Met	c.737C>T	p.Thr246Met	principal1	Y	1	.	.	+	ACG	2	0	C	C/C	C/C	C/C	C/C	0.027	0.46673	D	0.073	0.48688	T	0.996	0.68795	D	0.913	0.64880	D	0.21	0.45549	N	simple_aae	79.0	21.0	2.83	0.82191	M	-3.55	0.74296	D	0.608	0.62419	-0.7616	0.57140	T	0.2289	0.59266	T	10	0.0118563175	0.00254	T	0.024038	0.46809	T	0.317	0.63716	.	.	.	.	.	0.819830007893	0.81670	0.7281157812391854	0.72612	0.655512290444	0.58315	0.467225492001	0.34256	T	0.297402	0.66816	T	-0.321825	0.06557	T	-0.227665	0.51677	T	0.0169158800264063	0.00441	T	.	0.91526	.	0.26475862	0.49212	0.2838555	0.54171	0.3314129	0.55255	0.26372668	0.51982	-9.33	0.69874	D	0.0974	0.35559	LB	0.64624273715353	0.65262	0.71377310	0.86373	0.195	0.45457	.	.	.	.	.	.	4.289772	0.65479	24.8	0.99768528528554123	0.85678	0.131614	0.24846	N	0.315961225953202	0.56747	3.862512	0.173260709396764	0.48124	3.055297	5.32	4.44	0.53107	2.64	0.48287	3.703	0.54631	3.963000	0.40843	0.596	0.33565	1.0	0.71675	0.999000	0.35501	0.533	0.29823	973	0.05579	16	0.003194888178913738	1	7.564296520423601E-4	6	0.005964214711729622	4	0.005763688760806916	0	0.0	5	0.005112474437627812	1306	264690	0.004934074	.	416	108230	3.843670e-03	2	849	205656	4.128250e-03	6	948	234230	4.047300e-03	5	7	7116	9.836990e-04	0	39	16534	2.358780e-03	0	2	2310	8.658010e-04	0	0	8992	0.000000e+00	0	8	13394	5.972820e-04	0	313	42624	7.343280e-03	2	45	15404	2.921320e-03	0	313	42624	7.343280e-03	2	23	16112	1.427510e-03	0	62	29418	2.107550e-03	0	5	6178	8.093230e-04	0	0	13304	0.000000e+00	0	11	16722	6.578160e-04	0	636	89182	7.131480e-03	4	102	29978	3.402500e-03	2	636	89182	7.131480e-03	4	22	14796	1.486890e-03	0	84	33134	2.535160e-03	0	8	9532	8.392780e-04	0	0	17536	0.000000e+00	0	15	21618	6.938660e-04	0	699	102210	6.838860e-03	3	101	29896	3.378380e-03	2	699	102210	6.838860e-03	3	.	10638	1606620	6.621350e-03	55	9520	1175990	8.095310e-03	43	90	74778	1.203560e-03	0	2	912	2.192980e-03	0	224	59598	3.758520e-03	3	15	29462	5.091300e-04	0	1	44762	2.234040e-05	0	70	63756	1.097940e-03	0	20	5910	3.384090e-03	1	9520	1175990	8.095310e-03	43	320	89360	3.581020e-03	5	1182	178306	0.006629053425010936	0	360	0	0	4502	0	25	9456	0.002643824027072758	3	804	0.0037313432835820895	1	974	0.001026694045174538	0	1850	0	0	280	0	87	17442	0.004987960096319229	25	9816	0.0025468622656886716	0	6352	0	1298	213974	0.006066157570545954	not_specified|not_provided|Combined_oxidative_phosphorylation_defect_type_14	criteria_provided,_multiple_submitters,_no_conflicts	NC_000006.12:g.5404666C>T	ClinGen:CA290843	CN169374|C3661900|C4755312	614946	319519	Aminoacyl-tRNA synthetase, class II	Thr	Met	97.24	0.035211267605633804																																																																																																																																																																																																																																																																																																																																																																																																																																																																													5			97.24	Polar/Neutral	Threonine												-0.7								 T246-D242 (PAE:  1.0), T246-L250 (PAE: 1.0)	T246-L250 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGV, 5MGW, 8P8X, 3TUP), T246-D242 (PDBs: 8P8X, 3TUP), T246-Y101 (PDBs: 3TUP)	 T246-D242 (PAE:  1.0), T246-L250 (PAE: 1.0), T246-Y101 (PAE: 1.5)	T246-L250 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGV, 5MGW, 8P8X, 3TUP), T246-Y101 (PDBs: 5MGH, 8P8X), T246-D242 (PDBs: 8P8X, 3TUP)							119									-62.3	Morphology: VEFDLKQtLTRLMAH; Domain: tRNA-synt_2d			-49.7						H (helix)	H (α-helix)	Helix											97.24	3.521127	>90	<10	614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.7653180927828084	0.7699327126919627	false	false	false
F9	F9_His303Tyr	B_13-14	-1.5857317182942252	0.15682003259997593	0.23219090098135972	1.1755824753686785	0.27819227218051273	0.3293437544846715	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6250072084984677	0.6097551065990345	0.6373443982937326	0.7040960536034483	0.6477244871868825	0.7028182931342528	0.661910318870076	0.5854284682160837	0.6079782317983176	0.6066326614834505	0.5147106932205613	0.5383257508898472	0.7437262673984296	0.7100205061576812	0.800213875408579	0.6680561351040147	0.7047995199775077	0.711688666107088	F9	His303Tyr	NC_000023.11:139561592:C:T	907C>T	23	139561592	C	T	X	ENSG00000101981	52861	0	CCSBVarC004383	ALE00004383	ENSP00000218099.2	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	25680.0	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158.0	F9	HGNC:3551	Benign/Likely benign	0.0	Jan 29, 2024	1801202.0	-	RCV000011387|RCV001167683|RCV001081157|RCV002496326|RCV003944813	|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MedGen:C5393318,OMIM:301052|	FACTOR IX POLYMORPHISM|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease;Warfarin sensitivity, X-linked|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592.0	139561592.0	Xq27.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA121135,OMIM:300746.0085	3.0	10641.0	139561592.0	C	T	-	-	-	-	-	-	907C>T 	His303Tyr	NM_000133.4	2.0	Benign	Likely benign	10641	X	139561592.0	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	95.71	0.7445652173913043																																																																																																																																																																																																																																																																																																																																																																																																															1.004		0.921		0.885		0.853		0.883																																																						137			95.71	Positively-charged	Histidine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-3.2																		155									-60.0				-29.0						C (loop/coil)	T (turn)	Turn											95.71	74.45652	>90	10-90	306900;300807;306900;300807;306900;301052	x-linked	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; HEMOPHILIA B; WARFARIN SENSITIVITY, X-LINKED	false	0.6097551065990345	0.6250072084984677	false	false	false
ZC4H2	ZC4H2_Ala162Thr	B_13-14	-4.370447319580962	0.0032722768210010993	0.011426048863093417	5.128022691271471	0.0013566205853411412	0.003088584086973938	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.84604516564475	0.8833634249110522	0.669999055913481	0.7282409535804459	0.6922039327382961	0.7432120312075023	0.6394458344002252	0.6813952173702965	0.6490181767242176	0.6367934455728758	0.8221621021617584	0.7935687709166703	0.8469782280147795	0.7030126481062957	0.8074637304366744	0.7032046662540863	0.9445647476603461	0.8985215603728296	ZC4H2	Ala162Thr	NC_000023.11:64919119:C:T	484G>A	23	64919119	C	T	X	ENSG00000126970	4320	0	CCSBVarC009153	ALE00011040	ENSP00000363972.3																																	786889.0	single nucleotide variant	NM_018684.4(ZC4H2):c.484G>A (p.Ala162Thr)	55906.0	ZC4H2	HGNC:24931	Benign/Likely benign	0.0	Jul 19, 2023	763229158.0	-	RCV000976591|RCV002548407	MedGen:C3661900|MeSH:D030342,MedGen:C0950123	not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000023.11	X	64919119.0	64919119.0	Xq11.2	criteria provided, multiple submitters, no conflicts	3.0	-	N	-	2.0	793408.0	64919119.0	C	T	-	-	-	-	-	-	484G>A 	Ala162Thr	NM_018684.4	2.0	Benign	Likely benign	793408	X	64919119.0	C	T	A	T	rs763229158	X	64138999	X	64055724	162	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.484G>A	p.Ala162Thr	c.484G>A	p.Ala162Thr	principal1	Y	1	YES	Select	-	GCC	1	0	C	C/C	C/C	C/C	C/C	0.585	0.05935	T	0.549	0.09609	T	0.253	0.31264	B	0.042	0.24116	B	0.02	0.13669	N	simple_aae	98.0	2.0	0.975	0.24371	L	-0.73	0.20514	N	0.563	0.59694	-0.9631	0.38422	T	0.1409	0.45885	T	9	0.17710975	0.32362	T	0.276816	0.90062	D	0.118	0.32711	0.433	0.48193	Q9NQZ6	A162T	Gain of glycosylation at A162 (P = 0.048)| Gain of phosphorylation at A162 (P = 0.0546)| Gain of MoRF binding (P = 0.1162)| Loss of stability (P = 0.5478)| Gain of catalytic residue at A162 (P = 0.5863)	0.396617757867	0.38874	0.7068802814843511	0.70480	0.002779115915	0.00229	0.73517537117	0.72215	T	0.364445	0.72831	T	-0.170336	0.24842	T	-0.141903	0.59671	T	0.0535271790125423	0.06045	T	0.921908	0.71557	D	0.39003843	0.59709	0.37242544	0.62207	0.39003843	0.59709	0.37242544	0.62207	-5.158	0.38896	T	0.5862	0.68255	P	0.7151635813138	0.67549	0.89157920	0.90918	0.294	0.56292	.	.	.	.	.	.	3.063865	0.41235	21.3	0.99147030646255208	0.53786	.	.	.	.	.	.	.	.	.	5.4	5.4	0.77927	.	.	7.641	0.82558	7.492000	0.59446	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.996	0.76032	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	12	264690	4.533605E-5	.	9	76130	1.182190e-04	0	24	143121	1.676900e-04	0	23	162094	1.418930e-04	0	0	5609	0.000000e+00	0	6	13184	4.550970e-04	0	0	1586	0.000000e+00	0	0	6756	0.000000e+00	0	0	9673	0.000000e+00	0	1	29040	3.443530e-05	0	0	8936	0.000000e+00	0	6	13184	4.550970e-04	0	0	12852	0.000000e+00	0	18	23519	7.653390e-04	0	0	4116	0.000000e+00	0	0	9768	0.000000e+00	0	0	11828	0.000000e+00	0	1	60750	1.646090e-05	0	0	16908	0.000000e+00	0	18	23519	7.653390e-04	0	0	11779	0.000000e+00	0	17	26098	6.513910e-04	0	0	6264	0.000000e+00	0	0	12772	0.000000e+00	0	0	15504	0.000000e+00	0	1	68992	1.449440e-05	0	0	16843	0.000000e+00	0	17	26098	6.513910e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Inborn_genetic_diseases|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.64919119C>T	.	C0950123|C3661900	.	.	.	Ala	Thr	60.88	0.4056603773584906																																																																																																																																																																																																																																																																																																																																																																																																																																																																													43			60.88	Aliphatic	Alanine		Zinc finger C4H2 domain-containing protein								0.0136		1.8								 A162-A158 (PAE:  2.5)		 A162-Q166 (PAE:  5.0), A162-A158 (PAE: 2.5)								89									-62.8		Pocket 3: Mean pLDDT: 80.71, Volume: 332.58 Å³, Druggability score: 0.01		-36.4						H (helix)	H (α-helix)												60.88	40.56604	50-70	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.8833634249110522	0.84604516564475	false	false	false
RET	RET_Thr278Asn	B_13-14	-0.6907675516055969	0.5119595315860082	0.5938588178554586	7.025889276268805	0.000206750480846574	0.0006974028168262193	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8473668993114079	0.8441345364200094	0.6020732328919882	0.7083190891551883	0.639329224629643	0.67791159409718	0.8327654555823609	0.749530489207179	0.8626346062556214	0.689378499659667	0.8824877945560576	0.8800553471765347	0.5230577326119993	0.529127960052107	0.554003572054755	0.5147679661243095	0.8057812782839611	0.8146784514462809	RET	Thr278Asn	NC_000010.11:43105159:C:A	833C>A	10	43105159	C	A	10	ENSG00000165731	8858	0	CCSBVarC006877	ALE00006875	ENSP00000480088.1	CEGS2	CegsMutGDEh1029	D06	GDEhDisVCh_40066	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	50285.0	single nucleotide variant	NM_020975.6(RET):c.833C>A (p.Thr278Asn)	5979.0	RET	HGNC:9967	Benign/Likely benign	0.0	Sep 01, 2024	35118262.0	-	RCV000034778|RCV000121990|RCV000163444|RCV000490442|RCV000988341|RCV001104179|RCV001104178|RCV001104180|RCV001083124	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	not provided|not specified|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2	germline;unknown	germline	GRCh38	NC_000010.11	10	43105159.0	43105159.0	10q11.21	criteria provided, multiple submitters, no conflicts	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009353,UniProtKB:P07949#VAR_041763	2.0	41846.0	43105159.0	C	A	-	-	-	-	-	-	833C>A 	Thr278Asn	NM_020975.6	2.0	Benign	Likely benign	41846	10	43105159.0	C	A	T	N	rs35118262	10	43600607	10	42920613	278	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.833C>A	p.Thr278Asn	c.833C>A	p.Thr278Asn	principal4	Y	5	YES	Select	+	ACC	2	0	C	C/C	C/C	C/C	C/C	0.035	0.43867	D	0.194	0.28427	T	0.001	0.12194	B	0.004	0.16860	B	0.05	0.16373	N	simple_aae	95.0	5.0	2.595	0.75684	M	-1.04	0.27215	N	0.317	0.79815	-0.5698	0.65873	T	0.2726	0.64282	T	10	0.0058131814	0.00127	T	.	.	.	0.180	0.44851	.	.	.	.	.	0.764498015703	0.76048	0.8788456336718098	0.87776	0.869349038865	0.69149	0.447220146656	0.31525	T	0.476434	0.80560	T	-0.352383	0.04410	T	-0.258001	0.48694	T	0.0540457288643749	0.06132	T	0.865113	0.56224	D	0.48162338	0.65687	0.3053008	0.56338	0.48379323	0.65819	0.30986196	0.56777	-2.309	0.07193	T	0.1721	0.44951	B	0.723577208028241	0.67844	0.99777067	0.98500	0.561	0.75276	.	.	.	.	.	.	3.2057	0.43694	21.8	0.97103921571150231	0.32564	0.489384	0.52567	N	-0.160029608786539	0.34534	1.991452	-0.0125543226448844	0.38851	2.316717	4.73	3.82	0.43085	1.81	0.37505	3.421	0.52594	3.421000	0.38332	0.597	0.3436	0.996	0.3946	0.998000	0.34068	0.997	0.79771	862	0.33096	20	0.003993610223642172	0	0.0	0	0.0	0	0.0	19	0.018849206349206348	1	0.0010224948875255625	328	264690	0.0012391855	.	268	108738	2.464640e-03	5	382	203268	1.879290e-03	6	541	233088	2.321010e-03	7	0	7086	0.000000e+00	0	0	17050	0.000000e+00	0	0	2308	0.000000e+00	0	255	8972	2.842180e-02	5	0	13120	0.000000e+00	0	2	42634	4.691090e-05	0	10	15664	6.384070e-04	0	255	8972	2.842180e-02	5	0	15770	0.000000e+00	0	1	30418	3.287530e-05	0	0	6120	0.000000e+00	0	353	13264	2.661340e-02	6	0	16456	0.000000e+00	0	7	85866	8.152240e-05	0	18	30570	5.888130e-04	0	353	13264	2.661340e-02	6	0	14546	0.000000e+00	0	2	34182	5.851030e-05	0	0	9522	0.000000e+00	0	509	17618	2.889090e-02	7	0	21196	0.000000e+00	0	10	99950	1.000500e-04	0	18	30494	5.902800e-04	0	509	17618	2.889090e-02	7	.	1119	1612876	6.937920e-04	14	938	44842	2.091790e-02	13	0	75052	0.000000e+00	0	0	912	0.000000e+00	0	4	60014	6.665110e-05	0	0	29582	0.000000e+00	0	938	44842	2.091790e-02	13	0	62980	0.000000e+00	0	1	6044	1.654530e-04	0	35	1179890	2.966380e-05	0	75	91072	8.235240e-04	1	7	170470	4.1062943626444535E-5	0	176	0	104	4426	0.02349751468594668	0	4788	0	0	794	0	0	968	0	31	1788	0.017337807606263984	0	280	0	48	15660	0.0030651340996168583	0	4964	0	135	6214	0.021725136787898294	190	199350	9.530975670930524E-4	Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia_type_2A|not_specified	criteria_provided,_conflicting_classifications	NC_000010.11:g.43105159C>A	ClinGen:CA009353|UniProtKB:P07949#VAR_041763	C0027662|C3661900|C0031511|C1619700|C4048306|C0027672|C3888239|C0025268|CN169374	PS131100|171300|191830|142623|171400	276161|29072|411709|653|140162|388|247698|653	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Thr	Asn	95.1	0.4084507042253521																																																																																																																																																																																																																																																																																																																																																																																																																																																																													58			95.1	Polar/Neutral	Threonine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-0.7									T278-A373 (PDBs: 6GL7), T278-H392 (PDBs: 6Q2N)		T278-A373 (PDBs: 6GL7), T278-H392 (PDBs: 6Q2N, 6Q2S)							119									-123.6				129.0	Cadherin-like region 3 (CLD3)					B (undefined)	E (parallel sheets)							Extracellular					95.1	40.84507	>90	10-90	142623;171400;191830;171300	multiple	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; RENAL HYPODYSPLASIA/APLASIA 1; PHEOCHROMOCYTOMA	false	0.8441345364200094	0.8473668993114079	false	false	false
FARS2	FARS2_Gly3Val	B_13-14	-2.1910901347520046	0.41370840506561246	0.4371679027023429	-2.223769484475093	0.06650456444869174	0.09107995096372005	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6952207112729378	0.7280785810671186	0.5062510274812775	0.6875593585780526	0.6974007887678855	0.6051434062849468	0.5907104688597947	0.6822509714293267	0.6349022470016156	0.5598792556010265	0.7411550832703657	0.6976300607372066	0.6195763437100988	0.7125506061064444	0.7402164701544895	0.4526227993615285	0.7150020788638715	0.6928113618086691	FARS2	Gly3Val	NC_000006.12:5368578:G:T	8G>T	6	5368578	G	T	6	ENSG00000145982	12653	0	CCSBVarC011880	ALE00010797	ENSP00000274680.4																																	963613.0	single nucleotide variant	NM_006567.5(FARS2):c.8G>T (p.Gly3Val)	10667.0	FARS2	HGNC:21062	Likely benign	0.0	Jan 01, 2019	200380429.0	-	RCV001252485	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	Intellectual disability	inherited	germline	GRCh38	NC_000006.12	6	5368578.0	5368578.0	6p25.1	no assertion criteria provided	1.0	-	N	-	2.0	975692.0	5368578.0	G	T	-	-	-	-	-	-	8G>T 	Gly3Val	NM_006567.5		Benign	Likely benign	975692	6	5368578.0	G	T	G	V	rs200380429	6	5368811	6	5313810	3	FARS2	ENSG00000145982	ENST00000274680	ENSP00000274680	O95363	SYFM_HUMAN	c.8G>T	p.Gly3Val	c.8G>T	p.Gly3Val	principal1	Y	1	YES	Select	+	GGC	2	0	G	G/G	G/G	G/G	G/G	0.108	0.29555	T	0.173	0.33996	T	0.0	0.02950	B	0.0	0.01384	B	.	.	.	.	.	.	0.69	0.16877	N	0.37	0.03617	N	0.201	0.22970	-1.0183	0.24210	T	0.0490	0.20756	T	10	0.06419563	0.08450	T	0.011909	0.29732	T	0.063	0.18106	0.264	0.20839	O95363	G3V	Gain of stability (P = 0.0417)| Gain of helix (P = 0.0425)| Loss of disorder (P = 0.0976)| Loss of loop (P = 0.1242)| Loss of methylation at R7 (P = 0.1536)	0.533179623451	0.52623	.	0.50277	.	0.21965	0.352800011635	0.18315	T	0.028576	0.20467	T	-0.160298	0.26369	T	-0.468033	0.25378	T	0.0261529918185712	0.01420	T	0.706229	0.31439	T	0.04899978	0.08549	0.05854014	0.10844	0.04899978	0.08549	0.05854014	0.10843	-2.72	0.07480	T	0.0811	0.19666	B	0.0342656122538894	0.33942	0.14797659	0.70290	0.104	0.28905	.	.	.	.	.	.	0.478147	0.08506	5.236	0.72636894617756464	0.10205	0.048075	0.08031	N	-1.29901716008698	0.03647	0.1651864	-1.25431266583447	0.04988	0.2405891	5.01	1.67	0.23089	0.277	0.23484	0.253	0.18128	1.445000	0.26644	-0.779	0.0337	0.0	0.06393	0.002000	0.18256	0.033	0.13527	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1608378	1.865230e-06	0	3	1176546	2.549840e-06	0	0	74836	0.000000e+00	0	0	912	0.000000e+00	0	0	59726	0.000000e+00	0	0	29148	0.000000e+00	0	0	44808	0.000000e+00	0	0	63832	0.000000e+00	0	0	6032	0.000000e+00	0	3	1176546	2.549840e-06	0	0	90348	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Intellectual_disability	no_assertion_criteria_provided	NC_000006.12:g.5368578G>T	.	C3714756	.	.	.	Gly	Val	27.24	0.8333333333333334																																																																																																																																																																																																																																																																																																																																																																																																																																																																													70			27.24	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine												-0.4																		75									168.8				83.7						C (loop/coil)	C (loop/coil)												27.24	83.33333	$\leqslant$50	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3		false	0.7280785810671186	0.6952207112729378	false	false	false
F9	F9_His282Tyr	B_13-14	-1.3745699158063474	0.21165219075946431	0.2928182936373769	0.19248010003084795	0.8528312470245522	0.8796769748679333	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6814583027064108	0.6897074882183167	0.6679914731334197	0.782084953680111	0.7024517066185441	0.7672522807222477	0.7723490917973459	0.6514688700450747	0.7449465451408941	0.7034616037525708	0.6728408889841091	0.6630540129469306	0.7621554696471495	0.7534345431920135	0.8192233622193279	0.6325213425142685	0.7065740874525244	0.6998625924658911	F9	His282Tyr	NC_000023.11:139561529:C:T	844C>T	23	139561529	C	T	X	ENSG00000101981	52861	0	CCSBVarC030577	ALE00020743	ENSP00000218099.2																																	1150446.0	single nucleotide variant	NM_000133.4(F9):c.844C>T (p.His282Tyr)	2158.0	F9	HGNC:3551	Likely benign	0.0	Jan 11, 2024	763399530.0	-	RCV001480159	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561529.0	139561529.0	Xq27.1	criteria provided, single submitter	1.0	-	N	-	2.0	1142361.0	139561529.0	C	T	-	-	-	-	-	-	844C>T 	His282Tyr	NM_000133.4	1.0	Benign	Likely benign	1142361	X	139561529.0	C	T	H	Y	rs763399530	X	138643688	X	138471354	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.844C>T	p.His282Tyr	c.844C>T	p.His282Tyr	principal1	Y	1	YES	Select	+	CAT	1	0	C	C/C	C/C	C/C	C/C	0.68	0.06480	T	0.512	0.16506	T	0.015	0.17100	B	0.058	0.26454	B	0.03	0.10877	N	simple_aae	97.0	3.0	0.8	0.19557	N	-2.55	0.55206	D	0.148	0.14965	-0.5954	0.64851	T	0.5140	0.81707	D	10	0.18958774	0.34189	T	0.054279	0.65667	D	0.393	0.70688	0.78	0.90415	P00740	H282Y	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.96162791622	0.96087	0.9940287968305028	0.99398	0.807526858809	0.66347	0.379336297512	0.22139	T	0.829846	0.95894	D	-0.23264	0.16016	T	-0.302648	0.44102	T	0.117615622490317	0.14014	T	0.768423	0.39558	T	0.4559485	0.64101	0.36480957	0.61600	0.4559485	0.64101	0.36480957	0.61600	-3.409	0.15190	T	0.0731	0.06927	B	0.48480680668397	0.60322	0.99983406	0.99778	0.675	0.81949	.	.	.	.	.	.	0.540746	0.0912	5.876	0.52811199848246315	0.04879	.	.	.	.	.	.	.	.	.	5.42	1.91	0.24773	1.6	0.35226	0.11	0.1532	0.134000	0.15149	0.549	0.27038	0.051	0.21521	0.427000	0.24915	0.615	0.31811	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	77986	2.564560e-05	0	4	145968	2.740330e-05	0	4	165649	2.414740e-05	0	0	5683	0.000000e+00	0	0	13111	0.000000e+00	0	0	1665	0.000000e+00	0	0	6903	0.000000e+00	0	0	9844	0.000000e+00	0	0	30415	0.000000e+00	0	1	8955	1.116690e-04	0	1	8955	1.116690e-04	0	0	13056	0.000000e+00	0	0	23376	0.000000e+00	0	0	4328	0.000000e+00	0	0	10097	0.000000e+00	0	0	12043	0.000000e+00	0	0	62696	0.000000e+00	0	3	16890	1.776200e-04	0	3	16890	1.776200e-04	0	0	11986	0.000000e+00	0	0	26076	0.000000e+00	0	0	6612	0.000000e+00	0	0	13127	0.000000e+00	0	0	15766	0.000000e+00	0	0	71276	0.000000e+00	0	3	16825	1.783060e-04	0	3	16825	1.783060e-04	0	.	13	1200931	1.082490e-05	0	11	55470	1.983050e-04	0	0	56966	0.000000e+00	0	0	687	0.000000e+00	0	0	45208	0.000000e+00	0	0	21785	0.000000e+00	0	0	33709	0.000000e+00	0	0	46466	0.000000e+00	0	0	4344	0.000000e+00	0	0	889011	0.000000e+00	0	11	55470	1.983050e-04	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561529C>T	.	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	93.76	0.13043478260869565																																																																																																																																																																																																																																																																																																																																																																																																															0.941		0.888		0.9		0.877		0.878																																																						24			93.76	Positively-charged	Histidine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-3.2								 H282-W356 (PAE:  1.5), H282-E288 (PAE: 3.0), H282-L369 (PAE: 1.0)	H282-L369 (PDBs: 6X5J, 6X5L, 8OL9), H282-A233 (PDBs: 8OL9)	 H282-P235 (PAE:  1.0), H282-L369 (PAE: 1.0)	H282-K234 (PDBs: 6X5J, 6X5L), H282-P235 (PDBs: 8OL9), H282-A233 (PDBs: 8OL9), H282-E288 (PDBs: 8OL9), H282-V368 (PDBs: 8OL9), H282-L369 (PDBs: 8OL9)							155									-128.8				-44.1						C (loop/coil)	S (bend)	Beta strand											93.76	13.043478	>90	10-90	306900;300807	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.6897074882183167	0.6814583027064108	false	false	false
CTCF	CTCF_Arg567Leu	B_13-14	1.1800602714906496	0.2765194233427633	0.36299113304788855	4.033576251426681	0.004973192545738645	0.009369413061016851	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5434397263449392	0.5686378688672395	0.5764328970890905	0.524822948473296	0.5388410218169333	0.58707180101528	0.5661448848598243	0.4752721576535094	0.5061033311087048	0.5635096766498535	0.5443933966437263	0.5192978928019489	0.6079987171707357	0.6024098859803573	0.5435425658378874	0.5893561175283275	0.5928823410907527	0.5675815598879295	CTCF	Arg567Leu	NC_000016.10:67628551:G:T	1700G>T	16	67628551	G	T	16	ENSG00000102974	6173	0	CCSBVarC010820	ALE00009724	ENSP00000264010.4																																	445598.0	single nucleotide variant	NM_006565.4(CTCF):c.1700G>T (p.Arg567Leu)	10664.0	CTCF	HGNC:13723	Likely benign	0.0	Dec 18, 2020	761621858.0	-	RCV000521064	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000016.10	16	67628551.0	67628551.0	16q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA396321079	2.0	450577.0	67628551.0	G	T	-	-	-	-	-	-	1700G>T 	Arg567Leu	NM_006565.4	1.0	Benign	Likely benign	450577	16	67628551.0	G	T	R	L	rs761621858	16	67662454	16	66219955	567	CTCF	ENSG00000102974	ENST00000645699	ENSP00000495348	P49711	CTCF_HUMAN	c.1700G>T	p.Arg567Leu	c.1700G>T	p.Arg567Leu	principal4	Y	.	.	.	+	CGG	2	0	G	G/G	G/G	G/G	G/G	.	0.29555	.	.	0.29853	.	0.997	0.70687	D	0.993	0.81117	D	.	0.94378	.	.	.	.	1.59	0.40152	L	.	0.24626	.	.	0.90815	-0.0875	0.80295	T	0.5199	0.81993	D	10	0.6048416	0.66830	D	0.14978	0.83108	D	.	0.79046	0.52	0.62092	P49711	R567L	Loss of disorder (P = 0.0233)| Loss of glycosylation at T565 (P = 0.0575)| Loss of ubiquitination at K562 (P = 0.0666)| Loss of MoRF binding (P = 0.0734)| Loss of phosphorylation at T565 (P = 0.1284)	.	0.92815	.	0.88570	.	0.96651	0.925170183182	0.98690	D	0.711178	0.91685	D	0.317932	0.84211	D	0.218911	0.84006	D	0.84126740694046	0.49158	D	0.872913	0.60159	D	0.48211032	0.65717	0.3656615	0.61669	0.48211032	0.65717	0.3656615	0.61669	-8.963	0.67536	D	0.9523	0.88385	P	0.841414727856592	0.72676	0.95337390	0.93563	0.379	0.63130	.	.	.	.	.	.	5.346011	0.89703	31.0	0.99840494751249931	0.92149	0.947009	0.95695	D	0.451229343520457	0.64086	4.67813	0.577215871047949	0.73164	5.949525	5.72	5.72	0.89363	4.59	0.85410	9.972	0.99137	11.725000	0.94893	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	53	0.97599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000016.10:g.67628551G>T	ClinGen:CA396321079	CN517202	.	.	.	Arg	Leu	82.48	0.6693548387096774																																																																																																																																																																																																																																																																																																																																																																																																																																																																													166			82.48	Positively-charged	Arginine		Transcriptional repressor CTCF										-4.5								 R567-A571 (PAE:  1.5)	R567-A571 (PDBs: 1X6H, 7W1M, 8SSQ, 8SSR)	 R567-F555 (PAE:  3.0), R567-A571 (PAE: 1.5)	R567-F555 (PDBs: 1X6H, 8SSR), R567-A571 (PDBs: 1X6H, 7W1M, 8SSQ, 8SSR)							175									-55.5				-43.1				dbSNP: rs879255516; Variant type: LP/P; AA change: Arg567Trp; PTM type: Phosphorylation; PTM morphology: CGKTFtRR*NTM; Var class: II&rs879255516		H (helix)	H (α-helix)	Helix										C2H2-type 11; atypical	82.48	66.935486	70-90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.5686378688672395	0.5434397263449392	false	false	false
BAP1	BAP1_Thr423Lys	B_13-14	-1.3565825611557805	0.21703700719903737	0.2993073528882032	-4.899955064605282	0.0017532149414611572	0.003798287387935329	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6689440756094222	0.6839230477047811	0.4988874226521891	0.5296684784977757	0.5047793684825492	0.4901650906216084	0.5527668428103784	0.5277611007467553	0.49822692077877534	0.5646371111369559	0.7274065577498408	0.742684471171152	0.4275633384328385	0.4817976362183431	0.561110036216776	0.43313773416742224	0.6404395376597215	0.5952036800476923	BAP1	Thr423Lys	NC_000003.12:52403877:G:T	1268C>A	3	52403877	G	T	3	ENSG00000163930	3760	0	CCSBVarC009476	ALE00009257	ENSP00000417132.1																																	239268.0	single nucleotide variant	NM_004656.4(BAP1):c.1268C>A (p.Thr423Lys)	8314.0	BAP1	HGNC:950	Benign/Likely benign	0.0	Jul 16, 2024	115109161.0	-	RCV000228893|RCV000563367|RCV000844571|RCV001818616|RCV003316284	MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0011696,MedGen:C1847723,OMIM:606661,Orphanet:39044	BAP1-related tumor predisposition syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified|Melanoma, uveal, susceptibility to, 2	germline;unknown	germline	GRCh38	NC_000003.12	3	52403877.0	52403877.0	3p21.1	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA2436837	2.0	240045.0	52403877.0	G	T	-	-	-	-	-	-	1268C>A 	Thr423Lys	NM_004656.4	2.0	Benign	Likely benign	240045	3	52403877.0	G	T	T	K	rs115109161	3	52437893	3	52412933	423	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.1268C>A	p.Thr423Lys	c.1268C>A	p.Thr423Lys	principal1	Y	1	YES	Select	-	ACA	2	0	G	G/G	G/G	G/G	G/G	0.034	0.44516	D	0.017	0.60671	D	0.002	0.09864	B	0.002	0.06938	B	0.06	0.18971	N	simple_aae	94.0	6.0	0	0.06502	N	-1.03	0.27007	N	0.324	0.37371	-1.0250	0.22040	T	0.0638	0.26280	T	10	0.007293403	0.00163	T	.	.	.	0.054	0.15198	.	.	.	.	.	0.671732637855	0.66638	0.19555129210449032	0.19291	0.453964407394	0.44793	0.347844183445	0.17586	T	0.024049	0.18095	T	-0.488477	0.00629	T	-0.472382	0.24913	T	0.00967223067305719	0.00125	T	0.729627	0.34303	T	0.07225229	0.15912	0.09052727	0.21201	0.0865195	0.19931	0.09277198	0.21846	-0.415	0.00535	T	0.0922	0.16120	B	0.0551843815255829	0.38039	0.99352360	0.97351	0.092	0.25882	.	.	.	.	.	.	2.376386	0.30551	18.46	0.974649564021286	0.34277	0.073686	0.14558	N	-0.147163113713975	0.35080	2.029722	0.0881182991556912	0.43669	2.686219	6.04	5.1	0.68875	3.9	0.73887	2.575	0.4579	6.351000	0.55560	0.676	0.76753	0.94	0.32731	1.000000	0.68239	0.994	0.71086	68	0.97129	16	0.003194888178913738	16	0.012102874432677761	0	0.0	0	0.0	0	0.0	0	0.0	445	264690	0.001681212	.	52	109312	4.757030e-04	0	93	207980	4.471580e-04	0	91	236828	3.842450e-04	0	43	7164	6.002230e-03	0	8	17106	4.676720e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13304	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	43	7164	6.002230e-03	0	79	16212	4.872930e-03	0	12	30518	3.932110e-04	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16644	0.000000e+00	0	1	89508	1.117220e-05	0	0	30608	0.000000e+00	0	79	16212	4.872930e-03	0	75	14902	5.032880e-03	0	14	34252	4.087350e-04	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21542	0.000000e+00	0	1	102726	9.734630e-06	0	0	30526	0.000000e+00	0	75	14902	5.032880e-03	0	.	427	1614100	2.645440e-04	3	363	75032	4.837940e-03	3	363	75032	4.837940e-03	3	0	912	0.000000e+00	0	31	60026	5.164430e-04	0	0	29598	0.000000e+00	0	0	44890	0.000000e+00	0	0	63940	0.000000e+00	0	0	6062	0.000000e+00	0	11	1180040	9.321720e-06	0	0	91088	0.000000e+00	0	1	173836	5.752548378931867E-6	3	360	0.008333333333333333	0	4504	0	32	9418	0.0033977489912932683	1	796	0.001256281407035176	0	974	0	0	1850	0	0	280	0	4	17418	2.2964749110115972E-4	35	9778	0.003579464103088566	0	6354	0	41	209436	1.9576386103630704E-4	not_specified|BAP1-related_tumor_predisposition_syndrome|not_provided|Hereditary_cancer-predisposing_syndrome|Melanoma,_uveal,_susceptibility_to,_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52403877G>T	ClinGen:CA2436837	CN169374|C3280492|C3661900|C0027672|C1847723	614327|606661	289539|140162|39044	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Thr	Lys	32.94	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													147			32.94	Polar/Neutral	Threonine		Ubiquitin carboxyl-terminal hydrolase BAP1										-0.7																		119									-113.5				124.5	Disordered					C (loop/coil)	C (loop/coil)												32.94	100.0	$\leqslant$50	$\geqslant$90	614327;606661	autosomal dominant	GenCC	Rare genetic tumor	1	TUMOR PREDISPOSITION SYNDROME 1; MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2	false	0.6839230477047811	0.6689440756094222	false	false	false
CTCF	CTCF_Pro643Ser	B_13-14	-1.7124595339057247	0.13054179486316442	0.2027112424297919	0.40422285693115445	0.6981139918594725	0.7422066424416449	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5435077444542433	0.5736730857071849	0.5566469643432722	0.6185613779455905	0.6814603837222803	0.6111665307085297	0.5347561703228972	0.6551869868717287	0.6451158523202041	0.45497343905584403	0.6053469366585328	0.5751179948160524	0.6875768910941621	0.7077337805728319	0.592006903570977	0.6583204896307004	0.541999234755837	0.5118974940924342	CTCF	Pro643Ser	NC_000016.10:67636779:C:T	1927C>T	16	67636779	C	T	16	ENSG00000102974	6173	0	CCSBVarC010816	ALE00008908	ENSP00000264010.4																																	208297.0	single nucleotide variant	NM_006565.4(CTCF):c.1927C>T (p.Pro643Ser)	10664.0	CTCF	HGNC:13723	Benign/Likely benign	0.0	Nov 01, 2024	145727304.0	-	RCV000193895|RCV000427860|RCV000989613|RCV002314799|RCV004530110	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MeSH:D030342,MedGen:C0950123|	not specified|not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|Inborn genetic diseases|CTCF-related disorder	germline;unknown	germline	GRCh38	NC_000016.10	16	67636779.0	67636779.0	16q22.1	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA207677	2.0	210800.0	67636779.0	C	T	-	-	-	-	-	-	1927C>T 	Pro643Ser	NM_006565.4	2.0	Benign	Likely benign	210800	16	67636779.0	C	T	P	S	rs145727304	16	67670682	16	66228183	643	CTCF	ENSG00000102974	ENST00000646076	ENSP00000494538	P49711	CTCF_HUMAN	c.1927C>T	p.Pro643Ser	c.1927C>T	p.Pro643Ser	principal4	Y	.	.	.	+	CCA	1	0	C	C/C	C/C	C/C	C/C	.	0.36067	.	.	0.43323	.	0.993	0.65587	D	0.968	0.71743	D	.	0.81345	.	.	.	.	1.75	0.45271	L	.	0.13539	.	.	0.50538	-1.1289	0.01844	T	0.0334	0.14266	T	10	0.008668512	0.00193	T	0.022134	0.44775	T	.	0.47884	.	.	.	.	.	.	0.36087	0.4567110836694177	0.45390	.	0.88493	0.604438900948	0.53464	T	0.358122	0.72301	T	-0.428226	0.01423	T	-0.387077	0.34534	T	0.0343362705906861	0.02675	T	.	0.58028	.	0.048771452	0.08473	0.12885952	0.30913	0.057762917	0.11430	0.12383783	0.29781	-5.595	0.42817	T	.	0.19907	.	0.950983739944161	0.80561	0.51967055	0.82312	0.169	0.41634	.	.	.	.	.	.	4.725224	0.76095	26.4	0.99909288397707574	0.97950	0.770006	0.70400	D	0.635361922304199	0.75292	6.303452	0.69695071304512	0.82049	7.695614	6.03	6.03	0.97795	.	.	6.114	0.71317	7.668000	0.64675	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	50	0.97656	1	1.9968051118210862E-4	0	0.0	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	780	264690	0.0029468434	.	221	106748	2.070300e-03	2	481	202560	2.374610e-03	1	511	231178	2.210420e-03	2	4	7038	5.683430e-04	0	9	16122	5.582430e-04	0	0	2306	0.000000e+00	0	0	8772	0.000000e+00	0	0	13394	0.000000e+00	0	205	42284	4.848170e-03	2	0	15048	0.000000e+00	0	205	42284	4.848170e-03	2	14	15880	8.816120e-04	0	21	28602	7.342140e-04	0	0	6170	0.000000e+00	0	0	12828	0.000000e+00	0	3	16706	1.795760e-04	0	434	88384	4.910390e-03	1	0	29358	0.000000e+00	0	434	88384	4.910390e-03	1	11	14564	7.552870e-04	0	21	32292	6.503160e-04	0	0	9506	0.000000e+00	0	0	17100	0.000000e+00	0	7	21596	3.241340e-04	0	457	101466	4.503970e-03	2	0	29276	0.000000e+00	0	457	101466	4.503970e-03	2	.	7521	1605712	4.683900e-03	22	7107	1176036	6.043180e-03	20	71	74680	9.507230e-04	0	0	912	0.000000e+00	0	54	58944	9.161240e-04	0	2	29508	6.777820e-05	0	0	44268	0.000000e+00	0	26	63952	4.065550e-04	0	0	6046	0.000000e+00	0	7107	1176036	6.043180e-03	20	4	89172	4.485710e-05	0	992	194484	0.005100676662347545	0	360	0	0	4546	0	11	9432	0.001166242578456319	0	796	0	2	968	0.002066115702479339	0	1848	0	0	280	0	70	17414	0.004019754220741932	11	9792	0.0011233660130718953	0	6394	0	1075	230128	0.004671313356045331	not_specified|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|CTCF-related_disorder|not_provided|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.67636779C>T	ClinGen:CA207677	CN169374|C3809686|C3661900|C0950123	615502	363611	.	Pro	Ser	58.81	0.9191176470588235																																																																																																																																																																																																																																																																																																																																																																																																																																																																													125			58.81	Special, No backbone hydrogen	Proline		Transcriptional repressor CTCF		Pro residues								1.6																		115									-76.0				129.5	Disordered					H (helix)	P (polyproline helix)												58.81	91.911766	50-70	$\geqslant$90	615502	autosomal dominant	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21	false	0.5736730857071849	0.5435077444542433	false	false	false
RAF1	RAF1_Phe22Leu	B_13-14	0.9979103452561944	1.0	1.0	1.462481766348925	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6472693867982194	0.6602393810821736	0.6045129768942855	0.6617439710500543	0.7000250774471904	0.659870764910452	0.6542543450729279	0.6866761173128948	0.6491065880449182	0.6122746756500382	0.6726778171261594	0.6640708993306003	0.6654871847479763	0.7133740375814861	0.6743813540551905	0.5967512781385328	0.6478009450381879	0.6304678742658386	RAF1	Phe22Leu	NC_000003.12:12618656:A:C	66T>G	3	12618656	A	C	3	ENSG00000132155	732	0	CCSBVarC008857	ALE00008509	ENSP00000251849.4																																	49053.0	single nucleotide variant	NM_002880.4(RAF1):c.66T>G (p.Phe22Leu)	5894.0	RAF1	HGNC:9829	Likely benign	0.0	Apr 03, 2017	397516824.0	-	RCV000037696|RCV000168020|RCV003362667|RCV004541061	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736|	not specified|RASopathy|Cardiovascular phenotype|RAF1-related disorder	germline	germline	GRCh38	NC_000003.12	3	12618656.0	12618656.0	3p25.2	reviewed by expert panel	5.0	-	N	ClinGen:CA134746	2.0	40583.0	12618656.0	A	C	-	-	-	-	-	-	66T>G 	Phe22Leu	NM_002880.4	3.0	Benign	Likely benign	40583	3	12618656.0	A	C	F	L	rs397516824	3	12660155	3	12635155	22	RAF1	ENSG00000132155	ENST00000691899	ENSP00000508763	P04049	RAF1_HUMAN	.	.	c.66T>G	p.Phe22Leu	principal3	Y	.	.	.	-	TTT	3	2	A	A/A	A/A	A/A	A/A	.	0.51407	.	.	0.25352	.	0.06	0.23134	B	0.018	0.18486	B	.	0.78586	.	.	.	.	1.83	0.47902	L	.	0.21370	.	.	0.61652	-0.9080	0.46899	T	0.2084	0.56595	T	10	.	0.52770	.	0.038866	0.58315	D	.	0.31809	0.372	0.38195	P04049	F22L	Loss of sheet (P = 0.0181)| Gain of loop (P = 0.0312)| Loss of methylation at K18 (P = 0.0891)| Gain of relative solvent accessibility (P = 0.09)| Loss of ubiquitination at K18 (P = 0.1216)	.	0.74448	.	0.36376	.	0.85880	0.814390659332	0.84138	D	0.468965	0.80119	T	-0.176835	0.23871	T	-0.255119	0.48980	T	0.135316427567574	0.15665	T	.	0.44238	.	0.10763881	0.25223	0.120846346	0.29089	0.14490148	0.32960	0.14525777	0.34355	-2.426	0.05558	T	.	0.68345	.	0.900999158324285	0.76121	0.35689947	0.78477	0.566	0.75580	.	.	.	.	.	.	2.085276	0.2657	17.15	0.99825905109529411	0.90858	0.234715	0.35536	N	-0.344430833306449	0.27198	1.507842	-0.211098281217204	0.30821	1.759308	6.03	0.769	0.17595	0.598	0.25895	1.009	0.29585	1.026000	0.23526	0.756	0.943	1.0	0.71675	0.989000	0.31253	0.999	0.91597	615	0.66487	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	5	109406	4.570130e-05	0	12	208126	5.765740e-05	0	14	236942	5.908620e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	5	42768	1.169100e-04	0	0	15690	0.000000e+00	0	5	42768	1.169100e-04	0	0	16218	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	12	89554	1.339970e-04	0	0	30608	0.000000e+00	0	12	89554	1.339970e-04	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	14	102744	1.362610e-04	0	0	30526	0.000000e+00	0	14	102744	1.362610e-04	0	.	199	1614116	1.232870e-04	1	196	1180052	1.660940e-04	1	0	74934	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29608	0.000000e+00	0	0	44900	0.000000e+00	0	0	64042	0.000000e+00	0	0	6084	0.000000e+00	0	196	1180052	1.660940e-04	1	0	91094	0.000000e+00	0	3	37246	8.054556193953713E-5	0	122	0	0	112	0	0	3438	0	0	500	0	0	628	0	0	56	0	0	98	0	1	7060	1.4164305949008498E-4	0	3560	0	0	168	0	4	49260	8.120178643930166E-5	RASopathy|Cardiovascular_phenotype|not_specified|RAF1-related_disorder	reviewed_by_expert_panel	NC_000003.12:g.12618656A>C	ClinGen:CA134746	C5555857|CN230736|CN169374	.	536391	.	Phe	Leu	33.54	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													201			33.54	Aromatic	Phenylalanine		RAF proto-oncogene serine/threonine-protein kinase										2.8																		165									-142.6				128.3						C (loop/coil)	C (loop/coil)												33.54	100.0	$\leqslant$50	$\geqslant$90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.6602393810821736	0.6472693867982194	false	false	false
BRIP1	BRIP1_Ser520Thr	B_13-14	0.371993516515847	0.7214710962483611	0.7788312959462345	1.836987186608994	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.653747045232494	0.6875587368420544	0.6875182245707872	0.6709998695102145	0.7168708613222243	0.7396644388217675	0.7261689180037387	0.700141637563731	0.6343740799650309	0.6876144590252116	0.6582364306965206	0.6163322952006204	0.7531599596397963	0.7336000850807177	0.7076256590553981	0.6874219901163627	0.7168810429875881	0.6911617952643677	BRIP1	Ser520Thr	NC_000017.11:61784339:C:G	1559G>C	17	61784339	C	G	17	ENSG00000136492	55128	0	CCSBVarC031368	ALE00034506	ENSP00000259008.2																																	1670804.0	single nucleotide variant	NM_032043.3(BRIP1):c.1559G>C (p.Ser520Thr)	83990.0	BRIP1	HGNC:20473	Likely benign	0.0	Apr 19, 2022	757629526.0	-	RCV002226323	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Hereditary breast ovarian cancer syndrome	germline	germline	GRCh38	NC_000017.11	17	61784339.0	61784339.0	17q23.2	criteria provided, single submitter	1.0	-	N	-	2.0	1679010.0	61784339.0	C	G	-	-	-	-	-	-	1559G>C 	Ser520Thr	NM_032043.3	1.0	Benign	Likely benign	1679010	17	61784339.0	C	G	S	T	rs757629526	17	59861700	17	57216482	520	BRIP1	ENSG00000136492	ENST00000682453	ENSP00000506943	Q9BX63	FANCJ_HUMAN	.	.	c.1559G>C	p.Ser520Thr	principal2	Y	.	.	.	-	AGT	2	0	C	C/C	C/C	C/C	C/C	.	0.35312	.	.	0.25277	.	0.997	0.70687	D	0.985	0.76461	D	.	.	.	.	.	.	2.77	0.80725	M	.	0.47017	.	.	0.33568	0.2150	0.86105	D	0.5977	0.85609	D	9	.	0.52780	.	0.242835	0.88750	D	.	0.70117	0.37	0.37869	Q9BX63	S520T	Gain of loop (P = 0.0435)| Loss of helix (P = 0.079)| Gain of relative solvent accessibility (P = 0.09)| Loss of disorder (P = 0.099)| Gain of glycosylation at S520 (P = 0.1371)	.	0.88833	.	0.68862	.	0.43011	0.593239068985	0.51884	T	0.189817	0.54192	T	-0.00666905	0.50407	T	-0.150502	0.58913	T	0.951732993125916	0.63403	D	0.758424	0.38019	T	0.33792168	0.55782	0.27921516	0.53680	0.33792168	0.55782	0.27921516	0.53679	-8.391	0.63781	D	.	0.17342	.	0.273335049405932	0.53188	0.92831135	0.92318	0.238	0.50735	.	.	.	.	.	.	3.879663	0.56457	23.7	0.99605583092882555	0.74486	0.663288	0.63154	D	0.718735528270629	0.80755	7.388994	0.687325371777153	0.81314	7.521477	5.37	5.37	0.76916	.	.	4.902	0.63037	4.818000	0.45172	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.996	0.76032	49	0.97674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109392	0.000000e+00	0	1	208056	4.806400e-06	0	1	236844	4.222190e-06	0	0	7160	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42764	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16214	0.000000e+00	0	0	30508	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89510	0.000000e+00	0	1	30600	3.267970e-05	0	1	30600	3.267970e-05	0	0	14898	0.000000e+00	0	0	34244	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	0	102680	0.000000e+00	0	1	30518	3.276750e-05	0	1	30518	3.276750e-05	0	.	1	1613166	6.198990e-07	0	1	91054	1.098250e-05	0	0	74994	0.000000e+00	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29600	0.000000e+00	0	0	44820	0.000000e+00	0	0	64020	0.000000e+00	0	0	6032	0.000000e+00	0	0	1179258	0.000000e+00	0	1	91054	1.098250e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_breast_ovarian_cancer_syndrome	criteria_provided,_single_submitter	NC_000017.11:g.61784339C>G	.	C0677776	.	145	.	Ser	Thr	86.39	0.25384615384615383																																																																																																																																																																																																																																																																																																																																																																																																																																																																													33			86.39	Polar/Neutral	Serine		Fanconi anemia group J protein										-0.8								 S520-E421 (PAE:  3.0), S520-Q524 (PAE: 1.0)		 S520-Q524 (PAE:  1.0)								105									-55.9				148.8						C (loop/coil)	C (loop/coil)												86.39	25.384617	70-90	10-90		autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7		false	0.6875587368420544	0.653747045232494	false	false	false
RET	RET_Arg67His	B_13-14	0.8659334758591015	0.4152170581728022	0.507398964241876	6.2432579259442935	0.0004269310409800663	0.001224091344060034	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.783608927500589	0.7700415464701236	0.6787229979372557	0.741276757220525	0.7074247638531694	0.7827234379555936	0.9380313242207918	0.8161157782467812	0.9059439969597445	0.7393379209554325	0.7358510036055432	0.7596169537763294	0.6274155516903954	0.5987337494595576	0.5766095174813054	0.6181080749190788	0.8042320893347039	0.8076009012248485	RET	Arg67His	NC_000010.11:43100585:G:A	200G>A	10	43100585	G	A	10	ENSG00000165731	8858	0	CCSBVarC006873	ALE00006871	ENSP00000480088.1	CEGS2	CegsMutGDEh1027	E08	GDEhDisVCh_40066	H05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	50278.0	single nucleotide variant	NM_020975.6(RET):c.200G>A (p.Arg67His)	5979.0	RET	HGNC:9967	Benign/Likely benign	0.0	Mar 02, 2024	192489011.0	-	RCV000034768|RCV000121986|RCV000311573|RCV000271726|RCV000368621|RCV000393823|RCV000563975|RCV001080638|RCV002307371	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653	not provided|not specified|Multiple endocrine neoplasia|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	germline	germline	GRCh38	NC_000010.11	10	43100585.0	43100585.0	10q11.21	criteria provided, multiple submitters, no conflicts	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008548,UniProtKB:P07949#VAR_018153	2.0	41839.0	43100585.0	G	A	-	-	-	-	-	-	200G>A 	Arg67His	NM_020975.6	2.0	Benign	Likely benign	41839	10	43100585.0	G	A	R	H	rs192489011	10	43596033	10	42916039	67	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.200G>A	p.Arg67His	c.200G>A	p.Arg67His	principal4	Y	5	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.611	0.05754	T	0.58	0.29952	T	0.002	0.13655	B	0.001	0.06938	B	0.08	0.23785	N	simple_aae	92.0	8.0	0.905	0.23113	L	-0.47	0.15106	N	0.028	0.02855	-0.9730	0.36417	T	0.1253	0.42817	T	10	0.0068158507	0.00152	T	.	.	.	0.125	0.34250	.	.	.	.	.	0.47083157667	0.46339	0.5109484406135018	0.50823	0.934419907037	0.71797	0.233786687255	0.02262	T	0.367069	0.73048	T	-0.494179	0.00587	T	-0.473236	0.24820	T	0.0107988245138953	0.00152	T	0.59724	0.21954	T	0.026211439	0.01639	0.032374926	0.01973	0.043690175	0.06790	0.026637115	0.00770	-4.548	0.31573	T	0.0675	0.06414	B	0.00636577096918478	0.20556	0.98813590	0.96462	0.021	0.03256	.	.	.	.	.	.	0.923631	0.13006	9.492	0.77324054778089801	0.12021	0.064517	0.12358	N	-0.737658851988375	0.14788	0.7503831	-0.60610869746005	0.19037	1.036945	5.51	-0.21	0.12496	-1.31	0.14328	0.08	0.14701	0.062000	0.14201	-0.71	0.03958	0.899	0.31494	0.001000	0.17376	0.362	0.25981	862	0.33096	28	0.005591054313099041	0	0.0	0	0.0	0	0.0	27	0.026785714285714284	1	0.0010224948875255625	139	264690	5.2514265E-4	.	130	109312	1.189260e-03	0	206	207774	9.914620e-04	0	270	236724	1.140570e-03	0	0	7156	0.000000e+00	0	1	17100	5.847950e-05	0	0	2310	0.000000e+00	0	110	9044	1.216280e-02	0	4	13368	2.992220e-04	0	9	42734	2.106050e-04	0	6	15688	3.824580e-04	0	110	9044	1.216280e-02	0	0	16184	0.000000e+00	0	2	30500	6.557380e-05	0	0	6194	0.000000e+00	0	168	13406	1.253170e-02	0	7	16708	4.189610e-04	0	15	89320	1.679360e-04	0	11	30604	3.594300e-04	0	168	13406	1.253170e-02	0	0	14884	0.000000e+00	0	2	34240	5.841120e-05	0	0	9558	0.000000e+00	0	218	17690	1.232330e-02	0	15	21600	6.944440e-04	0	22	102612	2.144000e-04	0	11	30522	3.603960e-04	0	218	17690	1.232330e-02	0	.	646	1613870	4.002800e-04	6	377	44876	8.400930e-03	3	2	75036	2.665390e-05	0	0	912	0.000000e+00	0	8	60018	1.332930e-04	0	0	29604	0.000000e+00	0	377	44876	8.400930e-03	3	53	63766	8.311640e-04	0	2	6060	3.300330e-04	0	116	1180022	9.830330e-05	0	45	91076	4.940930e-04	3	16	174478	9.170210570960235E-5	0	176	0	39	4500	0.008666666666666666	0	4792	0	0	796	0	0	968	0	8	1848	0.004329004329004329	0	280	0	22	16002	0.0013748281464816899	0	4968	0	47	6348	0.0074039067422810335	85	203840	4.1699372056514916E-4	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|not_provided|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Pheochromocytoma|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43100585G>A	ClinGen:CA008548|UniProtKB:P07949#VAR_018153	C1619700|C0027662|C4048306|C3661900|C0027672|C0025268|C3888239|C0031511|CN169374	191830|PS131100|171400|142623|171300	411709|276161|653|140162|247698|653|388|29072	Ret, cadherin like domain 1	Arg	His	90.15	0.28225806451612906																																																																																																																																																																																																																																																																																																																																																																																																																																																																													70			90.15	Positively-charged	Arginine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-4.5								 R67-T130 (PAE:  6.0), R67-S128 (PAE: 4.0), R67-F126 (PAE: 1.5)	R67-F126 (PDBs: 6GL7, 6Q2J, 6Q2O, 6Q2R)	 R67-F126 (PAE:  1.5)	R67-F126 (PDBs: 6GL7, 6Q2J, 6Q2O, 6Q2R, 6Q2S)		R67-E134 (PDBs: 6GL7)					175									-126.5				140.4	Cadherin-like region 1 (CLD1)			dbSNP: rs192489011; Variant type: LB/B; AA change: Arg67His; PTM type: Phosphorylation; PTM morphology: PEEVPsFR*LGQ; Var class: II		B (undefined)	E (parallel sheets)							Extracellular					90.15	28.225807	>90	10-90	142623;191830;171300;171400	multiple	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; RENAL HYPODYSPLASIA/APLASIA 1; PHEOCHROMOCYTOMA; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	false	0.7700415464701236	0.783608927500589	false	false	false
AGXT	AGXT_Glu274Asp	B_7-8	-0.22820421056087306	0.8341574306900164	0.8675281603921643	0.22510939284155027	0.8363564861685491	0.8660915079679952	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8979734914341618	0.8784375994685603	0.7527676561323732	0.9329215673050483	0.8330161721707778	0.8323356181423006	0.8323356181423006	0.8330161721707778	0.9329215673050483	0.7527676561323732	0.8784375994685603	0.8979734914341618							AGXT	Glu274Asp	NC_000002.12:240875980:G:C	822G>C	2	240875980	G	C	2	ENSG00000172482	70497	3863	CCSBVarC008216	ALE00008202	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	C08	GDEhDisVCh_40002	A10	2	VUSMutGDDh004	C08	VUSN2Hmut_GDN2h_01	H08	VUSMutpDEST2_14	E09	VUSmut_GDEh01	H08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200556.0	single nucleotide variant	NM_000030.3(AGXT):c.822G>C (p.Glu274Asp)	189.0	AGXT	HGNC:341	Conflicting classifications of pathogenicity	1.0	Oct 27, 2023	146525143.0	-	RCV000186335|RCV001852426	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900	Primary hyperoxaluria, type I|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	240875980.0	240875980.0	2q37.3	criteria provided, conflicting classifications	6.0	-	N	ClinGen:CA275741	2.0	204129.0	240875980.0	G	C	-	-	-	-	-	-	822G>C 	Glu274Asp	NM_000030.3	1.0	Conflicting	Conflicting	204129	2	240875980.0	G	C	E	D	rs146525143	2	241815397	2	241464070	274	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.822G>C	p.Glu274Asp	c.822G>C	p.Glu274Asp	principal1	Y	1	YES	Select	+	GAG	3	2	G	G/G	G/G	G/G	G/G	0.004	0.65576	D	0.014	0.62681	D	0.999	0.77914	D	0.972	0.72694	D	0.61	0.77437	D	simple_aae	39.0	61.0	.	.	.	-2.62	0.56328	D	0.696	0.69943	0.9060	0.95746	D	0.8315	0.94339	D	9	0.9360423	0.92855	D	0.577796	0.96199	D	0.841	0.95012	0.908	0.98098	P21549	E274D	Gain of catalytic residue at E274 (P = 0.1308)| Loss of phosphorylation at S275 (P = 0.1949)| Loss of helix (P = 0.4763)| Loss of disorder (P = 0.494)| Gain of methylation at R273 (P = 0.506)	0.977685291992	0.97722	0.9316502935034346	0.93101	0.243237090943	0.26536	0.450038909912	0.31908	T	0.759101	0.93400	D	0.184814	0.72282	D	0.32802	0.89353	D	0.830606341362	0.48301	D	0.910709	0.68259	D	0.8916843	0.90518	0.78192014	0.86985	0.8916843	0.90520	0.78192014	0.86986	-8.261	0.62909	D	0.853	0.79882	P	0.989705789174505	0.88280	0.49860063	0.81859	0.955	0.98022	.	.	.	.	.	.	4.109541	0.61418	24.3	0.99884102013437492	0.95973	0.870897	0.79128	D	0.729535474857518	0.81467	7.553007	0.627385858870051	0.76809	6.583792	4.91	4.91	0.63852	1.28	0.31841	1.531	0.3573	6.315000	0.55503	0.674	0.70877	1.0	0.71675	1.000000	0.68239	0.752	0.35893	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	18	264690	6.800408E-5	.	6	109384	5.485260e-05	0	9	207982	4.327300e-05	0	14	236884	5.910070e-05	0	0	7162	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	3	9046	3.316380e-04	0	0	13392	0.000000e+00	0	2	42754	4.677920e-05	0	0	15690	0.000000e+00	0	3	9046	3.316380e-04	0	0	16202	0.000000e+00	0	0	30504	0.000000e+00	0	0	6208	0.000000e+00	0	1	13410	7.457120e-05	0	0	16732	0.000000e+00	0	7	89458	7.824900e-05	0	0	30606	0.000000e+00	0	7	89458	7.824900e-05	0	0	14892	0.000000e+00	0	0	34240	0.000000e+00	0	0	9568	0.000000e+00	0	5	17692	2.826140e-04	0	0	21630	0.000000e+00	0	8	102718	7.788310e-05	0	0	30524	0.000000e+00	0	5	17692	2.826140e-04	0	.	77	1614074	4.770540e-05	0	69	1180040	5.847260e-05	0	0	74924	0.000000e+00	0	0	912	0.000000e+00	0	1	60000	1.666670e-05	0	0	29608	0.000000e+00	0	2	44888	4.455530e-05	0	0	64046	0.000000e+00	0	0	6084	0.000000e+00	0	69	1180040	5.847260e-05	0	0	91084	0.000000e+00	0	4	26588	1.5044380923724988E-4	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4588	0	0	2918	0	0	112	0	4	35432	1.1289230074508918E-4	not_provided|Primary_hyperoxaluria,_type_I	criteria_provided,_conflicting_classifications	NC_000002.12:g.240875980G>C	ClinGen:CA275741	C3661900|C0268164	259900	416|93598	Aminotransferase class V domain	Glu	Asp	98.95	0.16494845360824742																																																																																																																																																																																																																																																																																																																																																																																																																																																																													32			98.95	Negatively-charged	Glutamic Acid		Alanine--glyoxylate aminotransferase								0.6906		-3.5								 E274-R36 (PAE:  1.0), E274-Y270 (PAE: 1.0), E274-L278 (PAE: 1.0)	E274-L278 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), E274-R36 (PDBs: 6RV1, 3R9A), E274-Y270 (PDBs: 6RV1, 3R9A)	 E274-Y270 (PAE:  1.0), E274-L278 (PAE: 1.0)	E274-L278 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), E274-Y270 (PDBs: 6RV1, 3R9A)		E274-R36 (PDBs: 5F9S, 3R9A)					146									-65.2		Pocket 1: Mean pLDDT: 99.71, Volume: 628.81 Å³, Druggability score: 0.69		-34.1						H (helix)	H (α-helix)	Helix											98.95	16.494844	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.8784375994685603	0.8979734914341618	false	false	false
DES	DES_Ala135Val	B_7-8	0.08051174882970531	0.9389535249335204	0.9544445091128387	1.1597233036798804	0.2841849682927966	0.3362214163876736	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6617847458764766	0.6507542773545381	0.718072391742347	0.7307022644497816	0.7163777351999883	0.760737812221042	0.9623398268081165	0.9426522204750959	0.9605369510367733	0.9409769391594284	0.6986837078517723	0.7484140284096341	0.5591357976339676	0.49010324992488064	0.50086757786279	0.4951678443252657	0.6028248468573039	0.5751554633433191	DES	Ala135Val	NC_000002.12:219418866:C:T	404C>T	2	219418866	C	T	2	ENSG00000175084	12573	2249	CCSBVarC007812	ALE00007798	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	B04	GDEhDisVCh_40003	D04	1	VUSMutGDDh003	B04	VUSN2Hmut_GDN2h_01	E02	NULL	NULL	VUSmut_GDEh01	E02	1.0	1.0	1.0	6.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	N	Y	N	Y	228917.0	single nucleotide variant	NM_001927.4(DES):c.404C>T (p.Ala135Val)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	0.0	Apr 03, 2024	546741834.0	-	RCV000217198|RCV002321829|RCV001079455|RCV000725598	MedGen:CN169374|MedGen:CN230736|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MedGen:C3661900	not specified|Cardiovascular phenotype|Desmin-related myofibrillar myopathy|not provided	germline	germline	GRCh38	NC_000002.12	2	219418866.0	219418866.0	2q35	criteria provided, conflicting classifications	8.0	ACMG2022	N	ClinGen:CA2125063	2.0	227281.0	219418866.0	C	T	-	-	-	-	-	-	404C>T 	Ala135Val	NM_001927.4	1.0	Conflicting	Conflicting	227281	2	219418866.0	C	T	A	V	rs546741834	2	220283588	2	219991832	135	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.404C>T	p.Ala135Val	c.404C>T	p.Ala135Val	principal1	Y	1	YES	Select	+	GCG	2	0	C	C/C	C/C	C/C	C/C	0.563	0.06360	T	0.687	0.06074	T	0.046	0.21889	B	0.036	0.22910	B	0.31	0.56225	N	simple_aae	69.0	31.0	-0.175	0.04280	N	0.3	0.04069	N	0.108	0.09316	-0.6472	0.62674	T	0.3289	0.69563	T	10	0.013397038	0.00281	T	0.01817	0.39903	T	0.204	0.48855	0.437	0.48851	P17661	A135V	Loss of disorder (P = 0.0867)| Gain of MoRF binding (P = 0.113)| Gain of solvent accessibility (P = 0.3819)| Gain of catalytic residue at E139 (P = 0.4569)| Loss of stability (P = 0.5077)	0.854105994948	0.85156	0.3769341727751992	0.37405	0.936586644213	0.71877	0.525028407574	0.42274	T	0.238984	0.60487	T	-0.407186	0.01956	T	-0.364935	0.37122	T	0.0307799845499151	0.02099	T	0.846915	0.52581	T	0.080895506	0.18390	0.08602342	0.19875	0.080895506	0.18390	0.08602342	0.19874	-3.088	0.11170	T	0.0919	0.13609	B	0.0174878335282905	0.28353	0.85537654	0.89794	0.045	0.11391	.	.	.	.	.	.	2.254848	0.28859	17.92	0.98255533875771961	0.39750	0.426181	0.48889	N	-0.555488882321916	0.20066	1.06983	-0.381881106907207	0.25219	1.404996	4.69	3.79	0.42689	0.704	0.26724	1.575	0.36208	1.287000	0.25473	0.599	0.40292	0.017	0.1941	1.000000	0.68239	0.957	0.51031	86	0.96402	2	3.9936102236421724E-4	0	0.0	0	0.0	0	0.0	0	0.0	2	0.002044989775051125	3	264690	1.1334013E-5	.	24	77438	3.099250e-04	0	49	152608	3.210840e-04	0	47	175110	2.684030e-04	0	0	3800	0.000000e+00	0	0	13414	0.000000e+00	0	0	1672	0.000000e+00	0	0	5772	0.000000e+00	0	0	11684	0.000000e+00	0	0	27264	0.000000e+00	0	24	12340	1.944890e-03	0	24	12340	1.944890e-03	0	0	10326	0.000000e+00	0	0	22818	0.000000e+00	0	0	5130	0.000000e+00	0	0	10366	0.000000e+00	0	0	13894	0.000000e+00	0	3	61582	4.871550e-05	0	46	24586	1.870980e-03	0	46	24586	1.870980e-03	0	0	9636	0.000000e+00	0	0	26736	0.000000e+00	0	0	8658	0.000000e+00	0	0	13092	0.000000e+00	0	0	16480	0.000000e+00	0	1	71314	1.402250e-05	0	46	24556	1.873270e-03	0	46	24556	1.873270e-03	0	.	218	1574676	1.384410e-04	3	189	86046	2.196500e-03	3	0	74270	0.000000e+00	0	0	910	0.000000e+00	0	0	53586	0.000000e+00	0	0	28960	0.000000e+00	0	1	42794	2.336780e-05	0	0	60432	0.000000e+00	0	3	5986	5.011690e-04	0	20	1160620	1.723220e-05	0	189	86046	2.196500e-03	3	1	15750	6.349206349206349E-5	0	122	0	0	112	0	0	3370	0	0	146	0	0	610	0	0	56	0	0	98	0	0	2772	0	0	3492	0	0	168	0	1	23036	4.341031429067546E-5	not_specified|Cardiovascular_phenotype|Desmin-related_myofibrillar_myopathy|not_provided	criteria_provided,_conflicting_classifications	NC_000002.12:g.219418866C>T	ClinGen:CA2125063	CN169374|CN230736|C1832370|C3661900	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ala	Val	96.33	0.5754716981132075																																																																																																																																																																																																																																																																																																																																																																																																																																																																													61			96.33	Aliphatic	Alanine		Desmin							IF rod			1.8								 A135-E139 (PAE:  1.5), A135-Q131 (PAE: 1.0)		 A135-E139 (PAE:  1.5), A135-Q131 (PAE: 1.0)								89									-63.1				-44.6	Coil 1A					H (helix)	H (α-helix)												96.33	57.54717	>90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.6507542773545381	0.6617847458764766	false	false	false
GSS	GSS_Pro314Leu	B_7-8	-2.545790263326417	0.051529303803173554	0.095219735935359	-3.353150462234164	0.012198061941918626	0.020348585148564254	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6378552568300022	0.6981712421233648	0.6262544221407789	0.7894408215177703	0.6863070500621022	0.7071519532784265	0.8112974379934063	0.7521931469004931	0.8389853242647527	0.7211177002143573	0.7469850817241637	0.7571590729771837	0.6030064685634468	0.6204209532237115	0.7398963187707879	0.5313911440672004	0.6493574025225659	0.5185514406828207	GSS	Pro314Leu	NC_000020.11:34932027:G:A	941C>T	20	34932027	G	A	20	ENSG00000100983	5132	215357	CCSBVarC006740	ALE00006738	ENSP00000498303.1	CEGS2	CegsMutGDEh1042	H09	GDEhDisVCh_40044	D01	2	CegsMutGDDh1042	H09	VUSN2Hmut_GDN2h_09	C01	VUSMutpDEST2_05	B01	VUSmut_GDEh09	C01	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	23569.0	single nucleotide variant	NM_000178.4(GSS):c.941C>T (p.Pro314Leu)	2937.0	GSS	HGNC:4624	Conflicting classifications of pathogenicity	0.0	Jan 27, 2024	75863437.0	-	RCV000009056|RCV000601337|RCV002227019	MONDO:MONDO:0017909,MedGen:CN030166,Orphanet:32|MedGen:CN169374|MedGen:C3661900	Inherited glutathione synthetase deficiency|not specified|not provided	germline	germline	GRCh38	NC_000020.11	20	34932027.0	34932027.0	20q11.22	criteria provided, conflicting classifications	6.0	-	N	ClinGen:CA119696,OMIM:601002.0006,ClinVar:2627798	2.0	8530.0	34932027.0	G	A	-	-	-	-	-	-	941C>T 	Pro314Leu	NM_000178.4	1.0	Conflicting	Conflicting	8530	20	34932027.0	G	A	P	L	rs75863437	20	33519830	20	32983491	314	GSS	ENSG00000100983	ENST00000651619	ENSP00000498303	P48637	GSHB_HUMAN	c.941C>T	p.Pro314Leu	c.941C>T	p.Pro314Leu	principal1	Y	.	YES	Select	-	CCG	2	0	G	G/G	G/G	G/G	G/G	.	0.68399	.	.	0.42259	.	0.414	0.35202	B	0.098	0.30481	B	.	0.26006	.	.	.	.	3.545	0.93121	H	.	0.97681	.	.	0.33134	0.2432	0.86575	D	0.6614	0.88199	D	10	.	0.00226	.	.	.	.	.	0.71872	.	.	.	.	.	.	0.86111	.	0.56988	.	.	0.274583131075	0.06747	T	0.965828	0.99589	D	-0.315148	0.07103	T	-0.217503	0.52660	T	0.138369524292667	0.15932	T	.	0.70530	.	0.3622977	0.57682	0.41533354	0.65397	0.29294342	0.51933	0.35441297	0.60748	-9.75	0.72481	D	.	0.27285	.	0.22520726946531	0.51129	0.62028116	0.84417	0.323	0.58780	.	.	.	.	.	.	1.282379	0.16845	12.79	0.80137825300222776	0.13272	0.135350	0.25351	N	-0.555841964804557	0.20056	1.069176	-0.720934024558455	0.16166	0.8696863	5.5	-4.41	0.03342	-4.84	0.04745	0.855	0.27552	-1.252000	0.05930	-0.116	0.14535	0.404	0.2629	0.000000	0.08389	0.966	0.53174	.	.	17	0.0033945686900958465	16	0.012102874432677761	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	865	264690	0.003267974	.	93	109404	8.500600e-04	0	197	208010	9.470700e-04	1	195	236914	8.230830e-04	1	71	7164	9.910660e-03	0	8	17112	4.675080e-04	0	0	2320	0.000000e+00	0	10	9044	1.105710e-03	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	1	15688	6.374300e-05	0	71	7164	9.910660e-03	0	151	16198	9.322140e-03	0	15	30524	4.914170e-04	0	0	6212	0.000000e+00	0	18	13402	1.343080e-03	1	0	16734	0.000000e+00	0	11	89474	1.229410e-04	0	1	30606	3.267330e-05	0	151	16198	9.322140e-03	0	143	14894	9.601180e-03	0	19	34260	5.545830e-04	0	0	9570	0.000000e+00	0	22	17690	1.243640e-03	1	0	21632	0.000000e+00	0	9	102726	8.761170e-05	0	1	30524	3.276110e-05	0	143	14894	9.601180e-03	0	.	918	1614176	5.687110e-04	2	703	75064	9.365340e-03	1	703	75064	9.365340e-03	1	0	912	0.000000e+00	0	42	60026	6.996970e-04	0	0	29608	0.000000e+00	0	65	44882	1.448240e-03	1	0	64032	0.000000e+00	0	1	6062	1.649620e-04	0	64	1180006	5.423700e-05	0	7	91076	7.685890e-05	0	10	175104	5.710891812865497E-5	0	360	0	9	4520	0.001991150442477876	82	9734	0.0084240805424286	2	812	0.0024630541871921183	1	1002	9.98003992015968E-4	5	1852	0.0026997840172786176	0	296	0	14	19520	7.172131147540983E-4	82	10094	0.008123637804636418	14	6372	0.002197112366603892	123	213200	5.76923076923077E-4	not_specified|Inherited_glutathione_synthetase_deficiency|not_provided	criteria_provided,_conflicting_classifications	NC_000020.11:g.34932027G>A	ClinGen:CA119696|OMIM:601002.0006	CN169374|CN030166|C3661900	.	32	.	Pro	Leu	95.04	0.9485294117647058																																																																																																																																																																																																																																																																																																																																																																																																																																																																													129			95.04	Special, No backbone hydrogen	Proline		Glutathione synthetase										1.6																		115									-53.5				135.1						C (loop/coil)	T (turn)												95.04	94.85294	>90	$\geqslant$90		autosomal recessive	OMIM	Rare genetic hematologic disease; Rare inborn errors of metabolism	2		false	0.6981712421233648	0.6378552568300022	false	false	false
TH	TH_Val468Met	B_7-8	-0.8946450601034721	0.4054332005420779	0.49767185927722923	-0.6290663103377626	0.5492757795795657	0.6021033784519134	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6580189884471843	0.7155724379591637	0.6531969106456008	0.8111967482153334	0.7771747650882397	0.7772057660010494	0.852773112070197	0.8009647269196174	0.8492250099559802	0.752904840277703	0.7611454276709131	0.7413454407225366	0.7016384199319017	0.753384803256862	0.7731684864746866	0.5534889810134987	0.6699994482474143	0.5746925361718319	TH	Val468Met	NC_000011.10:2164325:C:T	1402G>A	11	2164325	C	T	11	ENSG00000180176	71892	3996	CCSBVarC008280	ALE00008266	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	C09	GDEhDisVCh_40019	C09	1	VUSMutGDDh015	C09	VUSN2Hmut_GDN2h_04	E10	VUSMutpDEST2_15	A07	VUSmut_GDEh04	E10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	398531.0	single nucleotide variant	NM_000360.4(TH):c.1402G>A (p.Val468Met)	7054.0	TH	HGNC:11782	Conflicting classifications of pathogenicity	1.0	Feb 21, 2024	1800033.0	-	RCV000622901|RCV001106345	MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150	Inborn genetic diseases|Autosomal recessive DOPA responsive dystonia	germline;unknown	germline	GRCh38	NC_000011.10	11	2164325.0	2164325.0	11p15.5	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA5818247	2.0	412030.0	2164325.0	C	T	-	-	-	-	-	-	1402G>A 	Val468Met	NM_000360.4	1.0	Conflicting	Conflicting	412030	11	2164325.0	C	T	V	M	rs1800033	11	2185555	11	2142131	499	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.1495G>A	p.Val499Met	c.1495G>A	p.Val499Met	.	Y	1	.	.	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.037	0.61594	D	0.006	0.70891	D	1.0	0.90580	D	0.982	0.75481	D	0.43	0.66123	N	simple_aae	57.0	43.0	2.44	0.70564	M	-2.45	0.53599	N	0.26	0.35911	1.0321	0.97752	D	0.9833	0.99490	D	10	0.21288428	0.37377	T	0.917038	0.99384	D	0.594	0.83777	.	.	.	.	.	0.965064049163	0.96437	0.601903878565035	0.59942	1.54397379301	0.87734	0.672174930573	0.63088	T	0.940774	0.99058	D	-0.0676837	0.41351	T	0.0999216	0.76730	D	0.213748401309588	0.20888	T	0.910309	0.78512	D	0.1973214	0.41275	0.25129938	0.50545	0.19177647	0.40505	0.2998834	0.55804	-9.692	0.73045	D	0.1609	0.48651	B	0.440954620638456	0.58972	0.98934940	0.96634	0.304	0.57171	.	.	.	.	.	.	3.972416	0.58414	24.0	0.99826033731817365	0.90858	0.733189	0.67854	D	0.326629149541323	0.57301	3.919521	0.178604578808752	0.48413	3.080347	4.29	3.37	0.37618	0.983	0.29053	4.22	0.58451	2.573000	0.33457	0.549	0.27038	0.998	0.41403	0.991000	0.31563	0.118	0.19127	988	0.02004	3	5.990415335463259E-4	0	0.0	0	0.0	1	0.001440922190201729	2	0.001984126984126984	0	0.0	20	264690	7.556009E-5	.	13	87656	1.483070e-04	0	20	162034	1.234310e-04	0	23	185898	1.237240e-04	0	0	6338	0.000000e+00	0	2	12956	1.543690e-04	0	0	1542	0.000000e+00	0	11	7836	1.403780e-03	0	0	12490	0.000000e+00	0	0	33748	0.000000e+00	0	0	11286	0.000000e+00	0	11	7836	1.403780e-03	0	0	13914	0.000000e+00	0	3	23224	1.291770e-04	0	0	3990	0.000000e+00	0	17	10872	1.563650e-03	0	0	15298	0.000000e+00	0	0	69176	0.000000e+00	0	0	21944	0.000000e+00	0	17	10872	1.563650e-03	0	0	12686	0.000000e+00	0	3	25950	1.156070e-04	0	0	5912	0.000000e+00	0	20	14086	1.419850e-03	0	0	19456	0.000000e+00	0	0	81804	0.000000e+00	0	0	21868	0.000000e+00	0	20	14086	1.419850e-03	0	.	132	1539918	8.571880e-05	0	112	41818	2.678270e-03	0	0	71966	0.000000e+00	0	0	912	0.000000e+00	0	9	51438	1.749680e-04	0	0	26104	0.000000e+00	0	112	41818	2.678270e-03	0	0	61028	0.000000e+00	0	0	5754	0.000000e+00	0	7	1139664	6.142160e-06	0	1	81960	1.220110e-05	0	0	17810	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1254	0	0	2898	0	0	112	0	0	22928	0	Autosomal_recessive_DOPA_responsive_dystonia|Inborn_genetic_diseases	criteria_provided,_conflicting_classifications	NC_000011.10:g.2164325C>T	ClinGen:CA5818247	C2673535|C0950123	605407	101150	Aromatic amino acid hydroxylase, C-terminal|Aromatic amino acid hydroxylase, C-terminal	Val	Met	91.05	0.14084507042253522																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																91.05	14.084508	>90	10-90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.7155724379591637	0.6580189884471843	false	false	false
TH	TH_Arg306His	B_7-8	0.3175377478182183	0.7615954977388906	0.8099373055018269	0.4042154910868077	0.6981191634083265	0.7422066424416449	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.755656539830472	0.7605715795410193	0.5509757339479855	0.719123548557048	0.6592237944905799	0.6376644006637742	0.5432660156300055	0.5773096202066677	0.657205863954576	0.4749012797939134	0.7184995735771054	0.7268169623119103	0.7320627856975429	0.741137968774492	0.78104123315952	0.6270501881020577	0.8026435855049332	0.7844961173490336	TH	Arg306His	NC_000011.10:2166693:C:T	917G>A	11	2166693	C	T	11	ENSG00000180176	71892	4004	CCSBVarC008285	ALE00008271	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	A10	GDEhDisVCh_40019	H09	1	VUSMutGDDh015	A10	VUSN2Hmut_GDN2h_04	C11	VUSMutpDEST2_15	G07	VUSmut_GDEh04	C11	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	27367.0	single nucleotide variant	NM_000360.4(TH):c.917G>A (p.Arg306His)	7054.0	TH	HGNC:11782	Conflicting classifications of pathogenicity	1.0	Oct 17, 2023	28934580.0	-	RCV000013121	MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150	Autosomal recessive DOPA responsive dystonia	germline;unknown	germline	GRCh38	NC_000011.10	11	2166693.0	2166693.0	11p15.5	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA278131,UniProtKB:P07101#VAR_014030,OMIM:191290.0004	3.0	12328.0	2166693.0	C	T	-	-	-	-	-	-	917G>A 	Arg306His	NM_000360.4	1.0	Conflicting	Conflicting	12328	11	2166693.0	C	T	R	H	rs28934580	11	2187923	11	2144499	337	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.1010G>A	p.Arg337His	c.1010G>A	p.Arg337His	.	Y	1	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.97016	D	simple_aae	4.0	96.0	4.13	0.97427	H	-4.57	0.78753	D	0.933	0.93850	0.9255	0.96025	D	0.9932	0.99841	D	9	0.9871148	0.99050	D	0.978251	0.99880	D	0.967	0.99571	0.922	0.98631	P07101	R337H	Loss of methylation at R337 (P = 0.0693)| Loss of MoRF binding (P = 0.0717)| Gain of catalytic residue at F336 (P = 0.1379)| Loss of stability (P = 0.15)| Gain of sheet (P = 0.1945)	0.97776409184	0.97730	0.9223884878778954	0.92166	1.73545229533	0.90751	0.943151116371	0.99565	D	0.984939	0.99902	D	0.610562	0.97991	D	0.639253	0.97960	D	0.999609172344208	0.98098	D	0.969903	0.89158	D	0.9663403	0.97876	0.9367596	0.97517	0.96147084	0.97387	0.94916034	0.98324	-13.044	0.90241	D	0.7374	0.74466	P	0.997877967293049	0.93660	0.99845840	0.98795	0.988	0.99594	.	.	.	.	.	.	5.818016	0.93694	33.0	0.99950132737910591	0.99938	0.874584	0.79678	D	0.744607822286361	0.82459	7.791203	0.566192473920471	0.72381	5.824647	3.32	3.32	0.37060	.	.	7.41	0.79331	5.580000	0.49042	0.547	0.25831	1.0	0.71675	1.000000	0.68239	0.994	0.71086	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3202	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3316	0	0	112	0	0	14520	0	Autosomal_recessive_DOPA_responsive_dystonia	criteria_provided,_conflicting_classifications	NC_000011.10:g.2166693C>T	ClinGen:CA278131|OMIM:191290.0004|UniProtKB:P07101#VAR_014030	C2673535	605407	101150	Aromatic amino acid hydroxylase, C-terminal|Aromatic amino acid hydroxylase, C-terminal|Tyrosine 3-monooxygenase, catalytic domain	Arg	His	98.43	0.21370967741935484																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																98.43	21.370968	>90	10-90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.7605715795410193	0.755656539830472	false	false	false
DES	DES_Gly84Ser	B_7-8	0.8134272848864341	0.4470425426234478	0.537610538546545	1.6378745897205762	0.14545863969973005	0.18458962921784555	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6387946061493649	0.6291482443854179	0.6757976803124717	0.750371555520349	0.7379605569652252	0.7469459946506947	0.9282273434683206	0.9133277404246876	0.9271723407507267	0.8564452706738653	0.5960642730165322	0.6387946061493649	0.5656646458330687	0.562593373505763	0.5735707702899712	0.4951500899510779	0.6622322157543038		DES	Gly84Ser	NC_000002.12:219418712:G:A	250G>A	2	219418712	G	A	2	ENSG00000175084	12573	2237	CCSBVarC007801	ALE00007787	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	G02	GDEhDisVCh_40003	H02	1	VUSMutGDDh003	G02	VUSN2Hmut_GDN2h_01	G01	NULL	NULL	VUSmut_GDEh01	G01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	173630.0	single nucleotide variant	NM_001927.4(DES):c.250G>A (p.Gly84Ser)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	0.0	Feb 01, 2024	200545412.0	-	RCV000150379|RCV000724983|RCV000474215|RCV002426711	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MedGen:CN230736	not specified|not provided|Desmin-related myofibrillar myopathy|Cardiovascular phenotype	germline	germline	GRCh38	NC_000002.12	2	219418712.0	219418712.0	2q35	criteria provided, conflicting classifications	11.0	ACMG2022	N	ClinGen:CA175620	2.0	163024.0	219418712.0	G	A	-	-	-	-	-	-	250G>A 	Gly84Ser	NM_001927.4	1.0	Conflicting	Conflicting	163024	2	219418712.0	G	A	G	S	rs200545412	2	220283434	2	219991678	84	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.250G>A	p.Gly84Ser	c.250G>A	p.Gly84Ser	principal1	Y	1	YES	Select	+	GGC	1	0	G	G/G	G/G	G/G	G/G	0.875	0.02587	T	0.492	0.11657	T	0.947	0.53490	P	0.453	0.46203	P	0.34	0.58915	N	simple_aae	66.0	34.0	1.845	0.48501	L	0.01	0.06832	N	0.229	0.25568	-0.6459	0.62731	T	0.2678	0.63777	T	10	0.2356554	0.40242	T	0.063855	0.68986	D	0.276	0.59049	.	.	.	.	.	0.856494878783	0.85398	0.782236580147572	0.78051	1.28384199825	0.82511	0.82130420208	0.85202	D	0.23242	0.59683	T	-0.203718	0.19957	T	-0.21233	0.53156	T	0.249585598707199	0.22582	T	0.690631	0.29768	T	0.037865274	0.04889	0.06054859	0.11555	0.037865274	0.04889	0.06054859	0.11554	-4.123	0.25653	T	0.0911	0.13232	B	0.36605562464307	0.56560	0.92888397	0.92343	0.025	0.04491	.	.	.	.	.	.	3.56363	0.50242	22.9	0.99432219491336427	0.64373	0.839827	0.75630	D	-0.118228838230872	0.36325	2.1177	-0.0798604354560559	0.35920	2.105363	4.55	2.72	0.31097	0.139	0.22510	3.402	0.5245	6.400000	0.55643	0.59	0.31918	0.978	0.35124	1.000000	0.68239	0.962	0.52152	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	19	264690	7.178209E-5	.	6	72404	8.286830e-05	0	11	143572	7.661660e-05	0	17	165756	1.025600e-04	0	0	3696	0.000000e+00	0	0	12806	0.000000e+00	0	0	1540	0.000000e+00	0	0	5304	0.000000e+00	0	1	11598	8.622180e-05	0	4	24008	1.666110e-04	0	0	12016	0.000000e+00	0	4	24008	1.666110e-04	0	0	9886	0.000000e+00	0	0	21644	0.000000e+00	0	0	4868	0.000000e+00	0	0	10086	0.000000e+00	0	0	13722	0.000000e+00	0	10	55596	1.798690e-04	0	0	24056	0.000000e+00	0	10	55596	1.798690e-04	0	0	9278	0.000000e+00	0	0	25590	0.000000e+00	0	0	8426	0.000000e+00	0	0	12570	0.000000e+00	0	1	16176	6.182000e-05	0	15	65210	2.300260e-04	0	0	24034	0.000000e+00	0	15	65210	2.300260e-04	0	.	156	1564974	9.968220e-05	1	10	59914	1.669060e-04	0	0	74106	0.000000e+00	0	0	912	0.000000e+00	0	0	52120	0.000000e+00	0	1	28726	3.481170e-05	0	1	42494	2.353270e-05	0	10	59914	1.669060e-04	0	1	6008	1.664450e-04	0	139	1154620	1.203860e-04	1	0	85456	0.000000e+00	0	27	178094	1.5160533201567713E-4	0	360	0	1	4496	2.2241992882562276E-4	0	9376	0	0	796	0	0	968	0	0	1838	0	0	280	0	3	16972	1.767617251944379E-4	0	9736	0	1	6334	1.5787811809283233E-4	31	213180	1.4541701848203397E-4	not_specified|Desmin-related_myofibrillar_myopathy|not_provided|Cardiovascular_phenotype	criteria_provided,_conflicting_classifications	NC_000002.12:g.219418712G>A	ClinGen:CA175620	CN169374|C1832370|C3661900|CN230736	601419	363543|98909	Intermediate filament head, DNA-binding domain	Gly	Ser	37.72	0.8928571428571429																																																																																																																																																																																																																																																																																																																																																																																																																																																																													75			37.72	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Desmin										-0.4																		75									-68.9				144.0	Head					C (loop/coil)	C (loop/coil)												37.72	89.28571	$\leqslant$50	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.6291482443854179	0.6387946061493649	false	false	false
MVK	MVK_Val80Ile	B_7-8	1.4600743291691731	0.19456453607493554	0.2748655798100051	-1.6483862083671048	0.15036960443177746	0.19003321221233585	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.53964657716182	0.5903413013479646	0.664585052288365	0.6862653543500172	0.6436339249904452	0.6905822325892728	0.6641516661050648	0.6281984511875119	0.6528951281321717	0.6253182201194838	0.5897352882115505	0.617937751928764	0.7170127990734807	0.6590693987933784	0.7196355805678628	0.703851884457246	0.5909473144843788	0.46135540239487605	MVK	Val80Ile	NC_000012.12:109579813:G:A	238G>A	12	109579813	G	A	12	ENSG00000110921	281	6	CCSBVarC007117	ALE00007115	ENSP00000228510.3	Edgotyping3	VUSMutGDEh009	E11	GDEhDisVCh_40020	B06	2	VUSMutGDDh009	E11	VUSN2Hmut_GDN2h_03	B04	VUSMutpDEST2_01	E01	VUSmut_GDEh03	B04	1.0	1.0	1.0	5.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	103470.0	single nucleotide variant	NM_000431.4(MVK):c.238G>A (p.Val80Ile)	4598.0	MVK	HGNC:7530	Conflicting classifications of pathogenicity	0.0	Jan 31, 2024	76914224.0	-	RCV000083830|RCV000726403|RCV002262660|RCV001114047|RCV001087442|RCV004529878	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:C3661900|MONDO:MONDO:0019751,MedGen:C3890737,Orphanet:93665|MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29|MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900|MedGen:CN239294	Hyperimmunoglobulin D with periodic fever|not provided|Autoinflammatory syndrome|Mevalonic aciduria|Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever;Porokeratosis 3, disseminated superficial actinic type|MVK-related disorder	germline;unknown	germline	GRCh38	NC_000012.12	12	109579813.0	109579813.0	12q24.11	criteria provided, conflicting classifications	12.0	-	N	ClinGen:CA149807	2.0	97578.0	109579813.0	G	A	-	-	-	-	-	-	238G>A 	Val80Ile	NM_000431.4	1.0	Conflicting	Conflicting	97578	12	109579813.0	G	A	V	I	rs76914224	12	110017618	12	108502001	80	MVK	ENSG00000110921	ENST00000546277	ENSP00000438153	Q03426	KIME_HUMAN	c.238G>A	p.Val80Ile	c.238G>A	p.Val80Ile	principal1	Y	5	.	.	+	GTC	1	0	G	G/G	G/G	G/G	G/G	0.356	0.17108	T	0.532	0.12221	T	0.0	0.02950	B	0.0	0.04348	B	.	0.08015	.	.	.	.	1.24	0.30804	L	-0.49	0.15712	N	.	0.04782	-0.4975	0.68601	T	0.4529	0.78546	T	10	0.003958106	0.00075	T	0.120982	0.80106	D	0.206	0.49175	.	.	.	.	.	0.539343252841	0.53245	.	0.13119	.	0.31022	0.239075705409	0.02710	T	0.116596	0.43303	T	-0.401854	0.02125	T	-0.344603	0.39471	T	0.0118137968810339	0.00182	T	.	0.18628	.	0.06409519	0.13438	0.040863544	0.04527	0.051033422	0.09224	0.069176935	0.14536	-4.387	0.29411	T	0.0684	0.03823	LB	0.000332851489375095	0.05545	0.88135680	0.90581	0.051	0.13468	.	.	.	.	.	.	-0.728383	0.01259	0.065	0.55622202337578608	0.05452	0.051628	0.08996	N	-1.44932061698649	0.02200	0.09788562	-1.60837673276542	0.01586	0.07281622	4.54	-9.08	0.00617	-10.2	0.00199	-1.315	0.02821	-2.762000	0.03406	0.676	0.76753	0.0	0.06393	0.000000	0.08389	0.063	0.16222	730	0.54265	10	0.001996805111821086	10	0.007564296520423601	0	0.0	0	0.0	0	0.0	0	0.0	744	264690	0.0028108354	.	79	109400	7.221210e-04	1	173	208098	8.313390e-04	2	170	236938	7.174870e-04	2	55	7164	7.677280e-03	1	19	17106	1.110720e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	4	42766	9.353220e-05	0	0	15690	0.000000e+00	0	55	7164	7.677280e-03	1	130	16218	8.015780e-03	2	23	30514	7.537520e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	14	89534	1.563650e-04	0	2	30608	6.534240e-05	0	130	16218	8.015780e-03	2	120	14902	8.052610e-03	2	29	34250	8.467150e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	15	102744	1.459940e-04	0	2	30526	6.551790e-05	0	120	14902	8.052610e-03	2	.	851	1614236	5.271840e-04	7	596	75060	7.940310e-03	7	596	75060	7.940310e-03	7	0	912	0.000000e+00	0	82	60016	1.366300e-03	0	0	29608	0.000000e+00	0	0	44888	0.000000e+00	0	0	64048	0.000000e+00	0	11	6062	1.814580e-03	0	103	1180054	8.728410e-05	0	7	91084	7.685210e-05	0	6	49224	1.2189176011701609E-4	6	390	0.015384615384615385	0	148	0	82	11112	0.0073794096472282215	1	508	0.001968503937007874	0	634	0	0	58	0	0	104	0	7	9178	7.626933972543037E-4	88	11502	0.007650843331594505	0	206	0	102	71356	0.0014294523235607378	Hyperimmunoglobulin_D_with_periodic_fever|Mevalonic_aciduria|Autoinflammatory_syndrome|MVK-related_disorder|not_provided|Porokeratosis_3,_disseminated_superficial_actinic_type	criteria_provided,_conflicting_classifications	NC_000012.12:g.109579813G>A	ClinGen:CA149807	C0398691|C1959626|C3890737|CN239294|C3661900|C1867981	260920|610377|175900	343|29|93665	.	Val	Ile	51.82	0.4859154929577465																																																																																																																																																																																																																																																																																																																																																																																																																																																																													69			51.82	Aliphatic	Valine		Mevalonate kinase										4.2								 V80-R194 (PAE:  8.0)		 V80-K187 (PAE:  11.5), V80-Q191 (PAE: 10.5)								117									56.2				30.4						C (loop/coil)	C (loop/coil)												51.82	48.59155	50-70	10-90	260920;610377;610377;260920;175900	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; MEVALONIC ACIDURIA; MEVALONIC ACIDURIA; HYPER-IgD SYNDROME; POROKERATOSIS 3, MULTIPLE TYPES	false	0.5903413013479646	0.53964657716182	false	false	false
BAG3	BAG3_Arg218Trp	B_15-16	3.0623901535053406	0.01826191501497289	0.042442692512949694	-5.757757496590391	0.0006928724020747903	0.0017707811390072984	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.723598738831751	0.7500264611528175	0.5997127540680989	0.5584679763080791	0.5462586059639662	0.5963879309137367	0.6189418482895186	0.5930888797504046	0.6440502339180688	0.6250567550963311	0.6701998527776638	0.6153825674371927	0.5738340135379547	0.49942833217752786	0.4728857186980894	0.5743687530398667	0.8298530695279711	0.8318149102263093	BAG3	Arg218Trp	NC_000010.11:119672399:C:T	652C>T	10	119672399	C	T	10	ENSG00000151929	5066	201829	CCSBVarC003583	ALE00003583	ENSP00000358081.4	CEGS2	CegsMutGDEh1037	F05	GDEhDisVCh_40022	A07	2	CegsMutGDDh1037	F05	VUSN2Hmut_GDN2h_07	B08	VUSMutpDEST2_04	A12	VUSmut_GDEh07	B08	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	48063.0	single nucleotide variant	NM_004281.4(BAG3):c.652C>T (p.Arg218Trp)	9531.0	BAG3	HGNC:939	Conflicting classifications of pathogenicity	1.0	May 15, 2024	397514506.0	-	RCV000032660|RCV000171829|RCV000617935|RCV000648836|RCV003144117	MONDO:MONDO:0013479,MedGen:C3151293,OMIM:613881,Orphanet:154|MONDO:MONDO:0016342,MedGen:C4274968,OMIM:PS107970,Orphanet:217656|MedGen:CN230736|MONDO:MONDO:0013479,MedGen:C3151293,OMIM:613881,Orphanet:154;MONDO:MONDO:0013061,MedGen:C2751831,OMIM:612954,Orphanet:199340|MedGen:C3661900	Dilated cardiomyopathy 1HH|Familial isolated arrhythmogenic right ventricular dysplasia|Cardiovascular phenotype|Dilated cardiomyopathy 1HH;Myofibrillar myopathy 6|not provided	germline;unknown	germline	GRCh38	NC_000010.11	10	119672399.0	119672399.0	10q26.11	criteria provided, conflicting classifications	8.0	ACMG2022	N	ClinGen:CA261129,UniProtKB:O95817#VAR_066781,OMIM:603883.0007	3.0	39464.0	119672399.0	C	T	-	-	-	-	-	-	652C>T 	Arg218Trp	NM_004281.4	1.0	Conflicting	Conflicting	39464	10	119672399.0	C	T	R	W	rs397514506	10	121431911	10	121421901	218	BAG3	ENSG00000151929	ENST00000369085	ENSP00000358081	O95817	BAG3_HUMAN	c.652C>T	p.Arg218Trp	c.652C>T	p.Arg218Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.092	0.31822	T	0.11	0.41584	T	1.0	0.90580	D	0.936	0.67146	D	0.66	0.80260	D	simple_aae	34.0	66.0	2.135	0.59336	M	-2.81	0.66580	D	0.728	0.72801	0.0770	0.83681	D	0.5480	0.83350	D	10	0.28359956	0.45556	D	0.02157	0.44132	T	0.445	0.74592	0.479	0.55689	O95817	R218W	Loss of disorder (P = 0.0049)| Loss of glycosylation at T217 (P = 0.0802)| Gain of catalytic residue at Q214 (P = 0.2004)| Loss of sheet (P = 0.302)| Loss of MoRF binding (P = 0.3823)	0.952862676007	0.95196	0.31745554634334555	0.31458	0.420908205615	0.42324	0.535682559013	0.43773	T	0.270863	0.64115	T	0.0684161	0.60377	T	0.216876	0.83900	D	0.374252051115036	0.27658	T	0.904909	0.66451	D	0.135151	0.31108	0.08563715	0.19760	0.14707802	0.33356	0.101791844	0.24332	-6.686	0.51771	T	0.1403	0.51072	B	0.968162245806966	0.82965	0.99372170	0.97392	0.185	0.44051	.	.	.	.	.	.	4.613628	0.73242	25.9	0.99853739960379029	0.93284	0.372482	0.45627	N	0.542887003297111	0.69487	5.387244	0.53673566378738	0.70320	5.511464	6.17	5.24	0.72825	.	.	1.174	0.31644	2.708000	0.34295	0.599	0.40292	0.637	0.2815	0.994000	0.32271	0.949	0.49511	893	0.26484	.	.	.	.	.	.	.	.	.	.	.	.	15	264690	5.6670066E-5	.	12	109394	1.096950e-04	0	19	207972	9.135850e-05	0	21	236862	8.865920e-05	0	1	7164	1.395870e-04	0	2	17110	1.168910e-04	0	2	2320	8.620690e-04	0	6	9046	6.632770e-04	0	1	13392	7.467140e-05	0	0	42766	0.000000e+00	0	0	15682	0.000000e+00	0	6	9046	6.632770e-04	0	1	16206	6.170550e-05	0	2	30512	6.554800e-05	0	2	6210	3.220610e-04	0	12	13412	8.947210e-04	0	1	16732	5.976570e-05	0	0	89442	0.000000e+00	0	1	30598	3.268190e-05	0	12	13412	8.947210e-04	0	1	14900	6.711410e-05	0	2	34258	5.838050e-05	0	3	9568	3.135450e-04	0	12	17692	6.782730e-04	0	1	21630	4.623210e-05	0	1	102678	9.739180e-06	0	1	30518	3.276750e-05	0	12	17692	6.782730e-04	0	.	89	1614198	5.513570e-05	0	31	44866	6.909460e-04	0	10	75052	1.332410e-04	0	0	912	0.000000e+00	0	6	60034	9.994340e-05	0	6	29608	2.026480e-04	0	31	44866	6.909460e-04	0	1	64032	1.561720e-05	0	0	6062	0.000000e+00	0	22	1180036	1.864350e-05	0	7	91088	7.684880e-05	0	3	34348	8.734132991731687E-5	0	122	0	0	146	0	2	3824	5.230125523012552E-4	0	500	0	0	628	0	0	56	0	0	104	0	0	7036	0	2	3946	5.068423720223011E-4	0	202	0	5	46764	1.0691985287828244E-4	Familial_isolated_arrhythmogenic_right_ventricular_dysplasia|Dilated_cardiomyopathy_1HH|Myofibrillar_myopathy_6|not_provided|Cardiovascular_phenotype	criteria_provided,_conflicting_classifications	NC_000010.11:g.119672399C>T	ClinGen:CA261129|OMIM:603883.0007|UniProtKB:O95817#VAR_066781	C4274968|C3151293|C2751831|C3661900|CN230736	PS107970|613881|612954	217656|154|199340	.	Arg	Trp	43.06	0.8870967741935484																																																																																																																																																																																																																																																																																																																																																																																																																																																																													220			43.06	Positively-charged	Arginine		BAG family molecular chaperone regulator 3										-4.5																Morphology: IHEQNVTrPAAQPsF		175									-48.3				125.8						C (loop/coil)	C (loop/coil)												43.06	88.70968	$\leqslant$50	10-90	613881;613881;612954	autosomal dominant	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	CARDIOMYOPATHY, DILATED, 1HH; CARDIOMYOPATHY, DILATED, 1HH; MYOPATHY, MYOFIBRILLAR, 6	false	0.7500264611528175	0.723598738831751	false	false	false
SMAD3	SMAD3_Pro263Leu	B_15-16	-1.2273911124280488	0.5108794534883149	0.5343098252091614	-1.4591620594440884	0.3791190909831814	0.40939462425046685	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7468557190129532	0.7430460847089431	0.698053182721418	0.782404678819285	0.8570289704621064	0.798814680174708	0.784321427470044	0.8919230533143003	0.8882025263646656	0.6850769738156982	0.8360915687513752	0.83084739249131	0.813307932879372	0.8221348876099124	0.6766068312739044	0.711029391627138	0.6500006006665109	0.6628640455345964	SMAD3	Pro263Leu	NC_000015.10:67181370:C:T	788C>T	15	67181370	C	T	15	ENSG00000166949	11805	2150	CCSBVarC004695	ALE00004695	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	B02	GDEhDisVCh_40014	G08	2	VUSMutGDDh005	B02	VUSN2Hmut_GDN2h_01	D11	VUSMutpDEST2_09	F04	VUSmut_GDEh01	D11	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	N	Y	Y	Y	39270.0	single nucleotide variant	NM_005902.4(SMAD3):c.788C>T (p.Pro263Leu)	4088.0	SMAD3	HGNC:6769	Conflicting classifications of pathogenicity	1.0	Jul 19, 2019	387906855.0	-	RCV000023249|RCV002313720	MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Aneurysm-osteoarthritis syndrome|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000015.10	15	67181370.0	67181370.0	15q22.33	criteria provided, conflicting classifications	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020114,OMIM:603109.0009	3.0	30314.0	67181370.0	C	T	-	-	-	-	-	-	788C>T 	Pro263Leu	NM_005902.4	1.0	Conflicting	Conflicting	30314	15	67181370.0	C	T	P	L	rs387906855	15	67473708	15	65260762	263	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.788C>T	p.Pro263Leu	c.788C>T	p.Pro263Leu	principal1	Y	1	YES	Select	+	CCC	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.85	0.96253	A	simple_aae	15.0	85.0	2.49	0.72380	M	-9.59	0.98808	D	0.982	0.99191	1.0955	0.99468	D	0.9443	0.98173	D	10	0.96984494	0.96515	D	0.581491	0.96245	D	0.976	0.99783	0.825	0.93622	P84022	P263L	Loss of disorder (P = 0.0227)| Loss of phosphorylation at T261 (P = 0.1573)| Loss of loop (P = 0.2237)| Loss of sheet (P = 0.302)| Loss of glycosylation at T261 (P = 0.4771)	0.992895614317	0.99273	0.836052102763976	0.83466	2.47311793574	0.97497	0.920664668083	0.98373	D	0.979993	0.99833	D	0.552351	0.95801	D	0.555637	0.95738	D	0.999739825725555	0.98718	D	0.995025	0.98336	D	0.9749146	0.98677	0.86835384	0.92655	0.95531666	0.96755	0.8977261	0.94743	-11.3	0.82363	D	0.996	0.97843	P	0.999771546383172	0.97903	0.99466250	0.97597	0.959	0.98248	.	.	.	.	.	.	5.498544	0.91571	32.0	0.99902595282762019	0.97428	0.896739	0.83753	D	0.816673911283979	0.87065	9.115423	0.781711259757422	0.88432	9.603238	5.1	5.1	0.68875	.	.	7.803	0.84582	7.629000	0.62706	0.594	0.32546	1.0	0.71675	1.000000	0.68239	0.982	0.59239	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Aneurysm-osteoarthritis_syndrome	criteria_provided,_conflicting_classifications	NC_000015.10:g.67181370C>T	ClinGen:CA020114|OMIM:603109.0009	C4707243|C3151087	PS607086|613795	91387|284984	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Pro	Leu	92.14	0.8014705882352942																																																																																																																																																																																																																																																																																																																																																																																																																																																																													109			92.14	Special, No backbone hydrogen	Proline		Mothers against decapentaplegic homolog 3							MH2			1.6									P263-R268 (PDBs: 1MJS, 1MK2)									115									-86.7				-9.0						C (loop/coil)	S (bend)												92.14	80.14706	>90	10-90	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	false	0.7430460847089431	0.7468557190129532	false	false	false
TMEM43	TMEM43_Tyr371His	B_15-16	-1.892049657019767	0.10037248540292343	0.16498403366573472	1.917670484050527	0.09666054165626514	0.12825169482230406	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6527650721625662	0.6619024974311163	0.5469086881102792	0.7004737773025935	0.6735319782695943	0.5922406791549358	0.37983077171788576	0.6118977598178367	0.6043138136404687	0.3714755125546168	0.6098263788452591	0.5998205477677817	0.804650586591986	0.7351661967213521	0.7966337409647184	0.7223418636659414	0.7139786160169735	0.7057095965573508	TMEM43	Tyr371His	NC_000003.12:14141703:T:C	1111T>C	3	14141703	T	C	3	ENSG00000170876	3438	201183	CCSBVarC004829	ALE00004829	ENSP00000303992.5	CEGS2	CegsMutGDEh1038	D08	GDEhDisVCh_40077	A07	1	CegsMutGDDh1038	D08	VUSN2Hmut_GDN2h_07	F11	VUSMutpDEST2_03	G06	VUSmut_GDEh07	F11	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	55305.0	single nucleotide variant	NM_024334.3(TMEM43):c.1111T>C (p.Tyr371His)	79188.0	TMEM43	HGNC:28472	Conflicting classifications of pathogenicity	0.0	Jan 29, 2024	116911972.0	-	RCV000039378|RCV000172121|RCV000622090|RCV000769161|RCV001086894	MedGen:CN169374|MedGen:C3661900|MedGen:CN230736|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0011459,MedGen:C1858379,OMIM:604400	not specified|not provided|Cardiovascular phenotype|Cardiomyopathy|Arrhythmogenic right ventricular dysplasia 5	germline;unknown	germline	GRCh38	NC_000003.12	3	14141703.0	14141703.0	3p25.1	criteria provided, conflicting classifications	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA024587	2.0	46140.0	14141703.0	T	C	-	-	-	-	-	-	1111T>C 	Tyr371His	NM_024334.3	1.0	Conflicting	Conflicting	46140	3	14141703.0	T	C	Y	H	rs116911972	3	14183203	3	14158204	371	TMEM43	ENSG00000170876	ENST00000306077	ENSP00000303992	Q9BTV4	TMM43_HUMAN	c.1111T>C	p.Tyr371His	c.1111T>C	p.Tyr371His	principal1	Y	1	YES	Select	+	TAC	1	0	T	T/T	T/T	T/T	T/T	0.099	0.30794	T	0.291	0.21209	T	0.884	0.48632	P	0.493	0.47442	P	0.25	0.50204	N	simple_aae	75.0	25.0	1.515	0.38106	L	-2.96	0.61754	D	0.373	0.41210	-1.0399	0.17331	T	0.0591	0.24592	T	10	0.01143986	0.00246	T	.	.	.	0.237	0.53859	.	.	.	.	.	0.413241256734	0.40549	0.7310376780185068	0.72905	0.149854743473	0.16636	0.546152412891	0.45249	T	0.12007	0.43899	T	-0.325914	0.06236	T	-0.231534	0.51301	T	0.0863706943469327	0.10646	T	0.787321	0.42431	T	0.4390267	0.63020	0.30549034	0.56356	0.39964658	0.60383	0.30967325	0.56759	-5.938	0.45815	T	0.1914	0.41097	B	0.0927950499146744	0.42647	0.96912250	0.94589	0.364	0.62012	.	.	.	.	.	.	3.677512	0.5241	23.2	0.99116714110894211	0.52959	0.734544	0.67948	D	0.143284885127044	0.48245	3.061031	0.248822639348344	0.52334	3.432166	5.71	4.54	0.55168	.	.	4.603	0.60896	4.193000	0.42495	0.605	0.46302	1.0	0.71675	1.000000	0.68239	0.997	0.79771	830	0.39194	9	0.0017971246006389776	0	0.0	0	0.0	0	0.0	9	0.008928571428571428	0	0.0	87	264690	3.2868638E-4	.	92	109378	8.411200e-04	2	147	208082	7.064520e-04	2	199	236884	8.400740e-04	2	0	7164	0.000000e+00	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	86	9046	9.506960e-03	2	0	13376	0.000000e+00	0	1	42756	2.338850e-05	0	1	15690	6.373490e-05	0	86	9046	9.506960e-03	2	0	16218	0.000000e+00	0	2	30522	6.552650e-05	0	0	6210	0.000000e+00	0	139	13416	1.036080e-02	2	0	16716	0.000000e+00	0	3	89526	3.350980e-05	0	1	30608	3.267120e-05	0	139	13416	1.036080e-02	2	0	14902	0.000000e+00	0	2	34258	5.838050e-05	0	0	9570	0.000000e+00	0	193	17692	1.090890e-02	2	0	21610	0.000000e+00	0	1	102706	9.736530e-06	0	1	30526	3.275900e-05	0	193	17692	1.090890e-02	2	.	696	1614162	4.311830e-04	11	646	44880	1.439390e-02	9	0	75058	0.000000e+00	0	0	912	0.000000e+00	0	12	60026	1.999130e-04	0	0	29604	0.000000e+00	0	646	44880	1.439390e-02	9	0	64026	0.000000e+00	0	0	6060	0.000000e+00	0	10	1180006	8.474530e-06	0	2	91080	2.195870e-05	0	0	52472	0	0	122	0	0	152	0	0	3908	0	0	160	0	0	638	0	0	58	0	0	104	0	2	4042	4.948045522018803E-4	0	4030	0	0	210	0	2	61656	3.24380433372259E-5	Cardiovascular_phenotype|not_specified|not_provided|Arrhythmogenic_right_ventricular_dysplasia_5|Cardiomyopathy	criteria_provided,_conflicting_classifications	NC_000003.12:g.14141703T>C	ClinGen:CA024587	CN230736|CN169374|C3661900|C1858379|C0878544	604400	167848	.	Tyr	His	81.22	0.5900900900900901																																																																																																																																																																																																																																																																																																																																																																																																																																																																													131			81.22	Aromatic	Tyrosine		Transmembrane protein 43										-1.3																		181									-104.5				-41.0						C (loop/coil)	T (turn)									Helical			81.22	59.00901	70-90	10-90	604400	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5	false	0.6619024974311163	0.6527650721625662	false	false	false
NEXN	NEXN_Arg171Cys	B_7-8	3.1463038356279194	0.01990789375583609	0.04532071164916202	2.955369316929055	0.025435187901106524	0.03895957412231258	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6293248368816389	0.587221044400555	0.5726384402640047	0.5300163946196785	0.4580244886006033	0.5171922719174791	0.6157848681994837	0.6158600998044347	0.6354808194247035	0.5817870016012393	0.6366329411058482	0.6262448301084342	0.41859967563547434	0.30018887739677197	0.42455196981465354	0.56348987892677	0.5378091476952619	0.6324048436548436	NEXN	Arg171Cys	NC_000001.11:77926863:C:T	511C>T	1	77926863	C	T	1	ENSG00000162614	56360	205331	CCSBVarC003658	ALE00003658	ENSP00000333938.7	CEGS2	CegsMutGDEh1031	D06	GDEhDisVCh_40088	E05	2	CegsMutGDDh1031	D06	VUSN2Hmut_GDN2h_05	G08	VUSMutpDEST2_13	G07	VUSmut_GDEh05	G08	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	39951.0	single nucleotide variant	NM_144573.4(NEXN):c.835C>T (p.Arg279Cys)	91624.0	NEXN	HGNC:29557	Conflicting classifications of pathogenicity	1.0	Dec 04, 2023	146245480.0	-	RCV000023985|RCV000041184|RCV000143936|RCV000460527|RCV000769818|RCV001719699|RCV004017264|RCV004532402	MONDO:MONDO:0013477,MedGen:C3151267,OMIM:613876|MedGen:CN169374|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MONDO:MONDO:0013477,MedGen:C3151267,OMIM:613876;MONDO:MONDO:0013147,MedGen:C2751084,OMIM:613122,Orphanet:154|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MedGen:C3661900|MedGen:CN230736|	Hypertrophic cardiomyopathy 20|not specified|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC|Cardiomyopathy|not provided|Cardiovascular phenotype|NEXN-related disorder	germline	germline	GRCh38	NC_000001.11	1	77926863.0	77926863.0	1p31.1	criteria provided, conflicting classifications	9.0	-	N	ClinGen:CA129605,UniProtKB:Q0ZGT2#VAR_065478,OMIM:613121.0005	3.0	30994.0	77926863.0	C	T	-	-	-	-	-	-	835C>T 	Arg279Cys	NM_144573.4	1.0	Conflicting	Conflicting	30994	1	77926863.0	C	T	R	C	rs146245480	1	78392548	1	78165136	279	NEXN	ENSG00000162614	ENST00000334785	ENSP00000333938	Q0ZGT2	NEXN_HUMAN	c.835C>T	p.Arg279Cys	c.835C>T	p.Arg279Cys	principal3	Y	1	YES	Select	+	CGT	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.002	0.83643	D	1.0	0.90580	D	0.947	0.68403	D	0.54	0.74433	D	simple_aae	46.0	54.0	2.795	0.81335	M	-2.25	0.67045	N	0.571	0.63527	-0.2178	0.77106	T	0.4182	0.76331	T	10	0.007816255	0.00174	T	0.086501	0.74665	D	0.211	0.49965	.	.	.	.	.	0.899709129007	0.89794	0.11616732390764781	0.11393	0.335772900916	0.35288	0.359078586102	0.19231	T	0.072408	0.46688	T	-0.0191291	0.48649	T	0.202219	0.83129	D	0.208819026748622	0.20635	T	0.90351	0.80632	D	0.2912564	0.51776	0.1886412	0.42020	0.24724437	0.47371	0.2333834	0.48343	-9.093	0.68370	D	0.2314	0.53501	B	0.634538007437098	0.64892	0.99872303	0.98926	0.451	0.68202	.	.	.	.	.	.	5.071353	0.84607	28.4	0.99936363395094385	0.99621	0.774504	0.70712	D	0.647169693508292	0.76055	6.440154	0.613528332763639	0.75789	6.396956	5.63	5.63	0.86088	6.09	0.97906	4.689	0.61495	4.793000	0.44991	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.807	0.38072	730	0.54265	6	0.0011980830670926517	0	0.0	0	0.0	1	0.001440922190201729	5	0.00496031746031746	0	0.0	82	264690	3.0979636E-4	.	63	108502	5.806340e-04	1	101	205650	4.911260e-04	0	127	234360	5.419010e-04	1	0	7100	0.000000e+00	0	4	17020	2.350180e-04	0	0	2320	0.000000e+00	0	54	8636	6.252890e-03	1	0	13308	0.000000e+00	0	4	42602	9.389230e-05	0	1	15622	6.401230e-05	0	54	8636	6.252890e-03	1	0	15314	0.000000e+00	0	6	30414	1.972780e-04	0	0	6174	0.000000e+00	0	84	12978	6.472490e-03	0	0	16648	0.000000e+00	0	8	88806	9.008400e-05	0	2	30536	6.549650e-05	0	84	12978	6.472490e-03	0	0	14096	0.000000e+00	0	6	34152	1.756850e-04	0	0	9546	0.000000e+00	0	110	17278	6.366480e-03	1	0	21546	0.000000e+00	0	8	101766	7.861170e-05	0	2	30456	6.566850e-05	0	110	17278	6.366480e-03	1	.	362	1613862	2.243070e-04	1	220	44838	4.906550e-03	1	0	74990	0.000000e+00	0	0	912	0.000000e+00	0	11	60014	1.832910e-04	0	1	29594	3.379060e-05	0	220	44838	4.906550e-03	1	1	63918	1.564500e-05	0	0	6060	0.000000e+00	0	110	1179960	9.322350e-05	0	6	91072	6.588190e-05	0	19	157124	1.2092360174129986E-4	0	352	0	11	2686	0.004095309009679821	0	8826	0	0	442	0	0	950	0	0	652	0	0	280	0	1	9228	1.0836584308625921E-4	0	9178	0	11	3338	0.0032953864589574597	31	180540	1.7170710091946384E-4	Hypertrophic_cardiomyopathy_20|Dilated_cardiomyopathy_1CC|not_specified|not_provided|NEXN-related_disorder|Cardiovascular_phenotype|Cardiomyopathy|Primary_familial_hypertrophic_cardiomyopathy	criteria_provided,_conflicting_classifications	NC_000001.11:g.77926863C>T	ClinGen:CA129605|OMIM:613121.0005|UniProtKB:Q0ZGT2#VAR_065478	C3151267|C2751084|CN169374|C3661900|CN230736|C0878544|C0949658	613876|613122|PS192600	154|167848|155	.	Arg	Cys	86.43	0.7580645161290323																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																86.43	75.80645	70-90	10-90	613876;613876;613122	autosomal dominant	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CARDIOMYOPATHY, DILATED, 1CC	false	0.587221044400555	0.6293248368816389	false	false	false
CTH	CTH_Thr67Ile	B_15-16	2.0687059418227256	0.07736440760268969	0.13264454086278032	-6.920691883530966	0.00022707243344658552	0.0007534862845831545	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8197838813888709	0.8509057080964291	0.6014271871396891	0.7239138601785027	0.7025230259800599	0.6496158575477948	0.5938761715178107	0.6301805410949491	0.5940191416731602	0.6160952330681133	0.7938472912293298	0.7578523957193359	0.7053555435777789	0.7748655108651707	0.8538085786838452	0.5867591412112649	0.9079641249635282	0.8817153670584058	CTH	Thr67Ile	NC_000001.11:70415987:C:T	200C>T	1	70415987	C	T	1	ENSG00000116761	268	713	CCSBVarC000019	ALE00000019	ENSP00000359976.3	RC4	RC4_Mut_GDEh1008	E11	GDEhDisVCh_40012	A12	2	RC4_Mut_GDDh1008	E11	NULL	NULL	NULL	NULL	VUSmut_GDEh12	A09	1.0	1.0	1.0	1.0	0.0			0.0			1.0	1.0	99.0	Y	Y	N	N	Y	17978.0	single nucleotide variant	NM_001902.6(CTH):c.200C>T (p.Thr67Ile)	1491.0	CTH	HGNC:2501	Conflicting classifications of pathogenicity	1.0	Apr 04, 2024	28941785.0	-	RCV000003073|RCV000727631|RCV004758588	Human Phenotype Ontology:HP:0003153,MONDO:MONDO:0009058,MedGen:C0220993,OMIM:219500,Orphanet:212|MedGen:C3661900|	Cystathioninuria|not provided|CTH-related disorder	germline;unknown	germline	GRCh38	NC_000001.11	1	70415987.0	70415987.0	1p31.1	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA115889,UniProtKB:P32929#VAR_015450,OMIM:607657.0003	3.0	2939.0	70415987.0	C	T	-	-	-	-	-	-	200C>T 	Thr67Ile	NM_001902.6	1.0	Conflicting	Conflicting	2939	1	70415987.0	C	T	T	I	rs28941785	1	70881670	1	70654258	67	CTH	ENSG00000116761	ENST00000370938	ENSP00000359976	P32929	CGL_HUMAN	c.200C>T	p.Thr67Ile	c.200C>T	p.Thr67Ile	principal1	Y	1	YES	Select	+	ACT	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.023	0.57446	D	0.999	0.77914	D	0.995	0.83178	D	0.95	0.96253	A	simple_aae	5.0	95.0	3.455	0.92175	M	-5.47	0.86025	D	0.885	0.88339	0.8938	0.95574	D	0.8474	0.94898	D	9	0.023492247	0.00614	T	.	.	.	0.931	0.98376	.	.	.	.	.	0.99153092309	0.99134	0.9644773549522416	0.96414	0.6590327163	0.58509	0.671995460987	0.63062	T	0.885369	0.97607	D	0.125518	0.66684	D	0.414771	0.92523	D	0.0626467519820281	0.07494	T	0.978002	0.92720	D	0.93658304	0.94822	0.92582566	0.96759	0.953689	0.96588	0.9483326	0.98273	-12.397	0.86765	D	0.8136	0.83038	P	0.888343027577493	0.75284	0.19821586	0.73001	0.804	0.89163	.	.	.	.	.	.	4.521564	0.70954	25.6	0.99906710229661511	0.97728	0.931687	0.92058	D	0.983801676259925	0.95198	13.42158	0.922308322611668	0.96453	14.7398	5.55	5.55	0.83275	4.17	0.79380	6.098	0.71176	5.902000	0.50975	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	651	0.62844	13	0.002595846645367412	0	0.0	11	0.010934393638170975	0	0.0	0	0.0	2	0.002044989775051125	1875	264690	0.0070837582	.	636	109404	5.813320e-03	3	1308	208076	6.286160e-03	6	1514	236870	6.391690e-03	8	8	7164	1.116690e-03	0	131	17110	7.656340e-03	1	23	2320	9.913790e-03	1	0	9046	0.000000e+00	0	44	13392	3.285540e-03	0	387	42768	9.048820e-03	1	31	15690	1.975780e-03	0	387	42768	9.048820e-03	1	23	16196	1.420100e-03	0	214	30522	7.011340e-03	1	66	6212	1.062460e-02	1	0	13414	0.000000e+00	0	56	16732	3.346880e-03	0	863	89536	9.638580e-03	4	50	30608	1.633560e-03	0	863	89536	9.638580e-03	4	23	14880	1.545700e-03	0	261	34258	7.618660e-03	1	96	9570	1.003130e-02	1	0	17690	0.000000e+00	0	69	21630	3.190010e-03	0	965	102708	9.395570e-03	6	49	30526	1.605190e-03	0	965	102708	9.395570e-03	6	.	12927	1610620	8.026100e-03	73	584	60012	9.731390e-03	2	129	74978	1.720500e-03	1	1	912	1.096490e-03	0	584	60012	9.731390e-03	2	256	29584	8.653330e-03	1	1	44850	2.229650e-05	0	238	64012	3.718050e-03	1	23	6048	3.802910e-03	0	11097	1176802	9.429790e-03	67	151	91004	1.659270e-03	0	1806	196022	0.009213251573802941	0	360	0	0	4548	0	21	9438	0.0022250476795931343	5	804	0.006218905472636816	1	962	0.0010395010395010396	0	1850	0	0	280	0	124	17702	0.007004858208112078	21	9798	0.0021432945499081446	0	6398	0	1957	231966	0.008436581223110284	not_provided|Cystathioninuria	criteria_provided,_conflicting_classifications	NC_000001.11:g.70415987C>T	ClinGen:CA115889|OMIM:607657.0003|UniProtKB:P32929#VAR_015450	C3661900|C0220993	219500	212	.	Thr	Ile	98.82	0.028169014084507043																																																																																																																																																																																																																																																																																																																																																																																																																																																																													4			98.82	Polar/Neutral	Threonine		Cystathionine gamma-lyase								0.0244		-0.7								 T67-P40 (PAE:  1.0), T67-S42 (PAE: 1.0), T67-L71 (PAE: 1.0)	T67-L71 (PDBs: 2NMP, 3COG, 3ELP, 5TT2, 6NBA, 6OVG), T67-P40 (PDBs: 6OVG), T67-S42 (PDBs: 6OVG)	 T67-P40 (PAE:  1.0), T67-S42 (PAE: 1.0), T67-I41 (PAE: 1.0), T67-L71 (PAE: 1.0), T67-Y253 (PAE: 1.0)	T67-Y253 (PDBs: 2NMP, 3COG, 3ELP, 5TT2, 6NBA, 6OVG), T67-P40 (PDBs: 6OVG), T67-S42 (PDBs: 6OVG), T67-I41 (PDBs: 6OVG), T67-L71 (PDBs: 6OVG)							119									-67.3		Pocket 4: Mean pLDDT: 99.89, Volume: 223.39 Å³, Druggability score: 0.02		-42.0						H (helix)	H (α-helix)	Helix											98.82	2.8169014	>90	<10	219500	autosomal recessive	OMIM	Rare inborn errors of metabolism	1	CYSTATHIONINURIA	false	0.8509057080964291	0.8197838813888709	false	false	false
GLYCTK	GLYCTK_Phe493Cys	B_7-8	10.457055034760026	0.0018669234198676883	0.007459882284408545	-1.6265376770169002	0.15495995878183294	0.195430600937913	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7562484002002533	0.6689306564530304	0.39569367922954873	0.5344029379565509	0.5046636456452728	0.42074571689010026	0.42074571689010026	0.5121395407694617	0.5004481471217688	0.39569367922954873	0.7642970993418472	0.7562484002002533		0.49718775052108394	0.5683577287913332		0.5735642135642136		GLYCTK	Phe493Cys	NC_000003.12:52293032:T:G	1478T>G	3	52293032	T	G	3	ENSG00000168237	13554	204026	CCSBVarC003994	ALE00003994	ENSP00000389175.2	CEGS2	CegsMutGDEh1031	H03	GDEhDisVCh_40089	G05	1	CegsMutGDDh1031	H03	VUSN2Hmut_GDN2h_05	D07	NULL	NULL	VUSmut_GDEh05	D07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	39793.0	single nucleotide variant	NM_145262.4(GLYCTK):c.1478T>G (p.Phe493Cys)	132158.0	GLYCTK	HGNC:24247	Conflicting classifications of pathogenicity	1.0	Jun 26, 2023	121909448.0	-	RCV000023821|RCV001852029	MONDO:MONDO:0009070,MedGen:C0342765,OMIM:220120,Orphanet:941|MedGen:C3661900	D-Glyceric aciduria|not provided	germline;inherited;unknown	germline	GRCh38	NC_000003.12	3	52293032.0	52293032.0	3p21.2	criteria provided, conflicting classifications	6.0	-	N	ClinGen:CA129493,UniProtKB:Q8IVS8#VAR_065909,OMIM:610516.0002	3.0	30836.0	52293032.0	T	G	-	-	-	-	-	-	1478T>G 	Phe493Cys	NM_145262.4	1.0	Conflicting	Conflicting	30836	3	52293032.0	T	G	F	C	rs121909448	3	52327048	3	52302088	493	GLYCTK	ENSG00000168237	ENST00000436784	ENSP00000389175	Q8IVS8	GLCTK_HUMAN	c.1478T>G	p.Phe493Cys	c.1478T>G	p.Phe493Cys	principal1	Y	1	YES	Select	+	TTC	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.992	0.80453	D	0.39	0.63057	A	simple_aae	61.0	39.0	3.905	0.96088	H	-6.63	0.92194	D	0.972	0.98282	0.7321	0.93551	D	0.7468	0.91338	D	9	0.9744398	0.97124	D	0.330593	0.91721	D	0.911	0.97621	.	.	.	.	.	0.89042064206	0.88849	0.9269876415707099	0.92630	0.623199020469	0.56267	0.588805913925	0.51258	T	0.829987	0.95898	D	0.173081	0.71195	D	0.372753	0.91108	D	0.787333905696869	0.45228	D	0.872513	0.57839	D	0.86990744	0.88700	0.7916902	0.87596	0.860257	0.87945	0.7513012	0.85121	-8.848	0.66791	D	0.7585	0.75369	P	0.962466771958448	0.82073	0.61047447	0.84215	0.864	0.92591	.	.	.	.	.	.	5.120594	0.85675	28.7	0.98712095093697039	0.45179	0.891891	0.82765	D	0.652714827177747	0.76420	6.506256	0.537269529736736	0.70354	5.516813	5.22	5.22	0.72246	4.54	0.84756	5.913	0.69762	7.889000	0.72983	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.844	0.39891	85	0.96453	.	.	.	.	.	.	.	.	.	.	.	.	25	264690	9.445011E-5	.	20	109366	1.828720e-04	0	40	207996	1.923110e-04	0	45	236790	1.900420e-04	0	0	7164	0.000000e+00	0	10	17100	5.847950e-04	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13370	0.000000e+00	0	3	42764	7.015250e-05	0	6	15690	3.824090e-04	0	10	17100	5.847950e-04	0	0	16208	0.000000e+00	0	20	30510	6.555230e-04	0	0	6212	0.000000e+00	0	1	13416	7.453790e-05	0	0	16710	0.000000e+00	0	8	89474	8.941140e-05	0	11	30606	3.594070e-04	0	20	30510	6.555230e-04	0	0	14902	0.000000e+00	0	21	34244	6.132460e-04	0	0	9570	0.000000e+00	0	2	17692	1.130450e-04	0	0	21604	0.000000e+00	0	11	102638	1.071730e-04	0	11	30522	3.603960e-04	0	21	34244	6.132460e-04	0	.	164	1614002	1.016110e-04	0	28	59990	4.667440e-04	0	2	74936	2.668940e-05	0	0	910	0.000000e+00	0	28	59990	4.667440e-04	0	0	29608	0.000000e+00	0	2	44896	4.454740e-05	0	0	63998	0.000000e+00	0	0	6084	0.000000e+00	0	108	1180008	9.152480e-05	0	19	91084	2.085990e-04	0	18	163040	1.1040235525024534E-4	0	360	0	1	4500	2.2222222222222223E-4	0	9362	0	0	442	0	2	950	0.002105263157894737	0	1848	0	0	280	0	3	13164	2.2789425706472196E-4	0	9722	0	1	6348	1.575299306868305E-4	24	193946	1.2374578490920152E-4	D-Glyceric_aciduria|not_provided	criteria_provided,_conflicting_classifications	NC_000003.12:g.52293032T>G	ClinGen:CA129493|OMIM:610516.0002|UniProtKB:Q8IVS8#VAR_065909	C0342765|C3661900	220120	941	MOFRL domain	Phe	Cys	98.54	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.54	Aromatic	Phenylalanine		Glycerate kinase										2.8								 F493-S489 (PAE:  1.0)		 F493-G499 (PAE:  1.0), F493-S489 (PAE: 1.0)								165									-71.5				-33.0						H (helix)	H (α-helix)												98.54	0.0	>90	<10	220120	autosomal recessive	OMIM	Rare inborn errors of metabolism	1	D-GLYCERIC ACIDURIA	false	0.6689306564530304	0.7562484002002533	false	false	false
GFAP	GFAP_Glu205Lys	B_15-16	2.710647620962309	0.030170745833020405	0.06263709189246627	7.377049821734152	0.00015237144063026136	0.000562578659067464	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7835463921628014	0.7851838383144428	0.6270163870065877	0.7095707069996506	0.6894852978781645	0.7777755408086925	0.6566110787482999	0.6161343352875911	0.5878593316279834	0.5975565379243575	0.7171094175931375	0.7005737236782839	0.898940002869085	0.762836260468738	0.8312820823713178	0.6564762360888178	0.8532582590357481	0.866519060647319	GFAP	Glu205Lys	NC_000017.11:44913733:C:T	613G>A	17	44913733	C	T	17	ENSG00000131095	2920	214409	CCSBVarC004664	ALE00004664	ENSP00000466598.2	CEGS2	CegsMutGDEh1046	C05	GDEhDisVCh_40051	H09	1	CegsMutGDDh1046	C05	VUSN2Hmut_GDN2h_10	F01	VUSMutpDEST2_02	F12	VUSmut_GDEh10	F01	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77385.0	single nucleotide variant	NM_002055.5(GFAP):c.613G>A (p.Glu205Lys)	2670.0	GFAP	HGNC:4235	Conflicting classifications of pathogenicity	1.0	Oct 18, 2023	267607507.0	-	RCV000056889|RCV000192127	MedGen:C3661900|MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58	not provided|Alexander disease	germline	germline	GRCh38	NC_000017.11	17	44913733.0	44913733.0	17q21.31	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA217197	3.0	66488.0	44913733.0	C	T	-	-	-	-	-	-	613G>A 	Glu205Lys	NM_002055.5	1.0	Conflicting	Conflicting	66488	17	44913733.0	C	T	E	K	rs267607507	17	42991101	17	40346627	205	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.613G>A	p.Glu205Lys	c.613G>A	p.Glu205Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.72530	.	0.678	0.41364	P	0.208	0.37222	B	0.02	0.92786	A	without_aae	98.0	2.0	2.66	0.77681	M	.	0.65541	.	.	0.57130	0.4584	0.89916	D	0.6481	0.87688	D	10	0.9633239	0.95725	D	0.369657	0.92700	D	.	0.93363	0.878	0.96715	P14136	E205K	Gain of MoRF binding (P = 0.0031)| Gain of ubiquitination at E205 (P = 0.0267)| Gain of glycosylation at E205 (P = 0.103)| Gain of methylation at K202 (P = 0.2029)| Gain of solvent accessibility (P = 0.5334)	.	0.97822	.	0.70681	.	0.70954	0.555122435093	0.46512	T	0.835983	0.96099	D	0.270996	0.80385	D	0.15149	0.80132	D	0.990700542926788	0.80786	D	0.980602	0.95891	D	0.8730356	0.88952	0.78610134	0.87246	0.80766577	0.84202	0.80988264	0.88751	-10.55	0.77208	D	0.1933	0.60768	B	0.657841139808571	0.65634	0.99807230	0.98620	0.969	0.98785	.	.	.	.	.	.	4.909576	0.808	27.4	0.99881907086930022	0.95815	0.816657	0.73737	D	0.408766941163211	0.61707	4.39791	0.42873803932907	0.63166	4.568491	4.71	3.74	0.42041	3.93	0.74723	5.042	0.64084	7.657000	0.64073	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.954	0.50428	749	0.51874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1612218	1.240530e-06	0	2	1178208	1.697490e-06	0	0	75016	0.000000e+00	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29602	0.000000e+00	0	0	44878	0.000000e+00	0	0	64040	0.000000e+00	0	0	6060	0.000000e+00	0	2	1178208	1.697490e-06	0	0	91052	0.000000e+00	0	1	10090	9.910802775024777E-5	0	184	0	0	0	0	0	4654	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1434	0	0	4838	0	0	0	0	1	16362	6.111722283339445E-5	not_provided|Alexander_disease	criteria_provided,_conflicting_classifications	NC_000017.11:g.44913733C>T	ClinGen:CA217197	C3661900|C0270726	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Glu	Lys	95.96	0.6752577319587629																																																																																																																																																																																																																																																																																																																																																																																																																																																																													131			95.96	Negatively-charged	Glutamic Acid		Glial fibrillary acidic protein							IF rod	0.0331		-3.5								 E205-R209 (PAE:  1.0), E205-R201 (PAE: 1.0)	E205-R209 (PDBs: 6A9P), E205-R201 (PDBs: 6A9P)	 E205-R209 (PAE:  1.0), E205-R201 (PAE: 1.0)	E205-R209 (PDBs: 6A9P), E205-R201 (PDBs: 6A9P)		E205-R209 (PDBs: 6A9P)					146									-60.9		Pocket 4: Mean pLDDT: 97.36, Volume: 239.4 Å³, Druggability score: 0.03		-39.8	Coil 1B			dbSNP: -; Variant type: Disease; AA change: Glu205Lys; PTM type: Ubiquitylation; PTM morphology: IRFLRkIHE*EE; Var class: II		H (helix)	H (α-helix)	Helix											95.96	67.52577	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.7851838383144428	0.7835463921628014	false	false	false
GAMT	GAMT_Ala196Val	B_7-8	0.9946837864165531	0.35302251582401656	0.4444779203848857	-1.5821528881814027	0.1576293118691088	0.19852421913508214	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.554951163638389	0.5365110404919177	0.5517909256577915	0.6071050529571277	0.5841731543250693	0.6299359584329409	0.7011895043782516	0.637904548712643	0.676640711012177	0.6075272886097217	0.5543719280168836	0.5753014376742993	0.5586824124876304	0.5304417599374956	0.5375693949020783	0.49605456270586146	0.5186501529669517	0.5346008896024788	GAMT	Ala196Val	NC_000019.10:1397483:G:A	587C>T	19	1397483	G	A	19	ENSG00000130005	5865	1024	CCSBVarC008457	ALE00008430	ENSP00000252288.1	Edgotyping3	VUSmut_GDEh11	B07	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_05	D07	VUSmut_GDEh11	B07	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	203531.0	single nucleotide variant	NM_000156.6(GAMT):c.587C>T (p.Ala196Val)	2593.0	GAMT	HGNC:4136	Conflicting classifications of pathogenicity	0.0	Aug 15, 2022	565109128.0	-	RCV000793466|RCV001704993|RCV002354525	MONDO:MONDO:0000456,MedGen:C5244016,OMIM:PS300352,Orphanet:79172|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	Cerebral creatine deficiency syndrome|not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000019.10	19	1397483.0	1397483.0	19p13.3	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA314820,UniProtKB:Q14353#VAR_075302	2.0	205588.0	1397483.0	G	A	-	-	-	-	-	-	587C>T 	Ala196Val	NM_000156.6	1.0	Conflicting	Conflicting	205588	19	1397483.0	G	A	A	V	rs565109128	19	1397482	19	1348482	196	GAMT	ENSG00000130005	ENST00000252288	ENSP00000252288	Q14353	GAMT_HUMAN	c.587C>T	p.Ala196Val	c.587C>T	p.Ala196Val	principal1	Y	1	YES	Select	-	GCG	2	0	G	G/G	G/G	G/G	G/G	0.499	0.07820	T	0.543	0.09810	T	0.894	0.49197	P	0.13	0.32898	B	0.2	0.44282	N	simple_aae	80.0	20.0	2.39	0.68687	M	-1.23	0.31138	N	0.163	0.17040	-0.2271	0.76859	T	0.4568	0.78774	T	10	0.17520869	0.32074	T	0.08005	0.73283	D	0.267	0.57919	.	.	.	.	.	0.865043136896	0.86268	.	.	.	.	.	.	.	0.382087	0.74252	T	-0.261336	0.12489	T	-0.281103	0.46354	T	0.036913465191361	0.03116	T	0.873013	0.59819	D	0.18629842	0.39720	0.071512006	0.15316	0.15987574	0.35594	0.065640725	0.13331	-3.484	0.16222	T	0.084	0.12996	B	0.0477931877037313	0.36790	0.01351253	0.44853	0.065	0.18082	.	.	.	.	.	.	2.562639	0.33253	19.27	0.84216979462949715	0.15398	0.534676	0.55205	D	-0.197227169813385	0.32972	1.884218	-0.225742651347912	0.30300	1.725412	5.08	5.08	0.68332	3.61	0.66044	2.061	0.41133	5.744000	0.49664	0.676	0.76753	0.757	0.29301	0.999000	0.35501	0.15	0.2035	940	0.13655	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	20	264690	7.556009E-5	.	8	102704	7.789380e-05	0	16	199998	8.000080e-05	0	20	229846	8.701480e-05	0	0	7036	0.000000e+00	0	0	17054	0.000000e+00	0	0	2318	0.000000e+00	0	0	8960	0.000000e+00	0	0	7232	0.000000e+00	0	7	42588	1.643660e-04	0	1	15652	6.388960e-05	0	7	42588	1.643660e-04	0	0	15908	0.000000e+00	0	0	30448	0.000000e+00	0	0	6134	0.000000e+00	0	2	13294	1.504440e-04	0	0	10570	0.000000e+00	0	13	88310	1.472090e-04	0	1	30560	3.272250e-05	0	2	13294	1.504440e-04	0	0	14714	0.000000e+00	0	0	34192	0.000000e+00	0	0	9552	0.000000e+00	0	3	17606	1.703960e-04	0	0	15442	0.000000e+00	0	16	102296	1.564090e-04	0	1	30484	3.280410e-05	0	3	17606	1.703960e-04	0	.	132	1605296	8.222780e-05	0	123	1179840	1.042510e-04	0	0	75054	0.000000e+00	0	0	912	0.000000e+00	0	1	60020	1.666110e-05	0	0	29590	0.000000e+00	0	2	44880	4.456330e-05	0	0	55420	0.000000e+00	0	0	6060	0.000000e+00	0	123	1179840	1.042510e-04	0	2	91082	2.195820e-05	0	6	12242	4.90115994118608E-4	0	114	0	0	86	0	0	2832	0	0	146	0	0	610	0	0	26	0	0	98	0	1	1218	8.210180623973727E-4	0	2946	0	0	112	0	7	17372	4.0294727147133317E-4	not_provided|Inborn_genetic_diseases|Cerebral_creatine_deficiency_syndrome	criteria_provided,_conflicting_classifications	NC_000019.10:g.1397483G>A	ClinGen:CA314820|UniProtKB:Q14353#VAR_075302	C3661900|C0950123|C5244016	PS300352	79172	Arginine N-methyltransferase 2-like domain	Ala	Val	98.58	0.16037735849056603																																																																																																																																																																																																																																																																																																																																																																																																																																																																													17			98.58	Aliphatic	Alanine		Guanidinoacetate N-methyltransferase							RMT2			1.8								 A196-A200 (PAE:  1.0)	A196-A200 (PDBs: 3ORH)	 A196-A200 (PAE:  1.0)	A196-A200 (PDBs: 3ORH)							89									-69.0				-35.2						H (helix)	H (α-helix)	Helix											98.58	16.037735	>90	10-90		unknown		Rare genetic neurological disorder; Rare inborn errors of metabolism	2		false	0.5365110404919177	0.554951163638389	false	false	false
PYGL	PYGL_Thr586Met	B_7-8	-2.0721934287569113	0.08363322489823241	0.14186452891263224	-6.805458595288639	0.0004932524752688044	0.0013755597144654347	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8065893829331388	0.7192759124269491	0.5181270568305509	0.7603564174022689	0.6686542430099593	0.5480281861728601						0.9011155791999165	0.5480281861728601	0.6686542430099593	0.7603564174022689	0.5181270568305509	0.7192759124269491	0.7120631866663611	PYGL	Thr586Met	NC_000014.9:50912167:G:A	1757C>T	14	50912167	G	A	14	ENSG00000100504	55246	3219	CCSBVarC008110	ALE00008096	ENSP00000216392.7	Edgotyping3	VUSMutGDEh009	F01	GDEhDisVCh_40063	B12	1	VUSMutGDDh009	F01	VUSN2Hmut_GDN2h_02	F12	VUSMutpDEST2_13	C04	VUSmut_GDEh02	F12	1.0	6.0	1.0	5.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	N	N	N	Y	Y	329496.0	single nucleotide variant	NM_002863.5(PYGL):c.1757C>T (p.Thr586Met)	5836.0	PYGL	HGNC:9725	Conflicting classifications of pathogenicity	0.0	Jul 10, 2023	144989341.0	-	RCV000385175|RCV004791404|RCV003165843	MONDO:MONDO:0009294,MedGen:C0017925,OMIM:232700,Orphanet:369|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	Glycogen storage disease, type VI|not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000014.9	14	50912167.0	50912167.0	14q22.1	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA7183363	2.0	313323.0	50912167.0	G	A	-	-	-	-	-	-	1757C>T 	Thr586Met	NM_002863.5	1.0	Conflicting	Conflicting	313323	14	50912167.0	G	A	T	M	rs144989341	14	51378885	14	50448635	586	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.1757C>T	p.Thr586Met	c.1757C>T	p.Thr586Met	principal1	Y	1	YES	Select	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.027	0.47069	D	0.073	0.44069	T	1.0	0.90580	D	0.991	0.79680	D	0.09	0.26006	N	simple_aae	91.0	9.0	2.58	0.75182	M	-4.89	0.81462	D	0.732	0.73526	0.9014	0.95679	D	0.8739	0.95802	D	10	0.76371396	0.76313	D	0.159776	0.83948	D	0.729	0.90463	.	.	.	.	.	0.983271591063	0.98291	0.6051006865053474	0.60263	0.538728098851	0.50830	0.677598595619	0.63864	T	0.64197	0.88922	D	-0.032618	0.46702	T	0.0924241	0.76231	D	0.618836104869843	0.36849	D	0.988501	0.96045	D	0.51922214	0.67911	0.4924473	0.70383	0.49098244	0.66252	0.49094865	0.70292	-12.013	0.84957	D	0.3583	0.57067	A	0.799178434910215	0.70750	0.74193970	0.86986	0.623	0.78961	.	.	.	.	.	.	5.367646	0.9001	31.0	0.9991398997217521	0.98239	0.824508	0.74345	D	0.774113626498919	0.84377	8.294889	0.739260131455743	0.85270	8.555089	5.61	4.72	0.59198	.	.	6.86	0.75331	9.706000	0.81348	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.984	0.60417	364	0.84712	.	.	.	.	.	.	.	.	.	.	.	.	132	264690	4.986966E-4	.	40	109398	3.656370e-04	0	85	208122	4.084140e-04	1	99	236916	4.178700e-04	1	2	7164	2.791740e-04	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	3	13384	2.241480e-04	0	33	42768	7.716050e-04	0	0	15690	0.000000e+00	0	33	42768	7.716050e-04	0	4	16218	2.466400e-04	0	4	30524	1.310440e-04	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	9	16724	5.381490e-04	0	68	89556	7.593010e-04	1	0	30608	0.000000e+00	0	68	89556	7.593010e-04	1	4	14902	2.684200e-04	0	5	34260	1.459430e-04	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	9	21622	4.162430e-04	0	80	102726	7.787710e-04	1	0	30526	0.000000e+00	0	80	102726	7.787710e-04	1	.	942	1614072	5.836170e-04	3	876	1180052	7.423400e-04	3	12	74914	1.601840e-04	0	0	910	0.000000e+00	0	10	59998	1.666720e-04	0	1	29608	3.377470e-05	0	0	44896	0.000000e+00	0	22	64028	3.436000e-04	0	0	6084	0.000000e+00	0	876	1180052	7.423400e-04	3	0	91092	0.000000e+00	0	125	180082	6.941282304727846E-4	0	360	0	0	2710	0	1	9428	1.0606703436571913E-4	0	794	0	0	968	0	0	682	0	0	280	0	11	15600	7.051282051282052E-4	1	9788	1.021659174499387E-4	0	3392	0	137	210904	6.49584645146607E-4	Glycogen_storage_disease,_type_VI|Inborn_genetic_diseases	criteria_provided,_conflicting_classifications	NC_000014.9:g.50912167G>A	ClinGen:CA7183363	C0017925|C0950123	232700	369	.	Thr	Met	98.72	0.007042253521126761																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			98.72	Polar/Neutral	Threonine		Glycogen phosphorylase, liver form										-0.7								 T586-R590 (PAE:  1.0), T586-L582 (PAE: 1.0), T586-Y778 (PAE: 1.0)	T586-R590 (PDBs: 1FA9, 2QLL), T586-L582 (PDBs: 1FA9, 2QLL), T586-Y778 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 8EMS, 2QLL)	 T586-R590 (PAE:  1.0), T586-L582 (PAE: 1.0)	T586-R590 (PDBs: 1FA9, 2QLL), T586-L582 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 2QLL), T586-V742 (PDBs: 8EMS)							119									-58.8				-48.0						H (helix)	H (α-helix)	Helix											98.72	0.70422536	>90	<10	232700	autosomal recessive	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE VI	false	0.7192759124269491	0.8065893829331388	false	false	false
TH	TH_Ile209Met	B_7-8	0.0	1.0	1.0	0.903956903999821	0.39606091885626793	0.44945688689007524	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5951417667905892	0.6015457022113292	0.5777856647215974	0.6952592204469753	0.5897730328917296	0.5726444726944206	0.45194260629049354	0.6125939647848481	0.6304243347046343	0.40320739154718643	0.551686158174961	0.5493629657768895	0.6933463390983476	0.566952100998611	0.7600941061893163	0.7523639378960084	0.6514052462476974	0.6409205678042887	TH	Ile209Met	NC_000011.10:2167883:G:C	627C>G	11	2167883	G	C	11	ENSG00000180176	71892	4014	CCSBVarC008293	ALE00008279	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	B11	GDEhDisVCh_40019	H10	1	VUSMutGDDh015	B11	VUSN2Hmut_GDN2h_04	D12	VUSMutpDEST2_15	H08	VUSmut_GDEh04	D12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	313643.0	single nucleotide variant	NM_000360.4(TH):c.627C>G (p.Ile209Met)	7054.0	TH	HGNC:11782	Conflicting classifications of pathogenicity	0.0	Aug 29, 2024	202149985.0	-	RCV000289936|RCV000861197|RCV003930285	MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150|MedGen:C3661900|	Autosomal recessive DOPA responsive dystonia|not provided|TH-related disorder	germline	germline	GRCh38	NC_000011.10	11	2167883.0	2167883.0	11p15.5	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA5818574	2.0	304077.0	2167883.0	G	C	-	-	-	-	-	-	627C>G 	Ile209Met	NM_000360.4	1.0	Conflicting	Conflicting	304077	11	2167883.0	G	C	I	M	rs202149985	11	2189113	11	2145689	240	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.720C>G	p.Ile240Met	c.720C>G	p.Ile240Met	.	Y	1	.	.	-	ATC	3	3	G	G/G	G/G	G/G	G/G	0.015	0.52650	D	0.05	0.56535	T	0.635	0.40326	P	0.501	0.47676	P	0.03	0.42965	N	simple_aae	97.0	3.0	2.71	0.79120	M	-1.9	0.44290	N	0.787	0.80011	-0.8494	0.51819	T	0.1166	0.40952	T	10	0.018477052	0.00399	T	0.183285	0.85638	D	0.657	0.87075	.	.	.	.	.	0.742508269016	0.73815	0.6844765986470289	0.68229	0.17001482027	0.18896	0.622925639153	0.56077	T	0.842542	0.96312	D	-0.107544	0.34818	T	0.0757723	0.75111	D	0.180857070277504	0.19050	T	0.938606	0.81380	D	0.39146185	0.59810	0.27871373	0.53627	0.43429282	0.62713	0.29361874	0.55175	-7.662	0.60164	D	0.0936	0.32302	B	0.811925348702188	0.71300	0.96751183	0.94471	0.504	0.71706	.	.	.	.	.	.	0.192066	0.058	2.223	0.950610407071384	0.26321	0.257792	0.37443	N	-0.809060570200059	0.12920	0.641807	-1.03699325220356	0.08831	0.4442938	3.06	-6.12	0.01947	-5.26	0.04095	-0.637	0.05565	-20.000000	0.00163	-1.741	0.00702	0.045	0.21277	0.000000	0.08389	0.779	0.36903	988	0.02004	7	0.0013977635782747603	0	0.0	0	0.0	0	0.0	7	0.006944444444444444	0	0.0	78	264690	2.9468435E-4	.	76	105666	7.192470e-04	0	114	200630	5.682100e-04	0	152	228744	6.644980e-04	2	0	6524	0.000000e+00	0	0	16810	0.000000e+00	0	0	2214	0.000000e+00	0	57	8850	6.440680e-03	0	11	13194	8.337120e-04	0	5	41060	1.217730e-04	0	3	15162	1.978630e-04	0	57	8850	6.440680e-03	0	0	15114	0.000000e+00	0	0	29960	0.000000e+00	0	0	5968	0.000000e+00	0	84	13132	6.396590e-03	0	14	16444	8.513740e-04	0	8	85714	9.333360e-05	0	5	29584	1.690100e-04	0	84	13132	6.396590e-03	0	0	13924	0.000000e+00	0	0	33716	0.000000e+00	0	0	9408	0.000000e+00	0	114	17394	6.553980e-03	1	23	20180	1.139740e-03	1	8	99134	8.069890e-05	0	5	29512	1.694230e-04	0	114	17394	6.553980e-03	1	.	430	1608870	2.672680e-04	1	268	44680	5.998210e-03	1	1	74958	1.334080e-05	0	0	912	0.000000e+00	0	1	59716	1.674590e-05	0	0	29500	0.000000e+00	0	268	44680	5.998210e-03	1	68	62438	1.089080e-03	0	0	6052	0.000000e+00	0	37	1178104	3.140640e-05	0	15	90212	1.662750e-04	0	1	31182	3.2069783849656855E-5	0	114	0	0	86	0	0	2852	0	0	500	0	0	628	0	0	26	0	0	98	0	2	4784	4.180602006688963E-4	0	2966	0	0	112	0	3	40270	7.449714427613608E-5	TH-related_disorder|not_provided|Autosomal_recessive_DOPA_responsive_dystonia	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.2167883G>C	ClinGen:CA5818574	C3661900|C2673535	605407	101150	Aromatic amino acid hydroxylase, C-terminal|Aromatic amino acid hydroxylase, C-terminal|Aromatic amino acid hydroxylase, C-terminal|Tyrosine 3-monooxygenase, catalytic domain	Ile	Met	94.96	0.17751479289940827																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																94.96	17.75148	>90	10-90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.6015457022113292	0.5951417667905892	false	false	false
TPM1	TPM1_Ala22Thr	B_15-16	-1.7265206349833087	0.17400990159693325	0.24016878806327915	6.865547048461509	0.0002386768833822558	0.0007799652193099314	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8874186583635655	0.8792953015321494	0.6429721009288791	0.6149133743760753	0.7152185360111805	0.6702947762935358	0.6294395506595406	0.6572299106178803	0.5698110749405718	0.6262428241417284	0.8869190113302167	0.8847804504870813	0.711150001927531	0.7732071614044808	0.6600156738115788	0.6597013777160298	0.8716715917340823	0.8900568662400495	TPM1	Ala22Thr	NC_000015.10:63042893:G:A	64G>A	15	63042893	G	A	15	ENSG00000140416	4723	201727	CCSBVarC005630	ALE00005630	ENSP00000288398.6	CEGS2	CegsMutGDEh1039	H06	GDEhDisVCh_40050	H06	2	CegsMutGDDh1039	H06	VUSN2Hmut_GDN2h_08	G02	VUSMutpDEST2_04	B06	VUSmut_GDEh08	G02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	52602.0	single nucleotide variant	NM_001018005.2(TPM1):c.64G>A (p.Ala22Thr)	7168.0	TPM1	HGNC:12010	Conflicting classifications of pathogenicity	1.0	Jan 10, 2024	397516382.0	-	RCV000036351|RCV000223842|RCV000618601|RCV001170562|RCV001213017|RCV001807760	MedGen:CN169374|MedGen:C3661900|MedGen:CN230736|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569|MONDO:MONDO:0007267,MedGen:C1861863,OMIM:115196	not specified|not provided|Cardiovascular phenotype|Cardiomyopathy|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy 3	germline	germline	GRCh38	NC_000015.10	15	63042893.0	63042893.0	15q22.2	criteria provided, conflicting classifications	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018249	2.0	43432.0	63042893.0	G	A	-	-	-	-	-	-	64G>A 	Ala22Thr	NM_001018005.2	1.0	Conflicting	Conflicting	43432	15	63042893.0	G	A	A	T	rs397516382	15	63335092	15	61122145	22	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.64G>A	p.Ala22Thr	c.64G>A	p.Ala22Thr	alternative1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.01	0.79703	D	1.0	0.90580	D	0.99	0.84488	D	0.99	0.97926	D	simple_aae	1.0	99.0	3.83	0.95555	H	-2.12	0.49862	N	0.897	0.92437	1.0180	0.97492	D	0.9862	0.99587	D	10	0.8323053	0.82208	D	0.883472	0.99111	D	0.818	0.94144	0.336	0.32353	Q6ZN40	A22T	Gain of phosphorylation at A22 (P = 0.0142)| Loss of MoRF binding (P = 0.1235)| Loss of stability (P = 0.2542)| Gain of helix (P = 0.4875)| Loss of methylation at R21 (P = 0.5254)	0.943167966054	0.94212	.	0.94892	.	0.97323	0.800563097	0.82016	T	0.922034	0.98596	D	0.327563	0.84892	D	0.415513	0.92549	D	0.995953798294067	0.88288	D	0.985401	0.95212	D	0.76387364	0.81457	0.8085048	0.88662	0.6559611	0.75415	0.75670385	0.85446	-11.835	0.84084	D	0.5639	0.75919	A	0.98736643297736	0.87414	0.99958795	0.99514	0.822	0.90176	.	.	.	.	.	.	5.702498	0.93134	33.0	0.997838016827165	0.87054	0.946540	0.95595	D	0.828583274203449	0.87791	9.365541	0.754533178046959	0.86420	8.90764	4.61	4.61	0.56673	.	.	7.816	0.84747	11.572000	0.93301	0.67	0.6921	1.0	0.71675	1.000000	0.68239	0.996	0.76032	786	0.46777	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	2	264690	7.5560088E-6	.	2	107828	1.854810e-05	0	2	203468	9.829560e-06	0	2	233132	8.578830e-06	0	1	6912	1.446760e-04	0	0	16902	0.000000e+00	0	0	2300	0.000000e+00	0	1	8866	1.127900e-04	0	0	13218	0.000000e+00	0	0	42164	0.000000e+00	0	0	15568	0.000000e+00	0	1	6912	1.446760e-04	0	1	15756	6.346790e-05	0	0	30198	0.000000e+00	0	0	6136	0.000000e+00	0	1	13224	7.562010e-05	0	0	16488	0.000000e+00	0	0	86488	0.000000e+00	0	0	30392	0.000000e+00	0	1	13224	7.562010e-05	0	1	14548	6.873800e-05	0	0	33954	0.000000e+00	0	0	9536	0.000000e+00	0	1	17496	5.715590e-05	0	0	21304	0.000000e+00	0	0	100396	0.000000e+00	0	0	30322	0.000000e+00	0	1	14548	6.873800e-05	0	.	3	1612694	1.860240e-06	0	2	75038	2.665320e-05	0	2	75038	2.665320e-05	0	0	912	0.000000e+00	0	0	59916	0.000000e+00	0	0	29566	0.000000e+00	0	1	44808	2.231740e-05	0	0	63756	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179264	0.000000e+00	0	0	90950	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	not_specified|Cardiovascular_phenotype|Cardiomyopathy|not_provided|Hypertrophic_cardiomyopathy_3|Hypertrophic_cardiomyopathy	criteria_provided,_conflicting_classifications	NC_000015.10:g.63042893G>A	ClinGen:CA018249	CN169374|CN230736|C0878544|C3661900|C1861863|C0007194	115196	167848|217569	.	Ala	Thr	81.34	0.5283018867924528																																																																																																																																																																																																																																																																																																																																																																																																																																																																													56			81.34	Aliphatic	Alanine		Tropomyosin alpha-1 chain	Coiled coil	Basic and acidic residues								1.8								 A22-E26 (PAE:  4.5), A22-A18 (PAE: 5.0)		 A22-E26 (PAE:  4.5), A22-A18 (PAE: 5.0)								89									-71.3				-42.5	Disordered					H (helix)	H (α-helix)	Helix											81.34	52.83019	70-90	10-90	115196	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3	false	0.8792953015321494	0.8874186583635655	false	false	false
SFTPC	SFTPC_Val39Leu	B_7-8	-1.2627805536735215	0.25352400122526353	0.33767841167381685	3.0203975383493695	0.023385136624668155	0.036151411715472676	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6090781430075092	0.7048123107146855	0.5719680840975305	0.6628887878359345	0.7225132433162538	0.6427169385968082	0.8038812310820727	0.7890311971649671	0.7929171209263766	0.7057697793008822	0.6899427205404969	0.6487124966268274	0.48155264611154386	0.6559952894675406	0.5328604547454925	0.4381663888941789	0.7196819008888742	0.5694437893881911	SFTPC	Val39Leu	NC_000008.11:22162646:G:T	115G>T	8	22162646	G	T	8	ENSG00000168484	5723	668	CCSBVarC008454	ALE00008417	ENSP00000316152.3	Edgotyping3	VUSmut_GDEh11	E01	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_05	G05	VUSmut_GDEh11	E01	0.0		0.0		0.0			1.0	1.0	6.0	1.0	1.0	1.0	Y	N	N	Y	Y	227321.0	single nucleotide variant	NM_001317778.2(SFTPC):c.115G>T (p.Val39Leu)	6440.0	SFTPC	HGNC:10802	Conflicting classifications of pathogenicity	0.0	Jul 03, 2022	183533911.0	-	RCV000315399|RCV000490496|RCV002372211|RCV002515598	MONDO:MONDO:0800029,MedGen:C5561926,OMIM:178500,Orphanet:2032,Orphanet:79126|MONDO:MONDO:0024465,MedGen:C1970470,OMIM:610913|MONDO:MONDO:0012580,MedGen:C3711368,OMIM:PS265120,Orphanet:264675|MedGen:C3661900	Interstitial lung disease 2|Surfactant metabolism dysfunction, pulmonary, 2|Hereditary pulmonary alveolar proteinosis|not provided	germline	germline	GRCh38	NC_000008.11	8	22162646.0	22162646.0	8p21.3	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA4663906	2.0	225466.0	22162646.0	G	T	-	-	-	-	-	-	115G>T 	Val39Leu	NM_001317778.2	1.0	Conflicting	Conflicting	225466	8	22162646.0	G	T	V	L	rs183533911	8	22020159	8	22076104	39	SFTPC	ENSG00000168484	ENST00000318561	ENSP00000316152	P11686	PSPC_HUMAN	c.115G>T	p.Val39Leu	c.115G>T	p.Val39Leu	principal4	Y	1	.	.	+	GTG	1	0	G	G/G	G/G	G/G	G/G	0.079	0.35129	T	0.098	0.40612	T	0.015	0.17100	B	0.028	0.21332	B	0.81	0.91795	D	simple_aae	19.0	81.0	0.345	0.11102	N	-1.11	0.37748	N	0.489	0.70209	-0.1769	0.78160	T	0.5662	0.84204	D	10	0.013790548	0.00288	T	0.297374	0.90746	D	0.719	0.90015	0.742	0.87338	P11686	V39L	Loss of catalytic residue at V39 (P = 0.0109)| Loss of sheet (P = 0.1398)| Loss of methylation at K34 (P = 0.1582)| Loss of ubiquitination at K34 (P = 0.212)| Loss of stability (P = 0.2187)	0.887873315535	0.88590	0.756521225171479	0.75466	0.471083547616	0.46083	0.578885555267	0.49862	T	0.494229	0.81601	T	-0.291582	0.09256	T	-0.187748	0.55495	T	0.0184691944640206	0.00562	T	0.788521	0.43678	T	.	.	.	.	.	.	.	.	-3.822	0.21962	T	0.2643	0.49875	B	.	.	0.99466145	0.97597	0.049	0.12781	.	.	.	.	.	.	1.798575	0.229	15.79	0.98197382866295702	0.39229	0.372417	0.45623	N	-0.542381298460951	0.20475	1.09456	-0.458686758194731	0.22987	1.270073	4.41	0.918	0.18468	1.56	0.34791	0.053	0.14109	2.359000	0.32443	0.671	0.69477	0.943	0.32853	0.994000	0.32271	0.996	0.76032	555	0.71761	8	0.001597444089456869	0	0.0	0	0.0	0	0.0	7	0.006944444444444444	1	0.0010224948875255625	87	264690	3.2868638E-4	.	66	108446	6.085980e-04	0	122	206062	5.920550e-04	0	142	234816	6.047290e-04	0	0	7136	0.000000e+00	0	0	17052	0.000000e+00	0	0	2320	0.000000e+00	0	58	8638	6.714520e-03	0	0	13126	0.000000e+00	0	1	42604	2.347200e-05	0	7	15676	4.465420e-04	0	58	8638	6.714520e-03	0	0	15450	0.000000e+00	0	0	30460	0.000000e+00	0	0	6204	0.000000e+00	0	101	13000	7.769230e-03	0	0	16468	0.000000e+00	0	1	89094	1.122410e-05	0	19	30594	6.210370e-04	0	101	13000	7.769230e-03	0	0	14136	0.000000e+00	0	0	34190	0.000000e+00	0	0	9558	0.000000e+00	0	122	17284	7.058550e-03	0	0	21364	0.000000e+00	0	1	102230	9.781860e-06	0	19	30512	6.227060e-04	0	122	17284	7.058550e-03	0	.	494	1608710	3.070780e-04	1	375	44790	8.372400e-03	1	0	74886	0.000000e+00	0	0	912	0.000000e+00	0	1	59960	1.667780e-05	0	0	29536	0.000000e+00	0	375	44790	8.372400e-03	1	0	63710	0.000000e+00	0	0	6042	0.000000e+00	0	19	1175648	1.616130e-05	0	73	90932	8.027980e-04	0	0	31982	0	0	306	0	0	112	0	0	8024	0	0	146	0	0	610	0	0	56	0	0	98	0	2	4456	4.488330341113106E-4	0	8330	0	0	168	0	2	45790	4.367765887748417E-5	Surfactant_metabolism_dysfunction,_pulmonary,_2|Interstitial_lung_disease_2|Hereditary_pulmonary_alveolar_proteinosis|not_provided	criteria_provided,_conflicting_classifications	NC_000008.11:g.22162646G>T	ClinGen:CA4663906	C1970470|C5561926|C3711368|C3661900	610913|178500|PS265120	2032|79126|264675	Surfactant protein C, N-terminal propeptide	Val	Leu	90.16	0.5422535211267606																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	Aliphatic	Valine		Surfactant protein C										4.2																		117																																90.16	54.22535	>90	10-90	178500;610913	autosomal dominant	OMIM	Rare genetic respiratory disease	1	INTERSTITIAL LUNG DISEASE 2; SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2	false	0.7048123107146855	0.6090781430075092	false	false	false
SMAD3	SMAD3_Arg323His	B_15-16	-4.123073494706248	0.004442401882669836	0.014529088349142787	-1.6473665558952744	0.14347498143737641	0.1824508599706069	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7314664894842366	0.7253477783658412	0.5830383113911857	0.7836695677980592	0.7940845932973342	0.7188416079466369	0.8109234606851541	0.9187682327656452	0.9177762517085318	0.5962048462974006	0.8516061012441609	0.8379678835339716	0.6267597552081198	0.6694009538290231	0.6495628838875865	0.5698717764849708	0.5990894554875215	0.6249650954345018	SMAD3	Arg323His	NC_000015.10:67184823:G:A	968G>A	15	67184823	G	A	15	ENSG00000166949	11805	2167	CCSBVarC007743	ALE00007729	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	A04	GDEhDisVCh_40014	F10	2	VUSMutGDDh005	A04	VUSN2Hmut_GDN2h_02	B01	VUSMutpDEST2_09	E06	VUSmut_GDEh02	B01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	400325.0	single nucleotide variant	NM_005902.4(SMAD3):c.968G>A (p.Arg323His)	4088.0	SMAD3	HGNC:6769	Conflicting classifications of pathogenicity	0.0	Dec 26, 2023	758586312.0	-	RCV000464535|RCV000788823	MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3661900	Familial thoracic aortic aneurysm and aortic dissection|not provided	germline	germline	GRCh38	NC_000015.10	15	67184823.0	67184823.0	15q22.33	criteria provided, conflicting classifications	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA062868	2.0	405558.0	67184823.0	G	A	-	-	-	-	-	-	968G>A 	Arg323His	NM_005902.4	1.0	Conflicting	Conflicting	405558	15	67184823.0	G	A	R	H	rs758586312	15	67477161	15	65264215	323	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.968G>A	p.Arg323His	c.968G>A	p.Arg323His	principal1	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.517	0.07375	T	0.336	0.18864	T	1.0	0.90580	D	0.993	0.81117	D	0.91	0.92786	D	simple_aae	9.0	91.0	-0.34	0.03509	N	-1.6	0.66811	N	0.501	0.53123	0.9357	0.96173	D	0.9232	0.97455	D	10	0.42511484	0.56779	D	0.113256	0.79106	D	0.537	0.80504	0.421	0.46221	P84022	R323H	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.2417)| Loss of solvent accessibility (P = 0.2732)| Gain of catalytic residue at Q322 (P = 0.3376)| Gain of phosphorylation at Y324 (P = 0.3866)	0.892419942958	0.89053	0.7149443100743407	0.71289	1.68319369211	0.89985	0.877043426037	0.93550	D	0.786073	0.94348	D	0.0758244	0.61277	D	0.052668	0.73565	D	0.862852334976196	0.51048	D	0.954605	0.82696	D	0.5245612	0.68218	0.35912988	0.61137	0.5245612	0.68219	0.35912988	0.61137	-7.836	0.62459	D	0.8865	0.81829	P	0.97506739382047	0.84228	0.95927197	0.93915	0.409	0.65297	.	.	.	.	.	.	5.982822	0.94264	34.0	0.99910443962139217	0.98024	0.914006	0.87634	D	0.503748984147543	0.67139	5.064768	0.570251094908095	0.72669	5.87	5.28	5.28	0.74083	2.75	0.50313	7.909	0.86882	11.795000	0.96488	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	2	109404	1.828090e-05	0	4	208112	1.922040e-05	0	4	236910	1.688400e-05	0	0	7162	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	1	42768	2.338200e-05	0	1	15690	6.373490e-05	0	1	15690	6.373490e-05	0	0	16212	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	2	89544	2.233540e-05	0	2	30608	6.534240e-05	0	2	30608	6.534240e-05	0	0	14900	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	2	102712	1.947190e-05	0	2	30524	6.552220e-05	0	2	30524	6.552220e-05	0	.	22	1613464	1.363530e-05	0	2	5574	3.588090e-04	0	2	74910	2.669870e-05	0	0	912	0.000000e+00	0	0	60012	0.000000e+00	0	0	29608	0.000000e+00	0	0	44898	0.000000e+00	0	0	64024	0.000000e+00	0	2	5574	3.588090e-04	0	12	1180042	1.016910e-05	0	4	91062	4.392610e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	not_provided|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_conflicting_classifications	NC_000015.10:g.67184823G>A	ClinGen:CA062868	C3661900|C4707243	PS607086	91387	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Arg	His	96.89	0.2540322580645161																																																																																																																																																																																																																																																																																																																																																																																																																																																																													63			96.89	Positively-charged	Arginine		Mothers against decapentaplegic homolog 3							MH2			-4.5								 R323-E347 (PAE:  2.0), R323-K341 (PAE: 2.0), R323-N319 (PAE: 1.0)	R323-N319 (PDBs: 1MK2), R323-K341 (PDBs: 5XOC)	 R323-N319 (PAE:  1.0)	R323-N319 (PDBs: 1MK2, 5XOC)	 R323-E347 (PAE:  2.0)						175									-55.7				-37.0	Sufficient for interaction with XPO4					H (helix)	H (α-helix)	Helix											96.89	25.403225	>90	10-90		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.7253477783658412	0.7314664894842366	false	false	false
FXN	FXN_Gly130Val	B_7-8	-1.1677484162422846	0.2955586447345284	0.3829830471119059	-2.5403025271425497	0.038646934954087164	0.05646267965027862	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7692692984006686	0.8078383290775677	0.4973389089866616	0.5469965826867464	0.5059611664970993	0.5264568203886361	0.3863321499789139	0.5336213620471003	0.5170486234241675	0.379056210664969	0.7927900242238825	0.7692692984006686	0.6665814907983583	0.47830097094709845	0.5769445419493254	0.6156216073083542	0.8228866339312529		FXN	Gly130Val	NC_000009.12:69064942:G:T	389G>T	9	69064942	G	T	9	ENSG00000165060	10735	203291	CCSBVarC006449	ALE00006449	ENSP00000419243.2	CEGS2	CegsMutGDEh1044	E06	GDEhDisVCh_40038	E03	2	CegsMutGDDh1044	E06	VUSN2Hmut_GDN2h_09	C06	VUSMutpDEST2_08	E10	VUSmut_GDEh09	C06	1.0	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	7.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	19021.0	single nucleotide variant	NM_000144.5(FXN):c.389G>T (p.Gly130Val)	2395.0	FXN	HGNC:3951	Conflicting classifications of pathogenicity	1.0	Mar 21, 2024	104894107.0	-	RCV000004189|RCV000992016	MONDO:MONDO:0100339,MedGen:C0016719,Orphanet:95|MedGen:C3661900	Friedreich ataxia|not provided	germline;unknown	germline	GRCh38	NC_000009.12	9	69064942.0	69064942.0	9q21.11	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA252966,UniProtKB:Q16595#VAR_002429,OMIM:606829.0005	3.0	3982.0	69064942.0	G	T	-	-	-	-	-	-	389G>T 	Gly130Val	NM_000144.5	1.0	Conflicting	Conflicting	3982	9	69064942.0	G	T	G	V	rs104894107	9	71679858	9	70869678	130	FXN	ENSG00000165060	ENST00000484259	ENSP00000419243	Q16595	FRDA_HUMAN	c.389G>T	p.Gly130Val	c.389G>T	p.Gly130Val	principal1	Y	3	YES	Select	+	GGT	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.83643	.	1.0	0.90580	D	0.999	0.92348	D	.	0.94956	.	.	.	.	3.885	0.95950	H	.	0.97326	.	.	0.99488	0.5502	0.91204	D	0.6616	0.88206	D	9	0.96417105	0.95823	D	0.37633	0.92852	D	.	0.99976	.	.	.	.	.	.	0.97377	.	.	.	0.78379	0.646622419357	0.59442	T	0.981071	0.99849	D	0.466964	0.93164	D	0.613281	0.97305	D	0.997014880180359	0.90497	D	0.957104	0.83839	D	0.9941607	0.99938	0.98216015	0.99868	0.9927412	0.99888	0.9774854	0.99743	-13.797	0.92394	D	0.9661	0.91425	P	0.993136559806899	0.89879	0.98967546	0.96683	0.919	0.95868	.	.	.	.	.	.	4.940211	0.81556	27.6	0.99759157263068443	0.84944	0.930499	0.91759	D	0.665438809740473	0.77249	6.661974	0.666479887129897	0.79730	7.168837	5.46	5.46	0.79994	5.03	0.90264	9.302	0.95273	11.499000	0.92966	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	10	264690	3.7780046E-5	segdup	5	109384	4.571050e-05	0	6	208102	2.883200e-05	0	7	236920	2.954580e-05	0	0	7162	0.000000e+00	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13380	0.000000e+00	0	5	42766	1.169150e-04	0	0	15688	0.000000e+00	0	5	42766	1.169150e-04	0	0	16216	0.000000e+00	0	0	30516	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16720	0.000000e+00	0	6	89550	6.700170e-05	0	0	30606	0.000000e+00	0	6	89550	6.700170e-05	0	0	14900	0.000000e+00	0	0	34252	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21618	0.000000e+00	0	7	102742	6.813180e-05	0	0	30524	0.000000e+00	0	7	102742	6.813180e-05	0	.	67	1606160	4.171440e-05	0	62	1172912	5.285990e-05	0	1	74776	1.337330e-05	0	0	912	0.000000e+00	0	1	59980	1.667220e-05	0	0	29544	0.000000e+00	0	0	44858	0.000000e+00	0	0	64002	0.000000e+00	0	0	6072	0.000000e+00	0	62	1172912	5.285990e-05	0	0	90906	0.000000e+00	0	11	163762	6.717065008976442E-5	0	174	0	0	2712	0	0	4744	0	0	796	0	0	968	0	0	682	0	0	280	0	1	13730	7.283321194464675E-5	0	4918	0	0	3394	0	12	187848	6.388143605468251E-5	not_provided|Friedreich_ataxia	criteria_provided,_conflicting_classifications	NC_000009.12:g.69064942G>T	ClinGen:CA252966|OMIM:606829.0005|UniProtKB:Q16595#VAR_002429	C3661900|C0016719	.	95	.	Gly	Val	95.18	0.023809523809523808																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			95.18	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Frataxin intermediate form; Frataxin(56-210); Frataxin(78-210); Extramitochondrial frataxin; Frataxin mature form										-0.4				F:G130-R:S90 (PDBs: 5KZ5)				 G130-K147 (PAE:  1.0)	G130-K147 (PDBs: 1EKG, 3S4M, 5KZ5)	 G130-K147 (PAE:  1.0)	G130-K147 (PDBs: 1EKG, 1LY7, 3S4M, 6NZU, 8PK9), G130-N146 (PDBs: 5KZ5, 8PK8, 8PK9), G130-L103 (PDBs: 8PK9)							75									74.0				18.8						C (loop/coil)	T (turn)												95.18	2.3809524	>90	<10		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic neurological disorder	3		false	0.8078383290775677	0.7692692984006686	false	false	false
AGXT	AGXT_Ala248Ser	B_7-8	-0.3332991636980899	0.7608437318378843	0.8096749385157509	1.7994846860083331	0.169767512719998	0.2110592044994555	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6991932012445414	0.7031141084390373	0.7254502221563947	0.7224131012794925	0.7548603713542104	0.8068455472450917	0.8068455472450917	0.7548603713542104	0.7224131012794925	0.7254502221563947	0.7031141084390373	0.6991932012445414							AGXT	Ala248Ser	NC_000002.12:240875170:G:T	742G>T	2	240875170	G	T	2	ENSG00000172482	70497	3857	CCSBVarC008212	ALE00008198	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	G07	GDEhDisVCh_40002	E09	2	VUSMutGDDh004	G07	VUSN2Hmut_GDN2h_01	F08	VUSMutpDEST2_14	A09	VUSmut_GDEh01	F08	1.0	1.0	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200543.0	single nucleotide variant	NM_000030.3(AGXT):c.742G>T (p.Ala248Ser)	189.0	AGXT	HGNC:341	Conflicting classifications of pathogenicity	0.0	Oct 27, 2023	180177260.0	-	RCV000186253|RCV002517831	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900	Primary hyperoxaluria, type I|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	240875170.0	240875170.0	2q37.3	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA275588	2.0	204048.0	240875170.0	G	T	-	-	-	-	-	-	742G>T 	Ala248Ser	NM_000030.3	1.0	Conflicting	Conflicting	204048	2	240875170.0	G	T	A	S	rs180177260	2	241814587	2	241463260	248	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.742G>T	p.Ala248Ser	c.742G>T	p.Ala248Ser	principal1	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.232	0.18284	T	0.231	0.25352	T	0.041	0.21372	B	0.074	0.28222	B	0.16	0.38685	N	simple_aae	84.0	16.0	.	.	.	-1.18	0.30105	N	0.252	0.28302	-0.3137	0.74487	T	0.6112	0.86188	D	10	0.32142323	0.49129	D	0.46726	0.94608	D	0.316	0.63611	.	.	.	.	.	0.695510622515	0.69048	0.7330203489343271	0.73105	0.0412413693315	0.04295	0.354414582253	0.18551	T	0.315003	0.68485	T	-0.0256848	0.47708	T	-0.118305	0.61672	T	0.140800386667252	0.16140	T	0.868113	0.56858	D	0.24308634	0.46915	0.12050239	0.29008	0.24308634	0.46915	0.12050239	0.29007	-3.945	0.22999	T	0.1219	0.25495	B	0.601433428317838	0.63863	0.03013097	0.53998	0.45	0.68135	.	.	.	.	.	.	2.312524	0.29658	18.18	0.97126904255503099	0.32666	0.723108	0.67164	D	-0.435329538730944	0.23970	1.307475	-0.337707213875669	0.26572	1.488404	3.79	1.8	0.24003	.	.	1.743	0.37988	6.191000	0.54836	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.915	0.45059	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	12	264690	4.533605E-5	.	2	109388	1.828350e-05	0	5	208058	2.403180e-05	0	4	236880	1.688620e-05	0	0	7162	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	2	42766	4.676610e-05	0	0	15690	0.000000e+00	0	2	42766	4.676610e-05	0	0	16214	0.000000e+00	0	0	30510	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	5	89506	5.586220e-05	0	0	30608	0.000000e+00	0	5	89506	5.586220e-05	0	0	14898	0.000000e+00	0	0	34238	0.000000e+00	0	0	9564	0.000000e+00	0	0	17690	0.000000e+00	0	0	21632	0.000000e+00	0	4	102712	3.894380e-05	0	0	30526	0.000000e+00	0	4	102712	3.894380e-05	0	.	97	1613852	6.010460e-05	0	95	1179862	8.051790e-05	0	0	74938	0.000000e+00	0	0	912	0.000000e+00	0	0	60000	0.000000e+00	0	0	29598	0.000000e+00	0	0	44886	0.000000e+00	0	0	64016	0.000000e+00	0	0	6084	0.000000e+00	0	95	1179862	8.051790e-05	0	0	91086	0.000000e+00	0	1	9768	1.0237510237510238E-4	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	1	14710	6.798096532970769E-5	Primary_hyperoxaluria,_type_I|not_provided	criteria_provided,_conflicting_classifications	NC_000002.12:g.240875170G>T	ClinGen:CA275588	C0268164|C3661900	259900	416|93598	Aminotransferase class V domain	Ala	Ser	98.85	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.85	Aliphatic	Alanine		Alanine--glyoxylate aminotransferase										1.8								 A248-I244 (PAE:  1.0), A248-C253 (PAE: 1.0)	A248-C253 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), A248-I244 (PDBs: 6RV1, 3R9A)	 A248-I244 (PAE:  1.0), A248-G252 (PAE: 1.0), A248-C253 (PAE: 1.0)	A248-C253 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 3R9A), A248-I244 (PDBs: 6RV1, 7NS7, 3R9A), A248-G252 (PDBs: 6RV1, 3R9A), A248-L76 (PDBs: 6RV1, 3R9A), A248-D254 (PDBs: 3R9A)							89									-56.6				-46.4						H (helix)	H (α-helix)	Helix											98.85	0.0	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.7031141084390373	0.6991932012445414	false	false	false
FA2H	FA2H_Arg62Cys	B_7-8	0.25895478118151044	0.8043252017797662	0.8450640524624379	-6.329613996095075	0.00039282681334041133	0.0011453143277481894	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7939181337459368	0.829219604012476	0.5156257578139136	0.5699347495143952	0.5359226347477188	0.5396213641370394	0.5381998394163734	0.6026411973157777	0.644553398580584	0.4980670061618122	0.8429864250456435	0.8175948924875676	0.5410428888577055	0.46920407217966004	0.4953161004482064	0.533184509466015	0.8154527829793083	0.770241375004306	FA2H	Arg62Cys	NC_000016.10:74727290:G:A	184C>T	16	74727290	G	A	16	ENSG00000103089	513	213752	CCSBVarC005691	ALE00005691	ENSP00000219368.3	CEGS2	CegsMutGDEh1030	C06	GDEhDisVCh_40032	F11	2	CegsMutGDDh1030	C06	VUSN2Hmut_GDN2h_05	C04	VUSMutpDEST2_01	A08	VUSmut_GDEh05	C04	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	39829.0	single nucleotide variant	NM_024306.5(FA2H):c.460C>T (p.Arg154Cys)	79152.0	FA2H	HGNC:21197	Conflicting classifications of pathogenicity	1.0	Jun 16, 2023	387907040.0	-	RCV000023857|RCV000483483|RCV002513207|RCV003317044	MONDO:MONDO:0012866,MedGen:C3496228,OMIM:612319,Orphanet:171629|MedGen:C3661900|Human Phenotype Ontology:HP:0001258,Human Phenotype Ontology:HP:0007062,Human Phenotype Ontology:HP:0007124,Human Phenotype Ontology:HP:0007216,MedGen:C0037772|MONDO:MONDO:0018307,MedGen:C2931845,OMIM:PS234200,Orphanet:385	Hereditary spastic paraplegia 35|not provided|Spastic paraplegia|Neurodegeneration with brain iron accumulation	germline;unknown	germline	GRCh38	NC_000016.10	16	74727290.0	74727290.0	16q23.1	criteria provided, conflicting classifications	6.0	-	N	ClinGen:CA259930,UniProtKB:Q7L5A8#VAR_065245,OMIM:611026.0005	3.0	30872.0	74727290.0	G	A	-	-	-	-	-	-	460C>T 	Arg154Cys	NM_024306.5	1.0	Conflicting	Conflicting	30872	16	74727290.0	G	A	R	C	rs387907040	16	74761188	16	73318689	154	FA2H	ENSG00000103089	ENST00000219368	ENSP00000219368	Q7L5A8	FA2H_HUMAN	c.460C>T	p.Arg154Cys	c.460C>T	p.Arg154Cys	principal1	Y	1	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.53	0.92972	H	-7.88	0.96158	D	0.976	0.98669	1.0978	0.99568	D	0.9521	0.98440	D	10	0.8950144	0.88730	D	0.608389	0.96567	D	0.939	0.98671	0.68	0.81707	Q7L5A8	R154C	Gain of catalytic residue at L155 (P = 0.0135)| Loss of helix (P = 0.0376)| Gain of loop (P = 0.1069)| Loss of solvent accessibility (P = 0.239)| Loss of stability (P = 0.304)	0.954319041166	0.95345	0.8323383990450834	0.83091	0.960062711964	0.72809	0.712145626545	0.68851	T	0.781787	0.94197	D	0.37496	0.88303	D	0.555873	0.95741	D	0.936490509231983	0.60317	D	0.958204	0.84254	D	0.85282767	0.87377	0.7081425	0.82587	0.861598	0.88048	0.7766727	0.86662	-11.424	0.81988	D	0.4211	0.61451	A	0.996841005699156	0.92519	0.97384490	0.94962	0.986	0.99524	.	.	.	.	.	.	5.997905	0.94306	34.0	0.99924478294872676	0.98981	0.907383	0.86084	D	0.878096125862823	0.90595	10.49942	0.81364925806675	0.90676	10.54008	5.32	5.32	0.75341	4.11	0.78390	6.027	0.70598	9.943000	0.82699	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	804	0.43827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109336	0.000000e+00	0	4	207952	1.923520e-05	0	6	236816	2.533610e-05	0	0	7148	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13364	0.000000e+00	0	0	42748	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16190	0.000000e+00	0	4	30512	1.310960e-04	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16702	0.000000e+00	0	0	89458	0.000000e+00	0	0	30606	0.000000e+00	0	4	30512	1.310960e-04	0	0	14878	0.000000e+00	0	5	34248	1.459940e-04	0	1	9572	1.044710e-04	0	0	17690	0.000000e+00	0	0	21598	0.000000e+00	0	0	102686	0.000000e+00	0	0	30524	0.000000e+00	0	5	34248	1.459940e-04	0	.	15	1614020	9.293570e-06	0	5	60002	8.333060e-05	0	0	74912	0.000000e+00	0	0	912	0.000000e+00	0	5	60002	8.333060e-05	0	0	29606	0.000000e+00	0	0	44898	0.000000e+00	0	0	64010	0.000000e+00	0	0	6084	0.000000e+00	0	7	1180022	5.932090e-06	0	1	91090	1.097820e-05	0	0	7752	0	0	108	0	0	84	0	0	3182	0	0	146	0	0	610	0	0	24	0	0	94	0	0	710	0	0	3290	0	0	108	0	0	12710	0	Spastic_paraplegia|not_provided|Neurodegeneration_with_brain_iron_accumulation|Hereditary_spastic_paraplegia_35	criteria_provided,_conflicting_classifications	NC_000016.10:g.74727290G>A	ClinGen:CA259930|OMIM:611026.0005|UniProtKB:Q7L5A8#VAR_065245	C0037772|C3661900|C2931845|C3496228	PS234200|612319	385|171629	.	Arg	Cys	95.34	0.3629032258064516																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																95.34	36.290325	>90	10-90	612319	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION	false	0.829219604012476	0.7939181337459368	false	false	false
GATA2	GATA2_Pro41Ala	B_7-8	0.3726603001839369	0.7204286315574644	0.7774116871608796	3.1074304768556034	0.01714281406391746	0.027497433397979495	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5521786310339856	0.5957504541465826	0.5506441935307202	0.6413743751474343	0.5788622048204937	0.5784940724101709	0.7155174165875298	0.7584458501250821	0.7056085548218318	0.6811663938586872	0.6902020225064788	0.6353255780635574	0.441470728232812	0.3992785595159051	0.5771401954730367	0.42012199320275323	0.5012988857866862	0.46903168400441364	GATA2	Pro41Ala	NC_000003.12:128486911:G:C	121C>G	3	128486911	G	C	3	ENSG00000179348	7465	82	CCSBVarC008472	ALE00008445	ENSP00000345681.2	Edgotyping3	VUSmut_GDEh11	C05	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_06	A05	VUSmut_GDEh11	C05	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	239107.0	single nucleotide variant	NM_032638.5(GATA2):c.121C>G (p.Pro41Ala)	2624.0	GATA2	HGNC:4171	Conflicting classifications of pathogenicity	0.0	Aug 26, 2024	143590990.0	-	RCV000227295|RCV001084371|RCV000504452|RCV001146587|RCV002257600|RCV003320354|RCV003891822	MedGen:C3661900|MONDO:MONDO:0013540,MedGen:C3279664,OMIM:614038,Orphanet:3226;MONDO:MONDO:0013607,MedGen:C3280030,OMIM:614172,Orphanet:228423|MedGen:CN169374|MONDO:MONDO:0013540,MedGen:C3279664,OMIM:614038,Orphanet:3226|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013607,MedGen:C3280030,OMIM:614172,Orphanet:228423|	not provided|Deafness-lymphedema-leukemia syndrome;Monocytopenia with susceptibility to infections|not specified|Deafness-lymphedema-leukemia syndrome|Hereditary cancer-predisposing syndrome|Monocytopenia with susceptibility to infections|GATA2-related disorder	germline	germline	GRCh38	NC_000003.12	3	128486911.0	128486911.0	3q21.3	criteria provided, conflicting classifications	10.0	-	N	ClinGen:CA2600100	2.0	241716.0	128486911.0	G	C	-	-	-	-	-	-	121C>G 	Pro41Ala	NM_032638.5	1.0	Conflicting	Conflicting	241716	3	128486911.0	G	C	P	A	rs143590990	3	128205754	3	129688444	41	GATA2	ENSG00000179348	ENST00000487848	ENSP00000417074	P23769	GATA2_HUMAN	c.121C>G	p.Pro41Ala	c.121C>G	p.Pro41Ala	principal1	Y	1	.	Plus_Clinical	-	CCT	1	0	G	G/G	G/G	G/G	G/G	0.387	0.11010	T	0.705	0.23309	T	0.467	0.90580	P	0.132	0.86259	B	0.3	0.56225	N	simple_aae	70.0	30.0	1.67	0.42718	L	-2.18	0.70228	N	0.644	0.65757	0.8364	0.94843	D	0.9068	0.96904	D	10	0.28287715	0.45482	D	0.535017	0.95637	D	0.722	0.90150	.	.	.	.	.	0.849657817478	0.84703	.	0.56133	.	0.85676	0.770310938358	0.77432	T	0.745193	0.92909	D	-0.0646926	0.41826	T	0.0937639	0.76320	D	0.0859723091125488	0.10598	T	.	0.77495	.	0.28934696	0.51599	0.32273588	0.57984	0.2835604	0.51055	0.35373914	0.60692	-3.83	0.21272	T	0.2877	0.53850	B	0.593648841934463	0.63624	0.99601763	0.97938	0.367	0.62238	.	.	.	.	.	.	3.293979	0.45268	22.1	0.94330072822532807	0.24903	0.945538	0.95379	D	0.253379924137438	0.53573	3.548051	0.32186418156931	0.56598	3.846691	4.6	4.6	0.56461	.	.	9.556	0.97237	8.330000	0.77012	0.526	0.24477	1.0	0.71675	1.000000	0.68239	0.991	0.66489	648	0.63207	.	.	.	.	.	.	.	.	.	.	.	.	115	264690	4.344705E-4	.	63	107238	5.874780e-04	0	119	202456	5.877820e-04	0	143	232470	6.151330e-04	0	0	6710	0.000000e+00	0	3	16858	1.779570e-04	0	0	2232	0.000000e+00	0	0	8926	0.000000e+00	0	12	13272	9.041590e-04	0	48	41964	1.143840e-03	0	0	15392	0.000000e+00	0	48	41964	1.143840e-03	0	2	15430	1.296180e-04	0	6	30118	1.992160e-04	0	0	5984	0.000000e+00	0	0	13242	0.000000e+00	0	15	16520	9.079900e-04	0	91	86350	1.053850e-03	0	0	30094	0.000000e+00	0	91	86350	1.053850e-03	0	2	14296	1.398990e-04	0	7	33900	2.064900e-04	0	0	9416	0.000000e+00	0	0	17558	0.000000e+00	0	17	20854	8.151910e-04	0	112	100866	1.110380e-03	0	0	30030	0.000000e+00	0	112	100866	1.110380e-03	0	.	1150	1612868	7.130160e-04	0	69	63874	1.080250e-03	0	11	75046	1.465770e-04	0	0	912	0.000000e+00	0	11	59902	1.836330e-04	0	1	29482	3.391900e-05	0	0	44858	0.000000e+00	0	69	63874	1.080250e-03	0	0	6060	0.000000e+00	0	1035	1179600	8.774160e-04	0	0	90696	0.000000e+00	0	81	96904	8.358788078923471E-4	0	174	0	0	2672	0	0	4196	0	0	788	0	0	944	0	0	656	0	0	274	0	3	8052	3.7257824143070045E-4	0	4370	0	0	3328	0	84	114660	7.326007326007326E-4	Hereditary_cancer-predisposing_syndrome|Monocytopenia_with_susceptibility_to_infections|Deafness-lymphedema-leukemia_syndrome|not_specified|GATA2-related_disorder|not_provided	criteria_provided,_conflicting_classifications	NC_000003.12:g.128486911G>C	ClinGen:CA2600100	C0027672|C3280030|C3279664|CN169374|C3661900	614172|614038	140162|228423|3226	.	Pro	Ala	53.37	0.6911764705882353																																																																																																																																																																																																																																																																																																																																																																																																																																																																													94			53.37	Special, No backbone hydrogen	Proline		Endothelial transcription factor GATA-2										1.6																		115									-63.0				155.9						H (helix)	P (polyproline helix)												53.37	69.117645	50-70	10-90	614038;614172;614038;614172	autosomal dominant	OMIM	Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic skin disease; Rare genetic tumor	5	LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA; IMMUNODEFICIENCY 21; LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA; IMMUNODEFICIENCY 21	false	0.5957504541465826	0.5521786310339856	false	false	false
PRKAR1A	PRKAR1A_Arg74His	B_7-8	-1.9899247021105682	0.09372581795897901	0.1557770590238055	-1.0547323566679425	0.3321561461569745	0.38551962567871484	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5746671030605558	0.5660875289491378	0.5673360039972408	0.5840286373985208	0.5827032139197357	0.5750250666339167	0.6118009855179978	0.7028036702530271	0.6745851918325994	0.5766438210529812	0.6019290600888617	0.6277239540368609	0.5382491477498358	0.46260275758644426	0.4934720829644423	0.5580281869415005	0.5302459978094138	0.5216102520842507	PRKAR1A	Arg74His	NC_000017.11:68522799:G:A	221G>A	17	68522799	G	A	17	ENSG00000108946	2455	277	CCSBVarC008435	ALE00008467	ENSP00000464977.2	Edgotyping3	VUSmut_GDEh11	E08	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_01	G10	VUSmut_GDEh11	E08	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	242958.0	single nucleotide variant	NM_002734.5(PRKAR1A):c.221G>A (p.Arg74His)	5573.0	PRKAR1A	HGNC:9388	Conflicting classifications of pathogenicity	0.0	Sep 11, 2024	200069356.0	-	RCV000384218|RCV000561393|RCV000588205|RCV000990054|RCV004701317|RCV003947769	MONDO:MONDO:0007044,MedGen:C3276228,OMIM:101800,Orphanet:280651|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0008057,MedGen:C2607929,OMIM:160980,Orphanet:1359|MedGen:C1333600|	Acrodysostosis 1 with or without hormone resistance|Hereditary cancer-predisposing syndrome|not specified|Carney complex, type 1|Hereditary cancer|PRKAR1A-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	68522799.0	68522799.0	17q24.2	criteria provided, conflicting classifications	9.0	-	N	ClinGen:CA8729195	2.0	239382.0	68522799.0	G	A	-	-	-	-	-	-	221G>A 	Arg74His	NM_002734.5	1.0	Conflicting	Conflicting	239382	17	68522799.0	G	A	R	H	rs200069356	17	66518940	17	64030535	74	PRKAR1A	ENSG00000108946	ENST00000585427	ENSP00000464715	P10644	KAP0_HUMAN	c.221G>A	p.Arg74His	c.221G>A	p.Arg74His	principal1	Y	4	.	.	+	CGT	2	0	G	G/G	G/G	G/G	G/G	.	0.20715	.	0.114	0.38937	T	0.556	0.38262	P	0.032	0.22132	B	.	0.66863	.	.	.	.	0.895	0.22286	L	.	0.16323	.	.	0.27364	-0.3596	0.73156	T	0.3616	0.72191	T	10	0.03820449	0.02227	T	0.02937	0.51697	D	.	0.69785	.	.	.	.	.	0.75284057699	0.74864	.	0.34929	.	0.88045	0.384573072195	0.22877	T	0.291607	0.66248	T	-0.203057	0.20052	T	-0.123645	0.61230	T	0.0358265026425243	0.02928	T	.	0.45443	.	0.042455476	0.06379	0.05845954	0.10812	0.042455476	0.06379	0.05845954	0.10812	-4.527	0.33696	T	0.088	0.15718	LB	0.0829269956966594	0.41634	0.09462760	0.66014	0.078	0.22017	.	.	.	.	.	.	3.688975	0.5263	23.2	0.99804873886064605	0.88915	0.752837	0.69209	D	-0.00407159793110205	0.41408	2.4967	0.104111874423149	0.44479	2.751436	5.96	3.87	0.43756	4.61	0.85657	4.847	0.62649	6.398000	0.55639	-0.104	0.15767	1.0	0.71675	1.000000	0.68239	0.876	0.41839	961	0.08546	2	3.9936102236421724E-4	0	0.0	0	0.0	0	0.0	0	0.0	2	0.002044989775051125	123	264690	4.6469455E-4	segdup	41	109400	3.747710e-04	0	85	208088	4.084810e-04	0	101	236732	4.266430e-04	0	0	7164	0.000000e+00	0	17	17112	9.934550e-04	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13390	0.000000e+00	0	15	42768	3.507300e-04	0	6	15688	3.824580e-04	0	17	17112	9.934550e-04	0	0	16218	0.000000e+00	0	29	30520	9.501970e-04	0	0	6208	0.000000e+00	0	1	13414	7.454900e-05	0	0	16730	0.000000e+00	0	26	89534	2.903920e-04	0	20	30600	6.535950e-04	0	29	30520	9.501970e-04	0	0	14902	0.000000e+00	0	36	34254	1.050970e-03	0	0	9568	0.000000e+00	0	1	17690	5.652910e-05	0	0	21628	0.000000e+00	0	35	102560	3.412640e-04	0	20	30518	6.553510e-04	0	36	34254	1.050970e-03	0	.	475	1614122	2.942780e-04	1	7	6062	1.154730e-03	0	6	75036	7.996160e-05	0	0	912	0.000000e+00	0	66	60026	1.099520e-03	0	0	29604	0.000000e+00	0	1	44878	2.228260e-05	0	0	64036	0.000000e+00	0	7	6062	1.154730e-03	0	281	1179986	2.381380e-04	0	69	91080	7.575760e-04	0	12	48404	2.4791339558714154E-4	0	306	0	0	112	0	1	8034	1.2447099825740602E-4	0	498	0	0	628	0	0	56	0	0	98	0	2	8530	2.3446658851113716E-4	1	8340	1.1990407673860912E-4	0	168	0	15	66666	2.2500225002250023E-4	not_specified|Carney_complex,_type_1|Hereditary_cancer-predisposing_syndrome|PRKAR1A-related_disorder|Acrodysostosis_1_with_or_without_hormone_resistance	criteria_provided,_conflicting_classifications	NC_000017.11:g.68522799G>A	ClinGen:CA8729195	CN169374|C2607929|C0027672|C3276228	160980|101800	1359|140162|280651	.	Arg	His	50.37	0.8870967741935484																																																																																																																																																																																																																																																																																																																																																																																																																																																																													220			50.37	Positively-charged	Arginine		cAMP-dependent protein kinase type I-alpha regulatory subunit										-4.5																		175									-130.4				72.2	Dimerization and phosphorylation; Disordered			dbSNP: rs137853303; Variant type: LP/P; AA change: Arg74Cys; PTM type: Phosphorylation; PTM morphology: LQkAGtR*tDsR; Var class: II&rs137853303		C (loop/coil)	S (bend)												50.37	88.70968	50-70	10-90	101800;160980	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic endocrine disease; Rare genetic skin disease; Rare genetic tumor	5	ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; CARNEY COMPLEX, TYPE 1	false	0.5660875289491378	0.5746671030605558	false	false	false
PYGL	PYGL_Asp634His	B_7-8	-1.7129389463846318	0.14739758354016155	0.22283651538840693	-7.311132544434858	0.00033415885581146405	0.0010118506607492352	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9395155984020573	0.9136637548479871	0.7858295143890989	0.8908293017824227	0.783101067354314	0.8538400901136481	0.8961109161580322	0.7702718497158427	0.9120648986586406	0.8398327300768991	0.951500940431905	0.9395155984020573	0.8115692640692641	0.7959302849927851	0.8695937049062049	0.7318262987012987	0.8758265692640692		PYGL	Asp634His	NC_000014.9:50911799:C:G	1900G>C	14	50911799	C	G	14	ENSG00000100504	55246	219176	CCSBVarC003081	ALE00003081	ENSP00000216392.7	CEGS2	CegsMutGDEh1037	H10	GDEhDisVCh_40063	E08	1	CegsMutGDDh1037	H10	VUSN2Hmut_GDN2h_07	E09	VUSMutpDEST2_13	D05	VUSmut_GDEh07	E09	1.0	6.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	N	N	Y	Y	Y	34183.0	single nucleotide variant	NM_002863.5(PYGL):c.1900G>C (p.Asp634His)	5836.0	PYGL	HGNC:9725	Conflicting classifications of pathogenicity	0.0	Sep 01, 2024	35026927.0	-	RCV000020496|RCV000675363|RCV003934845	MONDO:MONDO:0009294,MedGen:C0017925,OMIM:232700,Orphanet:369|MedGen:C3661900|	Glycogen storage disease, type VI|not provided|PYGL-related disorder	germline;unknown	germline	GRCh38	NC_000014.9	14	50911799.0	50911799.0	14q22.1	criteria provided, conflicting classifications	12.0	-	N	ClinGen:CA240710	3.0	21331.0	50911799.0	C	G	-	-	-	-	-	-	1900G>C 	Asp634His	NM_002863.5	1.0	Conflicting	Conflicting	21331	14	50911799.0	C	G	D	H	rs35026927	14	51378517	14	50448267	634	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.1900G>C	p.Asp634His	c.1900G>C	p.Asp634His	principal1	Y	1	YES	Select	-	GAC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.87	0.92786	D	simple_aae	13.0	87.0	3.985	0.96603	H	-6.67	0.92366	D	0.986	0.99730	0.9197	0.95941	D	0.9554	0.98552	D	10	0.08306286	0.13670	T	0.601983	0.96493	D	0.980	0.99858	.	.	.	.	.	0.995091849292	0.99497	0.8931937295632685	0.89222	0.586950782726	0.54000	0.723738193512	0.70541	T	0.84066	0.96252	D	0.236173	0.77131	D	0.574431	0.96248	D	0.158602521293863	0.17547	T	0.989838	0.96773	D	0.9521314	0.96427	0.94500756	0.98062	0.9463303	0.95828	0.9381809	0.97613	-12.667	0.87973	D	0.767	0.78365	P	0.999553745060131	0.96973	0.79702870	0.88262	0.99	0.99661	.	.	.	.	.	.	5.023963	0.83539	28.1	0.99594895338626632	0.73897	0.931761	0.92080	D	1.06400766662805	0.97392	16.07781	0.962993736537786	0.97762	16.74134	5.61	5.61	0.85327	5.44	0.93951	7.879	0.8573	7.650000	0.63706	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.987	0.62545	364	0.84712	7	0.0013977635782747603	0	0.0	2	0.0019880715705765406	5	0.007204610951008645	0	0.0	0	0.0	1015	264690	0.0038346746	.	348	109408	3.180750e-03	1	755	208132	3.627510e-03	2	860	236900	3.630220e-03	2	10	7164	1.395870e-03	0	26	17112	1.519400e-03	0	18	2320	7.758620e-03	0	0	9046	0.000000e+00	0	25	13394	1.866510e-03	0	247	42768	5.775350e-03	1	10	15690	6.373490e-04	0	247	42768	5.775350e-03	1	19	16218	1.171540e-03	0	39	30524	1.277680e-03	0	33	6212	5.312300e-03	0	0	13416	0.000000e+00	0	33	16734	1.972030e-03	0	583	89554	6.510040e-03	2	22	30608	7.187660e-04	0	583	89554	6.510040e-03	2	17	14902	1.140790e-03	0	44	34260	1.284300e-03	0	57	9566	5.958600e-03	0	0	17692	0.000000e+00	0	44	21632	2.034020e-03	0	649	102706	6.319010e-03	2	22	30526	7.206970e-04	0	649	102706	6.319010e-03	2	.	10687	1614102	6.621020e-03	49	9721	1179938	8.238570e-03	48	79	75056	1.052550e-03	0	0	912	0.000000e+00	0	101	60022	1.682720e-03	0	194	29606	6.552730e-03	1	0	44886	0.000000e+00	0	131	64040	2.045600e-03	0	9	6062	1.484660e-03	0	9721	1179938	8.238570e-03	48	77	91070	8.455030e-04	0	659	96990	0.006794514898443138	0	174	0	0	2674	0	9	4200	0.002142857142857143	2	790	0.002531645569620253	2	946	0.0021141649048625794	0	656	0	0	274	0	41	8054	0.005090638192202632	9	4374	0.00205761316872428	0	3330	0	713	114758	0.006213074469753743	PYGL-related_disorder|not_provided|Glycogen_storage_disease,_type_VI	criteria_provided,_conflicting_classifications	NC_000014.9:g.50911799C>G	ClinGen:CA240710	C3661900|C0017925	232700	369	.	Asp	His	96.06	0.1165644171779141																																																																																																																																																																																																																																																																																																																																																																																																																																																																													19			96.06	Negatively-charged	Aspartic Acid		Glycogen phosphorylase, liver form										-3.5								 D634-K592 (PAE:  1.5), D634-Y588 (PAE: 1.0), D634-G638 (PAE: 1.5)	D634-K592 (PDBs: 1FA9), D634-Y588 (PDBs: 1FA9), D634-V630 (PDBs: 1FA9, 1EM6, 3CEJ, 3CEM, 3DD1, 2QLL), D634-G638 (PDBs: 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3DDS, 3DDW, 8EMS)	 D634-V630 (PAE:  1.0), D634-G638 (PAE: 1.5)	D634-V630 (PDBs: 1FA9, 2QLL), D634-G638 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 8EMS)	 D634-K592 (PAE:  1.5)	D634-K592 (PDBs: 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 2QLL)					132									-76.8				114.0						C (loop/coil)	C (loop/coil)												96.06	11.656442	>90	10-90	232700	autosomal recessive	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE VI	false	0.9136637548479871	0.9395155984020573	false	false	false
MVK	MVK_Asp386Asn	B_7-8	2.5995672600776927	0.0406858990080481	0.07849566363739989	1.0672657418340665	0.3269005235912685	0.3803820296702458	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5953015447258152	0.6024022046043077	0.5688139493587859	0.7290827874199757	0.6540480339301966	0.659653952631899	0.7213938586342045	0.7240592010139059	0.7470961709042294	0.5633237424069673	0.6172803187997067	0.6153549281936772	0.5979140466295934	0.5840368668464873	0.7110694039357219	0.5743041563106046	0.5875240904089087	0.5752481612579532	MVK	Asp386Asn	NC_000012.12:109596542:G:A	1156G>A	12	109596542	G	A	12	ENSG00000110921	281	28	CCSBVarC007133	ALE00007131	ENSP00000228510.3	Edgotyping3	VUSMutGDEh010	B02	GDEhDisVCh_40020	C08	2	VUSMutGDDh010	B02	VUSN2Hmut_GDN2h_03	A06	VUSMutpDEST2_01	H03	VUSmut_GDEh03	A06	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	N	Y	N	Y	103463.0	single nucleotide variant	NM_000431.4(MVK):c.1156G>A (p.Asp386Asn)	4598.0	MVK	HGNC:7530	Conflicting classifications of pathogenicity	0.0	Nov 01, 2024	104895380.0	-	RCV000887171|RCV001701591|RCV002262659|RCV000083823	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900|MedGen:C3661900|MONDO:MONDO:0019751,MedGen:C3890737,Orphanet:93665|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343	Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type|not provided|Autoinflammatory syndrome|Hyperimmunoglobulin D with periodic fever	germline;unknown	germline	GRCh38	NC_000012.12	12	109596542.0	109596542.0	12q24.11	criteria provided, conflicting classifications	9.0	-	N	ClinGen:CA149792	2.0	97571.0	109596542.0	G	A	-	-	-	-	-	-	1156G>A 	Asp386Asn	NM_000431.4	1.0	Conflicting	Conflicting	97571	12	109596542.0	G	A	D	N	rs104895380	12	110034347	12	108518730	386	MVK	ENSG00000110921	ENST00000228510	ENSP00000228510	Q03426	KIME_HUMAN	c.1156G>A	p.Asp386Asn	c.1156G>A	p.Asp386Asn	principal1	Y	1	YES	Select	+	GAC	1	0	G	G/G	G/G	G/G	G/G	0.174	0.22601	T	0.601	0.21410	T	0.0	0.02950	B	0.0	0.04348	B	0.02	0.40172	N	simple_aae	98.0	2.0	1.4	0.35208	L	-0.29	0.11659	N	0.055	0.12710	0.0050	0.82281	D	0.7159	0.90220	D	10	0.0047746897	0.00099	T	.	.	.	0.319	0.63925	.	.	.	.	.	0.910522511437	0.90895	0.4881495153160481	0.48539	0.344992086563	0.36131	0.330983877182	0.15070	T	0.164347	0.50724	T	-0.286739	0.09738	T	-0.178401	0.56370	T	0.03205848473422	0.02301	T	0.684232	0.29001	T	0.103988744	0.24361	0.05332206	0.08971	0.17923026	0.38675	0.047397982	0.06834	-3.016	0.10365	T	0.0894	0.12426	LB	0.0867587621801697	0.42039	0.95697940	0.93775	0.306	0.57345	.	.	.	.	.	.	2.171571	0.27721	17.54	0.9809090159591668	0.38336	0.110051	0.21626	N	-0.511332944727283	0.21458	1.154332	-0.377723370458746	0.25345	1.412656	5.06	2.89	0.32629	-0.175	0.20392	3.727	0.54802	3.623000	0.39371	0.676	0.76753	0.992	0.37639	1.000000	0.68239	0.023	0.12113	729	0.54435	17	0.0033945686900958465	0	0.0	0	0.0	0	0.0	6	0.005952380952380952	11	0.011247443762781187	19	264690	7.178209E-5	.	142	107520	1.320680e-03	3	291	205856	1.413610e-03	7	291	234814	1.239280e-03	7	0	7152	0.000000e+00	0	0	17106	0.000000e+00	0	0	2318	0.000000e+00	0	6	9038	6.638640e-04	0	0	11674	0.000000e+00	0	0	42646	0.000000e+00	0	134	15690	8.540470e-03	3	134	15690	8.540470e-03	3	0	16172	0.000000e+00	0	0	30514	0.000000e+00	0	0	6200	0.000000e+00	0	7	13394	5.226220e-04	0	0	15012	0.000000e+00	0	1	89122	1.122060e-05	0	276	30608	9.017250e-03	7	276	30608	9.017250e-03	7	0	14864	0.000000e+00	0	0	34254	0.000000e+00	0	0	9566	0.000000e+00	0	6	17684	3.392900e-04	0	0	19898	0.000000e+00	0	1	102424	9.763340e-06	0	276	30526	9.041470e-03	7	276	30526	9.041470e-03	7	.	829	1611848	5.143160e-04	10	757	91082	8.311190e-03	10	1	75056	1.332340e-05	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	0	29606	0.000000e+00	0	13	44888	2.896100e-04	0	0	61848	0.000000e+00	0	1	6024	1.660030e-04	0	10	1179938	8.475020e-06	0	757	91082	8.311190e-03	10	0	22106	0	0	122	0	1	146	0.00684931506849315	2	3852	5.192107995846313E-4	0	146	0	0	610	0	0	56	0	0	104	0	2	3318	6.027727546714888E-4	2	3974	5.032712632108706E-4	1	202	0.0049504950495049506	5	30460	1.6414970453053183E-4	Hyperimmunoglobulin_D_with_periodic_fever|Mevalonic_aciduria|Porokeratosis_3,_disseminated_superficial_actinic_type|not_provided|Autoinflammatory_syndrome	criteria_provided,_conflicting_classifications	NC_000012.12:g.109596542G>A	ClinGen:CA149792	C0398691|C1959626|C1867981|C3661900|C3890737	260920|610377|175900	343|29|93665	.	Asp	Asn	90.3	0.6012269938650306																																																																																																																																																																																																																																																																																																																																																																																																																																																																													98			90.3	Negatively-charged	Aspartic Acid		Mevalonate kinase										-3.5								 D386-Q390 (PAE:  1.5)		 D386-Q390 (PAE:  1.5)	D386-Q390 (PDBs: 2R3V)		D386-R388 (PDBs: 2R3V)					132									-63.4				148.9						C (loop/coil)	C (loop/coil)												90.3	60.1227	>90	10-90	260920;610377;175900;260920	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; MEVALONIC ACIDURIA; POROKERATOSIS 3, MULTIPLE TYPES; HYPER-IgD SYNDROME	false	0.6024022046043077	0.5953015447258152	false	false	false
DES	DES_Val394Met	B_7-8				0.9145295718633676	0.4278743330369286	0.48139141699740284	2024_01_Batch_7-8		false		false	false			false		false	false			0.5791380288342132		0.5520731273792838	0.7086335571449628									0.7086335571449628	0.5520731273792838		0.5791380288342132		DES	Val394Met	NC_000002.12:219421496:G:A	1180G>A	2	219421496	G	A	2	ENSG00000175084	12573	2316	CCSBVarC007872	ALE00007858	ENSP00000363071.3	Edgotyping3	VUSMutGDEh005	C10	GDEhDisVCh_40092	B05	1	VUSMutGDDh005	C10	VUSN2Hmut_GDN2h_02	E03	NULL	NULL	VUSmut_GDEh02	E03	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	274449.0	single nucleotide variant	NM_001927.4(DES):c.1180G>A (p.Val394Met)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	0.0	Sep 06, 2023	776786349.0	-	RCV000335144|RCV001171071|RCV001441657|RCV003352824|RCV004742370	MedGen:C3661900|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MedGen:CN230736|	not provided|Cardiomyopathy|Desmin-related myofibrillar myopathy|Cardiovascular phenotype|DES-related disorder	germline	germline	GRCh38	NC_000002.12	2	219421496.0	219421496.0	2q35	criteria provided, conflicting classifications	6.0	ACMG2022	N	ClinGen:CA2125253	2.0	290212.0	219421496.0	G	A	-	-	-	-	-	-	1180G>A 	Val394Met	NM_001927.4	1.0	Conflicting	Conflicting	290212	2	219421496.0	G	A	V	M	rs776786349	2	220286218	2	219994462	394	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1180G>A	p.Val394Met	c.1180G>A	p.Val394Met	principal1	Y	1	YES	Select	+	GTG	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.993	0.81117	D	0.61	0.77437	D	simple_aae	39.0	61.0	3.04	0.86441	M	-2.62	0.56328	D	0.836	0.83118	0.9695	0.96684	D	0.8804	0.96021	D	10	0.6605518	0.69860	D	0.291929	0.90571	D	0.818	0.94144	0.759	0.88753	P17661	V394M	Gain of ubiquitination at K395 (P = 0.0585)| Gain of disorder (P = 0.0793)| Loss of stability (P = 0.2347)| Gain of MoRF binding (P = 0.2403)| Loss of catalytic residue at D399 (P = 0.3313)	0.977928074204	0.97746	0.9208263430414811	0.92008	1.45319058204	0.86138	0.91997218132	0.98321	D	0.795064	0.94670	D	0.0787079	0.61618	D	0.310203	0.88582	D	0.378864972992131	0.27834	T	0.937306	0.76371	D	0.6561812	0.75426	0.6291627	0.78138	0.60620964	0.72743	0.6061829	0.76864	-10.825	0.78759	D	0.9587	0.87869	P	0.988720356513493	0.87902	0.99726510	0.98317	0.931	0.96596	.	.	.	.	.	.	5.787396	0.93561	33.0	0.99894524156984277	0.96821	0.967781	0.99022	D	0.758557536048813	0.83370	8.023538	0.666346965359945	0.79721	7.166667	4.94	4.05	0.46353	3.0	0.54868	8.017	0.8876	11.695000	0.94421	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.967	0.53449	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	26	109404	2.376510e-04	0	45	208078	2.162650e-04	1	45	236942	1.899200e-04	1	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	0	42766	0.000000e+00	0	26	15690	1.657110e-03	0	26	15690	1.657110e-03	0	0	16216	0.000000e+00	0	1	30522	3.276330e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	0	89510	0.000000e+00	0	44	30608	1.437530e-03	1	44	30608	1.437530e-03	1	0	14900	0.000000e+00	0	1	34258	2.919030e-05	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	0	102748	0.000000e+00	0	44	30526	1.441390e-03	1	44	30526	1.441390e-03	1	.	135	1613962	8.364510e-05	4	121	91084	1.328440e-03	4	0	74888	0.000000e+00	0	0	910	0.000000e+00	0	1	59994	1.666830e-05	0	0	29604	0.000000e+00	0	0	44880	0.000000e+00	0	0	64012	0.000000e+00	0	0	6084	0.000000e+00	0	10	1180020	8.474430e-06	0	121	91084	1.328440e-03	4	0	26666	0	0	114	0	0	120	0	0	3238	0	0	500	0	0	628	0	0	26	0	0	104	0	0	4696	0	0	3352	0	0	146	0	0	36092	0	not_provided|Cardiomyopathy|Cardiovascular_phenotype|Desmin-related_myofibrillar_myopathy	criteria_provided,_conflicting_classifications	NC_000002.12:g.219421496G>A	ClinGen:CA2125253	C3661900|C0878544|CN230736|C1832370	601419	167848|363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Val	Met	97.24	0.5915492957746479																																																																																																																																																																																																																																																																																																																																																																																																																																																																													84			97.24	Aliphatic	Valine		Desmin							IF rod			4.2								 V394-D390 (PAE:  1.0), V394-L398 (PAE: 1.0)		 V394-D390 (PAE:  1.0), V394-L398 (PAE: 1.0)								117									-60.6				-42.7	Interaction with NEB; Coil 2B					H (helix)	H (α-helix)												97.24	59.154926	>90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.5791380288342132		false		false
DES	DES_Arg222His	B_7-8	-0.7510189892448769	0.48104803727177536	0.5659220298057982	-0.7720764877349502	0.4653315440796689	0.5187626873549165	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7141649100839548	0.6387899466003558	0.6254290085465297	0.6698116713719021	0.6409292406615673	0.6246469905946522	0.8969561955300323	0.9123481297931253	0.9242408371745912	0.8257268501121864	0.6813635878891748	0.7141649100839548	0.3523377856592722	0.3695103515300093	0.4153825055692131	0.425131166980873	0.5962163053115368		DES	Arg222His	NC_000002.12:219420276:G:A	665G>A	2	219420276	G	A	2	ENSG00000175084	12573	2267	CCSBVarC007828	ALE00007814	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	B06	GDEhDisVCh_40003	D06	1	VUSMutGDDh003	B06	VUSN2Hmut_GDN2h_01	C03	NULL	NULL	VUSmut_GDEh01	C03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	173494.0	single nucleotide variant	NM_001927.4(DES):c.665G>A (p.Arg222His)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	0.0	Aug 19, 2024	367961979.0	-	RCV000324508|RCV000260200|RCV000379116|RCV000154697|RCV001657879|RCV000540698|RCV002362813|RCV003483525	MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146|MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154|MedGen:CN239446|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MedGen:CN230736|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909;MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154	Neurogenic scapuloperoneal syndrome, Kaeser type|Dilated cardiomyopathy 1I|Myofibrillar Myopathy, Dominant|not specified|not provided|Desmin-related myofibrillar myopathy|Cardiovascular phenotype|Desmin-related myofibrillar myopathy;Dilated cardiomyopathy 1I	germline;unknown	germline	GRCh38	NC_000002.12	2	219420276.0	219420276.0	2q35	criteria provided, conflicting classifications	11.0	ACMG2022	N	ClinGen:CA181192	2.0	178016.0	219420276.0	G	A	-	-	-	-	-	-	665G>A 	Arg222His	NM_001927.4	1.0	Conflicting	Conflicting	178016	2	219420276.0	G	A	R	H	rs367961979	2	220284998	2	219993242	222	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.665G>A	p.Arg222His	c.665G>A	p.Arg222His	principal1	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.011	0.55689	D	0.016	0.61305	D	0.97	0.56988	D	0.438	0.45631	B	0.51	0.71237	D	simple_aae	49.0	51.0	3.13	0.87936	M	-4.54	0.78505	D	0.868	0.86483	0.8035	0.94435	D	0.7737	0.92287	D	10	0.51628757	0.62070	D	0.183133	0.85628	D	0.822	0.94297	.	.	.	.	.	0.978528265712	0.97808	0.8940475061579246	0.89308	0.00632469907816	0.00530	0.777659058571	0.78538	T	0.809425	0.95182	D	0.137597	0.67865	D	0.384339	0.91525	D	0.209378197042361	0.20664	T	0.928457	0.73569	D	0.42114234	0.61846	0.3404945	0.59568	0.42114234	0.61846	0.3404945	0.59567	-10.252	0.75483	D	0.8324	0.78805	P	0.999447972737694	0.96611	0.99462890	0.97590	0.566	0.75580	.	.	.	.	.	.	6.074075	0.94505	34.0	0.99947236112165883	0.99913	0.960253	0.98091	D	0.718875810406954	0.80766	7.391071	0.675684526722206	0.80430	7.320793	4.38	4.38	0.51962	4.05	0.77340	9.861	0.98429	11.746000	0.95305	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.973	0.55324	86	0.96402	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	0	0.0	1	0.0010224948875255625	28	264690	1.0578412E-4	.	52	109394	4.753460e-04	0	82	208102	3.940380e-04	0	106	236918	4.474120e-04	0	0	7160	0.000000e+00	0	0	17110	0.000000e+00	0	2	2320	8.620690e-04	0	0	9046	0.000000e+00	0	24	13386	1.792920e-03	0	2	42768	4.676390e-05	0	22	15690	1.402170e-03	0	22	15690	1.402170e-03	0	0	16214	0.000000e+00	0	2	30514	6.554370e-05	0	5	6212	8.048940e-04	0	1	13416	7.453790e-05	0	24	16726	1.434890e-03	0	6	89550	6.700170e-05	0	41	30606	1.339610e-03	0	41	30606	1.339610e-03	0	0	14898	0.000000e+00	0	5	34250	1.459850e-04	0	12	9572	1.253660e-03	0	1	17692	5.652270e-05	0	27	21624	1.248610e-03	0	16	102738	1.557360e-04	0	41	30524	1.343210e-03	0	41	30524	1.343210e-03	0	.	344	1614200	2.131090e-04	0	123	91084	1.350400e-03	0	1	75046	1.332520e-05	0	0	912	0.000000e+00	0	5	60024	8.330000e-05	0	31	29608	1.047010e-03	0	3	44882	6.684190e-05	0	54	64032	8.433280e-04	0	0	6062	0.000000e+00	0	99	1180040	8.389550e-05	0	123	91084	1.350400e-03	0	10	47332	2.1127355700160567E-4	0	306	0	0	112	0	0	8092	0	0	500	0	0	628	0	0	56	0	0	98	0	2	8494	2.354603249352484E-4	0	8398	0	0	168	0	12	65618	1.8287664969977751E-4	Dilated_cardiomyopathy_1I|Desmin-related_myofibrillar_myopathy|Myofibrillar_Myopathy,_Dominant|Cardiovascular_phenotype|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type|not_specified|not_provided	criteria_provided,_conflicting_classifications	NC_000002.12:g.219420276G>A	ClinGen:CA181192	C1858154|C1832370|CN239446|CN230736|C1867005|CN169374|C3661900	604765|601419|181400	154|363543|98909|85146	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	His	96.57	0.5967741935483871																																																																																																																																																																																																																																																																																																																																																																																																																																																																													148			96.57	Positively-charged	Arginine		Desmin							IF rod			-4.5								 R222-E226 (PAE:  1.0), R222-A218 (PAE: 1.0)		 R222-E226 (PAE:  1.0), R222-A218 (PAE: 1.0)		 R222-E226 (PAE:  1.0)						175									-62.2				-47.4	Coil 1B					H (helix)	H (α-helix)												96.57	59.67742	>90	10-90	181400;604765;601419;601419;604765	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; CARDIOMYOPATHY, DILATED, 1I; MYOPATHY, MYOFIBRILLAR, 1; MYOPATHY, MYOFIBRILLAR, 1; CARDIOMYOPATHY, DILATED, 1I	false	0.6387899466003558	0.7141649100839548	false	false	false
SMAD3	SMAD3_Tyr364Cys	B_15-16	1.5725827656049594	0.15981243364537567	0.2357079137163456	3.0857233676155733	0.017672765648239788	0.028217061078414922	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7933306696862665	0.7868629261842015	0.6280797097351539	0.7025061847490655	0.7067634302117285	0.6989366112309466	0.6641499108040556	0.6933337583468857	0.7404360930939784	0.6793341296875895	0.6754416383477941	0.6822785106135573	0.7337233116578377	0.7201931020765714	0.6645762764041525	0.5768252897827183	0.8982842140206089	0.9043828287589758	SMAD3	Tyr364Cys	NC_000015.10:67187446:A:G	1091A>G	15	67187446	A	G	15	ENSG00000166949	11805	2172	CCSBVarC007748	ALE00007734	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	F04	GDEhDisVCh_40014	C11	2	VUSMutGDDh005	F04	VUSN2Hmut_GDN2h_02	D01	VUSMutpDEST2_09	B07	VUSmut_GDEh02	D01	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	N	Y	Y	Y	258945.0	single nucleotide variant	NM_005902.4(SMAD3):c.1091A>G (p.Tyr364Cys)	4088.0	SMAD3	HGNC:6769	Conflicting classifications of pathogenicity	1.0	Jan 29, 2024	886039177.0	-	RCV000766262	MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000015.10	15	67187446.0	67187446.0	15q22.33	criteria provided, conflicting classifications	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10587878	2.0	264500.0	67187446.0	A	G	-	-	-	-	-	-	1091A>G 	Tyr364Cys	NM_005902.4	1.0	Conflicting	Conflicting	264500	15	67187446.0	A	G	Y	C	rs886039177	15	67479784	15	65266838	364	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.1091A>G	p.Tyr364Cys	c.1091A>G	p.Tyr364Cys	principal1	Y	1	YES	Select	+	TAC	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.064	0.92967	T	1.0	0.90580	D	0.994	0.82066	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.565	0.93316	H	-8.18	0.97051	D	0.851	0.84673	1.0864	0.99099	D	0.9741	0.99188	D	10	0.9142802	0.90688	D	0.429449	0.93941	D	0.900	0.97205	0.647	0.78347	P84022	Y364C	Loss of helix (P = 0.0376)| Gain of loop (P = 0.069)| Loss of MoRF binding (P = 0.0926)| Loss of catalytic residue at Q365 (P = 0.0951)| Loss of phosphorylation at Y364 (P = 0.2602)	0.962665771354	0.96194	0.9410389441274153	0.94048	2.67568409033	0.98502	0.935143470764	0.99253	D	0.990989	0.99963	D	0.561097	0.96221	D	0.5682	0.96162	D	0.996547281742096	0.89478	D	0.992801	0.97638	D	0.97516596	0.98699	0.9579107	0.98840	0.97516596	0.98699	0.9579107	0.98841	-11.443	0.82113	D	0.9926	0.95665	P	0.999805724615396	0.98063	0.99419430	0.97492	0.959	0.98248	.	.	.	.	.	.	5.566621	0.92192	32.0	0.99812799275627184	0.89628	0.939230	0.93934	D	0.916702599725358	0.92512	11.49	0.863636728783099	0.93751	12.27985	5.71	5.71	0.89013	3.79	0.69847	9.105	0.93613	11.225000	0.89915	0.75	0.87077	1.0	0.71675	1.000000	0.68239	0.969	0.5403	923	0.18499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_conflicting_classifications	NC_000015.10:g.67187446A>G	ClinGen:CA10587878	C4707243	PS607086	91387	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Tyr	Cys	93.2	0.5495495495495496																																																																																																																																																																																																																																																																																																																																																																																																																																																																													122			93.2	Aromatic	Tyrosine		Mothers against decapentaplegic homolog 3							MH2			-1.3								 Y364-F360 (PAE:  1.0)	Y364-F360 (PDBs: 1MJS, 1MK2, 5XOC)	 Y364-F360 (PAE:  1.0)	Y364-F360 (PDBs: 1MJS, 1MK2, 5XOC)							181									-59.4				-40.2						H (helix)	H (α-helix)	Helix											93.2	54.954952	>90	10-90		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.7868629261842015	0.7933306696862665	false	false	false
AGXT	AGXT_Met49Leu	B_7-8	-2.9281126893010554	0.02208350813263721	0.048649942945025455	-0.9474545499387447	0.37495859053002134	0.42789117762598833	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.573345797870999	0.6041734276317741	0.6341620585583077	0.6774570080716054	0.5412591813254086	0.675839154798772	0.8030088094211318	0.5001208389768104	0.7615064285608634	0.7381512255399942	0.6196871286290052	0.6035590592755784	0.5486695001764121	0.5823975236740069	0.5934075875823472	0.5301728915766211	0.5886597266345428	0.5431325364664198	AGXT	Met49Leu	NC_000002.12:240869010:A:C	145A>C	2	240869010	A	C	2	ENSG00000172482	70497	3796	CCSBVarC008169	ALE00008155	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	B01	GDEhDisVCh_40002	A03	2	VUSMutGDDh004	B01	VUSN2Hmut_GDN2h_01	C06	VUSMutpDEST2_14	D02	VUSmut_GDEh01	C06	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	542045.0	single nucleotide variant	NM_000030.3(AGXT):c.145A>C (p.Met49Leu)	189.0	AGXT	HGNC:341	Conflicting classifications of pathogenicity	0.0	Jan 31, 2024	74205173.0	-	RCV000665056|RCV000885301|RCV001584529	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900|MedGen:CN169374	Primary hyperoxaluria, type I|not provided|not specified	germline;unknown	germline	GRCh38	NC_000002.12	2	240869010.0	240869010.0	2q37.3	criteria provided, conflicting classifications	6.0	-	N	-	2.0	550334.0	240869010.0	A	C	-	-	-	-	-	-	145A>C 	Met49Leu	NM_000030.3	1.0	Conflicting	Conflicting	550334	2	240869010.0	A	C	M	L	rs74205173	2	241808427	2	241457100	49	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.145A>C	p.Met49Leu	c.145A>C	p.Met49Leu	principal1	Y	1	YES	Select	+	ATG	1	0	A	A/A	A/A	A/A	A/A	1.0	0.00968	T	1.0	0.01173	T	0.006	0.13655	B	0.012	0.16009	B	0.31	0.56225	N	simple_aae	69.0	31.0	.	.	.	-0.77	0.21370	N	0.187	0.20263	-0.5519	0.66568	T	0.3734	0.73093	T	10	0.008694053	0.00194	T	0.086511	0.74667	D	0.314	0.63399	0.707	0.84254	P21549	M49L	Loss of helix (P = 0.0444)| Gain of loop (P = 0.069)| Loss of methylation at K51 (P = 0.0693)| Loss of disorder (P = 0.0858)| Loss of ubiquitination at K51 (P = 0.1055)	0.633221168995	0.62737	0.7699165858146282	0.76812	0.031904406079	0.03206	0.420078903437	0.27813	T	0.374541	0.73657	T	-0.27959	0.10476	T	-0.166426	0.57474	T	0.0172202937535903	0.00463	T	0.586341	0.21141	T	0.54840595	0.69569	0.33782086	0.59334	0.54840595	0.69570	0.33782086	0.59334	-3.01	0.10300	T	0.1146	0.23002	B	0.666284613852298	0.65907	0.01545938	0.46412	0.417	0.65860	.	.	.	.	.	.	1.323175	0.173	13.07	0.49863223087304998	0.04333	0.794242	0.72098	D	-0.936225864443296	0.09883	0.476044	-0.840310118443605	0.13288	0.701833	4.42	3.23	0.36073	2.42	0.44885	1.478	0.35156	3.649000	0.39451	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.057	0.15787	982	0.03399	10	0.001996805111821086	0	0.0	0	0.0	0	0.0	10	0.00992063492063492	0	0.0	109	264690	4.118025E-4	.	61	108294	5.632810e-04	0	87	202158	4.303560e-04	0	118	231292	5.101780e-04	0	0	6890	0.000000e+00	0	0	17036	0.000000e+00	0	0	2320	0.000000e+00	0	60	8538	7.027410e-03	0	0	13298	0.000000e+00	0	0	42756	0.000000e+00	0	1	15550	6.430870e-05	0	60	8538	7.027410e-03	0	0	15044	0.000000e+00	0	0	30418	0.000000e+00	0	0	6128	0.000000e+00	0	73	12492	5.843740e-03	0	0	16632	0.000000e+00	0	6	86320	6.950880e-05	0	2	30326	6.595000e-05	0	73	12492	5.843740e-03	0	0	13776	0.000000e+00	0	0	34128	0.000000e+00	0	0	9502	0.000000e+00	0	106	16792	6.312530e-03	0	0	21530	0.000000e+00	0	5	99770	5.011530e-05	0	2	30244	6.612880e-05	0	106	16792	6.312530e-03	0	.	255	1596674	1.597070e-04	0	186	40134	4.634470e-03	0	1	68130	1.467780e-05	0	0	912	0.000000e+00	0	3	59506	5.041510e-05	0	0	29596	0.000000e+00	0	186	40134	4.634470e-03	0	0	62682	0.000000e+00	0	1	6012	1.663340e-04	0	24	1179312	2.035080e-05	0	15	88536	1.694230e-04	0	2	15884	1.2591286829513975E-4	0	122	0	0	112	0	0	3418	0	0	146	0	0	610	0	0	54	0	0	98	0	2	2960	6.756756756756757E-4	0	3540	0	0	166	0	4	23404	1.7091095539224064E-4	not_provided|not_specified|Primary_hyperoxaluria,_type_I	criteria_provided,_conflicting_classifications	NC_000002.12:g.240869010A>C	.	C3661900|CN169374|C0268164	259900	416|93598	Aminotransferase class V domain	Met	Leu	98.39	0.3829787234042553																																																																																																																																																																																																																																																																																																																																																																																																																																																																													72			98.39	Aliphatic	Methionine		Alanine--glyoxylate aminotransferase										1.9										 M49-Y260 (PAE:  1.0), M49-Y54 (PAE: 1.0)	M49-Y54 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), M49-Y260 (PDBs: 6RV1, 3R9A)							149									-124.7				19.0						C (loop/coil)	T (turn)												98.39	38.297874	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.6041734276317741	0.573345797870999	false	false	false
SFTPC	SFTPC_Arg167Gln	B_7-8	-2.7016052906347334	0.03550011670524191	0.07077789447496038	-0.17398174607203204	0.8676015131971664	0.8924040228233185	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7351143245753695	0.7197594333375372	0.56003809386631	0.6529055868969827	0.5394030355779179	0.5588013965716886						0.8462647539053791	0.5588013965716886	0.5394030355779179	0.6529055868969827	0.56003809386631	0.7197594333375372	0.6239638952453598	SFTPC	Arg167Gln	NC_000008.11:22163947:G:A	500G>A	8	22163947	G	A	8	ENSG00000168484	5723	201966	CCSBVarC006061	ALE00006061	ENSP00000316152.3	CEGS2	CegsMutGDEh1036	G02	GDEhDisVCh_40072	G07	2	CegsMutGDDh1036	G02	VUSN2Hmut_GDN2h_07	F03	VUSMutpDEST2_05	B07	VUSmut_GDEh07	F03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	28248.0	single nucleotide variant	NM_001317778.2(SFTPC):c.482G>A (p.Arg161Gln)	6440.0	SFTPC	HGNC:10802	Conflicting classifications of pathogenicity	1.0	Jul 01, 2024	34957318.0	-	RCV000014096|RCV000261074|RCV002054436|RCV003904835|RCV002336082|RCV004700230	MONDO:MONDO:0024465,MedGen:C1970470,OMIM:610913|MONDO:MONDO:0800029,MedGen:C5561926,OMIM:178500,Orphanet:2032,Orphanet:79126|MedGen:C3661900||MONDO:MONDO:0012580,MedGen:C3711368,OMIM:PS265120,Orphanet:264675|MedGen:CN169374	Surfactant metabolism dysfunction, pulmonary, 2|Interstitial lung disease 2|not provided|SFTPC-related disorder|Hereditary pulmonary alveolar proteinosis|not specified	germline;unknown	germline	GRCh38	NC_000008.11	8	22163947.0	22163947.0	8p21.3	criteria provided, conflicting classifications	9.0	-	N	ClinGen:CA210538,OMIM:178620.0003	3.0	13209.0	22163947.0	G	A	-	-	-	-	-	-	482G>A 	Arg161Gln	NM_001317778.2	1.0	Conflicting	Conflicting	13209	8	22163947.0	G	A	R	Q	rs34957318	8	22021460	8	22077405	167	SFTPC	ENSG00000168484	ENST00000318561	ENSP00000316152	P11686	PSPC_HUMAN	c.500G>A	p.Arg167Gln	c.500G>A	p.Arg167Gln	principal4	Y	1	.	.	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.164	0.23477	T	0.32	0.19556	T	0.424	0.35468	B	0.09	0.29853	B	0.13	0.46772	N	simple_aae	87.0	13.0	1.04	0.26055	L	0.16	0.22237	N	0.075	0.08341	-0.8930	0.48469	T	0.1664	0.50308	T	9	0.053222448	0.05477	T	.	.	.	0.279	0.59416	.	.	.	.	.	0.362160248664	0.35426	0.5266273004203222	0.52394	0.582422543253	0.53710	0.251946687698	0.03977	T	0.093408	0.38923	T	-0.4801	0.00699	T	-0.448781	0.27477	T	0.00858084688936082	0.00104	T	0.610439	0.22877	T	.	.	.	.	.	.	.	.	-3.543	0.17380	T	0.0712	0.05165	B	.	.	0.97982420	0.95502	0.046	0.11740	.	.	.	.	.	.	-1.58019	0.0025	0.004	0.87534452064798651	0.17545	0.071529	0.14058	N	-1.55131984000293	0.01513	0.06667916	-1.74634681840222	0.00937	0.0423986	5.33	-10.7	0.00192	.	.	-2.611	0.00958	-11.353000	0.00616	-0.118	0.14421	0.0	0.06393	0.000000	0.08389	0.031	0.13278	555	0.71761	23	0.004592651757188498	23	0.01739788199697428	0	0.0	0	0.0	0	0.0	0	0.0	1257	264690	0.0047489516	.	130	108610	1.196940e-03	2	265	205508	1.289490e-03	5	246	234520	1.048950e-03	5	108	7136	1.513450e-02	1	13	17054	7.622850e-04	0	0	2318	0.000000e+00	0	3	8638	3.473030e-04	0	0	13306	0.000000e+00	0	2	42586	4.696380e-05	0	1	15676	6.379180e-05	0	108	7136	1.513450e-02	1	232	15418	1.504730e-02	4	19	30456	6.238510e-04	0	0	6188	0.000000e+00	0	4	12984	3.080710e-04	0	0	16646	0.000000e+00	0	2	88442	2.261370e-05	0	1	30592	3.268830e-05	0	232	15418	1.504730e-02	4	208	14128	1.472250e-02	4	23	34194	6.726330e-04	0	0	9560	0.000000e+00	0	8	17284	4.628560e-04	0	0	21542	0.000000e+00	0	2	101758	1.965450e-05	0	1	30512	3.277400e-05	0	208	14128	1.472250e-02	4	.	1260	1613684	7.808220e-04	14	1108	75068	1.476000e-02	12	1108	75068	1.476000e-02	12	0	912	0.000000e+00	0	54	60038	8.994300e-04	0	0	29608	0.000000e+00	0	5	44892	1.113780e-04	0	0	63776	0.000000e+00	0	0	5802	0.000000e+00	0	22	1180042	1.864340e-05	0	5	91072	5.490160e-05	0	38	97062	3.9150233871133915E-4	4	308	0.012987012987012988	0	152	0	111	8706	0.012749827705031013	1	514	0.0019455252918287938	0	656	0	0	84	0	0	104	0	15	14348	0.001045441873431837	115	9014	0.01275793210561349	0	236	0	169	121934	0.0013859957025932062	not_provided|Hereditary_pulmonary_alveolar_proteinosis|Surfactant_metabolism_dysfunction,_pulmonary,_2|Interstitial_lung_disease_2|SFTPC-related_disorder	criteria_provided,_conflicting_classifications	NC_000008.11:g.22163947G>A	ClinGen:CA210538|OMIM:178620.0003	C3661900|C3711368|C1970470|C5561926	PS265120|610913|178500	264675|2032|79126	BRICHOS domain|BRICHOS domain|BRICHOS domain	Arg	Gln	33.24	0.8870967741935484																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	Positively-charged	Arginine									BRICHOS			-4.5																		175												Propeptide									Beta strand											33.24	88.70968	$\leqslant$50	10-90	610913;178500	autosomal dominant	OMIM	Rare genetic respiratory disease	1	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; INTERSTITIAL LUNG DISEASE 2	false	0.7197594333375372	0.7351143245753695	false	false	false
NR0B1	NR0B1_Val126Met	B_15-16	0.09703910246071458	0.9254152980834089	0.944705087835014	-12.761330890819002	4.203542515575294e-6	0.000042875727323185605	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.9115398949294189	0.917726863651279	0.5137347500205436	0.7404279573484107	0.7636880415679513	0.6396585732921536	0.599842009492775	0.7523439290052296	0.6807368964352347	0.5476120438113539	0.91145587869792	0.9073974358959886	0.6794751370915321	0.7750321541306731	0.8001190182615867	0.47985745622973325	0.9239978486046381	0.9156823539628491	NR0B1	Val126Met	NC_000023.11:30308988:C:T	376G>A	23	30308988	C	T	X	ENSG00000169297	7215	1976	CCSBVarC008465	ALE00008472	ENSP00000368253.4	Edgotyping3	VUSmut_GDEh11	F04	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_06	H01	VUSmut_GDEh11	F04	0.0		0.0		0.0			1.0	6.0	1.0	1.0	1.0	6.0	Y	N	N	N	Y	227422.0	single nucleotide variant	NM_000475.5(NR0B1):c.376G>A (p.Val126Met)	190.0	NR0B1	HGNC:7960	Conflicting classifications of pathogenicity	0.0	Jan 31, 2024	193205940.0	-	RCV000490511|RCV000614813|RCV000864291|RCV001574018|RCV004530263	MONDO:MONDO:0010264,MedGen:C0342482,OMIM:300200,Orphanet:95702|MedGen:CN169374|MONDO:MONDO:0010264,MedGen:C0342482,OMIM:300200,Orphanet:95702;MONDO:MONDO:0010226,MedGen:C1848296,OMIM:300018|MedGen:C3661900|	Congenital adrenal hypoplasia, X-linked|not specified|Congenital adrenal hypoplasia, X-linked;46,XY sex reversal 2|not provided|NR0B1-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	30308988.0	30308988.0	Xp21.2	criteria provided, conflicting classifications	8.0	-	N	ClinGen:CA10376402	2.0	225425.0	30308988.0	C	T	-	-	-	-	-	-	376G>A 	Val126Met	NM_000475.5	1.0	Conflicting	Conflicting	225425	X	30308988.0	C	T	V	M	rs193205940	X	30327105	X	30237026	126	NR0B1	ENSG00000169297	ENST00000378970	ENSP00000368253	P51843	NR0B1_HUMAN	c.376G>A	p.Val126Met	c.376G>A	p.Val126Met	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.093	0.31672	T	0.106	0.38212	T	0.066	0.23601	B	0.005	0.11213	B	0.0	0.01751	P	simple_aae	100.0	0.0	1.355	0.33665	L	-0.03	0.07402	N	0.014	0.00154	-0.0460	0.81207	T	0.6670	0.88410	D	10	0.0038243532	0.00071	T	.	.	.	0.206	0.49175	.	.	.	.	.	0.769766781531	0.76583	0.2948685159531788	0.29201	0.574447789344	0.53186	0.527814149857	0.42665	T	0.229276	0.59289	T	-0.432242	0.01345	T	-0.367202	0.36857	T	0.00967123559447089	0.00125	T	0.670133	0.27626	T	0.044200767	0.06957	0.07927631	0.17817	0.04068658	0.05797	0.07107871	0.15171	-4.826	0.34934	T	0.0881	0.11803	B	0.0145279000094259	0.26858	0.24200998	0.74846	0.049	0.12781	.	.	.	.	.	.	0.051274	0.04661	1.304	0.95581791068106547	0.27512	.	.	.	.	.	.	.	.	.	3.63	-0.903	0.09969	-3.3	0.07810	-1.407	0.02594	-1.684000	0.04945	0.596	0.33565	0.0	0.06393	0.000000	0.08389	0.618	0.31887	832	0.38867	22	0.005827814569536424	0	0.0	0	0.0	0	0.0	21	0.0274869109947644	1	0.001392757660167131	.	.	.	.	256	79544	3.218340e-03	2	350	148149	2.362490e-03	2	480	168505	2.848580e-03	3	0	5555	0.000000e+00	0	0	13574	0.000000e+00	0	0	1751	0.000000e+00	0	251	6788	3.697700e-02	2	0	9862	0.000000e+00	0	0	30707	0.000000e+00	0	4	9875	4.050630e-04	0	251	6788	3.697700e-02	2	0	12392	0.000000e+00	0	0	24245	0.000000e+00	0	0	4549	0.000000e+00	0	340	9892	3.437120e-02	2	0	12108	0.000000e+00	0	3	62431	4.805310e-05	0	5	18988	2.633240e-04	0	340	9892	3.437120e-02	2	0	11473	0.000000e+00	0	0	27046	0.000000e+00	0	0	6987	0.000000e+00	0	470	13182	3.565470e-02	3	0	15786	0.000000e+00	0	3	71029	4.223630e-05	0	5	18926	2.641870e-04	0	470	13182	3.565470e-02	3	.	1123	1208542	9.292190e-04	12	1002	33624	2.980010e-02	12	0	56922	0.000000e+00	0	0	679	0.000000e+00	0	1	45811	2.182880e-05	0	0	21977	0.000000e+00	0	1002	33624	2.980010e-02	12	1	45981	2.174810e-05	0	0	4347	0.000000e+00	0	18	894831	2.011550e-05	0	13	56777	2.289660e-04	0	6	150774	3.979465955668749E-5	0	170	0	119	4488	0.026515151515151516	0	4634	0	0	442	0	0	950	0	45	1846	0.02437703141928494	0	276	0	71	11682	0.006077726416709468	0	4804	0	164	6334	0.025892011367224504	241	175262	0.0013750841597151692	not_provided|46,XY_sex_reversal_2|Congenital_adrenal_hypoplasia,_X-linked|NR0B1-related_disorder|not_specified	criteria_provided,_conflicting_classifications	NC_000023.11:g.30308988C>T	ClinGen:CA10376402	C3661900|C1848296|C0342482|CN169374	300018|300200	95702	.	Val	Met	41.81	0.8873239436619719																																																																																																																																																																																																																																																																																																																																																																																																																																																																													126			41.81	Aliphatic	Valine		Nuclear receptor subfamily 0 group B member 1										4.2																		117									-72.9				99.6	4 X 67 AA tandem repeats		2			C (loop/coil)	C (loop/coil)												41.81	88.73239	$\leqslant$50	10-90	300200;300200;300018	x-linked	OMIM	Rare genetic gynecological and obstetrical diseases; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic urogenital disease; Rare genetic endocrine disease; Genetic infertility; Rare genetic skin disease	7	ADRENAL HYPOPLASIA, CONGENITAL; ADRENAL HYPOPLASIA, CONGENITAL; 46,XY SEX REVERSAL 2	false	0.917726863651279	0.9115398949294189	false	false	false
DES	DES_Arg212Gln	B_7-8	-4.58790730766391	0.010122802958216645	0.027468798763494402	-0.9765423150948468	0.3613286976758955	0.4138814982741999	2024_01_Batch_7-8	false	false	true	false	false	false	false	false	false	false	false	false	0.736791240067789	0.6793130840976649	0.9389738593869317	0.8544506877433633	0.8315415324322347	0.9759373779623255	0.9759373779623255	0.9447509178459779	0.969470144389197	0.9389738593869317	0.7663039925034001	0.736791240067789		0.7183321470184916	0.7394312310975295		0.5923221756919298		DES	Arg212Gln	NC_000002.12:219420151:G:A	635G>A	2	219420151	G	A	2	ENSG00000175084	12573	2263	CCSBVarC007824	ALE00007810	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	F05	GDEhDisVCh_40003	H05	1	VUSMutGDDh003	F05	VUSN2Hmut_GDN2h_01	H02	NULL	NULL	VUSmut_GDEh01	H02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	173631.0	single nucleotide variant	NM_001927.4(DES):c.635G>A (p.Arg212Gln)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	0.0	Apr 19, 2024	144261171.0	-	RCV000154696|RCV000229797|RCV000157163|RCV000307432|RCV000393436|RCV000406154|RCV001798502|RCV002362812|RCV000725364|RCV001264391	MedGen:CN169374|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|Human Phenotype Ontology:HP:0011664,MedGen:C4021133|MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154|MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146|MedGen:CN239446|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MedGen:CN230736|MedGen:C3661900|	not specified|Desmin-related myofibrillar myopathy|Left ventricular noncompaction cardiomyopathy|Dilated cardiomyopathy 1I|Neurogenic scapuloperoneal syndrome, Kaeser type|Myofibrillar Myopathy, Dominant|Cardiomyopathy|Cardiovascular phenotype|not provided|See cases	germline;unknown	germline	GRCh38	NC_000002.12	2	219420151.0	219420151.0	2q35	criteria provided, conflicting classifications	13.0	ACMG2022	N	ClinGen:CA181189	2.0	178015.0	219420151.0	G	A	-	-	-	-	-	-	635G>A 	Arg212Gln	NM_001927.4	1.0	Conflicting	Conflicting	178015	2	219420151.0	G	A	R	Q	rs144261171	2	220284873	2	219993117	212	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.635G>A	p.Arg212Gln	c.635G>A	p.Arg212Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.061	0.37268	T	0.023	0.57446	D	1.0	0.90580	D	0.979	0.74458	D	0.68	0.81345	D	simple_aae	32.0	68.0	3.14	0.88093	M	-3.45	0.67623	D	0.908	0.90930	1.0155	0.97446	D	0.8917	0.96399	D	10	0.83806765	0.82783	D	0.311183	0.91170	D	0.847	0.95236	.	.	.	.	.	0.977054030142	0.97658	0.8698095077590553	0.86865	0.0197557497109	0.01879	0.653552174568	0.60427	T	0.78997	0.94486	D	0.180185	0.71853	D	0.328463	0.89370	D	0.476125359535217	0.31444	T	0.79572	0.43678	T	0.67932194	0.76672	0.5438082	0.73377	0.67932194	0.76673	0.5438082	0.73378	-10.822	0.78742	D	0.6975	0.72802	P	0.993541148401232	0.90109	0.99593747	0.97916	0.464	0.69079	.	.	.	.	.	.	5.874813	0.93914	33.0	0.99950986561934818	0.99945	0.966820	0.98924	D	0.922267496428608	0.92766	11.64076	0.838743449770566	0.92299	11.37129	4.56	4.56	0.55591	3.79	0.69847	9.864	0.98446	11.729000	0.94967	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.977	0.56847	86	0.96402	2	3.9936102236421724E-4	0	0.0	1	9.940357852882703E-4	0	0.0	1	9.92063492063492E-4	0	0.0	66	264690	2.493483E-4	.	21	109404	1.919490e-04	0	52	208130	2.498440e-04	0	56	236942	2.363450e-04	0	0	7162	0.000000e+00	0	7	17110	4.091170e-04	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13394	0.000000e+00	0	13	42768	3.039660e-04	0	0	15690	0.000000e+00	0	7	17110	4.091170e-04	0	0	16216	0.000000e+00	0	10	30522	3.276330e-04	0	0	6212	0.000000e+00	0	4	13416	2.981510e-04	0	0	16734	0.000000e+00	0	36	89556	4.019830e-04	0	0	30608	0.000000e+00	0	36	89556	4.019830e-04	0	0	14900	0.000000e+00	0	11	34258	3.210930e-04	0	0	9572	0.000000e+00	0	4	17692	2.260910e-04	0	3	21632	1.386830e-04	0	36	102742	3.503920e-04	0	0	30526	0.000000e+00	0	36	102742	3.503920e-04	0	.	388	1614220	2.403640e-04	1	24	60030	3.998000e-04	0	3	75054	3.997120e-05	0	0	912	0.000000e+00	0	24	60030	3.998000e-04	0	0	29606	0.000000e+00	0	6	44874	1.337080e-04	0	3	64050	4.683840e-05	0	2	6062	3.299240e-04	0	328	1180040	2.779570e-04	1	0	91082	0.000000e+00	0	54	180100	2.9983342587451415E-4	0	360	0	1	4502	2.221235006663705E-4	0	9432	0	0	796	0	1	968	0.0010330578512396695	0	1848	0	0	280	0	7	17428	4.01652513197154E-4	0	9792	0	1	6350	1.5748031496062991E-4	63	215714	2.9205336695810194E-4	Myofibrillar_Myopathy,_Dominant|Cardiovascular_phenotype|See_cases|Desmin-related_myofibrillar_myopathy|Cardiomyopathy|not_specified|Dilated_cardiomyopathy_1I|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type|not_provided|Left_ventricular_noncompaction_cardiomyopathy	criteria_provided,_conflicting_classifications	NC_000002.12:g.219420151G>A	ClinGen:CA181189	CN239446|CN230736|C1832370|C0878544|CN169374|C1858154|C1867005|C3661900|C4021133	601419|604765|181400	363543|98909|167848|154|85146	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Gln	96.48	0.6612903225806451																																																																																																																																																																																																																																																																																																																																																																																																																																																																													164			96.48	Positively-charged	Arginine		Desmin							IF rod	0.3248		-4.5								 R212-D216 (PAE:  1.0), R212-L208 (PAE: 1.0)		 R212-D216 (PAE:  1.0), R212-L208 (PAE: 1.0)								175									-64.1		Pocket 2: Mean pLDDT: 93.96, Volume: 446.51 Å³, Druggability score: 0.32		-46.4	Coil 1B					H (helix)	H (α-helix)												96.48	66.129036	>90	10-90	601419;604765;181400	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1; CARDIOMYOPATHY, DILATED, 1I; SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	false	0.6793130840976649	0.736791240067789	false	false	false
DES	DES_Gly44Ser	B_7-8	-1.1336437490917708	0.3001990995773189	0.38741910823829667	0.6114667206086883	0.560216206311982	0.6115388093887489	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7635592549860534	0.6423267775260276	0.6525942734693329	0.8101168834964635	0.7862615519030893	0.671082503624511	0.9461334162017614	0.9429050262162357	0.9523046529379797	0.8980542064125175	0.6672558176460494	0.7635592549860534	0.39603159104726066	0.6296180775899429	0.6679291140549473	0.4071343405261481	0.6173977374060059		DES	Gly44Ser	NC_000002.12:219418592:G:A	130G>A	2	219418592	G	A	2	ENSG00000175084	12573	2225	CCSBVarC007792	ALE00007778	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	E01	GDEhDisVCh_40003	F01	1	VUSMutGDDh003	E01	VUSN2Hmut_GDN2h_01	D01	NULL	NULL	VUSmut_GDEh01	D01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	405628.0	single nucleotide variant	NM_001927.4(DES):c.130G>A (p.Gly44Ser)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	1.0	Aug 04, 2023	1064794869.0	-	RCV000478404|RCV003766688	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219418592.0	219418592.0	2q35	criteria provided, conflicting classifications	2.0	ACMG2022	N	ClinGen:CA16617477	2.0	421043.0	219418592.0	G	A	-	-	-	-	-	-	130G>A 	Gly44Ser	NM_001927.4	1.0	Conflicting	Conflicting	421043	2	219418592.0	G	A	G	S	rs1064794869	2	220283314	2	219991558	44	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.130G>A	p.Gly44Ser	c.130G>A	p.Gly44Ser	principal1	Y	1	YES	Select	+	GGC	1	0	G	G/G	G/G	G/G	G/G	0.766	0.03439	T	0.787	0.04303	T	0.019	0.18002	B	0.017	0.18137	B	0.53	0.72539	A	simple_aae	47.0	53.0	-0.075	0.04827	N	0.5	0.02926	N	0.19	0.20657	-0.7046	0.60048	T	0.2513	0.61949	T	10	0.15737629	0.29270	T	0.294613	0.90658	D	0.249	0.55539	0.433	0.48193	P17661	G44S	Gain of phosphorylation at G44 (P = 0.0172)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1174)| Loss of catalytic residue at G44 (P = 0.1225)| Gain of glycosylation at S48 (P = 0.1607)	0.816924950932	0.81374	0.5698858653909474	0.56731	0.896747683907	0.70307	0.630877494812	0.57205	T	0.120581	0.43986	T	-0.0482011	0.44381	T	-0.307014	0.43636	T	0.763777494430542	0.43778	D	0.715328	0.32546	T	0.26261857	0.48992	0.27143043	0.52839	0.26261857	0.48992	0.27143043	0.52838	-2.592	0.06449	T	0.0964	0.15673	B	0.967084998067255	0.82787	0.89758780	0.91125	0.561	0.75276	.	.	.	.	.	.	3.345996	0.46214	22.2	0.94829188701079348	0.25842	0.759764	0.69689	D	-0.408216366332169	0.24906	1.365019	-0.185714924385563	0.31746	1.820328	5.13	5.13	0.69688	2.58	0.47294	3.055	0.49704	11.370000	0.92615	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.775	0.36746	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1605060	6.230300e-07	0	1	1176094	8.502720e-07	0	0	74860	0.000000e+00	0	0	912	0.000000e+00	0	0	59354	0.000000e+00	0	0	29176	0.000000e+00	0	0	44640	0.000000e+00	0	0	62144	0.000000e+00	0	0	6024	0.000000e+00	0	1	1176094	8.502720e-07	0	0	89848	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Desmin-related_myofibrillar_myopathy|not_provided	criteria_provided,_conflicting_classifications	NC_000002.12:g.219418592G>A	ClinGen:CA16617477	C1832370|C3661900	601419	363543|98909	Intermediate filament head, DNA-binding domain	Gly	Ser	37.77	0.8809523809523809																																																																																																																																																																																																																																																																																																																																																																																																																																																																													74			37.77	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Desmin										-0.4																		75									-72.4				126.8	Head					C (loop/coil)	C (loop/coil)												37.77	88.09524	$\leqslant$50	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.6423267775260276	0.7635592549860534	false	false	false
SMAD3	SMAD3_Leu219Phe	B_15-16	-0.014922583394858828	0.9885103532784623	0.9911048686413978	1.1450407086421948	0.2898280807040688	0.341357206734253	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7931917885748772	0.7946782355217414	0.5641908422565995	0.7261486079147774	0.7151791083338526	0.6128877265215553	0.63811563824964	0.772612178545987	0.76600601346796	0.5994597609049183	0.7277216552709123	0.7192421659140624	0.5876598147934706	0.6577460381217183	0.6862912023615948	0.5289219236082807	0.8616348157725707	0.8671414112356919	SMAD3	Leu219Phe	NC_000015.10:67170603:G:C	657G>C	15	67170603	G	C	15	ENSG00000166949	11805	2137	CCSBVarC007720	ALE00007706	ENSP00000332973.4	Edgotyping3	VUSMutGDEh004	C12	GDEhDisVCh_40014	B07	2	VUSMutGDDh004	C12	VUSN2Hmut_GDN2h_01	E10	VUSMutpDEST2_09	A03	VUSmut_GDEh01	E10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	255335.0	single nucleotide variant	NM_005902.4(SMAD3):c.657G>C (p.Leu219Phe)	4088.0	SMAD3	HGNC:6769	Conflicting classifications of pathogenicity	0.0	Apr 25, 2024	886038567.0	-	RCV000245553|RCV001182289|RCV003998995	MedGen:CN169374|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984	not specified|Familial thoracic aortic aneurysm and aortic dissection|Aneurysm-osteoarthritis syndrome	germline	germline	GRCh38	NC_000015.10	15	67170603.0	67170603.0	15q22.33	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10587208	2.0	259888.0	67170603.0	G	C	-	-	-	-	-	-	657G>C 	Leu219Phe	NM_005902.4	1.0	Conflicting	Conflicting	259888	15	67170603.0	G	C	L	F	rs886038567	15	67462941	15	65249995	219	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.657G>C	p.Leu219Phe	c.657G>C	p.Leu219Phe	principal1	Y	1	YES	Select	+	TTG	3	2	G	G/G	G/G	G/G	G/G	0.687	0.61594	T	0.602	0.58429	T	0.132	0.27225	B	0.089	0.29771	B	0.63	0.86494	D	simple_aae	37.0	63.0	1.935	0.51654	L	-1.42	0.48196	N	0.509	0.54878	0.7230	0.93437	D	0.8426	0.94731	D	10	0.37252486	0.59734	D	0.172802	0.84928	D	0.497	0.78048	0.313	0.28642	P84022	L219F	Loss of stability (P = 0.1246)| Loss of disorder (P = 0.1703)| Gain of glycosylation at P214 (P = 0.2651)| Gain of loop (P = 0.4248)| Loss of helix (P = 0.4763)	0.844003053477	0.84128	0.287072554320052	0.28423	1.37926964747	0.84668	0.723343253136	0.70483	T	0.472072	0.80303	T	0.194592	0.73189	D	0.0417414	0.72840	D	0.763146877288818	0.43741	D	0.742826	0.68309	T	0.2223409	0.44506	0.17373517	0.39590	0.2223409	0.44506	0.17373517	0.39589	-6.674	0.52537	T	0.1451	0.32057	B	0.758147554329335	0.69107	0.89037190	0.90876	0.178	0.43021	.	.	.	.	.	.	3.833367	0.55503	23.6	0.9979195902301099	0.87760	0.582839	0.58082	D	0.0317509673264675	0.43043	2.625929	0.117344192466707	0.45162	2.806798	5.21	4.29	0.50301	0.688	0.26598	3.087	0.49962	5.929000	0.51361	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.94	0.48078	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1613504	1.859310e-06	0	3	1179594	2.543250e-06	0	0	74932	0.000000e+00	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29600	0.000000e+00	0	0	44890	0.000000e+00	0	0	63926	0.000000e+00	0	0	6084	0.000000e+00	0	3	1179594	2.543250e-06	0	0	91080	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Aneurysm-osteoarthritis_syndrome	criteria_provided,_conflicting_classifications	NC_000015.10:g.67170603G>C	ClinGen:CA10587208	C4707243|CN169374|C3151087	PS607086|613795	91387|284984	.	Leu	Phe	60.32	0.6829268292682927																																																																																																																																																																																																																																																																																																																																																																																																																																																																													112			60.32	Aliphatic	Leucine		Mothers against decapentaplegic homolog 3										3.8																		131									-63.1				109.1	Linker					C (loop/coil)	C (loop/coil)												60.32	68.29269	50-70	10-90	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	false	0.7946782355217414	0.7931917885748772	false	false	false
SMAD3	SMAD3_Gly272Arg	B_15-16	-5.526501549075985	0.0008814842065896165	0.004317012396374788	-5.440776608440403	0.000965445714413201	0.00232798013922237	2025_03_Batch_15-16	false	true	false	false	false	false	false	false	false	false	false	false	0.9305897414972037	0.9045623845750843	0.5122382605478082	0.7734942014116185	0.7239834881805451	0.6035060957958954	0.6578812138387424	0.8024755713322411	0.8607246710609475	0.477958767881878	0.9452394165070077	0.9452976689457117	0.5491309777530484	0.645491405028849	0.6862637317622895	0.5465177532137383	0.863885352643161	0.9158818140486958	SMAD3	Gly272Arg	NC_000015.10:67181396:G:C	814G>C	15	67181396	G	C	15	ENSG00000166949	11805	2154	CCSBVarC007733	ALE00007719	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	E02	GDEhDisVCh_40014	B09	2	VUSMutGDDh005	E02	VUSN2Hmut_GDN2h_01	G11	VUSMutpDEST2_09	A05	VUSmut_GDEh01	G11	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	N	Y	Y	Y	376597.0	single nucleotide variant	NM_005902.4(SMAD3):c.814G>C (p.Gly272Arg)	4088.0	SMAD3	HGNC:6769	Conflicting classifications of pathogenicity	1.0	Jul 17, 2023	1057524127.0	-	RCV000443464|RCV000654805|RCV004594061	MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984	not provided|Familial thoracic aortic aneurysm and aortic dissection|Aneurysm-osteoarthritis syndrome	germline	germline	GRCh38	NC_000015.10	15	67181396.0	67181396.0	15q22.33	criteria provided, conflicting classifications	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA16607847	2.0	391534.0	67181396.0	G	C	-	-	-	-	-	-	814G>C 	Gly272Arg	NM_005902.4	1.0	Conflicting	Conflicting	391534	15	67181396.0	G	C	G	R	rs1057524127	15	67473734	15	65260788	272	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.814G>C	p.Gly272Arg	c.814G>C	p.Gly272Arg	principal1	Y	1	YES	Select	+	GGG	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	D	simple_aae	3.0	97.0	3.745	0.94897	H	-7.69	0.96411	D	0.993	0.99902	1.0598	0.98331	D	0.9824	0.99460	D	10	0.99072766	0.99579	D	0.76787	0.98159	D	0.982	0.99890	0.922	0.98631	P84022	G272R	Gain of MoRF binding (P = 0.0079)| Loss of sheet (P = 0.0817)| Loss of catalytic residue at N276 (P = 0.186)| Gain of disorder (P = 0.1936)| Gain of loop (P = 0.2045)	0.992621542804	0.99244	0.9586457074459955	0.95825	2.62646606766	0.98303	0.949114084244	0.99731	D	0.987878	0.99935	D	0.587069	0.97311	D	0.605508	0.97268	D	0.999505162239075	0.97654	D	0.991967	0.97495	D	0.9696464	0.98198	0.9542565	0.98630	0.9696464	0.98198	0.9542565	0.98630	-14.733	0.95205	D	0.9999	0.99952	P	0.999625254007167	0.97231	0.99666710	0.98126	0.999	0.99956	.	.	.	.	.	.	5.799435	0.93613	33.0	0.99920742236384996	0.98722	0.925708	0.90534	D	0.922630193058122	0.92784	11.65076	0.854909690387234	0.93263	11.95248	5.1	5.1	0.68875	.	.	9.87	0.98471	11.762000	0.95658	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.957	0.51031	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Aneurysm-osteoarthritis_syndrome	criteria_provided,_conflicting_classifications	NC_000015.10:g.67181396G>C	ClinGen:CA16607847	C3661900|C4707243|C3151087	PS607086|613795	91387|284984	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Gly	Arg	97.79	0.2976190476190476																																																																																																																																																																																																																																																																																																																																																																																																																																																																													25			97.79	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Mothers against decapentaplegic homolog 3							MH2			-0.4								 G272-R287 (PAE:  1.0), G272-F260 (PAE: 1.0)	G272-F260 (PDBs: 1MJS, 1MK2, 5XOC)	 G272-R287 (PAE:  1.0), G272-G259 (PAE: 1.0), G272-F260 (PAE: 1.0)	G272-R287 (PDBs: 1MJS, 5XOC), G272-G259 (PDBs: 1MJS, 5XOC), G272-F260 (PDBs: 1MJS, 1MK2, 5XOC)							75									-63.4				-31.6	Sufficient for interaction with XPO4					H (helix)	G (3₁₀-helix)	Helix											97.79	29.761904	>90	10-90	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	false	0.9045623845750843	0.9305897414972037	true	false	false
AIPL1	AIPL1_Arg302Leu	B_7-8	-0.8394368335242169	0.43339077201359616	0.5262405432587213	-6.413542151825731	0.0003625838988499698	0.0010714033081959656	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.923102944924229	0.9039491033764862	0.6204930830077271	0.6131721250098829	0.5050770089373953	0.5802088535318414	0.5964487464590016	0.5203141045952084	0.6742788185957667	0.5875003463788794	0.9552199694674144	0.923102944924229	0.5639689606046812	0.4898399132795821	0.5520654314239993	0.6534858196365748	0.852678237285558		AIPL1	Arg302Leu	NC_000017.11:6425710:C:A	905G>T	17	6425710	C	A	17	ENSG00000129221	7167	12758	CCSBVarC001136	ALE00001136	ENSP00000370521.3	RC4	RC4_Mut_GDEh1019	H05	GDEhDisVCh_40067	F10	1	RC4_Mut_GDDh1019	H05	NULL	NULL	VUSMutpDEST2_05	C12	VUSmut_GDEh13	C03	1.0	1.0	1.0	1.0	0.0			1.0	5.0	1.0	1.0	1.0	1.0	Y	Y	N	N	Y	76620.0	single nucleotide variant	NM_014336.5(AIPL1):c.905G>T (p.Arg302Leu)	23746.0	AIPL1	HGNC:359	Conflicting classifications of pathogenicity	0.0	May 01, 2024	62637015.0	-	RCV000055942|RCV000086236|RCV000179479|RCV000989684|RCV004537253	MONDO:MONDO:0011458,MedGen:C1858386,OMIM:604393|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0008764,MedGen:C2931258,OMIM:204000,Orphanet:65|MedGen:CN239169	Leber congenital amaurosis 4|not provided|not specified|Leber congenital amaurosis 1|AIPL1-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	6425710.0	6425710.0	17p13.2	criteria provided, conflicting classifications	12.0	-	N	ClinGen:CA203310,UniProtKB:Q9NZN9#VAR_067166	3.0	65712.0	6425710.0	C	A	-	-	-	-	-	-	905G>T 	Arg302Leu	NM_014336.5	1.0	Conflicting	Conflicting	65712	17	6425710.0	C	A	R	L	rs62637015	17	6329030	17	6269754	302	AIPL1	ENSG00000129221	ENST00000381129	ENSP00000370521	Q9NZN9	AIPL1_HUMAN	c.905G>T	p.Arg302Leu	c.905G>T	p.Arg302Leu	principal1	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.214	0.23036	T	0.252	0.32467	T	0.003	0.20144	B	0.006	0.19965	B	0.04	0.13669	N	simple_aae	96.0	4.0	0.55	0.14367	N	-3.36	0.66580	D	0.086	0.16491	-1.1342	0.01600	T	0.1323	0.44236	T	10	0.0067735612	0.00151	T	0.03948	0.58671	D	0.406	0.71718	.	.	.	.	.	0.434045841721	0.42633	0.42811152323532936	0.42527	0.233831914557	0.25635	0.291568279266	0.09145	T	0.257128	0.62603	T	-0.272105	0.11279	T	-0.157804	0.58259	T	0.0625567919696403	0.07480	T	0.337566	0.34343	T	0.20028594	0.41681	0.27257818	0.52966	0.2458464	0.47218	0.2033774	0.44252	-2.613	0.15136	T	0.1289	0.36272	B	0.00442768548106728	0.18004	0.92016060	0.91975	0.122	0.32993	.	.	.	.	.	.	1.465544	0.18913	13.98	0.96059384047437069	0.28800	0.206018	0.33022	N	-0.939645002544192	0.09807	0.4720182	-0.905343940075263	0.11761	0.6129108	4.98	-3.89	0.03918	-7.84	0.00960	-0.221	0.09236	-2.386000	0.03839	0.599	0.40292	0.062	0.21906	0.000000	0.08389	0.997	0.79771	872	0.31082	8	0.001597444089456869	0	0.0	3	0.002982107355864811	0	0.0	0	0.0	5	0.005112474437627812	420	264690	0.0015867619	.	277	105008	2.637890e-03	1	575	201610	2.852040e-03	3	612	230292	2.657500e-03	3	1	7146	1.399380e-04	0	63	17102	3.683780e-03	0	13	2308	5.632580e-03	0	0	9022	0.000000e+00	0	0	9146	0.000000e+00	0	48	42722	1.123540e-03	0	148	15686	9.435170e-03	1	148	15686	9.435170e-03	1	1	16180	6.180470e-05	0	119	30504	3.901130e-03	1	32	6194	5.166290e-03	0	0	13392	0.000000e+00	0	0	12484	0.000000e+00	0	131	87442	1.498140e-03	0	271	30600	8.856210e-03	2	271	30600	8.856210e-03	2	1	14868	6.725850e-05	0	138	34242	4.030140e-03	1	48	9552	5.025130e-03	0	0	17668	0.000000e+00	0	0	17344	0.000000e+00	0	128	100536	1.273180e-03	0	269	30518	8.814470e-03	2	269	30518	8.814470e-03	2	.	2496	1608168	1.552080e-03	11	848	91080	9.310500e-03	8	12	75048	1.598980e-04	0	0	910	0.000000e+00	0	227	60024	3.781820e-03	2	166	29590	5.610000e-03	1	1	44874	2.228460e-05	0	1	58114	1.720760e-05	0	53	6060	8.745870e-03	0	1024	1179992	8.678020e-04	0	848	91080	9.310500e-03	8	266	181886	0.0014624545044698328	0	358	0	0	2706	0	3	9356	3.206498503634032E-4	4	778	0.005141388174807198	0	966	0	0	682	0	3	272	0.011029411764705883	28	15474	0.0018094868812201111	3	9714	3.0883261272390367E-4	0	3388	0	304	212478	0.0014307363585877126	not_specified|Leber_congenital_amaurosis_4|AIPL1-related_disorder|Leber_congenital_amaurosis_1|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.6425710C>A	ClinGen:CA203310|UniProtKB:Q9NZN9#VAR_067166	CN169374|C1858386|CN239169|C2931258|C3661900	604393|204000	65	.	Arg	Leu	97.19	0.6370967741935484																																																																																																																																																																																																																																																																																																																																																																																																																																																																													158			97.19	Positively-charged	Arginine		Aryl-hydrocarbon-interacting protein-like 1								0.0148		-4.5								 R302-Q298 (PAE:  1.0)	R302-Q298 (PDBs: 6PX0), R302-R306 (PDBs: 6PX0)	 R302-Q298 (PAE:  1.0), R302-R306 (PAE: 1.0)	R302-Q298 (PDBs: 6PX0), R302-R306 (PDBs: 6PX0)							175									-62.1		Pocket 4: Mean pLDDT: 97.76, Volume: 717.23 Å³, Druggability score: 0.01		-24.6						H (helix)	H (α-helix)	Helix											97.19	63.709675	>90	10-90	604393;204000	autosomal recessive	OMIM	Rare genetic eye disease; Ciliopathy	2	LEBER CONGENITAL AMAUROSIS 4; LEBER CONGENITAL AMAUROSIS 1	false	0.9039491033764862	0.923102944924229	false	false	false
LITAF	LITAF_Ser15Leu	B_15-16	5.671832770763355	0.0007571151989367121	0.003815540976171821	-7.334674377212142	0.0001579897873358307	0.0005729471536783583	2025_03_Batch_15-16	false	false	true	false	false	true	false	false	false	false	false	true	0.9310588033016338	0.9568950328075809	0.88021608993039	0.8519724159711093	0.9165976619049375	0.9451711617521823	0.9261713463113976	0.8840208025219523	0.820342436240416	0.8627623004052171	0.9299060017024591	0.8913344316965826	0.9641709771929671	0.9491745212879228	0.8836023957018027	0.897669879455563	0.9838840639127027	0.9707831749066852	LITAF	Ser15Leu	NC_000016.10:11556687:G:A	44C>T	16	11556687	G	A	16	ENSG00000189067	52920	2689	CCSBVarC007946	ALE00007932	ENSP00000483114.1	Edgotyping3	VUSMutGDEh007	B02	GDEhDisVCh_40036	F07	2	VUSMutGDDh007	B02	VUSN2Hmut_GDN2h_02	D07	VUSMutpDEST2_12	D02	VUSmut_GDEh02	D07	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	341848.0	single nucleotide variant	NM_001136472.2(LITAF):c.44C>T (p.Ser15Leu)	9516.0	LITAF	HGNC:16841	Conflicting classifications of pathogenicity	0.0	Apr 01, 2024	138041990.0	-	RCV000549466|RCV001531224|RCV001173623|RCV002328830	MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083|MedGen:C3661900|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MeSH:D030342,MedGen:C0950123	Charcot-Marie-Tooth disease type 1C|not provided|Charcot-Marie-Tooth disease|Inborn genetic diseases	germline	germline	GRCh38	NC_000016.10	16	11556687.0	11556687.0	16p13.13	criteria provided, conflicting classifications	8.0	-	N	ClinGen:CA7904196	2.0	317789.0	11556687.0	G	A	-	-	-	-	-	-	44C>T 	Ser15Leu	NM_001136472.2	1.0	Conflicting	Conflicting	317789	16	11556687.0	G	A	S	L	rs138041990	16	11650543	16	11558044	15	LITAF	ENSG00000189067	ENST00000574763	ENSP00000461813	Q99732	LITAF_HUMAN	c.44C>T	p.Ser15Leu	c.44C>T	p.Ser15Leu	principal1	Y	3	.	.	-	TCA	2	0	G	G/G	G/G	G/G	G/G	.	0.55689	.	0.586	0.50577	T	0.043	0.21588	B	0.01	0.14938	B	0.07	0.23785	N	simple_aae	93.0	7.0	1.905	0.50677	L	.	0.26376	.	0.337	0.42877	-0.5982	0.64737	T	0.5187	0.81935	D	10	0.07831514	0.12382	T	0.086929	0.74751	D	.	0.49015	.	.	.	.	.	0.912831551716	0.91129	.	0.42358	.	0.15214	0.429683923721	0.29129	T	0.285514	0.65638	T	-0.210452	0.19009	T	-0.173634	0.56812	T	0.0628201961517334	0.07520	T	0.905209	0.66597	D	0.02885249	0.02269	0.032765433	0.02074	0.02885249	0.02269	0.032765433	0.02074	-4.875	0.35495	T	0.0918	0.32204	B	0.646442169999304	0.65268	0.83205900	0.89152	0.058	0.15819	.	.	.	.	.	.	0.885558	0.12608	9.116	0.98868554164953504	0.47697	0.155351	0.27838	N	-0.71383690716024	0.15441	0.7895085	-0.738858621686034	0.15729	0.8441074	5.31	3.35	0.37394	.	.	1.996	0.405	2.137000	0.30902	-0.123	0.13648	0.018	0.19519	0.108000	0.22830	0.002	0.04174	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	64	264690	2.4179228E-4	.	15	109408	1.371010e-04	0	41	208076	1.970430e-04	0	46	236866	1.942030e-04	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	15	42768	3.507300e-04	0	0	15690	0.000000e+00	0	15	42768	3.507300e-04	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	40	89500	4.469270e-04	0	0	30608	0.000000e+00	0	40	89500	4.469270e-04	0	0	14902	0.000000e+00	0	1	34260	2.918860e-05	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	1	21632	4.622780e-05	0	43	102668	4.188260e-04	0	0	30526	0.000000e+00	0	43	102668	4.188260e-04	0	.	455	1614086	2.818930e-04	0	435	1180056	3.686270e-04	0	0	74914	0.000000e+00	0	0	912	0.000000e+00	0	1	60000	1.666670e-05	0	1	29606	3.377690e-05	0	0	44896	0.000000e+00	0	5	64044	7.807130e-05	0	0	6084	0.000000e+00	0	435	1180056	3.686270e-04	0	0	91086	0.000000e+00	0	20	47336	4.225114078080108E-4	0	306	0	0	112	0	0	8092	0	0	500	0	0	628	0	0	56	0	0	98	0	3	8494	3.531904874028726E-4	0	8398	0	0	168	0	23	65622	3.5049221297735514E-4	Charcot-Marie-Tooth_disease|Inborn_genetic_diseases|Charcot-Marie-Tooth_disease_type_1C|not_provided	criteria_provided,_conflicting_classifications	NC_000016.10:g.11556687G>A	ClinGen:CA7904196	C0007959|C0950123|C0270913|C3661900	PS118220|601098	166|101083	.	Ser	Leu	52.32	0.9076923076923077																																																																																																																																																																																																																																																																																																																																																																																																																																																																													118			52.32	Polar/Neutral	Serine		Lipopolysaccharide-induced tumor necrosis factor-alpha factor										-0.8																		105									-136.4				101.7	Disordered					C (loop/coil)	C (loop/coil)												52.32	90.76923	50-70	$\geqslant$90	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.9568950328075809	0.9310588033016338	false	false	false
SMAD3	SMAD3_Arg385Gly	B_15-16	0.5327285922433171	0.6107074037701461	0.6849390142107922	7.566210399023609	0.00012989037427100868	0.0004934758525616997	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8614251236451832	0.8664284638281047	0.7843435716549232	0.7642763130398319	0.7850447255168749	0.8293778214021741	0.6711408653949448	0.6454750035002208	0.6194167808943252	0.6229285963457707	0.7856869617854609	0.7811411304742906	0.9876147774094035	0.924614447533529	0.9091358451853386	0.9457585469640756	0.9471699658707484	0.9417091168160758	SMAD3	Arg385Gly	NC_000015.10:67187508:A:G	1153A>G	15	67187508	A	G	15	ENSG00000166949	11805	2176	CCSBVarC007752	ALE00007738	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	B05	GDEhDisVCh_40014	G11	2	VUSMutGDDh005	B05	VUSN2Hmut_GDN2h_02	F01	VUSMutpDEST2_09	F07	VUSmut_GDEh02	F01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	258947.0	single nucleotide variant	NM_005902.4(SMAD3):c.1153A>G (p.Arg385Gly)	4088.0	SMAD3	HGNC:6769	Conflicting classifications of pathogenicity	1.0	Mar 08, 2021	886038836.0	-	RCV000250077|RCV002227113|RCV000993701|RCV001067156	MedGen:CN230736||MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Cardiovascular phenotype|See cases|Aneurysm-osteoarthritis syndrome|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000015.10	15	67187508.0	67187508.0	15q22.33	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10587879	2.0	263520.0	67187508.0	A	G	-	-	-	-	-	-	1153A>G 	Arg385Gly	NM_005902.4	1.0	Conflicting	Conflicting	263520	15	67187508.0	A	G	R	G	rs886038836	15	67479846	15	65266900	385	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.1153A>G	p.Arg385Gly	c.1153A>G	p.Arg385Gly	principal1	Y	1	YES	Select	+	AGG	1	2	A	A/A	A/A	A/A	A/A	0.006	0.61594	D	0.1	0.39084	T	0.967	0.56423	D	0.952	0.69100	D	1.0	0.99291	A	simple_aae	0.0	100.0	1.96	0.52924	M	-4.73	0.89554	D	0.874	0.87350	1.0717	0.98633	D	0.9443	0.98173	D	10	0.93217313	0.92469	D	0.423977	0.93837	D	0.910	0.97583	0.649	0.78559	P84022	R385G	Loss of MoRF binding (P = 0.032)| Loss of stability (P = 0.1595)| Gain of catalytic residue at R386 (P = 0.1685)| Loss of phosphorylation at T388 (P = 0.1896)| Gain of sheet (P = 0.1945)	0.988613958012	0.98836	0.9416965661071761	0.94114	1.77042804158	0.91237	0.864215016365	0.91719	D	0.972402	0.99708	D	0.50482	0.94391	D	0.487362	0.94311	D	0.949695408344269	0.62943	D	0.864413	0.84578	D	0.842638	0.86622	0.69864815	0.82043	0.842638	0.86623	0.69864815	0.82044	-11.629	0.85433	D	0.9862	0.93645	P	0.999462572478678	0.96673	0.99293670	0.97236	0.834	0.90858	.	.	.	.	.	.	6.888392	0.95878	35.0	0.99796321774366858	0.88204	0.873647	0.79537	D	0.661942960783644	0.77019	6.618468	0.597821431728659	0.74642	6.196222	5.71	5.71	0.89013	2.7	0.49372	7.049	0.76385	11.210000	0.89379	0.75	0.87077	1.0	0.71675	1.000000	0.68239	0.32	0.25019	923	0.18499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Aneurysm-osteoarthritis_syndrome|See_cases|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Cardiovascular_phenotype	criteria_provided,_conflicting_classifications	NC_000015.10:g.67187508A>G	ClinGen:CA10587879	C3151087|C4707243|CN230736	613795|PS607086	284984|91387	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Arg	Gly	95.6	0.6693548387096774																																																																																																																																																																																																																																																																																																																																																																																																																																																																													166			95.6	Positively-charged	Arginine		Mothers against decapentaplegic homolog 3							MH2			-4.5								 R385-E178 (PAE:  29.5)										175									-56.5				-22.1						C (loop/coil)	S (bend)	Beta strand											95.6	66.935486	>90	10-90	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	true	0.8664284638281047	0.8614251236451832	false	false	false
MVK	MVK_Ile268Val	B_7-8	1.46756550365208	0.1925952728239594	0.27268863683748146	3.5650222509333087	0.011855113934231486	0.01988494887505921	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6769438393112552	0.6795578482616145	0.5448552518840177	0.7391002176078942	0.6541907754358729	0.6175259679675857	0.6437523667657217	0.5844044988683561	0.7494756120289895	0.5652008101316377	0.6951417422184036	0.7065038768392744	0.5912995691694498	0.7239770520033896	0.7287248231867989	0.5245096936363977	0.6639739543048254	0.647383801783236	MVK	Ile268Val	NC_000012.12:109591274:A:G	802A>G	12	109591274	A	G	12	ENSG00000110921	281	19	CCSBVarC007126	ALE00007124	ENSP00000228510.3	Edgotyping3	VUSMutGDEh010	B01	GDEhDisVCh_40020	D07	2	VUSMutGDDh010	B01	VUSN2Hmut_GDN2h_03	C05	VUSMutpDEST2_01	H02	VUSmut_GDEh03	C05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	231822.0	single nucleotide variant	NM_000431.4(MVK):c.802A>G (p.Ile268Val)	4598.0	MVK	HGNC:7530	Conflicting classifications of pathogenicity	1.0	Feb 10, 2023	759997079.0	-	RCV000213141|RCV001340239	MedGen:C3661900|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900	not provided|Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type	germline	germline	GRCh38	NC_000012.12	12	109591274.0	109591274.0	12q24.11	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA6779384	2.0	234380.0	109591274.0	A	G	-	-	-	-	-	-	802A>G 	Ile268Val	NM_000431.4	1.0	Conflicting	Conflicting	234380	12	109591274.0	A	G	I	V	rs759997079	12	110029079	12	108513462	268	MVK	ENSG00000110921	ENST00000546277	ENSP00000438153	Q03426	KIME_HUMAN	.	.	c.802A>G	p.Ile268Val	principal1	Y	5	.	.	+	ATA	1	0	A	A/A	A/A	A/A	A/A	.	0.02664	.	.	0.09576	.	0.006	0.37885	B	0.006	0.41466	B	.	0.56225	.	.	.	.	1.635	0.41678	L	.	0.13154	.	.	0.33352	0.2978	0.87473	D	0.6471	0.87649	D	10	.	0.33914	.	0.048583	0.63301	D	.	0.73303	0.707	0.84254	Q03426	I268V	Gain of loop (P = 0.0195)| Loss of helix (P = 0.0196)| Loss of catalytic residue at L273 (P = 0.0355)| Gain of relative solvent accessibility (P = 0.1259)| Loss of stability (P = 0.1843)	.	0.80731	.	0.76078	.	0.32410	0.418854922056	0.27647	T	0.213762	0.57304	T	0.0655328	0.60021	T	-0.0607779	0.66037	T	0.676343500614166	0.39317	D	.	0.44511	.	0.07369645	0.16334	0.037476208	0.03423	0.05486027	0.10487	0.033548094	0.02279	-3.517	0.16684	T	.	0.12948	.	0.107561482216715	0.43991	0.96517570	0.94305	0.306	0.57345	.	.	.	.	.	.	1.356131	0.17668	13.29	0.25255150107421392	0.01151	0.250991	0.36890	N	-0.223510418962607	0.31891	1.811465	-0.155746456710409	0.32877	1.895852	4.6	4.6	0.56461	3.56	0.64876	2.977	0.49085	7.013000	0.57306	0.756	0.943	0.937	0.32615	1.000000	0.68239	0.361	0.25958	734	0.53826	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	1	109404	9.140430e-06	0	3	208128	1.441420e-05	0	2	236930	8.441310e-06	0	0	7164	0.000000e+00	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	17112	5.843850e-05	0	0	16218	0.000000e+00	0	1	30524	3.276110e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	1	89554	1.116640e-05	0	0	30608	0.000000e+00	0	1	30524	3.276110e-05	0	0	14902	0.000000e+00	0	1	34260	2.918860e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21626	0.000000e+00	0	0	102732	0.000000e+00	0	0	30526	0.000000e+00	0	1	34260	2.918860e-05	0	.	9	1614048	5.576040e-06	0	1	60010	1.666390e-05	0	0	74908	0.000000e+00	0	0	912	0.000000e+00	0	1	60010	1.666390e-05	0	0	29606	0.000000e+00	0	0	44882	0.000000e+00	0	0	64034	0.000000e+00	0	0	6082	0.000000e+00	0	6	1180044	5.084560e-06	0	0	91080	0.000000e+00	0	3	19776	1.5169902912621358E-4	0	298	0	0	86	0	0	7438	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1930	0	0	7736	0	0	112	0	3	30408	9.865824782951855E-5	Hyperimmunoglobulin_D_with_periodic_fever|Mevalonic_aciduria|Porokeratosis_3,_disseminated_superficial_actinic_type|not_provided	criteria_provided,_conflicting_classifications	NC_000012.12:g.109591274A>G	ClinGen:CA6779384	C0398691|C1959626|C1867981|CN517202	260920|610377|175900	343|29	.	Ile	Val	98.47	0.005917159763313609																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			98.47	Aliphatic	Isoleucine		Mevalonate kinase										4.5								 I268-L264 (PAE:  1.0), I268-S272 (PAE: 1.0)	I268-L264 (PDBs: 2R3V), I268-S272 (PDBs: 2R3V)	 I268-L264 (PAE:  1.0), I268-S272 (PAE: 1.0)	I268-L264 (PDBs: 2R3V), I268-S272 (PDBs: 2R3V)							131									-62.5				-38.6						H (helix)	H (α-helix)	Helix											98.47	0.591716	>90	<10	260920;610377;175900	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; MEVALONIC ACIDURIA; POROKERATOSIS 3, MULTIPLE TYPES	false	0.6795578482616145	0.6769438393112552	false	false	false
TH	TH_Pro2Leu	B_7-8	1.462558987836403	0.21741083148116663	0.2993905465962713	-3.8003707147212986	0.006711541310682285	0.0121696425939743	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6746426918743744	0.7325587602286736	0.8250962834848337	0.8424341554054265	0.7649808276305298	0.8559223213460389	0.8559223213460389	0.7449553528052683	0.8246844594177012	0.8250962834848337	0.6998818919361972	0.6640847908633734		0.7850063024557913	0.8601838513931519		0.7652356285211501	0.6852005928853755	TH	Pro2Leu	NC_000011.10:2171782:G:A	5C>T	11	2171782	G	A	11	ENSG00000180176	71892	4030	CCSBVarC008307	ALE00008293	ENSP00000325951.4	Edgotyping3	VUSMutGDEh016	B01	GDEhDisVCh_40019	F12	1	VUSMutGDDh016	B01	VUSN2Hmut_GDN2h_05	D02	VUSMutpDEST2_15	F10	VUSmut_GDEh05	D02	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	313653.0	single nucleotide variant	NM_000360.4(TH):c.5C>T (p.Pro2Leu)	7054.0	TH	HGNC:11782	Conflicting classifications of pathogenicity	0.0	Jan 25, 2024	139474171.0	-	RCV000284550|RCV003221899	MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150|MedGen:C3661900	Autosomal recessive DOPA responsive dystonia|not provided	germline	germline	GRCh38	NC_000011.10	11	2171782.0	2171782.0	11p15.5	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA5818895	2.0	304087.0	2171782.0	G	A	-	-	-	-	-	-	5C>T 	Pro2Leu	NM_000360.4	1.0	Conflicting	Conflicting	304087	11	2171782.0	G	A	P	L	rs139474171	11	2193012	11	2149588	2	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.5C>T	p.Pro2Leu	c.5C>T	p.Pro2Leu	.	Y	1	.	.	-	CCC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.28	0.58915	N	simple_aae	72.0	28.0	1.665	0.42444	L	-1.49	0.49533	N	0.738	0.74257	1.0514	0.98143	D	0.9809	0.99412	D	10	0.23886827	0.40627	T	0.971377	0.99827	D	0.591	0.83611	.	.	.	.	.	0.96914566453	0.96853	0.5524968909824044	0.54987	0.320785745375	0.33986	0.745362281799	0.73716	T	0.448411	0.78873	T	-0.102413	0.35667	T	0.0748768	0.75051	D	0.120964971620146	0.14340	T	0.832017	0.49809	T	0.27544641	0.50276	0.32219443	0.57935	0.27544641	0.50276	0.32219443	0.57934	-4.726	0.35777	T	0.2106	0.63154	B	0.669197245137506	0.66001	0.98854540	0.96519	0.425	0.66419	.	.	.	.	.	.	4.294356	0.65589	24.8	0.99788084150701251	0.87406	0.484582	0.52288	N	0.064542194843145	0.44555	2.748662	0.0133912741811886	0.40044	2.405589	3.85	1.9	0.24703	0.951	0.28776	6.526	0.73772	9.558000	0.81019	0.652	0.534	1.0	0.71675	1.000000	0.68239	0.317	0.24949	988	0.02004	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	0	0.0	1	0.0010224948875255625	6	264690	2.2668026E-5	.	47	107572	4.369170e-04	0	87	204320	4.258030e-04	0	87	231488	3.758290e-04	0	0	7126	0.000000e+00	0	0	17062	0.000000e+00	0	0	2304	0.000000e+00	0	0	9014	0.000000e+00	0	0	11858	0.000000e+00	0	0	42642	0.000000e+00	0	47	15678	2.997830e-03	0	47	15678	2.997830e-03	0	2	16094	1.242700e-04	0	0	30452	0.000000e+00	0	0	6156	0.000000e+00	0	0	13358	0.000000e+00	0	0	15194	0.000000e+00	0	0	87660	0.000000e+00	0	83	30588	2.713480e-03	0	83	30588	2.713480e-03	0	2	14842	1.347530e-04	0	0	34174	0.000000e+00	0	0	9478	0.000000e+00	0	0	17658	0.000000e+00	0	0	19888	0.000000e+00	0	0	99414	0.000000e+00	0	83	30504	2.720950e-03	0	83	30504	2.720950e-03	0	.	230	1611720	1.427050e-04	2	217	91044	2.383460e-03	2	5	75036	6.663470e-05	0	0	910	0.000000e+00	0	0	59996	0.000000e+00	0	0	29566	0.000000e+00	0	0	44858	0.000000e+00	0	0	62140	0.000000e+00	0	1	5942	1.682940e-04	0	0	1179774	0.000000e+00	0	217	91044	2.383460e-03	2	0	25400	0	0	300	0	0	112	0	1	7944	1.2588116817724068E-4	0	146	0	0	610	0	0	56	0	1	98	0.01020408163265306	1	4122	2.4260067928190198E-4	1	8244	1.2130033964095099E-4	0	168	0	3	38788	7.734350830153656E-5	not_provided|Autosomal_recessive_DOPA_responsive_dystonia	criteria_provided,_conflicting_classifications	NC_000011.10:g.2171782G>A	ClinGen:CA5818895	C3661900|C2673535	605407	101150	Tyrosine hydroxylase, conserved site	Pro	Leu	40.4	0.8823529411764706																																																																																																																																																																																																																																																																																																																																																																																																																																																																													123			40.44	Special, No backbone hydrogen	Proline		Tyrosine 3-monooxygenase										1.6																		115									-117.5				146.2						C (loop/coil)	C (loop/coil)												40.4	88.2353	$\leqslant$50	10-90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.7325587602286736	0.6746426918743744	false	false	false
GRN	GRN_Ala324Thr	B_7-8	1.1705090577007184	0.29129986913297	0.37782794808121745	0.23298360727689837	1.0	1.0	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7778670978015675	0.7879253500280479	0.8303890152484542	0.8956996416365628	0.8438670702596265	0.8905208344742576	0.8504720843707758	0.8590439673889709	0.898267971491236	0.789488133585616	0.7947842321169367	0.7778670978015675	0.9305695845777393	0.8286901731302821	0.8931313117818895	0.8712898969112924	0.7810664679391589		GRN	Ala324Thr	NC_000017.11:44351586:G:A	970G>A	17	44351586	G	A	17	ENSG00000030582	3980	201378	CCSBVarC004644	ALE00004644	ENSP00000053867.2	CEGS2	CegsMutGDEh1036	A09	GDEhDisVCh_40075	B06	1	CegsMutGDDh1036	A09	VUSN2Hmut_GDN2h_07	E06	VUSMutpDEST2_03	F12	VUSmut_GDEh07	E06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	104057.0	single nucleotide variant	NM_002087.4(GRN):c.970G>A (p.Ala324Thr)	2896.0	GRN	HGNC:4601	Conflicting classifications of pathogenicity	0.0	Aug 01, 2024	63750541.0	-	RCV000706214|RCV001128038|RCV000084468|RCV004549523|RCV001727569|RCV002381407	MONDO:MONDO:0013866,MedGen:C3539123,OMIM:614706,Orphanet:314629,Orphanet:79262;MONDO:MONDO:0011842,MedGen:C1843792,OMIM:607485,Orphanet:100070,Orphanet:282|MONDO:MONDO:0011842,MedGen:C1843792,OMIM:607485,Orphanet:100070,Orphanet:282|MedGen:C3661900||MedGen:CN169374|MeSH:D030342,MedGen:C0950123	Neuronal ceroid lipofuscinosis 11;GRN-related frontotemporal lobar degeneration with Tdp43 inclusions|GRN-related frontotemporal lobar degeneration with Tdp43 inclusions|not provided|GRN-related disorder|not specified|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000017.11	17	44351586.0	44351586.0	17q21.31	criteria provided, conflicting classifications	10.0	-	N	ClinGen:CA225301	2.0	98165.0	44351586.0	G	A	-	-	-	-	-	-	970G>A 	Ala324Thr	NM_002087.4	1.0	Conflicting	Conflicting	98165	17	44351586.0	G	A	A	T	rs63750541	17	42428954	17	39784480	324	GRN	ENSG00000030582	ENST00000053867	ENSP00000053867	P28799	GRN_HUMAN	c.970G>A	p.Ala324Thr	c.970G>A	p.Ala324Thr	principal1	Y	1	YES	Select	+	GCG	1	0	G	G/G	G/G	G/G	G/G	0.461	0.08764	T	0.525	0.10444	T	0.014	0.16880	B	0.011	0.15518	B	0.05	0.16373	N	simple_aae	95.0	5.0	0.895	0.22286	L	-0.82	0.22452	N	0.102	0.13700	-1.0469	0.15271	T	0.1729	0.51356	T	10	0.022455513	0.00558	T	0.010962	0.27814	T	0.093	0.26701	.	.	.	.	.	0.460616323599	0.45307	0.8061077457304078	0.80452	0.231353726995	0.25396	0.225505158305	0.01655	T	0.077038	0.35298	T	-0.524345	0.00400	T	-0.53151	0.18823	T	0.00135231434349549	0.00013	T	0.513749	0.16229	T	0.06649668	0.14181	0.048131984	0.07099	0.04338243	0.06688	0.04602051	0.06335	-4.884	0.35597	T	0.0802	0.08359	B	0.0137112322879371	0.26401	0.25785032	0.75432	0.016	0.01897	.	.	.	.	.	.	0.280591	0.06598	3.064	0.66996218183735445	0.08350	0.353292	0.44389	N	-1.4830889657123	0.01950	0.08646658	-1.52501801401499	0.02125	0.09858729	5.12	-3.06	0.05050	-2.06	0.11383	-1.087	0.03495	0.593000	0.19918	-0.972	0.01943	0.0	0.06393	0.000000	0.08389	0.044	0.14692	501	0.75979	5	9.98402555910543E-4	5	0.0037821482602118004	0	0.0	0	0.0	0	0.0	0	0.0	291	264690	0.0010993993	.	82	109398	7.495570e-04	0	174	208062	8.362890e-04	0	198	236896	8.358100e-04	0	11	7164	1.535460e-03	0	8	17104	4.677270e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	61	42766	1.426370e-03	0	1	15690	6.373490e-05	0	11	7164	1.535460e-03	0	27	16216	1.665020e-03	0	10	30512	3.277400e-04	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	135	89506	1.508280e-03	0	1	30608	3.267120e-05	0	27	16216	1.665020e-03	0	26	14902	1.744730e-03	0	11	34240	3.212620e-04	0	0	9562	0.000000e+00	0	0	17692	0.000000e+00	0	1	21632	4.622780e-05	0	157	102722	1.528400e-03	0	1	30526	3.275900e-05	0	26	14902	1.744730e-03	0	.	2074	1613886	1.285100e-03	3	125	74972	1.667290e-03	0	125	74972	1.667290e-03	0	0	912	0.000000e+00	0	15	60020	2.499170e-04	0	0	29606	0.000000e+00	0	0	44874	0.000000e+00	0	4	63990	6.250980e-05	0	0	6060	0.000000e+00	0	1867	1179882	1.582360e-03	3	2	91078	2.195920e-05	0	142	124784	0.0011379664059494806	0	308	0	0	1940	0	9	8676	0.001037344398340249	0	506	0	0	650	0	0	1248	0	0	104	0	15	16446	9.120758847136082E-4	9	8984	0.001001780943900267	0	3188	0	166	154662	0.0010733082463695025	Inborn_genetic_diseases|not_specified|GRN-related_disorder|GRN-related_frontotemporal_lobar_degeneration_with_Tdp43_inclusions|Neuronal_ceroid_lipofuscinosis_11|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.44351586G>A	ClinGen:CA225301	C0950123|CN169374|C1843792|C3539123|C3661900	607485|614706	100070|282|314629|79262	.	Ala	Thr	87.59	0.46226415094339623																																																																																																																																																																																																																																																																																																																																																																																																																																																																													49			87.59	Aliphatic	Alanine		Progranulin										1.8										 A324-Q311 (PAE:  3.0)								89								Granulin-4	-52.3				136.0						C (loop/coil)	T (turn)												87.59	46.226414	70-90	10-90	614706;607485;607485	multiple	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	CEROID LIPOFUSCINOSIS, NEURONAL, 11; FRONTOTEMPORAL DEMENTIA 2; FRONTOTEMPORAL DEMENTIA 2	false	0.7879253500280479	0.7778670978015675	false	false	false
DES	DES_Arg127Pro	B_7-8	-1.2911737219185722	0.2662083468037565	0.3521176886393178	-0.11975113923588376	0.9080447595346983	0.9262157497199396	2024_01_Batch_7-8	true	false	false	false	false	false	false	false	false	false	false	false	0.9405607927477755	0.9068288854519174	0.9111080232172821	0.7849761783028174	0.8419002387024862	0.9644186003325436	0.9644186003325436	0.9612758181107267	0.9623989647083854	0.9111080232172821	0.9272521325202587	0.9496420143420666		0.7225246592942457	0.6075533918972494		0.8864056383835761	0.9314795711534842	DES	Arg127Pro	NC_000002.12:219418842:G:C	380G>C	2	219418842	G	C	2	ENSG00000175084	12573	2247	CCSBVarC007810	ALE00007796	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	H03	GDEhDisVCh_40003	B04	1	VUSMutGDDh003	H03	VUSN2Hmut_GDN2h_01	C02	NULL	NULL	VUSmut_GDEh01	C02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	53426.0	single nucleotide variant	NM_001927.4(DES):c.380G>C (p.Arg127Pro)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	1.0	Dec 23, 2023	397516694.0	-	RCV000037239|RCV000183371|RCV000547988|RCV000852536	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MONDO:MONDO:0016587,MeSH:D019571,MedGen:C0349788,Orphanet:247	not specified|not provided|Desmin-related myofibrillar myopathy|Arrhythmogenic right ventricular cardiomyopathy	germline	germline	GRCh38	NC_000002.12	2	219418842.0	219418842.0	2q35	criteria provided, conflicting classifications	4.0	ACMG2022	N	ClinGen:CA133847	2.0	44259.0	219418842.0	G	C	-	-	-	-	-	-	380G>C 	Arg127Pro	NM_001927.4	1.0	Conflicting	Conflicting	44259	2	219418842.0	G	C	R	P	rs397516694	2	220283564	2	219991808	127	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.380G>C	p.Arg127Pro	c.380G>C	p.Arg127Pro	principal1	Y	1	YES	Select	+	CGC	2	0	G	./.	./.	./.	./.	0.003	0.68399	D	0.005	0.72530	D	1.0	0.90580	D	0.998	0.88579	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.51	0.98988	H	-6.15	0.90195	D	0.992	0.99826	1.0984	0.99594	D	0.9255	0.97533	D	10	0.9827864	0.98361	D	0.727322	0.97797	D	0.979	0.99840	0.833	0.94137	P17661	R127P	Loss of MoRF binding (P = 0.0345)| Gain of methylation at K125 (P = 0.0471)| Loss of ubiquitination at K125 (P = 0.0478)| Loss of disorder (P = 0.218)| Loss of stability (P = 0.2639)	0.995557322363	0.99545	0.9899011220446087	0.98982	2.40020819914	0.97165	0.835652351379	0.87408	D	0.956014	0.99392	D	0.510239	0.94527	D	0.495147	0.94446	D	0.998449802398682	0.94118	D	0.973153	0.90364	D	0.9750044	0.98685	0.9673073	0.99333	0.9750044	0.98685	0.9673073	0.99333	-15.883	0.97585	D	0.9988	0.98152	P	0.999949413936496	0.99079	0.99873240	0.98932	0.99	0.99661	.	.	.	.	.	.	6.417197	0.95184	34.0	0.99758435558645875	0.84864	0.988720	0.99988	D	1.06322235270167	0.97375	16.04908	0.942672829021469	0.97161	15.70842	4.69	4.69	0.58495	3.02	0.55215	9.771	0.98162	11.558000	0.93224	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Arrhythmogenic_right_ventricular_cardiomyopathy|Desmin-related_myofibrillar_myopathy|not_provided|not_specified	criteria_provided,_conflicting_classifications	NC_000002.12:g.219418842G>C	ClinGen:CA133847	C0349788|C1832370|C3661900|CN169374	601419	247|363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Pro	95.03	0.7459677419354839																																																																																																																																																																																																																																																																																																																																																																																																																																																																													185			95.03	Positively-charged	Arginine		Desmin							IF rod			-4.5								 R127-Q131 (PAE:  1.0), R127-I123 (PAE: 1.0)		 R127-Q131 (PAE:  1.0), R127-I123 (PAE: 1.0)								175									-61.9				-41.1	Coil 1A					H (helix)	H (α-helix)												95.03	74.59677	>90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	true	0.9068288854519174	0.9405607927477755	false	true	false
PMP22	PMP22_His51Arg	B_7-8	1.3999160915774596	0.21106529029849624	0.29255058379544835	-0.9362412193251884	0.3852842847453154	0.43858353753576534	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5551188896354843	0.5517734578540499	0.6161887051744752	0.635432029460868	0.5837391415074888	0.6683366275448027	0.6848404291662594	0.598023948635021	0.7818480792879696	0.5528818095701878	0.6413383169936717	0.6355902155057578	0.651832825923346	0.5694543343799566	0.4890159796337663	0.6794956007787626	0.46220859871442793	0.47464756376521083	PMP22	His51Arg	NC_000017.11:15259120:T:C	152A>G	17	15259120	T	C	17	ENSG00000109099	7323	394	CCSBVarC008466	ALE00008469	ENSP00000308937.3	Edgotyping3	VUSmut_GDEh11	D04	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_06	G02	VUSmut_GDEh11	D04	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	213241.0	single nucleotide variant	NM_000304.4(PMP22):c.152A>G (p.His51Arg)	5376.0	PMP22	HGNC:9118	Conflicting classifications of pathogenicity	0.0	Nov 27, 2023	368908933.0	-	RCV001172746|RCV000762229|RCV001087677	MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MedGen:C3661900|MONDO:MONDO:0019011,MedGen:C0751036,Orphanet:65753	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, type I	germline	germline	GRCh38	NC_000017.11	17	15259120.0	15259120.0	17p12	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA337251	2.0	215728.0	15259120.0	T	C	-	-	-	-	-	-	152A>G 	His51Arg	NM_000304.4	1.0	Conflicting	Conflicting	215728	17	15259120.0	T	C	H	R	rs368908933	17	15162437	17	15103162	51	PMP22	ENSG00000109099	ENST00000676221	ENSP00000502601	Q01453	PMP22_HUMAN	.	.	c.152A>G	p.His51Arg	principal1	Y	.	.	.	-	CAC	2	0	T	T/T	T/T	T/T	T/T	.	0.14728	.	.	0.21276	.	0.0	0.02950	B	0.001	0.04348	B	.	0.08015	.	.	.	.	0.145	0.08752	N	.	0.16117	.	.	0.11859	-0.6439	0.62818	T	0.4210	0.76519	T	10	.	0.00170	.	0.043985	0.61114	D	.	0.49965	.	.	.	.	.	.	0.57672	.	0.38182	.	0.51479	0.325654804707	0.14265	T	0.483764	0.80991	T	-0.441821	0.01179	T	-0.457863	0.26479	T	0.00661046275010484	0.00073	T	.	0.20232	.	0.06755707	0.14506	0.05325345	0.08946	0.06755707	0.14506	0.05325345	0.08945	-2.736	0.07618	T	.	0.07446	.	0.0218791664790184	0.30184	0.96079560	0.94012	0.033	0.07179	.	.	.	.	.	.	1.526541	0.1962	14.34	0.75086712119026633	0.11118	0.149594	0.27157	N	-0.993825228354788	0.08630	0.4107066	-0.951827317711244	0.10695	0.5508888	4.75	2.1	0.26157	0.615	0.26029	0.514	0.22572	1.198000	0.24901	0.665	0.62996	0.297	0.25383	0.892000	0.27925	0.808	0.38116	875	0.30453	7	0.0013977635782747603	0	0.0	0	0.0	0	0.0	0	0.0	7	0.007157464212678937	20	264690	7.556009E-5	.	15	109394	1.371190e-04	0	43	208086	2.066450e-04	0	43	236912	1.815020e-04	0	0	7160	0.000000e+00	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	2	42764	4.676830e-05	0	11	15686	7.012620e-04	0	11	15686	7.012620e-04	0	0	16212	0.000000e+00	0	2	30522	6.552650e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	8	89534	8.935150e-05	0	31	30594	1.013270e-03	0	31	30594	1.013270e-03	0	0	14896	0.000000e+00	0	2	34260	5.837710e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	9	102732	8.760660e-05	0	30	30512	9.832200e-04	0	30	30512	9.832200e-04	0	.	239	1613746	1.481030e-04	0	114	91058	1.251950e-03	0	2	75004	2.666520e-05	0	0	910	0.000000e+00	0	3	60026	4.997830e-05	0	0	29602	0.000000e+00	0	0	44876	0.000000e+00	0	0	64026	0.000000e+00	0	6	6062	9.897720e-04	0	97	1179712	8.222350e-05	0	114	91058	1.251950e-03	0	6	47336	1.2675342234240325E-4	0	306	0	0	112	0	1	8092	1.2357884330202668E-4	0	500	0	0	628	0	0	56	0	0	98	0	0	8494	0	1	8398	1.1907597046915932E-4	0	168	0	7	65622	1.0667154308006461E-4	Charcot-Marie-Tooth_disease|Charcot-Marie-Tooth_disease,_type_I|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.15259120T>C	ClinGen:CA337251	C0007959|C0751036|C3661900	PS118220	166|65753	.	His	Arg	67.06	0.6467391304347826																																																																																																																																																																																																																																																																																																																																																																																																																																																																													119			67.06	Positively-charged	Histidine		Peripheral myelin protein 22										-3.2								 H51-S43 (PAE:  6.5)		 H51-S43 (PAE:  6.5)								155									-83.0				-48.1						B (undefined)	E (parallel sheets)							Extracellular					67.06	64.67391	50-70	10-90		unknown		Genetic otorhinolaryngologic disease; Rare genetic neurological disorder; Rare chromosomal anomaly	3		false	0.5517734578540499	0.5551188896354843	false	false	false
THAP1	THAP1_Val193Ile	B_7-8	-0.35345791324667947	0.7415873634922885	0.7944093461975721	1.4834524001577232	0.18848001537128903	0.23212136121229218	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8567947444399259	0.7010431358001079	0.6622344347508061	0.7105854366544926	0.7505942384454636	0.7509820494153929	0.8158749397629034	0.7911564134892997	0.8545788782775939	0.7031508258431431	0.8307842880286259	0.8567947444399259	0.6860891590678825	0.7100320634016276	0.5665919950313913	0.6213180436584691	0.5713019835715898		THAP1	Val193Ile	NC_000008.11:42838027:C:T	577G>A	8	42838027	C	T	8	ENSG00000131931	1668	1855	CCSBVarC008434	ALE00008452	ENSP00000254250.3	Edgotyping3	VUSmut_GDEh11	C02	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_01	A09	VUSmut_GDEh11	C02	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	458918.0	single nucleotide variant	NM_018105.3(THAP1):c.577G>A (p.Val193Ile)	55145.0	THAP1	HGNC:20856	Conflicting classifications of pathogenicity	0.0	Jan 22, 2024	756694303.0	-	RCV000542002|RCV004023909	MONDO:MONDO:0011264,MedGen:C1414216,OMIM:602629,Orphanet:98806|MeSH:D030342,MedGen:C0950123	Torsion dystonia 6|Inborn genetic diseases	germline	germline	GRCh38	NC_000008.11	8	42838027.0	42838027.0	8p11.21	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA4734519	2.0	463445.0	42838027.0	C	T	-	-	-	-	-	-	577G>A 	Val193Ile	NM_018105.3	1.0	Conflicting	Conflicting	463445	8	42838027.0	C	T	V	I	rs756694303	8	42693170	8	42812327	193	THAP1	ENSG00000131931	ENST00000254250	ENSP00000254250	Q9NVV9	THAP1_HUMAN	c.577G>A	p.Val193Ile	c.577G>A	p.Val193Ile	principal1	Y	1	YES	Select	-	GTA	1	0	C	C/C	C/C	C/C	C/C	0.803	0.03109	T	0.689	0.06036	T	0.0	0.02950	B	0.0	0.01384	B	0.05	0.16373	N	simple_aae	95.0	5.0	0.345	0.11102	N	-0.18	0.09735	N	0.022	0.00364	0.1385	0.84792	D	0.6531	0.87882	D	10	0.0066585243	0.00148	T	0.048582	0.63301	D	0.169	0.42902	0.167	0.07143	Q9NVV9	V193I	Loss of ubiquitination at K188 (P = 0.0818)| Gain of loop (P = 0.1069)| Loss of sheet (P = 0.1158)| Loss of disorder (P = 0.1993)| Loss of phosphorylation at Y198 (P = 0.2028)	0.271610670623	0.26353	0.10335734239746494	0.10122	0.453175714291	0.44726	0.2616969347	0.05095	T	0.034608	0.23132	T	-0.426724	0.01454	T	-0.383401	0.34963	T	0.0111260656003856	0.00161	T	0.505449	0.15702	T	0.0138828205	0.00073	0.016503029	0.00017	0.013238958	0.00053	0.014177044	0.00002	-2.508	0.05841	T	0.0617	0.01233	B	0.00467098706214508	0.18378	0.00064747	0.11307	0.013	0.01216	.	.	.	.	.	.	-0.024408	0.04127	0.975	0.62029639421627714	0.06959	0.034946	0.04338	N	-1.51120202140699	0.01759	0.07778514	-1.53390343432235	0.02061	0.09553775	5.28	-6.31	0.01830	-4.89	0.04664	-0.777	0.04781	-3.292000	0.02917	-0.971	0.01948	0.0	0.06393	0.000000	0.08389	0.135	0.19804	302	0.87880	.	.	.	.	.	.	.	.	.	.	.	.	67	264690	2.531263E-4	.	88	109164	8.061270e-04	0	186	207662	8.956860e-04	0	193	236432	8.163020e-04	0	0	7160	0.000000e+00	0	87	17000	5.117650e-03	0	0	2318	0.000000e+00	0	0	9046	0.000000e+00	0	0	13372	0.000000e+00	0	0	42734	0.000000e+00	0	0	15622	0.000000e+00	0	87	17000	5.117650e-03	0	0	16206	0.000000e+00	0	185	30374	6.090740e-03	0	0	6204	0.000000e+00	0	0	13414	0.000000e+00	0	0	16708	0.000000e+00	0	0	89418	0.000000e+00	0	0	30486	0.000000e+00	0	185	30374	6.090740e-03	0	0	14890	0.000000e+00	0	192	34100	5.630500e-03	0	0	9560	0.000000e+00	0	0	17680	0.000000e+00	0	0	21590	0.000000e+00	0	0	102606	0.000000e+00	0	0	30404	0.000000e+00	0	192	34100	5.630500e-03	0	.	238	1613654	1.474910e-04	0	221	59890	3.690100e-03	0	1	74890	1.335290e-05	0	0	912	0.000000e+00	0	221	59890	3.690100e-03	0	0	29602	0.000000e+00	0	0	44904	0.000000e+00	0	0	63984	0.000000e+00	0	0	6084	0.000000e+00	0	11	1179950	9.322430e-06	0	0	90984	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	3	610	0.004918032786885246	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	3	14710	2.0394289598912304E-4	Torsion_dystonia_6|Inborn_genetic_diseases	criteria_provided,_conflicting_classifications	NC_000008.11:g.42838027C>T	ClinGen:CA4734519	C1414216|C0950123	602629	98806	.	Val	Ile	58.52	0.8873239436619719																																																																																																																																																																																																																																																																																																																																																																																																																																																																													126			58.52	Aliphatic	Valine		THAP domain-containing protein 1										4.2																		117									-86.8				-13.5						C (loop/coil)	T (turn)												58.52	88.73239	50-70	10-90	602629	autosomal dominant	OMIM	Rare genetic neurological disorder	1	DYSTONIA 6, TORSION	false	0.7010431358001079	0.8567947444399259	false	false	false
PSAP	PSAP_Met76Lys	B_7-8	0.8149304296010075	0.44624521429036246	0.537610538546545	-3.2169040124077752	0.01820800770672193	0.028927873715874235	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.503331486547502	0.5491670310343999	0.4778881054189625	0.5612058954673298	0.4984649471254028	0.4626326753591149	0.4895984872495128	0.5534943134248501	0.6425291896450951	0.48028712235715093	0.5373920398659986	0.5116452462870247	0.435666863468717	0.4434355808259554	0.47988260128956456	0.47548908848077404	0.5609420222028011	0.49501772680797945	PSAP	Met76Lys	NC_000010.11:71831868:A:T	227T>A	10	71831868	A	T	10	ENSG00000197746	4252	674	CCSBVarC008450	ALE00008425	ENSP00000378394.3	Edgotyping3	VUSmut_GDEh11	H04	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh11	H04	0.0		0.0		0.0			0.0			1.0	1.0	1.0	Y	N	N	N	Y	316058.0	single nucleotide variant	NM_002778.4(PSAP):c.227T>A (p.Met76Lys)	5660.0	PSAP	HGNC:9498	Conflicting classifications of pathogenicity	0.0	Oct 13, 2021	377024801.0	-	RCV000294452|RCV000329512|RCV000349338|RCV000384126	MONDO:MONDO:0009590,MedGen:C0268262,OMIM:249900,Orphanet:512|MONDO:MONDO:0012720,MedGen:C2673266,OMIM:611722,Orphanet:487|MONDO:MONDO:0012517,MedGen:C1864651,OMIM:610539,Orphanet:309252,Orphanet:355|MONDO:MONDO:0012719,MedGen:C2673635,OMIM:611721,Orphanet:139406	Sphingolipid activator protein 1 deficiency|Krabbe disease due to saposin A deficiency|Gaucher disease due to saposin C deficiency|Combined PSAP deficiency	germline	germline	GRCh38	NC_000010.11	10	71831868.0	71831868.0	10q22.1	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA5547842	2.0	300529.0	71831868.0	A	T	-	-	-	-	-	-	227T>A 	Met76Lys	NM_002778.4	1.0	Conflicting	Conflicting	300529	10	71831868.0	A	T	M	K	rs377024801	10	73591625	10	73261631	76	PSAP	ENSG00000197746	ENST00000394936	ENSP00000378394	P07602	SAP_HUMAN	c.227T>A	p.Met76Lys	c.227T>A	p.Met76Lys	principal1	Y	1	YES	Select	-	ATG	2	0	A	A/A	A/A	A/A	A/A	0.037	0.43243	D	0.091	0.40454	T	0.08	0.24559	B	0.158	0.34619	B	.	.	.	.	.	.	2.085	0.57546	M	-2.85	0.60060	D	0.536	0.56181	-0.4345	0.70785	T	0.3563	0.71779	T	10	0.5599681	0.64432	D	0.066882	0.69898	D	0.482	0.77085	0.735	0.86741	P07602	M76K	Gain of ubiquitination at M76 (P = 0.0211)| Gain of disorder (P = 0.0304)| Gain of solvent accessibility (P = 0.0837)| Gain of relative solvent accessibility (P = 0.09)| Loss of stability (P = 0.1384)	0.692655904403	0.68758	0.7540693200273559	0.75219	0.146899570786	0.16314	0.406780421734	0.25981	T	0.81192	0.95270	D	0.0926918	0.63231	D	-0.0891451	0.63971	T	0.224935539486016	0.21443	T	0.89931	0.64637	D	0.37538975	0.58652	0.43816403	0.66955	0.6325428	0.74159	0.5694017	0.74819	-10.671	0.77895	D	0.1758	0.38493	B	0.277898182777648	0.53368	0.27717432	0.76102	0.365	0.62087	.	.	.	.	.	.	3.726644	0.53365	23.3	0.98330775648339475	0.40472	0.911005	0.86922	D	-0.247335396712726	0.30930	1.747742	-0.0657895167217524	0.36511	2.147326	5.2	5.2	0.71681	3.83	0.71516	7.78	0.8433	11.201000	0.89048	0.756	0.943	0.975	0.34813	0.998000	0.34068	0.202	0.21999	804	0.43827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5	109380	4.571220e-05	0	6	207910	2.885860e-05	0	9	236798	3.800710e-05	0	0	7154	0.000000e+00	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	5	13394	3.733010e-04	0	0	42766	0.000000e+00	0	0	15680	0.000000e+00	0	.	.	.	.	0	16146	0.000000e+00	0	0	30514	0.000000e+00	0	0	6200	0.000000e+00	0	0	13402	0.000000e+00	0	6	16734	3.585510e-04	0	0	89460	0.000000e+00	0	0	30598	0.000000e+00	0	.	.	.	.	0	14892	0.000000e+00	0	0	34254	0.000000e+00	0	0	9566	0.000000e+00	0	0	17692	0.000000e+00	0	7	21632	3.235950e-04	0	2	102630	1.948750e-05	0	0	30516	0.000000e+00	0	2	102630	1.948750e-05	0	.	18	1613958	1.115270e-05	0	15	63940	2.345950e-04	0	0	74908	0.000000e+00	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29606	0.000000e+00	0	0	44902	0.000000e+00	0	15	63940	2.345950e-04	0	0	6082	0.000000e+00	0	3	1180024	2.542320e-06	0	0	91088	0.000000e+00	0	0	32650	0	0	122	0	0	112	0	0	3390	0	0	500	0	0	628	0	0	56	0	0	98	0	0	6864	0	0	3512	0	0	168	0	0	44420	0	Combined_PSAP_deficiency|Krabbe_disease_due_to_saposin_A_deficiency|Gaucher_disease_due_to_saposin_C_deficiency|Sphingolipid_activator_protein_1_deficiency	criteria_provided,_conflicting_classifications	NC_000010.11:g.71831868A>T	ClinGen:CA5547842	C2673635|C2673266|C1864651|C0268262	611721|611722|610539|249900	139406|487|309252|355|512	Saposin-like type B, region 1|Saposin B type domain|Saposin B type domain	Met	Lys	76.35	0.30319148936170215																																																																																																																																																																																																																																																																																																																																																																																																																																																																													57			76.35	Aliphatic	Methionine		Prosaposin; Saposin-A							Saposin B-type 1			1.9								 M76-A81 (PAE:  2.5), M76-A72 (PAE: 1.0)	M76-T82 (PDBs: 4DDJ), M76-A72 (PDBs: 4DDJ, 4UEX, 8EQU)	 M76-A81 (PAE:  2.5), M76-N80 (PAE: 2.5), M76-A72 (PAE: 1.0)	M76-T82 (PDBs: 4DDJ), M76-A72 (PDBs: 4DDJ, 4UEX, 8EQU)							149									-56.9				-39.6						H (helix)	H (α-helix)	Helix											76.35	30.319149	70-90	10-90	249900;611722;610539;611721	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY; KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY; GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY; COMBINED SAPOSIN DEFICIENCY	false	0.5491670310343999	0.503331486547502	false	false	false
TPM1	TPM1_Lys15Asn	B_15-16	-5.99447756688485	0.0006165957430971712	0.0032175827434775556	5.40965507564478	0.0011426891093417842	0.00263785433185437	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7169198426911072	0.711876216806021	0.6509988686890031	0.6800036569941166	0.7451763395125177	0.7348480364618538	0.6445880618620534	0.6349512896668728	0.5497554238804861	0.6321178192451411	0.6224858602521112	0.6257276092890085	0.8251080110616542	0.8554013893581626	0.810251890107747	0.6698799181328651	0.8012665733599308	0.8081120760932059	TPM1	Lys15Asn	NC_000015.10:63042874:G:T	45G>T	15	63042874	G	T	15	ENSG00000140416	4723	201724	CCSBVarC005629	ALE00005629	ENSP00000288398.6	CEGS2	CegsMutGDEh1039	F03	GDEhDisVCh_40050	F06	2	CegsMutGDDh1039	F03	VUSN2Hmut_GDN2h_08	H01	VUSMutpDEST2_04	G05	VUSmut_GDEh08	H01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	40552.0	single nucleotide variant	NM_001018005.2(TPM1):c.45G>T (p.Lys15Asn)	7168.0	TPM1	HGNC:12010	Conflicting classifications of pathogenicity	1.0	Apr 11, 2021	199476301.0	-	RCV000036334|RCV000024588|RCV001852574	MedGen:CN169374|MedGen:C3661900|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569	not specified|not provided|Hypertrophic cardiomyopathy	germline	germline	GRCh38	NC_000015.10	15	63042874.0	63042874.0	15q22.2	criteria provided, conflicting classifications	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018057,Leiden Muscular Dystrophy (TPM1):TPM1_00023	2.0	31892.0	63042874.0	G	T	-	-	-	-	-	-	45G>T 	Lys15Asn	NM_001018005.2	1.0	Conflicting	Conflicting	31892	15	63042874.0	G	T	K	N	rs199476301	15	63335073	15	61122126	15	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.45G>T	p.Lys15Asn	c.45G>T	p.Lys15Asn	alternative1	Y	1	YES	Select	+	AAG	3	2	G	./.	./.	./.	./.	0.0	0.91343	D	0.021	0.79703	D	0.999	0.90580	D	0.992	0.86259	D	0.99	0.97926	D	simple_aae	1.0	99.0	3.835	0.95592	H	-2.63	0.58437	D	0.8	0.81098	1.0007	0.97192	D	0.9918	0.99795	D	10	0.8188072	0.80904	D	0.938876	0.99564	D	0.791	0.93084	0.326	0.30737	Q6ZN40	K15N	Loss of ubiquitination at K15 (P = 0.0081)| Loss of MoRF binding (P = 0.0583)| Loss of glycosylation at K15 (P = 0.1104)| Loss of methylation at K15 (P = 0.373)| Gain of catalytic residue at M10 (P = 0.8297)	0.978677047956	0.97823	.	0.89141	.	0.98321	0.906412363052	0.97117	D	0.860477	0.96875	D	0.233383	0.76867	D	0.0974621	0.76565	D	0.99892383813858	0.95561	D	0.985701	0.95122	D	0.92938536	0.94088	0.73956	0.84420	0.89365023	0.90693	0.79319453	0.87690	-13.376	0.90872	D	0.991	0.97075	P	0.999824654099717	0.98179	0.99901750	0.99097	0.913	0.95505	.	.	.	.	.	.	5.629417	0.92673	32.0	0.99712603699582392	0.81441	0.950444	0.96395	D	0.80237206648682	0.86177	8.826676	0.677505070952652	0.80567	7.351656	4.61	3.69	0.41415	.	.	7.784	0.84365	8.345000	0.77036	0.67	0.6921	1.0	0.71675	1.000000	0.68239	0.999	0.91597	786	0.46777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|not_specified|Hypertrophic_cardiomyopathy	criteria_provided,_conflicting_classifications	NC_000015.10:g.63042874G>T	ClinGen:CA018057|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00023	C3661900|CN169374|C0007194	.	217569	.	Lys	Asn	77.39	0.7073170731707317																																																																																																																																																																																																																																																																																																																																																																																																																																																																													145	Morphology: MQMLkLDkENALDRA		77.39	Positively-charged	Lysine		Tropomyosin alpha-1 chain	Coiled coil	Basic and acidic residues								-3.9								 K15-L19 (PAE:  5.5), K15-L11 (PAE: 7.0)		 K15-L19 (PAE:  5.5), K15-L11 (PAE: 7.0)								147		Mutation: K -> N. Impairs interaction with LMOD2 and TMOD1.							-65.7				-42.0	Disordered					H (helix)	H (α-helix)	Helix									Morphology: MQMLkLDkENALDRA		77.39	70.731705	70-90	10-90		unknown		Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3		false	0.711876216806021	0.7169198426911072	false	false	false
KCTD1	KCTD1_Val248Ile	B_7-8	2.6037431100190918	0.035232675851661094	0.07052858645682429	-0.13115317402706467	0.8993439538021126	0.9198975224230082	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7611761511573472	0.7691195445274113	0.7095910547751174	0.7027990634369854	0.6895203524051994	0.7268451061495822	0.9705075409065845	0.8709362513222145	0.9514229487904095	0.9392682963475247	0.9742015457550453	0.9358824100400187	0.48318267139257975	0.5081044534881841	0.45417517808356134	0.47991381320271	0.5640375432997773	0.5864698922746756	KCTD1	Val248Ile	NC_000018.10:26455775:C:T	742G>A	18	26455775	C	T	18	ENSG00000134504	14221	2241	CCSBVarC008487	ALE00008475	ENSP00000464170.1	Edgotyping3	VUSmut_GDEh11	A01	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_11	E07	VUSmut_GDEh11	A01	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	2103533.0	single nucleotide variant	NM_001142730.3(KCTD1):c.2566G>A (p.Val856Ile)	284252.0	KCTD1	HGNC:18249	Conflicting classifications of pathogenicity	0.0	Jan 05, 2024	-1.0	-	RCV002918641|RCV004066231	MedGen:C3661900|MedGen:CN169374	not provided|not specified	germline	germline	GRCh38	NC_000018.10	18	26455775.0	26455775.0	18q11.2	criteria provided, conflicting classifications	2.0	-	N	-	2.0	2048230.0	26455775.0	C	T	-	-	-	-	-	-	2566G>A 	Val856Ile	NM_001142730.3	1.0	Conflicting	Conflicting	2048230	18	26455775.0	C	T	V	I	rs151239539	18	24035739	18	22289737	248	KCTD1	ENSG00000134504	ENST00000408011	ENSP00000384367	Q719H9	KCTD1_HUMAN	c.742G>A	p.Val248Ile	c.742G>A	p.Val248Ile	.	Y	1	.	.	-	GTC	1	0	C	C/C	C/C	C/C	C/C	0.479	0.08312	T	0.466	0.12574	T	0.007	0.14196	B	0.004	0.10086	B	0.15	0.37131	N	simple_aae	85.0	15.0	0.345	0.11102	N	-0.21	0.10245	N	0.25	0.28069	-0.8171	0.53929	T	0.2243	0.58686	T	10	0.038848937	0.02337	T	0.027632	0.50218	D	0.270	0.58301	.	.	.	.	.	0.117191471859	0.10908	0.2946845762458524	0.29183	0.48314849545	0.46981	0.626304149628	0.56555	T	0.009775	0.08856	T	-0.331457	0.05817	T	-0.289424	0.45494	T	0.0117292279601628	0.00179	T	.	0.57791	.	0.14634879	0.33223	0.15489364	0.36222	0.14634879	0.33223	0.15489364	0.36221	-3.543	0.17052	T	0.0657	0.11755	B	0.206093379761695	0.50223	0.05562701	0.60611	0.067	0.18708	.	.	.	.	.	.	3.319835	0.45736	22.2	0.97064578472092433	0.32395	0.358451	0.44726	N	-0.178865498017717	0.33738	1.936521	0.0979841216131403	0.44169	2.726326	5.98	5.98	0.97142	4.1	0.78208	3.023	0.49446	5.902000	0.50975	-0.236	0.07605	0.998	0.41403	1.000000	0.68239	0.877	0.41908	865	0.32573	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	247	264690	9.331671E-4	segdup	42	109340	3.841230e-04	0	112	208004	5.384510e-04	0	121	236812	5.109540e-04	0	4	7162	5.585030e-04	0	4	17078	2.342190e-04	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	1	13388	7.469380e-05	0	28	42760	6.548180e-04	0	4	15680	2.551020e-04	0	28	42760	6.548180e-04	0	16	16216	9.866800e-04	0	7	30456	2.298400e-04	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	1	16728	5.978000e-05	0	77	89532	8.600280e-04	0	8	30590	2.615230e-04	0	16	16216	9.866800e-04	0	15	14900	1.006710e-03	0	8	34192	2.339730e-04	0	0	9570	0.000000e+00	0	0	17688	0.000000e+00	0	1	21624	4.624490e-05	0	86	102720	8.372270e-04	0	8	30508	2.622260e-04	0	15	14900	1.006710e-03	0	.	1554	1614070	9.627840e-04	3	1402	1180016	1.188120e-03	3	49	75000	6.533330e-04	0	0	912	0.000000e+00	0	18	60006	2.999700e-04	0	1	29606	3.377690e-05	0	1	44878	2.228260e-05	0	7	64018	1.093440e-04	0	1	6062	1.649620e-04	0	1402	1180016	1.188120e-03	3	35	91064	3.843450e-04	0	92	99378	9.257582161041679E-4	0	308	0	0	1902	0	7	8214	8.522035549062576E-4	0	500	0	0	648	0	0	1248	0	0	98	0	12	15746	7.620983106820779E-4	7	8522	8.214034264257216E-4	0	3150	0	111	128042	8.669030474375596E-4	not_provided|not_specified	criteria_provided,_conflicting_classifications	NC_000018.10:g.26455775C>T	.	C3661900|CN169374	.	.	.	Val	Ile	51.09	0.8028169014084507																																																																																																																																																																																																																																																																																																																																																																																																																																																																													114			51.09	Aliphatic	Valine		BTB/POZ domain-containing protein KCTD1										4.2																		117									-95.4				105.8						C (loop/coil)	C (loop/coil)	Beta strand											51.09	80.28169	50-70	10-90		unknown		Rare genetic eye disease; Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	3		false	0.7691195445274113	0.7611761511573472	false	false	false
DES	DES_Asp312Ala	B_7-8	0.2321866144443234	0.8255971997985732	0.8616888806640846	0.9456266078630172	0.3758279923123328	0.42861675941151695	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5701650970226468	0.6141307794100791	0.6706358871395345	0.6712290914151784	0.5703153556665435	0.707665613619675	0.8934175609725685	0.7910884200798264	0.899061652738775	0.7706996560738686	0.712843065977154	0.6522122802130941	0.5219136662667814	0.34954229125326064	0.4433965300915817	0.5705721182052004	0.5154184928430042	0.4881179138321996	DES	Asp312Ala	NC_000002.12:219420865:A:C	935A>C	2	219420865	A	C	2	ENSG00000175084	12573	2284	CCSBVarC007842	ALE00007828	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	B08	GDEhDisVCh_40003	D08	1	VUSMutGDDh003	B08	VUSN2Hmut_GDN2h_01	A04	NULL	NULL	VUSmut_GDEh01	A04	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	53442.0	single nucleotide variant	NM_001927.4(DES):c.935A>C (p.Asp312Ala)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	0.0	Jul 25, 2024	148947510.0	-	RCV000037258|RCV000243219|RCV000725547|RCV001085666|RCV003914934	MedGen:CN169374|MedGen:CN230736|MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|	not specified|Cardiovascular phenotype|not provided|Desmin-related myofibrillar myopathy|DES-related disorder	germline;unknown	germline	GRCh38	NC_000002.12	2	219420865.0	219420865.0	2q35	criteria provided, conflicting classifications	8.0	ACMG2022	N	ClinGen:CA133886	2.0	44275.0	219420865.0	A	C	-	-	-	-	-	-	935A>C 	Asp312Ala	NM_001927.4	1.0	Conflicting	Conflicting	44275	2	219420865.0	A	C	D	A	rs148947510	2	220285587	2	219993831	312	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.935A>C	p.Asp312Ala	c.935A>C	p.Asp312Ala	principal1	Y	1	YES	Select	+	GAC	2	0	A	A/A	A/A	A/A	A/A	0.002	0.72322	D	0.007	0.69466	D	0.985	0.61134	D	0.928	0.66273	D	0.68	0.81345	D	simple_aae	32.0	68.0	2.025	0.55249	M	-5.02	0.82535	D	0.493	0.52416	0.0693	0.83533	D	0.4657	0.79278	T	10	0.017068505	0.00359	T	0.118895	0.79845	D	0.721	0.90105	.	.	.	.	.	0.913096572907	0.91156	0.7130644812438923	0.71100	1.5655755928	0.88055	0.805073261261	0.82706	D	0.781297	0.94179	D	-0.22402	0.17153	T	-0.0960393	0.63445	T	0.0798944890678637	0.09850	T	0.938406	0.76794	D	0.6129289	0.73104	0.5550765	0.74014	0.53220063	0.68656	0.5358749	0.72925	-9.608	0.71608	D	0.5354	0.66101	A	0.97157389977219	0.83560	0.98622966	0.96211	0.855	0.92066	.	.	.	.	.	.	5.207228	0.87384	29.2	0.99558415288902891	0.71618	0.960282	0.98095	D	0.578147953119817	0.71661	5.708199	0.512126560206819	0.68633	5.271022	4.91	4.91	0.63852	4.05	0.77340	9.325	0.96016	11.286000	0.91911	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.791	0.37387	86	0.96402	7	0.0013977635782747603	7	0.00529500756429652	0	0.0	0	0.0	0	0.0	0	0.0	224	264690	8.46273E-4	.	30	109124	2.749170e-04	0	83	207760	3.994990e-04	0	75	236588	3.170070e-04	0	21	7154	2.935420e-03	0	4	17104	2.338630e-04	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13154	0.000000e+00	0	3	42756	7.016560e-05	0	1	15686	6.375110e-05	0	21	7154	2.935420e-03	0	60	16198	3.704160e-03	0	8	30504	2.622610e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16494	0.000000e+00	0	9	89490	1.005700e-04	0	4	30594	1.307450e-04	0	60	16198	3.704160e-03	0	53	14884	3.560870e-03	0	9	34240	2.628500e-04	0	0	9572	0.000000e+00	0	0	17690	0.000000e+00	0	0	21388	0.000000e+00	0	8	102690	7.790440e-05	0	4	30512	1.310960e-04	0	53	14884	3.560870e-03	0	.	336	1613674	2.082200e-04	0	233	74956	3.108490e-03	0	233	74956	3.108490e-03	0	0	912	0.000000e+00	0	18	59978	3.001100e-04	0	0	29608	0.000000e+00	0	1	44844	2.229950e-05	0	0	63802	0.000000e+00	0	3	6062	4.948860e-04	0	52	1179960	4.406930e-05	0	8	91060	8.785420e-05	0	10	167646	5.9649499540698856E-5	2	360	0.005555555555555556	0	4502	0	21	9412	0.0022311942201444965	0	442	0	1	950	0.0010526315789473684	0	1848	0	0	280	0	5	13344	3.747002398081535E-4	23	9772	0.002353663528448629	0	6350	0	39	198784	1.9619285254346427E-4	not_specified|Desmin-related_myofibrillar_myopathy|not_provided|Cardiovascular_phenotype|DES-related_disorder	criteria_provided,_conflicting_classifications	NC_000002.12:g.219420865A>C	ClinGen:CA133886	CN169374|C1832370|C3661900|CN230736	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Asp	Ala	95.27	0.4539877300613497																																																																																																																																																																																																																																																																																																																																																																																																																																																																													74			95.27	Negatively-charged	Aspartic Acid		Desmin							IF rod			-3.5								 D312-Q316 (PAE:  1.0), D312-N308 (PAE: 1.0)		 D312-Q316 (PAE:  1.0), D312-N308 (PAE: 1.0)		 D312-R315 (PAE:  1.0)						132									-70.9				-42.4	Interaction with NEB; Coil 2B					H (helix)	H (α-helix)												95.27	45.398773	>90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.6141307794100791	0.5701650970226468	false	false	false
UBQLN2	UBQLN2_Pro525Ser	B_7-8	2.120584303367721	0.07165964328779754	0.12431418590344534	1.0527317211081442	0.3274407046903331	0.3807691337812175	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5559889805715238	0.5335503824026122	0.5360134020365469	0.5045277540962512	0.5193478452639857	0.5336767606199181	0.38241967292442136	0.4621358347302591	0.4486557668244163	0.3882327953512457	0.5372239615069867	0.523094032571619	0.6849338483154148	0.5765598557977122	0.5603997413680859	0.6837940087218481	0.5298768032982377	0.5888839285714286	UBQLN2	Pro525Ser	NC_000023.11:56565446:C:T	1573C>T	23	56565446	C	T	X	ENSG00000188021	71001	205677	CCSBVarC003506	ALE00003506	ENSP00000345195.5	CEGS2	CegsMutGDEh1034	D10	GDEhDisVCh_40022	C03	2	CegsMutGDDh1034	D10	VUSN2Hmut_GDN2h_06	C10	NULL	NULL	VUSmut_GDEh06	C10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	38909.0	single nucleotide variant	NM_013444.4(UBQLN2):c.1573C>T (p.Pro525Ser)	29978.0	UBQLN2	HGNC:12509	Conflicting classifications of pathogenicity	1.0	Nov 15, 2023	369947678.0	-	RCV000022846|RCV000625776|RCV003944836|RCV003441723	MONDO:MONDO:0010459,MedGen:C3275459,OMIM:300857,Orphanet:803|Human Phenotype Ontology:HP:0007354,MONDO:MONDO:0004976,MedGen:C0002736,Orphanet:803||MedGen:C3661900	Amyotrophic lateral sclerosis type 15|Amyotrophic lateral sclerosis|UBQLN2-related disorder|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	56565446.0	56565446.0	Xp11.21	criteria provided, conflicting classifications	8.0	-	N	ClinGen:CA259711,UniProtKB:Q9UHD9#VAR_066566,OMIM:300264.0005	3.0	29954.0	56565446.0	C	T	-	-	-	-	-	-	1573C>T 	Pro525Ser	NM_013444.4	1.0	Conflicting	Conflicting	29954	X	56565446.0	C	T	P	S	rs369947678	X	56591879	X	56608604	525	UBQLN2	ENSG00000188021	ENST00000338222	ENSP00000345195	Q9UHD9	UBQL2_HUMAN	c.1573C>T	p.Pro525Ser	c.1573C>T	p.Pro525Ser	principal1	Y	NA	YES	Select	+	CCT	1	0	C	./.	./.	./.	./.	0.154	0.24398	T	0.105	0.38356	T	0.001	0.07480	B	0.004	0.10086	B	0.13	0.33788	N	simple_aae	87.0	13.0	1.04	0.26055	L	-0.36	0.12963	N	0.735	0.73435	-0.9239	0.44821	T	0.2099	0.56798	T	10	0.01776573	0.00378	T	0.108443	0.78431	D	0.529	0.80024	0.246	0.18044	Q9UHD9	P525S	Gain of phosphorylation at P525 (P = 0.012)| Loss of catalytic residue at P524 (P = 0.0303)| Gain of glycosylation at P525 (P = 0.0362)| Gain of relative solvent accessibility (P = 0.1571)| Gain of solvent accessibility (P = 0.3304)	0.966643406064	0.96598	0.7089372609021355	0.70686	0.47578793126	0.46448	0.566214978695	0.48076	T	0.034527	0.23101	T	-0.141983	0.29220	T	-0.248076	0.49678	T	0.0101084311154355	0.00135	T	0.959204	0.84611	D	0.051366333	0.09336	0.08753971	0.20327	0.051366333	0.09335	0.08753971	0.20326	-1.944	0.02980	T	0.0652	0.02015	B	0.0243227870923525	0.31063	0.99875796	0.98948	0.054	0.14486	.	.	.	.	.	.	1.348179	0.17578	13.23	0.84241548258599741	0.15412	.	.	.	.	.	.	.	.	.	3.92	2.03	0.25645	.	.	-0.091	0.11147	.	.	0.599	0.40292	0.0	0.06393	.	.	0.976	0.56441	101	0.95825	.	.	.	.	.	.	.	.	.	.	.	.	36	264690	1.3600817E-4	.	13	64459	2.016790e-04	0	37	122737	3.014580e-04	0	45	139103	3.235010e-04	0	0	4018	0.000000e+00	0	0	12077	0.000000e+00	0	12	1400	8.571430e-03	0	0	5277	0.000000e+00	0	0	9215	0.000000e+00	0	1	22724	4.400630e-05	0	0	8492	0.000000e+00	0	1	22724	4.400630e-05	0	0	9321	0.000000e+00	0	0	21055	0.000000e+00	0	34	4000	8.500000e-03	0	0	8719	0.000000e+00	0	0	10932	0.000000e+00	0	3	49286	6.086920e-05	0	0	16345	0.000000e+00	0	3	49286	6.086920e-05	0	0	8531	0.000000e+00	0	0	23928	0.000000e+00	0	41	6504	6.303810e-03	0	0	10957	0.000000e+00	0	0	13665	0.000000e+00	0	4	55617	7.192050e-05	0	0	16307	0.000000e+00	0	4	55617	7.192050e-05	0	.	149	1194329	1.247560e-04	0	111	21705	5.114030e-03	0	0	56854	0.000000e+00	0	0	685	0.000000e+00	0	0	43524	0.000000e+00	0	111	21705	5.114030e-03	0	0	32827	0.000000e+00	0	0	45520	0.000000e+00	0	5	4358	1.147320e-03	0	16	886764	1.804310e-05	0	0	55115	0.000000e+00	0	12	15750	7.619047619047619E-4	0	122	0	0	112	0	1	3370	2.967359050445104E-4	0	146	0	0	610	0	0	56	0	0	98	0	8	2772	0.002886002886002886	1	3492	2.86368843069874E-4	0	168	0	21	23036	9.116166001041847E-4	UBQLN2-related_disorder|Amyotrophic_lateral_sclerosis_type_15|not_provided|Amyotrophic_lateral_sclerosis	criteria_provided,_conflicting_classifications	NC_000023.11:g.56565446C>T	ClinGen:CA259711|OMIM:300264.0005|UniProtKB:Q9UHD9#VAR_066566	C3275459|C3661900|C0002736	300857	803|803	.	Pro	Ser	44.37	0.9558823529411765																																																																																																																																																																																																																																																																																																																																																																																																																																																																													130			44.37	Special, No backbone hydrogen	Proline		Ubiquilin-2										1.6																		115									-81.4				157.9	12 X 3 AA tandem repeats of P-X-X; Disordered		12.0			H (helix)	P (polyproline helix)												44.37	95.588234	$\leqslant$50	$\geqslant$90	300857	x-linked dominant	OMIM		0	AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	false	0.5335503824026122	0.5559889805715238	false	false	false
AGXT	AGXT_Ala295Thr	B_7-8	-0.2537636482578714	0.8069703666616075	0.8464104340053104	3.10999699741361	0.017081283528209472	0.02744672090566058	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6437110846911209	0.6325819559370345	0.4224884260484384	0.5914739698152316	0.6019760729839216	0.4771851042245937	0.4546851215169998	0.5509373121422456	0.5025558981837537	0.48009109688750784	0.6410464350337834	0.6751041745292146	0.4996850869321876	0.6530148338255976	0.6803920414467095	0.364885755209369	0.6241174768402855	0.6123179948530272	AGXT	Ala295Thr	NC_000002.12:240877573:G:A	883G>A	2	240877573	G	A	2	ENSG00000172482	70497	3874	CCSBVarC008224	ALE00008210	ENSP00000302620.3	Edgotyping3	VUSMutGDEh005	B06	GDEhDisVCh_40002	A11	2	VUSMutGDDh005	B06	VUSN2Hmut_GDN2h_02	C02	VUSMutpDEST2_14	E10	VUSmut_GDEh02	C02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200576.0	single nucleotide variant	NM_000030.3(AGXT):c.883G>A (p.Ala295Thr)	189.0	AGXT	HGNC:341	Conflicting classifications of pathogenicity	0.0	Jan 31, 2024	13408961.0	-	RCV000186262|RCV000428366|RCV001844077	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900|MedGen:CN169374	Primary hyperoxaluria, type I|not provided|not specified	germline	germline	GRCh38	NC_000002.12	2	240877573.0	240877573.0	2q37.3	criteria provided, conflicting classifications	9.0	-	N	ClinGen:CA275599,UniProtKB:P21549#VAR_048237	2.0	204056.0	240877573.0	G	A	-	-	-	-	-	-	883G>A 	Ala295Thr	NM_000030.3	1.0	Conflicting	Conflicting	204056	2	240877573.0	G	A	A	T	rs13408961	2	241816990	2	241465663	295	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.883G>A	p.Ala295Thr	c.883G>A	p.Ala295Thr	principal1	Y	1	YES	Select	+	GCG	1	0	G	G/G	G/G	G/G	G/G	0.255	0.16942	T	0.251	0.23921	T	0.005	0.13006	B	0.009	0.14297	B	0.1	0.28107	P	simple_aae	90.0	10.0	.	.	.	-1.09	0.28250	N	0.148	0.14965	-0.7201	0.59286	T	0.0171	0.06983	T	9	0.0019549727	0.00026	T	.	.	.	0.220	0.51351	.	.	.	.	.	0.395894371353	0.38804	0.8465304553450383	0.84521	0.032564312496	0.03294	0.357241690159	0.18964	T	0.463552	0.79795	T	-0.413149	0.01782	T	-0.301151	0.44261	T	0.00730363592244397	0.00083	T	0.456654	0.12860	T	0.19085513	0.40375	0.10718673	0.25747	0.19085513	0.40375	0.10718673	0.25746	-5.314	0.40130	T	0.1162	0.23568	B	0.0265933263215585	0.31807	0.00512659	0.33499	0.096	0.26918	.	.	.	.	.	.	-0.059499	0.03899	0.85	0.91080197724006751	0.20584	0.394723	0.47006	N	-1.45811154325122	0.02132	0.09478659	-1.58276542791638	0.01739	0.08009337	4.58	-6.09	0.01966	-1.72	0.12625	0.001	0.1298	-0.959000	0.06817	-1.435	0.01112	0.0	0.06393	0.000000	0.08389	0.0	0.00835	982	0.03399	123	0.02456070287539936	120	0.0907715582450832	1	9.940357852882703E-4	1	0.001440922190201729	1	9.92063492063492E-4	0	0.0	6909	264690	0.026102234	.	347	64942	5.343230e-03	17	916	131354	6.973520e-03	36	988	149484	6.609400e-03	37	249	2858	8.712390e-02	17	48	12358	3.884120e-03	0	33	1454	2.269600e-02	0	2	4568	4.378280e-04	0	0	11440	0.000000e+00	0	10	19468	5.136630e-04	0	0	11436	0.000000e+00	0	249	2858	8.712390e-02	17	708	8426	8.402560e-02	35	71	20648	3.438590e-03	0	89	4736	1.879220e-02	1	3	8738	3.433280e-04	0	0	13450	0.000000e+00	0	29	49032	5.914500e-04	0	2	22766	8.785030e-05	0	708	8426	8.402560e-02	35	674	7928	8.501510e-02	35	84	24606	3.413800e-03	0	169	8240	2.050970e-02	2	3	10998	2.727770e-04	0	0	15318	0.000000e+00	0	37	55392	6.679660e-04	0	2	22752	8.790440e-05	0	674	7928	8.501510e-02	35	.	7708	1550806	4.970320e-03	244	5794	73164	7.919200e-02	233	5794	73164	7.919200e-02	233	0	910	0.000000e+00	0	256	50988	5.020790e-03	2	618	28632	2.158420e-02	4	12	40928	2.931980e-04	0	1	59146	1.690730e-05	0	20	5990	3.338900e-03	1	548	1146890	4.778140e-04	1	18	84052	2.141530e-04	0	170	106546	0.0015955549715615791	25	286	0.08741258741258741	0	130	0	439	8060	0.05446650124069479	13	514	0.02529182879377432	0	680	0	0	86	0	0	114	0	91	16482	0.005521174614731222	464	8346	0.055595494847831294	0	216	0	738	132898	0.005553130972625622	Primary_hyperoxaluria,_type_I|not_provided|not_specified	criteria_provided,_conflicting_classifications	NC_000002.12:g.240877573G>A	ClinGen:CA275599|UniProtKB:P21549#VAR_048237	C0268164|C3661900|CN169374	259900	416|93598	Aminotransferase class V domain	Ala	Thr	98.89	0.02830188679245283																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3			98.89	Aliphatic	Alanine		Alanine--glyoxylate aminotransferase										1.8								 A295-H291 (PAE:  1.0), A295-H299 (PAE: 1.0)	A295-H299 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), A295-H291 (PDBs: 6RV1, 3R9A)	 A295-H291 (PAE:  1.0), A295-H299 (PAE: 1.0)	A295-H299 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), A295-H291 (PDBs: 6RV1, 3R9A)							89									-64.5				-44.8				dbSNP: rs13408961; Variant type: LB/B; AA change: Ala295Thr; PTM type: Phosphorylation; PTM morphology: REAA*AyLHGRL; Var class: II		H (helix)	H (α-helix)	Helix											98.89	2.8301888	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.6325819559370345	0.6437110846911209	false	false	false
AGXT	AGXT_Arg118Cys	B_7-8	-0.17143244749607361	0.8687342467258636	0.8973944895870197	-0.3311272379366828	0.7502401594641195	0.7912015474808386	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.758090197908337	0.7562658331031067	0.576768398425586	0.6046135593697234	0.5391886526758891	0.5503899536355952	0.5641665754081919	0.48992598491096323	0.5583292350073903	0.6113751196143742	0.811999671214184	0.8253416628174526	0.5366133318629985	0.588451320440815	0.6508978837320565	0.5421616772367979	0.7005319949920292	0.6908387329992215	AGXT	Arg118Cys	NC_000002.12:240869356:C:T	352C>T	2	240869356	C	T	2	ENSG00000172482	70497	3815	CCSBVarC008184	ALE00008170	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	B03	GDEhDisVCh_40002	B05	2	VUSMutGDDh004	B03	VUSN2Hmut_GDN2h_01	H06	VUSMutpDEST2_14	D04	VUSmut_GDEh01	H06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	3.0	1.0	1.0	1.0	1.0	Y	Y	Y	N	Y	200475.0	single nucleotide variant	NM_000030.3(AGXT):c.352C>T (p.Arg118Cys)	189.0	AGXT	HGNC:341	Conflicting classifications of pathogenicity	1.0	Oct 27, 2023	376844297.0	-	RCV000186301|RCV000346525	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900	Primary hyperoxaluria, type I|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	240869356.0	240869356.0	2q37.3	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA275677	2.0	204095.0	240869356.0	C	T	-	-	-	-	-	-	352C>T 	Arg118Cys	NM_000030.3	1.0	Conflicting	Conflicting	204095	2	240869356.0	C	T	R	C	rs376844297	2	241808773	2	241457446	118	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.352C>T	p.Arg118Cys	c.352C>T	p.Arg118Cys	principal1	Y	1	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.95	0.94956	D	simple_aae	5.0	95.0	.	.	.	-7.68	0.95591	D	0.865	0.86161	0.8493	0.95004	D	0.8388	0.94598	D	10	0.9909246	0.99604	D	0.763519	0.98121	D	0.808	0.93758	.	.	.	.	.	0.941207063943	0.94012	0.9520002468871058	0.95155	0.279076304862	0.30091	0.619975447655	0.55660	T	0.914231	0.98391	D	0.244527	0.77923	D	0.339171	0.89814	D	0.992012798786163	0.82261	D	0.953905	0.82435	D	0.9492964	0.96135	0.89781386	0.94749	0.9492964	0.96135	0.89781386	0.94749	-10.19	0.75118	D	0.398	0.59422	A	0.998721560994694	0.94943	0.45367143	0.80860	0.993	0.99760	.	.	.	.	.	.	5.222616	0.87674	29.3	0.99911763582834989	0.98096	0.935183	0.92942	D	0.586352700719014	0.72174	5.787526	0.392664174417573	0.60902	4.306883	4.12	3.06	0.34295	.	.	1.4	0.34292	5.797000	0.49985	0.545	0.25635	1.0	0.71675	1.000000	0.68239	0.315	0.24902	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	10	264690	3.7780046E-5	.	4	98610	4.056380e-05	0	13	189350	6.865590e-05	0	13	215338	6.037020e-05	0	0	7152	0.000000e+00	0	0	16620	0.000000e+00	0	0	1762	0.000000e+00	0	1	9006	1.110370e-04	0	0	12124	0.000000e+00	0	1	37334	2.678520e-05	0	1	12856	7.778470e-05	0	1	9006	1.110370e-04	0	1	16020	6.242200e-05	0	0	29824	0.000000e+00	0	0	4672	0.000000e+00	0	1	13384	7.471610e-05	0	0	15258	0.000000e+00	0	6	80342	7.468070e-05	0	3	25364	1.182780e-04	0	3	25364	1.182780e-04	0	0	14798	0.000000e+00	0	1	33244	3.008060e-05	0	0	7328	0.000000e+00	0	2	17618	1.135200e-04	0	0	19618	0.000000e+00	0	5	92312	5.416410e-05	0	3	25282	1.186610e-04	0	3	25282	1.186610e-04	0	.	104	1591258	6.535710e-05	0	91	1167544	7.794140e-05	0	1	74678	1.339080e-05	0	0	910	0.000000e+00	0	1	59118	1.691530e-05	0	0	27764	0.000000e+00	0	1	44716	2.236340e-05	0	0	62070	0.000000e+00	0	0	5940	0.000000e+00	0	91	1167544	7.794140e-05	0	5	86858	5.756520e-05	0	3	19788	1.5160703456640388E-4	0	298	0	0	86	0	0	7448	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1936	0	0	7746	0	0	112	0	3	30436	9.856748587199369E-5	Primary_hyperoxaluria,_type_I|not_provided	criteria_provided,_conflicting_classifications	NC_000002.12:g.240869356C>T	ClinGen:CA275677	C0268164|C3661900	259900	416|93598	Aminotransferase class V domain	Arg	Cys	98.88	0.782258064516129																																																																																																																																																																																																																																																																																																																																																																																																																																																																													194			98.88	Positively-charged	Arginine		Alanine--glyoxylate aminotransferase								0.0027		-4.5			A:R118-B:P237 (PDBs: 5F9S, 5HHY, 7NS7), C:R118-A:D243 (PDBs: 3R9A), C:R118-A:P237 (PDBs: 3R9A), A:R118-C:P237 (PDBs: 3R9A), A:R118-C:D243 (PDBs: 3R9A)	B:R118-A:K236 (PDBs: 5F9S, 5HHY), B:R118-A:S239 (PDBs: 7NS7), C:R118-A:F240 (PDBs: 3R9A), C:R118-A:K236 (PDBs: 3R9A), C:R118-A:S239 (PDBs: 3R9A), C:R118-A:P237 (PDBs: 3R9A)	B:R118-A:D243 (PDBs: 5F9S, 5HHY, 7NS7), C:R118-A:D243 (PDBs: 3R9A), A:R118-C:D243 (PDBs: 3R9A)			 R118-D114 (PAE:  1.0)	R118-D114 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)	 R118-D114 (PAE:  1.0)	R118-D114 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)		R118-D114 (PDBs: 5F9S, 5HHY, 3R9A)					175									-60.4		Pocket 5: Mean pLDDT: 99.35, Volume: 244.55 Å³, Druggability score: 0		-31.2						H (helix)	H (α-helix)	Helix											98.88	78.22581	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.7562658331031067	0.758090197908337	false	false	false
TAT	TAT_Arg119Trp	B_7-8	-3.6097970417543794	0.008626510064041878	0.024266029782503664	-11.15317969985122	0.000010374633134358014	0.00007770388490427328	2024_01_Batch_7-8		true	false	false	false	false		true	false	false	false	false		0.9954642547850734	0.5245382512908017	0.6364722971226389	0.5732227441962533	0.5526907399468215	0.5334440758632071	0.5950988720916695	0.715230515894236	0.48680679012186256	0.9979067419775558		0.571937404030436	0.5513466163008371	0.5577140783510416	0.5622697124597407	0.993021767592591		TAT	Arg119Trp	NC_000016.10:71573592:G:A	355C>T	16	71573592	G	A	16	ENSG00000198650	54914	28861	CCSBVarC002396	ALE00002396	ENSP00000348234.4	RC4	RC4_Mut_GDEh1022	H05	GDEhDisVCh_40043	D11	1	RC4_Mut_GDDh1022	H05	VUSN2Hmut_GDN2h_10	F08	VUSMutpDEST2_13	B03	VUSmut_GDEh13	D04	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	547832.0	single nucleotide variant	NM_000353.3(TAT):c.355C>T (p.Arg119Trp)	6898.0	TAT	HGNC:11573	Conflicting classifications of pathogenicity	1.0	Oct 30, 2023	758306831.0	-	RCV000665945	MONDO:MONDO:0010160,MedGen:C0268487,OMIM:276600,Orphanet:28378	Tyrosinemia type II	germline;unknown	germline	GRCh38	NC_000016.10	16	71573592.0	71573592.0	16q22.2	criteria provided, conflicting classifications	3.0	-	N	-	2.0	550997.0	71573592.0	G	A	-	-	-	-	-	-	355C>T 	Arg119Trp	NM_000353.3	1.0	Conflicting	Conflicting	550997	16	71573592.0	G	A	R	W	rs758306831	16	71607495	16	70164996	119	TAT	ENSG00000198650	ENST00000355962	ENSP00000348234	P17735	ATTY_HUMAN	c.355C>T	p.Arg119Trp	c.355C>T	p.Arg119Trp	principal1	Y	1	YES	Select	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	D	simple_aae	0.0	100.0	3.715	0.94651	H	-7.77	0.95858	D	0.933	0.93850	1.0272	0.97659	D	0.9111	0.97048	D	10	0.99082315	0.99592	D	0.239468	0.88604	D	0.856	0.95570	0.926	0.98766	P17735	R119W	Loss of disorder (P = 0.0332)| Loss of phosphorylation at S117 (P = 0.0843)| Loss of catalytic residue at S117 (P = 0.1252)| Loss of stability (P = 0.184)| Loss of methylation at R119 (P = 0.2516)	0.983780418101	0.98343	0.9712149712737598	0.97094	0.922999217021	0.71360	0.537663757801	0.44052	T	0.910632	0.98296	D	0.442424	0.92077	D	0.408553	0.92331	D	0.998916864395142	0.95528	D	0.920908	0.71280	D	0.974964	0.98681	0.9449521	0.98058	0.9655974	0.97802	0.89713407	0.94701	-13.942	0.92880	D	0.9541	0.87330	P	0.993908754863417	0.90319	0.99308604	0.97265	0.897	0.94544	.	.	.	.	.	.	4.945567	0.81687	27.6	0.99894067057435609	0.96745	0.680657	0.64299	D	0.827251071217182	0.87712	9.337231	0.71975837237473	0.83791	8.139041	6.01	5.02	0.66699	4.67	0.86381	2.609	0.46082	5.796000	0.49978	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.782	0.37021	180	0.92994	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	3	66766	4.493300e-05	0	3	135856	2.208220e-05	0	4	155100	2.578980e-05	0	0	3072	0.000000e+00	0	0	12594	0.000000e+00	0	0	1494	0.000000e+00	0	0	4798	0.000000e+00	0	2	11536	1.733700e-04	0	0	20382	0.000000e+00	0	0	11514	0.000000e+00	0	.	.	.	.	0	9108	0.000000e+00	0	0	21062	0.000000e+00	0	0	4844	0.000000e+00	0	0	9072	0.000000e+00	0	2	13602	1.470370e-04	0	0	51622	0.000000e+00	0	0	22904	0.000000e+00	0	.	.	.	.	0	8518	0.000000e+00	0	0	25014	0.000000e+00	0	0	8388	0.000000e+00	0	0	11354	0.000000e+00	0	2	15584	1.283370e-04	0	1	59022	1.694280e-05	0	0	22886	0.000000e+00	0	1	59022	1.694280e-05	0	.	35	1553796	2.252550e-05	0	4	60040	6.662230e-05	0	0	73170	0.000000e+00	0	0	910	0.000000e+00	0	0	51388	0.000000e+00	0	1	28690	3.485540e-05	0	1	41186	2.428010e-05	0	4	60040	6.662230e-05	0	0	6010	0.000000e+00	0	28	1148070	2.438880e-05	0	0	84146	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Tyrosinemia_type_II	criteria_provided,_conflicting_classifications	NC_000016.10:g.71573592G>A	.	C0268487	276600	28378	Aminotransferase, class I/classII, large domain	Arg	Trp	98.86	0.10887096774193548																																																																																																																																																																																																																																																																																																																																																																																																																																																																													27			98.86	Positively-charged	Arginine		Tyrosine aminotransferase										-4.5								 R119-G114 (PAE:  1.0), R119-A123 (PAE: 1.0), R119-A135 (PAE: 1.0), R119-F115 (PAE: 1.0)	R119-G114 (PDBs: 3DYD), R119-A123 (PDBs: 3DYD), R119-A135 (PDBs: 3DYD), R119-F115 (PDBs: 3DYD)	 R119-K136 (PAE:  1.0), R119-G114 (PAE: 1.0), R119-A123 (PAE: 1.0), R119-F115 (PAE: 1.0)	R119-G114 (PDBs: 3DYD), R119-A123 (PDBs: 3DYD), R119-F115 (PDBs: 3DYD)							175									-70.8				-38.9						H (helix)	H (α-helix)	Helix											98.86	10.887096	>90	10-90	276600	autosomal recessive	OMIM	Rare genetic eye disease; Rare inborn errors of metabolism; Rare genetic skin disease	3	TYROSINEMIA, TYPE II	false	0.9954642547850734		true		true
SMAD3	SMAD3_Asp408His	B_15-16	2.0117278728368957	0.08415100825460003	0.14261617193104353	0.9816796361684548	0.35896141231524903	0.4114267280440237	2025_03_Batch_15-16	false	false	false	false	false	true	false	false	false	false	false	false	0.741754941832802	0.7270475999287973	0.7199365384067116	0.7199819356174368	0.7751301712915133	0.8073058569567241	0.8151980483376959	0.7676399841734952	0.8192258830322571	0.7531256155601777	0.7154772517118029	0.7340989792485265	0.7994136655757522	0.7826203584095313	0.6207379882026167	0.6867474612532454	0.7386179481457918	0.7494109044170776	SMAD3	Asp408His	NC_000015.10:67190480:G:C	1222G>C	15	67190480	G	C	15	ENSG00000166949	11805	2180	CCSBVarC007756	ALE00007742	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	F05	GDEhDisVCh_40014	C12	2	VUSMutGDDh005	F05	VUSN2Hmut_GDN2h_02	H01	VUSMutpDEST2_09	B08	VUSmut_GDEh02	H01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	210297.0	single nucleotide variant	NM_005902.4(SMAD3):c.1222G>C (p.Asp408His)	4088.0	SMAD3	HGNC:6769	Conflicting classifications of pathogenicity	1.0	Jul 10, 2023	201263330.0	-	RCV000198134|RCV003642875	MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000015.10	15	67190480.0	67190480.0	15q22.33	criteria provided, conflicting classifications	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA322624	2.0	213776.0	67190480.0	G	C	-	-	-	-	-	-	1222G>C 	Asp408His	NM_005902.4	1.0	Conflicting	Conflicting	213776	15	67190480.0	G	C	D	H	rs201263330	15	67482818	15	65269872	408	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.1222G>C	p.Asp408His	c.1222G>C	p.Asp408His	principal1	Y	1	YES	Select	+	GAC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.5	0.92661	M	-6.59	0.92019	D	0.91	0.91160	1.0912	0.99286	D	0.9696	0.99037	D	10	0.9601773	0.95366	D	0.765999	0.98142	D	0.917	0.97849	0.741	0.87254	P84022	D408H	Gain of methylation at K409 (P = 0.0475)| Gain of MoRF binding (P = 0.0612)| Loss of stability (P = 0.0627)| Gain of ubiquitination at K409 (P = 0.1993)| Gain of catalytic residue at L407 (P = 0.215)	0.949206091116	0.94825	0.9895067471596484	0.98942	2.62205694876	0.98265	0.537531137466	0.44033	T	0.954035	0.99351	D	0.423202	0.91124	D	0.370124	0.91014	D	0.994118571281433	0.85104	D	0.9977	0.99068	D	0.9573108	0.96960	0.87159723	0.92882	0.93575317	0.94737	0.89312273	0.94413	-14.976	0.95988	D	0.9997	0.99584	P	0.998753755793902	0.94998	0.99343526	0.97333	0.994	0.99793	.	.	.	.	.	.	5.682319	0.93015	33.0	0.99572379891359308	0.72534	0.888418	0.82085	D	0.992857247284046	0.95495	13.69927	0.906463780746671	0.95826	14.0316	4.96	4.96	0.65108	.	.	9.879	0.98503	11.877000	0.98732	0.671	0.69477	1.0	0.71675	1.000000	0.68239	1.0	0.97202	918	0.19592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided	criteria_provided,_conflicting_classifications	NC_000015.10:g.67190480G>C	ClinGen:CA322624	C4707243|C3661900	PS607086	91387	SMAD domain, Dwarfin-type	Asp	His	93.11	0.5950920245398773																																																																																																																																																																																																																																																																																																																																																																																																																																																																													97			93.11	Negatively-charged	Aspartic Acid		Mothers against decapentaplegic homolog 3							MH2			-3.5								 D408-L404 (PAE:  1.0), D408-T412 (PAE: 1.0)	D408-L404 (PDBs: 1MJS, 5XOC), D408-T412 (PDBs: 1MJS, 1MK2, 5XOC)	 D408-L404 (PAE:  1.0), D408-T412 (PAE: 1.0)	D408-L404 (PDBs: 1MJS, 5XOC), D408-T412 (PDBs: 1MJS, 1MK2, 5XOC)							132									-57.4				-45.5						H (helix)	H (α-helix)	Helix											93.11	59.5092	>90	10-90		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.7270475999287973	0.741754941832802	false	false	false
TPM1	TPM1_Ile92Thr	B_15-16	-1.2502316912487388	0.31406944578478146	0.38831695391100307	-0.7985111239349238	1.0	1.0	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.5671771330603576	0.5693131223497847	0.5282119509977294	0.6168785640289538	0.6418158898320634	0.5762719962557816	0.5925919252036901	0.6095589388873534	0.6394062884578108	0.5576217693982104	0.5532407971119102	0.5421389489054259	0.5599520673078732	0.6740728407767733	0.5943508396000967	0.49880213259724837	0.5853854475876592	0.5922153172152892	TPM1	Ile92Thr	NC_000015.10:63057019:T:C	275T>C	15	63057019	T	C	15	ENSG00000140416	4723	201736	CCSBVarC005638	ALE00005638	ENSP00000288398.6	CEGS2	CegsMutGDEh1040	E06	GDEhDisVCh_40050	F07	2	CegsMutGDDh1040	E06	VUSN2Hmut_GDN2h_08	F05	VUSMutpDEST2_04	A07	VUSmut_GDEh08	F05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	40551.0	single nucleotide variant	NM_001018005.2(TPM1):c.275T>C (p.Ile92Thr)	7168.0	TPM1	HGNC:12010	Conflicting classifications of pathogenicity	1.0	Jan 19, 2024	199476310.0	-	RCV000036322|RCV000024587|RCV001852573|RCV002433467	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569|MedGen:CN230736	Primary dilated cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	germline	germline	GRCh38	NC_000015.10	15	63057019.0	63057019.0	15q22.2	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017922,Leiden Muscular Dystrophy (TPM1):TPM1_00022	2.0	31891.0	63057019.0	T	C	-	-	-	-	-	-	275T>C 	Ile92Thr	NM_001018005.2	1.0	Conflicting	Conflicting	31891	15	63057019.0	T	C	I	T	rs199476310	15	63349218	15	61136271	92	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.275T>C	p.Ile92Thr	c.275T>C	p.Ile92Thr	alternative1	Y	1	YES	Select	+	ATC	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.027	0.66047	D	0.994	0.90580	D	0.983	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.98	0.96573	H	-4.15	0.75566	D	0.97	0.98762	1.0479	0.98068	D	0.9812	0.99422	D	10	0.93064904	0.92319	D	0.682504	0.97367	D	0.971	0.99671	.	0.87507	.	.	.	0.980339861484	0.97993	.	0.98744	.	0.98645	0.896006286144	0.95980	D	0.985278	0.99906	D	0.585436	0.97298	D	0.603162	0.97255	D	0.999610722064972	0.98146	D	0.849315	0.62192	T	0.8796756	0.89495	0.84244186	0.90881	0.8644084	0.88267	0.88067	0.93523	-13.293	0.90553	D	0.9894	0.96455	P	0.999934270394452	0.98982	0.99971932	0.99643	0.992	0.99727	.	.	.	.	.	.	5.388929	0.90303	31.0	0.99672395626409982	0.78675	0.964035	0.98603	D	0.993227536965325	0.95507	13.7106	0.912815890351302	0.96084	14.31064	5.72	5.72	0.89363	4.46	0.83695	8.017	0.8876	7.949000	0.75828	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.998	0.85369	797	0.45178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hypertrophic_cardiomyopathy|not_provided|Primary_dilated_cardiomyopathy|Cardiovascular_phenotype	criteria_provided,_conflicting_classifications	NC_000015.10:g.63057019T>C	ClinGen:CA017922|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00022	C0007194|C3661900|C0007193|CN230736	.	217569|217604	.	Ile	Thr	98.1	0.5088757396449705																																																																																																																																																																																																																																																																																																																																																																																																																																																																													86			98.1	Aliphatic	Isoleucine		Tropomyosin alpha-1 chain	Coiled coil							0.1229		4.5				P:I92-O:L88 (PDBs: 8EFH, 8EFI, 8ENC)				 I92-E96 (PAE:  1.0), I92-L88 (PAE: 1.0)	I92-L88 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), I92-E96 (PDBs: 8ENC)	 I92-E96 (PAE:  1.0), I92-L88 (PAE: 1.0)	I92-L88 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), I92-E96 (PDBs: 8ENC)							131									-59.2		Pocket 3: Mean pLDDT: 99.38, Volume: 213.68 Å³, Druggability score: 0.12		-49.8						H (helix)	H (α-helix)	Helix											98.1	50.887573	>90	10-90		unknown		Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3		false	0.5693131223497847	0.5671771330603576	false	false	false
ALAS2	ALAS2_Tyr549Phe	B_7-8	-1.2419785938348975	0.3024900913252658	0.3895860245659188	0.11079029450402801	0.9171190802153362	0.9318457985576644	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5259706729896643	0.6166475874381766	0.7473349900650023	0.6045038859564826	0.6711190819101767	0.7951709673851645	0.7951709673851645	0.7404622525335726	0.7528703103407209	0.7473349900650023	0.6166475874381766	0.5259706729896643		0.6017759112867808	0.4561374615722442				ALAS2	Tyr549Phe	NC_000023.11:55009187:T:A	1646A>T	23	55009187	T	A	X	ENSG00000158578	8420	216667	CCSBVarC003772	ALE00003772	ENSP00000337131.4	CEGS2	CegsMutGDEh1042	H07	GDEhDisVCh_40062	F09	2	CegsMutGDDh1042	H07	VUSN2Hmut_GDN2h_08	E12	VUSMutpDEST2_08	E04	VUSmut_GDEh08	E12	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	49400.0	single nucleotide variant	NM_000032.5(ALAS2):c.1757A>T (p.Tyr586Phe)	212.0	ALAS2	HGNC:397	Conflicting classifications of pathogenicity	0.0	Jun 27, 2024	139596860.0	-	RCV000199418|RCV000990842|RCV004698465|RCV000033870	MedGen:C3661900|MONDO:MONDO:0020721,MedGen:C4551511,OMIM:300751,Orphanet:75563|MONDO:MONDO:0010472,MedGen:C4317295,OMIM:300884,Orphanet:324422|MONDO:MONDO:0010420,MedGen:C2677889,OMIM:300752,Orphanet:443197	not provided|X-linked sideroblastic anemia 1|Developmental and epileptic encephalopathy, 36|X-linked erythropoietic protoporphyria	germline;unknown	germline	GRCh38	NC_000023.11	X	55009187.0	55009187.0	Xp11.21	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA323962,UniProtKB:P22557#VAR_066244	3.0	40978.0	55009187.0	T	A	-	-	-	-	-	-	1757A>T 	Tyr586Phe	NM_000032.5	1.0	Conflicting	Conflicting	40978	X	55009187.0	T	A	Y	F	rs139596860	X	55035620	X	55052345	586	ALAS2	ENSG00000158578	ENST00000650242	ENSP00000497236	P22557	HEM0_HUMAN	c.1757A>T	p.Tyr586Phe	c.1757A>T	p.Tyr586Phe	principal1	Y	.	YES	Select	-	TAT	2	0	T	T/T	T/T	T/T	T/T	.	0.32912	.	.	0.27806	.	0.016	0.17346	B	0.01	0.14938	B	.	0.08015	.	.	.	.	0.46	0.12865	N	.	0.23974	.	.	0.16077	-0.0931	0.80167	T	0.6147	0.86335	D	10	0.0068839192	0.00154	T	0.24127	0.88683	D	.	0.59172	.	.	.	.	.	.	0.82913	.	.	.	.	0.586005985737	0.50864	T	0.278107	0.64879	T	-0.283388	0.10079	T	-0.176536	0.56542	T	0.00354568635993432	0.00037	T	0.814619	0.46670	T	0.17343973	0.37787	0.11272655	0.27139	0.19320068	0.40705	0.09825714	0.23377	-3.661	0.19408	T	0.0815	0.08600	B	0.0609707361428915	0.38912	0.99215650	0.97091	0.099	0.27677	.	.	.	.	.	.	1.8376	0.2339	15.98	0.86788329881594373	0.17020	.	.	.	.	.	.	.	.	.	5.39	4.15	0.47919	2.87	0.52470	0.262	0.18291	5.085000	0.47378	0.665	0.62996	0.879	0.31059	1.000000	0.68239	0.991	0.66489	106	0.95645	8	0.002119205298013245	8	0.007976071784646061	0	0.0	0	0.0	0	0.0	0	0.0	555	264690	0.0020967925	.	37	75553	4.897220e-04	0	96	142850	6.720340e-04	0	87	162248	5.362160e-04	0	27	5172	5.220420e-03	0	9	13252	6.791430e-04	0	0	1654	0.000000e+00	0	0	6558	0.000000e+00	0	0	9576	0.000000e+00	0	0	28930	0.000000e+00	0	1	9027	1.107790e-04	0	27	5172	5.220420e-03	0	80	12369	6.467780e-03	0	14	23569	5.940010e-04	0	0	4466	0.000000e+00	0	0	9894	0.000000e+00	0	0	11558	0.000000e+00	0	1	60216	1.660690e-05	0	1	17333	5.769340e-05	0	80	12369	6.467780e-03	0	72	11370	6.332450e-03	0	14	26369	5.309260e-04	0	0	6922	0.000000e+00	0	0	12846	0.000000e+00	0	0	14735	0.000000e+00	0	0	68744	0.000000e+00	0	1	17282	5.786370e-05	0	72	11370	6.332450e-03	0	.	481	1205917	3.988670e-04	1	381	56937	6.691610e-03	0	381	56937	6.691610e-03	0	0	679	0.000000e+00	0	28	45364	6.172300e-04	0	0	21947	0.000000e+00	0	0	33661	0.000000e+00	0	0	46264	0.000000e+00	0	7	4344	1.611420e-03	0	10	893489	1.119210e-05	0	6	55748	1.076270e-04	0	0	15752	0	0	122	0	0	112	0	10	3344	0.0029904306220095694	0	146	0	0	608	0	0	56	0	0	98	0	0	2772	0	10	3466	0.0028851702250432777	0	168	0	10	23010	4.34593654932638E-4	X-linked_sideroblastic_anemia_1|X-linked_erythropoietic_protoporphyria|Developmental_and_epileptic_encephalopathy,_36|not_provided	criteria_provided,_conflicting_classifications	NC_000023.11:g.55009187T>A	ClinGen:CA323962|UniProtKB:P22557#VAR_066244	C4551511|C2677889|C4317295|C3661900	300751|300752|300884	75563|443197|324422	.	Tyr	Phe	56.77	0.6261261261261262																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																56.77	62.61261	50-70	10-90	300751;300884;300752	x-linked	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare inborn errors of metabolism; Rare genetic skin disease	4	ANEMIA, SIDEROBLASTIC, 1; DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36; PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED	false	0.6166475874381766	0.5259706729896643	false	false	false
TH	TH_Glu27Asp	B_7-8	1.7673778966898954	0.12758610808626697	0.1989301766896081	2.1401308466978546	0.06962085850226002	0.09519692649154034	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6138547902057361	0.6325195092015612	0.8061966022506148	0.6752480138350611	0.613926566645173	0.8490452051515682	0.8395531965527194	0.6355128248841525	0.6801795003281839	0.7566072501460588	0.5445896384850383	0.5478615534265834	0.8585372137504169	0.5923403084061936	0.6703165273419383	0.8557859543551709	0.7204493799180842	0.6798480269848888	TH	Glu27Asp	NC_000011.10:2171706:C:A	81G>T	11	2171706	C	A	11	ENSG00000180176	71892	4026	CCSBVarC008303	ALE00008289	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	D12	GDEhDisVCh_40019	B12	1	VUSMutGDDh015	D12	VUSN2Hmut_GDN2h_05	H01	VUSMutpDEST2_15	B10	VUSmut_GDEh05	H01	1.0	3.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	N	Y	Y	Y	Y	684245.0	single nucleotide variant	NM_000360.4(TH):c.81G>T (p.Glu27Asp)	7054.0	TH	HGNC:11782	Conflicting classifications of pathogenicity	0.0	Jul 27, 2024	139742336.0	-	RCV001103468|RCV001585801|RCV003928326	MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150|MedGen:C3661900|	Autosomal recessive DOPA responsive dystonia|not provided|TH-related disorder	germline;unknown	germline	GRCh38	NC_000011.10	11	2171706.0	2171706.0	11p15.5	criteria provided, conflicting classifications	8.0	-	N	-	2.0	695326.0	2171706.0	C	A	-	-	-	-	-	-	81G>T 	Glu27Asp	NM_000360.4	1.0	Conflicting	Conflicting	695326	11	2171706.0	C	A	E	D	rs139742336	11	2192936	11	2149512	27	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.81G>T	p.Glu27Asp	c.81G>T	p.Glu27Asp	.	Y	1	.	.	-	GAG	3	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.051	0.48180	T	0.986	0.64752	D	0.524	0.54709	P	0.0	0.16373	N	simple_aae	100.0	0.0	1.495	0.37283	L	-0.74	0.21585	N	0.252	0.30137	0.9270	0.96047	D	0.9506	0.98389	D	10	0.018453091	0.00398	T	0.753203	0.98030	D	0.373	0.69023	0.156	0.05927	P07101	E27D	Gain of relative solvent accessibility (P = 0.09)| Gain of loop (P = 0.1081)| Gain of MoRF binding (P = 0.1255)| Gain of solvent accessibility (P = 0.1376)| Loss of methylation at R32 (P = 0.1475)	0.992164874492	0.99198	0.1323063566020942	0.12995	0.242980448212	0.26513	0.729948043823	0.71449	T	0.376991	0.73852	T	-0.204667	0.19822	T	-0.0629009	0.65887	T	0.127560182663422	0.14963	T	0.90061	0.65375	D	0.3540841	0.57053	0.2248664	0.47237	0.3540841	0.57054	0.2248664	0.47236	-5.268	0.39673	T	0.2083	0.56998	B	0.284882446035111	0.53641	0.98435575	0.95986	0.056	0.15156	.	.	.	.	.	.	1.889336	0.24043	16.23	0.99537143849547249	0.70311	0.323890	0.42402	N	-0.102871915988097	0.36996	2.165761	-0.0833750436284776	0.35772	2.094979	3.35	2.37	0.28260	.	.	0.026	0.13532	0.201000	0.15920	0.578	0.29426	0.961	0.33751	0.973000	0.29946	0.994	0.71086	988	0.02004	5	9.98402555910543E-4	5	0.0037821482602118004	0	0.0	0	0.0	0	0.0	0	0.0	496	264690	0.0018738902	.	59	108642	5.430680e-04	0	118	206314	5.719440e-04	0	109	235000	4.638300e-04	0	55	7140	7.703080e-03	0	4	17082	2.341650e-04	0	0	2312	0.000000e+00	0	0	9022	0.000000e+00	0	0	12760	0.000000e+00	0	0	42736	0.000000e+00	0	0	15688	0.000000e+00	0	55	7140	7.703080e-03	0	110	16154	6.809460e-03	0	4	30474	1.312590e-04	0	0	6178	0.000000e+00	0	0	13368	0.000000e+00	0	0	16100	0.000000e+00	0	0	88594	0.000000e+00	0	0	30606	0.000000e+00	0	110	16154	6.809460e-03	0	103	14872	6.925770e-03	0	4	34206	1.169390e-04	0	0	9532	0.000000e+00	0	0	17668	0.000000e+00	0	0	20944	0.000000e+00	0	0	101664	0.000000e+00	0	0	30522	0.000000e+00	0	103	14872	6.925770e-03	0	.	511	1612396	3.169200e-04	0	443	75030	5.904300e-03	0	443	75030	5.904300e-03	0	0	912	0.000000e+00	0	18	60012	2.999400e-04	0	0	29582	0.000000e+00	0	0	44868	0.000000e+00	0	0	62952	0.000000e+00	0	3	5724	5.241090e-04	0	15	1179830	1.271370e-05	0	2	91058	2.196400e-05	0	3	56014	5.3558039061663156E-5	1	300	0.0033333333333333335	0	150	0	39	8442	0.004619758351101635	0	152	0	0	632	0	0	56	0	0	104	0	5	4892	0.0010220768601798855	40	8742	0.004575611988103409	0	206	0	48	70742	6.785219530123548E-4	Autosomal_recessive_DOPA_responsive_dystonia|TH-related_disorder|not_provided	criteria_provided,_conflicting_classifications	NC_000011.10:g.2171706C>A	.	C2673535|C3661900	605407	101150	.	Glu	Asp	31.87	0.6804123711340206																																																																																																																																																																																																																																																																																																																																																																																																																																																																													85			32.44	Negatively-charged	Glutamic Acid		Tyrosine 3-monooxygenase								0.4124		-3.5										 E27-S125 (PAE:  21.0)								146									-78.6		Pocket 2: Mean pLDDT: 51.19, Volume: 616.04 Å³, Druggability score: 0.41		-26.4						H (helix)	H (α-helix)												31.87	68.04124	$\leqslant$50	10-90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.6325195092015612	0.6138547902057361	false	false	false
GYG1	GYG1_Ala16Thr	B_7-8	0.46758661170577587	0.6542875728359084	0.7257196655729298	-3.2797566733467027	0.013491583133727178	0.02223832186856719	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6758116372357718	0.6810208614050826	0.627688160667647	0.7596531538333662	0.7197241638108307	0.6857572173596305	0.8625230514362509	0.8185593655817385	0.9036974102367861	0.8187736770971389	0.7905566315032516	0.8154068369640957	0.5089913832830101	0.6208889620399228	0.6156088974299464	0.436602644238155	0.5714850913069134	0.5362164375074479	GYG1	Ala16Thr	NC_000003.12:148994180:G:A	46G>A	3	148994180	G	A	3	ENSG00000163754	3483	1598	CCSBVarC008443	ALE00008473	ENSP00000296048.6	Edgotyping3	VUSmut_GDEh11	G03	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh11	G03	0.0		0.0		0.0			0.0			1.0	1.0	1.0	Y	N	N	N	Y	1630958.0	single nucleotide variant	NM_004130.4(GYG1):c.46G>A (p.Ala16Thr)	2992.0	GYG1	HGNC:4699	Conflicting classifications of pathogenicity	0.0	Jan 06, 2024	200947378.0	-	RCV002119013|RCV004046551|RCV002512176	MONDO:MONDO:0014526,MedGen:C4015452,OMIM:616199,Orphanet:456369;MONDO:MONDO:0013291,MedGen:C3150754,OMIM:613507,Orphanet:263297|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	Polyglucosan body myopathy type 2;Glycogen storage disease XV|Inborn genetic diseases|not provided	germline	germline	GRCh38	NC_000003.12	3	148994180.0	148994180.0	3q24	criteria provided, conflicting classifications	4.0	-	N	-	2.0	1632432.0	148994180.0	G	A	-	-	-	-	-	-	46G>A 	Ala16Thr	NM_004130.4	1.0	Conflicting	Conflicting	1632432	3	148994180.0	G	A	A	T	rs200947378	3	148711967	3	150194657	16	GYG1	ENSG00000163754	ENST00000345003	ENSP00000340736	P46976	GLYG_HUMAN	c.46G>A	p.Ala16Thr	c.46G>A	p.Ala16Thr	.	Y	1	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.086	0.34767	T	0.066	0.48432	T	0.14	0.41256	B	0.039	0.35928	B	0.06	0.23785	N	simple_aae	94.0	6.0	2.55	0.74256	M	-1.7	0.40464	N	0.414	0.45556	-0.8518	0.51652	T	0.1407	0.45848	T	10	0.01212883	0.00258	T	0.018955	0.40952	T	0.125	0.34250	0.607	0.73845	P46976	A16T	Gain of glycosylation at Y15 (P = 0.037)| Loss of catalytic residue at A16 (P = 0.098)| Gain of methylation at K17 (P = 0.0983)| Loss of ubiquitination at K17 (P = 0.1062)| Loss of MoRF binding (P = 0.1728)	0.656629922374	0.65107	0.554284495195052	0.55167	0.105508220992	0.11705	0.639343380928	0.58406	T	0.251625	0.61980	T	-0.372465	0.03317	T	-0.304768	0.43876	T	0.0903793995208192	0.11121	T	0.768423	0.39747	T	0.45805606	0.64234	0.3739901	0.62331	0.539859	0.69090	0.3447308	0.59931	-5.834	0.46094	T	0.1578	0.35076	B	0.0159572984011349	0.27612	0.00927670	0.40444	0.188	0.44481	.	.	.	.	.	.	3.692126	0.52693	23.3	0.99801614418373552	0.88648	0.844488	0.76057	D	0.283108905397718	0.55064	3.693315	0.404740604957056	0.61652	4.392114	5.29	5.29	0.74394	2.61	0.47779	6.403	0.73252	6.629000	0.56213	-0.119	0.14328	1.0	0.71675	1.000000	0.68239	0.922	0.45799	906	0.2308	4	7.987220447284345E-4	0	0.0	0	0.0	0	0.0	0	0.0	4	0.00408997955010225	13	264690	4.9114056E-5	segdup	115	109404	1.051150e-03	1	211	208098	1.013950e-03	2	210	236942	8.862930e-04	2	0	7164	0.000000e+00	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	112	15688	7.139210e-03	1	112	15688	7.139210e-03	1	0	16218	0.000000e+00	0	2	30520	6.553080e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	4	89530	4.467780e-05	0	202	30606	6.600010e-03	2	202	30606	6.600010e-03	2	0	14902	0.000000e+00	0	2	34256	5.838390e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	3	102748	2.919760e-05	0	202	30524	6.617740e-03	2	202	30524	6.617740e-03	2	.	739	1613466	4.580200e-04	9	635	91058	6.973580e-03	9	4	74858	5.343450e-05	0	0	912	0.000000e+00	0	2	59980	3.334440e-05	0	0	29604	0.000000e+00	0	0	44842	0.000000e+00	0	0	63926	0.000000e+00	0	12	6062	1.979540e-03	0	52	1179732	4.407780e-05	0	635	91058	6.973580e-03	9	6	35174	1.7058054244612497E-4	0	116	0	0	110	0	0	3362	0	0	500	0	0	628	0	0	54	0	0	94	0	2	7034	2.843332385555871E-4	0	3478	0	0	164	0	8	47072	1.699524133242692E-4	not_provided|Inborn_genetic_diseases|Polyglucosan_body_myopathy_type_2|Glycogen_storage_disease_XV	criteria_provided,_conflicting_classifications	NC_000003.12:g.148994180G>A	.	C3661900|C0950123|C4015452|C3150754	616199|613507	456369|263297	.	Ala	Thr	98.03	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.03	Aliphatic	Alanine		Glycogenin-1										1.8								 A16-L20 (PAE:  1.0), A16-N12 (PAE: 1.0)	A16-N12 (PDBs: 3U2T, 6EQJ, 3T7M, 3T7N, 3T7O, 3U2U, 3U2V, 3U2X, 6EQL), A16-L20 (PDBs: 6EQJ, 6EQL)	 A16-L20 (PAE:  1.0), A16-T10 (PAE: 1.0), A16-N12 (PAE: 1.0)	A16-N12 (PDBs: 3U2T, 6EQJ, 3T7M, 3T7N, 3T7O, 3U2U, 3U2V, 3U2X, 6EQL), A16-L20 (PDBs: 6EQJ, 6EQL), A16-T10 (PDBs: 6EQL)							89									-61.1				-33.4						H (helix)	H (α-helix)	Helix											98.03	0.0	>90	<10	616199;613507	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	POLYGLUCOSAN BODY MYOPATHY 2; GLYCOGEN STORAGE DISEASE XV	false	0.6810208614050826	0.6758116372357718	false	false	false
GYG1	GYG1_Arg33Lys	B_7-8	1.8513025770418732	0.10656320802744484	0.1725905997762311	-2.1112632206814244	0.07265278007230343	0.09875396402420503	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6284906056988442	0.6634598172637596	0.5140287295406717	0.6082640494347051	0.5331671055961906	0.527350269307979	0.4319016027475302	0.6274325975686966	0.6340471749809409	0.40524617088936465	0.6772849229964005	0.6775491016622586	0.6227989358684277	0.4389016136236847	0.5824809238884693	0.6228112881919787	0.6496347115311185	0.5794321097354298	GYG1	Arg33Lys	NC_000003.12:148994232:G:A	98G>A	3	148994232	G	A	3	ENSG00000163754	3483	1599	CCSBVarC008444	ALE00008440	ENSP00000296048.6	Edgotyping3	VUSmut_GDEh11	E07	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSmut_GDEh11	E07	0.0		0.0		0.0			0.0			1.0	1.0	1.0	Y	N	N	N	Y	518913.0	single nucleotide variant	NM_004130.4(GYG1):c.98G>A (p.Arg33Lys)	2992.0	GYG1	HGNC:4699	Conflicting classifications of pathogenicity	0.0	Jan 22, 2024	146101365.0	-	RCV000652499|RCV001532010|RCV004754519	MONDO:MONDO:0013291,MedGen:C3150754,OMIM:613507,Orphanet:263297;MONDO:MONDO:0014526,MedGen:C4015452,OMIM:616199,Orphanet:456369|MedGen:C3661900|	Glycogen storage disease XV;Polyglucosan body myopathy type 2|not provided|GYG1-related disorder	germline	germline	GRCh38	NC_000003.12	3	148994232.0	148994232.0	3q24	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA2658455	2.0	542121.0	148994232.0	G	A	-	-	-	-	-	-	98G>A 	Arg33Lys	NM_004130.4	1.0	Conflicting	Conflicting	542121	3	148994232.0	G	A	R	K	rs146101365	3	148712019	3	150194709	33	GYG1	ENSG00000163754	ENST00000345003	ENSP00000340736	P46976	GLYG_HUMAN	c.98G>A	p.Arg33Lys	c.98G>A	p.Arg33Lys	.	Y	1	YES	Select	+	AGG	2	0	G	./.	./.	./.	./.	0.206	0.20867	T	0.207	0.27269	T	0.105	0.26009	B	0.131	0.32953	B	0.0	0.05039	N	simple_aae	100.0	0.0	0.875	0.21401	L	-2.14	0.50354	N	0.333	0.40216	-0.9206	0.45279	T	0.1448	0.46600	T	10	0.013021946	0.00274	T	0.007242	0.18925	T	0.122	0.33595	.	.	.	.	.	0.775885925759	0.77205	0.5510947517954192	0.54847	0.104161591028	0.11559	0.383904278278	0.22784	T	0.291834	0.66270	T	-0.35641	0.04171	T	-0.288099	0.45630	T	0.0188382588328725	0.00593	T	0.694731	0.30191	T	0.4460754	0.63474	0.2043205	0.44391	0.54328907	0.69283	0.22091916	0.46711	-4.536	0.38099	T	0.1101	0.36192	B	0.134758069947158	0.46084	0.00738505	0.37770	0.058	0.15819	.	.	.	.	.	.	3.619496	0.51294	23.1	0.9836412009427874	0.40810	0.454375	0.50540	N	-0.084534632035142	0.37798	2.224175	0.104357937477414	0.44493	2.752456	5.31	4.31	0.50660	3.46	0.62650	3.093	0.50008	6.467000	0.55774	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.793	0.3747	906	0.2308	3	5.990415335463259E-4	0	0.0	2	0.0019880715705765406	0	0.0	0	0.0	1	0.0010224948875255625	274	264690	0.0010351732	segdup	166	109402	1.517340e-03	0	308	208104	1.480030e-03	0	353	236934	1.489870e-03	1	2	7164	2.791740e-04	0	7	17110	4.091170e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	18	13392	1.344090e-03	0	125	42768	2.922750e-03	0	12	15688	7.649160e-04	0	125	42768	2.922750e-03	0	6	16216	3.700050e-04	0	13	30522	4.259220e-04	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	24	16732	1.434380e-03	0	238	89540	2.658030e-03	0	19	30606	6.207930e-04	0	238	89540	2.658030e-03	0	6	14902	4.026310e-04	0	14	34258	4.086640e-04	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	29	21630	1.340730e-03	0	274	102740	2.666930e-03	1	19	30524	6.224610e-04	0	274	102740	2.666930e-03	1	.	3081	1613892	1.909050e-03	5	2798	1179844	2.371500e-03	4	24	74994	3.200260e-04	0	0	910	0.000000e+00	0	21	60018	3.498950e-04	0	0	29604	0.000000e+00	0	0	44882	0.000000e+00	0	78	63990	1.218940e-03	0	10	6062	1.649620e-03	0	2798	1179844	2.371500e-03	4	66	91078	7.246540e-04	1	223	101378	0.0021996882952908916	0	308	0	0	146	0	3	8652	3.4674063800277393E-4	0	500	0	0	648	0	0	82	0	0	104	0	20	11168	0.0017908309455587394	3	8960	3.348214285714286E-4	0	228	0	246	122986	0.002000227668189875	not_provided|Polyglucosan_body_myopathy_type_2|Glycogen_storage_disease_XV	criteria_provided,_conflicting_classifications	NC_000003.12:g.148994232G>A	ClinGen:CA2658455	C3661900|C4015452|C3150754	616199|613507	456369|263297	.	Arg	Lys	98.47	0.16532258064516128																																																																																																																																																																																																																																																																																																																																																																																																																																																																													41			98.47	Positively-charged	Arginine		Glycogenin-1										-4.5								 R33-Q4 (PAE:  1.0), R33-D112 (PAE: 1.0)	R33-Q4 (PDBs: 3U2T, 6EQJ, 3T7M, 3T7N, 3T7O, 3U2U, 3U2V, 3U2X, 6EQL)	 R33-M1 (PAE:  4.5), R33-Q4 (PAE: 1.0)	R33-Q4 (PDBs: 3U2T, 6EQJ, 3T7O, 3U2X, 6EQL), R33-M1 (PDBs: 3T7M, 3T7N, 3U2U, 3U2V, 6EQL)							175									-100.7				163.5						C (loop/coil)	S (bend)	Beta strand											98.47	16.532259	>90	10-90	613507;616199	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE XV; POLYGLUCOSAN BODY MYOPATHY 2	false	0.6634598172637596	0.6284906056988442	false	false	false
DES	DES_Ala213Val	B_7-8	-1.6659599252612116	0.146772484001518	0.2221358513810613	-0.07605005178348441	0.9415071896029289	0.9518819244745865	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6459022801229168	0.6613453567175639	0.660875444983073	0.7241596045877258	0.6183790241927913	0.6397011054519718	0.9378435748562222	0.9326021361288483	0.937901604387797	0.8988587250155909	0.7861902621121358	0.7892128495393178	0.34155863604772135	0.30415591225673444	0.5104176047876545	0.4228921649505552	0.536500451322992	0.502591710706516	DES	Ala213Val	NC_000002.12:219420154:C:T	638C>T	2	219420154	C	T	2	ENSG00000175084	12573	2264	CCSBVarC007825	ALE00007811	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	G05	GDEhDisVCh_40003	A06	1	VUSMutGDDh003	G05	VUSN2Hmut_GDN2h_01	A03	NULL	NULL	VUSmut_GDEh01	A03	1.0	1.0	1.0	6.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	N	Y	N	Y	53432.0	single nucleotide variant	NM_001927.4(DES):c.638C>T (p.Ala213Val)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	1.0	Feb 01, 2024	41272699.0	-	RCV000056805|RCV000250294|RCV000037245|RCV000203295|RCV000239721|RCV000263666|RCV000313133|RCV000367823|RCV001083932|RCV001171067	MedGen:C3661900|MedGen:CN230736|MedGen:CN169374|Human Phenotype Ontology:HP:0000776,Human Phenotype Ontology:HP:0006604,MONDO:MONDO:0005711,MeSH:D065630,MedGen:C0235833,OMIM:PS142340,Orphanet:2140|Human Phenotype Ontology:HP:0003715,MONDO:MONDO:0018943,MedGen:C2678065,OMIM:PS601419,Orphanet:593|MedGen:CN239446|MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154|MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848	not provided|Cardiovascular phenotype|not specified|Congenital diaphragmatic hernia|Myofibrillar myopathy|Myofibrillar Myopathy, Dominant|Dilated cardiomyopathy 1I|Neurogenic scapuloperoneal syndrome, Kaeser type|Desmin-related myofibrillar myopathy|Cardiomyopathy	germline;unknown	germline	GRCh38	NC_000002.12	2	219420154.0	219420154.0	2q35	criteria provided, conflicting classifications	22.0	ACMG2022	N	ClinGen:CA133860,UniProtKB:P17661#VAR_042451	2.0	44265.0	219420154.0	C	T	-	-	-	-	-	-	638C>T 	Ala213Val	NM_001927.4	1.0	Conflicting	Conflicting	44265	2	219420154.0	C	T	A	V	rs41272699	2	220284876	2	219993120	213	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.638C>T	p.Ala213Val	c.638C>T	p.Ala213Val	principal1	Y	1	YES	Select	+	GCG	2	0	C	C/C	C/C	C/C	C/C	0.003	0.68399	D	0.008	0.68204	D	0.896	0.49337	P	0.42	0.45079	B	0.21	0.45549	N	simple_aae	79.0	21.0	1.475	0.36913	L	-1.33	0.33171	N	0.589	0.60716	0.0041	0.82263	D	0.4049	0.75406	T	10	0.013873875	0.00289	T	.	.	.	0.362	0.68061	.	.	.	.	.	.	.	0.6188528821935099	0.61642	0.010741408872	0.00955	0.625550031662	0.56447	T	0.458698	0.79504	T	-0.324065	0.06380	T	-0.223993	0.52031	T	0.0168365968482842	0.00435	T	0.911209	0.68451	D	0.39832652	0.60291	0.37413678	0.62341	0.39832652	0.60292	0.37413678	0.62341	-5.977	0.46145	T	0.255	0.48973	B	0.696768021839026	0.66917	0.53389007	0.82616	0.292	0.56112	.	.	.	.	.	.	4.403811	0.68134	25.2	0.9990110878427193	0.97276	0.832121	0.74963	D	0.165067119769497	0.49282	3.152133	0.179269224704537	0.48449	3.083494	4.56	3.67	0.41167	-1.76	0.12471	1.514	0.35547	4.851000	0.45453	0.549	0.27038	0.803	0.29851	1.000000	0.68239	0.964	0.52647	86	0.96402	28	0.005591054313099041	0	0.0	19	0.018886679920477135	6	0.008645533141210375	0	0.0	3	0.003067484662576687	2550	264690	0.009633912	.	1016	109404	9.286680e-03	17	1875	208128	9.008880e-03	22	2129	236940	8.985400e-03	22	21	7162	2.932140e-03	0	106	17110	6.195210e-03	2	4	2320	1.724140e-03	0	0	9046	0.000000e+00	0	94	13394	7.018070e-03	3	712	42768	1.664800e-02	11	61	15690	3.887830e-03	1	712	42768	1.664800e-02	11	54	16216	3.330040e-03	0	164	30522	5.373170e-03	2	8	6212	1.287830e-03	0	1	13416	7.453790e-05	0	124	16734	7.410060e-03	3	1380	89554	1.540970e-02	15	104	30608	3.397800e-03	1	1380	89554	1.540970e-02	15	48	14900	3.221480e-03	0	197	34258	5.750480e-03	2	12	9572	1.253660e-03	0	1	17692	5.652270e-05	0	159	21632	7.350220e-03	3	1555	102740	1.513530e-02	15	104	30526	3.406930e-03	1	1555	102740	1.513530e-02	15	.	22813	1614216	1.413260e-02	233	21	912	2.302630e-02	0	221	75062	2.944230e-03	1	21	912	2.302630e-02	0	419	60030	6.979840e-03	4	46	29608	1.553630e-03	0	2	44882	4.456130e-05	0	571	64044	8.915750e-03	9	12	6062	1.979540e-03	0	20405	1180018	1.729210e-02	211	314	91086	3.447290e-03	1	3211	214654	0.014958957205549395	1	436	0.0022935779816513763	0	4802	0	45	11584	0.003884668508287293	13	1186	0.010961214165261383	9	1284	0.007009345794392523	0	1890	0	1	360	0.002777777777777778	219	20516	0.010674595437707156	46	12020	0.003826955074875208	0	6692	0	3499	256712	0.013630060145221104	Cardiomyopathy|Myofibrillar_Myopathy,_Dominant|Dilated_cardiomyopathy_1I|Cardiovascular_phenotype|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type|Congenital_diaphragmatic_hernia|not_provided|Desmin-related_myofibrillar_myopathy|not_specified|Myofibrillar_myopathy	criteria_provided,_conflicting_classifications	NC_000002.12:g.219420154C>T	ClinGen:CA133860|UniProtKB:P17661#VAR_042451	C0878544|CN239446|C1858154|CN230736|C1867005|C0235833|C3661900|C1832370|CN169374|C2678065	604765|181400|PS142340|601419|PS601419	167848|154|85146|2140|363543|98909|593	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ala	Val	96.16	0.5188679245283019																																																																																																																																																																																																																																																																																																																																																																																																																																																																													55			96.16	Aliphatic	Alanine		Desmin							IF rod			1.8								 A213-A209 (PAE:  1.0), A213-A217 (PAE: 1.0)		 A213-A209 (PAE:  1.0), A213-A217 (PAE: 1.0)								89									-60.6				-40.6	Coil 1B					H (helix)	H (α-helix)												96.16	51.88679	>90	10-90	604765;181400;601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	CARDIOMYOPATHY, DILATED, 1I; SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; MYOPATHY, MYOFIBRILLAR, 1	false	0.6613453567175639	0.6459022801229168	false	false	false
AGXT	AGXT_Ile279Thr	B_7-8	-1.7121985069289054	0.14753834017229125	0.22283651538840693	-4.6774190880570155	0.01846021147715831	0.02927786349229516	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7551852715681702	0.8233411262406076	0.6483588711831252	0.7088013094999238	0.5783696832909565	0.6642965587530352							0.6642965587530352	0.5783696832909565	0.7088013094999238	0.6483588711831252	0.8233411262406076	0.7551852715681702	AGXT	Ile279Thr	NC_000002.12:240875994:T:C	836T>C	2	240875994	T	C	2	ENSG00000172482	70497	3865	CCSBVarC008217	ALE00008203	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	D08	GDEhDisVCh_40002	B10	2	VUSMutGDDh004	D08	VUSN2Hmut_GDN2h_01	A09	VUSMutpDEST2_14	F09	VUSmut_GDEh01	A09	1.0	1.0	1.0	3.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	195847.0	single nucleotide variant	NM_000030.3(AGXT):c.836T>C (p.Ile279Thr)	189.0	AGXT	HGNC:341	Conflicting classifications of pathogenicity	0.0	May 07, 2024	140992177.0	-	RCV000180093|RCV000186256|RCV000966394|RCV003937630	MedGen:CN169374|MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900|	not specified|Primary hyperoxaluria, type I|not provided|AGXT-related disorder	germline;unknown	germline	GRCh38	NC_000002.12	2	240875994.0	240875994.0	2q37.3	criteria provided, conflicting classifications	12.0	-	N	ClinGen:CA203554,UniProtKB:P21549#VAR_060564,ClinVar:2681193	2.0	198686.0	240875994.0	T	C	-	-	-	-	-	-	836T>C 	Ile279Thr	NM_000030.3	1.0	Conflicting	Conflicting	198686	2	240875994.0	T	C	I	T	rs140992177	2	241815411	2	241464084	279	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.836T>C	p.Ile279Thr	c.836T>C	p.Ile279Thr	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.003	0.68399	D	0.006	0.70891	D	0.792	0.44702	P	0.767	0.56714	P	0.46	0.68318	N	simple_aae	54.0	46.0	.	.	.	-2.96	0.61754	D	0.851	0.84673	0.1018	0.84139	D	0.6856	0.89104	D	10	0.13906038	0.26125	T	0.642905	0.96955	D	0.551	0.81332	.	.	.	.	.	0.891630298008	0.88973	0.9228642908896372	0.92214	0.166420106522	0.18504	0.401479363441	0.25245	T	0.688609	0.90835	D	-0.112958	0.33923	T	0.0638117	0.74308	D	0.0745431843955837	0.09162	T	0.938306	0.76748	D	0.54239595	0.69231	0.3828894	0.63018	0.54239595	0.69233	0.3828894	0.63018	-9.843	0.73045	D	0.2204	0.45126	B	0.751731992522924	0.68866	0.17815484	0.72016	0.832	0.90743	.	.	.	.	.	.	3.640251	0.51695	23.1	0.99063147141110597	0.51612	0.930850	0.91847	D	0.324557321722741	0.57193	3.908379	0.190109641914516	0.49042	3.135197	4.91	4.91	0.63852	2.45	0.45325	5.19	0.65023	7.598000	0.61527	0.663	0.56753	0.725	0.28963	0.990000	0.31395	0.024	0.12278	982	0.03399	8	0.001597444089456869	0	0.0	1	9.940357852882703E-4	0	0.0	2	0.001984126984126984	5	0.005112474437627812	444	264690	0.001677434	.	183	109356	1.673430e-03	0	387	207908	1.861400e-03	0	416	236848	1.756400e-03	0	2	7160	2.793300e-04	0	8	17100	4.678360e-04	0	0	2320	0.000000e+00	0	2	9044	2.211410e-04	0	4	13392	2.986860e-04	0	132	42744	3.088150e-03	0	32	15682	2.040560e-03	0	132	42744	3.088150e-03	0	8	16192	4.940710e-04	0	11	30496	3.607030e-04	0	2	6204	3.223730e-04	0	2	13408	1.491650e-04	0	7	16732	4.183600e-04	0	278	89416	3.109060e-03	0	71	30600	2.320260e-03	0	278	89416	3.109060e-03	0	8	14890	5.372730e-04	0	15	34232	4.381860e-04	0	3	9570	3.134800e-04	0	2	17690	1.130580e-04	0	12	21628	5.548360e-04	0	298	102700	2.901660e-03	0	71	30518	2.326500e-03	0	298	102700	2.901660e-03	0	.	4677	1614098	2.897590e-03	11	4205	1179988	3.563600e-03	10	28	75042	3.731240e-04	0	0	910	0.000000e+00	0	29	60020	4.831720e-04	0	9	29606	3.039920e-04	0	2	44876	4.456730e-05	0	42	64012	6.561270e-04	0	6	6062	9.897720e-04	0	4205	1179988	3.563600e-03	10	214	91070	2.349840e-03	0	363	124776	0.0029092133102519716	0	308	0	1	1940	5.154639175257732E-4	2	8684	2.3030861354214648E-4	0	506	0	1	650	0.0015384615384615385	0	1248	0	1	104	0.009615384615384616	34	16450	0.0020668693009118543	2	8992	2.2241992882562276E-4	1	3188	3.136762860727729E-4	402	154666	0.00259914913426351	AGXT-related_disorder|not_specified|not_provided|Primary_hyperoxaluria,_type_I	criteria_provided,_conflicting_classifications	NC_000002.12:g.240875994T>C	ClinGen:CA203554|UniProtKB:P21549#VAR_060564	CN169374|C3661900|C0268164	259900	416|93598	Aminotransferase class V domain	Ile	Thr	98.85	0.05917159763313609																																																																																																																																																																																																																																																																																																																																																																																																																																																																													10			98.85	Aliphatic	Isoleucine		Alanine--glyoxylate aminotransferase										4.5								 I279-S275 (PAE:  1.0), I279-G283 (PAE: 1.0)	I279-G283 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), I279-S275 (PDBs: 6RV1, 3R9A)	 I279-S275 (PAE:  1.0), I279-G283 (PAE: 1.0)	I279-G283 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), I279-S275 (PDBs: 6RV1, 3R9A), I279-S287 (PDBs: 6RV1, 3R9A)							131									-72.3				-29.0				dbSNP: rs180177277; Variant type: LP/P; AA change: Ile279Met; PTM type: Phosphorylation; PTM morphology: YSLREsLALI*A; Var class: II&rs140992177		H (helix)	H (α-helix)	Helix											98.85	5.91716	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.8233411262406076	0.7551852715681702	false	false	false
TMEM43	TMEM43_Arg220Cys	B_15-16	-5.114964270701266	0.001376420511415188	0.005921088236042813	-4.538647307881698	0.002672001389706827	0.005447913944568919	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.542819534298254	0.6127298057157677	0.453204502266755	0.6234183337360422	0.628170966511516	0.4913106446721822	0.45726937691714925	0.5520572619690808	0.5782735567345275	0.4190440287607269	0.5966066263962978	0.5052056891826712	0.5253519124272151	0.7042846710539514	0.6685631107375567	0.4873649757727832	0.6288529850352376	0.5804333794138368	TMEM43	Arg220Cys	NC_000003.12:14134844:C:T	658C>T	3	14134844	C	T	3	ENSG00000170876	3438	288	CCSBVarC008441	ALE00008461	ENSP00000303992.5	Edgotyping3	VUSmut_GDEh11	D08	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_03	F05	VUSmut_GDEh11	D08	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	2.0	Y	N	N	Y	Y	178509.0	single nucleotide variant	NM_024334.3(TMEM43):c.658C>T (p.Arg220Cys)	79188.0	TMEM43	HGNC:28472	Conflicting classifications of pathogenicity	0.0	Jul 29, 2024	562700595.0	-	RCV000157522|RCV001372283|RCV001191324|RCV001701624|RCV002372027	MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|MONDO:MONDO:0011459,MedGen:C1858379,OMIM:604400|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MedGen:C3661900|MedGen:CN230736	Primary familial hypertrophic cardiomyopathy|Arrhythmogenic right ventricular dysplasia 5|Cardiomyopathy|not provided|Cardiovascular phenotype	germline	germline	GRCh38	NC_000003.12	3	14134844.0	14134844.0	3p25.1	criteria provided, conflicting classifications	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA024733	2.0	180543.0	14134844.0	C	T	-	-	-	-	-	-	658C>T 	Arg220Cys	NM_024334.3	1.0	Conflicting	Conflicting	180543	3	14134844.0	C	T	R	C	rs562700595	3	14176344	3	14151345	220	TMEM43	ENSG00000170876	ENST00000306077	ENSP00000303992	Q9BTV4	TMM43_HUMAN	c.658C>T	p.Arg220Cys	c.658C>T	p.Arg220Cys	principal1	Y	1	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	0.094	0.31523	T	0.063	0.45460	T	0.998	0.73231	D	0.84	0.60164	P	0.19	0.42965	N	simple_aae	81.0	19.0	2.015	0.54854	M	-0.97	0.25723	N	0.684	0.68886	-1.0379	0.17938	T	0.0799	0.31484	T	10	0.66139054	0.69906	D	0.031541	0.53411	D	0.121	0.33376	0.574	0.69717	Q9BTV4	R220C	Gain of sheet (P = 0.0085)| Gain of loop (P = 0.0435)| Loss of disorder (P = 0.0881)| Gain of catalytic residue at F225 (P = 0.1617)| Loss of solvent accessibility (P = 0.239)	0.542408980405	0.53554	0.543343270603609	0.54070	0.433128464994	0.43192	0.567520856857	0.48261	T	0.021062	0.16348	T	-0.250584	0.13758	T	-0.277714	0.46702	T	0.188966291021985	0.19539	T	0.882712	0.60261	D	0.122498415	0.28533	0.041794937	0.04848	0.1224451	0.28520	0.050339524	0.07896	-9.078	0.68275	D	0.2951	0.52570	B	0.672703267660818	0.66116	0.96513110	0.94302	0.19	0.44764	.	.	.	.	.	.	4.908856	0.80786	27.4	0.9989349805525527	0.96668	0.409467	0.47896	N	0.00507660748024311	0.41823	2.529199	0.126355643070262	0.45627	2.845217	5.33	4.46	0.53511	.	.	3.675	0.54431	7.615000	0.62126	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.993	0.69292	830	0.39194	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	3	109394	2.742380e-05	0	9	208088	4.325090e-05	0	10	236764	4.223620e-05	0	0	7158	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	2	9046	2.210920e-04	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	1	15690	6.373490e-05	0	2	9046	2.210920e-04	0	0	16208	0.000000e+00	0	0	30514	0.000000e+00	0	0	6210	0.000000e+00	0	6	13414	4.472940e-04	0	0	16734	0.000000e+00	0	0	89536	0.000000e+00	0	3	30608	9.801360e-05	0	6	13414	4.472940e-04	0	0	14896	0.000000e+00	0	0	34242	0.000000e+00	0	0	9556	0.000000e+00	0	7	17692	3.956590e-04	0	0	21632	0.000000e+00	0	0	102600	0.000000e+00	0	3	30526	9.827690e-05	0	7	17692	3.956590e-04	0	.	40	1614182	2.478040e-05	0	14	44870	3.120120e-04	0	3	75052	3.997230e-05	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29606	0.000000e+00	0	14	44870	3.120120e-04	0	0	64030	0.000000e+00	0	0	6062	0.000000e+00	0	15	1180030	1.271150e-05	0	5	91086	5.489320e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	not_provided|Arrhythmogenic_right_ventricular_dysplasia_5|Cardiovascular_phenotype|Primary_familial_hypertrophic_cardiomyopathy|Cardiomyopathy	criteria_provided,_conflicting_classifications	NC_000003.12:g.14134844C>T	ClinGen:CA024733	C3661900|C1858379|CN230736|C0949658|C0878544	604400|PS192600	155|167848	.	Arg	Cys	92.4	0.3225806451612903																																																																																																																																																																																																																																																																																																																																																																																																																																																																													80			92.4	Positively-charged	Arginine		Transmembrane protein 43										-4.5								 R220-S209 (PAE:  2.5), R220-D213 (PAE: 2.5), R220-L208 (PAE: 2.0)		 R220-D213 (PAE:  2.5), R220-L208 (PAE: 2.0)		 R220-D213 (PAE:  2.5)						175									-86.8				131.6						B (undefined)	E (parallel sheets)							Perinuclear space					92.4	32.258064	>90	10-90	604400	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5	false	0.6127298057157677	0.542819534298254	false	false	false
DCX	DCX_Arg186His	B_7-8	3.6010330692318058	0.011352419630740547	0.029866558532664525	3.0302219082120456	0.019108612651670513	0.03020181241672299	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7089313038016298	0.7085385185600797	0.7166667114836807	0.48904921191555445	0.5453449031897722	0.7331984608886929	0.8072204362274846	0.5338889111171121	0.5422175697584424	0.7934860041832195	0.7369930198140253	0.7677225195167431	0.6591764855499012	0.5568008952624324	0.4358808540726665	0.6398474187841418	0.6800840173061341	0.6501400880865166	DCX	Arg186His	NC_000023.11:111401138:C:T	557G>A	23	111401138	C	T	X	ENSG00000077279	8416	216642	CCSBVarC005196	ALE00005196	ENSP00000419861.1	CEGS2	CegsMutGDEh1041	D02	GDEhDisVCh_40049	H07	1	CegsMutGDDh1041	D02	VUSN2Hmut_GDN2h_08	G07	VUSMutpDEST2_08	E01	VUSmut_GDEh08	G07	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	169882.0	single nucleotide variant	NM_001195553.2(DCX):c.557G>A (p.Arg186His)	1641.0	DCX	HGNC:2714	Conflicting classifications of pathogenicity	1.0	Feb 14, 2023	587783563.0	-	RCV000145859|RCV000680148|RCV002274944|RCV003128580	MedGen:C0008519|MONDO:MONDO:0010239,MedGen:C4551968,OMIM:300067,Orphanet:2148|Human Phenotype Ontology:HP:0001250,Human Phenotype Ontology:HP:0001275,Human Phenotype Ontology:HP:0001303,Human Phenotype Ontology:HP:0002125,Human Phenotype Ontology:HP:0002182,Human Phenotype Ontology:HP:0002279,Human Phenotype Ontology:HP:0002306,Human Phenotype Ontology:HP:0002348,Human Phenotype Ontology:HP:0002391,Human Phenotype Ontology:HP:0002417,Human Phenotype Ontology:HP:0002430,Human Phenotype Ontology:HP:0002431,Human Phenotype Ontology:HP:0002432,Human Phenotype Ontology:HP:0002434,Human Phenotype Ontology:HP:0002437,Human Phenotype Ontology:HP:0002466,Human Phenotype Ontology:HP:0002479,Human Phenotype Ontology:HP:0002794,Human Phenotype Ontology:HP:0006997,Human Phenotype Ontology:HP:0010520,MedGen:C0036572|MedGen:C3661900	Ectopic tissue|Lissencephaly type 1 due to doublecortin gene mutation|Seizure|not provided	de novo;germline	germline	GRCh38	NC_000023.11	X	111401138.0	111401138.0	Xq23	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA171995	2.0	158477.0	111401138.0	C	T	-	-	-	-	-	-	557G>A 	Arg186His	NM_001195553.2	1.0	Conflicting	Conflicting	158477	X	111401138.0	C	T	R	H	rs587783563	X	110644366	X	110531022	186	DCX	ENSG00000077279	ENST00000635795	ENSP00000489635	O43602	DCX_HUMAN	c.557G>A	p.Arg186His	c.557G>A	p.Arg186His	alternative1	Y	1	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.72530	.	.	.	.	.	.	.	.	0.99291	.	.	.	.	.	.	.	.	0.72967	.	.	0.96886	1.0607	0.98353	D	0.9185	0.97296	D	10	0.9195298	0.91212	D	0.913073	0.99352	D	.	0.97887	.	.	.	.	.	.	0.99960	.	0.96898	.	.	0.853522896767	0.90128	D	.	0.75980	.	0.655733	0.99892	D	0.704139	0.99891	D	0.997337639331818	0.91238	D	0.940306	0.77428	D	0.92684865	0.93830	0.86720216	0.92575	0.91788983	0.92942	0.828491	0.89958	-12.7	0.88117	D	0.9917	0.94148	LP	0.992635019413731	0.89614	0.99966908	0.99591	0.973	0.98982	.	.	.	.	.	.	4.86582	0.79706	27.2	0.99935801605069219	0.99621	.	.	.	.	.	.	.	.	.	4.74	4.74	0.59667	4.4	0.82834	6.168	0.71848	7.638000	0.63114	0.599	0.40292	1.0	0.71675	1.000000	0.68239	1.0	0.97202	889	0.27289	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	13024	7.678132678132678E-5	0	92	0	0	110	0	0	3222	0	0	146	0	0	610	0	0	54	0	0	94	0	0	2794	0	0	3314	0	0	164	0	1	20146	4.963764519011218E-5	Lissencephaly_type_1_due_to_doublecortin_gene_mutation|Seizure|not_provided|Ectopic_tissue	criteria_provided,_conflicting_classifications	NC_000023.11:g.111401138C>T	ClinGen:CA171995	C4551968|C0036572|C3661900|C0008519	300067	2148	.	Arg	His	83.94	0.20161290322580644																																																																																																																																																																																																																																																																																																																																																																																																																																																																													50			83.94	Positively-charged	Arginine		Neuronal migration protein doublecortin							Doublecortin 2			-4.5								 R186-E221 (PAE:  6.0), R186-K193 (PAE: 3.0), R186-E255 (PAE: 9.5)			R186-R192 (PDBs: 6FNZ)							175									-70.8				124.1						B (undefined)	E (parallel sheets)	Beta strand											83.94	20.161291	70-90	10-90	300067	x-linked	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2	LISSENCEPHALY, X-LINKED, 1	false	0.7085385185600797	0.7089313038016298	false	false	false
SMAD3	SMAD3_Trp94Leu	B_15-16	-0.8753706257859403	0.4104008292533864	0.5024779383807487	-6.641025376143156	0.00029294506974572533	0.0009064994991288465	2025_03_Batch_15-16	true	true	false	false	false	false	true	true	false	false	false	false	0.9820841950304083	0.9818302328931098	0.5590397336006212	0.6923424729088072	0.6506623798222193	0.5785530817346769	0.5858117590372718	0.6479810546251533	0.7681462925213485	0.5794842303051053	0.9872850225036587	0.9837349037983392	0.5712944044320819	0.6533437050192854	0.6165386532962659	0.538595236896137	0.9763754432825609	0.9804334862624775	SMAD3	Trp94Leu	NC_000015.10:67164969:G:T	281G>T	15	67164969	G	T	15	ENSG00000166949	11805	2121	CCSBVarC007709	ALE00007695	ENSP00000332973.4	Edgotyping3	VUSMutGDEh004	F10	GDEhDisVCh_40014	F05	2	VUSMutGDDh004	F10	VUSN2Hmut_GDN2h_01	H09	VUSMutpDEST2_09	D01	VUSmut_GDEh01	H09	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	360980.0	single nucleotide variant	NM_005902.4(SMAD3):c.281G>T (p.Trp94Leu)	4088.0	SMAD3	HGNC:6769	Conflicting classifications of pathogenicity	1.0	Mar 20, 2019	1057518977.0	-	RCV000415342|RCV001197056	Human Phenotype Ontology:HP:0002617,MedGen:C0002940|MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984	Vascular dilatation|Aneurysm-osteoarthritis syndrome	unknown	unknown	GRCh38	NC_000015.10	15	67164969.0	67164969.0	15q22.33	criteria provided, conflicting classifications	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA16043497	2.0	374207.0	67164969.0	G	T	-	-	-	-	-	-	281G>T 	Trp94Leu	NM_005902.4	1.0	Conflicting	Conflicting	374207	15	67164969.0	G	T	W	L	rs1057518977	15	67457307	15	65244361	94	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.281G>T	p.Trp94Leu	c.281G>T	p.Trp94Leu	principal1	Y	1	YES	Select	+	TGG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.992	0.64752	D	0.943	0.67917	D	0.98	0.99291	A	simple_aae	2.0	98.0	3.74	0.94857	H	-11.9	0.99585	D	0.893	0.89230	0.9505	0.96391	D	0.8419	0.94707	D	10	0.99132484	0.99654	D	0.685509	0.97397	D	0.891	0.96866	0.929	0.98863	P84022	W94L	Loss of MoRF binding (P = 0.05)| Gain of disorder (P = 0.0961)| Loss of sheet (P = 0.302)| Gain of catalytic residue at W94 (P = 0.4075)| Gain of methylation at R93 (P = 0.5467)	0.957103155658	0.95627	0.9049563550473444	0.90408	3.22852605899	0.99521	0.833747029305	0.87115	D	0.956354	0.99400	D	0.47643	0.93517	D	0.446582	0.93436	D	0.999798238277435	0.99028	D	0.986201	0.95336	D	0.9260089	0.93746	0.93586737	0.97457	0.9476767	0.95968	0.9148931	0.95982	-15.789	0.97433	D	0.9984	0.97748	P	0.99934082994802	0.96318	0.99600947	0.97935	0.762	0.86821	.	.	.	.	.	.	5.891241	0.93973	33.0	0.97608190364511083	0.35054	0.953089	0.96897	D	0.93829901477333	0.93469	12.08452	0.835484967804169	0.92096	11.25816	4.39	4.39	0.52154	.	.	9.766	0.98149	11.833000	0.97587	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.989	0.64309	927	0.17628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613968	6.195910e-07	0	1	1180038	8.474300e-07	0	0	75068	0.000000e+00	0	0	912	0.000000e+00	0	0	60028	0.000000e+00	0	0	29608	0.000000e+00	0	0	44886	0.000000e+00	0	0	64008	0.000000e+00	0	0	5856	0.000000e+00	0	1	1180038	8.474300e-07	0	0	91078	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Vascular_dilatation|Aneurysm-osteoarthritis_syndrome	criteria_provided,_conflicting_classifications	NC_000015.10:g.67164969G>T	ClinGen:CA16043497	C0002940|C3151087	613795	284984	MAD homology 1, Dwarfin-type|MAD homology, MH1|MAD homology 1, Dwarfin-type	Trp	Leu	94.17	0.19823788546255505																																																																																																																																																																																																																																																																																																																																																																																																																																																																													45			94.17	Aromatic	Tryptophan		Mothers against decapentaplegic homolog 3							MH1			-0.9								 W94-C89 (PAE:  1.0)	W94-C89 (PDBs: 1MHD, 1OZJ, 5OD6, 5ODG)	 W94-R90 (PAE:  1.0), W94-C89 (PAE: 1.0)	W94-C89 (PDBs: 1MHD, 1OZJ, 5OD6, 5ODG), W94-R90 (PDBs: 5ODG)							204									-130.3				89.6						C (loop/coil)	C (loop/coil)												94.17	19.823788	>90	10-90	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	false	0.9818302328931098	0.9820841950304083	true	true	true
DES	DES_Arg355Pro	B_7-8	-1.8383353133829674	0.1156446369995083	0.18376144481619042	-7.658529705276042	0.00012029529906317643	0.00046471973427563947	2024_01_Batch_7-8		true	false	false	false	false		false	false	false	false	false		0.9579270633901052	0.6092380392110948	0.6127630638905293	0.5463308903058561	0.596198875236283	0.723427683696767	0.6957208500220307	0.7137826902395875	0.6611665921044119	0.9666643187507311		0.46897006677579894	0.3969409305896815	0.5117434375414711	0.5573094863177775	0.9491898080294794		DES	Arg355Pro	NC_000002.12:219421380:G:C	1064G>C	2	219421380	G	C	2	ENSG00000175084	12573	2305	CCSBVarC007862	ALE00007848	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	G10	GDEhDisVCh_40003	A11	1	VUSMutGDDh003	G10	VUSN2Hmut_GDN2h_01	B05	NULL	NULL	VUSmut_GDEh01	B05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	77286.0	single nucleotide variant	NM_001927.4(DES):c.1064G>C (p.Arg355Pro)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	1.0	Apr 23, 2023	61368398.0	-	RCV000056768|RCV000799745	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219421380.0	219421380.0	2q35	criteria provided, conflicting classifications	5.0	ACMG2022	N	ClinGen:CA217005,UniProtKB:P17661#VAR_042455	2.0	66389.0	219421380.0	G	C	-	-	-	-	-	-	1064G>C 	Arg355Pro	NM_001927.4	1.0	Conflicting	Conflicting	66389	2	219421380.0	G	C	R	P	rs61368398	2	220286102	2	219994346	355	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1064G>C	p.Arg355Pro	c.1064G>C	p.Arg355Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.006	0.70891	D	0.022	0.18690	B	0.087	0.29616	B	0.91	0.92786	A	simple_aae	9.0	91.0	3.815	0.95445	H	-3.99	0.73927	D	0.977	0.98762	0.6791	0.92887	D	0.8244	0.94086	D	10	0.97889805	0.97763	D	0.206675	0.87019	D	0.816	0.94067	0.903	0.97889	P17661	R355P	Loss of stability (P = 0.0793)| Loss of MoRF binding (P = 0.1037)| Loss of phosphorylation at S358 (P = 0.1319)| Loss of disorder (P = 0.2594)| Gain of glycosylation at R355 (P = 0.26)	0.965255970749	0.96456	0.9521321596262299	0.95168	0.94141016562	0.72051	0.566348552704	0.48097	T	0.925715	0.98688	D	0.454315	0.92616	D	0.414815	0.92525	D	0.995758712291718	0.87909	D	0.956971	0.83650	D	0.9472546	0.95923	0.9268864	0.96835	0.9564355	0.96870	0.8952646	0.94567	-14.652	0.94994	D	0.9894	0.93397	P	0.998922915506709	0.95326	0.99683964	0.98179	0.983	0.99413	.	.	.	.	.	.	5.147944	0.86231	28.8	0.99433685427223528	0.64422	0.986154	0.99969	D	0.425058262404788	0.62610	4.502473	0.495834276143032	0.67537	5.121064	5.12	5.12	0.69417	3.02	0.55215	5.759	0.68511	9.832000	0.81897	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Desmin-related_myofibrillar_myopathy	criteria_provided,_conflicting_classifications	NC_000002.12:g.219421380G>C	ClinGen:CA217005|UniProtKB:P17661#VAR_042455	C3661900|C1832370	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Pro	96.95	0.6048387096774194																																																																																																																																																																																																																																																																																																																																																																																																																																																																													150			96.95	Positively-charged	Arginine		Desmin							IF rod			-4.5								 R355-E351 (PAE:  1.0), R355-E359 (PAE: 1.0)		 R355-E351 (PAE:  1.0), R355-E359 (PAE: 1.0)								175									-62.5				-49.6	Interaction with NEB; Coil 2B			dbSNP: rs61368398; Variant type: LP/P; AA change: Arg355Pro; PTM type: Phosphorylation; PTM morphology: EDR*FAsEASGy; Var class: II		H (helix)	H (α-helix)												96.95	60.48387	>90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.9579270633901052		true		false
AGXT	AGXT_Ala248Val	B_7-8	-0.7186227279072356	0.4956546427067293	0.580086009540351	-1.1154178332513307	0.30149427480746244	0.35396160861912573	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5627406409409721	0.5576796531628223	0.6388738036987988	0.5892615089485131	0.5396418914508376	0.6709044980708746	0.6988876936350987	0.5821907687328666	0.5661668658997779	0.6731373479634987	0.5822565380677934	0.5683376574385177	0.6429213025066505	0.4970930141688088	0.6123561519972484	0.6046102594340989	0.5331027682578512	0.5571436244434264	AGXT	Ala248Val	NC_000002.12:240875171:C:T	743C>T	2	240875171	C	T	2	ENSG00000172482	70497	3858	CCSBVarC008213	ALE00008199	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	H07	GDEhDisVCh_40002	F09	2	VUSMutGDDh004	H07	VUSN2Hmut_GDN2h_01	G08	VUSMutpDEST2_14	B09	VUSmut_GDEh01	G08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	367164.0	single nucleotide variant	NM_000030.3(AGXT):c.743C>T (p.Ala248Val)	189.0	AGXT	HGNC:341	Conflicting classifications of pathogenicity	0.0	Jan 30, 2024	372482918.0	-	RCV000436183|RCV001276582|RCV003243122	MedGen:C3661900|MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MeSH:D030342,MedGen:C0950123	not provided|Primary hyperoxaluria, type I|Inborn genetic diseases	germline;unknown	germline	GRCh38	NC_000002.12	2	240875171.0	240875171.0	2q37.3	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA2209225	2.0	383368.0	240875171.0	C	T	-	-	-	-	-	-	743C>T 	Ala248Val	NM_000030.3	1.0	Conflicting	Conflicting	383368	2	240875171.0	C	T	A	V	rs372482918	2	241814588	2	241463261	248	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.743C>T	p.Ala248Val	c.743C>T	p.Ala248Val	principal1	Y	1	YES	Select	+	GCC	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.036	0.52410	D	0.995	0.67505	D	0.685	0.53605	P	0.19	0.42965	N	simple_aae	81.0	19.0	.	.	.	-2.92	0.61161	D	0.665	0.67228	0.5024	0.90544	D	0.7607	0.91828	D	10	0.697795	0.71998	D	0.691284	0.97454	D	0.651	0.86774	0.347	0.34133	P21549	A248V	Gain of ubiquitination at K245 (P = 0.0725)| Gain of methylation at K245 (P = 0.1101)| Gain of helix (P = 0.132)| Gain of MoRF binding (P = 0.1334)| Loss of catalytic residue at A248 (P = 0.1396)	0.949903990032	0.94896	0.7987129205601627	0.79708	0.150431908582	0.16704	0.394059687853	0.24212	T	0.629193	0.88368	D	-0.0476496	0.44464	T	0.118245	0.77957	D	0.450861220989125	0.30518	T	0.942906	0.78449	D	0.81012625	0.84363	0.70229065	0.82251	0.81012625	0.84365	0.70229065	0.82252	-6.458	0.50025	T	0.429	0.61092	A	0.912171827984884	0.76931	0.39633784	0.79497	0.974	0.99029	.	.	.	.	.	.	3.682405	0.52504	23.2	0.99907659182389397	0.97802	0.930169	0.91676	D	0.411768644272297	0.61870	4.416865	0.37051951201392	0.59536	4.155902	3.79	3.79	0.42689	1.9	0.38508	5.469	0.66555	4.614000	0.44126	0.587	0.31004	1.0	0.71675	1.000000	0.68239	0.919	0.45473	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	8	109376	7.314220e-05	0	17	208046	8.171270e-05	1	20	236848	8.444230e-05	1	0	7162	0.000000e+00	0	0	17092	0.000000e+00	0	0	2320	0.000000e+00	0	8	9046	8.843690e-04	0	0	13394	0.000000e+00	0	0	42758	0.000000e+00	0	0	15690	0.000000e+00	0	8	9046	8.843690e-04	0	0	16214	0.000000e+00	0	0	30504	0.000000e+00	0	0	6210	0.000000e+00	0	17	13414	1.267330e-03	1	0	16734	0.000000e+00	0	0	89498	0.000000e+00	0	0	30608	0.000000e+00	0	17	13414	1.267330e-03	1	0	14898	0.000000e+00	0	0	34232	0.000000e+00	0	0	9564	0.000000e+00	0	20	17692	1.130450e-03	1	0	21612	0.000000e+00	0	0	102706	0.000000e+00	0	0	30526	0.000000e+00	0	20	17692	1.130450e-03	1	.	31	1613842	1.920880e-05	1	21	44890	4.678100e-04	1	0	74932	0.000000e+00	0	0	912	0.000000e+00	0	1	60004	1.666560e-05	0	0	29600	0.000000e+00	0	21	44890	4.678100e-04	1	0	64012	0.000000e+00	0	0	6082	0.000000e+00	0	1	1179856	8.475610e-07	0	0	91080	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	not_provided|Inborn_genetic_diseases|Primary_hyperoxaluria,_type_I	criteria_provided,_conflicting_classifications	NC_000002.12:g.240875171C>T	ClinGen:CA2209225	C3661900|C0950123|C0268164	259900	416|93598	Aminotransferase class V domain	Ala	Val	98.85	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.85	Aliphatic	Alanine		Alanine--glyoxylate aminotransferase										1.8								 A248-I244 (PAE:  1.0), A248-C253 (PAE: 1.0)	A248-C253 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), A248-I244 (PDBs: 6RV1, 3R9A)	 A248-I244 (PAE:  1.0), A248-G252 (PAE: 1.0), A248-C253 (PAE: 1.0)	A248-C253 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 3R9A), A248-I244 (PDBs: 6RV1, 7NS7, 3R9A), A248-G252 (PDBs: 6RV1, 3R9A), A248-L76 (PDBs: 6RV1, 3R9A), A248-D254 (PDBs: 3R9A)							89									-56.6				-46.4						H (helix)	H (α-helix)	Helix											98.85	0.0	>90	<10	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.5576796531628223	0.5627406409409721	false	false	false
APOA1	APOA1_Ala188Ser	B_15-16	11.72794201782346	7.4151236159767266e-6	0.00018802063022898137	10.371170585559316	0.000016816591294592926	0.0001046048983917899	2025_03_Batch_15-16	false	false	true	true	false	true	false	false	false	false	false	false	0.8387089874945183	0.8992612316309481	0.853162646822101	0.9161065285607106	0.8923756950477224	0.864406167364183	0.864406167364183	0.8923756950477224	0.9161065285607106	0.853162646822101	0.8992612316309481	0.8178926191251019						0.8595253558639346	APOA1	Ala188Ser	NC_000011.10:116836050:C:A	562G>T	11	116836050	C	A	11	ENSG00000118137	5613	152	CCSBVarC008452	ALE00008437	ENSP00000236850.3	Edgotyping3	VUSmut_GDEh11	A04	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_05	F03	VUSmut_GDEh11	A04	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	6.0	Y	N	N	Y	Y	312407.0	single nucleotide variant	NM_000039.3(APOA1):c.562G>T (p.Ala188Ser)	335.0	APOA1	HGNC:600	Conflicting classifications of pathogenicity	0.0	Jan 28, 2024	140770089.0	-	RCV000328973|RCV001105372|RCV001193575|RCV001726099|RCV002348041	MONDO:MONDO:0011393,MedGen:C5231558,OMIM:604091,Orphanet:425|MONDO:MONDO:0007099,MedGen:C0268389,OMIM:105200,Orphanet:85450|MedGen:CN169374|MedGen:C3661900|MedGen:CN230736	Hypoalphalipoproteinemia, primary, 1|Familial visceral amyloidosis, Ostertag type|not specified|not provided|Cardiovascular phenotype	germline	germline	GRCh38	NC_000011.10	11	116836050.0	116836050.0	11q23.3	criteria provided, conflicting classifications	6.0	-	N	ClinGen:CA6289784	2.0	302502.0	116836050.0	C	A	-	-	-	-	-	-	562G>T 	Ala188Ser	NM_000039.3	1.0	Conflicting	Conflicting	302502	11	116836050.0	C	A	A	S	rs140770089	11	116706766	11	116211976	188	APOA1	ENSG00000118137	ENST00000375323	ENSP00000364472	P02647	APOA1_HUMAN	c.562G>T	p.Ala188Ser	c.562G>T	p.Ala188Ser	principal1	Y	1	.	.	-	GCC	1	0	C	C/C	C/C	C/C	C/C	0.133	0.36262	T	0.192	0.32259	T	0.003	0.11208	B	0.056	0.26150	B	0.2	0.45549	N	simple_aae	80.0	20.0	1.685	0.43087	L	-0.9	0.24192	N	0.153	0.15662	-0.8269	0.53311	T	0.2801	0.65052	T	10	0.04780358	0.04148	T	0.090425	0.75436	D	0.104	0.29456	.	.	.	.	.	0.839747281701	0.83695	.	0.17028	.	0.57879	0.38680845499	0.23193	T	0.15305	0.49105	T	-0.390185	0.02544	T	-0.402073	0.32782	T	0.0183428400890475	0.00550	T	.	0.35334	.	0.16465458	0.36389	0.12647322	0.30382	0.13827042	0.31711	0.13261956	0.31733	-4.028	0.24244	T	0.0937	0.18648	LB	0.0823097460352998	0.41566	0.97578716	0.95128	0.16	0.40171	.	.	.	.	.	.	1.049745	0.1433	10.89	0.92621336707004076	0.22340	0.498936	0.53120	N	-0.734318187791197	0.14879	0.7558063	-0.760686583561781	0.15198	0.8132123	4.81	2.46	0.28956	3.1	0.56488	-0.204	0.09456	-0.068000	0.12385	0.599	0.40292	0.001	0.13799	0.000000	0.08389	0.08	0.17286	489	0.76818	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	141	264690	5.3269864E-4	.	39	103426	3.770810e-04	0	87	197302	4.409480e-04	0	110	227038	4.845000e-04	0	0	6840	0.000000e+00	0	7	16968	4.125410e-04	0	0	2280	0.000000e+00	0	0	8814	0.000000e+00	0	1	9384	1.065640e-04	0	30	41700	7.194240e-04	0	0	15596	0.000000e+00	0	30	41700	7.194240e-04	0	0	14832	0.000000e+00	0	9	30290	2.971280e-04	0	0	5996	0.000000e+00	0	0	13118	0.000000e+00	0	1	12688	7.881460e-05	0	74	85274	8.677910e-04	0	0	30448	0.000000e+00	0	74	85274	8.677910e-04	0	0	13690	0.000000e+00	0	10	34066	2.935480e-04	0	0	9448	0.000000e+00	0	0	17432	0.000000e+00	0	1	17356	5.761700e-05	0	94	99232	9.472750e-04	0	0	30372	0.000000e+00	0	94	99232	9.472750e-04	0	.	1301	1605380	8.104000e-04	2	1211	1178792	1.027320e-03	2	14	74978	1.867210e-04	0	0	912	0.000000e+00	0	19	59908	3.171530e-04	0	0	29522	0.000000e+00	0	0	44800	0.000000e+00	0	5	57196	8.741870e-05	0	1	6016	1.662230e-04	0	1211	1178792	1.027320e-03	2	0	90964	0.000000e+00	0	28	36966	7.574527944597738E-4	0	122	0	0	112	0	0	3438	0	0	472	0	0	628	0	0	56	0	0	98	0	4	6820	5.865102639296188E-4	0	3560	0	0	168	0	32	48712	6.569223189357859E-4	Familial_visceral_amyloidosis,_Ostertag_type|Hypoalphalipoproteinemia,_primary,_1|not_provided|Cardiovascular_phenotype|not_specified	criteria_provided,_conflicting_classifications	NC_000011.10:g.116836050C>A	ClinGen:CA6289784	C0268389|C5231558|C3661900|CN230736|CN169374	105200|604091	85450|425	.	Ala	Ser	77.08	0.4339622641509434																																																																																																																																																																																																																																																																																																																																																																																																																																																																													46			77.08	Aliphatic	Alanine		Proapolipoprotein A-I; Apolipoprotein A-I; Truncated apolipoprotein A-I										1.8								 A188-D192 (PAE:  3.0), A188-R184 (PAE: 3.5)	A188-D192 (PDBs: 3R2P, 6W4F), A188-R184 (PDBs: 1AV1, 2N5E, 2MSC, 2MSD, 2MSE, 6CC9, 6CCH, 6CCX, 6PTS, 6PTW, 6W4E, 6W4F)	 A188-D192 (PAE:  3.0), A188-R184 (PAE: 3.5)	A188-R184 (PDBs: 1GW3, 1GW4, 3R2P, 1AV1, 2N5E, 2MSC, 2MSD, 2MSE, 6CC9, 6CCH, 6CCX, 6PTS, 6PTW, 6W4E, 6W4F), A188-D192 (PDBs: 3R2P, 6W4F)							89									-50.3				-54.4	10 X approximate tandem repeats		6			H (helix)	H (α-helix)	Helix											77.08	43.396225	70-90	10-90	604091;105200	autosomal dominant	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic renal disease; Rare genetic endocrine disease; Rare inborn errors of metabolism	4	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 1; AMYLOIDOSIS, HEREDITARY SYSTEMIC 2	false	0.8992612316309481	0.8387089874945183	false	false	false
BAG3	BAG3_Arg477His	B_15-16	4.362827008836926	0.012035453922377305	0.03119093214618813	0.9209457388789546	0.4091953979849465	0.46293067527890064	2025_03_Batch_15-16	false	false	false	true	false	false	false	false	false	true	false	false	0.7264015843896986	0.7963060285766077	0.6745899890471463	0.8918024058424283	0.7471921243520359	0.7145674173033876							0.7145674173033876	0.7471921243520359	0.8918024058424283	0.6745899890471463	0.7963060285766077	0.7264015843896986	BAG3	Arg477His	NC_000010.11:119676984:G:A	1430G>A	10	119676984	G	A	10	ENSG00000151929	5066	201834	CCSBVarC003587	ALE00003587	ENSP00000358081.4	CEGS2	CegsMutGDEh1031	F12	GDEhDisVCh_40022	B02	2	CegsMutGDDh1031	F12	VUSN2Hmut_GDN2h_05	A11	VUSMutpDEST2_04	E12	VUSmut_GDEh05	A11	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	99.0	1.0	Y	Y	Y	Y	Y	39356.0	single nucleotide variant	NM_004281.4(BAG3):c.1430G>A (p.Arg477His)	9531.0	BAG3	HGNC:939	Conflicting classifications of pathogenicity	1.0	Nov 24, 2024	387906876.0	-	RCV004700271|RCV000023352|RCV001065815	MedGen:C3661900|MONDO:MONDO:0013479,MedGen:C3151293,OMIM:613881,Orphanet:154|MONDO:MONDO:0013061,MedGen:C2751831,OMIM:612954,Orphanet:199340;MONDO:MONDO:0013479,MedGen:C3151293,OMIM:613881,Orphanet:154	not provided|Dilated cardiomyopathy 1HH|Myofibrillar myopathy 6;Dilated cardiomyopathy 1HH	germline	germline	GRCh38	NC_000010.11	10	119676984.0	119676984.0	10q26.11	criteria provided, conflicting classifications	3.0	ACMG2022	N	ClinGen:CA259793,UniProtKB:O95817#VAR_065480,OMIM:603883.0006	3.0	30399.0	119676984.0	G	A	-	-	-	-	-	-	1430G>A 	Arg477His	NM_004281.4	1.0	Conflicting	Conflicting	30399	10	119676984.0	G	A	R	H	rs387906876	10	121436496	10	121426486	477	BAG3	ENSG00000151929	ENST00000369085	ENSP00000358081	O95817	BAG3_HUMAN	c.1430G>A	p.Arg477His	c.1430G>A	p.Arg477His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	0.59	0.76257	D	simple_aae	41.0	59.0	2.755	0.80334	M	-4.54	0.78505	D	0.975	0.98575	0.9948	0.97093	D	0.9077	0.96934	D	10	0.9626827	0.95650	D	0.15801	0.83805	D	0.924	0.98114	0.848	0.95057	O95817	R477H	Loss of MoRF binding (P = 0.0301)| Loss of disorder (P = 0.1402)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2754)| Gain of methylation at R480 (P = 0.2983)	0.994062951759	0.99391	0.7280286656751705	0.72603	0.0842442114282	0.09313	0.852002859116	0.89899	D	0.909146	0.98256	D	0.506996	0.94434	D	0.490488	0.94355	D	0.99063693591834	0.80713	D	0.967203	0.88094	D	0.89186275	0.90534	0.8452984	0.91073	0.87617517	0.89209	0.83278984	0.90242	-13.488	0.91291	D	0.9864	0.92561	P	0.992319273814117	0.89450	0.94326407	0.93019	0.844	0.91431	.	.	.	.	.	.	5.252875	0.88212	29.5	0.99954261668296551	0.99963	.	.	.	0.959252590586913	0.94315	12.68686	0.926787759344475	0.96618	14.94734	5.59	5.59	0.84656	6.03	0.97566	9.478	0.96876	11.817000	0.97121	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	912	0.21478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614196	1.239010e-06	0	2	1180036	1.694860e-06	0	0	75048	0.000000e+00	0	0	910	0.000000e+00	0	0	60022	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64030	0.000000e+00	0	0	6062	0.000000e+00	0	2	1180036	1.694860e-06	0	0	91082	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Myofibrillar_myopathy_6|Dilated_cardiomyopathy_1HH	criteria_provided,_single_submitter	NC_000010.11:g.119676984G>A	ClinGen:CA259793|OMIM:603883.0006|UniProtKB:O95817#VAR_065480	C2751831|C3151293	612954|613881	199340|154	BAG domain|BAG domain|BAG domain	Arg	His	97.01	0.40725806451612906																																																																																																																																																																																																																																																																																																																																																																																																																																																																													101			97.01	Positively-charged	Arginine		BAG family molecular chaperone regulator 3							BAG			-4.5								 R477-R481 (PAE:  1.0), R477-R473 (PAE: 1.5), R477-G472 (PAE: 2.5)		 R477-R481 (PAE:  1.0), R477-R473 (PAE: 1.5)								175									-61.0				-32.0						H (helix)	H (α-helix)												97.01	40.725807	>90	10-90	613881;612954;613881	autosomal dominant	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	CARDIOMYOPATHY, DILATED, 1HH; MYOPATHY, MYOFIBRILLAR, 6; CARDIOMYOPATHY, DILATED, 1HH	false	0.7963060285766077	0.7264015843896986	false	false	false
TTPA	TTPA_Glu141Lys	B_7-8	-4.408351219787474	0.006967290626200585	0.02066385884478745	-5.831966142480954	0.0006422661280434942	0.001674285450085281	2024_01_Batch_7-8	true	false	false	false	false	false	false	false	false	false	false	false	0.9576858266487998	0.9280994565662386	0.8195790228720081	0.7484866043004571	0.7309304589735304	0.8553511306105194	0.7776811117434452	0.7184556781436755	0.7882759027953965	0.7034431389743148	0.9636561513433026	0.9576858266487998	0.9330211494775935	0.7434052398033854	0.7086973058055177	0.9357149067697016	0.8925427617891746		TTPA	Glu141Lys	NC_000008.11:63066035:C:T	421G>A	8	63066035	C	T	8	ENSG00000137561	13295	218060	CCSBVarC006532	ALE00006531	ENSP00000260116.4	CEGS2	CegsMutGDEh1046	H08	GDEhDisVCh_40014	F02	2	CegsMutGDDh1046	H08	VUSN2Hmut_GDN2h_10	F02	VUSMutpDEST2_11	D04	VUSmut_GDEh10	F02	1.0	1.0	1.0	2.0	1.0	2.0	6.0	1.0	2.0	99.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	76500.0	single nucleotide variant	NM_000370.3(TTPA):c.421G>A (p.Glu141Lys)	7274.0	TTPA	HGNC:12404	Conflicting classifications of pathogenicity	1.0	May 29, 2024	397515524.0	-	RCV000055798	MONDO:MONDO:0010188,MedGen:C1848533,OMIM:277460,Orphanet:96	Familial isolated deficiency of vitamin E	germline;unknown	germline	GRCh38	NC_000008.11	8	63066035.0	63066035.0	8q12.3	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA344920,UniProtKB:P49638#VAR_022390	3.0	65592.0	63066035.0	C	T	-	-	-	-	-	-	421G>A 	Glu141Lys	NM_000370.3	1.0	Conflicting	Conflicting	65592	8	63066035.0	C	T	E	K	rs397515524	8	63978594	8	64141148	141	TTPA	ENSG00000137561	ENST00000260116	ENSP00000260116	P49638	TTPA_HUMAN	c.421G>A	p.Glu141Lys	c.421G>A	p.Glu141Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.9	0.92286	A	simple_aae	10.0	90.0	2.77	0.80725	M	-3.74	0.71080	D	0.994	0.99902	0.9975	0.97139	D	0.9031	0.96780	D	10	0.98744607	0.99102	D	0.348669	0.92193	D	0.887	0.96718	0.92	0.98560	P49638	E141K	Gain of ubiquitination at E141 (P = 0.0219)| Gain of methylation at E141 (P = 0.1206)| Gain of relative solvent accessibility (P = 0.1259)| Gain of solvent accessibility (P = 0.1708)| Loss of stability (P = 0.2075)	0.98627421452	0.98598	0.970379455070802	0.97009	0.69377492024	0.60463	0.740854382515	0.73051	T	0.908769	0.98246	D	0.375718	0.88350	D	0.432367	0.93063	D	0.987489759922028	0.77807	D	0.935106	0.75590	D	0.9498995	0.96197	0.8566154	0.91842	0.9498995	0.96197	0.8566154	0.91843	-12.519	0.87318	D	0.9598	0.88003	P	0.971419713705444	0.83531	0.99942100	0.99371	0.835	0.90915	.	.	.	.	.	.	5.688415	0.9305	33.0	0.9993558932346619	0.99579	0.942717	0.94746	D	0.882193205527201	0.90811	10.60012	0.840243867374458	0.92390	11.42366	5.54	5.54	0.82883	3.33	0.60393	7.313	0.78341	7.633000	0.62883	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.981	0.58703	907	0.22720	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	2	109366	1.828720e-05	0	5	208002	2.403820e-05	0	6	236826	2.533510e-05	0	0	7164	0.000000e+00	0	0	17092	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	2	42758	4.677490e-05	0	0	15686	0.000000e+00	0	2	42758	4.677490e-05	0	0	16218	0.000000e+00	0	0	30462	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	5	89506	5.586220e-05	0	0	30600	0.000000e+00	0	5	89506	5.586220e-05	0	0	14902	0.000000e+00	0	0	34198	0.000000e+00	0	1	9572	1.044710e-04	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	5	102704	4.868360e-05	0	0	30518	0.000000e+00	0	5	102704	4.868360e-05	0	.	17	1613758	1.053440e-05	0	3	29602	1.013450e-04	0	0	74864	0.000000e+00	0	0	910	0.000000e+00	0	0	59942	0.000000e+00	0	3	29602	1.013450e-04	0	0	44862	0.000000e+00	0	0	63972	0.000000e+00	0	0	6082	0.000000e+00	0	13	1179974	1.101720e-05	0	0	91066	0.000000e+00	0	3	26588	1.1283285692793742E-4	0	114	0	0	86	0	0	3230	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4640	0	0	3344	0	0	112	0	3	35910	8.35421888053467E-5	Familial_isolated_deficiency_of_vitamin_E	criteria_provided,_conflicting_classifications	NC_000008.11:g.63066035C>T	ClinGen:CA344920|UniProtKB:P49638#VAR_022390	C1848533	277460	96	CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain	Glu	Lys	97.74	0.005154639175257732																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			97.74	Negatively-charged	Glutamic Acid		Alpha-tocopherol transfer protein							CRAL-TRIO			-3.5								 E141-Y73 (PAE:  1.0), E141-L137 (PAE: 1.0)	E141-L137 (PDBs: 1OIP, 1R5L, 5MUE, 5MUG, 6ZPD, 1OIZ), E141-Y73 (PDBs: 6ZPD, 1OIZ)	 E141-Q145 (PAE:  1.0), E141-L137 (PAE: 1.0)	E141-L137 (PDBs: 1OIP, 1R5L, 5MUE, 5MUG, 6ZPD, 1OIZ)							146									-66.7				-29.3						H (helix)	H (α-helix)	Helix											97.74	0.5154639	>90	<10	277460	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	ATAXIA WITH VITAMIN E DEFICIENCY	false	0.9280994565662386	0.9576858266487998	false	true	false
AGXT	AGXT_Pro11His	B_7-8	-1.1805553567349742	0.27633498205567636	0.36299113304788855	2.0491411407222	0.07963127427973171	0.10728589449582063	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7512930553174134	0.7238800254579264	0.6742843973682553	0.6123335262859736	0.6196146526413873	0.6762455355638128	0.6724334479849056	0.5345465398026532	0.5295991930105436	0.6991350278321146	0.640830628425952	0.6715777725768328	0.68005762314272	0.7046827654801214	0.6950678595614036	0.649433766904396	0.8069294224899008	0.831008338057994	AGXT	Pro11His	NC_000002.12:240868897:C:A	32C>A	2	240868897	C	A	2	ENSG00000172482	70497	3782	CCSBVarC008157	ALE00008143	ENSP00000302620.3	Edgotyping3	VUSMutGDEh003	C11	GDEhDisVCh_40002	D01	2	VUSMutGDDh003	C11	VUSN2Hmut_GDN2h_01	E05	VUSMutpDEST2_13	E12	VUSmut_GDEh01	E05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200423.0	single nucleotide variant	NM_000030.3(AGXT):c.32C>A (p.Pro11His)	189.0	AGXT	HGNC:341	Conflicting classifications of pathogenicity	0.0	Jan 28, 2024	34116584.0	-	RCV000186220|RCV000884267|RCV003416113	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900|	Primary hyperoxaluria, type I|not provided|AGXT-related disorder	germline	germline	GRCh38	NC_000002.12	2	240868897.0	240868897.0	2q37.3	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA275544	2.0	204018.0	240868897.0	C	A	-	-	-	-	-	-	32C>A 	Pro11His	NM_000030.3	1.0	Conflicting	Conflicting	204018	2	240868897.0	C	A	P	H	rs34116584	2	241808314	2	241456987	11	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.32C>A	p.Pro11His	c.32C>A	p.Pro11His	principal1	Y	1	YES	Select	+	CCC	2	0	C	./.	./.	./.	./.	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.12	0.31989	N	simple_aae	88.0	12.0	.	.	.	-8.06	0.96632	D	0.484	0.51613	0.8074	0.94484	D	0.8385	0.94587	D	10	0.2520356	0.42163	D	0.595799	0.96419	D	0.557	0.81681	0.428	0.47372	P21549	P11H	Loss of glycosylation at P11 (P = 0.0183)| Loss of ubiquitination at K16 (P = 0.0485)| Loss of sheet (P = 0.0817)| Loss of disorder (P = 0.0838)| Loss of catalytic residue at P10 (P = 0.0843)	0.987481040417	0.98720	0.859202037958865	0.85797	0.263506844727	0.28607	0.441160917282	0.30698	T	0.778405	0.94077	D	-0.0966162	0.36630	T	0.0479079	0.73247	D	0.265849734731026	0.23291	T	0.708829	0.31717	T	0.7841695	0.82697	0.5278463	0.72464	0.8076964	0.84204	0.51581556	0.71767	-11.547	0.82628	D	0.4996	0.64510	A	0.969274033572828	0.83153	0.35631388	0.78461	0.95	0.97732	.	.	.	.	.	.	3.718632	0.53206	23.3	0.99275985366786657	0.57795	0.905858	0.85740	D	0.441013851686614	0.63505	4.608273	0.264222692664953	0.53220	3.515059	4.42	4.42	0.52717	2.42	0.44885	6.621	0.74159	7.334000	0.58284	0.549	0.27038	0.998	0.41403	1.000000	0.68239	0.045	0.14786	982	0.03399	4	7.987220447284345E-4	1	7.564296520423601E-4	2	0.0019880715705765406	0	0.0	1	9.92063492063492E-4	0	0.0	.	.	.	.	47	108736	4.322400e-04	1	79	203856	3.875280e-04	2	86	233534	3.682550e-04	2	1	7090	1.410440e-04	0	4	17026	2.349350e-04	0	0	2310	0.000000e+00	0	13	9024	1.440600e-03	0	0	13350	0.000000e+00	0	27	42382	6.370630e-04	1	2	15652	1.277790e-04	0	13	9024	1.440600e-03	0	1	15924	6.279830e-05	0	5	30378	1.645930e-04	0	0	6112	0.000000e+00	0	21	13362	1.571620e-03	0	0	16660	0.000000e+00	0	47	86092	5.459280e-04	1	5	30528	1.637840e-04	1	21	13362	1.571620e-03	0	1	14694	6.805500e-05	0	9	34118	2.637900e-04	0	0	9546	0.000000e+00	0	25	17664	1.415310e-03	0	0	21414	0.000000e+00	0	45	100052	4.497660e-04	1	5	30454	1.641820e-04	1	25	17664	1.415310e-03	0	.	938	1612894	5.815630e-04	3	33	44862	7.355890e-04	0	18	75052	2.398340e-04	0	0	912	0.000000e+00	0	19	59990	3.167190e-04	0	0	29600	0.000000e+00	0	33	44862	7.355890e-04	0	0	63092	0.000000e+00	0	0	6058	0.000000e+00	0	811	1179800	6.874050e-04	1	22	91046	2.416360e-04	2	17	35032	4.8527060972824846E-4	0	182	0	0	434	0	28	5486	0.005103900838497995	0	538	0	0	4816	0	0	98	0	0	150	0	12	5706	0.002103049421661409	28	5668	0.004940014114326041	0	532	0	57	52442	0.0010869150680752069	not_provided|Primary_hyperoxaluria,_type_I|AGXT-related_disorder	criteria_provided,_conflicting_classifications	NC_000002.12:g.240868897C>A	ClinGen:CA275544	C3661900|C0268164	259900	416|93598	.	Pro	His	98.04	0.5514705882352942																																																																																																																																																																																																																																																																																																																																																																																																																																																																													75			98.04	Special, No backbone hydrogen	Proline		Alanine--glyoxylate aminotransferase										1.6										 P11-L15 (PAE:  1.0)	P11-L15 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 3R9A)							115									-66.1				121.7				dbSNP: rs34116584; Variant type: LB/B; AA change: Pro11Leu; PTM type: Phosphorylation; PTM morphology: HKLLVtPP*KAL; Var class: II&rs34116584		H (helix)	P (polyproline helix)												98.04	55.147057	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.7238800254579264	0.7512930553174134	false	false	false
DES	DES_Thr453Ile	B_7-8	0.48948912392630456	0.6452129048854832	0.7169032276505369	2.4330038727584293	0.04522076323151873	0.06477759604202722	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8028253960517509	0.816011296797732	0.8034649569225318	0.7274331255970088	0.6999690067072414	0.8116186477213827	0.9731137058451573	0.874610468051237	0.916701364464751	0.9371882300553187	0.8328261970275341	0.8028253960517509	0.650123589597608	0.5253275453632458	0.5381648867292665	0.6697416837897449	0.7991963965679298		DES	Thr453Ile	NC_000002.12:219425732:C:T	1358C>T	2	219425732	C	T	2	ENSG00000175084	12573	2339	CCSBVarC007888	ALE00007874	ENSP00000363071.3	Edgotyping3	VUSMutGDEh005	F12	GDEhDisVCh_40092	B07	1	VUSMutGDDh005	F12	VUSN2Hmut_GDN2h_02	E04	NULL	NULL	VUSmut_GDEh02	E04	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	77298.0	single nucleotide variant	NM_001927.4(DES):c.1358C>T (p.Thr453Ile)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	1.0	Dec 20, 2023	267607488.0	-	RCV000056788|RCV001854167	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219425732.0	219425732.0	2q35	criteria provided, conflicting classifications	5.0	ACMG2022	N	ClinGen:CA217040	2.0	66401.0	219425732.0	C	T	-	-	-	-	-	-	1358C>T 	Thr453Ile	NM_001927.4	1.0	Conflicting	Conflicting	66401	2	219425732.0	C	T	T	I	rs267607488	2	220290454	2	219998698	453	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1358C>T	p.Thr453Ile	c.1358C>T	p.Thr453Ile	principal1	Y	1	YES	Select	+	ACA	2	0	C	C/C	C/C	C/C	C/C	0.049	0.39974	D	0.108	0.37928	T	0.556	0.38262	P	0.285	0.40507	B	0.88	0.91311	D	simple_aae	12.0	88.0	2.945	0.84662	M	-4.22	0.75883	D	0.886	0.88450	1.0798	0.98872	D	0.9142	0.97152	D	10	0.8994965	0.89190	D	0.272563	0.89911	D	0.866	0.95939	0.765	0.89238	P17661	T453I	Loss of disorder (P = 0.0217)| Loss of phosphorylation at T453 (P = 0.0502)| Gain of ubiquitination at K449 (P = 0.0619)| Loss of MoRF binding (P = 0.1208)| Loss of methylation at K449 (P = 0.126)	0.989174474445	0.98893	0.9416893776271863	0.94113	1.20852012436	0.80661	0.849582314491	0.89534	D	0.515502	0.82807	D	0.499164	0.94218	D	0.479238	0.94139	D	0.989717602729797	0.79784	D	0.89951	0.64729	D	0.2914123	0.51791	0.2698449	0.52666	0.31616342	0.53981	0.30719104	0.56520	-8.974	0.67607	D	0.9232	0.84417	P	0.954984300687245	0.81053	0.99476490	0.97620	0.623	0.78961	.	.	.	.	.	.	4.301228	0.65738	24.9	0.99781439697647956	0.86791	0.960659	0.98150	D	0.473381259223795	0.65359	4.835499	0.50215197778991	0.67962	5.178534	4.46	4.46	0.53511	1.6	0.35226	6.054	0.70789	5.915000	0.51152	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.945	0.48842	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Desmin-related_myofibrillar_myopathy|not_provided	criteria_provided,_conflicting_classifications	NC_000002.12:g.219425732C>T	ClinGen:CA217040	C1832370|C3661900	601419	363543|98909	.	Thr	Ile	82.18	0.647887323943662																																																																																																																																																																																																																																																																																																																																																																																																																																																																													92			82.18	Polar/Neutral	Threonine		Desmin										-0.7																		119									-115.1				143.7	Tail; Interaction with CRYAB			dbSNP: rs267607488; Variant type: LP/P; AA change: Thr453Ile; PTM type: Ubiquitylation; PTM morphology: KTVMIkTIET*R; Var class: II		B (undefined)	E (parallel sheets)												82.18	64.788734	70-90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.816011296797732	0.8028253960517509	false	false	false
SMAD3	SMAD3_Met212Ile	B_15-16	-0.6266607611375039	0.5507634944169102	0.6299151343331129	0.22314264021113964	0.8297963269804212	0.8597837815791147	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7850341054964736	0.7994633783524653	0.6272997215768402	0.7805356037224171	0.7953292144440558	0.730499096921496	0.6278919553377699	0.7573992028147637	0.6357091242018783	0.624151734783676	0.7337935762749572	0.6969829680910127	0.8331062385052219	0.8332592260733478	0.9253620832429559	0.6304477083700044	0.8651331804299733	0.8730852429019346	SMAD3	Met212Ile	NC_000015.10:67170582:G:A	636G>A	15	67170582	G	A	15	ENSG00000166949	11805	2136	CCSBVarC007719	ALE00007705	ENSP00000332973.4	Edgotyping3	VUSMutGDEh004	B12	GDEhDisVCh_40014	A07	2	VUSMutGDDh004	B12	VUSN2Hmut_GDN2h_01	D10	VUSMutpDEST2_09	H02	VUSmut_GDEh01	D10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	247104.0	single nucleotide variant	NM_005902.4(SMAD3):c.636G>A (p.Met212Ile)	4088.0	SMAD3	HGNC:6769	Conflicting classifications of pathogenicity	0.0	Oct 01, 2024	202094530.0	-	RCV000238592|RCV000654829|RCV000842512|RCV003488492|RCV004535209|RCV004804965	MONDO:MONDO:0018954,MedGen:C2697932,OMIM:PS609192,Orphanet:60030|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3661900|MedGen:CN169374||MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984	Loeys-Dietz syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided|not specified|SMAD3-related disorder|Aneurysm-osteoarthritis syndrome	germline;unknown	germline	GRCh38	NC_000015.10	15	67170582.0	67170582.0	15q22.33	criteria provided, conflicting classifications	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA062445	2.0	252654.0	67170582.0	G	A	-	-	-	-	-	-	636G>A 	Met212Ile	NM_005902.4	1.0	Conflicting	Conflicting	252654	15	67170582.0	G	A	M	I	rs202094530	15	67462920	15	65249974	212	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.636G>A	p.Met212Ile	c.636G>A	p.Met212Ile	principal1	Y	1	YES	Select	+	ATG	3	0	G	G/G	G/G	G/G	G/G	0.342	0.24117	T	0.416	0.20164	T	0.0	0.02950	B	0.001	0.04348	B	0.39	0.63057	N	simple_aae	61.0	39.0	1.32	0.32853	L	-0.48	0.20296	N	0.418	0.48259	0.5853	0.91673	D	0.8357	0.94488	D	10	0.014187634	0.00295	T	0.133254	0.81509	D	0.291	0.60842	0.35	0.34618	P84022	M212I	Gain of catalytic residue at P214 (P = 0.0309)| Loss of disorder (P = 0.0883)| Loss of glycosylation at P211 (P = 0.0947)| Loss of phosphorylation at S213 (P = 0.1674)| Loss of sheet (P = 0.6423)	0.882259066559	0.88020	0.23132072786086563	0.22858	1.33699997907	0.83685	0.583553791046	0.50519	T	0.316858	0.68657	T	0.0288604	0.55266	T	-0.0160245	0.69066	D	0.0551169947228781	0.06309	T	0.842916	0.59052	T	0.21437395	0.43518	0.1453143	0.34368	0.21437395	0.43518	0.1453143	0.34367	-3.022	0.11644	T	0.1049	0.19303	B	0.0286493431530423	0.32430	0.89621323	0.91077	0.081	0.22877	.	.	.	.	.	.	3.464524	0.48391	22.6	0.98706343500769167	0.45093	0.444926	0.49990	N	-0.238333255595848	0.31292	1.771654	0.00273018607228478	0.39549	2.368523	5.21	5.21	0.71966	.	.	3.777	0.55162	11.840000	0.97788	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.998	0.85369	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	33	264690	1.2467414E-4	.	9	109376	8.228500e-05	0	42	208080	2.018450e-04	0	58	236912	2.448170e-04	0	0	7162	0.000000e+00	0	0	17110	0.000000e+00	0	7	2320	3.017240e-03	0	0	9046	0.000000e+00	0	0	13376	0.000000e+00	0	2	42766	4.676610e-05	0	0	15682	0.000000e+00	0	2	42766	4.676610e-05	0	0	16208	0.000000e+00	0	0	30522	0.000000e+00	0	33	6208	5.315720e-03	0	0	13416	0.000000e+00	0	0	16716	0.000000e+00	0	7	89546	7.817210e-05	0	0	30600	0.000000e+00	0	7	89546	7.817210e-05	0	0	14900	0.000000e+00	0	0	34258	0.000000e+00	0	50	9570	5.224660e-03	0	0	17692	0.000000e+00	0	0	21614	0.000000e+00	0	6	102742	5.839870e-05	0	0	30518	0.000000e+00	0	6	102742	5.839870e-05	0	.	216	1613876	1.338390e-04	0	167	29606	5.640750e-03	0	1	74922	1.334720e-05	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	167	29606	5.640750e-03	0	0	44896	0.000000e+00	0	0	63974	0.000000e+00	0	0	6084	0.000000e+00	0	29	1179902	2.457830e-05	0	1	91090	1.097820e-05	0	25	32648	7.657436902719922E-4	0	122	0	0	112	0	0	3390	0	0	500	0	0	628	0	0	56	0	0	98	0	6	6864	8.741258741258741E-4	0	3512	0	0	168	0	31	44418	6.979152595794497E-4	Loeys-Dietz_syndrome|not_specified|SMAD3-related_disorder|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided	criteria_provided,_conflicting_classifications	NC_000015.10:g.67170582G>A	ClinGen:CA062445	C2697932|CN169374|C4707243|C3661900	PS609192|PS607086	60030|91387	.	Met	Ile	42.15	0.9840425531914894																																																																																																																																																																																																																																																																																																																																																																																																																																																																													185			42.15	Aliphatic	Methionine		Mothers against decapentaplegic homolog 3										1.9																		149									-92.2				130.3	Linker					H (helix)	P (polyproline helix)												42.15	98.40425	$\leqslant$50	$\geqslant$90	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	false	0.7994633783524653	0.7850341054964736	false	false	false
TTPA	TTPA_Arg192His	B_7-8	-1.1228204799298365	0.30442419370573987	0.3910223335426786	-1.3166297482726848	0.2294301357084381	0.27720154989918083	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7776736796636277	0.7811518801095555	0.5516779473556921	0.6398207150765234	0.5911381934345716	0.5767717738321018	0.5364970620647449	0.6220401972369877	0.6392810216376259	0.5114250116123091	0.8651160467530877	0.85676866264276	0.6170464855994586	0.5602361896321557	0.640360408515421	0.5919308830990752	0.6971877134660233	0.6985786966844955	TTPA	Arg192His	NC_000008.11:63064294:C:T	575G>A	8	63064294	C	T	8	ENSG00000137561	13295	218062	CCSBVarC006534	ALE00006533	ENSP00000260116.4	CEGS2	CegsMutGDEh1046	D12	GDEhDisVCh_40014	A03	2	CegsMutGDDh1046	D12	VUSN2Hmut_GDN2h_10	H03	VUSMutpDEST2_11	F04	VUSmut_GDEh10	H03	1.0	1.0	1.0	1.0	1.0	5.0	6.0	1.0	6.0	99.0	1.0	1.0	1.0	Y	Y	N	N	Y	24179.0	single nucleotide variant	NM_000370.3(TTPA):c.575G>A (p.Arg192His)	7274.0	TTPA	HGNC:12404	Conflicting classifications of pathogenicity	1.0	Feb 08, 2024	121917850.0	-	RCV000009711|RCV000055803|RCV002260962|RCV003155023|RCV003415680	MedGen:C4016662|MONDO:MONDO:0010188,MedGen:C1848533,OMIM:277460,Orphanet:96|MedGen:C3661900|MedGen:CN169374|	Ataxia, Friedreich-like, with isolated vitamin E deficiency|Familial isolated deficiency of vitamin E|not provided|not specified|TTPA-related disorder	germline;unknown	germline	GRCh38	NC_000008.11	8	63064294.0	63064294.0	8q12.3	criteria provided, conflicting classifications	8.0	-	N	ClinGen:CA120138,UniProtKB:P49638#VAR_007858,OMIM:600415.0005	3.0	9140.0	63064294.0	C	T	-	-	-	-	-	-	575G>A 	Arg192His	NM_000370.3	1.0	Conflicting	Conflicting	9140	8	63064294.0	C	T	R	H	rs121917850	8	63976853	8	64139407	192	TTPA	ENSG00000137561	ENST00000260116	ENSP00000260116	P49638	TTPA_HUMAN	c.575G>A	p.Arg192His	c.575G>A	p.Arg192His	principal1	Y	1	YES	Select	-	CGT	2	0	C	C/C	C/C	C/C	C/C	0.004	0.65576	D	0.188	0.28977	T	0.999	0.77914	D	0.928	0.66273	D	0.59	0.76257	A	simple_aae	41.0	59.0	1.545	0.38945	L	-3.17	0.64389	D	0.925	0.92907	-0.0036	0.82102	T	0.4988	0.80968	T	9	0.86499214	0.85585	D	0.046702	0.62441	D	0.671	0.87765	.	.	.	.	.	0.94542596687	0.94441	0.8145160501819801	0.81298	0.642191404682	0.57513	0.786069154739	0.79809	T	0.797854	0.94769	D	0.141932	0.68280	D	0.157781	0.80528	D	0.457096292853499	0.30748	T	0.934107	0.75292	D	0.70232236	0.77931	0.59229034	0.76093	0.70232236	0.77932	0.59229034	0.76094	-6.467	0.50095	T	0.3321	0.55338	B	0.887676156291611	0.75242	0.99826354	0.98702	0.437	0.67248	.	.	.	.	.	.	5.326902	0.8942	30.0	0.99929120222213563	0.99279	0.875825	0.79872	D	0.70012735303872	0.79527	7.120631	0.723152984715383	0.84048	8.208891	5.67	5.67	0.87655	.	.	5.629	0.67548	5.914000	0.51138	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.999	0.91597	907	0.22720	.	.	.	.	.	.	.	.	.	.	.	.	19	264690	7.178209E-5	.	5	109014	4.586570e-05	0	12	207224	5.790840e-05	0	13	235926	5.510200e-05	0	1	7120	1.404490e-04	0	1	17030	5.871990e-05	0	0	2310	0.000000e+00	0	0	9038	0.000000e+00	0	0	13342	0.000000e+00	0	3	42618	7.039280e-05	0	0	15648	0.000000e+00	0	1	7120	1.404490e-04	0	1	16112	6.206550e-05	0	1	30336	3.296410e-05	0	0	6192	0.000000e+00	0	1	13392	7.467140e-05	0	0	16674	0.000000e+00	0	7	89176	7.849650e-05	0	2	30496	6.558240e-05	0	7	89176	7.849650e-05	0	1	14798	6.757670e-05	0	1	34078	2.934440e-05	0	0	9554	0.000000e+00	0	1	17682	5.655470e-05	0	0	21568	0.000000e+00	0	8	102236	7.825030e-05	0	2	30416	6.575490e-05	0	8	102236	7.825030e-05	0	.	130	1612170	8.063670e-05	0	113	1178964	9.584690e-05	0	4	74812	5.346740e-05	0	0	912	0.000000e+00	0	2	59860	3.341130e-05	0	0	29550	0.000000e+00	0	2	44758	4.468470e-05	0	0	63872	0.000000e+00	0	0	6072	0.000000e+00	0	113	1178964	9.584690e-05	0	6	90950	6.597030e-05	0	9	42104	2.1375641269238076E-4	0	290	0	0	86	0	2	7740	2.5839793281653745E-4	0	500	0	0	628	0	0	26	0	0	98	0	0	6238	0	2	8030	2.4906600249066E-4	0	112	0	11	57710	1.906082134811991E-4	not_provided|not_specified|TTPA-related_disorder|Ataxia,_Friedreich-like,_with_isolated_vitamin_E_deficiency|Familial_isolated_deficiency_of_vitamin_E	criteria_provided,_conflicting_classifications	NC_000008.11:g.63064294C>T	ClinGen:CA120138|OMIM:600415.0005|UniProtKB:P49638#VAR_007858	C3661900|CN169374|C4016662|C1848533	277460	96	CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain	Arg	His	98.41	0.40725806451612906																																																																																																																																																																																																																																																																																																																																																																																																																																																																													101			98.41	Positively-charged	Arginine	a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-bisphosphate)	Alpha-tocopherol transfer protein							CRAL-TRIO	0.0007		-4.5								 R192-I154 (PAE:  1.0)	R192-I154 (PDBs: 1OIP, 1R5L, 5MUE, 5MUG, 6ZPD, 1OIZ), R192-R221 (PDBs: 1OIZ)	 R192-I154 (PAE:  1.0)	R192-N152 (PDBs: 1OIP, 5MUG), R192-R221 (PDBs: 1R5L, 6ZPD, 1OIZ), R192-I154 (PDBs: 5MUE, 6ZPD, 1OIZ)							175									-92.4		Pocket 2: Mean pLDDT: 96.98, Volume: 611.87 Å³, Druggability score: 0		-21.5				dbSNP: rs121917850; Variant type: LP/P; AA change: Arg192His; PTM type: Ubiquitylation; PTM morphology: DSFPLkVR*GIH; Var class: II		B (undefined)	E (parallel sheets)	Beta strand											98.41	40.725807	>90	10-90	277460	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	ATAXIA WITH VITAMIN E DEFICIENCY	false	0.7811518801095555	0.7776736796636277	false	false	false
NCF2	NCF2_Arg188Lys	B_7-8	-0.5665039272434266	0.595533446642411	0.6710730873669647	2.204342157996726	0.06968414500848127	0.09521251384256377	2024_01_Batch_7-8		false	false	false	false	false		false	false	false	false	false		0.7035017442391793	0.6903374178994017	0.6601526955036902	0.6499103184868047	0.7360975143173666	0.7775882043628668	0.6524835389590641	0.7054400650717698	0.7358652344070574	0.7739779524393646		0.6946068242718664	0.6473370980145452	0.6148653259356105	0.6448096013917461	0.633025536038994		NCF2	Arg188Lys	NC_000001.11:183573231:C:T	563G>A	1	183573231	C	T	1	ENSG00000116701	3727	1707	CCSBVarC008448	ALE00008453	ENSP00000356505.4	Edgotyping3	VUSmut_GDEh11	A06	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_03	H10	VUSmut_GDEh11	A06	0.0		0.0		0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	278807.0	single nucleotide variant	NM_000433.4(NCF2):c.563G>A (p.Arg188Lys)	4688.0	NCF2	HGNC:7661	Conflicting classifications of pathogenicity	0.0	Jan 31, 2024	115365142.0	-	RCV001088101|RCV000437670|RCV000766500|RCV003930214	MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379|MedGen:CN169374|MedGen:C3661900|	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not specified|not provided|NCF2-related disorder	germline;maternal	germline	GRCh38	NC_000001.11	1	183573231.0	183573231.0	1q25.3	criteria provided, conflicting classifications	6.0	-	N	ClinGen:CA1284926	2.0	294084.0	183573231.0	C	T	-	-	-	-	-	-	563G>A 	Arg188Lys	NM_000433.4	1.0	Conflicting	Conflicting	294084	1	183573231.0	C	T	R	K	rs115365142	1	183542366	1	181808989	188	NCF2	ENSG00000116701	ENST00000367536	ENSP00000356506	P19878	NCF2_HUMAN	c.563G>A	p.Arg188Lys	c.563G>A	p.Arg188Lys	principal1	Y	1	.	.	-	AGA	2	0	C	C/C	C/C	C/C	C/C	0.813	0.03028	T	0.857	0.03777	T	0.0	0.02950	B	0.0	0.01384	B	0.01	0.05039	N	simple_aae	99.0	1.0	0.5	0.13320	N	-0.27	0.12963	N	0.055	0.05152	-1.0435	0.16258	T	0.0663	0.27150	T	10	0.0034295022	0.00059	T	0.004787	0.11716	T	0.106	0.29937	.	.	.	.	.	0.608695890411	0.60254	.	0.22159	.	0.33330	0.352489471436	0.18269	T	0.031737	0.21941	T	-0.526743	0.00387	T	-0.522157	0.19757	T	0.00789503613848239	0.00092	T	.	0.35287	.	0.23671912	0.46197	0.105956465	0.25428	0.20980504	0.42937	0.08984964	0.21005	-2.031	0.03304	T	0.0664	0.02553	LB	0.00981879687015151	0.23786	0.26414782	0.75656	0.097	0.27172	.	.	.	.	.	.	1.247166	0.16458	12.54	0.89452446053375101	0.19062	0.130900	0.24749	N	-0.57663397682875	0.19417	1.030446	-0.394154392462148	0.24852	1.382621	5.08	1.08	0.19414	2.77	0.50688	2.141	0.41896	-0.750000	0.07615	0.549	0.27038	1.0	0.71675	0.004000	0.19047	0.999	0.91597	729	0.54435	13	0.002595846645367412	13	0.009833585476550681	0	0.0	0	0.0	0	0.0	0	0.0	702	264690	0.0026521592	.	78	109408	7.129280e-04	0	165	208132	7.927660e-04	1	155	236940	6.541740e-04	1	73	7164	1.018980e-02	0	3	17112	1.753160e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	1	15690	6.373490e-05	0	73	7164	1.018980e-02	0	155	16218	9.557280e-03	1	8	30524	2.620890e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89556	1.116620e-05	0	1	30608	3.267120e-05	0	155	16218	9.557280e-03	1	142	14902	9.528920e-03	1	9	34260	2.626970e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	3	102738	2.920050e-05	0	1	30526	3.275900e-05	0	142	14902	9.528920e-03	1	.	741	1614180	4.590570e-04	2	687	75054	9.153410e-03	2	687	75054	9.153410e-03	2	0	912	0.000000e+00	0	23	60026	3.831670e-04	0	0	29606	0.000000e+00	0	0	44878	0.000000e+00	0	0	64028	0.000000e+00	0	2	6062	3.299240e-04	0	3	1180020	2.542330e-06	0	4	91082	4.391650e-05	0	0	180054	0	2	360	0.005555555555555556	0	4504	0	84	9456	0.008883248730964468	0	804	0	0	974	0	0	1850	0	0	280	0	5	17676	2.828694274722788E-4	86	9816	0.00876120619396903	0	6354	0	91	215958	4.213782309523148E-4	Granulomatous_disease,_chronic,_autosomal_recessive,_cytochrome_b-positive,_type_2|not_specified|not_provided|NCF2-related_disorder	criteria_provided,_conflicting_classifications	NC_000001.11:g.183573231C>T	ClinGen:CA1284926	C1856245|CN169374|C3661900	233710	379	.	Arg	Lys	88.05	0.7983870967741935																																																																																																																																																																																																																																																																																																																																																																																																																																																																													198			88.05	Positively-charged	Arginine		Neutrophil cytosol factor 2								0.1335		-4.5								 R188-Q192 (PAE:  1.5)	R188-Q192 (PDBs: 1HH8, 1WM5)	 R188-Q192 (PAE:  1.5)	R188-Q192 (PDBs: 1HH8, 1WM5)							175									-64.4		Pocket 3: Mean pLDDT: 92.5, Volume: 1043.75 Å³, Druggability score: 0.13		-39.5						H (helix)	H (α-helix)	Helix											88.05	79.838715	70-90	10-90	233710	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic skin disease	3	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2	false	0.7035017442391793		false		false
DES	DES_Ser298Leu	B_7-8	0.22748088667772784	0.8312040011757516	0.8656486598940488	1.5146917734391687	0.1736236211050416	0.2154153784501361	2024_01_Batch_7-8	false	false	true	false	false	true	false	false	false	false	false	false	0.6001957888212409	0.6220624512109301	0.9628046350855166	0.6896575535569021	0.7169698576147161	0.9860334583077686	0.9860334583077686	0.8388058765266844	0.8450518102902421	0.9628046350855166	0.607216410106637	0.6001957888212409		0.5951338387027478	0.534263296823562		0.6369084923152231		DES	Ser298Leu	NC_000002.12:219420652:C:T	893C>T	2	219420652	C	T	2	ENSG00000175084	12573	2282	CCSBVarC006503	ALE00006502	ENSP00000363071.3	CEGS2	CegsMutGDEh1046	E07	NULL	NULL	NULL	CegsMutGDDh1046	E07	VUSN2Hmut_GDN2h_10	D02	NULL	NULL	VUSmut_GDEh10	D02	0.0		1.0	1.0	1.0	5.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	77320.0	single nucleotide variant	NM_001927.4(DES):c.893C>T (p.Ser298Leu)	1674.0	DES	HGNC:2770	Conflicting classifications of pathogenicity	1.0	Jan 15, 2024	62636491.0	-	RCV000056814|RCV000171830|RCV000466593|RCV000735983|RCV001143228|RCV001142372|RCV003352761	MedGen:C3661900|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146|MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154|MedGen:CN230736	not provided|Primary dilated cardiomyopathy|Desmin-related myofibrillar myopathy|Cardiomyopathy|Neurogenic scapuloperoneal syndrome, Kaeser type|Dilated cardiomyopathy 1I|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000002.12	2	219420652.0	219420652.0	2q35	criteria provided, conflicting classifications	10.0	ACMG2022	N	ClinGen:CA217093	2.0	66423.0	219420652.0	C	T	-	-	-	-	-	-	893C>T 	Ser298Leu	NM_001927.4	1.0	Conflicting	Conflicting	66423	2	219420652.0	C	T	S	L	rs62636491	2	220285374	2	219993618	298	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.893C>T	p.Ser298Leu	c.893C>T	p.Ser298Leu	principal1	Y	1	YES	Select	+	TCG	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.005	0.72530	D	1.0	0.90580	D	0.966	0.71341	D	0.93	0.93829	D	simple_aae	7.0	93.0	2.515	0.73099	M	-5.49	0.85795	D	0.962	0.97221	0.2828	0.87228	D	0.6138	0.86298	D	10	0.9164904	0.90908	D	0.096455	0.76530	D	0.814	0.93989	.	.	.	.	.	0.946518848107	0.94552	0.7553604922186357	0.75349	1.35228464682	0.84021	0.839065551758	0.87932	D	0.794841	0.94662	D	0.185466	0.72342	D	0.334609	0.89626	D	0.890759289264679	0.53906	D	0.990738	0.97176	D	0.8999947	0.91258	0.8179161	0.89269	0.88453585	0.89905	0.8385416	0.90621	-8.224	0.62660	D	0.5321	0.65958	A	0.999808885053098	0.98063	0.99715600	0.98283	0.954	0.97964	.	.	.	.	.	.	5.857437	0.9385	33.0	0.99929625266775934	0.99279	0.978338	0.99762	D	0.781173463721291	0.84831	8.422946	0.737498849586618	0.85139	8.516113	4.67	4.67	0.58039	3.75	0.68915	7.905	0.86513	7.719000	0.67276	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.958	0.51242	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	46	264690	1.7378821E-4	.	9	109386	8.227740e-05	0	19	207910	9.138570e-05	0	18	236806	7.601160e-05	0	3	7162	4.188770e-04	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	5	42768	1.169100e-04	0	0	15672	0.000000e+00	0	3	7162	4.188770e-04	0	5	16184	3.089470e-04	0	1	30516	3.276970e-05	0	0	6208	0.000000e+00	0	0	13406	0.000000e+00	0	0	16734	0.000000e+00	0	12	89418	1.342010e-04	0	0	30586	0.000000e+00	0	5	16184	3.089470e-04	0	5	14888	3.358410e-04	0	1	34258	2.919030e-05	0	0	9570	0.000000e+00	0	0	17690	0.000000e+00	0	0	21630	0.000000e+00	0	11	102646	1.071640e-04	0	0	30504	0.000000e+00	0	5	14888	3.358410e-04	0	.	287	1613856	1.778350e-04	0	266	1180022	2.254200e-04	0	11	74878	1.469060e-04	0	0	912	0.000000e+00	0	2	59986	3.334110e-05	0	0	29606	0.000000e+00	0	0	44882	0.000000e+00	0	0	63952	0.000000e+00	0	1	6082	1.644200e-04	0	266	1180022	2.254200e-04	0	0	91052	0.000000e+00	0	13	42818	3.036106310430193E-4	0	298	0	0	86	0	3	7884	3.80517503805175E-4	0	500	0	0	628	0	0	26	0	0	98	0	2	6324	3.1625553447185326E-4	3	8182	3.6665851869958444E-4	0	112	0	18	58662	3.068425897514575E-4	Dilated_cardiomyopathy_1I|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type|Desmin-related_myofibrillar_myopathy|Cardiovascular_phenotype|Cardiomyopathy|Primary_dilated_cardiomyopathy|not_provided	criteria_provided,_conflicting_classifications	NC_000002.12:g.219420652C>T	ClinGen:CA217093	C1858154|C1867005|C1832370|CN230736|C0878544|C0007193|C3661900	604765|181400|601419	154|85146|363543|98909|167848|217604	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ser	Leu	95.66	0.5																																																																																																																																																																																																																																																																																																																																																																																																																																																																													65			95.66	Polar/Neutral	Serine		Desmin							IF rod			-0.8								 S298-D302 (PAE:  1.0), S298-E294 (PAE: 1.0)		 S298-D302 (PAE:  1.0), S298-E294 (PAE: 1.0)								105									-61.0				-46.6	Interaction with NEB; Coil 2B					H (helix)	H (α-helix)												95.66	50.0	>90	10-90	601419;181400;604765	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1; SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; CARDIOMYOPATHY, DILATED, 1I	false	0.6220624512109301	0.6001957888212409	false	false	false
FA2H	FA2H_Arg143Cys	B_7-8	-2.4316945168017323	0.05925679876594322	0.10657296199901276	-5.301010808018125	0.0018280520026520005	0.003923363070019206	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6773313878201161	0.8017338560791648	0.6719075019853407	0.6074484586067563	0.5864687126013687	0.6913267874212212	0.6913267874212212	0.640621162716572	0.7455007712882407	0.6719075019853407	0.8604497376840445	0.7875539786401311		0.5323162624861654	0.4693961459252721		0.7430179744742851	0.5671087970001013	FA2H	Arg143Cys	NC_000016.10:74719071:G:A	427C>T	16	74719071	G	A	16	ENSG00000103089	513	213753	CCSBVarC005692	ALE00005692	ENSP00000219368.3	CEGS2	CegsMutGDEh1032	H09	GDEhDisVCh_40032	H11	2	CegsMutGDDh1032	H09	VUSN2Hmut_GDN2h_06	E01	VUSMutpDEST2_01	B08	VUSmut_GDEh06	E01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	39827.0	single nucleotide variant	NM_024306.5(FA2H):c.703C>T (p.Arg235Cys)	79152.0	FA2H	HGNC:21197	Conflicting classifications of pathogenicity	1.0	Jan 09, 2023	387907039.0	-	RCV000023855|RCV001797590|RCV002509169	MONDO:MONDO:0012866,MedGen:C3496228,OMIM:612319,Orphanet:171629|MedGen:CN169374|MedGen:C3661900	Hereditary spastic paraplegia 35|not specified|not provided	germline;unknown	germline	GRCh38	NC_000016.10	16	74719071.0	74719071.0	16q23.1	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA259927,UniProtKB:Q7L5A8#VAR_064621,OMIM:611026.0003	3.0	30870.0	74719071.0	G	A	-	-	-	-	-	-	703C>T 	Arg235Cys	NM_024306.5	1.0	Conflicting	Conflicting	30870	16	74719071.0	G	A	R	C	rs387907039	16	74752969	16	73310470	235	FA2H	ENSG00000103089	ENST00000219368	ENSP00000219368	Q7L5A8	FA2H_HUMAN	c.703C>T	p.Arg235Cys	c.703C>T	p.Arg235Cys	principal1	Y	1	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.967	0.71532	D	0.88	0.91311	A	simple_aae	12.0	88.0	4.16	0.97582	H	-7.46	0.94944	D	0.996	0.99956	0.8630	0.95174	D	0.8596	0.95316	D	10	0.9870304	0.99036	D	0.412364	0.93612	D	0.845	0.95162	0.947	0.99343	Q7L5A8	R235C	Loss of disorder (P = 0.1558)| Gain of catalytic residue at H234 (P = 0.1729)| Loss of sheet (P = 0.1907)| Gain of helix (P = 0.2059)| Loss of loop (P = 0.2237)	0.909457546737	0.90786	0.9609548620468721	0.96058	0.959394493044	0.72780	0.712581276894	0.68915	T	0.931934	0.98842	D	0.411398	0.90492	D	0.436034	0.93164	D	0.999856948852539	0.99358	D	0.969603	0.95233	D	0.89012665	0.90384	0.70669526	0.82504	0.8645823	0.88280	0.74802494	0.84925	-13.114	0.89848	D	0.4235	0.63528	A	0.999907218249949	0.98723	0.95025283	0.93388	0.993	0.99760	.	.	.	.	.	.	6.176276	0.94737	34.0	0.99935005089797024	0.99579	0.796042	0.72227	D	0.9464208742722	0.93806	12.31481	0.844186985875566	0.92632	11.5631	5.36	4.4	0.52344	3.71	0.68166	6.589	0.74031	11.690000	0.94349	0.662	0.56385	1.0	0.71675	1.000000	0.68239	0.982	0.59239	657	0.62204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109184	9.158850e-06	0	1	207876	4.810560e-06	0	1	236710	4.224580e-06	0	0	7164	0.000000e+00	0	1	17104	5.846590e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13184	0.000000e+00	0	0	42764	0.000000e+00	0	0	15690	0.000000e+00	0	1	17104	5.846590e-05	0	0	16214	0.000000e+00	0	1	30512	3.277400e-05	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16524	0.000000e+00	0	0	89534	0.000000e+00	0	0	30608	0.000000e+00	0	1	30512	3.277400e-05	0	0	14902	0.000000e+00	0	1	34248	2.919880e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21422	0.000000e+00	0	0	102732	0.000000e+00	0	0	30526	0.000000e+00	0	1	34248	2.919880e-05	0	.	14	1613916	8.674550e-06	0	1	29602	3.378150e-05	0	1	74936	1.334470e-05	0	0	910	0.000000e+00	0	0	60012	0.000000e+00	0	1	29602	3.378150e-05	0	0	44890	0.000000e+00	0	0	63866	0.000000e+00	0	0	6084	0.000000e+00	0	11	1180040	9.321720e-06	0	1	91088	1.097840e-05	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Hereditary_spastic_paraplegia_35|not_provided|not_specified	criteria_provided,_conflicting_classifications	NC_000016.10:g.74719071G>A	ClinGen:CA259927|OMIM:611026.0003|UniProtKB:Q7L5A8#VAR_064621	C3496228|C3661900|CN169374	612319	171629	Fatty acid hydroxylase	Arg	Cys	97.82	0.3024193548387097																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.82	30.241936	>90	10-90	612319	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION	false	0.8017338560791648	0.6773313878201161	false	false	false
TPM1	TPM1_Glu54Lys	B_15-16	1.4221627760561493	0.20571044172958064	0.28639502633382274	0.004714510259513527	1.0	1.0	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6938066448949962	0.7075348491622582	0.708341502072555	0.76254292862485	0.7576028160456072	0.7423660178866194	0.6251212806116256	0.6280940635053582	0.6454467137947854	0.6181306589091017	0.6143150344951203	0.6202340691926547	0.859610755161613	0.887111568585856	0.8796391434549145	0.7985523452360083	0.8007546638293962	0.7673792205973378	TPM1	Glu54Lys	NC_000015.10:63044072:G:A	160G>A	15	63044072	G	A	15	ENSG00000140416	4723	201730	CCSBVarC005633	ALE00005633	ENSP00000288398.6	CEGS2	CegsMutGDEh1039	G10	GDEhDisVCh_40050	B07	2	CegsMutGDDh1039	G10	VUSN2Hmut_GDN2h_08	H03	VUSMutpDEST2_04	D06	VUSmut_GDEh08	H03	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	N	Y	Y	27497.0	single nucleotide variant	NM_001018005.2(TPM1):c.160G>A (p.Glu54Lys)	7168.0	TPM1	HGNC:12010	Conflicting classifications of pathogenicity	1.0	Nov 01, 2023	104894505.0	-	RCV000013274|RCV000159370|RCV001317675	MONDO:MONDO:0012744,MedGen:C2678476,OMIM:611878,Orphanet:154,Orphanet:54260|MedGen:C3661900|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569	Dilated cardiomyopathy 1Y|not provided|Hypertrophic cardiomyopathy	germline	germline	GRCh38	NC_000015.10	15	63044072.0	63044072.0	15q22.2	criteria provided, conflicting classifications	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018668,UniProtKB:P09493#VAR_043987,Leiden Muscular Dystrophy (TPM1):TPM1_00002,OMIM:191010.0004	3.0	12458.0	63044072.0	G	A	-	-	-	-	-	-	160G>A 	Glu54Lys	NM_001018005.2	1.0	Conflicting	Conflicting	12458	15	63044072.0	G	A	E	K	rs104894505	15	63336271	15	61123324	54	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.160G>A	p.Glu54Lys	c.160G>A	p.Glu54Lys	alternative1	Y	1	YES	Select	+	GAA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.186	0.79703	T	0.923	0.53896	P	0.849	0.60609	P	0.95	0.94956	A	simple_aae	5.0	95.0	1.615	0.41260	L	-2.46	0.55364	N	0.871	0.93732	0.1900	0.85679	D	0.5983	0.85636	D	10	0.83854204	0.82830	D	0.124171	0.80490	D	0.765	0.92017	.	0.81804	.	.	.	0.969516994073	0.96890	.	0.98041	.	0.97252	.	.	.	0.959245	0.99459	D	0.411828	0.90515	D	0.353786	0.90397	D	0.962629079818726	0.66207	D	0.988851	0.98403	D	0.8706735	0.88762	0.70945877	0.82663	0.8208865	0.85089	0.69432545	0.81798	-12.06	0.85183	D	0.5449	0.79591	A	0.998558441655984	0.94646	0.99969864	0.99622	0.955	0.98022	.	.	.	.	.	.	6.119894	0.94613	34.0	0.99808009421469879	0.89183	0.959701	0.98008	D	0.68766439300201	0.78709	6.950021	0.751913928960896	0.86224	8.845132	5.82	5.82	0.92730	.	.	9.561	0.97262	11.758000	0.95568	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	793	0.45754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	not_provided|Hypertrophic_cardiomyopathy|Dilated_cardiomyopathy_1Y	criteria_provided,_conflicting_classifications	NC_000015.10:g.63044072G>A	ClinGen:CA018668|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00002|OMIM:191010.0004|UniProtKB:P09493#VAR_043987	C3661900|C0007194|C2678476	611878	217569|154|54260	.	Glu	Lys	94.15	0.5103092783505154																																																																																																																																																																																																																																																																																																																																																																																																																																																																													99			94.15	Negatively-charged	Glutamic Acid		Tropomyosin alpha-1 chain	Coiled coil									-3.5								 E54-L50 (PAE:  2.5), E54-D58 (PAE: 2.0)	E54-D58 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), E54-L50 (PDBs: 8ENC)	 E54-L50 (PAE:  2.5), E54-D58 (PAE: 2.0)	E54-D58 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), E54-L50 (PDBs: 8ENC)							146									-65.8				-47.4				dbSNP: rs104894505; Variant type: LP/P; AA change: Glu54Lys; PTM type: Phosphorylation; PTM morphology: kKLKGtE*DELD; Var class: II&rs104894505		H (helix)	H (α-helix)	Helix											94.15	51.03093	>90	10-90	611878	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	CARDIOMYOPATHY, DILATED, 1Y	false	0.7075348491622582	0.6938066448949962	false	false	false
GCK	GCK_Val253Ala	B_7-8	3.246908235219246	0.047600907638126466	0.08939796813060133	1.1756540416952923	0.3245409050832905	0.37794727105632187	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7250633787370431	0.8094049698141877	0.8225928236224326	0.9294214628108484	0.8385035610412706	0.8832772285526476	0.8832772285526476	0.8385035610412706	0.9294214628108484	0.8225928236224326	0.8094049698141877	0.7250633787370431							GCK	Val253Ala	NC_000007.14:44147755:A:G	758T>C	7	44147755	A	G	7	ENSG00000106633	3689	214843	CCSBVarC006692	ALE00006690	ENSP00000384247.3	CEGS2	CegsMutGDEh1045	G02	GDEhDisVCh_40037	C04	1	CegsMutGDDh1045	G02	VUSN2Hmut_GDN2h_09	H08	VUSMutpDEST2_03	C09	VUSmut_GDEh09	H08	1.0	4.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	N	Y	Y	Y	Y	44916.0	single nucleotide variant	NM_000162.5(GCK):c.758T>C (p.Val253Ala)	2645.0	GCK	HGNC:4195	Conflicting classifications of pathogenicity	1.0	Sep 10, 2023	193921400.0	-	RCV000029915|RCV002472937	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900	Maturity-onset diabetes of the young type 2|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	44147755.0	44147755.0	7p13	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA213842	2.0	36252.0	44147755.0	A	G	-	-	-	-	-	-	758T>C 	Val253Ala	NM_000162.5	1.0	Conflicting	Conflicting	36252	7	44147755.0	A	G	V	A	rs193921400	7	44187354	7	44153879	253	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.758T>C	p.Val253Ala	c.758T>C	p.Val253Ala	principal1	Y	1	YES	Select	-	GTC	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.83643	D	0.046	0.32504	B	0.091	0.39681	B	1.0	0.99291	A	simple_aae	0.0	100.0	2.52	0.73336	M	-3.74	0.72508	D	0.946	0.95387	1.1157	0.99893	D	0.9563	0.98582	D	10	0.98990583	0.99469	D	0.866135	0.98971	D	0.944	0.98850	0.941	0.99203	P35557	V253A	Loss of stability (P = 0.1098)| Gain of disorder (P = 0.1266)| Loss of sheet (P = 0.1907)| Loss of loop (P = 0.2237)| Gain of phosphorylation at T255 (P = 0.3168)	0.956797812616	0.95596	.	0.99913	.	0.83247	0.752755045891	0.74809	T	0.952674	0.99322	D	0.537995	0.95317	D	0.535016	0.95247	D	0.994682133197784	0.86012	D	0.915608	0.69816	D	0.97441125	0.98633	0.9509784	0.98434	0.96781456	0.98022	0.94139534	0.97827	-11.973	0.85024	D	0.9629	0.91552	P	0.99694917489775	0.92617	0.99967897	0.99601	0.992	0.99727	.	.	.	.	.	.	5.084575	0.84903	28.4	0.99161198946824824	0.54174	0.949176	0.96141	D	0.39616959401749	0.61014	4.319522	0.468540282191959	0.65730	4.884625	5.23	5.23	0.72532	3.81	0.70705	9.228	0.94416	11.133000	0.86872	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.967	0.53449	698	0.58020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Maturity-onset_diabetes_of_the_young_type_2	criteria_provided,_conflicting_classifications	NC_000007.14:g.44147755A>G	ClinGen:CA213842	C3661900|C0342277	125851	552	Hexokinase, C-terminal	Val	Ala	97.54	0.0																																																																																																											0.21	1 mutation(s) (Val253Tyr: -0.578)	0.339																																																																																																																																																																																																																																																																																																																																																																0			97.54	Aliphatic	Valine		Hexokinase-4							Hexokinase			4.2								 V253-Y234 (PAE:  1.0)	V253-Y234 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9)	 V253-Y234 (PAE:  1.0)	V253-Y234 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9)							117									-112.1				127.1	Hexokinase large subdomain					B (undefined)	E (parallel sheets)	Beta strand											97.54	0.0	>90	<10	125851	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism	3	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2	false	0.8094049698141877	0.7250633787370431	false	false	false
AGXT	AGXT_Arg381Lys	B_7-8	-1.4040789921856829	0.20307399120206732	0.28453127494976865	3.8398848759614825	0.006375491182957675	0.01163541064929741	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6841868711647449	0.6727927197652822	0.5355123070124345	0.6223647854540775	0.5733298858564375	0.550456500180083	0.5238450091275083	0.5797125487474714	0.5879723080124108	0.4951612650244563	0.6684681827719061	0.6584132954512805	0.5770679912326576	0.5669472229654037	0.6567572628957441	0.5758633490004126	0.6771172567586583	0.7099604468782093	AGXT	Arg381Lys	NC_000002.12:240878784:G:A	1142G>A	2	240878784	G	A	2	ENSG00000172482	70497	3889	CCSBVarC008235	ALE00008221	ENSP00000302620.3	Edgotyping3	VUSMutGDEh005	G07	GDEhDisVCh_40002	E12	2	VUSMutGDDh005	G07	VUSN2Hmut_GDN2h_02	C03	VUSMutpDEST2_14	B12	VUSmut_GDEh02	C03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200605.0	single nucleotide variant	NM_000030.3(AGXT):c.1142G>A (p.Arg381Lys)	189.0	AGXT	HGNC:341	Conflicting classifications of pathogenicity	0.0	Jul 24, 2024	151185188.0	-	RCV000186266|RCV001753585	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900	Primary hyperoxaluria, type I|not provided	germline	germline	GRCh38	NC_000002.12	2	240878784.0	240878784.0	2q37.3	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA275605	2.0	204060.0	240878784.0	G	A	-	-	-	-	-	-	1142G>A 	Arg381Lys	NM_000030.3	1.0	Conflicting	Conflicting	204060	2	240878784.0	G	A	R	K	rs151185188	2	241818201	2	241466874	381	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.1142G>A	p.Arg381Lys	c.1142G>A	p.Arg381Lys	principal1	Y	1	YES	Select	+	AGG	2	0	G	G/G	G/G	A/G	G/G	0.893	0.02477	T	0.802	0.04107	T	0.0	0.02950	B	0.0	0.01384	B	0.11	0.30097	N	simple_aae	89.0	11.0	.	.	.	0.02	0.06704	N	0.024	0.00436	-0.6919	0.60652	T	0.3847	0.73938	T	10	0.010011077	0.00221	T	0.102356	0.77507	D	0.296	0.61420	.	.	.	.	.	0.590373781641	0.58401	0.5985930051462631	0.59610	0.032688509541	0.03303	0.203425750136	0.00565	T	0.099299	0.40110	T	-0.352731	0.04389	T	-0.304078	0.43950	T	0.0187729480706289	0.00587	T	0.473853	0.13864	T	0.22396617	0.44703	0.10043824	0.23971	0.22396617	0.44703	0.10043824	0.23970	-2.801	0.08201	T	0.0748	0.05469	B	0.501669373515744	0.60835	0.01034928	0.41724	0.031	0.06489	.	.	.	.	.	.	-0.076438	0.03795	0.796	0.53072880455640881	0.04930	0.458859	0.50801	N	-1.53412450816284	0.01615	0.07125464	-1.567439425603	0.01835	0.08470893	4.05	-6.47	0.01735	-4.35	0.05594	-0.606	0.05761	-0.347000	0.09814	-0.212	0.0834	0.001	0.13799	0.000000	0.08389	0.13	0.19611	976	0.04721	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	124	264690	4.6847254E-4	.	46	93284	4.931180e-04	0	82	180322	4.547420e-04	0	103	208890	4.930820e-04	0	0	5566	0.000000e+00	0	10	15502	6.450780e-04	0	0	1938	0.000000e+00	0	0	7704	0.000000e+00	0	3	9422	3.184040e-04	0	33	37972	8.690610e-04	0	0	13482	0.000000e+00	0	33	37972	8.690610e-04	0	0	13618	0.000000e+00	0	19	27208	6.983240e-04	0	1	5500	1.818180e-04	0	0	12278	0.000000e+00	0	6	12026	4.989190e-04	0	54	78660	6.864990e-04	0	0	26748	0.000000e+00	0	19	27208	6.983240e-04	0	0	12732	0.000000e+00	0	20	31060	6.439150e-04	0	1	8980	1.113590e-04	0	0	16014	0.000000e+00	0	7	15362	4.556700e-04	0	73	92856	7.861640e-04	0	0	26704	0.000000e+00	0	73	92856	7.861640e-04	0	.	772	1595076	4.839890e-04	0	48	59006	8.134770e-04	0	7	74908	9.344800e-05	0	0	912	0.000000e+00	0	41	57332	7.151330e-04	0	1	29148	3.430770e-05	0	0	44200	0.000000e+00	0	48	59006	8.134770e-04	0	0	6034	0.000000e+00	0	637	1173956	5.426100e-04	0	0	87648	0.000000e+00	0	80	102798	7.782252573007257E-4	0	308	0	0	112	0	2	8208	2.4366471734892786E-4	1	494	0.0020242914979757085	0	648	0	0	82	0	0	98	0	12	13914	8.624407072013799E-4	2	8516	2.3485204321277596E-4	0	194	0	95	126662	7.500276325969904E-4	not_provided|Primary_hyperoxaluria,_type_I	criteria_provided,_conflicting_classifications	NC_000002.12:g.240878784G>A	ClinGen:CA275605	C3661900|C0268164	259900	416|93598	.	Arg	Lys	98.86	0.43548387096774194																																																																																																																																																																																																																																																																																																																																																																																																																																																																													108			98.86	Positively-charged	Arginine		Alanine--glyoxylate aminotransferase										-4.5			A:R381-B:S612 (PDBs: 3R9A)					 R381-Q385 (PAE:  1.0), R381-T377 (PAE: 1.0)	R381-T377 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), R381-Q385 (PDBs: 6RV1, 3R9A)	 R381-L305 (PAE:  1.0), R381-Q385 (PAE: 1.0), R381-T377 (PAE: 1.0)	R381-T377 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), R381-Q385 (PDBs: 6RV1, 3R9A), R381-L305 (PDBs: 3R9A)		R381-E378 (PDBs: 5F9S, 5HHY)					175									-58.6				-47.1						H (helix)	H (α-helix)	Helix											98.86	43.548386	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.6727927197652822	0.6841868711647449	false	false	false
AGXT	AGXT_Lys12Arg	B_7-8	0.3977167369997957	0.7026886021167903	0.7643859916728108	0.7345570573911762	0.4864818279113292	0.5406990637294301	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5955026229396613	0.6113055890979593	0.6744838792560374	0.57484804377156	0.4557685997001238	0.6634151836013289	0.7983903165549082	0.5291363165464116	0.6025122804981689	0.8148618916771173	0.6249992417973962	0.6265364434486477	0.5284400506477497	0.382400882853836	0.5471838070449512	0.5341058668349574	0.5976119363985224	0.5644688024306749	AGXT	Lys12Arg	NC_000002.12:240868900:A:G	35A>G	2	240868900	A	G	2	ENSG00000172482	70497	3785	CCSBVarC008159	ALE00008145	ENSP00000302620.3	Edgotyping3	VUSMutGDEh003	E11	GDEhDisVCh_40002	F01	2	VUSMutGDDh003	E11	VUSN2Hmut_GDN2h_01	F05	VUSMutpDEST2_14	A01	VUSmut_GDEh01	F05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200426.0	single nucleotide variant	NM_000030.3(AGXT):c.35A>G (p.Lys12Arg)	189.0	AGXT	HGNC:341	Conflicting classifications of pathogenicity	0.0	Jan 25, 2024	142969817.0	-	RCV000186221|RCV000881725|RCV002516973	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	Primary hyperoxaluria, type I|not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000002.12	2	240868900.0	240868900.0	2q37.3	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA275546	2.0	204019.0	240868900.0	A	G	-	-	-	-	-	-	35A>G 	Lys12Arg	NM_000030.3	1.0	Conflicting	Conflicting	204019	2	240868900.0	A	G	K	R	rs142969817	2	241808317	2	241456990	12	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.35A>G	p.Lys12Arg	c.35A>G	p.Lys12Arg	principal1	Y	1	YES	Select	+	AAG	2	0	A	A/A	A/A	A/A	A/A	0.264	0.16450	T	0.346	0.17934	T	0.001	0.07480	B	0.004	0.10086	B	0.01	0.05039	N	simple_aae	99.0	1.0	.	.	.	-0.74	0.20730	N	0.077	0.05152	-0.5646	0.66079	T	0.5826	0.84944	D	10	0.011423498	0.00246	T	0.113283	0.79110	D	0.195	0.47390	.	.	.	.	.	0.852576503142	0.85000	0.7057758858334973	0.70368	0.0292579567146	0.02917	0.252770185471	0.04066	T	0.159404	0.50024	T	-0.376008	0.03149	T	-0.363327	0.37311	T	0.0137278296073621	0.00256	T	0.660234	0.26673	T	0.1604427	0.35690	0.11721031	0.28228	0.31366414	0.53769	0.10537001	0.25277	-4.277	0.27882	T	0.0765	0.06231	B	0.0605276084465051	0.38847	0.01542894	0.46389	0.168	0.41476	.	.	.	.	.	.	1.232211	0.16293	12.43	0.93443053077492666	0.23468	0.507369	0.53608	D	-0.858317044080703	0.11703	0.5739518	-0.848751405449089	0.13089	0.6902085	4.42	2.06	0.25862	1.54	0.34573	0.277	0.18559	0.393000	0.17982	0.691	0.84104	0.0	0.06393	0.000000	0.08389	0.225	0.22645	982	0.03399	2	3.9936102236421724E-4	0	0.0	2	0.0019880715705765406	0	0.0	0	0.0	0	0.0	97	264690	3.6646644E-4	.	102	109062	9.352480e-04	1	145	204380	7.094630e-04	1	186	234176	7.942740e-04	1	0	7116	0.000000e+00	0	2	17054	1.172750e-04	0	0	2314	0.000000e+00	0	0	9030	0.000000e+00	0	34	13378	2.541490e-03	0	57	42588	1.338410e-03	1	9	15668	5.744190e-04	0	57	42588	1.338410e-03	1	1	15970	6.261740e-05	0	2	30416	6.575490e-05	0	0	6114	0.000000e+00	0	0	13378	0.000000e+00	0	36	16708	2.154660e-03	0	86	86416	9.951860e-04	1	19	30560	6.217280e-04	0	86	86416	9.951860e-04	1	1	14734	6.787020e-05	0	2	34156	5.855490e-05	0	0	9548	0.000000e+00	0	0	17676	0.000000e+00	0	44	21528	2.043850e-03	0	118	100440	1.174830e-03	1	19	30486	6.232370e-04	0	118	100440	1.174830e-03	1	.	1028	1613050	6.373020e-04	6	135	63096	2.139600e-03	0	9	75036	1.199420e-04	0	0	912	0.000000e+00	0	4	60012	6.665330e-05	0	0	29602	0.000000e+00	0	0	44862	0.000000e+00	0	135	63096	2.139600e-03	0	0	6060	0.000000e+00	0	791	1179924	6.703820e-04	1	54	91058	5.930290e-04	3	31	47334	6.549203532344615E-4	0	306	0	0	112	0	3	8090	3.7082818294190356E-4	1	500	0.002	0	628	0	0	56	0	0	98	0	6	8494	7.063809748057452E-4	3	8396	3.5731300619342544E-4	0	168	0	41	65618	6.248285531409065E-4	Inborn_genetic_diseases|not_provided|Primary_hyperoxaluria,_type_I	criteria_provided,_conflicting_classifications	NC_000002.12:g.240868900A>G	ClinGen:CA275546	C0950123|C3661900|C0268164	259900	416|93598	.	Lys	Arg	98.55	0.8780487804878049																																																																																																																																																																																																																																																																																																																																																																																																																																																																													180			98.55	Positively-charged	Lysine		Alanine--glyoxylate aminotransferase										-3.9											K12-K16 (PDBs: 1H0C, 5OG0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A)							147									-54.6				-30.8						H (helix)	G (3₁₀-helix)												98.55	87.80488	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.6113055890979593	0.5955026229396613	false	false	false
TPM1	TPM1_Ala63Val	B_15-16	1.063885106635611	1.0	1.0	-3.5278904680414898	0.11173434785958897	0.13599098334044568	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7315027743830003	0.7246033090178537	0.6105691321071554	0.6631088640156442	0.6932213458578185	0.696925890247902	0.6331648736704787	0.6588953954690161	0.6654040836406087	0.5964320583397708	0.650767141094168	0.6546997103139928	0.7606869068253252	0.727547296246621	0.6608136443906796	0.6247062058745398	0.7984394769415395	0.8083058384520079	TPM1	Ala63Val	NC_000015.10:63044100:C:T	188C>T	15	63044100	C	T	15	ENSG00000140416	4723	201733	CCSBVarC005636	ALE00005636	ENSP00000288398.6	CEGS2	CegsMutGDEh1035	G04	GDEhDisVCh_40050	A05	2	CegsMutGDDh1035	G04	VUSN2Hmut_GDN2h_06	A12	VUSMutpDEST2_04	G06	VUSmut_GDEh06	A12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	40537.0	single nucleotide variant	NM_001018005.2(TPM1):c.188C>T (p.Ala63Val)	7168.0	TPM1	HGNC:12010	Conflicting classifications of pathogenicity	1.0	Jun 23, 2022	199476306.0	-	RCV000024573|RCV000229431|RCV000619544|RCV002470718	MedGen:C3661900|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569|MedGen:CN230736|MONDO:MONDO:0007267,MedGen:C1861863,OMIM:115196	not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Hypertrophic cardiomyopathy 3	germline	germline	GRCh38	NC_000015.10	15	63044100.0	63044100.0	15q22.2	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018699,UniProtKB:P09493#VAR_013135,Leiden Muscular Dystrophy (TPM1):TPM1_00005	2.0	31877.0	63044100.0	C	T	-	-	-	-	-	-	188C>T 	Ala63Val	NM_001018005.2	1.0	Conflicting	Conflicting	31877	15	63044100.0	C	T	A	V	rs199476306	15	63336299	15	61123352	63	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.188C>T	p.Ala63Val	c.188C>T	p.Ala63Val	alternative1	Y	1	YES	Select	+	GCT	2	0	C	C/C	C/C	C/C	C/C	0.057	0.44852	T	0.226	0.37375	T	0.016	0.17346	B	0.118	0.32091	B	0.98	0.97016	A	simple_aae	2.0	98.0	2.365	0.67977	M	-2.1	0.48366	N	0.523	0.77038	0.0472	0.83113	D	0.5785	0.84762	D	10	0.7223191	0.73498	D	0.336612	0.91882	D	0.567	0.82257	.	0.73245	.	.	.	0.906654671062	0.90502	.	0.96001	.	0.89948	.	.	.	0.896713	0.97922	D	0.0820447	0.62012	D	-0.119925	0.61538	T	0.931853950023651	0.59513	D	0.945705	0.80795	D	0.3789319	0.58912	0.29485577	0.55302	0.36183035	0.57647	0.33525535	0.59109	-7.944	0.60761	D	0.1591	0.57990	B	0.724281615654445	0.67869	0.99876800	0.98953	0.955	0.98022	.	.	.	.	.	.	4.799802	0.78013	26.8	0.98640763368327422	0.44157	0.960850	0.98177	D	0.157239985345982	0.48908	3.11912	0.290880591572731	0.54770	3.664183	5.73	4.82	0.61594	3.5	0.63398	7.537	0.80993	7.633000	0.62883	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.997	0.79771	793	0.45754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hypertrophic_cardiomyopathy|Hypertrophic_cardiomyopathy_3|Cardiovascular_phenotype|not_provided	criteria_provided,_conflicting_classifications	NC_000015.10:g.63044100C>T	ClinGen:CA018699|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00005|UniProtKB:P09493#VAR_013135	C0007194|C1861863|CN230736|C3661900	115196	217569	.	Ala	Val	96.14	0.5094339622641509																																																																																																																																																																																																																																																																																																																																																																																																																																																																													54			96.14	Aliphatic	Alanine		Tropomyosin alpha-1 chain	Coiled coil									1.8								 A63-K59 (PAE:  1.0), A63-A67 (PAE: 1.0)	A63-A67 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), A63-K59 (PDBs: 8ENC)	 A63-K59 (PAE:  1.0), A63-A67 (PAE: 1.0)	A63-A67 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), A63-K59 (PDBs: 8ENC)							89									-63.0				-37.8				dbSNP: rs199476306; Variant type: LP/P; AA change: Ala63Val; PTM type: Phosphorylation; PTM morphology: DELDkysEA*LK; Var class: II&rs199476306		H (helix)	H (α-helix)	Helix											96.14	50.943398	>90	10-90	115196	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3	false	0.7246033090178537	0.7315027743830003	false	false	false
TTPA	TTPA_Ala120Thr	B_7-8	1.6254241793867499	0.1551974652328554	0.23068261369241544	-3.0477181457056806	0.01864304234137802	0.02951680991926546	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6548626576241334	0.6753292677069072	0.5483135127293755	0.658366238237543	0.6040924647579689	0.6312411597957849	0.6126605622830008	0.6180124283119934	0.6304366799933435	0.5881922711909695	0.7492701548923276	0.7316139660069165	0.649821757308569	0.5901725012039442	0.6862957964817427	0.5084347542677813	0.6013883805214868	0.5781113492413502	TTPA	Ala120Thr	NC_000008.11:63072935:C:T	358G>A	8	63072935	C	T	8	ENSG00000137561	13295	218059	CCSBVarC006531	ALE00006530	ENSP00000260116.4	CEGS2	CegsMutGDEh1046	A07	GDEhDisVCh_40014	D02	2	CegsMutGDDh1046	A07	VUSN2Hmut_GDN2h_10	C02	VUSMutpDEST2_11	C04	VUSmut_GDEh10	C02	1.0	1.0	1.0	1.0	1.0	5.0	6.0	1.0	6.0	99.0	1.0	1.0	1.0	Y	Y	N	N	Y	76499.0	single nucleotide variant	NM_000370.3(TTPA):c.358G>A (p.Ala120Thr)	7274.0	TTPA	HGNC:12404	Conflicting classifications of pathogenicity	1.0	Mar 10, 2024	143010236.0	-	RCV000055796|RCV000800124	MONDO:MONDO:0010188,MedGen:C1848533,OMIM:277460,Orphanet:96|MedGen:C3661900	Familial isolated deficiency of vitamin E|not provided	germline;unknown	germline	GRCh38	NC_000008.11	8	63072935.0	63072935.0	8q12.3	criteria provided, conflicting classifications	6.0	-	N	ClinGen:CA344919	3.0	65591.0	63072935.0	C	T	-	-	-	-	-	-	358G>A 	Ala120Thr	NM_000370.3	1.0	Conflicting	Conflicting	65591	8	63072935.0	C	T	A	T	rs143010236	8	63985494	8	64148048	120	TTPA	ENSG00000137561	ENST00000260116	ENSP00000260116	P49638	TTPA_HUMAN	c.358G>A	p.Ala120Thr	c.358G>A	p.Ala120Thr	principal1	Y	1	YES	Select	-	GCA	1	0	C	C/C	C/C	C/C	C/C	0.01	0.56615	D	0.144	0.33436	T	0.273	0.31848	B	0.055	0.25997	B	0.4	0.63842	A	simple_aae	60.0	40.0	1.59	0.40152	L	-1.75	0.41427	N	0.746	0.74440	-0.3716	0.72792	T	0.4317	0.77229	T	9	0.809969	0.80091	D	0.137875	0.81986	D	0.520	0.79476	.	.	.	.	.	0.940828198447	0.93974	0.6777166181655423	0.67550	0.14692160482	0.16314	0.442280948162	0.30851	T	0.596357	0.86878	D	-0.0189422	0.48676	T	0.0144495	0.71058	D	0.293937921524048	0.24469	T	0.884611	0.60701	D	0.37382022	0.58537	0.3653555	0.61645	0.37382022	0.58538	0.3653555	0.61645	-9.222	0.69193	D	0.1339	0.29119	B	0.358608411723452	0.56307	0.99501000	0.97679	0.5	0.71448	.	.	.	.	.	.	4.028594	0.59625	24.1	0.9967819473625632	0.79065	0.677104	0.64062	D	0.00689913156362906	0.41905	2.535723	0.146339908246128	0.46680	2.932604	5.8	4.92	0.64102	3.9	0.73887	3.546	0.53501	1.752000	0.28568	0.589	0.31595	0.997	0.40243	0.922000	0.28426	0.484	0.28704	907	0.22720	.	.	.	.	.	.	.	.	.	.	.	.	22	264690	8.31161E-5	.	5	109354	4.572310e-05	0	7	208034	3.364830e-05	0	8	236724	3.379460e-05	0	2	7160	2.793300e-04	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13370	0.000000e+00	0	3	42762	7.015570e-05	0	0	15682	0.000000e+00	0	2	7160	2.793300e-04	0	4	16204	2.468530e-04	0	0	30514	0.000000e+00	0	0	6210	0.000000e+00	0	0	13410	0.000000e+00	0	0	16710	0.000000e+00	0	3	89524	3.351060e-05	0	0	30598	0.000000e+00	0	4	16204	2.468530e-04	0	4	14896	2.685280e-04	0	0	34250	0.000000e+00	0	0	9568	0.000000e+00	0	0	17688	0.000000e+00	0	0	21608	0.000000e+00	0	4	102584	3.899240e-05	0	0	30516	0.000000e+00	0	4	14896	2.685280e-04	0	.	91	1613882	5.638580e-05	0	14	74886	1.869510e-04	0	14	74886	1.869510e-04	0	0	912	0.000000e+00	0	0	59974	0.000000e+00	0	1	29604	3.377920e-05	0	0	44880	0.000000e+00	0	0	63998	0.000000e+00	0	0	6078	0.000000e+00	0	73	1179998	6.186450e-05	0	1	91076	1.097980e-05	0	7	156884	4.461895413171515E-5	0	352	0	0	4476	0	1	8772	1.1399908800729594E-4	0	442	0	0	950	0	0	1818	0	0	280	0	0	10860	0	1	9124	1.0960105217010084E-4	0	6294	0	8	184834	4.3282080136771374E-5	not_provided|Familial_isolated_deficiency_of_vitamin_E	criteria_provided,_conflicting_classifications	NC_000008.11:g.63072935C>T	ClinGen:CA344919	C3661900|C1848533	277460	96	CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain	Ala	Thr	98.34	0.5849056603773585																																																																																																																																																																																																																																																																																																																																																																																																																																																																													62			98.34	Aliphatic	Alanine		Alpha-tocopherol transfer protein							CRAL-TRIO			1.8																		89									-57.0				-22.3				dbSNP: rs143010236; Variant type: LP/P; AA change: Ala120Thr; PTM type: Ubiquitylation; PTM morphology: A*HWDPkVFTAY; Var class: II		H (helix)	G (3₁₀-helix)	Helix											98.34	58.49057	>90	10-90	277460	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	ATAXIA WITH VITAMIN E DEFICIENCY	true	0.6753292677069072	0.6548626576241334	false	false	false
PYGL	PYGL_Pro382Leu	B_7-8	-5.694681274020533	0.010735835113786826	0.028519395086693794	-9.766029688058108	0.00019147980283647359	0.0006543118029886947	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8714634093561752	0.8886725148771857	0.741159977688189	0.7411287398582443	0.5906010190193447	0.769554422971743	0.769554422971743	0.7072824978088044	0.8016080544291323	0.741159977688189	0.8886725148771857	0.8714634093561752		0.47391954022988503	0.6806494252873564				PYGL	Pro382Leu	NC_000014.9:50915919:G:A	1145C>T	14	50915919	G	A	14	ENSG00000100504	55246	3224	CCSBVarC008113	ALE00008099	ENSP00000216392.7	Edgotyping3	VUSMutGDEh009	A02	GDEhDisVCh_40063	E12	1	VUSMutGDDh009	A02	VUSN2Hmut_GDN2h_03	C01	VUSMutpDEST2_13	F04	VUSmut_GDEh03	C01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	513344.0	single nucleotide variant	NM_002863.5(PYGL):c.1145C>T (p.Pro382Leu)	5836.0	PYGL	HGNC:9725	Conflicting classifications of pathogenicity	0.0	Jan 13, 2024	143759519.0	-	RCV000625936|RCV003488738|RCV003917992|RCV003311865	MONDO:MONDO:0009294,MedGen:C0017925,OMIM:232700,Orphanet:369|MedGen:CN169374||MedGen:C3661900	Glycogen storage disease, type VI|not specified|PYGL-related disorder|not provided	germline;inherited;unknown	germline	GRCh38	NC_000014.9	14	50915919.0	50915919.0	14q22.1	criteria provided, conflicting classifications	10.0	-	N	ClinGen:CA7183547	2.0	522775.0	50915919.0	G	A	-	-	-	-	-	-	1145C>T 	Pro382Leu	NM_002863.5	1.0	Conflicting	Conflicting	522775	14	50915919.0	G	A	P	L	rs143759519	14	51382637	14	50452387	382	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.1145C>T	p.Pro382Leu	c.1145C>T	p.Pro382Leu	principal1	Y	1	YES	Select	-	CCG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.994	0.82066	D	0.84	0.90354	D	simple_aae	16.0	84.0	4.38	0.98551	H	-8.11	0.96790	D	0.991	0.99931	0.9293	0.96079	D	0.9141	0.97148	D	10	0.098901	0.17727	T	0.340959	0.91996	D	0.924	0.98114	.	.	.	.	.	0.996916127999	0.99684	0.9452338491035593	0.94471	0.545350321835	0.51282	0.793032765388	0.80869	T	0.814637	0.95367	D	0.189861	0.72749	D	0.511622	0.94806	D	0.166661954763206	0.18122	T	0.993601	0.97922	D	0.9647362	0.97716	0.90539914	0.95296	0.95915383	0.97150	0.91196984	0.95771	-13.522	0.91416	D	0.6351	0.70496	P	0.999807046151031	0.98063	0.88662580	0.90752	0.979	0.99252	.	.	.	.	.	.	5.267127	0.8846	29.6	0.99905294881567519	0.97578	0.930971	0.91880	D	1.10766323443215	0.98264	17.84405	1.01674911766596	0.98920	19.90689	5.41	5.41	0.78283	.	.	9.968	0.99105	11.712000	0.94677	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.986	0.61779	364	0.84712	9	0.0017971246006389776	1	7.564296520423601E-4	5	0.004970178926441352	1	0.001440922190201729	0	0.0	2	0.002044989775051125	1081	264690	0.0040840227	.	415	109388	3.793830e-03	0	833	208074	4.003380e-03	3	938	236878	3.959840e-03	5	9	7164	1.256280e-03	0	30	17110	1.753360e-03	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	34	13380	2.541110e-03	0	322	42768	7.528990e-03	0	14	15690	8.922880e-04	0	322	42768	7.528990e-03	0	17	16216	1.048350e-03	0	44	30522	1.441580e-03	1	3	6212	4.829360e-04	0	0	13410	0.000000e+00	0	42	16720	2.511960e-03	0	661	89524	7.383490e-03	2	48	30608	1.568220e-03	0	661	89524	7.383490e-03	2	15	14900	1.006710e-03	0	46	34258	1.342750e-03	0	11	9570	1.149430e-03	0	0	17686	0.000000e+00	0	60	21614	2.775980e-03	0	737	102710	7.175540e-03	5	48	30526	1.572430e-03	0	737	102710	7.175540e-03	5	.	8824	1614214	5.466440e-03	35	11	912	1.206140e-02	0	86	75056	1.145810e-03	0	11	912	1.206140e-02	0	84	60032	1.399250e-03	0	38	29608	1.283440e-03	1	0	44890	0.000000e+00	0	205	64032	3.201520e-03	0	8	6062	1.319700e-03	0	7992	1180026	6.772730e-03	32	141	91088	1.547950e-03	0	1311	184528	0.007104612850082372	0	360	0	0	4504	0	17	9456	0.0017978003384094754	4	804	0.004975124378109453	1	974	0.001026694045174538	0	1850	0	0	280	0	98	17692	0.005539226769161203	17	9816	0.0017318663406682966	0	6354	0	1431	220448	0.00649132675279431	Glycogen_storage_disease,_type_VI|not_provided|PYGL-related_disorder|not_specified	criteria_provided,_conflicting_classifications	NC_000014.9:g.50915919G>A	ClinGen:CA7183547	C0017925|C3661900|CN169374	232700	369	.	Pro	Leu	76.44	0.5294117647058824																																																																																																																																																																																																																																																																																																																																																																																																																																																																													72			76.44	Special, No backbone hydrogen	Proline		Glycogen phosphorylase, liver form										1.6								 P382-R387 (PAE:  2.0)	P382-R387 (PDBs: 1FA9)									115									-55.6				-35.2						H (helix)	G (3₁₀-helix)	Helix											76.44	52.941177	70-90	10-90	232700	autosomal recessive	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE VI	false	0.8886725148771857	0.8714634093561752	false	false	false
MLH1	MLH1_Gly147Arg	B_11-12	-0.4643113784640383	0.6608436910288769	0.7310475325624298	5.140502417422929	0.002872940677602566	0.005793237520220559	2024_12_Batch_11-12	true	true	true	false	false	true	true	true	false	false	false	false	0.9849990017436715	0.9849672915642513	0.8929041286221114	0.8041458195284921	0.8462214232316738	0.8933324714499334		0.9240826473902641		0.9179345861782342	0.9855809905502791	0.9843460606746367	0.8933324714499334	0.7683601990730836	0.8041458195284921	0.8678736710659887	0.9843535925782236	0.9856519428127063	MLH1	Gly147Arg	NC_000003.12:37007049:G:C	439G>C	3	37007049	G	C	3	ENSG00000076242	2713	200832	CCSBVarC003198	ALE00003198	ENSP00000231790.3	CEGS2	CegsMutGDEh1047	A02	GDEhDisVCh_40019	E03	1	CegsMutGDDh1047	A02	VUSN2Hmut_GDN2h_10	B04	VUSMutpDEST2_02	D08	VUSmut_GDEh10	B04	1.0	3.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	N	Y	Y	Y	Y	95692.0	single nucleotide variant	NM_000249.4(MLH1):c.439G>C (p.Gly147Arg)	4292.0	MLH1	HGNC:7127	Conflicting classifications of pathogenicity	1.0	Sep 07, 2023	267607747.0	-	RCV001296249|RCV001804821|RCV003460711	MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144	Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|Colorectal cancer, hereditary nonpolyposis, type 2	germline;unknown	germline	GRCh38	NC_000003.12	3	37007049.0	37007049.0	3p22.2	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA010397	2.0	90218.0	37007049.0	G	C	-	-	-	-	-	-	439G>C 	Gly147Arg	NM_000249.4	1.0	Conflicting	Conflicting	90218	3	37007049.0	G	C	G	R	rs267607747	3	37048540	3	37023544	147	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.439G>C	p.Gly147Arg	c.439G>C	p.Gly147Arg	principal1	Y	1	YES	Select	+	GGG	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.994	0.82066	D	.	.	.	.	.	.	4.845	0.99707	H	-7.58	0.96508	D	0.865	0.86161	0.5613	0.91353	D	0.7433	0.91212	D	10	0.9826564	0.98340	D	0.195461	0.86388	D	0.921	0.98001	0.949	0.99385	P40692	G147R	Loss of catalytic residue at T148 (P = 0.1326)| Gain of disorder (P = 0.2049)| Gain of MoRF binding (P = 0.2588)| Loss of sheet (P = 0.3635)| Gain of phosphorylation at T151 (P = 0.4565)	0.972475911563	0.97191	0.9617962722525801	0.96143	0.436062898333	0.43424	0.886325120926	0.94788	D	0.888425	0.97693	D	0.560816	0.96216	D	0.567797	0.96157	D	0.999492406845093	0.97611	D	0.991201	0.97304	D	0.93575203	0.94736	0.91927624	0.96295	0.9366411	0.94828	0.90880173	0.95542	-11.615	0.87142	D	0.998	0.97393	P	0.999857555735447	0.98365	0.99982232	0.99765	0.997	0.99892	.	.	.	.	.	.	5.502153	0.91609	32.0	0.99932712659676204	0.99439	0.929076	0.91397	D	0.879867916761638	0.90687	10.54288	0.87500134831501	0.94356	12.7222	6.16	6.16	0.99301	.	.	9.674	0.97905	11.740000	0.95180	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.995	0.73271	266	0.89557	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Hereditary_nonpolyposis_colorectal_neoplasms	criteria_provided,_conflicting_classifications	NC_000003.12:g.37007049G>C	ClinGen:CA010397	C0027672|C1333991|C0009405	609310	140162|144	.	Gly	Arg	96.19	0.047619047619047616																																																																																																																																																																																																																																																																																																																																																																																																																																																																													4			96.19	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		DNA mismatch repair protein Mlh1										-0.4								 G147-K118 (PAE:  1.0), G147-T117 (PAE: 1.5)	G147-K118 (PDBs: 4P7A), G147-T117 (PDBs: 4P7A)	 G147-K118 (PAE:  1.0), G147-G65 (PAE: 1.5)	G147-K118 (PDBs: 4P7A), G147-G65 (PDBs: 4P7A)							75									115.9				-165.5						B (undefined)	E (parallel sheets)	Beta strand											96.19	4.7619047	>90	<10	609310	autosomal dominant	GenCC	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 2	false	0.9849672915642513	0.9849990017436715	true	true	true
NEXN	NEXN_Tyr544Cys	B_7-8	0.11971645615453054	0.9086157343061153	0.9320386963075619	7.502152756180353	0.00029010805979610207	0.0009038171302645963	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7143079709726868	0.744925494524755	0.5550509235259028	0.6461856461483699	0.6136040159576086	0.591530775538673	0.6378879641117489	0.5705217494479877	0.6914905241224475	0.6000289442809954	0.8264208867976408	0.7807935537308286	0.5451735869655969	0.6566862824672296	0.6008807681742924	0.5100729027708102	0.6634301022518693	0.6478223882145451	NEXN	Tyr544Cys	NC_000001.11:77942756:A:G	1631A>G	1	77942756	A	G	1	ENSG00000162614	56360	205332	CCSBVarC003659	ALE00003659	ENSP00000333938.7	CEGS2	CegsMutGDEh1031	A12	GDEhDisVCh_40088	C06	2	CegsMutGDDh1031	A12	VUSN2Hmut_GDN2h_05	G10	VUSMutpDEST2_13	H07	VUSmut_GDEh05	G10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	15365.0	single nucleotide variant	NM_144573.4(NEXN):c.1955A>G (p.Tyr652Cys)	91624.0	NEXN	HGNC:29557	Conflicting classifications of pathogenicity	1.0	Mar 01, 2024	137853197.0	-	RCV000000354|RCV000183674|RCV000234084|RCV000246924|RCV000208290|RCV000491470|RCV001170736|RCV003147270	MONDO:MONDO:0013147,MedGen:C2751084,OMIM:613122,Orphanet:154|MedGen:C3661900|MONDO:MONDO:0013477,MedGen:C3151267,OMIM:613876;MONDO:MONDO:0013147,MedGen:C2751084,OMIM:613122,Orphanet:154|MedGen:CN230736|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0013262,MedGen:C1834481,OMIM:613426,Orphanet:154,Orphanet:54260|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|MONDO:MONDO:0013477,MedGen:C3151267,OMIM:613876	Dilated cardiomyopathy 1CC|not provided|Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC|Cardiovascular phenotype|Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Cardiomyopathy|Hypertrophic cardiomyopathy 20	germline;unknown	germline	GRCh38	NC_000001.11	1	77942756.0	77942756.0	1p31.1	criteria provided, conflicting classifications	15.0	-	N	ClinGen:CA142143,UniProtKB:Q0ZGT2#VAR_063011,OMIM:613121.0002	3.0	326.0	77942756.0	A	G	-	-	-	-	-	-	1955A>G 	Tyr652Cys	NM_144573.4	1.0	Conflicting	Conflicting	326	1	77942756.0	A	G	Y	C	rs137853197	1	78408441	1	78181029	652	NEXN	ENSG00000162614	ENST00000334785	ENSP00000333938	Q0ZGT2	NEXN_HUMAN	c.1955A>G	p.Tyr652Cys	c.1955A>G	p.Tyr652Cys	principal3	Y	1	YES	Select	+	TAT	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.405	0.98640	H	-6.84	0.93080	D	0.987	0.99555	0.8878	0.95492	D	0.7884	0.92803	D	9	0.9686218	0.96361	D	0.284254	0.90317	D	0.932	0.98414	.	.	.	.	.	.	.	0.9029271104929691	0.90203	0.352709131036	0.36811	0.773563623428	0.77919	T	0.41144	0.76422	T	0.282491	0.81394	D	0.404671	0.92207	D	0.976604521274567	0.71261	D	0.988501	0.96045	D	0.9286056	0.94008	0.9080022	0.95484	0.9302952	0.94180	0.89345485	0.94437	-13.551	0.91805	D	0.9965	0.97565	P	0.994226018154719	0.90514	0.99273100	0.97196	0.835	0.90915	.	.	.	.	.	.	4.969381	0.82258	27.7	0.99754865971793927	0.84551	0.954857	0.97218	D	1.03673529226291	0.96749	15.11629	0.936693912644128	0.96964	15.41688	5.84	5.84	0.93363	6.5	0.99641	9.325	0.96016	9.324000	0.80102	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.909	0.44474	720	0.55465	.	.	.	.	.	.	.	.	.	.	.	.	19	264690	7.178209E-5	.	6	108552	5.527300e-05	0	16	205970	7.768120e-05	0	13	234144	5.552140e-05	0	0	7126	0.000000e+00	0	0	17042	0.000000e+00	0	0	2316	0.000000e+00	0	0	8630	0.000000e+00	0	0	13302	0.000000e+00	0	5	42588	1.174040e-04	0	1	15654	6.388140e-05	0	5	42588	1.174040e-04	0	0	15416	0.000000e+00	0	0	30442	0.000000e+00	0	0	6180	0.000000e+00	0	0	12980	0.000000e+00	0	0	16642	0.000000e+00	0	13	88980	1.461000e-04	0	2	30554	6.545790e-05	0	13	88980	1.461000e-04	0	0	14120	0.000000e+00	0	0	34168	0.000000e+00	0	0	9532	0.000000e+00	0	0	17272	0.000000e+00	0	0	21486	0.000000e+00	0	10	101588	9.843680e-05	0	2	30472	6.563400e-05	0	10	101588	9.843680e-05	0	.	247	1613652	1.530690e-04	0	226	1179750	1.915660e-04	0	2	74888	2.670650e-05	0	0	912	0.000000e+00	0	1	59970	1.667500e-05	0	0	29594	0.000000e+00	0	0	44890	0.000000e+00	0	3	64024	4.685740e-05	0	0	6084	0.000000e+00	0	226	1179750	1.915660e-04	0	5	91068	5.490400e-05	0	25	163848	1.5258044040818318E-4	0	168	0	0	4476	0	0	4158	0	0	796	0	0	968	0	0	1818	0	1	280	0.0035714285714285713	1	13528	7.392075694855116E-5	0	4326	0	0	6294	0	27	190040	1.4207535255735635E-4	Dilated_cardiomyopathy_1CC|Hypertrophic_cardiomyopathy_20|not_provided|Primary_dilated_cardiomyopathy|Cardiovascular_phenotype|Dilated_cardiomyopathy_1S|Cardiomyopathy	criteria_provided,_conflicting_classifications	NC_000001.11:g.77942756A>G	ClinGen:CA142143|OMIM:613121.0002|UniProtKB:Q0ZGT2#VAR_063011	C2751084|C3151267|C3661900|C0007193|CN230736|C1834481|C0878544	613122|613876|613426	154|217604|154|54260|167848	.	Tyr	Cys	97.54	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.54	0.0	>90	<10	613122;613876;613122;613426;613876	autosomal dominant	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	CARDIOMYOPATHY, DILATED, 1CC; CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CARDIOMYOPATHY, DILATED, 1CC; CARDIOMYOPATHY, DILATED, 1S; CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20	false	0.744925494524755	0.7143079709726868	false	false	false
RAD51D	RAD51D_Phe305Leu	B_13-14	0.583403789039403	0.6005843938160091	0.675967113841236	7.076099825437383	0.005803811750101772	0.010725070051799348	2025_01_Batch_13-14	false	true	false	true	true	true	false	false	false	false	false	false	0.9586643884552024	0.956456009205624	0.7813067542933229	0.9169036265274331	0.8798377746162145	0.8957362689406257							0.8957362689406257	0.8798377746162145	0.9169036265274331	0.7813067542933229	0.956456009205624	0.9586643884552024	RAD51D	Phe305Leu	NC_000017.11:35101025:G:C	915C>G	17	35101025	G	C	17	ENSG00000185379	7201	0	CCSBVarC024886	ALE00031726	ENSP00000338790.6																																	478443.0	single nucleotide variant	NM_002878.4(RAD51D):c.915C>G (p.Phe305Leu)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Apr 01, 2024	1316114457.0	-	RCV001040689|RCV000568982|RCV004760603	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	germline	germline	GRCh38	NC_000017.11	17	35101025.0	35101025.0	17q12	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA399086171	2.0	480950.0	35101025.0	G	C	-	-	-	-	-	-	915C>G 	Phe305Leu	NM_002878.4	1.0	Conflicting	Conflicting	480950	17	35101025.0	G	C	F	L	rs1316114457	17	33428044	17	30452157	305	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.915C>G	p.Phe305Leu	c.915C>G	p.Phe305Leu	principal1	Y	1	YES	Select	-	TTC	3	2	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.05249	T	0.0	0.02950	B	0.0	0.01384	B	.	.	.	.	.	.	0.83	0.20850	L	0.13	0.05476	N	0.053	0.11150	-1.0215	0.23176	T	0.1042	0.38033	T	10	0.040840566	0.02691	T	0.009973	0.25673	T	0.024	0.04912	0.301	0.26717	O75771	F305L	Gain of disorder (P = 0.0917)| Gain of MoRF binding (P = 0.1056)| Loss of phosphorylation at T303 (P = 0.1899)| Gain of relative solvent accessibility (P = 0.2629)| Loss of sheet (P = 0.302)	0.444807159249	0.43722	.	0.23376	.	0.10592	.	.	.	0.051884	0.28757	T	-0.259589	0.12690	T	-0.610658	0.11674	T	0.0400510121688084	0.03670	T	.	0.18007	.	0.045180835	0.07283	0.032197934	0.01928	0.045180835	0.07282	0.032197934	0.01928	-2.604	0.08768	T	0.3499	0.57023	A	4.50213563311964e-06	0.00398	0.25410953	0.75297	0.005	0.00124	.	.	.	.	.	.	1.205182	0.15999	12.23	0.83537688913623076	0.15012	0.108385	0.21352	N	-1.04489556684859	0.07596	0.357995	-0.957731270841975	0.10562	0.543092	5.16	1.6	0.22627	1.17	0.30762	-0.02	0.12505	1.312000	0.25630	-0.105	0.15707	0.788	0.29661	1.000000	0.68239	0.621	0.31965	913	0.21155	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613800	1.239310e-06	0	2	1179680	1.695380e-06	0	0	75040	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29606	0.000000e+00	0	0	44886	0.000000e+00	0	0	64040	0.000000e+00	0	0	6062	0.000000e+00	0	2	1179680	1.695380e-06	0	0	91072	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101025G>C	ClinGen:CA399086171	C0027672|C3280345	614291	140162|145	.	Phe	Leu	91.25	0.3553299492385787																																																																																																																																																																																																																																																																																																																																																																																																																																																																													70			91.25	Aromatic	Phenylalanine		DNA repair protein RAD51 homolog 4										2.8								 F305-L295 (PAE:  2.0)	F305-L295 (PDBs: 8FAZ)		F305-C294 (PDBs: 8FAZ, 8OUY, 8OUZ), F305-A293 (PDBs: 8GBJ), F305-L92 (PDBs: 8OUZ), F305-L295 (PDBs: 8OUZ)							165									-60.2				136.3						C (loop/coil)	C (loop/coil)												91.25	35.532997	>90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.956456009205624	0.9586643884552024	true	false	false
CTCF	CTCF_Ala697Thr	B_13-14	-1.1232772209850925	0.298362229751802	0.385830642400773	0.8829117642446225	0.4065815603851444	0.46054145883132097	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5704400228176523	0.5724589014560164	0.4532682821445523	0.5769498070259355	0.6164565413426238	0.4857939398699596	0.41983522041075283	0.533930307773701	0.4863207111506794	0.41904686476376773	0.5828175724305668	0.577953689664669	0.5517526593291664	0.6989827749115467	0.6675789029011916	0.4874896995253368	0.562100230481466	0.5629263559706356	CTCF	Ala697Thr	NC_000016.10:67637777:G:A	2089G>A	16	67637777	G	A	16	ENSG00000102974	6173	0	CCSBVarC010818	ALE00010437	ENSP00000264010.4																																	580362.0	single nucleotide variant	NM_006565.4(CTCF):c.2089G>A (p.Ala697Thr)	10664.0	CTCF	HGNC:13723	Conflicting classifications of pathogenicity	0.0	Aug 22, 2023	201916739.0	-	RCV002318105|RCV004535791|RCV003323701	MeSH:D030342,MedGen:C0950123||MedGen:CN169374	Inborn genetic diseases|CTCF-related disorder|not specified	germline	germline	GRCh38	NC_000016.10	16	67637777.0	67637777.0	16q22.1	criteria provided, conflicting classifications	3.0	-	N	-	2.0	589165.0	67637777.0	G	A	-	-	-	-	-	-	2089G>A 	Ala697Thr	NM_006565.4	1.0	Conflicting	Conflicting	589165	16	67637777.0	G	A	A	T	rs201916739	16	67671680	16	66229181	697	CTCF	ENSG00000102974	ENST00000264010	ENSP00000264010	P49711	CTCF_HUMAN	c.2089G>A	p.Ala697Thr	c.2089G>A	p.Ala697Thr	principal4	Y	1	YES	Select	+	GCA	1	0	G	G/G	G/G	G/G	G/G	0.222	0.23840	T	0.358	0.23039	T	0.0	0.02950	B	0.0	0.01384	B	0.06	0.40172	N	simple_aae	94.0	6.0	0.345	0.11102	N	-0.8	0.23318	N	0.113	0.10018	-0.9502	0.40759	T	0.0130	0.05035	T	10	0.074863106	0.11429	T	0.003775	0.08537	T	0.085	0.24571	0.089	0.00976	P49711	A697T	Gain of phosphorylation at A697 (P = 0.0106)| Gain of glycosylation at A697 (P = 0.0115)| Gain of loop (P = 0.0502)| Gain of solvent accessibility (P = 0.2291)| Gain of helix (P = 0.2684)	0.352914559346	0.34492	.	0.11959	0.580823813372	0.53620	0.28278157115	0.07880	T	0.353355	0.71894	T	-0.426293	0.01463	T	-0.680989	0.06720	T	0.068806566298008	0.08383	T	.	0.24416	.	0.019917462	0.00532	0.048129845	0.07099	0.02436098	0.01251	0.0497265	0.07671	-4.231	0.28985	T	.	0.04616	.	0.0183708095774007	0.28756	0.18858771	0.72542	0.025	0.04491	.	.	.	.	.	.	1.499315	0.19306	14.18	0.90883258671168698	0.20385	0.269145	0.38347	N	-0.557516232399653	0.20004	1.066043	-0.41758376025414	0.24164	1.340807	5.92	2.91	0.32820	1.78	0.37175	3.992	0.56781	1.282000	0.25443	-0.108	0.15302	0.923	0.3214	0.001000	0.17376	0.323	0.25089	50	0.97656	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	1	109398	9.140930e-06	0	3	208038	1.442040e-05	0	3	236742	1.267200e-05	0	0	7162	0.000000e+00	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42764	0.000000e+00	0	0	15686	0.000000e+00	0	1	17112	5.843850e-05	0	0	16214	0.000000e+00	0	1	30522	3.276330e-05	0	0	6210	0.000000e+00	0	1	13416	7.453790e-05	0	0	16732	0.000000e+00	0	1	89478	1.117590e-05	0	0	30604	0.000000e+00	0	1	13416	7.453790e-05	0	0	14898	0.000000e+00	0	1	34256	2.919200e-05	0	0	9566	0.000000e+00	0	1	17690	5.652910e-05	0	0	21628	0.000000e+00	0	1	102564	9.750010e-06	0	0	30522	0.000000e+00	0	1	17690	5.652910e-05	0	.	36	1613310	2.231440e-05	0	3	44888	6.683300e-05	0	0	74890	0.000000e+00	0	0	912	0.000000e+00	0	1	59996	1.666780e-05	0	0	29602	0.000000e+00	0	3	44888	6.683300e-05	0	0	64024	0.000000e+00	0	0	5544	0.000000e+00	0	28	1180018	2.372850e-05	0	1	91036	1.098470e-05	0	9	163634	5.5000794455919916E-5	0	176	0	0	2710	0	0	4744	0	0	796	0	1	968	0.0010330578512396695	0	682	0	0	280	0	1	13700	7.299270072992701E-5	0	4920	0	0	3392	0	11	187690	5.860727795833555E-5	not_specified|CTCF-related_disorder|Inborn_genetic_diseases	criteria_provided,_conflicting_classifications	NC_000016.10:g.67637777G>A	.	CN169374|C0950123	.	.	.	Ala	Thr	36.77	0.7924528301886793																																																																																																																																																																																																																																																																																																																																																																																																																																																																													84			36.77	Aliphatic	Alanine		Transcriptional repressor CTCF		Acidic residues								1.8																		89									-155.1				134.7	Disordered					C (loop/coil)	C (loop/coil)												36.77	79.245285	$\leqslant$50	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.5724589014560164	0.5704400228176523	false	false	false
SDHD	SDHD_Ala90Val	B_13-14	3.9356948777612146	0.00674516202223278	0.019493125927521303	-0.46375151006751336	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7190970905344573	0.7505158628737891	0.6615055024256769	0.7015128207138532	0.7454514544613721	0.6940947210921373	0.7558808761574028	0.7593925667328328	0.7061510190696425	0.7179874367955237	0.7491277575717876	0.7123046699589681	0.6323085660268718	0.7315103421899113	0.696874622358064	0.6050235680558301	0.7519039681757906	0.7258895111099464	SDHD	Ala90Val	NC_000011.10:112088966:C:T	269C>T	11	112088966	C	T	11	ENSG00000204370	6363	0	CCSBVarC023308	ALE00021474	ENSP00000364699.3																																	398394.0	single nucleotide variant	NM_003002.4(SDHD):c.269C>T (p.Ala90Val)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Jan 25, 2024	200255724.0	-	RCV000562410|RCV001584171|RCV002230663|RCV001821298	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MedGen:C1868633|MedGen:CN169374	Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss|not specified	germline;unknown	germline	GRCh38	NC_000011.10	11	112088966.0	112088966.0	11q23.1	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA070974	2.0	412511.0	112088966.0	C	T	-	-	-	-	-	-	269C>T 	Ala90Val	NM_003002.4	1.0	Conflicting	Conflicting	412511	11	112088966.0	C	T	A	V	rs200255724	11	111959690	11	111464900	90	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.269C>T	p.Ala90Val	c.269C>T	p.Ala90Val	principal1	Y	1	YES	Select	+	GCG	2	0	C	./.	./.	./.	./.	0.458	0.15912	T	1.0	0.17298	T	0.006	0.13655	B	0.002	0.06938	B	0.13	0.45549	N	simple_aae	87.0	13.0	-0.4	0.02998	N	-0.49	0.18604	N	0.325	0.37474	-0.0242	0.81670	T	0.7223	0.90456	D	10	0.033454627	0.01525	T	0.039239	0.58532	D	0.538	0.80564	0.554	0.67018	O14521	A90V	Gain of catalytic residue at A90 (P = 0.0619)| Loss of glycosylation at S94 (P = 0.2021)| Loss of helix (P = 0.3949)| Gain of solvent accessibility (P = 0.4304)| Loss of sheet (P = 0.5184)	0.97841390163	0.97797	0.6562659735392878	0.65397	0.186988364634	0.20745	0.404172539711	0.25620	T	0.612815	0.87639	D	-0.096085	0.36716	T	0.0203817	0.71444	D	0.0642470002855991	0.07730	T	0.778722	0.41636	T	0.025199682	0.01422	0.04753903	0.06884	0.025199682	0.01422	0.04753903	0.06884	-3.974	0.23434	T	0.063	0.13138	B	0.0286794542137332	0.32439	0.96888520	0.94571	0.063	0.17447	.	.	.	.	.	.	1.598506	0.20471	14.75	0.96925041798389644	0.31823	0.374914	0.45781	N	-0.764187358777515	0.14078	0.7083525	-0.647685205617222	0.17985	0.9755563	5.04	1.52	0.22101	.	.	0.348	0.19856	-0.210000	0.10908	0.549	0.27038	0.03	0.20497	0.000000	0.08389	0.993	0.69292	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	segdup	17	109406	1.553850e-04	0	32	208128	1.537520e-04	0	31	236928	1.308410e-04	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	17	15690	1.083490e-03	0	17	15690	1.083490e-03	0	0	16218	0.000000e+00	0	1	30524	3.276110e-05	0	0	6212	0.000000e+00	0	1	13414	7.454900e-05	0	0	16734	0.000000e+00	0	2	89554	2.233290e-05	0	28	30608	9.147940e-04	0	28	30608	9.147940e-04	0	0	14902	0.000000e+00	0	1	34260	2.918860e-05	0	0	9572	0.000000e+00	0	0	17690	0.000000e+00	0	0	21632	0.000000e+00	0	2	102728	1.946890e-05	0	28	30526	9.172510e-04	0	28	30526	9.172510e-04	0	.	119	1614014	7.372920e-05	1	101	91090	1.108790e-03	1	0	74936	0.000000e+00	0	0	912	0.000000e+00	0	2	60008	3.332890e-05	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	64032	0.000000e+00	0	0	6060	0.000000e+00	0	15	1179998	1.271190e-05	0	101	91090	1.108790e-03	1	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Hereditary_cancer-predisposing_syndrome|not_provided|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|not_specified	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088966C>T	ClinGen:CA070974	C0027672|C3661900|C1868633|C1847319|C0031511|CN166604|CN169374	606864|171300	140162|97286|29072|201	.	Ala	Val	98.3	0.6320754716981132																																																																																																																																																																																																																																																																																																																																																																																																																																																																													67			98.3	Aliphatic	Alanine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										1.8								 A90-S94 (PAE:  1.0)	A90-S94 (PDBs: 8GS8)	 A90-S94 (PAE:  1.0)	A90-S94 (PDBs: 8GS8)							89									-61.7				-36.6						H (helix)	H (α-helix)	Helix						Mitochondrial intermembrane					98.3	63.20755	>90	10-90	171300;606864	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	false	0.7505158628737891	0.7190970905344573	false	false	false
RAD51D	RAD51D_Val132Ile	B_13-14	1.1951833385138684	0.270931637294705	0.3571286592359465	18.122854566401507	3.8520208993757504e-7	9.424611133806003e-6	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	false	false	0.9619516791937082	0.9644506533336035	0.7572019810870876	0.8976004544613356	0.8331435633184383	0.8393044044682156	0.8516881262472686	0.8261580596953884	0.8931120068824487	0.8041051369321671	0.9597185698395795	0.9690372297207361	0.8269206826891625	0.8401290669414883	0.9020889020402224	0.7102988252420082	0.9691827368276275	0.9548661286666801	RAD51D	Val132Ile	NC_000017.11:35107074:C:T	394G>A	17	35107074	C	T	17	ENSG00000185379	7201	0	CCSBVarC024822	ALE00029930	ENSP00000338790.6																																	184833.0	single nucleotide variant	NM_002878.4(RAD51D):c.394G>A (p.Val132Ile)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	May 13, 2024	201141245.0	-	RCV000164547|RCV000458927|RCV000588322|RCV001356158|RCV004764772	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Malignant tumor of breast|Hereditary breast ovarian cancer syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	35107074.0	35107074.0	17q12	criteria provided, conflicting classifications	15.0	-	N	ClinGen:CA191240	2.0	185178.0	35107074.0	C	T	-	-	-	-	-	-	394G>A 	Val132Ile	NM_002878.4	1.0	Conflicting	Conflicting	185178	17	35107074.0	C	T	V	I	rs201141245	17	33434093	17	30458206	132	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.394G>A	p.Val132Ile	c.394G>A	p.Val132Ile	principal1	Y	5	.	.	-	GTC	1	0	C	C/C	C/C	C/C	C/C	.	0.44188	.	0.039	0.53076	D	0.424	0.35468	B	0.382	0.43907	B	0.05	0.18971	N	simple_aae	95.0	5.0	2.62	0.76477	M	.	0.22672	.	0.216	0.24096	-0.3916	0.72168	T	0.3597	0.72046	T	10	0.109271616	0.20146	T	0.071049	0.71066	D	0.229	0.52699	.	.	.	.	.	0.62430428174	0.61834	.	0.37837	.	0.25574	.	.	.	0.15308	0.49109	T	-0.122049	0.32431	T	-0.107115	0.62576	T	0.0757847073892739	0.09324	T	0.738826	0.35767	T	0.08056444	0.18299	0.09804036	0.23318	0.08056444	0.18299	0.09804036	0.23318	-7.63	0.58592	D	0.1016	0.17936	B	0.000961144535626309	0.09382	0.62951803	0.84609	0.122	0.32993	.	.	.	.	.	.	1.358257	0.17693	13.3	0.72709087620192148	0.10230	0.067676	0.13137	N	-0.614819935582183	0.18271	0.9608728	-0.673516161556329	0.17340	0.9379878	4.65	2.66	0.30590	0.89	0.28255	1.984	0.40383	-0.207000	0.10935	-0.939	0.02107	0.942	0.32811	0.000000	0.08389	0.696	0.34057	921	0.19236	2	3.9936102236421724E-4	1	7.564296520423601E-4	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	30	264690	1.1334013E-4	.	6	109402	5.484360e-05	0	14	208126	6.726690e-05	0	15	236922	6.331200e-05	0	2	7164	2.791740e-04	0	3	17112	1.753160e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	1	13388	7.469380e-05	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	2	7164	2.791740e-04	0	5	16218	3.082990e-04	0	4	30524	1.310440e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	1	16728	5.978000e-05	0	4	89554	4.466580e-05	0	0	30608	0.000000e+00	0	5	16218	3.082990e-04	0	4	14902	2.684200e-04	0	5	34260	1.459430e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	1	21626	4.624060e-05	0	5	102724	4.867410e-05	0	0	30526	0.000000e+00	0	4	14902	2.684200e-04	0	.	72	1614046	4.460840e-05	0	3	6060	4.950500e-04	0	8	74988	1.066840e-04	0	0	912	0.000000e+00	0	7	60010	1.166470e-04	0	0	29606	0.000000e+00	0	4	44860	8.916630e-05	0	1	64012	1.562210e-05	0	3	6060	4.950500e-04	0	42	1180002	3.559320e-05	0	2	91086	2.195730e-05	0	12	179916	6.669779230307477E-5	0	360	0	0	2712	0	1	9384	1.0656436487638534E-4	0	796	0	0	968	0	0	682	0	0	278	0	0	15410	0	1	9744	1.0262725779967159E-4	0	3394	0	13	210506	6.175595945008693E-5	not_provided|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35107074C>T	ClinGen:CA191240	C3661900|C0027672|C0006142|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Val	Ile	97.74	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			97.74	Aliphatic	Valine		DNA repair protein RAD51 homolog 4										4.2								 V132-Q168 (PAE:  1.0), V132-R166 (PAE: 1.0)	V132-R166 (PDBs: 8FAZ, 8GBJ, 8OUZ), V132-Q168 (PDBs: 8OUY, 8OUZ)	 V132-Q168 (PAE:  1.0)	V132-A121 (PDBs: 8FAZ, 8GBJ), V132-R166 (PDBs: 8OUY, 8OUZ), V132-V124 (PDBs: 8OUZ), V132-Q168 (PDBs: 8OUZ), V132-V200 (PDBs: 8OUZ), V132-V202 (PDBs: 8OUZ), V132-I167 (PDBs: 8OUZ)							117									-123.4				129.5						B (undefined)	E (parallel sheets)	Beta strand											97.74	0.0	>90	<10	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.9644506533336035	0.9619516791937082	true	false	false
RAD51D	RAD51D_Asn138His	B_13-14	1.6166526065546751	0.14998682499991292	0.22531588998300964	14.59311297744467	1.6944447221729085e-6	0.000022369108382642354	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	false	false	0.9674125875475922	0.9755801464748463	0.7814436982564397	0.8807836573756975	0.8094823205889312	0.8499588062052414	0.7678398411004952	0.7605395375783912	0.822440928427971	0.7088100435442138	0.9739202999761202	0.9765537401874611	0.9320777713099877	0.8584251035994712	0.9391263863234242	0.8540773529686656	0.9772399929735723	0.9582714349077233	RAD51D	Asn138His	NC_000017.11:35107056:T:G	412A>C	17	35107056	T	G	17	ENSG00000185379	7201	0	CCSBVarC024825	ALE00021194	ENSP00000338790.6																																	133345.0	single nucleotide variant	NM_002878.4(RAD51D):c.412A>C (p.Asn138His)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Feb 22, 2024	141690729.0	-	RCV000649680|RCV000760062|RCV000572128|RCV003321505	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	35107056.0	35107056.0	17q12	criteria provided, conflicting classifications	11.0	-	N	ClinGen:CA287974	2.0	127888.0	35107056.0	T	G	-	-	-	-	-	-	412A>C 	Asn138His	NM_002878.4	1.0	Conflicting	Conflicting	127888	17	35107056.0	T	G	N	H	rs141690729	17	33434075	17	30458188	138	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.412A>C	p.Asn138His	c.412A>C	p.Asn138His	principal1	Y	5	.	.	-	AAT	1	0	T	T/T	T/T	T/T	T/T	.	0.28402	.	0.1	0.56982	T	0.395	0.34741	B	0.591	0.50477	P	0.06	0.18971	N	simple_aae	94.0	6.0	2.35	0.67323	M	.	0.48032	.	0.307	0.34427	-0.4330	0.70838	T	0.3126	0.68139	T	10	0.45225775	0.58437	D	0.154917	0.83550	D	0.281	0.59659	0.625	0.75933	O75771	N138H	Gain of sheet (P = 0.1945)| Gain of disorder (P = 0.2095)| Loss of stability (P = 0.211)| Loss of helix (P = 0.2662)| Loss of solvent accessibility (P = 0.2953)	0.920393908519	0.91898	.	0.26696	.	0.40252	.	.	.	0.188245	0.53985	T	-0.0652968	0.41729	T	-0.127971	0.60868	T	0.542844533920288	0.33898	D	0.843016	0.51848	T	0.14909644	0.33722	0.17573822	0.39925	0.14909644	0.33722	0.17573822	0.39925	-6.785	0.53382	T	0.1649	0.36807	B	0.00403443879358769	0.17381	0.62988700	0.84616	0.079	0.22306	.	.	.	.	.	.	4.260774	0.64815	24.7	0.51412546772186041	0.04613	0.615052	0.60072	D	0.261244387338902	0.53967	3.585971	0.218849069588625	0.50637	3.276757	4.65	3.52	0.39345	2.95	0.53955	4.397	0.59537	6.109000	0.53713	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.885	0.42478	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	2	109408	1.828020e-05	0	1	208132	4.804640e-06	0	11	236936	4.642600e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	2	42768	4.676390e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89554	1.116640e-05	0	0	30608	0.000000e+00	0	1	89554	1.116640e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	11	102732	1.070750e-04	0	0	30526	0.000000e+00	0	11	102732	1.070750e-04	0	.	22	1613968	1.363100e-05	0	21	1180018	1.779630e-05	0	0	74892	0.000000e+00	0	0	912	0.000000e+00	0	0	59980	0.000000e+00	0	0	29608	0.000000e+00	0	0	44872	0.000000e+00	0	0	64026	0.000000e+00	0	0	6084	0.000000e+00	0	21	1180018	1.779630e-05	0	0	91090	0.000000e+00	0	1	32854	3.0437694040299505E-5	0	114	0	0	86	0	0	2852	0	0	500	0	0	628	0	0	26	0	0	98	0	0	5026	0	0	2966	0	0	112	0	1	42184	2.370567039635881E-5	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35107056T>G	ClinGen:CA287974	C0027672|CN169374|C3661900|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Asn	His	90.24	0.5414012738853503																																																																																																																																																																																																																																																																																																																																																																																																																																																																													85			90.24	Polar/Neutral	Asparagine		DNA repair protein RAD51 homolog 4										-3.5			D:N138-C:H307 (PDBs: 8FAZ), D:N138-C:T310 (PDBs: 8GBJ)	D:N138-C:T310 (PDBs: 8FAZ, 8GBJ), C:N138-B:I270 (PDBs: 8OUY, 8OUZ), C:N138-B:T310 (PDBs: 8OUZ)				 N138-S207 (PAE:  3.5)	N138-D206 (PDBs: 8FAZ), N138-S207 (PDBs: 8GBJ)	 N138-S207 (PAE:  3.5)	N138-D206 (PDBs: 8FAZ, 8GBJ, 8OUZ), N138-S207 (PDBs: 8OUY, 8OUZ)							132									-114.7				-8.1						C (loop/coil)	S (bend)	Beta strand											90.24	54.140125	>90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.9755801464748463	0.9674125875475922	true	false	false
FH	FH_Leu303Ser	B_13-14	4.116431421416617	0.006241164929272879	0.018949049230109028	-6.983543805285113	0.0002146739640115828	0.0007196261669979084	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8227928398807439	0.8893777367640372	0.6553513254160817	0.8093243128565971	0.7290332594678112	0.737916097717283	0.8461415910047141	0.7771048730062192	0.9008297488583683	0.6815899211688519	0.8870510095100044	0.8142974771670095	0.6296906044298519	0.6809616459294031	0.7178188768548259	0.6291127296633116	0.89170446401807	0.8312882025944783	FH	Leu303Ser	NC_000001.11:241504242:A:G	908T>C	1	241504242	A	G	1	ENSG00000091483	3408	0	CCSBVarC004051	ALE00004051	ENSP00000355518.4	CEGS2	CegsMutGDEh1040	C11	GDEhDisVCh_40065	F08	1	CegsMutGDDh1040	C11	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	50023.0	single nucleotide variant	NM_000143.4(FH):c.908T>C (p.Leu303Ser)	2271.0	FH	HGNC:3700	Conflicting classifications of pathogenicity	1.0	Aug 26, 2024	201502246.0	-	RCV000034486|RCV000471678|RCV000568576|RCV004767031	MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374	not provided|Fumarase deficiency|Hereditary cancer-predisposing syndrome|not specified	germline	germline	GRCh38	NC_000001.11	1	241504242.0	241504242.0	1q43	criteria provided, conflicting classifications	8.0	-	N	ClinGen:CA215563	2.0	41584.0	241504242.0	A	G	-	-	-	-	-	-	908T>C 	Leu303Ser	NM_000143.4	1.0	Conflicting	Conflicting	41584	1	241504242.0	A	G	L	S	rs201502246	1	241667542	1	239734165	303	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.908T>C	p.Leu303Ser	c.908T>C	p.Leu303Ser	principal1	Y	1	YES	Select	-	TTG	2	0	A	./.	./.	./.	./.	0.011	0.55689	D	0.023	0.57446	D	1.0	0.90580	D	0.987	0.77493	D	0.99	0.97926	D	simple_aae	1.0	99.0	3.44	0.92016	M	-4.68	0.79692	D	0.874	0.87133	0.9670	0.96644	D	0.9919	0.99799	D	10	0.9618218	0.95552	D	0.846144	0.98810	D	0.946	0.98921	0.745	0.87592	P07954	L303S	Loss of stability (P = 0.0343)| Gain of glycosylation at L303 (P = 0.0808)| Gain of disorder (P = 0.2233)| Gain of phosphorylation at T301 (P = 0.2914)| Gain of MoRF binding (P = 0.2989)	0.993238567584	0.99308	0.9823634086207722	0.98220	0.74807911618	0.63377	0.741951107979	0.73213	T	0.984249	0.99894	D	0.547779	0.95628	D	0.564556	0.95967	D	0.981520354747772	0.73778	D	0.970103	0.89232	D	0.72908586	0.79431	0.67910284	0.80933	0.72908586	0.79432	0.67910284	0.80934	-11.157	0.80574	D	0.7218	0.73810	P	0.993515370856004	0.90091	0.94387890	0.93050	0.8	0.88939	.	.	.	.	.	.	4.874147	0.7991	27.2	0.99846162936952287	0.92581	0.938010	0.93635	D	1.02294957323601	0.96387	14.65791	0.942700215822651	0.97163	15.70981	5.73	5.73	0.89714	6.28	0.98834	8.711	0.91115	11.145000	0.87201	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.992	0.67791	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	segdup	0	109296	0.000000e+00	0	2	207286	9.648500e-06	0	1	235642	4.243730e-06	0	0	7160	0.000000e+00	0	0	17080	0.000000e+00	0	0	2318	0.000000e+00	0	0	9036	0.000000e+00	0	0	13390	0.000000e+00	0	0	42732	0.000000e+00	0	0	15672	0.000000e+00	0	.	.	.	.	0	15810	0.000000e+00	0	0	30442	0.000000e+00	0	0	6202	0.000000e+00	0	0	13406	0.000000e+00	0	0	16720	0.000000e+00	0	2	89310	2.239390e-05	0	0	30572	0.000000e+00	0	2	89310	2.239390e-05	0	0	14502	0.000000e+00	0	0	34174	0.000000e+00	0	0	9556	0.000000e+00	0	0	17666	0.000000e+00	0	0	21616	0.000000e+00	0	1	102080	9.796240e-06	0	0	30490	0.000000e+00	0	1	102080	9.796240e-06	0	.	65	1613904	4.027500e-05	0	65	1179950	5.508710e-05	0	0	74938	0.000000e+00	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29600	0.000000e+00	0	0	44900	0.000000e+00	0	0	64028	0.000000e+00	0	0	6030	0.000000e+00	0	65	1179950	5.508710e-05	0	0	91074	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	not_provided|Hereditary_cancer-predisposing_syndrome|Fumarase_deficiency	criteria_provided,_conflicting_classifications	NC_000001.11:g.241504242A>G	ClinGen:CA215563	C3661900|C0027672|C0342770	606812	140162|24	Fumarate lyase, N-terminal	Leu	Ser	98.71	0.13414634146341464																																																																																																																																																																																																																																																																																																																																																																																																																																																																													22			98.71	Aliphatic	Leucine		Fumarate hydratase, mitochondrial										3.8										 L303-A298 (PAE:  1.0)	L303-A298 (PDBs: 5D6B, 3E04, 5UPP, 7LUB)							131									-104.0				150.1						C (loop/coil)	S (bend)												98.71	13.414635	>90	10-90	606812	autosomal recessive	OMIM	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	FUMARASE DEFICIENCY	false	0.8893777367640372	0.8227928398807439	false	false	false
BRIP1	BRIP1_Val76Ile	B_13-14	0.573151287218121	0.5988089065274734	0.6689073046264973	0.5894749250073064	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6688637504356367	0.6981594536098121	0.6985108447310949	0.6668004814977897	0.6776268585192535	0.7413831623744204	0.8059399250037561	0.6803208775214667	0.6631436522210339	0.7616332970350471	0.6785923477208712	0.6513560806668558	0.6768263997450846	0.6749328395170403	0.6704573107745456	0.6353883924271427	0.717726559498753	0.6863714202044177	BRIP1	Val76Ile	NC_000017.11:61857211:C:T	226G>A	17	61857211	C	T	17	ENSG00000136492	55128	0	CCSBVarC031290	ALE00031330	ENSP00000259008.2																																	402301.0	single nucleotide variant	NM_032043.3(BRIP1):c.226G>A (p.Val76Ile)	83990.0	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	0.0	Dec 24, 2023	769573395.0	-	RCV000473938|RCV000562576|RCV002056711	MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Fanconi anemia complementation group J;Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided	germline	germline	GRCh38	NC_000017.11	17	61857211.0	61857211.0	17q23.2	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA16615534	2.0	407851.0	61857211.0	C	T	-	-	-	-	-	-	226G>A 	Val76Ile	NM_032043.3	1.0	Conflicting	Conflicting	407851	17	61857211.0	C	T	V	I	rs769573395	17	59934572	17	57289354	76	BRIP1	ENSG00000136492	ENST00000259008	ENSP00000259008	Q9BX63	FANCJ_HUMAN	c.226G>A	p.Val76Ile	c.226G>A	p.Val76Ile	principal2	Y	1	YES	Select	-	GTA	1	0	C	C/C	C/C	C/C	C/C	0.279	0.15648	T	0.352	0.19614	T	0.0	0.02950	B	0.0	0.01384	B	0.03	0.10877	N	simple_aae	97.0	3.0	0.55	0.14367	N	0.03	0.06578	N	0.068	0.08480	-0.9732	0.36374	T	0.1619	0.49568	T	9	0.046871662	0.03935	T	0.039492	0.58683	D	0.127	0.34681	0.421	0.46221	Q9BX63	V76I	Gain of loop (P = 0.1069)| Loss of disorder (P = 0.1257)| Gain of helix (P = 0.132)| Loss of catalytic residue at V76 (P = 0.1841)| Loss of phosphorylation at S77 (P = 0.1941)	0.233150807113	0.22520	0.11234678450338882	0.11014	0.129564647105	0.14353	0.25607085228	0.04436	T	0.067288	0.32914	T	-0.358382	0.04058	T	-0.57104	0.15067	T	0.064310478718449	0.07741	T	.	0.05921	.	0.021931265	0.00820	0.01949408	0.00093	0.021931265	0.00820	0.01949408	0.00093	-3.56	0.17295	T	0.0643	0.01788	B	0.000209254300804412	0.04287	0.13816178	0.69646	0.033	0.07179	.	.	.	.	.	.	-0.178575	0.0321	0.53	0.57826123189942369	0.05936	0.021994	0.01033	N	-1.75017022248378	0.00673	0.02929016	-1.70554440226488	0.01101	0.05002578	5.24	-1.16	0.09157	-8.68	0.00559	0.283	0.18669	-0.247000	0.10584	-1.852	0.00571	0.001	0.13799	0.000000	0.08389	0.003	0.0525	42	0.97870	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	0	109368	0.000000e+00	0	1	208030	4.807000e-06	0	1	236816	4.222690e-06	0	0	7164	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9038	0.000000e+00	0	0	13386	0.000000e+00	0	0	42760	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	1	16218	6.165990e-05	0	0	30504	0.000000e+00	0	0	6212	0.000000e+00	0	0	13400	0.000000e+00	0	0	16726	0.000000e+00	0	0	89504	0.000000e+00	0	0	30604	0.000000e+00	0	1	16218	6.165990e-05	0	1	14902	6.710510e-05	0	0	34242	0.000000e+00	0	0	9570	0.000000e+00	0	0	17678	0.000000e+00	0	0	21620	0.000000e+00	0	0	102668	0.000000e+00	0	0	30522	0.000000e+00	0	1	14902	6.710510e-05	0	.	6	1613616	3.718360e-06	0	1	29598	3.378610e-05	0	2	74908	2.669940e-05	0	0	912	0.000000e+00	0	0	59992	0.000000e+00	0	1	29598	3.378610e-05	0	0	44880	0.000000e+00	0	0	63982	0.000000e+00	0	0	6084	0.000000e+00	0	3	1179728	2.542960e-06	0	0	91058	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Fanconi_anemia_complementation_group_J	criteria_provided,_conflicting_classifications	NC_000017.11:g.61857211C>T	ClinGen:CA16615534	C0027672|C3661900|C0346153|C1836860	114480|609054	140162|227535|84	.	Val	Ile	32.86	0.8309859154929577																																																																																																																																																																																																																																																																																																																																																																																																																																																																													118			32.86	Aliphatic	Valine		Fanconi anemia group J protein							Helicase ATP-binding			4.2																		117									-147.5				118.4						C (loop/coil)	S (bend)												32.86	83.09859	$\leqslant$50	10-90	609054;114480	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	FANCONI ANEMIA, COMPLEMENTATION GROUP J; BREAST CANCER	false	0.6981594536098121	0.6688637504356367	false	false	false
SHOC2	SHOC2_Met173Val	B_13-14	-0.3926407601204963	0.7062668529828494	0.7673320188835281	5.776884920881023	0.0006794150947910288	0.0017397556078792627	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.786819942109232	0.8002640910476306	0.7296099672950265	0.8269089162960751	0.8910900713210457	0.8460286385053583	0.9421878711842	0.9442125203757015	0.9153607516221468	0.8345615542805394	0.8630079982282792	0.8558786567538004	0.7498694058265165	0.8379676222663899	0.7384570809700034	0.6246583803095135	0.7375201838669821	0.7177612274646636	SHOC2	Met173Val	NC_000010.11:110964875:A:G	517A>G	10	110964875	A	G	10	ENSG00000108061	11602	0	CCSBVarC028030	ALE00025799	ENSP00000358464.5																																	359795.0	single nucleotide variant	NM_007373.4(SHOC2):c.517A>G (p.Met173Val)	8036.0	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	1.0	Jul 17, 2023	1057518206.0	-	RCV000413825|RCV001584108|RCV002272224|RCV003922677|RCV003539878	MedGen:C3661900|MONDO:MONDO:0011899,MedGen:C1843181,OMIM:PS607721,Orphanet:2701|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701||MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not provided|Noonan syndrome-like disorder with loose anagen hair|Noonan syndrome-like disorder with loose anagen hair 1|SHOC2-related disorder|RASopathy	de novo;germline	germline	GRCh38	NC_000010.11	10	110964875.0	110964875.0	10q25.2	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA16042684	2.0	373090.0	110964875.0	A	G	-	-	-	-	-	-	517A>G 	Met173Val	NM_007373.4	1.0	Conflicting	Conflicting	373090	10	110964875.0	A	G	M	V	rs1057518206	10	112724633	10	112714623	173	SHOC2	ENSG00000108061	ENST00000369452	ENSP00000358464	Q9UQ13	SHOC2_HUMAN	c.517A>G	p.Met173Val	c.517A>G	p.Met173Val	principal1	Y	1	YES	Select	+	ATG	1	0	A	A/A	A/A	A/A	A/A	0.877	0.02574	T	0.71	0.05615	T	0.001	0.22981	B	0.002	0.23834	B	0.17	0.49097	A	simple_aae	83.0	17.0	-0.795	0.01632	N	0.96	0.01825	N	0.72	0.76196	-1.0948	0.04794	T	0.0449	0.19131	T	10	0.2705949	0.44206	D	0.099806	0.77096	D	0.428	0.73376	0.322	0.30091	Q9UQ13	M173V	Loss of catalytic residue at M173 (P = 0.0099)| Gain of sheet (P = 0.0827)| Loss of ubiquitination at K170 (P = 0.0863)| Gain of relative solvent accessibility (P = 0.09)| Loss of disorder (P = 0.0906)	0.660270521957	0.65475	0.6131685434429178	0.61071	0.514162079924	0.49084	0.843939304352	0.88676	D	0.106314	0.41460	T	-0.000997988	0.51194	T	-0.23921	0.50551	T	0.874729037284851	0.52197	D	.	0.77035	.	0.08041208	0.18257	0.10913989	0.26242	0.06424035	0.13484	0.11111266	0.26739	-7.545	0.57998	D	0.2724	0.59484	B	0.973092210519985	0.83842	0.00909550	0.40214	0.251	0.52136	.	.	.	.	.	.	2.561362	0.33237	19.26	0.30135072733151308	0.01631	0.893472	0.83085	D	-0.639719032405484	0.17541	0.9166258	-0.425424558940744	0.23937	1.327136	5.79	3.44	0.38414	.	.	9.325	0.96016	11.206000	0.89238	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.997	0.79771	916	0.20739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|SHOC2-related_disorder|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|Noonan_syndrome-like_disorder_with_loose_anagen_hair|RASopathy	criteria_provided,_conflicting_classifications	NC_000010.11:g.110964875A>G	ClinGen:CA16042684	C3661900|C4478716|C1843181|C5555857	607721|PS607721	2701|2701|536391	.	Met	Val	98.65	0.2393617021276596																																																																																																																																																																																																																																																																																																																																																																																																																																																																													45			98.65	Aliphatic	Methionine		Leucine-rich repeat protein SHOC-2										1.9								 M173-L151 (PAE:  1.0), M173-M149 (PAE: 1.0)	M173-L151 (PDBs: 7TVG, 7UPI), M173-M149 (PDBs: 7TVG, 7SD1, 7T7A, 7TYG, 7SD0, 7TVF, 7UPI)	 M173-M149 (PAE:  1.0)	M173-T196 (PDBs: 7TVG), M173-M149 (PDBs: 7TVG, 7SD1, 7T7A, 7TYG, 7SD0, 7TVF, 7UPI)							149									-127.2				125.5			LRR 4			B (undefined)	E (parallel sheets)	Beta strand											98.65	23.93617	>90	10-90	607721	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	false	0.8002640910476306	0.786819942109232	false	false	false
RAD51D	RAD51D_His23Arg	B_13-14	0.46032392122955723	0.6592416574464562	0.730790229670767	11.775670298904382	7.216084009177201e-6	0.000060740890627707175	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9616662315175977	0.9600191600496464	0.7645776491966026	0.8757822235022278	0.852647333692834	0.8342525375426465	0.7479093312608646	0.840639789862247	0.8139805669373311	0.6783789449978477	0.9557615126807214	0.9601995998672218	0.9205957438244284	0.8646548775234209	0.9375838800671245	0.8507763533953576	0.9642768074185715	0.9631328631679734	RAD51D	His23Arg	NC_000017.11:35119546:T:C	68A>G	17	35119546	T	C	17	ENSG00000185379	7201	0	CCSBVarC024711	ALE00031239	ENSP00000338790.6																																	409908.0	single nucleotide variant	NM_002878.4(RAD51D):c.68A>G (p.His23Arg)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Oct 19, 2023	990062370.0	-	RCV000485429|RCV000547804|RCV000566071	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	35119546.0	35119546.0	17q12	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA16620393	2.0	418673.0	35119546.0	T	C	-	-	-	-	-	-	68A>G 	His23Arg	NM_002878.4	1.0	Conflicting	Conflicting	418673	17	35119546.0	T	C	H	R	rs990062370	17	33446565	17	30470678	23	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.68A>G	p.His23Arg	c.68A>G	p.His23Arg	principal1	Y	5	.	.	-	CAC	2	0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	0.792	0.05378	T	0.0	0.02950	B	0.0	0.01384	B	.	.	.	.	.	.	-2.015	0.00188	N	-0.59	0.18393	N	0.064	0.10018	-0.9955	0.31058	T	0.0244	0.10333	T	10	0.032363117	0.01387	T	0.010514	0.26860	T	0.018	0.03036	0.425	0.46877	O75771	H23R	Loss of sheet (P = 0.003)| Gain of helix (P = 0.0034)| Gain of MoRF binding (P = 0.0286)| Gain of phosphorylation at S22 (P = 0.091)| Loss of ubiquitination at K26 (P = 0.1022)	0.319686207203	0.31162	.	0.34452	.	0.11066	.	.	.	0.115945	0.43190	T	-0.364518	0.03721	T	-0.761382	0.02907	T	0.0475806100992363	0.05021	T	0.0435956	0.00994	T	0.040238965	0.05652	0.052508783	0.08678	0.040238965	0.05652	0.052508783	0.08677	-1.909	0.10376	T	0.0613	0.02261	B	7.77047030966497e-07	0.00398	0.22299655	0.74091	0.028	0.05473	.	.	.	.	.	.	0.56021	0.09313	6.069	0.69154575729474244	0.09022	0.046472	0.07594	N	-1.35012510449794	0.03091	0.1390257	-1.25403651457861	0.04992	0.2407925	4.5	-1.34	0.08645	-3.41	0.07546	-1.008	0.03777	-1.240000	0.05963	-0.173	0.11029	0.0	0.06393	0.000000	0.08389	0.771	0.36593	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	0	107948	0.000000e+00	0	1	204124	4.898980e-06	0	1	233180	4.288530e-06	0	0	7098	0.000000e+00	0	0	17080	0.000000e+00	0	0	2320	0.000000e+00	0	0	8998	0.000000e+00	0	0	12186	0.000000e+00	0	0	42690	0.000000e+00	0	0	15678	0.000000e+00	0	.	.	.	.	0	16112	0.000000e+00	0	0	30490	0.000000e+00	0	0	6182	0.000000e+00	0	0	13344	0.000000e+00	0	0	15526	0.000000e+00	0	1	87036	1.148950e-05	0	0	30596	0.000000e+00	0	1	87036	1.148950e-05	0	0	14834	0.000000e+00	0	0	34228	0.000000e+00	0	0	9560	0.000000e+00	0	0	17644	0.000000e+00	0	0	20424	0.000000e+00	0	1	100384	9.961750e-06	0	0	30514	0.000000e+00	0	1	100384	9.961750e-06	0	.	1	1612358	6.202100e-07	0	1	1179926	8.475110e-07	0	0	74908	0.000000e+00	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29596	0.000000e+00	0	0	44882	0.000000e+00	0	0	62504	0.000000e+00	0	0	6084	0.000000e+00	0	1	1179926	8.475110e-07	0	0	91090	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_provided|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119546T>C	ClinGen:CA16620393	C3280345|C3661900|C0027672	614291	145|140162	RAD51D, N-terminal domain	His	Arg	90.21	0.40217391304347827																																																																																																																																																																																																																																																																																																																																																																																																																																																																													74			90.21	Positively-charged	Histidine		DNA repair protein RAD51 homolog 4										-3.2								 H23-L19 (PAE:  1.0), H23-C43 (PAE: 2.5)	H23-L19 (PDBs: 8GBJ, 8OUY, 8OUZ)	 H23-L19 (PAE:  1.0), H23-C43 (PAE: 2.5)	H23-L19 (PDBs: 8FAZ, 8OUY, 8OUZ), H23-C43 (PDBs: 8GBJ)							155									-95.2				21.4	preferentially binds ssDNA					C (loop/coil)	T (turn)												90.21	40.217392	>90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.9600191600496464	0.9616662315175977	false	false	false
RAD51D	RAD51D_Val66Met	B_13-14	-0.545546479468292	0.6023201818835449	0.6775215237912666	6.8572888119232625	0.0002404019141362116	0.0007849421929536446	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8352994623844752	0.8562278499774705	0.5764598796492009	0.6595390207328315	0.648788506038821	0.6409978187960976	0.7489398258048624	0.7641530325448443	0.7080952960417236	0.6380079513391783	0.8707367795483227	0.8342659062305267	0.5330558117873327	0.5334239795327977	0.6109827454239395	0.5149118079592234	0.8417189204066183	0.8363330185384237	RAD51D	Val66Met	NC_000017.11:35118568:C:T	196G>A	17	35118568	C	T	17	ENSG00000185379	7201	0	CCSBVarC024804	ALE00029792	ENSP00000338790.6																																	151292.0	single nucleotide variant	NM_002878.4(RAD51D):c.196G>A (p.Val66Met)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Jan 28, 2024	56026142.0	-	RCV000130161|RCV000238834|RCV000225779|RCV001030594|RCV001284344|RCV001798441|RCV003952682	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer|RAD51D-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	35118568.0	35118568.0	17q12	criteria provided, conflicting classifications	16.0	-	N	ClinGen:CA165840	2.0	141578.0	35118568.0	C	T	-	-	-	-	-	-	196G>A 	Val66Met	NM_002878.4	1.0	Conflicting	Conflicting	141578	17	35118568.0	C	T	V	M	rs56026142	17	33445587	17	30469700	66	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.196G>A	p.Val66Met	c.196G>A	p.Val66Met	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.095	0.34240	T	0.066	0.44850	T	0.476	0.36683	P	0.365	0.43339	B	0.05	0.16373	N	simple_aae	95.0	5.0	1.2	0.30152	L	-0.54	0.16529	N	0.358	0.39815	-0.9936	0.31561	T	0.1126	0.40048	T	10	0.010412663	0.00228	T	0.024861	0.47635	T	0.088	0.25383	0.532	0.63879	O75771	V66M	Loss of catalytic residue at V66 (P = 0.1757)| Gain of disorder (P = 0.2016)| Gain of relative solvent accessibility (P = 0.2816)| Loss of glycosylation at S62 (P = 0.3483)| Gain of loop (P = 0.3485)	0.485420873983	0.47807	.	.	.	.	.	.	.	0.159822	0.50082	T	-0.540521	0.00322	T	-0.547555	0.17258	T	0.0349691153311283	0.02783	T	.	0.67135	.	0.085984245	0.19788	0.05022742	0.07854	0.085984245	0.19787	0.05022742	0.07854	-4.122	0.28513	T	0.1196	0.24734	LB	0.000394112558413836	0.06034	0.88900130	0.90830	0.035	0.07875	.	.	.	.	.	.	1.488353	0.19181	14.12	0.85296696707845254	0.16045	0.093680	0.18747	N	-0.868469024722056	0.11459	0.5605822	-0.881724750457004	0.12311	0.6448988	4.79	-0.163	0.12675	-5.85	0.03264	0.004	0.13047	0.681000	0.20762	-1.926	0.00504	0.001	0.13799	0.444000	0.24998	0.443	0.27788	926	0.17784	3	5.990415335463259E-4	1	7.564296520423601E-4	0	0.0	0	0.0	2	0.001984126984126984	0	0.0	53	264690	2.0023424E-4	.	30	109376	2.742830e-04	0	60	208066	2.883700e-04	0	76	236884	3.208320e-04	0	1	7164	1.395870e-04	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	24	9044	2.653690e-03	0	0	13366	0.000000e+00	0	2	42766	4.676610e-05	0	1	15690	6.373490e-05	0	24	9044	2.653690e-03	0	1	16218	6.165990e-05	0	2	30524	6.552220e-05	0	0	6212	0.000000e+00	0	48	13414	3.578350e-03	0	0	16706	0.000000e+00	0	4	89522	4.468180e-05	0	1	30608	3.267120e-05	0	48	13414	3.578350e-03	0	1	14902	6.710510e-05	0	4	34260	1.167540e-04	0	0	9572	0.000000e+00	0	65	17690	3.674390e-03	0	0	21604	0.000000e+00	0	2	102710	1.947230e-05	0	1	30526	3.275900e-05	0	65	17690	3.674390e-03	0	.	420	1614178	2.601940e-04	1	374	44872	8.334820e-03	1	1	75058	1.332300e-05	0	0	912	0.000000e+00	0	5	60016	8.331110e-05	0	1	29608	3.377470e-05	0	374	44872	8.334820e-03	1	0	64024	0.000000e+00	0	1	6062	1.649620e-04	0	9	1180038	7.626870e-06	0	17	91078	1.866530e-04	0	1	153016	6.535264286087729E-6	0	176	0	18	4498	0.004001778568252557	0	4724	0	0	442	0	0	950	0	6	1848	0.003246753246753247	0	280	0	9	11718	7.680491551459293E-4	0	4900	0	24	6346	0.003781909864481563	34	177652	1.9138540517416071E-4	Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|RAD51D-related_disorder|not_provided|Hereditary_breast_ovarian_cancer_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118568C>T	ClinGen:CA165840	C0027672|CN221562|C3661900|C0677776|CN169374|C3280345	614291	140162|145|145	.	Val	Met	87.61	0.647887323943662																																																																																																																																																																																																																																																																																																																																																																																																																																																																													92			87.61	Aliphatic	Valine		DNA repair protein RAD51 homolog 4										4.2			D:V66-X:L117 (PDBs: 8FAZ, 8GBJ), C:V66-D:L117 (PDBs: 8OUY, 8OUZ)	D:V66-X:L117 (PDBs: 8FAZ, 8GBJ), C:V66-D:L117 (PDBs: 8OUY, 8OUZ), C:V66-D:F116 (PDBs: 8OUZ)														117									-109.1				144.7	preferentially binds ssDNA					C (loop/coil)	C (loop/coil)												87.61	64.788734	70-90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.8562278499774705	0.8352994623844752	false	false	false
RAD51D	RAD51D_Met308Val	B_13-14	-1.5191507364824384	0.17252213344359443	0.25077418179396144	16.536103346581474	7.220728928733058e-7	0.00001409578466406932	2025_01_Batch_13-14	true	true	true	false	false	true	false	true	false	false	false	false	0.9803198437953836	0.9890768411395043	0.8688293150456019	0.9465970963384119	0.8988722344550863	0.9188855028951137	0.8780947250837008	0.8689418109544154	0.917361112806667	0.821705659191091	0.9906374653074155	0.9791663149493526	0.9596762807065267	0.9288026579557574	0.9758330798701569	0.9159529709001127	0.9875162169715931	0.9814733726414147	RAD51D	Met308Val	NC_000017.11:35101018:T:C	922A>G	17	35101018	T	C	17	ENSG00000185379	7201	0	CCSBVarC024892	ALE00029928	ENSP00000338790.6																																	184803.0	single nucleotide variant	NM_002878.4(RAD51D):c.922A>G (p.Met308Val)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Sep 23, 2024	786201961.0	-	RCV000164512|RCV000649679|RCV004782268	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	germline	germline	GRCh38	NC_000017.11	17	35101018.0	35101018.0	17q12	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA191144	2.0	185144.0	35101018.0	T	C	-	-	-	-	-	-	922A>G 	Met308Val	NM_002878.4	1.0	Conflicting	Conflicting	185144	17	35101018.0	T	C	M	V	rs786201961	17	33428037	17	30452150	308	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.922A>G	p.Met308Val	c.922A>G	p.Met308Val	principal1	Y	1	YES	Select	-	ATG	1	0	T	T/T	T/T	T/T	T/T	0.274	0.15912	T	0.326	0.19266	T	0.0	0.09864	B	0.0	0.06938	B	0.04	0.13669	N	simple_aae	96.0	4.0	0.72	0.18616	N	-0.61	0.17975	N	0.017	0.04065	-0.9351	0.43192	T	0.0836	0.32564	T	10	0.091109514	0.15785	T	0.00703	0.18349	T	0.046	0.12499	0.368	0.37543	O75771	M308V	Loss of disorder (P = 0.066)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T303 (P = 0.2109)| Loss of MoRF binding (P = 0.2269)| Gain of glycosylation at T313 (P = 0.247)	0.445711490874	0.43808	.	0.24814	.	0.09186	.	.	.	0.090794	0.38381	T	-0.22766	0.16671	T	-0.564795	0.15640	T	0.04466512799263	0.04499	T	.	0.22727	.	0.09098598	0.21114	0.08494699	0.19556	0.09098598	0.21113	0.08494699	0.19555	-2.125	0.04505	T	0.0668	0.03206	LB	0.000116984907820501	0.03146	0.33311860	0.77819	0.031	0.06489	.	.	.	.	.	.	0.745387	0.11172	7.79	0.84883383379766109	0.15792	0.063394	0.12075	N	-1.10219193532207	0.06526	0.304481	-1.00842900774596	0.09439	0.4784977	5.16	-1.59	0.07985	0.883	0.28197	-0.196	0.09562	-0.511000	0.08784	0.665	0.62996	0.007	0.17722	0.000000	0.08389	0.941	0.48226	913	0.21155	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8	1613598	4.957860e-06	0	3	74880	4.006410e-05	0	3	74880	4.006410e-05	0	0	910	0.000000e+00	0	0	59998	0.000000e+00	0	0	29602	0.000000e+00	0	0	44890	0.000000e+00	0	0	64022	0.000000e+00	0	0	6084	0.000000e+00	0	5	1179678	4.238440e-06	0	0	91062	0.000000e+00	0	1	26588	3.761095230931247E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4588	0	0	2918	0	0	112	0	1	35432	2.8223075186272295E-5	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101018T>C	ClinGen:CA191144	C0027672|C3280345	614291	140162|145	.	Met	Val	91.85	0.43617021276595747																																																																																																																																																																																																																																																																																																																																																																																																																																																																													82			91.85	Aliphatic	Methionine		DNA repair protein RAD51 homolog 4										1.9								 M308-S88 (PAE:  1.0)	M308-S88 (PDBs: 8FAZ, 8GBJ, 8OUZ)		M308-R290 (PDBs: 8FAZ), M308-R291 (PDBs: 8GBJ, 8OUY, 8OUZ), M308-S88 (PDBs: 8OUZ), M308-M292 (PDBs: 8OUZ)							149									-82.5				127.8						B (undefined)	E (parallel sheets)	Beta strand											91.85	43.617023	>90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.9890768411395043	0.9803198437953836	true	true	true
BRCA1	BRCA1_Phe591Leu	B_13-14	1.6193629120142436	0.14940127798338723	0.22469011098288946	3.3120223510004188	0.012905647064930617	0.021354249201215224	2025_01_Batch_13-14	false	false	true	false	true	true	false	false	false	false	false	false	0.868970544184307	0.8755320644664457	0.8906417494804362	0.9188743986133163	0.9016629676366303	0.9266686749471575	0.9364265672905079	0.918051518626856	0.8873032098934528	0.9237286844973769	0.8478119646467244	0.8418173150554036	0.9169107826038071	0.8852744166464048	0.95044558733318	0.8575548144634955	0.9032521642861672	0.8961237733132104	BRCA1	Phe591Leu	NC_000017.11:43063941:A:T	1773T>A	17	43063941	A	T	17	ENSG00000012048	14613	0	CCSBVarC003305	ALE00003305	ENSP00000417148.1	CEGS2	CegsMutGDEh1019	H03	GDEhDisVCh_40059	F06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	70056.0	single nucleotide variant	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	672.0	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0.0	Apr 26, 2023	80357387.0	-	RCV000112493|RCV000562837|RCV001853018	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43063941.0	43063941.0	17q21.31	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003223	2.0	55389.0	43063941.0	A	T	-	-	-	-	-	-	5085T>A 	Phe1695Leu	NM_007294.4	1.0	Conflicting	Conflicting	55389	17	43063941.0	A	T	F	L	rs80357387	17	41215958	17	38469484	1695	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5085T>A	p.Phe1695Leu	principal2	Y	1	.	.	-	TTT	3	2	A	A/A	A/A	A/A	A/A	.	0.25997	.	.	0.09167	.	0.237	0.30812	B	0.107	0.31213	B	.	.	.	.	.	.	0.135	0.08601	N	.	0.42578	.	.	0.55139	0.4353	0.89578	D	0.6291	0.86934	D	10	.	0.54565	.	0.768432	0.98164	D	.	0.77150	.	.	.	.	.	.	0.82922	.	0.46484	.	0.27990	0.637575030327	0.58154	T	0.133578	0.46135	T	0.169896	0.70900	D	0.00626705	0.70525	D	0.324614346916885	0.25715	T	.	0.56037	.	0.2819536	0.50902	0.15177552	0.35630	0.2757978	0.50311	0.17792259	0.40291	-3.59	0.38578	T	.	0.80507	.	0.151693788840998	0.47210	0.99911267	0.99153	0.531	0.73422	.	.	.	.	.	.	1.972208	0.25095	16.62	0.91899320551777408	0.21471	0.371736	0.45580	N	-0.338194724745546	0.27430	1.522421	-0.156317829821601	0.32854	1.89438	5.83	4.74	0.59667	1.84	0.37836	1.51	0.35504	2.150000	0.30988	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.996	0.76032	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109358	0.000000e+00	0	0	207972	0.000000e+00	0	1	236754	4.223790e-06	0	0	7154	0.000000e+00	0	0	17104	0.000000e+00	0	0	2314	0.000000e+00	0	0	9038	0.000000e+00	0	0	13394	0.000000e+00	0	0	42754	0.000000e+00	0	0	15686	0.000000e+00	0	.	.	.	.	0	16194	0.000000e+00	0	0	30508	0.000000e+00	0	0	6206	0.000000e+00	0	0	13402	0.000000e+00	0	0	16734	0.000000e+00	0	0	89470	0.000000e+00	0	0	30600	0.000000e+00	0	.	.	.	.	0	14886	0.000000e+00	0	0	34246	0.000000e+00	0	0	9556	0.000000e+00	0	0	17682	0.000000e+00	0	0	21628	0.000000e+00	0	1	102632	9.743550e-06	0	0	30518	0.000000e+00	0	1	102632	9.743550e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000017.11:g.43063941A>T	ClinGen:CA003223	C0677776|C0027672|C2676676	604370	145|140162|145	BRCT domain|BRCT domain|BRCT domain	Phe	Leu	94.82	0.14213197969543148																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																94.82	14.213199	>90	10-90	604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.8755320644664457	0.868970544184307	false	false	false
SDHD	SDHD_Ile31Val	B_13-14	4.150235795989882	0.009338842715277238	0.023402525058847892	2.3664830937760195	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8191117765649352	0.8443778596879884	0.7395995818860305	0.7576859563883163	0.8447578977397892	0.806390384031618	0.8636460509545072	0.8933806757778583	0.7589935478331059	0.7539899934782075	0.8650252179364143	0.8470338439815854	0.7491347171087289	0.7961351197017199	0.7563783649435266	0.7252091702938535	0.8237305014395625	0.7911897091482849	SDHD	Ile31Val	NC_000011.10:112087895:A:G	91A>G	11	112087895	A	G	11	ENSG00000204370	6363	0	CCSBVarC023265	ALE00022446	ENSP00000364699.3																																	837951.0	single nucleotide variant	NM_003002.4(SDHD):c.91A>G (p.Ile31Val)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Sep 28, 2023	1865653068.0	-	RCV002240532|RCV002374977|RCV003151276|RCV004000160	MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Pheochromocytoma;Cowden syndrome 3|Hereditary cancer-predisposing syndrome|not specified|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112087895.0	112087895.0	11q23.1	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	-	2.0	860158.0	112087895.0	A	G	-	-	-	-	-	-	91A>G 	Ile31Val	NM_003002.4	1.0	Conflicting	Conflicting	860158	11	112087895.0	A	G	I	V	rs1865653068	11	111958619	11	111463829	31	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.91A>G	p.Ile31Val	c.91A>G	p.Ile31Val	principal1	Y	1	YES	Select	+	ATC	1	0	A	./.	./.	./.	./.	1.0	0.00968	T	1.0	0.03973	T	0.0	0.02950	B	0.0	0.01384	B	0.08	0.31989	N	simple_aae	92.0	8.0	-1.025	0.01134	N	0.18	0.05010	N	0.085	0.06176	-0.5465	0.66773	T	0.4158	0.76166	T	10	0.04787895	0.04166	T	0.031946	0.53719	D	0.476	0.76693	0.381	0.39663	O14521	I31V	Gain of sheet (P = 0.1208)| Gain of methylation at R27 (P = 0.1334)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2754)| Gain of catalytic residue at I31 (P = 0.2808)	0.786847784675	0.78318	0.43965305476109695	0.43682	0.15461328637	0.17194	0.309365063906	0.11802	T	0.146378	0.48116	T	0.0852895	0.62390	D	-0.115264	0.61922	T	0.0309518799185753	0.02125	T	0.533947	0.19158	T	0.02366694	0.01119	0.026847782	0.00805	0.02366694	0.01119	0.026847782	0.00805	-2.33	0.06038	T	0.0626	0.12187	B	0.00494223008028627	0.18766	0.92538464	0.92192	0.029	0.05809	.	.	.	.	.	.	0.134814	0.05315	1.791	0.74706428750991605	0.10972	0.118743	0.22993	N	-1.22373084351358	0.04605	0.2106841	-1.06657851552802	0.08227	0.4109787	4.81	2.78	0.31620	.	.	0.472	0.21905	2.708000	0.34295	-0.743	0.03658	0.37	0.26012	0.994000	0.32271	0.663	0.33093	635	0.64545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_specified|Hereditary_pheochromocytoma-paraganglioma|Cowden_syndrome_3|Carney-Stratakis_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000011.10:g.112087895A>G	.	CN169374|C1708353|CN166604|C1847319|C0031511|C1868633|C0027672	606864|171300	29072|201|97286|29072|140162	.	Ile	Val	46.82	0.9112426035502958																																																																																																																																																																																																																																																																																																																																																																																																																																																																													154			46.82	Aliphatic	Isoleucine												4.5																		131									-73.7				92.7						C (loop/coil)	C (loop/coil)								Mitochondrion				46.82	91.12426	$\leqslant$50	$\geqslant$90	606864;171300	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA	false	0.8443778596879884	0.8191117765649352	false	false	false
RAD51D	RAD51D_Ala231Ser	B_13-14	0.24888080055203415	0.8105973795143	0.8488163349080663	20.400137795378285	1.7053057366150723e-7	7.061886158006236e-6	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	false	false	0.9508600095959764	0.9603551768092998	0.7313711206606577	0.6795025059266462	0.7281646107578847	0.7392159525368392	0.5957401544312083	0.6282578485429239	0.44435365318722664	0.65016758234468	0.9604557885411291	0.9539350090721556	0.8826917506424702	0.8280713729728457	0.9146513586660658	0.8125746589766354	0.9602545650774705	0.9477850101197972	RAD51D	Ala231Ser	NC_000017.11:35103301:C:A	691G>T	17	35103301	C	A	17	ENSG00000185379	7201	0	CCSBVarC024850	ALE00021967	ENSP00000338790.6																																	478474.0	single nucleotide variant	NM_002878.4(RAD51D):c.691G>T (p.Ala231Ser)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Mar 21, 2024	772135704.0	-	RCV000575670|RCV001351481|RCV001764647	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35103301.0	35103301.0	17q12	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA8499378	2.0	480531.0	35103301.0	C	A	-	-	-	-	-	-	691G>T 	Ala231Ser	NM_002878.4	1.0	Conflicting	Conflicting	480531	17	35103301.0	C	A	A	S	rs772135704	17	33430320	17	30454433	231	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.691G>T	p.Ala231Ser	c.691G>T	p.Ala231Ser	principal1	Y	5	.	.	-	GCC	1	0	C	C/C	C/C	C/C	C/C	.	0.39016	.	0.148	0.35663	T	0.68	0.53374	P	0.562	0.49607	P	0.18	0.50204	N	simple_aae	82.0	18.0	1.42	0.35528	L	.	0.43338	.	0.222	0.39513	-0.6345	0.63221	T	0.2791	0.64952	T	10	0.45145473	0.58389	D	0.066725	0.69852	D	0.162	0.41623	0.644	0.78027	O75771	A231S	Gain of phosphorylation at A231 (P = 0.0655)| Gain of disorder (P = 0.0844)| Gain of MoRF binding (P = 0.1284)| Loss of ubiquitination at K235 (P = 0.2243)| Loss of methylation at R232 (P = 0.3779)	0.942670400808	0.94162	.	0.52746	.	0.36618	.	.	.	0.169282	0.51414	T	-0.0747325	0.40218	T	-0.00673246	0.69677	D	0.217512117147641	0.21078	T	0.864413	0.57408	D	0.5926053	0.72005	0.42019272	0.65736	0.5926053	0.72007	0.42019272	0.65736	-7.695	0.62579	D	0.116	0.32008	B	0.000766225569270482	0.08395	0.93499870	0.92618	0.232	0.50061	.	.	.	.	.	.	3.594988	0.50833	23.0	0.96226307501413078	0.29313	0.620192	0.60393	D	0.387026469158641	0.60517	4.263942	0.432911172391861	0.63430	4.600281	4.92	4.92	0.64102	3.22	0.58372	4.112	0.57674	2.653000	0.33911	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.998	0.85369	908	0.22602	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	8	106972	7.478590e-05	0	15	203574	7.368330e-05	0	15	232448	6.453060e-05	0	0	6872	0.000000e+00	0	0	16800	0.000000e+00	0	0	2230	0.000000e+00	0	0	8846	0.000000e+00	0	0	13256	0.000000e+00	0	0	41826	0.000000e+00	0	8	15260	5.242460e-04	0	8	15260	5.242460e-04	0	0	15702	0.000000e+00	0	0	29908	0.000000e+00	0	0	6046	0.000000e+00	0	0	13302	0.000000e+00	0	0	16488	0.000000e+00	0	0	87500	0.000000e+00	0	15	29876	5.020750e-04	0	15	29876	5.020750e-04	0	0	14484	0.000000e+00	0	0	33672	0.000000e+00	0	0	9430	0.000000e+00	0	0	17458	0.000000e+00	0	0	21108	0.000000e+00	0	0	100948	0.000000e+00	0	15	29796	5.034230e-04	0	15	29796	5.034230e-04	0	.	47	1611894	2.915820e-05	0	46	90536	5.080850e-04	0	0	74890	0.000000e+00	0	0	912	0.000000e+00	0	0	59658	0.000000e+00	0	0	29510	0.000000e+00	0	0	44848	0.000000e+00	0	0	63892	0.000000e+00	0	0	6052	0.000000e+00	0	0	1179196	0.000000e+00	0	46	90536	5.080850e-04	0	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35103301C>A	ClinGen:CA8499378	C0027672|C3661900|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Ala	Ser	97.85	0.02830188679245283																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3			97.85	Aliphatic	Alanine		DNA repair protein RAD51 homolog 4								0.0477		1.8								 A231-K235 (PAE:  1.0), A231-M227 (PAE: 1.0)	A231-M227 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ), A231-K235 (PDBs: 8OUZ)	 A231-K235 (PAE:  1.0), A231-M227 (PAE: 1.0)	A231-M227 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ), A231-V271 (PDBs: 8OUZ), A231-K235 (PDBs: 8OUZ)							89									-57.4		Pocket 3: Mean pLDDT: 97.77, Volume: 250.74 Å³, Druggability score: 0.05		-37.4						H (helix)	H (α-helix)	Helix	in Ref. 9; CAB55937										97.85	2.8301888	>90	<10	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.9603551768092998	0.9508600095959764	true	false	false
RET	RET_Gly321Arg	B_13-14	1.6968224836440589	0.13354425044658957	0.20653402295788345	8.107754851970034	0.00008367733864267227	0.00035708817769605495	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7913809771112161	0.8039925585148221	0.7657594075836034	0.8334050423348516	0.8079294671517272	0.8272006314562097	0.9770944215951931	0.9074493233730786	0.9484586359984883	0.8954324374372185	0.8521470532154323	0.8629167734432902	0.6773068413172264	0.7084096109303757	0.7183514486712147	0.6360863777299882	0.7558380638142119	0.7198451807791422	RET	Gly321Arg	NC_000010.11:43106469:G:A	961G>A	10	43106469	G	A	10	ENSG00000165731	8858	0	CCSBVarC006879	ALE00006877	ENSP00000480088.1	CEGS2	CegsMutGDEh1026	B06	GDEhDisVCh_40066	D05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	36222.0	single nucleotide variant	NM_020975.6(RET):c.961G>A (p.Gly321Arg)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Feb 06, 2024	377767388.0	-	RCV000148776|RCV000567555|RCV000231209|RCV000679758|RCV000709104|RCV001818171|RCV003460487|RCV004528128	Human Phenotype Ontology:HP:0002865,MONDO:MONDO:0015277,MeSH:C536914,MedGen:C0238462,Orphanet:1332|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|	Medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2A|not specified|Hirschsprung disease, susceptibility to, 1|RET-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	43106469.0	43106469.0	10q11.21	criteria provided, conflicting classifications	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009403	2.0	24881.0	43106469.0	G	A	-	-	-	-	-	-	961G>A 	Gly321Arg	NM_020975.6	1.0	Conflicting	Conflicting	24881	10	43106469.0	G	A	G	R	rs377767388	10	43601917	10	42921923	321	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.961G>A	p.Gly321Arg	c.961G>A	p.Gly321Arg	principal4	Y	5	YES	Select	+	GGG	1	0	G	G/G	G/G	G/G	G/G	0.231	0.18346	T	0.565	0.09199	T	0.007	0.16277	B	0.003	0.12129	B	0.04	0.13669	N	simple_aae	96.0	4.0	1.1	0.27864	L	-1.64	0.39308	N	0.222	0.27952	-0.9759	0.35787	T	0.1969	0.54992	T	10	0.103147626	0.18741	T	0.032094	0.53831	D	0.428	0.73376	0.69	0.82670	P07949	G321R	Gain of solvent accessibility (P = 0.019)| Gain of sheet (P = 0.0477)| Gain of MoRF binding (P = 0.0483)| Gain of phosphorylation at T323 (P = 0.1426)| Loss of catalytic residue at W324 (P = 0.1943)	0.940005915424	0.93891	0.6768714346963912	0.67466	0.238921890069	0.26162	0.346982002258	0.17459	T	0.435003	0.78028	T	-0.129129	0.31279	T	-0.186593	0.55604	T	0.0158652041221491	0.00371	T	0.673133	0.27914	T	0.1105618	0.25900	0.06433436	0.12879	0.07723053	0.17355	0.065889634	0.13420	-5.573	0.42597	T	0.0874	0.13936	B	0.0249176742024401	0.31262	0.99895360	0.99055	0.232	0.50061	.	.	.	.	.	.	0.991371	0.1371	10.23	0.90570527367935905	0.20078	0.047661	0.07918	N	-1.07470700909571	0.07027	0.3294123	-1.05180989670877	0.08525	0.4273997	5.32	-1.32	0.08700	-4.57	0.05201	0.268	0.18399	0.913000	0.22725	-0.752	0.03581	0.0	0.06393	0.204000	0.23666	0.251	0.23335	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	31	264690	1.17118136E-4	.	9	108388	8.303500e-05	0	14	205672	6.806950e-05	0	18	234342	7.681080e-05	0	0	7006	0.000000e+00	0	1	17008	5.879590e-05	0	0	2296	0.000000e+00	0	2	8970	2.229650e-04	0	0	13298	0.000000e+00	0	6	42326	1.417570e-04	0	0	15586	0.000000e+00	0	2	8970	2.229650e-04	0	1	15894	6.291680e-05	0	1	30330	3.297070e-05	0	0	6148	0.000000e+00	0	1	13284	7.527850e-05	0	0	16620	0.000000e+00	0	11	88210	1.247020e-04	0	0	30384	0.000000e+00	0	11	88210	1.247020e-04	0	0	14646	0.000000e+00	0	1	34086	2.933760e-05	0	0	9534	0.000000e+00	0	2	17588	1.137140e-04	0	0	20960	0.000000e+00	0	15	101642	1.475770e-04	0	0	30312	0.000000e+00	0	15	101642	1.475770e-04	0	.	86	1613150	5.331180e-05	0	8	44842	1.784040e-04	0	7	74884	9.347790e-05	0	0	912	0.000000e+00	0	6	59956	1.000730e-04	0	0	29578	0.000000e+00	0	8	44842	1.784040e-04	0	0	63818	0.000000e+00	0	0	6078	0.000000e+00	0	61	1179700	5.170810e-05	0	1	90932	1.099720e-05	0	5	31942	1.5653371736271994E-4	0	306	0	0	112	0	2	8442	2.3691068467187872E-4	0	146	0	0	610	0	0	56	0	0	98	0	0	4502	0	2	8748	2.2862368541380886E-4	0	168	0	7	46214	1.514692517418964E-4	RET-related_disorder|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|not_specified|not_provided|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Medullary_thyroid_carcinoma	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106469G>A	ClinGen:CA009403	C0025268|C3888239|CN169374|C3661900|C4048306|C0027672|C0238462	171400|142623	247698|653|388|653|140162|1332	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Gly	Arg	85.2	0.9880952380952381																																																																																																																																																																																																																																																																																																																																																																																																																																																																													83			85.2	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-0.4									G321-Q326 (PDBs: 6GL7)		G321-Q326 (PDBs: 6GL7), G321-A325 (PDBs: 6GL7)							75									-166.6				-51.7	Cadherin-like region 3 (CLD3)					C (loop/coil)	S (bend)							Extracellular					85.2	98.809525	70-90	$\geqslant$90	171400;142623	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	false	0.8039925585148221	0.7913809771112161	false	false	false
LMNA	LMNA_Ala43Thr	B_13-14	2.826701345748407	0.02552666596388305	0.054536836678989516	-4.328574699016766	0.0034438473295563443	0.006766016969738642	2025_01_Batch_13-14	false	false	true	false	true	true	false	false	false	false	false	false	0.8919418165424693	0.8863303284559272	0.8742318763190866	0.8366814520790291	0.9211854057852527	0.9409420908224024	0.9304860107509125	0.9345706433672077	0.7196353277390276	0.9038384049224868	0.8708615055980516	0.8916427209669553	0.9513981708938924	0.9078001682032975	0.9537275764190307	0.8446253477156863	0.9017991513138026	0.8922409121179833	LMNA	Ala43Thr	NC_000001.11:156115045:G:A	127G>A	1	156115045	G	A	1	ENSG00000160789	3903	0	CCSBVarC003606	ALE00003606	ENSP00000357284.2	CEGS2	CegsMutGDEh1035	C03	GDEhDisVCh_40057	F08	1	CegsMutGDDh1035	C03	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	77696.0	single nucleotide variant	NM_170707.4(LMNA):c.127G>A (p.Ala43Thr)	4000.0	LMNA	HGNC:6636	Conflicting classifications of pathogenicity	1.0	Oct 13, 2023	60446065.0	-	RCV000057262|RCV001225020	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746	not provided|Charcot-Marie-Tooth disease type 2	germline	germline	GRCh38	NC_000001.11	1	156115045.0	156115045.0	1q22	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016942,UniProtKB:P02545#VAR_039753	2.0	66799.0	156115045.0	G	A	-	-	-	-	-	-	127G>A 	Ala43Thr	NM_170707.4	1.0	Conflicting	Conflicting	66799	1	156115045.0	G	A	A	T	rs60446065	1	156084836	1	154351460	43	LMNA	ENSG00000160789	ENST00000675939	ENSP00000502256	P02545	LMNA_HUMAN	.	.	c.127G>A	p.Ala43Thr	principal1	Y	.	.	.	+	GCG	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.60671	.	1.0	0.90580	D	1.0	0.97365	D	.	0.99291	.	.	.	.	4.8	0.99640	H	.	0.67623	.	.	0.97975	1.0724	0.98653	D	0.9299	0.97681	D	10	.	0.99375	.	0.712602	0.97660	D	.	0.99545	0.924	0.98699	P02545	A43T	Gain of phosphorylation at A43 (P = 0.0767)| Gain of disorder (P = 0.0918)| Gain of MoRF binding (P = 0.1749)| Loss of stability (P = 0.302)| Gain of solvent accessibility (P = 0.3819)	.	0.98919	.	0.99215	.	0.94644	0.757743537426	0.75550	T	0.975701	0.99763	D	0.565194	0.96303	D	0.574085	0.96243	D	0.999742329120636	0.98769	D	.	0.97858	.	0.85589856	0.87609	0.7691078	0.86196	0.819483	0.84994	0.751655	0.85142	-10.307	0.75805	D	.	0.95185	.	0.999479217996385	0.96705	0.99996510	0.99965	0.984	0.99450	.	.	.	.	.	.	5.634268	0.92707	32.0	0.99901205079885413	0.97276	0.964074	0.98608	D	0.98056132522041	0.95089	13.32298	0.888889835448083	0.95043	13.28456	4.77	4.77	0.60376	.	.	9.953	0.98981	11.667000	0.94064	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.999	0.91597	420	0.81453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1597190	6.261000e-07	0	1	1171998	8.532440e-07	0	0	74668	0.000000e+00	0	0	912	0.000000e+00	0	0	57712	0.000000e+00	0	0	29200	0.000000e+00	0	0	43966	0.000000e+00	0	0	62534	0.000000e+00	0	0	6040	0.000000e+00	0	1	1171998	8.532440e-07	0	0	88354	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Charcot-Marie-Tooth_disease_type_2|not_provided	criteria_provided,_conflicting_classifications	NC_000001.11:g.156115045G>A	ClinGen:CA016942|UniProtKB:P02545#VAR_039753	C0270914|C3661900	.	64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ala	Thr	89.32	0.42452830188679247																																																																																																																																																																																																																																																																																																																																																																																																																																																																													45			89.32	Aliphatic	Alanine		Prelamin-A/C; Lamin-A/C							IF rod			1.8								 A43-D47 (PAE:  2.5), A43-N39 (PAE: 4.5)	A43-D47 (PDBs: 6JLB), A43-N39 (PDBs: 6JLB)	 A43-D47 (PAE:  2.5), A43-N39 (PAE: 4.5)	A43-D47 (PDBs: 6JLB), A43-N39 (PDBs: 6JLB)							89									-66.3				-47.9	Interaction with MLIP; Coil 1A			dbSNP: rs60446065; Variant type: LP/P; AA change: Ala43Thr; PTM type: Phosphorylation; PTM morphology: DrLA*VyIDrVR; Var class: II		H (helix)	H (α-helix)	Helix											89.32	42.45283	70-90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9		false	0.8863303284559272	0.8919418165424693	false	false	false
ZC4H2	ZC4H2_Ala157Thr	B_13-14	-10.081278927908906	0.00002028191414801023	0.0003428181948911464	9.564949391729368	0.000028662018291252733	0.00015606766636334945	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9368839378084957	0.950207522952268	0.6989461773989811	0.7974533878824412	0.7430550707100416	0.7634233842869707	0.8098387522892897	0.7712491281912028	0.7691613010208644	0.7240292047720468	0.9239811079790339	0.9105925968694234	0.7170080162846515	0.7148610132288803	0.825745474744018	0.6738631500259156	0.9764339379255019	0.963175278747568	ZC4H2	Ala157Thr	NC_000023.11:64919134:C:T	469G>A	23	64919134	C	T	X	ENSG00000126970	4320	0	CCSBVarC009160	ALE00011588	ENSP00000363972.3																																	1195791.0	single nucleotide variant	NM_018684.4(ZC4H2):c.469G>A (p.Ala157Thr)	55906.0	ZC4H2	HGNC:24931	Conflicting classifications of pathogenicity	0.0	Mar 01, 2023	756615930.0	-	RCV001572168	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000023.11	X	64919134.0	64919134.0	Xq11.2	criteria provided, conflicting classifications	2.0	-	N	-	2.0	1205492.0	64919134.0	C	T	-	-	-	-	-	-	469G>A 	Ala157Thr	NM_018684.4	1.0	Conflicting	Conflicting	1205492	X	64919134.0	C	T	A	T	rs756615930	X	64139014	X	64055739	157	ZC4H2	ENSG00000126970	ENST00000374839	ENSP00000363972	Q9NQZ6	ZC4H2_HUMAN	c.469G>A	p.Ala157Thr	c.469G>A	p.Ala157Thr	principal1	Y	1	YES	Select	-	GCT	1	0	C	./.	./.	./.	./.	0.345	0.12584	T	0.671	0.08074	T	0.999	0.77914	D	0.994	0.82066	D	0.07	0.44282	N	simple_aae	93.0	7.0	1.59	0.40152	L	-0.2	0.10073	N	0.56	0.58756	-0.5882	0.65140	T	0.3458	0.70954	T	9	0.355225	0.51923	D	0.179905	0.85417	D	0.212	0.50121	.	.	.	.	.	0.496162226526	0.48888	0.696682045515307	0.69455	0.00654792661685	0.00552	0.645161211491	0.59234	T	0.270772	0.64106	T	0.0837489	0.62210	D	-0.117477	0.61741	T	0.376825159565334	0.27756	T	0.927207	0.73106	D	0.30280557	0.52822	0.3234439	0.58049	0.30280557	0.52822	0.3234439	0.58048	-5.678	0.44103	T	0.4207	0.60657	A	0.690180673695841	0.66695	0.97556907	0.95109	0.138	0.36230	.	.	.	.	.	.	3.698819	0.52818	23.3	0.99793533325966355	0.87938	.	.	.	.	.	.	.	.	.	5.36	5.36	0.76590	.	.	7.638	0.82522	7.554000	0.60397	0.595	0.32887	1.0	0.71675	0.999000	0.35501	0.966	0.53174	40	0.97963	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	4	77492	5.161820e-05	0	4	145397	2.751090e-05	0	4	164610	2.429990e-05	0	0	5627	0.000000e+00	0	1	13221	7.563720e-05	0	0	1650	0.000000e+00	0	1	6793	1.472100e-04	0	0	9769	0.000000e+00	0	2	29771	6.717950e-05	0	0	9288	0.000000e+00	0	1	6793	1.472100e-04	0	0	12905	0.000000e+00	0	1	23514	4.252790e-05	0	0	4286	0.000000e+00	0	1	9851	1.015130e-04	0	0	11944	0.000000e+00	0	2	61889	3.231590e-05	0	0	17571	0.000000e+00	0	1	9851	1.015130e-04	0	0	11834	0.000000e+00	0	1	26175	3.820440e-05	0	0	6515	0.000000e+00	0	1	12811	7.805790e-05	0	0	15672	0.000000e+00	0	2	70182	2.849730e-05	0	0	17506	0.000000e+00	0	1	12811	7.805790e-05	0	.	14	1205217	1.161620e-05	0	3	45240	6.631300e-05	0	3	57025	5.260850e-05	0	0	685	0.000000e+00	0	3	45240	6.631300e-05	0	0	21757	0.000000e+00	0	1	33605	2.975750e-05	0	0	46483	0.000000e+00	0	0	4345	0.000000e+00	0	6	892775	6.720620e-06	0	0	55969	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	not_provided	criteria_provided,_conflicting_classifications	NC_000023.11:g.64919134C>T	.	C3661900	.	.	.	Ala	Thr	66.51	0.5849056603773585																																																																																																																																																																																																																																																																																																																																																																																																																																																																													62			66.51	Aliphatic	Alanine		Zinc finger C4H2 domain-containing protein										1.8								 A157-A161 (PAE:  2.0), A157-E153 (PAE: 3.0)		 A157-A161 (PAE:  2.0), A157-E153 (PAE: 3.0)								89									-62.8				-40.2						H (helix)	H (α-helix)												66.51	58.49057	50-70	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder	2		false	0.950207522952268	0.9368839378084957	false	false	false
SHOC2	SHOC2_Ile112Thr	B_13-14	-1.6941158363159368	0.13407053946967112	0.20701271656190123	6.175274595268666	0.000456121543039336	0.0012856882203950563	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6283290278546458	0.6777586022520401	0.651657398086099	0.7929253450102034	0.7830667801867459	0.7418623020437107	0.7905353055809256	0.8057774883710295	0.7218509654058295	0.7242677363885501	0.6834784539389458	0.6353223751627428	0.6931892985064958	0.7603560720024622	0.8639997246145772	0.5790470597836479	0.6720387505651343	0.6213356805465489	SHOC2	Ile112Thr	NC_000010.11:110964693:T:C	335T>C	10	110964693	T	C	10	ENSG00000108061	11602	0	CCSBVarC028015	ALE00021791	ENSP00000358464.5																																	359949.0	single nucleotide variant	NM_007373.4(SHOC2):c.335T>C (p.Ile112Thr)	8036.0	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	0.0	Sep 01, 2022	201289608.0	-	RCV000412950|RCV002058863	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	not specified|RASopathy	germline	germline	GRCh38	NC_000010.11	10	110964693.0	110964693.0	10q25.2	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA5689578	2.0	372672.0	110964693.0	T	C	-	-	-	-	-	-	335T>C 	Ile112Thr	NM_007373.4	1.0	Conflicting	Conflicting	372672	10	110964693.0	T	C	I	T	rs201289608	10	112724451	10	112714441	112	SHOC2	ENSG00000108061	ENST00000685059	ENSP00000510210	Q9UQ13	SHOC2_HUMAN	.	.	c.335T>C	p.Ile112Thr	principal1	Y	.	.	.	+	ATA	2	0	T	T/T	T/T	T/T	T/T	.	0.65576	.	.	0.72530	.	0.991	0.64084	D	0.859	0.68533	P	.	0.83457	.	.	.	.	2.215	0.62356	M	.	0.69394	.	.	0.77511	-0.8189	0.53817	T	0.1771	0.52019	T	10	.	0.06360	.	0.037699	0.57610	D	.	0.82485	.	.	.	.	.	.	0.32053	.	0.70286	.	0.60769	0.878477811813	0.93746	D	0.694651	0.91066	D	0.238977	0.77397	D	0.120984	0.78138	D	0.209546628069009	0.20673	T	.	0.80795	.	0.3715067	0.58367	0.31585136	0.57346	0.3715067	0.58368	0.31585136	0.57345	-14.224	0.93774	D	.	0.90095	.	0.98998296608994	0.88394	0.03607558	0.55979	0.724	0.84705	.	.	.	.	.	.	4.839965	0.79049	27.0	0.9982735190376778	0.90946	0.897770	0.83973	D	0.757518467026862	0.83302	8.00597	0.768186021251903	0.87440	9.246591	5.85	5.85	0.93654	.	.	8.017	0.8876	6.177000	0.54645	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.999	0.91597	915	0.20912	2	3.9936102236421724E-4	0	0.0	2	0.0019880715705765406	0	0.0	0	0.0	0	0.0	.	.	.	.	40	109400	3.656310e-04	0	52	208086	2.498970e-04	0	63	236544	2.663350e-04	0	0	7162	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	38	13394	2.837090e-03	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16214	0.000000e+00	0	0	30502	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	50	16734	2.987930e-03	0	1	89536	1.116870e-05	0	0	30608	0.000000e+00	0	1	89536	1.116870e-05	0	0	14900	0.000000e+00	0	0	34234	0.000000e+00	0	0	9560	0.000000e+00	0	0	17692	0.000000e+00	0	60	21632	2.773670e-03	0	2	102394	1.953240e-05	0	0	30526	0.000000e+00	0	2	102394	1.953240e-05	0	.	164	1614054	1.016080e-04	0	154	64038	2.404820e-03	0	1	74994	1.333440e-05	0	0	910	0.000000e+00	0	0	60004	0.000000e+00	0	0	29602	0.000000e+00	0	0	44884	0.000000e+00	0	154	64038	2.404820e-03	0	0	6062	0.000000e+00	0	5	1179980	4.237360e-06	0	0	91078	0.000000e+00	0	1	44446	2.2499212527561534E-5	0	108	0	0	122	0	0	3236	0	0	152	0	0	632	0	0	24	0	0	100	0	0	1484	0	0	3344	0	0	146	0	1	50304	1.9879134860050892E-5	RASopathy|not_specified	criteria_provided,_conflicting_classifications	NC_000010.11:g.110964693T>C	ClinGen:CA5689578	C5555857|CN169374	.	536391	.	Ile	Thr	93.16	0.01775147928994083																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3			93.16	Aliphatic	Isoleucine		Leucine-rich repeat protein SHOC-2										4.5								 I112-K134 (PAE:  1.0), I112-N133 (PAE: 1.5)	I112-K134 (PDBs: 7TVG, 7SD0, 7UPI), I112-N133 (PDBs: 7TVG, 7SD1, 7T7A, 7TYG, 7TVF)	 I112-K134 (PAE:  1.0), I112-L135 (PAE: 1.0)	I112-K134 (PDBs: 7TVG, 7UPI), I112-L135 (PDBs: 7TVG, 7SD1, 7T7A, 7TYG, 7SD0, 7TVF, 7UPI)							131									-68.6				128.5			LRR 1			C (loop/coil)	C (loop/coil)												93.16	1.7751479	>90	<10		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5		false	0.6777586022520401	0.6283290278546458	false	false	false
RAD51D	RAD51D_Ser46Cys	B_13-14	0.7829957094149949	0.4592952894564183	0.5465757027176068	3.7843682705812154	0.006853078574643705	0.012414016963939978	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.650998611963036	0.6618825102372428	0.4842066705657395	0.5849700416572905	0.6375141020058066	0.5319600220447889	0.5019088199905075	0.6446098215460457	0.5683118421890945	0.46497129737027026	0.6214168847075888	0.6315168014111925	0.5620112240990702	0.6304183824655674	0.6016282411254865	0.5034420437612088	0.7023481357668966	0.6704804225148795	RAD51D	Ser46Cys	NC_000017.11:35119118:G:C	137C>G	17	35119118	G	C	17	ENSG00000185379	7201	0	CCSBVarC024795	ALE00029713	ENSP00000338790.6																																	133339.0	single nucleotide variant	NM_002878.4(RAD51D):c.137C>G (p.Ser46Cys)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Mar 19, 2024	587780102.0	-	RCV000115808|RCV000212953|RCV000228533|RCV000656964|RCV001354278|RCV001798341|RCV003492493	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562|MedGen:C1333600	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Malignant tumor of breast|Breast and/or ovarian cancer|Hereditary cancer	germline;unknown	germline	GRCh38	NC_000017.11	17	35119118.0	35119118.0	17q12	criteria provided, conflicting classifications	17.0	-	N	ClinGen:CA287956	2.0	127882.0	35119118.0	G	C	-	-	-	-	-	-	137C>G 	Ser46Cys	NM_002878.4	1.0	Conflicting	Conflicting	127882	17	35119118.0	G	C	S	C	rs587780102	17	33446137	17	30470250	46	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.137C>G	p.Ser46Cys	c.137C>G	p.Ser46Cys	principal1	Y	5	.	.	-	TCT	2	0	G	G/G	G/G	G/G	G/G	0.007	0.63383	D	0.023	0.79703	D	1.0	0.90580	D	0.956	0.86259	D	.	0.68318	.	.	.	.	2.72	0.79369	M	-3.45	0.72035	D	0.683	0.70828	-0.3645	0.73009	T	0.3321	0.69833	T	10	0.7786217	0.77446	D	0.048765	0.63381	D	0.456	0.75352	.	.	.	.	.	0.947946397878	0.94697	.	0.54121	.	0.43501	.	.	.	0.683251	0.90627	D	-0.0213529	0.48331	T	-0.0134026	0.69239	D	0.823957562446594	0.47789	D	0.883212	0.68570	D	0.53418267	0.68768	0.28243348	0.54022	0.5920361	0.71975	0.31285465	0.57062	-10.77	0.78452	D	0.2118	0.50240	B	0.0651732501033949	0.39495	0.96507460	0.94298	0.545	0.74295	.	.	.	.	.	.	5.349603	0.89758	31.0	0.99138447258004703	0.53541	0.928860	0.91342	D	0.802452879217227	0.86184	8.828211	0.769679193341177	0.87549	9.284908	5.02	5.02	0.66699	.	.	5.745	0.68382	11.447000	0.92795	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.96	0.51684	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	31	264690	1.17118136E-4	.	8	109378	7.314090e-05	0	16	208038	7.690900e-05	0	18	236818	7.600770e-05	0	0	7160	0.000000e+00	0	1	17104	5.846590e-05	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	7	42754	1.637270e-04	0	0	15690	0.000000e+00	0	7	42754	1.637270e-04	0	0	16198	0.000000e+00	0	3	30514	9.831550e-05	0	0	6212	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	12	89498	1.340810e-04	0	0	30608	0.000000e+00	0	12	89498	1.340810e-04	0	0	14886	0.000000e+00	0	4	34250	1.167880e-04	0	0	9572	0.000000e+00	0	0	17688	0.000000e+00	0	0	21562	0.000000e+00	0	13	102716	1.265630e-04	0	0	30526	0.000000e+00	0	13	102716	1.265630e-04	0	.	169	1613388	1.047490e-04	0	9	59998	1.500050e-04	0	0	74900	0.000000e+00	0	0	912	0.000000e+00	0	9	59998	1.500050e-04	0	0	29604	0.000000e+00	0	0	44884	0.000000e+00	0	0	64038	0.000000e+00	0	0	6084	0.000000e+00	0	155	1179426	1.314200e-04	0	0	91082	0.000000e+00	0	13	32650	3.9816232771822357E-4	0	122	0	0	112	0	0	3390	0	1	500	0.002	0	628	0	0	56	0	0	98	0	0	6864	0	0	3512	0	0	168	0	14	44420	3.1517334533993696E-4	Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer|not_specified|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119118G>C	ClinGen:CA287956	C0006142|CN221562|C0027672|C3280345|C1333600|CN169374|C3661900	614291	140162|145	RAD51D, N-terminal domain	Ser	Cys	92.03	0.5692307692307692																																																																																																																																																																																																																																																																																																																																																																																																																																																																													74			92.03	Polar/Neutral	Serine		DNA repair protein RAD51 homolog 4										-0.8								 S46-L50 (PAE:  1.0)	S46-L50 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ)	 S46-L50 (PAE:  1.0)	S46-L50 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ)							105									-64.4				120.5	preferentially binds ssDNA					C (loop/coil)	C (loop/coil)												92.03	56.92308	>90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.6618825102372428	0.650998611963036	false	false	false
LMNA	LMNA_Arg349Leu	B_13-14	1.0956468444891008	0.3094917419063528	0.39673102485982137	4.355974567016565	0.0033304907987539976	0.0065856148876223975	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9026027627014069	0.9070168014344393	0.5253053024852812	0.6904957703919629	0.6189379104342978	0.5658295300096976	0.5450386500426811	0.7237175953162223	0.6559946015185242	0.531184364238326	0.9276997025513488	0.9218460829818209	0.586620409976714	0.5141582255523733	0.7249969392654015	0.5194262407322363	0.8863339003175299	0.883359442420993	LMNA	Arg349Leu	NC_000001.11:156136010:G:T	1046G>T	1	156136010	G	T	1	ENSG00000160789	3903	0	CCSBVarC003621	ALE00003621	ENSP00000357284.2	CEGS2	CegsMutGDEh1042	E02	GDEhDisVCh_40057	B10	1	CegsMutGDDh1042	E02	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	77660.0	single nucleotide variant	NM_170707.4(LMNA):c.1046G>T (p.Arg349Leu)	4000.0	LMNA	HGNC:6636	Conflicting classifications of pathogenicity	1.0	Aug 22, 2023	58789393.0	-	RCV000057219|RCV001854172|RCV003343625	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype	germline	germline	GRCh38	NC_000001.11	1	156136010.0	156136010.0	1q22	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	UniProtKB:P02545#VAR_039776,ClinGen:CA016488	2.0	66763.0	156136010.0	G	T	-	-	-	-	-	-	1046G>T 	Arg349Leu	NM_170707.4	1.0	Conflicting	Conflicting	66763	1	156136010.0	G	T	R	L	rs58789393	1	156105801	1	154372425	349	LMNA	ENSG00000160789	ENST00000361308	ENSP00000355292	P02545	LMNA_HUMAN	c.1046G>T	p.Arg349Leu	c.1046G>T	p.Arg349Leu	principal1	Y	5	.	.	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.003	0.79703	D	0.775	0.90580	P	0.896	0.86259	P	0.97	0.97016	D	simple_aae	3.0	97.0	3.8	0.95330	H	-6.56	0.91889	D	0.965	0.98762	0.9518	0.96410	D	0.8633	0.95442	D	10	0.97176325	0.96764	D	0.755624	0.98052	D	0.871	0.96123	0.801	0.91975	P02545	R349L	Loss of MoRF binding (P = 0.0632)| Loss of methylation at R349 (P = 0.2199)| Gain of stability (P = 0.2765)| Loss of catalytic residue at M345 (P = 0.6375)| Loss of solvent accessibility (P = 0.6392)	0.966327329089	0.96566	.	0.98457	.	0.96624	0.813560366631	0.84010	D	0.967344	0.99617	D	0.495723	0.94117	D	0.474295	0.94039	D	0.992853701114655	0.83317	D	.	0.96357	.	0.7229245	0.79081	0.65043724	0.79322	0.6761609	0.76503	0.61561835	0.77388	-8.52	0.71001	D	0.9091	0.83342	LP	0.999839382529083	0.98239	0.99996722	0.99978	0.981	0.99334	.	.	.	.	.	.	5.301637	0.89027	29.8	0.99846690473892685	0.92668	0.974698	0.99573	D	0.899982601079214	0.91714	11.04923	0.832866080674497	0.91933	11.169	5.74	4.83	0.61832	4.47	0.83830	10.003	0.9969	11.671000	0.94110	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.955	0.50625	460	0.78769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Charcot-Marie-Tooth_disease_type_2|Cardiovascular_phenotype|not_provided	criteria_provided,_conflicting_classifications	NC_000001.11:g.156136010G>T	ClinGen:CA016488|UniProtKB:P02545#VAR_039776	C0270914|CN230736|C3661900	.	64746	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Leu	94.82	0.6451612903225806																																																																																																																																																																																																																																																																																																																																																																																																																																																																													160			94.82	Positively-charged	Arginine		Prelamin-A/C; Lamin-A/C							IF rod			-4.5								 R349-Q353 (PAE:  3.5), R349-M345 (PAE: 2.5)	R349-M345 (PDBs: 1X8Y, 3V5B), R349-Q353 (PDBs: 2XV5)	 R349-Q353 (PAE:  3.5), R349-M345 (PAE: 2.5)	R349-M345 (PDBs: 1X8Y, 3V5B), R349-Q353 (PDBs: 3V5B, 2XV5)							175									-63.9				-41.9	Coil 2					H (helix)	H (α-helix)												94.82	64.51613	>90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Laminopathy; Rare genetic endocrine disease; Rare genetic neurological disorder; Genetic infertility; Rare genetic skin disease	9		false	0.9070168014344393	0.9026027627014069	false	false	false
SHOC2	SHOC2_Ser57Phe	B_13-14	-1.2094902213471577	0.26573292360703604	0.3517324214064025	4.543257396836306	0.002657356943427251	0.005436176132875145	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6704808654107329	0.6785483451032763	0.5802639396703223	0.7495802664946343	0.7490385932804057	0.7055721150615247	0.507993185812655	0.6752371831952553	0.577529165536847	0.48526707258892376	0.616763055859795	0.61166471529703	0.9031510443103945	0.8228400033655561	0.9216313674524217	0.6752608067517208	0.7403336343467577	0.7292970155244358	SHOC2	Ser57Phe	NC_000010.11:110964528:C:T	170C>T	10	110964528	C	T	10	ENSG00000108061	11602	0	CCSBVarC028011	ALE00021371	ENSP00000358464.5																																	174882.0	single nucleotide variant	NM_007373.4(SHOC2):c.170C>T (p.Ser57Phe)	8036.0	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	0.0	Feb 01, 2024	536611911.0	-	RCV000156558|RCV000471315|RCV001803094|RCV000680347|RCV002399558	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MedGen:C3661900|MedGen:CN230736	not specified|RASopathy|Noonan syndrome-like disorder with loose anagen hair 1|not provided|Cardiovascular phenotype	germline	germline	GRCh38	NC_000010.11	10	110964528.0	110964528.0	10q25.2	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA185080	2.0	179760.0	110964528.0	C	T	-	-	-	-	-	-	170C>T 	Ser57Phe	NM_007373.4	1.0	Conflicting	Conflicting	179760	10	110964528.0	C	T	S	F	rs536611911	10	112724286	10	112714276	57	SHOC2	ENSG00000108061	ENST00000688928	ENSP00000509273	Q9UQ13	SHOC2_HUMAN	.	.	c.170C>T	p.Ser57Phe	principal1	Y	.	.	.	+	TCC	2	0	C	C/C	C/C	C/C	C/C	.	0.48802	.	.	0.59495	.	0.214	0.33016	B	0.191	0.42849	B	.	0.63842	.	.	.	.	1.7	0.43657	L	.	0.42386	.	.	0.41012	0.3313	0.87999	D	0.7029	0.89743	D	10	.	0.24349	.	0.049509	0.63705	D	.	0.73303	0.197	0.10912	Q9UQ13	S57F	Loss of phosphorylation at S57 (P = 0.0075)| Loss of relative solvent accessibility (P = 0.0676)| Loss of loop (P = 0.0804)| Gain of helix (P = 0.0854)| Gain of methylation at K55 (P = 0.0918)	.	0.33999	.	0.11358	.	0.58683	0.648043274879	0.59645	T	0.393088	0.75087	T	-0.0567598	0.43068	T	-0.0642621	0.65789	T	0.111457248625392	0.13402	T	.	0.73431	.	0.24477392	0.47101	0.22556585	0.47330	0.24477392	0.47101	0.22556585	0.47329	-6.9	0.53367	T	.	0.31154	.	0.980925639856185	0.85540	0.01493649	0.46015	0.355	0.61325	.	.	.	.	.	.	3.839	0.55624	23.6	0.99584984580791636	0.73250	0.764929	0.70048	D	0.262239601804826	0.54016	3.590762	0.442202180045834	0.64024	4.67194	5.99	5.99	0.97294	3.68	0.67565	6.109	0.71273	7.666000	0.64570	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.993	0.69292	915	0.20912	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	0	0.0	1	0.0010224948875255625	10	264690	3.7780046E-5	.	7	109336	6.402280e-05	0	21	207858	1.010310e-04	0	23	236064	9.743120e-05	0	0	7148	0.000000e+00	0	2	17094	1.170000e-04	0	0	2320	0.000000e+00	0	0	9036	0.000000e+00	0	0	13392	0.000000e+00	0	4	42762	9.354100e-05	0	1	15672	6.380810e-05	0	2	17094	1.170000e-04	0	0	16156	0.000000e+00	0	4	30470	1.312770e-04	0	0	6204	0.000000e+00	0	0	13392	0.000000e+00	0	0	16728	0.000000e+00	0	14	89460	1.564950e-04	0	3	30590	9.807130e-05	0	14	89460	1.564950e-04	0	0	14884	0.000000e+00	0	5	34202	1.461900e-04	0	0	9540	0.000000e+00	0	0	17678	0.000000e+00	0	0	21616	0.000000e+00	0	15	102040	1.470010e-04	0	3	30508	9.833490e-05	0	15	102040	1.470010e-04	0	.	87	1614030	5.390230e-05	1	1	6062	1.649620e-04	0	0	75008	0.000000e+00	0	0	912	0.000000e+00	0	9	59982	1.500450e-04	0	0	29606	0.000000e+00	0	0	44872	0.000000e+00	0	0	64008	0.000000e+00	0	1	6062	1.649620e-04	0	67	1179988	5.678020e-05	1	6	91084	6.587330e-05	0	4	42688	9.37031484257871E-5	0	306	0	0	112	0	0	8020	0	0	500	0	0	628	0	0	56	0	0	98	0	1	8288	1.2065637065637066E-4	0	8326	0	0	168	0	5	60696	8.237775141689732E-5	Cardiovascular_phenotype|not_provided|RASopathy|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|not_specified	criteria_provided,_conflicting_classifications	NC_000010.11:g.110964528C>T	ClinGen:CA185080	CN230736|C3661900|C5555857|C4478716|CN169374	607721	536391|2701	.	Ser	Phe	29.3	0.8076923076923077																																																																																																																																																																																																																																																																																																																																																																																																																																																																													105			29.3	Polar/Neutral	Serine		Leucine-rich repeat protein SHOC-2		Basic and acidic residues								-0.8																		105									-105.4				139.2	Disordered					C (loop/coil)	C (loop/coil)												29.3	80.769226	$\leqslant$50	10-90	607721	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	false	0.6785483451032763	0.6704808654107329	false	false	false
BRIP1	BRIP1_Arg848His	B_13-14	2.578571129238601	0.0754963461161795	0.12378624124069341	0.3645848143152252	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7271708983849918	0.7564217793045473	0.7264766199982717	0.7645552408681349	0.7944960100590862	0.7753198801276273	0.7633244066999568	0.7440014759062855	0.7423893680307795	0.7194407542822114	0.730745043822426	0.7020842447568073	0.7873153535552977	0.8449905442118869	0.7867211137054904	0.7335124857143321	0.7820985147866686	0.7522575520131763	BRIP1	Arg848His	NC_000017.11:61693462:C:T	2543G>A	17	61693462	C	T	17	ENSG00000136492	55128	0	CCSBVarC031388	ALE00029791	ENSP00000259008.2																																	151213.0	single nucleotide variant	NM_032043.3(BRIP1):c.2543G>A (p.Arg848His)	83990.0	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	1.0	Sep 09, 2024	374334794.0	-	RCV000130056|RCV000699539|RCV001194712|RCV001255230|RCV000663220|RCV002273958|RCV003460909|RCV004760390	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:C3661900|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84;Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group J;Familial cancer of breast|not provided|Fanconi anemia complementation group J|Fanconi anemia complementation group J;Ovarian neoplasm|Neurodevelopmental delay|Familial cancer of breast|Hereditary breast ovarian cancer syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	61693462.0	61693462.0	17q23.2	criteria provided, conflicting classifications	13.0	-	N	ClinGen:CA165626	2.0	141499.0	61693462.0	C	T	-	-	-	-	-	-	2543G>A 	Arg848His	NM_032043.3	1.0	Conflicting	Conflicting	141499	17	61693462.0	C	T	R	H	rs374334794	17	59770823	17	57125605	848	BRIP1	ENSG00000136492	ENST00000259008	ENSP00000259008	Q9BX63	FANCJ_HUMAN	c.2543G>A	p.Arg848His	c.2543G>A	p.Arg848His	principal2	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.78	0.86494	D	simple_aae	22.0	78.0	4.15	0.97531	H	-4.6	0.79008	D	0.857	0.99270	1.0848	0.99040	D	0.9696	0.99037	D	9	0.94317496	0.93570	D	0.469494	0.94645	D	0.932	0.98414	.	.	.	.	.	0.999184905289	0.99916	0.8741008375185114	0.87298	0.750843833719	0.63531	0.644317030907	0.59114	T	0.839083	0.96201	D	0.542959	0.95468	D	0.542146	0.95401	D	0.999659895896912	0.98331	D	.	0.93863	.	0.9493171	0.96137	0.8188024	0.89326	0.9493171	0.96137	0.8188024	0.89327	-11.608	0.82941	D	0.8672	0.83733	P	0.999253341147957	0.96077	0.99724770	0.98313	0.641	0.80003	.	.	.	.	.	.	5.402014	0.90472	31.0	0.99942296316834778	0.99824	0.731722	0.67754	D	0.953849966561016	0.94104	12.5292	0.867844537858018	0.93982	12.44217	5.74	5.74	0.90056	.	.	5.053	0.6417	7.610000	0.61936	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.935	0.4738	139	0.94485	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10	1613508	6.197680e-06	0	3	74880	4.006410e-05	0	3	74880	4.006410e-05	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29590	0.000000e+00	0	0	44854	0.000000e+00	0	0	63978	0.000000e+00	0	0	6082	0.000000e+00	0	6	1179678	5.086130e-06	0	1	91078	1.097960e-05	0	0	19722	0	0	298	0	0	86	0	2	7418	2.6961445133459155E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	1922	0	2	7716	2.592016588906169E-4	0	112	0	2	30326	6.595000989250148E-5	Familial_cancer_of_breast|Neurodevelopmental_delay|Fanconi_anemia_complementation_group_J|Ovarian_neoplasm|not_provided|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.61693462C>T	ClinGen:CA165626	C0346153|C4022738|C1836860|C0919267|C3661900|C0027672	114480|609054	227535|84|140162	.	Arg	His	92.54	0.13709677419354838																																																																																																																																																																																																																																																																																																																																																																																																																																																																													34			92.54	Positively-charged	Arginine		Fanconi anemia group J protein										-4.5								 R848-A662 (PAE:  2.5), R848-N852 (PAE: 3.0)		 R848-N852 (PAE:  3.0), R848-Y856 (PAE: 2.0)		 R848-D846 (PAE:  1.0)						175									-57.9				-31.8						H (helix)	H (α-helix)												92.54	13.709678	>90	10-90	609054;114480;609054;609054;114480	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	FANCONI ANEMIA, COMPLEMENTATION GROUP J; BREAST CANCER; FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCONI ANEMIA, COMPLEMENTATION GROUP J; BREAST CANCER	true	0.7564217793045473	0.7271708983849918	false	false	false
RAD51D	RAD51D_Thr328Ile	B_13-14	0.5151692477436156	0.6222994408448728	0.6946767574597936	17.636571766015564	4.6430099714799027e-7	0.000010784713035019775	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	false	false	0.9661780807022601	0.973124490067996	0.8370593946464979	0.849545354066128	0.8234392181085936	0.8403848872628913	0.7514562046079563	0.7504941389093649	0.756226770416464	0.7697587490665923	0.9765633422563194	0.9757433865559109	0.9293135699178263	0.8963842973078222	0.9428639377157919	0.9043600402264036	0.9696856378796725	0.9566127748486093	RAD51D	Thr328Ile	NC_000017.11:35100957:G:A	983C>T	17	35100957	G	A	17	ENSG00000185379	7201	0	CCSBVarC024896	ALE00029788	ENSP00000338790.6																																	151057.0	single nucleotide variant	NM_002878.4(RAD51D):c.983C>T (p.Thr328Ile)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Feb 01, 2024	138969595.0	-	RCV000129828|RCV000254688|RCV000411668|RCV000859034|RCV003935215	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|RAD51D-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	35100957.0	35100957.0	17q12	criteria provided, conflicting classifications	11.0	-	N	ClinGen:CA294126	2.0	141343.0	35100957.0	G	A	-	-	-	-	-	-	983C>T 	Thr328Ile	NM_002878.4	1.0	Conflicting	Conflicting	141343	17	35100957.0	G	A	T	I	rs138969595	17	33427976	17	30452089	328	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.983C>T	p.Thr328Ile	c.983C>T	p.Thr328Ile	principal1	Y	1	YES	Select	-	ACA	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.0	0.02950	B	0.001	0.04348	B	0.0	0.01751	N	simple_aae	100.0	0.0	0.145	0.08752	N	-1.32	0.32965	N	0.053	0.21823	-1.0435	0.16258	T	0.0417	0.17815	T	10	0.009995133	0.00221	T	0.006771	0.17625	T	0.026	0.05575	.	.	.	.	.	0.207176502487	0.19935	.	0.26638	.	0.45724	.	.	.	0.115639	0.43135	T	-0.601611	0.00139	T	-0.677482	0.06933	T	0.075320455379959	0.09265	T	.	0.22097	.	0.08105616	0.18434	0.09681502	0.22979	0.08105616	0.18434	0.09681502	0.22979	-4.387	0.29411	T	0.1002	0.28639	LB	4.77421596645541e-05	0.01873	0.28552076	0.76376	0.032	0.06833	.	.	.	.	.	.	1.075211	0.14598	11.14	0.59940449977036514	0.06433	0.051862	0.09058	N	-1.19812197881439	0.04971	0.2282938	-1.22724989160509	0.05389	0.2610204	5.12	-1.75	0.07582	-1.09	0.15326	-0.5	0.065	-0.087000	0.12155	-0.119	0.14328	0.0	0.06393	0.000000	0.08389	0.07	0.16685	914	0.21043	4	7.987220447284345E-4	4	0.0030257186081694403	0	0.0	0	0.0	0	0.0	0	0.0	76	264690	2.8712835E-4	.	6	109408	5.484060e-05	0	19	208136	9.128650e-05	0	17	236950	7.174510e-05	0	6	7164	8.375210e-04	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	6	7164	8.375210e-04	0	17	16218	1.048220e-03	0	1	30524	3.276110e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89558	0.000000e+00	0	1	30608	3.267120e-05	0	17	16218	1.048220e-03	0	14	14902	9.394710e-04	0	2	34260	5.837710e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	0	102746	0.000000e+00	0	1	30526	3.275900e-05	0	14	14902	9.394710e-04	0	.	96	1611324	5.957830e-05	1	80	74978	1.066980e-03	1	80	74978	1.066980e-03	1	0	912	0.000000e+00	0	4	60018	6.664670e-05	0	0	29586	0.000000e+00	0	0	44862	0.000000e+00	0	0	64034	0.000000e+00	0	2	6032	3.315650e-04	0	0	1177472	0.000000e+00	0	2	91016	2.197420e-05	0	1	163022	6.13414140422765E-6	0	360	0	0	2712	0	9	9362	9.613330484939116E-4	0	442	0	0	950	0	0	682	0	0	280	0	0	11320	0	9	9722	9.257354453816088E-4	0	3394	0	10	189130	5.287368476709142E-5	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|RAD51D-related_disorder|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.35100957G>A	ClinGen:CA294126	C3280345|C0027672|CN169374|C3661900	614291	145|140162	.	Thr	Ile	39.66	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													217			39.66	Polar/Neutral	Threonine		DNA repair protein RAD51 homolog 4										-0.7																		119									63.9				360.0						C (loop/coil)	C (loop/coil)												39.66	100.0	$\leqslant$50	$\geqslant$90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.973124490067996	0.9661780807022601	true	false	false
RET	RET_Arg330Gln	B_13-14	-1.7958396916116608	0.11558602092288398	0.18376144481619042	17.287358910168212	5.325798048199852e-7	0.000011497458139349093	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	false	false	0.943323146302429	0.9587752559225962	0.8154916669110377	0.8896191078077246	0.9099148237310472	0.9057898061010897	0.9936305547128508	0.9540961554339173	0.9826600353216369	0.9722871404061223	0.970053829643265	0.9624211243935695	0.8179490574893287	0.865733492028177	0.7965781802938122	0.658696193415953	0.9474966822019273	0.9242251682112885	RET	Arg330Gln	NC_000010.11:43106497:G:A	989G>A	10	43106497	G	A	10	ENSG00000165731	8858	0	CCSBVarC006881	ALE00006879	ENSP00000480088.1	CEGS2	CegsMutGDEh1026	D12	GDEhDisVCh_40066	F05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	28965.0	single nucleotide variant	NM_020975.6(RET):c.989G>A (p.Arg330Gln)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	1.0	Feb 22, 2023	80236571.0	-	RCV000014951|RCV001379274|RCV004696636	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:C3661900	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|not provided	germline	germline	GRCh38	NC_000010.11	10	43106497.0	43106497.0	10q11.21	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	OMIM:164761.0022,ClinGen:CA009415,UniProtKB:P07949#VAR_006302	3.0	13926.0	43106497.0	G	A	-	-	-	-	-	-	989G>A 	Arg330Gln	NM_020975.6	1.0	Conflicting	Conflicting	13926	10	43106497.0	G	A	R	Q	rs80236571	10	43601945	10	42921951	330	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.989G>A	p.Arg330Gln	c.989G>A	p.Arg330Gln	principal4	Y	5	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.241	0.17740	T	0.612	0.07765	T	0.997	0.73231	D	0.775	0.63015	P	0.58	0.75656	D	simple_aae	42.0	58.0	2.585	0.75368	M	-0.99	0.26154	N	0.607	0.62248	-0.0406	0.81321	T	0.5279	0.82381	D	10	0.85925674	0.84978	D	0.089999	0.75354	D	0.569	0.82371	0.757	0.88590	P07949	R330Q	Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.1985)| Gain of loop (P = 0.2045)| Loss of catalytic residue at R330 (P = 0.2566)| Loss of MoRF binding (P = 0.3113)	0.965051945311	0.96435	0.6768372825309222	0.67462	0.826949697597	0.67244	0.388616234064	0.23448	T	0.474583	0.80450	T	0.330437	0.85088	D	0.236874	0.84893	D	0.956602513790131	0.64578	D	0.819018	0.47499	T	0.24423973	0.47042	0.1090586	0.26223	0.21209615	0.43230	0.109657414	0.26374	-3.803	0.21738	T	0.1014	0.27073	B	0.758352146287697	0.69115	0.99982280	0.99765	0.47	0.69480	.	.	.	.	.	.	4.587702	0.72592	25.8	0.99947467890025776	0.99913	0.525698	0.54678	D	0.535811506893486	0.69059	5.326549	0.557793047773544	0.71788	5.732199	5.32	5.32	0.75341	4.38	0.82553	4.133	0.57831	8.604000	0.77773	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.976	0.56441	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613734	6.196810e-07	0	1	1179844	8.475700e-07	0	0	75040	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29592	0.000000e+00	0	0	44862	0.000000e+00	0	0	63922	0.000000e+00	0	0	6056	0.000000e+00	0	1	1179844	8.475700e-07	0	0	91026	0.000000e+00	0	1	23858	4.191466174867969E-5	0	84	0	0	84	0	0	2230	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4558	0	0	2314	0	0	108	0	1	32060	3.1191515907673116E-5	Hirschsprung_disease,_susceptibility_to,_1|not_provided|Multiple_endocrine_neoplasia,_type_2	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106497G>A	ClinGen:CA009415|OMIM:164761.0022|UniProtKB:P07949#VAR_006302	C3888239|C3661900|C4048306	142623	388|653	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Arg	Gln	95.21	0.3588709677419355																																																																																																																																																																																																																																																																																																																																																																																																																																																																													89			95.21	Positively-charged	Arginine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-4.5								 R330-N359 (PAE:  2.0), R330-D290 (PAE: 2.0), R330-V357 (PAE: 1.0)	R330-Q341 (PDBs: 6GL7), R330-V357 (PDBs: 6Q2J, 6Q2N, 6Q2O, 6Q2R, 6Q2S)	 R330-V357 (PAE:  1.0)	R330-Q341 (PDBs: 6GL7), R330-V357 (PDBs: 6Q2J, 6Q2N, 6Q2O, 6Q2R, 6Q2S)	 R330-D290 (PAE:  2.0)	R330-E332 (PDBs: 6GL7)					175									-125.7				160.4	Cadherin-like region 3 (CLD3)					B (undefined)	E (parallel sheets)							Extracellular					95.21	35.887096	>90	10-90	142623	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	false	0.9587752559225962	0.943323146302429	true	false	false
SDHD	SDHD_Arg70Thr	B_13-14	6.934747073445434	0.00024459787473878774	0.0016455055296743155	-0.3796977806482231	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7900666272735973	0.825520533299325	0.7751987209249735	0.8292824034244872	0.8311523030944077	0.8461895648438374	0.8748368706280101	0.8598874080964839	0.8577868434725202	0.8430799071729828	0.8385699648679568	0.8126383148275721	0.8175422590596648	0.8024171980923315	0.8007779633764542	0.7073175346769642	0.8124711017306931	0.7674949397196226	SDHD	Arg70Thr	NC_000011.10:112088906:G:C	209G>C	11	112088906	G	C	11	ENSG00000204370	6363	0	CCSBVarC023288	ALE00027820	ENSP00000364699.3																																	810762.0	single nucleotide variant	NM_003002.4(SDHD):c.209G>C (p.Arg70Thr)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Feb 25, 2023	755047928.0	-	RCV001014432|RCV001597242|RCV003769463	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MedGen:C1868633	Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss	germline	germline	GRCh38	NC_000011.10	11	112088906.0	112088906.0	11q23.1	criteria provided, conflicting classifications	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	-	2.0	820714.0	112088906.0	G	C	-	-	-	-	-	-	209G>C 	Arg70Thr	NM_003002.4	1.0	Conflicting	Conflicting	820714	11	112088906.0	G	C	R	T	rs755047928	11	111959630	11	111464840	70	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.209G>C	p.Arg70Thr	c.209G>C	p.Arg70Thr	principal1	Y	1	YES	Select	+	AGG	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.004	0.74454	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.88	0.95915	H	-5.8	0.88177	D	0.956	0.96546	1.0507	0.98128	D	0.9847	0.99536	D	10	0.9923693	0.99772	D	0.720854	0.97738	D	0.962	0.99434	0.984	0.99843	O14521	R70T	Gain of catalytic residue at S73 (P = 0.146)| Loss of helix (P = 0.1706)| Loss of stability (P = 0.1869)| Loss of MoRF binding (P = 0.2156)| Gain of disorder (P = 0.2602)	0.983230327024	0.98287	0.9568632122871339	0.95645	0.91655607726	0.71085	0.688868284225	0.65485	T	0.981408	0.99854	D	0.576146	0.96900	D	0.589817	0.96849	D	0.999165654182434	0.96363	D	0.946705	0.81107	D	0.9203629	0.93183	0.85851985	0.91973	0.9137901	0.92543	0.8970499	0.94695	-11.753	0.91834	D	0.8906	0.82186	P	0.996839713185994	0.92509	0.99914825	0.99178	0.966	0.98629	.	.	.	.	.	.	4.65578	0.74309	26.1	0.98501578728992878	0.42352	0.955196	0.97277	D	0.796092789603072	0.85785	8.704333	0.69577891730792	0.81957	7.673905	5.04	4.1	0.47135	.	.	7.535	0.80966	7.554000	0.60397	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.998	0.85369	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Cowden_syndrome_3|Carney-Stratakis_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088906G>C	.	C1868633|C0031511|CN166604|C1847319|C0027672|C3661900	171300|606864	29072|201|97286|140162	.	Arg	Thr	98.66	0.4838709677419355																																																																																																																																																																																																																																																																																																																																																																																																																																																																													120			98.66	Positively-charged	Arginine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-4.5								 R70-W66 (PAE:  1.0), R70-V74 (PAE: 1.0)	R70-W66 (PDBs: 8GS8), R70-V74 (PDBs: 8GS8)	 R70-W66 (PAE:  1.0), R70-V74 (PAE: 1.0)	R70-W66 (PDBs: 8GS8), R70-V74 (PDBs: 8GS8)							175									-66.9		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-40.8						H (helix)	H (α-helix)	Helix								Helical			98.66	48.387096	>90	10-90	171300;606864	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	false	0.825520533299325	0.7900666272735973	false	false	false
BAP1	BAP1_Glu31Lys	B_13-14	0.06824504354142172	0.9474990528833314	0.9595563048818466	-0.5612576601246329	0.592127224854171	0.6404131113749473	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.5315214386026038	0.529300063899537	0.6057926667766844	0.6029058949661515	0.561748618028123	0.64326638120963	0.5774755407614304	0.5214417612644991	0.5347756041071292	0.5671263287540095	0.49309524451023573	0.47322444194184227	0.7090572216578295	0.602055474791747	0.6710361858251739	0.6444590047993595	0.5655048832888383	0.5898184352633653	BAP1	Glu31Lys	NC_000003.12:52409585:C:T	91G>A	3	52409585	C	T	3	ENSG00000163930	3760	0	CCSBVarC009499	ALE00015204	ENSP00000417132.1																																	1162267.0	single nucleotide variant	NM_004656.4(BAP1):c.91G>A (p.Glu31Lys)	8314.0	BAP1	HGNC:950	Conflicting classifications of pathogenicity	1.0	Jan 21, 2024	2153228535.0	-	RCV001797184|RCV002305612|RCV002568139	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539	Neurodevelopmental disorder|not provided|BAP1-related tumor predisposition syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52409585.0	52409585.0	3p21.1	criteria provided, conflicting classifications	3.0	-	N	-	2.0	1173078.0	52409585.0	C	T	-	-	-	-	-	-	91G>A 	Glu31Lys	NM_004656.4	1.0	Conflicting	Conflicting	1173078	3	52409585.0	C	T	E	K	rs2153228535	3	52443601	3	52418641	31	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.91G>A	p.Glu31Lys	c.91G>A	p.Glu31Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.045	0.96963	H	-3.77	0.72856	D	0.925	0.93495	0.4363	0.89592	D	0.5505	0.83470	D	10	0.9600752	0.95355	D	0.307408	0.91057	D	0.692	0.88771	0.866	0.96082	Q92560	E31K	Gain of glycosylation at Y33 (P = 0.0136)| Gain of ubiquitination at E31 (P = 0.0238)| Gain of methylation at E31 (P = 0.1374)| Loss of stability (P = 0.1598)| Loss of catalytic residue at E31 (P = 0.2264)	0.862246886347	0.85983	0.9484795993003543	0.94798	2.56847412068	0.97995	0.905887842178	0.97064	D	0.595912	0.86858	D	0.379185	0.88575	D	0.306897	0.88431	D	0.999779880046844	0.98923	D	0.989034	0.96357	D	0.95834297	0.97067	0.9142625	0.95935	0.95834297	0.97067	0.9142625	0.95936	-18.084	0.99558	D	0.9998	0.99584	P	0.986962859459876	0.87278	0.99976045	0.99689	0.896	0.94485	.	.	.	.	.	.	5.710604	0.93179	33.0	0.99932207852356958	0.99439	0.929216	0.91432	D	0.986620787527088	0.95291	13.50747	0.884071350561727	0.94811	13.08669	4.97	4.97	0.65374	2.7	0.49372	7.695	0.83532	7.645000	0.63450	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.999	0.91597	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Neurodevelopmental_disorder|not_provided|BAP1-related_tumor_predisposition_syndrome	criteria_provided,_conflicting_classifications	NC_000003.12:g.52409585C>T	.	C1535926|C3661900|C3280492	614327	289539	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Glu	Lys	93.71	0.29381443298969073																																																																																																																																																																																																																																																																																																																																																																																																																																																																													57			93.71	Negatively-charged	Glutamic Acid		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			-3.5					K:E31-M:R72 (PDBs: 8SVF)			 E31-N229 (PAE:  1.5)		 E31-N229 (PAE:  1.5)	E31-P12 (PDBs: 8SVF)							146									-87.3				135.7						B (undefined)	E (parallel sheets)												93.71	29.381443	>90	10-90	614327	autosomal dominant	GenCC	Rare genetic tumor	1	TUMOR PREDISPOSITION SYNDROME 1	false	0.529300063899537	0.5315214386026038	false	false	false
SHOC2	SHOC2_Asn527Ser	B_13-14	2.1059774962464166	0.0732220540664537	0.12656481743613263	1.085131532003488	0.3138147269308183	0.3671247852298619	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7574382171732205	0.7696888805520221	0.7312929511575879	0.785233529611636	0.8204058193387807	0.7935605920700113	0.7838812696244729	0.8355259491923103	0.7160371812221675	0.7651506302387878	0.7764968571478708	0.7388247652228905	0.8032399145155495	0.8052856894852509	0.8544298780011045	0.6974352720763878	0.7628809039561736	0.7760516691235504	SHOC2	Asn527Ser	NC_000010.11:111011649:A:G	1580A>G	10	111011649	A	G	10	ENSG00000108061	11602	0	CCSBVarC028088	ALE00037020	ENSP00000358464.5																																	1379432.0	single nucleotide variant	NM_007373.4(SHOC2):c.1580A>G (p.Asn527Ser)	8036.0	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	0.0	Aug 31, 2023	143242369.0	-	RCV001935101|RCV002397873	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736	RASopathy|Cardiovascular phenotype	germline	germline	GRCh38	NC_000010.11	10	111011649.0	111011649.0	10q25.2	criteria provided, conflicting classifications	2.0	-	N	-	2.0	1401446.0	111011649.0	A	G	-	-	-	-	-	-	1580A>G 	Asn527Ser	NM_007373.4	1.0	Conflicting	Conflicting	1401446	10	111011649.0	A	G	N	S	rs143242369	10	112771407	10	112761397	527	SHOC2	ENSG00000108061	ENST00000689118	ENSP00000510554	Q9UQ13	SHOC2_HUMAN	.	.	c.1580A>G	p.Asn527Ser	principal1	Y	.	.	.	+	AAC	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.79708	.	.	.	.	2.985	0.85444	M	.	0.78167	.	.	0.80998	0.6054	0.91942	D	0.6617	0.88210	D	10	.	0.82683	.	0.148691	0.83011	D	.	0.92680	.	.	.	.	.	.	0.83492	.	0.80359	.	0.89624	0.714541971684	0.69199	T	0.753664	0.93208	D	-0.0858249	0.38409	T	-0.0709149	0.65315	T	0.829529583454132	0.48217	D	0.966503	0.89784	D	0.72442025	0.79165	0.7285137	0.83768	0.72442025	0.79167	0.7285137	0.83769	-13.461	0.91191	D	.	0.88269	.	0.999616318320227	0.97193	0.07171734	0.63238	0.882	0.93649	.	.	.	.	.	.	5.115254	0.85562	28.6	0.99879465224645192	0.95576	0.904050	0.85334	D	0.986974554312165	0.95304	13.51815	0.906978951184953	0.95846	14.05383	5.42	5.42	0.78637	.	.	9.256	0.94731	11.209000	0.89344	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	914	0.21043	.	.	.	.	.	.	.	.	.	.	.	.	13	264690	4.9114056E-5	.	13	109396	1.188340e-04	0	25	208114	1.201260e-04	0	32	236904	1.350760e-04	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13384	0.000000e+00	0	12	42768	2.805840e-04	0	0	15690	0.000000e+00	0	12	42768	2.805840e-04	0	1	16218	6.165990e-05	0	2	30522	6.552650e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16724	0.000000e+00	0	20	89548	2.233440e-04	0	1	30608	3.267120e-05	0	20	89548	2.233440e-04	0	1	14902	6.710510e-05	0	2	34258	5.838050e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21620	0.000000e+00	0	26	102714	2.531300e-04	0	1	30526	3.275900e-05	0	26	102714	2.531300e-04	0	.	108	1613820	6.692200e-05	0	95	1179936	8.051280e-05	0	3	74862	4.007370e-05	0	0	912	0.000000e+00	0	3	59968	5.002670e-05	0	0	29602	0.000000e+00	0	1	44888	2.227770e-05	0	3	64004	4.687210e-05	0	0	6082	0.000000e+00	0	95	1179936	8.051280e-05	0	1	91082	1.097910e-05	0	4	61104	6.546216286986122E-5	0	116	0	0	118	0	0	3340	0	0	146	0	0	630	0	0	52	0	0	104	0	0	3012	0	0	3456	0	0	170	0	4	68622	5.829034420448253E-5	RASopathy|Cardiovascular_phenotype	criteria_provided,_conflicting_classifications	NC_000010.11:g.111011649A>G	.	C5555857|CN230736	.	536391	.	Asn	Ser	98.28	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.28	Polar/Neutral	Asparagine		Leucine-rich repeat protein SHOC-2										-3.5								 N527-L506 (PAE:  1.0), N527-L501 (PAE: 1.0)	N527-L506 (PDBs: 7TVG), N527-C551 (PDBs: 7TVG), N527-L501 (PDBs: 7TVG, 7SD1, 7TYG, 7TVF, 7UPI), N527-N504 (PDBs: 7T7A), N527-L505 (PDBs: 7SD0)	 N527-C551 (PAE:  1.0)	N527-C551 (PDBs: 7TVG, 7T7A, 7TYG, 7TVF), N527-L501 (PDBs: 7SD1), N527-E503 (PDBs: 7SD0, 7UPI), N527-G502 (PDBs: 7UPI)							132									-106.9				89.5			LRR 19			C (loop/coil)	C (loop/coil)												98.28	0.0	>90	<10		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5		false	0.7696888805520221	0.7574382171732205	false	false	false
RAD51D	RAD51D_Gly289Ser	B_13-14	7.092665294834583	0.00019491549970907673	0.0014374077391673228	7.140762735508007	0.00018686329218062857	0.0006433285950308694	2025_01_Batch_13-14	false	false	true	false	false	true	false	false	false	false	false	false	0.9129783413503287	0.9073515213457051	0.8705424005321369	0.9082843540611274	0.9011735924298294	0.9372714367054353	0.9491810776974358	0.874676107773696	0.8671206283781533	0.9317422952570268	0.8805141071442175	0.8860710221618355	0.9253617957134349	0.927671077085963	0.9494480797441014	0.8093425058072471	0.9341889355471925	0.9398856605388219	RAD51D	Gly289Ser	NC_000017.11:35101239:C:T	865G>A	17	35101239	C	T	17	ENSG00000185379	7201	0	CCSBVarC024877	ALE00029794	ENSP00000338790.6																																	151659.0	single nucleotide variant	NM_002878.4(RAD51D):c.865G>A (p.Gly289Ser)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	May 29, 2024	587782129.0	-	RCV000130672|RCV000462688|RCV000480701|RCV001194378	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified	germline	germline	GRCh38	NC_000017.11	17	35101239.0	35101239.0	17q12	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA166871	2.0	141945.0	35101239.0	C	T	-	-	-	-	-	-	865G>A 	Gly289Ser	NM_002878.4	1.0	Conflicting	Conflicting	141945	17	35101239.0	C	T	G	S	rs587782129	17	33428258	17	30452371	289	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.865G>A	p.Gly289Ser	c.865G>A	p.Gly289Ser	principal1	Y	5	.	.	-	GGC	1	0	C	C/C	C/C	C/C	C/C	.	0.00968	.	1.0	0.10481	T	0.008	0.20016	B	0.008	0.16009	B	0.06	0.18971	N	simple_aae	94.0	6.0	-0.395	0.03015	N	.	0.02351	.	0.225	0.25080	-1.0152	0.25206	T	0.1048	0.38180	T	10	0.047472775	0.04072	T	0.015582	0.36140	T	0.030	0.06938	0.393	0.41625	O75771	G289S	Gain of phosphorylation at G289 (P = 0.0191)| Gain of glycosylation at G289 (P = 0.0564)| Loss of methylation at R290 (P = 0.0588)| Gain of disorder (P = 0.0724)| Gain of MoRF binding (P = 0.1175)	0.0762999501168	0.06748	.	0.22253	.	0.36811	.	.	.	0.105892	0.41382	T	-0.28641	0.09770	T	-0.55233	0.16804	T	0.0316729542490267	0.02239	T	0.675032	0.28091	T	0.018450681	0.00366	0.023860626	0.00404	0.018450681	0.00366	0.023860626	0.00404	-2.752	0.11831	T	0.0718	0.06786	B	2.70558370001736e-05	0.01340	0.14648667	0.70195	0.008	0.00393	.	.	.	.	.	.	-0.012147	0.0421	1.022	0.74482722392783784	0.10886	0.042395	0.06461	N	-1.33388171991115	0.03260	0.1469401	-1.31009436204477	0.04234	0.2024671	4.86	0.314	0.15050	-1.35	0.14151	0.155	0.16235	-0.662000	0.08011	-0.181	0.10317	0.037	0.20898	0.000000	0.08389	0.001	0.02614	912	0.21478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109404	1.828090e-05	0	2	208106	9.610490e-06	0	3	236918	1.266260e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	1	42768	2.338200e-05	0	1	15690	6.373490e-05	0	1	15690	6.373490e-05	0	0	16214	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	1	89538	1.116840e-05	0	1	30608	3.267120e-05	0	1	30608	3.267120e-05	0	0	14902	0.000000e+00	0	1	34260	2.918860e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	1	102720	9.735200e-06	0	1	30526	3.275900e-05	0	1	30526	3.275900e-05	0	.	11	1614202	6.814510e-06	0	1	91088	1.097840e-05	0	0	75044	0.000000e+00	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29604	0.000000e+00	0	0	44874	0.000000e+00	0	0	64048	0.000000e+00	0	0	6062	0.000000e+00	0	9	1180036	7.626890e-06	0	1	91088	1.097840e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_specified	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101239C>T	ClinGen:CA166871	C3661900|C0027672|C3280345|CN169374	614291	140162|145	DNA repair protein RAD51 homolog 4, C-terminal	Gly	Ser	76.22	0.20238095238095238																																																																																																																																																																																																																																																																																																																																																																																																																																																																													17			76.22	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		DNA repair protein RAD51 homolog 4										-0.4								 G289-I311 (PAE:  4.0)	G289-I311 (PDBs: 8FAZ, 8GBJ)	 G289-I311 (PAE:  4.0), G289-G312 (PAE: 5.5)	G289-D310 (PDBs: 8FAZ, 8OUY, 8OUZ), G289-V309 (PDBs: 8GBJ), G289-I311 (PDBs: 8OUZ)							75									-66.1				-15.7						C (loop/coil)	C (loop/coil)												76.22	20.238096	70-90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.9073515213457051	0.9129783413503287	false	false	false
RAD51D	RAD51D_Ile251Val	B_13-14	0.7776406398453396	0.4622488886013073	0.5494059596941486	5.663339616909652	0.0007638183759416417	0.0019200092052779625	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9631273271194855	0.9590632997487634	0.8101577904956274	0.9214065463243999	0.8993914213374188	0.893276816666036	0.9995141444267794	0.950616898493024	0.9349669272489624	0.99954689179376	0.9319662742367756	0.941756248718027	0.7870394889052925	0.8481659441818137	0.9078461653998375	0.6207686891974947	0.9861603252607511	0.9844984055209439	RAD51D	Ile251Val	NC_000017.11:35101353:T:C	751A>G	17	35101353	T	C	17	ENSG00000185379	7201	0	CCSBVarC024857	ALE00029786	ENSP00000338790.6																																	151014.0	single nucleotide variant	NM_002878.4(RAD51D):c.751A>G (p.Ile251Val)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Feb 27, 2024	540273429.0	-	RCV000129767|RCV000236753|RCV000542443	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	germline	germline	GRCh38	NC_000017.11	17	35101353.0	35101353.0	17q12	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA165041	2.0	141300.0	35101353.0	T	C	-	-	-	-	-	-	751A>G 	Ile251Val	NM_002878.4	1.0	Conflicting	Conflicting	141300	17	35101353.0	T	C	I	V	rs540273429	17	33428372	17	30452485	251	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.751A>G	p.Ile251Val	c.751A>G	p.Ile251Val	principal1	Y	1	YES	Select	-	ATA	1	0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	1.0	0.03926	T	0.0	0.02950	B	0.001	0.04348	B	0.06	0.18971	N	simple_aae	94.0	6.0	-1.04	0.01100	N	0.1	0.05782	N	0.105	0.14965	-0.9577	0.39436	T	0.0599	0.24885	T	10	0.036506176	0.01956	T	0.010139	0.26052	T	0.070	0.20265	0.474	0.54885	O75771	I251V	Gain of phosphorylation at T248 (P = 0.0936)| Gain of disorder (P = 0.0983)| Gain of MoRF binding (P = 0.1184)| Gain of methylation at R255 (P = 0.2396)| Loss of stability (P = 0.2941)	0.388174495139	0.38033	.	0.16030	.	0.31871	.	.	.	0.075571	0.34949	T	-0.130246	0.31098	T	-0.424866	0.30159	T	0.0309130971524996	0.02119	T	.	0.39652	.	0.015923232	0.00166	0.02370252	0.00388	0.015923232	0.00166	0.02370252	0.00387	-0.859	0.00857	T	0.0667	0.04993	LB	1.1537049706086e-05	0.00991	0.23355223	0.74518	0.014	0.01428	.	.	.	.	.	.	-0.048466	0.03972	0.888	0.81310861979149396	0.13840	0.042627	0.06525	N	-1.20699475414867	0.04841	0.2220042	-1.14727300713446	0.06706	0.3294306	4.86	-3.91	0.03894	-5.59	0.03621	0.337	0.19651	-2.070000	0.04280	0.665	0.62996	0.881	0.31099	0.000000	0.08389	0.946	0.49004	911	0.21960	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109058	0.000000e+00	0	1	207758	4.813290e-06	0	1	236598	4.226580e-06	0	0	7158	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13062	0.000000e+00	0	0	42762	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16206	0.000000e+00	0	0	30522	0.000000e+00	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16402	0.000000e+00	0	1	89534	1.116890e-05	0	0	30606	0.000000e+00	0	1	89534	1.116890e-05	0	0	14896	0.000000e+00	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21300	0.000000e+00	0	1	102740	9.733310e-06	0	0	30524	0.000000e+00	0	1	102740	9.733310e-06	0	.	7	1613900	4.337320e-06	0	1	6060	1.650170e-04	0	0	75054	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	63756	0.000000e+00	0	1	6060	1.650170e-04	0	4	1180012	3.389800e-06	0	1	91084	1.097890e-05	0	0	6062	0	0	8	0	0	26	0	0	586	0	0	0	0	0	0	0	0	30	0	0	0	0	1	2276	4.393673110720562E-4	0	594	0	0	56	0	1	8988	1.1125945705384957E-4	Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101353T>C	ClinGen:CA165041	C0027672|C3661900|C3280345	614291	140162|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Ile	Val	93.94	0.25443786982248523																																																																																																																																																																																																																																																																																																																																																																																																																																																																													43			93.94	Aliphatic	Isoleucine		DNA repair protein RAD51 homolog 4								0.4068		4.5										 I251-G107 (PAE:  1.5)	I251-G108 (PDBs: 8FAZ, 8GBJ, 8OUZ), I251-V106 (PDBs: 8OUY, 8OUZ), I251-G107 (PDBs: 8OUZ), I251-K261 (PDBs: 8OUZ)							131									-95.2		Pocket 1: Mean pLDDT: 91.59, Volume: 402.91 Å³, Druggability score: 0.41		143.2						B (undefined)	E (parallel sheets)	Beta strand											93.94	25.443787	>90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.9590632997487634	0.9631273271194855	false	false	false
FLCN	FLCN_Arg239Cys	B_13-14	0.9174070101483766	0.38944335444511674	0.4802045235572453	-10.756855128131008	0.000013199851080663478	0.00008971009901117585	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9108426834661932	0.9448106082237612	0.5413648456677197	0.6435068740291519	0.5048247444042107	0.6166624559450038	0.6377302761136299	0.5249995111649677	0.7458279788865447	0.5044718523549359	0.944503167199732	0.8970910515557542	0.5955946357763777	0.48464997764345374	0.5411857691717589	0.5782578389805035	0.9451180492477903	0.9245943153766323	FLCN	Arg239Cys	NC_000017.11:17222565:G:A	715C>T	17	17222565	G	A	17	ENSG00000154803	7588	0	CCSBVarC001199	ALE00001199	ENSP00000373821.5	RC4	RC4_Mut_GDEh1002	H08	GDEhDisVCh_40008	C09	2	RC4_Mut_GDDh1002	H08	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	138166.0	single nucleotide variant	NM_144997.7(FLCN):c.715C>T (p.Arg239Cys)	201163.0	FLCN	HGNC:27310	Conflicting classifications of pathogenicity	0.0	Jul 31, 2024	78683075.0	-	RCV000121104|RCV000148504|RCV000656850|RCV000163388|RCV003945073	MedGen:CN169374|MONDO:MONDO:0800444,MedGen:C0346010,OMIM:PS135150,Orphanet:122|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	not specified|Birt-Hogg-Dube syndrome|not provided|Hereditary cancer-predisposing syndrome|FLCN-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	17222565.0	17222565.0	17p11.2	criteria provided, conflicting classifications	15.0	-	N	ClinGen:CA159776,UniProtKB:Q8NFG4#VAR_066026	2.0	134427.0	17222565.0	G	A	-	-	-	-	-	-	715C>T 	Arg239Cys	NM_144997.7	1.0	Conflicting	Conflicting	134427	17	17222565.0	G	A	R	C	rs78683075	17	17125879	17	17066604	239	FLCN	ENSG00000154803	ENST00000285071	ENSP00000285071	Q8NFG4	FLCN_HUMAN	c.715C>T	p.Arg239Cys	c.715C>T	p.Arg239Cys	principal1	Y	1	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	.	0.71237	.	.	.	.	2.82	0.81940	M	-5.68	0.90996	D	0.99	0.99730	0.9576	0.96499	D	0.8908	0.96369	D	10	0.8112291	0.80205	D	0.269279	0.89792	D	0.914	0.97735	.	.	.	.	.	0.92713276706	0.92582	0.8131863604073064	0.81164	1.37465409467	0.84558	0.877251982689	0.93578	D	0.965284	0.99578	D	0.232675	0.76800	D	0.441383	0.93307	D	0.409195610064091	0.28980	T	0.963104	0.86253	D	0.8436355	0.86694	0.653225	0.79478	0.8809669	0.89604	0.6441645	0.78972	-4.512	0.31080	T	0.9888	0.95096	P	0.987758183785664	0.87550	0.95808370	0.93842	0.906	0.95083	.	.	.	.	.	.	5.485253	0.91433	32.0	0.99936625225274212	0.99621	0.883493	0.81176	D	0.838685424223754	0.88390	9.584683	0.79110123621525	0.89107	9.865392	5.71	5.71	0.89013	3.64	0.66725	7.113	0.76785	11.729000	0.94967	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.875	0.41772	794	0.45529	3	5.990415335463259E-4	0	0.0	2	0.0019880715705765406	1	0.001440922190201729	0	0.0	0	0.0	61	264690	2.3045827E-4	.	29	109404	2.650730e-04	0	52	208032	2.499620e-04	0	60	236936	2.532330e-04	0	1	7164	1.395870e-04	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	25	42768	5.845490e-04	0	2	15690	1.274700e-04	0	25	42768	5.845490e-04	0	2	16216	1.233350e-04	0	1	30516	3.276970e-05	0	0	6206	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	44	89476	4.917520e-04	0	3	30608	9.801360e-05	0	44	89476	4.917520e-04	0	2	14902	1.342100e-04	0	2	34254	5.838730e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	52	102740	5.061320e-04	0	3	30526	9.827690e-05	0	52	102740	5.061320e-04	0	.	707	1614232	4.379790e-04	1	660	1180052	5.592970e-04	0	6	75048	7.994880e-05	0	0	912	0.000000e+00	0	5	60034	8.328610e-05	0	1	29602	3.378150e-05	0	1	44880	2.228160e-05	0	1	64044	1.561430e-05	0	1	6062	1.649620e-04	0	660	1180052	5.592970e-04	0	10	91086	1.097860e-04	1	34	50198	6.773178214271485E-4	0	306	0	0	132	0	0	8844	0	0	524	0	0	668	0	0	62	0	0	114	0	7	11386	6.147900930967855E-4	0	9150	0	0	194	0	41	72234	5.675997452723095E-4	Hereditary_cancer-predisposing_syndrome|Birt-Hogg-Dube_syndrome|not_specified|not_provided|FLCN-related_disorder	criteria_provided,_conflicting_classifications	NC_000017.11:g.17222565G>A	ClinGen:CA159776|UniProtKB:Q8NFG4#VAR_066026	C0027672|C0346010|CN169374|C3661900	PS135150	140162|122	Folliculin/SMCR8, longin domain|Folliculin/SMCR8, tripartite DENN domain	Arg	Cys	88.51	0.10483870967741936																																																																																																																																																																																																																																																																																																																																																																																																																																																																													26			88.51	Positively-charged	Arginine		Folliculin							uDENN FLCN/SMCR8-type			-4.5								 R239-E211 (PAE:  4.0), R239-D160 (PAE: 3.0)	R239-R168 (PDBs: 6NZD)	 R239-S243 (PAE:  4.0)		 R239-E211 (PAE:  4.0)						175									-68.9				142.3						C (loop/coil)	C (loop/coil)												88.51	10.4838705	70-90	10-90		unknown		Rare genetic tumor; Inherited cancer-predisposing syndrome	2		false	0.9448106082237612	0.9108426834661932	false	false	false
SHOC2	SHOC2_Thr321Ala	B_13-14	-3.868653257477352	0.006142367602687363	0.01880115724540523	0.2450729027692532	0.8134293844417977	0.848092568437897	2025_01_Batch_13-14	false	false	false	false	false	true	false	false	false	false	false	false	0.7883488604671831	0.8254319346421268	0.8441817557176223	0.8808308695164452	0.828961571370199	0.9604429745402213	0.9944616808846355	0.9781905247980143	0.9839156416769848	0.9610471832056016	0.9581604955282583	0.9340879753420134	0.9264242681958071	0.6797326179423838	0.7777460973559056	0.727316328229643	0.6927033737559952	0.642609745592353	SHOC2	Thr321Ala	NC_000010.11:111000534:A:G	961A>G	10	111000534	A	G	10	ENSG00000108061	11602	0	CCSBVarC028045	ALE00022890	ENSP00000358464.5																																	917044.0	single nucleotide variant	NM_007373.4(SHOC2):c.961A>G (p.Thr321Ala)	8036.0	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	0.0	Nov 18, 2023	779218281.0	-	RCV001193225|RCV001859169|RCV002379748|RCV002280165	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736|MedGen:C3661900	not specified|RASopathy|Cardiovascular phenotype|not provided	germline	germline	GRCh38	NC_000010.11	10	111000534.0	111000534.0	10q25.2	criteria provided, conflicting classifications	4.0	-	N	-	2.0	928787.0	111000534.0	A	G	-	-	-	-	-	-	961A>G 	Thr321Ala	NM_007373.4	1.0	Conflicting	Conflicting	928787	10	111000534.0	A	G	T	A	rs779218281	10	112760292	10	112750282	321	SHOC2	ENSG00000108061	ENST00000685059	ENSP00000510210	Q9UQ13	SHOC2_HUMAN	.	.	c.961A>G	p.Thr321Ala	principal1	Y	.	.	.	+	ACT	1	0	A	A/A	A/A	A/A	A/A	.	0.06123	.	.	0.05249	.	0.0	0.02950	B	0.002	0.06938	B	.	0.23785	.	.	.	.	-0.105	0.04679	N	.	0.12590	.	.	0.15523	-1.0717	0.09058	T	0.0918	0.34838	T	10	.	0.03581	.	0.006878	0.17933	T	.	0.23465	0.236	0.16520	Q9UQ13	T321A	Loss of loop (P = 0.0804)| Loss of catalytic residue at T321 (P = 0.1706)| Gain of helix (P = 0.1736)| Loss of glycosylation at S320 (P = 0.209)| Gain of phosphorylation at S325 (P = 0.2263)	.	0.20382	.	0.21554	.	0.46154	0.497421294451	0.38416	T	0.124581	0.44666	T	-0.328867	0.06011	T	-0.528024	0.19169	T	0.0732215866446495	0.08987	T	.	0.45108	.	0.026549106	0.01715	0.03730472	0.03368	0.026549106	0.01714	0.03730472	0.03367	-3.426	0.15421	T	.	0.03311	.	0.00459997630098467	0.18260	0.00088036	0.14164	0.054	0.14486	.	.	.	.	.	.	1.955164	0.2488	16.54	0.60839380689675338	0.06655	0.138109	0.25716	N	-0.440768684793817	0.23785	1.296133	-0.244151780804542	0.29656	1.683677	5.46	3.14	0.35119	2.46	0.45475	3.696	0.5458	3.033000	0.36131	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.999	0.91597	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	7	264690	2.644603E-5	.	2	108918	1.836240e-05	0	4	207458	1.928100e-05	0	4	236186	1.693580e-05	0	0	7138	0.000000e+00	0	2	17072	1.171510e-04	0	0	2320	0.000000e+00	0	0	9012	0.000000e+00	0	0	13096	0.000000e+00	0	0	42704	0.000000e+00	0	0	15668	0.000000e+00	0	2	17072	1.171510e-04	0	1	16184	6.178940e-05	0	2	30466	6.564700e-05	0	0	6210	0.000000e+00	0	0	13378	0.000000e+00	0	0	16434	0.000000e+00	0	0	89358	0.000000e+00	0	1	30582	3.269900e-05	0	2	30466	6.564700e-05	0	1	14870	6.724950e-05	0	2	34202	5.847610e-05	0	0	9566	0.000000e+00	0	0	17652	0.000000e+00	0	0	21326	0.000000e+00	0	0	102474	0.000000e+00	0	1	30500	3.278690e-05	0	1	14870	6.724950e-05	0	.	17	1611420	1.054970e-05	0	5	60006	8.332500e-05	0	2	74914	2.669730e-05	0	0	912	0.000000e+00	0	5	60006	8.332500e-05	0	0	29586	0.000000e+00	0	1	44808	2.231740e-05	0	0	63670	0.000000e+00	0	0	5984	0.000000e+00	0	2	1178128	1.697610e-06	0	6	91032	6.591090e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Cardiovascular_phenotype|not_specified|not_provided|RASopathy	criteria_provided,_conflicting_classifications	NC_000010.11:g.111000534A>G	.	CN230736|CN169374|C3661900|C5555857	.	536391	.	Thr	Ala	96.59	0.5352112676056338																																																																																																																																																																																																																																																																																																																																																																																																																																																																													76			96.59	Polar/Neutral	Threonine		Leucine-rich repeat protein SHOC-2										-0.7																		119									-151.1				156.0			LRR 10			C (loop/coil)	C (loop/coil)												96.59	53.521126	>90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5		false	0.8254319346421268	0.7883488604671831	false	false	false
SDHD	SDHD_Ala90Glu	B_13-14	6.330677185442039	0.0003987614285506209	0.0023162172634094234	4.21956897166154	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7480392649322932	0.7784601198159777	0.7783883726767082	0.7998402898445041	0.8000784274432831	0.8088822841177346	0.8291757744736382	0.8180020229186046	0.7941930419379484	0.8280872535424995	0.7596711468885944	0.7402425332680522	0.7885887937618308	0.7821548319679614	0.8054875377510596	0.7286894918109171	0.7972490927433612	0.7558359965965342	SDHD	Ala90Glu	NC_000011.10:112088966:C:A	269C>A	11	112088966	C	A	11	ENSG00000204370	6363	0	CCSBVarC023305	ALE00021471	ENSP00000364699.3																																	398391.0	single nucleotide variant	NM_003002.4(SDHD):c.269C>A (p.Ala90Glu)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Nov 02, 2023	200255724.0	-	RCV001016345|RCV001252746|RCV002230664|RCV003235231	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0000252,Human Phenotype Ontology:HP:0001366,Human Phenotype Ontology:HP:0005485,Human Phenotype Ontology:HP:0005489,Human Phenotype Ontology:HP:0005497,MONDO:MONDO:0001149,MedGen:C4551563|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MedGen:C1868633|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Microcephaly|Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss|not provided	germline	germline	GRCh38	NC_000011.10	11	112088966.0	112088966.0	11q23.1	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA070965	2.0	412512.0	112088966.0	C	A	-	-	-	-	-	-	269C>A 	Ala90Glu	NM_003002.4	1.0	Conflicting	Conflicting	412512	11	112088966.0	C	A	A	E	rs200255724	11	111959690	11	111464900	90	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.269C>A	p.Ala90Glu	c.269C>A	p.Ala90Glu	principal1	Y	1	YES	Select	+	GCG	2	0	C	./.	./.	./.	./.	0.007	0.65576	D	0.103	0.52087	T	0.932	0.52003	P	0.57	0.49852	P	.	.	.	.	.	.	2.42	0.69809	M	-3.44	0.67509	D	0.838	0.88119	0.6538	0.92564	D	0.9083	0.96954	D	10	0.71854925	0.73260	D	0.221482	0.87778	D	0.717	0.89925	0.651	0.78770	O14521	A90E	Gain of solvent accessibility (P = 0.1185)| Gain of helix (P = 0.132)| Loss of glycosylation at S94 (P = 0.2235)| Loss of loop (P = 0.2237)| Gain of disorder (P = 0.2283)	0.994050821033	0.99390	0.9025812371913887	0.90169	0.56273454734	0.52443	0.434535443783	0.29793	T	0.882903	0.97538	D	0.147502	0.68809	D	0.344014	0.90010	D	0.429612930299171	0.29737	T	0.662834	0.27239	T	0.5395673	0.69073	0.7364212	0.84234	0.5395673	0.69074	0.7364212	0.84235	-10.123	0.80928	D	0.5246	0.71218	A	0.962673093571584	0.82104	0.99742990	0.98376	0.483	0.70339	.	.	.	.	.	.	2.63182	0.34286	19.57	0.99093711970946219	0.52353	0.646940	0.62094	D	-0.0306763802736097	0.40204	2.403878	-0.139133932962987	0.33519	1.939294	5.04	1.52	0.22101	.	.	0.348	0.19856	-0.210000	0.10908	0.549	0.27038	0.03	0.20497	0.000000	0.08389	0.993	0.69292	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	3	109406	2.742080e-05	0	12	208128	5.765680e-05	0	11	236928	4.642760e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	3	9044	3.317120e-04	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	3	9044	3.317120e-04	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	12	13414	8.945880e-04	0	0	16734	0.000000e+00	0	0	89554	0.000000e+00	0	0	30608	0.000000e+00	0	12	13414	8.945880e-04	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	11	17690	6.218200e-04	0	0	21632	0.000000e+00	0	0	102728	0.000000e+00	0	0	30526	0.000000e+00	0	11	17690	6.218200e-04	0	.	21	1614014	1.301100e-05	0	21	44888	4.678310e-04	0	0	74936	0.000000e+00	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29606	0.000000e+00	0	21	44888	4.678310e-04	0	0	64032	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179998	0.000000e+00	0	0	91090	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	not_provided|Hereditary_cancer-predisposing_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Microcephaly	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088966C>A	ClinGen:CA070965	C3661900|C0027672|C1868633|C1847319|C0031511|CN166604|C4551563	606864|171300	140162|97286|29072|201	.	Ala	Glu	98.3	0.6320754716981132																																																																																																																																																																																																																																																																																																																																																																																																																																																																													67			98.3	Aliphatic	Alanine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										1.8								 A90-S94 (PAE:  1.0)	A90-S94 (PDBs: 8GS8)	 A90-S94 (PAE:  1.0)	A90-S94 (PDBs: 8GS8)							89									-61.7				-36.6						H (helix)	H (α-helix)	Helix						Mitochondrial intermembrane					98.3	63.20755	>90	10-90	171300;606864	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	false	0.7784601198159777	0.7480392649322932	false	false	false
SDHD	SDHD_Val111Ile	B_13-14	7.7451222208037676	0.00011337695822120214	0.0010072375232718063	0.03966887739272629	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7841799573911787	0.8056953271709224	0.6600082888290633	0.7802374132156374	0.822289584320909	0.7544933927066947	0.6741779896719853	0.7799443200832938	0.7077027022396258	0.6430720307810353	0.7430004364427228	0.7195583459179288	0.8348087957414041	0.8646348485585242	0.852772124191649	0.6769445468770912	0.8683902178991219	0.8488015688644288	SDHD	Val111Ile	NC_000011.10:112094821:G:A	331G>A	11	112094821	G	A	11	ENSG00000204370	6363	0	CCSBVarC023342	ALE00021461	ENSP00000364699.3																																	398070.0	single nucleotide variant	NM_003002.4(SDHD):c.331G>A (p.Val111Ile)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Jun 26, 2024	201869798.0	-	RCV000565076|RCV001591105|RCV002230665|RCV003476144|RCV003325203	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MedGen:C1868633|MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072	Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss|Mitochondrial complex 2 deficiency, nuclear type 3|Paragangliomas 1	germline;unknown	germline	GRCh38	NC_000011.10	11	112094821.0	112094821.0	11q23.1	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA071246	2.0	412515.0	112094821.0	G	A	-	-	-	-	-	-	331G>A 	Val111Ile	NM_003002.4	1.0	Conflicting	Conflicting	412515	11	112094821.0	G	A	V	I	rs201869798	11	111965545	11	111470755	111	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.331G>A	p.Val111Ile	c.331G>A	p.Val111Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	./.	./.	./.	./.	0.26	0.16832	T	0.779	0.15871	T	0.104	0.25957	B	0.055	0.25997	B	0.9	0.92786	D	simple_aae	10.0	90.0	.	.	.	-0.14	0.09078	N	0.052	0.11434	0.4711	0.90098	D	0.7829	0.92608	D	10	0.2911021	0.46306	D	0.050089	0.63956	D	0.572	0.82541	0.872	0.96404	O14521	V111I	Gain of helix (P = 0.1736)| Loss of sheet (P = 0.1907)| Gain of phosphorylation at Y114 (P = 0.2011)| Gain of catalytic residue at V111 (P = 0.4375)| Loss of disorder (P = 0.6326)	0.97911266155	0.97867	0.7076145117288314	0.70553	0.181760226822	0.20157	0.386111408472	0.23094	T	0.505437	0.82256	D	0.180199	0.71854	D	0.246769	0.85364	D	0.826030075550079	0.47946	D	0.852415	0.53609	D	0.023600794	0.01108	0.059936233	0.11338	0.027904507	0.02032	0.051471613	0.08303	-2.495	0.10596	T	0.081	0.08359	B	0.0132951746215333	0.26155	0.98876506	0.96548	0.232	0.50061	.	.	.	.	.	.	2.179907	0.27837	17.58	0.97373826413851394	0.33813	0.151882	0.27431	N	-0.212263563345696	0.32351	1.842281	-0.0625121141246808	0.36653	2.157289	4.85	2.83	0.32068	.	.	1.908	0.39642	3.805000	0.39965	0.672	0.70176	1.0	0.71675	1.000000	0.68239	1.0	0.97202	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	segdup	1	109400	9.140770e-06	0	3	207800	1.443700e-05	0	3	236248	1.269850e-05	0	0	7164	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	9046	1.105460e-04	0	0	16100	0.000000e+00	0	1	30508	3.277830e-05	0	0	6206	0.000000e+00	0	2	13416	1.490760e-04	0	0	16734	0.000000e+00	0	0	89376	0.000000e+00	0	0	30606	0.000000e+00	0	2	13416	1.490760e-04	0	0	14784	0.000000e+00	0	1	34244	2.920220e-05	0	0	9566	0.000000e+00	0	2	17692	1.130450e-04	0	0	21630	0.000000e+00	0	0	102210	0.000000e+00	0	0	30524	0.000000e+00	0	2	17692	1.130450e-04	0	.	111	1611796	6.886730e-05	0	109	44898	2.427730e-03	0	0	74848	0.000000e+00	0	0	912	0.000000e+00	0	2	59980	3.334440e-05	0	0	29602	0.000000e+00	0	109	44898	2.427730e-03	0	0	64020	0.000000e+00	0	0	4452	0.000000e+00	0	0	1179800	0.000000e+00	0	0	90990	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Hereditary_cancer-predisposing_syndrome|not_provided|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Mitochondrial_complex_2_deficiency,_nuclear_type_3|Paragangliomas_1	criteria_provided,_conflicting_classifications	NC_000011.10:g.112094821G>A	ClinGen:CA071246	C0027672|C3661900|C1868633|C1847319|C0031511|CN166604|C5436934|C3494181	606864|171300|619167|168000	140162|97286|29072|201|29072	.	Val	Ile	98.59	0.14084507042253522																																																																																																																																																																																																																																																																																																																																																																																																																																																																													20			98.59	Aliphatic	Valine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										4.2								 V111-L107 (PAE:  1.0), V111-V115 (PAE: 1.0)	V111-L107 (PDBs: 8GS8), V111-V115 (PDBs: 8GS8)	 V111-L107 (PAE:  1.0), V111-V115 (PAE: 1.0)	V111-L107 (PDBs: 8GS8), V111-V115 (PDBs: 8GS8)							117									-62.7				-43.3						H (helix)	H (α-helix)	Helix								Helical			98.59	14.084508	>90	10-90	171300;606864;619167;168000	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3; PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1	false	0.8056953271709224	0.7841799573911787	false	false	false
SDHD	SDHD_Gly138Val	B_13-14	4.8838800111042024	0.0027079461804252287	0.00943629916749189	-10.431320102129657	0.0009202589005377759	0.0019797429106914077	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8415631739418881	0.8742187984609637	0.6603152962446612	0.7984798067462082	0.7972459989349229	0.812991973518901	0.7850592719756109	0.7852598847779199	0.7638926565607702	0.6472923631584997	0.8383641369526188	0.7947490406042201	0.840924675062191	0.8092321130919259	0.8330669569316462	0.6733382293308227	0.9100734599693086	0.8883773072795559	SDHD	Gly138Val	NC_000011.10:112094903:G:T	413G>T	11	112094903	G	T	11	ENSG00000204370	6363	0	CCSBVarC023367	ALE00021764	ENSP00000364699.3																																	461681.0	single nucleotide variant	NM_003002.4(SDHD):c.413G>T (p.Gly138Val)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Jun 08, 2023	1401695686.0	-	RCV002526127|RCV003999154	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Pheochromocytoma;Cowden syndrome 3;Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112094903.0	112094903.0	11q23.1	criteria provided, conflicting classifications	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382619290	2.0	465238.0	112094903.0	G	T	-	-	-	-	-	-	413G>T 	Gly138Val	NM_003002.4	1.0	Conflicting	Conflicting	465238	11	112094903.0	G	T	G	V	rs1401695686	11	111965627	11	111470837	138	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.413G>T	p.Gly138Val	c.413G>T	p.Gly138Val	principal1	Y	1	YES	Select	+	GGG	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.003	0.76775	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	3.83	0.95555	H	-7.91	0.96234	D	0.976	0.99026	0.9995	0.97172	D	0.9890	0.99688	D	10	0.98711103	0.99050	D	0.662484	0.97162	D	0.973	0.99718	0.895	0.97537	O14521	G138V	Loss of sheet (P = 0.0315)| Gain of helix (P = 0.062)| Gain of catalytic residue at G138 (P = 0.2062)| Loss of stability (P = 0.6621)| Gain of MoRF binding (P = 0.7378)	0.994972793835	0.99485	0.986906335179873	0.98679	0.842846843757	0.67951	0.839876294136	0.88056	D	0.976803	0.99782	D	0.585153	0.97294	D	0.602755	0.97251	D	0.999767601490021	0.98872	D	0.944306	0.78902	D	0.9838489	0.99378	0.979656	0.99806	0.9838489	0.99378	0.979656	0.99807	-15.193	0.98253	D	0.7584	0.75365	P	0.999416088640572	0.96520	0.99923384	0.99231	0.965	0.98576	.	.	.	.	.	.	4.689578	0.75179	26.3	0.99775908092948307	0.86358	0.951372	0.96574	D	0.993936175157801	0.95530	13.73274	0.911916477651707	0.96049	14.27025	4.85	4.85	0.62327	.	.	9.578	0.97363	11.775000	0.95964	0.672	0.70176	1.0	0.71675	1.000000	0.68239	1.0	0.97202	638	0.64247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_pheochromocytoma-paraganglioma	criteria_provided,_conflicting_classifications	NC_000011.10:g.112094903G>T	ClinGen:CA382619290	C1847319|C0031511|CN166604|C1868633|C1708353	606864|171300	97286|29072|201|29072	.	Gly	Val	98.81	0.47619047619047616																																																																																																																																																																																																																																																																																																																																																																																																																																																																													40			98.81	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										-0.4				D:G138-C:L90 (PDBs: 8GS8), D:G138-C:A89 (PDBs: 8GS8), D:G138-C:G86 (PDBs: 8GS8)				 G138-F142 (PAE:  1.0), G138-L134 (PAE: 1.0)	G138-F142 (PDBs: 8GS8), G138-L134 (PDBs: 8GS8)	 G138-F142 (PAE:  1.0), G138-L134 (PAE: 1.0)	G138-F142 (PDBs: 8GS8), G138-L134 (PDBs: 8GS8)							75									-63.5				-41.9						H (helix)	H (α-helix)	Helix								Helical			98.81	47.61905	>90	10-90	171300;606864	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	false	0.8742187984609637	0.8415631739418881	false	false	false
SDHD	SDHD_Glu69Lys	B_13-14	7.232879738605847	0.00017436415792478971	0.0013339556762052085	-1.0918069182550203	1.0	1.0	2025_01_Batch_13-14	false	false	true	false	false	true	false	false	false	false	false	false	0.8393560180219272	0.8618276311660384	0.8266301377023137	0.8579640045385688	0.8726506841479802	0.8780065721835586	0.8777375342086445	0.8862798680250904	0.8648552680729613	0.8296905310611042	0.8692069987383989	0.8570683551900456	0.8782756101584728	0.8590215002708701	0.8510727410041762	0.8235697443435234	0.8544482635936781	0.8216436808538087	SDHD	Glu69Lys	NC_000011.10:112088902:G:A	205G>A	11	112088902	G	A	11	ENSG00000204370	6363	0	CCSBVarC023285	ALE00029807	ENSP00000364699.3																																	165952.0	single nucleotide variant	NM_003002.4(SDHD):c.205G>A (p.Glu69Lys)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Mar 22, 2024	202198133.0	-	RCV000144171|RCV000484125|RCV001290090|RCV002515941|RCV002415627|RCV004748597	MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MedGen:C3661900|MONDO:MONDO:0100294,MedGen:C5700310,OMIM:252011,Orphanet:3208|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	Mitochondrial complex 2 deficiency, nuclear type 3|not provided|Mitochondrial complex II deficiency, nuclear type 1|Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Cowden syndrome 3|Hereditary cancer-predisposing syndrome|SDHD-related disorder	germline;inherited	germline	GRCh38	NC_000011.10	11	112088902.0	112088902.0	11q23.1	criteria provided, conflicting classifications	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016681,UniProtKB:O14521#VAR_074105,OMIM:602690.0029	3.0	156153.0	112088902.0	G	A	-	-	-	-	-	-	205G>A 	Glu69Lys	NM_003002.4	1.0	Conflicting	Conflicting	156153	11	112088902.0	G	A	E	K	rs202198133	11	111959626	11	111464836	69	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.205G>A	p.Glu69Lys	c.205G>A	p.Glu69Lys	principal1	Y	1	YES	Select	+	GAG	1	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.004	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.83	0.95555	H	-4.0	0.74082	D	0.996	0.99956	1.0385	0.97876	D	0.9843	0.99522	D	10	0.9897574	0.99448	D	0.760838	0.98097	D	0.991	0.99981	0.955	0.99499	O14521	E69K	Gain of MoRF binding (P = 0.0031)| Gain of methylation at E69 (P = 0.0104)| Gain of ubiquitination at E69 (P = 0.0539)| Gain of relative solvent accessibility (P = 0.0999)| Gain of solvent accessibility (P = 0.1045)	0.972172681102	0.97161	0.9609739073875347	0.96060	0.784672596276	0.65221	0.732807695866	0.71868	T	0.979582	0.99826	D	0.572592	0.96621	D	0.600199	0.96985	D	0.999643564224243	0.98285	D	0.974503	0.92926	D	0.98499125	0.99456	0.95455986	0.98647	0.98053944	0.99136	0.9438836	0.97990	-11.599	0.91228	D	0.8013	0.78519	P	0.996962020332363	0.92637	0.99919051	0.99205	0.997	0.99892	.	.	.	.	.	.	5.407385	0.9054	31.0	0.99935591763030651	0.99579	0.950494	0.96405	D	0.966518903071094	0.94586	12.90049	0.888994358309617	0.95048	13.28898	5.04	5.04	0.67250	.	.	9.348	0.96472	11.792000	0.96405	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.997	0.79771	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	1	109406	9.140270e-06	0	2	208106	9.610490e-06	0	2	236722	8.448730e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16216	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13410	0.000000e+00	0	0	16734	0.000000e+00	0	2	89538	2.233690e-05	0	0	30608	0.000000e+00	0	2	89538	2.233690e-05	0	0	14900	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17686	0.000000e+00	0	0	21632	0.000000e+00	0	2	102538	1.950500e-05	0	0	30526	0.000000e+00	0	2	102538	1.950500e-05	0	.	4	1612768	2.480210e-06	0	4	1179938	3.390010e-06	0	0	74996	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29606	0.000000e+00	0	0	44872	0.000000e+00	0	0	64040	0.000000e+00	0	0	5002	0.000000e+00	0	4	1179938	3.390010e-06	0	0	91010	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Cowden_syndrome_3|Mitochondrial_complex_2_deficiency,_nuclear_type_3|not_provided|Mitochondrial_complex_II_deficiency,_nuclear_type_1	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088902G>A	ClinGen:CA016681|OMIM:602690.0029|UniProtKB:O14521#VAR_074105	C0027672|C0031511|C1868633|C1847319|CN166604|C5436934|C3661900|C5700310	171300|606864|619167|252011	140162|29072|97286|201|3208	.	Glu	Lys	98.58	0.06701030927835051																																																																																																																																																																																																																																																																																																																																																																																																																																																																													13			98.58	Negatively-charged	Glutamic Acid		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial								0.0021		-3.5								 E69-Q109 (PAE:  1.0), E69-H65 (PAE: 1.0), E69-S73 (PAE: 1.0)	E69-H65 (PDBs: 8GS8), E69-S73 (PDBs: 8GS8)	 E69-H65 (PAE:  1.0), E69-S73 (PAE: 1.0)	E69-H65 (PDBs: 8GS8), E69-W105 (PDBs: 8GS8), E69-S73 (PDBs: 8GS8)							146									-58.1		Pocket 5: Mean pLDDT: 99.68, Volume: 133.47 Å³, Druggability score: 0		-42.7						H (helix)	H (α-helix)	Helix								Helical			98.58	6.7010307	>90	<10	619167;252011;606864;171300	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3; MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA; PHEOCHROMOCYTOMA	false	0.8618276311660384	0.8393560180219272	false	false	false
RAD51D	RAD51D_Ile17Val	B_13-14	0.8297191536322671	0.4340774464288859	0.5267394680299696	13.558438555866092	2.791222873132887e-6	0.000031422662406127906	2025_01_Batch_13-14	false	true	false	false	false	false	false	false	false	false	false	false	0.951178504401488	0.9610567221812101	0.8171420616831244	0.8299458292087237	0.8349292400120566	0.8536439189290037	0.836562125768125	0.8548572350611808	0.7521774585436516	0.8500510239059706	0.9676190559117548	0.9714106299707133	0.8707257120898824	0.8150012449629324	0.9077141998737959	0.7842330994602782	0.9544943884506655	0.9309463788322627	RAD51D	Ile17Val	NC_000017.11:35119565:T:C	49A>G	17	35119565	T	C	17	ENSG00000185379	7201	0	CCSBVarC024709	ALE00022237	ENSP00000338790.6																																	645822.0	single nucleotide variant	NM_002878.4(RAD51D):c.49A>G (p.Ile17Val)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Jul 11, 2024	1002032036.0	-	RCV000816764|RCV000986016|RCV001183136|RCV001816897	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	35119565.0	35119565.0	17q12	criteria provided, conflicting classifications	7.0	-	N	-	2.0	659719.0	35119565.0	T	C	-	-	-	-	-	-	49A>G 	Ile17Val	NM_002878.4	1.0	Conflicting	Conflicting	659719	17	35119565.0	T	C	I	V	rs1002032036	17	33446584	17	30470697	17	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.49A>G	p.Ile17Val	c.49A>G	p.Ile17Val	principal1	Y	5	.	.	-	ATC	1	0	T	T/T	T/T	T/T	T/T	1.0	0.00968	T	1.0	0.01173	T	0.0	0.02950	B	0.001	0.04348	B	0.17	0.40172	N	simple_aae	83.0	17.0	-0.695	0.01869	N	-0.03	0.07402	N	0.046	0.02082	-0.9952	0.31138	T	0.0324	0.13833	T	10	0.04814577	0.04229	T	0.024558	0.47336	T	0.028	0.06252	0.37	0.37869	O75771	I17V	Gain of helix (P = 0.0854)| Gain of MoRF binding (P = 0.2615)| Loss of loop (P = 0.3664)| Loss of catalytic residue at L19 (P = 0.4141)| Gain of disorder (P = 0.4367)	0.429666569261	0.42198	.	0.13960	.	0.07621	.	.	.	0.075739	0.34990	T	-0.308413	0.07683	T	-0.680791	0.06732	T	0.0592468314962335	0.06971	T	0.689731	0.29652	T	0.029664483	0.02476	0.046668846	0.06571	0.029664483	0.02476	0.046668846	0.06570	-2.791	0.17524	T	0.0821	0.22858	B	8.01046792450614e-05	0.02668	0.25106364	0.75187	0.018	0.02411	.	.	.	.	.	.	1.523251	0.19582	14.32	0.6845253055721503	0.08798	0.077523	0.15429	N	-0.963300152951958	0.09283	0.4445345	-0.761465596440251	0.15180	0.8120932	4.37	2.36	0.28182	1.23	0.31344	0.452	0.21585	1.583000	0.27571	-0.201	0.08901	0.997	0.40243	0.906000	0.28131	0.792	0.37428	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13	1612670	8.061170e-06	0	1	60000	1.666670e-05	0	0	74904	0.000000e+00	0	0	912	0.000000e+00	0	1	60000	1.666670e-05	0	0	29600	0.000000e+00	0	0	44872	0.000000e+00	0	0	62816	0.000000e+00	0	0	6084	0.000000e+00	0	11	1179940	9.322510e-06	0	0	91086	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119565T>C	.	C3280345|C0027672|CN169374|C3661900	614291	145|140162	RAD51D, N-terminal domain	Ile	Val	90.86	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			90.86	Aliphatic	Isoleucine		DNA repair protein RAD51 homolog 4										4.5								 I17-T13 (PAE:  1.5), I17-R21 (PAE: 1.0)	I17-R21 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ), I17-T13 (PDBs: 8OUZ)	 I17-T13 (PAE:  1.5), I17-R21 (PAE: 1.0)	I17-L12 (PDBs: 8FAZ, 8GBJ, 8OUZ), I17-V6 (PDBs: 8OUY), I17-R5 (PDBs: 8OUZ), I17-T13 (PDBs: 8OUZ), I17-R21 (PDBs: 8OUZ)							131									-65.3				-41.2	preferentially binds ssDNA					H (helix)	H (α-helix)	Helix											90.86	0.0	>90	<10	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.9610567221812101	0.951178504401488	true	false	false
SHOC2	SHOC2_Gln269Arg	B_13-14	-1.8731767698109718	0.10319517574123058	0.16803306535869597	5.086797297438733	0.001420231443223506	0.003213470651436663	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6899625703013732	0.6716721222840889	0.620281324659611	0.5623588845318255	0.6412239067051407	0.6342079435703926	0.6127797033400668	0.690052350031507	0.5737753328936802	0.5999172339107693	0.6747978133218697	0.6877089285873452	0.6556361838007183	0.5923954633787745	0.5509424361699709	0.6406454154084528	0.668546431246308	0.6922162120154012	SHOC2	Gln269Arg	NC_000010.11:110985730:A:G	806A>G	10	110985730	A	G	10	ENSG00000108061	11602	0	CCSBVarC028042	ALE00021535	ENSP00000358464.5																																	215410.0	single nucleotide variant	NM_007373.4(SHOC2):c.806A>G (p.Gln269Arg)	8036.0	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	1.0	Jul 18, 2024	864309599.0	-	RCV000203043|RCV002272173|RCV002273987|RCV002515502|RCV003407717|RCV004701267|RCV004800333	MedGen:CN169374|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||MONDO:MONDO:0011899,MedGen:C1843181,OMIM:PS607721,Orphanet:2701|MedGen:C3661900	not specified|Noonan syndrome-like disorder with loose anagen hair 1|Noonan syndrome|RASopathy|SHOC2-related disorder|Noonan syndrome-like disorder with loose anagen hair|not provided	de novo;germline;unknown	germline	GRCh38	NC_000010.11	10	110985730.0	110985730.0	10q25.2	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA249249	2.0	218698.0	110985730.0	A	G	-	-	-	-	-	-	806A>G 	Gln269Arg	NM_007373.4	1.0	Conflicting	Conflicting	218698	10	110985730.0	A	G	Q	R	rs864309599	10	112745488	10	112735478	269	SHOC2	ENSG00000108061	ENST00000689118	ENSP00000510554	Q9UQ13	SHOC2_HUMAN	.	.	c.806A>G	p.Gln269Arg	principal1	Y	.	.	.	+	CAG	2	0	A	A/A	A/A	A/A	A/A	.	0.36067	.	.	0.39988	.	1.0	0.90580	D	0.993	0.81117	D	.	0.74433	.	.	.	.	0.495	0.13287	N	.	0.65771	.	.	0.73983	-0.7148	0.59546	T	0.1762	0.51878	T	10	.	0.78974	.	0.102537	0.77535	D	.	0.80145	0.373	0.38359	Q9UQ13	Q269R	Gain of catalytic residue at Q269 (P = 0.0705)| Loss of stability (P = 0.1347)| Gain of helix (P = 0.1736)| Gain of sheet (P = 0.1945)| Loss of loop (P = 0.2237)	.	0.54282	.	0.78075	.	0.85616	0.859452962875	0.91015	D	0.638614	0.88777	D	0.168599	0.70781	D	0.00440441	0.70403	D	0.967611908912659	0.67757	D	0.829317	0.49278	T	0.565797	0.70536	0.42715386	0.66215	0.565797	0.70537	0.42715386	0.66215	-10.657	0.77816	D	.	0.94636	.	0.999574318638691	0.97044	0.04268121	0.57803	0.597	0.77436	.	.	.	.	.	.	5.16137	0.865	28.9	0.99864455562198728	0.94280	0.932428	0.92250	D	0.552375503409867	0.70070	5.470645	0.642530690285397	0.77934	6.799966	5.85	5.85	0.93654	3.93	0.74723	9.325	0.96016	11.203000	0.89123	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.999	0.91597	918	0.19592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613338	1.239670e-06	0	1	44770	2.233640e-05	0	0	74870	0.000000e+00	0	0	912	0.000000e+00	0	0	59972	0.000000e+00	0	0	29588	0.000000e+00	0	1	44770	2.233640e-05	0	0	63982	0.000000e+00	0	0	6058	0.000000e+00	0	1	1179678	8.476890e-07	0	0	91038	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Noonan_syndrome|RASopathy|SHOC2-related_disorder|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|not_specified	criteria_provided,_conflicting_classifications	NC_000010.11:g.110985730A>G	ClinGen:CA249249	C0028326|C5555857|C4478716|CN169374	PS163950|607721	648|536391|2701	.	Gln	Arg	98.12	0.07575757575757576																																																																																																																																																																																																																																																																																																																																																																																																																																																																													15			98.12	Polar/Neutral	Glutamine		Leucine-rich repeat protein SHOC-2										-3.5								 Q269-H247 (PAE:  1.0)	Q269-H247 (PDBs: 7TVG, 7SD1, 7SD0, 7UPI), Q269-R292 (PDBs: 7TVG, 7T7A, 7TYG, 7TVF)		Q269-N294 (PDBs: 7TVG, 7UPI), Q269-R292 (PDBs: 7TVG, 7SD1, 7T7A, 7TYG, 7TVF, 7UPI), Q269-A246 (PDBs: 7SD0)							146		Mutation: Q -> H. Promotes SMP complex formation; when associated with Y-270.							-62.9				149.4			LRR 8			C (loop/coil)	C (loop/coil)												98.12	7.575758	>90	<10	607721	unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	false	0.6716721222840889	0.6899625703013732	false	false	false
BRIP1	BRIP1_His587Arg	B_13-14	1.584238978026326	0.18073804788590883	0.2529904329056715	3.0325933716536873	0.296404339231148	0.33039590340778574	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.679876752722005	0.7185903597208072	0.6842833576082465	0.6891490477358996	0.7007836912959655	0.7137845685473031	0.7890562256793805	0.6843739959313493	0.6707102336566012	0.740618479749426	0.7149334925635037	0.6699468293177294	0.6385129114152257	0.7171933866605816	0.707587861815198	0.6279482354670672	0.7222472268781108	0.6898066761262805	BRIP1	His587Arg	NC_000017.11:61780874:T:C	1760A>G	17	61780874	T	C	17	ENSG00000136492	55128	0	CCSBVarC031376	ALE00022880	ENSP00000259008.2																																	914095.0	single nucleotide variant	NM_032043.3(BRIP1):c.1760A>G (p.His587Arg)	83990.0	BRIP1	HGNC:20473	Conflicting classifications of pathogenicity	0.0	Jan 11, 2024	876660646.0	-	RCV001187524|RCV004570384	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Hereditary cancer-predisposing syndrome|Familial cancer of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	61780874.0	61780874.0	17q23.2	criteria provided, conflicting classifications	3.0	-	N	-	2.0	925546.0	61780874.0	T	C	-	-	-	-	-	-	1760A>G 	His587Arg	NM_032043.3	1.0	Conflicting	Conflicting	925546	17	61780874.0	T	C	H	R	rs876660646	17	59858235	17	57213017	587	BRIP1	ENSG00000136492	ENST00000683039	ENSP00000508303	Q9BX63	FANCJ_HUMAN	.	.	c.1760A>G	p.His587Arg	principal2	Y	.	.	.	-	CAT	2	0	T	T/T	T/T	T/T	T/T	.	0.14580	.	.	0.15078	.	0.004	0.12194	B	0.002	0.06938	B	.	.	.	.	.	.	0.935	0.23470	L	.	0.51830	.	.	0.37163	-1.0328	0.19528	T	0.0418	0.17856	T	9	.	0.24312	.	0.004931	0.12152	T	.	0.14866	0.491	0.57600	Q9BX63	H587R	Gain of MoRF binding (P = 0.0125)| Loss of methylation at K583 (P = 0.0639)| Loss of catalytic residue at L589 (P = 0.0953)| Gain of solvent accessibility (P = 0.1133)| Loss of loop (P = 0.1242)	.	0.09769	.	0.48927	.	0.22326	0.250247567892	0.03796	T	0.210366	0.56871	T	-0.251719	0.13623	T	-0.599353	0.12601	T	0.194684848189354	0.19868	T	.	0.24645	.	0.10351601	0.24247	0.11949802	0.28773	0.10351601	0.24247	0.11949802	0.28773	-10.008	0.74039	D	.	0.07115	.	0.00139744306121536	0.11129	0.46835166	0.81192	0.123	0.33205	.	.	.	.	.	.	0.721728	0.10931	7.579	0.77167040114901508	0.11955	0.345304	0.43862	N	-0.689993184120315	0.16104	0.8295734	-0.53367226512072	0.20931	1.148141	5.42	3.2	0.35749	-0.62	0.17698	0.573	0.23486	0.301000	0.17048	-0.118	0.14421	0.958	0.33576	0.991000	0.31563	0.993	0.69292	54	0.97580	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614206	6.195000e-07	0	1	1180040	8.474290e-07	0	0	75066	0.000000e+00	0	0	912	0.000000e+00	0	0	60032	0.000000e+00	0	0	29602	0.000000e+00	0	0	44880	0.000000e+00	0	0	64024	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180040	8.474290e-07	0	0	91078	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.61780874T>C	.	C0346153|C0027672	114480	227535|140162	.	His	Arg	90.54	0.1793478260869565																																																																																																																																																																																																																																																																																																																																																																																																																																																																													33			90.54	Positively-charged	Histidine		Fanconi anemia group J protein										-3.2								 H587-E412 (PAE:  2.5)		 H587-E412 (PAE:  2.5), H587-Q554 (PAE: 1.5)								155									-78.0				136.5						B (undefined)	E (parallel sheets)												90.54	17.934782	>90	10-90	114480	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	BREAST CANCER	false	0.7185903597208072	0.679876752722005	false	false	false
G6PD	G6PD_Gly378Ser	B_13-14	0.44980261220938383	0.6664511291342612	0.734145820106828	-6.3269334061858045	0.0003938383328659987	0.0011453143277481894	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7023031495045087	0.6959585114864357	0.45893755085036	0.5756486694523033	0.5128637010758649	0.4633952348897936	0.417828013997608	0.4656749392932767	0.5347446420980683	0.434650147849169	0.6484857796517478	0.6681294286811221	0.5089624557819792	0.5600524628584531	0.6165526968065382	0.48322495385155095	0.7434312433211236	0.7364768703278952	G6PD	Gly378Ser	NC_000023.11:154532722:C:T	1132G>A	23	154532722	C	T	X	ENSG00000160211	4006	0	CCSBVarC021515	ALE00037660	ENSP00000377192.3																																	1780130.0	single nucleotide variant	NM_001360016.2(G6PD):c.1132G>A (p.Gly378Ser)	2539.0	G6PD	HGNC:4057	Conflicting classifications of pathogenicity	1.0	Nov 17, 2023	-1.0	-	RCV002305724|RCV004700721	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026|MedGen:C3661900	Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	154532722.0	154532722.0	Xq28	criteria provided, conflicting classifications	3.0	-	N	-	2.0	1722614.0	154532722.0	C	T	-	-	-	-	-	-	1132G>A 	Gly378Ser	NM_001360016.2	1.0	Conflicting	Conflicting	1722614	X	154532722.0	C	T	G	S	rs371489738	X	153760937	X	153414131	378	G6PD	ENSG00000160211	ENST00000696430	ENSP00000512625	P11413	G6PD_HUMAN	.	.	c.1132G>A	p.Gly378Ser	principal4	Y	.	.	.	-	GGC	1	0	C	C/C	C/C	C/C	C/C	.	0.20791	.	.	0.31345	.	1.0	0.90580	D	0.983	0.75798	D	.	0.95575	.	.	.	.	1.855	0.48991	L	.	0.80118	.	.	0.69502	1.0912	0.99286	D	0.9601	0.98711	D	10	.	0.90197	.	0.683657	0.97378	D	.	0.92639	.	.	.	.	.	.	0.98330	.	.	.	0.94444	0.661729335785	0.61595	T	0.964038	0.99554	D	0.491478	0.93997	D	0.520035	0.94954	D	0.929728746414185	0.59158	D	0.913609	0.69172	D	0.86035365	0.87950	0.81130373	0.88841	0.857077	0.87700	0.76723653	0.86083	-8.453	0.67258	D	.	0.57080	.	0.987461282210342	0.87449	0.99859923	0.98864	0.905	0.95023	.	.	.	.	.	.	3.113311	0.42085	21.5	0.99607459962891864	0.74605	.	.	.	.	.	.	.	.	.	5.82	5.82	0.92730	4.13	0.78719	7.406	0.79294	3.963000	0.40843	0.585	0.3052	1.0	0.71675	0.999000	0.35501	0.232	0.22834	80	0.96675	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	0	79875	0.000000e+00	0	2	150869	1.325650e-05	0	1	171104	5.844400e-06	0	0	5668	0.000000e+00	0	0	13617	0.000000e+00	0	0	1760	0.000000e+00	0	0	6853	0.000000e+00	0	0	9912	0.000000e+00	0	0	30728	0.000000e+00	0	0	9893	0.000000e+00	0	.	.	.	.	0	13060	0.000000e+00	0	0	24309	0.000000e+00	0	0	4622	0.000000e+00	0	0	10047	0.000000e+00	0	0	12156	0.000000e+00	0	2	64114	3.119440e-05	0	0	18959	0.000000e+00	0	2	64114	3.119440e-05	0	0	12003	0.000000e+00	0	0	27090	0.000000e+00	0	0	7058	0.000000e+00	0	0	13231	0.000000e+00	0	0	15912	0.000000e+00	0	1	72783	1.373950e-05	0	0	18893	0.000000e+00	0	1	72783	1.373950e-05	0	.	12	1210896	9.910020e-06	0	1	46682	2.142150e-05	0	0	57586	0.000000e+00	0	0	683	0.000000e+00	0	0	45931	0.000000e+00	0	0	22045	0.000000e+00	0	0	33786	0.000000e+00	0	1	46682	2.142150e-05	0	0	4374	0.000000e+00	0	11	895342	1.228580e-05	0	0	56870	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	criteria_provided,_conflicting_classifications	NC_000023.11:g.154532722C>T	.	C2720289	300908	466026	Glucose-6-phosphate dehydrogenase, C-terminal	Gly	Ser	96.99	0.8571428571428571																																																																																																																																																																																																																																																																																																																																																																																																																																																																													72			96.99	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Glucose-6-phosphate 1-dehydrogenase								0.2364		-0.4			A:G378-B:K275 (PDBs: 7SNG, 7TOE), A:G378-D:D350 (PDBs: 7SNI, 7TOE), D:G378-A:D350 (PDBs: 7TOE), C:G378-B:D350 (PDBs: 7TOE), D:G378-C:K275 (PDBs: 7TOE), B:G378-A:K275 (PDBs: 7TOE), B:G378-C:D350 (PDBs: 7TOE)	C:G378-B:D350 (PDBs: 7SNG, 7SNH, 7SNI, 7TOE), D:G378-A:D350 (PDBs: 7TOE)														75									69.2		Pocket 4: Mean pLDDT: 97.1, Volume: 445.2 Å³, Druggability score: 0.24		50.9						C (loop/coil)	S (bend)												96.99	85.71429	>90	10-90	300908	x-linked	OMIM	Rare genetic hematologic disease	1	ANEMIA, CONGENITAL, NONSPHEROCYTIC HEMOLYTIC, 1	false	0.6959585114864357	0.7023031495045087	false	false	false
F9	F9_Val257Ile	B_13-14	-1.8257507063326923	0.11063229444803031	0.17771882455486787	4.318013076355253	0.0034886694691851866	0.006824849121487012	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6287204155574371	0.6559648162841043	0.47941937296599657	0.6908243666474851	0.6222208921268683	0.5834890156698997	0.6384124088916426	0.6395317253263273	0.6657806300374155	0.5284386333525051	0.6606989432982083	0.5924400478473762	0.528565622448157	0.6049100589274092	0.7158681032575549	0.430400112579488	0.6512306892700004	0.6650007832674978	F9	Val257Ile	NC_000023.11:139560786:G:A	769G>A	23	139560786	G	A	X	ENSG00000101981	52861	0	CCSBVarC030575	ALE00030455	ENSP00000218099.2																																	227419.0	single nucleotide variant	NM_000133.4(F9):c.769G>A (p.Val257Ile)	2158.0	F9	HGNC:3551	Conflicting classifications of pathogenicity	0.0	Jan 12, 2024	200608775.0	-	RCV000490374|RCV000862519|RCV003917862	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|F9-related disorder	germline	germline	GRCh38	NC_000023.11	X	139560786.0	139560786.0	Xq27.1	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA10529834	2.0	225354.0	139560786.0	G	A	-	-	-	-	-	-	769G>A 	Val257Ile	NM_000133.4	1.0	Conflicting	Conflicting	225354	X	139560786.0	G	A	V	I	rs200608775	X	138642945	X	138470611	257	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.769G>A	p.Val257Ile	c.769G>A	p.Val257Ile	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.488	0.08092	T	0.41	0.14754	T	0.0	0.02950	B	0.0	0.01384	B	0.07	0.21442	N	simple_aae	93.0	7.0	-1.135	0.00932	N	0.81	0.01825	N	0.396	0.66533	-0.8550	0.51428	T	0.2284	0.59203	T	10	0.025891602	0.00768	T	0.068982	0.70500	D	0.483	0.77150	.	.	.	.	.	0.975202009541	0.97469	0.8969268504407544	0.89598	0.51541283519	0.49159	0.24926649034	0.03692	T	0.385448	0.74512	T	-0.276942	0.10755	T	-0.195212	0.54792	T	0.0201428491067639	0.00712	T	0.808919	0.50832	T	0.050574146	0.09073	0.1163571	0.28024	0.07762356	0.17469	0.10740013	0.25799	-0.934	0.01014	T	0.0601	0.01289	B	0.0165363210494945	0.27901	0.99979204	0.99726	0.068	0.19020	.	.	.	.	.	.	-1.717606	0.00187	0.003	0.61038201019498284	0.06705	.	.	.	.	.	.	.	.	.	5.84	-5.82	0.02145	-10.4	0.00170	-0.992	0.03838	-0.886000	0.07077	-0.272	0.06718	0.0	0.06393	0.000000	0.08389	0.82	0.3867	924	0.18019	1	2.6490066225165563E-4	0	0.0	0	0.0	0	0.0	1	0.0013089005235602095	0	0.0	28	264690	1.0578412E-4	.	8	80322	9.959910e-05	0	22	151849	1.448810e-04	0	23	172240	1.335350e-04	0	0	5702	0.000000e+00	0	0	13666	0.000000e+00	0	0	1767	0.000000e+00	0	8	6916	1.156740e-03	0	0	9912	0.000000e+00	0	0	30957	0.000000e+00	0	0	9952	0.000000e+00	0	8	6916	1.156740e-03	0	0	13134	0.000000e+00	0	1	24390	4.100040e-05	0	0	4649	0.000000e+00	0	20	10127	1.974920e-03	0	1	12170	8.216930e-05	0	0	64682	0.000000e+00	0	0	19072	0.000000e+00	0	20	10127	1.974920e-03	0	0	12064	0.000000e+00	0	1	27168	3.680800e-05	0	0	7083	0.000000e+00	0	21	13318	1.576810e-03	0	1	15975	6.259780e-05	0	0	73479	0.000000e+00	0	0	19007	0.000000e+00	0	21	13318	1.576810e-03	0	.	231	1209089	1.910530e-04	1	203	33751	6.014640e-03	1	7	57201	1.223750e-04	0	0	684	0.000000e+00	0	2	45735	4.373020e-05	0	0	22020	0.000000e+00	0	203	33751	6.014640e-03	1	4	46494	8.603260e-05	0	1	4350	2.298850e-04	0	8	894497	8.943570e-06	0	0	56760	0.000000e+00	0	1	92828	1.0772611711983453E-5	1	168	0.005952380952380952	17	2680	0.006343283582089552	0	4020	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2062	0	1	4188	2.387774594078319E-4	17	3306	0.00514216575922565	19	104028	1.8264313454070057E-4	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_conflicting_classifications	NC_000023.11:g.139560786G>A	ClinGen:CA10529834	C0008533|C2749016	306900|300807	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Ile	97.45	0.028169014084507043																																																																																																																																																																																																																																																																																																																																																																																																															0.251		0.193	2 mutation(s) (Val257Pro: -0.019, Val257Asn: -0.002)	0.189	2 mutation(s) (Val257Pro: -0.010, Val257His: -0.006)	0.172	2 mutation(s) (Val257Pro: -0.009, Val257His: -0.005)	0.168	1 mutation(s) (Val257His: -0.012)																																																					4			97.45	Aliphatic	Valine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1	0.2107		4.2								 V257-W261 (PAE:  1.0)	V257-W261 (PDBs: 6X5J, 6X5L, 8OL9)	 V257-V263 (PAE:  1.0)	V257-T458 (PDBs: 6X5J, 6X5L, 8OL9), V257-P333 (PDBs: 8OL9), V257-V263 (PDBs: 8OL9), V257-W261 (PDBs: 8OL9)							117									-89.4		Pocket 2: Mean pLDDT: 91.87, Volume: 558.39 Å³, Druggability score: 0.21		-42.5						C (loop/coil)	C (loop/coil)	Beta strand											97.45	2.8169014	>90	<10	306900;306900;300807	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA B; HEMOPHILIA B; THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT	false	0.6559648162841043	0.6287204155574371	false	false	false
FARS2	FARS2_Ala166Thr	B_13-14	1.7169263893776356	1.0	1.0	-2.5932366695452966	0.035795255202522906	0.05279385382883707	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6547196122824003	0.6491145843511361	0.4614608494148925	0.6981973278235751	0.6322604522065071	0.5517118473911681	0.47310325126299624	0.6328859041127382	0.6684697797242347	0.41097083177168514	0.6304111161642513	0.6802103918722229	0.6303204435193399	0.631635000300276	0.7279248759229154	0.5119508670580999	0.6678180525380208	0.6292288326925777	FARS2	Ala166Thr	NC_000006.12:5369066:G:A	496G>A	6	5369066	G	A	6	ENSG00000145982	12653	0	CCSBVarC011877	ALE00009035	ENSP00000274680.4																																	211251.0	single nucleotide variant	NM_006567.5(FARS2):c.496G>A (p.Ala166Thr)	10667.0	FARS2	HGNC:21062	Conflicting classifications of pathogenicity	0.0	May 05, 2022	764932724.0	-	RCV000197977|RCV001853177	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	not specified|Combined oxidative phosphorylation defect type 14	germline	germline	GRCh38	NC_000006.12	6	5369066.0	5369066.0	6p25.1	criteria provided, conflicting classifications	2.0	-	N	ClinGen:CA322451	2.0	214328.0	5369066.0	G	A	-	-	-	-	-	-	496G>A 	Ala166Thr	NM_006567.5	1.0	Conflicting	Conflicting	214328	6	5369066.0	G	A	A	T	rs764932724	6	5369299	6	5314298	166	FARS2	ENSG00000145982	ENST00000324331	ENSP00000316335	O95363	SYFM_HUMAN	c.496G>A	p.Ala166Thr	c.496G>A	p.Ala166Thr	principal1	Y	1	.	.	+	GCG	1	0	G	G/G	G/G	G/G	G/G	0.349	0.12418	T	0.319	0.19439	T	0.789	0.44584	P	0.273	0.40008	B	0.1	0.28107	N	simple_aae	90.0	10.0	1.57	0.39465	L	-1.32	0.32965	N	0.253	0.28534	-1.0287	0.20841	T	0.0493	0.20874	T	10	0.12830508	0.24112	T	0.014536	0.34468	T	0.060	0.17153	0.351	0.34780	O95363	A166T	Loss of helix (P = 0.0196)| Gain of loop (P = 0.069)| Loss of stability (P = 0.0942)| Loss of sheet (P = 0.302)| Gain of disorder (P = 0.3125)	0.653491938199	0.64789	0.5003925295663422	0.49766	0.172407162635	0.19145	0.372067689896	0.21105	T	0.063676	0.31993	T	-0.340643	0.05166	T	-0.55124	0.16906	T	0.152796268463135	0.17108	T	.	0.43452	.	0.06440483	0.13537	0.10302442	0.24659	0.08581967	0.19742	0.10970226	0.26384	-6.934	0.53619	T	0.0898	0.12616	LB	0.20033392600971	0.49936	0.15600365	0.70784	0.037	0.08577	.	.	.	.	.	.	0.792367	0.11648	8.215	0.99410883744534362	0.63313	0.116843	0.22702	N	-0.396344597065005	0.25323	1.390813	-0.454383794869487	0.23109	1.27738	5.68	1.35	0.21027	-0.754	0.16971	0.428	0.2119	2.603000	0.33615	-0.675	0.04283	0.339	0.25753	0.998000	0.34068	0.571	0.30719	944	0.12756	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	2	109328	1.829360e-05	0	4	207998	1.923100e-05	0	5	236750	2.111930e-05	0	0	7164	0.000000e+00	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13314	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	2	17112	1.168770e-04	0	0	16210	0.000000e+00	0	2	30522	6.552650e-05	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16654	0.000000e+00	0	2	89522	2.234090e-05	0	0	30606	0.000000e+00	0	2	30522	6.552650e-05	0	0	14902	0.000000e+00	0	2	34260	5.837710e-05	0	0	9566	0.000000e+00	0	0	17692	0.000000e+00	0	0	21552	0.000000e+00	0	3	102636	2.922950e-05	0	0	30526	0.000000e+00	0	2	34260	5.837710e-05	0	.	18	1614038	1.115220e-05	0	3	6062	4.948860e-04	0	0	75018	0.000000e+00	0	0	912	0.000000e+00	0	2	60022	3.332110e-05	0	0	29606	0.000000e+00	0	0	44876	0.000000e+00	0	0	63952	0.000000e+00	0	3	6062	4.948860e-04	0	11	1180016	9.321910e-06	0	1	91064	1.098130e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Combined_oxidative_phosphorylation_defect_type_14|not_specified	criteria_provided,_conflicting_classifications	NC_000006.12:g.5369066G>A	ClinGen:CA322451	C4755312|CN169374	614946	319519	Phenylalanyl-tRNA synthetase	Ala	Thr	98.13	0.6132075471698113																																																																																																																																																																																																																																																																																																																																																																																																																																																																													65			98.13	Aliphatic	Alanine												1.8								 A166-D162 (PAE:  1.0)	A166-D162 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP)	 A166-D162 (PAE:  1.0)	A166-D162 (PDBs: 3CMQ, 3HFV, 3TEG, 5MGH, 5MGU, 5MGV, 5MGW, 8P8X, 3TUP)							89									-72.5				-1.5						C (loop/coil)	T (turn)												98.13	61.32075	>90	10-90	614946	autosomal recessive	GenCC	Rare genetic developmental defect during embryogenesis; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14	false	0.6491145843511361	0.6547196122824003	false	false	false
RAD51D	RAD51D_Val28Leu	B_13-14	-0.90363915640805	0.3962182548910523	0.4876139605940141	16.200443125934576	8.308316556276541e-7	0.00001534362961504208	2025_01_Batch_13-14	false	false	false	true	false	false	false	false	false	false	false	false	0.9479179944382452	0.9482386754306041	0.7922212349397246	0.9446089539897566	0.8679368487277319	0.9023184783349696	0.8559676305854494	0.8400075382646593	0.9275169638661283	0.716040959470255	0.9391265371434907	0.9406388556077788	0.9486693260844898	0.8958661591908044	0.9617009441133851	0.8684015104091942	0.9573508137177176	0.9551971332687115	RAD51D	Val28Leu	NC_000017.11:35119532:C:G	82G>C	17	35119532	C	G	17	ENSG00000185379	7201	0	CCSBVarC024750	ALE00036624	ENSP00000338790.6																																	1813922.0	single nucleotide variant	NM_002878.4(RAD51D):c.82G>C (p.Val28Leu)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	1.0	Nov 06, 2023	-1.0	-	RCV002430340|RCV003454215	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	germline;unknown	germline	GRCh38	NC_000017.11	17	35119532.0	35119532.0	17q12	criteria provided, conflicting classifications	2.0	-	N	-	2.0	1762829.0	35119532.0	C	G	-	-	-	-	-	-	82G>C 	Val28Leu	NM_002878.4	1.0	Conflicting	Conflicting	1762829	17	35119532.0	C	G	V	L	rs2142480064	17	33446551	17	30470664	28	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.82G>C	p.Val28Leu	c.82G>C	p.Val28Leu	principal1	Y	5	.	.	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.106	0.92967	T	1.0	0.90580	D	0.996	0.84488	D	.	.	.	.	.	.	2.71	0.79120	M	-2.45	0.56973	N	0.495	0.55314	-0.3621	0.73082	T	0.3608	0.72130	T	9	0.57687366	0.65335	D	0.226204	0.88003	D	0.229	0.52699	0.463	0.53105	O75771	V28L	Loss of sheet (P = 0.0126)| Gain of helix (P = 0.027)| Gain of loop (P = 0.0851)| Gain of ubiquitination at K26 (P = 0.1504)| Loss of phosphorylation at T27 (P = 0.2477)	0.834963111294	0.83208	.	0.68920	.	0.39860	.	.	.	0.485341	0.81083	T	0.0746214	0.61132	D	-0.130588	0.60646	T	0.984222710132599	0.75431	D	0.90461	0.67517	D	0.593787	0.72069	0.3945471	0.63896	0.593787	0.72070	0.3945471	0.63896	-8.931	0.67329	D	0.7085	0.75430	P	0.00939506599652921	0.23451	0.90928640	0.91550	0.676	0.82005	.	.	.	.	.	.	7.247327	0.96318	36.0	0.99800754297607808	0.88559	0.836844	0.75365	D	0.678883385112307	0.78132	6.833586	0.616344378564284	0.75995	6.433988	4.5	4.5	0.54328	.	.	3.379	0.52266	7.344000	0.58328	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.947	0.4917	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119532C>G	.	C0027672|C3280345	614291	140162|145	RAD51D, N-terminal domain	Val	Leu	89.91	0.07042253521126761																																																																																																																																																																																																																																																																																																																																																																																																																																																																													10			89.91	Aliphatic	Valine		DNA repair protein RAD51 homolog 4										4.2								 V28-G2 (PAE:  3.0), V28-V32 (PAE: 1.0)	V28-V32 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ), V28-G2 (PDBs: 8OUZ)	 V28-G2 (PAE:  3.0), V28-V32 (PAE: 1.0)	V28-V32 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ), V28-L4 (PDBs: 8OUZ), V28-G2 (PDBs: 8OUZ), V28-L57 (PDBs: 8OUZ)							117									-57.1				-39.1	preferentially binds ssDNA					H (helix)	H (α-helix)	Helix											89.91	7.042254	70-90	<10	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.9482386754306041	0.9479179944382452	false	false	false
RET	RET_Val292Met	B_13-14	-6.302622328210597	0.00040314669841361	0.0023094907934366306	5.722295950936414	0.0007186171011069104	0.001828935340542553	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8634323585702157	0.8583167992499499	0.5755588372257929	0.6584702504877745	0.5655531273445287	0.5969049800415613	0.5444311644160246	0.5190178465580404	0.6844864899272642	0.5312943005899784	0.8735698199876526	0.899796689467368	0.6493787956670982	0.612088408131017	0.6324540110482848	0.6198233738616074	0.843063778512247	0.8270680276730633	RET	Val292Met	NC_000010.11:43106382:G:A	874G>A	10	43106382	G	A	10	ENSG00000165731	8858	0	CCSBVarC006880	ALE00006878	ENSP00000480088.1	CEGS2	CegsMutGDEh1026	H07	GDEhDisVCh_40066	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	36221.0	single nucleotide variant	NM_020975.6(RET):c.874G>A (p.Val292Met)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Mar 02, 2024	34682185.0	-	RCV000034779|RCV000121992|RCV000367517|RCV000276548|RCV000333869|RCV000354891|RCV000755685|RCV000565970|RCV001083006|RCV003492298	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:C1333600	not provided|not specified|Multiple endocrine neoplasia|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hereditary cancer	germline;unknown	germline	GRCh38	NC_000010.11	10	43106382.0	43106382.0	10q11.21	criteria provided, conflicting classifications	15.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009374,UniProtKB:P07949#VAR_041764	2.0	24880.0	43106382.0	G	A	-	-	-	-	-	-	874G>A 	Val292Met	NM_020975.6	1.0	Conflicting	Conflicting	24880	10	43106382.0	G	A	V	M	rs34682185	10	43601830	10	42921836	292	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.874G>A	p.Val292Met	c.874G>A	p.Val292Met	principal4	Y	5	YES	Select	+	GTG	1	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.032	0.53775	D	1.0	0.90580	D	0.935	0.73565	D	0.12	0.31989	N	simple_aae	88.0	12.0	2.615	0.76302	M	-1.09	0.28250	N	0.558	0.60971	0.4163	0.89300	D	0.5416	0.83044	D	10	0.010467678	0.00229	T	.	.	.	0.409	0.71949	.	.	.	.	.	0.888871705788	0.88692	0.788903358267811	0.78722	1.83343156079	0.92045	0.564820885658	0.47880	T	0.467186	0.80012	T	-0.0978649	0.36423	T	0.0917746	0.76187	D	0.0599002876036932	0.07075	T	0.681032	0.28743	T	0.17939073	0.38700	0.13158411	0.31509	0.22824927	0.45215	0.13554715	0.32360	-8.694	0.65784	D	0.1243	0.33824	B	0.936206762942958	0.78979	0.99984658	0.99806	0.706	0.83697	.	.	.	.	.	.	4.280368	0.6527	24.8	0.99748410528429388	0.84091	0.558315	0.56606	D	0.404318965602062	0.61459	4.370004	0.288787131538424	0.54646	3.6522	4.86	4.86	0.62577	2.99	0.54692	6.727	0.74634	6.639000	0.56245	-0.168	0.1142	0.998	0.41403	1.000000	0.68239	0.08	0.17286	862	0.33096	19	0.0037939297124600637	0	0.0	1	9.940357852882703E-4	0	0.0	17	0.016865079365079364	1	0.0010224948875255625	81	264690	3.0601837E-4	.	78	107468	7.257970e-04	0	120	203952	5.883740e-04	0	149	233194	6.389530e-04	0	2	7086	2.822470e-04	0	2	17040	1.173710e-04	0	0	2316	0.000000e+00	0	65	9000	7.222220e-03	0	0	11960	0.000000e+00	0	3	42544	7.051520e-05	0	6	15632	3.838280e-04	0	65	9000	7.222220e-03	0	2	15900	1.257860e-04	0	4	30412	1.315270e-04	0	0	6136	0.000000e+00	0	95	13298	7.143930e-03	0	0	15296	0.000000e+00	0	5	87600	5.707760e-05	0	11	30514	3.604900e-04	0	95	13298	7.143930e-03	0	2	14664	1.363880e-04	0	4	34166	1.170750e-04	0	0	9544	0.000000e+00	0	123	17646	6.970420e-03	0	0	19796	0.000000e+00	0	6	101376	5.918560e-05	0	11	30434	3.614380e-04	0	123	17646	6.970420e-03	0	.	365	1610770	2.266000e-04	5	199	44880	4.434050e-03	2	7	75016	9.331340e-05	0	0	912	0.000000e+00	0	4	60016	6.664890e-05	0	2	29608	6.754930e-05	0	199	44880	4.434050e-03	2	1	61774	1.618800e-05	0	1	5300	1.886790e-04	0	73	1179870	6.187120e-05	0	39	91004	4.285530e-04	3	15	159894	9.381215054973921E-5	0	242	0	21	4726	0.004443504020313161	0	5982	0	0	1146	0	0	1160	0	5	1878	0.0026624068157614484	0	322	0	10	15512	6.446621970087674E-4	0	6224	0	26	6604	0.003937007874015748	51	190862	2.6720876863912143E-4	Hereditary_cancer|Multiple_endocrine_neoplasia,_type_2|Hirschsprung_disease,_susceptibility_to,_1|not_provided|not_specified|Multiple_endocrine_neoplasia_type_2B|Pheochromocytoma|Multiple_endocrine_neoplasia|Hereditary_cancer-predisposing_syndrome|Renal_hypodysplasia/aplasia_1	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106382G>A	ClinGen:CA009374|UniProtKB:P07949#VAR_041764	C1333600|C4048306|C3888239|C3661900|CN169374|C0025269|C0031511|C0027662|C0027672|C1619700	142623|162300|171300|PS131100|191830	653|388|247709|653|29072|276161|140162|411709	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Val	Met	96.26	0.47183098591549294																																																																																																																																																																																																																																																																																																																																																																																																																																																																													67			96.26	Aliphatic	Valine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										4.2											V292-R355 (PDBs: 6Q2O, 6Q2R)							117									-64.4				123.6	Cadherin-like region 3 (CLD3)					B (undefined)	E (parallel sheets)							Extracellular					96.26	47.183098	>90	10-90	171300;142623;191830;162300	multiple	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	PHEOCHROMOCYTOMA; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; RENAL HYPODYSPLASIA/APLASIA 1; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB	false	0.8583167992499499	0.8634323585702157	false	false	false
RET	RET_Leu56Met	B_13-14	2.070499399299519	0.07715984473902697	0.13241267156472733	4.94642043916327	0.0016629851829784886	0.003650212692303261	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7657479574782309	0.7572153704119508	0.7596328874196567	0.816272222528879	0.7930698518918358	0.8016583342002548	0.9532101802315346	0.8869210879558594	0.9205539698259609	0.84469685377409	0.8199347746601383	0.8445621291690999	0.6501064881689749	0.6992186158278121	0.7119904752317969	0.6745689210652236	0.6944959661637632	0.6869337857873619	RET	Leu56Met	NC_000010.11:43100551:C:A	166C>A	10	43100551	C	A	10	ENSG00000165731	8858	0	CCSBVarC006872	ALE00006870	ENSP00000480088.1	CEGS2	CegsMutGDEh1027	G04	GDEhDisVCh_40066	G05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	45384.0	single nucleotide variant	NM_020975.6(RET):c.166C>A (p.Leu56Met)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Nov 01, 2024	145633958.0	-	RCV000034766|RCV000030402|RCV000163266|RCV000148768|RCV000121985|RCV000202649|RCV001082759|RCV001108849|RCV001108851|RCV001108850	MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MedGen:CN169374|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072	not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Aganglionic megacolon|not specified|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma	germline;unknown	germline	GRCh38	NC_000010.11	10	43100551.0	43100551.0	10q11.21	criteria provided, conflicting classifications	26.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007702	2.0	36723.0	43100551.0	C	A	-	-	-	-	-	-	166C>A 	Leu56Met	NM_020975.6	1.0	Conflicting	Conflicting	36723	10	43100551.0	C	A	L	M	rs145633958	10	43595999	10	42916005	56	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.166C>A	p.Leu56Met	c.166C>A	p.Leu56Met	principal4	Y	5	YES	Select	+	CTG	1	2	C	C/C	C/C	C/C	C/C	0.393	0.11116	T	0.37	0.92967	T	0.558	0.44790	P	0.207	0.43709	B	0.08	0.23785	N	simple_aae	92.0	8.0	1.74	0.44959	L	-0.71	0.20082	N	0.234	0.27835	-0.4197	0.71275	T	0.2838	0.65421	T	10	0.01373741	0.00287	T	0.038562	0.58137	D	0.506	0.78612	.	.	.	.	.	0.965681725857	0.96499	0.5310686656002561	0.52839	0.936903531846	0.71884	0.436104416847	0.30008	T	0.443185	0.78547	T	-0.161264	0.26220	T	-0.00332951	0.69900	D	0.00669683503352234	0.00074	T	0.677732	0.28414	T	0.13296163	0.30675	0.057930265	0.10627	0.15338261	0.34482	0.070077136	0.14837	-5.112	0.38089	T	0.2222	0.51413	B	0.420929723777606	0.58343	0.99925655	0.99252	0.115	0.31465	.	.	.	.	.	.	0.98931	0.13688	10.21	0.97808508319477172	0.36268	0.071078	0.13951	N	-0.303488539195444	0.28736	1.605345	-0.361080103655587	0.25850	1.44365	5.51	3.41	0.38072	1.56	0.34791	0.376	0.2034	0.096000	0.14644	0.599	0.40292	0.307	0.25474	0.003000	0.18726	0.004	0.06081	862	0.33096	6	0.0011980830670926517	1	7.564296520423601E-4	4	0.003976143141153081	1	0.001440922190201729	0	0.0	0	0.0	779	264690	0.0029430655	.	289	109366	2.642500e-03	1	564	207736	2.714980e-03	1	625	236592	2.641680e-03	1	4	7148	5.595970e-04	0	27	17110	1.578020e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	35	13384	2.615060e-03	0	217	42756	5.075310e-03	1	0	15688	0.000000e+00	0	217	42756	5.075310e-03	1	11	16174	6.801040e-04	0	40	30516	1.310790e-03	0	0	6206	0.000000e+00	0	1	13410	7.457120e-05	0	44	16724	2.630950e-03	0	454	89240	5.087400e-03	1	0	30606	0.000000e+00	0	454	89240	5.087400e-03	1	9	14876	6.050010e-04	0	53	34256	1.547170e-03	0	0	9564	0.000000e+00	0	1	17692	5.652270e-05	0	49	21620	2.266420e-03	0	498	102440	4.861380e-03	1	0	30524	0.000000e+00	0	498	102440	4.861380e-03	1	.	7763	1613938	4.809970e-03	25	7135	1180022	6.046500e-03	24	54	75056	7.194630e-04	0	0	912	0.000000e+00	0	109	60026	1.815880e-03	0	1	29608	3.377470e-05	0	1	44880	2.228160e-05	0	194	63782	3.041610e-03	1	0	6060	0.000000e+00	0	7135	1180022	6.046500e-03	24	2	91090	2.195630e-05	0	981	198634	0.0049387315363935685	1	360	0.002777777777777778	0	4532	0	5	9432	5.301102629346904E-4	5	796	0.00628140703517588	0	966	0	0	1842	0	0	280	0	54	17500	0.003085714285714286	6	9792	6.127450980392157E-4	0	6374	0	1046	234342	0.004463561802835173	not_specified|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon	criteria_provided,_conflicting_classifications	NC_000010.11:g.43100551C>A	ClinGen:CA007702	CN169374|C1619700|C0027662|C3661900|C0031511|C0027672|C4048306|C0025268|C3888239|C0019569	191830|PS131100|171300|171400|142623|PS142623	411709|276161|29072|140162|653|247698|653|388|388	Ret, cadherin like domain 1	Leu	Met	94.01	0.042682926829268296																																																																																																																																																																																																																																																																																																																																																																																																																																																																													7			94.01	Aliphatic	Leucine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										3.8								 L56-Y30 (PAE:  1.0)	L56-Y30 (PDBs: 6GL7, 6Q2J, 6Q2N, 6Q2O, 6Q2R, 6Q2S)	 L56-Y30 (PAE:  1.0), L56-G183 (PAE: 1.0)	L56-Y30 (PDBs: 6GL7, 6Q2N, 6Q2S), L56-T184 (PDBs: 6Q2J, 6Q2O, 6Q2R, 6Q2S)							131									-89.5				163.9	Cadherin-like region 1 (CLD1)					B (undefined)	E (parallel sheets)							Extracellular					94.01	4.268293	>90	<10	171400;191830;142623;171300	multiple	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; RENAL HYPODYSPLASIA/APLASIA 1; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; PHEOCHROMOCYTOMA	false	0.7572153704119508	0.7657479574782309	false	false	false
SDHD	SDHD_His50Asp	B_13-14	5.2045723369280035	0.003547308842902077	0.011108594953036649	-0.5278983851524384	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	true	true	false	false	false	false	false	false	0.8639855268983924	0.88478288535053	0.8035060825761208	0.9145491463824333	0.9039814378043034	0.9134770914067805	0.9286151553144399	0.9303764412152746	0.9402442322709712	0.8381608720528464	0.9092061361915389	0.8834174086984895	0.8983390274991211	0.8775864343933322	0.8888540604938956	0.7688512930993951	0.8603596345095211	0.8445536450982952	SDHD	His50Asp	NC_000011.10:112087952:C:G	148C>G	11	112087952	C	G	11	ENSG00000204370	6363	0	CCSBVarC023279	ALE00026172	ENSP00000364699.3																																	425903.0	single nucleotide variant	NM_003002.4(SDHD):c.148C>G (p.His50Asp)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	1.0	Mar 24, 2024	779249550.0	-	RCV000497964|RCV000505346|RCV000569506|RCV002230973	MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286	not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Cowden syndrome 3;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome	germline	germline	GRCh38	NC_000011.10	11	112087952.0	112087952.0	11q23.1	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA382617089	2.0	431847.0	112087952.0	C	G	-	-	-	-	-	-	148C>G 	His50Asp	NM_003002.4	1.0	Conflicting	Conflicting	431847	11	112087952.0	C	G	H	D	rs779249550	11	111958676	11	111463886	50	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.148C>G	p.His50Asp	c.148C>G	p.His50Asp	principal1	Y	1	YES	Select	+	CAC	1	0	C	./.	./.	./.	./.	0.018	0.91343	D	0.008	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	.	.	.	.	.	.	2.875	0.83215	M	-3.14	0.89554	D	0.772	0.76851	0.9245	0.96011	D	0.8997	0.96666	D	10	0.84643626	0.83639	D	0.436238	0.94066	D	0.758	0.91722	0.534	0.64172	O14521	H50D	Loss of glycosylation at P53 (P = 0.0815)| Loss of sheet (P = 0.1398)| Loss of catalytic residue at S54 (P = 0.1704)| Gain of disorder (P = 0.1919)| Gain of relative solvent accessibility (P = 0.2363)	0.957064088694	0.95623	0.9054445795321721	0.90457	0.67055262571	0.59146	0.511507630348	0.40377	T	0.704104	0.91424	D	0.460795	0.92907	D	0.424123	0.92818	D	0.960621476173401	0.65639	D	0.862614	0.55690	D	0.41402334	0.61368	0.35787314	0.61034	0.41402334	0.61369	0.35787314	0.61034	-2.133	0.12713	T	0.3169	0.65739	B	0.974774869969241	0.84170	0.99681085	0.98169	0.574	0.76062	.	.	.	.	.	.	4.177101	0.62924	24.5	0.99032993676936265	0.50938	0.784431	0.71408	D	0.635376796190383	0.75292	6.303636	0.556168196419146	0.71674	5.714621	4.9	4.9	0.63598	.	.	3.351	0.52041	5.674000	0.49343	0.599	0.40292	0.999	0.42732	1.000000	0.68239	0.808	0.38116	635	0.64545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	0	109370	0.000000e+00	0	1	208096	4.805470e-06	0	0	236920	0.000000e+00	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13356	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16696	0.000000e+00	0	1	89556	1.116620e-05	0	0	30608	0.000000e+00	0	1	89556	1.116620e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21594	0.000000e+00	0	0	102754	0.000000e+00	0	0	30526	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|Carney-Stratakis_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Cowden_syndrome_3|not_provided|Hereditary_pheochromocytoma-paraganglioma	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.112087952C>G	ClinGen:CA382617089	C0027672|C1847319|C0031511|C1868633|CN166604|C3661900|C1708353	606864|171300	140162|97286|29072|201|29072	.	His	Asp	76.82	0.9619565217391305																																																																																																																																																																																																																																																																																																																																																																																																																																																																													177			76.82	Positively-charged	Histidine												-3.2																		155									-68.9				106.7						C (loop/coil)	C (loop/coil)								Mitochondrion				76.82	96.19565	70-90	$\geqslant$90	171300;606864	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	false	0.88478288535053	0.8639855268983924	false	false	false
FH	FH_Gln376Pro	B_13-14	4.964945865150239	0.0025396516076362347	0.009430132960958808	-6.772526112019	0.0002596180272702125	0.0008285201392014607	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9475361739990256	0.9545746335656853	0.5691630536658441	0.8469661931216068	0.6945859872540088	0.5899786478285141	0.4928312278912255	0.6709119174206641	0.7921799781175165	0.4653835281687405	0.9508370682725837	0.9451867737741334	0.6871260677658025	0.7182600570873533	0.9017524081256972	0.6729425791629476	0.9583121988587867	0.9498855742239178	FH	Gln376Pro	NC_000001.11:241502552:T:G	1127A>C	1	241502552	T	G	1	ENSG00000091483	3408	0	CCSBVarC004055	ALE00004055	ENSP00000355518.4	CEGS2	CegsMutGDEh1042	C05	GDEhDisVCh_40065	B09	1	CegsMutGDDh1042	C05	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	51260.0	single nucleotide variant	NM_000143.4(FH):c.1127A>C (p.Gln376Pro)	2271.0	FH	HGNC:3700	Conflicting classifications of pathogenicity	1.0	Mar 27, 2024	200796606.0	-	RCV000034920|RCV000163798|RCV000199873|RCV002280864|RCV004595492	MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0001402,Human Phenotype Ontology:HP:0002899,Human Phenotype Ontology:HP:0003007,Human Phenotype Ontology:HP:0006750,MONDO:MONDO:0007256,MedGen:C2239176,OMIM:114550,Orphanet:88673|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	Fumarase deficiency|Hereditary cancer-predisposing syndrome|not provided|Hepatocellular carcinoma|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	germline;unknown	germline	GRCh38	NC_000001.11	1	241502552.0	241502552.0	1q43	criteria provided, conflicting classifications	11.0	-	N	ClinGen:CA189211	3.0	42094.0	241502552.0	T	G	-	-	-	-	-	-	1127A>C 	Gln376Pro	NM_000143.4	1.0	Conflicting	Conflicting	42094	1	241502552.0	T	G	Q	P	rs200796606	1	241665852	1	239732475	376	FH	ENSG00000091483	ENST00000366560	ENSP00000355518	P07954	FUMH_HUMAN	c.1127A>C	p.Gln376Pro	c.1127A>C	p.Gln376Pro	principal1	Y	1	YES	Select	-	CAG	2	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.55	0.99107	H	-5.97	0.89297	D	0.588	0.60631	0.9801	0.96852	D	0.9899	0.99722	D	10	0.89965594	0.89206	D	0.783004	0.98288	D	0.970	0.99647	.	.	.	.	.	0.988874007372	0.98862	0.9931077487324933	0.99305	1.08544749973	0.77132	0.73917901516	0.72804	T	0.978282	0.99806	D	0.409114	0.90364	D	0.565222	0.95975	D	0.996202170848846	0.88780	D	0.989101	0.96387	D	0.99478674	0.99956	0.97383636	0.99614	0.99478674	0.99956	0.97383636	0.99615	-15.301	0.96526	D	0.89	0.82051	P	0.999990050804425	0.99831	0.96386050	0.94214	0.995	0.99826	.	.	.	.	.	.	4.747101	0.76664	26.5	0.99695009503082266	0.80201	0.750574	0.69053	D	0.94256199435676	0.93648	12.20484	0.851050495351092	0.93038	11.80997	5.96	5.96	0.96689	.	.	2.556	0.45625	7.892000	0.73146	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	975	0.05314	.	.	.	.	.	.	.	.	.	.	.	.	19	264690	7.178209E-5	segdup	7	109398	6.398650e-05	0	12	208098	5.766510e-05	0	15	236884	6.332210e-05	0	1	7164	1.395870e-04	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	1	13394	7.466030e-05	0	5	42768	1.169100e-04	0	0	15688	0.000000e+00	0	1	7164	1.395870e-04	0	1	16218	6.165990e-05	0	0	30502	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	1	16734	5.975860e-05	0	10	89552	1.116670e-04	0	0	30606	0.000000e+00	0	10	89552	1.116670e-04	0	1	14902	6.710510e-05	0	0	34238	0.000000e+00	0	0	9570	0.000000e+00	0	0	17688	0.000000e+00	0	2	21632	9.245560e-05	0	12	102714	1.168290e-04	0	0	30524	0.000000e+00	0	12	102714	1.168290e-04	0	.	75	1614038	4.646730e-05	0	10	64034	1.561670e-04	0	2	74940	2.668800e-05	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29600	0.000000e+00	0	0	44886	0.000000e+00	0	10	64034	1.561670e-04	0	0	6084	0.000000e+00	0	62	1180012	5.254180e-05	0	0	91086	0.000000e+00	0	18	178358	1.0092062032541293E-4	0	352	0	0	2686	0	1	8798	1.1366219595362583E-4	0	796	0	0	968	0	0	652	0	0	280	0	1	13144	7.608034083992696E-5	1	9150	1.092896174863388E-4	0	3338	0	20	206034	9.707135715464438E-5	not_provided|Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|Hepatocellular_carcinoma|Hereditary_leiomyomatosis_and_renal_cell_cancer	criteria_provided,_conflicting_classifications	NC_000001.11:g.241502552T>G	ClinGen:CA189211	C3661900|C0342770|C0027672|C2239176|C1708350	606812|114550|150800	24|140162|88673|523	Fumarate lyase, N-terminal	Gln	Pro	98.7	0.13636363636363635																																																																																																																																																																																																																																																																																																																																																																																																																																																																													27			98.7	Polar/Neutral	Glutamine		Fumarate hydratase, mitochondrial										-3.5			B:Q376-A:N78 (PDBs: 3E04), C:Q376-D:N78 (PDBs: 3E04), A:Q376-B:N78 (PDBs: 3E04), D:Q376-C:N78 (PDBs: 3E04)					 Q376-M380 (PAE:  1.0), Q376-S429 (PAE: 1.0)	Q376-M380 (PDBs: 5D6B, 7LUB), Q376-S429 (PDBs: 5D6B, 5UPP, 7LUB), Q376-N361 (PDBs: 3E04)	 Q376-M380 (PAE:  1.0), Q376-F430 (PAE: 1.0), Q376-S429 (PAE: 1.0)	Q376-M380 (PDBs: 5D6B, 7LUB), Q376-F430 (PDBs: 5D6B, 7LUB), Q376-N433 (PDBs: 5D6B, 7LUB), Q376-S429 (PDBs: 5D6B, 3E04, 5UPP, 7LUB)							146									-68.2				-33.3						H (helix)	H (α-helix)	Helix											98.7	13.636364	>90	10-90	606812;114550;606812;150800	multiple	OMIM	Rare genetic renal disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	6	FUMARASE DEFICIENCY; HEPATOCELLULAR CARCINOMA; FUMARASE DEFICIENCY; HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	false	0.9545746335656853	0.9475361739990256	false	false	false
SHOC2	SHOC2_Glu25Gly	B_13-14	-1.292301105093803	0.23727522836829176	0.31982758375683645	5.585971471324058	0.0008280271369182573	0.0020395030822080566	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6278626062957138	0.639184536370033	0.5506928552658503	0.7000359768676472	0.7564524206566638	0.6409013586571695	0.657920689257234	0.7826396926540184	0.6259217944897832	0.5334442851544641	0.6319198257329204	0.6064643749973093	0.6238820280571048	0.7302651486593092	0.7741501592455111	0.5679414253772366	0.6464492470071458	0.6492608375941183	SHOC2	Glu25Gly	NC_000010.11:110964432:A:G	74A>G	10	110964432	A	G	10	ENSG00000108061	11602	0	CCSBVarC028005	ALE00030466	ENSP00000358464.5																																	49107.0	single nucleotide variant	NM_007373.4(SHOC2):c.74A>G (p.Glu25Gly)	8036.0	SHOC2	HGNC:15454	Conflicting classifications of pathogenicity	0.0	Jan 29, 2024	730881019.0	-	RCV000159109|RCV000799563|RCV001004912|RCV000766822|RCV001261147|RCV001813276|RCV002390134	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MedGen:CN230736	not specified|RASopathy|Noonan syndrome-like disorder with loose anagen hair 1|not provided|Noonan syndrome|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000010.11	10	110964432.0	110964432.0	10q25.2	criteria provided, conflicting classifications	8.0	-	N	ClinGen:CA297172	2.0	40637.0	110964432.0	A	G	-	-	-	-	-	-	74A>G 	Glu25Gly	NM_007373.4	1.0	Conflicting	Conflicting	40637	10	110964432.0	A	G	E	G	rs730881019	10	112724190	10	112714180	25	SHOC2	ENSG00000108061	ENST00000691441	ENSP00000509686	Q9UQ13	SHOC2_HUMAN	.	.	c.74A>G	p.Glu25Gly	principal1	Y	.	.	.	+	GAA	2	0	A	A/A	A/A	A/A	A/A	.	0.49772	.	.	0.17349	.	0.155	0.30905	B	0.034	0.28329	B	.	0.69040	.	.	.	.	1.39	0.34781	L	.	0.14906	.	.	0.36225	-0.0194	0.81770	T	0.5438	0.83150	D	10	.	0.33747	.	0.063998	0.69032	D	.	0.64132	.	.	.	.	.	.	0.64350	.	0.07071	.	0.55333	0.767608106136	0.77026	T	0.188055	0.53960	T	0.140859	0.68178	D	0.169108	0.81220	D	0.0988420369111373	0.12074	T	.	0.70456	.	0.14603361	0.33168	0.1844349	0.41354	0.14603361	0.33167	0.1844349	0.41353	-4.653	0.32868	T	.	0.32853	.	0.832521291895995	0.72245	0.04450221	0.58250	0.292	0.56112	.	.	.	.	.	.	3.49988	0.49041	22.7	0.99728934202578479	0.82636	0.924804	0.90303	D	0.0860024101187209	0.45554	2.831403	0.319788099809874	0.56475	3.834094	5.99	5.99	0.97294	.	.	8.218	0.89747	11.206000	0.89238	0.751	0.87726	1.0	0.71675	1.000000	0.68239	1.0	0.97202	914	0.21043	.	.	.	.	.	.	.	.	.	.	.	.	28	264690	1.0578412E-4	.	5	109080	4.583790e-05	0	12	207202	5.791450e-05	0	13	235512	5.519890e-05	0	0	7148	0.000000e+00	0	1	16982	5.888590e-05	0	0	2316	0.000000e+00	0	0	8992	0.000000e+00	0	0	13390	0.000000e+00	0	4	42714	9.364610e-05	0	0	15632	0.000000e+00	0	4	42714	9.364610e-05	0	0	16084	0.000000e+00	0	1	30318	3.298370e-05	0	0	6186	0.000000e+00	0	0	13394	0.000000e+00	0	0	16712	0.000000e+00	0	10	89208	1.120980e-04	0	0	30476	0.000000e+00	0	10	89208	1.120980e-04	0	0	14794	0.000000e+00	0	1	34044	2.937380e-05	0	0	9532	0.000000e+00	0	0	17530	0.000000e+00	0	0	21604	0.000000e+00	0	11	102050	1.077900e-04	0	0	30394	0.000000e+00	0	11	102050	1.077900e-04	0	.	134	1613228	8.306330e-05	2	8	6080	1.315790e-03	1	1	74766	1.337510e-05	0	0	912	0.000000e+00	0	5	59788	8.362880e-05	0	0	29580	0.000000e+00	0	0	44896	0.000000e+00	0	0	64014	0.000000e+00	0	8	6080	1.315790e-03	1	110	1179872	9.323050e-05	1	0	90898	0.000000e+00	0	6	47002	1.2765414237692014E-4	0	306	0	0	112	0	1	7978	1.25344697919278E-4	0	500	0	0	628	0	0	56	0	0	98	0	0	8270	0	1	8284	1.2071463061323032E-4	0	168	0	7	64950	1.077752117013087E-4	Noonan_syndrome|Cardiovascular_phenotype|Noonan_syndrome_and_Noonan-related_syndrome|not_specified|RASopathy|not_provided|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1	criteria_provided,_conflicting_classifications	NC_000010.11:g.110964432A>G	ClinGen:CA297172	C0028326|CN230736|C5681679|CN169374|C5555857|C3661900|C4478716	PS163950|607721	648|98733|536391|2701	.	Glu	Gly	42.5	0.8041237113402062																																																																																																																																																																																																																																																																																																																																																																																																																																																																													156			42.5	Negatively-charged	Glutamic Acid		Leucine-rich repeat protein SHOC-2		Basic and acidic residues								-3.5																		146									-98.9				-4.6	Disordered					C (loop/coil)	T (turn)												42.5	80.41237	$\leqslant$50	10-90	607721	unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic developmental defect during embryogenesis; RASopathy; Rare genetic skin disease	5	NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1	false	0.639184536370033	0.6278626062957138	false	false	false
RAD51D	RAD51D_Val66Leu	B_13-14	3.332290913702663	0.01255158257903223	0.032309952520234296	1.1583845273616833	0.2846957175886964	0.3366086609376661	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7276372801440754	0.7362017159147797	0.5577562481555545	0.7620581256061227	0.6971861100412795	0.6038194527633556	0.7424625414251066	0.8240042867292163	0.8630985867235124	0.6269184337899861	0.8028759748563403	0.7916528678884659	0.4651763641016047	0.5703679333533427	0.6610176644887332	0.4885940625211228	0.669527456973219	0.6636216923996849	RAD51D	Val66Leu	NC_000017.11:35118568:C:A	196G>T	17	35118568	C	A	17	ENSG00000185379	7201	0	CCSBVarC024807	ALE00021596	ENSP00000338790.6																																	409903.0	single nucleotide variant	NM_002878.4(RAD51D):c.196G>T (p.Val66Leu)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Aug 10, 2023	56026142.0	-	RCV000484401|RCV001373871|RCV001524373	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	35118568.0	35118568.0	17q12	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA16620388	2.0	419663.0	35118568.0	C	A	-	-	-	-	-	-	196G>T 	Val66Leu	NM_002878.4	1.0	Conflicting	Conflicting	419663	17	35118568.0	C	A	V	L	rs56026142	17	33445587	17	30469700	66	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.196G>T	p.Val66Leu	c.196G>T	p.Val66Leu	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.831	0.13644	T	0.486	0.11871	T	0.0	0.02950	B	0.004	0.10086	B	0.06	0.18971	N	simple_aae	94.0	6.0	-0.185	0.04240	N	0.04	0.06455	N	0.164	0.17177	-1.0483	0.14873	T	0.0520	0.21919	T	10	0.057495058	0.06602	T	0.008992	0.23404	T	0.048	0.13183	0.513	0.61027	O75771	V66L	Gain of helix (P = 0.1736)| Loss of sheet (P = 0.1907)| Loss of catalytic residue at V66 (P = 0.2378)| Gain of disorder (P = 0.3398)| Gain of loop (P = 0.3485)	0.394990421082	0.38713	.	.	.	.	.	.	.	0.112411	0.42566	T	-0.25802	0.12873	T	-0.608404	0.11857	T	0.170912176370621	0.18410	T	.	0.24645	.	0.08530245	0.19601	0.0358917	0.02939	0.08530245	0.19601	0.0358917	0.02939	-4.193	0.26677	T	0.1367	0.29891	LB	1.88384050960672e-05	0.00991	0.78514117	0.87977	0.009	0.00522	.	.	.	.	.	.	0.314705	0.06924	3.434	0.81722106588712895	0.14047	0.088102	0.17661	N	-1.34751807488594	0.03118	0.1402777	-1.22328831331821	0.05450	0.2641167	4.79	-0.163	0.12675	-5.85	0.03264	0.004	0.13047	0.681000	0.20762	-1.926	0.00504	0.001	0.13799	0.444000	0.24998	0.443	0.27788	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614178	1.239020e-06	0	1	75058	1.332300e-05	0	1	75058	1.332300e-05	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29608	0.000000e+00	0	0	44872	0.000000e+00	0	0	64024	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180038	0.000000e+00	0	0	91078	0.000000e+00	0	0	153016	0	0	176	0	0	4498	0	0	4724	0	0	442	0	0	950	0	0	1848	0	0	280	0	0	11718	0	0	4900	0	0	6346	0	0	177652	0	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118568C>A	ClinGen:CA16620388	C3661900|C0027672|C3280345	614291	140162|145	.	Val	Leu	87.61	0.647887323943662																																																																																																																																																																																																																																																																																																																																																																																																																																																																													92			87.61	Aliphatic	Valine		DNA repair protein RAD51 homolog 4										4.2			D:V66-X:L117 (PDBs: 8FAZ, 8GBJ), C:V66-D:L117 (PDBs: 8OUY, 8OUZ)	D:V66-X:L117 (PDBs: 8FAZ, 8GBJ), C:V66-D:L117 (PDBs: 8OUY, 8OUZ), C:V66-D:F116 (PDBs: 8OUZ)														117									-109.1				144.7	preferentially binds ssDNA					C (loop/coil)	C (loop/coil)												87.61	64.788734	70-90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.7362017159147797	0.7276372801440754	false	false	false
RAD51D	RAD51D_Glu307Lys	B_13-14	-3.404294044082903	0.011375795993745073	0.029886891813002876	1.7479318109350837	0.12396650632555821	0.16042210092200235	2025_01_Batch_13-14	false	false	true	true	true	true	false	false	false	true	false	false	0.947796495826344	0.966678823765095	0.9236520181775864	0.9701967023826694	0.9377763693473753	0.9605552620871296	0.9947434021966698	0.9496696131260988	0.9677618001502153	0.9790818763431712	0.948891923308374	0.9139052066076926	0.9263671219775893	0.9258831255686518	0.9726316046151234	0.8682221600120015	0.9844657242218158	0.9816877850449953	RAD51D	Glu307Lys	NC_000017.11:35101021:C:T	919G>A	17	35101021	C	T	17	ENSG00000185379	7201	0	CCSBVarC024889	ALE00029718	ENSP00000338790.6																																	133352.0	single nucleotide variant	NM_002878.4(RAD51D):c.919G>A (p.Glu307Lys)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Sep 11, 2024	115031549.0	-	RCV000115821|RCV000212975|RCV000656966|RCV000989829|RCV001354385|RCV003905100|RCV003149803|RCV004700423	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142||MedGen:CN221562|MedGen:C1333600	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Malignant tumor of breast|RAD51D-related disorder|Breast and/or ovarian cancer|Hereditary cancer	germline;unknown	germline	GRCh38	NC_000017.11	17	35101021.0	35101021.0	17q12	criteria provided, conflicting classifications	12.0	-	N	ClinGen:CA287990	2.0	127895.0	35101021.0	C	T	-	-	-	-	-	-	919G>A 	Glu307Lys	NM_002878.4	1.0	Conflicting	Conflicting	127895	17	35101021.0	C	T	E	K	rs115031549	17	33428040	17	30452153	307	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.919G>A	p.Glu307Lys	c.919G>A	p.Glu307Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	C/C	C/C	C/C	C/C	0.178	0.22252	T	1.0	0.28071	T	0.001	0.15546	B	0.003	0.17739	B	0.04	0.16373	N	simple_aae	96.0	4.0	0.975	0.24371	L	-1.37	0.33974	N	0.183	0.40913	-1.0750	0.08363	T	0.0695	0.28228	T	10	0.005851954	0.00128	T	0.009794	0.25268	T	0.146	0.38573	.	.	.	.	.	0.607307720492	0.60114	.	0.58340	.	0.10516	.	.	.	0.12397	0.44563	T	-0.436555	0.01267	T	-0.402908	0.32684	T	0.0220424253485093	0.00910	T	.	0.44143	.	0.06279154	0.13032	0.07841017	0.17544	0.06279154	0.13031	0.07841017	0.17544	-3.296	0.19068	T	0.2196	0.48302	LB	0.00210343958860793	0.13347	0.64807075	0.84992	0.024	0.04173	.	.	.	.	.	.	2.74903	0.36098	20.1	0.95388473665255458	0.27048	0.227759	0.34944	N	-0.451516097100692	0.23421	1.273859	-0.296002730575465	0.27912	1.572344	5.16	4.19	0.48586	1.06	0.29739	2.03	0.40832	4.830000	0.45268	-0.187	0.09644	1.0	0.71675	1.000000	0.68239	0.789	0.37304	913	0.21155	3	5.990415335463259E-4	3	0.0022692889561270802	0	0.0	0	0.0	0	0.0	0	0.0	238	264690	8.9916505E-4	.	20	109408	1.828020e-04	0	55	208134	2.642530e-04	0	56	236948	2.363390e-04	0	17	7164	2.372980e-03	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	17	7164	2.372980e-03	0	46	16218	2.836350e-03	0	8	30524	2.620890e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89556	0.000000e+00	0	0	30608	0.000000e+00	0	46	16218	2.836350e-03	0	45	14902	3.019730e-03	0	9	34260	2.626970e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	0	102744	0.000000e+00	0	0	30526	0.000000e+00	0	45	14902	3.019730e-03	0	.	251	1613792	1.555340e-04	2	217	75054	2.891250e-03	2	217	75054	2.891250e-03	2	0	912	0.000000e+00	0	20	60010	3.332780e-04	0	0	29602	0.000000e+00	0	0	44888	0.000000e+00	0	0	64046	0.000000e+00	0	0	6062	0.000000e+00	0	3	1179658	2.543110e-06	0	0	91070	0.000000e+00	0	1	167370	5.9747864013861505E-6	3	362	0.008287292817679558	0	4488	0	28	8974	0.0031201248049922	0	460	0	0	1024	0	0	1820	0	0	296	0	0	11378	0	31	9336	0.0033204798628963155	0	6308	0	32	196172	1.6312215810615173E-4	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|RAD51D-related_disorder	criteria_provided,_conflicting_classifications	NC_000017.11:g.35101021C>T	ClinGen:CA287990	C0027672|CN169374|C3661900|C3280345|C0006142|CN221562	614291	140162|145	.	Glu	Lys	93.44	0.17525773195876287																																																																																																																																																																																																																																																																																																																																																																																																																																																																													34			93.44	Negatively-charged	Glutamic Acid		DNA repair protein RAD51 homolog 4										-3.5								 E307-K91 (PAE:  2.0), E307-A293 (PAE: 1.0)	E307-A293 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ)	 E307-A293 (PAE:  1.0)	E307-M292 (PDBs: 8FAZ, 8GBJ, 8OUZ), E307-L92 (PDBs: 8OUY, 8OUZ), E307-A293 (PDBs: 8OUZ)							146									-137.1				145.0						B (undefined)	E (parallel sheets)	Beta strand											93.44	17.525772	>90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.966678823765095	0.947796495826344	false	false	false
RET	RET_Val262Ala	B_13-14	-0.24949633256160386	0.8101398810197044	0.8488026180733051	4.25267392896843	0.003780624659097835	0.007333452694973074	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9084225330984834	0.8931344912774128	0.6239990900488173	0.7029849201195603	0.6688924437896111	0.70174764052372	0.8357196153649411	0.7173726574993111	0.8603979895291369	0.7204916480861477	0.9191310295898669	0.9403048114032468	0.5677756656824989	0.6204122300799112	0.5455718507099836	0.5275065320114867	0.8671379529649588	0.87654025479372	RET	Val262Ala	NC_000010.11:43105111:T:C	785T>C	10	43105111	T	C	10	ENSG00000165731	8858	0	CCSBVarC006876	ALE00006874	ENSP00000480088.1	CEGS2	CegsMutGDEh1029	C02	GDEhDisVCh_40066	C06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	50284.0	single nucleotide variant	NM_020975.6(RET):c.785T>C (p.Val262Ala)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Apr 09, 2024	139790943.0	-	RCV000034777|RCV000148775|RCV000223157|RCV000123327|RCV000573525|RCV001103897|RCV001104177|RCV000663296|RCV001103896|RCV001103898|RCV001269367|RCV004528165	MedGen:C3661900|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MedGen:CN169374|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0007254,MedGen:C0006142|	not provided|Aganglionic megacolon|not specified|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Multiple endocrine neoplasia|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Malignant tumor of breast|RET-related disorder	germline;unknown	germline	GRCh38	NC_000010.11	10	43105111.0	43105111.0	10q11.21	criteria provided, conflicting classifications	17.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009350	2.0	41845.0	43105111.0	T	C	-	-	-	-	-	-	785T>C 	Val262Ala	NM_020975.6	1.0	Conflicting	Conflicting	41845	10	43105111.0	T	C	V	A	rs139790943	10	43600559	10	42920565	262	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.785T>C	p.Val262Ala	c.785T>C	p.Val262Ala	principal4	Y	5	YES	Select	+	GTG	2	0	T	T/T	T/T	T/T	T/T	0.002	0.72322	D	0.011	0.65108	D	0.676	0.41333	P	0.568	0.49805	P	0.6	0.76851	D	simple_aae	40.0	60.0	2.325	0.66439	M	-2.44	0.53442	N	0.4	0.94561	0.2692	0.87004	D	0.6452	0.87575	D	10	0.23900184	0.40642	T	0.269317	0.89793	D	0.748	0.91294	.	.	.	.	.	0.986075961623	0.98577	0.9449520661963712	0.94443	1.39902537186	0.85084	0.654298603535	0.60534	T	0.747582	0.92993	D	0.147568	0.68816	D	0.296161	0.87936	D	0.110290273663753	0.13282	T	0.812119	0.46196	T	0.6398909	0.74551	0.46798772	0.68880	0.7156541	0.78674	0.51304674	0.71604	-11.708	0.84188	D	0.7004	0.80456	P	0.998087980433202	0.93939	0.99988472	0.99849	0.487	0.70601	.	.	.	.	.	.	5.265842	0.88433	29.6	0.99080146142778192	0.52036	0.704574	0.65902	D	0.206366859142037	0.51267	3.331407	0.220349645155146	0.50723	3.284379	4.79	3.64	0.40795	3.23	0.58548	5.516	0.66847	7.817000	0.69666	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.946	0.49004	862	0.33096	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	67	264690	2.531263E-4	.	21	108014	1.944190e-04	0	57	203892	2.795600e-04	0	56	233278	2.400570e-04	0	0	6988	0.000000e+00	0	1	17006	5.880280e-05	0	0	2296	0.000000e+00	0	0	8944	0.000000e+00	0	2	12800	1.562500e-04	0	10	42450	2.355710e-04	0	7	15644	4.474560e-04	0	7	15644	4.474560e-04	0	1	15892	6.292470e-05	0	2	30354	6.588920e-05	0	1	6138	1.629200e-04	0	0	13250	0.000000e+00	0	2	16134	1.239620e-04	0	33	86794	3.802110e-04	0	13	30536	4.257270e-04	0	13	30536	4.257270e-04	0	1	14656	6.823140e-05	0	3	34114	8.794040e-05	0	1	9526	1.049760e-04	0	0	17590	0.000000e+00	0	2	20676	9.673050e-05	0	32	100690	3.178070e-04	0	13	30462	4.267610e-04	0	13	30462	4.267610e-04	0	.	347	1612474	2.151970e-04	2	38	6044	6.287230e-03	2	7	74994	9.334080e-05	0	1	912	1.096490e-03	0	11	59988	1.833700e-04	0	2	29562	6.765440e-05	0	0	44818	0.000000e+00	0	3	62808	4.776460e-05	0	38	6044	6.287230e-03	2	229	1179820	1.940970e-04	0	34	91062	3.733720e-04	0	19	38968	4.87579552453295E-4	0	122	0	0	112	0	1	3452	2.8968713789107763E-4	0	498	0	0	628	0	0	56	0	0	98	0	6	7306	8.212428141253764E-4	1	3574	2.797985450475658E-4	0	168	0	26	51240	5.07416081186573E-4	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon|RET-related_disorder|not_provided|not_specified|Pheochromocytoma	criteria_provided,_conflicting_classifications	NC_000010.11:g.43105111T>C	ClinGen:CA009350	C1619700|C0027662|C4048306|C0027672|C0006142|C0025268|C3888239|C0019569|C3661900|CN169374|C0031511	191830|PS131100|171400|142623|PS142623|171300	411709|276161|653|140162|247698|653|388|388|29072	Cadherin-like	Val	Ala	94.03	0.007042253521126761																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			94.03	Aliphatic	Valine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment							Cadherin			4.2								 V262-E235 (PAE:  1.0)	V262-E235 (PDBs: 6Q2J, 6Q2O, 6Q2R, 6Q2S)	 V262-E235 (PAE:  1.0)	V262-E235 (PDBs: 6Q2J, 6Q2N, 6Q2O, 6Q2R, 6Q2S)							117									-82.8				134.2						B (undefined)	E (parallel sheets)	Beta strand						Extracellular					94.03	0.70422536	>90	<10	171300;171400;142623;191830	multiple	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	PHEOCHROMOCYTOMA; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; RENAL HYPODYSPLASIA/APLASIA 1	false	0.8931344912774128	0.9084225330984834	false	false	false
RAD51D	RAD51D_Cys9Ser	B_13-14	-0.430044793701963	0.6800918575546037	0.7461088155825922	10.929112713093579	0.000011876471256007736	0.00008382047982605459	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9049574675140837	0.9073692253989714	0.7319764168095583	0.8277857111665244	0.782147335139821	0.7658774714186023	0.6361546962702989	0.7370386782602983	0.7393153729443578	0.6288316240825861	0.8858011489836484	0.8835165680233084	0.8956002465669058	0.8272559920193437	0.9162560493886911	0.8351212095365305	0.9289373018142942	0.9263983670048591	RAD51D	Cys9Ser	NC_000017.11:35119588:C:G	26G>C	17	35119588	C	G	17	ENSG00000185379	7201	0	CCSBVarC024707	ALE00029715	ENSP00000338790.6																																	133343.0	single nucleotide variant	NM_002878.4(RAD51D):c.26G>C (p.Cys9Ser)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Nov 18, 2024	140825795.0	-	RCV000115812|RCV000587404|RCV000231466|RCV003492494|RCV001798342|RCV003389691|RCV001175378|RCV001357793	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C1333600|MedGen:CN221562||MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer|Breast and/or ovarian cancer|RAD51D-related disorder|not specified|Malignant tumor of breast	germline;unknown	germline	GRCh38	NC_000017.11	17	35119588.0	35119588.0	17q12	criteria provided, conflicting classifications	20.0	-	N	ClinGen:CA287968	2.0	127886.0	35119588.0	C	G	-	-	-	-	-	-	26G>C 	Cys9Ser	NM_002878.4	1.0	Conflicting	Conflicting	127886	17	35119588.0	C	G	C	S	rs140825795	17	33446607	17	30470720	9	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.26G>C	p.Cys9Ser	c.26G>C	p.Cys9Ser	principal1	Y	5	.	.	-	TGC	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.005	0.79703	D	0.948	0.77914	P	0.539	0.82066	P	0.0	0.33788	N	simple_aae	100.0	0.0	2.37	0.68084	M	-5.89	0.91889	D	0.767	0.76382	-0.5618	0.66187	T	0.3025	0.67215	T	10	0.23021111	0.39578	T	0.269442	0.89798	D	0.218	0.51046	0.75	0.88011	O75771	C9S	Gain of disorder (P = 0.0024)| Gain of phosphorylation at C9 (P = 0.0829)| Gain of methylation at R5 (P = 0.2031)| Gain of helix (P = 0.2294)| Gain of catalytic residue at G7 (P = 0.288)	0.89673440463	0.89492	.	0.75662	.	0.38233	.	.	.	0.542336	0.84209	D	-0.0621782	0.42220	T	0.0874681	0.75898	D	0.123274603139513	0.14560	T	0.89681	0.63880	D	0.90909326	0.92096	0.91432685	0.95940	0.9053122	0.91745	0.9265354	0.96810	-13.828	0.92500	D	0.7562	0.75474	P	0.0197165020029777	0.29331	0.98283120	0.95814	0.694	0.83023	.	.	.	.	.	.	4.809918	0.78275	26.9	0.99055369264790372	0.51428	0.811646	0.73360	D	0.419960104252545	0.62325	4.469254	0.393835298150661	0.60976	4.315044	4.5	4.5	0.54328	.	.	3.449	0.52806	7.405000	0.58667	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.842	0.39783	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	112	264690	4.231365E-4	.	27	108026	2.499400e-04	1	83	204386	4.060940e-04	1	81	233462	3.469520e-04	1	0	7118	0.000000e+00	0	6	17088	3.511240e-04	1	0	2320	0.000000e+00	0	0	9008	0.000000e+00	0	1	12198	8.198070e-05	0	20	42712	4.682520e-04	0	0	15682	0.000000e+00	0	20	42712	4.682520e-04	0	1	16132	6.198860e-05	0	12	30494	3.935200e-04	1	0	6188	0.000000e+00	0	0	13354	0.000000e+00	0	1	15538	6.435830e-05	0	68	87248	7.793870e-04	0	0	30600	0.000000e+00	0	68	87248	7.793870e-04	0	1	14856	6.731290e-05	0	13	34236	3.797170e-04	1	0	9562	0.000000e+00	0	0	17654	0.000000e+00	0	1	20436	4.893330e-05	0	64	100606	6.361450e-04	0	0	30518	0.000000e+00	0	64	100606	6.361450e-04	0	.	1058	1612440	6.561480e-04	1	980	1179946	8.305460e-04	0	12	75044	1.599060e-04	0	0	912	0.000000e+00	0	15	60030	2.498750e-04	1	0	29602	0.000000e+00	0	0	44872	0.000000e+00	0	2	62412	3.204510e-05	0	0	6062	0.000000e+00	0	980	1179946	8.305460e-04	0	0	91086	0.000000e+00	0	56	93168	6.010647432594882E-4	0	174	0	0	2674	0	0	4182	0	1	772	0.0012953367875647669	0	946	0	0	656	0	0	274	0	3	7122	4.2122999157540015E-4	0	4356	0	0	3330	0	60	109968	5.456132693147098E-4	Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided|RAD51D-related_disorder	criteria_provided,_conflicting_classifications	NC_000017.11:g.35119588C>G	ClinGen:CA287968	C0006142|CN221562|C3280345|C1333600|CN169374|C0027672|C3661900	614291	145|140162	RAD51D, N-terminal domain	Cys	Ser	80.18	0.05185185185185185																																																																																																																																																																																																																																																																																																																																																																																																																																																																													7			80.18	Special, a very reactive sulfhydryl group	Cysteine		DNA repair protein RAD51 homolog 4										2.5									C9-Q60 (PDBs: 8FAZ)		C9-L57 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ)							121									-149.0				157.1	preferentially binds ssDNA					C (loop/coil)	S (bend)												80.18	5.185185	70-90	<10	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.9073692253989714	0.9049574675140837	false	false	false
RET	RET_Thr338Ile	B_13-14	-1.424602819963752	0.19729169514798545	0.2781012086587839	0.29048171550285723	0.7798649762322163	0.8191483865976629	2025_01_Batch_13-14	false	false	true	false	false	true	false	false	false	false	false	false	0.771221700930397	0.7540413719366321	0.8604451579298633	0.75333539940088	0.8005212234345249	0.9182475041619986	0.9163992175366243	0.7063968804976237	0.5897163626255166	0.8983295445632536	0.6620512738652683	0.6779723622549312	0.920095790787373	0.8946455663714262	0.9169544361762433	0.8225607712964729	0.8460314700079961	0.8644710396058628	RET	Thr338Ile	NC_000010.11:43106521:C:T	1013C>T	10	43106521	C	T	10	ENSG00000165731	8858	0	CCSBVarC006878	ALE00006876	ENSP00000480088.1	CEGS2	CegsMutGDEh1025	A12	GDEhDisVCh_40066	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	47198.0	single nucleotide variant	NM_020975.6(RET):c.1013C>T (p.Thr338Ile)	5979.0	RET	HGNC:9967	Conflicting classifications of pathogenicity	0.0	Mar 13, 2024	377767433.0	-	RCV001262456|RCV000709106|RCV000570795|RCV001046577|RCV004566792|RCV004700294	MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900	Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000010.11	10	43106521.0	43106521.0	10q11.21	criteria provided, conflicting classifications	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA007399	2.0	38594.0	43106521.0	C	T	-	-	-	-	-	-	1013C>T 	Thr338Ile	NM_020975.6	1.0	Conflicting	Conflicting	38594	10	43106521.0	C	T	T	I	rs377767433	10	43601969	10	42921975	338	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.1013C>T	p.Thr338Ile	c.1013C>T	p.Thr338Ile	principal4	Y	5	YES	Select	+	ACC	2	0	C	C/C	C/C	C/C	C/C	0.478	0.08337	T	0.239	0.24837	T	0.017	0.24484	B	0.007	0.19965	B	0.91	0.92786	D	simple_aae	9.0	91.0	2.135	0.59336	M	-0.16	0.09401	N	0.235	0.30814	-0.8203	0.53729	T	0.2905	0.66078	T	10	0.2821769	0.45410	D	0.028251	0.50756	D	0.410	0.72027	0.755	0.88426	P07949	T338I	Loss of disorder (P = 0.0525)| Gain of catalytic residue at A342 (P = 0.1324)| Gain of sheet (P = 0.1945)| Gain of MoRF binding (P = 0.2848)| Loss of loop (P = 0.2897)	0.981789031089	0.98140	0.6790319585223052	0.67683	0.218286694533	0.24083	0.481091409922	0.36160	T	0.376246	0.73794	T	0.151122	0.69149	D	0.135665	0.79109	D	0.17234893143177	0.18506	T	0.726327	0.33844	T	0.14303645	0.32613	0.08598992	0.19866	0.099525385	0.23277	0.08741958	0.20292	-7.255	0.55945	T	0.3018	0.55809	B	0.094241815648635	0.42787	0.99947983	0.99419	0.065	0.18082	.	.	.	.	.	.	2.501402	0.32347	19.0	0.98805091438726533	0.46629	0.155931	0.27906	N	-0.117237538328119	0.36368	2.120756	0.048901495971743	0.41733	2.534287	5.32	5.32	0.75341	4.24	0.80495	1.993	0.40471	4.824000	0.45219	0.599	0.40292	0.974	0.34718	1.000000	0.68239	0.734	0.35269	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	6	109044	5.502370e-05	0	4	206970	1.932650e-05	0	8	235572	3.395990e-05	0	0	7096	0.000000e+00	0	0	17042	0.000000e+00	0	0	2312	0.000000e+00	0	0	9024	0.000000e+00	0	0	13372	0.000000e+00	0	6	42620	1.407790e-04	0	0	15670	0.000000e+00	0	6	42620	1.407790e-04	0	0	16044	0.000000e+00	0	0	30424	0.000000e+00	0	0	6182	0.000000e+00	0	0	13366	0.000000e+00	0	0	16712	0.000000e+00	0	4	88828	4.503080e-05	0	0	30574	0.000000e+00	0	4	88828	4.503080e-05	0	0	14776	0.000000e+00	0	0	34164	0.000000e+00	0	0	9550	0.000000e+00	0	0	17668	0.000000e+00	0	0	21236	0.000000e+00	0	8	102092	7.836070e-05	0	0	30494	0.000000e+00	0	8	102092	7.836070e-05	0	.	31	1613700	1.921050e-05	0	2	6078	3.290560e-04	0	0	74914	0.000000e+00	0	0	912	0.000000e+00	0	0	59994	0.000000e+00	0	0	29596	0.000000e+00	0	0	44888	0.000000e+00	0	0	63946	0.000000e+00	0	2	6078	3.290560e-04	0	28	1179836	2.373210e-05	0	1	91072	1.098030e-05	0	0	26588	0	0	114	0	0	86	0	0	3230	0	0	500	0	0	628	0	0	26	0	0	98	0	1	4640	2.1551724137931034E-4	0	3344	0	0	112	0	1	35910	2.78473962684489E-5	Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hirschsprung_disease,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000010.11:g.43106521C>T	ClinGen:CA007399	C4048306|C0027672|C0025268|C0025269|C3888239	171400|162300|142623	653|140162|247698|653|247709|653|388	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Thr	Ile	87.78	0.34507042253521125																																																																																																																																																																																																																																																																																																																																																																																																																																																																													49			87.78	Polar/Neutral	Threonine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-0.7								 T338-A349 (PAE:  1.0)	T338-E332 (PDBs: 6GL7), T338-A349 (PDBs: 6Q2J, 6Q2N, 6Q2O, 6Q2R, 6Q2S)	 T338-A349 (PAE:  1.0)	T338-E332 (PDBs: 6GL7), T338-A349 (PDBs: 6Q2J, 6Q2N, 6Q2O, 6Q2R, 6Q2S)							119									-133.9				154.0	Cadherin-like region 3 (CLD3)					B (undefined)	E (parallel sheets)							Extracellular					87.78	34.507042	70-90	10-90	162300;171400;142623	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	false	0.7540413719366321	0.771221700930397	false	false	false
SDHD	SDHD_Ser68Gly	B_13-14	6.045343083600106	0.0007737129719721013	0.0036499605032911256	3.271765987790615	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7942591537207393	0.8184679282035277	0.7222064897117912	0.8346376935138795	0.8384612148701542	0.7986032671319232	0.8185179546459311	0.8749112265090887	0.8593224908214592	0.7519338964542844	0.8249255611673767	0.7923833425101778	0.7786885796179153	0.8020112032312199	0.8099528962063	0.6924790829692982	0.8120102952396787	0.7961349649313008	SDHD	Ser68Gly	NC_000011.10:112088899:A:G	202A>G	11	112088899	A	G	11	ENSG00000204370	6363	0	CCSBVarC023282	ALE00034646	ENSP00000364699.3																																	1685180.0	single nucleotide variant	NM_003002.4(SDHD):c.202A>G (p.Ser68Gly)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Apr 16, 2024	2135269276.0	-	RCV002257333|RCV004804413	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma	germline	germline	GRCh38	NC_000011.10	11	112088899.0	112088899.0	11q23.1	criteria provided, conflicting classifications	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	-	2.0	1692740.0	112088899.0	A	G	-	-	-	-	-	-	202A>G 	Ser68Gly	NM_003002.4	1.0	Conflicting	Conflicting	1692740	11	112088899.0	A	G	S	G	rs2135269276	11	111959623	11	111464833	68	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.202A>G	p.Ser68Gly	c.202A>G	p.Ser68Gly	principal1	Y	1	YES	Select	+	AGC	1	0	A	./.	./.	./.	./.	0.976	0.05990	T	0.707	0.07740	T	0.001	0.07480	B	0.001	0.04348	B	0.13	0.33788	N	simple_aae	87.0	13.0	0.415	0.12397	N	-1.06	0.30311	N	0.309	0.34641	0.1300	0.84642	D	0.6363	0.87225	D	10	0.27792534	0.44975	D	0.027744	0.50323	D	0.589	0.83500	0.323	0.30252	O14521	S68G	Loss of disorder (P = 0.1141)| Loss of stability (P = 0.2528)| Loss of phosphorylation at S68 (P = 0.2631)| Gain of catalytic residue at T67 (P = 0.2736)| Loss of loop (P = 0.2897)	0.983747050717	0.98339	0.6418887932230426	0.63954	0.171667858329	0.19059	0.347676306963	0.17562	T	0.705796	0.91487	D	0.153806	0.69403	D	-0.016845	0.69011	D	0.118915073573589	0.14142	T	0.819918	0.49610	T	0.04305329	0.06580	0.04685765	0.06638	0.04305329	0.06580	0.04685765	0.06637	-1.587	0.38256	T	0.0495	0.00860	B	0.109295900523767	0.44137	0.97679627	0.95218	0.145	0.37545	.	.	.	.	.	.	1.080037	0.1465	11.19	0.73018468418494142	0.10342	0.321938	0.42266	N	-0.922609032286981	0.10190	0.4922996	-0.794832955240867	0.14373	0.7649354	5.04	-5.0	0.02780	.	.	0.898	0.2813	1.446000	0.26652	0.691	0.84104	0.885	0.31181	0.972000	0.29889	0.998	0.85369	637	0.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612668	6.200900e-07	0	1	91012	1.098760e-05	0	0	74984	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29606	0.000000e+00	0	0	44870	0.000000e+00	0	0	64046	0.000000e+00	0	0	4916	0.000000e+00	0	0	1179934	0.000000e+00	0	1	91012	1.098760e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000011.10:g.112088899A>G	.	C0027672	.	140162	.	Ser	Gly	98.25	0.38461538461538464																																																																																																																																																																																																																																																																																																																																																																																																																																																																													50			98.25	Polar/Neutral	Serine		Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial										-0.8								 S68-L64 (PAE:  1.0), S68-V72 (PAE: 1.0)	S68-L64 (PDBs: 8GS8), S68-V72 (PDBs: 8GS8)	 S68-L64 (PAE:  1.0), S68-V72 (PAE: 1.0)	S68-L64 (PDBs: 8GS8), S68-V72 (PDBs: 8GS8)							105									-60.1				-41.2						H (helix)	H (α-helix)	Helix								Helical			98.25	38.46154	>90	10-90		unknown		Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7		false	0.8184679282035277	0.7942591537207393	false	false	false
RAD51D	RAD51D_Arg55Trp	B_13-14	1.021432754244928	0.341046466783239	0.4316757796925027	0.5813170207797926	0.5792556789010563	0.6289551306410878	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7244478921697051	0.7189520173770886	0.5230778494168975	0.6375355986866804	0.6883497721011159	0.5581514984268736	0.5721343443178734	0.7139633206952738	0.6310496254617887	0.5361855083000576	0.7300006182272865	0.7414513142729353	0.544168652535874	0.662736223506958	0.6440215719115723	0.5099701905337373	0.7079034165268907	0.7074444700664747	RAD51D	Arg55Trp	NC_000017.11:35118601:G:A	163C>T	17	35118601	G	A	17	ENSG00000185379	7201	0	CCSBVarC024799	ALE00030574	ENSP00000338790.6																																	235907.0	single nucleotide variant	NM_002878.4(RAD51D):c.163C>T (p.Arg55Trp)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	Jan 18, 2024	775268017.0	-	RCV000222465|RCV000555250|RCV001547298|RCV002229933	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	35118601.0	35118601.0	17q12	criteria provided, conflicting classifications	9.0	-	N	ClinGen:CA8499638	2.0	230594.0	35118601.0	G	A	-	-	-	-	-	-	163C>T 	Arg55Trp	NM_002878.4	1.0	Conflicting	Conflicting	230594	17	35118601.0	G	A	R	W	rs775268017	17	33445620	17	30469733	55	RAD51D	ENSG00000185379	ENST00000345365	ENSP00000338790	O75771	RA51D_HUMAN	c.163C>T	p.Arg55Trp	c.163C>T	p.Arg55Trp	principal1	Y	1	YES	Select	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.001	0.83643	D	0.997	0.70687	D	0.915	0.65085	D	0.63	0.78586	D	simple_aae	37.0	63.0	2.6	0.75898	M	-5.15	0.83383	D	0.825	0.81999	-0.5240	0.67624	T	0.2724	0.64261	T	10	0.8072227	0.79845	D	0.111863	0.78916	D	0.374	0.69109	0.598	0.72759	O75771	R55W	Gain of catalytic residue at L53 (P = 0.0031)| Gain of helix (P = 0.005)| Loss of loop (P = 0.0153)| Loss of MoRF binding (P = 0.0884)| Loss of solvent accessibility (P = 0.1202)	0.873687315659	0.87147	.	.	.	.	.	.	.	0.547731	0.84489	D	0.0541436	0.58585	T	-0.0631489	0.65870	T	0.94793289899826	0.62559	D	.	0.72299	.	0.47494522	0.65280	0.46390733	0.68623	0.47494522	0.65280	0.46390733	0.68623	-9.321	0.69817	D	0.4599	0.65611	A	0.00577304038068542	0.19858	0.99482584	0.97637	0.599	0.77554	.	.	.	.	.	.	5.317904	0.89281	29.9	0.99887546840030128	0.96206	0.817233	0.73781	D	0.415643171291693	0.62085	4.441516	0.323933020451451	0.56721	3.859249	4.79	1.09	0.19474	1.94	0.38959	3.953	0.56497	3.143000	0.36573	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	1	109344	9.145450e-06	0	2	207876	9.621120e-06	0	2	236752	8.447660e-06	0	0	7164	0.000000e+00	0	0	17108	0.000000e+00	0	1	2320	4.310340e-04	0	0	9040	0.000000e+00	0	0	13344	0.000000e+00	0	0	42764	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16164	0.000000e+00	0	0	30520	0.000000e+00	0	1	6206	1.611340e-04	0	0	13410	0.000000e+00	0	0	16684	0.000000e+00	0	0	89422	0.000000e+00	0	1	30608	3.267120e-05	0	1	30608	3.267120e-05	0	0	14848	0.000000e+00	0	0	34256	0.000000e+00	0	1	9566	1.045370e-04	0	0	17686	0.000000e+00	0	0	21582	0.000000e+00	0	0	102668	0.000000e+00	0	1	30526	3.275900e-05	0	1	30526	3.275900e-05	0	.	36	1614066	2.230390e-05	0	31	6084	5.095330e-03	0	0	74938	0.000000e+00	0	0	912	0.000000e+00	0	2	60004	3.333110e-05	0	0	29608	0.000000e+00	0	0	44900	0.000000e+00	0	0	64002	0.000000e+00	0	31	6084	5.095330e-03	0	0	1180034	0.000000e+00	0	1	91096	1.097740e-05	0	1	19700	5.076142131979695E-5	0	298	0	0	86	0	0	7436	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1928	0	0	7734	0	0	112	0	1	30328	3.297283038776049E-5	not_specified|not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118601G>A	ClinGen:CA8499638	CN169374|C3661900|C0027672|C3280345	614291	140162|145	RAD51D, N-terminal domain	Arg	Trp	90.91	0.7540322580645161																																																																																																																																																																																																																																																																																																																																																																																																																																																																													187			90.91	Positively-charged	Arginine		DNA repair protein RAD51 homolog 4										-4.5								 R55-V51 (PAE:  1.0), R55-A59 (PAE: 1.0)	R55-A59 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ), R55-V51 (PDBs: 8OUZ)	 R55-V51 (PAE:  1.0), R55-A59 (PAE: 1.0)	R55-A59 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ), R55-V51 (PDBs: 8OUZ)							175									-63.3				-44.7	preferentially binds ssDNA					H (helix)	H (α-helix)	Helix											90.91	75.40323	>90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.7189520173770886	0.7244478921697051	false	false	false
FANCC	FANCC_Asp195Val	B_13-14	1.2566203609821562	0.24919974099408038	0.3328472065025829	-8.3577150671891	0.00006886492807326819	0.0003037671707078056	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.928289525577208	0.9314356137735734	0.548446468461392	0.616239031476636	0.6041234169511258	0.5419493661679651	0.6152852666236994	0.7136507464202357	0.6590668782834517	0.593038163599533	0.9228955816908118	0.929465641047897	0.4686134657122306	0.4945960874820159	0.5734111846698202	0.503854773323251	0.9399756458563351	0.927113410106519	FANCC	Asp195Val	NC_000009.12:95150025:T:A	584A>T	9	95150025	T	A	9	ENSG00000158169	7699	0	CCSBVarC001229	ALE00001229	ENSP00000289081.3	RC4	RC4_Mut_GDEh1009	B09	GDEhDisVCh_40044	E07	2	RC4_Mut_GDDh1009	B09	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N	138044.0	single nucleotide variant	NM_000136.3(FANCC):c.584A>T (p.Asp195Val)	2176.0	FANCC	HGNC:3584	Conflicting classifications of pathogenicity	0.0	Aug 01, 2024	1800365.0	-	RCV000120978|RCV001356570|RCV000124962|RCV000179716|RCV000667368|RCV000988215|RCV001083500	MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84	not specified|Malignant tumor of breast|Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia complementation group C|Fanconi anemia complementation group A|Fanconi anemia	germline;unknown	germline	GRCh38	NC_000009.12	9	95150025.0	95150025.0	9q22.32	criteria provided, conflicting classifications	26.0	-	N	ClinGen:CA247025,UniProtKB:Q00597#VAR_005228	2.0	134305.0	95150025.0	T	A	-	-	-	-	-	-	584A>T 	Asp195Val	NM_000136.3	1.0	Conflicting	Conflicting	134305	9	95150025.0	T	A	D	V	rs1800365	9	97912307	9	96952128	195	FANCC	ENSG00000158169	ENST00000375305	ENSP00000364454	Q00597	FANCC_HUMAN	c.584A>T	p.Asp195Val	c.584A>T	p.Asp195Val	principal1	Y	1	.	.	-	GAT	2	0	T	T/T	T/T	T/T	T/T	0.004	0.65576	D	0.002	0.79703	D	0.992	0.64752	D	0.971	0.72446	D	0.04	0.13669	N	simple_aae	96.0	4.0	2.395	0.69015	M	-5.58	0.86481	D	0.83	0.82505	-0.5256	0.67564	T	0.2312	0.59552	T	10	0.027212769	0.00870	T	.	.	.	0.417	0.72559	.	.	.	.	.	0.869862672899	0.86759	.	0.49056	.	0.40953	0.38103300333	0.22378	T	0.508738	0.82439	D	-0.186631	0.22426	T	-0.0371334	0.67662	D	0.028442771770713	0.01743	T	0.893711	0.71646	D	0.4535079	0.63947	0.3693059	0.61960	0.43107343	0.62503	0.41695112	0.65510	-4.396	0.29534	T	0.2603	0.50323	B	0.427087705106892	0.58537	0.48957047	0.81662	0.506	0.71835	.	.	.	.	.	.	3.822049	0.55272	23.6	0.99328517196819688	0.59720	0.471210	0.51517	N	0.491382671950936	0.66409	4.969212	0.405209269013319	0.61683	4.395473	4.77	4.77	0.60376	.	.	4.533	0.60413	5.887000	0.50787	0.665	0.62996	0.999	0.42732	1.000000	0.68239	0.174	0.21152	167	0.93511	13	0.002595846645367412	1	7.564296520423601E-4	12	0.011928429423459244	0	0.0	0	0.0	0	0.0	840	264690	0.0031735238	.	319	109386	2.916280e-03	2	661	208056	3.177030e-03	4	722	236802	3.048960e-03	4	4	7162	5.585030e-04	0	47	17110	2.746930e-03	0	5	2320	2.155170e-03	0	0	9044	0.000000e+00	0	3	13394	2.239810e-04	0	204	42762	4.770590e-03	2	49	15684	3.124200e-03	0	204	42762	4.770590e-03	2	6	16212	3.700960e-04	0	82	30508	2.687820e-03	1	18	6210	2.898550e-03	0	0	13414	0.000000e+00	0	5	16734	2.987930e-04	0	434	89528	4.847650e-03	3	102	30592	3.334210e-03	0	434	89528	4.847650e-03	3	5	14900	3.355700e-04	0	89	34242	2.599150e-03	1	37	9566	3.867870e-03	0	0	17690	0.000000e+00	0	7	21632	3.235950e-04	0	466	102654	4.539520e-03	3	102	30510	3.343170e-03	0	466	102654	4.539520e-03	3	.	6367	1614040	3.944760e-03	26	31	6060	5.115510e-03	0	52	75002	6.933150e-04	0	0	912	0.000000e+00	0	174	60004	2.899810e-03	1	94	29606	3.175030e-03	0	1	44868	2.228760e-05	0	37	64010	5.780350e-04	0	31	6060	5.115510e-03	0	5355	1180010	4.538100e-03	18	308	91058	3.382460e-03	4	442	92472	0.004779825244398304	0	174	0	0	2674	0	6	4186	0.001433349259436216	8	790	0.010126582278481013	2	946	0.0021141649048625794	0	656	0	1	274	0.0036496350364963502	41	8036	0.00510204081632653	6	4360	0.0013761467889908258	0	3330	0	500	110208	0.004536875725900116	Fanconi_anemia_complementation_group_A|Fanconi_anemia|Malignant_tumor_of_breast|Fanconi_anemia_complementation_group_C|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000009.12:g.95150025T>A	ClinGen:CA247025|UniProtKB:Q00597#VAR_005228	C3469521|C0015625|C0006142|C3468041|C3661900|CN169374|C0027672	227650|PS227650|227645	84|84|84|140162	.	Asp	Val	79.61	0.39263803680981596																																																																																																																																																																																																																																																																																																																																																																																																																																																																													64			79.61	Negatively-charged	Aspartic Acid		Fanconi anemia group C protein										-3.5																		132									-68.4				-18.3						C (loop/coil)	T (turn)												79.61	39.2638	70-90	10-90	227645;227650	autosomal recessive	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic skin disease; Inherited cancer-predisposing syndrome	6	FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCONI ANEMIA, COMPLEMENTATION GROUP A	true	0.9314356137735734	0.928289525577208	false	false	false
SDHD	SDHD_Phe34Cys	B_13-14	7.204566186715207	0.00017742529934530618	0.0013508570601183795	3.0721181130182984	1.0	1.0	2025_01_Batch_13-14	false	false	false	false	false	true	false	false	false	false	false	false	0.852481329086983	0.8721078778130961	0.7978471445546427	0.8767674716397239	0.8797940129445507	0.8706215672083083	0.893694527054899	0.9080737099986183	0.9174548777635265	0.8155372485327632	0.8887574491818067	0.8648183515695276	0.8475486073617176	0.8515143158904833	0.8360800655159213	0.780157040576522	0.8554583064443855	0.8401443066044386	SDHD	Phe34Cys	NC_000011.10:112087905:T:G	101T>G	11	112087905	T	G	11	ENSG00000204370	6363	0	CCSBVarC023269	ALE00029761	ENSP00000364699.3																																	138935.0	single nucleotide variant	NM_003002.4(SDHD):c.101T>G (p.Phe34Cys)	6392.0	SDHD	HGNC:10683	Conflicting classifications of pathogenicity	0.0	Aug 13, 2024	141802836.0	-	RCV000122008|RCV000569765|RCV001545828|RCV003230259|RCV002228410|RCV003997358|RCV004748588	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|	not specified|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 1|Cowden syndrome 3;Pheochromocytoma;Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss|Hereditary pheochromocytoma-paraganglioma|SDHD-related disorder	germline	germline	GRCh38	NC_000011.10	11	112087905.0	112087905.0	11q23.1	criteria provided, conflicting classifications	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016754	2.0	135196.0	112087905.0	T	G	-	-	-	-	-	-	101T>G 	Phe34Cys	NM_003002.4	1.0	Conflicting	Conflicting	135196	11	112087905.0	T	G	F	C	rs141802836	11	111958629	11	111463839	34	SDHD	ENSG00000204370	ENST00000375549	ENSP00000364699	O14521	DHSD_HUMAN	c.101T>G	p.Phe34Cys	c.101T>G	p.Phe34Cys	principal1	Y	1	YES	Select	+	TTT	2	0	T	./.	./.	./.	./.	0.081	0.78662	T	0.157	0.92967	T	0.953	0.54293	P	0.43	0.45391	B	0.13	0.52324	N	simple_aae	87.0	13.0	2.3	0.65510	M	-0.55	0.96333	N	0.622	0.70120	0.2199	0.86189	D	0.6593	0.88119	D	10	0.53285825	0.62974	D	0.151246	0.83237	D	0.691	0.88724	.	.	.	.	.	0.931227753352	0.92998	0.5560470912091142	0.55343	0.662533756427	0.58709	0.521012783051	0.41709	T	0.32663	0.69546	T	0.127906	0.66920	D	0.251929	0.85611	D	0.116020513204259	0.13859	T	0.860814	0.58949	D	0.08004188	0.18151	0.07223325	0.15552	0.08004188	0.18151	0.07223325	0.15552	-3.982	0.23555	T	0.1996	0.63627	B	0.144711279699783	0.46760	0.99037120	0.96789	0.241	0.51065	.	.	.	.	.	.	3.395206	0.47109	22.4	0.99261210856720172	0.57287	0.736750	0.68100	D	0.209532460011217	0.51422	3.345592	0.250926334821979	0.52455	3.443302	4.81	3.66	0.41042	.	.	2.022	0.40755	5.897000	0.50911	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.939	0.47934	635	0.64545	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	32	264690	1.2089614E-4	segdup	5	109398	4.570470e-05	0	8	208124	3.843860e-05	0	8	236946	3.376300e-05	0	3	7164	4.187600e-04	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13384	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	3	7164	4.187600e-04	0	6	16218	3.699590e-04	0	2	30524	6.552220e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16724	0.000000e+00	0	0	89558	0.000000e+00	0	0	30608	0.000000e+00	0	6	16218	3.699590e-04	0	6	14902	4.026310e-04	0	2	34260	5.837710e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21622	0.000000e+00	0	0	102754	0.000000e+00	0	0	30526	0.000000e+00	0	6	14902	4.026310e-04	0	.	44	1614066	2.726030e-05	0	38	75038	5.064100e-04	0	38	75038	5.064100e-04	0	0	912	0.000000e+00	0	3	60030	4.997500e-05	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64038	0.000000e+00	0	0	6060	0.000000e+00	0	0	1179892	0.000000e+00	0	0	91088	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	2	2784	7.183908045977011E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	2	2898	6.901311249137336E-4	0	112	0	2	14050	1.4234875444839857E-4	not_specified|Paragangliomas_1|not_provided|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Cowden_syndrome_3|Hereditary_pheochromocytoma-paraganglioma|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000011.10:g.112087905T>G	ClinGen:CA016754	CN169374|C3494181|C3661900|C0031511|C1847319|C1868633|CN166604|C1708353|C0027672	168000|171300|606864	29072|29072|97286|201|29072|140162	.	Phe	Cys	48.34	0.9289340101522843																																																																																																																																																																																																																																																																																																																																																																																																																																																																													183			48.34	Aromatic	Phenylalanine												2.8																		165									-75.8				68.0						C (loop/coil)	C (loop/coil)								Mitochondrion				48.34	92.8934	$\leqslant$50	$\geqslant$90	168000;171300;606864	autosomal dominant	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic tumor; Inherited cancer-predisposing syndrome	7	PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1; PHEOCHROMOCYTOMA; PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	false	0.8721078778130961	0.852481329086983	false	false	false
RAD51D	RAD51D_Val56Gly	B_13-14	1.9985217593357885	0.08580618781279473	0.14452364966705286	5.884913267417665	0.0006086853457433739	0.0016040557207708719	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7804585657363843	0.8022006057036613	0.5261957777053009	0.5856408008517234	0.6463333444846038	0.5599684135219797	0.6843867096325453	0.7573284296205087	0.688610538553572	0.6351310268825178	0.8624201565904631	0.8409107653519846	0.43555011741141403	0.5353382593486989	0.4826710631498749	0.41726052852808404	0.7419810548168595	0.7200063661207838	RAD51D	Val56Gly	NC_000017.11:35118597:A:C	167T>G	17	35118597	A	C	17	ENSG00000185379	7201	0	CCSBVarC024801	ALE00032628	ENSP00000338790.6																																	1087626.0	single nucleotide variant	NM_002878.4(RAD51D):c.167T>G (p.Val56Gly)	5892.0	RAD51D	HGNC:9823	Conflicting classifications of pathogenicity	0.0	May 03, 2021	745307359.0	-	RCV001779181|RCV001799083	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN221562	Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer	germline	germline	GRCh38	NC_000017.11	17	35118597.0	35118597.0	17q12	criteria provided, conflicting classifications	2.0	-	N	-	2.0	1098881.0	35118597.0	A	C	-	-	-	-	-	-	167T>G 	Val56Gly	NM_002878.4	1.0	Conflicting	Conflicting	1098881	17	35118597.0	A	C	V	G	rs745307359	17	33445616	17	30469729	56	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.167T>G	p.Val56Gly	c.167T>G	p.Val56Gly	principal1	Y	5	.	.	-	GTG	2	0	A	A/A	A/A	A/A	A/A	.	0.31374	.	0.002	0.79703	D	0.722	0.42404	P	0.488	0.47286	P	.	.	.	.	.	.	1.795	0.47093	L	.	0.62039	.	0.721	0.72170	-0.8783	0.49699	T	0.1726	0.51308	T	10	0.03294766	0.01460	T	0.089068	0.75174	D	.	0.75010	0.613	0.74554	O75771	V56G	Loss of stability (P = 2e-04)| Gain of helix (P = 0.0425)| Loss of loop (P = 0.0804)| Gain of relative solvent accessibility (P = 0.1066)| Loss of MoRF binding (P = 0.1311)	0.776739155903	0.77291	.	.	.	.	.	.	.	0.488934	0.81292	T	0.239419	0.77440	D	0.106132	0.77147	D	0.0787749525895067	0.09708	T	0.559044	0.19237	T	0.33676666	0.55690	0.3519664	0.60545	0.33676666	0.55690	0.3519664	0.60544	-8.078	0.61675	D	0.5902	0.68420	P	0.0493707858960898	0.37072	0.99278045	0.97206	0.385	0.63571	.	.	.	.	.	.	5.133939	0.85944	28.7	0.99732360981923829	0.82849	0.946436	0.95573	D	0.430607372517603	0.62920	4.538864	0.465062733801357	0.65503	4.855777	4.79	4.79	0.60860	.	.	7.519	0.80763	11.047000	0.85271	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.989	0.64309	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7	108972	6.423670e-05	0	8	207056	3.863690e-05	0	82	235244	3.485740e-04	0	0	7146	0.000000e+00	0	0	17078	0.000000e+00	0	0	2320	0.000000e+00	0	3	9000	3.333330e-04	0	1	13178	7.588400e-05	0	2	42660	4.688230e-05	0	1	15678	6.378360e-05	0	3	9000	3.333330e-04	0	1	16102	6.210410e-05	0	0	30476	0.000000e+00	0	0	6194	0.000000e+00	0	3	13346	2.247860e-04	0	1	16510	6.056940e-05	0	2	88982	2.247650e-05	0	1	30596	3.268400e-05	0	3	13346	2.247860e-04	0	1	14812	6.751280e-05	0	0	34214	0.000000e+00	0	0	9556	0.000000e+00	0	3	17638	1.700870e-04	0	39	20808	1.874280e-03	0	36	102102	3.525890e-04	0	1	30514	3.277180e-05	0	36	102102	3.525890e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	criteria_provided,_conflicting_classifications	NC_000017.11:g.35118597A>C	.	CN221562|C3280345	614291	145	RAD51D, N-terminal domain	Val	Gly	90.63	0.3380281690140845																																																																																																																																																																																																																																																																																																																																																																																																																																																																													48			90.63	Aliphatic	Valine		DNA repair protein RAD51 homolog 4										4.2								 V56-Q60 (PAE:  1.0), V56-A52 (PAE: 1.0)	V56-A52 (PDBs: 8FAZ, 8GBJ, 8OUY, 8OUZ), V56-Q60 (PDBs: 8OUZ)	 V56-Q60 (PAE:  1.0), V56-A52 (PAE: 1.0)	V56-C9 (PDBs: 8FAZ), V56-A52 (PDBs: 8GBJ, 8OUY, 8OUZ), V56-Q60 (PDBs: 8OUZ)							117									-65.6				-42.9	preferentially binds ssDNA					H (helix)	H (α-helix)	Helix											90.63	33.802814	>90	10-90	614291	autosomal dominant	GenCC	Rare genetic tumor	1	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	false	0.8022006057036613	0.7804585657363843	false	false	false
F9	F9_His282Arg	B_13-14	-2.5485677847101242	0.038183352616759834	0.07464708648721728	0.10650648567245825	0.9181685917700348	0.9323958859424538	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8073544641231967	0.8065738169690667	0.7173735390429172	0.8312333842212676	0.7433051819537391	0.8267884691692944	0.8048993067698108	0.7210355757300143	0.8344853345172211	0.638746821701804	0.8642824643297653	0.8768513108195758	0.8486776315687778	0.7655747881774637	0.827981433925314	0.7960002563840305	0.7488651696083681	0.7378576174268174	F9	His282Arg	NC_000023.11:139561530:A:G	845A>G	23	139561530	A	G	X	ENSG00000101981	52861	0	CCSBVarC030586	ALE00027369	ENSP00000218099.2																																	615669.0	single nucleotide variant	NM_000133.4(F9):c.845A>G (p.His282Arg)	2158.0	F9	HGNC:3551	Conflicting classifications of pathogenicity	1.0	Feb 14, 2024	753654616.0	-	RCV004588168|RCV000851898	MedGen:C3661900|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	not provided|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561530.0	139561530.0	Xq27.1	criteria provided, conflicting classifications	3.0	-	N	-	2.0	627146.0	139561530.0	A	G	-	-	-	-	-	-	845A>G 	His282Arg	NM_000133.4	1.0	Conflicting	Conflicting	627146	X	139561530.0	A	G	H	R	rs753654616	X	138643689	X	138471355	282	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.845A>G	p.His282Arg	c.845A>G	p.His282Arg	principal1	Y	1	YES	Select	+	CAT	2	0	A	A/A	A/A	A/A	A/A	0.601	0.06521	T	0.379	0.17349	T	0.046	0.21889	B	0.113	0.31692	B	0.83	0.90832	A	simple_aae	17.0	83.0	2.315	0.66058	M	-3.71	0.70711	D	0.405	0.78847	0.4026	0.89093	D	0.7468	0.91338	D	10	0.9492965	0.94197	D	0.669559	0.97236	D	0.707	0.89469	0.938	0.99125	P00740	H282R	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.999137776672	0.99911	0.9970016739794073	0.99698	1.73630748658	0.90767	0.379394561052	0.22147	T	0.866353	0.97052	D	0.370769	0.88019	D	0.294808	0.87868	D	0.900605976581573	0.55065	D	0.852415	0.53609	D	0.84553546	0.86834	0.8327217	0.90237	0.8688038	0.88613	0.81526446	0.89097	-6.135	0.50934	T	0.1387	0.45138	B	0.98658244579304	0.87152	0.99998010	0.99989	0.775	0.87544	.	.	.	.	.	.	2.423931	0.31233	18.66	0.92464920108666138	0.22143	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	4.839	0.62586	9.394000	0.80629	0.691	0.84104	0.856	0.30635	0.999000	0.35501	0.629	0.32173	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	33	1204562	2.739590e-05	0	32	890491	3.593520e-05	0	0	57696	0.000000e+00	0	0	689	0.000000e+00	0	0	45620	0.000000e+00	0	0	21828	0.000000e+00	0	0	33803	0.000000e+00	0	0	46844	0.000000e+00	0	0	4331	0.000000e+00	0	32	890491	3.593520e-05	0	0	55876	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Hereditary_factor_VIII_deficiency_disease|not_provided	criteria_provided,_conflicting_classifications	NC_000023.11:g.139561530A>G	.	C0019069|C3661900	134500|306700	98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Arg	93.76	0.13043478260869565																																																																																																																																																																																																																																																																																																																																																																																																															0.941		0.888		0.9		0.877		0.878																																																						24			93.76	Positively-charged	Histidine		Coagulation factor IX; Coagulation factor IXa heavy chain							Peptidase S1			-3.2								 H282-W356 (PAE:  1.5), H282-E288 (PAE: 3.0), H282-L369 (PAE: 1.0)	H282-L369 (PDBs: 6X5J, 6X5L, 8OL9), H282-A233 (PDBs: 8OL9)	 H282-P235 (PAE:  1.0), H282-L369 (PAE: 1.0)	H282-K234 (PDBs: 6X5J, 6X5L), H282-P235 (PDBs: 8OL9), H282-A233 (PDBs: 8OL9), H282-E288 (PDBs: 8OL9), H282-V368 (PDBs: 8OL9), H282-L369 (PDBs: 8OL9)							155									-128.8				-44.1						C (loop/coil)	S (bend)	Beta strand											93.76	13.043478	>90	10-90	306700	x-linked recessive	OMIM	Rare genetic hematologic disease	1	HEMOPHILIA A	false	0.8065738169690667	0.8073544641231967	false	false	false
DES	DES_Arg37Trp	B_7-8	1.5387506142886784	0.17478696980251116	0.25288626562916544	1.2699056443551826	0.2447009621079883	0.29367316250370085	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.784468977178967	0.7301634754383564	0.8044619749771813	0.8607077482645349	0.8589595255260891	0.8108340599704884	0.9899718740859771	0.9833900237416456	0.9905156724731986	0.9831038417460036	0.7847681630393932	0.784468977178967	0.6316962458549996	0.7345290273105325	0.7308998240558712	0.6258201082083589	0.6755587878373194		DES	Arg37Trp	NC_000002.12:219418571:C:T	109C>T	2	219418571	C	T	2	ENSG00000175084	12573	2223	CCSBVarC007790	ALE00007776	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	C01	GDEhDisVCh_40003	D01	1	VUSMutGDDh003	C01	VUSN2Hmut_GDN2h_01	C01	NULL	NULL	VUSmut_GDEh01	C01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	258243.0	single nucleotide variant	NM_001927.4(DES):c.109C>T (p.Arg37Trp)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Feb 01, 2024	537881554.0	-	RCV000250161|RCV000594311|RCV001217854|RCV002494794|RCV003114438	MedGen:CN230736|MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146;MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154;MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MedGen:CN169374	Cardiovascular phenotype|not provided|Desmin-related myofibrillar myopathy|Neurogenic scapuloperoneal syndrome, Kaeser type;Dilated cardiomyopathy 1I;Desmin-related myofibrillar myopathy|not specified	germline;unknown	germline	GRCh38	NC_000002.12	2	219418571.0	219418571.0	2q35	criteria provided, multiple submitters, no conflicts	8.0	ACMG2022	N	ClinGen:CA2125022	2.0	264441.0	219418571.0	C	T	-	-	-	-	-	-	109C>T 	Arg37Trp	NM_001927.4	2.0	VUS	VUS	264441	2	219418571.0	C	T	R	W	rs537881554	2	220283293	2	219991537	37	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.109C>T	p.Arg37Trp	c.109C>T	p.Arg37Trp	principal1	Y	1	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.031	0.45197	D	0.012	0.64242	D	0.994	0.66535	D	0.684	0.53578	P	.	.	.	.	.	.	2.28	0.64737	M	-2.04	0.46850	N	0.483	0.51524	0.1870	0.85628	D	0.5423	0.83078	D	10	0.59298563	0.66195	D	0.471806	0.94683	D	0.496	0.77984	0.587	0.71392	P17661	R37W	Gain of catalytic residue at R37 (P = 0.0123)| Loss of methylation at R37 (P = 0.0148)| Loss of MoRF binding (P = 0.094)| Gain of glycosylation at S32 (P = 0.0986)| Loss of phosphorylation at S32 (P = 0.1676)	0.948898980863	0.94793	0.645121213058477	0.64279	0.936043945633	0.71850	0.72876739502	0.71277	T	0.812821	0.95303	D	0.0671383	0.60220	T	-0.141337	0.59720	T	0.814698398113251	0.47102	D	0.884312	0.60605	D	0.63585836	0.74336	0.52952814	0.72560	0.63585836	0.74337	0.52952814	0.72561	-9.378	0.70176	D	0.43	0.61143	A	0.993600638916301	0.90143	0.98993110	0.96721	0.733	0.85206	.	.	.	.	.	.	4.04097	0.59896	24.1	0.99780169442497368	0.86704	0.729311	0.67588	D	0.192527593158667	0.50597	3.270265	0.181681914851628	0.48580	3.094961	5.13	5.13	0.69688	2.22	0.42274	0.348	0.19856	3.836000	0.40098	0.524	0.24207	0.001	0.13799	0.999000	0.35501	0.874	0.41704	86	0.96402	1	1.9968051118210862E-4	0	0.0	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	37	264690	1.3978616E-4	.	0	101806	0.000000e+00	0	1	186710	5.355900e-06	0	0	216776	0.000000e+00	0	0	6088	0.000000e+00	0	0	16208	0.000000e+00	0	0	2112	0.000000e+00	0	0	8204	0.000000e+00	0	0	12872	0.000000e+00	0	0	39842	0.000000e+00	0	0	14702	0.000000e+00	0	.	.	.	.	0	12826	0.000000e+00	0	1	28962	3.452800e-05	0	0	5548	0.000000e+00	0	0	12240	0.000000e+00	0	0	15918	0.000000e+00	0	0	77984	0.000000e+00	0	0	28868	0.000000e+00	0	1	28962	3.452800e-05	0	0	11900	0.000000e+00	0	0	32748	0.000000e+00	0	0	8884	0.000000e+00	0	0	16562	0.000000e+00	0	0	20362	0.000000e+00	0	0	92324	0.000000e+00	0	0	28808	0.000000e+00	0	.	.	.	.	.	21	1603654	1.309510e-05	0	15	58936	2.545130e-04	0	0	74626	0.000000e+00	0	0	912	0.000000e+00	0	15	58936	2.545130e-04	0	0	29120	0.000000e+00	0	0	44464	0.000000e+00	0	0	62104	0.000000e+00	0	0	6020	0.000000e+00	0	0	1175792	0.000000e+00	0	0	89776	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Cardiovascular_phenotype|not_specified|Desmin-related_myofibrillar_myopathy|Dilated_cardiomyopathy_1I|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219418571C>T	ClinGen:CA2125022	CN230736|CN169374|C1832370|C1858154|C1867005|C3661900	601419|604765|181400	363543|98909|154|85146	Intermediate filament head, DNA-binding domain	Arg	Trp	39.05	0.9919354838709677																																																																																																																																																																																																																																																																																																																																																																																																																																																																													246			39.05	Positively-charged	Arginine		Desmin										-4.5																Morphology: LssPVFPrAGFGskG; Domain: Filament_head	Asymmetric dimethylarginine; alternate; Omega-N-methylarginine; alternate	175									-66.2				98.9	Head					C (loop/coil)	C (loop/coil)												39.05	99.19355	$\leqslant$50	$\geqslant$90	601419;181400;604765;601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1; SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; CARDIOMYOPATHY, DILATED, 1I; MYOPATHY, MYOFIBRILLAR, 1	false	0.7301634754383564	0.784468977178967	false	false	false
MVK	MVK_Arg388Gln	B_7-8	0.8176754845216556	0.4447917728502375	0.5363335139797687	3.154521516757782	0.019701394166180403	0.031031809695228358	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6570532026349707	0.6346773368552228	0.5166002032508307	0.5729778285611927	0.6732147618220627	0.5472128547909019	0.5580742395494331	0.7122297017558719	0.5477041237218682	0.519009327355372	0.6677719233487194	0.6847938808978313	0.5363514700323706	0.6341998218882535	0.5982515334005173	0.5141910791462894	0.6015827503617261	0.6293125243721102	MVK	Arg388Gln	NC_000012.12:109596549:G:A	1163G>A	12	109596549	G	A	12	ENSG00000110921	281	29	CCSBVarC007134	ALE00007132	ENSP00000228510.3	Edgotyping3	VUSMutGDEh010	C02	GDEhDisVCh_40020	D08	2	VUSMutGDDh010	C02	VUSN2Hmut_GDN2h_03	B06	VUSMutpDEST2_01	A04	VUSmut_GDEh03	B06	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	N	Y	N	Y	329248.0	single nucleotide variant	NM_000431.4(MVK):c.1163G>A (p.Arg388Gln)	4598.0	MVK	HGNC:7530	Uncertain significance	0.0	Dec 29, 2022	886048934.0	-	RCV000266093|RCV000328212|RCV000821340|RCV004529550	MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:CN239294	Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type;Hyperimmunoglobulin D with periodic fever|MVK-related disorder	germline	germline	GRCh38	NC_000012.12	12	109596549.0	109596549.0	12q24.11	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA10640120	2.0	307101.0	109596549.0	G	A	-	-	-	-	-	-	1163G>A 	Arg388Gln	NM_000431.4	2.0	VUS	VUS	307101	12	109596549.0	G	A	R	Q	rs886048934	12	110034354	12	108518737	388	MVK	ENSG00000110921	ENST00000228510	ENSP00000228510	Q03426	KIME_HUMAN	c.1163G>A	p.Arg388Gln	c.1163G>A	p.Arg388Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.494	0.08287	T	0.506	0.11139	T	0.001	0.09864	B	0.0	0.04348	B	0.04	0.28107	N	simple_aae	96.0	4.0	0.755	0.19049	N	0.37	0.03740	N	0.112	0.19734	-0.1473	0.78887	T	0.6678	0.88440	D	10	0.061701566	0.07756	T	0.053357	0.65307	D	0.252	0.55947	0.215	0.13423	Q03426	R388Q	Gain of helix (P = 0.0199)| Loss of loop (P = 0.0235)| Loss of solvent accessibility (P = 0.0769)| Gain of disorder (P = 0.118)| Loss of glycosylation at S387 (P = 0.1457)	0.763584799786	0.75955	0.47798348979661365	0.47521	0.406638380673	0.41253	0.263497620821	0.05314	T	0.10127	0.40497	T	0.00505521	0.52033	T	-0.230515	0.51400	T	0.0420433384116413	0.04028	T	0.687731	0.29423	T	0.057992246	0.11505	0.059707735	0.11259	0.057992246	0.11505	0.059707735	0.11258	-4.562	0.31726	T	0.0765	0.06231	LB	0.0247744580937565	0.31216	0.94220835	0.92965	0.037	0.08577	.	.	.	.	.	.	1.052234	0.14353	10.91	0.83249499627755752	0.14852	0.041311	0.06155	N	-1.36721387082424	0.02920	0.1310651	-1.3978612682749	0.03227	0.1524316	5.06	-4.12	0.03653	-4.3	0.05686	1.899	0.39555	-1.395000	0.05567	-0.82	0.02975	0.013	0.18899	0.000000	0.08389	0.003	0.0525	729	0.54435	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11	1611328	6.826670e-06	0	2	44896	4.454740e-05	0	0	74930	0.000000e+00	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29608	0.000000e+00	0	2	44896	4.454740e-05	0	0	61472	0.000000e+00	0	0	6032	0.000000e+00	0	6	1179954	5.084940e-06	0	2	91080	2.195870e-05	0	1	6962	1.4363688595231256E-4	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	1	10680	9.363295880149813E-5	Hyperimmunoglobulin_D_with_periodic_fever|Mevalonic_aciduria|MVK-related_disorder|Porokeratosis_3,_disseminated_superficial_actinic_type	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.109596549G>A	ClinGen:CA10640120	C0398691|C1959626|CN239294|C1867981	260920|610377|175900	343|29	.	Arg	Gln	90.82	0.6774193548387096																																																																																																																																																																																																																																																																																																																																																																																																																																																																													168			90.82	Positively-charged	Arginine		Mevalonate kinase										-4.5								 R388-A392 (PAE:  1.0)	R388-A392 (PDBs: 2R3V)	 R388-A392 (PAE:  1.0)	R388-A392 (PDBs: 2R3V)		R388-D386 (PDBs: 2R3V)					175									-67.1				-38.1						H (helix)	H (α-helix)	Helix											90.82	67.741936	>90	10-90	610377;260920;610377;175900;260920	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	MEVALONIC ACIDURIA; HYPER-IgD SYNDROME; MEVALONIC ACIDURIA; POROKERATOSIS 3, MULTIPLE TYPES; HYPER-IgD SYNDROME	false	0.6346773368552228	0.6570532026349707	false	false	false
MLH1	MLH1_Lys670Arg	B_11-12	3.09202843062044	0.024508243285919672	0.05295333108156852	9.661402542333652	0.00007178343958553843	0.0003151258651661795	2024_12_Batch_11-12	true	true	true	true	true	true	false	false	false	false	false	false	0.9377736021959142	0.9432459277695123	0.9324762110815937	0.9203380393522627	0.9088925712637229	0.9577236234167684		0.9081031656130234		0.938427778769566	0.9557392942380711	0.9502340979631125	0.9577236234167684	0.9096819769144224	0.9203380393522627	0.9265246433936215	0.9307525613009535	0.9253131064287159	MLH1	Lys670Arg	NC_000003.12:37048923:A:G	2009A>G	3	37048923	A	G	3	ENSG00000076242	2713	971	CCSBVarC007394	ALE00007382	ENSP00000231790.3	Edgotyping3	VUSMutGDEh011	G10	GDEhDisVCh_40019	B08	1	VUSMutGDDh011	G10	VUSN2Hmut_GDN2h_04	D02	VUSMutpDEST2_02	G05	VUSmut_GDEh04	D02	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	N	Y	Y	Y	406258.0	single nucleotide variant	NM_000249.4(MLH1):c.2009A>G (p.Lys670Arg)	4292.0	MLH1	HGNC:7127	Uncertain significance	0.0	Mar 19, 2024	905983196.0	-	RCV000480957|RCV000572513|RCV000539594	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405	not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000003.12	3	37048923.0	37048923.0	3p22.2	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA16617935	2.0	422767.0	37048923.0	A	G	-	-	-	-	-	-	2009A>G 	Lys670Arg	NM_000249.4	2.0	VUS	VUS	422767	3	37048923.0	A	G	K	R	rs905983196	3	37090414	3	37065418	670	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.2009A>G	p.Lys670Arg	c.2009A>G	p.Lys670Arg	principal1	Y	1	YES	Select	+	AAG	2	0	A	A/A	A/A	A/A	A/A	0.056	0.38337	T	0.071	0.43880	T	0.035	0.20628	B	0.039	0.23609	B	0.74	0.85499	D	simple_aae	26.0	74.0	1.955	0.52690	M	-1.68	0.45230	N	0.542	0.56872	0.6923	0.93054	D	0.8053	0.93402	D	10	0.41654634	0.56234	D	0.16995	0.84723	D	0.535	0.80385	0.439	0.49179	P40692	K670R	Loss of ubiquitination at K670 (P = 0.0141)| Loss of methylation at K670 (P = 0.0388)| Loss of disorder (P = 0.0964)| Gain of phosphorylation at S675 (P = 0.2011)| Gain of helix (P = 0.2294)	0.972014943999	0.97145	0.7309883914861626	0.72900	0.0738909618718	0.08106	0.597270429134	0.52453	T	0.765944	0.93641	D	0.305724	0.83296	D	0.201375	0.83080	D	0.782333970069885	0.44907	D	0.888311	0.64729	D	0.28323787	0.51025	0.26524797	0.52155	0.28323787	0.51025	0.26524797	0.52154	-7.051	0.56983	T	0.0995	0.20538	B	0.3320226543946	0.55386	0.99913317	0.99166	0.378	0.63057	.	.	.	.	.	.	4.085218	0.60868	24.3	0.99787213212985049	0.87318	0.796633	0.72269	D	0.297508437034214	0.55798	3.766448	0.420491981613273	0.62643	4.506769	5.93	5.93	0.95881	5.27	0.92538	5.677	0.67884	11.240000	0.90409	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.982	0.59239	154	0.93969	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15	1614028	9.293520e-06	0	14	1179882	1.186560e-05	0	0	75036	0.000000e+00	0	0	912	0.000000e+00	0	0	60022	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64034	0.000000e+00	0	0	6060	0.000000e+00	0	14	1179882	1.186560e-05	0	0	91084	0.000000e+00	0	0	19780	0	0	298	0	0	86	0	0	7438	0	0	146	0	0	610	0	0	26	0	0	98	0	1	1930	5.181347150259067E-4	0	7736	0	0	112	0	1	30412	3.288175720110483E-5	not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.37048923A>G	ClinGen:CA16617935	C3661900|C0027672|C0009405	.	140162	DNA mismatch repair protein Mlh1, C-terminal	Lys	Arg	92.18	0.2780487804878049																																																																																																																																																																																																																																																																																																																																																																																																																																																																													57			92.18	Positively-charged	Lysine		DNA mismatch repair protein Mlh1										-3.9								 K670-E674 (PAE:  1.5), K670-S508 (PAE: 3.5)	K670-E512 (PDBs: 3RBN), K670-E674 (PDBs: 3RBN), K670-S508 (PDBs: 3RBN)	 K670-E674 (PAE:  1.5)	K670-E674 (PDBs: 3RBN)	 K670-E512 (PAE:  3.5)						147									-67.5				-49.5						H (helix)	H (α-helix)	Helix											92.18	27.804878	>90	10-90		unknown		Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3		false	0.9432459277695123	0.9377736021959142	true	true	false
SMAD3	SMAD3_Gln316Pro	B_15-16	-2.614826717155882	0.034669051113472384	0.06955660464992884	-3.3721800691867045	0.011884877606099907	0.019898494897074202	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8632079435592839	0.8636944514947715	0.7200340969830403	0.7996623736468131	0.8047573560999928	0.8094255575185854	0.8553782147521027	0.8788698825696035	0.9112210289888376	0.784325643288479	0.938122590842569	0.9416724908219234	0.7634729002850679	0.730644829630382	0.6881037183047887	0.6557425506776016	0.7892663121469741	0.7847433962966445	SMAD3	Gln316Pro	NC_000015.10:67184802:A:C	947A>C	15	67184802	A	C	15	ENSG00000166949	11805	2165	CCSBVarC007741	ALE00007727	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	G03	GDEhDisVCh_40014	D10	2	VUSMutGDDh005	G03	VUSN2Hmut_GDN2h_02	A01	VUSMutpDEST2_09	C06	VUSmut_GDEh02	A01	1.0	3.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	N	Y	Y	Y	Y	210290.0	single nucleotide variant	NM_005902.4(SMAD3):c.947A>C (p.Gln316Pro)	4088.0	SMAD3	HGNC:6769	Uncertain significance	0.0	May 12, 2021	863223745.0	-	RCV000199995	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000015.10	15	67184802.0	67184802.0	15q22.33	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA324543	2.0	213771.0	67184802.0	A	C	-	-	-	-	-	-	947A>C 	Gln316Pro	NM_005902.4	1.0	VUS	VUS	213771	15	67184802.0	A	C	Q	P	rs863223745	15	67477140	15	65264194	316	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.947A>C	p.Gln316Pro	c.947A>C	p.Gln316Pro	principal1	Y	1	YES	Select	+	CAG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.83643	D	0.996	0.68795	D	0.985	0.76461	D	0.98	0.97016	D	simple_aae	2.0	98.0	3.26	0.89820	M	-5.43	0.86481	D	0.957	0.97110	1.0966	0.99515	D	0.9639	0.98842	D	10	0.9841567	0.98579	D	0.516388	0.95371	D	0.986	0.99942	0.904	0.97931	P84022	Q316P	Loss of catalytic residue at Q316 (P = 0.0474)| Loss of sheet (P = 0.1158)| Gain of glycosylation at S317 (P = 0.1168)| Gain of loop (P = 0.3485)| Loss of stability (P = 0.4847)	0.986686039159	0.98639	0.997451050376014	0.99744	2.63092040909	0.98340	0.83236515522	0.86902	D	0.993373	0.99981	D	0.573338	0.96635	D	0.585784	0.96579	D	0.997444868087769	0.91499	D	0.994524	0.98193	D	0.98360646	0.99361	0.9693546	0.99427	0.98360646	0.99361	0.9693546	0.99428	-13.611	0.92144	D	0.9996	0.99584	P	0.999773671189146	0.97903	0.99506900	0.97694	0.956	0.98079	.	.	.	.	.	.	5.748332	0.93377	33.0	0.99443848312767302	0.64968	0.971704	0.99369	D	0.973567965030137	0.94844	13.11172	0.883547959132853	0.94784	13.06528	5.28	5.28	0.74083	3.79	0.69847	9.105	0.93613	11.181000	0.88328	0.75	0.87077	1.0	0.71675	1.000000	0.68239	0.976	0.56441	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000015.10:g.67184802A>C	ClinGen:CA324543	CN517202	.	.	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Gln	Pro	98.5	0.050505050505050504																																																																																																																																																																																																																																																																																																																																																																																																																																																																													10			98.5	Polar/Neutral	Glutamine		Mothers against decapentaplegic homolog 3							MH2	0.0146		-3.5								 Q316-R373 (PAE:  1.0), Q316-N163 (PAE: 29.0), Q316-A329 (PAE: 1.0)	Q316-R373 (PDBs: 1MJS, 5XOC), Q316-A329 (PDBs: 1MJS, 1MK2, 5XOC)	 Q316-R373 (PAE:  1.0)	Q316-R373 (PDBs: 1MJS, 1MK2, 5XOC)							146									-106.8		Pocket 3: Mean pLDDT: 64.24, Volume: 3139.95 Å³, Druggability score: 0.01		108.0	Sufficient for interaction with XPO4					B (undefined)	E (parallel sheets)	Beta strand											98.5	5.050505	>90	<10		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		true	0.8636944514947715	0.8632079435592839	false	false	false
MLH1	MLH1_Ser508Arg	B_11-12	13.978417304860892	0.0000832838097034532	0.0008074724697136831	10.622732754211617	0.00008883025985664059	0.0003696225098343208	2024_12_Batch_11-12	true	true	true	false	true	true	false	false	false	false	false	false	0.9249436202435688	0.9350914169499889	0.9115793669135726	0.8538886901175744	0.8772275909535661	0.9000671623842478		0.8816478930784883		0.9395871900591917	0.9749569636766211	0.9711111463541314	0.9000671623842478	0.8728072888286437	0.8538886901175744	0.8835715437679535	0.8952258702233566	0.8787760941330062	MLH1	Ser508Arg	NC_000003.12:37028898:T:G	1524T>G	3	37028898	T	G	3	ENSG00000076242	2713	838	CCSBVarC007380	ALE00007368	ENSP00000231790.3	Edgotyping3	VUSMutGDEh011	A09	GDEhDisVCh_40019	D06	1	VUSMutGDDh011	A09	VUSN2Hmut_GDN2h_04	D01	VUSMutpDEST2_02	A04	VUSmut_GDEh04	D01	1.0	3.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	N	Y	Y	Y	Y	290137.0	single nucleotide variant	NM_000249.4(MLH1):c.1524T>G (p.Ser508Arg)	4292.0	MLH1	HGNC:7127	Uncertain significance	0.0	Mar 04, 2024	886058383.0	-	RCV000322567|RCV000604019|RCV001861216|RCV003995880|RCV002392908	MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144|MedGen:CN169374|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Colorectal cancer, hereditary nonpolyposis, type 2|not specified|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome|Hereditary cancer-predisposing syndrome	germline;unknown	germline	GRCh38	NC_000003.12	3	37028898.0	37028898.0	3p22.2	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10615713	2.0	344908.0	37028898.0	T	G	-	-	-	-	-	-	1524T>G 	Ser508Arg	NM_000249.4	2.0	VUS	VUS	344908	3	37028898.0	T	G	S	R	rs886058383	3	37070389	3	37045393	508	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.1524T>G	p.Ser508Arg	c.1524T>G	p.Ser508Arg	principal1	Y	1	YES	Select	+	AGT	3	2	T	T/T	T/T	T/T	T/T	0.151	0.30937	T	0.428	0.15725	T	0.052	0.22508	B	0.017	0.18137	B	.	.	.	.	.	.	1.295	0.32304	L	-1.31	0.37944	N	0.392	0.44226	-0.9876	0.33081	T	0.1164	0.40907	T	10	0.170683	0.31382	T	0.033803	0.55064	D	0.559	0.81796	0.369	0.37706	P40692	S508R	Gain of MoRF binding (P = 0.0152)| Gain of catalytic residue at S508 (P = 0.0596)| Gain of solvent accessibility (P = 0.0766)| Loss of disorder (P = 0.12)| Gain of helix (P = 0.2294)	0.968872671725	0.96824	0.3926766823033091	0.38979	0.0766186226647	0.08416	0.443663448095	0.31039	T	0.647655	0.89161	D	0.145432	0.68612	D	-0.0288729	0.68215	D	0.153507858514786	0.17163	T	0.835117	0.50302	T	0.16460039	0.36380	0.16362803	0.37828	0.16460039	0.36379	0.16362803	0.37827	-5.163	0.52723	T	0.1971	0.58744	B	0.508943564620965	0.61056	0.99683565	0.98179	0.048	0.12436	.	.	.	.	.	.	1.519181	0.19538	14.3	0.99272043272877064	0.57657	0.118086	0.22892	N	-0.25953174666704	0.30444	1.715885	-0.252110032847867	0.29382	1.665995	5.9	0.682	0.17114	1.81	0.37505	-0.129	0.10527	0.050000	0.14043	0.665	0.62996	0.055	0.21668	0.523000	0.25400	0.99	0.65338	183	0.9287	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613984	1.239170e-06	0	2	1179984	1.694940e-06	0	0	74968	0.000000e+00	0	0	912	0.000000e+00	0	0	60000	0.000000e+00	0	0	29602	0.000000e+00	0	0	44870	0.000000e+00	0	0	64004	0.000000e+00	0	0	6062	0.000000e+00	0	2	1179984	1.694940e-06	0	0	91072	0.000000e+00	0	1	16898	5.917860101787194E-5	0	0	0	0	0	0	0	20	0	0	354	0	0	18	0	0	0	0	0	0	0	0	4092	0	0	20	0	0	0	0	1	21382	4.6768309793284074E-5	Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.37028898T>G	ClinGen:CA10615713	C1333991|C0027672|CN169374|C0009405|C4552100	609310	144|140162|144	DNA mismatch repair protein Mlh1, C-terminal	Ser	Arg	93.22	0.24615384615384617																																																																																																																																																																																																																																																																																																																																																																																																																																																																													32			93.22	Polar/Neutral	Serine		DNA mismatch repair protein Mlh1										-0.8								 S508-E512 (PAE:  1.0), S508-T504 (PAE: 2.5), S508-K670 (PAE: 3.5)	S508-E512 (PDBs: 3RBN), S508-T504 (PDBs: 3RBN), S508-K670 (PDBs: 3RBN)	 S508-E512 (PAE:  1.0), S508-T504 (PAE: 2.5)	S508-E512 (PDBs: 3RBN), S508-T504 (PDBs: 3RBN)							105									-62.8	Morphology: INLTSVLsLQEEINE; Domain: Mlh1_C			-39.5	Interaction with EXO1					H (helix)	H (α-helix)	Helix											93.22	24.615385	>90	10-90	609310	autosomal dominant	GenCC	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 2	false	0.9350914169499889	0.9249436202435688	true	true	false
PYGL	PYGL_Glu673Lys	B_7-8	-1.136580061505976	0.36629232878432594	0.44245089435096696	-6.141028273124434	0.001379535038934254	0.0030174273796938233	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6187249291429954	0.6294481627203665	0.5288705377581842	0.48391580569108367	0.4279412615292342	0.50448350132943	0.5389712455372927	0.4348712869731769	0.48123119020705596	0.5596113664323263	0.7018111238287636	0.723866638034841	0.46999575712156716	0.4210112360852915	0.4866004211751114	0.4981297090840421	0.5570852016119693	0.5135832202511498	PYGL	Glu673Lys	NC_000014.9:50910055:C:T	2017G>A	14	50910055	C	T	14	ENSG00000100504	55246	3215	CCSBVarC003082	ALE00003082	ENSP00000216392.7	Edgotyping3	VUSMutGDEh009	C01	GDEhDisVCh_40063	G11	1	VUSMutGDDh009	C01	VUSN2Hmut_GDN2h_02	C12	VUSMutpDEST2_13	H03	VUSmut_GDEh02	C12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	34184.0	single nucleotide variant	NM_002863.5(PYGL):c.2017G>A (p.Glu673Lys)	5836.0	PYGL	HGNC:9725	Uncertain significance	0.0	Jul 11, 2021	113993984.0	-	RCV000020497	MONDO:MONDO:0009294,MedGen:C0017925,OMIM:232700,Orphanet:369	Glycogen storage disease, type VI	germline;inherited;unknown	germline	GRCh38	NC_000014.9	14	50910055.0	50910055.0	14q22.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA341912	3.0	21332.0	50910055.0	C	T	-	-	-	-	-	-	2017G>A 	Glu673Lys	NM_002863.5	2.0	VUS	VUS	21332	14	50910055.0	C	T	E	K	rs113993984	14	51376773	14	50446523	673	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.2017G>A	p.Glu673Lys	c.2017G>A	p.Glu673Lys	principal1	Y	1	YES	Select	-	GAA	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.992	0.80453	D	0.95	0.96253	D	simple_aae	5.0	95.0	4.545	0.99092	H	-3.71	0.70711	D	0.97	0.98669	0.9674	0.96650	D	0.9911	0.99769	D	10	0.9887229	0.99297	D	0.770014	0.98177	D	0.978	0.99822	0.939	0.99152	P06737	E673K	Gain of ubiquitination at E673 (P = 0.0075)| Gain of methylation at E673 (P = 0.0245)| Gain of MoRF binding (P = 0.0296)| Gain of relative solvent accessibility (P = 0.1571)| Loss of glycosylation at T669 (P = 0.178)	0.991821394665	0.99163	0.986718870087724	0.98660	0.57211492241	0.53025	0.904029011726	0.96870	D	0.8578	0.96793	D	0.450038	0.92429	D	0.5902	0.96862	D	0.997689962387085	0.92096	D	0.998284	0.99194	D	0.9746767	0.98656	0.9338845	0.97322	0.97647595	0.98810	0.93752706	0.97569	-10.863	0.78969	D	0.9954	0.95716	P	0.999943577761801	0.99079	0.89032630	0.90875	0.989	0.99628	.	.	.	.	.	.	5.530287	0.91876	32.0	0.99938183818300519	0.99699	0.899112	0.84256	D	1.08942053313801	0.97921	17.06149	0.988681776713675	0.98387	18.16495	5.61	5.61	0.85327	5.43	0.93877	7.879	0.8573	7.674000	0.64997	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.959	0.5146	364	0.84712	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	1	109408	9.140100e-06	0	9	208132	4.324180e-05	0	9	236924	3.798690e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	1	15690	6.373490e-05	0	1	15690	6.373490e-05	0	0	16216	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	7	89556	7.816340e-05	0	2	30608	6.534240e-05	0	7	89556	7.816340e-05	0	0	14900	0.000000e+00	0	0	34260	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	7	102728	6.814110e-05	0	2	30526	6.551790e-05	0	7	102728	6.814110e-05	0	.	49	1614050	3.035840e-05	0	1	6084	1.643660e-04	0	1	74914	1.334860e-05	0	0	912	0.000000e+00	0	0	60012	0.000000e+00	0	0	29606	0.000000e+00	0	1	44906	2.226870e-05	0	0	64026	0.000000e+00	0	1	6084	1.643660e-04	0	38	1180014	3.220300e-05	0	6	91086	6.587180e-05	0	766	115666	0.006622516556291391	0	176	0	0	2708	0	0	4626	0	0	790	0	0	946	0	0	656	0	0	280	0	45	8428	0.005339345040341718	0	4802	0	0	3364	0	811	134276	0.006039798623730227	Glycogen_storage_disease,_type_VI	criteria_provided,_multiple_submitters,_no_conflicts	NC_000014.9:g.50910055C>T	ClinGen:CA341912	C0017925	232700	369	Phosphorylase pyridoxal-phosphate attachment site	Glu	Lys	88.25	0.14432989690721648																																																																																																																																																																																																																																																																																																																																																																																																																																																																													28			88.25	Negatively-charged	Glutamic Acid		Glycogen phosphorylase, liver form								0.6256		-3.5								 E673-S668 (PAE:  2.0), E673-D694 (PAE: 1.5), E673-Y574 (PAE: 1.5)	E673-S668 (PDBs: 1FA9), E673-D694 (PDBs: 1FA9, 8EMS, 2QLL), E673-K575 (PDBs: 1FA9, 1FC0, 1L7X, 3CEJ), E673-Y574 (PDBs: 1EM6, 1EXV, 1L5Q, 1L5R, 1L5S, 2ZB2, 3CEH, 3CEM, 3DD1, 3DDS, 3DDW, 2QLL)	 E673-G695 (PAE:  1.5)	E673-G695 (PDBs: 1FA9, 1EM6, 1FC0, 1L5Q, 1L5R, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 8EMS, 2QLL), E673-Y574 (PDBs: 1EXV, 1L5S)		E673-K575 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW)					146									-90.6		Pocket 1: Mean pLDDT: 90.27, Volume: 508.33 Å³, Druggability score: 0.63		125.3						C (loop/coil)	C (loop/coil)												88.25	14.432989	70-90	10-90	232700	autosomal recessive	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE VI	false	0.6294481627203665	0.6187249291429954	false	false	false
DES	DES_Tyr331Asn	B_7-8	-0.9596290908092282	0.3742995834541779	0.4654376330712759	-0.27132075503927977	0.7939714798630206	0.8325358088849388	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8366311934235876	0.7965109834683455	0.6147121368688155	0.5433495964535926	0.5190409261500178	0.5734674595367057	0.6632429364683229	0.5791758906279356	0.666191943080222	0.6417519547172563	0.8393442697945125	0.8627639257366564	0.4836919826050885	0.45890596167210007	0.4205072498269631	0.5876723190203746	0.7536776971421785	0.8104984611105188	DES	Tyr331Asn	NC_000002.12:219420921:T:A	991T>A	2	219420921	T	A	2	ENSG00000175084	12573	2291	CCSBVarC007849	ALE00007835	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	A09	GDEhDisVCh_40003	C09	1	VUSMutGDDh003	A09	VUSN2Hmut_GDN2h_01	B04	NULL	NULL	VUSmut_GDEh01	B04	1.0	1.0	1.0	1.0	1.0	5.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	405633.0	single nucleotide variant	NM_001927.4(DES):c.991T>A (p.Tyr331Asn)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Feb 21, 2023	1064795298.0	-	RCV000479076|RCV001851216	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219420921.0	219420921.0	2q35	criteria provided, multiple submitters, no conflicts	2.0	ACMG2022	N	ClinGen:CA16617480	2.0	421689.0	219420921.0	T	A	-	-	-	-	-	-	991T>A 	Tyr331Asn	NM_001927.4	2.0	VUS	VUS	421689	2	219420921.0	T	A	Y	N	rs1064795298	2	220285643	2	219993887	331	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.991T>A	p.Tyr331Asn	c.991T>A	p.Tyr331Asn	principal1	Y	1	YES	Select	+	TAC	1	0	T	T/T	T/T	T/T	T/T	0.101	0.30511	T	0.152	0.32573	T	0.992	0.64752	D	0.917	0.65301	D	0.91	0.92786	D	simple_aae	9.0	91.0	2.34	0.66959	M	-2.76	0.58599	D	0.815	0.80998	0.9699	0.96690	D	0.8837	0.96132	D	10	0.8892491	0.88134	D	0.26556	0.89654	D	0.833	0.94713	0.699	0.83516	P17661	Y331N	Gain of disorder (P = 0.0155)| Loss of stability (P = 0.2805)| Loss of phosphorylation at Y331 (P = 0.3209)| Gain of MoRF binding (P = 0.3313)| Loss of catalytic residue at Q327 (P = 0.5353)	0.980461431117	0.98005	0.9395362350757447	0.93896	1.44348691641	0.85950	0.901183605194	0.96567	D	0.781442	0.94184	D	0.296875	0.82590	D	0.188664	0.82366	D	0.972797155380249	0.69636	D	0.973003	0.90270	D	0.34583864	0.56411	0.34353057	0.59829	0.34583864	0.56411	0.34353057	0.59828	-4.261	0.27655	T	0.6155	0.69462	P	0.999083433487479	0.95667	0.99507916	0.97696	0.726	0.84817	.	.	.	.	.	.	5.312316	0.89197	29.9	0.9862827893088727	0.43995	0.915905	0.88091	D	0.542866202456617	0.69487	5.387055	0.526532917463196	0.69616	5.409629	4.91	4.91	0.63852	2.78	0.50870	2.891	0.48413	7.938000	0.75400	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613626	6.197220e-07	0	1	1179704	8.476700e-07	0	0	75032	0.000000e+00	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29598	0.000000e+00	0	0	44846	0.000000e+00	0	0	63904	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179704	8.476700e-07	0	0	91060	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Desmin-related_myofibrillar_myopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219420921T>A	ClinGen:CA16617480	C3661900|C1832370	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Tyr	Asn	93.77	0.6216216216216216																																																																																																																																																																																																																																																																																																																																																																																																																																																																													138			93.77	Aromatic	Tyrosine		Desmin							IF rod			-1.3								 Y331-Q327 (PAE:  1.0), Y331-I335 (PAE: 1.0)		 Y331-Q327 (PAE:  1.0), Y331-I335 (PAE: 1.0)								181									-64.6	Morphology: yRHQIQsytCEIDAL; Domain: Filament			-34.6	Interaction with NEB; Coil 2B					H (helix)	H (α-helix)												93.77	62.162163	>90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.7965109834683455	0.8366311934235876	false	false	false
TPM1	TPM1_Ile172Thr	B_15-16	1.406936914465017	0.26621642046872634	0.34019074072153127	4.706560236811825	0.0026453929738914374	0.00532041544660588	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7198032150305058	0.7056550491382387	0.5678343954356766	0.6531412410618335	0.6799286132417894	0.6198767708122355	0.6083721904104448	0.5950658943394883	0.6104979729944373	0.5720993221215717	0.6777599621618096	0.690491855315392	0.6313813512140262	0.7647913321440906	0.6957845091292296	0.5635694687497814	0.733550136114668	0.7491145747456197	TPM1	Ile172Thr	NC_000015.10:63060891:T:C	515T>C	15	63060891	T	C	15	ENSG00000140416	4723	201740	CCSBVarC005640	ALE00005640	ENSP00000288398.6	CEGS2	CegsMutGDEh1040	B10	GDEhDisVCh_40050	H07	2	CegsMutGDDh1040	B10	VUSN2Hmut_GDN2h_08	E06	VUSMutpDEST2_04	E07	VUSmut_GDEh08	E06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	40539.0	single nucleotide variant	NM_001018005.2(TPM1):c.515T>C (p.Ile172Thr)	7168.0	TPM1	HGNC:12010	Uncertain significance	1.0	Jun 15, 2023	199476312.0	-	RCV000024575|RCV000148916|RCV001314762	MedGen:C3661900|MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569	not provided|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	germline	germline	GRCh38	NC_000015.10	15	63060891.0	63060891.0	15q22.2	criteria provided, multiple submitters, no conflicts	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018094,Leiden Muscular Dystrophy (TPM1):TPM1_00008	2.0	31879.0	63060891.0	T	C	-	-	-	-	-	-	515T>C 	Ile172Thr	NM_001018005.2	2.0	VUS	VUS	31879	15	63060891.0	T	C	I	T	rs199476312	15	63353090	15	61140143	172	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.515T>C	p.Ile172Thr	c.515T>C	p.Ile172Thr	alternative1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.077	0.91343	T	0.417	0.17934	T	0.001	0.43052	B	0.017	0.66089	B	1.0	0.99291	A	simple_aae	0.0	100.0	1.29	0.32221	L	-2.66	0.64505	D	0.939	0.95739	0.8875	0.95488	D	0.9055	0.96860	D	10	0.77097404	0.76855	D	0.280615	0.90194	D	0.798	0.93363	.	.	.	.	.	0.983907537954	0.98356	.	0.92023	.	0.96349	0.874147295952	0.93146	D	0.937651	0.98984	D	0.53394	0.95249	D	0.529191	0.95179	D	0.922797620296478	0.58070	D	0.833317	0.50783	T	0.54620236	0.69445	0.4341739	0.66690	0.57172227	0.70864	0.41312367	0.65242	-13.183	0.90123	D	0.3002	0.67149	B	0.993530363297683	0.90103	0.99946028	0.99403	0.834	0.90858	.	.	.	.	.	.	4.306248	0.65862	24.9	0.99756736850104399	0.84707	0.914562	0.87766	D	0.0981743421761909	0.46122	2.879024	0.288546918746649	0.54633	3.650816	5.8	5.8	0.92070	4.46	0.83695	8.017	0.8876	7.911000	0.74068	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.993	0.69292	792	0.45931	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109378	9.142610e-06	0	1	208104	4.805290e-06	0	1	236896	4.221260e-06	0	1	7162	1.396260e-04	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13368	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	7162	1.396260e-04	0	1	16216	6.166750e-05	0	0	30522	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16708	0.000000e+00	0	0	89558	0.000000e+00	0	0	30608	0.000000e+00	0	1	16216	6.166750e-05	0	1	14900	6.711410e-05	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21606	0.000000e+00	0	0	102728	0.000000e+00	0	0	30526	0.000000e+00	0	1	14900	6.711410e-05	0	.	4	1614210	2.477990e-06	0	1	91082	1.097910e-05	0	0	75056	0.000000e+00	0	0	912	0.000000e+00	0	0	60026	0.000000e+00	0	0	29606	0.000000e+00	0	0	44892	0.000000e+00	0	0	64024	0.000000e+00	0	0	6062	0.000000e+00	0	3	1180038	2.542290e-06	0	1	91082	1.097910e-05	0	0	6126	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	302	0	0	426	0	0	0	0	0	6854	0	Hypertrophic_cardiomyopathy|Primary_familial_hypertrophic_cardiomyopathy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.63060891T>C	ClinGen:CA018094|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00008	C0007194|C0949658|C3661900	PS192600	217569|155	.	Ile	Thr	98.29	0.650887573964497																																																																																																																																																																																																																																																																																																																																																																																																																																																																													110			98.29	Aliphatic	Isoleucine		Tropomyosin alpha-1 chain	Coiled coil									4.5				O:I172-P:L176 (PDBs: 8EFH, 8EFI, 8ENC)				 I172-K168 (PAE:  1.0), I172-L176 (PAE: 1.0)	I172-L176 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), I172-K168 (PDBs: 8ENC)	 I172-K168 (PAE:  1.0), I172-L176 (PAE: 1.0)	I172-L176 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), I172-K168 (PDBs: 8ENC)							131									-64.5				-40.1						H (helix)	H (α-helix)	Helix											98.29	65.08875	>90	10-90		unknown		Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3		false	0.7056550491382387	0.7198032150305058	false	false	false
LITAF	LITAF_Pro135Arg	B_15-16	2.6633708415624735	0.0323087730878085	0.06626257649114613	-8.034572584147265	0.00008867276015700449	0.0003696225098343208	2025_03_Batch_15-16	false	true	false	false	false	false	false	false	false	false	false	false	0.9635541490597295	0.9714699062421215	0.5589204936293175	0.6334602056167411	0.6688339299761211	0.5952659072109487	0.5229755969047084	0.556834953539243	0.5440138903441557	0.4909994959049259	0.949330269225277	0.9440613911255581	0.667556217517189	0.7808329064129993	0.7229065208893264	0.626841491353709	0.993609543258966	0.983046906993901	LITAF	Pro135Arg	NC_000016.10:11549719:G:C	404C>G	16	11549719	G	C	16	ENSG00000189067	52920	2667	CCSBVarC007933	ALE00007919	ENSP00000483114.1	Edgotyping3	VUSMutGDEh006	E11	GDEhDisVCh_40036	G05	2	VUSMutGDDh006	E11	VUSN2Hmut_GDN2h_02	A05	VUSMutpDEST2_11	G11	VUSmut_GDEh02	A05	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	204476.0	single nucleotide variant	NM_001136472.2(LITAF):c.404C>G (p.Pro135Arg)	9516.0	LITAF	HGNC:16841	Uncertain significance	0.0	-	797044848.0	-	RCV000193485|RCV000789995	MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166	Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease	germline	germline	GRCh38	NC_000016.10	16	11549719.0	11549719.0	16p13.13	no assertion criteria provided	2.0	-	N	ClinGen:CA347387	3.0	208246.0	11549719.0	G	C	-	-	-	-	-	-	404C>G 	Pro135Arg	NM_001136472.2		VUS	VUS	208246	16	11549719.0	G	C	P	R	rs797044848	16	11643575	16	11551076	135	LITAF	ENSG00000189067	ENST00000570904	ENSP00000459138	Q99732	LITAF_HUMAN	c.404C>G	p.Pro135Arg	c.404C>G	p.Pro135Arg	principal1	Y	1	.	.	-	CCC	2	0	.	G/G	G/G	G/G	G/G	.	0.78662	.	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.725	0.94735	H	.	0.97667	.	0.972	0.98940	1.0147	0.97432	D	0.9054	0.96857	D	10	0.97077715	0.96635	D	0.503765	0.95185	D	.	0.99463	0.835	0.94263	Q99732	P135R	Gain of catalytic residue at P135 (P = 0.075)| Gain of sheet (P = 0.1208)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2045)| Loss of stability (P = 0.225)	0.999648150449	0.99963	.	0.90466	.	0.59185	0.718546390533	0.69783	T	0.974612	0.99745	D	0.500865	0.94280	D	0.481682	0.94201	D	0.998675525188446	0.94782	D	.	0.93125	.	0.9625677	0.97497	0.9273686	0.96869	0.9456549	0.95758	0.91507095	0.95994	-18.777	0.99765	D	.	0.94756	.	0.995914339645344	0.91700	0.99749820	0.98401	0.89	0.94126	.	.	.	.	.	.	5.446566	0.91015	32.0	0.99847757487877087	0.92756	0.881640	0.80844	D	0.856503082326334	0.89419	9.987213	0.737579241880503	0.85143	8.517887	5.01	4.03	0.46052	.	.	7.61	0.82198	11.543000	0.93152	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Charcot-Marie-Tooth_disease|Charcot-Marie-Tooth_disease_type_1C	no_assertion_criteria_provided	NC_000016.10:g.11549719G>C	ClinGen:CA347387	C0007959|C0270913	PS118220|601098	166|101083	LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor	Pro	Arg	75.73	0.029411764705882353																																																																																																																																																																																																																																																																																																																																																																																																																																																																													4			75.73	Special, No backbone hydrogen	Proline		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF	0.003		1.6																		115		Mutation: P -> T. Decreases protein stability and association with early endosome membranes. Impaired function in targeting endocytosed proteins for lysosomal degradation.							-62.1		Pocket 3: Mean pLDDT: 79.3, Volume: 304.37 Å³, Druggability score: 0		-27.1						H (helix)	H (α-helix)												75.73	2.9411764	70-90	<10	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.9714699062421215	0.9635541490597295	true	false	false
PMP22	PMP22_Leu80Pro	B_7-8	2.7283016909967612	0.034263132950688585	0.06892784805979092	-9.340359601347862	0.00008535587284447163	0.00036089407066729364	2024_01_Batch_7-8	true	true	false	false	false	false	true	true	false	false	false	false	0.9988246682788922	0.9982376194909792	0.6318555346588837	0.6111430788393113	0.7568007127216865	0.699958703682825	0.7748494761764815	0.8436332869099208	0.6986279630497017	0.6403720153863357	0.9989535949565862	0.998481337389785	0.6250679311891684	0.669968138533452	0.523658194628921	0.6233390539314317	0.9975216440253724	0.9991679991679993	PMP22	Leu80Pro	NC_000017.11:15239551:A:G	239T>C	17	15239551	A	G	17	ENSG00000109099	7323	13254	CCSBVarC001161	ALE00001161	ENSP00000308937.3	RC4	RC4_Mut_GDEh1011	D05	GDEhDisVCh_40078	C08	2	RC4_Mut_GDDh1011	D05	VUSN2Hmut_GDN2h_10	D06	VUSMutpDEST2_06	B03	VUSmut_GDEh12	E09	1.0	1.0	1.0	6.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	625389.0	single nucleotide variant	NM_000304.4(PMP22):c.239T>C (p.Leu80Pro)	5376.0	PMP22	HGNC:9118	Uncertain significance	0.0	-	1597607967.0	-	RCV000790176	MONDO:MONDO:0007790,MedGen:C0011195,OMIM:145900,Orphanet:64748	Dejerine-Sottas disease	germline	germline	GRCh38	NC_000017.11	17	15239551.0	15239551.0	17p12	no assertion criteria provided	1.0	-	N	-	2.0	637845.0	15239551.0	A	G	-	-	-	-	-	-	239T>C 	Leu80Pro	NM_000304.4		VUS	VUS	637845	17	15239551.0	A	G	L	P	rs1597607967	17	15142868	17	15083593	80	PMP22	ENSG00000109099	ENST00000675808	ENSP00000502310	Q01453	PMP22_HUMAN	.	.	c.239T>C	p.Leu80Pro	principal1	Y	.	.	.	-	CTG	2	0	A	A/A	A/A	A/A	A/A	.	0.78662	.	.	0.76775	.	1.0	0.90580	D	0.998	0.88579	D	.	0.99291	.	.	.	.	3.06	0.86793	M	.	0.88017	.	.	0.95269	0.8963	0.95608	D	0.8536	0.95111	D	10	.	0.96655	.	0.353976	0.92325	D	.	0.99091	0.852	0.95292	Q01453	L80P	Loss of stability (P = 0.0035)| Loss of helix (P = 0.3949)| Loss of MoRF binding (P = 0.4627)| Gain of catalytic residue at L82 (P = 0.5023)| Loss of sheet (P = 0.5184)	.	0.98822	.	0.97380	.	.	0.798331320286	0.81677	T	0.969157	0.99651	D	0.476874	0.93540	D	0.44722	0.93459	D	0.995610391758166	0.87648	D	.	0.55397	.	0.9314073	0.94293	0.94937897	0.98337	0.9268402	0.93830	0.93794453	0.97597	-14.195	0.93685	D	.	0.92093	.	0.99806639054089	0.93912	0.99984252	0.99792	0.952	0.97849	.	.	.	.	.	.	5.252667	0.88212	29.5	0.97973209126864258	0.37420	0.973020	0.99464	D	0.893388573000597	0.91384	10.88073	0.855024698652062	0.93269	11.95676	5.61	5.61	0.85327	3.85	0.72111	9.128	0.93734	11.120000	0.86546	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.951	0.49863	824	0.40289	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Dejerine-Sottas_disease	no_assertion_criteria_provided	NC_000017.11:g.15239551A>G	.	C0011195	145900	64748	.	Leu	Pro	96.38	0.20121951219512196																																																																																																																																																																																																																																																																																																																																																																																																																																																																													33			96.38	Aliphatic	Leucine		Peripheral myelin protein 22										3.8								 L80-F84 (PAE:  1.0), L80-S76 (PAE: 1.0)		 L80-F84 (PAE:  1.0), L80-H12 (PAE: 1.0), L80-S76 (PAE: 1.0)								131									-61.2				-43.6						H (helix)	H (α-helix)									Helical			96.38	20.121952	>90	10-90	145900	autosomal dominant	OMIM	Genetic otorhinolaryngologic disease; Rare genetic neurological disorder; Rare chromosomal anomaly	3	HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	false	0.9982376194909792	0.9988246682788922	true	true	true
SMAD3	SMAD3_Val410Phe	B_15-16	-2.215664893573161	0.06227439914219918	0.11064567661544226	-2.9410834464726863	0.021679838224477506	0.03385744948248189	2025_03_Batch_15-16	true	true	false	false	false	false	true	false	false	false	false	false	0.9689445670815475	0.9489115644323498	0.6921886149691359	0.8307414858147941	0.8060068733279755	0.7707224261484459	0.7665097885294396	0.8466000247759228	0.8850761153599477	0.7073649781277617	0.9524561640222571	0.972376431336893	0.7749350637674521	0.7654137218800281	0.7764068562696407	0.6770122518105101	0.9453669648424424	0.9655127028262022	SMAD3	Val410Phe	NC_000015.10:67190486:G:T	1228G>T	15	67190486	G	T	15	ENSG00000166949	11805	2181	CCSBVarC007757	ALE00007743	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	G05	GDEhDisVCh_40014	D12	2	VUSMutGDDh005	G05	VUSN2Hmut_GDN2h_02	A02	VUSMutpDEST2_09	C08	VUSmut_GDEh02	A02	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	N	Y	Y	Y	210298.0	single nucleotide variant	NM_005902.4(SMAD3):c.1228G>T (p.Val410Phe)	4088.0	SMAD3	HGNC:6769	Uncertain significance	0.0	May 19, 2023	863223748.0	-	RCV000535404|RCV000200368	MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3661900	Familial thoracic aortic aneurysm and aortic dissection|not provided	germline	germline	GRCh38	NC_000015.10	15	67190486.0	67190486.0	15q22.33	criteria provided, multiple submitters, no conflicts	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA324931	2.0	213777.0	67190486.0	G	T	-	-	-	-	-	-	1228G>T 	Val410Phe	NM_005902.4	2.0	VUS	VUS	213777	15	67190486.0	G	T	V	F	rs863223748	15	67482824	15	65269878	410	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.1228G>T	p.Val410Phe	c.1228G>T	p.Val410Phe	principal1	Y	1	YES	Select	+	GTC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.99	0.99291	D	simple_aae	1.0	99.0	2.56	0.74586	M	-4.71	0.79947	D	0.724	0.74074	1.1097	0.99863	D	0.9545	0.98521	D	10	0.89776367	0.89012	D	0.768609	0.98165	D	0.912	0.97659	0.653	0.78980	P84022	V410F	Loss of catalytic residue at V410 (P = 0.0175)| Loss of stability (P = 0.0865)| Gain of methylation at K409 (P = 0.0951)| Gain of ubiquitination at K409 (P = 0.2496)| Loss of MoRF binding (P = 0.2635)	0.961483364688	0.96073	0.9929549453340885	0.99290	2.76338610155	0.98752	0.795940756798	0.81312	T	0.933146	0.98873	D	0.4601	0.92877	D	0.423125	0.92789	D	0.997349143028259	0.91262	D	0.986151	0.95313	D	0.94756335	0.95955	0.8110456	0.88825	0.94756335	0.95955	0.8110456	0.88825	-14.001	0.94717	D	0.9983	0.97655	P	0.993955759918527	0.90349	0.99336445	0.97319	0.991	0.99694	.	.	.	.	.	.	5.55718	0.92116	32.0	0.9937762176901781	0.61769	0.892025	0.82794	D	0.874504626322981	0.90403	10.41226	0.831876702031497	0.91871	11.13552	4.97	4.97	0.65374	.	.	9.879	0.98503	11.875000	0.98680	0.671	0.69477	1.0	0.71675	1.000000	0.68239	1.0	0.97202	918	0.19592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.67190486G>T	ClinGen:CA324931	C3661900|C4707243	PS607086	91387	SMAD domain, Dwarfin-type	Val	Phe	92.9	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			92.9	Aliphatic	Valine		Mothers against decapentaplegic homolog 3							MH2			4.2								 V410-W406 (PAE:  1.0)	V410-M414 (PDBs: 1MJS, 5XOC), V410-W406 (PDBs: 1MJS, 1MK2)	 V410-M414 (PAE:  1.5), V410-W406 (PAE: 1.0)	V410-M414 (PDBs: 1MJS, 5XOC), V410-W406 (PDBs: 1MJS, 1MK2, 5XOC)							117									-80.4				-50.5						H (helix)	H (α-helix)	Helix											92.9	0.0	>90	<10		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.9489115644323498	0.9689445670815475	true	true	false
TPM1	TPM1_Ala239Thr	B_15-16	-3.72209863256976	0.017828016996262155	0.037904027890865	-0.4909444066012489	1.0	1.0	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.664650407781485	0.6740514508946138	0.6822878322220315	0.6928366142938521	0.7959723519918189	0.7191105682196683	0.6855532447734606	0.7727376105675293	0.7076016243607464	0.6385596164652643	0.613603519087347	0.5992143172273328	0.7526678916658762	0.8192070934161085	0.6780716042269579	0.7260160479787987	0.7344993827018805	0.7300864983356371	TPM1	Ala239Thr	NC_000015.10:63062588:G:A	715G>A	15	63062588	G	A	15	ENSG00000140416	4723	201746	CCSBVarC005647	ALE00005647	ENSP00000288398.6	CEGS2	CegsMutGDEh1036	C08	GDEhDisVCh_40050	E05	2	CegsMutGDDh1036	C08	VUSN2Hmut_GDN2h_07	A06	VUSMutpDEST2_04	B08	VUSmut_GDEh07	A06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	6.0	Y	Y	Y	N	Y	40555.0	single nucleotide variant	NM_001018005.2(TPM1):c.715G>A (p.Ala239Thr)	7168.0	TPM1	HGNC:12010	Uncertain significance	0.0	Apr 07, 2022	199476318.0	-	RCV000024591|RCV000471524	MedGen:C3661900|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569	not provided|Hypertrophic cardiomyopathy	germline	germline	GRCh38	NC_000015.10	15	63062588.0	63062588.0	15q22.2	criteria provided, multiple submitters, no conflicts	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA019305,Leiden Muscular Dystrophy (TPM1):TPM1_00026	2.0	31895.0	63062588.0	G	A	-	-	-	-	-	-	715G>A 	Ala239Thr	NM_001018005.2	2.0	VUS	VUS	31895	15	63062588.0	G	A	A	T	rs199476318	15	63354787	15	61141840	239	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.715G>A	p.Ala239Thr	c.715G>A	p.Ala239Thr	alternative1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.013	0.91343	D	0.014	0.63436	D	1.0	0.90580	D	1.0	0.97365	D	0.83	0.89397	D	simple_aae	17.0	83.0	4.655	0.99370	H	-3.0	0.66695	D	0.889	0.88784	1.0612	0.98365	D	0.9798	0.99376	D	10	0.9059943	0.89853	D	0.594235	0.96400	D	0.853	0.95458	.	.	.	.	.	0.957194814213	0.95637	.	0.93363	.	0.97323	0.887555360794	0.94946	D	0.991462	0.99967	D	0.587325	0.97313	D	0.605875	0.97270	D	0.999272048473358	0.96753	D	0.863014	0.55737	D	0.581563	0.71404	0.4669702	0.68816	0.5056727	0.67121	0.46191835	0.68498	-11.933	0.84567	D	0.7595	0.76984	P	0.996428704560746	0.92130	0.99960393	0.99523	0.922	0.96050	.	.	.	.	.	.	5.582751	0.92324	32.0	0.99935982939426926	0.99621	0.954925	0.97228	D	1.13616565809406	0.98743	19.24946	1.0752531503944	0.99623	24.49148	6.06	6.06	0.98338	.	.	10.003	0.9969	11.887000	0.98990	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	786	0.46777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hypertrophic_cardiomyopathy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.63062588G>A	ClinGen:CA019305|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00026	C0007194|C3661900	.	217569	.	Ala	Thr	94.08	0.4528301886792453																																																																																																																																																																																																																																																																																																																																																																																																																																																																													48			94.08	Aliphatic	Alanine		Tropomyosin alpha-1 chain	Coiled coil									1.8								 A239-A235 (PAE:  2.0), A239-E243 (PAE: 2.0)		 A239-A235 (PAE:  2.0), A239-E243 (PAE: 2.0)								89									-63.1				-46.5						H (helix)	H (α-helix)												94.08	45.28302	>90	10-90		unknown		Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3		false	0.6740514508946138	0.664650407781485	false	false	false
MVK	MVK_Val5Ala	B_7-8	-0.1041024907300826	0.9204806425657968	0.9416807859135896	0.6621971297310884	0.5324400401703991	0.5871559337215639	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5589663517315142	0.5661125156679743	0.6148206077386149	0.5513356655884116	0.49673638205110227	0.6082178450596034	0.6766584558263044	0.532709490250789	0.5170673570874622	0.6578609027692639	0.5830356605933602	0.5718272678417713	0.5397772342929024	0.46076327385141563	0.585603974089361	0.5717803127079658	0.5491893707425884	0.5461054356212572	MVK	Val5Ala	NC_000012.12:109574836:T:C	14T>C	12	109574836	T	C	12	ENSG00000110921	281	1	CCSBVarC007113	ALE00007111	ENSP00000228510.3	Edgotyping3	VUSMutGDEh009	A11	GDEhDisVCh_40020	F05	2	VUSMutGDDh009	A11	VUSN2Hmut_GDN2h_03	F03	VUSMutpDEST2_01	A01	VUSmut_GDEh03	F03	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	231816.0	single nucleotide variant	NM_000431.4(MVK):c.14T>C (p.Val5Ala)	4598.0	MVK	HGNC:7530	Uncertain significance	0.0	Jan 23, 2024	141765653.0	-	RCV000220987|RCV001052087|RCV001110713|RCV001112691|RCV002262823	MedGen:C3661900|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29|MONDO:MONDO:0019751,MedGen:C3890737,Orphanet:93665	not provided|Hyperimmunoglobulin D with periodic fever;Mevalonic aciduria;Porokeratosis 3, disseminated superficial actinic type|Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria|Autoinflammatory syndrome	germline;unknown	germline	GRCh38	NC_000012.12	12	109574836.0	109574836.0	12q24.11	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA6779127	2.0	234376.0	109574836.0	T	C	-	-	-	-	-	-	14T>C 	Val5Ala	NM_000431.4	2.0	VUS	VUS	234376	12	109574836.0	T	C	V	A	rs141765653	12	110012641	12	108497024	5	MVK	ENSG00000110921	ENST00000546277	ENSP00000438153	Q03426	KIME_HUMAN	c.14T>C	p.Val5Ala	c.14T>C	p.Val5Ala	principal1	Y	5	.	.	+	GTC	2	0	T	T/T	T/T	T/T	T/T	0.568	0.14239	T	0.69	0.06016	T	0.0	0.07480	B	0.0	0.06938	B	.	0.26006	.	.	.	.	0.3	0.10129	N	0.4	0.03802	N	.	0.06571	-0.7000	0.60269	T	0.3750	0.73213	T	10	0.033641785	0.01548	T	0.035499	0.56212	D	0.228	0.52551	.	.	.	.	.	0.634446159402	0.62860	.	0.48358	.	0.42823	0.450643271208	0.31992	T	0.097253	0.39703	T	-0.208185	0.19326	T	-0.354673	0.38313	T	0.01527058356357	0.00336	T	.	0.22487	.	0.1275727	0.29590	0.055716436	0.09836	0.1275727	0.29590	0.055716436	0.09836	-4.101	0.25329	T	0.0717	0.04173	LB	0.0231421820975821	0.30651	0.87979510	0.90531	0.127	0.34041	.	.	.	.	.	.	0.102585	0.05054	1.585	0.82535982878260539	0.14468	0.048057	0.08026	N	-1.21873929383849	0.04674	0.2140192	-1.20057263438218	0.05808	0.2825088	4.36	-2.75	0.05557	-6.47	0.02490	-1.546	0.02291	-3.019000	0.03152	0.665	0.62996	0.0	0.06393	0.000000	0.08389	0.955	0.50625	735	0.53648	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	19	264690	7.178209E-5	.	1	103532	9.658850e-06	0	8	197730	4.045920e-05	0	9	225650	3.988480e-05	0	0	6398	0.000000e+00	0	0	16528	0.000000e+00	0	0	2104	0.000000e+00	0	0	8708	0.000000e+00	0	0	13138	0.000000e+00	0	1	40226	2.485950e-05	0	0	14602	0.000000e+00	0	1	40226	2.485950e-05	0	0	15078	0.000000e+00	0	1	29308	3.412040e-05	0	0	5858	0.000000e+00	0	0	13208	0.000000e+00	0	0	16300	0.000000e+00	0	6	84732	7.081150e-05	0	1	28548	3.502870e-05	0	6	84732	7.081150e-05	0	0	13882	0.000000e+00	0	2	33082	6.045580e-05	0	0	9272	0.000000e+00	0	0	17296	0.000000e+00	0	0	20508	0.000000e+00	0	6	97684	6.142250e-05	0	1	28486	3.510500e-05	0	6	97684	6.142250e-05	0	.	37	1606410	2.303270e-05	0	9	6030	1.492540e-03	0	12	74964	1.600770e-04	0	0	912	0.000000e+00	0	5	58996	8.475150e-05	0	0	29362	0.000000e+00	0	0	44790	0.000000e+00	0	0	63594	0.000000e+00	0	9	6030	1.492540e-03	0	6	1176246	5.100970e-06	0	1	89238	1.120600e-05	0	4522	152900	0.029574885546108567	0	176	0	0	2710	0	0	4724	0	0	442	0	0	946	0	0	682	0	0	280	0	188	9888	0.01901294498381877	0	4900	0	0	3392	0	4710	172748	0.027265149234723413	not_provided|Mevalonic_aciduria|Hyperimmunoglobulin_D_with_periodic_fever|Porokeratosis_3,_disseminated_superficial_actinic_type|Autoinflammatory_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.109574836T>C	ClinGen:CA6779127	C3661900|C1959626|C0398691|C1867981|C3890737	610377|260920|175900	29|343|93665	.	Val	Ala	93.29	0.49295774647887325																																																																																																																																																																																																																																																																																																																																																																																																																																																																													70			93.29	Aliphatic	Valine		Mevalonate kinase										4.2											V5-R40 (PDBs: 2R3V), V5-Q42 (PDBs: 2R3V)							117									-74.2				129.3						H (helix)	P (polyproline helix)	Beta strand											93.29	49.295773	>90	10-90	260920;610377;175900;260920;610377	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; MEVALONIC ACIDURIA; POROKERATOSIS 3, MULTIPLE TYPES; HYPER-IgD SYNDROME; MEVALONIC ACIDURIA	false	0.5661125156679743	0.5589663517315142	false	false	false
MVK	MVK_Pro288Leu	B_11-12	0.017819860007656934	1.0	1.0	1.3423034601995882	1.0	1.0	2024_12_Batch_11-12	false	false	false	false	false	false	false	false	false	false	false	false	0.7129485253586817	0.7220744269166806	0.7200441768971182	0.723600395067858	0.705932010355568	0.7579936293125538	0.9279446739898334	0.8531683041084364	0.8889904766621524	0.8473295634249577	0.7867598687324682	0.7696073538455337	0.5880425846352741	0.5586957166026996	0.5582103134735636	0.5927587903692788	0.6573889851008928	0.6562896968718297	MVK	Pro288Leu	NC_000012.12:109591335:C:T	863C>T	12	109591335	C	T	12	ENSG00000110921	281	200097	CCSBVarC004844	ALE00004844	ENSP00000228510.3	CEGS2	CegsMutGDEh1041	G10	GDEhDisVCh_40020	B04	2	CegsMutGDDh1041	G10	VUSN2Hmut_GDN2h_08	C10	VUSMutpDEST2_01	G05	VUSmut_GDEh08	C10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	103526.0	single nucleotide variant	NM_000431.4(MVK):c.863C>T (p.Pro288Leu)	4598.0	MVK	HGNC:7530	Uncertain significance	0.0	Oct 04, 2024	104895355.0	-	RCV000083886|RCV000688958|RCV001664395|RCV004800278|RCV003448262	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29	Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever|not provided|not specified|Mevalonic aciduria	germline;unknown	germline	GRCh38	NC_000012.12	12	109591335.0	109591335.0	12q24.11	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA149921	2.0	97634.0	109591335.0	C	T	-	-	-	-	-	-	863C>T 	Pro288Leu	NM_000431.4	2.0	VUS	VUS	97634	12	109591335.0	C	T	P	L	rs104895355	12	110029140	12	108513523	288	MVK	ENSG00000110921	ENST00000228510	ENSP00000228510	Q03426	KIME_HUMAN	c.863C>T	p.Pro288Leu	c.863C>T	p.Pro288Leu	principal1	Y	1	YES	Select	+	CCG	2	0	C	C/C	C/C	C/C	C/C	0.387	0.16776	T	0.132	0.40298	T	0.001	0.07480	B	0.0	0.06938	B	0.86	0.91311	D	simple_aae	14.0	86.0	1.05	0.26672	L	-1.88	0.50191	N	0.688	0.69238	-0.3971	0.71995	T	0.6105	0.86158	D	10	0.16200942	0.30021	T	0.060997	0.68070	D	0.521	0.79537	.	.	.	.	.	0.761293763446	0.75723	0.5875543504859922	0.58503	0.361612119172	0.37537	0.321480095387	0.13635	T	0.130833	0.45694	T	0.000220765	0.51365	T	-0.0348054	0.67818	D	0.0169791182296562	0.00446	T	0.722228	0.33343	T	0.11103396	0.26006	0.051248696	0.08225	0.08333267	0.19065	0.04564394	0.06201	-4.233	0.27253	T	0.0707	0.03785	LB	0.138816507576405	0.46365	0.97048130	0.94693	0.217	0.48294	.	.	.	.	.	.	0.279556	0.06588	3.053	0.3892623085390553	0.02670	0.060856	0.11427	N	-1.10267242635347	0.06517	0.3040598	-1.14965361491939	0.06664	0.3272189	4.6	0.613	0.16730	-4.97	0.04537	-0.159	0.10075	-3.962000	0.02439	-0.193	0.0929	0.0	0.06393	0.000000	0.08389	0.05	0.15227	734	0.53826	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	6	109362	5.486370e-05	0	12	208056	5.767680e-05	0	13	236872	5.488200e-05	0	0	7164	0.000000e+00	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13350	0.000000e+00	0	1	42766	2.338310e-05	0	2	15690	1.274700e-04	0	2	15690	1.274700e-04	0	0	16218	0.000000e+00	0	2	30524	6.552220e-05	0	0	6212	0.000000e+00	0	1	13416	7.453790e-05	0	1	16690	5.991610e-05	0	5	89524	5.585090e-05	0	3	30608	9.801360e-05	0	3	30608	9.801360e-05	0	0	14902	0.000000e+00	0	2	34260	5.837710e-05	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	1	21588	4.632200e-05	0	6	102716	5.841350e-05	0	3	30526	9.827690e-05	0	3	30526	9.827690e-05	0	.	70	1614054	4.336910e-05	0	60	1180038	5.084580e-05	0	0	74942	0.000000e+00	0	0	912	0.000000e+00	0	2	60014	3.332560e-05	0	0	29608	0.000000e+00	0	1	44882	2.228060e-05	0	0	64004	0.000000e+00	0	0	6080	0.000000e+00	0	60	1180038	5.084580e-05	0	3	91088	3.293520e-05	0	2	42766	4.676612262077351E-5	0	298	0	0	86	0	0	7884	0	0	498	0	0	628	0	0	26	0	0	98	0	1	6322	1.5817779183802593E-4	0	8182	0	0	112	0	3	58606	5.1189298024093096E-5	Hyperimmunoglobulin_D_with_periodic_fever|Mevalonic_aciduria|Porokeratosis_3,_disseminated_superficial_actinic_type|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.109591335C>T	ClinGen:CA149921	C0398691|C1959626|C1867981|C3661900	260920|610377|175900	343|29	.	Pro	Leu	90.8	0.7058823529411765																																																																																																																																																																																																																																																																																																																																																																																																																																																																													96			90.8	Special, No backbone hydrogen	Proline		Mevalonate kinase								0.0672		1.6								 P288-L292 (PAE:  1.0)	P288-L292 (PDBs: 2R3V)	 P288-L292 (PAE:  1.0)	P288-L292 (PDBs: 2R3V)							115									-53.5		Pocket 3: Mean pLDDT: 87.56, Volume: 199.26 Å³, Druggability score: 0.07		-34.5						H (helix)	H (α-helix)	Helix											90.8	70.588234	>90	10-90	260920;175900;610377;260920;610377	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; POROKERATOSIS 3, MULTIPLE TYPES; MEVALONIC ACIDURIA; HYPER-IgD SYNDROME; MEVALONIC ACIDURIA	false	0.7220744269166806	0.7129485253586817	false	false	false
PMP22	PMP22_Arg157Gly	B_7-8	3.037681899141542	0.02287090261291949	0.04998103431427486	-4.610359344536307	0.003652082945871746	0.007106651331574394	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6955306446360932	0.708207023314658	0.544712530554404	0.5401909357798174	0.5367001986697211	0.5576353381182859	0.5323979401612212	0.5652720395065751	0.5830345807584527	0.463125962873092	0.7457791773782552	0.7519078501187473	0.5828727360753505	0.5081283578328671	0.49734729080118206	0.6262990982357161	0.6706348692510608	0.6391534391534391	PMP22	Arg157Gly	NC_000017.11:15230931:G:C	469C>G	17	15230931	G	C	17	ENSG00000109099	7323	13272	CCSBVarC001163	ALE00001163	ENSP00000308937.3	RC4	RC4_Mut_GDEh1011	F05	GDEhDisVCh_40078	E08	2	RC4_Mut_GDDh1011	F05	VUSN2Hmut_GDN2h_10	F06	VUSMutpDEST2_06	D03	VUSmut_GDEh12	G09	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	625362.0	single nucleotide variant	NM_000304.4(PMP22):c.469C>G (p.Arg157Gly)	5376.0	PMP22	HGNC:9118	Uncertain significance	0.0	-	28936682.0	-	RCV000789530	MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166	Charcot-Marie-Tooth disease	germline	germline	GRCh38	NC_000017.11	17	15230931.0	15230931.0	17p12	no assertion criteria provided	1.0	-	N	-	2.0	637387.0	15230931.0	G	C	-	-	-	-	-	-	469C>G 	Arg157Gly	NM_000304.4		VUS	VUS	637387	17	15230931.0	G	C	R	G	rs28936682	17	15134248	17	15074973	157	PMP22	ENSG00000109099	ENST00000674673	ENSP00000501804	Q01453	PMP22_HUMAN	.	.	c.469C>G	p.Arg157Gly	principal1	Y	.	.	.	-	CGG	1	2	G	G/G	G/G	G/G	G/G	.	0.72322	.	.	0.92967	.	1.0	0.90580	D	0.997	0.86259	D	.	0.95575	.	.	.	.	3.265	0.89891	M	.	0.91889	.	.	0.87025	1.0665	0.98496	D	0.9382	0.97964	D	10	.	0.82180	.	0.391269	0.93180	D	.	0.97887	0.679	0.81610	Q01453	R157G	Gain of ubiquitination at K158 (P = 0.0328)| Loss of MoRF binding (P = 0.0654)| Gain of glycosylation at K158 (P = 0.0722)| Loss of stability (P = 0.1272)| Gain of catalytic residue at V154 (P = 0.1602)	.	0.97386	.	0.89315	.	.	0.659289360046	0.61246	T	0.84091	0.96260	D	-0.271888	0.11303	T	-0.628325	0.10298	T	0.99061621151102	0.80692	D	.	0.73245	.	0.8037	0.83941	0.6761467	0.80766	0.7956994	0.83427	0.6409663	0.78794	-14.94	0.95720	D	.	0.90603	.	0.995822672892218	0.91628	0.99939180	0.99348	0.8	0.88939	.	.	.	.	.	.	4.75813	0.76943	26.6	0.99854278704618682	0.93373	0.781142	0.71176	D	0.756517669212871	0.83238	7.98904	0.694097570347044	0.81829	7.643295	5.05	5.05	0.67523	2.91	0.53205	3.165	0.50573	5.772000	0.49823	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.995	0.73271	806	0.43519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Charcot-Marie-Tooth_disease	no_assertion_criteria_provided	NC_000017.11:g.15230931G>C	.	C0007959	PS118220	166	.	Arg	Gly	86.92	0.6008064516129032																																																																																																																																																																																																																																																																																																																																																																																																																																																																													149			86.92	Positively-charged	Arginine		Peripheral myelin protein 22								0.6561		-4.5								 R157-G93 (PAE:  3.5)		 R157-G93 (PAE:  3.5)								175									-116.0		Pocket 1: Mean pLDDT: 62.92, Volume: 685.82 Å³, Druggability score: 0.66		130.3				dbSNP: rs28936682; Variant type: LB/B; AA change: Arg157Gly; PTM type: Phosphorylation; PTM morphology: LSGVIyVILR*K; Var class: II&rs28936682		B (undefined)	B (beta bridge)							Cytoplasmic					86.92	60.080647	70-90	10-90		unknown		Genetic otorhinolaryngologic disease; Rare genetic neurological disorder; Rare chromosomal anomaly	3		false	0.708207023314658	0.6955306446360932	false	false	false
AGXT	AGXT_Pro10Ala	B_7-8	-3.0519262638196674	0.0224563437708676	0.04930070873834151	6.130348732826524	0.0004766375899660144	0.0013353129428818875	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8417070748017721	0.8394373873008532	0.6725836948146646	0.6830298912843633	0.6374665773031196	0.7105573955969582	0.7746219001910073	0.6548835837220467	0.6748944906044568	0.688385271987721	0.8620293803570864	0.8393625928989052	0.646492891002909	0.6200495708841925	0.6911652919642699	0.6567821176416083	0.8168453942446198	0.844051556704639	AGXT	Pro10Ala	NC_000002.12:240868893:C:G	28C>G	2	240868893	C	G	2	ENSG00000172482	70497	3780	CCSBVarC008156	ALE00008142	ENSP00000302620.3	Edgotyping3	VUSMutGDEh003	B11	GDEhDisVCh_40002	C01	2	VUSMutGDDh003	B11	VUSN2Hmut_GDN2h_01	D05	VUSMutpDEST2_13	D12	VUSmut_GDEh01	D05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	366528.0	single nucleotide variant	NM_000030.3(AGXT):c.28C>G (p.Pro10Ala)	189.0	AGXT	HGNC:341	Uncertain significance	0.0	Feb 13, 2016	180177191.0	-	RCV000425921|RCV001833537	MedGen:CN517202|MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598	not provided|Primary hyperoxaluria, type I	germline	germline	GRCh38	NC_000002.12	2	240868893.0	240868893.0	2q37.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA2208964	2.0	383367.0	240868893.0	C	G	-	-	-	-	-	-	28C>G 	Pro10Ala	NM_000030.3	1.0	VUS	VUS	383367	2	240868893.0	C	G	P	A	rs180177191	2	241808310	2	241456983	10	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.28C>G	p.Pro10Ala	c.28C>G	p.Pro10Ala	principal1	Y	1	YES	Select	+	CCC	1	0	C	./.	./.	./.	./.	0.04	0.42356	D	0.065	0.45051	T	0.835	0.46269	P	0.338	0.42306	B	0.78	0.86494	D	simple_aae	22.0	78.0	.	.	.	-6.18	0.90311	D	0.402	0.44034	0.5430	0.91107	D	0.7088	0.89960	D	10	0.6039536	0.66782	D	0.371987	0.92753	D	0.430	0.73521	.	.	.	.	.	0.924345301417	0.92300	0.7963191980366471	0.79467	0.0697944257895	0.07650	0.399229168892	0.24932	T	0.707201	0.91539	D	0.0900666	0.62935	D	-0.108402	0.62475	T	0.6698277592659	0.39024	D	0.819218	0.47548	T	0.47627616	0.65361	0.25968835	0.51524	0.47627616	0.65361	0.25968835	0.51523	-7.451	0.57336	T	0.0906	0.12996	B	0.699428275066452	0.67008	0.21949981	0.73945	0.694	0.83023	.	.	.	.	.	.	2.691721	0.35209	19.82	0.9266392105030683	0.22394	0.682813	0.64442	D	0.0443550508906853	0.43624	2.672665	-0.0685913585749217	0.36394	2.138936	4.42	4.42	0.52717	.	.	3.842	0.55657	3.753000	0.39771	0.549	0.27038	0.925	0.32202	0.999000	0.35501	0.008	0.08289	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	0	108742	0.000000e+00	0	1	203722	4.908650e-06	0	1	233490	4.282840e-06	0	0	7040	0.000000e+00	0	0	17028	0.000000e+00	0	0	2306	0.000000e+00	0	0	9028	0.000000e+00	0	0	13366	0.000000e+00	0	0	42438	0.000000e+00	0	0	15636	0.000000e+00	0	.	.	.	.	0	15856	0.000000e+00	0	0	30388	0.000000e+00	0	0	6098	0.000000e+00	0	0	13366	0.000000e+00	0	0	16694	0.000000e+00	0	1	86048	1.162140e-05	0	0	30478	0.000000e+00	0	1	86048	1.162140e-05	0	0	14622	0.000000e+00	0	0	34128	0.000000e+00	0	0	9534	0.000000e+00	0	0	17670	0.000000e+00	0	0	21452	0.000000e+00	0	1	100094	9.990610e-06	0	0	30404	0.000000e+00	0	1	100094	9.990610e-06	0	.	13	1612864	8.060200e-06	0	1	74932	1.334540e-05	0	1	74932	1.334540e-05	0	0	912	0.000000e+00	0	0	59982	0.000000e+00	0	0	29592	0.000000e+00	0	0	44872	0.000000e+00	0	0	63130	0.000000e+00	0	0	6082	0.000000e+00	0	11	1179892	9.322890e-06	0	1	91006	1.098830e-05	0	0	37110	0	0	122	0	0	112	0	0	3390	0	0	500	0	0	628	0	0	56	0	0	98	0	0	6872	0	0	3512	0	0	168	0	0	48888	0	not_provided|Primary_hyperoxaluria,_type_I	criteria_provided,_single_submitter	NC_000002.12:g.240868893C>G	ClinGen:CA2208964	CN517202|C0268164	259900	416|93598	.	Pro	Ala	97.9	0.7058823529411765																																																																																																																																																																																																																																																																																																																																																																																																																																																																													96			97.9	Special, No backbone hydrogen	Proline		Alanine--glyoxylate aminotransferase										1.6				A:P10-B:Y66 (PDBs: 5F9S, 5HHY), A:P10-C:Y66 (PDBs: 3R9A)														115									-50.7				125.8						H (helix)	P (polyproline helix)												97.9	70.588234	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.8394373873008532	0.8417070748017721	false	false	false
SMAD3	SMAD3_Glu284Gln	B_15-16	-1.7252255525962519	0.12813815392048822	0.19946525997402814	-2.9358641510394374	0.021841324650669732	0.03408063837923381	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6612441195741967	0.6715001498288242	0.5756425777469115	0.7329828987372158	0.6985224192481826	0.6218620788379492	0.6743438382419884	0.8142417045945136	0.8297911200798171	0.6118354854058715	0.7705343949897541	0.7574295854386777	0.56938031943391	0.5828031339018516	0.6361746773946143	0.5394496700879515	0.5724659046678943	0.5650586537097158	SMAD3	Glu284Gln	NC_000015.10:67181432:G:C	850G>C	15	67181432	G	C	15	ENSG00000166949	11805	2157	CCSBVarC007735	ALE00007721	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	H02	GDEhDisVCh_40014	E09	2	VUSMutGDDh005	H02	VUSN2Hmut_GDN2h_01	B12	VUSMutpDEST2_09	D05	VUSmut_GDEh01	B12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	258944.0	single nucleotide variant	NM_005902.4(SMAD3):c.850G>C (p.Glu284Gln)	4088.0	SMAD3	HGNC:6769	Uncertain significance	0.0	Jun 18, 2023	886038991.0	-	RCV002310931|RCV003317176	MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374	Familial thoracic aortic aneurysm and aortic dissection|not specified	germline	germline	GRCh38	NC_000015.10	15	67181432.0	67181432.0	15q22.33	criteria provided, multiple submitters, no conflicts	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10587877	2.0	263961.0	67181432.0	G	C	-	-	-	-	-	-	850G>C 	Glu284Gln	NM_005902.4	2.0	VUS	VUS	263961	15	67181432.0	G	C	E	Q	rs886038991	15	67473770	15	65260824	284	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.850G>C	p.Glu284Gln	c.850G>C	p.Glu284Gln	principal1	Y	1	YES	Select	+	GAG	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.004	0.74454	D	0.999	0.77914	D	0.974	0.73159	D	0.9	0.92286	D	simple_aae	10.0	90.0	2.665	0.77788	M	-2.69	0.57463	D	0.822	0.82505	1.0923	0.99331	D	0.9413	0.98071	D	10	0.96244454	0.95623	D	0.418961	0.93741	D	0.849	0.95310	0.837	0.94387	P84022	E284Q	Gain of MoRF binding (P = 0.03)| Loss of phosphorylation at T286 (P = 0.2729)| Loss of disorder (P = 0.2888)| Loss of helix (P = 0.3949)| Gain of catalytic residue at A281 (P = 0.4945)	0.924524924817	0.92318	0.7899451232539257	0.78826	2.40020819914	0.97165	0.879806041718	0.93926	D	0.971126	0.99686	D	0.335625	0.85438	D	0.244326	0.85248	D	0.979407429695129	0.72626	D	0.979702	0.93056	D	0.9203211	0.93179	0.7357384	0.84193	0.9203211	0.93180	0.7357384	0.84195	-12.199	0.86270	D	0.937	0.87881	P	0.999220630200666	0.96001	0.98920906	0.96613	0.965	0.98576	.	.	.	.	.	.	5.372514	0.90077	31.0	0.99853867618855185	0.93284	0.898753	0.84180	D	0.825292498853389	0.87593	9.295664	0.783437005426422	0.88554	9.65054	5.1	5.1	0.68875	.	.	9.87	0.98471	11.742000	0.95221	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.488	0.28794	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_specified|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.67181432G>C	ClinGen:CA10587877	CN169374|C4707243	PS607086	91387	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Glu	Gln	98.1	0.4484536082474227																																																																																																																																																																																																																																																																																																																																																																																																																																																																													87			98.1	Negatively-charged	Glutamic Acid		Mothers against decapentaplegic homolog 3							MH2			-3.5								 E284-R288 (PAE:  1.0), E284-N280 (PAE: 1.0)	E284-R288 (PDBs: 1MJS, 5XOC), E284-N280 (PDBs: 1MJS, 1MK2, 5XOC)	 E284-R288 (PAE:  1.0), E284-N280 (PAE: 1.0)	E284-R288 (PDBs: 1MJS, 5XOC), E284-N280 (PDBs: 1MJS, 5XOC), E284-R279 (PDBs: 1MK2)							146									-56.3				-47.4	Sufficient for interaction with XPO4					H (helix)	H (α-helix)	Helix											98.1	44.84536	>90	10-90		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.6715001498288242	0.6612441195741967	false	false	false
DES	DES_Pro433Thr	B_7-8	0.3641508281359701	0.73063787165185	0.7854623887240442	2.808597977647757	0.026198625030003454	0.039895831477225176	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7829596558774432	0.7503456638179189	0.742868776037942	0.7036096776911076	0.6979148196673624	0.6992917450029734	0.9784713164753691	0.9409960535612173	0.9552799113265055	0.9687797709705784	0.8185071572346803	0.7829596558774432	0.42011217353057784	0.4548335857735075	0.45193944405570985	0.5169577811053057	0.6821841704011574		DES	Pro433Thr	NC_000002.12:219425671:C:A	1297C>A	2	219425671	C	A	2	ENSG00000175084	12573	2330	CCSBVarC007882	ALE00007868	ENSP00000363071.3	Edgotyping3	VUSMutGDEh005	G11	GDEhDisVCh_40092	D06	1	VUSMutGDDh005	G11	VUSN2Hmut_GDN2h_02	B04	NULL	NULL	VUSmut_GDEh02	B04	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	224254.0	single nucleotide variant	NM_001927.4(DES):c.1297C>A (p.Pro433Thr)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Nov 12, 2015	869025381.0	-	RCV000208119	MONDO:MONDO:0024573,MeSH:D024741,MedGen:C0949658,OMIM:PS192600,Orphanet:155	Primary familial hypertrophic cardiomyopathy	germline	germline	GRCh38	NC_000002.12	2	219425671.0	219425671.0	2q35	criteria provided, single submitter	1.0	ACMG2022	N	ClinGen:CA351781	2.0	222544.0	219425671.0	C	A	-	-	-	-	-	-	1297C>A 	Pro433Thr	NM_001927.4	1.0	VUS	VUS	222544	2	219425671.0	C	A	P	T	rs869025381	2	220290393	2	219998637	433	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1297C>A	p.Pro433Thr	c.1297C>A	p.Pro433Thr	principal1	Y	1	YES	Select	+	CCT	1	0	C	C/C	C/C	C/C	C/C	0.387	0.11010	T	0.435	0.13718	T	0.902	0.49757	P	0.714	0.54630	P	.	.	.	.	.	.	2.96	0.84955	M	-2.07	0.47354	N	0.305	0.34213	0.9636	0.96591	D	0.9211	0.97384	D	10	0.43036416	0.57108	D	0.301164	0.90866	D	0.656	0.87025	0.261	0.20368	P17661	P433T	Loss of glycosylation at P433 (P = 0.0915)| Gain of MoRF binding (P = 0.0964)| Loss of phosphorylation at S432 (P = 0.1604)| Loss of disorder (P = 0.2341)| Loss of catalytic residue at P433 (P = 0.2956)	0.990677171092	0.99046	0.8266698969841242	0.82520	0.735936696932	0.62727	0.737899303436	0.72615	T	0.193218	0.54641	T	0.351923	0.86540	D	0.267737	0.86363	D	0.96753466129303	0.67731	D	0.80082	0.44467	T	0.16709742	0.36786	0.16370194	0.37840	0.16709742	0.36786	0.16370194	0.37839	-3.787	0.20628	T	0.1235	0.26012	B	0.691072511874525	0.66725	0.99307644	0.97263	0.388	0.63790	.	.	.	.	.	.	3.833286	0.55503	23.6	0.99645680249325219	0.76969	0.938991	0.93876	D	0.496779476345738	0.66728	5.0106	0.48278198932266	0.66669	5.005951	4.46	4.46	0.53511	3.23	0.58548	3.729	0.54816	7.610000	0.61936	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.986	0.61779	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Primary_familial_hypertrophic_cardiomyopathy	criteria_provided,_single_submitter	NC_000002.12:g.219425671C>A	ClinGen:CA351781	C0949658	PS192600	155	.	Pro	Thr	38.56	0.8970588235294118																																																																																																																																																																																																																																																																																																																																																																																																																																																																													122			38.56	Special, No backbone hydrogen	Proline		Desmin										1.6																		115									-91.9				114.7	Tail					C (loop/coil)	C (loop/coil)												38.56	89.70589	$\leqslant$50	10-90		unknown		Rare genetic cardiac disease; Rare genetic neurological disorder	2		false	0.7503456638179189	0.7829596558774432	false	false	false
TH	TH_Arg133His	B_7-8	-0.33635557876328814	0.7480546133046534	0.7990963710357316	1.5481362622611954	0.16551654620675604	0.20689568275844505	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.539862920792648	0.5818653245344382	0.6779472543539238	0.615495224672125	0.5811328878291186	0.7223781300606728	0.7195488724951622	0.6133624055435587	0.6005934271877906	0.6380440192119821	0.511823447477962	0.502182551542006	0.7252073876261833	0.5489033701146786	0.6303970221564595	0.7178504894958656	0.6519072015909143	0.5775432900432901	TH	Arg133His	NC_000011.10:2168580:C:T	398G>A	11	2168580	C	T	11	ENSG00000180176	71892	4019	CCSBVarC008298	ALE00008284	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	G11	GDEhDisVCh_40019	E11	1	VUSMutGDDh015	G11	VUSN2Hmut_GDN2h_05	C01	VUSMutpDEST2_15	E09	VUSmut_GDEh05	C01	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	326992.0	single nucleotide variant	NM_000360.4(TH):c.398G>A (p.Arg133His)	7054.0	TH	HGNC:11782	Uncertain significance	0.0	Sep 13, 2022	376881948.0	-	RCV000487959|RCV000401042	MedGen:C3661900|MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150	not provided|Autosomal recessive DOPA responsive dystonia	germline;unknown	germline	GRCh38	NC_000011.10	11	2168580.0	2168580.0	11p15.5	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA5818680	2.0	304079.0	2168580.0	C	T	-	-	-	-	-	-	398G>A 	Arg133His	NM_000360.4	2.0	VUS	VUS	304079	11	2168580.0	C	T	R	H	rs376881948	11	2189810	11	2146386	164	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.491G>A	p.Arg164His	c.491G>A	p.Arg164His	.	Y	1	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.107	0.32128	T	0.101	0.42433	T	0.988	0.65587	D	0.818	0.64791	P	0.21	0.45549	N	simple_aae	79.0	21.0	2.415	0.69565	M	-2.55	0.55206	D	0.783	0.77890	1.0569	0.98265	D	0.9459	0.98229	D	10	0.8991172	0.89151	D	0.825009	0.98638	D	0.617	0.85019	.	.	.	.	.	0.965637806794	0.96496	0.7295375854633842	0.72755	0.229973161128	0.25263	0.819800853729	0.84971	D	0.710653	0.91666	D	0.0639613	0.59827	T	0.0596055	0.74026	D	0.219261228269706	0.21166	T	0.876412	0.89436	D	0.14576232	0.33116	0.20423481	0.44379	0.14576232	0.33116	0.20423481	0.44378	-7.646	0.73503	D	0.117	0.31051	B	0.679531237429789	0.66342	0.98775360	0.96409	0.594	0.77258	.	.	.	.	.	.	4.655138	0.74296	26.1	0.99822526137812173	0.90510	0.769222	0.70346	D	0.0708247675172762	0.44848	2.772711	-0.0736030563291237	0.36183	2.123933	3.31	3.31	0.36950	.	.	3.533	0.53409	3.780000	0.39867	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.012	0.09703	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	18	264690	6.800408E-5	.	3	106752	2.810250e-05	0	9	199460	4.512180e-05	0	9	229642	3.919140e-05	0	0	6644	0.000000e+00	0	0	16888	0.000000e+00	0	0	2256	0.000000e+00	0	0	8804	0.000000e+00	0	0	13278	0.000000e+00	0	3	41430	7.241130e-05	0	0	15592	0.000000e+00	0	3	41430	7.241130e-05	0	1	14404	6.942520e-05	0	0	30188	0.000000e+00	0	0	5948	0.000000e+00	0	0	13086	0.000000e+00	0	0	16530	0.000000e+00	0	8	84212	9.499830e-05	0	0	30438	0.000000e+00	0	8	84212	9.499830e-05	0	1	13294	7.522190e-05	0	0	33960	0.000000e+00	0	0	9418	0.000000e+00	0	0	17436	0.000000e+00	0	0	20950	0.000000e+00	0	8	98750	8.101270e-05	0	0	30372	0.000000e+00	0	8	98750	8.101270e-05	0	.	111	1611722	6.887040e-05	0	1	5948	1.681240e-04	0	2	74920	2.669510e-05	0	0	912	0.000000e+00	0	0	59968	0.000000e+00	0	0	29562	0.000000e+00	0	2	44844	4.459910e-05	0	0	62548	0.000000e+00	0	1	5948	1.681240e-04	0	98	1179674	8.307380e-05	0	1	91008	1.098800e-05	0	0	15748	0	0	122	0	0	112	0	0	3368	0	0	146	0	0	610	0	0	56	0	0	98	0	0	2772	0	0	3490	0	0	168	0	0	23032	0	Autosomal_recessive_DOPA_responsive_dystonia|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.2168580C>T	ClinGen:CA5818680	C2673535|C3661900	605407	101150	Tyrosine 3-monooxygenase-like, ACT domain	Arg	His	90.91	0.41935483870967744																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																90.91	41.935482	>90	10-90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.5818653245344382	0.539862920792648	false	false	false
APOA1	APOA1_Arg34Leu	B_15-16	18.643315252311247	3.1707843549310316e-7	0.00003363309873058644	5.691601733382731	0.000741765597934068	0.0018696976266607346	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7396526719839223	0.8054728580500983	0.5770719808768877	0.8603385295827427	0.7648258378167586	0.676880794011386	0.7349265295408132	0.8024798230327067	0.8627494089650066	0.6314263648301007	0.8035358780051346	0.7287234894807885	0.6188350584819589	0.7271718526008105	0.8579276502004788	0.5227175969236747	0.8074098380950621	0.7505818544870559	APOA1	Arg34Leu	NC_000011.10:116837100:C:A	101G>T	11	116837100	C	A	11	ENSG00000118137	5613	10211	CCSBVarC000857	ALE00000857	ENSP00000236850.3	CEGS2	CegsMutGDEh1046	B02	NULL	NULL	NULL	CegsMutGDDh1046	B02	VUSN2Hmut_GDN2h_09	C12	NULL	NULL	VUSmut_GDEh09	C12	0.0		1.0	1.0	1.0	1.0	7.0	0.0			1.0	1.0	6.0	Y	Y	Y	N	Y	32959.0	single nucleotide variant	NM_000039.3(APOA1):c.101G>T (p.Arg34Leu)	335.0	APOA1	HGNC:600	Uncertain significance	1.0	Sep 07, 2022	28929476.0	-	RCV000019513|RCV001508677|RCV002496420	|MedGen:C3661900|MONDO:MONDO:0032766,MedGen:C5551172,OMIM:618463;MONDO:MONDO:0859238,MedGen:C5677030,OMIM:619836;MONDO:MONDO:0007099,MedGen:C0268389,OMIM:105200,Orphanet:85450	APOLIPOPROTEIN A-I (BALTIMORE)|not provided|Hypoalphalipoproteinemia, primary, 2;Hypoalphalipoproteinemia, primary, 2, intermediate;Familial visceral amyloidosis, Ostertag type	germline;unknown	germline	GRCh38	NC_000011.10	11	116837100.0	116837100.0	11q23.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA127563,UniProtKB:P02647#VAR_000608,OMIM:107680.0013	3.0	17920.0	116837100.0	C	A	-	-	-	-	-	-	101G>T 	Arg34Leu	NM_000039.3	2.0	VUS	VUS	17920	11	116837100.0	C	A	R	L	rs28929476	11	116707816	11	116213026	34	APOA1	ENSG00000118137	ENST00000359492	ENSP00000352471	P02647	APOA1_HUMAN	c.101G>T	p.Arg34Leu	c.101G>T	p.Arg34Leu	principal1	Y	2	.	.	-	CGA	2	0	C	./.	./.	./.	./.	0.012	0.54841	D	0.013	0.63436	D	0.722	0.42404	P	0.293	0.40773	B	0.99	0.97926	A	simple_aae	1.0	99.0	1.7	0.43657	L	-2.85	0.60060	D	0.9	0.90017	-0.8206	0.53710	T	0.2111	0.56959	T	10	0.93084985	0.92339	D	0.132963	0.81478	D	0.367	0.68503	.	.	.	.	.	0.774399787919	0.77054	.	0.57167	.	0.82976	0.216481626034	0.01119	T	0.464298	0.79840	T	0.0483236	0.57835	T	-0.152877	0.58701	T	0.873907744884491	0.52115	D	.	0.48652	.	0.34981182	0.56723	0.21258928	0.45568	0.25585327	0.48291	0.21737294	0.46230	-5.912	0.45593	T	.	0.66171	.	0.964943673717094	0.82449	0.99580103	0.97879	0.308	0.57518	.	.	.	.	.	.	2.289635	0.29335	18.07	0.98712577026034276	0.45194	0.614637	0.60046	D	-0.826154307822542	0.12491	0.6176262	-1.00949564780553	0.09415	0.4771891	4.76	-4.05	0.03732	1.41	0.33185	-0.35	0.07789	-0.435000	0.09237	-0.202	0.08747	0.0	0.06393	0.000000	0.08389	0.981	0.58703	490	0.76745	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109386	9.141940e-06	0	2	207986	9.616030e-06	0	2	236642	8.451590e-06	0	0	7164	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13384	0.000000e+00	0	1	42766	2.338310e-05	0	0	15688	0.000000e+00	0	1	42766	2.338310e-05	0	0	16204	0.000000e+00	0	0	30506	0.000000e+00	0	0	6206	0.000000e+00	0	0	13416	0.000000e+00	0	0	16724	0.000000e+00	0	2	89468	2.235440e-05	0	0	30606	0.000000e+00	0	2	89468	2.235440e-05	0	0	14888	0.000000e+00	0	0	34242	0.000000e+00	0	0	9560	0.000000e+00	0	0	17692	0.000000e+00	0	0	21612	0.000000e+00	0	2	102514	1.950950e-05	0	0	30524	0.000000e+00	0	2	102514	1.950950e-05	0	.	5	1613950	3.097990e-06	0	5	1180020	4.237220e-06	0	0	74926	0.000000e+00	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29598	0.000000e+00	0	0	44890	0.000000e+00	0	0	63944	0.000000e+00	0	0	6084	0.000000e+00	0	5	1180020	4.237220e-06	0	0	91088	0.000000e+00	0	1	42832	2.3347030257751215E-5	0	298	0	0	120	0	0	7892	0	0	498	0	0	628	0	0	26	0	0	104	0	0	6360	0	0	8190	0	0	146	0	1	58758	1.7018959120460193E-5	not_provided|APOLIPOPROTEIN_A-I_(BALTIMORE)|Hypoalphalipoproteinemia,_primary,_2,_intermediate|Familial_visceral_amyloidosis,_Ostertag_type|Hypoalphalipoproteinemia,_primary,_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.116837100C>A	ClinGen:CA127563|OMIM:107680.0013|UniProtKB:P02647#VAR_000608	C3661900|C5677030|C0268389|C5551172	619836|105200|618463	85450	.	Arg	Leu	60.29	0.6048387096774194																																																																																																																																																																																																																																																																																																																																																																																																																																																																													150			60.29	Positively-charged	Arginine		Proapolipoprotein A-I; Apolipoprotein A-I; Truncated apolipoprotein A-I										-4.5					A:R34-B:E258 (PDBs: 3K2S)			 R34-Q29 (PAE:  7.5), R34-L38 (PAE: 3.0)	R34-L38 (PDBs: 3R2P)	 R34-S30 (PAE:  4.0), R34-L38 (PAE: 3.0)	R34-L38 (PDBs: 3R2P)		R34-D37 (PDBs: 3K2S)					175									-69.1				-34.0				dbSNP: rs28929476; Variant type: LB/B; AA change: Arg34Leu; PTM type: Ubiquitylation; PTM morphology: PWDR*VkDLATV; Var class: II		H (helix)	H (α-helix)	Helix											60.29	60.48387	50-70	10-90	618463;619836;105200	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic renal disease; Rare genetic endocrine disease; Rare inborn errors of metabolism	4	HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2; HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2, INTERMEDIATE; AMYLOIDOSIS, HEREDITARY SYSTEMIC 2	false	0.8054728580500983	0.7396526719839223	false	false	false
PMP22	PMP22_Cys109Arg	B_7-8	1.4862326071300347	0.1877683067257142	0.2674700201811037	-8.914144702366082	0.00011111280517218364	0.0004403714848616781	2024_01_Batch_7-8		true	false	false	false	false		true	false	false	false	false		0.9995149051029968	0.6289867291834981	0.5966375249855549	0.7043595068677353	0.6599049168423172	0.7426849324911058	0.7873894577980716	0.6767365462267239	0.6960722255834106	0.9997428449876559		0.5771249011935287	0.621329555937399	0.516538503744386	0.5619012327835856	0.9992869652183378		PMP22	Cys109Arg	NC_000017.11:15231075:A:G	325T>C	17	15231075	A	G	17	ENSG00000109099	7323	13263	CCSBVarC001162	ALE00001162	ENSP00000308937.3	RC4	RC4_Mut_GDEh1011	E05	GDEhDisVCh_40078	D08	2	RC4_Mut_GDDh1011	E05	VUSN2Hmut_GDN2h_10	E06	VUSMutpDEST2_06	C03	VUSmut_GDEh12	F09	1.0	1.0	1.0	4.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	625376.0	single nucleotide variant	NM_000304.4(PMP22):c.325T>C (p.Cys109Arg)	5376.0	PMP22	HGNC:9118	Uncertain significance	0.0	-	1597597876.0	-	RCV000790320	MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166	Charcot-Marie-Tooth disease	germline	germline	GRCh38	NC_000017.11	17	15231075.0	15231075.0	17p12	no assertion criteria provided	1.0	-	N	-	2.0	637939.0	15231075.0	A	G	-	-	-	-	-	-	325T>C 	Cys109Arg	NM_000304.4		VUS	VUS	637939	17	15231075.0	A	G	C	R	rs1597597876	17	15134392	17	15075117	109	PMP22	ENSG00000109099	ENST00000675808	ENSP00000502310	Q01453	PMP22_HUMAN	.	.	c.325T>C	p.Cys109Arg	principal1	Y	.	.	.	-	TGC	1	0	A	A/A	A/A	A/A	A/A	.	0.68399	.	.	0.61305	.	0.996	0.68795	D	0.897	0.63625	P	.	0.90354	.	.	.	.	3.14	0.88093	M	.	0.94581	.	.	0.70297	0.8526	0.95044	D	0.8326	0.94378	D	10	.	0.95095	.	0.59585	0.96419	D	.	0.97849	0.816	0.93022	Q01453	C109R	Gain of methylation at C109 (P = 0.0343)| Gain of MoRF binding (P = 0.0805)| Loss of helix (P = 0.3949)| Loss of catalytic residue at M111 (P = 0.4091)| Loss of glycosylation at S112 (P = 0.4628)	.	0.92422	.	0.94321	.	.	0.769037842751	0.77240	T	0.977952	0.99801	D	0.458307	0.92796	D	0.42055	0.92706	D	0.995944082736969	0.88269	D	.	0.70644	.	0.92893344	0.94041	0.9054477	0.95300	0.9227265	0.93417	0.8946771	0.94525	-15.447	0.96819	D	.	0.94292	.	0.996433940912139	0.92139	0.99978775	0.99726	0.951	0.97790	.	.	.	.	.	.	5.083605	0.84879	28.4	0.99690121748016147	0.79863	0.938402	0.93733	D	0.793599347255215	0.85624	8.656023	0.738866589931823	0.85241	8.546299	5.16	5.16	0.70523	3.85	0.72111	9.131	0.93747	11.238000	0.90348	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.914	0.44958	806	0.43519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Charcot-Marie-Tooth_disease	no_assertion_criteria_provided	NC_000017.11:g.15231075A>G	.	C0007959	PS118220	166	.	Cys	Arg	98.27	0.1111111111111111																																																																																																																																																																																																																																																																																																																																																																																																																																																																													15			98.27	Special, a very reactive sulfhydryl group	Cysteine		Peripheral myelin protein 22										2.5								 C109-A113 (PAE:  1.0), C109-L105 (PAE: 1.0)		 C109-L71 (PAE:  1.0), C109-A113 (PAE: 1.0), C109-L105 (PAE: 1.0)								121									-63.7				-37.7						H (helix)	H (α-helix)									Helical			98.27	11.111112	>90	10-90		unknown		Genetic otorhinolaryngologic disease; Rare genetic neurological disorder; Rare chromosomal anomaly	3		false	0.9995149051029968		true		true
RP2	RP2_Cys86Tyr	B_7-8	-4.961815998135415	0.002547617072175259	0.009430132960958808	-13.24687487253007	0.000011436126349653063	0.00008229526216318969	2024_01_Batch_7-8		true	false	false	false	false		true	false	false	false	false		0.9928507162801851	0.6965155237587555	0.8025322998571482	0.7511931928542351	0.8209219386033566	0.832608256255755	0.6606181865088213	0.8432334359290439	0.6794666006409021	0.9967595691021486		0.8092356209509584	0.841768199199649	0.7618311637852526	0.7135644468766088	0.9889418634582215		RP2	Cys86Tyr	NC_000023.11:46853630:G:A	257G>A	23	46853630	G	A	X	ENSG00000102218	11374	19275	CCSBVarC001706	ALE00001706	ENSP00000218340.3	RC4	RC4_Mut_GDEh1017	C08	GDEhDisVCh_40085	D09	1	RC4_Mut_GDDh1017	C08	NULL	NULL	VUSMutpDEST2_08	A11	VUSmut_GDEh13	A02	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	1362566.0	single nucleotide variant	NM_006915.3(RP2):c.257G>A (p.Cys86Tyr)	6102.0	RP2	HGNC:10274	Uncertain significance	0.0	Aug 23, 2022	2147081236.0	-	RCV001968924	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000023.11	X	46853630.0	46853630.0	Xp11.3	criteria provided, single submitter	1.0	-	N	-	2.0	1468322.0	46853630.0	G	A	-	-	-	-	-	-	257G>A 	Cys86Tyr	NM_006915.3	1.0	VUS	VUS	1468322	X	46853630.0	G	A	C	Y	rs2147081236	X	46713065	X	46598009	86	RP2	ENSG00000102218	ENST00000218340	ENSP00000218340	O75695	XRP2_HUMAN	c.257G>A	p.Cys86Tyr	c.257G>A	p.Cys86Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	D	simple_aae	3.0	97.0	3.145	0.88167	M	-11.0	0.99309	D	0.994	0.99902	1.0992	0.99627	D	0.9541	0.98508	D	10	0.99516106	0.99977	D	0.852818	0.98864	D	0.958	0.99315	0.936	0.99070	O75695	C86Y	Loss of stability (P = 0.279)| Loss of sheet (P = 0.302)| Loss of catalytic residue at T87 (P = 0.3356)| Gain of loop (P = 0.4248)| Gain of phosphorylation at T82 (P = 0.6238)	0.999260063426	0.99923	0.9810250568654212	0.98085	1.33722759673	0.83689	0.761965155602	0.76179	T	0.914607	0.98402	D	0.713678	0.99939	D	0.787372	0.99939	D	0.999903678894043	0.99626	D	0.980802	0.93437	D	0.99697745	0.99993	0.99584854	0.99999	0.9976109	0.99997	0.99539196	0.99999	-20.581	0.99962	D	0.9866	0.92613	P	0.989485594627791	0.88193	0.99966910	0.99591	0.974	0.99029	.	.	.	.	.	.	5.018824	0.83427	28.0	0.99770329450575013	0.85846	.	.	.	.	.	.	.	.	.	5.62	5.62	0.85695	3.72	0.68345	9.45	0.96778	11.839000	0.97763	0.672	0.70176	1.0	0.71675	1.000000	0.68239	1.0	0.97202	135	0.94621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000023.11:g.46853630G>A	.	C3661900	.	.	Tubulin binding cofactor C-like domain|Tubulin binding cofactor C-like domain|C-CAP/cofactor C-like domain|CARP motif	Cys	Tyr	98.83	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.83	Special, a very reactive sulfhydryl group	Cysteine		Protein XRP2							C-CAP/cofactor C-like			2.5								 C86-R106 (PAE:  1.0)	C86-R106 (PDBs: 2BX6, 3BH6, 3BH7)	 C86-C105 (PAE:  1.0), C86-C108 (PAE: 1.0), C86-C67 (PAE: 1.0), C86-R106 (PAE: 1.0), C86-I64 (PAE: 1.0)	C86-C105 (PDBs: 2BX6, 3BH7), C86-C108 (PDBs: 2BX6, 3BH7), C86-C67 (PDBs: 2BX6, 3BH6, 3BH7), C86-R106 (PDBs: 2BX6, 3BH7), C86-D66 (PDBs: 2BX6, 3BH7), C86-I64 (PDBs: 2BX6, 3BH7)							121									-91.8				136.4						C (loop/coil)	C (loop/coil)												98.83	0.0	>90	<10		unknown		Rare genetic eye disease; Ciliopathy	2		false	0.9928507162801851		true		true
LITAF	LITAF_Gly53Ala	B_15-16	-5.262481020621308	0.0011701725381026025	0.005302156330483825	3.6349830587430305	0.008342457694889522	0.014635191080422823	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6982019795802225	0.6941443596687402	0.6901189328680343	0.7676166308704848	0.7363875144020442	0.7291455306164343	0.6766215316187099	0.7339534099790971	0.7123811972398874	0.6569267843486097	0.6312128176654382	0.6447210802760447	0.7816695296141587	0.7388216188249912	0.8228520645010824	0.7233110813874588	0.7570759016720421	0.7516828788844002	LITAF	Gly53Ala	NC_000016.10:11556573:C:G	158G>C	16	11556573	C	G	16	ENSG00000189067	52920	2683	CCSBVarC007941	ALE00007927	ENSP00000483114.1	Edgotyping3	VUSMutGDEh007	D01	GDEhDisVCh_40036	A07	2	VUSMutGDDh007	D01	VUSN2Hmut_GDN2h_02	F06	VUSMutpDEST2_12	F01	VUSmut_GDEh02	F06	1.0	1.0	1.0	5.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	324076.0	single nucleotide variant	NM_001136472.2(LITAF):c.158G>C (p.Gly53Ala)	9516.0	LITAF	HGNC:16841	Uncertain significance	0.0	Jan 12, 2018	886051654.0	-	RCV000302266	MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083	Charcot-Marie-Tooth disease type 1C	germline	germline	GRCh38	NC_000016.10	16	11556573.0	11556573.0	16p13.13	criteria provided, single submitter	1.0	-	N	ClinGen:CA10636995	2.0	317785.0	11556573.0	C	G	-	-	-	-	-	-	158G>C 	Gly53Ala	NM_001136472.2	1.0	VUS	VUS	317785	16	11556573.0	C	G	G	A	rs886051654	16	11650429	16	11557930	53	LITAF	ENSG00000189067	ENST00000574763	ENSP00000461813	Q99732	LITAF_HUMAN	c.158G>C	p.Gly53Ala	c.158G>C	p.Gly53Ala	principal1	Y	3	.	.	-	GGG	2	0	C	C/C	C/C	C/C	C/C	.	0.10580	.	1.0	0.33327	T	0.429	0.35573	B	0.05	0.25280	B	.	.	.	.	.	.	1.645	0.41851	L	.	0.13539	.	0.3	0.44513	-0.2481	0.76304	T	0.4248	0.76774	T	10	0.20751491	0.36665	T	0.057579	0.66896	D	.	0.64439	0.146	0.04910	Q99732	G53A	Loss of sheet (P = 0.0817)| Loss of glycosylation at K54 (P = 0.1836)| Loss of phosphorylation at T49 (P = 0.2147)| Loss of catalytic residue at K54 (P = 0.2875)| Gain of loop (P = 0.3485)	0.992533182494	0.99235	.	0.57666	.	0.20481	0.484315544367	0.36602	T	0.198561	0.65469	T	0.0491388	0.57939	T	-0.167192	0.57405	T	0.46313750743866	0.30969	T	0.834817	0.54608	T	0.051705733	0.09448	0.047639705	0.06920	0.051705733	0.09447	0.047639705	0.06920	-4.163	0.32409	T	0.0998	0.56998	B	0.0929651042986704	0.42664	0.90233755	0.91294	0.055	0.14822	.	.	.	.	.	.	2.640419	0.34417	19.6	0.24779166531329125	0.01107	0.231655	0.35278	N	-0.154025899416392	0.34789	2.009318	-0.0654580913350089	0.36527	2.148336	5.39	4.38	0.51962	.	.	1.089	0.30601	5.740000	0.49643	0.599	0.40292	0.948	0.33071	1.000000	0.68239	0.071	0.16748	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Charcot-Marie-Tooth_disease_type_1C	criteria_provided,_single_submitter	NC_000016.10:g.11556573C>G	ClinGen:CA10636995	C0270913	601098	101083	.	Gly	Ala	50.92	0.9166666666666666																																																																																																																																																																																																																																																																																																																																																																																																																																																																													77			50.92	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Lipopolysaccharide-induced tumor necrosis factor-alpha factor										-0.4																		75									-161.4				93.1						C (loop/coil)	C (loop/coil)												50.92	91.66667	50-70	$\geqslant$90	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.6941443596687402	0.6982019795802225	false	false	false
COMP	COMP_Thr529Ile	B_7-8	-0.7648960072759741	0.4788601955883225	0.5638859269874821	0.41261969760049627	0.6922298247717562	0.7376548945738517	2024_01_Batch_7-8	false	false	true	false	false	false	false	false	false	false	false	false	0.6064122296406258	0.6935192675162765	0.9359963448847037	0.8229291119428934	0.7903025038719143	0.9586404017618321	0.9209696029871115	0.8147375893366515	0.8024808488360495	0.9174224342400612	0.6552498186766599	0.6064122296406258	0.9963112005365526	0.7658674184071771	0.8433773750497374	0.9545702555293464	0.7317887163558929		COMP	Thr529Ile	NC_000019.10:18785755:G:A	1586C>T	19	18785755	G	A	19	ENSG00000105664	56661	3348	CCSBVarC008144	ALE00008130	ENSP00000222271.2	Edgotyping3	VUSMutGDEh015	G07	GDEhDisVCh_40037	C11	1	VUSMutGDDh015	G07	VUSN2Hmut_GDN2h_04	A09	VUSMutpDEST2_13	D08	VUSmut_GDEh04	A09	1.0	1.0	1.0	1.0	1.0	6.0	7.0	1.0	6.0	1.0	1.0	1.0	1.0	Y	Y	N	N	Y	49412.0	single nucleotide variant	NM_000095.3(COMP):c.1586C>T (p.Thr529Ile)	1311.0	COMP	HGNC:2227	Uncertain significance	0.0	Apr 06, 2017	312262903.0	-	RCV000033882|RCV000489545	MONDO:MONDO:0008322,MedGen:C0410538,OMIM:177170,Orphanet:750|MedGen:C3661900	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided	germline	germline	GRCh38	NC_000019.10	19	18785755.0	18785755.0	19p13.11	criteria provided, single submitter	2.0	-	N	ClinGen:CA343855,UniProtKB:P49747#VAR_066825	3.0	40990.0	18785755.0	G	A	-	-	-	-	-	-	1586C>T 	Thr529Ile	NM_000095.3	1.0	VUS	VUS	40990	19	18785755.0	G	A	T	I	rs312262903	19	18896565	19	18757565	529	COMP	ENSG00000105664	ENST00000222271	ENSP00000222271	P49747	COMP_HUMAN	c.1586C>T	p.Thr529Ile	c.1586C>T	p.Thr529Ile	principal1	Y	1	YES	Select	-	ACC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	0.991	0.64084	D	0.906	0.64345	P	0.89	0.97926	D	simple_aae	11.0	89.0	3.205	0.89058	M	-5.53	0.86103	D	0.94	0.98852	1.0311	0.97733	D	0.9007	0.96699	D	10	0.979586	0.97866	D	0.717453	0.97706	D	0.936	0.98562	0.846	0.94938	P49747	T529I	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Loss of disorder (P = 0.2877)| Gain of catalytic residue at D530 (P = 0.3462)| Loss of phosphorylation at T529 (P = 0.5182)	0.946460260038	0.94546	0.874641970317747	0.87353	.	.	0.837638556957	0.87713	D	0.810058	0.95204	D	0.503912	0.94344	D	0.486058	0.94264	D	0.99781596660614	0.92425	D	0.990201	0.96983	D	0.88510036	0.89951	0.81622565	0.89160	0.88980496	0.90357	0.82841027	0.89953	-11.156	0.80842	D	0.9497	0.86847	P	0.994731794440022	0.90841	0.99778783	0.98508	0.926	0.96292	.	.	.	.	.	.	4.741443	0.76512	26.5	0.99877060839559428	0.95413	0.965412	0.98767	D	0.819562981969274	0.87243	9.175057	0.73476844681026	0.84933	8.456229	4.54	4.54	0.55168	.	.	9.796	0.9823	11.702000	0.94523	0.522	0.23977	1.0	0.71675	1.000000	0.68239	0.433	0.27566	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	not_provided|Pseudoachondroplastic_spondyloepiphyseal_dysplasia_syndrome	criteria_provided,_single_submitter	NC_000019.10:g.18785755G>A	ClinGen:CA343855|UniProtKB:P49747#VAR_066825	C3661900|C0410538	177170	750	.	Thr	Ile	93.92	0.056338028169014086																																																																																																																																																																																																																																																																																																																																																																																																																																																																													8			93.92	Polar/Neutral	Threonine		Cartilage oligomeric matrix protein										-0.7								 T529-Y739 (PAE:  1.0)	T529-Y739 (PDBs: 3FBY)	 T529-V519 (PAE:  1.5), T529-Y739 (PAE: 1.0)	T529-V519 (PDBs: 3FBY), T529-Y739 (PDBs: 3FBY)							119									-73.5				116.5	Mediates cell survival and induction of the IAP family of survival proteins					C (loop/coil)	C (loop/coil)												93.92	5.633803	>90	<10	177170	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	2	PSEUDOACHONDROPLASIA	false	0.6935192675162765	0.6064122296406258	false	false	false
PYGL	PYGL_Lys681Thr	B_7-8	-1.471348510579353	0.20116698418308046	0.28252127925712034	-7.280001947551816	0.0003420453081551726	0.0010289395745323635	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8464820625026077	0.8963548241843788	0.7498096194420528	0.6098346486447531	0.5924252851444594	0.7393706133595647	0.8442166507164512	0.7380197408837614	0.7261337450914118	0.8332177909863074	0.9635380779523057	0.962461628902052	0.6345245760026781	0.44683082940515734	0.4935355521980945	0.6664014478977982	0.829171570416452	0.7305024961031635	PYGL	Lys681Thr	NC_000014.9:50910030:T:G	2042A>C	14	50910030	T	G	14	ENSG00000100504	55246	219177	CCSBVarC003083	ALE00003083	ENSP00000216392.7	CEGS2	CegsMutGDEh1038	G06	GDEhDisVCh_40063	H08	1	CegsMutGDDh1038	G06	VUSN2Hmut_GDN2h_07	C11	VUSMutpDEST2_13	E05	VUSmut_GDEh07	C11	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	34187.0	single nucleotide variant	NM_002863.5(PYGL):c.2042A>C (p.Lys681Thr)	5836.0	PYGL	HGNC:9725	Uncertain significance	0.0	Mar 18, 2016	113993987.0	-	RCV000020500	MONDO:MONDO:0009294,MedGen:C0017925,OMIM:232700,Orphanet:369	Glycogen storage disease, type VI	germline;unknown	germline	GRCh38	NC_000014.9	14	50910030.0	50910030.0	14q22.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA341918	3.0	21335.0	50910030.0	T	G	-	-	-	-	-	-	2042A>C 	Lys681Thr	NM_002863.5	1.0	VUS	VUS	21335	14	50910030.0	T	G	K	T	rs113993987	14	51376748	14	50446498	681	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.2042A>C	p.Lys681Thr	c.2042A>C	p.Lys681Thr	principal1	Y	1	YES	Select	-	AAG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.99	0.99291	D	simple_aae	1.0	99.0	4.545	0.99092	H	-5.57	0.86403	D	0.95	0.95855	1.0958	0.99480	D	0.9582	0.98647	D	10	0.98236895	0.98294	D	0.410952	0.93584	D	0.989	0.99969	0.916	0.98413	P06737	K681T	Loss of ubiquitination at K681 (P = 0.0141)| Loss of methylation at K681 (P = 0.0216)| Loss of catalytic residue at K681 (P = 0.102)| Loss of disorder (P = 0.186)| Gain of phosphorylation at T677 (P = 0.22)	0.997601983733	0.99753	0.9466691902546355	0.94615	0.589039569719	0.54136	0.911538422108	0.97612	D	0.830708	0.95923	D	0.493196	0.94038	D	0.56752	0.96153	D	0.998852133750916	0.95336	D	0.991801	0.97448	D	0.99058306	0.99790	0.9653587	0.99237	0.98854196	0.99680	0.96658397	0.99298	-15.494	0.96908	D	0.995	0.95515	P	0.999956927874411	0.99183	0.89865220	0.91163	0.968	0.98734	.	.	.	.	.	.	5.21636	0.87556	29.3	0.99809021290042466	0.89272	0.922499	0.89719	D	1.04112154554283	0.96859	15.26589	0.937637308970848	0.96997	15.46267	5.61	5.61	0.85327	.	.	7.991	0.87929	7.891000	0.73091	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.978	0.57275	364	0.84712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109408	0.000000e+00	0	1	208134	4.804600e-06	0	1	236934	4.220580e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89556	0.000000e+00	0	1	30608	3.267120e-05	0	1	30608	3.267120e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	0	102730	0.000000e+00	0	1	30526	3.275900e-05	0	1	30526	3.275900e-05	0	.	2	1614156	1.239040e-06	0	1	91080	1.097940e-05	0	0	75050	0.000000e+00	0	0	912	0.000000e+00	0	0	60032	0.000000e+00	0	0	29602	0.000000e+00	0	0	44884	0.000000e+00	0	0	64026	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179998	8.474590e-07	0	1	91080	1.097940e-05	0	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Glycogen_storage_disease,_type_VI	criteria_provided,_single_submitter	NC_000014.9:g.50910030T>G	ClinGen:CA341918	C0017925	232700	369	Phosphorylase pyridoxal-phosphate attachment site	Lys	Thr	97.45	0.05853658536585366																																																																																																																																																																																																																																																																																																																																																																																																																																																																													12			97.45	Positively-charged	Lysine		Glycogen phosphorylase, liver form								0.6256		-3.9								 K681-N685 (PAE:  1.0)	K681-N685 (PDBs: 1FA9, 3CEJ, 2QLL), K681-T677 (PDBs: 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEM, 3DD1, 3DDS, 3DDW, 8EMS)	 K681-N685 (PAE:  1.0), K681-I487 (PAE: 1.0), K681-W492 (PAE: 1.0), K681-T677 (PAE: 1.0)	K681-N685 (PDBs: 1FA9, 2QLL), K681-W492 (PDBs: 1FA9, 8EMS, 2QLL), K681-T677 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 2QLL)						N6-(pyridoxal phosphate)lysine	147									-69.4		Pocket 1: Mean pLDDT: 90.27, Volume: 508.33 Å³, Druggability score: 0.63		-41.5						H (helix)	H (α-helix)	Helix											97.45	5.8536587	>90	<10	232700	autosomal recessive	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE VI	false	0.8963548241843788	0.8464820625026077	false	false	false
DES	DES_Gln131Lys	B_7-8	-0.42971978184520543	0.685288479839577	0.7500865309418865	0.02116473595085358	0.9837049055320388	0.9874718280368113	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6399340470230124	0.6885962600731369	0.6607055447244967	0.7899815831594054	0.7588476698585465	0.6688689495336426	0.9487883418909862	0.9590653922870718	0.962991354002074	0.8804639173583471	0.7238286231535211	0.7211474849665448	0.388949557176299	0.5586299474300211	0.6169718123167367	0.44094717209064643	0.6533638969927527	0.5587206090794801	DES	Gln131Lys	NC_000002.12:219418853:C:A	391C>A	2	219418853	C	A	2	ENSG00000175084	12573	2248	CCSBVarC007811	ALE00007797	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	A04	GDEhDisVCh_40003	C04	1	VUSMutGDDh003	A04	VUSN2Hmut_GDN2h_01	D02	NULL	NULL	VUSmut_GDEh01	D02	1.0	3.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	N	Y	N	N	Y	392712.0	single nucleotide variant	NM_001927.4(DES):c.391C>A (p.Gln131Lys)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Nov 08, 2023	771499260.0	-	RCV000470564|RCV000484887|RCV002489075|RCV003168845	MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MedGen:C3661900|MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154;MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909;MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146|MedGen:CN230736	Desmin-related myofibrillar myopathy|not provided|Dilated cardiomyopathy 1I;Desmin-related myofibrillar myopathy;Neurogenic scapuloperoneal syndrome, Kaeser type|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000002.12	2	219418853.0	219418853.0	2q35	criteria provided, multiple submitters, no conflicts	5.0	ACMG2022	N	ClinGen:CA2125062	2.0	411147.0	219418853.0	C	A	-	-	-	-	-	-	391C>A 	Gln131Lys	NM_001927.4	2.0	VUS	VUS	411147	2	219418853.0	C	A	Q	K	rs771499260	2	220283575	2	219991819	131	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.391C>A	p.Gln131Lys	c.391C>A	p.Gln131Lys	principal1	Y	1	YES	Select	+	CAG	1	0	C	./.	./.	./.	./.	0.001	0.78662	D	0.007	0.69466	D	0.995	0.67505	D	0.976	0.73565	D	0.84	0.89397	D	simple_aae	16.0	84.0	2.74	0.79912	M	-3.38	0.66811	D	0.708	0.71007	0.8348	0.94824	D	0.8235	0.94054	D	10	0.83552366	0.82528	D	0.13487	0.81679	D	0.809	0.93796	0.6	0.73004	P17661	Q131K	Gain of ubiquitination at Q131 (P = 0.0247)| Gain of MoRF binding (P = 0.0254)| Gain of disorder (P = 0.1478)| Gain of methylation at Q131 (P = 0.3708)| Loss of stability (P = 0.5421)	0.972732643255	0.97217	0.8879175780452033	0.88690	2.21030123888	0.95741	0.782971858978	0.79339	T	0.76374	0.93563	D	0.31831	0.84239	D	0.219454	0.84033	D	0.879371139313758	0.52674	D	0.908909	0.67661	D	0.85646397	0.87652	0.80263144	0.88288	0.85646397	0.87654	0.80263144	0.88288	-10.225	0.75324	D	0.3524	0.56692	A	0.999292893505082	0.96182	0.99766050	0.98458	0.886	0.93887	.	.	.	.	.	.	5.469399	0.91268	32.0	0.99521146762765444	0.69261	0.919417	0.88951	D	0.765233006811514	0.83804	8.138265	0.70855918127716	0.82935	7.915666	4.69	4.69	0.58495	.	.	5.975	0.70238	7.499000	0.59529	0.599	0.40292	1.0	0.71675	1.000000	0.68239	1.0	0.97202	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	10	264690	3.7780046E-5	.	3	82822	3.622230e-05	0	3	162400	1.847290e-05	0	3	185854	1.614170e-05	0	0	4270	0.000000e+00	0	0	14014	0.000000e+00	0	0	1732	0.000000e+00	0	0	6560	0.000000e+00	0	0	11930	0.000000e+00	0	3	30006	9.998000e-05	0	0	12750	0.000000e+00	0	3	30006	9.998000e-05	0	0	11358	0.000000e+00	0	0	24086	0.000000e+00	0	0	5264	0.000000e+00	0	0	11248	0.000000e+00	0	0	14262	0.000000e+00	0	3	66734	4.495460e-05	0	0	25366	0.000000e+00	0	3	66734	4.495460e-05	0	0	10562	0.000000e+00	0	0	27970	0.000000e+00	0	0	8752	0.000000e+00	0	0	14216	0.000000e+00	0	0	17114	0.000000e+00	0	3	77132	3.889440e-05	0	0	25324	0.000000e+00	0	3	77132	3.889440e-05	0	.	42	1580578	2.657260e-05	0	39	1163436	3.352140e-05	0	0	74348	0.000000e+00	0	0	912	0.000000e+00	0	0	54504	0.000000e+00	0	0	28992	0.000000e+00	0	0	43408	0.000000e+00	0	0	61002	0.000000e+00	0	0	6028	0.000000e+00	0	39	1163436	3.352140e-05	0	0	86624	0.000000e+00	0	1	26588	3.761095230931247E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4588	0	0	2918	0	0	112	0	1	35432	2.8223075186272295E-5	not_provided|Cardiovascular_phenotype|Desmin-related_myofibrillar_myopathy|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type|Dilated_cardiomyopathy_1I	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219418853C>A	ClinGen:CA2125062	C3661900|CN230736|C1832370|C1867005|C1858154	601419|181400|604765	363543|98909|85146|154	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Gln	Lys	96.38	0.696969696969697																																																																																																																																																																																																																																																																																																																																																																																																																																																																													138			96.38	Polar/Neutral	Glutamine		Desmin							IF rod			-3.5								 Q131-A135 (PAE:  1.0), Q131-R127 (PAE: 1.0)		 Q131-A135 (PAE:  1.0), Q131-R127 (PAE: 1.0)								146									-62.8				-41.8	Coil 1A					H (helix)	H (α-helix)												96.38	69.69697	>90	10-90	601419;604765;601419;181400	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1; CARDIOMYOPATHY, DILATED, 1I; MYOPATHY, MYOFIBRILLAR, 1; SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	false	0.6885962600731369	0.6399340470230124	false	false	false
AGXT	AGXT_Asp129His	B_7-8	-0.3655291571807772	0.7255120513220915	0.7820135541902905	2.467805221261747	0.04297095350638046	0.062039102819990664	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6651569219137485	0.6409432309223397	0.524387664095099	0.5769617876687674	0.5292886161305954	0.5659811840676389	0.5862475502279609	0.49757915046867457	0.5303256207335586	0.58313583834545	0.5822926248940304	0.598002760857097	0.5457148179073168	0.5609980817925163	0.6235979546039762	0.46563948984474796	0.6995938369506491	0.7323110829703999	AGXT	Asp129His	NC_000002.12:240870670:G:C	385G>C	2	240870670	G	C	2	ENSG00000172482	70497	3818	CCSBVarC008187	ALE00008173	ENSP00000302620.3	Edgotyping3	VUSMutGDEh004	E03	GDEhDisVCh_40002	E05	2	VUSMutGDDh004	E03	VUSN2Hmut_GDN2h_01	A07	VUSMutpDEST2_14	G04	VUSmut_GDEh01	A07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	200484.0	single nucleotide variant	NM_000030.3(AGXT):c.385G>C (p.Asp129His)	189.0	AGXT	HGNC:341	Uncertain significance	0.0	Oct 27, 2023	180177212.0	-	RCV000186238|RCV002513966|RCV002222437	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900|MedGen:CN169374	Primary hyperoxaluria, type I|not provided|not specified	germline	germline	GRCh38	NC_000002.12	2	240870670.0	240870670.0	2q37.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA275570	2.0	204034.0	240870670.0	G	C	-	-	-	-	-	-	385G>C 	Asp129His	NM_000030.3	2.0	VUS	VUS	204034	2	240870670.0	G	C	D	H	rs180177212	2	241810087	2	241458760	129	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.385G>C	p.Asp129His	c.385G>C	p.Asp129His	principal1	Y	1	YES	Select	+	GAC	1	0	G	G/G	G/G	G/G	G/G	0.01	0.56615	D	0.039	0.51463	D	0.645	0.40543	P	0.512	0.47968	P	0.06	0.18971	N	simple_aae	94.0	6.0	.	.	.	-1.72	0.40848	N	0.715	0.71633	0.2752	0.87101	D	0.7917	0.92920	D	10	0.78846216	0.78237	D	0.235147	0.88414	D	0.687	0.88535	.	.	.	.	.	0.923396311192	0.92203	0.7833976849183459	0.78167	0.0370864515619	0.03804	0.314858675003	0.12631	T	0.561051	0.85172	D	0.171118	0.71012	D	0.287458	0.87429	D	0.170265002236747	0.18367	T	0.842116	0.51695	T	0.2693243	0.49673	0.1301867	0.31205	0.2693243	0.49673	0.1301867	0.31204	-5.776	0.44420	T	0.1557	0.34514	B	0.759996279473852	0.69177	0.22190893	0.74046	0.663	0.81266	.	.	.	.	.	.	4.278683	0.6522	24.8	0.99315876216697052	0.59264	0.817572	0.73807	D	0.162502897144818	0.49159	3.141319	0.133153506068051	0.45982	2.874502	4.37	2.37	0.28260	.	.	2.297	0.43356	5.281000	0.48256	0.676	0.76753	0.993	0.37982	1.000000	0.68239	0.962	0.52152	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	14	264690	5.289206E-5	.	1	68402	1.461950e-05	0	9	138070	6.518430e-05	0	12	158078	7.591190e-05	0	0	3206	0.000000e+00	0	0	12718	0.000000e+00	0	0	1496	0.000000e+00	0	0	5072	0.000000e+00	0	0	11538	0.000000e+00	0	1	21328	4.688670e-05	0	0	11632	0.000000e+00	0	1	21328	4.688670e-05	0	0	9326	0.000000e+00	0	0	21342	0.000000e+00	0	0	4816	0.000000e+00	0	0	9552	0.000000e+00	0	1	13606	7.349700e-05	0	8	52560	1.522070e-04	0	0	23174	0.000000e+00	0	8	52560	1.522070e-04	0	0	8740	0.000000e+00	0	0	25276	0.000000e+00	0	0	8380	0.000000e+00	0	0	11908	0.000000e+00	0	1	15630	6.397950e-05	0	11	60566	1.816200e-04	0	0	23160	0.000000e+00	0	11	60566	1.816200e-04	0	.	171	1555546	1.099290e-04	0	161	1149454	1.400670e-04	0	1	73470	1.361100e-05	0	0	912	0.000000e+00	0	0	51546	0.000000e+00	0	0	28684	0.000000e+00	0	0	41582	0.000000e+00	0	4	59230	6.753330e-05	0	0	5988	0.000000e+00	0	161	1149454	1.400670e-04	0	0	84404	0.000000e+00	0	5	37110	1.3473457289140393E-4	0	122	0	0	112	0	0	3816	0	0	500	0	0	628	0	0	56	0	0	98	0	1	6924	1.4442518775274407E-4	0	3938	0	0	168	0	6	49366	1.2154114167645748E-4	not_specified|Primary_hyperoxaluria,_type_I|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.240870670G>C	ClinGen:CA275570	CN169374|C0268164|C3661900	259900	416|93598	Aminotransferase class V domain	Asp	His	97.41	0.8220858895705522																																																																																																																																																																																																																																																																																																																																																																																																																																																																													134			97.41	Negatively-charged	Aspartic Acid		Alanine--glyoxylate aminotransferase										-3.5																		132									-59.8				147.9						C (loop/coil)	C (loop/coil)												97.41	82.208595	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.6409432309223397	0.6651569219137485	false	false	false
LITAF	LITAF_Phe136Leu	B_15-16	1.6572231862946003	0.1414419739623293	0.21595057575383608	-9.31040331719552	0.00003419680347143609	0.00017980267727818114	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9555009711758522	0.9638642141224323	0.6781459416865434	0.6013717077814382	0.7354746727641419	0.7603916928758325	0.849520043060124	0.8605224785062581	0.7677712487610064	0.6931506174351411	0.9648714339984229	0.9563503492861322	0.6712633426915411	0.6104268670220258	0.43497216680186995	0.6631412659379458	0.9628569942464417	0.9546515930655723	LITAF	Phe136Leu	NC_000016.10:11549715:G:T	408C>A	16	11549715	G	T	16	ENSG00000189067	52920	2666	CCSBVarC007932	ALE00007918	ENSP00000483114.1	Edgotyping3	VUSMutGDEh006	D11	GDEhDisVCh_40036	F05	2	VUSMutGDDh006	D11	VUSN2Hmut_GDN2h_02	H04	VUSMutpDEST2_11	F11	VUSmut_GDEh02	H04	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	374977.0	single nucleotide variant	NM_001136472.2(LITAF):c.408C>A (p.Phe136Leu)	9516.0	LITAF	HGNC:16841	Uncertain significance	0.0	Dec 22, 2016	1057524422.0	-	RCV000425120	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000016.10	16	11549715.0	11549715.0	16p13.13	criteria provided, single submitter	1.0	-	N	ClinGen:CA16607226	2.0	392274.0	11549715.0	G	T	-	-	-	-	-	-	408C>A 	Phe136Leu	NM_001136472.2	1.0	VUS	VUS	392274	16	11549715.0	G	T	F	L	rs1057524422	16	11643571	16	11551072	136	LITAF	ENSG00000189067	ENST00000571688	ENSP00000459533	Q99732	LITAF_HUMAN	c.408C>A	p.Phe136Leu	c.408C>A	p.Phe136Leu	principal1	Y	1	.	.	-	TTC	3	2	.	G/G	G/G	G/G	G/G	.	0.37688	.	0.0	0.92967	D	0.999	0.77914	D	0.984	0.76117	D	.	.	.	.	.	.	2.255	0.63995	M	.	0.86025	.	0.917	0.97870	-0.3475	0.73508	T	0.5302	0.82492	D	9	0.7920629	0.78534	D	0.269463	0.89798	D	.	0.83333	0.706	0.84162	Q99732	F136L	Loss of sheet (P = 0.1907)| Gain of catalytic residue at F136 (P = 0.3392)| Loss of helix (P = 0.3949)| Gain of loop (P = 0.6993)| Loss of stability (P = 0.7046)	0.99372870826	0.99358	0.68165458318067	0.67946	0.70483266819	0.61094	0.747550785542	0.74039	T	0.859498	0.96845	D	0.153833	0.69405	D	-0.0168054	0.69014	D	0.979450285434723	0.72652	D	.	0.82530	.	0.27808318	0.50531	0.44919443	0.67681	0.27808318	0.50531	0.44919443	0.67681	-7.403	0.56997	T	.	0.93582	.	0.65386777729976	0.65506	0.98172830	0.95696	0.316	0.58198	.	.	.	.	.	.	5.259969	0.88332	29.6	0.99790667926705923	0.87671	0.481376	0.52104	N	0.035248250428069	0.43203	2.638867	0.0294208149127322	0.40799	2.462671	5.01	0.682	0.17114	.	.	1.435	0.34685	5.595000	0.49084	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.997	0.79771	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000016.10:g.11549715G>T	ClinGen:CA16607226	CN517202	.	.	LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor	Phe	Leu	74.63	0.34517766497461927																																																																																																																																																																																																																																																																																																																																																																																																																																																																													68			74.63	Aromatic	Phenylalanine		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF			2.8										 F136-Q142 (PAE:  7.0)								165									-79.9				-24.3						H (helix)	H (α-helix)												74.63	34.517765	70-90	10-90		unknown		Rare genetic neurological disorder	1		false	0.9638642141224323	0.9555009711758522	true	true	false
AGXT	AGXT_Arg301Cys	B_7-8	-1.938306151803061	0.09376859338960537	0.1557770590238055	-0.15263840613974952	0.8829900162725006	0.9056552710651408	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5624426020855101	0.5909882772896483	0.5020117213552903	0.671802271804909	0.6089604735400882	0.5271010663822261	0.5247198637022163	0.5973953864521675	0.6106560678583567	0.5385818365962609	0.6149249300507827	0.604032224894294	0.5294822690622358	0.6205255606280089	0.7329484757514613	0.46544160611431956	0.5670516245285139	0.5208529792767262	AGXT	Arg301Cys	NC_000002.12:240877591:C:T	901C>T	2	240877591	C	T	2	ENSG00000172482	70497	3876	CCSBVarC008226	ALE00008212	ENSP00000302620.3	Edgotyping3	VUSMutGDEh005	D06	GDEhDisVCh_40002	C11	2	VUSMutGDDh005	D06	VUSN2Hmut_GDN2h_02	E02	VUSMutpDEST2_14	G10	VUSmut_GDEh02	E02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	285575.0	single nucleotide variant	NM_000030.3(AGXT):c.901C>T (p.Arg301Cys)	189.0	AGXT	HGNC:341	Uncertain significance	0.0	Jan 12, 2018	886055841.0	-	RCV000384042	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598	Primary hyperoxaluria, type I	germline	germline	GRCh38	NC_000002.12	2	240877591.0	240877591.0	2q37.3	criteria provided, single submitter	1.0	-	N	ClinGen:CA10612915	2.0	335298.0	240877591.0	C	T	-	-	-	-	-	-	901C>T 	Arg301Cys	NM_000030.3	1.0	VUS	VUS	335298	2	240877591.0	C	T	R	C	rs886055841	2	241817008	2	241465681	301	AGXT	ENSG00000172482	ENST00000307503	ENSP00000302620	P21549	AGT1_HUMAN	c.901C>T	p.Arg301Cys	c.901C>T	p.Arg301Cys	principal1	Y	1	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	0.042	0.41793	D	0.015	0.61973	D	0.057	0.22892	B	0.019	0.18782	B	0.26	0.51279	N	simple_aae	74.0	26.0	.	.	.	-1.96	0.45412	N	0.213	0.23598	-0.4946	0.68704	T	0.4479	0.78248	T	10	0.47796422	0.59932	D	0.252115	0.89133	D	0.450	0.74940	0.712	0.84709	P21549	R301C	Loss of methylation at R301 (P = 0.0128)| Gain of catalytic residue at R301 (P = 0.0565)| Loss of MoRF binding (P = 0.0633)| Loss of disorder (P = 0.0772)| Gain of helix (P = 0.2294)	0.821825675267	0.81873	0.9363730697726261	0.93577	0.0417714676067	0.04357	0.485695838928	0.36793	T	0.63052	0.88427	D	0.0474805	0.57725	T	-0.169574	0.57186	T	0.214589267969131	0.20931	T	0.851115	0.53361	D	0.3519427	0.56888	0.18497115	0.41440	0.3519427	0.56888	0.18497115	0.41439	-8.349	0.63499	D	0.1072	0.20224	B	0.818719772023317	0.71603	0.04230620	0.57706	0.524	0.72981	.	.	.	.	.	.	2.772878	0.36471	20.2	0.98437593924158151	0.41602	0.730312	0.67657	D	-0.74916453229444	0.14478	0.7319235	-0.790928513601594	0.14467	0.7704575	4.58	0.0715	0.13655	2.45	0.45325	0.576	0.2353	0.203000	0.15941	0.599	0.40292	0.012	0.18747	0.000000	0.08389	0.013	0.0999	982	0.03399	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	2	65098	3.072290e-05	0	2	131570	1.520100e-05	0	2	149446	1.338280e-05	0	0	2874	0.000000e+00	0	0	12370	0.000000e+00	0	0	1456	0.000000e+00	0	0	4618	0.000000e+00	0	0	11454	0.000000e+00	0	1	19532	5.119800e-05	0	1	11428	8.750440e-05	0	1	11428	8.750440e-05	0	0	8432	0.000000e+00	0	0	20664	0.000000e+00	0	0	4726	0.000000e+00	0	0	8794	0.000000e+00	0	0	13476	0.000000e+00	0	1	49130	2.035420e-05	0	1	22772	4.391360e-05	0	1	22772	4.391360e-05	0	0	7962	0.000000e+00	0	0	24612	0.000000e+00	0	0	8242	0.000000e+00	0	0	11076	0.000000e+00	0	0	15354	0.000000e+00	0	1	55170	1.812580e-05	0	1	22762	4.393290e-05	0	1	22762	4.393290e-05	0	.	18	1550828	1.160670e-05	0	17	1146998	1.482130e-05	0	0	73082	0.000000e+00	0	0	912	0.000000e+00	0	0	50978	0.000000e+00	0	0	28636	0.000000e+00	0	0	40968	0.000000e+00	0	0	59074	0.000000e+00	0	0	6016	0.000000e+00	0	17	1146998	1.482130e-05	0	1	84074	1.189430e-05	0	0	9690	0	0	114	0	0	86	0	1	2784	3.5919540229885057E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	1	2898	3.450655624568668E-4	0	112	0	1	14050	7.117437722419929E-5	Primary_hyperoxaluria,_type_I	criteria_provided,_single_submitter	NC_000002.12:g.240877591C>T	ClinGen:CA10612915	C0268164	259900	416|93598	Aminotransferase class V domain	Arg	Cys	98.88	0.22983870967741934																																																																																																																																																																																																																																																																																																																																																																																																																																																																													57			98.88	Positively-charged	Arginine		Alanine--glyoxylate aminotransferase										-4.5								 R301-L305 (PAE:  1.0), R301-Y297 (PAE: 1.0)	R301-D374 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 5F9S, 5HHY, 7NS7, 3R9A), R301-Y297 (PDBs: 6RV1, 3R9A), R301-L305 (PDBs: 6RV1, 3R9A)	 R301-Y297 (PAE:  1.0), R301-T377 (PAE: 1.0), R301-L305 (PAE: 1.0)	R301-L305 (PDBs: 1H0C, 5OG0, 6RV0, 6RV1, 7NS7, 3R9A), R301-T377 (PDBs: 6RV1, 3R9A), R301-Y297 (PDBs: 6RV1, 5F9S, 5HHY, 3R9A)		R301-D374 (PDBs: 1H0C, 5OG0, 5F9S, 5HHY, 3R9A)					175									-64.2				-44.2						H (helix)	H (α-helix)	Helix											98.88	22.983871	>90	10-90	259900	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare inborn errors of metabolism	3	HYPEROXALURIA, PRIMARY, TYPE I	false	0.5909882772896483	0.5624426020855101	false	false	false
THAP1	THAP1_Lys89Arg	B_7-8	1.175594095139583	0.2926818324758446	0.38106496252819577	0.23106623338993568	0.8249412000541684	0.8562031120471714	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.672620055693374	0.6845552320467518	0.6032629761888115	0.6452756797278612	0.6535811777008171	0.6268033533869455	0.8106767964690832	0.7110796501514041	0.8618570074398475	0.7849372967528723	0.8463085063365775	0.8654473390104656	0.4429299103048077	0.5960827052502301	0.42869435201587475	0.42158865562475073	0.5228019577569261	0.4797927723762825	THAP1	Lys89Arg	NC_000008.11:42839187:T:C	266A>G	8	42839187	T	C	8	ENSG00000131931	1668	214086	CCSBVarC005993	ALE00005993	ENSP00000254250.3	CEGS2	CegsMutGDEh1033	H01	GDEhDisVCh_40085	D04	1	CegsMutGDDh1033	H01	VUSN2Hmut_GDN2h_06	G02	VUSMutpDEST2_01	F09	VUSmut_GDEh06	G02	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	16687.0	single nucleotide variant	NM_018105.3(THAP1):c.266A>G (p.Lys89Arg)	55145.0	THAP1	HGNC:20856	Uncertain significance	1.0	Oct 14, 2023	267607111.0	-	RCV000001715|RCV001659677	MONDO:MONDO:0011264,MedGen:C1414216,OMIM:602629,Orphanet:98806|MedGen:C3661900	Torsion dystonia 6|not provided	germline;maternal	germline	GRCh38	NC_000008.11	8	42839187.0	42839187.0	8p11.21	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA115122,UniProtKB:Q9NVV9#VAR_065885,OMIM:609520.0004	3.0	1648.0	42839187.0	T	C	-	-	-	-	-	-	266A>G 	Lys89Arg	NM_018105.3	2.0	VUS	VUS	1648	8	42839187.0	T	C	K	R	rs267607111	8	42694330	8	42813487	89	THAP1	ENSG00000131931	ENST00000254250	ENSP00000254250	Q9NVV9	THAP1_HUMAN	c.266A>G	p.Lys89Arg	c.266A>G	p.Lys89Arg	principal1	Y	1	YES	Select	-	AAG	2	0	T	T/T	T/T	T/T	T/T	0.178	0.22252	T	0.598	0.16211	T	0.982	0.60051	D	0.702	0.54222	P	0.8	0.87470	A	simple_aae	20.0	80.0	1.1	0.27864	L	-0.85	0.23101	N	0.507	0.53651	0.8493	0.95004	D	0.8603	0.95340	D	10	0.80317646	0.79486	D	0.122688	0.80313	D	0.657	0.87075	0.737	0.86913	Q9NVV9	K89R	Loss of ubiquitination at K89 (P = 9e-04)| Loss of glycosylation at K89 (P = 0.0341)| Gain of phosphorylation at T84 (P = 0.2037)| Loss of methylation at K89 (P = 0.2618)| Gain of loop (P = 0.3485)	0.872128253262	0.86988	0.31698391595504616	0.31411	0.558962522601	0.52167	0.575053930283	0.49323	T	0.045837	0.26986	T	0.319145	0.84296	D	0.220653	0.84091	D	0.854569673538208	0.50295	D	0.684832	0.29080	T	0.10757659	0.25210	0.10614009	0.25477	0.102745816	0.24063	0.09732432	0.23119	-4.479	0.30647	T	0.0739	0.07733	B	0.8227825285381	0.71789	0.01632758	0.47045	0.788	0.88269	.	.	.	.	.	.	4.232935	0.6419	24.7	0.99568864662730505	0.72291	0.529073	0.54875	D	0.356966242557956	0.58898	4.087619	0.446104671332894	0.64275	4.70257	5.92	5.92	0.95551	.	.	6.918	0.75669	6.034000	0.53023	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.957	0.51031	299	0.88036	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1613934	1.239210e-06	0	2	1179994	1.694920e-06	0	0	74930	0.000000e+00	0	0	912	0.000000e+00	0	0	60010	0.000000e+00	0	0	29598	0.000000e+00	0	0	44854	0.000000e+00	0	0	63988	0.000000e+00	0	0	6080	0.000000e+00	0	2	1179994	1.694920e-06	0	0	91088	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	not_provided|Torsion_dystonia_6	criteria_provided,_multiple_submitters,_no_conflicts	NC_000008.11:g.42839187T>C	ClinGen:CA115122|OMIM:609520.0004|UniProtKB:Q9NVV9#VAR_065885	C3661900|C1414216	602629	98806	.	Lys	Arg	39.33	0.9365853658536586																																																																																																																																																																																																																																																																																																																																																																																																																																																																													192			39.33	Positively-charged	Lysine		THAP domain-containing protein 1										-3.9																		147									173.2				108.2						C (loop/coil)	C (loop/coil)												39.33	93.65854	$\leqslant$50	$\geqslant$90	602629	autosomal dominant	OMIM	Rare genetic neurological disorder	1	DYSTONIA 6, TORSION	false	0.6845552320467518	0.672620055693374	false	false	false
GALE	GALE_Asp103Gly	B_7-8	-8.19782294729941	0.0012063073679603913	0.005398897002194592	-0.038963260923900706	0.9700076278374018	0.9774651274473544	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.593011030223307	0.6036802895768985	0.6648541644246173	0.5713322148291127	0.5151974988505499	0.6321629352033551	0.6321629352033551	0.5457726803506149	0.5309087514851158	0.6648541644246173	0.6001011302504733	0.6016084843945015		0.48462231735048494	0.6117556781731096		0.6072594489033236	0.5844135760521125	GALE	Asp103Gly	NC_000001.11:23798160:T:C	308A>G	1	23798160	T	C	1	ENSG00000117308	2767	214356	CCSBVarC005287	ALE00005287	ENSP00000483375.1	CEGS2	CegsMutGDEh1035	B05	GDEhDisVCh_40068	G06	2	CegsMutGDDh1035	B05	VUSN2Hmut_GDN2h_06	C12	VUSMutpDEST2_02	D10	VUSmut_GDEh06	C12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	18717.0	single nucleotide variant	NM_001008216.2(GALE):c.308A>G (p.Asp103Gly)	2582.0	GALE	HGNC:4116	Uncertain significance	1.0	Apr 20, 2023	28940883.0	-	RCV000003863	MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238	UDPglucose-4-epimerase deficiency	germline	germline	GRCh38	NC_000001.11	1	23798160.0	23798160.0	1p36.11	criteria provided, single submitter	2.0	-	N	ClinGen:CA252856,UniProtKB:Q14376#VAR_002541,OMIM:606953.0004	3.0	3678.0	23798160.0	T	C	-	-	-	-	-	-	308A>G 	Asp103Gly	NM_001008216.2	1.0	VUS	VUS	3678	1	23798160.0	T	C	D	G	rs28940883	1	24124650	1	23997237	103	GALE	ENSG00000117308	ENST00000617979	ENSP00000483375	Q14376	GALE_HUMAN	c.308A>G	p.Asp103Gly	c.308A>G	p.Asp103Gly	principal1	Y	1	YES	Select	-	GAT	2	0	T	T/T	T/T	T/T	T/T	.	0.46673	.	0.07	0.48180	T	0.201	0.29711	B	0.416	0.44961	B	.	0.38685	.	.	.	.	1.58	0.39613	L	.	0.57138	.	0.727	0.80799	0.6455	0.92459	D	0.7084	0.89945	D	9	0.58317554	0.65670	D	0.092387	0.75804	D	.	0.87765	0.759	0.88753	Q14376	D103G	Gain of methylation at K100 (P = 0.0503)| Loss of phosphorylation at Y104 (P = 0.1113)| Gain of catalytic residue at Y104 (P = 0.1137)| Loss of sheet (P = 0.1158)| Loss of helix (P = 0.1299)	0.876463876281	0.87430	0.7204325906072787	0.71841	.	0.33317	0.50388687849	0.39315	T	0.84509	0.96394	D	0.206272	0.74288	D	0.141384	0.79484	D	0.64476865530014	0.37931	D	.	0.95700	.	0.69980377	0.77792	0.5174209	0.71860	0.7325864	0.79631	0.39488113	0.63921	-9.636	0.71782	D	0.1516	0.37834	LB	0.944094538860277	0.79785	0.99920112	0.99211	0.601	0.77672	.	.	.	.	.	.	4.441585	0.69029	25.3	0.99569057006417738	0.72291	0.338067	0.43377	N	0.00711087336310426	0.41915	2.536483	0.135169915284393	0.46088	2.883339	4.79	4.79	0.60860	4.3	0.81401	2.027	0.40803	7.909000	0.73970	0.665	0.62996	0.997	0.40243	1.000000	0.68239	0.998	0.85369	510	0.75232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109406	9.140270e-06	0	1	208084	4.805750e-06	0	1	236938	4.220510e-06	0	0	7164	0.000000e+00	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	17110	5.844540e-05	0	0	16210	0.000000e+00	0	1	30522	3.276330e-05	0	0	6212	0.000000e+00	0	0	13412	0.000000e+00	0	0	16734	0.000000e+00	0	0	89526	0.000000e+00	0	0	30608	0.000000e+00	0	1	30522	3.276330e-05	0	0	14902	0.000000e+00	0	1	34258	2.919030e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	0	102736	0.000000e+00	0	0	30526	0.000000e+00	0	1	34258	2.919030e-05	0	.	3	1614090	1.858630e-06	0	2	44872	4.457120e-05	0	0	75024	0.000000e+00	0	0	912	0.000000e+00	0	1	60022	1.666060e-05	0	0	29606	0.000000e+00	0	2	44872	4.457120e-05	0	0	63986	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180012	0.000000e+00	0	0	91084	0.000000e+00	0	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	UDPglucose-4-epimerase_deficiency	criteria_provided,_single_submitter	NC_000001.11:g.23798160T>C	ClinGen:CA252856|OMIM:606953.0004|UniProtKB:Q14376#VAR_002541	C0751161	230350	352|79238	NAD(P)-binding domain	Asp	Gly	98.6	0.31901840490797545																																																																																																																																																																																																																																																																																																																																																																																																																																																																													52			98.6	Negatively-charged	Aspartic Acid		UDP-glucose 4-epimerase								0.1369		-3.5								 D103-V107 (PAE:  1.0)	D103-V107 (PDBs: 1EK5, 1EK6, 1HZJ)	 D103-V107 (PAE:  1.0)	D103-V107 (PDBs: 1EK5, 1EK6, 1HZJ)	 D103-R106 (PAE:  1.0)	D103-R106 (PDBs: 1EK6, 1HZJ)					132									-67.8		Pocket 2: Mean pLDDT: 96.99, Volume: 941.77 Å³, Druggability score: 0.14		-42.1				dbSNP: rs28940883; Variant type: US; AA change: Asp103Gly; PTM type: Phosphorylation; PTM morphology: QkPLD*yYRVNL; Var class: II&rs28940883		H (helix)	H (α-helix)	Helix											98.6	31.90184	>90	10-90	230350	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic hepatic disease; Rare inborn errors of metabolism	4	GALACTOSEMIA III	false	0.6036802895768985	0.593011030223307	false	false	false
DES	DES_His441Leu	B_7-8	0.01750853064760641	0.9865986218565289	0.9897076511270853	2.1166096739550437	0.07208146042931347	0.09805002215551537	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6353033953492814	0.7071679443016501	0.7596610275151249	0.7169216961447799	0.6994565810169746	0.7548501765042819	0.9546069257443497	0.8710393293629061	0.8814290195555601	0.9174791684738148	0.688273860379185	0.6353033953492814	0.5550934272642141	0.5278738326710433	0.5524143727339996	0.6018428865564349	0.726062028224115		DES	His441Leu	NC_000002.12:219425696:A:T	1322A>T	2	219425696	A	T	2	ENSG00000175084	12573	2333	CCSBVarC007884	ALE00007870	ENSP00000363071.3	Edgotyping3	VUSMutGDEh005	A12	GDEhDisVCh_40092	F06	1	VUSMutGDDh005	A12	VUSN2Hmut_GDN2h_02	C04	NULL	NULL	VUSmut_GDEh02	C04	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	405634.0	single nucleotide variant	NM_001927.4(DES):c.1322A>T (p.His441Leu)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Apr 26, 2022	1064796937.0	-	RCV000479938|RCV000695478	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219425696.0	219425696.0	2q35	criteria provided, multiple submitters, no conflicts	3.0	ACMG2022	N	ClinGen:CA16617481	2.0	424366.0	219425696.0	A	T	-	-	-	-	-	-	1322A>T 	His441Leu	NM_001927.4	2.0	VUS	VUS	424366	2	219425696.0	A	T	H	L	rs1064796937	2	220290418	2	219998662	441	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1322A>T	p.His441Leu	c.1322A>T	p.His441Leu	principal1	Y	1	YES	Select	+	CAT	2	0	A	A/A	A/A	A/A	A/A	0.007	0.60085	D	0.099	0.39233	T	0.822	0.45782	P	0.248	0.38946	B	.	.	.	.	.	.	2.8	0.81458	M	-5.68	0.87253	D	0.699	0.70209	0.9893	0.97002	D	0.9071	0.96914	D	10	0.8282013	0.81804	D	0.394741	0.93253	D	0.807	0.93718	0.387	0.40643	P17661	H441L	Loss of disorder (P = 0.0606)| Loss of methylation at K444 (P = 0.0643)| Gain of MoRF binding (P = 0.0888)| Gain of ubiquitination at K443 (P = 0.1092)| Loss of glycosylation at S438 (P = 0.1896)	0.992326528587	0.99214	0.8686013749055892	0.86744	0.661691890423	0.58660	0.827882051468	0.86214	D	0.556529	0.84942	D	0.480934	0.93686	D	0.453052	0.93607	D	0.984447479248047	0.75576	D	0.849215	0.53013	T	0.45339215	0.63939	0.5032912	0.71029	0.45339215	0.63940	0.5032912	0.71030	-4.488	0.30765	T	0.2031	0.42832	B	0.907511692378514	0.76585	0.99617180	0.97980	0.83	0.90630	.	.	.	.	.	.	4.249098	0.64557	24.7	0.97290984458069008	0.33412	0.980604	0.99847	D	0.45685086471993	0.64406	4.717334	0.489712399743287	0.67127	5.066492	4.46	4.46	0.53511	3.53	0.64053	7.357	0.78761	11.126000	0.86691	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.997	0.79771	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Desmin-related_myofibrillar_myopathy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219425696A>T	ClinGen:CA16617481	C1832370|CN517202	601419	363543|98909	.	His	Leu	47.66	0.5543478260869565																																																																																																																																																																																																																																																																																																																																																																																																																																																																													102			47.66	Positively-charged	Histidine		Desmin										-3.2								 H441-L470 (PAE:  11.5)										155									-65.9				113.8	Tail; Interaction with CRYAB					C (loop/coil)	C (loop/coil)												47.66	55.43478	$\leqslant$50	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.7071679443016501	0.6353033953492814	false	false	false
MVK	MVK_Arg106His	B_7-8	1.6495688051162365	0.15012490314098031	0.22531588998300964	0.38642471308068044	0.7125142302013368	0.7565849017758338	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6574869444399707	0.680197665163254	0.6468091195881814	0.7707995013909064	0.7259204648242676	0.719838640342164	0.7050201241700308	0.750923776978978	0.7376721364973353	0.6366030055304471	0.6934734704358211	0.6899223014790207	0.7346571565142973	0.7009171526695571	0.8039268662844773	0.6570152336459157	0.666921859890687	0.6250515874009208	MVK	Arg106His	NC_000012.12:109579892:G:A	317G>A	12	109579892	G	A	12	ENSG00000110921	281	8	CCSBVarC007119	ALE00007117	ENSP00000228510.3	Edgotyping3	VUSMutGDEh009	G11	GDEhDisVCh_40020	D06	2	VUSMutGDDh009	G11	VUSN2Hmut_GDN2h_03	D04	VUSMutpDEST2_01	G01	VUSmut_GDEh03	D04	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	323150.0	single nucleotide variant	NM_000431.4(MVK):c.317G>A (p.Arg106His)	4598.0	MVK	HGNC:7530	Uncertain significance	0.0	Dec 02, 2021	778337320.0	-	RCV000346491|RCV000400709|RCV002480115	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343	Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria|Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever	germline;unknown	germline	GRCh38	NC_000012.12	12	109579892.0	109579892.0	12q24.11	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA6779217	2.0	307093.0	109579892.0	G	A	-	-	-	-	-	-	317G>A 	Arg106His	NM_000431.4	2.0	VUS	VUS	307093	12	109579892.0	G	A	R	H	rs778337320	12	110017697	12	108502080	106	MVK	ENSG00000110921	ENST00000228510	ENSP00000228510	Q03426	KIME_HUMAN	c.317G>A	p.Arg106His	c.317G>A	p.Arg106His	principal1	Y	1	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	0.204	0.20183	T	0.145	0.33658	T	0.002	0.09864	B	0.0	0.08696	B	0.11	0.35500	N	simple_aae	89.0	11.0	0.075	0.08216	N	-0.23	0.10591	N	0.072	0.13841	-0.7277	0.58906	T	0.3370	0.70238	T	10	0.05925867	0.07081	T	0.031332	0.53251	D	0.457	0.75421	0.56	0.67844	Q03426	R106H	Loss of helix (P = 0.0093)| Gain of loop (P = 0.0111)| Gain of catalytic residue at R106 (P = 0.0512)| Gain of relative solvent accessibility (P = 0.09)| Gain of solvent accessibility (P = 0.1071)	0.742743444213	0.73839	0.19018989788309731	0.18757	0.439521257904	0.43696	0.218024164438	0.01201	T	0.105333	0.41277	T	-0.0859467	0.38390	T	-0.179705	0.56250	T	0.0208315910588868	0.00781	T	0.567543	0.19857	T	0.067127556	0.14376	0.033636685	0.02303	0.067127556	0.14375	0.033636685	0.02303	-3.733	0.19822	T	0.074	0.05122	LB	0.0898124945510192	0.42352	0.93773020	0.92747	0.138	0.36230	.	.	.	.	.	.	0.573052	0.09442	6.195	0.9108914964299768	0.20594	0.057221	0.10481	N	-1.36831500260649	0.02909	0.1305697	-1.3909136671942	0.03299	0.1559873	5.07	-6.01	0.02019	-10.3	0.00184	-0.402	0.07301	-1.162000	0.06178	-0.106	0.15547	0.0	0.06393	0.000000	0.08389	0.194	0.21765	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	3	109404	2.742130e-05	0	5	208114	2.402530e-05	0	10	236944	4.220410e-05	0	1	7164	1.395870e-04	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13394	0.000000e+00	0	1	42766	2.338310e-05	0	0	15690	0.000000e+00	0	1	7164	1.395870e-04	0	1	16216	6.166750e-05	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	2	16734	1.195170e-04	0	2	89544	2.233540e-05	0	0	30608	0.000000e+00	0	1	16216	6.166750e-05	0	1	14902	6.710510e-05	0	0	34256	0.000000e+00	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	4	21632	1.849110e-04	0	4	102744	3.893170e-05	0	0	30526	0.000000e+00	0	1	14902	6.710510e-05	0	.	51	1614114	3.159630e-05	0	20	64030	3.123540e-04	0	1	74938	1.334440e-05	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29606	0.000000e+00	0	0	44898	0.000000e+00	0	20	64030	3.123540e-04	0	0	6084	0.000000e+00	0	30	1180058	2.542250e-05	0	0	91094	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Mevalonic_aciduria|Porokeratosis_3,_disseminated_superficial_actinic_type|Hyperimmunoglobulin_D_with_periodic_fever	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.109579892G>A	ClinGen:CA6779217	C1959626|C1867981|C0398691	610377|175900|260920	29|343	.	Arg	His	90.8	0.31048387096774194																																																																																																																																																																																																																																																																																																																																																																																																																																																																													77			90.8	Positively-charged	Arginine		Mevalonate kinase										-4.5			A:R106-C:E284 (PDBs: 2R3V)					 R106-D99 (PAE:  4.5), R106-A102 (PAE: 2.5), R106-C101 (PAE: 3.5), R106-L110 (PAE: 1.0)	R106-A102 (PDBs: 2R3V), R106-D100 (PDBs: 2R3V), R106-L110 (PDBs: 2R3V)	 R106-A102 (PAE:  2.5), R106-C101 (PAE: 3.5), R106-L110 (PAE: 1.0)	R106-A102 (PDBs: 2R3V), R106-C101 (PDBs: 2R3V), R106-L110 (PDBs: 2R3V)							175									-56.2				-49.8						H (helix)	H (α-helix)	Helix											90.8	31.048388	>90	10-90	260920;610377;175900;610377;260920	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; MEVALONIC ACIDURIA; POROKERATOSIS 3, MULTIPLE TYPES; MEVALONIC ACIDURIA; HYPER-IgD SYNDROME	false	0.680197665163254	0.6574869444399707	false	false	false
TH	TH_Asp267His	B_7-8	2.7421026713323515	0.03364182428560032	0.06813866795523667	-0.008277408088881433	0.9936266204775519	0.9947107739096059	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7319598215590319	0.7843282841347705	0.7391650665703109	0.8170144191129093	0.7620586223988269	0.8335348484209628	0.7581729277343383	0.6714524702231335	0.7163685188839203	0.659523552253857	0.732408679394524	0.7005496707849134	0.9088967691075874	0.8526647745745204	0.9176603193418983	0.8188065808867648	0.8362478888750171	0.7633699723331505	TH	Asp267His	NC_000011.10:2166929:C:G	799G>C	11	2166929	C	G	11	ENSG00000180176	71892	4006	CCSBVarC008287	ALE00008273	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	C10	GDEhDisVCh_40019	B10	1	VUSMutGDDh015	C10	VUSN2Hmut_GDN2h_04	E11	VUSMutpDEST2_15	A08	VUSmut_GDEh04	E11	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	372119.0	single nucleotide variant	NM_000360.4(TH):c.799G>C (p.Asp267His)	7054.0	TH	HGNC:11782	Uncertain significance	0.0	Nov 27, 2023	1057524283.0	-	RCV000422915|RCV001271313	MedGen:C3661900|MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150	not provided|Autosomal recessive DOPA responsive dystonia	germline	germline	GRCh38	NC_000011.10	11	2166929.0	2166929.0	11p15.5	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA16606213	2.0	391909.0	2166929.0	C	G	-	-	-	-	-	-	799G>C 	Asp267His	NM_000360.4	2.0	VUS	VUS	391909	11	2166929.0	C	G	D	H	rs1057524283	11	2188159	11	2144735	298	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.892G>C	p.Asp298His	c.892G>C	p.Asp298His	.	Y	1	.	.	-	GAC	1	0	C	C/C	C/C	C/C	C/C	0.09	0.32128	T	0.049	0.48688	D	0.548	0.38093	P	0.239	0.38566	B	0.43	0.80805	N	simple_aae	57.0	43.0	3.09	0.87301	M	-3.41	0.67161	D	0.353	0.39714	1.0807	0.98901	D	0.9687	0.99007	D	10	0.632754	0.68334	D	0.974167	0.99849	D	0.502	0.78362	0.63	0.76495	P07101	D298H	Loss of disorder (P = 0.1471)| Loss of solvent accessibility (P = 0.1473)| Loss of phosphorylation at S293 (P = 0.1709)| Loss of relative solvent accessibility (P = 0.1807)| Gain of catalytic residue at R296 (P = 0.2259)	0.929766433918	0.92850	0.7716747337845588	0.76989	0.11063275855	0.12258	0.665202736855	0.62092	T	0.966224	0.99596	D	0.126738	0.66806	D	-0.0557266	0.66389	D	0.736417055130005	0.42249	D	0.939806	0.77226	D	0.63197136	0.74127	0.4737286	0.69238	0.63197136	0.74129	0.4737286	0.69238	-10.42	0.76830	D	0.2452	0.52142	B	0.389614463758324	0.57338	0.98304784	0.95838	0.79	0.88380	.	.	.	.	.	.	3.415921	0.47486	22.5	0.96251414744874442	0.29394	0.424130	0.48768	N	-0.19593264690871	0.33024	1.887881	-0.274460739037312	0.28625	1.617676	3.32	2.39	0.28416	3.82	0.71118	0.599	0.23874	4.511000	0.43726	0.549	0.27038	0.905	0.3164	1.000000	0.68239	0.82	0.3867	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	17	1602294	1.060980e-05	0	17	1175692	1.445960e-05	0	0	74828	0.000000e+00	0	0	912	0.000000e+00	0	0	58628	0.000000e+00	0	0	29294	0.000000e+00	0	0	44508	0.000000e+00	0	0	61456	0.000000e+00	0	0	6074	0.000000e+00	0	17	1175692	1.445960e-05	0	0	88870	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	not_provided|Autosomal_recessive_DOPA_responsive_dystonia	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.2166929C>G	ClinGen:CA16606213	C3661900|C2673535	605407	101150	Aromatic amino acid hydroxylase, C-terminal|Aromatic amino acid hydroxylase, C-terminal|Tyrosine 3-monooxygenase, catalytic domain	Asp	His	97.33	0.5644171779141104																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.33	56.44172	>90	10-90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.7843282841347705	0.7319598215590319	false	false	false
PYGL	PYGL_Leu739Met	B_7-8	-1.4986798374371693	0.18461252245791457	0.263732174939878	-3.405392445048341	0.01440002773666925	0.02359290258641792	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6676297747418691	0.677221444356954	0.5380879410131496	0.5904741586357127	0.5811738748945352	0.5924863415667097	0.5494679887156814	0.5980444884689009	0.5893977196821805	0.471938956255557	0.8032669081659468	0.8101528443506081	0.6355046944177379	0.5643032613201696	0.591550597589245	0.6042369257707422	0.5511759805479612	0.5251067051331302	PYGL	Leu739Met	NC_000014.9:50908918:G:T	2215C>A	14	50908918	G	T	14	ENSG00000100504	55246	3211	CCSBVarC008107	ALE00008093	ENSP00000216392.7	Edgotyping3	VUSMutGDEh009	A01	GDEhDisVCh_40063	E11	1	VUSMutGDDh009	A01	VUSN2Hmut_GDN2h_02	A12	VUSMutpDEST2_13	F03	VUSmut_GDEh02	A12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	336071.0	single nucleotide variant	NM_002863.5(PYGL):c.2215C>A (p.Leu739Met)	5836.0	PYGL	HGNC:9725	Uncertain significance	0.0	Jan 12, 2018	766875279.0	-	RCV000378008	MONDO:MONDO:0009294,MedGen:C0017925,OMIM:232700,Orphanet:369	Glycogen storage disease, type VI	germline	germline	GRCh38	NC_000014.9	14	50908918.0	50908918.0	14q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA7183172	2.0	313320.0	50908918.0	G	T	-	-	-	-	-	-	2215C>A 	Leu739Met	NM_002863.5	1.0	VUS	VUS	313320	14	50908918.0	G	T	L	M	rs766875279	14	51375636	14	50445386	739	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.2215C>A	p.Leu739Met	c.2215C>A	p.Leu739Met	principal1	Y	1	YES	Select	-	CTG	1	2	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.008	0.69466	D	0.997	0.70687	D	0.968	0.71743	D	0.44	0.66863	N	simple_aae	56.0	44.0	3.575	0.93413	H	-1.69	0.40848	N	0.727	0.76103	0.9966	0.97123	D	0.9067	0.96900	D	10	0.91078985	0.90337	D	0.261702	0.89509	D	0.842	0.95050	0.803	0.92118	P06737	L739M	Loss of stability (P = 0.0912)| Loss of methylation at K740 (P = 0.1315)| Gain of ubiquitination at K740 (P = 0.1696)| Gain of disorder (P = 0.2563)| Gain of catalytic residue at I743 (P = 0.4524)	0.961225517077	0.96046	0.8038279372039727	0.80222	0.531563760744	0.50358	0.55028706789	0.45833	T	0.620594	0.87987	D	0.286841	0.81761	D	0.257116	0.85855	D	0.975322008132935	0.70688	D	0.865813	0.88170	D	0.92766535	0.93913	0.71755433	0.83130	0.92766535	0.93914	0.71755433	0.83131	-9.183	0.68946	D	0.3245	0.62575	B	0.936392853061602	0.78997	0.77349330	0.87703	0.547	0.74419	.	.	.	.	.	.	4.421814	0.68556	25.2	0.99666355659749051	0.78289	0.701758	0.65710	D	0.682726141512927	0.78385	6.884341	0.611306400704437	0.75625	6.367855	5.83	4.0	0.45610	3.9	0.73887	2.911	0.48569	6.642000	0.56254	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.995	0.73271	364	0.84712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	109402	2.742180e-05	0	4	208122	1.921950e-05	0	4	236886	1.688580e-05	0	0	7164	0.000000e+00	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13388	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	1	17112	5.843850e-05	0	0	16218	0.000000e+00	0	1	30524	3.276110e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16728	0.000000e+00	0	3	89550	3.350080e-05	0	0	30608	0.000000e+00	0	3	89550	3.350080e-05	0	0	14902	0.000000e+00	0	1	34258	2.919030e-05	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21626	0.000000e+00	0	3	102696	2.921240e-05	0	0	30526	0.000000e+00	0	3	102696	2.921240e-05	0	.	58	1602298	3.619800e-05	0	50	1169840	4.274090e-05	0	2	74490	2.684920e-05	0	0	910	0.000000e+00	0	2	59928	3.337340e-05	0	0	29532	0.000000e+00	0	0	44748	0.000000e+00	0	0	63834	0.000000e+00	0	0	6060	0.000000e+00	0	50	1169840	4.274090e-05	0	0	90822	0.000000e+00	0	1	26588	3.761095230931247E-5	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4588	0	0	2918	0	0	112	0	1	35432	2.8223075186272295E-5	Glycogen_storage_disease,_type_VI	criteria_provided,_single_submitter	NC_000014.9:g.50908918G>T	ClinGen:CA7183172	C0017925	232700	369	.	Leu	Met	98.67	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.67	Aliphatic	Leucine		Glycogen phosphorylase, liver form										3.8								 L739-I743 (PAE:  1.0)	L739-I743 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 8EMS, 2QLL)	 L739-Y778 (PAE:  1.0), L739-I743 (PAE: 1.0)	L739-Y778 (PDBs: 1FA9, 2QLL), L739-I743 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 8EMS, 2QLL)							131									-61.7				-47.5						H (helix)	H (α-helix)	Helix											98.67	0.0	>90	<10	232700	autosomal recessive	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE VI	false	0.677221444356954	0.6676297747418691	false	false	false
SMAD3	SMAD3_Ser423Arg	B_15-16	1.6131488216432766	0.15074696978275082	0.22600212895216173	1.2293792625071869	0.2586457831990802	0.30819156634435857	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7076000137618748	0.7131283282992058	0.6301705955832868	0.6904349348196998	0.6741492524826505	0.6825391186524086	0.6441049586009404	0.5994916465552802	0.7170141963505916	0.6090703451549088	0.6366725933715536	0.6232121020133439	0.7209732787038766	0.7488068584100207	0.6638556732888079	0.6512708460116647	0.789584063226858	0.7919879255104058	SMAD3	Ser423Arg	NC_000015.10:67190527:T:A	1269T>A	15	67190527	T	A	15	ENSG00000166949	11805	2183	CCSBVarC007759	ALE00007745	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	A06	GDEhDisVCh_40014	F12	2	VUSMutGDDh005	A06	VUSN2Hmut_GDN2h_02	B02	VUSMutpDEST2_09	E08	VUSmut_GDEh02	B02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	400467.0	single nucleotide variant	NM_005902.4(SMAD3):c.1269T>A (p.Ser423Arg)	4088.0	SMAD3	HGNC:6769	Uncertain significance	0.0	Dec 25, 2016	1060500772.0	-	RCV000457806	MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000015.10	15	67190527.0	67190527.0	15q22.33	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA16614554	2.0	405568.0	67190527.0	T	A	-	-	-	-	-	-	1269T>A 	Ser423Arg	NM_005902.4	1.0	VUS	VUS	405568	15	67190527.0	T	A	S	R	rs1060500772	15	67482865	15	65269919	423	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.1269T>A	p.Ser423Arg	c.1269T>A	p.Ser423Arg	principal1	Y	1	YES	Select	+	AGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.988	0.62341	D	0.933	0.66812	D	0.88	0.92286	D	simple_aae	12.0	88.0	3.305	0.90410	M	-4.7	0.79862	D	0.776	0.77511	1.1243	0.99914	D	0.9756	0.99238	D	10	0.85988784	0.85045	D	0.813314	0.98542	D	0.774	0.92392	0.414	0.45072	P84022	S423R	Gain of MoRF binding (P = 0.0026)| Gain of solvent accessibility (P = 0.0171)| Loss of phosphorylation at S423 (P = 0.0233)| Gain of relative solvent accessibility (P = 0.0479)| Loss of catalytic residue at V424 (P = 0.1418)	0.974836882242	0.97432	0.9924587061072031	0.99239	2.5004208477	0.97619	0.787146925926	0.79972	T	0.909878	0.98276	D	0.401855	0.89950	D	0.33946	0.89824	D	0.996138751506805	0.88642	D	0.956938	0.83616	D	0.9178604	0.92938	0.7913277	0.87573	0.9178604	0.92939	0.7913277	0.87574	-13.957	0.93940	D	0.9989	0.98903	P	0.999023597266692	0.95535	0.99429965	0.97516	0.987	0.99559	.	.	.	.	.	.	2.426681	0.31271	18.67	0.99495682259131524	0.67785	0.160134	0.28388	N	-0.372278731524314	0.26185	1.444326	-0.660451406763918	0.17665	0.9569463	4.97	-8.36	0.00859	-6.44	0.02526	-0.755	0.04894	-1.839000	0.04656	-0.286	0.06355	0.023	0.19988	0.000000	0.08389	0.991	0.66489	919	0.19492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_single_submitter	NC_000015.10:g.67190527T>A	ClinGen:CA16614554	C4707243	PS607086	91387	SMAD domain, Dwarfin-type	Ser	Arg	89.58	0.9538461538461539																																																																																																																																																																																																																																																																																																																																																																																																																																																																													124			89.58	Polar/Neutral	Serine		Mothers against decapentaplegic homolog 3							MH2			-0.8																	Phosphoserine; by TGFBR1	105		Mutation: SSVS -> AAVA. Does not abolish protein nuclear export. Abolishes almost completely acetylation.; Mutation: SSVS -> EEVE. Forms heterotrimers.; Mutation: SSVS -> RRVR. Diminishes cargo protein export.							-87.4	Morphology: sPsIRCssVs_____			10.3		Regulatory site: S423-p; Morphology: SPSIRCSsVS_____; On-Function: activity, induced; intracellular localization; protein conformation; On-Process: carcinogenesis, induced; cell differentiation, induced; cell motility, altered; transcription, induced; transcription, altered; signaling pathway regulation; Notes: The triple mutants(S422/423/425A and S422/423/425D) were used in these experiments 				C (loop/coil)	S (bend)												89.58	95.38461	70-90	$\geqslant$90		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.7131283282992058	0.7076000137618748	false	false	false
TH	TH_Thr7Pro	B_7-8	-0.8677618911520972	0.4252048402144023	0.51728741707612	-3.754731526732098	0.007123857990997379	0.01277837674826998	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5477720559511611	0.595503344814302	0.5472151780544957	0.5377806530596925	0.5513458394938853	0.5755402671406724	0.7192480734480736	0.6307055167675367	0.5833271385066217	0.6945244060608171	0.5808361385953476	0.5477720559511611	0.4318324608332711	0.47198616222023376	0.4922341676127633	0.39990595004817425	0.6101705510332565		TH	Thr7Pro	NC_000011.10:2171768:T:G	19A>C	11	2171768	T	G	11	ENSG00000180176	71892	4028	CCSBVarC008305	ALE00008291	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	F12	GDEhDisVCh_40019	D12	1	VUSMutGDDh015	F12	VUSN2Hmut_GDN2h_05	B02	VUSMutpDEST2_15	D10	VUSmut_GDEh05	B02	1.0	1.0	1.0	5.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	398449.0	single nucleotide variant	NM_000360.4(TH):c.19A>C (p.Thr7Pro)	7054.0	TH	HGNC:11782	Uncertain significance	0.0	Jan 14, 2022	768150949.0	-	RCV001273892	MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150	Autosomal recessive DOPA responsive dystonia	germline	germline	GRCh38	NC_000011.10	11	2171768.0	2171768.0	11p15.5	criteria provided, single submitter	2.0	-	N	ClinGen:CA5818889	2.0	412031.0	2171768.0	T	G	-	-	-	-	-	-	19A>C 	Thr7Pro	NM_000360.4	1.0	VUS	VUS	412031	11	2171768.0	T	G	T	P	rs768150949	11	2192998	11	2149574	7	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.19A>C	p.Thr7Pro	c.19A>C	p.Thr7Pro	.	Y	1	.	.	-	ACC	1	0	T	T/T	T/T	T/T	T/T	0.14	0.26103	T	0.187	0.31647	T	0.0	0.02950	B	0.001	0.04348	B	0.13	0.37131	N	simple_aae	87.0	13.0	-0.55	0.02423	N	-0.4	0.17766	N	0.173	0.18399	0.5044	0.90572	D	0.7973	0.93118	D	10	0.120195866	0.22491	T	0.206504	0.87010	D	0.307	0.62646	0.114	0.02290	P07101	T7P	Loss of phosphorylation at T7 (P = 0.03)| Loss of MoRF binding (P = 0.0775)| Loss of glycosylation at T7 (P = 0.0942)| Gain of methylation at K12 (P = 0.2878)| Loss of stability (P = 0.3012)	0.594481630172	0.58817	0.2741446238996909	0.27131	0.0560482306113	0.06044	0.575460314751	0.49381	T	0.273607	0.64407	T	-0.0648148	0.41805	T	-0.22082	0.52340	T	0.0908068106879919	0.11170	T	0.506749	0.15778	T	0.10206764	0.23897	0.098131746	0.23342	0.10206764	0.23897	0.098131746	0.23342	-2.086	0.04001	T	0.0551	0.02708	B	0.0277337551666482	0.32158	0.93347150	0.92547	0.024	0.04173	.	.	.	.	.	.	0.326887	0.07036	3.569	0.74633928402363858	0.10944	0.567610	0.57162	D	-1.486938948339	0.01923	0.08524162	-1.46706815619774	0.02583	0.120774	3.85	-4.24	0.03521	-3.06	0.08408	0.534	0.22888	-3.239000	0.02960	-1.147	0.01436	0.801	0.29826	0.000000	0.08389	0.031	0.13278	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	16	264690	6.044807E-5	.	3	108396	2.767630e-05	0	4	205570	1.945810e-05	0	4	233248	1.714910e-05	0	0	7128	0.000000e+00	0	0	17072	0.000000e+00	0	0	2306	0.000000e+00	0	0	9018	0.000000e+00	0	0	12598	0.000000e+00	0	3	42694	7.026750e-05	0	0	15678	0.000000e+00	0	3	42694	7.026750e-05	0	0	16122	0.000000e+00	0	0	30464	0.000000e+00	0	0	6164	0.000000e+00	0	0	13370	0.000000e+00	0	0	15938	0.000000e+00	0	4	88092	4.540710e-05	0	0	30590	0.000000e+00	0	4	88092	4.540710e-05	0	0	14852	0.000000e+00	0	0	34188	0.000000e+00	0	0	9492	0.000000e+00	0	0	17662	0.000000e+00	0	0	20678	0.000000e+00	0	4	100298	3.988120e-05	0	0	30506	0.000000e+00	0	4	100298	3.988120e-05	0	.	40	1612248	2.481010e-05	1	6	59976	1.000400e-04	1	0	74874	0.000000e+00	0	0	910	0.000000e+00	0	6	59976	1.000400e-04	1	0	29572	0.000000e+00	0	0	44870	0.000000e+00	0	0	62808	0.000000e+00	0	0	5952	0.000000e+00	0	30	1179800	2.542800e-05	0	0	91050	0.000000e+00	0	0	26578	0	0	114	0	0	86	0	0	2804	0	2	500	0.004	0	628	0	0	26	0	0	98	0	0	4588	0	0	2918	0	0	112	0	2	35422	5.646208570944611E-5	Autosomal_recessive_DOPA_responsive_dystonia	criteria_provided,_single_submitter	NC_000011.10:g.2171768T>G	ClinGen:CA5818889	C2673535	605407	101150	Tyrosine hydroxylase, conserved site	Thr	Pro	26.76	0.9859154929577465																																																																																																																																																																																																																																																																																																																																																																																																																																																																													132			30.84	Polar/Neutral	Threonine		Tyrosine 3-monooxygenase										-0.7																		119									-66.3				94.1						C (loop/coil)	C (loop/coil)												26.76	98.591545	$\leqslant$50	$\geqslant$90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.595503344814302	0.5477720559511611	false	false	false
MVK	MVK_Val278Met	B_7-8	1.7800854766599254	0.12536181122990117	0.19610242379124587	0.5923954392178961	0.5752152752399553	0.6256787374423936	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5929259479845389	0.6233384983422907	0.5513223539986477	0.7205343351651083	0.6491464042477395	0.7036902519297863	0.6305948688518559	0.6267536047459448	0.5840400071539548	0.5780955568671201	0.5884930787805374	0.5809743892889214	0.7767856350077166	0.6715392037495341	0.8570286631762619	0.5245491511301753	0.6581839179040441	0.6048775066801564	MVK	Val278Met	NC_000012.12:109591304:G:A	832G>A	12	109591304	G	A	12	ENSG00000110921	281	21	CCSBVarC007128	ALE00007126	ENSP00000228510.3	Edgotyping3	VUSMutGDEh010	D01	GDEhDisVCh_40020	F07	2	VUSMutGDDh010	D01	VUSN2Hmut_GDN2h_03	E05	VUSMutpDEST2_01	B03	VUSmut_GDEh03	E05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	408510.0	single nucleotide variant	NM_000431.4(MVK):c.832G>A (p.Val278Met)	4598.0	MVK	HGNC:7530	Uncertain significance	0.0	May 18, 2022	574045811.0	-	RCV000483487|RCV002475929	MedGen:C3661900|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343	not provided|Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever	germline;unknown	germline	GRCh38	NC_000012.12	12	109591304.0	109591304.0	12q24.11	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA6779388	2.0	418346.0	109591304.0	G	A	-	-	-	-	-	-	832G>A 	Val278Met	NM_000431.4	2.0	VUS	VUS	418346	12	109591304.0	G	A	V	M	rs574045811	12	110029109	12	108513492	278	MVK	ENSG00000110921	ENST00000546277	ENSP00000438153	Q03426	KIME_HUMAN	.	.	c.832G>A	p.Val278Met	principal1	Y	5	.	.	+	GTG	1	0	G	G/G	G/G	G/G	G/G	.	0.39251	.	.	0.43507	.	0.899	0.49527	P	0.101	0.30767	B	.	0.53339	.	.	.	.	1.975	0.53326	M	.	0.35975	.	.	0.47149	0.0349	0.82872	D	0.6440	0.87528	D	10	.	0.35051	.	0.082854	0.73902	D	.	0.83666	0.627	0.76159	Q03426	V278M	Gain of disorder (P = 0.0567)| Loss of catalytic residue at V278 (P = 0.1893)| Loss of stability (P = 0.2248)| Loss of helix (P = 0.2271)| Gain of methylation at R277 (P = 0.6306)	.	0.92476	.	0.79441	.	0.40844	0.47846108675	0.35797	T	0.252998	0.62135	T	0.0365565	0.56292	T	0.123602	0.78315	D	0.0538757007955924	0.06104	T	.	0.37564	.	0.080025166	0.18149	0.07758571	0.17281	0.080025166	0.18148	0.07758571	0.17281	-8.043	0.61437	D	.	0.31610	.	0.48564691646273	0.60347	0.98822100	0.96473	0.299	0.56734	.	.	.	.	.	.	2.732165	0.35836	19.98	0.99564007589072556	0.71987	0.197461	0.32227	N	-0.050264068837211	0.39322	2.337168	-0.00318040332139061	0.39277	2.348337	4.6	2.77	0.31531	1.23	0.31344	1.254	0.32604	2.471000	0.32979	-0.106	0.15547	0.927	0.32266	0.993000	0.32003	0.991	0.66489	734	0.53826	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	7	109394	6.398890e-05	0	17	208116	8.168520e-05	0	17	236914	7.175600e-05	0	0	7164	0.000000e+00	0	3	17110	1.753360e-04	0	0	2320	0.000000e+00	0	3	9046	3.316380e-04	0	0	13382	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	3	9046	3.316380e-04	0	0	16218	0.000000e+00	0	7	30522	2.293430e-04	0	0	6212	0.000000e+00	0	7	13416	5.217650e-04	0	0	16722	0.000000e+00	0	1	89552	1.116670e-05	0	0	30608	0.000000e+00	0	7	13416	5.217650e-04	0	0	14902	0.000000e+00	0	7	34258	2.043320e-04	0	0	9572	0.000000e+00	0	7	17692	3.956590e-04	0	0	21618	0.000000e+00	0	1	102728	9.734440e-06	0	0	30526	0.000000e+00	0	7	17692	3.956590e-04	0	.	42	1614072	2.602110e-05	0	11	44878	2.451090e-04	0	2	74930	2.669160e-05	0	0	912	0.000000e+00	0	9	60006	1.499850e-04	0	0	29608	0.000000e+00	0	11	44878	2.451090e-04	0	0	64034	0.000000e+00	0	0	6080	0.000000e+00	0	17	1180050	1.440620e-05	0	0	91086	0.000000e+00	0	0	15752	0	0	122	0	0	112	0	0	3370	0	0	146	0	0	610	0	0	56	0	0	98	0	1	2772	3.6075036075036075E-4	0	3492	0	0	168	0	1	23038	4.340654570709263E-5	Hyperimmunoglobulin_D_with_periodic_fever|Porokeratosis_3,_disseminated_superficial_actinic_type|Mevalonic_aciduria|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000012.12:g.109591304G>A	ClinGen:CA6779388	C0398691|C1867981|C1959626|CN517202	260920|175900|610377	343|29	.	Val	Met	95.19	0.02112676056338028																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3			95.19	Aliphatic	Valine		Mevalonate kinase										4.2								 V278-M282 (PAE:  1.5), V278-E274 (PAE: 1.0)	V278-M282 (PDBs: 2R3V), V278-E274 (PDBs: 2R3V)	 V278-M282 (PAE:  1.5), V278-E274 (PAE: 1.0)	V278-M282 (PDBs: 2R3V), V278-E274 (PDBs: 2R3V)							117									-60.4				-47.1						H (helix)	H (α-helix)	Helix											95.19	2.112676	>90	<10	175900;610377;260920	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	POROKERATOSIS 3, MULTIPLE TYPES; MEVALONIC ACIDURIA; HYPER-IgD SYNDROME	false	0.6233384983422907	0.5929259479845389	false	false	false
MLH1	MLH1_Ile36Met	B_11-12	3.465513034772151	0.025428954862788424	0.0543889180155945	3.969467194239438	0.008205098616457143	0.014427578152588551	2024_12_Batch_11-12	false	false	false	false	false	false	false	false	false	false	false	false	0.7465734376271573	0.7428703784899862	0.7496827828635655	0.7411747093973315	0.687782395464926	0.7514190285395592		0.6755666792947351		0.7869528111458847	0.7415334371265726	0.7437923895435568	0.7514190285395592	0.6999981116351169	0.7411747093973315	0.7124127545812462	0.7442073198533998	0.7493544857107579	MLH1	Ile36Met	NC_000003.12:36993655:T:G	108T>G	3	36993655	T	G	3	ENSG00000076242	2713	462	CCSBVarC007373	ALE00007361	ENSP00000231790.3	Edgotyping3	VUSMutGDEh011	B08	GDEhDisVCh_40019	E05	1	VUSMutGDDh011	B08	VUSN2Hmut_GDN2h_03	C12	VUSMutpDEST2_02	B03	VUSmut_GDEh03	C12	1.0	3.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	N	N	Y	Y	Y	180130.0	single nucleotide variant	NM_000249.4(MLH1):c.108T>G (p.Ile36Met)	4292.0	MLH1	HGNC:7127	Uncertain significance	0.0	Jun 06, 2019	730881747.0	-	RCV000160553|RCV001017246	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	not provided|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000003.12	3	36993655.0	36993655.0	3p22.2	criteria provided, multiple submitters, no conflicts	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA004312	2.0	182535.0	36993655.0	T	G	-	-	-	-	-	-	108T>G 	Ile36Met	NM_000249.4	2.0	VUS	VUS	182535	3	36993655.0	T	G	I	M	rs730881747	3	37035146	3	37010150	36	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.108T>G	p.Ile36Met	c.108T>G	p.Ile36Met	principal1	Y	1	YES	Select	+	ATT	3	3	T	T/T	T/T	T/T	T/T	0.075	0.34590	T	0.129	0.35170	T	0.287	0.32247	B	0.2	0.36840	B	0.3	0.55288	N	simple_aae	70.0	30.0	1.465	0.36753	L	-1.25	0.31545	N	0.284	0.31928	-0.9326	0.43567	T	0.1193	0.41544	T	10	0.4066199	0.55588	D	0.074319	0.71915	D	0.577	0.82826	0.614	0.74670	P40692	I36M	Gain of catalytic residue at I36 (P = 0.0351)| Loss of ubiquitination at K33 (P = 0.1278)| Gain of disorder (P = 0.1983)| Gain of helix (P = 0.2294)| Loss of methylation at K33 (P = 0.2679)	0.961999749323	0.96125	0.6470504799026487	0.64472	0.126071351083	0.13958	0.608201861382	0.53996	T	0.636236	0.88674	D	0.208373	0.74488	D	0.0615373	0.74155	D	0.87938928604126	0.52675	D	0.935706	0.75867	D	0.46180832	0.64468	0.23033722	0.47953	0.46180832	0.64469	0.23033722	0.47952	-7.741	0.59364	D	0.0617	0.01233	B	0.500912815332985	0.60812	0.99769660	0.98474	0.516	0.72475	.	.	.	.	.	.	2.207685	0.2821	17.71	0.97697051892080622	0.35575	0.078973	0.15749	N	-0.295330029071013	0.29049	1.625413	-0.332543911977965	0.26736	1.498578	5.98	-2.59	0.05839	0.147	0.22567	-0.835	0.04499	0.243000	0.16400	0.661	0.55789	0.1	0.22873	0.996000	0.32869	0.999	0.91597	315	0.8722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1614094	1.858630e-06	0	3	1180010	2.542350e-06	0	0	75020	0.000000e+00	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	0	29600	0.000000e+00	0	0	44880	0.000000e+00	0	0	63994	0.000000e+00	0	0	6062	0.000000e+00	0	3	1180010	2.542350e-06	0	0	91078	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.36993655T>G	ClinGen:CA004312	C0027672|C3661900	.	140162	.	Ile	Met	94.47	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			94.47	Aliphatic	Isoleucine		DNA mismatch repair protein Mlh1										4.5								 I36-I32 (PAE:  1.0), I36-L40 (PAE: 1.0)	I36-I32 (PDBs: 4P7A), I36-L40 (PDBs: 4P7A)	 I36-I32 (PAE:  1.0), I36-L40 (PAE: 1.0)	I36-I32 (PDBs: 4P7A), I36-L40 (PDBs: 4P7A)							131									-62.8				-44.3						H (helix)	H (α-helix)	Helix											94.47	0.0	>90	<10		unknown		Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3		false	0.7428703784899862	0.7465734376271573	false	false	false
SMAD3	SMAD3_Asn59Asp	B_15-16	1.473924571349479	0.1839955103421203	0.26304747361785163	3.4795085466037174	0.010273077510476238	0.0175196070926802	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8424267162335899	0.8266947724397382	0.46312782500331473	0.6468777329972029	0.6483978274928868	0.47707394490203897	0.46815169640352994	0.6456138545550001	0.6393913383929359	0.4659345370391977	0.7133496500617815	0.7286108791613164	0.485996193400548	0.6511818004307733	0.6543641276014698	0.46032111296743183	0.9400398948176948	0.9562425533058633	SMAD3	Asn59Asp	NC_000015.10:67066329:A:G	175A>G	15	67066329	A	G	15	ENSG00000166949	11805	2113	CCSBVarC007701	ALE00007687	ENSP00000332973.4	Edgotyping3	VUSMutGDEh004	F09	GDEhDisVCh_40014	E04	2	VUSMutGDDh004	F09	VUSN2Hmut_GDN2h_01	F09	VUSMutpDEST2_08	B12	VUSmut_GDEh01	F09	1.0	3.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	N	Y	Y	Y	Y	360192.0	single nucleotide variant	NM_005902.4(SMAD3):c.175A>G (p.Asn59Asp)	4088.0	SMAD3	HGNC:6769	Uncertain significance	0.0	Feb 22, 2024	745387614.0	-	RCV000414061|RCV001187660|RCV003995924	MedGen:CN169374|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984	not specified|Familial thoracic aortic aneurysm and aortic dissection|Aneurysm-osteoarthritis syndrome	germline	germline	GRCh38	NC_000015.10	15	67066329.0	67066329.0	15q22.33	criteria provided, multiple submitters, no conflicts	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA061777	2.0	373708.0	67066329.0	A	G	-	-	-	-	-	-	175A>G 	Asn59Asp	NM_005902.4	2.0	VUS	VUS	373708	15	67066329.0	A	G	N	D	rs745387614	15	67358667	15	65145721	59	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.175A>G	p.Asn59Asp	c.175A>G	p.Asn59Asp	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.222	0.18924	T	0.098	0.39382	T	0.001	0.07480	B	0.012	0.16009	B	0.31	0.56225	N	simple_aae	69.0	31.0	0.3	0.10129	N	-1.69	0.40270	N	0.201	0.22080	-0.9153	0.45986	T	0.1797	0.52425	T	10	0.24608633	0.41478	T	0.05052	0.64145	D	0.248	0.55402	0.443	0.49834	P84022	N59D	Loss of catalytic residue at N59 (P = 0.1144)| Gain of disorder (P = 0.1519)| Gain of phosphorylation at T57 (P = 0.1761)| Loss of ubiquitination at K63 (P = 0.2335)| Loss of glycosylation at T56 (P = 0.2469)	0.707513707249	0.70265	0.7215144155326473	0.71949	1.36824918191	0.84402	0.739966392517	0.72921	T	0.776796	0.94020	D	-0.187469	0.22303	T	-0.491577	0.22887	T	0.791291654109955	0.45486	D	0.909609	0.67931	D	0.44707224	0.63538	0.405182	0.64674	0.44707224	0.63539	0.405182	0.64674	-8.204	0.62526	D	0.1224	0.25658	B	0.491286386550575	0.60520	0.74939233	0.87152	0.164	0.40832	.	.	.	.	.	.	3.701927	0.52881	23.3	0.98516926644092728	0.42533	0.916634	0.88269	D	-0.392204885774981	0.25470	1.399913	-0.208106703604719	0.30929	1.766371	4.21	3.08	0.34497	5.04	0.90360	7.127	0.76877	10.998000	0.84766	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.965	0.52907	880	0.29349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	108920	0.000000e+00	0	1	206238	4.848770e-06	0	2	235794	8.481980e-06	0	0	7060	0.000000e+00	0	0	17050	0.000000e+00	0	0	2316	0.000000e+00	0	0	9014	0.000000e+00	0	0	13378	0.000000e+00	0	0	42514	0.000000e+00	0	0	15682	0.000000e+00	0	.	.	.	.	0	15938	0.000000e+00	0	0	30426	0.000000e+00	0	0	6152	0.000000e+00	0	0	13364	0.000000e+00	0	0	16716	0.000000e+00	0	1	88238	1.133300e-05	0	0	30582	0.000000e+00	0	1	88238	1.133300e-05	0	0	14694	0.000000e+00	0	0	34174	0.000000e+00	0	0	9564	0.000000e+00	0	0	17660	0.000000e+00	0	0	21488	0.000000e+00	0	2	102104	1.958790e-05	0	0	30508	0.000000e+00	0	2	102104	1.958790e-05	0	.	8	1613274	4.958860e-06	0	8	1179740	6.781160e-06	0	0	74908	0.000000e+00	0	0	912	0.000000e+00	0	0	60016	0.000000e+00	0	0	29584	0.000000e+00	0	0	44772	0.000000e+00	0	0	63764	0.000000e+00	0	0	6058	0.000000e+00	0	8	1179740	6.781160e-06	0	0	91050	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	not_specified|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Aneurysm-osteoarthritis_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.67066329A>G	ClinGen:CA061777	CN169374|C4707243|C3151087	PS607086|613795	91387|284984	MAD homology 1, Dwarfin-type|MAD homology, MH1|MAD homology 1, Dwarfin-type	Asn	Asp	92.87	0.4394904458598726																																																																																																																																																																																																																																																																																																																																																																																																																																																																													69			92.87	Polar/Neutral	Asparagine		Mothers against decapentaplegic homolog 3							MH1			-3.5											N59-K53 (PDBs: 1MHD, 5ODG), N59-A54 (PDBs: 5OD6, 5ODG)							132									-95.4				122.6						C (loop/coil)	C (loop/coil)												92.87	43.949043	>90	10-90	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	false	0.8266947724397382	0.8424267162335899	false	false	false
TH	TH_Val136Met	B_7-8	1.9101262528501846	0.10468959073278017	0.17003156317994056	1.4557670007482093	0.18879346680435832	0.23235144975586688	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5351221859068374	0.5799384886637813	0.6311818261222657	0.5384620681770244	0.5259653281697353	0.6941649809566124	0.824698563829827	0.6121542812671784	0.5117106666621094	0.7615240026829296	0.5716365954212608	0.5590700654290025	0.5636313980833977	0.4397763750722922	0.5652134696919393	0.5008396495616019	0.5882403819063018	0.5111743063846722	TH	Val136Met	NC_000011.10:2168572:C:T	406G>A	11	2168572	C	T	11	ENSG00000180176	71892	4018	CCSBVarC008297	ALE00008283	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	F11	GDEhDisVCh_40019	D11	1	VUSMutGDDh015	F11	VUSN2Hmut_GDN2h_05	B01	VUSMutpDEST2_15	D09	VUSmut_GDEh05	B01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	326007.0	single nucleotide variant	NM_000360.4(TH):c.406G>A (p.Val136Met)	7054.0	TH	HGNC:11782	Uncertain significance	0.0	Oct 24, 2022	142046543.0	-	RCV000347269|RCV001528247	MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150|MedGen:C3661900	Autosomal recessive DOPA responsive dystonia|not provided	germline;unknown	germline	GRCh38	NC_000011.10	11	2168572.0	2168572.0	11p15.5	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA5818676	2.0	304078.0	2168572.0	C	T	-	-	-	-	-	-	406G>A 	Val136Met	NM_000360.4	2.0	VUS	VUS	304078	11	2168572.0	C	T	V	M	rs142046543	11	2189802	11	2146378	167	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.499G>A	p.Val167Met	c.499G>A	p.Val167Met	.	Y	1	.	.	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.441	0.44188	T	0.394	0.15871	T	0.865	0.50762	P	0.77	0.62818	P	0.07	0.21442	N	simple_aae	93.0	7.0	2.415	0.69565	M	-0.18	0.39687	N	0.655	0.66880	0.9571	0.96491	D	0.9361	0.97892	D	10	0.7946619	0.78751	D	0.743247	0.97942	D	0.491	0.77666	.	.	.	.	.	0.935318130101	0.93414	0.6946703590298725	0.69254	0.229573172322	0.25227	0.86289358139	0.91524	D	0.315598	0.68541	T	-0.0197464	0.48562	T	0.0519322	0.73516	D	0.143501097767042	0.16365	T	0.876912	0.72723	D	0.033611245	0.03582	0.055903405	0.09904	0.033611245	0.03581	0.055903405	0.09903	-6.013	0.46547	T	0.3251	0.58512	B	0.332290085574841	0.55396	0.97926460	0.95448	0.114	0.31241	.	.	.	.	.	.	2.461567	0.31767	18.82	0.97966612432171918	0.37369	0.500627	0.53218	D	-0.205415272767708	0.32633	1.861328	-0.29499866617438	0.27944	1.574419	3.31	2.35	0.28089	0.699	0.26685	2.221	0.42662	1.648000	0.27915	-0.306	0.06144	0.999	0.42732	1.000000	0.68239	0.009	0.08693	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	37	264690	1.3978616E-4	.	13	106950	1.215520e-04	0	21	199788	1.051110e-04	0	24	230152	1.042790e-04	0	0	6692	0.000000e+00	0	0	16902	0.000000e+00	0	0	2264	0.000000e+00	0	0	8824	0.000000e+00	0	0	13280	0.000000e+00	0	13	41538	3.129660e-04	0	0	15596	0.000000e+00	0	13	41538	3.129660e-04	0	0	14552	0.000000e+00	0	0	30206	0.000000e+00	0	0	5956	0.000000e+00	0	0	13108	0.000000e+00	0	0	16544	0.000000e+00	0	18	84296	2.135330e-04	0	0	30454	0.000000e+00	0	18	84296	2.135330e-04	0	0	13456	0.000000e+00	0	0	33988	0.000000e+00	0	0	9426	0.000000e+00	0	0	17456	0.000000e+00	0	0	21030	0.000000e+00	0	22	98944	2.223480e-04	0	0	30386	0.000000e+00	0	22	98944	2.223480e-04	0	.	330	1611688	2.047540e-04	0	309	1179678	2.619360e-04	0	4	74898	5.340600e-05	0	0	912	0.000000e+00	0	1	59954	1.667950e-05	0	1	29566	3.382260e-05	0	0	44848	0.000000e+00	0	0	62534	0.000000e+00	0	0	5950	0.000000e+00	0	309	1179678	2.619360e-04	0	0	91018	0.000000e+00	0	11	38784	2.8362211221122114E-4	0	122	0	0	112	0	0	3390	0	0	500	0	0	628	0	0	56	0	0	98	0	2	7114	2.81135788585887E-4	0	3512	0	0	168	0	13	50804	2.5588536335721597E-4	Autosomal_recessive_DOPA_responsive_dystonia|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.2168572C>T	ClinGen:CA5818676	C2673535|C3661900	605407	101150	Tyrosine 3-monooxygenase-like, ACT domain	Val	Met	93.51	0.028169014084507043																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																93.51	2.8169014	>90	<10	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	true	0.5799384886637813	0.5351221859068374	false	false	false
LITAF	LITAF_Pro34Thr	B_15-16	3.0209001547102066	0.019361689299216767	0.04444810884796157	-5.1927431927487255	0.0012630465135850515	0.002900738864115857	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6185560656372373	0.6742184597456661	0.572647603405096	0.5590775717247228	0.66454527446366	0.6348962627134921	0.5565117590502537	0.5932023334536665	0.47698556865430924	0.526752928423054	0.6387807115253054	0.6002107488357007	0.7132807663767304	0.7358882154736535	0.6411695747951364	0.618542278387138	0.7096562079660268	0.6369013824387738	LITAF	Pro34Thr	NC_000016.10:11556631:G:T	100C>A	16	11556631	G	T	16	ENSG00000189067	52920	2687	CCSBVarC007944	ALE00007930	ENSP00000483114.1	Edgotyping3	VUSMutGDEh007	H01	GDEhDisVCh_40036	D07	2	VUSMutGDDh007	H01	VUSN2Hmut_GDN2h_02	B07	VUSMutpDEST2_12	B02	VUSmut_GDEh02	B07	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	333683.0	single nucleotide variant	NM_001136472.2(LITAF):c.100C>A (p.Pro34Thr)	9516.0	LITAF	HGNC:16841	Uncertain significance	0.0	Dec 21, 2021	759905004.0	-	RCV000271680|RCV000506296	MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083|MedGen:CN169374	Charcot-Marie-Tooth disease type 1C|not specified	germline	germline	GRCh38	NC_000016.10	16	11556631.0	11556631.0	16p13.13	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA7904185	2.0	317787.0	11556631.0	G	T	-	-	-	-	-	-	100C>A 	Pro34Thr	NM_001136472.2	2.0	VUS	VUS	317787	16	11556631.0	G	T	P	T	rs759905004	16	11650487	16	11557988	34	LITAF	ENSG00000189067	ENST00000576036	ENSP00000461667	Q99732	LITAF_HUMAN	c.100C>A	p.Pro34Thr	c.100C>A	p.Pro34Thr	principal1	Y	4	.	.	-	CCC	1	0	G	G/G	G/G	G/G	G/G	.	0.55689	.	0.01	0.92967	D	0.001	0.07480	B	0.002	0.06938	B	0.27	0.54326	N	simple_aae	73.0	27.0	2.045	0.55836	M	.	0.47017	.	0.423	0.59354	0.1523	0.85033	D	0.5753	0.84619	D	10	0.31205457	0.48290	D	0.084304	0.74211	D	.	0.68415	0.232	0.15919	Q99732	P34T	Gain of relative solvent accessibility (P = 0.0166)| Gain of solvent accessibility (P = 0.0354)| Gain of glycosylation at P34 (P = 0.0649)| Gain of phosphorylation at P34 (P = 0.0895)| Gain of sheet (P = 0.1208)	0.991642860622	0.99145	.	0.62424	.	0.19233	0.471563458443	0.34849	T	0.495301	0.81663	T	0.0387286	0.56580	T	-0.0744885	0.65057	T	0.482679575681686	0.31684	T	.	0.42060	.	0.06650412	0.14185	0.07025294	0.14896	0.061261564	0.12549	0.0566497	0.10168	-4.096	0.28805	T	0.1219	0.58599	LB	0.6189378668008	0.64404	0.92698190	0.92260	0.168	0.41476	.	.	.	.	.	.	4.403245	0.68122	25.2	0.99647565336605282	0.77093	0.360058	0.44830	N	-0.165056864816364	0.34319	1.976615	-0.125057981389467	0.34074	1.977168	5.18	4.22	0.49095	.	.	3.672	0.5441	6.257000	0.55405	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.119	0.19168	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109406	0.000000e+00	0	4	208108	1.922080e-05	1	3	236894	1.266390e-05	1	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42766	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	2	89532	2.233840e-05	0	0	30608	0.000000e+00	0	2	89532	2.233840e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	1	102696	9.737480e-06	0	0	30526	0.000000e+00	0	1	102696	9.737480e-06	0	.	12	1614190	7.434070e-06	1	2	6060	3.300330e-04	1	0	75040	0.000000e+00	0	0	912	0.000000e+00	0	2	60022	3.332110e-05	0	0	29606	0.000000e+00	0	0	44882	0.000000e+00	0	0	64034	0.000000e+00	0	2	6060	3.300330e-04	1	8	1180032	6.779480e-06	0	0	91090	0.000000e+00	0	3	6062	4.948861761794787E-4	0	8	0	0	26	0	0	586	0	0	0	0	0	0	0	0	30	0	0	0	0	0	2276	0	0	594	0	0	56	0	3	8988	3.337783711615487E-4	Charcot-Marie-Tooth_disease_type_1C|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.11556631G>T	ClinGen:CA7904185	C0270913|CN169374	601098	101083	.	Pro	Thr	53.14	0.9191176470588235																																																																																																																																																																																																																																																																																																																																																																																																																																																																													125			53.14	Special, No backbone hydrogen	Proline		Lipopolysaccharide-induced tumor necrosis factor-alpha factor										1.6																		115									-70.1				100.4						C (loop/coil)	C (loop/coil)												53.14	91.911766	50-70	$\geqslant$90	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.6742184597456661	0.6185560656372373	false	false	false
FGD4	FGD4_Arg194His	B_7-8	-0.4964522660332161	0.6347834092244535	0.706136465706876	0.9274251231783852	0.38456815603736433	0.4380400784162406	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5873068776261811	0.5698347146622973	0.5444358078594255	0.5395222818322333	0.6049957941466547	0.5662092561882666	0.47767403562501376	0.6156331841713227	0.5472614758283652	0.44439610109313005	0.5493498189754238	0.5499711475949747	0.6547444767515195	0.5943584041219867	0.5317830878361014	0.644475514625721	0.5903196103491709	0.6246426076573874	FGD4	Arg194His	NC_000012.12:32611270:G:A	581G>A	12	32611270	G	A	12	ENSG00000139132	71286	205731	CCSBVarC004312	ALE00004312	ENSP00000449273.1	CEGS2	CegsMutGDEh1031	E02	GDEhDisVCh_40086	C04	2	CegsMutGDDh1031	E02	VUSN2Hmut_GDN2h_05	A07	NULL	NULL	VUSmut_GDEh05	A07	1.0	1.0	1.0	1.0	1.0	1.0	99.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	47002.0	single nucleotide variant	NM_001370298.3(FGD4):c.1736G>A (p.Arg579His)	121512.0	FGD4	HGNC:19125	Uncertain significance	0.0	Jan 06, 2016	281865063.0	-	RCV000031999|RCV000789100	MONDO:MONDO:0012250,MedGen:C1836336,OMIM:609311,Orphanet:99954|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166	Charcot-Marie-Tooth disease type 4H|Charcot-Marie-Tooth disease	germline;unknown	germline	GRCh38	NC_000012.12	12	32611270.0	32611270.0	12p11.21	no assertion criteria provided	3.0	-	N	ClinGen:CA343101	3.0	38443.0	32611270.0	G	A	-	-	-	-	-	-	1736G>A 	Arg579His	NM_001370298.3		VUS	VUS	38443	12	32611270.0	G	A	R	H	rs281865063	12	32764204	12	32655471	442	FGD4	ENSG00000139132	ENST00000583694	ENSP00000462623	Q96M96	FGD4_HUMAN	.	.	c.1325G>A	p.Arg442His	principal2	Y	3	.	.	+	CGC	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.79703	.	1.0	0.90580	D	0.998	0.88579	D	.	0.95575	.	.	.	.	3.315	0.90533	M	.	0.81218	.	.	0.96546	1.0049	0.97264	D	0.9012	0.96716	D	10	.	0.93720	.	0.127004	0.80819	D	.	0.99157	.	.	.	.	.	.	0.95059	.	.	.	0.80337	0.889804959297	0.95230	D	0.708606	0.92331	D	0.504629	0.94387	D	0.487088	0.94307	D	0.99836677312851	0.93893	D	.	0.98077	.	0.8034341	0.83924	0.74770975	0.84906	0.7677056	0.81689	0.76655555	0.86042	-12.012	0.84952	D	.	0.87547	.	0.970090613109405	0.83296	0.99779020	0.98508	0.801	0.88995	.	.	.	.	.	.	6.096155	0.94558	34.0	0.99938981336466814	0.99734	0.923093	0.89869	D	0.993778187367999	0.95525	13.72789	0.941998887500909	0.97140	15.67521	5.51	5.51	0.81744	4.54	0.84756	7.903	0.86169	11.771000	0.95867	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1614116	1.858600e-06	0	3	1180010	2.542350e-06	0	0	75034	0.000000e+00	0	0	910	0.000000e+00	0	0	60030	0.000000e+00	0	0	29606	0.000000e+00	0	0	44876	0.000000e+00	0	0	64010	0.000000e+00	0	0	6062	0.000000e+00	0	3	1180010	2.542350e-06	0	0	91074	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Charcot-Marie-Tooth_disease|Charcot-Marie-Tooth_disease_type_4H	no_assertion_criteria_provided	NC_000012.12:g.32611270G>A	ClinGen:CA343101	C0007959|C1836336	PS118220|609311	166|99954	Pleckstrin homology domain|Pleckstrin homology domain|Pleckstrin homology domain|FGD4, N-terminal PH domain	Arg	His	94.09	0.17338709677419356																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																94.09	17.338709	>90	10-90	609311	autosomal recessive	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4H	false	0.5698347146622973	0.5873068776261811	false	false	false
PLP1	PLP1_Leu189Pro	B_7-8	-1.9579359318679646	0.12184270042162369	0.1916965056056847	0.6380255820775189	0.5470199931583302	0.6003478991899138	2024_01_Batch_7-8	true	true	false	false	false	false	true	true	false	false	false	false	0.9956740473783458	0.9905946972345462	0.5828403259465931	0.7078759759900982	0.5279327642440239	0.65064320010223	0.65064320010223	0.5279327642440239	0.7078759759900982	0.5828403259465931	0.9905946972345462	0.9944911882223656						0.9968569065343259	PLP1	Leu189Pro	NC_000023.11:103788485:T:C	566T>C	23	103788485	T	C	X	ENSG00000123560	4062	201433	CCSBVarC005865	ALE00005865	ENSP00000477619.1	CEGS2	CegsMutGDEh1042	H03	GDEhDisVCh_40062	D09	2	CegsMutGDDh1042	H03	VUSN2Hmut_GDN2h_08	E11	VUSMutpDEST2_04	H03	VUSmut_GDEh08	E11	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	26119.0	single nucleotide variant	NM_000533.5(PLP1):c.671T>C (p.Leu224Pro)	5354.0	PLP1	HGNC:9086	Uncertain significance	1.0	Jun 10, 2023	132630283.0	-	RCV000011829|RCV003511973	Human Phenotype Ontology:HP:0003269,MONDO:MONDO:0010714,MedGen:C0205711,OMIM:312080,Orphanet:702|MONDO:MONDO:0010733,MedGen:C1839264,OMIM:312920,Orphanet:99015	Pelizaeus-Merzbacher disease|Hereditary spastic paraplegia 2	germline	germline	GRCh38	NC_000023.11	X	103788485.0	103788485.0	Xq22.2	criteria provided, single submitter	2.0	-	N	ClinGen:CA255690,UniProtKB:P60201#VAR_004562,OMIM:300401.0008	3.0	11080.0	103788485.0	T	C	-	-	-	-	-	-	671T>C 	Leu224Pro	NM_000533.5	1.0	VUS	VUS	11080	X	103788485.0	T	C	L	P	rs132630283	X	103043414	X	102930070	224	PLP1	ENSG00000123560	ENST00000612423	ENSP00000481006	P60201	MYPR_HUMAN	c.671T>C	p.Leu224Pro	c.671T>C	p.Leu224Pro	principal1	Y	2	.	.	+	CTT	2	0	T	T/T	T/T	T/T	T/T	.	.	.	0.001	0.83643	D	0.999	0.77914	D	0.977	0.73823	D	.	.	.	.	.	.	2.61	0.76153	M	.	.	.	0.987	0.99555	1.0596	0.98327	D	0.9814	0.99428	D	10	0.99298525	0.99832	D	0.885836	0.99130	D	.	.	0.966	0.99665	P60201	L224P	Loss of helix (P = 0.0104)| Loss of stability (P = 0.0132)| Gain of loop (P = 0.0195)| Loss of ubiquitination at K229 (P = 0.0853)| Gain of methylation at K229 (P = 0.1949)	0.999954151886	0.99995	0.9993224651044053	0.99932	.	.	0.832187771797	0.86875	D	0.977801	0.99798	D	0.542118	0.95454	D	0.540938	0.95387	D	0.989848280873816	0.79911	D	.	0.80099	.	0.96628857	0.97871	0.95308447	0.98560	0.97230804	0.98445	0.94863	0.98291	-11.238	0.81632	D	0.9985	0.98378	LP	0.99993352634651	0.98982	0.99868780	0.98911	0.941	0.97199	.	.	.	.	.	.	5.056879	0.84284	28.3	0.99897694798250414	0.97050	.	.	.	.	.	.	.	.	.	5.36	5.36	0.76590	3.61	0.66044	7.635	0.8249	7.885000	0.72767	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	428	0.80972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Hereditary_spastic_paraplegia_2|Pelizaeus-Merzbacher_disease	criteria_provided,_single_submitter	NC_000023.11:g.103788485T>C	ClinGen:CA255690|OMIM:300401.0008|UniProtKB:P60201#VAR_004562	C1839264|C0205711	312920|312080	99015|702	.	Leu	Pro	89.97	0.006097560975609756																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																89.97	0.60975605	70-90	<10	312080;312920	x-linked recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	PELIZAEUS-MERZBACHER DISEASE; SPASTIC PARAPLEGIA 2, X-LINKED	false	0.9905946972345462	0.9956740473783458	true	true	true
DES	DES_Thr445Ala	B_7-8	-3.345179823198169	0.028697143616057023	0.06003455017159793	-0.9116130012053344	0.3922839009214338	0.44580165209242284	2024_01_Batch_7-8	false	false	true	false	false	false	false	false	false	false	false	false	0.707647519271867	0.680830417366692	0.9415401063495784	0.7791133346097487	0.7367854604488251	0.97661446181458	0.97661446181458	0.9508337870893928	0.961015651057043	0.9415401063495784	0.7077251771370122	0.707647519271867		0.5227371338082575	0.5972110181624545		0.6539356575963718		DES	Thr445Ala	NC_000002.12:219425707:A:G	1333A>G	2	219425707	A	G	2	ENSG00000175084	12573	2336	CCSBVarC006509	ALE00006508	ENSP00000363071.3	Edgotyping3	VUSMutGDEh005	C12	GDEhDisVCh_40003	B12	1	VUSMutGDDh005	C12	VUSN2Hmut_GDN2h_02	D04	NULL	NULL	VUSmut_GDEh02	D04	1.0	6.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	N	Y	Y	N	Y	77296.0	single nucleotide variant	NM_001927.4(DES):c.1333A>G (p.Thr445Ala)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Aug 23, 2023	267607498.0	-	RCV000056785|RCV001854165|RCV003162434|RCV002483084	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MedGen:CN230736|MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146;MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154;MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy|Cardiovascular phenotype|Neurogenic scapuloperoneal syndrome, Kaeser type;Dilated cardiomyopathy 1I;Desmin-related myofibrillar myopathy	germline;unknown	germline	GRCh38	NC_000002.12	2	219425707.0	219425707.0	2q35	criteria provided, multiple submitters, no conflicts	5.0	ACMG2022	N	ClinGen:CA284676	2.0	66399.0	219425707.0	A	G	-	-	-	-	-	-	1333A>G 	Thr445Ala	NM_001927.4	2.0	VUS	VUS	66399	2	219425707.0	A	G	T	A	rs267607498	2	220290429	2	219998673	445	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1333A>G	p.Thr445Ala	c.1333A>G	p.Thr445Ala	principal1	Y	1	YES	Select	+	ACG	1	0	A	A/A	A/A	A/A	A/A	0.011	0.55689	D	0.242	0.24550	T	0.248	0.31165	B	0.206	0.37139	B	0.95	0.94956	D	simple_aae	5.0	95.0	3.035	0.86364	M	-1.9	0.44290	N	0.869	0.86590	0.7265	0.93481	D	0.8555	0.95176	D	10	0.76110244	0.76123	D	0.110002	0.78656	D	0.662	0.87323	0.401	0.42936	P17661	T445A	Loss of ubiquitination at K443 (P = 0.069)| Loss of phosphorylation at T445 (P = 0.0714)| Loss of disorder (P = 0.0834)| Gain of MoRF binding (P = 0.1107)| Loss of methylation at K449 (P = 0.1445)	0.970119442787	0.96951	0.8678796212183327	0.86671	0.676180710718	0.59477	0.810884594917	0.83599	D	0.243618	0.61045	T	0.497892	0.94188	D	0.477411	0.94110	D	0.958357453346252	0.65028	D	0.637636	0.24872	T	0.13686918	0.31442	0.1920148	0.42544	0.16638963	0.36671	0.17246689	0.39372	-4.581	0.31968	T	0.1581	0.35034	B	0.936535908078351	0.79011	0.99191093	0.97046	0.813	0.89669	.	.	.	.	.	.	4.271179	0.65061	24.8	0.99452367359405525	0.65371	0.970976	0.99312	D	0.104158331043393	0.46403	2.902692	0.229994648440223	0.51266	3.333756	4.46	4.46	0.53511	3.79	0.69847	7.365	0.78843	11.126000	0.86691	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.995	0.73271	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9	1598992	5.628550e-06	0	9	1173018	7.672520e-06	0	0	74630	0.000000e+00	0	0	912	0.000000e+00	0	0	57668	0.000000e+00	0	0	29102	0.000000e+00	0	0	44456	0.000000e+00	0	0	63258	0.000000e+00	0	0	6058	0.000000e+00	0	9	1173018	7.672520e-06	0	0	87834	0.000000e+00	0	1	9690	1.0319917440660474E-4	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	1	14050	7.117437722419929E-5	not_provided|Cardiovascular_phenotype|Desmin-related_myofibrillar_myopathy|Dilated_cardiomyopathy_1I|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219425707A>G	ClinGen:CA284676	C3661900|CN230736|C1832370|C1858154|C1867005	601419|604765|181400	363543|98909|154|85146	.	Thr	Ala	63.57	0.5211267605633803																																																																																																																																																																																																																																																																																																																																																																																																																																																																													74			63.57	Polar/Neutral	Threonine		Desmin										-0.7								 T445-H467 (PAE:  5.5)		 T445-H467 (PAE:  5.5)								119									-116.2				122.9	Tail; Interaction with CRYAB					B (undefined)	E (parallel sheets)												63.57	52.112675	50-70	10-90	601419;181400;604765;601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1; SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; CARDIOMYOPATHY, DILATED, 1I; MYOPATHY, MYOFIBRILLAR, 1	false	0.680830417366692	0.707647519271867	false	false	false
DES	DES_Arg227Cys	B_7-8	-2.870757142339565	0.06401066318247077	0.11268236560232181	-1.4252488431275485	0.19711210158443015	0.24129466738320837	2024_01_Batch_7-8	false	false	true	false	false	true	false	false	false	false	false	false	0.8498579851922166	0.7838654479686687	0.9744618166044526	0.8812190117235239	0.8682891600901872	0.986956993356643	0.986956993356643	0.9701845722323009	0.9861799952238857	0.9744618166044526	0.8479709988001428	0.8498579851922166		0.7663937479480735	0.7762580282231621		0.7197598971371947		DES	Arg227Cys	NC_000002.12:219420290:C:T	679C>T	2	219420290	C	T	2	ENSG00000175084	12573	2268	CCSBVarC007829	ALE00007815	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	C06	GDEhDisVCh_40003	E06	1	VUSMutGDDh003	C06	VUSN2Hmut_GDN2h_01	D03	NULL	NULL	VUSmut_GDEh01	D03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	392716.0	single nucleotide variant	NM_001927.4(DES):c.679C>T (p.Arg227Cys)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Feb 05, 2024	767743962.0	-	RCV000468464|RCV001809412|RCV004719831	MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146|MedGen:C3661900	Desmin-related myofibrillar myopathy|Neurogenic scapuloperoneal syndrome, Kaeser type|not provided	germline	germline	GRCh38	NC_000002.12	2	219420290.0	219420290.0	2q35	criteria provided, multiple submitters, no conflicts	3.0	ACMG2022	N	ClinGen:CA2125125	2.0	411141.0	219420290.0	C	T	-	-	-	-	-	-	679C>T 	Arg227Cys	NM_001927.4	2.0	VUS	VUS	411141	2	219420290.0	C	T	R	C	rs767743962	2	220285012	2	219993256	227	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.679C>T	p.Arg227Cys	c.679C>T	p.Arg227Cys	principal1	Y	1	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.994	0.82066	D	0.87	0.90832	D	simple_aae	13.0	87.0	2.68	0.78280	M	-6.99	0.93639	D	0.762	0.75916	0.5264	0.90880	D	0.7109	0.90037	D	10	0.87280554	0.86409	D	0.103529	0.77691	D	0.734	0.90683	0.539	0.64898	P17661	R227C	Loss of disorder (P = 0.026)| Gain of catalytic residue at S231 (P = 0.1009)| Loss of solvent accessibility (P = 0.1459)| Loss of MoRF binding (P = 0.3303)| Loss of phosphorylation at S231 (P = 0.3414)	0.945711882264	0.94470	0.7822368417972269	0.78051	0.0234930241752	0.02310	0.803139388561	0.82411	D	0.777808	0.94056	D	0.216874	0.75297	D	0.156614	0.80455	D	0.995925068855286	0.88231	D	0.986401	0.95392	D	0.83478796	0.86056	0.7226728	0.83428	0.83478796	0.86057	0.7226728	0.83429	-10.347	0.76039	D	0.8888	0.81974	P	0.999890109795168	0.98645	0.99673850	0.98148	0.773	0.87433	.	.	.	.	.	.	6.162564	0.94707	34.0	0.99928369862762989	0.99222	0.887967	0.82000	D	0.684053220620542	0.78472	6.901888	0.596176319816603	0.74524	6.17589	4.38	4.38	0.51962	.	.	2.787	0.47585	5.884000	0.50753	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.995	0.73271	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	1	109402	9.140600e-06	0	2	208116	9.610030e-06	0	1	236936	4.220550e-06	0	0	7162	0.000000e+00	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	17110	5.844540e-05	0	0	16216	0.000000e+00	0	1	30518	3.276750e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	1	89550	1.116690e-05	0	0	30608	0.000000e+00	0	1	30518	3.276750e-05	0	0	14900	0.000000e+00	0	1	34254	2.919370e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	0	102742	0.000000e+00	0	0	30526	0.000000e+00	0	1	34254	2.919370e-05	0	.	9	1614060	5.576000e-06	0	4	74914	5.339460e-05	0	4	74914	5.339460e-05	0	0	912	0.000000e+00	0	1	60006	1.666500e-05	0	0	29608	0.000000e+00	0	0	44884	0.000000e+00	0	0	64030	0.000000e+00	0	0	6084	0.000000e+00	0	4	1180046	3.389700e-06	0	0	91090	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Desmin-related_myofibrillar_myopathy|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219420290C>T	ClinGen:CA2125125	C1832370|C1867005	601419|181400	363543|98909|85146	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Cys	96.84	0.6370967741935484																																																																																																																																																																																																																																																																																																																																																																																																																																																																													158			96.84	Positively-charged	Arginine		Desmin							IF rod			-4.5								 R227-I223 (PAE:  1.0), R227-S231 (PAE: 1.0)		 R227-I223 (PAE:  1.0), R227-S231 (PAE: 1.0)		 R227-D224 (PAE:  1.0)						175									-61.4				-39.9	Coil 1B					H (helix)	H (α-helix)												96.84	63.709675	>90	10-90	601419;181400	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1; SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	false	0.7838654479686687	0.8498579851922166	false	false	false
LITAF	LITAF_Ala129Val	B_15-16	1.627831307591165	0.14758544082007055	0.22283651538840693	-7.56091656145503	0.00013046621385214623	0.0004946394678072073	2025_03_Batch_15-16	false	true	true	false	false	true	false	false	false	false	false	false	0.9092427244503738	0.934810771519463	0.7427005283797299	0.7416393404529392	0.8109138366270214	0.8597726854383281	0.9241295732752154	0.9102053264116382	0.8945934118201444	0.762415593143901	0.9659075482484354	0.9369214527719683	0.7954157976014408	0.7116223468424047	0.588685269085734	0.7229854636155587	0.9037139947904906	0.8815639961287793	LITAF	Ala129Val	NC_000016.10:11549737:G:A	386C>T	16	11549737	G	A	16	ENSG00000189067	52920	2671	CCSBVarC007936	ALE00007922	ENSP00000483114.1	Edgotyping3	VUSMutGDEh006	A12	GDEhDisVCh_40036	B06	2	VUSMutGDDh006	A12	VUSN2Hmut_GDN2h_02	E05	VUSMutpDEST2_11	C12	VUSmut_GDEh02	E05	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	340466.0	single nucleotide variant	NM_001136472.2(LITAF):c.386C>T (p.Ala129Val)	9516.0	LITAF	HGNC:16841	Uncertain significance	0.0	Nov 07, 2022	201512884.0	-	RCV000385548|RCV002356425	MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083|MeSH:D030342,MedGen:C0950123	Charcot-Marie-Tooth disease type 1C|Inborn genetic diseases	germline	germline	GRCh38	NC_000016.10	16	11549737.0	11549737.0	16p13.13	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA7904028	2.0	317780.0	11549737.0	G	A	-	-	-	-	-	-	386C>T 	Ala129Val	NM_001136472.2	2.0	VUS	VUS	317780	16	11549737.0	G	A	A	V	rs201512884	16	11643593	16	11551094	129	LITAF	ENSG00000189067	ENST00000576036	ENSP00000461667	Q99732	LITAF_HUMAN	c.386C>T	p.Ala129Val	c.386C>T	p.Ala129Val	principal1	Y	4	.	.	-	GCG	2	0	.	G/G	G/G	G/G	G/G	.	0.07894	.	0.34	0.18259	T	0.211	0.30005	B	0.04	0.23834	B	0.14	0.35500	N	simple_aae	86.0	14.0	0.93	0.23409	L	.	0.02540	.	0.331	0.40016	-0.7924	0.55407	T	0.3559	0.71747	T	9	0.16734588	0.30865	T	0.046235	0.62220	D	.	0.48694	0.524	0.62694	Q99732	A129V	Gain of sheet (P = 0.0827)| Gain of loop (P = 0.2045)| Loss of helix (P = 0.2662)| Gain of catalytic residue at F133 (P = 0.56)| Loss of stability (P = 0.8818)	0.9775445321	0.97707	.	0.40965	.	0.17433	0.476867556572	0.35578	T	0.316971	0.68667	T	-0.0721967	0.40627	T	-0.240852	0.50391	T	0.0558730279596516	0.06434	T	.	0.57977	.	0.026125083	0.01619	0.049342	0.07536	0.026125083	0.01619	0.049342	0.07536	-7.436	0.57230	T	0.2563	0.49161	LB	0.167409087704889	0.48160	0.82325697	0.88921	0.011	0.00835	.	.	.	.	.	.	1.428453	0.18488	13.75	0.86522591431886209	0.16839	0.078503	0.15646	N	-0.875501602823793	0.11290	0.5514063	-0.884890904832805	0.12236	0.6405666	5.01	1.99	0.25354	.	.	0.238	0.17842	4.271000	0.42924	0.665	0.62996	0.0	0.06393	0.999000	0.35501	0.116	0.19043	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	107848	9.272310e-06	0	1	204442	4.891360e-06	0	1	233228	4.287650e-06	0	0	6874	0.000000e+00	0	0	16936	0.000000e+00	0	0	2274	0.000000e+00	0	0	8956	0.000000e+00	0	0	13314	0.000000e+00	0	0	42166	0.000000e+00	0	1	15450	6.472490e-05	0	1	15450	6.472490e-05	0	0	15760	0.000000e+00	0	0	30168	0.000000e+00	0	0	6114	0.000000e+00	0	0	13320	0.000000e+00	0	0	16612	0.000000e+00	0	0	87512	0.000000e+00	0	1	30162	3.315430e-05	0	1	30162	3.315430e-05	0	0	14486	0.000000e+00	0	0	33914	0.000000e+00	0	0	9486	0.000000e+00	0	0	17572	0.000000e+00	0	0	21412	0.000000e+00	0	0	100718	0.000000e+00	0	1	30082	3.324250e-05	0	1	30082	3.324250e-05	0	.	9	1612324	5.582000e-06	0	1	44844	2.229950e-05	0	0	74884	0.000000e+00	0	0	910	0.000000e+00	0	1	59774	1.672970e-05	0	0	29564	0.000000e+00	0	1	44844	2.229950e-05	0	0	63932	0.000000e+00	0	0	6078	0.000000e+00	0	6	1179136	5.088470e-06	0	1	90774	1.101640e-05	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Charcot-Marie-Tooth_disease_type_1C|Inborn_genetic_diseases	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.11549737G>A	ClinGen:CA7904028	C0270913|C0950123	601098	101083	LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor	Ala	Val	70.51	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													112			70.51	Aliphatic	Alanine		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF			1.8																		89									-76.4				21.8	Membrane-binding amphipathic helix					C (loop/coil)	T (turn)												70.51	100.0	70-90	$\geqslant$90	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.934810771519463	0.9092427244503738	true	false	false
LITAF	LITAF_Asn30Tyr	B_15-16	2.807651247691414	0.026234273282023154	0.055861161615010285	-7.199532543407132	0.00017752827294070905	0.0006196758249753655	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8822926864795448	0.9027037705497545	0.6425256686408033	0.6562883960175653	0.7412544145267065	0.6607718409332697	0.5160116061822231	0.7083833628718543	0.5603822826104945	0.5404646263176696	0.883257414825021	0.8523816798950219	0.8055320756843162	0.7741254661815586	0.7521945094246361	0.744586710963937	0.922150126274488	0.9122036930640677	LITAF	Asn30Tyr	NC_000016.10:11556643:T:A	88A>T	16	11556643	T	A	16	ENSG00000189067	52920	2688	CCSBVarC007945	ALE00007931	ENSP00000483114.1	Edgotyping3	VUSMutGDEh007	A02	GDEhDisVCh_40036	E07	2	VUSMutGDDh007	A02	VUSN2Hmut_GDN2h_02	C07	VUSMutpDEST2_12	C02	VUSmut_GDEh02	C07	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	333687.0	single nucleotide variant	NM_001136472.2(LITAF):c.88A>T (p.Asn30Tyr)	9516.0	LITAF	HGNC:16841	Uncertain significance	0.0	Jul 05, 2018	368574479.0	-	RCV000816653	MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083	Charcot-Marie-Tooth disease type 1C	germline	germline	GRCh38	NC_000016.10	16	11556643.0	11556643.0	16p13.13	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA10642888	2.0	317788.0	11556643.0	T	A	-	-	-	-	-	-	88A>T 	Asn30Tyr	NM_001136472.2	2.0	VUS	VUS	317788	16	11556643.0	T	A	N	Y	rs368574479	16	11650499	16	11558000	30	LITAF	ENSG00000189067	ENST00000622633	ENSP00000483114	Q99732	LITAF_HUMAN	c.88A>T	p.Asn30Tyr	c.88A>T	p.Asn30Tyr	principal1	Y	1	YES	Select	-	AAC	1	0	T	T/T	T/T	T/T	T/T	.	0.14433	.	1.0	0.41584	T	0.0	0.02950	B	0.0	0.01384	B	.	0.38685	.	.	.	.	1.78	0.46014	L	.	0.38532	.	0.748	0.82708	-0.1958	0.77679	T	0.6113	0.86192	D	10	0.17475855	0.32005	T	0.097659	0.76736	D	.	0.81332	0.328	0.31060	Q99732	N30Y	Gain of phosphorylation at N30 (P = 0.0055)| Gain of sheet (P = 0.0085)| Loss of loop (P = 0.0512)| Gain of catalytic residue at P34 (P = 0.123)| Gain of glycosylation at P34 (P = 0.1662)	0.944914650993	0.94389	.	0.68840	.	0.20454	0.490920066833	0.37515	T	0.345762	0.71237	T	-0.035973	0.46209	T	-0.120321	0.61506	T	0.432429134845734	0.29841	T	.	0.46196	.	0.028476842	0.02174	0.038792573	0.03840	0.028476842	0.02173	0.038792573	0.03840	-6.92	0.53515	T	.	0.58791	.	0.65461952030081	0.65530	0.93537490	0.92635	0.034	0.07526	.	.	.	.	.	.	1.318645	0.17252	13.03	0.94929037881393497	0.26045	0.194806	0.31975	N	-0.747123755669469	0.14532	0.7351593	-0.785264978296469	0.14604	0.7784289	5.18	2.89	0.32629	.	.	0.658	0.2475	1.121000	0.24329	-0.127	0.13323	0.003	0.16092	0.472000	0.25137	0.183	0.21434	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	0	109388	0.000000e+00	0	0	208092	0.000000e+00	0	1	236860	4.221900e-06	0	0	7160	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	0	42754	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16214	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	0	89524	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14898	0.000000e+00	0	0	34260	0.000000e+00	0	0	9568	0.000000e+00	0	1	17692	5.652270e-05	0	0	21606	0.000000e+00	0	0	102690	0.000000e+00	0	0	30526	0.000000e+00	0	1	17692	5.652270e-05	0	.	10	1614056	6.195570e-06	0	3	44892	6.682710e-05	0	0	74902	0.000000e+00	0	0	910	0.000000e+00	0	0	60000	0.000000e+00	0	0	29608	0.000000e+00	0	3	44892	6.682710e-05	0	0	64038	0.000000e+00	0	0	6084	0.000000e+00	0	0	1180050	0.000000e+00	0	0	91090	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Charcot-Marie-Tooth_disease_type_1C	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.11556643T>A	ClinGen:CA10642888	C0270913	601098	101083	.	Asn	Tyr	56.96	0.8152866242038217																																																																																																																																																																																																																																																																																																																																																																																																																																																																													128			56.96	Polar/Neutral	Asparagine		Lipopolysaccharide-induced tumor necrosis factor-alpha factor								0.0888		-3.5										 N30-T26 (PAE:  5.5)								132									-87.6		Pocket 1: Mean pLDDT: 43.5, Volume: 1121.22 Å³, Druggability score: 0.09		0.8						C (loop/coil)	T (turn)												56.96	81.52866	50-70	10-90	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.9027037705497545	0.8822926864795448	false	false	false
MVK	MVK_Ser329Asn	B_11-12	-7.29022816493008	0.000622274082139747	0.0032949680452470593	-11.593562110792755	0.001354109329583656	0.003086696422094421	2024_12_Batch_11-12		true	true	true	true	true		true	true	false	false	true		0.9982746655753556	0.9438493857798648	0.927940300232192	0.951614226292381	0.964622789577567	0.9522043598034851	0.9452794856886005	0.9141556790952756	0.9161258721029192	0.9981346538139346		0.9770412193516489	0.9579489668961616	0.9417249213691083	0.9715728994568104	0.9984146773367766		MVK	Ser329Asn	NC_000012.12:109595128:G:A	986G>A	12	109595128	G	A	12	ENSG00000110921	281	200100	CCSBVarC004847	ALE00004847	ENSP00000228510.3	CEGS2	CegsMutGDEh1034	H03	GDEhDisVCh_40020	C01	2	CegsMutGDDh1034	H03	VUSN2Hmut_GDN2h_06	G07	VUSMutpDEST2_01	B06	VUSmut_GDEh06	G07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	103532.0	single nucleotide variant	NM_000431.4(MVK):c.986G>A (p.Ser329Asn)	4598.0	MVK	HGNC:7530	Uncertain significance	0.0	Mar 24, 2023	104895350.0	-	RCV000083893|RCV003764777	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0008293,MedGen:C1867981,OMIM:175900;MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29;MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343	Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type;Mevalonic aciduria;Hyperimmunoglobulin D with periodic fever	germline;unknown	germline	GRCh38	NC_000012.12	12	109595128.0	109595128.0	12q24.11	criteria provided, single submitter	2.0	-	N	ClinGen:CA149935	2.0	97640.0	109595128.0	G	A	-	-	-	-	-	-	986G>A 	Ser329Asn	NM_000431.4	1.0	VUS	VUS	97640	12	109595128.0	G	A	S	N	rs104895350	12	110032933	12	108517316	329	MVK	ENSG00000110921	ENST00000546277	ENSP00000438153	Q03426	KIME_HUMAN	.	.	c.986G>A	p.Ser329Asn	principal1	Y	5	.	.	+	AGC	2	0	G	G/G	G/G	G/G	G/G	.	0.72322	.	.	0.68204	.	1.0	0.90580	D	0.986	0.76920	D	.	0.99291	.	.	.	.	3.4	0.91562	M	.	0.58437	.	.	0.98669	0.9220	0.95974	D	0.8633	0.95442	D	10	.	0.98335	.	0.429145	0.93935	D	.	0.95384	0.938	0.99125	Q03426	S329N	Loss of glycosylation at S329 (P = 0.08)| Loss of catalytic residue at K330 (P = 0.0842)| Loss of disorder (P = 0.1093)| Gain of sheet (P = 0.1208)| Gain of MoRF binding (P = 0.1632)	.	0.98201	.	0.95960	.	0.77309	0.700985789299	0.67231	T	0.877738	0.97390	D	0.248659	0.78314	D	0.119405	0.78033	D	0.992818593978882	0.83265	D	.	0.97100	.	0.9421113	0.95392	0.8580474	0.91940	0.95420414	0.96641	0.8520869	0.91534	-15.463	0.96850	D	.	0.84409	.	0.99896519724822	0.95408	0.99711800	0.98269	0.856	0.92124	.	.	.	.	.	.	5.35298	0.89805	31.0	0.99783076369763812	0.86966	0.925360	0.90443	D	0.865341119463794	0.89908	10.19341	0.768415175219882	0.87456	9.252486	4.51	4.51	0.54535	.	.	8.756	0.91347	11.790000	0.96350	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.959	0.5146	729	0.54435	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614184	6.195080e-07	0	1	60026	1.665940e-05	0	0	75072	0.000000e+00	0	0	912	0.000000e+00	0	1	60026	1.665940e-05	0	0	29606	0.000000e+00	0	0	44856	0.000000e+00	0	0	64020	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180036	0.000000e+00	0	0	91084	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Mevalonic_aciduria|Hyperimmunoglobulin_D_with_periodic_fever|Porokeratosis_3,_disseminated_superficial_actinic_type	criteria_provided,_single_submitter	NC_000012.12:g.109595128G>A	ClinGen:CA149935	C1959626|C0398691|C1867981	610377|260920|175900	29|343	GHMP kinase, C-terminal domain	Ser	Asn	98.61	0.015384615384615385																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			98.61	Polar/Neutral	Serine		Mevalonate kinase										-0.8								 S329-C319 (PAE:  1.0), S329-T342 (PAE: 1.0), S329-T322 (PAE: 1.0)	S329-C319 (PDBs: 2R3V), S329-T342 (PDBs: 2R3V), S329-T322 (PDBs: 2R3V)	 S329-T342 (PAE:  1.0), S329-I298 (PAE: 1.0), S329-T322 (PAE: 1.0), S329-L318 (PAE: 1.0)	S329-T342 (PDBs: 2R3V), S329-T322 (PDBs: 2R3V), S329-I298 (PDBs: 2R3V), S329-C319 (PDBs: 2R3V), S329-L318 (PDBs: 2R3V)							105									-135.2				153.0						B (undefined)	E (parallel sheets)	Beta strand											98.61	1.5384616	>90	<10	260920;175900;610377;260920	multiple	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; POROKERATOSIS 3, MULTIPLE TYPES; MEVALONIC ACIDURIA; HYPER-IgD SYNDROME	false	0.9982746655753556		true		true
TPM1	TPM1_Lys37Glu	B_15-16	-4.692991736188501	0.002245016049664888	0.008588995025712597	-6.388978294635526	0.01441079579255391	0.021755795969459497	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7620580762772062	0.7570858034441328	0.6300086600526507	0.6611943152918742	0.6827182296141687	0.702946221334356	0.7552150947260422	0.6707901359599198	0.7173888240002051	0.7052841026852374	0.7129920130421976	0.7231005019001844	0.6506773479426697	0.6946463232684178	0.6049998065835432	0.554733217420064	0.8011795938460679	0.801015650654228	TPM1	Lys37Glu	NC_000015.10:63042938:A:G	109A>G	15	63042938	A	G	15	ENSG00000140416	4723	201726	CCSBVarC005632	ALE00005632	ENSP00000288398.6	CEGS2	CegsMutGDEh1034	C12	GDEhDisVCh_40050	H04	2	CegsMutGDDh1034	C12	VUSN2Hmut_GDN2h_06	F10	VUSMutpDEST2_04	A06	VUSmut_GDEh06	F10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	40557.0	single nucleotide variant	NM_001018005.2(TPM1):c.109A>G (p.Lys37Glu)	7168.0	TPM1	HGNC:12010	Uncertain significance	0.0	Jul 26, 2021	199476303.0	-	RCV000024593|RCV001852576	MedGen:C3661900|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569	not provided|Hypertrophic cardiomyopathy	germline	germline	GRCh38	NC_000015.10	15	63042938.0	63042938.0	15q22.2	criteria provided, single submitter	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018576,Leiden Muscular Dystrophy (TPM1):TPM1_00028	2.0	31897.0	63042938.0	A	G	-	-	-	-	-	-	109A>G 	Lys37Glu	NM_001018005.2	1.0	VUS	VUS	31897	15	63042938.0	A	G	K	E	rs199476303	15	63335137	15	61122190	37	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.109A>G	p.Lys37Glu	c.109A>G	p.Lys37Glu	alternative1	Y	1	YES	Select	+	AAG	1	0	A	A/A	A/A	A/A	A/A	0.218	0.78662	T	0.388	0.17989	T	0.001	0.62341	B	0.008	0.62509	B	1.0	0.99291	D	simple_aae	0.0	100.0	1.525	0.38436	L	-0.85	0.34375	N	0.742	0.85520	0.6479	0.92489	D	0.8651	0.95504	D	10	0.4276486	0.56938	D	0.534959	0.95636	D	0.543	0.80861	0.188	0.09720	Q6ZN40	K37E	Loss of ubiquitination at K37 (P = 0.0027)| Loss of methylation at K37 (P = 0.1134)| Loss of glycosylation at K37 (P = 0.1191)| Loss of MoRF binding (P = 0.2281)| Loss of solvent accessibility (P = 0.4011)	0.969984366057	0.96938	.	0.82624	.	0.99005	0.71869468689	0.69805	T	0.444128	0.78605	T	0.399032	0.89785	D	0.335406	0.89658	D	0.962665200233459	0.66219	D	0.954005	0.82661	D	0.4738983	0.65216	0.36210945	0.61382	0.3676073	0.58080	0.43091294	0.66470	-12.366	0.86622	D	0.3487	0.72785	A	0.995137467103665	0.91114	0.99868410	0.98905	0.248	0.51819	.	.	.	.	.	.	4.525324	0.71046	25.6	0.97790470471597657	0.36154	0.882558	0.81007	D	-0.154625612457761	0.34763	2.007563	-0.0527290293622686	0.37073	2.187343	4.61	3.47	0.38760	.	.	7.275	0.77988	10.974000	0.84577	0.683	0.82456	1.0	0.71675	1.000000	0.68239	0.999	0.91597	786	0.46777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Hypertrophic_cardiomyopathy	criteria_provided,_single_submitter	NC_000015.10:g.63042938A>G	ClinGen:CA018576|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00028	C3661900|C0007194	.	217569	.	Lys	Glu	90.93	0.6341463414634146																																																																																																																																																																																																																																																																																																																																																																																																																																																																													130			90.93	Positively-charged	Lysine		Tropomyosin alpha-1 chain	Coiled coil	Basic and acidic residues								-3.9								 K37-D41 (PAE:  2.5), K37-E33 (PAE: 3.0)		 K37-D41 (PAE:  2.5), K37-E33 (PAE: 3.0)								147									-60.5				-46.1	Disordered					H (helix)	H (α-helix)										Morphology: kAAEDRSkQLEDELV		90.93	63.414635	>90	10-90		unknown		Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3		false	0.7570858034441328	0.7620580762772062	false	false	false
DES	DES_Gly20Arg	B_7-8	-0.4582769510913665	0.6628829161580638	0.7319408516056284	-0.2644460565697902	0.7990532568270091	0.8364305341001493	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5409077864322452	0.6063005903794703	0.5269778651774242	0.7274261885532327	0.6697004202670389	0.577291933206066	0.5118092292879366	0.6009445752506573	0.6530170043438146	0.5155987110313947	0.6310618197241471	0.6585863902394534	0.6427746371241954	0.7384562652834205	0.8018353727626509	0.5383570193234536	0.5815393610347933	0.4232291826250371	DES	Gly20Arg	NC_000002.12:219418520:G:A	58G>A	2	219418520	G	A	2	ENSG00000175084	12573	2218	CCSBVarC007785	ALE00007771	ENSP00000363071.3	Edgotyping3	VUSMutGDEh002	D12	GDEhDisVCh_40092	A03	1	VUSMutGDDh002	D12	VUSN2Hmut_GDN2h_01	B01	NULL	NULL	VUSmut_GDEh01	B01	1.0	1.0	1.0	1.0	1.0	5.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	392581.0	single nucleotide variant	NM_001927.4(DES):c.58G>A (p.Gly20Arg)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Apr 06, 2022	759306707.0	-	RCV000461350	MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219418520.0	219418520.0	2q35	criteria provided, single submitter	1.0	ACMG2022	N	ClinGen:CA16610716	2.0	411153.0	219418520.0	G	A	-	-	-	-	-	-	58G>A 	Gly20Arg	NM_001927.4	1.0	VUS	VUS	411153	2	219418520.0	G	A	G	R	rs759306707	2	220283242	2	219991486	20	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.58G>A	p.Gly20Arg	c.58G>A	p.Gly20Arg	principal1	Y	1	YES	Select	+	GGG	1	0	G	G/G	G/G	G/G	G/G	0.317	0.13778	T	0.165	0.31245	T	0.969	0.56783	D	0.54	0.48823	P	.	.	.	.	.	.	2.16	0.60196	M	-1.64	0.39308	N	0.446	0.48167	0.2252	0.86277	D	0.5652	0.84157	D	10	0.6791601	0.70913	D	0.475273	0.94739	D	0.496	0.77984	0.561	0.67980	P17661	G20R	Gain of MoRF binding (P = 0.0084)| Gain of methylation at G20 (P = 0.0193)| Gain of helix (P = 0.062)| Gain of solvent accessibility (P = 0.0674)| Loss of catalytic residue at G20 (P = 0.0968)	0.918353723045	0.91691	0.7169835386287019	0.71494	1.06581538022	0.76486	0.758659005165	0.75687	T	0.447413	0.78811	T	0.0676673	0.60285	T	-0.140577	0.59786	T	0.820116519927979	0.47501	D	0.711829	0.32086	T	0.4224769	0.61934	0.39724138	0.64094	0.4224769	0.61935	0.39724138	0.64094	-6.895	0.53330	T	0.6131	0.69364	P	0.905866118417153	0.76465	0.97739150	0.95271	0.779	0.87767	.	.	.	.	.	.	4.288143	0.65442	24.8	0.99350484861868305	0.60631	0.577695	0.57770	D	0.221329693695368	0.51996	3.398845	0.144784661006563	0.46596	2.925708	5.12	4.24	0.49427	.	.	4.539	0.60453	9.517000	0.80958	0.59	0.31918	0.998	0.41403	1.000000	0.68239	0.981	0.58703	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1603044	1.871440e-06	0	2	1176448	1.700030e-06	0	0	73888	0.000000e+00	0	0	912	0.000000e+00	0	0	59306	0.000000e+00	0	0	29188	0.000000e+00	0	0	43730	0.000000e+00	0	0	61516	0.000000e+00	0	0	5948	0.000000e+00	0	2	1176448	1.700030e-06	0	0	90176	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Desmin-related_myofibrillar_myopathy	criteria_provided,_single_submitter	NC_000002.12:g.219418520G>A	ClinGen:CA16610716	C1832370	601419	363543|98909	Intermediate filament head, DNA-binding domain	Gly	Arg	37.3	0.8928571428571429																																																																																																																																																																																																																																																																																																																																																																																																																																																																													75			37.3	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Desmin										-0.4																		75									117.7				91.4	Head					C (loop/coil)	C (loop/coil)												37.3	89.28571	$\leqslant$50	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.6063005903794703	0.5409077864322452	false	false	false
LITAF	LITAF_Pro39Ser	B_15-16	1.714485014223526	0.1301575949289161	0.20227909382768897	-7.193699927316086	0.00017843085244934553	0.0006204741380623879	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8987860726311467	0.9260392411535612	0.6658204931343652	0.6542117287627643	0.7451964059387363	0.6658142986931768	0.7961234333251047	0.8775682803171141	0.7602598533237506	0.7807010220860473	0.8911053928737313	0.8582938421476118	0.5355051640612487	0.6128245315603584	0.5481636042017781	0.550939964182683	0.9609730894333911	0.9392783031146817	LITAF	Pro39Ser	NC_000016.10:11556616:G:A	115C>T	16	11556616	G	A	16	ENSG00000189067	52920	2686	CCSBVarC007943	ALE00007929	ENSP00000483114.1	Edgotyping3	VUSMutGDEh007	G01	GDEhDisVCh_40036	C07	2	VUSMutGDDh007	G01	VUSN2Hmut_GDN2h_02	A07	VUSMutpDEST2_12	A02	VUSmut_GDEh02	A07	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	242188.0	single nucleotide variant	NM_001136472.2(LITAF):c.115C>T (p.Pro39Ser)	9516.0	LITAF	HGNC:16841	Uncertain significance	0.0	Sep 19, 2023	375202318.0	-	RCV000230506	MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083	Charcot-Marie-Tooth disease type 1C	germline	germline	GRCh38	NC_000016.10	16	11556616.0	11556616.0	16p13.13	criteria provided, single submitter	1.0	-	N	ClinGen:CA7904182	2.0	240077.0	11556616.0	G	A	-	-	-	-	-	-	115C>T 	Pro39Ser	NM_001136472.2	1.0	VUS	VUS	240077	16	11556616.0	G	A	P	S	rs375202318	16	11650472	16	11557973	39	LITAF	ENSG00000189067	ENST00000570904	ENSP00000459138	Q99732	LITAF_HUMAN	c.115C>T	p.Pro39Ser	c.115C>T	p.Pro39Ser	principal1	Y	1	.	.	-	CCC	1	0	G	G/G	G/G	G/G	G/G	.	0.21254	.	0.55	0.92967	T	1.0	0.90580	D	0.994	0.82066	D	0.2	0.55288	N	simple_aae	80.0	20.0	1.87	0.49422	L	.	0.31748	.	0.514	0.66620	-0.0538	0.81041	T	0.7057	0.89846	D	10	0.3351394	0.59920	D	0.107252	0.78257	D	.	0.67972	.	.	.	.	.	0.994402621582	0.99427	.	0.63589	.	0.51559	0.405111074448	0.25749	T	0.291554	0.66242	T	0.0583622	0.59122	T	-0.0462861	0.67039	D	0.34233283996582	0.26418	T	.	0.62192	.	0.058607377	0.11703	0.066470414	0.13618	0.058607377	0.11702	0.066470414	0.13618	-4.916	0.35956	T	.	0.44036	.	0.23831113279899	0.51720	0.94830570	0.93283	0.199	0.45998	.	.	.	.	.	.	4.17067	0.62778	24.5	0.97556151897828225	0.34768	0.750303	0.69034	D	0.217357993732904	0.51803	3.380837	0.102771455394205	0.44412	2.745893	4.0	4.0	0.45610	.	.	5.748	0.68407	7.431000	0.58858	0.676	0.76753	0.999	0.42732	1.000000	0.68239	0.079	0.17228	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	1	109406	9.140270e-06	0	2	208096	9.610950e-06	0	3	236874	1.266500e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42766	2.338310e-05	0	0	15690	0.000000e+00	0	1	42766	2.338310e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6208	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	2	89526	2.233990e-05	0	0	30608	0.000000e+00	0	2	89526	2.233990e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9566	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	3	102680	2.921700e-05	0	0	30526	0.000000e+00	0	3	102680	2.921700e-05	0	.	31	1614120	1.920550e-05	0	31	1180056	2.626990e-05	0	0	74936	0.000000e+00	0	0	910	0.000000e+00	0	0	60008	0.000000e+00	0	0	29606	0.000000e+00	0	0	44896	0.000000e+00	0	0	64040	0.000000e+00	0	0	6082	0.000000e+00	0	31	1180056	2.626990e-05	0	0	91096	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Charcot-Marie-Tooth_disease_type_1C	criteria_provided,_single_submitter	NC_000016.10:g.11556616G>A	ClinGen:CA7904182	C0270913	601098	101083	.	Pro	Ser	53.17	0.9705882352941176																																																																																																																																																																																																																																																																																																																																																																																																																																																																													132			53.17	Special, No backbone hydrogen	Proline		Lipopolysaccharide-induced tumor necrosis factor-alpha factor										1.6																		115									-71.9				124.6						H (helix)	P (polyproline helix)												53.17	97.05882	50-70	$\geqslant$90	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.9260392411535612	0.8987860726311467	false	false	false
GFAP	GFAP_Arg79Ser	B_15-16	-0.8818582235662402	0.40711356826039713	0.499093013721026	23.68825137625999	6.071433245081874e-8	3.978957144544728e-6	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9652870252783066	0.9736318874711618	0.6196831601154156	0.8425094530028274	0.8349075584772423	0.7506005237000589	0.665958707164751	0.8223080760838439	0.7794983405117671	0.648754862597399	0.9712144571342247	0.9546980413638142	0.8352423402353668	0.8475070408706405	0.9055205654938876	0.590611457633432	0.976049317808099	0.9758760091927988	GFAP	Arg79Ser	NC_000017.11:44915252:G:T	235C>A	17	44915252	G	T	17	ENSG00000131095	2920	214406	CCSBVarC004661	ALE00004661	ENSP00000466598.2	CEGS2	CegsMutGDEh1039	F07	GDEhDisVCh_40051	G06	1	CegsMutGDDh1039	F07	VUSN2Hmut_GDN2h_08	A03	VUSMutpDEST2_02	E12	VUSmut_GDEh08	A03	1.0	1.0	1.0	1.0	1.0	5.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	77366.0	single nucleotide variant	NM_002055.5(GFAP):c.235C>A (p.Arg79Ser)	2670.0	GFAP	HGNC:4235	Uncertain significance	0.0	Aug 11, 2022	59793293.0	-	RCV000056866	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000017.11	17	44915252.0	44915252.0	17q21.31	criteria provided, single submitter	2.0	-	N	ClinGen:CA217163	2.0	66469.0	44915252.0	G	T	-	-	-	-	-	-	235C>A 	Arg79Ser	NM_002055.5	1.0	VUS	VUS	66469	17	44915252.0	G	T	R	S	rs59793293	17	42992620	17	40348146	79	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.235C>A	p.Arg79Ser	c.235C>A	p.Arg79Ser	principal1	Y	1	YES	Select	-	CGC	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.83643	.	0.986	0.61540	D	0.985	0.76461	D	0.02	0.99291	N	without_aae	98.0	2.0	4.21	0.97827	H	.	0.84133	.	.	0.99866	0.9597	0.96531	D	0.9057	0.96866	D	10	0.9863377	0.98927	D	0.635375	0.96873	D	.	0.98001	0.924	0.98699	P14136	R79S	Loss of MoRF binding (P = 0.0266)| Loss of stability (P = 0.0594)| Loss of methylation at R79 (P = 0.0851)| Loss of phosphorylation at S82 (P = 0.0967)| Gain of disorder (P = 0.1385)	.	0.99995	.	0.97759	.	0.81376	0.853920459747	0.90190	D	0.964856	0.99570	D	0.522241	0.94890	D	0.512387	0.94815	D	0.999066531658173	0.96022	D	0.983335	0.96339	D	0.9773088	0.98879	0.95050716	0.98406	0.9673779	0.97979	0.95629704	0.98749	-12.655	0.87920	D	0.9849	0.93307	P	0.998702850921566	0.94906	0.99927586	0.99267	0.999	0.99956	.	.	.	.	.	.	5.483676	0.91416	32.0	0.99773583738960192	0.86100	.	.	.	0.768327987196662	0.84006	8.192343	0.675101514911069	0.80385	7.310992	4.82	3.85	0.43489	3.93	0.74723	7.996	0.88001	9.916000	0.82494	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.993	0.69292	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000017.11:g.44915252G>T	ClinGen:CA217163	C3661900	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Ser	92.32	0.5443548387096774																																																																																																																																																																																																																																																																																																																																																																																																																																																																													135			92.32	Positively-charged	Arginine		Glial fibrillary acidic protein							IF rod			-4.5								 R79-Y83 (PAE:  2.0), R79-E75 (PAE: 2.0)		 R79-Y83 (PAE:  2.0), R79-E75 (PAE: 2.0)								175									-63.1				-44.2	Coil 1A			dbSNP: rs59793293; Variant type: LP/P; AA change: Arg79Cys; PTM type: Phosphorylation; PTM morphology: NDR*FAsYIEKV; Var class: II&rs59285727		H (helix)	H (α-helix)												92.32	54.435486	>90	10-90		unknown		Rare genetic eye disease; Rare genetic neurological disorder	2		false	0.9736318874711618	0.9652870252783066	true	true	false
DES	DES_Ala237Thr	B_7-8	-0.5897375314913874	0.5870680848191814	0.6634911491151695	0.32435322649379505	0.7551477916199006	0.7959196999554955	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7073131632553761	0.62857681845984	0.8820418622589459	0.7231752661022524	0.7770763775425995	0.8727800679379312	0.8727800679379312	0.8638291013141424	0.8592271567316171	0.8820418622589459	0.6729137825662722	0.7073131632553761		0.6903236537710566	0.5871233754728876		0.5842398543534079		DES	Ala237Thr	NC_000002.12:219420320:G:A	709G>A	2	219420320	G	A	2	ENSG00000175084	12573	2271	CCSBVarC007832	ALE00007818	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	F06	GDEhDisVCh_40003	H06	1	VUSMutGDDh003	F06	VUSN2Hmut_GDN2h_01	E03	NULL	NULL	VUSmut_GDEh01	E03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	53434.0	single nucleotide variant	NM_001927.4(DES):c.709G>A (p.Ala237Thr)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Dec 20, 2023	397516697.0	-	RCV000037248|RCV000727164|RCV000795291|RCV002482985|RCV004018831	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909;MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154;MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146|MedGen:CN230736	not specified|not provided|Desmin-related myofibrillar myopathy|Desmin-related myofibrillar myopathy;Dilated cardiomyopathy 1I;Neurogenic scapuloperoneal syndrome, Kaeser type|Cardiovascular phenotype	germline;unknown	germline	GRCh38	NC_000002.12	2	219420320.0	219420320.0	2q35	criteria provided, multiple submitters, no conflicts	8.0	ACMG2022	N	ClinGen:CA133869	2.0	44267.0	219420320.0	G	A	-	-	-	-	-	-	709G>A 	Ala237Thr	NM_001927.4	2.0	VUS	VUS	44267	2	219420320.0	G	A	A	T	rs397516697	2	220285042	2	219993286	237	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.709G>A	p.Ala237Thr	c.709G>A	p.Ala237Thr	principal1	Y	1	YES	Select	+	GCG	1	0	G	G/G	G/G	G/G	G/G	0.136	0.26210	T	0.333	0.18639	T	0.473	0.36609	P	0.12	0.32232	B	0.73	0.83975	D	simple_aae	27.0	73.0	1.76	0.45540	L	-1.32	0.32965	N	0.635	0.64639	-0.4175	0.71345	T	0.3739	0.73130	T	10	0.4802383	0.60062	D	0.039727	0.58815	D	0.372	0.68938	0.576	0.69978	P17661	A237T	Loss of ubiquitination at K240 (P = 0.0777)| Gain of phosphorylation at A237 (P = 0.0857)| Gain of methylation at K241 (P = 0.1189)| Loss of stability (P = 0.1907)| Gain of disorder (P = 0.244)	0.877472417996	0.87532	0.5000149002592893	0.49728	0.57321118132	0.53096	0.671454906464	0.62985	T	0.484228	0.81017	T	-0.129915	0.31152	T	-0.118414	0.61663	T	0.290330588817596	0.24320	T	0.884911	0.60851	D	0.21435587	0.43516	0.23250167	0.48232	0.21435587	0.43516	0.23250167	0.48231	-6.31	0.48862	T	0.0849	0.10254	B	0.355990871794971	0.56219	0.95927710	0.93916	0.288	0.55749	.	.	.	.	.	.	4.142138	0.62138	24.4	0.99782736038019937	0.86966	0.926417	0.90715	D	-0.0914459101449938	0.37495	2.202042	-0.0476628853965706	0.37292	2.203111	4.38	4.38	0.51962	4.05	0.77340	6.765	0.74822	8.586000	0.77700	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.731	0.35169	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	3	109336	2.743840e-05	0	6	208038	2.884090e-05	0	12	236860	5.066280e-05	0	0	7160	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	2	13334	1.499930e-04	0	1	42766	2.338310e-05	0	0	15686	0.000000e+00	0	1	42766	2.338310e-05	0	0	16214	0.000000e+00	0	0	30518	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	3	16674	1.799210e-04	0	3	89540	3.350460e-05	0	0	30602	0.000000e+00	0	3	89540	3.350460e-05	0	0	14898	0.000000e+00	0	0	34254	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	5	21572	2.317820e-04	0	6	102734	5.840330e-05	0	0	30520	0.000000e+00	0	6	102734	5.840330e-05	0	.	48	1614014	2.973950e-05	0	14	63996	2.187640e-04	0	1	74904	1.335040e-05	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29608	0.000000e+00	0	0	44888	0.000000e+00	0	14	63996	2.187640e-04	0	0	6076	0.000000e+00	0	30	1180056	2.542250e-05	0	1	91086	1.097860e-05	0	5	30302	1.6500561019074648E-4	0	306	0	0	112	0	0	8024	0	0	146	0	0	610	0	0	56	0	0	98	0	0	4212	0	0	8330	0	0	168	0	5	43866	1.139834951898965E-4	Cardiovascular_phenotype|not_specified|not_provided|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type|Dilated_cardiomyopathy_1I|Desmin-related_myofibrillar_myopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219420320G>A	ClinGen:CA133869	CN230736|CN169374|C3661900|C1867005|C1858154|C1832370	181400|604765|601419	85146|154|363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ala	Thr	96.58	0.5377358490566038																																																																																																																																																																																																																																																																																																																																																																																																																																																																													57			96.58	Aliphatic	Alanine		Desmin							IF rod			1.8								 A237-K241 (PAE:  1.0), A237-N233 (PAE: 1.0)		 A237-K241 (PAE:  1.0), A237-N233 (PAE: 1.0)								89									-65.7				-40.7	Coil 1B					H (helix)	H (α-helix)												96.58	53.773582	>90	10-90	601419;601419;604765;181400	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1; MYOPATHY, MYOFIBRILLAR, 1; CARDIOMYOPATHY, DILATED, 1I; SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	false	0.62857681845984	0.7073131632553761	false	false	false
DES	DES_Ala397Thr	B_7-8	0.8734268183045724	0.41601404106116663	0.508047837868816	1.7318040839811792	0.126915987225036	0.16343216600557267	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7399909691420066	0.6593639409596979	0.8060110188331068	0.6505613045941754	0.6207908442242396	0.7780041474518126	0.9267921417424677	0.8060536549661943	0.8029939749521986	0.9229753497208458	0.7311279773889243	0.7399909691420066	0.6292161531611574	0.43552803348228486	0.49812863423615217	0.6890466879453677	0.5875999045304713		DES	Ala397Thr	NC_000002.12:219421505:G:A	1189G>A	2	219421505	G	A	2	ENSG00000175084	12573	2317	CCSBVarC007873	ALE00007859	ENSP00000363071.3	Edgotyping3	VUSMutGDEh005	D10	GDEhDisVCh_40092	C05	1	VUSMutGDDh005	D10	VUSN2Hmut_GDN2h_02	F03	NULL	NULL	VUSmut_GDEh02	F03	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	173495.0	single nucleotide variant	NM_001927.4(DES):c.1189G>A (p.Ala397Thr)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Aug 17, 2023	727502951.0	-	RCV000150382|RCV003764906	MedGen:CN169374|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not specified|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219421505.0	219421505.0	2q35	criteria provided, multiple submitters, no conflicts	2.0	ACMG2022	N	ClinGen:CA175623	2.0	163028.0	219421505.0	G	A	-	-	-	-	-	-	1189G>A 	Ala397Thr	NM_001927.4	2.0	VUS	VUS	163028	2	219421505.0	G	A	A	T	rs727502951	2	220286227	2	219994471	397	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1189G>A	p.Ala397Thr	c.1189G>A	p.Ala397Thr	principal1	Y	1	YES	Select	+	GCC	1	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.83643	D	0.999	0.77914	D	0.984	0.76117	D	0.82	0.88440	D	simple_aae	18.0	82.0	2.965	0.85040	M	-3.5	0.68211	D	0.862	0.85840	0.9209	0.95958	D	0.8643	0.95477	D	10	0.9335302	0.92604	D	0.189314	0.86019	D	0.883	0.96569	0.702	0.83794	P17661	A397T	Loss of ubiquitination at K395 (P = 0.1091)| Gain of phosphorylation at A397 (P = 0.1884)| Loss of MoRF binding (P = 0.3252)| Gain of solvent accessibility (P = 0.3819)| Loss of catalytic residue at K395 (P = 0.5743)	0.965306710947	0.96461	0.8590769005686969	0.85784	1.4190350564	0.85516	0.881494879723	0.94153	D	0.814243	0.95353	D	0.40356	0.90049	D	0.438764	0.93237	D	0.990439414978027	0.80506	D	0.825817	0.48700	T	0.8802774	0.89545	0.8625305	0.92250	0.8802774	0.89547	0.8625305	0.92250	-12.663	0.87955	D	0.9653	0.88720	P	0.99923275062978	0.96026	0.99782866	0.98523	0.987	0.99559	.	.	.	.	.	.	5.778486	0.93521	33.0	0.99939997337061848	0.99767	0.977349	0.99718	D	0.888465931829144	0.91134	10.75624	0.827612862665667	0.91596	10.99242	4.94	4.94	0.64600	.	.	7.996	0.88001	11.695000	0.94421	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109400	0.000000e+00	0	1	208072	4.806030e-06	0	1	236914	4.220940e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13388	0.000000e+00	0	0	42766	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16216	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16728	0.000000e+00	0	0	89512	0.000000e+00	0	1	30608	3.267120e-05	0	1	30608	3.267120e-05	0	0	14900	0.000000e+00	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21622	0.000000e+00	0	0	102726	0.000000e+00	0	1	30526	3.275900e-05	0	1	30526	3.275900e-05	0	.	3	1614118	1.858600e-06	0	2	91084	2.195780e-05	0	0	75016	0.000000e+00	0	0	912	0.000000e+00	0	0	60014	0.000000e+00	0	0	29600	0.000000e+00	0	0	44872	0.000000e+00	0	0	64022	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180030	8.474360e-07	0	2	91084	2.195780e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_specified|Desmin-related_myofibrillar_myopathy	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219421505G>A	ClinGen:CA175623	CN169374|C1832370	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ala	Thr	96.61	0.4716981132075472																																																																																																																																																																																																																																																																																																																																																																																																																																																																													50			96.61	Aliphatic	Alanine		Desmin							IF rod			1.8								 A397-N393 (PAE:  1.0), A397-E401 (PAE: 1.0)		 A397-N393 (PAE:  1.0), A397-E401 (PAE: 1.0)								89									-60.5				-46.2	Interaction with NEB; Coil 2B					H (helix)	H (α-helix)												96.61	47.16981	>90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.6593639409596979	0.7399909691420066	false	false	false
MVK	MVK_Pro200Ser	B_7-8	1.2029342935602756	0.27431099294547645	0.3608360857616116	-1.0266186954951424	0.34419586119032525	0.3974823192474807	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6087399551372406	0.6378792296676998	0.6821822393873616	0.7367074612474573	0.751495172884312	0.7689822708646323	0.8220498274389076	0.7534002846167952	0.7525438662446234	0.7543958124709121	0.6515878099992624	0.6352434502620685	0.7159147142903571	0.7495900611518289	0.7208710562502914	0.6099686663038111	0.6241706493361372	0.5822364600124126	MVK	Pro200Ser	NC_000012.12:109586092:C:T	598C>T	12	109586092	C	T	12	ENSG00000110921	281	14	CCSBVarC007122	ALE00007120	ENSP00000228510.3	Edgotyping3	VUSMutGDEh009	D12	GDEhDisVCh_40020	H06	2	VUSMutGDDh009	D12	VUSN2Hmut_GDN2h_03	A05	VUSMutpDEST2_01	D02	VUSmut_GDEh03	A05	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	323159.0	single nucleotide variant	NM_000431.4(MVK):c.598C>T (p.Pro200Ser)	4598.0	MVK	HGNC:7530	Uncertain significance	0.0	Jun 14, 2016	886048932.0	-	RCV000350980|RCV000399509	MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29|MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343	Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever	germline	germline	GRCh38	NC_000012.12	12	109586092.0	109586092.0	12q24.11	criteria provided, single submitter	1.0	-	N	ClinGen:CA10636415	2.0	307098.0	109586092.0	C	T	-	-	-	-	-	-	598C>T 	Pro200Ser	NM_000431.4	1.0	VUS	VUS	307098	12	109586092.0	C	T	P	S	rs886048932	12	110023897	12	108508280	200	MVK	ENSG00000110921	ENST00000546277	ENSP00000438153	Q03426	KIME_HUMAN	c.598C>T	p.Pro200Ser	c.598C>T	p.Pro200Ser	principal1	Y	5	.	.	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	2.78	0.80945	M	-6.48	0.95749	D	.	0.84673	1.0868	0.99114	D	0.9696	0.99037	D	10	0.94524556	0.93780	D	0.394206	0.93242	D	0.800	0.93443	0.799	0.91830	Q03426	P200S	Gain of loop (P = 0.0166)| Loss of helix (P = 0.0237)| Gain of disorder (P = 0.0735)| Gain of catalytic residue at P200 (P = 0.1247)| Gain of sheet (P = 0.1451)	0.970328485176	0.96973	.	0.94797	.	0.78822	0.530679225922	0.43068	T	0.74077	0.92752	D	0.314182	0.83936	D	0.213524	0.83728	D	0.998515069484711	0.94317	D	.	0.85894	.	0.9283784	0.93985	0.832201	0.90202	0.9283784	0.93985	0.832201	0.90203	-10.776	0.78485	D	.	0.71024	.	0.985952121276136	0.86948	0.99844724	0.98790	0.998	0.99926	.	.	.	.	.	.	4.976928	0.8244	27.8	0.99897723992814547	0.97050	0.787924	0.71653	D	0.772911926349988	0.84300	8.273509	0.737801731326136	0.85160	8.522818	5.12	5.12	0.69417	.	.	7.063	0.76467	7.644000	0.63402	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.994	0.71086	735	0.53648	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Mevalonic_aciduria|Hyperimmunoglobulin_D_with_periodic_fever	criteria_provided,_single_submitter	NC_000012.12:g.109586092C>T	ClinGen:CA10636415	C1959626|C0398691	610377|260920	29|343	GHMP kinase N-terminal domain	Pro	Ser	87.45	0.13970588235294118																																																																																																																																																																																																																																																																																																																																																																																																																																																																													19			87.45	Special, No backbone hydrogen	Proline		Mevalonate kinase										1.6																		115									-66.2				151.2						C (loop/coil)	C (loop/coil)												87.45	13.970588	70-90	10-90	610377;260920	autosomal recessive	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	MEVALONIC ACIDURIA; HYPER-IgD SYNDROME	false	0.6378792296676998	0.6087399551372406	false	false	false
MLH1	MLH1_Cys39Tyr	B_11-12	2.950203764293115	0.027601091787204945	0.058063705017868804	9.207374804438935	0.000092662718330656	0.00038382864139222065	2024_12_Batch_11-12	true	true	false	false	false	false	true	true	false	false	false	false	0.9912945099022701	0.9895368773434325	0.7807978775065723	0.8036775201827252	0.7911484618551438	0.8152864794413581		0.7963547858001718		0.8158490117068502	0.9869739697850226	0.9892141127043805	0.8152864794413581	0.7859421379101157	0.8036775201827252	0.7457467433062943	0.9920997849018425	0.9933749071001595	MLH1	Cys39Tyr	NC_000003.12:36993663:G:A	116G>A	3	36993663	G	A	3	ENSG00000076242	2713	472	CCSBVarC007376	ALE00007364	ENSP00000231790.3	Edgotyping3	VUSMutGDEh011	E08	GDEhDisVCh_40019	H05	1	VUSMutGDDh011	E08	VUSN2Hmut_GDN2h_03	F12	VUSMutpDEST2_02	E03	VUSmut_GDEh03	F12	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	N	Y	Y	95136.0	single nucleotide variant	NM_000249.4(MLH1):c.116G>A (p.Cys39Tyr)	4292.0	MLH1	HGNC:7127	Uncertain significance	1.0	Jun 13, 2018	63751701.0	-	RCV000075134|RCV000202285|RCV001010101|RCV001325333|RCV003451009	MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144	Lynch syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|Colorectal cancer, hereditary nonpolyposis, type 2	germline;unknown	germline	GRCh38	NC_000003.12	3	36993663.0	36993663.0	3p22.2	reviewed by expert panel	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA004578	2.0	89662.0	36993663.0	G	A	-	-	-	-	-	-	116G>A 	Cys39Tyr	NM_000249.4	3.0	VUS	VUS	89662	3	36993663.0	G	A	C	Y	rs63751701	3	37035154	3	37010158	39	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.116G>A	p.Cys39Tyr	c.116G>A	p.Cys39Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.042	0.41793	D	0.032	0.53775	D	0.997	0.70687	D	0.981	0.75172	D	0.9	0.92286	D	simple_aae	10.0	90.0	1.905	0.50677	L	-4.62	0.79176	D	0.856	0.85202	-0.3406	0.73710	T	0.4059	0.75477	T	10	0.98710424	0.99048	D	0.317012	0.91340	D	0.884	0.96606	0.935	0.99041	P40692	C39Y	Loss of catalytic residue at L40 (P = 0.0636)| Gain of phosphorylation at C39 (P = 0.0794)| Loss of ubiquitination at K43 (P = 0.1498)| Loss of stability (P = 0.2434)| Gain of disorder (P = 0.3564)	0.950179299279	0.94924	0.9204246832792898	0.91968	0.498964592926	0.48060	0.827929139137	0.86222	D	0.920418	0.98554	D	0.435936	0.91768	D	0.388415	0.91666	D	0.997968852519989	0.92814	D	0.988951	0.96297	D	0.96398044	0.97640	0.9757141	0.99683	0.966683	0.97911	0.9708873	0.99495	-12.249	0.86079	D	0.9947	0.95370	P	0.99699929191921	0.92666	0.99976689	0.99701	0.98	0.99294	.	.	.	.	.	.	6.842335	0.95817	35.0	0.99303710154565628	0.58784	0.968279	0.99072	D	0.903529112561661	0.91886	11.14162	0.890948813122615	0.95140	13.37038	5.68	5.68	0.88004	.	.	9.383	0.96606	11.767000	0.95771	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.998	0.85369	315	0.8722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	16074	0	0	0	0	0	44	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	228	0	0	0	0	0	44	0	0	16346	0	not_provided|Hereditary_cancer-predisposing_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Lynch_syndrome_1|Hereditary_nonpolyposis_colorectal_neoplasms	reviewed_by_expert_panel	NC_000003.12:g.36993663G>A	ClinGen:CA004578	C3661900|C0027672|C1333991|C2936783|C0009405	609310|120435	140162|144|144	.	Cys	Tyr	94.17	0.022222222222222223																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3			94.17	Special, a very reactive sulfhydryl group	Cysteine		DNA mismatch repair protein Mlh1								0.4102		2.5								 C39-D63 (PAE:  2.0), C39-M35 (PAE: 1.0), C39-S44 (PAE: 1.5)	C39-D63 (PDBs: 4P7A), C39-M35 (PDBs: 4P7A), C39-S44 (PDBs: 4P7A)	 C39-M35 (PAE:  1.0), C39-S44 (PAE: 1.5), C39-K43 (PAE: 1.0)	C39-M35 (PDBs: 4P7A), C39-S44 (PDBs: 4P7A), C39-K43 (PDBs: 4P7A)							121									-64.7		Pocket 1: Mean pLDDT: 86.74, Volume: 948.3 Å³, Druggability score: 0.41		-37.7						H (helix)	H (α-helix)	Helix											94.17	2.2222223	>90	<10	120435;609310	autosomal dominant	OMIM	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 1; LYNCH SYNDROME 2	true	0.9895368773434325	0.9912945099022701	true	true	true
MLH1	MLH1_His318Gln	B_11-12	2.6631767864675164	0.03986614995610276	0.07714726080664262	7.328826338297669	0.00034192888125920366	0.0010289395745323635	2024_12_Batch_11-12	true	true	true	true	true	true	false	false	false	false	false	false	0.9183821668109973	0.9228426538498957	0.9256479589474405	0.9102391338497646	0.9062773531677293	0.9403632259682091		0.9297696116711718		0.94031440476036	0.9560454562928045	0.9475372566535765	0.9403632259682091	0.8827850946642868	0.9102391338497646	0.9109815131345209	0.8896398514069869	0.889227076968418	MLH1	His318Gln	NC_000003.12:37020379:C:A	954C>A	3	37020379	C	A	3	ENSG00000076242	2713	704	CCSBVarC007379	ALE00007367	ENSP00000231790.3	Edgotyping3	VUSMutGDEh011	H08	GDEhDisVCh_40019	C06	1	VUSMutGDDh011	H08	VUSN2Hmut_GDN2h_04	C01	VUSMutpDEST2_02	H03	VUSmut_GDEh04	C01	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	N	Y	Y	Y	182250.0	single nucleotide variant	NM_000249.4(MLH1):c.954C>A (p.His318Gln)	4292.0	MLH1	HGNC:7127	Uncertain significance	0.0	Sep 11, 2024	146777069.0	-	RCV000167219|RCV001005036|RCV003468801|RCV003995574|RCV000702569	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MeSH:D003123,MedGen:C0009405	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Colorectal cancer, hereditary nonpolyposis, type 2|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms	germline;unknown	germline	GRCh38	NC_000003.12	3	37020379.0	37020379.0	3p22.2	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA013266	2.0	187486.0	37020379.0	C	A	-	-	-	-	-	-	954C>A 	His318Gln	NM_000249.4	2.0	VUS	VUS	187486	3	37020379.0	C	A	H	Q	rs146777069	3	37061870	3	37036874	318	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.954C>A	p.His318Gln	c.954C>A	p.His318Gln	principal1	Y	1	YES	Select	+	CAC	3	2	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.006	0.70891	D	1.0	0.90580	D	0.985	0.76461	D	0.29	0.73810	N	simple_aae	71.0	29.0	2.015	0.54854	M	-6.0	0.93423	D	0.67	0.71007	-0.3381	0.73782	T	0.3195	0.68751	T	10	0.39457625	0.54781	D	0.0252	0.47969	D	0.453	0.75147	0.449	0.50817	P40692	H318Q	Loss of sheet (P = 0.1158)| Loss of helix (P = 0.1299)| Loss of disorder (P = 0.1382)| Gain of loop (P = 0.2045)| Loss of catalytic residue at E320 (P = 0.2614)	0.866226391659	0.86388	0.4882970306372191	0.48554	0.40212066749	0.40892	0.791368722916	0.80616	T	0.761047	0.93468	D	0.145786	0.68646	D	-0.0283647	0.68249	D	0.99485045671463	0.86301	D	0.981385	0.94072	D	0.7798397	0.82428	0.8749166	0.93115	0.7798397	0.82430	0.8749166	0.93116	-11.537	0.83262	D	0.7526	0.78008	P	0.986718518333562	0.87195	0.99899644	0.99084	0.468	0.69346	.	.	.	.	.	.	0.275922	0.06558	3.015	0.97716239911704261	0.35688	0.245953	0.36475	N	-1.01877197974811	0.08115	0.3843576	-1.20759923680254	0.05695	0.2767155	5.76	-9.56	0.00477	-11.6	0.00054	-2.243	0.01276	-14.574000	0.00400	-0.811	0.03072	0.0	0.06393	0.000000	0.08389	0.99	0.65338	224	0.9133	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	1614072	2.478200e-06	0	4	60004	6.666220e-05	0	0	74936	0.000000e+00	0	0	912	0.000000e+00	0	4	60004	6.666220e-05	0	0	29606	0.000000e+00	0	0	44886	0.000000e+00	0	0	64030	0.000000e+00	0	0	6084	0.000000e+00	0	0	1180036	0.000000e+00	0	0	91092	0.000000e+00	0	0	19778	0	0	298	0	0	86	0	0	7438	0	0	146	0	0	610	0	0	26	0	0	96	0	0	1930	0	0	7736	0	0	112	0	0	30408	0	Familial_cancer_of_breast|Hereditary_nonpolyposis_colorectal_neoplasms|Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Hereditary_cancer-predisposing_syndrome|Lynch_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.37020379C>A	ClinGen:CA013266	C0346153|C0009405|C1333991|C0027672|C4552100	114480|609310	227535|144|140162|144	DNA mismatch repair protein, S5 domain 2-like|DNA mismatch repair protein, S5 domain 2-like	His	Gln	85.0	0.5217391304347826																																																																																																																																																																																																																																																																																																																																																																																																																																																																													96			85.0	Positively-charged	Histidine		DNA mismatch repair protein Mlh1										-3.2								 H318-I322 (PAE:  2.5)		 H318-I322 (PAE:  2.5)								155									59.5				36.2						C (loop/coil)	T (turn)												85.0	52.173912	70-90	10-90	114480;609310	autosomal dominant	OMIM	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	BREAST CANCER; LYNCH SYNDROME 2	false	0.9228426538498957	0.9183821668109973	true	true	false
DES	DES_His243Tyr	B_7-8	0.4612203639404763	0.6608869624325451	0.7310475325624298	0.9834747644179446	0.35813703556130183	0.4108370114353041	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7825681701692279	0.7285094959296193	0.7810892941868288	0.8544336310596053	0.8553171281912133	0.7762039913733345	0.9848643311899057	0.979498523953619	0.9830764412220454	0.9756032666783592	0.7708956266528453	0.7825681701692279	0.5675436515567635	0.7311357324288075	0.7257908208971653	0.5865753216952984	0.6861233652063934		DES	His243Tyr	NC_000002.12:219420338:C:T	727C>T	2	219420338	C	T	2	ENSG00000175084	12573	2273	CCSBVarC007834	ALE00007820	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	H06	GDEhDisVCh_40003	B07	1	VUSMutGDDh003	H06	VUSN2Hmut_GDN2h_01	F03	NULL	NULL	VUSmut_GDEh01	F03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	198123.0	single nucleotide variant	NM_001927.4(DES):c.727C>T (p.His243Tyr)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Apr 12, 2023	769647148.0	-	RCV000183347|RCV000473075|RCV002381603|RCV002478624	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MedGen:CN230736|MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154;MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146;MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy|Cardiovascular phenotype|Dilated cardiomyopathy 1I;Neurogenic scapuloperoneal syndrome, Kaeser type;Desmin-related myofibrillar myopathy	germline;unknown	germline	GRCh38	NC_000002.12	2	219420338.0	219420338.0	2q35	criteria provided, multiple submitters, no conflicts	5.0	ACMG2022	N	ClinGen:CA308260	2.0	201702.0	219420338.0	C	T	-	-	-	-	-	-	727C>T 	His243Tyr	NM_001927.4	2.0	VUS	VUS	201702	2	219420338.0	C	T	H	Y	rs769647148	2	220285060	2	219993304	243	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.727C>T	p.His243Tyr	c.727C>T	p.His243Tyr	principal1	Y	1	YES	Select	+	CAT	1	0	C	C/C	C/C	C/C	C/C	0.017	0.51407	D	0.006	0.70891	D	1.0	0.90580	D	0.997	0.86259	D	0.92	0.93300	D	simple_aae	8.0	92.0	1.955	0.52690	M	-5.24	0.83995	D	0.885	0.88339	0.4146	0.89274	D	0.7648	0.91973	D	10	0.92131597	0.91390	D	0.160938	0.84040	D	0.813	0.93950	.	.	.	.	.	0.973804891215	0.97327	0.9328495991238097	0.93221	1.45423259158	0.86152	0.832234799862	0.86882	D	0.775685	0.93980	D	0.288192	0.81875	D	0.35772	0.90552	D	0.970529735088348	0.68775	D	0.90041	0.65304	D	0.7612482	0.81301	0.72054964	0.83304	0.7612482	0.81303	0.72054964	0.83305	-12.072	0.85241	D	0.8657	0.80587	P	0.999458929726436	0.96641	0.99765366	0.98455	0.888	0.94006	.	.	.	.	.	.	5.585406	0.92345	32.0	0.99790478345891298	0.87671	0.975075	0.99596	D	0.556833710321108	0.70342	5.510472	0.508972816892798	0.68420	5.24143	4.38	4.38	0.51962	.	.	7.798	0.84529	7.616000	0.62165	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.245	0.23179	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109268	9.151810e-06	0	3	207942	1.442710e-05	0	3	236746	1.267180e-05	0	0	7158	0.000000e+00	0	0	17100	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13284	0.000000e+00	0	1	42760	2.338630e-05	0	0	15686	0.000000e+00	0	1	42760	2.338630e-05	0	1	16210	6.169030e-05	0	0	30500	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16624	0.000000e+00	0	2	89522	2.234090e-05	0	0	30596	0.000000e+00	0	1	16210	6.169030e-05	0	1	14896	6.713210e-05	0	0	34236	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21520	0.000000e+00	0	2	102698	1.947460e-05	0	0	30514	0.000000e+00	0	1	14896	6.713210e-05	0	.	27	1613852	1.673020e-05	0	3	74890	4.005880e-05	0	3	74890	4.005880e-05	0	0	912	0.000000e+00	0	0	59998	0.000000e+00	0	0	29608	0.000000e+00	0	0	44884	0.000000e+00	0	0	63916	0.000000e+00	0	0	6072	0.000000e+00	0	24	1180014	2.033870e-05	0	0	91078	0.000000e+00	0	0	19754	0	0	298	0	0	86	0	0	7438	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1930	0	0	7736	0	0	112	0	0	30386	0	Dilated_cardiomyopathy_1I|Desmin-related_myofibrillar_myopathy|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type|Cardiovascular_phenotype|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219420338C>T	ClinGen:CA308260	C1858154|C1832370|C1867005|CN230736|C3661900	604765|601419|181400	154|363543|98909|85146	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	His	Tyr	93.69	0.5																																																																																																																																																																																																																																																																																																																																																																																																																																																																													92			93.69	Positively-charged	Histidine		Desmin							IF rod			-3.2								 H243-L239 (PAE:  1.0), H243-I247 (PAE: 1.0)		 H243-L239 (PAE:  1.0), H243-I247 (PAE: 1.0)								155									-62.7				-37.0	Coil 1B					H (helix)	H (α-helix)												93.69	50.0	>90	10-90	601419;604765;181400;601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1; CARDIOMYOPATHY, DILATED, 1I; SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; MYOPATHY, MYOFIBRILLAR, 1	true	0.7285094959296193	0.7825681701692279	false	false	false
DES	DES_Met349Ile	B_7-8	0.9768303093862564	0.3735155193403517	0.4647652390489067	1.2908173817140018	0.23776110442426152	0.2860928699137835	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6232973766009805	0.6079644807357802	0.7057308781906371	0.6747271976921236	0.660825982172718	0.7289929834300117	0.8913759846916216	0.8019594035216185	0.8246888450427058	0.8284379554477374	0.621298453922986	0.6232973766009805	0.5666099821684019	0.5196925608238175	0.5247655503415414	0.5830238009335367	0.5946305075485745		DES	Met349Ile	NC_000002.12:219421363:G:A	1047G>A	2	219421363	G	A	2	ENSG00000175084	12573	2301	CCSBVarC007858	ALE00007844	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	C10	GDEhDisVCh_40003	E10	1	VUSMutGDDh003	C10	VUSN2Hmut_GDN2h_01	H04	NULL	NULL	VUSmut_GDEh01	H04	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	198129.0	single nucleotide variant	NM_001927.4(DES):c.1047G>A (p.Met349Ile)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Jan 25, 2023	375005961.0	-	RCV000183375|RCV003765137	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219421363.0	219421363.0	2q35	criteria provided, multiple submitters, no conflicts	2.0	ACMG2022	N	ClinGen:CA308322	2.0	201724.0	219421363.0	G	A	-	-	-	-	-	-	1047G>A 	Met349Ile	NM_001927.4	2.0	VUS	VUS	201724	2	219421363.0	G	A	M	I	rs375005961	2	220286085	2	219994329	349	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1047G>A	p.Met349Ile	c.1047G>A	p.Met349Ile	principal1	Y	1	YES	Select	+	ATG	3	0	G	G/G	G/G	G/G	G/G	0.218	0.19192	T	0.214	0.26683	T	0.198	0.29606	B	0.085	0.29397	B	0.71	0.82936	D	simple_aae	29.0	71.0	0.22	0.09492	N	-2.42	0.53117	N	0.318	0.35596	-0.0791	0.80486	T	0.5792	0.84793	D	10	0.39050096	0.54502	D	0.046449	0.62319	D	0.599	0.84050	0.532	0.63879	P17661	M349I	Loss of disorder (P = 0.0531)| Loss of phosphorylation at S344 (P = 0.1806)| Loss of MoRF binding (P = 0.2081)| Gain of catalytic residue at L345 (P = 0.4814)| Loss of methylation at R347 (P = 0.6566)	0.90080054504	0.89906	0.8100296674903856	0.80846	0.789548036049	0.65481	0.736731052399	0.72444	T	0.572933	0.85759	D	0.319504	0.84324	D	0.221169	0.84120	D	0.784591317176819	0.45050	D	0.911409	0.68498	D	0.3809619	0.59058	0.32669765	0.58346	0.3809619	0.59059	0.32669765	0.58346	-4.947	0.36302	T	0.8502	0.79730	P	0.992565010972637	0.89577	0.98537993	0.96107	0.903	0.94903	.	.	.	.	.	.	4.412083	0.68326	25.2	0.98757538702150616	0.45862	0.977602	0.99729	D	-0.194592071241583	0.33081	1.891676	0.0179452865694482	0.40258	2.421678	5.24	4.36	0.51585	4.05	0.77340	7.87	0.85566	11.713000	0.94693	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	0	109400	0.000000e+00	0	1	208070	4.806070e-06	0	1	236926	4.220730e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42760	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16216	0.000000e+00	0	0	30522	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89500	1.117320e-05	0	0	30608	0.000000e+00	0	1	89500	1.117320e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102722	9.735010e-06	0	0	30526	0.000000e+00	0	1	102722	9.735010e-06	0	.	3	1614018	1.858720e-06	0	1	91084	1.097890e-05	0	0	74910	0.000000e+00	0	0	912	0.000000e+00	0	0	60002	0.000000e+00	0	0	29604	0.000000e+00	0	0	44888	0.000000e+00	0	0	64030	0.000000e+00	0	0	6084	0.000000e+00	0	2	1180022	1.694880e-06	0	1	91084	1.097890e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Desmin-related_myofibrillar_myopathy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219421363G>A	ClinGen:CA308322	C1832370|C3661900	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Met	Ile	91.0	0.601063829787234																																																																																																																																																																																																																																																																																																																																																																																																																																																																													113			91.0	Aliphatic	Methionine		Desmin							IF rod			1.9								 M349-L345 (PAE:  1.0), M349-E353 (PAE: 1.0)		 M349-L345 (PAE:  1.0), M349-E353 (PAE: 1.0)								149									-60.7				-48.5	Interaction with NEB; Coil 2B					H (helix)	H (α-helix)												91.0	60.106384	>90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.6079644807357802	0.6232973766009805	false	false	false
LITAF	LITAF_Val144Met	B_15-16	1.4358678886229772	0.19418094391154317	0.27452672307257403	-8.575555138315215	0.00005834106214939252	0.0002676396226103382	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9447333237103026	0.9773348794870528	0.580155479517815	0.6061167787858339	0.6044539984293906	0.5901093291774286	0.6897401760927161	0.6712863909061112	0.6880315708802767	0.6512283803399791	0.9786121787764519	0.952302571166329	0.4904784822621411	0.5376216059526702	0.5242019866913913	0.5090825786956508	0.9760575801976537	0.9371640762542763	LITAF	Val144Met	NC_000016.10:11549693:C:T	430G>A	16	11549693	C	T	16	ENSG00000189067	52920	2665	CCSBVarC007931	ALE00007917	ENSP00000483114.1	Edgotyping3	VUSMutGDEh006	C11	GDEhDisVCh_40036	E05	2	VUSMutGDDh006	C11	VUSN2Hmut_GDN2h_02	G04	VUSMutpDEST2_11	E11	VUSmut_GDEh02	G04	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	21100.0	single nucleotide variant	NM_001136472.2(LITAF):c.430G>A (p.Val144Met)	9516.0	LITAF	HGNC:16841	Uncertain significance	1.0	-	121908615.0	-	RCV000006433|RCV001173626	MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083|MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166	Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease	germline	germline	GRCh38	NC_000016.10	16	11549693.0	11549693.0	16p13.13	criteria provided, single submitter	2.0	-	N	ClinGen:CA253746,OMIM:603795.0005	3.0	6061.0	11549693.0	C	T	-	-	-	-	-	-	430G>A 	Val144Met	NM_001136472.2	1.0	VUS	VUS	6061	16	11549693.0	C	T	V	M	rs121908615	16	11643549	16	11551050	144	LITAF	ENSG00000189067	ENST00000570904	ENSP00000459138	Q99732	LITAF_HUMAN	c.430G>A	p.Val144Met	c.430G>A	p.Val144Met	principal1	Y	1	.	.	-	GTG	1	0	.	C/C	C/C	C/C	C/C	.	0.72322	.	0.0	0.92967	D	0.999	0.77914	D	0.766	0.56670	P	0.99	0.97926	D	simple_aae	1.0	99.0	2.81	0.81703	M	.	0.53280	.	0.746	0.80898	0.8217	0.94660	D	0.7647	0.91969	D	8	0.94915676	0.94182	D	0.59843	0.96450	D	.	0.91423	0.851	0.95234	Q99732	V144M	Loss of stability (P = 0.1636)| Loss of catalytic residue at V144 (P = 0.1772)| Gain of loop (P = 0.3485)| Loss of helix (P = 0.3949)| Gain of sheet (P = 0.4423)	0.991144892147	0.99094	.	0.64223	.	0.54773	0.75989741087	0.75871	T	0.959383	0.99462	D	-0.0128886	0.49534	T	-0.25629	0.48864	T	0.842732974174315	0.49279	D	.	0.62021	.	0.41639018	0.61528	0.55316937	0.73907	0.35525158	0.57143	0.52840275	0.72496	-10.535	0.77122	D	.	0.85762	.	0.909404959575029	0.76724	0.98763996	0.96394	0.412	0.65509	.	.	.	.	.	.	5.254593	0.8824	29.5	0.99881126166948764	0.95736	0.825017	0.74386	D	0.628516478100428	0.74851	6.226714	0.572778774622314	0.72846	5.898611	5.01	4.06	0.46510	.	.	6.053	0.70782	7.498000	0.59516	0.589	0.31595	1.0	0.71675	1.000000	0.68239	0.998	0.85369	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	108992	9.174990e-06	0	1	207138	4.827700e-06	0	1	236020	4.236930e-06	0	0	7080	0.000000e+00	0	0	17058	0.000000e+00	0	0	2302	0.000000e+00	0	0	9030	0.000000e+00	0	1	13378	7.474960e-05	0	0	42646	0.000000e+00	0	0	15596	0.000000e+00	0	.	.	.	.	0	16078	0.000000e+00	0	0	30434	0.000000e+00	0	0	6186	0.000000e+00	0	0	13392	0.000000e+00	0	1	16706	5.985870e-05	0	0	89076	0.000000e+00	0	0	30424	0.000000e+00	0	.	.	.	.	0	14776	0.000000e+00	0	0	34172	0.000000e+00	0	0	9538	0.000000e+00	0	0	17674	0.000000e+00	0	1	21578	4.634350e-05	0	0	102332	0.000000e+00	0	0	30348	0.000000e+00	0	.	.	.	.	.	16	1613658	9.915360e-06	0	1	63982	1.562940e-05	0	0	75022	0.000000e+00	0	0	912	0.000000e+00	0	0	59952	0.000000e+00	0	0	29590	0.000000e+00	0	0	44876	0.000000e+00	0	1	63982	1.562940e-05	0	0	6062	0.000000e+00	0	15	1179824	1.271380e-05	0	0	90950	0.000000e+00	0	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Charcot-Marie-Tooth_disease_type_1C|Charcot-Marie-Tooth_disease	criteria_provided,_single_submitter	NC_000016.10:g.11549693C>T	ClinGen:CA253746|OMIM:603795.0005	C0270913|C0007959	601098|PS118220	101083|166	LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor	Val	Met	92.64	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			92.64	Aliphatic	Valine		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF			4.2								 V144-Y158 (PAE:  2.5)		 V144-Y158 (PAE:  2.5)								117		Mutation: V -> M. No effect on location at endosomes, but impairs protein stability.							-121.5				113.9						B (undefined)	E (parallel sheets)												92.64	0.0	>90	<10	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.9773348794870528	0.9447333237103026	true	true	false
TH	TH_Ala226Thr	B_7-8	-1.6921789981439066	0.15139559080811088	0.2264413300262269	-1.6634927294255495	0.14016293837386606	0.17861041105280848	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6387618562254389	0.6631411848561484	0.7530765254136147	0.8250539075223469	0.7765608537588655	0.8230824933864765	0.7581132230272847	0.6988020730053814	0.7665982850085803	0.6671949114186896	0.6412465125648944	0.6387618562254389	0.8880517637456684	0.8543196345123496	0.8835095300361133	0.8389581394085398	0.6850358571474022		TH	Ala226Thr	NC_000011.10:2167454:C:T	676G>A	11	2167454	C	T	11	ENSG00000180176	71892	4010	CCSBVarC008289	ALE00008275	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	F10	GDEhDisVCh_40019	D10	1	VUSMutGDDh015	F10	VUSN2Hmut_GDN2h_04	H11	VUSMutpDEST2_15	D08	VUSmut_GDEh04	H11	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	Y	N	N	Y	319847.0	single nucleotide variant	NM_000360.4(TH):c.676G>A (p.Ala226Thr)	7054.0	TH	HGNC:11782	Uncertain significance	0.0	May 08, 2022	549188961.0	-	RCV000400092	MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150	Autosomal recessive DOPA responsive dystonia	germline	germline	GRCh38	NC_000011.10	11	2167454.0	2167454.0	11p15.5	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA5818541	2.0	304076.0	2167454.0	C	T	-	-	-	-	-	-	676G>A 	Ala226Thr	NM_000360.4	2.0	VUS	VUS	304076	11	2167454.0	C	T	A	T	rs549188961	11	2188684	11	2145260	257	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.769G>A	p.Ala257Thr	c.769G>A	p.Ala257Thr	.	Y	1	.	.	-	GCC	1	0	C	C/C	C/C	C/C	C/C	0.121	0.28651	T	0.165	0.31245	T	0.598	0.39288	P	0.15	0.34163	B	0.18	0.41597	N	simple_aae	82.0	18.0	1.895	0.50187	L	-1.13	0.29076	N	0.433	0.48994	-0.9751	0.35963	T	0.1387	0.45471	T	10	0.1764507	0.32263	T	0.393438	0.93226	D	0.443	0.74452	0.399	0.42608	P07101	A257T	Gain of catalytic residue at A257 (P = 0.0057)| Gain of sheet (P = 0.1208)| Gain of disorder (P = 0.1471)| Loss of phosphorylation at T256 (P = 0.1868)| Loss of loop (P = 0.2237)	0.897121398994	0.89532	0.35617486162107165	0.35329	0.0851033627391	0.09420	0.367853820324	0.20502	T	0.788618	0.94438	D	0.0828912	0.62110	D	-0.118709	0.61640	T	0.0534251257777214	0.06029	T	0.869413	0.75359	D	0.13747297	0.31556	0.15329076	0.35918	0.13747297	0.31556	0.15329076	0.35917	-8.307	0.64492	D	0.0673	0.15359	B	0.149542070375684	0.47072	0.88051070	0.90554	0.089	0.25085	.	.	.	.	.	.	1.708143	0.21788	15.33	0.9848747411063663	0.42174	0.156721	0.27998	N	-0.466007229040331	0.22935	1.244222	-0.645232754689914	0.18046	0.9791207	2.88	1.92	0.24845	2.63	0.48117	1.927	0.39829	2.418000	0.32757	0.537	0.2507	0.268	0.25112	0.977000	0.30209	0.193	0.21735	988	0.02004	2	3.9936102236421724E-4	0	0.0	0	0.0	0	0.0	0	0.0	2	0.002044989775051125	1	264690	3.7780044E-6	.	9	73432	1.225620e-04	0	10	146182	6.840790e-05	0	10	167776	5.960330e-05	0	0	3714	0.000000e+00	0	0	13238	0.000000e+00	0	0	1534	0.000000e+00	0	0	5774	0.000000e+00	0	6	11636	5.156410e-04	0	0	24198	0.000000e+00	0	2	11896	1.681240e-04	0	2	11896	1.681240e-04	0	0	10200	0.000000e+00	0	0	22466	0.000000e+00	0	0	4876	0.000000e+00	0	0	10396	0.000000e+00	0	6	13792	4.350350e-04	0	1	56956	1.755740e-05	0	2	23726	8.429570e-05	0	2	23726	8.429570e-05	0	0	9544	0.000000e+00	0	0	26390	0.000000e+00	0	0	8406	0.000000e+00	0	0	13100	0.000000e+00	0	6	15996	3.750940e-04	0	1	66132	1.512130e-05	0	2	23706	8.436680e-05	0	2	23706	8.436680e-05	0	.	26	1563854	1.662560e-05	0	9	59208	1.520060e-04	0	4	74040	5.402490e-05	0	0	910	0.000000e+00	0	0	52786	0.000000e+00	0	1	28732	3.480440e-05	0	0	42456	0.000000e+00	0	9	59208	1.520060e-04	0	0	5998	0.000000e+00	0	5	1154190	4.332040e-06	0	5	84962	5.884980e-05	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Autosomal_recessive_DOPA_responsive_dystonia	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.2167454C>T	ClinGen:CA5818541	C2673535	605407	101150	Aromatic amino acid hydroxylase, C-terminal|Aromatic amino acid hydroxylase, C-terminal|Tyrosine 3-monooxygenase, catalytic domain	Ala	Thr	98.28	0.8018867924528302																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																98.28	80.18868	>90	10-90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.6631411848561484	0.6387618562254389	false	false	false
DES	DES_Ser424Phe	B_7-8	0.10369691170729708	0.9214407947616203	0.942158414344055	2.1069291860630943	0.07311922921634885	0.09931442310288685	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7245852417865628	0.7188978907518979	0.6659671907721616	0.7425796299958805	0.7646587244913428	0.7025742550475733	0.9594703753584911	0.8476348745502509	0.887928600931647	0.9363837221725688	0.6965204438336836	0.7245852417865628	0.44567813473665546	0.6816825744324345	0.597230659060114	0.3955506593717545	0.7412753376701123		DES	Ser424Phe	NC_000002.12:219423803:C:T	1271C>T	2	219423803	C	T	2	ENSG00000175084	12573	2327	CCSBVarC007880	ALE00007866	ENSP00000363071.3	Edgotyping3	VUSMutGDEh005	E11	GDEhDisVCh_40092	B06	1	VUSMutGDDh005	E11	VUSN2Hmut_GDN2h_02	A04	NULL	NULL	VUSmut_GDEh02	A04	1.0	1.0	1.0	1.0	1.0	6.0	1.0	0.0			1.0	1.0	1.0	Y	Y	N	N	Y	268342.0	single nucleotide variant	NM_001927.4(DES):c.1271C>T (p.Ser424Phe)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Oct 24, 2016	886042791.0	-	RCV000274998	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000002.12	2	219423803.0	219423803.0	2q35	criteria provided, single submitter	1.0	ACMG2022	N	ClinGen:CA10604688	2.0	284105.0	219423803.0	C	T	-	-	-	-	-	-	1271C>T 	Ser424Phe	NM_001927.4	1.0	VUS	VUS	284105	2	219423803.0	C	T	S	F	rs886042791	2	220288525	2	219996769	424	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.1271C>T	p.Ser424Phe	c.1271C>T	p.Ser424Phe	principal1	Y	1	YES	Select	+	TCT	2	0	C	C/C	C/C	C/C	C/C	0.003	0.68399	D	0.034	0.53076	D	0.877	0.48237	P	0.434	0.45506	B	.	.	.	.	.	.	3.09	0.87301	M	-3.7	0.70591	D	0.876	0.87350	0.4831	0.90270	D	0.6699	0.88518	D	10	0.8356786	0.82544	D	0.18888	0.85993	D	0.758	0.91722	0.511	0.60719	P17661	S424F	Loss of disorder (P = 0.0262)| Loss of phosphorylation at Y423 (P = 0.1296)| Loss of glycosylation at T422 (P = 0.1761)| Loss of catalytic residue at Y423 (P = 0.427)| Loss of MoRF binding (P = 0.4899)	0.948559535363	0.94759	0.89889475880763	0.89797	0.663835845128	0.58762	0.715879440308	0.69394	T	0.599171	0.87010	D	0.390608	0.89288	D	0.323305	0.89155	D	0.983638167381287	0.75051	D	0.79572	0.43678	T	0.5171282	0.67790	0.4331056	0.66618	0.5171282	0.67791	0.4331056	0.66618	-13.681	0.91990	D	0.6068	0.69105	P	0.996788715160756	0.92462	0.99224824	0.97107	0.965	0.98576	.	.	.	.	.	.	5.120248	0.85664	28.7	0.9983667111804031	0.91806	0.967368	0.98980	D	0.726467666116946	0.81264	7.5057	0.753001886366408	0.86305	8.87095	5.97	5.97	0.96929	4.05	0.77340	6.671	0.74374	7.707000	0.66650	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.992	0.67791	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000002.12:g.219423803C>T	ClinGen:CA10604688	CN517202	.	.	.	Ser	Phe	36.1	0.9230769230769231																																																																																																																																																																																																																																																																																																																																																																																																																																																																													120			36.1	Polar/Neutral	Serine		Desmin										-0.8																	Phosphoserine	105									162.9	Morphology: NLPIQTysALNFRET			139.6	Tail					C (loop/coil)	C (loop/coil)												36.1	92.30769	$\leqslant$50	$\geqslant$90		unknown		Rare genetic cardiac disease; Rare genetic neurological disorder	2		false	0.7188978907518979	0.7245852417865628	false	false	false
LITAF	LITAF_Pro135Ser	B_15-16	-5.22826758660464	0.0012147510324238629	0.005420968392358828	-9.951200880740087	0.00002209518706840738	0.00012591511885257	2025_03_Batch_15-16	false	true	false	false	false	false	false	false	false	false	false	false	0.9515803922334204	0.96252376547225	0.6819738337821225	0.6482572032658162	0.7840852953959636	0.723056915594402	0.7782860537842062	0.8113445039492471	0.7368881006872142	0.6744152483685127	0.9528806987262459	0.9424613659562819	0.6678277774045976	0.7568260868426802	0.5596263058444181	0.6895324191957323	0.9721668322182542	0.9606994185105588	LITAF	Pro135Ser	NC_000016.10:11549720:G:A	403C>T	16	11549720	G	A	16	ENSG00000189067	52920	2668	CCSBVarC002196	ALE00002196	ENSP00000483114.1	Edgotyping3	VUSMutGDEh006	F11	NULL	NULL	NULL	VUSMutGDDh006	F11	VUSN2Hmut_GDN2h_02	B05	VUSMutpDEST2_11	H11	VUSmut_GDEh02	B05	0.0		1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	49655.0	single nucleotide variant	NM_001136472.2(LITAF):c.403C>T (p.Pro135Ser)	9516.0	LITAF	HGNC:16841	Uncertain significance	0.0	-	281865135.0	-	RCV000789998|RCV000034130	MONDO:MONDO:0015626,MedGen:C0007959,OMIM:PS118220,Orphanet:166|MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 1C	germline;unknown	germline	GRCh38	NC_000016.10	16	11549720.0	11549720.0	16p13.13	no assertion criteria provided	2.0	-	N	ClinGen:CA344236	3.0	41231.0	11549720.0	G	A	-	-	-	-	-	-	403C>T 	Pro135Ser	NM_001136472.2		VUS	VUS	41231	16	11549720.0	G	A	P	S	rs281865135	16	11643576	16	11551077	135	LITAF	ENSG00000189067	ENST00000570904	ENSP00000459138	Q99732	LITAF_HUMAN	c.403C>T	p.Pro135Ser	c.403C>T	p.Pro135Ser	principal1	Y	1	.	.	-	CCC	1	0	.	G/G	G/G	G/G	G/G	.	0.60085	.	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.725	0.94735	H	.	0.95712	.	0.936	0.97870	1.0634	0.98419	D	0.9140	0.97145	D	10	0.95584697	0.94890	D	0.287935	0.90440	D	.	0.97811	0.835	0.94263	Q99732	P135S	Gain of catalytic residue at P135 (P = 0.066)| Gain of sheet (P = 0.1208)| Loss of helix (P = 0.1706)| Loss of stability (P = 0.2044)| Gain of loop (P = 0.2045)	0.99972183212	0.99970	.	0.85108	.	0.58281	0.659740567207	0.61310	T	0.975354	0.99757	D	0.159561	0.69940	D	-0.00857759	0.69555	D	0.998399555683136	0.93976	D	.	0.94920	.	0.86884856	0.88616	0.86697114	0.92558	0.8326563	0.85906	0.85466963	0.91710	-13.258	0.90418	D	.	0.94404	.	0.989783921969932	0.88313	0.99675360	0.98151	0.919	0.95868	.	.	.	.	.	.	5.206492	0.87374	29.2	0.99919925547538835	0.98655	0.929561	0.91518	D	0.979700870126169	0.95059	13.2969	0.881479093443982	0.94683	12.98158	5.01	5.01	0.66433	.	.	7.61	0.82198	11.543000	0.93152	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.997	0.79771	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Charcot-Marie-Tooth_disease|Charcot-Marie-Tooth_disease_type_1C	no_assertion_criteria_provided	NC_000016.10:g.11549720G>A	ClinGen:CA344236	C0007959|C0270913	PS118220|601098	166|101083	LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor	Pro	Ser	75.73	0.029411764705882353																																																																																																																																																																																																																																																																																																																																																																																																																																																																													4			75.73	Special, No backbone hydrogen	Proline		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF	0.003		1.6																		115		Mutation: P -> T. Decreases protein stability and association with early endosome membranes. Impaired function in targeting endocytosed proteins for lysosomal degradation.							-62.1		Pocket 3: Mean pLDDT: 79.3, Volume: 304.37 Å³, Druggability score: 0		-27.1						H (helix)	H (α-helix)												75.73	2.9411764	70-90	<10	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.96252376547225	0.9515803922334204	true	false	false
SMAD3	SMAD3_Val294Met	B_15-16	-5.832147020816436	0.0006421479386354469	0.0033695125351475372	-4.402139959825962	0.003148670758726887	0.006266606119592015	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6086477949820692	0.6188515175532692	0.5238000749208173	0.6511247159152447	0.5562308955179602	0.5582707384352497	0.5227416884054413	0.554631797527451	0.7120534582240794	0.4577324074491506	0.6943641626585576	0.6703752334703544	0.5937997884650581	0.5578299935084696	0.5901959736064101	0.589867742392484	0.5433388724479807	0.5469203564937841	SMAD3	Val294Met	NC_000015.10:67184735:G:A	880G>A	15	67184735	G	A	15	ENSG00000166949	11805	2161	CCSBVarC007737	ALE00007723	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	C03	GDEhDisVCh_40014	H09	2	VUSMutGDDh005	C03	VUSN2Hmut_GDN2h_01	E12	VUSMutpDEST2_09	G05	VUSmut_GDEh01	E12	1.0	1.0	1.0	5.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	N	N	Y	Y	210287.0	single nucleotide variant	NM_005902.4(SMAD3):c.880G>A (p.Val294Met)	4088.0	SMAD3	HGNC:6769	Uncertain significance	0.0	Aug 24, 2022	863223744.0	-	RCV000197722|RCV003528152	MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000015.10	15	67184735.0	67184735.0	15q22.33	criteria provided, multiple submitters, no conflicts	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA322183	2.0	213770.0	67184735.0	G	A	-	-	-	-	-	-	880G>A 	Val294Met	NM_005902.4	2.0	VUS	VUS	213770	15	67184735.0	G	A	V	M	rs863223744	15	67477073	15	65264127	294	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.880G>A	p.Val294Met	c.880G>A	p.Val294Met	principal1	Y	1	YES	Select	+	GTG	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.02	0.83643	D	1.0	0.90580	D	0.959	0.70163	D	0.91	0.92786	D	simple_aae	9.0	91.0	3.12	0.87775	M	-2.62	0.56328	D	0.841	0.84151	1.0471	0.98052	D	0.9838	0.99506	D	10	0.9454768	0.93804	D	0.634975	0.96869	D	0.917	0.97849	0.803	0.92118	P84022	V294M	Gain of MoRF binding (P = 0.1148)| Loss of methylation at R292 (P = 0.1264)| Loss of sheet (P = 0.302)| Gain of loop (P = 0.3485)| Loss of helix (P = 0.3949)	0.970475585088	0.96987	0.7904201000035997	0.78874	2.36971887699	0.96921	0.867304801941	0.92169	D	0.982555	0.99871	D	0.517848	0.94773	D	0.506076	0.94696	D	0.989934384822845	0.80000	D	0.983252	0.94333	D	0.8390541	0.86362	0.7710088	0.86313	0.8390541	0.86364	0.7710088	0.86314	-11.908	0.84444	D	0.9725	0.90922	P	0.987073986806373	0.87315	0.99341387	0.97329	0.947	0.97555	.	.	.	.	.	.	5.852946	0.93834	33.0	0.9989052448744179	0.96438	0.910016	0.86692	D	0.963459008987247	0.94474	12.80994	0.892356275326731	0.95203	13.42919	5.28	5.28	0.74083	.	.	9.734	0.98037	11.795000	0.96488	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.878	0.41977	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614066	1.239110e-06	0	2	1180036	1.694860e-06	0	0	75062	0.000000e+00	0	0	912	0.000000e+00	0	0	60032	0.000000e+00	0	0	29608	0.000000e+00	0	0	44884	0.000000e+00	0	0	64038	0.000000e+00	0	0	5928	0.000000e+00	0	2	1180036	1.694860e-06	0	0	91076	0.000000e+00	0	0	19770	0	0	298	0	0	86	0	0	7438	0	0	146	0	0	610	0	0	26	0	0	98	0	1	1928	5.186721991701245E-4	0	7736	0	0	112	0	1	30400	3.289473684210526E-5	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.67184735G>A	ClinGen:CA322183	C4707243|C3661900	PS607086	91387	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Val	Met	98.76	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.76	Aliphatic	Valine		Mothers against decapentaplegic homolog 3							MH2			4.2								 V294-V257 (PAE:  1.0)	V294-V257 (PDBs: 1MJS, 1MK2, 5XOC)	 V294-V257 (PAE:  1.0)	V294-V257 (PDBs: 1MJS, 1MK2, 5XOC)							117									-121.9				133.1	Sufficient for interaction with XPO4					B (undefined)	E (parallel sheets)	Beta strand											98.76	0.0	>90	<10		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.6188515175532692	0.6086477949820692	false	false	false
NCF2	NCF2_Asp108Val	B_7-8	-1.1101663640562776	0.3174438498804712	0.4054964565090187	-4.933511083814512	0.0026209529389128587	0.005379696468573933	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7559147531590089	0.7692513407024202	0.5437608470583942	0.47525836304415275	0.4619424713873509	0.5430336954767725	0.5316365496601202	0.5061355442219864	0.4530242820250231	0.5247919271952146	0.8186789471878193	0.7559147531590089	0.5544308412934247	0.4177493985527154	0.4974924440632824	0.5627297669215738	0.7198237342170212		NCF2	Asp108Val	NC_000001.11:183577642:T:A	323A>T	1	183577642	T	A	1	ENSG00000116701	3727	214873	CCSBVarC003960	ALE00003960	ENSP00000356505.4	CEGS2	CegsMutGDEh1034	F07	GDEhDisVCh_40073	H06	1	CegsMutGDDh1034	F07	VUSN2Hmut_GDN2h_06	A09	VUSMutpDEST2_03	F11	VUSmut_GDEh06	A09	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	79384.0	single nucleotide variant	NM_000433.4(NCF2):c.323A>T (p.Asp108Val)	4688.0	NCF2	HGNC:7661	Uncertain significance	0.0	Mar 16, 2020	137854509.0	-	RCV000059364|RCV001559780	MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379|MedGen:C3661900	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2|not provided	germline	germline	GRCh38	NC_000001.11	1	183577642.0	183577642.0	1q25.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA145217,UniProtKB:P19878#VAR_065010,UniProtKB/Swiss-Prot:VAR_065010	3.0	68492.0	183577642.0	T	A	-	-	-	-	-	-	323A>T 	Asp108Val	NM_000433.4	1.0	VUS	VUS	68492	1	183577642.0	T	A	D	V	rs137854509	1	183546777	1	181813400	108	NCF2	ENSG00000116701	ENST00000697330	ENSP00000513258	P19878	NCF2_HUMAN	.	.	c.323A>T	p.Asp108Val	principal1	Y	.	.	.	-	GAC	2	0	T	T/T	T/T	T/T	T/T	.	0.78662	.	.	0.83643	.	0.99	0.63438	D	0.892	0.63270	P	.	0.97016	.	.	.	.	3.19	0.88840	M	.	0.97198	.	.	0.99902	0.2085	0.85993	D	0.5375	0.82847	D	10	.	0.95689	.	0.152661	0.83359	D	.	0.92308	0.838	0.94449	P19878	D108V	Loss of helix (P = 0.0237)| Gain of loop (P = 0.024)| Gain of methylation at K110 (P = 0.034)| Gain of ubiquitination at K110 (P = 0.0585)| Gain of MoRF binding (P = 0.1325)	.	0.87501	.	0.81371	.	0.78475	0.633937954903	0.57638	T	0.378523	0.73973	T	0.374089	0.88243	D	0.299577	0.88094	D	0.99654632806778	0.89478	D	0.956054	0.86253	D	0.8984274	0.91116	0.85336536	0.91620	0.92398995	0.93544	0.8788308	0.93392	-16.25	0.98115	D	.	0.88956	.	0.915510936481871	0.77188	0.70992460	0.86290	0.688	0.82685	.	.	.	.	.	.	5.045874	0.84042	28.2	0.99408826201833833	0.63220	0.715839	0.66666	D	0.746920982727203	0.82609	7.828707	0.72320110892554	0.84052	8.209902	5.66	5.66	0.87274	.	.	5.395	0.66113	7.855000	0.71196	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.992	0.67791	729	0.54435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Granulomatous_disease,_chronic,_autosomal_recessive,_cytochrome_b-positive,_type_2	criteria_provided,_single_submitter	NC_000001.11:g.183577642T>A	ClinGen:CA145217|UniProtKB/Swiss-Prot:VAR_065010|UniProtKB:P19878#VAR_065010	CN517202|C1856245	233710	379	.	Asp	Val	96.64	0.4233128834355828																																																																																																																																																																																																																																																																																																																																																																																																																																																																													69			96.64	Negatively-charged	Aspartic Acid		Neutrophil cytosol factor 2								0.2736		-3.5				B:D108-A:T25 (PDBs: 1E96)							D108-K117 (PDBs: 1E96)							132									-92.7		Pocket 2: Mean pLDDT: 96.72, Volume: 795.15 Å³, Druggability score: 0.27		112.6						B (undefined)	E (parallel sheets)	Beta strand											96.64	42.331287	>90	10-90	233710	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic skin disease	3	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2	false	0.7692513407024202	0.7559147531590089	false	false	false
PDGFRB	PDGFRB_Pro660Thr	B_7-8	-2.04853035133062	0.09582199453046765	0.15859619545337367	9.638042857777052	0.0006481162817246746	0.0016869409602337277	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8939056943340336	0.9180557796621851	0.7234786403327214	0.8009341124313283	0.7279456996235204	0.75409168190117	0.8410693659712287	0.8001471037806618	0.8803078701296189	0.8104516174100653	0.924999728708506	0.9164730048296831	0.6671139978311114	0.655744295466379	0.7215603547330377	0.6365056632553775	0.9111118306158643	0.8713383838383839	PDGFRB	Pro660Thr	NC_000005.10:150124295:G:T	1978C>A	5	150124295	G	T	5	ENSG00000113721	8409	216619	CCSBVarC002957	ALE00002957	ENSP00000261799.4	CEGS2	CegsMutGDEh1034	C08	GDEhDisVCh_40014	C01	2	CegsMutGDDh1034	C08	VUSN2Hmut_GDN2h_06	C09	VUSMutpDEST2_07	D10	VUSmut_GDEh06	C09	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	6.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	70503.0	single nucleotide variant	NM_002609.4(PDGFRB):c.1978C>A (p.Pro660Thr)	5159.0	PDGFRB	HGNC:8804	Uncertain significance	1.0	Apr 23, 2021	144050370.0	-	RCV000049265|RCV001853035	MONDO:MONDO:0009227,MedGen:C4551572,OMIM:228550,Orphanet:2591|MONDO:MONDO:0011150,MedGen:C1866182,OMIM:601812,Orphanet:363665;MONDO:MONDO:0014004,MedGen:C3554321,OMIM:615007,Orphanet:1980;MONDO:MONDO:0016824,MedGen:C0432284,OMIM:PS228550,Orphanet:2591;MONDO:MONDO:0014704,MedGen:C4225270,OMIM:616592,Orphanet:477831	Myofibromatosis, infantile, 1|Acroosteolysis-keloid-like lesions-premature aging syndrome;Basal ganglia calcification, idiopathic, 4;Infantile myofibromatosis;Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome	germline	germline	GRCh38	NC_000005.10	5	150124295.0	150124295.0	5q32	criteria provided, single submitter	2.0	-	N	ClinGen:CA143955,UniProtKB:P09619#VAR_069926,OMIM:173410.0004	3.0	55849.0	150124295.0	G	T	-	-	-	-	-	-	1978C>A 	Pro660Thr	NM_002609.4	1.0	VUS	VUS	55849	5	150124295.0	G	T	P	T	rs144050370	5	149503858	5	149484051	660	PDGFRB	ENSG00000113721	ENST00000261799	ENSP00000261799	P09619	PGFRB_HUMAN	c.1978C>A	p.Pro660Thr	c.1978C>A	p.Pro660Thr	principal1	Y	1	YES	Select	-	CCC	1	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.008	0.68204	D	1.0	0.90580	D	1.0	0.97365	D	0.86	0.90354	A	simple_aae	14.0	86.0	1.15	0.29146	L	-5.0	0.82367	D	0.746	0.74440	0.6207	0.92139	D	0.7317	0.90795	D	10	0.937964	0.93047	D	0.473534	0.94711	D	0.654	0.86925	.	.	.	.	.	0.790281759454	0.78667	0.6314617377453561	0.62908	1.2193180572	0.80944	0.862603366375	0.91482	D	0.822405	0.95638	D	0.161623	0.70133	D	0.0580301	0.73921	D	0.983385622501373	0.74893	D	0.947905	0.79875	D	0.62132746	0.73556	0.54125786	0.73232	0.62132746	0.73557	0.54125786	0.73232	-8.833	0.66693	D	0.7681	0.75790	P	0.989158118519305	0.88065	0.94798100	0.93265	0.959	0.98248	.	.	.	.	.	.	5.046087	0.84042	28.2	0.99806093231042015	0.89004	0.878682	0.80338	D	0.601673781824217	0.73138	5.940486	0.627114070850735	0.76789	6.579996	5.18	5.18	0.71100	5.41	0.93733	6.938	0.75774	9.937000	0.82654	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.986	0.61779	562	0.71136	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	1	109372	9.143110e-06	0	3	207852	1.443330e-05	0	3	236660	1.267640e-05	0	0	7164	0.000000e+00	0	0	17096	0.000000e+00	0	0	2318	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	1	42756	2.338850e-05	0	0	15690	0.000000e+00	0	1	42756	2.338850e-05	0	0	16216	0.000000e+00	0	0	30508	0.000000e+00	0	0	6208	0.000000e+00	0	0	13412	0.000000e+00	0	0	16732	0.000000e+00	0	3	89310	3.359090e-05	0	0	30606	0.000000e+00	0	3	89310	3.359090e-05	0	0	14902	0.000000e+00	0	0	34238	0.000000e+00	0	0	9560	0.000000e+00	0	0	17690	0.000000e+00	0	0	21628	0.000000e+00	0	3	102500	2.926830e-05	0	0	30526	0.000000e+00	0	3	102500	2.926830e-05	0	.	48	1613942	2.974080e-05	0	46	1179906	3.898620e-05	0	0	74938	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29600	0.000000e+00	0	0	44898	0.000000e+00	0	0	64036	0.000000e+00	0	0	6078	0.000000e+00	0	46	1179906	3.898620e-05	0	0	91088	0.000000e+00	0	1	9690	1.0319917440660474E-4	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	1	14528	6.883259911894274E-5	Myofibromatosis,_infantile,_1|Basal_ganglia_calcification,_idiopathic,_4|Infantile_myofibromatosis|Skeletal_overgrowth-craniofacial_dysmorphism-hyperelastic_skin-white_matter_lesions_syndrome|Acroosteolysis-keloid-like_lesions-premature_aging_syndrome	criteria_provided,_single_submitter	NC_000005.10:g.150124295G>T	ClinGen:CA143955|OMIM:173410.0004|UniProtKB:P09619#VAR_069926	C4551572|C3554321|C0432284|C4225270|C1866182	228550|615007|PS228550|616592|601812	2591|1980|2591|477831|363665	Serine-threonine/tyrosine-protein kinase, catalytic domain|Tyrosine-protein kinase, receptor class III, conserved site|Protein kinase domain|Tyrosine-protein kinase, catalytic domain	Pro	Thr	91.74	0.19117647058823528																																																																																																																																																																																																																																																																																																																																																																																																																																																																													26			91.74	Special, No backbone hydrogen	Proline		Platelet-derived growth factor receptor beta							Protein kinase			1.6										 P660-S988 (PAE:  3.0)								115									-78.5				147.1						C (loop/coil)	C (loop/coil)							Cytoplasmic					91.74	19.117647	>90	10-90	228550;601812;615007;616592	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic neurological disorder; Rare genetic skin disease; Rare genetic tumor	5	MYOFIBROMATOSIS, INFANTILE, 1; PREMATURE AGING SYNDROME, PENTTINEN TYPE; BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; KOSAKI OVERGROWTH SYNDROME	false	0.9180557796621851	0.8939056943340336	false	false	false
GAMT	GAMT_Asp219Asn	B_7-8	0.5710755662795356	0.5858072190842827	0.662850585575225	-0.2617121295948472	0.8010770975534496	0.8375934324846609	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5924056820179993	0.5963010673900158	0.5706377959822475	0.4589072639708216	0.47185262478381107	0.5401779970593243	0.6544205825353564	0.5522924848188379	0.47856833976751756	0.7006696729625645	0.7047125590154748	0.6971799564068594	0.4259354115832923	0.3914127647487842	0.4392461881741256	0.44060591900193047	0.4878895757645568	0.48763140762913904	GAMT	Asp219Asn	NC_000019.10:1397415:C:T	655G>A	19	1397415	C	T	19	ENSG00000130005	5865	1027	CCSBVarC008458	ALE00008427	ENSP00000252288.1	Edgotyping3	VUSmut_GDEh11	G07	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_05	E07	VUSmut_GDEh11	G07	0.0		0.0		0.0			1.0	7.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y	203526.0	single nucleotide variant	NM_000156.6(GAMT):c.655G>A (p.Asp219Asn)	2593.0	GAMT	HGNC:4136	Uncertain significance	0.0	Jun 06, 2022	753228876.0	-	RCV000655358|RCV001275200|RCV001704992|RCV002311267	MONDO:MONDO:0000456,MedGen:C5244016,OMIM:PS300352,Orphanet:79172|MONDO:MONDO:0012999,MedGen:C0574080,OMIM:612736,Orphanet:382|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	Cerebral creatine deficiency syndrome|Deficiency of guanidinoacetate methyltransferase|not provided|Inborn genetic diseases	germline	germline	GRCh38	NC_000019.10	19	1397415.0	1397415.0	19p13.3	reviewed by expert panel	5.0	-	N	ClinGen:CA314786	2.0	205569.0	1397415.0	C	T	-	-	-	-	-	-	655G>A 	Asp219Asn	NM_000156.6	3.0	VUS	VUS	205569	19	1397415.0	C	T	D	N	rs753228876	19	1397414	19	1348414	219	GAMT	ENSG00000130005	ENST00000252288	ENSP00000252288	Q14353	GAMT_HUMAN	c.655G>A	p.Asp219Asn	c.655G>A	p.Asp219Asn	principal1	Y	1	YES	Select	-	GAC	1	0	C	C/C	C/C	C/C	C/C	0.1	0.30652	T	0.101	0.38937	T	0.004	0.12194	B	0.002	0.06938	B	0.11	0.30097	N	simple_aae	89.0	11.0	2.105	0.58252	M	-2.88	0.60539	D	0.065	0.03720	-0.2242	0.76936	T	0.5809	0.84869	D	10	0.11926907	0.22301	T	0.031142	0.53106	D	0.293	0.61075	0.398	0.42445	Q14353	D219N	Gain of catalytic residue at D219 (P = 0.0202)| Loss of phosphorylation at Y222 (P = 0.1196)| Loss of stability (P = 0.1593)| Gain of loop (P = 0.2045)| Gain of helix (P = 0.2684)	0.890496652	0.88857	.	.	.	.	.	.	.	0.642717	0.88953	D	-0.399996	0.02187	T	-0.432848	0.29252	T	0.0366648364235101	0.03073	T	0.777822	0.40955	T	0.222495	0.44525	0.10106566	0.24138	0.222495	0.44525	0.10106566	0.24138	-4.206	0.26865	T	0.1057	0.19626	B	0.0108884882612296	0.24585	0.01982869	0.49279	0.132	0.35056	.	.	.	.	.	.	2.033162	0.25891	16.91	0.99675151615578961	0.78869	0.546276	0.55889	D	-0.3216260608313	0.28048	1.561578	-0.261990018539477	0.29043	1.644352	5.08	1.83	0.24213	1.4	0.33079	2.041	0.40938	1.366000	0.26003	0.599	0.40292	0.932	0.32434	0.770000	0.26773	0.611	0.31708	940	0.13655	.	.	.	.	.	.	.	.	.	.	.	.	23	264690	8.6894106E-5	.	19	106932	1.776830e-04	0	34	204038	1.666360e-04	0	35	233850	1.496690e-04	0	0	6882	0.000000e+00	0	12	17004	7.057160e-04	0	0	2288	0.000000e+00	0	3	8984	3.339270e-04	0	0	12034	0.000000e+00	0	1	42180	2.370790e-05	0	0	15690	0.000000e+00	0	12	17004	7.057160e-04	0	0	15758	0.000000e+00	0	24	30380	7.899930e-04	0	0	6106	0.000000e+00	0	3	13328	2.250900e-04	0	0	15320	0.000000e+00	0	3	87780	3.417630e-05	0	1	30600	3.267970e-05	0	24	30380	7.899930e-04	0	0	14528	0.000000e+00	0	26	34124	7.619270e-04	0	0	9532	0.000000e+00	0	3	17630	1.701640e-04	0	0	20060	0.000000e+00	0	2	101886	1.962980e-05	0	1	30526	3.275900e-05	0	26	34124	7.619270e-04	0	.	99	1611522	6.143260e-05	0	29	59986	4.834460e-04	0	0	74924	0.000000e+00	0	0	912	0.000000e+00	0	29	59986	4.834460e-04	0	0	29588	0.000000e+00	0	4	44890	8.910670e-05	0	1	61832	1.617290e-05	0	0	6080	0.000000e+00	0	57	1179836	4.831180e-05	0	1	91076	1.097980e-05	0	1	14230	7.02740688685875E-5	0	114	0	0	120	0	0	3212	0	0	146	0	1	610	0.001639344262295082	0	26	0	0	104	0	0	612	0	0	3326	0	0	146	0	2	19174	1.0430791697089809E-4	Inborn_genetic_diseases|not_provided|Cerebral_creatine_deficiency_syndrome|Deficiency_of_guanidinoacetate_methyltransferase	reviewed_by_expert_panel	NC_000019.10:g.1397415C>T	ClinGen:CA314786	C0950123|C3661900|C5244016|C0574080	PS300352|612736	79172|382	Arginine N-methyltransferase 2-like domain	Asp	Asn	92.83	0.7361963190184049																																																																																																																																																																																																																																																																																																																																																																																																																																																																													120			92.83	Negatively-charged	Aspartic Acid		Guanidinoacetate N-methyltransferase							RMT2	0.0105		-3.5																		132									-94.5		Pocket 4: Mean pLDDT: 97.5, Volume: 211.72 Å³, Druggability score: 0.01		1.2						C (loop/coil)	T (turn)												92.83	73.61964	>90	10-90	612736	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	CEREBRAL CREATINE DEFICIENCY SYNDROME 2	false	0.5963010673900158	0.5924056820179993	false	false	false
SMAD3	SMAD3_Met255Arg	B_15-16	-6.610829237427121	0.0005765908008770303	0.0030848415397062403	-5.514542070876259	0.0008926932622742277	0.002175421163709439	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9491202271532106	0.9533084192632325	0.6130524904925401	0.8553058073352757	0.752974781043045	0.6748268540501892	0.767134006996448	0.8418491409831639	0.9341881484806526	0.6739129873209325	0.9713536087274833	0.9526226446601913	0.5825197011039305	0.6641004211029262	0.7764234661898988	0.5521919936641476	0.9352632297989817	0.9456178096462301	SMAD3	Met255Arg	NC_000015.10:67181346:T:G	764T>G	15	67181346	T	G	15	ENSG00000166949	11805	2144	CCSBVarC007726	ALE00007712	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	D01	GDEhDisVCh_40014	A08	2	VUSMutGDDh005	D01	VUSN2Hmut_GDN2h_01	H10	VUSMutpDEST2_09	H03	VUSmut_GDEh01	H10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	258943.0	single nucleotide variant	NM_005902.4(SMAD3):c.764T>G (p.Met255Arg)	4088.0	SMAD3	HGNC:6769	Uncertain significance	0.0	Aug 16, 2013	886038899.0	-	RCV000251846	MedGen:CN230736	Cardiovascular phenotype	germline	germline	GRCh38	NC_000015.10	15	67181346.0	67181346.0	15q22.33	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10587876	2.0	263697.0	67181346.0	T	G	-	-	-	-	-	-	764T>G 	Met255Arg	NM_005902.4	1.0	VUS	VUS	263697	15	67181346.0	T	G	M	R	rs886038899	15	67473684	15	65260738	255	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.764T>G	p.Met255Arg	c.764T>G	p.Met255Arg	principal1	Y	1	YES	Select	+	ATG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.259	0.31489	B	0.226	0.38055	B	0.83	0.88920	D	simple_aae	17.0	83.0	0.55	0.14367	N	-3.89	0.75085	D	0.913	0.92907	0.7472	0.93736	D	0.8153	0.93761	D	10	0.87056255	0.86172	D	0.460992	0.94503	D	0.904	0.97356	0.685	0.82191	P84022	M255R	Loss of stability (P = 0.0453)| Gain of disorder (P = 0.0815)| Loss of glycosylation at T256 (P = 0.0856)| Gain of catalytic residue at M255 (P = 0.0991)| Gain of sheet (P = 0.1208)	0.995150686025	0.99503	0.914233956049413	0.91344	1.94559428542	0.93297	0.801789045334	0.82204	T	0.977827	0.99799	D	0.464195	0.93053	D	0.429008	0.92967	D	0.993998527526855	0.84919	D	0.938306	0.76748	D	0.9735266	0.98555	0.8939219	0.94470	0.9735266	0.98555	0.8939219	0.94470	-12.394	0.86751	D	0.9918	0.95051	P	0.872213503013788	0.74314	0.98777270	0.96411	0.994	0.99793	.	.	.	.	.	.	4.480143	0.69947	25.4	0.98087304946217524	0.38304	0.929997	0.91632	D	0.159433337569286	0.49012	3.128332	0.304962577909593	0.55595	3.745897	5.1	5.1	0.68875	.	.	7.914	0.86916	7.845000	0.70743	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.895	0.43251	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Cardiovascular_phenotype	criteria_provided,_single_submitter	NC_000015.10:g.67181346T>G	ClinGen:CA10587876	CN230736	.	.	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Met	Arg	95.32	0.010638297872340425																																																																																																																																																																																																																																																																																																																																																																																																																																																																													2			95.32	Aliphatic	Methionine		Mothers against decapentaplegic homolog 3							MH2			1.9								 M255-L296 (PAE:  1.0)	M255-L296 (PDBs: 1MJS, 1MK2, 5XOC)	 M255-L296 (PAE:  1.0)	M255-R295 (PDBs: 1MJS), M255-L296 (PDBs: 1MJS, 1MK2, 5XOC)							149									-141.1				167.1						B (undefined)	E (parallel sheets)	Beta strand											95.32	1.0638298	>90	<10		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.9533084192632325	0.9491202271532106	true	true	false
UBQLN2	UBQLN2_Pro509Ser	B_7-8	3.1234977236195824	0.016761464340140957	0.040068081213603536	1.156265172023083	0.28550581580751616	0.33734911268949913	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5158203607541962	0.5038242742630784	0.5567023186875919	0.47272604483398084	0.46820197578949213	0.5242291343756713	0.4493725727534919	0.3688442269127272	0.32256691118872566	0.5222180833346624	0.49193140897387566	0.4933634234096659	0.5990856959978507	0.567559724666257	0.6228851784792361	0.5911865540405215	0.5157171395522812	0.5382772980987267	UBQLN2	Pro509Ser	NC_000023.11:56565398:C:T	1525C>T	23	56565398	C	T	X	ENSG00000188021	71001	205676	CCSBVarC003505	ALE00003505	ENSP00000345195.5	CEGS2	CegsMutGDEh1034	H07	GDEhDisVCh_40022	B03	2	CegsMutGDDh1034	H07	VUSN2Hmut_GDN2h_06	B09	NULL	NULL	VUSmut_GDEh06	B09	1.0	1.0	1.0	1.0	1.0	2.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	38908.0	single nucleotide variant	NM_013444.4(UBQLN2):c.1525C>T (p.Pro509Ser)	29978.0	UBQLN2	HGNC:12509	Uncertain significance	1.0	Jul 19, 2023	387906712.0	-	RCV000022845|RCV004752721	MONDO:MONDO:0010459,MedGen:C3275459,OMIM:300857,Orphanet:803|	Amyotrophic lateral sclerosis type 15|UBQLN2-related disorder	germline	germline	GRCh38	NC_000023.11	X	56565398.0	56565398.0	Xp11.21	criteria provided, single submitter	3.0	-	N	ClinGen:CA259709,UniProtKB:Q9UHD9#VAR_066565,OMIM:300264.0004	3.0	29953.0	56565398.0	C	T	-	-	-	-	-	-	1525C>T 	Pro509Ser	NM_013444.4	1.0	VUS	VUS	29953	X	56565398.0	C	T	P	S	rs387906712	X	56591831	X	56608556	509	UBQLN2	ENSG00000188021	ENST00000338222	ENSP00000345195	Q9UHD9	UBQL2_HUMAN	c.1525C>T	p.Pro509Ser	c.1525C>T	p.Pro509Ser	principal1	Y	NA	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.141	0.25683	T	0.765	0.04629	T	0.002	0.09864	B	0.001	0.04348	B	0.64	0.79151	D	simple_aae	36.0	64.0	-0.55	0.02423	N	0.11	0.05678	N	0.339	0.37784	-0.6279	0.63501	T	0.4320	0.77248	T	10	0.12488434	0.23442	T	0.218552	0.87633	D	0.451	0.75010	0.286	0.24321	Q9UHD9	P509S	Gain of glycosylation at P509 (P = 0.0073)| Gain of phosphorylation at P509 (P = 0.0404)| Loss of sheet (P = 0.3635)| Gain of catalytic residue at P509 (P = 0.5241)| Loss of stability (P = 0.5677)	0.993751696936	0.99360	0.788948238069127	0.78726	0.47578793126	0.46448	0.773824691772	0.77957	T	0.036336	0.23803	T	0.0577613	0.59046	T	-0.0103975	0.69436	D	0.0546806218933188	0.06238	T	0.745725	0.36382	T	0.083539814	0.19119	0.12153215	0.29251	0.083539814	0.19119	0.12153215	0.29250	-6.494	0.50304	T	0.2195	0.45013	B	0.981223685267532	0.85616	0.99933255	0.99303	0.166	0.41156	.	.	.	.	.	.	2.825767	0.37308	20.4	0.82917156161282002	0.14671	.	.	.	.	.	.	.	.	.	4.18	4.18	0.48414	.	.	0.73	0.25803	5.251000	0.48169	0.599	0.40292	0.001	0.13799	1.000000	0.68239	0.999	0.91597	101	0.95825	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	2	65529	3.052080e-05	0	2	123909	1.614090e-05	0	3	140524	2.134870e-05	0	0	4156	0.000000e+00	0	0	12286	0.000000e+00	0	0	1458	0.000000e+00	0	0	5431	0.000000e+00	0	0	9239	0.000000e+00	0	2	23164	8.634090e-05	0	0	8551	0.000000e+00	0	2	23164	8.634090e-05	0	0	9477	0.000000e+00	0	0	21441	0.000000e+00	0	0	4043	0.000000e+00	0	0	8796	0.000000e+00	0	0	10961	0.000000e+00	0	2	49650	4.028200e-05	0	0	16465	0.000000e+00	0	2	49650	4.028200e-05	0	0	8674	0.000000e+00	0	0	24306	0.000000e+00	0	0	6541	0.000000e+00	0	0	11129	0.000000e+00	0	0	13746	0.000000e+00	0	3	56120	5.345690e-05	0	0	16419	0.000000e+00	0	3	56120	5.345690e-05	0	.	20	1193953	1.675110e-05	0	5	56835	8.797400e-05	0	5	56835	8.797400e-05	0	0	688	0.000000e+00	0	0	43764	0.000000e+00	0	0	21741	0.000000e+00	0	0	32805	0.000000e+00	0	0	45397	0.000000e+00	0	0	4339	0.000000e+00	0	14	886396	1.579430e-05	0	0	55027	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Amyotrophic_lateral_sclerosis_type_15	criteria_provided,_single_submitter	NC_000023.11:g.56565398C>T	ClinGen:CA259709|OMIM:300264.0004|UniProtKB:Q9UHD9#VAR_066565	C3275459	300857	803	.	Pro	Ser	44.58	0.9191176470588235																																																																																																																																																																																																																																																																																																																																																																																																																																																																													125			44.58	Special, No backbone hydrogen	Proline		Ubiquilin-2										1.6																		115									-86.4				142.3	12 X 3 AA tandem repeats of P-X-X		7.0			C (loop/coil)	C (loop/coil)												44.58	91.911766	$\leqslant$50	$\geqslant$90	300857	x-linked dominant	OMIM		0	AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	false	0.5038242742630784	0.5158203607541962	false	false	false
HPRT1	HPRT1_Gly140Asp	B_7-8	-1.2627931516071806	0.2471007161515184	0.3307374687101613	-4.09008856726419	0.004630444067381241	0.008786830262300495	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.616611234468799	0.6481473027905693	0.5423028464747792	0.6184076103694485	0.5759916795961412	0.5533350369996608	0.5773001642159374	0.653213560572162	0.6897409384330653	0.5718278791272298	0.7466936721829307	0.7518138260812841	0.529369909783384	0.4987697986201204	0.5470742823058317	0.5127778138223287	0.5496009333982079	0.48140864285631374	HPRT1	Gly140Asp	NC_000023.11:134493524:G:A	419G>A	23	134493524	G	A	X	ENSG00000165704	7982	202802	CCSBVarC005936	ALE00005936	ENSP00000298556.7	CEGS2	CegsMutGDEh1030	A04	GDEhDisVCh_40052	H07	2	CegsMutGDDh1030	A04	VUSN2Hmut_GDN2h_05	D03	VUSMutpDEST2_07	D07	VUSmut_GDEh05	D03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25119.0	single nucleotide variant	NM_000194.2(HPRT1):c.419G>A (p.Gly140Asp)	3251.0	HPRT1	HGNC:5157	Uncertain significance	1.0	Sep 02, 2021	137852503.0	-	RCV000010789|RCV000010790|RCV001857327	MONDO:MONDO:0010298,MedGen:C0023374,OMIM:300322,Orphanet:510||MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233;MONDO:MONDO:0010298,MedGen:C0023374,OMIM:300322,Orphanet:510	Lesch-Nyhan syndrome|HPRT TOKYO|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency;Lesch-Nyhan syndrome	germline	germline	GRCh38	NC_000023.11	X	134493524.0	134493524.0	Xq26.2	criteria provided, single submitter	2.0	-	N	OMIM:308000.0055,ClinGen:CA120911	3.0	10080.0	134493524.0	G	A	-	-	-	-	-	-	419G>A 	Gly140Asp	NM_000194.2	1.0	VUS	VUS	10080	X	134493524.0	G	A	G	D	rs137852503	X	133627554	X	133455220	140	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.419G>A	p.Gly140Asp	c.419G>A	p.Gly140Asp	principal1	Y	1	YES	Select	+	GGC	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.775	0.99600	H	-6.36	0.91036	D	0.995	0.99931	1.1798	0.99962	D	0.9997	0.99985	D	9	0.9959082	0.99994	D	0.902314	0.99264	D	0.982	0.99890	0.992	0.99914	P00492	G140D	Gain of ubiquitination at K141 (P = 0.0486)| Loss of catalytic residue at M143 (P = 0.1566)| Loss of helix (P = 0.1706)| Loss of MoRF binding (P = 0.2232)| Loss of stability (P = 0.311)	0.999689423292	0.99967	0.996352452330669	0.99633	3.31666214769	0.99593	0.881068468094	0.94096	D	0.997363	0.99997	D	0.739483	0.99968	D	0.824439	0.99968	D	0.999647617340088	0.98285	D	0.920508	0.71188	D	0.9939913	0.99933	0.99371535	0.99995	0.9939913	0.99933	0.99371535	0.99996	-13.811	0.92441	D	0.9979	0.97310	P	0.969317913136437	0.83160	0.99981004	0.99752	0.996	0.99859	.	.	.	.	.	.	4.988229	0.82708	27.8	0.99835117604640056	0.91634	.	.	.	.	.	.	.	.	.	5.56	5.56	0.83655	3.9	0.73887	9.298	0.95246	11.719000	0.94790	0.675	0.71144	1.0	0.71675	1.000000	0.68239	0.992	0.67791	218	0.91521	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Lesch-Nyhan_syndrome|Partial_hypoxanthine-guanine_phosphoribosyltransferase_deficiency|HPRT_TOKYO	criteria_provided,_single_submitter	NC_000023.11:g.134493524G>A	ClinGen:CA120911|OMIM:308000.0055	C0023374|C0268117	300322|300323	510|79233	Phosphoribosyltransferase domain|Phosphoribosyltransferase domain	Gly	Asp	93.09	0.047619047619047616																																																																																																																																																																																																																																																																																																																																																																																																																																																																													4			93.09	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine	GMP	Hypoxanthine-guanine phosphoribosyltransferase										-0.4								 G140-Q144 (PAE:  1.0)	G140-Q144 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)	 G140-Q144 (PAE:  1.0)	G140-Q144 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)							75									84.6				-5.2						C (loop/coil)	S (bend)	Beta strand											93.09	4.7619047	>90	<10	300322;300323;300322	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	LESCH-NYHAN SYNDROME; HYPERURICEMIA, HPRT-RELATED; LESCH-NYHAN SYNDROME	false	0.6481473027905693	0.616611234468799	false	false	false
RP2	RP2_Leu253Arg	B_7-8	-6.62744101759334	0.0011777976544242003	0.005318187990426058	-13.346044411371931	0.000010949714940379227	0.00008005070484301148	2024_01_Batch_7-8		true	false	false	false	false		true	false	false	false	false		0.9956635671766937	0.7116681180132958	0.877160517439524	0.7090397234978214	0.8214864198578313	0.7812067594976622	0.71679717672558	0.8407237885155655	0.62587846621558	0.9943998997035716		0.8617660802180005	0.7012822702700628	0.9135972463634824	0.7974577698110117	0.9969272346498158		RP2	Leu253Arg	NC_000023.11:46854131:T:G	758T>G	23	46854131	T	G	X	ENSG00000102218	11374	19294	CCSBVarC001708	ALE00001708	ENSP00000218340.3	RC4	RC4_Mut_GDEh1017	E08	GDEhDisVCh_40085	F09	1	RC4_Mut_GDDh1017	E08	NULL	NULL	VUSMutpDEST2_08	C11	VUSmut_GDEh13	C02	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	1513741.0	single nucleotide variant	NM_006915.3(RP2):c.758T>G (p.Leu253Arg)	6102.0	RP2	HGNC:10274	Uncertain significance	0.0	Aug 23, 2021	2147081596.0	-	RCV001916442	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000023.11	X	46854131.0	46854131.0	Xp11.3	criteria provided, single submitter	1.0	-	N	-	2.0	1410434.0	46854131.0	T	G	-	-	-	-	-	-	758T>G 	Leu253Arg	NM_006915.3	1.0	VUS	VUS	1410434	X	46854131.0	T	G	L	R	rs2147081596	X	46713566	X	46598510	253	RP2	ENSG00000102218	ENST00000218340	ENSP00000218340	O75695	XRP2_HUMAN	c.758T>G	p.Leu253Arg	c.758T>G	p.Leu253Arg	principal1	Y	1	YES	Select	+	CTA	2	0	T	T/T	T/T	T/T	T/T	0.005	0.63383	D	0.008	0.68204	D	0.981	0.59690	D	0.38	0.43841	B	0.68	0.81345	D	simple_aae	32.0	68.0	2.32	0.66223	M	-2.62	0.56328	D	0.956	0.96546	-0.1886	0.77864	T	0.3792	0.73529	T	10	0.98002446	0.97932	D	0.750718	0.98008	D	0.721	0.90105	0.857	0.95580	O75695	L253R	Gain of MoRF binding (P = 0.0193)| Loss of ubiquitination at K252 (P = 0.0546)| Gain of catalytic residue at M257 (P = 0.0862)| Loss of stability (P = 0.1117)| Gain of relative solvent accessibility (P = 0.1259)	0.999855749853	0.99985	0.9561116305392299	0.95569	0.920724502609	0.71269	0.766986370087	0.76932	T	0.472813	0.80346	T	0.440534	0.91989	D	0.39502	0.91890	D	0.97542816400528	0.70732	D	0.884611	0.60701	D	0.9582402	0.97056	0.86104774	0.92147	0.94600964	0.95795	0.7750783	0.86564	-6.611	0.51203	T	0.8944	0.82334	P	0.929271355625584	0.78335	0.99846804	0.98800	0.688	0.82685	.	.	.	.	.	.	3.772783	0.54284	23.5	0.99709652547400851	0.81232	.	.	.	.	.	.	.	.	.	5.75	5.75	0.90377	3.72	0.68345	7.555	0.81218	7.906000	0.73829	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	135	0.94621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000023.11:g.46854131T>G	.	C3661900	.	.	Tubulin binding cofactor C-like domain	Leu	Arg	98.06	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.06	Aliphatic	Leucine		Protein XRP2										3.8								 L253-M257 (PAE:  1.0), L253-N249 (PAE: 1.0)	L253-M257 (PDBs: 2BX6, 3BH7), L253-N249 (PDBs: 2BX6, 3BH6, 3BH7)	 L253-M257 (PAE:  1.0), L253-N249 (PAE: 1.0)	L253-M257 (PDBs: 2BX6, 3BH7), L253-N249 (PDBs: 2BX6, 3BH6, 3BH7)							131									-66.1				-41.3				dbSNP: rs2147081596; Variant type: LP/P; AA change: Leu253Arg; PTM type: Ubiquitylation; PTM morphology: IANARkL*IDEM; Var class: II		H (helix)	H (α-helix)	Helix											98.06	0.0	>90	<10		unknown		Rare genetic eye disease; Ciliopathy	2		false	0.9956635671766937		true		true
DES	DES_Val56Leu	B_7-8	-1.7503778347027323	0.1783574281808817	0.25710391533998794	-0.590950624551514	0.5731316652976064	0.6237820912343462	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7072206543164806	0.690936220133048	0.6022737096681385	0.68701455854462	0.6682169525603444	0.6686238455146732	0.6686238455146732	0.7934141400677277	0.8032366619494065	0.6022737096681385	0.7447273625449837	0.7072206543164806		0.5430197650529611	0.5707924551398336		0.6371450777211123		DES	Val56Leu	NC_000002.12:219418628:G:C	166G>C	2	219418628	G	C	2	ENSG00000175084	12573	2229	CCSBVarC007794	ALE00007780	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	H01	GDEhDisVCh_40003	A02	1	VUSMutGDDh003	H01	VUSN2Hmut_GDN2h_01	F01	NULL	NULL	VUSmut_GDEh01	F01	1.0	1.0	1.0	5.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	N	Y	N	Y	198112.0	single nucleotide variant	NM_001927.4(DES):c.166G>C (p.Val56Leu)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Jan 15, 2024	578066781.0	-	RCV000183360|RCV000467504|RCV000766842|RCV000617378|RCV002485225	MedGen:CN169374|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909|MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0011482,MedGen:C1858154,OMIM:604765,Orphanet:154;MONDO:MONDO:0008407,MedGen:C1867005,OMIM:181400,Orphanet:85146;MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not specified|Desmin-related myofibrillar myopathy|not provided|Cardiovascular phenotype|Dilated cardiomyopathy 1I;Neurogenic scapuloperoneal syndrome, Kaeser type;Desmin-related myofibrillar myopathy	germline;unknown	germline	GRCh38	NC_000002.12	2	219418628.0	219418628.0	2q35	criteria provided, multiple submitters, no conflicts	6.0	ACMG2022	N	ClinGen:CA308293	2.0	201713.0	219418628.0	G	C	-	-	-	-	-	-	166G>C 	Val56Leu	NM_001927.4	2.0	VUS	VUS	201713	2	219418628.0	G	C	V	L	rs578066781	2	220283350	2	219991594	56	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.166G>C	p.Val56Leu	c.166G>C	p.Val56Leu	principal1	Y	1	YES	Select	+	GTG	1	0	G	G/G	G/G	G/G	G/G	0.584	0.05954	T	0.641	0.07060	T	0.757	0.43450	P	0.333	0.42166	B	0.64	0.79151	D	simple_aae	36.0	64.0	1.995	0.53920	M	-0.59	0.17556	N	0.153	0.15662	-0.3224	0.74240	T	0.4421	0.77893	T	10	0.119993925	0.22449	T	0.491638	0.95000	D	0.494	0.77857	0.506	0.59950	P17661	V56L	Gain of catalytic residue at V56 (P = 0.0222)| Loss of sheet (P = 0.0228)| Loss of methylation at R58 (P = 0.1521)| Loss of MoRF binding (P = 0.1737)| Loss of phosphorylation at T59 (P = 0.192)	0.882733321463	0.88068	0.7608747449225713	0.75903	0.887879636192	0.69904	0.774017035961	0.77987	T	0.220856	0.58213	T	-0.166835	0.25373	T	-0.0798998	0.64661	T	0.0907904262314835	0.11169	T	0.839916	0.51317	T	0.355869	0.57191	0.368464	0.61893	0.355869	0.57191	0.368464	0.61893	-3.884	0.22082	T	0.3375	0.55708	B	0.467470339924222	0.59792	0.97356796	0.94939	0.244	0.51390	.	.	.	.	.	.	3.331922	0.45959	22.2	0.96076925737632624	0.28853	0.900921	0.84646	D	0.215243431845233	0.51700	3.371314	0.272356979327139	0.53690	3.559863	5.13	4.26	0.49774	1.43	0.33398	4.48	0.60062	6.207000	0.55034	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.999	0.91597	86	0.96402	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	59	264690	2.2290226E-4	.	8	99394	8.048780e-05	0	10	182972	5.465320e-05	0	10	213220	4.689990e-05	0	8	5974	1.339140e-03	0	0	16052	0.000000e+00	0	0	2016	0.000000e+00	0	0	8022	0.000000e+00	0	0	12630	0.000000e+00	0	0	38528	0.000000e+00	0	0	14442	0.000000e+00	0	8	5974	1.339140e-03	0	9	12650	7.114620e-04	0	1	28460	3.513700e-05	0	0	5402	0.000000e+00	0	0	12278	0.000000e+00	0	0	15478	0.000000e+00	0	0	76018	0.000000e+00	0	0	28438	0.000000e+00	0	9	12650	7.114620e-04	0	9	11860	7.588530e-04	0	1	32304	3.095590e-05	0	0	8772	0.000000e+00	0	0	16516	0.000000e+00	0	0	19512	0.000000e+00	0	0	90746	0.000000e+00	0	0	28394	0.000000e+00	0	9	11860	7.588530e-04	0	.	72	1601674	4.495300e-05	0	63	74810	8.421330e-04	0	63	74810	8.421330e-04	0	0	912	0.000000e+00	0	2	58746	3.404490e-05	0	0	29010	0.000000e+00	0	0	44522	0.000000e+00	0	0	61880	0.000000e+00	0	2	6020	3.322260e-04	0	2	1174456	1.702920e-06	0	0	89404	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	8	2784	0.0028735632183908046	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	8	2898	0.0027605244996549345	0	112	0	8	14050	5.693950177935943E-4	not_specified|Dilated_cardiomyopathy_1I|Desmin-related_myofibrillar_myopathy|Neurogenic_scapuloperoneal_syndrome,_Kaeser_type|not_provided|Cardiovascular_phenotype	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219418628G>C	ClinGen:CA308293	CN169374|C1858154|C1832370|C1867005|C3661900|CN230736	604765|601419|181400	154|363543|98909|85146	Intermediate filament head, DNA-binding domain	Val	Leu	35.62	0.8450704225352113																																																																																																																																																																																																																																																																																																																																																																																																																																																																													120			35.62	Aliphatic	Valine		Desmin										4.2																		117									-111.0				110.5	Head					C (loop/coil)	C (loop/coil)												35.62	84.50704	$\leqslant$50	10-90	601419;604765;181400;601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1; CARDIOMYOPATHY, DILATED, 1I; SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; MYOPATHY, MYOFIBRILLAR, 1	false	0.690936220133048	0.7072206543164806	false	false	false
TPM1	TPM1_Glu40Lys	B_15-16	4.0199836271875276	0.027271210416650198	0.05111865573066055	0.7775696356229105	1.0	1.0	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6360076527650166	0.6201716793644667	0.6724600212033706	0.675258049860213	0.6965664120263357	0.7251736957098412	0.6472925408056889	0.6105013402902172	0.5673412317666567	0.6178756268586455	0.5928488453430147	0.607181915301207	0.8030548506139936	0.7826314837624544	0.7831748679537691	0.7270444155480956	0.6474945133859186	0.6648333902288261	TPM1	Glu40Lys	NC_000015.10:63044030:G:A	118G>A	15	63044030	G	A	15	ENSG00000140416	4723	8945	CCSBVarC000697	ALE00000697	ENSP00000288398.6	RC4	RC4_Mut_GDEh1014	F09	GDEhDisVCh_40050	C11	2	RC4_Mut_GDDh1014	F09	VUSN2Hmut_GDN2h_10	G07	VUSMutpDEST2_04	C05	VUSmut_GDEh12	G11	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	N	Y	Y	27498.0	single nucleotide variant	NM_001018005.2(TPM1):c.118G>A (p.Glu40Lys)	7168.0	TPM1	HGNC:12010	Uncertain significance	1.0	Jul 07, 2022	104894501.0	-	RCV000013275|RCV002513006	MONDO:MONDO:0012744,MedGen:C2678476,OMIM:611878,Orphanet:154,Orphanet:54260|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569	Dilated cardiomyopathy 1Y|Hypertrophic cardiomyopathy	germline	germline	GRCh38	NC_000015.10	15	63044030.0	63044030.0	15q22.2	criteria provided, single submitter	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018647,UniProtKB:P09493#VAR_043986,Leiden Muscular Dystrophy (TPM1):TPM1_00001,OMIM:191010.0005	3.0	12459.0	63044030.0	G	A	-	-	-	-	-	-	118G>A 	Glu40Lys	NM_001018005.2	1.0	VUS	VUS	12459	15	63044030.0	G	A	E	K	rs104894501	15	63336229	15	61123282	40	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.118G>A	p.Glu40Lys	c.118G>A	p.Glu40Lys	alternative1	Y	1	YES	Select	+	GAA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.04	0.69466	D	0.924	0.51298	P	0.736	0.55524	P	0.97	0.96253	A	simple_aae	3.0	97.0	3.655	0.94139	H	-2.45	0.55526	N	0.829	0.93259	1.0361	0.97828	D	0.9120	0.97078	D	10	0.7564033	0.75784	D	0.346979	0.92150	D	0.719	0.90015	.	0.21625	.	.	.	0.985848152628	0.98553	.	0.98056	.	0.91900	.	.	.	0.898714	0.97976	D	0.49063	0.93977	D	0.466979	0.93900	D	0.989030539989471	0.79143	D	0.970003	0.89495	D	0.87422514	0.89048	0.74280983	0.84614	0.8231723	0.85246	0.64592105	0.79070	-11.333	0.81511	D	0.5525	0.75817	A	0.981079135819109	0.85578	0.99980682	0.99752	0.887	0.93946	.	.	.	.	.	.	6.131498	0.9464	34.0	0.99906962788800302	0.97728	0.963387	0.98522	D	0.936398494001761	0.93388	12.03099	0.904770568401222	0.95755	13.95774	5.67	5.67	0.87655	.	.	9.602	0.97629	11.756000	0.95524	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	793	0.45754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	36746	0	0	298	0	0	120	0	0	7892	0	0	500	0	0	628	0	0	26	0	0	104	0	0	6128	0	0	8190	0	0	146	0	0	52442	0	Dilated_cardiomyopathy_1Y|Hypertrophic_cardiomyopathy	criteria_provided,_single_submitter	NC_000015.10:g.63044030G>A	ClinGen:CA018647|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00001|OMIM:191010.0005|UniProtKB:P09493#VAR_043986	C2678476|C0007194	611878	154|54260|217569	.	Glu	Lys	89.83	0.5824742268041238																																																																																																																																																																																																																																																																																																																																																																																																																																																																													113			89.83	Negatively-charged	Glutamic Acid		Tropomyosin alpha-1 chain	Coiled coil									-3.5								 E40-S36 (PAE:  3.5), E40-V44 (PAE: 2.0)		 E40-S36 (PAE:  3.5), E40-V44 (PAE: 2.0)								146									-61.2				-45.4				dbSNP: rs104894501; Variant type: LP/P; AA change: Glu40Lys; PTM type: Ubiquitylation; PTM morphology: AEDRSkQLE*DE; Var class: II&rs104894501		H (helix)	H (α-helix)												89.83	58.24742	70-90	10-90	611878	autosomal dominant	OMIM	Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3	CARDIOMYOPATHY, DILATED, 1Y	false	0.6201716793644667	0.6360076527650166	false	false	false
TH	TH_Gln39Glu	B_7-8	-5.7937417648487886	0.010229924714018282	0.027636713159511907	-7.418120684288637	0.000308607045835826	0.000948566045408276	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5853494609116798	0.6604660927970618	0.7778064371735336	0.6606616691383036	0.5656733577450225	0.8461854752977827	0.8461854752977827	0.7387537843167947	0.7350000684102183	0.7778064371735336	0.7272097506850339			0.3925929311732503	0.5863232698663889		0.5937224349090897	0.5853494609116798	TH	Gln39Glu	NC_000011.10:2169847:G:C	115C>G	11	2169847	G	C	11	ENSG00000180176	71892	4025	CCSBVarC008302	ALE00008288	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	C12	GDEhDisVCh_40019	A12	1	VUSMutGDDh015	C12	VUSN2Hmut_GDN2h_05	G01	VUSMutpDEST2_15	A10	VUSmut_GDEh05	G01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	326011.0	single nucleotide variant	NM_000360.4(TH):c.115C>G (p.Gln39Glu)	7054.0	TH	HGNC:11782	Uncertain significance	0.0	Aug 23, 2022	886048115.0	-	RCV000323008	MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150	Autosomal recessive DOPA responsive dystonia	germline	germline	GRCh38	NC_000011.10	11	2169847.0	2169847.0	11p15.5	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA10638157	2.0	304085.0	2169847.0	G	C	-	-	-	-	-	-	115C>G 	Gln39Glu	NM_000360.4	2.0	VUS	VUS	304085	11	2169847.0	G	C	Q	E	rs886048115	11	2191077	11	2147653	70	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.208C>G	p.Gln70Glu	c.208C>G	p.Gln70Glu	.	Y	1	.	.	-	CAG	1	0	G	G/G	G/G	G/G	G/G	0.063	0.63383	T	0.27	0.34224	T	0.236	0.30787	B	0.312	0.41466	B	0.12	0.31989	N	simple_aae	88.0	12.0	1.76	0.45540	L	-0.81	0.27007	N	0.476	0.55747	0.9699	0.96690	D	0.9266	0.97570	D	10	0.6145692	0.67350	D	0.873203	0.99029	D	0.463	0.75827	0.233	0.16068	P07101	Q70E	Loss of MoRF binding (P = 0.0524)| Gain of relative solvent accessibility (P = 0.1259)| Gain of methylation at R68 (P = 0.1494)| Gain of solvent accessibility (P = 0.1903)| Gain of helix (P = 0.2059)	0.936910906656	0.93576	0.4947894399190836	0.49204	0.137785876348	0.15276	0.761887550354	0.76169	T	0.442295	0.78491	T	0.161736	0.70144	D	-0.00545437	0.69761	D	0.84101140499115	0.49137	D	0.962404	0.85894	D	0.11179718	0.26181	0.16783185	0.38572	0.11179718	0.26181	0.16783185	0.38571	-6.39	0.52215	T	0.2531	0.54016	B	0.319414609427749	0.54936	0.97618160	0.95163	0.045	0.11391	.	.	.	.	.	.	2.481447	0.32056	18.91	0.98472037381021738	0.41998	.	.	.	-0.184951872080205	0.33483	1.919061	-0.187835856813197	0.31668	1.815161	3.55	1.41	0.21407	1.71	0.36417	3.522	0.53328	9.446000	0.80871	-0.161	0.11601	1.0	0.71675	1.000000	0.68239	0.072	0.1681	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8	1610366	4.967810e-06	0	8	1179590	6.782020e-06	0	0	74980	0.000000e+00	0	0	912	0.000000e+00	0	0	59946	0.000000e+00	0	0	29548	0.000000e+00	0	0	44836	0.000000e+00	0	0	62512	0.000000e+00	0	0	4828	0.000000e+00	0	8	1179590	6.782020e-06	0	0	90972	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Autosomal_recessive_DOPA_responsive_dystonia	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.2169847G>C	ClinGen:CA10638157	C2673535	605407	101150	.	Gln	Glu	39.96	0.42424242424242425																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																39.96	42.424244	$\leqslant$50	10-90	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.6604660927970618	0.5853494609116798	false	false	false
SMAD3	SMAD3_Ser355Leu	B_15-16	-1.6947433507279288	0.13394834931330357	0.20699138122039631	-0.8972296535940535	0.39940186239459863	0.4529681195884354	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.7680439598044844	0.7561221976120003	0.5673734834331843	0.6941894755458999	0.6716611652529119	0.611465850098651	0.6415452499301373	0.7129494867186907	0.8145503179797982	0.6311764709866619	0.7969784233896828	0.797684110974678	0.5813864502671646	0.6303728437871329	0.5738286331120016	0.5035704958797068	0.7152659718343178	0.7384038086342908	SMAD3	Ser355Leu	NC_000015.10:67187419:C:T	1064C>T	15	67187419	C	T	15	ENSG00000166949	11805	2168	CCSBVarC007744	ALE00007730	ENSP00000332973.4	Edgotyping3	VUSMutGDEh005	B04	GDEhDisVCh_40014	G10	2	VUSMutGDDh005	B04	VUSN2Hmut_GDN2h_02	C01	VUSMutpDEST2_09	F06	VUSmut_GDEh02	C01	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	N	Y	Y	Y	210292.0	single nucleotide variant	NM_005902.4(SMAD3):c.1064C>T (p.Ser355Leu)	4088.0	SMAD3	HGNC:6769	Uncertain significance	0.0	Mar 09, 2023	752776110.0	-	RCV000196761|RCV003996913	MedGen:C3661900|MONDO:MONDO:0013426,MedGen:C3151087,OMIM:613795,Orphanet:284984	not provided|Aneurysm-osteoarthritis syndrome	germline	germline	GRCh38	NC_000015.10	15	67187419.0	67187419.0	15q22.33	criteria provided, multiple submitters, no conflicts	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA061579	2.0	213772.0	67187419.0	C	T	-	-	-	-	-	-	1064C>T 	Ser355Leu	NM_005902.4	2.0	VUS	VUS	213772	15	67187419.0	C	T	S	L	rs752776110	15	67479757	15	65266811	355	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.1064C>T	p.Ser355Leu	c.1064C>T	p.Ser355Leu	principal1	Y	1	YES	Select	+	TCG	2	0	C	C/C	C/C	C/C	C/C	0.023	0.61594	D	0.035	0.59495	D	0.807	0.45264	P	0.445	0.45920	B	0.89	0.93300	D	simple_aae	11.0	89.0	2.27	0.64340	M	-4.79	0.82986	D	0.848	0.84360	1.1053	0.99818	D	0.9457	0.98222	D	10	0.9113101	0.90390	D	0.193978	0.86300	D	0.901	0.97243	0.717	0.85159	P84022	S355L	Gain of helix (P = 0.1736)| Loss of loop (P = 0.2237)| Gain of stability (P = 0.3712)| Loss of disorder (P = 0.471)| Loss of MoRF binding (P = 0.5412)	0.990832486851	0.99062	0.9660793118492894	0.96575	1.791941562	0.91486	0.924586713314	0.98651	D	0.970902	0.99682	D	0.517112	0.94760	D	0.505019	0.94683	D	0.988173544406891	0.78383	D	0.979902	0.93212	D	0.80884343	0.84277	0.5695437	0.74826	0.80884343	0.84279	0.5695437	0.74827	-15.638	0.97558	D	0.9282	0.84827	P	0.99979322190633	0.98009	0.99207705	0.97076	0.871	0.93001	.	.	.	.	.	.	5.028314	0.83638	28.1	0.99908375458449483	0.97876	0.909306	0.86526	D	0.60016500589637	0.73041	5.925086	0.616602854998835	0.76015	6.437373	5.41	5.41	0.78283	3.79	0.69847	7.722	0.83782	7.676000	0.65104	0.594	0.32546	1.0	0.71675	1.000000	0.68239	0.406	0.26966	923	0.18499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109406	0.000000e+00	0	1	208134	4.804600e-06	0	0	236950	0.000000e+00	0	0	7162	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16216	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89558	1.116590e-05	0	0	30608	0.000000e+00	0	1	89558	1.116590e-05	0	0	14900	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	0	102748	0.000000e+00	0	0	30526	0.000000e+00	0	.	.	.	.	.	7	1614142	4.336670e-06	0	1	44880	2.228160e-05	0	0	75036	0.000000e+00	0	0	912	0.000000e+00	0	0	60022	0.000000e+00	0	0	29604	0.000000e+00	0	1	44880	2.228160e-05	0	0	64032	0.000000e+00	0	0	6062	0.000000e+00	0	6	1180012	5.084690e-06	0	0	91072	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Aneurysm-osteoarthritis_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000015.10:g.67187419C>T	ClinGen:CA061579	C3661900|C3151087	613795	284984	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Ser	Leu	94.46	0.03076923076923077																																																																																																																																																																																																																																																																																																																																																																																																																																																																													4			94.46	Polar/Neutral	Serine		Mothers against decapentaplegic homolog 3							MH2	0.0146		-0.8								 S355-L351 (PAE:  1.0)	S355-L351 (PDBs: 1MJS, 1MK2, 5XOC), S355-G359 (PDBs: 5XOC)	 S355-L351 (PAE:  1.0), S355-G359 (PAE: 1.5)	S355-L351 (PDBs: 1MJS, 5XOC), S355-G359 (PDBs: 1MJS, 1MK2, 5XOC)							105									-65.5		Pocket 3: Mean pLDDT: 64.24, Volume: 3139.95 Å³, Druggability score: 0.01		-24.0						H (helix)	H (α-helix)	Helix											94.46	3.0769231	>90	<10	613795	autosomal dominant	OMIM	Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2	LOEYS-DIETZ SYNDROME 3	false	0.7561221976120003	0.7680439598044844	false	false	false
SMAD3	SMAD3_Trp232Cys	B_15-16	-8.604777403381942	0.000057072976575916114	0.0006193715071590896	-8.602847499928926	0.00005715575556112543	0.00026485053397642716	2025_03_Batch_15-16	false	true	false	false	false	false	false	true	false	false	false	false	0.9612351923434012	0.9820800003897282	0.6654223405372801	0.8705380801261028	0.8290893556434856	0.8191693517689973	0.7400156070322119	0.8405209276994351	0.8110324386325585	0.7100913130968206	0.9847688729317994	0.9464136972809223	0.8983230965057828	0.8176577835875362	0.9300437216196471	0.6207533679777395	0.979391127847657	0.97605668740588	SMAD3	Trp232Cys	NC_000015.10:67181278:G:C	696G>C	15	67181278	G	C	15	ENSG00000166949	11805	2139	CCSBVarC007722	ALE00007708	ENSP00000332973.4	Edgotyping3	VUSMutGDEh004	E12	GDEhDisVCh_40014	D07	2	VUSMutGDDh004	E12	VUSN2Hmut_GDN2h_01	F10	VUSMutpDEST2_09	C03	VUSmut_GDEh01	F10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	Y	Y	Y	210275.0	single nucleotide variant	NM_005902.4(SMAD3):c.696G>C (p.Trp232Cys)	4088.0	SMAD3	HGNC:6769	Uncertain significance	0.0	Oct 26, 2017	778356642.0	-	RCV000198634	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000015.10	15	67181278.0	67181278.0	15q22.33	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA323169	2.0	213760.0	67181278.0	G	C	-	-	-	-	-	-	696G>C 	Trp232Cys	NM_005902.4	1.0	VUS	VUS	213760	15	67181278.0	G	C	W	C	rs778356642	15	67473616	15	65260670	232	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.696G>C	p.Trp232Cys	c.696G>C	p.Trp232Cys	principal1	Y	1	YES	Select	+	TGG	3	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	D	simple_aae	0.0	100.0	4.14	0.97479	H	-12.53	0.99879	D	0.967	0.98079	0.8991	0.95647	D	0.9967	0.99921	D	10	0.9864295	0.98941	D	0.821477	0.98609	D	0.936	0.98562	0.881	0.96866	P84022	W232C	Gain of catalytic residue at S234 (P = 0.0172)| Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of disorder (P = 0.3237)| Loss of glycosylation at P229 (P = 0.6843)	0.997579355193	0.99751	0.988478312534894	0.98838	3.0674637903	0.99314	0.89428126812	0.95777	D	0.990902	0.99962	D	0.588739	0.97323	D	0.607907	0.97280	D	0.999964356422424	0.99918	D	0.999608	0.99842	D	0.9905331	0.99787	0.96275264	0.99103	0.9905331	0.99787	0.96275264	0.99104	-13.677	0.93333	D	0.9999	0.99952	P	0.999958809336333	0.99183	0.99641340	0.98049	0.946	0.97496	.	.	.	.	.	.	6.082702	0.94526	34.0	0.99347637139010336	0.60509	0.928687	0.91298	D	1.06530743971235	0.97421	16.12609	0.965991003848059	0.97842	16.89889	5.1	5.1	0.68875	.	.	9.87	0.98471	11.754000	0.95479	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.998	0.85369	921	0.19236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000015.10:g.67181278G>C	ClinGen:CA323169	CN517202	.	.	SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type|SMAD domain, Dwarfin-type	Trp	Cys	95.43	0.07048458149779736																																																																																																																																																																																																																																																																																																																																																																																																																																																																													16			95.43	Aromatic	Tryptophan		Mothers against decapentaplegic homolog 3							MH2			-0.9								 W232-Q252 (PAE:  1.5), W232-A250 (PAE: 1.0), W232-N401 (PAE: 1.0)	W232-Q252 (PDBs: 1MJS, 5XOC), W232-N401 (PDBs: 1MJS, 1MK2, 5XOC), W232-A250 (PDBs: 5XOC)	 W232-N401 (PAE:  1.0)	W232-N401 (PDBs: 1MJS, 1MK2, 5XOC)							204									-75.3				-28.8						C (loop/coil)	S (bend)	Beta strand											95.43	7.048458	>90	<10		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.9820800003897282	0.9612351923434012	true	false	true
MLH1	MLH1_Ser295Thr	B_11-12	-5.508977801594286	0.007106063778041287	0.020977715326211527	-3.2483330107204096	0.04470036415113076	0.06408216266978511	2024_12_Batch_11-12	true	true	true	true	true	true	true	true	true	false	true	true	0.9780777545459836	0.9782432030429742	0.9671191269516082	0.9707155961640033	0.9840025377174417	0.9872102269750614		0.978931035005337		0.9600305284798955	0.97576465699234	0.9750296021962366	0.9872102269750614	0.9890740404295465	0.9707155961640033	0.9742077254233208	0.9807217490936084	0.9811259068957306	MLH1	Ser295Thr	NC_000003.12:37017599:G:C	884G>C	3	37017599	G	C	3	ENSG00000076242	2713	200850	CCSBVarC003202	ALE00003202	ENSP00000231790.3	CEGS2	CegsMutGDEh1044	A03	GDEhDisVCh_40019	H02	1	CegsMutGDDh1044	A03	VUSN2Hmut_GDN2h_09	A05	VUSMutpDEST2_02	H08	VUSmut_GDEh09	A05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	6.0	Y	Y	Y	N	Y	95890.0	single nucleotide variant	NM_000249.4(MLH1):c.884G>C (p.Ser295Thr)	4292.0	MLH1	HGNC:7127	Uncertain significance	1.0	Jun 13, 2018	63750144.0	-	RCV000075909|RCV000630082|RCV003452785	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0012249,MedGen:C1333991,OMIM:609310,Orphanet:144	Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|Colorectal cancer, hereditary nonpolyposis, type 2	germline;unknown	germline	GRCh38	NC_000003.12	3	37017599.0	37017599.0	3p22.2	reviewed by expert panel	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA012878,UniProtKB:P40692#VAR_012916	2.0	90416.0	37017599.0	G	C	-	-	-	-	-	-	884G>C 	Ser295Thr	NM_000249.4	3.0	VUS	VUS	90416	3	37017599.0	G	C	S	T	rs63750144	3	37059090	3	37034094	295	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.884G>C	p.Ser295Thr	c.884G>C	p.Ser295Thr	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.013	0.92967	D	0.986	0.61540	D	0.923	0.65825	D	1.0	0.99291	D	simple_aae	0.0	100.0	2.82	0.81940	M	-2.55	0.61161	D	0.746	0.79913	0.4399	0.89645	D	0.6044	0.85899	D	10	0.94928765	0.94196	D	0.248572	0.88989	D	0.894	0.96979	0.848	0.95057	P40692	S295T	Loss of stability (P = 0.0832)| Gain of catalytic residue at S295 (P = 0.1652)| Loss of loop (P = 0.2897)| Loss of disorder (P = 0.2999)| Loss of sheet (P = 0.302)	0.972414466802	0.97185	0.49435588644107525	0.49161	0.354849653055	0.36962	0.767698526382	0.77039	T	0.814587	0.95365	D	0.423914	0.91157	D	0.371147	0.91048	D	0.962290388955615	0.66111	D	0.962604	0.86554	D	0.911348	0.92308	0.75117254	0.85112	0.9053794	0.91751	0.7458156	0.84794	-11.117	0.86307	D	0.3344	0.68725	B	0.992692728921544	0.89645	0.99950540	0.99444	0.946	0.97496	.	.	.	.	.	.	6.553395	0.95401	35.0	0.99376984570292859	0.61769	0.932686	0.92315	D	0.966008038032389	0.94568	12.88554	0.879404328401345	0.94580	12.89785	5.05	5.05	0.67523	5.23	0.92191	9.591	0.97409	11.781000	0.96117	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.927	0.46372	234	0.90879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_nonpolyposis_colorectal_neoplasms|Colorectal_cancer,_hereditary_nonpolyposis,_type_2|Lynch_syndrome	reviewed_by_expert_panel	NC_000003.12:g.37017599G>C	ClinGen:CA012878|UniProtKB:P40692#VAR_012916	C0009405|C1333991|C4552100	609310	144|144	DNA mismatch repair protein, S5 domain 2-like|DNA mismatch repair protein, S5 domain 2-like	Ser	Thr	95.49	0.007692307692307693																																																																																																																																																																																																																																																																																																																																																																																																																																																																													1			95.49	Polar/Neutral	Serine		DNA mismatch repair protein Mlh1										-0.8								 S295-N243 (PAE:  1.0)	S295-N243 (PDBs: 4P7A)	 S295-N243 (PAE:  1.0), S295-H186 (PAE: 2.0)	S295-N243 (PDBs: 4P7A), S295-H186 (PDBs: 4P7A)							105									-123.0	Morphology: tHPFLyLsLEISPQN; Domain: DNA_mis_repair			112.6				dbSNP: rs63750144; Variant type: LP/P; AA change: Ser295Thr; PTM type: Phosphorylation; PTM morphology: PFLyLsLEISP; Var class: Ia&rs63750144		B (undefined)	E (parallel sheets)	Beta strand											95.49	0.7692308	>90	<10	609310	autosomal dominant	GenCC	Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3	LYNCH SYNDROME 2	true	0.9782432030429742	0.9780777545459836	true	true	true
MVK	MVK_Cys101Tyr	B_7-8	2.3033948515040046	0.06081680740371664	0.10876414058155316	2.704421905798014	0.03536738207506067	0.05225374082748496	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5508749080457556	0.5787498319992664	0.4880696140999528	0.5163511601833137	0.5193419285659562	0.49231087554577235	0.4289561171593392	0.5220196077365433	0.5146210352403	0.39316170259299565	0.597688307203979	0.6110529133692919	0.5556656339322056	0.5166642493953691	0.5180812851263273	0.58297752560691	0.5598113567945538	0.49069690272221916	MVK	Cys101Tyr	NC_000012.12:109579877:G:A	302G>A	12	109579877	G	A	12	ENSG00000110921	281	7	CCSBVarC007118	ALE00007116	ENSP00000228510.3	Edgotyping3	VUSMutGDEh009	F11	GDEhDisVCh_40020	C06	2	VUSMutGDDh009	F11	VUSN2Hmut_GDN2h_03	C04	VUSMutpDEST2_01	F01	VUSmut_GDEh03	C04	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	330396.0	single nucleotide variant	NM_000431.4(MVK):c.302G>A (p.Cys101Tyr)	4598.0	MVK	HGNC:7530	Uncertain significance	0.0	Jan 13, 2018	886048931.0	-	RCV000284532|RCV000395752	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343|MONDO:MONDO:0012481,MedGen:C1959626,OMIM:610377,Orphanet:29	Hyperimmunoglobulin D with periodic fever|Mevalonic aciduria	germline	germline	GRCh38	NC_000012.12	12	109579877.0	109579877.0	12q24.11	criteria provided, single submitter	1.0	-	N	ClinGen:CA10640830	2.0	307092.0	109579877.0	G	A	-	-	-	-	-	-	302G>A 	Cys101Tyr	NM_000431.4	1.0	VUS	VUS	307092	12	109579877.0	G	A	C	Y	rs886048931	12	110017682	12	108502065	101	MVK	ENSG00000110921	ENST00000546277	ENSP00000438153	Q03426	KIME_HUMAN	c.302G>A	p.Cys101Tyr	c.302G>A	p.Cys101Tyr	principal1	Y	5	.	.	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.203	0.33234	T	0.081	0.49742	T	0.956	0.54679	P	0.163	0.34894	B	.	.	.	.	.	.	2.28	0.64737	M	-1.54	0.38336	N	.	0.38805	-0.3411	0.73695	T	0.5429	0.83107	D	10	0.15691093	0.29195	T	0.087367	0.74839	D	0.396	0.70929	0.401	0.42936	Q03426	C101Y	Gain of solvent accessibility (P = 9e-04)| Gain of loop (P = 0.0045)| Loss of helix (P = 0.0093)| Gain of relative solvent accessibility (P = 0.0098)| Gain of phosphorylation at C101 (P = 0.0292)	0.863369914647	0.86097	.	0.45042	.	0.56287	0.321210920811	0.13593	T	0.184052	0.53429	T	0.0858659	0.62456	D	-0.114436	0.61987	T	0.0730041263245871	0.08957	T	.	0.29080	.	0.14424701	0.32839	0.09655802	0.22908	0.14424701	0.32838	0.09655802	0.22908	-4.048	0.24542	T	0.0905	0.22167	LB	0.717221420933905	0.67621	0.97579247	0.95128	0.57	0.75822	.	.	.	.	.	.	1.324563	0.17318	13.07	0.46105363416051176	0.03704	0.102140	0.20288	N	-0.525985011790723	0.20990	1.125913	-0.606981515530156	0.19015	1.03564	5.07	1.83	0.24213	0.67	0.26457	0.598	0.23859	0.831000	0.22030	0.676	0.76753	0.0	0.06393	0.000000	0.08389	0.03	0.13148	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hyperimmunoglobulin_D_with_periodic_fever|Mevalonic_aciduria	criteria_provided,_single_submitter	NC_000012.12:g.109579877G>A	ClinGen:CA10640830	C0398691|C1959626	260920|610377	343|29	.	Cys	Tyr	84.84	0.07407407407407407																																																																																																																																																																																																																																																																																																																																																																																																																																																																													10			84.84	Special, a very reactive sulfhydryl group	Cysteine		Mevalonate kinase										2.5								 C101-R106 (PAE:  3.5)	C101-E105 (PDBs: 2R3V)	 C101-R106 (PAE:  3.5)	C101-R106 (PDBs: 2R3V), C101-L97 (PDBs: 2R3V)							121									-54.6				132.3						C (loop/coil)	C (loop/coil)												84.84	7.4074073	70-90	<10	260920;610377	autosomal recessive	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME; MEVALONIC ACIDURIA	false	0.5787498319992664	0.5508749080457556	false	false	false
LITAF	LITAF_Pro84Leu	B_15-16	1.3262248766655964	0.2263986615950635	0.30733578084333424	-8.474347220659835	0.00006298573477875578	0.0002860861963342001	2025_03_Batch_15-16	false	true	false	false	false	false	false	false	false	false	false	false	0.9470222201776852	0.9784719836353027	0.7628795242570743	0.7208710363117445	0.8869976365197347	0.7938677989874534	0.7739714744900288	0.8456924504386675	0.8714859464339463	0.7100825733515781	0.9717390244409196	0.9288413951912171	0.8137641234848781	0.9283028226008021	0.5702561261895429	0.8156764751625705	0.9852049428296858	0.9652030451641533	LITAF	Pro84Leu	NC_000016.10:11553659:G:A	251C>T	16	11553659	G	A	16	ENSG00000189067	52920	2681	CCSBVarC007939	ALE00007925	ENSP00000483114.1	Edgotyping3	VUSMutGDEh007	B01	GDEhDisVCh_40036	G06	2	VUSMutGDDh007	B01	VUSN2Hmut_GDN2h_02	D06	VUSMutpDEST2_12	D01	VUSmut_GDEh02	D06	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	244941.0	single nucleotide variant	NM_001136472.2(LITAF):c.251C>T (p.Pro84Leu)	9516.0	LITAF	HGNC:16841	Uncertain significance	0.0	Jun 16, 2023	761746674.0	-	RCV000236418|RCV001857800	MedGen:C3661900|MONDO:MONDO:0010995,MedGen:C0270913,OMIM:601098,Orphanet:101083	not provided|Charcot-Marie-Tooth disease type 1C	germline	germline	GRCh38	NC_000016.10	16	11553659.0	11553659.0	16p13.13	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA7904101	2.0	245794.0	11553659.0	G	A	-	-	-	-	-	-	251C>T 	Pro84Leu	NM_001136472.2	2.0	VUS	VUS	245794	16	11553659.0	G	A	P	L	rs761746674	16	11647515	16	11555016	84	LITAF	ENSG00000189067	ENST00000574763	ENSP00000461813	Q99732	LITAF_HUMAN	c.251C>T	p.Pro84Leu	c.251C>T	p.Pro84Leu	principal1	Y	3	.	.	-	CCC	2	0	G	G/G	G/G	G/G	G/G	.	0.50291	.	0.067	0.44651	T	0.651	0.40723	P	0.084	0.29272	B	0.26	0.52324	N	simple_aae	74.0	26.0	1.995	0.53920	M	.	0.51010	.	0.672	0.70474	0.4557	0.89879	D	0.7604	0.91818	D	10	0.7308649	0.74046	D	0.087941	0.74953	D	.	0.82027	.	.	.	.	.	0.979593007013	0.97916	.	0.60242	.	0.43205	0.546142220497	0.45247	T	0.624612	0.88166	D	0.205058	0.74173	D	0.120421	0.78102	D	0.605903523112585	0.36326	D	0.936606	0.77541	D	0.07649278	0.17145	0.08779399	0.20403	0.07649278	0.17145	0.08779399	0.20402	-8.711	0.65895	D	0.4658	0.70143	A	0.969079740075641	0.83119	0.97659560	0.95200	0.144	0.37362	.	.	.	.	.	.	3.29571	0.45298	22.1	0.9940741916894722	0.63173	0.786339	0.71541	D	0.303884212031795	0.56124	3.799354	0.29597353962584	0.55068	3.693578	5.28	5.28	0.74083	.	.	5.116	0.64578	11.565000	0.93261	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.142	0.20063	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	1	109378	9.142610e-06	0	5	207982	2.404050e-05	0	4	236568	1.690850e-05	0	0	7160	0.000000e+00	0	0	17106	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13388	0.000000e+00	0	1	42764	2.338420e-05	0	0	15680	0.000000e+00	0	1	42764	2.338420e-05	0	0	16196	0.000000e+00	0	0	30508	0.000000e+00	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16728	0.000000e+00	0	5	89480	5.587840e-05	0	0	30594	0.000000e+00	0	5	89480	5.587840e-05	0	0	14898	0.000000e+00	0	0	34244	0.000000e+00	0	0	9552	0.000000e+00	0	0	17692	0.000000e+00	0	0	21606	0.000000e+00	0	4	102456	3.904110e-05	0	0	30512	0.000000e+00	0	4	102456	3.904110e-05	0	.	17	1614022	1.053270e-05	0	1	59994	1.666830e-05	0	1	74918	1.334790e-05	0	0	910	0.000000e+00	0	1	59994	1.666830e-05	0	0	29608	0.000000e+00	0	0	44894	0.000000e+00	0	0	64028	0.000000e+00	0	0	6084	0.000000e+00	0	14	1180024	1.186420e-05	0	0	91082	0.000000e+00	0	4	42734	9.360228389572705E-5	0	306	0	0	112	0	0	8044	0	0	500	0	0	628	0	0	56	0	0	98	0	1	8298	1.2051096649795132E-4	0	8350	0	0	168	0	5	60776	8.2269316835593E-5	not_provided|Charcot-Marie-Tooth_disease_type_1C	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.11553659G>A	ClinGen:CA7904101	C3661900|C0270913	601098	101083	LPS-induced tumour necrosis factor alpha factor	Pro	Leu	71.66	0.8823529411764706																																																																																																																																																																																																																																																																																																																																																																																																																																																																													120			71.66	Special, No backbone hydrogen	Proline		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF	0.0003		1.6																		115									-59.6		Pocket 4: Mean pLDDT: 64.08, Volume: 255.16 Å³, Druggability score: 0		101.6						C (loop/coil)	C (loop/coil)												71.66	88.2353	70-90	10-90	601098	autosomal dominant	OMIM	Rare genetic neurological disorder	1	CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C	false	0.9784719836353027	0.9470222201776852	true	false	false
DES	DES_Arg278Pro	B_7-8	-0.5999042892953972	0.5705160197057937	0.6482365244723771	3.7407240209770323	0.007255868264705601	0.012989773917790026	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8576963583475921	0.8326214762987364	0.755796457849552	0.8365617250445476	0.8301874001916328	0.7921060106301849	0.9923133261672235	0.96087477267917	0.9861469323507289	0.9688424935754356	0.8256212217307016	0.8576963583475921	0.5918986950931464	0.6995000277040957	0.6869765177383664	0.5427504221236682	0.8396217308667712		DES	Arg278Pro	NC_000002.12:219420592:G:C	833G>C	2	219420592	G	C	2	ENSG00000175084	12573	2279	CCSBVarC007839	ALE00007825	ENSP00000363071.3	Edgotyping3	VUSMutGDEh003	E07	GDEhDisVCh_40003	G07	1	VUSMutGDDh003	E07	VUSN2Hmut_GDN2h_01	H03	NULL	NULL	VUSmut_GDEh01	H03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	Y	Y	Y	N	Y	198125.0	single nucleotide variant	NM_001927.4(DES):c.833G>C (p.Arg278Pro)	1674.0	DES	HGNC:2770	Uncertain significance	0.0	Feb 06, 2020	761475402.0	-	RCV000183374|RCV001342240	MedGen:C3661900|MONDO:MONDO:0011076,MedGen:C1832370,OMIM:601419,Orphanet:363543,Orphanet:98909	not provided|Desmin-related myofibrillar myopathy	germline	germline	GRCh38	NC_000002.12	2	219420592.0	219420592.0	2q35	criteria provided, multiple submitters, no conflicts	2.0	ACMG2022	N	ClinGen:CA308319	2.0	201723.0	219420592.0	G	C	-	-	-	-	-	-	833G>C 	Arg278Pro	NM_001927.4	2.0	VUS	VUS	201723	2	219420592.0	G	C	R	P	rs761475402	2	220285314	2	219993558	278	DES	ENSG00000175084	ENST00000373960	ENSP00000363071	P17661	DESM_HUMAN	c.833G>C	p.Arg278Pro	c.833G>C	p.Arg278Pro	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.815	0.99664	H	-6.44	0.91373	D	0.941	0.94798	1.0518	0.98152	D	0.9363	0.97899	D	10	0.9858402	0.98848	D	0.339429	0.91956	D	0.896	0.97054	0.89	0.97304	P17661	R278P	Loss of MoRF binding (P = 0.0186)| Loss of stability (P = 0.0879)| Loss of catalytic residue at R278 (P = 0.1174)| Gain of phosphorylation at T283 (P = 0.1507)| Loss of helix (P = 0.1706)	0.990118346493	0.98989	0.9825296663198477	0.98236	1.76066134508	0.91089	0.786747097969	0.79912	T	0.955713	0.99386	D	0.531597	0.95149	D	0.525826	0.95077	D	0.999688148498535	0.98469	D	0.983202	0.94307	D	0.9819465	0.99242	0.9750921	0.99661	0.9819465	0.99242	0.9750921	0.99662	-16.858	0.98789	D	0.9994	0.98903	P	0.999917712863974	0.98806	0.99733895	0.98344	0.985	0.99487	.	.	.	.	.	.	6.47378	0.95276	34.0	0.99774613820726499	0.86185	0.992594	0.99998	D	0.989779301215551	0.95396	13.60425	0.837677593383323	0.92232	11.33404	4.67	3.79	0.42689	4.05	0.77340	10.003	0.9969	11.906000	0.99485	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	86	0.96402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Desmin-related_myofibrillar_myopathy|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.219420592G>C	ClinGen:CA308319	C1832370|C3661900	601419	363543|98909	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Pro	90.47	0.7782258064516129																																																																																																																																																																																																																																																																																																																																																																																																																																																																													193			90.47	Positively-charged	Arginine		Desmin							IF rod			-4.5								 R278-E282 (PAE:  2.5), R278-L274 (PAE: 1.5)		 R278-E282 (PAE:  2.5), R278-L274 (PAE: 1.5)								175									-62.6				-44.8	Interaction with NEB; Coil 2A					H (helix)	H (α-helix)												90.47	77.82258	>90	10-90	601419	multiple	OMIM	Rare genetic cardiac disease; Rare genetic neurological disorder	2	MYOPATHY, MYOFIBRILLAR, 1	false	0.8326214762987364	0.8576963583475921	false	false	false
COMP	COMP_Asp319Val	B_7-8	-1.8497832021564953	0.1614594513937135	0.23776989372551488	2.9165570338947635	0.022449831624268887	0.034911390703841874	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.9581457242447955	0.9576350051606817	0.8080976092365112	0.7755871840629245	0.7287425399760985	0.8202738581014491	0.8202738581014491	0.7161876705844907	0.7804653486770222	0.8080976092365112	0.9452600207017838	0.9581457242447955		0.7412974093677064	0.7707090194488267		0.9700099896195796		COMP	Asp319Val	NC_000019.10:18788231:T:A	956A>T	19	18788231	T	A	19	ENSG00000105664	56661	3363	CCSBVarC008150	ALE00008136	ENSP00000222271.2	Edgotyping3	VUSMutGDEh015	F08	GDEhDisVCh_40037	B12	1	VUSMutGDDh015	F08	VUSN2Hmut_GDN2h_04	H09	VUSMutpDEST2_13	C09	VUSmut_GDEh04	H09	1.0	6.0	1.0	5.0	1.0	6.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	N	N	N	Y	Y	360536.0	single nucleotide variant	NM_000095.3(COMP):c.956A>T (p.Asp319Val)	1311.0	COMP	HGNC:2227	Uncertain significance	0.0	Nov 30, 2016	1057517970.0	-	RCV000414567	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000019.10	19	18788231.0	18788231.0	19p13.11	criteria provided, single submitter	1.0	-	N	ClinGen:CA16043182	2.0	372764.0	18788231.0	T	A	-	-	-	-	-	-	956A>T 	Asp319Val	NM_000095.3	1.0	VUS	VUS	372764	19	18788231.0	T	A	D	V	rs1057517970	19	18899040	19	18760040	319	COMP	ENSG00000105664	ENST00000222271	ENSP00000222271	P49747	COMP_HUMAN	c.956A>T	p.Asp319Val	c.956A>T	p.Asp319Val	principal1	Y	1	YES	Select	-	GAC	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.032	0.56982	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	D	simple_aae	0.0	100.0	3.86	0.95772	H	-8.44	0.97214	D	0.837	0.96546	0.9134	0.95851	D	0.9971	0.99930	D	10	0.9375209	0.93003	D	0.965503	0.99781	D	0.963	0.99463	0.447	0.50489	P49747	D319V	Gain of catalytic residue at D319 (P = 0.0021)| Loss of helix (P = 0.2662)| Loss of loop (P = 0.3664)| Loss of solvent accessibility (P = 0.4218)| Gain of sheet (P = 0.4423)	0.956484479852	0.95565	0.9952554930384253	0.99522	.	.	0.696335792542	0.66559	T	0.990542	0.99959	D	0.424195	0.91173	D	0.371551	0.91064	D	0.974376164387585	0.70282	D	0.9974	0.98962	D	0.9757681	0.98749	0.94914746	0.98323	0.98403347	0.99391	0.95806706	0.98850	-20.33	0.99954	D	0.9893	0.94148	P	0.999624988091362	0.97231	0.99025345	0.96770	0.961	0.98360	.	.	.	.	.	.	5.461839	0.91186	32.0	0.99240553613495408	0.56601	0.949709	0.96247	D	0.787614298985284	0.85243	8.542318	0.621099494749011	0.76343	6.497738	3.68	3.68	0.41290	.	.	7.865	0.85503	7.757000	0.68285	0.598	0.34656	1.0	0.71675	1.000000	0.68239	0.012	0.09703	867	0.32049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_specified	criteria_provided,_single_submitter	NC_000019.10:g.18788231T>A	ClinGen:CA16043182	CN169374	.	.	.	Asp	Val	97.93	0.10429447852760736																																																																																																																																																																																																																																																																																																																																																																																																																																																																													17			97.93	Negatively-charged	Aspartic Acid		Cartilage oligomeric matrix protein										-3.5								 D319-N333 (PAE:  1.0)	D319-D315 (PDBs: 3FBY), D319-N333 (PDBs: 3FBY)	 D319-D315 (PAE:  1.0), D319-N333 (PAE: 1.0), D319-R332 (PAE: 1.5)	D319-D315 (PDBs: 3FBY), D319-N333 (PDBs: 3FBY)							132									-80.0				-12.2	Disordered		TSP type-3 2			C (loop/coil)	S (bend)	Beta strand											97.93	10.429448	>90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	2		false	0.9576350051606817	0.9581457242447955	true	true	false
SMAD3	SMAD3_Cys109Tyr	B_15-16	-7.2586046156903405	0.00016867116076930302	0.0012926039533242835	-9.05084304494648	0.000041121733188140844	0.00020673528876777658	2025_03_Batch_15-16	true	true	false	false	false	false	true	true	false	false	false	false	0.981410024471585	0.9949838937682689	0.534949383254513	0.7683355951373773	0.6836564037168145	0.5898557976916856	0.5441546866100851	0.6466810094293242	0.8070825959383232	0.4504153382104007	0.9955760576259024	0.9785425210246974	0.6355569087732862	0.7206317980043047	0.7295885943364313	0.6194834282986253	0.9943917299106355	0.9842775279184726	SMAD3	Cys109Tyr	NC_000015.10:67165014:G:A	326G>A	15	67165014	G	A	15	ENSG00000166949	11805	2123	CCSBVarC007710	ALE00007696	ENSP00000332973.4	Edgotyping3	VUSMutGDEh004	G10	GDEhDisVCh_40014	G05	2	VUSMutGDDh004	G10	VUSN2Hmut_GDN2h_01	A10	VUSMutpDEST2_09	E01	VUSmut_GDEh01	A10	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	6.0	1.0	1.0	1.0	2.0	Y	Y	Y	N	Y	242102.0	single nucleotide variant	NM_005902.4(SMAD3):c.326G>A (p.Cys109Tyr)	4088.0	SMAD3	HGNC:6769	Uncertain significance	0.0	Feb 07, 2020	878854814.0	-	RCV000229038	MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000015.10	15	67165014.0	67165014.0	15q22.33	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA10583258	2.0	240268.0	67165014.0	G	A	-	-	-	-	-	-	326G>A 	Cys109Tyr	NM_005902.4	1.0	VUS	VUS	240268	15	67165014.0	G	A	C	Y	rs878854814	15	67457352	15	65244406	109	SMAD3	ENSG00000166949	ENST00000327367	ENSP00000332973	P84022	SMAD3_HUMAN	c.326G>A	p.Cys109Tyr	c.326G>A	p.Cys109Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.94	0.94378	D	simple_aae	6.0	94.0	3.82	0.95483	H	-10.79	0.99200	D	0.989	0.99676	1.0726	0.98658	D	0.9730	0.99152	D	10	0.9858038	0.98842	D	0.641413	0.96939	D	0.954	0.99189	0.86	0.95750	P84022	C109Y	Gain of disorder (P = 0.0741)| Loss of sheet (P = 0.0817)| Gain of phosphorylation at C109 (P = 0.0857)| Loss of loop (P = 0.2237)| Gain of methylation at R104 (P = 0.3356)	0.986201186875	0.98590	0.9929561434140868	0.99290	3.18632837919	0.99465	0.933786809444	0.99187	D	0.957652	0.99427	D	0.590326	0.97337	D	0.610186	0.97294	D	0.999905705451965	0.99626	D	0.999058	0.99584	D	0.99407214	0.99935	0.98751056	0.99956	0.99407214	0.99935	0.98751056	0.99957	-11.596	0.82879	D	0.9999	0.99795	P	0.999947825746043	0.99079	0.99655390	0.98090	0.656	0.80866	.	.	.	.	.	.	5.663577	0.92898	33.0	0.97560413731590434	0.34789	0.957663	0.97690	D	1.0080443476891	0.95965	14.17718	0.884182624018134	0.94816	13.09115	4.39	4.39	0.52154	3.79	0.69847	9.772	0.98164	11.835000	0.97650	0.671	0.69477	1.0	0.71675	1.000000	0.68239	0.998	0.85369	927	0.17628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_single_submitter	NC_000015.10:g.67165014G>A	ClinGen:CA10583258	C4707243	PS607086	91387	MAD homology 1, Dwarfin-type|MAD homology, MH1|MAD homology 1, Dwarfin-type	Cys	Tyr	96.21	0.037037037037037035																																																																																																																																																																																																																																																																																																																																																																																																																																																																													5			96.21	Special, a very reactive sulfhydryl group	Cysteine	Zn(2+)	Mothers against decapentaplegic homolog 3							MH1			2.5								 C109-H126 (PAE:  1.0)		 C109-C121 (PAE:  1.0), C109-H126 (PAE: 1.0)	C109-H126 (PDBs: 1MHD)							121									-89.4				92.0						C (loop/coil)	C (loop/coil)												96.21	3.7037036	>90	<10		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.9949838937682689	0.981410024471585	true	true	true
TPM1	TPM1_Glu23Gln	B_15-16	-1.084672190848009	0.4777797621296539	0.5212698857964566	-0.2952395705313104	1.0	1.0	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6471100016921724	0.6503507111308771	0.6781795685824097	0.6703391428093374	0.6933814113943935	0.7131763198211549	0.7745962641160419	0.6799506816642054	0.6367214428435191	0.765982838860259	0.6325302670810412	0.6092883624923456	0.6517563755262681	0.7068121411245815	0.7039568427751557	0.5903762983045603	0.668171155180713	0.6849316408919991	TPM1	Glu23Gln	NC_000015.10:63042896:G:C	67G>C	15	63042896	G	C	15	ENSG00000140416	4723	201725	CCSBVarC005631	ALE00005631	ENSP00000288398.6	CEGS2	CegsMutGDEh1043	E10	GDEhDisVCh_40050	G09	2	CegsMutGDDh1043	E10	VUSN2Hmut_GDN2h_09	G03	VUSMutpDEST2_04	H05	VUSmut_GDEh09	G03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	40553.0	single nucleotide variant	NM_001018005.2(TPM1):c.67G>C (p.Glu23Gln)	7168.0	TPM1	HGNC:12010	Uncertain significance	0.0	Dec 06, 2022	199476302.0	-	RCV000024589|RCV001053173	MedGen:C3661900|Human Phenotype Ontology:HP:0001639,MONDO:MONDO:0005045,MeSH:D002312,MedGen:C0007194,Orphanet:217569	not provided|Hypertrophic cardiomyopathy	germline	germline	GRCh38	NC_000015.10	15	63042896.0	63042896.0	15q22.2	criteria provided, single submitter	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA019276,Leiden Muscular Dystrophy (TPM1):TPM1_00024	2.0	31893.0	63042896.0	G	C	-	-	-	-	-	-	67G>C 	Glu23Gln	NM_001018005.2	1.0	VUS	VUS	31893	15	63042896.0	G	C	E	Q	rs199476302	15	63335095	15	61122148	23	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.67G>C	p.Glu23Gln	c.67G>C	p.Glu23Gln	alternative1	Y	1	YES	Select	+	GAG	1	0	G	G/G	G/G	G/G	G/G	0.002	0.78662	D	0.271	0.48688	T	0.924	0.77914	P	0.798	0.75172	P	0.79	0.86984	D	simple_aae	21.0	79.0	3.54	0.93069	H	-1.38	0.38336	N	0.802	0.80207	1.0544	0.98208	D	0.9358	0.97882	D	10	0.62605613	0.67969	D	0.389066	0.93132	D	0.606	0.84430	0.17	0.07491	Q6ZN40	E23Q	Gain of MoRF binding (P = 0.0513)| Loss of methylation at R21 (P = 0.5245)| Loss of stability (P = 0.5682)| Gain of solvent accessibility (P = 0.5843)| Loss of helix (P = 0.6555)	0.916439570321	0.91496	.	0.88458	.	0.96801	0.697293639183	0.66698	T	0.670741	0.90125	D	0.277473	0.80961	D	0.160795	0.80715	D	0.990586340427399	0.80660	D	0.915108	0.94271	D	0.74762887	0.80498	0.53185207	0.72693	0.6821462	0.76826	0.50946385	0.71395	-5.584	0.46621	T	0.4901	0.67391	A	0.998181312605058	0.94079	0.99892910	0.99043	0.521	0.72793	.	.	.	.	.	.	5.439393	0.90928	32.0	0.99230354840988322	0.56283	0.946956	0.95682	D	0.622116447919551	0.74438	6.156055	0.544350560789529	0.70847	5.589423	4.61	3.7	0.41539	.	.	7.918	0.86946	11.580000	0.93346	0.67	0.6921	1.0	0.71675	1.000000	0.68239	0.993	0.69292	786	0.46777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Hypertrophic_cardiomyopathy	criteria_provided,_single_submitter	NC_000015.10:g.63042896G>C	ClinGen:CA019276|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00024	C3661900|C0007194	.	217569	.	Glu	Gln	81.45	0.654639175257732																																																																																																																																																																																																																																																																																																																																																																																																																																																																													127			81.45	Negatively-charged	Glutamic Acid		Tropomyosin alpha-1 chain	Coiled coil	Basic and acidic residues								-3.5								 E23-A27 (PAE:  3.0), E23-L19 (PAE: 4.0)		 E23-A27 (PAE:  3.0), E23-L19 (PAE: 4.0)								146									-64.3				-43.3	Disordered					H (helix)	H (α-helix)	Helix											81.45	65.46392	70-90	10-90		unknown		Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3		false	0.6503507111308771	0.6471100016921724	false	false	false
TH	TH_Thr283Met	B_7-8	-4.805128036937354	0.01715817096343997	0.04076132654250043	-4.369233612256514	0.02217531454051988	0.03457238927940015	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6731080656350659	0.7084598202400227	0.528960125784655	0.5255293830290575	0.4821049975345105	0.5153599260834907	0.5153599260834907	0.4821049975345105	0.5255293830290575	0.528960125784655	0.7084598202400227	0.6731080656350659							TH	Thr283Met	NC_000011.10:2166762:G:A	848C>T	11	2166762	G	A	11	ENSG00000180176	71892	4005	CCSBVarC008286	ALE00008272	ENSP00000325951.4	Edgotyping3	VUSMutGDEh015	B10	GDEhDisVCh_40019	A10	1	VUSMutGDDh015	B10	VUSN2Hmut_GDN2h_04	D11	VUSMutpDEST2_15	H07	VUSmut_GDEh04	D11	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	27369.0	single nucleotide variant	NM_000360.4(TH):c.848C>T (p.Thr283Met)	7054.0	TH	HGNC:11782	Uncertain significance	1.0	Mar 10, 2017	121917764.0	-	RCV000013123	MONDO:MONDO:0011551,MedGen:C2673535,OMIM:605407,Orphanet:101150	Autosomal recessive DOPA responsive dystonia	germline;unknown	germline	GRCh38	NC_000011.10	11	2166762.0	2166762.0	11p15.5	criteria provided, single submitter	2.0	-	N	ClinGen:CA278133,UniProtKB:P07101#VAR_014029,OMIM:191290.0007	3.0	12330.0	2166762.0	G	A	-	-	-	-	-	-	848C>T 	Thr283Met	NM_000360.4	1.0	VUS	VUS	12330	11	2166762.0	G	A	T	M	rs121917764	11	2187992	11	2144568	314	TH	ENSG00000180176	ENST00000381178	ENSP00000370571	P07101	TY3H_HUMAN	c.941C>T	p.Thr314Met	c.941C>T	p.Thr314Met	.	Y	1	.	.	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	0.99	0.97926	D	simple_aae	1.0	99.0	4.2	0.97779	H	-5.5	0.85874	D	0.876	0.87350	0.9307	0.96100	D	0.9940	0.99862	D	9	0.9895524	0.99418	D	0.984162	0.99923	D	0.939	0.98671	0.957	0.99533	P07101	T314M	Loss of phosphorylation at T314 (P = 0.0781)| Gain of methylation at R319 (P = 0.1401)| Loss of catalytic residue at T314 (P = 0.144)| Gain of MoRF binding (P = 0.1875)| Loss of disorder (P = 0.2592)	0.975963497245	0.97547	0.9165258968572103	0.91575	1.5901386893	0.88460	0.921825289726	0.98458	D	0.991738	0.99969	D	0.59328	0.97352	D	0.614429	0.97309	D	0.999060571193695	0.96022	D	0.975402	0.91293	D	0.94810903	0.96011	0.95537347	0.98695	0.9569529	0.96924	0.9664528	0.99291	-12.766	0.88620	D	0.828	0.81211	P	0.998028967835912	0.93858	0.99843070	0.98780	0.983	0.99413	.	.	.	.	.	.	5.703021	0.93137	33.0	0.99865582026979782	0.94371	0.888811	0.82163	D	0.761148923291464	0.83541	8.067741	0.581277791366391	0.73452	5.996752	3.32	3.32	0.37060	3.82	0.71118	6.268	0.72593	11.081000	0.85771	0.616	0.49504	1.0	0.71675	1.000000	0.68239	0.989	0.64309	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2632	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2716	0	0	108	0	0	11154	0	Autosomal_recessive_DOPA_responsive_dystonia	criteria_provided,_single_submitter	NC_000011.10:g.2166762G>A	ClinGen:CA278133|OMIM:191290.0007|UniProtKB:P07101#VAR_014029	C2673535	605407	101150	Aromatic amino acid hydroxylase, C-terminal|Aromatic amino acid hydroxylase, C-terminal|Tyrosine 3-monooxygenase, catalytic domain	Thr	Met	98.44	0.056338028169014086																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																98.44	5.633803	>90	<10	605407	autosomal recessive	OMIM	Rare genetic neurological disorder; Rare inborn errors of metabolism	2	SEGAWA SYNDROME, AUTOSOMAL RECESSIVE	false	0.7084598202400227	0.6731080656350659	false	false	false
MLH1	MLH1_Ile36Asn	B_11-12	-1.2311783465843094	0.3042810643954804	0.3910223335426786	0.8820639707383459	0.4421526758156034	0.49654232565583367	2024_12_Batch_11-12	true	true	false	false	true	false	true	true	false	false	false	false	0.9855010163327456	0.9886358502218764	0.8437188123034021	0.8134686195717858	0.870759776638039	0.8093485579831188		0.9188609472012037		0.8896212410110956	0.986202884747829	0.9814917207238548	0.8093485579831188	0.8226586060748745	0.8134686195717858	0.7978163835957084	0.9910688156959236	0.9895103119416362	MLH1	Ile36Asn	NC_000003.12:36993654:T:A	107T>A	3	36993654	T	A	3	ENSG00000076242	2713	461	CCSBVarC003190	ALE00003190	ENSP00000231790.3	Edgotyping3	VUSMutGDEh011	A08	GDEhDisVCh_40019	D05	1	VUSMutGDDh011	A08	VUSN2Hmut_GDN2h_03	B12	VUSMutpDEST2_02	A03	VUSmut_GDEh03	B12	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	N	Y	Y	Y	95112.0	single nucleotide variant	NM_000249.4(MLH1):c.107T>A (p.Ile36Asn)	4292.0	MLH1	HGNC:7127	Uncertain significance	0.0	Aug 05, 2020	267607707.0	-	RCV002417500	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000003.12	3	36993654.0	36993654.0	3p22.2	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	-	2.0	1786123.0	36993654.0	T	A	-	-	-	-	-	-	107T>A 	Ile36Asn	NM_000249.4	1.0	VUS	VUS	1786123	3	36993654.0	T	A	I	N	rs267607707	3	37035145	3	37010149	36	MLH1	ENSG00000076242	ENST00000231790	ENSP00000231790	P40692	MLH1_HUMAN	c.107T>A	p.Ile36Asn	c.107T>A	p.Ile36Asn	principal1	Y	1	YES	Select	+	ATT	2	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.003	0.76775	D	0.872	0.47917	P	0.751	0.56057	P	.	.	.	.	.	.	3.555	0.93221	H	-4.97	0.82092	D	0.824	0.81898	0.3266	0.87927	D	0.5738	0.84551	D	10	0.9633391	0.95726	D	0.621467	0.96718	D	0.939	0.98671	0.806	0.92331	P40692	I36N	Gain of disorder (P = 0.0328)| Loss of ubiquitination at K33 (P = 0.1113)| Loss of methylation at K33 (P = 0.2836)| Loss of stability (P = 0.3644)| Loss of helix (P = 0.3949)	0.957481091797	0.95666	0.8899532949857764	0.88895	0.422941986711	0.42488	0.734749674797	0.72153	T	0.946368	0.99185	D	0.428907	0.91413	D	0.378319	0.91307	D	0.998939096927643	0.95592	D	0.987726	0.95832	D	0.9883642	0.99669	0.9674163	0.99338	0.9882086	0.99660	0.96704894	0.99321	-14.403	0.94304	D	0.9471	0.86575	P	0.998931000562727	0.95346	0.99957258	0.99496	0.988	0.99594	.	.	.	.	.	.	5.530298	0.91876	32.0	0.98745831817523511	0.45680	0.863977	0.78184	D	0.528938362264372	0.68645	5.268531	0.528717341222316	0.69765	5.431214	5.98	4.81	0.61353	5.24	0.92284	7.624	0.82354	7.849000	0.70921	0.661	0.55789	1.0	0.71675	1.000000	0.68239	1.0	0.97202	315	0.8722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome	criteria_provided,_single_submitter	NC_000003.12:g.36993654T>A	.	C0027672	.	140162	.	Ile	Asn	94.47	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			94.47	Aliphatic	Isoleucine		DNA mismatch repair protein Mlh1										4.5								 I36-I32 (PAE:  1.0), I36-L40 (PAE: 1.0)	I36-I32 (PDBs: 4P7A), I36-L40 (PDBs: 4P7A)	 I36-I32 (PAE:  1.0), I36-L40 (PAE: 1.0)	I36-I32 (PDBs: 4P7A), I36-L40 (PDBs: 4P7A)							131									-62.8				-44.3						H (helix)	H (α-helix)	Helix											94.47	0.0	>90	<10		unknown		Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3		false	0.9886358502218764	0.9855010163327456	true	true	true
LITAF	LITAF_Ser118Pro	B_15-16	-4.761101686604823	0.002056832159782133	0.008033843405283996	-10.362203160056499	0.000016913152461878858	0.00010478241612753693	2025_03_Batch_15-16	true	true	true	false	false	true	false	false	false	false	false	false	0.9710813859372538	0.9783252925740662	0.8023431378193249	0.8203477908001209	0.812835728834884	0.8377899692733717	0.8242112148773209	0.8530796974360448	0.8341828800828295	0.745296226278058	0.9778221379322717	0.9615766551172743	0.8513687236694225	0.7725917602337232	0.8065127015174122	0.8593900493605917	0.9788284472158608	0.9805861167572334	LITAF	Ser118Pro	NC_000016.10:11553558:A:G	352T>C	16	11553558	A	G	16	ENSG00000189067	52920	2674	CCSBVarC007937	ALE00007923	ENSP00000483114.1	Edgotyping3	VUSMutGDEh006	C12	GDEhDisVCh_40036	D06	2	VUSMutGDDh006	C12	VUSN2Hmut_GDN2h_02	G05	VUSMutpDEST2_11	E12	VUSmut_GDEh02	G05	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	409439.0	single nucleotide variant	NM_001136472.2(LITAF):c.352T>C (p.Ser118Pro)	9516.0	LITAF	HGNC:16841	Uncertain significance	0.0	Aug 18, 2022	1064796753.0	-	RCV000480959	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000016.10	16	11553558.0	11553558.0	16p13.13	criteria provided, single submitter	1.0	-	N	ClinGen:CA16620065	2.0	424023.0	11553558.0	A	G	-	-	-	-	-	-	352T>C 	Ser118Pro	NM_001136472.2	1.0	VUS	VUS	424023	16	11553558.0	A	G	S	P	rs1064796753	16	11647414	16	11554915	118	LITAF	ENSG00000189067	ENST00000571688	ENSP00000459533	Q99732	LITAF_HUMAN	c.352T>C	p.Ser118Pro	c.352T>C	p.Ser118Pro	principal1	Y	1	.	.	-	TCC	1	0	.	A/A	A/A	A/A	A/A	.	0.60085	.	0.096	0.39683	T	0.996	0.68795	D	0.941	0.67655	D	.	.	.	.	.	.	2.295	0.65211	M	.	0.54240	.	0.866	0.87350	0.5697	0.91467	D	0.7561	0.91666	D	10	0.8675523	0.85854	D	0.180793	0.85476	D	.	0.92556	0.677	0.81414	Q99732	S118P	Gain of sheet (P = 0.0827)| Loss of helix (P = 0.2662)| Gain of loop (P = 0.2754)| Loss of stability (P = 0.2784)| Gain of catalytic residue at L117 (P = 0.3533)	0.998112035119	0.99806	0.9080913172718821	0.90724	0.730131102423	0.62449	0.50480479002	0.39443	T	0.933466	0.98881	D	0.396673	0.89650	D	0.332017	0.89521	D	0.935871618281123	0.60208	D	.	0.64637	.	0.86268204	0.88130	0.8903443	0.94213	0.86268204	0.88132	0.8903443	0.94213	-16.679	0.98615	D	.	0.89288	.	0.991922494000653	0.89258	0.99518390	0.97720	0.351	0.61015	.	.	.	.	.	.	5.145465	0.86187	28.8	0.99817986214576226	0.90158	0.912520	0.87281	D	0.65966794702558	0.76872	6.59044	0.640928431867364	0.77816	6.776444	5.48	5.48	0.80649	.	.	4.806	0.62344	10.894000	0.84131	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.978	0.57275	970	0.06217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	criteria_provided,_single_submitter	NC_000016.10:g.11553558A>G	ClinGen:CA16620065	CN517202	.	.	LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor|LPS-induced tumour necrosis factor alpha factor	Ser	Pro	87.68	0.2230769230769231																																																																																																																																																																																																																																																																																																																																																																																																																																																																													29			87.68	Polar/Neutral	Serine		Lipopolysaccharide-induced tumor necrosis factor-alpha factor							LITAF	0.003		-0.8								 S118-L122 (PAE:  2.0), S118-L114 (PAE: 3.0)		 S118-L122 (PAE:  2.0), S118-L114 (PAE: 3.0)								105									-66.8		Pocket 3: Mean pLDDT: 79.3, Volume: 304.37 Å³, Druggability score: 0		-42.1	Membrane-binding amphipathic helix					H (helix)	H (α-helix)												87.68	22.307692	70-90	10-90		unknown		Rare genetic neurological disorder	1		false	0.9783252925740662	0.9710813859372538	true	true	false
PYGL	PYGL_Asp629Tyr	B_7-8	-1.7127752151356586	0.1375908406942753	0.21094474334236465	-3.002044774597261	0.023944932324171192	0.036923488079709355	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5835841978517469	0.5495353959990613	0.6001394630600494	0.3880599850687393	0.38894613385818694	0.5121982956638998	0.6864727777200239	0.5866108617533642	0.5069432820456962	0.7080893415956087	0.6572321471524023	0.6586369960550726	0.33792381360777585	0.19128140596300972	0.26917668809178247	0.4921895845244902	0.4418386448457203	0.508531399648421	PYGL	Asp629Tyr	NC_000014.9:50911814:C:A	1885G>T	14	50911814	C	A	14	ENSG00000100504	55246	3218	CCSBVarC008109	ALE00008095	ENSP00000216392.7	Edgotyping3	VUSMutGDEh009	E01	GDEhDisVCh_40063	A12	1	VUSMutGDDh009	E01	VUSN2Hmut_GDN2h_02	E12	VUSMutpDEST2_13	B04	VUSmut_GDEh02	E12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	409130.0	single nucleotide variant	NM_002863.5(PYGL):c.1885G>T (p.Asp629Tyr)	5836.0	PYGL	HGNC:9725	Uncertain significance	0.0	Mar 10, 2017	1064796663.0	-	RCV000485266	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000014.9	14	50911814.0	50911814.0	14q22.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA16619871	2.0	423856.0	50911814.0	C	A	-	-	-	-	-	-	1885G>T 	Asp629Tyr	NM_002863.5	1.0	VUS	VUS	423856	14	50911814.0	C	A	D	Y	rs1064796663	14	51378532	14	50448282	629	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.1885G>T	p.Asp629Tyr	c.1885G>T	p.Asp629Tyr	principal1	Y	1	YES	Select	-	GAT	1	0	C	C/C	C/C	C/C	C/C	0.018	0.52012	D	0.017	0.61305	D	0.176	0.28911	B	0.272	0.39957	B	0.46	0.78014	N	simple_aae	54.0	46.0	3.325	0.90661	M	-4.44	0.77669	D	0.54	0.56526	0.8077	0.94487	D	0.8358	0.94491	D	10	0.63381565	0.68391	D	0.15059	0.83179	D	0.520	0.79476	0.487	0.56965	P06737	D629Y	Gain of MoRF binding (P = 0.09)| Loss of disorder (P = 0.1051)| Gain of helix (P = 0.2059)| Loss of stability (P = 0.2787)| Gain of catalytic residue at S626 (P = 0.3699)	0.943917850978	0.94288	0.6681687881542002	0.66591	0.228925084113	0.25167	0.296670138836	0.09900	T	0.64406	0.89010	D	0.164122	0.70366	D	-0.00202595	0.69985	D	0.928740501403809	0.58998	D	0.979302	0.92805	D	0.460095	0.64361	0.37685025	0.62553	0.460095	0.64361	0.37685025	0.62553	-10.508	0.76967	D	0.1441	0.38528	B	0.618328493527523	0.64385	0.43924250	0.80527	0.675	0.81949	.	.	.	.	.	.	3.095765	0.41779	21.4	0.99027756938240119	0.50808	0.445566	0.50027	N	-0.108596286594583	0.36745	2.147729	-0.106491256634604	0.34820	2.028623	5.61	1.63	0.22823	2.53	0.46530	1.43	0.34629	0.873000	0.22412	0.549	0.27038	0.708	0.28794	0.268000	0.24104	0.997	0.79771	364	0.84712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11	1614186	6.814580e-06	0	5	6062	8.248100e-04	0	1	75054	1.332370e-05	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29608	0.000000e+00	0	0	44888	0.000000e+00	0	0	64046	0.000000e+00	0	5	6062	8.248100e-04	0	0	1180008	0.000000e+00	0	0	91080	0.000000e+00	0	0	9688	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14048	0	not_provided	criteria_provided,_single_submitter	NC_000014.9:g.50911814C>A	ClinGen:CA16619871	CN517202	.	.	.	Asp	Tyr	96.02	0.6441717791411042																																																																																																																																																																																																																																																																																																																																																																																																																																																																													105			96.02	Negatively-charged	Aspartic Acid		Glycogen phosphorylase, liver form										-3.5								 D629-T625 (PAE:  1.0), D629-N633 (PAE: 1.0)	D629-T625 (PDBs: 1FA9, 8EMS, 2QLL), D629-N633 (PDBs: 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 2QLL)	 D629-T625 (PAE:  1.0), D629-N633 (PAE: 1.0)	D629-T625 (PDBs: 1FA9, 2QLL), D629-N633 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 8EMS, 2QLL)		D629-K555 (PDBs: 3CEH)					132									-60.3				-45.6						H (helix)	H (α-helix)	Helix											96.02	64.417175	>90	10-90		unknown		Rare genetic hepatic disease; Rare inborn errors of metabolism	2		false	0.5495353959990613	0.5835841978517469	false	false	false
RET	RET_Pro64Leu	B_13-14	-1.201347931595469	0.2686812116504655	0.35465177211637117	11.754841319223607	7.302190024442537e-6	0.00006090690315841844	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.904319444087418	0.8939775569343538	0.7650566938886204	0.8315458499568085	0.8679003962248002	0.8256336889879989	0.9807730789513702	0.9397006021800487	0.9724456247822896	0.9277580911069101	0.9448508690129539	0.9494237095422444	0.6704942990246276	0.7961001902695518	0.6906460751313274	0.6023552966703307	0.8431042448557537	0.8592151786325918	RET	Pro64Leu	NC_000010.11:43100576:C:T	191C>T	10	43100576	C	T	10	ENSG00000165731	8858	0	CCSBVarC006874	ALE00006872	ENSP00000480088.1	CEGS2	CegsMutGDEh1028	E01	GDEhDisVCh_40066	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	28963.0	single nucleotide variant	NM_020975.6(RET):c.191C>T (p.Pro64Leu)	5979.0	RET	HGNC:9967	Uncertain significance	0.0	Apr 27, 2023	77596424.0	-	RCV000014949|RCV003531901	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	germline	germline	GRCh38	NC_000010.11	10	43100576.0	43100576.0	10q11.21	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA008426,UniProtKB:P07949#VAR_006296,OMIM:164761.0019	3.0	13924.0	43100576.0	C	T	-	-	-	-	-	-	191C>T 	Pro64Leu	NM_020975.6	2.0	VUS	VUS	13924	10	43100576.0	C	T	P	L	rs77596424	10	43596024	10	42916030	64	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.191C>T	p.Pro64Leu	c.191C>T	p.Pro64Leu	principal4	Y	5	YES	Select	+	CCC	2	0	C	C/C	C/C	C/C	C/C	0.004	0.65576	D	0.004	0.74454	D	0.959	0.58322	D	0.411	0.51228	B	0.76	0.87470	D	simple_aae	24.0	76.0	2.67	0.77975	M	-3.22	0.64967	D	0.536	0.85733	0.0771	0.83683	D	0.5121	0.81614	D	10	0.89362335	0.88586	D	0.118491	0.79794	D	0.672	0.87814	0.818	0.93158	P07949	P64L	Loss of disorder (P = 0.0168)| Gain of sheet (P = 0.0266)| Loss of loop (P = 0.0374)| Loss of catalytic residue at P64 (P = 0.301)| Gain of stability (P = 0.3098)	0.926320950286	0.92500	0.9054588325528415	0.90458	0.905716289001	0.70658	0.415368586779	0.27167	T	0.721132	0.92046	D	0.22536	0.76106	D	0.0859375	0.75795	D	0.963108539581299	0.66346	D	0.863614	0.55862	D	0.24177787	0.46769	0.1777569	0.40264	0.2933445	0.51970	0.190038	0.42237	-3.563	0.17366	T	0.2	0.49988	B	0.356992193338291	0.56253	0.99964368	0.99561	0.512	0.72220	.	.	.	.	.	.	3.585512	0.50649	23.0	0.99877806916319922	0.95413	0.312706	0.41613	N	0.524681360864973	0.68387	5.233171	0.540917518592382	0.70609	5.553941	5.51	5.51	0.81744	3.8	0.70283	2.831	0.47943	4.843000	0.45380	0.599	0.40292	1.0	0.71675	0.996000	0.32869	0.839	0.39622	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia,_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43100576C>T	ClinGen:CA008426|OMIM:164761.0019|UniProtKB:P07949#VAR_006296	C3888239|C4048306	142623	388|653	Ret, cadherin like domain 1	Pro	Leu	87.13	0.2647058823529412																																																																																																																																																																																																																																																																																																																																																																																																																																																																													36			87.13	Special, No backbone hydrogen	Proline		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										1.6																		115									-67.3				135.7	Cadherin-like region 1 (CLD1)			dbSNP: rs77596424; Variant type: LP/P; AA change: Pro64Leu; PTM type: Phosphorylation; PTM morphology: PEEVP*sFRLGQ; Var class: II		C (loop/coil)	C (loop/coil)							Extracellular					87.13	26.470589	70-90	10-90	142623	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	false	0.8939775569343538	0.904319444087418	false	false	false
BAP1	BAP1_Thr93Ala	B_13-14	-0.6567658065858207	0.5323213743048774	0.6121215080808644	-1.5266053859990762	0.17069489538315274	0.21206847192152017	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7522391583384966	0.7452172284142314	0.524674508440205	0.5130952495060186	0.4632816692014744	0.5644824010103362	0.6117009842485693	0.4711544108247879	0.5527013428908805	0.5388428146682873	0.7553411341679528	0.7674710778111341	0.517263817772103	0.455408927578161	0.4734891561211568	0.5105062022121227	0.7350933226605101	0.7370072388658591	BAP1	Thr93Ala	NC_000003.12:52408056:T:C	277A>G	3	52408056	T	C	3	ENSG00000163930	3760	0	CCSBVarC009507	ALE00014374	ENSP00000417132.1																																	70527.0	single nucleotide variant	NM_004656.4(BAP1):c.277A>G (p.Thr93Ala)	8314.0	BAP1	HGNC:950	Uncertain significance	1.0	Dec 03, 2022	375129361.0	-	RCV000049290|RCV002433548	MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	BAP1-related tumor predisposition syndrome|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000003.12	3	52408056.0	52408056.0	3p21.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA143983,OMIM:603089.0008	3.0	55879.0	52408056.0	T	C	-	-	-	-	-	-	277A>G 	Thr93Ala	NM_004656.4	2.0	VUS	VUS	55879	3	52408056.0	T	C	T	A	rs375129361	3	52442072	3	52417112	93	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.277A>G	p.Thr93Ala	c.277A>G	p.Thr93Ala	principal1	Y	1	YES	Select	-	ACT	1	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.004	0.74454	D	0.999	0.77914	D	0.989	0.78402	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.105	0.97294	H	-4.56	0.80799	D	0.983	0.99488	0.4694	0.90073	D	0.5815	0.84895	D	10	0.9710113	0.96665	D	0.320929	0.91452	D	0.829	0.94563	0.874	0.96509	Q92560	T93A	Gain of helix (P = 0.132)| Loss of glycosylation at T93 (P = 0.3182)| Loss of stability (P = 0.3249)| Loss of catalytic residue at N89 (P = 0.4948)| Gain of disorder (P = 0.6407)	0.838735026799	0.83592	0.8901470396696406	0.88915	2.40817712881	0.97198	0.833551824093	0.87085	D	0.577416	0.85979	D	0.251032	0.78538	D	0.295271	0.87893	D	0.995927274227142	0.88231	D	0.994601	0.98251	D	0.9059349	0.91801	0.8396252	0.90693	0.8751512	0.89125	0.8592254	0.92021	-14.822	0.95431	D	0.9945	0.95276	P	0.999630510295007	0.97271	0.99965429	0.99571	0.818	0.89950	.	.	.	.	.	.	7.074994	0.96116	35.0	0.99807720587773441	0.89183	0.908893	0.86431	D	0.954170017245365	0.94117	12.5385	0.865996819397726	0.93882	12.37055	5.49	5.49	0.80997	3.34	0.60572	7.766	0.84189	7.827000	0.70012	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.995	0.73271	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	106374	0.000000e+00	0	0	202728	0.000000e+00	0	1	231230	4.324700e-06	0	0	6610	0.000000e+00	0	0	16808	0.000000e+00	0	0	2194	0.000000e+00	0	0	8894	0.000000e+00	0	0	13292	0.000000e+00	0	0	41496	0.000000e+00	0	0	15212	0.000000e+00	0	.	.	.	.	0	15408	0.000000e+00	0	0	29904	0.000000e+00	0	0	5990	0.000000e+00	0	0	13312	0.000000e+00	0	0	16576	0.000000e+00	0	0	87104	0.000000e+00	0	0	29660	0.000000e+00	0	.	.	.	.	0	14150	0.000000e+00	0	0	33660	0.000000e+00	0	0	9380	0.000000e+00	0	1	17510	5.711020e-05	0	0	21264	0.000000e+00	0	0	100148	0.000000e+00	0	0	29584	0.000000e+00	0	1	17510	5.711020e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	BAP1-related_tumor_predisposition_syndrome|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52408056T>C	ClinGen:CA143983|OMIM:603089.0008	C3280492|C0027672	614327	289539|140162	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Thr	Ala	96.63	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			96.63	Polar/Neutral	Threonine		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			-0.7								 T93-L97 (PAE:  1.0), T93-H141 (PAE: 1.0)	T93-L97 (PDBs: 8SVF), T93-H141 (PDBs: 8SVF)	 T93-H141 (PAE:  1.0), T93-L97 (PAE: 1.0)	T93-L97 (PDBs: 8SVF), T93-H141 (PDBs: 8SVF)							119									-72.1				-39.9						H (helix)	H (α-helix)	Helix											96.63	0.0	>90	<10	614327	autosomal dominant	GenCC	Rare genetic tumor	1	TUMOR PREDISPOSITION SYNDROME 1	true	0.7452172284142314	0.7522391583384966	false	false	false
BAP1	BAP1_Arg718Gln	B_13-14	-0.9458164145836372	0.37573764594446835	0.4662849593985026	-3.548642927115825	0.0093607514788508	0.016174179815151804	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6561118999888986	0.6604653641789137	0.562566191782517	0.554559082156702	0.5791425476554402	0.6029027031981118	0.6306354999453089	0.598644118717351	0.5065360375475854	0.5515339063695062	0.6629003506278779	0.6577599239625158	0.5751699064509147	0.5596409765935293	0.6025821267658187	0.5735984771955278	0.6580303777299494	0.6544638760152816	BAP1	Arg718Gln	NC_000003.12:52402325:C:T	2153G>A	3	52402325	C	T	3	ENSG00000163930	3760	0	CCSBVarC009488	ALE00015194	ENSP00000417132.1																																	1162261.0	single nucleotide variant	NM_004656.4(BAP1):c.2153G>A (p.Arg718Gln)	8314.0	BAP1	HGNC:950	Uncertain significance	1.0	Oct 30, 2023	1440748203.0	-	RCV001797190|RCV003365424|RCV002568140	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539	Neurodevelopmental disorder|Hereditary cancer-predisposing syndrome|BAP1-related tumor predisposition syndrome	de novo;germline;unknown	germline	GRCh38	NC_000003.12	3	52402325.0	52402325.0	3p21.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	-	2.0	1173084.0	52402325.0	C	T	-	-	-	-	-	-	2153G>A 	Arg718Gln	NM_004656.4	2.0	VUS	VUS	1173084	3	52402325.0	C	T	R	Q	rs1440748203	3	52436341	3	52411381	718	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.2153G>A	p.Arg718Gln	c.2153G>A	p.Arg718Gln	principal1	Y	1	YES	Select	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.029	0.47069	D	0.067	0.63436	T	0.105	0.26009	B	0.013	0.16457	B	0.45	0.67594	N	simple_aae	55.0	45.0	0.695	0.17891	N	-1.06	0.33774	N	0.486	0.51792	-1.0347	0.18929	T	0.0947	0.35615	T	10	0.27956486	0.45144	D	0.017745	0.39328	T	0.076	0.22039	0.284	0.24003	Q92560	R718Q	Gain of glycosylation at S721 (P = 0.0061)| Gain of relative solvent accessibility (P = 0.0999)| Loss of stability (P = 0.1254)| Gain of helix (P = 0.132)| Loss of ubiquitination at K714 (P = 0.1982)	0.666395784662	0.66096	0.9176963108472813	0.91693	1.18041734594	0.79892	0.887522280216	0.94942	D	0.031629	0.21892	T	-0.0791375	0.39503	T	-0.351452	0.38683	T	0.692419946193695	0.40057	D	0.89941	0.65736	D	0.23402792	0.45888	0.15140484	0.35558	0.23402792	0.45888	0.15140484	0.35557	-4.022	0.24154	T	0.9167	0.95515	P	0.894653573905079	0.75692	0.99749726	0.98401	0.514	0.72347	.	.	.	.	.	.	4.896201	0.80464	27.3	0.99844496711451181	0.92495	0.924435	0.90210	D	0.0651513950594368	0.44583	2.750997	0.22881620568532	0.51201	3.327653	5.52	4.64	0.57348	2.61	0.47779	7.848	0.85237	5.982000	0.52258	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	91766	1.089730e-05	0	1	177226	5.642510e-06	0	1	204170	4.897880e-06	0	0	5246	0.000000e+00	0	1	14932	6.697030e-05	0	0	1838	0.000000e+00	0	0	7348	0.000000e+00	0	0	11372	0.000000e+00	0	0	35934	0.000000e+00	0	0	13430	0.000000e+00	0	1	14932	6.697030e-05	0	0	13106	0.000000e+00	0	1	26036	3.840840e-05	0	0	5376	0.000000e+00	0	0	12242	0.000000e+00	0	0	13878	0.000000e+00	0	0	75596	0.000000e+00	0	0	26784	0.000000e+00	0	1	26036	3.840840e-05	0	0	12254	0.000000e+00	0	1	29894	3.345150e-05	0	0	8858	0.000000e+00	0	0	15560	0.000000e+00	0	0	17108	0.000000e+00	0	0	88666	0.000000e+00	0	0	26736	0.000000e+00	0	1	29894	3.345150e-05	0	.	3	1594688	1.881250e-06	0	1	56488	1.770290e-05	0	0	74946	0.000000e+00	0	0	912	0.000000e+00	0	1	56488	1.770290e-05	0	0	29090	0.000000e+00	0	0	44170	0.000000e+00	0	0	61120	0.000000e+00	0	0	6016	0.000000e+00	0	2	1172136	1.706290e-06	0	0	87956	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|Neurodevelopmental_disorder|BAP1-related_tumor_predisposition_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000003.12:g.52402325C>T	.	C0027672|C1535926|C3280492	614327	140162|289539	.	Arg	Gln	50.61	0.9435483870967742																																																																																																																																																																																																																																																																																																																																																																																																																																																																													234			50.61	Positively-charged	Arginine		Ubiquitin carboxyl-terminal hydrolase BAP1										-4.5																		175	Classical bipartite Nuclear localization signal (NLS); Non-classical PY-nuclear localization signal (PY-NLS)	Predominantly localizes to the cytosol.; Abolishes deubiquitination activity towards H2AK119ub1 substrates in the context of the nucleosome, probably due to disruption of nucleosome interaction. Does not affect deubiquitination of H2AK119ub1 on free histones.; Disrupts nucleosome interaction and abolishes deubiquitination activity towards H2AK119ub1 substrates in the context of the nucleosome. Does not affect deubiquitination of H2AK119ub1 on free histones.; Reduces deubiquitination activity towards H2AK119ub1 substrates in the context of the nucleosome, probably due to disruption of nucleosome interaction. Does not affect deubiquitination of H2AK119ub1 on free histones.; Impairs deubiquitination activity of histone H2AK118ub1 substrates, probably due to disruption of nucleosome association.; Mutation: RRKRSR -> AAAAAA. Abolishes nuclear localization.; Disrupts nucleosome interaction and reduces deubiquitination activity towards H2AK119ub1 substrates in the context of the nucleosome.							-93.1				40.1	Interaction with BRCA1; Disordered; Positively charged C-terminal extension (CTE)					C (loop/coil)	C (loop/coil)												50.61	94.354836	50-70	$\geqslant$90	614327	autosomal dominant	GenCC	Rare genetic tumor	1	TUMOR PREDISPOSITION SYNDROME 1	false	0.6604653641789137	0.6561118999888986	false	false	false
RET	RET_Arg313Gln	B_13-14	-2.285823693071175	0.05615212771343529	0.10185238740043819	6.63510375043922	0.00029455519250897794	0.0009099474381380042	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.7578088345842184	0.7841854665867589	0.764341337237384	0.7836702238096536	0.7865930641473681	0.8545253543681663	0.9189722341453119	0.7807128995273054	0.7111864533048358	0.8991709146944272	0.7286671293862774	0.7136954650276471	0.7900784745910208	0.7924732287674308	0.8561539943144713	0.6295117597803406	0.8397038037872403	0.8019222041407896	RET	Arg313Gln	NC_000010.11:43106446:G:A	938G>A	10	43106446	G	A	10	ENSG00000165731	8858	0	CCSBVarC006882	ALE00006880	ENSP00000480088.1	CEGS2	CegsMutGDEh1024	A02	GDEhDisVCh_40066	A05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	28971.0	single nucleotide variant	NM_020975.6(RET):c.938G>A (p.Arg313Gln)	5979.0	RET	HGNC:9967	Uncertain significance	0.0	Jan 18, 2024	77702891.0	-	RCV000014957|RCV000662693|RCV000654592|RCV000566081|RCV002476968|RCV003114192	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma;Multiple endocrine neoplasia type 2B;Multiple endocrine neoplasia type 2A;Pheochromocytoma;Hirschsprung disease, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000010.11	10	43106446.0	43106446.0	10q11.21	criteria provided, multiple submitters, no conflicts	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA009384,UniProtKB:P07949#VAR_009465,OMIM:164761.0028	3.0	13932.0	43106446.0	G	A	-	-	-	-	-	-	938G>A 	Arg313Gln	NM_020975.6	2.0	VUS	VUS	13932	10	43106446.0	G	A	R	Q	rs77702891	10	43601894	10	42921900	313	RET	ENSG00000165731	ENST00000355710	ENSP00000347942	P07949	RET_HUMAN	c.938G>A	p.Arg313Gln	c.938G>A	p.Arg313Gln	principal4	Y	5	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.017	0.51407	D	0.116	0.36834	T	0.943	0.56216	P	0.173	0.45142	B	0.64	0.79151	D	simple_aae	36.0	64.0	2.44	0.70564	M	-0.65	0.18812	N	0.45	0.48537	-0.6073	0.64360	T	0.3274	0.69436	T	10	0.22862077	0.39382	T	0.13682	0.81879	D	0.552	0.81390	0.723	0.85693	P07949	R313Q	Gain of sheet (P = 0.0049)| Gain of loop (P = 0.0312)| Loss of stability (P = 0.1084)| Loss of phosphorylation at T315 (P = 0.1211)| Gain of glycosylation at S316 (P = 0.2382)	0.928844329528	0.92757	0.8295473270931635	0.82810	0.306023030952	0.32606	0.403721630573	0.25557	T	0.452479	0.79124	T	-0.102543	0.35646	T	-0.0018559	0.69996	D	0.158066955150649	0.17507	T	0.875612	0.58615	D	0.2721727	0.49956	0.13592933	0.32442	0.18244144	0.39154	0.08550162	0.19721	-4.117	0.26502	T	0.1404	0.33018	B	0.547894901457323	0.62233	0.99958426	0.99505	0.446	0.67864	.	.	.	.	.	.	3.504925	0.49142	22.7	0.9989321191735554	0.96668	0.080145	0.16005	N	0.0737859261210792	0.44985	2.784067	0.0662528309478524	0.42582	2.600265	5.32	2.2	0.26894	2.0	0.39643	2.392	0.44189	6.435000	0.55709	0.672	0.70176	0.959	0.33632	1.000000	0.68239	0.71	0.34491	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	16	264690	6.044807E-5	.	13	108632	1.196700e-04	0	26	206054	1.261810e-04	0	30	234958	1.276820e-04	0	0	7066	0.000000e+00	0	13	17006	7.644360e-04	0	0	2304	0.000000e+00	0	0	8992	0.000000e+00	0	0	13308	0.000000e+00	0	0	42460	0.000000e+00	0	0	15588	0.000000e+00	0	13	17006	7.644360e-04	0	0	15982	0.000000e+00	0	24	30344	7.909310e-04	0	1	6162	1.622850e-04	0	0	13304	0.000000e+00	0	0	16628	0.000000e+00	0	1	88370	1.131610e-05	0	0	30438	0.000000e+00	0	24	30344	7.909310e-04	0	0	14734	0.000000e+00	0	26	34094	7.625980e-04	0	1	9550	1.047120e-04	0	0	17626	0.000000e+00	0	0	21064	0.000000e+00	0	2	101936	1.962020e-05	0	0	30362	0.000000e+00	0	26	34094	7.625980e-04	0	.	45	1613324	2.789270e-05	0	30	59952	5.004000e-04	0	1	74906	1.335010e-05	0	0	912	0.000000e+00	0	30	59952	5.004000e-04	0	1	29586	3.379980e-05	0	0	44874	0.000000e+00	0	0	63780	0.000000e+00	0	0	6052	0.000000e+00	0	9	1179830	7.628220e-06	0	2	90976	2.198380e-05	0	0	15826	0	0	122	0	0	146	0	1	3804	2.628811777076761E-4	0	146	0	0	610	0	0	56	0	0	104	0	0	2876	0	1	3926	2.5471217524197657E-4	0	202	0	1	23690	4.2211903756859436E-5	Multiple_endocrine_neoplasia,_type_2|not_provided|Pheochromocytoma|Hirschsprung_disease,_susceptibility_to,_1|Familial_medullary_thyroid_carcinoma|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.43106446G>A	ClinGen:CA009384|OMIM:164761.0028|UniProtKB:P07949#VAR_009465	C4048306|C3661900|C0031511|C3888239|C1833921|C0025268|C0025269|C0027672	171300|142623|155240|171400|162300	653|29072|388|653|99361|247698|653|247709|653|140162	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	Arg	Gln	78.93	0.13709677419354838																																																																																																																																																																																																																																																																																																																																																																																																																																																																													34			78.93	Positively-charged	Arginine		Proto-oncogene tyrosine-protein kinase receptor Ret; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment										-4.5								 R313-D266 (PAE:  5.5), R313-E309 (PAE: 5.5)	R313-S379 (PDBs: 6Q2J)	 R313-E309 (PAE:  5.5), R313-S379 (PAE: 4.0)	R313-S379 (PDBs: 6Q2J, 6Q2N, 6Q2O, 6Q2R, 6Q2S), R313-E309 (PDBs: 6Q2S)	 R313-D266 (PAE:  5.5), R313-D380 (PAE: 5.0), R313-E309 (PAE: 5.5)						175									-94.5				-64.1	Cadherin-like region 3 (CLD3)					H (helix)	H (α-helix)							Extracellular					78.93	13.709678	70-90	10-90	142623;171400;155240;162300;171400;171300;142623	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic gastroenterological disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; THYROID CARCINOMA, FAMILIAL MEDULLARY; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; PHEOCHROMOCYTOMA; HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	false	0.7841854665867589	0.7578088345842184	false	false	false
BAP1	BAP1_Cys91Gly	B_13-14	1.5164097053786887	0.17319848524644227	0.25137470123153854	-5.486804665013732	0.0009193072432989236	0.0022313872902824405	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8077694473789947	0.809713756484407	0.5808226285085566	0.7367306309221685	0.6884051919679341	0.6968080940984895	0.5917839325491205	0.57464017616627	0.5909053191925895	0.613271950686785	0.8379905402193969	0.8319877118132604	0.8018322556478585	0.8021702077695982	0.8825559426517475	0.5483733063303282	0.781436972749417	0.7835511829447289	BAP1	Cys91Gly	NC_000003.12:52408062:A:C	271T>G	3	52408062	A	C	3	ENSG00000163930	3760	0	CCSBVarC009482	ALE00015198	ENSP00000417132.1																																	1162264.0	single nucleotide variant	NM_004656.4(BAP1):c.271T>G (p.Cys91Gly)	8314.0	BAP1	HGNC:950	Uncertain significance	1.0	Sep 14, 2021	1705222655.0	-	RCV001797188|RCV002424967	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Neurodevelopmental disorder|Hereditary cancer-predisposing syndrome	de novo;germline	germline	GRCh38	NC_000003.12	3	52408062.0	52408062.0	3p21.1	criteria provided, single submitter	2.0	-	N	-	2.0	1173082.0	52408062.0	A	C	-	-	-	-	-	-	271T>G 	Cys91Gly	NM_004656.4	1.0	VUS	VUS	1173082	3	52408062.0	A	C	C	G	rs1705222655	3	52442078	3	52417118	91	BAP1	ENSG00000163930	ENST00000460680	ENSP00000417132	Q92560	BAP1_HUMAN	c.271T>G	p.Cys91Gly	c.271T>G	p.Cys91Gly	principal1	Y	1	YES	Select	-	TGT	1	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.145	0.97505	H	-11.35	0.99595	D	0.974	0.98575	1.1018	0.99732	D	0.9443	0.98173	D	10	0.99121475	0.99640	D	0.655758	0.97092	D	0.979	0.99840	0.923	0.98665	Q92560	C91G	Loss of stability (P = 0.0176)| Gain of disorder (P = 0.0416)| Gain of sheet (P = 0.1208)| Loss of helix (P = 0.1299)| Gain of loop (P = 0.2045)	0.981038681151	0.98064	0.9635444637645938	0.96320	2.76950302636	0.98787	0.846445500851	0.89059	D	0.614019	0.87693	D	0.551935	0.95794	D	0.55504	0.95730	D	0.999918460845947	0.99678	D	0.998744	0.99359	D	0.97112095	0.98337	0.9594046	0.98923	0.97112095	0.98337	0.9594046	0.98923	-13.296	0.90565	D	0.9988	0.98152	P	0.999985923692613	0.99579	0.99989021	0.99864	0.951	0.97790	.	.	.	.	.	.	5.258269	0.88304	29.5	0.97870451339973896	0.36682	0.954137	0.97089	D	1.0074398562281	0.95947	14.15777	0.917979903155774	0.96288	14.54242	5.49	5.49	0.80997	3.34	0.60572	9.031	0.93237	11.129000	0.86768	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.999	0.91597	68	0.97129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hereditary_cancer-predisposing_syndrome|Neurodevelopmental_disorder	criteria_provided,_single_submitter	NC_000003.12:g.52408062A>C	.	C0027672|C1535926	.	140162	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	Cys	Gly	93.1	0.14814814814814814																																																																																																																																																																																																																																																																																																																																																																																																																																																																													20		Nucleophile	93.1	Special, a very reactive sulfhydryl group	Cysteine		Ubiquitin carboxyl-terminal hydrolase BAP1							UCH catalytic			2.5								 C91-A95 (PAE:  1.0)	C91-A95 (PDBs: 8SVF)	 C91-Q85 (PAE:  1.5), C91-A95 (PAE: 1.0)	C91-Q85 (PDBs: 8SVF), C91-A95 (PDBs: 8SVF), C91-F170 (PDBs: 8SVF), C91-H169 (PDBs: 8SVF)							121		Mutation: C -> A. Abolishes deubiquitinase activity. Has no effect on interaction with HCFC1.							-59.3				-46.3						H (helix)	H (α-helix)	Helix											93.1	14.814815	>90	10-90		unknown		Rare genetic tumor	1		false	0.809713756484407	0.8077694473789947	false	false	false
GFAP	GFAP_Met74Thr	B_15-16	2.8382155689404236	0.025108732188749008	0.05382455497251471	15.922434612896655	9.351869696258336e-7	0.000016038019525826212	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.9261047220149976	0.9310215308981165	0.6545579580771356	0.8095488820498355	0.8777130019480658	0.7540914312122566	0.6969111308029378	0.8789744139967014	0.7831723930768113	0.6478949426898943	0.9170792938664398	0.9099563836805373	0.8112717316215754	0.8764515898994302	0.8359253710228597	0.6612209734643768	0.9449637679297931	0.9422530603494579	GFAP	Met74Thr	NC_000017.11:44915266:A:G	221T>C	17	44915266	A	G	17	ENSG00000131095	2920	214399	CCSBVarC004658	ALE00004658	ENSP00000466598.2	CEGS2	CegsMutGDEh1035	G05	GDEhDisVCh_40051	A05	1	CegsMutGDDh1035	G05	VUSN2Hmut_GDN2h_06	F12	VUSMutpDEST2_02	D12	VUSmut_GDEh06	F12	1.0	1.0	1.0	1.0	1.0	6.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	77363.0	single nucleotide variant	NM_002055.5(GFAP):c.221T>C (p.Met74Thr)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	267607504.0	-	RCV000056861|RCV000192102	MedGen:C3661900|MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58	not provided|Alexander disease	germline	germline	GRCh38	NC_000017.11	17	44915266.0	44915266.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217158,UniProtKB:P14136#VAR_071525	3.0	66466.0	44915266.0	A	G	-	-	-	-	-	-	221T>C 	Met74Thr	NM_002055.5		Others	Others	66466	17	44915266.0	A	G	M	T	rs267607504	17	42992634	17	40348160	74	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.221T>C	p.Met74Thr	c.221T>C	p.Met74Thr	principal1	Y	1	YES	Select	-	ATG	2	0	A	A/A	A/A	A/A	A/A	.	0.78662	.	.	0.64242	.	0.038	0.21017	B	0.102	0.30859	B	0.03	0.96253	A	without_aae	97.0	3.0	1.915	0.51044	L	.	0.40464	.	.	0.68361	0.1247	0.84550	D	0.6042	0.85890	D	10	0.7901194	0.78373	D	0.151143	0.83227	D	.	0.88724	.	.	.	.	.	.	0.98325	.	0.82753	.	0.61924	0.777369976044	0.78494	T	0.62743	0.88291	D	0.278818	0.81078	D	0.162726	0.80834	D	0.8764488697052	0.52371	D	0.90161	0.67029	D	0.7123407	0.78488	0.754556	0.85316	0.77287644	0.82003	0.76752824	0.86101	-6.166	0.49658	T	0.6927	0.78242	P	0.977458949566974	0.84731	0.99775344	0.98493	0.914	0.95566	.	.	.	.	.	.	3.889464	0.56659	23.8	0.97709189332848845	0.35646	.	.	.	0.00469948748182747	0.41806	2.52786	0.0715847062745323	0.42845	2.620939	4.82	3.73	0.41914	2.89	0.52837	2.282	0.43224	9.356000	0.80368	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	10090	0	0	184	0	0	0	0	1	4654	2.1486892995272884E-4	0	0	0	0	0	0	0	0	0	0	0	0	0	1434	0	1	4838	2.0669698222405952E-4	0	0	0	1	16362	6.111722283339445E-5	not_provided|Alexander_disease	no_classification_provided	NC_000017.11:g.44915266A>G	ClinGen:CA217158|UniProtKB:P14136#VAR_071525	C3661900|C0270726	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Met	Thr	88.27	0.6382978723404256																																																																																																																																																																																																																																																																																																																																																																																																																																																																													120			88.27	Aliphatic	Methionine		Glial fibrillary acidic protein							IF rod	0.0152		1.9								 M74-D78 (PAE:  1.5), M74-R70 (PAE: 2.0)		 M74-D78 (PAE:  1.5), M74-R70 (PAE: 2.0)								149									-66.7		Pocket 5: Mean pLDDT: 80.91, Volume: 329.67 Å³, Druggability score: 0.02		-47.4	Coil 1A					H (helix)	H (α-helix)												88.27	63.829784	70-90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.9310215308981165	0.9261047220149976	false	false	false
NT5C3A	NT5C3A_Gly202Arg	B_15-16	-0.9245292635559598	0.38597267577385513	0.4765402784279659	-8.876217494874219	0.000046673684619174725	0.00022900056490958722	2025_03_Batch_15-16	true	true	false	false	false	false	false	true	false	false	false	false	0.9758102764618659	0.9886759876881583	0.5361328297172865	0.5877613635878289	0.5878048559781783	0.5417952488569666	0.5901839645896579	0.639399407835094	0.6051997952068289	0.5846917165876315	0.9831594797088185	0.9609840645911005	0.4934065331242752	0.5362103041212628	0.570322931968829	0.48757394284694155	0.9941924956674981	0.9906364883326312	NT5C3A	Gly202Arg	NC_000007.14:33017528:C:G	604G>C	7	33017528	C	G	7	ENSG00000122643	14396	23459	CCSBVarC002092	ALE00002092	ENSP00000476480.2	RC4	RC4_Mut_GDEh1016	F10	GDEhDisVCh_40039	A09	1	RC4_Mut_GDDh1016	F10	NULL	NULL	VUSMutpDEST2_11	F08	VUSmut_GDEh12	E12	1.0	1.0	1.0	6.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	N	N	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	NaN	NaN		unknown		Rare genetic hematologic disease; Rare inborn errors of metabolism	2		false	0.9886759876881583	0.9758102764618659	true	true	true
CDKN1A	CDKN1A_Asp149Gly	B_15-16	-9.120145820154805	0.00003912877191801131	0.00048541851243916277	-6.275717036348992	0.0004137371060618369	0.0011937226251941364	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9650451510102604	0.9700123841453094	0.6630546240761412	0.8706432658598131	0.7837547487737511	0.819622165173205	0.6948354468261888	0.7046712534871735	0.7914285191518433	0.6010935692604814	0.9756614344114304	0.9718414017605828	0.944408883520221	0.8628382440603286	0.9498580125677829	0.725015678891801	0.9643633338791886	0.9582489002599381	CDKN1A	Asp149Gly	NC_000006.12:36685751:A:G	446A>G	6	36685751	A	G	6	ENSG00000124762	3192	5566	CCSBVarC000416	ALE00000416	ENSP00000244741.6	RC4	RC4_Mut_GDEh1011	B08	GDEhDisVCh_40040	E01	2	RC4_Mut_GDDh1011	B08	NULL	NULL	VUSMutpDEST2_03	D05	VUSmut_GDEh12	C10	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												142			62.9	Negatively-charged	Aspartic Acid		Cyclin-dependent kinase inhibitor 1										-3.5			X:D149-Y:R156 (PDBs: 2ZVV), X:D149-Y:L157 (PDBs: 2ZVV)	X:D149-Y:R156 (PDBs: 2ZVV)	X:D149-Y:R156 (PDBs: 2ZVV)				D149-R143 (PDBs: 5E0U)	 D149-S153 (PAE:  7.5)								132	PIP-box K+4 motif; Nuclear localization signal	Mutation: QTSMTDF -> ATSATDA. Abolishes interaction with PCNA and subsequent degradation by the proteasome.; Mutation: MTDFY -> ATDAAA. Abolishes interaction with PCNA and subsequent degradation by the proteasome.							-75.2				-15.7	Disordered					C (loop/coil)	T (turn)	Helix													NaN	NaN		unknown		Rare genetic endocrine disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3		false	0.9700123841453094	0.9650451510102604	true	true	false
SMAD3	SMAD3_Asn197Ile	B_15-16	2.234758690270437	0.06054426435918988	0.10837820517905593	2.7149578680825153	0.02998331403916871	0.044925020949342746	2025_03_Batch_15-16	false	false	true	true	true	true	false	false	false	false	false	true	0.8822418068476647	0.8814406531795396	0.8947377246284185	0.8963876922863607	0.8863071743852353	0.9567357341412912	0.9329928764245073	0.9118422980684626	0.9456433506722923	0.8657590755061888	0.8387910907887901	0.8376419147817569	0.9804785918580752	0.8607720507020079	0.8471320339004291	0.9237163737506481	0.9240902155702889	0.9268416989135725	SMAD3	Asn197Ile	NC_000015.10:67166836:A:T	590A>T	15	67166836	A	T	15	ENSG00000166949	11805	20082	CCSBVarC001756	ALE00001756	ENSP00000332973.4	RC4	RC4_Mut_GDEh1003	D03	GDEhDisVCh_40014	E03	2	RC4_Mut_GDDh1003	D03	VUSN2Hmut_GDN2h_10	H05	VUSMutpDEST2_09	F08	VUSmut_GDEh12	B06	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	2.0	Y	Y	N	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												131			41.11	Polar/Neutral	Asparagine		Mothers against decapentaplegic homolog 3										-3.5																		132									-161.9				171.2	Linker; Disordered					C (loop/coil)	C (loop/coil)														NaN	NaN		unknown		Rare genetic vascular disease; Rare genetic systemic or rheumatologic disease	2		false	0.8814406531795396	0.8822418068476647	false	false	false
GFAP	GFAP_Tyr366Cys	B_15-16	0.25465226319010015	0.8063108417668634	0.8461833559201698	7.119767769038466	0.00019033116676712798	0.0006516001698091043	2025_03_Batch_15-16	true	true	true	false	true	true	false	false	false	false	true	true	0.9684916086227857	0.9537371982344839	0.9223543821352382	0.8714929702418321	0.975339714391651	0.9275557500360682	0.8909969626216926	0.9849001728995015	0.8157244075629264	0.8800890154092146	0.952859990334006	0.9649552370679055	0.9641145374504437	0.9657792558838005	0.9272615329207378	0.964619748861262	0.9546144061349617	0.9720279801776659	GFAP	Tyr366Cys	NC_000017.11:44911266:T:C	1097A>G	17	44911266	T	C	17	ENSG00000131095	2920	214440	CCSBVarC004676	ALE00004676	ENSP00000466598.2	CEGS2	CegsMutGDEh1042	G05	GDEhDisVCh_40051	G08	1	CegsMutGDDh1042	G05	VUSN2Hmut_GDN2h_08	H11	VUSMutpDEST2_03	D02	VUSmut_GDEh08	H11	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77332.0	single nucleotide variant	NM_002055.5(GFAP):c.1097A>G (p.Tyr366Cys)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	267607502.0	-	RCV000056829|RCV000192168	MedGen:C3661900|MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58	not provided|Alexander disease	germline	germline	GRCh38	NC_000017.11	17	44911266.0	44911266.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217112	3.0	66435.0	44911266.0	T	C	-	-	-	-	-	-	1097A>G 	Tyr366Cys	NM_002055.5		Others	Others	66435	17	44911266.0	T	C	Y	C	rs267607502	17	42988634	17	40344160	366	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.1097A>G	p.Tyr366Cys	c.1097A>G	p.Tyr366Cys	principal1	Y	1	YES	Select	-	TAC	2	0	T	./.	./.	./.	./.	.	0.68399	.	.	0.92967	.	1.0	0.90580	D	0.998	0.88579	D	0.65	0.93829	A	without_aae	35.0	65.0	4.19	0.97731	H	.	0.96632	.	.	0.99956	1.0904	0.99253	D	0.9634	0.98825	D	10	0.9894265	0.99401	D	0.782273	0.98282	D	.	0.99918	0.933	0.98984	P14136	Y366C	Loss of ubiquitination at K368 (P = 0.0777)| Loss of catalytic residue at Y366 (P = 0.1329)| Loss of stability (P = 0.2049)| Loss of disorder (P = 0.2441)| Gain of methylation at K368 (P = 0.3299)	.	0.99966	.	0.99538	.	0.84272	0.878744781017	0.93782	D	0.971397	0.99691	D	0.574581	0.96658	D	0.58757	0.96602	D	0.999437987804413	0.97367	D	0.992851	0.99821	D	0.9352262	0.94683	0.94673157	0.98172	0.9158577	0.92743	0.9462733	0.98143	-12.978	0.89876	D	0.9918	0.94716	P	0.997334124018646	0.93023	0.99953771	0.99470	0.997	0.99892	.	.	.	.	.	.	5.875952	0.93918	33.0	0.9978115503749182	0.86791	0.972094	0.99398	D	0.900915099804877	0.91760	11.07347	0.77520726885406	0.87956	9.428903	4.25	4.25	0.49600	.	.	8.017	0.8876	7.887000	0.72871	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.998	0.85369	754	0.51253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Alexander_disease|not_provided	no_classification_provided	NC_000017.11:g.44911266T>C	ClinGen:CA217112	C0270726|C3661900	203450	58	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	Tyr	Cys	93.4	0.6396396396396397																																																																																																																																																																																																																																																																																																																																																																																																																																																																													142			93.4	Aromatic	Tyrosine		Glial fibrillary acidic protein							IF rod			-1.3								 Y366-L370 (PAE:  2.0), Y366-E362 (PAE: 1.0)		 Y366-L370 (PAE:  2.0), Y366-E362 (PAE: 1.0)								181									-63.0				-41.6	Coil 2B			dbSNP: rs58008462; Variant type: LP/P; AA change: Tyr366His; PTM type: Ubiquitylation; PTM morphology: IATY*RkLLEGE; Var class: II		H (helix)	H (α-helix)												93.4	63.963963	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.9537371982344839	0.9684916086227857	true	true	false
GALE	GALE_Lys257Arg	B_7-8	-0.5210813489145409	0.6209747316033636	0.6936033551827043	-3.754893891546669	0.007122343212654656	0.01277837674826998	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7016198549331394	0.7005555742195491	0.5522970016060802	0.7634237750551264	0.6562736375821412	0.5866462762137654	0.543546276170016	0.6410322408839746	0.7489986708762735	0.5243506381223964	0.657876124955323	0.6329708297698124	0.6297462762575149	0.6715150342803077	0.7778488792339793	0.580243365089764	0.7432350234837751	0.7702688800964663	GALE	Lys257Arg	NC_000001.11:23796722:T:C	770A>G	1	23796722	T	C	1	ENSG00000117308	2767	214361	CCSBVarC005290	ALE00005290	ENSP00000483375.1	CEGS2	CegsMutGDEh1035	E12	GDEhDisVCh_40068	A07	2	CegsMutGDDh1035	E12	VUSN2Hmut_GDN2h_07	A03	VUSMutpDEST2_02	H10	VUSmut_GDEh07	A03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	18718.0	single nucleotide variant	NM_001008216.2(GALE):c.770A>G (p.Lys257Arg)	2582.0	GALE	HGNC:4116	Conflicting classifications of pathogenicity; other	1.0	Dec 18, 2024	28940884.0	-	RCV000003864|RCV000609606|RCV000592410|RCV004752683	MONDO:MONDO:0009257,MedGen:C0751161,OMIM:230350,Orphanet:352,Orphanet:79238|MedGen:CN169374|MedGen:C3661900|	UDPglucose-4-epimerase deficiency|not specified|not provided|GALE-related disorder	germline;unknown	germline	GRCh38	NC_000001.11	1	23796722.0	23796722.0	1p36.11	criteria provided, conflicting classifications	13.0	-	N	ClinGen:CA340116,UniProtKB:Q14376#VAR_002544,OMIM:606953.0005	3.0	3679.0	23796722.0	T	C	-	-	-	-	-	-	770A>G 	Lys257Arg	NM_001008216.2	1.0	Others	Others	3679	1	23796722.0	T	C	K	R	rs28940884	1	24123212	1	23995799	257	GALE	ENSG00000117308	ENST00000374497	ENSP00000363621	Q14376	GALE_HUMAN	c.770A>G	p.Lys257Arg	c.770A>G	p.Lys257Arg	principal1	Y	1	.	.	-	AAG	2	0	T	T/T	T/T	T/T	T/T	0.195	0.31523	T	0.193	0.28516	T	0.057	0.31336	B	0.18	0.38824	B	0.66	0.80260	D	simple_aae	34.0	66.0	0.71	0.18510	N	-2.05	0.48864	N	0.864	0.86054	0.1733	0.85394	D	0.4892	0.80498	T	9	0.00929606	0.00206	T	.	.	.	0.623	0.85336	.	.	.	.	.	0.903362804597	0.90166	.	0.63757	0.174577858739	0.19391	0.71719700098	0.69587	T	0.773378	0.93899	D	-0.0762848	0.39967	T	0.133241	0.78951	D	0.0274686051134968	0.01603	T	0.959004	0.85894	D	0.7925315	0.83223	0.577098	0.75248	0.8132025	0.84570	0.6127861	0.77231	-6.083	0.47028	T	0.0876	0.15539	B	0.227477594124542	0.51233	0.99859315	0.98859	0.27	0.54055	.	.	.	.	.	.	3.454367	0.48201	22.6	0.99799876664003329	0.88470	0.947533	0.95803	D	0.0396364607887984	0.43408	2.655173	0.248236523326882	0.52303	3.429062	5.65	5.65	0.86862	.	.	7.347	0.7865	7.896000	0.73341	0.651	0.53214	1.0	0.71675	1.000000	0.68239	0.995	0.73271	507	0.75491	41	0.008186900958466454	38	0.028744326777609682	0	0.0	3	0.004322766570605188	0	0.0	0	0.0	1571	264690	0.005935245	.	153	108240	1.413530e-03	4	344	206252	1.667860e-03	6	325	234630	1.385160e-03	6	135	6946	1.943560e-02	3	12	16960	7.075470e-04	1	0	2260	0.000000e+00	0	0	9000	0.000000e+00	0	0	13374	0.000000e+00	0	3	42318	7.089180e-05	0	0	15490	0.000000e+00	0	135	6946	1.943560e-02	3	306	15924	1.921630e-02	5	23	30252	7.602800e-04	1	0	6128	0.000000e+00	0	0	13392	0.000000e+00	0	0	16694	0.000000e+00	0	12	88814	1.351140e-04	0	0	30222	0.000000e+00	0	306	15924	1.921630e-02	5	283	14618	1.935970e-02	5	26	33988	7.649760e-04	1	1	9482	1.054630e-04	0	0	17638	0.000000e+00	0	0	21352	0.000000e+00	0	10	101842	9.819130e-05	0	0	30140	0.000000e+00	0	283	14618	1.935970e-02	5	.	1914	1613138	1.186510e-03	24	1474	75008	1.965120e-02	23	1474	75008	1.965120e-02	23	0	910	0.000000e+00	0	66	59842	1.102900e-03	1	0	29554	0.000000e+00	0	0	44872	0.000000e+00	0	0	63992	0.000000e+00	0	1	6058	1.650710e-04	0	301	1179586	2.551740e-04	0	0	90828	0.000000e+00	0	50	179912	2.7791364667170617E-4	7	390	0.017948717948717947	0	4496	0	194	10548	0.01839211224876754	3	804	0.0037313432835820895	2	972	0.00205761316872428	0	1850	0	0	278	0	16	17722	9.02832637399842E-4	201	10938	0.018376302797586397	0	6346	0	272	216972	0.0012536179783566542	not_specified|not_provided|UDPglucose-4-epimerase_deficiency	criteria_provided,_conflicting_classifications	NC_000001.11:g.23796722T>C	ClinGen:CA340116|OMIM:606953.0005|UniProtKB:Q14376#VAR_002544	CN169374|C3661900|C0751161	230350	352|79238	NAD(P)-binding domain	Lys	Arg	98.64	0.0975609756097561																																																																																																																																																																																																																																																																																																																																																																																																																																																																													20			98.64	Positively-charged	Lysine		UDP-glucose 4-epimerase										-3.9								 K257-A253 (PAE:  1.0), K257-E317 (PAE: 1.0), K257-C262 (PAE: 1.0)	K257-A253 (PDBs: 1EK5, 1HZJ), K257-E317 (PDBs: 1EK5, 1HZJ), K257-C262 (PDBs: 1EK5, 1EK6)	 K257-A253 (PAE:  1.0), K257-C262 (PAE: 1.0)	K257-A253 (PDBs: 1EK5, 1HZJ), K257-C262 (PDBs: 1EK5, 1EK6, 1HZJ), K257-Q261 (PDBs: 1HZJ)	 K257-E260 (PAE:  1.0)	K257-E260 (PDBs: 1EK6, 1HZJ)					147									-59.7				-39.1				dbSNP: rs28940884; Variant type: LP/P; AA change: Lys257Arg; PTM type: Ubiquitylation; PTM morphology: ALRK*LkEQCGC; Var class: II		H (helix)	H (α-helix)	Helix											98.64	9.756097	>90	<10	230350	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic renal disease; Rare genetic hepatic disease; Rare inborn errors of metabolism	4	GALACTOSEMIA III	false	0.7005555742195491	0.7016198549331394	false	false	false
HBD	HBD_Asp100Asn	B_7-8	1.2066019300732655	0.2940641974982203	0.3818236690833452	-0.15563180849278413	0.8814272403354461	0.9045967483308409	2024_01_Batch_7-8	false	false	true	false	false	false	false	false	false	false	false	false	0.8827564742032015	0.6912760230443366	0.9463363814651422	0.7417673154387261	0.7361000426743631	0.9424015410952706	0.9424015410952706	0.9332947616243711	0.9469516319529807	0.9463363814651422	0.8885960445647689	0.8827564742032015		0.5389053237243553	0.5365829989244716		0.4939560015239041		HBD	Asp100Asn	NC_000011.10:5234008:C:T	298G>A	11	5234008	C	T	11	ENSG00000223609	13796	218149	CCSBVarC006563	ALE00006562	ENSP00000497529.1	CEGS2	CegsMutGDEh1045	G01	GDEhDisVCh_40036	D02	2	CegsMutGDDh1045	G01	VUSN2Hmut_GDN2h_09	E08	VUSMutpDEST2_11	C06	VUSmut_GDEh09	E08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	30084.0	single nucleotide variant	NM_000519.3(HBD):c.298G>A (p.Asp100Asn)	3045.0	HBD	HGNC:4829	other	0.0	Dec 12, 2017	35329985.0	-	RCV000016190	-	HEMOGLOBIN A(2) CANADA	germline	germline	GRCh38	NC_000011.10	11	5234008.0	5234008.0	11p15.4	no assertion criteria provided	1.0	-	N	HBVAR:673,ClinGen:CA124639,UniProtKB:P02042#VAR_003114,OMIM:142000.0004	1.0	15045.0	5234008.0	C	T	-	-	-	-	-	-	298G>A 	Asp100Asn	NM_000519.3		Others	Others	15045	11	5234008.0	C	T	D	N	rs35329985	11	5255238	11	5211814	100	HBD	ENSG00000223609	ENST00000650601	ENSP00000497529	P02042	HBD_HUMAN	c.298G>A	p.Asp100Asn	c.298G>A	p.Asp100Asn	principal1	Y	.	YES	Select	-	GAT	1	0	C	./.	./.	./.	./.	.	0.61594	.	.	0.83643	.	0.772	0.43988	P	0.768	0.56746	P	.	0.93829	.	.	.	.	4.11	0.97321	H	.	0.75644	.	.	0.84673	1.0639	0.98430	D	0.9260	0.97550	D	10	0.9185041	0.91109	D	0.282831	0.90269	D	.	0.95902	0.844	0.94817	P02042	D100N	Gain of ubiquitination at K96 (P = 0.1181)| Gain of methylation at K96 (P = 0.1507)| Loss of disorder (P = 0.3528)| Gain of catalytic residue at D100 (P = 0.3589)| Loss of helix (P = 0.3949)	.	0.98481	.	0.71928	.	.	0.590977787971	0.51565	T	0.121198	0.46301	T	0.172528	0.71144	D	0.0100479	0.70770	D	0.996606469154358	0.89607	D	.	0.73431	.	0.7370533	0.79886	0.5070583	0.71253	0.6931516	0.77428	0.5562797	0.74083	-10.421	0.76467	D	0.9789	0.90903	LP	0.718061441257727	0.67650	0.99992025	0.99909	0.617	0.78611	.	.	.	.	.	.	4.18446	0.63095	24.5	0.99867759545799928	0.94551	0.766759	0.70175	D	0.63819117566807	0.75477	6.335851	0.529301650153683	0.69807	5.436995	4.42	3.5	0.39111	2.94	0.53773	3.689	0.54529	.	.	0.53	0.24764	1.0	0.71675	0.000000	0.08389	0.982	0.59239	867	0.32049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	8	0	0	30	0	0	0	0	0	1084	0	0	0	0	0	0	0	0	0	0	0	0	0	0	32	0	0	1114	0	0	0	0	0	1154	0	HEMOGLOBIN_A(2)_CANADA	no_assertion_criteria_provided	NC_000011.10:g.5234008C>T	ClinGen:CA124639|HBVAR:673|OMIM:142000.0004|UniProtKB:P02042#VAR_003114	.	.	.	Globin|Globin	Asp	Asn	96.2	0.5337423312883436																																																																																																																																																																																																																																																																																																																																																																																																																																																																													87			96.2	Negatively-charged	Aspartic Acid		Hemoglobin subunit delta							Globin			-3.5																		132									-61.4				128.4				dbSNP: rs35329985; Variant type: LB/B; AA change: Asp100Asn; PTM type: Acetylation; PTM morphology: ELHCDkLHVD*P; Var class: II		C (loop/coil)	C (loop/coil)												96.2	53.37423	>90	10-90		unknown		Rare genetic hematologic disease	1		false	0.6912760230443366	0.8827564742032015	false	false	false
COMP	COMP_Asp605Asn	B_7-8	-0.7173305422161504	0.5128294513470152	0.5939989400077617	2.016794633768999	0.08352437088875973	0.11211940057123197	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7245738811198417	0.7160791380743168	0.8883330698751695	0.8307846606221505	0.7374853855095739	0.8936449220394902	0.8936449220394902	0.7900663118367455	0.7863034159584062	0.8883330698751695	0.732146807722728	0.7245738811198417		0.6849044591824023	0.8752659052858949		0.7000114684259056		COMP	Asp605Asn	NC_000019.10:18784997:C:T	1813G>A	19	18784997	C	T	19	ENSG00000105664	56661	219641	CCSBVarC006428	ALE00006428	ENSP00000222271.2	CEGS2	CegsMutGDEh1045	E01	GDEhDisVCh_40037	A04	1	CegsMutGDDh1045	E01	VUSN2Hmut_GDN2h_09	D08	VUSMutpDEST2_13	B10	VUSmut_GDEh09	D08	1.0	1.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	76463.0	single nucleotide variant	NM_000095.3(COMP):c.1813G>A (p.Asp605Asn)	1311.0	COMP	HGNC:2227	not provided	0.0	-	397515512.0	-	RCV002054895	Human Phenotype Ontology:HP:0002654,MONDO:MONDO:0016648,MedGen:C0026760,OMIM:PS132400,Orphanet:251	Multiple epiphyseal dysplasia	germline	germline	GRCh38	NC_000019.10	19	18784997.0	18784997.0	19p13.11	no classification provided	1.0	-	N	ClinGen:CA344888	1.0	65555.0	18784997.0	C	T	-	-	-	-	-	-	1813G>A 	Asp605Asn	NM_000095.3		Others	Others	65555	19	18784997.0	C	T	D	N	rs397515512	19	18895807	19	18756807	605	COMP	ENSG00000105664	ENST00000222271	ENSP00000222271	P49747	COMP_HUMAN	c.1813G>A	p.Asp605Asn	c.1813G>A	p.Asp605Asn	principal1	Y	1	YES	Select	-	GAC	1	0	C	./.	./.	./.	./.	0.069	0.35685	T	0.263	0.23579	T	1.0	0.90580	D	1.0	0.97365	D	0.93	0.93829	A	simple_aae	7.0	93.0	1.98	0.53535	M	-4.77	0.80457	D	0.853	0.84884	0.9687	0.96671	D	0.8956	0.96529	D	10	0.9249765	0.91756	D	0.536014	0.95650	D	0.805	0.93639	0.793	0.91393	P49747	D605N	Gain of catalytic residue at S608 (P = 0.1472)| Gain of sheet (P = 0.1539)| Loss of phosphorylation at Y610 (P = 0.1747)| Loss of loop (P = 0.2237)| Gain of MoRF binding (P = 0.3633)	0.925444043467	0.92411	0.695992405880419	0.69386	.	.	0.864790081978	0.91802	D	0.900734	0.98030	D	0.121919	0.66326	D	-0.0626487	0.65905	T	0.997239947319031	0.91003	D	0.966403	0.87710	D	0.66821533	0.76072	0.63807	0.78632	0.7214379	0.78998	0.53389585	0.72812	-7.713	0.62916	D	0.3784	0.64437	A	0.999622909725022	0.97231	0.99093220	0.96879	0.395	0.64297	.	.	.	.	.	.	5.373175	0.90084	31.0	0.99891333968165319	0.96515	0.797522	0.72332	D	0.582735195162419	0.71949	5.752462	0.533852668562058	0.70121	5.482371	4.19	4.19	0.48586	4.3	0.81401	4.684	0.61458	7.654000	0.63915	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.934	0.47248	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Multiple_epiphyseal_dysplasia	no_classification_provided	NC_000019.10:g.18784997C>T	ClinGen:CA344888	C0026760	PS132400	251	Thrombospondin, C-terminal|Thrombospondin, C-terminal	Asp	Asn	97.88	0.12883435582822086																																																																																																																																																																																																																																																																																																																																																																																																																																																																													21			97.88	Negatively-charged	Aspartic Acid		Cartilage oligomeric matrix protein							TSP C-terminal			-3.5																		132									-144.5				172.4	Mediates cell survival and induction of the IAP family of survival proteins					B (undefined)	E (parallel sheets)	Beta strand											97.88	12.883435	>90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	2		false	0.7160791380743168	0.7245738811198417	false	false	false
PYGL	PYGL_Tyr821His	B_7-8	1.548645980190947	0.17243738972314976	0.25077418179396144	-7.774108415944837	0.00023843223463495316	0.0007798986640911569	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7865406042991958	0.800437212711606	0.6500650772723822	0.7763123781245398	0.622318872777506	0.731217727721688	0.9189353768928944	0.7476652338597181	0.9323782386537715	0.8655883656884592	0.9215840199281694	0.9417185758259845	0.5435000785504818	0.49697251169529394	0.620246517595308	0.434541788856305	0.6792904054950425	0.6313626327724072	PYGL	Tyr821His	NC_000014.9:50905475:A:G	2461T>C	14	50905475	A	G	14	ENSG00000100504	55246	219181	CCSBVarC003084	ALE00003084	ENSP00000216392.7	CEGS2	CegsMutGDEh1038	F10	GDEhDisVCh_40063	B09	1	CegsMutGDDh1038	F10	VUSN2Hmut_GDN2h_07	E12	VUSMutpDEST2_13	G05	VUSmut_GDEh07	E12	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	34188.0	single nucleotide variant	NM_002863.5(PYGL):c.2461T>C (p.Tyr821His)	5836.0	PYGL	HGNC:9725	not provided	0.0	-	113993988.0	-	RCV000020501	MONDO:MONDO:0009294,MedGen:C0017925,OMIM:232700,Orphanet:369	Glycogen storage disease, type VI	unknown	unknown	GRCh38	NC_000014.9	14	50905475.0	50905475.0	14q22.1	no classification provided	1.0	-	N	ClinGen:CA341920	1.0	21336.0	50905475.0	A	G	-	-	-	-	-	-	2461T>C 	Tyr821His	NM_002863.5		Others	Others	21336	14	50905475.0	A	G	Y	H	rs113993988	14	51372193	14	50441943	821	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.2461T>C	p.Tyr821His	c.2461T>C	p.Tyr821His	principal1	Y	1	YES	Select	-	TAT	1	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.93	0.94956	A	simple_aae	7.0	93.0	4.54	0.99078	H	-4.52	0.78335	D	0.954	0.96317	1.0879	0.99155	D	0.9657	0.98904	D	10	0.96354115	0.95749	D	0.458648	0.94463	D	0.971	0.99671	0.85	0.95175	P06737	Y821H	Gain of disorder (P = 0.0339)| Gain of ubiquitination at K819 (P = 0.0592)| Gain of methylation at K819 (P = 0.07)| Loss of phosphorylation at Y821 (P = 0.0722)| Loss of MoRF binding (P = 0.1988)	0.986267851924	0.98597	0.9692329889096627	0.96894	0.614856790174	0.55701	0.748046636581	0.74113	T	0.822334	0.95635	D	0.456434	0.92710	D	0.599388	0.96959	D	0.997018337249756	0.90497	D	0.990601	0.97084	D	0.9796515	0.99067	0.87842375	0.93363	0.9718516	0.98404	0.91585046	0.96050	-14.559	0.94742	D	0.9947	0.95370	P	0.992732200343268	0.89666	0.87941970	0.90519	0.898	0.94604	.	.	.	.	.	.	5.068668	0.84548	28.3	0.99873706298305454	0.95079	0.943787	0.94990	D	1.11432369729959	0.98381	18.1483	1.02332574153489	0.99024	20.34655	5.98	5.98	0.97142	5.78	0.96072	9.325	0.96016	11.165000	0.87794	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.99	0.65338	364	0.84712	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	1	109400	9.140770e-06	0	8	208116	3.844010e-05	0	7	236926	2.954510e-05	0	1	7164	1.395870e-04	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42764	0.000000e+00	0	0	15688	0.000000e+00	0	1	7164	1.395870e-04	0	1	16216	6.166750e-05	0	0	30518	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	6	89550	6.700170e-05	0	0	30604	0.000000e+00	0	6	89550	6.700170e-05	0	1	14900	6.711410e-05	0	0	34254	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	5	102734	4.866940e-05	0	0	30522	0.000000e+00	0	1	14900	6.711410e-05	0	.	166	1613764	1.028650e-04	1	163	1179786	1.381610e-04	1	2	74902	2.670160e-05	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29600	0.000000e+00	0	0	44888	0.000000e+00	0	0	64028	0.000000e+00	0	0	6084	0.000000e+00	0	163	1179786	1.381610e-04	1	0	91088	0.000000e+00	0	6	115928	5.175626250776344E-5	0	176	0	0	2708	0	0	4674	0	0	790	0	0	946	0	0	656	0	0	280	0	0	8618	0	0	4850	0	0	3364	0	6	134776	4.451831186561406E-5	Glycogen_storage_disease,_type_VI	no_classification_provided	NC_000014.9:g.50905475A>G	ClinGen:CA341920	C0017925	232700	369	.	Tyr	His	97.95	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			97.95	Aromatic	Tyrosine		Glycogen phosphorylase, liver form										-1.3								 Y821-T817 (PAE:  1.0), Y821-I825 (PAE: 1.0), Y821-W826 (PAE: 1.0), Y821-N454 (PAE: 1.5), Y821-T376 (PAE: 1.0)	Y821-W826 (PDBs: 1FA9, 2QLL), Y821-I825 (PDBs: 1FA9, 2QLL), Y821-T817 (PDBs: 1FA9, 2QLL), Y821-N454 (PDBs: 1FA9, 1L5Q, 3CEH, 2QLL), Y821-T376 (PDBs: 1EM6, 1EXV, 1FC0, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 8EMS)	 Y821-I825 (PAE:  1.0), Y821-T817 (PAE: 1.0), Y821-W826 (PAE: 1.0)	Y821-W826 (PDBs: 1FA9, 1EXV, 1L5Q, 1L5S, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 2QLL), Y821-I825 (PDBs: 1FA9, 2QLL), Y821-K483 (PDBs: 1FA9), Y821-T817 (PDBs: 1FA9, 1EM6, 1FC0, 1L5R, 1L7X, 8EMS, 2QLL)							181									-62.7				-46.5						H (helix)	H (α-helix)	Helix											97.95	0.0	>90	<10	232700	autosomal recessive	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE VI	false	0.800437212711606	0.7865406042991958	false	false	false
SFTPA2	SFTPA2_Gly231Val	B_15-16	-4.916843443272604	0.0017198066617549843	0.0070338987664925485	-10.428694418923417	0.000016211848749571528	0.00010305590197656857	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9664455524768731	0.9703547138212358	0.39783225841238945	0.7620386377174575	0.7990107731965022	0.5045369699385809	0.6347451847122894	0.8505104661281631	0.7875153358151996	0.4939995779320342	0.9651562218983338	0.9574689874577266	0.37432875516487235	0.7475110802648411	0.7365619396197153	0.30166493889274465	0.9755532057441378	0.9754221174960197	SFTPA2	Gly231Val	NC_000010.11:79557264:C:A	692G>T	10	79557264	C	A	10	ENSG00000185303	56023	31344	CCSBVarC002523	ALE00002523	ENSP00000361400.2	RC4	RC4_Mut_GDEh1013	G06	GDEhDisVCh_40043	G05	1	RC4_Mut_GDDh1013	G06	NULL	NULL	VUSMutpDEST2_13	F07	VUSmut_GDEh12	B11	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	99.0	99.0	Y	Y	N	Y	Y	28238.0	single nucleotide variant	NM_001098668.4(SFTPA2):c.692G>T (p.Gly231Val)	729238.0	SFTPA2	HGNC:10799	Pathogenic/Likely risk allele	1.0	Jun 09, 2022	121917737.0	-	RCV000014086|RCV002509155	MONDO:MONDO:0800029,MedGen:C5561926,OMIM:178500,Orphanet:2032,Orphanet:79126|Human Phenotype Ontology:HP:0002206,Human Phenotype Ontology:HP:0006523,MONDO:MONDO:0002771,MedGen:C0034069	Interstitial lung disease 2|Pulmonary fibrosis	germline	germline	GRCh38	NC_000010.11	10	79557264.0	79557264.0	10q22.3	no assertion criteria provided	2.0	-	N	ClinGen:CA256736,OMIM:178642.0001	3.0	13199.0	79557264.0	C	A	-	-	-	-	-	-	692G>T 	Gly231Val	NM_001098668.4		Others	Others	13199	10	79557264.0	C	A	G	V	rs121917737	10	81317020	10	80987026	231	SFTPA2	ENSG00000185303	ENST00000372327	ENSP00000361402	Q8IWL1	SFPA2_HUMAN	c.692G>T	p.Gly231Val	c.692G>T	p.Gly231Val	principal1	Y	1	.	.	-	GGG	2	0	C	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	.	.	.	.	.	.	0.92	0.93300	A	simple_aae	8.0	92.0	3.365	0.91151	M	-8.8	0.97796	D	0.951	0.95970	0.3509	0.88304	D	0.5073	0.81382	D	9	0.9860673	0.98884	D	0.028109	0.50635	D	0.550	0.81273	0.96	0.99581	ENST00000372325	G231V	Gain of solvent accessibility (P = 0.0713)| Gain of catalytic residue at G231 (P = 0.0847)| Gain of relative solvent accessibility (P = 0.09)| Gain of phosphorylation at Y228 (P = 0.1757)| Loss of sheet (P = 0.302)	0.652253901461	0.64663	.	0.90652	.	0.97382	0.553801178932	0.46327	T	0.168613	0.51321	T	0.251576	0.78592	D	0.123595	0.78313	D	0.949136964143425	0.62820	D	.	.	.	.	.	.	.	.	.	.	.	-11.965	0.84724	D	0.9111	0.84719	P	.	.	0.96121150	0.94039	0.899	0.94663	.	.	.	.	.	.	3.853656	0.55923	23.7	0.99642244111277967	0.76782	0.276710	0.38939	N	0.452915742731941	0.64183	4.689808	0.238474635838869	0.51746	3.377622	2.81	2.81	0.31889	.	.	3.944	0.56429	7.383000	0.58531	0.444	0.2119	0.898	0.3147	1.000000	0.68239	0.36	0.25935	649	0.63066	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pulmonary_fibrosis|Interstitial_lung_disease_2	no_assertion_criteria_provided	NC_000010.11:g.79557264C>A	ClinGen:CA256736|OMIM:178642.0001	C0034069|C5561926	178500	2032|79126	C-type lectin-like|C-type lectin, conserved site|C-type lectin-like|C-type lectin-like|Collectin, C-type lectin-like domain	Gly	Val	98.44	0.011904761904761904																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Pulmonary surfactant-associated protein A2							C-type lectin			-0.4																		75																																98.44	1.1904762	>90	<10	178500	autosomal dominant	OMIM		0	INTERSTITIAL LUNG DISEASE 2	false	0.9703547138212358	0.9664455524768731	true	true	false
GFAP	GFAP_Glu371Val	B_15-16	-0.18990433174008153	0.8547736515913534	0.8848876284766857	15.927550283522942	9.331365516321612e-7	0.000016038019525826212	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.9431671051022912	0.9397740864126181	0.7214831871293323	0.8161017781758028	0.8591683936082204	0.8169335246328615	0.7945161509441068	0.8629155190255939	0.7999881349121674	0.7469587585437101	0.9375334340879008	0.9339371788721245	0.8393508983216162	0.8554212681908467	0.8322154214394382	0.6960076157149546	0.9420147387373354	0.9523970313324578	GFAP	Glu371Val	NC_000017.11:44911251:T:A	1112A>T	17	44911251	T	A	17	ENSG00000131095	2920	214445	CCSBVarC004678	ALE00004678	ENSP00000466598.2	CEGS2	CegsMutGDEh1044	A10	GDEhDisVCh_40051	F09	1	CegsMutGDDh1044	A10	VUSN2Hmut_GDN2h_09	B07	VUSMutpDEST2_03	G02	VUSmut_GDEh09	B07	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77335.0	single nucleotide variant	NM_002055.5(GFAP):c.1112A>T (p.Glu371Val)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	57815192.0	-	RCV000192171|RCV000056832	MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MedGen:C3661900	Alexander disease|not provided	germline	germline	GRCh38	NC_000017.11	17	44911251.0	44911251.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217117,UniProtKB:P14136#VAR_071561	3.0	66438.0	44911251.0	T	A	-	-	-	-	-	-	1112A>T 	Glu371Val	NM_002055.5		Others	Others	66438	17	44911251.0	T	A	E	V	rs57815192	17	42988619	17	40344145	371	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.1112A>T	p.Glu371Val	c.1112A>T	p.Glu371Val	principal1	Y	1	YES	Select	-	GAG	2	0	T	./.	./.	./.	./.	.	0.91343	.	.	0.92967	.	0.998	0.73231	D	0.968	0.71743	D	0.27	0.97926	A	without_aae	73.0	27.0	4.225	0.97896	H	.	0.90429	.	.	0.92554	1.0772	0.98792	D	0.9295	0.97668	D	10	0.9846542	0.98658	D	0.685946	0.97401	D	.	0.99890	0.896	0.97582	P14136	E371V	Loss of disorder (P = 0.0283)| Loss of ubiquitination at K368 (P = 0.0618)| Gain of catalytic residue at K368 (P = 0.1297)| Gain of methylation at K368 (P = 0.396)| Loss of solvent accessibility (P = 0.5485)	.	0.99869	.	0.91806	.	0.83207	0.711781620979	0.68798	T	0.973414	0.99725	D	0.553755	0.95825	D	0.557654	0.95762	D	0.999255955219269	0.96681	D	0.980702	0.97955	D	0.9747318	0.98661	0.96749395	0.99341	0.96709365	0.97951	0.9683607	0.99383	-16.646	0.98581	D	0.9708	0.90603	P	0.987607464043203	0.87498	0.99952447	0.99453	0.997	0.99892	.	.	.	.	.	.	5.772296	0.93491	33.0	0.99099802535135528	0.52527	0.961871	0.98321	D	0.864067518918313	0.89839	10.16316	0.750618527143092	0.86126	8.81481	4.25	4.25	0.49600	.	.	8.017	0.8876	7.887000	0.72871	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.997	0.79771	754	0.51253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Alexander_disease|not_provided	no_classification_provided	NC_000017.11:g.44911251T>A	ClinGen:CA217117|UniProtKB:P14136#VAR_071561	C0270726|C3661900	203450	58	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	Glu	Val	82.04	0.5567010309278351																																																																																																																																																																																																																																																																																																																																																																																																																																																																													108			82.04	Negatively-charged	Glutamic Acid		Glial fibrillary acidic protein							IF rod			-3.5								 E371-N375 (PAE:  3.0), E371-R367 (PAE: 2.0)		 E371-N375 (PAE:  3.0), E371-R367 (PAE: 2.0)								146									-59.0				-37.8	Coil 2B			dbSNP: rs267607526; Variant type: LP/P; AA change: Glu371Gln; PTM type: Ubiquitylation; PTM morphology: IATYRkLLE*GE; Var class: II&rs57815192		H (helix)	H (α-helix)												82.04	55.6701	70-90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.9397740864126181	0.9431671051022912	false	false	false
MVK	MVK_Ile119Met	B_7-8	-1.4570504063598197	0.19536472846022682	0.2757920409157673	-0.11710258551422485	0.9106002828607251	0.9277909600496561	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6351980863626471	0.6183763029260163	0.813778614813317	0.7749107597981257	0.7922879224271896	0.8979842678163601	0.8694126987956992	0.7134697745592538	0.7241195728970575	0.7969996594242463	0.6200063118794289	0.6225870490758344	0.9265558368370211	0.8711060702951254	0.8257019466991938	0.8305575702023877	0.6167462939726037	0.6478091236494598	MVK	Ile119Met	NC_000012.12:109579932:C:G	357C>G	12	109579932	C	G	12	ENSG00000110921	281	200087	CCSBVarC004834	ALE00004834	ENSP00000228510.3	CEGS2	CegsMutGDEh1038	B12	GDEhDisVCh_40020	A03	2	CegsMutGDDh1038	B12	VUSN2Hmut_GDN2h_08	B01	VUSMutpDEST2_01	F04	VUSmut_GDEh08	B01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	103474.0	single nucleotide variant	NM_000431.4(MVK):c.357C>G (p.Ile119Met)	4598.0	MVK	HGNC:7530	not provided	0.0	-	104895341.0	-	RCV000083834	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343	Hyperimmunoglobulin D with periodic fever	unknown	unknown	GRCh38	NC_000012.12	12	109579932.0	109579932.0	12q24.11	no classification provided	1.0	-	N	ClinGen:CA149815	2.0	97582.0	109579932.0	C	G	-	-	-	-	-	-	357C>G 	Ile119Met	NM_000431.4		Others	Others	97582	12	109579932.0	C	G	I	M	rs104895341	12	110017737	12	108502120	119	MVK	ENSG00000110921	ENST00000228510	ENSP00000228510	Q03426	KIME_HUMAN	c.357C>G	p.Ile119Met	c.357C>G	p.Ile119Met	principal1	Y	1	YES	Select	+	ATC	3	3	C	C/C	C/C	C/C	C/C	0.003	0.72322	D	0.005	0.72530	D	0.959	0.55150	D	0.875	0.62099	P	0.77	0.93829	D	simple_aae	23.0	77.0	3.18	0.88694	M	-2.23	0.50028	N	0.813	0.80799	0.8195	0.94633	D	0.8532	0.95097	D	10	0.93286395	0.92539	D	0.296827	0.90729	D	0.798	0.93363	0.829	0.93882	Q03426	I119M	Gain of catalytic residue at I119 (P = 0.0276)| Loss of ubiquitination at K122 (P = 0.1601)| Loss of methylation at K122 (P = 0.2342)| Gain of MoRF binding (P = 0.276)| Gain of disorder (P = 0.4133)	0.96238933022	0.96165	0.5709915555190409	0.56842	0.63478802556	0.57037	0.495771706104	0.38187	T	0.299091	0.72684	T	0.448101	0.92339	D	0.405889	0.92245	D	0.9623042345047	0.66114	D	0.855114	0.54106	D	0.53326344	0.68714	0.30127737	0.55943	0.51938814	0.67921	0.27504328	0.53231	-8.116	0.61933	D	0.2408	0.47494	LB	0.856387330960652	0.73441	0.99720700	0.98300	0.835	0.90915	.	.	.	.	.	.	4.3472	0.6681	25.0	0.9961912286375102	0.75321	0.401598	0.47424	N	0.510158584318399	0.67518	5.115252	0.467247692618781	0.65645	4.873871	4.92	4.01	0.45757	5.16	0.91535	1.98	0.40345	2.183000	0.31229	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.924	0.46023	730	0.54265	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hyperimmunoglobulin_D_with_periodic_fever	no_classification_provided	NC_000012.12:g.109579932C>G	ClinGen:CA149815	C0398691	260920	343	.	Ile	Met	92.27	0.01775147928994083																																																																																																																																																																																																																																																																																																																																																																																																																																																																													3			92.27	Aliphatic	Isoleucine		Mevalonate kinase										4.5								 I119-L115 (PAE:  1.0)	I119-L115 (PDBs: 2R3V)	 I119-L115 (PAE:  1.0)	I119-L115 (PDBs: 2R3V)							131									-77.7				-48.1						H (helix)	H (α-helix)	Helix											92.27	1.7751479	>90	<10	260920	autosomal recessive	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME	false	0.6183763029260163	0.6351980863626471	false	false	false
FOXP3	FOXP3_Leu242Pro	B_15-16	-2.7270833586918006	0.029462536943896656	0.06143389253585438	-9.363211252931189	0.000032955587335360155	0.0001742752240933311	2025_03_Batch_15-16	true	true	false	false	true	true	false	false	false	false	false	false	0.9316247236709285	0.9499047156707164	0.6963977956913603	0.8456901490201363	0.9112255653811472	0.8481109279261383	0.8274582644655514	0.9258481747169042	0.8182776347703958	0.6975046481732077	0.9640977296026298	0.9542216369449253	0.8687635913867251	0.8966029560453903	0.8731026632698768	0.6952909432095129	0.935711701738803	0.9090278103969316	FOXP3	Leu242Pro	NC_000023.11:49255725:A:G	725T>C	23	49255725	A	G	X	ENSG00000049768	53657	27196	CCSBVarC002262	ALE00002262	ENSP00000365380.4	RC4	RC4_Mut_GDEh1021	C05	GDEhDisVCh_40080	G10	2	RC4_Mut_GDDh1021	C05	NULL	NULL	NULL	NULL	VUSmut_GDEh13	H03	1.0	1.0	1.0	6.0	0.0			0.0			1.0	1.0	99.0	Y	N	N	N	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												107			79.49	Aliphatic	Leucine		Forkhead box protein P3; Forkhead box protein P3, C-terminally processed; Forkhead box protein P3 41 kDa form								0.0773		3.8								 L242-M238 (PAE:  1.0), L242-L246 (PAE: 1.0)		 L242-M238 (PAE:  1.0), L242-L246 (PAE: 1.0)								131	Nuclear export signal	Mutation: L -> A. Decrease in nuclear export; when associated with A-246 and A-248.							-66.2		Pocket 5: Mean pLDDT: 58.46, Volume: 796.06 Å³, Druggability score: 0.08		-38.0	Leucine-zipper					H (helix)	H (α-helix)														NaN	NaN		unknown		Rare genetic immune disease; Rare genetic endocrine disease; Rare genetic gastroenterological disease	3		false	0.9499047156707164	0.9316247236709285	true	true	false
GFAP	GFAP_Ala364Pro	B_15-16	-2.2464246117882904	0.059511161984062096	0.106767039501231	7.711442785145749	0.00011515774194813486	0.0004524934828154764	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8610468524645003	0.8647137427494127	0.7307688132618599	0.8006351271363527	0.7886148197802627	0.7483901046542161	0.6518899491330692	0.7761617210562479	0.7365095474261623	0.6359357548819913	0.8565444760916288	0.868051095363212	0.8448902601753631	0.8010679185042774	0.864760706846543	0.8256018716417287	0.8728830094071968	0.8540426095657885	GFAP	Ala364Pro	NC_000017.11:44911273:C:G	1090G>C	17	44911273	C	G	17	ENSG00000131095	2920	214433	CCSBVarC004675	ALE00004675	ENSP00000466598.2	CEGS2	CegsMutGDEh1044	D02	GDEhDisVCh_40051	D09	1	CegsMutGDDh1044	D02	VUSN2Hmut_GDN2h_09	G04	VUSMutpDEST2_03	B02	VUSmut_GDEh09	G04	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77329.0	single nucleotide variant	NM_002055.5(GFAP):c.1090G>C (p.Ala364Pro)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	58645997.0	-	RCV000192165|RCV000056826	MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MedGen:C3661900	Alexander disease|not provided	germline	germline	GRCh38	NC_000017.11	17	44911273.0	44911273.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217108,UniProtKB:P14136#VAR_071558	3.0	66432.0	44911273.0	C	G	-	-	-	-	-	-	1090G>C 	Ala364Pro	NM_002055.5		Others	Others	66432	17	44911273.0	C	G	A	P	rs58645997	17	42988641	17	40344167	364	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.1090G>C	p.Ala364Pro	c.1090G>C	p.Ala364Pro	principal1	Y	1	YES	Select	-	GCC	1	0	C	./.	./.	./.	./.	.	0.78662	.	.	0.74454	.	0.988	0.62341	D	0.919	0.65468	D	0.18	0.96253	A	without_aae	82.0	18.0	4.365	0.98493	H	.	0.78079	.	.	0.92320	0.8878	0.95492	D	0.8723	0.95747	D	10	0.98182255	0.98208	D	0.315499	0.91296	D	.	0.95902	0.949	0.99385	P14136	A364P	Gain of ubiquitination at K368 (P = 0.1278)| Gain of disorder (P = 0.2171)| Gain of phosphorylation at T365 (P = 0.2184)| Gain of methylation at K368 (P = 0.3269)| Gain of solvent accessibility (P = 0.4067)	.	0.99910	.	0.98467	.	0.84617	0.757443606853	0.75506	T	0.972124	0.99703	D	0.45574	0.92681	D	0.416862	0.92590	D	0.999285519123077	0.96791	D	0.972803	0.93928	D	0.97828716	0.98958	0.9354729	0.97430	0.97529674	0.98710	0.9484851	0.98282	-18.075	0.99555	D	0.9981	0.97748	P	0.998238838835262	0.94150	0.99939420	0.99348	0.992	0.99727	.	.	.	.	.	.	7.088437	0.96133	35.0	0.99742241980131796	0.83644	0.889470	0.82290	D	0.744912748173576	0.82476	7.796077	0.619242687316377	0.76207	6.472642	4.25	3.19	0.35642	3.57	0.65107	2.807	0.47751	4.877000	0.45703	0.596	0.33565	1.0	0.71675	1.000000	0.68239	1.0	0.97202	754	0.51253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Alexander_disease	no_classification_provided	NC_000017.11:g.44911273C>G	ClinGen:CA217108|UniProtKB:P14136#VAR_071558	C3661900|C0270726	203450	58	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	Ala	Pro	95.36	0.42452830188679247																																																																																																																																																																																																																																																																																																																																																																																																																																																																													45			95.36	Aliphatic	Alanine		Glial fibrillary acidic protein							IF rod			1.8								 A364-D360 (PAE:  1.0), A364-K368 (PAE: 1.0)		 A364-D360 (PAE:  1.0), A364-K368 (PAE: 1.0)								89									-63.5				-36.2	Coil 2B			dbSNP: rs58645997; Variant type: LP/P; AA change: Ala364Pro; PTM type: Ubiquitylation; PTM morphology: IA*TYRkLLEGE; Var class: II		H (helix)	H (α-helix)												95.36	42.45283	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.8647137427494127	0.8610468524645003	false	false	false
KRT6A	KRT6A_Leu468Pro	B_7-8	-1.088095214869225	0.3183174055181514	0.4058653167821557	-4.814187505747358	0.0019343686331709765	0.004103545019501435	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.9203691951095446	0.9011227959557031	0.5897425718381373	0.669593914909834	0.6243101129366144	0.6306303030122762	0.6458377606439605	0.7395478850171897	0.7621429591637379	0.5972670423845358	0.9263908859054653	0.9372365814397151	0.6154228453805919	0.5090723408560391	0.5770448706559302	0.5822181012917388	0.8758547060059411	0.9035018087793741	KRT6A	Leu468Pro	NC_000012.12:52488349:A:G	1403T>C	12	52488349	A	G	12	ENSG00000205420	4870	215290	CCSBVarC003676	ALE00003676	ENSP00000369317.3	CEGS2	CegsMutGDEh1036	D07	GDEhDisVCh_40048	B09	2	CegsMutGDDh1036	D07	VUSN2Hmut_GDN2h_07	D05	VUSMutpDEST2_04	G10	VUSmut_GDEh07	D05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77472.0	single nucleotide variant	NM_005554.4(KRT6A):c.1403T>C (p.Leu468Pro)	3853.0	KRT6A	HGNC:6443	not provided	0.0	-	59018888.0	-	RCV000056995	MedGen:CN517202	not provided	not provided	not provided	GRCh38	NC_000012.12	12	52488349.0	52488349.0	12q13.13	no classification provided	1.0	-	N	UniProtKB:P02538#VAR_072465,ClinGen:CA217339	2.0	66575.0	52488349.0	A	G	-	-	-	-	-	-	1403T>C 	Leu468Pro	NM_005554.4		Others	Others	66575	12	52488349.0	A	G	L	P	rs59018888	12	52882133	12	51168400	468	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.1403T>C	p.Leu468Pro	c.1403T>C	p.Leu468Pro	principal1	Y	1	YES	Select	-	CTG	2	0	.	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.92	0.93300	D	simple_aae	8.0	92.0	4.315	0.98290	H	-6.51	0.91674	D	0.995	0.99931	1.0964	0.99506	D	0.9576	0.98626	D	10	0.97682196	0.97459	D	0.373632	0.92791	D	0.982	0.99890	0.864	0.95972	P02538	L468P	Loss of stability (P = 0.0132)| Gain of disorder (P = 0.0216)| Gain of catalytic residue at L468 (P = 0.0267)| Gain of ubiquitination at K467 (P = 0.0539)| Gain of phosphorylation at Y465 (P = 0.1165)	0.994200044025	0.99405	0.90827803872817	0.90743	1.25766705416	0.81860	0.847344219685	0.89195	D	0.951565	0.99298	D	0.552911	0.95811	D	0.556442	0.95747	D	0.999769747257233	0.98872	D	0.959104	0.84578	D	0.9755703	0.98734	0.97148854	0.99520	0.9755703	0.98734	0.97148854	0.99520	-13.685	0.92004	D	0.9984	0.97748	P	0.997384177427371	0.93077	0.97116560	0.94747	0.998	0.99926	.	.	.	.	.	.	4.688877	0.75166	26.3	0.99926368272245947	0.99104	0.955114	0.97261	D	1.03222520383157	0.96633	14.96481	0.911466346752379	0.96031	14.25029	5.02	5.02	0.66699	.	.	8.983	0.93056	.	.	0.679	0.82395	1.0	0.71675	1.000000	0.68239	0.982	0.59239	734	0.53826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	no_classification_provided	NC_000012.12:g.52488349A>G	ClinGen:CA217339|UniProtKB:P02538#VAR_072465	CN517202	.	.	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Pro	86.54	0.7378048780487805																																																																																																																																																																																																																																																																																																																																																																																																																																																																													121			86.54	Aliphatic	Leucine		Keratin, type II cytoskeletal 6A							IF rod	0.1155		3.8								 L468-E472 (PAE:  5.0), L468-T464 (PAE: 2.5)		 L468-E472 (PAE:  5.0), L468-T464 (PAE: 2.5)								131									-70.3		Pocket 2: Mean pLDDT: 70.76, Volume: 452.79 Å³, Druggability score: 0.12		-41.7	Coil 2			dbSNP: rs59018888; Variant type: LP/P; AA change: Leu468Pro; PTM type: Ubiquitylation; PTM morphology: IATYRkL*LEGE; Var class: II&rs59018888		H (helix)	H (α-helix)												86.54	73.78049	70-90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2		false	0.9011227959557031	0.9203691951095446	false	false	false
GFAP	GFAP_Glu207Lys	B_15-16	3.5078217360875152	0.009888331448823923	0.027019618121965225	8.821109313301589	0.00004859836622654789	0.00023717553730243454	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8431054737147848	0.8565096387166026	0.47496854638268976	0.7356149419124169	0.7800590803683576	0.5507968363067448	0.4736451934511251	0.7703418271658241	0.6512133906476401	0.42115578512980745	0.8483009315809701	0.8472489227456252	0.6279484791623644	0.789776333570891	0.8200164931771938	0.5287813076355721	0.8647183458522351	0.8389620246839444	GFAP	Glu207Lys	NC_000017.11:44913430:C:T	619G>A	17	44913430	C	T	17	ENSG00000131095	2920	214418	CCSBVarC004665	ALE00004665	ENSP00000466598.2	CEGS2	CegsMutGDEh1040	F03	GDEhDisVCh_40051	C07	1	CegsMutGDDh1040	F03	VUSN2Hmut_GDN2h_08	B05	VUSMutpDEST2_03	B01	VUSmut_GDEh08	B05	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77388.0	single nucleotide variant	NM_002055.5(GFAP):c.619G>A (p.Glu207Lys)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	267607500.0	-	RCV000056892|RCV000192128	MedGen:C3661900|MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58	not provided|Alexander disease	germline	germline	GRCh38	NC_000017.11	17	44913430.0	44913430.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217201,UniProtKB:P14136#VAR_071540	3.0	66491.0	44913430.0	C	T	-	-	-	-	-	-	619G>A 	Glu207Lys	NM_002055.5		Others	Others	66491	17	44913430.0	C	T	E	K	rs267607500	17	42990798	17	40346324	207	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.619G>A	p.Glu207Lys	c.619G>A	p.Glu207Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.972	0.72694	D	0.75	0.99291	A	without_aae	25.0	75.0	4.035	0.96906	H	.	0.70228	.	.	0.89118	1.0946	0.99429	D	0.9521	0.98440	D	10	0.98428917	0.98601	D	0.446578	0.94253	D	.	0.99315	0.94	0.99178	P14136	E207K	Gain of MoRF binding (P = 0.0094)| Gain of ubiquitination at E207 (P = 0.0267)| Loss of stability (P = 0.1935)| Gain of methylation at K202 (P = 0.1967)| Gain of relative solvent accessibility (P = 0.2629)	.	0.99924	.	0.90928	.	0.82542	0.623541235924	0.56163	T	0.93325	0.98875	D	0.547688	0.95626	D	0.548939	0.95562	D	0.99921703338623	0.96540	D	0.994288	0.98133	D	0.94287944	0.95472	0.89241916	0.94362	0.9494401	0.96149	0.89824814	0.94780	-13.498	0.91328	D	0.8222	0.78296	P	0.995720969607167	0.91550	0.99945146	0.99395	0.997	0.99892	.	.	.	.	.	.	7.601435	0.96686	36.0	0.99926534709331449	0.99104	0.970368	0.99262	D	0.879090098822582	0.90646	10.52364	0.795199427649191	0.89401	9.982968	4.8	4.8	0.61109	3.93	0.74723	7.821	0.84821	7.694000	0.65990	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.763	0.36291	749	0.51874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Alexander_disease	no_classification_provided	NC_000017.11:g.44913430C>T	ClinGen:CA217201|UniProtKB:P14136#VAR_071540	C3661900|C0270726	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Glu	Lys	94.54	0.5257731958762887																																																																																																																																																																																																																																																																																																																																																																																																																																																																													102			94.54	Negatively-charged	Glutamic Acid		Glial fibrillary acidic protein							IF rod			-3.5								 E207-L211 (PAE:  1.0), E207-I203 (PAE: 1.0)	E207-I203 (PDBs: 6A9P), E207-L211 (PDBs: 6A9P)	 E207-L211 (PAE:  1.0), E207-I203 (PAE: 1.0)	E207-L211 (PDBs: 6A9P), E207-I203 (PDBs: 6A9P)							146									-60.1				-44.9	Coil 1B			dbSNP: rs267607500; Variant type: LP/P; AA change: Glu207Lys; PTM type: Ubiquitylation; PTM morphology: IRFLRkIHEEE*; Var class: II&rs267607500		H (helix)	H (α-helix)	Helix											94.54	52.577316	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	true	0.8565096387166026	0.8431054737147848	false	false	false
HBD	HBD_Arg105Ser	B_7-8	1.3598378195486276	0.22275808158860702	0.3037330971845687	-1.8476211312598232	0.10714042131869432	0.1408328604010058	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7079624063608442	0.734875282287377	0.7530889745832634	0.8147231144516631	0.7239194563878304	0.7482346213135912	0.971897949260107	0.9650789307292257	0.9782596188264039	0.9514497202435391	0.9053054232485402	0.9028257726005894	0.5245712933670754	0.4827599820464352	0.6511866100769225	0.5547282289229877	0.5644451413262136	0.513099040121099	HBD	Arg105Ser	NC_000011.10:5233991:C:A	315G>T	11	5233991	C	A	11	ENSG00000223609	13796	218148	CCSBVarC006562	ALE00006561	ENSP00000497529.1	CEGS2	CegsMutGDEh1044	E11	GDEhDisVCh_40036	C02	2	CegsMutGDDh1044	E11	VUSN2Hmut_GDN2h_09	G07	VUSMutpDEST2_11	B06	VUSmut_GDEh09	G07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	30122.0	single nucleotide variant	NM_000519.4(HBD):c.315G>T (p.Arg105Ser)	3045.0	HBD	HGNC:4829	other	0.0	Dec 12, 2017	34390965.0	-	RCV000016236	-	HEMOGLOBIN A(2) CAPRI	germline	germline	GRCh38	NC_000011.10	11	5233991.0	5233991.0	11p15.4	no assertion criteria provided	1.0	-	N	ClinGen:CA124705,UniProtKB:P02042#VAR_030508,OMIM:142000.0042	1.0	15083.0	5233991.0	C	A	-	-	-	-	-	-	315G>T 	Arg105Ser	NM_000519.4		Others	Others	15083	11	5233991.0	C	A	R	S	rs34390965	11	5255221	11	5211797	105	HBD	ENSG00000223609	ENST00000643122	ENSP00000494708	P02042	HBD_HUMAN	c.315G>T	p.Arg105Ser	c.315G>T	p.Arg105Ser	principal1	Y	.	.	.	-	AGG	3	2	C	./.	./.	./.	./.	.	0.91343	.	.	0.83643	.	0.204	0.29820	B	0.714	0.54630	P	.	0.91795	.	.	.	.	3.255	0.89751	M	.	0.66927	.	.	0.70120	0.6948	0.93085	D	0.8754	0.95853	D	9	0.8087406	0.87735	D	0.278975	0.90138	D	.	0.90240	0.747	0.87760	P02042	R105S	Loss of methylation at R105 (P = 0.1098)| Loss of stability (P = 0.2006)| Gain of disorder (P = 0.2367)| Loss of MoRF binding (P = 0.2856)| Gain of catalytic residue at E102 (P = 0.3747)	.	0.92307	0.49261445650698316	0.48986	.	.	0.29166918993	0.09161	T	0.033441	0.22662	T	0.383302	0.88842	D	0.312811	0.88702	D	0.968429267406464	0.68031	D	0.820618	0.47792	T	0.7309404	0.79536	0.58729833	0.75816	0.69215745	0.77373	0.6011523	0.76586	-9.627	0.71726	D	0.8576	0.80558	P	0.749936579020111	0.68799	0.99995494	0.99953	0.479	0.70075	.	.	.	.	.	.	4.141286	0.62114	24.4	0.98283362347797421	0.40016	0.728450	0.67529	D	0.116570431972184	0.46983	2.952148	0.0747240422629203	0.42999	2.633201	4.43	2.5	0.29277	2.07	0.40458	1.382	0.34086	.	.	0.53	0.24764	0.935	0.32542	0.000000	0.08389	0.836	0.39465	867	0.32049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	85100	0	0	208	0	0	466	0	2	5418	3.6913990402362494E-4	0	650	0	0	2154	0	0	124	0	0	164	0	0	2558	0	2	5626	3.5549235691432633E-4	0	590	0	2	96842	2.0652196361083E-5	HEMOGLOBIN_A(2)_CAPRI	no_assertion_criteria_provided	NC_000011.10:g.5233991C>A	ClinGen:CA124705|OMIM:142000.0042|UniProtKB:P02042#VAR_030508	.	.	.	Globin|Globin	Arg	Ser	98.05	0.4596774193548387																																																																																																																																																																																																																																																																																																																																																																																																																																																																													114			98.05	Positively-charged	Arginine		Hemoglobin subunit delta							Globin			-4.5								 R105-N109 (PAE:  1.0)		 R105-N109 (PAE:  1.0), R105-P101 (PAE: 1.0)								175									-66.2				-41.1						H (helix)	H (α-helix)	Helix											98.05	45.967743	>90	10-90		unknown		Rare genetic hematologic disease	1		false	0.734875282287377	0.7079624063608442	false	false	false
TTPA	TTPA_Gly246Arg	B_7-8	-4.592686229844849	0.005879243331272881	0.0181118625205342	-7.296099497011973	0.00016330789184360747	0.0005852929326816791	2024_01_Batch_7-8	true	true	false	false	false	false	false	false	false	false	false	false	0.975213057622112	0.9640450058712045	0.6653589828234339	0.7584275369164067	0.7356936516767864	0.7140093214743437	0.6805015697081904	0.7454067610707149	0.7758574036357918	0.6332701956282782	0.9848176241677922	0.975213057622112	0.747517073240497	0.7259805422828578	0.7409976701970217	0.6974477700185894	0.9432723875746167		TTPA	Gly246Arg	NC_000008.11:63061353:C:G	736G>C	8	63061353	C	G	8	ENSG00000137561	13295	218064	CCSBVarC006535	ALE00006534	ENSP00000260116.4	CEGS2	CegsMutGDEh1047	G04	GDEhDisVCh_40014	B03	2	CegsMutGDDh1047	G04	VUSN2Hmut_GDN2h_10	H04	VUSMutpDEST2_11	G04	VUSmut_GDEh10	H04	1.0	1.0	1.0	1.0	1.0	2.0	6.0	1.0	2.0	99.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	76506.0	single nucleotide variant	NM_000370.3(TTPA):c.736G>C (p.Gly246Arg)	7274.0	TTPA	HGNC:12404	not provided	0.0	-	397515526.0	-	RCV000055805	MONDO:MONDO:0010188,MedGen:C1848533,OMIM:277460,Orphanet:96	Familial isolated deficiency of vitamin E	unknown	unknown	GRCh38	NC_000008.11	8	63061353.0	63061353.0	8q12.3	no classification provided	1.0	-	N	ClinGen:CA344924,UniProtKB:P49638#VAR_022392	1.0	65598.0	63061353.0	C	G	-	-	-	-	-	-	736G>C 	Gly246Arg	NM_000370.3		Others	Others	65598	8	63061353.0	C	G	G	R	rs397515526	8	63973912	8	64136466	246	TTPA	ENSG00000137561	ENST00000260116	ENSP00000260116	P49638	TTPA_HUMAN	c.736G>C	p.Gly246Arg	c.736G>C	p.Gly246Arg	principal1	Y	1	YES	Select	-	GGT	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.002	0.79703	D	1.0	0.90580	D	0.998	0.88579	D	0.89	0.91795	A	simple_aae	11.0	89.0	3.375	0.91274	M	-7.09	0.93964	D	0.712	0.71364	1.0896	0.99220	D	0.9591	0.98677	D	10	0.9880507	0.99196	D	0.367616	0.92652	D	0.910	0.97583	0.953	0.99464	P49638	G246R	Gain of solvent accessibility (P = 0.0014)| Loss of catalytic residue at E244 (P = 0.1344)| Gain of relative solvent accessibility (P = 0.1571)| Loss of phosphorylation at Y245 (P = 0.1895)| Loss of disorder (P = 0.2322)	0.985692187521	0.98538	0.9571208821129769	0.95672	0.713788616662	0.61583	0.554139077663	0.46375	T	0.956042	0.99393	D	0.515083	0.94684	D	0.502105	0.94606	D	0.991561710834503	0.81735	D	0.923908	0.72114	D	0.8949944	0.90811	0.7846201	0.87153	0.8949944	0.90812	0.7846201	0.87154	-11.865	0.84233	D	0.682	0.72167	P	0.941838148495358	0.79546	0.99943727	0.99387	0.755	0.86432	.	.	.	.	.	.	4.647261	0.74089	26.1	0.99930168014787313	0.99334	0.852399	0.76846	D	0.926566243824055	0.92960	11.75841	0.870350746477352	0.94114	12.53909	5.86	5.86	0.93927	3.9	0.73887	4.207	0.58365	5.935000	0.51457	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.995	0.73271	907	0.22720	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	16890	0	0	0	0	0	0	0	0	20	0	0	354	0	0	18	0	0	0	0	0	0	0	1	4090	2.4449877750611245E-4	0	20	0	0	0	0	1	21372	4.679019277559424E-5	Familial_isolated_deficiency_of_vitamin_E	no_classification_provided	NC_000008.11:g.63061353C>G	ClinGen:CA344924|UniProtKB:P49638#VAR_022392	C1848533	277460	96	CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain|CRAL-TRIO lipid binding domain	Gly	Arg	97.38	0.19047619047619047																																																																																																																																																																																																																																																																																																																																																																																																																																																																													16			97.38	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Alpha-tocopherol transfer protein							CRAL-TRIO			-0.4										 G246-P242 (PAE:  1.0)	G246-K230 (PDBs: 1OIP, 1OIZ), G246-P242 (PDBs: 1R5L, 5MUE, 5MUG, 6ZPD, 1OIZ)							75									95.3				12.2						C (loop/coil)	T (turn)												97.38	19.047619	>90	10-90	277460	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3	ATAXIA WITH VITAMIN E DEFICIENCY	false	0.9640450058712045	0.975213057622112	true	true	false
AIPL1	AIPL1_Met79Thr	B_7-8	-0.08813052984784635	0.9326408208990806	0.9495436929196397	-8.417623811637617	0.00006577100710220402	0.00029348644823911756	2024_01_Batch_7-8	true	true	false	false	false	false	true	true	false	false	false	false	0.9938497846075343	0.9951109615911732	0.7427527439159037	0.6586926971236675	0.5964665739566268	0.7810884716024145	0.8042584845864823	0.6285787366322256	0.7527799748774281	0.760619234012183	0.996209142115744	0.9938497846075343	0.7579184586183466	0.564354411281028	0.564605419369907	0.7248862538196245	0.9940127810666024		AIPL1	Met79Thr	NC_000017.11:6433959:A:G	236T>C	17	6433959	A	G	17	ENSG00000129221	7167	12744	CCSBVarC001133	ALE00001133	ENSP00000370521.3	RC4	RC4_Mut_GDEh1019	E05	GDEhDisVCh_40067	C10	1	RC4_Mut_GDDh1019	E05	NULL	NULL	VUSMutpDEST2_05	H11	VUSmut_GDEh13	H02	1.0	6.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	N	Y	N	Y	Y	105681.0	single nucleotide variant	NM_014336.5(AIPL1):c.236T>C (p.Met79Thr)	23746.0	AIPL1	HGNC:359	not provided	0.0	-	62653017.0	-	RCV000086215	MedGen:CN517202	not provided	not provided	not provided	GRCh38	NC_000017.11	17	6433959.0	6433959.0	17p13.2	no classification provided	1.0	-	N	ClinGen:CA227870	2.0	99792.0	6433959.0	A	G	-	-	-	-	-	-	236T>C 	Met79Thr	NM_014336.5		Others	Others	99792	17	6433959.0	A	G	M	T	rs62653017	17	6337279	17	6278003	79	AIPL1	ENSG00000129221	ENST00000381129	ENSP00000370521	Q9NZN9	AIPL1_HUMAN	c.236T>C	p.Met79Thr	c.236T>C	p.Met79Thr	principal1	Y	1	YES	Select	-	ATG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	D	simple_aae	0.0	100.0	3.335	0.90780	M	-5.93	0.89056	D	0.882	0.95269	0.9245	0.96011	D	0.8671	0.95571	D	10	0.98921204	0.99369	D	0.423901	0.93836	D	0.913	0.97697	0.943	0.99252	Q9NZN9	M79T	Gain of catalytic residue at M79 (P = 0.0074)| Loss of stability (P = 0.0085)| Gain of glycosylation at S78 (P = 0.0595)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.2045)	0.974512163005	0.97399	0.987345975455114	0.98724	0.803311348883	0.66137	0.612213253975	0.54563	T	0.658027	0.89599	D	0.505339	0.94402	D	0.488108	0.94322	D	0.996370553970337	0.89126	D	0.963804	0.87414	D	0.9887639	0.99692	0.9628664	0.99109	0.98972005	0.99745	0.9571771	0.98799	-13.202	0.91472	D	0.9348	0.88816	P	0.669111264244597	0.65999	0.99889510	0.99020	0.965	0.98576	.	.	.	.	.	.	4.265371	0.64925	24.8	0.98965678176349769	0.49515	0.935006	0.92896	D	0.756990805471477	0.83270	7.997016	0.644605633432031	0.78088	6.830474	5.05	5.05	0.67523	4.47	0.83830	7.029	0.76268	11.124000	0.86642	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.599	0.31406	878	0.29756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614104	6.195390e-07	0	1	1180016	8.474460e-07	0	0	75038	0.000000e+00	0	0	912	0.000000e+00	0	0	60014	0.000000e+00	0	0	29604	0.000000e+00	0	0	44844	0.000000e+00	0	0	64046	0.000000e+00	0	0	6054	0.000000e+00	0	1	1180016	8.474460e-07	0	0	91070	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	no_classification_provided	NC_000017.11:g.6433959A>G	ClinGen:CA227870	CN517202	.	.	.	Met	Thr	95.91	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			95.91	Aliphatic	Methionine		Aryl-hydrocarbon-interacting protein-like 1							PPIase FKBP-type			1.9										 M79-L24 (PAE:  1.5), M79-L75 (PAE: 1.0), M79-L153 (PAE: 1.0)	M79-L153 (PDBs: 5U9A, 5U9J), M79-A85 (PDBs: 5U9I)							149		Mutation: M -> T. No interaction with NUB1.							-104.1				145.0						C (loop/coil)	C (loop/coil)												95.91	0.0	>90	<10		unknown		Rare genetic eye disease; Ciliopathy	2		false	0.9951109615911732	0.9938497846075343	true	true	true
GRN	GRN_Cys105Arg	B_7-8	-2.3017354405093404	0.07312972667728583	0.12427402055832626	6.541737821084694	0.00040601646746292897	0.0011371268085965053	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8632569094354614	0.8583172581957408	0.6653964399977994	0.7319010923458544	0.6754856289695689	0.6840725767660921	0.8199314753369195	0.8350120849763576	0.8568644102531269	0.8026676660444783	0.9011645583814766	0.9149588465476334	0.5482136781952648	0.5159591729627802	0.6069377744385821	0.5281252139511204	0.8154699580100049	0.8115549723232895	GRN	Cys105Arg	NC_000017.11:44349715:T:C	313T>C	17	44349715	T	C	17	ENSG00000030582	3980	201374	CCSBVarC004641	ALE00004641	ENSP00000053867.2	CEGS2	CegsMutGDEh1035	C09	GDEhDisVCh_40075	G05	1	CegsMutGDDh1035	C09	VUSN2Hmut_GDN2h_07	B02	VUSMutpDEST2_03	C12	VUSmut_GDEh07	B02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	99.0	Y	Y	Y	Y	Y	104024.0	single nucleotide variant	NM_002087.4(GRN):c.313T>C (p.Cys105Arg)	2896.0	GRN	HGNC:4601	not provided	0.0	-	63750441.0	-	RCV000084434	MedGen:C3661900	not provided	unknown	unknown	GRCh38	NC_000017.11	17	44349715.0	44349715.0	17q21.31	no classification provided	1.0	-	N	ClinGen:CA225225	2.0	98132.0	44349715.0	T	C	-	-	-	-	-	-	313T>C 	Cys105Arg	NM_002087.4		Others	Others	98132	17	44349715.0	T	C	C	R	rs63750441	17	42427083	17	39782609	105	GRN	ENSG00000030582	ENST00000053867	ENSP00000053867	P28799	GRN_HUMAN	c.313T>C	p.Cys105Arg	c.313T>C	p.Cys105Arg	principal1	Y	1	YES	Select	+	TGC	1	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.002	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	4.18	0.97682	H	-11.18	0.99366	D	0.966	0.97658	1.0755	0.98742	D	0.9426	0.98115	D	10	0.99334276	0.99864	D	0.942336	0.99592	D	0.920	0.97963	0.949	0.99385	P28799	C105R	Gain of MoRF binding (P = 0.0799)| Loss of catalytic residue at C105 (P = 0.0936)| Gain of relative solvent accessibility (P = 0.1259)| Gain of solvent accessibility (P = 0.1319)| Gain of methylation at R110 (P = 0.2485)	0.999801715818	0.99979	0.9742868208473522	0.97404	1.1666736912	0.79539	0.642860591412	0.58907	T	0.393107	0.75089	T	0.513513	0.94656	D	0.49985	0.94578	D	0.999868392944336	0.99413	D	0.858314	0.55938	D	0.9649559	0.97738	0.9265617	0.96811	0.9678754	0.98028	0.94288594	0.97925	-15.215	0.96345	D	0.927	0.84728	P	0.946401789882753	0.80036	0.99847645	0.98805	0.846	0.91546	.	.	.	.	.	.	5.091979	0.85067	28.5	0.99691917824287435	0.79998	0.944832	0.95222	D	0.705303598681118	0.79872	7.193904	0.587086819300691	0.73869	6.065475	4.11	4.11	0.47290	.	.	3.08	0.49907	7.892000	0.73146	0.659	0.54735	1.0	0.71675	1.000000	0.68239	0.981	0.58703	501	0.75979	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109372	0.000000e+00	0	0	207876	0.000000e+00	0	1	236644	4.225760e-06	0	0	7158	0.000000e+00	0	0	17100	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	0	42754	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16182	0.000000e+00	0	0	30498	0.000000e+00	0	0	6208	0.000000e+00	0	0	13410	0.000000e+00	0	0	16730	0.000000e+00	0	0	89382	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14878	0.000000e+00	0	0	34238	0.000000e+00	0	0	9566	0.000000e+00	0	0	17692	0.000000e+00	0	0	21532	0.000000e+00	0	1	102598	9.746780e-06	0	0	30526	0.000000e+00	0	1	102598	9.746780e-06	0	.	1	1612668	6.200900e-07	0	1	1178822	8.483040e-07	0	0	75038	0.000000e+00	0	0	912	0.000000e+00	0	0	60030	0.000000e+00	0	0	29590	0.000000e+00	0	0	44886	0.000000e+00	0	0	63818	0.000000e+00	0	0	6056	0.000000e+00	0	1	1178822	8.483040e-07	0	0	91058	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	no_classification_provided	NC_000017.11:g.44349715T>C	ClinGen:CA225225	C3661900	.	.	Granulin|Granulin|Granulin	Cys	Arg	83.4	0.22962962962962963																																																																																																																																																																																																																																																																																																																																																																																																																																																																													31			83.4	Special, a very reactive sulfhydryl group	Cysteine		Progranulin										2.5																		121									-74.7				139.9						B (undefined)	E (parallel sheets)												83.4	22.962963	70-90	10-90		unknown		Rare genetic eye disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	3		false	0.8583172581957408	0.8632569094354614	false	false	false
KRT6A	KRT6A_Ile178Asn	B_7-8	-1.1617413445341893	0.2894610404668932	0.3776438437785287	1.5331701183249142	0.16910048447765474	0.21051518929206	2024_01_Batch_7-8	true	false	false	false	false	false	false	false	false	false	false	false	0.9405324851277268	0.8997563878841066	0.6370225350301084	0.7425811132546923	0.6770046569423497	0.680939722899	0.6721599991509413	0.7686413237225518	0.7664975865553367	0.5767834708071338	0.8998021118264652	0.9561129061904862	0.6897194466470588	0.5853679901621476	0.718664639954048	0.6972615992530832	0.899710663941748	0.9249520640649673	KRT6A	Ile178Asn	NC_000012.12:52492656:A:T	533T>A	12	52492656	A	T	12	ENSG00000205420	4870	215279	CCSBVarC003672	ALE00003672	ENSP00000369317.3	CEGS2	CegsMutGDEh1041	D01	GDEhDisVCh_40048	H09	2	CegsMutGDDh1041	D01	VUSN2Hmut_GDN2h_08	C07	VUSMutpDEST2_04	A10	VUSmut_GDEh08	C07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77491.0	single nucleotide variant	NM_005554.4(KRT6A):c.533T>A (p.Ile178Asn)	3853.0	KRT6A	HGNC:6443	not provided	0.0	-	267607461.0	-	RCV000057017	MedGen:CN517202	not provided	not provided	not provided	GRCh38	NC_000012.12	12	52492656.0	52492656.0	12q13.13	no classification provided	1.0	-	N	ClinGen:CA217361,UniProtKB:P02538#VAR_072458	2.0	66594.0	52492656.0	A	T	-	-	-	-	-	-	533T>A 	Ile178Asn	NM_005554.4		Others	Others	66594	12	52492656.0	A	T	I	N	rs267607461	12	52886440	12	51172707	178	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.533T>A	p.Ile178Asn	c.533T>A	p.Ile178Asn	principal1	Y	1	YES	Select	-	ATC	2	0	.	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.94956	D	simple_aae	5.0	95.0	4.26	0.98056	H	-6.25	0.90587	D	0.993	0.99866	1.0938	0.99394	D	0.9263	0.97560	D	10	0.96701586	0.96163	D	0.178486	0.85321	D	0.951	0.99091	0.83	0.93946	P02538	I178N	Gain of disorder (P = 0.0102)| Loss of stability (P = 0.0119)| Loss of methylation at K180 (P = 0.0768)| Gain of relative solvent accessibility (P = 0.09)| Gain of MoRF binding (P = 0.0972)	0.972325520707	0.97176	0.836017027939198	0.83462	1.31927576329	0.83331	0.827195644379	0.86108	D	0.939981	0.99040	D	0.464832	0.93077	D	0.429922	0.92991	D	0.999765932559967	0.98872	D	0.965953	0.87462	D	0.93016094	0.94166	0.9314775	0.97156	0.93016094	0.94167	0.9314775	0.97156	-17.126	0.99016	D	0.9976	0.97075	P	0.991932151222525	0.89263	0.97034585	0.94682	0.999	0.99956	.	.	.	.	.	.	4.61123	0.73188	25.9	0.99393763018354409	0.62526	0.884175	0.81297	D	1.0576309646274	0.97250	15.84605	0.950223384888179	0.97396	16.08349	5.31	5.31	0.75027	.	.	9.078	0.93445	.	.	0.75	0.87077	1.0	0.71675	1.000000	0.68239	0.996	0.76032	764	0.49916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	no_classification_provided	NC_000012.12:g.52492656A>T	ClinGen:CA217361|UniProtKB:P02538#VAR_072458	CN517202	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ile	Asn	87.42	0.5798816568047337																																																																																																																																																																																																																																																																																																																																																																																																																																																																													98			87.42	Aliphatic	Isoleucine		Keratin, type II cytoskeletal 6A							IF rod	0.055		4.5								 I178-R182 (PAE:  2.0), I178-F174 (PAE: 2.0)		 I178-R182 (PAE:  2.0), I178-F174 (PAE: 2.0)								131									-63.3		Pocket 4: Mean pLDDT: 87.74, Volume: 232.01 Å³, Druggability score: 0.06		-44.5	Coil 1A			dbSNP: rs267607461; Variant type: LP/P; AA change: Ile178Asn; PTM type: Acetylation; PTM morphology: AsFI*DkVRFLE; Var class: II&rs267607461		H (helix)	H (α-helix)												87.42	57.988167	70-90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2		false	0.8997563878841066	0.9405324851277268	false	true	false
COMP	COMP_Asn555Lys	B_7-8	-3.0531014675946446	0.03791310685055363	0.07427080418928968	-0.10882584048097976	0.916394509420965	0.9318457985576644	2024_01_Batch_7-8	false	false	true	false	false	false	false	false	false	false	false	false	0.769870656921213	0.7033878202083008	0.9441038477112247	0.8628430871290574	0.746519026799772	0.952234258650517	0.952234258650517	0.8043132737308684	0.8720708067714689	0.9441038477112247	0.769662528361171	0.769870656921213		0.6887247798686756	0.853615367486646		0.6371131120554305		COMP	Asn555Lys	NC_000019.10:18785676:G:T	1665C>A	19	18785676	G	T	19	ENSG00000105664	56661	3346	CCSBVarC008142	ALE00008128	ENSP00000222271.2	Edgotyping3	VUSMutGDEh015	E07	GDEhDisVCh_40037	A11	1	VUSMutGDDh015	E07	VUSN2Hmut_GDN2h_04	G08	NULL	NULL	VUSmut_GDEh04	G08	1.0	1.0	1.0	5.0	1.0	6.0	7.0	0.0			1.0	1.0	1.0	Y	N	N	N	Y	76462.0	single nucleotide variant	NM_000095.3(COMP):c.1665C>A (p.Asn555Lys)	1311.0	COMP	HGNC:2227	not provided	0.0	-	397515511.0	-	RCV002054894	Human Phenotype Ontology:HP:0002654,MONDO:MONDO:0016648,MedGen:C0026760,OMIM:PS132400,Orphanet:251	Multiple epiphyseal dysplasia	germline	germline	GRCh38	NC_000019.10	19	18785676.0	18785676.0	19p13.11	no classification provided	1.0	-	N	ClinGen:CA344886	1.0	65554.0	18785676.0	G	T	-	-	-	-	-	-	1665C>A 	Asn555Lys	NM_000095.3		Others	Others	65554	19	18785676.0	G	T	N	K	rs397515511	19	18896486	19	18757486	555	COMP	ENSG00000105664	ENST00000222271	ENSP00000222271	P49747	COMP_HUMAN	c.1665C>A	p.Asn555Lys	c.1665C>A	p.Asn555Lys	principal1	Y	1	YES	Select	-	AAC	3	2	G	G/G	G/G	G/G	G/G	0.004	0.68399	D	0.103	0.40143	T	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97926	A	simple_aae	2.0	98.0	2.15	0.59964	M	-5.53	0.86103	D	0.819	0.98762	0.6483	0.92494	D	0.8278	0.94207	D	10	0.9735917	0.97008	D	0.693004	0.97471	D	0.724	0.90240	0.846	0.94938	P49747	N555K	Gain of methylation at N555 (P = 0.0183)| Gain of ubiquitination at N555 (P = 0.0289)| Loss of sheet (P = 0.0817)| Gain of solvent accessibility (P = 0.0837)| Gain of relative solvent accessibility (P = 0.09)	0.807247261781	0.80391	0.8804195252006213	0.87934	.	.	0.825716733932	0.85882	D	0.91802	0.98492	D	0.0433919	0.57193	T	-0.175447	0.56645	T	0.990224778652191	0.80291	D	0.964804	0.86963	D	0.91948634	0.93096	0.81873757	0.89322	0.9148342	0.92644	0.7800188	0.86869	-11.672	0.83975	D	0.8966	0.82480	P	0.975980676007937	0.84417	0.99067650	0.96838	0.891	0.94185	.	.	.	.	.	.	3.818424	0.55196	23.6	0.99710517447752123	0.81301	0.717006	0.66745	D	0.418890632473088	0.62265	4.462412	0.289923335300281	0.54713	3.658672	4.61	1.9	0.24703	1.87	0.38172	0.564	0.23348	0.746000	0.21281	0.522	0.23977	0.999	0.42732	0.996000	0.32869	0.83	0.39158	862	0.33096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50	0	0	426	0	0	0	0	0	476	0	Multiple_epiphyseal_dysplasia	no_classification_provided	NC_000019.10:g.18785676G>T	ClinGen:CA344886	C0026760	PS132400	251	Thrombospondin, C-terminal|Thrombospondin, C-terminal	Asn	Lys	93.91	0.08280254777070063																																																																																																																																																																																																																																																																																																																																																																																																																																																																													13			93.91	Polar/Neutral	Asparagine		Cartilage oligomeric matrix protein							TSP C-terminal			-3.5								 N555-E301 (PAE:  1.5), N555-S298 (PAE: 1.5)	N555-E301 (PDBs: 3FBY), N555-S298 (PDBs: 3FBY)	 N555-G299 (PAE:  1.5), N555-S298 (PAE: 1.5)	N555-E301 (PDBs: 3FBY), N555-G299 (PDBs: 3FBY), N555-S298 (PDBs: 3FBY)							132									46.1				41.5	Mediates cell survival and induction of the IAP family of survival proteins					H (helix)	G (3₁₀-helix)	Turn											93.91	8.280255	>90	<10		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic bone disease	2		false	0.7033878202083008	0.769870656921213	false	false	false
HPRT1	HPRT1_Ser104Arg	B_7-8	-0.22492312103311007	0.8284640116786027	0.8632658277720302	-2.3143153000208208	0.053843419423098365	0.07565289023076992	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.544382775179407	0.5441398819805636	0.4266728282831473	0.5626643583983812	0.5074119655294682	0.478115931809035	0.3728991601959859	0.40561496721525325	0.3655323316149095	0.4308546160237482	0.4861639849902919	0.49457092921536167	0.5833327034220841	0.6092089638436833	0.7597963851818529	0.4224910405425464	0.6021157789708352	0.5941946211434523	HPRT1	Ser104Arg	NC_000023.11:134475358:C:A	312C>A	23	134475358	C	A	X	ENSG00000165704	7982	202787	CCSBVarC005933	ALE00005933	ENSP00000298556.7	CEGS2	CegsMutGDEh1040	B06	GDEhDisVCh_40052	D09	2	CegsMutGDDh1040	B06	VUSN2Hmut_GDN2h_08	D05	VUSMutpDEST2_07	G05	VUSmut_GDEh08	D05	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	Y	Y	Y	N	Y	25081.0	single nucleotide variant	NM_000194.2(HPRT1):c.312C>A (p.Ser104Arg)	3251.0	HPRT1	HGNC:5157	Pathogenic; other	1.0	Sep 10, 2020	137852485.0	-	RCV000010738|RCV000010739	MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|	Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MUNICH	germline	germline	GRCh38	NC_000023.11	X	134475358.0	134475358.0	Xq26.2	no assertion criteria provided	1.0	-	N	ClinGen:CA120897,UniProtKB:P00492#VAR_006778,OMIM:308000.0014	1.0	10042.0	134475358.0	C	A	-	-	-	-	-	-	312C>A 	Ser104Arg	NM_000194.2		Others	Others	10042	X	134475358.0	C	A	S	R	rs137852485	X	133609388	X	133437054	104	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.312C>A	p.Ser104Arg	c.312C>A	p.Ser104Arg	principal1	Y	1	YES	Select	+	AGC	3	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.986	0.76920	D	0.78	0.86494	A	simple_aae	22.0	78.0	4.02	0.96818	H	-4.61	0.79093	D	0.957	0.96659	0.9503	0.96388	D	0.9937	0.99854	D	9	0.99277925	0.99813	D	0.949407	0.99651	D	0.929	0.98302	0.942	0.99227	P00492	S104R	Gain of MoRF binding (P = 0.0672)| Gain of ubiquitination at K103 (P = 0.0797)| Gain of catalytic residue at S104 (P = 0.1152)| Gain of methylation at K103 (P = 0.159)| Gain of solvent accessibility (P = 0.204)	0.99992416413	0.99992	0.9914110884314414	0.99135	1.88169425926	0.92581	0.832836985588	0.86975	D	0.986125	0.99916	D	0.673195	0.99903	D	0.729221	0.99903	D	0.996994972229004	0.90453	D	0.926807	0.72971	D	0.98768175	0.99628	0.93339515	0.97288	0.98768175	0.99629	0.93339515	0.97289	-13.677	0.91976	D	0.9963	0.96212	P	0.999290608351769	0.96182	0.99973470	0.99655	0.883	0.93708	.	.	.	.	.	.	4.381309	0.67602	25.1	0.99782675956322286	0.86966	.	.	.	.	.	.	.	.	.	4.68	4.68	0.58268	3.56	0.64876	0.95	0.28816	5.807000	0.50054	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.995	0.73271	280	0.88958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Partial_hypoxanthine-guanine_phosphoribosyltransferase_deficiency|HPRT_MUNICH	no_assertion_criteria_provided	NC_000023.11:g.134475358C>A	ClinGen:CA120897|OMIM:308000.0014|UniProtKB:P00492#VAR_006778	C0268117	300323	79233	Phosphoribosyltransferase domain|Phosphoribosyltransferase domain	Ser	Arg	60.05	0.6615384615384615																																																																																																																																																																																																																																																																																																																																																																																																																																																																													86			60.05	Polar/Neutral	Serine		Hypoxanthine-guanine phosphoribosyltransferase								0.1354		-0.8									S104-K115 (PDBs: 3GEP, 3GGC, 3GGJ)		S104-K115 (PDBs: 3GEP, 3GGC, 3GGJ)							105									-73.6	Morphology: VDFIRLksYCNDQsT; Domain: Pribosyltran	Pocket 2: Mean pLDDT: 38.4, Volume: 231.92 Å³, Druggability score: 0.14		127.4				dbSNP: rs137852485; Variant type: LP/P; AA change: Ser104Arg; PTM type: Phosphorylation; PTM morphology: FIRLksYCNDQ; Var class: I&rs137852485		B (undefined)	E (parallel sheets)												60.05	66.15385	50-70	10-90	300323	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	HYPERURICEMIA, HPRT-RELATED	false	0.5441398819805636	0.544382775179407	false	false	false
FBP1	FBP1_Asn213Lys	B_7-8	-0.4051552500348869	0.697459498926623	0.7594912445552165	0.4344536609138327	0.677036597292548	0.723144444721668	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6439269719760108	0.6304177827527738	0.5622363152338943	0.5407327032247864	0.667442455641069	0.5471007685680117	0.4474239349450677	0.6929860999078252	0.5677973077586776	0.5186256430842191	0.6673146863681727	0.6866173917305626	0.6467776021909557	0.6418988113743127	0.5136680986908951	0.6058469873835693	0.593520879137375	0.601236552221459	FBP1	Asn213Lys	NC_000009.12:94606881:G:C	639C>G	9	94606881	G	C	9	ENSG00000165140	2654	4170	CCSBVarC000307	ALE00000307	ENSP00000364475.5	RC4	RC4_Mut_GDEh1017	H01	GDEhDisVCh_40075	G07	1	RC4_Mut_GDDh1017	H01	NULL	NULL	VUSMutpDEST2_02	H01	VUSmut_GDEh13	F01	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												53			97.7	Polar/Neutral	Asparagine	substrate	Fructose-1,6-bisphosphatase 1								0.1505		-3.5			B:N213-A:A243 (PDBs: 2JJK, 2Y5K, 3A29, 3KBZ, 3KC0, 3KC1, 6LW2, 7C9Q, 7CVN, 7EZF, 7EZP, 7EZR), F:N213-E:A243 (PDBs: 2VT5, 2WBB, 2WBD, 2Y5L, 4MJO, 5LDZ), B:N213-D:A243 (PDBs: 7CVH), D:N213-C:A243 (PDBs: 7EZR), C:N213-D:A243 (PDBs: 7EZR)	A:N213-B:A243 (PDBs: 2JJK, 2VT5, 2WBB, 2WBD, 2Y5K, 2Y5L, 3KBZ, 3KC0, 3KC1, 4MJO, 5LDZ, 6LW2, 7C9Q, 7CVN, 7EZF, 7EZP, 7EZR), D:N213-C:G242 (PDBs: 3A29), B:N213-D:R244 (PDBs: 7CVH), C:N213-D:R244 (PDBs: 7EZR), C:N213-D:A243 (PDBs: 7EZR), A:N213-B:R244 (PDBs: 7EZR), D:N213-C:R244 (PDBs: 7EZR), B:N213-A:R244 (PDBs: 7EZR)						 N213-Y245 (PAE:  1.0)	N213-Y245 (PDBs: 2VT5, 2WBB, 2WBD, 2Y5K, 3A29, 3KC1, 6LW2, 7C9Q, 7CVH, 7CVN, 7CWE, 7EZP)							132									-79.7		Pocket 4: Mean pLDDT: 97.65, Volume: 97.61 Å³, Druggability score: 0.15		94.7						C (loop/coil)	C (loop/coil)														NaN	NaN		unknown		Rare inborn errors of metabolism	1		false	0.6304177827527738	0.6439269719760108	false	false	false
HPRT1	HPRT1_Asp201Gly	B_7-8	-1.7636328196095692	0.12115791616579123	0.19100007319543308	-2.786338184130667	0.027050428260432954	0.04115881911931548	2024_01_Batch_7-8	true	false	false	false	false	false	false	false	false	false	false	false	0.9345393692975876	0.9268079155415001	0.7113376555267994	0.833997292232913	0.8063441444952393	0.7439034655806602	0.9150262620884356	0.886789185186812	0.9369888875265375	0.8300585240745447	0.9508876833214804	0.9505724430187505	0.5727806690728848	0.7258991038036666	0.7310056969392884	0.5926167869790542	0.9027281477615199	0.9185062955764246	HPRT1	Asp201Gly	NC_000023.11:134498677:A:G	602A>G	23	134498677	A	G	X	ENSG00000165704	7982	202807	CCSBVarC005945	ALE00005945	ENSP00000298556.7	CEGS2	CegsMutGDEh1042	F03	GDEhDisVCh_40052	B10	2	CegsMutGDDh1042	F03	VUSN2Hmut_GDN2h_08	D11	VUSMutpDEST2_07	A08	VUSmut_GDEh08	D11	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25070.0	single nucleotide variant	NM_000194.2(HPRT1):c.602A>G (p.Asp201Gly)	3251.0	HPRT1	HGNC:5157	Pathogenic; other	1.0	Sep 10, 2020	137852479.0	-	RCV000010716|RCV000010717	MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|	Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT ASHVILLE	germline	germline	GRCh38	NC_000023.11	X	134498677.0	134498677.0	Xq26.2	no assertion criteria provided	1.0	-	N	ClinGen:CA120889,UniProtKB:P00492#VAR_006801,OMIM:308000.0003	1.0	10031.0	134498677.0	A	G	-	-	-	-	-	-	602A>G 	Asp201Gly	NM_000194.2		Others	Others	10031	X	134498677.0	A	G	D	G	rs137852479	X	133632707	X	133460373	201	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.602A>G	p.Asp201Gly	c.602A>G	p.Asp201Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.002	0.72322	D	0.029	0.54888	D	0.951	0.54003	P	0.671	0.53146	P	0.95	0.94956	A	simple_aae	5.0	95.0	2.47	0.71525	M	-5.99	0.89426	D	0.932	0.93732	1.1260	0.99918	D	0.9613	0.98753	D	9	0.9937526	0.99897	D	0.935233	0.99534	D	0.948	0.98989	0.915	0.98375	P00492	D201G	Loss of stability (P = 0.0059)| Gain of loop (P = 0.069)| Loss of helix (P = 0.079)| Gain of sheet (P = 0.1451)| Loss of catalytic residue at D201 (P = 0.175)	0.999946805639	0.99994	0.9677840419765368	0.96748	3.32765753199	0.99614	0.708687067032	0.68350	T	0.878659	0.97416	D	0.682112	0.99917	D	0.74203	0.99917	D	0.994803965091705	0.86215	D	0.985741	0.95163	D	0.9852093	0.99471	0.96987164	0.99450	0.9843035	0.99410	0.97590023	0.99690	-11.683	0.83323	D	0.9925	0.94441	P	0.999813754582483	0.98120	0.99973112	0.99655	0.978	0.99209	.	.	.	.	.	.	4.876405	0.79978	27.2	0.99816493338742684	0.89981	.	.	.	.	.	.	.	.	.	5.69	5.69	0.88329	3.9	0.73887	8.76	0.91369	8.039000	0.76341	0.729	0.85525	1.0	0.71675	1.000000	0.68239	1.0	0.97202	245	0.90406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Partial_hypoxanthine-guanine_phosphoribosyltransferase_deficiency|HPRT_ASHVILLE	no_assertion_criteria_provided	NC_000023.11:g.134498677A>G	ClinGen:CA120889|OMIM:308000.0003|UniProtKB:P00492#VAR_006801	C0268117	300323	79233	.	Asp	Gly	98.3	0.5950920245398773																																																																																																																																																																																																																																																																																																																																																																																																																																																																													97			98.3	Negatively-charged	Aspartic Acid		Hypoxanthine-guanine phosphoribosyltransferase										-3.5			B:D201-D:M95 (PDBs: 4IJQ, 4RAB, 4RAC, 4RAO, 4RAQ, 5W8V, 6BNJ), A:D201-C:M95 (PDBs: 4RAD, 4RAN, 6BNJ), D:D201-B:M95 (PDBs: 6BNJ), C:D201-A:M95 (PDBs: 6BNJ)	A:D201-C:M95 (PDBs: 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ), B:D201-D:M95 (PDBs: 6BNJ)				 D201-Y28 (PAE:  1.0)	D201-H27 (PDBs: 4KN6, 6BNJ), D201-Y28 (PDBs: 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)									132									-84.2				-1.1				dbSNP: rs137852479; Variant type: LP/P; AA change: Asp201Gly; PTM type: Phosphorylation; PTM morphology: LDYNEyFRD*LN; Var class: II&-		C (loop/coil)	T (turn)	Beta strand											98.3	59.5092	>90	10-90	300323	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	HYPERURICEMIA, HPRT-RELATED	false	0.9268079155415001	0.9345393692975876	false	true	false
KRT6A	KRT6A_Gln166Pro	B_7-8	-4.158104888900067	0.025293958588157885	0.05416083060917215	-3.340576359006381	0.012409863197787651	0.020589601236835748	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8667441091063137	0.8235636389334003	0.5503693427764774	0.6224894757104054	0.5588466764191005	0.566982097483164	0.566982097483164	0.5727577909226956	0.6225671599591722	0.5503693427764774	0.8461621881250022	0.8667441091063137		0.5449355619155052	0.6224117914616385		0.8009650897417985		KRT6A	Gln166Pro	NC_000012.12:52492692:T:G	497A>C	12	52492692	T	G	12	ENSG00000205420	4870	215278	CCSBVarC003664	ALE00003664	ENSP00000369317.3	CEGS2	CegsMutGDEh1039	H04	GDEhDisVCh_40048	E09	2	CegsMutGDDh1039	H04	VUSN2Hmut_GDN2h_08	D02	VUSMutpDEST2_04	H09	VUSmut_GDEh08	D02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77478.0	single nucleotide variant	NM_005554.4(KRT6A):c.497A>C (p.Gln166Pro)	3853.0	KRT6A	HGNC:6443	not provided	0.0	-	267607460.0	-	RCV000057003	MedGen:CN517202	not provided	not provided	not provided	GRCh38	NC_000012.12	12	52492692.0	52492692.0	12q13.13	no classification provided	1.0	-	N	ClinGen:CA217346,UniProtKB:P02538#VAR_072447	2.0	66581.0	52492692.0	T	G	-	-	-	-	-	-	497A>C 	Gln166Pro	NM_005554.4		Others	Others	66581	12	52492692.0	T	G	Q	P	rs267607460	12	52886476	12	51172743	166	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.497A>C	p.Gln166Pro	c.497A>C	p.Gln166Pro	principal1	Y	1	YES	Select	-	CAG	2	0	.	./.	./.	./.	./.	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.99	0.97926	D	simple_aae	1.0	99.0	4.425	0.98710	H	-5.33	0.84629	D	0.984	0.99346	1.0760	0.98756	D	0.9038	0.96803	D	10	0.98522544	0.98749	D	0.091156	0.75574	D	0.953	0.99157	0.893	0.97445	P02538	Q166P	Loss of MoRF binding (P = 0.0632)| Gain of catalytic residue at N171 (P = 0.078)| Gain of glycosylation at Q166 (P = 0.0985)| Loss of ubiquitination at K168 (P = 0.1216)| Gain of disorder (P = 0.2099)	0.978510382337	0.97806	0.8841963002573558	0.88315	1.07999894899	0.76974	0.61876475811	0.55488	T	0.950014	0.99265	D	0.48398	0.93781	D	0.457427	0.93702	D	0.999610364437103	0.98146	D	0.962304	0.85827	D	0.9722626	0.98441	0.9705391	0.99480	0.9722626	0.98441	0.9705391	0.99480	-15.191	0.96293	D	0.9873	0.92798	P	0.998057828873415	0.93898	0.97216990	0.94826	0.956	0.98079	.	.	.	.	.	.	3.93492	0.57622	23.9	0.99540156737583907	0.70497	0.942162	0.94620	D	1.03863587585226	0.96795	15.18005	0.922162853891413	0.96447	14.73314	5.31	5.31	0.75027	3.9	0.73887	7.811	0.84671	.	.	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.726	0.35004	764	0.49916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	no_classification_provided	NC_000012.12:g.52492692T>G	ClinGen:CA217346|UniProtKB:P02538#VAR_072447	CN517202	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Gln	Pro	77.27	0.6717171717171717																																																																																																																																																																																																																																																																																																																																																																																																																																																																													133			77.27	Polar/Neutral	Glutamine		Keratin, type II cytoskeletal 6A							IF rod			-3.5								 Q166-L170 (PAE:  3.5), Q166-E162 (PAE: 3.0)		 Q166-L170 (PAE:  3.5), Q166-E162 (PAE: 3.0)								146									-61.3				-44.0	Coil 1A			dbSNP: rs267607460; Variant type: LP/P; AA change: Gln166Pro; PTM type: Phosphorylation; PTM morphology: REQ*IktLNNkF; Var class: II&rs267607460		H (helix)	H (α-helix)												77.27	67.171715	70-90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2		false	0.8235636389334003	0.8667441091063137	false	false	false
KRT6A	KRT6A_Asn171Thr	B_7-8	-1.9383314929042983	0.11030637849928432	0.17749383566439178	-2.395276208353346	0.047796755169019996	0.06820143525283957	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.806500906061536	0.7899787073349367	0.5691777512331844	0.5920282664402818	0.5543357465084038	0.5905111770626565	0.48223348803114463	0.5412897071594626	0.5831431811732325	0.4644020321893691	0.8177401721778451	0.8625693177881386	0.6987888660941686	0.5673817858573451	0.6009133517073313	0.6739534702769996	0.7622172424920284	0.7504324943349334	KRT6A	Asn171Thr	NC_000012.12:52492677:T:G	512A>C	12	52492677	T	G	12	ENSG00000205420	4870	215282	CCSBVarC003670	ALE00003670	ENSP00000369317.3	CEGS2	CegsMutGDEh1031	B06	GDEhDisVCh_40048	E08	2	CegsMutGDDh1031	B06	VUSN2Hmut_GDN2h_05	F08	VUSMutpDEST2_04	D10	VUSmut_GDEh05	F08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	Y	Y	Y	N	Y	77484.0	single nucleotide variant	NM_005554.4(KRT6A):c.512A>C (p.Asn171Thr)	3853.0	KRT6A	HGNC:6443	not provided	0.0	-	58556099.0	-	RCV000057009	MedGen:CN517202	not provided	not provided	not provided	GRCh38	NC_000012.12	12	52492677.0	52492677.0	12q13.13	no classification provided	1.0	-	N	ClinGen:CA217353	2.0	66587.0	52492677.0	T	G	-	-	-	-	-	-	512A>C 	Asn171Thr	NM_005554.4		Others	Others	66587	12	52492677.0	T	G	N	T	rs58556099	12	52886461	12	51172728	171	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.512A>C	p.Asn171Thr	c.512A>C	p.Asn171Thr	principal1	Y	1	YES	Select	-	AAC	2	0	.	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.996	0.84488	D	1.0	0.99291	D	simple_aae	0.0	100.0	4.66	0.99381	H	-5.28	0.84274	D	0.962	0.97221	1.0720	0.98642	D	0.9693	0.99027	D	10	0.9635544	0.95751	D	0.164768	0.84338	D	0.931	0.98376	0.828	0.93817	P02538	N171T	Gain of catalytic residue at F174 (P = 0.0306)| Gain of ubiquitination at K168 (P = 0.1204)| Gain of MoRF binding (P = 0.1424)| Loss of methylation at K173 (P = 0.2176)| Loss of disorder (P = 0.2311)	0.963822673358	0.96311	0.8354104001000549	0.83401	0.984425732197	0.73691	0.713393330574	0.69032	T	0.933607	0.98884	D	0.354099	0.86696	D	0.270862	0.86522	D	0.998811721801758	0.95208	D	0.972403	0.90004	D	0.9417504	0.95355	0.9286016	0.96955	0.9417504	0.95355	0.9286016	0.96955	-15.233	0.96383	D	0.9887	0.93189	P	0.993127904314039	0.89874	0.94616980	0.93169	0.994	0.99793	.	.	.	.	.	.	4.320835	0.66198	24.9	0.99591237895379703	0.73662	0.867243	0.78616	D	1.0625598601594	0.97361	16.0245	0.938645148986713	0.97030	15.5121	5.31	5.31	0.75027	.	.	7.811	0.84671	.	.	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.998	0.85369	764	0.49916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	no_classification_provided	NC_000012.12:g.52492677T>G	ClinGen:CA217353	CN517202	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Asn	Thr	83.26	0.5732484076433121																																																																																																																																																																																																																																																																																																																																																																																																																																																																													90			83.26	Polar/Neutral	Asparagine		Keratin, type II cytoskeletal 6A							IF rod			-3.5								 N171-I167 (PAE:  3.0), N171-A175 (PAE: 2.5)		 N171-I167 (PAE:  3.0), N171-A175 (PAE: 2.5)								132									-66.5				-35.6	Coil 1A			dbSNP: rs62635294; Variant type: LP/P; AA change: Asn171Asp; PTM type: Phosphorylation; PTM morphology: REQIktLN*NkF; Var class: II&rs59685571		H (helix)	H (α-helix)												83.26	57.324837	70-90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2		false	0.7899787073349367	0.806500906061536	false	false	false
KRT6A	KRT6A_Ser176Pro	B_7-8	-3.454460025660637	0.025948579446990697	0.05537629803771199	-3.072310105996576	0.01800892875602393	0.02868609745425687	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8951343039132902	0.8626727713043651	0.6090828309025798	0.6882054725500448	0.7171107875970575	0.6658778198081214	0.6658778198081214	0.7572810031360078	0.7786232660740583	0.6090828309025798	0.8792115197641955	0.9301207605674175		0.6769405720581072	0.5977876790260312		0.8461340228445349	0.8601478472591627	KRT6A	Ser176Pro	NC_000012.12:52492663:A:G	526T>C	12	52492663	A	G	12	ENSG00000205420	4870	215273	CCSBVarC003671	ALE00003671	ENSP00000369317.3	CEGS2	CegsMutGDEh1035	H09	GDEhDisVCh_40048	H08	2	CegsMutGDDh1035	H09	VUSN2Hmut_GDN2h_07	C02	VUSMutpDEST2_04	D09	VUSmut_GDEh07	C02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77490.0	single nucleotide variant	NM_005554.4(KRT6A):c.526T>C (p.Ser176Pro)	3853.0	KRT6A	HGNC:6443	not provided	0.0	-	59642296.0	-	RCV000057016	MedGen:CN517202	not provided	not provided	not provided	GRCh38	NC_000012.12	12	52492663.0	52492663.0	12q13.13	no classification provided	1.0	-	N	ClinGen:CA217360,UniProtKB:P02538#VAR_072457	2.0	66593.0	52492663.0	A	G	-	-	-	-	-	-	526T>C 	Ser176Pro	NM_005554.4		Others	Others	66593	12	52492663.0	A	G	S	P	rs59642296	12	52886447	12	51172714	176	KRT6A	ENSG00000205420	ENST00000330722	ENSP00000369317	P02538	K2C6A_HUMAN	c.526T>C	p.Ser176Pro	c.526T>C	p.Ser176Pro	principal1	Y	1	YES	Select	-	TCC	1	0	.	./.	./.	./.	./.	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.992	0.80453	D	0.79	0.86984	D	simple_aae	21.0	79.0	3.895	0.96020	H	-4.4	0.77340	D	0.855	0.85095	1.0955	0.99468	D	0.9079	0.96940	D	10	0.96114427	0.95475	D	0.060276	0.67830	D	0.827	0.94487	0.86	0.95750	P02538	S176P	Gain of catalytic residue at I178 (P = 0.0102)| Loss of stability (P = 0.0334)| Loss of MoRF binding (P = 0.0444)| Gain of ubiquitination at K180 (P = 0.1111)| Gain of methylation at K173 (P = 0.1118)	0.986328258107	0.98603	0.8142784172112812	0.81274	1.09297155767	0.77365	0.731962203979	0.71743	T	0.796541	0.94722	D	0.448014	0.92336	D	0.405764	0.92242	D	0.998769342899323	0.95055	D	0.516848	0.16418	T	0.9561174	0.96837	0.9659167	0.99264	0.9561174	0.96838	0.9659167	0.99265	-15.747	0.97363	D	0.9896	0.93458	P	0.995244524722109	0.91193	0.97188210	0.94802	0.925	0.96232	.	.	.	.	.	.	4.673485	0.74765	26.2	0.99843778399265681	0.92408	0.718232	0.66829	D	0.871095003419076	0.90220	10.32996	0.763803763743461	0.87113	9.135609	5.31	5.31	0.75027	3.9	0.73887	3.955	0.56512	.	.	0.75	0.87077	1.0	0.71675	0.999000	0.35501	0.999	0.91597	764	0.49916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	no_classification_provided	NC_000012.12:g.52492663A>G	ClinGen:CA217360|UniProtKB:P02538#VAR_072457	CN517202	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Ser	Pro	84.98	0.5076923076923077																																																																																																																																																																																																																																																																																																																																																																																																																																																																													66			84.98	Polar/Neutral	Serine		Keratin, type II cytoskeletal 6A							IF rod			-0.8								 S176-N172 (PAE:  2.5), S176-K180 (PAE: 2.5)		 S176-N172 (PAE:  2.5), S176-K180 (PAE: 2.5)								105									-62.7	Morphology: tLNNkFAsFIDkVRF; Domain: Filament			-33.5	Coil 1A			dbSNP: rs59642296; Variant type: LP/P; AA change: Ser176Pro; PTM type: Acetylation; PTM morphology: As*FIDkVRFLE; Var class: II&rs59642296		H (helix)	H (α-helix)												84.98	50.769234	70-90	10-90		unknown		Rare genetic developmental defect during embryogenesis; Rare genetic skin disease	2		false	0.8626727713043651	0.8951343039132902	false	false	false
TAT	TAT_Leu273Pro	B_7-8	-3.1413107795303365	0.016349222691164414	0.03922991876900004	-10.863969739178302	0.000012358377673049448	0.00008590008723502174	2024_01_Batch_7-8		true	false	false	false	false		true	false	false	false	false		0.9950318264535324	0.5518713069606276	0.6649678994588492	0.5651668403058182	0.5762973177450659	0.5883010114149652	0.5770235294183299	0.77557126405179	0.540037608415906	0.9973504785618028		0.5642936240751666	0.5533101511933065	0.5543645348659083	0.5637050055053491	0.992713174345262		TAT	Leu273Pro	NC_000016.10:71570773:A:G	818T>C	16	71570773	A	G	16	ENSG00000198650	54914	28866	CCSBVarC002398	ALE00002398	ENSP00000348234.4	RC4	RC4_Mut_GDEh1022	A06	GDEhDisVCh_40043	E11	1	RC4_Mut_GDDh1022	A06	VUSN2Hmut_GDN2h_10	G08	VUSMutpDEST2_13	D03	VUSmut_GDEh13	E04	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												0			98.94	Aliphatic	Leucine		Tyrosine aminotransferase										3.8								 L273-A246 (PAE:  1.0), L273-I244 (PAE: 1.0)	L273-A246 (PDBs: 3DYD), L273-I244 (PDBs: 3DYD)	 L273-I244 (PAE:  1.0)	L273-I244 (PDBs: 3DYD)							131									-102.1				107.9						B (undefined)	E (parallel sheets)	Beta strand													NaN	NaN		unknown		Rare genetic eye disease; Rare inborn errors of metabolism; Rare genetic skin disease	3		false	0.9950318264535324		true		true
NCF2	NCF2_Ala140Asp	B_7-8	-0.48868114481836955	0.6457460899738856	0.7170785068896056	-5.340483933255421	0.0017604739974935743	0.0038095162563687606	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8121599308415659	0.8171277454258572	0.43796368824772935	0.5019077416538075	0.514116694487811	0.4505566073953689	0.4026989723778318	0.4917995946869794	0.5330081563592508	0.3902538872080923	0.8510048243919213	0.8121599308415659	0.498414242412906	0.5364337942886428	0.47080732694836414	0.4856734892873664	0.783250666459793		NCF2	Ala140Asp	NC_000001.11:183574569:G:T	419C>A	1	183574569	G	T	1	ENSG00000116701	3727	214875	CCSBVarC003961	ALE00003961	ENSP00000356505.4	CEGS2	CegsMutGDEh1031	A04	GDEhDisVCh_40073	G05	1	CegsMutGDDh1031	A04	VUSN2Hmut_GDN2h_05	E07	VUSMutpDEST2_03	H11	VUSmut_GDEh05	E07	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	Y	Y	N	N	Y	79386.0	single nucleotide variant	NM_000433.4(NCF2):c.419C>A (p.Ala140Asp)	4688.0	NCF2	HGNC:7661	not provided	0.0	-	137854520.0	-	RCV000059366	MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2	not provided	not provided	GRCh38	NC_000001.11	1	183574569.0	183574569.0	1q25.3	no classification provided	1.0	-	N	ClinGen:CA145221,UniProtKB:P19878#VAR_065012,UniProtKB/Swiss-Prot:VAR_065012	1.0	68494.0	183574569.0	G	T	-	-	-	-	-	-	419C>A 	Ala140Asp	NM_000433.4		Others	Others	68494	1	183574569.0	G	T	A	D	rs137854520	1	183543704	1	181810327	140	NCF2	ENSG00000116701	ENST00000367535	ENSP00000356505	P19878	NCF2_HUMAN	c.419C>A	p.Ala140Asp	c.419C>A	p.Ala140Asp	principal1	Y	1	YES	Select	-	GCT	2	0	G	./.	./.	./.	./.	0.001	0.78662	D	0.005	0.72530	D	1.0	0.90580	D	0.992	0.80453	D	0.97	0.96253	D	simple_aae	3.0	97.0	3.025	0.86187	M	-5.3	0.84415	D	0.971	0.98181	0.9308	0.96101	D	0.8717	0.95727	D	10	0.9751307	0.97219	D	0.23703	0.88498	D	0.931	0.98376	0.836	0.94325	P19878	A140D	Loss of helix (P = 0.0104)| Gain of loop (P = 0.024)| Gain of ubiquitination at K139 (P = 0.0661)| Loss of methylation at K139 (P = 0.109)| Gain of disorder (P = 0.1599)	0.985270168772	0.98495	0.9367580528120825	0.93616	1.27933527	0.82397	0.618323922157	0.55426	T	0.494129	0.81595	T	0.476339	0.93515	D	0.446451	0.93434	D	0.995268285274506	0.87011	D	.	0.54156	.	0.9240295	0.93546	0.9065171	0.95377	0.94379294	0.95567	0.8895538	0.94157	-18.086	0.99559	D	0.9797	0.91059	P	0.954210057759786	0.80955	0.99217260	0.97093	0.839	0.91143	.	.	.	.	.	.	5.490304	0.91489	32.0	0.99800748281321283	0.88559	0.920386	0.89189	D	0.925807728767205	0.92926	11.73743	0.873993337143781	0.94305	12.68249	5.32	5.32	0.75341	.	.	8.5	0.90354	11.768000	0.95795	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	729	0.54435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Granulomatous_disease,_chronic,_autosomal_recessive,_cytochrome_b-positive,_type_2	no_classification_provided	NC_000001.11:g.183574569G>T	ClinGen:CA145221|UniProtKB/Swiss-Prot:VAR_065012|UniProtKB:P19878#VAR_065012	C1856245	233710	379	.	Ala	Asp	97.49	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			97.49	Aliphatic	Alanine		Neutrophil cytosol factor 2										1.8								 A140-E136 (PAE:  1.0), A140-L144 (PAE: 1.0)	A140-L144 (PDBs: 1HH8, 1WM5, 1E96), A140-E136 (PDBs: 1WM5, 1E96)	 A140-L144 (PAE:  1.0), A140-E136 (PAE: 1.0), A140-Y131 (PAE: 1.0)	A140-Y131 (PDBs: 1HH8, 1WM5, 1E96), A140-L144 (PDBs: 1WM5, 1E96), A140-E136 (PDBs: 1WM5, 1E96)							89									-60.2				-44.2			TPR 3			H (helix)	H (α-helix)	Helix											97.49	0.0	>90	<10	233710	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic skin disease	3	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2	false	0.8171277454258572	0.8121599308415659	false	false	false
NT5C3A	NT5C3A_Cys108Arg	B_15-16	-2.5229825460026913	0.03963735544814745	0.07686025269640775	-8.636852046115273	0.000055716870437328863	0.00026259929932931245	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9795960505347754	0.9886766473922415	0.5095963051963361	0.6935676085945132	0.6543476958664491	0.5302210691027606	0.46755212472715435	0.5677170902072586	0.6259196683332475	0.47638783611036506	0.9803663840889635	0.960252155652177	0.5928900134783668	0.7409783015256398	0.7612155488557788	0.5428047742823073	0.9969869106955196	0.9989399454173736	NT5C3A	Cys108Arg	NC_000007.14:33022085:A:G	322T>C	7	33022085	A	G	7	ENSG00000122643	14396	23456	CCSBVarC002090	ALE00002090	ENSP00000476480.2	RC4	RC4_Mut_GDEh1016	D10	GDEhDisVCh_40039	G08	1	RC4_Mut_GDDh1016	D10	NULL	NULL	VUSMutpDEST2_11	D08	VUSmut_GDEh12	C12	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																	NaN	NaN		unknown		Rare genetic hematologic disease; Rare inborn errors of metabolism	2		false	0.9886766473922415	0.9795960505347754	true	true	false
PYGL	PYGL_Ser675Thr	B_7-8	2.588045061793996	0.041320287072472185	0.07963849476127334	-2.351317403243081	0.056955793906770975	0.07959930069986652	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5476511208726118	0.5629652597330996	0.6248097707075744	0.6372691452473962	0.588990924081557	0.6195183879618515	0.5911736102612636	0.5907688479015691	0.7018822919545175	0.605741384026354	0.5835258455210026	0.5634148374088395	0.6478631656624395	0.5872130002615448	0.572655998540275	0.6438781573887947	0.5424046739451965	0.531887404336384	PYGL	Ser675Thr	NC_000014.9:50910049:A:T	2023T>A	14	50910049	A	T	14	ENSG00000100504	55246	3214	CCSBVarC008108	ALE00008094	ENSP00000216392.7	Edgotyping3	VUSMutGDEh009	B01	GDEhDisVCh_40063	F11	1	VUSMutGDDh009	B01	VUSN2Hmut_GDN2h_02	B12	VUSMutpDEST2_13	G03	VUSmut_GDEh02	B12	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	N	Y	Y	Y	34185.0	single nucleotide variant	NM_002863.5(PYGL):c.2023T>A (p.Ser675Thr)	5836.0	PYGL	HGNC:9725	not provided	0.0	-	113993985.0	-	RCV000020498	MONDO:MONDO:0009294,MedGen:C0017925,OMIM:232700,Orphanet:369	Glycogen storage disease, type VI	unknown	unknown	GRCh38	NC_000014.9	14	50910049.0	50910049.0	14q22.1	no classification provided	1.0	-	N	ClinGen:CA341914	1.0	21333.0	50910049.0	A	T	-	-	-	-	-	-	2023T>A 	Ser675Thr	NM_002863.5		Others	Others	21333	14	50910049.0	A	T	S	T	rs113993985	14	51376767	14	50446517	675	PYGL	ENSG00000100504	ENST00000216392	ENSP00000216392	P06737	PYGL_HUMAN	c.2023T>A	p.Ser675Thr	c.2023T>A	p.Ser675Thr	principal1	Y	1	YES	Select	-	TCG	1	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.83643	D	0.999	0.77914	D	0.964	0.71005	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.54	0.99078	H	-2.83	0.59742	D	0.938	0.94442	1.0961	0.99494	D	0.9577	0.98629	D	10	0.9826757	0.98343	D	0.340542	0.91985	D	0.958	0.99315	0.911	0.98220	P06737	S675T	Loss of glycosylation at S675 (P = 0.0153)| Loss of phosphorylation at T672 (P = 0.1005)| Loss of disorder (P = 0.1566)| Gain of catalytic residue at S675 (P = 0.2339)| Loss of stability (P = 0.3041)	0.992509679024	0.99233	0.9240265248852371	0.92331	0.516598376616	0.49250	0.879616141319	0.93901	D	0.855299	0.96715	D	0.553855	0.95827	D	0.557798	0.95764	D	0.997612714767456	0.91920	D	0.994516	0.98188	D	0.97346616	0.98550	0.92917	0.96995	0.98044926	0.99129	0.9226592	0.96536	-14.9	0.95623	D	0.9148	0.83763	P	0.997533457417618	0.93247	0.87826200	0.90483	0.97	0.98836	.	.	.	.	.	.	4.560882	0.71922	25.7	0.9960668969954799	0.74605	0.926582	0.90759	D	1.07487532370086	0.97627	16.48719	0.974762322862999	0.98065	17.37442	5.61	5.61	0.85327	.	.	9.294	0.95192	11.217000	0.89634	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.845	0.39945	364	0.84712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Glycogen_storage_disease,_type_VI	no_classification_provided	NC_000014.9:g.50910049A>T	ClinGen:CA341914	C0017925	232700	369	Phosphorylase pyridoxal-phosphate attachment site	Ser	Thr	82.75	0.12307692307692308																																																																																																																																																																																																																																																																																																																																																																																																																																																																													16			82.75	Polar/Neutral	Serine		Glycogen phosphorylase, liver form								0.6256		-0.8								 S675-V456 (PAE:  2.0)	S675-N485 (PDBs: 1FA9), S675-A696 (PDBs: 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEH, 3CEJ, 3CEM, 3DD1, 3DDS, 3DDW, 2QLL)	 S675-V456 (PAE:  2.0)	S675-N485 (PDBs: 1FA9, 2QLL), S675-A696 (PDBs: 1FA9, 1EM6, 1EXV, 1FC0, 1L5Q, 1L5R, 1L5S, 1L7X, 2ZB2, 3CEM, 3DD1, 3DDS, 3DDW, 2QLL), S675-A457 (PDBs: 3CEH, 3CEJ, 8EMS), S675-V456 (PDBs: 2QLL)							105									-165.4		Pocket 1: Mean pLDDT: 90.27, Volume: 508.33 Å³, Druggability score: 0.63		114.3						C (loop/coil)	C (loop/coil)												82.75	12.307693	70-90	10-90	232700	autosomal recessive	OMIM	Rare genetic hepatic disease; Rare inborn errors of metabolism	2	GLYCOGEN STORAGE DISEASE VI	false	0.5629652597330996	0.5476511208726118	false	false	false
GFAP	GFAP_Arg239Pro	B_15-16	1.1081617173696656	0.30440966323989144	0.3910223335426786	9.603985772923496	0.000027906502763401285	0.00015286099274878018	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9720447178293334	0.9530695689492827	0.6691947275706984	0.7717822110451511	0.813180662029104	0.7215819277700094	0.6652069535770545	0.8045763797603266	0.7175982237122782	0.687405793159964	0.944813576026103	0.9660296228516397	0.7779569019629643	0.8217849442978813	0.825966198378024	0.6509836619814329	0.9613255618724624	0.9780598128070273	GFAP	Arg239Pro	NC_000017.11:44913333:C:G	716G>C	17	44913333	C	G	17	ENSG00000131095	2920	214415	CCSBVarC004670	ALE00004670	ENSP00000466598.2	CEGS2	CegsMutGDEh1041	B03	GDEhDisVCh_40051	H07	1	CegsMutGDDh1041	B03	VUSN2Hmut_GDN2h_08	A08	VUSMutpDEST2_03	A01	VUSmut_GDEh08	A08	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77394.0	single nucleotide variant	NM_002055.5(GFAP):c.716G>C (p.Arg239Pro)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	59565950.0	-	RCV000192136|RCV000056900	MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MedGen:C3661900	Alexander disease|not provided	germline	germline	GRCh38	NC_000017.11	17	44913333.0	44913333.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217210,UniProtKB:P14136#VAR_071546	3.0	66497.0	44913333.0	C	G	-	-	-	-	-	-	716G>C 	Arg239Pro	NM_002055.5		Others	Others	66497	17	44913333.0	C	G	R	P	rs59565950	17	42990701	17	40346227	239	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.716G>C	p.Arg239Pro	c.716G>C	p.Arg239Pro	principal1	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	0.42	0.97926	A	without_aae	58.0	42.0	4.765	0.99584	H	.	0.91415	.	.	0.99419	1.0735	0.98684	D	0.9326	0.97773	D	10	0.9924284	0.99778	D	0.579434	0.96220	D	.	0.97773	0.97	0.99713	P14136	R239P	Gain of glycosylation at T240 (P = 0.0313)| Gain of ubiquitination at K236 (P = 0.0477)| Loss of MoRF binding (P = 0.0876)| Loss of solvent accessibility (P = 0.1077)| Gain of phosphorylation at Y242 (P = 0.125)	.	0.99792	.	0.99116	.	0.86412	0.616715908051	0.55199	T	0.974249	0.99739	D	0.517926	0.94774	D	0.506189	0.94697	D	0.999540209770203	0.97827	D	0.983635	0.95417	D	0.9899586	0.99757	0.9846683	0.99917	0.9905992	0.99791	0.98431003	0.99911	-16.98	0.99089	D	0.9951	0.95614	P	0.996565375478044	0.92256	0.99926847	0.99259	1	0.99985	.	.	.	.	.	.	5.861009	0.93864	33.0	0.99503665164204025	0.68246	0.988223	0.99985	D	0.640997006466392	0.75657	6.368131	0.465836667375305	0.65552	4.862144	4.93	3.97	0.45177	.	.	7.905	0.86513	7.694000	0.65990	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.99	0.65338	749	0.51874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Alexander_disease	no_classification_provided	NC_000017.11:g.44913333C>G	ClinGen:CA217210|UniProtKB:P14136#VAR_071546	C3661900|C0270726	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Arg	Pro	91.82	0.6854838709677419																																																																																																																																																																																																																																																																																																																																																																																																																																																																													170			91.82	Positively-charged	Arginine		Glial fibrillary acidic protein							IF rod			-4.5								 R239-L235 (PAE:  1.5), R239-E243 (PAE: 2.0)		 R239-L235 (PAE:  1.5), R239-E243 (PAE: 2.0)								175									-61.5				-45.8	Coil 2A			dbSNP: rs58064122; Variant type: LP/P; AA change: Arg239Cys; PTM type: Phosphorylation; PTM morphology: LKEIR*tQyEAM; Var class: II&rs59565950		H (helix)	H (α-helix)												91.82	68.548386	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.9530695689492827	0.9720447178293334	true	true	false
MVK	MVK_Thr209Ala	B_7-8	-1.5068693182896413	0.18256329664124	0.261783706144721	-2.280358914615297	0.0627688148965986	0.08692888704547805	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7028957765148685	0.7219579596086506	0.8013006054207541	0.7979701272810632	0.8060953197430116	0.8999790784588982	0.9170526553835204	0.8191312178717243	0.876187539730024	0.8531385876969915	0.7991856187984857	0.7806825016446357	0.882905501534276	0.7930594216142991	0.7197527148321025	0.7494626231445167	0.6447303004188155	0.6251090513851013	MVK	Thr209Ala	NC_000012.12:109586119:A:G	625A>G	12	109586119	A	G	12	ENSG00000110921	281	200091	CCSBVarC004837	ALE00004837	ENSP00000228510.3	CEGS2	CegsMutGDEh1039	D11	GDEhDisVCh_40020	C03	2	CegsMutGDDh1039	D11	VUSN2Hmut_GDN2h_08	B04	VUSMutpDEST2_01	A05	VUSmut_GDEh08	B04	1.0	1.0	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	103496.0	single nucleotide variant	NM_000431.4(MVK):c.625A>G (p.Thr209Ala)	4598.0	MVK	HGNC:7530	not provided	0.0	-	104895302.0	-	RCV000083856	MONDO:MONDO:0009849,MedGen:C0398691,OMIM:260920,Orphanet:343	Hyperimmunoglobulin D with periodic fever	unknown	unknown	GRCh38	NC_000012.12	12	109586119.0	109586119.0	12q24.11	no classification provided	1.0	-	N	ClinGen:CA149861	2.0	97604.0	109586119.0	A	G	-	-	-	-	-	-	625A>G 	Thr209Ala	NM_000431.4		Others	Others	97604	12	109586119.0	A	G	T	A	rs104895302	12	110023924	12	108508307	209	MVK	ENSG00000110921	ENST00000228510	ENSP00000228510	Q03426	KIME_HUMAN	c.625A>G	p.Thr209Ala	c.625A>G	p.Thr209Ala	principal1	Y	1	YES	Select	+	ACC	1	0	A	A/A	A/A	A/A	A/A	0.172	0.24303	T	0.12	0.37375	T	0.995	0.67505	D	0.916	0.65195	D	0.96	0.97926	D	simple_aae	4.0	96.0	1.82	0.47623	L	-3.75	0.71195	D	0.964	0.97441	0.8434	0.94930	D	0.9046	0.96830	D	9	0.9828098	0.98364	D	0.375154	0.92825	D	0.865	0.95902	0.912	0.98259	Q03426	T209A	Gain of sheet (P = 0.0344)| Gain of loop (P = 0.069)| Loss of glycosylation at S208 (P = 0.105)| Gain of MoRF binding (P = 0.1302)| Gain of catalytic residue at T209 (P = 0.1539)	0.937065094234	0.93591	0.9494995096547759	0.94901	1.07623771461	0.76845	0.499371051788	0.38687	T	0.680778	0.90530	D	0.385617	0.88989	D	0.316136	0.88851	D	0.975448369979858	0.70740	D	0.920308	0.72019	D	0.5085484	0.67288	0.37892625	0.62714	0.48376015	0.65817	0.31798172	0.57543	-6.961	0.53817	T	0.2193	0.44988	LB	0.948101926279085	0.80227	0.99697316	0.98220	0.728	0.84929	.	.	.	.	.	.	4.018587	0.59414	24.1	0.99696083210866948	0.80337	0.668512	0.63495	D	0.434375595198409	0.63131	4.563787	0.423004581921893	0.62802	4.525522	5.27	4.12	0.47444	2.58	0.47294	6.612	0.74122	8.038000	0.76337	0.756	0.943	1.0	0.71675	0.999000	0.35501	0.742	0.35543	735	0.53648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109350	9.144950e-06	0	1	207922	4.809500e-06	0	1	236742	4.224010e-06	0	0	7158	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13390	0.000000e+00	0	1	42746	2.339400e-05	0	0	15676	0.000000e+00	0	1	42746	2.339400e-05	0	0	16206	0.000000e+00	0	0	30496	0.000000e+00	0	0	6206	0.000000e+00	0	0	13412	0.000000e+00	0	0	16728	0.000000e+00	0	1	89428	1.118220e-05	0	0	30586	0.000000e+00	0	1	89428	1.118220e-05	0	0	14894	0.000000e+00	0	0	34232	0.000000e+00	0	0	9570	0.000000e+00	0	0	17690	0.000000e+00	0	0	21618	0.000000e+00	0	1	102614	9.745260e-06	0	0	30504	0.000000e+00	0	1	102614	9.745260e-06	0	.	1	1613100	6.199240e-07	0	1	1179012	8.481680e-07	0	0	75020	0.000000e+00	0	0	912	0.000000e+00	0	0	60022	0.000000e+00	0	0	29598	0.000000e+00	0	0	44888	0.000000e+00	0	0	64046	0.000000e+00	0	0	6062	0.000000e+00	0	1	1179012	8.481680e-07	0	0	91064	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Hyperimmunoglobulin_D_with_periodic_fever	no_classification_provided	NC_000012.12:g.109586119A>G	ClinGen:CA149861	C0398691	260920	343	GHMP kinase N-terminal domain	Thr	Ala	97.79	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			97.79	Polar/Neutral	Threonine		Mevalonate kinase										-0.7								 T209-N205 (PAE:  1.0), T209-N186 (PAE: 1.0), T209-V377 (PAE: 1.0)	T209-N205 (PDBs: 2R3V), T209-V377 (PDBs: 2R3V)	 T209-V151 (PAE:  1.0), T209-N205 (PAE: 1.0), T209-N186 (PAE: 1.0), T209-V377 (PAE: 1.0)	T209-V151 (PDBs: 2R3V), T209-N205 (PDBs: 2R3V), T209-N186 (PDBs: 2R3V), T209-V377 (PDBs: 2R3V)							119									-82.1				-56.9						H (helix)	H (α-helix)	Helix											97.79	0.0	>90	<10	260920	autosomal recessive	OMIM	Rare genetic systemic or rheumatologic disease; Rare genetic eye disease; Rare genetic immune disease; Rare genetic developmental defect during embryogenesis; Rare inborn errors of metabolism; Rare genetic skin disease	6	HYPER-IgD SYNDROME	false	0.7219579596086506	0.7028957765148685	false	false	false
TAT	TAT_Pro220Ser	B_7-8	-1.1378174817141942	0.29263800150049146	0.38106496252819577	-8.49734485623604	0.00006189468337176139	0.00028323377552913253	2024_01_Batch_7-8	true	false	false	false	false	false	false	false	false	false	false	false	0.9376371526690618	0.9466659552102112	0.5871409180980229	0.5612587474779323	0.596101981897801	0.6336815735656874	0.6755139889185124	0.539756565541025	0.5314613437589814	0.6888296039261776	0.979922242815445	0.9659787291194705	0.5918491582128624	0.6524473982545769	0.5910561511968832	0.4854522322698681	0.9134096676049774	0.9092955762186531	TAT	Pro220Ser	NC_000016.10:71572234:G:A	658C>T	16	71572234	G	A	16	ENSG00000198650	54914	28864	CCSBVarC002397	ALE00002397	ENSP00000348234.4	RC4	RC4_Mut_GDEh1022	C06	GDEhDisVCh_40043	G11	1	RC4_Mut_GDDh1022	C06	VUSN2Hmut_GDN2h_10	A09	VUSMutpDEST2_13	C03	VUSmut_GDEh13	G04	1.0	1.0	1.0	1.0	1.0	99.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												0			98.41	Special, No backbone hydrogen	Proline		Tyrosine aminotransferase										1.6											P220-M375 (PDBs: 3DYD)							115									-100.2				-4.0						C (loop/coil)	T (turn)	Turn													NaN	NaN		unknown		Rare genetic eye disease; Rare inborn errors of metabolism; Rare genetic skin disease	3		false	0.9466659552102112	0.9376371526690618	false	true	false
CDKN1A	CDKN1A_Arg67Leu	B_15-16	-2.0080660272332036	0.0846067794697647	0.14300791928075274	2.173938495841072	0.06623078003599946	0.09110455874517168	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8167567868141112	0.8358762193569056	0.4457833229526589	0.6525606502738925	0.6018410985232758	0.4395408306066239	0.43498496234981154	0.5035498952229951	0.5478130339746247	0.43341377596514863	0.7969768093011864	0.8453466509576597	0.4440966988634363	0.7001323018235566	0.7573082665731604	0.4581528699401692	0.8747756294126249	0.7881669226705628	CDKN1A	Arg67Leu	NC_000006.12:36684301:G:T	200G>T	6	36684301	G	T	6	ENSG00000124762	3192	5564	CCSBVarC000414	ALE00000414	ENSP00000244741.6	RC4	RC4_Mut_GDEh1011	H07	GDEhDisVCh_40040	B01	2	RC4_Mut_GDDh1011	H07	NULL	NULL	VUSMutpDEST2_03	B05	VUSmut_GDEh12	A10	1.0	1.0	1.0	1.0	0.0			1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												201			88.51	Positively-charged	Arginine		Cyclin-dependent kinase inhibitor 1								0.3187		-4.5				C:R67-B:Y21 (PDBs: 6P8H)														175									-79.8		Pocket 2: Mean pLDDT: 87.24, Volume: 557.66 Å³, Druggability score: 0.32		102.7						C (loop/coil)	C (loop/coil)														NaN	NaN		unknown		Rare genetic endocrine disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3		false	0.8358762193569056	0.8167567868141112	false	false	false
HBD	HBD_Asn58Lys	B_7-8	2.027366722459982	0.09844110759070691	0.16208837542952603	-0.880748288327358	0.4123399147559426	0.46577466962415087	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5860931343625835	0.623194362480785	0.6921885575390962	0.713618576781465	0.6431874810556084	0.6944647043367487	0.7559525931769375	0.6852237391703286	0.7994549977612233	0.7337904332223515	0.6630101030716025	0.6183275959233238	0.6329768154965598	0.6011512229408883	0.6277821558017067	0.6505866818558409	0.5833786218899676	0.5538586728018433	HBD	Asn58Lys	NC_000011.10:5234132:G:T	174C>A	11	5234132	G	T	11	ENSG00000223609	13796	218146	CCSBVarC006560	ALE00006559	ENSP00000497529.1	CEGS2	CegsMutGDEh1047	D02	GDEhDisVCh_40036	D03	2	CegsMutGDDh1047	D02	VUSN2Hmut_GDN2h_10	C04	VUSMutpDEST2_11	H05	VUSmut_GDEh10	C04	1.0	1.0	1.0	1.0	1.0	5.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	N	Y	Y	30120.0	single nucleotide variant	NM_000519.4(HBD):c.174C>A (p.Asn58Lys)	3045.0	HBD	HGNC:4829	other	0.0	Dec 12, 2017	35666685.0	-	RCV000016234	-	HEMOGLOBIN A(2) CAMPANIA	germline	germline	GRCh38	NC_000011.10	11	5234132.0	5234132.0	11p15.4	no assertion criteria provided	1.0	-	N	HBVAR:1167,ClinGen:CA124701,UniProtKB:P02042#VAR_030503,OMIM:142000.0040	1.0	15081.0	5234132.0	G	T	-	-	-	-	-	-	174C>A 	Asn58Lys	NM_000519.4		Others	Others	15081	11	5234132.0	G	T	N	K	rs35666685	11	5255362	11	5211938	58	HBD	ENSG00000223609	ENST00000650601	ENSP00000497529	P02042	HBD_HUMAN	c.174C>A	p.Asn58Lys	c.174C>A	p.Asn58Lys	principal1	Y	.	YES	Select	-	AAC	3	2	G	./.	./.	./.	./.	.	0.91343	.	.	0.83643	.	1.0	0.90580	D	1.0	0.97365	D	.	0.94378	.	.	.	.	3.84	0.95628	H	.	0.87174	.	.	0.95621	0.9080	0.95774	D	0.9175	0.97262	D	10	0.9762368	0.97375	D	0.567999	0.96076	D	.	0.82485	0.926	0.98766	P02042	N58K	Gain of methylation at N58 (P = 0.0373)| Gain of MoRF binding (P = 0.0822)| Gain of disorder (P = 0.0859)| Gain of ubiquitination at N58 (P = 0.1767)| Gain of glycosylation at P59 (P = 0.2988)	.	0.90655	.	0.58036	.	.	0.618744313717	0.55485	T	0.134281	0.46247	T	0.149019	0.68952	D	-0.0237217	0.68557	D	0.994724333286285	0.86078	D	.	0.63832	.	0.9647321	0.97715	0.9353163	0.97419	0.9838037	0.99375	0.9285141	0.96950	-8.826	0.66647	D	0.9876	0.92879	LP	0.822080619868786	0.71757	0.99996100	0.99965	0.803	0.89107	.	.	.	.	.	.	1.219128	0.16151	12.34	0.98572613396847208	0.43248	0.410271	0.47944	N	-0.365139873290869	0.26442	1.460412	-0.729397196605755	0.15960	0.8576098	4.33	-6.84	0.01529	-4.79	0.04828	-0.941	0.04039	.	.	-0.258	0.06963	0.0	0.06393	0.000000	0.08389	0.939	0.47934	867	0.32049	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	segdup	1	109400	9.140770e-06	0	1	208104	4.805290e-06	0	1	236816	4.222690e-06	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9040	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30508	0.000000e+00	0	0	6212	0.000000e+00	0	0	13408	0.000000e+00	0	0	16734	0.000000e+00	0	1	89552	1.116670e-05	0	0	30606	0.000000e+00	0	1	89552	1.116670e-05	0	0	14902	0.000000e+00	0	0	34244	0.000000e+00	0	0	9568	0.000000e+00	0	0	17684	0.000000e+00	0	0	21632	0.000000e+00	0	1	102646	9.742220e-06	0	0	30524	0.000000e+00	0	1	102646	9.742220e-06	0	.	14	1614022	8.673980e-06	0	14	1179996	1.186440e-05	0	0	74972	0.000000e+00	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29604	0.000000e+00	0	0	44870	0.000000e+00	0	0	64018	0.000000e+00	0	0	6062	0.000000e+00	0	14	1179996	1.186440e-05	0	0	91076	0.000000e+00	0	0	25848	0	0	336	0	0	114	0	0	9558	0	0	154	0	0	616	0	0	58	0	0	98	0	0	4548	0	0	9894	0	0	172	0	0	41330	0	HEMOGLOBIN_A(2)_CAMPANIA	no_assertion_criteria_provided	NC_000011.10:g.5234132G>T	ClinGen:CA124701|HBVAR:1167|OMIM:142000.0040|UniProtKB:P02042#VAR_030503	.	.	.	Globin|Globin	Asn	Lys	98.57	0.07643312101910828																																																																																																																																																																																																																																																																																																																																																																																																																																																																													13			98.57	Polar/Neutral	Asparagine		Hemoglobin subunit delta							Globin	0.0011		-3.5								 N58-F46 (PAE:  1.0), N58-K62 (PAE: 1.0), N58-D48 (PAE: 1.0), N58-A54 (PAE: 1.0)		 N58-F46 (PAE:  1.0), N58-D48 (PAE: 1.0), N58-A54 (PAE: 1.0), N58-L49 (PAE: 1.0), N58-K62 (PAE: 1.0)								132									-64.8		Pocket 4: Mean pLDDT: 98.93, Volume: 314.25 Å³, Druggability score: 0		121.7				dbSNP: rs35666685; Variant type: LB/B; AA change: Asn58Lys; PTM type: Acetylation; PTM morphology: GN*PkVkAHGkk; Var class: II&rs35666685		C (loop/coil)	C (loop/coil)												98.57	7.6433125	>90	<10		unknown		Rare genetic hematologic disease	1		false	0.623194362480785	0.5860931343625835	false	false	false
HPRT1	HPRT1_Gly58Arg	B_7-8	-1.7633947398681797	0.12120004644652613	0.19100007319543308	-2.1927004658462597	0.0644214449290855	0.0890831585869419	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6296342600471416	0.6363491282718491	0.7737126755250817	0.7940897395463129	0.7526206006051592	0.8350171996634144	0.9161051883088027	0.8219590523995263	0.9031457034583604	0.8624778817057156	0.7223073092491519	0.7592947641284249	0.753929211018026	0.6832821488107923	0.6850337756342653	0.6849474693444478	0.5503909472945463	0.4999737559658583	HPRT1	Gly58Arg	NC_000023.11:134475218:G:A	172G>A	23	134475218	G	A	X	ENSG00000165704	7982	202792	CCSBVarC005926	ALE00005926	ENSP00000298556.7	CEGS2	CegsMutGDEh1045	B07	GDEhDisVCh_40052	A11	2	CegsMutGDDh1045	B07	VUSN2Hmut_GDN2h_09	C10	VUSMutpDEST2_07	D06	VUSmut_GDEh09	C10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25114.0	single nucleotide variant	NM_000194.2(HPRT1):c.172G>A (p.Gly58Arg)	3251.0	HPRT1	HGNC:5157	Pathogenic; other	1.0	May 12, 2011	137852500.0	-	RCV000010780|RCV000010779	|MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233	HPRT TOOWONG|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	germline	germline	GRCh38	NC_000023.11	X	134475218.0	134475218.0	Xq26.2	no assertion criteria provided	1.0	-	N	ClinGen:CA120907,UniProtKB:P00492#VAR_006771,OMIM:308000.0050	1.0	10075.0	134475218.0	G	A	-	-	-	-	-	-	172G>A 	Gly58Arg	NM_000194.2		Others	Others	10075	X	134475218.0	G	A	G	R	rs137852500	X	133609248	X	133436914	58	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.172G>A	p.Gly58Arg	c.172G>A	p.Gly58Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	./.	./.	./.	./.	0.03	0.45552	D	0.07	0.44069	T	0.029	0.19879	B	0.027	0.21085	B	0.88	0.91311	A	simple_aae	12.0	88.0	1.455	0.36610	L	-5.23	0.83927	D	0.898	0.89792	1.0183	0.97497	D	0.9401	0.98029	D	10	0.9213928	0.91398	D	0.917214	0.99386	D	0.788	0.92964	0.633	0.76828	P00492	G58R	Gain of solvent accessibility (P = 0.0037)| Gain of methylation at G58 (P = 0.0383)| Loss of ubiquitination at K55 (P = 0.0497)| Gain of MoRF binding (P = 0.0513)| Loss of sheet (P = 0.0817)	0.999939723104	0.99993	0.9681353823787991	0.96783	2.29650811605	0.96412	0.873305678368	0.93028	D	0.928197	0.98751	D	0.630872	0.99866	D	0.668427	0.99865	D	0.99007785320282	0.80139	D	0.968403	0.88541	D	0.93402696	0.94559	0.89629006	0.94640	0.93402696	0.94560	0.89629006	0.94641	-7.741	0.59364	D	0.5374	0.66189	A	0.878789165247002	0.74698	0.99946600	0.99411	0.871	0.93001	.	.	.	.	.	.	4.345045	0.66759	25.0	0.99828484665658213	0.91033	.	.	.	.	.	.	.	.	.	4.68	4.68	0.58268	3.92	0.74494	9.503	0.96982	11.563000	0.93250	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	280	0.88958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Partial_hypoxanthine-guanine_phosphoribosyltransferase_deficiency|HPRT_TOOWONG	no_assertion_criteria_provided	NC_000023.11:g.134475218G>A	ClinGen:CA120907|OMIM:308000.0050|UniProtKB:P00492#VAR_006771	C0268117	300323	79233	Phosphoribosyltransferase domain|Phosphoribosyltransferase domain	Gly	Arg	91.6	0.25																																																																																																																																																																																																																																																																																																																																																																																																																																																																													21			91.6	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Hypoxanthine-guanine phosphoribosyltransferase										-0.4								 G58-M54 (PAE:  1.0)	G58-R90 (PDBs: 1HMP, 1Z7G), G58-M54 (PDBs: 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)	 G58-M54 (PAE:  1.0)	G58-R90 (PDBs: 1BZY), G58-M54 (PDBs: 3GEP, 3GGC, 3GGJ, 4RAO, 6BNJ), G58-V53 (PDBs: 4IJQ, 4RAB, 4RAD, 4RAN, 5W8V), G58-R91 (PDBs: 4RAC, 4RAQ)							75									-69.5				6.9						C (loop/coil)	T (turn)												91.6	25.0	>90	10-90	300323	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	HYPERURICEMIA, HPRT-RELATED	false	0.6363491282718491	0.6296342600471416	false	false	false
SDC3	SDC3_Val136Ile	B_7-8	3.3314077236430135	0.01577909120412431	0.038442175224744725	-0.24233413839945683	0.8165921231428739	0.8504236923763755	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.8198532521996234	0.8479763634866986	0.796657335383772	0.8759057635346839	0.8246634607621555	0.8898143379827572	0.935732399596515	0.8442083829330611	0.9063210821697132	0.8166559785863063	0.9263344675874303	0.9222027333649102	0.8438962763689996	0.8051185385912497	0.8454904448996546	0.7766586921812376	0.769618259385967	0.7175037710343366	SDC3	Val136Ile	NC_000001.11:30876800:C:T	406G>A	1	30876800	C	T	1	ENSG00000162512	6231	11465	CCSBVarC000996	ALE00000996	ENSP00000338346.7	RC4	RC4_Mut_GDEh1006	C03	GDEhDisVCh_40088	E10	2	RC4_Mut_GDDh1006	C03	NULL	NULL	NULL	NULL	VUSmut_GDEh12	G07	1.0	1.0	1.0	1.0	0.0			0.0			1.0	1.0	7.0	Y	Y	N	N	Y	27795.0	single nucleotide variant	NM_014654.4(SDC3):c.622G>A (p.Val208Ile)	9672.0	SDC3	HGNC:10660	association	0.0	May 01, 2019	2491132.0	-	RCV000013593	MedGen:C4016383	Obesity, association with	germline	germline	GRCh38	NC_000001.11	1	30876800.0	30876800.0	1p35.2	no assertion criteria provided	1.0	-	N	ClinGen:CA122690,UniProtKB:O75056#VAR_027251,OMIM:186357.0002	1.0	12756.0	30876800.0	C	T	-	-	-	-	-	-	622G>A 	Val208Ile	NM_014654.4		Others	Others	12756	1	30876800.0	C	T	V	I	rs2491132	1	31349647	1	31122234	208	SDC3	ENSG00000162512	ENST00000339394	ENSP00000344468	O75056	SDC3_HUMAN	c.622G>A	p.Val208Ile	c.622G>A	p.Val208Ile	principal1	Y	1	YES	Select	-	GTA	1	0	C	C/C	C/C	C/C	C/C	0.865	0.04443	T	0.696	0.06595	T	0.002	0.09864	B	0.001	0.04348	B	0.05	0.16373	P	simple_aae	95.0	5.0	-0.46	0.02762	N	-0.06	0.08138	N	0.029	0.00658	-0.9563	0.39689	T	0.0000	0.00011	T	9	0.0026866794	0.00041	T	.	.	.	0.003	0.00092	.	.	.	.	.	.	.	0.08017695944537764	0.07824	0.0566921864667	0.06124	0.411072552204	0.26574	T	0.183392	0.53342	T	-0.849899	0.00002	T	-0.849777	0.00869	T	0.00593470694976562	0.00064	T	0.517348	0.16466	T	0.017965857	0.00319	0.018111072	0.00047	0.017965857	0.00318	0.018111072	0.00047	-4.549	0.31560	T	0.061	0.01328	B	0.000105249419178041	0.02994	0.00002100	0.00166	0.033	0.07179	.	.	.	.	.	.	-1.633693	0.00224	0.003	0.77546389433941987	0.12115	0.061736	0.11654	N	-1.6035883456554	0.01236	0.05423165	-1.67663908934798	0.01230	0.05606109	4.99	-8.71	0.00735	-7.43	0.01437	-1.922	0.01658	-7.759000	0.01098	-0.181	0.10317	0.0	0.06393	0.000000	0.08389	0.418	0.27233	952	0.10571	382	0.0762779552715655	12	0.009077155824508321	212	0.21073558648111332	70	0.10086455331412104	35	0.034722222222222224	53	0.0541922290388548	36304	264690	0.13715668	.	15145	105866	1.430580e-01	1404	29048	200614	1.447950e-01	2686	33409	226558	1.474630e-01	3099	222	7130	3.113600e-02	4	1341	16498	8.128260e-02	71	284	2068	1.373310e-01	21	461	9018	5.112000e-02	13	2517	12986	1.938240e-01	228	8834	41220	2.143130e-01	983	1183	15116	7.826140e-02	58	8834	41220	2.143130e-01	983	534	15934	3.351320e-02	9	2310	29230	7.902840e-02	118	769	5624	1.367350e-01	55	611	13378	4.567200e-02	14	3155	16216	1.945610e-01	297	18602	86156	2.159110e-01	2010	2323	29442	7.890090e-02	117	18602	86156	2.159110e-01	2010	484	14636	3.306910e-02	8	2719	32872	8.271480e-02	140	1193	8594	1.388180e-01	76	866	17412	4.973580e-02	21	3968	20662	1.920430e-01	375	20979	97696	2.147380e-01	2285	2325	29360	7.918940e-02	117	20979	97696	2.147380e-01	2285	.	307495	1601094	1.920530e-01	33054	269	910	2.956040e-01	32	2570	74610	3.444580e-02	61	269	910	2.956040e-01	32	5801	58600	9.899320e-02	356	4023	28704	1.401550e-01	275	1605	44706	3.590120e-02	43	12597	63456	1.985160e-01	1316	548	5954	9.203900e-02	30	261925	1172344	2.234200e-01	29499	7353	89984	8.171450e-02	374	38982	179660	0.21697651118779918	6	370	0.016216216216216217	190	4508	0.04214729370008873	407	9620	0.04230769230769231	57	464	0.12284482758620689	103	1040	0.09903846153846153	124	1848	0.0670995670995671	20	296	0.06756756756756757	2374	15212	0.15606100447015514	413	9990	0.04134134134134134	314	6356	0.04940213971050975	42263	213018	0.1984010740876358	Obesity,_association_with	no_assertion_criteria_provided	NC_000001.11:g.30876800C>T	ClinGen:CA122690|OMIM:186357.0002|UniProtKB:O75056#VAR_027251	C4016383	.	.	.	Val	Ile	44.45	0.9014084507042254																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																44.45	90.14085	$\leqslant$50	$\geqslant$90		unknown			0		false	0.8479763634866986	0.8198532521996234	false	false	false
MLH1	MLH1_Asp485Glu	B_11-12	-3.7028363448514408	0.026877550198173318	0.05685063220211632	-1.469696297051731	0.2137789279807527	0.2604809647043036	2024_12_Batch_11-12	true	true	true	false	true	true	false	false	false	false	false	false	0.8447851110665012	0.8666254317219411	0.905089777893745	0.8249894251956968	0.905452595116153	0.9255061536017661		0.9117971311942223		0.9088647541155495	0.8544900544338492	0.8384727130746521	0.9255061536017661	0.8991080590380834	0.8249894251956968	0.9013148016719406	0.8787608090100331	0.8510975090583504	MLH1	Asp485Glu	NC_000003.12:37028829:T:A	1455T>A	3	37028829	T	A	3	ENSG00000076242	2713	200868	CCSBVarC003206	ALE00003206	ENSP00000231790.3	CEGS2	CegsMutGDEh1044	F10	GDEhDisVCh_40019	C03	1	CegsMutGDDh1044	F10	VUSN2Hmut_GDN2h_09	E07	VUSMutpDEST2_02	D09	VUSmut_GDEh09	E07	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												108			30.04	Negatively-charged	Aspartic Acid		DNA mismatch repair protein Mlh1										-3.5												 D485-K488 (PAE:  5.0)						132									-83.3				18.4	Disordered; Interaction with EXO1			dbSNP: rs63750956; Variant type: LP/P; AA change: Asp485Glu; PTM type: Phosphorylation; PTM morphology: MVEDD*sRkEMT; Var class: II&rs63750956		C (loop/coil)	C (loop/coil)														NaN	NaN		unknown		Rare genetic immune disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	3		false	0.8666254317219411	0.8447851110665012	true	true	false
HPRT1	HPRT1_Asp194Glu	B_7-8	-1.7648722027773964	0.12093882250591405	0.19100007319543308	-3.492264135985463	0.010097779126858476	0.017304130326346492	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7167661607943172	0.7402986927938552	0.6131455612991951	0.6788322365457821	0.6157932836349653	0.6079766476307364	0.6548294549505917	0.6804203484785726	0.7119227084280629	0.6455142104567131	0.8148025695751949	0.8190710015025873	0.5611238403108811	0.551166218791358	0.6457417646635012	0.580776912141677	0.6657948160125154	0.6144613200860471	HPRT1	Asp194Glu	NC_000023.11:134498657:C:G	582C>G	23	134498657	C	G	X	ENSG00000165704	7982	202809	CCSBVarC005943	ALE00005943	ENSP00000298556.7	CEGS2	CegsMutGDEh1036	H03	GDEhDisVCh_40052	E08	2	CegsMutGDDh1036	H03	VUSN2Hmut_GDN2h_07	A04	VUSMutpDEST2_07	C08	VUSmut_GDEh07	A04	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25120.0	single nucleotide variant	NM_000194.2(HPRT1):c.582C>G (p.Asp194Glu)	3251.0	HPRT1	HGNC:5157	Pathogenic; other	1.0	Sep 10, 2020	137852504.0	-	RCV000010791|RCV000010792	MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233|	Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|HPRT MOOSE JAW	germline	germline	GRCh38	NC_000023.11	X	134498657.0	134498657.0	Xq26.2	no assertion criteria provided	1.0	-	N	ClinGen:CA120913,UniProtKB:P00492#VAR_006797,OMIM:308000.0056	1.0	10081.0	134498657.0	C	G	-	-	-	-	-	-	582C>G 	Asp194Glu	NM_000194.2		Others	Others	10081	X	134498657.0	C	G	D	E	rs137852504	X	133632687	X	133460353	194	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.582C>G	p.Asp194Glu	c.582C>G	p.Asp194Glu	principal1	Y	1	YES	Select	+	GAC	3	2	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.002	0.79703	D	0.52	0.37537	P	0.425	0.45258	B	0.33	0.58037	A	simple_aae	67.0	33.0	4.52	0.99019	H	-3.26	0.65425	D	0.939	0.94561	0.6522	0.92543	D	0.9972	0.99932	D	9	0.993011	0.99835	D	0.931769	0.99505	D	0.834	0.94750	0.967	0.99678	P00492	D194E	Loss of sheet (P = 0.0357)| Loss of loop (P = 0.0804)| Gain of helix (P = 0.0854)| Gain of phosphorylation at Y191 (P = 0.3327)| Loss of stability (P = 0.3478)	0.999909622329	0.99990	0.9955888622407131	0.99555	1.97621803285	0.93572	0.811060547829	0.83626	D	0.985124	0.99905	D	0.67454	0.99905	D	0.731153	0.99905	D	0.995533585548401	0.87499	D	0.975436	0.91331	D	0.96708125	0.97950	0.937422	0.97562	0.96708125	0.97950	0.937422	0.97562	-13.415	0.91019	D	0.9986	0.97942	P	0.99654212099184	0.92238	0.99966919	0.99591	0.983	0.99413	.	.	.	.	.	.	3.779974	0.54424	23.5	0.99385248915968338	0.62121	.	.	.	.	.	.	.	.	.	5.76	5.76	0.90713	3.09	0.56339	2.79	0.4761	3.332000	0.37716	0.579	0.29495	1.0	0.71675	1.000000	0.68239	0.997	0.79771	245	0.90406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Partial_hypoxanthine-guanine_phosphoribosyltransferase_deficiency|HPRT_MOOSE_JAW	no_assertion_criteria_provided	NC_000023.11:g.134498657C>G	ClinGen:CA120913|OMIM:308000.0056|UniProtKB:P00492#VAR_006797	C0268117	300323	79233	Phosphoribosyltransferase domain	Asp	Glu	96.89	0.2822085889570552																																																																																																																																																																																																																																																																																																																																																																																																																																																																													46			96.89	Negatively-charged	Aspartic Acid	GMP; Mg(2+)	Hypoxanthine-guanine phosphoribosyltransferase										-3.5								 D194-R200 (PAE:  1.0)	D194-R200 (PDBs: 4RAN)	 D194-R200 (PAE:  1.0)	D194-R200 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)	 D194-R200 (PAE:  1.0)	D194-R200 (PDBs: 4KN6, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)					132									-128.8				164.8				dbSNP: rs137852504; Variant type: LP/P; AA change: Asp194Glu; PTM type: Phosphorylation; PTM morphology: LD*YNEyFRDLN; Var class: II&rs267606863		C (loop/coil)	C (loop/coil)												96.89	28.22086	>90	10-90	300323	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	HYPERURICEMIA, HPRT-RELATED	false	0.7402986927938552	0.7167661607943172	false	false	false
HPRT1	HPRT1_Ile132Met	B_7-8	-0.8760142266321899	0.4100738553936838	0.5023996560628198	-3.2934310270143703	0.013239849103847469	0.021867797574761573	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.6381360976524757	0.6305881941283007	0.6441333751540239	0.6838257545558244	0.6487068555484594	0.6928938282434493	0.6327929869563577	0.6930275536145017	0.7028014292667971	0.5487107110903973	0.7416406010605308	0.726670977267323	0.7529946695305408	0.604386157482417	0.6648500798448518	0.7395560392176506	0.5195357871960706	0.5496012180376284	HPRT1	Ile132Met	NC_000023.11:134490199:T:G	396T>G	23	134490199	T	G	X	ENSG00000165704	7982	202799	CCSBVarC005935	ALE00005935	ENSP00000298556.7	CEGS2	CegsMutGDEh1040	H09	GDEhDisVCh_40052	E09	2	CegsMutGDDh1040	H09	VUSN2Hmut_GDN2h_08	C06	VUSMutpDEST2_07	A07	VUSmut_GDEh08	C06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	25068.0	single nucleotide variant	NM_000194.2(HPRT1):c.396T>G (p.Ile132Met)	3251.0	HPRT1	HGNC:5157	Pathogenic; other	1.0	Sep 10, 2020	137852477.0	-	RCV000010713|RCV000010712	|MONDO:MONDO:0010299,MedGen:C0268117,OMIM:300323,Orphanet:79233	HPRT ANN ARBOR|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	germline	germline	GRCh38	NC_000023.11	X	134490199.0	134490199.0	Xq26.2	no assertion criteria provided	1.0	-	N	ClinGen:CA120887,UniProtKB:P00492#VAR_006782,OMIM:308000.0001	1.0	10029.0	134490199.0	T	G	-	-	-	-	-	-	396T>G 	Ile132Met	NM_000194.2		Others	Others	10029	X	134490199.0	T	G	I	M	rs137852477	X	133624229	X	133451895	132	HPRT1	ENSG00000165704	ENST00000298556	ENSP00000298556	P00492	HPRT_HUMAN	c.396T>G	p.Ile132Met	c.396T>G	p.Ile132Met	principal1	Y	1	YES	Select	+	ATT	3	3	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.002	0.79703	D	0.93	0.51805	P	0.888	0.63015	P	0.76	0.85499	A	simple_aae	24.0	76.0	4.085	0.97187	H	-2.51	0.54569	D	0.724	0.72440	0.9601	0.96537	D	0.9951	0.99889	D	9	0.97596	0.97335	D	0.587054	0.96313	D	0.813	0.93950	0.899	0.97715	P00492	I132M	Gain of ubiquitination at K128 (P = 0.0913)| Loss of methylation at K128 (P = 0.1181)| Gain of sheet (P = 0.1451)| Loss of stability (P = 0.1562)| Gain of helix (P = 0.1736)	0.99992416413	0.99992	0.9322529828267213	0.93162	2.54765427674	0.97845	0.773405909538	0.77895	T	0.990621	0.99960	D	0.632489	0.99870	D	0.67075	0.99869	D	0.937008321285248	0.60410	D	0.972478	0.90100	D	0.94554245	0.95747	0.8758346	0.93180	0.94554245	0.95747	0.8758346	0.93181	-10.168	0.74989	D	0.7666	0.75724	P	0.45706471523632	0.59472	0.99970990	0.99632	0.441	0.67523	.	.	.	.	.	.	3.714471	0.53122	23.3	0.99648368148651267	0.77155	.	.	.	.	.	.	.	.	.	5.09	1.26	0.20485	0.805	0.27542	1.089	0.30601	4.071000	0.41744	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	232	0.90957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Partial_hypoxanthine-guanine_phosphoribosyltransferase_deficiency|HPRT_ANN_ARBOR	no_assertion_criteria_provided	NC_000023.11:g.134490199T>G	ClinGen:CA120887|OMIM:308000.0001|UniProtKB:P00492#VAR_006782	C0268117	300323	79233	Phosphoribosyltransferase domain|Phosphoribosyltransferase domain	Ile	Met	98.03	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			98.03	Aliphatic	Isoleucine		Hypoxanthine-guanine phosphoribosyltransferase										4.5								 I132-K159 (PAE:  1.0), I132-A161 (PAE: 1.0)	I132-K159 (PDBs: 4KN6, 6BNJ), I132-A161 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)	 I132-A161 (PAE:  1.0)	I132-A161 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ)							131									-83.0				132.6				dbSNP: rs137852477; Variant type: LP/P; AA change: Ile132Met; PTM type: Ubiquitylation; PTM morphology: STLTGkNVLI*V; Var class: II&-		B (undefined)	E (parallel sheets)	Beta strand											98.03	0.0	>90	<10	300323	x-linked recessive	OMIM	Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4	HYPERURICEMIA, HPRT-RELATED	false	0.6305881941283007	0.6381360976524757	false	false	false
GFAP	GFAP_Leu90Pro	B_15-16	0.6450381398787114	0.5394598959642993	0.6192117796224831	8.032564357874701	0.00008881451352091258	0.0003696225098343208	2025_03_Batch_15-16	true	true	false	false	false	false	false	false	false	false	false	false	0.9678921876322009	0.9624347704590737	0.5392759925057604	0.8372033136940631	0.7826336186140503	0.6855221255724889	0.682674660385244	0.7332975470639975	0.8286185577030241	0.6077014492763647	0.9498294609362123	0.9619846467248188	0.6883695907597338	0.8319696901641032	0.8457880696851022	0.47085053573515606	0.9750400799819349	0.9737997285395829	GFAP	Leu90Pro	NC_000017.11:44915218:A:G	269T>C	17	44915218	A	G	17	ENSG00000131095	2920	214394	CCSBVarC004663	ALE00004663	ENSP00000466598.2	CEGS2	CegsMutGDEh1039	F11	GDEhDisVCh_40051	A07	1	CegsMutGDDh1039	F11	VUSN2Hmut_GDN2h_08	C04	VUSMutpDEST2_02	B12	VUSmut_GDEh08	C04	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77376.0	single nucleotide variant	NM_002055.5(GFAP):c.269T>C (p.Leu90Pro)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	59661476.0	-	RCV000192120|RCV000056880	MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MedGen:C3661900	Alexander disease|not provided	germline	germline	GRCh38	NC_000017.11	17	44915218.0	44915218.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217184,UniProtKB:P14136#VAR_071535	3.0	66479.0	44915218.0	A	G	-	-	-	-	-	-	269T>C 	Leu90Pro	NM_002055.5		Others	Others	66479	17	44915218.0	A	G	L	P	rs59661476	17	42992586	17	40348112	90	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.269T>C	p.Leu90Pro	c.269T>C	p.Leu90Pro	principal1	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	.	0.68399	.	.	0.92967	.	0.661	0.40940	P	0.658	0.52745	P	0.26	0.97926	A	without_aae	74.0	26.0	4.535	0.99063	H	.	0.90118	.	.	0.94442	1.0980	0.99576	D	0.9542	0.98511	D	10	0.99057496	0.99560	D	0.626687	0.96777	D	.	0.99840	0.977	0.99784	P14136	L90P	Gain of disorder (P = 0.0216)| Loss of stability (P = 0.0511)| Loss of MoRF binding (P = 0.0559)| Gain of ubiquitination at K95 (P = 0.0861)| Gain of methylation at K86 (P = 0.1038)	.	0.97885	.	0.99538	.	0.87816	0.756330490112	0.75340	T	0.971653	0.99695	D	0.587461	0.97314	D	0.606071	0.97271	D	0.998223841190338	0.93506	D	0.758124	0.38779	T	0.98830265	0.99666	0.9854488	0.99929	0.98439956	0.99417	0.98420066	0.99909	-14.886	0.95589	D	0.9976	0.97843	P	0.999050266881334	0.95600	0.99934870	0.99318	0.997	0.99892	.	.	.	.	.	.	5.60865	0.92522	32.0	0.99880702332631377	0.95656	.	.	.	0.82941708320305	0.87840	9.383449	0.75424360629378	0.86400	8.900673	4.69	4.69	0.58495	3.93	0.74723	9.114	0.93666	11.225000	0.89915	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.995	0.73271	748	0.52085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Alexander_disease|not_provided	no_classification_provided	NC_000017.11:g.44915218A>G	ClinGen:CA217184|UniProtKB:P14136#VAR_071535	C0270726|C3661900	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Pro	96.59	0.4573170731707317																																																																																																																																																																																																																																																																																																																																																																																																																																																																													75			96.59	Aliphatic	Leucine		Glial fibrillary acidic protein							IF rod			3.8								 L90-N94 (PAE:  1.5), L90-K86 (PAE: 2.0)		 L90-N94 (PAE:  1.5), L90-K86 (PAE: 2.0)								131									-66.3				-38.3	Coil 1A			dbSNP: rs59661476; Variant type: LP/P; AA change: Leu90Pro; PTM type: Acetylation; PTM morphology: ASYIEkVRFL*E; Var class: II&rs59661476		H (helix)	H (α-helix)												96.59	45.73171	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.9624347704590737	0.9678921876322009	true	true	false
HBD	HBD_Asn13Lys	B_7-8	1.3722587310750038	0.2190729285313255	0.3007365061902263	0.8465884011388484	0.4252172926949539	0.47869554116272417	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.776881602386165	0.8215265144297733	0.8581550255079212	0.8451564860191849	0.7976603304302938	0.8594975425981346	0.9882134142265024	0.9701064044712909	0.9905520546783623	0.9778558671343982	0.9644773426983939	0.9675556712809791	0.7307816709697668	0.6252142563892968	0.6997609173600077	0.7384541838814442	0.6785756861611527	0.5862075334913509	HBD	Asn13Lys	NC_000011.10:5234395:A:T	39T>A	11	5234395	A	T	11	ENSG00000223609	13796	218138	CCSBVarC006555	ALE00006554	ENSP00000497529.1	CEGS2	CegsMutGDEh1045	G11	GDEhDisVCh_40036	G02	2	CegsMutGDDh1045	G11	VUSN2Hmut_GDN2h_09	G11	VUSMutpDEST2_11	C05	VUSmut_GDEh09	G11	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	30092.0	single nucleotide variant	NM_000519.3(HBD):c.39T>A (p.Asn13Lys)	3045.0	HBD	HGNC:4829	other	0.0	Dec 12, 2017	34313675.0	-	RCV000016199|RCV000016200	|	HEMOGLOBIN A(2) NYU|HEMOGLOBIN NYU	germline	germline	GRCh38	NC_000011.10	11	5234395.0	5234395.0	11p15.4	no assertion criteria provided	1.0	-	N	HBVAR:653,ClinGen:CA124655,UniProtKB:P02042#VAR_003098,OMIM:142000.0012	1.0	15053.0	5234395.0	A	T	-	-	-	-	-	-	39T>A 	Asn13Lys	NM_000519.3		Others	Others	15053	11	5234395.0	A	T	N	K	rs34313675	11	5255625	11	5212201	13	HBD	ENSG00000223609	ENST00000650601	ENSP00000497529	P02042	HBD_HUMAN	c.39T>A	p.Asn13Lys	c.39T>A	p.Asn13Lys	principal1	Y	.	YES	Select	-	AAT	3	2	A	A/A	A/A	A/A	A/A	.	0.78662	.	.	0.46983	.	0.039	0.21130	B	0.351	0.42849	B	.	0.99291	.	.	.	.	-0.26	0.03795	N	.	0.24848	.	.	0.68798	-0.3634	0.73042	T	0.4201	0.76459	T	10	0.030159026	0.01142	T	0.092135	0.75758	D	.	0.73082	0.467	0.53754	P02042	N13K	Loss of catalytic residue at N13 (P = 0.0125)| Gain of ubiquitination at N13 (P = 0.0203)| Gain of methylation at N13 (P = 0.0564)| Gain of MoRF binding (P = 0.0695)| Gain of disorder (P = 0.0994)	.	0.64239	.	0.37615	.	.	0.384683251381	0.22893	T	0.027764	0.20069	T	-0.0611353	0.42385	T	-0.217936	0.52619	T	0.0899266299059596	0.11067	T	.	0.24840	.	0.37039644	0.58286	0.13251624	0.31711	0.35939318	0.57461	0.11270694	0.27133	-1.938	0.02959	T	0.1439	0.69610	LB	0.209542398278616	0.50391	0.99932814	0.99303	0.05	0.13125	.	.	.	.	.	.	-1.864122	0.00137	0.002	0.86955441725352911	0.17135	0.248115	0.36652	N	-1.75555937593739	0.00658	0.02861174	-1.86551654645774	0.00566	0.02535776	4.61	-9.22	0.00576	.	.	-1.889	0.01705	.	.	-0.913	0.02253	0.0	0.06393	0.000000	0.08389	0.001	0.02614	867	0.32049	.	.	.	.	.	.	.	.	.	.	.	.	16	264690	6.044807E-5	segdup	7	109392	6.399010e-05	0	16	208094	7.688830e-05	0	21	236694	8.872210e-05	0	0	7164	0.000000e+00	0	0	17104	0.000000e+00	0	4	2320	1.724140e-03	0	0	9038	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30496	0.000000e+00	0	11	6212	1.770770e-03	0	0	13408	0.000000e+00	0	0	16734	0.000000e+00	0	3	89554	3.349930e-05	0	0	30608	0.000000e+00	0	3	89554	3.349930e-05	0	0	14902	0.000000e+00	0	0	34230	0.000000e+00	0	16	9568	1.672240e-03	0	0	17684	0.000000e+00	0	0	21632	0.000000e+00	0	3	102536	2.925800e-05	0	0	30526	0.000000e+00	0	3	102536	2.925800e-05	0	.	82	1613932	5.080760e-05	0	52	29608	1.756280e-03	0	0	74922	0.000000e+00	0	0	912	0.000000e+00	0	0	59992	0.000000e+00	0	52	29608	1.756280e-03	0	0	44902	0.000000e+00	0	0	64044	0.000000e+00	0	2	6084	3.287310e-04	0	24	1179906	2.034060e-05	0	0	91080	0.000000e+00	0	14	92288	1.5169902912621358E-4	0	174	0	0	2672	0	0	4136	0	1	784	0.0012755102040816326	0	946	0	0	656	0	0	274	0	5	7846	6.372673973999491E-4	0	4310	0	0	3328	0	20	109776	1.8218918524996356E-4	HEMOGLOBIN_A(2)_NYU|HEMOGLOBIN_NYU	no_assertion_criteria_provided	NC_000011.10:g.5234395A>T	ClinGen:CA124655|HBVAR:653|OMIM:142000.0012|UniProtKB:P02042#VAR_003098	.	.	.	Globin	Asn	Lys	97.83	0.4267515923566879																																																																																																																																																																																																																																																																																																																																																																																																																																																																													67			97.83	Polar/Neutral	Asparagine		Hemoglobin subunit delta							Globin			-3.5								 N13-G17 (PAE:  1.0), N13-K9 (PAE: 1.0)		 N13-G17 (PAE:  1.0), N13-K9 (PAE: 1.0)								132									-65.3				-37.6				dbSNP: rs34313675; Variant type: LB/B; AA change: Asn13Lys; PTM type: Phosphorylation; PTM morphology: tPEEktAVN*AL; Var class: II&rs34313675		H (helix)	H (α-helix)	Helix											97.83	42.67516	>90	10-90		unknown		Rare genetic hematologic disease	1		false	0.8215265144297733	0.776881602386165	false	false	false
HPRT1	HPRT1_Phe74Leu	B_7-8	-1.7713628288495669	0.11979760532728448	0.18941508789330577	-5.893937780605372	0.000603159916842087	0.0015948104429470168	2024_01_Batch_7-8	true	true	false	false	false	false	true	false	false	false	false	false	0.990233879876737	0.9818263673190959	0.7430185006378955	0.7374783237709313	0.6670775803516945	0.8212626151487408	0.8375270562446899	0.8103200088415381	0.854585635051982	0.7481213373111972	0.9949915275665744	0.990233879876737	0.8049981740527917	0.5238351518618509	0.6203710124898806	0.7379156639645938	0.9686612070716173		HPRT1	Phe74Leu	NC_000023.11:134475268:C:G	222C>G	23	134475268	C	G	X	ENSG00000165704	7982	202796	CCSBVarC005930	ALE00005930	ENSP00000298556.7	CEGS2	CegsMutGDEh1040	E02	GDEhDisVCh_40052	C09	2	CegsMutGDDh1040	E02	VUSN2Hmut_GDN2h_08	F04	VUSMutpDEST2_07	G06	VUSmut_GDEh08	F04	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												1			98.85	Aromatic	Phenylalanine		Hypoxanthine-guanine phosphoribosyltransferase										2.8								 F74-L78 (PAE:  1.0)	F74-L78 (PDBs: 4KN6, 1HMP, 1Z7G, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ), F74-G70 (PDBs: 1BZY)	 F74-L78 (PAE:  1.0), F74-Y191 (PAE: 1.0), F74-L163 (PAE: 1.0)	F74-L78 (PDBs: 4KN6, 1HMP, 1Z7G, 6BNJ), F74-Y191 (PDBs: 4KN6, 6BNJ), F74-L163 (PDBs: 4KN6, 3GEP, 3GGC, 3GGJ, 4IJQ, 4RAB, 4RAC, 4RAD, 4RAN, 4RAO, 4RAQ, 5W8V, 6BNJ), F74-G70 (PDBs: 1BZY)							165									-58.6				-42.5				dbSNP: rs137852481; Variant type: LP/P; AA change: Phe74Leu; PTM type: Ubiquitylation; PTM morphology: LKGGYkF*FADL; Var class: II		H (helix)	H (α-helix)	Helix													NaN	NaN		unknown		Rare genetic renal disease; Rare genetic hematologic disease; Rare genetic neurological disorder; Rare inborn errors of metabolism	4		false	0.9818263673190959	0.990233879876737	true	true	false
GFAP	GFAP_Leu235Pro	B_15-16	-0.260703808172917	0.8018239410818208	0.8433280437589635	4.903410011544068	0.0017463223217867938	0.0037923094206849307	2025_03_Batch_15-16	true	true	false	false	false	false	true	false	false	false	false	false	0.9803547248926859	0.9571874533327311	0.678863163749565	0.8141628941856689	0.800862246798818	0.7449280278570656	0.6923941046049896	0.7955468264596497	0.7609757003595462	0.66925000066313	0.954635781902272	0.9798930978962153	0.7974619511091416	0.8061776671379862	0.8673500880117917	0.688476326836	0.9597391247631903	0.9808163518891566	GFAP	Leu235Pro	NC_000017.11:44913345:A:G	704T>C	17	44913345	A	G	17	ENSG00000131095	2920	214420	CCSBVarC004667	ALE00004667	ENSP00000466598.2	CEGS2	CegsMutGDEh1036	E01	GDEhDisVCh_40051	E05	1	CegsMutGDDh1036	E01	VUSN2Hmut_GDN2h_07	D03	VUSMutpDEST2_03	D01	VUSmut_GDEh07	D03	1.0	6.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	N	Y	Y	Y	Y	77392.0	single nucleotide variant	NM_002055.5(GFAP):c.704T>C (p.Leu235Pro)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	60269890.0	-	RCV000056896|RCV000192133	MedGen:C3661900|MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58	not provided|Alexander disease	germline	germline	GRCh38	NC_000017.11	17	44913345.0	44913345.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217206,UniProtKB:P14136#VAR_071543	3.0	66495.0	44913345.0	A	G	-	-	-	-	-	-	704T>C 	Leu235Pro	NM_002055.5		Others	Others	66495	17	44913345.0	A	G	L	P	rs60269890	17	42990713	17	40346239	235	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.704T>C	p.Leu235Pro	c.704T>C	p.Leu235Pro	principal1	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	0.7	0.99291	A	without_aae	30.0	70.0	4.62	0.99290	H	.	0.91415	.	.	0.99902	1.0907	0.99266	D	0.9335	0.97804	D	10	0.9916148	0.99688	D	0.443274	0.94194	D	.	0.99434	0.971	0.99725	P14136	L235P	Gain of disorder (P = 0.0139)| Loss of stability (P = 0.0145)| Gain of glycosylation at T232 (P = 0.0376)| Gain of ubiquitination at K236 (P = 0.05)| Gain of phosphorylation at T232 (P = 0.0961)	.	0.99871	.	0.98318	.	0.87987	0.787110507488	0.79967	T	0.960297	0.99481	D	0.523586	0.94963	D	0.514319	0.94889	D	0.999253809452057	0.96681	D	0.9968	0.98810	D	0.98877126	0.99693	0.984175	0.99909	0.98643434	0.99551	0.9852856	0.99927	-16.137	0.97964	D	0.9932	0.95370	P	0.997280814254491	0.92969	0.99956460	0.99487	1	0.99985	.	.	.	.	.	.	5.573075	0.92246	32.0	0.99859049449159532	0.93734	0.984236	0.99940	D	0.885782586707135	0.90996	10.6892	0.726652888642014	0.84317	8.281976	4.93	4.93	0.64349	3.93	0.74723	9.325	0.96016	11.243000	0.90501	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.988	0.63383	749	0.51874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Alexander_disease|not_provided	no_classification_provided	NC_000017.11:g.44913345A>G	ClinGen:CA217206|UniProtKB:P14136#VAR_071543	C0270726|C3661900	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Leu	Pro	84.43	0.6158536585365854																																																																																																																																																																																																																																																																																																																																																																																																																																																																													101			84.43	Aliphatic	Leucine		Glial fibrillary acidic protein							IF rod			3.8								 L235-R239 (PAE:  1.5), L235-L231 (PAE: 3.0)		 L235-R239 (PAE:  1.5), L235-L231 (PAE: 3.0)								131									-65.3				-41.0	Coil 2A			dbSNP: rs60269890; Variant type: LP/P; AA change: Leu235Pro; PTM type: Phosphorylation; PTM morphology: L*KEIRtQyEAM; Var class: II		H (helix)	H (α-helix)												84.43	61.585365	70-90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.9571874533327311	0.9803547248926859	true	true	false
GCK	GCK_Gly385Arg	B_7-8	4.762989565362199	0.017574197821893525	0.04144039239483535	6.169766347765035	0.00857125852436886	0.015007881099443569	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7936029087645258	0.846632432960558	0.6077887380751965	0.6923873907728074	0.6310926978114478	0.6459102558321308	0.6459102558321308	0.6310926978114478	0.6923873907728074	0.6077887380751965	0.846632432960558	0.7936029087645258							GCK	Gly385Arg	NC_000007.14:44145597:C:T	1153G>A	7	44145597	C	T	7	ENSG00000106633	3689	214859	CCSBVarC006697	ALE00006695	ENSP00000384247.3	CEGS2	CegsMutGDEh1044	F08	GDEhDisVCh_40037	B03	1	CegsMutGDDh1044	F08	VUSN2Hmut_GDN2h_09	G06	VUSMutpDEST2_03	H09	VUSmut_GDEh09	G06	1.0	6.0	1.0	1.0	1.0	1.0	7.0	1.0	1.0	1.0	1.0	1.0	1.0	N	Y	Y	Y	Y	44843.0	single nucleotide variant	NM_000162.5(GCK):c.1153G>A (p.Gly385Arg)	2645.0	GCK	HGNC:4195	Likely pathogenic/Likely risk allele	1.0	Aug 18, 2011	193922267.0	-	RCV000029842|RCV002463594	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552	Maturity-onset diabetes of the young type 2|Maturity onset diabetes mellitus in young	germline;unknown	germline	GRCh38	NC_000007.14	7	44145597.0	44145597.0	7p13	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA213721	2.0	36179.0	44145597.0	C	T	-	-	-	-	-	-	1153G>A 	Gly385Arg	NM_000162.5	2.0	Others	Others	36179	7	44145597.0	C	T	G	R	rs193922267	7	44185196	7	44151721	385	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.1153G>A	p.Gly385Arg	c.1153G>A	p.Gly385Arg	principal1	Y	1	YES	Select	-	GGG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.8	0.95330	H	-5.13	0.87940	D	0.966	0.97658	1.0885	0.99178	D	0.9687	0.99007	D	10	0.99321365	0.99853	D	0.81417	0.98549	D	0.962	0.99434	0.976	0.99775	P35557	G385R	Gain of methylation at G385 (P = 0.0071)| Gain of MoRF binding (P = 0.0093)| Loss of catalytic residue at A384 (P = 0.0427)| Gain of disorder (P = 0.0551)| Loss of stability (P = 0.4192)	0.976041132959	0.97555	.	0.99910	.	0.97218	0.899795651436	0.96414	D	0.939492	0.99028	D	0.540798	0.95432	D	0.539042	0.95364	D	0.998842716217041	0.95303	D	0.963704	0.86505	D	0.9927741	0.99889	0.9464729	0.98155	0.9899593	0.99758	0.96298075	0.99116	-13.091	0.90510	D	0.9931	0.95140	P	0.99887997863384	0.95226	0.99983823	0.99792	0.984	0.99450	.	.	.	.	.	.	5.272541	0.88551	29.6	0.99894492961875325	0.96745	0.866045	0.78455	D	0.878649383831347	0.90623	10.51293	0.786564022153535	0.88782	9.73724	5.46	5.46	0.79994	3.81	0.70705	4.064	0.57311	7.531000	0.59982	0.596	0.33565	0.997	0.40243	1.000000	0.68239	0.958	0.51242	716	0.55914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.44145597C>T	ClinGen:CA213721	C0342277|C0342276	125851|606391	552|552	Hexokinase, C-terminal	Gly	Arg	98.76	0.0																																																																																																											-0.031	1 mutation(s) (Gly385Phe: -0.644)	0.564	1 mutation(s) (Gly385Lys: -0.492)																																																																																																																																																																																																																																																																																																																																																															0			98.76	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Hexokinase-4							Hexokinase			-0.4								 G385-M381 (PAE:  1.0), G385-Y289 (PAE: 1.0), G385-V389 (PAE: 1.0)	G385-V389 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3S41, 3VEV, 3VEY, 3VF6, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9)	 G385-M381 (PAE:  1.0), G385-V389 (PAE: 1.0)	G385-V389 (PDBs: 3F9M, 3FGU, 3H1V, 3ID8, 3IDH, 3VEY, 4DCH, 4DHY, 4ISE, 4ISF, 4ISG, 4L3Q, 4MLE, 4MLH, 4NO7, 4RCH, 6E0I, 4LC9), G385-M37 (PDBs: 3S41, 3VEV, 3VF6), G385-M381 (PDBs: 6E0I, 4LC9)							75									-61.8				-51.9	Hexokinase large subdomain			dbSNP: -; Variant type: LP/P; AA change: Gly385Val; PTM type: Phosphorylation; PTM morphology: AAHMCsAG*LAG; Var class: II		H (helix)	H (α-helix)	Helix											98.76	0.0	>90	<10	125851;606391	autosomal dominant	OMIM	Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism	3	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MATURITY-ONSET DIABETES OF THE YOUNG	false	0.846632432960558	0.7936029087645258	false	false	false
FOXP3	FOXP3_Gln70His	B_15-16	-5.1305318328863745	0.0013528524463037638	0.005846770465576084	-7.351906951299443	0.00015567730916313127	0.0005684780155260572	2025_03_Batch_15-16	false	false	false	false	false	true	false	false	false	false	false	false	0.8953170748268238	0.9085075280958919	0.6436957667317138	0.8555053139137323	0.7516100957804552	0.8170993773897606	0.8170993773897606	0.7516100957804552	0.8555053139137323	0.6436957667317138	0.9085075280958919	0.8885255568905066						0.9021085927631409	FOXP3	Gln70His	NC_000023.11:49258296:C:A	210G>T	23	49258296	C	A	X	ENSG00000049768	53657	27193	CCSBVarC002260	ALE00002260	ENSP00000365380.4	RC4	RC4_Mut_GDEh1021	E05	GDEhDisVCh_40080	A11	2	RC4_Mut_GDDh1021	E05	NULL	NULL	NULL	NULL	VUSmut_GDEh13	B04	1.0	1.0	1.0	1.0	0.0			0.0			1.0	1.0	99.0	Y	Y	N	N	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												171			31.45	Polar/Neutral	Glutamine		Forkhead box protein P3; Forkhead box protein P3, C-terminally processed; Forkhead box protein P3 41 kDa form										-3.5																		146	Nuclear export signal								52.4				113.3						C (loop/coil)	C (loop/coil)														NaN	NaN		unknown		Rare genetic immune disease; Rare genetic endocrine disease; Rare genetic gastroenterological disease	3		true	0.9085075280958919	0.8953170748268238	false	false	false
TPM1	TPM1_Leu185Arg	B_15-16	-0.5124086915844789	0.6547815984357114	0.710068544966515	-1.6423542558789532	0.4239446354480438	0.4444082931397225	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.6669264158501169	0.6458021446888931	0.6310716057056744	0.6781290644414315	0.6859628584857638	0.6855492842006454	0.786355827920996	0.6254067170656047	0.6237291552375174	0.7830562230815383	0.5967378677253277	0.6153685887487814	0.5847427404802948	0.746518999905923	0.7325289736453457	0.47908698832981056	0.6948664216524585	0.7184842429514524	TPM1	Leu185Arg	NC_000015.10:63060930:T:G	554T>G	15	63060930	T	G	15	ENSG00000140416	4723	201739	CCSBVarC005643	ALE00005643	ENSP00000288398.6	CEGS2	CegsMutGDEh1035	B12	GDEhDisVCh_40050	C05	2	CegsMutGDDh1035	B12	VUSN2Hmut_GDN2h_07	G02	VUSMutpDEST2_04	D07	VUSmut_GDEh07	G02	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	6.0	Y	Y	Y	Y	Y	40541.0	single nucleotide variant	NM_001018005.2(TPM1):c.554T>G (p.Leu185Arg)	7168.0	TPM1	HGNC:12010	not provided	0.0	Apr 15, 2012	199476314.0	-	RCV000024577	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000015.10	15	63060930.0	63060930.0	15q22.2	no classification provided	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA019057,Leiden Muscular Dystrophy (TPM1):TPM1_00012	2.0	31881.0	63060930.0	T	G	-	-	-	-	-	-	554T>G 	Leu185Arg	NM_001018005.2		Others	Others	31881	15	63060930.0	T	G	L	R	rs199476314	15	63353129	15	61140182	185	TPM1	ENSG00000140416	ENST00000403994	ENSP00000385107	P09493	TPM1_HUMAN	c.554T>G	p.Leu185Arg	c.554T>G	p.Leu185Arg	alternative1	Y	1	YES	Select	+	CTC	2	0	T	T/T	T/T	T/T	T/T	0.001	0.91343	D	0.469	0.26042	T	0.645	0.56216	P	0.818	0.66273	P	1.0	0.99291	D	simple_aae	0.0	100.0	3.48	0.92449	M	-3.8	0.82092	D	0.906	0.92907	1.0931	0.99364	D	0.9559	0.98569	D	10	0.8805148	0.87222	D	0.471584	0.94679	D	0.878	0.96382	.	0.71139	.	.	.	0.949110213178	0.94815	.	0.96621	.	0.99059	0.799039363861	0.81785	T	0.954359	0.99358	D	0.571509	0.96602	D	0.583157	0.96545	D	0.987627506256104	0.77921	D	0.555444	0.33715	T	0.87419313	0.89046	0.7562286	0.85417	0.8501861	0.87181	0.77905625	0.86809	-10.655	0.87245	D	0.3824	0.61818	A	0.991207691844717	0.88921	0.99967682	0.99601	0.958	0.98192	.	.	.	.	.	.	5.33747	0.89575	30.0	0.99669191949169444	0.78482	0.953810	0.97031	D	0.752049892136807	0.82943	7.913696	0.745487547072721	0.85743	8.695972	5.8	5.8	0.92070	4.46	0.83695	8.017	0.8876	7.910000	0.74019	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.998	0.85369	792	0.45931	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	no_classification_provided	NC_000015.10:g.63060930T>G	ClinGen:CA019057|Leiden_Muscular_Dystrophy_(TPM1):TPM1_00012	CN517202	.	.	.	Leu	Arg	98.15	0.6585365853658537																																																																																																																																																																																																																																																																																																																																																																																																																																																																													108			98.15	Aliphatic	Leucine		Tropomyosin alpha-1 chain	Coiled coil									3.8								 L185-E181 (PAE:  1.0), L185-K189 (PAE: 1.0)	L185-K189 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), L185-E181 (PDBs: 8ENC)	 L185-E181 (PAE:  1.0), L185-K189 (PAE: 1.0)	L185-K189 (PDBs: 6X5Z, 8EFH, 8EFI, 8ENC), L185-E181 (PDBs: 8ENC)							131									-61.7				-39.8						H (helix)	H (α-helix)	Helix											98.15	65.85366	>90	10-90		unknown		Rare genetic cardiac disease; Laminopathy; Rare genetic neurological disorder	3		false	0.6458021446888931	0.6669264158501169	false	false	false
GFAP	GFAP_Lys279Glu	B_15-16	-2.164273294780919	0.06718269669094776	0.1177238079630369	5.805418055645164	0.0006598798530521489	0.0017078695773634603	2025_03_Batch_15-16	true	true	true	false	false	false	false	false	false	false	false	false	0.9686500469419715	0.955495449245892	0.7775279413140237	0.7918661522750873	0.7793005008937612	0.7995846612354274	0.770152185589282	0.7353840897821634	0.7371129023384237	0.7674953417196253	0.9481529051951866	0.9605999313499931	0.8290171368815727	0.8232169120053592	0.8466194022117508	0.7875605409084221	0.9628379932965976	0.97670016253395	GFAP	Lys279Glu	NC_000017.11:44911743:T:C	835A>G	17	44911743	T	C	17	ENSG00000131095	2920	214427	CCSBVarC004672	ALE00004672	ENSP00000466598.2	CEGS2	CegsMutGDEh1041	A11	GDEhDisVCh_40051	D08	1	CegsMutGDDh1041	A11	VUSN2Hmut_GDN2h_08	D10	VUSMutpDEST2_03	H01	VUSmut_GDEh08	D10	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77404.0	single nucleotide variant	NM_002055.5(GFAP):c.835A>G (p.Lys279Glu)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	58536923.0	-	RCV000056911|RCV000192149	MedGen:C3661900|MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58	not provided|Alexander disease	germline	germline	GRCh38	NC_000017.11	17	44911743.0	44911743.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217224,UniProtKB:P14136#VAR_071552	3.0	66507.0	44911743.0	T	C	-	-	-	-	-	-	835A>G 	Lys279Glu	NM_002055.5		Others	Others	66507	17	44911743.0	T	C	K	E	rs58536923	17	42989111	17	40344637	279	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.835A>G	p.Lys279Glu	c.835A>G	p.Lys279Glu	principal1	Y	1	YES	Select	-	AAG	1	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.79703	.	1.0	0.90580	D	0.996	0.84488	D	0.75	0.99291	A	without_aae	25.0	75.0	2.875	0.83215	M	.	0.67738	.	.	0.93259	1.0175	0.97483	D	0.9068	0.96904	D	10	0.979491	0.97852	D	0.460809	0.94499	D	.	0.99545	0.867	0.96136	P14136	K279E	Loss of MoRF binding (P = 0.0024)| Loss of ubiquitination at K279 (P = 0.021)| Loss of glycosylation at K279 (P = 0.0708)| Gain of disorder (P = 0.3406)| Loss of methylation at K279 (P = 0.5083)	.	0.99967	.	0.99326	.	0.85908	0.718379616737	0.69759	T	0.858399	0.96811	D	0.5303	0.95128	D	0.523963	0.95056	D	0.994490504264832	0.85702	D	0.957304	0.83895	D	0.9595456	0.97190	0.9529121	0.98550	0.96011126	0.97248	0.96503973	0.99221	-10.379	0.77476	D	0.8473	0.79576	P	0.987722607458467	0.87540	0.99948114	0.99419	0.989	0.99628	.	.	.	.	.	.	5.430331	0.90819	31.0	0.99836022142609193	0.91720	0.959243	0.97938	D	0.693376304418743	0.79084	7.027401	0.624296928592611	0.76580	6.541182	4.42	4.42	0.52717	.	.	8.017	0.8876	6.077000	0.53382	0.576	0.29264	1.0	0.71675	1.000000	0.68239	0.993	0.69292	754	0.51253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Alexander_disease|not_provided	no_classification_provided	NC_000017.11:g.44911743T>C	ClinGen:CA217224|UniProtKB:P14136#VAR_071552	C0270726|C3661900	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Lys	Glu	96.02	0.6048780487804878																																																																																																																																																																																																																																																																																																																																																																																																																																																																													124			96.02	Positively-charged	Lysine		Glial fibrillary acidic protein							IF rod			-3.9								 K279-N283 (PAE:  1.0), K279-L275 (PAE: 1.0)		 K279-N283 (PAE:  1.0), K279-L275 (PAE: 1.0)								147									-65.1				-36.5	Coil 2B					H (helix)	H (α-helix)												96.02	60.48781	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.955495449245892	0.9686500469419715	true	true	false
GFAP	GFAP_Lys236Thr	B_15-16	-1.1436242618907324	0.2903773364473676	0.3785806912044178	21.82710058622292	1.0692821195017595e-7	5.945856634199178e-6	2025_03_Batch_15-16	true	true	true	false	false	false	true	false	false	false	false	false	0.9755565337072221	0.9734065701383479	0.7523296687049363	0.8489514120157975	0.838219746682793	0.7881137882264362	0.7442845388126176	0.8492809567502287	0.8522234150258599	0.7442267328079596	0.96708493396181	0.9719270507528173	0.8319430376402547	0.8271585366153572	0.8456794090057351	0.760432604601913	0.9797282063148857	0.979186016661627	GFAP	Lys236Thr	NC_000017.11:44913342:T:G	707A>C	17	44913342	T	G	17	ENSG00000131095	2920	214424	CCSBVarC004668	ALE00004668	ENSP00000466598.2	CEGS2	CegsMutGDEh1040	D07	GDEhDisVCh_40051	E07	1	CegsMutGDDh1040	D07	VUSN2Hmut_GDN2h_08	H05	VUSMutpDEST2_03	G01	VUSmut_GDEh08	H05	1.0	1.0	1.0	1.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77393.0	single nucleotide variant	NM_002055.5(GFAP):c.707A>C (p.Lys236Thr)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	267607525.0	-	RCV000192134|RCV000056897	MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MedGen:C3661900	Alexander disease|not provided	germline	germline	GRCh38	NC_000017.11	17	44913342.0	44913342.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217207,UniProtKB:P14136#VAR_071544	3.0	66496.0	44913342.0	T	G	-	-	-	-	-	-	707A>C 	Lys236Thr	NM_002055.5		Others	Others	66496	17	44913342.0	T	G	K	T	rs267607525	17	42990710	17	40346236	236	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.707A>C	p.Lys236Thr	c.707A>C	p.Lys236Thr	principal1	Y	1	YES	Select	-	AAA	2	0	T	T/T	T/T	T/T	T/T	.	0.78662	.	.	0.83643	.	0.084	0.24816	B	0.263	0.39595	B	0.01	0.90354	A	without_aae	99.0	1.0	0.885	0.21498	L	.	0.65084	.	.	0.80306	-0.0107	0.81954	T	0.5578	0.83812	D	10	0.7361313	0.74393	D	0.303118	0.90927	D	.	0.85909	0.478	0.55528	P14136	K236T	Loss of ubiquitination at K236 (P = 0.0255)| Gain of phosphorylation at K236 (P = 0.0501)| Loss of MoRF binding (P = 0.1405)| Loss of disorder (P = 0.1524)| Loss of solvent accessibility (P = 0.1922)	.	0.97653	.	0.82861	.	0.70265	0.430933237076	0.29300	T	0.755658	0.93278	D	0.225194	0.76089	D	0.0856987	0.75779	D	0.976693451404572	0.71303	D	0.80082	0.86963	T	0.5311976	0.68597	0.62981594	0.78174	0.6761736	0.76503	0.6822711	0.81113	-11.235	0.80991	D	0.4101	0.60088	A	0.761725126650371	0.69243	0.99685810	0.98185	0.938	0.97019	.	.	.	.	.	.	3.582516	0.50599	23.0	0.9968222130040002	0.79329	0.822897	0.74217	D	-0.36714717391248	0.26369	1.455875	-0.283377609723749	0.28327	1.598786	4.93	3.86	0.43622	2.88	0.52655	3.957	0.56527	2.760000	0.34679	-0.201	0.08901	0.998	0.41403	0.999000	0.35501	0.977	0.56847	749	0.51874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Alexander_disease	no_classification_provided	NC_000017.11:g.44913342T>G	ClinGen:CA217207|UniProtKB:P14136#VAR_071544	C3661900|C0270726	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Lys	Thr	87.37	0.6829268292682927																																																																																																																																																																																																																																																																																																																																																																																																																																																																													140			87.37	Positively-charged	Lysine		Glial fibrillary acidic protein							IF rod			-3.9								 K236-T232 (PAE:  2.5), K236-T240 (PAE: 1.5)		 K236-T232 (PAE:  2.5), K236-T240 (PAE: 1.5)								147									-63.7				-44.3	Coil 2A			dbSNP: rs267607525; Variant type: LP/P; AA change: Lys236Thr; PTM type: Phosphorylation; PTM morphology: LK*EIRtQyEAM; Var class: II		H (helix)	H (α-helix)												87.37	68.29269	70-90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.9734065701383479	0.9755565337072221	true	true	false
PLP1	PLP1_Gly74Arg	B_7-8	-3.0183580514664223	0.03922649801159243	0.07621832268783472	-2.8812595771610714	0.02801158320156561	0.04251551296515542	2024_01_Batch_7-8	true	true	false	false	false	false	true	true	false	false	false	false	0.9908733584735492	0.9955991361707426	0.9169964416769197	0.9486313001565186	0.8204858252511918	0.9518426844843374	0.9518426844843374	0.8204858252511918	0.9486313001565186	0.9169964416769197	0.9955991361707426	0.9908733584735492							PLP1	Gly74Arg	NC_000023.11:103786493:G:C	220G>C	23	103786493	G	C	X	ENSG00000123560	4062	201423	CCSBVarC005855	ALE00005855	ENSP00000477619.1	CEGS2	CegsMutGDEh1039	E03	GDEhDisVCh_40062	B06	2	CegsMutGDDh1039	E03	VUSN2Hmut_GDN2h_08	G01	VUSMutpDEST2_04	F02	VUSmut_GDEh08	G01	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												38			92.38	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Myelin proteolipid protein								0.9999		-0.4								 G74-Y70 (PAE:  1.0), G74-F78 (PAE: 1.0)		 G74-Y70 (PAE:  1.0), G74-F78 (PAE: 1.0)								75									-62.4		Pocket 1: Mean pLDDT: 91.36, Volume: 1487.75 Å³, Druggability score: 1		-43.0						H (helix)	H (α-helix)									Helical; Name=2					NaN	NaN		unknown		Rare genetic eye disease; Rare genetic neurological disorder	2		false	0.9955991361707426	0.9908733584735492	true	true	true
HBD	HBD_Leu76Val	B_7-8	0.8216533836064227	0.44866554892313754	0.537610538546545	-1.0003527824326115	0.35576027015950534	0.4087790205026251	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5244224932261842	0.5182940869256425	0.5911036504402174	0.562148810555092	0.5377424339620009	0.5765963535813469	0.7232931540719065	0.6220787334050452	0.6731759721004872	0.7209300449066774	0.5799104571207931	0.5687314522690667	0.42989955309078726	0.4534061345189567	0.451121649009697	0.46127725597375735	0.45667771673049184	0.4801135341833016	HBD	Leu76Val	NC_000011.10:5234080:G:C	226C>G	11	5234080	G	C	11	ENSG00000223609	13796	218151	CCSBVarC006565	ALE00006564	ENSP00000497529.1	CEGS2	CegsMutGDEh1045	H06	GDEhDisVCh_40036	F02	2	CegsMutGDDh1045	H06	VUSN2Hmut_GDN2h_09	B10	VUSMutpDEST2_11	E06	VUSmut_GDEh09	B10	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	30113.0	single nucleotide variant	NM_000519.4(HBD):c.226C>G (p.Leu76Val)	3045.0	HBD	HGNC:4829	Pathogenic; other	1.0	Dec 12, 2017	34430836.0	-	RCV000016226|RCV000016227	MedGen:C0271990|	delta Thalassemia|HEMOGLOBIN A(2) GROVETOWN	germline	germline	GRCh38	NC_000011.10	11	5234080.0	5234080.0	11p15.4	no assertion criteria provided	1.0	-	N	ClinGen:CA124687,UniProtKB:P02042#VAR_003111,OMIM:142000.0033	1.0	15074.0	5234080.0	G	C	-	-	-	-	-	-	226C>G 	Leu76Val	NM_000519.4		Others	Others	15074	11	5234080.0	G	C	L	V	rs34430836	11	5255310	11	5211886	76	HBD	ENSG00000223609	ENST00000650601	ENSP00000497529	P02042	HBD_HUMAN	c.226C>G	p.Leu76Val	c.226C>G	p.Leu76Val	principal1	Y	.	YES	Select	-	CTG	1	2	G	./.	./.	./.	./.	.	0.30372	.	.	0.01173	.	0.004	0.12194	B	0.027	0.21085	B	.	0.89875	.	.	.	.	-0.825	0.01539	N	.	0.07691	.	.	0.68098	-0.5609	0.66221	T	0.3481	0.71137	T	10	0.26084742	0.43149	D	0.137904	0.81989	D	.	0.83221	0.422	0.46386	P02042	L76V	Gain of catalytic residue at L76 (P = 0.0212)| Loss of loop (P = 0.1242)| Gain of helix (P = 0.2059)| Loss of disorder (P = 0.2617)| Gain of MoRF binding (P = 0.2805)	.	0.51823	.	0.64591	.	.	0.379381746054	0.22145	T	0.021142	0.16396	T	-0.0471067	0.44546	T	-0.123914	0.61208	T	0.111790502897058	0.13435	T	.	0.55397	.	0.10179405	0.23832	0.056731652	0.10200	0.11337489	0.26538	0.065680906	0.13345	-1.376	0.01530	T	0.1262	0.35990	LB	0.0279054574712455	0.32210	0.99926597	0.99259	0.084	0.23719	.	.	.	.	.	.	0.01983	0.04431	1.156	0.84363830618775926	0.15483	0.133674	0.25127	N	-1.60996147210803	0.01205	0.05285505	-1.61882659855262	0.01526	0.0699993	4.33	-4.52	0.03230	-5.01	0.04473	-0.565	0.06032	.	.	-0.392	0.05349	0.001	0.13799	0.000000	0.08389	0.531	0.29777	867	0.32049	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	5	264690	1.8890023E-5	segdup	1	109398	9.140930e-06	0	1	208102	4.805340e-06	0	1	236864	4.221830e-06	0	1	7164	1.395870e-04	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9040	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	7164	1.395870e-04	0	1	16218	6.165990e-05	0	0	30502	0.000000e+00	0	0	6212	0.000000e+00	0	0	13410	0.000000e+00	0	0	16734	0.000000e+00	0	0	89552	0.000000e+00	0	0	30608	0.000000e+00	0	1	16218	6.165990e-05	0	1	14902	6.710510e-05	0	0	34236	0.000000e+00	0	0	9572	0.000000e+00	0	0	17686	0.000000e+00	0	0	21632	0.000000e+00	0	0	102694	0.000000e+00	0	0	30526	0.000000e+00	0	1	14902	6.710510e-05	0	.	6	1614058	3.717340e-06	0	5	74986	6.667910e-05	0	5	74986	6.667910e-05	0	0	912	0.000000e+00	0	0	60010	0.000000e+00	0	0	29604	0.000000e+00	0	0	44876	0.000000e+00	0	0	64024	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180000	0.000000e+00	0	0	91076	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	1	2784	3.5919540229885057E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	1	2898	3.450655624568668E-4	0	112	0	1	14050	7.117437722419929E-5	HEMOGLOBIN_A(2)_GROVETOWN|delta_Thalassemia	no_assertion_criteria_provided	NC_000011.10:g.5234080G>C	ClinGen:CA124687|OMIM:142000.0033|UniProtKB:P02042#VAR_003111	C0271990	.	.	Globin|Globin	Leu	Val	97.14	0.03048780487804878																																																																																																																																																																																																																																																																																																																																																																																																																																																																													5			97.14	Aliphatic	Leucine		Hemoglobin subunit delta							Globin			3.8								 L76-F72 (PAE:  1.0)		 L76-F72 (PAE:  1.0)								131									-64.8				-34.3				dbSNP: rs34430836; Variant type: LB/B; AA change: Leu76Val; PTM type: Phosphorylation; PTM morphology: VLGAFsDGL*AH; Var class: II		H (helix)	H (α-helix)	Helix											97.14	3.0487804	>90	<10		unknown		Rare genetic hematologic disease	1		false	0.5182940869256425	0.5244224932261842	false	false	false
FOXP3	FOXP3_Pro187Leu	B_15-16	-4.467356722023371	0.0029101734485915643	0.01048760620152809	-2.3131435988201114	0.05393643421821846	0.0757255981564123	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.64123592954789	0.63902963047425	0.4916466859730825	0.6830003929959473	0.571879973166596	0.4930639394903198	0.39623691637299524	0.5638991118141443	0.6310363818068396	0.40166041142572584	0.6865919104118274	0.6908738318133789	0.5898909626076444	0.5798608345190477	0.7349644041850549	0.5816329605204391	0.5914673505366725	0.5915980272824012	FOXP3	Pro187Leu	NC_000023.11:49256838:G:A	560C>T	23	49256838	G	A	X	ENSG00000049768	53657	27195	CCSBVarC002261	ALE00002261	ENSP00000365380.4	RC4	RC4_Mut_GDEh1021	B05	GDEhDisVCh_40080	F10	2	RC4_Mut_GDDh1021	B05	NULL	NULL	NULL	NULL	VUSmut_GDEh13	G03	1.0	3.0	1.0	1.0	0.0			0.0			1.0	1.0	99.0	N	Y	N	N	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												111			40.65	Special, No backbone hydrogen	Proline		Forkhead box protein P3; Forkhead box protein P3, C-terminally processed; Forkhead box protein P3 41 kDa form										1.6																		115									-77.8				119.9	Interaction with ZFP90; Essential for transcriptional repressor activity and for interaction with KAT5 and HDAC7; Interaction with IKZF4					C (loop/coil)	C (loop/coil)														NaN	NaN		unknown		Rare genetic immune disease; Rare genetic endocrine disease; Rare genetic gastroenterological disease	3		false	0.63902963047425	0.64123592954789	false	false	false
HBD	HBD_Pro37His	B_7-8	2.0613012594223266	0.08490339847660626	0.1432557341787261	1.3165185333894052	0.22946547918084778	0.27720154989918083	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5429986762555244	0.5254244317573142	0.6469104963437637	0.562477383273053	0.5493947467244685	0.6292357103643895	0.6525719375891107	0.484224314048321	0.6236280865898353	0.6601183978016979	0.5363275083544629	0.5287332098974817	0.6058994831396682	0.6145651794006161	0.5013266799562707	0.6337025948858296	0.5145213551601655	0.5572641426135672	HBD	Pro37His	NC_000011.10:5234196:G:T	110C>A	11	5234196	G	T	11	ENSG00000223609	13796	218145	CCSBVarC006559	ALE00006558	ENSP00000497529.1	CEGS2	CegsMutGDEh1046	E11	GDEhDisVCh_40036	C03	2	CegsMutGDDh1046	E11	VUSN2Hmut_GDN2h_10	F03	VUSMutpDEST2_11	G05	VUSmut_GDEh10	F03	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	30119.0	single nucleotide variant	NM_000519.4(HBD):c.110C>A (p.Pro37His)	3045.0	HBD	HGNC:4829	other	0.0	Dec 12, 2017	34383555.0	-	RCV000016233	-	HEMOGLOBIN A(2) METAPONTO	germline	germline	GRCh38	NC_000011.10	11	5234196.0	5234196.0	11p15.4	no assertion criteria provided	1.0	-	N	ClinGen:CA124699,UniProtKB:P02042#VAR_030502,OMIM:142000.0039	1.0	15080.0	5234196.0	G	T	-	-	-	-	-	-	110C>A 	Pro37His	NM_000519.4		Others	Others	15080	11	5234196.0	G	T	P	H	rs34383555	11	5255426	11	5212002	37	HBD	ENSG00000223609	ENST00000650601	ENSP00000497529	P02042	HBD_HUMAN	c.110C>A	p.Pro37His	c.110C>A	p.Pro37His	principal1	Y	.	YES	Select	-	CCT	2	0	G	./.	./.	./.	./.	.	0.68399	.	.	0.92967	.	0.999	0.77914	D	0.993	0.81117	D	.	0.99291	.	.	.	.	4.48	0.98894	H	.	0.96761	.	.	0.85840	1.0483	0.98077	D	0.9826	0.99467	D	10	0.98551023	0.98795	D	0.598333	0.96449	D	.	0.96271	0.906	0.98016	P02042	P37H	Gain of catalytic residue at P37 (P = 0.0998)| Gain of MoRF binding (P = 0.1761)| Loss of stability (P = 0.3651)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.5184)	.	0.96674	.	0.74213	.	.	0.592143714428	0.51730	T	0.250561	0.63837	T	0.550656	0.95772	D	0.553203	0.95709	D	0.999064147472382	0.96022	D	.	0.37881	.	0.95735735	0.96965	0.9127865	0.95829	0.96463394	0.97706	0.9183806	0.96232	-11.453	0.82139	D	0.9574	0.87725	LP	0.836130188141873	0.72418	0.99995935	0.99965	0.773	0.87433	.	.	.	.	.	.	4.315958	0.66086	24.9	0.99222300490843296	0.56002	0.751509	0.69117	D	0.558816956668871	0.70464	5.528454	0.328541699083603	0.56997	3.887306	4.45	3.51	0.39227	2.97	0.54324	6.18	0.71983	.	.	0.509	0.23243	1.0	0.71675	0.999000	0.35501	0.635	0.32331	867	0.32049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	77002	0	0	124	0	0	382	0	0	3214	0	0	504	0	0	1544	0	0	100	0	0	70	0	0	2064	0	0	3338	0	0	482	0	0	85004	0	HEMOGLOBIN_A(2)_METAPONTO	no_assertion_criteria_provided	NC_000011.10:g.5234196G>T	ClinGen:CA124699|OMIM:142000.0039|UniProtKB:P02042#VAR_030502	.	.	.	Globin|Globin	Pro	His	97.87	0.5367647058823529																																																																																																																																																																																																																																																																																																																																																																																																																																																																													73			97.87	Special, No backbone hydrogen	Proline		Hemoglobin subunit delta							Globin			1.6																		115									-58.0				-26.4				dbSNP: rs34383555; Variant type: LB/B; AA change: Pro37His; PTM type: Phosphorylation; PTM morphology: VVyP*WtQRFFE; Var class: II&rs34383555		H (helix)	G (3₁₀-helix)	Helix											97.87	53.676468	>90	10-90		unknown		Rare genetic hematologic disease	1		false	0.5254244317573142	0.5429986762555244	false	false	false
GFAP	GFAP_Glu371Gly	B_15-16	-1.4372809441791912	0.19379386313564723	0.2741824285845083	7.877050884052467	0.00010061061663345712	0.00040741970085551475	2025_03_Batch_15-16	true	true	false	false	false	false	true	false	false	false	false	false	0.9765457988849895	0.9583637544441004	0.7357018770333074	0.8242984125800448	0.8147343507562212	0.7525122598411295	0.6867681988865022	0.8208358132134599	0.8242916564937603	0.6558238196360189	0.9489639209568135	0.9723499249037234	0.8182563207957567	0.8086328882989826	0.8243051686663291	0.8155799344305958	0.9677635879313874	0.9807416728662557	GFAP	Glu371Gly	NC_000017.11:44911251:T:C	1112A>G	17	44911251	T	C	17	ENSG00000131095	2920	214437	CCSBVarC004677	ALE00004677	ENSP00000466598.2	CEGS2	CegsMutGDEh1036	B05	GDEhDisVCh_40051	F05	1	CegsMutGDDh1036	B05	VUSN2Hmut_GDN2h_07	H04	VUSMutpDEST2_03	C02	VUSmut_GDEh07	H04	1.0	3.0	1.0	1.0	1.0	6.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	N	Y	N	Y	Y	77334.0	single nucleotide variant	NM_002055.5(GFAP):c.1112A>G (p.Glu371Gly)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	57815192.0	-	RCV000192170|RCV000056831	MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MedGen:C3661900	Alexander disease|not provided	germline	germline	GRCh38	NC_000017.11	17	44911251.0	44911251.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217115	3.0	66437.0	44911251.0	T	C	-	-	-	-	-	-	1112A>G 	Glu371Gly	NM_002055.5		Others	Others	66437	17	44911251.0	T	C	E	G	rs57815192	17	42988619	17	40344145	371	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.1112A>G	p.Glu371Gly	c.1112A>G	p.Glu371Gly	principal1	Y	1	YES	Select	-	GAG	2	0	T	./.	./.	./.	./.	.	0.78662	.	.	0.83643	.	0.998	0.73231	D	0.977	0.73823	D	0.27	0.99291	A	without_aae	73.0	27.0	4.225	0.97896	H	.	0.90390	.	.	0.93259	1.0723	0.98650	D	0.9267	0.97573	D	10	0.9906943	0.99575	D	0.740113	0.97913	D	.	0.99783	0.957	0.99533	P14136	E371G	Gain of catalytic residue at K368 (P = 0.1218)| Loss of ubiquitination at K368 (P = 0.1441)| Loss of disorder (P = 0.1525)| Loss of stability (P = 0.1888)| Loss of solvent accessibility (P = 0.2732)	.	0.99984	.	0.89161	.	0.83227	0.692762076855	0.66045	T	0.967903	0.99628	D	0.547176	0.95618	D	0.548204	0.95554	D	0.998627662658691	0.94631	D	0.979822	0.97874	D	0.9570444	0.96933	0.96423674	0.99180	0.96220696	0.97461	0.9730768	0.99585	-14.553	0.94725	D	0.9066	0.84506	P	0.996053103753831	0.91813	0.99946970	0.99411	1	0.99985	.	.	.	.	.	.	6.233244	0.94852	34.0	0.99878933679182036	0.95576	0.968860	0.99128	D	0.853486478566183	0.89249	9.917884	0.74394164066324	0.85624	8.660572	4.25	4.25	0.49600	.	.	8.017	0.8876	7.887000	0.72871	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.997	0.79771	754	0.51253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided|Alexander_disease	no_classification_provided	NC_000017.11:g.44911251T>C	ClinGen:CA217115	C3661900|C0270726	203450	58	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	Glu	Gly	82.04	0.5567010309278351																																																																																																																																																																																																																																																																																																																																																																																																																																																																													108			82.04	Negatively-charged	Glutamic Acid		Glial fibrillary acidic protein							IF rod			-3.5								 E371-N375 (PAE:  3.0), E371-R367 (PAE: 2.0)		 E371-N375 (PAE:  3.0), E371-R367 (PAE: 2.0)								146									-59.0				-37.8	Coil 2B			dbSNP: rs267607526; Variant type: LP/P; AA change: Glu371Gln; PTM type: Ubiquitylation; PTM morphology: IATYRkLLE*GE; Var class: II&rs57815192		H (helix)	H (α-helix)												82.04	55.6701	70-90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.9583637544441004	0.9765457988849895	true	true	false
HBD	HBD_His147Arg	B_7-8	-0.8995045416635244	0.4030387608705062	0.49505082524930344	-2.980085016459047	0.024633926203302986	0.037841922606554314	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5502573740760899	0.5894656975550403	0.6708660357791172	0.6197970471427461	0.5587694297473572	0.6676656107514214	0.6541092337075507	0.549339699030795	0.6474467716948185	0.6414984917288518	0.5728479117417941	0.5679614824395891	0.681221987795292	0.5681991604639194	0.5921473225906737	0.7002335798293825	0.6060834833682867	0.5325532657125905	HBD	His147Arg	NC_000011.10:5232968:T:C	440A>G	11	5232968	T	C	11	ENSG00000223609	13796	218155	CCSBVarC006568	ALE00006567	ENSP00000497529.1	CEGS2	CegsMutGDEh1044	D08	GDEhDisVCh_40036	A02	2	CegsMutGDDh1044	D08	VUSN2Hmut_GDN2h_09	F06	VUSMutpDEST2_11	H06	VUSmut_GDEh09	F06	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	30118.0	single nucleotide variant	NM_000519.4(HBD):c.440A>G (p.His147Arg)	3045.0	HBD	HGNC:4829	other	0.0	Dec 12, 2017	34149886.0	-	RCV000016232	-	HEMOGLOBIN A(2) MONREALE	germline	germline	GRCh38	NC_000011.10	11	5232968.0	5232968.0	11p15.4	no assertion criteria provided	1.0	-	N	ClinGen:CA124697,UniProtKB:P02042#VAR_014278,OMIM:142000.0038	1.0	15079.0	5232968.0	T	C	-	-	-	-	-	-	440A>G 	His147Arg	NM_000519.4		Others	Others	15079	11	5232968.0	T	C	H	R	rs34149886	11	5254198	11	5210774	147	HBD	ENSG00000223609	ENST00000643122	ENSP00000494708	P02042	HBD_HUMAN	c.440A>G	p.His147Arg	c.440A>G	p.His147Arg	principal1	Y	.	.	.	-	CAT	2	0	T	T/T	T/T	T/T	T/T	.	.	.	.	.	.	0.991	0.64084	D	0.529	0.48507	P	.	.	.	.	.	.	1.79	0.46598	L	.	.	.	.	.	-0.1041	0.79914	T	0.5481	0.83355	D	9	0.8802111	0.87190	D	0.45626	0.94422	D	.	.	0.73	0.86307	P02042	H147R	Gain of MoRF binding (P = 5e-04)| Loss of ubiquitination at K145 (P = 0.02)| Loss of methylation at K145 (P = 0.0365)| Loss of catalytic residue at K145 (P = 0.0905)| Loss of disorder (P = 0.105)	.	.	0.3949765965400606	0.39210	.	.	0.581453025341	0.50224	T	0.107298	0.41642	T	0.388213	0.89146	D	0.319865	0.89010	D	0.962633311748505	0.66210	D	0.983668	0.94480	D	0.70266646	0.77951	0.6246989	0.77890	0.5763573	0.71119	0.5182667	0.71910	-3.026	0.10474	T	0.8655	0.80963	P	0.926991682794693	0.78134	0.99993682	0.99939	0.572	0.75942	.	.	.	.	.	.	2.093717	0.26684	17.19	0.98850095641993907	0.47372	0.321809	0.42257	N	-0.13883675355425	0.35436	2.054694	-0.181833930691103	0.31890	1.829894	4.8	2.35	0.28089	3.8	0.70283	1.723	0.3778	.	.	0.665	0.62996	0.972	0.3454	0.000000	0.08389	0.463	0.28235	867	0.32049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	HEMOGLOBIN_A(2)_MONREALE	no_assertion_criteria_provided	NC_000011.10:g.5232968T>C	ClinGen:CA124697|OMIM:142000.0038|UniProtKB:P02042#VAR_014278	.	.	.	Globin	His	Arg	73.43	1.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													223			73.43	Positively-charged	Histidine		Hemoglobin subunit delta							Globin			-3.2																		155									-133.9				360.0				dbSNP: rs34149886; Variant type: LB/B; AA change: His147Arg; PTM type: Acetylation; PTM morphology: NALAHkyH*___; Var class: II&rs34149886		C (loop/coil)	C (loop/coil)												73.43	100.0	70-90	$\geqslant$90		unknown		Rare genetic hematologic disease	1		false	0.5894656975550403	0.5502573740760899	false	false	false
FKBP6	FKBP6_Phe72Leu	B_15-16	24.901243029146652	4.295945124712945e-8	0.000010256568985252155	1.2627043281142978	0.24713081235233042	0.2963954514160303	2025_03_Batch_15-16	false	false	false	false	false	false	false	false	false	false	false	false	0.8682621949463748	0.883130586113485	0.7117794294170379	0.8928917662278975	0.8749949441951552	0.8611227630448846	0.7494104711528147	0.8298202178985437	0.8551860401325426	0.5950096275635957	0.8866414891052679	0.873316897199172	0.9728350549369544	0.9201696704917668	0.9305974923232523	0.82854923127048	0.8796196831217022	0.8632074926935775	FKBP6	Phe72Leu	NC_000007.14:73329400:C:A	216C>A	7	73329400	C	A	7	ENSG00000077800	10177	18108	CCSBVarC001583	ALE00001583	ENSP00000252037.4	RC4	RC4_Mut_GDEh1005	H10	GDEhDisVCh_40046	B09	2	RC4_Mut_GDDh1005	H10	NULL	NULL	VUSMutpDEST2_08	H09	VUSmut_GDEh12	F07	1.0	1.0	1.0	1.0	0.0			1.0	1.0	99.0	1.0	1.0	99.0	Y	Y	N	Y	Y																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												37			93.97	Aromatic	Phenylalanine		Inactive peptidyl-prolyl cis-trans isomerase FKBP6							PPIase FKBP-type			2.8								 F72-G63 (PAE:  1.0)	F72-G63 (PDBs: 3B7X)	 F72-G63 (PAE:  1.0)	F72-G63 (PDBs: 3B7X)							165									-76.8				-25.3						C (loop/coil)	S (bend)	Beta strand													NaN	NaN		unknown			0		true	0.883130586113485	0.8682621949463748	false	false	false
NCF2	NCF2_Gly44Arg	B_7-8	0.36919829546845473	0.7270989975657536	0.7828405216181451	-5.870756123067199	0.0020346534065706504	0.004293587097609837	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.7975272293668652	0.8341262257544821	0.49450080488512205	0.43803206125148136	0.4588680804297368	0.4896507098590367	0.5078176378350001	0.4638883324644484	0.4226113027269437	0.49365915516127207	0.826104796868622	0.7975272293668652	0.47148378188307327	0.4538478283950252	0.45345281977601903	0.49534245460897197	0.8421476546403424		NCF2	Gly44Arg	NC_000001.11:183590200:C:G	130G>C	1	183590200	C	G	1	ENSG00000116701	3727	214871	CCSBVarC003958	ALE00003958	ENSP00000356505.4	CEGS2	CegsMutGDEh1034	G01	GDEhDisVCh_40073	D06	1	CegsMutGDDh1034	G01	VUSN2Hmut_GDN2h_06	A07	VUSMutpDEST2_03	E11	VUSmut_GDEh06	A07	1.0	2.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	79378.0	single nucleotide variant	NM_000433.4(NCF2):c.130G>C (p.Gly44Arg)	4688.0	NCF2	HGNC:7661	not provided	0.0	-	137854510.0	-	RCV000059358	MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2	not provided	not provided	GRCh38	NC_000001.11	1	183590200.0	183590200.0	1q25.3	no classification provided	1.0	-	N	ClinGen:CA145207,UniProtKB:P19878#VAR_065004,UniProtKB/Swiss-Prot:VAR_065004	1.0	68486.0	183590200.0	C	G	-	-	-	-	-	-	130G>C 	Gly44Arg	NM_000433.4		Others	Others	68486	1	183590200.0	C	G	G	R	rs137854510	1	183559335	1	181825958	44	NCF2	ENSG00000116701	ENST00000367535	ENSP00000356505	P19878	NCF2_HUMAN	c.130G>C	p.Gly44Arg	c.130G>C	p.Gly44Arg	principal1	Y	1	YES	Select	-	GGC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	D	simple_aae	2.0	98.0	3.07	0.86962	M	-7.43	0.95681	D	0.98	0.99270	0.6574	0.92611	D	0.7153	0.90198	D	10	0.98834276	0.99240	D	0.153251	0.83409	D	0.904	0.97356	0.952	0.99445	P19878	G44R	Gain of helix (P = 0.0199)| Loss of sheet (P = 0.0228)| Loss of catalytic residue at C45 (P = 0.0468)| Gain of MoRF binding (P = 0.05)| Loss of loop (P = 0.0603)	0.941422388643	0.94034	0.9620274466081157	0.96166	1.14020912728	0.78780	0.633312404156	0.57549	T	0.68514	0.90701	D	0.405725	0.90172	D	0.34502	0.90049	D	0.998757600784302	0.95025	D	.	0.73936	.	0.98732555	0.99607	0.97105813	0.99502	0.9794891	0.99054	0.9665649	0.99297	-14.942	0.95724	D	0.9902	0.96039	P	0.989274941084943	0.88111	0.83529544	0.89238	0.879	0.93471	.	.	.	.	.	.	5.31216	0.89189	29.9	0.99938910881463805	0.99734	0.789685	0.71777	D	0.762412993494246	0.83622	8.089398	0.686175920367716	0.81227	7.501139	4.97	4.97	0.65374	3.66	0.67175	5.961	0.70144	7.590000	0.61281	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.947	0.4917	708	0.56870	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Granulomatous_disease,_chronic,_autosomal_recessive,_cytochrome_b-positive,_type_2	no_classification_provided	NC_000001.11:g.183590200C>G	ClinGen:CA145207|UniProtKB/Swiss-Prot:VAR_065004|UniProtKB:P19878#VAR_065004	C1856245	233710	379	.	Gly	Arg	97.66	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																																																													0			97.66	Special, lack of a chiral carbon, smallest amino acid, very flexible	Glycine		Neutrophil cytosol factor 2										-0.4								 G44-T48 (PAE:  1.0), G44-C40 (PAE: 1.0)	G44-C40 (PDBs: 1HH8, 1WM5, 1E96), G44-T48 (PDBs: 1WM5, 1E96)	 G44-T48 (PAE:  1.0), G44-C40 (PAE: 1.0)	G44-C40 (PDBs: 1HH8, 1WM5, 1E96), G44-T48 (PDBs: 1WM5, 1E96)							75									-60.0				-41.9			TPR 1			H (helix)	H (α-helix)	Helix											97.66	0.0	>90	<10	233710	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic skin disease	3	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2	false	0.8341262257544821	0.7975272293668652	false	false	false
NCF2	NCF2_Asp93Glu	B_7-8	2.79247555666314	0.038332618365722146	0.074862271041441	4.382797695014504	0.004654089805640097	0.008813472438957254	2024_01_Batch_7-8	false	false	false	false	false	false	false	false	false	false	false	false	0.5502868294344099	0.6583149283186411	0.6056524829138785	0.6508038839736954	0.7445785484955278	0.6478010412511696	0.7500153729554686	0.792555994320889	0.7412615202574947	0.6857173911000785	0.6253946862795292	0.5502868294344099	0.5455867095468705	0.6966011026701667	0.5603462476898962	0.5255875747276787	0.691235170357753		NCF2	Asp93Glu	NC_000001.11:183577686:G:C	279C>G	1	183577686	G	C	1	ENSG00000116701	3727	214874	CCSBVarC003959	ALE00003959	ENSP00000356505.4	CEGS2	CegsMutGDEh1034	F05	GDEhDisVCh_40073	F06	1	CegsMutGDDh1034	F05	VUSN2Hmut_GDN2h_06	D08	VUSMutpDEST2_03	G11	VUSmut_GDEh06	D08	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	79382.0	single nucleotide variant	NM_000433.4(NCF2):c.279C>G (p.Asp93Glu)	4688.0	NCF2	HGNC:7661	not provided	0.0	-	137854507.0	-	RCV000059362	MONDO:MONDO:0009310,MedGen:C1856245,OMIM:233710,Orphanet:379	Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2	germline	germline	GRCh38	NC_000001.11	1	183577686.0	183577686.0	1q25.3	no classification provided	1.0	-	N	ClinGen:CA145213,UniProtKB:P19878#VAR_065007,UniProtKB/Swiss-Prot:VAR_065007	1.0	68490.0	183577686.0	G	C	-	-	-	-	-	-	279C>G 	Asp93Glu	NM_000433.4		Others	Others	68490	1	183577686.0	G	C	D	E	rs137854507	1	183546821	1	181813444	93	NCF2	ENSG00000116701	ENST00000367536	ENSP00000356506	P19878	NCF2_HUMAN	c.279C>G	p.Asp93Glu	c.279C>G	p.Asp93Glu	principal1	Y	1	.	.	-	GAC	3	2	G	G/G	G/G	G/G	G/G	0.005	0.63383	D	0.023	0.65108	D	0.979	0.59057	D	0.928	0.66273	D	0.97	0.96253	D	simple_aae	3.0	97.0	2.965	0.85040	M	-3.62	0.69872	D	0.9	0.92554	-0.5437	0.66879	T	0.4068	0.75540	T	10	0.93079865	0.92334	D	0.048703	0.63354	D	0.439	0.74168	0.839	0.94511	P19878	D93E	Gain of ubiquitination at K95 (P = 0.0671)| Gain of disorder (P = 0.3552)| Gain of methylation at K95 (P = 0.4094)| Loss of MoRF binding (P = 0.5493)| Gain of glycosylation at K95 (P = 0.622)	0.717316383056	0.71259	.	0.63863	.	0.72577	0.56613945961	0.48066	T	0.455016	0.79279	T	0.165265	0.70472	D	-0.000384377	0.70092	D	0.973301112651825	0.69841	D	.	0.50927	.	0.779605	0.82413	0.65467584	0.79559	0.79297864	0.83253	0.5759541	0.75185	-11.194	0.80773	D	0.8797	0.85065	LP	0.736760076970171	0.68315	0.28160042	0.76248	0.293	0.56202	.	.	.	.	.	.	3.283499	0.45084	22.0	0.99617706966780528	0.75261	0.298819	0.40607	N	0.497341006874161	0.66760	5.014918	0.423176417459648	0.62812	4.526822	5.66	3.72	0.41790	-2.98	0.08616	1.112	0.30887	2.461000	0.32938	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.969	0.5403	729	0.54435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109398	0.000000e+00	0	0	208122	0.000000e+00	0	1	236944	4.220410e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13386	0.000000e+00	0	0	42766	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16726	0.000000e+00	0	0	89552	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21624	0.000000e+00	0	1	102748	9.732550e-06	0	0	30526	0.000000e+00	0	1	102748	9.732550e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Granulomatous_disease,_chronic,_autosomal_recessive,_cytochrome_b-positive,_type_2	no_classification_provided	NC_000001.11:g.183577686G>C	ClinGen:CA145213|UniProtKB/Swiss-Prot:VAR_065007|UniProtKB:P19878#VAR_065007	C1856245	233710	379	.	Asp	Glu	98.08	0.04294478527607362																																																																																																																																																																																																																																																																																																																																																																																																																																																																													7			98.08	Negatively-charged	Aspartic Acid		Neutrophil cytosol factor 2										-3.5								 D93-R77 (PAE:  1.0), D93-L89 (PAE: 1.0), D93-A97 (PAE: 1.0)	D93-A97 (PDBs: 1HH8, 1WM5, 1E96), D93-R77 (PDBs: 1WM5, 1E96), D93-L89 (PDBs: 1WM5, 1E96)	 D93-L89 (PAE:  1.0), D93-A97 (PAE: 1.0)	D93-A97 (PDBs: 1HH8, 1WM5, 1E96), D93-L89 (PDBs: 1WM5, 1E96)		D93-R77 (PDBs: 1E96)					132									-67.7				-38.7			TPR 2			H (helix)	H (α-helix)	Helix											98.08	4.2944784	>90	<10	233710	autosomal recessive	OMIM	Rare genetic eye disease; Rare genetic immune disease; Rare genetic skin disease	3	GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2	false	0.6583149283186411	0.5502868294344099	false	false	false
GFAP	GFAP_Glu210Lys	B_15-16	-0.5011658970741384	0.6316272307816764	0.7034449042524793	8.60442234465284	0.00005708819585793344	0.00026485053397642716	2025_03_Batch_15-16	false	false	false	false	false	true	false	false	false	false	false	false	0.7215216857319433	0.747332911424719	0.6943977171073442	0.7804050337804191	0.7090059335455698	0.8360448012674586	0.8571427516361864	0.7543559325302333	0.8364468305965287	0.7872702887583531	0.7678636504734861	0.7416340343610863	0.8149468508987308	0.6636559345609063	0.7243632369643096	0.6015251454563353	0.7268021723759519	0.7014093371028004	GFAP	Glu210Lys	NC_000017.11:44913421:C:T	628G>A	17	44913421	C	T	17	ENSG00000131095	2920	214419	CCSBVarC004666	ALE00004666	ENSP00000466598.2	CEGS2	CegsMutGDEh1046	H10	GDEhDisVCh_40051	E10	1	CegsMutGDDh1046	H10	VUSN2Hmut_GDN2h_10	D03	VUSMutpDEST2_03	C01	VUSmut_GDEh10	D03	1.0	1.0	1.0	2.0	1.0	1.0	6.0	1.0	1.0	1.0	1.0	1.0	1.0	Y	Y	Y	Y	Y	77390.0	single nucleotide variant	NM_002055.5(GFAP):c.628G>A (p.Glu210Lys)	2670.0	GFAP	HGNC:4235	not provided	0.0	-	57661783.0	-	RCV000192130|RCV000056894	MONDO:MONDO:0008752,MedGen:C0270726,OMIM:203450,Orphanet:58|MedGen:C3661900	Alexander disease|not provided	germline	germline	GRCh38	NC_000017.11	17	44913421.0	44913421.0	17q21.31	no classification provided	2.0	-	N	ClinGen:CA217203,UniProtKB:P14136#VAR_071542	3.0	66493.0	44913421.0	C	T	-	-	-	-	-	-	628G>A 	Glu210Lys	NM_002055.5		Others	Others	66493	17	44913421.0	C	T	E	K	rs57661783	17	42990789	17	40346315	210	GFAP	ENSG00000131095	ENST00000588735	ENSP00000466598	P14136	GFAP_HUMAN	c.628G>A	p.Glu210Lys	c.628G>A	p.Glu210Lys	principal1	Y	1	YES	Select	-	GAA	1	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.76775	.	0.989	0.62839	D	0.854	0.60860	P	0.79	0.99291	A	without_aae	21.0	79.0	3.38	0.91332	M	.	0.67045	.	.	0.97658	0.8753	0.95330	D	0.8517	0.95045	D	10	0.9520761	0.94487	D	0.287824	0.90436	D	.	0.98414	0.849	0.95116	P14136	E210K	Gain of MoRF binding (P = 0.0089)| Gain of ubiquitination at E210 (P = 0.0238)| Loss of stability (P = 0.1256)| Gain of relative solvent accessibility (P = 0.1894)| Gain of glycosylation at E210 (P = 0.2034)	.	0.99959	.	0.82240	.	0.68434	0.594271063805	0.52029	T	0.827003	0.95798	D	0.464769	0.93075	D	0.429832	0.92989	D	0.995338678359985	0.87134	D	0.986901	0.95587	D	0.93532485	0.94693	0.8697194	0.92750	0.92857796	0.94007	0.8847438	0.93812	-11.158	0.80579	D	0.5754	0.67806	P	0.87133744791572	0.74264	0.99922620	0.99231	0.984	0.99450	.	.	.	.	.	.	5.408771	0.90554	31.0	0.99929585084274875	0.99279	0.967047	0.98947	D	0.852146803815946	0.89171	9.887148	0.80927079240167	0.90378	10.40393	4.93	4.93	0.64349	3.93	0.74723	7.821	0.84821	7.692000	0.65892	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.936	0.47515	749	0.51874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Alexander_disease|not_provided	no_classification_provided	NC_000017.11:g.44913421C>T	ClinGen:CA217203|UniProtKB:P14136#VAR_071542	C0270726|C3661900	203450	58	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	Glu	Lys	93.15	0.5412371134020618																																																																																																																																																																																																																																																																																																																																																																																																																																																																													105			93.15	Negatively-charged	Glutamic Acid		Glial fibrillary acidic protein							IF rod			-3.5			E:E210-C:H108 (PDBs: 6A9P)					 E210-E206 (PAE:  1.0), E210-Q214 (PAE: 1.0)	E210-E206 (PDBs: 6A9P)	 E210-E206 (PAE:  1.0), E210-Q214 (PAE: 1.0)	E210-E206 (PDBs: 6A9P)							146									-63.0				-43.1	Coil 1B					H (helix)	H (α-helix)	Helix											93.15	54.12371	>90	10-90	203450	autosomal dominant	OMIM	Rare genetic eye disease; Rare genetic neurological disorder	2	ALEXANDER DISEASE	false	0.747332911424719	0.7215216857319433	false	false	false
F9	F9_Cys407Arg	B_13-14	-3.15553232850932	0.016027863050384276	0.03870191962861438	3.7082932702910565	0.007571818081638279	0.013489598232821594	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.8315540190729288	0.8397494537278893	0.6250377283499877	0.7564243134409758	0.7387968885000538	0.7111978103021757	0.822440830242546	0.7460249349473425	0.7543622789212834	0.7717196626824185	0.8061806614667125	0.7964358873211456	0.5999547903618054	0.731568842052765	0.7584863479606682	0.4783557940175568	0.873318245989066	0.866672150824712	F9	Cys407Arg	NC_000023.11:139561904:T:C	1219T>C	23	139561904	T	C	X	ENSG00000101981	52861	0	CCSBVarC002183	ALE00002183	ENSP00000218099.2	RC4	RC4_Mut_GDEh1022	F11	GDEhDisVCh_40052	E12	2	RC4_Mut_GDDh1022	F11	NULL	NULL	NULL	NULL	NULL	NULL	1.0	6.0	1.0	1.0	0.0			0.0			0.0			N	Y	N	N	N																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														0.897		0.734		0.658		0.589		0.651																																																						10			61.02	Special, a very reactive sulfhydryl group	Cysteine		Coagulation factor IX; Coagulation factor IXa heavy chain						Disulfide bond 407-435	Peptidase S1			2.5						 C407-C435 (PAE:  10.0)	C407-C435 (PDBs: 8OL9)				C407-R358 (PDBs: 8OL9), C407-C435 (PDBs: 8OL9), C407-F360 (PDBs: 8OL9)							121									-123.8				-179.1						C (loop/coil)	C (loop/coil)														NaN	NaN		unknown		Rare genetic hematologic disease	1		false	0.8397494537278893	0.8315540190729288	false	false	false
RAF1	RAF1_Asp486Asn	B_13-14	0.4532753332934534	1.0	1.0	-4.952038637737814	0.025081302731899485	0.03445326228195973	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.9036459446576601	0.8957363463660819	0.7091603364304322	0.8832242648260644	0.8399975187720778	0.8306734542412378	0.8744353097436036	0.8732020696533017	0.9149259009530769	0.7717066197988209	0.9058156718628944	0.9123646591132117	0.7869115987388721	0.8067929678908539	0.8515226286990519	0.6466140530620436	0.8856570208692695	0.8949272302021085	RAF1	Asp486Asn	NC_000003.12:12585761:C:T	1456G>A	3	12585761	C	T	3	ENSG00000132155	732	0	CCSBVarC003426	ALE00003426	ENSP00000251849.4	CEGS2	CegsMutGDEh1014	G11	GDEhDisVCh_40029	D08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	34193.0	single nucleotide variant	NM_002880.4(RAF1):c.1456G>A (p.Asp486Asn)	5894.0	RAF1	HGNC:9829	not provided	0.0	-	80338798.0	-	RCV000020506	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500	Noonan syndrome with multiple lentigines	unknown	unknown	GRCh38	NC_000003.12	3	12585761.0	12585761.0	3p25.2	no classification provided	1.0	-	N	ClinGen:CA341928,UniProtKB:P04049#VAR_037817	1.0	21341.0	12585761.0	C	T	-	-	-	-	-	-	1456G>A 	Asp486Asn	NM_002880.4		Others	Others	21341	3	12585761.0	C	T	D	N	rs80338798	3	12627260	3	12602260	486	RAF1	ENSG00000132155	ENST00000685653	ENSP00000509968	P04049	RAF1_HUMAN	.	.	c.1456G>A	p.Asp486Asn	principal3	Y	.	.	.	-	GAT	1	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.79703	.	1.0	0.90580	D	0.998	0.88579	D	.	0.92286	.	.	.	.	2.89	0.83536	M	.	0.78079	.	.	0.99419	0.9420	0.96265	D	0.9946	0.99877	D	9	.	0.99202	.	0.825636	0.98643	D	.	0.97963	0.968	0.99690	P04049	D486N	Gain of MoRF binding (P = 0.0343)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K483 (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of ubiquitination at K483 (P = 0.1041)	.	0.95330	.	0.98776	.	0.97323	0.879874408245	0.93935	D	0.949346	0.99250	D	0.270705	0.80361	D	0.151072	0.80106	D	0.998047471046448	0.93025	D	0.9975	0.98985	D	0.94164735	0.95344	0.889279	0.94137	0.94205755	0.95387	0.8781777	0.93345	-14.009	0.93099	D	.	0.98152	.	0.99999342572825	0.99831	0.99668110	0.98129	0.995	0.99826	.	.	.	.	.	.	5.650199	0.92811	33.0	0.99921808742760565	0.98788	0.892841	0.82954	D	1.01881719419438	0.96274	14.52467	0.933976822940601	0.96872	15.28689	5.26	5.26	0.73443	5.35	0.93259	7.9	0.86061	7.684000	0.65502	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	692	0.58673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Noonan_syndrome_with_multiple_lentigines	no_classification_provided	NC_000003.12:g.12585761C>T	ClinGen:CA341928|UniProtKB:P04049#VAR_037817	C0175704	PS151100	500	Protein kinase domain|Protein kinase domain|Protein kinase domain	Asp	Asn	81.82	0.36809815950920244																																																																																																																																																																																																																																																																																																																																																																																																																																																																													60			81.82	Negatively-charged	Aspartic Acid		RAF proto-oncogene serine/threonine-protein kinase							Protein kinase	0.8539		-3.5			C:D486-D:S27 (PDBs: 7Z38), D:D486-C:R30 (PDBs: 8GFT)	C:D486-D:S27 (PDBs: 7Z38), D:D486-C:S27 (PDBs: 8GAE, 8GFT), C:D486-D:D24 (PDBs: 8U1L)	D:D486-C:R30 (PDBs: 8GFT)			 D486-K375 (PAE:  4.0)	D486-S359 (PDBs: 3OMV), D486-N473 (PDBs: 8CHF, 8CPD), D486-H466 (PDBs: 8CPD)		D486-N473 (PDBs: 8CHF, 8CPD, 8U1L), D486-A490 (PDBs: 8U1L), D486-F475 (PDBs: 8U1L)							132									54.8		Pocket 1: Mean pLDDT: 90.5, Volume: 729.78 Å³, Druggability score: 0.85		24.6				dbSNP: rs397516815; Variant type: LP/P; AA change: Asp486Gly; PTM type: Phosphorylation; PTM morphology: LHEGLtVKIGD*; Var class: II&rs80338798		C (loop/coil)	S (bend)												81.82	36.80982	70-90	10-90		unknown		Rare genetic eye disease; Rare genetic cardiac disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Genetic otorhinolaryngologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; RASopathy; Genetic infertility; Rare genetic skin disease; Inherited cancer-predisposing syndrome	11		false	0.8957363463660819	0.9036459446576601	false	false	false
BRCA1	BRCA1_Glu631Lys	B_13-14	1.0983392108185215	0.30839265196900983	0.39558761938267883	2.674997253307021	0.031768731924692914	0.047389447104914856	2025_01_Batch_13-14	false	false	true	false	false	true	false	false	false	false	false	false	0.8077886481572274	0.8107547087002973	0.8848281637129479	0.8448373217568426	0.8904195005124751	0.9201427306069005	0.8644447517655387	0.8601741398830551	0.7088937168593722	0.8426384452538356	0.6830718548443322	0.6872196071937112	0.9758407094482623	0.9206648611418949	0.980780926654313	0.9270178821720603	0.9384375625562625	0.9283576891207437	BRCA1	Glu631Lys	NC_000017.11:43057126:C:T	1891G>A	17	43057126	C	T	17	ENSG00000012048	14613	0	CCSBVarC003307	ALE00003307	ENSP00000417148.1	CEGS2	CegsMutGDEh1026	D09	GDEhDisVCh_40059	A09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	0.0		0.0			0.0			0.0			Y	N	N	N	N	70122.0	single nucleotide variant	NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys)	672.0	BRCA1	HGNC:1100	not provided	0.0	-	397509238.0	-	RCV000577367|RCV001072517	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43057126.0	43057126.0	17q21.31	no classification provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003353,UniProtKB:P38398#VAR_070505	3.0	55455.0	43057126.0	C	T	-	-	-	-	-	-	5203G>A 	Glu1735Lys	NM_007294.4		Others	Others	55455	17	43057126.0	C	T	E	K	rs397509238	17	41209143	17	38462669	1735	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5203G>A	p.Glu1735Lys	principal2	Y	1	.	.	-	GAA	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.904	0.90580	P	0.17	0.88579	B	.	.	.	.	.	.	3.64	0.94011	H	.	0.66115	.	.	0.97441	1.0854	0.99062	D	0.9540	0.98504	D	10	.	0.91685	.	0.776902	0.98236	D	.	0.94374	.	.	.	.	.	.	0.94343	.	0.86555	.	0.10057	0.611799120903	0.54504	T	0.384042	0.81335	T	0.454957	0.92647	D	0.415738	0.92557	D	0.99232280254364	0.82639	D	.	0.97033	.	0.87069577	0.88763	0.49804372	0.70717	0.8283224	0.85601	0.4636008	0.68604	-14.271	0.93916	D	.	0.86411	.	0.997865992856704	0.93647	0.99988377	0.99849	0.931	0.96596	.	.	.	.	.	.	4.661471	0.74461	26.2	0.99903481763990787	0.97503	0.684509	0.64555	D	0.813291850711605	0.86860	9.046169	0.751252984158328	0.86175	8.829661	5.07	5.07	0.68064	3.31	0.60027	4.681	0.61438	7.412000	0.58717	0.593	0.32293	1.0	0.71675	1.000000	0.68239	1.0	0.97202	518	0.74567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	no_classification_provided	NC_000017.11:g.43057126C>T	ClinGen:CA003353|UniProtKB:P38398#VAR_070505	C0346153|C2676676	114480|604370	227535|145	BRCT domain	Glu	Lys	97.25	0.061855670103092786																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																97.25	6.185567	>90	<10	114480;604370	multiple	OMIM	Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic bone disease; Rare genetic hematologic disease; Rare genetic gastroenterological disease; Rare genetic skin disease; Rare genetic tumor; Inherited cancer-predisposing syndrome	8	BREAST CANCER; BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	false	0.8107547087002973	0.8077886481572274	false	false	false
F9	F9_Glu73Lys	B_13-14	-4.161802409004811	0.0042322222478180975	0.014175664544450435	2.4435122724149703	0.044528944535031575	0.06393631707494753	2025_01_Batch_13-14	false	false	false	false	false	false	false	false	false	false	false	false	0.6246741414969328	0.6688688485660916	0.6744978801615258	0.6072676689810004	0.7020938690793623	0.7106459882016363	0.7982637837266543	0.7136628173444881	0.6009693658956632	0.7474263886879824	0.6488139240426675	0.5978807091342411	0.6230281926766184	0.6905249208142366	0.6135659720663376	0.6015693716350692	0.6889237730895158	0.6514675738596246	F9	Glu73Lys	NC_000023.11:139537138:G:A	217G>A	23	139537138	G	A	X	ENSG00000101981	52861	0	CCSBVarC002180	ALE00002180	ENSP00000218099.2	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1.0	1.0	1.0	1.0	0.0			0.0			0.0			Y	Y	N	N	N																																											Others	Others																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														1.004		0.808		0.84		0.061	5 mutation(s) (Glu73Lys: -0.019, Glu73Trp: -0.013, Glu73Ala: -0.005, Glu73Tyr: -0.005, Glu73Cys: -0.004)	0.964	4 mutation(s) (Glu73Thr: 1.256, Glu73Asn: 1.284, Glu73Gly: 1.293, Glu73Ser: 1.308)																																																					79			86.94	Negatively-charged	Glutamic Acid	Ca(2+); Ca(2+)	Coagulation factor IX; Coagulation factor IXa light chain							Gla			-3.5										 E73-V77 (PAE:  1.5)							4-carboxyglutamate	146									-62.5				-41.0						H (helix)	H (α-helix)	Helix													NaN	NaN		unknown		Rare genetic hematologic disease	1		false	0.6688688485660916	0.6246741414969328	false	false	false
